id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
144360496|NCT01352117|520529228|FG000|Overall Study|Death|15|||
144360497|NCT01352117|520529229|FG001|Overall Study|Death|16|||
144360498|NCT01352117|520529228|FG000|Overall Study|Withdrawal by Subject|1|||
144360499|NCT01352117|520529229|FG001|Overall Study|Withdrawal by Subject|0|||
144360500|NCT01352117|520529228|FG000|Overall Study|Lost to Follow-up|2|||
144360501|NCT01352117|520529229|FG001|Overall Study|Lost to Follow-up|7|||
144360502|NCT01352117|520529228|FG000|Overall Study|Non-adherent to study requirements|1|||
144360503|NCT01352117|520529229|FG001|Overall Study|Non-adherent to study requirements|1|||
144360504|NCT01352117|520529228|FG000|Overall Study|Did not initiate study treatment|1|||
144360505|NCT01352117|520529229|FG001|Overall Study|Did not initiate study treatment|0|||
144360506|NCT01352117|520529228|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
144360507|NCT01352117|520529229|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
144360508|NCT01766050|520529230|FG000|Overall Study|Adverse Event|1|||
144360509|NCT01766050|520529230|FG000|Overall Study|Lost to Follow-up|1|||
144360510|NCT01766050|520529230|FG000|Overall Study|Withdrawal by Subject|2|||
144360511|NCT02546609|520529236|FG000|Overall Study|Withdrawal by Subject|0|||
144360512|NCT02546609|520529237|FG001|Overall Study|Withdrawal by Subject|1|||
144360513|NCT02546609|520529238|FG002|Overall Study|Withdrawal by Subject|2|||
144360514|NCT02546609|520529236|FG000|Overall Study|Adverse Event|0|||
144360515|NCT02546609|520529237|FG001|Overall Study|Adverse Event|6|||
144360516|NCT02546609|520529238|FG002|Overall Study|Adverse Event|1|||
144360517|NCT02546609|520529236|FG000|Overall Study|Protocol Violation|0|||
144360518|NCT02546609|520529237|FG001|Overall Study|Protocol Violation|1|||
144360519|NCT02546609|520529238|FG002|Overall Study|Protocol Violation|1|||
144360520|NCT02546609|520529236|FG000|Overall Study|Lost to Follow-up|2|||
144360521|NCT02546609|520529237|FG001|Overall Study|Lost to Follow-up|3|||
144360522|NCT02546609|520529238|FG002|Overall Study|Lost to Follow-up|1|||
144360523|NCT02546609|520529236|FG000|Overall Study|travel or work schedule restriction|0|||
144360524|NCT02546609|520529237|FG001|Overall Study|travel or work schedule restriction|0|||
144360525|NCT02546609|520529238|FG002|Overall Study|travel or work schedule restriction|2|||
144360526|NCT00914849|520529243|FG000|Overall Study|Withdrawal by Subject|1|||
144360527|NCT00914849|520529244|FG001|Overall Study|Withdrawal by Subject|0|||
144360528|NCT00914849|520529243|FG000|Overall Study|Not eligible|0|||
144360529|NCT00914849|520529244|FG001|Overall Study|Not eligible|1|||
144360530|NCT02388269|520529247|FG000|Overall Study|Adverse Event|2|||
144700179|NCT00563706|521756126|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
144700180|NCT00563706|521756127|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
144700181|NCT00563706|521756128|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
144700182|NCT00563706|521756129|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
144199186|NCT00321737|519926518|FG001|Overall Study|Protocol Violation|0|||
144360531|NCT02388269|520529248|FG001|Overall Study|Adverse Event|0|||
144360532|NCT02388269|520529249|FG002|Overall Study|Adverse Event|0|||
144360533|NCT02388269|520529247|FG000|Overall Study|Withdrawal by Subject|1|||
144360534|NCT02388269|520529248|FG001|Overall Study|Withdrawal by Subject|2|||
144360535|NCT02388269|520529249|FG002|Overall Study|Withdrawal by Subject|0|||
144360536|NCT02388269|520529247|FG000|Overall Study|less than 50% stimulations|1|||
144360537|NCT02388269|520529248|FG001|Overall Study|less than 50% stimulations|0|||
144360538|NCT02388269|520529249|FG002|Overall Study|less than 50% stimulations|0|||
144360539|NCT02388269|520529247|FG000|Overall Study|no diary data|3|||
144360540|NCT02388269|520529248|FG001|Overall Study|no diary data|0|||
144360541|NCT02388269|520529249|FG002|Overall Study|no diary data|0|||
144360542|NCT02388269|520529247|FG000|Overall Study|Protocol Violation|2|||
144360543|NCT02388269|520529248|FG001|Overall Study|Protocol Violation|0|||
144360544|NCT02388269|520529249|FG002|Overall Study|Protocol Violation|0|||
144360545|NCT02388269|520529247|FG000|Overall Study|Screen Failure|0|||
144360546|NCT02388269|520529248|FG001|Overall Study|Screen Failure|0|||
144360547|NCT02388269|520529249|FG002|Overall Study|Screen Failure|10|||
144360548|NCT03448406|520529250|FG000|Overall Study|Noncompliance of scheduled visits|1|||
144360549|NCT03448406|520529251|FG001|Overall Study|Noncompliance of scheduled visits|2|||
144360550|NCT03448406|520529250|FG000|Overall Study|Withdrawal by Subject|1|||
144360551|NCT03448406|520529251|FG001|Overall Study|Withdrawal by Subject|2|||
144360552|NCT03448406|520529250|FG000|Overall Study|Protocol Violation|1|||
144360553|NCT03448406|520529251|FG001|Overall Study|Protocol Violation|0|||
144360554|NCT03448406|520529250|FG000|Overall Study|Adverse Event|8|||
144360555|NCT03448406|520529251|FG001|Overall Study|Adverse Event|9|||
144360556|NCT01292486|520529252|FG000|Overall Study|Protocol Violation|2|||
144360557|NCT01292486|520529252|FG000|Overall Study|Did not meet screening criteria|2|||
144360558|NCT01292486|520529252|FG000|Overall Study|Adverse Event|1|||
144360559|NCT01292486|520529252|FG000|Overall Study|Physician Decision|1|||
144360560|NCT00087152|520529253|FG000|Overall Study|Ineligible|6|||
144360561|NCT04602390|520529254|FG000|Overall Study|Withdrawal by Subject|0|||
144360562|NCT04602390|520529255|FG001|Overall Study|Withdrawal by Subject|0|||
144360563|NCT04602390|520529256|FG002|Overall Study|Withdrawal by Subject|0|||
144360564|NCT04602390|520529257|FG003|Overall Study|Withdrawal by Subject|0|||
144586978|NCT00432666|521348705|FG000|Main Period|Adverse Event|1|||
144360565|NCT04602390|520529258|FG004|Overall Study|Withdrawal by Subject|1|||
144360566|NCT04602390|520529259|FG005|Overall Study|Withdrawal by Subject|0|||
144360567|NCT04602390|520529254|FG000|Overall Study|Adverse Event|0|||
144360568|NCT04602390|520529255|FG001|Overall Study|Adverse Event|0|||
144360569|NCT04602390|520529256|FG002|Overall Study|Adverse Event|0|||
144360570|NCT04602390|520529257|FG003|Overall Study|Adverse Event|0|||
144360571|NCT04602390|520529258|FG004|Overall Study|Adverse Event|0|||
144360572|NCT04602390|520529259|FG005|Overall Study|Adverse Event|1|||
144360573|NCT03882021|520529260|FG000|Enrollment|Procedure aborted/cancelled|2|||
144360574|NCT03882021|520529260|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
144360575|NCT03882021|520529260|FG000|Enrollment to 3-Month|Death|1|||
144360576|NCT03882021|520529260|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
144360577|NCT03882021|520529260|FG000|Enrollment to 3-Month|Missed Visit|4|||
144360578|NCT03882021|520529260|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
144360579|NCT03882021|520529260|FG000|6-Month to 12-Month Visit|Death|1|||
144360580|NCT03882021|520529260|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
144360581|NCT01546857|520529261|FG000|Overall Study|Withdrawal by Subject|2|||
144360582|NCT01546857|520529262|FG001|Overall Study|Withdrawal by Subject|3|||
144360583|NCT01149096|520529263|FG000|Overall Study|Lost to Follow-up|0|||
144360584|NCT01149096|520529264|FG001|Overall Study|Lost to Follow-up|1|||
144360585|NCT04914364|520529266|FG000|Overall Study|No longer eligible for study|1|||
144360586|NCT04914364|520529266|FG000|Overall Study|Lost to Follow-up|2|||
144360587|NCT02358473|520529267|FG000|Overall Study|Disease Progession|6|||
144360588|NCT02358473|520529267|FG000|Overall Study|Adverse Event|3|||
144360589|NCT02358473|520529267|FG000|Overall Study|Withdrawal by Subject|2|||
144360590|NCT02358473|520529267|FG000|Overall Study|Physician Decision|2|||
144360591|NCT01263769|520529270|FG000|Overall Study|Non-Compliant with treatment|1|||
144360592|NCT01346358|520529283|FG000|Overall Study|Withdrawal by Subject|1|||
144360593|NCT01346358|520529284|FG001|Overall Study|Withdrawal by Subject|0|||
144360594|NCT01346358|520529285|FG002|Overall Study|Withdrawal by Subject|1|||
144360595|NCT01346358|520529286|FG003|Overall Study|Withdrawal by Subject|1|||
144360596|NCT01346358|520529287|FG004|Overall Study|Withdrawal by Subject|0|||
144360597|NCT01346358|520529288|FG005|Overall Study|Withdrawal by Subject|2|||
144360598|NCT01346358|520529289|FG006|Overall Study|Withdrawal by Subject|1|||
144360599|NCT01346358|520529290|FG007|Overall Study|Withdrawal by Subject|1|||
144360600|NCT01346358|520529291|FG008|Overall Study|Withdrawal by Subject|1|||
144360601|NCT01346358|520529283|FG000|Overall Study|Adverse Event|1|||
144360602|NCT01346358|520529284|FG001|Overall Study|Adverse Event|0|||
144360603|NCT01346358|520529285|FG002|Overall Study|Adverse Event|0|||
144360604|NCT01346358|520529286|FG003|Overall Study|Adverse Event|0|||
144360605|NCT01346358|520529287|FG004|Overall Study|Adverse Event|1|||
144360606|NCT01346358|520529288|FG005|Overall Study|Adverse Event|0|||
144360607|NCT01346358|520529289|FG006|Overall Study|Adverse Event|0|||
144360608|NCT01346358|520529290|FG007|Overall Study|Adverse Event|0|||
144360609|NCT01346358|520529291|FG008|Overall Study|Adverse Event|1|||
144360610|NCT01346358|520529283|FG000|Overall Study|Non-Compliance|0|||
144360611|NCT01346358|520529284|FG001|Overall Study|Non-Compliance|0|||
144360612|NCT01346358|520529285|FG002|Overall Study|Non-Compliance|0|||
144360613|NCT01346358|520529286|FG003|Overall Study|Non-Compliance|0|||
144360614|NCT01346358|520529287|FG004|Overall Study|Non-Compliance|0|||
144360615|NCT01346358|520529288|FG005|Overall Study|Non-Compliance|0|||
144360616|NCT01346358|520529289|FG006|Overall Study|Non-Compliance|0|||
144360617|NCT01346358|520529290|FG007|Overall Study|Non-Compliance|2|||
144360618|NCT01346358|520529291|FG008|Overall Study|Non-Compliance|0|||
144360619|NCT01346358|520529283|FG000|Overall Study|Physician Decision|0|||
144360620|NCT01346358|520529284|FG001|Overall Study|Physician Decision|1|||
144360621|NCT01346358|520529285|FG002|Overall Study|Physician Decision|0|||
144360622|NCT01346358|520529286|FG003|Overall Study|Physician Decision|0|||
144360623|NCT01346358|520529287|FG004|Overall Study|Physician Decision|0|||
144360624|NCT01346358|520529288|FG005|Overall Study|Physician Decision|0|||
144360625|NCT01346358|520529289|FG006|Overall Study|Physician Decision|0|||
144360626|NCT01346358|520529290|FG007|Overall Study|Physician Decision|1|||
144360627|NCT01346358|520529291|FG008|Overall Study|Physician Decision|1|||
144360628|NCT05058365|520529294|FG000|Overall Study|Migration|1|||
144360629|NCT05058365|520529295|FG001|Overall Study|Migration|1|||
144360630|NCT00702702|520529298|FG000|Overall Study|Study prematurely terminated|56|||
144360631|NCT04819945|520529299|FG000|Overall Study|Lost to Follow-up|1|||
144360632|NCT00703014|520529300|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
144360633|NCT00703014|520529301|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
144360634|NCT00703014|520529302|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
144360635|NCT00703014|520529303|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
144360636|NCT00703014|520529300|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
144360637|NCT00703014|520529301|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
144360638|NCT00703014|520529302|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
144360639|NCT00703014|520529303|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
144360640|NCT02004236|520529306|FG000|Overall Study|Lack of Efficacy|0|||
144360641|NCT02004236|520529307|FG001|Overall Study|Lack of Efficacy|0|||
144360642|NCT02004236|520529308|FG002|Overall Study|Lack of Efficacy|16|||
144360643|NCT00625131|520529313|FG000|Overall Study|Lost to Follow-up|3|||
144360644|NCT00625131|520529314|FG001|Overall Study|Lost to Follow-up|2|||
144360645|NCT00625131|520529315|FG002|Overall Study|Lost to Follow-up|0|||
144360646|NCT00625131|520529313|FG000|Overall Study|Withdrawal by Subject|1|||
144360647|NCT00625131|520529314|FG001|Overall Study|Withdrawal by Subject|0|||
144360648|NCT00625131|520529315|FG002|Overall Study|Withdrawal by Subject|5|||
144360649|NCT00918281|520529318|FG000|Overall Study|Physician Decision|29|||
144360650|NCT01667900|520529319|FG000|Part B|Death|0|||
144586979|NCT00432666|521348706|FG001|Main Period|Adverse Event|1|||
144586980|NCT00432666|521348705|FG000|Main Period|Consent Withdrawn|1|||
144586981|NCT00432666|521348706|FG001|Main Period|Consent Withdrawn|0|||
144586982|NCT00432666|521348705|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
144586983|NCT00432666|521348706|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
144586984|NCT00432666|521348705|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
144586985|NCT00432666|521348706|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
144586986|NCT00432666|521348705|FG000|Open-Label Extension Period|Adverse Event|5|||
144586987|NCT00432666|521348706|FG001|Open-Label Extension Period|Adverse Event|0|||
144586988|NCT00432666|521348705|FG000|Open-Label Extension Period|Consent withdrawn|10|||
144586989|NCT00432666|521348706|FG001|Open-Label Extension Period|Consent withdrawn|0|||
144586990|NCT00432666|521348705|FG000|Open-Label Extension Period|Physician Decision|3|||
144586991|NCT00432666|521348706|FG001|Open-Label Extension Period|Physician Decision|0|||
144586992|NCT00978627|521348707|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
144586993|NCT00978627|521348708|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
144586994|NCT00978627|521348707|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
144586995|NCT00978627|521348708|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
144586996|NCT00978627|521348707|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
144586997|NCT00978627|521348708|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
144586998|NCT00978627|521348707|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
144586999|NCT00978627|521348708|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
144587000|NCT00978627|521348707|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
144587001|NCT00978627|521348708|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
144587002|NCT00978627|521348707|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
144587003|NCT00978627|521348708|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
144587004|NCT00978627|521348707|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
144587005|NCT00978627|521348708|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
144587006|NCT00978627|521348707|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
144587007|NCT00978627|521348708|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
144587008|NCT00978627|521348707|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
144587009|NCT00978627|521348708|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
144587010|NCT00565851|521348709|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
144587011|NCT00565851|521348710|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
144587012|NCT00565851|521348711|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
144587013|NCT00565851|521348712|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
144587014|NCT00565851|521348713|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
144587015|NCT00565851|521348714|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
144587016|NCT00565851|521348715|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
144587017|NCT00565851|521348716|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
144587018|NCT00565851|521348709|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
144587019|NCT00565851|521348710|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
144587020|NCT00565851|521348711|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
144587021|NCT00565851|521348712|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
144587022|NCT00565851|521348713|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
144587023|NCT00565851|521348714|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
144587024|NCT00565851|521348715|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
144587025|NCT00565851|521348716|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
144587026|NCT02233543|521348717|FG000|Period 1|Withdrawal by Subject|1|||
144587027|NCT02233543|521348718|FG001|Period 1|Withdrawal by Subject|0|||
144587028|NCT02233543|521348717|FG000|Period 1|Participants required other treatment.|2|||
144587029|NCT02233543|521348718|FG001|Period 1|Participants required other treatment.|3|||
144587030|NCT02233543|521348717|FG000|Period 2|Adverse Event|1|||
144587031|NCT02233543|521348718|FG001|Period 2|Adverse Event|0|||
144587032|NCT02233543|521348717|FG000|Period 2|Participant required other treatment.|0|||
144587033|NCT02233543|521348718|FG001|Period 2|Participant required other treatment.|1|||
144587034|NCT02233543|521348717|FG000|Period 2|COPD exacerbation|1|||
144587035|NCT02233543|521348718|FG001|Period 2|COPD exacerbation|0|||
144587036|NCT00603304|521348719|FG000|Overall Study|Lost to Follow-up|5|||
144587037|NCT00603304|521348720|FG001|Overall Study|Lost to Follow-up|7|||
144587038|NCT00603304|521348719|FG000|Overall Study|Withdrawal by Subject|8|||
144587039|NCT00603304|521348720|FG001|Overall Study|Withdrawal by Subject|5|||
144587040|NCT00603304|521348719|FG000|Overall Study|Protocol Violation|1|||
144360651|NCT01667900|520529320|FG001|Part B|Death|0|||
144360652|NCT01667900|520529321|FG002|Part B|Death|0|||
144587041|NCT00603304|521348720|FG001|Overall Study|Protocol Violation|0|||
144587042|NCT00603304|521348719|FG000|Overall Study|Adverse Event|4|||
144587043|NCT00603304|521348720|FG001|Overall Study|Adverse Event|2|||
144587044|NCT00603304|521348719|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
144587045|NCT00603304|521348720|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
144587046|NCT00603304|521348719|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
144587047|NCT00603304|521348720|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
144587048|NCT00603304|521348719|FG000|Overall Study|Exclusionary Medication|2|||
144587049|NCT00603304|521348720|FG001|Overall Study|Exclusionary Medication|3|||
144587050|NCT00603304|521348719|FG000|Overall Study|Non-Compliant|0|||
144587051|NCT00603304|521348720|FG001|Overall Study|Non-Compliant|1|||
144587052|NCT00603304|521348719|FG000|Overall Study|Moved Away|0|||
144587053|NCT00603304|521348720|FG001|Overall Study|Moved Away|2|||
144587054|NCT00603304|521348719|FG000|Overall Study|Other|2|||
144587055|NCT00603304|521348720|FG001|Overall Study|Other|0|||
144587056|NCT00603304|521348719|FG000|Overall Study|Patient Decision|2|||
144587057|NCT00603304|521348720|FG001|Overall Study|Patient Decision|0|||
144587058|NCT01076192|521348721|FG000|Overall Study|Other|197|||
144587059|NCT01034176|521348722|FG000|Overall Study|Physician Decision|2|||
144587060|NCT01034176|521348723|FG001|Overall Study|Physician Decision|0|||
144587061|NCT01034176|521348722|FG000|Overall Study|Withdrawal by Subject|0|||
144587062|NCT01034176|521348723|FG001|Overall Study|Withdrawal by Subject|1|||
144587063|NCT01034176|521348722|FG000|Overall Study|Lost to Follow-up|0|||
144587064|NCT01034176|521348723|FG001|Overall Study|Lost to Follow-up|1|||
144587065|NCT05087979|521348726|FG000|Overall Study|Converted to general anesthesia|1|||
144587066|NCT05087979|521348727|FG001|Overall Study|Converted to general anesthesia|0|||
144587067|NCT00616902|521348728|FG000|Overall Study|Termination of study|6|||
144587068|NCT00616902|521348729|FG001|Overall Study|Termination of study|6|||
144587069|NCT02680002|521348731|FG000|Overall Study|Lost to Follow-up|5|||
144587070|NCT02680002|521348732|FG001|Overall Study|Lost to Follow-up|1|||
144587071|NCT02680002|521348733|FG002|Overall Study|Lost to Follow-up|4|||
144587072|NCT02680002|521348734|FG003|Overall Study|Lost to Follow-up|2|||
144587073|NCT02680002|521348735|FG004|Overall Study|Lost to Follow-up|0|||
144587074|NCT02680002|521348736|FG005|Overall Study|Lost to Follow-up|2|||
144587075|NCT02680002|521348731|FG000|Overall Study|Physician Decision|5|||
144587076|NCT02680002|521348732|FG001|Overall Study|Physician Decision|1|||
144587077|NCT02680002|521348733|FG002|Overall Study|Physician Decision|1|||
144587078|NCT02680002|521348734|FG003|Overall Study|Physician Decision|1|||
144587079|NCT02680002|521348735|FG004|Overall Study|Physician Decision|1|||
144587080|NCT02680002|521348736|FG005|Overall Study|Physician Decision|1|||
144587081|NCT02680002|521348731|FG000|Overall Study|Protocol Violation|1|||
144587082|NCT02680002|521348732|FG001|Overall Study|Protocol Violation|0|||
144587083|NCT02680002|521348733|FG002|Overall Study|Protocol Violation|1|||
144473704|NCT01108458|520934074|FG000|Overall Study|Withdrawal by Subject|1|||
144473705|NCT05044325|520934082|FG000|Part A:Treatment Period 1|Adverse Event|0|||
144473706|NCT05044325|520934083|FG001|Part A:Treatment Period 1|Adverse Event|0|||
144473707|NCT05044325|520934084|FG002|Part A:Treatment Period 1|Adverse Event|0|||
144473708|NCT05044325|520934085|FG003|Part A:Treatment Period 1|Adverse Event|0|||
144473709|NCT05044325|520934086|FG004|Part A:Treatment Period 1|Adverse Event|0|||
144473710|NCT05044325|520934087|FG005|Part A:Treatment Period 1|Adverse Event|1|||
144473711|NCT05044325|520934088|FG006|Part A:Treatment Period 1|Adverse Event|0|||
144473712|NCT05044325|520934089|FG007|Part A:Treatment Period 1|Adverse Event|1|||
144473713|NCT05044325|520934090|FG008|Part A:Treatment Period 1|Adverse Event|0|||
144473714|NCT05044325|520934091|FG009|Part A:Treatment Period 1|Adverse Event|0|||
144473715|NCT05044325|520934082|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473716|NCT05044325|520934083|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473717|NCT05044325|520934084|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473718|NCT05044325|520934085|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
144473719|NCT05044325|520934086|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
144473720|NCT05044325|520934087|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
144473721|NCT05044325|520934088|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473722|NCT05044325|520934089|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473723|NCT05044325|520934090|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473724|NCT05044325|520934091|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
144473725|NCT05044325|520934082|FG000|Part A:Treatment Period 1|Physician Decision|0|||
144473726|NCT05044325|520934083|FG001|Part A:Treatment Period 1|Physician Decision|0|||
144473727|NCT05044325|520934084|FG002|Part A:Treatment Period 1|Physician Decision|0|||
144473728|NCT05044325|520934085|FG003|Part A:Treatment Period 1|Physician Decision|0|||
144587084|NCT02680002|521348734|FG003|Overall Study|Protocol Violation|0|||
144587085|NCT02680002|521348735|FG004|Overall Study|Protocol Violation|1|||
144587086|NCT02680002|521348736|FG005|Overall Study|Protocol Violation|2|||
144587087|NCT02680002|521348731|FG000|Overall Study|Withdrawal by Subject|0|||
144587088|NCT02680002|521348732|FG001|Overall Study|Withdrawal by Subject|0|||
144587089|NCT02680002|521348733|FG002|Overall Study|Withdrawal by Subject|1|||
144587090|NCT02680002|521348734|FG003|Overall Study|Withdrawal by Subject|0|||
144587091|NCT02680002|521348735|FG004|Overall Study|Withdrawal by Subject|2|||
144587092|NCT02680002|521348736|FG005|Overall Study|Withdrawal by Subject|2|||
144587093|NCT02680002|521348731|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
144587094|NCT02680002|521348732|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
144587095|NCT02680002|521348733|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
144587096|NCT02680002|521348734|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
144587097|NCT02680002|521348735|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
144587098|NCT02680002|521348736|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
144587099|NCT02680002|521348731|FG000|Overall Study|Other|0|||
144587100|NCT02680002|521348732|FG001|Overall Study|Other|1|||
144587101|NCT02680002|521348733|FG002|Overall Study|Other|0|||
144587102|NCT02680002|521348734|FG003|Overall Study|Other|0|||
144587103|NCT02680002|521348735|FG004|Overall Study|Other|1|||
144587104|NCT02680002|521348736|FG005|Overall Study|Other|0|||
144587105|NCT02680002|521348731|FG000|Overall Study|Adverse Event|0|||
144587106|NCT02680002|521348732|FG001|Overall Study|Adverse Event|0|||
144587107|NCT02680002|521348733|FG002|Overall Study|Adverse Event|0|||
144587108|NCT02680002|521348734|FG003|Overall Study|Adverse Event|0|||
144587109|NCT02680002|521348735|FG004|Overall Study|Adverse Event|1|||
144587110|NCT02680002|521348736|FG005|Overall Study|Adverse Event|2|||
144587111|NCT00705679|521348737|FG000|Overall Study|Adverse Event|1|||
144587112|NCT00705679|521348738|FG001|Overall Study|Adverse Event|1|||
144587113|NCT00705679|521348739|FG002|Overall Study|Adverse Event|0|||
144587114|NCT00705679|521348740|FG003|Overall Study|Adverse Event|0|||
144587115|NCT00705679|521348741|FG004|Overall Study|Adverse Event|0|||
144587116|NCT00705679|521348737|FG000|Overall Study|Death|0|||
144587117|NCT00705679|521348738|FG001|Overall Study|Death|0|||
144587118|NCT00705679|521348739|FG002|Overall Study|Death|3|||
144587119|NCT00705679|521348740|FG003|Overall Study|Death|2|||
144587120|NCT00705679|521348741|FG004|Overall Study|Death|1|||
144587121|NCT00705679|521348737|FG000|Overall Study|Lost to Follow-up|32|||
144587122|NCT00705679|521348738|FG001|Overall Study|Lost to Follow-up|60|||
144587123|NCT00705679|521348739|FG002|Overall Study|Lost to Follow-up|44|||
144587124|NCT00705679|521348740|FG003|Overall Study|Lost to Follow-up|30|||
144587125|NCT00705679|521348741|FG004|Overall Study|Lost to Follow-up|35|||
144587126|NCT00705679|521348737|FG000|Overall Study|Physician Decision|0|||
144587127|NCT00705679|521348738|FG001|Overall Study|Physician Decision|1|||
144587128|NCT00705679|521348739|FG002|Overall Study|Physician Decision|0|||
144587129|NCT00705679|521348740|FG003|Overall Study|Physician Decision|1|||
144587130|NCT00705679|521348741|FG004|Overall Study|Physician Decision|0|||
144587131|NCT00705679|521348737|FG000|Overall Study|Withdrawal by Subject|32|||
144587132|NCT00705679|521348738|FG001|Overall Study|Withdrawal by Subject|77|||
144587133|NCT00705679|521348739|FG002|Overall Study|Withdrawal by Subject|68|||
144587134|NCT00705679|521348740|FG003|Overall Study|Withdrawal by Subject|47|||
144587135|NCT00705679|521348741|FG004|Overall Study|Withdrawal by Subject|33|||
144587136|NCT03730480|521348744|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
144587137|NCT01248780|521348745|FG000|Overall Study|Lack of Efficacy|2|||
144587138|NCT01248780|521348746|FG001|Overall Study|Lack of Efficacy|0|||
144587139|NCT01248780|521348745|FG000|Overall Study|Lost to Follow-up|0|||
144587140|NCT01248780|521348746|FG001|Overall Study|Lost to Follow-up|1|||
144587141|NCT01248780|521348745|FG000|Overall Study|Death|0|||
144587142|NCT01248780|521348746|FG001|Overall Study|Death|1|||
144587143|NCT01248780|521348745|FG000|Overall Study|Adverse Event|2|||
144587144|NCT01248780|521348746|FG001|Overall Study|Adverse Event|7|||
144587145|NCT01248780|521348745|FG000|Overall Study|Protocol Violation|1|||
144587146|NCT01248780|521348746|FG001|Overall Study|Protocol Violation|1|||
144587147|NCT01248780|521348745|FG000|Overall Study|Withdrawal by Subject|4|||
144473729|NCT05044325|520934086|FG004|Part A:Treatment Period 1|Physician Decision|0|||
144473730|NCT05044325|520934087|FG005|Part A:Treatment Period 1|Physician Decision|0|||
144473731|NCT05044325|520934088|FG006|Part A:Treatment Period 1|Physician Decision|1|||
144473732|NCT05044325|520934089|FG007|Part A:Treatment Period 1|Physician Decision|0|||
144473733|NCT05044325|520934090|FG008|Part A:Treatment Period 1|Physician Decision|0|||
144473734|NCT05044325|520934091|FG009|Part A:Treatment Period 1|Physician Decision|0|||
144473735|NCT05044325|520934082|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473736|NCT05044325|520934083|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473737|NCT05044325|520934084|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
144473738|NCT05044325|520934085|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473739|NCT05044325|520934086|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473740|NCT05044325|520934087|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473741|NCT05044325|520934088|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473742|NCT05044325|520934089|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473743|NCT05044325|520934090|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473744|NCT05044325|520934091|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
144473745|NCT05044325|520934082|FG000|Part A:Treatment Period 2|Adverse Event|0|||
144587148|NCT01248780|521348746|FG001|Overall Study|Withdrawal by Subject|4|||
144587149|NCT01248780|521348745|FG000|Overall Study|Not treated|0|||
144587150|NCT01248780|521348746|FG001|Overall Study|Not treated|1|||
144700183|NCT00563706|521756130|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
144473746|NCT05044325|520934083|FG001|Part A:Treatment Period 2|Adverse Event|1|||
144587151|NCT04097301|521348747|FG000|Overall Study|Death|1|||
144587152|NCT04097301|521348747|FG000|Overall Study|Withdrawal by Subject|1|||
144587153|NCT04097301|521348747|FG000|Overall Study|Screening Failure|5|||
144587154|NCT01227577|521348748|FG000|Overall Study|Protocol deviation|3|||
144587155|NCT01227577|521348748|FG000|Overall Study|Death|3|||
144587156|NCT01227577|521348748|FG000|Overall Study|Administrative problems|2|||
144587157|NCT01227577|521348748|FG000|Overall Study|Lost to Follow-up|1|||
144587158|NCT01227577|521348748|FG000|Overall Study|Withdrawal by Subject|4|||
144587159|NCT01227577|521348748|FG000|Overall Study|Lack of Efficacy|5|||
144587160|NCT01227577|521348748|FG000|Overall Study|Adverse Event|17|||
144473747|NCT05044325|520934084|FG002|Part A:Treatment Period 2|Adverse Event|0|||
144473748|NCT05044325|520934085|FG003|Part A:Treatment Period 2|Adverse Event|0|||
144473749|NCT05044325|520934086|FG004|Part A:Treatment Period 2|Adverse Event|1|||
144473750|NCT05044325|520934087|FG005|Part A:Treatment Period 2|Adverse Event|1|||
144473751|NCT05044325|520934088|FG006|Part A:Treatment Period 2|Adverse Event|0|||
144473752|NCT05044325|520934089|FG007|Part A:Treatment Period 2|Adverse Event|0|||
144473753|NCT05044325|520934090|FG008|Part A:Treatment Period 2|Adverse Event|0|||
144473754|NCT05044325|520934091|FG009|Part A:Treatment Period 2|Adverse Event|0|||
144473755|NCT05044325|520934082|FG000|Part A:Treatment Period 2|Physician Decision|0|||
144473756|NCT05044325|520934083|FG001|Part A:Treatment Period 2|Physician Decision|0|||
144473757|NCT05044325|520934084|FG002|Part A:Treatment Period 2|Physician Decision|0|||
144473758|NCT05044325|520934085|FG003|Part A:Treatment Period 2|Physician Decision|0|||
144473759|NCT05044325|520934086|FG004|Part A:Treatment Period 2|Physician Decision|0|||
144473760|NCT05044325|520934087|FG005|Part A:Treatment Period 2|Physician Decision|1|||
144473761|NCT05044325|520934088|FG006|Part A:Treatment Period 2|Physician Decision|0|||
144473762|NCT05044325|520934089|FG007|Part A:Treatment Period 2|Physician Decision|0|||
144473763|NCT05044325|520934090|FG008|Part A:Treatment Period 2|Physician Decision|0|||
144587161|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
144587162|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
144587163|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
144587164|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
144587165|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
144587166|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
144587167|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
144587168|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
144587169|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
144587170|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
144587171|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
144587172|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
144587173|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
144587174|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
144473764|NCT05044325|520934091|FG009|Part A:Treatment Period 2|Physician Decision|0|||
144587175|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
144587176|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
144587177|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
144587178|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
144587179|NCT02480153|521348749|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
144587180|NCT02480153|521348750|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
144587181|NCT02480153|521348751|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
144587182|NCT02480153|521348749|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
144587183|NCT02480153|521348750|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
144587184|NCT02480153|521348751|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
144587185|NCT02480153|521348749|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
144587186|NCT02480153|521348750|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
144587187|NCT02480153|521348751|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
144587188|NCT02480153|521348749|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
144587189|NCT02480153|521348750|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
144587190|NCT02480153|521348751|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
144587191|NCT02480153|521348749|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
144587192|NCT02480153|521348750|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
144587193|NCT02480153|521348751|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
144587194|NCT02480153|521348749|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
144587195|NCT02480153|521348750|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
144587196|NCT02480153|521348751|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
144700184|NCT00563706|521756131|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
144473765|NCT05044325|520934082|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144587197|NCT02480153|521348749|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
144587198|NCT02480153|521348750|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
144587199|NCT02480153|521348751|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
144587200|NCT02480153|521348749|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
144587201|NCT02480153|521348750|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
144587202|NCT02480153|521348751|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
144587203|NCT02480153|521348749|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
144587204|NCT02480153|521348750|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
144587205|NCT02480153|521348751|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
144587206|NCT02480153|521348749|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
144587207|NCT02480153|521348750|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
144587208|NCT02480153|521348751|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
144587209|NCT02480153|521348749|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
144587210|NCT02480153|521348750|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
144587211|NCT02480153|521348751|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
144587212|NCT02480153|521348749|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
144587213|NCT02480153|521348750|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
144587214|NCT02480153|521348751|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
144587215|NCT03241225|521348752|FG000|Overall Study|Lost to Follow-up|2|||
144587216|NCT03241225|521348753|FG001|Overall Study|Lost to Follow-up|1|||
144587217|NCT03241225|521348752|FG000|Overall Study|Protocol Violation|4|||
144587218|NCT03241225|521348753|FG001|Overall Study|Protocol Violation|1|||
144587219|NCT03241225|521348752|FG000|Overall Study|Withdrawal by Subject|1|||
144587220|NCT03241225|521348753|FG001|Overall Study|Withdrawal by Subject|0|||
144587221|NCT00852540|521348754|FG000|Overall Study|Adverse Event|10|||
144587222|NCT00852540|521348755|FG001|Overall Study|Adverse Event|3|||
144587223|NCT00852540|521348754|FG000|Overall Study|Lack of Efficacy|15|||
144587224|NCT00852540|521348755|FG001|Overall Study|Lack of Efficacy|3|||
144587225|NCT00852540|521348754|FG000|Overall Study|Protocol Violation|1|||
144587226|NCT00852540|521348755|FG001|Overall Study|Protocol Violation|2|||
144587227|NCT00852540|521348754|FG000|Overall Study|Lost to Follow-up|2|||
144587228|NCT00852540|521348755|FG001|Overall Study|Lost to Follow-up|3|||
144587229|NCT00852540|521348754|FG000|Overall Study|Investigator Discretion|2|||
144587230|NCT00852540|521348755|FG001|Overall Study|Investigator Discretion|3|||
144587231|NCT00852540|521348754|FG000|Overall Study|Withdrawal by Subject|3|||
144587232|NCT00852540|521348755|FG001|Overall Study|Withdrawal by Subject|1|||
144587233|NCT00852540|521348754|FG000|Overall Study|Did Not Receive Study Drug|3|||
144587234|NCT00852540|521348755|FG001|Overall Study|Did Not Receive Study Drug|3|||
144587235|NCT01119105|521348756|FG000|Overall Study|Withdrawal by Subject|1|||
144587236|NCT01119105|521348757|FG001|Overall Study|Withdrawal by Subject|1|||
144587237|NCT01119105|521348758|FG002|Overall Study|Withdrawal by Subject|1|||
144587238|NCT01119105|521348756|FG000|Overall Study|Lost to Follow-up|0|||
144587239|NCT01119105|521348757|FG001|Overall Study|Lost to Follow-up|2|||
144587240|NCT01119105|521348758|FG002|Overall Study|Lost to Follow-up|5|||
144587241|NCT01119105|521348756|FG000|Overall Study|Adverse Event|1|||
144587242|NCT01119105|521348757|FG001|Overall Study|Adverse Event|0|||
144587243|NCT01119105|521348758|FG002|Overall Study|Adverse Event|1|||
144587244|NCT01119105|521348756|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
144587245|NCT01119105|521348757|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
144587246|NCT01119105|521348758|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
144587247|NCT01119105|521348756|FG000|Overall Study|Other|1|||
144587248|NCT01119105|521348757|FG001|Overall Study|Other|1|||
144587249|NCT01119105|521348758|FG002|Overall Study|Other|0|||
144587250|NCT01639495|521348759|FG000|Overall Study|Lost to Follow-up|6|||
144587251|NCT01639495|521348759|FG000|Overall Study|Consented but didn't have study catheter|4|||
144587252|NCT01639495|521348759|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
144587253|NCT01639495|521348759|FG000|Overall Study|No radiofrequency energy applied|2|||
144587254|NCT04214600|521348762|FG000|Overall Study|Lost to Follow-up|9|||
144587255|NCT04214600|521348763|FG001|Overall Study|Lost to Follow-up|14|||
144587256|NCT01635920|521348770|FG000|Overall Study|Adverse Event|1|||
144587257|NCT01635920|521348771|FG001|Overall Study|Adverse Event|0|||
144587258|NCT01635920|521348770|FG000|Overall Study|Lost to Follow-up|0|||
144587259|NCT01635920|521348771|FG001|Overall Study|Lost to Follow-up|1|||
144587260|NCT01635920|521348770|FG000|Overall Study|Subject decision|2|||
144587261|NCT01635920|521348771|FG001|Overall Study|Subject decision|0|||
144587262|NCT01813929|521348773|FG000|Overall Study|Withdrawal by Subject|0|||
144587263|NCT01813929|521348774|FG001|Overall Study|Withdrawal by Subject|1|||
144587264|NCT00007345|521348775|FG000|Overall Study|Refused further treatment|0|||
144587265|NCT00007345|521348776|FG001|Overall Study|Refused further treatment|7|||
144587266|NCT00007345|521348775|FG000|Overall Study|Switched to alternative treatment|0|||
144587267|NCT00007345|521348776|FG001|Overall Study|Switched to alternative treatment|3|||
144587268|NCT00007345|521348775|FG000|Overall Study|Intercurrent illness|1|||
144700185|NCT00563706|521756132|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
144587269|NCT00007345|521348776|FG001|Overall Study|Intercurrent illness|0|||
144587270|NCT00007345|521348775|FG000|Overall Study|Death on study|1|||
144587271|NCT00007345|521348776|FG001|Overall Study|Death on study|1|||
144587272|NCT04433585|521348777|FG000|Overall Study|Withdrawal by Subject|15|||
144587273|NCT04433585|521348778|FG001|Overall Study|Withdrawal by Subject|3|||
144587274|NCT04433585|521348779|FG002|Overall Study|Withdrawal by Subject|15|||
144587275|NCT04433585|521348780|FG003|Overall Study|Withdrawal by Subject|6|||
144587276|NCT04433585|521348777|FG000|Overall Study|Adverse Event|10|||
144587277|NCT04433585|521348778|FG001|Overall Study|Adverse Event|4|||
144587278|NCT04433585|521348779|FG002|Overall Study|Adverse Event|1|||
144587279|NCT04433585|521348780|FG003|Overall Study|Adverse Event|0|||
144587280|NCT04433585|521348777|FG000|Overall Study|Due to the conflict in Ukraine|2|||
144587281|NCT04433585|521348778|FG001|Overall Study|Due to the conflict in Ukraine|1|||
144587282|NCT04433585|521348779|FG002|Overall Study|Due to the conflict in Ukraine|1|||
144587283|NCT04433585|521348780|FG003|Overall Study|Due to the conflict in Ukraine|2|||
144587284|NCT04433585|521348777|FG000|Overall Study|Physician Decision|1|||
144587285|NCT04433585|521348778|FG001|Overall Study|Physician Decision|2|||
144587286|NCT04433585|521348779|FG002|Overall Study|Physician Decision|0|||
144587287|NCT04433585|521348780|FG003|Overall Study|Physician Decision|0|||
144587288|NCT04433585|521348777|FG000|Overall Study|Lost to Follow-up|1|||
144587289|NCT04433585|521348778|FG001|Overall Study|Lost to Follow-up|1|||
144587290|NCT04433585|521348779|FG002|Overall Study|Lost to Follow-up|1|||
144587291|NCT04433585|521348780|FG003|Overall Study|Lost to Follow-up|0|||
144587292|NCT04433585|521348777|FG000|Overall Study|Lack of Efficacy|0|||
144587293|NCT04433585|521348778|FG001|Overall Study|Lack of Efficacy|1|||
144587294|NCT04433585|521348779|FG002|Overall Study|Lack of Efficacy|1|||
144587295|NCT04433585|521348780|FG003|Overall Study|Lack of Efficacy|1|||
144587296|NCT04433585|521348777|FG000|Overall Study|Death|0|||
144587297|NCT04433585|521348778|FG001|Overall Study|Death|1|||
144587298|NCT04433585|521348779|FG002|Overall Study|Death|0|||
144587299|NCT04433585|521348780|FG003|Overall Study|Death|0|||
144587300|NCT02342743|521348781|FG000|Baseline Period|Withdrawal by Subject|3|||
144587301|NCT02342743|521348781|FG000|Baseline Period|Lost to Follow-up|2|||
144587302|NCT02342743|521348781|FG000|Baseline Period|Change in prophylactic medication|3|||
144587303|NCT02342743|521348781|FG000|Baseline Period|Screening failure regarding baseline|7|||
144587304|NCT02342743|521348781|FG000|Treatment Period|Withdrawal by Subject|2|||
144587305|NCT02342743|521348781|FG000|Treatment Period|Lost to Follow-up|8|||
144587306|NCT02342743|521348781|FG000|Treatment Period|Change in prophylactic medication|1|||
144587307|NCT00686725|521348782|FG000|Overall Study|Adverse Event|1|||
144587308|NCT00686725|521348783|FG001|Overall Study|Adverse Event|1|||
144587309|NCT00686725|521348782|FG000|Overall Study|Progressive Disease|17|||
144587310|NCT00686725|521348783|FG001|Overall Study|Progressive Disease|23|||
144587311|NCT00686725|521348782|FG000|Overall Study|Lost to Follow-up|7|||
144587312|NCT00686725|521348783|FG001|Overall Study|Lost to Follow-up|5|||
144587313|NCT00686725|521348782|FG000|Overall Study|Death|6|||
144587314|NCT00686725|521348783|FG001|Overall Study|Death|3|||
144587315|NCT00686725|521348782|FG000|Overall Study|Withdrawal by Subject|13|||
144587316|NCT00686725|521348783|FG001|Overall Study|Withdrawal by Subject|4|||
144587317|NCT00686725|521348782|FG000|Overall Study|Protocol Violation|1|||
144587318|NCT00686725|521348783|FG001|Overall Study|Protocol Violation|3|||
144587319|NCT00686725|521348782|FG000|Overall Study|Other|1|||
144587320|NCT00686725|521348783|FG001|Overall Study|Other|3|||
144587321|NCT00092495|521348784|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
144587322|NCT00092495|521348785|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
144587323|NCT00092495|521348786|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
144587324|NCT00092495|521348787|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
144587325|NCT00092495|521348788|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
144587326|NCT00092495|521348784|FG000|Base Study Vaccination Period|Extended|0|||
144587327|NCT00092495|521348785|FG001|Base Study Vaccination Period|Extended|0|||
144587328|NCT00092495|521348786|FG002|Base Study Vaccination Period|Extended|0|||
144587329|NCT00092495|521348787|FG003|Base Study Vaccination Period|Extended|1|||
144587330|NCT00092495|521348788|FG004|Base Study Vaccination Period|Extended|0|||
144587331|NCT00092495|521348784|FG000|Base Study Vaccination Period|*Clinical AE|1|||
144587332|NCT00092495|521348785|FG001|Base Study Vaccination Period|*Clinical AE|0|||
144700186|NCT00563706|521756133|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
144700187|NCT00563706|521756134|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
144700188|NCT00563706|521756126|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
144700189|NCT00563706|521756127|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
144700190|NCT00563706|521756128|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
144700191|NCT00563706|521756129|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
144700192|NCT00563706|521756130|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
144700193|NCT00563706|521756131|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
144700194|NCT00563706|521756132|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
144700195|NCT00563706|521756133|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
144700196|NCT00563706|521756134|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
144700197|NCT00563706|521756126|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
144700198|NCT00563706|521756127|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
144587333|NCT00092495|521348786|FG002|Base Study Vaccination Period|*Clinical AE|1|||
144587334|NCT00092495|521348787|FG003|Base Study Vaccination Period|*Clinical AE|2|||
144587335|NCT00092495|521348788|FG004|Base Study Vaccination Period|*Clinical AE|0|||
144587336|NCT00092495|521348784|FG000|Base Study Vaccination Period|*Other reasons|1|||
144587337|NCT00092495|521348785|FG001|Base Study Vaccination Period|*Other reasons|0|||
144587338|NCT00092495|521348786|FG002|Base Study Vaccination Period|*Other reasons|0|||
144587339|NCT00092495|521348787|FG003|Base Study Vaccination Period|*Other reasons|1|||
144587340|NCT00092495|521348788|FG004|Base Study Vaccination Period|*Other reasons|0|||
144587341|NCT00092495|521348784|FG000|Base Study Vaccination Period|*Pregnancy|0|||
144587342|NCT00092495|521348785|FG001|Base Study Vaccination Period|*Pregnancy|2|||
144587343|NCT00092495|521348786|FG002|Base Study Vaccination Period|*Pregnancy|5|||
144587344|NCT00092495|521348787|FG003|Base Study Vaccination Period|*Pregnancy|7|||
144587345|NCT00092495|521348788|FG004|Base Study Vaccination Period|*Pregnancy|0|||
144587346|NCT00092495|521348784|FG000|Base Study Vaccination Period|Adverse Event|1|||
144587347|NCT00092495|521348785|FG001|Base Study Vaccination Period|Adverse Event|0|||
144587348|NCT00092495|521348786|FG002|Base Study Vaccination Period|Adverse Event|0|||
144587349|NCT00092495|521348787|FG003|Base Study Vaccination Period|Adverse Event|3|||
144587350|NCT00092495|521348788|FG004|Base Study Vaccination Period|Adverse Event|0|||
144587351|NCT00092495|521348784|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
144587352|NCT00092495|521348785|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
144587353|NCT00092495|521348786|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
144587354|NCT00092495|521348787|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
144587355|NCT00092495|521348788|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
144587356|NCT00092495|521348784|FG000|Base Study Vaccination Period|Moved|3|||
144587357|NCT00092495|521348785|FG001|Base Study Vaccination Period|Moved|1|||
144587358|NCT00092495|521348786|FG002|Base Study Vaccination Period|Moved|2|||
144587359|NCT00092495|521348787|FG003|Base Study Vaccination Period|Moved|2|||
144587360|NCT00092495|521348788|FG004|Base Study Vaccination Period|Moved|0|||
144587361|NCT00092495|521348784|FG000|Base Study Vaccination Period|Other|1|||
144587362|NCT00092495|521348785|FG001|Base Study Vaccination Period|Other|1|||
144587363|NCT00092495|521348786|FG002|Base Study Vaccination Period|Other|0|||
144587364|NCT00092495|521348787|FG003|Base Study Vaccination Period|Other|2|||
144587365|NCT00092495|521348788|FG004|Base Study Vaccination Period|Other|0|||
144587366|NCT00092495|521348784|FG000|Base Study Vaccination Period|Pregnancy|2|||
144587367|NCT00092495|521348785|FG001|Base Study Vaccination Period|Pregnancy|0|||
144587368|NCT00092495|521348786|FG002|Base Study Vaccination Period|Pregnancy|0|||
144587369|NCT00092495|521348787|FG003|Base Study Vaccination Period|Pregnancy|0|||
144587370|NCT00092495|521348788|FG004|Base Study Vaccination Period|Pregnancy|0|||
144587371|NCT00092495|521348784|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
144587372|NCT00092495|521348785|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
144587373|NCT00092495|521348786|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
144587374|NCT00092495|521348787|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
144587375|NCT00092495|521348788|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
144587376|NCT00092495|521348784|FG000|Base Study Vaccination Period|Protocol Violation|1|||
144587377|NCT00092495|521348785|FG001|Base Study Vaccination Period|Protocol Violation|0|||
144587378|NCT00092495|521348786|FG002|Base Study Vaccination Period|Protocol Violation|0|||
144587379|NCT00092495|521348787|FG003|Base Study Vaccination Period|Protocol Violation|0|||
144587380|NCT00092495|521348788|FG004|Base Study Vaccination Period|Protocol Violation|0|||
144587381|NCT00092495|521348784|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
144587382|NCT00092495|521348785|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
144587383|NCT00092495|521348786|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
144587384|NCT00092495|521348787|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
144587385|NCT00092495|521348788|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
144587386|NCT00092495|521348784|FG000|Base Study Follow-up Period|Extended|0|||
144587387|NCT00092495|521348785|FG001|Base Study Follow-up Period|Extended|0|||
144587388|NCT00092495|521348786|FG002|Base Study Follow-up Period|Extended|1|||
144587389|NCT00092495|521348787|FG003|Base Study Follow-up Period|Extended|2|||
144587390|NCT00092495|521348788|FG004|Base Study Follow-up Period|Extended|0|||
144587391|NCT00092495|521348784|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
144587392|NCT00092495|521348785|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
144587393|NCT00092495|521348786|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
144587394|NCT00092495|521348787|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
144587395|NCT00092495|521348788|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
144587396|NCT00092495|521348784|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
144587397|NCT00092495|521348785|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
144587398|NCT00092495|521348786|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
144587399|NCT00092495|521348787|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
144700199|NCT00563706|521756128|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
144587400|NCT00092495|521348788|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
144587401|NCT00938470|521348793|FG000|Overall Study|Disease Progression|3|||
144587402|NCT00938470|521348794|FG001|Overall Study|Disease Progression|0|||
144587403|NCT00938470|521348793|FG000|Overall Study|Alternate Treatment|1|||
144587404|NCT00938470|521348794|FG001|Overall Study|Alternate Treatment|0|||
144587405|NCT00938470|521348793|FG000|Overall Study|Death|3|||
144587406|NCT00938470|521348794|FG001|Overall Study|Death|2|||
144587407|NCT00938470|521348793|FG000|Overall Study|Other Reason|0|||
144587408|NCT00938470|521348794|FG001|Overall Study|Other Reason|1|||
144587409|NCT01346475|521348796|FG000|First Intervention|Lost to Follow-up|4|||
144587410|NCT01346475|521348797|FG001|First Intervention|Lost to Follow-up|3|||
144587411|NCT01552603|521348798|FG000|Overall Study|Physician Decision|1|||
144587412|NCT00618618|521348799|FG000|Overall Study|Patient Request|0|||
144587413|NCT00618618|521348800|FG001|Overall Study|Patient Request|0|||
144587414|NCT00618618|521348801|FG002|Overall Study|Patient Request|2|||
144587415|NCT00618618|521348802|FG003|Overall Study|Patient Request|0|||
144587416|NCT00618618|521348799|FG000|Overall Study|Inability to Complete Study Procedures|0|||
144587417|NCT00618618|521348800|FG001|Overall Study|Inability to Complete Study Procedures|1|||
144587418|NCT00618618|521348801|FG002|Overall Study|Inability to Complete Study Procedures|0|||
144587419|NCT00618618|521348802|FG003|Overall Study|Inability to Complete Study Procedures|0|||
144587420|NCT00618618|521348799|FG000|Overall Study|Lost to Follow-up|3|||
144587421|NCT00618618|521348800|FG001|Overall Study|Lost to Follow-up|0|||
144587422|NCT00618618|521348801|FG002|Overall Study|Lost to Follow-up|0|||
144587423|NCT00618618|521348802|FG003|Overall Study|Lost to Follow-up|1|||
144587424|NCT00618618|521348799|FG000|Overall Study|Non-compliance|1|||
144587425|NCT00618618|521348800|FG001|Overall Study|Non-compliance|1|||
144587426|NCT00618618|521348801|FG002|Overall Study|Non-compliance|0|||
144587427|NCT00618618|521348802|FG003|Overall Study|Non-compliance|0|||
144587428|NCT00618618|521348799|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
144587429|NCT00618618|521348800|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
144587430|NCT00618618|521348801|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
144587431|NCT00618618|521348802|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
144587432|NCT00618618|521348799|FG000|Overall Study|Death|0|||
144587433|NCT00618618|521348800|FG001|Overall Study|Death|1|||
144587434|NCT00618618|521348801|FG002|Overall Study|Death|0|||
144587435|NCT00618618|521348802|FG003|Overall Study|Death|0|||
144587436|NCT04797650|521348805|FG000|Overall Study|Reason Not Specified|5|||
144587437|NCT04797650|521348806|FG001|Overall Study|Reason Not Specified|12|||
144587438|NCT04797650|521348807|FG002|Overall Study|Reason Not Specified|5|||
144587439|NCT04797650|521348805|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
144587440|NCT04797650|521348806|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
144587441|NCT04797650|521348807|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
144587442|NCT04797650|521348805|FG000|Overall Study|Lack of Efficacy|1|||
144587443|NCT04797650|521348806|FG001|Overall Study|Lack of Efficacy|0|||
144587444|NCT04797650|521348807|FG002|Overall Study|Lack of Efficacy|1|||
144587445|NCT04797650|521348805|FG000|Overall Study|Non-compliance with Study Drug|0|||
144587446|NCT04797650|521348806|FG001|Overall Study|Non-compliance with Study Drug|0|||
144587447|NCT04797650|521348807|FG002|Overall Study|Non-compliance with Study Drug|2|||
144587448|NCT04797650|521348805|FG000|Overall Study|Lost to Follow-up|4|||
144587449|NCT04797650|521348806|FG001|Overall Study|Lost to Follow-up|6|||
144587450|NCT04797650|521348807|FG002|Overall Study|Lost to Follow-up|1|||
144587451|NCT01183234|521348810|FG000|First Intervention|Adverse Event|1|||
144587452|NCT01183234|521348811|FG001|First Intervention|Adverse Event|0|||
144587453|NCT00473265|521348812|FG000|Overall Study|Unrelated adverse event|5|||
144587454|NCT00473265|521348812|FG000|Overall Study|Off treatment early|15|||
144587455|NCT00309959|521348813|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
144587456|NCT02947087|521348814|FG000|Overall Study|Withdrawal by Subject|3|||
144587457|NCT02947087|521348815|FG001|Overall Study|Withdrawal by Subject|2|||
144587458|NCT00768079|521348820|FG000|Overall Study|Lost to Follow-up|2|||
144587459|NCT00768079|521348821|FG001|Overall Study|Lost to Follow-up|0|||
144587460|NCT00768079|521348822|FG002|Overall Study|Lost to Follow-up|4|||
144587461|NCT00768079|521348820|FG000|Overall Study|Participant incarcerated|0|||
144587462|NCT00768079|521348821|FG001|Overall Study|Participant incarcerated|1|||
144587463|NCT00768079|521348822|FG002|Overall Study|Participant incarcerated|0|||
144587464|NCT03212989|521348824|FG000|Overall Study|Physician Decision|8|||
144587465|NCT01844687|521348826|FG000|Visit 1|Protocol Violation|3|||
144587466|NCT01844687|521348826|FG000|Visit 1|Lost to Follow-up|5|||
144587467|NCT01844687|521348826|FG000|Visit 2|Withdrawal by Subject|1|||
144587468|NCT01844687|521348826|FG000|Visit 2|Protocol Violation|1|||
144700200|NCT00563706|521756129|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
144700201|NCT00563706|521756130|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
144587469|NCT01844687|521348826|FG000|Visit 3|Lost to Follow-up|1|||
144587470|NCT01844687|521348826|FG000|Visit 3|Withdrawal by Subject|3|||
144587471|NCT01844687|521348826|FG000|Visit 3|child care problems|1|||
144587472|NCT01844687|521348826|FG000|Visit 4|Pregnancy|1|||
144587473|NCT01844687|521348826|FG000|Visit 4|Lost to Follow-up|1|||
144587474|NCT01844687|521348826|FG000|Visit 4|Withdrawal by Subject|2|||
144587475|NCT02057523|521348829|FG000|Overall Study|Withdrawal by Subject|1|||
144587476|NCT02057523|521348829|FG000|Overall Study|Lack of Efficacy|1|||
144587477|NCT01871805|521348834|FG000|Phase I|Death|7|||
144587478|NCT01871805|521348835|FG001|Phase I|Death|4|||
144587479|NCT01871805|521348836|FG002|Phase I|Death|6|||
144587480|NCT01871805|521348837|FG003|Phase I|Death|2|||
144587481|NCT01871805|521348838|FG004|Phase I|Death|9|||
144587482|NCT01871805|521348839|FG005|Phase I|Death|0|||
144587483|NCT01871805|521348834|FG000|Phase I|Alive in Survival Follow-up|0|||
144587484|NCT01871805|521348835|FG001|Phase I|Alive in Survival Follow-up|2|||
144587485|NCT01871805|521348836|FG002|Phase I|Alive in Survival Follow-up|4|||
144587486|NCT01871805|521348837|FG003|Phase I|Alive in Survival Follow-up|5|||
144587487|NCT01871805|521348838|FG004|Phase I|Alive in Survival Follow-up|4|||
144587488|NCT01871805|521348839|FG005|Phase I|Alive in Survival Follow-up|0|||
144587489|NCT01871805|521348834|FG000|Phase I|Lost to Follow-up|0|||
144587490|NCT01871805|521348835|FG001|Phase I|Lost to Follow-up|1|||
144587491|NCT01871805|521348836|FG002|Phase I|Lost to Follow-up|3|||
144587492|NCT01871805|521348837|FG003|Phase I|Lost to Follow-up|0|||
144587493|NCT01871805|521348838|FG004|Phase I|Lost to Follow-up|0|||
144587494|NCT01871805|521348839|FG005|Phase I|Lost to Follow-up|0|||
144587495|NCT01871805|521348834|FG000|Phase II|Death|0|||
144587496|NCT01871805|521348835|FG001|Phase II|Death|0|||
144587497|NCT01871805|521348836|FG002|Phase II|Death|0|||
144587498|NCT01871805|521348837|FG003|Phase II|Death|0|||
144587499|NCT01871805|521348838|FG004|Phase II|Death|0|||
144587500|NCT01871805|521348839|FG005|Phase II|Death|45|||
144587501|NCT01871805|521348834|FG000|Phase II|Alive in Survival Follow-up|0|||
144587502|NCT01871805|521348835|FG001|Phase II|Alive in Survival Follow-up|0|||
144587503|NCT01871805|521348836|FG002|Phase II|Alive in Survival Follow-up|0|||
144587504|NCT01871805|521348837|FG003|Phase II|Alive in Survival Follow-up|0|||
144587505|NCT01871805|521348838|FG004|Phase II|Alive in Survival Follow-up|0|||
144587506|NCT01871805|521348839|FG005|Phase II|Alive in Survival Follow-up|29|||
144587507|NCT01871805|521348834|FG000|Phase II|Lost to Follow-up|0|||
144587508|NCT01871805|521348835|FG001|Phase II|Lost to Follow-up|0|||
144587509|NCT01871805|521348836|FG002|Phase II|Lost to Follow-up|0|||
144587510|NCT01871805|521348837|FG003|Phase II|Lost to Follow-up|0|||
144587511|NCT01871805|521348838|FG004|Phase II|Lost to Follow-up|0|||
144587512|NCT01871805|521348839|FG005|Phase II|Lost to Follow-up|13|||
144587513|NCT00564889|521348840|FG000|Overall Study|Death|7|||
144587514|NCT00564889|521348840|FG000|Overall Study|Adverse Event|12|||
144587515|NCT00564889|521348840|FG000|Overall Study|Alternative treatment|3|||
144587516|NCT00564889|521348840|FG000|Overall Study|Disease progression|3|||
144587517|NCT00564889|521348840|FG000|Overall Study|Other, not specified|4|||
144587518|NCT00635427|521348841|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
144587519|NCT00635427|521348842|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
144587520|NCT00635427|521348843|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
144587521|NCT00635427|521348844|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
144587522|NCT00635427|521348845|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
144587523|NCT00635427|521348841|FG000|Overall Study|Death|0|||
144587524|NCT00635427|521348842|FG001|Overall Study|Death|0|||
144587525|NCT00635427|521348843|FG002|Overall Study|Death|0|||
144587526|NCT00635427|521348844|FG003|Overall Study|Death|1|||
144587527|NCT00635427|521348845|FG004|Overall Study|Death|0|||
144587528|NCT00635427|521348841|FG000|Overall Study|Termination Of Study By Sponsor|12|||
144587529|NCT00635427|521348842|FG001|Overall Study|Termination Of Study By Sponsor|6|||
144587530|NCT00635427|521348843|FG002|Overall Study|Termination Of Study By Sponsor|10|||
144587531|NCT00635427|521348844|FG003|Overall Study|Termination Of Study By Sponsor|6|||
144587532|NCT00635427|521348845|FG004|Overall Study|Termination Of Study By Sponsor|6|||
144587533|NCT00635427|521348841|FG000|Overall Study|Withdrawal Of Consent|0|||
144587534|NCT00635427|521348842|FG001|Overall Study|Withdrawal Of Consent|0|||
144587535|NCT00635427|521348843|FG002|Overall Study|Withdrawal Of Consent|0|||
144587536|NCT00635427|521348844|FG003|Overall Study|Withdrawal Of Consent|2|||
144587537|NCT00635427|521348845|FG004|Overall Study|Withdrawal Of Consent|2|||
144587538|NCT01021215|521348846|FG000|Overall Study|Lost to Follow-up|3|||
144587539|NCT01021215|521348847|FG001|Overall Study|Lost to Follow-up|0|||
144587540|NCT05593445|521348857|FG000|12-Week DBVC Period|Adverse Event|1|||
144587541|NCT05593445|521348858|FG001|12-Week DBVC Period|Adverse Event|0|||
144587542|NCT05593445|521348859|FG002|12-Week DBVC Period|Adverse Event|0|||
144587543|NCT05593445|521348860|FG003|12-Week DBVC Period|Adverse Event|0|||
144587544|NCT05593445|521348857|FG000|12-Week DBVC Period|Physician Decision|0|||
144587545|NCT05593445|521348858|FG001|12-Week DBVC Period|Physician Decision|1|||
144587546|NCT05593445|521348859|FG002|12-Week DBVC Period|Physician Decision|0|||
144587547|NCT05593445|521348860|FG003|12-Week DBVC Period|Physician Decision|0|||
144587548|NCT05593445|521348857|FG000|12-Week DBVC Period|Protocol Violation|0|||
144587549|NCT05593445|521348858|FG001|12-Week DBVC Period|Protocol Violation|1|||
144587550|NCT05593445|521348859|FG002|12-Week DBVC Period|Protocol Violation|0|||
144587551|NCT05593445|521348860|FG003|12-Week DBVC Period|Protocol Violation|0|||
144587552|NCT05593445|521348857|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
144587553|NCT05593445|521348858|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
144587554|NCT05593445|521348859|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
144587555|NCT05593445|521348860|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
144587556|NCT05593445|521348857|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
144587557|NCT05593445|521348858|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
144587558|NCT05593445|521348859|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
144587559|NCT05593445|521348860|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
144587560|NCT05593445|521348857|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
144587561|NCT05593445|521348858|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
144587562|NCT05593445|521348859|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
144587563|NCT05593445|521348860|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
144587564|NCT05593445|521348857|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
144587565|NCT05593445|521348858|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
144587566|NCT05593445|521348859|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
144587567|NCT05593445|521348860|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
144587568|NCT05593445|521348857|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144587569|NCT05593445|521348858|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144587570|NCT05593445|521348859|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
144587571|NCT05593445|521348860|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144614747|NCT00708500|521450186|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
144614748|NCT00708500|521450184|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
144614749|NCT00708500|521450185|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
144614750|NCT00708500|521450186|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
144614751|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
144614752|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
144614753|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
144614754|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
144614755|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
144614756|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
144614757|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
144614758|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
144614759|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
144614760|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
144614761|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
144614762|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
144614763|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
144614764|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
144614765|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
144614766|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
144614767|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
144614768|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
144614769|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
144614770|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
144614771|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
144614772|NCT00708500|521450184|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
144614773|NCT00708500|521450185|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
144614774|NCT00708500|521450186|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
144614775|NCT00708500|521450184|FG000|FOLLOWUP|Adverse Event|0|||
144614776|NCT00708500|521450185|FG001|FOLLOWUP|Adverse Event|1|||
144614777|NCT00708500|521450186|FG002|FOLLOWUP|Adverse Event|0|||
144614778|NCT00708500|521450184|FG000|FOLLOWUP|Lost to Follow-up|1|||
144614779|NCT00708500|521450185|FG001|FOLLOWUP|Lost to Follow-up|6|||
144614780|NCT00708500|521450186|FG002|FOLLOWUP|Lost to Follow-up|4|||
144614781|NCT00708500|521450184|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
144614782|NCT00708500|521450185|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
144614783|NCT00708500|521450186|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
144614784|NCT00708500|521450184|FG000|FOLLOWUP|Subject withdrew consent|31|||
144614785|NCT00708500|521450185|FG001|FOLLOWUP|Subject withdrew consent|4|||
144614786|NCT00708500|521450186|FG002|FOLLOWUP|Subject withdrew consent|5|||
144614787|NCT00708500|521450184|FG000|FOLLOWUP|Non-compliance with protocol|5|||
144614788|NCT00708500|521450185|FG001|FOLLOWUP|Non-compliance with protocol|0|||
144614789|NCT00708500|521450186|FG002|FOLLOWUP|Non-compliance with protocol|1|||
144614790|NCT02255409|521450193|FG000|Overall Study|Administrative Reason|3|||
144614791|NCT02255409|521450194|FG001|Overall Study|Administrative Reason|7|||
144614792|NCT02255409|521450193|FG000|Overall Study|Withdrawal by Subject|1|||
144614793|NCT02255409|521450194|FG001|Overall Study|Withdrawal by Subject|5|||
144614794|NCT02255409|521450193|FG000|Overall Study|Lost to Follow-up|10|||
144614795|NCT02255409|521450194|FG001|Overall Study|Lost to Follow-up|19|||
144614796|NCT01227044|521450198|FG000|Overall Study|Lost to Follow-up|5|||
144614797|NCT01227044|521450199|FG001|Overall Study|Lost to Follow-up|7|||
144614798|NCT01227044|521450198|FG000|Overall Study|Discontinued Intervention|1|||
144614799|NCT01227044|521450199|FG001|Overall Study|Discontinued Intervention|2|||
144614800|NCT00205855|521450210|FG000|Overall Study|Only received temporary implants|16|||
144700202|NCT00563706|521756131|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
144587572|NCT04058366|521350397|FG000|Overall Study|Adverse Event|14|||
144587573|NCT04058366|521350397|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
144587574|NCT04058366|521350397|FG000|Overall Study|Commercial drug is available for participants|6|||
144587575|NCT04058366|521350397|FG000|Overall Study|Death|1|||
144587576|NCT04058366|521350397|FG000|Overall Study|Other non-compliance|2|||
144587577|NCT04058366|521350397|FG000|Overall Study|Other|6|||
144587578|NCT01589237|521350407|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
144587579|NCT01589237|521350408|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
144587580|NCT01589237|521350409|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
144587581|NCT01589237|521350410|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
144587582|NCT01589237|521350407|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
144587583|NCT01589237|521350408|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
144587584|NCT01589237|521350409|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
144587585|NCT01589237|521350410|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
144587586|NCT01589237|521350407|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
144587587|NCT01589237|521350408|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
144587588|NCT01589237|521350409|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
144587589|NCT01589237|521350410|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
144587590|NCT01589237|521350407|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
144587591|NCT01589237|521350408|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
144587592|NCT01589237|521350409|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
144587593|NCT01589237|521350410|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
144587594|NCT00910689|521350413|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
144587595|NCT00910689|521350414|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
144587596|NCT00910689|521350415|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
144587597|NCT00910689|521350416|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
144587598|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
144587599|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
144587600|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
144587601|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
144587602|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
144587603|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
144587604|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
144587605|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
144587606|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
144587607|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
144587608|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
144587609|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
144587610|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
144587611|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
144587612|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
144587613|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
144587614|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
144587615|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
144587616|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
144587617|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
144587618|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
144587619|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
144587620|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
144587621|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
144587622|NCT00910689|521350413|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
144587623|NCT00910689|521350414|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
144587624|NCT00910689|521350415|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
144587625|NCT00910689|521350416|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
144587626|NCT00910689|521350413|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
144587627|NCT00910689|521350414|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
144587628|NCT00910689|521350415|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
144587629|NCT00910689|521350416|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
144587630|NCT00910689|521350413|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
144587631|NCT00910689|521350414|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
144587632|NCT00910689|521350415|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
144587633|NCT00910689|521350416|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
144587634|NCT00910689|521350413|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
144587635|NCT00910689|521350414|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
144587636|NCT00910689|521350415|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
144587637|NCT00910689|521350416|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
144587638|NCT00910689|521350413|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
144587639|NCT00910689|521350414|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
144587640|NCT00910689|521350415|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
144587641|NCT00910689|521350416|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
144587642|NCT00910689|521350413|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
144587643|NCT00910689|521350414|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
144587644|NCT00910689|521350415|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
144587645|NCT00910689|521350416|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
144587646|NCT00910689|521350413|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
144587647|NCT00910689|521350414|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
144587648|NCT00910689|521350415|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
144587649|NCT00910689|521350416|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
144587650|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
144587651|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
144587652|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
144587653|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
144587654|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
144587655|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
144587656|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
144587657|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
144587658|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
144587659|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
144587660|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
144587661|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
144587662|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
144587663|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
144587664|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
144587665|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
144587666|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
144587667|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
144587668|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
144587669|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
144587670|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
144587671|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
144587672|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
144587673|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
144587674|NCT00910689|521350413|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
144587675|NCT00910689|521350414|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
144587676|NCT00910689|521350415|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
144587677|NCT00910689|521350416|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
144587678|NCT03207009|521350417|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
144587679|NCT00645801|521350418|FG000|Overall Study|unclear if patient took all the medication.|1|||
144587680|NCT00645801|521350419|FG001|Overall Study|unclear if patient took all the medication.|0|||
144587681|NCT00645801|521350418|FG000|Overall Study|Lost to Follow-up|19|||
144587682|NCT00645801|521350419|FG001|Overall Study|Lost to Follow-up|15|||
144587683|NCT00203476|521350420|FG000|Overall Study|Lost to Follow-up|1|||
144587684|NCT00203476|521350421|FG001|Overall Study|Lost to Follow-up|0|||
144587685|NCT00203476|521350422|FG002|Overall Study|Lost to Follow-up|0|||
144587686|NCT00203476|521350420|FG000|Overall Study|Withdrawal by Subject|0|||
144587687|NCT00203476|521350421|FG001|Overall Study|Withdrawal by Subject|1|||
144587688|NCT00203476|521350422|FG002|Overall Study|Withdrawal by Subject|0|||
144587689|NCT00512317|521350424|FG000|Overall Study|Insufficient clinical response|36|||
144587690|NCT00512317|521350424|FG000|Overall Study|Withdrawal by Subject|23|||
144587691|NCT00512317|521350424|FG000|Overall Study|Sponsor closure of study|21|||
144587692|NCT00512317|521350424|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
144587693|NCT00512317|521350424|FG000|Overall Study|Adverse Event|13|||
144587694|NCT00512317|521350424|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
144587695|NCT00512317|521350424|FG000|Overall Study|Lost to Follow-up|2|||
144587696|NCT00512317|521350424|FG000|Overall Study|Other|2|||
144587697|NCT00107120|521350425|FG000|Overall Study|Adverse Event|4|||
144587698|NCT00107120|521350426|FG001|Overall Study|Adverse Event|1|||
144587699|NCT00107120|521350425|FG000|Overall Study|Lack of Efficacy|5|||
144587700|NCT00107120|521350426|FG001|Overall Study|Lack of Efficacy|5|||
144587701|NCT00107120|521350425|FG000|Overall Study|Protocol Violation|3|||
144700203|NCT00563706|521756132|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
144587702|NCT00107120|521350426|FG001|Overall Study|Protocol Violation|0|||
144587703|NCT00107120|521350425|FG000|Overall Study|Withdrawal by Subject|8|||
144587704|NCT00107120|521350426|FG001|Overall Study|Withdrawal by Subject|9|||
144700204|NCT00563706|521756133|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
144587705|NCT00107120|521350425|FG000|Overall Study|Lost to Follow-up|8|||
144587706|NCT00107120|521350426|FG001|Overall Study|Lost to Follow-up|6|||
144587707|NCT00107120|521350425|FG000|Overall Study|Pregnancy|0|||
144587708|NCT00107120|521350426|FG001|Overall Study|Pregnancy|1|||
144587709|NCT00107120|521350425|FG000|Overall Study|moving away from site|1|||
144587710|NCT00107120|521350426|FG001|Overall Study|moving away from site|1|||
144587711|NCT00107120|521350425|FG000|Overall Study|death of parent|0|||
144587712|NCT00107120|521350426|FG001|Overall Study|death of parent|1|||
144587713|NCT02074553|521350427|FG000|Intervention Period 1|Family Emergency|0|||
144587714|NCT02074553|521350428|FG001|Intervention Period 1|Family Emergency|0|||
144587715|NCT02074553|521350429|FG002|Intervention Period 1|Family Emergency|0|||
144587716|NCT02074553|521350430|FG003|Intervention Period 1|Family Emergency|1|||
144587717|NCT02074553|521350431|FG004|Intervention Period 1|Family Emergency|0|||
144587718|NCT02074553|521350432|FG005|Intervention Period 1|Family Emergency|0|||
144587719|NCT02074553|521350433|FG006|Intervention Period 1|Family Emergency|0|||
144587720|NCT02074553|521350434|FG007|Intervention Period 1|Family Emergency|0|||
144587721|NCT02074553|521350427|FG000|Washout Period 1|Adverse Event|1|||
144587722|NCT02074553|521350428|FG001|Washout Period 1|Adverse Event|0|||
144587723|NCT02074553|521350429|FG002|Washout Period 1|Adverse Event|0|||
144587724|NCT02074553|521350430|FG003|Washout Period 1|Adverse Event|0|||
144587725|NCT02074553|521350431|FG004|Washout Period 1|Adverse Event|0|||
144587726|NCT02074553|521350432|FG005|Washout Period 1|Adverse Event|0|||
144587727|NCT02074553|521350433|FG006|Washout Period 1|Adverse Event|0|||
144587728|NCT02074553|521350434|FG007|Washout Period 1|Adverse Event|0|||
144587729|NCT02074553|521350427|FG000|Washout Period 1|Physician Decision|0|||
144587730|NCT02074553|521350428|FG001|Washout Period 1|Physician Decision|0|||
144587731|NCT02074553|521350429|FG002|Washout Period 1|Physician Decision|0|||
144587732|NCT02074553|521350430|FG003|Washout Period 1|Physician Decision|1|||
144587733|NCT02074553|521350431|FG004|Washout Period 1|Physician Decision|0|||
144587734|NCT02074553|521350432|FG005|Washout Period 1|Physician Decision|0|||
144587735|NCT02074553|521350433|FG006|Washout Period 1|Physician Decision|0|||
144587736|NCT02074553|521350434|FG007|Washout Period 1|Physician Decision|0|||
144587737|NCT02074553|521350427|FG000|Washout Period 1|Other|0|||
144587738|NCT02074553|521350428|FG001|Washout Period 1|Other|0|||
144587739|NCT02074553|521350429|FG002|Washout Period 1|Other|0|||
144587740|NCT02074553|521350430|FG003|Washout Period 1|Other|0|||
144587741|NCT02074553|521350431|FG004|Washout Period 1|Other|0|||
144587742|NCT02074553|521350432|FG005|Washout Period 1|Other|1|||
144587743|NCT02074553|521350433|FG006|Washout Period 1|Other|0|||
144587744|NCT02074553|521350434|FG007|Washout Period 1|Other|0|||
144587745|NCT02074553|521350427|FG000|Washout Period 2|Adverse Event|0|||
144587746|NCT02074553|521350428|FG001|Washout Period 2|Adverse Event|0|||
144587747|NCT02074553|521350429|FG002|Washout Period 2|Adverse Event|0|||
144587748|NCT02074553|521350430|FG003|Washout Period 2|Adverse Event|0|||
144587749|NCT02074553|521350431|FG004|Washout Period 2|Adverse Event|0|||
144587750|NCT02074553|521350432|FG005|Washout Period 2|Adverse Event|0|||
144587751|NCT02074553|521350433|FG006|Washout Period 2|Adverse Event|1|||
144587752|NCT02074553|521350434|FG007|Washout Period 2|Adverse Event|0|||
144587753|NCT02074553|521350427|FG000|Washout Period 2|Physician Decision|0|||
144587754|NCT02074553|521350428|FG001|Washout Period 2|Physician Decision|0|||
144587755|NCT02074553|521350429|FG002|Washout Period 2|Physician Decision|0|||
144587756|NCT02074553|521350430|FG003|Washout Period 2|Physician Decision|0|||
144587757|NCT02074553|521350431|FG004|Washout Period 2|Physician Decision|0|||
144587758|NCT02074553|521350432|FG005|Washout Period 2|Physician Decision|1|||
144700205|NCT00563706|521756134|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
144700206|NCT00563706|521756126|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
144700207|NCT00563706|521756127|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700208|NCT00563706|521756128|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700209|NCT00563706|521756129|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700210|NCT00563706|521756130|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700211|NCT00563706|521756131|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700212|NCT00563706|521756132|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700213|NCT00563706|521756133|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
144700214|NCT00563706|521756134|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
144700215|NCT00563706|521756126|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700216|NCT00563706|521756127|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700217|NCT00563706|521756128|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700218|NCT00563706|521756129|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700219|NCT00563706|521756130|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700220|NCT00563706|521756131|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700221|NCT00563706|521756132|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
144700222|NCT00563706|521756133|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
144587759|NCT02074553|521350433|FG006|Washout Period 2|Physician Decision|0|||
144587760|NCT02074553|521350434|FG007|Washout Period 2|Physician Decision|0|||
144587761|NCT02074553|521350427|FG000|Washout Period 2|Lost to Follow-up|0|||
144587762|NCT02074553|521350428|FG001|Washout Period 2|Lost to Follow-up|0|||
144700223|NCT00563706|521756134|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
144700224|NCT03280628|521756137|FG000|Overall Study|Lost to Follow-up|8|||
144700225|NCT03280628|521756138|FG001|Overall Study|Lost to Follow-up|6|||
144700226|NCT03280628|521756139|FG002|Overall Study|Lost to Follow-up|11|||
144700227|NCT01361308|521756142|FG000|Overall Study|Withdrawal by Subject|9|||
144700228|NCT01361308|521756143|FG001|Overall Study|Withdrawal by Subject|13|||
144700229|NCT01361308|521756142|FG000|Overall Study|Physician Decision|3|||
144700230|NCT01361308|521756143|FG001|Overall Study|Physician Decision|3|||
144700231|NCT01361308|521756142|FG000|Overall Study|Lack of Efficacy|2|||
144700232|NCT01361308|521756143|FG001|Overall Study|Lack of Efficacy|0|||
144700233|NCT01361308|521756142|FG000|Overall Study|Protocol Violation|1|||
144700234|NCT01361308|521756143|FG001|Overall Study|Protocol Violation|0|||
144700235|NCT01361308|521756142|FG000|Overall Study|Lost to Follow-up|5|||
144700236|NCT01361308|521756143|FG001|Overall Study|Lost to Follow-up|4|||
144700237|NCT01361308|521756142|FG000|Overall Study|Adverse Event|8|||
144700238|NCT01361308|521756143|FG001|Overall Study|Adverse Event|4|||
144700239|NCT01361308|521756142|FG000|Overall Study|Eligibility Criteria Not Met|2|||
144700240|NCT01361308|521756143|FG001|Overall Study|Eligibility Criteria Not Met|3|||
144700241|NCT01361308|521756142|FG000|Overall Study|Failed C-SSRS|5|||
144700242|NCT01361308|521756143|FG001|Overall Study|Failed C-SSRS|2|||
144700243|NCT01361308|521756142|FG000|Overall Study|Other|0|||
144700244|NCT01361308|521756143|FG001|Overall Study|Other|1|||
144700245|NCT03839693|521756148|FG000|Overall Study|Lost to Follow-up|0|||
144700246|NCT03839693|521756149|FG001|Overall Study|Lost to Follow-up|2|||
144700247|NCT03839693|521756150|FG002|Overall Study|Lost to Follow-up|2|||
144700248|NCT03839693|521756148|FG000|Overall Study|Withdrawal by Subject|1|||
144700249|NCT03839693|521756149|FG001|Overall Study|Withdrawal by Subject|0|||
144700250|NCT03839693|521756150|FG002|Overall Study|Withdrawal by Subject|2|||
144700251|NCT03839693|521756148|FG000|Overall Study|subject moved out of the area|1|||
144700252|NCT03839693|521756149|FG001|Overall Study|subject moved out of the area|0|||
144700253|NCT03839693|521756150|FG002|Overall Study|subject moved out of the area|0|||
144700254|NCT00700115|521756159|FG000|Overall Study|Withdrawal by Subject|1|||
144700255|NCT00700115|521756160|FG001|Overall Study|Withdrawal by Subject|0|||
144700256|NCT00700115|521756159|FG000|Overall Study|Lost to Follow-up|0|||
144700257|NCT00700115|521756160|FG001|Overall Study|Lost to Follow-up|1|||
144700258|NCT02503215|521756161|FG000|Overall Study|Unable to wear compression stockings|1|||
144700259|NCT02503215|521756161|FG000|Overall Study|Unable to use positive airway pressure|2|||
144700260|NCT02983305|521756162|FG000|Overall Study|incomplete data|2|||
144700261|NCT02983305|521756163|FG001|Overall Study|incomplete data|0|||
144700262|NCT00706901|521756164|FG000|Overall Study|Lost to Follow-up|2|||
144700263|NCT00706901|521756165|FG001|Overall Study|Lost to Follow-up|3|||
144700264|NCT00706901|521756166|FG002|Overall Study|Lost to Follow-up|2|||
144700265|NCT00706901|521756164|FG000|Overall Study|Withdrawal by Subject|4|||
144700266|NCT00706901|521756165|FG001|Overall Study|Withdrawal by Subject|2|||
144700267|NCT00706901|521756166|FG002|Overall Study|Withdrawal by Subject|5|||
144700268|NCT00706901|521756164|FG000|Overall Study|In Jail|1|||
144700269|NCT00706901|521756165|FG001|Overall Study|In Jail|0|||
144700270|NCT00706901|521756166|FG002|Overall Study|In Jail|1|||
144700271|NCT00706901|521756164|FG000|Overall Study|Death|1|||
144700272|NCT00706901|521756165|FG001|Overall Study|Death|0|||
144700273|NCT00706901|521756166|FG002|Overall Study|Death|0|||
144700274|NCT00822237|521756167|FG000|Dose 1 Vaccination|Not vaccinated|3|||
144700275|NCT00822237|521756168|FG001|Dose 1 Vaccination|Not vaccinated|0|||
144700276|NCT00822237|521756167|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
144700277|NCT00822237|521756168|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
144700278|NCT00822237|521756167|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
144700279|NCT00822237|521756168|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
144700280|NCT00822237|521756167|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
144700281|NCT00822237|521756168|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
144700282|NCT00822237|521756167|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
144700283|NCT00822237|521756168|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
144700284|NCT03433482|521756169|FG000|Overall Study|Lost to Follow-up|1|||
144700285|NCT03433482|521756170|FG001|Overall Study|Lost to Follow-up|0|||
144700286|NCT03433482|521756171|FG002|Overall Study|Lost to Follow-up|1|||
144700287|NCT03433482|521756172|FG003|Overall Study|Lost to Follow-up|1|||
144700288|NCT03433482|521756169|FG000|Overall Study|Withdrawal by Subject|0|||
144700289|NCT03433482|521756170|FG001|Overall Study|Withdrawal by Subject|0|||
144700290|NCT03433482|521756171|FG002|Overall Study|Withdrawal by Subject|1|||
144700291|NCT03433482|521756172|FG003|Overall Study|Withdrawal by Subject|0|||
144700292|NCT03433482|521756169|FG000|Overall Study|Unknown reason|0|||
144700293|NCT03433482|521756170|FG001|Overall Study|Unknown reason|0|||
144700294|NCT03433482|521756171|FG002|Overall Study|Unknown reason|2|||
144700295|NCT03433482|521756172|FG003|Overall Study|Unknown reason|0|||
144700296|NCT01519635|521756173|FG000|Overall Study|Withdrawal by Subject|0|||
144700297|NCT01519635|521756174|FG001|Overall Study|Withdrawal by Subject|1|||
144700298|NCT01519635|521756173|FG000|Overall Study|No possibility to put a catheter|1|||
144700299|NCT01519635|521756174|FG001|Overall Study|No possibility to put a catheter|2|||
144700300|NCT00968539|521756175|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
144700301|NCT00968539|521756176|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
144700302|NCT03985982|521756177|FG000|Double-Blind Phase|Lost to Follow-up|4|||
144700303|NCT03985982|521756178|FG001|Double-Blind Phase|Lost to Follow-up|3|||
144700304|NCT03985982|521756179|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144700305|NCT03985982|521756177|FG000|Double-Blind Phase|Physician Decision|1|||
144700306|NCT03985982|521756178|FG001|Double-Blind Phase|Physician Decision|0|||
144700307|NCT03985982|521756179|FG002|Double-Blind Phase|Physician Decision|0|||
144700308|NCT03985982|521756177|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
144700309|NCT03985982|521756178|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
144700310|NCT03985982|521756179|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144587763|NCT02074553|521350429|FG002|Washout Period 2|Lost to Follow-up|1|||
144587764|NCT02074553|521350430|FG003|Washout Period 2|Lost to Follow-up|0|||
144587765|NCT02074553|521350431|FG004|Washout Period 2|Lost to Follow-up|0|||
144587766|NCT02074553|521350432|FG005|Washout Period 2|Lost to Follow-up|0|||
144587767|NCT02074553|521350433|FG006|Washout Period 2|Lost to Follow-up|0|||
144587768|NCT02074553|521350434|FG007|Washout Period 2|Lost to Follow-up|0|||
144587769|NCT02074553|521350427|FG000|Washout Period 3|Physician Decision|0|||
144587770|NCT02074553|521350428|FG001|Washout Period 3|Physician Decision|0|||
144587771|NCT02074553|521350429|FG002|Washout Period 3|Physician Decision|0|||
144587772|NCT02074553|521350430|FG003|Washout Period 3|Physician Decision|0|||
144587773|NCT02074553|521350431|FG004|Washout Period 3|Physician Decision|0|||
144587774|NCT02074553|521350432|FG005|Washout Period 3|Physician Decision|0|||
144587775|NCT02074553|521350433|FG006|Washout Period 3|Physician Decision|0|||
144587776|NCT02074553|521350434|FG007|Washout Period 3|Physician Decision|1|||
144587777|NCT00194987|521350435|FG000|Overall Study|Withdrawal by Subject|0|||
144587778|NCT00194987|521350436|FG001|Overall Study|Withdrawal by Subject|3|||
144587779|NCT04875676|521350437|FG000|Overall Study|Lost to Follow-up|1|||
144587780|NCT04875676|521350438|FG001|Overall Study|Lost to Follow-up|0|||
144587781|NCT04875676|521350439|FG002|Overall Study|Lost to Follow-up|0|||
144587782|NCT01970345|521350442|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
144587783|NCT01970345|521350443|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
144587784|NCT01970345|521350442|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
144587785|NCT01970345|521350443|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
144587786|NCT04289051|521350450|FG000|Overall Study|Lost to Follow-up|0|||
144587787|NCT04289051|521350451|FG001|Overall Study|Lost to Follow-up|0|||
144587788|NCT04289051|521350452|FG002|Overall Study|Lost to Follow-up|2|||
144587789|NCT00657020|521350453|FG000|PERIOD 1|Adverse Event|0|||
144587790|NCT00657020|521350454|FG001|PERIOD 1|Adverse Event|1|||
144587791|NCT02937454|521350461|FG000|Overall Study|Adverse Event|0|||
144587792|NCT02937454|521350462|FG001|Overall Study|Adverse Event|1|||
144587793|NCT02937454|521350461|FG000|Overall Study|Death|98|||
144587794|NCT02937454|521350462|FG001|Overall Study|Death|95|||
144587795|NCT02937454|521350461|FG000|Overall Study|Lost to Follow-up|1|||
144587796|NCT02937454|521350462|FG001|Overall Study|Lost to Follow-up|1|||
144700311|NCT03985982|521756177|FG000|Double-Blind Phase|COVID-19|1|||
144700312|NCT03985982|521756178|FG001|Double-Blind Phase|COVID-19|0|||
144700313|NCT03985982|521756179|FG002|Double-Blind Phase|COVID-19|0|||
144700314|NCT03985982|521756177|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
144700315|NCT03985982|521756178|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
144700316|NCT03985982|521756179|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
144700317|NCT03985982|521756177|FG000|Open-Label Phase|Lost to Follow-up|0|||
144700318|NCT03985982|521756178|FG001|Open-Label Phase|Lost to Follow-up|0|||
144700319|NCT03985982|521756179|FG002|Open-Label Phase|Lost to Follow-up|13|||
144700320|NCT03985982|521756177|FG000|Open-Label Phase|Physician Decision|0|||
144199187|NCT00321737|519926519|FG002|Overall Study|Protocol Violation|1|||
144587797|NCT02937454|521350461|FG000|Overall Study|Physician Decision|0|||
144587798|NCT02937454|521350462|FG001|Overall Study|Physician Decision|1|||
144587799|NCT02937454|521350461|FG000|Overall Study|Protocol Violation|6|||
144587800|NCT02937454|521350462|FG001|Overall Study|Protocol Violation|10|||
144587801|NCT02937454|521350461|FG000|Overall Study|Withdrawal by Subject|27|||
144587802|NCT02937454|521350462|FG001|Overall Study|Withdrawal by Subject|15|||
144587803|NCT02937454|521350461|FG000|Overall Study|Other|8|||
144587804|NCT02937454|521350462|FG001|Overall Study|Other|5|||
144587805|NCT01156792|521350463|FG000|Overall Study|Adverse Event|1|||
144587806|NCT01156792|521350463|FG000|Overall Study|Lack of Efficacy|36|||
144587807|NCT01156792|521350463|FG000|Overall Study|Protocol Violation|6|||
144587808|NCT01156792|521350463|FG000|Overall Study|Lost to Follow-up|3|||
144587809|NCT01156792|521350463|FG000|Overall Study|Physician Decision|3|||
144587810|NCT01156792|521350463|FG000|Overall Study|Withdrawal by Subject|9|||
144587811|NCT01156792|521350463|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
144587812|NCT01097707|521350464|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144587813|NCT01097707|521350465|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144587814|NCT01097707|521350466|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
144700321|NCT03985982|521756178|FG001|Open-Label Phase|Physician Decision|0|||
144700322|NCT03985982|521756179|FG002|Open-Label Phase|Physician Decision|2|||
144587815|NCT01097707|521350467|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
144587816|NCT01097707|521350468|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
144587817|NCT01097707|521350464|FG000|Overall Study|Adverse Event|4|||
144587818|NCT01097707|521350465|FG001|Overall Study|Adverse Event|2|||
144587819|NCT01097707|521350466|FG002|Overall Study|Adverse Event|3|||
144587820|NCT01097707|521350467|FG003|Overall Study|Adverse Event|1|||
144587821|NCT01097707|521350468|FG004|Overall Study|Adverse Event|3|||
144587822|NCT01097707|521350464|FG000|Overall Study|Entry Criteria Not Met|2|||
144587823|NCT01097707|521350465|FG001|Overall Study|Entry Criteria Not Met|1|||
144587824|NCT01097707|521350466|FG002|Overall Study|Entry Criteria Not Met|1|||
144587825|NCT01097707|521350467|FG003|Overall Study|Entry Criteria Not Met|0|||
144587826|NCT01097707|521350468|FG004|Overall Study|Entry Criteria Not Met|1|||
144587827|NCT01097707|521350464|FG000|Overall Study|Lack of Efficacy|1|||
144587828|NCT01097707|521350465|FG001|Overall Study|Lack of Efficacy|0|||
144587829|NCT01097707|521350466|FG002|Overall Study|Lack of Efficacy|0|||
144587830|NCT01097707|521350467|FG003|Overall Study|Lack of Efficacy|1|||
144587831|NCT01097707|521350468|FG004|Overall Study|Lack of Efficacy|0|||
144587832|NCT01097707|521350464|FG000|Overall Study|Lost to Follow-up|1|||
144587833|NCT01097707|521350465|FG001|Overall Study|Lost to Follow-up|1|||
144587834|NCT01097707|521350466|FG002|Overall Study|Lost to Follow-up|2|||
144587835|NCT01097707|521350467|FG003|Overall Study|Lost to Follow-up|0|||
144587836|NCT01097707|521350468|FG004|Overall Study|Lost to Follow-up|3|||
144587837|NCT01097707|521350464|FG000|Overall Study|Protocol Violation|2|||
144587838|NCT01097707|521350465|FG001|Overall Study|Protocol Violation|2|||
144587839|NCT01097707|521350466|FG002|Overall Study|Protocol Violation|3|||
144587840|NCT01097707|521350467|FG003|Overall Study|Protocol Violation|2|||
144587841|NCT01097707|521350468|FG004|Overall Study|Protocol Violation|2|||
144587842|NCT01097707|521350464|FG000|Overall Study|Sponsor Decision|31|||
144587843|NCT01097707|521350465|FG001|Overall Study|Sponsor Decision|31|||
144587844|NCT01097707|521350466|FG002|Overall Study|Sponsor Decision|34|||
144587845|NCT01097707|521350467|FG003|Overall Study|Sponsor Decision|35|||
144587846|NCT01097707|521350468|FG004|Overall Study|Sponsor Decision|36|||
144587847|NCT01097707|521350464|FG000|Overall Study|Withdrawal by Subject|3|||
144587848|NCT01097707|521350465|FG001|Overall Study|Withdrawal by Subject|6|||
144587849|NCT01097707|521350466|FG002|Overall Study|Withdrawal by Subject|1|||
144587850|NCT01097707|521350467|FG003|Overall Study|Withdrawal by Subject|4|||
144587851|NCT01097707|521350468|FG004|Overall Study|Withdrawal by Subject|3|||
144587852|NCT01097707|521350464|FG000|Overall Study|Reason unknown|0|||
144587853|NCT01097707|521350465|FG001|Overall Study|Reason unknown|0|||
144587854|NCT01097707|521350466|FG002|Overall Study|Reason unknown|0|||
144587855|NCT01097707|521350467|FG003|Overall Study|Reason unknown|0|||
144587856|NCT01097707|521350468|FG004|Overall Study|Reason unknown|1|||
144587857|NCT01236534|521350471|FG000|Overall Study|Adverse Event|3|||
144587858|NCT01236534|521350472|FG001|Overall Study|Adverse Event|0|||
144587859|NCT01014143|521350473|FG000|Second Intervention|Lost to Follow-up|2|||
144587860|NCT01014143|521350474|FG001|Second Intervention|Lost to Follow-up|0|||
144587861|NCT01014143|521350475|FG002|Second Intervention|Lost to Follow-up|0|||
144587862|NCT01801735|521350486|FG000|Overall Study|Adverse Event|79|||
144587863|NCT01801735|521350486|FG000|Overall Study|Lack of Efficacy|28|||
144587864|NCT01801735|521350486|FG000|Overall Study|Withdrawal by Subject|27|||
144587865|NCT01801735|521350486|FG000|Overall Study|Protocol Violation|25|||
144587866|NCT01801735|521350486|FG000|Overall Study|Lost to Follow-up|15|||
144587867|NCT01801735|521350486|FG000|Overall Study|Non-compliance with Trial Drug|13|||
144587868|NCT01801735|521350486|FG000|Overall Study|Physician Decision|3|||
144587869|NCT01801735|521350486|FG000|Overall Study|Death|1|||
144587870|NCT01801735|521350486|FG000|Overall Study|Other, including site closure|19|||
144700323|NCT03985982|521756177|FG000|Open-Label Phase|Withdrawal by Subject|0|||
144700324|NCT03985982|521756178|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144700325|NCT03985982|521756179|FG002|Open-Label Phase|Withdrawal by Subject|11|||
144700326|NCT00812968|521756181|FG000|Overall Study|Relapse after erythroid response|6|||
144700327|NCT00812968|521756181|FG000|Overall Study|Disease progression|1|||
144700328|NCT00812968|521756181|FG000|Overall Study|No further treatment required|1|||
144587871|NCT00938860|521350487|FG000|Overall Study|Adverse Event|2|||
144587872|NCT00938860|521350488|FG001|Overall Study|Adverse Event|1|||
144587873|NCT00938860|521350487|FG000|Overall Study|Abnormal laboratory values|2|||
144587874|NCT00938860|521350488|FG001|Overall Study|Abnormal laboratory values|2|||
144587875|NCT00938860|521350487|FG000|Overall Study|Withdrawal by Subject|11|||
144587876|NCT00938860|521350488|FG001|Overall Study|Withdrawal by Subject|8|||
144587877|NCT00938860|521350487|FG000|Overall Study|Lost to Follow-up|4|||
144587878|NCT00938860|521350488|FG001|Overall Study|Lost to Follow-up|4|||
144587879|NCT00938860|521350487|FG000|Overall Study|Administration problems|2|||
144587880|NCT00938860|521350488|FG001|Overall Study|Administration problems|0|||
144587881|NCT00938860|521350487|FG000|Overall Study|Death|1|||
144587882|NCT00938860|521350488|FG001|Overall Study|Death|1|||
144587883|NCT00938860|521350487|FG000|Overall Study|Protocol Violation|3|||
144587884|NCT00938860|521350488|FG001|Overall Study|Protocol Violation|1|||
144587885|NCT01605019|521350489|FG000|Overall Study|pt did not meet transplant endpoint|3|||
144700329|NCT00812968|521756181|FG000|Overall Study|Study closed due to marketing approval|3|||
144700330|NCT00494234|521756182|FG000|Overall Study|Withdrawal by Subject|1|||
144700331|NCT00494234|521756183|FG001|Overall Study|Withdrawal by Subject|0|||
144700332|NCT00494234|521756182|FG000|Overall Study|Disease progression|11|||
144700333|NCT00494234|521756183|FG001|Overall Study|Disease progression|8|||
144700334|NCT00494234|521756182|FG000|Overall Study|Death|2|||
144700335|NCT00494234|521756183|FG001|Overall Study|Death|1|||
144700336|NCT01298362|521756187|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
144700337|NCT01298362|521756188|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
144700338|NCT01283009|521756189|FG000|Overall Study|Death|83|||
144700339|NCT01283009|521756190|FG001|Overall Study|Death|78|||
144700340|NCT01283009|521756189|FG000|Overall Study|Study ended early|23|||
144700341|NCT01283009|521756190|FG001|Overall Study|Study ended early|26|||
144700342|NCT01283009|521756189|FG000|Overall Study|Withdrawal by Subject|10|||
144700343|NCT01283009|521756190|FG001|Overall Study|Withdrawal by Subject|8|||
144700344|NCT01283009|521756189|FG000|Overall Study|Physician Decision|1|||
144700345|NCT01283009|521756190|FG001|Overall Study|Physician Decision|1|||
144587886|NCT01605019|521350490|FG001|Overall Study|pt did not meet transplant endpoint|0|||
144587887|NCT00468559|521350496|FG000|Open-label Treatment Phase|Adverse Event|5|||
144587888|NCT00468559|521350497|FG001|Open-label Treatment Phase|Adverse Event|0|||
144587889|NCT00468559|521350498|FG002|Open-label Treatment Phase|Adverse Event|0|||
144587890|NCT00468559|521350496|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
144587891|NCT00468559|521350497|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
144587892|NCT00468559|521350498|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
144587893|NCT00468559|521350496|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
144587894|NCT00468559|521350497|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
144587895|NCT00468559|521350498|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
144587896|NCT00468559|521350496|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
144587897|NCT00468559|521350497|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
144587898|NCT00468559|521350498|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
144587899|NCT00468559|521350496|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
144587900|NCT00468559|521350497|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
144587901|NCT00468559|521350498|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
144587902|NCT01153958|521350499|FG000|Overall Study|Study Terminated|36|||
144587903|NCT01153958|521350500|FG001|Overall Study|Study Terminated|32|||
144587904|NCT02971761|521350502|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
144587905|NCT02624791|521350503|FG000|Overall Study|Withdrawal by Subject|2|||
144587906|NCT02624791|521350504|FG001|Overall Study|Withdrawal by Subject|0|||
144587907|NCT02624791|521350505|FG002|Overall Study|Withdrawal by Subject|0|||
144587908|NCT02624791|521350506|FG003|Overall Study|Withdrawal by Subject|0|||
144587909|NCT02624791|521350507|FG004|Overall Study|Withdrawal by Subject|0|||
144587910|NCT02624791|521350508|FG005|Overall Study|Withdrawal by Subject|0|||
144587911|NCT01034163|521350509|FG000|Overall Study|Treatment completed as per protocol|8|||
144587912|NCT01034163|521350510|FG001|Overall Study|Treatment completed as per protocol|7|||
144587913|NCT01034163|521350509|FG000|Overall Study|Withdrawal by Subject|8|||
144587914|NCT01034163|521350510|FG001|Overall Study|Withdrawal by Subject|2|||
144587915|NCT01034163|521350509|FG000|Overall Study|Protocol deviation|1|||
144587916|NCT01034163|521350510|FG001|Overall Study|Protocol deviation|0|||
144587917|NCT01034163|521350509|FG000|Overall Study|Disease progression|3|||
144587918|NCT01034163|521350510|FG001|Overall Study|Disease progression|4|||
144587919|NCT01034163|521350509|FG000|Overall Study|Adverse Event|6|||
144587920|NCT01034163|521350510|FG001|Overall Study|Adverse Event|0|||
144587921|NCT01034163|521350509|FG000|Overall Study|Administrative problems|0|||
144587922|NCT01034163|521350510|FG001|Overall Study|Administrative problems|1|||
144587923|NCT01034163|521350509|FG000|Overall Study|Abnormal laboratory value|1|||
144587924|NCT01034163|521350510|FG001|Overall Study|Abnormal laboratory value|0|||
144587925|NCT02533531|521350512|FG000|Overall Study|Device did not turn on|1|||
144587926|NCT01942590|521350513|FG000|Overall Study|Withdrawal by Subject|0|||
144587927|NCT01942590|521350514|FG001|Overall Study|Withdrawal by Subject|1|||
144587928|NCT01942590|521350513|FG000|Overall Study|Adverse Event|1|||
144587929|NCT01942590|521350514|FG001|Overall Study|Adverse Event|0|||
144587930|NCT01226095|521350515|FG000|Overall Study|Poor compliance|1|||
144587931|NCT01285609|521350516|FG000|Randomized|Progressive Disease|41|||
144587932|NCT01285609|521350517|FG001|Randomized|Progressive Disease|61|||
144587933|NCT01285609|521350516|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
144587934|NCT01285609|521350517|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
144587935|NCT01285609|521350516|FG000|Randomized|Study Drug Toxicity|13|||
144587936|NCT01285609|521350517|FG001|Randomized|Study Drug Toxicity|14|||
144587937|NCT01285609|521350516|FG000|Randomized|Death|5|||
144587938|NCT01285609|521350517|FG001|Randomized|Death|7|||
144587939|NCT01285609|521350516|FG000|Randomized|Withdrawal by Subject|8|||
144587940|NCT01285609|521350517|FG001|Randomized|Withdrawal by Subject|11|||
144587941|NCT01285609|521350516|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
144700346|NCT01283009|521756189|FG000|Overall Study|Lost to Follow-up|1|||
144700347|NCT01283009|521756190|FG001|Overall Study|Lost to Follow-up|0|||
144700348|NCT01283009|521756189|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
144700349|NCT01283009|521756190|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
144700350|NCT00505765|521756197|FG000|Overall Study|Withdrawal by Subject|1|||
144587942|NCT01285609|521350517|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
144587943|NCT01285609|521350516|FG000|Randomized|Undisclosed Reasons|1|||
144587944|NCT01285609|521350517|FG001|Randomized|Undisclosed Reasons|0|||
144587945|NCT01285609|521350516|FG000|Randomized|Randomized but not Treated|4|||
144587946|NCT01285609|521350517|FG001|Randomized|Randomized but not Treated|4|||
144587947|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
144587948|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
144587949|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
144587950|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
144587951|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
144700351|NCT00505765|521756198|FG001|Overall Study|Withdrawal by Subject|0|||
144700352|NCT00505765|521756199|FG002|Overall Study|Withdrawal by Subject|0|||
144700353|NCT00505765|521756197|FG000|Overall Study|Adverse Event|1|||
144700354|NCT00505765|521756198|FG001|Overall Study|Adverse Event|2|||
144700355|NCT00505765|521756199|FG002|Overall Study|Adverse Event|0|||
144700356|NCT00505765|521756197|FG000|Overall Study|Noncompliance|0|||
144700357|NCT00505765|521756198|FG001|Overall Study|Noncompliance|1|||
144700358|NCT00505765|521756199|FG002|Overall Study|Noncompliance|3|||
144700359|NCT02743117|521756200|FG000|Overall Study|Lost to Follow-up|0|||
144700360|NCT02743117|521756201|FG001|Overall Study|Lost to Follow-up|1|||
144700361|NCT02743117|521756200|FG000|Overall Study|Other|1|||
144700362|NCT02743117|521756201|FG001|Overall Study|Other|0|||
144700363|NCT00183170|521756205|FG000|First Intervention|Did not complete study|1|||
144700364|NCT00183170|521756206|FG001|First Intervention|Did not complete study|0|||
144587952|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
144587953|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
144587954|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
144587955|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Death|11|||
144587956|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Death|3|||
144700365|NCT00183170|521756205|FG000|First Intervention|Did not meet targeted BrAC|1|||
144700366|NCT00183170|521756206|FG001|First Intervention|Did not meet targeted BrAC|0|||
144700367|NCT00183170|521756205|FG000|Washout 1 Week|Did not complete study|6|||
144700368|NCT00183170|521756206|FG001|Washout 1 Week|Did not complete study|8|||
144700369|NCT00183170|521756205|FG000|Second Intervention|Did not complete study|1|||
144700370|NCT00183170|521756206|FG001|Second Intervention|Did not complete study|0|||
144700371|NCT00183170|521756205|FG000|Second Intervention|Did not meet targeted BrAC|0|||
144700372|NCT00183170|521756206|FG001|Second Intervention|Did not meet targeted BrAC|2|||
144587957|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
144587958|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
144587959|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Not Reported|0|||
144587960|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Not Reported|2|||
144587961|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
144587962|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
144587963|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
144587964|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
144587965|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
144587966|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
144587967|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
144587968|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
144587969|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
144587970|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
144587971|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
144587972|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
144587973|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
144587974|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
144587975|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
144587976|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
144587977|NCT01285609|521350516|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
144587978|NCT01285609|521350517|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
144587979|NCT01285609|521350516|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
144587980|NCT01285609|521350517|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
144587981|NCT04822597|521350518|FG000|Overall Study|Withdrawal by Subject|0|||
144587982|NCT04822597|521350519|FG001|Overall Study|Withdrawal by Subject|1|||
144587983|NCT04822597|521350520|FG002|Overall Study|Withdrawal by Subject|1|||
144587984|NCT04822597|521350521|FG003|Overall Study|Withdrawal by Subject|0|||
144587985|NCT04822597|521350518|FG000|Overall Study|Physician Decision|0|||
144587986|NCT04822597|521350519|FG001|Overall Study|Physician Decision|0|||
144700373|NCT00924820|521756207|FG000|Overall Study|Death|2|||
144700374|NCT00924820|521756207|FG000|Overall Study|Ineligible, Screen Failure|5|||
144700375|NCT00761969|521756208|FG000|Overall Study|Death|112|||
144700376|NCT00761969|521756209|FG001|Overall Study|Death|47|||
144700377|NCT00761969|521756208|FG000|Overall Study|Lost to Follow-up|88|||
144700378|NCT00761969|521756209|FG001|Overall Study|Lost to Follow-up|93|||
144700379|NCT00585468|521756210|FG000|First Intervention|Withdrawal by Subject|1|||
144700380|NCT00585468|521756211|FG001|First Intervention|Withdrawal by Subject|1|||
144587987|NCT04822597|521350520|FG002|Overall Study|Physician Decision|1|||
144587988|NCT04822597|521350521|FG003|Overall Study|Physician Decision|1|||
144700381|NCT00762073|521756214|FG000|Overall Study|Lack of Efficacy|1|||
144700382|NCT00762073|521756215|FG001|Overall Study|Lack of Efficacy|1|||
144700383|NCT00762073|521756216|FG002|Overall Study|Lack of Efficacy|0|||
144700384|NCT00762073|521756217|FG003|Overall Study|Lack of Efficacy|0|||
144700385|NCT00762073|521756214|FG000|Overall Study|Adverse Event|1|||
144700386|NCT00762073|521756215|FG001|Overall Study|Adverse Event|0|||
144700387|NCT00762073|521756216|FG002|Overall Study|Adverse Event|1|||
144700388|NCT00762073|521756217|FG003|Overall Study|Adverse Event|1|||
144700389|NCT00762073|521756214|FG000|Overall Study|Significant Subject Noncompliance|0|||
144700390|NCT00762073|521756215|FG001|Overall Study|Significant Subject Noncompliance|1|||
144700391|NCT00762073|521756216|FG002|Overall Study|Significant Subject Noncompliance|0|||
144700392|NCT00762073|521756217|FG003|Overall Study|Significant Subject Noncompliance|1|||
144700393|NCT00762073|521756214|FG000|Overall Study|Withdrawal by Subject|1|||
144700394|NCT00762073|521756215|FG001|Overall Study|Withdrawal by Subject|2|||
144700395|NCT00762073|521756216|FG002|Overall Study|Withdrawal by Subject|1|||
144700396|NCT00762073|521756217|FG003|Overall Study|Withdrawal by Subject|1|||
144700397|NCT00762073|521756214|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
144700398|NCT00762073|521756215|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
144700399|NCT00762073|521756216|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
144700400|NCT00762073|521756217|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
144700401|NCT01068418|521756226|FG000|Overall Study|Physician Decision|12|||
144700402|NCT04365387|521756235|FG000|Overall Study|Adverse Event|4|||
144700403|NCT04365387|521756236|FG001|Overall Study|Adverse Event|2|||
144700404|NCT04365387|521756235|FG000|Overall Study|Participants request|14|||
144700405|NCT04365387|521756236|FG001|Overall Study|Participants request|14|||
144700406|NCT04365387|521756235|FG000|Overall Study|Lost to Follow-up|8|||
144700407|NCT04365387|521756236|FG001|Overall Study|Lost to Follow-up|5|||
144700408|NCT04365387|521756235|FG000|Overall Study|Protocol deviation|3|||
144700409|NCT04365387|521756236|FG001|Overall Study|Protocol deviation|4|||
144700410|NCT04365387|521756235|FG000|Overall Study|Participant compliance with visit schedule|1|||
144700411|NCT04365387|521756236|FG001|Overall Study|Participant compliance with visit schedule|0|||
144700412|NCT04365387|521756235|FG000|Overall Study|Participant incarcerated|1|||
144700413|NCT04365387|521756236|FG001|Overall Study|Participant incarcerated|0|||
144700414|NCT04365387|521756235|FG000|Overall Study|Participant moved out of town (relocated)|0|||
144700415|NCT04365387|521756236|FG001|Overall Study|Participant moved out of town (relocated)|1|||
144700416|NCT04365387|521756235|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
144700417|NCT04365387|521756236|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
144700418|NCT04365387|521756235|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
144700419|NCT04365387|521756236|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
144700420|NCT05770401|521756237|FG000|Overall Study|Lost to Follow-up|5|||
144700421|NCT05770401|521756238|FG001|Overall Study|Lost to Follow-up|4|||
144700422|NCT00402298|521756239|FG000|Overall Study|Withdrawal by Subject|1|||
144700423|NCT00402298|521756240|FG001|Overall Study|Withdrawal by Subject|0|||
144700424|NCT00480077|521756241|FG000|Overall Study|Death|19|||
144700425|NCT00480077|521756242|FG001|Overall Study|Death|15|||
144700426|NCT00480077|521756241|FG000|Overall Study|early exit|12|||
144700427|NCT00480077|521756242|FG001|Overall Study|early exit|11|||
144700428|NCT04784455|521756243|FG000|Overall Study|Death|4|||
144700429|NCT04298229|521756246|FG000|Overall Study|Physician Decision|1|||
144700430|NCT04298229|521756247|FG001|Overall Study|Physician Decision|1|||
144700431|NCT04298229|521756246|FG000|Overall Study|Withdrawal by Subject|1|||
144700432|NCT04298229|521756247|FG001|Overall Study|Withdrawal by Subject|1|||
144700433|NCT04298229|521756246|FG000|Overall Study|Did not receive IV loop diuretics|2|||
144700434|NCT04298229|521756247|FG001|Overall Study|Did not receive IV loop diuretics|0|||
144700435|NCT00262119|521756248|FG000|Overall Study|Lost to Follow-up|38|||
144700436|NCT00262119|521756249|FG001|Overall Study|Lost to Follow-up|51|||
144700437|NCT00262119|521756250|FG002|Overall Study|Lost to Follow-up|42|||
144700438|NCT00262119|521756248|FG000|Overall Study|Death|20|||
144700439|NCT00262119|521756249|FG001|Overall Study|Death|19|||
144587989|NCT04822597|521350518|FG000|Overall Study|Subject withdrawn after enrollment|0|||
144587990|NCT04822597|521350519|FG001|Overall Study|Subject withdrawn after enrollment|1|||
144587991|NCT04822597|521350520|FG002|Overall Study|Subject withdrawn after enrollment|0|||
144587992|NCT04822597|521350521|FG003|Overall Study|Subject withdrawn after enrollment|1|||
144587993|NCT04822597|521350518|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
144700440|NCT00262119|521756250|FG002|Overall Study|Death|16|||
144700441|NCT00859313|521756251|FG000|Overall Study|Lack of Efficacy|2|||
144700442|NCT00859313|521756251|FG000|Overall Study|Adverse Event|1|||
144700443|NCT00859313|521756251|FG000|Overall Study|staff error|1|||
144700444|NCT00071006|521756252|FG000|Overall Study|Lack of Efficacy|7|||
144700445|NCT00071006|521756252|FG000|Overall Study|Adverse Event|1|||
144700446|NCT00071006|521756252|FG000|Overall Study|Withdrawal by Subject|1|||
144700447|NCT00071006|521756252|FG000|Overall Study|Other|3|||
144700448|NCT05261126|521756257|FG000|Overall Study|Death|0|||
144700449|NCT05261126|521756258|FG001|Overall Study|Death|0|||
144700450|NCT05261126|521756259|FG002|Overall Study|Death|1|||
144700451|NCT05261126|521756260|FG003|Overall Study|Death|0|||
144700452|NCT05261126|521756261|FG004|Overall Study|Death|0|||
144700453|NCT05261126|521756257|FG000|Overall Study|Lost to Follow-up|0|||
144700454|NCT05261126|521756258|FG001|Overall Study|Lost to Follow-up|0|||
144700455|NCT05261126|521756259|FG002|Overall Study|Lost to Follow-up|0|||
144700456|NCT05261126|521756260|FG003|Overall Study|Lost to Follow-up|0|||
144700457|NCT05261126|521756261|FG004|Overall Study|Lost to Follow-up|1|||
144700458|NCT05261126|521756257|FG000|Overall Study|Physician Decision|1|||
144700459|NCT05261126|521756258|FG001|Overall Study|Physician Decision|0|||
144700460|NCT05261126|521756259|FG002|Overall Study|Physician Decision|0|||
144700461|NCT05261126|521756260|FG003|Overall Study|Physician Decision|0|||
144700462|NCT05261126|521756261|FG004|Overall Study|Physician Decision|0|||
144700463|NCT05261126|521756257|FG000|Overall Study|Screen Failure|0|||
144700464|NCT05261126|521756258|FG001|Overall Study|Screen Failure|0|||
144700465|NCT05261126|521756259|FG002|Overall Study|Screen Failure|0|||
144700466|NCT05261126|521756260|FG003|Overall Study|Screen Failure|0|||
144700467|NCT05261126|521756261|FG004|Overall Study|Screen Failure|1|||
144700468|NCT05261126|521756257|FG000|Overall Study|Withdrawal by Subject|1|||
144700469|NCT05261126|521756258|FG001|Overall Study|Withdrawal by Subject|0|||
144700470|NCT05261126|521756259|FG002|Overall Study|Withdrawal by Subject|1|||
144700471|NCT05261126|521756260|FG003|Overall Study|Withdrawal by Subject|1|||
144700472|NCT05261126|521756261|FG004|Overall Study|Withdrawal by Subject|0|||
144700473|NCT05261126|521756257|FG000|Overall Study|Not Recorded|0|||
144700474|NCT05261126|521756258|FG001|Overall Study|Not Recorded|0|||
144700475|NCT05261126|521756259|FG002|Overall Study|Not Recorded|0|||
144700476|NCT05261126|521756260|FG003|Overall Study|Not Recorded|1|||
144700477|NCT05261126|521756261|FG004|Overall Study|Not Recorded|0|||
144700478|NCT05939388|521756262|FG000|Overall Study|Lost to Follow-up|1|||
144700479|NCT03901274|521756263|FG000|Overall Study|Lost to Follow-up|120|||
144700480|NCT03901274|521756264|FG001|Overall Study|Lost to Follow-up|124|||
144700481|NCT03901274|521756263|FG000|Overall Study|Withdrawal by Subject|0|||
144700482|NCT03901274|521756264|FG001|Overall Study|Withdrawal by Subject|6|||
144700483|NCT05570604|521756265|FG000|Overall Study|Lost to Follow-up|1|||
144700484|NCT05570604|521756266|FG001|Overall Study|Lost to Follow-up|5|||
144700485|NCT05570604|521756265|FG000|Overall Study|Illness|2|||
144700486|NCT05570604|521756266|FG001|Overall Study|Illness|2|||
144700487|NCT00938366|521756269|FG000|Overall Study|Withdrawal by Subject|1|||
144700488|NCT00938366|521756270|FG001|Overall Study|Withdrawal by Subject|0|||
144700489|NCT01215968|521756273|FG000|Overall Study|Adverse Event|0|||
144700490|NCT01215968|521756274|FG001|Overall Study|Adverse Event|2|||
144700491|NCT01215968|521756273|FG000|Overall Study|Protocol Violation|2|||
144700492|NCT01215968|521756274|FG001|Overall Study|Protocol Violation|4|||
144700493|NCT01215968|521756273|FG000|Overall Study|Not received study drug|0|||
144700494|NCT01215968|521756274|FG001|Overall Study|Not received study drug|1|||
144700495|NCT01958619|521756277|FG000|Overall Study|Protocol Violation|2|||
144700496|NCT01958619|521756278|FG001|Overall Study|Protocol Violation|0|||
144700497|NCT01958619|521756279|FG002|Overall Study|Protocol Violation|1|||
144700498|NCT01958619|521756280|FG003|Overall Study|Protocol Violation|0|||
144700499|NCT04794491|521756281|FG000|Overall Study|Adverse Event|1|||
144700500|NCT04794491|521756281|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
144700501|NCT04794491|521756281|FG000|Overall Study|Noncompliance With Study Intervention|1|||
144700502|NCT04794491|521756281|FG000|Overall Study|Withdrawal by Subject|2|||
144700503|NCT03795233|521756282|FG000|Overall Study|Withdrawal by Subject|2|||
144700504|NCT03795233|521756283|FG001|Overall Study|Withdrawal by Subject|1|||
144700505|NCT03795233|521756282|FG000|Overall Study|Lost to Follow-up|1|||
144700506|NCT03795233|521756283|FG001|Overall Study|Lost to Follow-up|0|||
144700507|NCT03795233|521756282|FG000|Overall Study|Death|1|||
144700508|NCT03795233|521756283|FG001|Overall Study|Death|0|||
144700509|NCT01054443|521756284|FG000|Overall Study|Withdrawal by Subject|0|||
144700510|NCT01054443|521756285|FG001|Overall Study|Withdrawal by Subject|0|||
144700511|NCT01054443|521756286|FG002|Overall Study|Withdrawal by Subject|0|||
144700512|NCT01054443|521756287|FG003|Overall Study|Withdrawal by Subject|1|||
144700513|NCT00985114|521756289|FG000|Overall Study|Adverse Event|1|||
144700514|NCT00985114|521756290|FG001|Overall Study|Adverse Event|0|||
144700515|NCT00985114|521756289|FG000|Overall Study|Withdrawal by Subject|0|||
144700516|NCT00985114|521756290|FG001|Overall Study|Withdrawal by Subject|2|||
144700517|NCT02950831|521756291|FG000|Overall Study|Lost to Follow-up|1|||
144700518|NCT02950831|521756291|FG000|Overall Study|Withdrawal by Subject|3|||
144700519|NCT02950831|521756291|FG000|Overall Study|stimulation trail failure|5|||
144700520|NCT01119118|521756292|FG000|Overall Study|Adverse Event|1|||
144700521|NCT02711306|521756298|FG000|Overall Study|Withdrawal by Subject|2|||
144700522|NCT02711306|521756299|FG001|Overall Study|Withdrawal by Subject|2|||
144700523|NCT03145207|521756304|FG000|Overall Study|volunteer started taking allergy shots|1|||
144700524|NCT03145207|521756304|FG000|Overall Study|baseline blood pressure high|1|||
144700525|NCT02325414|521758162|FG000|Overall Study|Withdrawal by Subject|3|||
144700526|NCT02325414|521758163|FG001|Overall Study|Withdrawal by Subject|1|||
144700527|NCT02325414|521758162|FG000|Overall Study|Lost to Follow-up|5|||
144700528|NCT02325414|521758163|FG001|Overall Study|Lost to Follow-up|5|||
144700529|NCT00347776|521758164|FG000|1.5 Month Follow-up|Death|2|||
144700530|NCT00347776|521758165|FG001|1.5 Month Follow-up|Death|0|||
144700531|NCT00347776|521758166|FG002|1.5 Month Follow-up|Death|0|||
144700532|NCT00347776|521758164|FG000|1.5 Month Follow-up|reached the endpoint|12|||
144700533|NCT00347776|521758165|FG001|1.5 Month Follow-up|reached the endpoint|8|||
144700534|NCT00347776|521758166|FG002|1.5 Month Follow-up|reached the endpoint|12|||
144700535|NCT00347776|521758164|FG000|6 Month Follow-up|Death|2|||
144700536|NCT00347776|521758165|FG001|6 Month Follow-up|Death|1|||
144700537|NCT00347776|521758166|FG002|6 Month Follow-up|Death|3|||
144700538|NCT00347776|521758164|FG000|6 Month Follow-up|reached endpont|20|||
144700539|NCT00347776|521758165|FG001|6 Month Follow-up|reached endpont|12|||
144700540|NCT00347776|521758166|FG002|6 Month Follow-up|reached endpont|15|||
144700541|NCT00347776|521758164|FG000|12 Month Follow-up|Lost to Follow-up|7|||
144700542|NCT00347776|521758165|FG001|12 Month Follow-up|Lost to Follow-up|6|||
144700543|NCT00347776|521758166|FG002|12 Month Follow-up|Lost to Follow-up|6|||
144700544|NCT00347776|521758164|FG000|12 Month Follow-up|Death|3|||
144700545|NCT00347776|521758165|FG001|12 Month Follow-up|Death|4|||
144700546|NCT00347776|521758166|FG002|12 Month Follow-up|Death|4|||
144700547|NCT00347776|521758164|FG000|12 Month Follow-up|Reached endpoint|13|||
144700548|NCT00347776|521758165|FG001|12 Month Follow-up|Reached endpoint|6|||
144700549|NCT00347776|521758166|FG002|12 Month Follow-up|Reached endpoint|9|||
144700550|NCT00457249|521758167|FG000|Overall Study|Lost to Follow-up|3|||
144700551|NCT00457249|521758168|FG001|Overall Study|Lost to Follow-up|0|||
144700552|NCT00457249|521758167|FG000|Overall Study|Protocol Violation|4|||
144700553|NCT00457249|521758168|FG001|Overall Study|Protocol Violation|1|||
144700554|NCT00457249|521758167|FG000|Overall Study|Withdrawal by Subject|3|||
144700555|NCT00457249|521758168|FG001|Overall Study|Withdrawal by Subject|1|||
144700556|NCT00457249|521758167|FG000|Overall Study|Serious Adverse Events|2|||
144700557|NCT00457249|521758168|FG001|Overall Study|Serious Adverse Events|0|||
144700558|NCT00326118|521758169|FG000|Active Phase|Withdrawal by Subject|4|||
144700559|NCT00326118|521758170|FG001|Active Phase|Withdrawal by Subject|1|||
144700560|NCT00938392|521758171|FG000|Overall Study|Adverse Event|0|||
144700561|NCT00938392|521758172|FG001|Overall Study|Adverse Event|1|||
144700562|NCT00938392|521758171|FG000|Overall Study|Withdrawal by Subject|0|||
144700563|NCT00938392|521758172|FG001|Overall Study|Withdrawal by Subject|1|||
144700564|NCT00938392|521758171|FG000|Overall Study|Lost to Follow-up|2|||
144700565|NCT00938392|521758172|FG001|Overall Study|Lost to Follow-up|2|||
144700566|NCT02916056|521758173|FG000|Overall Study|Adverse Event|6|||
144700567|NCT02916056|521758173|FG000|Overall Study|Lost to Follow-up|1|||
144700568|NCT02916056|521758173|FG000|Overall Study|Other|12|||
144700569|NCT02916056|521758173|FG000|Overall Study|Protocol Violation|1|||
144700570|NCT02916056|521758173|FG000|Overall Study|Withdrawal by Subject|8|||
144700571|NCT02916056|521758173|FG000|Overall Study|Study Terminated by Sponsor|269|||
144700572|NCT00124709|521758174|FG000|Overall Study|Randomized but did not take medication|3|||
144700573|NCT00124709|521758175|FG001|Overall Study|Randomized but did not take medication|1|||
144700574|NCT00124709|521758174|FG000|Overall Study|Adverse Event|3|||
144700575|NCT00124709|521758175|FG001|Overall Study|Adverse Event|0|||
144700576|NCT00124709|521758174|FG000|Overall Study|Lack of Efficacy|5|||
144700577|NCT00124709|521758175|FG001|Overall Study|Lack of Efficacy|10|||
144700578|NCT00124709|521758174|FG000|Overall Study|Protocol Violation|3|||
144700579|NCT00124709|521758175|FG001|Overall Study|Protocol Violation|5|||
144700580|NCT00124709|521758174|FG000|Overall Study|Withdrawal by Subject|127|||
144700581|NCT00124709|521758175|FG001|Overall Study|Withdrawal by Subject|136|||
144700582|NCT00124709|521758174|FG000|Overall Study|Lost to Follow-up|114|||
144700583|NCT00124709|521758175|FG001|Overall Study|Lost to Follow-up|120|||
144700584|NCT00122954|521758176|FG000|Overall Study|Withdrawal by Subject|2|||
144700585|NCT00122954|521758177|FG001|Overall Study|Withdrawal by Subject|2|||
144700586|NCT00122954|521758176|FG000|Overall Study|Protocol Violation|0|||
144700587|NCT00122954|521758177|FG001|Overall Study|Protocol Violation|1|||
144700588|NCT04341727|521758183|FG000|Overall Study|Withdrawal by Subject|0|||
144700589|NCT04341727|521758184|FG001|Overall Study|Withdrawal by Subject|0|||
144700590|NCT04341727|521758185|FG002|Overall Study|Withdrawal by Subject|1|||
144700591|NCT04341727|521758186|FG003|Overall Study|Withdrawal by Subject|0|||
144700592|NCT04341727|521758183|FG000|Overall Study|Lost to Follow-up|0|||
144700593|NCT04341727|521758184|FG001|Overall Study|Lost to Follow-up|0|||
144700594|NCT04341727|521758185|FG002|Overall Study|Lost to Follow-up|0|||
144700595|NCT04341727|521758186|FG003|Overall Study|Lost to Follow-up|1|||
144700596|NCT05604521|521758187|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
144700597|NCT05604521|521758188|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
144700598|NCT05604521|521758187|FG000|Overall Study|Adverse Event|1|||
144700599|NCT05604521|521758188|FG001|Overall Study|Adverse Event|0|||
144700600|NCT01491737|521758189|FG000|Overall Study|Withdrawal by Subject|20|||
144700601|NCT01491737|521758190|FG001|Overall Study|Withdrawal by Subject|17|||
144700602|NCT01491737|521758189|FG000|Overall Study|Lost to Follow-up|2|||
144700603|NCT01491737|521758190|FG001|Overall Study|Lost to Follow-up|10|||
144700604|NCT01491737|521758189|FG000|Overall Study|Death|63|||
144700605|NCT01491737|521758190|FG001|Overall Study|Death|57|||
144700606|NCT01491737|521758189|FG000|Overall Study|Study Termination by Sponsor|36|||
144700607|NCT01491737|521758190|FG001|Overall Study|Study Termination by Sponsor|36|||
144700608|NCT01491737|521758189|FG000|Overall Study|Reason Not Specified|8|||
144700609|NCT01491737|521758190|FG001|Overall Study|Reason Not Specified|9|||
144700610|NCT01817764|521758191|FG000|Overall Study|Adverse Event|7|||
144700611|NCT01817764|521758192|FG001|Overall Study|Adverse Event|10|||
144700612|NCT01817764|521758191|FG000|Overall Study|Lack of Efficacy|9|||
144700613|NCT01817764|521758192|FG001|Overall Study|Lack of Efficacy|7|||
144700614|NCT01817764|521758191|FG000|Overall Study|Protocol Violation|7|||
144700615|NCT01817764|521758192|FG001|Overall Study|Protocol Violation|5|||
144700616|NCT01817764|521758191|FG000|Overall Study|Lost to Follow-up|1|||
144700617|NCT01817764|521758192|FG001|Overall Study|Lost to Follow-up|4|||
144700618|NCT01817764|521758191|FG000|Overall Study|Withdrawal by Subject|10|||
144700619|NCT01817764|521758192|FG001|Overall Study|Withdrawal by Subject|12|||
144700620|NCT05279807|521758193|FG000|Overall Study|Withdrawal by Subject|1|||
144700621|NCT05279807|521758194|FG001|Overall Study|Withdrawal by Subject|0|||
144700622|NCT05279807|521758193|FG000|Overall Study|Adverse Event|0|||
144700623|NCT05279807|521758194|FG001|Overall Study|Adverse Event|1|||
144700624|NCT05279807|521758193|FG000|Overall Study|Laboratory Abnormal Results|1|||
144700625|NCT05279807|521758194|FG001|Overall Study|Laboratory Abnormal Results|0|||
144700626|NCT05993299|521758196|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
144700627|NCT05993299|521758196|FG000|Overall Study|Ongoing|4|||
144700628|NCT05644756|521758197|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
144700629|NCT05644756|521758197|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
144700630|NCT03110107|521758198|FG000|Treatment Period|Disease Progression|3|||
144700631|NCT03110107|521758199|FG001|Treatment Period|Disease Progression|9|||
144700632|NCT03110107|521758200|FG002|Treatment Period|Disease Progression|8|||
144700633|NCT03110107|521758201|FG003|Treatment Period|Disease Progression|11|||
144700634|NCT03110107|521758202|FG004|Treatment Period|Disease Progression|8|||
144700635|NCT03110107|521758203|FG005|Treatment Period|Disease Progression|4|||
144700636|NCT03110107|521758204|FG006|Treatment Period|Disease Progression|6|||
144700637|NCT03110107|521758205|FG007|Treatment Period|Disease Progression|7|||
144700638|NCT03110107|521758206|FG008|Treatment Period|Disease Progression|2|||
144700639|NCT03110107|521758207|FG009|Treatment Period|Disease Progression|10|||
144700640|NCT03110107|521758208|FG010|Treatment Period|Disease Progression|5|||
144700641|NCT03110107|521758209|FG011|Treatment Period|Disease Progression|2|||
144700642|NCT03110107|521758210|FG012|Treatment Period|Disease Progression|0|||
144700643|NCT03110107|521758211|FG013|Treatment Period|Disease Progression|5|||
144700644|NCT03110107|521758212|FG014|Treatment Period|Disease Progression|14|||
144700645|NCT03110107|521758213|FG015|Treatment Period|Disease Progression|14|||
144700646|NCT03110107|521758214|FG016|Treatment Period|Disease Progression|4|||
144700647|NCT03110107|521758215|FG017|Treatment Period|Disease Progression|3|||
144700648|NCT03110107|521758216|FG018|Treatment Period|Disease Progression|16|||
144700649|NCT03110107|521758217|FG019|Treatment Period|Disease Progression|14|||
144700650|NCT03110107|521758218|FG020|Treatment Period|Disease Progression|12|||
144700651|NCT03110107|521758219|FG021|Treatment Period|Disease Progression|16|||
144700652|NCT03110107|521758220|FG022|Treatment Period|Disease Progression|18|||
144700653|NCT03110107|521758221|FG023|Treatment Period|Disease Progression|13|||
144700654|NCT03110107|521758222|FG024|Treatment Period|Disease Progression|16|||
144700655|NCT03110107|521758223|FG025|Treatment Period|Disease Progression|31|||
144700656|NCT03110107|521758198|FG000|Treatment Period|Study drug toxicity|1|||
144700657|NCT03110107|521758199|FG001|Treatment Period|Study drug toxicity|0|||
144700658|NCT03110107|521758200|FG002|Treatment Period|Study drug toxicity|1|||
144700659|NCT03110107|521758201|FG003|Treatment Period|Study drug toxicity|2|||
144700660|NCT03110107|521758202|FG004|Treatment Period|Study drug toxicity|0|||
144700661|NCT03110107|521758203|FG005|Treatment Period|Study drug toxicity|3|||
144700662|NCT03110107|521758204|FG006|Treatment Period|Study drug toxicity|1|||
144700663|NCT03110107|521758205|FG007|Treatment Period|Study drug toxicity|1|||
144700664|NCT03110107|521758206|FG008|Treatment Period|Study drug toxicity|3|||
144473766|NCT05044325|520934083|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144700665|NCT03110107|521758207|FG009|Treatment Period|Study drug toxicity|2|||
144700666|NCT03110107|521758208|FG010|Treatment Period|Study drug toxicity|0|||
144700667|NCT03110107|521758209|FG011|Treatment Period|Study drug toxicity|2|||
144700668|NCT03110107|521758210|FG012|Treatment Period|Study drug toxicity|0|||
144700669|NCT03110107|521758211|FG013|Treatment Period|Study drug toxicity|0|||
144700670|NCT03110107|521758212|FG014|Treatment Period|Study drug toxicity|2|||
144700671|NCT03110107|521758213|FG015|Treatment Period|Study drug toxicity|3|||
144700672|NCT03110107|521758214|FG016|Treatment Period|Study drug toxicity|3|||
144700673|NCT03110107|521758215|FG017|Treatment Period|Study drug toxicity|3|||
144700674|NCT03110107|521758216|FG018|Treatment Period|Study drug toxicity|1|||
144700675|NCT03110107|521758217|FG019|Treatment Period|Study drug toxicity|2|||
144700676|NCT03110107|521758218|FG020|Treatment Period|Study drug toxicity|2|||
144700677|NCT03110107|521758219|FG021|Treatment Period|Study drug toxicity|0|||
144700678|NCT03110107|521758220|FG022|Treatment Period|Study drug toxicity|2|||
144700679|NCT03110107|521758221|FG023|Treatment Period|Study drug toxicity|6|||
144700680|NCT03110107|521758222|FG024|Treatment Period|Study drug toxicity|7|||
144700681|NCT03110107|521758223|FG025|Treatment Period|Study drug toxicity|6|||
144700682|NCT03110107|521758198|FG000|Treatment Period|Death|0|||
144700683|NCT03110107|521758199|FG001|Treatment Period|Death|0|||
144700684|NCT03110107|521758200|FG002|Treatment Period|Death|0|||
144700685|NCT03110107|521758201|FG003|Treatment Period|Death|0|||
144700686|NCT03110107|521758202|FG004|Treatment Period|Death|0|||
144700687|NCT03110107|521758203|FG005|Treatment Period|Death|0|||
144700688|NCT03110107|521758204|FG006|Treatment Period|Death|0|||
144700689|NCT03110107|521758205|FG007|Treatment Period|Death|0|||
144700690|NCT03110107|521758206|FG008|Treatment Period|Death|0|||
144700691|NCT03110107|521758207|FG009|Treatment Period|Death|0|||
144700692|NCT03110107|521758208|FG010|Treatment Period|Death|0|||
144700693|NCT03110107|521758209|FG011|Treatment Period|Death|0|||
144700694|NCT03110107|521758210|FG012|Treatment Period|Death|1|||
144700695|NCT03110107|521758211|FG013|Treatment Period|Death|0|||
144700696|NCT03110107|521758212|FG014|Treatment Period|Death|0|||
144700697|NCT03110107|521758213|FG015|Treatment Period|Death|0|||
144700698|NCT03110107|521758214|FG016|Treatment Period|Death|0|||
144700699|NCT03110107|521758215|FG017|Treatment Period|Death|0|||
144700700|NCT03110107|521758216|FG018|Treatment Period|Death|0|||
144700701|NCT03110107|521758217|FG019|Treatment Period|Death|0|||
144700702|NCT03110107|521758218|FG020|Treatment Period|Death|0|||
144700703|NCT03110107|521758219|FG021|Treatment Period|Death|0|||
144700704|NCT03110107|521758220|FG022|Treatment Period|Death|0|||
144700705|NCT03110107|521758221|FG023|Treatment Period|Death|0|||
144700706|NCT03110107|521758222|FG024|Treatment Period|Death|0|||
144700707|NCT03110107|521758223|FG025|Treatment Period|Death|0|||
144700708|NCT03110107|521758198|FG000|Treatment Period|Adverse Event|0|||
144700709|NCT03110107|521758199|FG001|Treatment Period|Adverse Event|0|||
144700710|NCT03110107|521758200|FG002|Treatment Period|Adverse Event|1|||
144700711|NCT03110107|521758201|FG003|Treatment Period|Adverse Event|0|||
144700712|NCT03110107|521758202|FG004|Treatment Period|Adverse Event|0|||
144700713|NCT03110107|521758203|FG005|Treatment Period|Adverse Event|2|||
144700714|NCT03110107|521758204|FG006|Treatment Period|Adverse Event|0|||
144700715|NCT03110107|521758205|FG007|Treatment Period|Adverse Event|2|||
144700716|NCT03110107|521758206|FG008|Treatment Period|Adverse Event|0|||
144700717|NCT03110107|521758207|FG009|Treatment Period|Adverse Event|1|||
144700718|NCT03110107|521758208|FG010|Treatment Period|Adverse Event|0|||
144700719|NCT03110107|521758209|FG011|Treatment Period|Adverse Event|0|||
144700720|NCT03110107|521758210|FG012|Treatment Period|Adverse Event|0|||
144700721|NCT03110107|521758211|FG013|Treatment Period|Adverse Event|0|||
144700722|NCT03110107|521758212|FG014|Treatment Period|Adverse Event|0|||
144700723|NCT03110107|521758213|FG015|Treatment Period|Adverse Event|2|||
144700724|NCT03110107|521758214|FG016|Treatment Period|Adverse Event|0|||
144700725|NCT03110107|521758215|FG017|Treatment Period|Adverse Event|1|||
144700726|NCT03110107|521758216|FG018|Treatment Period|Adverse Event|2|||
144700727|NCT03110107|521758217|FG019|Treatment Period|Adverse Event|1|||
144700728|NCT03110107|521758218|FG020|Treatment Period|Adverse Event|4|||
144700729|NCT03110107|521758219|FG021|Treatment Period|Adverse Event|2|||
144700730|NCT03110107|521758220|FG022|Treatment Period|Adverse Event|2|||
144700731|NCT03110107|521758221|FG023|Treatment Period|Adverse Event|2|||
144700732|NCT03110107|521758222|FG024|Treatment Period|Adverse Event|2|||
144700733|NCT03110107|521758223|FG025|Treatment Period|Adverse Event|4|||
144700734|NCT03110107|521758198|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
144700735|NCT03110107|521758199|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
144700736|NCT03110107|521758200|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
144700737|NCT03110107|521758201|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
144700738|NCT03110107|521758202|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
144700739|NCT03110107|521758203|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
144700740|NCT03110107|521758204|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
144700741|NCT03110107|521758205|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
144700742|NCT03110107|521758206|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
144700743|NCT03110107|521758207|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
144247345|NCT01313221|520104057|FG000|Overall Study|Protocol Violation|0|||
144700744|NCT03110107|521758208|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
144700745|NCT03110107|521758209|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
144700746|NCT03110107|521758210|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
144700747|NCT03110107|521758211|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
144700748|NCT03110107|521758212|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
144700749|NCT03110107|521758213|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
144700750|NCT03110107|521758214|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
144700751|NCT03110107|521758215|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
144700752|NCT03110107|521758216|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
144700753|NCT03110107|521758217|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
144700754|NCT03110107|521758218|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
144700755|NCT03110107|521758219|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
144700756|NCT03110107|521758220|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
144700757|NCT03110107|521758221|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
144700758|NCT03110107|521758222|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
144700759|NCT03110107|521758223|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
144700760|NCT03110107|521758198|FG000|Treatment Period|Participant withdrew consent|0|||
144700761|NCT03110107|521758199|FG001|Treatment Period|Participant withdrew consent|0|||
144700762|NCT03110107|521758200|FG002|Treatment Period|Participant withdrew consent|1|||
144700763|NCT03110107|521758201|FG003|Treatment Period|Participant withdrew consent|0|||
144700764|NCT03110107|521758202|FG004|Treatment Period|Participant withdrew consent|4|||
144700765|NCT03110107|521758203|FG005|Treatment Period|Participant withdrew consent|3|||
144700766|NCT03110107|521758204|FG006|Treatment Period|Participant withdrew consent|0|||
144700767|NCT03110107|521758205|FG007|Treatment Period|Participant withdrew consent|0|||
144700768|NCT03110107|521758206|FG008|Treatment Period|Participant withdrew consent|0|||
144700769|NCT03110107|521758207|FG009|Treatment Period|Participant withdrew consent|1|||
144700770|NCT03110107|521758208|FG010|Treatment Period|Participant withdrew consent|0|||
144700771|NCT03110107|521758209|FG011|Treatment Period|Participant withdrew consent|0|||
144700772|NCT03110107|521758210|FG012|Treatment Period|Participant withdrew consent|0|||
144700773|NCT03110107|521758211|FG013|Treatment Period|Participant withdrew consent|0|||
144700774|NCT03110107|521758212|FG014|Treatment Period|Participant withdrew consent|0|||
144700775|NCT03110107|521758213|FG015|Treatment Period|Participant withdrew consent|0|||
144700776|NCT03110107|521758214|FG016|Treatment Period|Participant withdrew consent|0|||
144700777|NCT03110107|521758215|FG017|Treatment Period|Participant withdrew consent|0|||
144700778|NCT03110107|521758216|FG018|Treatment Period|Participant withdrew consent|0|||
144700779|NCT03110107|521758217|FG019|Treatment Period|Participant withdrew consent|1|||
144700780|NCT03110107|521758218|FG020|Treatment Period|Participant withdrew consent|0|||
144700781|NCT03110107|521758219|FG021|Treatment Period|Participant withdrew consent|2|||
144700782|NCT03110107|521758220|FG022|Treatment Period|Participant withdrew consent|0|||
144700783|NCT03110107|521758221|FG023|Treatment Period|Participant withdrew consent|0|||
144700784|NCT03110107|521758222|FG024|Treatment Period|Participant withdrew consent|0|||
144700785|NCT03110107|521758223|FG025|Treatment Period|Participant withdrew consent|2|||
144700786|NCT03110107|521758198|FG000|Treatment Period|Participants no longer meets study criteria|0|||
144700787|NCT03110107|521758199|FG001|Treatment Period|Participants no longer meets study criteria|0|||
144700788|NCT03110107|521758200|FG002|Treatment Period|Participants no longer meets study criteria|0|||
144700789|NCT03110107|521758201|FG003|Treatment Period|Participants no longer meets study criteria|0|||
144700790|NCT03110107|521758202|FG004|Treatment Period|Participants no longer meets study criteria|0|||
144700791|NCT03110107|521758203|FG005|Treatment Period|Participants no longer meets study criteria|0|||
144700792|NCT03110107|521758204|FG006|Treatment Period|Participants no longer meets study criteria|0|||
144700793|NCT03110107|521758205|FG007|Treatment Period|Participants no longer meets study criteria|0|||
144700794|NCT03110107|521758206|FG008|Treatment Period|Participants no longer meets study criteria|0|||
144700795|NCT03110107|521758207|FG009|Treatment Period|Participants no longer meets study criteria|0|||
144700796|NCT03110107|521758208|FG010|Treatment Period|Participants no longer meets study criteria|0|||
144700797|NCT03110107|521758209|FG011|Treatment Period|Participants no longer meets study criteria|0|||
144700798|NCT03110107|521758210|FG012|Treatment Period|Participants no longer meets study criteria|0|||
144700799|NCT03110107|521758211|FG013|Treatment Period|Participants no longer meets study criteria|0|||
144700800|NCT03110107|521758212|FG014|Treatment Period|Participants no longer meets study criteria|0|||
144700801|NCT03110107|521758213|FG015|Treatment Period|Participants no longer meets study criteria|0|||
144700802|NCT03110107|521758214|FG016|Treatment Period|Participants no longer meets study criteria|0|||
144700803|NCT03110107|521758215|FG017|Treatment Period|Participants no longer meets study criteria|0|||
144700804|NCT03110107|521758216|FG018|Treatment Period|Participants no longer meets study criteria|0|||
144700805|NCT03110107|521758217|FG019|Treatment Period|Participants no longer meets study criteria|0|||
144700806|NCT03110107|521758218|FG020|Treatment Period|Participants no longer meets study criteria|0|||
144700807|NCT03110107|521758219|FG021|Treatment Period|Participants no longer meets study criteria|0|||
144700808|NCT03110107|521758220|FG022|Treatment Period|Participants no longer meets study criteria|0|||
144700809|NCT03110107|521758221|FG023|Treatment Period|Participants no longer meets study criteria|1|||
144700810|NCT03110107|521758222|FG024|Treatment Period|Participants no longer meets study criteria|0|||
144700811|NCT03110107|521758223|FG025|Treatment Period|Participants no longer meets study criteria|0|||
144700812|NCT03110107|521758198|FG000|Treatment Period|Other Reasons|0|||
144700813|NCT03110107|521758199|FG001|Treatment Period|Other Reasons|0|||
144700814|NCT03110107|521758200|FG002|Treatment Period|Other Reasons|1|||
144247346|NCT01313221|520104058|FG001|Overall Study|Protocol Violation|1|||
144700815|NCT03110107|521758201|FG003|Treatment Period|Other Reasons|1|||
144700816|NCT03110107|521758202|FG004|Treatment Period|Other Reasons|0|||
144700817|NCT03110107|521758203|FG005|Treatment Period|Other Reasons|1|||
144700818|NCT03110107|521758204|FG006|Treatment Period|Other Reasons|0|||
144700819|NCT03110107|521758205|FG007|Treatment Period|Other Reasons|0|||
144700820|NCT03110107|521758206|FG008|Treatment Period|Other Reasons|0|||
144700821|NCT03110107|521758207|FG009|Treatment Period|Other Reasons|0|||
144700822|NCT03110107|521758208|FG010|Treatment Period|Other Reasons|0|||
144700823|NCT03110107|521758209|FG011|Treatment Period|Other Reasons|0|||
144700824|NCT03110107|521758210|FG012|Treatment Period|Other Reasons|0|||
144700825|NCT03110107|521758211|FG013|Treatment Period|Other Reasons|0|||
144700826|NCT03110107|521758212|FG014|Treatment Period|Other Reasons|0|||
144700827|NCT03110107|521758213|FG015|Treatment Period|Other Reasons|0|||
144700828|NCT03110107|521758214|FG016|Treatment Period|Other Reasons|0|||
144700829|NCT03110107|521758215|FG017|Treatment Period|Other Reasons|0|||
144700830|NCT03110107|521758216|FG018|Treatment Period|Other Reasons|0|||
144700831|NCT03110107|521758217|FG019|Treatment Period|Other Reasons|0|||
144700832|NCT03110107|521758218|FG020|Treatment Period|Other Reasons|0|||
144700833|NCT03110107|521758219|FG021|Treatment Period|Other Reasons|0|||
144700834|NCT03110107|521758220|FG022|Treatment Period|Other Reasons|0|||
144700835|NCT03110107|521758221|FG023|Treatment Period|Other Reasons|0|||
144700836|NCT03110107|521758222|FG024|Treatment Period|Other Reasons|1|||
144700837|NCT03110107|521758223|FG025|Treatment Period|Other Reasons|0|||
144700838|NCT03526549|521758228|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
144700839|NCT03526549|521758229|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
144700840|NCT03526549|521758228|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
144700841|NCT03526549|521758229|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
144700842|NCT03526549|521758228|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
144700843|NCT03526549|521758229|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
144700844|NCT03526549|521758228|FG000|Open-label Phase|Adverse Event|4|||
144700845|NCT03526549|521758229|FG001|Open-label Phase|Adverse Event|0|||
144700846|NCT03526549|521758228|FG000|Open-label Phase|Withdrawal by Subject|54|||
144700847|NCT03526549|521758229|FG001|Open-label Phase|Withdrawal by Subject|0|||
144700848|NCT03526549|521758228|FG000|Open-label Phase|Lost to Follow-up|35|||
144700849|NCT03526549|521758229|FG001|Open-label Phase|Lost to Follow-up|0|||
144700850|NCT03526549|521758228|FG000|Open-label Phase|Other than Specified|5|||
144700851|NCT03526549|521758229|FG001|Open-label Phase|Other than Specified|0|||
144700852|NCT00478933|521758234|FG000|Overall Study|Protocol Violation|22|||
144700853|NCT00478933|521758234|FG000|Overall Study|Informed consent not verified|3|||
144700854|NCT00478933|521758234|FG000|Overall Study|Inadequate data available|53|||
144700855|NCT01453296|521758239|FG000|Treatment Period 1|Adverse Event|0|||
144700856|NCT01453296|521758240|FG001|Treatment Period 1|Adverse Event|1|||
144700857|NCT01453296|521758239|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
144700858|NCT01453296|521758240|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
144700859|NCT01453296|521758239|FG000|Treatment Period 2|Adverse Event|1|||
144700860|NCT01453296|521758240|FG001|Treatment Period 2|Adverse Event|0|||
144700861|NCT01453296|521758239|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144700862|NCT01453296|521758240|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144700863|NCT03155269|521758241|FG000|Overall Study|Withdrawal by Subject|4|||
144700864|NCT03155269|521758242|FG001|Overall Study|Withdrawal by Subject|5|||
144700865|NCT03155269|521758241|FG000|Overall Study|Lost to Follow-up|1|||
144700866|NCT03155269|521758242|FG001|Overall Study|Lost to Follow-up|2|||
144700867|NCT02686749|521758250|FG000|Overall Study|terminated for poor enrollment|2|||
144700868|NCT02686749|521758251|FG001|Overall Study|terminated for poor enrollment|2|||
144700869|NCT03707145|521758256|FG000|Overall Study|Lost to Follow-up|0|||
144700870|NCT03707145|521758257|FG001|Overall Study|Lost to Follow-up|1|||
144700871|NCT03707145|521758258|FG002|Overall Study|Lost to Follow-up|1|||
144700872|NCT03707145|521758259|FG003|Overall Study|Lost to Follow-up|0|||
144700873|NCT04882085|521758260|FG000|Overall Study|Death|6|||
144700874|NCT04882085|521758261|FG001|Overall Study|Death|9|||
144700875|NCT04882085|521758260|FG000|Overall Study|Withdrawal by Subject|0|||
144700876|NCT04882085|521758261|FG001|Overall Study|Withdrawal by Subject|3|||
144700877|NCT04882085|521758260|FG000|Overall Study|Randomized not treated|1|||
144700878|NCT04882085|521758261|FG001|Overall Study|Randomized not treated|0|||
144700879|NCT00145119|521758262|FG000|Overall Study|Death|45|||
144700880|NCT05403502|521758263|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
144700881|NCT05403502|521758263|FG000|Humalog Lead-In Period|Physician Decision|2|||
144700882|NCT05403502|521758263|FG000|Humalog Lead-In Period|Protocol Violation|1|||
144700883|NCT05403502|521758263|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
144700884|NCT05403502|521758263|FG000|Lyumjev Treatment Period|Physician Decision|2|||
144700885|NCT01003691|521758264|FG000|Overall Study|Adverse Event|0|||
144700886|NCT01003691|521758265|FG001|Overall Study|Adverse Event|0|||
144700887|NCT01003691|521758266|FG002|Overall Study|Adverse Event|0|||
144473767|NCT05044325|520934084|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144700888|NCT01003691|521758267|FG003|Overall Study|Adverse Event|1|||
144726952|NCT05630547|521854411|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
144700889|NCT04814654|521758268|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
144700890|NCT04814654|521758269|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
144700891|NCT04814654|521758270|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
144700892|NCT01676818|521758276|FG000|Overall Study|Physician Decision|1|||
144700893|NCT01676818|521758276|FG000|Overall Study|Withdrawal by Subject|1|||
144700894|NCT03213704|521758281|FG000|Overall Study|Physician Decision|3|||
144700895|NCT03213704|521758281|FG000|Overall Study|Protocol Violation|1|||
144700896|NCT03213704|521758281|FG000|Overall Study|Progressive disease|4|||
144700897|NCT02207413|521758282|FG000|Overall Study|Withdrawal by Subject|1|||
144700898|NCT02207413|521758283|FG001|Overall Study|Withdrawal by Subject|0|||
144700899|NCT02207413|521758284|FG002|Overall Study|Withdrawal by Subject|0|||
144700900|NCT02207413|521758285|FG003|Overall Study|Withdrawal by Subject|0|||
144700901|NCT02207413|521758286|FG004|Overall Study|Withdrawal by Subject|3|||
144700902|NCT02207413|521758287|FG005|Overall Study|Withdrawal by Subject|7|||
144700903|NCT02207413|521758282|FG000|Overall Study|Lost to Follow-up|0|||
144700904|NCT02207413|521758283|FG001|Overall Study|Lost to Follow-up|0|||
144700905|NCT02207413|521758284|FG002|Overall Study|Lost to Follow-up|0|||
144700906|NCT02207413|521758285|FG003|Overall Study|Lost to Follow-up|1|||
144700907|NCT02207413|521758286|FG004|Overall Study|Lost to Follow-up|1|||
144700908|NCT02207413|521758287|FG005|Overall Study|Lost to Follow-up|5|||
144700909|NCT02207413|521758282|FG000|Overall Study|Adverse Event|0|||
144700910|NCT02207413|521758283|FG001|Overall Study|Adverse Event|0|||
144700911|NCT02207413|521758284|FG002|Overall Study|Adverse Event|0|||
144700912|NCT02207413|521758285|FG003|Overall Study|Adverse Event|0|||
144700913|NCT02207413|521758286|FG004|Overall Study|Adverse Event|2|||
144700914|NCT02207413|521758287|FG005|Overall Study|Adverse Event|1|||
144700915|NCT02207413|521758282|FG000|Overall Study|Migrated/moved from study area|0|||
144700916|NCT02207413|521758283|FG001|Overall Study|Migrated/moved from study area|0|||
144700917|NCT02207413|521758284|FG002|Overall Study|Migrated/moved from study area|0|||
144700918|NCT02207413|521758285|FG003|Overall Study|Migrated/moved from study area|0|||
144700919|NCT02207413|521758286|FG004|Overall Study|Migrated/moved from study area|1|||
144700920|NCT02207413|521758287|FG005|Overall Study|Migrated/moved from study area|0|||
144700921|NCT04075656|521758288|FG000|Overall Study|Withdrawal by Subject|5|||
144700922|NCT04075656|521758289|FG001|Overall Study|Withdrawal by Subject|5|||
144726953|NCT05630547|521854412|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
144726954|NCT05630547|521854413|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
144726955|NCT05630547|521854410|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
144726956|NCT05630547|521854411|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
144726957|NCT05630547|521854412|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
144726958|NCT05630547|521854413|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
144726959|NCT05630547|521854410|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
144726960|NCT05630547|521854411|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
144726961|NCT05630547|521854412|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
144726962|NCT05630547|521854413|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
144726963|NCT05630547|521854410|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
144726964|NCT05630547|521854411|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
144726965|NCT05630547|521854412|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
144726966|NCT05630547|521854413|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
144726967|NCT05630547|521854410|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
144726968|NCT05630547|521854411|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
144726969|NCT05630547|521854412|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
144726970|NCT05630547|521854413|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
144726971|NCT00977470|521854414|FG000|Overall Study|Lack of Efficacy|32|||
144726972|NCT00977470|521854415|FG001|Overall Study|Lack of Efficacy|30|||
144726973|NCT00977470|521854414|FG000|Overall Study|Physician Decision|2|||
144726974|NCT00977470|521854415|FG001|Overall Study|Physician Decision|0|||
144726975|NCT00977470|521854414|FG000|Overall Study|Adverse Event|1|||
144726976|NCT00977470|521854415|FG001|Overall Study|Adverse Event|2|||
144726977|NCT00977470|521854414|FG000|Overall Study|Protocol Violation|1|||
144726978|NCT00977470|521854415|FG001|Overall Study|Protocol Violation|0|||
144726979|NCT00977470|521854414|FG000|Overall Study|Withdrawal by Subject|0|||
144726980|NCT00977470|521854415|FG001|Overall Study|Withdrawal by Subject|2|||
144726981|NCT00977470|521854414|FG000|Overall Study|Death|0|||
144726982|NCT00977470|521854415|FG001|Overall Study|Death|2|||
144726983|NCT00977470|521854414|FG000|Overall Study|clinical decline|0|||
144726984|NCT00977470|521854415|FG001|Overall Study|clinical decline|1|||
144726985|NCT00977470|521854414|FG000|Overall Study|prolonged recovery post-surgery|0|||
144726986|NCT00977470|521854415|FG001|Overall Study|prolonged recovery post-surgery|1|||
144726987|NCT00977470|521854414|FG000|Overall Study|Still on-study|2|||
144726988|NCT00977470|521854415|FG001|Overall Study|Still on-study|0|||
144726989|NCT00796822|521854416|FG000|Overall Study|Lost to Follow-up|2|||
144700923|NCT01646268|521759990|FG000|Overall Study|Adverse Event|6|||
144700924|NCT01646268|521759991|FG001|Overall Study|Adverse Event|7|||
144700925|NCT01646268|521759990|FG000|Overall Study|Lack of Efficacy|1|||
144700926|NCT01646268|521759991|FG001|Overall Study|Lack of Efficacy|3|||
144700927|NCT01646268|521759990|FG000|Overall Study|Protocol Violation|0|||
144700928|NCT01646268|521759991|FG001|Overall Study|Protocol Violation|1|||
144700929|NCT01646268|521759990|FG000|Overall Study|Withdrawal by Subject|2|||
144700930|NCT01646268|521759991|FG001|Overall Study|Withdrawal by Subject|5|||
144700931|NCT01646268|521759990|FG000|Overall Study|Other|2|||
144700932|NCT01646268|521759991|FG001|Overall Study|Other|0|||
144700933|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
144700934|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
144700935|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
144700936|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144700937|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144700938|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144700939|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144700940|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144700941|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
144700942|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
144700943|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144700944|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144700945|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144700946|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144700947|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
144700948|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
144700949|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
144700950|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144700951|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144700952|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144700953|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144700954|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
144700955|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
144700956|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
144700957|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144700958|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144700959|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144700960|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144700961|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
144700962|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
144700963|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
144700964|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
144700965|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
144700966|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
144700967|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
144700968|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
144700969|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
144700970|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
144700971|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
144700972|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
144700973|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
144700974|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
144700975|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
144700976|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
144700977|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
144247347|NCT01313221|520104059|FG002|Overall Study|Protocol Violation|1|||
144247348|NCT01313221|520104057|FG000|Overall Study|Non-compliance|3|||
144700978|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
144700979|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
144700980|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
144700981|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
144700982|NCT04242446|521760002|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144700983|NCT04242446|521760003|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
144473768|NCT05044325|520934085|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
144700984|NCT04242446|521760004|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
144700985|NCT04242446|521760005|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144700986|NCT04242446|521760006|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144700987|NCT04242446|521760007|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144700988|NCT04242446|521760008|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144700989|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144700990|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144700991|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144700992|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
144700993|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
144700994|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
144700995|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
144700996|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144700997|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144700998|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144700999|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
144701000|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
144701001|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
144701002|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
144701003|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701004|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701005|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701006|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
144701007|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
144701008|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
144701009|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
144701010|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
144701011|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
144701012|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
144701013|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
144701014|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
144701015|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
144701016|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
144701017|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
144701018|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
144701019|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
144701020|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
144701021|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
144701022|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
144701023|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
144701024|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
144701025|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
144701026|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
144701027|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
144701028|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
144701029|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
144701030|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
144701031|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
144701032|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
144701033|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
144701034|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
144701035|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
144701036|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
144701037|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
144701038|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
144701039|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
144701040|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
144701041|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
144701042|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
144701043|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
144701044|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
144701045|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
144701046|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
144701047|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
144701048|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
144701049|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
144701050|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
144701051|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
144701052|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
144701053|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
144701054|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
144701055|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
144701056|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
144701057|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
144701058|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
144701059|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
144701060|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
144701061|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
144701062|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
144701063|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
144701064|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
144701065|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
144701066|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
144701067|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
144701068|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
144701069|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
144701070|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
144701071|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
144701072|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
144701073|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
144701074|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
144701075|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
144701076|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
144701077|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
144701078|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
144701079|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
144701080|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
144701081|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
144701082|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
144701083|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
144701084|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
144701085|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
144701086|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
144701087|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
144701088|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
144701089|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
144701090|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
144701091|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
144701092|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
144701093|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
144701094|NCT04242446|521760002|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
144726990|NCT00796822|521854417|FG001|Overall Study|Lost to Follow-up|0|||
144473769|NCT05044325|520934086|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
144360653|NCT01667900|520529322|FG003|Part B|Death|0|||
144701095|NCT04242446|521760003|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
144701096|NCT04242446|521760004|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
144701097|NCT04242446|521760005|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
144701098|NCT04242446|521760006|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
144701099|NCT04242446|521760007|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
144701100|NCT04242446|521760008|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
144701101|NCT03587116|521760009|FG000|Overall Study|Lost to Follow-up|0|||
144701102|NCT03587116|521760010|FG001|Overall Study|Lost to Follow-up|1|||
144701103|NCT03587116|521760009|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
144701104|NCT03587116|521760010|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
144701105|NCT03587116|521760009|FG000|Overall Study|Withdrawal by Subject|4|||
144701106|NCT03587116|521760010|FG001|Overall Study|Withdrawal by Subject|0|||
144701107|NCT05981365|521760013|FG000|Period 1|Adverse Event|1|||
144701108|NCT05981365|521760014|FG001|Period 1|Adverse Event|0|||
144701109|NCT03927989|521760017|FG000|Overall Study|Withdrawal by Subject|0|||
144701110|NCT03927989|521760018|FG001|Overall Study|Withdrawal by Subject|1|||
144701111|NCT02593175|521760019|FG000|Overall Study|Adverse Event|5|||
144701112|NCT02593175|521760019|FG000|Overall Study|Disease progression|4|||
144701113|NCT00643006|521760021|FG000|Overall Study|Lost to Follow-up|5|||
144701114|NCT00643006|521760022|FG001|Overall Study|Lost to Follow-up|4|||
144701115|NCT03772574|521760023|FG000|Overall Study|Protocol Violation|2|||
144701116|NCT03772574|521760024|FG001|Overall Study|Protocol Violation|0|||
144701117|NCT03772574|521760025|FG002|Overall Study|Protocol Violation|0|||
144701118|NCT03772574|521760023|FG000|Overall Study|Discomfort|0|||
144701119|NCT03772574|521760024|FG001|Overall Study|Discomfort|5|||
144701120|NCT03772574|521760025|FG002|Overall Study|Discomfort|4|||
144701121|NCT03586427|521760028|FG000|Overall Study|Lost to Follow-up|0|||
144701122|NCT03586427|521760029|FG001|Overall Study|Lost to Follow-up|3|||
144701123|NCT03586427|521760030|FG002|Overall Study|Lost to Follow-up|1|||
144701124|NCT03586427|521760031|FG003|Overall Study|Lost to Follow-up|3|||
144701125|NCT03586427|521760032|FG004|Overall Study|Lost to Follow-up|3|||
144701126|NCT03586427|521760028|FG000|Overall Study|Withdrawal by Subject|0|||
144701127|NCT03586427|521760029|FG001|Overall Study|Withdrawal by Subject|1|||
144701128|NCT03586427|521760030|FG002|Overall Study|Withdrawal by Subject|2|||
144701129|NCT03586427|521760031|FG003|Overall Study|Withdrawal by Subject|1|||
144701130|NCT03586427|521760032|FG004|Overall Study|Withdrawal by Subject|1|||
144701131|NCT03586427|521760028|FG000|Overall Study|Adverse Event|0|||
144701132|NCT03586427|521760029|FG001|Overall Study|Adverse Event|0|||
144701133|NCT03586427|521760030|FG002|Overall Study|Adverse Event|1|||
144701134|NCT03586427|521760031|FG003|Overall Study|Adverse Event|0|||
144701135|NCT03586427|521760032|FG004|Overall Study|Adverse Event|0|||
144701136|NCT03586427|521760028|FG000|Overall Study|Protocol Violation|0|||
144701137|NCT03586427|521760029|FG001|Overall Study|Protocol Violation|0|||
144701138|NCT03586427|521760030|FG002|Overall Study|Protocol Violation|1|||
144701139|NCT03586427|521760031|FG003|Overall Study|Protocol Violation|0|||
144701140|NCT03586427|521760032|FG004|Overall Study|Protocol Violation|1|||
144701141|NCT03586427|521760028|FG000|Overall Study|Noncompliance with study drug|0|||
144701142|NCT03586427|521760029|FG001|Overall Study|Noncompliance with study drug|0|||
144701143|NCT03586427|521760030|FG002|Overall Study|Noncompliance with study drug|1|||
144701144|NCT03586427|521760031|FG003|Overall Study|Noncompliance with study drug|0|||
144701145|NCT03586427|521760032|FG004|Overall Study|Noncompliance with study drug|0|||
144701146|NCT03193996|521760035|FG000|Overall Study|Withdrawal by Subject|4|||
144701147|NCT03193996|521760035|FG000|Overall Study|Lost to Follow-up|4|||
144701148|NCT03193996|521760035|FG000|Overall Study|Physician Decision|2|||
144701149|NCT03193996|521760035|FG000|Overall Study|Pregnancy|1|||
144701150|NCT03193996|521760035|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
144701151|NCT03193996|521760035|FG000|Overall Study|Complicating disease|1|||
144701152|NCT00593385|521760038|FG000|Overall Study|Death|14|||
144701153|NCT00593385|521760038|FG000|Overall Study|Lost to Follow-up|17|||
144701154|NCT00593385|521760038|FG000|Overall Study|Withdrawal by Subject|9|||
144701155|NCT01471197|521760039|FG000|Overall Study|Disease Progression|4|||
144701156|NCT01471197|521760040|FG001|Overall Study|Disease Progression|2|||
144701157|NCT01471197|521760039|FG000|Overall Study|Death|1|||
144701158|NCT01471197|521760040|FG001|Overall Study|Death|0|||
144701159|NCT01471197|521760039|FG000|Overall Study|Study Drug Toxicity|1|||
144701160|NCT01471197|521760040|FG001|Overall Study|Study Drug Toxicity|0|||
144701161|NCT00924313|521760043|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
144701162|NCT04983589|521760051|FG000|Overall Study|Withdrawal by Subject|0|||
144701163|NCT04983589|521760052|FG001|Overall Study|Withdrawal by Subject|3|||
144701164|NCT04983589|521760051|FG000|Overall Study|COVID-19 Infection|1|||
144701165|NCT04983589|521760052|FG001|Overall Study|COVID-19 Infection|0|||
144701166|NCT04983589|521760051|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
144701167|NCT04983589|521760052|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
144701168|NCT00978120|521760055|FG000|Overall Study|Death|0|||
144701169|NCT00978120|521760056|FG001|Overall Study|Death|0|||
144701170|NCT00978120|521760057|FG002|Overall Study|Death|0|||
144701171|NCT00978120|521760058|FG003|Overall Study|Death|1|||
144701172|NCT00978120|521760055|FG000|Overall Study|Lost to Follow-up|0|||
144701173|NCT00978120|521760056|FG001|Overall Study|Lost to Follow-up|0|||
144701174|NCT00978120|521760057|FG002|Overall Study|Lost to Follow-up|3|||
144701175|NCT00978120|521760058|FG003|Overall Study|Lost to Follow-up|0|||
144701176|NCT00978120|521760055|FG000|Overall Study|Withdrawal by Subject|2|||
144701177|NCT00978120|521760056|FG001|Overall Study|Withdrawal by Subject|0|||
144701178|NCT00978120|521760057|FG002|Overall Study|Withdrawal by Subject|0|||
144701179|NCT00978120|521760058|FG003|Overall Study|Withdrawal by Subject|0|||
144701180|NCT00978120|521760055|FG000|Overall Study|Moved out of state|0|||
144701181|NCT00978120|521760056|FG001|Overall Study|Moved out of state|0|||
144701182|NCT00978120|521760057|FG002|Overall Study|Moved out of state|0|||
144701183|NCT00978120|521760058|FG003|Overall Study|Moved out of state|1|||
144701184|NCT00455923|521760060|FG000|Overall Study|Pregnancy|0|||
144701185|NCT00455923|521760061|FG001|Overall Study|Pregnancy|2|||
144701186|NCT00455923|521760060|FG000|Overall Study|Other|3|||
144701187|NCT00455923|521760061|FG001|Overall Study|Other|1|||
144701188|NCT01870921|521760062|FG000|Overall Study|Subject decision|80|||
144701189|NCT01870921|521760062|FG000|Overall Study|Severe non-compliance to protocol|7|||
144701190|NCT01870921|521760062|FG000|Overall Study|Subject Lost to Follow up|2|||
144701191|NCT01870921|521760062|FG000|Overall Study|Other|1|||
144701192|NCT02152982|521760063|FG000|Overall Study|Withdrawal by Subject|17|||
144701193|NCT02152982|521760064|FG001|Overall Study|Withdrawal by Subject|16|||
144701194|NCT02152982|521760063|FG000|Overall Study|Did not start treatment|11|||
144701195|NCT02152982|521760064|FG001|Overall Study|Did not start treatment|5|||
144701196|NCT02152982|521760063|FG000|Overall Study|Disease progression|41|||
144701197|NCT02152982|521760064|FG001|Overall Study|Disease progression|52|||
144701198|NCT02152982|521760063|FG000|Overall Study|Adverse Event|7|||
144701199|NCT02152982|521760064|FG001|Overall Study|Adverse Event|12|||
144701200|NCT02152982|521760063|FG000|Overall Study|Complicating disease|1|||
144701201|NCT02152982|521760064|FG001|Overall Study|Complicating disease|1|||
144701202|NCT02152982|521760063|FG000|Overall Study|Death|0|||
144701203|NCT02152982|521760064|FG001|Overall Study|Death|3|||
144701204|NCT02152982|521760063|FG000|Overall Study|Physician Decision|3|||
144701205|NCT02152982|521760064|FG001|Overall Study|Physician Decision|0|||
144701206|NCT03075826|521760065|FG000|Overall Study|Withdrawal by Subject|1|||
144701207|NCT03075826|521760065|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
144701208|NCT00650806|521760066|FG000|Overall Study|Adverse Event|0|||
144701209|NCT00650806|521760067|FG001|Overall Study|Adverse Event|5|||
144701210|NCT00650806|521760068|FG002|Overall Study|Adverse Event|3|||
144701211|NCT00650806|521760069|FG003|Overall Study|Adverse Event|4|||
144701212|NCT00650806|521760066|FG000|Overall Study|Lost to Follow-up|7|||
144701213|NCT00650806|521760067|FG001|Overall Study|Lost to Follow-up|6|||
144701214|NCT00650806|521760068|FG002|Overall Study|Lost to Follow-up|11|||
144701215|NCT00650806|521760069|FG003|Overall Study|Lost to Follow-up|10|||
144701216|NCT00650806|521760066|FG000|Overall Study|Protocol Violation|0|||
144701217|NCT00650806|521760067|FG001|Overall Study|Protocol Violation|0|||
144701218|NCT00650806|521760068|FG002|Overall Study|Protocol Violation|0|||
144701219|NCT00650806|521760069|FG003|Overall Study|Protocol Violation|1|||
144701220|NCT00650806|521760066|FG000|Overall Study|Pregnancy|0|||
144701221|NCT00650806|521760067|FG001|Overall Study|Pregnancy|0|||
144701222|NCT00650806|521760068|FG002|Overall Study|Pregnancy|0|||
144701223|NCT00650806|521760069|FG003|Overall Study|Pregnancy|1|||
144701224|NCT00650806|521760066|FG000|Overall Study|Withdrawal by Subject|7|||
144701225|NCT00650806|521760067|FG001|Overall Study|Withdrawal by Subject|5|||
144701226|NCT00650806|521760068|FG002|Overall Study|Withdrawal by Subject|8|||
144701227|NCT00650806|521760069|FG003|Overall Study|Withdrawal by Subject|6|||
144701228|NCT00650806|521760066|FG000|Overall Study|Noncompliance with study drug regimen|1|||
144701229|NCT00650806|521760067|FG001|Overall Study|Noncompliance with study drug regimen|1|||
144701230|NCT00650806|521760068|FG002|Overall Study|Noncompliance with study drug regimen|0|||
144701231|NCT00650806|521760069|FG003|Overall Study|Noncompliance with study drug regimen|0|||
144701232|NCT00650806|521760066|FG000|Overall Study|Study terminated by sponsor|2|||
144701233|NCT00650806|521760067|FG001|Overall Study|Study terminated by sponsor|3|||
144701234|NCT00650806|521760068|FG002|Overall Study|Study terminated by sponsor|5|||
144701235|NCT00650806|521760069|FG003|Overall Study|Study terminated by sponsor|4|||
144701236|NCT00650806|521760066|FG000|Overall Study|Other|1|||
144701237|NCT00650806|521760067|FG001|Overall Study|Other|1|||
144701238|NCT00650806|521760068|FG002|Overall Study|Other|2|||
144701239|NCT00650806|521760069|FG003|Overall Study|Other|0|||
144701240|NCT04221477|521760070|FG000|Overall Study|Adverse Event|1|||
144701241|NCT04221477|521760071|FG001|Overall Study|Adverse Event|1|||
144701242|NCT04221477|521760070|FG000|Overall Study|Death|5|||
144701243|NCT04221477|521760071|FG001|Overall Study|Death|4|||
144701244|NCT04221477|521760070|FG000|Overall Study|Lack of Efficacy|1|||
144701245|NCT04221477|521760071|FG001|Overall Study|Lack of Efficacy|2|||
144701246|NCT04221477|521760070|FG000|Overall Study|Lost to Follow-up|1|||
144701247|NCT04221477|521760071|FG001|Overall Study|Lost to Follow-up|2|||
144701248|NCT04221477|521760070|FG000|Overall Study|Non-compliance with Study Drug|1|||
144726991|NCT00796822|521854416|FG000|Overall Study|Adverse Event|1|||
144701249|NCT04221477|521760071|FG001|Overall Study|Non-compliance with Study Drug|0|||
144701250|NCT04221477|521760070|FG000|Overall Study|Reason not Specified|0|||
144701251|NCT04221477|521760071|FG001|Overall Study|Reason not Specified|5|||
144701252|NCT04221477|521760070|FG000|Overall Study|Physician Decision|0|||
144701253|NCT04221477|521760071|FG001|Overall Study|Physician Decision|6|||
144701254|NCT04221477|521760070|FG000|Overall Study|Withdrawal by Subject|10|||
144701255|NCT04221477|521760071|FG001|Overall Study|Withdrawal by Subject|14|||
144701256|NCT04221477|521760070|FG000|Overall Study|Ongoing in the Study|116|||
144701257|NCT04221477|521760071|FG001|Overall Study|Ongoing in the Study|102|||
144701258|NCT02242942|521760072|FG000|Overall Study|Death|17|||
144701259|NCT02242942|521760073|FG001|Overall Study|Death|20|||
144701260|NCT02242942|521760074|FG002|Overall Study|Death|2|||
144701261|NCT02242942|521760072|FG000|Overall Study|Physician Decision|1|||
144701262|NCT02242942|521760073|FG001|Overall Study|Physician Decision|0|||
144701263|NCT02242942|521760074|FG002|Overall Study|Physician Decision|0|||
144701264|NCT02242942|521760072|FG000|Overall Study|Withdrawal by Subject|8|||
144701265|NCT02242942|521760073|FG001|Overall Study|Withdrawal by Subject|10|||
144701266|NCT02242942|521760074|FG002|Overall Study|Withdrawal by Subject|0|||
144701267|NCT02242942|521760072|FG000|Overall Study|On-going in Study|190|||
144701268|NCT02242942|521760073|FG001|Overall Study|On-going in Study|186|||
144701269|NCT02242942|521760074|FG002|Overall Study|On-going in Study|11|||
144701270|NCT00098475|521760083|FG000|Step 1|Progressive disease|33|||
144701271|NCT00098475|521760084|FG001|Step 1|Progressive disease|35|||
144701272|NCT00098475|521760085|FG002|Step 1|Progressive disease|2|||
144701273|NCT00098475|521760086|FG003|Step 1|Progressive disease|1|||
144701274|NCT00098475|521760083|FG000|Step 1|Adverse Event|56|||
144701275|NCT00098475|521760084|FG001|Step 1|Adverse Event|37|||
144701276|NCT00098475|521760085|FG002|Step 1|Adverse Event|0|||
144701277|NCT00098475|521760086|FG003|Step 1|Adverse Event|1|||
144701278|NCT00098475|521760083|FG000|Step 1|Death|8|||
144701279|NCT00098475|521760084|FG001|Step 1|Death|5|||
144701280|NCT00098475|521760085|FG002|Step 1|Death|0|||
144701281|NCT00098475|521760086|FG003|Step 1|Death|1|||
144701282|NCT00098475|521760083|FG000|Step 1|Withdrawal by Subject|14|||
144701283|NCT00098475|521760084|FG001|Step 1|Withdrawal by Subject|11|||
144701284|NCT00098475|521760085|FG002|Step 1|Withdrawal by Subject|0|||
144701285|NCT00098475|521760086|FG003|Step 1|Withdrawal by Subject|0|||
144701286|NCT00098475|521760083|FG000|Step 1|Physician Decision|5|||
144701287|NCT00098475|521760084|FG001|Step 1|Physician Decision|2|||
144701288|NCT00098475|521760085|FG002|Step 1|Physician Decision|0|||
144701289|NCT00098475|521760086|FG003|Step 1|Physician Decision|0|||
144701290|NCT00098475|521760083|FG000|Step 1|Alternative therapy|31|||
144701291|NCT00098475|521760084|FG001|Step 1|Alternative therapy|43|||
144701292|NCT00098475|521760085|FG002|Step 1|Alternative therapy|1|||
144701293|NCT00098475|521760086|FG003|Step 1|Alternative therapy|0|||
144701294|NCT00098475|521760083|FG000|Step 1|Other disease|2|||
144701295|NCT00098475|521760084|FG001|Step 1|Other disease|1|||
144701296|NCT00098475|521760085|FG002|Step 1|Other disease|1|||
144701297|NCT00098475|521760086|FG003|Step 1|Other disease|0|||
144701298|NCT00098475|521760083|FG000|Step 1|Never started treatment|0|||
144701299|NCT00098475|521760084|FG001|Step 1|Never started treatment|2|||
144701300|NCT00098475|521760085|FG002|Step 1|Never started treatment|0|||
144701301|NCT00098475|521760086|FG003|Step 1|Never started treatment|0|||
144701302|NCT00098475|521760083|FG000|Step 1|Still on treatment as of this analysis|14|||
144701303|NCT00098475|521760084|FG001|Step 1|Still on treatment as of this analysis|27|||
144701304|NCT00098475|521760085|FG002|Step 1|Still on treatment as of this analysis|0|||
144701305|NCT00098475|521760086|FG003|Step 1|Still on treatment as of this analysis|0|||
144701306|NCT00098475|521760083|FG000|Step 1|Knee surgery|1|||
144701307|NCT00098475|521760084|FG001|Step 1|Knee surgery|0|||
144701308|NCT00098475|521760085|FG002|Step 1|Knee surgery|0|||
144701309|NCT00098475|521760086|FG003|Step 1|Knee surgery|0|||
144701310|NCT00098475|521760083|FG000|Step 1|Complications|1|||
144701311|NCT00098475|521760084|FG001|Step 1|Complications|0|||
144701312|NCT00098475|521760085|FG002|Step 1|Complications|0|||
144701313|NCT00098475|521760086|FG003|Step 1|Complications|0|||
144701314|NCT00098475|521760083|FG000|Step 1|Cannot comply due to other tx|0|||
144701315|NCT00098475|521760084|FG001|Step 1|Cannot comply due to other tx|1|||
144701316|NCT00098475|521760085|FG002|Step 1|Cannot comply due to other tx|0|||
144701317|NCT00098475|521760086|FG003|Step 1|Cannot comply due to other tx|0|||
144701318|NCT00098475|521760083|FG000|Step 1|Both patient and physician's decision|2|||
144701319|NCT00098475|521760084|FG001|Step 1|Both patient and physician's decision|1|||
144701320|NCT00098475|521760085|FG002|Step 1|Both patient and physician's decision|0|||
144701321|NCT00098475|521760086|FG003|Step 1|Both patient and physician's decision|0|||
144701322|NCT00098475|521760083|FG000|Step 1|Incorrect disease assessment|2|||
144701323|NCT00098475|521760084|FG001|Step 1|Incorrect disease assessment|0|||
144701324|NCT00098475|521760085|FG002|Step 1|Incorrect disease assessment|0|||
144701325|NCT00098475|521760086|FG003|Step 1|Incorrect disease assessment|0|||
144701326|NCT00098475|521760083|FG000|Step 1|Off treatment for > specified timeframe|1|||
144701327|NCT00098475|521760084|FG001|Step 1|Off treatment for > specified timeframe|1|||
144701328|NCT00098475|521760085|FG002|Step 1|Off treatment for > specified timeframe|0|||
144701329|NCT00098475|521760086|FG003|Step 1|Off treatment for > specified timeframe|0|||
144701330|NCT00098475|521760083|FG000|Step 1|Declining performance status|0|||
144701331|NCT00098475|521760084|FG001|Step 1|Declining performance status|1|||
144701332|NCT00098475|521760085|FG002|Step 1|Declining performance status|0|||
144701333|NCT00098475|521760086|FG003|Step 1|Declining performance status|0|||
144701334|NCT00098475|521760083|FG000|Step 1|Insurance issue|0|||
144701335|NCT00098475|521760084|FG001|Step 1|Insurance issue|1|||
144701336|NCT00098475|521760085|FG002|Step 1|Insurance issue|0|||
144701337|NCT00098475|521760086|FG003|Step 1|Insurance issue|0|||
144701338|NCT00098475|521760083|FG000|Step 1|Rising paraprotein|0|||
144701339|NCT00098475|521760084|FG001|Step 1|Rising paraprotein|1|||
144701340|NCT00098475|521760085|FG002|Step 1|Rising paraprotein|0|||
144701341|NCT00098475|521760086|FG003|Step 1|Rising paraprotein|0|||
144701342|NCT00098475|521760083|FG000|Step 1|Referred to other physicians|0|||
144701343|NCT00098475|521760084|FG001|Step 1|Referred to other physicians|1|||
144701344|NCT00098475|521760085|FG002|Step 1|Referred to other physicians|0|||
144701345|NCT00098475|521760086|FG003|Step 1|Referred to other physicians|0|||
144701346|NCT00098475|521760083|FG000|Step 1|Criteria to continue treatment not met|0|||
144701347|NCT00098475|521760084|FG001|Step 1|Criteria to continue treatment not met|1|||
144701348|NCT00098475|521760085|FG002|Step 1|Criteria to continue treatment not met|0|||
144701349|NCT00098475|521760086|FG003|Step 1|Criteria to continue treatment not met|0|||
144701350|NCT00098475|521760083|FG000|Step 1|Misinterpretation of lab data|0|||
144701351|NCT00098475|521760084|FG001|Step 1|Misinterpretation of lab data|1|||
144701352|NCT00098475|521760085|FG002|Step 1|Misinterpretation of lab data|0|||
144701353|NCT00098475|521760086|FG003|Step 1|Misinterpretation of lab data|0|||
144701354|NCT00098475|521760083|FG000|Step 1|Patient fell with fracture|1|||
144701355|NCT00098475|521760084|FG001|Step 1|Patient fell with fracture|0|||
144701356|NCT00098475|521760085|FG002|Step 1|Patient fell with fracture|0|||
144701357|NCT00098475|521760086|FG003|Step 1|Patient fell with fracture|0|||
144701358|NCT00098475|521760083|FG000|Step 1|Not documented|0|||
144701359|NCT00098475|521760084|FG001|Step 1|Not documented|1|||
144701360|NCT00098475|521760085|FG002|Step 1|Not documented|0|||
144701361|NCT00098475|521760086|FG003|Step 1|Not documented|0|||
144701362|NCT00098475|521760083|FG000|Step 2|Disease progression|1|||
144701363|NCT00098475|521760084|FG001|Step 2|Disease progression|4|||
144701364|NCT00098475|521760085|FG002|Step 2|Disease progression|0|||
144701365|NCT00098475|521760086|FG003|Step 2|Disease progression|0|||
144701366|NCT00098475|521760083|FG000|Step 2|Adverse Event|2|||
144701367|NCT00098475|521760084|FG001|Step 2|Adverse Event|0|||
144701368|NCT00098475|521760085|FG002|Step 2|Adverse Event|0|||
144701369|NCT00098475|521760086|FG003|Step 2|Adverse Event|0|||
144701370|NCT00098475|521760083|FG000|Step 2|Withdrawal by Subject|0|||
144701371|NCT00098475|521760084|FG001|Step 2|Withdrawal by Subject|2|||
144701372|NCT00098475|521760085|FG002|Step 2|Withdrawal by Subject|0|||
144701373|NCT00098475|521760086|FG003|Step 2|Withdrawal by Subject|0|||
144701374|NCT00098475|521760083|FG000|Step 2|Physician Decision|0|||
144701375|NCT00098475|521760084|FG001|Step 2|Physician Decision|1|||
144701376|NCT00098475|521760085|FG002|Step 2|Physician Decision|0|||
144701377|NCT00098475|521760086|FG003|Step 2|Physician Decision|0|||
144701378|NCT00098475|521760083|FG000|Step 2|Alternative therapy|1|||
144701379|NCT00098475|521760084|FG001|Step 2|Alternative therapy|2|||
144701380|NCT00098475|521760085|FG002|Step 2|Alternative therapy|0|||
144701381|NCT00098475|521760086|FG003|Step 2|Alternative therapy|0|||
144701382|NCT00098475|521760083|FG000|Step 2|Never started treatment|1|||
144701383|NCT00098475|521760084|FG001|Step 2|Never started treatment|1|||
144701384|NCT00098475|521760085|FG002|Step 2|Never started treatment|0|||
144701385|NCT00098475|521760086|FG003|Step 2|Never started treatment|0|||
144701386|NCT05681715|521760087|FG000|Training Period (6-weeks)|Adverse Event|3|||
144701387|NCT05681715|521760088|FG001|Training Period (6-weeks)|Adverse Event|0|||
144701388|NCT05681715|521760089|FG002|Training Period (6-weeks)|Adverse Event|0|||
144701389|NCT05681715|521760087|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
144701390|NCT05681715|521760088|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
144701391|NCT05681715|521760089|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
144701392|NCT05681715|521760087|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
144701393|NCT05681715|521760088|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
144701394|NCT05681715|521760089|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
144701395|NCT05681715|521760087|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
144701396|NCT05681715|521760088|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
144701397|NCT05681715|521760089|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
144726992|NCT00796822|521854417|FG001|Overall Study|Adverse Event|0|||
144726993|NCT02364557|521854418|FG000|Overall Study|Protocol Violation|3|||
144726994|NCT02364557|521854419|FG001|Overall Study|Protocol Violation|1|||
144726995|NCT03978624|521854420|FG000|Overall Study|Protocol Violation|1|||
144726996|NCT03978624|521854421|FG001|Overall Study|Protocol Violation|0|||
144726997|NCT05097989|521854423|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144726998|NCT05097989|521854424|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144726999|NCT05097989|521854425|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144727000|NCT05097989|521854426|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144727001|NCT05097989|521854427|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144727002|NCT05097989|521854428|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
144727003|NCT05097989|521854429|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144727004|NCT05097989|521854430|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144727005|NCT05097989|521854431|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
144727006|NCT05097989|521854423|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
144727007|NCT05097989|521854424|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
144727008|NCT05097989|521854425|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
144727009|NCT05097989|521854426|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
144727010|NCT05097989|521854427|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
144727011|NCT05097989|521854428|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
144727012|NCT05097989|521854429|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
144727013|NCT05097989|521854430|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
144727014|NCT05097989|521854431|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
144727015|NCT05097989|521854423|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
144727016|NCT05097989|521854424|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
144727017|NCT05097989|521854425|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
144727018|NCT05097989|521854426|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
144727019|NCT05097989|521854427|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
144727020|NCT05097989|521854428|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
144727021|NCT05097989|521854429|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
144727022|NCT05097989|521854430|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
144727023|NCT05097989|521854431|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
144727024|NCT05097989|521854423|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
144727025|NCT05097989|521854424|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
144727026|NCT05097989|521854425|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
144727027|NCT05097989|521854426|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
144727028|NCT05097989|521854427|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
144727029|NCT05097989|521854428|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
144727030|NCT05097989|521854429|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
144727031|NCT05097989|521854430|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
144727032|NCT05097989|521854431|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
144727033|NCT05097989|521854423|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144701398|NCT05681715|521760087|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
144701399|NCT05681715|521760088|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
144701400|NCT05681715|521760089|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
144701401|NCT05681715|521760087|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
144701402|NCT05681715|521760088|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
144701403|NCT05681715|521760089|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
144701404|NCT05681715|521760087|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
144701405|NCT05681715|521760088|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
144701406|NCT05681715|521760089|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
144701407|NCT05681715|521760087|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
144701408|NCT05681715|521760088|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
144701409|NCT05681715|521760089|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
144701410|NCT05455684|521760090|FG000|Overall Study|Withdrawal by Subject|7|||
144701411|NCT05455684|521760091|FG001|Overall Study|Withdrawal by Subject|4|||
144701412|NCT05455684|521760090|FG000|Overall Study|Lost to Follow-up|3|||
144701413|NCT05455684|521760091|FG001|Overall Study|Lost to Follow-up|3|||
144701414|NCT05455684|521760090|FG000|Overall Study|Adverse Event|2|||
144701415|NCT05455684|521760091|FG001|Overall Study|Adverse Event|3|||
144701416|NCT05455684|521760090|FG000|Overall Study|Protocol Violation|1|||
144701417|NCT05455684|521760091|FG001|Overall Study|Protocol Violation|1|||
144701418|NCT05455684|521760090|FG000|Overall Study|Non-Compliant with study drug|0|||
144701419|NCT05455684|521760091|FG001|Overall Study|Non-Compliant with study drug|1|||
144701420|NCT05455684|521760090|FG000|Overall Study|Other|1|||
144701421|NCT05455684|521760091|FG001|Overall Study|Other|2|||
144701422|NCT05455684|521760090|FG000|Overall Study|Randomized but not treated|1|||
144701423|NCT05455684|521760091|FG001|Overall Study|Randomized but not treated|0|||
144701424|NCT05116241|521760092|FG000|Study|Withdrawal by Subject|5|||
144701425|NCT05116241|521760093|FG001|Study|Withdrawal by Subject|2|||
144701426|NCT05116241|521760094|FG002|Study|Withdrawal by Subject|1|||
144701427|NCT05116241|521760092|FG000|Study|Lost to Follow-up|0|||
144701428|NCT05116241|521760093|FG001|Study|Lost to Follow-up|2|||
144701429|NCT05116241|521760094|FG002|Study|Lost to Follow-up|2|||
144701430|NCT05204563|521760095|FG000|Overall Study|Other than Specified|2|||
144701431|NCT05204563|521760096|FG001|Overall Study|Other than Specified|1|||
144701432|NCT05204563|521760095|FG000|Overall Study|Death|18|||
144701433|NCT05204563|521760096|FG001|Overall Study|Death|4|||
144701434|NCT05204563|521760095|FG000|Overall Study|Lost to Follow-up|6|||
144701435|NCT05204563|521760096|FG001|Overall Study|Lost to Follow-up|3|||
144701436|NCT05204563|521760095|FG000|Overall Study|Withdrawal by Subject|12|||
144701437|NCT05204563|521760096|FG001|Overall Study|Withdrawal by Subject|3|||
144701438|NCT05204563|521760095|FG000|Overall Study|Enrolled, Not Treated|1|||
144701439|NCT05204563|521760096|FG001|Overall Study|Enrolled, Not Treated|0|||
144701440|NCT04755283|521760099|FG000|Overall Study|Withdrawal by Subject|14|||
144701441|NCT04755283|521760100|FG001|Overall Study|Withdrawal by Subject|3|||
144701442|NCT04755283|521760101|FG002|Overall Study|Withdrawal by Subject|6|||
144701443|NCT04755283|521760099|FG000|Overall Study|Lost to Follow-up|0|||
144701444|NCT04755283|521760100|FG001|Overall Study|Lost to Follow-up|0|||
144701445|NCT04755283|521760101|FG002|Overall Study|Lost to Follow-up|1|||
144701446|NCT04755283|521760099|FG000|Overall Study|Death|31|||
144701447|NCT04755283|521760100|FG001|Overall Study|Death|36|||
144701448|NCT04755283|521760101|FG002|Overall Study|Death|34|||
144701449|NCT02268214|521760102|FG000|Overall Study|Subject no longer meets study criteria|0|||
144701450|NCT02268214|521760103|FG001|Overall Study|Subject no longer meets study criteria|2|||
144701451|NCT02268214|521760104|FG002|Overall Study|Subject no longer meets study criteria|0|||
144701452|NCT02268214|521760102|FG000|Overall Study|Pregnancy|2|||
144701453|NCT02268214|521760103|FG001|Overall Study|Pregnancy|2|||
144701454|NCT02268214|521760104|FG002|Overall Study|Pregnancy|1|||
144701455|NCT02268214|521760102|FG000|Overall Study|Lost to Follow-up|3|||
144701456|NCT02268214|521760103|FG001|Overall Study|Lost to Follow-up|3|||
144701457|NCT02268214|521760104|FG002|Overall Study|Lost to Follow-up|4|||
144701458|NCT02268214|521760102|FG000|Overall Study|Lack of Efficacy|1|||
144701459|NCT02268214|521760103|FG001|Overall Study|Lack of Efficacy|0|||
144701460|NCT02268214|521760104|FG002|Overall Study|Lack of Efficacy|2|||
144701461|NCT02268214|521760102|FG000|Overall Study|Adverse Event|11|||
144701462|NCT02268214|521760103|FG001|Overall Study|Adverse Event|14|||
144701463|NCT02268214|521760104|FG002|Overall Study|Adverse Event|9|||
144701464|NCT02268214|521760102|FG000|Overall Study|Withdrawal by Subject|4|||
144701465|NCT02268214|521760103|FG001|Overall Study|Withdrawal by Subject|5|||
144701466|NCT02268214|521760104|FG002|Overall Study|Withdrawal by Subject|10|||
144701467|NCT02268214|521760102|FG000|Overall Study|Subject request to discontinue treatment|10|||
144701468|NCT02268214|521760103|FG001|Overall Study|Subject request to discontinue treatment|8|||
144701469|NCT02268214|521760104|FG002|Overall Study|Subject request to discontinue treatment|6|||
144360654|NCT01667900|520529323|FG004|Part B|Death|0|||
144701470|NCT02268214|521760102|FG000|Overall Study|Poor/non-compliance|2|||
144701471|NCT02268214|521760103|FG001|Overall Study|Poor/non-compliance|1|||
144701472|NCT02268214|521760104|FG002|Overall Study|Poor/non-compliance|2|||
144701473|NCT02268214|521760102|FG000|Overall Study|Other reasons|7|||
144701474|NCT02268214|521760103|FG001|Overall Study|Other reasons|3|||
144701475|NCT02268214|521760104|FG002|Overall Study|Other reasons|3|||
144701476|NCT02268214|521760102|FG000|Overall Study|Not entering long-term period|2|||
144701477|NCT02268214|521760103|FG001|Overall Study|Not entering long-term period|3|||
144701478|NCT02268214|521760104|FG002|Overall Study|Not entering long-term period|5|||
144701479|NCT04342390|521760105|FG000|Overall Study|Lost to Follow-up|3|||
144701480|NCT04342390|521760106|FG001|Overall Study|Lost to Follow-up|0|||
144701481|NCT02951130|521760110|FG000|Overall Study|Protocol Violation|1|||
144701482|NCT02951130|521760111|FG001|Overall Study|Protocol Violation|1|||
144360655|NCT01667900|520529324|FG005|Part B|Death|0|||
144360656|NCT01667900|520529325|FG006|Part B|Death|0|||
144360657|NCT01667900|520529326|FG007|Part B|Death|0|||
144247349|NCT01313221|520104058|FG001|Overall Study|Non-compliance|0|||
144247350|NCT01313221|520104059|FG002|Overall Study|Non-compliance|2|||
144247351|NCT01313221|520104057|FG000|Overall Study|Withdrawal by Subject|2|||
144247352|NCT01313221|520104058|FG001|Overall Study|Withdrawal by Subject|3|||
144247353|NCT01313221|520104059|FG002|Overall Study|Withdrawal by Subject|5|||
144247354|NCT01313221|520104057|FG000|Overall Study|Requirement for alternative therapy|0|||
144247355|NCT01313221|520104058|FG001|Overall Study|Requirement for alternative therapy|1|||
144247356|NCT01313221|520104059|FG002|Overall Study|Requirement for alternative therapy|1|||
144247357|NCT01313221|520104057|FG000|Overall Study|Lost to Follow-up|6|||
144247358|NCT01313221|520104058|FG001|Overall Study|Lost to Follow-up|3|||
144247359|NCT01313221|520104059|FG002|Overall Study|Lost to Follow-up|1|||
144247360|NCT01313221|520104057|FG000|Overall Study|Other|1|||
144247361|NCT01313221|520104058|FG001|Overall Study|Other|0|||
144247362|NCT01313221|520104059|FG002|Overall Study|Other|0|||
144247363|NCT01313221|520104057|FG000|Overall Study|Adverse Event|0|||
144247364|NCT01313221|520104058|FG001|Overall Study|Adverse Event|0|||
144247365|NCT01313221|520104059|FG002|Overall Study|Adverse Event|7|||
144247366|NCT01313221|520104057|FG000|Overall Study|Disease progression|0|||
144247367|NCT01313221|520104058|FG001|Overall Study|Disease progression|0|||
144247368|NCT01313221|520104059|FG002|Overall Study|Disease progression|2|||
144247369|NCT01313221|520104057|FG000|Overall Study|Physician Decision|0|||
144247370|NCT01313221|520104058|FG001|Overall Study|Physician Decision|0|||
144247371|NCT01313221|520104059|FG002|Overall Study|Physician Decision|2|||
144247372|NCT01313221|520104057|FG000|Overall Study|Pregnancy|0|||
144247373|NCT01313221|520104058|FG001|Overall Study|Pregnancy|0|||
144247374|NCT01313221|520104059|FG002|Overall Study|Pregnancy|2|||
144247375|NCT02864316|520104064|FG000|Overall Study|Progressive Disease|2|||
144247376|NCT02864316|520104065|FG001|Overall Study|Progressive Disease|1|||
144247377|NCT02864316|520104064|FG000|Overall Study|Adverse Event|0|||
144247378|NCT02864316|520104065|FG001|Overall Study|Adverse Event|1|||
144247379|NCT05459558|520104066|FG000|Overall Study|Adverse Event|1|||
144247380|NCT05459558|520104067|FG001|Overall Study|Adverse Event|0|||
144247381|NCT05459558|520104068|FG002|Overall Study|Adverse Event|0|||
144247382|NCT05459558|520104066|FG000|Overall Study|Scheduling issue|0|||
144247383|NCT05459558|520104067|FG001|Overall Study|Scheduling issue|1|||
144247384|NCT05459558|520104068|FG002|Overall Study|Scheduling issue|3|||
144247385|NCT05459558|520104066|FG000|Overall Study|Withdrawal by Subject|0|||
144247386|NCT05459558|520104067|FG001|Overall Study|Withdrawal by Subject|0|||
144247387|NCT05459558|520104068|FG002|Overall Study|Withdrawal by Subject|2|||
144247388|NCT01472939|520104073|FG000|Overall Study|Adverse Event|3|||
144247389|NCT01472939|520104074|FG001|Overall Study|Adverse Event|7|||
144247390|NCT01472939|520104075|FG002|Overall Study|Adverse Event|7|||
144247391|NCT01472939|520104076|FG003|Overall Study|Adverse Event|14|||
144247392|NCT01472939|520104073|FG000|Overall Study|Lack of Efficacy|1|||
144247393|NCT01472939|520104074|FG001|Overall Study|Lack of Efficacy|0|||
144247394|NCT01472939|520104075|FG002|Overall Study|Lack of Efficacy|0|||
144247395|NCT01472939|520104076|FG003|Overall Study|Lack of Efficacy|1|||
144247396|NCT01472939|520104073|FG000|Overall Study|Lost to Follow-up|3|||
144247397|NCT01472939|520104074|FG001|Overall Study|Lost to Follow-up|0|||
144247398|NCT01472939|520104075|FG002|Overall Study|Lost to Follow-up|2|||
144247399|NCT01472939|520104076|FG003|Overall Study|Lost to Follow-up|0|||
144247400|NCT01472939|520104073|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
144247401|NCT01472939|520104074|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
144247402|NCT01472939|520104075|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
144247403|NCT01472939|520104076|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
144247404|NCT01472939|520104073|FG000|Overall Study|Prohibited Medication|0|||
144247405|NCT01472939|520104074|FG001|Overall Study|Prohibited Medication|1|||
144247406|NCT01472939|520104075|FG002|Overall Study|Prohibited Medication|0|||
144247407|NCT01472939|520104076|FG003|Overall Study|Prohibited Medication|0|||
144247408|NCT01472939|520104073|FG000|Overall Study|Withdrawal By PI|1|||
144247409|NCT01472939|520104074|FG001|Overall Study|Withdrawal By PI|0|||
144247410|NCT01472939|520104075|FG002|Overall Study|Withdrawal By PI|0|||
144247411|NCT01472939|520104076|FG003|Overall Study|Withdrawal By PI|0|||
144247412|NCT01472939|520104073|FG000|Overall Study|Protocol Violation|3|||
144247413|NCT01472939|520104074|FG001|Overall Study|Protocol Violation|3|||
144247414|NCT01472939|520104075|FG002|Overall Study|Protocol Violation|0|||
144247415|NCT01472939|520104076|FG003|Overall Study|Protocol Violation|1|||
144360658|NCT01667900|520529327|FG008|Part B|Death|0|||
144360659|NCT01667900|520529328|FG009|Part B|Death|0|||
144360660|NCT01667900|520529329|FG010|Part B|Death|0|||
144360661|NCT01667900|520529330|FG011|Part B|Death|0|||
144360662|NCT01667900|520529331|FG012|Part B|Death|0|||
144360663|NCT01667900|520529332|FG013|Part B|Death|0|||
144360664|NCT01667900|520529333|FG014|Part B|Death|0|||
144360665|NCT01667900|520529334|FG015|Part B|Death|0|||
144360666|NCT01667900|520529335|FG016|Part B|Death|1|||
144360667|NCT01667900|520529336|FG017|Part B|Death|0|||
144360668|NCT01667900|520529337|FG018|Part B|Death|0|||
144360669|NCT01667900|520529338|FG019|Part B|Death|0|||
144360670|NCT01446159|520529341|FG000|Overall Study|Withdrawal by Subject|1|||
144259273|NCT03904420|520150348|FG000|Overall Study|Study terminated|2|||
144259274|NCT03904420|520150349|FG001|Overall Study|Study terminated|2|||
144259275|NCT01089127|520150354|FG000|Overall Study|Adverse Event|5|||
144259276|NCT01089127|520150355|FG001|Overall Study|Adverse Event|1|||
144259277|NCT01089127|520150356|FG002|Overall Study|Adverse Event|1|||
144259278|NCT01089127|520150357|FG003|Overall Study|Adverse Event|0|||
144259279|NCT01089127|520150358|FG004|Overall Study|Adverse Event|0|||
144259280|NCT01089127|520150359|FG005|Overall Study|Adverse Event|1|||
144259281|NCT01089127|520150354|FG000|Overall Study|Subject withdrew consent|0|||
144259282|NCT01089127|520150355|FG001|Overall Study|Subject withdrew consent|1|||
144259283|NCT01089127|520150356|FG002|Overall Study|Subject withdrew consent|1|||
144259313|NCT01300247|520150368|FG001|Overall Study|Death|1|||
144247416|NCT01472939|520104073|FG000|Overall Study|Withdrawal by Subject|9|||
144247417|NCT01472939|520104074|FG001|Overall Study|Withdrawal by Subject|3|||
144247418|NCT01472939|520104075|FG002|Overall Study|Withdrawal by Subject|1|||
144247419|NCT01472939|520104076|FG003|Overall Study|Withdrawal by Subject|4|||
144247420|NCT00114738|520104077|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
144247421|NCT00114738|520104078|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
144247422|NCT00114738|520104079|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
144247423|NCT00114738|520104077|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
144247424|NCT00114738|520104078|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
144247425|NCT00114738|520104079|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
144247426|NCT00114738|520104077|FG000|Screening for Randomization|Neuropathy|17|||
144247427|NCT00114738|520104078|FG001|Screening for Randomization|Neuropathy|0|||
144247428|NCT00114738|520104079|FG002|Screening for Randomization|Neuropathy|0|||
144247429|NCT00114738|520104077|FG000|Screening for Randomization|Progressive disease|2|||
144247430|NCT00114738|520104078|FG001|Screening for Randomization|Progressive disease|0|||
144247431|NCT00114738|520104079|FG002|Screening for Randomization|Progressive disease|0|||
144247432|NCT00114738|520104077|FG000|Screening for Randomization|CNS Hemorrhage|1|||
144247433|NCT00114738|520104078|FG001|Screening for Randomization|CNS Hemorrhage|0|||
144247434|NCT00114738|520104079|FG002|Screening for Randomization|CNS Hemorrhage|0|||
144247435|NCT00114738|520104077|FG000|Screening for Randomization|Other|1|||
144247436|NCT00114738|520104078|FG001|Screening for Randomization|Other|0|||
144247437|NCT00114738|520104079|FG002|Screening for Randomization|Other|0|||
144247438|NCT05940077|520104080|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
144247439|NCT01492101|520104081|FG000|Overall Study|Death|323|||
144247440|NCT01492101|520104082|FG001|Overall Study|Death|322|||
144247441|NCT01492101|520104081|FG000|Overall Study|Withdrawal by Subject|14|||
144247442|NCT01492101|520104082|FG001|Overall Study|Withdrawal by Subject|18|||
144247443|NCT01492101|520104081|FG000|Overall Study|Lost to Follow-up|0|||
144247444|NCT01492101|520104082|FG001|Overall Study|Lost to Follow-up|2|||
144247445|NCT02696434|520104083|FG000|Overall Study|Adverse Event|3|||
144247446|NCT02696434|520104084|FG001|Overall Study|Adverse Event|1|||
144247447|NCT02696434|520104083|FG000|Overall Study|Lost to Follow-up|5|||
144247448|NCT02696434|520104084|FG001|Overall Study|Lost to Follow-up|4|||
144247449|NCT02696434|520104083|FG000|Overall Study|Withdrawal by Subject|14|||
144247450|NCT02696434|520104084|FG001|Overall Study|Withdrawal by Subject|12|||
144247451|NCT02696434|520104083|FG000|Overall Study|Physician Decision|0|||
144247452|NCT02696434|520104084|FG001|Overall Study|Physician Decision|1|||
144247453|NCT00316914|520104106|FG000|Overall Study|Withdrawal by Subject|5|||
144247454|NCT00316914|520104107|FG001|Overall Study|Withdrawal by Subject|3|||
144247455|NCT00316914|520104106|FG000|Overall Study|Adverse Event|8|||
144247456|NCT00316914|520104107|FG001|Overall Study|Adverse Event|7|||
144247457|NCT00316914|520104106|FG000|Overall Study|Other Problems|6|||
144247458|NCT00316914|520104107|FG001|Overall Study|Other Problems|11|||
144247459|NCT00316914|520104106|FG000|Overall Study|Missing end of treatment documentation|14|||
144247460|NCT00316914|520104107|FG001|Overall Study|Missing end of treatment documentation|15|||
144247461|NCT01675154|520104108|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
144247462|NCT01675154|520104109|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
144247463|NCT01675154|520104110|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
144247464|NCT01675154|520104111|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
144247465|NCT02971800|520104114|FG000|Overall Study|Protocol Violation|1|||
144247466|NCT02971800|520104114|FG000|Overall Study|Withdrawal by Subject|1|||
144247467|NCT02971800|520104114|FG000|Overall Study|Exclusion criteria prior intervention|1|||
144247468|NCT02971800|520104114|FG000|Overall Study|Number evaluable participant already reached|4|||
144247469|NCT00616603|520104115|FG000|Overall Study|Physician Decision|2|||
144247470|NCT00616603|520104116|FG001|Overall Study|Physician Decision|0|||
144247471|NCT00616603|520104117|FG002|Overall Study|Physician Decision|2|||
144247472|NCT04245202|520104119|FG000|Overall Study|Lack of Efficacy|10|||
144247473|NCT04245202|520104120|FG001|Overall Study|Lack of Efficacy|1|||
144247474|NCT03515629|520104121|FG000|Overall Study|Death|0|||
144247475|NCT03515629|520104122|FG001|Overall Study|Death|1|||
144247476|NCT03515629|520104123|FG002|Overall Study|Death|1|||
144247477|NCT03515629|520104121|FG000|Overall Study|Progressive disease|0|||
144247478|NCT03515629|520104122|FG001|Overall Study|Progressive disease|1|||
144247479|NCT03515629|520104123|FG002|Overall Study|Progressive disease|0|||
144247480|NCT00424021|520104124|FG000|NCT00046319 Study Period|Adverse Event|1|||
144247481|NCT00424021|520104125|FG001|NCT00046319 Study Period|Adverse Event|0|||
144247482|NCT00424021|520104126|FG002|NCT00046319 Study Period|Adverse Event|1|||
144247483|NCT00424021|520104127|FG003|NCT00046319 Study Period|Adverse Event|1|||
144247484|NCT00424021|520104124|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
144247485|NCT00424021|520104125|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
144247486|NCT00424021|520104126|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
144247487|NCT00424021|520104127|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
144247488|NCT00424021|520104124|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
144247489|NCT00424021|520104125|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
144247490|NCT00424021|520104126|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
144247491|NCT00424021|520104127|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
144247492|NCT00424021|520104124|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
144247493|NCT00424021|520104125|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
144247494|NCT00424021|520104126|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
144247495|NCT00424021|520104127|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
144247496|NCT00424021|520104124|FG000|AMB-220-E Study Period|Adverse Event|1|||
144247497|NCT00424021|520104125|FG001|AMB-220-E Study Period|Adverse Event|1|||
144247498|NCT00424021|520104126|FG002|AMB-220-E Study Period|Adverse Event|3|||
144247499|NCT00424021|520104127|FG003|AMB-220-E Study Period|Adverse Event|7|||
144247500|NCT00424021|520104124|FG000|AMB-220-E Study Period|Death|0|||
144247501|NCT00424021|520104125|FG001|AMB-220-E Study Period|Death|0|||
144247502|NCT00424021|520104126|FG002|AMB-220-E Study Period|Death|1|||
144247503|NCT00424021|520104127|FG003|AMB-220-E Study Period|Death|1|||
144247504|NCT00424021|520104124|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
144247505|NCT00424021|520104125|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
144247506|NCT00424021|520104126|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
144247507|NCT00424021|520104127|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
144247508|NCT00424021|520104124|FG000|AMB-220-E Study Period|Physician Decision|0|||
144247509|NCT00424021|520104125|FG001|AMB-220-E Study Period|Physician Decision|0|||
144247510|NCT00424021|520104126|FG002|AMB-220-E Study Period|Physician Decision|0|||
144247511|NCT00424021|520104127|FG003|AMB-220-E Study Period|Physician Decision|1|||
144247512|NCT00987402|520104128|FG000|Overall Study|Insufficient data entry|86|||
144247513|NCT00987402|520104129|FG001|Overall Study|Insufficient data entry|98|||
144247514|NCT03769194|520104130|FG000|Overall Study|Withdrawal by Subject|0|||
144247515|NCT03769194|520104131|FG001|Overall Study|Withdrawal by Subject|7|||
144247516|NCT03769194|520104132|FG002|Overall Study|Withdrawal by Subject|4|||
144247517|NCT03769194|520104133|FG003|Overall Study|Withdrawal by Subject|1|||
144247518|NCT03769194|520104130|FG000|Overall Study|moved from study area|0|||
144247519|NCT03769194|520104131|FG001|Overall Study|moved from study area|2|||
144247520|NCT03769194|520104132|FG002|Overall Study|moved from study area|1|||
144247521|NCT03769194|520104133|FG003|Overall Study|moved from study area|1|||
144247522|NCT03769194|520104130|FG000|Overall Study|Lost to Follow-up|3|||
144247523|NCT03769194|520104131|FG001|Overall Study|Lost to Follow-up|6|||
144247524|NCT03769194|520104132|FG002|Overall Study|Lost to Follow-up|3|||
144247525|NCT03769194|520104133|FG003|Overall Study|Lost to Follow-up|6|||
144247526|NCT03769194|520104130|FG000|Overall Study|other|1|||
144247527|NCT03769194|520104131|FG001|Overall Study|other|3|||
144247528|NCT03769194|520104132|FG002|Overall Study|other|0|||
144247529|NCT03769194|520104133|FG003|Overall Study|other|1|||
144247530|NCT00312572|520104139|FG000|Overall Study|Adverse Event|10|||
144247531|NCT00312572|520104140|FG001|Overall Study|Adverse Event|16|||
144247532|NCT00312572|520104139|FG000|Overall Study|Lost to Follow-up|1|||
144247533|NCT00312572|520104140|FG001|Overall Study|Lost to Follow-up|1|||
144247534|NCT00312572|520104139|FG000|Overall Study|Administrative|4|||
144247535|NCT00312572|520104140|FG001|Overall Study|Administrative|2|||
144247536|NCT00312572|520104139|FG000|Overall Study|Lack of Efficacy|1|||
144247537|NCT00312572|520104140|FG001|Overall Study|Lack of Efficacy|2|||
144247538|NCT03597022|520104141|FG000|Overall Study|Premature termination of the study|7|||
144247539|NCT03597022|520104142|FG001|Overall Study|Premature termination of the study|7|||
144247540|NCT03597022|520104143|FG002|Overall Study|Premature termination of the study|8|||
144247541|NCT03597022|520104141|FG000|Overall Study|Serious adverse event|1|||
144247542|NCT03597022|520104142|FG001|Overall Study|Serious adverse event|1|||
144247543|NCT03597022|520104143|FG002|Overall Study|Serious adverse event|0|||
144247544|NCT01362517|520104148|FG000|Overall Study|Protocol Violation|1|||
144247545|NCT01362517|520104148|FG000|Overall Study|Lost to Follow-up|1|||
144247546|NCT00553358|520104149|FG000|Overall Study|Randomized but did not receive treatment|3|||
144247547|NCT00553358|520104150|FG001|Overall Study|Randomized but did not receive treatment|3|||
144247548|NCT00553358|520104151|FG002|Overall Study|Randomized but did not receive treatment|1|||
144247549|NCT00553358|520104149|FG000|Overall Study|Lost to Follow-up|22|||
144247550|NCT00553358|520104150|FG001|Overall Study|Lost to Follow-up|26|||
144247551|NCT00553358|520104151|FG002|Overall Study|Lost to Follow-up|18|||
144247552|NCT00553358|520104149|FG000|Overall Study|Withdrew completely|23|||
144247553|NCT00553358|520104150|FG001|Overall Study|Withdrew completely|33|||
144247554|NCT00553358|520104151|FG002|Overall Study|Withdrew completely|34|||
144247555|NCT00553358|520104149|FG000|Overall Study|Died during clinical follow-up|25|||
144247556|NCT00553358|520104150|FG001|Overall Study|Died during clinical follow-up|29|||
144247557|NCT00553358|520104151|FG002|Overall Study|Died during clinical follow-up|32|||
144247558|NCT00553358|520104149|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
144247559|NCT00553358|520104150|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
144247560|NCT00553358|520104151|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
144247561|NCT00553358|520104149|FG000|Overall Study|Died after clinical follow-up ended|1|||
144247562|NCT00553358|520104150|FG001|Overall Study|Died after clinical follow-up ended|2|||
144247563|NCT00553358|520104151|FG002|Overall Study|Died after clinical follow-up ended|0|||
144247564|NCT00553358|520104149|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
144247565|NCT00553358|520104150|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
144247566|NCT00553358|520104151|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
144247567|NCT01672294|520104152|FG000|Overall Study|Withdrawal by Subject|4|||
144247568|NCT01672294|520104153|FG001|Overall Study|Withdrawal by Subject|4|||
144247569|NCT01672294|520104154|FG002|Overall Study|Withdrawal by Subject|4|||
144247570|NCT01672294|520104155|FG003|Overall Study|Withdrawal by Subject|4|||
144247571|NCT01672294|520104152|FG000|Overall Study|Excluded by study|1|||
144247572|NCT01672294|520104153|FG001|Overall Study|Excluded by study|1|||
144247573|NCT01672294|520104154|FG002|Overall Study|Excluded by study|0|||
144247574|NCT01672294|520104155|FG003|Overall Study|Excluded by study|0|||
144247575|NCT01672294|520104152|FG000|Overall Study|Lost to Follow-up|1|||
144247576|NCT01672294|520104153|FG001|Overall Study|Lost to Follow-up|16|||
144247577|NCT01672294|520104154|FG002|Overall Study|Lost to Follow-up|7|||
144247578|NCT01672294|520104155|FG003|Overall Study|Lost to Follow-up|9|||
144247579|NCT01273155|520104156|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
144247580|NCT01273155|520104157|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
144247581|NCT01273155|520104158|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
144259314|NCT01300247|520150367|FG000|Overall Study|Lost to Follow-up|2|||
144247582|NCT01273155|520104159|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
144247583|NCT01273155|520104160|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
144247584|NCT01273155|520104161|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
144247585|NCT01273155|520104162|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
144247586|NCT01273155|520104156|FG000|Overall Study|Change in liver function/no longer eval.|0|||
144247587|NCT01273155|520104157|FG001|Overall Study|Change in liver function/no longer eval.|1|||
144247588|NCT01273155|520104158|FG002|Overall Study|Change in liver function/no longer eval.|0|||
144247589|NCT01273155|520104159|FG003|Overall Study|Change in liver function/no longer eval.|0|||
144247590|NCT01273155|520104160|FG004|Overall Study|Change in liver function/no longer eval.|1|||
144247591|NCT01273155|520104161|FG005|Overall Study|Change in liver function/no longer eval.|0|||
144247592|NCT01273155|520104162|FG006|Overall Study|Change in liver function/no longer eval.|0|||
144247593|NCT01273155|520104156|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
144247594|NCT01273155|520104157|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
144247595|NCT01273155|520104158|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
144247596|NCT01273155|520104159|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
144247597|NCT01273155|520104160|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
144247598|NCT01273155|520104161|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
144247599|NCT01273155|520104162|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
144247600|NCT01273155|520104156|FG000|Overall Study|Died during Cycle 1|0|||
144247601|NCT01273155|520104157|FG001|Overall Study|Died during Cycle 1|0|||
144247602|NCT01273155|520104158|FG002|Overall Study|Died during Cycle 1|1|||
144247603|NCT01273155|520104159|FG003|Overall Study|Died during Cycle 1|1|||
144247604|NCT01273155|520104160|FG004|Overall Study|Died during Cycle 1|0|||
144247605|NCT01273155|520104161|FG005|Overall Study|Died during Cycle 1|2|||
144247606|NCT01273155|520104162|FG006|Overall Study|Died during Cycle 1|2|||
144247607|NCT01273155|520104156|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
144247608|NCT01273155|520104157|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
144247609|NCT01273155|520104158|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
144247610|NCT01273155|520104159|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
144247611|NCT01273155|520104160|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
144247612|NCT01273155|520104161|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
144247613|NCT01273155|520104162|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
144247614|NCT01256385|520104163|FG000|Overall Study|Physician Decision|1|||
144247615|NCT01256385|520104164|FG001|Overall Study|Physician Decision|1|||
144247616|NCT01256385|520104163|FG000|Overall Study|Withdrawal by Subject|2|||
144247617|NCT01256385|520104164|FG001|Overall Study|Withdrawal by Subject|2|||
144247618|NCT00401960|520104165|FG000|Overall Study|Lost to Follow-up|3|||
144247619|NCT00401960|520104166|FG001|Overall Study|Lost to Follow-up|0|||
144247620|NCT00401960|520104165|FG000|Overall Study|Death|2|||
144247621|NCT00401960|520104166|FG001|Overall Study|Death|0|||
144247622|NCT02649426|520104167|FG000|Overall Study|Follow-up on going|1|||
144247623|NCT02649426|520104168|FG001|Overall Study|Follow-up on going|26|||
144247624|NCT02649426|520104169|FG002|Overall Study|Follow-up on going|28|||
144247625|NCT02649426|520104170|FG003|Overall Study|Follow-up on going|31|||
144247626|NCT01606202|520104171|FG000|Overall Study|Adverse Event|5|||
144247627|NCT01606202|520104172|FG001|Overall Study|Adverse Event|0|||
144247628|NCT01606202|520104171|FG000|Overall Study|Withdrawal by Subject|2|||
144247629|NCT01606202|520104172|FG001|Overall Study|Withdrawal by Subject|1|||
144247630|NCT01606202|520104171|FG000|Overall Study|Personal problems|0|||
144247631|NCT01606202|520104172|FG001|Overall Study|Personal problems|1|||
144247632|NCT01606202|520104171|FG000|Overall Study|Problems with administration|0|||
144247633|NCT01606202|520104172|FG001|Overall Study|Problems with administration|1|||
144247634|NCT03008278|520104173|FG000|Overall Study|Progressive Disease|0|||
144247635|NCT03008278|520104174|FG001|Overall Study|Progressive Disease|0|||
144247636|NCT03008278|520104175|FG002|Overall Study|Progressive Disease|32|||
144247637|NCT03008278|520104173|FG000|Overall Study|Adverse Event|0|||
144247638|NCT03008278|520104174|FG001|Overall Study|Adverse Event|0|||
144247639|NCT03008278|520104175|FG002|Overall Study|Adverse Event|4|||
144247640|NCT03008278|520104173|FG000|Overall Study|Withdrawal by Subject|0|||
144247641|NCT03008278|520104174|FG001|Overall Study|Withdrawal by Subject|0|||
144247642|NCT03008278|520104175|FG002|Overall Study|Withdrawal by Subject|3|||
144247643|NCT03008278|520104173|FG000|Overall Study|Physician Decision|0|||
144247644|NCT03008278|520104174|FG001|Overall Study|Physician Decision|2|||
144247645|NCT03008278|520104175|FG002|Overall Study|Physician Decision|0|||
144247646|NCT01389258|520104176|FG000|Overall Study|Lost to Follow-up|5|||
144247647|NCT04249622|520104177|FG000|Overall Study|Withdrawal by Subject|1|||
144247648|NCT04249622|520104178|FG001|Overall Study|Withdrawal by Subject|1|||
144247649|NCT04249622|520104177|FG000|Overall Study|Alternative therapy|1|||
144247650|NCT04249622|520104178|FG001|Overall Study|Alternative therapy|0|||
144247651|NCT04249622|520104177|FG000|Overall Study|Discontinuation of pertuzumab|1|||
144247652|NCT04249622|520104178|FG001|Overall Study|Discontinuation of pertuzumab|0|||
144247653|NCT02918552|520104179|FG000|Overall Study|Failed Pharmacokinetics|1|||
144247654|NCT02918552|520104180|FG001|Overall Study|Failed Pharmacokinetics|0|||
144247655|NCT02918552|520104179|FG000|Overall Study|Withdrawal by Subject|0|||
144247656|NCT02918552|520104180|FG001|Overall Study|Withdrawal by Subject|1|||
144247657|NCT02918552|520104179|FG000|Overall Study|Lost to Follow-up|0|||
144247658|NCT02918552|520104180|FG001|Overall Study|Lost to Follow-up|1|||
144247659|NCT04395274|520104181|FG000|Overall Study|Lost to Follow-up|20|||
144247660|NCT04395274|520104182|FG001|Overall Study|Lost to Follow-up|11|||
144247661|NCT04395274|520104181|FG000|Overall Study|Withdrawal by Subject|13|||
144247662|NCT04395274|520104182|FG001|Overall Study|Withdrawal by Subject|10|||
144247663|NCT04395274|520104181|FG000|Overall Study|Moved Abroad|0|||
144247664|NCT04395274|520104182|FG001|Overall Study|Moved Abroad|1|||
144247665|NCT03482167|520104185|FG000|Allocated to Intervention|Physician Decision|1|||
144247666|NCT03482167|520104186|FG001|Allocated to Intervention|Physician Decision|2|||
144247667|NCT03482167|520104185|FG000|Received Intervention|Adverse Event|3|||
144247668|NCT03482167|520104186|FG001|Received Intervention|Adverse Event|1|||
144247669|NCT03482167|520104185|FG000|Received Intervention|Physician Decision|1|||
144360671|NCT01446159|520529342|FG001|Overall Study|Withdrawal by Subject|0|||
144360672|NCT01446159|520529343|FG002|Overall Study|Withdrawal by Subject|14|||
144360673|NCT01446159|520529344|FG003|Overall Study|Withdrawal by Subject|11|||
144360674|NCT01446159|520529341|FG000|Overall Study|Lost to Follow-up|0|||
144360675|NCT01446159|520529342|FG001|Overall Study|Lost to Follow-up|0|||
144360676|NCT01446159|520529343|FG002|Overall Study|Lost to Follow-up|1|||
144360677|NCT01446159|520529344|FG003|Overall Study|Lost to Follow-up|2|||
144360678|NCT01446159|520529341|FG000|Overall Study|Death|2|||
144360679|NCT01446159|520529342|FG001|Overall Study|Death|3|||
144360680|NCT01446159|520529343|FG002|Overall Study|Death|43|||
144360681|NCT01446159|520529344|FG003|Overall Study|Death|36|||
144360682|NCT01446159|520529341|FG000|Overall Study|Other|0|||
144360683|NCT01446159|520529342|FG001|Overall Study|Other|0|||
144360684|NCT01446159|520529343|FG002|Overall Study|Other|13|||
144360685|NCT01446159|520529344|FG003|Overall Study|Other|13|||
144360686|NCT00537394|520529345|FG000|First Year of Follow-up|Death|7|||
144360687|NCT00537394|520529346|FG001|First Year of Follow-up|Death|0|||
144360688|NCT00537394|520529347|FG002|First Year of Follow-up|Death|0|||
144360689|NCT00537394|520529345|FG000|First Year of Follow-up|Severe debilitation|1|||
144360690|NCT00537394|520529346|FG001|First Year of Follow-up|Severe debilitation|0|||
144360691|NCT00537394|520529347|FG002|First Year of Follow-up|Severe debilitation|1|||
144360692|NCT00537394|520529345|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
144360693|NCT00537394|520529346|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
144360694|NCT00537394|520529347|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
144360695|NCT00537394|520529345|FG000|First Year of Follow-up|Lost to Follow-up|1|||
144360696|NCT00537394|520529346|FG001|First Year of Follow-up|Lost to Follow-up|5|||
144360697|NCT00537394|520529347|FG002|First Year of Follow-up|Lost to Follow-up|1|||
144360698|NCT00537394|520529345|FG000|2nd Year of Follow-up|Death|4|||
144360699|NCT00537394|520529346|FG001|2nd Year of Follow-up|Death|1|||
144360700|NCT00537394|520529347|FG002|2nd Year of Follow-up|Death|2|||
144360701|NCT00537394|520529345|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
144360702|NCT00537394|520529346|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
144360703|NCT00537394|520529347|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
144360704|NCT00537394|520529345|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
144360705|NCT00537394|520529346|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
144360706|NCT00537394|520529347|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
144360707|NCT00537394|520529345|FG000|2nd Year of Follow-up|Clinic site closure|1|||
144360708|NCT00537394|520529346|FG001|2nd Year of Follow-up|Clinic site closure|0|||
144360709|NCT00537394|520529347|FG002|2nd Year of Follow-up|Clinic site closure|0|||
144360710|NCT01283139|520529348|FG000|Overall Study|Lost to Follow-up|5|||
144360711|NCT01283139|520529349|FG001|Overall Study|Lost to Follow-up|2|||
144360712|NCT01283139|520529350|FG002|Overall Study|Lost to Follow-up|3|||
144360713|NCT01283139|520529351|FG003|Overall Study|Lost to Follow-up|1|||
144360714|NCT01283139|520529348|FG000|Overall Study|Withdrawal by Subject|8|||
144360715|NCT01283139|520529349|FG001|Overall Study|Withdrawal by Subject|8|||
144360716|NCT01283139|520529350|FG002|Overall Study|Withdrawal by Subject|6|||
144360717|NCT01283139|520529351|FG003|Overall Study|Withdrawal by Subject|8|||
144360718|NCT01283139|520529348|FG000|Overall Study|Death|2|||
144360719|NCT01283139|520529349|FG001|Overall Study|Death|0|||
144360720|NCT01283139|520529350|FG002|Overall Study|Death|2|||
144360721|NCT01283139|520529351|FG003|Overall Study|Death|2|||
144360722|NCT01283139|520529348|FG000|Overall Study|Lack of Efficacy|1|||
144360723|NCT01283139|520529349|FG001|Overall Study|Lack of Efficacy|2|||
144360724|NCT01283139|520529350|FG002|Overall Study|Lack of Efficacy|2|||
144360725|NCT01283139|520529351|FG003|Overall Study|Lack of Efficacy|1|||
144360726|NCT01283139|520529348|FG000|Overall Study|Early termination due to AE/SAE|1|||
144360727|NCT01283139|520529349|FG001|Overall Study|Early termination due to AE/SAE|1|||
144360728|NCT01283139|520529350|FG002|Overall Study|Early termination due to AE/SAE|0|||
144360729|NCT01283139|520529351|FG003|Overall Study|Early termination due to AE/SAE|0|||
144360730|NCT01283139|520529348|FG000|Overall Study|Participant's refusal to continue|0|||
144360731|NCT01283139|520529349|FG001|Overall Study|Participant's refusal to continue|3|||
144360732|NCT01283139|520529350|FG002|Overall Study|Participant's refusal to continue|1|||
144360733|NCT01283139|520529351|FG003|Overall Study|Participant's refusal to continue|1|||
144360734|NCT01283139|520529348|FG000|Overall Study|Pregnancy|0|||
144360735|NCT01283139|520529349|FG001|Overall Study|Pregnancy|1|||
144360736|NCT01283139|520529350|FG002|Overall Study|Pregnancy|1|||
144360737|NCT01283139|520529351|FG003|Overall Study|Pregnancy|0|||
144360738|NCT01283139|520529348|FG000|Overall Study|Missed follow-up visit|0|||
144360739|NCT01283139|520529349|FG001|Overall Study|Missed follow-up visit|1|||
144360740|NCT01283139|520529350|FG002|Overall Study|Missed follow-up visit|2|||
144360741|NCT01283139|520529351|FG003|Overall Study|Missed follow-up visit|2|||
144360742|NCT01283139|520529348|FG000|Overall Study|Participant randomized in error|0|||
144360743|NCT01283139|520529349|FG001|Overall Study|Participant randomized in error|0|||
144360744|NCT01283139|520529350|FG002|Overall Study|Participant randomized in error|1|||
144360745|NCT01283139|520529351|FG003|Overall Study|Participant randomized in error|0|||
144360746|NCT00784563|520529352|FG000|Years 1 & 2|Withdrawal by Subject|3|||
144360747|NCT00784563|520529353|FG001|Years 1 & 2|Withdrawal by Subject|2|||
144360748|NCT00784563|520529354|FG002|Years 1 & 2|Withdrawal by Subject|0|||
144360749|NCT00784563|520529352|FG000|Years 1 & 2|Adverse Event|0|||
144360750|NCT00784563|520529353|FG001|Years 1 & 2|Adverse Event|3|||
144360751|NCT00784563|520529354|FG002|Years 1 & 2|Adverse Event|0|||
144360752|NCT00784563|520529352|FG000|Year 3|Withdrawal by Subject|0|||
144360753|NCT00784563|520529353|FG001|Year 3|Withdrawal by Subject|0|||
144360754|NCT00784563|520529354|FG002|Year 3|Withdrawal by Subject|2|||
144360755|NCT00784563|520529352|FG000|Year 3|Adverse Event|0|||
144360756|NCT00784563|520529353|FG001|Year 3|Adverse Event|0|||
144360757|NCT00784563|520529354|FG002|Year 3|Adverse Event|1|||
144360758|NCT00762164|520529355|FG000|Overall Study|Lost to Follow-up|1|||
144360759|NCT00762164|520529356|FG001|Overall Study|Lost to Follow-up|1|||
144360760|NCT00762164|520529355|FG000|Overall Study|Discontinued medication|2|||
144360761|NCT00762164|520529356|FG001|Overall Study|Discontinued medication|0|||
144360762|NCT00762164|520529355|FG000|Overall Study|Withdrawal by Subject|0|||
144360763|NCT00762164|520529356|FG001|Overall Study|Withdrawal by Subject|1|||
144360764|NCT02954536|520529357|FG000|Overall Study|Adverse Event|2|||
144360765|NCT02954536|520529357|FG000|Overall Study|Death|12|||
144360766|NCT01927497|520529361|FG000|Overall Study|Death|0|||
144360767|NCT01927497|520529362|FG001|Overall Study|Death|1|||
144360768|NCT01927497|520529361|FG000|Overall Study|Protocol Violation|2|||
144360769|NCT01927497|520529362|FG001|Overall Study|Protocol Violation|0|||
144360770|NCT00395746|520529363|FG000|Overall Study|Adverse Event|5|||
144360771|NCT00395746|520529364|FG001|Overall Study|Adverse Event|2|||
144360772|NCT00395746|520529365|FG002|Overall Study|Adverse Event|2|||
144360773|NCT00395746|520529363|FG000|Overall Study|Protocol Violation|0|||
144247670|NCT03482167|520104186|FG001|Received Intervention|Physician Decision|1|||
144247671|NCT03482167|520104185|FG000|Received Intervention|Withdrawal by Subject|1|||
144247672|NCT03482167|520104186|FG001|Received Intervention|Withdrawal by Subject|0|||
144247673|NCT02680834|520104189|FG000|Overall Study|Physician Decision|5|||
144247674|NCT02680834|520104190|FG001|Overall Study|Physician Decision|2|||
144247675|NCT02680834|520104189|FG000|Overall Study|Withdrawal by Subject|6|||
144360774|NCT00395746|520529364|FG001|Overall Study|Protocol Violation|1|||
144360775|NCT00395746|520529365|FG002|Overall Study|Protocol Violation|0|||
144360776|NCT00395746|520529363|FG000|Overall Study|Lack of Efficacy|2|||
144360777|NCT00395746|520529364|FG001|Overall Study|Lack of Efficacy|0|||
144360778|NCT00395746|520529365|FG002|Overall Study|Lack of Efficacy|17|||
144360779|NCT00395746|520529363|FG000|Overall Study|Hypoglycaemia|2|||
144247676|NCT02680834|520104190|FG001|Overall Study|Withdrawal by Subject|0|||
144247677|NCT02680834|520104189|FG000|Overall Study|Lost to Follow-up|0|||
144247678|NCT02680834|520104190|FG001|Overall Study|Lost to Follow-up|1|||
144247679|NCT01362244|520104191|FG000|Overall Study|Adverse Event|3|||
144247680|NCT01362244|520104192|FG001|Overall Study|Adverse Event|5|||
144247681|NCT01362244|520104191|FG000|Overall Study|Lack of Efficacy|5|||
144247682|NCT01362244|520104192|FG001|Overall Study|Lack of Efficacy|11|||
144247683|NCT01362244|520104191|FG000|Overall Study|Lost to Follow-up|0|||
144247684|NCT01362244|520104192|FG001|Overall Study|Lost to Follow-up|2|||
144247685|NCT01362244|520104191|FG000|Overall Study|Protocol Violation|5|||
144247686|NCT01362244|520104192|FG001|Overall Study|Protocol Violation|1|||
144247687|NCT01362244|520104191|FG000|Overall Study|Withdrawal by Subject|2|||
144247688|NCT01362244|520104192|FG001|Overall Study|Withdrawal by Subject|1|||
144247689|NCT01362244|520104191|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
144247690|NCT01362244|520104192|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
144247691|NCT01362244|520104191|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
144247692|NCT01362244|520104192|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
144247693|NCT02407054|520104195|FG000|Overall Study|Adverse Event|1|||
144247694|NCT02407054|520104196|FG001|Overall Study|Adverse Event|4|||
144247695|NCT02407054|520104197|FG002|Overall Study|Adverse Event|1|||
144247696|NCT02407054|520104195|FG000|Overall Study|Non-compliance with Study|0|||
144247697|NCT02407054|520104196|FG001|Overall Study|Non-compliance with Study|2|||
144247698|NCT02407054|520104197|FG002|Overall Study|Non-compliance with Study|1|||
144247699|NCT02407054|520104195|FG000|Overall Study|Physician Decision|1|||
144247700|NCT02407054|520104196|FG001|Overall Study|Physician Decision|3|||
144247701|NCT02407054|520104197|FG002|Overall Study|Physician Decision|3|||
144360780|NCT00395746|520529364|FG001|Overall Study|Hypoglycaemia|1|||
144360781|NCT00395746|520529365|FG002|Overall Study|Hypoglycaemia|0|||
144360782|NCT00395746|520529363|FG000|Overall Study|Subject decision|0|||
144360783|NCT00395746|520529364|FG001|Overall Study|Subject decision|0|||
144360784|NCT00395746|520529365|FG002|Overall Study|Subject decision|1|||
144360785|NCT00395746|520529363|FG000|Overall Study|Withdrawal of consent|0|||
144360786|NCT00395746|520529364|FG001|Overall Study|Withdrawal of consent|0|||
144360787|NCT00395746|520529365|FG002|Overall Study|Withdrawal of consent|1|||
144360788|NCT00395746|520529363|FG000|Overall Study|Difficultulty in use of device|0|||
144360789|NCT00395746|520529364|FG001|Overall Study|Difficultulty in use of device|0|||
144360790|NCT00395746|520529365|FG002|Overall Study|Difficultulty in use of device|1|||
144360791|NCT00395746|520529363|FG000|Overall Study|Unable to visit site on schedule|1|||
144360792|NCT00395746|520529364|FG001|Overall Study|Unable to visit site on schedule|0|||
144360793|NCT00395746|520529365|FG002|Overall Study|Unable to visit site on schedule|0|||
144360794|NCT04528641|520529366|FG000|Overall Study|Withdrawal by Subject|0|||
144360795|NCT04528641|520529367|FG001|Overall Study|Withdrawal by Subject|0|||
144360796|NCT04528641|520529368|FG002|Overall Study|Withdrawal by Subject|0|||
144360797|NCT04528641|520529369|FG003|Overall Study|Withdrawal by Subject|1|||
144360798|NCT04528641|520529370|FG004|Overall Study|Withdrawal by Subject|0|||
144360799|NCT04528641|520529371|FG005|Overall Study|Withdrawal by Subject|1|||
144360800|NCT00517296|520529372|FG000|Overall Study|Withdrawal by Subject|1|||
144360801|NCT00517296|520529373|FG001|Overall Study|Withdrawal by Subject|0|||
144360802|NCT03413891|520529374|FG000|Overall Study|Lost to Follow-up|2|||
144360803|NCT03413891|520529375|FG001|Overall Study|Lost to Follow-up|1|||
144360804|NCT03413891|520529374|FG000|Overall Study|Protocol Violation|0|||
144360805|NCT03413891|520529375|FG001|Overall Study|Protocol Violation|1|||
144360806|NCT03137992|520529378|FG000|Washout Period 1|Adverse Event|1|||
144360807|NCT03137992|520529379|FG001|Washout Period 1|Adverse Event|1|||
144360808|NCT03137992|520529380|FG002|Washout Period 1|Adverse Event|0|||
144360809|NCT03137992|520529381|FG003|Washout Period 1|Adverse Event|0|||
144360810|NCT03137992|520529382|FG004|Washout Period 1|Adverse Event|0|||
144360811|NCT03137992|520529383|FG005|Washout Period 1|Adverse Event|1|||
144360812|NCT03137992|520529378|FG000|Washout Period 1|Withdrawal by Subject|0|||
144360813|NCT03137992|520529379|FG001|Washout Period 1|Withdrawal by Subject|1|||
144360814|NCT03137992|520529380|FG002|Washout Period 1|Withdrawal by Subject|1|||
144360815|NCT03137992|520529381|FG003|Washout Period 1|Withdrawal by Subject|0|||
144360816|NCT03137992|520529382|FG004|Washout Period 1|Withdrawal by Subject|0|||
144360817|NCT03137992|520529383|FG005|Washout Period 1|Withdrawal by Subject|0|||
144360818|NCT03137992|520529378|FG000|Washout Period 1|Principal Investigator Discretion|0|||
144360819|NCT03137992|520529379|FG001|Washout Period 1|Principal Investigator Discretion|1|||
144360820|NCT03137992|520529380|FG002|Washout Period 1|Principal Investigator Discretion|0|||
144360821|NCT03137992|520529381|FG003|Washout Period 1|Principal Investigator Discretion|0|||
144360822|NCT03137992|520529382|FG004|Washout Period 1|Principal Investigator Discretion|0|||
144360823|NCT03137992|520529383|FG005|Washout Period 1|Principal Investigator Discretion|0|||
144360824|NCT03137992|520529378|FG000|Washout Period 1|COPD Exacerbation|1|||
144360825|NCT03137992|520529379|FG001|Washout Period 1|COPD Exacerbation|1|||
144360826|NCT03137992|520529380|FG002|Washout Period 1|COPD Exacerbation|1|||
144360827|NCT03137992|520529381|FG003|Washout Period 1|COPD Exacerbation|0|||
144360828|NCT03137992|520529382|FG004|Washout Period 1|COPD Exacerbation|1|||
144360829|NCT03137992|520529383|FG005|Washout Period 1|COPD Exacerbation|1|||
144360830|NCT03137992|520529378|FG000|Washout Period 1|Subject Noncompliance|1|||
144360831|NCT03137992|520529379|FG001|Washout Period 1|Subject Noncompliance|0|||
144360832|NCT03137992|520529380|FG002|Washout Period 1|Subject Noncompliance|0|||
144360833|NCT03137992|520529381|FG003|Washout Period 1|Subject Noncompliance|0|||
144360834|NCT03137992|520529382|FG004|Washout Period 1|Subject Noncompliance|1|||
144360835|NCT03137992|520529383|FG005|Washout Period 1|Subject Noncompliance|0|||
144360836|NCT03137992|520529378|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
144360837|NCT03137992|520529379|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
144360838|NCT03137992|520529380|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
144360839|NCT03137992|520529381|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
144360840|NCT03137992|520529382|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
144360841|NCT03137992|520529383|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
144360842|NCT03137992|520529378|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
144360843|NCT03137992|520529379|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
144360844|NCT03137992|520529380|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
144360845|NCT03137992|520529381|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
144360846|NCT03137992|520529382|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
144360847|NCT03137992|520529383|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
144360848|NCT03137992|520529378|FG000|Period 2 (Visit 3)|Adverse Event|0|||
144360849|NCT03137992|520529379|FG001|Period 2 (Visit 3)|Adverse Event|1|||
144360850|NCT03137992|520529380|FG002|Period 2 (Visit 3)|Adverse Event|0|||
144360851|NCT03137992|520529381|FG003|Period 2 (Visit 3)|Adverse Event|0|||
144360852|NCT03137992|520529382|FG004|Period 2 (Visit 3)|Adverse Event|0|||
144360853|NCT03137992|520529383|FG005|Period 2 (Visit 3)|Adverse Event|0|||
144360854|NCT03137992|520529378|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
144360855|NCT03137992|520529379|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
144360856|NCT03137992|520529380|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
144360857|NCT03137992|520529381|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
144360858|NCT03137992|520529382|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
144360859|NCT03137992|520529383|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
144360860|NCT03137992|520529378|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
144360861|NCT03137992|520529379|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
144360862|NCT03137992|520529380|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
144360863|NCT03137992|520529381|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
144360864|NCT03137992|520529382|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
144360865|NCT03137992|520529383|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
144360866|NCT03137992|520529378|FG000|Washout Period 2|COPD Exacerbation|1|||
144360867|NCT03137992|520529379|FG001|Washout Period 2|COPD Exacerbation|1|||
144360868|NCT03137992|520529380|FG002|Washout Period 2|COPD Exacerbation|0|||
144360869|NCT03137992|520529381|FG003|Washout Period 2|COPD Exacerbation|0|||
144360870|NCT03137992|520529382|FG004|Washout Period 2|COPD Exacerbation|1|||
144360871|NCT03137992|520529383|FG005|Washout Period 2|COPD Exacerbation|0|||
144360872|NCT03137992|520529378|FG000|Washout Period 2|Subject Non-compliance|0|||
144360873|NCT03137992|520529379|FG001|Washout Period 2|Subject Non-compliance|1|||
144360874|NCT03137992|520529380|FG002|Washout Period 2|Subject Non-compliance|0|||
144360875|NCT03137992|520529381|FG003|Washout Period 2|Subject Non-compliance|0|||
144360876|NCT03137992|520529382|FG004|Washout Period 2|Subject Non-compliance|0|||
144360877|NCT03137992|520529383|FG005|Washout Period 2|Subject Non-compliance|0|||
144360878|NCT03137992|520529378|FG000|Washout Period 2|Adverse Event|0|||
144360879|NCT03137992|520529379|FG001|Washout Period 2|Adverse Event|0|||
144360880|NCT03137992|520529380|FG002|Washout Period 2|Adverse Event|0|||
144360881|NCT03137992|520529381|FG003|Washout Period 2|Adverse Event|1|||
144360882|NCT03137992|520529382|FG004|Washout Period 2|Adverse Event|1|||
144360883|NCT03137992|520529383|FG005|Washout Period 2|Adverse Event|0|||
144360884|NCT03137992|520529378|FG000|Washout Period 2|Withdrawal by Subject|1|||
144360885|NCT03137992|520529379|FG001|Washout Period 2|Withdrawal by Subject|0|||
144360886|NCT03137992|520529380|FG002|Washout Period 2|Withdrawal by Subject|0|||
144360887|NCT03137992|520529381|FG003|Washout Period 2|Withdrawal by Subject|0|||
144360888|NCT03137992|520529382|FG004|Washout Period 2|Withdrawal by Subject|1|||
144360889|NCT03137992|520529383|FG005|Washout Period 2|Withdrawal by Subject|0|||
144360890|NCT03137992|520529378|FG000|Washout Period 2|Sponsor Decision|0|||
144360891|NCT03137992|520529379|FG001|Washout Period 2|Sponsor Decision|0|||
144360892|NCT03137992|520529380|FG002|Washout Period 2|Sponsor Decision|0|||
144360893|NCT03137992|520529381|FG003|Washout Period 2|Sponsor Decision|0|||
144360894|NCT03137992|520529382|FG004|Washout Period 2|Sponsor Decision|0|||
144360895|NCT03137992|520529383|FG005|Washout Period 2|Sponsor Decision|1|||
144360896|NCT03137992|520529378|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
144360897|NCT03137992|520529379|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
144360898|NCT03137992|520529380|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
144360899|NCT03137992|520529381|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
144360900|NCT03137992|520529382|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
144360901|NCT03137992|520529383|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
144360902|NCT03137992|520529378|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
144360903|NCT03137992|520529379|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
144360904|NCT03137992|520529380|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
144360905|NCT03137992|520529381|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
144360906|NCT03137992|520529382|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
144360907|NCT03137992|520529383|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
144360908|NCT03137992|520529378|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
144360909|NCT03137992|520529379|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
144360910|NCT03137992|520529380|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
144360911|NCT03137992|520529381|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
144360912|NCT03137992|520529382|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
144360913|NCT03137992|520529383|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
144360914|NCT03137992|520529378|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
144360915|NCT03137992|520529379|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
144360916|NCT03137992|520529380|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
144360917|NCT03137992|520529381|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
144360918|NCT03137992|520529382|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
144360919|NCT03137992|520529383|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
144360920|NCT03137992|520529378|FG000|Part 2 (Open-label Extension)|Per study team|1|||
144360921|NCT03137992|520529379|FG001|Part 2 (Open-label Extension)|Per study team|0|||
144360922|NCT03137992|520529380|FG002|Part 2 (Open-label Extension)|Per study team|0|||
144360923|NCT03137992|520529381|FG003|Part 2 (Open-label Extension)|Per study team|0|||
144360924|NCT03137992|520529382|FG004|Part 2 (Open-label Extension)|Per study team|0|||
144360925|NCT03137992|520529383|FG005|Part 2 (Open-label Extension)|Per study team|0|||
144360926|NCT03137992|520529378|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
144360927|NCT03137992|520529379|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
144360928|NCT03137992|520529380|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
144360929|NCT03137992|520529381|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
144360930|NCT03137992|520529382|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
144360931|NCT03137992|520529383|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
144360932|NCT00795704|520529388|FG000|Overall Study|Withdrawal by Subject|3|||
144360933|NCT00795704|520529389|FG001|Overall Study|Withdrawal by Subject|2|||
144360934|NCT00795704|520529388|FG000|Overall Study|Adverse Event|1|||
144360935|NCT00795704|520529389|FG001|Overall Study|Adverse Event|1|||
144360936|NCT01247324|520529390|FG000|Overall Study|Death|6|||
144360937|NCT01247324|520529391|FG001|Overall Study|Death|10|||
144360938|NCT01247324|520529390|FG000|Overall Study|Physician Decision|2|||
144360939|NCT01247324|520529391|FG001|Overall Study|Physician Decision|3|||
144360940|NCT01247324|520529390|FG000|Overall Study|Non-compliance with study drug|3|||
144360941|NCT01247324|520529391|FG001|Overall Study|Non-compliance with study drug|0|||
144360942|NCT01247324|520529390|FG000|Overall Study|Lack of Efficacy|24|||
144360943|NCT01247324|520529391|FG001|Overall Study|Lack of Efficacy|14|||
144360944|NCT01247324|520529390|FG000|Overall Study|Non-compliance|3|||
144360945|NCT01247324|520529391|FG001|Overall Study|Non-compliance|2|||
144360946|NCT01247324|520529390|FG000|Overall Study|Pregnancy|5|||
144360947|NCT01247324|520529391|FG001|Overall Study|Pregnancy|10|||
144360948|NCT01247324|520529390|FG000|Overall Study|Protocol Violation|1|||
144360949|NCT01247324|520529391|FG001|Overall Study|Protocol Violation|1|||
144360950|NCT01247324|520529390|FG000|Overall Study|Reason not specified|42|||
144360951|NCT01247324|520529391|FG001|Overall Study|Reason not specified|32|||
144360952|NCT01247324|520529390|FG000|Overall Study|Consent withdrawn by participant|41|||
144360953|NCT01247324|520529391|FG001|Overall Study|Consent withdrawn by participant|56|||
144360954|NCT01247324|520529390|FG000|Overall Study|Adverse Event|49|||
144360955|NCT01247324|520529391|FG001|Overall Study|Adverse Event|35|||
144360956|NCT01247324|520529390|FG000|Overall Study|Lost to Follow-up|3|||
144360957|NCT01247324|520529391|FG001|Overall Study|Lost to Follow-up|6|||
144360958|NCT01247324|520529390|FG000|Overall Study|Study Terminated by Sponsor|4|||
144360959|NCT01247324|520529391|FG001|Overall Study|Study Terminated by Sponsor|1|||
144360960|NCT01247324|520529390|FG000|Overall Study|Missing|2|||
144360961|NCT01247324|520529391|FG001|Overall Study|Missing|1|||
144360962|NCT01691794|520529394|FG000|Overall Study|Poor/Non-Compliance|1|||
144360963|NCT01691794|520529395|FG001|Overall Study|Poor/Non-Compliance|4|||
144360964|NCT01691794|520529396|FG002|Overall Study|Poor/Non-Compliance|1|||
144360965|NCT01691794|520529394|FG000|Overall Study|Death|0|||
144360966|NCT01691794|520529395|FG001|Overall Study|Death|0|||
144360967|NCT01691794|520529396|FG002|Overall Study|Death|1|||
144360968|NCT01691794|520529394|FG000|Overall Study|Lack of Efficacy|0|||
144360969|NCT01691794|520529395|FG001|Overall Study|Lack of Efficacy|7|||
144360970|NCT01691794|520529396|FG002|Overall Study|Lack of Efficacy|1|||
144360971|NCT01691794|520529394|FG000|Overall Study|Participant request to discontinue|0|||
144360972|NCT01691794|520529395|FG001|Overall Study|Participant request to discontinue|1|||
144360973|NCT01691794|520529396|FG002|Overall Study|Participant request to discontinue|0|||
144360974|NCT01691794|520529394|FG000|Overall Study|Adverse Event|0|||
144360975|NCT01691794|520529395|FG001|Overall Study|Adverse Event|1|||
144360976|NCT01691794|520529396|FG002|Overall Study|Adverse Event|1|||
144360977|NCT01691794|520529394|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
144360978|NCT01691794|520529395|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
144360979|NCT01691794|520529396|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
144360980|NCT01691794|520529394|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
144360981|NCT01691794|520529395|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
144360982|NCT01691794|520529396|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
144360983|NCT00844844|520529397|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
144360984|NCT00844844|520529397|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
144360985|NCT00844844|520529397|FG000|Extension Treatment Period|Adverse Event|2|||
144360986|NCT00844844|520529397|FG000|Post Treatment Period|Withdrawal by Subject|1|||
144360987|NCT03905096|520529398|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
144360988|NCT03905096|520529399|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
144360989|NCT00945009|520529403|FG000|Overall Study|Lack of Efficacy|10|||
144360990|NCT00945009|520529404|FG001|Overall Study|Lack of Efficacy|0|||
144360991|NCT00945009|520529405|FG002|Overall Study|Lack of Efficacy|0|||
144360992|NCT00945009|520529403|FG000|Overall Study|Physician Decision|21|||
144360993|NCT00945009|520529404|FG001|Overall Study|Physician Decision|4|||
144360994|NCT00945009|520529405|FG002|Overall Study|Physician Decision|3|||
144360995|NCT00945009|520529403|FG000|Overall Study|Protocol Violation|6|||
144360996|NCT00945009|520529404|FG001|Overall Study|Protocol Violation|1|||
144360997|NCT00945009|520529405|FG002|Overall Study|Protocol Violation|0|||
144360998|NCT00945009|520529403|FG000|Overall Study|Withdrawal by Subject|1|||
144360999|NCT00945009|520529404|FG001|Overall Study|Withdrawal by Subject|0|||
144361000|NCT00945009|520529405|FG002|Overall Study|Withdrawal by Subject|0|||
144361001|NCT00945009|520529403|FG000|Overall Study|Ineligible|6|||
144361002|NCT00945009|520529404|FG001|Overall Study|Ineligible|1|||
144361003|NCT00945009|520529405|FG002|Overall Study|Ineligible|0|||
144361004|NCT00945009|520529403|FG000|Overall Study|Inevaluable|0|||
144361005|NCT00945009|520529404|FG001|Overall Study|Inevaluable|1|||
144361006|NCT00945009|520529405|FG002|Overall Study|Inevaluable|0|||
144361007|NCT00945009|520529403|FG000|Overall Study|Refusal of further protocol|1|||
144361008|NCT00945009|520529404|FG001|Overall Study|Refusal of further protocol|0|||
144361009|NCT00945009|520529405|FG002|Overall Study|Refusal of further protocol|0|||
144361010|NCT02994108|520531159|FG000|Intervention Messages|Withdrawal by Subject|2|||
144361011|NCT02994108|520531160|FG001|Intervention Messages|Withdrawal by Subject|0|||
144361012|NCT02994108|520531159|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
144361013|NCT02994108|520531160|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
144361014|NCT02994108|520531159|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
144361015|NCT02994108|520531160|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
144361016|NCT02994108|520531159|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
144361017|NCT02994108|520531160|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
144361018|NCT00089297|520531161|FG000|Overall Study|Adverse Event|9|||
144361019|NCT00089297|520531161|FG000|Overall Study|Death|1|||
144361020|NCT00089297|520531161|FG000|Overall Study|Withdrawal by Subject|12|||
144361021|NCT00089297|520531161|FG000|Overall Study|Disease progression|2|||
144361022|NCT00089297|520531161|FG000|Overall Study|Ineligible|11|||
144361023|NCT00089297|520531161|FG000|Overall Study|Secondary malignancy|1|||
144361024|NCT00089297|520531161|FG000|Overall Study|IRB approval not ready|1|||
144361025|NCT00089297|520531161|FG000|Overall Study|Non-compliance|1|||
144361026|NCT00385671|520531164|FG000|Overall Study|Adverse Event|14|||
144361027|NCT00385671|520531165|FG001|Overall Study|Adverse Event|27|||
144361028|NCT00385671|520531166|FG002|Overall Study|Adverse Event|18|||
144361029|NCT00385671|520531164|FG000|Overall Study|Lack of Efficacy|5|||
144361030|NCT00385671|520531165|FG001|Overall Study|Lack of Efficacy|9|||
144361031|NCT00385671|520531166|FG002|Overall Study|Lack of Efficacy|5|||
144361032|NCT00385671|520531164|FG000|Overall Study|Lost to Follow-up|6|||
144361033|NCT00385671|520531165|FG001|Overall Study|Lost to Follow-up|6|||
144361034|NCT00385671|520531166|FG002|Overall Study|Lost to Follow-up|5|||
144361035|NCT00385671|520531164|FG000|Overall Study|Physician Decision|2|||
144361036|NCT00385671|520531165|FG001|Overall Study|Physician Decision|1|||
144361037|NCT00385671|520531166|FG002|Overall Study|Physician Decision|2|||
144361038|NCT00385671|520531164|FG000|Overall Study|Protocol Violation|5|||
144361039|NCT00385671|520531165|FG001|Overall Study|Protocol Violation|2|||
144361040|NCT00385671|520531166|FG002|Overall Study|Protocol Violation|1|||
144361041|NCT00385671|520531164|FG000|Overall Study|Sponsor Decision|2|||
144361042|NCT00385671|520531165|FG001|Overall Study|Sponsor Decision|2|||
144361043|NCT00385671|520531166|FG002|Overall Study|Sponsor Decision|1|||
144361044|NCT00385671|520531164|FG000|Overall Study|Withdrawal by Subject|4|||
144361045|NCT00385671|520531165|FG001|Overall Study|Withdrawal by Subject|4|||
144361046|NCT00385671|520531166|FG002|Overall Study|Withdrawal by Subject|4|||
144361047|NCT00755183|520531172|FG000|Overall Study|Adverse Event|5|||
144361048|NCT00755183|520531173|FG001|Overall Study|Adverse Event|2|||
144361049|NCT00755183|520531172|FG000|Overall Study|Protocol Violation|0|||
144361050|NCT00755183|520531173|FG001|Overall Study|Protocol Violation|1|||
144361051|NCT00755183|520531172|FG000|Overall Study|Withdrawal by Subject|0|||
144361052|NCT00755183|520531173|FG001|Overall Study|Withdrawal by Subject|2|||
144361053|NCT00755183|520531172|FG000|Overall Study|Administrative|2|||
144361054|NCT00755183|520531173|FG001|Overall Study|Administrative|1|||
144361055|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
144361056|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
144361057|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
144361058|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Death|9|||
144361059|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Death|0|||
144361060|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Death|0|||
144361061|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
144361062|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
144361063|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
144361064|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
144361065|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
144361066|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
144361067|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Other|135|||
144361068|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Other|0|||
144361069|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Other|0|||
144361070|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
144361071|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
144361072|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
144361073|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
144361074|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
144361075|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
144361076|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
144471614|NCT00246337|520925255|FG003|Overall Study|Protocol Violation|0|||
144361077|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
144361078|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
144361079|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Other|3|||
144361080|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Other|0|||
144361081|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Other|0|||
144361082|NCT02118584|520531174|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
144361083|NCT02118584|520531175|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
144361084|NCT02118584|520531176|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
144361085|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
144361086|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
144361087|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
144361088|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
144361089|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
144361090|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
144361091|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
144361092|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
144361093|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
144361094|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
144361095|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
144361096|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
144361097|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
144361098|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
144361099|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
144361100|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
144361101|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
144361102|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
144361103|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
144361104|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
144361105|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
144361106|NCT02118584|520531174|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
144361107|NCT02118584|520531175|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
144361108|NCT02118584|520531176|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
144361109|NCT02766023|520531179|FG000|Overall Study|Lost to Follow-up|23|||
144361110|NCT02766023|520531180|FG001|Overall Study|Lost to Follow-up|11|||
144361111|NCT02766023|520531179|FG000|Overall Study|Pregnancy|1|||
144361112|NCT02766023|520531180|FG001|Overall Study|Pregnancy|0|||
144361113|NCT02766023|520531179|FG000|Overall Study|Adverse Event|1|||
144361114|NCT02766023|520531180|FG001|Overall Study|Adverse Event|0|||
144361115|NCT02766023|520531179|FG000|Overall Study|Withdrawal by Subject|4|||
144361116|NCT02766023|520531180|FG001|Overall Study|Withdrawal by Subject|5|||
144361117|NCT02766023|520531179|FG000|Overall Study|Physician Decision|1|||
144361118|NCT02766023|520531180|FG001|Overall Study|Physician Decision|0|||
144361119|NCT02766023|520531179|FG000|Overall Study|Not Eligible at Enrollment|0|||
144361120|NCT02766023|520531180|FG001|Overall Study|Not Eligible at Enrollment|1|||
144361121|NCT02587221|520531192|FG000|Overall Study|Adverse Event|3|||
144361122|NCT02587221|520531193|FG001|Overall Study|Adverse Event|3|||
144361123|NCT02587221|520531192|FG000|Overall Study|Death|33|||
144361124|NCT02587221|520531193|FG001|Overall Study|Death|34|||
144361125|NCT02587221|520531192|FG000|Overall Study|Withdrawal by Subject|66|||
144361126|NCT02587221|520531193|FG001|Overall Study|Withdrawal by Subject|61|||
144361127|NCT02587221|520531192|FG000|Overall Study|Lost to Follow-up|21|||
144361128|NCT02587221|520531193|FG001|Overall Study|Lost to Follow-up|19|||
144361129|NCT02587221|520531192|FG000|Overall Study|Protocol Violation|6|||
144361130|NCT02587221|520531193|FG001|Overall Study|Protocol Violation|5|||
144361131|NCT02587221|520531192|FG000|Overall Study|Other Reason or Unspecified|2|||
144361132|NCT02587221|520531193|FG001|Overall Study|Other Reason or Unspecified|1|||
144361133|NCT02476617|520531198|FG000|Overall Study|Adverse Event|1|||
144361134|NCT02476617|520531198|FG000|Overall Study|Lost to Follow-up|1|||
144361135|NCT02491684|520531200|FG000|Treatment Phase|Adverse Event|2|||
144361136|NCT02491684|520531201|FG001|Treatment Phase|Adverse Event|2|||
144361137|NCT02491684|520531200|FG000|Treatment Phase|Incorrect randomisation|1|||
144361138|NCT02491684|520531201|FG001|Treatment Phase|Incorrect randomisation|0|||
144361139|NCT02491684|520531200|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
144361140|NCT02491684|520531201|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
144361141|NCT00771914|520531204|FG000|Overall Study|Physician Decision|0|||
144361142|NCT00771914|520531205|FG001|Overall Study|Physician Decision|0|||
144361143|NCT00771914|520531206|FG002|Overall Study|Physician Decision|0|||
144361144|NCT00771914|520531207|FG003|Overall Study|Physician Decision|1|||
144361145|NCT00771914|520531204|FG000|Overall Study|Lost to Follow-up|0|||
144361146|NCT00771914|520531205|FG001|Overall Study|Lost to Follow-up|0|||
144361147|NCT00771914|520531206|FG002|Overall Study|Lost to Follow-up|0|||
144361148|NCT00771914|520531207|FG003|Overall Study|Lost to Follow-up|1|||
144361149|NCT01521117|520531208|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
144361150|NCT01521117|520531209|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
144361151|NCT01521117|520531208|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
144361152|NCT01521117|520531209|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
144361153|NCT01521117|520531208|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
144361154|NCT01521117|520531209|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
144361155|NCT00004563|520531210|FG000|Overall Study|Withdrawal by Subject|20|||
144361156|NCT00004563|520531211|FG001|Overall Study|Withdrawal by Subject|16|||
144361157|NCT00004563|520531210|FG000|Overall Study|Lack of Efficacy|3|||
144361158|NCT00004563|520531211|FG001|Overall Study|Lack of Efficacy|5|||
144361159|NCT00004563|520531210|FG000|Overall Study|Death|2|||
144361160|NCT00004563|520531211|FG001|Overall Study|Death|3|||
144361161|NCT01668784|520531214|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
144361162|NCT01668784|520531215|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
144361163|NCT01668784|520531214|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
144361164|NCT01668784|520531215|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
144361165|NCT01668784|520531214|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
144361166|NCT01668784|520531215|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
144361167|NCT01668784|520531214|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
144361168|NCT01668784|520531215|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
144361169|NCT01668784|520531214|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
144361170|NCT01668784|520531215|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
144361171|NCT01668784|520531214|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
144361172|NCT01668784|520531215|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
144361173|NCT01668784|520531214|FG000|Treatment Period|Disease Progression|316|||
144361174|NCT01668784|520531215|FG001|Treatment Period|Disease Progression|293|||
144361175|NCT01668784|520531214|FG000|Treatment Period|Study Drug Toxicity|46|||
144361176|NCT01668784|520531215|FG001|Treatment Period|Study Drug Toxicity|53|||
144361177|NCT01668784|520531214|FG000|Treatment Period|Death|1|||
144361178|NCT01668784|520531215|FG001|Treatment Period|Death|1|||
144361179|NCT01668784|520531214|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
144361180|NCT01668784|520531215|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
144361181|NCT01668784|520531214|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
144361182|NCT01668784|520531215|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
144361183|NCT01668784|520531214|FG000|Treatment Period|Withdrawal by Subject|5|||
144361184|NCT01668784|520531215|FG001|Treatment Period|Withdrawal by Subject|3|||
144361185|NCT01668784|520531214|FG000|Treatment Period|Maximal Clinical Benefit|3|||
144361186|NCT01668784|520531215|FG001|Treatment Period|Maximal Clinical Benefit|3|||
144361187|NCT01668784|520531214|FG000|Treatment Period|Other|2|||
144361188|NCT01668784|520531215|FG001|Treatment Period|Other|8|||
144361189|NCT01668784|520531214|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
144361190|NCT01668784|520531215|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
144361191|NCT00685165|520531218|FG000|Washout Period of 14 Days|Adverse Event|1|||
144361192|NCT00685165|520531219|FG001|Washout Period of 14 Days|Adverse Event|0|||
144361193|NCT05135871|520531226|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
144361194|NCT05135871|520531227|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
144361195|NCT05135871|520531228|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
144361196|NCT05135871|520531229|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
144361197|NCT04576988|520531233|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
144361198|NCT04576988|520531234|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
144361199|NCT04576988|520531233|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
144361200|NCT04576988|520531234|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
144361201|NCT04576988|520531233|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
144361202|NCT04576988|520531234|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
144361203|NCT04576988|520531233|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
144361204|NCT04576988|520531234|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
144361205|NCT04576988|520531233|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
144361206|NCT04576988|520531234|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
144361207|NCT04576988|520531233|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
144361208|NCT04576988|520531234|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
144361209|NCT04576988|520531233|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
144361210|NCT04576988|520531234|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
144361211|NCT04576988|520531233|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
144361212|NCT04576988|520531234|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
144361213|NCT04576988|520531233|FG000|Long Term Double Blind (LTDB)|Death|2|||
144361214|NCT04576988|520531234|FG001|Long Term Double Blind (LTDB)|Death|1|||
144361215|NCT04576988|520531233|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
144361216|NCT04576988|520531234|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
144361217|NCT01576341|520531237|FG000|Overall Study|Withdrawal by Subject|24|||
144361218|NCT01576341|520531237|FG000|Overall Study|Adverse Event|10|||
144361219|NCT01576341|520531237|FG000|Overall Study|Death|21|||
144361220|NCT01576341|520531237|FG000|Overall Study|Physician Decision|2|||
144361221|NCT01576341|520531237|FG000|Overall Study|Lost to Follow-up|2|||
144361222|NCT01576341|520531237|FG000|Overall Study|Kidney transplantation|10|||
144361223|NCT01576341|520531237|FG000|Overall Study|Protocol Violation|12|||
144361224|NCT01576341|520531237|FG000|Overall Study|Other|12|||
144361225|NCT01844765|520531238|FG000|Overall Study|Adverse Event|6|||
144361226|NCT01844765|520531239|FG001|Overall Study|Adverse Event|8|||
144361227|NCT01844765|520531238|FG000|Overall Study|Withdrawal by Subject|2|||
144361228|NCT01844765|520531239|FG001|Overall Study|Withdrawal by Subject|3|||
144361229|NCT01844765|520531238|FG000|Overall Study|Disease progression|1|||
144361230|NCT01844765|520531239|FG001|Overall Study|Disease progression|0|||
144361231|NCT01844765|520531238|FG000|Overall Study|Administrative problems|3|||
144361232|NCT01844765|520531239|FG001|Overall Study|Administrative problems|4|||
144361233|NCT01844765|520531238|FG000|Overall Study|Protocol deviation|2|||
144361234|NCT01844765|520531239|FG001|Overall Study|Protocol deviation|0|||
144361235|NCT01844765|520531238|FG000|Overall Study|Untreated|1|||
144361236|NCT01844765|520531239|FG001|Overall Study|Untreated|0|||
144361237|NCT00556075|520531248|FG000|Overall Study|Lost to Follow-up|3|||
144361238|NCT00556075|520531249|FG001|Overall Study|Lost to Follow-up|0|||
144361239|NCT00556075|520531250|FG002|Overall Study|Lost to Follow-up|3|||
144361240|NCT00556075|520531248|FG000|Overall Study|Withdrawal by Subject|3|||
144361241|NCT00556075|520531249|FG001|Overall Study|Withdrawal by Subject|3|||
144361242|NCT00556075|520531250|FG002|Overall Study|Withdrawal by Subject|0|||
144361243|NCT00556075|520531248|FG000|Overall Study|Protocol Violation|1|||
144361244|NCT00556075|520531249|FG001|Overall Study|Protocol Violation|1|||
144361245|NCT00556075|520531250|FG002|Overall Study|Protocol Violation|3|||
144361246|NCT00556075|520531248|FG000|Overall Study|Not eligible|1|||
144361247|NCT00556075|520531249|FG001|Overall Study|Not eligible|1|||
144361248|NCT00556075|520531250|FG002|Overall Study|Not eligible|2|||
144361249|NCT00556075|520531248|FG000|Overall Study|Adverse Event|1|||
144361250|NCT00556075|520531249|FG001|Overall Study|Adverse Event|2|||
144361251|NCT00556075|520531250|FG002|Overall Study|Adverse Event|0|||
144361252|NCT00556075|520531248|FG000|Overall Study|Personal issues|4|||
144361253|NCT00556075|520531249|FG001|Overall Study|Personal issues|1|||
144361254|NCT00556075|520531250|FG002|Overall Study|Personal issues|0|||
144361255|NCT00556075|520531248|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
144361256|NCT00556075|520531249|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
144361257|NCT00556075|520531250|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
144361258|NCT03914417|520531251|FG000|Overall Study|Withdrawal by Subject|2|||
144361259|NCT03836625|520531256|FG000|Overall Study|Lost to Follow-up|9|||
144361260|NCT03836625|520531257|FG001|Overall Study|Lost to Follow-up|9|||
144361261|NCT03836625|520531256|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
144361262|NCT03836625|520531257|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
144361263|NCT03836625|520531256|FG000|Overall Study|Death|0|||
144361264|NCT03836625|520531257|FG001|Overall Study|Death|1|||
144361265|NCT03836625|520531256|FG000|Overall Study|Refused follow-up|0|||
144361266|NCT03836625|520531257|FG001|Overall Study|Refused follow-up|1|||
144361267|NCT01420861|520531260|FG000|Overall Study|Adverse Event|2|||
144361268|NCT01420861|520531260|FG000|Overall Study|Study terminated by Sponsor|7|||
144361269|NCT01420861|520531260|FG000|Overall Study|Screen failure|7|||
144361270|NCT01420861|520531260|FG000|Overall Study|Randomized not Treated|2|||
144361271|NCT03361137|520531261|FG000|Overall Study|Reason not specified|1|||
144361272|NCT03361137|520531262|FG001|Overall Study|Reason not specified|0|||
144361273|NCT03361137|520531263|FG002|Overall Study|Reason not specified|0|||
144361274|NCT03361137|520531264|FG003|Overall Study|Reason not specified|0|||
144361275|NCT03361137|520531265|FG004|Overall Study|Reason not specified|0|||
144361276|NCT00791934|520531266|FG000|Overall Study|Withdrawal by Subject|2|||
144361277|NCT00791934|520531266|FG000|Overall Study|Did not consent for extended follow-up|13|||
144361278|NCT04905134|520531268|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
144361279|NCT04905134|520531268|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
144361280|NCT03009058|520531269|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
144361281|NCT03221556|520531270|FG000|Allocation|post-randomization exclusion|0|||
144361282|NCT03221556|520531271|FG001|Allocation|post-randomization exclusion|1|||
144361283|NCT03221556|520531270|FG000|Follow-Up|Withdrawal by Subject|0|||
144361284|NCT03221556|520531271|FG001|Follow-Up|Withdrawal by Subject|1|||
144361285|NCT02783690|520531272|FG000|Overall Study|Withdrawal by Subject|3|||
144361286|NCT02783690|520531273|FG001|Overall Study|Withdrawal by Subject|3|||
144361287|NCT01486966|520531276|FG000|Overall Study|Adverse Event|0|||
144361288|NCT01486966|520531277|FG001|Overall Study|Adverse Event|1|||
144587994|NCT04822597|521350519|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
144361289|NCT01486966|520531276|FG000|Overall Study|Withdrawal by Subject|0|||
144361290|NCT01486966|520531277|FG001|Overall Study|Withdrawal by Subject|1|||
144361291|NCT02234843|520531278|FG000|Overall Study|Death|1|||
144361292|NCT02234843|520531279|FG001|Overall Study|Death|0|||
144361293|NCT02234843|520531280|FG002|Overall Study|Death|0|||
144361294|NCT02234843|520531281|FG003|Overall Study|Death|0|||
144361295|NCT02234843|520531282|FG004|Overall Study|Death|0|||
144361296|NCT02234843|520531283|FG005|Overall Study|Death|0|||
144361297|NCT02234843|520531284|FG006|Overall Study|Death|0|||
144361298|NCT02234843|520531285|FG007|Overall Study|Death|0|||
144361299|NCT02234843|520531286|FG008|Overall Study|Death|0|||
144361300|NCT02234843|520531287|FG009|Overall Study|Death|0|||
144361301|NCT02234843|520531278|FG000|Overall Study|Protocol Violation|1|||
144361302|NCT02234843|520531279|FG001|Overall Study|Protocol Violation|0|||
144361303|NCT02234843|520531280|FG002|Overall Study|Protocol Violation|1|||
144361304|NCT02234843|520531281|FG003|Overall Study|Protocol Violation|0|||
144361305|NCT02234843|520531282|FG004|Overall Study|Protocol Violation|0|||
144361306|NCT02234843|520531283|FG005|Overall Study|Protocol Violation|0|||
144361307|NCT02234843|520531284|FG006|Overall Study|Protocol Violation|0|||
144361308|NCT02234843|520531285|FG007|Overall Study|Protocol Violation|0|||
144361309|NCT02234843|520531286|FG008|Overall Study|Protocol Violation|0|||
144361310|NCT02234843|520531287|FG009|Overall Study|Protocol Violation|0|||
144361311|NCT02234843|520531278|FG000|Overall Study|Efficacy outcome reached|2|||
144361312|NCT02234843|520531279|FG001|Overall Study|Efficacy outcome reached|0|||
144361313|NCT02234843|520531280|FG002|Overall Study|Efficacy outcome reached|0|||
144361314|NCT02234843|520531281|FG003|Overall Study|Efficacy outcome reached|0|||
144361315|NCT02234843|520531282|FG004|Overall Study|Efficacy outcome reached|0|||
144361316|NCT02234843|520531283|FG005|Overall Study|Efficacy outcome reached|2|||
144361317|NCT02234843|520531284|FG006|Overall Study|Efficacy outcome reached|0|||
144361318|NCT02234843|520531285|FG007|Overall Study|Efficacy outcome reached|0|||
144361319|NCT02234843|520531286|FG008|Overall Study|Efficacy outcome reached|0|||
144361320|NCT02234843|520531287|FG009|Overall Study|Efficacy outcome reached|0|||
144361321|NCT02234843|520531278|FG000|Overall Study|Patient convenience|2|||
144361322|NCT02234843|520531279|FG001|Overall Study|Patient convenience|0|||
144361323|NCT02234843|520531280|FG002|Overall Study|Patient convenience|0|||
144361324|NCT02234843|520531281|FG003|Overall Study|Patient convenience|0|||
144361325|NCT02234843|520531282|FG004|Overall Study|Patient convenience|0|||
144361326|NCT02234843|520531283|FG005|Overall Study|Patient convenience|1|||
144361327|NCT02234843|520531284|FG006|Overall Study|Patient convenience|0|||
144361328|NCT02234843|520531285|FG007|Overall Study|Patient convenience|0|||
144361329|NCT02234843|520531286|FG008|Overall Study|Patient convenience|0|||
144361330|NCT02234843|520531287|FG009|Overall Study|Patient convenience|0|||
144361331|NCT02234843|520531278|FG000|Overall Study|Withdrawal by Subject|5|||
144361332|NCT02234843|520531279|FG001|Overall Study|Withdrawal by Subject|1|||
144361333|NCT02234843|520531280|FG002|Overall Study|Withdrawal by Subject|1|||
144361334|NCT02234843|520531281|FG003|Overall Study|Withdrawal by Subject|0|||
144361335|NCT02234843|520531282|FG004|Overall Study|Withdrawal by Subject|0|||
144361336|NCT02234843|520531283|FG005|Overall Study|Withdrawal by Subject|7|||
144361337|NCT02234843|520531284|FG006|Overall Study|Withdrawal by Subject|0|||
144361338|NCT02234843|520531285|FG007|Overall Study|Withdrawal by Subject|0|||
144361339|NCT02234843|520531286|FG008|Overall Study|Withdrawal by Subject|0|||
144361340|NCT02234843|520531287|FG009|Overall Study|Withdrawal by Subject|0|||
144361341|NCT02234843|520531278|FG000|Overall Study|Recovery|1|||
144361342|NCT02234843|520531279|FG001|Overall Study|Recovery|0|||
144361343|NCT02234843|520531280|FG002|Overall Study|Recovery|0|||
144361344|NCT02234843|520531281|FG003|Overall Study|Recovery|0|||
144361345|NCT02234843|520531282|FG004|Overall Study|Recovery|0|||
144361346|NCT02234843|520531283|FG005|Overall Study|Recovery|0|||
144361347|NCT02234843|520531284|FG006|Overall Study|Recovery|0|||
144361348|NCT02234843|520531285|FG007|Overall Study|Recovery|0|||
144361349|NCT02234843|520531286|FG008|Overall Study|Recovery|0|||
144361350|NCT02234843|520531287|FG009|Overall Study|Recovery|0|||
144361351|NCT02234843|520531278|FG000|Overall Study|Other|0|||
144361352|NCT02234843|520531279|FG001|Overall Study|Other|2|||
144361353|NCT02234843|520531280|FG002|Overall Study|Other|0|||
144361354|NCT02234843|520531281|FG003|Overall Study|Other|1|||
144361355|NCT02234843|520531282|FG004|Overall Study|Other|0|||
144361356|NCT02234843|520531283|FG005|Overall Study|Other|1|||
144361357|NCT02234843|520531284|FG006|Overall Study|Other|0|||
144361358|NCT02234843|520531285|FG007|Overall Study|Other|1|||
144361359|NCT02234843|520531286|FG008|Overall Study|Other|0|||
144361360|NCT02234843|520531287|FG009|Overall Study|Other|0|||
144361361|NCT02234843|520531278|FG000|Overall Study|Physician Decision|4|||
144361362|NCT02234843|520531279|FG001|Overall Study|Physician Decision|1|||
144361363|NCT02234843|520531280|FG002|Overall Study|Physician Decision|0|||
144361364|NCT02234843|520531281|FG003|Overall Study|Physician Decision|1|||
144361365|NCT02234843|520531282|FG004|Overall Study|Physician Decision|0|||
144361366|NCT02234843|520531283|FG005|Overall Study|Physician Decision|0|||
144361367|NCT02234843|520531284|FG006|Overall Study|Physician Decision|0|||
144361368|NCT02234843|520531285|FG007|Overall Study|Physician Decision|1|||
144361369|NCT02234843|520531286|FG008|Overall Study|Physician Decision|0|||
144361370|NCT02234843|520531287|FG009|Overall Study|Physician Decision|0|||
144361371|NCT02234843|520531278|FG000|Overall Study|Adverse Event|5|||
144361372|NCT02234843|520531279|FG001|Overall Study|Adverse Event|1|||
144361373|NCT02234843|520531280|FG002|Overall Study|Adverse Event|1|||
144361374|NCT02234843|520531281|FG003|Overall Study|Adverse Event|3|||
144361375|NCT02234843|520531282|FG004|Overall Study|Adverse Event|2|||
144587995|NCT04822597|521350520|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
144259315|NCT01300247|520150368|FG001|Overall Study|Lost to Follow-up|0|||
144259316|NCT01300247|520150367|FG000|Overall Study|Withdrawal by Subject|1|||
144259317|NCT01300247|520150368|FG001|Overall Study|Withdrawal by Subject|0|||
144259318|NCT01300247|520150367|FG000|Overall Study|Non-Compliance|0|||
144259319|NCT01300247|520150368|FG001|Overall Study|Non-Compliance|1|||
144259320|NCT06060496|520150369|FG000|Overall Study|Withdrawal by Subject|2|||
144259321|NCT06060496|520150369|FG000|Overall Study|Lost to Follow-up|2|||
144259322|NCT02258659|520150370|FG000|Overall Study|Withdrawal by Subject|1|||
144259323|NCT03990051|520150371|FG000|Masked Period|Lost to Follow-up|1|||
144259324|NCT03990051|520150372|FG001|Masked Period|Lost to Follow-up|0|||
144259325|NCT03990051|520150371|FG000|Long Term Period|Death|1|||
144259326|NCT03990051|520150372|FG001|Long Term Period|Death|1|||
144259327|NCT03990051|520150371|FG000|Long Term Period|Lost to Follow-up|7|||
144259328|NCT03990051|520150372|FG001|Long Term Period|Lost to Follow-up|2|||
144259329|NCT00272844|520150373|FG000|Overall Study|Withdrawal by Subject|5|||
144259330|NCT03060291|520150374|FG000|3-month Follow-up|Declined to respond|8|||
144259331|NCT03060291|520150375|FG001|3-month Follow-up|Declined to respond|10|||
144259332|NCT03060291|520150376|FG002|3-month Follow-up|Declined to respond|2|||
144259333|NCT03060291|520150374|FG000|6-month Follow-up|Declined to respond|7|||
144259334|NCT03060291|520150375|FG001|6-month Follow-up|Declined to respond|13|||
144259335|NCT03060291|520150376|FG002|6-month Follow-up|Declined to respond|4|||
144259336|NCT03060291|520150374|FG000|12-month Follow-up|Declined to respond|7|||
144259337|NCT03060291|520150375|FG001|12-month Follow-up|Declined to respond|16|||
144259338|NCT03060291|520150376|FG002|12-month Follow-up|Declined to respond|6|||
144259339|NCT00618826|520150377|FG000|Overall Study|Adverse Event|1|||
144259340|NCT01509664|520150379|FG000|Overall Study|Lost to Follow-up|15|||
144259341|NCT01509664|520150380|FG001|Overall Study|Lost to Follow-up|21|||
144259342|NCT01556932|520150381|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
144259343|NCT01556932|520150382|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
144259344|NCT00158262|520150388|FG000|Overall Study|Lost to Follow-up|1|||
144259345|NCT00158262|520150389|FG001|Overall Study|Lost to Follow-up|1|||
144259346|NCT01421641|520150392|FG000|Overall Study|Protocol Violation|2|||
144259347|NCT01421641|520150393|FG001|Overall Study|Protocol Violation|2|||
144259348|NCT02420119|520150395|FG000|Overall Study|insufficient laboratory data|5|||
144259349|NCT03231306|520150396|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
144259350|NCT03231306|520150396|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
144259351|NCT03231306|520150396|FG000|Overall Study|Treatment delay > 21 days|2|||
144259352|NCT03231306|520150396|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
144259353|NCT03231306|520150396|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
144259354|NCT03231306|520150396|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
144259355|NCT03231306|520150396|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
144259356|NCT03231306|520150396|FG000|Overall Study|More than 1 Reason|2|||
144259357|NCT05464420|520150400|FG000|Overall Study|Death|0|||
144259358|NCT05464420|520150401|FG001|Overall Study|Death|0|||
144259359|NCT05464420|520150402|FG002|Overall Study|Death|0|||
144259360|NCT05464420|520150403|FG003|Overall Study|Death|1|||
144259361|NCT05464420|520150400|FG000|Overall Study|Lost to Follow-up|16|||
144259362|NCT05464420|520150401|FG001|Overall Study|Lost to Follow-up|11|||
144259363|NCT05464420|520150402|FG002|Overall Study|Lost to Follow-up|11|||
144259364|NCT05464420|520150403|FG003|Overall Study|Lost to Follow-up|11|||
144259365|NCT05464420|520150400|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
144259366|NCT05464420|520150401|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
144259367|NCT05464420|520150402|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
144259368|NCT05464420|520150403|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
144259369|NCT05464420|520150400|FG000|Overall Study|Withdrawal by Subject|4|||
144361376|NCT02234843|520531283|FG005|Overall Study|Adverse Event|1|||
144361377|NCT02234843|520531284|FG006|Overall Study|Adverse Event|0|||
144361378|NCT02234843|520531285|FG007|Overall Study|Adverse Event|0|||
144361379|NCT02234843|520531286|FG008|Overall Study|Adverse Event|1|||
144361380|NCT02234843|520531287|FG009|Overall Study|Adverse Event|0|||
144361381|NCT02234843|520531278|FG000|Overall Study|Non-compliance with study drug|1|||
144361382|NCT02234843|520531279|FG001|Overall Study|Non-compliance with study drug|0|||
144361383|NCT02234843|520531280|FG002|Overall Study|Non-compliance with study drug|0|||
144361384|NCT02234843|520531281|FG003|Overall Study|Non-compliance with study drug|0|||
144361385|NCT02234843|520531282|FG004|Overall Study|Non-compliance with study drug|0|||
144361386|NCT02234843|520531283|FG005|Overall Study|Non-compliance with study drug|1|||
144361387|NCT02234843|520531284|FG006|Overall Study|Non-compliance with study drug|1|||
144361388|NCT02234843|520531285|FG007|Overall Study|Non-compliance with study drug|0|||
144361389|NCT02234843|520531286|FG008|Overall Study|Non-compliance with study drug|0|||
144361390|NCT02234843|520531287|FG009|Overall Study|Non-compliance with study drug|0|||
144361391|NCT02234843|520531278|FG000|Overall Study|Lost to Follow-up|0|||
144361392|NCT02234843|520531279|FG001|Overall Study|Lost to Follow-up|1|||
144361393|NCT02234843|520531280|FG002|Overall Study|Lost to Follow-up|0|||
144361394|NCT02234843|520531281|FG003|Overall Study|Lost to Follow-up|0|||
144361395|NCT02234843|520531282|FG004|Overall Study|Lost to Follow-up|0|||
144361396|NCT02234843|520531283|FG005|Overall Study|Lost to Follow-up|0|||
144361397|NCT02234843|520531284|FG006|Overall Study|Lost to Follow-up|1|||
144361398|NCT02234843|520531285|FG007|Overall Study|Lost to Follow-up|0|||
144361399|NCT02234843|520531286|FG008|Overall Study|Lost to Follow-up|0|||
144361400|NCT02234843|520531287|FG009|Overall Study|Lost to Follow-up|0|||
144361401|NCT00506350|520531288|FG000|Overall Study|Serious Adverse Event|1|||
144361402|NCT00506350|520531289|FG001|Overall Study|Serious Adverse Event|0|||
144361403|NCT00506350|520531290|FG002|Overall Study|Serious Adverse Event|0|||
144361404|NCT00506350|520531291|FG003|Overall Study|Serious Adverse Event|0|||
144361405|NCT00506350|520531292|FG004|Overall Study|Serious Adverse Event|0|||
144361406|NCT00506350|520531293|FG005|Overall Study|Serious Adverse Event|0|||
144361407|NCT00506350|520531294|FG006|Overall Study|Serious Adverse Event|0|||
144361408|NCT00506350|520531295|FG007|Overall Study|Serious Adverse Event|0|||
144361409|NCT00506350|520531296|FG008|Overall Study|Serious Adverse Event|0|||
144361410|NCT00506350|520531288|FG000|Overall Study|Adverse Event|0|||
144361411|NCT00506350|520531289|FG001|Overall Study|Adverse Event|0|||
144361412|NCT00506350|520531290|FG002|Overall Study|Adverse Event|0|||
144361413|NCT00506350|520531291|FG003|Overall Study|Adverse Event|0|||
144361414|NCT00506350|520531292|FG004|Overall Study|Adverse Event|0|||
144361415|NCT00506350|520531293|FG005|Overall Study|Adverse Event|0|||
144361416|NCT00506350|520531294|FG006|Overall Study|Adverse Event|0|||
144361417|NCT00506350|520531295|FG007|Overall Study|Adverse Event|1|||
144361418|NCT00506350|520531296|FG008|Overall Study|Adverse Event|1|||
144361419|NCT00506350|520531288|FG000|Overall Study|Protocol Violation|0|||
144361420|NCT00506350|520531289|FG001|Overall Study|Protocol Violation|0|||
144361421|NCT00506350|520531290|FG002|Overall Study|Protocol Violation|1|||
144361422|NCT00506350|520531291|FG003|Overall Study|Protocol Violation|0|||
144361423|NCT00506350|520531292|FG004|Overall Study|Protocol Violation|0|||
144361424|NCT00506350|520531293|FG005|Overall Study|Protocol Violation|0|||
144361425|NCT00506350|520531294|FG006|Overall Study|Protocol Violation|1|||
144361426|NCT00506350|520531295|FG007|Overall Study|Protocol Violation|0|||
144361427|NCT00506350|520531296|FG008|Overall Study|Protocol Violation|0|||
144361428|NCT00506350|520531288|FG000|Overall Study|Withdrawal by Subject|0|||
144361429|NCT00506350|520531289|FG001|Overall Study|Withdrawal by Subject|1|||
144361430|NCT00506350|520531290|FG002|Overall Study|Withdrawal by Subject|1|||
144361431|NCT00506350|520531291|FG003|Overall Study|Withdrawal by Subject|1|||
144361432|NCT00506350|520531292|FG004|Overall Study|Withdrawal by Subject|4|||
144361433|NCT00506350|520531293|FG005|Overall Study|Withdrawal by Subject|1|||
144361434|NCT00506350|520531294|FG006|Overall Study|Withdrawal by Subject|1|||
144361435|NCT00506350|520531295|FG007|Overall Study|Withdrawal by Subject|2|||
144361436|NCT00506350|520531296|FG008|Overall Study|Withdrawal by Subject|0|||
144361437|NCT00506350|520531288|FG000|Overall Study|Lost to Follow-up|1|||
144361438|NCT00506350|520531289|FG001|Overall Study|Lost to Follow-up|1|||
144361439|NCT00506350|520531290|FG002|Overall Study|Lost to Follow-up|1|||
144361440|NCT00506350|520531291|FG003|Overall Study|Lost to Follow-up|1|||
144361441|NCT00506350|520531292|FG004|Overall Study|Lost to Follow-up|2|||
144361442|NCT00506350|520531293|FG005|Overall Study|Lost to Follow-up|1|||
144361443|NCT00506350|520531294|FG006|Overall Study|Lost to Follow-up|0|||
144361444|NCT00506350|520531295|FG007|Overall Study|Lost to Follow-up|0|||
144361445|NCT00506350|520531296|FG008|Overall Study|Lost to Follow-up|2|||
144361446|NCT00506350|520531288|FG000|Overall Study|Medical Reason|0|||
144361447|NCT00506350|520531289|FG001|Overall Study|Medical Reason|0|||
144361448|NCT00506350|520531290|FG002|Overall Study|Medical Reason|0|||
144361449|NCT00506350|520531291|FG003|Overall Study|Medical Reason|0|||
144361450|NCT00506350|520531292|FG004|Overall Study|Medical Reason|1|||
144361451|NCT00506350|520531293|FG005|Overall Study|Medical Reason|0|||
144361452|NCT00506350|520531294|FG006|Overall Study|Medical Reason|0|||
144361453|NCT00506350|520531295|FG007|Overall Study|Medical Reason|0|||
144361454|NCT00506350|520531296|FG008|Overall Study|Medical Reason|0|||
144361455|NCT00506350|520531288|FG000|Overall Study|Other|1|||
144361456|NCT00506350|520531289|FG001|Overall Study|Other|1|||
144361457|NCT00506350|520531290|FG002|Overall Study|Other|3|||
144361458|NCT00506350|520531291|FG003|Overall Study|Other|0|||
144361459|NCT00506350|520531292|FG004|Overall Study|Other|3|||
144361460|NCT00506350|520531293|FG005|Overall Study|Other|0|||
144361461|NCT00506350|520531294|FG006|Overall Study|Other|0|||
144361462|NCT00506350|520531295|FG007|Overall Study|Other|2|||
144361463|NCT00506350|520531296|FG008|Overall Study|Other|2|||
144361464|NCT04886154|520531297|FG000|Overall Study|Adverse Event|0|||
144361465|NCT04886154|520531298|FG001|Overall Study|Adverse Event|0|||
144361466|NCT04886154|520531299|FG002|Overall Study|Adverse Event|0|||
144361467|NCT04886154|520531300|FG003|Overall Study|Adverse Event|0|||
144361468|NCT04886154|520531301|FG004|Overall Study|Adverse Event|1|||
144361469|NCT04886154|520531302|FG005|Overall Study|Adverse Event|0|||
144361470|NCT04886154|520531303|FG006|Overall Study|Adverse Event|0|||
144361471|NCT04886154|520531304|FG007|Overall Study|Adverse Event|1|||
144361472|NCT04886154|520531305|FG008|Overall Study|Adverse Event|1|||
144361473|NCT04886154|520531306|FG009|Overall Study|Adverse Event|0|||
144361474|NCT04886154|520531307|FG010|Overall Study|Adverse Event|0|||
144361475|NCT04886154|520531308|FG011|Overall Study|Adverse Event|1|||
144361476|NCT04886154|520531309|FG012|Overall Study|Adverse Event|0|||
144361477|NCT04886154|520531310|FG013|Overall Study|Adverse Event|0|||
144361478|NCT04886154|520531311|FG014|Overall Study|Adverse Event|3|||
144361479|NCT04886154|520531297|FG000|Overall Study|Lost to Follow-up|1|||
144361480|NCT04886154|520531298|FG001|Overall Study|Lost to Follow-up|0|||
144361481|NCT04886154|520531299|FG002|Overall Study|Lost to Follow-up|2|||
144361482|NCT04886154|520531300|FG003|Overall Study|Lost to Follow-up|0|||
144361483|NCT04886154|520531301|FG004|Overall Study|Lost to Follow-up|17|||
144361484|NCT04886154|520531302|FG005|Overall Study|Lost to Follow-up|7|||
144361485|NCT04886154|520531303|FG006|Overall Study|Lost to Follow-up|8|||
144361486|NCT04886154|520531304|FG007|Overall Study|Lost to Follow-up|7|||
144361487|NCT04886154|520531305|FG008|Overall Study|Lost to Follow-up|8|||
144361488|NCT04886154|520531306|FG009|Overall Study|Lost to Follow-up|0|||
144361489|NCT04886154|520531307|FG010|Overall Study|Lost to Follow-up|2|||
144361490|NCT04886154|520531308|FG011|Overall Study|Lost to Follow-up|0|||
144361491|NCT04886154|520531309|FG012|Overall Study|Lost to Follow-up|0|||
144361492|NCT04886154|520531310|FG013|Overall Study|Lost to Follow-up|0|||
144361493|NCT04886154|520531311|FG014|Overall Study|Lost to Follow-up|0|||
144361494|NCT04886154|520531297|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361495|NCT04886154|520531298|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361496|NCT04886154|520531299|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361497|NCT04886154|520531300|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361498|NCT04886154|520531301|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361499|NCT04886154|520531302|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361500|NCT04886154|520531303|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
144361501|NCT04886154|520531304|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361502|NCT04886154|520531305|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361503|NCT04886154|520531306|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361504|NCT04886154|520531307|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361505|NCT04886154|520531308|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361506|NCT04886154|520531309|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361507|NCT04886154|520531310|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361508|NCT04886154|520531311|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
144361509|NCT04886154|520531297|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361510|NCT04886154|520531298|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361511|NCT04886154|520531299|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361512|NCT04886154|520531300|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361513|NCT04886154|520531301|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144361514|NCT04886154|520531302|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361515|NCT04886154|520531303|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
144361516|NCT04886154|520531304|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144361517|NCT04886154|520531305|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361518|NCT04886154|520531306|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361519|NCT04886154|520531307|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361520|NCT04886154|520531308|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361521|NCT04886154|520531309|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361522|NCT04886154|520531310|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144361523|NCT04886154|520531311|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144361524|NCT04886154|520531297|FG000|Overall Study|Other, Not Specified|0|||
144361525|NCT04886154|520531298|FG001|Overall Study|Other, Not Specified|0|||
144361526|NCT04886154|520531299|FG002|Overall Study|Other, Not Specified|0|||
144361527|NCT04886154|520531300|FG003|Overall Study|Other, Not Specified|0|||
144361528|NCT04886154|520531301|FG004|Overall Study|Other, Not Specified|11|||
144361529|NCT04886154|520531302|FG005|Overall Study|Other, Not Specified|8|||
144361530|NCT04886154|520531303|FG006|Overall Study|Other, Not Specified|9|||
144361531|NCT04886154|520531304|FG007|Overall Study|Other, Not Specified|10|||
144361532|NCT04886154|520531305|FG008|Overall Study|Other, Not Specified|6|||
144361533|NCT04886154|520531306|FG009|Overall Study|Other, Not Specified|1|||
144361534|NCT04886154|520531307|FG010|Overall Study|Other, Not Specified|1|||
144361535|NCT04886154|520531308|FG011|Overall Study|Other, Not Specified|2|||
144361536|NCT04886154|520531309|FG012|Overall Study|Other, Not Specified|1|||
144361537|NCT04886154|520531310|FG013|Overall Study|Other, Not Specified|2|||
144361538|NCT04886154|520531311|FG014|Overall Study|Other, Not Specified|3|||
144361539|NCT03919773|520531312|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
144361540|NCT03919773|520531313|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
144361541|NCT03919773|520531312|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
144361542|NCT03919773|520531313|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
144361543|NCT02336282|520531317|FG000|Overall Study|Unrelated illness|1|||
144361544|NCT02336282|520531317|FG000|Overall Study|Uncomfortable with technology|1|||
144361545|NCT02336282|520531317|FG000|Overall Study|Lost to Follow-up|1|||
144361546|NCT02336282|520531317|FG000|Overall Study|Not enough time to complete sessions|2|||
144361547|NCT04875975|520531319|FG000|Overall Study|Adverse Event|1|||
144361548|NCT04875975|520531320|FG001|Overall Study|Adverse Event|2|||
144361549|NCT04875975|520531319|FG000|Overall Study|Lack of Efficacy|2|||
144361550|NCT04875975|520531320|FG001|Overall Study|Lack of Efficacy|2|||
144361551|NCT04875975|520531319|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
144361552|NCT04875975|520531320|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
144361553|NCT04875975|520531319|FG000|Overall Study|Relapse With Insults|0|||
144361554|NCT04875975|520531320|FG001|Overall Study|Relapse With Insults|1|||
144361555|NCT04875975|520531319|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
144361556|NCT04875975|520531320|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
144361557|NCT05472090|520531321|FG000|Overall Study|Adverse Event|2|||
144361558|NCT05472090|520531322|FG001|Overall Study|Adverse Event|3|||
144361559|NCT05472090|520531321|FG000|Overall Study|Lack of Efficacy|1|||
144361560|NCT05472090|520531322|FG001|Overall Study|Lack of Efficacy|0|||
144361561|NCT05472090|520531321|FG000|Overall Study|Physician Decision|1|||
144361562|NCT05472090|520531322|FG001|Overall Study|Physician Decision|0|||
144361563|NCT05472090|520531321|FG000|Overall Study|Withdrawal by Subject|2|||
144361564|NCT05472090|520531322|FG001|Overall Study|Withdrawal by Subject|0|||
144361565|NCT05472090|520531321|FG000|Overall Study|Lost to Follow-up|0|||
144361566|NCT05472090|520531322|FG001|Overall Study|Lost to Follow-up|3|||
144361567|NCT00904969|520532723|FG000|Overall Study|Lost to Follow-up|4|||
144361568|NCT00904969|520532723|FG000|Overall Study|Withdrawal by Subject|3|||
144361569|NCT00904969|520532723|FG000|Overall Study|Additional Treatments|11|||
144361570|NCT00904969|520532723|FG000|Overall Study|Case Aborted; Subject Exited|1|||
144361571|NCT01702311|520532731|FG000|Overall Study|Withdrawal by Subject|3|||
144361572|NCT01702311|520532732|FG001|Overall Study|Withdrawal by Subject|2|||
144361573|NCT01702311|520532731|FG000|Overall Study|Discharge less than 24 hours|10|||
144361574|NCT01702311|520532732|FG001|Overall Study|Discharge less than 24 hours|7|||
144361575|NCT01702311|520532731|FG000|Overall Study|Physician Decision|3|||
144361576|NCT01702311|520532732|FG001|Overall Study|Physician Decision|4|||
144361577|NCT00804908|520532734|FG000|Overall Study|Other|115|||
144361578|NCT00804908|520532735|FG001|Overall Study|Other|116|||
144361579|NCT00804908|520532736|FG002|Overall Study|Other|114|||
144361580|NCT02177695|520532737|FG000|ITT Analysis|Ineligible|5|||
144361581|NCT02177695|520532738|FG001|ITT Analysis|Ineligible|5|||
144361582|NCT02177695|520532737|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
144361583|NCT02177695|520532738|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
144361584|NCT02177695|520532737|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
144361585|NCT02177695|520532738|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
144361586|NCT02177695|520532737|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
144361587|NCT02177695|520532738|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
144361588|NCT00248625|520532741|FG000|Overall Study|Withdrawal by Subject|0|||
144361589|NCT00248625|520532742|FG001|Overall Study|Withdrawal by Subject|2|||
144361590|NCT01074502|520532745|FG000|Overall Study|Withdrawal by Subject|1|||
144361591|NCT05176314|520532759|FG000|Overall Study|Lost to Follow-up|2|||
144361592|NCT05176314|520532759|FG000|Overall Study|Physician Decision|1|||
144361593|NCT05176314|520532759|FG000|Overall Study|Adverse Event|1|||
144361594|NCT02939287|520532765|FG000|Overall Study|met exclusion criteria|1|||
144361595|NCT02939287|520532766|FG001|Overall Study|met exclusion criteria|1|||
144361596|NCT02939287|520532767|FG002|Overall Study|met exclusion criteria|1|||
144361597|NCT02939287|520532765|FG000|Overall Study|Did not complete survey|2|||
144361598|NCT02939287|520532766|FG001|Overall Study|Did not complete survey|2|||
144361599|NCT02939287|520532767|FG002|Overall Study|Did not complete survey|0|||
144361600|NCT02939287|520532765|FG000|Overall Study|Withdrawal by Subject|1|||
144361601|NCT02939287|520532766|FG001|Overall Study|Withdrawal by Subject|1|||
144361602|NCT02939287|520532767|FG002|Overall Study|Withdrawal by Subject|0|||
144361603|NCT00671658|520532772|FG000|Overall Study|Physician Decision|5|||
144361604|NCT01527149|520532774|FG000|Overall Study|Death|2|||
144361605|NCT01680341|520532776|FG000|Overall Study|Adverse Event|3|||
144361606|NCT01680341|520532777|FG001|Overall Study|Adverse Event|2|||
144361607|NCT01680341|520532776|FG000|Overall Study|Unclassified|18|||
144361608|NCT01680341|520532777|FG001|Overall Study|Unclassified|15|||
144361609|NCT00499486|520532779|FG000|Overall Study|Withdrawal by Subject|16|||
144361610|NCT03796728|520532780|FG000|Overall Study|Lost to Follow-up|8|||
144361611|NCT03796728|520532780|FG000|Overall Study|Reason not Specified|16|||
144361612|NCT00333775|520532782|FG000|Overall Study|Death|144|||
144361613|NCT00333775|520532783|FG001|Overall Study|Death|149|||
144361614|NCT00333775|520532784|FG002|Overall Study|Death|143|||
144361615|NCT00333775|520532782|FG000|Overall Study|In Follow-up When Study Stopped|87|||
144361616|NCT00333775|520532783|FG001|Overall Study|In Follow-up When Study Stopped|92|||
144361617|NCT00333775|520532784|FG002|Overall Study|In Follow-up When Study Stopped|96|||
144361618|NCT00333775|520532782|FG000|Overall Study|Lost to Follow-up|10|||
144361619|NCT00333775|520532783|FG001|Overall Study|Lost to Follow-up|7|||
144361620|NCT00333775|520532784|FG002|Overall Study|Lost to Follow-up|8|||
144361621|NCT01383928|520532788|FG000|Overall Study|Initiation of ASCT|2|||
144361622|NCT01383928|520532789|FG001|Overall Study|Initiation of ASCT|1|||
144361623|NCT01383928|520532790|FG002|Overall Study|Initiation of ASCT|18|||
144361624|NCT01383928|520532788|FG000|Overall Study|Adverse Event|1|||
144361625|NCT01383928|520532789|FG001|Overall Study|Adverse Event|2|||
144361626|NCT01383928|520532790|FG002|Overall Study|Adverse Event|8|||
144361627|NCT01383928|520532788|FG000|Overall Study|Other|1|||
144361628|NCT01383928|520532789|FG001|Overall Study|Other|3|||
144361629|NCT01383928|520532790|FG002|Overall Study|Other|4|||
144361630|NCT01383928|520532788|FG000|Overall Study|Progressive Disease|1|||
144361631|NCT01383928|520532789|FG001|Overall Study|Progressive Disease|1|||
144361632|NCT01383928|520532790|FG002|Overall Study|Progressive Disease|5|||
144361633|NCT01383928|520532788|FG000|Overall Study|Withdrawal by Subject|0|||
144361634|NCT01383928|520532789|FG001|Overall Study|Withdrawal by Subject|0|||
144361635|NCT01383928|520532790|FG002|Overall Study|Withdrawal by Subject|4|||
144361636|NCT01383928|520532788|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
144361637|NCT01383928|520532789|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
144361638|NCT01383928|520532790|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
144361639|NCT03651765|520532792|FG000|Overall Study|Adverse Event|6|||
144361640|NCT03651765|520532792|FG000|Overall Study|Lack of Efficacy|18|||
144361641|NCT03651765|520532792|FG000|Overall Study|Lost to Follow-up|5|||
144361642|NCT03651765|520532792|FG000|Overall Study|Non-Compliance with Study Drug|4|||
144361643|NCT03651765|520532792|FG000|Overall Study|Physician Decision|6|||
144361644|NCT03651765|520532792|FG000|Overall Study|Pregnancy|1|||
144361645|NCT03651765|520532792|FG000|Overall Study|Discontinued by Sponsor|40|||
144361646|NCT03651765|520532792|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
144361647|NCT03651765|520532792|FG000|Overall Study|Withdrawal by Subject|24|||
144361648|NCT03651765|520532792|FG000|Overall Study|Miscellaneous|6|||
144361649|NCT00551759|520532793|FG000|Overall Study|Adverse Event|7|||
144361650|NCT00551759|520532793|FG000|Overall Study|Death|5|||
144361651|NCT00551759|520532793|FG000|Overall Study|Ineligible|1|||
144361652|NCT03279081|520532794|FG000|Overall Study|Withdrawal by Subject|12|||
144361653|NCT03279081|520532795|FG001|Overall Study|Withdrawal by Subject|20|||
144361654|NCT03279081|520532794|FG000|Overall Study|Physician Decision|4|||
144361655|NCT03279081|520532795|FG001|Overall Study|Physician Decision|1|||
144361656|NCT03279081|520532794|FG000|Overall Study|Lost to Follow-up|8|||
144199188|NCT00321737|519926517|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
144199189|NCT00321737|519926518|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
144199190|NCT00321737|519926519|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
144199191|NCT00321737|519926517|FG000|Overall Study|Possible Barrett's Esophagus|2|||
144199192|NCT00321737|519926518|FG001|Overall Study|Possible Barrett's Esophagus|1|||
144199193|NCT00321737|519926519|FG002|Overall Study|Possible Barrett's Esophagus|1|||
144199194|NCT00321737|519926517|FG000|Overall Study|Therapeutic Failure|6|||
144199195|NCT00321737|519926518|FG001|Overall Study|Therapeutic Failure|0|||
144199196|NCT00321737|519926519|FG002|Overall Study|Therapeutic Failure|2|||
144199197|NCT00321737|519926517|FG000|Overall Study|Pregnancy|0|||
144199198|NCT00321737|519926518|FG001|Overall Study|Pregnancy|2|||
144199199|NCT00321737|519926519|FG002|Overall Study|Pregnancy|0|||
144199200|NCT00321737|519926517|FG000|Overall Study|Noncompliance|2|||
144199201|NCT00321737|519926518|FG001|Overall Study|Noncompliance|0|||
144199202|NCT00321737|519926519|FG002|Overall Study|Noncompliance|0|||
144199203|NCT00321737|519926517|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
144199204|NCT00321737|519926518|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
144199205|NCT00321737|519926519|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
144199206|NCT01079832|519926520|FG000|Overall Study|Withdrawal by Subject|1|||
144199207|NCT02283294|519926521|FG000|Overall Study|Lost to Follow-up|1|||
144199208|NCT02283294|519926522|FG001|Overall Study|Lost to Follow-up|1|||
144199209|NCT02283294|519926521|FG000|Overall Study|Withdrawal by Subject|1|||
144199210|NCT02283294|519926522|FG001|Overall Study|Withdrawal by Subject|6|||
144199211|NCT02283294|519926521|FG000|Overall Study|Protocol Violation|1|||
144199212|NCT02283294|519926522|FG001|Overall Study|Protocol Violation|0|||
144199213|NCT02283294|519926521|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
144199214|NCT02283294|519926522|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
144361657|NCT03279081|520532795|FG001|Overall Study|Lost to Follow-up|8|||
144361658|NCT03279081|520532794|FG000|Overall Study|Death|0|||
144361659|NCT03279081|520532795|FG001|Overall Study|Death|1|||
144361660|NCT03279081|520532794|FG000|Overall Study|Adverse Event|1|||
144361661|NCT03279081|520532795|FG001|Overall Study|Adverse Event|0|||
144361662|NCT03279081|520532794|FG000|Overall Study|Reason not Specified|14|||
144361663|NCT03279081|520532795|FG001|Overall Study|Reason not Specified|4|||
144361664|NCT03521570|520532796|FG000|Overall Study|Not eligible|11|||
144361665|NCT04842747|520532801|FG000|Overall Study|Withdrawal by Subject|6|||
144361666|NCT04842747|520532802|FG001|Overall Study|Withdrawal by Subject|2|||
144361667|NCT04842747|520532801|FG000|Overall Study|Lost to Follow-up|1|||
144361668|NCT04842747|520532802|FG001|Overall Study|Lost to Follow-up|2|||
144361669|NCT04842747|520532801|FG000|Overall Study|Physician Decision|1|||
144361670|NCT04842747|520532802|FG001|Overall Study|Physician Decision|0|||
144361671|NCT04842747|520532801|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
144361672|NCT04842747|520532802|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
144361673|NCT00976274|520532805|FG000|Overall Study|Lost to Follow-up|5|||
144361674|NCT00976274|520532806|FG001|Overall Study|Lost to Follow-up|5|||
144361675|NCT00976274|520532805|FG000|Overall Study|Withdrawal by Subject|1|||
144361676|NCT00976274|520532806|FG001|Overall Study|Withdrawal by Subject|1|||
144361677|NCT00976274|520532805|FG000|Overall Study|Physician Decision|1|||
144361678|NCT00976274|520532806|FG001|Overall Study|Physician Decision|2|||
144361679|NCT00627393|520532807|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
144361680|NCT00627393|520532808|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
144361681|NCT00627393|520532807|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
144361682|NCT00627393|520532808|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
144361683|NCT00627393|520532807|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
144361684|NCT00627393|520532808|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
144361685|NCT00627393|520532807|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
144471615|NCT00246337|520925256|FG004|Overall Study|Protocol Violation|1|||
144361686|NCT00627393|520532808|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
144361687|NCT02183675|520532809|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
144361688|NCT02183675|520532810|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
144361689|NCT02183675|520532811|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
144361690|NCT02183675|520532812|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
144361691|NCT02183675|520532813|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
144361692|NCT02183675|520532814|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
144361693|NCT03337308|520532815|FG000|Overall Study|Adverse Event|2|||
144361694|NCT03337308|520532816|FG001|Overall Study|Adverse Event|3|||
144361695|NCT03337308|520532817|FG002|Overall Study|Adverse Event|3|||
144361696|NCT03337308|520532818|FG003|Overall Study|Adverse Event|1|||
144361697|NCT03337308|520532815|FG000|Overall Study|Lost to Follow-up|1|||
144361698|NCT03337308|520532816|FG001|Overall Study|Lost to Follow-up|2|||
144361699|NCT03337308|520532817|FG002|Overall Study|Lost to Follow-up|0|||
144361700|NCT03337308|520532818|FG003|Overall Study|Lost to Follow-up|0|||
144361701|NCT03337308|520532815|FG000|Overall Study|Withdrawal by Subject|2|||
144361702|NCT03337308|520532816|FG001|Overall Study|Withdrawal by Subject|1|||
144361703|NCT03337308|520532817|FG002|Overall Study|Withdrawal by Subject|2|||
144361704|NCT03337308|520532818|FG003|Overall Study|Withdrawal by Subject|1|||
144361705|NCT03337308|520532815|FG000|Overall Study|Protocol Violation|0|||
144361706|NCT03337308|520532816|FG001|Overall Study|Protocol Violation|1|||
144361707|NCT03337308|520532817|FG002|Overall Study|Protocol Violation|0|||
144361708|NCT03337308|520532818|FG003|Overall Study|Protocol Violation|0|||
144361709|NCT02946580|520532819|FG000|Overall Study|Withdrawal by Subject|1|||
144473770|NCT05044325|520934087|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144361710|NCT02946580|520532820|FG001|Overall Study|Withdrawal by Subject|2|||
144361711|NCT02946580|520532819|FG000|Overall Study|Adverse Event|0|||
144361712|NCT02946580|520532820|FG001|Overall Study|Adverse Event|2|||
144361713|NCT02946580|520532819|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
144361714|NCT02946580|520532820|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
144361715|NCT02761330|520532821|FG000|Treatment Week 1|Withdrawal by Subject|0|||
144361716|NCT02761330|520532822|FG001|Treatment Week 1|Withdrawal by Subject|0|||
144361717|NCT02761330|520532823|FG002|Treatment Week 1|Withdrawal by Subject|0|||
144361718|NCT02761330|520532824|FG003|Treatment Week 1|Withdrawal by Subject|1|||
144361719|NCT02761330|520532825|FG004|Treatment Week 1|Withdrawal by Subject|0|||
144361720|NCT02761330|520532826|FG005|Treatment Week 1|Withdrawal by Subject|1|||
144361721|NCT00888134|520532827|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
144361722|NCT00888134|520532827|FG000|Follow-up|being followed for long-term survival|1|||
144361723|NCT03043313|520532828|FG000|Overall Study|Withdrawal by Subject|5|||
144361724|NCT03043313|520532829|FG001|Overall Study|Withdrawal by Subject|1|||
144361725|NCT03043313|520532830|FG002|Overall Study|Withdrawal by Subject|1|||
144361726|NCT03043313|520532828|FG000|Overall Study|Lost to Follow-up|1|||
144361727|NCT03043313|520532829|FG001|Overall Study|Lost to Follow-up|1|||
144361728|NCT03043313|520532830|FG002|Overall Study|Lost to Follow-up|0|||
144361729|NCT03043313|520532828|FG000|Overall Study|Death|28|||
144361730|NCT03043313|520532829|FG001|Overall Study|Death|26|||
144361731|NCT03043313|520532830|FG002|Overall Study|Death|17|||
144361732|NCT03043313|520532828|FG000|Overall Study|Participation terminated by sponsor|11|||
144361733|NCT03043313|520532829|FG001|Overall Study|Participation terminated by sponsor|13|||
144361734|NCT03043313|520532830|FG002|Overall Study|Participation terminated by sponsor|13|||
144361735|NCT02657889|520532831|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
144361736|NCT02657889|520532832|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
144361737|NCT02657889|520532833|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
144361738|NCT02657889|520532834|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
144361739|NCT02657889|520532831|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
144361740|NCT02657889|520532832|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
144199215|NCT01769339|519926523|FG000|Overall Study|Lost to Follow-up|42|||
144361741|NCT02657889|520532833|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
144361742|NCT02657889|520532834|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
144361743|NCT02657889|520532831|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
144361744|NCT02657889|520532832|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
144361745|NCT02657889|520532833|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
144361746|NCT02657889|520532834|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
144361747|NCT02657889|520532831|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
144361748|NCT02657889|520532832|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
144361749|NCT02657889|520532833|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
144361750|NCT02657889|520532834|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
144361751|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
144361752|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
144361753|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
144361754|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
144361755|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
144361756|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
144361757|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
144361758|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
144361759|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
144361760|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
144361761|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
144361762|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
144361763|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
144361764|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
144361765|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
144361766|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
144361767|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
144361768|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
144361769|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
144361770|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
144361771|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
144361772|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
144361773|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
144361774|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
144361775|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
144361776|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
144361777|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
144361778|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
144361779|NCT02657889|520532831|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
144361780|NCT02657889|520532832|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
144361781|NCT02657889|520532833|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
144361782|NCT02657889|520532834|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
144361783|NCT00795535|520532835|FG000|Overall Study|incomplete data and technical problems|20|||
144361784|NCT00374140|520532837|FG000|Overall Study|Lost to Follow-up|1|||
144361785|NCT00374140|520532837|FG000|Overall Study|Protocol Violation|1|||
144361786|NCT00617734|520532838|FG000|Overall Study|Withdrew Consent|2|||
144361787|NCT00617734|520532839|FG001|Overall Study|Withdrew Consent|0|||
144361788|NCT00617734|520532838|FG000|Overall Study|Adverse Event|4|||
144361789|NCT00617734|520532839|FG001|Overall Study|Adverse Event|1|||
144361790|NCT00617734|520532838|FG000|Overall Study|Protocol Violation|1|||
144361791|NCT00617734|520532839|FG001|Overall Study|Protocol Violation|0|||
144361792|NCT00617734|520532838|FG000|Overall Study|Found Ineligible After Randomization|1|||
144361793|NCT00617734|520532839|FG001|Overall Study|Found Ineligible After Randomization|4|||
144361794|NCT00617734|520532838|FG000|Overall Study|Lost to Follow-up|0|||
144361795|NCT00617734|520532839|FG001|Overall Study|Lost to Follow-up|1|||
144361796|NCT02485691|520532840|FG000|Overall Study|Adverse Event|25|||
144361797|NCT02485691|520532841|FG001|Overall Study|Adverse Event|11|||
144361798|NCT02485691|520532840|FG000|Overall Study|Poor compliance to protocol|0|||
144361799|NCT02485691|520532841|FG001|Overall Study|Poor compliance to protocol|1|||
144361800|NCT02485691|520532840|FG000|Overall Study|Disease progression|57|||
144361801|NCT02485691|520532841|FG001|Overall Study|Disease progression|92|||
144361802|NCT02485691|520532840|FG000|Overall Study|Investigator's decision|23|||
144361803|NCT02485691|520532841|FG001|Overall Study|Investigator's decision|5|||
144361804|NCT02485691|520532840|FG000|Overall Study|Participant's request|13|||
144473771|NCT05044325|520934088|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144473772|NCT05044325|520934089|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144361805|NCT02485691|520532841|FG001|Overall Study|Participant's request|6|||
144361806|NCT02485691|520532840|FG000|Overall Study|Other reason|8|||
144361807|NCT02485691|520532841|FG001|Overall Study|Other reason|9|||
144361808|NCT02485691|520532840|FG000|Overall Study|Randomized and not treated|3|||
144361809|NCT02485691|520532841|FG001|Overall Study|Randomized and not treated|2|||
144361810|NCT00604565|520532842|FG000|Overall Study|Study terminated|0|||
144361811|NCT00604565|520532843|FG001|Overall Study|Study terminated|3|||
144361812|NCT04292535|520532845|FG000|Overall Study|Withdrawal by Subject|0|||
144361813|NCT04292535|520532846|FG001|Overall Study|Withdrawal by Subject|0|||
144361814|NCT04292535|520532847|FG002|Overall Study|Withdrawal by Subject|0|||
144361815|NCT04292535|520532848|FG003|Overall Study|Withdrawal by Subject|0|||
144361816|NCT04292535|520532849|FG004|Overall Study|Withdrawal by Subject|0|||
144361817|NCT04292535|520532850|FG005|Overall Study|Withdrawal by Subject|0|||
144361818|NCT04292535|520532851|FG006|Overall Study|Withdrawal by Subject|0|||
144361819|NCT04292535|520532852|FG007|Overall Study|Withdrawal by Subject|1|||
144361820|NCT04292535|520532853|FG008|Overall Study|Withdrawal by Subject|0|||
144361821|NCT04292535|520532854|FG009|Overall Study|Withdrawal by Subject|0|||
144361822|NCT04292535|520532855|FG010|Overall Study|Withdrawal by Subject|0|||
144361823|NCT04292535|520532856|FG011|Overall Study|Withdrawal by Subject|0|||
144361824|NCT04292535|520532857|FG012|Overall Study|Withdrawal by Subject|0|||
144361825|NCT04292535|520532858|FG013|Overall Study|Withdrawal by Subject|0|||
144361826|NCT04292535|520532845|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361827|NCT04292535|520532846|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361828|NCT04292535|520532847|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361829|NCT04292535|520532848|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361830|NCT04292535|520532849|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361831|NCT04292535|520532850|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361832|NCT04292535|520532851|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361833|NCT04292535|520532852|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
144361834|NCT04292535|520532853|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361835|NCT04292535|520532854|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361836|NCT04292535|520532855|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361837|NCT04292535|520532856|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
144361838|NCT04292535|520532857|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
144361839|NCT04292535|520532858|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
144361840|NCT04292535|520532845|FG000|Overall Study|Report of Dizziness|0|||
144361841|NCT04292535|520532846|FG001|Overall Study|Report of Dizziness|0|||
144361842|NCT04292535|520532847|FG002|Overall Study|Report of Dizziness|0|||
144361843|NCT04292535|520532848|FG003|Overall Study|Report of Dizziness|0|||
144361844|NCT04292535|520532849|FG004|Overall Study|Report of Dizziness|0|||
144361845|NCT04292535|520532850|FG005|Overall Study|Report of Dizziness|0|||
144361846|NCT04292535|520532851|FG006|Overall Study|Report of Dizziness|0|||
144361847|NCT04292535|520532852|FG007|Overall Study|Report of Dizziness|0|||
144361848|NCT04292535|520532853|FG008|Overall Study|Report of Dizziness|0|||
144361849|NCT04292535|520532854|FG009|Overall Study|Report of Dizziness|0|||
144361850|NCT04292535|520532855|FG010|Overall Study|Report of Dizziness|0|||
144361851|NCT04292535|520532856|FG011|Overall Study|Report of Dizziness|0|||
144361852|NCT04292535|520532857|FG012|Overall Study|Report of Dizziness|0|||
144361853|NCT04292535|520532858|FG013|Overall Study|Report of Dizziness|1|||
144361854|NCT04292535|520532845|FG000|Overall Study|Equipment Failure|0|||
144361855|NCT04292535|520532846|FG001|Overall Study|Equipment Failure|0|||
144361856|NCT04292535|520532847|FG002|Overall Study|Equipment Failure|0|||
144361857|NCT04292535|520532848|FG003|Overall Study|Equipment Failure|0|||
144361858|NCT04292535|520532849|FG004|Overall Study|Equipment Failure|0|||
144361859|NCT04292535|520532850|FG005|Overall Study|Equipment Failure|0|||
144361860|NCT04292535|520532851|FG006|Overall Study|Equipment Failure|0|||
144361861|NCT04292535|520532852|FG007|Overall Study|Equipment Failure|0|||
144361862|NCT04292535|520532853|FG008|Overall Study|Equipment Failure|0|||
144361863|NCT04292535|520532854|FG009|Overall Study|Equipment Failure|0|||
144361864|NCT04292535|520532855|FG010|Overall Study|Equipment Failure|0|||
144361865|NCT04292535|520532856|FG011|Overall Study|Equipment Failure|1|||
144361866|NCT04292535|520532857|FG012|Overall Study|Equipment Failure|0|||
144361867|NCT04292535|520532858|FG013|Overall Study|Equipment Failure|0|||
144361868|NCT03474588|520532859|FG000|Overall Study|Withdrawal by Subject|4|||
144361869|NCT03474588|520532860|FG001|Overall Study|Withdrawal by Subject|3|||
144361870|NCT03474588|520532859|FG000|Overall Study|Death|0|||
144361871|NCT03474588|520532860|FG001|Overall Study|Death|1|||
144361872|NCT04659044|520532864|FG000|Induction|Physician Decision|1|||
144361873|NCT04659044|520532864|FG000|Induction|Adverse Event|2|||
144361874|NCT04966013|520532865|FG000|Overall Study|Withdrawal by Subject|0|||
144361875|NCT04966013|520532866|FG001|Overall Study|Withdrawal by Subject|2|||
144361876|NCT04966013|520532867|FG002|Overall Study|Withdrawal by Subject|1|||
144361877|NCT04966013|520532865|FG000|Overall Study|Adverse Event|2|||
144361878|NCT04966013|520532866|FG001|Overall Study|Adverse Event|1|||
144361879|NCT04966013|520532867|FG002|Overall Study|Adverse Event|1|||
144361880|NCT00668148|520532885|FG000|Overall Study|Adverse Event|5|||
144361881|NCT00668148|520532885|FG000|Overall Study|Subject Non-compliance|1|||
144361882|NCT00668148|520532885|FG000|Overall Study|Progressive Disease Before Treatment|2|||
144361883|NCT00668148|520532885|FG000|Overall Study|Withdrawal of Consent|2|||
144361884|NCT02458313|520535014|FG000|Overall Study|Withdrawal by Subject|6|||
144361885|NCT02458313|520535015|FG001|Overall Study|Withdrawal by Subject|8|||
144361886|NCT02458313|520535014|FG000|Overall Study|Excluded for motion during MRI|1|||
144361887|NCT02458313|520535015|FG001|Overall Study|Excluded for motion during MRI|2|||
144361888|NCT00199381|520535016|FG000|Overall Study|Withdrawal by Subject|38|||
144361889|NCT00199381|520535016|FG000|Overall Study|Adverse Event|73|||
144361890|NCT00199381|520535016|FG000|Overall Study|Protocol Violation|6|||
144361891|NCT00199381|520535016|FG000|Overall Study|Lack of Efficacy|27|||
144361892|NCT00199381|520535016|FG000|Overall Study|Not including due to early termination|37|||
144361893|NCT00199381|520535016|FG000|Overall Study|Study termination by Sponsor|323|||
144361894|NCT03414983|520535018|FG000|Pre-Treatment|Other reasons|1|||
144361895|NCT03414983|520535019|FG001|Pre-Treatment|Other reasons|0|||
144471616|NCT00246337|520925257|FG005|Overall Study|Protocol Violation|0|||
144587996|NCT04822597|521350521|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
144199216|NCT01769339|519926523|FG000|Overall Study|Adverse Event|1|||
144361896|NCT03414983|520535018|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
144361897|NCT03414983|520535019|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
144361898|NCT03414983|520535018|FG000|Pre-Treatment|Participant withdrew consent|1|||
144361899|NCT03414983|520535019|FG001|Pre-Treatment|Participant withdrew consent|3|||
144361900|NCT03414983|520535018|FG000|Treatment|Participant withdrew consent|4|||
144361901|NCT03414983|520535019|FG001|Treatment|Participant withdrew consent|3|||
144361902|NCT03414983|520535018|FG000|Treatment|Participant request to discontinue study treatment|8|||
144471617|NCT00246337|520925258|FG006|Overall Study|Protocol Violation|1|||
144361903|NCT03414983|520535019|FG001|Treatment|Participant request to discontinue study treatment|10|||
144361904|NCT03414983|520535018|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
144361905|NCT03414983|520535019|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
144361906|NCT03414983|520535018|FG000|Treatment|Death|0|||
144361907|NCT03414983|520535019|FG001|Treatment|Death|1|||
144361908|NCT03414983|520535018|FG000|Treatment|Study Drug Toxicity|10|||
144361909|NCT03414983|520535019|FG001|Treatment|Study Drug Toxicity|5|||
144361910|NCT03414983|520535018|FG000|Treatment|Disease Progression|75|||
144361911|NCT03414983|520535019|FG001|Treatment|Disease Progression|29|||
144361912|NCT03414983|520535018|FG000|Treatment|Not reported|1|||
144361913|NCT03414983|520535019|FG001|Treatment|Not reported|0|||
144361914|NCT03414983|520535018|FG000|Treatment|Other reasons|3|||
144361915|NCT03414983|520535019|FG001|Treatment|Other reasons|2|||
144361916|NCT03414983|520535018|FG000|Treatment|Poor/non-compliance|2|||
144361917|NCT03414983|520535019|FG001|Treatment|Poor/non-compliance|0|||
144361918|NCT03414983|520535018|FG000|Treatment|Maximum clinical benefit|5|||
144361919|NCT03414983|520535019|FG001|Treatment|Maximum clinical benefit|9|||
144361920|NCT03414983|520535018|FG000|Treatment|Lost to Follow-up|0|||
144361921|NCT03414983|520535019|FG001|Treatment|Lost to Follow-up|1|||
144361922|NCT03414983|520535018|FG000|Treatment|Administrative reasons by sponsor|1|||
144361923|NCT03414983|520535019|FG001|Treatment|Administrative reasons by sponsor|0|||
144361924|NCT02608684|520535020|FG000|Overall Study|Physician Decision|2|||
144361925|NCT02608684|520535020|FG000|Overall Study|Withdrawal by Subject|1|||
144361926|NCT00751296|520535021|FG000|Overall Study|Adverse Event|2|||
144361927|NCT01775501|520535024|FG000|Overall Study|Discontinued prior to treatment|1|||
144361928|NCT02326155|520535030|FG000|Overall Study|Adverse Event|21|||
144361929|NCT02326155|520535031|FG001|Overall Study|Adverse Event|5|||
144361930|NCT02326155|520535030|FG000|Overall Study|Death|3|||
144361931|NCT02326155|520535031|FG001|Overall Study|Death|0|||
144361932|NCT02326155|520535030|FG000|Overall Study|Lack of Efficacy|49|||
144361933|NCT02326155|520535031|FG001|Overall Study|Lack of Efficacy|5|||
144361934|NCT02326155|520535030|FG000|Overall Study|Lost to Follow-up|14|||
144361935|NCT02326155|520535031|FG001|Overall Study|Lost to Follow-up|3|||
144361936|NCT02326155|520535030|FG000|Overall Study|Protocol Violation|2|||
144361937|NCT02326155|520535031|FG001|Overall Study|Protocol Violation|0|||
144361938|NCT02326155|520535030|FG000|Overall Study|Withdrawal by Subject|34|||
144361939|NCT02326155|520535031|FG001|Overall Study|Withdrawal by Subject|11|||
144361940|NCT02326155|520535030|FG000|Overall Study|Disease progression|37|||
144361941|NCT02326155|520535031|FG001|Overall Study|Disease progression|4|||
144361942|NCT02326155|520535030|FG000|Overall Study|Study close|188|||
144361943|NCT02326155|520535031|FG001|Overall Study|Study close|21|||
144361944|NCT02326155|520535030|FG000|Overall Study|except for study close|46|||
144361945|NCT02326155|520535031|FG001|Overall Study|except for study close|13|||
144361946|NCT05024032|520535032|FG000|Overall Study|Withdrawal by Subject|0|||
144361947|NCT05024032|520535033|FG001|Overall Study|Withdrawal by Subject|3|||
144361948|NCT05024032|520535034|FG002|Overall Study|Withdrawal by Subject|4|||
144361949|NCT05024032|520535032|FG000|Overall Study|Adverse Event|0|||
144361950|NCT05024032|520535033|FG001|Overall Study|Adverse Event|1|||
144361951|NCT05024032|520535034|FG002|Overall Study|Adverse Event|0|||
144361952|NCT05024032|520535032|FG000|Overall Study|Protocol Deviation|1|||
144361953|NCT05024032|520535033|FG001|Overall Study|Protocol Deviation|0|||
144361954|NCT05024032|520535034|FG002|Overall Study|Protocol Deviation|0|||
144361955|NCT01209689|520535037|FG000|Overall Study|Insufficient Therapeutic Response|7|||
144361956|NCT01209689|520535038|FG001|Overall Study|Insufficient Therapeutic Response|2|||
144361957|NCT01209689|520535037|FG000|Overall Study|Refused Treatment|8|||
144361958|NCT01209689|520535038|FG001|Overall Study|Refused Treatment|3|||
144361959|NCT01209689|520535037|FG000|Overall Study|Adverse Event|4|||
144361960|NCT01209689|520535038|FG001|Overall Study|Adverse Event|0|||
144361961|NCT01209689|520535037|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
144361962|NCT01209689|520535038|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
144361963|NCT01209689|520535037|FG000|Overall Study|Failure to Return|3|||
144361964|NCT01209689|520535038|FG001|Overall Study|Failure to Return|0|||
144361965|NCT01209689|520535037|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
144361966|NCT01209689|520535038|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
144361967|NCT03780244|520535039|FG000|Overall Study|Lost to Follow-up|1|||
144361968|NCT03780244|520535040|FG001|Overall Study|Lost to Follow-up|0|||
144361969|NCT03175367|520535041|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
144361970|NCT03175367|520535042|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
144361971|NCT03175367|520535043|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
144361972|NCT03175367|520535044|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
144361973|NCT03175367|520535045|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
144361974|NCT03175367|520535046|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
144361975|NCT03175367|520535047|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
144361976|NCT03175367|520535041|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
144361977|NCT03175367|520535042|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
144361978|NCT03175367|520535043|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
144361979|NCT03175367|520535044|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
144361980|NCT03175367|520535045|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
144361981|NCT03175367|520535046|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
144361982|NCT03175367|520535047|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
144361983|NCT03175367|520535041|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
144361984|NCT03175367|520535042|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
144361985|NCT03175367|520535043|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
144361986|NCT03175367|520535044|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
144361987|NCT03175367|520535045|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144361988|NCT03175367|520535046|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
144361989|NCT03175367|520535047|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144361990|NCT03175367|520535041|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
144361991|NCT03175367|520535042|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
144361992|NCT03175367|520535043|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
144361993|NCT03175367|520535044|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
144361994|NCT03175367|520535045|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
144361995|NCT03175367|520535046|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
144361996|NCT03175367|520535047|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
144361997|NCT03175367|520535041|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144361998|NCT03175367|520535042|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144361999|NCT03175367|520535043|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
144362000|NCT03175367|520535044|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144362001|NCT03175367|520535045|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
144362002|NCT03175367|520535046|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144362003|NCT03175367|520535047|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144362004|NCT03175367|520535041|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
144362005|NCT03175367|520535042|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
144362006|NCT03175367|520535043|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
144362007|NCT03175367|520535044|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
144362008|NCT03175367|520535045|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
144362009|NCT03175367|520535046|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
144362010|NCT03175367|520535047|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
144362011|NCT03175367|520535041|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362012|NCT03175367|520535042|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362013|NCT03175367|520535043|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362014|NCT03175367|520535044|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362015|NCT03175367|520535045|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362016|NCT03175367|520535046|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
144362017|NCT03175367|520535047|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
144362018|NCT01280903|520535050|FG000|Overall Study|Lost to Follow-up|23|||
144362019|NCT01280903|520535051|FG001|Overall Study|Lost to Follow-up|16|||
144362020|NCT03453164|520535052|FG000|Overall Study|Lack of Efficacy|16|||
144362021|NCT03453164|520535052|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
144362022|NCT03459079|520535056|FG000|Overall Study|Adverse Event|4|||
144362023|NCT03459079|520535057|FG001|Overall Study|Adverse Event|2|||
144362024|NCT03459079|520535058|FG002|Overall Study|Adverse Event|0|||
144362025|NCT03459079|520535056|FG000|Overall Study|Withdrawal by Subject|2|||
144362026|NCT03459079|520535057|FG001|Overall Study|Withdrawal by Subject|2|||
144362027|NCT03459079|520535058|FG002|Overall Study|Withdrawal by Subject|0|||
144362028|NCT02220920|520535059|FG000|Overall Study|Adverse Event|1|||
144362029|NCT02220920|520535060|FG001|Overall Study|Adverse Event|0|||
144362030|NCT02220920|520535059|FG000|Overall Study|Lack of Efficacy|0|||
144362031|NCT02220920|520535060|FG001|Overall Study|Lack of Efficacy|1|||
144362032|NCT02220920|520535059|FG000|Overall Study|Withdrawal by Subject|1|||
144362033|NCT02220920|520535060|FG001|Overall Study|Withdrawal by Subject|0|||
144362034|NCT02220920|520535059|FG000|Overall Study|Conflict with the stopping criteria|1|||
144362035|NCT02220920|520535060|FG001|Overall Study|Conflict with the stopping criteria|2|||
144362036|NCT04945733|520535061|FG000|Overall Study|Physician Decision|1|||
144362037|NCT04945733|520535062|FG001|Overall Study|Physician Decision|3|||
144362038|NCT04945733|520535063|FG002|Overall Study|Physician Decision|0|||
144362039|NCT04945733|520535061|FG000|Overall Study|Withdrawal by Subject|3|||
144362040|NCT04945733|520535062|FG001|Overall Study|Withdrawal by Subject|3|||
144362041|NCT04945733|520535063|FG002|Overall Study|Withdrawal by Subject|0|||
144362042|NCT00726063|520535064|FG000|Overall Study|Adverse Event|9|||
144362043|NCT00726063|520535065|FG001|Overall Study|Adverse Event|7|||
144362044|NCT02007096|520535066|FG000|Overall Study|medication not available|2|||
144362045|NCT02007096|520535067|FG001|Overall Study|medication not available|0|||
144362046|NCT02007096|520535066|FG000|Overall Study|did not inject saline|0|||
144362047|NCT02007096|520535067|FG001|Overall Study|did not inject saline|3|||
144362048|NCT02007096|520535066|FG000|Overall Study|did not follow postoperative protocol|8|||
144362049|NCT02007096|520535067|FG001|Overall Study|did not follow postoperative protocol|11|||
144362050|NCT02007096|520535066|FG000|Overall Study|converted to open surgery|1|||
144362051|NCT02007096|520535067|FG001|Overall Study|converted to open surgery|1|||
144362052|NCT02007096|520535066|FG000|Overall Study|no mesh placed|0|||
144362053|NCT02007096|520535067|FG001|Overall Study|no mesh placed|1|||
144362054|NCT01231984|520535068|FG000|Study Period 1|Withdrawal by Subject|0|||
144362055|NCT01231984|520535069|FG001|Study Period 1|Withdrawal by Subject|0|||
144362056|NCT01231984|520535070|FG002|Study Period 1|Withdrawal by Subject|0|||
144362057|NCT01231984|520535071|FG003|Study Period 1|Withdrawal by Subject|1|||
144362058|NCT01231984|520535068|FG000|Study Period 1|Lost to Follow-up|1|||
144362059|NCT01231984|520535069|FG001|Study Period 1|Lost to Follow-up|1|||
144362060|NCT01231984|520535070|FG002|Study Period 1|Lost to Follow-up|1|||
144362061|NCT01231984|520535071|FG003|Study Period 1|Lost to Follow-up|0|||
144362062|NCT01231984|520535068|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
144362063|NCT01231984|520535069|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
144362064|NCT01231984|520535070|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
144362065|NCT01231984|520535071|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
144362066|NCT01231984|520535068|FG000|Study Period 1|Screen Failure|0|||
144362067|NCT01231984|520535069|FG001|Study Period 1|Screen Failure|0|||
144362068|NCT01231984|520535070|FG002|Study Period 1|Screen Failure|0|||
144362069|NCT01231984|520535071|FG003|Study Period 1|Screen Failure|1|||
144362070|NCT01231984|520535068|FG000|Study Period 1|Non-compliance with study requirements|5|||
144362071|NCT01231984|520535069|FG001|Study Period 1|Non-compliance with study requirements|0|||
144362072|NCT01231984|520535070|FG002|Study Period 1|Non-compliance with study requirements|2|||
144362073|NCT01231984|520535071|FG003|Study Period 1|Non-compliance with study requirements|1|||
144362074|NCT01231984|520535068|FG000|Study Period 1|Protocol Violation|3|||
144362075|NCT01231984|520535069|FG001|Study Period 1|Protocol Violation|4|||
144362076|NCT01231984|520535070|FG002|Study Period 1|Protocol Violation|2|||
144362077|NCT01231984|520535071|FG003|Study Period 1|Protocol Violation|3|||
144362078|NCT01231984|520535068|FG000|Study Period 1|Adverse Event|1|||
144362079|NCT01231984|520535069|FG001|Study Period 1|Adverse Event|0|||
144362080|NCT01231984|520535070|FG002|Study Period 1|Adverse Event|0|||
144362081|NCT01231984|520535071|FG003|Study Period 1|Adverse Event|0|||
144362082|NCT01231984|520535068|FG000|Study Period 1|Other|0|||
144362083|NCT01231984|520535069|FG001|Study Period 1|Other|0|||
144362084|NCT01231984|520535070|FG002|Study Period 1|Other|0|||
144362085|NCT01231984|520535071|FG003|Study Period 1|Other|1|||
144362086|NCT01231984|520535068|FG000|Study Period 2|Withdrawal by Subject|1|||
144362087|NCT01231984|520535069|FG001|Study Period 2|Withdrawal by Subject|1|||
144362088|NCT01231984|520535070|FG002|Study Period 2|Withdrawal by Subject|0|||
144362089|NCT01231984|520535071|FG003|Study Period 2|Withdrawal by Subject|0|||
144362090|NCT01231984|520535068|FG000|Study Period 2|Lost to Follow-up|1|||
144362091|NCT01231984|520535069|FG001|Study Period 2|Lost to Follow-up|0|||
144362092|NCT01231984|520535070|FG002|Study Period 2|Lost to Follow-up|0|||
144362093|NCT01231984|520535071|FG003|Study Period 2|Lost to Follow-up|3|||
144362094|NCT01231984|520535068|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
144362095|NCT01231984|520535069|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
144362096|NCT01231984|520535070|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
144362097|NCT01231984|520535071|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
144362098|NCT02182895|520535074|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
144362099|NCT02182895|520535075|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
144362100|NCT03103542|520535076|FG000|Overall Study|Physician Decision|2|||
144362101|NCT03103542|520535076|FG000|Overall Study|Adverse Event|2|||
144362102|NCT03103542|520535076|FG000|Overall Study|Other|2|||
144362103|NCT03103542|520535076|FG000|Overall Study|Withdrawal by Subject|1|||
144362104|NCT03566511|520535078|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
144362105|NCT03566511|520535079|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
144362106|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
144362107|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
144362108|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
144362109|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
144362110|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
144362111|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
144362112|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
144362113|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
144362114|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
144362115|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144362116|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
144362117|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144362118|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
144362119|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
144362120|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
144362121|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
144362122|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
144362123|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
144362124|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
144362125|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
144362126|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
144362127|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
144362128|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
144362129|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
144362130|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
144362131|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
144362132|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
144362133|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
144362134|NCT04026113|520535080|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
144362135|NCT04026113|520535081|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
144362136|NCT04026113|520535082|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
144362137|NCT04026113|520535083|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
144362138|NCT04026113|520535080|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
144362139|NCT04026113|520535081|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
144362140|NCT04026113|520535082|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
144362141|NCT04026113|520535083|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
144362142|NCT04613362|520535084|FG000|3 Month Follow-up|Lost to Follow-up|1|||
144362143|NCT04613362|520535085|FG001|3 Month Follow-up|Lost to Follow-up|2|||
144362144|NCT04613362|520535084|FG000|6 Month Follow-up|Lost to Follow-up|0|||
144362145|NCT04613362|520535085|FG001|6 Month Follow-up|Lost to Follow-up|1|||
144362146|NCT02218372|520535086|FG000|Overall Study|Adverse Event|1|||
144362147|NCT02218372|520535087|FG001|Overall Study|Adverse Event|1|||
144362148|NCT02218372|520535086|FG000|Overall Study|Miscellaneous|2|||
144362149|NCT02218372|520535087|FG001|Overall Study|Miscellaneous|1|||
144362150|NCT02218372|520535086|FG000|Overall Study|Randomized but did not receive treatment|2|||
144362151|NCT02218372|520535087|FG001|Overall Study|Randomized but did not receive treatment|3|||
144362152|NCT02218372|520535086|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144362153|NCT02218372|520535087|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144362154|NCT03406780|520535088|FG000|Overall Study|Withdrawal by Subject|1|||
144362155|NCT03406780|520535089|FG001|Overall Study|Withdrawal by Subject|1|||
144473773|NCT05044325|520934090|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144473774|NCT05044325|520934091|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
144473775|NCT00755222|520934092|FG000|Overall Study|Withdrawal by Subject|4|||
144473776|NCT00755222|520934093|FG001|Overall Study|Withdrawal by Subject|2|||
144473777|NCT00755222|520934092|FG000|Overall Study|Adverse Event|2|||
144473778|NCT00755222|520934093|FG001|Overall Study|Adverse Event|0|||
144473779|NCT00755222|520934092|FG000|Overall Study|Protocol Violation|2|||
144473780|NCT00755222|520934093|FG001|Overall Study|Protocol Violation|0|||
144473781|NCT02243202|520934094|FG000|Overall Study|Adverse Event|5|||
144473782|NCT02243202|520934095|FG001|Overall Study|Adverse Event|6|||
144473783|NCT02243202|520934096|FG002|Overall Study|Adverse Event|10|||
144473784|NCT02243202|520934097|FG003|Overall Study|Adverse Event|4|||
144473785|NCT02243202|520934094|FG000|Overall Study|Lost to Follow-up|9|||
144473786|NCT02243202|520934095|FG001|Overall Study|Lost to Follow-up|9|||
144473787|NCT02243202|520934096|FG002|Overall Study|Lost to Follow-up|14|||
144473788|NCT02243202|520934097|FG003|Overall Study|Lost to Follow-up|11|||
144473789|NCT02243202|520934094|FG000|Overall Study|Protocol Violation|3|||
144473790|NCT02243202|520934095|FG001|Overall Study|Protocol Violation|1|||
144473791|NCT02243202|520934096|FG002|Overall Study|Protocol Violation|2|||
144473792|NCT02243202|520934097|FG003|Overall Study|Protocol Violation|1|||
144473793|NCT02243202|520934094|FG000|Overall Study|Withdrawal by Subject|7|||
144473794|NCT02243202|520934095|FG001|Overall Study|Withdrawal by Subject|6|||
144473795|NCT02243202|520934096|FG002|Overall Study|Withdrawal by Subject|4|||
144473796|NCT02243202|520934097|FG003|Overall Study|Withdrawal by Subject|4|||
144473797|NCT02243202|520934094|FG000|Overall Study|Other|1|||
144473798|NCT02243202|520934095|FG001|Overall Study|Other|3|||
144473799|NCT02243202|520934096|FG002|Overall Study|Other|1|||
144473800|NCT02243202|520934097|FG003|Overall Study|Other|2|||
144473801|NCT02243202|520934094|FG000|Overall Study|Randomized but not received treatment|0|||
144473802|NCT02243202|520934095|FG001|Overall Study|Randomized but not received treatment|0|||
144473803|NCT02243202|520934096|FG002|Overall Study|Randomized but not received treatment|0|||
144473804|NCT02243202|520934097|FG003|Overall Study|Randomized but not received treatment|1|||
144473805|NCT03430063|520934104|FG000|Overall Study|Adverse Event|0|||
144473806|NCT03430063|520934105|FG001|Overall Study|Adverse Event|1|||
144473807|NCT03430063|520934106|FG002|Overall Study|Adverse Event|0|||
144362156|NCT03406780|520535088|FG000|Overall Study|Other|0|||
144473808|NCT03430063|520934104|FG000|Overall Study|Death|3|||
144473809|NCT03430063|520934105|FG001|Overall Study|Death|2|||
144473810|NCT03430063|520934106|FG002|Overall Study|Death|3|||
144473811|NCT03430063|520934104|FG000|Overall Study|Lost to Follow-up|0|||
144473812|NCT03430063|520934105|FG001|Overall Study|Lost to Follow-up|1|||
144473813|NCT03430063|520934106|FG002|Overall Study|Lost to Follow-up|0|||
144473814|NCT03430063|520934104|FG000|Overall Study|Withdrawal by Subject|0|||
144473815|NCT03430063|520934105|FG001|Overall Study|Withdrawal by Subject|0|||
144362157|NCT03406780|520535089|FG001|Overall Study|Other|2|||
144362158|NCT01488045|520535091|FG000|Overall Study|Withdrawal by Subject|6|||
144362159|NCT01488045|520535092|FG001|Overall Study|Withdrawal by Subject|11|||
144473816|NCT03430063|520934106|FG002|Overall Study|Withdrawal by Subject|1|||
144473817|NCT03430063|520934104|FG000|Overall Study|Withdrawal of consent|3|||
144473818|NCT03430063|520934105|FG001|Overall Study|Withdrawal of consent|1|||
144473819|NCT03430063|520934106|FG002|Overall Study|Withdrawal of consent|2|||
144473820|NCT03430063|520934104|FG000|Overall Study|Progressive disease|1|||
144473821|NCT03430063|520934105|FG001|Overall Study|Progressive disease|2|||
144473822|NCT03430063|520934106|FG002|Overall Study|Progressive disease|1|||
144473823|NCT03430063|520934104|FG000|Overall Study|Other un-specified|1|||
144473824|NCT03430063|520934105|FG001|Overall Study|Other un-specified|1|||
144473825|NCT03430063|520934106|FG002|Overall Study|Other un-specified|0|||
144473826|NCT03430063|520934104|FG000|Overall Study|Randomized, but never treated|0|||
144473827|NCT03430063|520934105|FG001|Overall Study|Randomized, but never treated|0|||
144473828|NCT03430063|520934106|FG002|Overall Study|Randomized, but never treated|1|||
144473829|NCT03131960|520934109|FG000|Overall Study|Adverse Event|0|||
144473830|NCT03131960|520934110|FG001|Overall Study|Adverse Event|1|||
144473831|NCT01215357|520934112|FG000|Overall Study|Withdrawal by Subject|3|||
144473832|NCT01215357|520934112|FG000|Overall Study|Protocol Violation|9|||
144473833|NCT01719237|520934113|FG000|Overall Study|Physician Decision|0|||
144473834|NCT01719237|520934114|FG001|Overall Study|Physician Decision|1|||
144473835|NCT01859793|520934120|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
144473836|NCT01859793|520934121|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
144473837|NCT01859793|520934120|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
144473838|NCT01859793|520934121|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
144473839|NCT01859793|520934120|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
144473840|NCT01859793|520934121|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
144362160|NCT01488045|520535091|FG000|Overall Study|Failure to present for colonoscopy|3|||
144362161|NCT01488045|520535092|FG001|Overall Study|Failure to present for colonoscopy|6|||
144362162|NCT01488045|520535091|FG000|Overall Study|Failure to report exclusion criteria|0|||
144362163|NCT01488045|520535092|FG001|Overall Study|Failure to report exclusion criteria|1|||
144362164|NCT05365217|520535094|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144362165|NCT05365217|520535095|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144362166|NCT02230410|520535096|FG000|Overall Study|Screen Failure|3|||
144362167|NCT00656513|520535100|FG000|Overall Study|Protocol Violation|1|||
144362168|NCT00656513|520535101|FG001|Overall Study|Protocol Violation|0|||
144362169|NCT00656513|520535102|FG002|Overall Study|Protocol Violation|2|||
144362170|NCT00656513|520535100|FG000|Overall Study|Withdrawal by Subject|0|||
144362171|NCT00656513|520535101|FG001|Overall Study|Withdrawal by Subject|11|||
144362172|NCT00656513|520535102|FG002|Overall Study|Withdrawal by Subject|4|||
144362173|NCT00656513|520535100|FG000|Overall Study|Death|0|||
144362174|NCT00656513|520535101|FG001|Overall Study|Death|0|||
144362175|NCT00656513|520535102|FG002|Overall Study|Death|1|||
144362176|NCT00656513|520535100|FG000|Overall Study|Missing data|0|||
144362177|NCT00656513|520535101|FG001|Overall Study|Missing data|11|||
144362178|NCT00656513|520535102|FG002|Overall Study|Missing data|9|||
144362179|NCT00656513|520535100|FG000|Overall Study|Incomplete treatment|3|||
144362180|NCT00656513|520535101|FG001|Overall Study|Incomplete treatment|0|||
144362181|NCT00656513|520535102|FG002|Overall Study|Incomplete treatment|0|||
144362182|NCT00656513|520535100|FG000|Overall Study|Treatment completed outside of timeframe|0|||
144362183|NCT00656513|520535101|FG001|Overall Study|Treatment completed outside of timeframe|3|||
144362184|NCT00656513|520535102|FG002|Overall Study|Treatment completed outside of timeframe|1|||
144362185|NCT00656513|520535100|FG000|Overall Study|Missing baseline form|0|||
144362186|NCT00656513|520535101|FG001|Overall Study|Missing baseline form|5|||
144587997|NCT00911768|521350527|FG000|Overall Study|Protocol Violation|5|||
144362187|NCT00656513|520535102|FG002|Overall Study|Missing baseline form|5|||
144362188|NCT04558125|520535103|FG000|Overall Study|Death|1|||
144362189|NCT03379818|520535104|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
144362190|NCT03379818|520535105|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
144362191|NCT03379818|520535104|FG000|Overall Study|Withdrawal by Subject|2|||
144362192|NCT03379818|520535105|FG001|Overall Study|Withdrawal by Subject|3|||
144362193|NCT03379818|520535104|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
144362194|NCT03379818|520535105|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
144362195|NCT03199976|520535106|FG000|Overall Study|Lack of Efficacy|3|||
144362196|NCT03199976|520535107|FG001|Overall Study|Lack of Efficacy|6|||
144362197|NCT03199976|520535108|FG002|Overall Study|Lack of Efficacy|13|||
144362198|NCT03199976|520535106|FG000|Overall Study|Withdrawal by Subject|1|||
144362199|NCT03199976|520535107|FG001|Overall Study|Withdrawal by Subject|0|||
144362200|NCT03199976|520535108|FG002|Overall Study|Withdrawal by Subject|0|||
144362201|NCT03199976|520535106|FG000|Overall Study|Lost to Follow-up|0|||
144362202|NCT03199976|520535107|FG001|Overall Study|Lost to Follow-up|1|||
144362203|NCT03199976|520535108|FG002|Overall Study|Lost to Follow-up|1|||
144362204|NCT01761877|520535109|FG000|Overall Study|Adverse Event|7|||
144362205|NCT01761877|520535110|FG001|Overall Study|Adverse Event|0|||
144362206|NCT01761877|520535109|FG000|Overall Study|Withdrawal by Subject|6|||
144362207|NCT01761877|520535110|FG001|Overall Study|Withdrawal by Subject|4|||
144362208|NCT01761877|520535109|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
144362209|NCT01761877|520535110|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
144362210|NCT01761877|520535109|FG000|Overall Study|Death|0|||
144362211|NCT01761877|520535110|FG001|Overall Study|Death|1|||
144362212|NCT01761877|520535109|FG000|Overall Study|MRI intolerant|1|||
144362213|NCT01761877|520535110|FG001|Overall Study|MRI intolerant|6|||
144362214|NCT04739982|520535111|FG000|Overall Study|Lost to Follow-up|176|||
144362215|NCT04739982|520535112|FG001|Overall Study|Lost to Follow-up|65|||
144362216|NCT04739982|520535111|FG000|Overall Study|Withdrawal by Subject|19|||
144362217|NCT04739982|520535112|FG001|Overall Study|Withdrawal by Subject|0|||
144362218|NCT04739982|520535111|FG000|Overall Study|Protocol Violation|0|||
144362219|NCT04739982|520535112|FG001|Overall Study|Protocol Violation|5|||
144362220|NCT00322881|520535115|FG000|Overall Study|Death|2|||
144362221|NCT00322881|520535115|FG000|Overall Study|Adverse Event|1|||
144362222|NCT00322881|520535115|FG000|Overall Study|Disease Progression|2|||
144362223|NCT01743469|520535116|FG000|Active Treatment Phase|Adverse Event|10|||
144362224|NCT01743469|520535117|FG001|Active Treatment Phase|Adverse Event|5|||
144362225|NCT01743469|520535118|FG002|Active Treatment Phase|Adverse Event|8|||
144362226|NCT01743469|520535119|FG003|Active Treatment Phase|Adverse Event|1|||
144362227|NCT01743469|520535116|FG000|Active Treatment Phase|Disease Progression|40|||
144362228|NCT01743469|520535117|FG001|Active Treatment Phase|Disease Progression|47|||
144362229|NCT01743469|520535118|FG002|Active Treatment Phase|Disease Progression|30|||
144362230|NCT01743469|520535119|FG003|Active Treatment Phase|Disease Progression|20|||
144362231|NCT01743469|520535116|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
144362232|NCT01743469|520535117|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
144362233|NCT01743469|520535118|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
144362234|NCT01743469|520535119|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
144362235|NCT01743469|520535116|FG000|Active Treatment Phase|Missing|1|||
144362236|NCT01743469|520535117|FG001|Active Treatment Phase|Missing|0|||
144362237|NCT01743469|520535118|FG002|Active Treatment Phase|Missing|0|||
144362238|NCT01743469|520535119|FG003|Active Treatment Phase|Missing|0|||
144362239|NCT01743469|520535116|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
144362240|NCT01743469|520535117|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
144362241|NCT01743469|520535118|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
144362242|NCT01743469|520535119|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
144362243|NCT01743469|520535116|FG000|Follow-up Period - Post-Treatment|Death|43|||
144362244|NCT01743469|520535117|FG001|Follow-up Period - Post-Treatment|Death|47|||
144362245|NCT01743469|520535118|FG002|Follow-up Period - Post-Treatment|Death|22|||
144362246|NCT01743469|520535119|FG003|Follow-up Period - Post-Treatment|Death|16|||
144362247|NCT01743469|520535116|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
144362248|NCT01743469|520535117|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
144362249|NCT01743469|520535118|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
144362250|NCT01743469|520535119|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
144362251|NCT01451606|520535120|FG000|Overall Study|Withdrawal by Subject|4|||
144362252|NCT01451606|520535121|FG001|Overall Study|Withdrawal by Subject|3|||
144362253|NCT04484961|520535124|FG000|Overall Study|Lost to Follow-up|9|||
144362254|NCT04484961|520535125|FG001|Overall Study|Lost to Follow-up|9|||
144362255|NCT00388349|520535126|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
144362256|NCT00388349|520535127|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
144362257|NCT01345240|520535131|FG000|Overall Study|Adverse Event|3|||
144362258|NCT01345240|520535132|FG001|Overall Study|Adverse Event|5|||
144362259|NCT01345240|520535133|FG002|Overall Study|Adverse Event|4|||
144362260|NCT01345240|520535134|FG003|Overall Study|Adverse Event|2|||
144362261|NCT01345240|520535135|FG004|Overall Study|Adverse Event|1|||
144362262|NCT01345240|520535131|FG000|Overall Study|Lost to Follow-up|8|||
144362263|NCT01345240|520535132|FG001|Overall Study|Lost to Follow-up|9|||
144362264|NCT01345240|520535133|FG002|Overall Study|Lost to Follow-up|14|||
144362265|NCT01345240|520535134|FG003|Overall Study|Lost to Follow-up|7|||
144362266|NCT01345240|520535135|FG004|Overall Study|Lost to Follow-up|9|||
144362267|NCT04011540|520535136|FG000|Overall Study|Lost to Follow-up|9|||
144362268|NCT04011540|520535137|FG001|Overall Study|Lost to Follow-up|6|||
144362269|NCT00231816|520535141|FG000|Overall Study|Adverse Event|1|||
144362270|NCT00231816|520535142|FG001|Overall Study|Adverse Event|0|||
144362271|NCT00231816|520535141|FG000|Overall Study|Lost to Follow-up|8|||
144362272|NCT00231816|520535142|FG001|Overall Study|Lost to Follow-up|5|||
144362273|NCT00231816|520535141|FG000|Overall Study|Protocol Violation|2|||
144362274|NCT00231816|520535142|FG001|Overall Study|Protocol Violation|3|||
144362275|NCT00231816|520535141|FG000|Overall Study|Withdrawal by Subject|3|||
144362276|NCT00231816|520535142|FG001|Overall Study|Withdrawal by Subject|3|||
144362277|NCT00231816|520535141|FG000|Overall Study|Other|2|||
144362278|NCT00231816|520535142|FG001|Overall Study|Other|1|||
144362279|NCT00468169|520535143|FG000|Overall Study|Withdrawal by Subject|1|||
144362280|NCT00468169|520535144|FG001|Overall Study|Withdrawal by Subject|0|||
144362281|NCT01126749|520535149|FG000|Phase 1b|Other|0|||
144362282|NCT01126749|520535150|FG001|Phase 1b|Other|1|||
144362283|NCT01126749|520535151|FG002|Phase 1b|Other|0|||
144362284|NCT01126749|520535152|FG003|Phase 1b|Other|0|||
144362285|NCT01126749|520535149|FG000|Phase 1b|Withdrawal by Subject|0|||
144362286|NCT01126749|520535150|FG001|Phase 1b|Withdrawal by Subject|1|||
144362287|NCT01126749|520535151|FG002|Phase 1b|Withdrawal by Subject|0|||
144362288|NCT01126749|520535152|FG003|Phase 1b|Withdrawal by Subject|0|||
144362289|NCT01126749|520535149|FG000|Phase 1b|Death|3|||
144362290|NCT01126749|520535150|FG001|Phase 1b|Death|4|||
144362291|NCT01126749|520535151|FG002|Phase 1b|Death|0|||
144362292|NCT01126749|520535152|FG003|Phase 1b|Death|0|||
144362293|NCT01126749|520535149|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
144362294|NCT01126749|520535150|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
144362295|NCT01126749|520535151|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
144362296|NCT01126749|520535152|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
144362297|NCT01126749|520535149|FG000|Phase 2|Study Termination by Sponsor|0|||
144362298|NCT01126749|520535150|FG001|Phase 2|Study Termination by Sponsor|0|||
144362299|NCT01126749|520535151|FG002|Phase 2|Study Termination by Sponsor|12|||
144362300|NCT01126749|520535152|FG003|Phase 2|Study Termination by Sponsor|6|||
144362301|NCT01126749|520535149|FG000|Phase 2|Other|0|||
144473841|NCT01859793|520934120|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
144473842|NCT01859793|520934121|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
144473843|NCT01597505|520934131|FG000|Overall Study|Physician Decision|5|||
144473844|NCT01597505|520934132|FG001|Overall Study|Physician Decision|0|||
144473845|NCT01597505|520934131|FG000|Overall Study|Adverse Event|19|||
144473846|NCT01597505|520934132|FG001|Overall Study|Adverse Event|7|||
144473847|NCT01597505|520934131|FG000|Overall Study|Lost to Follow-up|4|||
144473848|NCT01597505|520934132|FG001|Overall Study|Lost to Follow-up|2|||
144473849|NCT01597505|520934131|FG000|Overall Study|Withdrawal by Subject|10|||
144473850|NCT01597505|520934132|FG001|Overall Study|Withdrawal by Subject|18|||
144473851|NCT01597505|520934131|FG000|Overall Study|Other|5|||
144473852|NCT01597505|520934132|FG001|Overall Study|Other|6|||
144473853|NCT01597505|520934131|FG000|Overall Study|Missing|1|||
144473854|NCT01597505|520934132|FG001|Overall Study|Missing|0|||
144473855|NCT03728972|520934133|FG000|Overall Study|Death|1|||
144473856|NCT03728972|520934134|FG001|Overall Study|Death|0|||
144473857|NCT03728972|520934133|FG000|Overall Study|Lack of Efficacy|1|||
144473858|NCT03728972|520934134|FG001|Overall Study|Lack of Efficacy|0|||
144473859|NCT03728972|520934133|FG000|Overall Study|Physician Decision|3|||
144473860|NCT03728972|520934134|FG001|Overall Study|Physician Decision|0|||
144473861|NCT03728972|520934133|FG000|Overall Study|Disease progression|4|||
144473862|NCT03728972|520934134|FG001|Overall Study|Disease progression|3|||
144473863|NCT04543188|520934135|FG000|Phase 1a|Adverse Event|0|||
144473864|NCT04543188|520934136|FG001|Phase 1a|Adverse Event|0|||
144473865|NCT04543188|520934137|FG002|Phase 1a|Adverse Event|0|||
144473866|NCT04543188|520934138|FG003|Phase 1a|Adverse Event|1|||
144473867|NCT04543188|520934139|FG004|Phase 1a|Adverse Event|0|||
144473868|NCT04543188|520934140|FG005|Phase 1a|Adverse Event|0|||
144473869|NCT04543188|520934141|FG006|Phase 1a|Adverse Event|1|||
144473870|NCT04543188|520934142|FG007|Phase 1a|Adverse Event|0|||
144473871|NCT04543188|520934143|FG008|Phase 1a|Adverse Event|0|||
144473872|NCT04543188|520934144|FG009|Phase 1a|Adverse Event|0|||
144362302|NCT01126749|520535150|FG001|Phase 2|Other|0|||
144362303|NCT01126749|520535151|FG002|Phase 2|Other|4|||
144473873|NCT04543188|520934145|FG010|Phase 1a|Adverse Event|0|||
144473874|NCT04543188|520934146|FG011|Phase 1a|Adverse Event|0|||
144473875|NCT04543188|520934147|FG012|Phase 1a|Adverse Event|0|||
144473876|NCT04543188|520934148|FG013|Phase 1a|Adverse Event|0|||
144473877|NCT04543188|520934149|FG014|Phase 1a|Adverse Event|0|||
144473878|NCT04543188|520934135|FG000|Phase 1a|Other (Death)|0|||
144473879|NCT04543188|520934136|FG001|Phase 1a|Other (Death)|1|||
144473880|NCT04543188|520934137|FG002|Phase 1a|Other (Death)|0|||
144362304|NCT01126749|520535152|FG003|Phase 2|Other|2|||
144362305|NCT01126749|520535149|FG000|Phase 2|Withdrawal by Subject|0|||
144362306|NCT01126749|520535150|FG001|Phase 2|Withdrawal by Subject|0|||
144362307|NCT01126749|520535151|FG002|Phase 2|Withdrawal by Subject|0|||
144362308|NCT01126749|520535152|FG003|Phase 2|Withdrawal by Subject|2|||
144362309|NCT01126749|520535149|FG000|Phase 2|Lost to Follow-up|0|||
144362310|NCT01126749|520535150|FG001|Phase 2|Lost to Follow-up|0|||
144362311|NCT01126749|520535151|FG002|Phase 2|Lost to Follow-up|0|||
144362312|NCT01126749|520535152|FG003|Phase 2|Lost to Follow-up|1|||
144362313|NCT01126749|520535149|FG000|Phase 2|Death|0|||
144362314|NCT01126749|520535150|FG001|Phase 2|Death|0|||
144362315|NCT01126749|520535151|FG002|Phase 2|Death|22|||
144362316|NCT01126749|520535152|FG003|Phase 2|Death|22|||
144362317|NCT01126749|520535149|FG000|Phase 2|Adverse Event|0|||
144362318|NCT01126749|520535150|FG001|Phase 2|Adverse Event|0|||
144362319|NCT01126749|520535151|FG002|Phase 2|Adverse Event|0|||
144362320|NCT01126749|520535152|FG003|Phase 2|Adverse Event|1|||
144362321|NCT01056822|520535154|FG000|Overall Study|Adverse Event|0|||
144362322|NCT01056822|520535155|FG001|Overall Study|Adverse Event|1|||
144362323|NCT01056822|520535154|FG000|Overall Study|Protocol Violation|6|||
144362324|NCT01056822|520535155|FG001|Overall Study|Protocol Violation|5|||
144362325|NCT01056822|520535154|FG000|Overall Study|Withdrawal by Subject|1|||
144362326|NCT01056822|520535155|FG001|Overall Study|Withdrawal by Subject|1|||
144362327|NCT01056822|520535154|FG000|Overall Study|Lost to Follow-up|1|||
144362328|NCT01056822|520535155|FG001|Overall Study|Lost to Follow-up|0|||
144362329|NCT01614249|520535159|FG000|Overall Study|Lost to Follow-up|11|||
144362330|NCT01614249|520535160|FG001|Overall Study|Lost to Follow-up|23|||
144362331|NCT03341299|520535174|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
144362332|NCT03341299|520535175|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
144362333|NCT03341299|520535176|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
144362334|NCT03341299|520535177|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
144362335|NCT02702492|520535185|FG000|Overall Study|Disease progression|3|||
144362336|NCT02702492|520535186|FG001|Overall Study|Disease progression|3|||
144362337|NCT02702492|520535187|FG002|Overall Study|Disease progression|2|||
144362338|NCT02702492|520535188|FG003|Overall Study|Disease progression|4|||
144362339|NCT02702492|520535189|FG004|Overall Study|Disease progression|4|||
144362340|NCT02702492|520535190|FG005|Overall Study|Disease progression|1|||
144362341|NCT02702492|520535191|FG006|Overall Study|Disease progression|2|||
144362342|NCT02702492|520535192|FG007|Overall Study|Disease progression|8|||
144362343|NCT02702492|520535193|FG008|Overall Study|Disease progression|5|||
144362344|NCT02702492|520535194|FG009|Overall Study|Disease progression|1|||
144362345|NCT02702492|520535195|FG010|Overall Study|Disease progression|0|||
144362346|NCT02702492|520535196|FG011|Overall Study|Disease progression|3|||
144362347|NCT02702492|520535197|FG012|Overall Study|Disease progression|2|||
144362348|NCT02702492|520535185|FG000|Overall Study|Clinical progression|0|||
144362349|NCT02702492|520535186|FG001|Overall Study|Clinical progression|0|||
144362350|NCT02702492|520535187|FG002|Overall Study|Clinical progression|2|||
144362351|NCT02702492|520535188|FG003|Overall Study|Clinical progression|1|||
144362352|NCT02702492|520535189|FG004|Overall Study|Clinical progression|0|||
144362353|NCT02702492|520535190|FG005|Overall Study|Clinical progression|2|||
144362354|NCT02702492|520535191|FG006|Overall Study|Clinical progression|1|||
144362355|NCT02702492|520535192|FG007|Overall Study|Clinical progression|4|||
144362356|NCT02702492|520535193|FG008|Overall Study|Clinical progression|0|||
144362357|NCT02702492|520535194|FG009|Overall Study|Clinical progression|0|||
144362358|NCT02702492|520535195|FG010|Overall Study|Clinical progression|1|||
144362359|NCT02702492|520535196|FG011|Overall Study|Clinical progression|2|||
144362360|NCT02702492|520535197|FG012|Overall Study|Clinical progression|0|||
144362361|NCT02702492|520535185|FG000|Overall Study|Adverse Event|0|||
144362362|NCT02702492|520535186|FG001|Overall Study|Adverse Event|0|||
144362363|NCT02702492|520535187|FG002|Overall Study|Adverse Event|1|||
144362364|NCT02702492|520535188|FG003|Overall Study|Adverse Event|2|||
144362365|NCT02702492|520535189|FG004|Overall Study|Adverse Event|1|||
144362366|NCT02702492|520535190|FG005|Overall Study|Adverse Event|0|||
144362367|NCT02702492|520535191|FG006|Overall Study|Adverse Event|1|||
144362368|NCT02702492|520535192|FG007|Overall Study|Adverse Event|0|||
144362369|NCT02702492|520535193|FG008|Overall Study|Adverse Event|2|||
144362370|NCT02702492|520535194|FG009|Overall Study|Adverse Event|0|||
144362371|NCT02702492|520535195|FG010|Overall Study|Adverse Event|0|||
144362372|NCT02702492|520535196|FG011|Overall Study|Adverse Event|0|||
144362373|NCT02702492|520535197|FG012|Overall Study|Adverse Event|1|||
144362374|NCT02702492|520535185|FG000|Overall Study|Other|0|||
144362375|NCT02702492|520535186|FG001|Overall Study|Other|0|||
144362376|NCT02702492|520535187|FG002|Overall Study|Other|0|||
144362377|NCT02702492|520535188|FG003|Overall Study|Other|0|||
144362378|NCT02702492|520535189|FG004|Overall Study|Other|0|||
144362379|NCT02702492|520535190|FG005|Overall Study|Other|0|||
144362380|NCT02702492|520535191|FG006|Overall Study|Other|0|||
144362381|NCT02702492|520535192|FG007|Overall Study|Other|0|||
144362382|NCT02702492|520535193|FG008|Overall Study|Other|0|||
144473881|NCT04543188|520934138|FG003|Phase 1a|Other (Death)|0|||
144473882|NCT04543188|520934139|FG004|Phase 1a|Other (Death)|1|||
144473883|NCT04543188|520934140|FG005|Phase 1a|Other (Death)|0|||
144473884|NCT04543188|520934141|FG006|Phase 1a|Other (Death)|0|||
144473885|NCT04543188|520934142|FG007|Phase 1a|Other (Death)|0|||
144473886|NCT04543188|520934143|FG008|Phase 1a|Other (Death)|0|||
144473887|NCT04543188|520934144|FG009|Phase 1a|Other (Death)|1|||
144473888|NCT04543188|520934145|FG010|Phase 1a|Other (Death)|0|||
144473889|NCT04543188|520934146|FG011|Phase 1a|Other (Death)|0|||
144473890|NCT04543188|520934147|FG012|Phase 1a|Other (Death)|0|||
144473891|NCT04543188|520934148|FG013|Phase 1a|Other (Death)|0|||
144473892|NCT04543188|520934149|FG014|Phase 1a|Other (Death)|0|||
144473893|NCT04543188|520934135|FG000|Phase 1a|Lost to Follow-up|0|||
144473894|NCT04543188|520934136|FG001|Phase 1a|Lost to Follow-up|0|||
144473895|NCT04543188|520934137|FG002|Phase 1a|Lost to Follow-up|0|||
144473896|NCT04543188|520934138|FG003|Phase 1a|Lost to Follow-up|0|||
144473897|NCT04543188|520934139|FG004|Phase 1a|Lost to Follow-up|0|||
144473898|NCT04543188|520934140|FG005|Phase 1a|Lost to Follow-up|0|||
144473899|NCT04543188|520934141|FG006|Phase 1a|Lost to Follow-up|0|||
144473900|NCT04543188|520934142|FG007|Phase 1a|Lost to Follow-up|0|||
144473901|NCT04543188|520934143|FG008|Phase 1a|Lost to Follow-up|0|||
144473902|NCT04543188|520934144|FG009|Phase 1a|Lost to Follow-up|0|||
144473903|NCT04543188|520934145|FG010|Phase 1a|Lost to Follow-up|1|||
144473904|NCT04543188|520934146|FG011|Phase 1a|Lost to Follow-up|0|||
144473905|NCT04543188|520934147|FG012|Phase 1a|Lost to Follow-up|0|||
144473906|NCT04543188|520934148|FG013|Phase 1a|Lost to Follow-up|0|||
144473907|NCT04543188|520934149|FG014|Phase 1a|Lost to Follow-up|0|||
144473908|NCT04543188|520934135|FG000|Phase 1a|Progressive Disease|2|||
144473909|NCT04543188|520934136|FG001|Phase 1a|Progressive Disease|2|||
144473910|NCT04543188|520934137|FG002|Phase 1a|Progressive Disease|3|||
144473911|NCT04543188|520934138|FG003|Phase 1a|Progressive Disease|1|||
144473912|NCT04543188|520934139|FG004|Phase 1a|Progressive Disease|4|||
144473913|NCT04543188|520934140|FG005|Phase 1a|Progressive Disease|2|||
144473914|NCT04543188|520934141|FG006|Phase 1a|Progressive Disease|3|||
144473915|NCT04543188|520934142|FG007|Phase 1a|Progressive Disease|4|||
144473916|NCT04543188|520934143|FG008|Phase 1a|Progressive Disease|1|||
144473917|NCT04543188|520934144|FG009|Phase 1a|Progressive Disease|0|||
144473918|NCT04543188|520934145|FG010|Phase 1a|Progressive Disease|4|||
144473919|NCT04543188|520934146|FG011|Phase 1a|Progressive Disease|0|||
144473920|NCT04543188|520934147|FG012|Phase 1a|Progressive Disease|0|||
144473921|NCT04543188|520934148|FG013|Phase 1a|Progressive Disease|0|||
144473922|NCT04543188|520934149|FG014|Phase 1a|Progressive Disease|0|||
144473923|NCT04543188|520934135|FG000|Phase 1a|Study terminated by sponsor|0|||
144473924|NCT04543188|520934136|FG001|Phase 1a|Study terminated by sponsor|0|||
144473925|NCT04543188|520934137|FG002|Phase 1a|Study terminated by sponsor|0|||
144473926|NCT04543188|520934138|FG003|Phase 1a|Study terminated by sponsor|0|||
144473927|NCT04543188|520934139|FG004|Phase 1a|Study terminated by sponsor|1|||
144473928|NCT04543188|520934140|FG005|Phase 1a|Study terminated by sponsor|0|||
144473929|NCT04543188|520934141|FG006|Phase 1a|Study terminated by sponsor|0|||
144473930|NCT04543188|520934142|FG007|Phase 1a|Study terminated by sponsor|0|||
144473931|NCT04543188|520934143|FG008|Phase 1a|Study terminated by sponsor|0|||
144473932|NCT04543188|520934144|FG009|Phase 1a|Study terminated by sponsor|0|||
144473933|NCT04543188|520934145|FG010|Phase 1a|Study terminated by sponsor|1|||
144473934|NCT04543188|520934146|FG011|Phase 1a|Study terminated by sponsor|0|||
144473935|NCT04543188|520934147|FG012|Phase 1a|Study terminated by sponsor|0|||
144473936|NCT04543188|520934148|FG013|Phase 1a|Study terminated by sponsor|0|||
144473937|NCT04543188|520934149|FG014|Phase 1a|Study terminated by sponsor|0|||
144473938|NCT04543188|520934135|FG000|Phase 1a|Withdrawal by Subject|0|||
144473939|NCT04543188|520934136|FG001|Phase 1a|Withdrawal by Subject|0|||
144473940|NCT04543188|520934137|FG002|Phase 1a|Withdrawal by Subject|0|||
144473941|NCT04543188|520934138|FG003|Phase 1a|Withdrawal by Subject|0|||
144473942|NCT04543188|520934139|FG004|Phase 1a|Withdrawal by Subject|3|||
144473943|NCT04543188|520934140|FG005|Phase 1a|Withdrawal by Subject|0|||
144473944|NCT04543188|520934141|FG006|Phase 1a|Withdrawal by Subject|0|||
144473945|NCT04543188|520934142|FG007|Phase 1a|Withdrawal by Subject|0|||
144473946|NCT04543188|520934143|FG008|Phase 1a|Withdrawal by Subject|1|||
144473947|NCT04543188|520934144|FG009|Phase 1a|Withdrawal by Subject|1|||
144473948|NCT04543188|520934145|FG010|Phase 1a|Withdrawal by Subject|2|||
144473949|NCT04543188|520934146|FG011|Phase 1a|Withdrawal by Subject|0|||
144473950|NCT04543188|520934147|FG012|Phase 1a|Withdrawal by Subject|0|||
144473951|NCT04543188|520934148|FG013|Phase 1a|Withdrawal by Subject|0|||
144473952|NCT04543188|520934149|FG014|Phase 1a|Withdrawal by Subject|0|||
144473953|NCT04543188|520934135|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
144473954|NCT04543188|520934136|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
144473955|NCT04543188|520934137|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
144473956|NCT04543188|520934138|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
144473957|NCT04543188|520934139|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
144473958|NCT04543188|520934140|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
144473959|NCT04543188|520934141|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
144473960|NCT04543188|520934142|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
144473961|NCT04543188|520934143|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
144473962|NCT04543188|520934144|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
144473963|NCT04543188|520934145|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
144473964|NCT04543188|520934146|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
144473965|NCT04543188|520934147|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
144473966|NCT04543188|520934148|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
144473967|NCT04543188|520934149|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
144473968|NCT04543188|520934135|FG000|Phase 1a|Other|0|||
144473969|NCT04543188|520934136|FG001|Phase 1a|Other|0|||
144473970|NCT04543188|520934137|FG002|Phase 1a|Other|0|||
144473971|NCT04543188|520934138|FG003|Phase 1a|Other|0|||
144473972|NCT04543188|520934139|FG004|Phase 1a|Other|0|||
144473973|NCT04543188|520934140|FG005|Phase 1a|Other|0|||
144473974|NCT04543188|520934141|FG006|Phase 1a|Other|0|||
144473975|NCT04543188|520934142|FG007|Phase 1a|Other|0|||
144473976|NCT04543188|520934143|FG008|Phase 1a|Other|0|||
144473977|NCT04543188|520934144|FG009|Phase 1a|Other|1|||
144473978|NCT04543188|520934145|FG010|Phase 1a|Other|0|||
144473979|NCT04543188|520934146|FG011|Phase 1a|Other|0|||
144473980|NCT04543188|520934147|FG012|Phase 1a|Other|0|||
144473981|NCT04543188|520934148|FG013|Phase 1a|Other|0|||
144473982|NCT04543188|520934149|FG014|Phase 1a|Other|0|||
144473983|NCT04543188|520934135|FG000|Phase 1b|Adverse Event|0|||
144473984|NCT04543188|520934136|FG001|Phase 1b|Adverse Event|0|||
144473985|NCT04543188|520934137|FG002|Phase 1b|Adverse Event|0|||
144473986|NCT04543188|520934138|FG003|Phase 1b|Adverse Event|0|||
144473987|NCT04543188|520934139|FG004|Phase 1b|Adverse Event|0|||
144473988|NCT04543188|520934140|FG005|Phase 1b|Adverse Event|0|||
144473989|NCT04543188|520934141|FG006|Phase 1b|Adverse Event|0|||
144473990|NCT04543188|520934142|FG007|Phase 1b|Adverse Event|0|||
144473991|NCT04543188|520934143|FG008|Phase 1b|Adverse Event|0|||
144473992|NCT04543188|520934144|FG009|Phase 1b|Adverse Event|0|||
144473993|NCT04543188|520934145|FG010|Phase 1b|Adverse Event|0|||
144473994|NCT04543188|520934146|FG011|Phase 1b|Adverse Event|0|||
144473995|NCT04543188|520934147|FG012|Phase 1b|Adverse Event|0|||
144473996|NCT04543188|520934148|FG013|Phase 1b|Adverse Event|0|||
144473997|NCT04543188|520934149|FG014|Phase 1b|Adverse Event|2|||
144473998|NCT04543188|520934135|FG000|Phase 1b|Other (Death)|0|||
144473999|NCT04543188|520934136|FG001|Phase 1b|Other (Death)|0|||
144474000|NCT04543188|520934137|FG002|Phase 1b|Other (Death)|0|||
144474001|NCT04543188|520934138|FG003|Phase 1b|Other (Death)|0|||
144474002|NCT04543188|520934139|FG004|Phase 1b|Other (Death)|0|||
144474003|NCT04543188|520934140|FG005|Phase 1b|Other (Death)|0|||
144474004|NCT04543188|520934141|FG006|Phase 1b|Other (Death)|0|||
144474005|NCT04543188|520934142|FG007|Phase 1b|Other (Death)|0|||
144474006|NCT04543188|520934143|FG008|Phase 1b|Other (Death)|0|||
144474007|NCT04543188|520934144|FG009|Phase 1b|Other (Death)|0|||
144474008|NCT04543188|520934145|FG010|Phase 1b|Other (Death)|0|||
144474009|NCT04543188|520934146|FG011|Phase 1b|Other (Death)|0|||
144474010|NCT04543188|520934147|FG012|Phase 1b|Other (Death)|1|||
144474011|NCT04543188|520934148|FG013|Phase 1b|Other (Death)|0|||
144474012|NCT04543188|520934149|FG014|Phase 1b|Other (Death)|1|||
144474013|NCT04543188|520934135|FG000|Phase 1b|Progressive Disease|0|||
144474014|NCT04543188|520934136|FG001|Phase 1b|Progressive Disease|0|||
144474015|NCT04543188|520934137|FG002|Phase 1b|Progressive Disease|0|||
144474016|NCT04543188|520934138|FG003|Phase 1b|Progressive Disease|0|||
144474017|NCT04543188|520934139|FG004|Phase 1b|Progressive Disease|0|||
144474018|NCT04543188|520934140|FG005|Phase 1b|Progressive Disease|0|||
144474019|NCT04543188|520934141|FG006|Phase 1b|Progressive Disease|0|||
144474020|NCT04543188|520934142|FG007|Phase 1b|Progressive Disease|0|||
144474021|NCT04543188|520934143|FG008|Phase 1b|Progressive Disease|0|||
144474022|NCT04543188|520934144|FG009|Phase 1b|Progressive Disease|0|||
144474023|NCT04543188|520934145|FG010|Phase 1b|Progressive Disease|0|||
144474024|NCT04543188|520934146|FG011|Phase 1b|Progressive Disease|0|||
144474025|NCT04543188|520934147|FG012|Phase 1b|Progressive Disease|2|||
144474026|NCT04543188|520934148|FG013|Phase 1b|Progressive Disease|1|||
144474027|NCT04543188|520934149|FG014|Phase 1b|Progressive Disease|5|||
144474028|NCT04543188|520934135|FG000|Phase 1b|Study Terminated By Sponsor|0|||
144474029|NCT04543188|520934136|FG001|Phase 1b|Study Terminated By Sponsor|0|||
144474030|NCT04543188|520934137|FG002|Phase 1b|Study Terminated By Sponsor|0|||
144474031|NCT04543188|520934138|FG003|Phase 1b|Study Terminated By Sponsor|0|||
144474032|NCT04543188|520934139|FG004|Phase 1b|Study Terminated By Sponsor|0|||
144474033|NCT04543188|520934140|FG005|Phase 1b|Study Terminated By Sponsor|0|||
144474034|NCT04543188|520934141|FG006|Phase 1b|Study Terminated By Sponsor|0|||
144474035|NCT04543188|520934142|FG007|Phase 1b|Study Terminated By Sponsor|0|||
144474036|NCT04543188|520934143|FG008|Phase 1b|Study Terminated By Sponsor|0|||
144474037|NCT04543188|520934144|FG009|Phase 1b|Study Terminated By Sponsor|0|||
144474038|NCT04543188|520934145|FG010|Phase 1b|Study Terminated By Sponsor|0|||
144474039|NCT04543188|520934146|FG011|Phase 1b|Study Terminated By Sponsor|1|||
144474040|NCT04543188|520934147|FG012|Phase 1b|Study Terminated By Sponsor|1|||
144474041|NCT04543188|520934148|FG013|Phase 1b|Study Terminated By Sponsor|0|||
144474042|NCT04543188|520934149|FG014|Phase 1b|Study Terminated By Sponsor|1|||
144474043|NCT04543188|520934135|FG000|Phase 1b|Withdrawal by Subject|0|||
144474044|NCT04543188|520934136|FG001|Phase 1b|Withdrawal by Subject|0|||
144474045|NCT04543188|520934137|FG002|Phase 1b|Withdrawal by Subject|0|||
144474046|NCT04543188|520934138|FG003|Phase 1b|Withdrawal by Subject|0|||
144474047|NCT04543188|520934139|FG004|Phase 1b|Withdrawal by Subject|0|||
144474048|NCT04543188|520934140|FG005|Phase 1b|Withdrawal by Subject|0|||
144474049|NCT04543188|520934141|FG006|Phase 1b|Withdrawal by Subject|0|||
144474050|NCT04543188|520934142|FG007|Phase 1b|Withdrawal by Subject|0|||
144474051|NCT04543188|520934143|FG008|Phase 1b|Withdrawal by Subject|0|||
144474052|NCT04543188|520934144|FG009|Phase 1b|Withdrawal by Subject|0|||
144474053|NCT04543188|520934145|FG010|Phase 1b|Withdrawal by Subject|0|||
144474054|NCT04543188|520934146|FG011|Phase 1b|Withdrawal by Subject|0|||
144474055|NCT04543188|520934147|FG012|Phase 1b|Withdrawal by Subject|0|||
144474056|NCT04543188|520934148|FG013|Phase 1b|Withdrawal by Subject|0|||
144474057|NCT04543188|520934149|FG014|Phase 1b|Withdrawal by Subject|2|||
144474058|NCT01320943|520934151|FG000|Overall Study|Lost to Follow-up|1|||
144474059|NCT01320943|520934152|FG001|Overall Study|Lost to Follow-up|0|||
144474060|NCT01320943|520934151|FG000|Overall Study|Physician Decision|0|||
144474061|NCT01320943|520934152|FG001|Overall Study|Physician Decision|1|||
144474062|NCT01320943|520934151|FG000|Overall Study|Randomized but not Treated|0|||
144474063|NCT01320943|520934152|FG001|Overall Study|Randomized but not Treated|1|||
144474064|NCT00728962|520934155|FG000|Implant Placement Surgery|Adverse Event|8|||
144474065|NCT00728962|520934155|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
144474066|NCT00728962|520934155|FG000|Implant Placement Surgery|Protocol Violation|1|||
144474067|NCT00728962|520934155|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
144474068|NCT00728962|520934155|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
144474069|NCT00532155|520934156|FG000|Overall Study|Adverse Event|66|||
144474070|NCT00532155|520934157|FG001|Overall Study|Adverse Event|123|||
144474071|NCT00532155|520934156|FG000|Overall Study|Lack of Efficacy|332|||
144474072|NCT00532155|520934157|FG001|Overall Study|Lack of Efficacy|255|||
144474073|NCT00532155|520934156|FG000|Overall Study|Protocol Violation|1|||
144474074|NCT00532155|520934157|FG001|Overall Study|Protocol Violation|3|||
144474075|NCT00532155|520934156|FG000|Overall Study|Lost to Follow-up|2|||
144474076|NCT00532155|520934157|FG001|Overall Study|Lost to Follow-up|0|||
144474077|NCT00532155|520934156|FG000|Overall Study|Physician Decision|16|||
144474078|NCT00532155|520934157|FG001|Overall Study|Physician Decision|15|||
144474079|NCT00532155|520934156|FG000|Overall Study|Withdrawal by Subject|23|||
144474080|NCT00532155|520934157|FG001|Overall Study|Withdrawal by Subject|44|||
144474081|NCT00532155|520934156|FG000|Overall Study|Consent withdrawn|5|||
144474082|NCT00532155|520934157|FG001|Overall Study|Consent withdrawn|7|||
144474083|NCT00532155|520934156|FG000|Overall Study|Moved|1|||
144474084|NCT00532155|520934157|FG001|Overall Study|Moved|0|||
144474085|NCT00532155|520934156|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
144474086|NCT00532155|520934157|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
144474087|NCT00532155|520934156|FG000|Overall Study|Occurence of a second cancer|0|||
144474088|NCT00532155|520934157|FG001|Overall Study|Occurence of a second cancer|1|||
144474089|NCT00532155|520934156|FG000|Overall Study|Occurence of a secondary cancer|0|||
144474090|NCT00532155|520934157|FG001|Overall Study|Occurence of a secondary cancer|1|||
144474091|NCT00532155|520934156|FG000|Overall Study|Promotor ended study|1|||
144474092|NCT00532155|520934157|FG001|Overall Study|Promotor ended study|0|||
144474093|NCT00532155|520934156|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
144474094|NCT00532155|520934157|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
144474095|NCT00532155|520934156|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
144474096|NCT00532155|520934157|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
144474097|NCT00532155|520934156|FG000|Overall Study|Study stopped|1|||
144474098|NCT00532155|520934157|FG001|Overall Study|Study stopped|0|||
144474099|NCT00532155|520934156|FG000|Overall Study|Study terminated by sponsor|1|||
144474100|NCT00532155|520934157|FG001|Overall Study|Study terminated by sponsor|0|||
144474101|NCT00532155|520934156|FG000|Overall Study|Study termination stop further treatment|4|||
144474102|NCT00532155|520934157|FG001|Overall Study|Study termination stop further treatment|0|||
144474103|NCT00532155|520934156|FG000|Overall Study|Did not receive study medication|2|||
144474104|NCT00532155|520934157|FG001|Overall Study|Did not receive study medication|6|||
144474105|NCT03483038|520934158|FG000|Overall Study|Subjects still in follow-up|18|||
144474106|NCT02134925|520934159|FG000|Overall Study|Withdrawal by Subject|1|||
144474107|NCT02134925|520934160|FG001|Overall Study|Withdrawal by Subject|0|||
144474108|NCT02134925|520934159|FG000|Overall Study|Cancel|1|||
144474109|NCT02134925|520934160|FG001|Overall Study|Cancel|6|||
144474110|NCT01064297|520934161|FG000|Overall Study|Lost to Follow-up|791|||
144474111|NCT01064297|520934162|FG001|Overall Study|Lost to Follow-up|48|||
144474112|NCT01064297|520934163|FG002|Overall Study|Lost to Follow-up|133|||
144474113|NCT04027348|520934164|FG000|Overall Study|Adverse Event|2|||
144474114|NCT02158884|520934165|FG000|Baseline Assessment|Missed performance assessment|3|||
144474115|NCT02158884|520934165|FG000|Baseline Assessment|Missed SMFA|1|||
144474116|NCT02158884|520934165|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
144474117|NCT02158884|520934165|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
144474118|NCT02158884|520934165|FG000|6 Month Assessment|Missed SMFA|20|||
144474119|NCT02158884|520934165|FG000|12 Month Assessment|Missed SMFA|17|||
144474120|NCT02487472|520934166|FG000|Overall Study|Did not complete telephonic interviews|9|||
144474121|NCT02487472|520934166|FG000|Overall Study|Other|2|||
144474122|NCT01313286|520934171|FG000|Period 1|Withdrawal by Subject|2|||
144474123|NCT01313286|520934172|FG001|Period 1|Withdrawal by Subject|0|||
144474124|NCT00654901|520934173|FG000|Overall Study|Lost to Follow-up|1|||
144474125|NCT00654901|520934174|FG001|Overall Study|Lost to Follow-up|0|||
144474126|NCT00654901|520934175|FG002|Overall Study|Lost to Follow-up|1|||
144474127|NCT00654901|520934176|FG003|Overall Study|Lost to Follow-up|0|||
144474128|NCT00654901|520934173|FG000|Overall Study|Withdrawal by Subject|3|||
144474129|NCT00654901|520934174|FG001|Overall Study|Withdrawal by Subject|0|||
144474130|NCT00654901|520934175|FG002|Overall Study|Withdrawal by Subject|1|||
144474131|NCT00654901|520934176|FG003|Overall Study|Withdrawal by Subject|0|||
144474132|NCT04843930|520934177|FG000|Randomization|Withdrawal by Subject|6|||
144474133|NCT04843930|520934178|FG001|Randomization|Withdrawal by Subject|6|||
144474134|NCT04843930|520934179|FG002|Randomization|Withdrawal by Subject|0|||
144474135|NCT04843930|520934180|FG003|Randomization|Withdrawal by Subject|0|||
144474136|NCT04843930|520934177|FG000|Week 6 Assessment|Adverse Event|3|||
144474137|NCT04843930|520934178|FG001|Week 6 Assessment|Adverse Event|0|||
144474138|NCT04843930|520934179|FG002|Week 6 Assessment|Adverse Event|0|||
144474139|NCT04843930|520934180|FG003|Week 6 Assessment|Adverse Event|0|||
144474140|NCT04843930|520934177|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
144474141|NCT04843930|520934178|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
144474142|NCT04843930|520934179|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
144474143|NCT04843930|520934180|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
144474144|NCT04843930|520934177|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
144474145|NCT04843930|520934178|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
144474146|NCT04843930|520934179|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
144474147|NCT04843930|520934180|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
144474148|NCT02552238|520934183|FG000|Overall Study|Withdrawal by Subject|2|||
144474149|NCT02552238|520934183|FG000|Overall Study|Adverse Event|2|||
144474150|NCT03324880|520934184|FG000|Overall Study|Adverse Event|0|||
144474151|NCT03324880|520934185|FG001|Overall Study|Adverse Event|2|||
144474152|NCT03324880|520934184|FG000|Overall Study|Withdrawal by Subject|2|||
144474153|NCT03324880|520934185|FG001|Overall Study|Withdrawal by Subject|2|||
144474154|NCT03324880|520934184|FG000|Overall Study|Lost to Follow-up|0|||
144474155|NCT03324880|520934185|FG001|Overall Study|Lost to Follow-up|1|||
144474156|NCT03324880|520934184|FG000|Overall Study|Product Recall|0|||
144474157|NCT03324880|520934185|FG001|Overall Study|Product Recall|1|||
144474158|NCT01547299|520934186|FG000|Overall Study|Withdrawal by Subject|2|||
144474159|NCT01547299|520934187|FG001|Overall Study|Withdrawal by Subject|2|||
144474160|NCT04770779|520934188|FG000|Overall Study|Randomized, never treated|0|||
144474161|NCT04770779|520934189|FG001|Overall Study|Randomized, never treated|1|||
144474162|NCT04770779|520934188|FG000|Overall Study|Adverse Event|9|||
144474163|NCT04770779|520934189|FG001|Overall Study|Adverse Event|1|||
144474164|NCT04770779|520934188|FG000|Overall Study|Withdrawal by Subject|7|||
144474165|NCT04770779|520934189|FG001|Overall Study|Withdrawal by Subject|1|||
144474166|NCT04770779|520934188|FG000|Overall Study|Pregnancy|0|||
144474167|NCT04770779|520934189|FG001|Overall Study|Pregnancy|1|||
144474168|NCT03692052|520934190|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
144474169|NCT03692052|520934190|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
144474170|NCT03692052|520934190|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
144474171|NCT03692052|520934190|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
144474172|NCT04241094|520934191|FG000|Overall Study|Dropped out of treatment|4|||
144474173|NCT04241094|520934191|FG000|Overall Study|Ineligible after clinical assessment|2|||
144474174|NCT04241094|520934191|FG000|Overall Study|Lost to Follow-up|2|||
144474175|NCT01669798|520934192|FG000|Overall Study|Physician Decision|5|||
144474176|NCT05918978|520934196|FG000|Overall Study|Study Terminated by Sponsor|17|||
144474177|NCT05918978|520934197|FG001|Overall Study|Study Terminated by Sponsor|11|||
144474178|NCT05918978|520934196|FG000|Overall Study|Withdrawal by Subject|1|||
144474179|NCT05918978|520934197|FG001|Overall Study|Withdrawal by Subject|1|||
144474180|NCT05918978|520934196|FG000|Overall Study|Adverse Event|1|||
144474181|NCT05918978|520934197|FG001|Overall Study|Adverse Event|0|||
144474182|NCT05918978|520934196|FG000|Overall Study|Other|0|||
144474183|NCT05918978|520934197|FG001|Overall Study|Other|1|||
144474184|NCT06387472|520934200|FG000|Overall Study|Withdrawal by Subject|1|||
144474185|NCT06387472|520934200|FG000|Overall Study|Lost to Follow-up|2|||
144474186|NCT06387472|520934200|FG000|Overall Study|Physician Decision|1|||
144474187|NCT02332590|520934203|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
144474188|NCT02332590|520934204|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
144474189|NCT02332590|520934203|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
144474190|NCT02332590|520934204|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
144474191|NCT02332590|520934203|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
144474192|NCT02332590|520934204|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
144474193|NCT02332590|520934203|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
144474194|NCT02332590|520934204|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
144474195|NCT02332590|520934203|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
144474196|NCT02332590|520934204|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
144474197|NCT02332590|520934203|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
144474198|NCT02332590|520934204|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
144474199|NCT02332590|520934203|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
144474200|NCT02332590|520934204|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
144474201|NCT02332590|520934203|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
144474202|NCT02332590|520934204|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
144474203|NCT02332590|520934203|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
144474204|NCT02332590|520934204|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
144474205|NCT00279201|520934205|FG000|Initiation|Death|1|||
144474206|NCT00279201|520934206|FG001|Initiation|Death|5|||
144474207|NCT00279201|520934207|FG002|Initiation|Death|0|||
144474208|NCT00279201|520934208|FG003|Initiation|Death|0|||
144474209|NCT00279201|520934209|FG004|Initiation|Death|0|||
144474210|NCT00279201|520934210|FG005|Initiation|Death|0|||
144474211|NCT00279201|520934205|FG000|Initiation|Adverse Event|6|||
144474212|NCT00279201|520934206|FG001|Initiation|Adverse Event|15|||
144474213|NCT00279201|520934207|FG002|Initiation|Adverse Event|0|||
144474214|NCT00279201|520934208|FG003|Initiation|Adverse Event|0|||
144474215|NCT00279201|520934209|FG004|Initiation|Adverse Event|0|||
144474216|NCT00279201|520934210|FG005|Initiation|Adverse Event|0|||
144474217|NCT00279201|520934205|FG000|Initiation|Lost to Follow-up|42|||
144474218|NCT00279201|520934206|FG001|Initiation|Lost to Follow-up|41|||
144474219|NCT00279201|520934207|FG002|Initiation|Lost to Follow-up|0|||
144474220|NCT00279201|520934208|FG003|Initiation|Lost to Follow-up|0|||
144474221|NCT00279201|520934209|FG004|Initiation|Lost to Follow-up|0|||
144474222|NCT00279201|520934210|FG005|Initiation|Lost to Follow-up|0|||
144474223|NCT00279201|520934205|FG000|Initiation|Entry Criteria Exclusion|7|||
144474224|NCT00279201|520934206|FG001|Initiation|Entry Criteria Exclusion|9|||
144474225|NCT00279201|520934207|FG002|Initiation|Entry Criteria Exclusion|0|||
144474226|NCT00279201|520934208|FG003|Initiation|Entry Criteria Exclusion|0|||
144474227|NCT00279201|520934209|FG004|Initiation|Entry Criteria Exclusion|0|||
144474228|NCT00279201|520934210|FG005|Initiation|Entry Criteria Exclusion|0|||
144474229|NCT00279201|520934205|FG000|Initiation|Protocol Violation|9|||
144474230|NCT00279201|520934206|FG001|Initiation|Protocol Violation|10|||
144474231|NCT00279201|520934207|FG002|Initiation|Protocol Violation|0|||
144474232|NCT00279201|520934208|FG003|Initiation|Protocol Violation|0|||
144474233|NCT00279201|520934209|FG004|Initiation|Protocol Violation|0|||
144474234|NCT00279201|520934210|FG005|Initiation|Protocol Violation|0|||
144474235|NCT00279201|520934205|FG000|Initiation|Withdrawal by Subject|35|||
144474236|NCT00279201|520934206|FG001|Initiation|Withdrawal by Subject|41|||
144474237|NCT00279201|520934207|FG002|Initiation|Withdrawal by Subject|0|||
144474238|NCT00279201|520934208|FG003|Initiation|Withdrawal by Subject|0|||
144474239|NCT00279201|520934209|FG004|Initiation|Withdrawal by Subject|0|||
144474240|NCT00279201|520934210|FG005|Initiation|Withdrawal by Subject|0|||
144474241|NCT00279201|520934205|FG000|Initiation|Physician Decision|15|||
144474242|NCT00279201|520934206|FG001|Initiation|Physician Decision|18|||
144474243|NCT00279201|520934207|FG002|Initiation|Physician Decision|0|||
144474244|NCT00279201|520934208|FG003|Initiation|Physician Decision|0|||
144474245|NCT00279201|520934209|FG004|Initiation|Physician Decision|0|||
144474246|NCT00279201|520934210|FG005|Initiation|Physician Decision|0|||
144474247|NCT00279201|520934205|FG000|Initiation|Sponsor Decision|13|||
144474248|NCT00279201|520934206|FG001|Initiation|Sponsor Decision|5|||
144474249|NCT00279201|520934207|FG002|Initiation|Sponsor Decision|0|||
144474250|NCT00279201|520934208|FG003|Initiation|Sponsor Decision|0|||
144474251|NCT00279201|520934209|FG004|Initiation|Sponsor Decision|0|||
144474252|NCT00279201|520934210|FG005|Initiation|Sponsor Decision|0|||
144474253|NCT00279201|520934205|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
144474254|NCT00279201|520934206|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
144474255|NCT00279201|520934207|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
144474256|NCT00279201|520934208|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
144474257|NCT00279201|520934209|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
144474258|NCT00279201|520934210|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
144474259|NCT00279201|520934205|FG000|Maintenance|Lack of Efficacy|32|||
144474260|NCT00279201|520934206|FG001|Maintenance|Lack of Efficacy|30|||
144474261|NCT00279201|520934207|FG002|Maintenance|Lack of Efficacy|0|||
144474262|NCT00279201|520934208|FG003|Maintenance|Lack of Efficacy|0|||
144474263|NCT00279201|520934209|FG004|Maintenance|Lack of Efficacy|0|||
144474264|NCT00279201|520934210|FG005|Maintenance|Lack of Efficacy|0|||
144474265|NCT00279201|520934205|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
144474266|NCT00279201|520934206|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
144474267|NCT00279201|520934207|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
144474268|NCT00279201|520934208|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
144474269|NCT00279201|520934209|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
144474270|NCT00279201|520934210|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
144474271|NCT00279201|520934205|FG000|Maintenance|Adverse Event|4|||
144474272|NCT00279201|520934206|FG001|Maintenance|Adverse Event|4|||
144474273|NCT00279201|520934207|FG002|Maintenance|Adverse Event|0|||
144474274|NCT00279201|520934208|FG003|Maintenance|Adverse Event|0|||
144474275|NCT00279201|520934209|FG004|Maintenance|Adverse Event|0|||
144474276|NCT00279201|520934210|FG005|Maintenance|Adverse Event|0|||
144474277|NCT00279201|520934205|FG000|Maintenance|Death|4|||
144474278|NCT00279201|520934206|FG001|Maintenance|Death|4|||
144474279|NCT00279201|520934207|FG002|Maintenance|Death|0|||
144474280|NCT00279201|520934208|FG003|Maintenance|Death|0|||
144474281|NCT00279201|520934209|FG004|Maintenance|Death|0|||
144474282|NCT00279201|520934210|FG005|Maintenance|Death|0|||
144474283|NCT00279201|520934205|FG000|Maintenance|Lost to Follow-up|17|||
144474284|NCT00279201|520934206|FG001|Maintenance|Lost to Follow-up|13|||
144474285|NCT00279201|520934207|FG002|Maintenance|Lost to Follow-up|0|||
144474286|NCT00279201|520934208|FG003|Maintenance|Lost to Follow-up|0|||
144474287|NCT00279201|520934209|FG004|Maintenance|Lost to Follow-up|0|||
144474288|NCT00279201|520934210|FG005|Maintenance|Lost to Follow-up|0|||
144474289|NCT00279201|520934205|FG000|Maintenance|Entry Criteria Exclusion|1|||
144474290|NCT00279201|520934206|FG001|Maintenance|Entry Criteria Exclusion|4|||
144474291|NCT00279201|520934207|FG002|Maintenance|Entry Criteria Exclusion|0|||
144474292|NCT00279201|520934208|FG003|Maintenance|Entry Criteria Exclusion|0|||
144474293|NCT00279201|520934209|FG004|Maintenance|Entry Criteria Exclusion|0|||
144474294|NCT00279201|520934210|FG005|Maintenance|Entry Criteria Exclusion|0|||
144474295|NCT00279201|520934205|FG000|Maintenance|Protocol Violation|16|||
144474296|NCT00279201|520934206|FG001|Maintenance|Protocol Violation|24|||
144474297|NCT00279201|520934207|FG002|Maintenance|Protocol Violation|0|||
144474298|NCT00279201|520934208|FG003|Maintenance|Protocol Violation|0|||
144474299|NCT00279201|520934209|FG004|Maintenance|Protocol Violation|0|||
144474300|NCT00279201|520934210|FG005|Maintenance|Protocol Violation|0|||
144474301|NCT00279201|520934205|FG000|Maintenance|Withdrawal by Subject|18|||
144474302|NCT00279201|520934206|FG001|Maintenance|Withdrawal by Subject|18|||
144474303|NCT00279201|520934207|FG002|Maintenance|Withdrawal by Subject|0|||
144474304|NCT00279201|520934208|FG003|Maintenance|Withdrawal by Subject|0|||
144474305|NCT00279201|520934209|FG004|Maintenance|Withdrawal by Subject|0|||
144474306|NCT00279201|520934210|FG005|Maintenance|Withdrawal by Subject|0|||
144474307|NCT00279201|520934205|FG000|Maintenance|Physician Decision|9|||
144474308|NCT00279201|520934206|FG001|Maintenance|Physician Decision|9|||
144474309|NCT00279201|520934207|FG002|Maintenance|Physician Decision|0|||
144474310|NCT00279201|520934208|FG003|Maintenance|Physician Decision|0|||
144474311|NCT00279201|520934209|FG004|Maintenance|Physician Decision|0|||
144474312|NCT00279201|520934210|FG005|Maintenance|Physician Decision|0|||
144474313|NCT00279201|520934205|FG000|Maintenance|Sponsor Decision|4|||
144474314|NCT00279201|520934206|FG001|Maintenance|Sponsor Decision|0|||
144474315|NCT00279201|520934207|FG002|Maintenance|Sponsor Decision|0|||
144474316|NCT00279201|520934208|FG003|Maintenance|Sponsor Decision|0|||
144474317|NCT00279201|520934209|FG004|Maintenance|Sponsor Decision|0|||
144474318|NCT00279201|520934210|FG005|Maintenance|Sponsor Decision|0|||
144474319|NCT00279201|520934205|FG000|Maintenance|HbA1c>7.5%|123|||
144474320|NCT00279201|520934206|FG001|Maintenance|HbA1c>7.5%|126|||
144474321|NCT00279201|520934207|FG002|Maintenance|HbA1c>7.5%|0|||
144474322|NCT00279201|520934208|FG003|Maintenance|HbA1c>7.5%|0|||
144474323|NCT00279201|520934209|FG004|Maintenance|HbA1c>7.5%|0|||
144474324|NCT00279201|520934210|FG005|Maintenance|HbA1c>7.5%|0|||
144474325|NCT00279201|520934205|FG000|Intensification Addendum|Withdrawal by Subject|0|||
144474326|NCT00279201|520934206|FG001|Intensification Addendum|Withdrawal by Subject|0|||
144474327|NCT00279201|520934207|FG002|Intensification Addendum|Withdrawal by Subject|12|||
144474328|NCT00279201|520934208|FG003|Intensification Addendum|Withdrawal by Subject|14|||
144474329|NCT00279201|520934209|FG004|Intensification Addendum|Withdrawal by Subject|9|||
144474330|NCT00279201|520934210|FG005|Intensification Addendum|Withdrawal by Subject|18|||
144474331|NCT00279201|520934205|FG000|Intensification Addendum|Lost to Follow-up|0|||
144474332|NCT00279201|520934206|FG001|Intensification Addendum|Lost to Follow-up|0|||
144474333|NCT00279201|520934207|FG002|Intensification Addendum|Lost to Follow-up|4|||
144474334|NCT00279201|520934208|FG003|Intensification Addendum|Lost to Follow-up|6|||
144474335|NCT00279201|520934209|FG004|Intensification Addendum|Lost to Follow-up|7|||
144474336|NCT00279201|520934210|FG005|Intensification Addendum|Lost to Follow-up|7|||
144474337|NCT00279201|520934205|FG000|Intensification Addendum|Protocol Violation|0|||
144474338|NCT00279201|520934206|FG001|Intensification Addendum|Protocol Violation|0|||
144474339|NCT00279201|520934207|FG002|Intensification Addendum|Protocol Violation|2|||
144474340|NCT00279201|520934208|FG003|Intensification Addendum|Protocol Violation|2|||
144474341|NCT00279201|520934209|FG004|Intensification Addendum|Protocol Violation|6|||
144474342|NCT00279201|520934210|FG005|Intensification Addendum|Protocol Violation|6|||
144474343|NCT00279201|520934205|FG000|Intensification Addendum|Adverse Event|0|||
144474344|NCT00279201|520934206|FG001|Intensification Addendum|Adverse Event|0|||
144474345|NCT00279201|520934207|FG002|Intensification Addendum|Adverse Event|0|||
144474346|NCT00279201|520934208|FG003|Intensification Addendum|Adverse Event|4|||
144474347|NCT00279201|520934209|FG004|Intensification Addendum|Adverse Event|1|||
144474348|NCT00279201|520934210|FG005|Intensification Addendum|Adverse Event|3|||
144474349|NCT00279201|520934205|FG000|Intensification Addendum|Physician Decision|0|||
144474350|NCT00279201|520934206|FG001|Intensification Addendum|Physician Decision|0|||
144474351|NCT00279201|520934207|FG002|Intensification Addendum|Physician Decision|4|||
144474352|NCT00279201|520934208|FG003|Intensification Addendum|Physician Decision|1|||
144474353|NCT00279201|520934209|FG004|Intensification Addendum|Physician Decision|3|||
144474354|NCT00279201|520934210|FG005|Intensification Addendum|Physician Decision|2|||
144474355|NCT00279201|520934205|FG000|Intensification Addendum|Sponsor Decision|0|||
144474356|NCT00279201|520934206|FG001|Intensification Addendum|Sponsor Decision|0|||
144474357|NCT00279201|520934207|FG002|Intensification Addendum|Sponsor Decision|0|||
144474358|NCT00279201|520934208|FG003|Intensification Addendum|Sponsor Decision|0|||
144474359|NCT00279201|520934209|FG004|Intensification Addendum|Sponsor Decision|1|||
144474360|NCT00279201|520934210|FG005|Intensification Addendum|Sponsor Decision|1|||
144474361|NCT00279201|520934205|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
144474362|NCT00279201|520934206|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
144474363|NCT00279201|520934207|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
144474364|NCT00279201|520934208|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
144474365|NCT00279201|520934209|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
144474366|NCT00279201|520934210|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
144474367|NCT00279201|520934205|FG000|Intensification Addendum|Lack of Efficacy|0|||
144474368|NCT00279201|520934206|FG001|Intensification Addendum|Lack of Efficacy|0|||
144474369|NCT00279201|520934207|FG002|Intensification Addendum|Lack of Efficacy|0|||
144474370|NCT00279201|520934208|FG003|Intensification Addendum|Lack of Efficacy|1|||
144474371|NCT00279201|520934209|FG004|Intensification Addendum|Lack of Efficacy|1|||
144474372|NCT00279201|520934210|FG005|Intensification Addendum|Lack of Efficacy|0|||
144474373|NCT00279201|520934205|FG000|Intensification Addendum|Death|0|||
144474374|NCT00279201|520934206|FG001|Intensification Addendum|Death|0|||
144474375|NCT00279201|520934207|FG002|Intensification Addendum|Death|0|||
144474376|NCT00279201|520934208|FG003|Intensification Addendum|Death|0|||
144474377|NCT00279201|520934209|FG004|Intensification Addendum|Death|1|||
144474378|NCT00279201|520934210|FG005|Intensification Addendum|Death|0|||
144474379|NCT04739761|520934218|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
144474380|NCT04739761|520934219|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
144474381|NCT04739761|520934218|FG000|Overall Study|By complete response from the participant|1|||
144474382|NCT04739761|520934219|FG001|Overall Study|By complete response from the participant|0|||
144474383|NCT04739761|520934218|FG000|Overall Study|Lost to Follow-up|3|||
144474384|NCT04739761|520934219|FG001|Overall Study|Lost to Follow-up|3|||
144474385|NCT04739761|520934218|FG000|Overall Study|Death|13|||
144474386|NCT04739761|520934219|FG001|Overall Study|Death|13|||
144474387|NCT04739761|520934218|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
144474388|NCT04739761|520934219|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
144474389|NCT04739761|520934218|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
144474390|NCT04739761|520934219|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
144474391|NCT04739761|520934218|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
144474392|NCT04739761|520934219|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
144474393|NCT04739761|520934218|FG000|Overall Study|Adverse Event|0|||
144474394|NCT04739761|520934219|FG001|Overall Study|Adverse Event|3|||
144474395|NCT04739761|520934218|FG000|Overall Study|Participant decision|1|||
144474396|NCT04739761|520934219|FG001|Overall Study|Participant decision|0|||
144474397|NCT04739761|520934218|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
144474398|NCT04739761|520934219|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
144474399|NCT04739761|520934218|FG000|Overall Study|Participant immediately started next line of treatment|1|||
144474400|NCT04739761|520934219|FG001|Overall Study|Participant immediately started next line of treatment|0|||
144474401|NCT04739761|520934218|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
144474402|NCT04739761|520934219|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
144474403|NCT04739761|520934218|FG000|Overall Study|Lack of clinical benefit|1|||
144474404|NCT04739761|520934219|FG001|Overall Study|Lack of clinical benefit|0|||
144474405|NCT04739761|520934218|FG000|Overall Study|Disease progression|5|||
144474406|NCT04739761|520934219|FG001|Overall Study|Disease progression|5|||
144474407|NCT04739761|520934218|FG000|Overall Study|Withdrawal by Subject|14|||
144474408|NCT04739761|520934219|FG001|Overall Study|Withdrawal by Subject|13|||
144474409|NCT04739761|520934218|FG000|Overall Study|Protocol Violation|1|||
144474410|NCT04739761|520934219|FG001|Overall Study|Protocol Violation|0|||
144474411|NCT04739761|520934218|FG000|Overall Study|Physician Decision|2|||
144474412|NCT04739761|520934219|FG001|Overall Study|Physician Decision|0|||
144538175|NCT02722434|521174114|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
144538176|NCT04559698|521174115|FG000|Overall Study|Lost to Follow-up|14|||
144538177|NCT04559698|521174116|FG001|Overall Study|Lost to Follow-up|15|||
144538178|NCT04559698|521174115|FG000|Overall Study|Withdrawal by Subject|0|||
144538179|NCT04559698|521174116|FG001|Overall Study|Withdrawal by Subject|1|||
144538180|NCT04989816|521174118|FG000|Overall Study|Death|77|||
144538181|NCT04989816|521174118|FG000|Overall Study|Lost to Follow-up|3|||
144538182|NCT03437733|521174119|FG000|Overall Study|Eligibility criteria not met|0|||
144538183|NCT03437733|521174120|FG001|Overall Study|Eligibility criteria not met|3|||
144538184|NCT01982682|521174121|FG000|Overall Study|Physician Decision|1|||
144474413|NCT02202434|520935964|FG000|Overall Study|Death|70|||
144474414|NCT02202434|520935965|FG001|Overall Study|Death|39|||
144474415|NCT02202434|520935966|FG002|Overall Study|Death|13|||
144474416|NCT02202434|520935967|FG003|Overall Study|Death|27|||
144474417|NCT02202434|520935964|FG000|Overall Study|Lost to Follow-up|1|||
144474418|NCT02202434|520935965|FG001|Overall Study|Lost to Follow-up|1|||
144474419|NCT02202434|520935966|FG002|Overall Study|Lost to Follow-up|1|||
144474420|NCT02202434|520935967|FG003|Overall Study|Lost to Follow-up|0|||
144474421|NCT02202434|520935964|FG000|Overall Study|Physician Decision|2|||
144474422|NCT02202434|520935965|FG001|Overall Study|Physician Decision|3|||
144474423|NCT02202434|520935966|FG002|Overall Study|Physician Decision|0|||
144474424|NCT02202434|520935967|FG003|Overall Study|Physician Decision|0|||
144474425|NCT02202434|520935964|FG000|Overall Study|Withdrawal by Subject|13|||
144474426|NCT02202434|520935965|FG001|Overall Study|Withdrawal by Subject|14|||
144474427|NCT02202434|520935966|FG002|Overall Study|Withdrawal by Subject|1|||
144474428|NCT02202434|520935967|FG003|Overall Study|Withdrawal by Subject|4|||
144474429|NCT02202434|520935964|FG000|Overall Study|Completed Study|1|||
144474430|NCT02202434|520935965|FG001|Overall Study|Completed Study|0|||
144474431|NCT02202434|520935966|FG002|Overall Study|Completed Study|0|||
144474432|NCT02202434|520935967|FG003|Overall Study|Completed Study|0|||
144474433|NCT02202434|520935964|FG000|Overall Study|Visit Missed|21|||
144474434|NCT02202434|520935965|FG001|Overall Study|Visit Missed|12|||
144474435|NCT02202434|520935966|FG002|Overall Study|Visit Missed|0|||
144474436|NCT02202434|520935967|FG003|Overall Study|Visit Missed|5|||
144474437|NCT02202434|520935964|FG000|Overall Study|Other|1|||
144474438|NCT02202434|520935965|FG001|Overall Study|Other|0|||
144474439|NCT02202434|520935966|FG002|Overall Study|Other|0|||
144474440|NCT02202434|520935967|FG003|Overall Study|Other|1|||
144474441|NCT03237858|520935968|FG000|Overall Study|Death|19|||
144474442|NCT03237858|520935968|FG000|Overall Study|Withdrawal by Subject|37|||
144474443|NCT02013388|520935973|FG000|Overall Study|work emergency|1|||
144474444|NCT02013388|520935974|FG001|Overall Study|work emergency|0|||
144474445|NCT02013388|520935975|FG002|Overall Study|work emergency|0|||
144474446|NCT02013388|520935976|FG003|Overall Study|work emergency|0|||
144474447|NCT02013388|520935977|FG004|Overall Study|work emergency|1|||
144474448|NCT02013388|520935978|FG005|Overall Study|work emergency|0|||
144474449|NCT02013388|520935979|FG006|Overall Study|work emergency|0|||
144474450|NCT02013388|520935980|FG007|Overall Study|work emergency|0|||
144474451|NCT03243422|520935981|FG000|Overall Study|Death|20|||
144474452|NCT03243422|520935982|FG001|Overall Study|Death|21|||
144474453|NCT03243422|520935981|FG000|Overall Study|Lost to Follow-up|9|||
144474454|NCT03243422|520935982|FG001|Overall Study|Lost to Follow-up|21|||
144474455|NCT03243422|520935981|FG000|Overall Study|Withdrawal by Subject|22|||
144474456|NCT03243422|520935982|FG001|Overall Study|Withdrawal by Subject|8|||
144474457|NCT02801669|520935986|FG000|Overall Study|Death|66|||
144474458|NCT02801669|520935987|FG001|Overall Study|Death|69|||
144474459|NCT02801669|520935986|FG000|Overall Study|Withdrawal by Subject|81|||
144474460|NCT02801669|520935987|FG001|Overall Study|Withdrawal by Subject|77|||
144474461|NCT02801669|520935986|FG000|Overall Study|Other|4|||
144474462|NCT02801669|520935987|FG001|Overall Study|Other|6|||
144474463|NCT04461795|520935989|FG000|Overall Study|Lost to Follow-up|2|||
144474464|NCT04461795|520935989|FG000|Overall Study|Withdrawal by Subject|2|||
144474465|NCT04461795|520935989|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
144474466|NCT00615264|520935990|FG000|Overall Study|Withdrawal by Subject|17|||
144474467|NCT00615264|520935991|FG001|Overall Study|Withdrawal by Subject|19|||
144474468|NCT00615264|520935990|FG000|Overall Study|Lost to Follow-up|6|||
144474469|NCT00615264|520935991|FG001|Overall Study|Lost to Follow-up|13|||
144474470|NCT00615264|520935990|FG000|Overall Study|Adverse Event|8|||
144474471|NCT00615264|520935991|FG001|Overall Study|Adverse Event|5|||
144474472|NCT00615264|520935990|FG000|Overall Study|Death|1|||
144474473|NCT00615264|520935991|FG001|Overall Study|Death|1|||
144474474|NCT00615264|520935990|FG000|Overall Study|Protocol Violation|11|||
144474475|NCT00615264|520935991|FG001|Overall Study|Protocol Violation|7|||
144474476|NCT00615264|520935990|FG000|Overall Study|Not defined|7|||
144474477|NCT00615264|520935991|FG001|Overall Study|Not defined|4|||
144474478|NCT00615264|520935990|FG000|Overall Study|Dermal Hypersensitivity|0|||
144474479|NCT00615264|520935991|FG001|Overall Study|Dermal Hypersensitivity|3|||
144474480|NCT00058422|520935992|FG000|Overall Study|Not treated|2|||
144474481|NCT02396537|520935994|FG000|Overall Study|Protocol Violation|0|||
144474482|NCT02396537|520935995|FG001|Overall Study|Protocol Violation|1|||
144474483|NCT01982435|520935996|FG000|Overall Study|Adverse Event|1|||
144474484|NCT01982435|520935997|FG001|Overall Study|Adverse Event|0|||
144474485|NCT00871403|520935998|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
144474486|NCT00871403|520935999|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
144474487|NCT00871403|520936000|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
144474488|NCT00871403|520935998|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
144474489|NCT00871403|520935999|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
144474490|NCT00871403|520936000|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
144474491|NCT00871403|520935998|FG000|Combination Treatment Phase|Adverse Event|0|||
144474492|NCT00871403|520935999|FG001|Combination Treatment Phase|Adverse Event|17|||
144474493|NCT00871403|520936000|FG002|Combination Treatment Phase|Adverse Event|2|||
144474494|NCT00871403|520935998|FG000|Combination Treatment Phase|Disease Progression|0|||
144474495|NCT00871403|520935999|FG001|Combination Treatment Phase|Disease Progression|8|||
144474496|NCT00871403|520936000|FG002|Combination Treatment Phase|Disease Progression|5|||
144474497|NCT00871403|520935998|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
144474498|NCT00871403|520935999|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
144474499|NCT00871403|520936000|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
144474500|NCT00871403|520935998|FG000|Combination Treatment Phase|Physician Decision|0|||
144474501|NCT00871403|520935999|FG001|Combination Treatment Phase|Physician Decision|1|||
144474502|NCT00871403|520936000|FG002|Combination Treatment Phase|Physician Decision|3|||
144474503|NCT00871403|520935998|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
144474504|NCT00871403|520935999|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
144474505|NCT00871403|520936000|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
144474506|NCT00871403|520935998|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
144474507|NCT00871403|520935999|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
144474508|NCT00871403|520936000|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
144474509|NCT03075904|520936004|FG000|Overall Study|Physician Decision|3|||
144474510|NCT03075904|520936004|FG000|Overall Study|Need for Medication not Permitted|1|||
144474511|NCT00985985|520936007|FG000|Overall Study|Adverse Event|4|||
144474512|NCT00985985|520936008|FG001|Overall Study|Adverse Event|2|||
144474513|NCT00985985|520936009|FG002|Overall Study|Adverse Event|2|||
144474514|NCT00985985|520936010|FG003|Overall Study|Adverse Event|2|||
144474515|NCT00985985|520936007|FG000|Overall Study|Lost to Follow-up|4|||
144474516|NCT00985985|520936008|FG001|Overall Study|Lost to Follow-up|11|||
144474517|NCT00985985|520936009|FG002|Overall Study|Lost to Follow-up|2|||
144474518|NCT00985985|520936010|FG003|Overall Study|Lost to Follow-up|3|||
144474519|NCT00985985|520936007|FG000|Overall Study|Protocol Violation|1|||
144474520|NCT00985985|520936008|FG001|Overall Study|Protocol Violation|2|||
144474521|NCT00985985|520936009|FG002|Overall Study|Protocol Violation|0|||
144474522|NCT00985985|520936010|FG003|Overall Study|Protocol Violation|1|||
144474523|NCT00985985|520936007|FG000|Overall Study|Lack of Efficacy|5|||
144474524|NCT00985985|520936008|FG001|Overall Study|Lack of Efficacy|6|||
144474525|NCT00985985|520936009|FG002|Overall Study|Lack of Efficacy|1|||
144474526|NCT00985985|520936010|FG003|Overall Study|Lack of Efficacy|3|||
144474527|NCT00985985|520936007|FG000|Overall Study|Withdrawal by Subject|4|||
144474528|NCT00985985|520936008|FG001|Overall Study|Withdrawal by Subject|2|||
144474529|NCT00985985|520936009|FG002|Overall Study|Withdrawal by Subject|2|||
144474530|NCT00985985|520936010|FG003|Overall Study|Withdrawal by Subject|2|||
144474531|NCT00985985|520936007|FG000|Overall Study|Other Reason|6|||
144474532|NCT00985985|520936008|FG001|Overall Study|Other Reason|1|||
144474533|NCT00985985|520936009|FG002|Overall Study|Other Reason|4|||
144474534|NCT00985985|520936010|FG003|Overall Study|Other Reason|2|||
144474535|NCT00509236|520936013|FG000|Overall Study|Adverse Event|7|||
144474536|NCT00509236|520936014|FG001|Overall Study|Adverse Event|9|||
144474537|NCT00509236|520936013|FG000|Overall Study|Withdrawal by Subject|5|||
144474538|NCT00509236|520936014|FG001|Overall Study|Withdrawal by Subject|10|||
144474539|NCT00509236|520936013|FG000|Overall Study|Protocol Violation|3|||
144474540|NCT00509236|520936014|FG001|Overall Study|Protocol Violation|0|||
144474541|NCT00509236|520936013|FG000|Overall Study|Excluded Medication|1|||
144474542|NCT00509236|520936014|FG001|Overall Study|Excluded Medication|1|||
144474543|NCT00509236|520936013|FG000|Overall Study|Scheduled Kidney Transplant|1|||
144474544|NCT00509236|520936014|FG001|Overall Study|Scheduled Kidney Transplant|0|||
144474545|NCT00927355|520936015|FG000|Overall Study|Adverse Event|1|||
144474546|NCT00927355|520936016|FG001|Overall Study|Adverse Event|1|||
144474547|NCT01572389|520936017|FG000|Overall Study|Death|1|||
144474548|NCT01572389|520936018|FG001|Overall Study|Death|3|||
144474549|NCT01572389|520936017|FG000|Overall Study|Withdrawal by Subject|14|||
144474550|NCT01572389|520936018|FG001|Overall Study|Withdrawal by Subject|2|||
144474551|NCT01572389|520936017|FG000|Overall Study|Lost to Follow-up|25|||
144474552|NCT01572389|520936018|FG001|Overall Study|Lost to Follow-up|14|||
144474553|NCT01572389|520936017|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
144474554|NCT01572389|520936018|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
144474555|NCT03954743|520936019|FG000|Overall Study|Adverse Event|1|||
144474556|NCT03954743|520936020|FG001|Overall Study|Adverse Event|0|||
144474557|NCT03954743|520936019|FG000|Overall Study|Lost to Follow-up|6|||
144474558|NCT03954743|520936020|FG001|Overall Study|Lost to Follow-up|4|||
144474559|NCT03954743|520936019|FG000|Overall Study|Protocol Violation|1|||
144474560|NCT03954743|520936020|FG001|Overall Study|Protocol Violation|0|||
144474561|NCT03954743|520936019|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
144474562|NCT03954743|520936020|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
144474563|NCT03954743|520936019|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
144474564|NCT03954743|520936020|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144474565|NCT02387996|520936033|FG000|Overall Study|Disease Progression|167|||
144474566|NCT02387996|520936033|FG000|Overall Study|Study Drug Toxicity|31|||
144474567|NCT02387996|520936033|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
144474568|NCT02387996|520936033|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
144474569|NCT02387996|520936033|FG000|Overall Study|Subject Withdrew Consent|5|||
144474570|NCT02387996|520936033|FG000|Overall Study|Lost to Follow-up|1|||
144474571|NCT02387996|520936033|FG000|Overall Study|Poor/Non-Compliance|1|||
144474572|NCT02387996|520936033|FG000|Overall Study|Other Reasons|5|||
144474573|NCT02387996|520936033|FG000|Overall Study|Death|1|||
144474574|NCT01446796|520936034|FG000|Overall Study|Withdrawal by Subject|1|||
144474575|NCT01446796|520936035|FG001|Overall Study|Withdrawal by Subject|0|||
144474576|NCT04581200|520936043|FG000|Overall Study|Lost to Follow-up|6|||
144474577|NCT04581200|520936044|FG001|Overall Study|Lost to Follow-up|5|||
144474578|NCT01781390|520936045|FG000|Overall Study|Withdrawal of Consent|0|||
144474579|NCT01781390|520936046|FG001|Overall Study|Withdrawal of Consent|3|||
144474580|NCT01781390|520936047|FG002|Overall Study|Withdrawal of Consent|1|||
144474581|NCT01781390|520936045|FG000|Overall Study|Lost to Follow-up|1|||
144474582|NCT01781390|520936046|FG001|Overall Study|Lost to Follow-up|1|||
144474583|NCT01781390|520936047|FG002|Overall Study|Lost to Follow-up|1|||
144474584|NCT01781390|520936045|FG000|Overall Study|Adverse Event|1|||
144474585|NCT01781390|520936046|FG001|Overall Study|Adverse Event|2|||
144474586|NCT01781390|520936047|FG002|Overall Study|Adverse Event|1|||
144474587|NCT01781390|520936045|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
144474588|NCT01781390|520936046|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
144474589|NCT01781390|520936047|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
144474590|NCT00622713|520936048|FG000|Overall Study|Adverse Event|35|||
144474591|NCT00622713|520936048|FG000|Overall Study|Administrative problems|4|||
144474592|NCT00622713|520936048|FG000|Overall Study|Withdrawal by Subject|11|||
144474593|NCT00622713|520936048|FG000|Overall Study|Lost to Follow-up|5|||
144474594|NCT00622713|520936048|FG000|Overall Study|Death|2|||
144474595|NCT00622713|520936048|FG000|Overall Study|Subject no longer required study drug|1|||
144474596|NCT00622713|520936048|FG000|Overall Study|Did not meet eligibility criteria|1|||
144474597|NCT03485911|520936051|FG000|Part 1|Perceived lack of efficacy|1|||
144474598|NCT03485911|520936052|FG001|Part 1|Perceived lack of efficacy|1|||
144474599|NCT03485911|520936053|FG002|Part 1|Perceived lack of efficacy|2|||
144474600|NCT03485911|520936054|FG003|Part 1|Perceived lack of efficacy|0|||
144474601|NCT03485911|520936051|FG000|Part 1|Subject withdrew consent|0|||
144474602|NCT03485911|520936052|FG001|Part 1|Subject withdrew consent|1|||
144474603|NCT03485911|520936053|FG002|Part 1|Subject withdrew consent|0|||
144474604|NCT03485911|520936054|FG003|Part 1|Subject withdrew consent|1|||
144474605|NCT03485911|520936051|FG000|Part 1|Lab abnormalities/AEs|3|||
144474606|NCT03485911|520936052|FG001|Part 1|Lab abnormalities/AEs|1|||
144474607|NCT03485911|520936053|FG002|Part 1|Lab abnormalities/AEs|1|||
144474608|NCT03485911|520936054|FG003|Part 1|Lab abnormalities/AEs|0|||
144474609|NCT03485911|520936051|FG000|Part 1|Withdrew Consent prior to dosing|0|||
144474610|NCT03485911|520936052|FG001|Part 1|Withdrew Consent prior to dosing|0|||
144474611|NCT03485911|520936053|FG002|Part 1|Withdrew Consent prior to dosing|0|||
144474612|NCT03485911|520936054|FG003|Part 1|Withdrew Consent prior to dosing|1|||
144474613|NCT03485911|520936051|FG000|Part 1|Other NOS|0|||
144474614|NCT03485911|520936052|FG001|Part 1|Other NOS|0|||
144474615|NCT03485911|520936053|FG002|Part 1|Other NOS|0|||
144474616|NCT03485911|520936054|FG003|Part 1|Other NOS|1|||
144474617|NCT03485911|520936051|FG000|Part 2|Perceived lack of efficacy|5|||
144474618|NCT03485911|520936052|FG001|Part 2|Perceived lack of efficacy|3|||
144474619|NCT03485911|520936053|FG002|Part 2|Perceived lack of efficacy|0|||
144474620|NCT03485911|520936054|FG003|Part 2|Perceived lack of efficacy|2|||
144474621|NCT03485911|520936051|FG000|Part 2|Subject withdrew consent|1|||
144474622|NCT03485911|520936052|FG001|Part 2|Subject withdrew consent|0|||
144474623|NCT03485911|520936053|FG002|Part 2|Subject withdrew consent|2|||
144474624|NCT03485911|520936054|FG003|Part 2|Subject withdrew consent|1|||
144474625|NCT03485911|520936051|FG000|Part 2|Lab abnormalities/AEs|1|||
144474626|NCT03485911|520936052|FG001|Part 2|Lab abnormalities/AEs|2|||
144474627|NCT03485911|520936053|FG002|Part 2|Lab abnormalities/AEs|0|||
144474628|NCT03485911|520936054|FG003|Part 2|Lab abnormalities/AEs|0|||
144474629|NCT03485911|520936051|FG000|Part 2|Other NOS|0|||
144474630|NCT03485911|520936052|FG001|Part 2|Other NOS|1|||
144474631|NCT03485911|520936053|FG002|Part 2|Other NOS|0|||
144474632|NCT03485911|520936054|FG003|Part 2|Other NOS|0|||
144474633|NCT03485911|520936051|FG000|Part 2|Intercurrent illness/new medical condition|1|||
144474634|NCT03485911|520936052|FG001|Part 2|Intercurrent illness/new medical condition|0|||
144474635|NCT03485911|520936053|FG002|Part 2|Intercurrent illness/new medical condition|0|||
144474636|NCT03485911|520936054|FG003|Part 2|Intercurrent illness/new medical condition|0|||
144474637|NCT03485911|520936051|FG000|Part 2|Investigator judgement|1|||
144474638|NCT03485911|520936052|FG001|Part 2|Investigator judgement|0|||
144474639|NCT03485911|520936053|FG002|Part 2|Investigator judgement|0|||
144474640|NCT03485911|520936054|FG003|Part 2|Investigator judgement|0|||
144474641|NCT03485911|520936051|FG000|Part 3|Perceived lack of efficacy|2|||
144474642|NCT03485911|520936052|FG001|Part 3|Perceived lack of efficacy|2|||
144474643|NCT03485911|520936053|FG002|Part 3|Perceived lack of efficacy|2|||
144474644|NCT03485911|520936054|FG003|Part 3|Perceived lack of efficacy|0|||
144474645|NCT03485911|520936051|FG000|Part 3|Subject withdrew consent|1|||
144474646|NCT03485911|520936052|FG001|Part 3|Subject withdrew consent|4|||
144474647|NCT03485911|520936053|FG002|Part 3|Subject withdrew consent|0|||
144474648|NCT03485911|520936054|FG003|Part 3|Subject withdrew consent|1|||
144474649|NCT03485911|520936051|FG000|Part 3|Lab abnormalities/AEs|1|||
144474650|NCT03485911|520936052|FG001|Part 3|Lab abnormalities/AEs|1|||
144474651|NCT03485911|520936053|FG002|Part 3|Lab abnormalities/AEs|0|||
144474652|NCT03485911|520936054|FG003|Part 3|Lab abnormalities/AEs|2|||
144474653|NCT03485911|520936051|FG000|Part 3|Other NOS|1|||
144474654|NCT03485911|520936052|FG001|Part 3|Other NOS|1|||
144474655|NCT03485911|520936053|FG002|Part 3|Other NOS|0|||
144474656|NCT03485911|520936054|FG003|Part 3|Other NOS|0|||
144474657|NCT03485911|520936051|FG000|Part 3|Intercurrent illness/new medical condition|0|||
144474658|NCT03485911|520936052|FG001|Part 3|Intercurrent illness/new medical condition|1|||
144474659|NCT03485911|520936053|FG002|Part 3|Intercurrent illness/new medical condition|1|||
144474660|NCT03485911|520936054|FG003|Part 3|Intercurrent illness/new medical condition|0|||
144474661|NCT03485911|520936051|FG000|Part 3|Sponsor discontinuation|1|||
144474662|NCT03485911|520936052|FG001|Part 3|Sponsor discontinuation|0|||
144474663|NCT03485911|520936053|FG002|Part 3|Sponsor discontinuation|0|||
144474664|NCT03485911|520936054|FG003|Part 3|Sponsor discontinuation|0|||
144474665|NCT03485911|520936051|FG000|Part 3|Berotralstat provided by alternative means|13|||
144474666|NCT03485911|520936052|FG001|Part 3|Berotralstat provided by alternative means|13|||
144474667|NCT03485911|520936053|FG002|Part 3|Berotralstat provided by alternative means|7|||
144474668|NCT03485911|520936054|FG003|Part 3|Berotralstat provided by alternative means|7|||
144474669|NCT02914314|520936055|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
144474670|NCT02914314|520936056|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
144474671|NCT02914314|520936057|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
144474672|NCT02914314|520936058|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
144474673|NCT02914314|520936055|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
144474674|NCT02914314|520936056|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
144474675|NCT02914314|520936057|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
144474676|NCT02914314|520936058|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
144474677|NCT02914314|520936055|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
144474678|NCT02914314|520936056|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
144474679|NCT02914314|520936057|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
144474680|NCT02914314|520936058|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
144474681|NCT02914314|520936055|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
144474682|NCT02914314|520936056|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
144474683|NCT02914314|520936057|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
144474684|NCT02914314|520936058|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
144474685|NCT02914314|520936055|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
144474686|NCT02914314|520936056|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
144474687|NCT02914314|520936057|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
144474688|NCT02914314|520936058|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
144474689|NCT05375955|520936059|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
144474690|NCT05375955|520936060|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
144474691|NCT05375955|520936061|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
144474692|NCT05375955|520936062|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
144474693|NCT05375955|520936063|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
144474694|NCT05375955|520936064|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
144474695|NCT05375955|520936065|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
144474696|NCT05375955|520936059|FG000|Treatment (12 Weeks)|Physician Decision|4|||
144474697|NCT05375955|520936060|FG001|Treatment (12 Weeks)|Physician Decision|1|||
144474698|NCT05375955|520936061|FG002|Treatment (12 Weeks)|Physician Decision|3|||
144474699|NCT05375955|520936062|FG003|Treatment (12 Weeks)|Physician Decision|0|||
144474700|NCT05375955|520936063|FG004|Treatment (12 Weeks)|Physician Decision|0|||
144474701|NCT05375955|520936064|FG005|Treatment (12 Weeks)|Physician Decision|1|||
144474702|NCT05375955|520936065|FG006|Treatment (12 Weeks)|Physician Decision|0|||
144474703|NCT05375955|520936059|FG000|Treatment (12 Weeks)|Other|0|||
144474704|NCT05375955|520936060|FG001|Treatment (12 Weeks)|Other|1|||
144474705|NCT05375955|520936061|FG002|Treatment (12 Weeks)|Other|0|||
144474706|NCT05375955|520936062|FG003|Treatment (12 Weeks)|Other|0|||
144474707|NCT05375955|520936063|FG004|Treatment (12 Weeks)|Other|0|||
144474708|NCT05375955|520936064|FG005|Treatment (12 Weeks)|Other|0|||
144474709|NCT05375955|520936065|FG006|Treatment (12 Weeks)|Other|0|||
144474710|NCT05375955|520936059|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
144474711|NCT05375955|520936060|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
144474712|NCT05375955|520936061|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
144474713|NCT05375955|520936062|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
144474714|NCT05375955|520936063|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
144474715|NCT05375955|520936064|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
144474716|NCT05375955|520936065|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
144474717|NCT05375955|520936059|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
144474718|NCT05375955|520936060|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
144474719|NCT05375955|520936061|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
144474720|NCT05375955|520936062|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
144474721|NCT05375955|520936063|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
144474722|NCT05375955|520936064|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
144474723|NCT05375955|520936065|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
144474724|NCT05375955|520936059|FG000|Treatment (12 Weeks)|Pregnancy|0|||
144474725|NCT05375955|520936060|FG001|Treatment (12 Weeks)|Pregnancy|0|||
144474726|NCT05375955|520936061|FG002|Treatment (12 Weeks)|Pregnancy|1|||
144474727|NCT05375955|520936062|FG003|Treatment (12 Weeks)|Pregnancy|0|||
144474728|NCT05375955|520936063|FG004|Treatment (12 Weeks)|Pregnancy|0|||
144474729|NCT05375955|520936064|FG005|Treatment (12 Weeks)|Pregnancy|0|||
144474730|NCT05375955|520936065|FG006|Treatment (12 Weeks)|Pregnancy|0|||
144474731|NCT05375955|520936059|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
144474732|NCT05375955|520936060|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
144474733|NCT05375955|520936061|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
144474734|NCT05375955|520936062|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
144474735|NCT05375955|520936063|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
144474736|NCT05375955|520936064|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
144474737|NCT05375955|520936065|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
144474738|NCT05375955|520936059|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
144474739|NCT05375955|520936060|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
144474740|NCT05375955|520936061|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
144474741|NCT05375955|520936062|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
144474742|NCT05375955|520936063|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
144474743|NCT05375955|520936064|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
144474744|NCT05375955|520936065|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
144474745|NCT05375955|520936059|FG000|Follow-up (up to 5 Weeks)|Other|0|||
144474746|NCT05375955|520936060|FG001|Follow-up (up to 5 Weeks)|Other|1|||
144474747|NCT05375955|520936061|FG002|Follow-up (up to 5 Weeks)|Other|0|||
144474748|NCT05375955|520936062|FG003|Follow-up (up to 5 Weeks)|Other|0|||
144474749|NCT05375955|520936063|FG004|Follow-up (up to 5 Weeks)|Other|0|||
144474750|NCT05375955|520936064|FG005|Follow-up (up to 5 Weeks)|Other|0|||
144474751|NCT05375955|520936065|FG006|Follow-up (up to 5 Weeks)|Other|0|||
144474752|NCT05375955|520936059|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
144474753|NCT05375955|520936060|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
144474754|NCT05375955|520936061|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
144474755|NCT05375955|520936062|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
144474756|NCT05375955|520936063|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
144474757|NCT05375955|520936064|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
144474758|NCT05375955|520936065|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
144474759|NCT05375955|520936059|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
144474760|NCT05375955|520936060|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
144474761|NCT05375955|520936061|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
144474762|NCT05375955|520936062|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
144474763|NCT05375955|520936063|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
144474764|NCT05375955|520936064|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
144474765|NCT05375955|520936065|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
144474766|NCT05454410|520936066|FG000|Overall Study|Withdrawal by Subject|0|||
144474767|NCT05454410|520936067|FG001|Overall Study|Withdrawal by Subject|0|||
144474768|NCT05454410|520936068|FG002|Overall Study|Withdrawal by Subject|1|||
144474769|NCT05454410|520936069|FG003|Overall Study|Withdrawal by Subject|1|||
144474770|NCT05004688|520936079|FG000|Overall Study|Protocol Violation|7|||
144474771|NCT05004688|520936079|FG000|Overall Study|Physician Decision|2|||
144474772|NCT05004688|520936079|FG000|Overall Study|Withdrawal by Subject|2|||
144474773|NCT00895622|520936080|FG000|Overall Study|Protocol Violation|5|||
144474774|NCT00895622|520936081|FG001|Overall Study|Protocol Violation|4|||
144474775|NCT00895622|520936082|FG002|Overall Study|Protocol Violation|4|||
144474776|NCT03879408|520936083|FG000|Overall Study|Lost to Follow-up|0|||
144474777|NCT03879408|520936084|FG001|Overall Study|Lost to Follow-up|3|||
144474778|NCT03879408|520936085|FG002|Overall Study|Lost to Follow-up|2|||
144474779|NCT03879408|520936086|FG003|Overall Study|Lost to Follow-up|1|||
144474780|NCT03879408|520936087|FG004|Overall Study|Lost to Follow-up|0|||
144474781|NCT03879408|520936083|FG000|Overall Study|Withdrawal by Subject|2|||
144474782|NCT03879408|520936084|FG001|Overall Study|Withdrawal by Subject|1|||
144474783|NCT03879408|520936085|FG002|Overall Study|Withdrawal by Subject|1|||
144474784|NCT03879408|520936086|FG003|Overall Study|Withdrawal by Subject|0|||
144474785|NCT03879408|520936087|FG004|Overall Study|Withdrawal by Subject|1|||
144474786|NCT03489057|520936096|FG000|Overall Study|Lost to Follow-up|16|||
144474787|NCT03489057|520936097|FG001|Overall Study|Lost to Follow-up|16|||
144474788|NCT03489057|520936098|FG002|Overall Study|Lost to Follow-up|14|||
144474789|NCT03489057|520936099|FG003|Overall Study|Lost to Follow-up|14|||
144474790|NCT03489057|520936096|FG000|Overall Study|Withdrawal by Subject|12|||
144474791|NCT03489057|520936097|FG001|Overall Study|Withdrawal by Subject|12|||
144474792|NCT03489057|520936098|FG002|Overall Study|Withdrawal by Subject|8|||
144474793|NCT03489057|520936099|FG003|Overall Study|Withdrawal by Subject|8|||
144474794|NCT03489057|520936096|FG000|Overall Study|Protocol Violation|7|||
144474795|NCT03489057|520936097|FG001|Overall Study|Protocol Violation|7|||
144474796|NCT03489057|520936098|FG002|Overall Study|Protocol Violation|2|||
144474797|NCT03489057|520936099|FG003|Overall Study|Protocol Violation|2|||
144474798|NCT05158296|520936100|FG000|Overall Study|Sponsor Decision|2|||
144474799|NCT05158296|520936101|FG001|Overall Study|Sponsor Decision|3|||
144474800|NCT05158296|520936102|FG002|Overall Study|Sponsor Decision|2|||
144474801|NCT02010632|520936106|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
144474802|NCT02010632|520936107|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
144474803|NCT00652938|520936111|FG000|Overall Study|Adverse Event|1|||
144474804|NCT00652938|520936112|FG001|Overall Study|Adverse Event|0|||
144474805|NCT00652938|520936113|FG002|Overall Study|Adverse Event|2|||
144474806|NCT00652938|520936111|FG000|Overall Study|Withdrawal by Subject|0|||
144474807|NCT00652938|520936112|FG001|Overall Study|Withdrawal by Subject|6|||
144474808|NCT00652938|520936113|FG002|Overall Study|Withdrawal by Subject|1|||
144474809|NCT00652938|520936111|FG000|Overall Study|Lost to Follow-up|0|||
144474810|NCT00652938|520936112|FG001|Overall Study|Lost to Follow-up|0|||
144474811|NCT00652938|520936113|FG002|Overall Study|Lost to Follow-up|2|||
144474812|NCT00652938|520936111|FG000|Overall Study|fear of blood sampling|0|||
144474813|NCT00652938|520936112|FG001|Overall Study|fear of blood sampling|1|||
144474814|NCT00652938|520936113|FG002|Overall Study|fear of blood sampling|0|||
144474815|NCT01412801|520936114|FG000|Overall Study|Death|0|||
144474816|NCT01412801|520936115|FG001|Overall Study|Death|1|||
144474817|NCT01412801|520936116|FG002|Overall Study|Death|0|||
144474818|NCT01412801|520936117|FG003|Overall Study|Death|4|||
144474819|NCT01412801|520936118|FG004|Overall Study|Death|2|||
144474820|NCT01412801|520936119|FG005|Overall Study|Death|2|||
144474821|NCT01412801|520936114|FG000|Overall Study|Lost to Follow-up|1|||
144474822|NCT01412801|520936115|FG001|Overall Study|Lost to Follow-up|2|||
144474823|NCT01412801|520936116|FG002|Overall Study|Lost to Follow-up|4|||
144474824|NCT01412801|520936117|FG003|Overall Study|Lost to Follow-up|0|||
144474825|NCT01412801|520936118|FG004|Overall Study|Lost to Follow-up|1|||
144474826|NCT01412801|520936119|FG005|Overall Study|Lost to Follow-up|1|||
144474827|NCT01412801|520936114|FG000|Overall Study|Withdrawal by Subject|3|||
144474828|NCT01412801|520936115|FG001|Overall Study|Withdrawal by Subject|2|||
144474829|NCT01412801|520936116|FG002|Overall Study|Withdrawal by Subject|1|||
144474830|NCT01412801|520936117|FG003|Overall Study|Withdrawal by Subject|0|||
144474831|NCT01412801|520936118|FG004|Overall Study|Withdrawal by Subject|0|||
144474832|NCT01412801|520936119|FG005|Overall Study|Withdrawal by Subject|0|||
144474833|NCT01412801|520936114|FG000|Overall Study|Relocated to another area|0|||
144474834|NCT01412801|520936115|FG001|Overall Study|Relocated to another area|0|||
144474835|NCT01412801|520936116|FG002|Overall Study|Relocated to another area|2|||
144474836|NCT01412801|520936117|FG003|Overall Study|Relocated to another area|0|||
144474837|NCT01412801|520936118|FG004|Overall Study|Relocated to another area|0|||
144474838|NCT01412801|520936119|FG005|Overall Study|Relocated to another area|0|||
144474839|NCT00622180|520936120|FG000|Overall Study|Lost to Follow-up|1|||
144474840|NCT00622180|520936121|FG001|Overall Study|Lost to Follow-up|2|||
144474841|NCT02272725|520936123|FG000|Overall Study|equipment malfunction|2|||
144474842|NCT02272725|520936124|FG001|Overall Study|equipment malfunction|0|||
144474843|NCT00975221|520938225|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
144474844|NCT00975221|520938226|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
144474845|NCT00975221|520938225|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
144474846|NCT00975221|520938226|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
144474847|NCT00975221|520938225|FG000|Titration Phase (Weeks 1-12)|Other|0|||
144474848|NCT00975221|520938226|FG001|Titration Phase (Weeks 1-12)|Other|1|||
144474849|NCT00975221|520938225|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
144474850|NCT00975221|520938226|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
144474851|NCT00975221|520938225|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
144474852|NCT00975221|520938226|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
144474853|NCT00975221|520938225|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
144474854|NCT00975221|520938226|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
144474855|NCT01862991|520938229|FG000|Overall Study|Lost to Follow-up|2|||
144474856|NCT01862991|520938230|FG001|Overall Study|Lost to Follow-up|1|||
144474857|NCT01862991|520938231|FG002|Overall Study|Lost to Follow-up|1|||
144474858|NCT01862991|520938229|FG000|Overall Study|Protocol Violation|1|||
144474859|NCT01862991|520938230|FG001|Overall Study|Protocol Violation|0|||
144474860|NCT01862991|520938231|FG002|Overall Study|Protocol Violation|0|||
144474861|NCT04858802|520938232|FG000|Overall Study|Lost to Follow-up|1|||
144474862|NCT04858802|520938233|FG001|Overall Study|Lost to Follow-up|1|||
144474863|NCT04858802|520938232|FG000|Overall Study|Withdrawal by Subject|1|||
144474864|NCT04858802|520938233|FG001|Overall Study|Withdrawal by Subject|1|||
144474865|NCT02026232|520938234|FG000|Overall Study|incomplete visit/missing data|3|||
144474866|NCT02026232|520938235|FG001|Overall Study|incomplete visit/missing data|2|||
144474867|NCT03610737|520938238|FG000|Overall Study|Withdrawal by Subject|1|||
144474868|NCT03610737|520938239|FG001|Overall Study|Withdrawal by Subject|5|||
144474869|NCT03610737|520938238|FG000|Overall Study|Death|1|||
144474870|NCT03610737|520938239|FG001|Overall Study|Death|0|||
144474871|NCT03610737|520938238|FG000|Overall Study|Not treated|5|||
144474872|NCT03610737|520938239|FG001|Overall Study|Not treated|2|||
144474873|NCT03610737|520938238|FG000|Overall Study|Missed Visit|1|||
144474874|NCT03610737|520938239|FG001|Overall Study|Missed Visit|2|||
144474875|NCT00215540|520938240|FG000|Overall Study|Withdrew from study medication|1|||
144474876|NCT00215540|520938241|FG001|Overall Study|Withdrew from study medication|0|||
144474877|NCT00215540|520938242|FG002|Overall Study|Withdrew from study medication|0|||
144474878|NCT03145766|520938243|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
144474879|NCT03145766|520938244|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
144474880|NCT03145766|520938245|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
144474881|NCT03145766|520938246|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
144474882|NCT03145766|520938247|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
144474883|NCT03145766|520938243|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
144474884|NCT03145766|520938244|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
144474885|NCT03145766|520938245|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
144474886|NCT03145766|520938246|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
144474887|NCT03145766|520938247|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
144474888|NCT03145766|520938243|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
144474889|NCT03145766|520938244|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
144474890|NCT03145766|520938245|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
144474891|NCT03145766|520938246|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
144474892|NCT03145766|520938247|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
144474893|NCT03145766|520938243|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
144474894|NCT03145766|520938244|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
144474895|NCT03145766|520938245|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
144474896|NCT03145766|520938246|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
144474897|NCT03145766|520938247|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
144474898|NCT03145766|520938243|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
144474899|NCT03145766|520938244|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
144474900|NCT03145766|520938245|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
144474901|NCT03145766|520938246|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
144474902|NCT03145766|520938247|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
144474903|NCT03145766|520938243|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
144474904|NCT03145766|520938244|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
144474905|NCT03145766|520938245|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
144474906|NCT03145766|520938246|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
144474907|NCT03145766|520938247|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
144474908|NCT03145766|520938243|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
144474909|NCT03145766|520938244|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
144474910|NCT03145766|520938245|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
144474911|NCT03145766|520938246|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
144474912|NCT03145766|520938247|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
144474913|NCT00674570|520938249|FG000|Overall Study|Withdrawal by Subject|0|||
144474914|NCT00674570|520938250|FG001|Overall Study|Withdrawal by Subject|2|||
144474915|NCT00674570|520938251|FG002|Overall Study|Withdrawal by Subject|0|||
144474916|NCT01966003|520938252|FG000|Overall Study|Death|43|||
144474917|NCT01966003|520938253|FG001|Overall Study|Death|36|||
144474918|NCT01966003|520938252|FG000|Overall Study|Protocol Violation|6|||
144474919|NCT01966003|520938253|FG001|Overall Study|Protocol Violation|4|||
144474920|NCT01966003|520938252|FG000|Overall Study|Lost to Follow-up|4|||
144474921|NCT01966003|520938253|FG001|Overall Study|Lost to Follow-up|3|||
144474922|NCT01966003|520938252|FG000|Overall Study|Physician Decision|12|||
144474923|NCT01966003|520938253|FG001|Overall Study|Physician Decision|13|||
144474924|NCT01966003|520938252|FG000|Overall Study|Withdrawal by Subject|29|||
144474925|NCT01966003|520938253|FG001|Overall Study|Withdrawal by Subject|19|||
144474926|NCT01966003|520938252|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
144474927|NCT01966003|520938253|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
144474928|NCT01966003|520938252|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
144474929|NCT01966003|520938253|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
144474930|NCT01966003|520938252|FG000|Overall Study|Other|1|||
144474931|NCT01966003|520938253|FG001|Overall Study|Other|1|||
144474932|NCT00185640|520938255|FG000|Overall Study|Not Eligible|4|||
144474933|NCT00185640|520938255|FG000|Overall Study|Withdrawal by Subject|3|||
144474934|NCT00185640|520938255|FG000|Overall Study|Death|138|||
144474935|NCT00633932|520938260|FG000|Overall Study|Adverse Event|1|||
144474936|NCT00633932|520938261|FG001|Overall Study|Adverse Event|3|||
144474937|NCT00633932|520938262|FG002|Overall Study|Adverse Event|4|||
144474938|NCT00633932|520938260|FG000|Overall Study|Withdrawal by Subject|3|||
144474939|NCT00633932|520938261|FG001|Overall Study|Withdrawal by Subject|9|||
144538185|NCT00146172|521174122|FG000|Overall Study|Adverse Event|0|||
144474940|NCT00633932|520938262|FG002|Overall Study|Withdrawal by Subject|1|||
144474941|NCT00633932|520938260|FG000|Overall Study|Lost to Follow-up|1|||
144474942|NCT00633932|520938261|FG001|Overall Study|Lost to Follow-up|0|||
144474943|NCT00633932|520938262|FG002|Overall Study|Lost to Follow-up|2|||
144474944|NCT00633932|520938260|FG000|Overall Study|Protocol Violation|5|||
144474945|NCT00633932|520938261|FG001|Overall Study|Protocol Violation|2|||
144474946|NCT00633932|520938262|FG002|Overall Study|Protocol Violation|3|||
144474947|NCT00633932|520938260|FG000|Overall Study|Physician Decision|0|||
144474948|NCT00633932|520938261|FG001|Overall Study|Physician Decision|0|||
144474949|NCT00633932|520938262|FG002|Overall Study|Physician Decision|1|||
144474950|NCT00633932|520938260|FG000|Overall Study|Doctor's judgement|1|||
144474951|NCT00633932|520938261|FG001|Overall Study|Doctor's judgement|0|||
144474952|NCT00633932|520938262|FG002|Overall Study|Doctor's judgement|0|||
144474953|NCT00633932|520938260|FG000|Overall Study|Moved Away|1|||
144474954|NCT00633932|520938261|FG001|Overall Study|Moved Away|0|||
144474955|NCT00633932|520938262|FG002|Overall Study|Moved Away|0|||
144474956|NCT00482274|520938263|FG000|Overall Study|Adverse Event|1|||
144474957|NCT04836858|520938264|FG000|Overall Study|Adverse Event|0|||
144474958|NCT04836858|520938265|FG001|Overall Study|Adverse Event|0|||
144474959|NCT04836858|520938266|FG002|Overall Study|Adverse Event|0|||
144474960|NCT04836858|520938267|FG003|Overall Study|Adverse Event|1|||
144474961|NCT04836858|520938264|FG000|Overall Study|Lost to Follow-up|1|||
144474962|NCT04836858|520938265|FG001|Overall Study|Lost to Follow-up|0|||
144474963|NCT04836858|520938266|FG002|Overall Study|Lost to Follow-up|0|||
144474964|NCT04836858|520938267|FG003|Overall Study|Lost to Follow-up|0|||
144474965|NCT04836858|520938264|FG000|Overall Study|Subject/Guardian decision|3|||
144474966|NCT04836858|520938265|FG001|Overall Study|Subject/Guardian decision|0|||
144474967|NCT04836858|520938266|FG002|Overall Study|Subject/Guardian decision|0|||
144474968|NCT04836858|520938267|FG003|Overall Study|Subject/Guardian decision|1|||
144474969|NCT04836858|520938264|FG000|Overall Study|Randomized but not treated|4|||
144474970|NCT04836858|520938265|FG001|Overall Study|Randomized but not treated|0|||
144474971|NCT04836858|520938266|FG002|Overall Study|Randomized but not treated|0|||
144474972|NCT04836858|520938267|FG003|Overall Study|Randomized but not treated|0|||
144474973|NCT04887948|520938271|FG000|Overall Study|Death|1|||
144474974|NCT04887948|520938272|FG001|Overall Study|Death|0|||
144474975|NCT04887948|520938273|FG002|Overall Study|Death|0|||
144474976|NCT04887948|520938271|FG000|Overall Study|Lost to Follow-up|1|||
144474977|NCT04887948|520938272|FG001|Overall Study|Lost to Follow-up|0|||
144474978|NCT04887948|520938273|FG002|Overall Study|Lost to Follow-up|3|||
144474979|NCT04887948|520938271|FG000|Overall Study|Physician Decision|0|||
144474980|NCT04887948|520938272|FG001|Overall Study|Physician Decision|4|||
144474981|NCT04887948|520938273|FG002|Overall Study|Physician Decision|1|||
144474982|NCT04887948|520938271|FG000|Overall Study|Protocol Violation|1|||
144474983|NCT04887948|520938272|FG001|Overall Study|Protocol Violation|1|||
144474984|NCT04887948|520938273|FG002|Overall Study|Protocol Violation|0|||
144474985|NCT04887948|520938271|FG000|Overall Study|Withdrawal by Subject|0|||
144474986|NCT04887948|520938272|FG001|Overall Study|Withdrawal by Subject|6|||
144474987|NCT04887948|520938273|FG002|Overall Study|Withdrawal by Subject|1|||
144474988|NCT04887948|520938271|FG000|Overall Study|No longer met eligibility criteria|1|||
144474989|NCT04887948|520938272|FG001|Overall Study|No longer met eligibility criteria|2|||
144474990|NCT04887948|520938273|FG002|Overall Study|No longer met eligibility criteria|1|||
144474991|NCT04887948|520938271|FG000|Overall Study|Other|2|||
144474992|NCT04887948|520938272|FG001|Overall Study|Other|1|||
144474993|NCT04887948|520938273|FG002|Overall Study|Other|1|||
144474994|NCT00787319|520938274|FG000|Overall Study|Lost to Follow-up|2|||
144474995|NCT00787319|520938274|FG000|Overall Study|Withdrawal by Subject|15|||
144474996|NCT00787319|520938274|FG000|Overall Study|Adverse Event|3|||
144474997|NCT00787319|520938274|FG000|Overall Study|Objective progression or relapse|30|||
144474998|NCT00787319|520938274|FG000|Overall Study|Lack of Efficacy|1|||
144474999|NCT00787319|520938274|FG000|Overall Study|Budget exhausted/exceeded|1|||
144475000|NCT00787319|520938274|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
144475001|NCT00787319|520938274|FG000|Overall Study|No health insurance reimbursement|2|||
144475002|NCT00787319|520938274|FG000|Overall Study|Stabilized disease findings|3|||
144475003|NCT00787319|520938274|FG000|Overall Study|Inactive disease|5|||
144475004|NCT02312856|520938275|FG000|Overall Study|Death|1|||
144475005|NCT02312856|520938275|FG000|Overall Study|Lost to Follow-up|3|||
144475006|NCT01932294|520938276|FG000|Overall Study|Death|43|||
144475007|NCT01932294|520938276|FG000|Overall Study|Lost to Follow-up|8|||
144475008|NCT01932294|520938276|FG000|Overall Study|VAD Implantation|20|||
144475009|NCT01932294|520938276|FG000|Overall Study|Heart Transplantation|16|||
144475010|NCT01932294|520938276|FG000|Overall Study|Transferred to other hospitals|12|||
144475011|NCT04415151|520938277|FG000|Overall Study|Death|1|||
144475012|NCT04415151|520938278|FG001|Overall Study|Death|1|||
144475013|NCT04415151|520938277|FG000|Overall Study|Withdrawal by Subject|1|||
144475014|NCT04415151|520938278|FG001|Overall Study|Withdrawal by Subject|0|||
144475015|NCT00638235|520938284|FG000|Overall Study|Lost to Follow-up|31|||
144475016|NCT00638235|520938285|FG001|Overall Study|Lost to Follow-up|3|||
144475017|NCT00638235|520938286|FG002|Overall Study|Lost to Follow-up|18|||
144475018|NCT00638235|520938287|FG003|Overall Study|Lost to Follow-up|10|||
144475019|NCT00638235|520938288|FG004|Overall Study|Lost to Follow-up|13|||
144475020|NCT00638235|520938289|FG005|Overall Study|Lost to Follow-up|26|||
144475021|NCT00638235|520938290|FG006|Overall Study|Lost to Follow-up|0|||
144475022|NCT00638235|520938291|FG007|Overall Study|Lost to Follow-up|1|||
144475023|NCT00638235|520938292|FG008|Overall Study|Lost to Follow-up|18|||
144475024|NCT01473381|520938297|FG000|Overall Study|Adverse Event|8|||
144475025|NCT01473381|520938298|FG001|Overall Study|Adverse Event|20|||
144475026|NCT01473381|520938299|FG002|Overall Study|Adverse Event|25|||
144475027|NCT01473381|520938300|FG003|Overall Study|Adverse Event|17|||
144475028|NCT01473381|520938297|FG000|Overall Study|Insufficient Therapeutic Response|10|||
144475029|NCT01473381|520938298|FG001|Overall Study|Insufficient Therapeutic Response|1|||
144475030|NCT01473381|520938299|FG002|Overall Study|Insufficient Therapeutic Response|2|||
144475031|NCT01473381|520938300|FG003|Overall Study|Insufficient Therapeutic Response|3|||
144475032|NCT01473381|520938297|FG000|Overall Study|Protocol Violation|17|||
144475033|NCT01473381|520938298|FG001|Overall Study|Protocol Violation|23|||
144475034|NCT01473381|520938299|FG002|Overall Study|Protocol Violation|19|||
144475035|NCT01473381|520938300|FG003|Overall Study|Protocol Violation|17|||
144475036|NCT01473381|520938297|FG000|Overall Study|Withdrawal of Consent|20|||
144475037|NCT01473381|520938298|FG001|Overall Study|Withdrawal of Consent|21|||
144475038|NCT01473381|520938299|FG002|Overall Study|Withdrawal of Consent|20|||
144475039|NCT01473381|520938300|FG003|Overall Study|Withdrawal of Consent|26|||
144475040|NCT01473381|520938297|FG000|Overall Study|Lost to Follow-up|25|||
144475041|NCT01473381|520938298|FG001|Overall Study|Lost to Follow-up|28|||
144475042|NCT01473381|520938299|FG002|Overall Study|Lost to Follow-up|35|||
144475043|NCT01473381|520938300|FG003|Overall Study|Lost to Follow-up|23|||
144475044|NCT01473381|520938297|FG000|Overall Study|Other Reasons|0|||
144475045|NCT01473381|520938298|FG001|Overall Study|Other Reasons|0|||
144475046|NCT01473381|520938299|FG002|Overall Study|Other Reasons|1|||
144475047|NCT01473381|520938300|FG003|Overall Study|Other Reasons|3|||
144475048|NCT00539643|520938301|FG000|Overall Study|Adverse Event|1|||
144475049|NCT00539643|520938302|FG001|Overall Study|Adverse Event|0|||
144475050|NCT00539643|520938301|FG000|Overall Study|Death|2|||
144475051|NCT00539643|520938302|FG001|Overall Study|Death|1|||
144475052|NCT00539643|520938301|FG000|Overall Study|Physician Decision|3|||
144475053|NCT00539643|520938302|FG001|Overall Study|Physician Decision|1|||
144475054|NCT00539643|520938301|FG000|Overall Study|Withdrawal by Subject|0|||
144475055|NCT00539643|520938302|FG001|Overall Study|Withdrawal by Subject|1|||
144475056|NCT02228395|520938303|FG000|First Intervention Period|No longer willing to participate|1|||
144475057|NCT02228395|520938304|FG001|First Intervention Period|No longer willing to participate|0|||
144475058|NCT02228395|520938305|FG002|First Intervention Period|No longer willing to participate|0|||
144475059|NCT02228395|520938303|FG000|First Intervention Period|Unable to comply with study dates|0|||
144475060|NCT02228395|520938304|FG001|First Intervention Period|Unable to comply with study dates|1|||
144475061|NCT02228395|520938305|FG002|First Intervention Period|Unable to comply with study dates|1|||
144475062|NCT02569437|520938309|FG000|Overall Study|Lost to Follow-up|12|||
144475063|NCT02569437|520938310|FG001|Overall Study|Lost to Follow-up|14|||
144475064|NCT02255357|520938311|FG000|Overall Study|Physician Decision|10|||
144475065|NCT02255357|520938312|FG001|Overall Study|Physician Decision|24|||
144475066|NCT01641926|520938313|FG000|Overall Study|Adverse Event|5|||
144475067|NCT01641926|520938314|FG001|Overall Study|Adverse Event|2|||
144475068|NCT01641926|520938315|FG002|Overall Study|Adverse Event|3|||
144475069|NCT01641926|520938316|FG003|Overall Study|Adverse Event|1|||
144475070|NCT01641926|520938313|FG000|Overall Study|Lost to Follow-up|2|||
144475071|NCT01641926|520938314|FG001|Overall Study|Lost to Follow-up|2|||
144475072|NCT01641926|520938315|FG002|Overall Study|Lost to Follow-up|1|||
144475073|NCT01641926|520938316|FG003|Overall Study|Lost to Follow-up|0|||
144475074|NCT01641926|520938313|FG000|Overall Study|Physician Decision|6|||
144475075|NCT01641926|520938314|FG001|Overall Study|Physician Decision|5|||
144475076|NCT01641926|520938315|FG002|Overall Study|Physician Decision|0|||
144475077|NCT01641926|520938316|FG003|Overall Study|Physician Decision|1|||
144475078|NCT01641926|520938313|FG000|Overall Study|Protocol Violation|1|||
144475079|NCT01641926|520938314|FG001|Overall Study|Protocol Violation|0|||
144475080|NCT01641926|520938315|FG002|Overall Study|Protocol Violation|0|||
144475081|NCT01641926|520938316|FG003|Overall Study|Protocol Violation|1|||
144475082|NCT01641926|520938313|FG000|Overall Study|Withdrawal by Subject|13|||
144475083|NCT01641926|520938314|FG001|Overall Study|Withdrawal by Subject|5|||
144475084|NCT01641926|520938315|FG002|Overall Study|Withdrawal by Subject|6|||
144475085|NCT01641926|520938316|FG003|Overall Study|Withdrawal by Subject|1|||
144475086|NCT01641926|520938313|FG000|Overall Study|Not Treated|1|||
144475087|NCT01641926|520938314|FG001|Overall Study|Not Treated|1|||
144475088|NCT01641926|520938315|FG002|Overall Study|Not Treated|1|||
144475089|NCT01641926|520938316|FG003|Overall Study|Not Treated|0|||
144475090|NCT01287520|520938317|FG000|Overall Study|Adverse Event|2|||
144475091|NCT01287520|520938318|FG001|Overall Study|Adverse Event|2|||
144475092|NCT01287520|520938319|FG002|Overall Study|Adverse Event|2|||
144475093|NCT01287520|520938320|FG003|Overall Study|Adverse Event|1|||
144475094|NCT01287520|520938321|FG004|Overall Study|Adverse Event|1|||
144475095|NCT01287520|520938322|FG005|Overall Study|Adverse Event|2|||
144475096|NCT01287520|520938323|FG006|Overall Study|Adverse Event|0|||
144475097|NCT01287520|520938324|FG007|Overall Study|Adverse Event|2|||
144475098|NCT01287520|520938325|FG008|Overall Study|Adverse Event|0|||
144475099|NCT01287520|520938317|FG000|Overall Study|Physician Decision|1|||
144475100|NCT01287520|520938318|FG001|Overall Study|Physician Decision|1|||
144475101|NCT01287520|520938319|FG002|Overall Study|Physician Decision|2|||
144475102|NCT01287520|520938320|FG003|Overall Study|Physician Decision|0|||
144475103|NCT01287520|520938321|FG004|Overall Study|Physician Decision|1|||
144475104|NCT01287520|520938322|FG005|Overall Study|Physician Decision|1|||
144475105|NCT01287520|520938323|FG006|Overall Study|Physician Decision|0|||
144475106|NCT01287520|520938324|FG007|Overall Study|Physician Decision|1|||
144475107|NCT01287520|520938325|FG008|Overall Study|Physician Decision|0|||
144475108|NCT01287520|520938317|FG000|Overall Study|Progressive disease|0|||
144475109|NCT01287520|520938318|FG001|Overall Study|Progressive disease|4|||
144475110|NCT01287520|520938319|FG002|Overall Study|Progressive disease|1|||
144475111|NCT01287520|520938320|FG003|Overall Study|Progressive disease|6|||
144475112|NCT01287520|520938321|FG004|Overall Study|Progressive disease|1|||
144475113|NCT01287520|520938322|FG005|Overall Study|Progressive disease|0|||
144475114|NCT01287520|520938323|FG006|Overall Study|Progressive disease|2|||
144475115|NCT01287520|520938324|FG007|Overall Study|Progressive disease|2|||
144475116|NCT01287520|520938325|FG008|Overall Study|Progressive disease|4|||
144475117|NCT01287520|520938317|FG000|Overall Study|Withdrawal by Subject|0|||
144475118|NCT01287520|520938318|FG001|Overall Study|Withdrawal by Subject|0|||
144475119|NCT01287520|520938319|FG002|Overall Study|Withdrawal by Subject|0|||
144475120|NCT01287520|520938320|FG003|Overall Study|Withdrawal by Subject|0|||
144475121|NCT01287520|520938321|FG004|Overall Study|Withdrawal by Subject|0|||
144475122|NCT01287520|520938322|FG005|Overall Study|Withdrawal by Subject|1|||
144475123|NCT01287520|520938323|FG006|Overall Study|Withdrawal by Subject|0|||
144475124|NCT01287520|520938324|FG007|Overall Study|Withdrawal by Subject|0|||
144475125|NCT01287520|520938325|FG008|Overall Study|Withdrawal by Subject|1|||
144475126|NCT03587142|520938326|FG000|Overall Study|Lost to Follow-up|5|||
144475127|NCT03587142|520938327|FG001|Overall Study|Lost to Follow-up|3|||
144475128|NCT03587142|520938326|FG000|Overall Study|Did not complete the f4 visit|3|||
144475129|NCT03587142|520938327|FG001|Overall Study|Did not complete the f4 visit|7|||
144475130|NCT03673462|520938328|FG000|Overall Study|Adverse Event|11|||
144475131|NCT03673462|520938329|FG001|Overall Study|Adverse Event|1|||
144475132|NCT03673462|520938328|FG000|Overall Study|Protocol Violation|25|||
144475133|NCT03673462|520938329|FG001|Overall Study|Protocol Violation|11|||
144475134|NCT03673462|520938328|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
144475135|NCT03673462|520938329|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
144475136|NCT03673462|520938328|FG000|Overall Study|Lost to Follow-up|102|||
144475137|NCT03673462|520938329|FG001|Overall Study|Lost to Follow-up|19|||
144475138|NCT02768662|520938330|FG000|Overall Study|Adverse Event|1|||
144475139|NCT02768662|520938330|FG000|Overall Study|Lost to Follow-up|4|||
144475140|NCT02768662|520938330|FG000|Overall Study|Withdrawal by Subject|3|||
144475141|NCT02768662|520938330|FG000|Overall Study|Study terminated by Sponsor|78|||
144475142|NCT01800201|520938331|FG000|Overall Study|Withdrawal by Subject|2|||
144475143|NCT01800201|520938332|FG001|Overall Study|Withdrawal by Subject|0|||
144475144|NCT01800201|520938331|FG000|Overall Study|patient privacy concerns|1|||
144475145|NCT01800201|520938332|FG001|Overall Study|patient privacy concerns|1|||
144475146|NCT01800201|520938331|FG000|Overall Study|did not want to use device|0|||
144475147|NCT01800201|520938332|FG001|Overall Study|did not want to use device|1|||
144475148|NCT01800201|520938331|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
144475149|NCT01800201|520938332|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
144475150|NCT00708435|520938333|FG000|Overall Study|Death / Serious Adverse Event|10|||
144475151|NCT00708435|520938334|FG001|Overall Study|Death / Serious Adverse Event|5|||
144475152|NCT00708435|520938333|FG000|Overall Study|Lost to Follow-up|9|||
144475153|NCT00708435|520938334|FG001|Overall Study|Lost to Follow-up|4|||
144475154|NCT00708435|520938333|FG000|Overall Study|Withdrawal by Subject|3|||
144475155|NCT00708435|520938334|FG001|Overall Study|Withdrawal by Subject|7|||
144475156|NCT00708435|520938333|FG000|Overall Study|Adverse Event|1|||
144475157|NCT00708435|520938334|FG001|Overall Study|Adverse Event|0|||
144475158|NCT00708435|520938333|FG000|Overall Study|Protocol Violation|0|||
144475159|NCT00708435|520938334|FG001|Overall Study|Protocol Violation|1|||
144475160|NCT00708435|520938333|FG000|Overall Study|Intervention by primary care physician|1|||
144475161|NCT00708435|520938334|FG001|Overall Study|Intervention by primary care physician|0|||
144475162|NCT00708435|520938333|FG000|Overall Study|Refused hospitalization|1|||
144475163|NCT00708435|520938334|FG001|Overall Study|Refused hospitalization|0|||
144475164|NCT05061537|520938342|FG000|Treatment Phase|Progressive disease|0|||
144475165|NCT05061537|520938343|FG001|Treatment Phase|Progressive disease|1|||
144360274|NCT00772538|520527435|FG000|Overall Study|Lost to Follow-up|1|||
144475166|NCT05061537|520938344|FG002|Treatment Phase|Progressive disease|2|||
144475167|NCT05061537|520938345|FG003|Treatment Phase|Progressive disease|0|||
144475168|NCT05061537|520938346|FG004|Treatment Phase|Progressive disease|0|||
144475169|NCT05061537|520938342|FG000|Treatment Phase|Adverse Event|0|||
144475170|NCT05061537|520938343|FG001|Treatment Phase|Adverse Event|0|||
144475171|NCT05061537|520938344|FG002|Treatment Phase|Adverse Event|2|||
144475172|NCT05061537|520938345|FG003|Treatment Phase|Adverse Event|0|||
144475173|NCT05061537|520938346|FG004|Treatment Phase|Adverse Event|0|||
144475174|NCT05061537|520938342|FG000|Treatment Phase|Global deterioration of health status|0|||
144475175|NCT05061537|520938343|FG001|Treatment Phase|Global deterioration of health status|1|||
144475176|NCT05061537|520938344|FG002|Treatment Phase|Global deterioration of health status|0|||
144475177|NCT05061537|520938345|FG003|Treatment Phase|Global deterioration of health status|0|||
144475178|NCT05061537|520938346|FG004|Treatment Phase|Global deterioration of health status|0|||
144475179|NCT05061537|520938342|FG000|Follow up|Other|2|||
144475180|NCT05061537|520938343|FG001|Follow up|Other|0|||
144475181|NCT05061537|520938344|FG002|Follow up|Other|2|||
144475182|NCT05061537|520938345|FG003|Follow up|Other|0|||
144475183|NCT05061537|520938346|FG004|Follow up|Other|0|||
144475184|NCT05061537|520938342|FG000|Follow up|Study terminated by sponsor|0|||
144475185|NCT05061537|520938343|FG001|Follow up|Study terminated by sponsor|0|||
144475186|NCT05061537|520938344|FG002|Follow up|Study terminated by sponsor|2|||
144475187|NCT05061537|520938345|FG003|Follow up|Study terminated by sponsor|0|||
144475188|NCT05061537|520938346|FG004|Follow up|Study terminated by sponsor|0|||
144475189|NCT05061537|520938342|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
144475190|NCT05061537|520938343|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
144475191|NCT05061537|520938344|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
144475192|NCT05061537|520938345|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
144475193|NCT05061537|520938346|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
144475194|NCT05061537|520938342|FG000|Long-term Follow-up|Death|0|||
144475195|NCT05061537|520938343|FG001|Long-term Follow-up|Death|1|||
144475196|NCT05061537|520938344|FG002|Long-term Follow-up|Death|0|||
144475197|NCT05061537|520938345|FG003|Long-term Follow-up|Death|0|||
144475198|NCT05061537|520938346|FG004|Long-term Follow-up|Death|0|||
144475199|NCT04503096|520938347|FG000|Overall Study|Withdrawal by Subject|3|||
144475200|NCT02343003|520938348|FG000|Overall Study|Withdrawal by Subject|9|||
144475201|NCT02343003|520938349|FG001|Overall Study|Withdrawal by Subject|4|||
144475202|NCT02343003|520938348|FG000|Overall Study|Lost to Follow-up|5|||
144475203|NCT02343003|520938349|FG001|Overall Study|Lost to Follow-up|1|||
144475204|NCT02343003|520938348|FG000|Overall Study|Protocol Violation|1|||
144475205|NCT02343003|520938349|FG001|Overall Study|Protocol Violation|0|||
144475206|NCT02343003|520938348|FG000|Overall Study|Death|0|||
144475207|NCT02343003|520938349|FG001|Overall Study|Death|1|||
144475208|NCT02343003|520938348|FG000|Overall Study|exclusion criteria met|1|||
144475209|NCT02343003|520938349|FG001|Overall Study|exclusion criteria met|1|||
144475210|NCT02343003|520938348|FG000|Overall Study|terminated by sponsor|2|||
144475211|NCT02343003|520938349|FG001|Overall Study|terminated by sponsor|0|||
144475212|NCT02635724|520938350|FG000|Overall Study|Withdrawal by Subject|0|||
144475213|NCT02635724|520938351|FG001|Overall Study|Withdrawal by Subject|1|||
144475214|NCT02635724|520938352|FG002|Overall Study|Withdrawal by Subject|0|||
144475215|NCT02281760|520938353|FG000|Overall Study|Withdrawal by Subject|1|||
144475216|NCT01576367|520938360|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144475217|NCT01576367|520938360|FG000|Overall Study|Moved to commercial use after 6 months|1|||
144475218|NCT02424591|520938361|FG000|Overall Study|Protocol Violation|2|||
144475219|NCT02424591|520938362|FG001|Overall Study|Protocol Violation|3|||
144475220|NCT00770432|520938363|FG000|Overall Study|Other|4|||
144475221|NCT00770432|520938364|FG001|Overall Study|Other|6|||
144475222|NCT00770432|520938363|FG000|Overall Study|Non-compliance|0|||
144475223|NCT00770432|520938364|FG001|Overall Study|Non-compliance|1|||
144475224|NCT00312702|520938365|FG000|Immunization Phase|Lost to Follow-up|0|||
144475225|NCT00312702|520938366|FG001|Immunization Phase|Lost to Follow-up|1|||
144475226|NCT00312702|520938367|FG002|Immunization Phase|Lost to Follow-up|0|||
144475227|NCT00988221|520938370|FG000|Part I|Adverse Event|0|||
144475228|NCT00988221|520938371|FG001|Part I|Adverse Event|1|||
144475229|NCT00988221|520938372|FG002|Part I|Adverse Event|2|||
144475230|NCT00988221|520938373|FG003|Part I|Adverse Event|0|||
144475231|NCT00988221|520938370|FG000|Part I|Insufficient Therapeutic Response|4|||
144475232|NCT00988221|520938371|FG001|Part I|Insufficient Therapeutic Response|6|||
144475233|NCT00988221|520938372|FG002|Part I|Insufficient Therapeutic Response|5|||
144475234|NCT00988221|520938373|FG003|Part I|Insufficient Therapeutic Response|0|||
144475235|NCT00988221|520938370|FG000|Part I|Refused Treatment|0|||
144475236|NCT00988221|520938371|FG001|Part I|Refused Treatment|2|||
144475237|NCT00988221|520938372|FG002|Part I|Refused Treatment|1|||
144475238|NCT00988221|520938373|FG003|Part I|Refused Treatment|0|||
144475239|NCT00988221|520938370|FG000|Part I|Lost to Follow-up|0|||
144475240|NCT00988221|520938371|FG001|Part I|Lost to Follow-up|1|||
144475241|NCT00988221|520938372|FG002|Part I|Lost to Follow-up|0|||
144475242|NCT00988221|520938373|FG003|Part I|Lost to Follow-up|0|||
144475243|NCT00988221|520938370|FG000|Part II|Adverse Event|1|||
144475244|NCT00988221|520938371|FG001|Part II|Adverse Event|0|||
144475245|NCT00988221|520938372|FG002|Part II|Adverse Event|0|||
144475246|NCT00988221|520938373|FG003|Part II|Adverse Event|1|||
144475247|NCT00988221|520938370|FG000|Part II|Withdrawal by Subject|0|||
144475248|NCT00988221|520938371|FG001|Part II|Withdrawal by Subject|0|||
144475249|NCT00988221|520938372|FG002|Part II|Withdrawal by Subject|2|||
144475250|NCT00988221|520938373|FG003|Part II|Withdrawal by Subject|2|||
144475251|NCT00988221|520938370|FG000|Part II|Reason not Specified|0|||
144475252|NCT00988221|520938371|FG001|Part II|Reason not Specified|0|||
144475253|NCT00988221|520938372|FG002|Part II|Reason not Specified|1|||
144475254|NCT00988221|520938373|FG003|Part II|Reason not Specified|0|||
144475255|NCT00988221|520938370|FG000|Part III|Adverse Event|1|||
144475256|NCT00988221|520938371|FG001|Part III|Adverse Event|0|||
144475257|NCT00988221|520938372|FG002|Part III|Adverse Event|1|||
144475258|NCT00988221|520938373|FG003|Part III|Adverse Event|0|||
144475259|NCT00988221|520938370|FG000|Part III|Insufficient Therapeutic Response|0|||
144475260|NCT00988221|520938371|FG001|Part III|Insufficient Therapeutic Response|1|||
144475261|NCT00988221|520938372|FG002|Part III|Insufficient Therapeutic Response|1|||
144475262|NCT00988221|520938373|FG003|Part III|Insufficient Therapeutic Response|0|||
144475263|NCT00988221|520938370|FG000|Part III|Refused Treatment|0|||
144475264|NCT00988221|520938371|FG001|Part III|Refused Treatment|0|||
144475265|NCT00988221|520938372|FG002|Part III|Refused Treatment|1|||
144475266|NCT00988221|520938373|FG003|Part III|Refused Treatment|0|||
144475267|NCT01453348|520938374|FG000|Overall Study|Death|0|||
144475268|NCT01453348|520938375|FG001|Overall Study|Death|0|||
144475269|NCT01453348|520938376|FG002|Overall Study|Death|1|||
144475270|NCT01453348|520938374|FG000|Overall Study|Withdrawal by Subject|0|||
144475271|NCT01453348|520938375|FG001|Overall Study|Withdrawal by Subject|1|||
144475272|NCT01453348|520938376|FG002|Overall Study|Withdrawal by Subject|0|||
144475273|NCT01453348|520938374|FG000|Overall Study|Protocol Violation|1|||
144475274|NCT01453348|520938375|FG001|Overall Study|Protocol Violation|0|||
144475275|NCT01453348|520938376|FG002|Overall Study|Protocol Violation|0|||
144475276|NCT00954733|520938384|FG000|Overall Study|blood gas machine did not work|1|||
144475277|NCT03579290|520938385|FG000|Overall Study|Lost to Follow-up|9|||
144475278|NCT00605319|520940252|FG000|Overall Study|Adverse Event|6|||
144475279|NCT02991482|520940253|FG000|Overall Study|Disease progression|56|||
144475280|NCT02991482|520940254|FG001|Overall Study|Disease progression|47|||
144475281|NCT02991482|520940253|FG000|Overall Study|Death|4|||
144475282|NCT02991482|520940254|FG001|Overall Study|Death|4|||
144475283|NCT02991482|520940253|FG000|Overall Study|Adverse Event|1|||
144475284|NCT02991482|520940254|FG001|Overall Study|Adverse Event|6|||
144475285|NCT02991482|520940253|FG000|Overall Study|Patient decision|1|||
144475286|NCT02991482|520940254|FG001|Overall Study|Patient decision|1|||
144475287|NCT02991482|520940253|FG000|Overall Study|Physician Decision|0|||
144475288|NCT02991482|520940254|FG001|Overall Study|Physician Decision|6|||
144475289|NCT02991482|520940253|FG000|Overall Study|Clinical deterioration|1|||
144475290|NCT02991482|520940254|FG001|Overall Study|Clinical deterioration|0|||
144475291|NCT02991482|520940253|FG000|Overall Study|Patient feeling too unwell|1|||
144475292|NCT02991482|520940254|FG001|Overall Study|Patient feeling too unwell|0|||
144475293|NCT02991482|520940253|FG000|Overall Study|Worsening of performance status|0|||
144475294|NCT02991482|520940254|FG001|Overall Study|Worsening of performance status|1|||
144475295|NCT02991482|520940253|FG000|Overall Study|Death prior to study drug initiation|1|||
144475296|NCT02991482|520940254|FG001|Overall Study|Death prior to study drug initiation|0|||
144475297|NCT02991482|520940253|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
144475298|NCT02991482|520940254|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
144475299|NCT02110732|520940256|FG000|Overall Study|Physician Decision|5|||
144475300|NCT02110732|520940257|FG001|Overall Study|Physician Decision|2|||
144475301|NCT02110732|520940256|FG000|Overall Study|Lost to Follow-up|1|||
144475302|NCT02110732|520940257|FG001|Overall Study|Lost to Follow-up|1|||
144475303|NCT01691521|520940258|FG000|Overall Study|Adverse Event|4|||
144475304|NCT01691521|520940259|FG001|Overall Study|Adverse Event|0|||
144475305|NCT01691521|520940260|FG002|Overall Study|Adverse Event|1|||
144475306|NCT01691521|520940258|FG000|Overall Study|Lack of Efficacy|1|||
144475307|NCT01691521|520940259|FG001|Overall Study|Lack of Efficacy|1|||
144475308|NCT01691521|520940260|FG002|Overall Study|Lack of Efficacy|2|||
144475309|NCT01691521|520940258|FG000|Overall Study|Protocol Violation|0|||
144475310|NCT01691521|520940259|FG001|Overall Study|Protocol Violation|3|||
144475311|NCT01691521|520940260|FG002|Overall Study|Protocol Violation|0|||
144475312|NCT01691521|520940258|FG000|Overall Study|Lost to Follow-up|0|||
144475313|NCT01691521|520940259|FG001|Overall Study|Lost to Follow-up|2|||
144475314|NCT01691521|520940260|FG002|Overall Study|Lost to Follow-up|2|||
144475315|NCT01691521|520940258|FG000|Overall Study|Physician Decision|2|||
144475316|NCT01691521|520940259|FG001|Overall Study|Physician Decision|1|||
144475317|NCT01691521|520940260|FG002|Overall Study|Physician Decision|0|||
144475318|NCT01691521|520940258|FG000|Overall Study|Withdrawal by Subject|5|||
144475319|NCT01691521|520940259|FG001|Overall Study|Withdrawal by Subject|9|||
144475320|NCT01691521|520940260|FG002|Overall Study|Withdrawal by Subject|4|||
144475321|NCT01480596|520940263|FG000|Overall Study|Adverse Event|3|||
144475322|NCT01480596|520940264|FG001|Overall Study|Adverse Event|0|||
144475323|NCT01480596|520940263|FG000|Overall Study|MG exacerbation or change in medication|2|||
144475324|NCT01480596|520940264|FG001|Overall Study|MG exacerbation or change in medication|2|||
144475325|NCT01153269|520940265|FG000|Overall Study|Withdrawal by Subject|1|||
144475326|NCT01153269|520940265|FG000|Overall Study|Antiretroviral therapy break|1|||
144475327|NCT00100932|520940266|FG000|Overall Study|Adverse Event|11|||
144475328|NCT00100932|520940267|FG001|Overall Study|Adverse Event|2|||
144475329|NCT00100932|520940266|FG000|Overall Study|Withdrawal by Subject|6|||
144475330|NCT00100932|520940267|FG001|Overall Study|Withdrawal by Subject|0|||
144475331|NCT00100932|520940266|FG000|Overall Study|Progressive Disease|44|||
144475332|NCT00100932|520940267|FG001|Overall Study|Progressive Disease|18|||
144475333|NCT00100932|520940266|FG000|Overall Study|Physician Decision|7|||
144475334|NCT00100932|520940267|FG001|Overall Study|Physician Decision|5|||
144475335|NCT00100932|520940266|FG000|Overall Study|Other|5|||
144475336|NCT00100932|520940267|FG001|Overall Study|Other|2|||
144475337|NCT02756832|520940268|FG000|Overall Study|Lost for Observation after Baseline|6|||
144475338|NCT02756832|520940268|FG000|Overall Study|Lost for Observation|13|||
144475339|NCT02756832|520940268|FG000|Overall Study|Patient's Unwillingness|12|||
144475340|NCT02756832|520940268|FG000|Overall Study|Insufficient Efficacy|2|||
144475341|NCT02756832|520940268|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
144475342|NCT02756832|520940268|FG000|Overall Study|Reason not Specified|9|||
144475343|NCT02756832|520940268|FG000|Overall Study|Protocol Deviation|10|||
144475344|NCT04359771|520940269|FG000|Overall Study|Lack of Efficacy|2|||
144475345|NCT04359771|520940270|FG001|Overall Study|Lack of Efficacy|2|||
144475346|NCT03592277|520940273|FG000|Overall Study|Withdrawal by Subject|6|||
144475347|NCT03592277|520940274|FG001|Overall Study|Withdrawal by Subject|8|||
144475348|NCT01346514|520940275|FG000|Overall Study|Lost to Follow-up|19|||
144475349|NCT01346514|520940276|FG001|Overall Study|Lost to Follow-up|30|||
144475350|NCT01346514|520940275|FG000|Overall Study|Withdrawal by Subject|7|||
144475351|NCT01346514|520940276|FG001|Overall Study|Withdrawal by Subject|3|||
144475352|NCT01346514|520940275|FG000|Overall Study|Death|3|||
144475353|NCT01346514|520940276|FG001|Overall Study|Death|4|||
144475354|NCT00909480|520940277|FG000|Overall Study|Adverse Event|5|||
144475355|NCT00909480|520940278|FG001|Overall Study|Adverse Event|3|||
144475356|NCT00909480|520940277|FG000|Overall Study|Protocol Violation|6|||
144475357|NCT00909480|520940278|FG001|Overall Study|Protocol Violation|8|||
144475358|NCT00909480|520940277|FG000|Overall Study|Withdrawal criteria|9|||
144475359|NCT00909480|520940278|FG001|Overall Study|Withdrawal criteria|11|||
144475360|NCT00909480|520940277|FG000|Overall Study|Unclassified|18|||
144475361|NCT00909480|520940278|FG001|Overall Study|Unclassified|19|||
144475362|NCT03528174|520940288|FG000|Overall Study|Adverse Event|1|||
144475363|NCT03528174|520940288|FG000|Overall Study|sensors dislodged|1|||
144475364|NCT03002038|520940289|FG000|Overall Study|Adverse Event|3|||
144475365|NCT03002038|520940290|FG001|Overall Study|Adverse Event|1|||
144475366|NCT03002038|520940289|FG000|Overall Study|Withdrawal by Subject|8|||
144475367|NCT03002038|520940290|FG001|Overall Study|Withdrawal by Subject|4|||
144475368|NCT03002038|520940289|FG000|Overall Study|Immigration to another region|0|||
144475369|NCT03002038|520940290|FG001|Overall Study|Immigration to another region|2|||
144475370|NCT00979602|520940299|FG000|Overall Study|Serious Adverse Event|5|||
144475371|NCT00979602|520940300|FG001|Overall Study|Serious Adverse Event|3|||
144475372|NCT00979602|520940299|FG000|Overall Study|Protocol Violation|3|||
144475373|NCT00979602|520940300|FG001|Overall Study|Protocol Violation|0|||
144475374|NCT00979602|520940299|FG000|Overall Study|Withdrawal by Subject|31|||
144475375|NCT00979602|520940300|FG001|Overall Study|Withdrawal by Subject|25|||
144475376|NCT00979602|520940299|FG000|Overall Study|Lost to Follow-up|100|||
144475377|NCT00979602|520940300|FG001|Overall Study|Lost to Follow-up|96|||
144475378|NCT00979602|520940299|FG000|Overall Study|Migrated/moved from study area|3|||
144475379|NCT00979602|520940300|FG001|Overall Study|Migrated/moved from study area|6|||
144475380|NCT00979602|520940299|FG000|Overall Study|Others|3|||
144475381|NCT00979602|520940300|FG001|Overall Study|Others|3|||
144475382|NCT02904902|520940301|FG000|Overall Study|Withdrawal by Subject|1|||
144475383|NCT02712398|520940305|FG000|Overall Study|Withdrawal by Subject|6|||
144475384|NCT02712398|520940305|FG000|Overall Study|Lost to Follow-up|6|||
144475385|NCT02712398|520940305|FG000|Overall Study|Sponsor Decision|1|||
144475386|NCT02712398|520940305|FG000|Overall Study|Physician Decision|1|||
144475387|NCT02712398|520940305|FG000|Overall Study|Death|2|||
144475388|NCT02712398|520940305|FG000|Overall Study|Re-operation|21|||
144475389|NCT01725386|520940307|FG000|Overall Study|Death|84|||
144475390|NCT01725386|520940308|FG001|Overall Study|Death|40|||
144475391|NCT01725386|520940307|FG000|Overall Study|Lost to Follow-up|81|||
144475392|NCT01725386|520940308|FG001|Overall Study|Lost to Follow-up|6|||
144475393|NCT01725386|520940307|FG000|Overall Study|Withdrawal by Subject|10|||
144475394|NCT01725386|520940308|FG001|Overall Study|Withdrawal by Subject|0|||
144475395|NCT00879996|520940316|FG000|Overall Study|Lost to Follow-up|7|||
144475396|NCT00879996|520940317|FG001|Overall Study|Lost to Follow-up|6|||
144475397|NCT00879996|520940316|FG000|Overall Study|non-compliance|6|||
144475398|NCT00879996|520940317|FG001|Overall Study|non-compliance|4|||
144475399|NCT00879996|520940316|FG000|Overall Study|Physician Decision|1|||
144475400|NCT00879996|520940317|FG001|Overall Study|Physician Decision|2|||
144475401|NCT00879996|520940316|FG000|Overall Study|psychiatric problem|0|||
144475402|NCT00879996|520940317|FG001|Overall Study|psychiatric problem|1|||
144475403|NCT00879996|520940316|FG000|Overall Study|put on parole|1|||
144475404|NCT00879996|520940317|FG001|Overall Study|put on parole|0|||
144475405|NCT02002182|520940326|FG000|Overall Study|Withdraw from study|3|||
144475406|NCT02002182|520940327|FG001|Overall Study|Withdraw from study|1|||
144475407|NCT02002182|520940326|FG000|Overall Study|Health Reasons|1|||
144475408|NCT02002182|520940327|FG001|Overall Study|Health Reasons|0|||
144475409|NCT02002182|520940326|FG000|Overall Study|Death|1|||
144475410|NCT02002182|520940327|FG001|Overall Study|Death|0|||
144475411|NCT04772053|520940332|FG000|Overall Study|Physician Decision|2|||
144475412|NCT04772053|520940332|FG000|Overall Study|Withdrawal by Subject|3|||
144475413|NCT04772053|520940332|FG000|Overall Study|Study Terminated by Sponsor|1|||
144475414|NCT04146896|520940333|FG000|Overall Study|Adverse Event|5|||
144475415|NCT04146896|520940334|FG001|Overall Study|Adverse Event|8|||
144475416|NCT04146896|520940333|FG000|Overall Study|Lack of Efficacy|3|||
144475417|NCT04146896|520940334|FG001|Overall Study|Lack of Efficacy|2|||
144475418|NCT04146896|520940333|FG000|Overall Study|Lost to Follow-up|0|||
144475419|NCT04146896|520940334|FG001|Overall Study|Lost to Follow-up|1|||
144475420|NCT04146896|520940333|FG000|Overall Study|Non-compliance|5|||
144475421|NCT04146896|520940334|FG001|Overall Study|Non-compliance|4|||
144475422|NCT04146896|520940333|FG000|Overall Study|Withdrawal by Subject|3|||
144475423|NCT04146896|520940334|FG001|Overall Study|Withdrawal by Subject|5|||
144475424|NCT04146896|520940333|FG000|Overall Study|Randomized in error|1|||
144475425|NCT04146896|520940334|FG001|Overall Study|Randomized in error|2|||
144475426|NCT02118337|520940335|FG000|Overall Study|Other|1|||
144475427|NCT02118337|520940336|FG001|Overall Study|Other|0|||
144475428|NCT02118337|520940337|FG002|Overall Study|Other|0|||
144475429|NCT02118337|520940338|FG003|Overall Study|Other|0|||
144475430|NCT02118337|520940339|FG004|Overall Study|Other|2|||
144475431|NCT02118337|520940340|FG005|Overall Study|Other|3|||
144475432|NCT02118337|520940341|FG006|Overall Study|Other|1|||
144475433|NCT02118337|520940342|FG007|Overall Study|Other|28|||
144475434|NCT02118337|520940343|FG008|Overall Study|Other|15|||
144475435|NCT02118337|520940335|FG000|Overall Study|Lost to Follow-up|0|||
144475436|NCT02118337|520940336|FG001|Overall Study|Lost to Follow-up|0|||
144475437|NCT02118337|520940337|FG002|Overall Study|Lost to Follow-up|0|||
144475438|NCT02118337|520940338|FG003|Overall Study|Lost to Follow-up|0|||
144475439|NCT02118337|520940339|FG004|Overall Study|Lost to Follow-up|0|||
144475440|NCT02118337|520940340|FG005|Overall Study|Lost to Follow-up|0|||
144475441|NCT02118337|520940341|FG006|Overall Study|Lost to Follow-up|0|||
144475442|NCT02118337|520940342|FG007|Overall Study|Lost to Follow-up|1|||
144475443|NCT02118337|520940343|FG008|Overall Study|Lost to Follow-up|0|||
144475444|NCT02118337|520940335|FG000|Overall Study|Withdrawal by Subject|1|||
144475445|NCT02118337|520940336|FG001|Overall Study|Withdrawal by Subject|3|||
144475446|NCT02118337|520940337|FG002|Overall Study|Withdrawal by Subject|2|||
144475447|NCT02118337|520940338|FG003|Overall Study|Withdrawal by Subject|1|||
144475448|NCT02118337|520940339|FG004|Overall Study|Withdrawal by Subject|2|||
144475449|NCT02118337|520940340|FG005|Overall Study|Withdrawal by Subject|2|||
144475450|NCT02118337|520940341|FG006|Overall Study|Withdrawal by Subject|1|||
144475451|NCT02118337|520940342|FG007|Overall Study|Withdrawal by Subject|4|||
144475452|NCT02118337|520940343|FG008|Overall Study|Withdrawal by Subject|2|||
144475453|NCT02118337|520940335|FG000|Overall Study|Death|2|||
144475454|NCT02118337|520940336|FG001|Overall Study|Death|2|||
144475455|NCT02118337|520940337|FG002|Overall Study|Death|1|||
144475456|NCT02118337|520940338|FG003|Overall Study|Death|2|||
144475457|NCT02118337|520940339|FG004|Overall Study|Death|5|||
144475458|NCT02118337|520940340|FG005|Overall Study|Death|1|||
144475459|NCT02118337|520940341|FG006|Overall Study|Death|2|||
144475460|NCT02118337|520940342|FG007|Overall Study|Death|9|||
144475461|NCT02118337|520940343|FG008|Overall Study|Death|4|||
144475462|NCT04296890|520940345|FG000|Overall Study|Withdrawal by Subject|1|||
144475463|NCT04296890|520940345|FG000|Overall Study|Death|62|||
144475464|NCT04296890|520940345|FG000|Overall Study|Lost to Follow-up|3|||
144475465|NCT04296890|520940345|FG000|Overall Study|Other than specified|2|||
144475466|NCT03787680|520940346|FG000|Overall Study|Physician Decision|2|||
144475467|NCT03787680|520940347|FG001|Overall Study|Physician Decision|3|||
144475468|NCT03787680|520940346|FG000|Overall Study|Adverse Event|7|||
144475469|NCT03787680|520940347|FG001|Overall Study|Adverse Event|3|||
144475470|NCT03787680|520940346|FG000|Overall Study|Withdrawal by Subject|2|||
144475471|NCT03787680|520940347|FG001|Overall Study|Withdrawal by Subject|1|||
144475472|NCT05400746|520940348|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
144475473|NCT05400746|520940349|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
144475474|NCT05400746|520940350|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
144475475|NCT03724396|520940353|FG000|Overall Study|Lost to Follow-up|1|||
144475476|NCT03724396|520940354|FG001|Overall Study|Lost to Follow-up|1|||
144475477|NCT03724396|520940353|FG000|Overall Study|Withdrawal by Subject|1|||
144475478|NCT03724396|520940354|FG001|Overall Study|Withdrawal by Subject|0|||
144475479|NCT01490125|520940355|FG000|Period I|Adverse Event|4|||
144475480|NCT01490125|520940356|FG001|Period I|Adverse Event|1|||
144475481|NCT01490125|520940357|FG002|Period I|Adverse Event|1|||
144475482|NCT01490125|520940358|FG003|Period I|Adverse Event|3|||
144475483|NCT01490125|520940359|FG004|Period I|Adverse Event|2|||
144475484|NCT01490125|520940360|FG005|Period I|Adverse Event|4|||
144475485|NCT01490125|520940355|FG000|Period I|Protocol Violation|1|||
144475486|NCT01490125|520940356|FG001|Period I|Protocol Violation|1|||
144475487|NCT01490125|520940357|FG002|Period I|Protocol Violation|1|||
144475488|NCT01490125|520940358|FG003|Period I|Protocol Violation|1|||
144475489|NCT01490125|520940359|FG004|Period I|Protocol Violation|0|||
144475490|NCT01490125|520940360|FG005|Period I|Protocol Violation|0|||
144475491|NCT01490125|520940355|FG000|Period I|Withdrawal by Subject|1|||
144475492|NCT01490125|520940356|FG001|Period I|Withdrawal by Subject|3|||
144475493|NCT01490125|520940357|FG002|Period I|Withdrawal by Subject|2|||
144475494|NCT01490125|520940358|FG003|Period I|Withdrawal by Subject|1|||
144475495|NCT01490125|520940359|FG004|Period I|Withdrawal by Subject|2|||
144475496|NCT01490125|520940360|FG005|Period I|Withdrawal by Subject|1|||
144475497|NCT01490125|520940355|FG000|Period II|Adverse Event|2|||
144475498|NCT01490125|520940356|FG001|Period II|Adverse Event|3|||
144475499|NCT01490125|520940357|FG002|Period II|Adverse Event|2|||
144475500|NCT01490125|520940358|FG003|Period II|Adverse Event|2|||
144475501|NCT01490125|520940359|FG004|Period II|Adverse Event|4|||
144475502|NCT01490125|520940360|FG005|Period II|Adverse Event|2|||
144475503|NCT01490125|520940355|FG000|Period II|Protocol Violation|0|||
144475504|NCT01490125|520940356|FG001|Period II|Protocol Violation|0|||
144475505|NCT01490125|520940357|FG002|Period II|Protocol Violation|1|||
144475506|NCT01490125|520940358|FG003|Period II|Protocol Violation|1|||
144475507|NCT01490125|520940359|FG004|Period II|Protocol Violation|0|||
144475508|NCT01490125|520940360|FG005|Period II|Protocol Violation|0|||
144475509|NCT01490125|520940355|FG000|Period II|Lost to Follow-up|0|||
144475510|NCT01490125|520940356|FG001|Period II|Lost to Follow-up|1|||
144475511|NCT01490125|520940357|FG002|Period II|Lost to Follow-up|0|||
144475512|NCT01490125|520940358|FG003|Period II|Lost to Follow-up|0|||
144475513|NCT01490125|520940359|FG004|Period II|Lost to Follow-up|0|||
144475514|NCT01490125|520940360|FG005|Period II|Lost to Follow-up|0|||
144475515|NCT01490125|520940355|FG000|Period II|Withdrawal by Subject|1|||
144475516|NCT01490125|520940356|FG001|Period II|Withdrawal by Subject|0|||
144475517|NCT01490125|520940357|FG002|Period II|Withdrawal by Subject|0|||
144475518|NCT01490125|520940358|FG003|Period II|Withdrawal by Subject|0|||
144475519|NCT01490125|520940359|FG004|Period II|Withdrawal by Subject|0|||
144475520|NCT01490125|520940360|FG005|Period II|Withdrawal by Subject|0|||
144475521|NCT01490125|520940355|FG000|Period III|Adverse Event|3|||
144475522|NCT01490125|520940356|FG001|Period III|Adverse Event|1|||
144475523|NCT01490125|520940357|FG002|Period III|Adverse Event|0|||
144475524|NCT01490125|520940358|FG003|Period III|Adverse Event|1|||
144475525|NCT01490125|520940359|FG004|Period III|Adverse Event|0|||
144475526|NCT01490125|520940360|FG005|Period III|Adverse Event|0|||
144475527|NCT01490125|520940355|FG000|Period III|Death|0|||
144475528|NCT01490125|520940356|FG001|Period III|Death|0|||
144475529|NCT01490125|520940357|FG002|Period III|Death|0|||
144475530|NCT01490125|520940358|FG003|Period III|Death|1|||
144475531|NCT01490125|520940359|FG004|Period III|Death|0|||
144475532|NCT01490125|520940360|FG005|Period III|Death|0|||
144475533|NCT01490125|520940355|FG000|Period III|Lack of Efficacy|0|||
144475534|NCT01490125|520940356|FG001|Period III|Lack of Efficacy|0|||
144475535|NCT01490125|520940357|FG002|Period III|Lack of Efficacy|0|||
144475536|NCT01490125|520940358|FG003|Period III|Lack of Efficacy|0|||
144475537|NCT01490125|520940359|FG004|Period III|Lack of Efficacy|1|||
144475538|NCT01490125|520940360|FG005|Period III|Lack of Efficacy|0|||
144475539|NCT02237508|520940361|FG000|Overall Study|Withdrawal by Subject|0|||
144475540|NCT02237508|520940362|FG001|Overall Study|Withdrawal by Subject|2|||
144475541|NCT02237508|520940363|FG002|Overall Study|Withdrawal by Subject|0|||
144475542|NCT02237508|520940364|FG003|Overall Study|Withdrawal by Subject|1|||
144475543|NCT02237508|520940365|FG004|Overall Study|Withdrawal by Subject|0|||
144475544|NCT02237508|520940366|FG005|Overall Study|Withdrawal by Subject|1|||
144475545|NCT02237508|520940367|FG006|Overall Study|Withdrawal by Subject|1|||
144475546|NCT02237508|520940368|FG007|Overall Study|Withdrawal by Subject|0|||
144475547|NCT02237508|520940369|FG008|Overall Study|Withdrawal by Subject|1|||
144475548|NCT02237508|520940370|FG009|Overall Study|Withdrawal by Subject|0|||
144475549|NCT02237508|520940361|FG000|Overall Study|Physician Decision|0|||
144475550|NCT02237508|520940362|FG001|Overall Study|Physician Decision|1|||
144475551|NCT02237508|520940363|FG002|Overall Study|Physician Decision|0|||
144475552|NCT02237508|520940364|FG003|Overall Study|Physician Decision|0|||
144475553|NCT02237508|520940365|FG004|Overall Study|Physician Decision|0|||
144475554|NCT02237508|520940366|FG005|Overall Study|Physician Decision|0|||
144475555|NCT02237508|520940367|FG006|Overall Study|Physician Decision|0|||
144475556|NCT02237508|520940368|FG007|Overall Study|Physician Decision|0|||
144475557|NCT02237508|520940369|FG008|Overall Study|Physician Decision|0|||
144475558|NCT02237508|520940370|FG009|Overall Study|Physician Decision|0|||
144475559|NCT02237508|520940361|FG000|Overall Study|Protocol Violation|0|||
144475560|NCT02237508|520940362|FG001|Overall Study|Protocol Violation|0|||
144475561|NCT02237508|520940363|FG002|Overall Study|Protocol Violation|1|||
144475562|NCT02237508|520940364|FG003|Overall Study|Protocol Violation|0|||
144475563|NCT02237508|520940365|FG004|Overall Study|Protocol Violation|0|||
144475564|NCT02237508|520940366|FG005|Overall Study|Protocol Violation|0|||
144475565|NCT02237508|520940367|FG006|Overall Study|Protocol Violation|0|||
144475566|NCT02237508|520940368|FG007|Overall Study|Protocol Violation|0|||
144475567|NCT02237508|520940369|FG008|Overall Study|Protocol Violation|0|||
144475568|NCT02237508|520940370|FG009|Overall Study|Protocol Violation|0|||
144475569|NCT04000594|520940371|FG000|Overall Study|Withdrawal by Subject|1|||
144475570|NCT04000594|520940372|FG001|Overall Study|Withdrawal by Subject|0|||
144475571|NCT04000594|520940373|FG002|Overall Study|Withdrawal by Subject|0|||
144475572|NCT04522180|520940374|FG000|Overall Study|Investigator judgement|3|||
144475573|NCT04522180|520940375|FG001|Overall Study|Investigator judgement|4|||
144475574|NCT04522180|520940374|FG000|Overall Study|Voluntary withdrawal|1|||
144475575|NCT04522180|520940375|FG001|Overall Study|Voluntary withdrawal|0|||
144475576|NCT04522180|520940374|FG000|Overall Study|Pregnancy|0|||
144475577|NCT04522180|520940375|FG001|Overall Study|Pregnancy|1|||
144475578|NCT04522180|520940374|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
144475579|NCT04522180|520940375|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
144475580|NCT04522180|520940374|FG000|Overall Study|Reason not specified|8|||
144475581|NCT04522180|520940375|FG001|Overall Study|Reason not specified|5|||
144475582|NCT05807919|520940376|FG000|Overall Study|Received antibiotics - excluded|0|||
144475583|NCT05807919|520940377|FG001|Overall Study|Received antibiotics - excluded|1|||
144475584|NCT05807919|520940376|FG000|Overall Study|Withdrawal by Subject|0|||
144475585|NCT05807919|520940377|FG001|Overall Study|Withdrawal by Subject|3|||
144475586|NCT05807919|520940376|FG000|Overall Study|Adverse Event|1|||
144475587|NCT05807919|520940377|FG001|Overall Study|Adverse Event|1|||
144475588|NCT01905046|520940378|FG000|Months 13-24|Withdrawal by Subject|10|||
144475589|NCT01905046|520940379|FG001|Months 13-24|Withdrawal by Subject|10|||
144475590|NCT01905046|520940378|FG000|Months 13-24|Adverse Event|3|||
144475591|NCT01905046|520940379|FG001|Months 13-24|Adverse Event|2|||
144475592|NCT01905046|520940378|FG000|Months 13-24|Protocol Violation|3|||
144475593|NCT01905046|520940379|FG001|Months 13-24|Protocol Violation|3|||
144475594|NCT01905046|520940378|FG000|Months 13-24|Physician Decision|1|||
144475595|NCT01905046|520940379|FG001|Months 13-24|Physician Decision|0|||
144475596|NCT03635489|520940384|FG000|Overall Study|Death|19|||
144475597|NCT03635489|520940385|FG001|Overall Study|Death|13|||
144475598|NCT03635489|520940384|FG000|Overall Study|Lost to Follow-up|1|||
144475599|NCT03635489|520940385|FG001|Overall Study|Lost to Follow-up|2|||
144475600|NCT03635489|520940384|FG000|Overall Study|Withdrawal by Subject|1|||
144475601|NCT03635489|520940385|FG001|Overall Study|Withdrawal by Subject|2|||
144475602|NCT03635489|520940384|FG000|Overall Study|Study Ended by Sponsor|28|||
144475603|NCT03635489|520940385|FG001|Overall Study|Study Ended by Sponsor|34|||
144475604|NCT00943306|520940396|FG000|Overall Study|Physician Decision|1|||
144475605|NCT00943306|520940396|FG000|Overall Study|Death|1|||
144475606|NCT00943306|520940396|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
144475607|NCT00733980|520940397|FG000|Overall Study|Adverse Event|5|||
144475608|NCT00733980|520940398|FG001|Overall Study|Adverse Event|2|||
144475609|NCT00733980|520940397|FG000|Overall Study|Lack of Efficacy|0|||
144475610|NCT00733980|520940398|FG001|Overall Study|Lack of Efficacy|1|||
144475611|NCT00733980|520940397|FG000|Overall Study|Protocol Violation|2|||
144475612|NCT00733980|520940398|FG001|Overall Study|Protocol Violation|1|||
144475613|NCT00733980|520940397|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
144475614|NCT00733980|520940398|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
144475615|NCT00733980|520940397|FG000|Overall Study|Lost to Follow-up|6|||
144475616|NCT00733980|520940398|FG001|Overall Study|Lost to Follow-up|11|||
144475617|NCT00733980|520940397|FG000|Overall Study|Physician Decision|2|||
144475618|NCT00733980|520940398|FG001|Overall Study|Physician Decision|3|||
144475619|NCT00733980|520940397|FG000|Overall Study|Withdrawal by Subject|6|||
144475620|NCT00733980|520940398|FG001|Overall Study|Withdrawal by Subject|2|||
144475621|NCT01552954|520940399|FG000|Overall Study|Adverse Event|1|||
144475622|NCT01552954|520940400|FG001|Overall Study|Adverse Event|2|||
144475623|NCT01552954|520940399|FG000|Overall Study|Lost to Follow-up|1|||
144475624|NCT01552954|520940400|FG001|Overall Study|Lost to Follow-up|1|||
144475625|NCT01552954|520940399|FG000|Overall Study|Withdrawal by Subject|1|||
144475626|NCT01552954|520940400|FG001|Overall Study|Withdrawal by Subject|1|||
144475627|NCT01552954|520940399|FG000|Overall Study|Protocol Violation|1|||
144475628|NCT01552954|520940400|FG001|Overall Study|Protocol Violation|2|||
144475629|NCT01552954|520940399|FG000|Overall Study|diagnosed DM|1|||
144475630|NCT01552954|520940400|FG001|Overall Study|diagnosed DM|0|||
144475631|NCT01931735|520940402|FG000|Randomized Phase|Lost to Follow-up|2|||
144475632|NCT01931735|520940403|FG001|Randomized Phase|Lost to Follow-up|2|||
144475633|NCT01931735|520940404|FG002|Randomized Phase|Lost to Follow-up|5|||
144475634|NCT01931735|520940405|FG003|Randomized Phase|Lost to Follow-up|0|||
144475635|NCT01931735|520940402|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
144475636|NCT01931735|520940403|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
144475637|NCT01931735|520940404|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
144475638|NCT01931735|520940405|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
144475639|NCT01931735|520940402|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
144475640|NCT01931735|520940403|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
144475641|NCT01931735|520940404|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
144475642|NCT01931735|520940405|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
144475643|NCT00779779|520940406|FG000|Overall Study|Adverse Event|1|||
144475644|NCT00779779|520940406|FG000|Overall Study|Protocol Violation|14|||
144475645|NCT00779779|520940406|FG000|Overall Study|Withdrawal by Subject|4|||
144475646|NCT00779779|520940406|FG000|Overall Study|Lost to Follow-up|5|||
144475647|NCT02404389|520940407|FG000|Overall Study|Adverse Event|1|||
144475648|NCT02404389|520940408|FG001|Overall Study|Adverse Event|0|||
144475649|NCT02404389|520940409|FG002|Overall Study|Adverse Event|1|||
144475650|NCT02404389|520940410|FG003|Overall Study|Adverse Event|0|||
144475651|NCT02404389|520940411|FG004|Overall Study|Adverse Event|2|||
144475652|NCT02404389|520940407|FG000|Overall Study|Subject/guardian decision|1|||
144475653|NCT02404389|520940408|FG001|Overall Study|Subject/guardian decision|0|||
144475654|NCT02404389|520940409|FG002|Overall Study|Subject/guardian decision|0|||
144475655|NCT02404389|520940410|FG003|Overall Study|Subject/guardian decision|1|||
144475656|NCT02404389|520940411|FG004|Overall Study|Subject/guardian decision|1|||
144475657|NCT03300570|520940412|FG000|Overall Study|Adverse Event|0|||
144475658|NCT03300570|520940413|FG001|Overall Study|Adverse Event|1|||
144475659|NCT03300570|520940412|FG000|Overall Study|Withdrawal by Subject|1|||
144475660|NCT03300570|520940413|FG001|Overall Study|Withdrawal by Subject|0|||
144475661|NCT03300570|520940412|FG000|Overall Study|Inadequate bowel prep|1|||
144475662|NCT03300570|520940413|FG001|Overall Study|Inadequate bowel prep|0|||
144475663|NCT00117156|520940414|FG000|Overall Study|Adverse Event|9|||
144475664|NCT00117156|520940414|FG000|Overall Study|Physician Decision|1|||
144475665|NCT00117156|520940414|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
144475666|NCT04043962|520940415|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
144475667|NCT04043962|520940415|FG000|Post-Treatment|Withdrawal by Subject|5|||
144475668|NCT04043962|520940415|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
144475669|NCT01987817|520940416|FG000|Overall Study|Adverse Event|4|||
144475670|NCT01987817|520940417|FG001|Overall Study|Adverse Event|0|||
144475671|NCT01987817|520940416|FG000|Overall Study|Withdrawal by Subject|1|||
144475672|NCT01987817|520940417|FG001|Overall Study|Withdrawal by Subject|1|||
144475673|NCT01987817|520940416|FG000|Overall Study|Physician Decision|1|||
144475674|NCT01987817|520940417|FG001|Overall Study|Physician Decision|0|||
144475675|NCT01576718|520940418|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
144475676|NCT01576718|520940419|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144475677|NCT01576718|520940420|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144475678|NCT01576718|520940421|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144475679|NCT01576718|520940422|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144475680|NCT01576718|520940423|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144475681|NCT01576718|520940424|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144475682|NCT01576718|520940418|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
144475683|NCT01576718|520940419|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144475684|NCT01576718|520940420|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144475685|NCT01576718|520940421|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144475686|NCT01576718|520940422|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144475687|NCT01576718|520940423|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144475688|NCT01576718|520940424|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144475689|NCT01576718|520940418|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
144475690|NCT01576718|520940419|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144475691|NCT01576718|520940420|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144475692|NCT01576718|520940421|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144475693|NCT01576718|520940422|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144475694|NCT01576718|520940423|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144475695|NCT01576718|520940424|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144475696|NCT01576718|520940418|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
144475697|NCT01576718|520940419|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144475698|NCT01576718|520940420|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144475699|NCT01576718|520940421|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144475700|NCT01576718|520940422|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144475701|NCT01576718|520940423|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144475702|NCT01576718|520940424|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144475703|NCT01576718|520940418|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
144475704|NCT01576718|520940419|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144475705|NCT01576718|520940420|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144475706|NCT01576718|520940421|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144475707|NCT01576718|520940422|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144475708|NCT01576718|520940423|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144475709|NCT01576718|520940424|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144475710|NCT01576718|520940418|FG000|Treatment Period|Adverse Event|0|||
144475711|NCT01576718|520940419|FG001|Treatment Period|Adverse Event|1|||
144475712|NCT01576718|520940420|FG002|Treatment Period|Adverse Event|1|||
144475713|NCT01576718|520940421|FG003|Treatment Period|Adverse Event|1|||
144475714|NCT01576718|520940422|FG004|Treatment Period|Adverse Event|1|||
144475715|NCT01576718|520940423|FG005|Treatment Period|Adverse Event|1|||
144475716|NCT01576718|520940424|FG006|Treatment Period|Adverse Event|0|||
144475717|NCT01576718|520940418|FG000|Treatment Period|Withdrawal by Subject|0|||
144475718|NCT01576718|520940419|FG001|Treatment Period|Withdrawal by Subject|1|||
144475719|NCT01576718|520940420|FG002|Treatment Period|Withdrawal by Subject|1|||
144475720|NCT01576718|520940421|FG003|Treatment Period|Withdrawal by Subject|0|||
144475721|NCT01576718|520940422|FG004|Treatment Period|Withdrawal by Subject|2|||
144475722|NCT01576718|520940423|FG005|Treatment Period|Withdrawal by Subject|4|||
144475723|NCT01576718|520940424|FG006|Treatment Period|Withdrawal by Subject|2|||
144475724|NCT01576718|520940418|FG000|Treatment Period|Physician Decision|0|||
144475725|NCT01576718|520940419|FG001|Treatment Period|Physician Decision|1|||
144475726|NCT01576718|520940420|FG002|Treatment Period|Physician Decision|1|||
144475727|NCT01576718|520940421|FG003|Treatment Period|Physician Decision|1|||
144475728|NCT01576718|520940422|FG004|Treatment Period|Physician Decision|1|||
144475729|NCT01576718|520940423|FG005|Treatment Period|Physician Decision|0|||
144475730|NCT01576718|520940424|FG006|Treatment Period|Physician Decision|0|||
144475731|NCT01576718|520940418|FG000|Treatment Period|Protocol Violation|0|||
144475732|NCT01576718|520940419|FG001|Treatment Period|Protocol Violation|5|||
144475733|NCT01576718|520940420|FG002|Treatment Period|Protocol Violation|4|||
144475734|NCT01576718|520940421|FG003|Treatment Period|Protocol Violation|10|||
144475735|NCT01576718|520940422|FG004|Treatment Period|Protocol Violation|6|||
144475736|NCT01576718|520940423|FG005|Treatment Period|Protocol Violation|8|||
144475737|NCT01576718|520940424|FG006|Treatment Period|Protocol Violation|12|||
144475738|NCT01576718|520940418|FG000|Treatment Period|Sponsor request|0|||
144475739|NCT01576718|520940419|FG001|Treatment Period|Sponsor request|1|||
144475740|NCT01576718|520940420|FG002|Treatment Period|Sponsor request|0|||
144475741|NCT01576718|520940421|FG003|Treatment Period|Sponsor request|0|||
144475742|NCT01576718|520940422|FG004|Treatment Period|Sponsor request|0|||
144475743|NCT01576718|520940423|FG005|Treatment Period|Sponsor request|1|||
144475744|NCT01576718|520940424|FG006|Treatment Period|Sponsor request|0|||
144475745|NCT01576718|520940418|FG000|Treatment Period|Met stopping criteria|0|||
144475746|NCT01576718|520940419|FG001|Treatment Period|Met stopping criteria|16|||
144475747|NCT01576718|520940420|FG002|Treatment Period|Met stopping criteria|13|||
144475748|NCT01576718|520940421|FG003|Treatment Period|Met stopping criteria|19|||
144475749|NCT01576718|520940422|FG004|Treatment Period|Met stopping criteria|16|||
144475750|NCT01576718|520940423|FG005|Treatment Period|Met stopping criteria|33|||
144475751|NCT01576718|520940424|FG006|Treatment Period|Met stopping criteria|15|||
144475752|NCT01576718|520940418|FG000|Treatment Period|Lost to Follow-up|0|||
144475753|NCT01576718|520940419|FG001|Treatment Period|Lost to Follow-up|0|||
144475754|NCT01576718|520940420|FG002|Treatment Period|Lost to Follow-up|0|||
144475755|NCT01576718|520940421|FG003|Treatment Period|Lost to Follow-up|0|||
144475756|NCT01576718|520940422|FG004|Treatment Period|Lost to Follow-up|1|||
144475757|NCT01576718|520940423|FG005|Treatment Period|Lost to Follow-up|0|||
144475758|NCT01576718|520940424|FG006|Treatment Period|Lost to Follow-up|0|||
144475759|NCT01576718|520940418|FG000|Treatment Period|Noncompliance to study medication|0|||
144475760|NCT01576718|520940419|FG001|Treatment Period|Noncompliance to study medication|0|||
144475761|NCT01576718|520940420|FG002|Treatment Period|Noncompliance to study medication|0|||
144475762|NCT01576718|520940421|FG003|Treatment Period|Noncompliance to study medication|0|||
144475763|NCT01576718|520940422|FG004|Treatment Period|Noncompliance to study medication|0|||
144475764|NCT01576718|520940423|FG005|Treatment Period|Noncompliance to study medication|1|||
144475765|NCT01576718|520940424|FG006|Treatment Period|Noncompliance to study medication|1|||
144475766|NCT04631705|520940425|FG000|Overall Study|Withdrawal by Subject|0|||
144475767|NCT04631705|520940426|FG001|Overall Study|Withdrawal by Subject|0|||
144475768|NCT04631705|520940427|FG002|Overall Study|Withdrawal by Subject|0|||
144475769|NCT04631705|520940428|FG003|Overall Study|Withdrawal by Subject|0|||
144475770|NCT04631705|520940429|FG004|Overall Study|Withdrawal by Subject|0|||
144475771|NCT04631705|520940430|FG005|Overall Study|Withdrawal by Subject|0|||
144475772|NCT04631705|520940431|FG006|Overall Study|Withdrawal by Subject|1|||
144475773|NCT04631705|520940432|FG007|Overall Study|Withdrawal by Subject|0|||
144475774|NCT04631705|520940433|FG008|Overall Study|Withdrawal by Subject|0|||
144475775|NCT00957931|520941904|FG000|Overall Study|Death|4|||
144475776|NCT00857805|520941905|FG000|Overall Study|Withdrawal by Subject|1|||
144475777|NCT00857805|520941906|FG001|Overall Study|Withdrawal by Subject|1|||
144475778|NCT01062763|520941907|FG000|Overall Study|Adverse Event|3|||
144475779|NCT01062763|520941908|FG001|Overall Study|Adverse Event|4|||
144475780|NCT02392611|520941914|FG000|Overall Study|Adverse Event|0|||
144475781|NCT02392611|520941915|FG001|Overall Study|Adverse Event|0|||
144475782|NCT02392611|520941916|FG002|Overall Study|Adverse Event|0|||
144475783|NCT02392611|520941917|FG003|Overall Study|Adverse Event|1|||
144475784|NCT02392611|520941918|FG004|Overall Study|Adverse Event|0|||
144475785|NCT02392611|520941919|FG005|Overall Study|Adverse Event|0|||
144475786|NCT02392611|520941920|FG006|Overall Study|Adverse Event|0|||
144475787|NCT02392611|520941921|FG007|Overall Study|Adverse Event|0|||
144475788|NCT02392611|520941922|FG008|Overall Study|Adverse Event|0|||
144475789|NCT02392611|520941914|FG000|Overall Study|Progressive disease|0|||
144475790|NCT02392611|520941915|FG001|Overall Study|Progressive disease|0|||
144475791|NCT02392611|520941916|FG002|Overall Study|Progressive disease|0|||
144475792|NCT02392611|520941917|FG003|Overall Study|Progressive disease|2|||
144475793|NCT02392611|520941918|FG004|Overall Study|Progressive disease|1|||
144475794|NCT02392611|520941919|FG005|Overall Study|Progressive disease|0|||
144475795|NCT02392611|520941920|FG006|Overall Study|Progressive disease|0|||
144475796|NCT02392611|520941921|FG007|Overall Study|Progressive disease|0|||
144475797|NCT02392611|520941922|FG008|Overall Study|Progressive disease|0|||
144475798|NCT02392611|520941914|FG000|Overall Study|Death|1|||
144475799|NCT02392611|520941915|FG001|Overall Study|Death|0|||
144475800|NCT02392611|520941916|FG002|Overall Study|Death|0|||
144475801|NCT02392611|520941917|FG003|Overall Study|Death|0|||
144475802|NCT02392611|520941918|FG004|Overall Study|Death|0|||
144475803|NCT02392611|520941919|FG005|Overall Study|Death|1|||
144475804|NCT02392611|520941920|FG006|Overall Study|Death|0|||
144475805|NCT02392611|520941921|FG007|Overall Study|Death|0|||
144475806|NCT02392611|520941922|FG008|Overall Study|Death|0|||
144475807|NCT02392611|520941914|FG000|Overall Study|Withdrawal by Subject|0|||
144475808|NCT02392611|520941915|FG001|Overall Study|Withdrawal by Subject|0|||
144475809|NCT02392611|520941916|FG002|Overall Study|Withdrawal by Subject|0|||
144475810|NCT02392611|520941917|FG003|Overall Study|Withdrawal by Subject|1|||
144475811|NCT02392611|520941918|FG004|Overall Study|Withdrawal by Subject|0|||
144475812|NCT02392611|520941919|FG005|Overall Study|Withdrawal by Subject|0|||
144475813|NCT02392611|520941920|FG006|Overall Study|Withdrawal by Subject|0|||
144475814|NCT02392611|520941921|FG007|Overall Study|Withdrawal by Subject|0|||
144475815|NCT02392611|520941922|FG008|Overall Study|Withdrawal by Subject|0|||
144475816|NCT02392611|520941914|FG000|Overall Study|Lost to Follow-up|0|||
144475817|NCT02392611|520941915|FG001|Overall Study|Lost to Follow-up|0|||
144475818|NCT02392611|520941916|FG002|Overall Study|Lost to Follow-up|0|||
144475819|NCT02392611|520941917|FG003|Overall Study|Lost to Follow-up|0|||
144475820|NCT02392611|520941918|FG004|Overall Study|Lost to Follow-up|0|||
144475821|NCT02392611|520941919|FG005|Overall Study|Lost to Follow-up|0|||
144475822|NCT02392611|520941920|FG006|Overall Study|Lost to Follow-up|1|||
144475823|NCT02392611|520941921|FG007|Overall Study|Lost to Follow-up|0|||
144475824|NCT02392611|520941922|FG008|Overall Study|Lost to Follow-up|0|||
144475825|NCT02392611|520941914|FG000|Overall Study|Enrolled, not treated|0|||
144475826|NCT02392611|520941915|FG001|Overall Study|Enrolled, not treated|0|||
144475827|NCT02392611|520941916|FG002|Overall Study|Enrolled, not treated|0|||
144475828|NCT02392611|520941917|FG003|Overall Study|Enrolled, not treated|2|||
144475829|NCT02392611|520941918|FG004|Overall Study|Enrolled, not treated|0|||
144475830|NCT02392611|520941919|FG005|Overall Study|Enrolled, not treated|0|||
144475831|NCT02392611|520941920|FG006|Overall Study|Enrolled, not treated|0|||
144475832|NCT02392611|520941921|FG007|Overall Study|Enrolled, not treated|0|||
144475833|NCT02392611|520941922|FG008|Overall Study|Enrolled, not treated|0|||
144475834|NCT00369681|520941924|FG000|Overall Study|Death|1|||
144475835|NCT01250119|520941926|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
144475836|NCT01250119|520941927|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
144475837|NCT01250119|520941926|FG000|Diagnostic Phase|Participants Not Tested|44|||
144475838|NCT01250119|520941927|FG001|Diagnostic Phase|Participants Not Tested|0|||
144475839|NCT01250119|520941926|FG000|Treatment Phase|Progressive Disease|0|||
144475840|NCT01250119|520941927|FG001|Treatment Phase|Progressive Disease|32|||
144475841|NCT01250119|520941926|FG000|Treatment Phase|Death|0|||
144475842|NCT01250119|520941927|FG001|Treatment Phase|Death|2|||
144475843|NCT01250119|520941926|FG000|Treatment Phase|Withdrawal by Subject|0|||
144475844|NCT01250119|520941927|FG001|Treatment Phase|Withdrawal by Subject|1|||
144475845|NCT01250119|520941926|FG000|Treatment Phase|Adverse Event|0|||
144475846|NCT01250119|520941927|FG001|Treatment Phase|Adverse Event|2|||
144475847|NCT01250119|520941926|FG000|Treatment Phase|Unknown reason|0|||
144587998|NCT00911768|521350528|FG001|Overall Study|Protocol Violation|4|||
144587999|NCT00911768|521350527|FG000|Overall Study|Withdrawal by Subject|1|||
144588000|NCT00911768|521350528|FG001|Overall Study|Withdrawal by Subject|0|||
144588001|NCT00515853|521350530|FG000|Overall Study|Lost to Follow-up|9|||
144588002|NCT00515853|521350531|FG001|Overall Study|Lost to Follow-up|13|||
144588003|NCT00515853|521350530|FG000|Overall Study|Withdrawal by Subject|6|||
144588004|NCT00515853|521350531|FG001|Overall Study|Withdrawal by Subject|4|||
144588005|NCT02631577|521350532|FG000|Overall Study|Death|1|||
144588006|NCT02631577|521350533|FG001|Overall Study|Death|7|||
144588007|NCT02631577|521350532|FG000|Overall Study|Withdrawal by Subject|0|||
144475848|NCT01250119|520941927|FG001|Treatment Phase|Unknown reason|4|||
144475849|NCT02670538|520941930|FG000|Overall Study|Withdrawal of Consent|8|||
144475850|NCT02670538|520941931|FG001|Overall Study|Withdrawal of Consent|6|||
144475851|NCT02670538|520941932|FG002|Overall Study|Withdrawal of Consent|5|||
144475852|NCT02670538|520941930|FG000|Overall Study|Lost to Follow-up|8|||
144475853|NCT02670538|520941931|FG001|Overall Study|Lost to Follow-up|12|||
144475854|NCT02670538|520941932|FG002|Overall Study|Lost to Follow-up|7|||
144475855|NCT02670538|520941930|FG000|Overall Study|Adverse Event|5|||
144360275|NCT00772538|520527436|FG001|Overall Study|Lost to Follow-up|1|||
144475856|NCT02670538|520941931|FG001|Overall Study|Adverse Event|5|||
144475857|NCT02670538|520941932|FG002|Overall Study|Adverse Event|11|||
144475858|NCT02670538|520941930|FG000|Overall Study|Lack of Efficacy|7|||
144475859|NCT02670538|520941931|FG001|Overall Study|Lack of Efficacy|1|||
144475860|NCT02670538|520941932|FG002|Overall Study|Lack of Efficacy|2|||
144475861|NCT02670538|520941930|FG000|Overall Study|Protocol Violation|3|||
144588008|NCT02631577|521350533|FG001|Overall Study|Withdrawal by Subject|3|||
144588009|NCT00979134|521350534|FG000|Overall Study|Disease progression|18|||
144588010|NCT00979134|521350535|FG001|Overall Study|Disease progression|2|||
144588011|NCT00979134|521350536|FG002|Overall Study|Disease progression|5|||
144588012|NCT00979134|521350534|FG000|Overall Study|Adverse Event|0|||
144588013|NCT00979134|521350535|FG001|Overall Study|Adverse Event|0|||
144588014|NCT00979134|521350536|FG002|Overall Study|Adverse Event|2|||
144588015|NCT00979134|521350534|FG000|Overall Study|Withdrawal by Subject|1|||
144588016|NCT00979134|521350535|FG001|Overall Study|Withdrawal by Subject|1|||
144588017|NCT00979134|521350536|FG002|Overall Study|Withdrawal by Subject|2|||
144588018|NCT00979134|521350534|FG000|Overall Study|Lost to Follow-up|2|||
144588019|NCT00979134|521350535|FG001|Overall Study|Lost to Follow-up|2|||
144588020|NCT00979134|521350536|FG002|Overall Study|Lost to Follow-up|0|||
144588021|NCT00979134|521350534|FG000|Overall Study|Death|4|||
144588022|NCT00979134|521350535|FG001|Overall Study|Death|0|||
144588023|NCT00979134|521350536|FG002|Overall Study|Death|26|||
144588024|NCT00979134|521350534|FG000|Overall Study|Other|8|||
144588025|NCT00979134|521350535|FG001|Overall Study|Other|1|||
144588026|NCT00979134|521350536|FG002|Overall Study|Other|5|||
144588027|NCT00867308|521350537|FG000|Overall Study|Death|1|||
144588028|NCT00867308|521350538|FG001|Overall Study|Death|0|||
144588029|NCT00867308|521350537|FG000|Overall Study|Adverse Event|1|||
144588030|NCT00867308|521350538|FG001|Overall Study|Adverse Event|4|||
144588031|NCT00867308|521350537|FG000|Overall Study|Lack of Efficacy|6|||
144588032|NCT00867308|521350538|FG001|Overall Study|Lack of Efficacy|12|||
144588033|NCT00867308|521350537|FG000|Overall Study|Withdrawal by Subject|1|||
144701483|NCT04584294|521760112|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
144701484|NCT04584294|521760113|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
144701485|NCT04584294|521760112|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
144701486|NCT04584294|521760113|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
144701487|NCT04584294|521760112|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
144701488|NCT04584294|521760113|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
144701489|NCT04584294|521760112|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
144701490|NCT04584294|521760113|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
144701491|NCT04584294|521760112|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
144701492|NCT04584294|521760113|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
144701493|NCT04584294|521760112|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
144701494|NCT04584294|521760113|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
144475862|NCT02670538|520941931|FG001|Overall Study|Protocol Violation|4|||
144475863|NCT02670538|520941932|FG002|Overall Study|Protocol Violation|1|||
144475864|NCT02670538|520941930|FG000|Overall Study|Noncompliance with Study Drug|1|||
144475865|NCT02670538|520941931|FG001|Overall Study|Noncompliance with Study Drug|3|||
144475866|NCT02670538|520941932|FG002|Overall Study|Noncompliance with Study Drug|2|||
144475867|NCT02670538|520941930|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144475868|NCT02670538|520941931|FG001|Overall Study|Other Miscellaneous Reasons|1|||
144475869|NCT02670538|520941932|FG002|Overall Study|Other Miscellaneous Reasons|2|||
144475870|NCT02887989|520941933|FG000|Overall Study|Withdrawal by Subject|8|||
144475871|NCT02887989|520941934|FG001|Overall Study|Withdrawal by Subject|11|||
144475872|NCT02887989|520941933|FG000|Overall Study|Death|1|||
144475873|NCT02887989|520941934|FG001|Overall Study|Death|0|||
144475874|NCT01216163|520941938|FG000|Overall Study|Withdrawal by Subject|1|||
144475875|NCT01216163|520941939|FG001|Overall Study|Withdrawal by Subject|1|||
144475876|NCT01216163|520941940|FG002|Overall Study|Withdrawal by Subject|0|||
144475877|NCT01368900|520941942|FG000|Overall Study|Lost to Follow-up|7|||
144475878|NCT02277743|520941946|FG000|Overall Study|Protocol Violation|1|||
144475879|NCT02277743|520941947|FG001|Overall Study|Protocol Violation|1|||
144475880|NCT02277743|520941948|FG002|Overall Study|Protocol Violation|1|||
144475881|NCT02277743|520941946|FG000|Overall Study|Adverse Event|10|||
144475882|NCT02277743|520941947|FG001|Overall Study|Adverse Event|6|||
144475883|NCT02277743|520941948|FG002|Overall Study|Adverse Event|6|||
144475884|NCT02277743|520941946|FG000|Overall Study|Lack of Efficacy|11|||
144475885|NCT02277743|520941947|FG001|Overall Study|Lack of Efficacy|4|||
144475886|NCT02277743|520941948|FG002|Overall Study|Lack of Efficacy|3|||
144475887|NCT02277743|520941946|FG000|Overall Study|Other than specified above|18|||
144475888|NCT02277743|520941947|FG001|Overall Study|Other than specified above|5|||
144475889|NCT02277743|520941948|FG002|Overall Study|Other than specified above|16|||
144475890|NCT01224158|520941949|FG000|Overall Study|Withdrawal by Subject|1|||
144475891|NCT01224158|520941950|FG001|Overall Study|Withdrawal by Subject|0|||
144701495|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
144701496|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
144475892|NCT02055157|520941951|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
144475893|NCT02055157|520941952|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
144475894|NCT02055157|520941953|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
144475895|NCT02055157|520941954|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
144588034|NCT00867308|521350538|FG001|Overall Study|Withdrawal by Subject|2|||
144588035|NCT00604825|521350539|FG000|Overall Study|Adverse Event|2|||
144475896|NCT02055157|520941951|FG000|Initial 6 Months|Adverse Event|0|||
144475897|NCT02055157|520941952|FG001|Initial 6 Months|Adverse Event|0|||
144475898|NCT02055157|520941953|FG002|Initial 6 Months|Adverse Event|0|||
144475899|NCT02055157|520941954|FG003|Initial 6 Months|Adverse Event|1|||
144475900|NCT02055157|520941951|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
144701497|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
144701498|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144701499|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144701500|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144701501|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
144701502|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
144701503|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
144701504|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
144701505|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
144701506|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
144701507|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
144701508|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
144701509|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
144701510|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144701511|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
144701512|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144701513|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144701514|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144701515|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
144701516|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
144701517|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144701518|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
144701519|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144701520|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144701521|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144701522|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
144701523|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
144701524|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
144701525|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
144701526|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144701527|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144701528|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144701529|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
144701530|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
144701531|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
144701532|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
144701533|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
144701534|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
144701535|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
144701536|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
144701537|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
144701538|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
144701539|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
144701540|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
144701541|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
144701542|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
144701543|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
144701544|NCT04242498|521760114|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144701545|NCT04242498|521760115|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
144701546|NCT04242498|521760116|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
144701547|NCT04242498|521760117|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144701548|NCT04242498|521760118|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144701549|NCT04242498|521760119|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144701550|NCT04242498|521760120|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
144701551|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144475901|NCT02055157|520941952|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
144475902|NCT02055157|520941953|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
144475903|NCT02055157|520941954|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
144475904|NCT02055157|520941951|FG000|18-month Extension|Investigator decision|0|||
144475905|NCT02055157|520941952|FG001|18-month Extension|Investigator decision|1|||
144475906|NCT02055157|520941953|FG002|18-month Extension|Investigator decision|0|||
144475907|NCT02055157|520941954|FG003|18-month Extension|Investigator decision|0|||
144475908|NCT02055157|520941951|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
144475909|NCT02055157|520941952|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
144475910|NCT02055157|520941953|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
144475911|NCT02055157|520941954|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
144475912|NCT03976466|520941955|FG000|Overall Study|Lost to Follow-up|1|||
144475913|NCT03976466|520941956|FG001|Overall Study|Lost to Follow-up|3|||
144475914|NCT00733499|520941959|FG000|Pre-operative|Protocol Violation|0|||
144475915|NCT00733499|520941960|FG001|Pre-operative|Protocol Violation|1|||
144475916|NCT00733499|520941959|FG000|3 Months Follow-up|Death|1|||
144475917|NCT00733499|520941960|FG001|3 Months Follow-up|Death|2|||
144475918|NCT00733499|520941959|FG000|6 Months Follow-up|Death|0|||
144475919|NCT00733499|520941960|FG001|6 Months Follow-up|Death|2|||
144475920|NCT00733499|520941959|FG000|6 Months Follow-up|Adverse Event|0|||
144475921|NCT00733499|520941960|FG001|6 Months Follow-up|Adverse Event|1|||
144475922|NCT00733499|520941959|FG000|12 Months Follow-up|Death|2|||
144475923|NCT00733499|520941960|FG001|12 Months Follow-up|Death|1|||
144475924|NCT00733499|520941959|FG000|24 Months Follow-up|Death|0|||
144475925|NCT00733499|520941960|FG001|24 Months Follow-up|Death|1|||
144475926|NCT00733499|520941959|FG000|5 Year Followup|Adverse Event|2|||
144475927|NCT00733499|520941960|FG001|5 Year Followup|Adverse Event|2|||
144475928|NCT00733499|520941959|FG000|5 Year Followup|Non device related AE|0|||
144475929|NCT00733499|520941960|FG001|5 Year Followup|Non device related AE|1|||
144475930|NCT00733499|520941959|FG000|5 Year Followup|Revision of Study Implant|0|||
144475931|NCT00733499|520941960|FG001|5 Year Followup|Revision of Study Implant|1|||
144475932|NCT00733499|520941959|FG000|5 Year Followup|Lost to Follow-up|2|||
144588036|NCT00604825|521350540|FG001|Overall Study|Adverse Event|6|||
144588037|NCT00604825|521350541|FG002|Overall Study|Adverse Event|7|||
144588038|NCT00604825|521350542|FG003|Overall Study|Adverse Event|4|||
144588039|NCT00604825|521350539|FG000|Overall Study|Lost to Follow-up|0|||
144588040|NCT00604825|521350540|FG001|Overall Study|Lost to Follow-up|3|||
144588041|NCT00604825|521350541|FG002|Overall Study|Lost to Follow-up|1|||
144588042|NCT00604825|521350542|FG003|Overall Study|Lost to Follow-up|0|||
144588043|NCT00604825|521350539|FG000|Overall Study|Protocol Violation|0|||
144588044|NCT00604825|521350540|FG001|Overall Study|Protocol Violation|1|||
144588045|NCT00604825|521350541|FG002|Overall Study|Protocol Violation|0|||
144588046|NCT00604825|521350542|FG003|Overall Study|Protocol Violation|0|||
144588047|NCT00604825|521350539|FG000|Overall Study|Withdrawal by Subject|4|||
144588048|NCT00604825|521350540|FG001|Overall Study|Withdrawal by Subject|3|||
144588049|NCT00604825|521350541|FG002|Overall Study|Withdrawal by Subject|5|||
144588050|NCT00604825|521350542|FG003|Overall Study|Withdrawal by Subject|5|||
144588051|NCT00604825|521350539|FG000|Overall Study|Lack of Efficacy|3|||
144588052|NCT00604825|521350540|FG001|Overall Study|Lack of Efficacy|2|||
144588053|NCT00604825|521350541|FG002|Overall Study|Lack of Efficacy|1|||
144588054|NCT00604825|521350542|FG003|Overall Study|Lack of Efficacy|0|||
144588055|NCT00604825|521350539|FG000|Overall Study|Did not meet eligibility criteria|0|||
144588056|NCT00604825|521350540|FG001|Overall Study|Did not meet eligibility criteria|0|||
144588057|NCT00604825|521350541|FG002|Overall Study|Did not meet eligibility criteria|2|||
144588058|NCT00604825|521350542|FG003|Overall Study|Did not meet eligibility criteria|0|||
144588059|NCT00604825|521350539|FG000|Overall Study|Physician Decision|0|||
144588060|NCT00604825|521350540|FG001|Overall Study|Physician Decision|0|||
144588061|NCT00604825|521350541|FG002|Overall Study|Physician Decision|0|||
144588062|NCT00604825|521350542|FG003|Overall Study|Physician Decision|1|||
144588063|NCT00604825|521350539|FG000|Overall Study|Exclusion criterion met|0|||
144588064|NCT00604825|521350540|FG001|Overall Study|Exclusion criterion met|0|||
144588065|NCT00604825|521350541|FG002|Overall Study|Exclusion criterion met|0|||
144588066|NCT00604825|521350542|FG003|Overall Study|Exclusion criterion met|1|||
144588067|NCT03647488|521352268|FG000|Overall Study|Progressive disease|10|||
144588068|NCT03647488|521352269|FG001|Overall Study|Progressive disease|0|||
144588069|NCT03647488|521352270|FG002|Overall Study|Progressive disease|0|||
144588070|NCT03647488|521352268|FG000|Overall Study|Adverse Event|5|||
144588071|NCT03647488|521352269|FG001|Overall Study|Adverse Event|0|||
144588072|NCT03647488|521352270|FG002|Overall Study|Adverse Event|0|||
144588073|NCT03647488|521352268|FG000|Overall Study|Clinical progression|2|||
144588074|NCT03647488|521352269|FG001|Overall Study|Clinical progression|0|||
144588075|NCT03647488|521352270|FG002|Overall Study|Clinical progression|0|||
144588076|NCT03647488|521352268|FG000|Overall Study|Participant refused to take investigational product|1|||
144588077|NCT03647488|521352269|FG001|Overall Study|Participant refused to take investigational product|0|||
144588078|NCT03647488|521352270|FG002|Overall Study|Participant refused to take investigational product|0|||
144588079|NCT00812331|521352271|FG000|Overall Study|Adverse Event|1|||
144588080|NCT00812331|521352272|FG001|Overall Study|Adverse Event|0|||
144588081|NCT00812331|521352273|FG002|Overall Study|Adverse Event|0|||
144588082|NCT00812331|521352274|FG003|Overall Study|Adverse Event|0|||
144475933|NCT00733499|520941960|FG001|5 Year Followup|Lost to Follow-up|0|||
144475934|NCT00733499|520941959|FG000|5 Year Followup|Death|13|||
144475935|NCT00733499|520941960|FG001|5 Year Followup|Death|19|||
144475936|NCT00733499|520941959|FG000|5 Year Followup|missing, unable to locate|0|||
144475937|NCT00733499|520941960|FG001|5 Year Followup|missing, unable to locate|1|||
144475938|NCT00733499|520941959|FG000|5 Year Followup|Withdrawal by Subject|4|||
144475939|NCT00733499|520941960|FG001|5 Year Followup|Withdrawal by Subject|1|||
144475940|NCT00733499|520941959|FG000|10 Year Followup|Death|9|||
144475941|NCT00733499|520941960|FG001|10 Year Followup|Death|7|||
144475942|NCT00733499|520941959|FG000|10 Year Followup|Adverse Event|3|||
144475943|NCT00733499|520941960|FG001|10 Year Followup|Adverse Event|3|||
144475944|NCT00733499|520941959|FG000|10 Year Followup|Lost to Follow-up|3|||
144475945|NCT00733499|520941960|FG001|10 Year Followup|Lost to Follow-up|2|||
144475946|NCT00733499|520941959|FG000|10 Year Followup|Withdrawal by Subject|5|||
144475947|NCT00733499|520941960|FG001|10 Year Followup|Withdrawal by Subject|5|||
144475948|NCT00733499|520941959|FG000|10 Year Followup|missing, unable to locate|0|||
144475949|NCT00733499|520941960|FG001|10 Year Followup|missing, unable to locate|2|||
144475950|NCT02739347|520941961|FG000|Overall Study|Adverse Event|3|||
144475951|NCT02739347|520941962|FG001|Overall Study|Adverse Event|0|||
144475952|NCT02739347|520941961|FG000|Overall Study|Protocol Violation|0|||
144475953|NCT02739347|520941962|FG001|Overall Study|Protocol Violation|1|||
144475954|NCT02739347|520941961|FG000|Overall Study|Lost to Follow-up|0|||
144475955|NCT02739347|520941962|FG001|Overall Study|Lost to Follow-up|2|||
144475956|NCT01395823|520941963|FG000|Overall Study|Death|4|||
144475957|NCT01395823|520941964|FG001|Overall Study|Death|4|||
144475958|NCT01395823|520941963|FG000|Overall Study|Physician Decision|3|||
144475959|NCT01395823|520941964|FG001|Overall Study|Physician Decision|1|||
144475960|NCT01395823|520941963|FG000|Overall Study|Lost to Follow-up|1|||
144475961|NCT01395823|520941964|FG001|Overall Study|Lost to Follow-up|0|||
144475962|NCT01395823|520941963|FG000|Overall Study|Transplant|1|||
144475963|NCT01395823|520941964|FG001|Overall Study|Transplant|0|||
144475964|NCT01395823|520941963|FG000|Overall Study|GI symptoms|1|||
144475965|NCT01395823|520941964|FG001|Overall Study|GI symptoms|0|||
144475966|NCT01395823|520941963|FG000|Overall Study|Withdrawal by Subject|5|||
144475967|NCT01395823|520941964|FG001|Overall Study|Withdrawal by Subject|4|||
144475968|NCT02719990|520941965|FG000|Overall Study|Physician Decision|2|||
144475969|NCT02719990|520941965|FG000|Overall Study|Withdrawal by Subject|2|||
144475970|NCT02719990|520941965|FG000|Overall Study|Study Terminated By Sponsor|32|||
144475971|NCT00116272|520941970|FG000|Overall Study|Lost to Follow-up|11|||
144475972|NCT00116272|520941971|FG001|Overall Study|Lost to Follow-up|6|||
144475973|NCT03188120|520941973|FG000|Overall Study|Adverse Event|4|||
144475974|NCT03188120|520941973|FG000|Overall Study|Insufficient Effectiveness|8|||
144475975|NCT03188120|520941973|FG000|Overall Study|Improved|12|||
144475976|NCT03188120|520941973|FG000|Overall Study|Lost to Follow-up|7|||
144475977|NCT03188120|520941973|FG000|Overall Study|Other than specified|3|||
144475978|NCT03188120|520941973|FG000|Overall Study|No visit after the first visit|13|||
144475979|NCT00576732|520941974|FG000|DOUBLE BLIND|Adverse Event|0|||
144475980|NCT00576732|520941975|FG001|DOUBLE BLIND|Adverse Event|0|||
144475981|NCT00576732|520941976|FG002|DOUBLE BLIND|Adverse Event|1|||
144475982|NCT00576732|520941977|FG003|DOUBLE BLIND|Adverse Event|0|||
144475983|NCT00576732|520941978|FG004|DOUBLE BLIND|Adverse Event|0|||
144475984|NCT00576732|520941979|FG005|DOUBLE BLIND|Adverse Event|0|||
144475985|NCT00576732|520941974|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
144475986|NCT00576732|520941975|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
144475987|NCT00576732|520941976|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
144475988|NCT00576732|520941977|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
144475989|NCT00576732|520941978|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
144475990|NCT00576732|520941979|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
144475991|NCT00576732|520941974|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
144475992|NCT00576732|520941975|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
144475993|NCT00576732|520941976|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
144475994|NCT00576732|520941977|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
144475995|NCT00576732|520941978|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
144475996|NCT00576732|520941979|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
144475997|NCT00576732|520941974|FG000|DOUBLE BLIND|OTHER|0|||
144475998|NCT00576732|520941975|FG001|DOUBLE BLIND|OTHER|2|||
144475999|NCT00576732|520941976|FG002|DOUBLE BLIND|OTHER|1|||
144476000|NCT00576732|520941977|FG003|DOUBLE BLIND|OTHER|0|||
144476001|NCT00576732|520941978|FG004|DOUBLE BLIND|OTHER|0|||
144476002|NCT00576732|520941979|FG005|DOUBLE BLIND|OTHER|0|||
144476003|NCT00576732|520941974|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
144476004|NCT00576732|520941975|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
144476005|NCT00576732|520941976|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
144476006|NCT00576732|520941977|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
144476007|NCT00576732|520941978|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
144476008|NCT00576732|520941979|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
144476009|NCT00576732|520941974|FG000|DOUBLE BLIND|Protocol Violation|1|||
144476010|NCT00576732|520941975|FG001|DOUBLE BLIND|Protocol Violation|0|||
144476011|NCT00576732|520941976|FG002|DOUBLE BLIND|Protocol Violation|0|||
144476012|NCT00576732|520941977|FG003|DOUBLE BLIND|Protocol Violation|0|||
144476013|NCT00576732|520941978|FG004|DOUBLE BLIND|Protocol Violation|0|||
144476014|NCT00576732|520941979|FG005|DOUBLE BLIND|Protocol Violation|0|||
144476015|NCT00576732|520941974|FG000|OPEN LABEL|Adverse Event|0|||
144476016|NCT00576732|520941975|FG001|OPEN LABEL|Adverse Event|0|||
144476017|NCT00576732|520941976|FG002|OPEN LABEL|Adverse Event|0|||
144476018|NCT00576732|520941977|FG003|OPEN LABEL|Adverse Event|4|||
144476019|NCT00576732|520941978|FG004|OPEN LABEL|Adverse Event|0|||
144476020|NCT00576732|520941979|FG005|OPEN LABEL|Adverse Event|1|||
144476021|NCT00576732|520941974|FG000|OPEN LABEL|Lost to Follow-up|0|||
144476022|NCT00576732|520941975|FG001|OPEN LABEL|Lost to Follow-up|0|||
144476023|NCT00576732|520941976|FG002|OPEN LABEL|Lost to Follow-up|0|||
144476024|NCT00576732|520941977|FG003|OPEN LABEL|Lost to Follow-up|2|||
144476025|NCT00576732|520941978|FG004|OPEN LABEL|Lost to Follow-up|1|||
144476026|NCT00576732|520941979|FG005|OPEN LABEL|Lost to Follow-up|1|||
144476027|NCT00576732|520941974|FG000|OPEN LABEL|Withdrawal by Subject|0|||
144476028|NCT00576732|520941975|FG001|OPEN LABEL|Withdrawal by Subject|0|||
144476029|NCT00576732|520941976|FG002|OPEN LABEL|Withdrawal by Subject|0|||
144476030|NCT00576732|520941977|FG003|OPEN LABEL|Withdrawal by Subject|1|||
144476031|NCT00576732|520941978|FG004|OPEN LABEL|Withdrawal by Subject|0|||
144476032|NCT00576732|520941979|FG005|OPEN LABEL|Withdrawal by Subject|1|||
144476033|NCT00576732|520941974|FG000|OPEN LABEL|OTHER|0|||
144476034|NCT00576732|520941975|FG001|OPEN LABEL|OTHER|0|||
144476035|NCT00576732|520941976|FG002|OPEN LABEL|OTHER|0|||
144476036|NCT00576732|520941977|FG003|OPEN LABEL|OTHER|0|||
144476037|NCT00576732|520941978|FG004|OPEN LABEL|OTHER|0|||
144476038|NCT00576732|520941979|FG005|OPEN LABEL|OTHER|2|||
144476039|NCT00576732|520941974|FG000|OPEN LABEL|Lack of Efficacy|0|||
144476040|NCT00576732|520941975|FG001|OPEN LABEL|Lack of Efficacy|0|||
144476041|NCT00576732|520941976|FG002|OPEN LABEL|Lack of Efficacy|0|||
144476042|NCT00576732|520941977|FG003|OPEN LABEL|Lack of Efficacy|2|||
144476043|NCT00576732|520941978|FG004|OPEN LABEL|Lack of Efficacy|2|||
144476044|NCT00576732|520941979|FG005|OPEN LABEL|Lack of Efficacy|3|||
144476045|NCT00576732|520941974|FG000|OPEN LABEL|Protocol Violation|0|||
144476046|NCT00576732|520941975|FG001|OPEN LABEL|Protocol Violation|0|||
144476047|NCT00576732|520941976|FG002|OPEN LABEL|Protocol Violation|0|||
144476048|NCT00576732|520941977|FG003|OPEN LABEL|Protocol Violation|2|||
144476049|NCT00576732|520941978|FG004|OPEN LABEL|Protocol Violation|1|||
144476050|NCT00576732|520941979|FG005|OPEN LABEL|Protocol Violation|0|||
144476051|NCT01235403|520941980|FG000|Overall Study|Adverse Event|14|||
144476052|NCT01235403|520941980|FG000|Overall Study|Lost to Follow-up|2|||
144476053|NCT01235403|520941980|FG000|Overall Study|Withdrawal by Subject|4|||
144476054|NCT01235403|520941980|FG000|Overall Study|Lack of Efficacy|2|||
144476055|NCT01235403|520941980|FG000|Overall Study|Other reasons for premature termination|4|||
144476056|NCT02978443|520941983|FG000|Overall Study|Withdrawal by Subject|1|||
144476057|NCT02978443|520941983|FG000|Overall Study|Adverse Event|3|||
144476058|NCT02978443|520941983|FG000|Overall Study|Disease Progression on study|6|||
144476059|NCT02978443|520941983|FG000|Overall Study|Death|1|||
144476060|NCT02978443|520941983|FG000|Overall Study|Physician Decision|1|||
144476061|NCT02978443|520941983|FG000|Overall Study|Switch to alternative therapy|1|||
144476062|NCT02978443|520941983|FG000|Overall Study|Refused further treatment|1|||
144476063|NCT02296190|520941984|FG000|Overall Study|Lost to Follow-up|0|||
144476064|NCT02296190|520941985|FG001|Overall Study|Lost to Follow-up|0|||
144476065|NCT02296190|520941986|FG002|Overall Study|Lost to Follow-up|0|||
144476066|NCT02296190|520941987|FG003|Overall Study|Lost to Follow-up|0|||
144476067|NCT02296190|520941988|FG004|Overall Study|Lost to Follow-up|1|||
144476068|NCT02296190|520941989|FG005|Overall Study|Lost to Follow-up|0|||
144476069|NCT02296190|520941984|FG000|Overall Study|Failure to induce PSVT|6|||
144476070|NCT02296190|520941985|FG001|Overall Study|Failure to induce PSVT|10|||
144476071|NCT02296190|520941986|FG002|Overall Study|Failure to induce PSVT|5|||
144476072|NCT02296190|520941987|FG003|Overall Study|Failure to induce PSVT|13|||
144476073|NCT02296190|520941988|FG004|Overall Study|Failure to induce PSVT|8|||
144476074|NCT02296190|520941989|FG005|Overall Study|Failure to induce PSVT|0|||
144476075|NCT02296190|520941984|FG000|Overall Study|Physician Decision|1|||
144476076|NCT02296190|520941985|FG001|Overall Study|Physician Decision|1|||
144476077|NCT02296190|520941986|FG002|Overall Study|Physician Decision|0|||
144476078|NCT02296190|520941987|FG003|Overall Study|Physician Decision|1|||
144476079|NCT02296190|520941988|FG004|Overall Study|Physician Decision|2|||
144476080|NCT02296190|520941989|FG005|Overall Study|Physician Decision|0|||
144476081|NCT02296190|520941984|FG000|Overall Study|Withdrawal by Subject|0|||
144476082|NCT02296190|520941985|FG001|Overall Study|Withdrawal by Subject|1|||
144476083|NCT02296190|520941986|FG002|Overall Study|Withdrawal by Subject|0|||
144476084|NCT02296190|520941987|FG003|Overall Study|Withdrawal by Subject|0|||
144476085|NCT02296190|520941988|FG004|Overall Study|Withdrawal by Subject|0|||
144476086|NCT02296190|520941989|FG005|Overall Study|Withdrawal by Subject|0|||
144476087|NCT02296190|520941984|FG000|Overall Study|PSVT < 5 minutes|5|||
144476088|NCT02296190|520941985|FG001|Overall Study|PSVT < 5 minutes|6|||
144476089|NCT02296190|520941986|FG002|Overall Study|PSVT < 5 minutes|6|||
144476090|NCT02296190|520941987|FG003|Overall Study|PSVT < 5 minutes|6|||
144476091|NCT02296190|520941988|FG004|Overall Study|PSVT < 5 minutes|5|||
144476092|NCT02296190|520941989|FG005|Overall Study|PSVT < 5 minutes|0|||
144476093|NCT02296190|520941984|FG000|Overall Study|Patient was given Propofol|0|||
144476094|NCT02296190|520941985|FG001|Overall Study|Patient was given Propofol|1|||
144476095|NCT02296190|520941986|FG002|Overall Study|Patient was given Propofol|0|||
144476096|NCT02296190|520941987|FG003|Overall Study|Patient was given Propofol|1|||
144476097|NCT02296190|520941988|FG004|Overall Study|Patient was given Propofol|0|||
144476098|NCT02296190|520941989|FG005|Overall Study|Patient was given Propofol|0|||
144476099|NCT02296190|520941984|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
144476100|NCT02296190|520941985|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
144476101|NCT02296190|520941986|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
144476102|NCT02296190|520941987|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
144476103|NCT02296190|520941988|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
144476104|NCT02296190|520941989|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
144476105|NCT02296190|520941984|FG000|Overall Study|Blood pressure <100 after sedation|0|||
144476106|NCT02296190|520941985|FG001|Overall Study|Blood pressure <100 after sedation|0|||
144476107|NCT02296190|520941986|FG002|Overall Study|Blood pressure <100 after sedation|0|||
144476108|NCT02296190|520941987|FG003|Overall Study|Blood pressure <100 after sedation|1|||
144701552|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144701553|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144701554|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
144701555|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
144701556|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
144701557|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
144701558|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144701559|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144701560|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144701561|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
144701562|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
144701563|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
144701564|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
144701565|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701566|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701567|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701568|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701569|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
144701570|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
144701571|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
144701572|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
144701573|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
144701574|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
144701575|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
144701576|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
144701577|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
144701578|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
144701579|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
144701580|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
144701581|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
144701582|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
144701583|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
144701584|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
144701585|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
144476109|NCT02296190|520941988|FG004|Overall Study|Blood pressure <100 after sedation|0|||
144476110|NCT02296190|520941989|FG005|Overall Study|Blood pressure <100 after sedation|0|||
144476111|NCT02296190|520941984|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
144476112|NCT02296190|520941985|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
144476113|NCT02296190|520941986|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
144476114|NCT02296190|520941987|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
144701586|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
144701587|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
144476115|NCT02296190|520941988|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
144476116|NCT02296190|520941989|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
144476117|NCT02296190|520941984|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
144476118|NCT02296190|520941985|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
144476119|NCT02296190|520941986|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
144476120|NCT02296190|520941987|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
144476121|NCT02296190|520941988|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
144476122|NCT02296190|520941989|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
144476123|NCT02296190|520941984|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
144476124|NCT02296190|520941985|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
144476125|NCT02296190|520941986|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
144476126|NCT02296190|520941987|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
144476127|NCT02296190|520941988|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
144476128|NCT02296190|520941989|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
144476129|NCT02296190|520941984|FG000|Overall Study|Lab result not available in time|1|||
144476130|NCT02296190|520941985|FG001|Overall Study|Lab result not available in time|0|||
144476131|NCT02296190|520941986|FG002|Overall Study|Lab result not available in time|0|||
144476132|NCT02296190|520941987|FG003|Overall Study|Lab result not available in time|0|||
144476133|NCT02296190|520941988|FG004|Overall Study|Lab result not available in time|0|||
144476134|NCT02296190|520941989|FG005|Overall Study|Lab result not available in time|0|||
144476135|NCT05076149|520941991|FG000|Overall Study|Adverse Event|3|||
144476136|NCT05076149|520941992|FG001|Overall Study|Adverse Event|9|||
144476137|NCT05076149|520941991|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
144476138|NCT05076149|520941992|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
144476139|NCT05076149|520941991|FG000|Overall Study|Lost to Follow-up|0|||
144476140|NCT05076149|520941992|FG001|Overall Study|Lost to Follow-up|1|||
144476141|NCT05076149|520941991|FG000|Overall Study|Commercial drug is available for participant|0|||
144476142|NCT05076149|520941992|FG001|Overall Study|Commercial drug is available for participant|1|||
144476143|NCT05076149|520941991|FG000|Overall Study|Other non compliance|1|||
144476144|NCT05076149|520941992|FG001|Overall Study|Other non compliance|1|||
144476145|NCT05076149|520941991|FG000|Overall Study|Physician Decision|0|||
144476146|NCT05076149|520941992|FG001|Overall Study|Physician Decision|1|||
144476147|NCT05076149|520941991|FG000|Overall Study|Other|5|||
144476148|NCT05076149|520941992|FG001|Overall Study|Other|4|||
144476149|NCT00717314|520941993|FG000|Overall Study|Adverse Event|3|||
144476150|NCT00717314|520941994|FG001|Overall Study|Adverse Event|2|||
144476151|NCT00717314|520941993|FG000|Overall Study|Protocol Violation|1|||
144476152|NCT00717314|520941994|FG001|Overall Study|Protocol Violation|0|||
144476153|NCT00717314|520941993|FG000|Overall Study|Lost to Follow-up|1|||
144476154|NCT00717314|520941994|FG001|Overall Study|Lost to Follow-up|5|||
144476155|NCT00717314|520941993|FG000|Overall Study|Withdrawal by Subject|1|||
144476156|NCT00717314|520941994|FG001|Overall Study|Withdrawal by Subject|3|||
144476157|NCT05096208|520941995|FG000|Overall Study|Lost to Follow-up|3|||
144476158|NCT05096208|520941996|FG001|Overall Study|Lost to Follow-up|5|||
144476159|NCT05096208|520941997|FG002|Overall Study|Lost to Follow-up|5|||
144476160|NCT05096208|520941998|FG003|Overall Study|Lost to Follow-up|2|||
144476161|NCT05096208|520941995|FG000|Overall Study|Withdrawal by Subject|0|||
144476162|NCT05096208|520941996|FG001|Overall Study|Withdrawal by Subject|1|||
144476163|NCT05096208|520941997|FG002|Overall Study|Withdrawal by Subject|2|||
144476164|NCT05096208|520941998|FG003|Overall Study|Withdrawal by Subject|3|||
144476165|NCT05096208|520941995|FG000|Overall Study|No longer met eligibility criteria|1|||
144476166|NCT05096208|520941996|FG001|Overall Study|No longer met eligibility criteria|0|||
144476167|NCT05096208|520941997|FG002|Overall Study|No longer met eligibility criteria|0|||
144476168|NCT05096208|520941998|FG003|Overall Study|No longer met eligibility criteria|0|||
144476169|NCT05096208|520941995|FG000|Overall Study|Other|0|||
144476170|NCT05096208|520941996|FG001|Overall Study|Other|0|||
144476171|NCT05096208|520941997|FG002|Overall Study|Other|1|||
144476172|NCT05096208|520941998|FG003|Overall Study|Other|0|||
144476173|NCT00782496|520941999|FG000|Overall Study|Lost to Follow-up|14|||
144476174|NCT00782496|520942000|FG001|Overall Study|Lost to Follow-up|15|||
144476175|NCT01919970|520942004|FG000|Overall Study|Withdrawal by Subject|3|||
144476176|NCT01919970|520942005|FG001|Overall Study|Withdrawal by Subject|0|||
144476177|NCT00990340|520942007|FG000|First 14-day Treatment|Not Compliant|2|||
144476178|NCT00990340|520942008|FG001|First 14-day Treatment|Not Compliant|1|||
144476179|NCT00990340|520942007|FG000|First 14-day Treatment|Lost to Follow-up|2|||
144476180|NCT00990340|520942008|FG001|First 14-day Treatment|Lost to Follow-up|1|||
144476181|NCT00990340|520942007|FG000|First 14-day Treatment|Protocol Violation|2|||
144476182|NCT00990340|520942008|FG001|First 14-day Treatment|Protocol Violation|2|||
144476183|NCT04615182|520942009|FG000|Overall Study|Re-transplanted|2|||
144476184|NCT04615182|520942009|FG000|Overall Study|Protocol Violation|6|||
144476185|NCT04615182|520942009|FG000|Overall Study|Death|6|||
144476186|NCT04615182|520942009|FG000|Overall Study|Death and protocol violation|1|||
144476187|NCT01874145|520942012|FG000|Core Period|Non-compliance|1|||
144476188|NCT01874145|520942013|FG001|Core Period|Non-compliance|0|||
144476189|NCT01874145|520942012|FG000|Core Period|Protocol Violation|1|||
144476190|NCT01874145|520942013|FG001|Core Period|Protocol Violation|1|||
144476191|NCT01874145|520942012|FG000|Core Period|Physician Decision|1|||
144476192|NCT01874145|520942013|FG001|Core Period|Physician Decision|1|||
144476193|NCT01874145|520942012|FG000|Core Period|Adverse Event|0|||
144476194|NCT01874145|520942013|FG001|Core Period|Adverse Event|1|||
144476195|NCT01874145|520942012|FG000|Core Period|Withdrawal by Subject|0|||
144476196|NCT01874145|520942013|FG001|Core Period|Withdrawal by Subject|4|||
144476197|NCT01874145|520942012|FG000|Extension Period|Adverse Event|3|||
144476198|NCT01874145|520942013|FG001|Extension Period|Adverse Event|2|||
144476199|NCT01874145|520942012|FG000|Extension Period|Withdrawal by Subject|2|||
144476200|NCT01874145|520942013|FG001|Extension Period|Withdrawal by Subject|1|||
144476201|NCT01874145|520942012|FG000|Extension Period|Lost to Follow-up|1|||
144476202|NCT01874145|520942013|FG001|Extension Period|Lost to Follow-up|1|||
144476203|NCT02070484|520942018|FG000|Overall Study|Withdrawal by Subject|1|||
144476204|NCT02070484|520942019|FG001|Overall Study|Withdrawal by Subject|0|||
144476205|NCT02658630|520942020|FG000|Overall Study|Withdrawal by Subject|4|||
144476206|NCT02130284|520942021|FG000|Overall Study|Withdrawal by Subject|3|||
144476207|NCT02130284|520942021|FG000|Overall Study|Subject Withdrew Consent|1|||
144476208|NCT02130284|520942021|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
144476209|NCT02130284|520942021|FG000|Overall Study|Subject was screened as backup for study|3|||
144476210|NCT02130284|520942021|FG000|Overall Study|Screen Failure|1|||
144476211|NCT01521884|520942022|FG000|Overall Study|Non Responders|10|||
144476212|NCT01521884|520942022|FG000|Overall Study|Adverse Event|5|||
144476213|NCT01521884|520942022|FG000|Overall Study|Pregnancy|1|||
144476214|NCT01521884|520942022|FG000|Overall Study|Withdrawal by Subject|1|||
144476215|NCT01521884|520942022|FG000|Overall Study|Physician Decision|2|||
144476216|NCT01521884|520942022|FG000|Overall Study|Protocol Violation|3|||
144476217|NCT01521884|520942022|FG000|Overall Study|Participant non-eligible|1|||
144476218|NCT01521884|520942022|FG000|Overall Study|Lost to Follow-up|4|||
144476219|NCT02821819|520942023|FG000|Overall Study|Protocol Violation|1|||
144476220|NCT02839343|520942024|FG000|Overall Study|Withdrawal by Subject|3|||
144588083|NCT00812331|521352275|FG004|Overall Study|Adverse Event|0|||
144588084|NCT01506453|521352276|FG000|Overall Study|Withdrawal prior to treatment|0|||
144588085|NCT01506453|521352277|FG001|Overall Study|Withdrawal prior to treatment|2|||
144588086|NCT03694275|521352278|FG000|Overall Study|Adverse Event|0|||
144588087|NCT03694275|521352279|FG001|Overall Study|Adverse Event|1|||
144588088|NCT03694275|521352278|FG000|Overall Study|Reason not Specified|0|||
144588089|NCT03694275|521352279|FG001|Overall Study|Reason not Specified|1|||
144588090|NCT02502799|521352280|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
144588091|NCT02502799|521352281|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
144588092|NCT02502799|521352282|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
144588093|NCT02502799|521352283|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
144588094|NCT02502799|521352280|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
144588095|NCT02502799|521352281|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
144588096|NCT02502799|521352282|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
144588097|NCT02502799|521352283|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
144588098|NCT02502799|521352280|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
144588099|NCT02502799|521352281|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
144588100|NCT02502799|521352282|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
144588101|NCT02502799|521352283|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
144588102|NCT02502799|521352280|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
144588103|NCT02502799|521352281|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
144588104|NCT02502799|521352282|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
144588105|NCT02502799|521352283|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
144588106|NCT02502799|521352280|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
144588107|NCT02502799|521352281|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
144588108|NCT02502799|521352282|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
144588109|NCT02502799|521352283|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
144588110|NCT00153062|521352287|FG000|Overall Study|Death|360|||
144588111|NCT00153062|521352288|FG001|Overall Study|Death|352|||
144588112|NCT00153062|521352289|FG002|Overall Study|Death|369|||
144588113|NCT00153062|521352290|FG003|Overall Study|Death|365|||
144588114|NCT00153062|521352287|FG000|Overall Study|Withdrawal by Subject|14|||
144588115|NCT00153062|521352288|FG001|Overall Study|Withdrawal by Subject|30|||
144588116|NCT00153062|521352289|FG002|Overall Study|Withdrawal by Subject|27|||
144588117|NCT00153062|521352290|FG003|Overall Study|Withdrawal by Subject|28|||
144588118|NCT00153062|521352287|FG000|Overall Study|Lost to Follow-up|12|||
144588119|NCT00153062|521352288|FG001|Overall Study|Lost to Follow-up|20|||
144588120|NCT00153062|521352289|FG002|Overall Study|Lost to Follow-up|15|||
144588121|NCT00153062|521352290|FG003|Overall Study|Lost to Follow-up|16|||
144588122|NCT00153062|521352287|FG000|Overall Study|Adverse Event|0|||
144588123|NCT00153062|521352288|FG001|Overall Study|Adverse Event|1|||
144588124|NCT00153062|521352289|FG002|Overall Study|Adverse Event|1|||
144588125|NCT00153062|521352290|FG003|Overall Study|Adverse Event|0|||
144588126|NCT00153062|521352287|FG000|Overall Study|Protocol Violation|0|||
144588127|NCT00153062|521352288|FG001|Overall Study|Protocol Violation|2|||
144588128|NCT00153062|521352289|FG002|Overall Study|Protocol Violation|1|||
144588129|NCT00153062|521352290|FG003|Overall Study|Protocol Violation|1|||
144588130|NCT00153062|521352287|FG000|Overall Study|No disposition data available|1|||
144476221|NCT02839343|520942025|FG001|Overall Study|Withdrawal by Subject|1|||
144476222|NCT02839343|520942024|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
144476223|NCT02839343|520942025|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
144476224|NCT02839343|520942024|FG000|Overall Study|Adverse Event|1|||
144476225|NCT02839343|520942025|FG001|Overall Study|Adverse Event|0|||
144476226|NCT01353222|520942032|FG000|Overall Study|Death|30|||
144476227|NCT01353222|520942033|FG001|Overall Study|Death|30|||
144476228|NCT01353222|520942032|FG000|Overall Study|Withdrawal by Subject|8|||
144476229|NCT01353222|520942033|FG001|Overall Study|Withdrawal by Subject|5|||
144476230|NCT01353222|520942032|FG000|Overall Study|Study Terminated|31|||
144476231|NCT01353222|520942033|FG001|Overall Study|Study Terminated|37|||
144476232|NCT01353222|520942032|FG000|Overall Study|Site closed research department|1|||
144476233|NCT01353222|520942033|FG001|Overall Study|Site closed research department|0|||
144476234|NCT01654601|520942037|FG000|1st Administration|Withdrawal by Subject|2|||
144476235|NCT01654601|520942038|FG001|1st Administration|Withdrawal by Subject|0|||
144476236|NCT01654601|520942037|FG000|1st Administration|Protocol Violation|0|||
144476237|NCT01654601|520942038|FG001|1st Administration|Protocol Violation|2|||
144476238|NCT01654601|520942037|FG000|2nd Administration|Adverse Event|1|||
144476239|NCT01654601|520942038|FG001|2nd Administration|Adverse Event|0|||
144476240|NCT01654601|520942037|FG000|2nd Administration|Protocol Violation|0|||
144476241|NCT01654601|520942038|FG001|2nd Administration|Protocol Violation|1|||
144476242|NCT02636270|520942039|FG000|Overall Study|Adverse Event|1|||
144476243|NCT02636270|520942040|FG001|Overall Study|Adverse Event|0|||
144476244|NCT02636270|520942041|FG002|Overall Study|Adverse Event|0|||
144476245|NCT02636270|520942039|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
144476246|NCT02636270|520942040|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
144476247|NCT02636270|520942041|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
144476248|NCT01119898|520942042|FG000|Overall Study|Adverse Event|4|||
144476249|NCT01119898|520942043|FG001|Overall Study|Adverse Event|5|||
144476250|NCT01119898|520942042|FG000|Overall Study|Withdrawal by Subject|1|||
144476251|NCT01119898|520942043|FG001|Overall Study|Withdrawal by Subject|4|||
144701588|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
144701589|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
144701590|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
144701591|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
144701592|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
144476252|NCT01119898|520942042|FG000|Overall Study|Lack of Efficacy|0|||
144476253|NCT01119898|520942043|FG001|Overall Study|Lack of Efficacy|2|||
144476254|NCT01119898|520942042|FG000|Overall Study|Protocol Violation|1|||
144476255|NCT01119898|520942043|FG001|Overall Study|Protocol Violation|1|||
144476256|NCT01119898|520942042|FG000|Overall Study|Medical procedure|1|||
144476257|NCT01119898|520942043|FG001|Overall Study|Medical procedure|0|||
144476258|NCT01119898|520942042|FG000|Overall Study|Randomized in error did not participate|1|||
144476259|NCT01119898|520942043|FG001|Overall Study|Randomized in error did not participate|0|||
144476260|NCT01806584|520942044|FG000|Overall Study|Adverse Event|2|||
144476261|NCT01806584|520942045|FG001|Overall Study|Adverse Event|1|||
144476262|NCT01806584|520942044|FG000|Overall Study|Death|1|||
144476263|NCT01806584|520942045|FG001|Overall Study|Death|0|||
144476264|NCT01806584|520942044|FG000|Overall Study|Lost to Follow-up|0|||
144476265|NCT01806584|520942045|FG001|Overall Study|Lost to Follow-up|2|||
144476266|NCT01806584|520942044|FG000|Overall Study|Study terminated by sponsor|9|||
144476267|NCT01806584|520942045|FG001|Overall Study|Study terminated by sponsor|14|||
144476268|NCT01806584|520942044|FG000|Overall Study|Withdrawal by Subject|1|||
144476269|NCT01806584|520942045|FG001|Overall Study|Withdrawal by Subject|1|||
144476270|NCT01806584|520942044|FG000|Overall Study|Other unspecified|1|||
144476271|NCT01806584|520942045|FG001|Overall Study|Other unspecified|0|||
144476272|NCT01833143|520942046|FG000|Overall Study|Not Treated|1|||
144476273|NCT03021668|520942047|FG000|Overall Study|Physician Decision|0|||
144476274|NCT03021668|520942048|FG001|Overall Study|Physician Decision|1|||
144476275|NCT02217280|520942049|FG000|Overall Study|Withdrawal by Subject|2|||
144476276|NCT02217280|520942049|FG000|Overall Study|Post-consent sceen fail|2|||
144476277|NCT00116844|520942052|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
144476278|NCT00116844|520942053|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
144476279|NCT00116844|520942052|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
144476280|NCT00116844|520942053|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
144360427|NCT00168844|520527491|FG002|Overall Study|Lost to Follow-up|11|||
144476281|NCT00116844|520942052|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
144476282|NCT00116844|520942053|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
144476283|NCT00116844|520942052|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
144476284|NCT00116844|520942053|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
144476285|NCT00116844|520942052|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
144476286|NCT00116844|520942053|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
144476287|NCT00116844|520942052|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
144476288|NCT00116844|520942053|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
144476289|NCT00116844|520942052|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
144476290|NCT00116844|520942053|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
144476291|NCT00116844|520942052|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
144476292|NCT00116844|520942053|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
144476293|NCT00116844|520942052|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
144476294|NCT00116844|520942053|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
144476295|NCT03995784|520942054|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
144476296|NCT01786330|520942061|FG000|Overall Study|Withdrawal by Subject|0|||
144476297|NCT01786330|520942062|FG001|Overall Study|Withdrawal by Subject|1|||
144476298|NCT01786330|520942061|FG000|Overall Study|Lost to Follow-up|0|||
144476299|NCT01786330|520942062|FG001|Overall Study|Lost to Follow-up|1|||
144476300|NCT01786330|520942061|FG000|Overall Study|Excluded intraoperatively|0|||
144476301|NCT01786330|520942062|FG001|Overall Study|Excluded intraoperatively|1|||
144476302|NCT01786330|520942061|FG000|Overall Study|Protocol Violation|1|||
144476303|NCT01786330|520942062|FG001|Overall Study|Protocol Violation|0|||
144476304|NCT02172625|520942063|FG000|Overall Study|Adverse Event|0|||
144476305|NCT02172625|520942064|FG001|Overall Study|Adverse Event|1|||
144476306|NCT02172625|520942063|FG000|Overall Study|Pregnancy|0|||
144476307|NCT02172625|520942064|FG001|Overall Study|Pregnancy|1|||
144476308|NCT02172625|520942063|FG000|Overall Study|car accident|0|||
144476309|NCT02172625|520942064|FG001|Overall Study|car accident|1|||
144476310|NCT00429494|520944098|FG000|Overall Study|Withdrawal by Subject|9|||
144476311|NCT00429494|520944098|FG000|Overall Study|Death|6|||
144476312|NCT00976703|520944099|FG000|Overall Study|Physician Decision|1|||
144476313|NCT00976703|520944100|FG001|Overall Study|Physician Decision|1|||
144476314|NCT00976703|520944099|FG000|Overall Study|ineligible for study|2|||
144476315|NCT00976703|520944100|FG001|Overall Study|ineligible for study|2|||
144476316|NCT03075501|520944109|FG000|Overall Study|Scheduling difficulties|15|||
144476317|NCT03075501|520944110|FG001|Overall Study|Scheduling difficulties|9|||
144476318|NCT02045433|520944118|FG000|Overall Study|Withdrawal by Subject|1|||
144476319|NCT01559454|520944119|FG000|Overall Study|Lost to Follow-up|3|||
144476320|NCT01559454|520944120|FG001|Overall Study|Lost to Follow-up|2|||
144476321|NCT01559454|520944119|FG000|Overall Study|Withdrawal by Subject|0|||
144476322|NCT01559454|520944120|FG001|Overall Study|Withdrawal by Subject|1|||
144476323|NCT01559454|520944119|FG000|Overall Study|Physician Decision|0|||
144476324|NCT01559454|520944120|FG001|Overall Study|Physician Decision|1|||
144476325|NCT01559454|520944119|FG000|Overall Study|Protocol Violation|0|||
144476326|NCT01559454|520944120|FG001|Overall Study|Protocol Violation|1|||
144476327|NCT01559454|520944119|FG000|Overall Study|Lack of Efficacy|0|||
144476328|NCT01559454|520944120|FG001|Overall Study|Lack of Efficacy|1|||
144701593|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
144701594|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
144701595|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
144701596|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
144701597|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
144701598|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
144701599|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
144701600|NCT04242498|521760114|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
144701601|NCT04242498|521760115|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
144701602|NCT04242498|521760116|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
144701603|NCT04242498|521760117|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
144701604|NCT04242498|521760118|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
144701605|NCT04242498|521760119|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
144701606|NCT04242498|521760120|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
144701607|NCT01083121|521760121|FG000|Overall Study|Use of Humira outside the approved label|81|||
144701608|NCT03743571|521760122|FG000|Overall Study|Withdrawal by Subject|1|||
144701609|NCT03743571|521760123|FG001|Overall Study|Withdrawal by Subject|1|||
144701610|NCT03743571|521760122|FG000|Overall Study|Lost to Follow-up|1|||
144701611|NCT03743571|521760123|FG001|Overall Study|Lost to Follow-up|2|||
144701612|NCT01233284|521760134|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
144701613|NCT01233284|521760135|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144476329|NCT02207725|520944121|FG000|Overall Study|Did Not Receive Treatment|0|||
144476330|NCT02207725|520944122|FG001|Overall Study|Did Not Receive Treatment|1|||
144476331|NCT02207725|520944123|FG002|Overall Study|Did Not Receive Treatment|1|||
144476332|NCT02207725|520944124|FG003|Overall Study|Did Not Receive Treatment|1|||
144476333|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
144476334|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
144476335|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Adverse Event|2|||
144476336|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Adverse Event|5|||
144701614|NCT01233284|521760136|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144701615|NCT01233284|521760137|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144701616|NCT01233284|521760138|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144701617|NCT01233284|521760134|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144701618|NCT01233284|521760135|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
144701619|NCT01233284|521760136|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144701620|NCT01233284|521760137|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144701621|NCT01233284|521760138|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144701622|NCT01233284|521760134|FG000|Period 1 (4 Weeks)|Other|0|||
144701623|NCT01233284|521760135|FG001|Period 1 (4 Weeks)|Other|0|||
144701624|NCT01233284|521760136|FG002|Period 1 (4 Weeks)|Other|1|||
144701625|NCT01233284|521760137|FG003|Period 1 (4 Weeks)|Other|0|||
144701626|NCT01233284|521760138|FG004|Period 1 (4 Weeks)|Other|0|||
144701627|NCT01233284|521760134|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144701628|NCT01233284|521760135|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144701629|NCT01233284|521760136|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
144701630|NCT01233284|521760137|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144701631|NCT01233284|521760138|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144701632|NCT01233284|521760134|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144701633|NCT01233284|521760135|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144701634|NCT01233284|521760136|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
144701635|NCT01233284|521760137|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144701636|NCT01233284|521760138|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144701637|NCT01233284|521760134|FG000|Period 3 (4 Weeks)|Other|0|||
144701638|NCT01233284|521760135|FG001|Period 3 (4 Weeks)|Other|0|||
144701639|NCT01233284|521760136|FG002|Period 3 (4 Weeks)|Other|0|||
144701640|NCT01233284|521760137|FG003|Period 3 (4 Weeks)|Other|1|||
144701641|NCT01233284|521760138|FG004|Period 3 (4 Weeks)|Other|0|||
144701642|NCT01233284|521760134|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
144701643|NCT01233284|521760135|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
144701644|NCT01233284|521760136|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
144701645|NCT01233284|521760137|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
144701646|NCT01233284|521760138|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
144701647|NCT01233284|521760134|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
144701648|NCT01233284|521760135|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
144701649|NCT01233284|521760136|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
144701650|NCT01233284|521760137|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
144701651|NCT01233284|521760138|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
144701652|NCT00167414|521760140|FG000|Overall Study|Death|10|||
144701653|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
144701654|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
144701655|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
144701656|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
144701657|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
144701658|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
144701659|NCT00828009|521760146|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
144701660|NCT00828009|521760146|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
144701661|NCT00828009|521760146|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
144701662|NCT00828009|521760146|FG000|Step 2 - Maintenance Therapy|Death|1|||
144701663|NCT00828009|521760146|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
144701664|NCT00828009|521760146|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
144701665|NCT00828009|521760146|FG000|Step 2 - Maintenance Therapy|Other|1|||
144701666|NCT04478994|521761587|FG000|Overall Study|Withdrawal by Subject|1|||
144701667|NCT04478994|521761588|FG001|Overall Study|Withdrawal by Subject|1|||
144701668|NCT01100073|521761589|FG000|Overall Study|Lack of Efficacy|4|||
144701669|NCT01100073|521761589|FG000|Overall Study|Insufficient Tolerability|21|||
144701670|NCT01100073|521761589|FG000|Overall Study|Withdrawal by Subject|13|||
144701671|NCT01100073|521761589|FG000|Overall Study|Lost to Follow-up|39|||
144701672|NCT01100073|521761589|FG000|Overall Study|Lack of effect + patient's wish|2|||
144701673|NCT01100073|521761589|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
144701674|NCT01100073|521761589|FG000|Overall Study|Other|8|||
144701675|NCT01100073|521761589|FG000|Overall Study|Missing|5|||
144701676|NCT00299546|521761590|FG000|Overall Study|Death|3|||
144701677|NCT00299546|521761591|FG001|Overall Study|Death|2|||
144701678|NCT00299546|521761592|FG002|Overall Study|Death|0|||
144701679|NCT00299546|521761590|FG000|Overall Study|Lost to Follow-up|2|||
144701680|NCT00299546|521761591|FG001|Overall Study|Lost to Follow-up|2|||
144701681|NCT00299546|521761592|FG002|Overall Study|Lost to Follow-up|5|||
144701682|NCT00299546|521761590|FG000|Overall Study|Adverse Event|37|||
144701683|NCT00299546|521761591|FG001|Overall Study|Adverse Event|22|||
144701684|NCT00299546|521761592|FG002|Overall Study|Adverse Event|27|||
144701685|NCT00299546|521761590|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
144701686|NCT00299546|521761591|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
144701687|NCT00299546|521761592|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
144701688|NCT00299546|521761590|FG000|Overall Study|Other|24|||
144701689|NCT00299546|521761591|FG001|Overall Study|Other|26|||
144701690|NCT00299546|521761592|FG002|Overall Study|Other|19|||
144476337|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
144701691|NCT00299546|521761590|FG000|Overall Study|Not treated|0|||
144701692|NCT00299546|521761591|FG001|Overall Study|Not treated|1|||
144701693|NCT00299546|521761592|FG002|Overall Study|Not treated|1|||
144701694|NCT03099265|521761593|FG000|Overall Study|Adverse Event|1|||
144476338|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
144476339|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
144476340|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
144701695|NCT01741259|521761597|FG000|Overall Study|Protocol Violation|6|||
144701696|NCT01741259|521761598|FG001|Overall Study|Protocol Violation|4|||
144701697|NCT01741259|521761597|FG000|Overall Study|Withdrawal by Subject|0|||
144701698|NCT01741259|521761598|FG001|Overall Study|Withdrawal by Subject|2|||
144701699|NCT02074982|521761599|FG000|Overall Study|Adverse Event|15|||
144701700|NCT02074982|521761600|FG001|Overall Study|Adverse Event|7|||
144701701|NCT02074982|521761599|FG000|Overall Study|Lack of Efficacy|6|||
144701702|NCT02074982|521761600|FG001|Overall Study|Lack of Efficacy|1|||
144701703|NCT02074982|521761599|FG000|Overall Study|Lost to Follow-up|9|||
144701704|NCT02074982|521761600|FG001|Overall Study|Lost to Follow-up|10|||
144701705|NCT02074982|521761599|FG000|Overall Study|Non-compliance with study treatment|0|||
144701706|NCT02074982|521761600|FG001|Overall Study|Non-compliance with study treatment|2|||
144701707|NCT02074982|521761599|FG000|Overall Study|Physician Decision|1|||
144701708|NCT02074982|521761600|FG001|Overall Study|Physician Decision|1|||
144701709|NCT02074982|521761599|FG000|Overall Study|Pregnancy|1|||
144701710|NCT02074982|521761600|FG001|Overall Study|Pregnancy|2|||
144701711|NCT02074982|521761599|FG000|Overall Study|Protocol deviation|4|||
144701712|NCT02074982|521761600|FG001|Overall Study|Protocol deviation|3|||
144701713|NCT02074982|521761599|FG000|Overall Study|Technical problems|0|||
144701714|NCT02074982|521761600|FG001|Overall Study|Technical problems|2|||
144701715|NCT02074982|521761599|FG000|Overall Study|Subject/guardian decision|15|||
144701716|NCT02074982|521761600|FG001|Overall Study|Subject/guardian decision|24|||
144701717|NCT02074982|521761599|FG000|Overall Study|Death|0|||
144701718|NCT02074982|521761600|FG001|Overall Study|Death|2|||
144701719|NCT02094573|521761603|FG000|Overall Study|Adverse Event|4|||
144701720|NCT02094573|521761604|FG001|Overall Study|Adverse Event|14|||
144701721|NCT02094573|521761603|FG000|Overall Study|Clinical Progressive Disease|9|||
144701722|NCT02094573|521761604|FG001|Overall Study|Clinical Progressive Disease|13|||
144701723|NCT02094573|521761603|FG000|Overall Study|Death|11|||
144701724|NCT02094573|521761604|FG001|Overall Study|Death|3|||
144701725|NCT02094573|521761603|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
144701726|NCT02094573|521761604|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
144701727|NCT02094573|521761603|FG000|Overall Study|Non-compliance with Study Drug|1|||
144701728|NCT02094573|521761604|FG001|Overall Study|Non-compliance with Study Drug|1|||
144701729|NCT02094573|521761603|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
144701730|NCT02094573|521761604|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
144701731|NCT02094573|521761603|FG000|Overall Study|Physician Decision|4|||
144701732|NCT02094573|521761604|FG001|Overall Study|Physician Decision|4|||
144476341|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Randomized by error|0|||
144476342|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Randomized by error|5|||
144476343|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
144476344|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
144476345|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
144476346|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
144476347|NCT02948959|520944128|FG000|52 Weeks Treatment Period|Change of residence location|0|||
144476348|NCT02948959|520944129|FG001|52 Weeks Treatment Period|Change of residence location|1|||
144476349|NCT02948959|520944128|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
144476350|NCT02948959|520944129|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
144476351|NCT02948959|520944128|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
144476352|NCT02948959|520944129|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
144476353|NCT02948959|520944128|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
144476354|NCT02948959|520944129|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
144476355|NCT02948959|520944128|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
144476356|NCT02948959|520944129|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
144476357|NCT02948959|520944128|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
144476358|NCT02948959|520944129|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
144476359|NCT02948959|520944128|FG000|12 Weeks Follow-up Period|Study site closure|1|||
144701733|NCT02094573|521761603|FG000|Overall Study|Site Terminated by Sponsor|10|||
144701734|NCT02094573|521761604|FG001|Overall Study|Site Terminated by Sponsor|17|||
144701735|NCT02094573|521761603|FG000|Overall Study|Withdrawal by Subject|6|||
144476360|NCT02948959|520944129|FG001|12 Weeks Follow-up Period|Study site closure|0|||
144476361|NCT00409786|520944130|FG000|Overall Study|Withdrawal by Subject|3|||
144701736|NCT02094573|521761604|FG001|Overall Study|Withdrawal by Subject|8|||
144701737|NCT02094573|521761603|FG000|Overall Study|Randomized but not Treated|3|||
144701738|NCT02094573|521761604|FG001|Overall Study|Randomized but not Treated|0|||
144701739|NCT02411110|521761607|FG000|Treatment Period 1|Adverse Event|4|||
144476362|NCT00597714|520944131|FG000|Overall Study|Death|56|||
144476363|NCT00597714|520944132|FG001|Overall Study|Death|46|||
144476364|NCT00597714|520944133|FG002|Overall Study|Death|0|||
144476365|NCT00597714|520944131|FG000|Overall Study|Recipient death|0|||
144476366|NCT00597714|520944132|FG001|Overall Study|Recipient death|0|||
144476367|NCT00597714|520944133|FG002|Overall Study|Recipient death|10|||
144476368|NCT01350141|520944134|FG000|Overall Study|Lost to Follow-up|1|||
144476369|NCT01350141|520944135|FG001|Overall Study|Lost to Follow-up|0|||
144476370|NCT01350141|520944136|FG002|Overall Study|Lost to Follow-up|1|||
144476371|NCT01350141|520944134|FG000|Overall Study|Withdrawal by Subject|1|||
144476372|NCT01350141|520944135|FG001|Overall Study|Withdrawal by Subject|0|||
144476373|NCT01350141|520944136|FG002|Overall Study|Withdrawal by Subject|0|||
144476374|NCT01350141|520944134|FG000|Overall Study|Randomized but not treated|1|||
144476375|NCT01350141|520944135|FG001|Overall Study|Randomized but not treated|0|||
144476376|NCT01350141|520944136|FG002|Overall Study|Randomized but not treated|0|||
144476377|NCT00519896|520944137|FG000|Overall Study|Protocol Violation|1|||
144476378|NCT00519896|520944137|FG000|Overall Study|Adverse Event|1|||
144476379|NCT00810082|520944138|FG000|Overall Study|Lost to Follow-up|0|||
144476380|NCT00810082|520944139|FG001|Overall Study|Lost to Follow-up|4|||
144476381|NCT01588990|520944140|FG000|Phase A|Withdrawal by Subject|5|||
144476382|NCT01588990|520944140|FG000|Phase A|Physician Decision|11|||
144476383|NCT01588990|520944140|FG000|Phase A|Other|14|||
144476384|NCT01588990|520944140|FG000|Phase A|Lost to Follow-up|1|||
144476385|NCT01588990|520944140|FG000|Phase A|Death|5|||
144476386|NCT01588990|520944140|FG000|Phase A|Adverse Event|28|||
144476387|NCT01588990|520944140|FG000|Phase A|Still on therapy at end of study|6|||
144476388|NCT01588990|520944140|FG000|Phase B|Adverse Event|2|||
144701740|NCT02411110|521761608|FG001|Treatment Period 1|Adverse Event|2|||
144701741|NCT02411110|521761607|FG000|Treatment Period 1|Lost to Follow-up|1|||
144701742|NCT02411110|521761608|FG001|Treatment Period 1|Lost to Follow-up|0|||
144701743|NCT02411110|521761607|FG000|Treatment Period 1|Personal Reasons|2|||
144701744|NCT02411110|521761608|FG001|Treatment Period 1|Personal Reasons|5|||
144701745|NCT02411110|521761607|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
144701746|NCT02411110|521761608|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
144701747|NCT02411110|521761607|FG000|Treatment Period 2|Adverse Event|1|||
144701748|NCT02411110|521761608|FG001|Treatment Period 2|Adverse Event|0|||
144701749|NCT02411110|521761607|FG000|Treatment Period 2|Lost to Follow-up|0|||
144701750|NCT02411110|521761608|FG001|Treatment Period 2|Lost to Follow-up|2|||
144701751|NCT02411110|521761607|FG000|Treatment Period 2|Personal Reasons|0|||
144701752|NCT02411110|521761608|FG001|Treatment Period 2|Personal Reasons|2|||
144701753|NCT00526162|521761609|FG000|Overall Study|Device not implanted|3|||
144701754|NCT01353586|521761610|FG000|Overall Study|Procedure terminated prior to ablation|3|||
144701755|NCT01353586|521761611|FG001|Overall Study|Procedure terminated prior to ablation|0|||
144701756|NCT01353586|521761610|FG000|Overall Study|Never had insertion of study catheter|4|||
144701757|NCT01353586|521761611|FG001|Overall Study|Never had insertion of study catheter|1|||
144701758|NCT01353586|521761610|FG000|Overall Study|Neurological exam not done|0|||
144701759|NCT01353586|521761611|FG001|Overall Study|Neurological exam not done|1|||
144701760|NCT05027958|521761612|FG000|Overall Study|Lost to Follow-up|1|||
144701761|NCT05027958|521761613|FG001|Overall Study|Lost to Follow-up|1|||
144701762|NCT05027958|521761612|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
144701763|NCT05027958|521761613|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
144701764|NCT05027958|521761612|FG000|Overall Study|Physician Decision|1|||
144701765|NCT05027958|521761613|FG001|Overall Study|Physician Decision|4|||
144701766|NCT05027958|521761612|FG000|Overall Study|Adverse Event|0|||
144701767|NCT05027958|521761613|FG001|Overall Study|Adverse Event|1|||
144701768|NCT00491322|521761615|FG000|Overall Study|Protocol Violation|1|||
144701769|NCT00491322|521761616|FG001|Overall Study|Protocol Violation|0|||
144701770|NCT00491322|521761615|FG000|Overall Study|Pregnancy|0|||
144701771|NCT00491322|521761616|FG001|Overall Study|Pregnancy|1|||
144701772|NCT02060188|521761629|FG000|Overall Study|Disease Progression|36|||
144701773|NCT02060188|521761630|FG001|Overall Study|Disease Progression|42|||
144701774|NCT02060188|521761631|FG002|Overall Study|Disease Progression|8|||
144701775|NCT02060188|521761632|FG003|Overall Study|Disease Progression|5|||
144701776|NCT02060188|521761633|FG004|Overall Study|Disease Progression|6|||
144701777|NCT02060188|521761634|FG005|Overall Study|Disease Progression|3|||
144476389|NCT01588990|520944140|FG000|Phase B|Still on therapy at end of study|5|||
144476390|NCT01588990|520944140|FG000|Phase B|Withdrawal by Subject|3|||
144476391|NCT01588990|520944140|FG000|Phase B|Physician Decision|4|||
144476392|NCT01588990|520944140|FG000|Phase B|Other|2|||
144476393|NCT02367716|520944145|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
144476394|NCT02341456|520944146|FG000|Overall Study|Disease progression|2|||
144476395|NCT02341456|520944147|FG001|Overall Study|Disease progression|3|||
144701778|NCT02060188|521761635|FG006|Overall Study|Disease Progression|23|||
144701779|NCT02060188|521761636|FG007|Overall Study|Disease Progression|20|||
144701780|NCT02060188|521761637|FG008|Overall Study|Disease Progression|43|||
144476396|NCT02341456|520944148|FG002|Overall Study|Disease progression|1|||
144476397|NCT02341456|520944146|FG000|Overall Study|Death|1|||
144476398|NCT02341456|520944147|FG001|Overall Study|Death|1|||
144476399|NCT02341456|520944148|FG002|Overall Study|Death|1|||
144476400|NCT02341456|520944146|FG000|Overall Study|Withdrawal by Subject|0|||
144476401|NCT02341456|520944147|FG001|Overall Study|Withdrawal by Subject|1|||
144476402|NCT02341456|520944148|FG002|Overall Study|Withdrawal by Subject|1|||
144476403|NCT02341456|520944146|FG000|Overall Study|Moved to local access programme.|0|||
144476404|NCT02341456|520944147|FG001|Overall Study|Moved to local access programme.|1|||
144476405|NCT02341456|520944148|FG002|Overall Study|Moved to local access programme.|1|||
144476406|NCT02341456|520944146|FG000|Overall Study|Physician Decision|1|||
144476407|NCT02341456|520944147|FG001|Overall Study|Physician Decision|0|||
144476408|NCT02341456|520944148|FG002|Overall Study|Physician Decision|0|||
144476409|NCT01077362|520944149|FG000|Overall Study|Lack of Efficacy|13|||
144476410|NCT01077362|520944150|FG001|Overall Study|Lack of Efficacy|8|||
144476411|NCT01077362|520944151|FG002|Overall Study|Lack of Efficacy|10|||
144476412|NCT01077362|520944149|FG000|Overall Study|Lost to Follow-up|1|||
144476413|NCT01077362|520944150|FG001|Overall Study|Lost to Follow-up|0|||
144476414|NCT01077362|520944151|FG002|Overall Study|Lost to Follow-up|3|||
144476415|NCT01077362|520944149|FG000|Overall Study|Adverse Event|12|||
144476416|NCT01077362|520944150|FG001|Overall Study|Adverse Event|7|||
144476417|NCT01077362|520944151|FG002|Overall Study|Adverse Event|4|||
144476418|NCT01077362|520944149|FG000|Overall Study|Withdrawal by Subject|5|||
144476419|NCT01077362|520944150|FG001|Overall Study|Withdrawal by Subject|3|||
144476420|NCT01077362|520944151|FG002|Overall Study|Withdrawal by Subject|5|||
144476421|NCT01077362|520944149|FG000|Overall Study|Other|0|||
144476422|NCT01077362|520944150|FG001|Overall Study|Other|1|||
144476423|NCT01077362|520944151|FG002|Overall Study|Other|2|||
144476424|NCT02508532|520944152|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476425|NCT02508532|520944153|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476426|NCT02508532|520944154|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476427|NCT02508532|520944155|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476428|NCT02508532|520944156|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476429|NCT02508532|520944157|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476430|NCT02508532|520944158|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
144476431|NCT02508532|520944159|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476432|NCT02508532|520944160|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
144476433|NCT02508532|520944152|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476434|NCT02508532|520944153|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476435|NCT02508532|520944154|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476436|NCT02508532|520944155|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476437|NCT02508532|520944156|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476438|NCT02508532|520944157|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476439|NCT02508532|520944158|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476440|NCT02508532|520944159|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
144476441|NCT02508532|520944160|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
144476442|NCT02508532|520944152|FG000|Part 2 - Treatment|Disease Progression|0|||
144476443|NCT02508532|520944153|FG001|Part 2 - Treatment|Disease Progression|0|||
144476444|NCT02508532|520944154|FG002|Part 2 - Treatment|Disease Progression|0|||
144476445|NCT02508532|520944155|FG003|Part 2 - Treatment|Disease Progression|0|||
144476446|NCT02508532|520944156|FG004|Part 2 - Treatment|Disease Progression|0|||
144476447|NCT02508532|520944157|FG005|Part 2 - Treatment|Disease Progression|0|||
144476448|NCT02508532|520944158|FG006|Part 2 - Treatment|Disease Progression|0|||
144476449|NCT02508532|520944159|FG007|Part 2 - Treatment|Disease Progression|0|||
144476450|NCT02508532|520944160|FG008|Part 2 - Treatment|Disease Progression|118|||
144476451|NCT02508532|520944152|FG000|Part 2 - Treatment|Adverse Event|0|||
144476452|NCT02508532|520944153|FG001|Part 2 - Treatment|Adverse Event|0|||
144476453|NCT02508532|520944154|FG002|Part 2 - Treatment|Adverse Event|0|||
144476454|NCT02508532|520944155|FG003|Part 2 - Treatment|Adverse Event|0|||
144476455|NCT02508532|520944156|FG004|Part 2 - Treatment|Adverse Event|0|||
144476456|NCT02508532|520944157|FG005|Part 2 - Treatment|Adverse Event|0|||
144476457|NCT02508532|520944158|FG006|Part 2 - Treatment|Adverse Event|0|||
144476458|NCT02508532|520944159|FG007|Part 2 - Treatment|Adverse Event|0|||
144476459|NCT02508532|520944160|FG008|Part 2 - Treatment|Adverse Event|49|||
144476460|NCT02508532|520944152|FG000|Part 2 - Treatment|Physician Decision|0|||
144476461|NCT02508532|520944153|FG001|Part 2 - Treatment|Physician Decision|0|||
144476462|NCT02508532|520944154|FG002|Part 2 - Treatment|Physician Decision|0|||
144476463|NCT02508532|520944155|FG003|Part 2 - Treatment|Physician Decision|0|||
144476464|NCT02508532|520944156|FG004|Part 2 - Treatment|Physician Decision|0|||
144476465|NCT02508532|520944157|FG005|Part 2 - Treatment|Physician Decision|0|||
144476466|NCT02508532|520944158|FG006|Part 2 - Treatment|Physician Decision|0|||
144476467|NCT02508532|520944159|FG007|Part 2 - Treatment|Physician Decision|0|||
144476468|NCT02508532|520944160|FG008|Part 2 - Treatment|Physician Decision|12|||
144476469|NCT02508532|520944152|FG000|Part 2 - Treatment|Administrative|0|||
144476470|NCT02508532|520944153|FG001|Part 2 - Treatment|Administrative|0|||
144476471|NCT02508532|520944154|FG002|Part 2 - Treatment|Administrative|0|||
144476472|NCT02508532|520944155|FG003|Part 2 - Treatment|Administrative|0|||
144476473|NCT02508532|520944156|FG004|Part 2 - Treatment|Administrative|0|||
144476474|NCT02508532|520944157|FG005|Part 2 - Treatment|Administrative|0|||
144476475|NCT02508532|520944158|FG006|Part 2 - Treatment|Administrative|0|||
144476476|NCT02508532|520944159|FG007|Part 2 - Treatment|Administrative|0|||
144476477|NCT02508532|520944160|FG008|Part 2 - Treatment|Administrative|3|||
144476478|NCT02508532|520944152|FG000|Part 2 - Treatment|Sponsor Decision|0|||
144476479|NCT02508532|520944153|FG001|Part 2 - Treatment|Sponsor Decision|0|||
144476480|NCT02508532|520944154|FG002|Part 2 - Treatment|Sponsor Decision|0|||
144476481|NCT02508532|520944155|FG003|Part 2 - Treatment|Sponsor Decision|0|||
144476482|NCT02508532|520944156|FG004|Part 2 - Treatment|Sponsor Decision|0|||
144476483|NCT02508532|520944157|FG005|Part 2 - Treatment|Sponsor Decision|0|||
144476484|NCT02508532|520944158|FG006|Part 2 - Treatment|Sponsor Decision|0|||
144476485|NCT02508532|520944159|FG007|Part 2 - Treatment|Sponsor Decision|0|||
144476486|NCT02508532|520944160|FG008|Part 2 - Treatment|Sponsor Decision|28|||
144476487|NCT02508532|520944152|FG000|Part 2 - Treatment|Death|0|||
144476488|NCT02508532|520944153|FG001|Part 2 - Treatment|Death|0|||
144476489|NCT02508532|520944154|FG002|Part 2 - Treatment|Death|0|||
144476490|NCT02508532|520944155|FG003|Part 2 - Treatment|Death|0|||
144476491|NCT02508532|520944156|FG004|Part 2 - Treatment|Death|0|||
144476492|NCT02508532|520944157|FG005|Part 2 - Treatment|Death|0|||
144476493|NCT02508532|520944158|FG006|Part 2 - Treatment|Death|0|||
144476494|NCT02508532|520944159|FG007|Part 2 - Treatment|Death|0|||
144476495|NCT02508532|520944160|FG008|Part 2 - Treatment|Death|1|||
144476496|NCT02508532|520944152|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
144476497|NCT02508532|520944153|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
144476498|NCT02508532|520944154|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
144476499|NCT02508532|520944155|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
144476500|NCT02508532|520944156|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
144476501|NCT02508532|520944157|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
144476502|NCT02508532|520944158|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
144476503|NCT02508532|520944159|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
144476504|NCT02508532|520944160|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
144476505|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
144476506|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
144476507|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
144476508|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
144476509|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
144476510|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
144476511|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
144476512|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
144476513|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
144476514|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
144476515|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
144476516|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
144476517|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
144476518|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
144476519|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
144476520|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
144476521|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
144476522|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
144476523|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Death|0|||
144476524|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Death|4|||
144476525|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Death|2|||
144476526|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Death|4|||
144476527|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Death|3|||
144476528|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Death|0|||
144476529|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Death|0|||
144476530|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Death|1|||
144476531|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Death|111|||
144476532|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
144476533|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
144476534|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
144476535|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
144476536|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
144476537|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
144476538|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
144476539|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
144476540|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
144476541|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476542|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476543|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476544|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476545|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144538186|NCT00146172|521174123|FG001|Overall Study|Adverse Event|0|||
144476546|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476547|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476548|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
144476549|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
144476550|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
144476551|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
144476552|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
144476553|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
144476554|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
144476555|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
144476556|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
144476557|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
144476558|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
144476559|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476560|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476561|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476562|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476563|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476564|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476565|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476566|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
144476567|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
144476568|NCT02508532|520944152|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
144476569|NCT02508532|520944153|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
144476570|NCT02508532|520944154|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
144476571|NCT02508532|520944155|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
144476572|NCT02508532|520944156|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
144476573|NCT02508532|520944157|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
144476574|NCT02508532|520944158|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
144476575|NCT02508532|520944159|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
144476576|NCT02508532|520944160|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
144476577|NCT00301080|520944163|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
144476578|NCT00301080|520944164|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
144476579|NCT00301080|520944165|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
144476580|NCT00301080|520944166|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
144476581|NCT00301080|520944167|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
144476582|NCT03502616|520944168|FG000|Up to Week 16|Withdrawal by Subject|1|||
144476583|NCT03502616|520944169|FG001|Up to Week 16|Withdrawal by Subject|2|||
144476584|NCT03502616|520944168|FG000|Up to Week 16|Lost to Follow-up|0|||
144476585|NCT03502616|520944169|FG001|Up to Week 16|Lost to Follow-up|1|||
144476586|NCT03502616|520944168|FG000|Up to Week 16|Randomized, but not treated|1|||
144476587|NCT03502616|520944169|FG001|Up to Week 16|Randomized, but not treated|0|||
144476588|NCT03502616|520944168|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
144476589|NCT03502616|520944169|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
144476590|NCT03502616|520944168|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
144476591|NCT03502616|520944169|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
144476592|NCT02917265|520944171|FG000|Overall Study|Physician Decision|1|||
144476593|NCT02917265|520944172|FG001|Overall Study|Physician Decision|0|||
144476594|NCT02917265|520944171|FG000|Overall Study|Withdrawal by Subject|1|||
144476595|NCT02917265|520944172|FG001|Overall Study|Withdrawal by Subject|0|||
144476596|NCT05672680|520944173|FG000|Overall Study|Patient Did Not Complete the Form|5|||
144476597|NCT05672680|520944174|FG001|Overall Study|Patient Did Not Complete the Form|4|||
144476598|NCT05672680|520944173|FG000|Overall Study|Procedure Aborted|1|||
144476599|NCT05672680|520944174|FG001|Overall Study|Procedure Aborted|0|||
144476600|NCT03682705|520944175|FG000|Overall Study|Adverse Event|1|||
144476601|NCT03682705|520944176|FG001|Overall Study|Adverse Event|1|||
144476602|NCT03682705|520944177|FG002|Overall Study|Adverse Event|1|||
144476603|NCT03682705|520944178|FG003|Overall Study|Adverse Event|0|||
144476604|NCT03682705|520944179|FG004|Overall Study|Adverse Event|1|||
144701781|NCT02060188|521761629|FG000|Overall Study|Study Drug Toxicity|10|||
144701782|NCT02060188|521761630|FG001|Overall Study|Study Drug Toxicity|18|||
144476605|NCT03682705|520944180|FG005|Overall Study|Adverse Event|1|||
144476606|NCT03682705|520944175|FG000|Overall Study|Withdrawal by Subject|1|||
144476607|NCT03682705|520944176|FG001|Overall Study|Withdrawal by Subject|3|||
144476608|NCT03682705|520944177|FG002|Overall Study|Withdrawal by Subject|2|||
144476609|NCT03682705|520944178|FG003|Overall Study|Withdrawal by Subject|4|||
144476610|NCT03682705|520944179|FG004|Overall Study|Withdrawal by Subject|0|||
144476611|NCT03682705|520944180|FG005|Overall Study|Withdrawal by Subject|1|||
144476612|NCT03682705|520944175|FG000|Overall Study|Other, not specified|0|||
144476613|NCT03682705|520944176|FG001|Overall Study|Other, not specified|0|||
144538187|NCT00146172|521174124|FG002|Overall Study|Adverse Event|1|||
144476614|NCT03682705|520944177|FG002|Overall Study|Other, not specified|0|||
144476615|NCT03682705|520944178|FG003|Overall Study|Other, not specified|1|||
144476616|NCT03682705|520944179|FG004|Overall Study|Other, not specified|2|||
144476617|NCT03682705|520944180|FG005|Overall Study|Other, not specified|0|||
144476618|NCT03682705|520944175|FG000|Overall Study|Lost to Follow-up|0|||
144476619|NCT03682705|520944176|FG001|Overall Study|Lost to Follow-up|0|||
144476620|NCT03682705|520944177|FG002|Overall Study|Lost to Follow-up|0|||
144476621|NCT03682705|520944178|FG003|Overall Study|Lost to Follow-up|0|||
144476622|NCT03682705|520944179|FG004|Overall Study|Lost to Follow-up|3|||
144476623|NCT03682705|520944180|FG005|Overall Study|Lost to Follow-up|0|||
144476624|NCT00094328|520944181|FG000|Overall Study|Lost to Follow-up|1|||
144476625|NCT01483937|520944182|FG000|Overall Study|Withdrawal by Subject|4|||
144476626|NCT01483937|520944183|FG001|Overall Study|Withdrawal by Subject|3|||
144476627|NCT02213328|520944184|FG000|Overall Study|Withdrawal by Subject|10|||
144476628|NCT02213328|520944184|FG000|Overall Study|Physician Decision|2|||
144476629|NCT02213328|520944184|FG000|Overall Study|Lost to Follow-up|16|||
144476630|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
144476631|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
144476632|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
144476633|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
144476634|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
144476635|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
144476636|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
144476637|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
144476638|NCT01336621|520944185|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
144476639|NCT01336621|520944185|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
144701783|NCT02060188|521761631|FG002|Overall Study|Study Drug Toxicity|7|||
144701784|NCT02060188|521761632|FG003|Overall Study|Study Drug Toxicity|4|||
144701785|NCT02060188|521761633|FG004|Overall Study|Study Drug Toxicity|3|||
144701786|NCT02060188|521761634|FG005|Overall Study|Study Drug Toxicity|0|||
144701787|NCT02060188|521761635|FG006|Overall Study|Study Drug Toxicity|2|||
144701788|NCT02060188|521761636|FG007|Overall Study|Study Drug Toxicity|5|||
144701789|NCT02060188|521761637|FG008|Overall Study|Study Drug Toxicity|0|||
144701790|NCT02060188|521761629|FG000|Overall Study|Adverse event unrelated to study drug|2|||
144701791|NCT02060188|521761630|FG001|Overall Study|Adverse event unrelated to study drug|5|||
144701792|NCT02060188|521761631|FG002|Overall Study|Adverse event unrelated to study drug|6|||
144701793|NCT02060188|521761632|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144701794|NCT02060188|521761633|FG004|Overall Study|Adverse event unrelated to study drug|1|||
144701795|NCT02060188|521761634|FG005|Overall Study|Adverse event unrelated to study drug|0|||
144701796|NCT02060188|521761635|FG006|Overall Study|Adverse event unrelated to study drug|4|||
144701797|NCT02060188|521761636|FG007|Overall Study|Adverse event unrelated to study drug|4|||
144701798|NCT02060188|521761637|FG008|Overall Study|Adverse event unrelated to study drug|1|||
144701799|NCT02060188|521761629|FG000|Overall Study|Participant request to discontinue study treatment|7|||
144701800|NCT02060188|521761630|FG001|Overall Study|Participant request to discontinue study treatment|7|||
144701801|NCT02060188|521761631|FG002|Overall Study|Participant request to discontinue study treatment|4|||
144701802|NCT02060188|521761632|FG003|Overall Study|Participant request to discontinue study treatment|0|||
144701803|NCT02060188|521761633|FG004|Overall Study|Participant request to discontinue study treatment|0|||
144701804|NCT02060188|521761634|FG005|Overall Study|Participant request to discontinue study treatment|0|||
144701805|NCT02060188|521761635|FG006|Overall Study|Participant request to discontinue study treatment|1|||
144701806|NCT02060188|521761636|FG007|Overall Study|Participant request to discontinue study treatment|1|||
144701807|NCT02060188|521761637|FG008|Overall Study|Participant request to discontinue study treatment|0|||
144701808|NCT02060188|521761629|FG000|Overall Study|Participant withdrew consent|3|||
144701809|NCT02060188|521761630|FG001|Overall Study|Participant withdrew consent|0|||
144701810|NCT02060188|521761631|FG002|Overall Study|Participant withdrew consent|0|||
144701811|NCT02060188|521761632|FG003|Overall Study|Participant withdrew consent|0|||
144701812|NCT02060188|521761633|FG004|Overall Study|Participant withdrew consent|0|||
144701813|NCT02060188|521761634|FG005|Overall Study|Participant withdrew consent|0|||
144701814|NCT02060188|521761635|FG006|Overall Study|Participant withdrew consent|0|||
144701815|NCT02060188|521761636|FG007|Overall Study|Participant withdrew consent|0|||
144701816|NCT02060188|521761637|FG008|Overall Study|Participant withdrew consent|0|||
144701817|NCT02060188|521761629|FG000|Overall Study|Maximum clinical benefit|13|||
144701818|NCT02060188|521761630|FG001|Overall Study|Maximum clinical benefit|38|||
144701819|NCT02060188|521761631|FG002|Overall Study|Maximum clinical benefit|19|||
144701820|NCT02060188|521761632|FG003|Overall Study|Maximum clinical benefit|0|||
144701821|NCT02060188|521761633|FG004|Overall Study|Maximum clinical benefit|0|||
144701822|NCT02060188|521761634|FG005|Overall Study|Maximum clinical benefit|0|||
144701823|NCT02060188|521761635|FG006|Overall Study|Maximum clinical benefit|0|||
144701824|NCT02060188|521761636|FG007|Overall Study|Maximum clinical benefit|10|||
144701825|NCT02060188|521761637|FG008|Overall Study|Maximum clinical benefit|0|||
144476640|NCT01336621|520944185|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
144476641|NCT01336621|520944185|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
144476642|NCT01336621|520944185|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
144476643|NCT01336621|520944185|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
144476644|NCT01126060|520944188|FG000|Overall Study|Protocol Violation|0|||
144476645|NCT01126060|520944189|FG001|Overall Study|Protocol Violation|2|||
144476646|NCT00402337|520944194|FG000|Overall Study|Adverse Event|0|||
144476647|NCT00402337|520944195|FG001|Overall Study|Adverse Event|2|||
144476648|NCT00402337|520944196|FG002|Overall Study|Adverse Event|2|||
144476649|NCT00402337|520944197|FG003|Overall Study|Adverse Event|3|||
144476650|NCT00402337|520944198|FG004|Overall Study|Adverse Event|2|||
144476651|NCT00402337|520944194|FG000|Overall Study|Noncompliance|0|||
144476652|NCT00402337|520944195|FG001|Overall Study|Noncompliance|0|||
144476653|NCT00402337|520944196|FG002|Overall Study|Noncompliance|0|||
144476654|NCT00402337|520944197|FG003|Overall Study|Noncompliance|0|||
144476655|NCT00402337|520944198|FG004|Overall Study|Noncompliance|2|||
144476656|NCT00402337|520944194|FG000|Overall Study|Withdrawal by Subject|5|||
144476657|NCT00402337|520944195|FG001|Overall Study|Withdrawal by Subject|3|||
144476658|NCT00402337|520944196|FG002|Overall Study|Withdrawal by Subject|1|||
144476659|NCT00402337|520944197|FG003|Overall Study|Withdrawal by Subject|6|||
144476660|NCT00402337|520944198|FG004|Overall Study|Withdrawal by Subject|4|||
144476661|NCT00402337|520944194|FG000|Overall Study|Lost to Follow-up|0|||
144476662|NCT00402337|520944195|FG001|Overall Study|Lost to Follow-up|0|||
144476663|NCT00402337|520944196|FG002|Overall Study|Lost to Follow-up|1|||
144476664|NCT00402337|520944197|FG003|Overall Study|Lost to Follow-up|2|||
144476665|NCT00402337|520944198|FG004|Overall Study|Lost to Follow-up|0|||
144476666|NCT00402337|520944194|FG000|Overall Study|Physician Decision|0|||
144476667|NCT00402337|520944195|FG001|Overall Study|Physician Decision|0|||
144476668|NCT00402337|520944196|FG002|Overall Study|Physician Decision|0|||
144476669|NCT00402337|520944197|FG003|Overall Study|Physician Decision|1|||
144476670|NCT00402337|520944198|FG004|Overall Study|Physician Decision|0|||
144476671|NCT00402337|520944194|FG000|Overall Study|Other Reason|0|||
144476672|NCT00402337|520944195|FG001|Overall Study|Other Reason|1|||
144476673|NCT00402337|520944196|FG002|Overall Study|Other Reason|0|||
144476674|NCT00402337|520944197|FG003|Overall Study|Other Reason|0|||
144476675|NCT00402337|520944198|FG004|Overall Study|Other Reason|0|||
144476676|NCT02178566|520944199|FG000|Overall Study|patient did not complete due to noncompliance|0|||
144476677|NCT02178566|520944200|FG001|Overall Study|patient did not complete due to noncompliance|1|||
144476678|NCT00682643|520944206|FG000|Overall Study|Adverse Event|12|||
144476679|NCT00682643|520944207|FG001|Overall Study|Adverse Event|23|||
144476680|NCT00682643|520944206|FG000|Overall Study|Lack of Efficacy|2|||
144476681|NCT00682643|520944207|FG001|Overall Study|Lack of Efficacy|0|||
144476682|NCT00682643|520944206|FG000|Overall Study|Protocol Violation|38|||
144476683|NCT00682643|520944207|FG001|Overall Study|Protocol Violation|76|||
144476684|NCT00682643|520944206|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
144476685|NCT00682643|520944207|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
144476686|NCT00682643|520944206|FG000|Overall Study|Lost to Follow-up|1|||
144476687|NCT00682643|520944207|FG001|Overall Study|Lost to Follow-up|6|||
144476688|NCT00682643|520944206|FG000|Overall Study|Physician Decision|2|||
144476689|NCT00682643|520944207|FG001|Overall Study|Physician Decision|6|||
144476690|NCT00682643|520944206|FG000|Overall Study|Withdrawal by Subject|19|||
144476691|NCT00682643|520944207|FG001|Overall Study|Withdrawal by Subject|53|||
144476692|NCT00682643|520944206|FG000|Overall Study|Did Not Receive Study Drug|1|||
144476693|NCT00682643|520944207|FG001|Overall Study|Did Not Receive Study Drug|1|||
144476694|NCT05778526|520944208|FG000|Overall Study|Lost to Follow-up|0|||
144476695|NCT05778526|520944209|FG001|Overall Study|Lost to Follow-up|1|||
144476696|NCT05778526|520944210|FG002|Overall Study|Lost to Follow-up|3|||
144476697|NCT05778526|520944208|FG000|Overall Study|Protocol Violation|0|||
144476698|NCT05778526|520944209|FG001|Overall Study|Protocol Violation|0|||
144476699|NCT05778526|520944210|FG002|Overall Study|Protocol Violation|8|||
144476700|NCT00085202|520944211|FG000|Overall Study|Still on therapy|2|||
144476701|NCT00085202|520944212|FG001|Overall Study|Still on therapy|0|||
144476702|NCT00085202|520944211|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
144476703|NCT00085202|520944212|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
144476704|NCT00085202|520944211|FG000|Overall Study|Excessive toxicity|6|||
144476705|NCT00085202|520944212|FG001|Overall Study|Excessive toxicity|5|||
144476706|NCT00085202|520944211|FG000|Overall Study|Non-specified|3|||
144476707|NCT00085202|520944212|FG001|Overall Study|Non-specified|5|||
144476708|NCT00085202|520944211|FG000|Overall Study|Withdrawal by Subject|2|||
144476709|NCT00085202|520944212|FG001|Overall Study|Withdrawal by Subject|1|||
144476710|NCT00085202|520944211|FG000|Overall Study|Physician Decision|4|||
144476711|NCT00085202|520944212|FG001|Overall Study|Physician Decision|1|||
144476712|NCT00085202|520944211|FG000|Overall Study|Progressive disease|1|||
144476713|NCT00085202|520944212|FG001|Overall Study|Progressive disease|11|||
144476714|NCT03238300|520944216|FG000|Baseline (Before Intervention)|Physician Decision|0|||
144476715|NCT03238300|520944217|FG001|Baseline (Before Intervention)|Physician Decision|1|||
144476716|NCT03238300|520944216|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
144476717|NCT03238300|520944217|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
144701826|NCT02060188|521761629|FG000|Overall Study|Other reason|3|||
144701827|NCT02060188|521761630|FG001|Overall Study|Other reason|7|||
144701828|NCT02060188|521761631|FG002|Overall Study|Other reason|0|||
144701829|NCT02060188|521761632|FG003|Overall Study|Other reason|1|||
144476718|NCT03238300|520944216|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
144476719|NCT03238300|520944217|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
144476720|NCT03238300|520944216|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
144701830|NCT02060188|521761633|FG004|Overall Study|Other reason|0|||
144701831|NCT02060188|521761634|FG005|Overall Study|Other reason|0|||
144701832|NCT02060188|521761635|FG006|Overall Study|Other reason|0|||
144701833|NCT02060188|521761636|FG007|Overall Study|Other reason|9|||
144701834|NCT02060188|521761637|FG008|Overall Study|Other reason|0|||
144701835|NCT02060188|521761629|FG000|Overall Study|Death|0|||
144701836|NCT02060188|521761630|FG001|Overall Study|Death|1|||
144701837|NCT02060188|521761631|FG002|Overall Study|Death|0|||
144701838|NCT02060188|521761632|FG003|Overall Study|Death|0|||
144701839|NCT02060188|521761633|FG004|Overall Study|Death|0|||
144701840|NCT02060188|521761634|FG005|Overall Study|Death|0|||
144701841|NCT02060188|521761635|FG006|Overall Study|Death|0|||
144701842|NCT02060188|521761636|FG007|Overall Study|Death|1|||
144701843|NCT02060188|521761637|FG008|Overall Study|Death|0|||
144701844|NCT02060188|521761629|FG000|Overall Study|Administrative reasons by sponsor|0|||
144701845|NCT02060188|521761630|FG001|Overall Study|Administrative reasons by sponsor|1|||
144701846|NCT02060188|521761631|FG002|Overall Study|Administrative reasons by sponsor|0|||
144701847|NCT02060188|521761632|FG003|Overall Study|Administrative reasons by sponsor|0|||
144701848|NCT02060188|521761633|FG004|Overall Study|Administrative reasons by sponsor|0|||
144701849|NCT02060188|521761634|FG005|Overall Study|Administrative reasons by sponsor|0|||
144701850|NCT02060188|521761635|FG006|Overall Study|Administrative reasons by sponsor|0|||
144701851|NCT02060188|521761636|FG007|Overall Study|Administrative reasons by sponsor|0|||
144701852|NCT02060188|521761637|FG008|Overall Study|Administrative reasons by sponsor|0|||
144701853|NCT02060188|521761629|FG000|Overall Study|Lost to Follow-up|0|||
144701854|NCT02060188|521761630|FG001|Overall Study|Lost to Follow-up|0|||
144701855|NCT02060188|521761631|FG002|Overall Study|Lost to Follow-up|1|||
144701856|NCT02060188|521761632|FG003|Overall Study|Lost to Follow-up|0|||
144701857|NCT02060188|521761633|FG004|Overall Study|Lost to Follow-up|0|||
144701858|NCT02060188|521761634|FG005|Overall Study|Lost to Follow-up|0|||
144701859|NCT02060188|521761635|FG006|Overall Study|Lost to Follow-up|0|||
144701860|NCT02060188|521761636|FG007|Overall Study|Lost to Follow-up|0|||
144701861|NCT02060188|521761637|FG008|Overall Study|Lost to Follow-up|0|||
144701862|NCT04150107|521761641|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
144701863|NCT04150107|521761642|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
144701864|NCT04150107|521761641|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
144701865|NCT04150107|521761642|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
144701866|NCT04456998|521761646|FG000|Overall Study|Adverse Event|0|||
144701867|NCT04456998|521761647|FG001|Overall Study|Adverse Event|4|||
144701868|NCT04456998|521761646|FG000|Overall Study|Protocol Deviation|0|||
144701869|NCT04456998|521761647|FG001|Overall Study|Protocol Deviation|1|||
144701870|NCT04456998|521761646|FG000|Overall Study|Withdrawal by Subject|0|||
144701871|NCT04456998|521761647|FG001|Overall Study|Withdrawal by Subject|1|||
144701872|NCT04455620|521761651|FG000|Overall Study|Withdrawal by Subject|0|||
144701873|NCT04455620|521761652|FG001|Overall Study|Withdrawal by Subject|0|||
144701874|NCT04455620|521761653|FG002|Overall Study|Withdrawal by Subject|2|||
144701875|NCT04455620|521761654|FG003|Overall Study|Withdrawal by Subject|0|||
144701876|NCT04455620|521761655|FG004|Overall Study|Withdrawal by Subject|1|||
144701877|NCT04455620|521761651|FG000|Overall Study|Lost to Follow-up|0|||
144701878|NCT04455620|521761652|FG001|Overall Study|Lost to Follow-up|0|||
144476721|NCT03238300|520944217|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
144476722|NCT01435655|520944221|FG000|Overall Study|Death|2|||
144476723|NCT01435655|520944221|FG000|Overall Study|Other|1|||
144476724|NCT01436201|520944222|FG000|Overall Study|Adverse Event|2|||
144476725|NCT01436201|520944222|FG000|Overall Study|Withdrawal by Subject|1|||
144476726|NCT01436201|520944222|FG000|Overall Study|Protocol Violation|1|||
144476727|NCT00110890|520944223|FG000|Overall Study|Adverse Event|30|||
144476728|NCT00110890|520944224|FG001|Overall Study|Adverse Event|7|||
144476729|NCT00110890|520944223|FG000|Overall Study|Death|16|||
144476730|NCT00110890|520944224|FG001|Overall Study|Death|9|||
144476731|NCT00110890|520944223|FG000|Overall Study|Lost to Follow-up|3|||
144476732|NCT00110890|520944224|FG001|Overall Study|Lost to Follow-up|1|||
144476733|NCT00110890|520944223|FG000|Overall Study|Physician Decision|4|||
144701879|NCT04455620|521761653|FG002|Overall Study|Lost to Follow-up|1|||
144701880|NCT04455620|521761654|FG003|Overall Study|Lost to Follow-up|1|||
144701881|NCT04455620|521761655|FG004|Overall Study|Lost to Follow-up|0|||
144701882|NCT04455620|521761651|FG000|Overall Study|Death|1|||
144476734|NCT00110890|520944224|FG001|Overall Study|Physician Decision|5|||
144476735|NCT00110890|520944223|FG000|Overall Study|Withdrawal by Subject|17|||
144476736|NCT00110890|520944224|FG001|Overall Study|Withdrawal by Subject|5|||
144476737|NCT00110890|520944223|FG000|Overall Study|Protocol Deviation|1|||
144476738|NCT00110890|520944224|FG001|Overall Study|Protocol Deviation|0|||
144476739|NCT00110890|520944223|FG000|Overall Study|Noncompliance|10|||
144476740|NCT00110890|520944224|FG001|Overall Study|Noncompliance|0|||
144476741|NCT00110890|520944223|FG000|Overall Study|Kidney Transplant|16|||
144476742|NCT00110890|520944224|FG001|Overall Study|Kidney Transplant|12|||
144476743|NCT00110890|520944223|FG000|Overall Study|Invest. Product Commercially Available|217|||
144476744|NCT00110890|520944224|FG001|Overall Study|Invest. Product Commercially Available|110|||
144476745|NCT00110890|520944223|FG000|Overall Study|Other|34|||
144476746|NCT00110890|520944224|FG001|Overall Study|Other|23|||
144476747|NCT00110890|520944223|FG000|Overall Study|Ineligibility determined|3|||
144476748|NCT00110890|520944224|FG001|Overall Study|Ineligibility determined|0|||
144476749|NCT00110890|520944223|FG000|Overall Study|Requirement for alternative therapy|0|||
144476750|NCT00110890|520944224|FG001|Overall Study|Requirement for alternative therapy|1|||
144476751|NCT00110890|520944223|FG000|Overall Study|Disease progression|0|||
144476752|NCT00110890|520944224|FG001|Overall Study|Disease progression|1|||
144476753|NCT00110890|520944223|FG000|Overall Study|Parathyroidectomy|0|||
144476754|NCT00110890|520944224|FG001|Overall Study|Parathyroidectomy|1|||
144476755|NCT00110890|520944223|FG000|Overall Study|Did not enter follow-up phase|10|||
144476756|NCT00110890|520944224|FG001|Overall Study|Did not enter follow-up phase|4|||
144476757|NCT01686581|520944225|FG000|Overall Study|Side-effects or Health Problems|15|||
144476758|NCT01686581|520944225|FG000|Overall Study|Lack of Efficacy|90|||
144476759|NCT01686581|520944225|FG000|Overall Study|Participant Concerned about Risks|6|||
144476760|NCT01686581|520944225|FG000|Overall Study|Thinks Injections Too Painful|8|||
144476761|NCT01686581|520944225|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
144476762|NCT01686581|520944225|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
144476763|NCT01686581|520944225|FG000|Overall Study|Thinks it is Inconvenient|17|||
144476764|NCT01686581|520944225|FG000|Overall Study|Other Miscellaneous Reasons|36|||
144476765|NCT01686581|520944225|FG000|Overall Study|Reason Missing|1|||
144476766|NCT01975220|520944226|FG000|Test Period 1|Not treated|0|||
144476767|NCT01975220|520944227|FG001|Test Period 1|Not treated|1|||
144476768|NCT01975220|520944228|FG002|Test Period 1|Not treated|0|||
144476769|NCT01975220|520944229|FG003|Test Period 1|Not treated|0|||
144476770|NCT01975220|520944230|FG004|Test Period 1|Not treated|0|||
144476771|NCT01975220|520944231|FG005|Test Period 1|Not treated|0|||
144476772|NCT01852058|520944234|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
144476773|NCT01852058|520944235|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476774|NCT01852058|520944236|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476775|NCT01852058|520944237|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476776|NCT01852058|520944238|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476777|NCT01852058|520944239|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476778|NCT01852058|520944240|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476779|NCT01852058|520944241|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476780|NCT01852058|520944242|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476781|NCT01852058|520944243|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476782|NCT01852058|520944244|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476783|NCT01852058|520944245|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
144476784|NCT01852058|520944234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476785|NCT01852058|520944235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476786|NCT01852058|520944236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476787|NCT01852058|520944237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476788|NCT01852058|520944238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
144476789|NCT01852058|520944239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476790|NCT01852058|520944240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476791|NCT01852058|520944241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476792|NCT01852058|520944242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476793|NCT01852058|520944243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476794|NCT01852058|520944244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476795|NCT01852058|520944245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
144476796|NCT01852058|520944234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476797|NCT01852058|520944235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476798|NCT01852058|520944236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476799|NCT01852058|520944237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476800|NCT01852058|520944238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
144476801|NCT01852058|520944239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
144476802|NCT01852058|520944240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476803|NCT01852058|520944241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476804|NCT01852058|520944242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476805|NCT01852058|520944243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476806|NCT01852058|520944244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476807|NCT01852058|520944245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
144476808|NCT01852058|520944234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476809|NCT01852058|520944235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476810|NCT01852058|520944236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476811|NCT01852058|520944237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476812|NCT01852058|520944238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
144476813|NCT01852058|520944239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476814|NCT01852058|520944240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476815|NCT01852058|520944241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476816|NCT01852058|520944242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476817|NCT01852058|520944243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476818|NCT01852058|520944244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476819|NCT01852058|520944245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
144476820|NCT01852058|520944234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476821|NCT01852058|520944235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476822|NCT01852058|520944236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476823|NCT01852058|520944237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476824|NCT01852058|520944238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
144476825|NCT01852058|520944239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
144476826|NCT01852058|520944240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476827|NCT01852058|520944241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476828|NCT01852058|520944242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476829|NCT01852058|520944243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476830|NCT01852058|520944244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476831|NCT01852058|520944245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
144476832|NCT01852058|520944234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476833|NCT01852058|520944235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476834|NCT01852058|520944236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476835|NCT01852058|520944237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
144476836|NCT01852058|520944238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476837|NCT01852058|520944239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476838|NCT01852058|520944240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476839|NCT01852058|520944241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476840|NCT01852058|520944242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476841|NCT01852058|520944243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476842|NCT01852058|520944244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476843|NCT01852058|520944245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
144476844|NCT01852058|520944234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476845|NCT01852058|520944235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476846|NCT01852058|520944236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476847|NCT01852058|520944237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476848|NCT01852058|520944238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
144476849|NCT01852058|520944239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
144476850|NCT01852058|520944240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476851|NCT01852058|520944241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476852|NCT01852058|520944242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476853|NCT01852058|520944243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476854|NCT01852058|520944244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476855|NCT01852058|520944245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
144476856|NCT01852058|520944234|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476857|NCT01852058|520944235|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476858|NCT01852058|520944236|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476859|NCT01852058|520944237|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476860|NCT01852058|520944238|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476861|NCT01852058|520944239|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476862|NCT01852058|520944240|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476863|NCT01852058|520944241|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
144476864|NCT01852058|520944242|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476865|NCT01852058|520944243|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476866|NCT01852058|520944244|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476867|NCT01852058|520944245|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
144476868|NCT01852058|520944234|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476869|NCT01852058|520944235|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144538188|NCT00146172|521174125|FG003|Overall Study|Adverse Event|1|||
144701883|NCT04455620|521761652|FG001|Overall Study|Death|6|||
144701884|NCT04455620|521761653|FG002|Overall Study|Death|20|||
144701885|NCT04455620|521761654|FG003|Overall Study|Death|1|||
144701886|NCT04455620|521761655|FG004|Overall Study|Death|7|||
144701887|NCT04455620|521761651|FG000|Overall Study|Study Termination|0|||
144701888|NCT04455620|521761652|FG001|Overall Study|Study Termination|2|||
144701889|NCT04455620|521761653|FG002|Overall Study|Study Termination|1|||
144701890|NCT04455620|521761654|FG003|Overall Study|Study Termination|0|||
144701891|NCT04455620|521761655|FG004|Overall Study|Study Termination|6|||
144476870|NCT01852058|520944236|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144701892|NCT05012943|521761656|FG000|Overall Study|Adverse Event|2|||
144701893|NCT05012943|521761657|FG001|Overall Study|Adverse Event|1|||
144701894|NCT05012943|521761658|FG002|Overall Study|Adverse Event|0|||
144701895|NCT05012943|521761656|FG000|Overall Study|Withdrawal by Subject|1052|||
144701896|NCT05012943|521761657|FG001|Overall Study|Withdrawal by Subject|1006|||
144701897|NCT05012943|521761658|FG002|Overall Study|Withdrawal by Subject|20|||
144701898|NCT05012943|521761656|FG000|Overall Study|Death|25|||
144701899|NCT05012943|521761657|FG001|Overall Study|Death|17|||
144701900|NCT05012943|521761658|FG002|Overall Study|Death|4|||
144701901|NCT05012943|521761656|FG000|Overall Study|Lost to Follow-up|11|||
144701902|NCT05012943|521761657|FG001|Overall Study|Lost to Follow-up|24|||
144701903|NCT05012943|521761658|FG002|Overall Study|Lost to Follow-up|3|||
144701904|NCT05012943|521761656|FG000|Overall Study|Physician Decision|1|||
144701905|NCT05012943|521761657|FG001|Overall Study|Physician Decision|1|||
144701906|NCT05012943|521761658|FG002|Overall Study|Physician Decision|0|||
144476871|NCT01852058|520944237|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476872|NCT01852058|520944238|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476873|NCT01852058|520944239|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476874|NCT01852058|520944240|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476875|NCT01852058|520944241|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476876|NCT01852058|520944242|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
144476877|NCT01852058|520944243|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476878|NCT01852058|520944244|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476879|NCT01852058|520944245|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
144476880|NCT00263328|520944246|FG000|Overall Study|Death|0|||
144476881|NCT00263328|520944247|FG001|Overall Study|Death|0|||
144476882|NCT00263328|520944248|FG002|Overall Study|Death|1|||
144476883|NCT00263328|520944246|FG000|Overall Study|Lost to Follow-up|1|||
144476884|NCT00263328|520944247|FG001|Overall Study|Lost to Follow-up|1|||
144476885|NCT00263328|520944248|FG002|Overall Study|Lost to Follow-up|0|||
144476886|NCT00263328|520944246|FG000|Overall Study|Withdrawal by Subject|3|||
144476887|NCT00263328|520944247|FG001|Overall Study|Withdrawal by Subject|0|||
144476888|NCT00263328|520944248|FG002|Overall Study|Withdrawal by Subject|1|||
144476889|NCT00263328|520944246|FG000|Overall Study|Other|3|||
144476890|NCT00263328|520944247|FG001|Overall Study|Other|0|||
144476891|NCT00263328|520944248|FG002|Overall Study|Other|1|||
144476892|NCT00263328|520944246|FG000|Overall Study|Adverse Event|1|||
144476893|NCT00263328|520944247|FG001|Overall Study|Adverse Event|1|||
144476894|NCT00263328|520944248|FG002|Overall Study|Adverse Event|4|||
144476895|NCT01301274|520944253|FG000|Overall Study|Physician Decision|2|||
144476896|NCT01301274|520944254|FG001|Overall Study|Physician Decision|1|||
144476897|NCT00661661|520944255|FG000|Overall Study|Adverse Event|99|||
144476898|NCT00661661|520944256|FG001|Overall Study|Adverse Event|24|||
144476899|NCT00661661|520944255|FG000|Overall Study|Lack of Efficacy|3|||
144476900|NCT00661661|520944256|FG001|Overall Study|Lack of Efficacy|2|||
144476901|NCT00661661|520944255|FG000|Overall Study|Lost to Follow-up|0|||
144476902|NCT00661661|520944256|FG001|Overall Study|Lost to Follow-up|1|||
144476903|NCT00661661|520944255|FG000|Overall Study|Withdrawal by Subject|15|||
144476904|NCT00661661|520944256|FG001|Overall Study|Withdrawal by Subject|5|||
144701907|NCT05012943|521761656|FG000|Overall Study|Other than Specified|2|||
144701908|NCT05012943|521761657|FG001|Overall Study|Other than Specified|1|||
144701909|NCT05012943|521761658|FG002|Overall Study|Other than Specified|0|||
144701910|NCT04228107|521761659|FG000|Overall Study|Protocol Violation|1|||
144701911|NCT04228107|521761660|FG001|Overall Study|Protocol Violation|0|||
144701912|NCT04228107|521761659|FG000|Overall Study|Withdrawal by Subject|6|||
144701913|NCT04228107|521761660|FG001|Overall Study|Withdrawal by Subject|0|||
144247702|NCT02407054|520104195|FG000|Overall Study|Withdrawal by Subject|5|||
144476905|NCT00661661|520944255|FG000|Overall Study|Other|22|||
144476906|NCT00661661|520944256|FG001|Overall Study|Other|7|||
144476907|NCT00661661|520944255|FG000|Overall Study|Not assigned treatment|1|||
144476908|NCT00661661|520944256|FG001|Overall Study|Not assigned treatment|0|||
144476909|NCT01893827|520944257|FG000|Overall Study|Lost to Follow-up|19|||
144476910|NCT01893827|520944258|FG001|Overall Study|Lost to Follow-up|26|||
144701914|NCT04228107|521761659|FG000|Overall Study|Lost to Follow-up|18|||
144701915|NCT04228107|521761660|FG001|Overall Study|Lost to Follow-up|0|||
144701916|NCT04228107|521761659|FG000|Overall Study|No controller use data|1|||
144701917|NCT04228107|521761660|FG001|Overall Study|No controller use data|0|||
144701918|NCT04228107|521761659|FG000|Overall Study|No medication data collected|1|||
144476911|NCT00399763|520944259|FG000|Overall Study|Lost to Follow-up|2|||
144476912|NCT00399763|520944260|FG001|Overall Study|Lost to Follow-up|3|||
144476913|NCT04182880|520944263|FG000|Overall Study|Pregnancy|1|||
144476914|NCT04182880|520944264|FG001|Overall Study|Pregnancy|0|||
144476915|NCT03389477|520944265|FG000|Step 1|Withdrawal by Subject|1|||
144476916|NCT03389477|520944266|FG001|Step 1|Withdrawal by Subject|0|||
144476917|NCT03389477|520944265|FG000|Step 2|Withdrawal by Subject|1|||
144476918|NCT03389477|520944266|FG001|Step 2|Withdrawal by Subject|2|||
144476919|NCT03389477|520944265|FG000|Step 2|Disease progression|1|||
144476920|NCT03389477|520944266|FG001|Step 2|Disease progression|0|||
144476921|NCT03389477|520944265|FG000|Step 2|Death|0|||
144476922|NCT03389477|520944266|FG001|Step 2|Death|1|||
144476923|NCT03389477|520944265|FG000|Step 2|Poor performance status and nutrition|0|||
144476924|NCT03389477|520944266|FG001|Step 2|Poor performance status and nutrition|1|||
144476925|NCT03389477|520944265|FG000|Step 3|Withdrawal after 3 cycles|0|||
144476926|NCT03389477|520944266|FG001|Step 3|Withdrawal after 3 cycles|1|||
144476927|NCT03389477|520944265|FG000|Step 3|Still receiving active treatment|4|||
144476928|NCT03389477|520944266|FG001|Step 3|Still receiving active treatment|0|||
144476929|NCT03389477|520944265|FG000|Step 3|Progressive disease after 2 cycles|1|||
144476930|NCT03389477|520944266|FG001|Step 3|Progressive disease after 2 cycles|0|||
144476931|NCT04512066|520944267|FG000|Double-blind Treatment Period|Adverse Event|6|||
144476932|NCT04512066|520944268|FG001|Double-blind Treatment Period|Adverse Event|4|||
144476933|NCT04512066|520944269|FG002|Double-blind Treatment Period|Adverse Event|5|||
144476934|NCT04512066|520944270|FG003|Double-blind Treatment Period|Adverse Event|1|||
144476935|NCT04512066|520944271|FG004|Double-blind Treatment Period|Adverse Event|0|||
144476936|NCT04512066|520944272|FG005|Double-blind Treatment Period|Adverse Event|0|||
144476937|NCT04512066|520944267|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
144476938|NCT04512066|520944268|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
144476939|NCT04512066|520944269|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
144476940|NCT04512066|520944270|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
144476941|NCT04512066|520944271|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
144476942|NCT04512066|520944272|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
144476943|NCT04512066|520944267|FG000|Double-blind Treatment Period|Physician Decision|1|||
144476944|NCT04512066|520944268|FG001|Double-blind Treatment Period|Physician Decision|0|||
144476945|NCT04512066|520944269|FG002|Double-blind Treatment Period|Physician Decision|1|||
144476946|NCT04512066|520944270|FG003|Double-blind Treatment Period|Physician Decision|0|||
144476947|NCT04512066|520944271|FG004|Double-blind Treatment Period|Physician Decision|0|||
144476948|NCT04512066|520944272|FG005|Double-blind Treatment Period|Physician Decision|0|||
144476949|NCT04512066|520944267|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
144476950|NCT04512066|520944268|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
144476951|NCT04512066|520944269|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
144476952|NCT04512066|520944270|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
144476953|NCT04512066|520944271|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
144476954|NCT04512066|520944272|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
144476955|NCT04512066|520944267|FG000|Extension Period|Adverse Event|0|||
144476956|NCT04512066|520944268|FG001|Extension Period|Adverse Event|1|||
144476957|NCT04512066|520944269|FG002|Extension Period|Adverse Event|4|||
144476958|NCT04512066|520944270|FG003|Extension Period|Adverse Event|3|||
144476959|NCT04512066|520944271|FG004|Extension Period|Adverse Event|1|||
144476960|NCT04512066|520944272|FG005|Extension Period|Adverse Event|3|||
144476961|NCT04512066|520944267|FG000|Extension Period|Death|0|||
144476962|NCT04512066|520944268|FG001|Extension Period|Death|0|||
144476963|NCT04512066|520944269|FG002|Extension Period|Death|0|||
144476964|NCT04512066|520944270|FG003|Extension Period|Death|0|||
144476965|NCT04512066|520944271|FG004|Extension Period|Death|0|||
144476966|NCT04512066|520944272|FG005|Extension Period|Death|1|||
144476967|NCT04512066|520944267|FG000|Extension Period|Lack of Efficacy|0|||
144476968|NCT04512066|520944268|FG001|Extension Period|Lack of Efficacy|4|||
144476969|NCT04512066|520944269|FG002|Extension Period|Lack of Efficacy|4|||
144476970|NCT04512066|520944270|FG003|Extension Period|Lack of Efficacy|1|||
144476971|NCT04512066|520944271|FG004|Extension Period|Lack of Efficacy|3|||
144476972|NCT04512066|520944272|FG005|Extension Period|Lack of Efficacy|3|||
144476973|NCT04512066|520944267|FG000|Extension Period|Lost to Follow-up|0|||
144476974|NCT04512066|520944268|FG001|Extension Period|Lost to Follow-up|1|||
144476975|NCT04512066|520944269|FG002|Extension Period|Lost to Follow-up|5|||
144476976|NCT04512066|520944270|FG003|Extension Period|Lost to Follow-up|2|||
144476977|NCT04512066|520944271|FG004|Extension Period|Lost to Follow-up|3|||
144476978|NCT04512066|520944272|FG005|Extension Period|Lost to Follow-up|2|||
144476979|NCT04512066|520944267|FG000|Extension Period|Non-compliance with study drug|0|||
144476980|NCT04512066|520944268|FG001|Extension Period|Non-compliance with study drug|1|||
144476981|NCT04512066|520944269|FG002|Extension Period|Non-compliance with study drug|0|||
144476982|NCT04512066|520944270|FG003|Extension Period|Non-compliance with study drug|0|||
144476983|NCT04512066|520944271|FG004|Extension Period|Non-compliance with study drug|0|||
144476984|NCT04512066|520944272|FG005|Extension Period|Non-compliance with study drug|1|||
144476985|NCT04512066|520944267|FG000|Extension Period|Other|0|||
144701919|NCT04228107|521761660|FG001|Overall Study|No medication data collected|0|||
144701920|NCT00400985|521761661|FG000|Overall Study|Withdrawal by Subject|5|||
144701921|NCT00400985|521761661|FG000|Overall Study|system modification|8|||
144701922|NCT00400985|521761661|FG000|Overall Study|Death|30|||
144701923|NCT00400985|521761661|FG000|Overall Study|Lost to Follow-up|9|||
144701924|NCT00965562|521761662|FG000|Overall Study|Lost to Follow-up|1|||
144701925|NCT00965562|521761663|FG001|Overall Study|Lost to Follow-up|2|||
144701926|NCT00965562|521761664|FG002|Overall Study|Lost to Follow-up|3|||
144701927|NCT00965562|521761662|FG000|Overall Study|Withdrawal by Subject|2|||
144701928|NCT00965562|521761663|FG001|Overall Study|Withdrawal by Subject|2|||
144701929|NCT00965562|521761664|FG002|Overall Study|Withdrawal by Subject|0|||
144701930|NCT03792633|521761665|FG000|Overall Study|Alternative Treatment|17|||
144701931|NCT03792633|521761666|FG001|Overall Study|Alternative Treatment|19|||
144701932|NCT03792633|521761665|FG000|Overall Study|Death|2|||
144701933|NCT03792633|521761666|FG001|Overall Study|Death|0|||
144701934|NCT03792633|521761665|FG000|Overall Study|Disease progression|8|||
144701935|NCT03792633|521761666|FG001|Overall Study|Disease progression|9|||
144701936|NCT03792633|521761665|FG000|Overall Study|Lost to Follow-up|1|||
144701937|NCT03792633|521761666|FG001|Overall Study|Lost to Follow-up|1|||
144701938|NCT03792633|521761665|FG000|Overall Study|Screen fail|1|||
144701939|NCT03792633|521761666|FG001|Overall Study|Screen fail|0|||
144701940|NCT03792633|521761665|FG000|Overall Study|Second malignancy|0|||
144701941|NCT03792633|521761666|FG001|Overall Study|Second malignancy|1|||
144701942|NCT05048875|521761668|FG000|Overall Study|Withdrawal by Subject|1|||
144701943|NCT05048875|521761669|FG001|Overall Study|Withdrawal by Subject|0|||
144701944|NCT05048875|521761670|FG002|Overall Study|Withdrawal by Subject|0|||
144701945|NCT05048875|521761671|FG003|Overall Study|Withdrawal by Subject|0|||
144701946|NCT05048875|521761672|FG004|Overall Study|Withdrawal by Subject|0|||
144701947|NCT05048875|521761673|FG005|Overall Study|Withdrawal by Subject|0|||
144701948|NCT05048875|521761674|FG006|Overall Study|Withdrawal by Subject|0|||
144701949|NCT05048875|521761675|FG007|Overall Study|Withdrawal by Subject|0|||
144701950|NCT05048875|521761668|FG000|Overall Study|Adverse Event|0|||
144701951|NCT05048875|521761669|FG001|Overall Study|Adverse Event|0|||
144701952|NCT05048875|521761670|FG002|Overall Study|Adverse Event|0|||
144701953|NCT05048875|521761671|FG003|Overall Study|Adverse Event|1|||
144701954|NCT05048875|521761672|FG004|Overall Study|Adverse Event|0|||
144701955|NCT05048875|521761673|FG005|Overall Study|Adverse Event|0|||
144701956|NCT05048875|521761674|FG006|Overall Study|Adverse Event|0|||
144701957|NCT05048875|521761675|FG007|Overall Study|Adverse Event|0|||
144701958|NCT02684162|521761681|FG000|Overall Study|Physician Decision|0|||
144701959|NCT02684162|521761682|FG001|Overall Study|Physician Decision|1|||
144701960|NCT02684162|521761683|FG002|Overall Study|Physician Decision|0|||
144701961|NCT05153629|521761685|FG000|Overall Study|Withdrawal by Subject|0|||
144701962|NCT05153629|521761686|FG001|Overall Study|Withdrawal by Subject|2|||
144701963|NCT04089566|521761691|FG000|Overall Study|Death|0|||
144701964|NCT04089566|521761692|FG001|Overall Study|Death|6|||
144701965|NCT04089566|521761693|FG002|Overall Study|Death|10|||
144701966|NCT04089566|521761694|FG003|Overall Study|Death|0|||
144701967|NCT04089566|521761695|FG004|Overall Study|Death|0|||
144701968|NCT04089566|521761696|FG005|Overall Study|Death|0|||
144701969|NCT04089566|521761691|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
144701970|NCT04089566|521761692|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
144701971|NCT04089566|521761693|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
144476986|NCT04512066|520944268|FG001|Extension Period|Other|2|||
144476987|NCT04512066|520944269|FG002|Extension Period|Other|0|||
144701972|NCT04089566|521761694|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
144701973|NCT04089566|521761695|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
144701974|NCT04089566|521761696|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
144701975|NCT04089566|521761691|FG000|Overall Study|Reason not Specified|0|||
144701976|NCT04089566|521761692|FG001|Overall Study|Reason not Specified|4|||
144701977|NCT04089566|521761693|FG002|Overall Study|Reason not Specified|4|||
144701978|NCT04089566|521761694|FG003|Overall Study|Reason not Specified|1|||
144701979|NCT04089566|521761695|FG004|Overall Study|Reason not Specified|0|||
144476988|NCT04512066|520944270|FG003|Extension Period|Other|0|||
144476989|NCT04512066|520944271|FG004|Extension Period|Other|0|||
144476990|NCT04512066|520944272|FG005|Extension Period|Other|0|||
144476991|NCT04512066|520944267|FG000|Extension Period|Physician Decision|0|||
144476992|NCT04512066|520944268|FG001|Extension Period|Physician Decision|2|||
144476993|NCT04512066|520944269|FG002|Extension Period|Physician Decision|0|||
144476994|NCT04512066|520944270|FG003|Extension Period|Physician Decision|1|||
144476995|NCT04512066|520944271|FG004|Extension Period|Physician Decision|1|||
144476996|NCT04512066|520944272|FG005|Extension Period|Physician Decision|0|||
144476997|NCT04512066|520944267|FG000|Extension Period|Withdrawal by Subject|0|||
144476998|NCT04512066|520944268|FG001|Extension Period|Withdrawal by Subject|3|||
144701980|NCT04089566|521761696|FG005|Overall Study|Reason not Specified|0|||
144701981|NCT01489865|521761701|FG000|Overall Study|Progression of Disease|4|||
144701982|NCT01489865|521761702|FG001|Overall Study|Progression of Disease|2|||
144701983|NCT01489865|521761703|FG002|Overall Study|Progression of Disease|2|||
144701984|NCT01489865|521761704|FG003|Overall Study|Progression of Disease|3|||
144476999|NCT04512066|520944269|FG002|Extension Period|Withdrawal by Subject|7|||
144477000|NCT04512066|520944270|FG003|Extension Period|Withdrawal by Subject|11|||
144477001|NCT04512066|520944271|FG004|Extension Period|Withdrawal by Subject|8|||
144477002|NCT04512066|520944272|FG005|Extension Period|Withdrawal by Subject|4|||
144477003|NCT00445679|520944273|FG000|Overall Study|Adverse Event|22|||
144477004|NCT00445679|520944274|FG001|Overall Study|Adverse Event|12|||
144477005|NCT00445679|520944275|FG002|Overall Study|Adverse Event|30|||
144477006|NCT00445679|520944276|FG003|Overall Study|Adverse Event|19|||
144477007|NCT00445679|520944273|FG000|Overall Study|Failed to return|1|||
144477008|NCT00445679|520944274|FG001|Overall Study|Failed to return|3|||
144477009|NCT00445679|520944275|FG002|Overall Study|Failed to return|2|||
144477010|NCT00445679|520944276|FG003|Overall Study|Failed to return|2|||
144477011|NCT00445679|520944273|FG000|Overall Study|Physician Decision|0|||
144477012|NCT00445679|520944274|FG001|Overall Study|Physician Decision|0|||
144477013|NCT00445679|520944275|FG002|Overall Study|Physician Decision|1|||
144477014|NCT00445679|520944276|FG003|Overall Study|Physician Decision|0|||
144477015|NCT00445679|520944273|FG000|Overall Study|Lost to Follow-up|10|||
144477016|NCT00445679|520944274|FG001|Overall Study|Lost to Follow-up|6|||
144477017|NCT00445679|520944275|FG002|Overall Study|Lost to Follow-up|6|||
144477018|NCT00445679|520944276|FG003|Overall Study|Lost to Follow-up|5|||
144477019|NCT00445679|520944273|FG000|Overall Study|Compliance|3|||
144477020|NCT00445679|520944274|FG001|Overall Study|Compliance|2|||
144477021|NCT00445679|520944275|FG002|Overall Study|Compliance|1|||
144477022|NCT00445679|520944276|FG003|Overall Study|Compliance|2|||
144477023|NCT00445679|520944273|FG000|Overall Study|Withdrawal of Informed Consent|0|||
144477024|NCT00445679|520944274|FG001|Overall Study|Withdrawal of Informed Consent|0|||
144477025|NCT00445679|520944275|FG002|Overall Study|Withdrawal of Informed Consent|1|||
144477026|NCT00445679|520944276|FG003|Overall Study|Withdrawal of Informed Consent|0|||
144477027|NCT00445679|520944273|FG000|Overall Study|Protocol Violation|2|||
144477028|NCT00445679|520944274|FG001|Overall Study|Protocol Violation|3|||
144477029|NCT00445679|520944275|FG002|Overall Study|Protocol Violation|3|||
144477030|NCT00445679|520944276|FG003|Overall Study|Protocol Violation|1|||
144477031|NCT00445679|520944273|FG000|Overall Study|Withdrawal by Subject|8|||
144477032|NCT00445679|520944274|FG001|Overall Study|Withdrawal by Subject|14|||
144477033|NCT00445679|520944275|FG002|Overall Study|Withdrawal by Subject|20|||
144477034|NCT00445679|520944276|FG003|Overall Study|Withdrawal by Subject|18|||
144477035|NCT00445679|520944273|FG000|Overall Study|Lack of Efficacy|2|||
144477036|NCT00445679|520944274|FG001|Overall Study|Lack of Efficacy|6|||
144477037|NCT00445679|520944275|FG002|Overall Study|Lack of Efficacy|2|||
144477038|NCT00445679|520944276|FG003|Overall Study|Lack of Efficacy|0|||
144477039|NCT03535337|520944277|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
144477040|NCT03535337|520944278|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
144477041|NCT03535337|520944279|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
144477042|NCT03535337|520944280|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
144477043|NCT03535337|520944281|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
144477044|NCT03535337|520944282|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
144477045|NCT03535337|520944283|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
144477046|NCT03535337|520944284|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
144477047|NCT03535337|520944285|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
144477048|NCT03535337|520944286|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
144477049|NCT01816763|520945816|FG000|Overall Study|The main reason for an incomplete survey|4|||
144477050|NCT01816763|520945817|FG001|Overall Study|The main reason for an incomplete survey|15|||
144477051|NCT01816763|520945818|FG002|Overall Study|The main reason for an incomplete survey|11|||
144477052|NCT00311155|520945819|FG000|Overall Study|Adverse Event|21|||
144477053|NCT00311155|520945819|FG000|Overall Study|Withdrawal by Subject|17|||
144477054|NCT00311155|520945819|FG000|Overall Study|Did not meet entry criteria|55|||
144477055|NCT01992549|520945821|FG000|Overall Study|Lost to Follow-up|2|||
144477056|NCT01992549|520945821|FG000|Overall Study|Serious Adverse Event|1|||
144477057|NCT01992549|520945821|FG000|Overall Study|Product Switch to Extend Half Life|1|||
144477058|NCT00767104|520945823|FG000|Overall Study|Lost to Follow-up|1|||
144477059|NCT00767104|520945824|FG001|Overall Study|Lost to Follow-up|2|||
144477060|NCT00840996|520945825|FG000|Overall Study|Withdrawal by Subject|1|||
144477061|NCT00840996|520945826|FG001|Overall Study|Withdrawal by Subject|0|||
144477062|NCT04022889|520945827|FG000|Stage 1: Period 1|Adverse Event|1|||
144477063|NCT04022889|520945828|FG001|Stage 1: Period 1|Adverse Event|0|||
144477064|NCT04022889|520945829|FG002|Stage 1: Period 1|Adverse Event|0|||
144701985|NCT01489865|521761705|FG004|Overall Study|Progression of Disease|1|||
144701986|NCT01489865|521761706|FG005|Overall Study|Progression of Disease|6|||
144477065|NCT04022889|520945827|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
144477066|NCT04022889|520945828|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
144477067|NCT04022889|520945829|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
144477068|NCT04022889|520945827|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
144477069|NCT04022889|520945828|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
144477070|NCT04022889|520945829|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
144477071|NCT04022889|520945827|FG000|Stage 2|Screen Failure|0|||
144477072|NCT04022889|520945828|FG001|Stage 2|Screen Failure|0|||
144701987|NCT01489865|521761707|FG006|Overall Study|Progression of Disease|3|||
144701988|NCT01489865|521761708|FG007|Overall Study|Progression of Disease|0|||
144477073|NCT04022889|520945829|FG002|Stage 2|Screen Failure|3|||
144477074|NCT04022889|520945827|FG000|Stage 2|Ineligible for apheresis donation|0|||
144477075|NCT04022889|520945828|FG001|Stage 2|Ineligible for apheresis donation|0|||
144477076|NCT04022889|520945829|FG002|Stage 2|Ineligible for apheresis donation|2|||
144477077|NCT04022889|520945827|FG000|Stage 2|Adverse Event|0|||
144477078|NCT04022889|520945828|FG001|Stage 2|Adverse Event|0|||
144477079|NCT04022889|520945829|FG002|Stage 2|Adverse Event|2|||
144477080|NCT04022889|520945827|FG000|Stage 2|Protocol Violation|0|||
144477081|NCT04022889|520945828|FG001|Stage 2|Protocol Violation|0|||
144477082|NCT04022889|520945829|FG002|Stage 2|Protocol Violation|1|||
144477083|NCT04022889|520945827|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
144477084|NCT04022889|520945828|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
144477085|NCT04022889|520945829|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
144477086|NCT01900054|520945833|FG000|Overall Study|Physician Decision|1|||
144477087|NCT01900054|520945833|FG000|Overall Study|Withdrawal by Subject|1|||
144477088|NCT01186328|520945834|FG000|Overall Study|Death|1|||
144477089|NCT01186328|520945835|FG001|Overall Study|Death|0|||
144477090|NCT01186328|520945836|FG002|Overall Study|Death|0|||
144477091|NCT03285295|520945841|FG000|Alinity s HBsAg|Protocol Violation|11|||
144477092|NCT03285295|520945842|FG001|Alinity s HBsAg|Protocol Violation|0|||
144701989|NCT01489865|521761709|FG008|Overall Study|Progression of Disease|23|||
144701990|NCT01489865|521761701|FG000|Overall Study|Adverse Event|2|||
144701991|NCT01489865|521761702|FG001|Overall Study|Adverse Event|0|||
144701992|NCT01489865|521761703|FG002|Overall Study|Adverse Event|0|||
144701993|NCT01489865|521761704|FG003|Overall Study|Adverse Event|0|||
144701994|NCT01489865|521761705|FG004|Overall Study|Adverse Event|1|||
144701995|NCT01489865|521761706|FG005|Overall Study|Adverse Event|0|||
144701996|NCT01489865|521761707|FG006|Overall Study|Adverse Event|2|||
144701997|NCT01489865|521761708|FG007|Overall Study|Adverse Event|0|||
144701998|NCT01489865|521761709|FG008|Overall Study|Adverse Event|5|||
144701999|NCT01489865|521761701|FG000|Overall Study|Death|0|||
144702000|NCT01489865|521761702|FG001|Overall Study|Death|1|||
144702001|NCT01489865|521761703|FG002|Overall Study|Death|0|||
144702002|NCT01489865|521761704|FG003|Overall Study|Death|0|||
144702003|NCT01489865|521761705|FG004|Overall Study|Death|1|||
144702004|NCT01489865|521761706|FG005|Overall Study|Death|0|||
144702005|NCT01489865|521761707|FG006|Overall Study|Death|0|||
144702006|NCT01489865|521761708|FG007|Overall Study|Death|0|||
144702007|NCT01489865|521761709|FG008|Overall Study|Death|2|||
144702008|NCT01489865|521761701|FG000|Overall Study|Withdrawal by Subject|0|||
144702009|NCT01489865|521761702|FG001|Overall Study|Withdrawal by Subject|0|||
144702010|NCT01489865|521761703|FG002|Overall Study|Withdrawal by Subject|0|||
144702011|NCT01489865|521761704|FG003|Overall Study|Withdrawal by Subject|0|||
144702012|NCT01489865|521761705|FG004|Overall Study|Withdrawal by Subject|0|||
144702013|NCT01489865|521761706|FG005|Overall Study|Withdrawal by Subject|1|||
144702014|NCT01489865|521761707|FG006|Overall Study|Withdrawal by Subject|1|||
144702015|NCT01489865|521761708|FG007|Overall Study|Withdrawal by Subject|0|||
144702016|NCT01489865|521761709|FG008|Overall Study|Withdrawal by Subject|2|||
144702017|NCT01489865|521761701|FG000|Overall Study|Shifted|0|||
144702018|NCT01489865|521761702|FG001|Overall Study|Shifted|0|||
144702019|NCT01489865|521761703|FG002|Overall Study|Shifted|1|||
144702020|NCT01489865|521761704|FG003|Overall Study|Shifted|0|||
144702021|NCT01489865|521761705|FG004|Overall Study|Shifted|0|||
144702022|NCT01489865|521761706|FG005|Overall Study|Shifted|0|||
144702023|NCT01489865|521761707|FG006|Overall Study|Shifted|0|||
144702024|NCT01489865|521761708|FG007|Overall Study|Shifted|0|||
144702025|NCT01489865|521761709|FG008|Overall Study|Shifted|0|||
144702026|NCT04115488|521761710|FG000|Overall Study|Adverse Event|8|||
144477093|NCT03285295|520945843|FG002|Alinity s HBsAg|Protocol Violation|0|||
144477094|NCT03285295|520945844|FG003|Alinity s HBsAg|Protocol Violation|0|||
144477095|NCT03285295|520945845|FG004|Alinity s HBsAg|Protocol Violation|0|||
144477096|NCT03285295|520945841|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
144702027|NCT04115488|521761711|FG001|Overall Study|Adverse Event|4|||
144702028|NCT04115488|521761710|FG000|Overall Study|Withdrawal by Subject|3|||
144702029|NCT04115488|521761711|FG001|Overall Study|Withdrawal by Subject|6|||
144702030|NCT04115488|521761710|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
144702031|NCT04115488|521761711|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
144702032|NCT04115488|521761710|FG000|Overall Study|Patient 's location change|1|||
144702033|NCT04115488|521761711|FG001|Overall Study|Patient 's location change|0|||
144702034|NCT04115488|521761710|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
144477097|NCT03285295|520945842|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
144477098|NCT03285295|520945843|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
144477099|NCT03285295|520945844|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
144702035|NCT04115488|521761711|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
144477100|NCT03285295|520945845|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
144702036|NCT00885677|521761712|FG000|Overall Study|Death|40|||
144477101|NCT03285295|520945841|FG000|Alinity s HBsAg|No Results Generated|74|||
144477102|NCT03285295|520945842|FG001|Alinity s HBsAg|No Results Generated|6|||
144477103|NCT03285295|520945843|FG002|Alinity s HBsAg|No Results Generated|0|||
144477104|NCT03285295|520945844|FG003|Alinity s HBsAg|No Results Generated|0|||
144477105|NCT03285295|520945845|FG004|Alinity s HBsAg|No Results Generated|0|||
144477106|NCT03285295|520945841|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
144477107|NCT03285295|520945842|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
144477108|NCT03285295|520945843|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
144477109|NCT03285295|520945844|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
144477110|NCT03285295|520945845|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
144477111|NCT03285295|520945841|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
144477112|NCT03285295|520945842|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
144477113|NCT03285295|520945843|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
144477114|NCT03285295|520945844|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
144477115|NCT03285295|520945845|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
144477116|NCT03285295|520945841|FG000|Alinity s HTLV I/II|No Results Generated|70|||
144477117|NCT03285295|520945842|FG001|Alinity s HTLV I/II|No Results Generated|0|||
144477118|NCT03285295|520945843|FG002|Alinity s HTLV I/II|No Results Generated|0|||
144477119|NCT03285295|520945844|FG003|Alinity s HTLV I/II|No Results Generated|0|||
144477120|NCT03285295|520945845|FG004|Alinity s HTLV I/II|No Results Generated|0|||
144477121|NCT03285295|520945841|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
144477122|NCT03285295|520945842|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
144477123|NCT03285295|520945843|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
144477124|NCT03285295|520945844|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
144477125|NCT03285295|520945845|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
144477126|NCT03285295|520945841|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
144477127|NCT03285295|520945842|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
144477128|NCT03285295|520945843|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
144477129|NCT03285295|520945844|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
144477130|NCT03285295|520945845|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
144477131|NCT03285295|520945841|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
144477132|NCT03285295|520945842|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
144477133|NCT03285295|520945843|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
144477134|NCT03285295|520945844|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
144477135|NCT03285295|520945845|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
144477136|NCT03285295|520945841|FG000|Alinity s Anti-HCV|No Results Generated|71|||
144477137|NCT03285295|520945842|FG001|Alinity s Anti-HCV|No Results Generated|0|||
144477138|NCT03285295|520945843|FG002|Alinity s Anti-HCV|No Results Generated|0|||
144477139|NCT03285295|520945844|FG003|Alinity s Anti-HCV|No Results Generated|0|||
144477140|NCT03285295|520945845|FG004|Alinity s Anti-HCV|No Results Generated|0|||
144477141|NCT03285295|520945841|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
144477142|NCT03285295|520945842|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
144477143|NCT03285295|520945843|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
144477144|NCT03285295|520945844|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
144477145|NCT03285295|520945845|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
144477146|NCT03285295|520945841|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
144477147|NCT03285295|520945842|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
144477148|NCT03285295|520945843|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
144477149|NCT03285295|520945844|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
144477150|NCT03285295|520945845|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
144477151|NCT03285295|520945841|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
144477152|NCT03285295|520945842|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
144477153|NCT03285295|520945843|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
144477154|NCT03285295|520945844|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
144477155|NCT03285295|520945845|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
144477156|NCT03285295|520945841|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
144477157|NCT03285295|520945842|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
144477158|NCT03285295|520945843|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
144477159|NCT03285295|520945844|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
144477160|NCT03285295|520945845|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
144477161|NCT03285295|520945841|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
144477162|NCT03285295|520945842|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
144477163|NCT03285295|520945843|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
144477164|NCT03285295|520945844|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
144477165|NCT03285295|520945845|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
144477166|NCT03285295|520945841|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
144477167|NCT03285295|520945842|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
144477168|NCT03285295|520945843|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
144702037|NCT00885677|521761713|FG001|Overall Study|Death|34|||
144702038|NCT00885677|521761712|FG000|Overall Study|Lost to Follow-up|15|||
144702039|NCT00885677|521761713|FG001|Overall Study|Lost to Follow-up|13|||
144702040|NCT00885677|521761712|FG000|Overall Study|Protocol Violation|54|||
144702041|NCT00885677|521761713|FG001|Overall Study|Protocol Violation|54|||
144702042|NCT00885677|521761712|FG000|Overall Study|premature study closure|41|||
144702043|NCT00885677|521761713|FG001|Overall Study|premature study closure|44|||
144702044|NCT00885677|521761712|FG000|Overall Study|device/lead revision or replacement|7|||
144702045|NCT00885677|521761713|FG001|Overall Study|device/lead revision or replacement|6|||
144702046|NCT00885677|521761712|FG000|Overall Study|Heart transplantation|1|||
144702047|NCT00885677|521761713|FG001|Overall Study|Heart transplantation|0|||
144702048|NCT00885677|521761712|FG000|Overall Study|Inclusion/exclusion not met|25|||
144702049|NCT00885677|521761713|FG001|Overall Study|Inclusion/exclusion not met|27|||
144702050|NCT00972309|521761714|FG000|Overall Study|Switched to alternative treatment|0|||
144702051|NCT00972309|521761715|FG001|Overall Study|Switched to alternative treatment|2|||
144702052|NCT00972309|521761714|FG000|Overall Study|Refused further treatment|0|||
144702053|NCT00972309|521761715|FG001|Overall Study|Refused further treatment|1|||
144702054|NCT00972309|521761714|FG000|Overall Study|Late determination of ineligibility|0|||
144702055|NCT00972309|521761715|FG001|Overall Study|Late determination of ineligibility|1|||
144702056|NCT00972309|521761714|FG000|Overall Study|Second malignancy|1|||
144702057|NCT00972309|521761715|FG001|Overall Study|Second malignancy|1|||
144702058|NCT00972309|521761714|FG000|Overall Study|Visa issues|0|||
144702059|NCT00972309|521761715|FG001|Overall Study|Visa issues|1|||
144702060|NCT00972309|521761714|FG000|Overall Study|Secondary cancer (SCC)|0|||
144702061|NCT00972309|521761715|FG001|Overall Study|Secondary cancer (SCC)|1|||
144702062|NCT00972309|521761714|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
144702063|NCT00972309|521761715|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
144702064|NCT00972309|521761714|FG000|Overall Study|Lost to Follow-up|1|||
144702065|NCT00972309|521761715|FG001|Overall Study|Lost to Follow-up|1|||
144702066|NCT00972309|521761714|FG000|Overall Study|Disease progression on study|10|||
144702067|NCT00972309|521761715|FG001|Overall Study|Disease progression on study|4|||
144702068|NCT02756182|521761718|FG000|Overall Study|StudyTechnical Difficulties|4|||
144702069|NCT01593761|521761719|FG000|Overall Study|Lost to Follow-up|1|||
144702070|NCT01593761|521761719|FG000|Overall Study|culture negative for MRSA at baseline|5|||
144702071|NCT01593761|521761719|FG000|Overall Study|positive for hepatitis C virus|1|||
144702072|NCT01593761|521761719|FG000|Overall Study|secondary cellulitis|1|||
144702073|NCT00795886|521761722|FG000|Overall Study|Death|10|||
144702074|NCT01656850|521763201|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
144702075|NCT01656850|521763202|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
144702076|NCT02674568|521763203|FG000|Overall Study|Withdrawal by Subject|5|||
144702077|NCT02674568|521763203|FG000|Overall Study|Death|303|||
144702078|NCT02674568|521763203|FG000|Overall Study|Physician Decision|2|||
144702079|NCT02674568|521763203|FG000|Overall Study|Lost to Follow-up|9|||
144702080|NCT02674568|521763203|FG000|Overall Study|Other, Not Specified|20|||
144702081|NCT00396318|521763204|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
144702082|NCT01118949|521763205|FG000|Overall Study|Adverse Event|5|||
144702083|NCT01118949|521763205|FG000|Overall Study|Withdrawal by Subject|4|||
144702084|NCT03255226|521763211|FG000|Overall Study|Adverse Event|2|||
144477169|NCT03285295|520945844|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
144477170|NCT03285295|520945845|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
144477171|NCT03285295|520945841|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
144477172|NCT03285295|520945842|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
144477173|NCT03285295|520945843|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
144477174|NCT03285295|520945844|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
144477175|NCT03285295|520945845|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
144477176|NCT03285295|520945841|FG000|Alinity s Anti-HBc|No Results Generated|70|||
144477177|NCT03285295|520945842|FG001|Alinity s Anti-HBc|No Results Generated|0|||
144477178|NCT03285295|520945843|FG002|Alinity s Anti-HBc|No Results Generated|0|||
144477179|NCT03285295|520945844|FG003|Alinity s Anti-HBc|No Results Generated|0|||
144477180|NCT03285295|520945845|FG004|Alinity s Anti-HBc|No Results Generated|0|||
144477181|NCT03285295|520945841|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
144477182|NCT03285295|520945842|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
144477183|NCT03285295|520945843|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
144477184|NCT03285295|520945844|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
144477185|NCT03285295|520945845|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
144477186|NCT03285295|520945841|FG000|Alinity s Chagas|Protocol Violation|76|||
144477187|NCT03285295|520945842|FG001|Alinity s Chagas|Protocol Violation|0|||
144477188|NCT03285295|520945843|FG002|Alinity s Chagas|Protocol Violation|0|||
144477189|NCT03285295|520945844|FG003|Alinity s Chagas|Protocol Violation|0|||
144477190|NCT03285295|520945845|FG004|Alinity s Chagas|Protocol Violation|0|||
144477191|NCT03285295|520945841|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
144477192|NCT03285295|520945842|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
144477193|NCT03285295|520945843|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
144538189|NCT00146172|521174126|FG004|Overall Study|Adverse Event|0|||
144477194|NCT03285295|520945844|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
144477195|NCT03285295|520945845|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
144477196|NCT03285295|520945841|FG000|Alinity s Chagas|No Results Generated|105|||
144477197|NCT03285295|520945842|FG001|Alinity s Chagas|No Results Generated|0|||
144477198|NCT03285295|520945843|FG002|Alinity s Chagas|No Results Generated|0|||
144477199|NCT03285295|520945844|FG003|Alinity s Chagas|No Results Generated|0|||
144477200|NCT03285295|520945845|FG004|Alinity s Chagas|No Results Generated|0|||
144477201|NCT03285295|520945841|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
144477202|NCT03285295|520945842|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
144477203|NCT03285295|520945843|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
144477204|NCT03285295|520945844|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
144477205|NCT03285295|520945845|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
144477206|NCT03015116|520945846|FG000|Overall Study|Lost to Follow-up|3|||
144477207|NCT03015116|520945847|FG001|Overall Study|Lost to Follow-up|0|||
144477208|NCT03015116|520945848|FG002|Overall Study|Lost to Follow-up|2|||
144477209|NCT03015116|520945846|FG000|Overall Study|Withdrawal by Subject|3|||
144477210|NCT03015116|520945847|FG001|Overall Study|Withdrawal by Subject|1|||
144477211|NCT03015116|520945848|FG002|Overall Study|Withdrawal by Subject|0|||
144477212|NCT03015116|520945846|FG000|Overall Study|Subject has New Medical Status|1|||
144477213|NCT03015116|520945847|FG001|Overall Study|Subject has New Medical Status|0|||
144477214|NCT03015116|520945848|FG002|Overall Study|Subject has New Medical Status|0|||
144477215|NCT03015116|520945846|FG000|Overall Study|Physician Decision|0|||
144477216|NCT03015116|520945847|FG001|Overall Study|Physician Decision|1|||
144477217|NCT03015116|520945848|FG002|Overall Study|Physician Decision|0|||
144477218|NCT02762981|520945853|FG000|Overall Study|Adverse Event|2|||
144477219|NCT02762981|520945854|FG001|Overall Study|Adverse Event|3|||
144477220|NCT02762981|520945855|FG002|Overall Study|Adverse Event|1|||
144477221|NCT02762981|520945856|FG003|Overall Study|Adverse Event|1|||
144477222|NCT02762981|520945857|FG004|Overall Study|Adverse Event|3|||
144477223|NCT02762981|520945853|FG000|Overall Study|Physician Decision|0|||
144477224|NCT02762981|520945854|FG001|Overall Study|Physician Decision|1|||
144477225|NCT02762981|520945855|FG002|Overall Study|Physician Decision|0|||
144477226|NCT02762981|520945856|FG003|Overall Study|Physician Decision|0|||
144477227|NCT02762981|520945857|FG004|Overall Study|Physician Decision|1|||
144477228|NCT02762981|520945853|FG000|Overall Study|Disease progression|11|||
144477229|NCT02762981|520945854|FG001|Overall Study|Disease progression|23|||
144477230|NCT02762981|520945855|FG002|Overall Study|Disease progression|4|||
144477231|NCT02762981|520945856|FG003|Overall Study|Disease progression|10|||
144477232|NCT02762981|520945857|FG004|Overall Study|Disease progression|1|||
144477233|NCT02762981|520945853|FG000|Overall Study|Enrolled not treated|1|||
144477234|NCT02762981|520945854|FG001|Overall Study|Enrolled not treated|5|||
144477235|NCT02762981|520945855|FG002|Overall Study|Enrolled not treated|0|||
144477236|NCT02762981|520945856|FG003|Overall Study|Enrolled not treated|2|||
144477237|NCT02762981|520945857|FG004|Overall Study|Enrolled not treated|0|||
144477238|NCT02762981|520945853|FG000|Overall Study|Other|2|||
144477239|NCT02762981|520945854|FG001|Overall Study|Other|3|||
144477240|NCT02762981|520945855|FG002|Overall Study|Other|1|||
144477241|NCT02762981|520945856|FG003|Overall Study|Other|0|||
144477242|NCT02762981|520945857|FG004|Overall Study|Other|0|||
144477243|NCT02762981|520945853|FG000|Overall Study|Missing|1|||
144477244|NCT02762981|520945854|FG001|Overall Study|Missing|0|||
144477245|NCT02762981|520945855|FG002|Overall Study|Missing|0|||
144477246|NCT02762981|520945856|FG003|Overall Study|Missing|0|||
144477247|NCT02762981|520945857|FG004|Overall Study|Missing|0|||
144702085|NCT03255226|521763211|FG000|Overall Study|Physician Decision|3|||
144702086|NCT03255226|521763211|FG000|Overall Study|Withdrawal by Subject|1|||
144702087|NCT03255226|521763211|FG000|Overall Study|Serum or blood sodium increased|4|||
144702088|NCT03255226|521763211|FG000|Overall Study|Serum or blood potassium increased|4|||
144702089|NCT00602927|521763212|FG000|Period 1: 13 Days|Protocol Violation|2|||
144702090|NCT00602927|521763213|FG001|Period 1: 13 Days|Protocol Violation|4|||
144702091|NCT00602927|521763212|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
144702092|NCT00602927|521763213|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
144702093|NCT00602927|521763212|FG000|Period 1: 13 Days|Time|1|||
144702094|NCT00602927|521763213|FG001|Period 1: 13 Days|Time|0|||
144702095|NCT00602927|521763212|FG000|Period 1: 13 Days|Claustrophobia|0|||
144702096|NCT00602927|521763213|FG001|Period 1: 13 Days|Claustrophobia|1|||
144702097|NCT00602927|521763212|FG000|Period 2: 14 Days|Protocol Violation|0|||
144477248|NCT02762981|520945853|FG000|Overall Study|Withdrawal by Subject|0|||
144702098|NCT00602927|521763213|FG001|Period 2: 14 Days|Protocol Violation|2|||
144702099|NCT00602927|521763212|FG000|Period 3: 13 Days|Protocol Violation|0|||
144702100|NCT00602927|521763213|FG001|Period 3: 13 Days|Protocol Violation|1|||
144702101|NCT00602927|521763212|FG000|Period 3: 13 Days|MRI data quality|2|||
144702102|NCT00602927|521763213|FG001|Period 3: 13 Days|MRI data quality|2|||
144702103|NCT00685763|521763220|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
144702104|NCT00685763|521763220|FG000|Overall Study|Protocol Violation|1|||
144702105|NCT02875340|521763222|FG000|Overall Study|Death|2|||
144477249|NCT02762981|520945854|FG001|Overall Study|Withdrawal by Subject|5|||
144477250|NCT02762981|520945855|FG002|Overall Study|Withdrawal by Subject|1|||
144702106|NCT02875340|521763222|FG000|Overall Study|Withdrawal by Subject|2|||
144702107|NCT02875340|521763222|FG000|Overall Study|Physician Decision|3|||
144702108|NCT02875340|521763222|FG000|Overall Study|Adverse Event|1|||
144702109|NCT01160770|521763223|FG000|Overall Study|Adverse Event|10|||
144702110|NCT01160770|521763223|FG000|Overall Study|Protocol Violation|2|||
144702111|NCT01160770|521763223|FG000|Overall Study|Subject/parent/caregiver request|33|||
144702112|NCT01160770|521763223|FG000|Overall Study|Physician Decision|1|||
144702113|NCT01160770|521763223|FG000|Overall Study|Lost to Follow-up|7|||
144702114|NCT01160770|521763223|FG000|Overall Study|Study termination or sponsor request|1|||
144702115|NCT01160770|521763223|FG000|Overall Study|Death|9|||
144702116|NCT01160770|521763223|FG000|Overall Study|Lack of Efficacy|15|||
144702117|NCT01160770|521763223|FG000|Overall Study|Other Reasons|1|||
144702118|NCT04930536|521763224|FG000|Overall Study|Adverse Event|1|||
144702119|NCT04930536|521763225|FG001|Overall Study|Adverse Event|0|||
144702120|NCT04930536|521763224|FG000|Overall Study|Disease Progression|2|||
144477251|NCT02762981|520945856|FG003|Overall Study|Withdrawal by Subject|3|||
144477252|NCT02762981|520945857|FG004|Overall Study|Withdrawal by Subject|0|||
144477253|NCT01289041|520945858|FG000|Overall Study|Adverse Event|24|||
144477254|NCT01289041|520945858|FG000|Overall Study|Physician Decision|1|||
144477255|NCT01289041|520945858|FG000|Overall Study|Progressive Disease|41|||
144477256|NCT01289041|520945858|FG000|Overall Study|Withdrawal by Subject|3|||
144477257|NCT01289041|520945858|FG000|Overall Study|Death|1|||
144477258|NCT02494921|520945860|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
144477259|NCT02494921|520945861|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
144477260|NCT02494921|520945862|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
144477261|NCT02494921|520945863|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
144477262|NCT02494921|520945864|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
144477263|NCT02494921|520945860|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
144477264|NCT02494921|520945861|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
144477265|NCT02494921|520945862|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
144477266|NCT02494921|520945863|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
144477267|NCT02494921|520945864|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
144477268|NCT02494921|520945860|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
144477269|NCT02494921|520945861|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
144477270|NCT02494921|520945862|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
144477271|NCT02494921|520945863|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
144477272|NCT02494921|520945864|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
144477273|NCT02714868|520945870|FG000|Overall Study|Withdrawal by Subject|3|||
144477274|NCT02714868|520945871|FG001|Overall Study|Withdrawal by Subject|0|||
144477275|NCT02714868|520945870|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
144477276|NCT02714868|520945871|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
144477277|NCT02714868|520945870|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
144477278|NCT02714868|520945871|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
144477279|NCT05648357|520945878|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
144477280|NCT00255346|520945879|FG000|Overall Study|Adverse Event|1|||
144477281|NCT00255346|520945880|FG001|Overall Study|Adverse Event|0|||
144477282|NCT00255346|520945881|FG002|Overall Study|Adverse Event|0|||
144477283|NCT00255346|520945882|FG003|Overall Study|Adverse Event|0|||
144477284|NCT00255346|520945883|FG004|Overall Study|Adverse Event|0|||
144477285|NCT00674323|520945884|FG000|Overall Study|Adverse Event|0|||
144477286|NCT00674323|520945885|FG001|Overall Study|Adverse Event|1|||
144477287|NCT00674323|520945886|FG002|Overall Study|Adverse Event|0|||
144477288|NCT00674323|520945884|FG000|Overall Study|Protocol Violation|1|||
144477289|NCT00674323|520945885|FG001|Overall Study|Protocol Violation|0|||
144477290|NCT00674323|520945886|FG002|Overall Study|Protocol Violation|0|||
144477291|NCT05458024|520945904|FG000|Overall Study|Withdrawal by Subject|1|||
144477292|NCT05458024|520945905|FG001|Overall Study|Withdrawal by Subject|1|||
144477293|NCT01036022|520945918|FG000|Overall Study|Adverse Event|1|||
144477294|NCT01036022|520945919|FG001|Overall Study|Adverse Event|3|||
144477295|NCT01036022|520945920|FG002|Overall Study|Adverse Event|2|||
144477296|NCT01036022|520945921|FG003|Overall Study|Adverse Event|1|||
144477297|NCT01036022|520945922|FG004|Overall Study|Adverse Event|0|||
144477298|NCT01036022|520945923|FG005|Overall Study|Adverse Event|2|||
144477299|NCT01036022|520945918|FG000|Overall Study|Lack of Efficacy|1|||
144477300|NCT01036022|520945919|FG001|Overall Study|Lack of Efficacy|1|||
144477301|NCT01036022|520945920|FG002|Overall Study|Lack of Efficacy|1|||
144477302|NCT01036022|520945921|FG003|Overall Study|Lack of Efficacy|0|||
144477303|NCT01036022|520945922|FG004|Overall Study|Lack of Efficacy|1|||
144477304|NCT01036022|520945923|FG005|Overall Study|Lack of Efficacy|1|||
144702121|NCT04930536|521763225|FG001|Overall Study|Disease Progression|0|||
144702122|NCT04930536|521763224|FG000|Overall Study|Patient Decision|4|||
144702123|NCT04930536|521763225|FG001|Overall Study|Patient Decision|2|||
144477305|NCT01036022|520945918|FG000|Overall Study|Physician Decision|0|||
144477306|NCT01036022|520945919|FG001|Overall Study|Physician Decision|0|||
144477307|NCT01036022|520945920|FG002|Overall Study|Physician Decision|1|||
144477308|NCT01036022|520945921|FG003|Overall Study|Physician Decision|0|||
144477309|NCT01036022|520945922|FG004|Overall Study|Physician Decision|0|||
144477310|NCT01036022|520945923|FG005|Overall Study|Physician Decision|0|||
144477311|NCT01036022|520945918|FG000|Overall Study|Withdrawal by Subject|0|||
144477312|NCT01036022|520945919|FG001|Overall Study|Withdrawal by Subject|0|||
144477313|NCT01036022|520945920|FG002|Overall Study|Withdrawal by Subject|0|||
144477314|NCT01036022|520945921|FG003|Overall Study|Withdrawal by Subject|1|||
144477315|NCT01036022|520945922|FG004|Overall Study|Withdrawal by Subject|2|||
144477316|NCT01036022|520945923|FG005|Overall Study|Withdrawal by Subject|0|||
144477317|NCT02087501|520945924|FG000|Overall Study|Death|7|||
144477318|NCT02087501|520945924|FG000|Overall Study|Open repair of aneurysm|1|||
144477319|NCT02087501|520945924|FG000|Overall Study|Lost to Follow-up|2|||
144477320|NCT01875185|520945925|FG000|Overall Study|study was terminated|52|||
144477321|NCT01875185|520945926|FG001|Overall Study|study was terminated|48|||
144477322|NCT03565068|520945928|FG000|Overall Study|Protocol Violation|0|||
144477323|NCT03565068|520945929|FG001|Overall Study|Protocol Violation|0|||
144477324|NCT03565068|520945930|FG002|Overall Study|Protocol Violation|0|||
144477325|NCT03565068|520945931|FG003|Overall Study|Protocol Violation|0|||
144477326|NCT03565068|520945932|FG004|Overall Study|Protocol Violation|1|||
144477327|NCT03565068|520945933|FG005|Overall Study|Protocol Violation|0|||
144477328|NCT03565068|520945934|FG006|Overall Study|Protocol Violation|0|||
144477329|NCT03565068|520945935|FG007|Overall Study|Protocol Violation|1|||
144477330|NCT03565068|520945936|FG008|Overall Study|Protocol Violation|0|||
144477331|NCT03565068|520945928|FG000|Overall Study|Sponsor decision|0|||
144477332|NCT03565068|520945929|FG001|Overall Study|Sponsor decision|0|||
144477333|NCT03565068|520945930|FG002|Overall Study|Sponsor decision|0|||
144477334|NCT03565068|520945931|FG003|Overall Study|Sponsor decision|0|||
144477335|NCT03565068|520945932|FG004|Overall Study|Sponsor decision|1|||
144477336|NCT03565068|520945933|FG005|Overall Study|Sponsor decision|1|||
144477337|NCT03565068|520945934|FG006|Overall Study|Sponsor decision|0|||
144477338|NCT03565068|520945935|FG007|Overall Study|Sponsor decision|0|||
144477339|NCT03565068|520945936|FG008|Overall Study|Sponsor decision|0|||
144477340|NCT03565068|520945928|FG000|Overall Study|Withdrawal by Subject|0|||
144477341|NCT03565068|520945929|FG001|Overall Study|Withdrawal by Subject|0|||
144477342|NCT03565068|520945930|FG002|Overall Study|Withdrawal by Subject|1|||
144477343|NCT03565068|520945931|FG003|Overall Study|Withdrawal by Subject|0|||
144477344|NCT03565068|520945932|FG004|Overall Study|Withdrawal by Subject|2|||
144477345|NCT03565068|520945933|FG005|Overall Study|Withdrawal by Subject|0|||
144477346|NCT03565068|520945934|FG006|Overall Study|Withdrawal by Subject|1|||
144477347|NCT03565068|520945935|FG007|Overall Study|Withdrawal by Subject|5|||
144477348|NCT03565068|520945936|FG008|Overall Study|Withdrawal by Subject|1|||
144477349|NCT03565068|520945928|FG000|Overall Study|Physician Decision|0|||
144477350|NCT03565068|520945929|FG001|Overall Study|Physician Decision|0|||
144477351|NCT03565068|520945930|FG002|Overall Study|Physician Decision|0|||
144477352|NCT03565068|520945931|FG003|Overall Study|Physician Decision|0|||
144477353|NCT03565068|520945932|FG004|Overall Study|Physician Decision|0|||
144477354|NCT03565068|520945933|FG005|Overall Study|Physician Decision|0|||
144477355|NCT03565068|520945934|FG006|Overall Study|Physician Decision|0|||
144477356|NCT03565068|520945935|FG007|Overall Study|Physician Decision|1|||
144477357|NCT03565068|520945936|FG008|Overall Study|Physician Decision|0|||
144477358|NCT03565068|520945928|FG000|Overall Study|Lost to Follow-up|0|||
144477359|NCT03565068|520945929|FG001|Overall Study|Lost to Follow-up|0|||
144477360|NCT03565068|520945930|FG002|Overall Study|Lost to Follow-up|0|||
144477361|NCT03565068|520945931|FG003|Overall Study|Lost to Follow-up|0|||
144477362|NCT03565068|520945932|FG004|Overall Study|Lost to Follow-up|0|||
144477363|NCT03565068|520945933|FG005|Overall Study|Lost to Follow-up|0|||
144477364|NCT03565068|520945934|FG006|Overall Study|Lost to Follow-up|0|||
144477365|NCT03565068|520945935|FG007|Overall Study|Lost to Follow-up|1|||
144477366|NCT03565068|520945936|FG008|Overall Study|Lost to Follow-up|0|||
144477367|NCT02613221|520945937|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
144477368|NCT02613221|520945937|FG000|Overall Study|Adverse Event|2|||
144477369|NCT02613221|520945937|FG000|Overall Study|Voluntary Discontinuation|1|||
144477370|NCT02613221|520945937|FG000|Overall Study|Delayed Treatment|1|||
144477371|NCT02613221|520945937|FG000|Overall Study|Enrolled but Not Treated|1|||
144477372|NCT02917941|520945938|FG000|Treatment Period|Adverse Event|11|||
144477373|NCT02917941|520945938|FG000|Treatment Period|Progressive Disease|11|||
144477374|NCT02917941|520945938|FG000|Treatment Period|Reason not Specified|2|||
144477375|NCT02917941|520945938|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
144477376|NCT02917941|520945938|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
144477377|NCT03520400|520945949|FG000|Overall Study|Physician Decision|15|||
144477378|NCT03520400|520945950|FG001|Overall Study|Physician Decision|7|||
144477379|NCT00909428|520945953|FG000|Overall Study|Lost to Follow-up|13|||
144477380|NCT00909428|520945954|FG001|Overall Study|Lost to Follow-up|10|||
144477381|NCT00909428|520945955|FG002|Overall Study|Lost to Follow-up|9|||
144477382|NCT01933880|520945956|FG000|Overall Study|Withdrawal by Subject|5|||
144477383|NCT01933880|520945957|FG001|Overall Study|Withdrawal by Subject|0|||
144477384|NCT01933880|520945956|FG000|Overall Study|Lack of Efficacy|1|||
144477385|NCT01933880|520945957|FG001|Overall Study|Lack of Efficacy|0|||
144477386|NCT01933880|520945956|FG000|Overall Study|Concomitant medication Interference|0|||
144477387|NCT01933880|520945957|FG001|Overall Study|Concomitant medication Interference|1|||
144477388|NCT01933880|520945956|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
144477389|NCT01933880|520945957|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
144477390|NCT01933880|520945956|FG000|Overall Study|Other|4|||
144477391|NCT01933880|520945957|FG001|Overall Study|Other|0|||
144477392|NCT01933880|520945956|FG000|Overall Study|Protocol Violation|1|||
144477393|NCT01933880|520945957|FG001|Overall Study|Protocol Violation|0|||
144477394|NCT03474549|520945958|FG000|Overall Study|Death|31|||
144477395|NCT03474549|520945958|FG000|Overall Study|Lost to Follow-up|4|||
144477396|NCT03474549|520945958|FG000|Overall Study|Withdrawal by Subject|2|||
144477397|NCT00738101|520945959|FG000|Overall Study|Physician Decision|5|||
144477398|NCT00738101|520945959|FG000|Overall Study|Death|1|||
144477399|NCT00738101|520945959|FG000|Overall Study|Repeat enrollment|1|||
144477400|NCT00709059|520945964|FG000|Overall Study|Lost to Follow-up|34|||
144477401|NCT00709059|520945964|FG000|Overall Study|Withdrawal by Subject|19|||
144477402|NCT00709059|520945964|FG000|Overall Study|Physician Decision|7|||
144477403|NCT00709059|520945964|FG000|Overall Study|Disease complication|3|||
144477404|NCT00709059|520945964|FG000|Overall Study|Side effects|20|||
144477405|NCT00709059|520945964|FG000|Overall Study|Serious side effects|11|||
144477406|NCT01396317|520945965|FG000|Overall Study|Adverse Event|1|||
144477407|NCT01396317|520945966|FG001|Overall Study|Adverse Event|0|||
144477408|NCT03315130|520945967|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
144477409|NCT03315130|520945968|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
144477410|NCT03315130|520945969|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
144477411|NCT03315130|520945970|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
144477412|NCT03315130|520945967|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
144477413|NCT03315130|520945968|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
144477414|NCT03315130|520945969|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
144477415|NCT03315130|520945970|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
144477416|NCT03315130|520945967|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
144477417|NCT03315130|520945968|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
144477418|NCT03315130|520945969|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
144702124|NCT04930536|521763224|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
144702125|NCT04930536|521763225|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
144702126|NCT01432600|521763226|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
144702127|NCT01432600|521763227|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
144702128|NCT01432600|521763228|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
144702129|NCT00348348|521763232|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
144702130|NCT00348348|521763233|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
144702131|NCT00348348|521763232|FG000|Overall Study|Lack of Efficacy|1|||
144702132|NCT00348348|521763233|FG001|Overall Study|Lack of Efficacy|1|||
144702133|NCT00348348|521763232|FG000|Overall Study|Lost to Follow-up|8|||
144702134|NCT00348348|521763233|FG001|Overall Study|Lost to Follow-up|10|||
144702135|NCT00348348|521763232|FG000|Overall Study|Withdrawal by Subject|4|||
144702136|NCT00348348|521763233|FG001|Overall Study|Withdrawal by Subject|1|||
144702137|NCT00348348|521763232|FG000|Overall Study|Other|7|||
144702138|NCT00348348|521763233|FG001|Overall Study|Other|4|||
144702139|NCT00348348|521763232|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
144702140|NCT00348348|521763233|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
144702141|NCT00348348|521763232|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
144702142|NCT00348348|521763233|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
144702143|NCT00348348|521763232|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
144702144|NCT00348348|521763233|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
144702145|NCT00348348|521763232|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
144702146|NCT00348348|521763233|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
144702147|NCT00348348|521763232|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
144702148|NCT00348348|521763233|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
144702149|NCT00348348|521763232|FG000|Overall Study|Adverse event probably related to study|1|||
144702150|NCT00348348|521763233|FG001|Overall Study|Adverse event probably related to study|0|||
144702151|NCT01605370|521763236|FG000|Overall Study|Adverse Event|1|||
144702152|NCT01605370|521763237|FG001|Overall Study|Adverse Event|0|||
144702153|NCT05102162|521763241|FG000|Overall Study|Withdrawal by Subject|3|||
144702154|NCT05102162|521763242|FG001|Overall Study|Withdrawal by Subject|0|||
144702155|NCT05102162|521763241|FG000|Overall Study|Baseline cultures negative|4|||
144702156|NCT05102162|521763242|FG001|Overall Study|Baseline cultures negative|2|||
144702157|NCT05102162|521763241|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
144702158|NCT05102162|521763242|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
144702159|NCT05102162|521763241|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
144702160|NCT05102162|521763242|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
144702161|NCT01165424|521763243|FG000|Overall Study|Clinical adverse experiences|1|||
144702162|NCT01165424|521763243|FG000|Overall Study|Laboratory adverse experiences|1|||
144702163|NCT01165424|521763243|FG000|Overall Study|Did not meet entry criteria|1|||
144702164|NCT01165424|521763243|FG000|Overall Study|Participant moved (relocated)|1|||
144702165|NCT02181673|521763244|FG000|Up to Week 24|Adverse Event|2|||
144702166|NCT02181673|521763245|FG001|Up to Week 24|Adverse Event|0|||
144702167|NCT02181673|521763246|FG002|Up to Week 24|Adverse Event|3|||
144702168|NCT02181673|521763244|FG000|Up to Week 24|Death|1|||
144702169|NCT02181673|521763245|FG001|Up to Week 24|Death|0|||
144702170|NCT02181673|521763246|FG002|Up to Week 24|Death|0|||
144702171|NCT02181673|521763244|FG000|Up to Week 24|Lack of Efficacy|1|||
144702172|NCT02181673|521763245|FG001|Up to Week 24|Lack of Efficacy|0|||
144702173|NCT02181673|521763246|FG002|Up to Week 24|Lack of Efficacy|0|||
144702174|NCT02181673|521763244|FG000|Up to Week 24|Lost to Follow-up|1|||
144702175|NCT02181673|521763245|FG001|Up to Week 24|Lost to Follow-up|0|||
144702176|NCT02181673|521763246|FG002|Up to Week 24|Lost to Follow-up|0|||
144702177|NCT02181673|521763244|FG000|Up to Week 24|Physician Decision|0|||
144702178|NCT02181673|521763245|FG001|Up to Week 24|Physician Decision|0|||
144702179|NCT02181673|521763246|FG002|Up to Week 24|Physician Decision|3|||
144702180|NCT02181673|521763244|FG000|Up to Week 24|Withdrawal by Subject|10|||
144702181|NCT02181673|521763245|FG001|Up to Week 24|Withdrawal by Subject|0|||
144702182|NCT02181673|521763246|FG002|Up to Week 24|Withdrawal by Subject|1|||
144702183|NCT02181673|521763244|FG000|Up to Week 24|Other|2|||
144702184|NCT02181673|521763245|FG001|Up to Week 24|Other|0|||
144702185|NCT02181673|521763246|FG002|Up to Week 24|Other|3|||
144702186|NCT02181673|521763244|FG000|Up to Week 24|Randomized not Treated|0|||
144702187|NCT02181673|521763245|FG001|Up to Week 24|Randomized not Treated|0|||
144702188|NCT02181673|521763246|FG002|Up to Week 24|Randomized not Treated|1|||
144702189|NCT02181673|521763244|FG000|Week 24-Week 60|Adverse Event|0|||
144702190|NCT02181673|521763245|FG001|Week 24-Week 60|Adverse Event|4|||
144702191|NCT02181673|521763246|FG002|Week 24-Week 60|Adverse Event|10|||
144702192|NCT02181673|521763244|FG000|Week 24-Week 60|Other|0|||
144702193|NCT02181673|521763245|FG001|Week 24-Week 60|Other|2|||
144702194|NCT02181673|521763246|FG002|Week 24-Week 60|Other|1|||
144362383|NCT02702492|520535194|FG009|Overall Study|Other|0|||
144702195|NCT02181673|521763244|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
144702196|NCT02181673|521763245|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
144702197|NCT02181673|521763246|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
144477419|NCT03315130|520945970|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
144477420|NCT03315130|520945967|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
144477421|NCT03315130|520945968|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
144477422|NCT03315130|520945969|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
144477423|NCT03315130|520945970|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
144477424|NCT03315130|520945967|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
144477425|NCT03315130|520945968|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
144477426|NCT03315130|520945969|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
144477427|NCT03315130|520945970|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
144477428|NCT03315130|520945967|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
144477429|NCT03315130|520945968|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
144477430|NCT03315130|520945969|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
144477431|NCT03315130|520945970|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
144477432|NCT04398537|520945971|FG000|Overall Study|Physician Decision|10|||
144477433|NCT04398537|520945972|FG001|Overall Study|Physician Decision|15|||
144477434|NCT02089230|520945973|FG000|Overall Study|Death|0|||
144477435|NCT02089230|520945974|FG001|Overall Study|Death|0|||
144477436|NCT02089230|520945975|FG002|Overall Study|Death|2|||
144477437|NCT02089230|520945973|FG000|Overall Study|Seeking Alternative Therapy|0|||
144477438|NCT02089230|520945974|FG001|Overall Study|Seeking Alternative Therapy|0|||
144477439|NCT02089230|520945975|FG002|Overall Study|Seeking Alternative Therapy|4|||
144477440|NCT02764775|520947776|FG000|Overall Study|Death|1|||
144477441|NCT02764775|520947776|FG000|Overall Study|Lost to Follow-up|2|||
144477442|NCT02764775|520947776|FG000|Overall Study|Withdrawal by Subject|3|||
144477443|NCT04867785|520947790|FG000|Overall Study|Adverse Event|1|||
144477444|NCT04867785|520947791|FG001|Overall Study|Adverse Event|0|||
144477445|NCT04867785|520947792|FG002|Overall Study|Adverse Event|1|||
144477446|NCT04867785|520947793|FG003|Overall Study|Adverse Event|0|||
144477447|NCT04867785|520947794|FG004|Overall Study|Adverse Event|0|||
144477448|NCT04867785|520947795|FG005|Overall Study|Adverse Event|0|||
144477449|NCT04867785|520947796|FG006|Overall Study|Adverse Event|0|||
144477450|NCT04867785|520947797|FG007|Overall Study|Adverse Event|2|||
144477451|NCT04867785|520947790|FG000|Overall Study|Lost to Follow-up|4|||
144477452|NCT04867785|520947791|FG001|Overall Study|Lost to Follow-up|4|||
144477453|NCT04867785|520947792|FG002|Overall Study|Lost to Follow-up|3|||
144477454|NCT04867785|520947793|FG003|Overall Study|Lost to Follow-up|2|||
144477455|NCT04867785|520947794|FG004|Overall Study|Lost to Follow-up|0|||
144477456|NCT04867785|520947795|FG005|Overall Study|Lost to Follow-up|1|||
144477457|NCT04867785|520947796|FG006|Overall Study|Lost to Follow-up|0|||
144477458|NCT04867785|520947797|FG007|Overall Study|Lost to Follow-up|1|||
144477459|NCT04867785|520947790|FG000|Overall Study|Withdrawal by Subject|6|||
144477460|NCT04867785|520947791|FG001|Overall Study|Withdrawal by Subject|2|||
144477461|NCT04867785|520947792|FG002|Overall Study|Withdrawal by Subject|2|||
144477462|NCT04867785|520947793|FG003|Overall Study|Withdrawal by Subject|1|||
144477463|NCT04867785|520947794|FG004|Overall Study|Withdrawal by Subject|2|||
144477464|NCT04867785|520947795|FG005|Overall Study|Withdrawal by Subject|0|||
144477465|NCT04867785|520947796|FG006|Overall Study|Withdrawal by Subject|2|||
144477466|NCT04867785|520947797|FG007|Overall Study|Withdrawal by Subject|5|||
144477467|NCT04867785|520947790|FG000|Overall Study|Physician Decision|0|||
144477468|NCT04867785|520947791|FG001|Overall Study|Physician Decision|0|||
144477469|NCT04867785|520947792|FG002|Overall Study|Physician Decision|0|||
144477470|NCT04867785|520947793|FG003|Overall Study|Physician Decision|0|||
144477471|NCT04867785|520947794|FG004|Overall Study|Physician Decision|0|||
144477472|NCT04867785|520947795|FG005|Overall Study|Physician Decision|0|||
144477473|NCT04867785|520947796|FG006|Overall Study|Physician Decision|0|||
144477474|NCT04867785|520947797|FG007|Overall Study|Physician Decision|1|||
144477475|NCT04867785|520947790|FG000|Overall Study|Inadvertent Enrollment|0|||
144477476|NCT04867785|520947791|FG001|Overall Study|Inadvertent Enrollment|0|||
144477477|NCT04867785|520947792|FG002|Overall Study|Inadvertent Enrollment|0|||
144477478|NCT04867785|520947793|FG003|Overall Study|Inadvertent Enrollment|1|||
144477479|NCT04867785|520947794|FG004|Overall Study|Inadvertent Enrollment|1|||
144477480|NCT04867785|520947795|FG005|Overall Study|Inadvertent Enrollment|0|||
144477481|NCT04867785|520947796|FG006|Overall Study|Inadvertent Enrollment|0|||
144477482|NCT04867785|520947797|FG007|Overall Study|Inadvertent Enrollment|1|||
144477483|NCT04867785|520947790|FG000|Overall Study|Eligibility Criteria Not Met|0|||
144477484|NCT04867785|520947791|FG001|Overall Study|Eligibility Criteria Not Met|0|||
144477485|NCT04867785|520947792|FG002|Overall Study|Eligibility Criteria Not Met|0|||
144477486|NCT04867785|520947793|FG003|Overall Study|Eligibility Criteria Not Met|0|||
144477487|NCT04867785|520947794|FG004|Overall Study|Eligibility Criteria Not Met|0|||
144477488|NCT04867785|520947795|FG005|Overall Study|Eligibility Criteria Not Met|0|||
144477489|NCT04867785|520947796|FG006|Overall Study|Eligibility Criteria Not Met|0|||
144477490|NCT04867785|520947797|FG007|Overall Study|Eligibility Criteria Not Met|1|||
144477491|NCT03585296|520947798|FG000|Overall Study|Adverse Event|1|||
144477492|NCT03585296|520947798|FG000|Overall Study|Lost to Follow-up|2|||
144477493|NCT03585296|520947798|FG000|Overall Study|Withdrawal by Subject|2|||
144702198|NCT02181673|521763244|FG000|Week 24-Week 60|Pregnancy|0|||
144702199|NCT02181673|521763245|FG001|Week 24-Week 60|Pregnancy|0|||
144702200|NCT02181673|521763246|FG002|Week 24-Week 60|Pregnancy|1|||
144702201|NCT02181673|521763244|FG000|Week 24-Week 60|Lack of Efficacy|0|||
144702202|NCT02181673|521763245|FG001|Week 24-Week 60|Lack of Efficacy|0|||
144702203|NCT02181673|521763246|FG002|Week 24-Week 60|Lack of Efficacy|1|||
144702204|NCT02181673|521763244|FG000|Week 24-Week 60|Lost to Follow-up|0|||
144702205|NCT02181673|521763245|FG001|Week 24-Week 60|Lost to Follow-up|0|||
144702206|NCT02181673|521763246|FG002|Week 24-Week 60|Lost to Follow-up|1|||
144702207|NCT02181673|521763244|FG000|Week 24-Week 60|Physician Decision|0|||
144702208|NCT02181673|521763245|FG001|Week 24-Week 60|Physician Decision|0|||
144702209|NCT02181673|521763246|FG002|Week 24-Week 60|Physician Decision|1|||
144702210|NCT00433771|521763247|FG000|Overall Study|screen fail|14|||
144702211|NCT00433771|521763247|FG000|Overall Study|Treated and later found to be ineligible|2|||
144702212|NCT00433771|521763247|FG000|Overall Study|Death|2|||
144702213|NCT00433771|521763247|FG000|Overall Study|Failure to deploy stent|1|||
144702214|NCT02871921|521763250|FG000|Overall Study|Withdrawal by Subject|34|||
144702215|NCT02871921|521763251|FG001|Overall Study|Withdrawal by Subject|27|||
144702216|NCT02871921|521763252|FG002|Overall Study|Withdrawal by Subject|27|||
144702217|NCT02871921|521763253|FG003|Overall Study|Withdrawal by Subject|30|||
144702218|NCT00320801|521763254|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
144702219|NCT00320801|521763255|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
144702220|NCT00320801|521763256|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
144702221|NCT00320801|521763257|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
144702222|NCT00320801|521763254|FG000|Open-label Run-in Period|Adverse Event|33|||
144702223|NCT00320801|521763255|FG001|Open-label Run-in Period|Adverse Event|0|||
144702224|NCT00320801|521763256|FG002|Open-label Run-in Period|Adverse Event|0|||
144702225|NCT00320801|521763257|FG003|Open-label Run-in Period|Adverse Event|0|||
144702226|NCT00320801|521763254|FG000|Open-label Run-in Period|Administrative|10|||
144702227|NCT00320801|521763255|FG001|Open-label Run-in Period|Administrative|0|||
144702228|NCT00320801|521763256|FG002|Open-label Run-in Period|Administrative|0|||
144702229|NCT00320801|521763257|FG003|Open-label Run-in Period|Administrative|0|||
144702230|NCT00320801|521763254|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
144702231|NCT00320801|521763255|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
144702232|NCT00320801|521763256|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
144702233|NCT00320801|521763257|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
144702234|NCT00320801|521763254|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
144702235|NCT00320801|521763255|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
144702236|NCT00320801|521763256|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
144702237|NCT00320801|521763257|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
144702238|NCT00320801|521763254|FG000|Open-label Run-in Period|Did not qualify|1|||
144702239|NCT00320801|521763255|FG001|Open-label Run-in Period|Did not qualify|0|||
144702240|NCT00320801|521763256|FG002|Open-label Run-in Period|Did not qualify|0|||
144702241|NCT00320801|521763257|FG003|Open-label Run-in Period|Did not qualify|0|||
144702242|NCT00320801|521763254|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144702243|NCT00320801|521763255|FG001|Double-blind Phase|Withdrawal by Subject|0|||
144702244|NCT00320801|521763256|FG002|Double-blind Phase|Withdrawal by Subject|1|||
144702245|NCT00320801|521763257|FG003|Double-blind Phase|Withdrawal by Subject|0|||
144702246|NCT00320801|521763254|FG000|Double-blind Phase|Adverse Event|0|||
144702247|NCT00320801|521763255|FG001|Double-blind Phase|Adverse Event|2|||
144702248|NCT00320801|521763256|FG002|Double-blind Phase|Adverse Event|8|||
144702249|NCT00320801|521763257|FG003|Double-blind Phase|Adverse Event|0|||
144702250|NCT00320801|521763254|FG000|Double-blind Phase|Administrative|0|||
144702251|NCT00320801|521763255|FG001|Double-blind Phase|Administrative|0|||
144702252|NCT00320801|521763256|FG002|Double-blind Phase|Administrative|4|||
144702253|NCT00320801|521763257|FG003|Double-blind Phase|Administrative|0|||
144702254|NCT00320801|521763254|FG000|Double-blind Phase|Lack of Efficacy|0|||
144702255|NCT00320801|521763255|FG001|Double-blind Phase|Lack of Efficacy|9|||
144702256|NCT00320801|521763256|FG002|Double-blind Phase|Lack of Efficacy|1|||
144702257|NCT00320801|521763257|FG003|Double-blind Phase|Lack of Efficacy|0|||
144702258|NCT00320801|521763254|FG000|Extension Phase|Withdrawal by Subject|0|||
144702259|NCT00320801|521763255|FG001|Extension Phase|Withdrawal by Subject|0|||
144702260|NCT00320801|521763256|FG002|Extension Phase|Withdrawal by Subject|0|||
144702261|NCT00320801|521763257|FG003|Extension Phase|Withdrawal by Subject|6|||
144702262|NCT00320801|521763254|FG000|Extension Phase|Adverse Event|0|||
144702263|NCT00320801|521763255|FG001|Extension Phase|Adverse Event|0|||
144702264|NCT00320801|521763256|FG002|Extension Phase|Adverse Event|0|||
144702265|NCT00320801|521763257|FG003|Extension Phase|Adverse Event|8|||
144702266|NCT00320801|521763254|FG000|Extension Phase|Administrative|0|||
144702267|NCT00320801|521763255|FG001|Extension Phase|Administrative|0|||
144702268|NCT00320801|521763256|FG002|Extension Phase|Administrative|0|||
144702269|NCT00320801|521763257|FG003|Extension Phase|Administrative|29|||
144702270|NCT00320801|521763254|FG000|Extension Phase|Lack of Efficacy|0|||
144702271|NCT00320801|521763255|FG001|Extension Phase|Lack of Efficacy|0|||
144702272|NCT00320801|521763256|FG002|Extension Phase|Lack of Efficacy|0|||
144702273|NCT00320801|521763257|FG003|Extension Phase|Lack of Efficacy|2|||
144702274|NCT00320801|521763254|FG000|Extension Phase|Lost to Follow-up|0|||
144477494|NCT00462670|520947801|FG000|Overall Study|Adverse Event|3|||
144477495|NCT00462670|520947802|FG001|Overall Study|Adverse Event|5|||
144477496|NCT00462670|520947801|FG000|Overall Study|Lack of Efficacy|1|||
144477497|NCT00462670|520947802|FG001|Overall Study|Lack of Efficacy|0|||
144477498|NCT00462670|520947801|FG000|Overall Study|Protocol Violation|1|||
144477499|NCT00462670|520947802|FG001|Overall Study|Protocol Violation|0|||
144702275|NCT00320801|521763255|FG001|Extension Phase|Lost to Follow-up|0|||
144702276|NCT00320801|521763256|FG002|Extension Phase|Lost to Follow-up|0|||
144702277|NCT00320801|521763257|FG003|Extension Phase|Lost to Follow-up|3|||
144702278|NCT04764669|521763260|FG000|Overall Study|Adverse Event|1|||
144702279|NCT04764669|521763261|FG001|Overall Study|Adverse Event|0|||
144702280|NCT04764669|521763262|FG002|Overall Study|Adverse Event|1|||
144702281|NCT04764669|521763263|FG003|Overall Study|Adverse Event|0|||
144702282|NCT04764669|521763260|FG000|Overall Study|Subject Choice|0|||
144702283|NCT04764669|521763261|FG001|Overall Study|Subject Choice|0|||
144702284|NCT04764669|521763262|FG002|Overall Study|Subject Choice|1|||
144702285|NCT04764669|521763263|FG003|Overall Study|Subject Choice|0|||
144702286|NCT04764669|521763260|FG000|Overall Study|Withdrawal by Subject|2|||
144702287|NCT04764669|521763261|FG001|Overall Study|Withdrawal by Subject|0|||
144702288|NCT04764669|521763262|FG002|Overall Study|Withdrawal by Subject|0|||
144702289|NCT04764669|521763263|FG003|Overall Study|Withdrawal by Subject|0|||
144702290|NCT00625846|521763264|FG000|Overall Study|Withdrawal by Subject|2|||
144702291|NCT00625846|521763265|FG001|Overall Study|Withdrawal by Subject|0|||
144702292|NCT00625846|521763266|FG002|Overall Study|Withdrawal by Subject|1|||
144702293|NCT00625846|521763267|FG003|Overall Study|Withdrawal by Subject|2|||
144702294|NCT00807040|521763268|FG000|Overall Study|Death|24|||
144702295|NCT00807040|521763269|FG001|Overall Study|Death|29|||
144702296|NCT00807040|521763268|FG000|Overall Study|Withdrawal by Subject|8|||
144702297|NCT00807040|521763269|FG001|Overall Study|Withdrawal by Subject|6|||
144702298|NCT00807040|521763268|FG000|Overall Study|Lost to Follow-up|4|||
144702299|NCT00807040|521763269|FG001|Overall Study|Lost to Follow-up|6|||
144702300|NCT00890409|521763270|FG000|Overall Study|Lost to Follow-up|20|||
144477500|NCT00462670|520947801|FG000|Overall Study|Resolution of signs and symptoms|0|||
144477501|NCT00462670|520947802|FG001|Overall Study|Resolution of signs and symptoms|2|||
144477502|NCT02966002|520947803|FG000|Overall Study|Withdrawal by Subject|2|||
144477503|NCT02966002|520947803|FG000|Overall Study|Adverse Event|1|||
144477504|NCT02966002|520947803|FG000|Overall Study|Lost to Follow-up|1|||
144477505|NCT02291432|520947805|FG000|Overall Study|Withdrawal by Subject|2|||
144477506|NCT00584805|520947808|FG000|Overall Study|No longer at risk of exposure|39|||
144477507|NCT00584805|520947808|FG000|Overall Study|Relocation|36|||
144477508|NCT00584805|520947808|FG000|Overall Study|Withdrawal by Subject|18|||
144477509|NCT00584805|520947808|FG000|Overall Study|Non-compliance|1|||
144477510|NCT00584805|520947808|FG000|Overall Study|Lost to follow up|3|||
144477511|NCT00584805|520947808|FG000|Overall Study|Screen failures|2|||
144477512|NCT03097861|520947813|FG000|Overall Study|Adverse Event|3|||
144477513|NCT03097861|520947814|FG001|Overall Study|Adverse Event|8|||
144477514|NCT03097861|520947815|FG002|Overall Study|Adverse Event|4|||
144477515|NCT03097861|520947813|FG000|Overall Study|Investigator Decision|0|||
144477516|NCT03097861|520947814|FG001|Overall Study|Investigator Decision|1|||
144477517|NCT03097861|520947815|FG002|Overall Study|Investigator Decision|0|||
144477518|NCT03097861|520947813|FG000|Overall Study|Lost to Follow-up|0|||
144477519|NCT03097861|520947814|FG001|Overall Study|Lost to Follow-up|7|||
144477520|NCT03097861|520947815|FG002|Overall Study|Lost to Follow-up|1|||
144477521|NCT03097861|520947813|FG000|Overall Study|Withdrawal by Subject|1|||
144477522|NCT03097861|520947814|FG001|Overall Study|Withdrawal by Subject|5|||
144477523|NCT03097861|520947815|FG002|Overall Study|Withdrawal by Subject|3|||
144477524|NCT03097861|520947813|FG000|Overall Study|Reason not provided|3|||
144477525|NCT03097861|520947814|FG001|Overall Study|Reason not provided|1|||
144477526|NCT03097861|520947815|FG002|Overall Study|Reason not provided|1|||
144477527|NCT01785563|520947816|FG000|Overall Study|Physician Decision|10|||
144477528|NCT01785563|520947816|FG000|Overall Study|Withdrawal by Subject|1|||
144477529|NCT01785563|520947816|FG000|Overall Study|Protocol Violation|2|||
144702301|NCT00890409|521763271|FG001|Overall Study|Lost to Follow-up|21|||
144477530|NCT01616771|520947819|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
144477531|NCT00744328|520947820|FG000|Overall Study|Lost to Follow-up|2|||
144477532|NCT00744328|520947821|FG001|Overall Study|Lost to Follow-up|5|||
144702302|NCT02353572|521763272|FG000|Overall Study|Withdrawal by Subject|1|||
144702303|NCT02353572|521763272|FG000|Overall Study|Study terminated|2|||
144702304|NCT03426995|521763274|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702305|NCT03426995|521763275|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144477533|NCT00744328|520947822|FG002|Overall Study|Lost to Follow-up|3|||
144477534|NCT00744328|520947820|FG000|Overall Study|Withdrawal by Subject|5|||
144477535|NCT00744328|520947821|FG001|Overall Study|Withdrawal by Subject|3|||
144477536|NCT00744328|520947822|FG002|Overall Study|Withdrawal by Subject|4|||
144477537|NCT00744328|520947820|FG000|Overall Study|Found ineligible after randomization|0|||
144477538|NCT00744328|520947821|FG001|Overall Study|Found ineligible after randomization|0|||
144477539|NCT00744328|520947822|FG002|Overall Study|Found ineligible after randomization|1|||
144477540|NCT02387216|520947827|FG000|Overall Study|Progressive disease|2|||
144477541|NCT02387216|520947828|FG001|Overall Study|Progressive disease|0|||
144477542|NCT02387216|520947827|FG000|Overall Study|Withdrawal by Subject|3|||
144477543|NCT02387216|520947828|FG001|Overall Study|Withdrawal by Subject|5|||
144477544|NCT02387216|520947827|FG000|Overall Study|Physician Decision|2|||
144727034|NCT05097989|521854424|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727035|NCT05097989|521854425|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
144727036|NCT05097989|521854426|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727037|NCT05097989|521854427|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727038|NCT05097989|521854428|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727039|NCT05097989|521854429|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727040|NCT05097989|521854430|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727041|NCT05097989|521854431|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
144727042|NCT05097989|521854423|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727043|NCT05097989|521854424|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
144727044|NCT05097989|521854425|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727045|NCT05097989|521854426|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727046|NCT05097989|521854427|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727047|NCT05097989|521854428|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727048|NCT05097989|521854429|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727049|NCT05097989|521854430|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727050|NCT05097989|521854431|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
144727051|NCT05097989|521854423|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727052|NCT05097989|521854424|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727053|NCT05097989|521854425|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727054|NCT05097989|521854426|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727055|NCT05097989|521854427|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144727056|NCT05097989|521854428|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727057|NCT05097989|521854429|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727058|NCT05097989|521854430|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727059|NCT05097989|521854431|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144727060|NCT05097989|521854423|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727061|NCT05097989|521854424|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727062|NCT05097989|521854425|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727063|NCT05097989|521854426|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727064|NCT05097989|521854427|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
144727065|NCT05097989|521854428|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727066|NCT05097989|521854429|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727067|NCT05097989|521854430|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727068|NCT05097989|521854431|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
144727069|NCT05097989|521854423|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727070|NCT05097989|521854424|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
144727071|NCT05097989|521854425|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727072|NCT05097989|521854426|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
144727073|NCT05097989|521854427|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727074|NCT05097989|521854428|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727075|NCT05097989|521854429|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727076|NCT05097989|521854430|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727077|NCT05097989|521854431|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144727078|NCT05097989|521854423|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
144727079|NCT05097989|521854424|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
144727080|NCT05097989|521854425|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
144727081|NCT05097989|521854426|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
144727082|NCT05097989|521854427|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
144727083|NCT05097989|521854428|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
144727084|NCT05097989|521854429|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
144727085|NCT05097989|521854430|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
144477545|NCT02387216|520947828|FG001|Overall Study|Physician Decision|0|||
144477546|NCT02387216|520947827|FG000|Overall Study|Sponsor Decision|28|||
144477547|NCT02387216|520947828|FG001|Overall Study|Sponsor Decision|12|||
144477548|NCT02387216|520947827|FG000|Overall Study|Death|60|||
144477549|NCT02387216|520947828|FG001|Overall Study|Death|23|||
144477550|NCT02387216|520947827|FG000|Overall Study|Other|5|||
144477551|NCT02387216|520947828|FG001|Overall Study|Other|4|||
144477552|NCT02387216|520947827|FG000|Overall Study|Lost to Follow-up|0|||
144477553|NCT02387216|520947828|FG001|Overall Study|Lost to Follow-up|3|||
144477554|NCT00154310|520947829|FG000|Overall Study|Adverse Event|19|||
144477555|NCT00154310|520947830|FG001|Overall Study|Adverse Event|9|||
144477556|NCT00154310|520947829|FG000|Overall Study|Lack of Efficacy|5|||
144477557|NCT00154310|520947830|FG001|Overall Study|Lack of Efficacy|4|||
144477558|NCT00154310|520947829|FG000|Overall Study|Protocol Violation|4|||
144477559|NCT00154310|520947830|FG001|Overall Study|Protocol Violation|2|||
144477560|NCT00154310|520947829|FG000|Overall Study|Withdrawal by Subject|9|||
144477561|NCT00154310|520947830|FG001|Overall Study|Withdrawal by Subject|3|||
144477562|NCT00154310|520947829|FG000|Overall Study|Lost to Follow-up|0|||
144477563|NCT00154310|520947830|FG001|Overall Study|Lost to Follow-up|8|||
144477564|NCT00154310|520947829|FG000|Overall Study|Administrative problems|0|||
144477565|NCT00154310|520947830|FG001|Overall Study|Administrative problems|1|||
144477566|NCT00154310|520947829|FG000|Overall Study|Death|0|||
144477567|NCT00154310|520947830|FG001|Overall Study|Death|1|||
144477568|NCT04399356|520947831|FG000|Overall Study|Lost to Follow-up|1|||
144477569|NCT04399356|520947832|FG001|Overall Study|Lost to Follow-up|1|||
144477570|NCT04399356|520947831|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
144477571|NCT04399356|520947832|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
144477572|NCT04399356|520947831|FG000|Overall Study|Withdrawal by Subject|1|||
144477573|NCT04399356|520947832|FG001|Overall Study|Withdrawal by Subject|0|||
144477574|NCT04041440|520947833|FG000|Overall Study|Withdrawal by Subject|0|||
144477575|NCT04041440|520947834|FG001|Overall Study|Withdrawal by Subject|1|||
144477576|NCT04041440|520947833|FG000|Overall Study|Lost to Follow-up|0|||
144477577|NCT04041440|520947834|FG001|Overall Study|Lost to Follow-up|1|||
144477578|NCT02306265|520947835|FG000|Overall Study|Withdrawal by Subject|1|||
144477579|NCT02247804|520947840|FG000|Treatment Period 1|Adverse Event|9|||
144477580|NCT02247804|520947841|FG001|Treatment Period 1|Adverse Event|2|||
144477581|NCT02247804|520947842|FG002|Treatment Period 1|Adverse Event|0|||
144477582|NCT02247804|520947840|FG000|Treatment Period 1|Lack of Efficacy|0|||
144477583|NCT02247804|520947841|FG001|Treatment Period 1|Lack of Efficacy|0|||
144477584|NCT02247804|520947842|FG002|Treatment Period 1|Lack of Efficacy|2|||
144477585|NCT02247804|520947840|FG000|Treatment Period 1|Lost to Follow-up|1|||
144477586|NCT02247804|520947841|FG001|Treatment Period 1|Lost to Follow-up|0|||
144477587|NCT02247804|520947842|FG002|Treatment Period 1|Lost to Follow-up|2|||
144477588|NCT02247804|520947840|FG000|Treatment Period 1|Personal Reasons|7|||
144477589|NCT02247804|520947841|FG001|Treatment Period 1|Personal Reasons|1|||
144477590|NCT02247804|520947842|FG002|Treatment Period 1|Personal Reasons|2|||
144477591|NCT02247804|520947840|FG000|Treatment Period 1|Protocol Deviation|0|||
144477592|NCT02247804|520947841|FG001|Treatment Period 1|Protocol Deviation|0|||
144477593|NCT02247804|520947842|FG002|Treatment Period 1|Protocol Deviation|1|||
144477594|NCT02247804|520947840|FG000|Treatment Period 1|Randomized but not Treated|5|||
144477595|NCT02247804|520947841|FG001|Treatment Period 1|Randomized but not Treated|1|||
144477596|NCT02247804|520947842|FG002|Treatment Period 1|Randomized but not Treated|1|||
144477597|NCT02247804|520947840|FG000|Treatment Period 2|Adverse Event|6|||
144477598|NCT02247804|520947841|FG001|Treatment Period 2|Adverse Event|3|||
144477599|NCT02247804|520947842|FG002|Treatment Period 2|Adverse Event|3|||
144477600|NCT02247804|520947840|FG000|Treatment Period 2|Lack of Efficacy|0|||
144477601|NCT02247804|520947841|FG001|Treatment Period 2|Lack of Efficacy|0|||
144477602|NCT02247804|520947842|FG002|Treatment Period 2|Lack of Efficacy|1|||
144477603|NCT02247804|520947840|FG000|Treatment Period 2|Lost to Follow-up|0|||
144477604|NCT02247804|520947841|FG001|Treatment Period 2|Lost to Follow-up|1|||
144477605|NCT02247804|520947842|FG002|Treatment Period 2|Lost to Follow-up|1|||
144477606|NCT02247804|520947840|FG000|Treatment Period 2|Personal Reasons|2|||
144477607|NCT02247804|520947841|FG001|Treatment Period 2|Personal Reasons|1|||
144477608|NCT02247804|520947842|FG002|Treatment Period 2|Personal Reasons|1|||
144477609|NCT02247804|520947840|FG000|Treatment Period 2|Reason not Specified|0|||
144477610|NCT02247804|520947841|FG001|Treatment Period 2|Reason not Specified|0|||
144477611|NCT02247804|520947842|FG002|Treatment Period 2|Reason not Specified|2|||
144477612|NCT02247804|520947840|FG000|Treatment Period 3|Adverse Event|4|||
144477613|NCT02247804|520947841|FG001|Treatment Period 3|Adverse Event|3|||
144477614|NCT02247804|520947842|FG002|Treatment Period 3|Adverse Event|3|||
144477615|NCT02247804|520947840|FG000|Treatment Period 3|Lack of Efficacy|0|||
144702306|NCT03426995|521763276|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
144702307|NCT03426995|521763277|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702308|NCT03426995|521763278|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702309|NCT03426995|521763279|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702310|NCT03426995|521763280|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702311|NCT03426995|521763281|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702312|NCT03426995|521763282|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702313|NCT03426995|521763283|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702314|NCT03426995|521763284|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702315|NCT03426995|521763285|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702316|NCT03426995|521763286|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702317|NCT03426995|521763287|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702318|NCT03426995|521763288|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702319|NCT03426995|521763289|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702320|NCT03426995|521763290|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702321|NCT03426995|521763291|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702322|NCT03426995|521763292|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
144702323|NCT03426995|521763274|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702324|NCT03426995|521763275|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702325|NCT03426995|521763276|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702326|NCT03426995|521763277|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702327|NCT03426995|521763278|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702328|NCT03426995|521763279|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
144702329|NCT03426995|521763280|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702330|NCT03426995|521763281|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702331|NCT03426995|521763282|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702332|NCT03426995|521763283|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702333|NCT03426995|521763284|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702334|NCT03426995|521763285|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702335|NCT03426995|521763286|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702336|NCT03426995|521763287|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702337|NCT03426995|521763288|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702338|NCT03426995|521763289|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702339|NCT03426995|521763290|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702340|NCT03426995|521763291|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702341|NCT03426995|521763292|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
144702342|NCT03426995|521763274|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702343|NCT03426995|521763275|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702344|NCT03426995|521763276|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702345|NCT03426995|521763277|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702346|NCT03426995|521763278|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
144702347|NCT03426995|521763279|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
144702348|NCT03426995|521763280|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702349|NCT03426995|521763281|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702350|NCT03426995|521763282|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702351|NCT03426995|521763283|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702352|NCT03426995|521763284|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702353|NCT03426995|521763285|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702354|NCT03426995|521763286|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144477616|NCT02247804|520947841|FG001|Treatment Period 3|Lack of Efficacy|1|||
144477617|NCT02247804|520947842|FG002|Treatment Period 3|Lack of Efficacy|0|||
144477618|NCT02247804|520947840|FG000|Treatment Period 3|Lost to Follow-up|1|||
144477619|NCT02247804|520947841|FG001|Treatment Period 3|Lost to Follow-up|2|||
144477620|NCT02247804|520947842|FG002|Treatment Period 3|Lost to Follow-up|2|||
144477621|NCT02247804|520947840|FG000|Treatment Period 3|Personal Reasons|4|||
144477622|NCT02247804|520947841|FG001|Treatment Period 3|Personal Reasons|3|||
144477623|NCT02247804|520947842|FG002|Treatment Period 3|Personal Reasons|2|||
144477624|NCT02247804|520947840|FG000|Treatment Period 3|Reason not Specified|2|||
144477625|NCT02247804|520947841|FG001|Treatment Period 3|Reason not Specified|1|||
144702355|NCT03426995|521763287|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702356|NCT03426995|521763288|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702357|NCT03426995|521763289|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702358|NCT03426995|521763290|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702359|NCT03426995|521763291|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144477626|NCT02247804|520947842|FG002|Treatment Period 3|Reason not Specified|3|||
144477627|NCT03447730|520947843|FG000|Overall Study|Adverse Event|0|||
144477628|NCT03447730|520947844|FG001|Overall Study|Adverse Event|2|||
144477629|NCT03447730|520947845|FG002|Overall Study|Adverse Event|0|||
144477630|NCT01350505|520947849|FG000|Overall Study|Lost to Follow-up|4|||
144477631|NCT04251065|520947850|FG000|Overall Study|Death|2|||
144477632|NCT04251065|520947850|FG000|Overall Study|Lack of Efficacy|3|||
144477633|NCT04251065|520947850|FG000|Overall Study|Death|1|||
144477634|NCT01054573|520947851|FG000|Overall Study|Adverse Event|1|||
144477635|NCT01054573|520947852|FG001|Overall Study|Adverse Event|0|||
144477636|NCT01054573|520947853|FG002|Overall Study|Adverse Event|1|||
144477637|NCT01054573|520947854|FG003|Overall Study|Adverse Event|1|||
144477638|NCT01054573|520947851|FG000|Overall Study|Lost to Follow-up|0|||
144477639|NCT01054573|520947852|FG001|Overall Study|Lost to Follow-up|2|||
144477640|NCT01054573|520947853|FG002|Overall Study|Lost to Follow-up|0|||
144477641|NCT01054573|520947854|FG003|Overall Study|Lost to Follow-up|0|||
144477642|NCT01054573|520947851|FG000|Overall Study|Withdrawal by Subject|0|||
144477643|NCT01054573|520947852|FG001|Overall Study|Withdrawal by Subject|2|||
144477644|NCT01054573|520947853|FG002|Overall Study|Withdrawal by Subject|2|||
144477645|NCT01054573|520947854|FG003|Overall Study|Withdrawal by Subject|1|||
144477646|NCT05266963|520947855|FG000|Drug Period A|Withdrawal by Subject|0|||
144477647|NCT05266963|520947856|FG001|Drug Period A|Withdrawal by Subject|1|||
144477648|NCT03812536|520947857|FG000|Overall Study|Protocol Violation|2|||
144477649|NCT03812536|520947858|FG001|Overall Study|Protocol Violation|0|||
144477650|NCT03812536|520947857|FG000|Overall Study|Withdrawal by Subject|1|||
144477651|NCT03812536|520947858|FG001|Overall Study|Withdrawal by Subject|1|||
144477652|NCT00152009|520947859|FG000|Overall Study|Adverse Event|9|||
144477653|NCT00152009|520947860|FG001|Overall Study|Adverse Event|13|||
144477654|NCT00152009|520947861|FG002|Overall Study|Adverse Event|20|||
144477655|NCT00152009|520947862|FG003|Overall Study|Adverse Event|1|||
144477656|NCT00152009|520947859|FG000|Overall Study|Protocol Violation|3|||
144477657|NCT00152009|520947860|FG001|Overall Study|Protocol Violation|0|||
144477658|NCT00152009|520947861|FG002|Overall Study|Protocol Violation|0|||
144477659|NCT00152009|520947862|FG003|Overall Study|Protocol Violation|1|||
144477660|NCT00152009|520947859|FG000|Overall Study|Withdrawal by Subject|2|||
144477661|NCT00152009|520947860|FG001|Overall Study|Withdrawal by Subject|3|||
144477662|NCT00152009|520947861|FG002|Overall Study|Withdrawal by Subject|4|||
144477663|NCT00152009|520947862|FG003|Overall Study|Withdrawal by Subject|9|||
144477664|NCT00152009|520947859|FG000|Overall Study|Lost to Follow-up|2|||
144477665|NCT00152009|520947860|FG001|Overall Study|Lost to Follow-up|4|||
144477666|NCT00152009|520947861|FG002|Overall Study|Lost to Follow-up|3|||
144477667|NCT00152009|520947862|FG003|Overall Study|Lost to Follow-up|3|||
144477668|NCT00152009|520947859|FG000|Overall Study|Lack of Efficacy|8|||
144477669|NCT00152009|520947860|FG001|Overall Study|Lack of Efficacy|6|||
144477670|NCT00152009|520947861|FG002|Overall Study|Lack of Efficacy|7|||
144477671|NCT00152009|520947862|FG003|Overall Study|Lack of Efficacy|15|||
144477672|NCT00152009|520947859|FG000|Overall Study|ECG abnormalities|2|||
144477673|NCT00152009|520947860|FG001|Overall Study|ECG abnormalities|2|||
144477674|NCT00152009|520947861|FG002|Overall Study|ECG abnormalities|2|||
144477675|NCT00152009|520947862|FG003|Overall Study|ECG abnormalities|1|||
144477676|NCT00152009|520947859|FG000|Overall Study|Sponsor's decision|3|||
144477677|NCT00152009|520947860|FG001|Overall Study|Sponsor's decision|3|||
144477678|NCT00152009|520947861|FG002|Overall Study|Sponsor's decision|1|||
144477679|NCT00152009|520947862|FG003|Overall Study|Sponsor's decision|3|||
144477680|NCT04091360|520947865|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477681|NCT04091360|520947866|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477682|NCT04091360|520947867|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477683|NCT04091360|520947868|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477684|NCT04091360|520947869|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477685|NCT04091360|520947870|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477686|NCT04091360|520947871|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477687|NCT04091360|520947872|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
144477688|NCT04091360|520947873|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
144477689|NCT04091360|520947874|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
144477690|NCT04091360|520947865|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477691|NCT04091360|520947866|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477692|NCT04091360|520947867|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477693|NCT04091360|520947868|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477694|NCT04091360|520947869|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477695|NCT04091360|520947870|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477696|NCT04091360|520947871|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
144477697|NCT04091360|520947872|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
144477698|NCT04091360|520947873|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477699|NCT04091360|520947874|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
144477700|NCT04091360|520947865|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477701|NCT04091360|520947866|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477702|NCT04091360|520947867|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477703|NCT04091360|520947868|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477704|NCT04091360|520947869|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477705|NCT04091360|520947870|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477706|NCT04091360|520947871|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
144477707|NCT04091360|520947872|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477708|NCT04091360|520947873|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
144477709|NCT04091360|520947874|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
144477710|NCT01735396|520947875|FG000|Overall Study|not evaluable|1|||
144477711|NCT00423852|520947878|FG000|Overall Study|Removed pior to the high-dose portion|3|||
144477712|NCT00980005|520947879|FG000|Overall Study|Withdrawal by Subject|6|||
144477713|NCT00980005|520947880|FG001|Overall Study|Withdrawal by Subject|17|||
144477714|NCT00980005|520947879|FG000|Overall Study|Lost to Follow-up|37|||
144477715|NCT00980005|520947880|FG001|Overall Study|Lost to Follow-up|43|||
144477716|NCT00980005|520947879|FG000|Overall Study|Other|4|||
144477717|NCT00980005|520947880|FG001|Overall Study|Other|3|||
144477718|NCT00572624|520947881|FG000|Overall Study|Lost to Follow-up|10|||
144477719|NCT00572624|520947882|FG001|Overall Study|Lost to Follow-up|4|||
144477720|NCT00572624|520947881|FG000|Overall Study|Wanted to do a different diet program|1|||
144477721|NCT00572624|520947882|FG001|Overall Study|Wanted to do a different diet program|0|||
144477722|NCT00572624|520947881|FG000|Overall Study|Medication change|1|||
144477723|NCT00572624|520947882|FG001|Overall Study|Medication change|0|||
144477724|NCT00572624|520947881|FG000|Overall Study|Started a new job-- no time for study|1|||
144477725|NCT00572624|520947882|FG001|Overall Study|Started a new job-- no time for study|0|||
144477726|NCT00572624|520947881|FG000|Overall Study|Admitted to being a smoker|1|||
144477727|NCT00572624|520947882|FG001|Overall Study|Admitted to being a smoker|0|||
144477728|NCT00572624|520947881|FG000|Overall Study|Refused to do the stress test|1|||
144477729|NCT00572624|520947882|FG001|Overall Study|Refused to do the stress test|0|||
144477730|NCT00572624|520947881|FG000|Overall Study|Problem with vascular access|1|||
144477731|NCT00572624|520947882|FG001|Overall Study|Problem with vascular access|0|||
144477732|NCT00572624|520947881|FG000|Overall Study|Health issues unrelated to the study|1|||
144477733|NCT00572624|520947882|FG001|Overall Study|Health issues unrelated to the study|0|||
144477734|NCT02597933|520947883|FG000|Overall Study|Withdrawal by Subject|7|||
144477735|NCT02597933|520947884|FG001|Overall Study|Withdrawal by Subject|5|||
144477736|NCT02597933|520947883|FG000|Overall Study|Protocol Violation|2|||
144477737|NCT02597933|520947884|FG001|Overall Study|Protocol Violation|2|||
144477738|NCT02597933|520947883|FG000|Overall Study|Adverse Event|20|||
144477739|NCT02597933|520947884|FG001|Overall Study|Adverse Event|28|||
144477740|NCT02597933|520947883|FG000|Overall Study|Not treated|2|||
144477741|NCT02597933|520947884|FG001|Overall Study|Not treated|2|||
144477742|NCT02597933|520947883|FG000|Overall Study|Other than stated above|7|||
144477743|NCT02597933|520947884|FG001|Overall Study|Other than stated above|14|||
144477744|NCT04145037|520947888|FG000|Overall Study|Study terminated|2|||
144477745|NCT04145037|520947889|FG001|Overall Study|Study terminated|0|||
144477746|NCT04145037|520947888|FG000|Overall Study|Withdrawal by Subject|1|||
144477747|NCT04145037|520947889|FG001|Overall Study|Withdrawal by Subject|0|||
144477748|NCT04145037|520947888|FG000|Overall Study|Lost to Follow-up|1|||
144477749|NCT04145037|520947889|FG001|Overall Study|Lost to Follow-up|0|||
144477750|NCT04599101|520947892|FG000|Overall Study|Lost to Follow-up|5|||
144477751|NCT04599101|520947893|FG001|Overall Study|Lost to Follow-up|5|||
144477752|NCT00098254|520947894|FG000|Overall Study|Adverse Event|2|||
144477753|NCT00098254|520947894|FG000|Overall Study|Death|1|||
144477754|NCT00744263|520947897|FG000|Overall Study|Death|3006|||
144477755|NCT00744263|520947898|FG001|Overall Study|Death|3005|||
144477756|NCT00744263|520947897|FG000|Overall Study|Lost to Follow-up|2038|||
144477757|NCT00744263|520947898|FG001|Overall Study|Lost to Follow-up|2135|||
144477758|NCT00744263|520947897|FG000|Overall Study|Withdrawal by Subject|166|||
144477759|NCT00744263|520947898|FG001|Overall Study|Withdrawal by Subject|150|||
144477760|NCT00744263|520947897|FG000|Overall Study|Physician Decision|20|||
144477761|NCT00744263|520947898|FG001|Overall Study|Physician Decision|23|||
144477762|NCT00744263|520947897|FG000|Overall Study|Protocol Violation|3|||
144477763|NCT00744263|520947898|FG001|Overall Study|Protocol Violation|5|||
144477764|NCT00744263|520947897|FG000|Overall Study|Adverse Event|1|||
144477765|NCT00744263|520947898|FG001|Overall Study|Adverse Event|0|||
144477766|NCT00744263|520947897|FG000|Overall Study|Other|2|||
144477767|NCT00744263|520947898|FG001|Overall Study|Other|2|||
144477768|NCT01913639|520947899|FG000|Overall Study|Not Eligible|3|||
144477769|NCT03107377|520947900|FG000|Overall Study|Adverse Event|3|||
144477770|NCT03107377|520947901|FG001|Overall Study|Adverse Event|3|||
144477771|NCT03107377|520947900|FG000|Overall Study|Protocol Violation|9|||
144477772|NCT03107377|520947901|FG001|Overall Study|Protocol Violation|12|||
144477773|NCT03107377|520947900|FG000|Overall Study|Physician Decision|3|||
144477774|NCT03107377|520947901|FG001|Overall Study|Physician Decision|6|||
144477775|NCT03107377|520947900|FG000|Overall Study|Pregnancy|7|||
144477776|NCT03107377|520947901|FG001|Overall Study|Pregnancy|7|||
144477777|NCT03107377|520947900|FG000|Overall Study|Withdrawal by Subject|16|||
144477778|NCT03107377|520947901|FG001|Overall Study|Withdrawal by Subject|22|||
144477779|NCT03107377|520947900|FG000|Overall Study|Lost to Follow-up|37|||
144477780|NCT03107377|520947901|FG001|Overall Study|Lost to Follow-up|34|||
144477781|NCT03107377|520947900|FG000|Overall Study|Other reason not specified|16|||
144477782|NCT03107377|520947901|FG001|Overall Study|Other reason not specified|15|||
144477783|NCT00130793|520947913|FG000|Overall Study|Lost to Follow-up|1|||
144477784|NCT00130793|520947914|FG001|Overall Study|Lost to Follow-up|4|||
144477785|NCT00130793|520947913|FG000|Overall Study|Withdrew consent|2|||
144477786|NCT00130793|520947914|FG001|Overall Study|Withdrew consent|0|||
144477787|NCT00211237|520947915|FG000|Baseline|Withdrew|1|||
144477788|NCT00211237|520947916|FG001|Baseline|Withdrew|3|||
144477789|NCT00211237|520947917|FG002|Baseline|Withdrew|0|||
144477790|NCT00211237|520947915|FG000|Baseline|Refused random assignment|1|||
144477791|NCT00211237|520947916|FG001|Baseline|Refused random assignment|0|||
144477792|NCT00211237|520947917|FG002|Baseline|Refused random assignment|0|||
144477793|NCT00211237|520947915|FG000|1 Month|Death|2|||
144477794|NCT00211237|520947916|FG001|1 Month|Death|1|||
144477795|NCT00211237|520947917|FG002|1 Month|Death|0|||
144477796|NCT00211237|520947915|FG000|1 Month|Lost to Follow-up|0|||
144477797|NCT00211237|520947916|FG001|1 Month|Lost to Follow-up|2|||
144477798|NCT00211237|520947917|FG002|1 Month|Lost to Follow-up|0|||
144477799|NCT00211237|520947915|FG000|1 Month|Withdrew|0|||
144477800|NCT00211237|520947916|FG001|1 Month|Withdrew|4|||
144477801|NCT00211237|520947917|FG002|1 Month|Withdrew|0|||
144477802|NCT00211237|520947915|FG000|1 Month|Additional surgery needed|1|||
144477803|NCT00211237|520947916|FG001|1 Month|Additional surgery needed|0|||
144477804|NCT00211237|520947917|FG002|1 Month|Additional surgery needed|0|||
144477805|NCT00211237|520947915|FG000|1 Month|Non-medical problem|0|||
144477806|NCT00211237|520947916|FG001|1 Month|Non-medical problem|2|||
144477807|NCT00211237|520947917|FG002|1 Month|Non-medical problem|0|||
144477808|NCT00211237|520947915|FG000|3 Months|Death|7|||
144477809|NCT00211237|520947916|FG001|3 Months|Death|3|||
144477810|NCT00211237|520947917|FG002|3 Months|Death|0|||
144477811|NCT00211237|520947915|FG000|3 Months|Could not comply with protocol|1|||
144477812|NCT00211237|520947916|FG001|3 Months|Could not comply with protocol|0|||
144477813|NCT00211237|520947917|FG002|3 Months|Could not comply with protocol|0|||
144477814|NCT00211237|520947915|FG000|3 Months|Withdrew|0|||
144477815|NCT00211237|520947916|FG001|3 Months|Withdrew|1|||
144477816|NCT00211237|520947917|FG002|3 Months|Withdrew|0|||
144477817|NCT00211237|520947915|FG000|3 Months|Non-medical problem|0|||
144477818|NCT00211237|520947916|FG001|3 Months|Non-medical problem|0|||
144477819|NCT00211237|520947917|FG002|3 Months|Non-medical problem|1|||
144477820|NCT00211237|520947915|FG000|6 Months|Death|6|||
144477821|NCT00211237|520947916|FG001|6 Months|Death|0|||
144477822|NCT00211237|520947917|FG002|6 Months|Death|3|||
144477823|NCT00211237|520947915|FG000|6 Months|Lost to Follow-up|2|||
144477824|NCT00211237|520947916|FG001|6 Months|Lost to Follow-up|0|||
144477825|NCT00211237|520947917|FG002|6 Months|Lost to Follow-up|0|||
144477826|NCT00211237|520947915|FG000|6 Months|Could not comply with protocol|0|||
144477827|NCT00211237|520947916|FG001|6 Months|Could not comply with protocol|2|||
144477828|NCT00211237|520947917|FG002|6 Months|Could not comply with protocol|0|||
144477829|NCT00211237|520947915|FG000|12 Months|Death|8|||
144477830|NCT00211237|520947916|FG001|12 Months|Death|2|||
144477831|NCT00211237|520947917|FG002|12 Months|Death|3|||
144477832|NCT00211237|520947915|FG000|12 Months|Lost to Follow-up|1|||
144477833|NCT00211237|520947916|FG001|12 Months|Lost to Follow-up|0|||
144477834|NCT00211237|520947917|FG002|12 Months|Lost to Follow-up|1|||
144477835|NCT00211237|520947915|FG000|12 Months|Withdrew|0|||
144477836|NCT00211237|520947916|FG001|12 Months|Withdrew|0|||
144477837|NCT00211237|520947917|FG002|12 Months|Withdrew|1|||
144477838|NCT00211237|520947915|FG000|12 Months|unrelated medical problem|0|||
144477839|NCT00211237|520947916|FG001|12 Months|unrelated medical problem|0|||
144477840|NCT00211237|520947917|FG002|12 Months|unrelated medical problem|1|||
144477841|NCT01515189|520947921|FG000|Induction|Disease Progression|109|||
144477842|NCT01515189|520947922|FG001|Induction|Disease Progression|155|||
144477843|NCT01515189|520947921|FG000|Induction|Study drug toxicity|86|||
144477844|NCT01515189|520947922|FG001|Induction|Study drug toxicity|36|||
144477845|NCT01515189|520947921|FG000|Induction|Death|24|||
144477846|NCT01515189|520947922|FG001|Induction|Death|17|||
144477847|NCT01515189|520947921|FG000|Induction|Adverse Event|14|||
144477848|NCT01515189|520947922|FG001|Induction|Adverse Event|9|||
144477849|NCT01515189|520947921|FG000|Induction|Withdrawal by Subject|3|||
144477850|NCT01515189|520947922|FG001|Induction|Withdrawal by Subject|9|||
144477851|NCT01515189|520947921|FG000|Induction|No longer meets study criteria|0|||
144477852|NCT01515189|520947922|FG001|Induction|No longer meets study criteria|2|||
144477853|NCT01515189|520947921|FG000|Induction|Lost to Follow-up|1|||
144477854|NCT01515189|520947922|FG001|Induction|Lost to Follow-up|0|||
144477855|NCT01515189|520947921|FG000|Induction|Other|0|||
144477856|NCT01515189|520947922|FG001|Induction|Other|4|||
144538190|NCT00146172|521174127|FG005|Overall Study|Adverse Event|2|||
144702360|NCT03426995|521763292|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
144702361|NCT03426995|521763274|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702362|NCT03426995|521763275|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702363|NCT03426995|521763276|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702364|NCT03426995|521763277|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702365|NCT03426995|521763278|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702366|NCT03426995|521763279|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702367|NCT03426995|521763280|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702368|NCT03426995|521763281|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702369|NCT03426995|521763282|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702370|NCT03426995|521763283|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702371|NCT03426995|521763284|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
144702372|NCT03426995|521763285|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702373|NCT03426995|521763286|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702374|NCT03426995|521763287|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702375|NCT03426995|521763288|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702376|NCT03426995|521763289|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702377|NCT03426995|521763290|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702378|NCT03426995|521763291|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702379|NCT03426995|521763292|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
144702380|NCT03426995|521763274|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702381|NCT03426995|521763275|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702382|NCT03426995|521763276|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702383|NCT03426995|521763277|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702384|NCT03426995|521763278|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702385|NCT03426995|521763279|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702386|NCT03426995|521763280|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702387|NCT03426995|521763281|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
144702388|NCT03426995|521763282|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702389|NCT03426995|521763283|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702390|NCT03426995|521763284|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702391|NCT03426995|521763285|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702392|NCT03426995|521763286|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702393|NCT03426995|521763287|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702394|NCT03426995|521763288|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702395|NCT03426995|521763289|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702396|NCT03426995|521763290|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702397|NCT03426995|521763291|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702398|NCT03426995|521763292|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
144702399|NCT03426995|521763274|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702400|NCT03426995|521763275|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702401|NCT03426995|521763276|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702402|NCT03426995|521763277|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702403|NCT03426995|521763278|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702404|NCT03426995|521763279|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702405|NCT03426995|521763280|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702406|NCT03426995|521763281|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702407|NCT03426995|521763282|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702408|NCT03426995|521763283|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702409|NCT03426995|521763284|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702410|NCT03426995|521763285|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702411|NCT03426995|521763286|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702412|NCT03426995|521763287|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702413|NCT03426995|521763288|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
144702414|NCT03426995|521763289|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
144702415|NCT03426995|521763290|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702416|NCT03426995|521763291|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702417|NCT03426995|521763292|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
144702418|NCT03426995|521763274|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702419|NCT03426995|521763275|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702420|NCT03426995|521763276|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702421|NCT03426995|521763277|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702422|NCT03426995|521763278|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702423|NCT03426995|521763279|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702424|NCT03426995|521763280|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702425|NCT03426995|521763281|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702426|NCT03426995|521763282|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702427|NCT03426995|521763283|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702428|NCT03426995|521763284|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702429|NCT03426995|521763285|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702430|NCT03426995|521763286|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702431|NCT03426995|521763287|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702432|NCT03426995|521763288|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
144702433|NCT03426995|521763289|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
144702434|NCT03426995|521763290|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702435|NCT03426995|521763291|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702436|NCT03426995|521763292|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
144702437|NCT02335411|521763293|FG000|Overall Study|Death|223|||
144702438|NCT02335411|521763294|FG001|Overall Study|Death|22|||
144702439|NCT02335411|521763295|FG002|Overall Study|Death|26|||
144702440|NCT02335411|521763293|FG000|Overall Study|Physician Decision|3|||
144702441|NCT02335411|521763294|FG001|Overall Study|Physician Decision|0|||
144702442|NCT02335411|521763295|FG002|Overall Study|Physician Decision|0|||
144702443|NCT02335411|521763293|FG000|Overall Study|Protocol Violation|1|||
144702444|NCT02335411|521763294|FG001|Overall Study|Protocol Violation|0|||
144702445|NCT02335411|521763295|FG002|Overall Study|Protocol Violation|0|||
144702446|NCT02335411|521763293|FG000|Overall Study|Withdrawal by Subject|11|||
144702447|NCT02335411|521763294|FG001|Overall Study|Withdrawal by Subject|0|||
144702448|NCT02335411|521763295|FG002|Overall Study|Withdrawal by Subject|3|||
144702449|NCT02335411|521763293|FG000|Overall Study|Sponsor Decision|12|||
144702450|NCT02335411|521763294|FG001|Overall Study|Sponsor Decision|3|||
144702451|NCT02335411|521763295|FG002|Overall Study|Sponsor Decision|2|||
144702452|NCT02335411|521763293|FG000|Overall Study|Adverse Event|9|||
144702453|NCT02335411|521763294|FG001|Overall Study|Adverse Event|0|||
144702454|NCT02335411|521763295|FG002|Overall Study|Adverse Event|0|||
144702455|NCT01058707|521763303|FG000|Overall Study|Disease Progression|15|||
144702456|NCT01058707|521763304|FG001|Overall Study|Disease Progression|20|||
144702457|NCT01058707|521763305|FG002|Overall Study|Disease Progression|20|||
144702458|NCT01058707|521763306|FG003|Overall Study|Disease Progression|15|||
144702459|NCT01058707|521763307|FG004|Overall Study|Disease Progression|23|||
144702460|NCT01058707|521763308|FG005|Overall Study|Disease Progression|10|||
144702461|NCT01058707|521763309|FG006|Overall Study|Disease Progression|12|||
144702462|NCT01058707|521763303|FG000|Overall Study|Adverse Event|11|||
144702463|NCT01058707|521763304|FG001|Overall Study|Adverse Event|4|||
144702464|NCT01058707|521763305|FG002|Overall Study|Adverse Event|7|||
144702465|NCT01058707|521763306|FG003|Overall Study|Adverse Event|6|||
144702466|NCT01058707|521763307|FG004|Overall Study|Adverse Event|7|||
144702467|NCT01058707|521763308|FG005|Overall Study|Adverse Event|3|||
144702468|NCT01058707|521763309|FG006|Overall Study|Adverse Event|1|||
144702469|NCT01058707|521763303|FG000|Overall Study|Subject Decision|5|||
144702470|NCT01058707|521763304|FG001|Overall Study|Subject Decision|3|||
144702471|NCT01058707|521763305|FG002|Overall Study|Subject Decision|3|||
144702472|NCT01058707|521763306|FG003|Overall Study|Subject Decision|1|||
144702473|NCT01058707|521763307|FG004|Overall Study|Subject Decision|2|||
144702474|NCT01058707|521763308|FG005|Overall Study|Subject Decision|3|||
144702475|NCT01058707|521763309|FG006|Overall Study|Subject Decision|6|||
144702476|NCT01058707|521763303|FG000|Overall Study|Lost to Follow-up|0|||
144702477|NCT01058707|521763304|FG001|Overall Study|Lost to Follow-up|0|||
144702478|NCT01058707|521763305|FG002|Overall Study|Lost to Follow-up|1|||
144702479|NCT01058707|521763306|FG003|Overall Study|Lost to Follow-up|0|||
144702480|NCT01058707|521763307|FG004|Overall Study|Lost to Follow-up|0|||
144702481|NCT01058707|521763308|FG005|Overall Study|Lost to Follow-up|0|||
144702482|NCT01058707|521763309|FG006|Overall Study|Lost to Follow-up|0|||
144702483|NCT01058707|521763303|FG000|Overall Study|Reason Not Specified|0|||
144702484|NCT01058707|521763304|FG001|Overall Study|Reason Not Specified|3|||
144702485|NCT01058707|521763305|FG002|Overall Study|Reason Not Specified|2|||
144702486|NCT01058707|521763306|FG003|Overall Study|Reason Not Specified|0|||
144702487|NCT01058707|521763307|FG004|Overall Study|Reason Not Specified|7|||
144702488|NCT01058707|521763308|FG005|Overall Study|Reason Not Specified|1|||
144702489|NCT01058707|521763309|FG006|Overall Study|Reason Not Specified|7|||
144702490|NCT04880850|521763311|FG000|Overall Study|Death|2|||
144702491|NCT04880850|521763312|FG001|Overall Study|Death|1|||
144702492|NCT04880850|521763311|FG000|Overall Study|Lost to Follow-up|3|||
144702493|NCT04880850|521763312|FG001|Overall Study|Lost to Follow-up|6|||
144702494|NCT04880850|521763311|FG000|Overall Study|Physician Decision|2|||
144702495|NCT04880850|521763312|FG001|Overall Study|Physician Decision|1|||
144702496|NCT04880850|521763311|FG000|Overall Study|Withdrawal by Subject|9|||
144702497|NCT04880850|521763312|FG001|Overall Study|Withdrawal by Subject|10|||
144702498|NCT01875731|521763313|FG000|Overall Study|Fail to obtain lab sample|1|||
144702499|NCT01875731|521763314|FG001|Overall Study|Fail to obtain lab sample|0|||
144702500|NCT02576951|521763315|FG000|Overall Study|Lost to Follow-up|0|||
144702501|NCT02576951|521763316|FG001|Overall Study|Lost to Follow-up|0|||
144702502|NCT02576951|521763317|FG002|Overall Study|Lost to Follow-up|2|||
144477857|NCT01515189|520947921|FG000|First Re-Induction Phase|Disease progression|6|||
144477858|NCT01515189|520947922|FG001|First Re-Induction Phase|Disease progression|14|||
144477859|NCT01515189|520947921|FG000|First Re-Induction Phase|Study drug toxicity|5|||
144477860|NCT01515189|520947922|FG001|First Re-Induction Phase|Study drug toxicity|0|||
144477861|NCT01515189|520947921|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
144477862|NCT01515189|520947922|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
144477863|NCT01515189|520947921|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
144477864|NCT01515189|520947922|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
144477865|NCT01515189|520947921|FG000|First Re-Induction Phase|Other|1|||
144477866|NCT01515189|520947922|FG001|First Re-Induction Phase|Other|0|||
144477867|NCT00453102|520947923|FG000|Overall Study|Withdrawal by Subject|2|||
144477868|NCT04078035|520947924|FG000|Session 2|Lost to Follow-up|3|||
144477869|NCT04078035|520947925|FG001|Session 2|Lost to Follow-up|1|||
144477870|NCT04078035|520947924|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
144477871|NCT04078035|520947925|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
144477872|NCT01013792|520947928|FG000|Overall Study|Study suspended|2|||
144477873|NCT01013792|520947929|FG001|Overall Study|Study suspended|1|||
144477874|NCT01013792|520947928|FG000|Overall Study|Adverse Event|0|||
144477875|NCT01013792|520947929|FG001|Overall Study|Adverse Event|3|||
144477876|NCT01013792|520947928|FG000|Overall Study|Lost to Follow-up|0|||
144477877|NCT01013792|520947929|FG001|Overall Study|Lost to Follow-up|1|||
144477878|NCT02100722|520947930|FG000|Overall Study|Withdrawal pre-procedure|4|||
144477879|NCT02100722|520947931|FG001|Overall Study|Withdrawal pre-procedure|9|||
144477880|NCT02100722|520947930|FG000|Overall Study|Withdrawal post-procedure|0|||
144477881|NCT02100722|520947931|FG001|Overall Study|Withdrawal post-procedure|3|||
144477882|NCT02100722|520947930|FG000|Overall Study|Lost to Follow-up|2|||
144477883|NCT02100722|520947931|FG001|Overall Study|Lost to Follow-up|2|||
144477884|NCT02100722|520947930|FG000|Overall Study|Continuing on study|751|||
144477885|NCT02100722|520947931|FG001|Overall Study|Continuing on study|729|||
144477886|NCT05644353|520947937|FG000|Overall Study|Physician Decision|1|||
144477887|NCT05644353|520947938|FG001|Overall Study|Physician Decision|0|||
144477888|NCT05644353|520947939|FG002|Overall Study|Physician Decision|0|||
144477889|NCT05644353|520947940|FG003|Overall Study|Physician Decision|0|||
144477890|NCT05644353|520947941|FG004|Overall Study|Physician Decision|0|||
144477891|NCT05644353|520947942|FG005|Overall Study|Physician Decision|0|||
144477892|NCT05644353|520947937|FG000|Overall Study|Protocol Violation|1|||
144477893|NCT05644353|520947938|FG001|Overall Study|Protocol Violation|0|||
144477894|NCT05644353|520947939|FG002|Overall Study|Protocol Violation|0|||
144477895|NCT05644353|520947940|FG003|Overall Study|Protocol Violation|0|||
144477896|NCT05644353|520947941|FG004|Overall Study|Protocol Violation|0|||
144477897|NCT05644353|520947942|FG005|Overall Study|Protocol Violation|0|||
144477898|NCT05644353|520947937|FG000|Overall Study|Withdrawal by Subject|0|||
144477899|NCT05644353|520947938|FG001|Overall Study|Withdrawal by Subject|2|||
144477900|NCT05644353|520947939|FG002|Overall Study|Withdrawal by Subject|0|||
144477901|NCT05644353|520947940|FG003|Overall Study|Withdrawal by Subject|0|||
144477902|NCT05644353|520947941|FG004|Overall Study|Withdrawal by Subject|1|||
144477903|NCT05644353|520947942|FG005|Overall Study|Withdrawal by Subject|0|||
144477904|NCT05644353|520947937|FG000|Overall Study|Lost to Follow-up|0|||
144477905|NCT05644353|520947938|FG001|Overall Study|Lost to Follow-up|0|||
144477906|NCT05644353|520947939|FG002|Overall Study|Lost to Follow-up|1|||
144477907|NCT05644353|520947940|FG003|Overall Study|Lost to Follow-up|0|||
144477908|NCT05644353|520947941|FG004|Overall Study|Lost to Follow-up|0|||
144477909|NCT05644353|520947942|FG005|Overall Study|Lost to Follow-up|0|||
144477910|NCT03500640|520947943|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
144477911|NCT03500640|520947944|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
144477912|NCT03500640|520947945|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
144477913|NCT03500640|520947943|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
144477914|NCT03500640|520947944|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
144477915|NCT03500640|520947945|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
144477916|NCT03500640|520947943|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
144477917|NCT03500640|520947944|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
144477918|NCT03500640|520947945|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
144477919|NCT03500640|520947943|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
144477920|NCT03500640|520947944|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
144477921|NCT03500640|520947945|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
144477922|NCT03500640|520947943|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
144477923|NCT03500640|520947944|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
144477924|NCT03500640|520947945|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
144477925|NCT03500640|520947943|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
144477926|NCT03500640|520947944|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
144702503|NCT02576951|521763318|FG003|Overall Study|Lost to Follow-up|2|||
144702504|NCT02576951|521763315|FG000|Overall Study|Withdrawal by Subject|1|||
144702505|NCT02576951|521763316|FG001|Overall Study|Withdrawal by Subject|0|||
144702506|NCT02576951|521763317|FG002|Overall Study|Withdrawal by Subject|0|||
144702507|NCT02576951|521763318|FG003|Overall Study|Withdrawal by Subject|2|||
144702508|NCT02576951|521763315|FG000|Overall Study|Protocol Violation|0|||
144702509|NCT02576951|521763316|FG001|Overall Study|Protocol Violation|0|||
144702510|NCT02576951|521763317|FG002|Overall Study|Protocol Violation|0|||
144702511|NCT02576951|521763318|FG003|Overall Study|Protocol Violation|1|||
144702512|NCT03417102|521763319|FG000|Overall Study|Adverse Event|0|||
144702513|NCT03417102|521763320|FG001|Overall Study|Adverse Event|1|||
144702514|NCT03417102|521763319|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
144702515|NCT03417102|521763320|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
144702516|NCT03417102|521763319|FG000|Overall Study|Other|0|||
144702517|NCT03417102|521763320|FG001|Overall Study|Other|1|||
144702518|NCT03188991|521763322|FG000|Overall Study|Withdrawal by Subject|0|||
144702519|NCT03188991|521763323|FG001|Overall Study|Withdrawal by Subject|0|||
144702520|NCT03188991|521763324|FG002|Overall Study|Withdrawal by Subject|0|||
144702521|NCT03188991|521763325|FG003|Overall Study|Withdrawal by Subject|1|||
144702522|NCT00157820|521763328|FG000|Randomized|Physician Decision|4|||
144702523|NCT00157820|521763329|FG001|Randomized|Physician Decision|2|||
144702524|NCT00157820|521763330|FG002|Randomized|Physician Decision|3|||
144702525|NCT00157820|521763328|FG000|Randomized|Withdrawal by Subject|1|||
144702526|NCT00157820|521763329|FG001|Randomized|Withdrawal by Subject|2|||
144702527|NCT00157820|521763330|FG002|Randomized|Withdrawal by Subject|3|||
144702528|NCT00157820|521763328|FG000|Randomized|Protocol Violation|2|||
144702529|NCT00157820|521763329|FG001|Randomized|Protocol Violation|1|||
144702530|NCT00157820|521763330|FG002|Randomized|Protocol Violation|2|||
144702531|NCT00157820|521763328|FG000|1st 8 Month|Death|7|||
144702532|NCT00157820|521763329|FG001|1st 8 Month|Death|8|||
144702533|NCT00157820|521763330|FG002|1st 8 Month|Death|3|||
144702534|NCT00157820|521763328|FG000|1st 8 Month|Lost to Follow-up|1|||
144702535|NCT00157820|521763329|FG001|1st 8 Month|Lost to Follow-up|2|||
144702536|NCT00157820|521763330|FG002|1st 8 Month|Lost to Follow-up|1|||
144702537|NCT00157820|521763328|FG000|1st 8 Month|Premature cross-over|0|||
144702538|NCT00157820|521763329|FG001|1st 8 Month|Premature cross-over|2|||
144702539|NCT00157820|521763330|FG002|1st 8 Month|Premature cross-over|2|||
144702540|NCT00157820|521763328|FG000|2nd 8 Months|Death|3|||
144702541|NCT00157820|521763329|FG001|2nd 8 Months|Death|1|||
144702542|NCT00157820|521763330|FG002|2nd 8 Months|Death|3|||
144702543|NCT00157820|521763328|FG000|2nd 8 Months|Lost to Follow-up|1|||
144702544|NCT00157820|521763329|FG001|2nd 8 Months|Lost to Follow-up|5|||
144702545|NCT00157820|521763330|FG002|2nd 8 Months|Lost to Follow-up|2|||
144702546|NCT00157820|521763328|FG000|2nd 8 Months|Premature cross-over|1|||
144702547|NCT00157820|521763329|FG001|2nd 8 Months|Premature cross-over|7|||
144702548|NCT00157820|521763330|FG002|2nd 8 Months|Premature cross-over|9|||
144702549|NCT01319994|521764776|FG000|Overall Study|Protocol Violation|7|||
144702550|NCT01319994|521764777|FG001|Overall Study|Protocol Violation|6|||
144702551|NCT01340794|521764778|FG000|Overall Study|Withdrawal by Subject|0|||
144702552|NCT01340794|521764779|FG001|Overall Study|Withdrawal by Subject|1|||
144702553|NCT00698009|521764784|FG000|Overall Study|Withdrawal by Subject|1|||
144702554|NCT00798707|521764792|FG000|Overall Study|Adverse Event|6|||
144702555|NCT00798707|521764793|FG001|Overall Study|Adverse Event|8|||
144702556|NCT00798707|521764794|FG002|Overall Study|Adverse Event|8|||
144702557|NCT00798707|521764792|FG000|Overall Study|Failed to return|2|||
144702558|NCT00798707|521764793|FG001|Overall Study|Failed to return|2|||
144702559|NCT00798707|521764794|FG002|Overall Study|Failed to return|0|||
144702560|NCT00798707|521764792|FG000|Overall Study|Investigator|0|||
144702561|NCT00798707|521764793|FG001|Overall Study|Investigator|1|||
144702562|NCT00798707|521764794|FG002|Overall Study|Investigator|2|||
144702563|NCT00798707|521764792|FG000|Overall Study|Lack of Efficacy|2|||
144702564|NCT00798707|521764793|FG001|Overall Study|Lack of Efficacy|2|||
144702565|NCT00798707|521764794|FG002|Overall Study|Lack of Efficacy|1|||
144702566|NCT00798707|521764792|FG000|Overall Study|Lost to Follow-up|5|||
144702567|NCT00798707|521764793|FG001|Overall Study|Lost to Follow-up|6|||
144702568|NCT00798707|521764794|FG002|Overall Study|Lost to Follow-up|6|||
144702569|NCT00798707|521764792|FG000|Overall Study|Other|0|||
144702570|NCT00798707|521764793|FG001|Overall Study|Other|1|||
144702571|NCT00798707|521764794|FG002|Overall Study|Other|0|||
144702572|NCT00798707|521764792|FG000|Overall Study|Protocol Violation|4|||
144702573|NCT00798707|521764793|FG001|Overall Study|Protocol Violation|0|||
144702574|NCT00798707|521764794|FG002|Overall Study|Protocol Violation|2|||
144702575|NCT00798707|521764792|FG000|Overall Study|Withdrawal by Subject|3|||
144702576|NCT00798707|521764793|FG001|Overall Study|Withdrawal by Subject|8|||
144702577|NCT00798707|521764794|FG002|Overall Study|Withdrawal by Subject|2|||
144702578|NCT00798707|521764792|FG000|Overall Study|Randomized not treated|4|||
144702579|NCT00798707|521764793|FG001|Overall Study|Randomized not treated|5|||
144702580|NCT00798707|521764794|FG002|Overall Study|Randomized not treated|1|||
144702581|NCT02525627|521764797|FG000|Overall Study|Revision|1|||
144702582|NCT02525627|521764798|FG001|Overall Study|Revision|1|||
144702583|NCT02525627|521764797|FG000|Overall Study|Withdrawal by Subject|1|||
144702584|NCT02525627|521764798|FG001|Overall Study|Withdrawal by Subject|2|||
144702585|NCT02525627|521764797|FG000|Overall Study|Death|1|||
144702586|NCT02525627|521764798|FG001|Overall Study|Death|0|||
144702587|NCT02525627|521764797|FG000|Overall Study|Site terminated|11|||
144702588|NCT02525627|521764798|FG001|Overall Study|Site terminated|10|||
144702589|NCT01473589|521764799|FG000|Overall Study|Adverse Event|1|||
144702590|NCT01473589|521764800|FG001|Overall Study|Adverse Event|1|||
144702591|NCT01473589|521764799|FG000|Overall Study|Death|2|||
144702592|NCT01473589|521764800|FG001|Overall Study|Death|0|||
144702593|NCT01473589|521764799|FG000|Overall Study|Lost to Follow-up|2|||
144702594|NCT01473589|521764800|FG001|Overall Study|Lost to Follow-up|2|||
144702595|NCT01473589|521764799|FG000|Overall Study|Protocol Violation|1|||
144702596|NCT01473589|521764800|FG001|Overall Study|Protocol Violation|0|||
144702597|NCT01473589|521764799|FG000|Overall Study|Withdrawal by Subject|5|||
144702598|NCT01473589|521764800|FG001|Overall Study|Withdrawal by Subject|11|||
144702599|NCT01473589|521764799|FG000|Overall Study|Physician Decision|0|||
144702600|NCT01473589|521764800|FG001|Overall Study|Physician Decision|1|||
144702601|NCT01473589|521764799|FG000|Overall Study|Entry criteria not met|0|||
144702602|NCT01473589|521764800|FG001|Overall Study|Entry criteria not met|1|||
144702603|NCT03457727|521764801|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
144702604|NCT03457727|521764802|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
144702605|NCT03457727|521764803|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
144702606|NCT03457727|521764804|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
144702607|NCT00929201|521764805|FG000|Period 1|Withdrawal by Subject|0|||
144702608|NCT00929201|521764806|FG001|Period 1|Withdrawal by Subject|1|||
144702609|NCT00464308|521764810|FG000|Overall Study|Adverse Event|22|||
144702610|NCT00464308|521764811|FG001|Overall Study|Adverse Event|27|||
144702611|NCT00464308|521764812|FG002|Overall Study|Adverse Event|16|||
144702612|NCT00464308|521764810|FG000|Overall Study|Lost to Follow-up|29|||
144702613|NCT00464308|521764811|FG001|Overall Study|Lost to Follow-up|19|||
144702614|NCT00464308|521764812|FG002|Overall Study|Lost to Follow-up|20|||
144702615|NCT00464308|521764810|FG000|Overall Study|Patient discontinued and other reasons|17|||
144702616|NCT00464308|521764811|FG001|Overall Study|Patient discontinued and other reasons|17|||
144702617|NCT00464308|521764812|FG002|Overall Study|Patient discontinued and other reasons|23|||
144702618|NCT00464308|521764810|FG000|Overall Study|Physician Decision|1|||
144702619|NCT00464308|521764811|FG001|Overall Study|Physician Decision|0|||
144702620|NCT00464308|521764812|FG002|Overall Study|Physician Decision|0|||
144702621|NCT03722849|521764819|FG000|Overall Study|Withdrawal by Subject|1|||
144702622|NCT03722849|521764820|FG001|Overall Study|Withdrawal by Subject|1|||
144702623|NCT03533608|521764821|FG000|Overall Study|Withdrawal by Subject|3|||
144702624|NCT03533608|521764821|FG000|Overall Study|Physician Decision|2|||
144702625|NCT03286426|521764822|FG000|Overall Study|Physician Decision|3|||
144702626|NCT03514121|521764825|FG000|Overall Study|Withdrawal by Subject|0|||
144702627|NCT03514121|521764826|FG001|Overall Study|Withdrawal by Subject|0|||
144702628|NCT03514121|521764827|FG002|Overall Study|Withdrawal by Subject|0|||
144702629|NCT03514121|521764828|FG003|Overall Study|Withdrawal by Subject|0|||
144702630|NCT03514121|521764829|FG004|Overall Study|Withdrawal by Subject|1|||
144702631|NCT03514121|521764830|FG005|Overall Study|Withdrawal by Subject|2|||
144702632|NCT03514121|521764831|FG006|Overall Study|Withdrawal by Subject|1|||
144702633|NCT03514121|521764832|FG007|Overall Study|Withdrawal by Subject|1|||
144702634|NCT03514121|521764833|FG008|Overall Study|Withdrawal by Subject|7|||
144702635|NCT03514121|521764834|FG009|Overall Study|Withdrawal by Subject|2|||
144702636|NCT03514121|521764825|FG000|Overall Study|Death|0|||
144702637|NCT03514121|521764826|FG001|Overall Study|Death|0|||
144702638|NCT03514121|521764827|FG002|Overall Study|Death|0|||
144702639|NCT03514121|521764828|FG003|Overall Study|Death|0|||
144702640|NCT03514121|521764829|FG004|Overall Study|Death|0|||
144477927|NCT03500640|520947945|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
144477928|NCT03500640|520947943|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
144477929|NCT03500640|520947944|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
144477930|NCT03500640|520947945|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
144477931|NCT03500640|520947943|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
144477932|NCT03500640|520947944|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
144477933|NCT03500640|520947945|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
144477934|NCT03500640|520947943|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
144477935|NCT03500640|520947944|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
144702641|NCT03514121|521764830|FG005|Overall Study|Death|3|||
144702642|NCT03514121|521764831|FG006|Overall Study|Death|2|||
144702643|NCT03514121|521764832|FG007|Overall Study|Death|1|||
144702644|NCT03514121|521764833|FG008|Overall Study|Death|26|||
144702645|NCT03514121|521764834|FG009|Overall Study|Death|3|||
144702646|NCT03514121|521764825|FG000|Overall Study|Lost to Follow-up|0|||
144477936|NCT03500640|520947945|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
144477937|NCT03500640|520947943|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
144477938|NCT03500640|520947944|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
144477939|NCT03500640|520947945|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
144477940|NCT01650519|520947946|FG000|Overall Study|Withdrawal by Subject|1|||
144477941|NCT01650519|520947947|FG001|Overall Study|Withdrawal by Subject|0|||
144477942|NCT02954458|520947951|FG000|Overall Study|Adverse Event|0|||
144477943|NCT02954458|520947952|FG001|Overall Study|Adverse Event|0|||
144477944|NCT02954458|520947953|FG002|Overall Study|Adverse Event|0|||
144477945|NCT02954458|520947954|FG003|Overall Study|Adverse Event|1|||
144477946|NCT02954458|520947951|FG000|Overall Study|Withdrawal by Subject|0|||
144477947|NCT02954458|520947952|FG001|Overall Study|Withdrawal by Subject|0|||
144477948|NCT02954458|520947953|FG002|Overall Study|Withdrawal by Subject|0|||
144477949|NCT02954458|520947954|FG003|Overall Study|Withdrawal by Subject|1|||
144477950|NCT02954458|520947951|FG000|Overall Study|Physician Decision|0|||
144477951|NCT02954458|520947952|FG001|Overall Study|Physician Decision|0|||
144477952|NCT02954458|520947953|FG002|Overall Study|Physician Decision|1|||
144477953|NCT02954458|520947954|FG003|Overall Study|Physician Decision|1|||
144477954|NCT02954458|520947951|FG000|Overall Study|Lost to Follow-up|1|||
144477955|NCT02954458|520947952|FG001|Overall Study|Lost to Follow-up|0|||
144477956|NCT02954458|520947953|FG002|Overall Study|Lost to Follow-up|0|||
144477957|NCT02954458|520947954|FG003|Overall Study|Lost to Follow-up|1|||
144477958|NCT02954458|520947951|FG000|Overall Study|Death|0|||
144477959|NCT02954458|520947952|FG001|Overall Study|Death|0|||
144477960|NCT02954458|520947953|FG002|Overall Study|Death|0|||
144477961|NCT02954458|520947954|FG003|Overall Study|Death|1|||
144477962|NCT02954458|520947951|FG000|Overall Study|Other|0|||
144477963|NCT02954458|520947952|FG001|Overall Study|Other|0|||
144477964|NCT02954458|520947953|FG002|Overall Study|Other|0|||
144477965|NCT02954458|520947954|FG003|Overall Study|Other|7|||
144477966|NCT00747123|520947955|FG000|Overall Study|Investigator's request|0|||
144477967|NCT00747123|520947956|FG001|Overall Study|Investigator's request|0|||
144477968|NCT00747123|520947957|FG002|Overall Study|Investigator's request|1|||
144477969|NCT00747123|520947958|FG003|Overall Study|Investigator's request|0|||
144477970|NCT00747123|520947955|FG000|Overall Study|Withdrew consent|0|||
144477971|NCT00747123|520947956|FG001|Overall Study|Withdrew consent|1|||
144477972|NCT00747123|520947957|FG002|Overall Study|Withdrew consent|0|||
144477973|NCT00747123|520947958|FG003|Overall Study|Withdrew consent|0|||
144477974|NCT00747123|520947955|FG000|Overall Study|Adverse Event|0|||
144477975|NCT00747123|520947956|FG001|Overall Study|Adverse Event|1|||
144477976|NCT00747123|520947957|FG002|Overall Study|Adverse Event|0|||
144477977|NCT00747123|520947958|FG003|Overall Study|Adverse Event|1|||
144477978|NCT03929562|520947961|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
144477979|NCT03929562|520947962|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
144477980|NCT03929562|520947961|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
144477981|NCT03929562|520947962|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
144477982|NCT03929562|520947961|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
144477983|NCT03929562|520947962|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
144477984|NCT01778556|520947963|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
144477985|NCT01778556|520947964|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
144477986|NCT01778556|520947963|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
144477987|NCT01778556|520947964|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
144477988|NCT01778556|520947963|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
144477989|NCT01778556|520947964|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
144477990|NCT01778556|520947963|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
144477991|NCT01778556|520947964|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
144477992|NCT02243631|520950049|FG000|Overall Study|no synovial fluid on second aspirate|0|||
144477993|NCT02243631|520950050|FG001|Overall Study|no synovial fluid on second aspirate|1|||
144477994|NCT01590771|520950051|FG000|Overall Study|Other Protocol Specified Criteria|5|||
144477995|NCT01590771|520950052|FG001|Overall Study|Other Protocol Specified Criteria|14|||
144477996|NCT01590771|520950051|FG000|Overall Study|Withdrawal by Subject|8|||
144477997|NCT01590771|520950052|FG001|Overall Study|Withdrawal by Subject|15|||
144477998|NCT01590771|520950051|FG000|Overall Study|Protocol Violation|1|||
144477999|NCT01590771|520950052|FG001|Overall Study|Protocol Violation|2|||
144478000|NCT01590771|520950051|FG000|Overall Study|Lost to Follow-up|1|||
144478001|NCT01590771|520950052|FG001|Overall Study|Lost to Follow-up|1|||
144478002|NCT01590771|520950051|FG000|Overall Study|Lack of Efficacy|1|||
144478003|NCT01590771|520950052|FG001|Overall Study|Lack of Efficacy|0|||
144478004|NCT01590771|520950051|FG000|Overall Study|Adverse Event|3|||
144478005|NCT01590771|520950052|FG001|Overall Study|Adverse Event|7|||
144478006|NCT01785628|520950053|FG000|Overall Study|Lost to Follow-up|2|||
144478007|NCT01785628|520950054|FG001|Overall Study|Lost to Follow-up|3|||
144478008|NCT02200939|520950055|FG000|Overall Study|Participant withdrew consent|0|||
144478009|NCT02200939|520950056|FG001|Overall Study|Participant withdrew consent|1|||
144478010|NCT02200939|520950055|FG000|Overall Study|Lost to Follow-up|2|||
144478011|NCT02200939|520950056|FG001|Overall Study|Lost to Follow-up|9|||
144478012|NCT02200939|520950055|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
144478013|NCT02200939|520950056|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
144478014|NCT02746575|520950057|FG000|Overall Study|Surgery cancelled or time chaned|13|||
144478015|NCT02746575|520950057|FG000|Overall Study|Received epidural|10|||
144478016|NCT02746575|520950057|FG000|Overall Study|Withdrawal by Subject|3|||
144478017|NCT02746575|520950057|FG000|Overall Study|Bradycardia/hypotension|9|||
144478018|NCT02746575|520950057|FG000|Overall Study|Study paused|8|||
144478019|NCT02746575|520950057|FG000|Overall Study|put on beta-blocker|3|||
144478020|NCT02746575|520950057|FG000|Overall Study|type of surgery|1|||
144478021|NCT02746575|520950057|FG000|Overall Study|typ of surgery|1|||
144478022|NCT02746575|520950057|FG000|Overall Study|PI unavailable|1|||
144478023|NCT02746575|520950057|FG000|Overall Study|Unknown history of CVA|1|||
144478024|NCT04567693|520950058|FG000|Overall Study|Death|0|||
144478025|NCT04567693|520950059|FG001|Overall Study|Death|0|||
144478026|NCT04567693|520950060|FG002|Overall Study|Death|2|||
144478027|NCT04567693|520950058|FG000|Overall Study|Lost to Follow-up|1|||
144478028|NCT04567693|520950059|FG001|Overall Study|Lost to Follow-up|0|||
144478029|NCT04567693|520950060|FG002|Overall Study|Lost to Follow-up|2|||
144478030|NCT04567693|520950058|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
144478031|NCT04567693|520950059|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
144478032|NCT04567693|520950060|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
144478033|NCT00976482|520950063|FG000|Overall Study|Death|208|||
144478034|NCT00976482|520950063|FG000|Overall Study|Withdrawal by Subject|45|||
144478035|NCT00976482|520950063|FG000|Overall Study|Center terminated|1|||
144478036|NCT00976482|520950063|FG000|Overall Study|Protocol Violation|5|||
144478037|NCT03722264|520950066|FG000|Overall Study|Physician Decision|3|||
144478038|NCT00720902|520950067|FG000|Overall Study|Withdrawal by Subject|1|||
144478039|NCT00720902|520950068|FG001|Overall Study|Withdrawal by Subject|0|||
144478040|NCT00720902|520950067|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
144478041|NCT00720902|520950068|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
144478042|NCT01486758|520950069|FG000|Overall Study|Lost to Follow-up|0|||
144478043|NCT01486758|520950070|FG001|Overall Study|Lost to Follow-up|1|||
144478044|NCT03239873|520950077|FG000|Overall Study|Lost to Follow-up|15|||
144478045|NCT03239873|520950078|FG001|Overall Study|Lost to Follow-up|16|||
144478046|NCT03239873|520950077|FG000|Overall Study|Physician Decision|1|||
144478047|NCT03239873|520950078|FG001|Overall Study|Physician Decision|0|||
144478048|NCT03239873|520950077|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
144478049|NCT03239873|520950078|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
144478050|NCT03239873|520950077|FG000|Overall Study|Withdrawal by Subject|2|||
144478051|NCT03239873|520950078|FG001|Overall Study|Withdrawal by Subject|0|||
144478052|NCT03239873|520950077|FG000|Overall Study|Contraindication to study medication|1|||
144478053|NCT03239873|520950078|FG001|Overall Study|Contraindication to study medication|0|||
144478054|NCT03239873|520950077|FG000|Overall Study|Protocol Violation|1|||
144478055|NCT03239873|520950078|FG001|Overall Study|Protocol Violation|0|||
144478056|NCT01161472|520950080|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
144478057|NCT01161472|520950081|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
144478058|NCT01161472|520950082|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
144478059|NCT01161472|520950083|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
144478060|NCT00798174|520950085|FG000|Overall Study|inability to implant azygos coil|3|||
144478061|NCT00798174|520950086|FG001|Overall Study|inability to implant azygos coil|3|||
144478062|NCT00798174|520950085|FG000|Overall Study|Inability to sedate for DFT testing|1|||
144478063|NCT00798174|520950086|FG001|Overall Study|Inability to sedate for DFT testing|0|||
144478064|NCT01478113|520950091|FG000|Overall Study|Withdrawal by Subject|0|||
144478065|NCT01478113|520950092|FG001|Overall Study|Withdrawal by Subject|1|||
144478066|NCT01478113|520950091|FG000|Overall Study|Physician Decision|1|||
144478067|NCT01478113|520950092|FG001|Overall Study|Physician Decision|0|||
144478068|NCT01454830|520950093|FG000|Overall Study|Withdrawal by Subject|4|||
144478069|NCT01454830|520950094|FG001|Overall Study|Withdrawal by Subject|4|||
144478070|NCT01454830|520950093|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
144478071|NCT01454830|520950094|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
144478072|NCT01454830|520950093|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
144478073|NCT01454830|520950094|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
144478074|NCT01454830|520950093|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
144478075|NCT01454830|520950094|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
144478076|NCT01454830|520950093|FG000|Overall Study|Withdrawal - no polysomnography|3|||
144478077|NCT01454830|520950094|FG001|Overall Study|Withdrawal - no polysomnography|2|||
144478078|NCT01872910|520950101|FG000|Overall Study|Lost to Follow-up|2|||
144478079|NCT01872910|520950102|FG001|Overall Study|Lost to Follow-up|0|||
144702647|NCT03514121|521764826|FG001|Overall Study|Lost to Follow-up|0|||
144702648|NCT03514121|521764827|FG002|Overall Study|Lost to Follow-up|1|||
144702649|NCT03514121|521764828|FG003|Overall Study|Lost to Follow-up|0|||
144702650|NCT03514121|521764829|FG004|Overall Study|Lost to Follow-up|0|||
144702651|NCT03514121|521764830|FG005|Overall Study|Lost to Follow-up|0|||
144702652|NCT03514121|521764831|FG006|Overall Study|Lost to Follow-up|0|||
144702653|NCT03514121|521764832|FG007|Overall Study|Lost to Follow-up|0|||
144702654|NCT03514121|521764833|FG008|Overall Study|Lost to Follow-up|1|||
144702655|NCT03514121|521764834|FG009|Overall Study|Lost to Follow-up|0|||
144702656|NCT03514121|521764825|FG000|Overall Study|Adverse Event|0|||
144702657|NCT03514121|521764826|FG001|Overall Study|Adverse Event|0|||
144702658|NCT03514121|521764827|FG002|Overall Study|Adverse Event|0|||
144702659|NCT03514121|521764828|FG003|Overall Study|Adverse Event|0|||
144702660|NCT03514121|521764829|FG004|Overall Study|Adverse Event|0|||
144702661|NCT03514121|521764830|FG005|Overall Study|Adverse Event|0|||
144702662|NCT03514121|521764831|FG006|Overall Study|Adverse Event|1|||
144702663|NCT03514121|521764832|FG007|Overall Study|Adverse Event|0|||
144702664|NCT03514121|521764833|FG008|Overall Study|Adverse Event|0|||
144702665|NCT03514121|521764834|FG009|Overall Study|Adverse Event|0|||
144702666|NCT03514121|521764825|FG000|Overall Study|Other|0|||
144702667|NCT03514121|521764826|FG001|Overall Study|Other|1|||
144702668|NCT03514121|521764827|FG002|Overall Study|Other|1|||
144702669|NCT03514121|521764828|FG003|Overall Study|Other|0|||
144702670|NCT03514121|521764829|FG004|Overall Study|Other|1|||
144702671|NCT03514121|521764830|FG005|Overall Study|Other|2|||
144702672|NCT03514121|521764831|FG006|Overall Study|Other|3|||
144702673|NCT03514121|521764832|FG007|Overall Study|Other|2|||
144702674|NCT03514121|521764833|FG008|Overall Study|Other|7|||
144702675|NCT03514121|521764834|FG009|Overall Study|Other|3|||
144702676|NCT03514121|521764825|FG000|Overall Study|Study termination by Sponsor|0|||
144702677|NCT03514121|521764826|FG001|Overall Study|Study termination by Sponsor|0|||
144702678|NCT03514121|521764827|FG002|Overall Study|Study termination by Sponsor|0|||
144702679|NCT03514121|521764828|FG003|Overall Study|Study termination by Sponsor|0|||
144702680|NCT03514121|521764829|FG004|Overall Study|Study termination by Sponsor|0|||
144702681|NCT03514121|521764830|FG005|Overall Study|Study termination by Sponsor|0|||
144702682|NCT03514121|521764831|FG006|Overall Study|Study termination by Sponsor|0|||
144702683|NCT03514121|521764832|FG007|Overall Study|Study termination by Sponsor|0|||
144702684|NCT03514121|521764833|FG008|Overall Study|Study termination by Sponsor|11|||
144702685|NCT03514121|521764834|FG009|Overall Study|Study termination by Sponsor|3|||
144702686|NCT03514121|521764825|FG000|Overall Study|Investigator decision|0|||
144702687|NCT03514121|521764826|FG001|Overall Study|Investigator decision|0|||
144702688|NCT03514121|521764827|FG002|Overall Study|Investigator decision|0|||
144702689|NCT03514121|521764828|FG003|Overall Study|Investigator decision|0|||
144702690|NCT03514121|521764829|FG004|Overall Study|Investigator decision|0|||
144702691|NCT03514121|521764830|FG005|Overall Study|Investigator decision|0|||
144702692|NCT03514121|521764831|FG006|Overall Study|Investigator decision|0|||
144702693|NCT03514121|521764832|FG007|Overall Study|Investigator decision|0|||
144702694|NCT03514121|521764833|FG008|Overall Study|Investigator decision|1|||
144702695|NCT03514121|521764834|FG009|Overall Study|Investigator decision|0|||
144702696|NCT05553600|521764835|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
144702697|NCT05553600|521764836|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
144702698|NCT05553600|521764837|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
144702699|NCT05553600|521764838|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
144702700|NCT05553600|521764835|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
144702701|NCT05553600|521764836|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
144702702|NCT05553600|521764837|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
144702703|NCT05553600|521764838|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
144702704|NCT05553600|521764835|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
144702705|NCT05553600|521764836|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
144702706|NCT05553600|521764837|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
144702707|NCT05553600|521764838|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
144702708|NCT05553600|521764835|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
144702709|NCT05553600|521764836|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
144702710|NCT05553600|521764837|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
144702711|NCT05553600|521764838|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
144702712|NCT05553600|521764835|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
144702713|NCT05553600|521764836|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
144702714|NCT05553600|521764837|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
144702715|NCT05553600|521764838|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
144478080|NCT01872910|520950103|FG002|Overall Study|Lost to Follow-up|2|||
144478081|NCT01872910|520950104|FG003|Overall Study|Lost to Follow-up|0|||
144478082|NCT01872910|520950105|FG004|Overall Study|Lost to Follow-up|0|||
144478083|NCT01872910|520950106|FG005|Overall Study|Lost to Follow-up|0|||
144478084|NCT01306201|520950109|FG000|Overall Study|Arrhythmia|4|||
144478085|NCT01306201|520950109|FG000|Overall Study|Files could not be processed|3|||
144478086|NCT01306201|520950109|FG000|Overall Study|Files unreadable|3|||
144478087|NCT04702568|520950110|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
144478088|NCT04702568|520950111|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
144478089|NCT04702568|520950110|FG000|Overall Study|Pregnancy|1|||
144478090|NCT04702568|520950111|FG001|Overall Study|Pregnancy|0|||
144478091|NCT04702568|520950110|FG000|Overall Study|Bone marrow transplant|1|||
144478092|NCT04702568|520950111|FG001|Overall Study|Bone marrow transplant|0|||
144478093|NCT04702568|520950110|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
144478094|NCT04702568|520950111|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
144478095|NCT04702568|520950110|FG000|Overall Study|Withdrawal by Subject|0|||
144478096|NCT04702568|520950111|FG001|Overall Study|Withdrawal by Subject|2|||
144478097|NCT00393523|520950112|FG000|Overall Study|Lost to Follow-up|0|||
144478098|NCT00393523|520950113|FG001|Overall Study|Lost to Follow-up|0|||
144478099|NCT00393523|520950114|FG002|Overall Study|Lost to Follow-up|0|||
144478100|NCT00393523|520950115|FG003|Overall Study|Lost to Follow-up|2|||
144478101|NCT00393523|520950116|FG004|Overall Study|Lost to Follow-up|1|||
144478102|NCT00393523|520950112|FG000|Overall Study|Protocol Violation|6|||
144478103|NCT00393523|520950113|FG001|Overall Study|Protocol Violation|2|||
144478104|NCT00393523|520950114|FG002|Overall Study|Protocol Violation|0|||
144478105|NCT00393523|520950115|FG003|Overall Study|Protocol Violation|1|||
144478106|NCT00393523|520950116|FG004|Overall Study|Protocol Violation|0|||
144478107|NCT00393523|520950112|FG000|Overall Study|Withdrawal by Subject|6|||
144478108|NCT00393523|520950113|FG001|Overall Study|Withdrawal by Subject|7|||
144478109|NCT00393523|520950114|FG002|Overall Study|Withdrawal by Subject|2|||
144478110|NCT00393523|520950115|FG003|Overall Study|Withdrawal by Subject|3|||
144478111|NCT00393523|520950116|FG004|Overall Study|Withdrawal by Subject|0|||
144478112|NCT00393523|520950112|FG000|Overall Study|Difficulties in specimen collection|0|||
144478113|NCT00393523|520950113|FG001|Overall Study|Difficulties in specimen collection|0|||
144478114|NCT00393523|520950114|FG002|Overall Study|Difficulties in specimen collection|1|||
144478115|NCT00393523|520950115|FG003|Overall Study|Difficulties in specimen collection|0|||
144478116|NCT00393523|520950116|FG004|Overall Study|Difficulties in specimen collection|0|||
144478117|NCT00393523|520950112|FG000|Overall Study|Vaccine supply issue|0|||
144478118|NCT00393523|520950113|FG001|Overall Study|Vaccine supply issue|0|||
144478119|NCT00393523|520950114|FG002|Overall Study|Vaccine supply issue|1|||
144478120|NCT00393523|520950115|FG003|Overall Study|Vaccine supply issue|0|||
144478121|NCT00393523|520950116|FG004|Overall Study|Vaccine supply issue|0|||
144478122|NCT02912468|520950117|FG000|Overall Study|Adverse Event|3|||
144478123|NCT02912468|520950118|FG001|Overall Study|Adverse Event|2|||
144478124|NCT02912468|520950117|FG000|Overall Study|Withdrawal by Subject|6|||
144478125|NCT02912468|520950118|FG001|Overall Study|Withdrawal by Subject|2|||
144478126|NCT02912468|520950117|FG000|Overall Study|Randomized and not treated|0|||
144478127|NCT02912468|520950118|FG001|Overall Study|Randomized and not treated|1|||
144478128|NCT00692406|520950121|FG000|Overall Study|PI dropped, bad data|57|||
144478129|NCT00525265|520950126|FG000|Overall Study|Protocol Violation|1|||
144478130|NCT00525265|520950127|FG001|Overall Study|Protocol Violation|0|||
144478131|NCT00265330|520950128|FG000|Overall Study|Adverse Event|41|||
144478132|NCT00265330|520950128|FG000|Overall Study|Lost to Follow-up|8|||
144478133|NCT00265330|520950128|FG000|Overall Study|Withdrawal by Subject|34|||
144478134|NCT00265330|520950128|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
144478135|NCT00265330|520950128|FG000|Overall Study|Lack of Efficacy|4|||
144478136|NCT00265330|520950128|FG000|Overall Study|Family Scheduling Conflicts|1|||
144478137|NCT00265330|520950128|FG000|Overall Study|Began Taking Formulary Geodon|1|||
144478138|NCT00265330|520950128|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
144478139|NCT00265330|520950128|FG000|Overall Study|Site Closed by Sponsor|1|||
144478140|NCT00265330|520950128|FG000|Overall Study|Principal Investigators Request|1|||
144478141|NCT00265330|520950128|FG000|Overall Study|Withdrew Consent|1|||
144478142|NCT00265330|520950128|FG000|Overall Study|Protocol Violation|1|||
144478143|NCT03403426|520950136|FG000|Overall Study|Death|1|||
144478144|NCT03403426|520950136|FG000|Overall Study|Lost to Follow-up|2|||
144478145|NCT01657266|520950138|FG000|Overall Study|Lost to Follow-up|2|||
144478146|NCT01657266|520950139|FG001|Overall Study|Lost to Follow-up|2|||
144478147|NCT01657266|520950138|FG000|Overall Study|Adverse Event|2|||
144478148|NCT01657266|520950139|FG001|Overall Study|Adverse Event|3|||
144478149|NCT00736489|520950142|FG000|Period 1|Lost to Follow-up|1|||
144478150|NCT00736489|520950143|FG001|Period 1|Lost to Follow-up|0|||
144478151|NCT00736489|520950144|FG002|Period 1|Lost to Follow-up|0|||
144478152|NCT00736489|520950145|FG003|Period 1|Lost to Follow-up|0|||
144478153|NCT00736489|520950146|FG004|Period 1|Lost to Follow-up|0|||
144702716|NCT05553600|521764835|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
144702717|NCT05553600|521764836|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
144702718|NCT05553600|521764837|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
144702719|NCT05553600|521764838|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
144702720|NCT05553600|521764835|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
144702721|NCT05553600|521764836|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
144702722|NCT05553600|521764837|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
144702723|NCT05553600|521764838|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
144702724|NCT05553600|521764835|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
144702725|NCT05553600|521764836|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
144702726|NCT05553600|521764837|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
144702727|NCT05553600|521764838|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
144702728|NCT05553600|521764835|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
144702729|NCT05553600|521764836|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
144702730|NCT05553600|521764837|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
144702731|NCT05553600|521764838|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
144702732|NCT05553600|521764835|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
144702733|NCT05553600|521764836|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
144702734|NCT05553600|521764837|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
144702735|NCT05553600|521764838|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
144702736|NCT05553600|521764835|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
144702737|NCT05553600|521764836|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
144702738|NCT05553600|521764837|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
144702739|NCT05553600|521764838|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
144702740|NCT05553600|521764835|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
144702741|NCT05553600|521764836|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
144702742|NCT05553600|521764837|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
144702743|NCT05553600|521764838|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
144702744|NCT04633434|521764839|FG000|Overall Study|Lost to Follow-up|32|||
144478154|NCT00736489|520950147|FG005|Period 1|Lost to Follow-up|0|||
144478155|NCT00736489|520950142|FG000|Period 1|Withdrawal by Subject|0|||
144478156|NCT00736489|520950143|FG001|Period 1|Withdrawal by Subject|0|||
144478157|NCT00736489|520950144|FG002|Period 1|Withdrawal by Subject|0|||
144478158|NCT00736489|520950145|FG003|Period 1|Withdrawal by Subject|0|||
144478159|NCT00736489|520950146|FG004|Period 1|Withdrawal by Subject|0|||
144478160|NCT00736489|520950147|FG005|Period 1|Withdrawal by Subject|1|||
144478161|NCT00510458|520950150|FG000|Overall Study|5 year not evaluable/missed|21|||
144478162|NCT00510458|520950150|FG000|Overall Study|Death|1|||
144478163|NCT00510458|520950150|FG000|Overall Study|Terminated|14|||
144478164|NCT00510458|520950150|FG000|Overall Study|Lost to Follow-up|6|||
144478165|NCT00510458|520950150|FG000|Overall Study|Withdrawal by Subject|3|||
144478166|NCT00510458|520950150|FG000|Overall Study|Revision|2|||
144478167|NCT02569710|520950151|FG000|Overall Study|Adverse Event|1|||
144478168|NCT02569710|520950152|FG001|Overall Study|Adverse Event|0|||
144478169|NCT02569710|520950153|FG002|Overall Study|Adverse Event|0|||
144478170|NCT02569710|520950154|FG003|Overall Study|Adverse Event|0|||
144478171|NCT02569710|520950155|FG004|Overall Study|Adverse Event|0|||
144478172|NCT02569710|520950156|FG005|Overall Study|Adverse Event|0|||
144478173|NCT02569710|520950157|FG006|Overall Study|Adverse Event|0|||
144478174|NCT02569710|520950158|FG007|Overall Study|Adverse Event|0|||
144478175|NCT02569710|520950159|FG008|Overall Study|Adverse Event|0|||
144478176|NCT02569710|520950160|FG009|Overall Study|Adverse Event|0|||
144478177|NCT02569710|520950151|FG000|Overall Study|Lost to Follow-up|0|||
144478178|NCT02569710|520950152|FG001|Overall Study|Lost to Follow-up|0|||
144478179|NCT02569710|520950153|FG002|Overall Study|Lost to Follow-up|0|||
144478180|NCT02569710|520950154|FG003|Overall Study|Lost to Follow-up|0|||
144478181|NCT02569710|520950155|FG004|Overall Study|Lost to Follow-up|0|||
144478182|NCT02569710|520950156|FG005|Overall Study|Lost to Follow-up|0|||
144478183|NCT02569710|520950157|FG006|Overall Study|Lost to Follow-up|1|||
144478184|NCT02569710|520950158|FG007|Overall Study|Lost to Follow-up|0|||
144478185|NCT02569710|520950159|FG008|Overall Study|Lost to Follow-up|1|||
144478186|NCT02569710|520950160|FG009|Overall Study|Lost to Follow-up|0|||
144478187|NCT02569710|520950151|FG000|Overall Study|Virologic failure|0|||
144478188|NCT02569710|520950152|FG001|Overall Study|Virologic failure|0|||
144478189|NCT02569710|520950153|FG002|Overall Study|Virologic failure|0|||
144478190|NCT02569710|520950154|FG003|Overall Study|Virologic failure|0|||
144478191|NCT02569710|520950155|FG004|Overall Study|Virologic failure|1|||
144478192|NCT02569710|520950156|FG005|Overall Study|Virologic failure|0|||
144478193|NCT02569710|520950157|FG006|Overall Study|Virologic failure|1|||
144478194|NCT02569710|520950158|FG007|Overall Study|Virologic failure|0|||
144478195|NCT02569710|520950159|FG008|Overall Study|Virologic failure|0|||
144702745|NCT04633434|521764840|FG001|Overall Study|Lost to Follow-up|32|||
144702746|NCT01976104|521764844|FG000|Overall Study|Adverse Event|0|||
144702747|NCT01976104|521764845|FG001|Overall Study|Adverse Event|0|||
144702748|NCT01976104|521764846|FG002|Overall Study|Adverse Event|1|||
144702749|NCT01976104|521764847|FG003|Overall Study|Adverse Event|0|||
144702750|NCT01976104|521764844|FG000|Overall Study|Lost to Follow-up|3|||
144702751|NCT01976104|521764845|FG001|Overall Study|Lost to Follow-up|0|||
144702752|NCT01976104|521764846|FG002|Overall Study|Lost to Follow-up|1|||
144702753|NCT01976104|521764847|FG003|Overall Study|Lost to Follow-up|1|||
144702754|NCT01976104|521764844|FG000|Overall Study|Subject Choice|0|||
144702755|NCT01976104|521764845|FG001|Overall Study|Subject Choice|1|||
144702756|NCT01976104|521764846|FG002|Overall Study|Subject Choice|0|||
144702757|NCT01976104|521764847|FG003|Overall Study|Subject Choice|1|||
144702758|NCT01976104|521764844|FG000|Overall Study|Withdrawal by Subject|3|||
144702759|NCT01976104|521764845|FG001|Overall Study|Withdrawal by Subject|0|||
144702760|NCT01976104|521764846|FG002|Overall Study|Withdrawal by Subject|0|||
144702761|NCT01976104|521764847|FG003|Overall Study|Withdrawal by Subject|1|||
144702762|NCT01976104|521764844|FG000|Overall Study|Other|0|||
144702763|NCT01976104|521764845|FG001|Overall Study|Other|1|||
144702764|NCT01976104|521764846|FG002|Overall Study|Other|0|||
144702765|NCT01976104|521764847|FG003|Overall Study|Other|0|||
144702766|NCT01353209|521764848|FG000|Overall Study|Adverse Event|1|||
144702767|NCT01353209|521764849|FG001|Overall Study|Adverse Event|1|||
144702768|NCT00337727|521764851|FG000|Overall Study|Adverse Event|5|||
144702769|NCT00337727|521764852|FG001|Overall Study|Adverse Event|3|||
144702770|NCT00337727|521764851|FG000|Overall Study|Lost to Follow-up|5|||
144702771|NCT00337727|521764852|FG001|Overall Study|Lost to Follow-up|4|||
144702772|NCT00337727|521764851|FG000|Overall Study|Physician Decision|1|||
144702773|NCT00337727|521764852|FG001|Overall Study|Physician Decision|0|||
144702774|NCT00337727|521764851|FG000|Overall Study|Protocol Violation|4|||
144702775|NCT00337727|521764852|FG001|Overall Study|Protocol Violation|0|||
144702776|NCT00337727|521764851|FG000|Overall Study|Withdrawal by Subject|3|||
144702777|NCT00337727|521764852|FG001|Overall Study|Withdrawal by Subject|5|||
144702778|NCT00943826|521764853|FG000|Concurrent Phase|Adverse Event|50|||
144702779|NCT00943826|521764854|FG001|Concurrent Phase|Adverse Event|27|||
144702780|NCT00943826|521764853|FG000|Concurrent Phase|Withdrew consent|3|||
144702781|NCT00943826|521764854|FG001|Concurrent Phase|Withdrew consent|7|||
144702782|NCT00943826|521764853|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
144702783|NCT00943826|521764854|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
144702784|NCT00943826|521764853|FG000|Concurrent Phase|Administrative reasons|2|||
144702785|NCT00943826|521764854|FG001|Concurrent Phase|Administrative reasons|1|||
144702786|NCT00943826|521764853|FG000|Concurrent Phase|Protocol Violation|1|||
144702787|NCT00943826|521764854|FG001|Concurrent Phase|Protocol Violation|0|||
144702788|NCT00943826|521764853|FG000|Maintenance Phase|Adverse Event|31|||
144702789|NCT00943826|521764854|FG001|Maintenance Phase|Adverse Event|30|||
144702790|NCT00943826|521764853|FG000|Maintenance Phase|Withdrew consent|2|||
144702791|NCT00943826|521764854|FG001|Maintenance Phase|Withdrew consent|4|||
144702792|NCT00943826|521764853|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
144702793|NCT00943826|521764854|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
144702794|NCT00943826|521764853|FG000|Maintenance Phase|Administrative reasons|4|||
144702795|NCT00943826|521764854|FG001|Maintenance Phase|Administrative reasons|1|||
144702796|NCT00943826|521764853|FG000|Maintenance Phase|Failure to return|0|||
144702797|NCT00943826|521764854|FG001|Maintenance Phase|Failure to return|1|||
144702798|NCT00943826|521764853|FG000|Monotherapy Phase|Adverse Event|42|||
144702799|NCT00943826|521764854|FG001|Monotherapy Phase|Adverse Event|5|||
144702800|NCT00943826|521764853|FG000|Monotherapy Phase|Administrative reasons|11|||
144702801|NCT00943826|521764854|FG001|Monotherapy Phase|Administrative reasons|5|||
144702802|NCT00943826|521764853|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
144702803|NCT00943826|521764854|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
144702804|NCT00943826|521764853|FG000|Monotherapy Phase|Withdrew Consent|2|||
144702805|NCT00943826|521764854|FG001|Monotherapy Phase|Withdrew Consent|3|||
144702806|NCT00943826|521764853|FG000|Monotherapy Phase|Failure to return|2|||
144702807|NCT00943826|521764854|FG001|Monotherapy Phase|Failure to return|1|||
144702808|NCT00943826|521764853|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
144702809|NCT00943826|521764854|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
144702810|NCT00943826|521764853|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
144702811|NCT00943826|521764854|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
144702812|NCT00943826|521764853|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
144702813|NCT00943826|521764854|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
144702814|NCT00943826|521764853|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
144702815|NCT00943826|521764854|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
144702816|NCT00326625|521764855|FG000|Overall Study|Adverse Event|20|||
144702817|NCT00326625|521764856|FG001|Overall Study|Adverse Event|9|||
144702818|NCT00326625|521764855|FG000|Overall Study|Withdrawal by Subject|15|||
144362384|NCT02702492|520535195|FG010|Overall Study|Other|0|||
144702819|NCT00326625|521764856|FG001|Overall Study|Withdrawal by Subject|12|||
144702820|NCT00326625|521764855|FG000|Overall Study|Death|18|||
144702821|NCT00326625|521764856|FG001|Overall Study|Death|16|||
144702822|NCT00326625|521764855|FG000|Overall Study|Lost to Follow-up|1|||
144702823|NCT00326625|521764856|FG001|Overall Study|Lost to Follow-up|0|||
144702824|NCT00326625|521764855|FG000|Overall Study|prescheduled medical intervention|0|||
144702825|NCT00326625|521764856|FG001|Overall Study|prescheduled medical intervention|1|||
144702826|NCT00077766|521764864|FG000|Overall Study|Adverse Event|1|||
144702827|NCT00077766|521764865|FG001|Overall Study|Adverse Event|1|||
144702828|NCT00077766|521764864|FG000|Overall Study|Withdrawal by Subject|4|||
144702829|NCT00077766|521764865|FG001|Overall Study|Withdrawal by Subject|3|||
144702830|NCT00077766|521764864|FG000|Overall Study|Death|12|||
144702831|NCT00077766|521764865|FG001|Overall Study|Death|10|||
144702832|NCT00077766|521764864|FG000|Overall Study|Lost to Follow-up|2|||
144702833|NCT00077766|521764865|FG001|Overall Study|Lost to Follow-up|0|||
144702834|NCT00077766|521764864|FG000|Overall Study|Protocol Violation|1|||
144702835|NCT00077766|521764865|FG001|Overall Study|Protocol Violation|0|||
144702836|NCT00077766|521764864|FG000|Overall Study|Kidney Transplantation|9|||
144702837|NCT00077766|521764865|FG001|Overall Study|Kidney Transplantation|5|||
144702838|NCT00077766|521764864|FG000|Overall Study|Transplantation|5|||
144702839|NCT00077766|521764865|FG001|Overall Study|Transplantation|1|||
144702840|NCT00077766|521764864|FG000|Overall Study|Investigators Discretion|1|||
144702841|NCT00077766|521764865|FG001|Overall Study|Investigators Discretion|0|||
144702842|NCT00077766|521764864|FG000|Overall Study|Participant's decision|1|||
144702843|NCT00077766|521764865|FG001|Overall Study|Participant's decision|0|||
144702844|NCT00077766|521764864|FG000|Overall Study|Dialysis Discontinued|1|||
144702845|NCT00077766|521764865|FG001|Overall Study|Dialysis Discontinued|0|||
144702846|NCT00077766|521764864|FG000|Overall Study|Dialysis|0|||
144702847|NCT00077766|521764865|FG001|Overall Study|Dialysis|1|||
144702848|NCT00077766|521764864|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
144702849|NCT00077766|521764865|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
144702850|NCT00077766|521764864|FG000|Overall Study|Started Nocturnal Dialysis|0|||
144702851|NCT00077766|521764865|FG001|Overall Study|Started Nocturnal Dialysis|1|||
144478196|NCT02569710|520950160|FG009|Overall Study|Virologic failure|0|||
144478197|NCT02569710|520950151|FG000|Overall Study|Withdrawal by Subject|0|||
144478198|NCT02569710|520950152|FG001|Overall Study|Withdrawal by Subject|0|||
144478199|NCT02569710|520950153|FG002|Overall Study|Withdrawal by Subject|0|||
144478200|NCT02569710|520950154|FG003|Overall Study|Withdrawal by Subject|0|||
144478201|NCT02569710|520950155|FG004|Overall Study|Withdrawal by Subject|0|||
144478202|NCT02569710|520950156|FG005|Overall Study|Withdrawal by Subject|1|||
144478203|NCT02569710|520950157|FG006|Overall Study|Withdrawal by Subject|0|||
144478204|NCT02569710|520950158|FG007|Overall Study|Withdrawal by Subject|0|||
144478205|NCT02569710|520950159|FG008|Overall Study|Withdrawal by Subject|0|||
144478206|NCT02569710|520950160|FG009|Overall Study|Withdrawal by Subject|0|||
144478207|NCT01125722|520950161|FG000|Overall Study|Withdrawal by Subject|2|||
144478208|NCT01125722|520950162|FG001|Overall Study|Withdrawal by Subject|1|||
144478209|NCT01125722|520950161|FG000|Overall Study|Lost to Follow-up|1|||
144478210|NCT01125722|520950162|FG001|Overall Study|Lost to Follow-up|0|||
144478211|NCT03573908|520950163|FG000|Treatment Period|Adverse Event|4|||
144478212|NCT03573908|520950164|FG001|Treatment Period|Adverse Event|9|||
144478213|NCT03573908|520950165|FG002|Treatment Period|Adverse Event|0|||
144478214|NCT03573908|520950166|FG003|Treatment Period|Adverse Event|0|||
144478215|NCT03573908|520950167|FG004|Treatment Period|Adverse Event|0|||
144478216|NCT03573908|520950163|FG000|Treatment Period|Protocol Violation|1|||
144478217|NCT03573908|520950164|FG001|Treatment Period|Protocol Violation|0|||
144478218|NCT03573908|520950165|FG002|Treatment Period|Protocol Violation|0|||
144478219|NCT03573908|520950166|FG003|Treatment Period|Protocol Violation|0|||
144478220|NCT03573908|520950167|FG004|Treatment Period|Protocol Violation|0|||
144478221|NCT03573908|520950163|FG000|Treatment Period|Withdrawal by Subject|7|||
144478222|NCT03573908|520950164|FG001|Treatment Period|Withdrawal by Subject|5|||
144478223|NCT03573908|520950165|FG002|Treatment Period|Withdrawal by Subject|0|||
144478224|NCT03573908|520950166|FG003|Treatment Period|Withdrawal by Subject|0|||
144478225|NCT03573908|520950167|FG004|Treatment Period|Withdrawal by Subject|0|||
144478226|NCT03573908|520950163|FG000|Treatment Period|Lost to Follow-up|7|||
144478227|NCT03573908|520950164|FG001|Treatment Period|Lost to Follow-up|6|||
144478228|NCT03573908|520950165|FG002|Treatment Period|Lost to Follow-up|0|||
144478229|NCT03573908|520950166|FG003|Treatment Period|Lost to Follow-up|0|||
144478230|NCT03573908|520950167|FG004|Treatment Period|Lost to Follow-up|0|||
144478231|NCT03573908|520950163|FG000|Treatment Period|Pregnancy|1|||
144478232|NCT03573908|520950164|FG001|Treatment Period|Pregnancy|0|||
144702852|NCT00077766|521764864|FG000|Overall Study|Stop Dialysis|0|||
144702853|NCT00077766|521764865|FG001|Overall Study|Stop Dialysis|1|||
144478233|NCT03573908|520950165|FG002|Treatment Period|Pregnancy|0|||
144702854|NCT00077766|521764864|FG000|Overall Study|Participants Vacation|2|||
144702855|NCT00077766|521764865|FG001|Overall Study|Participants Vacation|1|||
144702856|NCT02255422|521764868|FG000|Overall Study|Withdrawal by Subject|0|||
144702857|NCT02255422|521764869|FG001|Overall Study|Withdrawal by Subject|0|||
144702858|NCT02255422|521764870|FG002|Overall Study|Withdrawal by Subject|0|||
144702859|NCT02255422|521764871|FG003|Overall Study|Withdrawal by Subject|0|||
144702860|NCT02255422|521764872|FG004|Overall Study|Withdrawal by Subject|0|||
144702861|NCT02255422|521764873|FG005|Overall Study|Withdrawal by Subject|0|||
144702862|NCT02255422|521764874|FG006|Overall Study|Withdrawal by Subject|2|||
144702863|NCT02255422|521764868|FG000|Overall Study|Lost to Follow-up|0|||
144702864|NCT02255422|521764869|FG001|Overall Study|Lost to Follow-up|0|||
144702865|NCT02255422|521764870|FG002|Overall Study|Lost to Follow-up|1|||
144702866|NCT02255422|521764871|FG003|Overall Study|Lost to Follow-up|0|||
144702867|NCT02255422|521764872|FG004|Overall Study|Lost to Follow-up|0|||
144702868|NCT02255422|521764873|FG005|Overall Study|Lost to Follow-up|0|||
144702869|NCT02255422|521764874|FG006|Overall Study|Lost to Follow-up|0|||
144702870|NCT04411641|521764875|FG000|DB Period|Other|7|||
144702871|NCT04411641|521764876|FG001|DB Period|Other|27|||
144702872|NCT04411641|521764877|FG002|DB Period|Other|0|||
144702873|NCT04411641|521764878|FG003|DB Period|Other|0|||
144702874|NCT04411641|521764875|FG000|DB Period|Withdrawal by Subject|67|||
144702875|NCT04411641|521764876|FG001|DB Period|Withdrawal by Subject|122|||
144702876|NCT04411641|521764877|FG002|DB Period|Withdrawal by Subject|0|||
144702877|NCT04411641|521764878|FG003|DB Period|Withdrawal by Subject|0|||
144702878|NCT04411641|521764875|FG000|DB Period|Progressive disease|76|||
144702879|NCT04411641|521764876|FG001|DB Period|Progressive disease|116|||
144702880|NCT04411641|521764877|FG002|DB Period|Progressive disease|0|||
144702881|NCT04411641|521764878|FG003|DB Period|Progressive disease|0|||
144702882|NCT04411641|521764875|FG000|DB Period|Poor compliance to protocol|1|||
144702883|NCT04411641|521764876|FG001|DB Period|Poor compliance to protocol|5|||
144702884|NCT04411641|521764877|FG002|DB Period|Poor compliance to protocol|0|||
144702885|NCT04411641|521764878|FG003|DB Period|Poor compliance to protocol|0|||
144702886|NCT04411641|521764875|FG000|DB Period|Lack of Efficacy|19|||
144702887|NCT04411641|521764876|FG001|DB Period|Lack of Efficacy|19|||
144702888|NCT04411641|521764877|FG002|DB Period|Lack of Efficacy|0|||
144702889|NCT04411641|521764878|FG003|DB Period|Lack of Efficacy|0|||
144702890|NCT04411641|521764875|FG000|DB Period|Adverse Event|13|||
144702891|NCT04411641|521764876|FG001|DB Period|Adverse Event|29|||
144702892|NCT04411641|521764877|FG002|DB Period|Adverse Event|0|||
144702893|NCT04411641|521764878|FG003|DB Period|Adverse Event|0|||
144702894|NCT04411641|521764875|FG000|DB Period|Randomized and not treated|2|||
144702895|NCT04411641|521764876|FG001|DB Period|Randomized and not treated|2|||
144702896|NCT04411641|521764877|FG002|DB Period|Randomized and not treated|0|||
144702897|NCT04411641|521764878|FG003|DB Period|Randomized and not treated|0|||
144702898|NCT04411641|521764875|FG000|OL|Withdrawal by Subject|0|||
144702899|NCT04411641|521764876|FG001|OL|Withdrawal by Subject|0|||
144702900|NCT04411641|521764877|FG002|OL|Withdrawal by Subject|6|||
144702901|NCT04411641|521764878|FG003|OL|Withdrawal by Subject|17|||
144702902|NCT04411641|521764875|FG000|OL|Progressive disease|0|||
144702903|NCT04411641|521764876|FG001|OL|Progressive disease|0|||
144702904|NCT04411641|521764877|FG002|OL|Progressive disease|1|||
144702905|NCT04411641|521764878|FG003|OL|Progressive disease|2|||
144702906|NCT04411641|521764875|FG000|OL|Poor compliance to protocol|0|||
144702907|NCT04411641|521764876|FG001|OL|Poor compliance to protocol|0|||
144702908|NCT04411641|521764877|FG002|OL|Poor compliance to protocol|1|||
144702909|NCT04411641|521764878|FG003|OL|Poor compliance to protocol|0|||
144702910|NCT04411641|521764875|FG000|OL|Adverse Event|0|||
144702911|NCT04411641|521764876|FG001|OL|Adverse Event|0|||
144702912|NCT04411641|521764877|FG002|OL|Adverse Event|1|||
144702913|NCT04411641|521764878|FG003|OL|Adverse Event|0|||
144702914|NCT04411641|521764875|FG000|OL|Other|0|||
144702915|NCT04411641|521764876|FG001|OL|Other|0|||
144702916|NCT04411641|521764877|FG002|OL|Other|0|||
144702917|NCT04411641|521764878|FG003|OL|Other|6|||
144702918|NCT00352664|521764888|FG000|Overall Study|Withdrawal by Subject|7|||
144702919|NCT00352664|521764889|FG001|Overall Study|Withdrawal by Subject|0|||
144702920|NCT04410978|521764898|FG000|Overall Study|Poor compliance to protocol|2|||
144702921|NCT04410978|521764899|FG001|Overall Study|Poor compliance to protocol|4|||
144702922|NCT04410978|521764898|FG000|Overall Study|Withdrawal by Subject|64|||
144702923|NCT04410978|521764899|FG001|Overall Study|Withdrawal by Subject|66|||
144702924|NCT04410978|521764898|FG000|Overall Study|Other|6|||
144478234|NCT03573908|520950166|FG003|Treatment Period|Pregnancy|0|||
144478235|NCT03573908|520950167|FG004|Treatment Period|Pregnancy|0|||
144478236|NCT03573908|520950163|FG000|Treatment Period|Other, Not Specified|4|||
144478237|NCT03573908|520950164|FG001|Treatment Period|Other, Not Specified|6|||
144478238|NCT03573908|520950165|FG002|Treatment Period|Other, Not Specified|0|||
144478239|NCT03573908|520950166|FG003|Treatment Period|Other, Not Specified|0|||
144478240|NCT03573908|520950167|FG004|Treatment Period|Other, Not Specified|0|||
144478241|NCT03573908|520950163|FG000|Randomized Withdrawal Period|Adverse Event|0|||
144478242|NCT03573908|520950164|FG001|Randomized Withdrawal Period|Adverse Event|0|||
144478243|NCT03573908|520950165|FG002|Randomized Withdrawal Period|Adverse Event|3|||
144478244|NCT03573908|520950166|FG003|Randomized Withdrawal Period|Adverse Event|0|||
144478245|NCT03573908|520950167|FG004|Randomized Withdrawal Period|Adverse Event|0|||
144478246|NCT03573908|520950163|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144478247|NCT03573908|520950164|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144478248|NCT03573908|520950165|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144478249|NCT03573908|520950166|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144478250|NCT03573908|520950167|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
144478251|NCT03573908|520950163|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
144478252|NCT03573908|520950164|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
144478253|NCT03573908|520950165|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
144478254|NCT03573908|520950166|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
144478255|NCT03573908|520950167|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
144478256|NCT03573908|520950163|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
144478257|NCT03573908|520950164|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
144478258|NCT03573908|520950165|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
144478259|NCT03573908|520950166|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
144478260|NCT03573908|520950167|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
144478261|NCT04006925|520950168|FG000|Overall Study|Side effects|2|||
144478262|NCT04006925|520950169|FG001|Overall Study|Side effects|0|||
144478263|NCT01555164|520950178|FG000|Overall Study|Adverse Event|5|||
144478264|NCT01555164|520950179|FG001|Overall Study|Adverse Event|7|||
144478265|NCT01555164|520950178|FG000|Overall Study|Hyperglycemia|0|||
144478266|NCT01555164|520950179|FG001|Overall Study|Hyperglycemia|1|||
144478267|NCT01555164|520950178|FG000|Overall Study|Investigator's Discretion|2|||
144478268|NCT01555164|520950179|FG001|Overall Study|Investigator's Discretion|2|||
144478269|NCT01555164|520950178|FG000|Overall Study|Lost to Follow-up|4|||
144478270|NCT01555164|520950179|FG001|Overall Study|Lost to Follow-up|3|||
144478271|NCT01555164|520950178|FG000|Overall Study|Protocol Violation|9|||
144478272|NCT01555164|520950179|FG001|Overall Study|Protocol Violation|5|||
144478273|NCT01555164|520950178|FG000|Overall Study|Subject Non-compliance|14|||
144478274|NCT01555164|520950179|FG001|Overall Study|Subject Non-compliance|6|||
144478275|NCT01555164|520950178|FG000|Overall Study|Subject Withdrew Consent|6|||
144478276|NCT01555164|520950179|FG001|Overall Study|Subject Withdrew Consent|11|||
144478277|NCT03443713|520950180|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
144478278|NCT03443713|520950181|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
144478279|NCT03443713|520950182|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
144478280|NCT01672853|520950187|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
144478281|NCT01672853|520950188|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
144478282|NCT01672853|520950189|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
144478283|NCT01672853|520950187|FG000|Overall Study|Pregnancy|0|||
144478284|NCT01672853|520950188|FG001|Overall Study|Pregnancy|1|||
144478285|NCT01672853|520950189|FG002|Overall Study|Pregnancy|0|||
144478286|NCT01672853|520950187|FG000|Overall Study|Investigator's Discretion|1|||
144478287|NCT01672853|520950188|FG001|Overall Study|Investigator's Discretion|0|||
144478288|NCT01672853|520950189|FG002|Overall Study|Investigator's Discretion|0|||
144478289|NCT01672853|520950187|FG000|Overall Study|Withdrew Consent|5|||
144478290|NCT01672853|520950188|FG001|Overall Study|Withdrew Consent|5|||
144478291|NCT01672853|520950189|FG002|Overall Study|Withdrew Consent|5|||
144478292|NCT01672853|520950187|FG000|Overall Study|Adverse Event|4|||
144478293|NCT01672853|520950188|FG001|Overall Study|Adverse Event|6|||
144478294|NCT01672853|520950189|FG002|Overall Study|Adverse Event|8|||
144478295|NCT01672853|520950187|FG000|Overall Study|Lost to Follow-up|0|||
144478296|NCT01672853|520950188|FG001|Overall Study|Lost to Follow-up|1|||
144478297|NCT01672853|520950189|FG002|Overall Study|Lost to Follow-up|0|||
144478298|NCT01672853|520950187|FG000|Overall Study|Randomized but Never Treated|0|||
144478299|NCT01672853|520950188|FG001|Overall Study|Randomized but Never Treated|0|||
144478300|NCT01672853|520950189|FG002|Overall Study|Randomized but Never Treated|1|||
144478301|NCT02969525|520950192|FG000|Double-Blind Period|Adverse Event|0|||
144478302|NCT02969525|520950193|FG001|Double-Blind Period|Adverse Event|0|||
144478303|NCT02969525|520950194|FG002|Double-Blind Period|Adverse Event|1|||
144478304|NCT02969525|520950195|FG003|Double-Blind Period|Adverse Event|1|||
144478305|NCT02969525|520950196|FG004|Double-Blind Period|Adverse Event|0|||
144478306|NCT02969525|520950197|FG005|Double-Blind Period|Adverse Event|0|||
144478307|NCT02969525|520950198|FG006|Double-Blind Period|Adverse Event|0|||
144478308|NCT02969525|520950199|FG007|Double-Blind Period|Adverse Event|0|||
144702925|NCT04410978|521764899|FG001|Overall Study|Other|7|||
144702926|NCT04410978|521764898|FG000|Overall Study|Missing study status|1|||
144702927|NCT04410978|521764899|FG001|Overall Study|Missing study status|0|||
144702928|NCT05554471|521764904|FG000|Overall Study|Physician Decision|2|||
144702929|NCT05554471|521764905|FG001|Overall Study|Physician Decision|1|||
144702930|NCT05554471|521764904|FG000|Overall Study|Lost to Follow-up|2|||
144702931|NCT05554471|521764905|FG001|Overall Study|Lost to Follow-up|1|||
144702932|NCT05554471|521764904|FG000|Overall Study|Death|0|||
144702933|NCT05554471|521764905|FG001|Overall Study|Death|1|||
144702934|NCT02062385|521764909|FG000|Overall Study|Adverse Event|19|||
144702935|NCT02062385|521764910|FG001|Overall Study|Adverse Event|13|||
144702936|NCT02062385|521764911|FG002|Overall Study|Adverse Event|1|||
144702937|NCT02062385|521764912|FG003|Overall Study|Adverse Event|0|||
144702938|NCT02062385|521764909|FG000|Overall Study|Protocol Violation|1|||
144702939|NCT02062385|521764910|FG001|Overall Study|Protocol Violation|0|||
144702940|NCT02062385|521764911|FG002|Overall Study|Protocol Violation|0|||
144702941|NCT02062385|521764912|FG003|Overall Study|Protocol Violation|0|||
144702942|NCT02062385|521764909|FG000|Overall Study|Incomplete EPI by database lock|2|||
144702943|NCT02062385|521764910|FG001|Overall Study|Incomplete EPI by database lock|0|||
144702944|NCT02062385|521764911|FG002|Overall Study|Incomplete EPI by database lock|0|||
144702945|NCT02062385|521764912|FG003|Overall Study|Incomplete EPI by database lock|0|||
144702946|NCT02062385|521764909|FG000|Overall Study|Moved|10|||
144702947|NCT02062385|521764910|FG001|Overall Study|Moved|11|||
144702948|NCT02062385|521764911|FG002|Overall Study|Moved|1|||
144702949|NCT02062385|521764912|FG003|Overall Study|Moved|0|||
144702950|NCT02062385|521764909|FG000|Overall Study|Withdrawn by parent/guardian|46|||
144702951|NCT02062385|521764910|FG001|Overall Study|Withdrawn by parent/guardian|41|||
144702952|NCT02062385|521764911|FG002|Overall Study|Withdrawn by parent/guardian|9|||
144702953|NCT02062385|521764912|FG003|Overall Study|Withdrawn by parent/guardian|8|||
144702954|NCT02062385|521764909|FG000|Overall Study|Death|0|||
144702955|NCT02062385|521764910|FG001|Overall Study|Death|0|||
144702956|NCT02062385|521764911|FG002|Overall Study|Death|0|||
144702957|NCT02062385|521764912|FG003|Overall Study|Death|1|||
144702958|NCT02062385|521764909|FG000|Overall Study|Lost to Follow-up|0|||
144702959|NCT02062385|521764910|FG001|Overall Study|Lost to Follow-up|0|||
144702960|NCT02062385|521764911|FG002|Overall Study|Lost to Follow-up|1|||
144702961|NCT02062385|521764912|FG003|Overall Study|Lost to Follow-up|0|||
144702962|NCT00223990|521764915|FG000|Overall Study|Moved from area|2|||
144702963|NCT00223990|521764916|FG001|Overall Study|Moved from area|1|||
144702964|NCT00223990|521764915|FG000|Overall Study|Withdrawal by Subject|4|||
144702965|NCT00223990|521764916|FG001|Overall Study|Withdrawal by Subject|8|||
144702966|NCT00223990|521764915|FG000|Overall Study|Lost to Follow-up|1|||
144702967|NCT00223990|521764916|FG001|Overall Study|Lost to Follow-up|0|||
144702968|NCT00242567|521766771|FG000|Overall Study|Adverse Event|70|||
144702969|NCT00242567|521766772|FG001|Overall Study|Adverse Event|43|||
144702970|NCT00242567|521766771|FG000|Overall Study|Disease Progression|17|||
144702971|NCT00242567|521766772|FG001|Overall Study|Disease Progression|22|||
144702972|NCT00242567|521766771|FG000|Overall Study|Symptomatic deterioration|9|||
144702973|NCT00242567|521766772|FG001|Overall Study|Symptomatic deterioration|3|||
144702974|NCT00242567|521766771|FG000|Overall Study|Lack of Efficacy|2|||
144702975|NCT00242567|521766772|FG001|Overall Study|Lack of Efficacy|2|||
144702976|NCT00242567|521766771|FG000|Overall Study|Lost to Follow-up|9|||
144702977|NCT00242567|521766772|FG001|Overall Study|Lost to Follow-up|19|||
144478309|NCT02969525|520950200|FG008|Double-Blind Period|Adverse Event|0|||
144478310|NCT02969525|520950201|FG009|Double-Blind Period|Adverse Event|0|||
144478311|NCT02969525|520950202|FG010|Double-Blind Period|Adverse Event|0|||
144478312|NCT02969525|520950203|FG011|Double-Blind Period|Adverse Event|0|||
144478313|NCT02969525|520950192|FG000|Double-Blind Period|LOW EGFR|0|||
144478314|NCT02969525|520950193|FG001|Double-Blind Period|LOW EGFR|0|||
144478315|NCT02969525|520950194|FG002|Double-Blind Period|LOW EGFR|0|||
144478316|NCT02969525|520950195|FG003|Double-Blind Period|LOW EGFR|1|||
144478317|NCT02969525|520950196|FG004|Double-Blind Period|LOW EGFR|0|||
144478318|NCT02969525|520950197|FG005|Double-Blind Period|LOW EGFR|0|||
144478319|NCT02969525|520950198|FG006|Double-Blind Period|LOW EGFR|0|||
144478320|NCT02969525|520950199|FG007|Double-Blind Period|LOW EGFR|0|||
144478321|NCT02969525|520950200|FG008|Double-Blind Period|LOW EGFR|0|||
144478322|NCT02969525|520950201|FG009|Double-Blind Period|LOW EGFR|0|||
144478323|NCT02969525|520950202|FG010|Double-Blind Period|LOW EGFR|0|||
144478324|NCT02969525|520950203|FG011|Double-Blind Period|LOW EGFR|0|||
144478325|NCT02969525|520950192|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
144478326|NCT02969525|520950193|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478327|NCT02969525|520950194|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478328|NCT02969525|520950195|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
144478329|NCT02969525|520950196|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478330|NCT02969525|520950197|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478331|NCT02969525|520950198|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478332|NCT02969525|520950199|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478333|NCT02969525|520950200|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478334|NCT02969525|520950201|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478335|NCT02969525|520950202|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478336|NCT02969525|520950203|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
144478337|NCT02969525|520950192|FG000|Dose-Blind Period|Adverse Event|0|||
144478338|NCT02969525|520950193|FG001|Dose-Blind Period|Adverse Event|0|||
144478339|NCT02969525|520950194|FG002|Dose-Blind Period|Adverse Event|0|||
144478340|NCT02969525|520950195|FG003|Dose-Blind Period|Adverse Event|0|||
144478341|NCT02969525|520950196|FG004|Dose-Blind Period|Adverse Event|0|||
144478342|NCT02969525|520950197|FG005|Dose-Blind Period|Adverse Event|0|||
144478343|NCT02969525|520950198|FG006|Dose-Blind Period|Adverse Event|0|||
144478344|NCT02969525|520950199|FG007|Dose-Blind Period|Adverse Event|0|||
144478345|NCT02969525|520950200|FG008|Dose-Blind Period|Adverse Event|0|||
144478346|NCT02969525|520950201|FG009|Dose-Blind Period|Adverse Event|1|||
144478347|NCT02969525|520950202|FG010|Dose-Blind Period|Adverse Event|1|||
144478348|NCT02969525|520950203|FG011|Dose-Blind Period|Adverse Event|1|||
144478349|NCT02969525|520950192|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
144702978|NCT00242567|521766771|FG000|Overall Study|Withdrawal by Subject|33|||
144702979|NCT00242567|521766772|FG001|Overall Study|Withdrawal by Subject|28|||
144702980|NCT00242567|521766771|FG000|Overall Study|Protocol Violation|12|||
144702981|NCT00242567|521766772|FG001|Overall Study|Protocol Violation|12|||
144702982|NCT00242567|521766771|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
144702983|NCT00242567|521766772|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
144702984|NCT00242567|521766771|FG000|Overall Study|Other|14|||
144702985|NCT00242567|521766772|FG001|Overall Study|Other|9|||
144478350|NCT02969525|520950193|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
144478351|NCT02969525|520950194|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
144478352|NCT02969525|520950195|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
144478353|NCT02969525|520950196|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
144478354|NCT02969525|520950197|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
144478355|NCT02969525|520950198|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
144478356|NCT02969525|520950199|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
144478357|NCT02969525|520950200|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
144478358|NCT02969525|520950201|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
144478359|NCT02969525|520950202|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
144478360|NCT02969525|520950203|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
144478361|NCT02969525|520950192|FG000|Dose-Blind Period|Non-cooperating patient|0|||
144478362|NCT02969525|520950193|FG001|Dose-Blind Period|Non-cooperating patient|0|||
144478363|NCT02969525|520950194|FG002|Dose-Blind Period|Non-cooperating patient|0|||
144478364|NCT02969525|520950195|FG003|Dose-Blind Period|Non-cooperating patient|0|||
144478365|NCT02969525|520950196|FG004|Dose-Blind Period|Non-cooperating patient|0|||
144478366|NCT02969525|520950197|FG005|Dose-Blind Period|Non-cooperating patient|0|||
144478367|NCT02969525|520950198|FG006|Dose-Blind Period|Non-cooperating patient|0|||
144478368|NCT02969525|520950199|FG007|Dose-Blind Period|Non-cooperating patient|0|||
144478369|NCT02969525|520950200|FG008|Dose-Blind Period|Non-cooperating patient|0|||
144478370|NCT02969525|520950201|FG009|Dose-Blind Period|Non-cooperating patient|0|||
144478371|NCT02969525|520950202|FG010|Dose-Blind Period|Non-cooperating patient|0|||
144478372|NCT02969525|520950203|FG011|Dose-Blind Period|Non-cooperating patient|1|||
144478373|NCT02969525|520950192|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478374|NCT02969525|520950193|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478375|NCT02969525|520950194|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478376|NCT02969525|520950195|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478377|NCT02969525|520950196|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478378|NCT02969525|520950197|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478379|NCT02969525|520950198|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478380|NCT02969525|520950199|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478381|NCT02969525|520950200|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478382|NCT02969525|520950201|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478383|NCT02969525|520950202|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
144478384|NCT02969525|520950203|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
144478385|NCT03445065|520950204|FG000|Overall Study|Withdrawal by Subject|3|||
144478386|NCT03445065|520950205|FG001|Overall Study|Withdrawal by Subject|6|||
144478387|NCT03445065|520950206|FG002|Overall Study|Withdrawal by Subject|2|||
144478388|NCT03445065|520950207|FG003|Overall Study|Withdrawal by Subject|2|||
144478389|NCT03445065|520950204|FG000|Overall Study|Other|4|||
144478390|NCT03445065|520950205|FG001|Overall Study|Other|3|||
144478391|NCT03445065|520950206|FG002|Overall Study|Other|3|||
144478392|NCT03445065|520950207|FG003|Overall Study|Other|1|||
144478393|NCT00524030|520950208|FG000|Overall Study|Lack of Efficacy|10|||
144478394|NCT00524030|520950209|FG001|Overall Study|Lack of Efficacy|24|||
144478395|NCT00524030|520950208|FG000|Overall Study|Lost to Follow-up|0|||
144478396|NCT00524030|520950209|FG001|Overall Study|Lost to Follow-up|2|||
144478397|NCT00524030|520950208|FG000|Overall Study|Withdrawal by Subject|3|||
144478398|NCT00524030|520950209|FG001|Overall Study|Withdrawal by Subject|8|||
144478399|NCT00524030|520950208|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
144478400|NCT00524030|520950209|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
144478401|NCT00524030|520950208|FG000|Overall Study|Protocol Violation|0|||
144478402|NCT00524030|520950209|FG001|Overall Study|Protocol Violation|1|||
144478403|NCT00524030|520950208|FG000|Overall Study|Pregnancy|1|||
144478404|NCT00524030|520950209|FG001|Overall Study|Pregnancy|0|||
144478405|NCT00524030|520950208|FG000|Overall Study|Adverse Event|3|||
144478406|NCT00524030|520950209|FG001|Overall Study|Adverse Event|21|||
144478407|NCT00524030|520950208|FG000|Overall Study|Death|0|||
144478408|NCT00524030|520950209|FG001|Overall Study|Death|1|||
144478409|NCT02944656|520950217|FG000|Overall Study|No longer eligible|3|||
144478410|NCT02944656|520950218|FG001|Overall Study|No longer eligible|0|||
144478411|NCT02944656|520950217|FG000|Overall Study|Lost to Follow-up|7|||
144478412|NCT02944656|520950218|FG001|Overall Study|Lost to Follow-up|10|||
144478413|NCT01598298|520950219|FG000|Overall Study|Not eligible|5|||
144478414|NCT01598298|520950220|FG001|Overall Study|Not eligible|5|||
144478415|NCT01598298|520950219|FG000|Overall Study|Adverse Event|21|||
144478416|NCT01598298|520950220|FG001|Overall Study|Adverse Event|19|||
144478417|NCT01598298|520950219|FG000|Overall Study|Progression/relapse|0|||
144478418|NCT01598298|520950220|FG001|Overall Study|Progression/relapse|2|||
144478419|NCT01598298|520950219|FG000|Overall Study|Withdrawal by Subject|10|||
144478420|NCT01598298|520950220|FG001|Overall Study|Withdrawal by Subject|15|||
144478421|NCT01598298|520950219|FG000|Overall Study|Other reason (not protocol specified)|4|||
144478422|NCT01598298|520950220|FG001|Overall Study|Other reason (not protocol specified)|0|||
144478423|NCT02959671|520951664|FG000|Overall Study|Adverse Event|2|||
144478424|NCT02959671|520951664|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
144702986|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
144702987|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
144702988|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
144702989|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
144702990|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
144702991|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
144702992|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
144702993|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
144702994|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
144702995|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
144702996|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
144702997|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
144702998|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
144702999|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
144703000|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
144703001|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
144703002|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
144703003|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
144703004|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
144703005|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
144703006|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
144703007|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
144703008|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
144703009|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
144703010|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
144703011|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
144703012|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
144703013|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
144703014|NCT01299272|521766773|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
144703015|NCT01299272|521766774|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
144703016|NCT01299272|521766775|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
144703017|NCT01299272|521766776|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
144703018|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
144703019|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
144703020|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
144703021|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
144703022|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
144703023|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
144703024|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
144703025|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
144703026|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
144703027|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
144703028|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
144703029|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
144703030|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
144703031|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
144703032|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
144703033|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
144703034|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
144703035|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
144703036|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
144703037|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
144703038|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
144703039|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
144703040|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
144703041|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
144703042|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
144703043|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
144703044|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
144703045|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
144703046|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
144703047|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
144703048|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
144703049|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
144478425|NCT04105972|520951667|FG000|Overall Study|Adverse Event|2|||
144478426|NCT04105972|520951668|FG001|Overall Study|Adverse Event|1|||
144478427|NCT00553202|520951671|FG000|Overall Study|Death|16|||
144478428|NCT00553202|520951671|FG000|Overall Study|Lost to Follow-up|1|||
144478429|NCT00553202|520951671|FG000|Overall Study|Physician Decision|28|||
144478430|NCT00553202|520951671|FG000|Overall Study|Withdrawal by Subject|1|||
144478431|NCT00553202|520951671|FG000|Overall Study|No donor identified|16|||
144478432|NCT00553202|520951671|FG000|Overall Study|Fails to meet organ function|6|||
144478433|NCT03093428|520951675|FG000|Overall Study|Not eligible for treatment|2|||
144478434|NCT03093428|520951676|FG001|Overall Study|Not eligible for treatment|1|||
144478435|NCT03093428|520951675|FG000|Overall Study|Progression|14|||
144478436|NCT03093428|520951676|FG001|Overall Study|Progression|4|||
144478437|NCT03093428|520951675|FG000|Overall Study|Death|1|||
144478438|NCT03093428|520951676|FG001|Overall Study|Death|0|||
144478439|NCT03093428|520951675|FG000|Overall Study|Adverse Event|1|||
144478440|NCT03093428|520951676|FG001|Overall Study|Adverse Event|0|||
144478441|NCT03093428|520951675|FG000|Overall Study|Withdrawal by Subject|1|||
144478442|NCT03093428|520951676|FG001|Overall Study|Withdrawal by Subject|1|||
144478443|NCT03980184|520951677|FG000|Overall Study|Dropped out before treatment|2|||
144478444|NCT03980184|520951678|FG001|Overall Study|Dropped out before treatment|2|||
144478445|NCT03980184|520951677|FG000|Overall Study|Lost to Follow-up|11|||
144478446|NCT03980184|520951678|FG001|Overall Study|Lost to Follow-up|13|||
144478447|NCT02002884|520951679|FG000|Main Period (MP)|Other|0|||
144478448|NCT02002884|520951680|FG001|Main Period (MP)|Other|3|||
144478449|NCT02002884|520951681|FG002|Main Period (MP)|Other|3|||
144478450|NCT02002884|520951682|FG003|Main Period (MP)|Other|0|||
144478451|NCT02002884|520951679|FG000|Main Period (MP)|Adverse Event|0|||
144478452|NCT02002884|520951680|FG001|Main Period (MP)|Adverse Event|1|||
144478453|NCT02002884|520951681|FG002|Main Period (MP)|Adverse Event|1|||
144478454|NCT02002884|520951682|FG003|Main Period (MP)|Adverse Event|0|||
144478455|NCT02002884|520951679|FG000|Main Period (MP)|Withdrawal by Subject|6|||
144478456|NCT02002884|520951680|FG001|Main Period (MP)|Withdrawal by Subject|2|||
144478457|NCT02002884|520951681|FG002|Main Period (MP)|Withdrawal by Subject|2|||
144478458|NCT02002884|520951682|FG003|Main Period (MP)|Withdrawal by Subject|0|||
144478459|NCT02002884|520951679|FG000|Main Period (MP)|Lost to Follow-up|0|||
144478460|NCT02002884|520951680|FG001|Main Period (MP)|Lost to Follow-up|0|||
144478461|NCT02002884|520951681|FG002|Main Period (MP)|Lost to Follow-up|2|||
144478462|NCT02002884|520951682|FG003|Main Period (MP)|Lost to Follow-up|0|||
144478463|NCT02002884|520951679|FG000|Open-Label Extension Period (OLEX)|Other|0|||
144478464|NCT02002884|520951680|FG001|Open-Label Extension Period (OLEX)|Other|0|||
144478465|NCT02002884|520951681|FG002|Open-Label Extension Period (OLEX)|Other|0|||
144478466|NCT02002884|520951682|FG003|Open-Label Extension Period (OLEX)|Other|24|||
144478467|NCT02002884|520951679|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
144478468|NCT02002884|520951680|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
144478469|NCT02002884|520951681|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
144478470|NCT02002884|520951682|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
144478471|NCT02002884|520951679|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
144478472|NCT02002884|520951680|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
144478473|NCT02002884|520951681|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
144478474|NCT02002884|520951682|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
144478475|NCT02002884|520951679|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
144478476|NCT02002884|520951680|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
144478477|NCT02002884|520951681|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
144478478|NCT02002884|520951682|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
144478479|NCT02002884|520951679|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
144478480|NCT02002884|520951680|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
144478481|NCT02002884|520951681|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
144478482|NCT02002884|520951682|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
144478483|NCT02176421|520951683|FG000|Overall Study|Lost to Follow-up|4|||
144478484|NCT02176421|520951683|FG000|Overall Study|Adverse Event|1|||
144478485|NCT02145078|520951684|FG000|Overall Study|Death|1|||
144478486|NCT02145078|520951684|FG000|Overall Study|Reason not given|3|||
144478487|NCT03327402|520951687|FG000|Overall Study|Withdrawal by Subject|1|||
144478488|NCT03327402|520951687|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
144478489|NCT02091739|520951694|FG000|MP: 16 Weeks|Adverse Event|1|||
144478490|NCT02091739|520951695|FG001|MP: 16 Weeks|Adverse Event|1|||
144478491|NCT02091739|520951696|FG002|MP: 16 Weeks|Adverse Event|1|||
144478492|NCT02091739|520951697|FG003|MP: 16 Weeks|Adverse Event|0|||
144478493|NCT02091739|520951698|FG004|MP: 16 Weeks|Adverse Event|0|||
144478494|NCT02091739|520951694|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
144478495|NCT02091739|520951695|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
144478496|NCT02091739|520951696|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
144478497|NCT02091739|520951697|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
144478498|NCT02091739|520951698|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
144478499|NCT02091739|520951694|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
144478500|NCT02091739|520951695|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
144478501|NCT02091739|520951696|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
144478502|NCT02091739|520951697|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
144478503|NCT02091739|520951698|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
144478504|NCT02091739|520951694|FG000|EP: 48 Weeks|Other|0|||
144478505|NCT02091739|520951695|FG001|EP: 48 Weeks|Other|0|||
144478506|NCT02091739|520951696|FG002|EP: 48 Weeks|Other|0|||
144478507|NCT02091739|520951697|FG003|EP: 48 Weeks|Other|1|||
144478508|NCT02091739|520951698|FG004|EP: 48 Weeks|Other|0|||
144478509|NCT02091739|520951694|FG000|EP: 48 Weeks|Death|0|||
144478510|NCT02091739|520951695|FG001|EP: 48 Weeks|Death|0|||
144478511|NCT02091739|520951696|FG002|EP: 48 Weeks|Death|0|||
144478512|NCT02091739|520951697|FG003|EP: 48 Weeks|Death|3|||
144478513|NCT02091739|520951698|FG004|EP: 48 Weeks|Death|2|||
144478514|NCT02091739|520951694|FG000|EP: 48 Weeks|Adverse Event|0|||
144478515|NCT02091739|520951695|FG001|EP: 48 Weeks|Adverse Event|0|||
144478516|NCT02091739|520951696|FG002|EP: 48 Weeks|Adverse Event|0|||
144478517|NCT02091739|520951697|FG003|EP: 48 Weeks|Adverse Event|2|||
144478518|NCT02091739|520951698|FG004|EP: 48 Weeks|Adverse Event|6|||
144478519|NCT02091739|520951694|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
144478520|NCT02091739|520951695|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
144478521|NCT02091739|520951696|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
144478522|NCT02091739|520951697|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
144478523|NCT02091739|520951698|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
144478524|NCT03469349|520951699|FG000|Overall Study|Withdrawal by Subject|1|||
144478525|NCT03469349|520951700|FG001|Overall Study|Withdrawal by Subject|3|||
144478526|NCT03469349|520951699|FG000|Overall Study|Progressive Disease|0|||
144478527|NCT03469349|520951700|FG001|Overall Study|Progressive Disease|1|||
144478528|NCT03469349|520951699|FG000|Overall Study|Lost to Follow-up|2|||
144478529|NCT03469349|520951700|FG001|Overall Study|Lost to Follow-up|2|||
144478530|NCT03469349|520951699|FG000|Overall Study|Adverse Event|2|||
144478531|NCT03469349|520951700|FG001|Overall Study|Adverse Event|4|||
144478532|NCT01617005|520951705|FG000|Overall Study|Pregnancy|1|||
144478533|NCT01617005|520951705|FG000|Overall Study|Lack of motivation for treatment|1|||
144478534|NCT01320735|520951706|FG000|Overall Study|Adverse Event|3|||
144478535|NCT01320735|520951706|FG000|Overall Study|Withdrawal by Subject|3|||
144478536|NCT01320735|520951706|FG000|Overall Study|Lost to Follow-up|13|||
144478537|NCT01320735|520951706|FG000|Overall Study|Administrative Reason|6|||
144478538|NCT01320735|520951706|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
144478539|NCT01320735|520951706|FG000|Overall Study|Protocol Violation|1|||
144478540|NCT01320735|520951706|FG000|Overall Study|Other|1|||
144478541|NCT01320735|520951706|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
144478542|NCT01320735|520951706|FG000|Overall Study|Investigator Unable to be Contacted|17|||
144478543|NCT02307513|520951707|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
144478544|NCT02307513|520951708|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
144478545|NCT02307513|520951707|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
144478546|NCT02307513|520951708|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
144478547|NCT02307513|520951707|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
144478548|NCT02307513|520951708|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
144478549|NCT02307513|520951707|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
144478550|NCT02307513|520951708|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
144478551|NCT02307513|520951707|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
144478552|NCT02307513|520951708|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
144478553|NCT02307513|520951707|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
144478554|NCT02307513|520951708|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
144478555|NCT02307513|520951707|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
144478556|NCT02307513|520951708|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
144478557|NCT02307513|520951707|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
144478558|NCT02307513|520951708|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
144478559|NCT02307513|520951707|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
144478560|NCT02307513|520951708|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
144478561|NCT02307513|520951707|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
144478562|NCT02307513|520951708|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
144478563|NCT02307513|520951707|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
144538191|NCT00146172|521174128|FG006|Overall Study|Adverse Event|3|||
144478564|NCT02307513|520951708|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
144703050|NCT01299272|521766773|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
144703051|NCT01299272|521766774|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
144703052|NCT01299272|521766775|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
144703053|NCT01299272|521766776|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
144703054|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
144703055|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
144703056|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
144703057|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
144703058|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
144703059|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
144703060|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
144703061|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
144703062|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
144703063|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
144703064|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
144703065|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
144703066|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
144703067|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
144703068|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
144703069|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
144703070|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
144703071|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
144703072|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
144703073|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
144703074|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
144703075|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
144703076|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
144703077|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
144703078|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
144703079|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
144703080|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
144703081|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
144703082|NCT01299272|521766773|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
144703083|NCT01299272|521766774|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
144703084|NCT01299272|521766775|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
144703085|NCT01299272|521766776|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
144703086|NCT01721200|521766777|FG000|Overall Study|Lost to Follow-up|3|||
144703087|NCT01721200|521766778|FG001|Overall Study|Lost to Follow-up|5|||
144703088|NCT01513759|521766779|FG000|Overall Study|Protocol Violation|4|||
144703089|NCT01513759|521766779|FG000|Overall Study|Death during catheter placement|1|||
144703090|NCT03606109|521766780|FG000|Overall Study|Lost to Follow-up|2|||
144703091|NCT03606109|521766781|FG001|Overall Study|Lost to Follow-up|1|||
144703092|NCT00630994|521766782|FG000|Overall Study|Adverse Event|1|||
144703093|NCT00630994|521766782|FG000|Overall Study|Disease Progression|1|||
144703094|NCT00630994|521766782|FG000|Overall Study|Lack of Efficacy|1|||
144703095|NCT00630994|521766782|FG000|Overall Study|Other|1|||
144703096|NCT03669640|521766783|FG000|Overall Study|Study Terminated by Sponsor|0|||
144703097|NCT03669640|521766784|FG001|Overall Study|Study Terminated by Sponsor|0|||
144703098|NCT03669640|521766785|FG002|Overall Study|Study Terminated by Sponsor|0|||
144703099|NCT03669640|521766786|FG003|Overall Study|Study Terminated by Sponsor|0|||
144703100|NCT03669640|521766787|FG004|Overall Study|Study Terminated by Sponsor|1|||
144703101|NCT03669640|521766788|FG005|Overall Study|Study Terminated by Sponsor|0|||
144703102|NCT03669640|521766783|FG000|Overall Study|Lost to Follow-up|0|||
144703103|NCT03669640|521766784|FG001|Overall Study|Lost to Follow-up|0|||
144703104|NCT03669640|521766785|FG002|Overall Study|Lost to Follow-up|2|||
144703105|NCT03669640|521766786|FG003|Overall Study|Lost to Follow-up|0|||
144703106|NCT03669640|521766787|FG004|Overall Study|Lost to Follow-up|0|||
144703107|NCT03669640|521766788|FG005|Overall Study|Lost to Follow-up|0|||
144703108|NCT03669640|521766783|FG000|Overall Study|Death|0|||
144703109|NCT03669640|521766784|FG001|Overall Study|Death|0|||
144703110|NCT03669640|521766785|FG002|Overall Study|Death|1|||
144478565|NCT02307513|520951707|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
144703111|NCT03669640|521766786|FG003|Overall Study|Death|0|||
144703112|NCT03669640|521766787|FG004|Overall Study|Death|0|||
144703113|NCT03669640|521766788|FG005|Overall Study|Death|0|||
144703114|NCT03669640|521766783|FG000|Overall Study|Withdrawal by Subject|1|||
144703115|NCT03669640|521766784|FG001|Overall Study|Withdrawal by Subject|2|||
144703116|NCT03669640|521766785|FG002|Overall Study|Withdrawal by Subject|1|||
144703117|NCT03669640|521766786|FG003|Overall Study|Withdrawal by Subject|0|||
144703118|NCT03669640|521766787|FG004|Overall Study|Withdrawal by Subject|1|||
144703119|NCT03669640|521766788|FG005|Overall Study|Withdrawal by Subject|3|||
144478566|NCT02307513|520951708|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
144478567|NCT02307513|520951707|FG000|Long-term Extension|Physician Decision|1|||
144478568|NCT02307513|520951708|FG001|Long-term Extension|Physician Decision|0|||
144478569|NCT05952297|520951710|FG000|Overall Study|Withdrawal by Subject|1|||
144478570|NCT05952297|520951711|FG001|Overall Study|Withdrawal by Subject|0|||
144478571|NCT01225822|520951712|FG000|Overall Study|Adverse Event|13|||
144478572|NCT01225822|520951713|FG001|Overall Study|Adverse Event|31|||
144478573|NCT01225822|520951714|FG002|Overall Study|Adverse Event|18|||
144478574|NCT01225822|520951715|FG003|Overall Study|Adverse Event|23|||
144478575|NCT01225822|520951716|FG004|Overall Study|Adverse Event|14|||
144703120|NCT03669640|521766783|FG000|Overall Study|Protocol Violation|1|||
144703121|NCT03669640|521766784|FG001|Overall Study|Protocol Violation|0|||
144703122|NCT03669640|521766785|FG002|Overall Study|Protocol Violation|0|||
144703123|NCT03669640|521766786|FG003|Overall Study|Protocol Violation|0|||
144703124|NCT03669640|521766787|FG004|Overall Study|Protocol Violation|0|||
144703125|NCT03669640|521766788|FG005|Overall Study|Protocol Violation|0|||
144703126|NCT03669640|521766783|FG000|Overall Study|Physician Decision|0|||
144703127|NCT03669640|521766784|FG001|Overall Study|Physician Decision|2|||
144703128|NCT03669640|521766785|FG002|Overall Study|Physician Decision|0|||
144703129|NCT03669640|521766786|FG003|Overall Study|Physician Decision|0|||
144703130|NCT03669640|521766787|FG004|Overall Study|Physician Decision|0|||
144703131|NCT03669640|521766788|FG005|Overall Study|Physician Decision|0|||
144703132|NCT03669640|521766783|FG000|Overall Study|Disease Relapse|1|||
144703133|NCT03669640|521766784|FG001|Overall Study|Disease Relapse|0|||
144703134|NCT03669640|521766785|FG002|Overall Study|Disease Relapse|0|||
144703135|NCT03669640|521766786|FG003|Overall Study|Disease Relapse|0|||
144703136|NCT03669640|521766787|FG004|Overall Study|Disease Relapse|0|||
144703137|NCT03669640|521766788|FG005|Overall Study|Disease Relapse|0|||
144703138|NCT03669640|521766783|FG000|Overall Study|Adverse Event|2|||
144703139|NCT03669640|521766784|FG001|Overall Study|Adverse Event|1|||
144703140|NCT03669640|521766785|FG002|Overall Study|Adverse Event|0|||
144703141|NCT03669640|521766786|FG003|Overall Study|Adverse Event|0|||
144703142|NCT03669640|521766787|FG004|Overall Study|Adverse Event|1|||
144703143|NCT03669640|521766788|FG005|Overall Study|Adverse Event|0|||
144703144|NCT00366678|521766789|FG000|Infant Series|Withdrawal by Subject|8|||
144703145|NCT00366678|521766790|FG001|Infant Series|Withdrawal by Subject|6|||
144703146|NCT00366678|521766791|FG002|Infant Series|Withdrawal by Subject|0|||
144703147|NCT00366678|521766789|FG000|Infant Series|Protocol Violation|4|||
144703148|NCT00366678|521766790|FG001|Infant Series|Protocol Violation|3|||
144703149|NCT00366678|521766791|FG002|Infant Series|Protocol Violation|0|||
144703150|NCT00366678|521766789|FG000|Infant Series|Failed to return|1|||
144703151|NCT00366678|521766790|FG001|Infant Series|Failed to return|1|||
144703152|NCT00366678|521766791|FG002|Infant Series|Failed to return|0|||
144703153|NCT00366678|521766789|FG000|Infant Series|Adverse Event|1|||
144703154|NCT00366678|521766790|FG001|Infant Series|Adverse Event|0|||
144703155|NCT00366678|521766791|FG002|Infant Series|Adverse Event|0|||
144703156|NCT00366678|521766789|FG000|After Infant|Withdrawal by Subject|8|||
144703157|NCT00366678|521766790|FG001|After Infant|Withdrawal by Subject|4|||
144703158|NCT00366678|521766791|FG002|After Infant|Withdrawal by Subject|0|||
144703159|NCT00366678|521766789|FG000|After Infant|Lost to Follow-up|2|||
144703160|NCT00366678|521766790|FG001|After Infant|Lost to Follow-up|1|||
144703161|NCT00366678|521766791|FG002|After Infant|Lost to Follow-up|0|||
144703162|NCT00366678|521766789|FG000|After Infant|Failed to return|5|||
144703163|NCT00366678|521766790|FG001|After Infant|Failed to return|5|||
144703164|NCT00366678|521766791|FG002|After Infant|Failed to return|0|||
144703165|NCT00366678|521766789|FG000|After Infant|Adverse Event|1|||
144703166|NCT00366678|521766790|FG001|After Infant|Adverse Event|0|||
144703167|NCT00366678|521766791|FG002|After Infant|Adverse Event|0|||
144703168|NCT00366678|521766789|FG000|After Infant|Protocol Violation|1|||
144703169|NCT00366678|521766790|FG001|After Infant|Protocol Violation|0|||
144703170|NCT00366678|521766791|FG002|After Infant|Protocol Violation|0|||
144703171|NCT00366678|521766789|FG000|Toddler Dose|Protocol Violation|2|||
144703172|NCT00366678|521766790|FG001|Toddler Dose|Protocol Violation|1|||
144703173|NCT00366678|521766791|FG002|Toddler Dose|Protocol Violation|0|||
144703174|NCT00366678|521766789|FG000|Toddler Dose|Failed to return|1|||
144478576|NCT01225822|520951712|FG000|Overall Study|Protocol Violation|6|||
144478577|NCT01225822|520951713|FG001|Overall Study|Protocol Violation|8|||
144703175|NCT00366678|521766790|FG001|Toddler Dose|Failed to return|0|||
144703176|NCT00366678|521766791|FG002|Toddler Dose|Failed to return|0|||
144703177|NCT00366678|521766789|FG000|Toddler Dose|Withdrawal by Subject|1|||
144703178|NCT00366678|521766790|FG001|Toddler Dose|Withdrawal by Subject|0|||
144703179|NCT00366678|521766791|FG002|Toddler Dose|Withdrawal by Subject|0|||
144703180|NCT00366678|521766789|FG000|Toddler Dose|protocol deviation|1|||
144703181|NCT00366678|521766790|FG001|Toddler Dose|protocol deviation|0|||
144703182|NCT00366678|521766791|FG002|Toddler Dose|protocol deviation|0|||
144703183|NCT04292171|521766792|FG000|Overall Study|Pharmacy error|2|||
144703184|NCT04292171|521766793|FG001|Overall Study|Pharmacy error|0|||
144703185|NCT04292171|521766792|FG000|Overall Study|Delivered prior to procedure|0|||
144703186|NCT04292171|521766793|FG001|Overall Study|Delivered prior to procedure|1|||
144703187|NCT00826176|521766800|FG000|Overall Study|Lost to Follow-up|1|||
144703188|NCT00826176|521766801|FG001|Overall Study|Lost to Follow-up|0|||
144703189|NCT00826176|521766800|FG000|Overall Study|Subject Withdrew Consent|3|||
144703190|NCT00826176|521766801|FG001|Overall Study|Subject Withdrew Consent|0|||
144703191|NCT00826176|521766800|FG000|Overall Study|Administrative|9|||
144703192|NCT00826176|521766801|FG001|Overall Study|Administrative|0|||
144703193|NCT03079869|521766803|FG000|Overall Study|Adverse Event|6|||
144703194|NCT03079869|521766804|FG001|Overall Study|Adverse Event|8|||
144703195|NCT03079869|521766803|FG000|Overall Study|Withdrawal by Subject|4|||
144703196|NCT03079869|521766804|FG001|Overall Study|Withdrawal by Subject|1|||
144703197|NCT03079869|521766803|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
144478578|NCT01225822|520951714|FG002|Overall Study|Protocol Violation|6|||
144478579|NCT01225822|520951715|FG003|Overall Study|Protocol Violation|7|||
144703198|NCT03079869|521766804|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
144703199|NCT00388674|521766806|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
144703200|NCT00388674|521766807|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
144703201|NCT00388674|521766806|FG000|Initial Treatment|Adverse Event|22|||
144703202|NCT00388674|521766807|FG001|Initial Treatment|Adverse Event|87|||
144703203|NCT00388674|521766806|FG000|Initial Treatment|Death|215|||
144478580|NCT01225822|520951716|FG004|Overall Study|Protocol Violation|4|||
144703204|NCT00388674|521766807|FG001|Initial Treatment|Death|216|||
144703205|NCT00388674|521766806|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
144703206|NCT00388674|521766807|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
144703207|NCT00388674|521766806|FG000|Initial Treatment|HCC|12|||
144703208|NCT00388674|521766807|FG001|Initial Treatment|HCC|20|||
144703209|NCT00388674|521766806|FG000|Initial Treatment|Lost to Follow-up|526|||
144703210|NCT00388674|521766807|FG001|Initial Treatment|Lost to Follow-up|624|||
144703211|NCT00388674|521766806|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
144703212|NCT00388674|521766807|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
144703213|NCT00388674|521766806|FG000|Initial Treatment|Never Treated with Study Medication|1|||
144703214|NCT00388674|521766807|FG001|Initial Treatment|Never Treated with Study Medication|7|||
144703215|NCT00388674|521766806|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
144703216|NCT00388674|521766807|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
144703217|NCT00388674|521766806|FG000|Initial Treatment|Not Defined|125|||
144703218|NCT00388674|521766807|FG001|Initial Treatment|Not Defined|172|||
144703219|NCT00388674|521766806|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
144703220|NCT00388674|521766807|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
144703221|NCT00388674|521766806|FG000|Initial Treatment|Pregnancy|26|||
144703222|NCT00388674|521766807|FG001|Initial Treatment|Pregnancy|16|||
144703223|NCT00388674|521766806|FG000|Initial Treatment|Study Drug Toxicity|5|||
144703224|NCT00388674|521766807|FG001|Initial Treatment|Study Drug Toxicity|92|||
144703225|NCT00388674|521766806|FG000|Initial Treatment|Participant Request|501|||
144703226|NCT00388674|521766807|FG001|Initial Treatment|Participant Request|673|||
144703227|NCT00388674|521766806|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
144703228|NCT00388674|521766807|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
144703229|NCT00388674|521766806|FG000|Initial Treatment|Not Reported|10|||
144703230|NCT00388674|521766807|FG001|Initial Treatment|Not Reported|12|||
144703231|NCT00388674|521766806|FG000|End of Study|Administrative Reason By Sponsor|299|||
144703232|NCT00388674|521766807|FG001|End of Study|Administrative Reason By Sponsor|253|||
144703233|NCT00388674|521766806|FG000|End of Study|Death|239|||
144703234|NCT00388674|521766807|FG001|End of Study|Death|262|||
144703235|NCT00388674|521766806|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
144703236|NCT00388674|521766807|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
144703237|NCT00388674|521766806|FG000|End of Study|HCC|8|||
144703238|NCT00388674|521766807|FG001|End of Study|HCC|7|||
144703239|NCT00388674|521766806|FG000|End of Study|Lost to Follow-up|587|||
144703240|NCT00388674|521766807|FG001|End of Study|Lost to Follow-up|715|||
144703241|NCT00388674|521766806|FG000|End of Study|Malignancy (Non-HCC)|1|||
144703242|NCT00388674|521766807|FG001|End of Study|Malignancy (Non-HCC)|1|||
144703243|NCT00388674|521766806|FG000|End of Study|Non-Study Related Comorbidities|3|||
144703244|NCT00388674|521766807|FG001|End of Study|Non-Study Related Comorbidities|4|||
144703245|NCT00388674|521766806|FG000|End of Study|Not Defined|135|||
144703246|NCT00388674|521766807|FG001|End of Study|Not Defined|214|||
144703247|NCT00388674|521766806|FG000|End of Study|Participant Withdrew Consent|437|||
144703248|NCT00388674|521766807|FG001|End of Study|Participant Withdrew Consent|673|||
144703249|NCT00388674|521766806|FG000|End of Study|No Off-Treatment Status Data|22|||
144703250|NCT00388674|521766807|FG001|End of Study|No Off-Treatment Status Data|30|||
144703251|NCT00388674|521766806|FG000|End of Study|Not Reported|0|||
144703252|NCT00388674|521766807|FG001|End of Study|Not Reported|1|||
144703253|NCT00297882|521766811|FG000|Day 14|Lack of Efficacy|12|||
144703254|NCT00297882|521766812|FG001|Day 14|Lack of Efficacy|49|||
144703255|NCT00297882|521766811|FG000|Day 28|Lost to Follow-up|13|||
144703256|NCT00297882|521766812|FG001|Day 28|Lost to Follow-up|23|||
144703257|NCT00297882|521766811|FG000|Day 28|Lack of Efficacy|3|||
144703258|NCT00297882|521766812|FG001|Day 28|Lack of Efficacy|0|||
144703259|NCT04242264|521766813|FG000|Overall Study|Lost to Follow-up|2|||
144703260|NCT04242264|521766814|FG001|Overall Study|Lost to Follow-up|2|||
144703261|NCT04242264|521766815|FG002|Overall Study|Lost to Follow-up|1|||
144703262|NCT04242264|521766816|FG003|Overall Study|Lost to Follow-up|1|||
144703263|NCT04242264|521766813|FG000|Overall Study|Withdrawal by Subject|1|||
144703264|NCT04242264|521766814|FG001|Overall Study|Withdrawal by Subject|0|||
144703265|NCT04242264|521766815|FG002|Overall Study|Withdrawal by Subject|0|||
144703266|NCT04242264|521766816|FG003|Overall Study|Withdrawal by Subject|0|||
144703267|NCT00848965|521766819|FG000|Overall Study|Adverse Event|1|||
144703268|NCT00848965|521766819|FG000|Overall Study|Withdrawal by Subject|1|||
144703269|NCT06067191|521766827|FG000|Overall Study|Withdrawal by Subject|0|||
144703270|NCT06067191|521766828|FG001|Overall Study|Withdrawal by Subject|1|||
144703271|NCT01833897|521766835|FG000|Overall Study|Lack of Efficacy|1|||
144703272|NCT02860039|521766836|FG000|Overall Study|Death|4|||
144703273|NCT02860039|521766837|FG001|Overall Study|Death|0|||
144703274|NCT02860039|521766836|FG000|Overall Study|Lost to Follow-up|2|||
144703275|NCT02860039|521766837|FG001|Overall Study|Lost to Follow-up|2|||
144703276|NCT02860039|521766836|FG000|Overall Study|Protocol Violation|3|||
144703277|NCT02860039|521766837|FG001|Overall Study|Protocol Violation|1|||
144703278|NCT02860039|521766836|FG000|Overall Study|Withdrawal by Subject|1|||
144703279|NCT02860039|521766837|FG001|Overall Study|Withdrawal by Subject|0|||
144703280|NCT02860039|521766836|FG000|Overall Study|Not otherwise eligible|1|||
144362385|NCT02702492|520535196|FG011|Overall Study|Other|0|||
144478581|NCT01225822|520951712|FG000|Overall Study|Lost to Follow-up|0|||
144703281|NCT02860039|521766837|FG001|Overall Study|Not otherwise eligible|1|||
144703282|NCT00669110|521766838|FG000|Overall Study|Adverse Event|4|||
144478582|NCT01225822|520951713|FG001|Overall Study|Lost to Follow-up|0|||
144478583|NCT01225822|520951714|FG002|Overall Study|Lost to Follow-up|0|||
144247703|NCT02407054|520104196|FG001|Overall Study|Withdrawal by Subject|9|||
144478584|NCT01225822|520951715|FG003|Overall Study|Lost to Follow-up|1|||
144478585|NCT01225822|520951716|FG004|Overall Study|Lost to Follow-up|0|||
144478586|NCT01225822|520951712|FG000|Overall Study|Withdrawal by Subject|6|||
144478587|NCT01225822|520951713|FG001|Overall Study|Withdrawal by Subject|7|||
144478588|NCT01225822|520951714|FG002|Overall Study|Withdrawal by Subject|7|||
144478589|NCT01225822|520951715|FG003|Overall Study|Withdrawal by Subject|11|||
144478590|NCT01225822|520951716|FG004|Overall Study|Withdrawal by Subject|6|||
144362386|NCT02702492|520535197|FG012|Overall Study|Other|1|||
144471618|NCT00246337|520925259|FG007|Overall Study|Protocol Violation|1|||
144471619|NCT00246337|520925260|FG008|Overall Study|Protocol Violation|0|||
144471620|NCT00246337|520925252|FG000|Overall Study|Withdrawal by Subject|2|||
144471621|NCT00246337|520925253|FG001|Overall Study|Withdrawal by Subject|0|||
144471622|NCT00246337|520925254|FG002|Overall Study|Withdrawal by Subject|0|||
144471623|NCT00246337|520925255|FG003|Overall Study|Withdrawal by Subject|0|||
144471624|NCT00246337|520925256|FG004|Overall Study|Withdrawal by Subject|0|||
144471625|NCT00246337|520925257|FG005|Overall Study|Withdrawal by Subject|0|||
144471626|NCT00246337|520925258|FG006|Overall Study|Withdrawal by Subject|1|||
144471627|NCT00246337|520925259|FG007|Overall Study|Withdrawal by Subject|1|||
144471628|NCT00246337|520925260|FG008|Overall Study|Withdrawal by Subject|0|||
144471629|NCT00246337|520925252|FG000|Overall Study|Lack of Qualifying Event|8|||
144471630|NCT00246337|520925253|FG001|Overall Study|Lack of Qualifying Event|2|||
144471631|NCT00246337|520925254|FG002|Overall Study|Lack of Qualifying Event|1|||
144471632|NCT00246337|520925255|FG003|Overall Study|Lack of Qualifying Event|1|||
144471633|NCT00246337|520925256|FG004|Overall Study|Lack of Qualifying Event|1|||
144471634|NCT00246337|520925257|FG005|Overall Study|Lack of Qualifying Event|3|||
144471635|NCT00246337|520925258|FG006|Overall Study|Lack of Qualifying Event|3|||
144471636|NCT00246337|520925259|FG007|Overall Study|Lack of Qualifying Event|2|||
144471637|NCT00246337|520925260|FG008|Overall Study|Lack of Qualifying Event|5|||
144471638|NCT00246337|520925252|FG000|Overall Study|Site Terminated|10|||
144471639|NCT00246337|520925253|FG001|Overall Study|Site Terminated|0|||
144471640|NCT00246337|520925254|FG002|Overall Study|Site Terminated|0|||
144471641|NCT00246337|520925255|FG003|Overall Study|Site Terminated|0|||
144471642|NCT00246337|520925256|FG004|Overall Study|Site Terminated|0|||
144471643|NCT00246337|520925257|FG005|Overall Study|Site Terminated|7|||
144471644|NCT00246337|520925258|FG006|Overall Study|Site Terminated|1|||
144471645|NCT00246337|520925259|FG007|Overall Study|Site Terminated|6|||
144471646|NCT00246337|520925260|FG008|Overall Study|Site Terminated|2|||
144471647|NCT00246337|520925252|FG000|Overall Study|Abnormal baseline lab values|7|||
144471648|NCT00246337|520925253|FG001|Overall Study|Abnormal baseline lab values|0|||
144471649|NCT00246337|520925254|FG002|Overall Study|Abnormal baseline lab values|2|||
144471650|NCT00246337|520925255|FG003|Overall Study|Abnormal baseline lab values|0|||
144471651|NCT00246337|520925256|FG004|Overall Study|Abnormal baseline lab values|0|||
144471652|NCT00246337|520925257|FG005|Overall Study|Abnormal baseline lab values|2|||
144471653|NCT00246337|520925258|FG006|Overall Study|Abnormal baseline lab values|2|||
144471654|NCT00246337|520925259|FG007|Overall Study|Abnormal baseline lab values|0|||
144471655|NCT00246337|520925260|FG008|Overall Study|Abnormal baseline lab values|4|||
144471656|NCT00246337|520925252|FG000|Overall Study|Overwhelmed|0|||
144471657|NCT00246337|520925253|FG001|Overall Study|Overwhelmed|0|||
144471658|NCT00246337|520925254|FG002|Overall Study|Overwhelmed|0|||
144471659|NCT00246337|520925255|FG003|Overall Study|Overwhelmed|0|||
144471660|NCT00246337|520925256|FG004|Overall Study|Overwhelmed|0|||
144471661|NCT00246337|520925257|FG005|Overall Study|Overwhelmed|1|||
144471662|NCT00246337|520925258|FG006|Overall Study|Overwhelmed|0|||
144471663|NCT00246337|520925259|FG007|Overall Study|Overwhelmed|0|||
144471664|NCT00246337|520925260|FG008|Overall Study|Overwhelmed|0|||
144471665|NCT00246337|520925252|FG000|Overall Study|Protocol Violator|1|||
144471666|NCT00246337|520925253|FG001|Overall Study|Protocol Violator|0|||
144471667|NCT00246337|520925254|FG002|Overall Study|Protocol Violator|0|||
144471668|NCT00246337|520925255|FG003|Overall Study|Protocol Violator|0|||
144471669|NCT00246337|520925256|FG004|Overall Study|Protocol Violator|0|||
144471670|NCT00246337|520925257|FG005|Overall Study|Protocol Violator|0|||
144471671|NCT00246337|520925258|FG006|Overall Study|Protocol Violator|0|||
144471672|NCT00246337|520925259|FG007|Overall Study|Protocol Violator|0|||
144471673|NCT00246337|520925260|FG008|Overall Study|Protocol Violator|0|||
144478591|NCT01225822|520951712|FG000|Overall Study|Other|13|||
144478592|NCT01225822|520951713|FG001|Overall Study|Other|10|||
144471674|NCT00246337|520925252|FG000|Overall Study|Reported as completing trial in error|0|||
144471675|NCT00246337|520925253|FG001|Overall Study|Reported as completing trial in error|0|||
144471676|NCT00246337|520925254|FG002|Overall Study|Reported as completing trial in error|0|||
144478593|NCT01225822|520951714|FG002|Overall Study|Other|7|||
144471677|NCT00246337|520925255|FG003|Overall Study|Reported as completing trial in error|0|||
144471678|NCT00246337|520925256|FG004|Overall Study|Reported as completing trial in error|0|||
144471679|NCT00246337|520925257|FG005|Overall Study|Reported as completing trial in error|0|||
144478594|NCT01225822|520951715|FG003|Overall Study|Other|10|||
144478595|NCT01225822|520951716|FG004|Overall Study|Other|7|||
144478596|NCT01290822|520951717|FG000|Overall Study|Withdrawal by Subject|1|||
144478597|NCT01290822|520951717|FG000|Overall Study|Physician Decision|10|||
144478598|NCT02541383|520951718|FG000|Overall Study|Death|50|||
144478599|NCT02541383|520951719|FG001|Overall Study|Death|37|||
144478600|NCT02541383|520951720|FG002|Overall Study|Death|48|||
144478601|NCT02541383|520951721|FG003|Overall Study|Death|41|||
144478602|NCT02541383|520951722|FG004|Overall Study|Death|21|||
144478603|NCT02541383|520951723|FG005|Overall Study|Death|25|||
144478604|NCT02541383|520951718|FG000|Overall Study|Lost to Follow-up|5|||
144478605|NCT02541383|520951719|FG001|Overall Study|Lost to Follow-up|3|||
144478606|NCT02541383|520951720|FG002|Overall Study|Lost to Follow-up|1|||
144478607|NCT02541383|520951721|FG003|Overall Study|Lost to Follow-up|1|||
144478608|NCT02541383|520951722|FG004|Overall Study|Lost to Follow-up|3|||
144478609|NCT02541383|520951723|FG005|Overall Study|Lost to Follow-up|0|||
144478610|NCT02541383|520951718|FG000|Overall Study|Consent withdrawn|5|||
144478611|NCT02541383|520951719|FG001|Overall Study|Consent withdrawn|6|||
144478612|NCT02541383|520951720|FG002|Overall Study|Consent withdrawn|1|||
144478613|NCT02541383|520951721|FG003|Overall Study|Consent withdrawn|1|||
144478614|NCT02541383|520951722|FG004|Overall Study|Consent withdrawn|0|||
144478615|NCT02541383|520951723|FG005|Overall Study|Consent withdrawn|0|||
144478616|NCT02541383|520951718|FG000|Overall Study|Sponsor's decision|1|||
144478617|NCT02541383|520951719|FG001|Overall Study|Sponsor's decision|1|||
144478618|NCT02541383|520951720|FG002|Overall Study|Sponsor's decision|0|||
144478619|NCT02541383|520951721|FG003|Overall Study|Sponsor's decision|0|||
144478620|NCT02541383|520951722|FG004|Overall Study|Sponsor's decision|0|||
144478621|NCT02541383|520951723|FG005|Overall Study|Sponsor's decision|0|||
144478622|NCT02487095|520951729|FG000|Dose Expansion|Unable to scan/restage participant|0|||
144478623|NCT02487095|520951730|FG001|Dose Expansion|Unable to scan/restage participant|0|||
144362387|NCT00781768|520536874|FG000|Overall Study|Not transplanted.|0|||
144362388|NCT00781768|520536875|FG001|Overall Study|Not transplanted.|2|||
144362389|NCT04944992|520536878|FG000|Overall Study|Lost to Follow-up|1|||
144362390|NCT04944992|520536879|FG001|Overall Study|Lost to Follow-up|1|||
144362391|NCT04944992|520536878|FG000|Overall Study|Physician Decision|1|||
144362392|NCT04944992|520536879|FG001|Overall Study|Physician Decision|0|||
144538192|NCT00146172|521174129|FG007|Overall Study|Adverse Event|10|||
144703283|NCT00669110|521766839|FG001|Overall Study|Adverse Event|3|||
144703284|NCT00669110|521766838|FG000|Overall Study|Caregiver request|3|||
144703285|NCT00669110|521766839|FG001|Overall Study|Caregiver request|2|||
144703286|NCT00669110|521766838|FG000|Overall Study|Physician Decision|0|||
144703287|NCT00669110|521766839|FG001|Overall Study|Physician Decision|1|||
144703288|NCT00669110|521766838|FG000|Overall Study|Lost to Follow-up|1|||
144703289|NCT00669110|521766839|FG001|Overall Study|Lost to Follow-up|0|||
144703290|NCT00669110|521766838|FG000|Overall Study|Protocol Violation|0|||
144703291|NCT00669110|521766839|FG001|Overall Study|Protocol Violation|5|||
144703292|NCT00669110|521766838|FG000|Overall Study|Withdrawal by Subject|0|||
144703293|NCT00669110|521766839|FG001|Overall Study|Withdrawal by Subject|2|||
144703294|NCT01244516|521766840|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
144703295|NCT01244516|521766841|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
144703296|NCT01244516|521766842|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
144703297|NCT01244516|521766840|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
144703298|NCT01244516|521766841|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
144703299|NCT01244516|521766842|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
144703300|NCT01244516|521766840|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
144703301|NCT01244516|521766841|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
144703302|NCT01244516|521766842|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
144703303|NCT01244516|521766840|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
144703304|NCT01244516|521766841|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
144703305|NCT01244516|521766842|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
144703306|NCT01244516|521766840|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
144703307|NCT01244516|521766841|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
144703308|NCT01244516|521766842|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
144703309|NCT01244516|521766840|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
144703310|NCT01244516|521766841|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
144703311|NCT01244516|521766842|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
144703312|NCT01244516|521766840|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
144703313|NCT01244516|521766841|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
144703314|NCT01244516|521766842|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
144703315|NCT01102972|521766846|FG000|Overall Study|Adverse Event|8|||
144703316|NCT01102972|521766847|FG001|Overall Study|Adverse Event|2|||
144703317|NCT01102972|521766846|FG000|Overall Study|Lack of Efficacy|2|||
144703318|NCT01102972|521766847|FG001|Overall Study|Lack of Efficacy|1|||
144703319|NCT01102972|521766846|FG000|Overall Study|Protocol Violation|1|||
144703320|NCT01102972|521766847|FG001|Overall Study|Protocol Violation|0|||
144703321|NCT01102972|521766846|FG000|Overall Study|Lost to Follow-up|10|||
144703322|NCT01102972|521766847|FG001|Overall Study|Lost to Follow-up|5|||
144703323|NCT01102972|521766846|FG000|Overall Study|Investigator Discretion|2|||
144703324|NCT01102972|521766847|FG001|Overall Study|Investigator Discretion|0|||
144703325|NCT01102972|521766846|FG000|Overall Study|Withdrawal by Subject|6|||
144703326|NCT01102972|521766847|FG001|Overall Study|Withdrawal by Subject|6|||
144703327|NCT01856257|521766851|FG000|Overall Study|Death|2|||
144703328|NCT01856257|521766852|FG001|Overall Study|Death|0|||
144703329|NCT01856257|521766853|FG002|Overall Study|Death|0|||
144703330|NCT01856257|521766854|FG003|Overall Study|Death|0|||
144703331|NCT01856257|521766851|FG000|Overall Study|Physician Decision|0|||
144703332|NCT01856257|521766852|FG001|Overall Study|Physician Decision|0|||
144703333|NCT01856257|521766853|FG002|Overall Study|Physician Decision|0|||
144703334|NCT01856257|521766854|FG003|Overall Study|Physician Decision|1|||
144703335|NCT01856257|521766851|FG000|Overall Study|Withdrawal by Subject|1|||
144703336|NCT01856257|521766852|FG001|Overall Study|Withdrawal by Subject|1|||
144703337|NCT01856257|521766853|FG002|Overall Study|Withdrawal by Subject|0|||
144703338|NCT01856257|521766854|FG003|Overall Study|Withdrawal by Subject|0|||
144703339|NCT01856257|521766851|FG000|Overall Study|Donor complication|0|||
144703340|NCT01856257|521766852|FG001|Overall Study|Donor complication|0|||
144703341|NCT01856257|521766853|FG002|Overall Study|Donor complication|0|||
144703342|NCT01856257|521766854|FG003|Overall Study|Donor complication|1|||
144703343|NCT03664024|521766855|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
144703344|NCT03664024|521766855|FG000|Overall Study|Lost to Follow-up|2|||
144703345|NCT03664024|521766855|FG000|Overall Study|Withdrawal by Subject|2|||
144703346|NCT03664024|521766855|FG000|Overall Study|Death|80|||
144703347|NCT01157065|521766856|FG000|Overall Study|Death|0|||
144703348|NCT01157065|521766857|FG001|Overall Study|Death|1|||
144703349|NCT05275673|521766860|FG000|Overall Study|Study Termination by Sponsor|2|||
144703350|NCT05275673|521766861|FG001|Overall Study|Study Termination by Sponsor|3|||
144703351|NCT05275673|521766860|FG000|Overall Study|Death|1|||
144362393|NCT04944992|520536878|FG000|Overall Study|Withdrawal by Subject|6|||
144362394|NCT04944992|520536879|FG001|Overall Study|Withdrawal by Subject|1|||
144362395|NCT01295814|520536880|FG000|Overall Study|Lack of Efficacy|0|||
144362396|NCT01295814|520536881|FG001|Overall Study|Lack of Efficacy|2|||
144362397|NCT01295814|520536880|FG000|Overall Study|Withdrawal by Subject|2|||
144362398|NCT01295814|520536881|FG001|Overall Study|Withdrawal by Subject|0|||
144362399|NCT00303069|520536882|FG000|Overall Study|Lost to Follow-up|1|||
144362400|NCT00303069|520536883|FG001|Overall Study|Lost to Follow-up|0|||
144362401|NCT00303069|520536884|FG002|Overall Study|Lost to Follow-up|0|||
144478624|NCT02487095|520951731|FG002|Dose Expansion|Unable to scan/restage participant|0|||
144478625|NCT02487095|520951732|FG003|Dose Expansion|Unable to scan/restage participant|0|||
144478626|NCT02487095|520951733|FG004|Dose Expansion|Unable to scan/restage participant|1|||
144478627|NCT03108157|520951736|FG000|Overall Study|Protocol Violation|15|||
144478628|NCT03108157|520951737|FG001|Overall Study|Protocol Violation|4|||
144478629|NCT01279343|520951740|FG000|Overall Study|Did not receive treatment|2|||
144478630|NCT01279343|520951741|FG001|Overall Study|Did not receive treatment|6|||
144362402|NCT00303069|520536885|FG003|Overall Study|Lost to Follow-up|2|||
144362403|NCT00303069|520536882|FG000|Overall Study|subject moved|1|||
144362404|NCT00303069|520536883|FG001|Overall Study|subject moved|0|||
144362405|NCT00303069|520536884|FG002|Overall Study|subject moved|0|||
144362406|NCT00303069|520536885|FG003|Overall Study|subject moved|0|||
144362407|NCT00303069|520536882|FG000|Overall Study|Recruitment into Army Reserves|0|||
144362408|NCT00303069|520536883|FG001|Overall Study|Recruitment into Army Reserves|0|||
144362409|NCT00303069|520536884|FG002|Overall Study|Recruitment into Army Reserves|1|||
144362410|NCT00303069|520536885|FG003|Overall Study|Recruitment into Army Reserves|0|||
144362411|NCT01972217|520536886|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
144362412|NCT01972217|520536887|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
144362413|NCT01972217|520536888|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
144362414|NCT01972217|520536889|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
144362415|NCT01972217|520536886|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
144362416|NCT01972217|520536887|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
144362417|NCT01972217|520536888|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
144362418|NCT01972217|520536889|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
144362419|NCT01972217|520536886|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
144362420|NCT01972217|520536887|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
144362421|NCT01972217|520536888|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
144362422|NCT01972217|520536889|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
144362423|NCT01972217|520536886|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
144362424|NCT01972217|520536887|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
144362425|NCT01972217|520536888|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
144362426|NCT01972217|520536889|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
144362427|NCT01972217|520536886|FG000|Part B Double-blind, Randomised Period|Death|0|||
144362428|NCT01972217|520536887|FG001|Part B Double-blind, Randomised Period|Death|0|||
144362429|NCT01972217|520536888|FG002|Part B Double-blind, Randomised Period|Death|43|||
144362430|NCT01972217|520536889|FG003|Part B Double-blind, Randomised Period|Death|44|||
144362431|NCT01972217|520536886|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
144362432|NCT01972217|520536887|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
144362433|NCT01972217|520536888|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
144362434|NCT01972217|520536889|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
144362435|NCT01972217|520536886|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
144362436|NCT01972217|520536887|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
144362437|NCT01972217|520536888|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
144362438|NCT01972217|520536889|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
144478631|NCT04534114|520951742|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
144478632|NCT04534114|520951743|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
144478633|NCT04534114|520951744|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
144478634|NCT04534114|520951745|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
144362439|NCT01972217|520536886|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
144362440|NCT01972217|520536887|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
144362441|NCT01972217|520536888|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
144362442|NCT01972217|520536889|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
144362443|NCT01972217|520536886|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
144362444|NCT01972217|520536887|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
144362445|NCT01972217|520536888|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
144362446|NCT01972217|520536889|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
144362447|NCT02318706|520536892|FG000|Double-blind Phase|Adverse Event|7|||
144362448|NCT02318706|520536893|FG001|Double-blind Phase|Adverse Event|4|||
144362449|NCT02318706|520536894|FG002|Double-blind Phase|Adverse Event|3|||
144362450|NCT02318706|520536895|FG003|Double-blind Phase|Adverse Event|10|||
144362451|NCT02318706|520536896|FG004|Double-blind Phase|Adverse Event|0|||
144362452|NCT02318706|520536892|FG000|Double-blind Phase|Lost to Follow-up|1|||
144362453|NCT02318706|520536893|FG001|Double-blind Phase|Lost to Follow-up|0|||
144362454|NCT02318706|520536894|FG002|Double-blind Phase|Lost to Follow-up|0|||
144362455|NCT02318706|520536895|FG003|Double-blind Phase|Lost to Follow-up|0|||
144362456|NCT02318706|520536896|FG004|Double-blind Phase|Lost to Follow-up|0|||
144362457|NCT02318706|520536892|FG000|Double-blind Phase|Protocol Violation|4|||
144362458|NCT02318706|520536893|FG001|Double-blind Phase|Protocol Violation|2|||
144362459|NCT02318706|520536894|FG002|Double-blind Phase|Protocol Violation|4|||
144362460|NCT02318706|520536895|FG003|Double-blind Phase|Protocol Violation|3|||
144362461|NCT02318706|520536896|FG004|Double-blind Phase|Protocol Violation|0|||
144362462|NCT02318706|520536892|FG000|Double-blind Phase|Withdrawal by Subject|9|||
144362463|NCT02318706|520536893|FG001|Double-blind Phase|Withdrawal by Subject|5|||
144362464|NCT02318706|520536894|FG002|Double-blind Phase|Withdrawal by Subject|7|||
144362465|NCT02318706|520536895|FG003|Double-blind Phase|Withdrawal by Subject|10|||
144362466|NCT02318706|520536896|FG004|Double-blind Phase|Withdrawal by Subject|0|||
144362467|NCT02318706|520536892|FG000|Double-blind Phase|Other|4|||
144362468|NCT02318706|520536893|FG001|Double-blind Phase|Other|1|||
144362469|NCT02318706|520536894|FG002|Double-blind Phase|Other|2|||
144362470|NCT02318706|520536895|FG003|Double-blind Phase|Other|1|||
144362471|NCT02318706|520536896|FG004|Double-blind Phase|Other|0|||
144362472|NCT02318706|520536892|FG000|Double-blind Phase|Death|0|||
144362473|NCT02318706|520536893|FG001|Double-blind Phase|Death|0|||
144362474|NCT02318706|520536894|FG002|Double-blind Phase|Death|2|||
144362475|NCT02318706|520536895|FG003|Double-blind Phase|Death|0|||
144362476|NCT02318706|520536896|FG004|Double-blind Phase|Death|0|||
144362477|NCT02318706|520536892|FG000|Open-label Extension Phase|Adverse Event|0|||
144362478|NCT02318706|520536893|FG001|Open-label Extension Phase|Adverse Event|0|||
144362479|NCT02318706|520536894|FG002|Open-label Extension Phase|Adverse Event|0|||
144362480|NCT02318706|520536895|FG003|Open-label Extension Phase|Adverse Event|0|||
144362481|NCT02318706|520536896|FG004|Open-label Extension Phase|Adverse Event|21|||
144362482|NCT02318706|520536892|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
144362483|NCT02318706|520536893|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
144362484|NCT02318706|520536894|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
144362485|NCT02318706|520536895|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
144362486|NCT02318706|520536896|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
144362487|NCT02318706|520536892|FG000|Open-label Extension Phase|Death|0|||
144362488|NCT02318706|520536893|FG001|Open-label Extension Phase|Death|0|||
144362489|NCT02318706|520536894|FG002|Open-label Extension Phase|Death|0|||
144478635|NCT04534114|520951742|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
144478636|NCT04534114|520951743|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
144478637|NCT04534114|520951744|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
144478638|NCT04534114|520951745|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
144478639|NCT04534114|520951742|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
144478640|NCT04534114|520951743|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
144478641|NCT04534114|520951744|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
144478642|NCT04534114|520951745|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
144478643|NCT04534114|520951742|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
144478644|NCT04534114|520951743|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
144362490|NCT02318706|520536895|FG003|Open-label Extension Phase|Death|0|||
144362491|NCT02318706|520536896|FG004|Open-label Extension Phase|Death|1|||
144362492|NCT02318706|520536892|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
144362493|NCT02318706|520536893|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
144362494|NCT02318706|520536894|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
144362495|NCT02318706|520536895|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
144362496|NCT02318706|520536896|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
144362497|NCT01456039|520536897|FG000|Phase 1 (First Step)|Disease Progression|1|||
144478645|NCT04534114|520951744|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
144478646|NCT04534114|520951745|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
144703352|NCT05275673|521766861|FG001|Overall Study|Death|0|||
144362498|NCT01456039|520536898|FG001|Phase 1 (First Step)|Disease Progression|1|||
144362499|NCT01456039|520536899|FG002|Phase 1 (First Step)|Disease Progression|0|||
144362500|NCT01456039|520536897|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
144362501|NCT01456039|520536898|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
144362502|NCT01456039|520536899|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
144362503|NCT01456039|520536897|FG000|Phase 1 (First Step)|Adverse Event|0|||
144362504|NCT01456039|520536898|FG001|Phase 1 (First Step)|Adverse Event|3|||
144362505|NCT01456039|520536899|FG002|Phase 1 (First Step)|Adverse Event|0|||
144362506|NCT01456039|520536897|FG000|Phase 1 (First Step)|Other|0|||
144362507|NCT01456039|520536898|FG001|Phase 1 (First Step)|Other|1|||
144362508|NCT01456039|520536899|FG002|Phase 1 (First Step)|Other|0|||
144362509|NCT01456039|520536897|FG000|Phase 2 (Second Step)|Disease Progression|0|||
144362510|NCT01456039|520536898|FG001|Phase 2 (Second Step)|Disease Progression|0|||
144362511|NCT01456039|520536899|FG002|Phase 2 (Second Step)|Disease Progression|17|||
144362512|NCT01456039|520536897|FG000|Phase 2 (Second Step)|Adverse Event|0|||
144362513|NCT01456039|520536898|FG001|Phase 2 (Second Step)|Adverse Event|0|||
144362514|NCT01456039|520536899|FG002|Phase 2 (Second Step)|Adverse Event|10|||
144362515|NCT01456039|520536897|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
144362516|NCT01456039|520536898|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
144362517|NCT01456039|520536899|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
144362518|NCT01456039|520536897|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
144362519|NCT01456039|520536898|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
144362520|NCT01456039|520536899|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
144362521|NCT01456039|520536897|FG000|Phase 2 (Second Step)|Other|0|||
144362522|NCT01456039|520536898|FG001|Phase 2 (Second Step)|Other|0|||
144362523|NCT01456039|520536899|FG002|Phase 2 (Second Step)|Other|1|||
144362524|NCT00335777|520536902|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
144362525|NCT00335777|520536902|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
144362526|NCT00335777|520536902|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
144362527|NCT00335777|520536902|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
144362528|NCT00335777|520536902|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
144362529|NCT04106557|520536906|FG000|Overall Study|Physician Decision|0|||
144362530|NCT04106557|520536907|FG001|Overall Study|Physician Decision|1|||
144362531|NCT04106557|520536908|FG002|Overall Study|Physician Decision|0|||
144362532|NCT04106557|520536906|FG000|Overall Study|Protocol Violation|0|||
144362533|NCT04106557|520536907|FG001|Overall Study|Protocol Violation|1|||
144362534|NCT04106557|520536908|FG002|Overall Study|Protocol Violation|0|||
144362535|NCT03714672|520536913|FG000|Overall Study|Adverse Event|0|||
144362536|NCT03714672|520536914|FG001|Overall Study|Adverse Event|0|||
144362537|NCT03714672|520536915|FG002|Overall Study|Adverse Event|3|||
144362538|NCT03714672|520536916|FG003|Overall Study|Adverse Event|0|||
144362539|NCT03714672|520536913|FG000|Overall Study|Physician Decision|0|||
144362540|NCT03714672|520536914|FG001|Overall Study|Physician Decision|1|||
144362541|NCT03714672|520536915|FG002|Overall Study|Physician Decision|0|||
144362542|NCT03714672|520536916|FG003|Overall Study|Physician Decision|0|||
144362543|NCT03714672|520536913|FG000|Overall Study|Other Reason|1|||
144362544|NCT03714672|520536914|FG001|Overall Study|Other Reason|2|||
144362545|NCT03714672|520536915|FG002|Overall Study|Other Reason|1|||
144362546|NCT03714672|520536916|FG003|Overall Study|Other Reason|1|||
144362547|NCT03714672|520536913|FG000|Overall Study|Lost to Follow-up|1|||
144362548|NCT03714672|520536914|FG001|Overall Study|Lost to Follow-up|1|||
144362549|NCT03714672|520536915|FG002|Overall Study|Lost to Follow-up|0|||
144362550|NCT03714672|520536916|FG003|Overall Study|Lost to Follow-up|0|||
144362551|NCT01054885|520536917|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
144362552|NCT01054885|520536918|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144362553|NCT01054885|520536919|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144362554|NCT01054885|520536920|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144362555|NCT01054885|520536921|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144362556|NCT01054885|520536922|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144362557|NCT01054885|520536923|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144362558|NCT01054885|520536917|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
144362559|NCT01054885|520536918|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
144362560|NCT01054885|520536919|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
144362561|NCT01054885|520536920|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
144362562|NCT01054885|520536921|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
144362563|NCT01054885|520536922|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
144362564|NCT01054885|520536923|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
144362565|NCT01054885|520536917|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
144362566|NCT01054885|520536918|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144362567|NCT01054885|520536919|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144362568|NCT01054885|520536920|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144362569|NCT01054885|520536921|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144538193|NCT00146172|521174122|FG000|Overall Study|Lost to Follow-up|0|||
144362570|NCT01054885|520536922|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144362571|NCT01054885|520536923|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144362572|NCT01054885|520536917|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
144362573|NCT01054885|520536918|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144362574|NCT01054885|520536919|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144362575|NCT01054885|520536920|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144362576|NCT01054885|520536921|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144362577|NCT01054885|520536922|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144362578|NCT01054885|520536923|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144362579|NCT01054885|520536917|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
144362580|NCT01054885|520536918|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
144362581|NCT01054885|520536919|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
144362582|NCT01054885|520536920|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
144362583|NCT01054885|520536921|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
144362584|NCT01054885|520536922|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
144362585|NCT01054885|520536923|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
144362586|NCT01054885|520536917|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
144362587|NCT01054885|520536918|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144362588|NCT01054885|520536919|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144362589|NCT01054885|520536920|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144362590|NCT01054885|520536921|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144362591|NCT01054885|520536922|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144362592|NCT01054885|520536923|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144362593|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
144362594|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
144362595|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
144362596|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
144362597|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
144362598|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
144362599|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
144362600|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144362601|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144362602|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
144362603|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
144362604|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144362605|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
144362606|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144362607|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
144362608|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
144362609|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
144362610|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
144362611|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
144362612|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
144362613|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
144362614|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
144362615|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
144362616|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
144362617|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
144362618|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
144362619|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
144362620|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
144362621|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
144362622|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
144362623|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
144362624|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
144362625|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
144362626|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
144362627|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
144362628|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
144362629|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
144362630|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
144362631|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
144362632|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
144362633|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
144362634|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
144362635|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144362636|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
144362637|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
144362638|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144362639|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144362640|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
144362641|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
144362642|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
144362643|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
144362644|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
144362645|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
144362646|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
144362647|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
144362648|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
144362649|NCT01054885|520536917|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144362650|NCT01054885|520536918|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
144362651|NCT01054885|520536919|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
144362652|NCT01054885|520536920|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
144362653|NCT01054885|520536921|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
144362654|NCT01054885|520536922|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
144362655|NCT01054885|520536923|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
144362656|NCT03085095|520536925|FG000|Overall Study|Adverse Event|23|||
144362657|NCT03085095|520536926|FG001|Overall Study|Adverse Event|8|||
144362658|NCT03085095|520536925|FG000|Overall Study|Protocol Violation|0|||
144362659|NCT03085095|520536926|FG001|Overall Study|Protocol Violation|1|||
144362660|NCT03085095|520536925|FG000|Overall Study|Lost to Follow-up|2|||
144362661|NCT03085095|520536926|FG001|Overall Study|Lost to Follow-up|1|||
144362662|NCT03085095|520536925|FG000|Overall Study|Withdrawal by Subject|17|||
144362663|NCT03085095|520536926|FG001|Overall Study|Withdrawal by Subject|6|||
144362664|NCT03085095|520536925|FG000|Overall Study|Physician Decision|9|||
144362665|NCT03085095|520536926|FG001|Overall Study|Physician Decision|3|||
144362666|NCT03085095|520536925|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
144362667|NCT03085095|520536926|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
144362668|NCT03085095|520536925|FG000|Overall Study|Did not Receive Study Drug|2|||
144362669|NCT03085095|520536926|FG001|Overall Study|Did not Receive Study Drug|2|||
144362670|NCT03085095|520536925|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
144362671|NCT03085095|520536926|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
144362672|NCT03363841|520536927|FG000|Overall Study|Adverse Event|1|||
144362673|NCT03363841|520536927|FG000|Overall Study|Withdrawal by Subject|1|||
144362674|NCT03363841|520536927|FG000|Overall Study|Death|7|||
144362675|NCT03363841|520536927|FG000|Overall Study|Physician Decision|1|||
144362676|NCT02156076|520536930|FG000|Treatment Period|no longer meets study criteria|0|||
144362677|NCT02156076|520536931|FG001|Treatment Period|no longer meets study criteria|0|||
144362678|NCT02156076|520536932|FG002|Treatment Period|no longer meets study criteria|1|||
144362679|NCT02156076|520536933|FG003|Treatment Period|no longer meets study criteria|0|||
144362680|NCT02156076|520536930|FG000|Treatment Period|Poor/non-compliance|0|||
144362681|NCT02156076|520536931|FG001|Treatment Period|Poor/non-compliance|1|||
144362682|NCT02156076|520536932|FG002|Treatment Period|Poor/non-compliance|0|||
144362683|NCT02156076|520536933|FG003|Treatment Period|Poor/non-compliance|0|||
144362684|NCT02156076|520536930|FG000|Treatment Period|Lost to Follow-up|0|||
144362685|NCT02156076|520536931|FG001|Treatment Period|Lost to Follow-up|0|||
144362686|NCT02156076|520536932|FG002|Treatment Period|Lost to Follow-up|0|||
144362687|NCT02156076|520536933|FG003|Treatment Period|Lost to Follow-up|1|||
144362688|NCT02156076|520536930|FG000|Treatment Period|Withdrawal by Subject|0|||
144362689|NCT02156076|520536931|FG001|Treatment Period|Withdrawal by Subject|0|||
144362690|NCT02156076|520536932|FG002|Treatment Period|Withdrawal by Subject|1|||
144362691|NCT02156076|520536933|FG003|Treatment Period|Withdrawal by Subject|0|||
144362692|NCT02156076|520536930|FG000|Treatment Period|Subject request to discontinue treatment|0|||
144362693|NCT02156076|520536931|FG001|Treatment Period|Subject request to discontinue treatment|1|||
144362694|NCT02156076|520536932|FG002|Treatment Period|Subject request to discontinue treatment|0|||
144362695|NCT02156076|520536933|FG003|Treatment Period|Subject request to discontinue treatment|0|||
144362696|NCT02156076|520536930|FG000|Treatment Period|Adverse Event|0|||
144362697|NCT02156076|520536931|FG001|Treatment Period|Adverse Event|0|||
144362698|NCT02156076|520536932|FG002|Treatment Period|Adverse Event|0|||
144362699|NCT02156076|520536933|FG003|Treatment Period|Adverse Event|1|||
144362700|NCT02156076|520536930|FG000|Follow-up Period|Withdrawal by Subject|1|||
144362701|NCT02156076|520536931|FG001|Follow-up Period|Withdrawal by Subject|0|||
144362702|NCT02156076|520536932|FG002|Follow-up Period|Withdrawal by Subject|0|||
144362703|NCT02156076|520536933|FG003|Follow-up Period|Withdrawal by Subject|0|||
144362704|NCT06271993|520536934|FG000|Overall Study|Not reactive to histamine|5|||
144362705|NCT06271993|520536935|FG001|Overall Study|Not reactive to histamine|5|||
144362706|NCT06271993|520536936|FG002|Overall Study|Not reactive to histamine|5|||
144362707|NCT00687596|520536937|FG000|Overall Study|Adverse Event (AE)|10|||
144362708|NCT00687596|520536938|FG001|Overall Study|Adverse Event (AE)|3|||
144362709|NCT00687596|520536937|FG000|Overall Study|Radiological Disease Progression|6|||
144362710|NCT00687596|520536938|FG001|Overall Study|Radiological Disease Progression|2|||
144362711|NCT00687596|520536937|FG000|Overall Study|Clinical Disease Progression|1|||
144362712|NCT00687596|520536938|FG001|Overall Study|Clinical Disease Progression|3|||
144362713|NCT00687596|520536937|FG000|Overall Study|Investigator Discretion|3|||
144362714|NCT00687596|520536938|FG001|Overall Study|Investigator Discretion|1|||
144362715|NCT00687596|520536937|FG000|Overall Study|Sponsor Terminated Study|6|||
144362716|NCT00687596|520536938|FG001|Overall Study|Sponsor Terminated Study|17|||
144362717|NCT03331315|520536946|FG000|Overall Study|Physician Decision|18|||
144362718|NCT03331315|520536947|FG001|Overall Study|Physician Decision|14|||
144362719|NCT02558894|520536950|FG000|Overall Study|Death; any cause, entire study duration|28|||
144362720|NCT02558894|520536951|FG001|Overall Study|Death; any cause, entire study duration|31|||
144362721|NCT02558894|520536950|FG000|Overall Study|Withdrawal by Subject|2|||
144362722|NCT02558894|520536951|FG001|Overall Study|Withdrawal by Subject|1|||
144362723|NCT02558894|520536950|FG000|Overall Study|Closure of Part A|2|||
144362724|NCT02558894|520536951|FG001|Overall Study|Closure of Part A|1|||
144362725|NCT02992288|520536952|FG000|Overall Study|Adverse Event|8|||
144362726|NCT02992288|520536953|FG001|Overall Study|Adverse Event|2|||
144362727|NCT02992288|520536954|FG002|Overall Study|Adverse Event|2|||
144362728|NCT02992288|520536955|FG003|Overall Study|Adverse Event|2|||
144362729|NCT02992288|520536956|FG004|Overall Study|Adverse Event|2|||
144362730|NCT02992288|520536957|FG005|Overall Study|Adverse Event|7|||
144362731|NCT02992288|520536952|FG000|Overall Study|Non-compliance with study drug|0|||
144362732|NCT02992288|520536953|FG001|Overall Study|Non-compliance with study drug|1|||
144362733|NCT02992288|520536954|FG002|Overall Study|Non-compliance with study drug|1|||
144362734|NCT02992288|520536955|FG003|Overall Study|Non-compliance with study drug|0|||
144362735|NCT02992288|520536956|FG004|Overall Study|Non-compliance with study drug|1|||
144362736|NCT02992288|520536957|FG005|Overall Study|Non-compliance with study drug|0|||
144362737|NCT02992288|520536952|FG000|Overall Study|Physician Decision|3|||
144362738|NCT02992288|520536953|FG001|Overall Study|Physician Decision|0|||
144362739|NCT02992288|520536954|FG002|Overall Study|Physician Decision|1|||
144362740|NCT02992288|520536955|FG003|Overall Study|Physician Decision|0|||
144362741|NCT02992288|520536956|FG004|Overall Study|Physician Decision|0|||
144362742|NCT02992288|520536957|FG005|Overall Study|Physician Decision|1|||
144362743|NCT02992288|520536952|FG000|Overall Study|Death|2|||
144362744|NCT02992288|520536953|FG001|Overall Study|Death|0|||
144362745|NCT02992288|520536954|FG002|Overall Study|Death|2|||
144362746|NCT02992288|520536955|FG003|Overall Study|Death|1|||
144362747|NCT02992288|520536956|FG004|Overall Study|Death|2|||
144362748|NCT02992288|520536957|FG005|Overall Study|Death|0|||
144362749|NCT02992288|520536952|FG000|Overall Study|Lost to Follow-up|0|||
144362750|NCT02992288|520536953|FG001|Overall Study|Lost to Follow-up|0|||
144362751|NCT02992288|520536954|FG002|Overall Study|Lost to Follow-up|0|||
144362752|NCT02992288|520536955|FG003|Overall Study|Lost to Follow-up|1|||
144362753|NCT02992288|520536956|FG004|Overall Study|Lost to Follow-up|0|||
144362754|NCT02992288|520536957|FG005|Overall Study|Lost to Follow-up|0|||
144362755|NCT02992288|520536952|FG000|Overall Study|Protocol Violation|0|||
144362756|NCT02992288|520536953|FG001|Overall Study|Protocol Violation|0|||
144362757|NCT02992288|520536954|FG002|Overall Study|Protocol Violation|0|||
144362758|NCT02992288|520536955|FG003|Overall Study|Protocol Violation|0|||
144362759|NCT02992288|520536956|FG004|Overall Study|Protocol Violation|0|||
144362760|NCT02992288|520536957|FG005|Overall Study|Protocol Violation|1|||
144362761|NCT02992288|520536952|FG000|Overall Study|Withdrawal by Subject|4|||
144362762|NCT02992288|520536953|FG001|Overall Study|Withdrawal by Subject|2|||
144362763|NCT02992288|520536954|FG002|Overall Study|Withdrawal by Subject|1|||
144362764|NCT02992288|520536955|FG003|Overall Study|Withdrawal by Subject|5|||
144362765|NCT02992288|520536956|FG004|Overall Study|Withdrawal by Subject|3|||
144362766|NCT02992288|520536957|FG005|Overall Study|Withdrawal by Subject|4|||
144362767|NCT01867671|520536961|FG000|Overall Study|Adverse Event|5|||
144362768|NCT01867671|520536962|FG001|Overall Study|Adverse Event|3|||
144362769|NCT01867671|520536961|FG000|Overall Study|Anaphylaxis|0|||
144362770|NCT01867671|520536962|FG001|Overall Study|Anaphylaxis|1|||
144362771|NCT01867671|520536961|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
144362772|NCT01867671|520536962|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
144362773|NCT01867671|520536961|FG000|Overall Study|Lost to Follow-up|0|||
144362774|NCT01867671|520536962|FG001|Overall Study|Lost to Follow-up|1|||
144362775|NCT01867671|520536961|FG000|Overall Study|Non-compliance with Study Drug|1|||
144362776|NCT01867671|520536962|FG001|Overall Study|Non-compliance with Study Drug|2|||
144362777|NCT01867671|520536961|FG000|Overall Study|Withdrawal by Subject|21|||
144362778|NCT01867671|520536962|FG001|Overall Study|Withdrawal by Subject|21|||
144362779|NCT05236270|520536965|FG000|Overall Study|Lost to Follow-up|3|||
144362780|NCT05236270|520536966|FG001|Overall Study|Lost to Follow-up|2|||
144362781|NCT05236270|520536967|FG002|Overall Study|Lost to Follow-up|0|||
144362782|NCT05236270|520536968|FG003|Overall Study|Lost to Follow-up|0|||
144362783|NCT05236270|520536969|FG004|Overall Study|Lost to Follow-up|2|||
144362784|NCT05236270|520536970|FG005|Overall Study|Lost to Follow-up|0|||
144362785|NCT05236270|520536971|FG006|Overall Study|Lost to Follow-up|1|||
144362786|NCT05236270|520536972|FG007|Overall Study|Lost to Follow-up|3|||
144362787|NCT01499940|520536973|FG000|Overall Study|Study was withdrawn before completion.|9|||
144362788|NCT02435212|520536975|FG000|Core Phase|Adverse Event|8|||
144362789|NCT02435212|520536976|FG001|Core Phase|Adverse Event|5|||
144362790|NCT02435212|520536975|FG000|Core Phase|Withdrawal by Subject|3|||
144362791|NCT02435212|520536976|FG001|Core Phase|Withdrawal by Subject|0|||
144362792|NCT02435212|520536975|FG000|Core Phase|Withdrawal by parent/guardian|9|||
144362793|NCT02435212|520536976|FG001|Core Phase|Withdrawal by parent/guardian|4|||
144362794|NCT02435212|520536975|FG000|Core Phase|Protocol Violation|1|||
144362795|NCT02435212|520536976|FG001|Core Phase|Protocol Violation|2|||
144362796|NCT02435212|520536975|FG000|Core Phase|Physician Decision|3|||
144362797|NCT02435212|520536976|FG001|Core Phase|Physician Decision|0|||
144362798|NCT02435212|520536975|FG000|Core Phase|Lost to Follow-up|0|||
144362799|NCT02435212|520536976|FG001|Core Phase|Lost to Follow-up|1|||
144362800|NCT02435212|520536975|FG000|Core Phase|Lack of Efficacy|0|||
144362801|NCT02435212|520536976|FG001|Core Phase|Lack of Efficacy|1|||
144362802|NCT02435212|520536975|FG000|Core Phase|Recovery|1|||
144362803|NCT02435212|520536976|FG001|Core Phase|Recovery|0|||
144362804|NCT02435212|520536975|FG000|Optional Extension Phase|Adverse Event|3|||
144362805|NCT02435212|520536976|FG001|Optional Extension Phase|Adverse Event|9|||
144362806|NCT02435212|520536975|FG000|Optional Extension Phase|Physician Decision|6|||
144362807|NCT02435212|520536976|FG001|Optional Extension Phase|Physician Decision|8|||
144362808|NCT02435212|520536975|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
144362809|NCT02435212|520536976|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
144362810|NCT02435212|520536975|FG000|Optional Extension Phase|Lack of Efficacy|2|||
144362811|NCT02435212|520536976|FG001|Optional Extension Phase|Lack of Efficacy|3|||
144362812|NCT02435212|520536975|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
144362813|NCT02435212|520536976|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
144362814|NCT02435212|520536975|FG000|Optional Extension Phase|Protocol Violation|0|||
144362815|NCT02435212|520536976|FG001|Optional Extension Phase|Protocol Violation|1|||
144362816|NCT02435212|520536975|FG000|Optional Extension Phase|Recovery|1|||
144362817|NCT02435212|520536976|FG001|Optional Extension Phase|Recovery|1|||
144362818|NCT02435212|520536975|FG000|Optional Extension Phase|Death|1|||
144362819|NCT02435212|520536976|FG001|Optional Extension Phase|Death|0|||
144362820|NCT02435212|520536975|FG000|Optional Extension Phase|Technical problems|2|||
144362821|NCT02435212|520536976|FG001|Optional Extension Phase|Technical problems|0|||
144362822|NCT04711850|520536977|FG000|Overall Study|Graft loss|2|||
144362823|NCT04711850|520536978|FG001|Overall Study|Graft loss|1|||
144362824|NCT04711850|520536977|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
144362825|NCT04711850|520536978|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
144362826|NCT04711850|520536977|FG000|Overall Study|Study terminated by sponsor|5|||
144362827|NCT04711850|520536978|FG001|Overall Study|Study terminated by sponsor|3|||
144362828|NCT04711850|520536977|FG000|Overall Study|Sponsor decision|0|||
144362829|NCT04711850|520536978|FG001|Overall Study|Sponsor decision|2|||
144362830|NCT04531176|520536994|FG000|Overall Study|Study was stopped early|24|||
144362831|NCT04531176|520536995|FG001|Overall Study|Study was stopped early|26|||
144362832|NCT04531176|520536996|FG002|Overall Study|Study was stopped early|24|||
144362833|NCT00561652|520536997|FG000|Overall Study|Withdrawal by Subject|0|||
144362834|NCT00561652|520536998|FG001|Overall Study|Withdrawal by Subject|1|||
144362835|NCT02285855|520536999|FG000|Overall Study|Withdrawal by Subject|2|||
144362836|NCT02285855|520537000|FG001|Overall Study|Withdrawal by Subject|1|||
144362837|NCT00528112|520537001|FG000|Treatment up to 3 Years|Adverse Event|313|||
144362838|NCT00528112|520537002|FG001|Treatment up to 3 Years|Adverse Event|278|||
144362839|NCT00528112|520537001|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
144362840|NCT00528112|520537002|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
144362841|NCT00528112|520537001|FG000|Treatment up to 3 Years|Protocol Violation|16|||
144362842|NCT00528112|520537002|FG001|Treatment up to 3 Years|Protocol Violation|16|||
144362843|NCT00528112|520537001|FG000|Treatment up to 3 Years|Death|0|||
144362844|NCT00528112|520537002|FG001|Treatment up to 3 Years|Death|1|||
144362845|NCT00528112|520537001|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
144362846|NCT00528112|520537002|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
144362847|NCT00528112|520537001|FG000|Treatment up to 3 Years|Pregnancy|9|||
144362848|NCT00528112|520537002|FG001|Treatment up to 3 Years|Pregnancy|10|||
144362849|NCT00528112|520537001|FG000|Treatment up to 3 Years|Other reasons|186|||
144362850|NCT00528112|520537002|FG001|Treatment up to 3 Years|Other reasons|186|||
144362851|NCT00528112|520537001|FG000|Extension Phase|Withdrawal by Subject|0|||
144362852|NCT00528112|520537002|FG001|Extension Phase|Withdrawal by Subject|3|||
144362853|NCT00528112|520537001|FG000|Extension Phase|Other reasons|0|||
144362854|NCT00528112|520537002|FG001|Extension Phase|Other reasons|100|||
144362855|NCT00528112|520537001|FG000|Extension Phase|Pregnancy|0|||
144362856|NCT00528112|520537002|FG001|Extension Phase|Pregnancy|3|||
144362857|NCT00528112|520537001|FG000|Extension Phase|Lost to Follow-up|0|||
144362858|NCT00528112|520537002|FG001|Extension Phase|Lost to Follow-up|12|||
144362859|NCT00528112|520537001|FG000|Extension Phase|Death|0|||
144362860|NCT00528112|520537002|FG001|Extension Phase|Death|1|||
144362861|NCT00528112|520537001|FG000|Extension Phase|Adverse Event|0|||
144362862|NCT00528112|520537002|FG001|Extension Phase|Adverse Event|36|||
144362863|NCT00528112|520537001|FG000|Extension Phase|Protocol Violation|0|||
144362864|NCT00528112|520537002|FG001|Extension Phase|Protocol Violation|2|||
144362865|NCT02718898|520537003|FG000|Blinded Treatment Period|Adverse Event|5|||
144362866|NCT02718898|520537004|FG001|Blinded Treatment Period|Adverse Event|1|||
144362867|NCT02718898|520537005|FG002|Blinded Treatment Period|Adverse Event|0|||
144362868|NCT02718898|520537006|FG003|Blinded Treatment Period|Adverse Event|0|||
144362869|NCT02718898|520537007|FG004|Blinded Treatment Period|Adverse Event|0|||
144362870|NCT02718898|520537008|FG005|Blinded Treatment Period|Adverse Event|0|||
144362871|NCT02718898|520537009|FG006|Blinded Treatment Period|Adverse Event|0|||
144362872|NCT02718898|520537003|FG000|Blinded Treatment Period|Physician Decision|1|||
144362873|NCT02718898|520537004|FG001|Blinded Treatment Period|Physician Decision|0|||
144362874|NCT02718898|520537005|FG002|Blinded Treatment Period|Physician Decision|0|||
144362875|NCT02718898|520537006|FG003|Blinded Treatment Period|Physician Decision|0|||
144362876|NCT02718898|520537007|FG004|Blinded Treatment Period|Physician Decision|0|||
144362877|NCT02718898|520537008|FG005|Blinded Treatment Period|Physician Decision|0|||
144362878|NCT02718898|520537009|FG006|Blinded Treatment Period|Physician Decision|0|||
144362879|NCT02718898|520537003|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
144362880|NCT02718898|520537004|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
144362881|NCT02718898|520537005|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
144362882|NCT02718898|520537006|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
144362883|NCT02718898|520537007|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
144362884|NCT02718898|520537008|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
144362885|NCT02718898|520537009|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
144362886|NCT02718898|520537003|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
144362887|NCT02718898|520537004|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
144362888|NCT02718898|520537005|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
144362889|NCT02718898|520537006|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
144362890|NCT02718898|520537007|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
144362891|NCT02718898|520537008|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
144362892|NCT02718898|520537009|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
144362893|NCT02718898|520537003|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
144362894|NCT02718898|520537004|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
144362895|NCT02718898|520537005|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
144362896|NCT02718898|520537006|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
144362897|NCT02718898|520537007|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
144362898|NCT02718898|520537008|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
144362899|NCT02718898|520537009|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
144362900|NCT02718898|520537003|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
144362901|NCT02718898|520537004|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
144362902|NCT02718898|520537005|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
144362903|NCT02718898|520537006|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
144362904|NCT02718898|520537007|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
144362905|NCT02718898|520537008|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
144362906|NCT02718898|520537009|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
144362907|NCT02718898|520537003|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362908|NCT02718898|520537004|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362909|NCT02718898|520537005|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
144362910|NCT02718898|520537006|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
144362911|NCT02718898|520537007|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362912|NCT02718898|520537008|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362913|NCT02718898|520537009|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144362914|NCT02718898|520537003|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
144362915|NCT02718898|520537004|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
144362916|NCT02718898|520537005|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
144362917|NCT02718898|520537006|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
144478647|NCT04534114|520951742|FG000|Main Treatment Period|Physician Decision|0|||
144362918|NCT02718898|520537007|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
144362919|NCT02718898|520537008|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
144362920|NCT02718898|520537009|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
144362921|NCT02718898|520537003|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
144362922|NCT02718898|520537004|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
144362923|NCT02718898|520537005|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
144362924|NCT02718898|520537006|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
144362925|NCT02718898|520537007|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
144478648|NCT04534114|520951743|FG001|Main Treatment Period|Physician Decision|0|||
144362926|NCT02718898|520537008|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
144362927|NCT02718898|520537009|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
144362928|NCT02718898|520537003|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
144362929|NCT02718898|520537004|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
144362930|NCT02718898|520537005|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
144362931|NCT02718898|520537006|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
144362932|NCT02718898|520537007|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
144362933|NCT02718898|520537008|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
144362934|NCT02718898|520537009|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
144362935|NCT02718898|520537003|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
144362936|NCT02718898|520537004|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
144362937|NCT02718898|520537005|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
144362938|NCT02718898|520537006|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
144362939|NCT02718898|520537007|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
144362940|NCT02718898|520537008|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
144362941|NCT02718898|520537009|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
144362942|NCT02718898|520537003|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
144362943|NCT02718898|520537004|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
144362944|NCT02718898|520537005|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
144362945|NCT02718898|520537006|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
144362946|NCT02718898|520537007|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
144362947|NCT02718898|520537008|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
144362948|NCT02718898|520537009|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
144362949|NCT02718898|520537003|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144362950|NCT02718898|520537004|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144362951|NCT02718898|520537005|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144362952|NCT02718898|520537006|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144362953|NCT02718898|520537007|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144362954|NCT02718898|520537008|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
144362955|NCT02718898|520537009|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
144362956|NCT02559622|520537011|FG000|Overall Study|Progressive disease|0|||
144362957|NCT02559622|520537012|FG001|Overall Study|Progressive disease|1|||
144362958|NCT02559622|520537013|FG002|Overall Study|Progressive disease|0|||
144362959|NCT02559622|520537014|FG003|Overall Study|Progressive disease|0|||
144362960|NCT02559622|520537011|FG000|Overall Study|Adverse Event|0|||
144362961|NCT02559622|520537012|FG001|Overall Study|Adverse Event|2|||
144362962|NCT02559622|520537013|FG002|Overall Study|Adverse Event|2|||
144362963|NCT02559622|520537014|FG003|Overall Study|Adverse Event|2|||
144362964|NCT02559622|520537011|FG000|Overall Study|Patient/guardian decision|1|||
144362965|NCT02559622|520537012|FG001|Overall Study|Patient/guardian decision|2|||
144362966|NCT02559622|520537013|FG002|Overall Study|Patient/guardian decision|0|||
144362967|NCT02559622|520537014|FG003|Overall Study|Patient/guardian decision|1|||
144362968|NCT02163538|520537015|FG000|Overall Study|Protocol Violation|1|||
144362969|NCT02163538|520537016|FG001|Overall Study|Protocol Violation|0|||
144362970|NCT02163538|520537015|FG000|Overall Study|Physician Decision|0|||
144362971|NCT02163538|520537016|FG001|Overall Study|Physician Decision|1|||
144362972|NCT01502293|520537019|FG000|Overall Study|Progressive Disease|20|||
144362973|NCT01502293|520537020|FG001|Overall Study|Progressive Disease|12|||
144362974|NCT01502293|520537021|FG002|Overall Study|Progressive Disease|2|||
144362975|NCT01502293|520537019|FG000|Overall Study|Withdrawal by Subject|3|||
144362976|NCT01502293|520537020|FG001|Overall Study|Withdrawal by Subject|3|||
144362977|NCT01502293|520537021|FG002|Overall Study|Withdrawal by Subject|1|||
144362978|NCT01502293|520537019|FG000|Overall Study|Adverse Event|0|||
144362979|NCT01502293|520537020|FG001|Overall Study|Adverse Event|2|||
144703353|NCT05275673|521766860|FG000|Overall Study|Withdrawal by Subject|1|||
144362980|NCT01502293|520537021|FG002|Overall Study|Adverse Event|0|||
144362981|NCT01502293|520537019|FG000|Overall Study|Reason Not Specified|2|||
144362982|NCT01502293|520537020|FG001|Overall Study|Reason Not Specified|0|||
144362983|NCT01502293|520537021|FG002|Overall Study|Reason Not Specified|0|||
144362984|NCT01502293|520537019|FG000|Overall Study|Physician Decision|0|||
144362985|NCT01502293|520537020|FG001|Overall Study|Physician Decision|0|||
144362986|NCT01502293|520537021|FG002|Overall Study|Physician Decision|1|||
144362987|NCT01339832|520537025|FG000|Overall Study|Lost to Follow-up|3|||
144362988|NCT01339832|520537025|FG000|Overall Study|Death|11|||
144362989|NCT00774046|520537026|FG000|Screening|Not eligible|56|||
144362990|NCT00774046|520537026|FG000|Enrollment|Desired other therapy/refused|28|||
144362991|NCT00774046|520537026|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
144362992|NCT05498649|520537027|FG000|Overall Study|Lost to Follow-up|1|||
144362993|NCT03804528|520537028|FG000|Overall Study|Time Commitment|18|||
144362994|NCT03804528|520537028|FG000|Overall Study|Health Reasons|5|||
144362995|NCT04607005|520537031|FG000|Overall Study|Adverse Event|0|||
144362996|NCT04607005|520537032|FG001|Overall Study|Adverse Event|1|||
144362997|NCT04607005|520537031|FG000|Overall Study|Lack of Efficacy|1|||
144362998|NCT04607005|520537032|FG001|Overall Study|Lack of Efficacy|6|||
144362999|NCT04607005|520537031|FG000|Overall Study|Withdrawal by Subject|4|||
144363000|NCT04607005|520537032|FG001|Overall Study|Withdrawal by Subject|9|||
144363001|NCT04607005|520537031|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
144363002|NCT04607005|520537032|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
144363003|NCT01350999|520537040|FG000|Overall Study|Adverse Event|4|||
144363004|NCT01350999|520537041|FG001|Overall Study|Adverse Event|9|||
144363005|NCT01350999|520537042|FG002|Overall Study|Adverse Event|10|||
144363006|NCT01350999|520537040|FG000|Overall Study|Voluntary withdrawal|3|||
144363007|NCT01350999|520537041|FG001|Overall Study|Voluntary withdrawal|4|||
144363008|NCT01350999|520537042|FG002|Overall Study|Voluntary withdrawal|6|||
144363009|NCT01350999|520537040|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
144363010|NCT01350999|520537041|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
144363011|NCT01350999|520537042|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
144363012|NCT02892344|520538792|FG000|Overall Study|Protocol deviation|3|||
144363013|NCT02892344|520538793|FG001|Overall Study|Protocol deviation|4|||
144363014|NCT02892344|520538792|FG000|Overall Study|Adverse Event|1|||
144363015|NCT02892344|520538793|FG001|Overall Study|Adverse Event|8|||
144363016|NCT02892344|520538792|FG000|Overall Study|Lost to Follow-up|0|||
144363017|NCT02892344|520538793|FG001|Overall Study|Lost to Follow-up|1|||
144363018|NCT02892344|520538792|FG000|Overall Study|Non-compliance with study treatment|0|||
144363019|NCT02892344|520538793|FG001|Overall Study|Non-compliance with study treatment|1|||
144363020|NCT02892344|520538792|FG000|Overall Study|Physician Decision|0|||
144363021|NCT02892344|520538793|FG001|Overall Study|Physician Decision|2|||
144363022|NCT02892344|520538792|FG000|Overall Study|Subject/guardian decision|0|||
144363023|NCT02892344|520538793|FG001|Overall Study|Subject/guardian decision|4|||
144363024|NCT02892344|520538792|FG000|Overall Study|Technical problems|0|||
144363025|NCT02892344|520538793|FG001|Overall Study|Technical problems|1|||
144363026|NCT04328077|520538797|FG000|Overall Study|Lost to Follow-up|0|||
144363027|NCT04328077|520538798|FG001|Overall Study|Lost to Follow-up|1|||
144363028|NCT04328077|520538799|FG002|Overall Study|Lost to Follow-up|0|||
144363029|NCT04328077|520538800|FG003|Overall Study|Lost to Follow-up|0|||
144363030|NCT04328077|520538797|FG000|Overall Study|Withdrawal by Subject|0|||
144363031|NCT04328077|520538798|FG001|Overall Study|Withdrawal by Subject|1|||
144363032|NCT04328077|520538799|FG002|Overall Study|Withdrawal by Subject|1|||
144363033|NCT04328077|520538800|FG003|Overall Study|Withdrawal by Subject|3|||
144363034|NCT00939393|520538805|FG000|Overall Study|Withdrawal by Subject|1|||
144363035|NCT00939393|520538806|FG001|Overall Study|Withdrawal by Subject|0|||
144363036|NCT00939393|520538805|FG000|Overall Study|Lost to Follow-up|3|||
144363037|NCT00939393|520538806|FG001|Overall Study|Lost to Follow-up|0|||
144363038|NCT02851615|520538807|FG000|Overall Study|Cognitive Issue|1|||
144363039|NCT02851615|520538808|FG001|Overall Study|Cognitive Issue|0|||
144363040|NCT02851615|520538807|FG000|Overall Study|Lost to Follow-up|0|||
144363041|NCT02851615|520538808|FG001|Overall Study|Lost to Follow-up|4|||
144363042|NCT00313014|520538809|FG000|Overall Study|Withdrawal by Subject|11|||
144363043|NCT00313014|520538810|FG001|Overall Study|Withdrawal by Subject|7|||
144363044|NCT00313014|520538811|FG002|Overall Study|Withdrawal by Subject|5|||
144363045|NCT00313014|520538809|FG000|Overall Study|Adverse Event|14|||
144363046|NCT00313014|520538810|FG001|Overall Study|Adverse Event|29|||
144363047|NCT00313014|520538811|FG002|Overall Study|Adverse Event|16|||
144363048|NCT00313014|520538809|FG000|Overall Study|Lost to Follow-up|7|||
144363049|NCT00313014|520538810|FG001|Overall Study|Lost to Follow-up|6|||
144363050|NCT00313014|520538811|FG002|Overall Study|Lost to Follow-up|10|||
144363051|NCT00313014|520538809|FG000|Overall Study|Administrative|9|||
144363052|NCT00313014|520538810|FG001|Overall Study|Administrative|6|||
144363053|NCT00313014|520538811|FG002|Overall Study|Administrative|14|||
144363054|NCT00313014|520538809|FG000|Overall Study|Lack of Efficacy|52|||
144363055|NCT00313014|520538810|FG001|Overall Study|Lack of Efficacy|25|||
144363056|NCT00313014|520538811|FG002|Overall Study|Lack of Efficacy|16|||
144363057|NCT00371150|520538813|FG000|Overall Study|Lost to Follow-up|3|||
144363058|NCT00371150|520538814|FG001|Overall Study|Lost to Follow-up|2|||
144363059|NCT02345070|520538816|FG000|Overall Study|Adverse Event|12|||
144363060|NCT02345070|520538817|FG001|Overall Study|Adverse Event|8|||
144363061|NCT02345070|520538818|FG002|Overall Study|Adverse Event|16|||
144363062|NCT02345070|520538816|FG000|Overall Study|Poor compliance to protocol|2|||
144363063|NCT02345070|520538817|FG001|Overall Study|Poor compliance to protocol|0|||
144363064|NCT02345070|520538818|FG002|Overall Study|Poor compliance to protocol|0|||
144363065|NCT02345070|520538816|FG000|Overall Study|Other than specified above|6|||
144363066|NCT02345070|520538817|FG001|Overall Study|Other than specified above|3|||
144363067|NCT02345070|520538818|FG002|Overall Study|Other than specified above|7|||
144363068|NCT02151058|520538819|FG000|Overall Study|Withdrawal by Subject|1|||
144363069|NCT02151058|520538820|FG001|Overall Study|Withdrawal by Subject|1|||
144363070|NCT02151058|520538821|FG002|Overall Study|Withdrawal by Subject|3|||
144363071|NCT02151058|520538819|FG000|Overall Study|Lost to Follow-up|1|||
144363072|NCT02151058|520538820|FG001|Overall Study|Lost to Follow-up|0|||
144363073|NCT02151058|520538821|FG002|Overall Study|Lost to Follow-up|2|||
144363074|NCT00124943|520538824|FG000|Phase II|Adverse Event|0|||
144363075|NCT00124943|520538825|FG001|Phase II|Adverse Event|2|||
144363076|NCT00124943|520538826|FG002|Phase II|Adverse Event|0|||
144363077|NCT00124943|520538827|FG003|Phase II|Adverse Event|1|||
144363078|NCT00124943|520538824|FG000|Phase II|Protocol Violation|0|||
144363079|NCT00124943|520538825|FG001|Phase II|Protocol Violation|0|||
144363080|NCT00124943|520538826|FG002|Phase II|Protocol Violation|0|||
144363081|NCT00124943|520538827|FG003|Phase II|Protocol Violation|1|||
144363082|NCT00124943|520538824|FG000|Phase II|Lost to Follow-up|0|||
144363083|NCT00124943|520538825|FG001|Phase II|Lost to Follow-up|0|||
144363084|NCT00124943|520538826|FG002|Phase II|Lost to Follow-up|0|||
144363085|NCT00124943|520538827|FG003|Phase II|Lost to Follow-up|1|||
144363086|NCT00124943|520538824|FG000|Phase II|Withdrawal by Subject|0|||
144363087|NCT00124943|520538825|FG001|Phase II|Withdrawal by Subject|0|||
144363088|NCT00124943|520538826|FG002|Phase II|Withdrawal by Subject|0|||
144363089|NCT00124943|520538827|FG003|Phase II|Withdrawal by Subject|2|||
144363090|NCT03829228|520538828|FG000|Overall Study|Protocol Violation|1|||
144363091|NCT03337477|520538829|FG000|Overall Study|not categorized into the listed ones|11|||
144363092|NCT03337477|520538830|FG001|Overall Study|not categorized into the listed ones|9|||
144363093|NCT03337477|520538829|FG000|Overall Study|Withdrawal by Subject|0|||
144363094|NCT03337477|520538830|FG001|Overall Study|Withdrawal by Subject|1|||
144363095|NCT03337477|520538829|FG000|Overall Study|Death|0|||
144363096|NCT03337477|520538830|FG001|Overall Study|Death|1|||
144363097|NCT03337477|520538829|FG000|Overall Study|Lost to Follow-up|0|||
144363098|NCT03337477|520538830|FG001|Overall Study|Lost to Follow-up|2|||
144363099|NCT02443688|520538833|FG000|Overall Study|Adverse Event|2|||
144363100|NCT02443688|520538834|FG001|Overall Study|Adverse Event|3|||
144363101|NCT02443688|520538835|FG002|Overall Study|Adverse Event|2|||
144363102|NCT02443688|520538833|FG000|Overall Study|Lost to Follow-up|1|||
144363103|NCT02443688|520538834|FG001|Overall Study|Lost to Follow-up|0|||
144363104|NCT02443688|520538835|FG002|Overall Study|Lost to Follow-up|0|||
144363105|NCT02443688|520538833|FG000|Overall Study|Physician Decision|3|||
144363106|NCT02443688|520538834|FG001|Overall Study|Physician Decision|0|||
144363107|NCT02443688|520538835|FG002|Overall Study|Physician Decision|1|||
144363108|NCT02443688|520538833|FG000|Overall Study|Pregnancy|0|||
144363109|NCT02443688|520538834|FG001|Overall Study|Pregnancy|0|||
144363110|NCT02443688|520538835|FG002|Overall Study|Pregnancy|1|||
144363111|NCT02443688|520538833|FG000|Overall Study|Withdrawal by Subject|3|||
144363112|NCT02443688|520538834|FG001|Overall Study|Withdrawal by Subject|3|||
144363113|NCT02443688|520538835|FG002|Overall Study|Withdrawal by Subject|4|||
144363114|NCT02443688|520538833|FG000|Overall Study|Non-compliance with study drug|1|||
144363115|NCT02443688|520538834|FG001|Overall Study|Non-compliance with study drug|2|||
144363116|NCT02443688|520538835|FG002|Overall Study|Non-compliance with study drug|4|||
144363117|NCT02443688|520538833|FG000|Overall Study|Sponsor Request|2|||
144363118|NCT02443688|520538834|FG001|Overall Study|Sponsor Request|1|||
144363119|NCT02443688|520538835|FG002|Overall Study|Sponsor Request|0|||
144363120|NCT00408317|520538836|FG000|First Intervention Period|Adverse Event|0|||
144363121|NCT00408317|520538837|FG001|First Intervention Period|Adverse Event|1|||
144363122|NCT00408317|520538836|FG000|Second Intervention Period|Adverse Event|2|||
144363123|NCT00408317|520538837|FG001|Second Intervention Period|Adverse Event|0|||
144363124|NCT00408317|520538836|FG000|Second Intervention Period|Protocol Violation|0|||
144363125|NCT00408317|520538837|FG001|Second Intervention Period|Protocol Violation|1|||
144363126|NCT00408317|520538836|FG000|Second Intervention Period|Withdrawal of consent|0|||
144363127|NCT00408317|520538837|FG001|Second Intervention Period|Withdrawal of consent|1|||
144363128|NCT00674817|520538838|FG000|Period 1|Withdrawal by Subject|2|||
144363129|NCT00674817|520538838|FG000|Period 1|Protocol Violation|1|||
144363130|NCT00674817|520538838|FG000|Period 3|Adverse Event|1|||
144363131|NCT00674817|520538838|FG000|Period 3|Protocol Violation|1|||
144363132|NCT00674817|520538838|FG000|Period 4|Adverse Event|1|||
144363133|NCT00473564|520538839|FG000|Overall Study|robot surgery aborted in OR|23|||
144363134|NCT02379728|520538840|FG000|Overall Study|Lost to Follow-up|1|||
144363135|NCT02379728|520538841|FG001|Overall Study|Lost to Follow-up|0|||
144363136|NCT02379728|520538842|FG002|Overall Study|Lost to Follow-up|3|||
144363137|NCT02379728|520538843|FG003|Overall Study|Lost to Follow-up|0|||
144363138|NCT02379728|520538840|FG000|Overall Study|Withdrawal by Subject|5|||
144363139|NCT02379728|520538841|FG001|Overall Study|Withdrawal by Subject|0|||
144363140|NCT02379728|520538842|FG002|Overall Study|Withdrawal by Subject|5|||
144363141|NCT02379728|520538843|FG003|Overall Study|Withdrawal by Subject|3|||
144363142|NCT02379728|520538840|FG000|Overall Study|Protocol Violation|0|||
144363143|NCT02379728|520538841|FG001|Overall Study|Protocol Violation|0|||
144363144|NCT02379728|520538842|FG002|Overall Study|Protocol Violation|2|||
144363145|NCT02379728|520538843|FG003|Overall Study|Protocol Violation|0|||
144363146|NCT01112917|520538844|FG000|Overall Study|Death|2|||
144363147|NCT01112917|520538845|FG001|Overall Study|Death|11|||
144363148|NCT01112917|520538844|FG000|Overall Study|Lost to Follow-up|1|||
144363149|NCT01112917|520538845|FG001|Overall Study|Lost to Follow-up|1|||
144363150|NCT01112917|520538844|FG000|Overall Study|Withdrawal by Subject|1|||
144363151|NCT01112917|520538845|FG001|Overall Study|Withdrawal by Subject|3|||
144363152|NCT01112917|520538844|FG000|Overall Study|Unable to Convert Filter|3|||
144363153|NCT01112917|520538845|FG001|Overall Study|Unable to Convert Filter|0|||
144363154|NCT05101122|520538846|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
144363155|NCT05101122|520538846|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
144363156|NCT05101122|520538846|FG000|AD313 80/5|Withdrawal by Subject|1|||
144363157|NCT05101122|520538846|FG000|AD313 80/10|Physician Decision|1|||
144363158|NCT03131219|520538848|FG000|Initial Evaluation Period|Adverse Event|2|||
144363159|NCT03131219|520538849|FG001|Initial Evaluation Period|Adverse Event|0|||
144363160|NCT03131219|520538848|FG000|Initial Evaluation Period|Protocol Violation|1|||
144363161|NCT03131219|520538849|FG001|Initial Evaluation Period|Protocol Violation|0|||
144363162|NCT03131219|520538848|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
144363163|NCT03131219|520538849|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
144363164|NCT03131219|520538848|FG000|Initial Evaluation Period|Physician Decision|1|||
144363165|NCT03131219|520538849|FG001|Initial Evaluation Period|Physician Decision|0|||
144363166|NCT03131219|520538848|FG000|Extension Period|Physician Decision|1|||
144363167|NCT03131219|520538849|FG001|Extension Period|Physician Decision|0|||
144363168|NCT00616759|520538850|FG000|Overall Study|Physician Decision|2|||
144363169|NCT00616759|520538851|FG001|Overall Study|Physician Decision|0|||
144363170|NCT00616759|520538850|FG000|Overall Study|Withdrawal by Subject|1|||
144363171|NCT00616759|520538851|FG001|Overall Study|Withdrawal by Subject|2|||
144363172|NCT05660577|520538853|FG000|Overall Study|Discontinued|9|||
144363173|NCT00981656|520538866|FG000|Overall Study|Protocol Violation|1|||
144363174|NCT00981656|520538866|FG000|Overall Study|Did not start protocol treatment|2|||
144363175|NCT02903771|520538867|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
144363176|NCT02903771|520538868|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
144363177|NCT02903771|520538869|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
144363178|NCT02903771|520538870|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
144363179|NCT02903771|520538871|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
144363180|NCT02903771|520538872|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
144363181|NCT02903771|520538873|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
144363182|NCT02903771|520538867|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
144363183|NCT02903771|520538868|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
144363184|NCT02903771|520538869|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
144363185|NCT02903771|520538870|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
144363186|NCT02903771|520538871|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
144363187|NCT02903771|520538872|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
144363188|NCT02903771|520538873|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
144363189|NCT02903771|520538867|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
144363190|NCT02903771|520538868|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
144363191|NCT02903771|520538869|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
144363192|NCT02903771|520538870|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
144363193|NCT02903771|520538871|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
144363194|NCT02903771|520538872|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
144363195|NCT02903771|520538873|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
144363196|NCT02903771|520538867|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
144363197|NCT02903771|520538868|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
144363198|NCT02903771|520538869|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
144363199|NCT02903771|520538870|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
144363200|NCT02903771|520538871|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
144363201|NCT02903771|520538872|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
144363202|NCT02903771|520538873|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
144363203|NCT02903771|520538867|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
144363204|NCT02903771|520538868|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
144363205|NCT02903771|520538869|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
144363206|NCT02903771|520538870|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
144363207|NCT02903771|520538871|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
144363208|NCT02903771|520538872|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
144363209|NCT02903771|520538873|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
144363210|NCT02903771|520538867|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
144363211|NCT02903771|520538868|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
144363212|NCT02903771|520538869|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
144363213|NCT02903771|520538870|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
144363214|NCT02903771|520538871|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
144363215|NCT02903771|520538872|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
144363216|NCT02903771|520538873|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
144478649|NCT04534114|520951744|FG002|Main Treatment Period|Physician Decision|0|||
144478650|NCT04534114|520951745|FG003|Main Treatment Period|Physician Decision|1|||
144478651|NCT04534114|520951742|FG000|Main Treatment Period|Death|1|||
144478652|NCT04534114|520951743|FG001|Main Treatment Period|Death|0|||
144363217|NCT02903771|520538867|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
144363218|NCT02903771|520538868|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
144363219|NCT02903771|520538869|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
144363220|NCT02903771|520538870|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
144363221|NCT02903771|520538871|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
144363222|NCT02903771|520538872|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
144363223|NCT02903771|520538873|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
144363224|NCT02903771|520538867|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
144363225|NCT02903771|520538868|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
144363226|NCT02903771|520538869|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
144363227|NCT02903771|520538870|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
144363228|NCT02903771|520538871|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
144363229|NCT02903771|520538872|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
144363230|NCT02903771|520538873|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
144363231|NCT02903771|520538867|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
144363232|NCT02903771|520538868|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
144363233|NCT02903771|520538869|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
144363234|NCT02903771|520538870|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
144363235|NCT02903771|520538871|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
144363236|NCT02903771|520538872|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
144363237|NCT02903771|520538873|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
144363238|NCT02903771|520538867|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
144363239|NCT02903771|520538868|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
144363240|NCT02903771|520538869|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
144363241|NCT02903771|520538870|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
144363242|NCT02903771|520538871|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
144363243|NCT02903771|520538872|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
144363244|NCT02903771|520538873|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
144363245|NCT02903771|520538867|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
144363246|NCT02903771|520538868|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
144363247|NCT02903771|520538869|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
144363248|NCT02903771|520538870|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
144363249|NCT02903771|520538871|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
144363250|NCT02903771|520538872|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
144363251|NCT02903771|520538873|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
144363252|NCT01709721|520538874|FG000|Open Label Phase|Withdrawal by Subject|0|||
144363253|NCT01709721|520538875|FG001|Open Label Phase|Withdrawal by Subject|0|||
144363254|NCT01709721|520538876|FG002|Open Label Phase|Withdrawal by Subject|5|||
144363255|NCT01709721|520538874|FG000|Open Label Phase|Adverse Event|0|||
144363256|NCT01709721|520538875|FG001|Open Label Phase|Adverse Event|0|||
144363257|NCT01709721|520538876|FG002|Open Label Phase|Adverse Event|8|||
144363258|NCT01709721|520538874|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
144363259|NCT01709721|520538875|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
144363260|NCT01709721|520538876|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
144363261|NCT01709721|520538874|FG000|Open Label Phase|Investigator Decision|0|||
144363262|NCT01709721|520538875|FG001|Open Label Phase|Investigator Decision|0|||
144363263|NCT01709721|520538876|FG002|Open Label Phase|Investigator Decision|1|||
144363264|NCT01709721|520538874|FG000|Open Label Phase|Sponsor Decision|0|||
144363265|NCT01709721|520538875|FG001|Open Label Phase|Sponsor Decision|0|||
144363266|NCT01709721|520538876|FG002|Open Label Phase|Sponsor Decision|2|||
144363267|NCT01709721|520538874|FG000|Open Label Phase|Protocol Violation|0|||
144363268|NCT01709721|520538875|FG001|Open Label Phase|Protocol Violation|0|||
144363269|NCT01709721|520538876|FG002|Open Label Phase|Protocol Violation|1|||
144363270|NCT01709721|520538874|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
144363271|NCT01709721|520538875|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
144363272|NCT01709721|520538876|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
144363273|NCT01709721|520538874|FG000|Open Label Phase|Inadequate Pain Control|0|||
144363274|NCT01709721|520538875|FG001|Open Label Phase|Inadequate Pain Control|0|||
144363275|NCT01709721|520538876|FG002|Open Label Phase|Inadequate Pain Control|37|||
144363276|NCT01709721|520538874|FG000|Open Label Phase|Other, Specify in text field in database|0|||
144363277|NCT01709721|520538875|FG001|Open Label Phase|Other, Specify in text field in database|0|||
144363278|NCT01709721|520538876|FG002|Open Label Phase|Other, Specify in text field in database|14|||
144363279|NCT01709721|520538874|FG000|Randomized Phase|Adverse Event|0|||
144363280|NCT01709721|520538875|FG001|Randomized Phase|Adverse Event|1|||
144363281|NCT01709721|520538876|FG002|Randomized Phase|Adverse Event|0|||
144363282|NCT01709721|520538874|FG000|Randomized Phase|Lost to Follow-up|1|||
144478653|NCT04534114|520951744|FG002|Main Treatment Period|Death|0|||
144478654|NCT04534114|520951745|FG003|Main Treatment Period|Death|1|||
144478655|NCT04534114|520951742|FG000|Main Treatment Period|Other reason|1|||
144363283|NCT01709721|520538875|FG001|Randomized Phase|Lost to Follow-up|0|||
144478656|NCT04534114|520951743|FG001|Main Treatment Period|Other reason|1|||
144363284|NCT01709721|520538876|FG002|Randomized Phase|Lost to Follow-up|0|||
144363285|NCT01709721|520538874|FG000|Randomized Phase|Inadequate Pain Control|1|||
144363286|NCT01709721|520538875|FG001|Randomized Phase|Inadequate Pain Control|2|||
144363287|NCT01709721|520538876|FG002|Randomized Phase|Inadequate Pain Control|0|||
144363288|NCT01709721|520538874|FG000|Randomized Phase|Other, Specify text field in database|1|||
144363289|NCT01709721|520538875|FG001|Randomized Phase|Other, Specify text field in database|3|||
144363290|NCT01709721|520538876|FG002|Randomized Phase|Other, Specify text field in database|0|||
144363291|NCT03137381|520538877|FG000|Overall Study|Adverse Event|3|||
144363292|NCT03137381|520538878|FG001|Overall Study|Adverse Event|0|||
144363293|NCT03137381|520538879|FG002|Overall Study|Adverse Event|2|||
144363294|NCT03137381|520538880|FG003|Overall Study|Adverse Event|0|||
144363295|NCT03137381|520538877|FG000|Overall Study|Lost to Follow-up|2|||
144363296|NCT03137381|520538878|FG001|Overall Study|Lost to Follow-up|1|||
144363297|NCT03137381|520538879|FG002|Overall Study|Lost to Follow-up|1|||
144363298|NCT03137381|520538880|FG003|Overall Study|Lost to Follow-up|0|||
144363299|NCT03137381|520538877|FG000|Overall Study|Protocol deviation|1|||
144363300|NCT03137381|520538878|FG001|Overall Study|Protocol deviation|1|||
144363301|NCT03137381|520538879|FG002|Overall Study|Protocol deviation|0|||
144363302|NCT03137381|520538880|FG003|Overall Study|Protocol deviation|1|||
144363303|NCT03137381|520538877|FG000|Overall Study|Withdrawal by Investigator|0|||
144363304|NCT03137381|520538878|FG001|Overall Study|Withdrawal by Investigator|1|||
144363305|NCT03137381|520538879|FG002|Overall Study|Withdrawal by Investigator|1|||
144363306|NCT03137381|520538880|FG003|Overall Study|Withdrawal by Investigator|0|||
144363307|NCT03137381|520538877|FG000|Overall Study|Withdrawal by Subject|3|||
144363308|NCT03137381|520538878|FG001|Overall Study|Withdrawal by Subject|4|||
144363309|NCT03137381|520538879|FG002|Overall Study|Withdrawal by Subject|3|||
144363310|NCT03137381|520538880|FG003|Overall Study|Withdrawal by Subject|0|||
144363311|NCT03137381|520538877|FG000|Overall Study|Pregnancy|0|||
144363312|NCT03137381|520538878|FG001|Overall Study|Pregnancy|0|||
144363313|NCT03137381|520538879|FG002|Overall Study|Pregnancy|1|||
144363314|NCT03137381|520538880|FG003|Overall Study|Pregnancy|0|||
144363315|NCT00459316|520538881|FG000|Steps 1 & 2|Other eligibility failure|1|||
144363316|NCT00459316|520538882|FG001|Steps 1 & 2|Other eligibility failure|1|||
144363317|NCT00459316|520538883|FG002|Steps 1 & 2|Other eligibility failure|0|||
144363318|NCT00459316|520538881|FG000|Steps 1 & 2|Death|1|||
144363319|NCT00459316|520538882|FG001|Steps 1 & 2|Death|1|||
144363320|NCT00459316|520538883|FG002|Steps 1 & 2|Death|0|||
144363321|NCT00459316|520538881|FG000|Steps 1 & 2|Not able to get to clinic|7|||
144363322|NCT00459316|520538882|FG001|Steps 1 & 2|Not able to get to clinic|4|||
144363323|NCT00459316|520538883|FG002|Steps 1 & 2|Not able to get to clinic|0|||
144363324|NCT00459316|520538881|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
144363325|NCT00459316|520538882|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
144363326|NCT00459316|520538883|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
144363327|NCT00459316|520538881|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
144363328|NCT00459316|520538882|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
144363329|NCT00459316|520538883|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
144363330|NCT00459316|520538881|FG000|Steps 1 & 2|Lost to Follow-up|5|||
144363331|NCT00459316|520538882|FG001|Steps 1 & 2|Lost to Follow-up|0|||
144363332|NCT00459316|520538883|FG002|Steps 1 & 2|Lost to Follow-up|2|||
144363333|NCT00459316|520538881|FG000|Step 3|Withdrawal by Subject|3|||
144363334|NCT00459316|520538882|FG001|Step 3|Withdrawal by Subject|0|||
144363335|NCT00459316|520538883|FG002|Step 3|Withdrawal by Subject|1|||
144363336|NCT01435382|520538886|FG000|Overall Study|Lost to Follow-up|1|||
144363337|NCT01435382|520538887|FG001|Overall Study|Lost to Follow-up|0|||
144363338|NCT01435382|520538888|FG002|Overall Study|Lost to Follow-up|1|||
144363339|NCT01435382|520538889|FG003|Overall Study|Lost to Follow-up|0|||
144363340|NCT01435382|520538886|FG000|Overall Study|Withdrawal by Subject|0|||
144363341|NCT01435382|520538887|FG001|Overall Study|Withdrawal by Subject|2|||
144363342|NCT01435382|520538888|FG002|Overall Study|Withdrawal by Subject|0|||
144363343|NCT01435382|520538889|FG003|Overall Study|Withdrawal by Subject|1|||
144363344|NCT00423579|520538891|FG000|Overall Study|Lost to Follow-up|3|||
144363345|NCT00423579|520538892|FG001|Overall Study|Lost to Follow-up|0|||
144363346|NCT00423579|520538891|FG000|Overall Study|Protocol Violation|1|||
144478657|NCT04534114|520951744|FG002|Main Treatment Period|Other reason|0|||
144478658|NCT04534114|520951745|FG003|Main Treatment Period|Other reason|0|||
144363347|NCT00423579|520538892|FG001|Overall Study|Protocol Violation|3|||
144363348|NCT00423579|520538891|FG000|Overall Study|Diagnosis of diabetes|0|||
144363349|NCT00423579|520538892|FG001|Overall Study|Diagnosis of diabetes|1|||
144363350|NCT01310777|520538897|FG000|Overall Study|Adverse Event|23|||
144363351|NCT01310777|520538898|FG001|Overall Study|Adverse Event|1|||
144363352|NCT01310777|520538899|FG002|Overall Study|Adverse Event|15|||
144363353|NCT01310777|520538897|FG000|Overall Study|Lost to Follow-up|0|||
144363354|NCT01310777|520538898|FG001|Overall Study|Lost to Follow-up|4|||
144363355|NCT01310777|520538899|FG002|Overall Study|Lost to Follow-up|1|||
144363356|NCT01310777|520538897|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
144363357|NCT01310777|520538898|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
144363358|NCT01310777|520538899|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
144363359|NCT01310777|520538897|FG000|Overall Study|Inadequate Control of IOP|5|||
144363360|NCT01310777|520538898|FG001|Overall Study|Inadequate Control of IOP|7|||
144363361|NCT01310777|520538899|FG002|Overall Study|Inadequate Control of IOP|10|||
144363362|NCT01310777|520538897|FG000|Overall Study|Other|4|||
144363363|NCT01310777|520538898|FG001|Overall Study|Other|1|||
144363364|NCT01310777|520538899|FG002|Overall Study|Other|2|||
144363365|NCT03962491|520538900|FG000|Overall Study|Lost to Follow-up|4|||
144363366|NCT03962491|520538901|FG001|Overall Study|Lost to Follow-up|5|||
144363367|NCT03697252|520538908|FG000|Overall Study|Adverse Event|3|||
144363368|NCT03697252|520538909|FG001|Overall Study|Adverse Event|2|||
144363369|NCT03697252|520538908|FG000|Overall Study|Withdrawal by Subject|14|||
144363370|NCT03697252|520538909|FG001|Overall Study|Withdrawal by Subject|14|||
144363371|NCT03697252|520538908|FG000|Overall Study|Lost to Follow-up|0|||
144363372|NCT03697252|520538909|FG001|Overall Study|Lost to Follow-up|1|||
144363373|NCT03697252|520538908|FG000|Overall Study|Physician Decision|1|||
144363374|NCT03697252|520538909|FG001|Overall Study|Physician Decision|1|||
144363375|NCT03697252|520538908|FG000|Overall Study|Other|0|||
144363376|NCT03697252|520538909|FG001|Overall Study|Other|1|||
144363377|NCT03125395|520538910|FG000|Overall Study|Adverse Event|2|||
144363378|NCT03125395|520538910|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
144363379|NCT03125395|520538910|FG000|Overall Study|Physician Decision|2|||
144363380|NCT03125395|520538910|FG000|Overall Study|Commercial drug is available|5|||
144363381|NCT00106704|520538911|FG000|Overall Study|Adverse Event|10|||
144363382|NCT00106704|520538912|FG001|Overall Study|Adverse Event|7|||
144363383|NCT00106704|520538911|FG000|Overall Study|Death|2|||
144363384|NCT00106704|520538912|FG001|Overall Study|Death|1|||
144363385|NCT00106704|520538911|FG000|Overall Study|Lack of Efficacy|67|||
144363386|NCT00106704|520538912|FG001|Overall Study|Lack of Efficacy|69|||
144363387|NCT00106704|520538911|FG000|Overall Study|Lost to Follow-up|7|||
144363388|NCT00106704|520538912|FG001|Overall Study|Lost to Follow-up|3|||
144363389|NCT00106704|520538911|FG000|Overall Study|Pregnancy|1|||
144363390|NCT00106704|520538912|FG001|Overall Study|Pregnancy|0|||
144363391|NCT00106704|520538911|FG000|Overall Study|Protocol Violation|4|||
144363392|NCT00106704|520538912|FG001|Overall Study|Protocol Violation|7|||
144363393|NCT00106704|520538911|FG000|Overall Study|Withdrawal by Subject|14|||
144363394|NCT00106704|520538912|FG001|Overall Study|Withdrawal by Subject|21|||
144363395|NCT00106704|520538911|FG000|Overall Study|Patient moved|1|||
144363396|NCT00106704|520538912|FG001|Overall Study|Patient moved|0|||
144363397|NCT00106704|520538911|FG000|Overall Study|Site terminated|0|||
144363398|NCT00106704|520538912|FG001|Overall Study|Site terminated|1|||
144363399|NCT00106704|520538911|FG000|Overall Study|Planned major surgery|1|||
144363400|NCT00106704|520538912|FG001|Overall Study|Planned major surgery|0|||
144363401|NCT00106704|520538911|FG000|Overall Study|Patient Received Glycemic Medication|22|||
144363402|NCT00106704|520538912|FG001|Overall Study|Patient Received Glycemic Medication|41|||
144363403|NCT00106704|520538911|FG000|Overall Study|Unable to re-enter US|1|||
144363404|NCT00106704|520538912|FG001|Overall Study|Unable to re-enter US|0|||
144363405|NCT00106704|520538911|FG000|Overall Study|Laboratory test|1|||
144363406|NCT00106704|520538912|FG001|Overall Study|Laboratory test|1|||
144363407|NCT01780506|520538913|FG000|Double-Blind Phase|Randomized but not Treated|3|||
144363408|NCT01780506|520538914|FG001|Double-Blind Phase|Randomized but not Treated|2|||
144363409|NCT01780506|520538913|FG000|Double-Blind Phase|Adverse Event|4|||
144363410|NCT01780506|520538914|FG001|Double-Blind Phase|Adverse Event|14|||
144363411|NCT01780506|520538913|FG000|Double-Blind Phase|Death|1|||
144363412|NCT01780506|520538914|FG001|Double-Blind Phase|Death|2|||
144363413|NCT01780506|520538913|FG000|Double-Blind Phase|Pregnancy|2|||
144363414|NCT01780506|520538914|FG001|Double-Blind Phase|Pregnancy|1|||
144363415|NCT01780506|520538913|FG000|Double-Blind Phase|Lack of Efficacy|1|||
144363416|NCT01780506|520538914|FG001|Double-Blind Phase|Lack of Efficacy|1|||
144363417|NCT01780506|520538913|FG000|Double-Blind Phase|Investigator's Discretion|5|||
144363418|NCT01780506|520538914|FG001|Double-Blind Phase|Investigator's Discretion|2|||
144363419|NCT01780506|520538913|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
144363420|NCT01780506|520538914|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
144363421|NCT01780506|520538913|FG000|Double-Blind Phase|Protocol Violation|4|||
144363422|NCT01780506|520538914|FG001|Double-Blind Phase|Protocol Violation|3|||
144703354|NCT05275673|521766861|FG001|Overall Study|Withdrawal by Subject|0|||
144363423|NCT01780506|520538913|FG000|Double-Blind Phase|Withdrew Consent|23|||
144363424|NCT01780506|520538914|FG001|Double-Blind Phase|Withdrew Consent|24|||
144363425|NCT01780506|520538913|FG000|Double-Blind Phase|Lost to Follow-up|23|||
144363426|NCT01780506|520538914|FG001|Double-Blind Phase|Lost to Follow-up|26|||
144363427|NCT01780506|520538913|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
144363428|NCT01780506|520538914|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
144363429|NCT03486912|520538918|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
144363430|NCT03486912|520538919|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
144363431|NCT03486912|520538920|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
144363432|NCT03486912|520538921|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
144363433|NCT03486912|520538918|FG000|Treatment Period|Withdrawal by Subject|3|||
144363434|NCT03486912|520538919|FG001|Treatment Period|Withdrawal by Subject|3|||
144363435|NCT03486912|520538920|FG002|Treatment Period|Withdrawal by Subject|3|||
144363436|NCT03486912|520538921|FG003|Treatment Period|Withdrawal by Subject|2|||
144363437|NCT03486912|520538918|FG000|Treatment Period|Other Reasons|0|||
144363438|NCT03486912|520538919|FG001|Treatment Period|Other Reasons|2|||
144363439|NCT03486912|520538920|FG002|Treatment Period|Other Reasons|1|||
144363440|NCT03486912|520538921|FG003|Treatment Period|Other Reasons|1|||
144363441|NCT03486912|520538918|FG000|Treatment Period|Adverse Event|0|||
144363442|NCT03486912|520538919|FG001|Treatment Period|Adverse Event|1|||
144363443|NCT03486912|520538920|FG002|Treatment Period|Adverse Event|1|||
144363444|NCT03486912|520538921|FG003|Treatment Period|Adverse Event|0|||
144363445|NCT03486912|520538918|FG000|Treatment Period|Lost to Follow-up|1|||
144363446|NCT03486912|520538919|FG001|Treatment Period|Lost to Follow-up|0|||
144363447|NCT03486912|520538920|FG002|Treatment Period|Lost to Follow-up|0|||
144363448|NCT03486912|520538921|FG003|Treatment Period|Lost to Follow-up|2|||
144363449|NCT00412984|520538922|FG000|Overall Study|Death|331|||
144363450|NCT00412984|520538923|FG001|Overall Study|Death|349|||
144363451|NCT00412984|520538922|FG000|Overall Study|Adverse Event|679|||
144363452|NCT00412984|520538923|FG001|Overall Study|Adverse Event|738|||
144363453|NCT00412984|520538922|FG000|Overall Study|Withdrawal by Subject|921|||
144363454|NCT00412984|520538923|FG001|Overall Study|Withdrawal by Subject|989|||
144363455|NCT00412984|520538922|FG000|Overall Study|Lost to Follow-up|51|||
144363456|NCT00412984|520538923|FG001|Overall Study|Lost to Follow-up|39|||
144363457|NCT00412984|520538922|FG000|Overall Study|Poor/Noncompliance|57|||
144363458|NCT00412984|520538923|FG001|Overall Study|Poor/Noncompliance|77|||
144363459|NCT00412984|520538922|FG000|Overall Study|Pregnancy|1|||
144363460|NCT00412984|520538923|FG001|Overall Study|Pregnancy|0|||
144363461|NCT00412984|520538922|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
144363462|NCT00412984|520538923|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
144363463|NCT00412984|520538922|FG000|Overall Study|Administrative Reason by Sponsor|11|||
144363464|NCT00412984|520538923|FG001|Overall Study|Administrative Reason by Sponsor|8|||
144363465|NCT00412984|520538922|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
144363466|NCT00412984|520538923|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
144363467|NCT00412984|520538922|FG000|Overall Study|Other Reason|80|||
144363468|NCT00412984|520538923|FG001|Overall Study|Other Reason|92|||
144363469|NCT00412984|520538922|FG000|Overall Study|Not Reported|11|||
144363470|NCT00412984|520538923|FG001|Overall Study|Not Reported|12|||
144363471|NCT00317473|520538928|FG000|Overall Study|Withdrawal by Subject|2|||
144363472|NCT00317473|520538929|FG001|Overall Study|Withdrawal by Subject|1|||
144363473|NCT00317473|520538930|FG002|Overall Study|Withdrawal by Subject|2|||
144363474|NCT00317473|520538931|FG003|Overall Study|Withdrawal by Subject|1|||
144363475|NCT00317473|520538932|FG004|Overall Study|Withdrawal by Subject|3|||
144363476|NCT00317473|520538933|FG005|Overall Study|Withdrawal by Subject|1|||
144363477|NCT00317473|520538928|FG000|Overall Study|Relocation|1|||
144363478|NCT00317473|520538929|FG001|Overall Study|Relocation|0|||
144363479|NCT00317473|520538930|FG002|Overall Study|Relocation|1|||
144363480|NCT00317473|520538931|FG003|Overall Study|Relocation|1|||
144363481|NCT00317473|520538932|FG004|Overall Study|Relocation|5|||
144363482|NCT00317473|520538933|FG005|Overall Study|Relocation|2|||
144363483|NCT00317473|520538928|FG000|Overall Study|Death|1|||
144363484|NCT00317473|520538929|FG001|Overall Study|Death|0|||
144363485|NCT00317473|520538930|FG002|Overall Study|Death|0|||
144363486|NCT00317473|520538931|FG003|Overall Study|Death|0|||
144363487|NCT00317473|520538932|FG004|Overall Study|Death|0|||
144363488|NCT00317473|520538933|FG005|Overall Study|Death|0|||
144363489|NCT00317473|520538928|FG000|Overall Study|Other|0|||
144363490|NCT00317473|520538929|FG001|Overall Study|Other|2|||
144363491|NCT00317473|520538930|FG002|Overall Study|Other|0|||
144363492|NCT00317473|520538931|FG003|Overall Study|Other|0|||
144363493|NCT00317473|520538932|FG004|Overall Study|Other|0|||
144363494|NCT00317473|520538933|FG005|Overall Study|Other|0|||
144363495|NCT04609319|520538938|FG000|Overall Study|Death|64|||
144363496|NCT04609319|520538939|FG001|Overall Study|Death|49|||
144363497|NCT04609319|520538940|FG002|Overall Study|Death|1|||
144363498|NCT04609319|520538938|FG000|Overall Study|Withdrawal of consent|15|||
144363499|NCT04609319|520538939|FG001|Overall Study|Withdrawal of consent|3|||
144363500|NCT04609319|520538940|FG002|Overall Study|Withdrawal of consent|0|||
144363501|NCT04609319|520538938|FG000|Overall Study|Lost to Follow-up|20|||
144363502|NCT04609319|520538939|FG001|Overall Study|Lost to Follow-up|33|||
144363503|NCT04609319|520538940|FG002|Overall Study|Lost to Follow-up|0|||
144363504|NCT04609319|520538938|FG000|Overall Study|Alive until end of follow-up|60|||
144363505|NCT04609319|520538939|FG001|Overall Study|Alive until end of follow-up|53|||
144363506|NCT04609319|520538940|FG002|Overall Study|Alive until end of follow-up|1|||
144363507|NCT02331134|520538941|FG000|Overall Study|Withdrawal by Subject|1|||
144363508|NCT04825574|520538942|FG000|Overall Study|Commercial treatment became available|1|||
144363509|NCT04825574|520538942|FG000|Overall Study|Disease progression|1|||
144363510|NCT03518086|520538943|FG000|Overall Study|Adverse Event|23|||
144363511|NCT03518086|520538944|FG001|Overall Study|Adverse Event|15|||
144363512|NCT03518086|520538945|FG002|Overall Study|Adverse Event|3|||
144363513|NCT03518086|520538946|FG003|Overall Study|Adverse Event|2|||
144363514|NCT03518086|520538943|FG000|Overall Study|Withdrawal by Subject|8|||
144363515|NCT03518086|520538944|FG001|Overall Study|Withdrawal by Subject|5|||
144363516|NCT03518086|520538945|FG002|Overall Study|Withdrawal by Subject|1|||
144363517|NCT03518086|520538946|FG003|Overall Study|Withdrawal by Subject|0|||
144363518|NCT03518086|520538943|FG000|Overall Study|Lack of Efficacy|5|||
144363519|NCT03518086|520538944|FG001|Overall Study|Lack of Efficacy|5|||
144363520|NCT03518086|520538945|FG002|Overall Study|Lack of Efficacy|0|||
144363521|NCT03518086|520538946|FG003|Overall Study|Lack of Efficacy|2|||
144363522|NCT03518086|520538943|FG000|Overall Study|Protocol Violation|1|||
144363523|NCT03518086|520538944|FG001|Overall Study|Protocol Violation|5|||
144363524|NCT03518086|520538945|FG002|Overall Study|Protocol Violation|1|||
144363525|NCT03518086|520538946|FG003|Overall Study|Protocol Violation|3|||
144363526|NCT03518086|520538943|FG000|Overall Study|Lost to Follow-up|0|||
144363527|NCT03518086|520538944|FG001|Overall Study|Lost to Follow-up|3|||
144363528|NCT03518086|520538945|FG002|Overall Study|Lost to Follow-up|0|||
144363529|NCT03518086|520538946|FG003|Overall Study|Lost to Follow-up|0|||
144363530|NCT03518086|520538943|FG000|Overall Study|Insufficient Diary Data|0|||
144363531|NCT03518086|520538944|FG001|Overall Study|Insufficient Diary Data|2|||
144363532|NCT03518086|520538945|FG002|Overall Study|Insufficient Diary Data|0|||
144363533|NCT03518086|520538946|FG003|Overall Study|Insufficient Diary Data|0|||
144363534|NCT03518086|520538943|FG000|Overall Study|Non- compliance to Protocol|0|||
144363535|NCT03518086|520538944|FG001|Overall Study|Non- compliance to Protocol|1|||
144363536|NCT03518086|520538945|FG002|Overall Study|Non- compliance to Protocol|0|||
144363537|NCT03518086|520538946|FG003|Overall Study|Non- compliance to Protocol|0|||
144363538|NCT03518086|520538943|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
144363539|NCT03518086|520538944|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
144363540|NCT03518086|520538945|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
144363541|NCT03518086|520538946|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
144363542|NCT03518086|520538943|FG000|Overall Study|Site Terminated by Sponsor|0|||
144363543|NCT03518086|520538944|FG001|Overall Study|Site Terminated by Sponsor|1|||
144363544|NCT03518086|520538945|FG002|Overall Study|Site Terminated by Sponsor|0|||
144363545|NCT03518086|520538946|FG003|Overall Study|Site Terminated by Sponsor|0|||
144363546|NCT03518086|520538943|FG000|Overall Study|Pregnancy|0|||
144363547|NCT03518086|520538944|FG001|Overall Study|Pregnancy|0|||
144363548|NCT03518086|520538945|FG002|Overall Study|Pregnancy|0|||
144363549|NCT03518086|520538946|FG003|Overall Study|Pregnancy|2|||
144363550|NCT03253393|520538947|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
144363551|NCT03253393|520538948|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
144363552|NCT03253393|520538949|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
144363553|NCT03204188|520538950|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
144363554|NCT03204188|520538950|FG000|Immunotherapy Phase (1 Year)|Death|1|||
144363555|NCT03204188|520538950|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
144363556|NCT03204188|520538950|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
144363557|NCT00744497|520540912|FG000|Overall Study|Withdrawal by Subject|21|||
144363558|NCT00744497|520540913|FG001|Overall Study|Withdrawal by Subject|18|||
144363559|NCT00744497|520540912|FG000|Overall Study|Death|11|||
144363560|NCT00744497|520540913|FG001|Overall Study|Death|9|||
144363561|NCT00744497|520540912|FG000|Overall Study|Lost to Follow-up|4|||
144363562|NCT00744497|520540913|FG001|Overall Study|Lost to Follow-up|2|||
144363563|NCT00744497|520540912|FG000|Overall Study|Poor compliance/noncompliance|9|||
144363564|NCT00744497|520540913|FG001|Overall Study|Poor compliance/noncompliance|5|||
144363565|NCT00744497|520540912|FG000|Overall Study|No longer meets study criteria|7|||
144363566|NCT00744497|520540913|FG001|Overall Study|No longer meets study criteria|3|||
144363567|NCT00744497|520540912|FG000|Overall Study|Administrative Reason By Sponsor|25|||
144363568|NCT00744497|520540913|FG001|Overall Study|Administrative Reason By Sponsor|8|||
144363569|NCT00744497|520540912|FG000|Overall Study|Disease progression|312|||
144363570|NCT00744497|520540913|FG001|Overall Study|Disease progression|219|||
144363571|NCT00744497|520540912|FG000|Overall Study|Study drug toxicity|68|||
144363572|NCT00744497|520540913|FG001|Overall Study|Study drug toxicity|141|||
144363573|NCT00744497|520540912|FG000|Overall Study|Adverse event unrelated to study drug|78|||
144363574|NCT00744497|520540913|FG001|Overall Study|Adverse event unrelated to study drug|122|||
144363575|NCT00744497|520540912|FG000|Overall Study|Patient requested to stop study drug|65|||
144363576|NCT00744497|520540913|FG001|Overall Study|Patient requested to stop study drug|80|||
144363577|NCT00744497|520540912|FG000|Overall Study|Maximum clinical benefit|141|||
144363578|NCT00744497|520540913|FG001|Overall Study|Maximum clinical benefit|142|||
144363579|NCT00744497|520540912|FG000|Overall Study|Not defined|19|||
144363580|NCT00744497|520540913|FG001|Overall Study|Not defined|13|||
144363581|NCT03182374|520540918|FG000|Overall Study|Lost to Follow-up|3|||
144363582|NCT03182374|520540919|FG001|Overall Study|Lost to Follow-up|2|||
144363583|NCT03182374|520540918|FG000|Overall Study|Lack of Efficacy|8|||
144363584|NCT03182374|520540919|FG001|Overall Study|Lack of Efficacy|14|||
144363585|NCT03182374|520540918|FG000|Overall Study|Withdrawal by Subject|1|||
144363586|NCT03182374|520540919|FG001|Overall Study|Withdrawal by Subject|1|||
144363587|NCT03182374|520540918|FG000|Overall Study|exit for non-compliance|1|||
144363588|NCT03182374|520540919|FG001|Overall Study|exit for non-compliance|1|||
144363589|NCT03182374|520540918|FG000|Overall Study|one subject was randomized but not treated|1|||
144538194|NCT00146172|521174123|FG001|Overall Study|Lost to Follow-up|0|||
144363590|NCT03182374|520540919|FG001|Overall Study|one subject was randomized but not treated|0|||
144363591|NCT03182374|520540918|FG000|Overall Study|Other reasons|0|||
144363592|NCT03182374|520540919|FG001|Overall Study|Other reasons|3|||
144363593|NCT03198715|520540923|FG000|Overall Study|Death|0|||
144363594|NCT03198715|520540924|FG001|Overall Study|Death|0|||
144363595|NCT03198715|520540925|FG002|Overall Study|Death|1|||
144363596|NCT03198715|520540926|FG003|Overall Study|Death|0|||
144363597|NCT03198715|520540927|FG004|Overall Study|Death|2|||
144363598|NCT03198715|520540923|FG000|Overall Study|Other|0|||
144363599|NCT03198715|520540924|FG001|Overall Study|Other|1|||
144363600|NCT03198715|520540925|FG002|Overall Study|Other|1|||
144363601|NCT03198715|520540926|FG003|Overall Study|Other|0|||
144363602|NCT03198715|520540927|FG004|Overall Study|Other|0|||
144363603|NCT00914316|520540932|FG000|Phase 1|Physician Decision|4|||
144363604|NCT00914316|520540933|FG001|Phase 1|Physician Decision|0|||
144363605|NCT00914316|520540934|FG002|Phase 1|Physician Decision|1|||
144363606|NCT00914316|520540935|FG003|Phase 1|Physician Decision|2|||
144363607|NCT00914316|520540932|FG000|Phase 1|Withdrawal by Subject|0|||
144363608|NCT00914316|520540933|FG001|Phase 1|Withdrawal by Subject|2|||
144363609|NCT00914316|520540934|FG002|Phase 1|Withdrawal by Subject|4|||
144363610|NCT00914316|520540935|FG003|Phase 1|Withdrawal by Subject|0|||
144363611|NCT00914316|520540932|FG000|Phase 1|Adverse Event|1|||
144363612|NCT00914316|520540933|FG001|Phase 1|Adverse Event|0|||
144363613|NCT00914316|520540934|FG002|Phase 1|Adverse Event|0|||
144363614|NCT00914316|520540935|FG003|Phase 1|Adverse Event|0|||
144363615|NCT00914316|520540932|FG000|Phase 2|Withdrawal by Subject|1|||
144363616|NCT00914316|520540933|FG001|Phase 2|Withdrawal by Subject|0|||
144363617|NCT00914316|520540934|FG002|Phase 2|Withdrawal by Subject|1|||
144363618|NCT00914316|520540935|FG003|Phase 2|Withdrawal by Subject|0|||
144363619|NCT02177123|520540940|FG000|Overall Study|Lost to Follow-up|6|||
144363620|NCT02177123|520540940|FG000|Overall Study|Withdrawal by Subject|4|||
144363621|NCT02177123|520540940|FG000|Overall Study|Adverse Event|4|||
144363622|NCT02177123|520540940|FG000|Overall Study|Physician Decision|3|||
144363623|NCT02177123|520540940|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
144363624|NCT02177123|520540940|FG000|Overall Study|Excluded for medical reasons|2|||
144363625|NCT02177123|520540940|FG000|Overall Study|Death|1|||
144363626|NCT02177123|520540940|FG000|Overall Study|Other|1|||
144363627|NCT02177123|520540940|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
144363628|NCT01391546|520540941|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
144363629|NCT01391546|520540942|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
144363630|NCT00481832|520540951|FG000|Enrollment|Physician Decision|8|||
144363631|NCT00481832|520540951|FG000|Enrollment|Unable to collect enough stem cells|2|||
144363632|NCT00481832|520540951|FG000|Inter-transplant Period|Adverse Event|4|||
144363633|NCT00481832|520540951|FG000|Inter-transplant Period|Death|3|||
144363634|NCT00481832|520540951|FG000|Inter-transplant Period|Physician Decision|4|||
144363635|NCT00481832|520540951|FG000|Inter-transplant Period|Disease relapse|11|||
144363636|NCT00481832|520540951|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
144363637|NCT00581308|520540952|FG000|Pre Discharge|Lost to Follow-up|1|||
144363638|NCT00581308|520540952|FG000|Pre Discharge|Device Removed|1|||
144363639|NCT00581308|520540952|FG000|Month 1|Lost to Follow-up|3|||
144363640|NCT00581308|520540952|FG000|Month 1|Withdrawal by Subject|2|||
144363641|NCT00581308|520540952|FG000|Month 1|Device Removed|2|||
144363642|NCT00581308|520540952|FG000|Month 1|Uknown|1|||
144363643|NCT00581308|520540952|FG000|Month 6|Lost to Follow-up|1|||
144363644|NCT00581308|520540952|FG000|Month 6|Withdrawal by Subject|2|||
144363645|NCT00581308|520540952|FG000|Month 12|Death|1|||
144363646|NCT00581308|520540952|FG000|Month 12|Lost to Follow-up|14|||
144363647|NCT00581308|520540952|FG000|Month 12|Withdrawal by Subject|3|||
144363648|NCT00581308|520540952|FG000|Month 12|Device Removed|1|||
144363649|NCT00581308|520540952|FG000|Month 12|Other|1|||
144363650|NCT02006472|520540956|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
144363651|NCT02006472|520540957|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
144363652|NCT02006472|520540958|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
144363653|NCT02006472|520540959|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
144363654|NCT02006472|520540960|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
144363655|NCT02006472|520540956|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
144363656|NCT02006472|520540957|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
144363657|NCT02006472|520540958|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
144363658|NCT02006472|520540959|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
144363659|NCT02006472|520540960|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
144363660|NCT02006472|520540956|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
144363661|NCT02006472|520540957|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
144363662|NCT02006472|520540958|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
144363663|NCT02006472|520540959|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
144363664|NCT02006472|520540960|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
144363665|NCT02006472|520540956|FG000|Period 1 (Through Week 26)|Other|1|||
144363666|NCT02006472|520540957|FG001|Period 1 (Through Week 26)|Other|5|||
144363667|NCT02006472|520540958|FG002|Period 1 (Through Week 26)|Other|0|||
144363668|NCT02006472|520540959|FG003|Period 1 (Through Week 26)|Other|2|||
144363669|NCT02006472|520540960|FG004|Period 1 (Through Week 26)|Other|3|||
144363670|NCT02006472|520540956|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
144363671|NCT02006472|520540957|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
144363672|NCT02006472|520540958|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
144363673|NCT02006472|520540959|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
144363674|NCT02006472|520540960|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
144363675|NCT02006472|520540956|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
144363676|NCT02006472|520540957|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
144363677|NCT02006472|520540958|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
144363678|NCT02006472|520540959|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
144363679|NCT02006472|520540960|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
144363680|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
144363681|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
144363682|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
144363683|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
144363684|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
144363685|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
144363686|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
144363687|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
144363688|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
144363689|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
144363690|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
144363691|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
144363692|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
144363693|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
144363694|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
144363695|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Other|0|||
144363696|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Other|1|||
144363697|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Other|0|||
144363698|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Other|1|||
144363699|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Other|0|||
144363700|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Not treated|0|||
144363701|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Not treated|0|||
144363702|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Not treated|2|||
144363703|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Not treated|0|||
144363704|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Not treated|0|||
144363705|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
144363706|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
144363707|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
144363708|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
144363709|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
144363710|NCT02006472|520540956|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
144363711|NCT02006472|520540957|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
144363712|NCT02006472|520540958|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
144363713|NCT02006472|520540959|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
144363714|NCT02006472|520540960|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
144363715|NCT00886379|520540961|FG000|Overall Study|Transferred Schools|0|||
144363716|NCT00886379|520540962|FG001|Overall Study|Transferred Schools|0|||
144363717|NCT00886379|520540963|FG002|Overall Study|Transferred Schools|2|||
144363718|NCT00886379|520540964|FG003|Overall Study|Transferred Schools|1|||
144363719|NCT00886379|520540965|FG004|Overall Study|Transferred Schools|1|||
144363720|NCT00886379|520540961|FG000|Overall Study|Final blood draw not obtained|3|||
144363721|NCT00886379|520540962|FG001|Overall Study|Final blood draw not obtained|3|||
144363722|NCT00886379|520540963|FG002|Overall Study|Final blood draw not obtained|4|||
144363723|NCT00886379|520540964|FG003|Overall Study|Final blood draw not obtained|2|||
144363724|NCT00886379|520540965|FG004|Overall Study|Final blood draw not obtained|2|||
144363725|NCT03219723|520540966|FG000|Overall Study|Case Report Forms Uncollected|6|||
144363726|NCT03219723|520540966|FG000|Overall Study|Protocol Deviation|4|||
144363727|NCT01980017|520540971|FG000|Overall Study|Lost to Follow-up|30|||
144363728|NCT01980017|520540972|FG001|Overall Study|Lost to Follow-up|21|||
144363729|NCT01980017|520540971|FG000|Overall Study|Death|0|||
144363730|NCT01980017|520540972|FG001|Overall Study|Death|1|||
144363731|NCT03044106|520540974|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
144363732|NCT03044106|520540975|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
144363733|NCT01207414|520540976|FG000|Overall Study|Adverse Event|25|||
144363734|NCT01207414|520540977|FG001|Overall Study|Adverse Event|39|||
144363735|NCT01207414|520540976|FG000|Overall Study|Abnormal test procedure results|0|||
144363736|NCT01207414|520540977|FG001|Overall Study|Abnormal test procedure results|1|||
144363737|NCT01207414|520540976|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
144363738|NCT01207414|520540977|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
144363739|NCT01207414|520540976|FG000|Overall Study|Patient withdrew consent|14|||
144363740|NCT01207414|520540977|FG001|Overall Study|Patient withdrew consent|11|||
144363741|NCT01207414|520540976|FG000|Overall Study|Lost to Follow-up|15|||
144363742|NCT01207414|520540977|FG001|Overall Study|Lost to Follow-up|17|||
144363743|NCT01207414|520540976|FG000|Overall Study|Administrative problems|1|||
144363744|NCT01207414|520540977|FG001|Overall Study|Administrative problems|1|||
144363745|NCT01207414|520540976|FG000|Overall Study|Protocol deviation|12|||
144363746|NCT01207414|520540977|FG001|Overall Study|Protocol deviation|9|||
144363747|NCT01207414|520540976|FG000|Overall Study|Randomized in error|1|||
144363748|NCT01207414|520540977|FG001|Overall Study|Randomized in error|0|||
144363749|NCT01748292|520540978|FG000|Overall Study|Adverse Event|2|||
144363750|NCT01748292|520540979|FG001|Overall Study|Adverse Event|4|||
144363751|NCT01748292|520540978|FG000|Overall Study|Lost to Follow-up|0|||
144363752|NCT01748292|520540979|FG001|Overall Study|Lost to Follow-up|3|||
144363753|NCT01748292|520540978|FG000|Overall Study|Death|0|||
144363754|NCT01748292|520540979|FG001|Overall Study|Death|3|||
144363755|NCT01748292|520540978|FG000|Overall Study|Withdrawal by Subject|0|||
144363756|NCT01748292|520540979|FG001|Overall Study|Withdrawal by Subject|2|||
144363757|NCT02057250|520540980|FG000|AID Assessment Phase|Adverse Event|3|||
144363758|NCT02057250|520540981|FG001|AID Assessment Phase|Adverse Event|2|||
144363759|NCT02057250|520540982|FG002|AID Assessment Phase|Adverse Event|6|||
144363760|NCT02057250|520540983|FG003|AID Assessment Phase|Adverse Event|1|||
144363761|NCT02057250|520540984|FG004|AID Assessment Phase|Adverse Event|0|||
144363762|NCT02057250|520540980|FG000|AID Assessment Phase|Other than specified above|1|||
144363763|NCT02057250|520540981|FG001|AID Assessment Phase|Other than specified above|1|||
144363764|NCT02057250|520540982|FG002|AID Assessment Phase|Other than specified above|1|||
144363765|NCT02057250|520540983|FG003|AID Assessment Phase|Other than specified above|1|||
144363766|NCT02057250|520540984|FG004|AID Assessment Phase|Other than specified above|0|||
144363767|NCT02057250|520540980|FG000|Extension Phase|Adverse Event|0|||
144363768|NCT02057250|520540981|FG001|Extension Phase|Adverse Event|0|||
144363769|NCT02057250|520540982|FG002|Extension Phase|Adverse Event|0|||
144363770|NCT02057250|520540983|FG003|Extension Phase|Adverse Event|0|||
144363771|NCT02057250|520540984|FG004|Extension Phase|Adverse Event|15|||
144363772|NCT02057250|520540980|FG000|Extension Phase|Lack of Efficacy|0|||
144363773|NCT02057250|520540981|FG001|Extension Phase|Lack of Efficacy|0|||
144363774|NCT02057250|520540982|FG002|Extension Phase|Lack of Efficacy|0|||
144363775|NCT02057250|520540983|FG003|Extension Phase|Lack of Efficacy|0|||
144363776|NCT02057250|520540984|FG004|Extension Phase|Lack of Efficacy|10|||
144363777|NCT02057250|520540980|FG000|Extension Phase|Entered in this period but not treated|0|||
144363778|NCT02057250|520540981|FG001|Extension Phase|Entered in this period but not treated|0|||
144363779|NCT02057250|520540982|FG002|Extension Phase|Entered in this period but not treated|0|||
144363780|NCT02057250|520540983|FG003|Extension Phase|Entered in this period but not treated|0|||
144363781|NCT02057250|520540984|FG004|Extension Phase|Entered in this period but not treated|4|||
144363782|NCT02057250|520540980|FG000|Extension Phase|Other than specified above|0|||
144363783|NCT02057250|520540981|FG001|Extension Phase|Other than specified above|0|||
144363784|NCT02057250|520540982|FG002|Extension Phase|Other than specified above|0|||
144363785|NCT02057250|520540983|FG003|Extension Phase|Other than specified above|0|||
144363786|NCT02057250|520540984|FG004|Extension Phase|Other than specified above|7|||
144363787|NCT00910650|520540985|FG000|Overall Study|Death|2|||
144363788|NCT02383576|520540986|FG000|Overall Study|Death|53|||
144363789|NCT02383576|520540987|FG001|Overall Study|Death|33|||
144363790|NCT02383576|520540986|FG000|Overall Study|Lost to Follow-up|7|||
144363791|NCT02383576|520540987|FG001|Overall Study|Lost to Follow-up|1|||
144363792|NCT02383576|520540986|FG000|Overall Study|Withdrew Consent|1|||
144363793|NCT02383576|520540987|FG001|Overall Study|Withdrew Consent|6|||
144363794|NCT02383576|520540986|FG000|Overall Study|Investigator's Decision|0|||
144363795|NCT02383576|520540987|FG001|Overall Study|Investigator's Decision|1|||
144363796|NCT02383576|520540986|FG000|Overall Study|Administrative/Other|2|||
144363797|NCT02383576|520540987|FG001|Overall Study|Administrative/Other|4|||
144363798|NCT04218240|520540988|FG000|Overall Study|Withdrawal by Subject|6|||
144363799|NCT04218240|520540989|FG001|Overall Study|Withdrawal by Subject|0|||
144363800|NCT04218240|520540988|FG000|Overall Study|Lack of Efficacy|24|||
144363801|NCT04218240|520540989|FG001|Overall Study|Lack of Efficacy|19|||
144363802|NCT04218240|520540988|FG000|Overall Study|Physician Decision|0|||
144363803|NCT04218240|520540989|FG001|Overall Study|Physician Decision|1|||
144363804|NCT04218240|520540988|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
144363805|NCT04218240|520540989|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
144363806|NCT04097678|520540990|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
144363807|NCT04097678|520540991|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
144363808|NCT03694678|520540992|FG000|Overall Study|Withdrawal by Subject|2|||
144363809|NCT03694678|520540993|FG001|Overall Study|Withdrawal by Subject|0|||
144363810|NCT03694678|520540992|FG000|Overall Study|Lost to Follow-up|2|||
144363811|NCT03694678|520540993|FG001|Overall Study|Lost to Follow-up|3|||
144363812|NCT04852302|520541008|FG000|Overall Study|Withdrawal by Subject|2|||
144363813|NCT04852302|520541008|FG000|Overall Study|Did not complete CALM therapy.|2|||
144363814|NCT03267277|520541009|FG000|Overall Study|Withdrawal by Subject|1|||
144363815|NCT01436149|520541010|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
144363816|NCT01436149|520541011|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
144363817|NCT01436149|520541012|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
144363818|NCT01436149|520541010|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
144363819|NCT01436149|520541011|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
144363820|NCT01436149|520541012|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
144363821|NCT01436149|520541010|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
144363822|NCT01436149|520541011|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144363823|NCT01436149|520541012|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144363824|NCT01436149|520541010|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
144363825|NCT01436149|520541011|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144363826|NCT01436149|520541012|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144363827|NCT01436149|520541010|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
144363828|NCT01436149|520541011|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
144363829|NCT01436149|520541012|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
144363830|NCT01436149|520541010|FG000|Antidepressant Lead-in Phase|Other|119|||
144363831|NCT01436149|520541011|FG001|Antidepressant Lead-in Phase|Other|0|||
144363832|NCT01436149|520541012|FG002|Antidepressant Lead-in Phase|Other|0|||
144363833|NCT01436149|520541010|FG000|Randomized Phase|Adverse Event|9|||
144363834|NCT01436149|520541011|FG001|Randomized Phase|Adverse Event|10|||
144363835|NCT01436149|520541012|FG002|Randomized Phase|Adverse Event|11|||
144363836|NCT01436149|520541010|FG000|Randomized Phase|Protocol Violation|4|||
144363837|NCT01436149|520541011|FG001|Randomized Phase|Protocol Violation|5|||
144363838|NCT01436149|520541012|FG002|Randomized Phase|Protocol Violation|0|||
144363839|NCT01436149|520541010|FG000|Randomized Phase|Withdrawal by Subject|16|||
144363840|NCT01436149|520541011|FG001|Randomized Phase|Withdrawal by Subject|10|||
144363841|NCT01436149|520541012|FG002|Randomized Phase|Withdrawal by Subject|10|||
144363842|NCT01436149|520541010|FG000|Randomized Phase|Lost to Follow-up|34|||
144363843|NCT01436149|520541011|FG001|Randomized Phase|Lost to Follow-up|5|||
144363844|NCT01436149|520541012|FG002|Randomized Phase|Lost to Follow-up|6|||
144363845|NCT01436149|520541010|FG000|Randomized Phase|Lack of Efficacy|0|||
144363846|NCT01436149|520541011|FG001|Randomized Phase|Lack of Efficacy|0|||
144363847|NCT01436149|520541012|FG002|Randomized Phase|Lack of Efficacy|1|||
144363848|NCT01436149|520541010|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
144363849|NCT01436149|520541011|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
144363850|NCT01436149|520541012|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
144363851|NCT01436149|520541010|FG000|Randomized Phase|Other|12|||
144363852|NCT01436149|520541011|FG001|Randomized Phase|Other|5|||
144363853|NCT01436149|520541012|FG002|Randomized Phase|Other|11|||
144363854|NCT04849364|520541014|FG000|Overall Study|Eligibility criteria not meet|0|||
144363855|NCT04849364|520541015|FG001|Overall Study|Eligibility criteria not meet|1|||
144363856|NCT04849364|520541016|FG002|Overall Study|Eligibility criteria not meet|0|||
144363857|NCT02738801|520541025|FG000|Overall Study|Adverse Event|1|||
144363858|NCT02738801|520541026|FG001|Overall Study|Adverse Event|1|||
144363859|NCT02738801|520541025|FG000|Overall Study|Withdrawal by Subject|0|||
144363860|NCT02738801|520541026|FG001|Overall Study|Withdrawal by Subject|1|||
144363861|NCT01643668|520541027|FG000|Overall Study|Death|1|||
144363862|NCT03253796|520541038|FG000|Period 1: Run-In|Adverse Event|4|||
144363863|NCT03253796|520541039|FG001|Period 1: Run-In|Adverse Event|0|||
144363864|NCT03253796|520541040|FG002|Period 1: Run-In|Adverse Event|0|||
144363865|NCT03253796|520541041|FG003|Period 1: Run-In|Adverse Event|0|||
144363866|NCT03253796|520541042|FG004|Period 1: Run-In|Adverse Event|0|||
144363867|NCT03253796|520541038|FG000|Period 1: Run-In|Lack of Efficacy|1|||
144363868|NCT03253796|520541039|FG001|Period 1: Run-In|Lack of Efficacy|0|||
144363869|NCT03253796|520541040|FG002|Period 1: Run-In|Lack of Efficacy|0|||
144363870|NCT03253796|520541041|FG003|Period 1: Run-In|Lack of Efficacy|0|||
144363871|NCT03253796|520541042|FG004|Period 1: Run-In|Lack of Efficacy|0|||
144363872|NCT03253796|520541038|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
144363873|NCT03253796|520541039|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
144363874|NCT03253796|520541040|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
144363875|NCT03253796|520541041|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
144363876|NCT03253796|520541042|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
144363877|NCT03253796|520541038|FG000|Period 1: Run-In|Protocol Violation|5|||
144363878|NCT03253796|520541039|FG001|Period 1: Run-In|Protocol Violation|0|||
144363879|NCT03253796|520541040|FG002|Period 1: Run-In|Protocol Violation|0|||
144363880|NCT03253796|520541041|FG003|Period 1: Run-In|Protocol Violation|0|||
144363881|NCT03253796|520541042|FG004|Period 1: Run-In|Protocol Violation|0|||
144363882|NCT03253796|520541038|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
144363883|NCT03253796|520541039|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
144363884|NCT03253796|520541040|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
144363885|NCT03253796|520541041|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
144363886|NCT03253796|520541042|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
144363887|NCT03253796|520541038|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
144363888|NCT03253796|520541039|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
144363889|NCT03253796|520541040|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
144363890|NCT03253796|520541041|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
144363891|NCT03253796|520541042|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
144363892|NCT03253796|520541038|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
144363893|NCT03253796|520541039|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
144363894|NCT03253796|520541040|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
144363895|NCT03253796|520541041|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
144363896|NCT03253796|520541042|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
144363897|NCT03253796|520541038|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
144363898|NCT03253796|520541039|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
144363899|NCT03253796|520541040|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
144363900|NCT03253796|520541041|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
144363901|NCT03253796|520541042|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
144363902|NCT03253796|520541038|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
144363903|NCT03253796|520541039|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
144363904|NCT03253796|520541040|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
144363905|NCT03253796|520541041|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
144363906|NCT03253796|520541042|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
144363907|NCT03253796|520541038|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
144363908|NCT03253796|520541039|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
144363909|NCT03253796|520541040|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
144363910|NCT03253796|520541041|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
144363911|NCT03253796|520541042|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
144363912|NCT03253796|520541038|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
144363913|NCT03253796|520541039|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
144363914|NCT03253796|520541040|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
144363915|NCT03253796|520541041|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
144363916|NCT03253796|520541042|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
144363917|NCT00894803|520541043|FG000|Overall Study|Death|20|||
144363918|NCT00894803|520541044|FG001|Overall Study|Death|4|||
144363919|NCT00894803|520541043|FG000|Overall Study|Lost to Follow-up|0|||
144363920|NCT00894803|520541044|FG001|Overall Study|Lost to Follow-up|1|||
144363921|NCT01075243|520541046|FG000|Overall Study|Lost to Follow-up|5|||
144363922|NCT01075243|520541047|FG001|Overall Study|Lost to Follow-up|2|||
144363923|NCT01075243|520541048|FG002|Overall Study|Lost to Follow-up|0|||
144363924|NCT01075243|520541046|FG000|Overall Study|Withdrawal by Subject|1|||
144703355|NCT02325739|521766862|FG000|Phase I Part|Adverse Event|1|||
144363925|NCT01075243|520541047|FG001|Overall Study|Withdrawal by Subject|1|||
144363926|NCT01075243|520541048|FG002|Overall Study|Withdrawal by Subject|0|||
144363927|NCT03094416|520541054|FG000|Run-in|Screening failure|8|||
144363928|NCT03094416|520541054|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
144363929|NCT03094416|520541054|FG000|Run-in|Withdrawal by Subject|3|||
144363930|NCT03094416|520541054|FG000|Treatment Period|Withdrawal by Subject|2|||
144363931|NCT03050801|520541057|FG000|Experiment 1|Lost to Follow-up|0|||
144363932|NCT03050801|520541058|FG001|Experiment 1|Lost to Follow-up|1|||
144363933|NCT03050801|520541059|FG002|Experiment 1|Lost to Follow-up|0|||
144363934|NCT03050801|520541060|FG003|Experiment 1|Lost to Follow-up|0|||
144363935|NCT03050801|520541061|FG004|Experiment 1|Lost to Follow-up|0|||
144363936|NCT03050801|520541062|FG005|Experiment 1|Lost to Follow-up|0|||
144363937|NCT03050801|520541057|FG000|Experiment 1|Physician Decision|0|||
144363938|NCT03050801|520541058|FG001|Experiment 1|Physician Decision|3|||
144363939|NCT03050801|520541059|FG002|Experiment 1|Physician Decision|0|||
144363940|NCT03050801|520541060|FG003|Experiment 1|Physician Decision|0|||
144363941|NCT03050801|520541061|FG004|Experiment 1|Physician Decision|0|||
144363942|NCT03050801|520541062|FG005|Experiment 1|Physician Decision|0|||
144363943|NCT03050801|520541057|FG000|Experiment 1|Change of experimental design|0|||
144363944|NCT03050801|520541058|FG001|Experiment 1|Change of experimental design|3|||
144363945|NCT03050801|520541059|FG002|Experiment 1|Change of experimental design|0|||
144363946|NCT03050801|520541060|FG003|Experiment 1|Change of experimental design|0|||
144363947|NCT03050801|520541061|FG004|Experiment 1|Change of experimental design|0|||
144363948|NCT03050801|520541062|FG005|Experiment 1|Change of experimental design|0|||
144363949|NCT03050801|520541057|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
144363950|NCT03050801|520541058|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
144363951|NCT03050801|520541059|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
144363952|NCT03050801|520541060|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
144363953|NCT03050801|520541061|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
144363954|NCT03050801|520541062|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
144363955|NCT03050801|520541057|FG000|Experiment 2|Lost to Follow-up|0|||
144363956|NCT03050801|520541058|FG001|Experiment 2|Lost to Follow-up|0|||
144363957|NCT03050801|520541059|FG002|Experiment 2|Lost to Follow-up|0|||
144363958|NCT03050801|520541060|FG003|Experiment 2|Lost to Follow-up|1|||
144363959|NCT03050801|520541061|FG004|Experiment 2|Lost to Follow-up|1|||
144363960|NCT03050801|520541062|FG005|Experiment 2|Lost to Follow-up|0|||
144363961|NCT03050801|520541057|FG000|Experiment 2|Physician Decision|0|||
144363962|NCT03050801|520541058|FG001|Experiment 2|Physician Decision|0|||
144363963|NCT03050801|520541059|FG002|Experiment 2|Physician Decision|0|||
144363964|NCT03050801|520541060|FG003|Experiment 2|Physician Decision|0|||
144363965|NCT03050801|520541061|FG004|Experiment 2|Physician Decision|1|||
144363966|NCT03050801|520541062|FG005|Experiment 2|Physician Decision|0|||
144363967|NCT03050801|520541057|FG000|Experiment 2|Pregnancy|0|||
144363968|NCT03050801|520541058|FG001|Experiment 2|Pregnancy|0|||
144363969|NCT03050801|520541059|FG002|Experiment 2|Pregnancy|0|||
144363970|NCT03050801|520541060|FG003|Experiment 2|Pregnancy|0|||
144363971|NCT03050801|520541061|FG004|Experiment 2|Pregnancy|1|||
144363972|NCT03050801|520541062|FG005|Experiment 2|Pregnancy|0|||
144363973|NCT03050801|520541057|FG000|Experiment 2|Withdrawal by Subject|0|||
144363974|NCT03050801|520541058|FG001|Experiment 2|Withdrawal by Subject|0|||
144363975|NCT03050801|520541059|FG002|Experiment 2|Withdrawal by Subject|0|||
144363976|NCT03050801|520541060|FG003|Experiment 2|Withdrawal by Subject|1|||
144363977|NCT03050801|520541061|FG004|Experiment 2|Withdrawal by Subject|0|||
144363978|NCT03050801|520541062|FG005|Experiment 2|Withdrawal by Subject|0|||
144363979|NCT03050801|520541057|FG000|Experiment 2|Poor data quality|0|||
144363980|NCT03050801|520541058|FG001|Experiment 2|Poor data quality|0|||
144363981|NCT03050801|520541059|FG002|Experiment 2|Poor data quality|0|||
144363982|NCT03050801|520541060|FG003|Experiment 2|Poor data quality|4|||
144363983|NCT03050801|520541061|FG004|Experiment 2|Poor data quality|1|||
144363984|NCT03050801|520541062|FG005|Experiment 2|Poor data quality|0|||
144363985|NCT03050801|520541057|FG000|Experiment 2|Discomfort during stimulation|0|||
144363986|NCT03050801|520541058|FG001|Experiment 2|Discomfort during stimulation|0|||
144363987|NCT03050801|520541059|FG002|Experiment 2|Discomfort during stimulation|0|||
144363988|NCT03050801|520541060|FG003|Experiment 2|Discomfort during stimulation|0|||
144363989|NCT03050801|520541061|FG004|Experiment 2|Discomfort during stimulation|0|||
144363990|NCT03050801|520541062|FG005|Experiment 2|Discomfort during stimulation|2|||
144363991|NCT03600909|520541063|FG000|Overall Study|Not treated|0|||
144363992|NCT03600909|520541064|FG001|Overall Study|Not treated|3|||
144363993|NCT03600909|520541065|FG002|Overall Study|Not treated|0|||
144363994|NCT00521079|520541066|FG000|Overall Study|Adverse Event|7|||
144363995|NCT00521079|520541067|FG001|Overall Study|Adverse Event|1|||
144363996|NCT00521079|520541066|FG000|Overall Study|Lost to Follow-up|2|||
144363997|NCT00521079|520541067|FG001|Overall Study|Lost to Follow-up|1|||
144363998|NCT00521079|520541066|FG000|Overall Study|Withdrawal by Subject|5|||
144363999|NCT00521079|520541067|FG001|Overall Study|Withdrawal by Subject|3|||
144364000|NCT02246530|520541068|FG000|Overall Study|Lost to Follow-up|4|||
144364001|NCT02246530|520541069|FG001|Overall Study|Lost to Follow-up|0|||
144364002|NCT01506596|520541070|FG000|Overall Study|ineligible pathology|1|||
144364003|NCT01488890|520541073|FG000|Overall Study|Serious adverse event|2|||
144364004|NCT01488890|520541074|FG001|Overall Study|Serious adverse event|0|||
144364005|NCT01488890|520541075|FG002|Overall Study|Serious adverse event|0|||
144364006|NCT01488890|520541076|FG003|Overall Study|Serious adverse event|0|||
144364007|NCT01488890|520541073|FG000|Overall Study|Protocol Violation|3|||
144364008|NCT01488890|520541074|FG001|Overall Study|Protocol Violation|0|||
144364009|NCT01488890|520541075|FG002|Overall Study|Protocol Violation|4|||
144364010|NCT01488890|520541076|FG003|Overall Study|Protocol Violation|0|||
144364011|NCT01488890|520541073|FG000|Overall Study|Lost to Follow-up|13|||
144364012|NCT01488890|520541074|FG001|Overall Study|Lost to Follow-up|10|||
144364013|NCT01488890|520541075|FG002|Overall Study|Lost to Follow-up|20|||
144364014|NCT01488890|520541076|FG003|Overall Study|Lost to Follow-up|3|||
144364015|NCT01488890|520541073|FG000|Overall Study|Withdrawal by Subject|14|||
144364016|NCT01488890|520541074|FG001|Overall Study|Withdrawal by Subject|10|||
144364017|NCT01488890|520541075|FG002|Overall Study|Withdrawal by Subject|11|||
144364018|NCT01488890|520541076|FG003|Overall Study|Withdrawal by Subject|2|||
144364019|NCT05712460|520541077|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364020|NCT05712460|520541078|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364021|NCT05712460|520541079|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364022|NCT05712460|520541080|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364023|NCT05712460|520541081|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364024|NCT05712460|520541082|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364025|NCT05712460|520541083|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364026|NCT05712460|520541084|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
144364027|NCT05712460|520541085|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364028|NCT05712460|520541086|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364029|NCT05712460|520541087|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364030|NCT05712460|520541088|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
144364031|NCT04366349|520541091|FG000|Overall Study|Withdrawal by Subject|1|||
144364032|NCT04366349|520541092|FG001|Overall Study|Withdrawal by Subject|0|||
144364033|NCT04366349|520541093|FG002|Overall Study|Withdrawal by Subject|0|||
144364034|NCT04366349|520541094|FG003|Overall Study|Withdrawal by Subject|0|||
144364035|NCT04366349|520541095|FG004|Overall Study|Withdrawal by Subject|0|||
144364036|NCT04366349|520541096|FG005|Overall Study|Withdrawal by Subject|0|||
144478659|NCT04534114|520951742|FG000|Main Treatment Period|Participant decision|1|||
144478660|NCT04534114|520951743|FG001|Main Treatment Period|Participant decision|3|||
144478661|NCT04534114|520951744|FG002|Main Treatment Period|Participant decision|3|||
144478662|NCT04534114|520951745|FG003|Main Treatment Period|Participant decision|1|||
144478663|NCT04534114|520951742|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
144478664|NCT04534114|520951743|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
144478665|NCT04534114|520951744|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
144478666|NCT04534114|520951745|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
144478667|NCT04534114|520951742|FG000|Main Treatment Period|Adverse Event|4|||
144478668|NCT04534114|520951743|FG001|Main Treatment Period|Adverse Event|2|||
144478669|NCT04534114|520951744|FG002|Main Treatment Period|Adverse Event|1|||
144364049|NCT05138653|520541102|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
144364050|NCT05138653|520541103|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364051|NCT05138653|520541104|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364052|NCT05138653|520541105|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364053|NCT05138653|520541106|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364054|NCT05138653|520541107|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364055|NCT05138653|520541108|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364056|NCT05138653|520541109|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364057|NCT05138653|520541110|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364058|NCT05138653|520541111|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364059|NCT05138653|520541112|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364060|NCT05138653|520541113|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364061|NCT05138653|520541114|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364062|NCT05138653|520541115|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364063|NCT05138653|520541116|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364064|NCT05138653|520541117|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
144364065|NCT05138653|520541102|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364066|NCT05138653|520541103|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
144364067|NCT05138653|520541104|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364068|NCT05138653|520541105|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364069|NCT05138653|520541106|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364070|NCT05138653|520541107|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364071|NCT05138653|520541108|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364072|NCT05138653|520541109|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364073|NCT05138653|520541110|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
144364074|NCT05138653|520541111|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364075|NCT05138653|520541112|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364076|NCT05138653|520541113|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364077|NCT05138653|520541114|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364078|NCT05138653|520541115|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364079|NCT05138653|520541116|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364080|NCT05138653|520541117|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
144364081|NCT05138653|520541102|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364082|NCT05138653|520541103|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
144364083|NCT05138653|520541104|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364084|NCT05138653|520541105|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364085|NCT05138653|520541106|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
144364086|NCT05138653|520541107|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364087|NCT05138653|520541108|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364088|NCT05138653|520541109|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364089|NCT05138653|520541110|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364090|NCT05138653|520541111|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364091|NCT05138653|520541112|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364092|NCT05138653|520541113|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364093|NCT05138653|520541114|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364094|NCT05138653|520541115|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364095|NCT05138653|520541116|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364096|NCT05138653|520541117|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
144364097|NCT05138653|520541102|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364098|NCT05138653|520541103|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364099|NCT05138653|520541104|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364100|NCT05138653|520541105|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364101|NCT05138653|520541106|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364102|NCT05138653|520541107|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364103|NCT05138653|520541108|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
144364104|NCT05138653|520541109|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364105|NCT05138653|520541110|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364106|NCT05138653|520541111|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364107|NCT05138653|520541112|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364108|NCT05138653|520541113|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364109|NCT05138653|520541114|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364110|NCT05138653|520541115|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364111|NCT05138653|520541116|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364112|NCT05138653|520541117|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
144364113|NCT05138653|520541102|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364114|NCT05138653|520541103|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364115|NCT05138653|520541104|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364116|NCT05138653|520541105|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364117|NCT05138653|520541106|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364118|NCT05138653|520541107|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364119|NCT05138653|520541108|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364120|NCT05138653|520541109|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364121|NCT05138653|520541110|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364122|NCT05138653|520541111|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364123|NCT05138653|520541112|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
144364124|NCT05138653|520541113|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364125|NCT05138653|520541114|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
144364126|NCT05138653|520541115|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364127|NCT05138653|520541116|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
144364128|NCT05138653|520541117|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
144364129|NCT05138653|520541102|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364130|NCT05138653|520541103|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364131|NCT05138653|520541104|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364132|NCT05138653|520541105|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364133|NCT05138653|520541106|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364134|NCT05138653|520541107|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364135|NCT05138653|520541108|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144538195|NCT00146172|521174124|FG002|Overall Study|Lost to Follow-up|0|||
144364136|NCT05138653|520541109|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364137|NCT05138653|520541110|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364138|NCT05138653|520541111|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364139|NCT05138653|520541112|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364140|NCT05138653|520541113|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364141|NCT05138653|520541114|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364142|NCT05138653|520541115|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364143|NCT05138653|520541116|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
144364144|NCT05138653|520541117|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
144364145|NCT05138653|520541102|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364146|NCT05138653|520541103|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364147|NCT05138653|520541104|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364148|NCT05138653|520541105|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364149|NCT05138653|520541106|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364150|NCT05138653|520541107|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364151|NCT05138653|520541108|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364152|NCT05138653|520541109|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364153|NCT05138653|520541110|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364154|NCT05138653|520541111|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364155|NCT05138653|520541112|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364156|NCT05138653|520541113|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364157|NCT05138653|520541114|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364158|NCT05138653|520541115|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
144364159|NCT05138653|520541116|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364160|NCT05138653|520541117|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
144364161|NCT05967260|520541118|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
144364162|NCT05967260|520541119|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
144364163|NCT00626106|520541120|FG000|Overall Study|Withdrawal by Subject|2|||
144364164|NCT00626106|520541121|FG001|Overall Study|Withdrawal by Subject|1|||
144364165|NCT00626106|520541120|FG000|Overall Study|Lost to Follow-up|1|||
144364166|NCT00626106|520541121|FG001|Overall Study|Lost to Follow-up|4|||
144364167|NCT00626106|520541120|FG000|Overall Study|Death|64|||
144364168|NCT00626106|520541121|FG001|Overall Study|Death|19|||
144364169|NCT00079417|520543031|FG000|Overall Study|Physician Decision|2|||
144364170|NCT00079417|520543031|FG000|Overall Study|Ineligible|7|||
144364171|NCT01615939|520543032|FG000|Overall Study|Lost to Follow-up|5|||
144364172|NCT01615939|520543033|FG001|Overall Study|Lost to Follow-up|0|||
144364173|NCT02121535|520543037|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
144364174|NCT02121535|520543038|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
144364175|NCT02121535|520543037|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
144364176|NCT02121535|520543038|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
144364177|NCT00092417|520543039|FG000|Overall Study|Lost to Follow-up|2|||
144364178|NCT00092417|520543040|FG001|Overall Study|Lost to Follow-up|0|||
144364179|NCT00092417|520543039|FG000|Overall Study|Withdrawal by Subject|2|||
144364180|NCT00092417|520543040|FG001|Overall Study|Withdrawal by Subject|1|||
144364181|NCT00092417|520543039|FG000|Overall Study|Other|1|||
144364182|NCT00092417|520543040|FG001|Overall Study|Other|0|||
144364183|NCT01520506|520543041|FG000|Overall Study|Missed Visit|4|||
144364184|NCT01520506|520543041|FG000|Overall Study|Lost to Follow-up|1|||
144364185|NCT01520506|520543041|FG000|Overall Study|Withdrawal by Subject|1|||
144364186|NCT00425269|520543042|FG000|Overall Study|Pregnancy|5|||
144364187|NCT00425269|520543043|FG001|Overall Study|Pregnancy|7|||
144364188|NCT00425269|520543042|FG000|Overall Study|Lost to Follow-up|9|||
144364189|NCT00425269|520543043|FG001|Overall Study|Lost to Follow-up|9|||
144364190|NCT00425269|520543042|FG000|Overall Study|moved or medical reason|5|||
144364191|NCT00425269|520543043|FG001|Overall Study|moved or medical reason|4|||
144364192|NCT01084655|520543046|FG000|Overall Study|Radiographic disease progression|3|||
144364193|NCT01084655|520543047|FG001|Overall Study|Radiographic disease progression|2|||
144364194|NCT01084655|520543048|FG002|Overall Study|Radiographic disease progression|8|||
144478670|NCT04534114|520951745|FG003|Main Treatment Period|Adverse Event|2|||
144478671|NCT04534114|520951742|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
144478672|NCT04534114|520951743|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
144364195|NCT01084655|520543046|FG000|Overall Study|Withdrawal by Subject|1|||
144364196|NCT01084655|520543047|FG001|Overall Study|Withdrawal by Subject|0|||
144364197|NCT01084655|520543048|FG002|Overall Study|Withdrawal by Subject|4|||
144364198|NCT01084655|520543046|FG000|Overall Study|Adverse Event|2|||
144364199|NCT01084655|520543047|FG001|Overall Study|Adverse Event|1|||
144364200|NCT01084655|520543048|FG002|Overall Study|Adverse Event|2|||
144364201|NCT01084655|520543046|FG000|Overall Study|Other|0|||
144364202|NCT01084655|520543047|FG001|Overall Study|Other|3|||
144364203|NCT01084655|520543048|FG002|Overall Study|Other|2|||
144364204|NCT01084655|520543046|FG000|Overall Study|Symptomatic deterioration|0|||
144364205|NCT01084655|520543047|FG001|Overall Study|Symptomatic deterioration|0|||
144364206|NCT01084655|520543048|FG002|Overall Study|Symptomatic deterioration|2|||
144364207|NCT01084655|520543046|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
144364208|NCT01084655|520543047|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
144364209|NCT01084655|520543048|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
144364210|NCT01256788|520543049|FG000|Overall Study|Lost to Follow-up|5|||
144364211|NCT01256788|520543050|FG001|Overall Study|Lost to Follow-up|8|||
144364212|NCT01256788|520543051|FG002|Overall Study|Lost to Follow-up|3|||
144364213|NCT00906204|520543052|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
144364214|NCT00906204|520543053|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
144364215|NCT00906204|520543052|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
144364216|NCT00906204|520543053|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
144364217|NCT00906204|520543052|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
144364218|NCT00906204|520543053|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
144364219|NCT00906204|520543052|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
144364220|NCT00906204|520543053|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
144364221|NCT00906204|520543052|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
144364222|NCT00906204|520543053|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
144364223|NCT00992108|520543054|FG000|Overall Study|Lost to Follow-up|0|||
144364224|NCT00992108|520543055|FG001|Overall Study|Lost to Follow-up|1|||
144364225|NCT00535496|520543056|FG000|Overall Study|Lost to Follow-up|0|||
144364226|NCT00535496|520543057|FG001|Overall Study|Lost to Follow-up|1|||
144364227|NCT00535496|520543058|FG002|Overall Study|Lost to Follow-up|0|||
144364228|NCT00535496|520543059|FG003|Overall Study|Lost to Follow-up|0|||
144364229|NCT00535496|520543056|FG000|Overall Study|Not treated with sugammadex|0|||
144364230|NCT00535496|520543057|FG001|Overall Study|Not treated with sugammadex|1|||
144364231|NCT00535496|520543058|FG002|Overall Study|Not treated with sugammadex|0|||
144364232|NCT00535496|520543059|FG003|Overall Study|Not treated with sugammadex|0|||
144364233|NCT01083771|520543063|FG000|Overall Study|non-compliant|2|||
144364234|NCT01083771|520543063|FG000|Overall Study|Withdrawal by Subject|3|||
144364235|NCT00321620|520543066|FG000|Overall Study|Death|269|||
144364236|NCT00321620|520543067|FG001|Overall Study|Death|294|||
144364237|NCT00321620|520543066|FG000|Overall Study|Withdrawal by Subject|164|||
144364238|NCT00321620|520543067|FG001|Overall Study|Withdrawal by Subject|147|||
144364239|NCT00321620|520543066|FG000|Overall Study|Disease progression|113|||
144364240|NCT00321620|520543067|FG001|Overall Study|Disease progression|117|||
144364241|NCT00321620|520543066|FG000|Overall Study|Adverse Event|43|||
144364242|NCT00321620|520543067|FG001|Overall Study|Adverse Event|56|||
144364243|NCT00321620|520543066|FG000|Overall Study|Lost to Follow-up|13|||
144364244|NCT00321620|520543067|FG001|Overall Study|Lost to Follow-up|9|||
144364245|NCT00321620|520543066|FG000|Overall Study|Physician Decision|4|||
144364246|NCT00321620|520543067|FG001|Overall Study|Physician Decision|1|||
144364247|NCT00321620|520543066|FG000|Overall Study|Noncompliance|14|||
144364248|NCT00321620|520543067|FG001|Overall Study|Noncompliance|7|||
144364249|NCT00321620|520543066|FG000|Overall Study|Protocol deviation|4|||
144364250|NCT00321620|520543067|FG001|Overall Study|Protocol deviation|3|||
144364251|NCT00321620|520543066|FG000|Overall Study|Ineligibility determined|2|||
144364252|NCT00321620|520543067|FG001|Overall Study|Ineligibility determined|3|||
144364253|NCT00321620|520543066|FG000|Overall Study|Participant request|75|||
144364254|NCT00321620|520543067|FG001|Overall Study|Participant request|52|||
144364255|NCT00321620|520543066|FG000|Overall Study|Other|42|||
144364256|NCT00321620|520543067|FG001|Overall Study|Other|33|||
144364257|NCT03181932|520543068|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
144364258|NCT03181932|520543069|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
144364259|NCT03181932|520543068|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
144364260|NCT03181932|520543069|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
144364261|NCT03181932|520543068|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
144364262|NCT03181932|520543069|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
144364263|NCT03181932|520543068|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
144364264|NCT03181932|520543069|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
144364265|NCT03181932|520543068|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
144364266|NCT03181932|520543069|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
144364267|NCT03181932|520543068|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
144364268|NCT03181932|520543069|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
144364269|NCT03181932|520543068|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
144364270|NCT03181932|520543069|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
144364271|NCT03181932|520543068|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
144364272|NCT03181932|520543069|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
144364273|NCT03181932|520543068|FG000|Period 2 (Open-label Period)|Reason missing|2|||
144364274|NCT03181932|520543069|FG001|Period 2 (Open-label Period)|Reason missing|0|||
144364275|NCT03304626|520543070|FG000|Overall Study|Adverse Event|1|||
144364276|NCT03304626|520543071|FG001|Overall Study|Adverse Event|0|||
144364277|NCT03304626|520543070|FG000|Overall Study|Lack of Efficacy|1|||
144364278|NCT03304626|520543071|FG001|Overall Study|Lack of Efficacy|1|||
144364279|NCT01462370|520543075|FG000|Overall Study|Lack of Qualifying Event|1|||
144364280|NCT01462370|520543076|FG001|Overall Study|Lack of Qualifying Event|1|||
144364281|NCT01462370|520543075|FG000|Overall Study|Physician Decision|0|||
144364282|NCT01462370|520543076|FG001|Overall Study|Physician Decision|1|||
144364283|NCT01462370|520543075|FG000|Overall Study|Withdrawal by Subject|0|||
144364284|NCT01462370|520543076|FG001|Overall Study|Withdrawal by Subject|3|||
144364285|NCT01747876|520543077|FG000|Overall Study|Adverse Event|1|||
144364286|NCT01747876|520543078|FG001|Overall Study|Adverse Event|0|||
144364287|NCT01747876|520543079|FG002|Overall Study|Adverse Event|2|||
144364288|NCT01747876|520543077|FG000|Overall Study|Withdrawal by Subject|0|||
144364289|NCT01747876|520543078|FG001|Overall Study|Withdrawal by Subject|1|||
144364290|NCT01747876|520543079|FG002|Overall Study|Withdrawal by Subject|1|||
144364291|NCT01747876|520543077|FG000|Overall Study|Disease progression|4|||
144364292|NCT01747876|520543078|FG001|Overall Study|Disease progression|13|||
144364293|NCT01747876|520543079|FG002|Overall Study|Disease progression|8|||
144364294|NCT01747876|520543077|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
144364295|NCT01747876|520543078|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
144364296|NCT01747876|520543079|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
144364297|NCT00853307|520543080|FG000|Overall Study|Adverse Event|1|||
144364298|NCT00853307|520543081|FG001|Overall Study|Adverse Event|2|||
144364299|NCT00853307|520543080|FG000|Overall Study|Withdrawal by Subject|1|||
144364300|NCT00853307|520543081|FG001|Overall Study|Withdrawal by Subject|2|||
144364301|NCT00853307|520543080|FG000|Overall Study|Reason Not Specified|0|||
144364302|NCT00853307|520543081|FG001|Overall Study|Reason Not Specified|1|||
144364303|NCT02399163|520543085|FG000|Overall Study|Adverse Event|2|||
144364304|NCT02399163|520543085|FG000|Overall Study|Protocol Deviation|2|||
144364305|NCT02399163|520543085|FG000|Overall Study|Withdrawal by Participant|5|||
144364306|NCT04225897|520543089|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364307|NCT04225897|520543090|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
144364308|NCT04225897|520543091|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364309|NCT04225897|520543092|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364310|NCT04225897|520543093|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364311|NCT04225897|520543094|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364312|NCT04225897|520543095|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364313|NCT04225897|520543096|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364314|NCT04225897|520543097|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364315|NCT04225897|520543098|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364316|NCT04225897|520543099|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364317|NCT04225897|520543100|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
144364318|NCT04225897|520543089|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364319|NCT04225897|520543090|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364320|NCT04225897|520543091|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
144364321|NCT04225897|520543092|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364322|NCT04225897|520543093|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364323|NCT04225897|520543094|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364324|NCT04225897|520543095|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364325|NCT04225897|520543096|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364326|NCT04225897|520543097|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364327|NCT04225897|520543098|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364328|NCT04225897|520543099|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364329|NCT04225897|520543100|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
144364330|NCT04225897|520543089|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364331|NCT04225897|520543090|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364332|NCT04225897|520543091|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
144364333|NCT04225897|520543092|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364334|NCT04225897|520543093|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364335|NCT04225897|520543094|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364336|NCT04225897|520543095|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364337|NCT04225897|520543096|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364338|NCT04225897|520543097|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364339|NCT04225897|520543098|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364340|NCT04225897|520543099|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364341|NCT04225897|520543100|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
144364342|NCT04225897|520543089|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364343|NCT04225897|520543090|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364344|NCT04225897|520543091|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364345|NCT04225897|520543092|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364346|NCT04225897|520543093|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364347|NCT04225897|520543094|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364348|NCT04225897|520543095|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364349|NCT04225897|520543096|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
144364350|NCT04225897|520543097|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364351|NCT04225897|520543098|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364352|NCT04225897|520543099|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364353|NCT04225897|520543100|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
144364354|NCT00074711|520543102|FG000|Overall Study|Withdrawal by Subject|1|||
144364355|NCT00074711|520543103|FG001|Overall Study|Withdrawal by Subject|1|||
144364356|NCT00074711|520543102|FG000|Overall Study|Lost to Follow-up|10|||
144364357|NCT00074711|520543103|FG001|Overall Study|Lost to Follow-up|8|||
144364358|NCT00074711|520543102|FG000|Overall Study|Participant stopped study drug|4|||
144364359|NCT00074711|520543103|FG001|Overall Study|Participant stopped study drug|6|||
144364360|NCT03466658|520543104|FG000|Overall Study|Withdrawal by Subject|3|||
144364361|NCT00837434|520543105|FG000|Overall Study|Physician Decision|3|||
144364362|NCT00837434|520543106|FG001|Overall Study|Physician Decision|0|||
144364363|NCT00837434|520543105|FG000|Overall Study|Lost to Follow-up|1|||
144364364|NCT00837434|520543106|FG001|Overall Study|Lost to Follow-up|1|||
144364365|NCT00837434|520543105|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
144364366|NCT00837434|520543106|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
144364367|NCT00837434|520543105|FG000|Overall Study|Noncompliant|2|||
144364368|NCT00837434|520543106|FG001|Overall Study|Noncompliant|0|||
144364369|NCT00837434|520543105|FG000|Overall Study|Baseline assessments not done in time|1|||
144364370|NCT00837434|520543106|FG001|Overall Study|Baseline assessments not done in time|0|||
144364371|NCT00837434|520543105|FG000|Overall Study|Unable to obtain study drug|1|||
144364372|NCT00837434|520543106|FG001|Overall Study|Unable to obtain study drug|0|||
144364373|NCT01921205|520543107|FG000|Overall Study|Adverse Event|12|||
144364374|NCT01921205|520543108|FG001|Overall Study|Adverse Event|7|||
144364375|NCT01921205|520543107|FG000|Overall Study|Lack of Efficacy|1|||
144364376|NCT01921205|520543108|FG001|Overall Study|Lack of Efficacy|0|||
144364377|NCT01921205|520543107|FG000|Overall Study|Protocol Violation|1|||
144364378|NCT01921205|520543108|FG001|Overall Study|Protocol Violation|3|||
144364379|NCT01921205|520543107|FG000|Overall Study|Lost to Follow-up|1|||
144364380|NCT01921205|520543108|FG001|Overall Study|Lost to Follow-up|1|||
144364381|NCT01921205|520543107|FG000|Overall Study|Withdrawal by Subject|6|||
144364382|NCT01921205|520543108|FG001|Overall Study|Withdrawal by Subject|5|||
144364383|NCT01921205|520543107|FG000|Overall Study|Use Of Prohibited Medication|0|||
144364384|NCT01921205|520543108|FG001|Overall Study|Use Of Prohibited Medication|1|||
144364385|NCT01921205|520543107|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
144364386|NCT01921205|520543108|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
144364387|NCT01921205|520543107|FG000|Overall Study|Non Compliance Of The Parent|0|||
144364388|NCT01921205|520543108|FG001|Overall Study|Non Compliance Of The Parent|1|||
144364389|NCT01921205|520543107|FG000|Overall Study|Non Compliance Of Child|0|||
144364390|NCT01921205|520543108|FG001|Overall Study|Non Compliance Of Child|1|||
144364391|NCT00360230|520543109|FG000|Overall Study|Withdrawal by Subject|1|||
144364392|NCT00360230|520543110|FG001|Overall Study|Withdrawal by Subject|1|||
144364393|NCT00360230|520543111|FG002|Overall Study|Withdrawal by Subject|0|||
144364394|NCT00360230|520543112|FG003|Overall Study|Withdrawal by Subject|1|||
144364395|NCT00360230|520543113|FG004|Overall Study|Withdrawal by Subject|1|||
144364396|NCT00360230|520543114|FG005|Overall Study|Withdrawal by Subject|1|||
144364397|NCT00360230|520543115|FG006|Overall Study|Withdrawal by Subject|0|||
144364398|NCT00360230|520543109|FG000|Overall Study|Migrated|4|||
144364399|NCT00360230|520543110|FG001|Overall Study|Migrated|1|||
144364400|NCT00360230|520543111|FG002|Overall Study|Migrated|3|||
144364401|NCT00360230|520543112|FG003|Overall Study|Migrated|1|||
144364402|NCT00360230|520543113|FG004|Overall Study|Migrated|4|||
144364403|NCT00360230|520543114|FG005|Overall Study|Migrated|1|||
144364404|NCT00360230|520543115|FG006|Overall Study|Migrated|1|||
144364405|NCT00360230|520543109|FG000|Overall Study|Other|1|||
144364406|NCT00360230|520543110|FG001|Overall Study|Other|0|||
144364407|NCT00360230|520543111|FG002|Overall Study|Other|0|||
144364408|NCT00360230|520543112|FG003|Overall Study|Other|0|||
144364409|NCT00360230|520543113|FG004|Overall Study|Other|0|||
144364410|NCT00360230|520543114|FG005|Overall Study|Other|0|||
144364411|NCT00360230|520543115|FG006|Overall Study|Other|0|||
144364412|NCT00360230|520543109|FG000|Overall Study|Protocol Violation|0|||
144364413|NCT00360230|520543110|FG001|Overall Study|Protocol Violation|0|||
144364414|NCT00360230|520543111|FG002|Overall Study|Protocol Violation|0|||
144364415|NCT00360230|520543112|FG003|Overall Study|Protocol Violation|0|||
144364416|NCT00360230|520543113|FG004|Overall Study|Protocol Violation|0|||
144364417|NCT00360230|520543114|FG005|Overall Study|Protocol Violation|1|||
144364418|NCT00360230|520543115|FG006|Overall Study|Protocol Violation|0|||
144364419|NCT00360230|520543109|FG000|Overall Study|Death|0|||
144364420|NCT00360230|520543110|FG001|Overall Study|Death|1|||
144364421|NCT00360230|520543111|FG002|Overall Study|Death|0|||
144364422|NCT00360230|520543112|FG003|Overall Study|Death|0|||
144364423|NCT00360230|520543113|FG004|Overall Study|Death|0|||
144364424|NCT00360230|520543114|FG005|Overall Study|Death|1|||
144364425|NCT00360230|520543115|FG006|Overall Study|Death|1|||
144364426|NCT00456846|520543116|FG000|Overall Study|Adverse Event|2|||
144364427|NCT00456846|520543117|FG001|Overall Study|Adverse Event|15|||
144364428|NCT00456846|520543116|FG000|Overall Study|Physician Decision|11|||
144364429|NCT00456846|520543117|FG001|Overall Study|Physician Decision|6|||
144364430|NCT00456846|520543116|FG000|Overall Study|Protocol Deviation|2|||
144364431|NCT00456846|520543117|FG001|Overall Study|Protocol Deviation|0|||
144364432|NCT00456846|520543116|FG000|Overall Study|Participant Discretion|1|||
144364433|NCT00456846|520543117|FG001|Overall Study|Participant Discretion|5|||
144364434|NCT00456846|520543116|FG000|Overall Study|Other|0|||
144364435|NCT00456846|520543117|FG001|Overall Study|Other|2|||
144364436|NCT03367793|520543118|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
144364437|NCT03367793|520543119|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
144364438|NCT03367793|520543120|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
144364439|NCT03367793|520543121|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
144364440|NCT03367793|520543122|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
144364441|NCT03367793|520543123|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
144364442|NCT00260533|520543124|FG000|Overall Study|Other|3|||
144364443|NCT00260533|520543125|FG001|Overall Study|Other|3|||
144364444|NCT00003475|520543126|FG000|Overall Study|Not evaluable|13|||
144364445|NCT04682366|520543127|FG000|Overall Study|Lost to Follow-up|1|||
144364446|NCT04682366|520543128|FG001|Overall Study|Lost to Follow-up|1|||
144364447|NCT02224560|520543133|FG000|Overall Study|Protocol Deviation|1|||
144364448|NCT02224560|520543134|FG001|Overall Study|Protocol Deviation|0|||
144364449|NCT02224560|520543135|FG002|Overall Study|Protocol Deviation|0|||
144364450|NCT02224560|520543133|FG000|Overall Study|Withdrawal by Subject|2|||
144364451|NCT02224560|520543134|FG001|Overall Study|Withdrawal by Subject|0|||
144364452|NCT02224560|520543135|FG002|Overall Study|Withdrawal by Subject|1|||
144364453|NCT02224560|520543133|FG000|Overall Study|Met Withdrawal Criteria|1|||
144364454|NCT02224560|520543134|FG001|Overall Study|Met Withdrawal Criteria|0|||
144364455|NCT02224560|520543135|FG002|Overall Study|Met Withdrawal Criteria|0|||
144364456|NCT02224560|520543133|FG000|Overall Study|Adverse Event|4|||
144364457|NCT02224560|520543134|FG001|Overall Study|Adverse Event|1|||
144364458|NCT02224560|520543135|FG002|Overall Study|Adverse Event|1|||
144364459|NCT02224560|520543133|FG000|Overall Study|Withdrawn by Investigator|1|||
144364460|NCT02224560|520543134|FG001|Overall Study|Withdrawn by Investigator|1|||
144364461|NCT02224560|520543135|FG002|Overall Study|Withdrawn by Investigator|0|||
144364462|NCT04543279|520543136|FG000|Overall Study|Withdrawal by Subject|1|||
144364463|NCT04543279|520543137|FG001|Overall Study|Withdrawal by Subject|0|||
144364464|NCT04543279|520543136|FG000|Overall Study|Adverse Event|1|||
144364465|NCT04543279|520543137|FG001|Overall Study|Adverse Event|0|||
144364466|NCT04543279|520543136|FG000|Overall Study|Physician Decision|1|||
144364467|NCT04543279|520543137|FG001|Overall Study|Physician Decision|0|||
144364468|NCT00929695|520543139|FG000|Overall Study|Death|2|||
144364469|NCT00929695|520543140|FG001|Overall Study|Death|1|||
144364470|NCT00929695|520543139|FG000|Overall Study|Withdrawal by Subject|0|||
144364471|NCT00929695|520543140|FG001|Overall Study|Withdrawal by Subject|2|||
144364472|NCT00929695|520543139|FG000|Overall Study|discharge home|4|||
144364473|NCT00929695|520543140|FG001|Overall Study|discharge home|3|||
144364474|NCT00929695|520543139|FG000|Overall Study|incorrect stratification|2|||
144364475|NCT00929695|520543140|FG001|Overall Study|incorrect stratification|0|||
144364476|NCT04030143|520543141|FG000|Overall Study|Adverse Event|5|||
144364477|NCT04030143|520543142|FG001|Overall Study|Adverse Event|10|||
144364478|NCT04030143|520543141|FG000|Overall Study|Lost to Follow-up|3|||
144364479|NCT04030143|520543142|FG001|Overall Study|Lost to Follow-up|7|||
144364480|NCT04030143|520543141|FG000|Overall Study|Protocol Deviation|2|||
144364481|NCT04030143|520543142|FG001|Overall Study|Protocol Deviation|2|||
144364482|NCT04030143|520543141|FG000|Overall Study|Withdrawal by Subject|16|||
144364483|NCT04030143|520543142|FG001|Overall Study|Withdrawal by Subject|18|||
144364484|NCT04030143|520543141|FG000|Overall Study|Physician Decision|1|||
144364485|NCT04030143|520543142|FG001|Overall Study|Physician Decision|1|||
144364486|NCT04030143|520543141|FG000|Overall Study|Due to Covid-19|2|||
144364487|NCT04030143|520543142|FG001|Overall Study|Due to Covid-19|3|||
144364488|NCT04030143|520543141|FG000|Overall Study|Not Due to Covid-19|1|||
144364489|NCT04030143|520543142|FG001|Overall Study|Not Due to Covid-19|1|||
144364490|NCT05966142|520543143|FG000|Overall Study|Death|3|||
144364491|NCT05966142|520543144|FG001|Overall Study|Death|3|||
144364492|NCT05966142|520543143|FG000|Overall Study|Lost to Follow-up|55|||
144364493|NCT05966142|520543144|FG001|Overall Study|Lost to Follow-up|52|||
144364494|NCT05966142|520543143|FG000|Overall Study|Physician Decision|1|||
144364495|NCT05966142|520543144|FG001|Overall Study|Physician Decision|0|||
144364496|NCT05966142|520543143|FG000|Overall Study|Withdrawal by Subject|9|||
144364497|NCT05966142|520543144|FG001|Overall Study|Withdrawal by Subject|8|||
144364498|NCT05966142|520543143|FG000|Overall Study|Duplicate Enrollment|1|||
144364499|NCT05966142|520543144|FG001|Overall Study|Duplicate Enrollment|0|||
144364500|NCT05966142|520543143|FG000|Overall Study|Study Logistical Reason|1|||
144364501|NCT05966142|520543144|FG001|Overall Study|Study Logistical Reason|0|||
144364502|NCT05966142|520543143|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
144364503|NCT05966142|520543144|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
144364504|NCT05249582|520543145|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
144364505|NCT05249582|520543146|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
144364506|NCT05249582|520543145|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
144364507|NCT05249582|520543146|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
144364508|NCT05249582|520543145|FG000|Overall Study|Declined to use virtual reality headset|1|||
144364509|NCT05249582|520543146|FG001|Overall Study|Declined to use virtual reality headset|0|||
144364510|NCT05386329|520543147|FG000|Overall Study|Lost to Follow-up|3|||
144364511|NCT04408989|520543150|FG000|Overall Study|Lost to Follow-up|0|||
144364512|NCT04408989|520543151|FG001|Overall Study|Lost to Follow-up|0|||
144364513|NCT04408989|520543152|FG002|Overall Study|Lost to Follow-up|1|||
144364514|NCT04408989|520543150|FG000|Overall Study|Withdrawal by Subject|0|||
144364515|NCT04408989|520543151|FG001|Overall Study|Withdrawal by Subject|0|||
144364516|NCT04408989|520543152|FG002|Overall Study|Withdrawal by Subject|2|||
144364517|NCT05135767|520543153|FG000|Baseline|Lost to Follow-up|1|||
144364518|NCT05135767|520543154|FG001|Baseline|Lost to Follow-up|1|||
144364519|NCT05135767|520543153|FG000|Baseline|Withdrawal by Subject|0|||
144364520|NCT05135767|520543154|FG001|Baseline|Withdrawal by Subject|2|||
144364521|NCT05135767|520543153|FG000|Active Study Phase|Lost to Follow-up|2|||
144364522|NCT05135767|520543154|FG001|Active Study Phase|Lost to Follow-up|0|||
144364523|NCT02694185|520543155|FG000|Overall Study|Withdrawal by Subject|45|||
144364524|NCT02694185|520543156|FG001|Overall Study|Withdrawal by Subject|0|||
144364525|NCT05082857|520543157|FG000|Overall Study|participants relocated and could not continue|2|||
144364526|NCT05082857|520543158|FG001|Overall Study|participants relocated and could not continue|1|||
144364527|NCT05082857|520543157|FG000|Overall Study|Lost to Follow-up|1|||
144364528|NCT05082857|520543158|FG001|Overall Study|Lost to Follow-up|3|||
144364529|NCT04363320|520543159|FG000|Overall Study|Lost to Follow-up|43|||
144364530|NCT04363320|520543160|FG001|Overall Study|Lost to Follow-up|42|||
144364531|NCT04363320|520543161|FG002|Overall Study|Lost to Follow-up|24|||
144364532|NCT04363320|520543162|FG003|Overall Study|Lost to Follow-up|29|||
144364533|NCT04363320|520543159|FG000|Overall Study|Death|0|||
144364534|NCT04363320|520543160|FG001|Overall Study|Death|0|||
144364535|NCT04363320|520543161|FG002|Overall Study|Death|1|||
144364536|NCT04363320|520543162|FG003|Overall Study|Death|0|||
144364537|NCT02260934|520543172|FG000|Overall Study|Lost to Follow-up|2|||
144364538|NCT02260934|520543173|FG001|Overall Study|Lost to Follow-up|1|||
144364539|NCT02260934|520543172|FG000|Overall Study|Withdrawal by Subject|0|||
144364540|NCT02260934|520543173|FG001|Overall Study|Withdrawal by Subject|2|||
144364541|NCT02260934|520543172|FG000|Overall Study|Participant Relocated|1|||
144364542|NCT02260934|520543173|FG001|Overall Study|Participant Relocated|0|||
144364543|NCT02260934|520543172|FG000|Overall Study|Site error|0|||
144364544|NCT02260934|520543173|FG001|Overall Study|Site error|1|||
144364545|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
144364546|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
144364547|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
144364548|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
144364549|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
144364550|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
144364551|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
144364552|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
144364553|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
144364554|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
144364555|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
144364556|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
144364557|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
144364558|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
144364559|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
144364560|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
144364561|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
144364562|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
144364563|NCT03605667|520543176|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
144364564|NCT03605667|520543177|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
144364565|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
144364566|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
144478673|NCT04534114|520951744|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
144478674|NCT04534114|520951745|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
144364567|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Other|6|||
144364568|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Other|8|||
144364569|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
144364570|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
144364571|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
144364572|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
144364573|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
144364574|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
144364575|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
144364576|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
144364577|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
144364578|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
144364579|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
144364580|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
144364581|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Death|0|||
144364582|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Death|2|||
144364583|NCT03605667|520543176|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
144364584|NCT03605667|520543177|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
144364585|NCT05632211|520543178|FG000|Overall Study|Withdrawal by Subject|2|||
144364586|NCT05632211|520543179|FG001|Overall Study|Withdrawal by Subject|0|||
144364587|NCT05632211|520543180|FG002|Overall Study|Withdrawal by Subject|2|||
144364588|NCT05632211|520543178|FG000|Overall Study|Other reasons|1|||
144364589|NCT05632211|520543179|FG001|Overall Study|Other reasons|1|||
144364590|NCT05632211|520543180|FG002|Overall Study|Other reasons|1|||
144364591|NCT02532517|520543186|FG000|Overall Study|Did not complete 24-Month visit|4|||
144364592|NCT02532517|520543186|FG000|Overall Study|Failed Angiographic eligibility|1|||
144364593|NCT02532517|520543186|FG000|Overall Study|Lost to Follow-up|4|||
144364594|NCT02532517|520543186|FG000|Overall Study|Withdrawal by Subject|4|||
144364595|NCT02532517|520543186|FG000|Overall Study|Death|4|||
144364596|NCT00400179|520543187|FG000|Overall Study|Adverse Event|2|||
144364597|NCT00400179|520543188|FG001|Overall Study|Adverse Event|2|||
144364598|NCT00400179|520543187|FG000|Overall Study|Death|1|||
144364599|NCT00400179|520543188|FG001|Overall Study|Death|2|||
144364600|NCT00400179|520543187|FG000|Overall Study|Withdrew Consent|1|||
144364601|NCT00400179|520543188|FG001|Overall Study|Withdrew Consent|5|||
144364602|NCT00400179|520543187|FG000|Overall Study|Disease progression|1|||
144364603|NCT00400179|520543188|FG001|Overall Study|Disease progression|1|||
144364604|NCT00400179|520543187|FG000|Overall Study|Intercurrent illness|0|||
144364605|NCT00400179|520543188|FG001|Overall Study|Intercurrent illness|1|||
144364606|NCT00400179|520543187|FG000|Overall Study|Investigator judgment|0|||
144364607|NCT00400179|520543188|FG001|Overall Study|Investigator judgment|1|||
144364608|NCT00400179|520543187|FG000|Overall Study|Randomization error/patient ineligible|1|||
144364609|NCT00400179|520543188|FG001|Overall Study|Randomization error/patient ineligible|6|||
144364610|NCT04780061|520543189|FG000|Overall Study|Withdrawal by Subject|5|||
144364611|NCT04780061|520543190|FG001|Overall Study|Withdrawal by Subject|8|||
144364612|NCT04780061|520543189|FG000|Overall Study|Adverse Event|2|||
144364613|NCT04780061|520543190|FG001|Overall Study|Adverse Event|2|||
144364614|NCT04780061|520543189|FG000|Overall Study|Lost to Follow-up|1|||
144364615|NCT04780061|520543190|FG001|Overall Study|Lost to Follow-up|5|||
144364616|NCT00734149|520543191|FG000|Overall Study|Withdrawal by Subject|1|||
144364617|NCT05417438|520543192|FG000|Overall Study|Withdrawal by Subject|3|||
144364618|NCT02681523|520543193|FG000|Overall Study|Adverse Event|1|||
144364619|NCT02681523|520543193|FG000|Overall Study|Patient Non-compliance|1|||
144364620|NCT04639245|520545028|FG000|Overall Study|Death|1|||
144364621|NCT03591406|520545029|FG000|Overall Study|Adverse Event|5|||
144364622|NCT03591406|520545030|FG001|Overall Study|Adverse Event|3|||
144364623|NCT03591406|520545029|FG000|Overall Study|Protocol Violation|2|||
144364624|NCT03591406|520545030|FG001|Overall Study|Protocol Violation|1|||
144364625|NCT03591406|520545029|FG000|Overall Study|Withdrawal by Subject|0|||
144364626|NCT03591406|520545030|FG001|Overall Study|Withdrawal by Subject|5|||
144364627|NCT02703597|520545055|FG000|Assignment to Baseline|Lost to Follow-up|17|||
144364628|NCT02703597|520545056|FG001|Assignment to Baseline|Lost to Follow-up|16|||
144364629|NCT02703597|520545055|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
144364630|NCT02703597|520545056|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
144364631|NCT02703597|520545055|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
144364632|NCT02703597|520545056|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
144364633|NCT02703597|520545055|FG000|First Post-test to First Follow-up|Site drop out|0|||
144364634|NCT02703597|520545056|FG001|First Post-test to First Follow-up|Site drop out|58|||
144364635|NCT02703597|520545055|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
144364636|NCT02703597|520545056|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
144364637|NCT02703597|520545055|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
144364638|NCT02703597|520545056|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
144364639|NCT02703597|520545055|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
144364640|NCT02703597|520545056|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
144364641|NCT01614886|520545057|FG000|Overall Study|Adverse Event|15|||
144364642|NCT01614886|520545058|FG001|Overall Study|Adverse Event|20|||
144364643|NCT01614886|520545057|FG000|Overall Study|Withdrawal by Subject|4|||
144538196|NCT00146172|521174125|FG003|Overall Study|Lost to Follow-up|0|||
144364644|NCT01614886|520545058|FG001|Overall Study|Withdrawal by Subject|4|||
144364645|NCT01614886|520545057|FG000|Overall Study|Death|1|||
144364646|NCT01614886|520545058|FG001|Overall Study|Death|0|||
144364647|NCT01614886|520545057|FG000|Overall Study|Protocol deviation|0|||
144364648|NCT01614886|520545058|FG001|Overall Study|Protocol deviation|2|||
144364649|NCT02461758|520545059|FG000|Overall Study|Lost to Follow-up|0|||
144364650|NCT02461758|520545060|FG001|Overall Study|Lost to Follow-up|1|||
144364651|NCT02461758|520545061|FG002|Overall Study|Lost to Follow-up|1|||
144364652|NCT02461758|520545062|FG003|Overall Study|Lost to Follow-up|0|||
144364653|NCT03216226|520545063|FG000|Overall Study|Adverse Event|3|||
144364654|NCT03216226|520545064|FG001|Overall Study|Adverse Event|0|||
144364655|NCT03216226|520545063|FG000|Overall Study|Protocol Violation|1|||
144364656|NCT03216226|520545064|FG001|Overall Study|Protocol Violation|3|||
144364657|NCT03216226|520545063|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
144364658|NCT03216226|520545064|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
144364659|NCT03216226|520545063|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
144364660|NCT03216226|520545064|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
144364661|NCT03216226|520545063|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
144364662|NCT03216226|520545064|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
144364663|NCT01352715|520545065|FG000|Overall Study|Death|3|||
144364664|NCT01352715|520545066|FG001|Overall Study|Death|3|||
144364665|NCT01352715|520545065|FG000|Overall Study|Lost to Follow-up|5|||
144364666|NCT01352715|520545066|FG001|Overall Study|Lost to Follow-up|7|||
144364667|NCT01352715|520545065|FG000|Overall Study|Withdrawal by Subject|4|||
144364668|NCT01352715|520545066|FG001|Overall Study|Withdrawal by Subject|8|||
144364669|NCT01352715|520545065|FG000|Overall Study|site closure|16|||
144364670|NCT01352715|520545066|FG001|Overall Study|site closure|15|||
144364671|NCT01352715|520545065|FG000|Overall Study|no final visit in closeout period|15|||
144364672|NCT01352715|520545066|FG001|Overall Study|no final visit in closeout period|12|||
144364673|NCT01352715|520545065|FG000|Overall Study|major ineligibility|2|||
144364674|NCT01352715|520545066|FG001|Overall Study|major ineligibility|1|||
144364675|NCT04596267|520545067|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
144364676|NCT04596267|520545068|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
144364677|NCT04596267|520545067|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
144364678|NCT04596267|520545068|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
144364679|NCT01710345|520545069|FG000|Overall Study|Adverse Event|0|||
144364680|NCT01710345|520545070|FG001|Overall Study|Adverse Event|2|||
144364681|NCT01710345|520545071|FG002|Overall Study|Adverse Event|0|||
144364682|NCT01710345|520545069|FG000|Overall Study|Lack of Efficacy|2|||
144364683|NCT01710345|520545070|FG001|Overall Study|Lack of Efficacy|3|||
144364684|NCT01710345|520545071|FG002|Overall Study|Lack of Efficacy|1|||
144364685|NCT01710345|520545069|FG000|Overall Study|Drug Dosing Error|1|||
144364686|NCT01710345|520545070|FG001|Overall Study|Drug Dosing Error|0|||
144364687|NCT01710345|520545071|FG002|Overall Study|Drug Dosing Error|0|||
144364688|NCT00449696|520545072|FG000|Overall Study|Other Treatment Required|6|||
144364689|NCT00449696|520545073|FG001|Overall Study|Other Treatment Required|1|||
144364690|NCT00449696|520545072|FG000|Overall Study|Withdrawal by Subject|5|||
144364691|NCT00449696|520545073|FG001|Overall Study|Withdrawal by Subject|5|||
144364692|NCT00449696|520545072|FG000|Overall Study|Lost to Follow-up|2|||
144364693|NCT00449696|520545073|FG001|Overall Study|Lost to Follow-up|3|||
144364694|NCT00449696|520545072|FG000|Overall Study|Others|7|||
144364695|NCT00449696|520545073|FG001|Overall Study|Others|0|||
144364696|NCT01353898|520545080|FG000|Overall Study|Study site terminated|0|||
144364697|NCT01353898|520545081|FG001|Overall Study|Study site terminated|0|||
144364698|NCT01353898|520545082|FG002|Overall Study|Study site terminated|0|||
144478675|NCT04534114|520951742|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
144478676|NCT04534114|520951743|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
144364699|NCT01353898|520545083|FG003|Overall Study|Study site terminated|0|||
144478677|NCT04534114|520951744|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
144364700|NCT01353898|520545084|FG004|Overall Study|Study site terminated|0|||
144364701|NCT01353898|520545085|FG005|Overall Study|Study site terminated|1|||
144364702|NCT03558737|520545088|FG000|Overall Study|Death|1|||
144364703|NCT03558737|520545089|FG001|Overall Study|Death|1|||
144364704|NCT02158442|520545090|FG000|Overall Study|Withdrawal by Subject|1|||
144364705|NCT02158442|520545091|FG001|Overall Study|Withdrawal by Subject|0|||
144364706|NCT02158442|520545090|FG000|Overall Study|Perfusion staff not available|1|||
144364707|NCT02158442|520545091|FG001|Overall Study|Perfusion staff not available|0|||
144364708|NCT01409707|520545092|FG000|Overall Study|Withdrawal by Subject|5|||
144364709|NCT01409707|520545093|FG001|Overall Study|Withdrawal by Subject|17|||
144364710|NCT01409707|520545094|FG002|Overall Study|Withdrawal by Subject|16|||
144364711|NCT01217229|520545095|FG000|Overall Study|Adverse Event|1|||
144364712|NCT01217229|520545095|FG000|Overall Study|Disease progression, deterioration|2|||
144478678|NCT04534114|520951745|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
144478679|NCT04534114|520951742|FG000|Extension Treatment Period|Other reason|0|||
144478680|NCT04534114|520951743|FG001|Extension Treatment Period|Other reason|1|||
144478681|NCT04534114|520951744|FG002|Extension Treatment Period|Other reason|0|||
144478682|NCT04534114|520951745|FG003|Extension Treatment Period|Other reason|0|||
144478683|NCT04534114|520951742|FG000|Extension Treatment Period|Death|0|||
144478684|NCT04534114|520951743|FG001|Extension Treatment Period|Death|0|||
144478685|NCT04534114|520951744|FG002|Extension Treatment Period|Death|1|||
144478686|NCT04534114|520951745|FG003|Extension Treatment Period|Death|2|||
144478687|NCT04534114|520951742|FG000|Extension Treatment Period|Adverse Event|0|||
144478688|NCT04534114|520951743|FG001|Extension Treatment Period|Adverse Event|1|||
144478689|NCT04534114|520951744|FG002|Extension Treatment Period|Adverse Event|0|||
144478690|NCT04534114|520951745|FG003|Extension Treatment Period|Adverse Event|1|||
144478691|NCT04534114|520951742|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
144478692|NCT04534114|520951743|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
144478693|NCT04534114|520951744|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
144478694|NCT04534114|520951745|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
144478695|NCT03287414|520951746|FG000|Treatment Epoch|Adverse Event|0|||
144478696|NCT03287414|520951747|FG001|Treatment Epoch|Adverse Event|1|||
144478697|NCT03287414|520951746|FG000|Treatment Epoch|Study terminated by sponsor|2|||
144478698|NCT03287414|520951747|FG001|Treatment Epoch|Study terminated by sponsor|2|||
144478699|NCT03287414|520951746|FG000|Treatment Epoch|Subject/Guardian decision|4|||
144478700|NCT03287414|520951747|FG001|Treatment Epoch|Subject/Guardian decision|0|||
144478701|NCT03287414|520951746|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
144478702|NCT03287414|520951747|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
144478703|NCT03287414|520951746|FG000|Treatment Epoch|Withdrawal by Subject|1|||
144478704|NCT03287414|520951747|FG001|Treatment Epoch|Withdrawal by Subject|0|||
144478705|NCT03287414|520951746|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
144478706|NCT03287414|520951747|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
144478707|NCT03287414|520951746|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
144478708|NCT03287414|520951747|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
144478709|NCT02759185|520951748|FG000|Stage 1|Adverse Event|0|||
144364713|NCT01217229|520545095|FG000|Overall Study|Disease progression, Cheson criteria|14|||
144364714|NCT01217229|520545095|FG000|Overall Study|Protocol Violation|1|||
144364715|NCT01217229|520545095|FG000|Overall Study|Disease progression not confirmed|2|||
144364716|NCT02651675|520545098|FG000|Overall Study|Death|0|||
144364717|NCT02651675|520545099|FG001|Overall Study|Death|0|||
144364718|NCT02651675|520545100|FG002|Overall Study|Death|1|||
144364719|NCT03597347|520545105|FG000|Overall Study|Withdrawal by Subject|1|||
144364720|NCT03597347|520545106|FG001|Overall Study|Withdrawal by Subject|1|||
144364721|NCT03597347|520545107|FG002|Overall Study|Withdrawal by Subject|0|||
144364722|NCT03597347|520545105|FG000|Overall Study|Withdrawal due to Covid-19|3|||
144364723|NCT03597347|520545106|FG001|Overall Study|Withdrawal due to Covid-19|0|||
144364724|NCT03597347|520545107|FG002|Overall Study|Withdrawal due to Covid-19|0|||
144364725|NCT03597347|520545105|FG000|Overall Study|Sponsor decision to terminate study|3|||
144364726|NCT03597347|520545106|FG001|Overall Study|Sponsor decision to terminate study|2|||
144364727|NCT03597347|520545107|FG002|Overall Study|Sponsor decision to terminate study|4|||
144364728|NCT04606134|520545108|FG000|Overall Study|Adverse Event|0|||
144364729|NCT04606134|520545109|FG001|Overall Study|Adverse Event|1|||
144364730|NCT00107653|520545110|FG000|Overall Study|Adverse Event|24|||
144364731|NCT00107653|520545111|FG001|Overall Study|Adverse Event|43|||
144364732|NCT00107653|520545110|FG000|Overall Study|Insufficient Therapeutic Response|25|||
144364733|NCT00107653|520545111|FG001|Overall Study|Insufficient Therapeutic Response|11|||
144364734|NCT00107653|520545110|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
144364735|NCT00107653|520545111|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
144478710|NCT02759185|520951749|FG001|Stage 1|Adverse Event|1|||
144478711|NCT02759185|520951750|FG002|Stage 1|Adverse Event|3|||
144478712|NCT02759185|520951751|FG003|Stage 1|Adverse Event|0|||
144478713|NCT02759185|520951752|FG004|Stage 1|Adverse Event|0|||
144478714|NCT02759185|520951753|FG005|Stage 1|Adverse Event|0|||
144478715|NCT02759185|520951754|FG006|Stage 1|Adverse Event|0|||
144478716|NCT02759185|520951748|FG000|Stage 1|Withdrawal by Subject|1|||
144478717|NCT02759185|520951749|FG001|Stage 1|Withdrawal by Subject|0|||
144478718|NCT02759185|520951750|FG002|Stage 1|Withdrawal by Subject|0|||
144478719|NCT02759185|520951751|FG003|Stage 1|Withdrawal by Subject|0|||
144478720|NCT02759185|520951752|FG004|Stage 1|Withdrawal by Subject|0|||
144478721|NCT02759185|520951753|FG005|Stage 1|Withdrawal by Subject|0|||
144478722|NCT02759185|520951754|FG006|Stage 1|Withdrawal by Subject|0|||
144478723|NCT02759185|520951748|FG000|Stage 2|Adverse Event|0|||
144478724|NCT02759185|520951749|FG001|Stage 2|Adverse Event|0|||
144364736|NCT00107653|520545110|FG000|Overall Study|Protocol Violation|1|||
144364737|NCT00107653|520545111|FG001|Overall Study|Protocol Violation|0|||
144364738|NCT00107653|520545110|FG000|Overall Study|Withdrawal by Subject|12|||
144364739|NCT00107653|520545111|FG001|Overall Study|Withdrawal by Subject|13|||
144364740|NCT00107653|520545110|FG000|Overall Study|Lost to Follow-up|13|||
144364741|NCT00107653|520545111|FG001|Overall Study|Lost to Follow-up|5|||
144364742|NCT00107653|520545110|FG000|Overall Study|Administrative Reasons|3|||
144364743|NCT00107653|520545111|FG001|Overall Study|Administrative Reasons|3|||
144364744|NCT02018562|520545115|FG000|Overall Study|Withdrawal by Subject|2|||
144364745|NCT02018562|520545116|FG001|Overall Study|Withdrawal by Subject|0|||
144364746|NCT02018562|520545115|FG000|Overall Study|Discharged prior to study completion|1|||
144364747|NCT02018562|520545116|FG001|Overall Study|Discharged prior to study completion|0|||
144364748|NCT05194124|520545117|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364749|NCT05194124|520545118|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364750|NCT05194124|520545119|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364751|NCT05194124|520545120|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
144364752|NCT05194124|520545121|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364753|NCT05194124|520545122|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
144364754|NCT05194124|520545123|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364755|NCT05194124|520545124|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364756|NCT05194124|520545125|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364757|NCT05194124|520545126|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
144364758|NCT05194124|520545117|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364759|NCT05194124|520545118|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364760|NCT05194124|520545119|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364761|NCT05194124|520545120|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364762|NCT05194124|520545121|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364763|NCT05194124|520545122|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364764|NCT05194124|520545123|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364765|NCT05194124|520545124|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364766|NCT05194124|520545125|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
144364767|NCT05194124|520545126|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
144364768|NCT03642873|520545127|FG000|Third Intervention (1 Day)|Screen failure|0|||
144364769|NCT03642873|520545128|FG001|Third Intervention (1 Day)|Screen failure|0|||
144364770|NCT03642873|520545129|FG002|Third Intervention (1 Day)|Screen failure|0|||
144364771|NCT03642873|520545130|FG003|Third Intervention (1 Day)|Screen failure|0|||
144364772|NCT03642873|520545131|FG004|Third Intervention (1 Day)|Screen failure|1|||
144364773|NCT03642873|520545132|FG005|Third Intervention (1 Day)|Screen failure|0|||
144364774|NCT01253291|520545133|FG000|Overall Study|Withdrawal by Subject|1|||
144364775|NCT01253291|520545134|FG001|Overall Study|Withdrawal by Subject|1|||
144364776|NCT01253291|520545135|FG002|Overall Study|Withdrawal by Subject|0|||
144364777|NCT01253291|520545136|FG003|Overall Study|Withdrawal by Subject|0|||
144364778|NCT01253291|520545137|FG004|Overall Study|Withdrawal by Subject|0|||
144364779|NCT01253291|520545133|FG000|Overall Study|Adverse Event|0|||
144364780|NCT01253291|520545134|FG001|Overall Study|Adverse Event|1|||
144364781|NCT01253291|520545135|FG002|Overall Study|Adverse Event|0|||
144364782|NCT01253291|520545136|FG003|Overall Study|Adverse Event|0|||
144364783|NCT01253291|520545137|FG004|Overall Study|Adverse Event|0|||
144364784|NCT01253291|520545133|FG000|Overall Study|Lack of Efficacy|1|||
144364785|NCT01253291|520545134|FG001|Overall Study|Lack of Efficacy|0|||
144364786|NCT01253291|520545135|FG002|Overall Study|Lack of Efficacy|0|||
144364787|NCT01253291|520545136|FG003|Overall Study|Lack of Efficacy|0|||
144364788|NCT01253291|520545137|FG004|Overall Study|Lack of Efficacy|0|||
144364789|NCT01253291|520545133|FG000|Overall Study|Physician Decision|2|||
144364790|NCT01253291|520545134|FG001|Overall Study|Physician Decision|0|||
144364791|NCT01253291|520545135|FG002|Overall Study|Physician Decision|0|||
144364792|NCT01253291|520545136|FG003|Overall Study|Physician Decision|0|||
144364793|NCT01253291|520545137|FG004|Overall Study|Physician Decision|2|||
144478725|NCT02759185|520951750|FG002|Stage 2|Adverse Event|0|||
144364794|NCT01838395|520545141|FG000|Overall Study|Withdrawal by Subject|0|||
144478726|NCT02759185|520951751|FG003|Stage 2|Adverse Event|0|||
144478727|NCT02759185|520951752|FG004|Stage 2|Adverse Event|1|||
144478728|NCT02759185|520951753|FG005|Stage 2|Adverse Event|2|||
144478729|NCT02759185|520951754|FG006|Stage 2|Adverse Event|0|||
144478730|NCT02759185|520951748|FG000|Stage 2|Withdrawal by Subject|0|||
144703356|NCT02325739|521766863|FG001|Phase I Part|Adverse Event|0|||
144478731|NCT02759185|520951749|FG001|Stage 2|Withdrawal by Subject|0|||
144478732|NCT02759185|520951750|FG002|Stage 2|Withdrawal by Subject|0|||
144478733|NCT02759185|520951751|FG003|Stage 2|Withdrawal by Subject|0|||
144478734|NCT02759185|520951752|FG004|Stage 2|Withdrawal by Subject|1|||
144478735|NCT02759185|520951753|FG005|Stage 2|Withdrawal by Subject|1|||
144478736|NCT02759185|520951754|FG006|Stage 2|Withdrawal by Subject|1|||
144478737|NCT04395183|520951759|FG000|Overall Study|Withdrawal by Subject|1|||
144478738|NCT04395183|520951760|FG001|Overall Study|Withdrawal by Subject|0|||
144478739|NCT04395183|520951761|FG002|Overall Study|Withdrawal by Subject|2|||
144478740|NCT04395183|520951762|FG003|Overall Study|Withdrawal by Subject|2|||
144478741|NCT01008475|520951763|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
144478742|NCT01008475|520951764|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
144478743|NCT01008475|520951765|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
144478744|NCT01008475|520951766|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
144478745|NCT01008475|520951767|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
144478746|NCT01008475|520951768|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
144478747|NCT01008475|520951769|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
144478748|NCT02668016|520951770|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
144478749|NCT02668016|520951770|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
144478750|NCT02668016|520951770|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
144478751|NCT02668016|520951770|FG000|Month 4|Withdrawal due to severe symptoms|1|||
144478752|NCT02668016|520951770|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
144478753|NCT02668016|520951770|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
144478754|NCT02668016|520951770|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
144478755|NCT02668016|520951770|FG000|Month 6|Withdrawal due to severe symptoms|2|||
144478756|NCT02668016|520951770|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
144478757|NCT02668016|520951770|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
144478758|NCT02668016|520951770|FG000|Month 8|Withdrawal due to severe symptoms|1|||
144478759|NCT02668016|520951770|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
144478760|NCT02668016|520951770|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
144478761|NCT02668016|520951770|FG000|Month 10|Withdrawal due to severe symptoms|1|||
144478762|NCT02668016|520951770|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
144478763|NCT01122381|520951776|FG000|Overall Study|study terminated early|0|||
144478764|NCT01122381|520951777|FG001|Overall Study|study terminated early|1|||
144478765|NCT02395133|520951778|FG000|Overall Study|Adverse Event|4|||
144478766|NCT02395133|520951779|FG001|Overall Study|Adverse Event|1|||
144478767|NCT02395133|520951780|FG002|Overall Study|Adverse Event|3|||
144478768|NCT02395133|520951781|FG003|Overall Study|Adverse Event|0|||
144478769|NCT02395133|520951778|FG000|Overall Study|Lack of Efficacy|1|||
144478770|NCT02395133|520951779|FG001|Overall Study|Lack of Efficacy|0|||
144478771|NCT02395133|520951780|FG002|Overall Study|Lack of Efficacy|1|||
144364795|NCT01838395|520545142|FG001|Overall Study|Withdrawal by Subject|0|||
144364796|NCT01838395|520545143|FG002|Overall Study|Withdrawal by Subject|0|||
144364797|NCT01838395|520545144|FG003|Overall Study|Withdrawal by Subject|0|||
144364798|NCT01838395|520545145|FG004|Overall Study|Withdrawal by Subject|1|||
144364799|NCT01838395|520545146|FG005|Overall Study|Withdrawal by Subject|0|||
144364800|NCT01838395|520545141|FG000|Overall Study|Death|0|||
144364801|NCT01838395|520545142|FG001|Overall Study|Death|0|||
144364802|NCT01838395|520545143|FG002|Overall Study|Death|1|||
144364803|NCT01838395|520545144|FG003|Overall Study|Death|0|||
144364804|NCT01838395|520545145|FG004|Overall Study|Death|0|||
144364805|NCT01838395|520545146|FG005|Overall Study|Death|0|||
144364806|NCT01838395|520545141|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
144364807|NCT01838395|520545142|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
144364808|NCT01838395|520545143|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
144364809|NCT01838395|520545144|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
144364810|NCT01838395|520545145|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
144364811|NCT01838395|520545146|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
144364812|NCT03312231|520545147|FG000|Overall Study|Lost to Follow-up|2|||
144364813|NCT03312231|520545148|FG001|Overall Study|Lost to Follow-up|6|||
144364814|NCT03312231|520545149|FG002|Overall Study|Lost to Follow-up|1|||
144364815|NCT03312231|520545150|FG003|Overall Study|Lost to Follow-up|3|||
144478772|NCT02395133|520951781|FG003|Overall Study|Lack of Efficacy|1|||
144478773|NCT02395133|520951778|FG000|Overall Study|Protocol Violation|1|||
144364816|NCT03312231|520545151|FG004|Overall Study|Lost to Follow-up|1|||
144364817|NCT03312231|520545147|FG000|Overall Study|Withdrawal by Subject|0|||
144364818|NCT03312231|520545148|FG001|Overall Study|Withdrawal by Subject|3|||
144364819|NCT03312231|520545149|FG002|Overall Study|Withdrawal by Subject|1|||
144364820|NCT03312231|520545150|FG003|Overall Study|Withdrawal by Subject|0|||
144478774|NCT02395133|520951779|FG001|Overall Study|Protocol Violation|1|||
144478775|NCT02395133|520951780|FG002|Overall Study|Protocol Violation|0|||
144478776|NCT02395133|520951781|FG003|Overall Study|Protocol Violation|3|||
144478777|NCT02395133|520951778|FG000|Overall Study|Lost to Follow-up|0|||
144478778|NCT02395133|520951779|FG001|Overall Study|Lost to Follow-up|1|||
144478779|NCT02395133|520951780|FG002|Overall Study|Lost to Follow-up|1|||
144478780|NCT02395133|520951781|FG003|Overall Study|Lost to Follow-up|0|||
144478781|NCT02395133|520951778|FG000|Overall Study|Pregnancy|0|||
144478782|NCT02395133|520951779|FG001|Overall Study|Pregnancy|0|||
144478783|NCT02395133|520951780|FG002|Overall Study|Pregnancy|3|||
144478784|NCT02395133|520951781|FG003|Overall Study|Pregnancy|0|||
144478785|NCT02395133|520951778|FG000|Overall Study|Consent withdrawn with no reason given|1|||
144478786|NCT02395133|520951779|FG001|Overall Study|Consent withdrawn with no reason given|3|||
144478787|NCT02395133|520951780|FG002|Overall Study|Consent withdrawn with no reason given|0|||
144478788|NCT02395133|520951781|FG003|Overall Study|Consent withdrawn with no reason given|2|||
144478789|NCT02395133|520951778|FG000|Overall Study|Consent withdrawn with personal reason|0|||
144478790|NCT02395133|520951779|FG001|Overall Study|Consent withdrawn with personal reason|1|||
144478791|NCT02395133|520951780|FG002|Overall Study|Consent withdrawn with personal reason|0|||
144478792|NCT02395133|520951781|FG003|Overall Study|Consent withdrawn with personal reason|3|||
144478793|NCT02395133|520951778|FG000|Overall Study|Sponsor decision|2|||
144478794|NCT02395133|520951779|FG001|Overall Study|Sponsor decision|0|||
144478795|NCT02395133|520951780|FG002|Overall Study|Sponsor decision|0|||
144478796|NCT02395133|520951781|FG003|Overall Study|Sponsor decision|1|||
144478797|NCT02395133|520951778|FG000|Overall Study|Other than specified above|5|||
144478798|NCT02395133|520951779|FG001|Overall Study|Other than specified above|2|||
144478799|NCT02395133|520951780|FG002|Overall Study|Other than specified above|2|||
144478800|NCT02395133|520951781|FG003|Overall Study|Other than specified above|4|||
144478801|NCT00962247|520951784|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
144478802|NCT00962247|520951784|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
144478803|NCT03203694|520951788|FG000|Overall Study|Withdrawal by Subject|2|||
144478804|NCT03203694|520951789|FG001|Overall Study|Withdrawal by Subject|0|||
144478805|NCT03203694|520951790|FG002|Overall Study|Withdrawal by Subject|0|||
144478806|NCT03203694|520951791|FG003|Overall Study|Withdrawal by Subject|0|||
144478807|NCT03203694|520951792|FG004|Overall Study|Withdrawal by Subject|0|||
144478808|NCT03203694|520951793|FG005|Overall Study|Withdrawal by Subject|0|||
144478809|NCT01709305|520951796|FG000|Phase 1|Clinical Adverse Event|80|||
144478810|NCT01709305|520951797|FG001|Phase 1|Clinical Adverse Event|0|||
144478811|NCT01709305|520951798|FG002|Phase 1|Clinical Adverse Event|0|||
144478812|NCT01709305|520951799|FG003|Phase 1|Clinical Adverse Event|0|||
144478813|NCT01709305|520951800|FG004|Phase 1|Clinical Adverse Event|0|||
144478814|NCT01709305|520951796|FG000|Phase 1|Death|2|||
144478815|NCT01709305|520951797|FG001|Phase 1|Death|0|||
144478816|NCT01709305|520951798|FG002|Phase 1|Death|0|||
144478817|NCT01709305|520951799|FG003|Phase 1|Death|0|||
144478818|NCT01709305|520951800|FG004|Phase 1|Death|0|||
144478819|NCT01709305|520951796|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
144478820|NCT01709305|520951797|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
144478821|NCT01709305|520951798|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
144478822|NCT01709305|520951799|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
144478823|NCT01709305|520951800|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
144478824|NCT01709305|520951796|FG000|Phase 1|Laboratory Adverse Event|16|||
144478825|NCT01709305|520951797|FG001|Phase 1|Laboratory Adverse Event|0|||
144478826|NCT01709305|520951798|FG002|Phase 1|Laboratory Adverse Event|0|||
144478827|NCT01709305|520951799|FG003|Phase 1|Laboratory Adverse Event|0|||
144478828|NCT01709305|520951800|FG004|Phase 1|Laboratory Adverse Event|0|||
144478829|NCT01709305|520951796|FG000|Phase 1|Lost to Follow-up|147|||
144478830|NCT01709305|520951797|FG001|Phase 1|Lost to Follow-up|0|||
144478831|NCT01709305|520951798|FG002|Phase 1|Lost to Follow-up|0|||
144478832|NCT01709305|520951799|FG003|Phase 1|Lost to Follow-up|0|||
144478833|NCT01709305|520951800|FG004|Phase 1|Lost to Follow-up|0|||
144478834|NCT01709305|520951796|FG000|Phase 1|Travel, moving, etc.|30|||
144478835|NCT01709305|520951797|FG001|Phase 1|Travel, moving, etc.|0|||
144478836|NCT01709305|520951798|FG002|Phase 1|Travel, moving, etc.|0|||
144478837|NCT01709305|520951799|FG003|Phase 1|Travel, moving, etc.|0|||
144478838|NCT01709305|520951800|FG004|Phase 1|Travel, moving, etc.|0|||
144478839|NCT01709305|520951796|FG000|Phase 1|Physician Decision|13|||
144478840|NCT01709305|520951797|FG001|Phase 1|Physician Decision|0|||
144478841|NCT01709305|520951798|FG002|Phase 1|Physician Decision|0|||
144478842|NCT01709305|520951799|FG003|Phase 1|Physician Decision|0|||
144478843|NCT01709305|520951800|FG004|Phase 1|Physician Decision|0|||
144478844|NCT01709305|520951796|FG000|Phase 1|Protocol Violation|118|||
144478845|NCT01709305|520951797|FG001|Phase 1|Protocol Violation|0|||
144478846|NCT01709305|520951798|FG002|Phase 1|Protocol Violation|0|||
144478847|NCT01709305|520951799|FG003|Phase 1|Protocol Violation|0|||
144478848|NCT01709305|520951800|FG004|Phase 1|Protocol Violation|0|||
144364821|NCT03312231|520545151|FG004|Overall Study|Withdrawal by Subject|0|||
144364822|NCT03312231|520545147|FG000|Overall Study|Death|0|||
144364823|NCT03312231|520545148|FG001|Overall Study|Death|1|||
144364824|NCT03312231|520545149|FG002|Overall Study|Death|1|||
144364825|NCT03312231|520545150|FG003|Overall Study|Death|0|||
144364826|NCT03312231|520545151|FG004|Overall Study|Death|0|||
144364827|NCT03312231|520545147|FG000|Overall Study|Study Vaccination not Received|1|||
144364828|NCT03312231|520545148|FG001|Overall Study|Study Vaccination not Received|1|||
144364829|NCT03312231|520545149|FG002|Overall Study|Study Vaccination not Received|1|||
144364830|NCT03312231|520545150|FG003|Overall Study|Study Vaccination not Received|0|||
144364831|NCT03312231|520545151|FG004|Overall Study|Study Vaccination not Received|0|||
144364832|NCT03157830|520545156|FG000|Overall Study|Lost to Follow-up|1|||
144364833|NCT03157830|520545156|FG000|Overall Study|Withdrawal by Subject|1|||
144364834|NCT03694353|520545160|FG000|Overall Study|Withdrawal by Subject|1|||
144364835|NCT03694353|520545160|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
144364836|NCT05720897|520545162|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
144364837|NCT05720897|520545163|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
144364838|NCT04050553|520545164|FG000|Period 1|Physician Decision|2|||
144364839|NCT04050553|520545165|FG001|Period 1|Physician Decision|2|||
144364840|NCT04050553|520545164|FG000|Period 1|Adverse Event|1|||
144364841|NCT04050553|520545165|FG001|Period 1|Adverse Event|1|||
144364842|NCT04050553|520545164|FG000|Period 1|Withdrawal by Subject|0|||
144364843|NCT04050553|520545165|FG001|Period 1|Withdrawal by Subject|1|||
144364844|NCT04050553|520545164|FG000|Wash-out|Adverse Event|0|||
144364845|NCT04050553|520545165|FG001|Wash-out|Adverse Event|1|||
144364846|NCT04050553|520545164|FG000|Wash-out|Withdrawal by Subject|0|||
144364847|NCT04050553|520545165|FG001|Wash-out|Withdrawal by Subject|1|||
144364848|NCT05430854|520545167|FG000|Overall Study|Trial terminated by Sponsor|39|||
144364849|NCT05430854|520545168|FG001|Overall Study|Trial terminated by Sponsor|50|||
144364850|NCT05430854|520545169|FG002|Overall Study|Trial terminated by Sponsor|46|||
144364851|NCT05430854|520545167|FG000|Overall Study|Withdrawal by Subject|0|||
144364852|NCT05430854|520545168|FG001|Overall Study|Withdrawal by Subject|3|||
144364853|NCT05430854|520545169|FG002|Overall Study|Withdrawal by Subject|0|||
144364854|NCT04314284|520545170|FG000|Overall Study|Withdrawal by Subject|4|||
144364855|NCT04314284|520545171|FG001|Overall Study|Withdrawal by Subject|7|||
144364856|NCT04314284|520545170|FG000|Overall Study|Consented but did not complete survey|0|||
144364857|NCT04314284|520545171|FG001|Overall Study|Consented but did not complete survey|6|||
144364858|NCT01652235|520545177|FG000|Overall Study|Death|9|||
144364859|NCT01652235|520545177|FG000|Overall Study|Lost to Follow-up|5|||
144364860|NCT01652235|520545177|FG000|Overall Study|Withdrawal by Subject|2|||
144364861|NCT02023086|520545180|FG000|Overall Study|Withdrawal by Subject|2|||
144364862|NCT02023086|520545181|FG001|Overall Study|Withdrawal by Subject|0|||
144364863|NCT03589859|520545184|FG000|Overall Study|Withdrawal by Subject|0|||
144364864|NCT03589859|520545185|FG001|Overall Study|Withdrawal by Subject|6|||
144364865|NCT05565742|520545187|FG000|Overall Study|Withdrawal by Subject|0|||
144364866|NCT05565742|520545188|FG001|Overall Study|Withdrawal by Subject|0|||
144364867|NCT05565742|520545189|FG002|Overall Study|Withdrawal by Subject|2|||
144364868|NCT05565742|520545190|FG003|Overall Study|Withdrawal by Subject|2|||
144364869|NCT05565742|520545191|FG004|Overall Study|Withdrawal by Subject|2|||
144364870|NCT05565742|520545187|FG000|Overall Study|Death|1|||
144364871|NCT05565742|520545188|FG001|Overall Study|Death|0|||
144364872|NCT05565742|520545189|FG002|Overall Study|Death|0|||
144364873|NCT05565742|520545190|FG003|Overall Study|Death|0|||
144364874|NCT05565742|520545191|FG004|Overall Study|Death|0|||
144364875|NCT05565742|520545187|FG000|Overall Study|Participant Travelled Abroad|0|||
144364876|NCT05565742|520545188|FG001|Overall Study|Participant Travelled Abroad|0|||
144364877|NCT05565742|520545189|FG002|Overall Study|Participant Travelled Abroad|0|||
144364878|NCT05565742|520545190|FG003|Overall Study|Participant Travelled Abroad|0|||
144364879|NCT05565742|520545191|FG004|Overall Study|Participant Travelled Abroad|1|||
144364880|NCT04163341|520545192|FG000|Overall Study|Withdrawal by Subject|2|||
144364881|NCT04163341|520545193|FG001|Overall Study|Withdrawal by Subject|0|||
144364882|NCT04163341|520545192|FG000|Overall Study|Lost to Follow-up|3|||
144364883|NCT04163341|520545193|FG001|Overall Study|Lost to Follow-up|4|||
144364884|NCT04272242|520545194|FG000|Overall Study|Withdrawal by Subject|3|||
144364885|NCT04272242|520545194|FG000|Overall Study|Lost to Follow-up|1|||
144703357|NCT02325739|521766864|FG002|Phase I Part|Adverse Event|1|||
144364886|NCT04272242|520545194|FG000|Overall Study|Adverse Event|1|||
144364887|NCT02638220|520545195|FG000|Overall Study|Lost to Follow-up|6|||
144364888|NCT02638220|520545195|FG000|Overall Study|Withdrawal by Subject|3|||
144364889|NCT02638220|520545195|FG000|Overall Study|Physician Decision|1|||
144364890|NCT02638220|520545195|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
144364891|NCT01586364|520547394|FG000|Overall Study|Withdrawal by Subject|40|||
144364892|NCT01586364|520547394|FG000|Overall Study|Adverse Event|37|||
144364893|NCT01586364|520547394|FG000|Overall Study|Lost to Follow-up|17|||
144364894|NCT01586364|520547394|FG000|Overall Study|Protocol Violation|16|||
144364895|NCT01586364|520547394|FG000|Overall Study|Lack of Efficacy|1|||
144364896|NCT01586364|520547394|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
144364897|NCT01586364|520547394|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
144364898|NCT01586364|520547394|FG000|Overall Study|Other-Site closure due to PI illness|1|||
144364899|NCT01586364|520547394|FG000|Overall Study|Other-PI discretion, site closing|2|||
144364900|NCT01586364|520547394|FG000|Overall Study|Other-Not specified|1|||
144364901|NCT00091949|520547395|FG000|Overall Study|Withdrawal by Subject|117|||
144364902|NCT00091949|520547396|FG001|Overall Study|Withdrawal by Subject|110|||
144364903|NCT00091949|520547395|FG000|Overall Study|Lost to Follow-up|58|||
144364904|NCT00091949|520547396|FG001|Overall Study|Lost to Follow-up|41|||
144364905|NCT05366738|520547397|FG000|Overall Study|Adverse Event|0|||
144364906|NCT05366738|520547398|FG001|Overall Study|Adverse Event|1|||
144364907|NCT05366738|520547399|FG002|Overall Study|Adverse Event|0|||
144364908|NCT05291520|520547400|FG000|Overall Study|Lost to Follow-up|0|||
144364909|NCT05291520|520547401|FG001|Overall Study|Lost to Follow-up|0|||
144364910|NCT05291520|520547402|FG002|Overall Study|Lost to Follow-up|1|||
144364911|NCT01347112|520547403|FG000|Overall Study|Withdrawal by Subject|1|||
144364912|NCT01347112|520547404|FG001|Overall Study|Withdrawal by Subject|7|||
144364913|NCT01347112|520547403|FG000|Overall Study|Lost to Follow-up|3|||
144364914|NCT01347112|520547404|FG001|Overall Study|Lost to Follow-up|5|||
144364915|NCT00696072|520547405|FG000|Overall Study|continuing active treatment|10|||
144364916|NCT00696072|520547406|FG001|Overall Study|continuing active treatment|13|||
144364917|NCT00696072|520547405|FG000|Overall Study|Adverse Event|10|||
144364918|NCT00696072|520547406|FG001|Overall Study|Adverse Event|6|||
144364919|NCT00696072|520547405|FG000|Overall Study|Patient Request|3|||
144364920|NCT00696072|520547406|FG001|Overall Study|Patient Request|7|||
144364921|NCT00696072|520547405|FG000|Overall Study|Investigator Request|1|||
144364922|NCT00696072|520547406|FG001|Overall Study|Investigator Request|4|||
144364923|NCT00696072|520547405|FG000|Overall Study|Sponsor Request|0|||
144364924|NCT00696072|520547406|FG001|Overall Study|Sponsor Request|1|||
144364925|NCT00696072|520547405|FG000|Overall Study|Disease Progression|32|||
144364926|NCT00696072|520547406|FG001|Overall Study|Disease Progression|30|||
144364927|NCT00696072|520547405|FG000|Overall Study|Non-specified|1|||
144364928|NCT00696072|520547406|FG001|Overall Study|Non-specified|2|||
144364929|NCT01597596|520547407|FG000|Overall Study|Study terminated by sponsor|1|||
144364930|NCT01597596|520547408|FG001|Overall Study|Study terminated by sponsor|0|||
144364931|NCT01597596|520547407|FG000|Overall Study|Physician Decision|0|||
144364932|NCT01597596|520547408|FG001|Overall Study|Physician Decision|1|||
144364933|NCT02419001|520547417|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
144364934|NCT02419001|520547418|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
144364935|NCT00129402|520547429|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
144364936|NCT00129402|520547430|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
144364937|NCT00129402|520547431|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
144364938|NCT00129402|520547432|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
144364939|NCT00129402|520547433|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
144364940|NCT00129402|520547434|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
144364941|NCT00129402|520547435|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
144364942|NCT00129402|520547429|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
144364943|NCT00129402|520547430|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
144364944|NCT00129402|520547431|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
144364945|NCT00129402|520547432|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
144364946|NCT00129402|520547433|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
144364947|NCT00129402|520547434|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
144364948|NCT00129402|520547435|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
144478849|NCT01709305|520951796|FG000|Phase 1|Withdrawal by Subject|218|||
144478850|NCT01709305|520951797|FG001|Phase 1|Withdrawal by Subject|0|||
144478851|NCT01709305|520951798|FG002|Phase 1|Withdrawal by Subject|0|||
144478852|NCT01709305|520951799|FG003|Phase 1|Withdrawal by Subject|0|||
144478853|NCT01709305|520951800|FG004|Phase 1|Withdrawal by Subject|0|||
144478854|NCT01709305|520951796|FG000|Phase 2|Clinical Adverse Event|0|||
144364949|NCT00129402|520547429|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
144364950|NCT00129402|520547430|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
144364951|NCT00129402|520547431|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
144364952|NCT00129402|520547432|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
144364953|NCT00129402|520547433|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
144364954|NCT00129402|520547434|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
144364955|NCT00129402|520547435|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
144364956|NCT00129402|520547429|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
144364957|NCT00129402|520547430|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
144364958|NCT00129402|520547431|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
144364959|NCT00129402|520547432|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
144478855|NCT01709305|520951797|FG001|Phase 2|Clinical Adverse Event|10|||
144478856|NCT01709305|520951798|FG002|Phase 2|Clinical Adverse Event|10|||
144364960|NCT00129402|520547433|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
144364961|NCT00129402|520547434|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
144478857|NCT01709305|520951799|FG003|Phase 2|Clinical Adverse Event|6|||
144478858|NCT01709305|520951800|FG004|Phase 2|Clinical Adverse Event|11|||
144478859|NCT01709305|520951796|FG000|Phase 2|Death|0|||
144478860|NCT01709305|520951797|FG001|Phase 2|Death|0|||
144478861|NCT01709305|520951798|FG002|Phase 2|Death|1|||
144478862|NCT01709305|520951799|FG003|Phase 2|Death|0|||
144478863|NCT01709305|520951800|FG004|Phase 2|Death|0|||
144478864|NCT01709305|520951796|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
144478865|NCT01709305|520951797|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
144478866|NCT01709305|520951798|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
144478867|NCT01709305|520951799|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
144478868|NCT01709305|520951800|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
144478869|NCT01709305|520951796|FG000|Phase 2|Laboratory Adverse Event|0|||
144478870|NCT01709305|520951797|FG001|Phase 2|Laboratory Adverse Event|1|||
144478871|NCT01709305|520951798|FG002|Phase 2|Laboratory Adverse Event|0|||
144478872|NCT01709305|520951799|FG003|Phase 2|Laboratory Adverse Event|1|||
144478873|NCT01709305|520951800|FG004|Phase 2|Laboratory Adverse Event|1|||
144478874|NCT01709305|520951796|FG000|Phase 2|Lost to Follow-up|0|||
144478875|NCT01709305|520951797|FG001|Phase 2|Lost to Follow-up|10|||
144478876|NCT01709305|520951798|FG002|Phase 2|Lost to Follow-up|6|||
144478877|NCT01709305|520951799|FG003|Phase 2|Lost to Follow-up|9|||
144478878|NCT01709305|520951800|FG004|Phase 2|Lost to Follow-up|5|||
144478879|NCT01709305|520951796|FG000|Phase 2|Travel, moving, etc.|0|||
144478880|NCT01709305|520951797|FG001|Phase 2|Travel, moving, etc.|2|||
144478881|NCT01709305|520951798|FG002|Phase 2|Travel, moving, etc.|3|||
144478882|NCT01709305|520951799|FG003|Phase 2|Travel, moving, etc.|3|||
144478883|NCT01709305|520951800|FG004|Phase 2|Travel, moving, etc.|5|||
144478884|NCT01709305|520951796|FG000|Phase 2|Physician Decision|0|||
144478885|NCT01709305|520951797|FG001|Phase 2|Physician Decision|2|||
144478886|NCT01709305|520951798|FG002|Phase 2|Physician Decision|0|||
144478887|NCT01709305|520951799|FG003|Phase 2|Physician Decision|1|||
144478888|NCT01709305|520951800|FG004|Phase 2|Physician Decision|2|||
144478889|NCT01709305|520951796|FG000|Phase 2|Protocol Violation|0|||
144478890|NCT01709305|520951797|FG001|Phase 2|Protocol Violation|19|||
144478891|NCT01709305|520951798|FG002|Phase 2|Protocol Violation|19|||
144478892|NCT01709305|520951799|FG003|Phase 2|Protocol Violation|13|||
144478893|NCT01709305|520951800|FG004|Phase 2|Protocol Violation|9|||
144478894|NCT01709305|520951796|FG000|Phase 2|Withdrawal by Subject|0|||
144478895|NCT01709305|520951797|FG001|Phase 2|Withdrawal by Subject|8|||
144478896|NCT01709305|520951798|FG002|Phase 2|Withdrawal by Subject|6|||
144478897|NCT01709305|520951799|FG003|Phase 2|Withdrawal by Subject|15|||
144478898|NCT01709305|520951800|FG004|Phase 2|Withdrawal by Subject|12|||
144478899|NCT01103960|520951801|FG000|Overall Study|Adverse Event|2|||
144478900|NCT01103960|520951802|FG001|Overall Study|Adverse Event|1|||
144478901|NCT01103960|520951801|FG000|Overall Study|Withdrawal by Subject|2|||
144478902|NCT01103960|520951802|FG001|Overall Study|Withdrawal by Subject|1|||
144478903|NCT01103960|520951801|FG000|Overall Study|Other|1|||
144478904|NCT01103960|520951802|FG001|Overall Study|Other|0|||
144478905|NCT00118898|520951807|FG000|Overall Study|Death|6|||
144478906|NCT00118898|520951808|FG001|Overall Study|Death|11|||
144478907|NCT00118898|520951809|FG002|Overall Study|Death|6|||
144478908|NCT00118898|520951810|FG003|Overall Study|Death|8|||
144478909|NCT00118898|520951807|FG000|Overall Study|Lost to Follow-up|26|||
144478910|NCT00118898|520951808|FG001|Overall Study|Lost to Follow-up|34|||
144478911|NCT00118898|520951809|FG002|Overall Study|Lost to Follow-up|33|||
144478912|NCT00118898|520951810|FG003|Overall Study|Lost to Follow-up|33|||
144478913|NCT00118898|520951807|FG000|Overall Study|Withdrawal by Subject|10|||
144478914|NCT00118898|520951808|FG001|Overall Study|Withdrawal by Subject|5|||
144478915|NCT00118898|520951809|FG002|Overall Study|Withdrawal by Subject|8|||
144478916|NCT00118898|520951810|FG003|Overall Study|Withdrawal by Subject|8|||
144478917|NCT00118898|520951807|FG000|Overall Study|Site Closure|33|||
144478918|NCT00118898|520951808|FG001|Overall Study|Site Closure|31|||
144478919|NCT00118898|520951809|FG002|Overall Study|Site Closure|28|||
144478920|NCT00118898|520951810|FG003|Overall Study|Site Closure|37|||
144478921|NCT00118898|520951807|FG000|Overall Study|Severe debilitation|1|||
144478922|NCT00118898|520951808|FG001|Overall Study|Severe debilitation|4|||
144364962|NCT00129402|520547435|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
144478923|NCT00118898|520951809|FG002|Overall Study|Severe debilitation|6|||
144478924|NCT00118898|520951810|FG003|Overall Study|Severe debilitation|4|||
144478925|NCT00118898|520951807|FG000|Overall Study|Not compliant with requirements|11|||
144478926|NCT00118898|520951808|FG001|Overall Study|Not compliant with requirements|13|||
144478927|NCT00118898|520951809|FG002|Overall Study|Not compliant with requirements|11|||
144478928|NCT00118898|520951810|FG003|Overall Study|Not compliant with requirements|11|||
144478929|NCT00118898|520951807|FG000|Overall Study|Not able to get to clinic|34|||
144478930|NCT00118898|520951808|FG001|Overall Study|Not able to get to clinic|43|||
144478931|NCT00118898|520951809|FG002|Overall Study|Not able to get to clinic|31|||
144478932|NCT00118898|520951810|FG003|Overall Study|Not able to get to clinic|40|||
144478933|NCT01338012|520951813|FG000|Overall Study|Death|4|||
144478934|NCT01338012|520951813|FG000|Overall Study|Study terminated|4|||
144478935|NCT02714205|520951814|FG000|Overall Study|Cannot tolerate medication|1|||
144478936|NCT02714205|520951815|FG001|Overall Study|Cannot tolerate medication|0|||
144478937|NCT02714205|520951814|FG000|Overall Study|Adverse Event|2|||
144364963|NCT00129402|520547429|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
144364964|NCT00129402|520547430|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
144364965|NCT00129402|520547431|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
144364966|NCT00129402|520547432|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
144364967|NCT00129402|520547433|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
144364968|NCT00129402|520547434|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
144364969|NCT00129402|520547435|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
144364970|NCT00129402|520547429|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
144364971|NCT00129402|520547430|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
144364972|NCT00129402|520547431|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
144364973|NCT00129402|520547432|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
144364974|NCT00129402|520547433|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
144364975|NCT00129402|520547434|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
144364976|NCT00129402|520547435|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
144364977|NCT00129402|520547429|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
144364978|NCT00129402|520547430|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
144364979|NCT00129402|520547431|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
144364980|NCT00129402|520547432|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
144478938|NCT02714205|520951815|FG001|Overall Study|Adverse Event|0|||
144478939|NCT02714205|520951814|FG000|Overall Study|Too busy|1|||
144364981|NCT00129402|520547433|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
144364982|NCT00129402|520547434|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
144364983|NCT00129402|520547435|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
144364984|NCT00129402|520547429|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
144364985|NCT00129402|520547430|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
144364986|NCT00129402|520547431|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
144364987|NCT00129402|520547432|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
144364988|NCT00129402|520547433|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
144364989|NCT00129402|520547434|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
144364990|NCT00129402|520547435|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
144364991|NCT00129402|520547429|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
144364992|NCT00129402|520547430|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
144364993|NCT00129402|520547431|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
144364994|NCT00129402|520547432|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
144364995|NCT00129402|520547433|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
144364996|NCT00129402|520547434|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
144364997|NCT00129402|520547435|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
144364998|NCT00129402|520547429|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
144364999|NCT00129402|520547430|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
144365000|NCT00129402|520547431|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
144365001|NCT00129402|520547432|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
144365002|NCT00129402|520547433|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
144365003|NCT00129402|520547434|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
144365004|NCT00129402|520547435|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
144365005|NCT00129402|520547429|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
144365006|NCT00129402|520547430|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
144365007|NCT00129402|520547431|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
144365008|NCT00129402|520547432|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
144365009|NCT00129402|520547433|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
144365010|NCT00129402|520547434|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
144365011|NCT00129402|520547435|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
144365012|NCT00129402|520547429|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
144365013|NCT00129402|520547430|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
144365014|NCT00129402|520547431|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
144365015|NCT00129402|520547432|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
144365016|NCT00129402|520547433|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
144365017|NCT00129402|520547434|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
144365018|NCT00129402|520547435|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
144365019|NCT00129402|520547429|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
144365020|NCT00129402|520547430|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
144365021|NCT00129402|520547431|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
144365022|NCT00129402|520547432|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
144478940|NCT02714205|520951815|FG001|Overall Study|Too busy|0|||
144478941|NCT02714205|520951814|FG000|Overall Study|Incomplete outcome data|0|||
144478942|NCT02714205|520951815|FG001|Overall Study|Incomplete outcome data|1|||
144478943|NCT02073097|520951816|FG000|Overall Study|Adverse Event|0|||
144478944|NCT02073097|520951817|FG001|Overall Study|Adverse Event|0|||
144478945|NCT02073097|520951818|FG002|Overall Study|Adverse Event|0|||
144478946|NCT02073097|520951819|FG003|Overall Study|Adverse Event|0|||
144478947|NCT02073097|520951820|FG004|Overall Study|Adverse Event|0|||
144478948|NCT02073097|520951821|FG005|Overall Study|Adverse Event|0|||
144478949|NCT02073097|520951822|FG006|Overall Study|Adverse Event|0|||
144478950|NCT02073097|520951823|FG007|Overall Study|Adverse Event|2|||
144478951|NCT02073097|520951816|FG000|Overall Study|Withdrawal by Subject|0|||
144478952|NCT02073097|520951817|FG001|Overall Study|Withdrawal by Subject|0|||
144478953|NCT02073097|520951818|FG002|Overall Study|Withdrawal by Subject|0|||
144478954|NCT02073097|520951819|FG003|Overall Study|Withdrawal by Subject|0|||
144478955|NCT02073097|520951820|FG004|Overall Study|Withdrawal by Subject|0|||
144478956|NCT02073097|520951821|FG005|Overall Study|Withdrawal by Subject|0|||
144478957|NCT02073097|520951822|FG006|Overall Study|Withdrawal by Subject|0|||
144478958|NCT02073097|520951823|FG007|Overall Study|Withdrawal by Subject|2|||
144478959|NCT02073097|520951816|FG000|Overall Study|Death|0|||
144478960|NCT02073097|520951817|FG001|Overall Study|Death|0|||
144478961|NCT02073097|520951818|FG002|Overall Study|Death|0|||
144478962|NCT02073097|520951819|FG003|Overall Study|Death|0|||
144478963|NCT02073097|520951820|FG004|Overall Study|Death|0|||
144478964|NCT02073097|520951821|FG005|Overall Study|Death|0|||
144478965|NCT02073097|520951822|FG006|Overall Study|Death|0|||
144478966|NCT02073097|520951823|FG007|Overall Study|Death|1|||
144478967|NCT02073097|520951816|FG000|Overall Study|Physician Decision|0|||
144478968|NCT02073097|520951817|FG001|Overall Study|Physician Decision|0|||
144478969|NCT02073097|520951818|FG002|Overall Study|Physician Decision|0|||
144478970|NCT02073097|520951819|FG003|Overall Study|Physician Decision|0|||
144478971|NCT02073097|520951820|FG004|Overall Study|Physician Decision|0|||
144478972|NCT02073097|520951821|FG005|Overall Study|Physician Decision|0|||
144478973|NCT02073097|520951822|FG006|Overall Study|Physician Decision|0|||
144478974|NCT02073097|520951823|FG007|Overall Study|Physician Decision|1|||
144478975|NCT03462706|520952888|FG000|Overall Study|Polyp was pedunculated|1|||
144478976|NCT03462706|520952889|FG001|Overall Study|Polyp was pedunculated|0|||
144478977|NCT03462706|520952890|FG002|Overall Study|Polyp was pedunculated|1|||
144478978|NCT03462706|520952891|FG003|Overall Study|Polyp was pedunculated|0|||
144478979|NCT03462706|520952888|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
144478980|NCT03462706|520952889|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
144478981|NCT03462706|520952890|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
144478982|NCT03462706|520952891|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
144478983|NCT02254408|520952902|FG000|Overall Study|Randomized But Not Treated|1|||
144703358|NCT02325739|521766865|FG003|Phase I Part|Adverse Event|2|||
144703359|NCT02325739|521766866|FG004|Phase I Part|Adverse Event|3|||
144703360|NCT02325739|521766867|FG005|Phase I Part|Adverse Event|1|||
144703361|NCT02325739|521766868|FG006|Phase I Part|Adverse Event|0|||
144703362|NCT02325739|521766869|FG007|Phase I Part|Adverse Event|2|||
144703363|NCT02325739|521766870|FG008|Phase I Part|Adverse Event|0|||
144703364|NCT02325739|521766871|FG009|Phase I Part|Adverse Event|0|||
144703365|NCT02325739|521766872|FG010|Phase I Part|Adverse Event|0|||
144703366|NCT02325739|521766862|FG000|Phase I Part|Progressive disease|9|||
144703367|NCT02325739|521766863|FG001|Phase I Part|Progressive disease|6|||
144703368|NCT02325739|521766864|FG002|Phase I Part|Progressive disease|3|||
144703369|NCT02325739|521766865|FG003|Phase I Part|Progressive disease|23|||
144703370|NCT02325739|521766866|FG004|Phase I Part|Progressive disease|14|||
144703371|NCT02325739|521766867|FG005|Phase I Part|Progressive disease|6|||
144703372|NCT02325739|521766868|FG006|Phase I Part|Progressive disease|6|||
144703373|NCT02325739|521766869|FG007|Phase I Part|Progressive disease|3|||
144703374|NCT02325739|521766870|FG008|Phase I Part|Progressive disease|0|||
144703375|NCT02325739|521766871|FG009|Phase I Part|Progressive disease|0|||
144703376|NCT02325739|521766872|FG010|Phase I Part|Progressive disease|0|||
144703377|NCT02325739|521766862|FG000|Phase I Part|Subject/guardian decision|1|||
144703378|NCT02325739|521766863|FG001|Phase I Part|Subject/guardian decision|0|||
144703379|NCT02325739|521766864|FG002|Phase I Part|Subject/guardian decision|1|||
144703380|NCT02325739|521766865|FG003|Phase I Part|Subject/guardian decision|1|||
144703381|NCT02325739|521766866|FG004|Phase I Part|Subject/guardian decision|0|||
144703382|NCT02325739|521766867|FG005|Phase I Part|Subject/guardian decision|0|||
144478984|NCT02254408|520952903|FG001|Overall Study|Randomized But Not Treated|3|||
144478985|NCT02254408|520952902|FG000|Overall Study|Adverse Event|1|||
144478986|NCT02254408|520952903|FG001|Overall Study|Adverse Event|0|||
144478987|NCT02254408|520952902|FG000|Overall Study|Death|2|||
144478988|NCT02254408|520952903|FG001|Overall Study|Death|3|||
144478989|NCT02254408|520952902|FG000|Overall Study|Investigator's Discretion|0|||
144478990|NCT02254408|520952903|FG001|Overall Study|Investigator's Discretion|1|||
144478991|NCT02254408|520952902|FG000|Overall Study|Withdrawal by Subject|3|||
144478992|NCT02254408|520952903|FG001|Overall Study|Withdrawal by Subject|3|||
144478993|NCT02254408|520952902|FG000|Overall Study|Lost to Follow-up|1|||
144703383|NCT02325739|521766868|FG006|Phase I Part|Subject/guardian decision|0|||
144478994|NCT02254408|520952903|FG001|Overall Study|Lost to Follow-up|0|||
144478995|NCT02914184|520952907|FG000|Overall Study|Lost to Follow-up|7|||
144478996|NCT02914184|520952908|FG001|Overall Study|Lost to Follow-up|10|||
144478997|NCT02914184|520952909|FG002|Overall Study|Lost to Follow-up|8|||
144478998|NCT02914184|520952910|FG003|Overall Study|Lost to Follow-up|7|||
144478999|NCT02914184|520952907|FG000|Overall Study|Withdrawal by Subject|4|||
144479000|NCT02914184|520952908|FG001|Overall Study|Withdrawal by Subject|2|||
144479001|NCT02914184|520952909|FG002|Overall Study|Withdrawal by Subject|7|||
144479002|NCT02914184|520952910|FG003|Overall Study|Withdrawal by Subject|3|||
144479003|NCT02914184|520952907|FG000|Overall Study|Other|1|||
144479004|NCT02914184|520952908|FG001|Overall Study|Other|0|||
144479005|NCT02914184|520952909|FG002|Overall Study|Other|0|||
144479006|NCT02914184|520952910|FG003|Overall Study|Other|0|||
144479007|NCT02914184|520952907|FG000|Overall Study|Migrated/moved from the study area|2|||
144479008|NCT02914184|520952908|FG001|Overall Study|Migrated/moved from the study area|1|||
144479009|NCT02914184|520952909|FG002|Overall Study|Migrated/moved from the study area|2|||
144479010|NCT02914184|520952910|FG003|Overall Study|Migrated/moved from the study area|1|||
144479011|NCT00768430|520952911|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
144479012|NCT00768430|520952912|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
144479013|NCT00802659|520952913|FG000|Overall Study|Physician Decision|0|||
144479014|NCT00802659|520952914|FG001|Overall Study|Physician Decision|1|||
144479015|NCT00802659|520952915|FG002|Overall Study|Physician Decision|0|||
144479016|NCT00802659|520952916|FG003|Overall Study|Physician Decision|0|||
144479017|NCT00041756|520952917|FG000|Overall Study|Adverse Event|4|||
144479018|NCT00041756|520952918|FG001|Overall Study|Adverse Event|10|||
144479019|NCT00041756|520952919|FG002|Overall Study|Adverse Event|6|||
144479020|NCT00041756|520952920|FG003|Overall Study|Adverse Event|11|||
144479021|NCT00041756|520952921|FG004|Overall Study|Adverse Event|34|||
144479022|NCT00041756|520952917|FG000|Overall Study|Protocol Violation|1|||
144479023|NCT00041756|520952918|FG001|Overall Study|Protocol Violation|1|||
144479024|NCT00041756|520952919|FG002|Overall Study|Protocol Violation|2|||
144479025|NCT00041756|520952920|FG003|Overall Study|Protocol Violation|2|||
144479026|NCT00041756|520952921|FG004|Overall Study|Protocol Violation|1|||
144479027|NCT00041756|520952917|FG000|Overall Study|Withdrawal by Subject|3|||
144479028|NCT00041756|520952918|FG001|Overall Study|Withdrawal by Subject|3|||
144479029|NCT00041756|520952919|FG002|Overall Study|Withdrawal by Subject|4|||
144479030|NCT00041756|520952920|FG003|Overall Study|Withdrawal by Subject|2|||
144479031|NCT00041756|520952921|FG004|Overall Study|Withdrawal by Subject|3|||
144479032|NCT00041756|520952917|FG000|Overall Study|Lost to Follow-up|0|||
144479033|NCT00041756|520952918|FG001|Overall Study|Lost to Follow-up|1|||
144479034|NCT00041756|520952919|FG002|Overall Study|Lost to Follow-up|0|||
144479035|NCT00041756|520952920|FG003|Overall Study|Lost to Follow-up|1|||
144479036|NCT00041756|520952921|FG004|Overall Study|Lost to Follow-up|0|||
144479037|NCT00041756|520952917|FG000|Overall Study|Unable to meet protocol criteria|0|||
144479038|NCT00041756|520952918|FG001|Overall Study|Unable to meet protocol criteria|0|||
144479039|NCT00041756|520952919|FG002|Overall Study|Unable to meet protocol criteria|1|||
144479040|NCT00041756|520952920|FG003|Overall Study|Unable to meet protocol criteria|0|||
144479041|NCT00041756|520952921|FG004|Overall Study|Unable to meet protocol criteria|1|||
144479042|NCT00041756|520952917|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
144479043|NCT00041756|520952918|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
144479044|NCT00041756|520952919|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
144479045|NCT00041756|520952920|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
144479046|NCT00041756|520952921|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
144479047|NCT00067990|520952922|FG000|Overall Study|Death|5|||
144479048|NCT00067990|520952923|FG001|Overall Study|Death|7|||
144479049|NCT00067990|520952922|FG000|Overall Study|ESRD, Non IF/TA|1|||
144479050|NCT00067990|520952923|FG001|Overall Study|ESRD, Non IF/TA|3|||
144479051|NCT00067990|520952922|FG000|Overall Study|Withdrawal by Subject|4|||
144479052|NCT00067990|520952923|FG001|Overall Study|Withdrawal by Subject|12|||
144479053|NCT03810313|520952926|FG000|Overall Study|Study terminated by sponsor|164|||
144479054|NCT03810313|520952927|FG001|Overall Study|Study terminated by sponsor|159|||
144479055|NCT03810313|520952926|FG000|Overall Study|Subject decision|10|||
144479056|NCT03810313|520952927|FG001|Overall Study|Subject decision|11|||
144479057|NCT03810313|520952926|FG000|Overall Study|Lost to Follow-up|3|||
144479058|NCT03810313|520952927|FG001|Overall Study|Lost to Follow-up|3|||
144479059|NCT03810313|520952926|FG000|Overall Study|Adverse Event|2|||
144479060|NCT03810313|520952927|FG001|Overall Study|Adverse Event|1|||
144479061|NCT03810313|520952926|FG000|Overall Study|Death|2|||
144479062|NCT03810313|520952927|FG001|Overall Study|Death|1|||
144479063|NCT03810313|520952926|FG000|Overall Study|Physician Decision|0|||
144479064|NCT03810313|520952927|FG001|Overall Study|Physician Decision|1|||
144479065|NCT01111838|520952928|FG000|Overall Study|Patient Ineligible|2|||
144479066|NCT01111838|520952928|FG000|Overall Study|Not Treated|3|||
144479067|NCT01111838|520952928|FG000|Overall Study|Clinical deterioration|1|||
144479068|NCT01111838|520952928|FG000|Overall Study|Other Complicating Disease|1|||
144479069|NCT01540565|520952929|FG000|Overall Study|Ineligible|2|||
144479070|NCT04488003|520952930|FG000|Assessed for Eligibility|Screen Failure|24|||
144479071|NCT04488003|520952931|FG001|Assessed for Eligibility|Screen Failure|0|||
144479072|NCT04488003|520952932|FG002|Assessed for Eligibility|Screen Failure|0|||
144479073|NCT04488003|520952930|FG000|Assessed for Eligibility|Adverse Event|1|||
144479074|NCT04488003|520952931|FG001|Assessed for Eligibility|Adverse Event|0|||
144479075|NCT04488003|520952932|FG002|Assessed for Eligibility|Adverse Event|0|||
144479076|NCT04488003|520952930|FG000|Assessed for Eligibility|Death|1|||
144479077|NCT04488003|520952931|FG001|Assessed for Eligibility|Death|0|||
144479078|NCT04488003|520952932|FG002|Assessed for Eligibility|Death|0|||
144479079|NCT04488003|520952930|FG000|Assessed for Eligibility|Physician Decision|1|||
144479080|NCT04488003|520952931|FG001|Assessed for Eligibility|Physician Decision|0|||
144479081|NCT04488003|520952932|FG002|Assessed for Eligibility|Physician Decision|0|||
144479082|NCT04488003|520952930|FG000|Allocated to Treatment|Progressive Disease|51|||
144479083|NCT04488003|520952931|FG001|Allocated to Treatment|Progressive Disease|0|||
144479084|NCT04488003|520952932|FG002|Allocated to Treatment|Progressive Disease|0|||
144479085|NCT04488003|520952930|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
144479086|NCT04488003|520952931|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
144479087|NCT04488003|520952932|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
144479088|NCT04488003|520952930|FG000|Allocated to Treatment|Adverse Event|6|||
144479089|NCT04488003|520952931|FG001|Allocated to Treatment|Adverse Event|0|||
144479090|NCT04488003|520952932|FG002|Allocated to Treatment|Adverse Event|0|||
144479091|NCT04488003|520952930|FG000|Allocated to Treatment|Other|5|||
144479092|NCT04488003|520952931|FG001|Allocated to Treatment|Other|0|||
144479093|NCT04488003|520952932|FG002|Allocated to Treatment|Other|0|||
144479094|NCT04488003|520952930|FG000|Allocated to Treatment|Physician Decision|4|||
144479095|NCT04488003|520952931|FG001|Allocated to Treatment|Physician Decision|0|||
144479096|NCT04488003|520952932|FG002|Allocated to Treatment|Physician Decision|0|||
144479097|NCT04488003|520952930|FG000|Allocated to Treatment|Death|4|||
144479098|NCT04488003|520952931|FG001|Allocated to Treatment|Death|0|||
144479099|NCT04488003|520952932|FG002|Allocated to Treatment|Death|0|||
144479100|NCT02086162|520952934|FG000|Overall Study|Withdrawal by Subject|4|||
144479101|NCT02086162|520952935|FG001|Overall Study|Withdrawal by Subject|4|||
144479102|NCT02086162|520952934|FG000|Overall Study|moved|1|||
144479103|NCT02086162|520952935|FG001|Overall Study|moved|1|||
144479104|NCT02086162|520952934|FG000|Overall Study|Lost to Follow-up|4|||
144479105|NCT02086162|520952935|FG001|Overall Study|Lost to Follow-up|2|||
144479106|NCT02086162|520952934|FG000|Overall Study|Death|1|||
144479107|NCT02086162|520952935|FG001|Overall Study|Death|0|||
144479108|NCT01248962|520952939|FG000|Overall Study|Withdrawal by Subject|1|||
144479109|NCT01248962|520952940|FG001|Overall Study|Withdrawal by Subject|1|||
144479110|NCT01248962|520952939|FG000|Overall Study|Adverse Event|2|||
144479111|NCT01248962|520952940|FG001|Overall Study|Adverse Event|1|||
144479112|NCT01248962|520952939|FG000|Overall Study|Complete Response after 4 Cycles|1|||
144479113|NCT01248962|520952940|FG001|Overall Study|Complete Response after 4 Cycles|0|||
144479114|NCT01248962|520952939|FG000|Overall Study|Complete Response after 3 Cycles|0|||
144479115|NCT01248962|520952940|FG001|Overall Study|Complete Response after 3 Cycles|1|||
144479116|NCT01248962|520952939|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
144479117|NCT01248962|520952940|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
144479118|NCT01827254|520952941|FG000|Overall Study|Death|10|||
144479119|NCT01827254|520952941|FG000|Overall Study|Case report form not completed|4|||
144479120|NCT01827254|520952941|FG000|Overall Study|Invalidated centre|3|||
144479121|NCT01827254|520952941|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
144365023|NCT00129402|520547433|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
144479122|NCT01827254|520952941|FG000|Overall Study|Did not complete re-challenge|1|||
144479123|NCT01827254|520952941|FG000|Overall Study|Disease progression|36|||
144479124|NCT01827254|520952941|FG000|Overall Study|Intolerance to treatment|4|||
144479125|NCT01834222|520952942|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
144479126|NCT05796518|520952947|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
144479127|NCT01535274|520952948|FG000|Overall Study|Determined to be ineligible|0|||
144479128|NCT01535274|520952949|FG001|Overall Study|Determined to be ineligible|1|||
144479129|NCT01535274|520952948|FG000|Overall Study|Misallocated to propofol intervention|0|||
144479130|NCT01535274|520952949|FG001|Overall Study|Misallocated to propofol intervention|1|||
144365024|NCT00129402|520547434|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
144479131|NCT03679767|520952950|FG000|Overall Study|Death|16|||
144479132|NCT03679767|520952951|FG001|Overall Study|Death|11|||
144479133|NCT03679767|520952952|FG002|Overall Study|Death|17|||
144479134|NCT03679767|520952953|FG003|Overall Study|Death|10|||
144479135|NCT03679767|520952950|FG000|Overall Study|Lost to Follow-up|1|||
144479136|NCT03679767|520952951|FG001|Overall Study|Lost to Follow-up|1|||
144479137|NCT03679767|520952952|FG002|Overall Study|Lost to Follow-up|1|||
144479138|NCT03679767|520952953|FG003|Overall Study|Lost to Follow-up|1|||
144479139|NCT03679767|520952950|FG000|Overall Study|Withdrawal by Subject|0|||
144479140|NCT03679767|520952951|FG001|Overall Study|Withdrawal by Subject|0|||
144479141|NCT03679767|520952952|FG002|Overall Study|Withdrawal by Subject|0|||
144479142|NCT03679767|520952953|FG003|Overall Study|Withdrawal by Subject|1|||
144479143|NCT03679767|520952950|FG000|Overall Study|Follow-up Completed|18|||
144479144|NCT03679767|520952951|FG001|Overall Study|Follow-up Completed|11|||
144479145|NCT03679767|520952952|FG002|Overall Study|Follow-up Completed|11|||
144479146|NCT03679767|520952953|FG003|Overall Study|Follow-up Completed|20|||
144479147|NCT03679767|520952950|FG000|Overall Study|Entered Hospice Care|0|||
144479148|NCT03679767|520952951|FG001|Overall Study|Entered Hospice Care|0|||
144479149|NCT03679767|520952952|FG002|Overall Study|Entered Hospice Care|0|||
144479150|NCT03679767|520952953|FG003|Overall Study|Entered Hospice Care|1|||
144479151|NCT03679767|520952950|FG000|Overall Study|Progressive Disease|0|||
144479152|NCT03679767|520952951|FG001|Overall Study|Progressive Disease|0|||
144479153|NCT03679767|520952952|FG002|Overall Study|Progressive Disease|0|||
144479154|NCT03679767|520952953|FG003|Overall Study|Progressive Disease|1|||
144479155|NCT02690077|520952954|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
144479156|NCT02690077|520952955|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
144479157|NCT02690077|520952954|FG000|Overall Study|Withdrawal by Subject|0|||
144479158|NCT02690077|520952955|FG001|Overall Study|Withdrawal by Subject|5|||
144479159|NCT02690077|520952954|FG000|Overall Study|Excluded by IRB|0|||
144479160|NCT02690077|520952955|FG001|Overall Study|Excluded by IRB|2|||
144479161|NCT05229653|520952956|FG000|Overall Study|Lost to Follow-up|1|||
144479162|NCT05229653|520952957|FG001|Overall Study|Lost to Follow-up|0|||
144479163|NCT01845974|520952958|FG000|Overall Study|screen failure|1|||
144479164|NCT01845974|520952959|FG001|Overall Study|screen failure|0|||
144479165|NCT02667886|520952960|FG000|Dose Escalation (Part A)|Adverse Event|1|||
144479166|NCT02667886|520952961|FG001|Dose Escalation (Part A)|Adverse Event|3|||
144479167|NCT02667886|520952962|FG002|Dose Escalation (Part A)|Adverse Event|1|||
144479168|NCT02667886|520952963|FG003|Dose Escalation (Part A)|Adverse Event|0|||
144479169|NCT02667886|520952964|FG004|Dose Escalation (Part A)|Adverse Event|0|||
144479170|NCT02667886|520952960|FG000|Dose Escalation (Part A)|Disease Progression|1|||
144479171|NCT02667886|520952961|FG001|Dose Escalation (Part A)|Disease Progression|4|||
144479172|NCT02667886|520952962|FG002|Dose Escalation (Part A)|Disease Progression|3|||
144479173|NCT02667886|520952963|FG003|Dose Escalation (Part A)|Disease Progression|0|||
144479174|NCT02667886|520952964|FG004|Dose Escalation (Part A)|Disease Progression|0|||
144479175|NCT02667886|520952960|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
144479176|NCT02667886|520952961|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
144479177|NCT02667886|520952962|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
144479178|NCT02667886|520952963|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
144479179|NCT02667886|520952964|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
144479180|NCT02667886|520952960|FG000|Dose Expansion (Part B)|Adverse Event|0|||
144479181|NCT02667886|520952961|FG001|Dose Expansion (Part B)|Adverse Event|0|||
144479182|NCT02667886|520952962|FG002|Dose Expansion (Part B)|Adverse Event|0|||
144479183|NCT02667886|520952963|FG003|Dose Expansion (Part B)|Adverse Event|9|||
144479184|NCT02667886|520952964|FG004|Dose Expansion (Part B)|Adverse Event|0|||
144479185|NCT02667886|520952960|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
144479186|NCT02667886|520952961|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
144479187|NCT02667886|520952962|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
144479188|NCT02667886|520952963|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
144479189|NCT02667886|520952964|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
144479190|NCT02667886|520952960|FG000|Dose Expansion (Part B)|Disease Progression|0|||
144479191|NCT02667886|520952961|FG001|Dose Expansion (Part B)|Disease Progression|0|||
144479192|NCT02667886|520952962|FG002|Dose Expansion (Part B)|Disease Progression|0|||
144479193|NCT02667886|520952963|FG003|Dose Expansion (Part B)|Disease Progression|38|||
144479194|NCT02667886|520952964|FG004|Dose Expansion (Part B)|Disease Progression|0|||
144479195|NCT02667886|520952960|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
144479196|NCT02667886|520952961|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
144479197|NCT02667886|520952962|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
144479198|NCT02667886|520952963|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
144479199|NCT02667886|520952964|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
144479200|NCT02667886|520952960|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
144479201|NCT02667886|520952961|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
144479202|NCT02667886|520952962|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
144479203|NCT02667886|520952963|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
144479204|NCT02667886|520952964|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
144479205|NCT02667886|520952960|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
144479206|NCT02667886|520952961|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
144479207|NCT02667886|520952962|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
144479208|NCT02667886|520952963|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
144479209|NCT02667886|520952964|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
144479210|NCT00594217|520952965|FG000|Overall Study|Withdrawal by Subject|1|||
144479211|NCT00594217|520952966|FG001|Overall Study|Withdrawal by Subject|3|||
144703384|NCT02325739|521766869|FG007|Phase I Part|Subject/guardian decision|1|||
144479212|NCT05408468|520952967|FG000|Overall Study|Lost to Follow-up|3|||
144479213|NCT05408468|520952968|FG001|Overall Study|Lost to Follow-up|1|||
144479214|NCT05408468|520952967|FG000|Overall Study|Physician Decision|1|||
144479215|NCT05408468|520952968|FG001|Overall Study|Physician Decision|0|||
144479216|NCT05408468|520952967|FG000|Overall Study|Overwhelmed by clinical situation|3|||
144479217|NCT05408468|520952968|FG001|Overall Study|Overwhelmed by clinical situation|0|||
144479218|NCT05408468|520952967|FG000|Overall Study|Personal illness precluding participation|1|||
144479219|NCT05408468|520952968|FG001|Overall Study|Personal illness precluding participation|0|||
144479220|NCT05408468|520952967|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
144479221|NCT05408468|520952968|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
144479222|NCT00405639|520952972|FG000|Overall Study|Withdrawal by Subject|1|||
144479223|NCT00405639|520952973|FG001|Overall Study|Withdrawal by Subject|0|||
144479224|NCT00405639|520952972|FG000|Overall Study|Adverse Event|1|||
144479225|NCT00405639|520952973|FG001|Overall Study|Adverse Event|0|||
144479226|NCT00405639|520952972|FG000|Overall Study|Seizure prior to receiving BNP|1|||
144479227|NCT00405639|520952973|FG001|Overall Study|Seizure prior to receiving BNP|0|||
144479228|NCT00612534|520952974|FG000|Overall Study|Adverse Event|0|||
144479229|NCT00612534|520952975|FG001|Overall Study|Adverse Event|4|||
144479230|NCT00612534|520952976|FG002|Overall Study|Adverse Event|2|||
144479231|NCT00612534|520952977|FG003|Overall Study|Adverse Event|1|||
144479232|NCT00612534|520952974|FG000|Overall Study|Lack of Efficacy|13|||
144479233|NCT00612534|520952975|FG001|Overall Study|Lack of Efficacy|12|||
144479234|NCT00612534|520952976|FG002|Overall Study|Lack of Efficacy|5|||
144479235|NCT00612534|520952977|FG003|Overall Study|Lack of Efficacy|16|||
144479236|NCT00612534|520952974|FG000|Overall Study|Other Reason|0|||
144479237|NCT00612534|520952975|FG001|Overall Study|Other Reason|1|||
144479238|NCT00612534|520952976|FG002|Overall Study|Other Reason|0|||
144479239|NCT00612534|520952977|FG003|Overall Study|Other Reason|0|||
144479240|NCT02223754|520952978|FG000|Period 1|Adverse Event|1|||
144479241|NCT02223754|520952979|FG001|Period 1|Adverse Event|0|||
144479242|NCT02223754|520952978|FG000|Period 1|Lost to Follow-up|0|||
144479243|NCT02223754|520952979|FG001|Period 1|Lost to Follow-up|1|||
144479244|NCT02223754|520952978|FG000|Period 1|Protocol Violation|2|||
144479245|NCT02223754|520952979|FG001|Period 1|Protocol Violation|4|||
144479246|NCT02223754|520952978|FG000|Period 1|Withdrawal by Subject|0|||
144479247|NCT02223754|520952979|FG001|Period 1|Withdrawal by Subject|4|||
144479248|NCT02223754|520952978|FG000|Period 1|Test Article No Longer Available|1|||
144479249|NCT02223754|520952979|FG001|Period 1|Test Article No Longer Available|5|||
144479250|NCT02223754|520952978|FG000|Period 1|Unsatisfactory Visual Response|0|||
144479251|NCT02223754|520952979|FG001|Period 1|Unsatisfactory Visual Response|1|||
144479252|NCT02223754|520952978|FG000|Period 2|Adverse Event|0|||
144479253|NCT02223754|520952979|FG001|Period 2|Adverse Event|1|||
144479254|NCT02223754|520952978|FG000|Period 2|Protocol Violation|1|||
144479255|NCT02223754|520952979|FG001|Period 2|Protocol Violation|0|||
144479256|NCT02223754|520952978|FG000|Period 2|Lens Discomfort|1|||
144479257|NCT02223754|520952979|FG001|Period 2|Lens Discomfort|1|||
144479258|NCT02223754|520952978|FG000|Period 2|Lost to Follow-up|1|||
144479259|NCT02223754|520952979|FG001|Period 2|Lost to Follow-up|0|||
144479260|NCT02223754|520952978|FG000|Period 2|Test Article No Longer Available|0|||
144479261|NCT02223754|520952979|FG001|Period 2|Test Article No Longer Available|1|||
144479262|NCT01807650|520952988|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
144479263|NCT01807650|520952988|FG000|Overall Study|Adverse Event|5|||
144479264|NCT01807650|520952988|FG000|Overall Study|Other|2|||
144479265|NCT02234063|520953001|FG000|Overall Study|Lost to Follow-up|235|||
144479266|NCT02234063|520953002|FG001|Overall Study|Lost to Follow-up|42|||
144479267|NCT02234063|520953001|FG000|Overall Study|Withdrawal by Subject|20|||
144479268|NCT02234063|520953002|FG001|Overall Study|Withdrawal by Subject|1|||
144479269|NCT02946918|520953005|FG000|Overall Study|Patient unblinded himself|1|||
144479270|NCT02946918|520953006|FG001|Overall Study|Patient unblinded himself|0|||
144479271|NCT02946918|520953005|FG000|Overall Study|Physician Decision|0|||
144479272|NCT02946918|520953006|FG001|Overall Study|Physician Decision|2|||
144479273|NCT02946918|520953005|FG000|Overall Study|Ran out of study medication|0|||
144479274|NCT02946918|520953006|FG001|Overall Study|Ran out of study medication|1|||
144479275|NCT01861522|520953007|FG000|Overall Study|Adverse Event|1|||
144479276|NCT01861522|520953008|FG001|Overall Study|Adverse Event|0|||
144479277|NCT01861522|520953007|FG000|Overall Study|Withdrawal by Subject|2|||
144479278|NCT01861522|520953008|FG001|Overall Study|Withdrawal by Subject|0|||
144479279|NCT02716038|520953009|FG000|Overall Study|Not evaluable|1|||
144479280|NCT02716038|520953009|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
144479281|NCT02716038|520953009|FG000|Overall Study|Unresectable|3|||
144479282|NCT00069784|520953010|FG000|Overall Study|Adverse Event|105|||
144479283|NCT00069784|520953011|FG001|Overall Study|Adverse Event|0|||
144479284|NCT00069784|520953010|FG000|Overall Study|Withdrawal by Subject|1090|||
144479285|NCT00069784|520953011|FG001|Overall Study|Withdrawal by Subject|0|||
144479286|NCT00069784|520953010|FG000|Overall Study|Other|17|||
144479287|NCT00069784|520953011|FG001|Overall Study|Other|0|||
144479288|NCT02669095|520953017|FG000|Overall Study|Adverse Event|1|||
144479289|NCT02669095|520953018|FG001|Overall Study|Adverse Event|0|||
144479290|NCT02669095|520953017|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
144479291|NCT02669095|520953018|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
144479292|NCT02669095|520953017|FG000|Overall Study|Torn Lens|0|||
144479293|NCT02669095|520953018|FG001|Overall Study|Torn Lens|1|||
144479294|NCT02669095|520953017|FG000|Overall Study|Visit 5 assessments not completed|0|||
144479295|NCT02669095|520953018|FG001|Overall Study|Visit 5 assessments not completed|1|||
144479296|NCT00886639|520953021|FG000|Overall Study|acute exacerbation|14|||
144479297|NCT00886639|520953021|FG000|Overall Study|non-compliance|2|||
144479298|NCT00926003|520953022|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
144479299|NCT00926003|520953023|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
144479300|NCT00926003|520953024|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
144479301|NCT00926003|520953022|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
144479302|NCT00926003|520953023|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
144479303|NCT00926003|520953024|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
144479304|NCT01871558|520953025|FG000|Overall Study|Other reason|0|||
144479305|NCT01871558|520953026|FG001|Overall Study|Other reason|1|||
144479306|NCT01871558|520953025|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
144479307|NCT01871558|520953026|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
144479308|NCT01871558|520953025|FG000|Overall Study|Withdrawal by Subject|2|||
144479309|NCT01871558|520953026|FG001|Overall Study|Withdrawal by Subject|0|||
144479310|NCT05879198|520953028|FG000|Overall Study|Lost to Follow-up|1|||
144479311|NCT01683994|520954971|FG000|Overall Study|Withdrawal by Subject|1|||
144479312|NCT01683994|520954972|FG001|Overall Study|Withdrawal by Subject|0|||
144479313|NCT01683994|520954973|FG002|Overall Study|Withdrawal by Subject|0|||
144479314|NCT01683994|520954974|FG003|Overall Study|Withdrawal by Subject|1|||
144479315|NCT01683994|520954975|FG004|Overall Study|Withdrawal by Subject|0|||
144479316|NCT01683994|520954971|FG000|Overall Study|Intercurrent illness|0|||
144479317|NCT01683994|520954972|FG001|Overall Study|Intercurrent illness|0|||
144479318|NCT01683994|520954973|FG002|Overall Study|Intercurrent illness|0|||
144479319|NCT01683994|520954974|FG003|Overall Study|Intercurrent illness|2|||
144479320|NCT01683994|520954975|FG004|Overall Study|Intercurrent illness|1|||
144479321|NCT00999661|520954976|FG000|Overall Study|Lost to Follow-up|59|||
144479322|NCT00999661|520954976|FG000|Overall Study|Adverse Event|1|||
144479323|NCT00999661|520954976|FG000|Overall Study|Withdrawal by Subject|1|||
144479324|NCT00999661|520954976|FG000|Overall Study|Not meeting eligibility criteria|9|||
144479325|NCT00917267|520954977|FG000|Overall Study|Adverse Event|15|||
144479326|NCT00917267|520954978|FG001|Overall Study|Adverse Event|36|||
144479327|NCT00917267|520954977|FG000|Overall Study|Physician Decision|2|||
144479328|NCT00917267|520954978|FG001|Overall Study|Physician Decision|4|||
144479329|NCT00917267|520954977|FG000|Overall Study|Protocol Violation|9|||
144479330|NCT00917267|520954978|FG001|Overall Study|Protocol Violation|18|||
144479331|NCT00917267|520954977|FG000|Overall Study|Withdrawal by Subject|5|||
144479332|NCT00917267|520954978|FG001|Overall Study|Withdrawal by Subject|12|||
144479333|NCT00917267|520954977|FG000|Overall Study|Lost to follow up|0|||
144479334|NCT00917267|520954978|FG001|Overall Study|Lost to follow up|2|||
144479335|NCT00917267|520954977|FG000|Overall Study|Entry Criteria Not Met|1|||
144479336|NCT00917267|520954978|FG001|Overall Study|Entry Criteria Not Met|0|||
144479337|NCT00917267|520954977|FG000|Overall Study|Sponsor Decision|5|||
144479338|NCT00917267|520954978|FG001|Overall Study|Sponsor Decision|5|||
144199217|NCT04221789|519928859|FG000|Overall Study|deviation from protoco|22|||
144479339|NCT00917267|520954977|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
144479340|NCT00917267|520954978|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
144479341|NCT02960763|520954980|FG000|Step 1|Withdrawal by Subject|10|||
144479342|NCT02960763|520954981|FG001|Step 1|Withdrawal by Subject|8|||
144479343|NCT02960763|520954982|FG002|Step 1|Withdrawal by Subject|13|||
144479344|NCT02960763|520954983|FG003|Step 1|Withdrawal by Subject|0|||
144479345|NCT02960763|520954984|FG004|Step 1|Withdrawal by Subject|0|||
144479346|NCT02960763|520954980|FG000|Step 1|Lost to Follow-up|7|||
144479347|NCT02960763|520954981|FG001|Step 1|Lost to Follow-up|9|||
144479348|NCT02960763|520954982|FG002|Step 1|Lost to Follow-up|12|||
144479349|NCT02960763|520954983|FG003|Step 1|Lost to Follow-up|0|||
144479350|NCT02960763|520954984|FG004|Step 1|Lost to Follow-up|0|||
144479351|NCT02960763|520954980|FG000|Step 1|Death|1|||
144479352|NCT02960763|520954981|FG001|Step 1|Death|1|||
144479353|NCT02960763|520954982|FG002|Step 1|Death|1|||
144479354|NCT02960763|520954983|FG003|Step 1|Death|0|||
144479355|NCT02960763|520954984|FG004|Step 1|Death|0|||
144479356|NCT02960763|520954980|FG000|Step 1|Investigator discretion|1|||
144479357|NCT02960763|520954981|FG001|Step 1|Investigator discretion|0|||
144479358|NCT02960763|520954982|FG002|Step 1|Investigator discretion|1|||
144479359|NCT02960763|520954983|FG003|Step 1|Investigator discretion|0|||
144479360|NCT02960763|520954984|FG004|Step 1|Investigator discretion|0|||
144479361|NCT02960763|520954980|FG000|Step 1|Other|0|||
144479362|NCT02960763|520954981|FG001|Step 1|Other|0|||
144479363|NCT02960763|520954982|FG002|Step 1|Other|1|||
144479364|NCT02960763|520954983|FG003|Step 1|Other|0|||
144479365|NCT02960763|520954984|FG004|Step 1|Other|0|||
144479366|NCT02960763|520954980|FG000|Step 2|Withdrawal by Subject|0|||
144479367|NCT02960763|520954981|FG001|Step 2|Withdrawal by Subject|0|||
144479368|NCT02960763|520954982|FG002|Step 2|Withdrawal by Subject|0|||
144479369|NCT02960763|520954983|FG003|Step 2|Withdrawal by Subject|7|||
144479370|NCT02960763|520954984|FG004|Step 2|Withdrawal by Subject|3|||
144479371|NCT02960763|520954980|FG000|Step 2|Lost to Follow-up|0|||
144479372|NCT02960763|520954981|FG001|Step 2|Lost to Follow-up|0|||
144479373|NCT02960763|520954982|FG002|Step 2|Lost to Follow-up|0|||
144479374|NCT02960763|520954983|FG003|Step 2|Lost to Follow-up|4|||
144479375|NCT02960763|520954984|FG004|Step 2|Lost to Follow-up|1|||
144479376|NCT02960763|520954980|FG000|Step 2|Investigator discretion|0|||
144479377|NCT02960763|520954981|FG001|Step 2|Investigator discretion|0|||
144479378|NCT02960763|520954982|FG002|Step 2|Investigator discretion|0|||
144479379|NCT02960763|520954983|FG003|Step 2|Investigator discretion|0|||
144479380|NCT02960763|520954984|FG004|Step 2|Investigator discretion|1|||
144479381|NCT00312858|520954986|FG000|Overall Study|Adverse Event|0|||
144479382|NCT00312858|520954987|FG001|Overall Study|Adverse Event|1|||
144479383|NCT00312858|520954986|FG000|Overall Study|Lost to Follow-up|25|||
144479384|NCT00312858|520954987|FG001|Overall Study|Lost to Follow-up|42|||
144479385|NCT00312858|520954986|FG000|Overall Study|Protocol Violation|3|||
144479386|NCT00312858|520954987|FG001|Overall Study|Protocol Violation|8|||
144479387|NCT00312858|520954986|FG000|Overall Study|Withdraw by Participant|20|||
144479388|NCT00312858|520954987|FG001|Overall Study|Withdraw by Participant|20|||
144479389|NCT00312858|520954986|FG000|Overall Study|Participant Moved|11|||
144479390|NCT00312858|520954987|FG001|Overall Study|Participant Moved|10|||
144479391|NCT00312858|520954986|FG000|Overall Study|Other|9|||
144479392|NCT00312858|520954987|FG001|Overall Study|Other|12|||
144479393|NCT03638635|520954988|FG000|Initial Hospitalization|Study terminated prematurely|0|||
144479394|NCT03638635|520954989|FG001|Initial Hospitalization|Study terminated prematurely|1|||
144479395|NCT03638635|520954988|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
144479396|NCT03638635|520954989|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
144479397|NCT03638635|520954988|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
144479398|NCT03638635|520954989|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
144479399|NCT02318719|520954992|FG000|Double-blind Phase|Adverse Event|7|||
144479400|NCT02318719|520954993|FG001|Double-blind Phase|Adverse Event|6|||
144479401|NCT02318719|520954994|FG002|Double-blind Phase|Adverse Event|12|||
144479402|NCT02318719|520954995|FG003|Double-blind Phase|Adverse Event|4|||
144479403|NCT02318719|520954996|FG004|Double-blind Phase|Adverse Event|0|||
144479404|NCT02318719|520954992|FG000|Double-blind Phase|Lack of Efficacy|5|||
144479405|NCT02318719|520954993|FG001|Double-blind Phase|Lack of Efficacy|0|||
144479406|NCT02318719|520954994|FG002|Double-blind Phase|Lack of Efficacy|1|||
144479407|NCT02318719|520954995|FG003|Double-blind Phase|Lack of Efficacy|1|||
144479408|NCT02318719|520954996|FG004|Double-blind Phase|Lack of Efficacy|0|||
144479409|NCT02318719|520954992|FG000|Double-blind Phase|Protocol Violation|0|||
144479410|NCT02318719|520954993|FG001|Double-blind Phase|Protocol Violation|1|||
144479411|NCT02318719|520954994|FG002|Double-blind Phase|Protocol Violation|3|||
144479412|NCT02318719|520954995|FG003|Double-blind Phase|Protocol Violation|0|||
144479413|NCT02318719|520954996|FG004|Double-blind Phase|Protocol Violation|0|||
144479414|NCT02318719|520954992|FG000|Double-blind Phase|Withdrawal by Subject|25|||
144479415|NCT02318719|520954993|FG001|Double-blind Phase|Withdrawal by Subject|7|||
144479416|NCT02318719|520954994|FG002|Double-blind Phase|Withdrawal by Subject|9|||
144479417|NCT02318719|520954995|FG003|Double-blind Phase|Withdrawal by Subject|10|||
144479418|NCT02318719|520954996|FG004|Double-blind Phase|Withdrawal by Subject|0|||
144479419|NCT02318719|520954992|FG000|Double-blind Phase|Other|1|||
144479420|NCT02318719|520954993|FG001|Double-blind Phase|Other|2|||
144479421|NCT02318719|520954994|FG002|Double-blind Phase|Other|0|||
144479422|NCT02318719|520954995|FG003|Double-blind Phase|Other|0|||
144479423|NCT02318719|520954996|FG004|Double-blind Phase|Other|0|||
144479424|NCT02318719|520954992|FG000|Open-label Extension Phase|Adverse Event|0|||
144479425|NCT02318719|520954993|FG001|Open-label Extension Phase|Adverse Event|0|||
144479426|NCT02318719|520954994|FG002|Open-label Extension Phase|Adverse Event|0|||
144479427|NCT02318719|520954995|FG003|Open-label Extension Phase|Adverse Event|0|||
144479428|NCT02318719|520954996|FG004|Open-label Extension Phase|Adverse Event|15|||
144479429|NCT02318719|520954992|FG000|Open-label Extension Phase|Death|0|||
144479430|NCT02318719|520954993|FG001|Open-label Extension Phase|Death|0|||
144479431|NCT02318719|520954994|FG002|Open-label Extension Phase|Death|0|||
144479432|NCT02318719|520954995|FG003|Open-label Extension Phase|Death|0|||
144479433|NCT02318719|520954996|FG004|Open-label Extension Phase|Death|1|||
144479434|NCT02318719|520954992|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
144479435|NCT02318719|520954993|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
144479436|NCT02318719|520954994|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
144479437|NCT02318719|520954995|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
144479438|NCT02318719|520954996|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
144479439|NCT02318719|520954992|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
144479440|NCT02318719|520954993|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
144479441|NCT02318719|520954994|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
144479442|NCT02318719|520954995|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
144479443|NCT02318719|520954996|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
144479444|NCT02318719|520954992|FG000|Open-label Extension Phase|Other|0|||
144479445|NCT02318719|520954993|FG001|Open-label Extension Phase|Other|0|||
144479446|NCT02318719|520954994|FG002|Open-label Extension Phase|Other|0|||
144479447|NCT02318719|520954995|FG003|Open-label Extension Phase|Other|0|||
144479448|NCT02318719|520954996|FG004|Open-label Extension Phase|Other|7|||
144479449|NCT00432835|520955000|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
144365025|NCT00129402|520547435|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
144365026|NCT03041038|520547436|FG000|Overall Study|Withdrawal by Subject|4|||
144365027|NCT03041038|520547437|FG001|Overall Study|Withdrawal by Subject|0|||
144365028|NCT03041038|520547436|FG000|Overall Study|Lost to Follow-up|1|||
144365029|NCT03041038|520547437|FG001|Overall Study|Lost to Follow-up|1|||
144365030|NCT03041038|520547436|FG000|Overall Study|Protocol Violation|1|||
144365031|NCT03041038|520547437|FG001|Overall Study|Protocol Violation|1|||
144365032|NCT01527370|520547438|FG000|Overall Study|Withdrawal by Subject|4|||
144365033|NCT01527370|520547438|FG000|Overall Study|Physician Decision|1|||
144365034|NCT01527370|520547438|FG000|Overall Study|Death|1|||
144365035|NCT01472289|520547442|FG000|Overall Study|Death|2|||
144365036|NCT02435992|520547443|FG000|Overall Study|non compliance with protocol|2|||
144365037|NCT02435992|520547444|FG001|Overall Study|non compliance with protocol|0|||
144365038|NCT02435992|520547445|FG002|Overall Study|non compliance with protocol|1|||
144365039|NCT02435992|520547446|FG003|Overall Study|non compliance with protocol|0|||
144365040|NCT02435992|520547447|FG004|Overall Study|non compliance with protocol|0|||
144365041|NCT02435992|520547443|FG000|Overall Study|Adverse Event|11|||
144365042|NCT02435992|520547444|FG001|Overall Study|Adverse Event|6|||
144365043|NCT02435992|520547445|FG002|Overall Study|Adverse Event|12|||
144365044|NCT02435992|520547446|FG003|Overall Study|Adverse Event|0|||
144365045|NCT02435992|520547447|FG004|Overall Study|Adverse Event|0|||
144365046|NCT02435992|520547443|FG000|Overall Study|Lack of Efficacy|4|||
144365047|NCT02435992|520547444|FG001|Overall Study|Lack of Efficacy|10|||
144365048|NCT02435992|520547445|FG002|Overall Study|Lack of Efficacy|9|||
144365049|NCT02435992|520547446|FG003|Overall Study|Lack of Efficacy|0|||
144365050|NCT02435992|520547447|FG004|Overall Study|Lack of Efficacy|0|||
144365051|NCT02435992|520547443|FG000|Overall Study|Withdrawal by Subject|10|||
144365052|NCT02435992|520547444|FG001|Overall Study|Withdrawal by Subject|8|||
144365053|NCT02435992|520547445|FG002|Overall Study|Withdrawal by Subject|20|||
144365054|NCT02435992|520547446|FG003|Overall Study|Withdrawal by Subject|0|||
144365055|NCT02435992|520547447|FG004|Overall Study|Withdrawal by Subject|0|||
144365056|NCT02435992|520547443|FG000|Overall Study|Other Reason|1|||
144365057|NCT02435992|520547444|FG001|Overall Study|Other Reason|0|||
144365058|NCT02435992|520547445|FG002|Overall Study|Other Reason|0|||
144365059|NCT02435992|520547446|FG003|Overall Study|Other Reason|0|||
144365060|NCT02435992|520547447|FG004|Overall Study|Other Reason|0|||
144365061|NCT02435992|520547443|FG000|Overall Study|Physician Decision|0|||
144365062|NCT02435992|520547444|FG001|Overall Study|Physician Decision|0|||
144365063|NCT02435992|520547445|FG002|Overall Study|Physician Decision|1|||
144365064|NCT02435992|520547446|FG003|Overall Study|Physician Decision|0|||
144365065|NCT02435992|520547447|FG004|Overall Study|Physician Decision|0|||
144479450|NCT00432835|520955001|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
144479451|NCT00289770|520955002|FG000|Year 15|Withdrawal by Subject|1|||
144479452|NCT00423293|520955003|FG000|Overall Study|Ineligible / No protocol treatment|11|||
144479453|NCT00603265|520955012|FG000|Overall Study|Adverse Event|2|||
144365066|NCT03873116|520547448|FG000|Part 1|Study drug discontinuation due to rash|0|||
144365067|NCT03873116|520547449|FG001|Part 1|Study drug discontinuation due to rash|0|||
144365068|NCT03873116|520547450|FG002|Part 1|Study drug discontinuation due to rash|0|||
144365069|NCT03873116|520547451|FG003|Part 1|Study drug discontinuation due to rash|0|||
144365070|NCT03873116|520547452|FG004|Part 1|Study drug discontinuation due to rash|0|||
144365071|NCT03873116|520547453|FG005|Part 1|Study drug discontinuation due to rash|1|||
144365072|NCT03873116|520547448|FG000|Part 2|Withdrawal by Subject|0|||
144365073|NCT03873116|520547449|FG001|Part 2|Withdrawal by Subject|0|||
144365074|NCT03873116|520547450|FG002|Part 2|Withdrawal by Subject|1|||
144365075|NCT03873116|520547451|FG003|Part 2|Withdrawal by Subject|0|||
144365076|NCT03873116|520547452|FG004|Part 2|Withdrawal by Subject|0|||
144365077|NCT03873116|520547453|FG005|Part 2|Withdrawal by Subject|0|||
144365078|NCT03873116|520547448|FG000|Part 2|Lab abnormality or AE|0|||
144365079|NCT03873116|520547449|FG001|Part 2|Lab abnormality or AE|0|||
144365080|NCT03873116|520547450|FG002|Part 2|Lab abnormality or AE|0|||
144365081|NCT03873116|520547451|FG003|Part 2|Lab abnormality or AE|0|||
144365082|NCT03873116|520547452|FG004|Part 2|Lab abnormality or AE|1|||
144365083|NCT03873116|520547453|FG005|Part 2|Lab abnormality or AE|0|||
144365084|NCT03873116|520547448|FG000|Part 3|Withdrawal by Subject|0|||
144479454|NCT00603265|520955013|FG001|Overall Study|Adverse Event|11|||
144479455|NCT00603265|520955014|FG002|Overall Study|Adverse Event|1|||
144365085|NCT03873116|520547449|FG001|Part 3|Withdrawal by Subject|0|||
144365086|NCT03873116|520547450|FG002|Part 3|Withdrawal by Subject|0|||
144479456|NCT00603265|520955012|FG000|Overall Study|Withdrawal by Subject|1|||
144479457|NCT00603265|520955013|FG001|Overall Study|Withdrawal by Subject|2|||
144365087|NCT03873116|520547451|FG003|Part 3|Withdrawal by Subject|0|||
144365088|NCT03873116|520547452|FG004|Part 3|Withdrawal by Subject|1|||
144365089|NCT03873116|520547453|FG005|Part 3|Withdrawal by Subject|0|||
144365090|NCT02531802|520547454|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
144365091|NCT02531802|520547455|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
144365092|NCT02531802|520547456|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
144365093|NCT02531802|520547457|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
144479458|NCT00603265|520955014|FG002|Overall Study|Withdrawal by Subject|1|||
144479459|NCT00603265|520955012|FG000|Overall Study|Lack of Efficacy|3|||
144479460|NCT00603265|520955013|FG001|Overall Study|Lack of Efficacy|0|||
144479461|NCT00603265|520955014|FG002|Overall Study|Lack of Efficacy|3|||
144479462|NCT00603265|520955012|FG000|Overall Study|Lost to Follow-up|0|||
144479463|NCT00603265|520955013|FG001|Overall Study|Lost to Follow-up|1|||
144479464|NCT00603265|520955014|FG002|Overall Study|Lost to Follow-up|0|||
144479465|NCT00603265|520955012|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
144479466|NCT00603265|520955013|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
144479467|NCT00603265|520955014|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
144479468|NCT00603265|520955012|FG000|Overall Study|Participant Left Country, No Responses|0|||
144479469|NCT00603265|520955013|FG001|Overall Study|Participant Left Country, No Responses|1|||
144479470|NCT00603265|520955014|FG002|Overall Study|Participant Left Country, No Responses|0|||
144479471|NCT00603265|520955012|FG000|Overall Study|Protocol Violation|1|||
144479472|NCT00603265|520955013|FG001|Overall Study|Protocol Violation|0|||
144479473|NCT00603265|520955014|FG002|Overall Study|Protocol Violation|0|||
144479474|NCT05340751|520955016|FG000|Overall Study|Physician Decision|3|||
144479475|NCT04399551|520955017|FG000|Overall Study|Adverse Event|15|||
144479476|NCT04399551|520955017|FG000|Overall Study|Withdrawal by Subject|6|||
144479477|NCT04399551|520955017|FG000|Overall Study|Physician Decision|3|||
144479478|NCT04399551|520955017|FG000|Overall Study|Lost to Follow-up|2|||
144479479|NCT04399551|520955017|FG000|Overall Study|Protocol Deviation|2|||
144479480|NCT01014975|520955031|FG000|Overall Study|Withdrawal by Subject|1|||
144479481|NCT01014975|520955032|FG001|Overall Study|Withdrawal by Subject|0|||
144479482|NCT01014975|520955033|FG002|Overall Study|Withdrawal by Subject|1|||
144479483|NCT01014975|520955031|FG000|Overall Study|Death|3|||
144479484|NCT01014975|520955032|FG001|Overall Study|Death|3|||
144479485|NCT01014975|520955033|FG002|Overall Study|Death|4|||
144479486|NCT01014975|520955031|FG000|Overall Study|Lost to Follow-up|0|||
144479487|NCT01014975|520955032|FG001|Overall Study|Lost to Follow-up|0|||
144479488|NCT01014975|520955033|FG002|Overall Study|Lost to Follow-up|1|||
144479489|NCT01112514|520955036|FG000|Overall Study|Lost to Follow-up|1|||
144479490|NCT01336634|520955037|FG000|Overall Study|Study closed/terminated|5|||
144479491|NCT01336634|520955038|FG001|Overall Study|Study closed/terminated|6|||
144479492|NCT01336634|520955039|FG002|Overall Study|Study closed/terminated|6|||
144479493|NCT01336634|520955037|FG000|Overall Study|Lost to Follow-up|2|||
144479494|NCT01336634|520955038|FG001|Overall Study|Lost to Follow-up|1|||
144479495|NCT01336634|520955039|FG002|Overall Study|Lost to Follow-up|1|||
144479496|NCT01336634|520955037|FG000|Overall Study|Physician Decision|1|||
144479497|NCT01336634|520955038|FG001|Overall Study|Physician Decision|1|||
144479498|NCT01336634|520955039|FG002|Overall Study|Physician Decision|0|||
144479499|NCT01336634|520955037|FG000|Overall Study|Withdrawal by Subject|6|||
144479500|NCT01336634|520955038|FG001|Overall Study|Withdrawal by Subject|0|||
144479501|NCT01336634|520955039|FG002|Overall Study|Withdrawal by Subject|2|||
144479502|NCT02961881|520955040|FG000|Overall Study|Adverse Event|1|||
144479503|NCT02961881|520955041|FG001|Overall Study|Adverse Event|2|||
144479504|NCT02961881|520955042|FG002|Overall Study|Adverse Event|2|||
144479505|NCT02961881|520955043|FG003|Overall Study|Adverse Event|0|||
144479506|NCT02961881|520955044|FG004|Overall Study|Adverse Event|1|||
144479507|NCT02961881|520955040|FG000|Overall Study|Participant request|0|||
144479508|NCT02961881|520955041|FG001|Overall Study|Participant request|2|||
144479509|NCT02961881|520955042|FG002|Overall Study|Participant request|0|||
144479510|NCT02961881|520955043|FG003|Overall Study|Participant request|0|||
144479511|NCT02961881|520955044|FG004|Overall Study|Participant request|0|||
144479512|NCT02961881|520955040|FG000|Overall Study|Disease progression|1|||
144479513|NCT02961881|520955041|FG001|Overall Study|Disease progression|0|||
144479514|NCT02961881|520955042|FG002|Overall Study|Disease progression|1|||
144479515|NCT02961881|520955043|FG003|Overall Study|Disease progression|0|||
144479516|NCT02961881|520955044|FG004|Overall Study|Disease progression|0|||
144479517|NCT01118455|520955045|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
144479518|NCT01118455|520955046|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
144479519|NCT01973491|520955047|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
144479520|NCT01973491|520955047|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
144479521|NCT01973491|520955047|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
144479522|NCT03377790|520955048|FG000|Overall Study|Withdrawal by Subject|1|||
144479523|NCT03377790|520955049|FG001|Overall Study|Withdrawal by Subject|0|||
144479524|NCT03377790|520955048|FG000|Overall Study|Adverse Event|1|||
144479525|NCT03377790|520955049|FG001|Overall Study|Adverse Event|0|||
144479526|NCT03377790|520955048|FG000|Overall Study|Lost to Follow-up|0|||
144479527|NCT03377790|520955049|FG001|Overall Study|Lost to Follow-up|2|||
144479528|NCT03377790|520955048|FG000|Overall Study|Randomized but not treated|1|||
144479529|NCT03377790|520955049|FG001|Overall Study|Randomized but not treated|0|||
144479530|NCT03377790|520955048|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
144479531|NCT03377790|520955049|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
144479532|NCT00152763|520955057|FG000|Overall Study|Death|4|||
144479533|NCT00152763|520955058|FG001|Overall Study|Death|1|||
144479534|NCT00152763|520955059|FG002|Overall Study|Death|2|||
144479535|NCT00152763|520955060|FG003|Overall Study|Death|1|||
144479536|NCT00152763|520955057|FG000|Overall Study|Lost to Follow-up|6|||
144479537|NCT00152763|520955058|FG001|Overall Study|Lost to Follow-up|4|||
144479538|NCT00152763|520955059|FG002|Overall Study|Lost to Follow-up|2|||
144479539|NCT00152763|520955060|FG003|Overall Study|Lost to Follow-up|13|||
144479540|NCT02567825|520955065|FG000|Overall Study|No follow-up post-randomization|5|||
144479541|NCT02567825|520955066|FG001|Overall Study|No follow-up post-randomization|1|||
144479542|NCT02567825|520955065|FG000|Overall Study|Follow-up less than 23 months|16|||
144479543|NCT02567825|520955066|FG001|Overall Study|Follow-up less than 23 months|20|||
144479544|NCT04741802|520955067|FG000|Overall Study|Death|1|||
144479545|NCT04741802|520955067|FG000|Overall Study|Lost to Follow-up|11|||
144479546|NCT01678820|520955068|FG000|Overall Study|Study Terminated by Sponsor|45|||
144479547|NCT01678820|520955069|FG001|Overall Study|Study Terminated by Sponsor|43|||
144479548|NCT01678820|520955070|FG002|Overall Study|Study Terminated by Sponsor|43|||
144479549|NCT01678820|520955068|FG000|Overall Study|Withdrawal by Subject|2|||
144479550|NCT01678820|520955069|FG001|Overall Study|Withdrawal by Subject|5|||
144479551|NCT01678820|520955070|FG002|Overall Study|Withdrawal by Subject|2|||
144479552|NCT01678820|520955068|FG000|Overall Study|Protocol Specified Criteria|2|||
144479553|NCT01678820|520955069|FG001|Overall Study|Protocol Specified Criteria|3|||
144479554|NCT01678820|520955070|FG002|Overall Study|Protocol Specified Criteria|1|||
144479555|NCT01678820|520955068|FG000|Overall Study|Adverse Event|2|||
144479556|NCT01678820|520955069|FG001|Overall Study|Adverse Event|2|||
144479557|NCT01678820|520955070|FG002|Overall Study|Adverse Event|2|||
144479558|NCT01678820|520955068|FG000|Overall Study|Lost to Follow-up|7|||
144479559|NCT01678820|520955069|FG001|Overall Study|Lost to Follow-up|2|||
144479560|NCT01678820|520955070|FG002|Overall Study|Lost to Follow-up|2|||
144479561|NCT01678820|520955068|FG000|Overall Study|Non-compliance with study drug|0|||
144479562|NCT01678820|520955069|FG001|Overall Study|Non-compliance with study drug|1|||
144479563|NCT01678820|520955070|FG002|Overall Study|Non-compliance with study drug|0|||
144479564|NCT01678820|520955068|FG000|Overall Study|Physician Decision|0|||
144479565|NCT01678820|520955069|FG001|Overall Study|Physician Decision|0|||
144479566|NCT01678820|520955070|FG002|Overall Study|Physician Decision|1|||
144479567|NCT01678820|520955068|FG000|Overall Study|Protocol Violation|4|||
144479568|NCT01678820|520955069|FG001|Overall Study|Protocol Violation|5|||
144479569|NCT01678820|520955070|FG002|Overall Study|Protocol Violation|4|||
144479570|NCT01678820|520955068|FG000|Overall Study|Not treated with double-blind study drug|0|||
144479571|NCT01678820|520955069|FG001|Overall Study|Not treated with double-blind study drug|2|||
144479572|NCT01678820|520955070|FG002|Overall Study|Not treated with double-blind study drug|2|||
144479573|NCT01381874|520955071|FG000|Overall Study|Lost to Follow-up|1|||
144479574|NCT01381874|520955072|FG001|Overall Study|Lost to Follow-up|1|||
144479575|NCT01381874|520955073|FG002|Overall Study|Lost to Follow-up|0|||
144479576|NCT01381874|520955071|FG000|Overall Study|Withdrawal by Subject|9|||
144479577|NCT01381874|520955072|FG001|Overall Study|Withdrawal by Subject|10|||
144479578|NCT01381874|520955073|FG002|Overall Study|Withdrawal by Subject|9|||
144479579|NCT01381874|520955071|FG000|Overall Study|Other|67|||
144479580|NCT01381874|520955072|FG001|Overall Study|Other|52|||
144479581|NCT01381874|520955073|FG002|Overall Study|Other|67|||
144479582|NCT01539863|520955074|FG000|Overall Study|Lost to Follow-up|5|||
144479583|NCT01539863|520955075|FG001|Overall Study|Lost to Follow-up|4|||
144479584|NCT00557622|520955076|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
144479585|NCT00557622|520955077|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
144479586|NCT00557622|520955076|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
144479587|NCT00557622|520955077|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
144479588|NCT00557622|520955076|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
144479589|NCT00557622|520955077|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
144479590|NCT01512745|520955078|FG000|Overall Study|Adverse Event|22|||
144479591|NCT01512745|520955079|FG001|Overall Study|Adverse Event|3|||
144479592|NCT01512745|520955078|FG000|Overall Study|Death|9|||
144479593|NCT01512745|520955079|FG001|Overall Study|Death|13|||
144479594|NCT01512745|520955078|FG000|Overall Study|Withdrawal by Subject|2|||
144479595|NCT01512745|520955079|FG001|Overall Study|Withdrawal by Subject|2|||
144479596|NCT01512745|520955078|FG000|Overall Study|Lost to Follow-up|4|||
144479597|NCT01512745|520955079|FG001|Overall Study|Lost to Follow-up|0|||
144479598|NCT01512745|520955078|FG000|Overall Study|Lack of Efficacy|2|||
144479599|NCT01512745|520955079|FG001|Overall Study|Lack of Efficacy|2|||
144479600|NCT01512745|520955078|FG000|Overall Study|Protocol Violation|1|||
144479601|NCT01512745|520955079|FG001|Overall Study|Protocol Violation|0|||
144479602|NCT02357810|520955080|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
144479603|NCT02357810|520955080|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
144479604|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Adverse Event|5|||
144479605|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
144479606|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
144479607|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
144479608|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Death|1|||
144479609|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Physician Decision|1|||
144479610|NCT02357810|520955080|FG000|Reached 12 Weeks Response|Other|1|||
144479611|NCT02357810|520955080|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
144479612|NCT02357810|520955080|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
144479613|NCT02357810|520955080|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
144479614|NCT02357810|520955080|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
144479615|NCT02357810|520955080|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
144479616|NCT02357810|520955080|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
144479617|NCT00936221|520955082|FG000|Overall Study|Withdrawal by Subject|1|||
144479618|NCT00936221|520955083|FG001|Overall Study|Withdrawal by Subject|1|||
144479619|NCT03820323|520955084|FG000|Overall Study|Lost to Follow-up|2|||
144479620|NCT03820323|520955085|FG001|Overall Study|Lost to Follow-up|1|||
144479621|NCT03820323|520955084|FG000|Overall Study|Missed 12-month visit|22|||
144479622|NCT03820323|520955085|FG001|Overall Study|Missed 12-month visit|14|||
144479623|NCT03820323|520955084|FG000|Overall Study|Death|2|||
144479624|NCT03820323|520955085|FG001|Overall Study|Death|1|||
144479625|NCT03820323|520955084|FG000|Overall Study|Transferred out|13|||
144479626|NCT03820323|520955085|FG001|Overall Study|Transferred out|11|||
144479627|NCT03820323|520955084|FG000|Overall Study|Terminated|0|||
144479628|NCT03820323|520955085|FG001|Overall Study|Terminated|3|||
144479629|NCT03820323|520955084|FG000|Overall Study|Withdrawal by Subject|1|||
144479630|NCT03820323|520955085|FG001|Overall Study|Withdrawal by Subject|6|||
144479631|NCT03151395|520955086|FG000|Overall Study|Adverse Event|2|||
144479632|NCT03151395|520955086|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
144479633|NCT03151395|520955086|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
144479634|NCT03151395|520955086|FG000|Overall Study|Unspecified reason|4|||
144479635|NCT01107743|520955089|FG000|Overall Study|Protocol Violation|46|||
144479636|NCT00308737|520955090|FG000|Overall Study|Adverse Event|104|||
144479637|NCT00308737|520955091|FG001|Overall Study|Adverse Event|9|||
144479638|NCT00308737|520955092|FG002|Overall Study|Adverse Event|0|||
144479639|NCT00308737|520955090|FG000|Overall Study|Death|4|||
144479640|NCT00308737|520955091|FG001|Overall Study|Death|3|||
144479641|NCT00308737|520955092|FG002|Overall Study|Death|0|||
144479642|NCT00308737|520955090|FG000|Overall Study|Lost to Follow-up|56|||
144479643|NCT00308737|520955091|FG001|Overall Study|Lost to Follow-up|80|||
144479644|NCT00308737|520955092|FG002|Overall Study|Lost to Follow-up|5|||
144479645|NCT00308737|520955090|FG000|Overall Study|Physician Decision|15|||
144479646|NCT00308737|520955091|FG001|Overall Study|Physician Decision|2|||
144479647|NCT00308737|520955092|FG002|Overall Study|Physician Decision|1|||
144479648|NCT00308737|520955090|FG000|Overall Study|Protocol Violation|34|||
144479649|NCT00308737|520955091|FG001|Overall Study|Protocol Violation|9|||
144479650|NCT00308737|520955092|FG002|Overall Study|Protocol Violation|5|||
144479651|NCT00308737|520955090|FG000|Overall Study|Withdrawal by Subject|218|||
144479652|NCT00308737|520955091|FG001|Overall Study|Withdrawal by Subject|166|||
144479653|NCT00308737|520955092|FG002|Overall Study|Withdrawal by Subject|18|||
144479654|NCT00308737|520955090|FG000|Overall Study|Various|32|||
144479655|NCT00308737|520955091|FG001|Overall Study|Various|20|||
144479656|NCT00308737|520955092|FG002|Overall Study|Various|8|||
144479657|NCT00089895|520955095|FG000|Overall Study|Consent Withdrawn|11|||
144479658|NCT00089895|520955096|FG001|Overall Study|Consent Withdrawn|14|||
144479659|NCT00089895|520955095|FG000|Overall Study|Technical reason|7|||
144479660|NCT00089895|520955096|FG001|Overall Study|Technical reason|2|||
144479661|NCT00089895|520955095|FG000|Overall Study|Surgery|0|||
144479662|NCT00089895|520955096|FG001|Overall Study|Surgery|1|||
144479663|NCT00089895|520955095|FG000|Overall Study|Bleeding|0|||
144479664|NCT00089895|520955096|FG001|Overall Study|Bleeding|2|||
144703385|NCT02325739|521766870|FG008|Phase I Part|Subject/guardian decision|0|||
144703386|NCT02325739|521766871|FG009|Phase I Part|Subject/guardian decision|0|||
144703387|NCT02325739|521766872|FG010|Phase I Part|Subject/guardian decision|0|||
144703388|NCT02325739|521766862|FG000|Phase I Part|Death|0|||
144703389|NCT02325739|521766863|FG001|Phase I Part|Death|0|||
144703390|NCT02325739|521766864|FG002|Phase I Part|Death|0|||
144703391|NCT02325739|521766865|FG003|Phase I Part|Death|0|||
144703392|NCT02325739|521766866|FG004|Phase I Part|Death|2|||
144703393|NCT02325739|521766867|FG005|Phase I Part|Death|0|||
144703394|NCT02325739|521766868|FG006|Phase I Part|Death|0|||
144703395|NCT02325739|521766869|FG007|Phase I Part|Death|0|||
144703396|NCT02325739|521766870|FG008|Phase I Part|Death|0|||
144703397|NCT02325739|521766871|FG009|Phase I Part|Death|0|||
144703398|NCT02325739|521766872|FG010|Phase I Part|Death|0|||
144703399|NCT02325739|521766862|FG000|Phase II Part|Adverse Event|0|||
144479665|NCT00089895|520955095|FG000|Overall Study|Physician Decision|3|||
144703400|NCT02325739|521766863|FG001|Phase II Part|Adverse Event|0|||
144703401|NCT02325739|521766864|FG002|Phase II Part|Adverse Event|0|||
144703402|NCT02325739|521766865|FG003|Phase II Part|Adverse Event|0|||
144703403|NCT02325739|521766866|FG004|Phase II Part|Adverse Event|0|||
144479666|NCT00089895|520955096|FG001|Overall Study|Physician Decision|7|||
144479667|NCT00089895|520955095|FG000|Overall Study|Exclusion criteria met|6|||
144479668|NCT00089895|520955096|FG001|Overall Study|Exclusion criteria met|6|||
144703404|NCT02325739|521766867|FG005|Phase II Part|Adverse Event|0|||
144703405|NCT02325739|521766868|FG006|Phase II Part|Adverse Event|0|||
144703406|NCT02325739|521766869|FG007|Phase II Part|Adverse Event|0|||
144365094|NCT02531802|520547458|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
144365095|NCT02531802|520547459|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
144365096|NCT02531802|520547460|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
144365097|NCT02531802|520547461|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
144365098|NCT02531802|520547462|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
144365099|NCT02531802|520547463|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
144365100|NCT02531802|520547464|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
144365101|NCT02531802|520547465|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
144365102|NCT02531802|520547466|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
144365103|NCT02531802|520547467|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
144365104|NCT02531802|520547468|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
144365105|NCT02531802|520547469|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
144365106|NCT02531802|520547470|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
144365107|NCT02531802|520547471|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
144365108|NCT02531802|520547472|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
144365109|NCT02531802|520547473|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
144365110|NCT02531802|520547474|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
144365111|NCT02531802|520547454|FG000|Received Vaccination 2|Physician Decision|0|||
144365112|NCT02531802|520547455|FG001|Received Vaccination 2|Physician Decision|0|||
144365113|NCT02531802|520547456|FG002|Received Vaccination 2|Physician Decision|0|||
144365114|NCT02531802|520547457|FG003|Received Vaccination 2|Physician Decision|0|||
144365115|NCT02531802|520547458|FG004|Received Vaccination 2|Physician Decision|0|||
144365116|NCT02531802|520547459|FG005|Received Vaccination 2|Physician Decision|1|||
144365117|NCT02531802|520547460|FG006|Received Vaccination 2|Physician Decision|0|||
144365118|NCT02531802|520547461|FG007|Received Vaccination 2|Physician Decision|0|||
144365119|NCT02531802|520547462|FG008|Received Vaccination 2|Physician Decision|0|||
144365120|NCT02531802|520547463|FG009|Received Vaccination 2|Physician Decision|2|||
144365121|NCT02531802|520547464|FG010|Received Vaccination 2|Physician Decision|0|||
144365122|NCT02531802|520547465|FG011|Received Vaccination 2|Physician Decision|0|||
144365123|NCT02531802|520547466|FG012|Received Vaccination 2|Physician Decision|0|||
144365124|NCT02531802|520547467|FG013|Received Vaccination 2|Physician Decision|1|||
144365125|NCT02531802|520547468|FG014|Received Vaccination 2|Physician Decision|0|||
144365126|NCT02531802|520547469|FG015|Received Vaccination 2|Physician Decision|0|||
144365127|NCT02531802|520547470|FG016|Received Vaccination 2|Physician Decision|0|||
144365128|NCT02531802|520547471|FG017|Received Vaccination 2|Physician Decision|1|||
144365129|NCT02531802|520547472|FG018|Received Vaccination 2|Physician Decision|0|||
144365130|NCT02531802|520547473|FG019|Received Vaccination 2|Physician Decision|0|||
144365131|NCT02531802|520547474|FG020|Received Vaccination 2|Physician Decision|0|||
144365132|NCT02531802|520547454|FG000|Received Vaccination 2|Adverse Event|0|||
144365133|NCT02531802|520547455|FG001|Received Vaccination 2|Adverse Event|0|||
144365134|NCT02531802|520547456|FG002|Received Vaccination 2|Adverse Event|0|||
144365135|NCT02531802|520547457|FG003|Received Vaccination 2|Adverse Event|0|||
144365136|NCT02531802|520547458|FG004|Received Vaccination 2|Adverse Event|0|||
144365137|NCT02531802|520547459|FG005|Received Vaccination 2|Adverse Event|2|||
144365138|NCT02531802|520547460|FG006|Received Vaccination 2|Adverse Event|0|||
144365139|NCT02531802|520547461|FG007|Received Vaccination 2|Adverse Event|0|||
144365140|NCT02531802|520547462|FG008|Received Vaccination 2|Adverse Event|0|||
144365141|NCT02531802|520547463|FG009|Received Vaccination 2|Adverse Event|0|||
144365142|NCT02531802|520547464|FG010|Received Vaccination 2|Adverse Event|0|||
144365143|NCT02531802|520547465|FG011|Received Vaccination 2|Adverse Event|0|||
144365144|NCT02531802|520547466|FG012|Received Vaccination 2|Adverse Event|0|||
144365145|NCT02531802|520547467|FG013|Received Vaccination 2|Adverse Event|0|||
144365146|NCT02531802|520547468|FG014|Received Vaccination 2|Adverse Event|0|||
144365147|NCT02531802|520547469|FG015|Received Vaccination 2|Adverse Event|0|||
144365148|NCT02531802|520547470|FG016|Received Vaccination 2|Adverse Event|0|||
144365149|NCT02531802|520547471|FG017|Received Vaccination 2|Adverse Event|2|||
144365150|NCT02531802|520547472|FG018|Received Vaccination 2|Adverse Event|1|||
144365151|NCT02531802|520547473|FG019|Received Vaccination 2|Adverse Event|0|||
144365152|NCT02531802|520547474|FG020|Received Vaccination 2|Adverse Event|1|||
144365153|NCT02531802|520547454|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
144365154|NCT02531802|520547455|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
144365155|NCT02531802|520547456|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
144365156|NCT02531802|520547457|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
144365157|NCT02531802|520547458|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
144365158|NCT02531802|520547459|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
144365159|NCT02531802|520547460|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
144365160|NCT02531802|520547461|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
144365161|NCT02531802|520547462|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
144365162|NCT02531802|520547463|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
144365163|NCT02531802|520547464|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
144538197|NCT00146172|521174126|FG004|Overall Study|Lost to Follow-up|0|||
144703407|NCT02325739|521766870|FG008|Phase II Part|Adverse Event|4|||
144703408|NCT02325739|521766871|FG009|Phase II Part|Adverse Event|5|||
144703409|NCT02325739|521766872|FG010|Phase II Part|Adverse Event|1|||
144703410|NCT02325739|521766862|FG000|Phase II Part|Physician Decision|0|||
144703411|NCT02325739|521766863|FG001|Phase II Part|Physician Decision|0|||
144703412|NCT02325739|521766864|FG002|Phase II Part|Physician Decision|0|||
144703413|NCT02325739|521766865|FG003|Phase II Part|Physician Decision|0|||
144703414|NCT02325739|521766866|FG004|Phase II Part|Physician Decision|0|||
144703415|NCT02325739|521766867|FG005|Phase II Part|Physician Decision|0|||
144703416|NCT02325739|521766868|FG006|Phase II Part|Physician Decision|0|||
144703417|NCT02325739|521766869|FG007|Phase II Part|Physician Decision|0|||
144703418|NCT02325739|521766870|FG008|Phase II Part|Physician Decision|0|||
144703419|NCT02325739|521766871|FG009|Phase II Part|Physician Decision|1|||
144703420|NCT02325739|521766872|FG010|Phase II Part|Physician Decision|0|||
144703421|NCT02325739|521766862|FG000|Phase II Part|Progressive disease|0|||
144703422|NCT02325739|521766863|FG001|Phase II Part|Progressive disease|0|||
144703423|NCT02325739|521766864|FG002|Phase II Part|Progressive disease|0|||
144703424|NCT02325739|521766865|FG003|Phase II Part|Progressive disease|0|||
144703425|NCT02325739|521766866|FG004|Phase II Part|Progressive disease|0|||
144703426|NCT02325739|521766867|FG005|Phase II Part|Progressive disease|0|||
144703427|NCT02325739|521766868|FG006|Phase II Part|Progressive disease|0|||
144703428|NCT02325739|521766869|FG007|Phase II Part|Progressive disease|0|||
144703429|NCT02325739|521766870|FG008|Phase II Part|Progressive disease|22|||
144703430|NCT02325739|521766871|FG009|Phase II Part|Progressive disease|29|||
144703431|NCT02325739|521766872|FG010|Phase II Part|Progressive disease|18|||
144703432|NCT02325739|521766862|FG000|Phase II Part|Subject/guardian decision|0|||
144703433|NCT02325739|521766863|FG001|Phase II Part|Subject/guardian decision|0|||
144703434|NCT02325739|521766864|FG002|Phase II Part|Subject/guardian decision|0|||
144703435|NCT02325739|521766865|FG003|Phase II Part|Subject/guardian decision|0|||
144703436|NCT02325739|521766866|FG004|Phase II Part|Subject/guardian decision|0|||
144703437|NCT02325739|521766867|FG005|Phase II Part|Subject/guardian decision|0|||
144703438|NCT02325739|521766868|FG006|Phase II Part|Subject/guardian decision|0|||
144703439|NCT02325739|521766869|FG007|Phase II Part|Subject/guardian decision|0|||
144703440|NCT02325739|521766870|FG008|Phase II Part|Subject/guardian decision|4|||
144703441|NCT02325739|521766871|FG009|Phase II Part|Subject/guardian decision|1|||
144703442|NCT02325739|521766872|FG010|Phase II Part|Subject/guardian decision|1|||
144703443|NCT00227591|521766873|FG000|Overall Study|Withdrawal by Subject|1|||
144703444|NCT01886105|521766874|FG000|Overall Study|Lack of Efficacy|3|||
144703445|NCT02057549|521766876|FG000|Overall Study|Lost to Follow-up|1|||
144703446|NCT02057549|521766877|FG001|Overall Study|Lost to Follow-up|0|||
144703447|NCT02057549|521766876|FG000|Overall Study|Physician Decision|1|||
144703448|NCT02057549|521766877|FG001|Overall Study|Physician Decision|0|||
144703449|NCT02057549|521766876|FG000|Overall Study|Withdrawal by Subject|1|||
144703450|NCT02057549|521766877|FG001|Overall Study|Withdrawal by Subject|0|||
144703451|NCT03843775|521766880|FG000|Overall Study|Adverse Event|1|||
144703452|NCT03843775|521766881|FG001|Overall Study|Adverse Event|1|||
144703453|NCT03843775|521766880|FG000|Overall Study|Lack of Efficacy|2|||
144703454|NCT03843775|521766881|FG001|Overall Study|Lack of Efficacy|6|||
144703455|NCT03843775|521766880|FG000|Overall Study|Withdrawal by Subject|0|||
144703456|NCT03843775|521766881|FG001|Overall Study|Withdrawal by Subject|1|||
144703457|NCT00530621|521766882|FG000|Overall Study|Adverse Event|11|||
144703458|NCT00530621|521766883|FG001|Overall Study|Adverse Event|8|||
144703459|NCT00530621|521766882|FG000|Overall Study|Physician Decision|2|||
144703460|NCT00530621|521766883|FG001|Overall Study|Physician Decision|4|||
144703461|NCT00530621|521766882|FG000|Overall Study|Progressive Disease (PD)|47|||
144703462|NCT00530621|521766883|FG001|Overall Study|Progressive Disease (PD)|40|||
144703463|NCT00530621|521766882|FG000|Overall Study|Sponsor Decision|12|||
144703464|NCT00530621|521766883|FG001|Overall Study|Sponsor Decision|15|||
144703465|NCT00530621|521766882|FG000|Overall Study|Subject Decision|4|||
144703466|NCT00530621|521766883|FG001|Overall Study|Subject Decision|7|||
144703467|NCT00530621|521766882|FG000|Overall Study|Death|3|||
144703468|NCT00530621|521766883|FG001|Overall Study|Death|6|||
144703469|NCT00530621|521766882|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
144703470|NCT00530621|521766883|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
144703471|NCT04611152|521766886|FG000|Overall Study|Adverse Event|9|||
144703472|NCT04611152|521766887|FG001|Overall Study|Adverse Event|8|||
144703473|NCT04611152|521766886|FG000|Overall Study|Non-compliance with study schedule|1|||
144703474|NCT04611152|521766887|FG001|Overall Study|Non-compliance with study schedule|3|||
144703475|NCT04611152|521766886|FG000|Overall Study|Withdrawal by Subject|5|||
144703476|NCT04611152|521766887|FG001|Overall Study|Withdrawal by Subject|6|||
144703477|NCT04611152|521766886|FG000|Overall Study|Lost to Follow-up|11|||
144703478|NCT04611152|521766887|FG001|Overall Study|Lost to Follow-up|2|||
144703479|NCT00605839|521766893|FG000|Overall Study|Protocol Violation|1|||
144703480|NCT00605839|521766894|FG001|Overall Study|Protocol Violation|0|||
144703481|NCT00605839|521766895|FG002|Overall Study|Protocol Violation|0|||
144703482|NCT03917654|521766896|FG000|Year 1|Withdrawal by Subject|1|||
144703483|NCT03917654|521766897|FG001|Year 1|Withdrawal by Subject|0|||
144538198|NCT00146172|521174127|FG005|Overall Study|Lost to Follow-up|0|||
144703484|NCT03917654|521766898|FG002|Year 1|Withdrawal by Subject|0|||
144703485|NCT03917654|521766899|FG003|Year 1|Withdrawal by Subject|0|||
144703486|NCT03917654|521766900|FG004|Year 1|Withdrawal by Subject|0|||
144703487|NCT03917654|521766901|FG005|Year 1|Withdrawal by Subject|1|||
144703488|NCT03917654|521766902|FG006|Year 1|Withdrawal by Subject|6|||
144703489|NCT03917654|521766903|FG007|Year 1|Withdrawal by Subject|2|||
144703490|NCT03917654|521766904|FG008|Year 1|Withdrawal by Subject|5|||
144703491|NCT03917654|521766905|FG009|Year 1|Withdrawal by Subject|3|||
144703492|NCT03917654|521766906|FG010|Year 1|Withdrawal by Subject|1|||
144703493|NCT03917654|521766907|FG011|Year 1|Withdrawal by Subject|0|||
144703494|NCT03917654|521766896|FG000|Year 1|Travel|0|||
144703495|NCT03917654|521766897|FG001|Year 1|Travel|1|||
144703496|NCT03917654|521766898|FG002|Year 1|Travel|1|||
144703497|NCT03917654|521766899|FG003|Year 1|Travel|0|||
144703498|NCT03917654|521766900|FG004|Year 1|Travel|4|||
144703499|NCT03917654|521766901|FG005|Year 1|Travel|4|||
144703500|NCT03917654|521766902|FG006|Year 1|Travel|10|||
144703501|NCT03917654|521766903|FG007|Year 1|Travel|8|||
144703502|NCT03917654|521766904|FG008|Year 1|Travel|2|||
144703503|NCT03917654|521766905|FG009|Year 1|Travel|5|||
144703504|NCT03917654|521766906|FG010|Year 1|Travel|3|||
144703505|NCT03917654|521766907|FG011|Year 1|Travel|3|||
144703506|NCT03917654|521766896|FG000|Year 1|Subject moved away from site|0|||
144703507|NCT03917654|521766897|FG001|Year 1|Subject moved away from site|1|||
144703508|NCT03917654|521766898|FG002|Year 1|Subject moved away from site|0|||
144703509|NCT03917654|521766899|FG003|Year 1|Subject moved away from site|0|||
144703510|NCT03917654|521766900|FG004|Year 1|Subject moved away from site|0|||
144703511|NCT03917654|521766901|FG005|Year 1|Subject moved away from site|0|||
144703512|NCT03917654|521766902|FG006|Year 1|Subject moved away from site|1|||
144703513|NCT03917654|521766903|FG007|Year 1|Subject moved away from site|2|||
144703514|NCT03917654|521766904|FG008|Year 1|Subject moved away from site|1|||
144703515|NCT03917654|521766905|FG009|Year 1|Subject moved away from site|0|||
144703516|NCT03917654|521766906|FG010|Year 1|Subject moved away from site|0|||
144703517|NCT03917654|521766907|FG011|Year 1|Subject moved away from site|3|||
144703518|NCT03917654|521766896|FG000|Year 1|Spouse/Family member request|0|||
144703519|NCT03917654|521766897|FG001|Year 1|Spouse/Family member request|0|||
144703520|NCT03917654|521766898|FG002|Year 1|Spouse/Family member request|1|||
144703521|NCT03917654|521766899|FG003|Year 1|Spouse/Family member request|0|||
144703522|NCT03917654|521766900|FG004|Year 1|Spouse/Family member request|1|||
144703523|NCT03917654|521766901|FG005|Year 1|Spouse/Family member request|0|||
144703524|NCT03917654|521766902|FG006|Year 1|Spouse/Family member request|0|||
144703525|NCT03917654|521766903|FG007|Year 1|Spouse/Family member request|2|||
144703526|NCT03917654|521766904|FG008|Year 1|Spouse/Family member request|0|||
144703527|NCT03917654|521766905|FG009|Year 1|Spouse/Family member request|0|||
144703528|NCT03917654|521766906|FG010|Year 1|Spouse/Family member request|0|||
144703529|NCT03917654|521766907|FG011|Year 1|Spouse/Family member request|1|||
144703530|NCT03917654|521766896|FG000|Year 1|Death|0|||
144703531|NCT03917654|521766897|FG001|Year 1|Death|0|||
144703532|NCT03917654|521766898|FG002|Year 1|Death|0|||
144703533|NCT03917654|521766899|FG003|Year 1|Death|0|||
144703534|NCT03917654|521766900|FG004|Year 1|Death|0|||
144703535|NCT03917654|521766901|FG005|Year 1|Death|0|||
144703536|NCT03917654|521766902|FG006|Year 1|Death|0|||
144703537|NCT03917654|521766903|FG007|Year 1|Death|0|||
144703538|NCT03917654|521766904|FG008|Year 1|Death|1|||
144703539|NCT03917654|521766905|FG009|Year 1|Death|1|||
144703540|NCT03917654|521766906|FG010|Year 1|Death|0|||
144703541|NCT03917654|521766907|FG011|Year 1|Death|0|||
144703542|NCT03917654|521766896|FG000|Year 1|Lost to Follow-up|0|||
144703543|NCT03917654|521766897|FG001|Year 1|Lost to Follow-up|0|||
144703544|NCT03917654|521766898|FG002|Year 1|Lost to Follow-up|0|||
144703545|NCT03917654|521766899|FG003|Year 1|Lost to Follow-up|0|||
144703546|NCT03917654|521766900|FG004|Year 1|Lost to Follow-up|0|||
144703547|NCT03917654|521766901|FG005|Year 1|Lost to Follow-up|0|||
144703548|NCT03917654|521766902|FG006|Year 1|Lost to Follow-up|2|||
144703549|NCT03917654|521766903|FG007|Year 1|Lost to Follow-up|0|||
144703550|NCT03917654|521766904|FG008|Year 1|Lost to Follow-up|0|||
144703551|NCT03917654|521766905|FG009|Year 1|Lost to Follow-up|0|||
144703552|NCT03917654|521766906|FG010|Year 1|Lost to Follow-up|0|||
144703553|NCT03917654|521766907|FG011|Year 1|Lost to Follow-up|0|||
144703554|NCT03917654|521766896|FG000|Year 1|Missed visits|0|||
144703555|NCT03917654|521766897|FG001|Year 1|Missed visits|0|||
144703556|NCT03917654|521766898|FG002|Year 1|Missed visits|0|||
144703557|NCT03917654|521766899|FG003|Year 1|Missed visits|0|||
144703558|NCT03917654|521766900|FG004|Year 1|Missed visits|0|||
144703559|NCT03917654|521766901|FG005|Year 1|Missed visits|0|||
144703560|NCT03917654|521766902|FG006|Year 1|Missed visits|0|||
144703561|NCT03917654|521766903|FG007|Year 1|Missed visits|0|||
144703562|NCT03917654|521766904|FG008|Year 1|Missed visits|0|||
144703563|NCT03917654|521766905|FG009|Year 1|Missed visits|0|||
144703564|NCT03917654|521766906|FG010|Year 1|Missed visits|1|||
144703565|NCT03917654|521766907|FG011|Year 1|Missed visits|1|||
144703566|NCT03917654|521766896|FG000|Year 1|Pregnancy|0|||
144703567|NCT03917654|521766897|FG001|Year 1|Pregnancy|0|||
144703568|NCT03917654|521766898|FG002|Year 1|Pregnancy|0|||
144703569|NCT03917654|521766899|FG003|Year 1|Pregnancy|0|||
144703570|NCT03917654|521766900|FG004|Year 1|Pregnancy|0|||
144703571|NCT03917654|521766901|FG005|Year 1|Pregnancy|0|||
144703572|NCT03917654|521766902|FG006|Year 1|Pregnancy|0|||
144703573|NCT03917654|521766903|FG007|Year 1|Pregnancy|1|||
144703574|NCT03917654|521766904|FG008|Year 1|Pregnancy|0|||
144703575|NCT03917654|521766905|FG009|Year 1|Pregnancy|1|||
144703576|NCT03917654|521766906|FG010|Year 1|Pregnancy|0|||
144703577|NCT03917654|521766907|FG011|Year 1|Pregnancy|0|||
144703578|NCT03917654|521766896|FG000|Year 2|Travel|1|||
144703579|NCT03917654|521766897|FG001|Year 2|Travel|0|||
144703580|NCT03917654|521766898|FG002|Year 2|Travel|0|||
144703581|NCT03917654|521766899|FG003|Year 2|Travel|0|||
144703582|NCT03917654|521766900|FG004|Year 2|Travel|1|||
144703583|NCT03917654|521766901|FG005|Year 2|Travel|1|||
144703584|NCT03917654|521766902|FG006|Year 2|Travel|2|||
144703585|NCT03917654|521766903|FG007|Year 2|Travel|1|||
144703586|NCT03917654|521766904|FG008|Year 2|Travel|0|||
144703587|NCT03917654|521766905|FG009|Year 2|Travel|1|||
144703588|NCT03917654|521766906|FG010|Year 2|Travel|0|||
144703589|NCT03917654|521766907|FG011|Year 2|Travel|1|||
144703590|NCT03917654|521766896|FG000|Year 2|Married|1|||
144703591|NCT03917654|521766897|FG001|Year 2|Married|0|||
144703592|NCT03917654|521766898|FG002|Year 2|Married|0|||
144703593|NCT03917654|521766899|FG003|Year 2|Married|0|||
144703594|NCT03917654|521766900|FG004|Year 2|Married|0|||
144703595|NCT03917654|521766901|FG005|Year 2|Married|0|||
144703596|NCT03917654|521766902|FG006|Year 2|Married|1|||
144703597|NCT03917654|521766903|FG007|Year 2|Married|1|||
144703598|NCT03917654|521766904|FG008|Year 2|Married|0|||
144703599|NCT03917654|521766905|FG009|Year 2|Married|0|||
144703600|NCT03917654|521766906|FG010|Year 2|Married|0|||
144703601|NCT03917654|521766907|FG011|Year 2|Married|0|||
144703602|NCT03917654|521766896|FG000|Year 2|Subject moved away from site|1|||
144703603|NCT03917654|521766897|FG001|Year 2|Subject moved away from site|0|||
144703604|NCT03917654|521766898|FG002|Year 2|Subject moved away from site|0|||
144703605|NCT03917654|521766899|FG003|Year 2|Subject moved away from site|0|||
144703606|NCT03917654|521766900|FG004|Year 2|Subject moved away from site|1|||
144703607|NCT03917654|521766901|FG005|Year 2|Subject moved away from site|0|||
144703608|NCT03917654|521766902|FG006|Year 2|Subject moved away from site|2|||
144703609|NCT03917654|521766903|FG007|Year 2|Subject moved away from site|3|||
144703610|NCT03917654|521766904|FG008|Year 2|Subject moved away from site|0|||
144703611|NCT03917654|521766905|FG009|Year 2|Subject moved away from site|2|||
144703612|NCT03917654|521766906|FG010|Year 2|Subject moved away from site|0|||
144703613|NCT03917654|521766907|FG011|Year 2|Subject moved away from site|1|||
144703614|NCT03917654|521766896|FG000|Year 2|Year 2 Screening failure|0|||
144703615|NCT03917654|521766897|FG001|Year 2|Year 2 Screening failure|1|||
144703616|NCT03917654|521766898|FG002|Year 2|Year 2 Screening failure|0|||
144703617|NCT03917654|521766899|FG003|Year 2|Year 2 Screening failure|0|||
144703618|NCT03917654|521766900|FG004|Year 2|Year 2 Screening failure|2|||
144703619|NCT03917654|521766901|FG005|Year 2|Year 2 Screening failure|0|||
144703620|NCT03917654|521766902|FG006|Year 2|Year 2 Screening failure|4|||
144703621|NCT03917654|521766903|FG007|Year 2|Year 2 Screening failure|3|||
144703622|NCT03917654|521766904|FG008|Year 2|Year 2 Screening failure|10|||
144703623|NCT03917654|521766905|FG009|Year 2|Year 2 Screening failure|2|||
144703624|NCT03917654|521766906|FG010|Year 2|Year 2 Screening failure|1|||
144703625|NCT03917654|521766907|FG011|Year 2|Year 2 Screening failure|1|||
144703626|NCT03917654|521766896|FG000|Year 2|Death|0|||
144703627|NCT03917654|521766897|FG001|Year 2|Death|0|||
144703628|NCT03917654|521766898|FG002|Year 2|Death|0|||
144703629|NCT03917654|521766899|FG003|Year 2|Death|0|||
144703630|NCT03917654|521766900|FG004|Year 2|Death|0|||
144703631|NCT03917654|521766901|FG005|Year 2|Death|1|||
144703632|NCT03917654|521766902|FG006|Year 2|Death|0|||
144365164|NCT02531802|520547465|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
144703633|NCT03917654|521766903|FG007|Year 2|Death|0|||
144703634|NCT03917654|521766904|FG008|Year 2|Death|1|||
144703635|NCT03917654|521766905|FG009|Year 2|Death|1|||
144703636|NCT03917654|521766906|FG010|Year 2|Death|0|||
144703637|NCT03917654|521766907|FG011|Year 2|Death|0|||
144365165|NCT02531802|520547466|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
144703638|NCT03917654|521766896|FG000|Year 2|Withdrawal by Subject|0|||
144703639|NCT03917654|521766897|FG001|Year 2|Withdrawal by Subject|0|||
144703640|NCT03917654|521766898|FG002|Year 2|Withdrawal by Subject|0|||
144703641|NCT03917654|521766899|FG003|Year 2|Withdrawal by Subject|0|||
144703642|NCT03917654|521766900|FG004|Year 2|Withdrawal by Subject|0|||
144703643|NCT03917654|521766901|FG005|Year 2|Withdrawal by Subject|0|||
144703644|NCT03917654|521766902|FG006|Year 2|Withdrawal by Subject|3|||
144703645|NCT03917654|521766903|FG007|Year 2|Withdrawal by Subject|0|||
144703646|NCT03917654|521766904|FG008|Year 2|Withdrawal by Subject|2|||
144703647|NCT03917654|521766905|FG009|Year 2|Withdrawal by Subject|5|||
144703648|NCT03917654|521766906|FG010|Year 2|Withdrawal by Subject|0|||
144703649|NCT03917654|521766907|FG011|Year 2|Withdrawal by Subject|0|||
144703650|NCT03917654|521766896|FG000|Year 2|Spouse/family member request|0|||
144703651|NCT03917654|521766897|FG001|Year 2|Spouse/family member request|0|||
144703652|NCT03917654|521766898|FG002|Year 2|Spouse/family member request|0|||
144703653|NCT03917654|521766899|FG003|Year 2|Spouse/family member request|0|||
144703654|NCT03917654|521766900|FG004|Year 2|Spouse/family member request|0|||
144703655|NCT03917654|521766901|FG005|Year 2|Spouse/family member request|0|||
144703656|NCT03917654|521766902|FG006|Year 2|Spouse/family member request|1|||
144703657|NCT03917654|521766903|FG007|Year 2|Spouse/family member request|0|||
144703658|NCT03917654|521766904|FG008|Year 2|Spouse/family member request|0|||
144703659|NCT03917654|521766905|FG009|Year 2|Spouse/family member request|0|||
144703660|NCT03917654|521766906|FG010|Year 2|Spouse/family member request|0|||
144703661|NCT03917654|521766907|FG011|Year 2|Spouse/family member request|0|||
144703662|NCT03917654|521766896|FG000|Year 2|Lost to Follow-up|0|||
144703663|NCT03917654|521766897|FG001|Year 2|Lost to Follow-up|0|||
144703664|NCT03917654|521766898|FG002|Year 2|Lost to Follow-up|0|||
144703665|NCT03917654|521766899|FG003|Year 2|Lost to Follow-up|0|||
144703666|NCT03917654|521766900|FG004|Year 2|Lost to Follow-up|0|||
144703667|NCT03917654|521766901|FG005|Year 2|Lost to Follow-up|0|||
144703668|NCT03917654|521766902|FG006|Year 2|Lost to Follow-up|1|||
144703669|NCT03917654|521766903|FG007|Year 2|Lost to Follow-up|0|||
144703670|NCT03917654|521766904|FG008|Year 2|Lost to Follow-up|1|||
144703671|NCT03917654|521766905|FG009|Year 2|Lost to Follow-up|0|||
144703672|NCT03917654|521766906|FG010|Year 2|Lost to Follow-up|0|||
144703673|NCT03917654|521766907|FG011|Year 2|Lost to Follow-up|1|||
144703674|NCT03917654|521766896|FG000|Year 2|Adverse Event|0|||
144703675|NCT03917654|521766897|FG001|Year 2|Adverse Event|0|||
144703676|NCT03917654|521766898|FG002|Year 2|Adverse Event|0|||
144703677|NCT03917654|521766899|FG003|Year 2|Adverse Event|0|||
144703678|NCT03917654|521766900|FG004|Year 2|Adverse Event|0|||
144703679|NCT03917654|521766901|FG005|Year 2|Adverse Event|0|||
144703680|NCT03917654|521766902|FG006|Year 2|Adverse Event|0|||
144703681|NCT03917654|521766903|FG007|Year 2|Adverse Event|0|||
144703682|NCT03917654|521766904|FG008|Year 2|Adverse Event|0|||
144703683|NCT03917654|521766905|FG009|Year 2|Adverse Event|1|||
144703684|NCT03917654|521766906|FG010|Year 2|Adverse Event|0|||
144703685|NCT03917654|521766907|FG011|Year 2|Adverse Event|0|||
144703686|NCT00602667|521766908|FG000|Overall Study|Still on Therapy|0|||
144703687|NCT00602667|521766909|FG001|Overall Study|Still on Therapy|2|||
144703688|NCT00602667|521766910|FG002|Overall Study|Still on Therapy|2|||
144703689|NCT00602667|521766908|FG000|Overall Study|Death|0|||
144703690|NCT00602667|521766909|FG001|Overall Study|Death|1|||
144703691|NCT00602667|521766910|FG002|Overall Study|Death|1|||
144703692|NCT00602667|521766908|FG000|Overall Study|Family request|3|||
144703693|NCT00602667|521766909|FG001|Overall Study|Family request|25|||
144703694|NCT00602667|521766910|FG002|Overall Study|Family request|6|||
144703695|NCT00602667|521766908|FG000|Overall Study|Excessive toxicity|1|||
144703696|NCT00602667|521766909|FG001|Overall Study|Excessive toxicity|1|||
144703697|NCT00602667|521766910|FG002|Overall Study|Excessive toxicity|0|||
144703698|NCT00602667|521766908|FG000|Overall Study|Second malignancy|0|||
144703699|NCT00602667|521766909|FG001|Overall Study|Second malignancy|1|||
144703700|NCT00602667|521766910|FG002|Overall Study|Second malignancy|0|||
144703701|NCT00602667|521766908|FG000|Overall Study|Physician Decision|2|||
144703702|NCT00602667|521766909|FG001|Overall Study|Physician Decision|3|||
144703703|NCT00602667|521766910|FG002|Overall Study|Physician Decision|8|||
144703704|NCT00602667|521766908|FG000|Overall Study|Progressive disease|13|||
144703705|NCT00602667|521766909|FG001|Overall Study|Progressive disease|48|||
144703706|NCT00602667|521766910|FG002|Overall Study|Progressive disease|45|||
144703707|NCT00602667|521766908|FG000|Overall Study|Progressive disease prior to therapy|0|||
144703708|NCT00602667|521766909|FG001|Overall Study|Progressive disease prior to therapy|0|||
144703709|NCT00602667|521766910|FG002|Overall Study|Progressive disease prior to therapy|1|||
144703710|NCT03179462|521766916|FG000|Overall Study|screening failure|1|||
144365166|NCT02531802|520547467|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
144365167|NCT02531802|520547468|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
144365168|NCT02531802|520547469|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
144365169|NCT02531802|520547470|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
144365170|NCT02531802|520547471|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
144365171|NCT02531802|520547472|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
144365172|NCT02531802|520547473|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
144538199|NCT00146172|521174128|FG006|Overall Study|Lost to Follow-up|0|||
144703711|NCT03179462|521766917|FG001|Overall Study|screening failure|2|||
144703712|NCT03179462|521766918|FG002|Overall Study|screening failure|0|||
144703713|NCT04636437|521766919|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
144703714|NCT04636437|521766920|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
144703715|NCT04636437|521766921|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
144703716|NCT04636437|521766919|FG000|Overall Study|Started weight loss drug/program|2|||
144703717|NCT04636437|521766920|FG001|Overall Study|Started weight loss drug/program|1|||
144703718|NCT04636437|521766921|FG002|Overall Study|Started weight loss drug/program|1|||
144703719|NCT04636437|521766919|FG000|Overall Study|Lost to Follow-up|3|||
144703720|NCT04636437|521766920|FG001|Overall Study|Lost to Follow-up|1|||
144703721|NCT04636437|521766921|FG002|Overall Study|Lost to Follow-up|4|||
144703722|NCT04636437|521766919|FG000|Overall Study|Participant or physician decision|3|||
144703723|NCT04636437|521766920|FG001|Overall Study|Participant or physician decision|1|||
144703724|NCT04636437|521766921|FG002|Overall Study|Participant or physician decision|1|||
144703725|NCT00816166|521766925|FG000|Overall Study|Lost to Follow-up|6|||
144703726|NCT00816166|521766926|FG001|Overall Study|Lost to Follow-up|10|||
144703727|NCT00816166|521766925|FG000|Overall Study|Death|4|||
144703728|NCT00816166|521766926|FG001|Overall Study|Death|2|||
144703729|NCT02851069|521766927|FG000|Overall Study|Failure to Return|3|||
144703730|NCT02851069|521766927|FG000|Overall Study|Other|3|||
144703731|NCT02146365|521766928|FG000|Overall Study|Lost to Follow-up|2|||
144703732|NCT02146365|521766929|FG001|Overall Study|Lost to Follow-up|1|||
144703733|NCT02146365|521766930|FG002|Overall Study|Lost to Follow-up|3|||
144703734|NCT02146365|521766931|FG003|Overall Study|Lost to Follow-up|3|||
144703735|NCT02146365|521766932|FG004|Overall Study|Lost to Follow-up|1|||
144703736|NCT02146365|521766933|FG005|Overall Study|Lost to Follow-up|1|||
144703737|NCT02146365|521766934|FG006|Overall Study|Lost to Follow-up|0|||
144703738|NCT02146365|521766935|FG007|Overall Study|Lost to Follow-up|1|||
144703739|NCT02146365|521766928|FG000|Overall Study|Withdrawal by Subject|1|||
144703740|NCT02146365|521766929|FG001|Overall Study|Withdrawal by Subject|2|||
144703741|NCT02146365|521766930|FG002|Overall Study|Withdrawal by Subject|1|||
144703742|NCT02146365|521766931|FG003|Overall Study|Withdrawal by Subject|5|||
144703743|NCT02146365|521766932|FG004|Overall Study|Withdrawal by Subject|1|||
144703744|NCT02146365|521766933|FG005|Overall Study|Withdrawal by Subject|0|||
144703745|NCT02146365|521766934|FG006|Overall Study|Withdrawal by Subject|0|||
144703746|NCT02146365|521766935|FG007|Overall Study|Withdrawal by Subject|0|||
144703747|NCT02146365|521766928|FG000|Overall Study|Unable to Comply with Protocol|0|||
144703748|NCT02146365|521766929|FG001|Overall Study|Unable to Comply with Protocol|1|||
144703749|NCT02146365|521766930|FG002|Overall Study|Unable to Comply with Protocol|1|||
144703750|NCT02146365|521766931|FG003|Overall Study|Unable to Comply with Protocol|0|||
144703751|NCT02146365|521766932|FG004|Overall Study|Unable to Comply with Protocol|0|||
144703752|NCT02146365|521766933|FG005|Overall Study|Unable to Comply with Protocol|0|||
144703753|NCT02146365|521766934|FG006|Overall Study|Unable to Comply with Protocol|0|||
144703754|NCT02146365|521766935|FG007|Overall Study|Unable to Comply with Protocol|0|||
144703755|NCT02146365|521766928|FG000|Overall Study|Other|1|||
144703756|NCT02146365|521766929|FG001|Overall Study|Other|0|||
144703757|NCT02146365|521766930|FG002|Overall Study|Other|2|||
144703758|NCT02146365|521766931|FG003|Overall Study|Other|1|||
144703759|NCT02146365|521766932|FG004|Overall Study|Other|0|||
144703760|NCT02146365|521766933|FG005|Overall Study|Other|0|||
144703761|NCT02146365|521766934|FG006|Overall Study|Other|0|||
144703762|NCT02146365|521766935|FG007|Overall Study|Other|0|||
144703763|NCT01392469|521768750|FG000|Overall Study|Adverse Event|2|||
144703764|NCT01392469|521768750|FG000|Overall Study|Withdrawal by Subject|1|||
144703765|NCT01392469|521768750|FG000|Overall Study|Protocol Violation|1|||
144703766|NCT00648739|521768753|FG000|Overall Study|Adverse Event|1|||
144703767|NCT00648739|521768754|FG001|Overall Study|Adverse Event|0|||
144703768|NCT00648739|521768755|FG002|Overall Study|Adverse Event|1|||
144703769|NCT00648739|521768756|FG003|Overall Study|Adverse Event|2|||
144703770|NCT00648739|521768757|FG004|Overall Study|Adverse Event|1|||
144703771|NCT00648739|521768758|FG005|Overall Study|Adverse Event|0|||
144703772|NCT00648739|521768759|FG006|Overall Study|Adverse Event|0|||
144703773|NCT00648739|521768753|FG000|Overall Study|Withdrawal by Subject|1|||
144703774|NCT00648739|521768754|FG001|Overall Study|Withdrawal by Subject|0|||
144703775|NCT00648739|521768755|FG002|Overall Study|Withdrawal by Subject|1|||
144703776|NCT00648739|521768756|FG003|Overall Study|Withdrawal by Subject|0|||
144703777|NCT00648739|521768757|FG004|Overall Study|Withdrawal by Subject|0|||
144703778|NCT00648739|521768758|FG005|Overall Study|Withdrawal by Subject|2|||
144703779|NCT00648739|521768759|FG006|Overall Study|Withdrawal by Subject|0|||
144703780|NCT00648739|521768753|FG000|Overall Study|Lack of Efficacy|0|||
144703781|NCT00648739|521768754|FG001|Overall Study|Lack of Efficacy|0|||
144703782|NCT00648739|521768755|FG002|Overall Study|Lack of Efficacy|0|||
144703783|NCT00648739|521768756|FG003|Overall Study|Lack of Efficacy|0|||
144703784|NCT00648739|521768757|FG004|Overall Study|Lack of Efficacy|1|||
144703785|NCT00648739|521768758|FG005|Overall Study|Lack of Efficacy|2|||
144703786|NCT00648739|521768759|FG006|Overall Study|Lack of Efficacy|0|||
144703787|NCT00648739|521768753|FG000|Overall Study|Investigator Considered it Advisable|0|||
144703788|NCT00648739|521768754|FG001|Overall Study|Investigator Considered it Advisable|0|||
144703789|NCT00648739|521768755|FG002|Overall Study|Investigator Considered it Advisable|0|||
144703790|NCT00648739|521768756|FG003|Overall Study|Investigator Considered it Advisable|0|||
144703791|NCT00648739|521768757|FG004|Overall Study|Investigator Considered it Advisable|0|||
144703792|NCT00648739|521768758|FG005|Overall Study|Investigator Considered it Advisable|1|||
144703793|NCT00648739|521768759|FG006|Overall Study|Investigator Considered it Advisable|1|||
144703794|NCT00648739|521768753|FG000|Overall Study|Death|0|||
144703795|NCT00648739|521768754|FG001|Overall Study|Death|1|||
144703796|NCT00648739|521768755|FG002|Overall Study|Death|0|||
144703797|NCT00648739|521768756|FG003|Overall Study|Death|0|||
144703798|NCT00648739|521768757|FG004|Overall Study|Death|0|||
144703799|NCT00648739|521768758|FG005|Overall Study|Death|0|||
144703800|NCT00648739|521768759|FG006|Overall Study|Death|0|||
144703801|NCT00648739|521768753|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
144703802|NCT00648739|521768754|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
144703803|NCT00648739|521768755|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
144365173|NCT02531802|520547474|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
144365174|NCT01523366|520547475|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144365175|NCT01523366|520547476|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144365176|NCT01523366|520547475|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
144365177|NCT01523366|520547476|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
144365178|NCT00071058|520547484|FG000|Overall Study|brain tumor-removed from study|1|||
144365179|NCT04109547|520547489|FG000|Overall Study|Withdrawal by Subject|3|||
144365180|NCT04109547|520547490|FG001|Overall Study|Withdrawal by Subject|2|||
144365181|NCT04109547|520547491|FG002|Overall Study|Withdrawal by Subject|6|||
144365182|NCT04109547|520547492|FG003|Overall Study|Withdrawal by Subject|6|||
144365183|NCT04109547|520547489|FG000|Overall Study|Lost to Follow-up|0|||
144365184|NCT04109547|520547490|FG001|Overall Study|Lost to Follow-up|0|||
144365185|NCT04109547|520547491|FG002|Overall Study|Lost to Follow-up|0|||
144365186|NCT04109547|520547492|FG003|Overall Study|Lost to Follow-up|1|||
144365187|NCT04109547|520547489|FG000|Overall Study|Physician Decision|1|||
144365188|NCT04109547|520547490|FG001|Overall Study|Physician Decision|2|||
144365189|NCT04109547|520547491|FG002|Overall Study|Physician Decision|0|||
144365190|NCT04109547|520547492|FG003|Overall Study|Physician Decision|0|||
144365191|NCT01210313|520547495|FG000|Overall Study|Withdrawal by Subject|3|||
144365192|NCT01210313|520547495|FG000|Overall Study|Adverse Event|2|||
144365193|NCT01210313|520547495|FG000|Overall Study|Distant recurrence|4|||
144365194|NCT01210313|520547495|FG000|Overall Study|Non-compliance|7|||
144365195|NCT04189952|520547496|FG000|Follow-up Period|Death|1|||
144365196|NCT04189952|520547496|FG000|Follow-up Period|Withdrawal by Subject|1|||
144365197|NCT00870740|520547497|FG000|Overall Study|Adverse Event|2|||
144365198|NCT00870740|520547498|FG001|Overall Study|Adverse Event|1|||
144365199|NCT00870740|520547499|FG002|Overall Study|Adverse Event|3|||
144365200|NCT00870740|520547500|FG003|Overall Study|Adverse Event|2|||
144365201|NCT00870740|520547501|FG004|Overall Study|Adverse Event|1|||
144365202|NCT00870740|520547502|FG005|Overall Study|Adverse Event|6|||
144365203|NCT00870740|520547497|FG000|Overall Study|Consent Withdrawn|6|||
144365204|NCT00870740|520547498|FG001|Overall Study|Consent Withdrawn|3|||
144365205|NCT00870740|520547499|FG002|Overall Study|Consent Withdrawn|4|||
144365206|NCT00870740|520547500|FG003|Overall Study|Consent Withdrawn|6|||
144365207|NCT00870740|520547501|FG004|Overall Study|Consent Withdrawn|6|||
144365208|NCT00870740|520547502|FG005|Overall Study|Consent Withdrawn|5|||
144365209|NCT00870740|520547497|FG000|Overall Study|Investigator Decision|2|||
144365210|NCT00870740|520547498|FG001|Overall Study|Investigator Decision|0|||
144365211|NCT00870740|520547499|FG002|Overall Study|Investigator Decision|1|||
144365212|NCT00870740|520547500|FG003|Overall Study|Investigator Decision|0|||
144365213|NCT00870740|520547501|FG004|Overall Study|Investigator Decision|0|||
144365214|NCT00870740|520547502|FG005|Overall Study|Investigator Decision|0|||
144365215|NCT00870740|520547497|FG000|Overall Study|Subject Non-compliance|0|||
144365216|NCT00870740|520547498|FG001|Overall Study|Subject Non-compliance|0|||
144365217|NCT00870740|520547499|FG002|Overall Study|Subject Non-compliance|0|||
144365218|NCT00870740|520547500|FG003|Overall Study|Subject Non-compliance|0|||
144365219|NCT00870740|520547501|FG004|Overall Study|Subject Non-compliance|0|||
144365220|NCT00870740|520547502|FG005|Overall Study|Subject Non-compliance|1|||
144365221|NCT00870740|520547497|FG000|Overall Study|Death|0|||
144365222|NCT00870740|520547498|FG001|Overall Study|Death|0|||
144365223|NCT00870740|520547499|FG002|Overall Study|Death|0|||
144365224|NCT00870740|520547500|FG003|Overall Study|Death|0|||
144365225|NCT00870740|520547501|FG004|Overall Study|Death|1|||
144365226|NCT00870740|520547502|FG005|Overall Study|Death|0|||
144365227|NCT00870740|520547497|FG000|Overall Study|Other|2|||
144365228|NCT00870740|520547498|FG001|Overall Study|Other|5|||
144365229|NCT00870740|520547499|FG002|Overall Study|Other|2|||
144365230|NCT00870740|520547500|FG003|Overall Study|Other|4|||
144365231|NCT00870740|520547501|FG004|Overall Study|Other|3|||
144365232|NCT00870740|520547502|FG005|Overall Study|Other|5|||
144365233|NCT01033019|520547504|FG000|Overall Study|Withdrawal by Subject|1|||
144365234|NCT01033019|520547505|FG001|Overall Study|Withdrawal by Subject|0|||
144703804|NCT00648739|521768756|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
144365235|NCT00551642|520547508|FG000|Treatment Period|Protocol Deviation|6|||
144703805|NCT00648739|521768757|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
144365236|NCT00551642|520547509|FG001|Treatment Period|Protocol Deviation|11|||
144365237|NCT00551642|520547508|FG000|Treatment Period|Delivery device failure|1|||
144365238|NCT00551642|520547509|FG001|Treatment Period|Delivery device failure|3|||
144365239|NCT00551642|520547508|FG000|Treatment Period|Physician Decision|0|||
144365240|NCT00551642|520547509|FG001|Treatment Period|Physician Decision|1|||
144365241|NCT00551642|520547508|FG000|Treatment Period|Death|33|||
144365242|NCT00551642|520547509|FG001|Treatment Period|Death|31|||
144365243|NCT00551642|520547508|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
144365244|NCT00551642|520547509|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
144365245|NCT00551642|520547508|FG000|Treatment Period|Adverse Event|15|||
144365246|NCT00551642|520547509|FG001|Treatment Period|Adverse Event|12|||
144365247|NCT00551642|520547508|FG000|Treatment Period|Withdrawal by Subject|2|||
144365248|NCT00551642|520547509|FG001|Treatment Period|Withdrawal by Subject|1|||
144365249|NCT03011099|520547510|FG000|Overall Study|Withdrawal by Subject|0|||
144365250|NCT03011099|520547511|FG001|Overall Study|Withdrawal by Subject|2|||
144365251|NCT00283296|520547514|FG000|Overall Study|in-home trial not completed|5|||
144365252|NCT02668653|520547515|FG000|Overall Study|Refractory disease|41|||
144365253|NCT02668653|520547516|FG001|Overall Study|Refractory disease|70|||
144365254|NCT02668653|520547515|FG000|Overall Study|Relapse|44|||
144365255|NCT02668653|520547516|FG001|Overall Study|Relapse|65|||
144365256|NCT02668653|520547515|FG000|Overall Study|Adverse Event|58|||
144365257|NCT02668653|520547516|FG001|Overall Study|Adverse Event|23|||
144365258|NCT02668653|520547515|FG000|Overall Study|Subject decision to stop study drug|25|||
144365259|NCT02668653|520547516|FG001|Overall Study|Subject decision to stop study drug|23|||
144365260|NCT02668653|520547515|FG000|Overall Study|Other reasons not specified|16|||
144365261|NCT02668653|520547516|FG001|Overall Study|Other reasons not specified|11|||
144365262|NCT02668653|520547515|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
144365263|NCT02668653|520547516|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
144365264|NCT02668653|520547515|FG000|Overall Study|Investigator decision|10|||
144365265|NCT02668653|520547516|FG001|Overall Study|Investigator decision|7|||
144365266|NCT02668653|520547515|FG000|Overall Study|Failure to meet continuation criteria|5|||
144365267|NCT02668653|520547516|FG001|Overall Study|Failure to meet continuation criteria|12|||
144365268|NCT02668653|520547515|FG000|Overall Study|Lost to Follow-up|1|||
144365269|NCT02668653|520547516|FG001|Overall Study|Lost to Follow-up|0|||
144365270|NCT02668653|520547515|FG000|Overall Study|Pregnancy|0|||
144365271|NCT02668653|520547516|FG001|Overall Study|Pregnancy|1|||
144365272|NCT02668653|520547515|FG000|Overall Study|Death|0|||
144365273|NCT02668653|520547516|FG001|Overall Study|Death|1|||
144365274|NCT01294553|520547517|FG000|Overall Study|Duplicated Participants|1|||
144365275|NCT01294553|520547517|FG000|Overall Study|Protocol Violation|268|||
144365276|NCT03041181|520547520|FG000|Overall Study|Disease Progression|1|||
144365277|NCT03041181|520547521|FG001|Overall Study|Disease Progression|2|||
144365278|NCT03224819|520547522|FG000|Overall Study|Withdrawal by Subject|0|||
144365279|NCT03224819|520547523|FG001|Overall Study|Withdrawal by Subject|0|||
144365280|NCT03224819|520547524|FG002|Overall Study|Withdrawal by Subject|0|||
144365281|NCT03224819|520547525|FG003|Overall Study|Withdrawal by Subject|0|||
144365282|NCT03224819|520547526|FG004|Overall Study|Withdrawal by Subject|0|||
144365283|NCT03224819|520547527|FG005|Overall Study|Withdrawal by Subject|0|||
144365284|NCT03224819|520547528|FG006|Overall Study|Withdrawal by Subject|0|||
144365285|NCT03224819|520547529|FG007|Overall Study|Withdrawal by Subject|0|||
144365286|NCT03224819|520547530|FG008|Overall Study|Withdrawal by Subject|0|||
144365287|NCT03224819|520547531|FG009|Overall Study|Withdrawal by Subject|0|||
144365288|NCT03224819|520547532|FG010|Overall Study|Withdrawal by Subject|0|||
144365289|NCT03224819|520547533|FG011|Overall Study|Withdrawal by Subject|0|||
144365290|NCT03224819|520547534|FG012|Overall Study|Withdrawal by Subject|1|||
144365291|NCT03224819|520547535|FG013|Overall Study|Withdrawal by Subject|0|||
144365292|NCT03224819|520547522|FG000|Overall Study|Sponsor Decision|0|||
144365293|NCT03224819|520547523|FG001|Overall Study|Sponsor Decision|0|||
144365294|NCT03224819|520547524|FG002|Overall Study|Sponsor Decision|0|||
144365295|NCT03224819|520547525|FG003|Overall Study|Sponsor Decision|1|||
144365296|NCT03224819|520547526|FG004|Overall Study|Sponsor Decision|1|||
144365297|NCT03224819|520547527|FG005|Overall Study|Sponsor Decision|2|||
144365298|NCT03224819|520547528|FG006|Overall Study|Sponsor Decision|1|||
144365299|NCT03224819|520547529|FG007|Overall Study|Sponsor Decision|1|||
144365300|NCT03224819|520547530|FG008|Overall Study|Sponsor Decision|1|||
144365301|NCT03224819|520547531|FG009|Overall Study|Sponsor Decision|2|||
144365302|NCT03224819|520547532|FG010|Overall Study|Sponsor Decision|1|||
144365303|NCT03224819|520547533|FG011|Overall Study|Sponsor Decision|1|||
144365304|NCT03224819|520547534|FG012|Overall Study|Sponsor Decision|1|||
144365305|NCT03224819|520547535|FG013|Overall Study|Sponsor Decision|0|||
144365306|NCT03224819|520547522|FG000|Overall Study|Lost to Follow-up|0|||
144365307|NCT03224819|520547523|FG001|Overall Study|Lost to Follow-up|0|||
144365308|NCT03224819|520547524|FG002|Overall Study|Lost to Follow-up|0|||
144365309|NCT03224819|520547525|FG003|Overall Study|Lost to Follow-up|0|||
144365310|NCT03224819|520547526|FG004|Overall Study|Lost to Follow-up|0|||
144365311|NCT03224819|520547527|FG005|Overall Study|Lost to Follow-up|0|||
144365312|NCT03224819|520547528|FG006|Overall Study|Lost to Follow-up|0|||
144365313|NCT03224819|520547529|FG007|Overall Study|Lost to Follow-up|0|||
144365314|NCT03224819|520547530|FG008|Overall Study|Lost to Follow-up|1|||
144365315|NCT03224819|520547531|FG009|Overall Study|Lost to Follow-up|0|||
144365316|NCT03224819|520547532|FG010|Overall Study|Lost to Follow-up|0|||
144365317|NCT03224819|520547533|FG011|Overall Study|Lost to Follow-up|0|||
144365318|NCT03224819|520547534|FG012|Overall Study|Lost to Follow-up|0|||
144365319|NCT03224819|520547535|FG013|Overall Study|Lost to Follow-up|0|||
144365320|NCT03224819|520547522|FG000|Overall Study|Death|0|||
144365321|NCT03224819|520547523|FG001|Overall Study|Death|1|||
144365322|NCT03224819|520547524|FG002|Overall Study|Death|0|||
144365323|NCT03224819|520547525|FG003|Overall Study|Death|0|||
144365324|NCT03224819|520547526|FG004|Overall Study|Death|0|||
144365325|NCT03224819|520547527|FG005|Overall Study|Death|0|||
144365326|NCT03224819|520547528|FG006|Overall Study|Death|0|||
144365327|NCT03224819|520547529|FG007|Overall Study|Death|1|||
144365328|NCT03224819|520547530|FG008|Overall Study|Death|0|||
144365329|NCT03224819|520547531|FG009|Overall Study|Death|0|||
144365330|NCT03224819|520547532|FG010|Overall Study|Death|0|||
144365331|NCT03224819|520547533|FG011|Overall Study|Death|1|||
144365332|NCT03224819|520547534|FG012|Overall Study|Death|0|||
144365333|NCT03224819|520547535|FG013|Overall Study|Death|0|||
144365334|NCT01903460|520547538|FG000|Overall Study|Adverse Event|0|||
144365335|NCT01903460|520547539|FG001|Overall Study|Adverse Event|0|||
144365336|NCT01903460|520547540|FG002|Overall Study|Adverse Event|0|||
144365337|NCT01903460|520547541|FG003|Overall Study|Adverse Event|1|||
144365338|NCT03104868|520547542|FG000|6 Week Follow up|Lost to Follow-up|5|||
144365339|NCT03104868|520547543|FG001|6 Week Follow up|Lost to Follow-up|8|||
144365340|NCT03104868|520547542|FG000|6 Week Follow up|Death|1|||
144365341|NCT03104868|520547543|FG001|6 Week Follow up|Death|1|||
144365342|NCT03104868|520547542|FG000|6 Week Follow up|Withdrawal by Subject|7|||
144365343|NCT03104868|520547543|FG001|6 Week Follow up|Withdrawal by Subject|6|||
144365344|NCT03104868|520547542|FG000|6 Week Follow up|Completed Later Timepoint|24|||
144365345|NCT03104868|520547543|FG001|6 Week Follow up|Completed Later Timepoint|22|||
144365346|NCT03104868|520547542|FG000|6 Month Follow up|Lost to Follow-up|2|||
144365347|NCT03104868|520547543|FG001|6 Month Follow up|Lost to Follow-up|2|||
144365348|NCT03104868|520547542|FG000|6 Month Follow up|Death|0|||
144365349|NCT03104868|520547543|FG001|6 Month Follow up|Death|1|||
144365350|NCT03104868|520547542|FG000|6 Month Follow up|Completed Later Timepoint|22|||
144365351|NCT03104868|520547543|FG001|6 Month Follow up|Completed Later Timepoint|32|||
144365352|NCT03104868|520547542|FG000|12 Month Follow up|Lost to Follow-up|1|||
144365353|NCT03104868|520547543|FG001|12 Month Follow up|Lost to Follow-up|2|||
144365354|NCT03104868|520547542|FG000|12 Month Follow up|Death|0|||
144365355|NCT03104868|520547543|FG001|12 Month Follow up|Death|1|||
144365356|NCT03104868|520547542|FG000|12 Month Follow up|Withdrawal by Subject|0|||
144365357|NCT03104868|520547543|FG001|12 Month Follow up|Withdrawal by Subject|3|||
144365358|NCT03104868|520547542|FG000|12 Month Follow up|Completed Later Timepoint|32|||
144365359|NCT03104868|520547543|FG001|12 Month Follow up|Completed Later Timepoint|29|||
144365360|NCT03104868|520547542|FG000|18 Month Follow up|Lost to Follow-up|7|||
144365361|NCT03104868|520547543|FG001|18 Month Follow up|Lost to Follow-up|11|||
144365362|NCT03104868|520547542|FG000|18 Month Follow up|Death|2|||
144365363|NCT03104868|520547543|FG001|18 Month Follow up|Death|1|||
144365364|NCT03104868|520547542|FG000|18 Month Follow up|Withdrawal by Subject|1|||
144365365|NCT03104868|520547543|FG001|18 Month Follow up|Withdrawal by Subject|2|||
144365366|NCT03104868|520547542|FG000|18 Month Follow up|Graft Loss|1|||
144365367|NCT03104868|520547543|FG001|18 Month Follow up|Graft Loss|1|||
144365368|NCT03104868|520547542|FG000|18 Month Follow up|Completed Later Timepoint|19|||
144365369|NCT03104868|520547543|FG001|18 Month Follow up|Completed Later Timepoint|20|||
144365370|NCT03104868|520547542|FG000|24 Month Follow up|Lost to Follow-up|15|||
144365371|NCT03104868|520547543|FG001|24 Month Follow up|Lost to Follow-up|16|||
144365372|NCT03104868|520547542|FG000|24 Month Follow up|Death|3|||
144365373|NCT03104868|520547543|FG001|24 Month Follow up|Death|2|||
144365374|NCT03104868|520547542|FG000|24 Month Follow up|Withdrawal by Subject|1|||
144365375|NCT03104868|520547543|FG001|24 Month Follow up|Withdrawal by Subject|0|||
144365376|NCT03104868|520547542|FG000|24 Month Follow up|Graft Loss|2|||
144365377|NCT03104868|520547543|FG001|24 Month Follow up|Graft Loss|0|||
144365378|NCT00005780|520547544|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
144365379|NCT04973449|520547545|FG000|Overall Study|Withdrawal by Subject|3|||
144365380|NCT04973449|520547546|FG001|Overall Study|Withdrawal by Subject|3|||
144365381|NCT04973449|520547547|FG002|Overall Study|Withdrawal by Subject|2|||
144365382|NCT04973449|520547548|FG003|Overall Study|Withdrawal by Subject|5|||
144365383|NCT04973449|520547549|FG004|Overall Study|Withdrawal by Subject|5|||
144703806|NCT00648739|521768758|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
144703807|NCT00648739|521768759|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
144703808|NCT00648739|521768753|FG000|Overall Study|Follow-up Visits Not Completed|0|||
144703809|NCT00648739|521768754|FG001|Overall Study|Follow-up Visits Not Completed|1|||
144703810|NCT00648739|521768755|FG002|Overall Study|Follow-up Visits Not Completed|0|||
144703811|NCT00648739|521768756|FG003|Overall Study|Follow-up Visits Not Completed|0|||
144703812|NCT00648739|521768757|FG004|Overall Study|Follow-up Visits Not Completed|0|||
144365384|NCT04973449|520547550|FG005|Overall Study|Withdrawal by Subject|4|||
144365385|NCT04973449|520547551|FG006|Overall Study|Withdrawal by Subject|7|||
144365386|NCT04973449|520547552|FG007|Overall Study|Withdrawal by Subject|5|||
144365387|NCT04973449|520547545|FG000|Overall Study|Lost to Follow-up|15|||
144365388|NCT04973449|520547546|FG001|Overall Study|Lost to Follow-up|16|||
144365389|NCT04973449|520547547|FG002|Overall Study|Lost to Follow-up|16|||
144365390|NCT04973449|520547548|FG003|Overall Study|Lost to Follow-up|13|||
144365391|NCT04973449|520547549|FG004|Overall Study|Lost to Follow-up|5|||
144365392|NCT04973449|520547550|FG005|Overall Study|Lost to Follow-up|6|||
144365393|NCT04973449|520547551|FG006|Overall Study|Lost to Follow-up|10|||
144365394|NCT04973449|520547552|FG007|Overall Study|Lost to Follow-up|6|||
144365395|NCT04973449|520547545|FG000|Overall Study|Death|1|||
144365396|NCT04973449|520547546|FG001|Overall Study|Death|0|||
144365397|NCT04973449|520547547|FG002|Overall Study|Death|0|||
144365398|NCT04973449|520547548|FG003|Overall Study|Death|0|||
144365399|NCT04973449|520547549|FG004|Overall Study|Death|0|||
144365400|NCT04973449|520547550|FG005|Overall Study|Death|1|||
144365401|NCT04973449|520547551|FG006|Overall Study|Death|0|||
144365402|NCT04973449|520547552|FG007|Overall Study|Death|0|||
144365403|NCT04973449|520547545|FG000|Overall Study|Other|1|||
144365404|NCT04973449|520547546|FG001|Overall Study|Other|1|||
144365405|NCT04973449|520547547|FG002|Overall Study|Other|2|||
144365406|NCT04973449|520547548|FG003|Overall Study|Other|1|||
144365407|NCT04973449|520547549|FG004|Overall Study|Other|4|||
144365408|NCT04973449|520547550|FG005|Overall Study|Other|0|||
144365409|NCT04973449|520547551|FG006|Overall Study|Other|2|||
144365410|NCT04973449|520547552|FG007|Overall Study|Other|2|||
144365411|NCT00888173|520547553|FG000|Overall Study|Wrong Primary|1|||
144365412|NCT00888173|520547553|FG000|Overall Study|Ineligible: required test not done|1|||
144365413|NCT00829426|520547559|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
144365414|NCT00829426|520547560|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
144365415|NCT04672239|520547563|FG000|Week 2 Survey|Failed survey check items|1|||
144365416|NCT04672239|520547564|FG001|Week 2 Survey|Failed survey check items|2|||
144365417|NCT04672239|520547565|FG002|Week 2 Survey|Failed survey check items|3|||
144365418|NCT04672239|520547563|FG000|Week 2 Survey|Partially completed survey|7|||
144365419|NCT04672239|520547564|FG001|Week 2 Survey|Partially completed survey|1|||
144365420|NCT04672239|520547565|FG002|Week 2 Survey|Partially completed survey|4|||
144365421|NCT04672239|520547563|FG000|Week 2 Survey|Withdrawal by Subject|0|||
144365422|NCT04672239|520547564|FG001|Week 2 Survey|Withdrawal by Subject|1|||
144365423|NCT04672239|520547565|FG002|Week 2 Survey|Withdrawal by Subject|0|||
144365424|NCT04672239|520547563|FG000|Week 2 Survey|Lost to Follow-up|3|||
144365425|NCT04672239|520547564|FG001|Week 2 Survey|Lost to Follow-up|2|||
144365426|NCT04672239|520547565|FG002|Week 2 Survey|Lost to Follow-up|5|||
144365427|NCT04672239|520547563|FG000|Week 6 Survey|Failed survey check items|2|||
144365428|NCT04672239|520547564|FG001|Week 6 Survey|Failed survey check items|2|||
144365429|NCT04672239|520547565|FG002|Week 6 Survey|Failed survey check items|2|||
144365430|NCT04672239|520547563|FG000|Week 6 Survey|Partially completed survey|3|||
144365431|NCT04672239|520547564|FG001|Week 6 Survey|Partially completed survey|3|||
144365432|NCT04672239|520547565|FG002|Week 6 Survey|Partially completed survey|2|||
144365433|NCT04672239|520547563|FG000|Week 6 Survey|Withdrawal by Subject|1|||
144365434|NCT04672239|520547564|FG001|Week 6 Survey|Withdrawal by Subject|1|||
144365435|NCT04672239|520547565|FG002|Week 6 Survey|Withdrawal by Subject|1|||
144365436|NCT04672239|520547563|FG000|Week 6 Survey|Withdrawn by PI|0|||
144365437|NCT04672239|520547564|FG001|Week 6 Survey|Withdrawn by PI|1|||
144365438|NCT04672239|520547565|FG002|Week 6 Survey|Withdrawn by PI|0|||
144365439|NCT04672239|520547563|FG000|Week 6 Survey|Lost to Follow-up|12|||
144365440|NCT04672239|520547564|FG001|Week 6 Survey|Lost to Follow-up|2|||
144365441|NCT04672239|520547565|FG002|Week 6 Survey|Lost to Follow-up|5|||
144365442|NCT04672239|520547563|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
144365443|NCT04672239|520547564|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
144365444|NCT04672239|520547565|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
144365445|NCT04672239|520547563|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
144365446|NCT04672239|520547564|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
144365447|NCT04672239|520547565|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
144365448|NCT04672239|520547563|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
144365449|NCT04672239|520547564|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
144365450|NCT04672239|520547565|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
144365451|NCT04672239|520547563|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
144365452|NCT04672239|520547564|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
144365453|NCT04672239|520547565|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
144365454|NCT04672239|520547563|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
144365455|NCT04672239|520547564|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
144365456|NCT04672239|520547565|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
144365457|NCT04672239|520547563|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
144365458|NCT04672239|520547564|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
144365459|NCT04672239|520547565|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
144365460|NCT04672239|520547563|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
144365461|NCT04672239|520547564|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
144365462|NCT04672239|520547565|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
144365463|NCT01099267|520547566|FG000|MDS-003 Study|Adverse Event|37|||
144365464|NCT01099267|520547566|FG000|MDS-003 Study|Lack of Efficacy|52|||
144365465|NCT01099267|520547566|FG000|MDS-003 Study|Withdrawal by Subject|8|||
144365466|NCT01099267|520547566|FG000|MDS-003 Study|Lost to Follow-up|1|||
144365467|NCT01099267|520547566|FG000|MDS-003 Study|Death|11|||
144365468|NCT01099267|520547566|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
144365469|NCT01099267|520547566|FG000|MDS-003 Study|Disease Progression|7|||
144365470|NCT01099267|520547566|FG000|MDS-003 Study|Investigator Decision|2|||
144365471|NCT01099267|520547566|FG000|MDS-003 Study|Non-Compliance|2|||
144365472|NCT01099267|520547566|FG000|MDS-003 Study|Loss of Response|1|||
144365473|NCT01099267|520547566|FG000|MDS-003 Study|Secondary Malign Disease|1|||
144365474|NCT04986904|520547567|FG000|Overall Study|Lost to Follow-up|11|||
144365475|NCT04986904|520547567|FG000|Overall Study|Withdrawal by Subject|1|||
144365476|NCT03472885|520547573|FG000|24-Week Treatment Period|Adverse Event|1|||
144365477|NCT02201953|520547574|FG000|Overall Study|Randomized but Never Treated|1|||
144365478|NCT02201953|520547575|FG001|Overall Study|Randomized but Never Treated|5|||
144365479|NCT02201953|520547574|FG000|Overall Study|Lack of Efficacy|9|||
144365480|NCT02201953|520547575|FG001|Overall Study|Lack of Efficacy|30|||
144365481|NCT02201953|520547574|FG000|Overall Study|Lost to Follow-up|8|||
144365482|NCT02201953|520547575|FG001|Overall Study|Lost to Follow-up|8|||
144365483|NCT02201953|520547574|FG000|Overall Study|Withdrew Consent|2|||
144365484|NCT02201953|520547575|FG001|Overall Study|Withdrew Consent|5|||
144365485|NCT02201953|520547574|FG000|Overall Study|Adverse Event|0|||
144365486|NCT02201953|520547575|FG001|Overall Study|Adverse Event|5|||
144365487|NCT02201953|520547574|FG000|Overall Study|Death|0|||
144365488|NCT02201953|520547575|FG001|Overall Study|Death|3|||
144365489|NCT01710501|520549262|FG000|Overall Study|Lost to Follow-up|2|||
144365490|NCT01710501|520549263|FG001|Overall Study|Lost to Follow-up|0|||
144365491|NCT01710501|520549264|FG002|Overall Study|Lost to Follow-up|0|||
144365492|NCT02144610|520549267|FG000|Overall Study|Physician Decision|1|||
144365493|NCT02144610|520549268|FG001|Overall Study|Physician Decision|0|||
144365494|NCT02144610|520549267|FG000|Overall Study|Withdrawal by Subject|1|||
144365495|NCT02144610|520549268|FG001|Overall Study|Withdrawal by Subject|5|||
144365496|NCT02144610|520549267|FG000|Overall Study|Death|2|||
144365497|NCT02144610|520549268|FG001|Overall Study|Death|2|||
144365498|NCT02144610|520549267|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
144365499|NCT02144610|520549268|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
144365500|NCT02144610|520549267|FG000|Overall Study|Other|0|||
144365501|NCT02144610|520549268|FG001|Overall Study|Other|1|||
144365502|NCT01198795|520549279|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
144365503|NCT01198795|520549279|FG000|Overall Study|Withdrawal by Subject|17|||
144365504|NCT01198795|520549279|FG000|Overall Study|Lost to Follow-up|15|||
144365505|NCT01198795|520549279|FG000|Overall Study|Adverse Event|9|||
144365506|NCT01198795|520549279|FG000|Overall Study|Lack of Efficacy|5|||
144365507|NCT01198795|520549279|FG000|Overall Study|Protocol Violation|2|||
144365508|NCT01198795|520549279|FG000|Overall Study|Other Reason|4|||
144365509|NCT02131259|520549287|FG000|Overall Study|Progressive disease|751|||
144365510|NCT02131259|520549287|FG000|Overall Study|Adverse Event|341|||
144365511|NCT02131259|520549287|FG000|Overall Study|Lost to Follow-up|7|||
144365512|NCT02131259|520549287|FG000|Overall Study|Relocation|32|||
144365513|NCT02131259|520549287|FG000|Overall Study|Other|63|||
144365514|NCT02131259|520549287|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
144365515|NCT02131259|520549287|FG000|Overall Study|Progressive disease/relocation|1|||
144365516|NCT02131259|520549287|FG000|Overall Study|Progressive disease/other|2|||
144365517|NCT02131259|520549287|FG000|Overall Study|AE/lost to follow-up|1|||
144365518|NCT02131259|520549287|FG000|Overall Study|AE/other|1|||
144365519|NCT02131259|520549287|FG000|Overall Study|Progressive disease/AE/other|1|||
144365520|NCT02131259|520549287|FG000|Overall Study|Missing|3|||
144365521|NCT02796170|520549288|FG000|Overall Study|Lost to Follow-up|3|||
144365522|NCT02796170|520549289|FG001|Overall Study|Lost to Follow-up|0|||
144365523|NCT01055197|520549298|FG000|Overall Study|Protocol Violation|7|||
144365524|NCT01055197|520549299|FG001|Overall Study|Protocol Violation|2|||
144365525|NCT01055197|520549298|FG000|Overall Study|Withdrawal by Subject|2|||
144365526|NCT01055197|520549299|FG001|Overall Study|Withdrawal by Subject|0|||
144365527|NCT00538902|520549300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
144365528|NCT00538902|520549301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
144365529|NCT00538902|520549302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
144365530|NCT00538902|520549300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
144365531|NCT00538902|520549301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
144365532|NCT00538902|520549302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
144365533|NCT00538902|520549300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
144365534|NCT00538902|520549301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
144365535|NCT00538902|520549302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
144365536|NCT00538902|520549300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
144365537|NCT00538902|520549301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
144479669|NCT00089895|520955095|FG000|Overall Study|Not otherwise specified|4|||
144479670|NCT00089895|520955096|FG001|Overall Study|Not otherwise specified|8|||
144365538|NCT00538902|520549302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
144365539|NCT00538902|520549300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
144365540|NCT00538902|520549301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
144365541|NCT00538902|520549302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
144365542|NCT00538902|520549300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
144365543|NCT00538902|520549301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
144365544|NCT00538902|520549302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
144365545|NCT00538902|520549300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
144365546|NCT00538902|520549301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
144703813|NCT00648739|521768758|FG005|Overall Study|Follow-up Visits Not Completed|0|||
144703814|NCT00648739|521768759|FG006|Overall Study|Follow-up Visits Not Completed|0|||
144703815|NCT03387423|521768760|FG000|Overall Study|Lost to Follow-up|16|||
144703816|NCT03387423|521768761|FG001|Overall Study|Lost to Follow-up|12|||
144703817|NCT03387423|521768762|FG002|Overall Study|Lost to Follow-up|1|||
144703818|NCT03387423|521768763|FG003|Overall Study|Lost to Follow-up|0|||
144703819|NCT03387423|521768760|FG000|Overall Study|Other|0|||
144703820|NCT03387423|521768761|FG001|Overall Study|Other|3|||
144703821|NCT03387423|521768762|FG002|Overall Study|Other|0|||
144703822|NCT03387423|521768763|FG003|Overall Study|Other|0|||
144365547|NCT00538902|520549302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
144365548|NCT00538902|520549300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
144365549|NCT00538902|520549301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
144365550|NCT00538902|520549302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
144365551|NCT03131570|520549303|FG000|Overall Study|Adverse Event|1|||
144365552|NCT03131570|520549304|FG001|Overall Study|Adverse Event|0|||
144365553|NCT02000440|520549307|FG000|Overall Study|Adverse Event|3|||
144365554|NCT02000440|520549307|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
144365555|NCT00871975|520549309|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
144365556|NCT00871975|520549309|FG000|Overall Study|Catheters could not be inserted|1|||
144365557|NCT00871975|520549309|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
144365558|NCT00871975|520549309|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
144365559|NCT01690143|520549310|FG000|Overall Study|Withdrawal by Subject|1|||
144365560|NCT03113487|520549314|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
144365561|NCT04298697|520549325|FG000|Overall Study|Lost to Follow-up|5|||
144365562|NCT04298697|520549326|FG001|Overall Study|Lost to Follow-up|5|||
144365563|NCT04298697|520549327|FG002|Overall Study|Lost to Follow-up|1|||
144365564|NCT04298697|520549328|FG003|Overall Study|Lost to Follow-up|0|||
144365565|NCT04298697|520549325|FG000|Overall Study|Withdrawal by Subject|0|||
144365566|NCT04298697|520549326|FG001|Overall Study|Withdrawal by Subject|3|||
144365567|NCT04298697|520549327|FG002|Overall Study|Withdrawal by Subject|2|||
144365568|NCT04298697|520549328|FG003|Overall Study|Withdrawal by Subject|3|||
144365569|NCT01498068|520549331|FG000|Overall Study|Withdrawal by Subject|1|||
144365570|NCT01498068|520549332|FG001|Overall Study|Withdrawal by Subject|1|||
144365571|NCT00198822|520549334|FG000|Overall Study|Lost to Follow-up|14|||
144365572|NCT00198822|520549335|FG001|Overall Study|Lost to Follow-up|20|||
144365573|NCT00198822|520549336|FG002|Overall Study|Lost to Follow-up|21|||
144365574|NCT00453206|520549339|FG000|Overall Study|Death|1|||
144365575|NCT03058146|520549345|FG000|Overall Study|Withdrawal by Subject|4|||
144365576|NCT03058146|520549346|FG001|Overall Study|Withdrawal by Subject|1|||
144365577|NCT03058146|520549345|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
144365578|NCT03058146|520549346|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
144365579|NCT00632229|520549347|FG000|Overall Study|Adverse Event|6|||
144365580|NCT00632229|520549348|FG001|Overall Study|Adverse Event|0|||
144365581|NCT00632229|520549347|FG000|Overall Study|Lost to Follow-up|0|||
144365582|NCT00632229|520549348|FG001|Overall Study|Lost to Follow-up|3|||
144365583|NCT00632229|520549347|FG000|Overall Study|Lack of Efficacy|0|||
144365584|NCT00632229|520549348|FG001|Overall Study|Lack of Efficacy|2|||
144365585|NCT00632229|520549347|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
144365586|NCT00632229|520549348|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
144365587|NCT00577889|520549350|FG000|Overall Study|Withdrawal by Subject|1|||
144365588|NCT00577889|520549351|FG001|Overall Study|Withdrawal by Subject|0|||
144365589|NCT00577889|520549352|FG002|Overall Study|Withdrawal by Subject|0|||
144365590|NCT00993967|520549356|FG000|Overall Study|Adverse Event|8|||
144365591|NCT00993967|520549356|FG000|Overall Study|Death|1|||
144365592|NCT00993967|520549356|FG000|Overall Study|Lost to Follow-up|14|||
144365593|NCT00993967|520549356|FG000|Overall Study|Withdrawal by Subject|36|||
144365594|NCT00993967|520549356|FG000|Overall Study|Protocol Violation|2|||
144365595|NCT01467960|520549357|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
144365596|NCT01467960|520549358|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
144365597|NCT01467960|520549359|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
144365598|NCT01467960|520549360|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
144365599|NCT01467960|520549361|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
144365600|NCT01467960|520549362|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
144365601|NCT00737672|520549369|FG000|Overall Study|Graft Abandonment|48|||
144703823|NCT03387423|521768760|FG000|Overall Study|Administrative Reason|166|||
144365602|NCT00737672|520549370|FG001|Overall Study|Graft Abandonment|56|||
144365603|NCT00737672|520549369|FG000|Overall Study|Death|23|||
144365604|NCT00737672|520549370|FG001|Overall Study|Death|22|||
144365605|NCT00737672|520549369|FG000|Overall Study|Withdrawal by Subject|1|||
144365606|NCT00737672|520549370|FG001|Overall Study|Withdrawal by Subject|2|||
144703824|NCT03387423|521768761|FG001|Overall Study|Administrative Reason|89|||
144703825|NCT03387423|521768762|FG002|Overall Study|Administrative Reason|17|||
144703826|NCT03387423|521768763|FG003|Overall Study|Administrative Reason|19|||
144703827|NCT03387423|521768760|FG000|Overall Study|Revocation Consent|76|||
144703828|NCT03387423|521768761|FG001|Overall Study|Revocation Consent|32|||
144703829|NCT03387423|521768762|FG002|Overall Study|Revocation Consent|3|||
144703830|NCT03387423|521768763|FG003|Overall Study|Revocation Consent|5|||
144703831|NCT03862807|521768764|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
144365607|NCT00737672|520549369|FG000|Overall Study|Lost to Follow-up|1|||
144365608|NCT00737672|520549370|FG001|Overall Study|Lost to Follow-up|0|||
144365609|NCT00737672|520549369|FG000|Overall Study|Miscellaneous|7|||
144365610|NCT00737672|520549370|FG001|Overall Study|Miscellaneous|1|||
144365611|NCT00737672|520549369|FG000|Overall Study|Physician Decision|0|||
144365612|NCT00737672|520549370|FG001|Overall Study|Physician Decision|2|||
144365613|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
144365614|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
144365615|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
144703832|NCT04362761|521768765|FG000|Part A (48 Weeks)|Adverse Event|2|||
144703833|NCT04362761|521768765|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
144703834|NCT04362761|521768765|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
144703835|NCT04362761|521768765|FG000|Part A (48 Weeks)|Other|5|||
144365616|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
144365617|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Adverse Event|2|||
144365618|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Adverse Event|5|||
144365619|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Adverse Event|1|||
144365620|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Adverse Event|2|||
144365621|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Death|13|||
144365622|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Death|17|||
144365623|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Death|1|||
144365624|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Death|0|||
144365625|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
144365626|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
144365627|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
144365628|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
144365629|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Disease Progression|2|||
144365630|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Disease Progression|0|||
144365631|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Disease Progression|0|||
144365632|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Disease Progression|0|||
144365633|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
144365634|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
144365635|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
144365636|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
144365637|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
144365638|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
144365639|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
144365640|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
144365641|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
144365642|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
144365643|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
144365644|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
144365645|NCT03955146|520549373|FG000|DB Period (48 Weeks)|Participant Decision|9|||
144365646|NCT03955146|520549374|FG001|DB Period (48 Weeks)|Participant Decision|12|||
144365647|NCT03955146|520549375|FG002|DB Period (48 Weeks)|Participant Decision|1|||
144365648|NCT03955146|520549376|FG003|DB Period (48 Weeks)|Participant Decision|1|||
144365649|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
144365650|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
144365651|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
144365652|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
144365653|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
144703836|NCT04362761|521768765|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
144703837|NCT04362761|521768765|FG000|Part B (86 Weeks)|Other|4|||
144703838|NCT03286400|521768768|FG000|Overall Study|Death|10|||
144703839|NCT03286400|521768768|FG000|Overall Study|Lost to Follow-up|10|||
144703840|NCT03286400|521768768|FG000|Overall Study|Physician Decision|1|||
144703841|NCT03286400|521768768|FG000|Overall Study|Scheduling difficulty|4|||
144703842|NCT03576131|521768771|FG000|Overall Study|Investigator decision|0|||
144703843|NCT03576131|521768772|FG001|Overall Study|Investigator decision|0|||
144365654|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
144365655|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
144365656|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
144365657|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
144365658|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
144365659|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
144365660|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
144365661|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
144365662|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
144365663|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
144365664|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
144365665|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
144365666|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
144365667|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
144365668|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
144365669|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
144365670|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
144365671|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
144365672|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
144365673|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
144365674|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
144365675|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
144365676|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
144365677|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
144365678|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
144365679|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
144365680|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
144365681|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
144365682|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
144365683|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
144365684|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
144365685|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
144365686|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
144365687|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
144365688|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
144365689|NCT03955146|520549373|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
144365690|NCT03955146|520549374|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
144365691|NCT03955146|520549375|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
144365692|NCT03955146|520549376|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
144365693|NCT02002598|520549379|FG000|Dose Level 1|Withdrawal by Subject|1|||
144365694|NCT02002598|520549380|FG001|Dose Level 1|Withdrawal by Subject|0|||
144365695|NCT02002598|520549381|FG002|Dose Level 1|Withdrawal by Subject|0|||
144365696|NCT02002598|520549382|FG003|Dose Level 1|Withdrawal by Subject|0|||
144365697|NCT02002598|520549383|FG004|Dose Level 1|Withdrawal by Subject|0|||
144365698|NCT02628873|520549384|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
144365699|NCT02628873|520549385|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
144365700|NCT02628873|520549384|FG000|Second Test (1 Hour)|Physician Decision|1|||
144365701|NCT02628873|520549385|FG001|Second Test (1 Hour)|Physician Decision|0|||
144365702|NCT00541658|520549386|FG000|Overall Study|Adverse Event|28|||
144365703|NCT00541658|520549387|FG001|Overall Study|Adverse Event|37|||
144365704|NCT00541658|520549388|FG002|Overall Study|Adverse Event|25|||
144365705|NCT00541658|520549386|FG000|Overall Study|Physician Decision|0|||
144365706|NCT00541658|520549387|FG001|Overall Study|Physician Decision|0|||
144365707|NCT00541658|520549388|FG002|Overall Study|Physician Decision|4|||
144365708|NCT00541658|520549386|FG000|Overall Study|Lost to Follow-up|3|||
144365709|NCT00541658|520549387|FG001|Overall Study|Lost to Follow-up|3|||
144365710|NCT00541658|520549388|FG002|Overall Study|Lost to Follow-up|6|||
144365711|NCT00541658|520549386|FG000|Overall Study|Protocol Violation|0|||
144365712|NCT00541658|520549387|FG001|Overall Study|Protocol Violation|1|||
144365713|NCT00541658|520549388|FG002|Overall Study|Protocol Violation|1|||
144365714|NCT00541658|520549386|FG000|Overall Study|Withdrawal by Subject|28|||
144365715|NCT00541658|520549387|FG001|Overall Study|Withdrawal by Subject|32|||
144365716|NCT00541658|520549388|FG002|Overall Study|Withdrawal by Subject|32|||
144365717|NCT00541658|520549386|FG000|Overall Study|Took No Study Drug|1|||
144365718|NCT00541658|520549387|FG001|Overall Study|Took No Study Drug|0|||
144365719|NCT00541658|520549388|FG002|Overall Study|Took No Study Drug|0|||
144365720|NCT04123470|520549391|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
144365721|NCT04123470|520549392|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
144365722|NCT04123470|520549391|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
144365723|NCT04123470|520549392|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
144365724|NCT04123470|520549391|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
144365725|NCT04123470|520549392|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
144365726|NCT04123470|520549391|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
144703844|NCT03576131|521768773|FG002|Overall Study|Investigator decision|0|||
144703845|NCT03576131|521768774|FG003|Overall Study|Investigator decision|1|||
144365727|NCT04123470|520549392|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
144365728|NCT05972993|520549406|FG000|Overall Study|Lost to Follow-up|2|||
144365729|NCT05972993|520549407|FG001|Overall Study|Lost to Follow-up|0|||
144365730|NCT05972993|520549408|FG002|Overall Study|Lost to Follow-up|1|||
144365731|NCT05972993|520549409|FG003|Overall Study|Lost to Follow-up|0|||
144365732|NCT05972993|520549410|FG004|Overall Study|Lost to Follow-up|0|||
144365733|NCT05972993|520549411|FG005|Overall Study|Lost to Follow-up|0|||
144365734|NCT05972993|520549412|FG006|Overall Study|Lost to Follow-up|0|||
144365735|NCT05972993|520549413|FG007|Overall Study|Lost to Follow-up|2|||
144365736|NCT05972993|520549414|FG008|Overall Study|Lost to Follow-up|0|||
144365737|NCT03866577|520549417|FG000|Overall Study|Protocol Violation|0|||
144365738|NCT03866577|520549418|FG001|Overall Study|Protocol Violation|0|||
144365739|NCT03866577|520549419|FG002|Overall Study|Protocol Violation|0|||
144365740|NCT03866577|520549420|FG003|Overall Study|Protocol Violation|0|||
144365741|NCT03866577|520549421|FG004|Overall Study|Protocol Violation|0|||
144365742|NCT03866577|520549422|FG005|Overall Study|Protocol Violation|0|||
144365743|NCT03866577|520549423|FG006|Overall Study|Protocol Violation|0|||
144365744|NCT03866577|520549424|FG007|Overall Study|Protocol Violation|0|||
144365745|NCT03866577|520549425|FG008|Overall Study|Protocol Violation|0|||
144365746|NCT03866577|520549426|FG009|Overall Study|Protocol Violation|0|||
144365747|NCT03866577|520549427|FG010|Overall Study|Protocol Violation|0|||
144365748|NCT03866577|520549428|FG011|Overall Study|Protocol Violation|1|||
144365749|NCT03866577|520549429|FG012|Overall Study|Protocol Violation|0|||
144365750|NCT03866577|520549417|FG000|Overall Study|Withdrawal by Subject|0|||
144365751|NCT03866577|520549418|FG001|Overall Study|Withdrawal by Subject|0|||
144365752|NCT03866577|520549419|FG002|Overall Study|Withdrawal by Subject|0|||
144365753|NCT03866577|520549420|FG003|Overall Study|Withdrawal by Subject|0|||
144365754|NCT03866577|520549421|FG004|Overall Study|Withdrawal by Subject|0|||
144365755|NCT03866577|520549422|FG005|Overall Study|Withdrawal by Subject|0|||
144365756|NCT03866577|520549423|FG006|Overall Study|Withdrawal by Subject|0|||
144365757|NCT03866577|520549424|FG007|Overall Study|Withdrawal by Subject|0|||
144365758|NCT03866577|520549425|FG008|Overall Study|Withdrawal by Subject|1|||
144365759|NCT03866577|520549426|FG009|Overall Study|Withdrawal by Subject|1|||
144365760|NCT03866577|520549427|FG010|Overall Study|Withdrawal by Subject|0|||
144365761|NCT03866577|520549428|FG011|Overall Study|Withdrawal by Subject|0|||
144365762|NCT03866577|520549429|FG012|Overall Study|Withdrawal by Subject|0|||
144365763|NCT03866577|520549417|FG000|Overall Study|Not qualified for IVIg infusion|0|||
144365764|NCT03866577|520549418|FG001|Overall Study|Not qualified for IVIg infusion|0|||
144365765|NCT03866577|520549419|FG002|Overall Study|Not qualified for IVIg infusion|0|||
144365766|NCT03866577|520549420|FG003|Overall Study|Not qualified for IVIg infusion|0|||
144365767|NCT03866577|520549421|FG004|Overall Study|Not qualified for IVIg infusion|0|||
144365768|NCT03866577|520549422|FG005|Overall Study|Not qualified for IVIg infusion|0|||
144365769|NCT03866577|520549423|FG006|Overall Study|Not qualified for IVIg infusion|0|||
144365770|NCT03866577|520549424|FG007|Overall Study|Not qualified for IVIg infusion|0|||
144365771|NCT03866577|520549425|FG008|Overall Study|Not qualified for IVIg infusion|0|||
144365772|NCT03866577|520549426|FG009|Overall Study|Not qualified for IVIg infusion|1|||
144365773|NCT03866577|520549427|FG010|Overall Study|Not qualified for IVIg infusion|0|||
144365774|NCT03866577|520549428|FG011|Overall Study|Not qualified for IVIg infusion|0|||
144365775|NCT03866577|520549429|FG012|Overall Study|Not qualified for IVIg infusion|0|||
144365776|NCT05523089|520549431|FG000|Overall Study|Withdrawal by Subject|1|||
144365777|NCT05523089|520549432|FG001|Overall Study|Withdrawal by Subject|0|||
144365778|NCT05523089|520549433|FG002|Overall Study|Withdrawal by Subject|0|||
144365779|NCT05523089|520549431|FG000|Overall Study|Lost to Follow-up|1|||
144365780|NCT05523089|520549432|FG001|Overall Study|Lost to Follow-up|0|||
144365781|NCT05523089|520549433|FG002|Overall Study|Lost to Follow-up|0|||
144365782|NCT02514083|520549434|FG000|Overall Study|Adverse Event|1|||
144365783|NCT01899040|520549435|FG000|Overall Study|Randomized in error|0|||
144365784|NCT01899040|520549436|FG001|Overall Study|Randomized in error|1|||
144365785|NCT01899040|520549437|FG002|Overall Study|Randomized in error|1|||
144365786|NCT01899040|520549435|FG000|Overall Study|Adverse Event|3|||
144365787|NCT01899040|520549436|FG001|Overall Study|Adverse Event|1|||
144365788|NCT01899040|520549437|FG002|Overall Study|Adverse Event|2|||
144365789|NCT01899040|520549435|FG000|Overall Study|Unspecified reasons|4|||
144703846|NCT03576131|521768775|FG004|Overall Study|Investigator decision|0|||
144703847|NCT03576131|521768776|FG005|Overall Study|Investigator decision|1|||
144365790|NCT01899040|520549436|FG001|Overall Study|Unspecified reasons|4|||
144365791|NCT01899040|520549437|FG002|Overall Study|Unspecified reasons|0|||
144365792|NCT01899040|520549435|FG000|Overall Study|Compliance issues|1|||
144365793|NCT01899040|520549436|FG001|Overall Study|Compliance issues|2|||
144365794|NCT01899040|520549437|FG002|Overall Study|Compliance issues|0|||
144365795|NCT02083354|520551430|FG000|Overall Study|Withdrawal by Subject|9|||
144365796|NCT02083354|520551430|FG000|Overall Study|Lost to Follow-up|1|||
144365797|NCT02083354|520551430|FG000|Overall Study|Adverse Event|3|||
144365798|NCT02083354|520551430|FG000|Overall Study|Disease progression|46|||
144365799|NCT02083354|520551430|FG000|Overall Study|Study closed/terminated|5|||
144365800|NCT02066181|520551445|FG000|Overall Study|Withdrawal by Subject|1|||
144365801|NCT02066181|520551446|FG001|Overall Study|Withdrawal by Subject|1|||
144365802|NCT02141295|520551450|FG000|Overall Study|Adverse Event|1|||
144365803|NCT02141295|520551451|FG001|Overall Study|Adverse Event|18|||
144365804|NCT02141295|520551452|FG002|Overall Study|Adverse Event|11|||
144365805|NCT02141295|520551450|FG000|Overall Study|Physician Decision|2|||
144365806|NCT02141295|520551451|FG001|Overall Study|Physician Decision|19|||
144365807|NCT02141295|520551452|FG002|Overall Study|Physician Decision|14|||
144365808|NCT02141295|520551450|FG000|Overall Study|Study terminated by sponsor|0|||
144365809|NCT02141295|520551451|FG001|Overall Study|Study terminated by sponsor|6|||
144365810|NCT02141295|520551452|FG002|Overall Study|Study terminated by sponsor|6|||
144365811|NCT02141295|520551450|FG000|Overall Study|Non-compliance|0|||
144365812|NCT02141295|520551451|FG001|Overall Study|Non-compliance|1|||
144365813|NCT02141295|520551452|FG002|Overall Study|Non-compliance|0|||
144365814|NCT02141295|520551450|FG000|Overall Study|Progressive disease|3|||
144365815|NCT02141295|520551451|FG001|Overall Study|Progressive disease|32|||
144365816|NCT02141295|520551452|FG002|Overall Study|Progressive disease|50|||
144365817|NCT02141295|520551450|FG000|Overall Study|Reason not specified|0|||
144365818|NCT02141295|520551451|FG001|Overall Study|Reason not specified|9|||
144365819|NCT02141295|520551452|FG002|Overall Study|Reason not specified|10|||
144365820|NCT02141295|520551450|FG000|Overall Study|Withdrawal by Subject|0|||
144365821|NCT02141295|520551451|FG001|Overall Study|Withdrawal by Subject|9|||
144365822|NCT02141295|520551452|FG002|Overall Study|Withdrawal by Subject|4|||
144365823|NCT02536976|520551453|FG000|Overall Study|Physician Decision|0|||
144365824|NCT02536976|520551454|FG001|Overall Study|Physician Decision|1|||
144365825|NCT00214201|520551455|FG000|Overall Study|Withdrawal by Subject|2|||
144365826|NCT00214201|520551456|FG001|Overall Study|Withdrawal by Subject|0|||
144365827|NCT00214201|520551455|FG000|Overall Study|Death|0|||
144365828|NCT00214201|520551456|FG001|Overall Study|Death|2|||
144365829|NCT01432730|520551457|FG000|Period 1|Adverse Event|2|||
144365830|NCT01432730|520551458|FG001|Period 1|Adverse Event|0|||
144365831|NCT01432730|520551457|FG000|Period 2|Adverse Event|0|||
144365832|NCT01432730|520551458|FG001|Period 2|Adverse Event|4|||
144365833|NCT03038100|520551463|FG000|Overall Study|Death|289|||
144365834|NCT03038100|520551464|FG001|Overall Study|Death|272|||
144365835|NCT03038100|520551463|FG000|Overall Study|Lost to Follow-up|9|||
144365836|NCT03038100|520551464|FG001|Overall Study|Lost to Follow-up|10|||
144365837|NCT03038100|520551463|FG000|Overall Study|Protocol Deviation|1|||
144365838|NCT03038100|520551464|FG001|Overall Study|Protocol Deviation|4|||
144365839|NCT03038100|520551463|FG000|Overall Study|Withdrawal by Subject|45|||
144365840|NCT03038100|520551464|FG001|Overall Study|Withdrawal by Subject|51|||
144365841|NCT03038100|520551463|FG000|Overall Study|Study Terminated By Sponsor|305|||
144365842|NCT03038100|520551464|FG001|Overall Study|Study Terminated By Sponsor|311|||
144365843|NCT03038100|520551463|FG000|Overall Study|Physician Decision|1|||
144365844|NCT03038100|520551464|FG001|Overall Study|Physician Decision|3|||
144365845|NCT03250273|520551465|FG000|Overall Study|Disease Progression|2|||
144365846|NCT03250273|520551466|FG001|Overall Study|Disease Progression|11|||
144365847|NCT03250273|520551465|FG000|Overall Study|Death|0|||
144365848|NCT03250273|520551466|FG001|Overall Study|Death|1|||
144365849|NCT04154904|520551467|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
144365850|NCT04154904|520551468|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
144365851|NCT04154904|520551469|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
144365852|NCT02392624|520551470|FG000|Overall Study|Withdrawal by Subject|15|||
144365853|NCT02392624|520551471|FG001|Overall Study|Withdrawal by Subject|12|||
144365854|NCT02392624|520551472|FG002|Overall Study|Withdrawal by Subject|9|||
144365855|NCT02392624|520551470|FG000|Overall Study|Adverse Event|4|||
144365856|NCT02392624|520551471|FG001|Overall Study|Adverse Event|1|||
144365857|NCT02392624|520551472|FG002|Overall Study|Adverse Event|2|||
144365858|NCT02392624|520551470|FG000|Overall Study|Pregnancy|1|||
144365859|NCT02392624|520551471|FG001|Overall Study|Pregnancy|0|||
144365860|NCT02392624|520551472|FG002|Overall Study|Pregnancy|0|||
144365861|NCT02392624|520551470|FG000|Overall Study|Protocol Violation|0|||
144365862|NCT02392624|520551471|FG001|Overall Study|Protocol Violation|0|||
144365863|NCT02392624|520551472|FG002|Overall Study|Protocol Violation|1|||
144365864|NCT02392624|520551470|FG000|Overall Study|Sponsor/Investigator Decision|2|||
144365865|NCT02392624|520551471|FG001|Overall Study|Sponsor/Investigator Decision|1|||
144365866|NCT02392624|520551472|FG002|Overall Study|Sponsor/Investigator Decision|0|||
144703848|NCT03576131|521768777|FG006|Overall Study|Investigator decision|0|||
144703849|NCT03576131|521768778|FG007|Overall Study|Investigator decision|0|||
144365867|NCT02392624|520551470|FG000|Overall Study|Other|49|||
144365868|NCT02392624|520551471|FG001|Overall Study|Other|1|||
144365869|NCT02392624|520551472|FG002|Overall Study|Other|1|||
144365870|NCT00706238|520551473|FG000|Overall Study|Disease progression|4|||
144365871|NCT00706238|520551473|FG000|Overall Study|Other|1|||
144703850|NCT03576131|521768771|FG000|Overall Study|Withdrawal by Subject|1|||
144365872|NCT00936715|520551474|FG000|Overall Study|Investigators Discretion|1|||
144365873|NCT00936715|520551474|FG000|Overall Study|Protocol Violation|1|||
144365874|NCT00936715|520551474|FG000|Overall Study|Safety or Tolerability Reasons|4|||
144365875|NCT02492763|520551475|FG000|Overall Study|Withdrawal by Subject|0|||
144365876|NCT02492763|520551476|FG001|Overall Study|Withdrawal by Subject|2|||
144365877|NCT02492763|520551477|FG002|Overall Study|Withdrawal by Subject|1|||
144365878|NCT02492763|520551478|FG003|Overall Study|Withdrawal by Subject|0|||
144365879|NCT02492763|520551475|FG000|Overall Study|Adverse Event|3|||
144365880|NCT02492763|520551476|FG001|Overall Study|Adverse Event|1|||
144365881|NCT02492763|520551477|FG002|Overall Study|Adverse Event|1|||
144365882|NCT02492763|520551478|FG003|Overall Study|Adverse Event|2|||
144365883|NCT02492763|520551475|FG000|Overall Study|Death|0|||
144365884|NCT02492763|520551476|FG001|Overall Study|Death|0|||
144365885|NCT02492763|520551477|FG002|Overall Study|Death|1|||
144365886|NCT02492763|520551478|FG003|Overall Study|Death|0|||
144365887|NCT02492763|520551475|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
144365888|NCT02492763|520551476|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
144365889|NCT02492763|520551477|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
144365890|NCT02492763|520551478|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
144365891|NCT02492763|520551475|FG000|Overall Study|Lost to Follow-up|0|||
144365892|NCT02492763|520551476|FG001|Overall Study|Lost to Follow-up|0|||
144365893|NCT02492763|520551477|FG002|Overall Study|Lost to Follow-up|1|||
144365894|NCT02492763|520551478|FG003|Overall Study|Lost to Follow-up|0|||
144365895|NCT02492763|520551475|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144365896|NCT02492763|520551476|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144365897|NCT02492763|520551477|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144365898|NCT02492763|520551478|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144365899|NCT02492763|520551475|FG000|Overall Study|Screen Failure|0|||
144365900|NCT02492763|520551476|FG001|Overall Study|Screen Failure|0|||
144365901|NCT02492763|520551477|FG002|Overall Study|Screen Failure|0|||
144365902|NCT02492763|520551478|FG003|Overall Study|Screen Failure|1|||
144365903|NCT02492763|520551475|FG000|Overall Study|Study Terminated by Sponsor|13|||
144365904|NCT02492763|520551476|FG001|Overall Study|Study Terminated by Sponsor|10|||
144365905|NCT02492763|520551477|FG002|Overall Study|Study Terminated by Sponsor|6|||
144365906|NCT02492763|520551478|FG003|Overall Study|Study Terminated by Sponsor|10|||
144365907|NCT01337960|520551479|FG000|Overall Study|Lost to Follow-up|1|||
144365908|NCT01337960|520551480|FG001|Overall Study|Lost to Follow-up|0|||
144365909|NCT01337960|520551481|FG002|Overall Study|Lost to Follow-up|0|||
144365910|NCT01337960|520551479|FG000|Overall Study|Withdrawal by Subject|1|||
144365911|NCT01337960|520551480|FG001|Overall Study|Withdrawal by Subject|0|||
144365912|NCT01337960|520551481|FG002|Overall Study|Withdrawal by Subject|0|||
144365913|NCT03877510|520551482|FG000|Overall Study|Death|6|||
144365914|NCT03877510|520551482|FG000|Overall Study|Lost to Follow-up|2|||
144365915|NCT03877510|520551482|FG000|Overall Study|Non-compliance with study drug|2|||
144365916|NCT03877510|520551482|FG000|Overall Study|Lack of Efficacy|14|||
144365917|NCT03877510|520551482|FG000|Overall Study|Adverse Event|20|||
144365918|NCT03877510|520551482|FG000|Overall Study|Withdrawal by Subject|22|||
144365919|NCT03877510|520551482|FG000|Overall Study|Miscellaneous|1|||
144365920|NCT01744977|520551483|FG000|Overall Study|Withdrawal by Subject|1|||
144365921|NCT01744977|520551484|FG001|Overall Study|Withdrawal by Subject|2|||
144365922|NCT01744977|520551483|FG000|Overall Study|Death|2|||
144365923|NCT01744977|520551484|FG001|Overall Study|Death|3|||
144365924|NCT01744977|520551483|FG000|Overall Study|Lost to Follow-up|2|||
144365925|NCT01744977|520551484|FG001|Overall Study|Lost to Follow-up|0|||
144365926|NCT01744977|520551483|FG000|Overall Study|No longer meets inclusion|6|||
144365927|NCT01744977|520551484|FG001|Overall Study|No longer meets inclusion|0|||
144365928|NCT04004988|520551485|FG000|Period 1|Physician Decision|2|||
144365929|NCT04004988|520551486|FG001|Period 1|Physician Decision|0|||
144365930|NCT04004988|520551485|FG000|Period 1|Withdrawal by Subject|0|||
144365931|NCT04004988|520551486|FG001|Period 1|Withdrawal by Subject|1|||
144365932|NCT04004988|520551485|FG000|Period 1|Adverse Event|1|||
144365933|NCT04004988|520551486|FG001|Period 1|Adverse Event|2|||
144365934|NCT00912808|520551487|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
144365935|NCT00912808|520551488|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
144365936|NCT00912808|520551487|FG000|Washout|Withdrawal by Subject|0|||
144365937|NCT00912808|520551488|FG001|Washout|Withdrawal by Subject|1|||
144365938|NCT00912808|520551487|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
144365939|NCT00912808|520551488|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
144365940|NCT00912808|520551487|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
144365941|NCT00912808|520551488|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
144365942|NCT00702221|520551489|FG000|Overall Study|Adverse Event|4|||
144703851|NCT03576131|521768772|FG001|Overall Study|Withdrawal by Subject|1|||
144703852|NCT03576131|521768773|FG002|Overall Study|Withdrawal by Subject|0|||
144365943|NCT00702221|520551490|FG001|Overall Study|Adverse Event|3|||
144365944|NCT03345784|520551493|FG000|Overall Study|Withdrawal by Subject|2|||
144365945|NCT03345784|520551494|FG001|Overall Study|Withdrawal by Subject|1|||
144703853|NCT03576131|521768774|FG003|Overall Study|Withdrawal by Subject|1|||
144703854|NCT03576131|521768775|FG004|Overall Study|Withdrawal by Subject|2|||
144365946|NCT04798196|520551495|FG000|Overall Study|Lost to Follow-up|3|||
144365947|NCT04798196|520551496|FG001|Overall Study|Lost to Follow-up|1|||
144365948|NCT04798196|520551497|FG002|Overall Study|Lost to Follow-up|3|||
144365949|NCT00482053|520551500|FG000|Inter-treatment Period|Disease progression|1|||
144365950|NCT00728689|520551503|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
144365951|NCT00728689|520551504|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
144703855|NCT03576131|521768776|FG005|Overall Study|Withdrawal by Subject|3|||
144365952|NCT00389610|520551510|FG000|Overall Study|Disease Progression|0|||
144365953|NCT00389610|520551511|FG001|Overall Study|Disease Progression|19|||
144365954|NCT00389610|520551510|FG000|Overall Study|Death|0|||
144365955|NCT00389610|520551511|FG001|Overall Study|Death|1|||
144365956|NCT00389610|520551510|FG000|Overall Study|Physician Decision|0|||
144365957|NCT00389610|520551511|FG001|Overall Study|Physician Decision|1|||
144365958|NCT00389610|520551510|FG000|Overall Study|Withdrawal by Subject|0|||
144365959|NCT00389610|520551511|FG001|Overall Study|Withdrawal by Subject|1|||
144365960|NCT00887809|520551512|FG000|Overall Study|Patient Not Treated|3|||
144365961|NCT00887809|520551513|FG001|Overall Study|Patient Not Treated|0|||
144365962|NCT00887809|520551512|FG000|Overall Study|Death|1|||
144365963|NCT00887809|520551513|FG001|Overall Study|Death|0|||
144365964|NCT01550003|520551514|FG000|Overall Study|Adverse Event|0|||
144365965|NCT01550003|520551515|FG001|Overall Study|Adverse Event|9|||
144365966|NCT01550003|520551516|FG002|Overall Study|Adverse Event|15|||
144365967|NCT01550003|520551514|FG000|Overall Study|Lack of Efficacy|4|||
144365968|NCT01550003|520551515|FG001|Overall Study|Lack of Efficacy|11|||
144365969|NCT01550003|520551516|FG002|Overall Study|Lack of Efficacy|15|||
144365970|NCT01550003|520551514|FG000|Overall Study|Protocol Violation|0|||
144365971|NCT01550003|520551515|FG001|Overall Study|Protocol Violation|3|||
144365972|NCT01550003|520551516|FG002|Overall Study|Protocol Violation|2|||
144365973|NCT01550003|520551514|FG000|Overall Study|Lost to Follow-up|1|||
144365974|NCT01550003|520551515|FG001|Overall Study|Lost to Follow-up|4|||
144365975|NCT01550003|520551516|FG002|Overall Study|Lost to Follow-up|8|||
144365976|NCT01550003|520551514|FG000|Overall Study|Consent withdrawn|2|||
144365977|NCT01550003|520551515|FG001|Overall Study|Consent withdrawn|11|||
144365978|NCT01550003|520551516|FG002|Overall Study|Consent withdrawn|23|||
144365979|NCT01550003|520551514|FG000|Overall Study|Missing|1|||
144365980|NCT01550003|520551515|FG001|Overall Study|Missing|0|||
144365981|NCT01550003|520551516|FG002|Overall Study|Missing|2|||
144365982|NCT01550003|520551514|FG000|Overall Study|Study closure as announced by sponsor|7|||
144365983|NCT01550003|520551515|FG001|Overall Study|Study closure as announced by sponsor|6|||
144365984|NCT01550003|520551516|FG002|Overall Study|Study closure as announced by sponsor|24|||
144365985|NCT01550003|520551514|FG000|Overall Study|Protocol Noncompliance|1|||
144365986|NCT01550003|520551515|FG001|Overall Study|Protocol Noncompliance|0|||
144365987|NCT01550003|520551516|FG002|Overall Study|Protocol Noncompliance|0|||
144365988|NCT01550003|520551514|FG000|Overall Study|Study closure|0|||
144365989|NCT01550003|520551515|FG001|Overall Study|Study closure|1|||
144365990|NCT01550003|520551516|FG002|Overall Study|Study closure|1|||
144365991|NCT01550003|520551514|FG000|Overall Study|Patient reached adulthood|0|||
144365992|NCT01550003|520551515|FG001|Overall Study|Patient reached adulthood|1|||
144365993|NCT01550003|520551516|FG002|Overall Study|Patient reached adulthood|0|||
144365994|NCT01550003|520551514|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
144365995|NCT01550003|520551515|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
144365996|NCT01550003|520551516|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
144365997|NCT01550003|520551514|FG000|Overall Study|Sponsor's order|0|||
144365998|NCT01550003|520551515|FG001|Overall Study|Sponsor's order|3|||
144365999|NCT01550003|520551516|FG002|Overall Study|Sponsor's order|3|||
144366000|NCT01550003|520551514|FG000|Overall Study|Sponsor's decision|1|||
144366001|NCT01550003|520551515|FG001|Overall Study|Sponsor's decision|5|||
144366002|NCT01550003|520551516|FG002|Overall Study|Sponsor's decision|4|||
144366003|NCT01550003|520551514|FG000|Overall Study|Subject mother passed away|0|||
144366004|NCT01550003|520551515|FG001|Overall Study|Subject mother passed away|1|||
144366005|NCT01550003|520551516|FG002|Overall Study|Subject mother passed away|0|||
144366006|NCT01550003|520551514|FG000|Overall Study|Discontinuation|0|||
144366007|NCT01550003|520551515|FG001|Overall Study|Discontinuation|1|||
144366008|NCT01550003|520551516|FG002|Overall Study|Discontinuation|0|||
144366009|NCT01550003|520551514|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
144366010|NCT01550003|520551515|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
144366011|NCT01550003|520551516|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
144366012|NCT01550003|520551514|FG000|Overall Study|Site closure|0|||
144366013|NCT01550003|520551515|FG001|Overall Study|Site closure|2|||
144366014|NCT01550003|520551516|FG002|Overall Study|Site closure|0|||
144366015|NCT01550003|520551514|FG000|Overall Study|Pregnancy|0|||
144703856|NCT03576131|521768777|FG006|Overall Study|Withdrawal by Subject|1|||
144366016|NCT01550003|520551515|FG001|Overall Study|Pregnancy|1|||
144366017|NCT01550003|520551516|FG002|Overall Study|Pregnancy|0|||
144366018|NCT01550003|520551514|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
144703857|NCT03576131|521768778|FG007|Overall Study|Withdrawal by Subject|0|||
144366019|NCT01550003|520551515|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
144366020|NCT01550003|520551516|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
144366021|NCT01550003|520551514|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
144366022|NCT01550003|520551515|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
144366023|NCT01550003|520551516|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
144366024|NCT01550003|520551514|FG000|Overall Study|Switching to adult rheumatologist|0|||
144366025|NCT01550003|520551515|FG001|Overall Study|Switching to adult rheumatologist|0|||
144366026|NCT01550003|520551516|FG002|Overall Study|Switching to adult rheumatologist|1|||
144366027|NCT01550003|520551514|FG000|Overall Study|Patient transition to adult care|0|||
144366028|NCT01550003|520551515|FG001|Overall Study|Patient transition to adult care|0|||
144366029|NCT01550003|520551516|FG002|Overall Study|Patient transition to adult care|1|||
144366030|NCT01550003|520551514|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
144366031|NCT01550003|520551515|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
144366032|NCT01550003|520551516|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
144366033|NCT01550003|520551514|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
144366034|NCT01550003|520551515|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
144366035|NCT01550003|520551516|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
144366036|NCT01550003|520551514|FG000|Overall Study|Per Sponsor request|1|||
144366037|NCT01550003|520551515|FG001|Overall Study|Per Sponsor request|0|||
144366038|NCT01550003|520551516|FG002|Overall Study|Per Sponsor request|1|||
144366039|NCT01550003|520551514|FG000|Overall Study|Patient not compliance|0|||
144366040|NCT01550003|520551515|FG001|Overall Study|Patient not compliance|0|||
144366041|NCT01550003|520551516|FG002|Overall Study|Patient not compliance|1|||
144366042|NCT01550003|520551514|FG000|Overall Study|Non-compliance|0|||
144366043|NCT01550003|520551515|FG001|Overall Study|Non-compliance|0|||
144366044|NCT01550003|520551516|FG002|Overall Study|Non-compliance|1|||
144366045|NCT01550003|520551514|FG000|Overall Study|Study closed|0|||
144366046|NCT01550003|520551515|FG001|Overall Study|Study closed|1|||
144366047|NCT01550003|520551516|FG002|Overall Study|Study closed|0|||
144366048|NCT01550003|520551514|FG000|Overall Study|Transitioned to adult rheumatology|0|||
144366049|NCT01550003|520551515|FG001|Overall Study|Transitioned to adult rheumatology|0|||
144366050|NCT01550003|520551516|FG002|Overall Study|Transitioned to adult rheumatology|1|||
144366051|NCT05567783|520551517|FG000|Overall Study|Death|2|||
144366052|NCT05567783|520551518|FG001|Overall Study|Death|3|||
144366053|NCT05567783|520551519|FG002|Overall Study|Death|0|||
144366054|NCT05567783|520551517|FG000|Overall Study|Lost to Follow-up|25|||
144366055|NCT05567783|520551518|FG001|Overall Study|Lost to Follow-up|19|||
144366056|NCT05567783|520551519|FG002|Overall Study|Lost to Follow-up|17|||
144366057|NCT05567783|520551517|FG000|Overall Study|Physician Decision|10|||
144366058|NCT05567783|520551518|FG001|Overall Study|Physician Decision|7|||
144366059|NCT05567783|520551519|FG002|Overall Study|Physician Decision|9|||
144366060|NCT05567783|520551517|FG000|Overall Study|Study Terminated by Sponsor|924|||
144366061|NCT05567783|520551518|FG001|Overall Study|Study Terminated by Sponsor|937|||
144366062|NCT05567783|520551519|FG002|Overall Study|Study Terminated by Sponsor|941|||
144366063|NCT05567783|520551517|FG000|Overall Study|Withdrawal by Subject|23|||
144366064|NCT05567783|520551518|FG001|Overall Study|Withdrawal by Subject|27|||
144366065|NCT05567783|520551519|FG002|Overall Study|Withdrawal by Subject|24|||
144366066|NCT05567783|520551517|FG000|Overall Study|Incarcerated|1|||
144366067|NCT05567783|520551518|FG001|Overall Study|Incarcerated|0|||
144366068|NCT05567783|520551519|FG002|Overall Study|Incarcerated|0|||
144366069|NCT05567783|520551517|FG000|Overall Study|Participant randomized in error|4|||
144366070|NCT05567783|520551518|FG001|Overall Study|Participant randomized in error|2|||
144366071|NCT05567783|520551519|FG002|Overall Study|Participant randomized in error|2|||
144366072|NCT03675126|520551522|FG000|Overall Study|Study Terminated by Sponsor|9|||
144366073|NCT03675126|520551522|FG000|Overall Study|Death|2|||
144366074|NCT03675126|520551522|FG000|Overall Study|Withdrawal by Subject|4|||
144366075|NCT00001959|520551523|FG000|Overall Study|newly diagnosed colon cancer|1|||
144366076|NCT00001959|520551523|FG000|Overall Study|disabling sedation|1|||
144366077|NCT00001959|520551523|FG000|Overall Study|non-compliance|1|||
144366078|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
144366079|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
144366080|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
144366081|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
144366082|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
144366083|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
144366084|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
144366085|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
144366086|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
144366087|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
144366088|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
144366089|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
144366090|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
144366091|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
144366092|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
144366093|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
144366094|NCT03773978|520551526|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
144366095|NCT03773978|520551527|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
144366096|NCT03773978|520551526|FG000|DBW Period|Adverse Event|2|||
144366097|NCT03773978|520551527|FG001|DBW Period|Adverse Event|2|||
144199218|NCT04221789|519928860|FG001|Overall Study|deviation from protoco|8|||
144366098|NCT03773978|520551526|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
144366099|NCT03773978|520551527|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
144366100|NCT03773978|520551526|FG000|DBW Period|Withdrawal by Subject|2|||
144366101|NCT03773978|520551527|FG001|DBW Period|Withdrawal by Subject|1|||
144366102|NCT03773978|520551526|FG000|DBW Period|Due to epidemic or pandemic|5|||
144366103|NCT03773978|520551527|FG001|DBW Period|Due to epidemic or pandemic|6|||
144366104|NCT03773978|520551526|FG000|DBW Period|Study team decision|1|||
144366105|NCT03773978|520551527|FG001|DBW Period|Study team decision|0|||
144366106|NCT03777982|520551528|FG000|Overall Study|Physician Decision|0|||
144366107|NCT03777982|520551529|FG001|Overall Study|Physician Decision|1|||
144366108|NCT03995368|520551530|FG000|Overall Study|Lost to Follow-up|1|||
144366109|NCT03995368|520551531|FG001|Overall Study|Lost to Follow-up|4|||
144366110|NCT03995368|520551532|FG002|Overall Study|Lost to Follow-up|1|||
144366111|NCT03995368|520551530|FG000|Overall Study|Did not meet inclusion criteria|1|||
144366112|NCT03995368|520551531|FG001|Overall Study|Did not meet inclusion criteria|6|||
144366113|NCT03995368|520551532|FG002|Overall Study|Did not meet inclusion criteria|3|||
144366114|NCT03995368|520551530|FG000|Overall Study|Withdrawal by Subject|0|||
144366115|NCT03995368|520551531|FG001|Overall Study|Withdrawal by Subject|1|||
144366116|NCT03995368|520551532|FG002|Overall Study|Withdrawal by Subject|1|||
144366117|NCT03592186|520551533|FG000|Overall Study|Withdrawal by Subject|1|||
144366118|NCT03592186|520551534|FG001|Overall Study|Withdrawal by Subject|0|||
144366119|NCT03592186|520551533|FG000|Overall Study|Lost to Follow-up|16|||
144366120|NCT03592186|520551534|FG001|Overall Study|Lost to Follow-up|11|||
144366121|NCT03755934|520551535|FG000|Overall Study|Adverse Event|4|||
144366122|NCT03755934|520551536|FG001|Overall Study|Adverse Event|1|||
144366123|NCT03755934|520551537|FG002|Overall Study|Adverse Event|1|||
144366124|NCT03755934|520551538|FG003|Overall Study|Adverse Event|3|||
144366125|NCT03755934|520551535|FG000|Overall Study|Physician Decision|2|||
144366126|NCT03755934|520551536|FG001|Overall Study|Physician Decision|0|||
144366127|NCT03755934|520551537|FG002|Overall Study|Physician Decision|0|||
144366128|NCT03755934|520551538|FG003|Overall Study|Physician Decision|1|||
144366129|NCT03755934|520551535|FG000|Overall Study|Withdrawal by Subject|5|||
144366130|NCT03755934|520551536|FG001|Overall Study|Withdrawal by Subject|0|||
144366131|NCT03755934|520551537|FG002|Overall Study|Withdrawal by Subject|0|||
144366132|NCT03755934|520551538|FG003|Overall Study|Withdrawal by Subject|1|||
144366133|NCT03755934|520551535|FG000|Overall Study|Other|3|||
144366134|NCT03755934|520551536|FG001|Overall Study|Other|1|||
144366135|NCT03755934|520551537|FG002|Overall Study|Other|3|||
144366136|NCT03755934|520551538|FG003|Overall Study|Other|1|||
144366137|NCT01052493|520551539|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
144366138|NCT01052493|520551540|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
144366139|NCT01052493|520551541|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
144366140|NCT00307801|520551542|FG000|Overall Study|Adverse Event|12|||
144366141|NCT00307801|520551543|FG001|Overall Study|Adverse Event|4|||
144366142|NCT00307801|520551542|FG000|Overall Study|Withdrawal by Subject|9|||
144366143|NCT00307801|520551543|FG001|Overall Study|Withdrawal by Subject|4|||
144366144|NCT00307801|520551542|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
144366145|NCT00307801|520551543|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
144366146|NCT00307801|520551542|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
144366147|NCT00307801|520551543|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
144366148|NCT00307801|520551542|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
144366149|NCT00307801|520551543|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
144366150|NCT00307801|520551542|FG000|Overall Study|Wrong Randomization|1|||
144366151|NCT00307801|520551543|FG001|Overall Study|Wrong Randomization|0|||
144366152|NCT00307801|520551542|FG000|Overall Study|Lack of Efficacy|0|||
144366153|NCT00307801|520551543|FG001|Overall Study|Lack of Efficacy|2|||
144366154|NCT00307801|520551542|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
144366155|NCT00307801|520551543|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
144366156|NCT00307801|520551542|FG000|Overall Study|Frustration with e-diary|1|||
144366157|NCT00307801|520551543|FG001|Overall Study|Frustration with e-diary|0|||
144366158|NCT00307801|520551542|FG000|Overall Study|Protocol Violation|3|||
144366159|NCT00307801|520551543|FG001|Overall Study|Protocol Violation|2|||
144366160|NCT00307801|520551542|FG000|Overall Study|No reason specified|2|||
144366161|NCT00307801|520551543|FG001|Overall Study|No reason specified|0|||
144366162|NCT00307801|520551542|FG000|Overall Study|Pregnancy|0|||
144366163|NCT00307801|520551543|FG001|Overall Study|Pregnancy|1|||
144366164|NCT03944577|520551546|FG000|Overall Study|Adverse Event|3|||
144366165|NCT04825678|520551547|FG000|Overall Study|Decision by Sponsor|2|||
144366166|NCT04825678|520551548|FG001|Overall Study|Decision by Sponsor|3|||
144366167|NCT04825678|520551547|FG000|Overall Study|Withdrawal of Consent From Study|7|||
144366168|NCT04825678|520551548|FG001|Overall Study|Withdrawal of Consent From Study|9|||
144366169|NCT04825678|520551547|FG000|Overall Study|Lost to Follow-up|3|||
144366170|NCT04825678|520551548|FG001|Overall Study|Lost to Follow-up|4|||
144366171|NCT04825678|520551547|FG000|Overall Study|Never Received Investigational Product|1|||
144366172|NCT04825678|520551548|FG001|Overall Study|Never Received Investigational Product|1|||
144366173|NCT05530252|520551549|FG000|Overall Study|Lost to Follow-up|1|||
144366174|NCT05530252|520551550|FG001|Overall Study|Lost to Follow-up|1|||
144366175|NCT05530252|520551551|FG002|Overall Study|Lost to Follow-up|1|||
144366176|NCT00651742|520551556|FG000|Overall Study|Objective Disease Progression|22|||
144366177|NCT00651742|520551556|FG000|Overall Study|Toxicity|3|||
144366178|NCT00651742|520551556|FG000|Overall Study|Investigator Judgment|1|||
144366179|NCT00651742|520551556|FG000|Overall Study|Withdrawal of Consent|1|||
144366180|NCT00651742|520551556|FG000|Overall Study|Enrolled but not treated|1|||
144366181|NCT01535040|520551558|FG000|Overall Study|Physician Decision|0|||
144366182|NCT01535040|520551559|FG001|Overall Study|Physician Decision|1|||
144366183|NCT01535040|520551558|FG000|Overall Study|Withdrawal by Subject|13|||
144366184|NCT01535040|520551559|FG001|Overall Study|Withdrawal by Subject|10|||
144366185|NCT01535040|520551558|FG000|Overall Study|Never Started|9|||
144366186|NCT01535040|520551559|FG001|Overall Study|Never Started|4|||
144366187|NCT01535040|520551558|FG000|Overall Study|Toxicity|7|||
144366188|NCT01535040|520551559|FG001|Overall Study|Toxicity|5|||
144366189|NCT01535040|520551558|FG000|Overall Study|Multiple Reasons|1|||
144366190|NCT01535040|520551559|FG001|Overall Study|Multiple Reasons|1|||
144366191|NCT01074970|520551560|FG000|Overall Study|Never Treated|0|||
144366192|NCT01074970|520551561|FG001|Overall Study|Never Treated|0|||
144366193|NCT01074970|520551562|FG002|Overall Study|Never Treated|8|||
144366194|NCT01074970|520551563|FG003|Overall Study|Never Treated|1|||
144366195|NCT01074970|520551560|FG000|Overall Study|Adverse Event|1|||
144366196|NCT01074970|520551561|FG001|Overall Study|Adverse Event|0|||
144366197|NCT01074970|520551562|FG002|Overall Study|Adverse Event|4|||
144703858|NCT03576131|521768771|FG000|Overall Study|Death|3|||
144703859|NCT03576131|521768772|FG001|Overall Study|Death|3|||
144703860|NCT03576131|521768773|FG002|Overall Study|Death|1|||
144703861|NCT03576131|521768774|FG003|Overall Study|Death|5|||
144703862|NCT03576131|521768775|FG004|Overall Study|Death|4|||
144703863|NCT03576131|521768776|FG005|Overall Study|Death|1|||
144703864|NCT03576131|521768777|FG006|Overall Study|Death|0|||
144703865|NCT03576131|521768778|FG007|Overall Study|Death|1|||
144703866|NCT03576131|521768771|FG000|Overall Study|New anti-cancer treatment|5|||
144703867|NCT03576131|521768772|FG001|Overall Study|New anti-cancer treatment|1|||
144703868|NCT03576131|521768773|FG002|Overall Study|New anti-cancer treatment|2|||
144703869|NCT03576131|521768774|FG003|Overall Study|New anti-cancer treatment|3|||
144366198|NCT01074970|520551563|FG003|Overall Study|Adverse Event|3|||
144703870|NCT03576131|521768775|FG004|Overall Study|New anti-cancer treatment|0|||
144703871|NCT03576131|521768776|FG005|Overall Study|New anti-cancer treatment|0|||
144366199|NCT01074970|520551560|FG000|Overall Study|Disease progression during treatment|3|||
144366200|NCT01074970|520551561|FG001|Overall Study|Disease progression during treatment|1|||
144366201|NCT01074970|520551562|FG002|Overall Study|Disease progression during treatment|2|||
144366202|NCT01074970|520551563|FG003|Overall Study|Disease progression during treatment|9|||
144366203|NCT01074970|520551560|FG000|Overall Study|Lost to Follow-up|0|||
144366204|NCT01074970|520551561|FG001|Overall Study|Lost to Follow-up|0|||
144703872|NCT03576131|521768777|FG006|Overall Study|New anti-cancer treatment|0|||
144703873|NCT03576131|521768778|FG007|Overall Study|New anti-cancer treatment|0|||
144366205|NCT01074970|520551562|FG002|Overall Study|Lost to Follow-up|1|||
144366206|NCT01074970|520551563|FG003|Overall Study|Lost to Follow-up|0|||
144366207|NCT01074970|520551560|FG000|Overall Study|Withdrawal by Subject|0|||
144366208|NCT01074970|520551561|FG001|Overall Study|Withdrawal by Subject|0|||
144366209|NCT01074970|520551562|FG002|Overall Study|Withdrawal by Subject|6|||
144366210|NCT01074970|520551563|FG003|Overall Study|Withdrawal by Subject|4|||
144366211|NCT00911170|520551566|FG000|Treatment Period|Randomized in error|1|||
144366212|NCT00911170|520551567|FG001|Treatment Period|Randomized in error|1|||
144366213|NCT00911170|520551566|FG000|Treatment Period|Ineligibility determined|1|||
144366214|NCT00911170|520551567|FG001|Treatment Period|Ineligibility determined|3|||
144366215|NCT00911170|520551566|FG000|Treatment Period|Protocol deviation|1|||
144366216|NCT00911170|520551567|FG001|Treatment Period|Protocol deviation|2|||
144366217|NCT00911170|520551566|FG000|Treatment Period|Adverse Event|9|||
144366218|NCT00911170|520551567|FG001|Treatment Period|Adverse Event|10|||
144366219|NCT00911170|520551566|FG000|Treatment Period|Withdrawal by Subject|4|||
144366220|NCT00911170|520551567|FG001|Treatment Period|Withdrawal by Subject|4|||
144366221|NCT00911170|520551566|FG000|Treatment Period|Disease progression|0|||
144366222|NCT00911170|520551567|FG001|Treatment Period|Disease progression|2|||
144366223|NCT00911170|520551566|FG000|Treatment Period|Physician Decision|5|||
144366224|NCT00911170|520551567|FG001|Treatment Period|Physician Decision|5|||
144366225|NCT00911170|520551566|FG000|Treatment Period|Lost to Follow-up|0|||
144366226|NCT00911170|520551567|FG001|Treatment Period|Lost to Follow-up|1|||
144366227|NCT00911170|520551566|FG000|Treatment Period|Death|6|||
144366228|NCT00911170|520551567|FG001|Treatment Period|Death|9|||
144366229|NCT00911170|520551566|FG000|Long Term Follow-Up|Continuing in study|274|||
144366230|NCT00911170|520551567|FG001|Long Term Follow-Up|Continuing in study|269|||
144366231|NCT00911170|520551566|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
144366232|NCT00911170|520551567|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
144366233|NCT00911170|520551566|FG000|Long Term Follow-Up|Physician Decision|5|||
144366234|NCT00911170|520551567|FG001|Long Term Follow-Up|Physician Decision|4|||
144366235|NCT00911170|520551566|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
144366236|NCT00911170|520551567|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
144366237|NCT00911170|520551566|FG000|Long Term Follow-Up|Death|116|||
144366238|NCT00911170|520551567|FG001|Long Term Follow-Up|Death|121|||
144366239|NCT02594124|520551568|FG000|Overall Study|Adverse Event|0|||
144366240|NCT02594124|520551569|FG001|Overall Study|Adverse Event|5|||
144366241|NCT02594124|520551570|FG002|Overall Study|Adverse Event|8|||
144366242|NCT02594124|520551571|FG003|Overall Study|Adverse Event|1|||
144366243|NCT02594124|520551572|FG004|Overall Study|Adverse Event|0|||
144366244|NCT02594124|520551573|FG005|Overall Study|Adverse Event|0|||
144366245|NCT02594124|520551574|FG006|Overall Study|Adverse Event|2|||
144366246|NCT02594124|520551575|FG007|Overall Study|Adverse Event|2|||
144366247|NCT02594124|520551576|FG008|Overall Study|Adverse Event|0|||
144366248|NCT02594124|520551568|FG000|Overall Study|Withdrawal by Subject|2|||
144366249|NCT02594124|520551569|FG001|Overall Study|Withdrawal by Subject|3|||
144366250|NCT02594124|520551570|FG002|Overall Study|Withdrawal by Subject|5|||
144366251|NCT02594124|520551571|FG003|Overall Study|Withdrawal by Subject|1|||
144366252|NCT02594124|520551572|FG004|Overall Study|Withdrawal by Subject|8|||
144366253|NCT02594124|520551573|FG005|Overall Study|Withdrawal by Subject|4|||
144366254|NCT02594124|520551574|FG006|Overall Study|Withdrawal by Subject|13|||
144366255|NCT02594124|520551575|FG007|Overall Study|Withdrawal by Subject|19|||
144366256|NCT02594124|520551576|FG008|Overall Study|Withdrawal by Subject|0|||
144366257|NCT02594124|520551568|FG000|Overall Study|Physician Decision|0|||
144366258|NCT02594124|520551569|FG001|Overall Study|Physician Decision|2|||
144366259|NCT02594124|520551570|FG002|Overall Study|Physician Decision|0|||
144366260|NCT02594124|520551571|FG003|Overall Study|Physician Decision|0|||
144366261|NCT02594124|520551572|FG004|Overall Study|Physician Decision|0|||
144366262|NCT02594124|520551573|FG005|Overall Study|Physician Decision|0|||
144703874|NCT03576131|521768771|FG000|Overall Study|Unspecified reason|0|||
144703875|NCT03576131|521768772|FG001|Overall Study|Unspecified reason|0|||
144703876|NCT03576131|521768773|FG002|Overall Study|Unspecified reason|1|||
144703877|NCT03576131|521768774|FG003|Overall Study|Unspecified reason|1|||
144703878|NCT03576131|521768775|FG004|Overall Study|Unspecified reason|1|||
144703879|NCT03576131|521768776|FG005|Overall Study|Unspecified reason|1|||
144703880|NCT03576131|521768777|FG006|Overall Study|Unspecified reason|0|||
144366263|NCT02594124|520551574|FG006|Overall Study|Physician Decision|0|||
144366264|NCT02594124|520551575|FG007|Overall Study|Physician Decision|1|||
144366265|NCT02594124|520551576|FG008|Overall Study|Physician Decision|0|||
144366266|NCT02594124|520551568|FG000|Overall Study|Commercial drug|0|||
144366267|NCT02594124|520551569|FG001|Overall Study|Commercial drug|1|||
144366268|NCT02594124|520551570|FG002|Overall Study|Commercial drug|6|||
144366269|NCT02594124|520551571|FG003|Overall Study|Commercial drug|3|||
144366270|NCT02594124|520551572|FG004|Overall Study|Commercial drug|0|||
144366271|NCT02594124|520551573|FG005|Overall Study|Commercial drug|0|||
144366272|NCT02594124|520551574|FG006|Overall Study|Commercial drug|7|||
144366273|NCT02594124|520551575|FG007|Overall Study|Commercial drug|11|||
144366274|NCT02594124|520551576|FG008|Overall Study|Commercial drug|2|||
144366275|NCT02594124|520551568|FG000|Overall Study|Reason Not Specified|1|||
144703881|NCT03576131|521768778|FG007|Overall Study|Unspecified reason|0|||
144366276|NCT02594124|520551569|FG001|Overall Study|Reason Not Specified|3|||
144366277|NCT02594124|520551570|FG002|Overall Study|Reason Not Specified|4|||
144366278|NCT02594124|520551571|FG003|Overall Study|Reason Not Specified|0|||
144366279|NCT02594124|520551572|FG004|Overall Study|Reason Not Specified|0|||
144366280|NCT02594124|520551573|FG005|Overall Study|Reason Not Specified|1|||
144366281|NCT02594124|520551574|FG006|Overall Study|Reason Not Specified|1|||
144366282|NCT02594124|520551575|FG007|Overall Study|Reason Not Specified|6|||
144366283|NCT02594124|520551576|FG008|Overall Study|Reason Not Specified|1|||
144366284|NCT01824836|520551577|FG000|Overall Study|Adverse Event|48|||
144366285|NCT01824836|520551577|FG000|Overall Study|Withdrawal by Subject|63|||
144366286|NCT01824836|520551577|FG000|Overall Study|Other complicating disease|116|||
144366287|NCT01824836|520551577|FG000|Overall Study|Disease progression|5|||
144366288|NCT01824836|520551577|FG000|Overall Study|Alternative therapy|2|||
144366289|NCT01824836|520551577|FG000|Overall Study|Depression|1|||
144366290|NCT01824836|520551577|FG000|Overall Study|Non-compliance|3|||
144366291|NCT01824836|520551577|FG000|Overall Study|Patient regained ovarian function|3|||
144366292|NCT01824836|520551577|FG000|Overall Study|Lost to Follow-up|8|||
144366293|NCT01824836|520551577|FG000|Overall Study|Physician Decision|2|||
144366294|NCT01824836|520551577|FG000|Overall Study|Research office was closed|3|||
144366295|NCT01824836|520551577|FG000|Overall Study|Relocation|3|||
144366296|NCT01824836|520551577|FG000|Overall Study|Insurance-related issue|1|||
144366297|NCT01824836|520551577|FG000|Overall Study|Transportation issue|1|||
144366298|NCT01824836|520551577|FG000|Overall Study|Patient transferred care|1|||
144366299|NCT01824836|520551577|FG000|Overall Study|Unknown reasons|4|||
144366300|NCT01824836|520551577|FG000|Overall Study|Never started treatment|16|||
144366301|NCT04323124|520551580|FG000|Overall Study|Adverse Event|0|||
144366302|NCT04323124|520551581|FG001|Overall Study|Adverse Event|0|||
144366303|NCT04323124|520551582|FG002|Overall Study|Adverse Event|0|||
144366304|NCT04323124|520551583|FG003|Overall Study|Adverse Event|0|||
144366305|NCT04323124|520551584|FG004|Overall Study|Adverse Event|0|||
144366306|NCT04323124|520551585|FG005|Overall Study|Adverse Event|1|||
144366307|NCT04323124|520551586|FG006|Overall Study|Adverse Event|0|||
144366308|NCT04323124|520551587|FG007|Overall Study|Adverse Event|1|||
144366309|NCT04323124|520551588|FG008|Overall Study|Adverse Event|1|||
144366310|NCT04323124|520551589|FG009|Overall Study|Adverse Event|0|||
144366311|NCT04323124|520551590|FG010|Overall Study|Adverse Event|0|||
144366312|NCT04323124|520551591|FG011|Overall Study|Adverse Event|0|||
144366313|NCT04323124|520551592|FG012|Overall Study|Adverse Event|0|||
144366314|NCT04323124|520551593|FG013|Overall Study|Adverse Event|0|||
144366315|NCT04323124|520551594|FG014|Overall Study|Adverse Event|0|||
144366316|NCT04323124|520551580|FG000|Overall Study|Other|0|||
144366317|NCT04323124|520551581|FG001|Overall Study|Other|0|||
144366318|NCT04323124|520551582|FG002|Overall Study|Other|0|||
144366319|NCT04323124|520551583|FG003|Overall Study|Other|0|||
144366320|NCT04323124|520551584|FG004|Overall Study|Other|1|||
144366321|NCT04323124|520551585|FG005|Overall Study|Other|0|||
144366322|NCT04323124|520551586|FG006|Overall Study|Other|0|||
144366323|NCT04323124|520551587|FG007|Overall Study|Other|0|||
144366324|NCT04323124|520551588|FG008|Overall Study|Other|1|||
144366325|NCT04323124|520551589|FG009|Overall Study|Other|0|||
144366326|NCT04323124|520551590|FG010|Overall Study|Other|0|||
144366327|NCT04323124|520551591|FG011|Overall Study|Other|0|||
144366328|NCT04323124|520551592|FG012|Overall Study|Other|0|||
144366329|NCT04323124|520551593|FG013|Overall Study|Other|0|||
144366330|NCT04323124|520551594|FG014|Overall Study|Other|0|||
144366331|NCT04323124|520551580|FG000|Overall Study|Coming from a red zone (COVID)|0|||
144366332|NCT04323124|520551581|FG001|Overall Study|Coming from a red zone (COVID)|0|||
144366333|NCT04323124|520551582|FG002|Overall Study|Coming from a red zone (COVID)|0|||
144366334|NCT04323124|520551583|FG003|Overall Study|Coming from a red zone (COVID)|0|||
144366335|NCT04323124|520551584|FG004|Overall Study|Coming from a red zone (COVID)|1|||
144366336|NCT04323124|520551585|FG005|Overall Study|Coming from a red zone (COVID)|1|||
144366337|NCT04323124|520551586|FG006|Overall Study|Coming from a red zone (COVID)|0|||
144366338|NCT04323124|520551587|FG007|Overall Study|Coming from a red zone (COVID)|0|||
144366339|NCT04323124|520551588|FG008|Overall Study|Coming from a red zone (COVID)|0|||
144366340|NCT04323124|520551589|FG009|Overall Study|Coming from a red zone (COVID)|0|||
144366341|NCT04323124|520551590|FG010|Overall Study|Coming from a red zone (COVID)|0|||
144366342|NCT04323124|520551591|FG011|Overall Study|Coming from a red zone (COVID)|0|||
144366343|NCT04323124|520551592|FG012|Overall Study|Coming from a red zone (COVID)|0|||
144366344|NCT04323124|520551593|FG013|Overall Study|Coming from a red zone (COVID)|0|||
144366345|NCT04323124|520551594|FG014|Overall Study|Coming from a red zone (COVID)|0|||
144366346|NCT04323124|520551580|FG000|Overall Study|No longer meets eligibility criteria|0|||
144366347|NCT04323124|520551581|FG001|Overall Study|No longer meets eligibility criteria|0|||
144366348|NCT04323124|520551582|FG002|Overall Study|No longer meets eligibility criteria|0|||
144366349|NCT04323124|520551583|FG003|Overall Study|No longer meets eligibility criteria|0|||
144366350|NCT04323124|520551584|FG004|Overall Study|No longer meets eligibility criteria|0|||
144366351|NCT04323124|520551585|FG005|Overall Study|No longer meets eligibility criteria|0|||
144366352|NCT04323124|520551586|FG006|Overall Study|No longer meets eligibility criteria|0|||
144366353|NCT04323124|520551587|FG007|Overall Study|No longer meets eligibility criteria|1|||
144703882|NCT03576131|521768771|FG000|Overall Study|Subject non-compliance|0|||
144703883|NCT03576131|521768772|FG001|Overall Study|Subject non-compliance|0|||
144703884|NCT03576131|521768773|FG002|Overall Study|Subject non-compliance|0|||
144703885|NCT03576131|521768774|FG003|Overall Study|Subject non-compliance|0|||
144703886|NCT03576131|521768775|FG004|Overall Study|Subject non-compliance|0|||
144703887|NCT03576131|521768776|FG005|Overall Study|Subject non-compliance|1|||
144703888|NCT03576131|521768777|FG006|Overall Study|Subject non-compliance|0|||
144703889|NCT03576131|521768778|FG007|Overall Study|Subject non-compliance|0|||
144703890|NCT00996632|521768783|FG000|Overall Study|Physician Decision|0|||
144703891|NCT00996632|521768784|FG001|Overall Study|Physician Decision|0|||
144703892|NCT04484805|521768795|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
144703893|NCT04484805|521768796|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
144703894|NCT04484805|521768795|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
144703895|NCT04484805|521768796|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
144703896|NCT02118896|521768797|FG000|Overall Study|Death|4|||
144703897|NCT02118896|521768798|FG001|Overall Study|Death|0|||
144703898|NCT02118896|521768799|FG002|Overall Study|Death|4|||
144703899|NCT02118896|521768800|FG003|Overall Study|Death|6|||
144703900|NCT02118896|521768801|FG004|Overall Study|Death|3|||
144703901|NCT02118896|521768802|FG005|Overall Study|Death|1|||
144703902|NCT02118896|521768803|FG006|Overall Study|Death|0|||
144703903|NCT02118896|521768804|FG007|Overall Study|Death|0|||
144703904|NCT02118896|521768805|FG008|Overall Study|Death|0|||
144703905|NCT02118896|521768806|FG009|Overall Study|Death|0|||
144703906|NCT02118896|521768797|FG000|Overall Study|Adverse Event|5|||
144703907|NCT02118896|521768798|FG001|Overall Study|Adverse Event|4|||
144703908|NCT02118896|521768799|FG002|Overall Study|Adverse Event|4|||
144703909|NCT02118896|521768800|FG003|Overall Study|Adverse Event|5|||
144703910|NCT02118896|521768801|FG004|Overall Study|Adverse Event|5|||
144703911|NCT02118896|521768802|FG005|Overall Study|Adverse Event|9|||
144703912|NCT02118896|521768803|FG006|Overall Study|Adverse Event|1|||
144703913|NCT02118896|521768804|FG007|Overall Study|Adverse Event|1|||
144703914|NCT02118896|521768805|FG008|Overall Study|Adverse Event|4|||
144703915|NCT02118896|521768806|FG009|Overall Study|Adverse Event|0|||
144703916|NCT02118896|521768797|FG000|Overall Study|Consent withdrawn|2|||
144366354|NCT04323124|520551588|FG008|Overall Study|No longer meets eligibility criteria|0|||
144366355|NCT04323124|520551589|FG009|Overall Study|No longer meets eligibility criteria|0|||
144366356|NCT04323124|520551590|FG010|Overall Study|No longer meets eligibility criteria|0|||
144366357|NCT04323124|520551591|FG011|Overall Study|No longer meets eligibility criteria|0|||
144366358|NCT04323124|520551592|FG012|Overall Study|No longer meets eligibility criteria|0|||
144366359|NCT04323124|520551593|FG013|Overall Study|No longer meets eligibility criteria|1|||
144366360|NCT04323124|520551594|FG014|Overall Study|No longer meets eligibility criteria|1|||
144366361|NCT04323124|520551580|FG000|Overall Study|Study terminated by sponsor|0|||
144366362|NCT04323124|520551581|FG001|Overall Study|Study terminated by sponsor|0|||
144366363|NCT04323124|520551582|FG002|Overall Study|Study terminated by sponsor|0|||
144366364|NCT04323124|520551583|FG003|Overall Study|Study terminated by sponsor|0|||
144366365|NCT04323124|520551584|FG004|Overall Study|Study terminated by sponsor|0|||
144479671|NCT00089895|520955095|FG000|Overall Study|Missing|4|||
144479672|NCT00089895|520955096|FG001|Overall Study|Missing|2|||
144479673|NCT02494206|520955110|FG000|Overall Study|Adverse Event|1|||
144479674|NCT02494206|520955110|FG000|Overall Study|Disease Progression|1|||
144479675|NCT04186403|520955113|FG000|Overall Study|Adverse Event|1|||
144479676|NCT04186403|520955114|FG001|Overall Study|Adverse Event|8|||
144479677|NCT04186403|520955113|FG000|Overall Study|Lost to Follow-up|7|||
144479678|NCT04186403|520955114|FG001|Overall Study|Lost to Follow-up|3|||
144479679|NCT04186403|520955113|FG000|Overall Study|Physician Decision|1|||
144479680|NCT04186403|520955114|FG001|Overall Study|Physician Decision|0|||
144479681|NCT04186403|520955113|FG000|Overall Study|Withdrawal by Subject|7|||
144479682|NCT04186403|520955114|FG001|Overall Study|Withdrawal by Subject|8|||
144479683|NCT04186403|520955113|FG000|Overall Study|Other: Not Related to Covid-19|3|||
144479684|NCT04186403|520955114|FG001|Overall Study|Other: Not Related to Covid-19|0|||
144479685|NCT02875834|520955115|FG000|Open-label Phase|Withdrawal by Subject|3|||
144479686|NCT02875834|520955116|FG001|Open-label Phase|Withdrawal by Subject|0|||
144479687|NCT02875834|520955117|FG002|Open-label Phase|Withdrawal by Subject|0|||
144479688|NCT02875834|520955118|FG003|Open-label Phase|Withdrawal by Subject|0|||
144479689|NCT02875834|520955115|FG000|Open-label Phase|(Not collected)|4|||
144479690|NCT02875834|520955116|FG001|Open-label Phase|(Not collected)|0|||
144479691|NCT02875834|520955117|FG002|Open-label Phase|(Not collected)|0|||
144366366|NCT04323124|520551585|FG005|Overall Study|Study terminated by sponsor|0|||
144479692|NCT02875834|520955118|FG003|Open-label Phase|(Not collected)|0|||
144479693|NCT02875834|520955115|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
144479694|NCT02875834|520955116|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
144479695|NCT02875834|520955117|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
144703917|NCT02118896|521768798|FG001|Overall Study|Consent withdrawn|0|||
144703918|NCT02118896|521768799|FG002|Overall Study|Consent withdrawn|3|||
144703919|NCT02118896|521768800|FG003|Overall Study|Consent withdrawn|4|||
144703920|NCT02118896|521768801|FG004|Overall Study|Consent withdrawn|1|||
144703921|NCT02118896|521768802|FG005|Overall Study|Consent withdrawn|4|||
144703922|NCT02118896|521768803|FG006|Overall Study|Consent withdrawn|0|||
144703923|NCT02118896|521768804|FG007|Overall Study|Consent withdrawn|0|||
144366367|NCT04323124|520551586|FG006|Overall Study|Study terminated by sponsor|0|||
144366368|NCT04323124|520551587|FG007|Overall Study|Study terminated by sponsor|0|||
144366369|NCT04323124|520551588|FG008|Overall Study|Study terminated by sponsor|0|||
144366370|NCT04323124|520551589|FG009|Overall Study|Study terminated by sponsor|0|||
144366371|NCT04323124|520551590|FG010|Overall Study|Study terminated by sponsor|0|||
144366372|NCT04323124|520551591|FG011|Overall Study|Study terminated by sponsor|2|||
144366373|NCT04323124|520551592|FG012|Overall Study|Study terminated by sponsor|1|||
144366374|NCT04323124|520551593|FG013|Overall Study|Study terminated by sponsor|0|||
144366375|NCT04323124|520551594|FG014|Overall Study|Study terminated by sponsor|0|||
144366376|NCT01671319|520553494|FG000|Overall Study|Withdrawal by Subject|1|||
144366377|NCT01389596|520553495|FG000|Overall Study|Protocol Violation|3|||
144366378|NCT01389596|520553496|FG001|Overall Study|Protocol Violation|4|||
144366379|NCT01389596|520553497|FG002|Overall Study|Protocol Violation|3|||
144366380|NCT01389596|520553495|FG000|Overall Study|Withdrawal by Subject|1|||
144366381|NCT01389596|520553496|FG001|Overall Study|Withdrawal by Subject|2|||
144366382|NCT01389596|520553497|FG002|Overall Study|Withdrawal by Subject|2|||
144366383|NCT01389596|520553495|FG000|Overall Study|Insufficient Clinical Response|3|||
144366384|NCT01389596|520553496|FG001|Overall Study|Insufficient Clinical Response|4|||
144366385|NCT01389596|520553497|FG002|Overall Study|Insufficient Clinical Response|5|||
144366386|NCT01389596|520553495|FG000|Overall Study|Adverse Event|1|||
144366387|NCT01389596|520553496|FG001|Overall Study|Adverse Event|4|||
144366388|NCT01389596|520553497|FG002|Overall Study|Adverse Event|0|||
144366389|NCT01389596|520553495|FG000|Overall Study|Death|0|||
144366390|NCT01389596|520553496|FG001|Overall Study|Death|1|||
144366391|NCT01389596|520553497|FG002|Overall Study|Death|0|||
144366392|NCT01389596|520553495|FG000|Overall Study|Other Unspecified|2|||
144366393|NCT01389596|520553496|FG001|Overall Study|Other Unspecified|1|||
144366394|NCT01389596|520553497|FG002|Overall Study|Other Unspecified|0|||
144366395|NCT01354899|520553498|FG000|Overall Study|discharge from the hospital|2|||
144366396|NCT01354899|520553498|FG000|Overall Study|Protocol Violation|1|||
144366397|NCT00463567|520553499|FG000|Overall Study|Adverse Event|29|||
144366398|NCT00463567|520553500|FG001|Overall Study|Adverse Event|26|||
144366399|NCT00463567|520553501|FG002|Overall Study|Adverse Event|17|||
144366400|NCT00463567|520553502|FG003|Overall Study|Adverse Event|46|||
144366401|NCT00463567|520553503|FG004|Overall Study|Adverse Event|10|||
144366402|NCT00463567|520553504|FG005|Overall Study|Adverse Event|10|||
144366403|NCT00463567|520553505|FG006|Overall Study|Adverse Event|4|||
144366404|NCT00463567|520553499|FG000|Overall Study|Withdrawal by Subject|29|||
144366405|NCT00463567|520553500|FG001|Overall Study|Withdrawal by Subject|22|||
144366406|NCT00463567|520553501|FG002|Overall Study|Withdrawal by Subject|20|||
144366407|NCT00463567|520553502|FG003|Overall Study|Withdrawal by Subject|37|||
144366408|NCT00463567|520553503|FG004|Overall Study|Withdrawal by Subject|6|||
144366409|NCT00463567|520553504|FG005|Overall Study|Withdrawal by Subject|5|||
144366410|NCT00463567|520553505|FG006|Overall Study|Withdrawal by Subject|1|||
144366411|NCT00463567|520553499|FG000|Overall Study|Protocol Deviation|13|||
144366412|NCT00463567|520553500|FG001|Overall Study|Protocol Deviation|9|||
144366413|NCT00463567|520553501|FG002|Overall Study|Protocol Deviation|14|||
144366414|NCT00463567|520553502|FG003|Overall Study|Protocol Deviation|11|||
144366415|NCT00463567|520553503|FG004|Overall Study|Protocol Deviation|1|||
144366416|NCT00463567|520553504|FG005|Overall Study|Protocol Deviation|1|||
144366417|NCT00463567|520553505|FG006|Overall Study|Protocol Deviation|2|||
144366418|NCT00463567|520553499|FG000|Overall Study|Lost to Follow-up|12|||
144366419|NCT00463567|520553500|FG001|Overall Study|Lost to Follow-up|6|||
144366420|NCT00463567|520553501|FG002|Overall Study|Lost to Follow-up|13|||
144366421|NCT00463567|520553502|FG003|Overall Study|Lost to Follow-up|8|||
144366422|NCT00463567|520553503|FG004|Overall Study|Lost to Follow-up|1|||
144366423|NCT00463567|520553504|FG005|Overall Study|Lost to Follow-up|1|||
144366424|NCT00463567|520553505|FG006|Overall Study|Lost to Follow-up|1|||
144366425|NCT00463567|520553499|FG000|Overall Study|Administrative problems|5|||
144366426|NCT00463567|520553500|FG001|Overall Study|Administrative problems|3|||
144366427|NCT00463567|520553501|FG002|Overall Study|Administrative problems|6|||
144366428|NCT00463567|520553502|FG003|Overall Study|Administrative problems|9|||
144703924|NCT02118896|521768805|FG008|Overall Study|Consent withdrawn|0|||
144703925|NCT02118896|521768806|FG009|Overall Study|Consent withdrawn|0|||
144366429|NCT00463567|520553503|FG004|Overall Study|Administrative problems|3|||
144366430|NCT00463567|520553504|FG005|Overall Study|Administrative problems|2|||
144366431|NCT00463567|520553505|FG006|Overall Study|Administrative problems|2|||
144366432|NCT00463567|520553499|FG000|Overall Study|Lack of Efficacy|4|||
144366433|NCT00463567|520553500|FG001|Overall Study|Lack of Efficacy|9|||
144366434|NCT00463567|520553501|FG002|Overall Study|Lack of Efficacy|9|||
144366435|NCT00463567|520553502|FG003|Overall Study|Lack of Efficacy|17|||
144703926|NCT02118896|521768797|FG000|Overall Study|Non-compliance|2|||
144703927|NCT02118896|521768798|FG001|Overall Study|Non-compliance|1|||
144366436|NCT00463567|520553503|FG004|Overall Study|Lack of Efficacy|1|||
144366437|NCT00463567|520553504|FG005|Overall Study|Lack of Efficacy|0|||
144366438|NCT00463567|520553505|FG006|Overall Study|Lack of Efficacy|1|||
144366439|NCT00463567|520553499|FG000|Overall Study|Abnormal lab value(s)|1|||
144366440|NCT00463567|520553500|FG001|Overall Study|Abnormal lab value(s)|1|||
144366441|NCT00463567|520553501|FG002|Overall Study|Abnormal lab value(s)|2|||
144366442|NCT00463567|520553502|FG003|Overall Study|Abnormal lab value(s)|1|||
144366443|NCT00463567|520553503|FG004|Overall Study|Abnormal lab value(s)|1|||
144366444|NCT00463567|520553504|FG005|Overall Study|Abnormal lab value(s)|0|||
144366445|NCT00463567|520553505|FG006|Overall Study|Abnormal lab value(s)|0|||
144366446|NCT00463567|520553499|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144366447|NCT00463567|520553500|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144366448|NCT00463567|520553501|FG002|Overall Study|Abnormal test procedure result(s)|6|||
144366449|NCT00463567|520553502|FG003|Overall Study|Abnormal test procedure result(s)|2|||
144366450|NCT00463567|520553503|FG004|Overall Study|Abnormal test procedure result(s)|0|||
144366451|NCT00463567|520553504|FG005|Overall Study|Abnormal test procedure result(s)|2|||
144366452|NCT00463567|520553505|FG006|Overall Study|Abnormal test procedure result(s)|0|||
144366453|NCT00463567|520553499|FG000|Overall Study|Death|1|||
144366454|NCT00463567|520553500|FG001|Overall Study|Death|0|||
144366455|NCT00463567|520553501|FG002|Overall Study|Death|2|||
144366456|NCT00463567|520553502|FG003|Overall Study|Death|0|||
144366457|NCT00463567|520553503|FG004|Overall Study|Death|0|||
144366458|NCT00463567|520553504|FG005|Overall Study|Death|0|||
144366459|NCT00463567|520553505|FG006|Overall Study|Death|0|||
144366460|NCT01124006|520553506|FG000|Overall Study|Withdrawal by Subject|2|||
144366461|NCT01124006|520553507|FG001|Overall Study|Withdrawal by Subject|2|||
144366462|NCT01124006|520553508|FG002|Overall Study|Withdrawal by Subject|0|||
144366463|NCT01124006|520553506|FG000|Overall Study|Lost to Follow-up|1|||
144366464|NCT01124006|520553507|FG001|Overall Study|Lost to Follow-up|0|||
144366465|NCT01124006|520553508|FG002|Overall Study|Lost to Follow-up|1|||
144366466|NCT01124006|520553506|FG000|Overall Study|Other|0|||
144366467|NCT01124006|520553507|FG001|Overall Study|Other|0|||
144366468|NCT01124006|520553508|FG002|Overall Study|Other|1|||
144366469|NCT01803607|520553510|FG000|Overall Study|Adverse Event|5|||
144366470|NCT01803607|520553511|FG001|Overall Study|Adverse Event|3|||
144366471|NCT01803607|520553510|FG000|Overall Study|Lack of Efficacy|0|||
144366472|NCT01803607|520553511|FG001|Overall Study|Lack of Efficacy|1|||
144366473|NCT01803607|520553510|FG000|Overall Study|Protocol Violation|3|||
144366474|NCT01803607|520553511|FG001|Overall Study|Protocol Violation|2|||
144366475|NCT01803607|520553510|FG000|Overall Study|Study terminated by sponsor|54|||
144366476|NCT01803607|520553511|FG001|Overall Study|Study terminated by sponsor|56|||
144366477|NCT01803607|520553510|FG000|Overall Study|Withdrawal by Subject|6|||
144366478|NCT01803607|520553511|FG001|Overall Study|Withdrawal by Subject|5|||
144366479|NCT03819114|520553550|FG000|Overall Study|Protocol Violation|0|||
144703928|NCT02118896|521768799|FG002|Overall Study|Non-compliance|1|||
144703929|NCT02118896|521768800|FG003|Overall Study|Non-compliance|5|||
144703930|NCT02118896|521768801|FG004|Overall Study|Non-compliance|0|||
144703931|NCT02118896|521768802|FG005|Overall Study|Non-compliance|1|||
144703932|NCT02118896|521768803|FG006|Overall Study|Non-compliance|0|||
144703933|NCT02118896|521768804|FG007|Overall Study|Non-compliance|1|||
144703934|NCT02118896|521768805|FG008|Overall Study|Non-compliance|0|||
144703935|NCT02118896|521768806|FG009|Overall Study|Non-compliance|0|||
144703936|NCT02118896|521768797|FG000|Overall Study|Pregnancy|1|||
144703937|NCT02118896|521768798|FG001|Overall Study|Pregnancy|1|||
144703938|NCT02118896|521768799|FG002|Overall Study|Pregnancy|0|||
144703939|NCT02118896|521768800|FG003|Overall Study|Pregnancy|0|||
144703940|NCT02118896|521768801|FG004|Overall Study|Pregnancy|1|||
144703941|NCT02118896|521768802|FG005|Overall Study|Pregnancy|3|||
144366480|NCT03819114|520553551|FG001|Overall Study|Protocol Violation|1|||
144366481|NCT03819114|520553552|FG002|Overall Study|Protocol Violation|1|||
144366482|NCT03819114|520553553|FG003|Overall Study|Protocol Violation|0|||
144703942|NCT02118896|521768803|FG006|Overall Study|Pregnancy|1|||
144703943|NCT02118896|521768804|FG007|Overall Study|Pregnancy|0|||
144703944|NCT02118896|521768805|FG008|Overall Study|Pregnancy|0|||
144366483|NCT03819114|520553550|FG000|Overall Study|Lost to Follow-up|0|||
144366484|NCT03819114|520553551|FG001|Overall Study|Lost to Follow-up|0|||
144366485|NCT03819114|520553552|FG002|Overall Study|Lost to Follow-up|1|||
144366486|NCT03819114|520553553|FG003|Overall Study|Lost to Follow-up|0|||
144366487|NCT03841604|520553554|FG000|Overall Study|Withdrawal by Subject|3|||
144366488|NCT03841604|520553555|FG001|Overall Study|Withdrawal by Subject|1|||
144366489|NCT03841604|520553554|FG000|Overall Study|Adverse Event|4|||
144366490|NCT03841604|520553555|FG001|Overall Study|Adverse Event|2|||
144366491|NCT03841604|520553554|FG000|Overall Study|Physician Decision|1|||
144366492|NCT03841604|520553555|FG001|Overall Study|Physician Decision|0|||
144366493|NCT02085161|520553557|FG000|Overall Study|Not Treated|1|||
144703945|NCT02118896|521768806|FG009|Overall Study|Pregnancy|0|||
144703946|NCT02118896|521768797|FG000|Overall Study|Lost to Follow-up|1|||
144703947|NCT02118896|521768798|FG001|Overall Study|Lost to Follow-up|2|||
144703948|NCT02118896|521768799|FG002|Overall Study|Lost to Follow-up|1|||
144703949|NCT02118896|521768800|FG003|Overall Study|Lost to Follow-up|0|||
144366494|NCT02085161|520553558|FG001|Overall Study|Not Treated|0|||
144366495|NCT02085161|520553559|FG002|Overall Study|Not Treated|0|||
144366496|NCT02085161|520553560|FG003|Overall Study|Not Treated|0|||
144366497|NCT02085161|520553557|FG000|Overall Study|Adverse Event|8|||
144366498|NCT02085161|520553558|FG001|Overall Study|Adverse Event|5|||
144366499|NCT02085161|520553559|FG002|Overall Study|Adverse Event|4|||
144366500|NCT02085161|520553560|FG003|Overall Study|Adverse Event|5|||
144366501|NCT02085161|520553557|FG000|Overall Study|Protocol Violation|0|||
144366502|NCT02085161|520553558|FG001|Overall Study|Protocol Violation|1|||
144366503|NCT02085161|520553559|FG002|Overall Study|Protocol Violation|0|||
144366504|NCT02085161|520553560|FG003|Overall Study|Protocol Violation|1|||
144366505|NCT02085161|520553557|FG000|Overall Study|Withdrawal by Subject|2|||
144366506|NCT02085161|520553558|FG001|Overall Study|Withdrawal by Subject|4|||
144366507|NCT02085161|520553559|FG002|Overall Study|Withdrawal by Subject|0|||
144366508|NCT02085161|520553560|FG003|Overall Study|Withdrawal by Subject|3|||
144366509|NCT02085161|520553557|FG000|Overall Study|Other Reason|1|||
144366510|NCT02085161|520553558|FG001|Overall Study|Other Reason|0|||
144366511|NCT02085161|520553559|FG002|Overall Study|Other Reason|1|||
144366512|NCT02085161|520553560|FG003|Overall Study|Other Reason|1|||
144366513|NCT01936870|520553563|FG000|Overall Study|No Visit After Treatment|176|||
144366514|NCT01936870|520553563|FG000|Overall Study|Protocol Violation|12|||
144479696|NCT02875834|520955118|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
144479697|NCT02875834|520955115|FG000|Randomized Treatment Phase|Protocol Violation|0|||
144479698|NCT02875834|520955116|FG001|Randomized Treatment Phase|Protocol Violation|2|||
144479699|NCT02875834|520955117|FG002|Randomized Treatment Phase|Protocol Violation|0|||
144479700|NCT02875834|520955118|FG003|Randomized Treatment Phase|Protocol Violation|0|||
144479701|NCT02875834|520955115|FG000|Randomized Treatment Phase|(Not collected)|0|||
144479702|NCT02875834|520955116|FG001|Randomized Treatment Phase|(Not collected)|9|||
144479703|NCT02875834|520955117|FG002|Randomized Treatment Phase|(Not collected)|10|||
144479704|NCT02875834|520955118|FG003|Randomized Treatment Phase|(Not collected)|9|||
144479705|NCT02294474|520955119|FG000|Overall Study|Adverse Event|7|||
144479706|NCT02294474|520955120|FG001|Overall Study|Adverse Event|7|||
144479707|NCT02294474|520955119|FG000|Overall Study|Lack of Efficacy|2|||
144479708|NCT02294474|520955120|FG001|Overall Study|Lack of Efficacy|1|||
144479709|NCT02294474|520955119|FG000|Overall Study|Protocol Violation|4|||
144479710|NCT02294474|520955120|FG001|Overall Study|Protocol Violation|2|||
144479711|NCT02294474|520955119|FG000|Overall Study|Other than specified above|12|||
144479712|NCT02294474|520955120|FG001|Overall Study|Other than specified above|12|||
144479713|NCT00539279|520955121|FG000|Treatment|Withdrawal by Subject|10|||
144479714|NCT00539279|520955122|FG001|Treatment|Withdrawal by Subject|8|||
144479715|NCT00539279|520955121|FG000|Treatment|Death|1|||
144479716|NCT00539279|520955122|FG001|Treatment|Death|0|||
144479717|NCT00539279|520955121|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
144479718|NCT00539279|520955122|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
144479719|NCT00539279|520955121|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
144479720|NCT00539279|520955122|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
144479721|NCT03813147|520955123|FG000|Overall Study|Lack of Efficacy|4|||
144479722|NCT03813147|520955124|FG001|Overall Study|Lack of Efficacy|4|||
144479723|NCT03813147|520955123|FG000|Overall Study|Physician Decision|2|||
144479724|NCT03813147|520955124|FG001|Overall Study|Physician Decision|1|||
144479725|NCT01693692|520955125|FG000|Overall Study|Withdrawal by Subject|12|||
144479726|NCT01693692|520955126|FG001|Overall Study|Withdrawal by Subject|10|||
144479727|NCT01693692|520955127|FG002|Overall Study|Withdrawal by Subject|11|||
144479728|NCT01693692|520955125|FG000|Overall Study|Adverse Event|7|||
144479729|NCT01693692|520955126|FG001|Overall Study|Adverse Event|14|||
144479730|NCT01693692|520955127|FG002|Overall Study|Adverse Event|9|||
144479731|NCT01693692|520955125|FG000|Overall Study|Physician Decision|0|||
144479732|NCT01693692|520955126|FG001|Overall Study|Physician Decision|0|||
144479733|NCT01693692|520955127|FG002|Overall Study|Physician Decision|1|||
144479734|NCT01693692|520955125|FG000|Overall Study|Protocol Violation|5|||
144479735|NCT01693692|520955126|FG001|Overall Study|Protocol Violation|4|||
144479736|NCT01693692|520955127|FG002|Overall Study|Protocol Violation|6|||
144479737|NCT01693692|520955125|FG000|Overall Study|Lost to Follow-up|2|||
144479738|NCT01693692|520955126|FG001|Overall Study|Lost to Follow-up|2|||
144366515|NCT01936870|520553563|FG000|Overall Study|No Drug Administration|1|||
144366516|NCT00628108|520553566|FG000|Overall Study|Adverse Event|0|||
144366517|NCT00628108|520553567|FG001|Overall Study|Adverse Event|3|||
144366518|NCT00628108|520553566|FG000|Overall Study|Withdrawal by Subject|1|||
144366519|NCT00628108|520553567|FG001|Overall Study|Withdrawal by Subject|0|||
144366520|NCT03848832|520553568|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
144479739|NCT01693692|520955127|FG002|Overall Study|Lost to Follow-up|3|||
144479740|NCT01693692|520955125|FG000|Overall Study|Other|4|||
144479741|NCT01693692|520955126|FG001|Overall Study|Other|4|||
144479742|NCT01693692|520955127|FG002|Overall Study|Other|6|||
144479743|NCT01167179|520957601|FG000|Overall Study|disease recurrence|4|||
144479744|NCT01167179|520957602|FG001|Overall Study|disease recurrence|4|||
144479745|NCT01167179|520957601|FG000|Overall Study|Death|4|||
144479746|NCT01167179|520957602|FG001|Overall Study|Death|10|||
144479747|NCT01167179|520957601|FG000|Overall Study|Withdrawal by Subject|1|||
144703950|NCT02118896|521768801|FG004|Overall Study|Lost to Follow-up|2|||
144703951|NCT02118896|521768802|FG005|Overall Study|Lost to Follow-up|1|||
144703952|NCT02118896|521768803|FG006|Overall Study|Lost to Follow-up|0|||
144703953|NCT02118896|521768804|FG007|Overall Study|Lost to Follow-up|0|||
144703954|NCT02118896|521768805|FG008|Overall Study|Lost to Follow-up|0|||
144703955|NCT02118896|521768806|FG009|Overall Study|Lost to Follow-up|0|||
144703956|NCT02118896|521768797|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
144703957|NCT02118896|521768798|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
144703958|NCT02118896|521768799|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
144703959|NCT02118896|521768800|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
144703960|NCT02118896|521768801|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
144703961|NCT02118896|521768802|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
144366521|NCT03848832|520553569|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
144366522|NCT03848832|520553570|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
144366523|NCT03848832|520553568|FG000|Overall Study|Withdrawal by Subject|0|||
144366524|NCT03848832|520553569|FG001|Overall Study|Withdrawal by Subject|0|||
144366525|NCT03848832|520553570|FG002|Overall Study|Withdrawal by Subject|1|||
144366526|NCT03848832|520553568|FG000|Overall Study|Withdrawal (Covid-19)|0|||
144366527|NCT03848832|520553569|FG001|Overall Study|Withdrawal (Covid-19)|2|||
144366528|NCT03848832|520553570|FG002|Overall Study|Withdrawal (Covid-19)|0|||
144366529|NCT03848832|520553568|FG000|Overall Study|Physician Decision|2|||
144703962|NCT02118896|521768803|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
144703963|NCT02118896|521768804|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
144366530|NCT03848832|520553569|FG001|Overall Study|Physician Decision|1|||
144703964|NCT02118896|521768805|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
144703965|NCT02118896|521768806|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
144366531|NCT03848832|520553570|FG002|Overall Study|Physician Decision|3|||
144366532|NCT03848832|520553568|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
144366533|NCT03848832|520553569|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
144366534|NCT03848832|520553570|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
144366535|NCT03848832|520553568|FG000|Overall Study|Adverse Event|1|||
144366536|NCT03848832|520553569|FG001|Overall Study|Adverse Event|0|||
144366537|NCT03848832|520553570|FG002|Overall Study|Adverse Event|0|||
144366538|NCT00719472|520553572|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
144366539|NCT00719472|520553572|FG000|Enrolled in Study|Subject decision to withdraw|8|||
144366540|NCT00719472|520553572|FG000|Enrolled in Study|Various Reasons|17|||
144366541|NCT00719472|520553572|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
144366542|NCT00719472|520553572|FG000|Received Cycle 1 Treatment|Death|5|||
144366543|NCT00719472|520553572|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
144366544|NCT00719472|520553572|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
144366545|NCT00719472|520553572|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
144366546|NCT00719472|520553572|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
144703966|NCT02118896|521768797|FG000|Overall Study|Prohibited medication|0|||
144703967|NCT02118896|521768798|FG001|Overall Study|Prohibited medication|0|||
144703968|NCT02118896|521768799|FG002|Overall Study|Prohibited medication|0|||
144703969|NCT02118896|521768800|FG003|Overall Study|Prohibited medication|0|||
144366547|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
144366548|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Death|6|||
144366549|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Disease progression|3|||
144366550|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
144366551|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
144366552|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
144703970|NCT02118896|521768801|FG004|Overall Study|Prohibited medication|1|||
144703971|NCT02118896|521768802|FG005|Overall Study|Prohibited medication|3|||
144703972|NCT02118896|521768803|FG006|Overall Study|Prohibited medication|0|||
144703973|NCT02118896|521768804|FG007|Overall Study|Prohibited medication|0|||
144703974|NCT02118896|521768805|FG008|Overall Study|Prohibited medication|0|||
144703975|NCT02118896|521768806|FG009|Overall Study|Prohibited medication|0|||
144703976|NCT02118896|521768797|FG000|Overall Study|Miscellaneous|1|||
144366553|NCT00719472|520553572|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
144366554|NCT00711191|520553575|FG000|Overall Study|Adverse Event|1|||
144366555|NCT00711191|520553576|FG001|Overall Study|Adverse Event|1|||
144366556|NCT00711191|520553577|FG002|Overall Study|Adverse Event|2|||
144366557|NCT00711191|520553575|FG000|Overall Study|Objective progression or relapse|2|||
144366558|NCT00711191|520553576|FG001|Overall Study|Objective progression or relapse|3|||
144366559|NCT00711191|520553577|FG002|Overall Study|Objective progression or relapse|7|||
144366560|NCT00711191|520553575|FG000|Overall Study|Withdrawal by Subject|0|||
144703977|NCT02118896|521768798|FG001|Overall Study|Miscellaneous|2|||
144703978|NCT02118896|521768799|FG002|Overall Study|Miscellaneous|0|||
144366561|NCT00711191|520553576|FG001|Overall Study|Withdrawal by Subject|1|||
144703979|NCT02118896|521768800|FG003|Overall Study|Miscellaneous|2|||
144703980|NCT02118896|521768801|FG004|Overall Study|Miscellaneous|0|||
144703981|NCT02118896|521768802|FG005|Overall Study|Miscellaneous|4|||
144703982|NCT02118896|521768803|FG006|Overall Study|Miscellaneous|0|||
144703983|NCT02118896|521768804|FG007|Overall Study|Miscellaneous|0|||
144703984|NCT02118896|521768805|FG008|Overall Study|Miscellaneous|0|||
144703985|NCT02118896|521768806|FG009|Overall Study|Miscellaneous|0|||
144703986|NCT02116309|521768807|FG000|Overall Study|Lost to Follow-up|0|||
144703987|NCT02116309|521768808|FG001|Overall Study|Lost to Follow-up|1|||
144703988|NCT03292731|521768809|FG000|Overall Study|Protocol Violation|4|||
144366562|NCT00711191|520553577|FG002|Overall Study|Withdrawal by Subject|3|||
144366563|NCT04646044|520553578|FG000|Overall Study|Lost to Follow-up|0|||
144703989|NCT03292731|521768810|FG001|Overall Study|Protocol Violation|11|||
144703990|NCT03292731|521768811|FG002|Overall Study|Protocol Violation|1|||
144703991|NCT00471237|521768812|FG000|Overall Study|Adverse Event|6|||
144703992|NCT00471237|521768813|FG001|Overall Study|Adverse Event|5|||
144366564|NCT04646044|520553579|FG001|Overall Study|Lost to Follow-up|0|||
144366565|NCT04646044|520553580|FG002|Overall Study|Lost to Follow-up|1|||
144366566|NCT04646044|520553581|FG003|Overall Study|Lost to Follow-up|0|||
144366567|NCT04646044|520553578|FG000|Overall Study|Withdrawal by Subject|0|||
144366568|NCT04646044|520553579|FG001|Overall Study|Withdrawal by Subject|1|||
144366569|NCT04646044|520553580|FG002|Overall Study|Withdrawal by Subject|0|||
144366570|NCT04646044|520553581|FG003|Overall Study|Withdrawal by Subject|0|||
144366571|NCT03038880|520553587|FG000|Overall Study|Death|1|||
144366572|NCT03038880|520553588|FG001|Overall Study|Death|2|||
144366573|NCT03038880|520553589|FG002|Overall Study|Death|0|||
144366574|NCT03038880|520553587|FG000|Overall Study|Physician Decision|2|||
144366575|NCT03038880|520553588|FG001|Overall Study|Physician Decision|1|||
144366576|NCT03038880|520553589|FG002|Overall Study|Physician Decision|0|||
144366577|NCT02803580|520553590|FG000|Overall Study|Death|13|||
144366578|NCT02803580|520553590|FG000|Overall Study|Lost to Follow-up|19|||
144366579|NCT02803580|520553590|FG000|Overall Study|Withdrawal by Subject|3|||
144366580|NCT02803580|520553590|FG000|Overall Study|Inclusion in clinical trial|1|||
144366581|NCT02054104|520553591|FG000|Overall Study|Did not want to continue due to college classes|1|||
144366582|NCT02054104|520553592|FG001|Overall Study|Did not want to continue due to college classes|0|||
144366583|NCT02054104|520553591|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
144366584|NCT02054104|520553592|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
144366585|NCT02054104|520553591|FG000|Overall Study|No evidence of immunologic response|2|||
144366586|NCT02054104|520553592|FG001|Overall Study|No evidence of immunologic response|2|||
144703993|NCT00471237|521768814|FG002|Overall Study|Adverse Event|4|||
144703994|NCT00471237|521768815|FG003|Overall Study|Adverse Event|8|||
144703995|NCT00471237|521768816|FG004|Overall Study|Adverse Event|7|||
144703996|NCT00471237|521768817|FG005|Overall Study|Adverse Event|5|||
144703997|NCT00471237|521768818|FG006|Overall Study|Adverse Event|0|||
144703998|NCT00471237|521768812|FG000|Overall Study|Lost to Follow-up|1|||
144703999|NCT00471237|521768813|FG001|Overall Study|Lost to Follow-up|1|||
144704000|NCT00471237|521768814|FG002|Overall Study|Lost to Follow-up|0|||
144704001|NCT00471237|521768815|FG003|Overall Study|Lost to Follow-up|2|||
144704002|NCT00471237|521768816|FG004|Overall Study|Lost to Follow-up|3|||
144704003|NCT00471237|521768817|FG005|Overall Study|Lost to Follow-up|0|||
144704004|NCT00471237|521768818|FG006|Overall Study|Lost to Follow-up|0|||
144704005|NCT00471237|521768812|FG000|Overall Study|Protocol Violation|3|||
144704006|NCT00471237|521768813|FG001|Overall Study|Protocol Violation|6|||
144704007|NCT00471237|521768814|FG002|Overall Study|Protocol Violation|3|||
144704008|NCT00471237|521768815|FG003|Overall Study|Protocol Violation|2|||
144704009|NCT00471237|521768816|FG004|Overall Study|Protocol Violation|2|||
144704010|NCT00471237|521768817|FG005|Overall Study|Protocol Violation|4|||
144704011|NCT00471237|521768818|FG006|Overall Study|Protocol Violation|1|||
144704012|NCT00471237|521768812|FG000|Overall Study|Withdrawal by Subject|8|||
144366587|NCT02054104|520553591|FG000|Overall Study|Disease Progression On Study|4|||
144366588|NCT02054104|520553592|FG001|Overall Study|Disease Progression On Study|5|||
144366589|NCT02054104|520553591|FG000|Overall Study|Diagnosis of lymphoma|0|||
144704013|NCT00471237|521768813|FG001|Overall Study|Withdrawal by Subject|6|||
144366590|NCT02054104|520553592|FG001|Overall Study|Diagnosis of lymphoma|1|||
144366591|NCT02054104|520553591|FG000|Overall Study|Inconclusive response|0|||
144366592|NCT02054104|520553592|FG001|Overall Study|Inconclusive response|1|||
144366593|NCT03910244|520553595|FG000|Overall Study|Adverse Event|14|||
144366594|NCT03910244|520553596|FG001|Overall Study|Adverse Event|0|||
144366595|NCT03910244|520553595|FG000|Overall Study|Death|1|||
144366596|NCT03910244|520553596|FG001|Overall Study|Death|0|||
144366597|NCT03910244|520553595|FG000|Overall Study|Lost to Follow-up|0|||
144704014|NCT00471237|521768814|FG002|Overall Study|Withdrawal by Subject|5|||
144704015|NCT00471237|521768815|FG003|Overall Study|Withdrawal by Subject|8|||
144704016|NCT00471237|521768816|FG004|Overall Study|Withdrawal by Subject|7|||
144704017|NCT00471237|521768817|FG005|Overall Study|Withdrawal by Subject|4|||
144704018|NCT00471237|521768818|FG006|Overall Study|Withdrawal by Subject|2|||
144704019|NCT00471237|521768812|FG000|Overall Study|Sponsor terminated study|20|||
144366598|NCT03910244|520553596|FG001|Overall Study|Lost to Follow-up|2|||
144366599|NCT03910244|520553595|FG000|Overall Study|Joint withdrawal decision|1|||
144704020|NCT00471237|521768813|FG001|Overall Study|Sponsor terminated study|23|||
144704021|NCT00471237|521768814|FG002|Overall Study|Sponsor terminated study|19|||
144704022|NCT00471237|521768815|FG003|Overall Study|Sponsor terminated study|22|||
144366600|NCT03910244|520553596|FG001|Overall Study|Joint withdrawal decision|0|||
144366601|NCT03910244|520553595|FG000|Overall Study|Study Terminated by Sponsor|7|||
144366602|NCT03910244|520553596|FG001|Overall Study|Study Terminated by Sponsor|4|||
144366603|NCT03910244|520553595|FG000|Overall Study|Physician Decision|1|||
144366604|NCT03910244|520553596|FG001|Overall Study|Physician Decision|0|||
144366605|NCT03910244|520553595|FG000|Overall Study|Protocol Violation|1|||
144366606|NCT03910244|520553596|FG001|Overall Study|Protocol Violation|0|||
144366607|NCT03910244|520553595|FG000|Overall Study|Withdrawal by Subject|7|||
144366608|NCT03910244|520553596|FG001|Overall Study|Withdrawal by Subject|2|||
144366609|NCT03774576|520553597|FG000|Period 2|Adverse Event|1|||
144366610|NCT01746901|520553598|FG000|Naloxone Challenge Phase|Adverse Event|2|||
144366611|NCT01746901|520553599|FG001|Naloxone Challenge Phase|Adverse Event|0|||
144366612|NCT01746901|520553600|FG002|Naloxone Challenge Phase|Adverse Event|0|||
144366613|NCT01746901|520553601|FG003|Naloxone Challenge Phase|Adverse Event|0|||
144366614|NCT01746901|520553602|FG004|Naloxone Challenge Phase|Adverse Event|0|||
144366615|NCT01746901|520553603|FG005|Naloxone Challenge Phase|Adverse Event|0|||
144366616|NCT01746901|520553604|FG006|Naloxone Challenge Phase|Adverse Event|0|||
144366617|NCT01746901|520553605|FG007|Naloxone Challenge Phase|Adverse Event|0|||
144366618|NCT01746901|520553606|FG008|Naloxone Challenge Phase|Adverse Event|0|||
144366619|NCT01746901|520553598|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
144366620|NCT01746901|520553599|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366621|NCT01746901|520553600|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366622|NCT01746901|520553601|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366623|NCT01746901|520553602|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366624|NCT01746901|520553603|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366625|NCT01746901|520553604|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366626|NCT01746901|520553605|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366627|NCT01746901|520553606|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
144366628|NCT01746901|520553598|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366629|NCT01746901|520553599|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
144366630|NCT01746901|520553600|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366631|NCT01746901|520553601|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366632|NCT01746901|520553602|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366633|NCT01746901|520553603|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366634|NCT01746901|520553604|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366635|NCT01746901|520553605|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366636|NCT01746901|520553606|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144366637|NCT01746901|520553598|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366638|NCT01746901|520553599|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
144366639|NCT01746901|520553600|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
144366640|NCT01746901|520553601|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366641|NCT01746901|520553602|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366642|NCT01746901|520553603|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366643|NCT01746901|520553604|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366644|NCT01746901|520553605|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366645|NCT01746901|520553606|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
144366646|NCT01746901|520553598|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366647|NCT01746901|520553599|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
144366648|NCT01746901|520553600|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
144366649|NCT01746901|520553601|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366650|NCT01746901|520553602|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366651|NCT01746901|520553603|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366652|NCT01746901|520553604|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366653|NCT01746901|520553605|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366654|NCT01746901|520553606|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
144366655|NCT01746901|520553598|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366656|NCT01746901|520553599|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
144366657|NCT01746901|520553600|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
144366658|NCT01746901|520553601|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366659|NCT01746901|520553602|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366660|NCT01746901|520553603|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366661|NCT01746901|520553604|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366662|NCT01746901|520553605|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366663|NCT01746901|520553606|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144366664|NCT01746901|520553598|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
144366665|NCT01746901|520553599|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
144366666|NCT01746901|520553600|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
144704023|NCT00471237|521768816|FG004|Overall Study|Sponsor terminated study|18|||
144366667|NCT01746901|520553601|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
144366668|NCT01746901|520553602|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
144366669|NCT01746901|520553603|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
144366670|NCT01746901|520553604|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
144366671|NCT01746901|520553605|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
144366672|NCT01746901|520553606|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
144366673|NCT01746901|520553598|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366674|NCT01746901|520553599|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366675|NCT01746901|520553600|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366676|NCT01746901|520553601|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366677|NCT01746901|520553602|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366678|NCT01746901|520553603|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366679|NCT01746901|520553604|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366680|NCT01746901|520553605|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
144366681|NCT01746901|520553606|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
144366682|NCT01746901|520553598|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366683|NCT01746901|520553599|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366684|NCT01746901|520553600|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366685|NCT01746901|520553601|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366686|NCT01746901|520553602|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366687|NCT01746901|520553603|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
144366688|NCT01746901|520553604|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
144366689|NCT01746901|520553605|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366690|NCT01746901|520553606|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
144366691|NCT01746901|520553598|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366692|NCT01746901|520553599|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366693|NCT01746901|520553600|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366694|NCT01746901|520553601|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
144366695|NCT01746901|520553602|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366696|NCT01746901|520553603|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366697|NCT01746901|520553604|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366698|NCT01746901|520553605|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366699|NCT01746901|520553606|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
144366700|NCT01746901|520553598|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366701|NCT01746901|520553599|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366702|NCT01746901|520553600|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366703|NCT01746901|520553601|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366704|NCT01746901|520553602|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366705|NCT01746901|520553603|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
144366706|NCT01746901|520553604|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366707|NCT01746901|520553605|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
144366708|NCT01746901|520553606|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
144366709|NCT01746901|520553598|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366710|NCT01746901|520553599|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366711|NCT01746901|520553600|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366712|NCT01746901|520553601|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366713|NCT01746901|520553602|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366714|NCT01746901|520553603|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366715|NCT01746901|520553604|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
144366716|NCT01746901|520553605|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
144366717|NCT01746901|520553606|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
144366718|NCT00763035|520553608|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
144366719|NCT00763035|520553609|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
144366720|NCT00763035|520553608|FG000|First Intervention|Adverse Event|0|||
144366721|NCT00763035|520553609|FG001|First Intervention|Adverse Event|1|||
144366722|NCT00763035|520553608|FG000|Second Intervention|Adverse Event|1|||
144366723|NCT00763035|520553609|FG001|Second Intervention|Adverse Event|0|||
144366724|NCT00763035|520553608|FG000|Second Intervention|Physician Decision|2|||
144366725|NCT00763035|520553609|FG001|Second Intervention|Physician Decision|0|||
144366726|NCT00907335|520553612|FG000|Overall Study|Withdrawal by Subject|2|||
144366727|NCT00907335|520553613|FG001|Overall Study|Withdrawal by Subject|0|||
144366728|NCT00907335|520553612|FG000|Overall Study|Adverse Event|4|||
144366729|NCT00907335|520553613|FG001|Overall Study|Adverse Event|1|||
144366730|NCT00907335|520553612|FG000|Overall Study|Lost to Follow-up|2|||
144704024|NCT00471237|521768817|FG005|Overall Study|Sponsor terminated study|24|||
144366731|NCT00907335|520553613|FG001|Overall Study|Lost to Follow-up|0|||
144366732|NCT03879772|520553614|FG000|Overall Study|Adverse Event|2|||
144366733|NCT03879772|520553615|FG001|Overall Study|Adverse Event|2|||
144366734|NCT03879772|520553616|FG002|Overall Study|Adverse Event|3|||
144366735|NCT03879772|520553617|FG003|Overall Study|Adverse Event|4|||
144366736|NCT03879772|520553618|FG004|Overall Study|Adverse Event|3|||
144366737|NCT03879772|520553614|FG000|Overall Study|Treatment Failure|1|||
144366738|NCT03879772|520553615|FG001|Overall Study|Treatment Failure|0|||
144366739|NCT03879772|520553616|FG002|Overall Study|Treatment Failure|0|||
144366740|NCT03879772|520553617|FG003|Overall Study|Treatment Failure|2|||
144366741|NCT03879772|520553618|FG004|Overall Study|Treatment Failure|1|||
144366742|NCT03879772|520553614|FG000|Overall Study|Lost to Follow-up|0|||
144366743|NCT03879772|520553615|FG001|Overall Study|Lost to Follow-up|0|||
144366744|NCT03879772|520553616|FG002|Overall Study|Lost to Follow-up|0|||
144366745|NCT03879772|520553617|FG003|Overall Study|Lost to Follow-up|0|||
144366746|NCT03879772|520553618|FG004|Overall Study|Lost to Follow-up|1|||
144366747|NCT03879772|520553614|FG000|Overall Study|Withdrawal by Subject|0|||
144366748|NCT03879772|520553615|FG001|Overall Study|Withdrawal by Subject|1|||
144366749|NCT03879772|520553616|FG002|Overall Study|Withdrawal by Subject|3|||
144366750|NCT03879772|520553617|FG003|Overall Study|Withdrawal by Subject|1|||
144366751|NCT03879772|520553618|FG004|Overall Study|Withdrawal by Subject|1|||
144366752|NCT03879772|520553614|FG000|Overall Study|Protocol Violation|0|||
144366753|NCT03879772|520553615|FG001|Overall Study|Protocol Violation|0|||
144366754|NCT03879772|520553616|FG002|Overall Study|Protocol Violation|3|||
144366755|NCT03879772|520553617|FG003|Overall Study|Protocol Violation|1|||
144366756|NCT03879772|520553618|FG004|Overall Study|Protocol Violation|2|||
144366757|NCT03879772|520553614|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
144366758|NCT03879772|520553615|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
144366759|NCT03879772|520553616|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
144366760|NCT03879772|520553617|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
144366761|NCT03879772|520553618|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
144366762|NCT00930046|520553619|FG000|Overall Study|Wound catheter malfunctioned|1|||
144366763|NCT00930046|520553620|FG001|Overall Study|Wound catheter malfunctioned|2|||
144366764|NCT01598532|520553621|FG000|Overall Study|Lost to Follow-up|3|||
144366765|NCT01598532|520553621|FG000|Overall Study|Did not meet inclusion criteria|8|||
144366766|NCT01249261|520553623|FG000|Overall Study|Withdrawal by Subject|1|||
144366767|NCT01249261|520553624|FG001|Overall Study|Withdrawal by Subject|0|||
144366768|NCT00361296|520553627|FG000|Overall Study|Physician Decision|1|||
144366769|NCT00361296|520553627|FG000|Overall Study|Lack of Efficacy|2|||
144366770|NCT00391586|520553629|FG000|Overall Study|Progressive disease|13|||
144366771|NCT00391586|520553629|FG000|Overall Study|Adverse Event|5|||
144366772|NCT00391586|520553629|FG000|Overall Study|Physician Decision|2|||
144366773|NCT00391586|520553629|FG000|Overall Study|Death|4|||
144366774|NCT00904982|520553631|FG000|Overall Study|Withdrawal by Subject|2|||
144366775|NCT00904982|520553632|FG001|Overall Study|Withdrawal by Subject|0|||
144366776|NCT00904982|520553633|FG002|Overall Study|Withdrawal by Subject|0|||
144366777|NCT00904982|520553634|FG003|Overall Study|Withdrawal by Subject|0|||
144366778|NCT00686712|520553639|FG000|Overall Study|Protocol Violation|8|||
144366779|NCT00686712|520553640|FG001|Overall Study|Protocol Violation|8|||
144366780|NCT00686712|520553641|FG002|Overall Study|Protocol Violation|10|||
144366781|NCT00686712|520553639|FG000|Overall Study|Lost to Follow-up|1|||
144366782|NCT00686712|520553640|FG001|Overall Study|Lost to Follow-up|2|||
144366783|NCT00686712|520553641|FG002|Overall Study|Lost to Follow-up|3|||
144366784|NCT00686712|520553639|FG000|Overall Study|Adverse Event|1|||
144366785|NCT00686712|520553640|FG001|Overall Study|Adverse Event|1|||
144366786|NCT00686712|520553641|FG002|Overall Study|Adverse Event|0|||
144366787|NCT01318915|520553644|FG000|Overall Study|Lost to Follow-up|1|||
144366788|NCT00926237|520553646|FG000|Overall Study|Withdrawal by Subject|2|||
144366789|NCT00926237|520553647|FG001|Overall Study|Withdrawal by Subject|1|||
144366790|NCT01352793|520553653|FG000|Overall Study|Lost to Follow-up|289|||
144366791|NCT01352793|520553654|FG001|Overall Study|Lost to Follow-up|125|||
144366792|NCT01352793|520553653|FG000|Overall Study|Withdrawal by Subject|120|||
144366793|NCT01352793|520553654|FG001|Overall Study|Withdrawal by Subject|55|||
144366794|NCT01352793|520553653|FG000|Overall Study|Protocol Violation|44|||
144366795|NCT01352793|520553654|FG001|Overall Study|Protocol Violation|23|||
144366796|NCT01352793|520553653|FG000|Overall Study|Adverse Event|44|||
144366797|NCT01352793|520553654|FG001|Overall Study|Adverse Event|10|||
144366798|NCT01352793|520553653|FG000|Overall Study|Physician Decision|1|||
144366799|NCT01352793|520553654|FG001|Overall Study|Physician Decision|0|||
144366800|NCT01352793|520553653|FG000|Overall Study|Pregnancy|26|||
144366801|NCT01352793|520553654|FG001|Overall Study|Pregnancy|8|||
144366802|NCT01352793|520553653|FG000|Overall Study|Other|25|||
144366803|NCT01352793|520553654|FG001|Overall Study|Other|7|||
144366804|NCT01352793|520553653|FG000|Overall Study|Medication error|2|||
144366805|NCT01352793|520553654|FG001|Overall Study|Medication error|2|||
144366806|NCT01352793|520553653|FG000|Overall Study|Death|1|||
144366807|NCT01352793|520553654|FG001|Overall Study|Death|0|||
144366808|NCT01352793|520553653|FG000|Overall Study|Randomized but not vaccinated|8|||
144366809|NCT01352793|520553654|FG001|Overall Study|Randomized but not vaccinated|0|||
144366810|NCT01352793|520553653|FG000|Overall Study|No longer meets eligibility criteria|25|||
144538200|NCT00146172|521174129|FG007|Overall Study|Lost to Follow-up|1|||
144366811|NCT01352793|520553654|FG001|Overall Study|No longer meets eligibility criteria|15|||
144366812|NCT01929317|520553657|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
144704025|NCT00471237|521768818|FG006|Overall Study|Sponsor terminated study|0|||
144704026|NCT00471237|521768812|FG000|Overall Study|Non-compliance|0|||
144704027|NCT00471237|521768813|FG001|Overall Study|Non-compliance|1|||
144704028|NCT00471237|521768814|FG002|Overall Study|Non-compliance|0|||
144704029|NCT00471237|521768815|FG003|Overall Study|Non-compliance|1|||
144704030|NCT00471237|521768816|FG004|Overall Study|Non-compliance|0|||
144704031|NCT00471237|521768817|FG005|Overall Study|Non-compliance|0|||
144704032|NCT00471237|521768818|FG006|Overall Study|Non-compliance|0|||
144704033|NCT00471237|521768812|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
144704034|NCT00471237|521768813|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
144704035|NCT00471237|521768814|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
144704036|NCT00471237|521768815|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
144704037|NCT00471237|521768816|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
144704038|NCT00471237|521768817|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
144366813|NCT01929317|520553658|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
144366814|NCT01929317|520553657|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
144366815|NCT01929317|520553658|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
144366816|NCT01929317|520553657|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
144366817|NCT01929317|520553658|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
144366818|NCT01929317|520553657|FG000|Long-term Phase|Adverse Event|5|||
144366819|NCT01929317|520553658|FG001|Long-term Phase|Adverse Event|1|||
144366820|NCT01929317|520553657|FG000|Long-term Phase|Physician Decision|3|||
144366821|NCT01929317|520553658|FG001|Long-term Phase|Physician Decision|0|||
144366822|NCT01929317|520553657|FG000|Long-term Phase|Withdrawal by Subject|4|||
144366823|NCT01929317|520553658|FG001|Long-term Phase|Withdrawal by Subject|0|||
144366824|NCT01929317|520553657|FG000|Long-term Phase|Protocol Violation|1|||
144366825|NCT01929317|520553658|FG001|Long-term Phase|Protocol Violation|0|||
144366826|NCT01929317|520553657|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
144366827|NCT01929317|520553658|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
144366828|NCT01929317|520553657|FG000|Long-term Phase|Study Closed/Terminated|5|||
144366829|NCT01929317|520553658|FG001|Long-term Phase|Study Closed/Terminated|3|||
144366830|NCT02667119|520553659|FG000|Overall Study|Lost to Follow-up|3|||
144366831|NCT02667119|520553660|FG001|Overall Study|Lost to Follow-up|0|||
144366832|NCT01523756|520553661|FG000|Baseline Period|Adverse Event|0|||
144366833|NCT01523756|520553662|FG001|Baseline Period|Adverse Event|1|||
144366834|NCT01523756|520553661|FG000|Test Period 1|Adverse Event|1|||
144366835|NCT01523756|520553662|FG001|Test Period 1|Adverse Event|0|||
144366836|NCT01523756|520553661|FG000|Test Period 2|Withdrawal by Subject|0|||
144366837|NCT01523756|520553662|FG001|Test Period 2|Withdrawal by Subject|1|||
144366838|NCT03783078|520553663|FG000|Overall Study|Death|31|||
144366839|NCT03783078|520553663|FG000|Overall Study|Sponsor Decision|23|||
144366840|NCT03783078|520553663|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144366841|NCT02059278|520553667|FG000|Overall Study|Adverse Event|1|||
144366842|NCT02059278|520553668|FG001|Overall Study|Adverse Event|1|||
144366843|NCT02059278|520553667|FG000|Overall Study|Lost to Follow-up|1|||
144366844|NCT02059278|520553668|FG001|Overall Study|Lost to Follow-up|0|||
144366845|NCT02059278|520553667|FG000|Overall Study|Withdrawal by Subject|0|||
144366846|NCT02059278|520553668|FG001|Overall Study|Withdrawal by Subject|3|||
144366847|NCT02059278|520553667|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
144366848|NCT02059278|520553668|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
144704039|NCT00471237|521768818|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
144704040|NCT00471237|521768812|FG000|Overall Study|Early stopping due to non-efficacy|1|||
144704041|NCT00471237|521768813|FG001|Overall Study|Early stopping due to non-efficacy|0|||
144704042|NCT00471237|521768814|FG002|Overall Study|Early stopping due to non-efficacy|0|||
144704043|NCT00471237|521768815|FG003|Overall Study|Early stopping due to non-efficacy|0|||
144704044|NCT00471237|521768816|FG004|Overall Study|Early stopping due to non-efficacy|1|||
144704045|NCT00471237|521768817|FG005|Overall Study|Early stopping due to non-efficacy|0|||
144704046|NCT00471237|521768818|FG006|Overall Study|Early stopping due to non-efficacy|0|||
144704047|NCT00471237|521768812|FG000|Overall Study|Participant planned to travel to abraod|1|||
144704048|NCT00471237|521768813|FG001|Overall Study|Participant planned to travel to abraod|0|||
144704049|NCT00471237|521768814|FG002|Overall Study|Participant planned to travel to abraod|0|||
144704050|NCT00471237|521768815|FG003|Overall Study|Participant planned to travel to abraod|0|||
144704051|NCT00471237|521768816|FG004|Overall Study|Participant planned to travel to abraod|0|||
144704052|NCT00471237|521768817|FG005|Overall Study|Participant planned to travel to abraod|1|||
144704053|NCT00471237|521768818|FG006|Overall Study|Participant planned to travel to abraod|0|||
144704054|NCT00471237|521768812|FG000|Overall Study|High parathyroid hormone|0|||
144366849|NCT03043794|520553671|FG000|Overall Study|Lost to Follow-up|1|||
144366850|NCT03205423|520553676|FG000|Overall Study|Personal|1|||
144366851|NCT03205423|520553677|FG001|Overall Study|Personal|1|||
144366852|NCT03205423|520553676|FG000|Overall Study|Physician Decision|0|||
144366853|NCT03205423|520553677|FG001|Overall Study|Physician Decision|2|||
144366854|NCT05786651|520553680|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
144366855|NCT02855125|520553681|FG000|Overall Study|Withdrawal by Subject|2|||
144366856|NCT02855125|520553682|FG001|Overall Study|Withdrawal by Subject|2|||
144366857|NCT02855125|520553681|FG000|Overall Study|Clinical Disease Progression|5|||
144366858|NCT02855125|520553682|FG001|Overall Study|Clinical Disease Progression|4|||
144366859|NCT02855125|520553681|FG000|Overall Study|Radiologic Disease Progression|36|||
144366860|NCT02855125|520553682|FG001|Overall Study|Radiologic Disease Progression|39|||
144366861|NCT02855125|520553681|FG000|Overall Study|Adverse Event|11|||
144366862|NCT02855125|520553682|FG001|Overall Study|Adverse Event|7|||
144366863|NCT02855125|520553681|FG000|Overall Study|Physician Decision|1|||
144366864|NCT02855125|520553682|FG001|Overall Study|Physician Decision|0|||
144366865|NCT02855125|520553681|FG000|Overall Study|On Treatment|9|||
144366866|NCT02855125|520553682|FG001|Overall Study|On Treatment|11|||
144366867|NCT02855125|520553681|FG000|Overall Study|Randomized but not treated|0|||
144366868|NCT02855125|520553682|FG001|Overall Study|Randomized but not treated|1|||
144366869|NCT04467905|520553683|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
144366870|NCT04467905|520553684|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
144366871|NCT04467905|520553685|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
144366872|NCT04467905|520553683|FG000|Overall Study|Conversion to SR|0|||
144366873|NCT04467905|520553684|FG001|Overall Study|Conversion to SR|0|||
144366874|NCT04467905|520553685|FG002|Overall Study|Conversion to SR|3|||
144366875|NCT04467905|520553683|FG000|Overall Study|Technical issue with Holter ECG|0|||
144366876|NCT04467905|520553684|FG001|Overall Study|Technical issue with Holter ECG|0|||
144366877|NCT04467905|520553685|FG002|Overall Study|Technical issue with Holter ECG|3|||
144366878|NCT04467905|520553683|FG000|Overall Study|Hemodynamic instability|0|||
144366879|NCT04467905|520553684|FG001|Overall Study|Hemodynamic instability|0|||
144366880|NCT04467905|520553685|FG002|Overall Study|Hemodynamic instability|1|||
144366881|NCT04467905|520553683|FG000|Overall Study|Site misinterpretation of protocol|0|||
144366882|NCT04467905|520553684|FG001|Overall Study|Site misinterpretation of protocol|0|||
144366883|NCT04467905|520553685|FG002|Overall Study|Site misinterpretation of protocol|1|||
144366884|NCT04145349|520555339|FG000|Overall Study|Withdrawal by Subject|3|||
144366885|NCT04145349|520555340|FG001|Overall Study|Withdrawal by Subject|0|||
144366886|NCT04145349|520555339|FG000|Overall Study|Lost to Follow-up|0|||
144366887|NCT04145349|520555340|FG001|Overall Study|Lost to Follow-up|1|||
144366888|NCT04145349|520555339|FG000|Overall Study|On study treatment (Ongoing)|0|||
144366889|NCT04145349|520555340|FG001|Overall Study|On study treatment (Ongoing)|1|||
144366890|NCT00775190|520555341|FG000|Overall Study|Lost to Follow-up|2|||
144366891|NCT00775190|520555342|FG001|Overall Study|Lost to Follow-up|3|||
144366892|NCT00775190|520555341|FG000|Overall Study|Withdrawal by Subject|1|||
144366893|NCT00775190|520555342|FG001|Overall Study|Withdrawal by Subject|2|||
144366894|NCT00775190|520555341|FG000|Overall Study|Protocol Violation|1|||
144366895|NCT00775190|520555342|FG001|Overall Study|Protocol Violation|0|||
144366896|NCT01709084|520555343|FG000|Overall Study|Lost to Follow-up|4|||
144366897|NCT01709084|520555344|FG001|Overall Study|Lost to Follow-up|7|||
144366898|NCT01709084|520555343|FG000|Overall Study|Withdrawal by Subject|2|||
144366899|NCT01709084|520555344|FG001|Overall Study|Withdrawal by Subject|2|||
144366900|NCT01709084|520555343|FG000|Overall Study|Adverse Event|5|||
144366901|NCT01709084|520555344|FG001|Overall Study|Adverse Event|0|||
144366902|NCT01709084|520555343|FG000|Overall Study|Other|5|||
144366903|NCT01709084|520555344|FG001|Overall Study|Other|3|||
144366904|NCT01709084|520555343|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
144366905|NCT01709084|520555344|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
144366906|NCT01709084|520555343|FG000|Overall Study|Not Treated|0|||
144366907|NCT01709084|520555344|FG001|Overall Study|Not Treated|2|||
144366908|NCT01942837|520555355|FG000|Overall Study|Death|1|||
144366909|NCT01942837|520555355|FG000|Overall Study|Symptomatic or radiographic progression|49|||
144366910|NCT01942837|520555355|FG000|Overall Study|Adverse Event|6|||
144366911|NCT01942837|520555355|FG000|Overall Study|Physician Decision|3|||
144366912|NCT01942837|520555355|FG000|Overall Study|Withdrawal by Subject|2|||
144366913|NCT01942837|520555355|FG000|Overall Study|Intercurrent Illness|1|||
144704055|NCT00471237|521768813|FG001|Overall Study|High parathyroid hormone|0|||
144704056|NCT00471237|521768814|FG002|Overall Study|High parathyroid hormone|1|||
144704057|NCT00471237|521768815|FG003|Overall Study|High parathyroid hormone|0|||
144704058|NCT00471237|521768816|FG004|Overall Study|High parathyroid hormone|0|||
144366914|NCT01942837|520555355|FG000|Overall Study|On treatment|3|||
144366915|NCT01942837|520555355|FG000|Overall Study|Never initiate the treatment|2|||
144366916|NCT01298648|520555356|FG000|Overall Study|Withdrawal by Subject|2|||
144366917|NCT01298648|520555356|FG000|Overall Study|Lost to Follow-up|21|||
144366918|NCT02351856|520555360|FG000|Overall Study|Adverse Event|2|||
144366919|NCT02351856|520555360|FG000|Overall Study|Physician Decision|5|||
144366920|NCT02351856|520555360|FG000|Overall Study|Study terminated by sponsor|1|||
144366921|NCT02038933|520555361|FG000|Overall Study|Disease progression|104|||
144366922|NCT02038933|520555361|FG000|Overall Study|Study drug toxicity|6|||
144366923|NCT02038933|520555361|FG000|Overall Study|Adverse event unrelated to study drug|6|||
144704059|NCT00471237|521768817|FG005|Overall Study|High parathyroid hormone|0|||
144704060|NCT00471237|521768818|FG006|Overall Study|High parathyroid hormone|0|||
144366924|NCT02038933|520555361|FG000|Overall Study|Participant request to discontinue treatment|2|||
144366925|NCT02038933|520555361|FG000|Overall Study|Lost to Follow-up|1|||
144366926|NCT02038933|520555361|FG000|Overall Study|Other reasons|2|||
144366927|NCT04226742|520555362|FG000|Overall Study|Lost to Follow-up|16|||
144366928|NCT04226742|520555363|FG001|Overall Study|Lost to Follow-up|13|||
144366929|NCT04226742|520555362|FG000|Overall Study|Withdrawal by Subject|5|||
144366930|NCT04226742|520555363|FG001|Overall Study|Withdrawal by Subject|3|||
144366931|NCT01193244|520555366|FG000|Overall Study|Withdrawal by Subject|79|||
144366932|NCT01193244|520555367|FG001|Overall Study|Withdrawal by Subject|97|||
144366933|NCT01193244|520555366|FG000|Overall Study|Other|303|||
144366934|NCT01193244|520555367|FG001|Overall Study|Other|278|||
144366935|NCT01193244|520555366|FG000|Overall Study|Lost to Follow-up|6|||
144366936|NCT01193244|520555367|FG001|Overall Study|Lost to Follow-up|15|||
144366937|NCT01772316|520555368|FG000|Overall Study|Serious adverse event|1|||
144366938|NCT01772316|520555368|FG000|Overall Study|Inform consent withdrawn|1|||
144366939|NCT01772316|520555368|FG000|Overall Study|Withdrawn by sponsor decision|5|||
144366940|NCT03763877|520555377|FG000|Overall Study|Withdrawal by Subject|3|||
144366941|NCT03763877|520555378|FG001|Overall Study|Withdrawal by Subject|1|||
144366942|NCT03763877|520555379|FG002|Overall Study|Withdrawal by Subject|3|||
144366943|NCT03763877|520555380|FG003|Overall Study|Withdrawal by Subject|4|||
144366944|NCT03763877|520555377|FG000|Overall Study|Adverse Event|1|||
144366945|NCT03763877|520555378|FG001|Overall Study|Adverse Event|1|||
144366946|NCT03763877|520555379|FG002|Overall Study|Adverse Event|3|||
144366947|NCT03763877|520555380|FG003|Overall Study|Adverse Event|1|||
144366948|NCT03763877|520555377|FG000|Overall Study|Protocol Violation|1|||
144366949|NCT03763877|520555378|FG001|Overall Study|Protocol Violation|1|||
144366950|NCT03763877|520555379|FG002|Overall Study|Protocol Violation|0|||
144366951|NCT03763877|520555380|FG003|Overall Study|Protocol Violation|0|||
144366952|NCT03763877|520555377|FG000|Overall Study|Lost to Follow-up|0|||
144366953|NCT03763877|520555378|FG001|Overall Study|Lost to Follow-up|1|||
144366954|NCT03763877|520555379|FG002|Overall Study|Lost to Follow-up|1|||
144366955|NCT03763877|520555380|FG003|Overall Study|Lost to Follow-up|0|||
144366956|NCT03040336|520555381|FG000|Overall Study|Death|1|||
144366957|NCT03040336|520555382|FG001|Overall Study|Death|0|||
144366958|NCT03040336|520555381|FG000|Overall Study|Withdrawal by Subject|2|||
144366959|NCT03040336|520555382|FG001|Overall Study|Withdrawal by Subject|3|||
144366960|NCT01774721|520555388|FG000|Overall Study|Death|133|||
144366961|NCT01774721|520555389|FG001|Overall Study|Death|152|||
144366962|NCT01774721|520555388|FG000|Overall Study|Withdrawal by Subject|20|||
144366963|NCT01774721|520555389|FG001|Overall Study|Withdrawal by Subject|14|||
144366964|NCT01774721|520555388|FG000|Overall Study|Lost to Follow-up|6|||
144366965|NCT01774721|520555389|FG001|Overall Study|Lost to Follow-up|7|||
144366966|NCT01774721|520555388|FG000|Overall Study|Did not meet eligibility criteria|0|||
144366967|NCT01774721|520555389|FG001|Overall Study|Did not meet eligibility criteria|3|||
144366968|NCT01774721|520555388|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
144366969|NCT01774721|520555389|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
144366970|NCT01774721|520555388|FG000|Overall Study|Study terminated by sponsor|5|||
144366971|NCT01774721|520555389|FG001|Overall Study|Study terminated by sponsor|0|||
144366972|NCT01774721|520555388|FG000|Overall Study|Disease progression|5|||
144366973|NCT01774721|520555389|FG001|Overall Study|Disease progression|0|||
144366974|NCT01600716|520555390|FG000|Overall Study|Other Reasons|3|||
144366975|NCT01600716|520555391|FG001|Overall Study|Other Reasons|1|||
144366976|NCT01600716|520555390|FG000|Overall Study|Personal Reasons|0|||
144366977|NCT01600716|520555391|FG001|Overall Study|Personal Reasons|2|||
144366978|NCT01600716|520555390|FG000|Overall Study|Lost to Follow-up|0|||
144366979|NCT01600716|520555391|FG001|Overall Study|Lost to Follow-up|2|||
144366980|NCT01600716|520555390|FG000|Overall Study|Pregnancy|1|||
144366981|NCT01600716|520555391|FG001|Overall Study|Pregnancy|0|||
144366982|NCT01600716|520555390|FG000|Overall Study|Lack of Efficacy|2|||
144366983|NCT01600716|520555391|FG001|Overall Study|Lack of Efficacy|1|||
144366984|NCT01600716|520555390|FG000|Overall Study|Adverse Event|1|||
144366985|NCT01600716|520555391|FG001|Overall Study|Adverse Event|1|||
144366986|NCT03847896|520555397|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
144366987|NCT03847896|520555398|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
144366988|NCT03847896|520555399|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
144366989|NCT03847896|520555400|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
144366990|NCT03847896|520555401|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
144366991|NCT03847896|520555397|FG000|Overall Study|Withdrawal by Subject|2|||
144366992|NCT03847896|520555398|FG001|Overall Study|Withdrawal by Subject|10|||
144366993|NCT03847896|520555399|FG002|Overall Study|Withdrawal by Subject|5|||
144366994|NCT03847896|520555400|FG003|Overall Study|Withdrawal by Subject|9|||
144366995|NCT03847896|520555401|FG004|Overall Study|Withdrawal by Subject|8|||
144366996|NCT03847896|520555397|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144366997|NCT03847896|520555398|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144366998|NCT03847896|520555399|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144366999|NCT03847896|520555400|FG003|Overall Study|Withdrawal by parent/guardian|0|||
144367000|NCT03847896|520555401|FG004|Overall Study|Withdrawal by parent/guardian|0|||
144367001|NCT03847896|520555397|FG000|Overall Study|Adverse Event|2|||
144367002|NCT03847896|520555398|FG001|Overall Study|Adverse Event|1|||
144704061|NCT00471237|521768812|FG000|Overall Study|Participant lost medication|0|||
144704062|NCT00471237|521768813|FG001|Overall Study|Participant lost medication|0|||
144704063|NCT00471237|521768814|FG002|Overall Study|Participant lost medication|0|||
144704064|NCT00471237|521768815|FG003|Overall Study|Participant lost medication|0|||
144704065|NCT00471237|521768816|FG004|Overall Study|Participant lost medication|1|||
144704066|NCT00471237|521768817|FG005|Overall Study|Participant lost medication|0|||
144704067|NCT00471237|521768818|FG006|Overall Study|Participant lost medication|0|||
144704068|NCT00471237|521768812|FG000|Overall Study|Administration of prohibited medicine|0|||
144704069|NCT00471237|521768813|FG001|Overall Study|Administration of prohibited medicine|0|||
144704070|NCT00471237|521768814|FG002|Overall Study|Administration of prohibited medicine|0|||
144704071|NCT00471237|521768815|FG003|Overall Study|Administration of prohibited medicine|0|||
144704072|NCT00471237|521768816|FG004|Overall Study|Administration of prohibited medicine|1|||
144367003|NCT03847896|520555399|FG002|Overall Study|Adverse Event|3|||
144367004|NCT03847896|520555400|FG003|Overall Study|Adverse Event|2|||
144367005|NCT03847896|520555401|FG004|Overall Study|Adverse Event|4|||
144367006|NCT03847896|520555397|FG000|Overall Study|A severe exacerbation event|0|||
144367007|NCT03847896|520555398|FG001|Overall Study|A severe exacerbation event|0|||
144367008|NCT03847896|520555399|FG002|Overall Study|A severe exacerbation event|0|||
144367009|NCT03847896|520555400|FG003|Overall Study|A severe exacerbation event|0|||
144367010|NCT03847896|520555401|FG004|Overall Study|A severe exacerbation event|3|||
144367011|NCT03847896|520555397|FG000|Overall Study|Protocol Violation|0|||
144367012|NCT03847896|520555398|FG001|Overall Study|Protocol Violation|2|||
144367013|NCT03847896|520555399|FG002|Overall Study|Protocol Violation|1|||
144367014|NCT03847896|520555400|FG003|Overall Study|Protocol Violation|0|||
144367015|NCT03847896|520555401|FG004|Overall Study|Protocol Violation|2|||
144367016|NCT03847896|520555397|FG000|Overall Study|Lost to Follow-up|0|||
144367017|NCT03847896|520555398|FG001|Overall Study|Lost to Follow-up|0|||
144367018|NCT03847896|520555399|FG002|Overall Study|Lost to Follow-up|0|||
144367019|NCT03847896|520555400|FG003|Overall Study|Lost to Follow-up|1|||
144367020|NCT03847896|520555401|FG004|Overall Study|Lost to Follow-up|0|||
144367021|NCT03847896|520555397|FG000|Overall Study|Condition under investigation worsened|0|||
144367022|NCT03847896|520555398|FG001|Overall Study|Condition under investigation worsened|0|||
144367023|NCT03847896|520555399|FG002|Overall Study|Condition under investigation worsened|0|||
144367024|NCT03847896|520555400|FG003|Overall Study|Condition under investigation worsened|1|||
144367025|NCT03847896|520555401|FG004|Overall Study|Condition under investigation worsened|1|||
144367026|NCT03847896|520555397|FG000|Overall Study|Lack of Efficacy|0|||
144367027|NCT03847896|520555398|FG001|Overall Study|Lack of Efficacy|0|||
144367028|NCT03847896|520555399|FG002|Overall Study|Lack of Efficacy|0|||
144367029|NCT03847896|520555400|FG003|Overall Study|Lack of Efficacy|2|||
144367030|NCT03847896|520555401|FG004|Overall Study|Lack of Efficacy|2|||
144367031|NCT03847896|520555397|FG000|Overall Study|Other reasons|3|||
144367032|NCT03847896|520555398|FG001|Overall Study|Other reasons|3|||
144367033|NCT03847896|520555399|FG002|Overall Study|Other reasons|1|||
144367034|NCT03847896|520555400|FG003|Overall Study|Other reasons|2|||
144367035|NCT03847896|520555401|FG004|Overall Study|Other reasons|1|||
144367036|NCT02453321|520555402|FG000|Overall Study|Weakness|1|||
144367037|NCT02453321|520555403|FG001|Overall Study|Weakness|1|||
144367038|NCT02453321|520555404|FG002|Overall Study|Weakness|2|||
144367039|NCT02453321|520555402|FG000|Overall Study|Deep Venous Thrombosis|0|||
144367040|NCT02453321|520555403|FG001|Overall Study|Deep Venous Thrombosis|1|||
144367041|NCT02453321|520555404|FG002|Overall Study|Deep Venous Thrombosis|0|||
144367042|NCT02404025|520555408|FG000|Overall Study|Adverse Event|1|||
144367043|NCT02404025|520555408|FG000|Overall Study|Lack of Efficacy|3|||
144367044|NCT02633306|520555410|FG000|Overall Study|Withdrawal by Subject|3|||
144367045|NCT01213472|520555413|FG000|Overall Study|Recurrence/Progressive disease|25|||
144704073|NCT00471237|521768817|FG005|Overall Study|Administration of prohibited medicine|0|||
144367046|NCT01213472|520555413|FG000|Overall Study|Withdrawal by Subject|1|||
144704074|NCT00471237|521768818|FG006|Overall Study|Administration of prohibited medicine|0|||
144367047|NCT01213472|520555413|FG000|Overall Study|Physician Decision|1|||
144367048|NCT03594110|520555417|FG000|Interventional Part|Participant concerned about study treatment|23|||
144367049|NCT03594110|520555418|FG001|Interventional Part|Participant concerned about study treatment|28|||
144704075|NCT00471237|521768812|FG000|Overall Study|Participant shifted residence|0|||
144367050|NCT03594110|520555417|FG000|Interventional Part|Doctor advice|38|||
144367051|NCT03594110|520555418|FG001|Interventional Part|Doctor advice|40|||
144367052|NCT03594110|520555417|FG000|Interventional Part|Participants' wish|89|||
144367053|NCT03594110|520555418|FG001|Interventional Part|Participants' wish|68|||
144367054|NCT03594110|520555417|FG000|Interventional Part|Adverse event-non-fatal events|119|||
144367055|NCT03594110|520555418|FG001|Interventional Part|Adverse event-non-fatal events|116|||
144479748|NCT01167179|520957602|FG001|Overall Study|Withdrawal by Subject|2|||
144367056|NCT03594110|520555417|FG000|Interventional Part|Study drug stopped, reason missing|336|||
144479749|NCT01167179|520957601|FG000|Overall Study|diverse|6|||
144367057|NCT03594110|520555418|FG001|Interventional Part|Study drug stopped, reason missing|294|||
144367058|NCT03594110|520555417|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
144367059|NCT03594110|520555418|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
144367060|NCT03594110|520555417|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
144367061|NCT03594110|520555418|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
144367062|NCT03594110|520555417|FG000|Interventional Part|Contraindicated drug started|32|||
144367063|NCT03594110|520555418|FG001|Interventional Part|Contraindicated drug started|18|||
144367064|NCT03594110|520555417|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
144367065|NCT03594110|520555418|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
144367066|NCT03594110|520555417|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
144367067|NCT03594110|520555418|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
144367068|NCT03594110|520555417|FG000|Non-interventional Part|Withdrawal by Subject|3|||
144367069|NCT03594110|520555418|FG001|Non-interventional Part|Withdrawal by Subject|4|||
144367070|NCT03594110|520555417|FG000|Non-interventional Part|Lost to Follow-up|45|||
144367071|NCT03594110|520555418|FG001|Non-interventional Part|Lost to Follow-up|41|||
144367072|NCT02085460|520555419|FG000|Overall Study|Adverse Event|2|||
144367073|NCT02085460|520555420|FG001|Overall Study|Adverse Event|2|||
144367074|NCT02085460|520555421|FG002|Overall Study|Adverse Event|1|||
144367075|NCT02085460|520555419|FG000|Overall Study|Physician Decision|1|||
144367076|NCT02085460|520555420|FG001|Overall Study|Physician Decision|1|||
144367077|NCT02085460|520555421|FG002|Overall Study|Physician Decision|2|||
144367078|NCT02085460|520555419|FG000|Overall Study|Withdrawal by Subject|11|||
144367079|NCT02085460|520555420|FG001|Overall Study|Withdrawal by Subject|5|||
144367080|NCT02085460|520555421|FG002|Overall Study|Withdrawal by Subject|7|||
144367081|NCT01967940|520555425|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
144367082|NCT01967940|520555426|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
144367083|NCT01967940|520555427|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
144367084|NCT01967940|520555428|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
144367085|NCT01967940|520555425|FG000|Part 2|Adverse Event|0|||
144367086|NCT01967940|520555426|FG001|Part 2|Adverse Event|0|||
144367087|NCT01967940|520555427|FG002|Part 2|Adverse Event|0|||
144367088|NCT01967940|520555428|FG003|Part 2|Adverse Event|1|||
144367089|NCT01967940|520555425|FG000|Part 2|Unknown Reason|0|||
144367090|NCT01967940|520555426|FG001|Part 2|Unknown Reason|0|||
144367091|NCT01967940|520555427|FG002|Part 2|Unknown Reason|0|||
144367092|NCT01967940|520555428|FG003|Part 2|Unknown Reason|1|||
144367093|NCT02072668|520555434|FG000|Second Intervention|Lost to Follow-up|1|||
144367094|NCT02072668|520555435|FG001|Second Intervention|Lost to Follow-up|0|||
144367095|NCT02420821|520555440|FG000|Overall Study|Lost to Follow-up|6|||
144367096|NCT02420821|520555441|FG001|Overall Study|Lost to Follow-up|6|||
144367097|NCT02420821|520555440|FG000|Overall Study|Non-compliance|0|||
144367098|NCT02420821|520555441|FG001|Overall Study|Non-compliance|2|||
144367099|NCT02420821|520555440|FG000|Overall Study|Physician Decision|6|||
144367100|NCT02420821|520555441|FG001|Overall Study|Physician Decision|2|||
144367101|NCT02420821|520555440|FG000|Overall Study|Withdrawal by Subject|32|||
144367102|NCT02420821|520555441|FG001|Overall Study|Withdrawal by Subject|25|||
144367103|NCT02420821|520555440|FG000|Overall Study|Death|270|||
144367104|NCT02420821|520555441|FG001|Overall Study|Death|263|||
144367105|NCT02420821|520555440|FG000|Overall Study|Study Terminated By Sponsor|145|||
144367106|NCT02420821|520555441|FG001|Overall Study|Study Terminated By Sponsor|149|||
144367107|NCT02420821|520555440|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
144367108|NCT02420821|520555441|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
144367109|NCT02420821|520555440|FG000|Overall Study|Adverse Event|0|||
144367110|NCT02420821|520555441|FG001|Overall Study|Adverse Event|1|||
144367111|NCT02420821|520555440|FG000|Overall Study|Protinuria|0|||
144367112|NCT02420821|520555441|FG001|Overall Study|Protinuria|1|||
144367113|NCT02420821|520555440|FG000|Overall Study|Progressive Disease|1|||
144367114|NCT02420821|520555441|FG001|Overall Study|Progressive Disease|1|||
144367115|NCT02420821|520555440|FG000|Overall Study|Disease Progression|0|||
144367116|NCT02420821|520555441|FG001|Overall Study|Disease Progression|1|||
144367117|NCT02420821|520555440|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
144367118|NCT02420821|520555441|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
144367119|NCT01658436|520555442|FG000|Overall Study|Adverse Event|6|||
144367120|NCT01658436|520555443|FG001|Overall Study|Adverse Event|5|||
144367121|NCT01658436|520555442|FG000|Overall Study|Physician Decision|1|||
144367122|NCT01658436|520555443|FG001|Overall Study|Physician Decision|0|||
144367123|NCT01658436|520555442|FG000|Overall Study|Progressive disease|12|||
144367124|NCT01658436|520555443|FG001|Overall Study|Progressive disease|4|||
144367125|NCT01658436|520555442|FG000|Overall Study|Study terminated by sponsor|0|||
144367126|NCT01658436|520555443|FG001|Overall Study|Study terminated by sponsor|1|||
144367127|NCT01658436|520555442|FG000|Overall Study|Subject/guardian decision|0|||
144367128|NCT01658436|520555443|FG001|Overall Study|Subject/guardian decision|1|||
144367129|NCT01658436|520555442|FG000|Overall Study|Death|1|||
144367130|NCT01658436|520555443|FG001|Overall Study|Death|0|||
144367131|NCT04119414|520555444|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
144367132|NCT04322526|520555445|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
144367133|NCT04322526|520555446|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
144367134|NCT04322526|520555445|FG000|Washout (1 Week)|Lost to Follow-up|1|||
144367135|NCT04322526|520555446|FG001|Washout (1 Week)|Lost to Follow-up|2|||
144367136|NCT01716234|520555447|FG000|Overall Study|Protocol Violation|0|||
144367137|NCT01716234|520555448|FG001|Overall Study|Protocol Violation|0|||
144367138|NCT01716234|520555449|FG002|Overall Study|Protocol Violation|0|||
144367139|NCT01716234|520555450|FG003|Overall Study|Protocol Violation|1|||
144367140|NCT01716234|520555451|FG004|Overall Study|Protocol Violation|1|||
144367141|NCT01716234|520555452|FG005|Overall Study|Protocol Violation|1|||
144367142|NCT01716234|520555453|FG006|Overall Study|Protocol Violation|0|||
144367143|NCT01716234|520555447|FG000|Overall Study|Lack of Efficacy|0|||
144367144|NCT01716234|520555448|FG001|Overall Study|Lack of Efficacy|0|||
144367145|NCT01716234|520555449|FG002|Overall Study|Lack of Efficacy|0|||
144367146|NCT01716234|520555450|FG003|Overall Study|Lack of Efficacy|1|||
144367147|NCT01716234|520555451|FG004|Overall Study|Lack of Efficacy|0|||
144367148|NCT01716234|520555452|FG005|Overall Study|Lack of Efficacy|0|||
144367149|NCT01716234|520555453|FG006|Overall Study|Lack of Efficacy|0|||
144367150|NCT01716234|520555447|FG000|Overall Study|Did not meet protocol eligibility|0|||
144367151|NCT01716234|520555448|FG001|Overall Study|Did not meet protocol eligibility|0|||
144367152|NCT01716234|520555449|FG002|Overall Study|Did not meet protocol eligibility|1|||
144367153|NCT01716234|520555450|FG003|Overall Study|Did not meet protocol eligibility|0|||
144367154|NCT01716234|520555451|FG004|Overall Study|Did not meet protocol eligibility|0|||
144367155|NCT01716234|520555452|FG005|Overall Study|Did not meet protocol eligibility|4|||
144367156|NCT01716234|520555453|FG006|Overall Study|Did not meet protocol eligibility|0|||
144367157|NCT01716234|520555447|FG000|Overall Study|Adverse Event|7|||
144367158|NCT01716234|520555448|FG001|Overall Study|Adverse Event|10|||
144367159|NCT01716234|520555449|FG002|Overall Study|Adverse Event|2|||
144367160|NCT01716234|520555450|FG003|Overall Study|Adverse Event|8|||
144367161|NCT01716234|520555451|FG004|Overall Study|Adverse Event|3|||
144367162|NCT01716234|520555452|FG005|Overall Study|Adverse Event|6|||
144704076|NCT00471237|521768813|FG001|Overall Study|Participant shifted residence|0|||
144704077|NCT00471237|521768814|FG002|Overall Study|Participant shifted residence|0|||
144704078|NCT00471237|521768815|FG003|Overall Study|Participant shifted residence|0|||
144704079|NCT00471237|521768816|FG004|Overall Study|Participant shifted residence|1|||
144704080|NCT00471237|521768817|FG005|Overall Study|Participant shifted residence|0|||
144704081|NCT00471237|521768818|FG006|Overall Study|Participant shifted residence|0|||
144704082|NCT00471237|521768812|FG000|Overall Study|Participant's decision|0|||
144704083|NCT00471237|521768813|FG001|Overall Study|Participant's decision|0|||
144704084|NCT00471237|521768814|FG002|Overall Study|Participant's decision|0|||
144704085|NCT00471237|521768815|FG003|Overall Study|Participant's decision|0|||
144704086|NCT00471237|521768816|FG004|Overall Study|Participant's decision|0|||
144704087|NCT00471237|521768817|FG005|Overall Study|Participant's decision|1|||
144704088|NCT00471237|521768818|FG006|Overall Study|Participant's decision|0|||
144704089|NCT03710824|521768819|FG000|Overall Study|Withdrawal by Subject|1|||
144704090|NCT03710824|521768819|FG000|Overall Study|Lost to Follow-up|3|||
144704091|NCT03710824|521768819|FG000|Overall Study|Adverse Event|25|||
144704092|NCT03710824|521768819|FG000|Overall Study|Treatment discontinuation|2|||
144704093|NCT02329834|521768820|FG000|Overall Study|Physician Decision|1|||
144704094|NCT02329834|521768821|FG001|Overall Study|Physician Decision|0|||
144704095|NCT01317199|521768822|FG000|Dose-escalation Phase 1|Physician Decision|5|||
144704096|NCT01317199|521768823|FG001|Dose-escalation Phase 1|Physician Decision|0|||
144704097|NCT01317199|521768824|FG002|Dose-escalation Phase 1|Physician Decision|0|||
144704098|NCT01317199|521768825|FG003|Dose-escalation Phase 1|Physician Decision|0|||
144704099|NCT01317199|521768822|FG000|Dose-escalation Phase 1|Disease progression|1|||
144704100|NCT01317199|521768823|FG001|Dose-escalation Phase 1|Disease progression|0|||
144704101|NCT01317199|521768824|FG002|Dose-escalation Phase 1|Disease progression|0|||
144704102|NCT01317199|521768825|FG003|Dose-escalation Phase 1|Disease progression|0|||
144704103|NCT01317199|521768822|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
144704104|NCT01317199|521768823|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
144704105|NCT01317199|521768824|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
144704106|NCT01317199|521768825|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
144367163|NCT01716234|520555453|FG006|Overall Study|Adverse Event|0|||
144367164|NCT01716234|520555447|FG000|Overall Study|Withdrawal by Subject|3|||
144367165|NCT01716234|520555448|FG001|Overall Study|Withdrawal by Subject|0|||
144367166|NCT01716234|520555449|FG002|Overall Study|Withdrawal by Subject|2|||
144367167|NCT01716234|520555450|FG003|Overall Study|Withdrawal by Subject|2|||
144367168|NCT01716234|520555451|FG004|Overall Study|Withdrawal by Subject|1|||
144367169|NCT01716234|520555452|FG005|Overall Study|Withdrawal by Subject|3|||
144367170|NCT01716234|520555453|FG006|Overall Study|Withdrawal by Subject|0|||
144367171|NCT00474812|520555456|FG000|Overall Study|Withdrawal by Subject|5|||
144367172|NCT00474812|520555456|FG000|Overall Study|No Initiation of treatment|2|||
144367173|NCT05408429|520555459|FG000|Overall Study|Lost to Follow-up|1|||
144704107|NCT01317199|521768822|FG000|Randomized Phase 2|Disease progression|0|||
144704108|NCT01317199|521768823|FG001|Randomized Phase 2|Disease progression|3|||
144704109|NCT01317199|521768824|FG002|Randomized Phase 2|Disease progression|7|||
144704110|NCT01317199|521768825|FG003|Randomized Phase 2|Disease progression|5|||
144704111|NCT01317199|521768822|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
144704112|NCT01317199|521768823|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
144704113|NCT01317199|521768824|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
144704114|NCT01317199|521768825|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
144704115|NCT01317199|521768822|FG000|Randomized Phase 2|Adverse Event|0|||
144704116|NCT01317199|521768823|FG001|Randomized Phase 2|Adverse Event|0|||
144704117|NCT01317199|521768824|FG002|Randomized Phase 2|Adverse Event|0|||
144704118|NCT01317199|521768825|FG003|Randomized Phase 2|Adverse Event|1|||
144704119|NCT01317199|521768822|FG000|Randomized Phase 2|Comorbidities|0|||
144704120|NCT01317199|521768823|FG001|Randomized Phase 2|Comorbidities|2|||
144704121|NCT01317199|521768824|FG002|Randomized Phase 2|Comorbidities|2|||
144704122|NCT01317199|521768825|FG003|Randomized Phase 2|Comorbidities|2|||
144704123|NCT01317199|521768822|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
144704124|NCT01317199|521768823|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
144704125|NCT01317199|521768824|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
144704126|NCT01317199|521768825|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
144704127|NCT01317199|521768822|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
144704128|NCT01317199|521768823|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
144704129|NCT01317199|521768824|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
144704130|NCT01317199|521768825|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
144704131|NCT01317199|521768822|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
144704132|NCT01317199|521768823|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
144704133|NCT01317199|521768824|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
144704134|NCT01317199|521768825|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
144704135|NCT01317199|521768822|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
144704136|NCT01317199|521768823|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
144704137|NCT01317199|521768824|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
144704138|NCT01317199|521768825|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
144704139|NCT01301625|521768831|FG000|Overall Study|Death|5|||
144704140|NCT01301625|521768831|FG000|Overall Study|Not Due|21|||
144704141|NCT01301625|521768831|FG000|Overall Study|Expected|8|||
144704142|NCT01301625|521768831|FG000|Overall Study|Lost to Follow-up|1|||
144367174|NCT05408429|520555460|FG001|Overall Study|Lost to Follow-up|1|||
144367175|NCT05408429|520555461|FG002|Overall Study|Lost to Follow-up|0|||
144367176|NCT05408429|520555459|FG000|Overall Study|Withdrawal by Subject|5|||
144367177|NCT05408429|520555460|FG001|Overall Study|Withdrawal by Subject|0|||
144367178|NCT05408429|520555461|FG002|Overall Study|Withdrawal by Subject|1|||
144367179|NCT03435211|520555462|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
144367180|NCT02195518|520555463|FG000|Overall Study|Adverse Event|1|||
144367181|NCT02195518|520555463|FG000|Overall Study|Protocol Violation|4|||
144367182|NCT02195518|520555463|FG000|Overall Study|Pregnancy|2|||
144367183|NCT02195518|520555463|FG000|Overall Study|Withdrawal by Subject|1|||
144367184|NCT02195518|520555463|FG000|Overall Study|Lost to Follow-up|1|||
144367185|NCT03818256|520555464|FG000|Overall Study|Withdrawal by Subject|2|||
144367186|NCT03818256|520555465|FG001|Overall Study|Withdrawal by Subject|2|||
144367187|NCT03818256|520555464|FG000|Overall Study|Adverse Event|3|||
144367188|NCT03818256|520555465|FG001|Overall Study|Adverse Event|1|||
144367189|NCT03818256|520555464|FG000|Overall Study|Lost to Follow-up|0|||
144367190|NCT03818256|520555465|FG001|Overall Study|Lost to Follow-up|5|||
144367191|NCT03818256|520555464|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
144367192|NCT03818256|520555465|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
144367193|NCT03818256|520555464|FG000|Overall Study|Not reporting for scheduled visits|1|||
144367194|NCT03818256|520555465|FG001|Overall Study|Not reporting for scheduled visits|0|||
144367195|NCT03818256|520555464|FG000|Overall Study|Non-compliant with investigational product|1|||
144367196|NCT03818256|520555465|FG001|Overall Study|Non-compliant with investigational product|0|||
144367197|NCT01342211|520555466|FG000|Overall Study|Lost to Follow-up|0|||
144367198|NCT01342211|520555467|FG001|Overall Study|Lost to Follow-up|0|||
144367199|NCT01342211|520555468|FG002|Overall Study|Lost to Follow-up|0|||
144367200|NCT01342211|520555469|FG003|Overall Study|Lost to Follow-up|1|||
144367201|NCT01342211|520555470|FG004|Overall Study|Lost to Follow-up|0|||
144367202|NCT01342211|520555466|FG000|Overall Study|Adverse Event|0|||
144367203|NCT01342211|520555467|FG001|Overall Study|Adverse Event|0|||
144367204|NCT01342211|520555468|FG002|Overall Study|Adverse Event|0|||
144367205|NCT01342211|520555469|FG003|Overall Study|Adverse Event|0|||
144367206|NCT01342211|520555470|FG004|Overall Study|Adverse Event|1|||
144367207|NCT01342211|520555466|FG000|Overall Study|Withdrawal by Subject|0|||
144704143|NCT03237325|521768835|FG000|Overall Study|Lost to Follow-up|3|||
144367208|NCT01342211|520555467|FG001|Overall Study|Withdrawal by Subject|0|||
144367209|NCT01342211|520555468|FG002|Overall Study|Withdrawal by Subject|0|||
144367210|NCT01342211|520555469|FG003|Overall Study|Withdrawal by Subject|1|||
144367211|NCT01342211|520555470|FG004|Overall Study|Withdrawal by Subject|0|||
144367212|NCT01342211|520555466|FG000|Overall Study|Randomized, but not Treated|0|||
144367213|NCT01342211|520555467|FG001|Overall Study|Randomized, but not Treated|2|||
144367214|NCT01342211|520555468|FG002|Overall Study|Randomized, but not Treated|0|||
144367215|NCT01342211|520555469|FG003|Overall Study|Randomized, but not Treated|0|||
144367216|NCT01342211|520555470|FG004|Overall Study|Randomized, but not Treated|1|||
144367217|NCT01588522|520555473|FG000|Overall Study|Withdrawal by Subject|1|||
144367218|NCT01588522|520555474|FG001|Overall Study|Withdrawal by Subject|5|||
144367219|NCT01588522|520555475|FG002|Overall Study|Withdrawal by Subject|3|||
144367220|NCT01588522|520555476|FG003|Overall Study|Withdrawal by Subject|1|||
144367221|NCT01588522|520555477|FG004|Overall Study|Withdrawal by Subject|2|||
144367222|NCT01588522|520555478|FG005|Overall Study|Withdrawal by Subject|0|||
144367223|NCT01588522|520555473|FG000|Overall Study|Lack of Efficacy|0|||
144479750|NCT01167179|520957602|FG001|Overall Study|diverse|5|||
144479751|NCT00663117|520957603|FG000|Overall Study|Lack of Efficacy|1|||
144479752|NCT00663117|520957604|FG001|Overall Study|Lack of Efficacy|0|||
144479753|NCT01158378|520957605|FG000|Overall Study|Death|4|||
144479754|NCT01158378|520957606|FG001|Overall Study|Death|5|||
144479755|NCT01158378|520957605|FG000|Overall Study|Lost to Follow-up|2|||
144479756|NCT01158378|520957606|FG001|Overall Study|Lost to Follow-up|4|||
144479757|NCT01158378|520957605|FG000|Overall Study|Withdrawal by Subject|4|||
144479758|NCT01158378|520957606|FG001|Overall Study|Withdrawal by Subject|0|||
144479759|NCT02769065|520957607|FG000|Overall Study|Voluntary Withdrawal|1|||
144479760|NCT02769065|520957608|FG001|Overall Study|Voluntary Withdrawal|0|||
144479761|NCT02769065|520957609|FG002|Overall Study|Voluntary Withdrawal|0|||
144479762|NCT02769065|520957610|FG003|Overall Study|Voluntary Withdrawal|0|||
144479763|NCT02769065|520957611|FG004|Overall Study|Voluntary Withdrawal|0|||
144479764|NCT02769065|520957612|FG005|Overall Study|Voluntary Withdrawal|0|||
144479765|NCT02769065|520957613|FG006|Overall Study|Voluntary Withdrawal|0|||
144479766|NCT02769065|520957614|FG007|Overall Study|Voluntary Withdrawal|0|||
144479767|NCT02769065|520957615|FG008|Overall Study|Voluntary Withdrawal|0|||
144479768|NCT02769065|520957616|FG009|Overall Study|Voluntary Withdrawal|0|||
144479769|NCT02769065|520957617|FG010|Overall Study|Voluntary Withdrawal|0|||
144479770|NCT02769065|520957618|FG011|Overall Study|Voluntary Withdrawal|0|||
144479771|NCT02769065|520957619|FG012|Overall Study|Voluntary Withdrawal|0|||
144479772|NCT02769065|520957620|FG013|Overall Study|Voluntary Withdrawal|0|||
144479773|NCT02769065|520957621|FG014|Overall Study|Voluntary Withdrawal|0|||
144479774|NCT02769065|520957622|FG015|Overall Study|Voluntary Withdrawal|0|||
144479775|NCT02769065|520957623|FG016|Overall Study|Voluntary Withdrawal|0|||
144479776|NCT02769065|520957624|FG017|Overall Study|Voluntary Withdrawal|0|||
144479777|NCT02769065|520957625|FG018|Overall Study|Voluntary Withdrawal|0|||
144479778|NCT02769065|520957626|FG019|Overall Study|Voluntary Withdrawal|0|||
144479779|NCT02769065|520957627|FG020|Overall Study|Voluntary Withdrawal|0|||
144479780|NCT02769065|520957628|FG021|Overall Study|Voluntary Withdrawal|0|||
144479781|NCT02769065|520957629|FG022|Overall Study|Voluntary Withdrawal|0|||
144479782|NCT02769065|520957630|FG023|Overall Study|Voluntary Withdrawal|0|||
144479783|NCT02769065|520957631|FG024|Overall Study|Voluntary Withdrawal|0|||
144479784|NCT02769065|520957632|FG025|Overall Study|Voluntary Withdrawal|0|||
144479785|NCT02769065|520957633|FG026|Overall Study|Voluntary Withdrawal|0|||
144479786|NCT02769065|520957634|FG027|Overall Study|Voluntary Withdrawal|0|||
144479787|NCT02769065|520957635|FG028|Overall Study|Voluntary Withdrawal|0|||
144479788|NCT02769065|520957636|FG029|Overall Study|Voluntary Withdrawal|0|||
144479789|NCT02769065|520957607|FG000|Overall Study|Reason Not Specified|0|||
144479790|NCT02769065|520957608|FG001|Overall Study|Reason Not Specified|0|||
144479791|NCT02769065|520957609|FG002|Overall Study|Reason Not Specified|0|||
144479792|NCT02769065|520957610|FG003|Overall Study|Reason Not Specified|0|||
144479793|NCT02769065|520957611|FG004|Overall Study|Reason Not Specified|0|||
144479794|NCT02769065|520957612|FG005|Overall Study|Reason Not Specified|0|||
144479795|NCT02769065|520957613|FG006|Overall Study|Reason Not Specified|1|||
144479796|NCT02769065|520957614|FG007|Overall Study|Reason Not Specified|0|||
144479797|NCT02769065|520957615|FG008|Overall Study|Reason Not Specified|0|||
144479798|NCT02769065|520957616|FG009|Overall Study|Reason Not Specified|0|||
144479799|NCT02769065|520957617|FG010|Overall Study|Reason Not Specified|0|||
144479800|NCT02769065|520957618|FG011|Overall Study|Reason Not Specified|0|||
144479801|NCT02769065|520957619|FG012|Overall Study|Reason Not Specified|0|||
144479802|NCT02769065|520957620|FG013|Overall Study|Reason Not Specified|0|||
144479803|NCT02769065|520957621|FG014|Overall Study|Reason Not Specified|0|||
144479804|NCT02769065|520957622|FG015|Overall Study|Reason Not Specified|0|||
144479805|NCT02769065|520957623|FG016|Overall Study|Reason Not Specified|0|||
144479806|NCT02769065|520957624|FG017|Overall Study|Reason Not Specified|0|||
144367224|NCT01588522|520555474|FG001|Overall Study|Lack of Efficacy|0|||
144367225|NCT01588522|520555475|FG002|Overall Study|Lack of Efficacy|0|||
144479807|NCT02769065|520957625|FG018|Overall Study|Reason Not Specified|0|||
144479808|NCT02769065|520957626|FG019|Overall Study|Reason Not Specified|0|||
144479809|NCT02769065|520957627|FG020|Overall Study|Reason Not Specified|0|||
144479810|NCT02769065|520957628|FG021|Overall Study|Reason Not Specified|0|||
144479811|NCT02769065|520957629|FG022|Overall Study|Reason Not Specified|0|||
144479812|NCT02769065|520957630|FG023|Overall Study|Reason Not Specified|0|||
144479813|NCT02769065|520957631|FG024|Overall Study|Reason Not Specified|0|||
144479814|NCT02769065|520957632|FG025|Overall Study|Reason Not Specified|0|||
144479815|NCT02769065|520957633|FG026|Overall Study|Reason Not Specified|0|||
144704144|NCT03237325|521768836|FG001|Overall Study|Lost to Follow-up|5|||
144367226|NCT01588522|520555476|FG003|Overall Study|Lack of Efficacy|0|||
144367227|NCT01588522|520555477|FG004|Overall Study|Lack of Efficacy|1|||
144367228|NCT01588522|520555478|FG005|Overall Study|Lack of Efficacy|0|||
144367229|NCT01588522|520555473|FG000|Overall Study|Adverse Event|0|||
144367230|NCT01588522|520555474|FG001|Overall Study|Adverse Event|0|||
144367231|NCT01588522|520555475|FG002|Overall Study|Adverse Event|0|||
144367232|NCT01588522|520555476|FG003|Overall Study|Adverse Event|1|||
144367233|NCT01588522|520555477|FG004|Overall Study|Adverse Event|0|||
144367234|NCT01588522|520555478|FG005|Overall Study|Adverse Event|0|||
144367235|NCT01588522|520555473|FG000|Overall Study|Grade 2 alopecia|1|||
144367236|NCT01588522|520555474|FG001|Overall Study|Grade 2 alopecia|0|||
144367237|NCT01588522|520555475|FG002|Overall Study|Grade 2 alopecia|0|||
144367238|NCT01588522|520555476|FG003|Overall Study|Grade 2 alopecia|0|||
144367239|NCT01588522|520555477|FG004|Overall Study|Grade 2 alopecia|0|||
144367240|NCT01588522|520555478|FG005|Overall Study|Grade 2 alopecia|0|||
144367241|NCT01588522|520555473|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
144367242|NCT01588522|520555474|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
144367243|NCT01588522|520555475|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
144367244|NCT01588522|520555476|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
144367245|NCT01588522|520555477|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
144367246|NCT01588522|520555478|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
144367247|NCT01588522|520555473|FG000|Overall Study|Taken off taxane-based regimen|0|||
144367248|NCT01588522|520555474|FG001|Overall Study|Taken off taxane-based regimen|0|||
144367249|NCT01588522|520555475|FG002|Overall Study|Taken off taxane-based regimen|0|||
144367250|NCT01588522|520555476|FG003|Overall Study|Taken off taxane-based regimen|1|||
144367251|NCT01588522|520555477|FG004|Overall Study|Taken off taxane-based regimen|0|||
144367252|NCT01588522|520555478|FG005|Overall Study|Taken off taxane-based regimen|0|||
144367253|NCT01588522|520555473|FG000|Overall Study|Did not initiate chemotherapy|0|||
144367254|NCT01588522|520555474|FG001|Overall Study|Did not initiate chemotherapy|0|||
144367255|NCT01588522|520555475|FG002|Overall Study|Did not initiate chemotherapy|0|||
144367256|NCT01588522|520555476|FG003|Overall Study|Did not initiate chemotherapy|0|||
144367257|NCT01588522|520555477|FG004|Overall Study|Did not initiate chemotherapy|1|||
144367258|NCT01588522|520555478|FG005|Overall Study|Did not initiate chemotherapy|0|||
144367259|NCT02749422|520555479|FG000|Overall Study|Lost to Follow-up|0|||
144367260|NCT02749422|520555480|FG001|Overall Study|Lost to Follow-up|2|||
144367261|NCT02749422|520555479|FG000|Overall Study|Ineligible|0|||
144367262|NCT02749422|520555480|FG001|Overall Study|Ineligible|1|||
144367263|NCT04586205|520555481|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
144367264|NCT04586205|520555482|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
144367265|NCT00905164|520555483|FG000|Period 1|Protocol Violation|0|||
144367266|NCT00905164|520555484|FG001|Period 1|Protocol Violation|1|||
144367267|NCT03312634|520557258|FG000|Overall Study|Adverse Event|11|||
144367268|NCT03312634|520557259|FG001|Overall Study|Adverse Event|0|||
144367269|NCT03312634|520557258|FG000|Overall Study|Sponsor request|2|||
144367270|NCT03312634|520557259|FG001|Overall Study|Sponsor request|0|||
144367271|NCT03312634|520557258|FG000|Overall Study|Withdrawal by Subject|31|||
144367272|NCT03312634|520557259|FG001|Overall Study|Withdrawal by Subject|9|||
144367273|NCT03312634|520557258|FG000|Overall Study|Enrolled in an interventional study|0|||
144367274|NCT03312634|520557259|FG001|Overall Study|Enrolled in an interventional study|52|||
144367275|NCT03312634|520557258|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
144367276|NCT03312634|520557259|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
144367277|NCT03312634|520557258|FG000|Overall Study|Death|0|||
144367278|NCT03312634|520557259|FG001|Overall Study|Death|1|||
144367279|NCT03312634|520557258|FG000|Overall Study|Non-compliance|0|||
144367280|NCT03312634|520557259|FG001|Overall Study|Non-compliance|2|||
144367281|NCT03312634|520557258|FG000|Overall Study|Lost to Follow-up|0|||
144367282|NCT03312634|520557259|FG001|Overall Study|Lost to Follow-up|1|||
144367283|NCT03312634|520557258|FG000|Overall Study|Enrolled into non-interventional study|0|||
144367284|NCT03312634|520557259|FG001|Overall Study|Enrolled into non-interventional study|5|||
144367285|NCT03312634|520557258|FG000|Overall Study|Worsening clinical condition|0|||
144367286|NCT03312634|520557259|FG001|Overall Study|Worsening clinical condition|1|||
144479816|NCT02769065|520957634|FG027|Overall Study|Reason Not Specified|0|||
144704145|NCT03237325|521768835|FG000|Overall Study|Physician Decision|2|||
144367287|NCT03312634|520557258|FG000|Overall Study|Participant did not want to travel|0|||
144367288|NCT03312634|520557259|FG001|Overall Study|Participant did not want to travel|1|||
144367289|NCT03312634|520557258|FG000|Overall Study|Physician Decision|1|||
144367290|NCT03312634|520557259|FG001|Overall Study|Physician Decision|0|||
144367291|NCT03312634|520557258|FG000|Overall Study|Other|13|||
144367292|NCT03312634|520557259|FG001|Overall Study|Other|0|||
144479817|NCT02769065|520957635|FG028|Overall Study|Reason Not Specified|0|||
144538201|NCT00146172|521174122|FG000|Overall Study|Disease Progression|2|||
144367293|NCT01148979|520557268|FG000|Overall Study|Lost to Follow-up|0|||
144367294|NCT01148979|520557269|FG001|Overall Study|Lost to Follow-up|1|||
144367295|NCT00777153|520557270|FG000|Overall Study|Lost to Follow-up|1|||
144367296|NCT00777153|520557271|FG001|Overall Study|Lost to Follow-up|1|||
144367297|NCT00777153|520557272|FG002|Overall Study|Lost to Follow-up|0|||
144367298|NCT00777153|520557270|FG000|Overall Study|Death|85|||
144367299|NCT00777153|520557271|FG001|Overall Study|Death|73|||
144367300|NCT00777153|520557272|FG002|Overall Study|Death|33|||
144367301|NCT00777153|520557270|FG000|Overall Study|Withdrawal by Subject|3|||
144367302|NCT00777153|520557271|FG001|Overall Study|Withdrawal by Subject|4|||
144367303|NCT00777153|520557272|FG002|Overall Study|Withdrawal by Subject|3|||
144367304|NCT00777153|520557270|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
144367305|NCT00777153|520557271|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
144367306|NCT00777153|520557272|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
144367307|NCT00554216|520557274|FG000|Overall Study|Lost to Follow-up|92|||
144367308|NCT00554216|520557275|FG001|Overall Study|Lost to Follow-up|31|||
144367309|NCT00554216|520557276|FG002|Overall Study|Lost to Follow-up|63|||
144367310|NCT00554216|520557274|FG000|Overall Study|Adverse Event|16|||
144367311|NCT00554216|520557275|FG001|Overall Study|Adverse Event|16|||
144367312|NCT00554216|520557276|FG002|Overall Study|Adverse Event|36|||
144367313|NCT00554216|520557274|FG000|Overall Study|Withdrawal by Subject|92|||
144367314|NCT00554216|520557275|FG001|Overall Study|Withdrawal by Subject|31|||
144367315|NCT00554216|520557276|FG002|Overall Study|Withdrawal by Subject|43|||
144367316|NCT00554216|520557274|FG000|Overall Study|Non compliance|10|||
144367317|NCT00554216|520557275|FG001|Overall Study|Non compliance|4|||
144367318|NCT00554216|520557276|FG002|Overall Study|Non compliance|5|||
144367319|NCT00554216|520557274|FG000|Overall Study|Pregnancy|2|||
144367320|NCT00554216|520557275|FG001|Overall Study|Pregnancy|1|||
144367321|NCT00554216|520557276|FG002|Overall Study|Pregnancy|14|||
144367322|NCT00554216|520557274|FG000|Overall Study|Restricted med|3|||
144367323|NCT00554216|520557275|FG001|Overall Study|Restricted med|1|||
144367324|NCT00554216|520557276|FG002|Overall Study|Restricted med|1|||
144367325|NCT00554216|520557274|FG000|Overall Study|Other|12|||
144367326|NCT00554216|520557275|FG001|Overall Study|Other|7|||
144367327|NCT00554216|520557276|FG002|Overall Study|Other|10|||
144367328|NCT00554216|520557274|FG000|Overall Study|Lack of Efficacy|15|||
144367329|NCT00554216|520557275|FG001|Overall Study|Lack of Efficacy|3|||
144367330|NCT00554216|520557276|FG002|Overall Study|Lack of Efficacy|0|||
144367331|NCT05462756|520557279|FG000|Treatment Period|Adverse Event|3|||
144367332|NCT05462756|520557280|FG001|Treatment Period|Adverse Event|0|||
144367333|NCT05462756|520557279|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
144367334|NCT05462756|520557280|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
144367335|NCT05462756|520557279|FG000|Treatment Period|Death|0|||
144367336|NCT05462756|520557280|FG001|Treatment Period|Death|1|||
144367337|NCT05462756|520557279|FG000|Treatment Period|Lost to Follow-up|2|||
144367338|NCT05462756|520557280|FG001|Treatment Period|Lost to Follow-up|1|||
144367339|NCT05462756|520557279|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
144367340|NCT05462756|520557280|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
144367341|NCT05462756|520557279|FG000|Treatment Period|Physician Decision|2|||
144367342|NCT05462756|520557280|FG001|Treatment Period|Physician Decision|0|||
144367343|NCT05462756|520557279|FG000|Treatment Period|Protocol Violation|0|||
144367344|NCT05462756|520557280|FG001|Treatment Period|Protocol Violation|1|||
144367345|NCT05462756|520557279|FG000|Treatment Period|Withdrawal by Subject|5|||
144367346|NCT05462756|520557280|FG001|Treatment Period|Withdrawal by Subject|12|||
144367347|NCT05462756|520557279|FG000|Follow-Up Period|Adverse Event|1|||
144367348|NCT05462756|520557280|FG001|Follow-Up Period|Adverse Event|0|||
144367349|NCT05462756|520557279|FG000|Follow-Up Period|Death|1|||
144367350|NCT05462756|520557280|FG001|Follow-Up Period|Death|0|||
144367351|NCT05462756|520557279|FG000|Follow-Up Period|Lost to Follow-up|3|||
144367352|NCT05462756|520557280|FG001|Follow-Up Period|Lost to Follow-up|1|||
144367353|NCT05462756|520557279|FG000|Follow-Up Period|Withdrawal by Subject|0|||
144367354|NCT05462756|520557280|FG001|Follow-Up Period|Withdrawal by Subject|4|||
144367355|NCT02079246|520557281|FG000|OLEX|Withdrawal before treatment|1|||
144367356|NCT02079246|520557282|FG001|OLEX|Withdrawal before treatment|0|||
144367357|NCT02079246|520557281|FG000|OLEX|Death|11|||
144367358|NCT02079246|520557282|FG001|OLEX|Death|0|||
144367359|NCT02079246|520557281|FG000|OLEX|Adverse Event|66|||
144367360|NCT02079246|520557282|FG001|OLEX|Adverse Event|0|||
144367361|NCT02079246|520557281|FG000|OLEX|Withdrawal by Subject|60|||
144367362|NCT02079246|520557282|FG001|OLEX|Withdrawal by Subject|0|||
144367363|NCT02079246|520557281|FG000|OLEX|Lost to Follow-up|6|||
144367364|NCT02079246|520557282|FG001|OLEX|Lost to Follow-up|0|||
144367365|NCT02079246|520557281|FG000|OLEX|Protocol Violation|6|||
144367366|NCT02079246|520557282|FG001|OLEX|Protocol Violation|0|||
144367367|NCT02079246|520557281|FG000|OLEX|Lack of Efficacy|3|||
144367368|NCT02079246|520557282|FG001|OLEX|Lack of Efficacy|0|||
144367369|NCT02079246|520557281|FG000|OLEX|Results of the lead-in studies|58|||
144704146|NCT03237325|521768836|FG001|Overall Study|Physician Decision|4|||
144704147|NCT03237325|521768835|FG000|Overall Study|Withdrawal by Subject|9|||
144704148|NCT03237325|521768836|FG001|Overall Study|Withdrawal by Subject|12|||
144704149|NCT03237325|521768835|FG000|Overall Study|Noncompliance with Study Procedures|1|||
144704150|NCT03237325|521768836|FG001|Overall Study|Noncompliance with Study Procedures|1|||
144704151|NCT03237325|521768835|FG000|Overall Study|Termination by Sponsor|0|||
144704152|NCT03237325|521768836|FG001|Overall Study|Termination by Sponsor|1|||
144704153|NCT03237325|521768835|FG000|Overall Study|Reason other than described|0|||
144704154|NCT03237325|521768836|FG001|Overall Study|Reason other than described|2|||
144704155|NCT02684370|521768837|FG000|Part A|Adverse Event|2|||
144704156|NCT02684370|521768838|FG001|Part A|Adverse Event|0|||
144704157|NCT02684370|521768839|FG002|Part A|Adverse Event|1|||
144704158|NCT02684370|521768840|FG003|Part A|Adverse Event|0|||
144704159|NCT02684370|521768841|FG004|Part A|Adverse Event|0|||
144704160|NCT02684370|521768842|FG005|Part A|Adverse Event|0|||
144704161|NCT02684370|521768837|FG000|Part A|Lost to Follow-up|1|||
144704162|NCT02684370|521768838|FG001|Part A|Lost to Follow-up|1|||
144704163|NCT02684370|521768839|FG002|Part A|Lost to Follow-up|0|||
144704164|NCT02684370|521768840|FG003|Part A|Lost to Follow-up|0|||
144704165|NCT02684370|521768841|FG004|Part A|Lost to Follow-up|0|||
144704166|NCT02684370|521768842|FG005|Part A|Lost to Follow-up|0|||
144704167|NCT02684370|521768837|FG000|Part A|Subject Withdrawal|1|||
144704168|NCT02684370|521768838|FG001|Part A|Subject Withdrawal|0|||
144704169|NCT02684370|521768839|FG002|Part A|Subject Withdrawal|3|||
144704170|NCT02684370|521768840|FG003|Part A|Subject Withdrawal|0|||
144704171|NCT02684370|521768841|FG004|Part A|Subject Withdrawal|0|||
144704172|NCT02684370|521768842|FG005|Part A|Subject Withdrawal|0|||
144704173|NCT02684370|521768837|FG000|Part A|Other|0|||
144704174|NCT02684370|521768838|FG001|Part A|Other|0|||
144704175|NCT02684370|521768839|FG002|Part A|Other|1|||
144704176|NCT02684370|521768840|FG003|Part A|Other|0|||
144704177|NCT02684370|521768841|FG004|Part A|Other|0|||
144704178|NCT02684370|521768842|FG005|Part A|Other|0|||
144704179|NCT02684370|521768837|FG000|Part B|Adverse Event|0|||
144704180|NCT02684370|521768838|FG001|Part B|Adverse Event|0|||
144704181|NCT02684370|521768839|FG002|Part B|Adverse Event|0|||
144704182|NCT02684370|521768840|FG003|Part B|Adverse Event|0|||
144704183|NCT02684370|521768841|FG004|Part B|Adverse Event|2|||
144704184|NCT02684370|521768842|FG005|Part B|Adverse Event|1|||
144704185|NCT02684370|521768837|FG000|Part B|Lost to Follow-up|0|||
144704186|NCT02684370|521768838|FG001|Part B|Lost to Follow-up|0|||
144704187|NCT02684370|521768839|FG002|Part B|Lost to Follow-up|0|||
144704188|NCT02684370|521768840|FG003|Part B|Lost to Follow-up|1|||
144704189|NCT02684370|521768841|FG004|Part B|Lost to Follow-up|2|||
144704190|NCT02684370|521768842|FG005|Part B|Lost to Follow-up|5|||
144704191|NCT02684370|521768837|FG000|Part B|Subject Withdrawal|0|||
144704192|NCT02684370|521768838|FG001|Part B|Subject Withdrawal|0|||
144704193|NCT02684370|521768839|FG002|Part B|Subject Withdrawal|0|||
144704194|NCT02684370|521768840|FG003|Part B|Subject Withdrawal|1|||
144704195|NCT02684370|521768841|FG004|Part B|Subject Withdrawal|1|||
144704196|NCT02684370|521768842|FG005|Part B|Subject Withdrawal|2|||
144704197|NCT04139642|521768848|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
144704198|NCT04139642|521768849|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
144704199|NCT00138658|521768854|FG000|Overall Study|Adverse Event|23|||
144704200|NCT00138658|521768854|FG000|Overall Study|Death|1|||
144704201|NCT00138658|521768854|FG000|Overall Study|Disease Progression|21|||
144704202|NCT00138658|521768854|FG000|Overall Study|Physician Decision|11|||
144704203|NCT00138658|521768854|FG000|Overall Study|Withdrawal by Subject|5|||
144704204|NCT03733301|521768855|FG000|Overall Study|Screen Fail|1|||
144704205|NCT03733301|521768856|FG001|Overall Study|Screen Fail|0|||
144704206|NCT03733301|521768857|FG002|Overall Study|Screen Fail|0|||
144704207|NCT03733301|521768855|FG000|Overall Study|Non-compliance|1|||
144367370|NCT02079246|520557282|FG001|OLEX|Results of the lead-in studies|0|||
144367371|NCT02079246|520557281|FG000|OLEX|Other: Disallowed medication|8|||
144704208|NCT03733301|521768856|FG001|Overall Study|Non-compliance|0|||
144367372|NCT02079246|520557282|FG001|OLEX|Other: Disallowed medication|0|||
144704209|NCT03733301|521768857|FG002|Overall Study|Non-compliance|0|||
144704210|NCT03733301|521768855|FG000|Overall Study|Lack of Efficacy|2|||
144367373|NCT02079246|520557281|FG000|OLEX|Other: Insufficient compliance|2|||
144367374|NCT02079246|520557282|FG001|OLEX|Other: Insufficient compliance|0|||
144367375|NCT02079246|520557281|FG000|OLEX|Other: Caregiver unavailable|3|||
144704211|NCT03733301|521768856|FG001|Overall Study|Lack of Efficacy|3|||
144704212|NCT03733301|521768857|FG002|Overall Study|Lack of Efficacy|0|||
144704213|NCT03733301|521768855|FG000|Overall Study|Adverse Event|0|||
144704214|NCT03733301|521768856|FG001|Overall Study|Adverse Event|1|||
144704215|NCT03733301|521768857|FG002|Overall Study|Adverse Event|3|||
144704216|NCT03733301|521768855|FG000|Overall Study|Withdrawal by Subject|3|||
144704217|NCT03733301|521768856|FG001|Overall Study|Withdrawal by Subject|5|||
144704218|NCT03733301|521768857|FG002|Overall Study|Withdrawal by Subject|1|||
144704219|NCT02050373|521768858|FG000|Overall Study|Adverse Event|4|||
144704220|NCT02050373|521768859|FG001|Overall Study|Adverse Event|7|||
144704221|NCT02050373|521768858|FG000|Overall Study|Death|3|||
144704222|NCT02050373|521768859|FG001|Overall Study|Death|3|||
144704223|NCT01067339|521768865|FG000|Overall Study|Withdrawal by Subject|6|||
144704224|NCT01067339|521768866|FG001|Overall Study|Withdrawal by Subject|5|||
144704225|NCT00769132|521768867|FG000|Period 1|Adverse Event|1|||
144704226|NCT00769132|521768868|FG001|Period 1|Adverse Event|0|||
144704227|NCT00769132|521768869|FG002|Period 1|Adverse Event|0|||
144704228|NCT00769132|521768870|FG003|Period 1|Adverse Event|1|||
144704229|NCT00769132|521768867|FG000|Period 2|Withdrawal by Subject|0|||
144704230|NCT00769132|521768868|FG001|Period 2|Withdrawal by Subject|0|||
144704231|NCT00769132|521768869|FG002|Period 2|Withdrawal by Subject|0|||
144704232|NCT00769132|521768870|FG003|Period 2|Withdrawal by Subject|1|||
144704233|NCT00769132|521768867|FG000|Period 3|Withdrawal by Subject|1|||
144704234|NCT00769132|521768868|FG001|Period 3|Withdrawal by Subject|0|||
144704235|NCT00769132|521768869|FG002|Period 3|Withdrawal by Subject|0|||
144704236|NCT00769132|521768870|FG003|Period 3|Withdrawal by Subject|0|||
144704237|NCT00769132|521768867|FG000|Period 4|Withdrawal by Subject|0|||
144704238|NCT00769132|521768868|FG001|Period 4|Withdrawal by Subject|1|||
144704239|NCT00769132|521768869|FG002|Period 4|Withdrawal by Subject|0|||
144704240|NCT00769132|521768870|FG003|Period 4|Withdrawal by Subject|0|||
144704241|NCT02230332|521768871|FG000|Overall Study|Adverse Event|2|||
144704242|NCT02230332|521768872|FG001|Overall Study|Adverse Event|1|||
144704243|NCT02230332|521768871|FG000|Overall Study|Lost to Follow-up|1|||
144704244|NCT02230332|521768872|FG001|Overall Study|Lost to Follow-up|0|||
144704245|NCT02230332|521768871|FG000|Overall Study|Protocol Violation|1|||
144704246|NCT02230332|521768872|FG001|Overall Study|Protocol Violation|0|||
144704247|NCT00877799|521768874|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
144704248|NCT00877799|521768875|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
144704249|NCT00877799|521768876|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
144704250|NCT00877799|521768877|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
144704251|NCT00877799|521768878|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
144704252|NCT00877799|521768874|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
144704253|NCT00877799|521768875|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
144704254|NCT00877799|521768876|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
144704255|NCT00877799|521768877|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
144704256|NCT00877799|521768878|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
144704257|NCT00877799|521768874|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
144704258|NCT00877799|521768875|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
144704259|NCT00877799|521768876|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
144704260|NCT00877799|521768877|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
144704261|NCT00877799|521768878|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
144704262|NCT00877799|521768874|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
144704263|NCT00877799|521768875|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
144704264|NCT00877799|521768876|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
144704265|NCT00877799|521768877|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
144704266|NCT00877799|521768878|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
144704267|NCT00877799|521768874|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
144704268|NCT00877799|521768875|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
144704269|NCT00877799|521768876|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
144704270|NCT00877799|521768877|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
144704271|NCT00877799|521768878|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
144704272|NCT00557830|521768879|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
144704273|NCT00557830|521768880|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
144704274|NCT00557830|521768881|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
144704275|NCT00557830|521768879|FG000|Screening Treatment Phase|Adverse Event|2|||
144704276|NCT00557830|521768880|FG001|Screening Treatment Phase|Adverse Event|0|||
144704277|NCT00557830|521768881|FG002|Screening Treatment Phase|Adverse Event|0|||
144704278|NCT00557830|521768879|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
144704279|NCT00557830|521768880|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
144704280|NCT00557830|521768881|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
144367376|NCT02079246|520557282|FG001|OLEX|Other: Caregiver unavailable|0|||
144367377|NCT02079246|520557281|FG000|OLEX|Other: Coordinator decision|1|||
144367378|NCT02079246|520557282|FG001|OLEX|Other: Coordinator decision|0|||
144367379|NCT02079246|520557281|FG000|OLEX|Other: Worsening of condition|1|||
144367380|NCT02079246|520557282|FG001|OLEX|Other: Worsening of condition|0|||
144704281|NCT00538473|521768885|FG000|Overall Study|Adverse Event|1|||
144704282|NCT00538473|521768886|FG001|Overall Study|Adverse Event|0|||
144704283|NCT01803464|521768887|FG000|Overall Study|Incomplete data|0|||
144704284|NCT01803464|521768888|FG001|Overall Study|Incomplete data|0|||
144704285|NCT01803464|521768889|FG002|Overall Study|Incomplete data|4|||
144704286|NCT01803464|521768890|FG003|Overall Study|Incomplete data|0|||
144704287|NCT01803464|521768887|FG000|Overall Study|Withdrawal by Subject|1|||
144704288|NCT01803464|521768888|FG001|Overall Study|Withdrawal by Subject|0|||
144704289|NCT01803464|521768889|FG002|Overall Study|Withdrawal by Subject|0|||
144704290|NCT01803464|521768890|FG003|Overall Study|Withdrawal by Subject|0|||
144704291|NCT01360021|521768896|FG000|Overall Study|Eligibility criteria + other|2|||
144704292|NCT01360021|521768897|FG001|Overall Study|Eligibility criteria + other|1|||
144479818|NCT02769065|520957636|FG029|Overall Study|Reason Not Specified|0|||
144479819|NCT02769065|520957607|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479820|NCT02769065|520957608|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479821|NCT02769065|520957609|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479822|NCT02769065|520957610|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479823|NCT02769065|520957611|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479824|NCT02769065|520957612|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479825|NCT02769065|520957613|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479826|NCT02769065|520957614|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479827|NCT02769065|520957615|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479828|NCT02769065|520957616|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479829|NCT02769065|520957617|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
144479830|NCT02769065|520957618|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479831|NCT02769065|520957619|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479832|NCT02769065|520957620|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479833|NCT02769065|520957621|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479834|NCT02769065|520957622|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479835|NCT02769065|520957623|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479836|NCT02769065|520957624|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479837|NCT02769065|520957625|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479838|NCT02769065|520957626|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479839|NCT02769065|520957627|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479840|NCT02769065|520957628|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479841|NCT02769065|520957629|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479842|NCT02769065|520957630|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479843|NCT02769065|520957631|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479844|NCT02769065|520957632|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479845|NCT02769065|520957633|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479846|NCT02769065|520957634|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479847|NCT02769065|520957635|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479848|NCT02769065|520957636|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
144479849|NCT03017235|520957637|FG000|Overall Study|Withdrawal by Subject|4|||
144479850|NCT03017235|520957638|FG001|Overall Study|Withdrawal by Subject|3|||
144479851|NCT03017235|520957637|FG000|Overall Study|Lost to Follow-up|2|||
144479852|NCT03017235|520957638|FG001|Overall Study|Lost to Follow-up|7|||
144479853|NCT03017235|520957637|FG000|Overall Study|Adverse Event|0|||
144479854|NCT03017235|520957638|FG001|Overall Study|Adverse Event|1|||
144479855|NCT03017235|520957637|FG000|Overall Study|Protocol Violation|2|||
144479856|NCT03017235|520957638|FG001|Overall Study|Protocol Violation|1|||
144479857|NCT03017235|520957637|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
144479858|NCT03017235|520957638|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
144479859|NCT00437125|520957642|FG000|Overall Study|Adverse Event|12|||
144479860|NCT00437125|520957642|FG000|Overall Study|Death|1|||
144479861|NCT00437125|520957642|FG000|Overall Study|Clinical Relapse|1|||
144479862|NCT00437125|520957642|FG000|Overall Study|Lack of Efficacy|1|||
144479863|NCT00437125|520957642|FG000|Overall Study|Lost to Follow-up|1|||
144479864|NCT00437125|520957642|FG000|Overall Study|Withdrawal by Subject|13|||
144479865|NCT00437125|520957642|FG000|Overall Study|Withdrawal by Caregiver|2|||
144479866|NCT00437125|520957642|FG000|Overall Study|Physician Decision|1|||
144479867|NCT02248961|520957643|FG000|Overall Study|Adverse Event|1|||
144479868|NCT02248961|520957644|FG001|Overall Study|Adverse Event|0|||
144479869|NCT02248961|520957643|FG000|Overall Study|Withdrawal by Subject|1|||
144479870|NCT02248961|520957644|FG001|Overall Study|Withdrawal by Subject|2|||
144479871|NCT02248961|520957643|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
144479872|NCT02248961|520957644|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
144479873|NCT02531295|520957645|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
144479874|NCT02531295|520957646|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
144479875|NCT02531295|520957647|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
144479876|NCT02531295|520957648|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
144479877|NCT02531295|520957649|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
144479878|NCT02531295|520957650|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
144479879|NCT01806740|520957653|FG000|Overall Study|Withdrawal by Subject|4|||
144704293|NCT01360021|521768898|FG002|Overall Study|Eligibility criteria + other|1|||
144479880|NCT01806740|520957653|FG000|Overall Study|Physician Decision|1|||
144479881|NCT01806740|520957653|FG000|Overall Study|Patient's refusal of treatment|1|||
144479882|NCT04666922|520957654|FG000|Overall Study|Withdrawal by Subject|1|||
144479883|NCT04666922|520957655|FG001|Overall Study|Withdrawal by Subject|0|||
144479884|NCT04666922|520957656|FG002|Overall Study|Withdrawal by Subject|0|||
144704294|NCT01360021|521768896|FG000|Overall Study|Protocol Violation|0|||
144704295|NCT01360021|521768897|FG001|Overall Study|Protocol Violation|0|||
144704296|NCT01360021|521768898|FG002|Overall Study|Protocol Violation|1|||
144704297|NCT01360021|521768896|FG000|Overall Study|Withdrawal by Subject|4|||
144704298|NCT01360021|521768897|FG001|Overall Study|Withdrawal by Subject|0|||
144704299|NCT01360021|521768898|FG002|Overall Study|Withdrawal by Subject|2|||
144704300|NCT01360021|521768896|FG000|Overall Study|Adverse Event|2|||
144704301|NCT01360021|521768897|FG001|Overall Study|Adverse Event|3|||
144704302|NCT01360021|521768898|FG002|Overall Study|Adverse Event|3|||
144704303|NCT00127192|521768899|FG000|Overall Study|Adverse Event|0|||
144704304|NCT00127192|521768900|FG001|Overall Study|Adverse Event|1|||
144704305|NCT00127192|521768901|FG002|Overall Study|Adverse Event|1|||
144704306|NCT00127192|521768902|FG003|Overall Study|Adverse Event|1|||
144704307|NCT00127192|521768903|FG004|Overall Study|Adverse Event|0|||
144704308|NCT00127192|521768899|FG000|Overall Study|Lack of Efficacy|2|||
144704309|NCT00127192|521768900|FG001|Overall Study|Lack of Efficacy|0|||
144704310|NCT00127192|521768901|FG002|Overall Study|Lack of Efficacy|0|||
144704311|NCT00127192|521768902|FG003|Overall Study|Lack of Efficacy|0|||
144704312|NCT00127192|521768903|FG004|Overall Study|Lack of Efficacy|2|||
144704313|NCT00127192|521768899|FG000|Overall Study|Withdrawal by Subject|0|||
144704314|NCT00127192|521768900|FG001|Overall Study|Withdrawal by Subject|0|||
144704315|NCT00127192|521768901|FG002|Overall Study|Withdrawal by Subject|1|||
144704316|NCT00127192|521768902|FG003|Overall Study|Withdrawal by Subject|0|||
144704317|NCT00127192|521768903|FG004|Overall Study|Withdrawal by Subject|3|||
144704318|NCT00127192|521768899|FG000|Overall Study|Adverse event in pre-treatment period|1|||
144704319|NCT00127192|521768900|FG001|Overall Study|Adverse event in pre-treatment period|0|||
144704320|NCT00127192|521768901|FG002|Overall Study|Adverse event in pre-treatment period|0|||
144704321|NCT00127192|521768902|FG003|Overall Study|Adverse event in pre-treatment period|0|||
144704322|NCT00127192|521768903|FG004|Overall Study|Adverse event in pre-treatment period|0|||
144704323|NCT00203892|521768904|FG000|Overall Study|Physician Decision|1|||
144704324|NCT00203892|521768905|FG001|Overall Study|Physician Decision|2|||
144704325|NCT00203892|521768906|FG002|Overall Study|Physician Decision|0|||
144704326|NCT00203892|521768904|FG000|Overall Study|Death|1|||
144704327|NCT00203892|521768905|FG001|Overall Study|Death|0|||
144704328|NCT00203892|521768906|FG002|Overall Study|Death|0|||
144704329|NCT00806416|521768909|FG000|Period 1 - Part I|Adverse Event|0|||
144704330|NCT00806416|521768910|FG001|Period 1 - Part I|Adverse Event|1|||
144704331|NCT00806416|521768911|FG002|Period 1 - Part I|Adverse Event|0|||
144704332|NCT00806416|521768912|FG003|Period 1 - Part I|Adverse Event|0|||
144704333|NCT00806416|521768909|FG000|Period 1 - Part I|Lost to Follow-up|0|||
144704334|NCT00806416|521768910|FG001|Period 1 - Part I|Lost to Follow-up|2|||
144704335|NCT00806416|521768911|FG002|Period 1 - Part I|Lost to Follow-up|0|||
144704336|NCT00806416|521768912|FG003|Period 1 - Part I|Lost to Follow-up|0|||
144704337|NCT00806416|521768909|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
144704338|NCT00806416|521768910|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
144704339|NCT00806416|521768911|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
144704340|NCT00806416|521768912|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
144704341|NCT00806416|521768909|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
144704342|NCT00806416|521768910|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
144704343|NCT00806416|521768911|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
144704344|NCT00806416|521768912|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
144704345|NCT04935931|521768917|FG000|Overall Study|Withdrawal by Subject|1|||
144704346|NCT02596009|521768923|FG000|Overall Study|Administrative problems|0|||
144704347|NCT02596009|521768924|FG001|Overall Study|Administrative problems|1|||
144704348|NCT02596009|521768925|FG002|Overall Study|Administrative problems|0|||
144704349|NCT02596009|521768926|FG003|Overall Study|Administrative problems|0|||
144704350|NCT02596009|521768927|FG004|Overall Study|Administrative problems|0|||
144367381|NCT02079246|520557281|FG000|OLEX|Other: Moved to nursing home|1|||
144367382|NCT02079246|520557282|FG001|OLEX|Other: Moved to nursing home|0|||
144367383|NCT02079246|520557281|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
144367384|NCT02079246|520557282|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
144367385|NCT02079246|520557281|FG000|OLEX-MEM|Adverse Event|0|||
144367386|NCT02079246|520557282|FG001|OLEX-MEM|Adverse Event|6|||
144367387|NCT02079246|520557281|FG000|OLEX-MEM|Withdrawal by Subject|0|||
144367388|NCT02079246|520557282|FG001|OLEX-MEM|Withdrawal by Subject|7|||
144704351|NCT02596009|521768928|FG005|Overall Study|Administrative problems|0|||
144367389|NCT02079246|520557281|FG000|OLEX-MEM|Protocol Violation|0|||
144704352|NCT01821391|521768929|FG000|Overall Study|Adverse Event|1|||
144704353|NCT01821391|521768930|FG001|Overall Study|Adverse Event|0|||
144704354|NCT01843660|521768931|FG000|Overall Study|Other|30|||
144704355|NCT01977482|521768932|FG000|Overall Study|Adverse Event|0|||
144704356|NCT01977482|521768933|FG001|Overall Study|Adverse Event|1|||
144704357|NCT01977482|521768934|FG002|Overall Study|Adverse Event|1|||
144704358|NCT01977482|521768935|FG003|Overall Study|Adverse Event|0|||
144704359|NCT01977482|521768936|FG004|Overall Study|Adverse Event|2|||
144704360|NCT01977482|521768937|FG005|Overall Study|Adverse Event|0|||
144367390|NCT02079246|520557282|FG001|OLEX-MEM|Protocol Violation|2|||
144704361|NCT01977482|521768932|FG000|Overall Study|Lost to Follow-up|1|||
144704362|NCT01977482|521768933|FG001|Overall Study|Lost to Follow-up|0|||
144704363|NCT01977482|521768934|FG002|Overall Study|Lost to Follow-up|0|||
144704364|NCT01977482|521768935|FG003|Overall Study|Lost to Follow-up|0|||
144704365|NCT01977482|521768936|FG004|Overall Study|Lost to Follow-up|0|||
144704366|NCT01977482|521768937|FG005|Overall Study|Lost to Follow-up|0|||
144704367|NCT01977482|521768932|FG000|Overall Study|Physician Decision|0|||
144704368|NCT01977482|521768933|FG001|Overall Study|Physician Decision|1|||
144704369|NCT01977482|521768934|FG002|Overall Study|Physician Decision|0|||
144704370|NCT01977482|521768935|FG003|Overall Study|Physician Decision|0|||
144704371|NCT01977482|521768936|FG004|Overall Study|Physician Decision|0|||
144704372|NCT01977482|521768937|FG005|Overall Study|Physician Decision|0|||
144704373|NCT01977482|521768932|FG000|Overall Study|Protocol Violation|0|||
144704374|NCT01977482|521768933|FG001|Overall Study|Protocol Violation|0|||
144704375|NCT01977482|521768934|FG002|Overall Study|Protocol Violation|1|||
144704376|NCT01977482|521768935|FG003|Overall Study|Protocol Violation|0|||
144704377|NCT01977482|521768936|FG004|Overall Study|Protocol Violation|0|||
144704378|NCT01977482|521768937|FG005|Overall Study|Protocol Violation|0|||
144704379|NCT01977482|521768932|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
144704380|NCT01977482|521768933|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
144704381|NCT01977482|521768934|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
144704382|NCT01977482|521768935|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
144704383|NCT01977482|521768936|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
144704384|NCT01977482|521768937|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
144704385|NCT01977482|521768932|FG000|Overall Study|Withdrawal by Subject|2|||
144704386|NCT01977482|521768933|FG001|Overall Study|Withdrawal by Subject|4|||
144704387|NCT01977482|521768934|FG002|Overall Study|Withdrawal by Subject|1|||
144704388|NCT01977482|521768935|FG003|Overall Study|Withdrawal by Subject|3|||
144704389|NCT01977482|521768936|FG004|Overall Study|Withdrawal by Subject|1|||
144704390|NCT01977482|521768937|FG005|Overall Study|Withdrawal by Subject|5|||
144704391|NCT00209560|521768938|FG000|Overall Study|Lack of Efficacy|1|||
144704392|NCT00209560|521768939|FG001|Overall Study|Lack of Efficacy|0|||
144704393|NCT03222856|521768942|FG000|Overall Study|Adverse Event|6|||
144704394|NCT03222856|521768942|FG000|Overall Study|Death|1|||
144704395|NCT01721369|521768943|FG000|Overall Study|Not initial etiological diagnosis|12|||
144704396|NCT03505606|521770159|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
144704397|NCT03505606|521770160|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
144704398|NCT03505606|521770161|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
144704399|NCT03505606|521770159|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
144704400|NCT03505606|521770160|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
144704401|NCT03505606|521770161|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
144704402|NCT03505606|521770159|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
144704403|NCT03505606|521770160|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
144704404|NCT03505606|521770161|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
144704405|NCT03505606|521770159|FG000|Overall Study|Poor compliance with refractive correction|0|||
144704406|NCT03505606|521770160|FG001|Overall Study|Poor compliance with refractive correction|0|||
144704407|NCT03505606|521770161|FG002|Overall Study|Poor compliance with refractive correction|1|||
144704408|NCT03505606|521770159|FG000|Overall Study|Insufficient anisometropia|0|||
144704409|NCT03505606|521770160|FG001|Overall Study|Insufficient anisometropia|0|||
144704410|NCT03505606|521770161|FG002|Overall Study|Insufficient anisometropia|2|||
144704411|NCT03505606|521770159|FG000|Overall Study|Ectopia Lentis|0|||
144704412|NCT03505606|521770160|FG001|Overall Study|Ectopia Lentis|0|||
144704413|NCT03505606|521770161|FG002|Overall Study|Ectopia Lentis|1|||
144704414|NCT03505606|521770159|FG000|Overall Study|alternation of amblyopic eye|0|||
144704415|NCT03505606|521770160|FG001|Overall Study|alternation of amblyopic eye|1|||
144704416|NCT03505606|521770161|FG002|Overall Study|alternation of amblyopic eye|0|||
144704417|NCT02087865|521770163|FG000|Overall Study|Withdrawal by Subject|6|||
144704418|NCT02087865|521770164|FG001|Overall Study|Withdrawal by Subject|0|||
144704419|NCT02087865|521770165|FG002|Overall Study|Withdrawal by Subject|1|||
144704420|NCT02087865|521770163|FG000|Overall Study|Lost to Follow-up|0|||
144704421|NCT02087865|521770164|FG001|Overall Study|Lost to Follow-up|0|||
144704422|NCT02087865|521770165|FG002|Overall Study|Lost to Follow-up|1|||
144704423|NCT02087865|521770163|FG000|Overall Study|Drug Non-compliance|0|||
144704424|NCT02087865|521770164|FG001|Overall Study|Drug Non-compliance|2|||
144704425|NCT02087865|521770165|FG002|Overall Study|Drug Non-compliance|0|||
144704426|NCT02087865|521770163|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
144704427|NCT02087865|521770164|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
144479885|NCT04666922|520957657|FG003|Overall Study|Withdrawal by Subject|0|||
144704428|NCT02087865|521770165|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
144704429|NCT01808508|521770166|FG000|Overall Study|Lost to Follow-up|1|||
144704430|NCT01808508|521770167|FG001|Overall Study|Lost to Follow-up|0|||
144704431|NCT01808508|521770168|FG002|Overall Study|Lost to Follow-up|0|||
144704432|NCT01017731|521770169|FG000|Overall Study|Lost to Follow-up|2|||
144704433|NCT01017731|521770169|FG000|Overall Study|Withdrawal by Subject|3|||
144704434|NCT01017731|521770169|FG000|Overall Study|Physician Decision|2|||
144704435|NCT01017731|521770169|FG000|Overall Study|Adverse Event|1|||
144704436|NCT01035229|521770170|FG000|Overall Study|Adverse Event|61|||
144704437|NCT01035229|521770171|FG001|Overall Study|Adverse Event|14|||
144704438|NCT01035229|521770170|FG000|Overall Study|Withdrawal by Subject|20|||
144704439|NCT01035229|521770171|FG001|Overall Study|Withdrawal by Subject|7|||
144704440|NCT01035229|521770170|FG000|Overall Study|Lost to Follow-up|1|||
144704441|NCT01035229|521770171|FG001|Overall Study|Lost to Follow-up|0|||
144704442|NCT01035229|521770170|FG000|Overall Study|Administrative problems|1|||
144704443|NCT01035229|521770171|FG001|Overall Study|Administrative problems|1|||
144704444|NCT01035229|521770170|FG000|Overall Study|Death|13|||
144704445|NCT01035229|521770171|FG001|Overall Study|Death|5|||
144704446|NCT01035229|521770170|FG000|Overall Study|New cancer therapy|2|||
144704447|NCT01035229|521770171|FG001|Overall Study|New cancer therapy|0|||
144704448|NCT01035229|521770170|FG000|Overall Study|Protocol Violation|0|||
144704449|NCT01035229|521770171|FG001|Overall Study|Protocol Violation|2|||
144704450|NCT01035229|521770170|FG000|Overall Study|Sponsor's decision to end study|3|||
144704451|NCT01035229|521770171|FG001|Overall Study|Sponsor's decision to end study|3|||
144704452|NCT01035229|521770170|FG000|Overall Study|Disease Progression|261|||
144704453|NCT01035229|521770171|FG001|Overall Study|Disease Progression|152|||
144704454|NCT00564486|521770178|FG000|Overall Study|Adverse Event|0|||
144704455|NCT00564486|521770179|FG001|Overall Study|Adverse Event|1|||
144704456|NCT00564486|521770180|FG002|Overall Study|Adverse Event|0|||
144704457|NCT00564486|521770181|FG003|Overall Study|Adverse Event|0|||
144704458|NCT00564486|521770178|FG000|Overall Study|Withdrawal by Subject|4|||
144704459|NCT00564486|521770179|FG001|Overall Study|Withdrawal by Subject|0|||
144704460|NCT00564486|521770180|FG002|Overall Study|Withdrawal by Subject|0|||
144704461|NCT00564486|521770181|FG003|Overall Study|Withdrawal by Subject|5|||
144704462|NCT00564486|521770178|FG000|Overall Study|Subject refused to have blood drawn|0|||
144704463|NCT00564486|521770179|FG001|Overall Study|Subject refused to have blood drawn|0|||
144704464|NCT00564486|521770180|FG002|Overall Study|Subject refused to have blood drawn|1|||
144704465|NCT00564486|521770181|FG003|Overall Study|Subject refused to have blood drawn|0|||
144704466|NCT00564486|521770178|FG000|Overall Study|Lost to Follow-up|3|||
144704467|NCT00564486|521770179|FG001|Overall Study|Lost to Follow-up|0|||
144704468|NCT00564486|521770180|FG002|Overall Study|Lost to Follow-up|2|||
144704469|NCT00564486|521770181|FG003|Overall Study|Lost to Follow-up|2|||
144704470|NCT00578448|521770186|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
144704471|NCT00578448|521770186|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
144704472|NCT00578448|521770186|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
144704473|NCT00578448|521770186|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
144704474|NCT04221373|521770187|FG000|Overall Study|Physician Decision|4|||
144704475|NCT04221373|521770188|FG001|Overall Study|Physician Decision|0|||
144704476|NCT00627094|521770189|FG000|Overall Study|Adverse Event|8|||
144704477|NCT00627094|521770190|FG001|Overall Study|Adverse Event|7|||
144704478|NCT00627094|521770189|FG000|Overall Study|Lost to Follow-up|1|||
144704479|NCT00627094|521770190|FG001|Overall Study|Lost to Follow-up|0|||
144704480|NCT00627094|521770189|FG000|Overall Study|Withdrawal by Subject|1|||
144704481|NCT00627094|521770190|FG001|Overall Study|Withdrawal by Subject|1|||
144704482|NCT00627094|521770189|FG000|Overall Study|ulcer healed|1|||
144704483|NCT00627094|521770190|FG001|Overall Study|ulcer healed|7|||
144704484|NCT00627094|521770189|FG000|Overall Study|Other reason|1|||
144704485|NCT00627094|521770190|FG001|Overall Study|Other reason|0|||
144704486|NCT00539006|521770196|FG000|Pre-treatment|Other|0|||
144704487|NCT00539006|521770197|FG001|Pre-treatment|Other|1|||
144704488|NCT00539006|521770198|FG002|Pre-treatment|Other|0|||
144704489|NCT00539006|521770199|FG003|Pre-treatment|Other|0|||
144704490|NCT00539006|521770196|FG000|Treatment Period 1|Lost to Follow-up|0|||
144704491|NCT00539006|521770197|FG001|Treatment Period 1|Lost to Follow-up|0|||
144704492|NCT00539006|521770198|FG002|Treatment Period 1|Lost to Follow-up|1|||
144704493|NCT00539006|521770199|FG003|Treatment Period 1|Lost to Follow-up|0|||
144704494|NCT00539006|521770196|FG000|Treatment Period 1|Protocol Violation|0|||
144704495|NCT00539006|521770197|FG001|Treatment Period 1|Protocol Violation|0|||
144704496|NCT00539006|521770198|FG002|Treatment Period 1|Protocol Violation|1|||
144367391|NCT02079246|520557281|FG000|OLEX-MEM|Lost to Follow-up|0|||
144367392|NCT02079246|520557282|FG001|OLEX-MEM|Lost to Follow-up|1|||
144704497|NCT00539006|521770199|FG003|Treatment Period 1|Protocol Violation|0|||
144704498|NCT00539006|521770196|FG000|Treatment Period 1|Lack of Efficacy|0|||
144704499|NCT00539006|521770197|FG001|Treatment Period 1|Lack of Efficacy|0|||
144704500|NCT00539006|521770198|FG002|Treatment Period 1|Lack of Efficacy|0|||
144704501|NCT00539006|521770199|FG003|Treatment Period 1|Lack of Efficacy|1|||
144704502|NCT00539006|521770196|FG000|Washout|Adverse Event|2|||
144704503|NCT00539006|521770197|FG001|Washout|Adverse Event|1|||
144704504|NCT00539006|521770198|FG002|Washout|Adverse Event|0|||
144704505|NCT00539006|521770199|FG003|Washout|Adverse Event|0|||
144704506|NCT00539006|521770196|FG000|Washout|Protocol Violation|1|||
144704507|NCT00539006|521770197|FG001|Washout|Protocol Violation|1|||
144704508|NCT00539006|521770198|FG002|Washout|Protocol Violation|0|||
144704509|NCT00539006|521770199|FG003|Washout|Protocol Violation|0|||
144704510|NCT00539006|521770196|FG000|Washout|Withdrawal by Subject|0|||
144704511|NCT00539006|521770197|FG001|Washout|Withdrawal by Subject|2|||
144704512|NCT00539006|521770198|FG002|Washout|Withdrawal by Subject|0|||
144704513|NCT00539006|521770199|FG003|Washout|Withdrawal by Subject|0|||
144704514|NCT00539006|521770196|FG000|Washout|Failed to meet continuation criteria|16|||
144704515|NCT00539006|521770197|FG001|Washout|Failed to meet continuation criteria|5|||
144704516|NCT00539006|521770198|FG002|Washout|Failed to meet continuation criteria|14|||
144704517|NCT00539006|521770199|FG003|Washout|Failed to meet continuation criteria|6|||
144704518|NCT00539006|521770196|FG000|Washout|Other|1|||
144704519|NCT00539006|521770197|FG001|Washout|Other|1|||
144704520|NCT00539006|521770198|FG002|Washout|Other|2|||
144704521|NCT00539006|521770199|FG003|Washout|Other|3|||
144704522|NCT00539006|521770196|FG000|Treatment Period 2|Protocol Violation|1|||
144704523|NCT00539006|521770197|FG001|Treatment Period 2|Protocol Violation|0|||
144704524|NCT00539006|521770198|FG002|Treatment Period 2|Protocol Violation|0|||
144704525|NCT00539006|521770199|FG003|Treatment Period 2|Protocol Violation|0|||
144704526|NCT00539006|521770196|FG000|Treatment Period 2|Other|0|||
144704527|NCT00539006|521770197|FG001|Treatment Period 2|Other|1|||
144704528|NCT00539006|521770198|FG002|Treatment Period 2|Other|0|||
144704529|NCT00539006|521770199|FG003|Treatment Period 2|Other|0|||
144704530|NCT01965431|521770202|FG000|Overall Study|Adverse Event|0|||
144704531|NCT01965431|521770203|FG001|Overall Study|Adverse Event|1|||
144704532|NCT01965431|521770204|FG002|Overall Study|Adverse Event|0|||
144704533|NCT01965431|521770205|FG003|Overall Study|Adverse Event|0|||
144704534|NCT01965431|521770206|FG004|Overall Study|Adverse Event|0|||
144704535|NCT01965431|521770207|FG005|Overall Study|Adverse Event|0|||
144704536|NCT01965431|521770202|FG000|Overall Study|Other than stated above|6|||
144704537|NCT01965431|521770203|FG001|Overall Study|Other than stated above|5|||
144704538|NCT01965431|521770204|FG002|Overall Study|Other than stated above|6|||
144704539|NCT01965431|521770205|FG003|Overall Study|Other than stated above|6|||
144704540|NCT01965431|521770206|FG004|Overall Study|Other than stated above|6|||
144704541|NCT01965431|521770207|FG005|Overall Study|Other than stated above|6|||
144704542|NCT04635631|521770208|FG000|Overall Study|Adverse Event|1|||
144704543|NCT04635631|521770208|FG000|Overall Study|Progressive disease|13|||
144704544|NCT04635631|521770208|FG000|Overall Study|Withdrawal by Subject|1|||
144704545|NCT00577031|521770209|FG000|Overall Study|Adverse Event|52|||
144704546|NCT00577031|521770209|FG000|Overall Study|Progression of disease|93|||
144704547|NCT00577031|521770209|FG000|Overall Study|Protocol Violation|5|||
144704548|NCT00577031|521770209|FG000|Overall Study|Participant withdrew consent|13|||
144704549|NCT00577031|521770209|FG000|Overall Study|Participant non-compliance|5|||
144704550|NCT00577031|521770209|FG000|Overall Study|Need for surgery|17|||
144704551|NCT00577031|521770209|FG000|Overall Study|Medical decision|14|||
144704552|NCT00577031|521770209|FG000|Overall Study|Death|6|||
144704553|NCT04054011|521770210|FG000|Overall Study|COVID|3|||
144704554|NCT01036594|521770211|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
144704555|NCT01036594|521770212|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
144704556|NCT01036594|521770211|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
144704557|NCT01036594|521770212|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
144704558|NCT01036594|521770211|FG000|Week 12 Evaluation|Adverse Event|5|||
144704559|NCT01036594|521770212|FG001|Week 12 Evaluation|Adverse Event|0|||
144704560|NCT01036594|521770211|FG000|Week 12 Evaluation|Physician Decision|1|||
144704561|NCT01036594|521770212|FG001|Week 12 Evaluation|Physician Decision|0|||
144704562|NCT01036594|521770211|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
144704563|NCT01036594|521770212|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
144704564|NCT01036594|521770211|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
144704565|NCT01036594|521770212|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
144704566|NCT01036594|521770211|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
144704567|NCT01036594|521770212|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
144704568|NCT01036594|521770211|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
144704569|NCT01036594|521770212|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
144704570|NCT01036594|521770211|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
144704571|NCT01036594|521770212|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
144704572|NCT00244881|521770213|FG000|Overall Study|Withdrawal by Subject|3|||
144704573|NCT01125358|521770217|FG000|Overall Study|Adverse Event|3|||
144704574|NCT01125358|521770218|FG001|Overall Study|Adverse Event|0|||
144704575|NCT01125358|521770219|FG002|Overall Study|Adverse Event|0|||
144704576|NCT01125358|521770220|FG003|Overall Study|Adverse Event|2|||
144704577|NCT01125358|521770217|FG000|Overall Study|Perceived Lack of Efficacy|6|||
144704578|NCT01125358|521770218|FG001|Overall Study|Perceived Lack of Efficacy|3|||
144704579|NCT01125358|521770219|FG002|Overall Study|Perceived Lack of Efficacy|7|||
144704580|NCT01125358|521770220|FG003|Overall Study|Perceived Lack of Efficacy|4|||
144704581|NCT01125358|521770217|FG000|Overall Study|Protocol Violation|1|||
144704582|NCT01125358|521770218|FG001|Overall Study|Protocol Violation|0|||
144704583|NCT01125358|521770219|FG002|Overall Study|Protocol Violation|0|||
144704584|NCT01125358|521770220|FG003|Overall Study|Protocol Violation|0|||
144704585|NCT01125358|521770217|FG000|Overall Study|Sponsor Decision|0|||
144704586|NCT01125358|521770218|FG001|Overall Study|Sponsor Decision|0|||
144704587|NCT01125358|521770219|FG002|Overall Study|Sponsor Decision|1|||
144704588|NCT01125358|521770220|FG003|Overall Study|Sponsor Decision|1|||
144704589|NCT01125358|521770217|FG000|Overall Study|Withdrawal by Subject|2|||
144704590|NCT01125358|521770218|FG001|Overall Study|Withdrawal by Subject|1|||
144704591|NCT01125358|521770219|FG002|Overall Study|Withdrawal by Subject|1|||
144704592|NCT01125358|521770220|FG003|Overall Study|Withdrawal by Subject|1|||
144704593|NCT05168657|521770221|FG000|Overall Study|Adverse Event|0|||
144704594|NCT05168657|521770222|FG001|Overall Study|Adverse Event|0|||
144704595|NCT05168657|521770223|FG002|Overall Study|Adverse Event|1|||
144704596|NCT05168657|521770224|FG003|Overall Study|Adverse Event|0|||
144704597|NCT05168657|521770225|FG004|Overall Study|Adverse Event|0|||
144704598|NCT05168657|521770226|FG005|Overall Study|Adverse Event|0|||
144704599|NCT05168657|521770227|FG006|Overall Study|Adverse Event|0|||
144704600|NCT05168657|521770228|FG007|Overall Study|Adverse Event|0|||
144704601|NCT03159611|521770231|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
144704602|NCT03159611|521770232|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
144704603|NCT03159611|521770231|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
144704604|NCT03159611|521770232|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
144704605|NCT03159611|521770231|FG000|Overall Study|Protocol Violation|7|||
144704606|NCT03159611|521770232|FG001|Overall Study|Protocol Violation|4|||
144704607|NCT03159611|521770231|FG000|Overall Study|Adverse Event|1|||
144704608|NCT03159611|521770232|FG001|Overall Study|Adverse Event|0|||
144704609|NCT03159611|521770231|FG000|Overall Study|Withdrawal by Subject|1|||
144704610|NCT03159611|521770232|FG001|Overall Study|Withdrawal by Subject|1|||
144704611|NCT03159611|521770231|FG000|Overall Study|Non-compliance with protocol requirement|3|||
144704612|NCT03159611|521770232|FG001|Overall Study|Non-compliance with protocol requirement|2|||
144704613|NCT03159611|521770231|FG000|Overall Study|Inability to perform procedures|1|||
144704614|NCT03159611|521770232|FG001|Overall Study|Inability to perform procedures|0|||
144704615|NCT01984229|521770233|FG000|Safety Follow-up Period|Adverse Event|1|||
144704616|NCT01984229|521770234|FG001|Safety Follow-up Period|Adverse Event|1|||
144704617|NCT01984229|521770233|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
144704618|NCT01984229|521770234|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
144704619|NCT02072174|521770235|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
144704620|NCT02072174|521770236|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
144704621|NCT02072174|521770235|FG000|Overall Study|Protocol Violation|16|||
144704622|NCT02072174|521770236|FG001|Overall Study|Protocol Violation|23|||
144704623|NCT02072174|521770235|FG000|Overall Study|Physician Decision|0|||
144704624|NCT02072174|521770236|FG001|Overall Study|Physician Decision|1|||
144704625|NCT02072174|521770235|FG000|Overall Study|Non-compliance with protocol requirement|2|||
144704626|NCT02072174|521770236|FG001|Overall Study|Non-compliance with protocol requirement|0|||
144704627|NCT00824993|521770248|FG000|Overall Study|Withdrawal by Subject|1|||
144704628|NCT00824993|521770249|FG001|Overall Study|Withdrawal by Subject|1|||
144704629|NCT00824993|521770248|FG000|Overall Study|Malignancy Relapse|9|||
144704630|NCT00824993|521770249|FG001|Overall Study|Malignancy Relapse|10|||
144704631|NCT00824993|521770248|FG000|Overall Study|Rapid Bone Loss|0|||
144704632|NCT00824993|521770249|FG001|Overall Study|Rapid Bone Loss|1|||
144704633|NCT00824993|521770248|FG000|Overall Study|Non-Compliant|2|||
144704634|NCT00824993|521770249|FG001|Overall Study|Non-Compliant|1|||
144704635|NCT00824993|521770248|FG000|Overall Study|Insurance Issue|2|||
144704636|NCT00824993|521770249|FG001|Overall Study|Insurance Issue|1|||
144704637|NCT00824993|521770248|FG000|Overall Study|Death|0|||
144704638|NCT00824993|521770249|FG001|Overall Study|Death|3|||
144704639|NCT03409328|521770250|FG000|Overall Study|Lost to Follow-up|6|||
144704640|NCT03409328|521770251|FG001|Overall Study|Lost to Follow-up|3|||
144704641|NCT00518011|521770252|FG000|Overall Study|Death|1|||
144704642|NCT00518011|521770253|FG001|Overall Study|Death|1|||
144704643|NCT00518011|521770252|FG000|Overall Study|Adverse Event|2|||
144704644|NCT00518011|521770253|FG001|Overall Study|Adverse Event|3|||
144704645|NCT00518011|521770252|FG000|Overall Study|Disease Progression|2|||
144704646|NCT00518011|521770253|FG001|Overall Study|Disease Progression|2|||
144704647|NCT00518011|521770252|FG000|Overall Study|Other Reasons|3|||
144704648|NCT00518011|521770253|FG001|Overall Study|Other Reasons|2|||
144704649|NCT00518011|521770252|FG000|Overall Study|Withdrawal by Subject|1|||
144704650|NCT00518011|521770253|FG001|Overall Study|Withdrawal by Subject|0|||
144704651|NCT02998645|521770254|FG000|Treatment Period 1|Adverse Event|6|||
144704652|NCT02998645|521770254|FG000|Treatment Period 1|Death|5|||
144704653|NCT02998645|521770254|FG000|Treatment Period 1|Technical Problems|4|||
144704654|NCT02998645|521770254|FG000|Treatment Period 1|Lack of Efficacy|2|||
144704655|NCT02998645|521770254|FG000|Treatment Period 1|Progressive disease|1|||
144704656|NCT02998645|521770254|FG000|Treatment Period 1|Subject/guardian decision|1|||
144704657|NCT02998645|521770254|FG000|Treatment Period 2|Lack of Efficacy|5|||
144704658|NCT02998645|521770254|FG000|Treatment Period 2|Adverse Event|2|||
144704659|NCT02998645|521770254|FG000|Treatment Period 2|Progressive disease|2|||
144704660|NCT02998645|521770254|FG000|Treatment Period 2|Physician Decision|1|||
144704661|NCT03930615|521770255|FG000|Overall Study|Death|9|||
144704662|NCT03930615|521770256|FG001|Overall Study|Death|3|||
144704663|NCT03930615|521770255|FG000|Overall Study|Lost to Follow-up|1|||
144704664|NCT03930615|521770256|FG001|Overall Study|Lost to Follow-up|2|||
144704665|NCT03930615|521770255|FG000|Overall Study|Physician Decision|3|||
144704666|NCT03930615|521770256|FG001|Overall Study|Physician Decision|4|||
144704667|NCT03930615|521770255|FG000|Overall Study|Withdrawal by Subject|13|||
144704668|NCT03930615|521770256|FG001|Overall Study|Withdrawal by Subject|2|||
144704669|NCT03930615|521770255|FG000|Overall Study|Not treated|1|||
144704670|NCT03930615|521770256|FG001|Overall Study|Not treated|1|||
144704671|NCT00358670|521770258|FG000|Overall Study|Adverse Event|26|||
144704672|NCT00358670|521770259|FG001|Overall Study|Adverse Event|29|||
144704673|NCT00358670|521770258|FG000|Overall Study|Lack of Efficacy|20|||
144704674|NCT00358670|521770259|FG001|Overall Study|Lack of Efficacy|23|||
144704675|NCT00358670|521770258|FG000|Overall Study|Protocol Violation|6|||
144704676|NCT00358670|521770259|FG001|Overall Study|Protocol Violation|9|||
144704677|NCT00358670|521770258|FG000|Overall Study|Lost to Follow-up|4|||
144704678|NCT00358670|521770259|FG001|Overall Study|Lost to Follow-up|5|||
144704679|NCT00358670|521770258|FG000|Overall Study|Withdrawal by Subject|13|||
144704680|NCT00358670|521770259|FG001|Overall Study|Withdrawal by Subject|24|||
144704681|NCT00358670|521770258|FG000|Overall Study|Protocol Defined Clinical Event|0|||
144704682|NCT00358670|521770259|FG001|Overall Study|Protocol Defined Clinical Event|1|||
144704683|NCT00358670|521770258|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
144704684|NCT00358670|521770259|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
144704685|NCT00358670|521770258|FG000|Overall Study|Administrative|153|||
144704686|NCT00358670|521770259|FG001|Overall Study|Administrative|125|||
144704687|NCT00905437|521770262|FG000|Overall Study|Adverse Event|3|||
144704688|NCT00905437|521770263|FG001|Overall Study|Adverse Event|2|||
144704689|NCT00905437|521770262|FG000|Overall Study|Lost to Follow-up|0|||
144704690|NCT00905437|521770263|FG001|Overall Study|Lost to Follow-up|1|||
144704691|NCT00905437|521770262|FG000|Overall Study|Withdrawal by Subject|0|||
144704692|NCT00905437|521770263|FG001|Overall Study|Withdrawal by Subject|1|||
144704693|NCT00905437|521770262|FG000|Overall Study|Other|5|||
144704694|NCT00905437|521770263|FG001|Overall Study|Other|6|||
144704695|NCT03252015|521770266|FG000|Overall Study|Withdrawal by Subject|0|||
144704696|NCT03252015|521770267|FG001|Overall Study|Withdrawal by Subject|1|||
144704697|NCT03252015|521770268|FG002|Overall Study|Withdrawal by Subject|1|||
144704698|NCT03252015|521770269|FG003|Overall Study|Withdrawal by Subject|0|||
144704699|NCT03252015|521770266|FG000|Overall Study|Adverse Event|1|||
144704700|NCT03252015|521770267|FG001|Overall Study|Adverse Event|0|||
144704701|NCT03252015|521770268|FG002|Overall Study|Adverse Event|0|||
144704702|NCT03252015|521770269|FG003|Overall Study|Adverse Event|1|||
144704703|NCT03128931|521770270|FG000|Overall Study|Physician Decision|1|||
144704704|NCT03128931|521770270|FG000|Overall Study|Equipment Issues|3|||
144704705|NCT04993339|521770271|FG000|Overall Study|Lost to Follow-up|0|||
144704706|NCT04993339|521770272|FG001|Overall Study|Lost to Follow-up|1|||
144704707|NCT04993339|521770271|FG000|Overall Study|no MRI scan|3|||
144704708|NCT04993339|521770272|FG001|Overall Study|no MRI scan|1|||
144704709|NCT01071278|521770273|FG000|Overall Study|Premature Discontinuation|254|||
144704710|NCT01071278|521770273|FG000|Overall Study|Completion Status Unknown|459|||
144704711|NCT00903409|521770274|FG000|Overall Study|Adverse Event|11|||
144704712|NCT00903409|521770275|FG001|Overall Study|Adverse Event|9|||
144704713|NCT00903409|521770274|FG000|Overall Study|Non-compliance with Protocol|1|||
144704714|NCT00903409|521770275|FG001|Overall Study|Non-compliance with Protocol|1|||
144704715|NCT00903409|521770274|FG000|Overall Study|Laboratory Abnormality|2|||
144704716|NCT00903409|521770275|FG001|Overall Study|Laboratory Abnormality|0|||
144704717|NCT00903409|521770274|FG000|Overall Study|Withdrawal by Subject|8|||
144704718|NCT00903409|521770275|FG001|Overall Study|Withdrawal by Subject|8|||
144704719|NCT00903409|521770274|FG000|Overall Study|Other|2|||
144704720|NCT00903409|521770275|FG001|Overall Study|Other|3|||
144704721|NCT00903409|521770274|FG000|Overall Study|Lost to Follow-up|2|||
144704722|NCT00903409|521770275|FG001|Overall Study|Lost to Follow-up|6|||
144704723|NCT03539952|521770277|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
144704724|NCT03539952|521770278|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
144704725|NCT03539952|521770277|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
144704726|NCT03539952|521770278|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
144704727|NCT03539952|521770277|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
144704728|NCT03539952|521770278|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
144704729|NCT03539952|521770277|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
144704730|NCT03539952|521770278|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
144704731|NCT03539952|521770277|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
144704732|NCT03539952|521770278|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
144704733|NCT03539952|521770277|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
144704734|NCT03539952|521770278|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
144704735|NCT03539952|521770277|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
144704736|NCT03539952|521770278|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
144704737|NCT02184988|521770279|FG000|Overall Study|Pregnancy|2|||
144704738|NCT02184988|521770279|FG000|Overall Study|Adverse Event|2|||
144704739|NCT02184988|521770279|FG000|Overall Study|moving away/travelling/unable to complet|6|||
144704740|NCT02184988|521770279|FG000|Overall Study|work scheduling issues|4|||
144704741|NCT02184988|521770279|FG000|Overall Study|various other reasons|9|||
144704742|NCT02184988|521770279|FG000|Overall Study|Lost to Follow-up|32|||
144704743|NCT03075215|521770282|FG000|12-Month Primary Endpoint|Death|152|||
144704744|NCT03075215|521770282|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
144704745|NCT03075215|521770282|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
144704746|NCT03075215|521770282|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
144704747|NCT01608321|521770295|FG000|Overall Study|Withdrawal by Subject|1|||
144704748|NCT01608321|521770296|FG001|Overall Study|Withdrawal by Subject|0|||
144704749|NCT01819467|521771883|FG000|Overall Study|Physician Decision|20|||
144704750|NCT01819467|521771884|FG001|Overall Study|Physician Decision|9|||
144704751|NCT03256526|521771885|FG000|Overall Study|Adverse Event|1|||
144704752|NCT03256526|521771886|FG001|Overall Study|Adverse Event|0|||
144704753|NCT03256526|521771887|FG002|Overall Study|Adverse Event|1|||
144704754|NCT03256526|521771885|FG000|Overall Study|Lost to Follow-up|1|||
144704755|NCT03256526|521771886|FG001|Overall Study|Lost to Follow-up|0|||
144704756|NCT03256526|521771887|FG002|Overall Study|Lost to Follow-up|2|||
144704757|NCT01607398|521771890|FG000|Overall Study|Adverse Event|0|||
144704758|NCT01607398|521771891|FG001|Overall Study|Adverse Event|2|||
144704759|NCT01607398|521771890|FG000|Overall Study|Severe COPD|2|||
144704760|NCT01607398|521771891|FG001|Overall Study|Severe COPD|0|||
144704761|NCT03926728|521771892|FG000|Overall Study|Withdrawal by Subject|0|||
144704762|NCT03926728|521771893|FG001|Overall Study|Withdrawal by Subject|1|||
144704763|NCT03926728|521771894|FG002|Overall Study|Withdrawal by Subject|1|||
144704764|NCT03926728|521771895|FG003|Overall Study|Withdrawal by Subject|0|||
144704765|NCT03926728|521771896|FG004|Overall Study|Withdrawal by Subject|0|||
144704766|NCT03926728|521771897|FG005|Overall Study|Withdrawal by Subject|1|||
144704767|NCT03926728|521771898|FG006|Overall Study|Withdrawal by Subject|1|||
144704768|NCT03926728|521771899|FG007|Overall Study|Withdrawal by Subject|0|||
144704769|NCT03926728|521771900|FG008|Overall Study|Withdrawal by Subject|0|||
144704770|NCT03926728|521771901|FG009|Overall Study|Withdrawal by Subject|1|||
144704771|NCT03926728|521771902|FG010|Overall Study|Withdrawal by Subject|0|||
144704772|NCT03926728|521771903|FG011|Overall Study|Withdrawal by Subject|0|||
144704773|NCT03993288|521771904|FG000|Overall Study|Lost to Follow-up|2|||
144704774|NCT03993288|521771905|FG001|Overall Study|Lost to Follow-up|1|||
144704775|NCT03993288|521771904|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
144704776|NCT03993288|521771905|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
144704777|NCT03993288|521771904|FG000|Overall Study|wrong randomization|0|||
144704778|NCT03993288|521771905|FG001|Overall Study|wrong randomization|1|||
144704779|NCT03993288|521771904|FG000|Overall Study|improper enrollment|0|||
144704780|NCT03993288|521771905|FG001|Overall Study|improper enrollment|1|||
144704781|NCT03993288|521771904|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
144704782|NCT03993288|521771905|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
144704783|NCT03993288|521771904|FG000|Overall Study|developed SAE|2|||
144704784|NCT03993288|521771905|FG001|Overall Study|developed SAE|0|||
144704785|NCT03993288|521771904|FG000|Overall Study|consent withdrawal|1|||
144367393|NCT02079246|520557281|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
144367394|NCT02079246|520557282|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
144367395|NCT04040933|520557287|FG000|Overall Study|Protocol Violation|1|||
144367396|NCT04040933|520557287|FG000|Overall Study|Withdrawal by Subject|2|||
144367397|NCT00641667|520557290|FG000|Overall Study|Withdrawal by Subject|1|||
144367398|NCT00641667|520557290|FG000|Overall Study|Adverse Event|1|||
144367399|NCT00641667|520557290|FG000|Overall Study|Physician Decision|1|||
144367400|NCT00641667|520557290|FG000|Overall Study|Worsening of underlying disease|3|||
144367401|NCT01235741|520557291|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
144367402|NCT01235741|520557292|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
144367403|NCT01235741|520557293|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
144367404|NCT01235741|520557291|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
144704786|NCT03993288|521771905|FG001|Overall Study|consent withdrawal|0|||
144704787|NCT03993288|521771904|FG000|Overall Study|did not follow the treatment schedule|1|||
144704788|NCT03993288|521771905|FG001|Overall Study|did not follow the treatment schedule|0|||
144704789|NCT03993288|521771904|FG000|Overall Study|did not follow the treatment regimen|1|||
144367405|NCT01235741|520557292|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
144367406|NCT01235741|520557293|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
144367407|NCT01235741|520557291|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
144704790|NCT03993288|521771905|FG001|Overall Study|did not follow the treatment regimen|0|||
144704791|NCT03993288|521771904|FG000|Overall Study|Adverse Event|1|||
144704792|NCT03993288|521771905|FG001|Overall Study|Adverse Event|0|||
144704793|NCT03993288|521771904|FG000|Overall Study|Withdrawal by Subject|1|||
144704794|NCT03993288|521771905|FG001|Overall Study|Withdrawal by Subject|1|||
144704795|NCT02729545|521771906|FG000|Overall Study|Pregnancy|1|||
144704796|NCT02729545|521771907|FG001|Overall Study|Pregnancy|1|||
144704797|NCT02729545|521771906|FG000|Overall Study|Lost to Follow-up|0|||
144704798|NCT02729545|521771907|FG001|Overall Study|Lost to Follow-up|1|||
144704799|NCT02729545|521771906|FG000|Overall Study|Withdrawal by Subject|2|||
144704800|NCT02729545|521771907|FG001|Overall Study|Withdrawal by Subject|3|||
144704801|NCT00915473|521771908|FG000|Screening|Withdrawal by Subject|1|||
144704802|NCT00915473|521771909|FG001|Screening|Withdrawal by Subject|0|||
144704803|NCT00915473|521771908|FG000|4-week Follow Up|Lost to Follow-up|1|||
144704804|NCT00915473|521771909|FG001|4-week Follow Up|Lost to Follow-up|5|||
144704805|NCT03443973|521771912|FG000|Double-blind Treatment Period|Adverse Event|5|||
144704806|NCT03443973|521771913|FG001|Double-blind Treatment Period|Adverse Event|19|||
144704807|NCT03443973|521771914|FG002|Double-blind Treatment Period|Adverse Event|0|||
144704808|NCT03443973|521771915|FG003|Double-blind Treatment Period|Adverse Event|0|||
144704809|NCT03443973|521771912|FG000|Double-blind Treatment Period|Death|5|||
144704810|NCT03443973|521771913|FG001|Double-blind Treatment Period|Death|7|||
144704811|NCT03443973|521771914|FG002|Double-blind Treatment Period|Death|0|||
144704812|NCT03443973|521771915|FG003|Double-blind Treatment Period|Death|0|||
144704813|NCT03443973|521771912|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
144704814|NCT03443973|521771913|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
144704815|NCT03443973|521771914|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
144704816|NCT03443973|521771915|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
144704817|NCT03443973|521771912|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144704818|NCT03443973|521771913|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
144704819|NCT03443973|521771914|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
144704820|NCT03443973|521771915|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
144704821|NCT03443973|521771912|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
144704822|NCT03443973|521771913|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
144704823|NCT03443973|521771914|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
144704824|NCT03443973|521771915|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
144704825|NCT03443973|521771912|FG000|Double-blind Treatment Period|Physician Decision|5|||
144704826|NCT03443973|521771913|FG001|Double-blind Treatment Period|Physician Decision|6|||
144704827|NCT03443973|521771914|FG002|Double-blind Treatment Period|Physician Decision|0|||
144704828|NCT03443973|521771915|FG003|Double-blind Treatment Period|Physician Decision|0|||
144704829|NCT03443973|521771912|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
144704830|NCT03443973|521771913|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
144704831|NCT03443973|521771914|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
144704832|NCT03443973|521771915|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
144704833|NCT03443973|521771912|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
144704834|NCT03443973|521771913|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
144704835|NCT03443973|521771914|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144704836|NCT03443973|521771915|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
144704837|NCT03443973|521771912|FG000|Open-label Extension Period|Reason Not Specified|0|||
144704838|NCT03443973|521771913|FG001|Open-label Extension Period|Reason Not Specified|0|||
144704839|NCT03443973|521771914|FG002|Open-label Extension Period|Reason Not Specified|3|||
144704840|NCT03443973|521771915|FG003|Open-label Extension Period|Reason Not Specified|0|||
144704841|NCT03443973|521771912|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
144704842|NCT03443973|521771913|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
144704843|NCT03443973|521771914|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
144704844|NCT03443973|521771915|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
144704845|NCT00398632|521771916|FG000|Overall Study|Withdrawal by Subject|1|||
144704846|NCT00398632|521771916|FG000|Overall Study|Lack of Efficacy|1|||
144704847|NCT01777191|521771921|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
144704848|NCT01777191|521771922|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
144704849|NCT01777191|521771921|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
144704850|NCT01777191|521771922|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
144704851|NCT01777191|521771921|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
144704852|NCT01777191|521771922|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
144704853|NCT01777191|521771921|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
144704854|NCT01777191|521771922|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
144704855|NCT01777191|521771921|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
144704856|NCT01777191|521771922|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
144704857|NCT01777191|521771921|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
144704858|NCT01777191|521771922|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
144704859|NCT01777191|521771921|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
144704860|NCT01777191|521771922|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
144704861|NCT01777191|521771921|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
144704862|NCT01777191|521771922|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
144704863|NCT01777191|521771921|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
144704864|NCT01777191|521771922|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
144704865|NCT01777191|521771921|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
144704866|NCT01777191|521771922|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
144704867|NCT01777191|521771921|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
144704868|NCT01777191|521771922|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
144704869|NCT04465916|521771923|FG000|Overall Study|Withdrawal by Subject|0|||
144704870|NCT04465916|521771924|FG001|Overall Study|Withdrawal by Subject|1|||
144704871|NCT01325701|521771934|FG000|Overall Study|Adverse Event|12|||
144704872|NCT01325701|521771935|FG001|Overall Study|Adverse Event|0|||
144704873|NCT01325701|521771934|FG000|Overall Study|Protocol Violation|1|||
144704874|NCT01325701|521771935|FG001|Overall Study|Protocol Violation|0|||
144704875|NCT01325701|521771934|FG000|Overall Study|Physician Decision|2|||
144704876|NCT01325701|521771935|FG001|Overall Study|Physician Decision|2|||
144704877|NCT01325701|521771934|FG000|Overall Study|Withdrawal by Subject|2|||
144704878|NCT01325701|521771935|FG001|Overall Study|Withdrawal by Subject|1|||
144704879|NCT01325701|521771934|FG000|Overall Study|Rollerover Extension Study|4|||
144704880|NCT01325701|521771935|FG001|Overall Study|Rollerover Extension Study|0|||
144704881|NCT00568776|521771941|FG000|Overall Study|Adverse Event|8|||
144704882|NCT00568776|521771942|FG001|Overall Study|Adverse Event|8|||
144704883|NCT00568776|521771943|FG002|Overall Study|Adverse Event|10|||
144704884|NCT00568776|521771944|FG003|Overall Study|Adverse Event|8|||
144704885|NCT00568776|521771941|FG000|Overall Study|Death|0|||
144704886|NCT00568776|521771942|FG001|Overall Study|Death|1|||
144704887|NCT00568776|521771943|FG002|Overall Study|Death|4|||
144704888|NCT00568776|521771944|FG003|Overall Study|Death|3|||
144704889|NCT00568776|521771941|FG000|Overall Study|Physician Decision|0|||
144704890|NCT00568776|521771942|FG001|Overall Study|Physician Decision|2|||
144704891|NCT00568776|521771943|FG002|Overall Study|Physician Decision|0|||
144704892|NCT00568776|521771944|FG003|Overall Study|Physician Decision|0|||
144704893|NCT00568776|521771941|FG000|Overall Study|Lack of Efficacy|2|||
144704894|NCT00568776|521771942|FG001|Overall Study|Lack of Efficacy|2|||
144704895|NCT00568776|521771943|FG002|Overall Study|Lack of Efficacy|2|||
144704896|NCT00568776|521771944|FG003|Overall Study|Lack of Efficacy|4|||
144704897|NCT00568776|521771941|FG000|Overall Study|Lost to Follow-up|1|||
144704898|NCT00568776|521771942|FG001|Overall Study|Lost to Follow-up|1|||
144704899|NCT00568776|521771943|FG002|Overall Study|Lost to Follow-up|1|||
144704900|NCT00568776|521771944|FG003|Overall Study|Lost to Follow-up|1|||
144704901|NCT00568776|521771941|FG000|Overall Study|Protocol Violation|1|||
144704902|NCT00568776|521771942|FG001|Overall Study|Protocol Violation|0|||
144704903|NCT00568776|521771943|FG002|Overall Study|Protocol Violation|1|||
144704904|NCT00568776|521771944|FG003|Overall Study|Protocol Violation|1|||
144704905|NCT00568776|521771941|FG000|Overall Study|Withdrawal by Subject|13|||
144704906|NCT00568776|521771942|FG001|Overall Study|Withdrawal by Subject|15|||
144704907|NCT00568776|521771943|FG002|Overall Study|Withdrawal by Subject|13|||
144704908|NCT00568776|521771944|FG003|Overall Study|Withdrawal by Subject|7|||
144704909|NCT00568776|521771941|FG000|Overall Study|Loss of Caregiver|0|||
144367408|NCT01235741|520557292|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
144367409|NCT01235741|520557293|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
144479886|NCT04666922|520957658|FG004|Overall Study|Withdrawal by Subject|0|||
144479887|NCT04666922|520957659|FG005|Overall Study|Withdrawal by Subject|0|||
144479888|NCT04666922|520957660|FG006|Overall Study|Withdrawal by Subject|0|||
144479889|NCT01382940|520957661|FG000|Overall Study|Adverse Event|19|||
144479890|NCT01382940|520957661|FG000|Overall Study|Lost to Follow-up|4|||
144479891|NCT01382940|520957661|FG000|Overall Study|Physician Decision|7|||
144479892|NCT01382940|520957661|FG000|Overall Study|Withdrawal by Subject|23|||
144704910|NCT00568776|521771942|FG001|Overall Study|Loss of Caregiver|2|||
144704911|NCT00568776|521771943|FG002|Overall Study|Loss of Caregiver|1|||
144704912|NCT00568776|521771944|FG003|Overall Study|Loss of Caregiver|2|||
144704913|NCT00568776|521771941|FG000|Overall Study|Sponsor Decision|2|||
144704914|NCT00568776|521771942|FG001|Overall Study|Sponsor Decision|2|||
144704915|NCT00568776|521771943|FG002|Overall Study|Sponsor Decision|41|||
144704916|NCT00568776|521771944|FG003|Overall Study|Sponsor Decision|42|||
144704917|NCT00568776|521771941|FG000|Overall Study|Miscellaeneous|3|||
144367410|NCT01235741|520557291|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
144367411|NCT01235741|520557292|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
144367412|NCT01235741|520557293|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
144367413|NCT01235741|520557291|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
144367414|NCT01235741|520557292|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
144367415|NCT01235741|520557293|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
144367416|NCT01235741|520557291|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
144479893|NCT01382940|520957661|FG000|Overall Study|Protocol Violation|20|||
144704918|NCT00568776|521771942|FG001|Overall Study|Miscellaeneous|3|||
144704919|NCT00568776|521771943|FG002|Overall Study|Miscellaeneous|1|||
144704920|NCT00568776|521771944|FG003|Overall Study|Miscellaeneous|4|||
144704921|NCT01005680|521771945|FG000|Overall Study|Lost to Follow-up|4|||
144704922|NCT01005680|521771946|FG001|Overall Study|Lost to Follow-up|6|||
144704923|NCT01005680|521771945|FG000|Overall Study|Withdrawal by Subject|1|||
144704924|NCT01005680|521771946|FG001|Overall Study|Withdrawal by Subject|4|||
144704925|NCT01005680|521771945|FG000|Overall Study|Physician Decision|1|||
144704926|NCT01005680|521771946|FG001|Overall Study|Physician Decision|1|||
144704927|NCT01179191|521771961|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
144704928|NCT01179191|521771961|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
144704929|NCT01179191|521771961|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
144479894|NCT00244374|520957664|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
144704930|NCT01179191|521771961|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
144704931|NCT01179191|521771961|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
144704932|NCT01179191|521771961|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
144704933|NCT01179191|521771961|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
144704934|NCT01179191|521771961|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
144704935|NCT01179191|521771961|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
144704936|NCT01179191|521771961|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
144704937|NCT01179191|521771961|FG000|Maintenance Phase (8 Weeks)|Other|66|||
144704938|NCT00572910|521771962|FG000|Overall Study|Adverse Event|1|||
144704939|NCT00572910|521771963|FG001|Overall Study|Adverse Event|2|||
144704940|NCT00572910|521771964|FG002|Overall Study|Adverse Event|0|||
144704941|NCT00572910|521771965|FG003|Overall Study|Adverse Event|2|||
144704942|NCT00572910|521771966|FG004|Overall Study|Adverse Event|0|||
144704943|NCT00572910|521771967|FG005|Overall Study|Adverse Event|0|||
144704944|NCT00572910|521771968|FG006|Overall Study|Adverse Event|4|||
144704945|NCT00572910|521771969|FG007|Overall Study|Adverse Event|2|||
144704946|NCT00572910|521771970|FG008|Overall Study|Adverse Event|1|||
144704947|NCT00572910|521771971|FG009|Overall Study|Adverse Event|3|||
144704948|NCT00572910|521771972|FG010|Overall Study|Adverse Event|2|||
144704949|NCT00572910|521771962|FG000|Overall Study|Lost to Follow-up|0|||
144704950|NCT00572910|521771963|FG001|Overall Study|Lost to Follow-up|1|||
144704951|NCT00572910|521771964|FG002|Overall Study|Lost to Follow-up|1|||
144704952|NCT00572910|521771965|FG003|Overall Study|Lost to Follow-up|2|||
144704953|NCT00572910|521771966|FG004|Overall Study|Lost to Follow-up|1|||
144704954|NCT00572910|521771967|FG005|Overall Study|Lost to Follow-up|0|||
144704955|NCT00572910|521771968|FG006|Overall Study|Lost to Follow-up|0|||
144704956|NCT00572910|521771969|FG007|Overall Study|Lost to Follow-up|0|||
144704957|NCT00572910|521771970|FG008|Overall Study|Lost to Follow-up|0|||
144704958|NCT00572910|521771971|FG009|Overall Study|Lost to Follow-up|1|||
144704959|NCT00572910|521771972|FG010|Overall Study|Lost to Follow-up|0|||
144704960|NCT00572910|521771962|FG000|Overall Study|Withdrawal by Subject|3|||
144704961|NCT00572910|521771963|FG001|Overall Study|Withdrawal by Subject|0|||
144704962|NCT00572910|521771964|FG002|Overall Study|Withdrawal by Subject|1|||
144704963|NCT00572910|521771965|FG003|Overall Study|Withdrawal by Subject|0|||
144704964|NCT00572910|521771966|FG004|Overall Study|Withdrawal by Subject|1|||
144704965|NCT00572910|521771967|FG005|Overall Study|Withdrawal by Subject|3|||
144704966|NCT00572910|521771968|FG006|Overall Study|Withdrawal by Subject|0|||
144704967|NCT00572910|521771969|FG007|Overall Study|Withdrawal by Subject|2|||
144704968|NCT00572910|521771970|FG008|Overall Study|Withdrawal by Subject|2|||
144704969|NCT00572910|521771971|FG009|Overall Study|Withdrawal by Subject|2|||
144704970|NCT00572910|521771972|FG010|Overall Study|Withdrawal by Subject|1|||
144704971|NCT00916617|521771973|FG000|Overall Study|Adverse Event|3|||
144704972|NCT00916617|521771974|FG001|Overall Study|Adverse Event|2|||
144704973|NCT00916617|521771975|FG002|Overall Study|Adverse Event|6|||
144704974|NCT00916617|521771976|FG003|Overall Study|Adverse Event|3|||
144704975|NCT00916617|521771973|FG000|Overall Study|Withdrawal by Subject|3|||
144704976|NCT00916617|521771974|FG001|Overall Study|Withdrawal by Subject|2|||
144704977|NCT00916617|521771975|FG002|Overall Study|Withdrawal by Subject|0|||
144704978|NCT00916617|521771976|FG003|Overall Study|Withdrawal by Subject|1|||
144704979|NCT00916617|521771973|FG000|Overall Study|Caregiver Request|3|||
144704980|NCT00916617|521771974|FG001|Overall Study|Caregiver Request|2|||
144704981|NCT00916617|521771975|FG002|Overall Study|Caregiver Request|1|||
144704982|NCT00916617|521771976|FG003|Overall Study|Caregiver Request|0|||
144704983|NCT00916617|521771973|FG000|Overall Study|Physician Decision|1|||
144704984|NCT00916617|521771974|FG001|Overall Study|Physician Decision|1|||
144479895|NCT00244374|520957665|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
144704985|NCT00916617|521771975|FG002|Overall Study|Physician Decision|0|||
144704986|NCT00916617|521771976|FG003|Overall Study|Physician Decision|0|||
144704987|NCT00916617|521771973|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
144704988|NCT00916617|521771974|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
144704989|NCT00916617|521771975|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
144704990|NCT00916617|521771976|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
144704991|NCT00916617|521771973|FG000|Overall Study|Lost to Follow-up|2|||
144704992|NCT00916617|521771974|FG001|Overall Study|Lost to Follow-up|1|||
144704993|NCT00916617|521771975|FG002|Overall Study|Lost to Follow-up|0|||
144704994|NCT00916617|521771976|FG003|Overall Study|Lost to Follow-up|0|||
144704995|NCT00916617|521771973|FG000|Overall Study|Lack of Efficacy|1|||
144704996|NCT00916617|521771974|FG001|Overall Study|Lack of Efficacy|0|||
144704997|NCT00916617|521771975|FG002|Overall Study|Lack of Efficacy|0|||
144704998|NCT00916617|521771976|FG003|Overall Study|Lack of Efficacy|0|||
144704999|NCT00916617|521771973|FG000|Overall Study|Other|2|||
144705000|NCT00916617|521771974|FG001|Overall Study|Other|0|||
144705001|NCT00916617|521771975|FG002|Overall Study|Other|0|||
144705002|NCT00916617|521771976|FG003|Overall Study|Other|2|||
144705003|NCT01260194|521771977|FG000|Overall Study|Withdrawal of Consent|1|||
144705004|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
144705005|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
144705006|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
144705007|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
144705008|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
144705009|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
144705010|NCT00566631|521771979|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
144705011|NCT00566631|521771979|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
144705012|NCT00566631|521771979|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
144705013|NCT00566631|521771979|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
144705014|NCT00566631|521771979|FG000|Part 2: Extension Phase|Adverse Event|11|||
144705015|NCT00566631|521771979|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
144705016|NCT00566631|521771979|FG000|Part 2: Extension Phase|Death|1|||
144705017|NCT00566631|521771979|FG000|Part 2: Extension Phase|Other|5|||
144705018|NCT00592007|521771980|FG000|Overall Study|Withdrawal by Subject|1|||
144705019|NCT00592007|521771980|FG000|Overall Study|patient ineligible (out of lab range)|1|||
144705020|NCT00595127|521771981|FG000|Overall Study|Death|6|||
144705021|NCT00595127|521771981|FG000|Overall Study|Relapsed|3|||
144705022|NCT00595127|521771981|FG000|Overall Study|joined another trial|1|||
144705023|NCT01569074|521771983|FG000|Overall Study|Study stopped|6|||
144705024|NCT01569074|521771984|FG001|Overall Study|Study stopped|6|||
144705025|NCT01569074|521771985|FG002|Overall Study|Study stopped|8|||
144705026|NCT01569074|521771986|FG003|Overall Study|Study stopped|7|||
144705027|NCT01569074|521771987|FG004|Overall Study|Study stopped|7|||
144705028|NCT01569074|521771983|FG000|Overall Study|Study-specific discontinuation criteria|0|||
144705029|NCT01569074|521771984|FG001|Overall Study|Study-specific discontinuation criteria|1|||
144705030|NCT01569074|521771985|FG002|Overall Study|Study-specific discontinuation criteria|0|||
144705031|NCT01569074|521771986|FG003|Overall Study|Study-specific discontinuation criteria|0|||
144705032|NCT01569074|521771987|FG004|Overall Study|Study-specific discontinuation criteria|0|||
144705033|NCT01569074|521771983|FG000|Overall Study|Severe non-compliance to protocol|0|||
144705034|NCT01569074|521771984|FG001|Overall Study|Severe non-compliance to protocol|0|||
144705035|NCT01569074|521771985|FG002|Overall Study|Severe non-compliance to protocol|1|||
144705036|NCT01569074|521771986|FG003|Overall Study|Severe non-compliance to protocol|0|||
144705037|NCT01569074|521771987|FG004|Overall Study|Severe non-compliance to protocol|0|||
144705038|NCT01569074|521771983|FG000|Overall Study|eg change in circumstances|0|||
144705039|NCT01569074|521771984|FG001|Overall Study|eg change in circumstances|2|||
144705040|NCT01569074|521771985|FG002|Overall Study|eg change in circumstances|0|||
144705041|NCT01569074|521771986|FG003|Overall Study|eg change in circumstances|1|||
144705042|NCT01569074|521771987|FG004|Overall Study|eg change in circumstances|1|||
144705043|NCT01569074|521771983|FG000|Overall Study|Adverse Event|1|||
144705044|NCT01569074|521771984|FG001|Overall Study|Adverse Event|0|||
144705045|NCT01569074|521771985|FG002|Overall Study|Adverse Event|3|||
144705046|NCT01569074|521771986|FG003|Overall Study|Adverse Event|0|||
144705047|NCT01569074|521771987|FG004|Overall Study|Adverse Event|0|||
144705048|NCT02723786|521771988|FG000|Overall Study|Lost to Follow-up|1|||
144705049|NCT03345485|521771991|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
144705050|NCT03345485|521771992|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
144705051|NCT03345485|521771993|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
144705052|NCT03345485|521771994|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
144705053|NCT03345485|521771995|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
144705054|NCT03345485|521771996|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
144705055|NCT03345485|521771997|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
144705056|NCT03345485|521771998|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
144705057|NCT03345485|521771999|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
144705058|NCT03345485|521772000|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
144705059|NCT03345485|521772001|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
144705060|NCT03345485|521772002|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
144705061|NCT03345485|521772003|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
144705062|NCT01610284|521772004|FG000|Randomization Phase|Adverse Event|1|||
144705063|NCT01610284|521772005|FG001|Randomization Phase|Adverse Event|0|||
144705064|NCT01610284|521772004|FG000|Randomization Phase|Physician Decision|1|||
144479896|NCT00244374|520957666|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
144479897|NCT00244374|520957667|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
144479898|NCT00244374|520957668|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
144479899|NCT00244374|520957664|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
144479900|NCT00244374|520957665|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
144479901|NCT00244374|520957666|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
144479902|NCT00244374|520957667|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
144479903|NCT00244374|520957668|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
144479904|NCT00244374|520957664|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
144479905|NCT00244374|520957665|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
144479906|NCT00244374|520957666|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
144479907|NCT00244374|520957667|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
144479908|NCT00244374|520957668|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
144479909|NCT00244374|520957664|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
144479910|NCT00244374|520957665|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
144479911|NCT00244374|520957666|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
144479912|NCT00244374|520957667|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
144479913|NCT00244374|520957668|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
144479914|NCT00244374|520957664|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
144479915|NCT00244374|520957665|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
144479916|NCT00244374|520957666|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
144479917|NCT00244374|520957667|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
144479918|NCT00244374|520957668|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
144479919|NCT00244374|520957664|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
144367417|NCT01235741|520557292|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
144367418|NCT01235741|520557293|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
144367419|NCT01235741|520557291|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
144367420|NCT01235741|520557292|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
144367421|NCT01235741|520557293|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
144367422|NCT01235741|520557291|FG000|Randomized to Treatment|Adverse Event|0|||
144367423|NCT01235741|520557292|FG001|Randomized to Treatment|Adverse Event|1|||
144367424|NCT01235741|520557293|FG002|Randomized to Treatment|Adverse Event|1|||
144367425|NCT01235741|520557291|FG000|Randomized to Treatment|Sponsor terminated study|0|||
144367426|NCT01235741|520557292|FG001|Randomized to Treatment|Sponsor terminated study|35|||
144367427|NCT01235741|520557293|FG002|Randomized to Treatment|Sponsor terminated study|34|||
144367428|NCT01235741|520557291|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
144367429|NCT01235741|520557292|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
144367430|NCT01235741|520557293|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
144367431|NCT01235741|520557291|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
144367432|NCT01235741|520557292|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
144367433|NCT01235741|520557293|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
144367434|NCT01235741|520557291|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
144367435|NCT01235741|520557292|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
144367436|NCT01235741|520557293|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
144367437|NCT01421719|520557294|FG000|Overall Study|Withdrawal by Subject|4|||
144367438|NCT01712399|520557301|FG000|Overall Study|Lost to Follow-up|1|||
144367439|NCT01712399|520557301|FG000|Overall Study|Withdrawal by Subject|39|||
144367440|NCT01712399|520557301|FG000|Overall Study|Death|1|||
144367441|NCT01712399|520557301|FG000|Overall Study|Adverse Event|11|||
144367442|NCT01712399|520557301|FG000|Overall Study|Study closure|345|||
144367443|NCT01357850|520557302|FG000|Overall Study|Lost to Follow-up|1|||
144367444|NCT01357850|520557303|FG001|Overall Study|Lost to Follow-up|0|||
144367445|NCT01357850|520557304|FG002|Overall Study|Lost to Follow-up|0|||
144367446|NCT01357850|520557305|FG003|Overall Study|Lost to Follow-up|0|||
144367447|NCT04610281|520557306|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
144367448|NCT04610281|520557307|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
144367449|NCT03077412|520557308|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
144367450|NCT03077412|520557309|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
144367451|NCT03077412|520557310|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
144367452|NCT03077412|520557308|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
144367453|NCT03077412|520557309|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
144705065|NCT01610284|521772005|FG001|Randomization Phase|Physician Decision|1|||
144705066|NCT01610284|521772004|FG000|Randomization Phase|Death|0|||
144705067|NCT01610284|521772005|FG001|Randomization Phase|Death|1|||
144705068|NCT01610284|521772004|FG000|Treatment Phase|Adverse Event|80|||
144705069|NCT01610284|521772005|FG001|Treatment Phase|Adverse Event|12|||
144705070|NCT01610284|521772004|FG000|Treatment Phase|Lost to Follow-up|1|||
144705071|NCT01610284|521772005|FG001|Treatment Phase|Lost to Follow-up|0|||
144705072|NCT01610284|521772004|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
144705073|NCT01610284|521772005|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
144705074|NCT01610284|521772004|FG000|Treatment Phase|Physician Decision|27|||
144705075|NCT01610284|521772005|FG001|Treatment Phase|Physician Decision|24|||
144705076|NCT01610284|521772004|FG000|Treatment Phase|Progressive Disease|377|||
144705077|NCT01610284|521772005|FG001|Treatment Phase|Progressive Disease|486|||
144705078|NCT01610284|521772004|FG000|Treatment Phase|Protocol Deviation|2|||
144705079|NCT01610284|521772005|FG001|Treatment Phase|Protocol Deviation|3|||
144705080|NCT01610284|521772004|FG000|Treatment Phase|Study terminated by Sponsor|18|||
144705081|NCT01610284|521772005|FG001|Treatment Phase|Study terminated by Sponsor|15|||
144705082|NCT01610284|521772004|FG000|Treatment Phase|Subject/Guardian Decision|55|||
144705083|NCT01610284|521772005|FG001|Treatment Phase|Subject/Guardian Decision|23|||
144705084|NCT01610284|521772004|FG000|Treatment Phase|Death|6|||
144705085|NCT01610284|521772005|FG001|Treatment Phase|Death|5|||
144705086|NCT01610284|521772004|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
144705087|NCT01610284|521772005|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144705088|NCT01610284|521772004|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
144705089|NCT01610284|521772005|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
144705090|NCT01610284|521772004|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
144705091|NCT01610284|521772005|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
144705092|NCT01610284|521772004|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
144705093|NCT01610284|521772005|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
144705094|NCT01610284|521772004|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
144705095|NCT01610284|521772005|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
144705096|NCT01610284|521772004|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
144705097|NCT01610284|521772005|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
144705098|NCT01060007|521772006|FG000|Overall Study|Withdrawal by Subject|1|||
144705099|NCT01060007|521772006|FG000|Overall Study|Inevaluable for response at surgery|3|||
144705100|NCT01418365|521772008|FG000|First Intervention|Withdrawal by Subject|0|||
144705101|NCT01418365|521772009|FG001|First Intervention|Withdrawal by Subject|1|||
144705102|NCT01418365|521772008|FG000|First Intervention|Non-compliance|1|||
144705103|NCT01418365|521772009|FG001|First Intervention|Non-compliance|0|||
144705104|NCT01418365|521772008|FG000|Second Intervention|Withdrawal by Subject|0|||
144705105|NCT01418365|521772009|FG001|Second Intervention|Withdrawal by Subject|1|||
144705106|NCT03319368|521772010|FG000|Overall Study|Discharge swabs not collected from resident|57|||
144705107|NCT03319368|521772011|FG001|Overall Study|Discharge swabs not collected from resident|46|||
144705108|NCT00956813|521772014|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
144705109|NCT00956813|521772015|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
144705110|NCT00956813|521772014|FG000|Flaxseed and Placebo|Ineligible|3|||
144705111|NCT00956813|521772015|FG001|Flaxseed and Placebo|Ineligible|1|||
144705112|NCT04797637|521772016|FG000|Overall Study|Lost to Follow-up|23|||
144705113|NCT04797637|521772017|FG001|Overall Study|Lost to Follow-up|32|||
144705114|NCT04797637|521772016|FG000|Overall Study|Withdrawal by Subject|0|||
144705115|NCT04797637|521772017|FG001|Overall Study|Withdrawal by Subject|1|||
144705116|NCT02392377|521772022|FG000|Overall Study|Withdrawal by Subject|0|||
144705117|NCT02392377|521772023|FG001|Overall Study|Withdrawal by Subject|1|||
144705118|NCT01126359|521772026|FG000|First Intervention (20-minutes)|Physician Decision|0|||
144705119|NCT01126359|521772027|FG001|First Intervention (20-minutes)|Physician Decision|1|||
144705120|NCT00902486|521772028|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
144705121|NCT00902486|521772029|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
144705122|NCT00902486|521772030|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
144705123|NCT00902486|521772031|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
144705124|NCT00902486|521772032|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
144705125|NCT00902486|521772033|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
144705126|NCT00902486|521772028|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
144705127|NCT00902486|521772029|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
144705128|NCT00902486|521772030|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
144705129|NCT00902486|521772031|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
144705130|NCT00902486|521772032|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
144705131|NCT00902486|521772033|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
144705132|NCT00902486|521772028|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
144705133|NCT00902486|521772029|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
144705134|NCT00902486|521772030|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
144705135|NCT00902486|521772031|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
144705136|NCT00902486|521772032|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
144705137|NCT00902486|521772033|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
144705138|NCT00902486|521772028|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
144705139|NCT00902486|521772029|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
144705140|NCT00902486|521772030|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
144705141|NCT00902486|521772031|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
144705142|NCT00902486|521772032|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
144705143|NCT00902486|521772033|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
144705144|NCT00902486|521772028|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
144705145|NCT00902486|521772029|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
144705146|NCT00902486|521772030|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
144705147|NCT00902486|521772031|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
144705148|NCT00902486|521772032|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
144705149|NCT00902486|521772033|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
144705150|NCT00902486|521772028|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
144705151|NCT00902486|521772029|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
144705152|NCT00902486|521772030|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
144705153|NCT00902486|521772031|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
144705154|NCT00902486|521772032|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
144705155|NCT00902486|521772033|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
144705156|NCT00902486|521772028|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
144705157|NCT00902486|521772029|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
144705158|NCT00902486|521772030|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
144705159|NCT00902486|521772031|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
144705160|NCT00902486|521772032|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
144705161|NCT00902486|521772033|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
144705162|NCT00902486|521772028|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
144705163|NCT00902486|521772029|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
144705164|NCT00902486|521772030|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
144705165|NCT00902486|521772031|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
144705166|NCT00902486|521772032|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
144705167|NCT00902486|521772033|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
144705168|NCT00902486|521772028|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
144705169|NCT00902486|521772029|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
144705170|NCT00902486|521772030|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
144705171|NCT00902486|521772031|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
144705172|NCT00902486|521772032|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
144705173|NCT00902486|521772033|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
144705174|NCT00902486|521772028|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
144705175|NCT00902486|521772029|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
144705176|NCT00902486|521772030|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
144705177|NCT00902486|521772031|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
144705178|NCT00902486|521772032|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
144705179|NCT00902486|521772033|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
144705180|NCT00902486|521772028|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
144705181|NCT00902486|521772029|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
144705182|NCT00902486|521772030|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
144705183|NCT00902486|521772031|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
144705184|NCT00902486|521772032|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
144705185|NCT00902486|521772033|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
144705186|NCT00526227|521772034|FG000|Overall Study|Device not implanted|1|||
144705187|NCT00526227|521772034|FG000|Overall Study|Death|1|||
144705188|NCT01525407|521772035|FG000|Overall Study|Change in recipient treatment plan|2|||
144705189|NCT01525407|521772036|FG001|Overall Study|Change in recipient treatment plan|2|||
144705190|NCT01525407|521772035|FG000|Overall Study|Withdrawal by Subject|0|||
144705191|NCT01525407|521772036|FG001|Overall Study|Withdrawal by Subject|1|||
144705192|NCT01525407|521772035|FG000|Overall Study|Transplant was delayed|0|||
144705193|NCT01525407|521772036|FG001|Overall Study|Transplant was delayed|1|||
144705194|NCT01525407|521772035|FG000|Overall Study|Delay in Transplant|1|||
144705195|NCT01525407|521772036|FG001|Overall Study|Delay in Transplant|0|||
144705196|NCT05378269|521773496|FG000|Overall Study|Protocol Violation|1|||
144705197|NCT05378269|521773497|FG001|Overall Study|Protocol Violation|0|||
144705198|NCT05378269|521773498|FG002|Overall Study|Protocol Violation|2|||
144705199|NCT05378269|521773499|FG003|Overall Study|Protocol Violation|0|||
144705200|NCT05378269|521773500|FG004|Overall Study|Protocol Violation|0|||
144705201|NCT00684645|521773501|FG000|Overall Study|Death|2|||
144705202|NCT00684645|521773501|FG000|Overall Study|Progressive disease|67|||
144705203|NCT00684645|521773501|FG000|Overall Study|Adverse Event|27|||
144705204|NCT00684645|521773501|FG000|Overall Study|Lost to Follow-up|3|||
144705205|NCT00684645|521773501|FG000|Overall Study|Other|15|||
144705206|NCT01389024|521773507|FG000|Overall Study|Withdrawal by Subject|0|||
144705207|NCT01389024|521773508|FG001|Overall Study|Withdrawal by Subject|1|||
144705208|NCT01389024|521773507|FG000|Overall Study|Lost to Follow-up|1|||
144705209|NCT01389024|521773508|FG001|Overall Study|Lost to Follow-up|0|||
144705210|NCT02325401|521773510|FG000|Overall Study|Withdrawal by Subject|0|||
144705211|NCT02325401|521773511|FG001|Overall Study|Withdrawal by Subject|1|||
144705212|NCT02325401|521773512|FG002|Overall Study|Withdrawal by Subject|1|||
144705213|NCT03526679|521773513|FG000|Overall Study|still under treatment|2|||
144705214|NCT01956123|521773514|FG000|COS Cycle 2|Protocol Violation|8|||
144705215|NCT01956123|521773515|FG001|COS Cycle 2|Protocol Violation|3|||
144705216|NCT01956123|521773516|FG002|COS Cycle 2|Protocol Violation|0|||
144705217|NCT01956123|521773517|FG003|COS Cycle 2|Protocol Violation|0|||
144705218|NCT01956123|521773514|FG000|COS Cycle 2|Adverse Event|3|||
144705219|NCT01956123|521773515|FG001|COS Cycle 2|Adverse Event|4|||
144705220|NCT01956123|521773516|FG002|COS Cycle 2|Adverse Event|0|||
144705221|NCT01956123|521773517|FG003|COS Cycle 2|Adverse Event|0|||
144705222|NCT01956123|521773514|FG000|COS Cycle 2|Personal Reasons|2|||
144705223|NCT01956123|521773515|FG001|COS Cycle 2|Personal Reasons|0|||
144705224|NCT01956123|521773516|FG002|COS Cycle 2|Personal Reasons|0|||
144705225|NCT01956123|521773517|FG003|COS Cycle 2|Personal Reasons|0|||
144705226|NCT01956123|521773514|FG000|COS Cycle 2|Withdrawal by Subject|1|||
144705227|NCT01956123|521773515|FG001|COS Cycle 2|Withdrawal by Subject|0|||
144705228|NCT01956123|521773516|FG002|COS Cycle 2|Withdrawal by Subject|0|||
144705229|NCT01956123|521773517|FG003|COS Cycle 2|Withdrawal by Subject|0|||
144705230|NCT01956123|521773514|FG000|COS Cycle 3|Protocol Violation|0|||
144705231|NCT01956123|521773515|FG001|COS Cycle 3|Protocol Violation|0|||
144705232|NCT01956123|521773516|FG002|COS Cycle 3|Protocol Violation|2|||
144705233|NCT01956123|521773517|FG003|COS Cycle 3|Protocol Violation|1|||
144705234|NCT01956123|521773514|FG000|COS Cycle 3|Adverse Event|0|||
144705235|NCT01956123|521773515|FG001|COS Cycle 3|Adverse Event|0|||
144705236|NCT01956123|521773516|FG002|COS Cycle 3|Adverse Event|3|||
144705237|NCT01956123|521773517|FG003|COS Cycle 3|Adverse Event|0|||
144705238|NCT01956123|521773514|FG000|COS Cycle 3|Personal Reasons|0|||
144705239|NCT01956123|521773515|FG001|COS Cycle 3|Personal Reasons|0|||
144705240|NCT01956123|521773516|FG002|COS Cycle 3|Personal Reasons|1|||
144705241|NCT01956123|521773517|FG003|COS Cycle 3|Personal Reasons|0|||
144705242|NCT01956123|521773514|FG000|COS Cycle 3|Withdrawal by Subject|0|||
144705243|NCT01956123|521773515|FG001|COS Cycle 3|Withdrawal by Subject|0|||
144705244|NCT01956123|521773516|FG002|COS Cycle 3|Withdrawal by Subject|0|||
144705245|NCT01956123|521773517|FG003|COS Cycle 3|Withdrawal by Subject|1|||
144705246|NCT00267020|521773520|FG000|Overall Study|Adverse Event|22|||
144705247|NCT00267020|521773521|FG001|Overall Study|Adverse Event|5|||
144705248|NCT00267020|521773520|FG000|Overall Study|Death|2|||
144705249|NCT00267020|521773521|FG001|Overall Study|Death|1|||
144705250|NCT00267020|521773520|FG000|Overall Study|Withdrawal by Subject|17|||
144705251|NCT00267020|521773521|FG001|Overall Study|Withdrawal by Subject|7|||
144705252|NCT00267020|521773520|FG000|Overall Study|Physician Decision|3|||
144705253|NCT00267020|521773521|FG001|Overall Study|Physician Decision|2|||
144705254|NCT00267020|521773520|FG000|Overall Study|Disease Progression|39|||
144705255|NCT00267020|521773521|FG001|Overall Study|Disease Progression|25|||
144705256|NCT00267020|521773520|FG000|Overall Study|Unrelated Complication|1|||
144705257|NCT00267020|521773521|FG001|Overall Study|Unrelated Complication|1|||
144705258|NCT00267020|521773520|FG000|Overall Study|Sponsor Request|1|||
144705259|NCT00267020|521773521|FG001|Overall Study|Sponsor Request|0|||
144705260|NCT00267020|521773520|FG000|Overall Study|Other|1|||
144367454|NCT03077412|520557310|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
144367455|NCT03077412|520557308|FG000|Overall Study|Adverse Event|1|||
144367456|NCT03077412|520557309|FG001|Overall Study|Adverse Event|2|||
144367457|NCT03077412|520557310|FG002|Overall Study|Adverse Event|2|||
144367458|NCT03077412|520557308|FG000|Overall Study|Investigator's Discretion|0|||
144367459|NCT03077412|520557309|FG001|Overall Study|Investigator's Discretion|1|||
144367460|NCT03077412|520557310|FG002|Overall Study|Investigator's Discretion|1|||
144367461|NCT03077412|520557308|FG000|Overall Study|Withdrew Consent|0|||
144705261|NCT00267020|521773521|FG001|Overall Study|Other|2|||
144705262|NCT00640614|521773525|FG000|Overall Study|Lost to Follow-up|1|||
144705263|NCT00640614|521773526|FG001|Overall Study|Lost to Follow-up|0|||
144705264|NCT00529802|521773527|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
144705265|NCT00529802|521773527|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
144705266|NCT00529802|521773527|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
144705267|NCT00529802|521773527|FG000|Evaluable for Primary Endpoint|Death|1|||
144705268|NCT00529802|521773527|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
144705269|NCT00529802|521773527|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
144705270|NCT00529802|521773527|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
144367462|NCT03077412|520557309|FG001|Overall Study|Withdrew Consent|2|||
144367463|NCT03077412|520557310|FG002|Overall Study|Withdrew Consent|0|||
144705271|NCT02209454|521773529|FG000|Second Period|Adverse Event|1|||
144705272|NCT02209454|521773530|FG001|Second Period|Adverse Event|0|||
144705273|NCT02545868|521773531|FG000|Overall Study|Lack of Efficacy|1|||
144705274|NCT02545868|521773532|FG001|Overall Study|Lack of Efficacy|1|||
144705275|NCT02545868|521773533|FG002|Overall Study|Lack of Efficacy|0|||
144705276|NCT02545868|521773531|FG000|Overall Study|Lost to Follow-up|1|||
144705277|NCT02545868|521773532|FG001|Overall Study|Lost to Follow-up|5|||
144705278|NCT02545868|521773533|FG002|Overall Study|Lost to Follow-up|1|||
144705279|NCT02545868|521773531|FG000|Overall Study|Non-compliance|1|||
144705280|NCT02545868|521773532|FG001|Overall Study|Non-compliance|1|||
144705281|NCT02545868|521773533|FG002|Overall Study|Non-compliance|1|||
144705282|NCT02545868|521773531|FG000|Overall Study|Treatment change|21|||
144705283|NCT02545868|521773532|FG001|Overall Study|Treatment change|19|||
144705284|NCT02545868|521773533|FG002|Overall Study|Treatment change|22|||
144705285|NCT02545868|521773531|FG000|Overall Study|Physician Decision|1|||
144705286|NCT02545868|521773532|FG001|Overall Study|Physician Decision|1|||
144705287|NCT02545868|521773533|FG002|Overall Study|Physician Decision|1|||
144705288|NCT02545868|521773531|FG000|Overall Study|Withdrawal by Subject|6|||
144705289|NCT02545868|521773532|FG001|Overall Study|Withdrawal by Subject|7|||
144705290|NCT02545868|521773533|FG002|Overall Study|Withdrawal by Subject|9|||
144705291|NCT00740480|521773538|FG000|Overall Study|Adverse Event|1|||
144705292|NCT00740480|521773538|FG000|Overall Study|Physician Decision|1|||
144705293|NCT01856686|521773542|FG000|Overall Study|Lost to Follow-up|5|||
144705294|NCT01856686|521773543|FG001|Overall Study|Lost to Follow-up|11|||
144705295|NCT00602979|521773544|FG000|Overall Study|Lost to Follow-up|3|||
144705296|NCT00602979|521773545|FG001|Overall Study|Lost to Follow-up|2|||
144705297|NCT00602979|521773546|FG002|Overall Study|Lost to Follow-up|3|||
144705298|NCT00602979|521773547|FG003|Overall Study|Lost to Follow-up|2|||
144705299|NCT00602979|521773548|FG004|Overall Study|Lost to Follow-up|3|||
144705300|NCT00602979|521773544|FG000|Overall Study|Failed Intubation|0|||
144705301|NCT00602979|521773545|FG001|Overall Study|Failed Intubation|1|||
144705302|NCT00602979|521773546|FG002|Overall Study|Failed Intubation|0|||
144705303|NCT00602979|521773547|FG003|Overall Study|Failed Intubation|1|||
144705304|NCT00602979|521773548|FG004|Overall Study|Failed Intubation|0|||
144705305|NCT00468312|521773549|FG000|Overall Study|Adverse Event|2|||
144705306|NCT00468312|521773550|FG001|Overall Study|Adverse Event|1|||
144705307|NCT00468312|521773549|FG000|Overall Study|Lack of Efficacy|0|||
144705308|NCT00468312|521773550|FG001|Overall Study|Lack of Efficacy|1|||
144705309|NCT00468312|521773549|FG000|Overall Study|Withdrawal by Subject|0|||
144705310|NCT00468312|521773550|FG001|Overall Study|Withdrawal by Subject|1|||
144705311|NCT00468312|521773549|FG000|Overall Study|Protocol Violation|2|||
144705312|NCT00468312|521773550|FG001|Overall Study|Protocol Violation|1|||
144705313|NCT00468312|521773549|FG000|Overall Study|Did not meet protocol eligibility|0|||
144705314|NCT00468312|521773550|FG001|Overall Study|Did not meet protocol eligibility|1|||
144705315|NCT03170271|521773555|FG000|Overall Study|Adverse Event|7|||
144705316|NCT03170271|521773556|FG001|Overall Study|Adverse Event|2|||
144705317|NCT03170271|521773555|FG000|Overall Study|Lost to Follow-up|0|||
144705318|NCT03170271|521773556|FG001|Overall Study|Lost to Follow-up|1|||
144705319|NCT03170271|521773555|FG000|Overall Study|Physician Decision|1|||
144705320|NCT03170271|521773556|FG001|Overall Study|Physician Decision|0|||
144705321|NCT03170271|521773555|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
144705322|NCT03170271|521773556|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
144705323|NCT03170271|521773555|FG000|Overall Study|Withdrawal by Subject|17|||
144705324|NCT03170271|521773556|FG001|Overall Study|Withdrawal by Subject|5|||
144705325|NCT03170271|521773555|FG000|Overall Study|Other|2|||
144705326|NCT03170271|521773556|FG001|Overall Study|Other|2|||
144705327|NCT03170271|521773555|FG000|Overall Study|Randomized in error|4|||
144705328|NCT03170271|521773556|FG001|Overall Study|Randomized in error|0|||
144705329|NCT03466060|521773572|FG000|Period 1|Test Lens Damage|0|||
144705330|NCT03466060|521773573|FG001|Period 1|Test Lens Damage|2|||
144705331|NCT03466060|521773574|FG002|Period 1|Test Lens Damage|0|||
144705332|NCT03466060|521773575|FG003|Period 1|Test Lens Damage|0|||
144705333|NCT03466060|521773576|FG004|Period 1|Test Lens Damage|0|||
144705334|NCT03466060|521773577|FG005|Period 1|Test Lens Damage|0|||
144705335|NCT03466060|521773572|FG000|Period 1|Withdrawal by Subject|0|||
144705336|NCT03466060|521773573|FG001|Period 1|Withdrawal by Subject|0|||
144705337|NCT03466060|521773574|FG002|Period 1|Withdrawal by Subject|2|||
144705338|NCT03466060|521773575|FG003|Period 1|Withdrawal by Subject|0|||
144705339|NCT03466060|521773576|FG004|Period 1|Withdrawal by Subject|0|||
144705340|NCT03466060|521773577|FG005|Period 1|Withdrawal by Subject|0|||
144705341|NCT03466060|521773572|FG000|Period 1|Lost to Follow-up|0|||
144705342|NCT03466060|521773573|FG001|Period 1|Lost to Follow-up|0|||
144705343|NCT03466060|521773574|FG002|Period 1|Lost to Follow-up|0|||
144705344|NCT03466060|521773575|FG003|Period 1|Lost to Follow-up|1|||
144705345|NCT03466060|521773576|FG004|Period 1|Lost to Follow-up|0|||
144705346|NCT03466060|521773577|FG005|Period 1|Lost to Follow-up|0|||
144705347|NCT03466060|521773572|FG000|Period 1|Grade 2 Conjunctivitis|0|||
144705348|NCT03466060|521773573|FG001|Period 1|Grade 2 Conjunctivitis|0|||
144705349|NCT03466060|521773574|FG002|Period 1|Grade 2 Conjunctivitis|1|||
144705350|NCT03466060|521773575|FG003|Period 1|Grade 2 Conjunctivitis|0|||
144705351|NCT03466060|521773576|FG004|Period 1|Grade 2 Conjunctivitis|0|||
144705352|NCT03466060|521773577|FG005|Period 1|Grade 2 Conjunctivitis|0|||
144705353|NCT03466060|521773572|FG000|Period 2|Lens Handling Difficulties|0|||
144705354|NCT03466060|521773573|FG001|Period 2|Lens Handling Difficulties|0|||
144705355|NCT03466060|521773574|FG002|Period 2|Lens Handling Difficulties|1|||
144705356|NCT03466060|521773575|FG003|Period 2|Lens Handling Difficulties|0|||
144705357|NCT03466060|521773576|FG004|Period 2|Lens Handling Difficulties|0|||
144705358|NCT03466060|521773577|FG005|Period 2|Lens Handling Difficulties|0|||
144705359|NCT01612780|521773578|FG000|Overall Study|Treatment not completed|1|||
144705360|NCT01612780|521773578|FG000|Overall Study|Withdrawal by Subject|5|||
144705361|NCT00556166|521773579|FG000|Overall Study|Withdrawal by Subject|1|||
144705362|NCT02985515|521773582|FG000|Olfaction Testing|Lost to Follow-up|0|||
144705363|NCT02985515|521773583|FG001|Olfaction Testing|Lost to Follow-up|5|||
144705364|NCT02985515|521773582|FG000|Olfaction Testing|Protocol Violation|0|||
144705365|NCT02985515|521773583|FG001|Olfaction Testing|Protocol Violation|3|||
144705366|NCT03359473|521773584|FG000|Overall Study|Adverse Event|0|||
144705367|NCT03359473|521773585|FG001|Overall Study|Adverse Event|2|||
144705368|NCT03359473|521773586|FG002|Overall Study|Adverse Event|5|||
144705369|NCT03359473|521773587|FG003|Overall Study|Adverse Event|3|||
144705370|NCT03359473|521773584|FG000|Overall Study|Lost to Follow-up|0|||
144705371|NCT03359473|521773585|FG001|Overall Study|Lost to Follow-up|1|||
144705372|NCT03359473|521773586|FG002|Overall Study|Lost to Follow-up|0|||
144705373|NCT03359473|521773587|FG003|Overall Study|Lost to Follow-up|0|||
144705374|NCT03359473|521773584|FG000|Overall Study|Physician Decision|0|||
144705375|NCT03359473|521773585|FG001|Overall Study|Physician Decision|1|||
144705376|NCT03359473|521773586|FG002|Overall Study|Physician Decision|0|||
144705377|NCT03359473|521773587|FG003|Overall Study|Physician Decision|1|||
144705378|NCT03359473|521773584|FG000|Overall Study|Withdrawal by Subject|1|||
144705379|NCT03359473|521773585|FG001|Overall Study|Withdrawal by Subject|2|||
144705380|NCT03359473|521773586|FG002|Overall Study|Withdrawal by Subject|1|||
144705381|NCT03359473|521773587|FG003|Overall Study|Withdrawal by Subject|0|||
144705382|NCT03359473|521773584|FG000|Overall Study|Protocol-defined stopping criteria|1|||
144705383|NCT03359473|521773585|FG001|Overall Study|Protocol-defined stopping criteria|0|||
144705384|NCT03359473|521773586|FG002|Overall Study|Protocol-defined stopping criteria|0|||
144705385|NCT03359473|521773587|FG003|Overall Study|Protocol-defined stopping criteria|1|||
144705386|NCT05302414|521773588|FG000|Pretest to Posttest|Lost to Follow-up|12|||
144705387|NCT05302414|521773589|FG001|Pretest to Posttest|Lost to Follow-up|8|||
144705388|NCT05302414|521773590|FG002|Pretest to Posttest|Lost to Follow-up|8|||
144705389|NCT05302414|521773588|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
144705390|NCT05302414|521773589|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
144705391|NCT05302414|521773590|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
144705392|NCT03701516|521773593|FG000|Period 1|Lost to Follow-up|0|||
144705393|NCT03701516|521773594|FG001|Period 1|Lost to Follow-up|1|||
144705394|NCT03701516|521773593|FG000|Period 1|Adverse Event|0|||
144705395|NCT03701516|521773594|FG001|Period 1|Adverse Event|2|||
144705396|NCT03701516|521773593|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
144705397|NCT03701516|521773594|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
144705398|NCT03701516|521773593|FG000|Period 1|Non Compliance to Protocol|2|||
144705399|NCT03701516|521773594|FG001|Period 1|Non Compliance to Protocol|1|||
144705400|NCT03701516|521773593|FG000|Period 1|Withdrawal by Subject|0|||
144705401|NCT03701516|521773594|FG001|Period 1|Withdrawal by Subject|1|||
144705402|NCT03701516|521773593|FG000|Period 2|failed to meet all eligibility creiteria|1|||
144705403|NCT03701516|521773594|FG001|Period 2|failed to meet all eligibility creiteria|0|||
144705404|NCT03701516|521773593|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
144705405|NCT03701516|521773594|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
144705406|NCT03644927|521773597|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
144705407|NCT03644927|521773598|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
144705408|NCT02864953|521773601|FG000|Overall Study|Adverse Event|22|||
144705409|NCT02864953|521773602|FG001|Overall Study|Adverse Event|19|||
144705410|NCT02864953|521773601|FG000|Overall Study|Withdrawal by Subject|1|||
144705411|NCT02864953|521773602|FG001|Overall Study|Withdrawal by Subject|0|||
144705412|NCT02864953|521773601|FG000|Overall Study|Physician Decision|4|||
144705413|NCT02864953|521773602|FG001|Overall Study|Physician Decision|2|||
144705414|NCT02864953|521773601|FG000|Overall Study|Death|3|||
144705415|NCT02864953|521773602|FG001|Overall Study|Death|13|||
144705416|NCT02864953|521773601|FG000|Overall Study|Reason not specified|14|||
144705417|NCT02864953|521773602|FG001|Overall Study|Reason not specified|12|||
144705418|NCT02864953|521773601|FG000|Overall Study|Withdrew Prior to Dosing|9|||
144367464|NCT02266888|520557312|FG000|Overall Study|Death|2|||
144367465|NCT02266888|520557313|FG001|Overall Study|Death|2|||
144705419|NCT02864953|521773602|FG001|Overall Study|Withdrew Prior to Dosing|8|||
144705420|NCT00981019|521773603|FG000|Overall Study|Did not respond|65|||
144705421|NCT00981019|521773603|FG000|Overall Study|Did not match target population|94|||
144705422|NCT00981019|521773603|FG000|Overall Study|Inadvertent exclusion|239|||
144367466|NCT02266888|520557314|FG002|Overall Study|Death|4|||
144705423|NCT00981019|521773603|FG000|Overall Study|Hit the survey after closure|79|||
144705424|NCT05083559|521773604|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
144705425|NCT05083559|521773605|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
144705426|NCT05083559|521773604|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
144705427|NCT05083559|521773605|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
144705428|NCT05083559|521773604|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
144705429|NCT05083559|521773605|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
144705430|NCT00621309|521773607|FG000|Overall Study|Withdrawal by Subject|2|||
144705431|NCT00621309|521773608|FG001|Overall Study|Withdrawal by Subject|0|||
144705432|NCT00621309|521773609|FG002|Overall Study|Withdrawal by Subject|1|||
144705433|NCT00621309|521773610|FG003|Overall Study|Withdrawal by Subject|1|||
144705434|NCT00621309|521773611|FG004|Overall Study|Withdrawal by Subject|1|||
144705435|NCT00621309|521773612|FG005|Overall Study|Withdrawal by Subject|1|||
144705436|NCT01306968|521773613|FG000|Overall Study|Lost to Follow-up|1|||
144705437|NCT01306968|521773614|FG001|Overall Study|Lost to Follow-up|1|||
144705438|NCT01306968|521773615|FG002|Overall Study|Lost to Follow-up|0|||
144705439|NCT01306968|521773616|FG003|Overall Study|Lost to Follow-up|0|||
144705440|NCT01306968|521773613|FG000|Overall Study|Physician Decision|0|||
144705441|NCT01306968|521773614|FG001|Overall Study|Physician Decision|1|||
144705442|NCT01306968|521773615|FG002|Overall Study|Physician Decision|0|||
144705443|NCT01306968|521773616|FG003|Overall Study|Physician Decision|0|||
144705444|NCT01306968|521773613|FG000|Overall Study|Relocated and left active duty|0|||
144705445|NCT01306968|521773614|FG001|Overall Study|Relocated and left active duty|1|||
144705446|NCT01306968|521773615|FG002|Overall Study|Relocated and left active duty|1|||
144705447|NCT01306968|521773616|FG003|Overall Study|Relocated and left active duty|1|||
144705448|NCT01306968|521773613|FG000|Overall Study|Withdrew - time commitment|0|||
144705449|NCT01306968|521773614|FG001|Overall Study|Withdrew - time commitment|0|||
144705450|NCT01306968|521773615|FG002|Overall Study|Withdrew - time commitment|0|||
144705451|NCT01306968|521773616|FG003|Overall Study|Withdrew - time commitment|2|||
144705452|NCT01306968|521773613|FG000|Overall Study|Withdrew over privacy concerns|0|||
144705453|NCT01306968|521773614|FG001|Overall Study|Withdrew over privacy concerns|0|||
144705454|NCT01306968|521773615|FG002|Overall Study|Withdrew over privacy concerns|0|||
144705455|NCT01306968|521773616|FG003|Overall Study|Withdrew over privacy concerns|1|||
144705456|NCT01329562|521773617|FG000|Overall Study|Protocol Violation|5|||
144705457|NCT01329562|521773618|FG001|Overall Study|Protocol Violation|3|||
144705458|NCT01329562|521773617|FG000|Overall Study|Lost to Follow-up|1|||
144705459|NCT01329562|521773618|FG001|Overall Study|Lost to Follow-up|1|||
144705460|NCT01329562|521773617|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
144705461|NCT01329562|521773618|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
144705462|NCT01329562|521773617|FG000|Overall Study|Physician Decision|0|||
144705463|NCT01329562|521773618|FG001|Overall Study|Physician Decision|1|||
144705464|NCT00061568|521773619|FG000|Overall Study|Lost to Follow-up|12|||
144705465|NCT00061568|521773620|FG001|Overall Study|Lost to Follow-up|0|||
144705466|NCT00061568|521773619|FG000|Overall Study|Death|6|||
144705467|NCT00061568|521773620|FG001|Overall Study|Death|0|||
144705468|NCT00061568|521773619|FG000|Overall Study|Withdrawal by Subject|1|||
144705469|NCT00061568|521773620|FG001|Overall Study|Withdrawal by Subject|0|||
144705470|NCT01381068|521773621|FG000|Overall Study|Death|1|||
144705471|NCT01381068|521773622|FG001|Overall Study|Death|0|||
144705472|NCT00797316|521773623|FG000|Overall Study|Administrative problems|1|||
144705473|NCT00797316|521773624|FG001|Overall Study|Administrative problems|0|||
144705474|NCT00797316|521773623|FG000|Overall Study|Adverse Event|5|||
144705475|NCT00797316|521773624|FG001|Overall Study|Adverse Event|3|||
144705476|NCT00797316|521773623|FG000|Overall Study|Lost to Follow-up|4|||
144705477|NCT00797316|521773624|FG001|Overall Study|Lost to Follow-up|8|||
144705478|NCT00797316|521773623|FG000|Overall Study|Protocol Deviation|1|||
144705479|NCT00797316|521773624|FG001|Overall Study|Protocol Deviation|2|||
144705480|NCT00797316|521773623|FG000|Overall Study|Patient withdrew consent|12|||
144705481|NCT00797316|521773624|FG001|Overall Study|Patient withdrew consent|6|||
144705482|NCT00797316|521773623|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144705483|NCT00797316|521773624|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
144705484|NCT03239340|521773631|FG000|Overall Study|Other|26|||
144705485|NCT03239340|521773631|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
144705486|NCT03239340|521773631|FG000|Overall Study|Death|40|||
144705487|NCT03239340|521773631|FG000|Overall Study|Lost to Follow-up|2|||
144705488|NCT03239340|521773631|FG000|Overall Study|Physician Decision|16|||
144705489|NCT03239340|521773631|FG000|Overall Study|Withdrawal by Subject|27|||
144705490|NCT02061293|521773637|FG000|Overall Study|Elevated Blood Pressure|1|||
144705491|NCT02061293|521773638|FG001|Overall Study|Elevated Blood Pressure|1|||
144705492|NCT00690573|521773640|FG000|Overall Study|Lack of Efficacy|8|||
144705493|NCT00690573|521773640|FG000|Overall Study|Withdrawal by Subject|1|||
144705494|NCT02332655|521773641|FG000|Overall Study|Lack of Efficacy|1|||
144705495|NCT01298661|521773642|FG000|Overall Study|Withdrawal by Subject|2|||
144705496|NCT01298661|521773643|FG001|Overall Study|Withdrawal by Subject|0|||
144705497|NCT01298661|521773644|FG002|Overall Study|Withdrawal by Subject|2|||
144705498|NCT01186744|521775321|FG000|Overall Study|Lack of Efficacy|156|||
144705499|NCT01186744|521775322|FG001|Overall Study|Lack of Efficacy|99|||
144705500|NCT01186744|521775323|FG002|Overall Study|Lack of Efficacy|0|||
144705501|NCT01186744|521775324|FG003|Overall Study|Lack of Efficacy|2|||
144705502|NCT01186744|521775325|FG004|Overall Study|Lack of Efficacy|2|||
144705503|NCT01186744|521775326|FG005|Overall Study|Lack of Efficacy|5|||
144705504|NCT01186744|521775321|FG000|Overall Study|Protocol Violation|1|||
144705505|NCT01186744|521775322|FG001|Overall Study|Protocol Violation|2|||
144705506|NCT01186744|521775323|FG002|Overall Study|Protocol Violation|0|||
144705507|NCT01186744|521775324|FG003|Overall Study|Protocol Violation|1|||
144705508|NCT01186744|521775325|FG004|Overall Study|Protocol Violation|1|||
144705509|NCT01186744|521775326|FG005|Overall Study|Protocol Violation|2|||
144705510|NCT01186744|521775321|FG000|Overall Study|Lost to Follow-up|15|||
144705511|NCT01186744|521775322|FG001|Overall Study|Lost to Follow-up|16|||
144705512|NCT01186744|521775323|FG002|Overall Study|Lost to Follow-up|2|||
144705513|NCT01186744|521775324|FG003|Overall Study|Lost to Follow-up|1|||
144705514|NCT01186744|521775325|FG004|Overall Study|Lost to Follow-up|1|||
144705515|NCT01186744|521775326|FG005|Overall Study|Lost to Follow-up|4|||
144367467|NCT02266888|520557315|FG003|Overall Study|Death|2|||
144367468|NCT02266888|520557312|FG000|Overall Study|Physician Decision|0|||
144367469|NCT02266888|520557313|FG001|Overall Study|Physician Decision|1|||
144705516|NCT01186744|521775321|FG000|Overall Study|Screen failure|1|||
144705517|NCT01186744|521775322|FG001|Overall Study|Screen failure|1|||
144705518|NCT01186744|521775323|FG002|Overall Study|Screen failure|0|||
144705519|NCT01186744|521775324|FG003|Overall Study|Screen failure|1|||
144705520|NCT01186744|521775325|FG004|Overall Study|Screen failure|0|||
144705521|NCT01186744|521775326|FG005|Overall Study|Screen failure|0|||
144705522|NCT01186744|521775321|FG000|Overall Study|Withdrawal by Subject|14|||
144705523|NCT01186744|521775322|FG001|Overall Study|Withdrawal by Subject|10|||
144705524|NCT01186744|521775323|FG002|Overall Study|Withdrawal by Subject|2|||
144705525|NCT01186744|521775324|FG003|Overall Study|Withdrawal by Subject|5|||
144705526|NCT01186744|521775325|FG004|Overall Study|Withdrawal by Subject|0|||
144705527|NCT01186744|521775326|FG005|Overall Study|Withdrawal by Subject|6|||
144705528|NCT01186744|521775321|FG000|Overall Study|Study terminated by Sponsor|1|||
144705529|NCT01186744|521775322|FG001|Overall Study|Study terminated by Sponsor|0|||
144705530|NCT01186744|521775323|FG002|Overall Study|Study terminated by Sponsor|0|||
144705531|NCT01186744|521775324|FG003|Overall Study|Study terminated by Sponsor|0|||
144705532|NCT01186744|521775325|FG004|Overall Study|Study terminated by Sponsor|0|||
144705533|NCT01186744|521775326|FG005|Overall Study|Study terminated by Sponsor|0|||
144705534|NCT01186744|521775321|FG000|Overall Study|Other|9|||
144705535|NCT01186744|521775322|FG001|Overall Study|Other|10|||
144705536|NCT01186744|521775323|FG002|Overall Study|Other|1|||
144705537|NCT01186744|521775324|FG003|Overall Study|Other|2|||
144705538|NCT01186744|521775325|FG004|Overall Study|Other|1|||
144705539|NCT01186744|521775326|FG005|Overall Study|Other|5|||
144705540|NCT01186744|521775321|FG000|Overall Study|Adverse Event|10|||
144705541|NCT01186744|521775322|FG001|Overall Study|Adverse Event|14|||
144705542|NCT01186744|521775323|FG002|Overall Study|Adverse Event|1|||
144705543|NCT01186744|521775324|FG003|Overall Study|Adverse Event|0|||
144705544|NCT01186744|521775325|FG004|Overall Study|Adverse Event|1|||
144705545|NCT01186744|521775326|FG005|Overall Study|Adverse Event|4|||
144705546|NCT01186744|521775321|FG000|Overall Study|Death|1|||
144705547|NCT01186744|521775322|FG001|Overall Study|Death|0|||
144705548|NCT01186744|521775323|FG002|Overall Study|Death|0|||
144705549|NCT01186744|521775324|FG003|Overall Study|Death|0|||
144705550|NCT01186744|521775325|FG004|Overall Study|Death|0|||
144367470|NCT02266888|520557314|FG002|Overall Study|Physician Decision|2|||
144367471|NCT02266888|520557315|FG003|Overall Study|Physician Decision|2|||
144367472|NCT02266888|520557312|FG000|Overall Study|Study Terminated|5|||
144367473|NCT02266888|520557313|FG001|Overall Study|Study Terminated|1|||
144367474|NCT02266888|520557314|FG002|Overall Study|Study Terminated|0|||
144367475|NCT02266888|520557315|FG003|Overall Study|Study Terminated|0|||
144367476|NCT02266888|520557312|FG000|Overall Study|No Longer Eligible|0|||
144367477|NCT02266888|520557313|FG001|Overall Study|No Longer Eligible|0|||
144705551|NCT01186744|521775326|FG005|Overall Study|Death|0|||
144705552|NCT01461369|521775329|FG000|Overall Study|Lack of Efficacy|2|||
144705553|NCT01461369|521775330|FG001|Overall Study|Lack of Efficacy|0|||
144705554|NCT01461369|521775331|FG002|Overall Study|Lack of Efficacy|6|||
144705555|NCT01461369|521775329|FG000|Overall Study|Lost to Follow-up|0|||
144705556|NCT01461369|521775330|FG001|Overall Study|Lost to Follow-up|0|||
144705557|NCT01461369|521775331|FG002|Overall Study|Lost to Follow-up|3|||
144705558|NCT01461369|521775329|FG000|Overall Study|Adverse Event|9|||
144705559|NCT01461369|521775330|FG001|Overall Study|Adverse Event|12|||
144367478|NCT02266888|520557314|FG002|Overall Study|No Longer Eligible|0|||
144367479|NCT02266888|520557315|FG003|Overall Study|No Longer Eligible|2|||
144367480|NCT02266888|520557312|FG000|Overall Study|Randomization Closed|0|||
144367481|NCT02266888|520557313|FG001|Overall Study|Randomization Closed|0|||
144705560|NCT01461369|521775331|FG002|Overall Study|Adverse Event|4|||
144705561|NCT01461369|521775329|FG000|Overall Study|Protocol Violation|1|||
144705562|NCT01461369|521775330|FG001|Overall Study|Protocol Violation|2|||
144705563|NCT01461369|521775331|FG002|Overall Study|Protocol Violation|2|||
144705564|NCT01461369|521775329|FG000|Overall Study|Withdrawal by Subject|1|||
144705565|NCT01461369|521775330|FG001|Overall Study|Withdrawal by Subject|3|||
144705566|NCT01461369|521775331|FG002|Overall Study|Withdrawal by Subject|2|||
144705567|NCT00734617|521775334|FG000|Overall Study|Adverse Event|4|||
144705568|NCT00734617|521775335|FG001|Overall Study|Adverse Event|7|||
144705569|NCT00734617|521775334|FG000|Overall Study|Withdrawal by Subject|103|||
144705570|NCT00734617|521775335|FG001|Overall Study|Withdrawal by Subject|95|||
144705571|NCT00499252|521775340|FG000|Overall Study|Adverse Event|3|||
144705572|NCT00499252|521775340|FG000|Overall Study|Refused further treatment|2|||
144705573|NCT00499252|521775340|FG000|Overall Study|Ineligible|4|||
144705574|NCT00499252|521775340|FG000|Overall Study|<no further label>|3|||
144705575|NCT01988337|521775341|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
144705576|NCT02742818|521775342|FG000|Overall Study|Adverse Event|0|||
144705577|NCT02742818|521775343|FG001|Overall Study|Adverse Event|1|||
144705578|NCT02742818|521775342|FG000|Overall Study|Protocol Violation|0|||
144705579|NCT02742818|521775343|FG001|Overall Study|Protocol Violation|1|||
144705580|NCT00457418|521775344|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
144705581|NCT00457418|521775344|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
144705582|NCT00457418|521775344|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
144705583|NCT00457418|521775344|FG000|Post PK Maintenance|Adverse Event|10|||
144705584|NCT00457418|521775344|FG000|Post PK Maintenance|Progression of Disease|6|||
144705585|NCT00457418|521775344|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
144705586|NCT00457418|521775344|FG000|Post PK Maintenance|Lost to Follow-up|1|||
144705587|NCT01785472|521775345|FG000|Overall Study|Adverse Event|5|||
144705588|NCT01785472|521775346|FG001|Overall Study|Adverse Event|4|||
144705589|NCT01785472|521775347|FG002|Overall Study|Adverse Event|6|||
144705590|NCT01785472|521775345|FG000|Overall Study|Lack of Efficacy|2|||
144705591|NCT01785472|521775346|FG001|Overall Study|Lack of Efficacy|0|||
144705592|NCT01785472|521775347|FG002|Overall Study|Lack of Efficacy|1|||
144705593|NCT01785472|521775345|FG000|Overall Study|Lost to Follow-up|1|||
144705594|NCT01785472|521775346|FG001|Overall Study|Lost to Follow-up|2|||
144705595|NCT01785472|521775347|FG002|Overall Study|Lost to Follow-up|0|||
144705596|NCT01785472|521775345|FG000|Overall Study|Physician Decision|1|||
144705597|NCT01785472|521775346|FG001|Overall Study|Physician Decision|1|||
144705598|NCT01785472|521775347|FG002|Overall Study|Physician Decision|1|||
144705599|NCT01785472|521775345|FG000|Overall Study|Protocol deviation|0|||
144705600|NCT01785472|521775346|FG001|Overall Study|Protocol deviation|2|||
144367482|NCT02266888|520557314|FG002|Overall Study|Randomization Closed|4|||
144367483|NCT02266888|520557315|FG003|Overall Study|Randomization Closed|0|||
144367484|NCT02266888|520557312|FG000|Overall Study|Personnel unavailable at transplant|0|||
144367485|NCT02266888|520557313|FG001|Overall Study|Personnel unavailable at transplant|0|||
144367486|NCT02266888|520557314|FG002|Overall Study|Personnel unavailable at transplant|0|||
144367487|NCT02266888|520557315|FG003|Overall Study|Personnel unavailable at transplant|1|||
144367488|NCT02266888|520557312|FG000|Overall Study|Transfer of care|0|||
144479920|NCT00244374|520957665|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
144479921|NCT00244374|520957666|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
144479922|NCT00244374|520957667|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
144479923|NCT00244374|520957668|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
144479924|NCT00244374|520957664|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
144479925|NCT00244374|520957665|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
144479926|NCT00244374|520957666|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
144479927|NCT00244374|520957667|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
144479928|NCT00244374|520957668|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
144479929|NCT00244374|520957664|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
144479930|NCT00244374|520957665|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
144705601|NCT01785472|521775347|FG002|Overall Study|Protocol deviation|2|||
144705602|NCT01785472|521775345|FG000|Overall Study|Subject/guardian decision|15|||
144705603|NCT01785472|521775346|FG001|Overall Study|Subject/guardian decision|10|||
144705604|NCT01785472|521775347|FG002|Overall Study|Subject/guardian decision|11|||
144705605|NCT01785472|521775345|FG000|Overall Study|Technical problems|0|||
144367489|NCT02266888|520557313|FG001|Overall Study|Transfer of care|0|||
144705606|NCT01785472|521775346|FG001|Overall Study|Technical problems|0|||
144705607|NCT01785472|521775347|FG002|Overall Study|Technical problems|1|||
144705608|NCT02086968|521775349|FG000|Overall Study|Adverse Event|1|||
144705609|NCT02086968|521775350|FG001|Overall Study|Adverse Event|5|||
144705610|NCT02086968|521775349|FG000|Overall Study|Lost to Follow-up|2|||
144367490|NCT02266888|520557314|FG002|Overall Study|Transfer of care|1|||
144705611|NCT02086968|521775350|FG001|Overall Study|Lost to Follow-up|3|||
144705612|NCT02086968|521775349|FG000|Overall Study|Study drug received outside protocol|0|||
144705613|NCT02086968|521775350|FG001|Overall Study|Study drug received outside protocol|1|||
144705614|NCT02086968|521775349|FG000|Overall Study|Physician Decision|4|||
144705615|NCT02086968|521775350|FG001|Overall Study|Physician Decision|0|||
144705616|NCT02086968|521775349|FG000|Overall Study|Withdrawal by Subject|1|||
144705617|NCT02086968|521775350|FG001|Overall Study|Withdrawal by Subject|4|||
144705618|NCT03387735|521775354|FG000|Overall Study|Lost to Follow-up|4|||
144705619|NCT03387735|521775355|FG001|Overall Study|Lost to Follow-up|8|||
144705620|NCT03387735|521775354|FG000|Overall Study|Death|4|||
144705621|NCT03387735|521775355|FG001|Overall Study|Death|8|||
144705622|NCT03099161|521775356|FG000|Overall Study|Adverse Event|0|||
144705623|NCT03099161|521775357|FG001|Overall Study|Adverse Event|0|||
144705624|NCT03099161|521775358|FG002|Overall Study|Adverse Event|2|||
144705625|NCT03099161|521775356|FG000|Overall Study|Physician Decision|2|||
144705626|NCT03099161|521775357|FG001|Overall Study|Physician Decision|0|||
144705627|NCT03099161|521775358|FG002|Overall Study|Physician Decision|0|||
144705628|NCT03099161|521775356|FG000|Overall Study|Progressive Disease|1|||
144705629|NCT03099161|521775357|FG001|Overall Study|Progressive Disease|4|||
144705630|NCT03099161|521775358|FG002|Overall Study|Progressive Disease|1|||
144705631|NCT00110084|521775359|FG000|Overall Study|Adverse Event|9|||
144705632|NCT00110084|521775359|FG000|Overall Study|Death|1|||
144705633|NCT00110084|521775359|FG000|Overall Study|Patient Refusal|10|||
144705634|NCT00110084|521775359|FG000|Overall Study|Alternate Therapy|5|||
144705635|NCT00110084|521775359|FG000|Overall Study|Intercurrent Illness|1|||
144705636|NCT00110084|521775359|FG000|Overall Study|Other|2|||
144705637|NCT00537056|521775361|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
144705638|NCT04854707|521775362|FG000|Overall Study|Lack of Efficacy|78|||
144705639|NCT04854707|521775363|FG001|Overall Study|Lack of Efficacy|59|||
144705640|NCT04854707|521775364|FG002|Overall Study|Lack of Efficacy|30|||
144705641|NCT01257737|521775366|FG000|Overall Study|Lost to Follow-up|1|||
144705642|NCT01257737|521775367|FG001|Overall Study|Lost to Follow-up|2|||
144705643|NCT01257737|521775366|FG000|Overall Study|Liver transplant|1|||
144705644|NCT01257737|521775367|FG001|Overall Study|Liver transplant|0|||
144705645|NCT01257737|521775366|FG000|Overall Study|Relocation out of the country|0|||
144705646|NCT01257737|521775367|FG001|Overall Study|Relocation out of the country|1|||
144705647|NCT01257737|521775366|FG000|Overall Study|Withdrew from study|0|||
144705648|NCT01257737|521775367|FG001|Overall Study|Withdrew from study|1|||
144705649|NCT01071083|521775379|FG000|Overall Study|Adverse Event|1|||
144705650|NCT01071083|521775380|FG001|Overall Study|Adverse Event|0|||
144705651|NCT01071083|521775381|FG002|Overall Study|Adverse Event|1|||
144705652|NCT01071083|521775382|FG003|Overall Study|Adverse Event|0|||
144705653|NCT01071083|521775383|FG004|Overall Study|Adverse Event|1|||
144705654|NCT01071083|521775379|FG000|Overall Study|Withdrawal by Subject|3|||
144705655|NCT01071083|521775380|FG001|Overall Study|Withdrawal by Subject|0|||
144705656|NCT01071083|521775381|FG002|Overall Study|Withdrawal by Subject|2|||
144705657|NCT01071083|521775382|FG003|Overall Study|Withdrawal by Subject|0|||
144705658|NCT01071083|521775383|FG004|Overall Study|Withdrawal by Subject|3|||
144705659|NCT01071083|521775379|FG000|Overall Study|Physician Decision|1|||
144705660|NCT01071083|521775380|FG001|Overall Study|Physician Decision|0|||
144705661|NCT01071083|521775381|FG002|Overall Study|Physician Decision|0|||
144705662|NCT01071083|521775382|FG003|Overall Study|Physician Decision|1|||
144705663|NCT01071083|521775383|FG004|Overall Study|Physician Decision|1|||
144705664|NCT01071083|521775379|FG000|Overall Study|Early Rescue|1|||
144705665|NCT01071083|521775380|FG001|Overall Study|Early Rescue|0|||
144705666|NCT01071083|521775381|FG002|Overall Study|Early Rescue|0|||
144705667|NCT01071083|521775382|FG003|Overall Study|Early Rescue|0|||
144705668|NCT01071083|521775383|FG004|Overall Study|Early Rescue|1|||
144705669|NCT01071083|521775379|FG000|Overall Study|Subject Moved|0|||
144705670|NCT01071083|521775380|FG001|Overall Study|Subject Moved|1|||
144705671|NCT01071083|521775381|FG002|Overall Study|Subject Moved|0|||
144705672|NCT01071083|521775382|FG003|Overall Study|Subject Moved|0|||
144705673|NCT01071083|521775383|FG004|Overall Study|Subject Moved|0|||
144705674|NCT01071083|521775379|FG000|Overall Study|Images Not Usable (Motion)|0|||
144705675|NCT01071083|521775380|FG001|Overall Study|Images Not Usable (Motion)|1|||
144705676|NCT01071083|521775381|FG002|Overall Study|Images Not Usable (Motion)|0|||
144705677|NCT01071083|521775382|FG003|Overall Study|Images Not Usable (Motion)|0|||
144705678|NCT01071083|521775383|FG004|Overall Study|Images Not Usable (Motion)|0|||
144705679|NCT01071083|521775379|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
144367491|NCT02266888|520557315|FG003|Overall Study|Transfer of care|0|||
144367492|NCT01458392|520557316|FG000|Overall Study|Death|2|||
144705680|NCT01071083|521775380|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
144705681|NCT01071083|521775381|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
144705682|NCT01071083|521775382|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
144705683|NCT01071083|521775383|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
144705684|NCT01071083|521775379|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
144705685|NCT01071083|521775380|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
144705686|NCT01071083|521775381|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
144705687|NCT01071083|521775382|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
144705688|NCT01071083|521775383|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
144705689|NCT01071083|521775379|FG000|Overall Study|Subject Refused to Continue|1|||
144705690|NCT01071083|521775380|FG001|Overall Study|Subject Refused to Continue|0|||
144705691|NCT01071083|521775381|FG002|Overall Study|Subject Refused to Continue|0|||
144705692|NCT01071083|521775382|FG003|Overall Study|Subject Refused to Continue|0|||
144705693|NCT01071083|521775383|FG004|Overall Study|Subject Refused to Continue|0|||
144705694|NCT03972709|521775384|FG000|Overall Study|Withdrawal by Subject|18|||
144705695|NCT03972709|521775385|FG001|Overall Study|Withdrawal by Subject|7|||
144705696|NCT03972709|521775386|FG002|Overall Study|Withdrawal by Subject|14|||
144705697|NCT03972709|521775384|FG000|Overall Study|Study Terminated by Sponsor|48|||
144705698|NCT03972709|521775385|FG001|Overall Study|Study Terminated by Sponsor|25|||
144705699|NCT03972709|521775386|FG002|Overall Study|Study Terminated by Sponsor|50|||
144705700|NCT03972709|521775384|FG000|Overall Study|Physician Decision|1|||
144705701|NCT03972709|521775385|FG001|Overall Study|Physician Decision|0|||
144705702|NCT03972709|521775386|FG002|Overall Study|Physician Decision|0|||
144705703|NCT03972709|521775384|FG000|Overall Study|COVID-19|0|||
144705704|NCT03972709|521775385|FG001|Overall Study|COVID-19|1|||
144705705|NCT03972709|521775386|FG002|Overall Study|COVID-19|1|||
144705706|NCT03972709|521775384|FG000|Overall Study|Lost to Follow-up|6|||
144705707|NCT03972709|521775385|FG001|Overall Study|Lost to Follow-up|1|||
144705708|NCT03972709|521775386|FG002|Overall Study|Lost to Follow-up|2|||
144705709|NCT03972709|521775384|FG000|Overall Study|Death|5|||
144705710|NCT03972709|521775385|FG001|Overall Study|Death|1|||
144705711|NCT03972709|521775386|FG002|Overall Study|Death|4|||
144705712|NCT03972709|521775384|FG000|Overall Study|Adverse Event|3|||
144705713|NCT03972709|521775385|FG001|Overall Study|Adverse Event|1|||
144705714|NCT03972709|521775386|FG002|Overall Study|Adverse Event|4|||
144705715|NCT03972709|521775384|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
144705716|NCT03972709|521775385|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
144705717|NCT03972709|521775386|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
144705718|NCT03972709|521775384|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
144705719|NCT03972709|521775385|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
144705720|NCT03972709|521775386|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
144705721|NCT03972709|521775384|FG000|Overall Study|Subject Unable to be Contacted|0|||
144705722|NCT03972709|521775385|FG001|Overall Study|Subject Unable to be Contacted|1|||
144705723|NCT03972709|521775386|FG002|Overall Study|Subject Unable to be Contacted|0|||
144705724|NCT03972709|521775384|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
144705725|NCT03972709|521775385|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
144705726|NCT03972709|521775386|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
144705727|NCT03972709|521775384|FG000|Overall Study|Subject Moved|0|||
144705728|NCT03972709|521775385|FG001|Overall Study|Subject Moved|1|||
144705729|NCT03972709|521775386|FG002|Overall Study|Subject Moved|0|||
144705730|NCT03972709|521775384|FG000|Overall Study|Missed Study Visits|1|||
144705731|NCT03972709|521775385|FG001|Overall Study|Missed Study Visits|0|||
144705732|NCT03972709|521775386|FG002|Overall Study|Missed Study Visits|0|||
144705733|NCT01523301|521775387|FG000|Overall Study|Adverse Event|25|||
144705734|NCT01523301|521775388|FG001|Overall Study|Adverse Event|16|||
144705735|NCT01523301|521775387|FG000|Overall Study|Lack of Efficacy|0|||
144705736|NCT01523301|521775388|FG001|Overall Study|Lack of Efficacy|2|||
144705737|NCT01523301|521775387|FG000|Overall Study|Protocol Violation|3|||
144705738|NCT01523301|521775388|FG001|Overall Study|Protocol Violation|4|||
144705739|NCT01523301|521775387|FG000|Overall Study|Lost to Follow-up|1|||
144705740|NCT01523301|521775388|FG001|Overall Study|Lost to Follow-up|0|||
144705741|NCT01523301|521775387|FG000|Overall Study|Withdrawal by Subject|6|||
144705742|NCT01523301|521775388|FG001|Overall Study|Withdrawal by Subject|8|||
144705743|NCT01523301|521775387|FG000|Overall Study|Other Reason|0|||
144705744|NCT01523301|521775388|FG001|Overall Study|Other Reason|2|||
144705745|NCT01339000|521775389|FG000|Overall Study|study closed due to lack of drug supply|1|||
144705746|NCT01339000|521775390|FG001|Overall Study|study closed due to lack of drug supply|0|||
144705747|NCT00728988|521775391|FG000|Overall Study|Not Treated|2|||
144705748|NCT00728988|521775392|FG001|Overall Study|Not Treated|2|||
144705749|NCT00728988|521775391|FG000|Overall Study|Death|1|||
144705750|NCT00728988|521775392|FG001|Overall Study|Death|1|||
144705751|NCT00728988|521775391|FG000|Overall Study|Adverse Event|3|||
144705752|NCT00728988|521775392|FG001|Overall Study|Adverse Event|2|||
144705753|NCT00728988|521775391|FG000|Overall Study|Other|85|||
144705754|NCT00728988|521775392|FG001|Overall Study|Other|77|||
144705755|NCT00728988|521775391|FG000|Overall Study|Withdrawal by Subject|2|||
144705756|NCT00728988|521775392|FG001|Overall Study|Withdrawal by Subject|6|||
144705757|NCT05674721|521775395|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
144705758|NCT05674721|521775396|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
144705759|NCT05674721|521775395|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
144705760|NCT05674721|521775396|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
144705761|NCT05013749|521775402|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
144705762|NCT05013749|521775403|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
144705763|NCT05013749|521775402|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
144705764|NCT05013749|521775403|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
144705765|NCT02017535|521775406|FG000|Overall Study|Withdrawal by Subject|1|||
144705766|NCT02017535|521775407|FG001|Overall Study|Withdrawal by Subject|0|||
144705767|NCT02017535|521775408|FG002|Overall Study|Withdrawal by Subject|0|||
144705768|NCT02017535|521775409|FG003|Overall Study|Withdrawal by Subject|0|||
144705769|NCT01393626|521775410|FG000|Overall Study|Adverse Event|2|||
144705770|NCT01393626|521775411|FG001|Overall Study|Adverse Event|1|||
144705771|NCT01393626|521775412|FG002|Overall Study|Adverse Event|5|||
144705772|NCT01393626|521775413|FG003|Overall Study|Adverse Event|0|||
144705773|NCT01393626|521775410|FG000|Overall Study|Did not meet entrance criteria|1|||
144705774|NCT01393626|521775411|FG001|Overall Study|Did not meet entrance criteria|0|||
144705775|NCT01393626|521775412|FG002|Overall Study|Did not meet entrance criteria|0|||
144705776|NCT01393626|521775413|FG003|Overall Study|Did not meet entrance criteria|0|||
144705777|NCT01393626|521775410|FG000|Overall Study|Lack of Efficacy|6|||
144705778|NCT01393626|521775411|FG001|Overall Study|Lack of Efficacy|6|||
144705779|NCT01393626|521775412|FG002|Overall Study|Lack of Efficacy|4|||
144705780|NCT01393626|521775413|FG003|Overall Study|Lack of Efficacy|1|||
144705781|NCT01393626|521775410|FG000|Overall Study|Lost to Follow-up|1|||
144705782|NCT01393626|521775411|FG001|Overall Study|Lost to Follow-up|1|||
144705783|NCT01393626|521775412|FG002|Overall Study|Lost to Follow-up|1|||
144705784|NCT01393626|521775413|FG003|Overall Study|Lost to Follow-up|0|||
144705785|NCT01393626|521775410|FG000|Overall Study|Withdrawal by Subject|6|||
144705786|NCT01393626|521775411|FG001|Overall Study|Withdrawal by Subject|4|||
144705787|NCT01393626|521775412|FG002|Overall Study|Withdrawal by Subject|0|||
144705788|NCT01393626|521775413|FG003|Overall Study|Withdrawal by Subject|0|||
144705789|NCT01393626|521775410|FG000|Overall Study|Other|1|||
144705790|NCT01393626|521775411|FG001|Overall Study|Other|0|||
144705791|NCT01393626|521775412|FG002|Overall Study|Other|0|||
144705792|NCT01393626|521775413|FG003|Overall Study|Other|0|||
144705793|NCT01393626|521775410|FG000|Overall Study|Protocol Violation|1|||
144705794|NCT01393626|521775411|FG001|Overall Study|Protocol Violation|0|||
144705795|NCT01393626|521775412|FG002|Overall Study|Protocol Violation|2|||
144705796|NCT01393626|521775413|FG003|Overall Study|Protocol Violation|0|||
144705797|NCT02426125|521775414|FG000|Overall Study|Lost to Follow-up|14|||
144705798|NCT02426125|521775415|FG001|Overall Study|Lost to Follow-up|12|||
144705799|NCT02426125|521775414|FG000|Overall Study|Withdrawal by Subject|13|||
144705800|NCT02426125|521775415|FG001|Overall Study|Withdrawal by Subject|14|||
144705801|NCT02426125|521775414|FG000|Overall Study|Death|185|||
144705802|NCT02426125|521775415|FG001|Overall Study|Death|200|||
144705803|NCT02426125|521775414|FG000|Overall Study|Randomized, But Never Treated|5|||
144705804|NCT02426125|521775415|FG001|Overall Study|Randomized, But Never Treated|2|||
144705805|NCT02858076|521775416|FG000|Overall Study|Death|6|||
144705806|NCT02858076|521775417|FG001|Overall Study|Death|3|||
144705807|NCT02858076|521775416|FG000|Overall Study|Withdrawal by Subject|1|||
144705808|NCT02858076|521775417|FG001|Overall Study|Withdrawal by Subject|5|||
144705809|NCT02858076|521775416|FG000|Overall Study|Lost to Follow-up|2|||
144705810|NCT02858076|521775417|FG001|Overall Study|Lost to Follow-up|7|||
144705811|NCT02858076|521775416|FG000|Overall Study|Completed Out of Window|1|||
144705812|NCT02858076|521775417|FG001|Overall Study|Completed Out of Window|3|||
144705813|NCT03506425|521775418|FG000|Overall Study|Adverse Event|1|||
144705814|NCT03506425|521775419|FG001|Overall Study|Adverse Event|3|||
144705815|NCT03506425|521775420|FG002|Overall Study|Adverse Event|0|||
144705816|NCT03506425|521775418|FG000|Overall Study|Death|1|||
144705817|NCT03506425|521775419|FG001|Overall Study|Death|0|||
144705818|NCT03506425|521775420|FG002|Overall Study|Death|0|||
144705819|NCT03506425|521775418|FG000|Overall Study|Withdrawal by Subject|0|||
144705820|NCT03506425|521775419|FG001|Overall Study|Withdrawal by Subject|0|||
144705821|NCT03506425|521775420|FG002|Overall Study|Withdrawal by Subject|1|||
144705822|NCT00938015|521775426|FG000|Overall Study|Death|2|||
144705823|NCT00938015|521775426|FG000|Overall Study|Lost to Follow-up|32|||
144705824|NCT00938015|521775426|FG000|Overall Study|Adverse Event|32|||
144705825|NCT00938015|521775426|FG000|Overall Study|Non-responder|52|||
144705826|NCT00938015|521775426|FG000|Overall Study|Reason not related to Etanercept|29|||
144705827|NCT02341482|521775427|FG000|Overall Study|Adverse Event|1|||
144705828|NCT03186794|521775428|FG000|Overall Study|Physician Decision|2|||
144705829|NCT03186794|521775428|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
144705830|NCT00664066|521775435|FG000|Overall Study|Study terminated|3|||
144705831|NCT03000075|521775436|FG000|Part A|Adverse Event|4|||
144705832|NCT03000075|521775437|FG001|Part A|Adverse Event|0|||
144705833|NCT03000075|521775438|FG002|Part A|Adverse Event|0|||
144705834|NCT03000075|521775439|FG003|Part A|Adverse Event|0|||
144705835|NCT03000075|521775440|FG004|Part A|Adverse Event|0|||
144705836|NCT03000075|521775441|FG005|Part A|Adverse Event|0|||
144705837|NCT03000075|521775442|FG006|Part A|Adverse Event|0|||
144538202|NCT00146172|521174123|FG001|Overall Study|Disease Progression|4|||
144705838|NCT03000075|521775436|FG000|Part B|Not dosed due to AE|0|||
144705839|NCT03000075|521775437|FG001|Part B|Not dosed due to AE|0|||
144705840|NCT03000075|521775438|FG002|Part B|Not dosed due to AE|0|||
144705841|NCT03000075|521775439|FG003|Part B|Not dosed due to AE|0|||
144705842|NCT03000075|521775440|FG004|Part B|Not dosed due to AE|0|||
144705843|NCT03000075|521775441|FG005|Part B|Not dosed due to AE|2|||
144705844|NCT03000075|521775442|FG006|Part B|Not dosed due to AE|1|||
144705845|NCT03000075|521775436|FG000|Part B|Adverse Event|0|||
144705846|NCT03000075|521775437|FG001|Part B|Adverse Event|0|||
144705847|NCT03000075|521775438|FG002|Part B|Adverse Event|0|||
144705848|NCT03000075|521775439|FG003|Part B|Adverse Event|0|||
144705849|NCT03000075|521775440|FG004|Part B|Adverse Event|1|||
144705850|NCT03000075|521775441|FG005|Part B|Adverse Event|0|||
144705851|NCT03000075|521775442|FG006|Part B|Adverse Event|0|||
144705852|NCT02666768|521775443|FG000|Overall Study|Withdrawal by Subject|4|||
144705853|NCT01023022|521775444|FG000|Overall Study|Death|5|||
144705854|NCT01023022|521775444|FG000|Overall Study|Lost to Follow-up|7|||
144705855|NCT01023022|521775444|FG000|Overall Study|due to technical issues|2|||
144705856|NCT03728257|521775445|FG000|Overall Study|Death|3|||
144705857|NCT03728257|521775446|FG001|Overall Study|Death|0|||
144705858|NCT03868059|521775451|FG000|Overall Study|Adverse Event|3|||
144705859|NCT03868059|521775451|FG000|Overall Study|Lost to Follow-up|3|||
144705860|NCT03868059|521775451|FG000|Overall Study|Withdrawal by Subject|6|||
144705861|NCT03205163|521775452|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
144705862|NCT03205163|521775453|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
144705863|NCT04502862|521775454|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
144705864|NCT04502862|521775455|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
144705865|NCT04502862|521775454|FG000|Overall Study|Withdrawal by Subject|1|||
144705866|NCT04502862|521775455|FG001|Overall Study|Withdrawal by Subject|0|||
144705867|NCT04502862|521775454|FG000|Overall Study|Adverse Event|1|||
144705868|NCT04502862|521775455|FG001|Overall Study|Adverse Event|1|||
144705869|NCT01563029|521777245|FG000|Overall Study|Adverse Event|1|||
144705870|NCT01563029|521777246|FG001|Overall Study|Adverse Event|0|||
144705871|NCT01563029|521777247|FG002|Overall Study|Adverse Event|1|||
144705872|NCT01563029|521777248|FG003|Overall Study|Adverse Event|2|||
144705873|NCT01563029|521777249|FG004|Overall Study|Adverse Event|1|||
144705874|NCT01563029|521777245|FG000|Overall Study|Lack of Efficacy|42|||
144705875|NCT01563029|521777246|FG001|Overall Study|Lack of Efficacy|16|||
144705876|NCT01563029|521777247|FG002|Overall Study|Lack of Efficacy|23|||
144705877|NCT01563029|521777248|FG003|Overall Study|Lack of Efficacy|21|||
144705878|NCT01563029|521777249|FG004|Overall Study|Lack of Efficacy|19|||
144705879|NCT01563029|521777245|FG000|Overall Study|Protocol Violation|1|||
144705880|NCT01563029|521777246|FG001|Overall Study|Protocol Violation|2|||
144705881|NCT01563029|521777247|FG002|Overall Study|Protocol Violation|3|||
144705882|NCT01563029|521777248|FG003|Overall Study|Protocol Violation|1|||
144705883|NCT01563029|521777249|FG004|Overall Study|Protocol Violation|3|||
144705884|NCT01563029|521777245|FG000|Overall Study|Protocol defined stopping criteria|1|||
144705885|NCT01563029|521777246|FG001|Overall Study|Protocol defined stopping criteria|0|||
144705886|NCT01563029|521777247|FG002|Overall Study|Protocol defined stopping criteria|0|||
144705887|NCT01563029|521777248|FG003|Overall Study|Protocol defined stopping criteria|0|||
144705888|NCT01563029|521777249|FG004|Overall Study|Protocol defined stopping criteria|0|||
144705889|NCT01563029|521777245|FG000|Overall Study|Lost to Follow-up|1|||
144705890|NCT01563029|521777246|FG001|Overall Study|Lost to Follow-up|0|||
144705891|NCT01563029|521777247|FG002|Overall Study|Lost to Follow-up|1|||
144705892|NCT01563029|521777248|FG003|Overall Study|Lost to Follow-up|1|||
144705893|NCT01563029|521777249|FG004|Overall Study|Lost to Follow-up|1|||
144705894|NCT01563029|521777245|FG000|Overall Study|Physician Decision|3|||
144705895|NCT01563029|521777246|FG001|Overall Study|Physician Decision|5|||
144705896|NCT01563029|521777247|FG002|Overall Study|Physician Decision|2|||
144705897|NCT01563029|521777248|FG003|Overall Study|Physician Decision|4|||
144705898|NCT01563029|521777249|FG004|Overall Study|Physician Decision|2|||
144705899|NCT01563029|521777245|FG000|Overall Study|Withdrawal by Subject|4|||
144705900|NCT01563029|521777246|FG001|Overall Study|Withdrawal by Subject|1|||
144705901|NCT01563029|521777247|FG002|Overall Study|Withdrawal by Subject|3|||
144705902|NCT01563029|521777248|FG003|Overall Study|Withdrawal by Subject|4|||
144705903|NCT01563029|521777249|FG004|Overall Study|Withdrawal by Subject|3|||
144705904|NCT01569594|521777250|FG000|Overall Study|Physician Decision|4|||
144705905|NCT01569594|521777250|FG000|Overall Study|Death|13|||
144705906|NCT01569594|521777250|FG000|Overall Study|Lost to Follow-up|22|||
144705907|NCT01569594|521777250|FG000|Overall Study|Adverse Event|2|||
144705908|NCT01569594|521777250|FG000|Overall Study|Withdrawal by Subject|13|||
144705909|NCT01569594|521777250|FG000|Overall Study|Other|4|||
144705910|NCT01569594|521777250|FG000|Overall Study|No ECM used|9|||
144705911|NCT03069365|521777251|FG000|Overall Study|Adverse Event|1|||
144705912|NCT02861534|521777252|FG000|Overall Study|Death|541|||
144705913|NCT02861534|521777253|FG001|Overall Study|Death|552|||
144705914|NCT02861534|521777252|FG000|Overall Study|Lost to Follow-up|14|||
144705915|NCT02861534|521777253|FG001|Overall Study|Lost to Follow-up|14|||
144705916|NCT02861534|521777252|FG000|Overall Study|Site Terminated by Sponsor|4|||
144705917|NCT02861534|521777253|FG001|Overall Study|Site Terminated by Sponsor|3|||
144705918|NCT02861534|521777252|FG000|Overall Study|Withdrawal by Subject|15|||
144705919|NCT02861534|521777253|FG001|Overall Study|Withdrawal by Subject|18|||
144705920|NCT02886494|521777254|FG000|Overall Study|Adverse Event|1|||
144705921|NCT02886494|521777255|FG001|Overall Study|Adverse Event|0|||
144705922|NCT02886494|521777254|FG000|Overall Study|Withdrawal by Subject|12|||
144705923|NCT02886494|521777255|FG001|Overall Study|Withdrawal by Subject|3|||
144705924|NCT02886494|521777254|FG000|Overall Study|Protocol Violation|4|||
144705925|NCT02886494|521777255|FG001|Overall Study|Protocol Violation|1|||
144705926|NCT02780115|521777258|FG000|Overall Study|Withdrawal by Subject|0|||
144705927|NCT02780115|521777259|FG001|Overall Study|Withdrawal by Subject|1|||
144705928|NCT02780115|521777260|FG002|Overall Study|Withdrawal by Subject|1|||
144705929|NCT02780115|521777261|FG003|Overall Study|Withdrawal by Subject|0|||
144705930|NCT02780115|521777262|FG004|Overall Study|Withdrawal by Subject|0|||
144705931|NCT02780115|521777258|FG000|Overall Study|Adverse Event|0|||
144705932|NCT02780115|521777259|FG001|Overall Study|Adverse Event|0|||
144705933|NCT02780115|521777260|FG002|Overall Study|Adverse Event|0|||
144705934|NCT02780115|521777261|FG003|Overall Study|Adverse Event|1|||
144705935|NCT02780115|521777262|FG004|Overall Study|Adverse Event|1|||
144705936|NCT03020966|521777270|FG000|Overall Study|Withdrawal by Subject|2|||
144705937|NCT03020966|521777271|FG001|Overall Study|Withdrawal by Subject|0|||
144705938|NCT00742859|521777274|FG000|Overall Study|Adverse Event|5|||
144705939|NCT00742859|521777275|FG001|Overall Study|Adverse Event|6|||
144705940|NCT00742859|521777276|FG002|Overall Study|Adverse Event|3|||
144705941|NCT00742859|521777277|FG003|Overall Study|Adverse Event|1|||
144705942|NCT00742859|521777274|FG000|Overall Study|Death|1|||
144705943|NCT00742859|521777275|FG001|Overall Study|Death|0|||
144705944|NCT00742859|521777276|FG002|Overall Study|Death|0|||
144705945|NCT00742859|521777277|FG003|Overall Study|Death|1|||
144705946|NCT00742859|521777274|FG000|Overall Study|Physician Decision|1|||
144705947|NCT00742859|521777275|FG001|Overall Study|Physician Decision|2|||
144705948|NCT00742859|521777276|FG002|Overall Study|Physician Decision|0|||
144705949|NCT00742859|521777277|FG003|Overall Study|Physician Decision|0|||
144705950|NCT00742859|521777274|FG000|Overall Study|Withdrawal by Subject|4|||
144705951|NCT00742859|521777275|FG001|Overall Study|Withdrawal by Subject|2|||
144705952|NCT00742859|521777276|FG002|Overall Study|Withdrawal by Subject|4|||
144705953|NCT00742859|521777277|FG003|Overall Study|Withdrawal by Subject|1|||
144705954|NCT00742859|521777274|FG000|Overall Study|Endpoint|0|||
144705955|NCT00742859|521777275|FG001|Overall Study|Endpoint|1|||
144705956|NCT00742859|521777276|FG002|Overall Study|Endpoint|1|||
144705957|NCT00742859|521777277|FG003|Overall Study|Endpoint|2|||
144705958|NCT00742859|521777274|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
144705959|NCT00742859|521777275|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
144705960|NCT00742859|521777276|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
144705961|NCT00742859|521777277|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
144705962|NCT00742859|521777274|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
144705963|NCT00742859|521777275|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
144705964|NCT00742859|521777276|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
144705965|NCT00742859|521777277|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
144705966|NCT00742859|521777274|FG000|Overall Study|Sponsor request patient out of town|0|||
144705967|NCT00742859|521777275|FG001|Overall Study|Sponsor request patient out of town|0|||
144705968|NCT00742859|521777276|FG002|Overall Study|Sponsor request patient out of town|1|||
144705969|NCT00742859|521777277|FG003|Overall Study|Sponsor request patient out of town|1|||
144705970|NCT00742859|521777274|FG000|Overall Study|Site error|0|||
144705971|NCT00742859|521777275|FG001|Overall Study|Site error|0|||
144705972|NCT00742859|521777276|FG002|Overall Study|Site error|1|||
144705973|NCT00742859|521777277|FG003|Overall Study|Site error|1|||
144705974|NCT00962013|521777288|FG000|Overall Study|Did not have surgery|1|||
144705975|NCT00962013|521777288|FG000|Overall Study|Death|8|||
144705976|NCT00962013|521777288|FG000|Overall Study|Lost to Follow-up|12|||
144705977|NCT00962013|521777288|FG000|Overall Study|Unable/Unwilling to return|6|||
144705978|NCT00962013|521777288|FG000|Overall Study|Withdrawal by Subject|8|||
144705979|NCT00962013|521777288|FG000|Overall Study|Removal of study device|3|||
144705980|NCT00962013|521777288|FG000|Overall Study|Site Termination|24|||
144705981|NCT00962013|521777288|FG000|Overall Study|No 5 year evaluation|6|||
144705982|NCT00424632|521777291|FG000|Overall Study|Death|0|||
144705983|NCT00424632|521777292|FG001|Overall Study|Death|0|||
144705984|NCT00424632|521777293|FG002|Overall Study|Death|0|||
144705985|NCT00424632|521777294|FG003|Overall Study|Death|0|||
144367493|NCT01458392|520557317|FG001|Overall Study|Death|11|||
144367494|NCT01458392|520557318|FG002|Overall Study|Death|22|||
144367495|NCT01458392|520557316|FG000|Overall Study|At the discretion of the sponsor|0|||
144705986|NCT00424632|521777295|FG004|Overall Study|Death|0|||
144705987|NCT00424632|521777296|FG005|Overall Study|Death|2|||
144705988|NCT00424632|521777297|FG006|Overall Study|Death|0|||
144705989|NCT00424632|521777298|FG007|Overall Study|Death|0|||
144705990|NCT00424632|521777299|FG008|Overall Study|Death|0|||
144705991|NCT00424632|521777300|FG009|Overall Study|Death|0|||
144705992|NCT00424632|521777291|FG000|Overall Study|Adverse Event|0|||
144705993|NCT00424632|521777292|FG001|Overall Study|Adverse Event|0|||
144705994|NCT00424632|521777293|FG002|Overall Study|Adverse Event|0|||
144705995|NCT00424632|521777294|FG003|Overall Study|Adverse Event|0|||
144705996|NCT00424632|521777295|FG004|Overall Study|Adverse Event|0|||
144705997|NCT00424632|521777296|FG005|Overall Study|Adverse Event|0|||
144705998|NCT00424632|521777297|FG006|Overall Study|Adverse Event|0|||
144705999|NCT00424632|521777298|FG007|Overall Study|Adverse Event|0|||
144706000|NCT00424632|521777299|FG008|Overall Study|Adverse Event|3|||
144706001|NCT00424632|521777300|FG009|Overall Study|Adverse Event|2|||
144706002|NCT00424632|521777291|FG000|Overall Study|Global deterioration of health status|0|||
144706003|NCT00424632|521777292|FG001|Overall Study|Global deterioration of health status|0|||
144706004|NCT00424632|521777293|FG002|Overall Study|Global deterioration of health status|0|||
144706005|NCT00424632|521777294|FG003|Overall Study|Global deterioration of health status|1|||
144706006|NCT00424632|521777295|FG004|Overall Study|Global deterioration of health status|1|||
144706007|NCT00424632|521777296|FG005|Overall Study|Global deterioration of health status|0|||
144706008|NCT00424632|521777297|FG006|Overall Study|Global deterioration of health status|0|||
144706009|NCT00424632|521777298|FG007|Overall Study|Global deterioration of health status|0|||
144706010|NCT00424632|521777299|FG008|Overall Study|Global deterioration of health status|0|||
144706011|NCT00424632|521777300|FG009|Overall Study|Global deterioration of health status|0|||
144706012|NCT00424632|521777291|FG000|Overall Study|Objective progression or relapse|1|||
144706013|NCT00424632|521777292|FG001|Overall Study|Objective progression or relapse|1|||
144706014|NCT00424632|521777293|FG002|Overall Study|Objective progression or relapse|1|||
144706015|NCT00424632|521777294|FG003|Overall Study|Objective progression or relapse|2|||
144706016|NCT00424632|521777295|FG004|Overall Study|Objective progression or relapse|2|||
144706017|NCT00424632|521777296|FG005|Overall Study|Objective progression or relapse|13|||
144706018|NCT00424632|521777297|FG006|Overall Study|Objective progression or relapse|7|||
144706019|NCT00424632|521777298|FG007|Overall Study|Objective progression or relapse|3|||
144706020|NCT00424632|521777299|FG008|Overall Study|Objective progression or relapse|12|||
144706021|NCT00424632|521777300|FG009|Overall Study|Objective progression or relapse|4|||
144706022|NCT00424632|521777291|FG000|Overall Study|Other|0|||
144706023|NCT00424632|521777292|FG001|Overall Study|Other|0|||
144706024|NCT00424632|521777293|FG002|Overall Study|Other|0|||
144706025|NCT00424632|521777294|FG003|Overall Study|Other|1|||
144706026|NCT00424632|521777295|FG004|Overall Study|Other|0|||
144706027|NCT00424632|521777296|FG005|Overall Study|Other|0|||
144706028|NCT00424632|521777297|FG006|Overall Study|Other|0|||
144706029|NCT00424632|521777298|FG007|Overall Study|Other|0|||
144706030|NCT00424632|521777299|FG008|Overall Study|Other|1|||
144706031|NCT00424632|521777300|FG009|Overall Study|Other|0|||
144706032|NCT02628418|521777301|FG000|Overall Study|Lost to Follow-up|1|||
144706033|NCT02628418|521777302|FG001|Overall Study|Lost to Follow-up|2|||
144706034|NCT00445458|521777311|FG000|Overall Study|Disease Progression|3|||
144706035|NCT00445458|521777312|FG001|Overall Study|Disease Progression|4|||
144706036|NCT00445458|521777313|FG002|Overall Study|Disease Progression|54|||
144706037|NCT00445458|521777314|FG003|Overall Study|Disease Progression|27|||
144706038|NCT00445458|521777311|FG000|Overall Study|Withdrawal by Subject|0|||
144706039|NCT00445458|521777312|FG001|Overall Study|Withdrawal by Subject|0|||
144706040|NCT00445458|521777313|FG002|Overall Study|Withdrawal by Subject|7|||
144706041|NCT00445458|521777314|FG003|Overall Study|Withdrawal by Subject|0|||
144706042|NCT00445458|521777311|FG000|Overall Study|Adverse Event|0|||
144706043|NCT00445458|521777312|FG001|Overall Study|Adverse Event|0|||
144706044|NCT00445458|521777313|FG002|Overall Study|Adverse Event|3|||
144706045|NCT00445458|521777314|FG003|Overall Study|Adverse Event|0|||
144706046|NCT00445458|521777311|FG000|Overall Study|Death|0|||
144706047|NCT00445458|521777312|FG001|Overall Study|Death|1|||
144706048|NCT00445458|521777313|FG002|Overall Study|Death|2|||
144706049|NCT00445458|521777314|FG003|Overall Study|Death|0|||
144706050|NCT00445458|521777311|FG000|Overall Study|Physician Decision|0|||
144706051|NCT00445458|521777312|FG001|Overall Study|Physician Decision|0|||
144706052|NCT00445458|521777313|FG002|Overall Study|Physician Decision|1|||
144706053|NCT00445458|521777314|FG003|Overall Study|Physician Decision|1|||
144706054|NCT00445458|521777311|FG000|Overall Study|Surgery|0|||
144706055|NCT00445458|521777312|FG001|Overall Study|Surgery|0|||
144706056|NCT00445458|521777313|FG002|Overall Study|Surgery|1|||
144706057|NCT00445458|521777314|FG003|Overall Study|Surgery|0|||
144706058|NCT04732728|521777317|FG000|Overall Study|Death|12|||
144706059|NCT04732728|521777317|FG000|Overall Study|Withdrawn|136|||
144706060|NCT02180659|521777328|FG000|Overall Study|Adverse Event|1|||
144706061|NCT02180659|521777329|FG001|Overall Study|Adverse Event|0|||
144706062|NCT02180659|521777328|FG000|Overall Study|Lost to Follow-up|4|||
144706063|NCT02180659|521777329|FG001|Overall Study|Lost to Follow-up|2|||
144706064|NCT02180659|521777328|FG000|Overall Study|Subject incarcerated during conduct|1|||
144706065|NCT02180659|521777329|FG001|Overall Study|Subject incarcerated during conduct|0|||
144706066|NCT02180659|521777328|FG000|Overall Study|Withdrawal by Subject|0|||
144706067|NCT02180659|521777329|FG001|Overall Study|Withdrawal by Subject|2|||
144706068|NCT02180659|521777328|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
144706069|NCT02180659|521777329|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
144706070|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
144706071|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
144706072|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Death|5|||
144706073|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Death|2|||
144706074|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
144706075|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
144706076|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
144706077|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
144706078|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
144706079|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
144706080|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Relapse|1|||
144706081|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Relapse|0|||
144706082|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
144706083|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
144706084|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
144706085|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
144706086|NCT00111007|521777330|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
144706087|NCT00111007|521777331|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
144706088|NCT00111007|521777330|FG000|Active Follow-up|Adverse Event|1|||
144706089|NCT00111007|521777331|FG001|Active Follow-up|Adverse Event|0|||
144706090|NCT00111007|521777330|FG000|Active Follow-up|Death|2|||
144706091|NCT00111007|521777331|FG001|Active Follow-up|Death|0|||
144706092|NCT00111007|521777330|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
144706093|NCT00111007|521777331|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
144706094|NCT00111007|521777330|FG000|Long Term Follow-up|Death|34|||
144706095|NCT00111007|521777331|FG001|Long Term Follow-up|Death|39|||
144706096|NCT00111007|521777330|FG000|Long Term Follow-up|Lost to Follow-up|1|||
144706097|NCT00111007|521777331|FG001|Long Term Follow-up|Lost to Follow-up|1|||
144706098|NCT00111007|521777330|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
144706099|NCT00111007|521777331|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
144706100|NCT00111007|521777330|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
144706101|NCT00111007|521777331|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
144706102|NCT00111007|521777330|FG000|Long Term Follow-up|Missing|10|||
144706103|NCT00111007|521777331|FG001|Long Term Follow-up|Missing|3|||
144706104|NCT01495793|521777332|FG000|Overall Study|Lost to Follow-up|1|||
144706105|NCT01495793|521777332|FG000|Overall Study|Violation of inclusion criteria|1|||
144706106|NCT00440193|521777333|FG000|Treatment Period|Adverse Event|74|||
144706107|NCT00440193|521777334|FG001|Treatment Period|Adverse Event|67|||
144706108|NCT00440193|521777333|FG000|Treatment Period|Death|19|||
144706109|NCT00440193|521777334|FG001|Treatment Period|Death|22|||
144706110|NCT00440193|521777333|FG000|Treatment Period|Lack of Efficacy|0|||
144706111|NCT00440193|521777334|FG001|Treatment Period|Lack of Efficacy|1|||
144706112|NCT00440193|521777333|FG000|Treatment Period|Lost to Follow-up|12|||
144706113|NCT00440193|521777334|FG001|Treatment Period|Lost to Follow-up|18|||
144706114|NCT00440193|521777333|FG000|Treatment Period|Physician Decision|3|||
144706115|NCT00440193|521777334|FG001|Treatment Period|Physician Decision|6|||
144706116|NCT00440193|521777333|FG000|Treatment Period|Protocol Violation|16|||
144706117|NCT00440193|521777334|FG001|Treatment Period|Protocol Violation|19|||
144706118|NCT00440193|521777333|FG000|Treatment Period|Withdrawal by Subject|36|||
144706119|NCT00440193|521777334|FG001|Treatment Period|Withdrawal by Subject|77|||
144706120|NCT00440193|521777333|FG000|Treatment Period|Clinical endpoint reached|28|||
144706121|NCT00440193|521777334|FG001|Treatment Period|Clinical endpoint reached|25|||
144706122|NCT00440193|521777333|FG000|Treatment Period|Study terminated by sponsor|102|||
144706123|NCT00440193|521777334|FG001|Treatment Period|Study terminated by sponsor|94|||
144706124|NCT00440193|521777333|FG000|Treatment Period|Protocol driven decision point|2|||
144706125|NCT00440193|521777334|FG001|Treatment Period|Protocol driven decision point|2|||
144706126|NCT00440193|521777333|FG000|Treatment Period|Switch to commercial drug|0|||
144706127|NCT00440193|521777334|FG001|Treatment Period|Switch to commercial drug|2|||
144706128|NCT00440193|521777333|FG000|Treatment Period|Technical problems|1|||
144706129|NCT00440193|521777334|FG001|Treatment Period|Technical problems|1|||
144706130|NCT00440193|521777333|FG000|Treatment Period|Participant convenience|5|||
144706131|NCT00440193|521777334|FG001|Treatment Period|Participant convenience|2|||
144706132|NCT00440193|521777333|FG000|Treatment Period|Participant did not receive treatment|7|||
144706133|NCT00440193|521777334|FG001|Treatment Period|Participant did not receive treatment|13|||
144706134|NCT00440193|521777333|FG000|Treatment Period|Site closed by investigator|0|||
144706135|NCT00440193|521777334|FG001|Treatment Period|Site closed by investigator|2|||
144706136|NCT00440193|521777333|FG000|Observational Period|Adverse Event|2|||
144706137|NCT00440193|521777334|FG001|Observational Period|Adverse Event|2|||
144706138|NCT00440193|521777333|FG000|Observational Period|Death|15|||
144706139|NCT00440193|521777334|FG001|Observational Period|Death|20|||
144706140|NCT00440193|521777333|FG000|Observational Period|Lost to Follow-up|12|||
144706141|NCT00440193|521777334|FG001|Observational Period|Lost to Follow-up|8|||
144706142|NCT00440193|521777333|FG000|Observational Period|Protocol Violation|1|||
144706143|NCT00440193|521777334|FG001|Observational Period|Protocol Violation|0|||
144706144|NCT00440193|521777333|FG000|Observational Period|Withdrawal by Subject|11|||
144706145|NCT00440193|521777334|FG001|Observational Period|Withdrawal by Subject|8|||
144706146|NCT00440193|521777333|FG000|Observational Period|Physician Decision|1|||
144706147|NCT00440193|521777334|FG001|Observational Period|Physician Decision|0|||
144706148|NCT00440193|521777333|FG000|Observational Period|Clinical endpoint reached|1|||
144706149|NCT00440193|521777334|FG001|Observational Period|Clinical endpoint reached|0|||
144706150|NCT00440193|521777333|FG000|Observational Period|Participant convenience|2|||
144706151|NCT00440193|521777334|FG001|Observational Period|Participant convenience|0|||
144706152|NCT00834366|521777335|FG000|Treatment Period 1|Adverse Event|1|||
144706153|NCT00834366|521777336|FG001|Treatment Period 1|Adverse Event|1|||
144706154|NCT03014570|521777337|FG000|Overall Study|COVID-19 Restrictions|38|||
144706155|NCT03014570|521777338|FG001|Overall Study|COVID-19 Restrictions|24|||
144706156|NCT03014570|521777337|FG000|Overall Study|Death|70|||
144706157|NCT03014570|521777338|FG001|Overall Study|Death|79|||
144706158|NCT03014570|521777337|FG000|Overall Study|Transfer from facility|11|||
144706159|NCT03014570|521777338|FG001|Overall Study|Transfer from facility|14|||
144706160|NCT03014570|521777337|FG000|Overall Study|Hospitalized|5|||
144706161|NCT03014570|521777338|FG001|Overall Study|Hospitalized|3|||
144706162|NCT03014570|521777337|FG000|Overall Study|Transfer within facility|1|||
144706163|NCT03014570|521777338|FG001|Overall Study|Transfer within facility|0|||
144706164|NCT03014570|521777337|FG000|Overall Study|Site refusal|0|||
144706165|NCT03014570|521777338|FG001|Overall Study|Site refusal|11|||
144706166|NCT00090259|521777339|FG000|Overall Study|Lost to Follow-up|30|||
144706167|NCT00090259|521777340|FG001|Overall Study|Lost to Follow-up|26|||
144706168|NCT00090259|521777339|FG000|Overall Study|Withdrawal by Subject|21|||
144706169|NCT00090259|521777340|FG001|Overall Study|Withdrawal by Subject|15|||
144706170|NCT00090259|521777339|FG000|Overall Study|Investigator site closed|11|||
144706171|NCT00090259|521777340|FG001|Overall Study|Investigator site closed|7|||
144706172|NCT00478673|521777341|FG000|30-Days Post-Procedure|Death|2|||
144706173|NCT00478673|521777341|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
144706174|NCT00478673|521777341|FG000|30-Days Post-Procedure|Missed Visit|7|||
144706175|NCT00478673|521777341|FG000|12-Months Post-Procedure|Death|23|||
144706176|NCT00478673|521777341|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
144706177|NCT00478673|521777341|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
144706178|NCT00478673|521777341|FG000|12-Months Post-Procedure|Missed Visit|25|||
144706179|NCT00478673|521777341|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
144706180|NCT02380248|521777345|FG000|Overall Study|Lost to Follow-up|11|||
144706181|NCT02380248|521777345|FG000|Overall Study|Withdrawal by Subject|3|||
144706182|NCT03083639|521777346|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
144706183|NCT03083639|521777347|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
144706184|NCT03083639|521777346|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
144706185|NCT03083639|521777347|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
144706186|NCT01275170|521777348|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
144706187|NCT01275170|521777349|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706188|NCT01275170|521777350|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706189|NCT01275170|521777351|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706190|NCT01275170|521777352|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706191|NCT01275170|521777353|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706192|NCT01275170|521777354|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706193|NCT01275170|521777355|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
144706194|NCT00960687|521777356|FG000|Washout Period of 7 Days|Adverse Event|3|||
144706195|NCT00960687|521777357|FG001|Washout Period of 7 Days|Adverse Event|2|||
144706196|NCT00960687|521777356|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
144706197|NCT00960687|521777357|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144706198|NCT02704130|521777359|FG000|Overall Study|Physician Decision|5|||
144706199|NCT02704130|521777360|FG001|Overall Study|Physician Decision|3|||
144706200|NCT05004181|521777367|FG000|Overall Study|Withdrawal of consent|0|||
144706201|NCT05004181|521777368|FG001|Overall Study|Withdrawal of consent|0|||
144706202|NCT05004181|521777369|FG002|Overall Study|Withdrawal of consent|1|||
144706203|NCT05004181|521777370|FG003|Overall Study|Withdrawal of consent|3|||
144706204|NCT05004181|521777371|FG004|Overall Study|Withdrawal of consent|3|||
144706205|NCT05004181|521777372|FG005|Overall Study|Withdrawal of consent|0|||
144706206|NCT05004181|521777373|FG006|Overall Study|Withdrawal of consent|30|||
144706207|NCT05004181|521777374|FG007|Overall Study|Withdrawal of consent|9|||
144706208|NCT05004181|521777375|FG008|Overall Study|Withdrawal of consent|3|||
144706209|NCT05004181|521777376|FG009|Overall Study|Withdrawal of consent|2|||
144706210|NCT05004181|521777377|FG010|Overall Study|Withdrawal of consent|5|||
144367496|NCT01458392|520557317|FG001|Overall Study|At the discretion of the sponsor|2|||
144367497|NCT01458392|520557318|FG002|Overall Study|At the discretion of the sponsor|7|||
144706211|NCT05004181|521777378|FG011|Overall Study|Withdrawal of consent|1|||
144706212|NCT05004181|521777367|FG000|Overall Study|Lost to Follow-up|2|||
144706213|NCT05004181|521777368|FG001|Overall Study|Lost to Follow-up|4|||
144706214|NCT05004181|521777369|FG002|Overall Study|Lost to Follow-up|2|||
144706215|NCT05004181|521777370|FG003|Overall Study|Lost to Follow-up|3|||
144706216|NCT05004181|521777371|FG004|Overall Study|Lost to Follow-up|5|||
144367498|NCT01458392|520557316|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
144706217|NCT05004181|521777372|FG005|Overall Study|Lost to Follow-up|2|||
144706218|NCT05004181|521777373|FG006|Overall Study|Lost to Follow-up|15|||
144706219|NCT05004181|521777374|FG007|Overall Study|Lost to Follow-up|12|||
144706220|NCT05004181|521777375|FG008|Overall Study|Lost to Follow-up|38|||
144706221|NCT05004181|521777376|FG009|Overall Study|Lost to Follow-up|6|||
144706222|NCT05004181|521777377|FG010|Overall Study|Lost to Follow-up|6|||
144706223|NCT05004181|521777378|FG011|Overall Study|Lost to Follow-up|0|||
144706224|NCT05004181|521777367|FG000|Overall Study|Death|0|||
144706225|NCT05004181|521777368|FG001|Overall Study|Death|0|||
144706226|NCT05004181|521777369|FG002|Overall Study|Death|0|||
144706227|NCT05004181|521777370|FG003|Overall Study|Death|0|||
144706228|NCT05004181|521777371|FG004|Overall Study|Death|0|||
144706229|NCT05004181|521777372|FG005|Overall Study|Death|0|||
144706230|NCT05004181|521777373|FG006|Overall Study|Death|1|||
144706231|NCT05004181|521777374|FG007|Overall Study|Death|0|||
144706232|NCT05004181|521777375|FG008|Overall Study|Death|2|||
144706233|NCT05004181|521777376|FG009|Overall Study|Death|0|||
144706234|NCT05004181|521777377|FG010|Overall Study|Death|0|||
144706235|NCT05004181|521777378|FG011|Overall Study|Death|0|||
144706236|NCT05004181|521777367|FG000|Overall Study|Physician Decision|0|||
144706237|NCT05004181|521777368|FG001|Overall Study|Physician Decision|0|||
144706238|NCT05004181|521777369|FG002|Overall Study|Physician Decision|0|||
144706239|NCT05004181|521777370|FG003|Overall Study|Physician Decision|0|||
144706240|NCT05004181|521777371|FG004|Overall Study|Physician Decision|0|||
144706241|NCT05004181|521777372|FG005|Overall Study|Physician Decision|0|||
144706242|NCT05004181|521777373|FG006|Overall Study|Physician Decision|2|||
144706243|NCT05004181|521777374|FG007|Overall Study|Physician Decision|0|||
144706244|NCT05004181|521777375|FG008|Overall Study|Physician Decision|7|||
144706245|NCT05004181|521777376|FG009|Overall Study|Physician Decision|0|||
144706246|NCT05004181|521777377|FG010|Overall Study|Physician Decision|0|||
144706247|NCT05004181|521777378|FG011|Overall Study|Physician Decision|0|||
144706248|NCT05004181|521777367|FG000|Overall Study|Withdrawal by Subject|2|||
144706249|NCT05004181|521777368|FG001|Overall Study|Withdrawal by Subject|3|||
144706250|NCT05004181|521777369|FG002|Overall Study|Withdrawal by Subject|2|||
144706251|NCT05004181|521777370|FG003|Overall Study|Withdrawal by Subject|2|||
144706252|NCT05004181|521777371|FG004|Overall Study|Withdrawal by Subject|4|||
144706253|NCT05004181|521777372|FG005|Overall Study|Withdrawal by Subject|2|||
144706254|NCT05004181|521777373|FG006|Overall Study|Withdrawal by Subject|4|||
144706255|NCT05004181|521777374|FG007|Overall Study|Withdrawal by Subject|22|||
144706256|NCT05004181|521777375|FG008|Overall Study|Withdrawal by Subject|8|||
144706257|NCT05004181|521777376|FG009|Overall Study|Withdrawal by Subject|1|||
144706258|NCT05004181|521777377|FG010|Overall Study|Withdrawal by Subject|3|||
144706259|NCT05004181|521777378|FG011|Overall Study|Withdrawal by Subject|2|||
144706260|NCT05004181|521777367|FG000|Overall Study|Protocol Violation|2|||
144706261|NCT05004181|521777368|FG001|Overall Study|Protocol Violation|3|||
144706262|NCT05004181|521777369|FG002|Overall Study|Protocol Violation|0|||
144706263|NCT05004181|521777370|FG003|Overall Study|Protocol Violation|0|||
144706264|NCT05004181|521777371|FG004|Overall Study|Protocol Violation|1|||
144706265|NCT05004181|521777372|FG005|Overall Study|Protocol Violation|0|||
144706266|NCT05004181|521777373|FG006|Overall Study|Protocol Violation|16|||
144706267|NCT05004181|521777374|FG007|Overall Study|Protocol Violation|18|||
144706268|NCT05004181|521777375|FG008|Overall Study|Protocol Violation|2|||
144706269|NCT05004181|521777376|FG009|Overall Study|Protocol Violation|2|||
144706270|NCT05004181|521777377|FG010|Overall Study|Protocol Violation|2|||
144706271|NCT05004181|521777378|FG011|Overall Study|Protocol Violation|1|||
144706272|NCT05004181|521777367|FG000|Overall Study|Not further specified|1|||
144706273|NCT05004181|521777368|FG001|Overall Study|Not further specified|0|||
144706274|NCT05004181|521777369|FG002|Overall Study|Not further specified|0|||
144706275|NCT05004181|521777370|FG003|Overall Study|Not further specified|0|||
144706276|NCT05004181|521777371|FG004|Overall Study|Not further specified|0|||
144706277|NCT05004181|521777372|FG005|Overall Study|Not further specified|0|||
144706278|NCT05004181|521777373|FG006|Overall Study|Not further specified|1|||
144706279|NCT05004181|521777374|FG007|Overall Study|Not further specified|0|||
144706280|NCT05004181|521777375|FG008|Overall Study|Not further specified|2|||
144706281|NCT05004181|521777376|FG009|Overall Study|Not further specified|1|||
144706282|NCT05004181|521777377|FG010|Overall Study|Not further specified|0|||
144706283|NCT05004181|521777378|FG011|Overall Study|Not further specified|1|||
144706284|NCT04066894|521777379|FG000|Overall Study|Lack of Efficacy|1|||
144706285|NCT04066894|521777379|FG000|Overall Study|Screen Failure|1|||
144706286|NCT02949219|521777380|FG000|Overall Study|Withdrawal by Subject|1|||
144706287|NCT04278872|521777381|FG000|Overall Study|Adverse Event|1|||
144706288|NCT04278872|521777382|FG001|Overall Study|Adverse Event|0|||
144706289|NCT04278872|521777381|FG000|Overall Study|Protocol Violation|0|||
144706290|NCT04278872|521777382|FG001|Overall Study|Protocol Violation|1|||
144706291|NCT04278872|521777381|FG000|Overall Study|Study Termination|2|||
144706292|NCT04278872|521777382|FG001|Overall Study|Study Termination|0|||
144706293|NCT03494816|521777383|FG000|Overall Study|Protocol Violation|2|||
144706294|NCT03494816|521777383|FG000|Overall Study|Physician Decision|2|||
144706295|NCT03494816|521777383|FG000|Overall Study|Did not start trial treatment|1|||
144706296|NCT03494816|521777383|FG000|Overall Study|Adverse Event|1|||
144706297|NCT00096031|521777388|FG000|Overall Study|Adverse Event|3|||
144706298|NCT00096031|521777388|FG000|Overall Study|Lack of Efficacy|42|||
144706299|NCT00096031|521777388|FG000|Overall Study|Death|4|||
144706300|NCT00096031|521777388|FG000|Overall Study|Withdrawal by Subject|1|||
144706301|NCT00096031|521777388|FG000|Overall Study|Ineligible|8|||
144706302|NCT00096031|521777388|FG000|Overall Study|Not protocol specified|5|||
144706303|NCT01283282|521777389|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
144706304|NCT01283282|521777390|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
144706305|NCT01283282|521777389|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
144706306|NCT01283282|521777390|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
144706307|NCT01283282|521777389|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
144706308|NCT01283282|521777390|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
144706309|NCT00777920|521777391|FG000|Overall Study|Adverse Event|39|||
144706310|NCT00777920|521777391|FG000|Overall Study|Withdrawal of Consent|4|||
144706311|NCT00777920|521777391|FG000|Overall Study|Lost to Follow-up|1|||
144706312|NCT00777920|521777391|FG000|Overall Study|Investigator's discretion|1|||
144706313|NCT00777920|521777391|FG000|Overall Study|Clinical status did not improve|1|||
144706314|NCT00777920|521777391|FG000|Overall Study|Other, not specified|4|||
144706315|NCT00483717|521777392|FG000|Overall Study|Protocol Violation|5|||
144706316|NCT00483717|521777393|FG001|Overall Study|Protocol Violation|7|||
144706317|NCT00483717|521777392|FG000|Overall Study|Time of dosing missing|1|||
144706318|NCT00483717|521777393|FG001|Overall Study|Time of dosing missing|1|||
144706319|NCT00483717|521777392|FG000|Overall Study|No treatment for migraine|16|||
144706320|NCT00483717|521777393|FG001|Overall Study|No treatment for migraine|13|||
144706321|NCT00483717|521777392|FG000|Overall Study|Lost to Follow-up|1|||
144706322|NCT00483717|521777393|FG001|Overall Study|Lost to Follow-up|0|||
144706323|NCT00483717|521777392|FG000|Overall Study|Withdrawal by Subject|1|||
144706324|NCT00483717|521777393|FG001|Overall Study|Withdrawal by Subject|0|||
144706325|NCT00083226|521777394|FG000|Overall Study|Lack of Efficacy|19|||
144706326|NCT00083226|521777394|FG000|Overall Study|Adverse Event|9|||
144706327|NCT00083226|521777394|FG000|Overall Study|Death|4|||
144706328|NCT00083226|521777394|FG000|Overall Study|Withdrawal by Subject|4|||
144706329|NCT00083226|521777394|FG000|Overall Study|Other|2|||
144706330|NCT00083226|521777394|FG000|Overall Study|ineligible or not receiving treatment|4|||
144706331|NCT00909857|521777395|FG000|Overall Study|Withdrawal by Subject|6|||
144706332|NCT00909857|521777396|FG001|Overall Study|Withdrawal by Subject|10|||
144706333|NCT00909857|521777395|FG000|Overall Study|Adverse Event|5|||
144706334|NCT00909857|521777396|FG001|Overall Study|Adverse Event|5|||
144706335|NCT00909857|521777395|FG000|Overall Study|Lost to Follow-up|2|||
144706336|NCT00909857|521777396|FG001|Overall Study|Lost to Follow-up|5|||
144706337|NCT00909857|521777395|FG000|Overall Study|Protocol Violation|2|||
144706338|NCT00909857|521777396|FG001|Overall Study|Protocol Violation|1|||
144706339|NCT00909857|521777395|FG000|Overall Study|Pregnancy|1|||
144706340|NCT00909857|521777396|FG001|Overall Study|Pregnancy|0|||
144706341|NCT00909857|521777395|FG000|Overall Study|Other|1|||
144706342|NCT00909857|521777396|FG001|Overall Study|Other|0|||
144706343|NCT00909857|521777395|FG000|Overall Study|Did not receive study medication|19|||
144706344|NCT00909857|521777396|FG001|Overall Study|Did not receive study medication|24|||
144706345|NCT03878108|521777397|FG000|Overall Study|Adverse Event|1|||
144706346|NCT03878108|521777398|FG001|Overall Study|Adverse Event|0|||
144706347|NCT05257109|521777405|FG000|Overall Study|Withdrawal by Subject|1|||
144706348|NCT05257109|521777406|FG001|Overall Study|Withdrawal by Subject|0|||
144706349|NCT05257109|521777407|FG002|Overall Study|Withdrawal by Subject|0|||
144706350|NCT05257109|521777408|FG003|Overall Study|Withdrawal by Subject|0|||
144706351|NCT03515837|521779459|FG000|Overall Study|Death|219|||
144706352|NCT03515837|521779460|FG001|Overall Study|Death|227|||
144706353|NCT03515837|521779459|FG000|Overall Study|Lost to Follow-up|0|||
144706354|NCT03515837|521779460|FG001|Overall Study|Lost to Follow-up|1|||
144706355|NCT03515837|521779459|FG000|Overall Study|Withdrawal by Subject|0|||
144367499|NCT01458392|520557317|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
144367500|NCT01458392|520557318|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
144367501|NCT01281124|520557321|FG000|Overall Study|Death|1|||
144367502|NCT00753506|520557322|FG000|Overall Study|Withdrawal by Subject|4|||
144367503|NCT00753506|520557323|FG001|Overall Study|Withdrawal by Subject|1|||
144367504|NCT00753506|520557322|FG000|Overall Study|Lost to Follow-up|2|||
144367505|NCT00753506|520557323|FG001|Overall Study|Lost to Follow-up|0|||
144367506|NCT00753506|520557322|FG000|Overall Study|Other reason|1|||
144706356|NCT03515837|521779460|FG001|Overall Study|Withdrawal by Subject|4|||
144706357|NCT03515837|521779459|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
144706358|NCT03515837|521779460|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
144706359|NCT01964898|521779461|FG000|Overall Study|ineligible post-randomization|1|||
144706360|NCT01964898|521779462|FG001|Overall Study|ineligible post-randomization|1|||
144706361|NCT01964898|521779461|FG000|Overall Study|did not receive the allocated interventi|2|||
144706362|NCT01964898|521779462|FG001|Overall Study|did not receive the allocated interventi|1|||
144706363|NCT01964898|521779461|FG000|Overall Study|Lost to Follow-up|3|||
144706364|NCT01964898|521779462|FG001|Overall Study|Lost to Follow-up|5|||
144706365|NCT01964898|521779461|FG000|Overall Study|Withdrawal by Subject|1|||
144706366|NCT01964898|521779462|FG001|Overall Study|Withdrawal by Subject|0|||
144706367|NCT02957682|521779465|FG000|Overall Study|Adverse Event|64|||
144706368|NCT02957682|521779466|FG001|Overall Study|Adverse Event|67|||
144706369|NCT02957682|521779465|FG000|Overall Study|Poor Compliance to Protocol|30|||
144706370|NCT02957682|521779466|FG001|Overall Study|Poor Compliance to Protocol|26|||
144706371|NCT02957682|521779465|FG000|Overall Study|Physician Decision|4|||
144706372|NCT02957682|521779466|FG001|Overall Study|Physician Decision|4|||
144706373|NCT02957682|521779465|FG000|Overall Study|Study Terminated by Sponsor|4|||
144706374|NCT02957682|521779466|FG001|Overall Study|Study Terminated by Sponsor|3|||
144706375|NCT02957682|521779465|FG000|Overall Study|Subject Moved|10|||
144706376|NCT02957682|521779466|FG001|Overall Study|Subject Moved|16|||
144706377|NCT02957682|521779465|FG000|Overall Study|Withdrawal by Subject|64|||
144706378|NCT02957682|521779466|FG001|Overall Study|Withdrawal by Subject|33|||
144706379|NCT02957682|521779465|FG000|Overall Study|Related to IMP Administration|3|||
144706380|NCT02957682|521779466|FG001|Overall Study|Related to IMP Administration|6|||
144706381|NCT02957682|521779465|FG000|Overall Study|Non-disclosed|16|||
144706382|NCT02957682|521779466|FG001|Overall Study|Non-disclosed|12|||
144706383|NCT02957682|521779465|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
144706384|NCT02957682|521779466|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
144706385|NCT02953262|521779474|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
144706386|NCT02953262|521779475|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
144706387|NCT02953262|521779476|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
144706388|NCT02953262|521779477|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
144706389|NCT00934622|521779478|FG000|Overall Study|Lost to Follow-up|7|||
144706390|NCT00934622|521779478|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
144706391|NCT03284424|521779479|FG000|Overall Study|Death|70|||
144706392|NCT03284424|521779480|FG001|Overall Study|Death|24|||
144706393|NCT03284424|521779479|FG000|Overall Study|Lost to Follow-up|3|||
144706394|NCT03284424|521779480|FG001|Overall Study|Lost to Follow-up|1|||
144706395|NCT03284424|521779479|FG000|Overall Study|Physician Decision|1|||
144706396|NCT03284424|521779480|FG001|Overall Study|Physician Decision|2|||
144706397|NCT03284424|521779479|FG000|Overall Study|Withdrawal by Subject|4|||
144706398|NCT03284424|521779480|FG001|Overall Study|Withdrawal by Subject|5|||
144706399|NCT03284424|521779479|FG000|Overall Study|Sponsor's decision|27|||
144706400|NCT03284424|521779480|FG001|Overall Study|Sponsor's decision|22|||
144706401|NCT03349437|521779483|FG000|Screening|Screen Fail|4|||
144706402|NCT03349437|521779484|FG001|Screening|Screen Fail|0|||
144706403|NCT03349437|521779485|FG002|Screening|Screen Fail|0|||
144706404|NCT03349437|521779483|FG000|Screening|Withdrawn|1|||
144706405|NCT03349437|521779484|FG001|Screening|Withdrawn|0|||
144706406|NCT03349437|521779485|FG002|Screening|Withdrawn|0|||
144706407|NCT02406742|521779486|FG000|Overall Study|Progression of Disease|5|||
144706408|NCT02406742|521779487|FG001|Overall Study|Progression of Disease|1|||
144706409|NCT02406742|521779488|FG002|Overall Study|Progression of Disease|6|||
144706410|NCT02406742|521779486|FG000|Overall Study|Adverse Event|3|||
144706411|NCT02406742|521779487|FG001|Overall Study|Adverse Event|0|||
144706412|NCT02406742|521779488|FG002|Overall Study|Adverse Event|2|||
144706413|NCT02406742|521779486|FG000|Overall Study|Death|1|||
144706414|NCT02406742|521779487|FG001|Overall Study|Death|0|||
144706415|NCT02406742|521779488|FG002|Overall Study|Death|0|||
144706416|NCT02406742|521779486|FG000|Overall Study|Lack of Efficacy|0|||
144706417|NCT02406742|521779487|FG001|Overall Study|Lack of Efficacy|0|||
144706418|NCT02406742|521779488|FG002|Overall Study|Lack of Efficacy|1|||
144706419|NCT02406742|521779486|FG000|Overall Study|Withdrawal by Participant|1|||
144706420|NCT02406742|521779487|FG001|Overall Study|Withdrawal by Participant|2|||
144706421|NCT02406742|521779488|FG002|Overall Study|Withdrawal by Participant|0|||
144706422|NCT02406742|521779486|FG000|Overall Study|Physician Decision|1|||
144706423|NCT02406742|521779487|FG001|Overall Study|Physician Decision|2|||
144706424|NCT02406742|521779488|FG002|Overall Study|Physician Decision|1|||
144706425|NCT02406742|521779486|FG000|Overall Study|Transition to other treatment|2|||
144706426|NCT02406742|521779487|FG001|Overall Study|Transition to other treatment|0|||
144706427|NCT02406742|521779488|FG002|Overall Study|Transition to other treatment|1|||
144706428|NCT02406742|521779486|FG000|Overall Study|Other Reasons|1|||
144706429|NCT02406742|521779487|FG001|Overall Study|Other Reasons|11|||
144706430|NCT02406742|521779488|FG002|Overall Study|Other Reasons|5|||
144706431|NCT00765999|521779489|FG000|Overall Study|Adverse Event|203|||
144706432|NCT00765999|521779489|FG000|Overall Study|Insufficient Therapeutic Response|100|||
144706433|NCT00765999|521779489|FG000|Overall Study|Protocol Violation|95|||
144706434|NCT00765999|521779489|FG000|Overall Study|Consent Withdrawn|202|||
144706435|NCT00765999|521779489|FG000|Overall Study|Lost to Follow-up|131|||
144706436|NCT00765999|521779489|FG000|Overall Study|Study Terminated by Sponsor|2|||
144706437|NCT00765999|521779489|FG000|Overall Study|Other Miscellaneous Reasons|51|||
144706438|NCT02367729|521779490|FG000|Overall Study|Organic disorder diagnosed|2|||
144706439|NCT02367729|521779491|FG001|Overall Study|Organic disorder diagnosed|1|||
144706440|NCT02367729|521779490|FG000|Overall Study|Adverse Event|1|||
144706441|NCT02367729|521779491|FG001|Overall Study|Adverse Event|2|||
144706442|NCT02367729|521779490|FG000|Overall Study|Withdrawal by Subject|0|||
144706443|NCT02367729|521779491|FG001|Overall Study|Withdrawal by Subject|5|||
144706444|NCT00759174|521779496|FG000|Overall Study|Other|0|||
144706445|NCT00759174|521779497|FG001|Overall Study|Other|2|||
144706446|NCT01890109|521779498|FG000|Overall Study|Withdrawal by Subject|0|||
144706447|NCT01890109|521779499|FG001|Overall Study|Withdrawal by Subject|3|||
144706448|NCT01890109|521779498|FG000|Overall Study|Lost to Follow-up|1|||
144706449|NCT01890109|521779499|FG001|Overall Study|Lost to Follow-up|2|||
144706450|NCT01643928|521779500|FG000|Overall Study|Lost to Follow-up|1|||
144706451|NCT01643928|521779501|FG001|Overall Study|Lost to Follow-up|0|||
144706452|NCT01643928|521779502|FG002|Overall Study|Lost to Follow-up|2|||
144706453|NCT01643928|521779503|FG003|Overall Study|Lost to Follow-up|0|||
144706454|NCT01643928|521779504|FG004|Overall Study|Lost to Follow-up|0|||
144706455|NCT01643928|521779500|FG000|Overall Study|Withdrawal by Subject|2|||
144706456|NCT01643928|521779501|FG001|Overall Study|Withdrawal by Subject|0|||
144706457|NCT01643928|521779502|FG002|Overall Study|Withdrawal by Subject|0|||
144706458|NCT01643928|521779503|FG003|Overall Study|Withdrawal by Subject|1|||
144706459|NCT01643928|521779504|FG004|Overall Study|Withdrawal by Subject|0|||
144706460|NCT01643928|521779500|FG000|Overall Study|Pregnancy|0|||
144706461|NCT01643928|521779501|FG001|Overall Study|Pregnancy|0|||
144706462|NCT01643928|521779502|FG002|Overall Study|Pregnancy|0|||
144706463|NCT01643928|521779503|FG003|Overall Study|Pregnancy|1|||
144706464|NCT01643928|521779504|FG004|Overall Study|Pregnancy|0|||
144706465|NCT01643928|521779500|FG000|Overall Study|Other|5|||
144706466|NCT01643928|521779501|FG001|Overall Study|Other|1|||
144706467|NCT01643928|521779502|FG002|Overall Study|Other|1|||
144706468|NCT01643928|521779503|FG003|Overall Study|Other|0|||
144706469|NCT01643928|521779504|FG004|Overall Study|Other|0|||
144706470|NCT01643928|521779500|FG000|Overall Study|Adverse Event|2|||
144706471|NCT01643928|521779501|FG001|Overall Study|Adverse Event|1|||
144706472|NCT01643928|521779502|FG002|Overall Study|Adverse Event|0|||
144706473|NCT01643928|521779503|FG003|Overall Study|Adverse Event|1|||
144706474|NCT01643928|521779504|FG004|Overall Study|Adverse Event|2|||
144706475|NCT03692078|521779506|FG000|Overall Study|Adverse Event|0|||
144706476|NCT03692078|521779507|FG001|Overall Study|Adverse Event|0|||
144706477|NCT03692078|521779508|FG002|Overall Study|Adverse Event|0|||
144706478|NCT03692078|521779509|FG003|Overall Study|Adverse Event|0|||
144706479|NCT03692078|521779510|FG004|Overall Study|Adverse Event|0|||
144706480|NCT03692078|521779511|FG005|Overall Study|Adverse Event|1|||
144706481|NCT03692078|521779512|FG006|Overall Study|Adverse Event|0|||
144706482|NCT03692078|521779506|FG000|Overall Study|Enrollment Closed|5|||
144706483|NCT03692078|521779507|FG001|Overall Study|Enrollment Closed|0|||
144706484|NCT03692078|521779508|FG002|Overall Study|Enrollment Closed|0|||
144706485|NCT03692078|521779509|FG003|Overall Study|Enrollment Closed|0|||
144706486|NCT03692078|521779510|FG004|Overall Study|Enrollment Closed|0|||
144706487|NCT03692078|521779511|FG005|Overall Study|Enrollment Closed|0|||
144706488|NCT03692078|521779512|FG006|Overall Study|Enrollment Closed|0|||
144706489|NCT03692078|521779506|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
144706490|NCT03692078|521779507|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
144706491|NCT03692078|521779508|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
144706492|NCT03692078|521779509|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
144706493|NCT03692078|521779510|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
144706494|NCT03692078|521779511|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
144706495|NCT03692078|521779512|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
144706496|NCT03692078|521779506|FG000|Overall Study|Withdrawal by Subject|0|||
144706497|NCT03692078|521779507|FG001|Overall Study|Withdrawal by Subject|2|||
144706498|NCT03692078|521779508|FG002|Overall Study|Withdrawal by Subject|0|||
144706499|NCT03692078|521779509|FG003|Overall Study|Withdrawal by Subject|1|||
144706500|NCT03692078|521779510|FG004|Overall Study|Withdrawal by Subject|5|||
144706501|NCT03692078|521779511|FG005|Overall Study|Withdrawal by Subject|3|||
144706502|NCT03692078|521779512|FG006|Overall Study|Withdrawal by Subject|3|||
144706503|NCT04101721|521779515|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
144706504|NCT04101721|521779516|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
144706505|NCT04101721|521779515|FG000|Overall Study|Death|0|||
144706506|NCT04101721|521779516|FG001|Overall Study|Death|1|||
144706507|NCT04101721|521779515|FG000|Overall Study|Lost to Follow-up|0|||
144706508|NCT04101721|521779516|FG001|Overall Study|Lost to Follow-up|3|||
144706509|NCT00756652|521779517|FG000|Original Phase|Withdrawal by Subject|864|||
144706510|NCT00756652|521779518|FG001|Original Phase|Withdrawal by Subject|23|||
144706511|NCT00756652|521779517|FG000|Original Phase|Lost to Follow-up|601|||
144706512|NCT00756652|521779518|FG001|Original Phase|Lost to Follow-up|0|||
144706513|NCT00756652|521779517|FG000|Original Phase|Other Discontinuation|797|||
144706514|NCT00756652|521779518|FG001|Original Phase|Other Discontinuation|5|||
144706515|NCT00756652|521779517|FG000|Original Phase|Participant Noncompliance|18622|||
144706516|NCT00756652|521779518|FG001|Original Phase|Participant Noncompliance|424|||
144706517|NCT00756652|521779517|FG000|Original Phase|Unknown Discontinuation Reason|2|||
144706518|NCT00756652|521779518|FG001|Original Phase|Unknown Discontinuation Reason|0|||
144706519|NCT00756652|521779517|FG000|Original Phase|Participants without data|3259|||
144706520|NCT00756652|521779518|FG001|Original Phase|Participants without data|466|||
144706521|NCT00756652|521779517|FG000|Original Phase|Death|168|||
144706522|NCT00756652|521779518|FG001|Original Phase|Death|1|||
144706523|NCT00756652|521779517|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
144706524|NCT00756652|521779518|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
144706525|NCT00756652|521779517|FG000|Re-Op Phase|Withdrawal by Subject|62|||
144706526|NCT00756652|521779518|FG001|Re-Op Phase|Withdrawal by Subject|0|||
144706527|NCT00756652|521779517|FG000|Re-Op Phase|Death|6|||
144706528|NCT00756652|521779518|FG001|Re-Op Phase|Death|0|||
144706529|NCT00756652|521779517|FG000|Re-Op Phase|Lost to Follow-up|340|||
144706530|NCT00756652|521779518|FG001|Re-Op Phase|Lost to Follow-up|0|||
144706531|NCT00756652|521779517|FG000|Re-Op Phase|Site Closed|2454|||
144706532|NCT00756652|521779518|FG001|Re-Op Phase|Site Closed|0|||
144706533|NCT00756652|521779517|FG000|Re-Op Phase|Withdrawn after explant|14|||
144706534|NCT00756652|521779518|FG001|Re-Op Phase|Withdrawn after explant|0|||
144706535|NCT02564952|521779519|FG000|Overall Study|Adverse Event|6|||
144706536|NCT02564952|521779519|FG000|Overall Study|Lost to Follow-up|1|||
144706537|NCT02564952|521779519|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
144706538|NCT02564952|521779519|FG000|Overall Study|Withdrawal by Subject|1|||
144706539|NCT02564952|521779519|FG000|Overall Study|Low Efficacy|1|||
144706540|NCT02564952|521779519|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
144706541|NCT01215955|521779520|FG000|Overall Study|Adverse Event|1|||
144706542|NCT01215955|521779521|FG001|Overall Study|Adverse Event|4|||
144706543|NCT01215955|521779522|FG002|Overall Study|Adverse Event|2|||
144706544|NCT01215955|521779523|FG003|Overall Study|Adverse Event|3|||
144706545|NCT01215955|521779520|FG000|Overall Study|Death|2|||
144706546|NCT01215955|521779521|FG001|Overall Study|Death|0|||
144706547|NCT01215955|521779522|FG002|Overall Study|Death|1|||
144706548|NCT01215955|521779523|FG003|Overall Study|Death|3|||
144706549|NCT01215955|521779520|FG000|Overall Study|Entry Criteria Not Met|1|||
144706550|NCT01215955|521779521|FG001|Overall Study|Entry Criteria Not Met|3|||
144706551|NCT01215955|521779522|FG002|Overall Study|Entry Criteria Not Met|4|||
144706552|NCT01215955|521779523|FG003|Overall Study|Entry Criteria Not Met|7|||
144706553|NCT01215955|521779520|FG000|Overall Study|Lack of Efficacy|1|||
144706554|NCT01215955|521779521|FG001|Overall Study|Lack of Efficacy|2|||
144706555|NCT01215955|521779522|FG002|Overall Study|Lack of Efficacy|1|||
144706556|NCT01215955|521779523|FG003|Overall Study|Lack of Efficacy|0|||
144706557|NCT01215955|521779520|FG000|Overall Study|Lost to Follow-up|4|||
144706558|NCT01215955|521779521|FG001|Overall Study|Lost to Follow-up|4|||
144706559|NCT01215955|521779522|FG002|Overall Study|Lost to Follow-up|8|||
144706560|NCT01215955|521779523|FG003|Overall Study|Lost to Follow-up|9|||
144706561|NCT01215955|521779520|FG000|Overall Study|Physician Decision|4|||
144706562|NCT01215955|521779521|FG001|Overall Study|Physician Decision|10|||
144706563|NCT01215955|521779522|FG002|Overall Study|Physician Decision|8|||
144706564|NCT01215955|521779523|FG003|Overall Study|Physician Decision|11|||
144706565|NCT01215955|521779520|FG000|Overall Study|Protocol Violation|17|||
144706566|NCT01215955|521779521|FG001|Overall Study|Protocol Violation|13|||
144706567|NCT01215955|521779522|FG002|Overall Study|Protocol Violation|8|||
144706568|NCT01215955|521779523|FG003|Overall Study|Protocol Violation|8|||
144706569|NCT01215955|521779520|FG000|Overall Study|Sponsor Decision|1|||
144706570|NCT01215955|521779521|FG001|Overall Study|Sponsor Decision|2|||
144706571|NCT01215955|521779522|FG002|Overall Study|Sponsor Decision|0|||
144706572|NCT01215955|521779523|FG003|Overall Study|Sponsor Decision|1|||
144706573|NCT01215955|521779520|FG000|Overall Study|Withdrawal by Subject|14|||
144706574|NCT01215955|521779521|FG001|Overall Study|Withdrawal by Subject|15|||
144706575|NCT01215955|521779522|FG002|Overall Study|Withdrawal by Subject|13|||
144706576|NCT01215955|521779523|FG003|Overall Study|Withdrawal by Subject|9|||
144706577|NCT01215955|521779520|FG000|Overall Study|Quality Issues|0|||
144706578|NCT01215955|521779521|FG001|Overall Study|Quality Issues|0|||
144706579|NCT01215955|521779522|FG002|Overall Study|Quality Issues|3|||
144706580|NCT01215955|521779523|FG003|Overall Study|Quality Issues|2|||
144706581|NCT00038467|521779524|FG000|Overall Study|Adverse Event|170|||
144706582|NCT00038467|521779525|FG001|Overall Study|Adverse Event|145|||
144706583|NCT00038467|521779524|FG000|Overall Study|Withdrawal by Subject|150|||
144706584|NCT00038467|521779525|FG001|Overall Study|Withdrawal by Subject|107|||
144706585|NCT00038467|521779524|FG000|Overall Study|Protocol Violation|19|||
144706586|NCT00038467|521779525|FG001|Overall Study|Protocol Violation|22|||
144706587|NCT00038467|521779524|FG000|Overall Study|Death|22|||
144706588|NCT00038467|521779525|FG001|Overall Study|Death|16|||
144706589|NCT00038467|521779524|FG000|Overall Study|Lost to Follow-up|15|||
144706590|NCT00038467|521779525|FG001|Overall Study|Lost to Follow-up|10|||
144706591|NCT00038467|521779524|FG000|Overall Study|Recurrence|109|||
144706592|NCT00038467|521779525|FG001|Overall Study|Recurrence|179|||
144706593|NCT00038467|521779524|FG000|Overall Study|Randomized, but not treated|31|||
144706594|NCT00038467|521779525|FG001|Overall Study|Randomized, but not treated|35|||
144706595|NCT00038467|521779524|FG000|Overall Study|Other|26|||
144706596|NCT00038467|521779525|FG001|Overall Study|Other|28|||
144706597|NCT01787188|521779526|FG000|Overall Study|Adverse Event|2|||
144706598|NCT01787188|521779527|FG001|Overall Study|Adverse Event|4|||
144706599|NCT01787188|521779528|FG002|Overall Study|Adverse Event|6|||
144706600|NCT01787188|521779526|FG000|Overall Study|Lack of Efficacy|7|||
144706601|NCT01787188|521779527|FG001|Overall Study|Lack of Efficacy|3|||
144706602|NCT01787188|521779528|FG002|Overall Study|Lack of Efficacy|5|||
144706603|NCT01787188|521779526|FG000|Overall Study|Non-compliance with Study Drug|0|||
144706604|NCT01787188|521779527|FG001|Overall Study|Non-compliance with Study Drug|1|||
144706605|NCT01787188|521779528|FG002|Overall Study|Non-compliance with Study Drug|0|||
144706606|NCT01787188|521779526|FG000|Overall Study|Withdrawal by Subject|4|||
144706607|NCT01787188|521779527|FG001|Overall Study|Withdrawal by Subject|3|||
144706608|NCT01787188|521779528|FG002|Overall Study|Withdrawal by Subject|2|||
144706609|NCT01787188|521779526|FG000|Overall Study|Protocol Violation|3|||
144706610|NCT01787188|521779527|FG001|Overall Study|Protocol Violation|2|||
144706611|NCT01787188|521779528|FG002|Overall Study|Protocol Violation|3|||
144706612|NCT01787188|521779526|FG000|Overall Study|Lost to Follow-up|1|||
144706613|NCT01787188|521779527|FG001|Overall Study|Lost to Follow-up|2|||
144706614|NCT01787188|521779528|FG002|Overall Study|Lost to Follow-up|2|||
144706615|NCT01787188|521779526|FG000|Overall Study|Other, including patient moved|0|||
144706616|NCT01787188|521779527|FG001|Overall Study|Other, including patient moved|3|||
144706617|NCT01787188|521779528|FG002|Overall Study|Other, including patient moved|0|||
144706618|NCT02643394|521779529|FG000|Overall Study|Protocol Violation|4|||
144706619|NCT02643394|521779530|FG001|Overall Study|Protocol Violation|5|||
144706620|NCT00943384|521779531|FG000|Overall Study|Dispositioned prior to treatment|23|||
144706621|NCT00943384|521779531|FG000|Overall Study|Treated off protocol-protocol violation|5|||
144706622|NCT00943384|521779531|FG000|Overall Study|Lost to Follow-up|16|||
144706623|NCT00943384|521779531|FG000|Overall Study|Withdrawal by Subject|5|||
144706624|NCT04088734|521779532|FG000|Overall Study|Other, Not Specified|5|||
144706625|NCT00096200|521779533|FG000|Overall Study|Adverse Event|0|||
144706626|NCT00096200|521779534|FG001|Overall Study|Adverse Event|4|||
144706627|NCT00096200|521779535|FG002|Overall Study|Adverse Event|0|||
144706628|NCT00096200|521779533|FG000|Overall Study|Withdrawal by Subject|1|||
144706629|NCT00096200|521779534|FG001|Overall Study|Withdrawal by Subject|2|||
144706630|NCT00096200|521779535|FG002|Overall Study|Withdrawal by Subject|0|||
144706631|NCT00096200|521779533|FG000|Overall Study|Ineligible pathology|0|||
144706632|NCT00096200|521779534|FG001|Overall Study|Ineligible pathology|1|||
144706633|NCT00096200|521779535|FG002|Overall Study|Ineligible pathology|0|||
144706634|NCT00835068|521779536|FG000|Overall Study|Death|1|||
144706635|NCT00835068|521779537|FG001|Overall Study|Death|0|||
144706636|NCT00835068|521779536|FG000|Overall Study|Adverse Event|0|||
144706637|NCT00835068|521779537|FG001|Overall Study|Adverse Event|1|||
144706638|NCT00835068|521779536|FG000|Overall Study|Other|8|||
144706639|NCT00835068|521779537|FG001|Overall Study|Other|0|||
144706640|NCT00835068|521779536|FG000|Overall Study|Withdrawal by Subject|1|||
144706641|NCT00835068|521779537|FG001|Overall Study|Withdrawal by Subject|0|||
144706642|NCT02575807|521779538|FG000|Overall Study|Death|8|||
144706643|NCT02575807|521779539|FG001|Overall Study|Death|3|||
144706644|NCT02575807|521779540|FG002|Overall Study|Death|7|||
144706645|NCT02575807|521779541|FG003|Overall Study|Death|0|||
144706646|NCT02575807|521779542|FG004|Overall Study|Death|1|||
144706647|NCT02575807|521779538|FG000|Overall Study|Study terminated by Sponsor|0|||
144706648|NCT02575807|521779539|FG001|Overall Study|Study terminated by Sponsor|1|||
144706649|NCT02575807|521779540|FG002|Overall Study|Study terminated by Sponsor|7|||
144706650|NCT02575807|521779541|FG003|Overall Study|Study terminated by Sponsor|0|||
144706651|NCT02575807|521779542|FG004|Overall Study|Study terminated by Sponsor|1|||
144706652|NCT02575807|521779538|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
144706653|NCT02575807|521779539|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
144706654|NCT02575807|521779540|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
144706655|NCT02575807|521779541|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
144706656|NCT02575807|521779542|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
144706657|NCT02575807|521779538|FG000|Overall Study|Terminated due to physician decision|0|||
144706658|NCT02575807|521779539|FG001|Overall Study|Terminated due to physician decision|0|||
144706659|NCT02575807|521779540|FG002|Overall Study|Terminated due to physician decision|1|||
144706660|NCT02575807|521779541|FG003|Overall Study|Terminated due to physician decision|0|||
144706661|NCT02575807|521779542|FG004|Overall Study|Terminated due to physician decision|0|||
144706662|NCT02575807|521779538|FG000|Overall Study|Subject ineligible - medical implant|0|||
144706663|NCT02575807|521779539|FG001|Overall Study|Subject ineligible - medical implant|0|||
144706664|NCT02575807|521779540|FG002|Overall Study|Subject ineligible - medical implant|0|||
144706665|NCT02575807|521779541|FG003|Overall Study|Subject ineligible - medical implant|1|||
144706666|NCT02575807|521779542|FG004|Overall Study|Subject ineligible - medical implant|0|||
144706667|NCT02575807|521779538|FG000|Overall Study|Withdrawal by Subject|0|||
144706668|NCT02575807|521779539|FG001|Overall Study|Withdrawal by Subject|0|||
144706669|NCT02575807|521779540|FG002|Overall Study|Withdrawal by Subject|1|||
144706670|NCT02575807|521779541|FG003|Overall Study|Withdrawal by Subject|1|||
144706671|NCT02575807|521779542|FG004|Overall Study|Withdrawal by Subject|2|||
144706672|NCT01154673|521779545|FG000|Overall Study|Lost to Follow-up|1|||
144706673|NCT01154673|521779546|FG001|Overall Study|Lost to Follow-up|0|||
144706674|NCT01154673|521779545|FG000|Overall Study|moved out of province|1|||
144706675|NCT01154673|521779546|FG001|Overall Study|moved out of province|0|||
144706676|NCT02362646|521779555|FG000|Overall Study|Death|15|||
144706677|NCT02362646|521779556|FG001|Overall Study|Death|8|||
144706678|NCT02362646|521779555|FG000|Overall Study|Withdrawal by Subject|2|||
144706679|NCT02362646|521779556|FG001|Overall Study|Withdrawal by Subject|2|||
144706680|NCT02362646|521779555|FG000|Overall Study|received transplant|21|||
144706681|NCT02362646|521779556|FG001|Overall Study|received transplant|14|||
144706682|NCT00865306|521779557|FG000|Controlled Trial|Lost to Follow-up|1|||
144706683|NCT00865306|521779558|FG001|Controlled Trial|Lost to Follow-up|1|||
144706684|NCT00865306|521779557|FG000|Controlled Trial|Difficulty commuting|2|||
144706685|NCT00865306|521779558|FG001|Controlled Trial|Difficulty commuting|0|||
144706686|NCT00865306|521779557|FG000|Controlled Trial|Improved btw baseline and first session|1|||
144706687|NCT00865306|521779558|FG001|Controlled Trial|Improved btw baseline and first session|0|||
144706688|NCT00865306|521779557|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
144706689|NCT00865306|521779558|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
144706690|NCT00865306|521779557|FG000|Controlled Trial|Withdrawal by Subject|0|||
144706691|NCT00865306|521779558|FG001|Controlled Trial|Withdrawal by Subject|1|||
144706692|NCT01216319|521779564|FG000|Overall Study|Lost to Follow-up|2|||
144706693|NCT01216319|521779564|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
144706694|NCT03611751|521779565|FG000|Pre-treatment|Randomized but not treated|1|||
144706695|NCT03611751|521779566|FG001|Pre-treatment|Randomized but not treated|1|||
144706696|NCT03611751|521779567|FG002|Pre-treatment|Randomized but not treated|0|||
144706697|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
144706698|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
144706699|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
144706700|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
144706701|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
144706702|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
144706703|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
144706704|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
144706705|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
144706706|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
144706707|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
144706708|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
144706709|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
144706710|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
144706711|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
144706712|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
144706713|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
144706714|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
144706715|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
144706716|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
144706717|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
144706718|NCT03611751|521779565|FG000|Treatment Week 0 - Week 16|Death|0|||
144706719|NCT03611751|521779566|FG001|Treatment Week 0 - Week 16|Death|0|||
144706720|NCT03611751|521779567|FG002|Treatment Week 0 - Week 16|Death|1|||
144706721|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
144706722|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
144706723|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
144706724|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
144706725|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
144706726|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
144706727|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
144706728|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
144706729|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
144706730|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
144706731|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
144706732|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
144706733|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
144706734|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
144706735|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
144706736|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
144706737|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
144706738|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
144706739|NCT03611751|521779565|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
144706740|NCT03611751|521779566|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
144706741|NCT03611751|521779567|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
144706742|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
144706743|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
144706744|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
144706745|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
144706746|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
144706747|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
144706748|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
144706749|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
144706750|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
144706751|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
144706752|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
144706753|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
144706754|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
144706755|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
144706756|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
144706757|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
144706758|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
144706759|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
144706760|NCT03611751|521779565|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
144706761|NCT03611751|521779566|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
144706762|NCT03611751|521779567|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
144706763|NCT00929864|521779568|FG000|Overall Study|Death|1|||
144706764|NCT00929864|521779569|FG001|Overall Study|Death|1|||
144706765|NCT00929864|521779568|FG000|Overall Study|Adverse Event|11|||
144706766|NCT00929864|521779569|FG001|Overall Study|Adverse Event|30|||
144706767|NCT00929864|521779568|FG000|Overall Study|Lack of Efficacy|19|||
144706768|NCT00929864|521779569|FG001|Overall Study|Lack of Efficacy|16|||
144706769|NCT00929864|521779568|FG000|Overall Study|Lost to Follow-up|7|||
144706770|NCT00929864|521779569|FG001|Overall Study|Lost to Follow-up|12|||
144706771|NCT00929864|521779568|FG000|Overall Study|Withdrawal by Subject|20|||
144706772|NCT00929864|521779569|FG001|Overall Study|Withdrawal by Subject|9|||
144706773|NCT00929864|521779568|FG000|Overall Study|No longer met criteria|2|||
144706774|NCT00929864|521779569|FG001|Overall Study|No longer met criteria|1|||
144706775|NCT00929864|521779568|FG000|Overall Study|Poor or non-compliance|3|||
144706776|NCT00929864|521779569|FG001|Overall Study|Poor or non-compliance|3|||
144706777|NCT00929864|521779568|FG000|Overall Study|Pregnancy|0|||
144706778|NCT00929864|521779569|FG001|Overall Study|Pregnancy|3|||
144706779|NCT00929864|521779568|FG000|Overall Study|Administrative reason by Sponsor|1|||
144706780|NCT00929864|521779569|FG001|Overall Study|Administrative reason by Sponsor|1|||
144706781|NCT00929864|521779568|FG000|Overall Study|Non-specified|2|||
144706782|NCT00929864|521779569|FG001|Overall Study|Non-specified|7|||
144706783|NCT03940742|521779572|FG000|Overall Study|Lost to Follow-up|0|||
144706784|NCT03940742|521779573|FG001|Overall Study|Lost to Follow-up|0|||
144706785|NCT03940742|521779574|FG002|Overall Study|Lost to Follow-up|0|||
144706786|NCT03940742|521779575|FG003|Overall Study|Lost to Follow-up|1|||
144706787|NCT02032823|521779576|FG000|Overall Study|Death|75|||
144706788|NCT02032823|521779577|FG001|Overall Study|Death|109|||
144706789|NCT02032823|521779576|FG000|Overall Study|Lost to Follow-up|18|||
144706790|NCT02032823|521779577|FG001|Overall Study|Lost to Follow-up|17|||
144706791|NCT02032823|521779576|FG000|Overall Study|Withdrawal by Subject|70|||
144706792|NCT02032823|521779577|FG001|Overall Study|Withdrawal by Subject|53|||
144706793|NCT02032823|521779576|FG000|Overall Study|Ongoing study at data cut-off|755|||
144706794|NCT02032823|521779577|FG001|Overall Study|Ongoing study at data cut-off|731|||
144706795|NCT02032823|521779576|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
144706796|NCT02032823|521779577|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
144706797|NCT03428217|521779578|FG000|Overall Study|Death|89|||
144706798|NCT03428217|521779579|FG001|Overall Study|Death|93|||
144706799|NCT03428217|521779578|FG000|Overall Study|Withdrawal by Subject|8|||
144706800|NCT03428217|521779579|FG001|Overall Study|Withdrawal by Subject|7|||
144706801|NCT03428217|521779578|FG000|Overall Study|Lost to Follow-up|1|||
144706802|NCT03428217|521779579|FG001|Overall Study|Lost to Follow-up|3|||
144706803|NCT03428217|521779578|FG000|Overall Study|Study terminated by sponsor|124|||
144706804|NCT03428217|521779579|FG001|Overall Study|Study terminated by sponsor|118|||
144367507|NCT00753506|520557323|FG001|Overall Study|Other reason|1|||
144706805|NCT03428217|521779578|FG000|Overall Study|Other, Not Specified|1|||
144706806|NCT03428217|521779579|FG001|Overall Study|Other, Not Specified|0|||
144706807|NCT03889197|521779580|FG000|Overall Study|Withdrawal by Subject|1|||
144706808|NCT03889197|521779581|FG001|Overall Study|Withdrawal by Subject|0|||
144706809|NCT03889197|521779580|FG000|Overall Study|Physician Decision|0|||
144367508|NCT01417377|520557326|FG000|Overall Study|Lost to Follow-up|12|||
144706810|NCT03889197|521779581|FG001|Overall Study|Physician Decision|1|||
144706811|NCT03889197|521779580|FG000|Overall Study|met exclusion criteria|0|||
144706812|NCT03889197|521779581|FG001|Overall Study|met exclusion criteria|1|||
144706813|NCT03889197|521779580|FG000|Overall Study|Protocol Violation|1|||
144367509|NCT01417377|520557326|FG000|Overall Study|Enrolled, but not treated|1|||
144367510|NCT02113982|520557327|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
144706814|NCT03889197|521779581|FG001|Overall Study|Protocol Violation|0|||
144706815|NCT05246111|521779582|FG000|Period 01|NOT ELIGIBLE IC5|1|||
144706816|NCT05246111|521779583|FG001|Period 01|NOT ELIGIBLE IC5|0|||
144706817|NCT03151226|521779584|FG000|Overall Study|Withdrawal by Subject|2|||
144706818|NCT03151226|521779584|FG000|Overall Study|not wear device correctly|1|||
144706819|NCT00402779|521779585|FG000|Overall Study|Screen Failure|77|||
144706820|NCT00402779|521779586|FG001|Overall Study|Screen Failure|76|||
144706821|NCT00604175|521779589|FG000|Entry Through Week 28|Death|2|||
144706822|NCT00604175|521779590|FG001|Entry Through Week 28|Death|0|||
144706823|NCT00604175|521779591|FG002|Entry Through Week 28|Death|0|||
144706824|NCT00604175|521779589|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
144706825|NCT00604175|521779590|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
144706826|NCT00604175|521779591|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
144706827|NCT00604175|521779589|FG000|Entry Through Week 28|Lost to Follow-up|4|||
144706828|NCT00604175|521779590|FG001|Entry Through Week 28|Lost to Follow-up|3|||
144706829|NCT00604175|521779591|FG002|Entry Through Week 28|Lost to Follow-up|0|||
144706830|NCT00604175|521779589|FG000|Entry Through Week 28|Ineligible|1|||
144706831|NCT00604175|521779590|FG001|Entry Through Week 28|Ineligible|0|||
144706832|NCT00604175|521779591|FG002|Entry Through Week 28|Ineligible|0|||
144706833|NCT00604175|521779589|FG000|Entry Through Week 28|Did not start intervention|2|||
144706834|NCT00604175|521779590|FG001|Entry Through Week 28|Did not start intervention|0|||
144706835|NCT00604175|521779591|FG002|Entry Through Week 28|Did not start intervention|1|||
144706836|NCT00604175|521779589|FG000|Week 29 Through Week 72|Death|0|||
144706837|NCT00604175|521779590|FG001|Week 29 Through Week 72|Death|0|||
144706838|NCT00604175|521779591|FG002|Week 29 Through Week 72|Death|1|||
144706839|NCT00604175|521779589|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
144706840|NCT00604175|521779590|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
144706841|NCT00604175|521779591|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
144706842|NCT00604175|521779589|FG000|Week 29 Through Week 72|Site closure|0|||
144706843|NCT00604175|521779590|FG001|Week 29 Through Week 72|Site closure|1|||
144706844|NCT00604175|521779591|FG002|Week 29 Through Week 72|Site closure|0|||
144706845|NCT00604175|521779589|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
144706846|NCT00604175|521779590|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
144706847|NCT00604175|521779591|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
144706848|NCT01682681|521779592|FG000|Overall Study|Lack of Efficacy|62|||
144706849|NCT01682681|521779592|FG000|Overall Study|Withdrawal by Subject|1|||
144706850|NCT01682681|521779592|FG000|Overall Study|Moved to other hospital|10|||
144706851|NCT01682681|521779592|FG000|Overall Study|Lost to Follow-up|174|||
144706852|NCT01682681|521779592|FG000|Overall Study|Adverse Event|46|||
144706853|NCT01682681|521779592|FG000|Overall Study|tapering of topiramate|5|||
144706854|NCT01682681|521779592|FG000|Overall Study|Other|21|||
144706855|NCT01682681|521779592|FG000|Overall Study|Low compliance|13|||
144706856|NCT02044094|521779593|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
144706857|NCT02044094|521779593|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
144706858|NCT02044094|521779593|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
144706859|NCT02044094|521779593|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
144706860|NCT02044094|521779593|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
144706861|NCT02044094|521779593|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
144706862|NCT02044094|521779593|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
144706863|NCT02044094|521779593|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
144706864|NCT03353415|521779596|FG000|Masked CGM Wear|Lost to Follow-up|2|||
144706865|NCT03353415|521779596|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
144706866|NCT00975000|521779597|FG000|Overall Study|Other|1|||
144706867|NCT00975000|521779598|FG001|Overall Study|Other|0|||
144706868|NCT00975000|521779597|FG000|Overall Study|Adverse Event|1|||
144706869|NCT00975000|521779598|FG001|Overall Study|Adverse Event|1|||
144706870|NCT00975000|521779597|FG000|Overall Study|Withdrawal by Subject|2|||
144706871|NCT00975000|521779598|FG001|Overall Study|Withdrawal by Subject|2|||
144706872|NCT00975000|521779597|FG000|Overall Study|Lost to Follow-up|0|||
144706873|NCT00975000|521779598|FG001|Overall Study|Lost to Follow-up|1|||
144706874|NCT00975000|521779597|FG000|Overall Study|Protocol-specified Criteria|1|||
144706875|NCT00975000|521779598|FG001|Overall Study|Protocol-specified Criteria|0|||
144706876|NCT00975000|521779597|FG000|Overall Study|Non-compliance|0|||
144706877|NCT00975000|521779598|FG001|Overall Study|Non-compliance|1|||
144706878|NCT00005879|521779599|FG000|Overall Study|Withdrawal by Subject|8|||
144706879|NCT00005879|521779600|FG001|Overall Study|Withdrawal by Subject|10|||
144706880|NCT01238172|521779601|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
144706881|NCT01238172|521779602|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
144706882|NCT01238172|521779601|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
144706883|NCT01238172|521779602|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
144706884|NCT05022121|521779603|FG000|Overall Study|Lack of Efficacy|1|||
144706885|NCT05022121|521779604|FG001|Overall Study|Lack of Efficacy|0|||
144706886|NCT05022121|521779603|FG000|Overall Study|Lost to Follow-up|0|||
144706887|NCT05022121|521779604|FG001|Overall Study|Lost to Follow-up|2|||
144706888|NCT00359073|521780529|FG000|Overall Study|Withdrawal by Subject|1|||
144706889|NCT00359073|521780530|FG001|Overall Study|Withdrawal by Subject|1|||
144706890|NCT00359073|521780529|FG000|Overall Study|Eligibility criteria no longer met|3|||
144706891|NCT00359073|521780530|FG001|Overall Study|Eligibility criteria no longer met|0|||
144706892|NCT00359073|521780529|FG000|Overall Study|developed RV16 antibody|0|||
144706893|NCT00359073|521780530|FG001|Overall Study|developed RV16 antibody|1|||
144706894|NCT01371006|521780531|FG000|Overall Study|Adverse Event|1|||
144706895|NCT01371006|521780532|FG001|Overall Study|Adverse Event|0|||
144706896|NCT00891527|521780533|FG000|Overall Study|Withdrawal by Subject|2|||
144706897|NCT03978117|521780537|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
144706898|NCT03978117|521780538|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
144706899|NCT03978117|521780537|FG000|Overall Study|Lost to Follow-up|4|||
144706900|NCT03978117|521780538|FG001|Overall Study|Lost to Follow-up|4|||
144706901|NCT00791154|521780539|FG000|Overall Study|Noncompliance|0|||
144706902|NCT00791154|521780540|FG001|Overall Study|Noncompliance|1|||
144706903|NCT00791154|521780541|FG002|Overall Study|Noncompliance|0|||
144706904|NCT00791154|521780542|FG003|Overall Study|Noncompliance|0|||
144706905|NCT00791154|521780543|FG004|Overall Study|Noncompliance|1|||
144706906|NCT00791154|521780544|FG005|Overall Study|Noncompliance|1|||
144706907|NCT00791154|521780545|FG006|Overall Study|Noncompliance|1|||
144706908|NCT00791154|521780539|FG000|Overall Study|Adverse Event|0|||
144706909|NCT00791154|521780540|FG001|Overall Study|Adverse Event|0|||
144706910|NCT00791154|521780541|FG002|Overall Study|Adverse Event|0|||
144706911|NCT00791154|521780542|FG003|Overall Study|Adverse Event|0|||
144706912|NCT00791154|521780543|FG004|Overall Study|Adverse Event|2|||
144706913|NCT00791154|521780544|FG005|Overall Study|Adverse Event|0|||
144706914|NCT00791154|521780545|FG006|Overall Study|Adverse Event|1|||
144706915|NCT00791154|521780539|FG000|Overall Study|Full Consent withdrawn|1|||
144706916|NCT00791154|521780540|FG001|Overall Study|Full Consent withdrawn|3|||
144706917|NCT00791154|521780541|FG002|Overall Study|Full Consent withdrawn|0|||
144706918|NCT00791154|521780542|FG003|Overall Study|Full Consent withdrawn|0|||
144706919|NCT00791154|521780543|FG004|Overall Study|Full Consent withdrawn|1|||
144706920|NCT00791154|521780544|FG005|Overall Study|Full Consent withdrawn|3|||
144706921|NCT00791154|521780545|FG006|Overall Study|Full Consent withdrawn|1|||
144706922|NCT00791154|521780539|FG000|Overall Study|Lost to Follow-up|0|||
144706923|NCT00791154|521780540|FG001|Overall Study|Lost to Follow-up|0|||
144706924|NCT00791154|521780541|FG002|Overall Study|Lost to Follow-up|0|||
144706925|NCT00791154|521780542|FG003|Overall Study|Lost to Follow-up|1|||
144706926|NCT00791154|521780543|FG004|Overall Study|Lost to Follow-up|2|||
144706927|NCT00791154|521780544|FG005|Overall Study|Lost to Follow-up|0|||
144706928|NCT00791154|521780545|FG006|Overall Study|Lost to Follow-up|4|||
144706929|NCT00791154|521780539|FG000|Overall Study|Death|5|||
144706930|NCT00791154|521780540|FG001|Overall Study|Death|4|||
144706931|NCT00791154|521780541|FG002|Overall Study|Death|4|||
144706932|NCT00791154|521780542|FG003|Overall Study|Death|7|||
144706933|NCT00791154|521780543|FG004|Overall Study|Death|54|||
144706934|NCT00791154|521780544|FG005|Overall Study|Death|54|||
144706935|NCT00791154|521780545|FG006|Overall Study|Death|52|||
144706936|NCT00791154|521780539|FG000|Overall Study|Other event|0|||
144706937|NCT00791154|521780540|FG001|Overall Study|Other event|0|||
144706938|NCT00791154|521780541|FG002|Overall Study|Other event|2|||
144706939|NCT00791154|521780542|FG003|Overall Study|Other event|0|||
144706940|NCT00791154|521780543|FG004|Overall Study|Other event|2|||
144706941|NCT00791154|521780544|FG005|Overall Study|Other event|4|||
144706942|NCT00791154|521780545|FG006|Overall Study|Other event|2|||
144706943|NCT01652573|521780546|FG000|Overall Study|Adverse Event|0|||
144706944|NCT01652573|521780547|FG001|Overall Study|Adverse Event|1|||
144706945|NCT01052038|521780551|FG000|Overall Study|Lost to Follow-up|2|||
144706946|NCT01052038|521780552|FG001|Overall Study|Lost to Follow-up|3|||
144706947|NCT01052038|521780553|FG002|Overall Study|Lost to Follow-up|1|||
144706948|NCT01052038|521780551|FG000|Overall Study|Protocol Violation|2|||
144706949|NCT01052038|521780552|FG001|Overall Study|Protocol Violation|3|||
144706950|NCT01052038|521780553|FG002|Overall Study|Protocol Violation|3|||
144706951|NCT03976076|521780554|FG000|Overall Study|Withdrawal by Subject|2|||
144706952|NCT05723835|521780558|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
144706953|NCT05723835|521780559|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
144706954|NCT05723835|521780560|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
144706955|NCT05723835|521780561|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
144706956|NCT05723835|521780562|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
144706957|NCT05723835|521780563|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
144706958|NCT05723835|521780564|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
144706959|NCT05723835|521780565|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
144706960|NCT05226286|521780566|FG000|Overall Study|Screen failures prior to implant|62|||
144706961|NCT05226286|521780566|FG000|Overall Study|Withdrawal by Subject|13|||
144706962|NCT05226286|521780566|FG000|Overall Study|Lost to Follow-up|3|||
144706963|NCT05226286|521780566|FG000|Overall Study|Physician Decision|1|||
144706964|NCT05226286|521780566|FG000|Overall Study|Adverse Event|1|||
144706965|NCT05226286|521780566|FG000|Overall Study|Death|1|||
144706966|NCT05226286|521780566|FG000|Overall Study|Device explant with no planned replacement|1|||
144706967|NCT05226286|521780566|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
144706968|NCT05226286|521780566|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
144706969|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
144706970|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
144706971|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
144706972|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
144706973|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
144706974|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
144706975|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
144706976|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
144706977|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
144706978|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
144706979|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
144706980|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
144706981|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
144706982|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
144706983|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
144706984|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
144706985|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
144706986|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
144706987|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
144706988|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
144706989|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
144706990|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
144367511|NCT02113982|520557328|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
144367512|NCT02113982|520557329|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
144367513|NCT02113982|520557330|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
144367514|NCT02113982|520557331|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
144367515|NCT02113982|520557332|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
144367516|NCT02113982|520557333|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
144706991|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
144706992|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
144706993|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
144706994|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
144706995|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
144706996|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
144706997|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
144706998|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
144706999|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
144707000|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
144707001|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
144707002|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
144707003|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
144707004|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
144707005|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
144707006|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
144707007|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
144707008|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
144707009|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
144707010|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
144707011|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
144707012|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
144707013|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
144367517|NCT02113982|520557334|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
144367518|NCT02113982|520557335|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
144367519|NCT02113982|520557336|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
144367520|NCT02113982|520557337|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
144367521|NCT02113982|520557338|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
144367522|NCT02113982|520557339|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
144538203|NCT00146172|521174124|FG002|Overall Study|Disease Progression|2|||
144367523|NCT02113982|520557340|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
144367524|NCT02113982|520557327|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
144707014|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
144707015|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
144707016|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
144707017|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
144707018|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
144707019|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
144707020|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
144707021|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
144707022|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
144707023|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
144707024|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
144707025|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
144707026|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
144707027|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
144707028|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
144707029|NCT03395197|521780567|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
144707030|NCT03395197|521780568|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
144707031|NCT03395197|521780569|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
144707032|NCT03395197|521780570|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
144707033|NCT03395197|521780571|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
144707034|NCT03395197|521780572|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
144707035|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Death|0|||
144707036|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Death|0|||
144707037|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Death|0|||
144707038|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Death|0|||
144707039|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Death|1|||
144707040|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Death|4|||
144707041|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
144707042|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
144707043|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
144707044|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
144707045|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
144707046|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
144707047|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
144707048|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
144707049|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
144707050|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
144707051|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
144707052|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
144707053|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
144707054|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
144707055|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
144707056|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
144707057|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
144707058|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
144707059|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
144707060|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
144707061|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
144707062|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
144707063|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
144707064|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
144707065|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
144707066|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
144707067|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
144707068|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
144707069|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
144707070|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
144707071|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
144707072|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
144707073|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
144707074|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
144707075|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
144707076|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
144707077|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Other|0|||
144707078|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Other|0|||
144707079|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Other|0|||
144707080|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Other|0|||
144707081|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Other|3|||
144707082|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Other|3|||
144707083|NCT03395197|521780567|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
144707084|NCT03395197|521780568|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
144707085|NCT03395197|521780569|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
144707086|NCT03395197|521780570|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
144707087|NCT03395197|521780571|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
144707088|NCT03395197|521780572|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
144707089|NCT00602641|521780573|FG000|Overall Study|Never started protocol therapy|6|||
144707090|NCT00602641|521780574|FG001|Overall Study|Never started protocol therapy|2|||
144707091|NCT00602641|521780573|FG000|Overall Study|Still on treatment at time of analysis|8|||
144707092|NCT00602641|521780574|FG001|Overall Study|Still on treatment at time of analysis|15|||
144707093|NCT00602641|521780573|FG000|Overall Study|Adverse Event|62|||
144707094|NCT00602641|521780574|FG001|Overall Study|Adverse Event|53|||
144707095|NCT00602641|521780573|FG000|Overall Study|Disease progression|38|||
144707096|NCT00602641|521780574|FG001|Overall Study|Disease progression|55|||
144707097|NCT00602641|521780573|FG000|Overall Study|Death|6|||
144707098|NCT00602641|521780574|FG001|Overall Study|Death|5|||
144707099|NCT00602641|521780573|FG000|Overall Study|Withdrawal by Subject|15|||
144707100|NCT00602641|521780574|FG001|Overall Study|Withdrawal by Subject|12|||
144707101|NCT00602641|521780573|FG000|Overall Study|Alternative therapy|5|||
144707102|NCT00602641|521780574|FG001|Overall Study|Alternative therapy|2|||
144707103|NCT00602641|521780573|FG000|Overall Study|Other Complicating Disease|5|||
144707104|NCT00602641|521780574|FG001|Overall Study|Other Complicating Disease|2|||
144707105|NCT00602641|521780573|FG000|Overall Study|Physician Decision|5|||
144707106|NCT00602641|521780574|FG001|Overall Study|Physician Decision|4|||
144707107|NCT00602641|521780573|FG000|Overall Study|Administrative Closure|1|||
144707108|NCT00602641|521780574|FG001|Overall Study|Administrative Closure|1|||
144707109|NCT00602641|521780573|FG000|Overall Study|Other|3|||
144707110|NCT00602641|521780574|FG001|Overall Study|Other|1|||
144707111|NCT03901352|521780576|FG000|Double-blind Phase|Adverse Event|6|||
144707112|NCT03901352|521780577|FG001|Double-blind Phase|Adverse Event|4|||
144707113|NCT03901352|521780576|FG000|Double-blind Phase|Death|1|||
144707114|NCT03901352|521780577|FG001|Double-blind Phase|Death|0|||
144707115|NCT03901352|521780576|FG000|Double-blind Phase|Lack of Efficacy|0|||
144707116|NCT03901352|521780577|FG001|Double-blind Phase|Lack of Efficacy|1|||
144707117|NCT03901352|521780576|FG000|Double-blind Phase|Protocol Violation|0|||
144707118|NCT03901352|521780577|FG001|Double-blind Phase|Protocol Violation|1|||
144707119|NCT03901352|521780576|FG000|Double-blind Phase|Withdrawal by Subject|10|||
144707120|NCT03901352|521780577|FG001|Double-blind Phase|Withdrawal by Subject|8|||
144707121|NCT03901352|521780576|FG000|Open-label Extension Phase|Adverse Event|24|||
144707122|NCT03901352|521780577|FG001|Open-label Extension Phase|Adverse Event|0|||
144707123|NCT03901352|521780576|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
144707124|NCT03901352|521780577|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
144707125|NCT03901352|521780576|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
144707126|NCT03901352|521780577|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
144707127|NCT03901352|521780576|FG000|Open-label Extension Phase|Other|1|||
144707128|NCT03901352|521780577|FG001|Open-label Extension Phase|Other|0|||
144707129|NCT01826201|521780580|FG000|Overall Study|Non compliance with protocol|4|||
144707130|NCT01615822|521780581|FG000|Period 1|Withdrawal by Subject|0|||
144707131|NCT01615822|521780582|FG001|Period 1|Withdrawal by Subject|1|||
144707132|NCT01615822|521780583|FG002|Period 1|Withdrawal by Subject|0|||
144707133|NCT01615822|521780581|FG000|Period 1|Adverse Event|1|||
144707134|NCT01615822|521780582|FG001|Period 1|Adverse Event|1|||
144707135|NCT01615822|521780583|FG002|Period 1|Adverse Event|0|||
144707136|NCT01615822|521780581|FG000|Period 2|Lost to Follow-up|0|||
144707137|NCT01615822|521780582|FG001|Period 2|Lost to Follow-up|1|||
144707138|NCT01615822|521780583|FG002|Period 2|Lost to Follow-up|2|||
144707139|NCT03981614|521780584|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
144538204|NCT00146172|521174125|FG003|Overall Study|Disease Progression|5|||
144707140|NCT03981614|521780585|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
144707141|NCT03981614|521780586|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
144707142|NCT03901339|521780587|FG000|Overall Study|Death|220|||
144707143|NCT03901339|521780588|FG001|Overall Study|Death|192|||
144707144|NCT03901339|521780587|FG000|Overall Study|Informed consent withdrawn|13|||
144707145|NCT03901339|521780588|FG001|Overall Study|Informed consent withdrawn|40|||
144707146|NCT03901339|521780587|FG000|Overall Study|Sponsor request|30|||
144707147|NCT03901339|521780588|FG001|Overall Study|Sponsor request|23|||
144707148|NCT03901339|521780587|FG000|Overall Study|Reason not specified|5|||
144707149|NCT03901339|521780588|FG001|Overall Study|Reason not specified|7|||
144707150|NCT03901339|521780587|FG000|Overall Study|Lost to Follow-up|4|||
144707151|NCT03901339|521780588|FG001|Overall Study|Lost to Follow-up|7|||
144707152|NCT03901339|521780587|FG000|Overall Study|Covid19|0|||
144707153|NCT03901339|521780588|FG001|Overall Study|Covid19|2|||
144707154|NCT04701658|521780589|FG000|Overall Study|Lost to Follow-up|6|||
144707155|NCT01346501|521780591|FG000|Overall Study|Initiated Other Biological Agents|3|||
144707156|NCT01346501|521780592|FG001|Overall Study|Initiated Other Biological Agents|1|||
144707157|NCT01346501|521780591|FG000|Overall Study|Other|8|||
144707158|NCT01346501|521780592|FG001|Overall Study|Other|12|||
144707159|NCT05511428|521780593|FG000|Overall Study|Withdrawal by Subject|1|||
144707160|NCT05511428|521780593|FG000|Overall Study|Adverse Event|1|||
144707161|NCT04971226|521780596|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
144707162|NCT04971226|521780597|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
144707163|NCT04971226|521780598|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
144707164|NCT04971226|521780599|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
144707165|NCT04971226|521780596|FG000|Overall Study|Adverse Event|6|||
144707166|NCT04971226|521780597|FG001|Overall Study|Adverse Event|5|||
144707167|NCT04971226|521780598|FG002|Overall Study|Adverse Event|11|||
144707168|NCT04971226|521780599|FG003|Overall Study|Adverse Event|10|||
144707169|NCT04971226|521780596|FG000|Overall Study|Progressive disease|2|||
144707170|NCT04971226|521780597|FG001|Overall Study|Progressive disease|0|||
144707171|NCT04971226|521780598|FG002|Overall Study|Progressive disease|3|||
144707172|NCT04971226|521780599|FG003|Overall Study|Progressive disease|1|||
144707173|NCT04971226|521780596|FG000|Overall Study|Protocol Deviation|1|||
144707174|NCT04971226|521780597|FG001|Overall Study|Protocol Deviation|0|||
144707175|NCT04971226|521780598|FG002|Overall Study|Protocol Deviation|1|||
144707176|NCT04971226|521780599|FG003|Overall Study|Protocol Deviation|1|||
144707177|NCT04971226|521780596|FG000|Overall Study|Subject Decision|0|||
144707178|NCT04971226|521780597|FG001|Overall Study|Subject Decision|1|||
144707179|NCT04971226|521780598|FG002|Overall Study|Subject Decision|1|||
144707180|NCT04971226|521780599|FG003|Overall Study|Subject Decision|1|||
144707181|NCT04971226|521780596|FG000|Overall Study|Pregnancy|0|||
144707182|NCT04971226|521780597|FG001|Overall Study|Pregnancy|0|||
144707183|NCT04971226|521780598|FG002|Overall Study|Pregnancy|0|||
144707184|NCT04971226|521780599|FG003|Overall Study|Pregnancy|1|||
144707185|NCT04971226|521780596|FG000|Overall Study|Participants not treated|1|||
144707186|NCT04971226|521780597|FG001|Overall Study|Participants not treated|0|||
144707187|NCT04971226|521780598|FG002|Overall Study|Participants not treated|2|||
144707188|NCT04971226|521780599|FG003|Overall Study|Participants not treated|1|||
144707189|NCT04439149|521780600|FG000|Overall Study|Ineligible|1|||
144707190|NCT04439149|521780600|FG000|Overall Study|Never start protocol therapy|1|||
144707191|NCT04439149|521780600|FG000|Overall Study|Adverse Event|4|||
144707192|NCT04439149|521780600|FG000|Overall Study|Disease Progression|14|||
144707193|NCT04439149|521780600|FG000|Overall Study|Complicating disease|1|||
144707194|NCT04439149|521780600|FG000|Overall Study|Withdrawal by Subject|3|||
144707195|NCT05264506|521780601|FG000|Overall Study|Adverse Event|59|||
144707196|NCT05264506|521780601|FG000|Overall Study|Lost to Follow-up|204|||
144707197|NCT05264506|521780601|FG000|Overall Study|Protocol Violation|185|||
144707198|NCT05264506|521780601|FG000|Overall Study|Pregnancy|60|||
144707199|NCT05264506|521780601|FG000|Overall Study|Physician Decision|6|||
144707200|NCT05264506|521780601|FG000|Overall Study|Non-compliance with Study Drug|29|||
144707201|NCT05264506|521780601|FG000|Overall Study|Study termination|677|||
144707202|NCT05264506|521780601|FG000|Overall Study|Withdrawal by Subject|208|||
144707203|NCT05264506|521780601|FG000|Overall Study|Discontinued prior treatment|89|||
144707204|NCT05919823|521780609|FG000|Pre-Treatment Period|Screen failure|1|||
144707205|NCT05919823|521780610|FG001|Pre-Treatment Period|Screen failure|0|||
144707206|NCT05919823|521780611|FG002|Pre-Treatment Period|Screen failure|0|||
144707207|NCT05919823|521780612|FG003|Pre-Treatment Period|Screen failure|0|||
144707208|NCT05919823|521780609|FG000|Pre-Treatment Period|Protocol Violation|0|||
144707209|NCT05919823|521780610|FG001|Pre-Treatment Period|Protocol Violation|1|||
144707210|NCT05919823|521780611|FG002|Pre-Treatment Period|Protocol Violation|0|||
144707211|NCT05919823|521780612|FG003|Pre-Treatment Period|Protocol Violation|0|||
144707212|NCT05919823|521780609|FG000|Double-Blind Period|Adverse Event|8|||
144707213|NCT05919823|521780610|FG001|Double-Blind Period|Adverse Event|9|||
144707214|NCT05919823|521780611|FG002|Double-Blind Period|Adverse Event|0|||
144707215|NCT05919823|521780612|FG003|Double-Blind Period|Adverse Event|0|||
144707216|NCT05919823|521780609|FG000|Double-Blind Period|Protocol Violation|2|||
144707217|NCT05919823|521780610|FG001|Double-Blind Period|Protocol Violation|1|||
144707218|NCT05919823|521780611|FG002|Double-Blind Period|Protocol Violation|0|||
144707219|NCT05919823|521780612|FG003|Double-Blind Period|Protocol Violation|0|||
144707220|NCT05919823|521780609|FG000|Double-Blind Period|Participant withdrew consent|11|||
144707221|NCT05919823|521780610|FG001|Double-Blind Period|Participant withdrew consent|7|||
144707222|NCT05919823|521780611|FG002|Double-Blind Period|Participant withdrew consent|0|||
144707223|NCT05919823|521780612|FG003|Double-Blind Period|Participant withdrew consent|0|||
144707224|NCT05919823|521780609|FG000|Double-Blind Period|Other reasons|2|||
144707225|NCT05919823|521780610|FG001|Double-Blind Period|Other reasons|3|||
144707226|NCT05919823|521780611|FG002|Double-Blind Period|Other reasons|0|||
144707227|NCT05919823|521780612|FG003|Double-Blind Period|Other reasons|0|||
144707228|NCT05919823|521780609|FG000|Open Label Period|Adverse Event|0|||
144707229|NCT05919823|521780610|FG001|Open Label Period|Adverse Event|0|||
144707230|NCT05919823|521780611|FG002|Open Label Period|Adverse Event|2|||
144707231|NCT05919823|521780612|FG003|Open Label Period|Adverse Event|4|||
144707232|NCT05919823|521780609|FG000|Open Label Period|Lost to Follow-up|0|||
144707233|NCT05919823|521780610|FG001|Open Label Period|Lost to Follow-up|0|||
144707234|NCT05919823|521780611|FG002|Open Label Period|Lost to Follow-up|1|||
144707235|NCT05919823|521780612|FG003|Open Label Period|Lost to Follow-up|0|||
144707236|NCT05919823|521780609|FG000|Open Label Period|Protocol Violation|0|||
144707237|NCT05919823|521780610|FG001|Open Label Period|Protocol Violation|0|||
144707238|NCT05919823|521780611|FG002|Open Label Period|Protocol Violation|0|||
144707239|NCT05919823|521780612|FG003|Open Label Period|Protocol Violation|1|||
144707240|NCT05919823|521780609|FG000|Open Label Period|Participant withdrew consent|0|||
144707241|NCT05919823|521780610|FG001|Open Label Period|Participant withdrew consent|0|||
144707242|NCT05919823|521780611|FG002|Open Label Period|Participant withdrew consent|8|||
144707243|NCT05919823|521780612|FG003|Open Label Period|Participant withdrew consent|6|||
144707244|NCT05919823|521780609|FG000|Open Label Period|Death|0|||
144707245|NCT05919823|521780610|FG001|Open Label Period|Death|0|||
144707246|NCT05919823|521780611|FG002|Open Label Period|Death|0|||
144707247|NCT05919823|521780612|FG003|Open Label Period|Death|1|||
144707248|NCT05919823|521780609|FG000|Open Label Period|Other reasons|0|||
144707249|NCT05919823|521780610|FG001|Open Label Period|Other reasons|0|||
144707250|NCT05919823|521780611|FG002|Open Label Period|Other reasons|9|||
144707251|NCT05919823|521780612|FG003|Open Label Period|Other reasons|5|||
144707252|NCT06065176|521780613|FG000|Overall Study|Lost to Follow-up|11|||
144707253|NCT06065176|521780614|FG001|Overall Study|Lost to Follow-up|11|||
144707254|NCT06065176|521780615|FG002|Overall Study|Lost to Follow-up|10|||
144707255|NCT06065176|521780613|FG000|Overall Study|Withdrawal by Subject|1|||
144707256|NCT06065176|521780614|FG001|Overall Study|Withdrawal by Subject|1|||
144707257|NCT06065176|521780615|FG002|Overall Study|Withdrawal by Subject|2|||
144707258|NCT06065176|521780613|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
144707259|NCT06065176|521780614|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
144707260|NCT06065176|521780615|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
144707261|NCT04521608|521780616|FG000|Overall Study|Death|8|||
144707262|NCT04521608|521780617|FG001|Overall Study|Death|9|||
144707263|NCT04521608|521780616|FG000|Overall Study|Withdrawal by Subject|25|||
144707264|NCT04521608|521780617|FG001|Overall Study|Withdrawal by Subject|18|||
144707265|NCT04521608|521780616|FG000|Overall Study|Disease Progression|3|||
144707266|NCT04521608|521780617|FG001|Overall Study|Disease Progression|10|||
144707267|NCT04521608|521780616|FG000|Overall Study|Complicating Disease|6|||
144707268|NCT04521608|521780617|FG001|Overall Study|Complicating Disease|3|||
144707269|NCT04521608|521780616|FG000|Overall Study|Lost Contact|25|||
144707270|NCT04521608|521780617|FG001|Overall Study|Lost Contact|27|||
144707271|NCT04521608|521780616|FG000|Overall Study|Ineligible|1|||
144707272|NCT04521608|521780617|FG001|Overall Study|Ineligible|0|||
144707273|NCT04521608|521780616|FG000|Overall Study|Refused Further Study Participation|13|||
144707274|NCT04521608|521780617|FG001|Overall Study|Refused Further Study Participation|7|||
144707275|NCT02588651|521780618|FG000|Overall Study|Adverse Event|1|||
144707276|NCT02588651|521780618|FG000|Overall Study|Withdrawal by Subject|2|||
144707277|NCT02588651|521780618|FG000|Overall Study|Death|1|||
144707278|NCT02588651|521780618|FG000|Overall Study|Lack of Efficacy|13|||
144707279|NCT02588651|521780618|FG000|Overall Study|Lost to Follow-up|1|||
144707280|NCT02588651|521780618|FG000|Overall Study|Physician Decision|1|||
144707281|NCT02588651|521780618|FG000|Overall Study|Disease progression|2|||
144707282|NCT00285012|521780619|FG000|Assigned to Study Treatment (Tx)|Other|2|||
144707283|NCT00285012|521780620|FG001|Assigned to Study Treatment (Tx)|Other|3|||
144707284|NCT00285012|521780619|FG000|Received Study Tx|Death|2|||
144707285|NCT00285012|521780620|FG001|Received Study Tx|Death|1|||
144707286|NCT00285012|521780619|FG000|Received Study Tx|Adverse Event|5|||
144707287|NCT00285012|521780620|FG001|Received Study Tx|Adverse Event|11|||
144707288|NCT00285012|521780619|FG000|Received Study Tx|Lack of Efficacy|0|||
144707289|NCT00285012|521780620|FG001|Received Study Tx|Lack of Efficacy|3|||
144707290|NCT00285012|521780619|FG000|Received Study Tx|Lost to Follow-up|29|||
144707291|NCT00285012|521780620|FG001|Received Study Tx|Lost to Follow-up|31|||
144707292|NCT00285012|521780619|FG000|Received Study Tx|Withdrawal by Subject|31|||
144707293|NCT00285012|521780620|FG001|Received Study Tx|Withdrawal by Subject|43|||
144707294|NCT00285012|521780619|FG000|Received Study Tx|Other|5|||
144707295|NCT00285012|521780620|FG001|Received Study Tx|Other|5|||
144707296|NCT04256759|521781508|FG000|Overall Study|Physician Decision|1|||
144707297|NCT04256759|521781508|FG000|Overall Study|Lack of Efficacy|1|||
144707298|NCT04075292|521781515|FG000|Overall Study|Withdrawal by Subject|1|||
144707299|NCT04075292|521781516|FG001|Overall Study|Withdrawal by Subject|9|||
144707300|NCT04075292|521781515|FG000|Overall Study|Death|2|||
144707301|NCT04075292|521781516|FG001|Overall Study|Death|5|||
144707302|NCT04075292|521781515|FG000|Overall Study|Remained on study at time of DCO|74|||
144707303|NCT04075292|521781516|FG001|Overall Study|Remained on study at time of DCO|64|||
144707304|NCT03829462|521781518|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
144707305|NCT03829462|521781519|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
144707306|NCT03829462|521781518|FG000|Overall Study|No treatment due to progression disease|0|||
144707307|NCT03829462|521781519|FG001|Overall Study|No treatment due to progression disease|1|||
144707308|NCT00569127|521781526|FG000|Overall Study|Adverse Event|57|||
144707309|NCT00569127|521781527|FG001|Overall Study|Adverse Event|47|||
144707310|NCT00569127|521781526|FG000|Overall Study|Withdrawal by Subject|13|||
144707311|NCT00569127|521781527|FG001|Overall Study|Withdrawal by Subject|27|||
144707312|NCT00569127|521781526|FG000|Overall Study|Progression|99|||
144707313|NCT00569127|521781527|FG001|Overall Study|Progression|100|||
144707314|NCT00569127|521781526|FG000|Overall Study|Death|4|||
144707315|NCT00569127|521781527|FG001|Overall Study|Death|3|||
144707316|NCT00569127|521781526|FG000|Overall Study|Other|20|||
144707317|NCT00569127|521781527|FG001|Overall Study|Other|19|||
144707318|NCT00569127|521781526|FG000|Overall Study|Lost to Follow-up|0|||
144707319|NCT00569127|521781527|FG001|Overall Study|Lost to Follow-up|3|||
144707320|NCT00569127|521781526|FG000|Overall Study|Not Eligible|14|||
144707321|NCT00569127|521781527|FG001|Overall Study|Not Eligible|11|||
144707322|NCT00569127|521781526|FG000|Overall Study|Still on Treatment|7|||
144707323|NCT00569127|521781527|FG001|Overall Study|Still on Treatment|3|||
144707324|NCT04083378|521781530|FG000|Overall Study|Death|18|||
144707325|NCT04083378|521781531|FG001|Overall Study|Death|4|||
144707326|NCT04083378|521781530|FG000|Overall Study|Lost to Follow-up|4|||
144707327|NCT04083378|521781531|FG001|Overall Study|Lost to Follow-up|0|||
144707328|NCT04803214|521781532|FG000|Overall Study|Adverse Event|1|||
144707329|NCT04803214|521781533|FG001|Overall Study|Adverse Event|0|||
144707330|NCT04803214|521781532|FG000|Overall Study|Withdrawal by Subject|1|||
144707331|NCT04803214|521781533|FG001|Overall Study|Withdrawal by Subject|2|||
144707332|NCT04803214|521781532|FG000|Overall Study|Lost to Follow-up|2|||
144707333|NCT04803214|521781533|FG001|Overall Study|Lost to Follow-up|4|||
144707334|NCT04803214|521781532|FG000|Overall Study|Physician Decision|1|||
144707335|NCT04803214|521781533|FG001|Overall Study|Physician Decision|1|||
144707336|NCT04803214|521781532|FG000|Overall Study|Missed 12 month visit|0|||
144707337|NCT04803214|521781533|FG001|Overall Study|Missed 12 month visit|3|||
144707338|NCT00644228|521781534|FG000|Randomization & Eligibility|Ineligible|31|||
144707339|NCT00644228|521781535|FG001|Randomization & Eligibility|Ineligible|21|||
144707340|NCT00644228|521781534|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
144707341|NCT00644228|521781535|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
144707342|NCT00644228|521781534|FG000|Randomization & Eligibility|Invalid Consent|0|||
144707343|NCT00644228|521781535|FG001|Randomization & Eligibility|Invalid Consent|1|||
144707344|NCT00644228|521781534|FG000|Induction Therapy|Adverse Event|22|||
144707345|NCT00644228|521781535|FG001|Induction Therapy|Adverse Event|55|||
144707346|NCT00644228|521781534|FG000|Induction Therapy|Withdrawal by Subject|10|||
144707347|NCT00644228|521781535|FG001|Induction Therapy|Withdrawal by Subject|3|||
144707348|NCT00644228|521781534|FG000|Induction Therapy|Progression/Relapse|24|||
144707349|NCT00644228|521781535|FG001|Induction Therapy|Progression/Relapse|12|||
144707350|NCT00644228|521781534|FG000|Induction Therapy|Death|3|||
144707351|NCT00644228|521781535|FG001|Induction Therapy|Death|7|||
144707352|NCT00644228|521781534|FG000|Induction Therapy|Not Protocol-Specified|24|||
144707353|NCT00644228|521781535|FG001|Induction Therapy|Not Protocol-Specified|28|||
144707354|NCT00644228|521781534|FG000|Maintenance|Adverse Event|27|||
144707355|NCT00644228|521781535|FG001|Maintenance|Adverse Event|31|||
144707356|NCT00644228|521781534|FG000|Maintenance|Withdrawal by Subject|6|||
144707357|NCT00644228|521781535|FG001|Maintenance|Withdrawal by Subject|4|||
144707358|NCT00644228|521781534|FG000|Maintenance|Progression/Relapse|67|||
144707359|NCT00644228|521781535|FG001|Maintenance|Progression/Relapse|42|||
144707360|NCT00644228|521781534|FG000|Maintenance|Death|3|||
144707361|NCT00644228|521781535|FG001|Maintenance|Death|3|||
144707362|NCT00644228|521781534|FG000|Maintenance|Not Protocol-Specified|14|||
144707363|NCT00644228|521781535|FG001|Maintenance|Not Protocol-Specified|15|||
144707364|NCT00644228|521781534|FG000|Maintenance|On Treatment|26|||
144707365|NCT00644228|521781535|FG001|Maintenance|On Treatment|40|||
144707366|NCT06078124|521781536|FG000|Overall Study|Lost to Follow-up|14|||
144707367|NCT06078124|521781537|FG001|Overall Study|Lost to Follow-up|14|||
144707368|NCT05824273|521781538|FG000|Overall Study|Lost to Follow-up|16|||
144707369|NCT05824273|521781539|FG001|Overall Study|Lost to Follow-up|13|||
144707370|NCT02736695|521781540|FG000|Overall Study|Ineligible|6|||
144707371|NCT02736695|521781541|FG001|Overall Study|Ineligible|0|||
144707372|NCT04050293|521781543|FG000|Overall Study|Lost to Follow-up|1|||
144707373|NCT04050293|521781544|FG001|Overall Study|Lost to Follow-up|2|||
144707374|NCT04050293|521781543|FG000|Overall Study|Withdrawal by Subject|2|||
144707375|NCT04050293|521781544|FG001|Overall Study|Withdrawal by Subject|0|||
144707376|NCT05631093|521781547|FG000|Overall Study|Death|0|||
144707377|NCT05631093|521781548|FG001|Overall Study|Death|1|||
144707378|NCT05631093|521781547|FG000|Overall Study|Lost to Follow-up|1|||
144707379|NCT05631093|521781548|FG001|Overall Study|Lost to Follow-up|2|||
144707380|NCT05631093|521781547|FG000|Overall Study|Physician Decision|1|||
144367525|NCT02113982|520557328|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
144707381|NCT05631093|521781548|FG001|Overall Study|Physician Decision|0|||
144707382|NCT05631093|521781547|FG000|Overall Study|Withdrawal by Subject|4|||
144707383|NCT05631093|521781548|FG001|Overall Study|Withdrawal by Subject|1|||
144707384|NCT05631093|521781547|FG000|Overall Study|Ongoing|353|||
144367526|NCT02113982|520557329|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
144367527|NCT02113982|520557330|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
144367528|NCT02113982|520557331|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
144367529|NCT02113982|520557332|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
144367530|NCT02113982|520557333|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
144367531|NCT02113982|520557334|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
144367532|NCT02113982|520557335|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
144367533|NCT02113982|520557336|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
144367534|NCT02113982|520557337|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
144367535|NCT02113982|520557338|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
144707385|NCT05631093|521781548|FG001|Overall Study|Ongoing|177|||
144367536|NCT02113982|520557339|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
144367537|NCT02113982|520557340|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
144367538|NCT02113982|520557327|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367539|NCT02113982|520557328|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367540|NCT02113982|520557329|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367541|NCT02113982|520557330|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367542|NCT02113982|520557331|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367543|NCT02113982|520557332|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367544|NCT02113982|520557333|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
144367545|NCT02113982|520557334|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367546|NCT02113982|520557335|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367547|NCT02113982|520557336|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367548|NCT02113982|520557337|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367549|NCT02113982|520557338|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367550|NCT02113982|520557339|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367551|NCT02113982|520557340|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
144367552|NCT02113982|520557327|FG000|Stage 1: Dose Escalation|Transplant|0|||
144367553|NCT02113982|520557328|FG001|Stage 1: Dose Escalation|Transplant|1|||
144367554|NCT02113982|520557329|FG002|Stage 1: Dose Escalation|Transplant|0|||
144367555|NCT02113982|520557330|FG003|Stage 1: Dose Escalation|Transplant|0|||
144367556|NCT02113982|520557331|FG004|Stage 1: Dose Escalation|Transplant|0|||
144367557|NCT02113982|520557332|FG005|Stage 1: Dose Escalation|Transplant|1|||
144367558|NCT02113982|520557333|FG006|Stage 1: Dose Escalation|Transplant|0|||
144367559|NCT02113982|520557334|FG007|Stage 1: Dose Escalation|Transplant|0|||
144367560|NCT02113982|520557335|FG008|Stage 1: Dose Escalation|Transplant|0|||
144367561|NCT02113982|520557336|FG009|Stage 1: Dose Escalation|Transplant|0|||
144367562|NCT02113982|520557337|FG010|Stage 1: Dose Escalation|Transplant|0|||
144367563|NCT02113982|520557338|FG011|Stage 1: Dose Escalation|Transplant|0|||
144367564|NCT02113982|520557339|FG012|Stage 1: Dose Escalation|Transplant|0|||
144367565|NCT02113982|520557340|FG013|Stage 1: Dose Escalation|Transplant|0|||
144367566|NCT02113982|520557327|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
144367567|NCT02113982|520557328|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
144367568|NCT02113982|520557329|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
144367569|NCT02113982|520557330|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
144367570|NCT02113982|520557331|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
144367571|NCT02113982|520557332|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
144367572|NCT02113982|520557333|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
144367573|NCT02113982|520557334|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
144367574|NCT02113982|520557335|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
144367575|NCT02113982|520557336|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
144367576|NCT02113982|520557337|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
144367577|NCT02113982|520557338|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
144367578|NCT02113982|520557339|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
144367579|NCT02113982|520557340|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
144367580|NCT02113982|520557327|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
144707386|NCT05631093|521781547|FG000|Overall Study|Adverse Event|0|||
144707387|NCT05631093|521781548|FG001|Overall Study|Adverse Event|1|||
144707388|NCT04223193|521781549|FG000|Overall Study|Adverse Event|6|||
144707389|NCT04223193|521781550|FG001|Overall Study|Adverse Event|36|||
144707390|NCT04223193|521781549|FG000|Overall Study|Lack of Efficacy|2|||
144707391|NCT04223193|521781550|FG001|Overall Study|Lack of Efficacy|2|||
144707392|NCT04223193|521781549|FG000|Overall Study|Lost to Follow-up|1|||
144707393|NCT04223193|521781550|FG001|Overall Study|Lost to Follow-up|1|||
144707394|NCT04223193|521781549|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
144707395|NCT04223193|521781550|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
144707396|NCT04223193|521781549|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
144367581|NCT02113982|520557328|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
144367582|NCT02113982|520557329|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
144367583|NCT02113982|520557330|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
144367584|NCT02113982|520557331|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
144707397|NCT04223193|521781550|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
144707398|NCT04223193|521781549|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144707399|NCT04223193|521781550|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144707400|NCT04223193|521781549|FG000|Overall Study|Physician Decision|0|||
144707401|NCT04223193|521781550|FG001|Overall Study|Physician Decision|1|||
144707402|NCT04223193|521781549|FG000|Overall Study|Protocol Violation|1|||
144707403|NCT04223193|521781550|FG001|Overall Study|Protocol Violation|1|||
144707404|NCT04223193|521781549|FG000|Overall Study|Site Terminated by Sponsor|1|||
144707405|NCT04223193|521781550|FG001|Overall Study|Site Terminated by Sponsor|3|||
144707406|NCT04223193|521781549|FG000|Overall Study|Withdrawal by Subject|5|||
144707407|NCT04223193|521781550|FG001|Overall Study|Withdrawal by Subject|6|||
144707408|NCT04223193|521781549|FG000|Overall Study|Other|3|||
144707409|NCT04223193|521781550|FG001|Overall Study|Other|6|||
144707410|NCT03193190|521781553|FG000|Stage 1|Arm Terminated by Sponsor|0|||
144707411|NCT03193190|521781554|FG001|Stage 1|Arm Terminated by Sponsor|0|||
144707412|NCT03193190|521781555|FG002|Stage 1|Arm Terminated by Sponsor|0|||
144707413|NCT03193190|521781556|FG003|Stage 1|Arm Terminated by Sponsor|1|||
144707414|NCT03193190|521781557|FG004|Stage 1|Arm Terminated by Sponsor|0|||
144707415|NCT03193190|521781558|FG005|Stage 1|Arm Terminated by Sponsor|2|||
144707416|NCT03193190|521781559|FG006|Stage 1|Arm Terminated by Sponsor|0|||
144707417|NCT03193190|521781560|FG007|Stage 1|Arm Terminated by Sponsor|0|||
144707418|NCT03193190|521781561|FG008|Stage 1|Arm Terminated by Sponsor|0|||
144707419|NCT03193190|521781562|FG009|Stage 1|Arm Terminated by Sponsor|0|||
144707420|NCT03193190|521781563|FG010|Stage 1|Arm Terminated by Sponsor|0|||
144707421|NCT03193190|521781564|FG011|Stage 1|Arm Terminated by Sponsor|0|||
144707422|NCT03193190|521781565|FG012|Stage 1|Arm Terminated by Sponsor|0|||
144707423|NCT03193190|521781566|FG013|Stage 1|Arm Terminated by Sponsor|0|||
144707424|NCT03193190|521781567|FG014|Stage 1|Arm Terminated by Sponsor|0|||
144707425|NCT03193190|521781568|FG015|Stage 1|Arm Terminated by Sponsor|0|||
144707426|NCT03193190|521781553|FG000|Stage 1|Death|22|||
144707427|NCT03193190|521781554|FG001|Stage 1|Death|8|||
144707428|NCT03193190|521781555|FG002|Stage 1|Death|23|||
144707429|NCT03193190|521781556|FG003|Stage 1|Death|14|||
144707430|NCT03193190|521781557|FG004|Stage 1|Death|34|||
144707431|NCT03193190|521781558|FG005|Stage 1|Death|28|||
144707432|NCT03193190|521781559|FG006|Stage 1|Death|19|||
144707433|NCT03193190|521781560|FG007|Stage 1|Death|21|||
144707434|NCT03193190|521781561|FG008|Stage 1|Death|14|||
144707435|NCT03193190|521781562|FG009|Stage 1|Death|10|||
144707436|NCT03193190|521781563|FG010|Stage 1|Death|59|||
144707437|NCT03193190|521781564|FG011|Stage 1|Death|14|||
144707438|NCT03193190|521781565|FG012|Stage 1|Death|14|||
144707439|NCT03193190|521781566|FG013|Stage 1|Death|0|||
144707440|NCT03193190|521781567|FG014|Stage 1|Death|0|||
144707441|NCT03193190|521781568|FG015|Stage 1|Death|0|||
144707442|NCT03193190|521781553|FG000|Stage 1|Lost to Follow-up|2|||
144707443|NCT03193190|521781554|FG001|Stage 1|Lost to Follow-up|1|||
144707444|NCT03193190|521781555|FG002|Stage 1|Lost to Follow-up|1|||
144707445|NCT03193190|521781556|FG003|Stage 1|Lost to Follow-up|0|||
144707446|NCT03193190|521781557|FG004|Stage 1|Lost to Follow-up|0|||
144707447|NCT03193190|521781558|FG005|Stage 1|Lost to Follow-up|0|||
144707448|NCT03193190|521781559|FG006|Stage 1|Lost to Follow-up|1|||
144707449|NCT03193190|521781560|FG007|Stage 1|Lost to Follow-up|0|||
144707450|NCT03193190|521781561|FG008|Stage 1|Lost to Follow-up|0|||
144707451|NCT03193190|521781562|FG009|Stage 1|Lost to Follow-up|0|||
144707452|NCT03193190|521781563|FG010|Stage 1|Lost to Follow-up|0|||
144707453|NCT03193190|521781564|FG011|Stage 1|Lost to Follow-up|0|||
144707454|NCT03193190|521781565|FG012|Stage 1|Lost to Follow-up|0|||
144707455|NCT03193190|521781566|FG013|Stage 1|Lost to Follow-up|0|||
144707456|NCT03193190|521781567|FG014|Stage 1|Lost to Follow-up|0|||
144707457|NCT03193190|521781568|FG015|Stage 1|Lost to Follow-up|0|||
144707458|NCT03193190|521781553|FG000|Stage 1|Reason not Specified|1|||
144707459|NCT03193190|521781554|FG001|Stage 1|Reason not Specified|0|||
144707460|NCT03193190|521781555|FG002|Stage 1|Reason not Specified|0|||
144707461|NCT03193190|521781556|FG003|Stage 1|Reason not Specified|1|||
144707462|NCT03193190|521781557|FG004|Stage 1|Reason not Specified|0|||
144707463|NCT03193190|521781558|FG005|Stage 1|Reason not Specified|1|||
144707464|NCT03193190|521781559|FG006|Stage 1|Reason not Specified|2|||
144707465|NCT03193190|521781560|FG007|Stage 1|Reason not Specified|2|||
144707466|NCT03193190|521781561|FG008|Stage 1|Reason not Specified|0|||
144707467|NCT03193190|521781562|FG009|Stage 1|Reason not Specified|1|||
144707468|NCT03193190|521781563|FG010|Stage 1|Reason not Specified|3|||
144707469|NCT03193190|521781564|FG011|Stage 1|Reason not Specified|0|||
144707470|NCT03193190|521781565|FG012|Stage 1|Reason not Specified|1|||
144707471|NCT03193190|521781566|FG013|Stage 1|Reason not Specified|0|||
144707472|NCT03193190|521781567|FG014|Stage 1|Reason not Specified|0|||
144707473|NCT03193190|521781568|FG015|Stage 1|Reason not Specified|0|||
144707474|NCT03193190|521781553|FG000|Stage 1|Physician Decision|0|||
144707475|NCT03193190|521781554|FG001|Stage 1|Physician Decision|0|||
144707476|NCT03193190|521781555|FG002|Stage 1|Physician Decision|0|||
144707477|NCT03193190|521781556|FG003|Stage 1|Physician Decision|0|||
144707478|NCT03193190|521781557|FG004|Stage 1|Physician Decision|0|||
144707479|NCT03193190|521781558|FG005|Stage 1|Physician Decision|0|||
144707480|NCT03193190|521781559|FG006|Stage 1|Physician Decision|0|||
144707481|NCT03193190|521781560|FG007|Stage 1|Physician Decision|0|||
144707482|NCT03193190|521781561|FG008|Stage 1|Physician Decision|0|||
144707483|NCT03193190|521781562|FG009|Stage 1|Physician Decision|0|||
144707484|NCT03193190|521781563|FG010|Stage 1|Physician Decision|0|||
144707485|NCT03193190|521781564|FG011|Stage 1|Physician Decision|1|||
144707486|NCT03193190|521781565|FG012|Stage 1|Physician Decision|0|||
144707487|NCT03193190|521781566|FG013|Stage 1|Physician Decision|0|||
144707488|NCT03193190|521781567|FG014|Stage 1|Physician Decision|0|||
144707489|NCT03193190|521781568|FG015|Stage 1|Physician Decision|0|||
144707490|NCT03193190|521781553|FG000|Stage 1|Progressive Disease|1|||
144707491|NCT03193190|521781554|FG001|Stage 1|Progressive Disease|0|||
144367585|NCT02113982|520557332|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
144367586|NCT02113982|520557333|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
144367587|NCT02113982|520557334|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
144367588|NCT02113982|520557335|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
144367589|NCT02113982|520557336|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
144367590|NCT02113982|520557337|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
144367591|NCT02113982|520557338|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
144367592|NCT02113982|520557339|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
144367593|NCT02113982|520557340|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
144367594|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
144367595|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
144367596|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
144367597|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
144367598|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
144367599|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
144367600|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
144367601|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
144367602|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
144367603|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
144367604|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
144367605|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
144367606|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
144367607|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
144367608|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
144367609|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
144367610|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
144367611|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
144367612|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
144367613|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
144367614|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
144367615|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
144367616|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
144367617|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
144367618|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
144367619|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
144367620|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
144367621|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
144367622|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367623|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367624|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367625|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367626|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367627|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
144707492|NCT03193190|521781555|FG002|Stage 1|Progressive Disease|0|||
144707493|NCT03193190|521781556|FG003|Stage 1|Progressive Disease|0|||
144707494|NCT03193190|521781557|FG004|Stage 1|Progressive Disease|0|||
144707495|NCT03193190|521781558|FG005|Stage 1|Progressive Disease|0|||
144707496|NCT03193190|521781559|FG006|Stage 1|Progressive Disease|0|||
144707497|NCT03193190|521781560|FG007|Stage 1|Progressive Disease|0|||
144707498|NCT03193190|521781561|FG008|Stage 1|Progressive Disease|0|||
144707499|NCT03193190|521781562|FG009|Stage 1|Progressive Disease|0|||
144707500|NCT03193190|521781563|FG010|Stage 1|Progressive Disease|0|||
144367628|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367629|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
144367630|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367631|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
144367632|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
144367633|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367634|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367635|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
144367636|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144707501|NCT03193190|521781564|FG011|Stage 1|Progressive Disease|0|||
144707502|NCT03193190|521781565|FG012|Stage 1|Progressive Disease|0|||
144707503|NCT03193190|521781566|FG013|Stage 1|Progressive Disease|0|||
144707504|NCT03193190|521781567|FG014|Stage 1|Progressive Disease|0|||
144707505|NCT03193190|521781568|FG015|Stage 1|Progressive Disease|0|||
144707506|NCT03193190|521781553|FG000|Stage 1|Study Terminated By Sponsor|3|||
144707507|NCT03193190|521781554|FG001|Stage 1|Study Terminated By Sponsor|0|||
144707508|NCT03193190|521781555|FG002|Stage 1|Study Terminated By Sponsor|0|||
144707509|NCT03193190|521781556|FG003|Stage 1|Study Terminated By Sponsor|0|||
144707510|NCT03193190|521781557|FG004|Stage 1|Study Terminated By Sponsor|6|||
144707511|NCT03193190|521781558|FG005|Stage 1|Study Terminated By Sponsor|0|||
144707512|NCT03193190|521781559|FG006|Stage 1|Study Terminated By Sponsor|0|||
144707513|NCT03193190|521781560|FG007|Stage 1|Study Terminated By Sponsor|0|||
144707514|NCT03193190|521781561|FG008|Stage 1|Study Terminated By Sponsor|0|||
144707515|NCT03193190|521781562|FG009|Stage 1|Study Terminated By Sponsor|0|||
144707516|NCT03193190|521781563|FG010|Stage 1|Study Terminated By Sponsor|0|||
144707517|NCT03193190|521781564|FG011|Stage 1|Study Terminated By Sponsor|0|||
144707518|NCT03193190|521781565|FG012|Stage 1|Study Terminated By Sponsor|0|||
144707519|NCT03193190|521781566|FG013|Stage 1|Study Terminated By Sponsor|0|||
144707520|NCT03193190|521781567|FG014|Stage 1|Study Terminated By Sponsor|0|||
144707521|NCT03193190|521781568|FG015|Stage 1|Study Terminated By Sponsor|0|||
144707522|NCT03193190|521781553|FG000|Stage 1|Withdrawal by Subject|6|||
144707523|NCT03193190|521781554|FG001|Stage 1|Withdrawal by Subject|0|||
144707524|NCT03193190|521781555|FG002|Stage 1|Withdrawal by Subject|1|||
144707525|NCT03193190|521781556|FG003|Stage 1|Withdrawal by Subject|0|||
144707526|NCT03193190|521781557|FG004|Stage 1|Withdrawal by Subject|2|||
144707527|NCT03193190|521781558|FG005|Stage 1|Withdrawal by Subject|0|||
144707528|NCT03193190|521781559|FG006|Stage 1|Withdrawal by Subject|3|||
144707529|NCT03193190|521781560|FG007|Stage 1|Withdrawal by Subject|2|||
144707530|NCT03193190|521781561|FG008|Stage 1|Withdrawal by Subject|2|||
144707531|NCT03193190|521781562|FG009|Stage 1|Withdrawal by Subject|4|||
144707532|NCT03193190|521781563|FG010|Stage 1|Withdrawal by Subject|9|||
144707533|NCT03193190|521781564|FG011|Stage 1|Withdrawal by Subject|1|||
144707534|NCT03193190|521781565|FG012|Stage 1|Withdrawal by Subject|0|||
144707535|NCT03193190|521781566|FG013|Stage 1|Withdrawal by Subject|0|||
144707536|NCT03193190|521781567|FG014|Stage 1|Withdrawal by Subject|0|||
144707537|NCT03193190|521781568|FG015|Stage 1|Withdrawal by Subject|0|||
144707538|NCT03193190|521781553|FG000|Stage 2|Death|0|||
144707539|NCT03193190|521781554|FG001|Stage 2|Death|0|||
144707540|NCT03193190|521781555|FG002|Stage 2|Death|0|||
144707541|NCT03193190|521781556|FG003|Stage 2|Death|0|||
144707542|NCT03193190|521781557|FG004|Stage 2|Death|0|||
144707543|NCT03193190|521781558|FG005|Stage 2|Death|0|||
144707544|NCT03193190|521781559|FG006|Stage 2|Death|0|||
144707545|NCT03193190|521781560|FG007|Stage 2|Death|0|||
144707546|NCT03193190|521781561|FG008|Stage 2|Death|0|||
144707547|NCT03193190|521781562|FG009|Stage 2|Death|0|||
144707548|NCT03193190|521781563|FG010|Stage 2|Death|0|||
144707549|NCT03193190|521781564|FG011|Stage 2|Death|0|||
144707550|NCT03193190|521781565|FG012|Stage 2|Death|0|||
144707551|NCT03193190|521781566|FG013|Stage 2|Death|14|||
144707552|NCT03193190|521781567|FG014|Stage 2|Death|4|||
144707553|NCT03193190|521781568|FG015|Stage 2|Death|1|||
144707554|NCT03193190|521781553|FG000|Stage 2|Lost to Follow-up|0|||
144707555|NCT03193190|521781554|FG001|Stage 2|Lost to Follow-up|0|||
144707556|NCT03193190|521781555|FG002|Stage 2|Lost to Follow-up|0|||
144707557|NCT03193190|521781556|FG003|Stage 2|Lost to Follow-up|0|||
144707558|NCT03193190|521781557|FG004|Stage 2|Lost to Follow-up|0|||
144707559|NCT03193190|521781558|FG005|Stage 2|Lost to Follow-up|0|||
144707560|NCT03193190|521781559|FG006|Stage 2|Lost to Follow-up|0|||
144707561|NCT03193190|521781560|FG007|Stage 2|Lost to Follow-up|0|||
144707562|NCT03193190|521781561|FG008|Stage 2|Lost to Follow-up|0|||
144707563|NCT03193190|521781562|FG009|Stage 2|Lost to Follow-up|0|||
144707564|NCT03193190|521781563|FG010|Stage 2|Lost to Follow-up|0|||
144707565|NCT03193190|521781564|FG011|Stage 2|Lost to Follow-up|0|||
144707566|NCT03193190|521781565|FG012|Stage 2|Lost to Follow-up|0|||
144707567|NCT03193190|521781566|FG013|Stage 2|Lost to Follow-up|0|||
144707568|NCT03193190|521781567|FG014|Stage 2|Lost to Follow-up|1|||
144707569|NCT03193190|521781568|FG015|Stage 2|Lost to Follow-up|0|||
144707570|NCT03193190|521781553|FG000|Stage 2|Withdrawal by Subject|0|||
144707571|NCT03193190|521781554|FG001|Stage 2|Withdrawal by Subject|0|||
144707572|NCT03193190|521781555|FG002|Stage 2|Withdrawal by Subject|0|||
144707573|NCT03193190|521781556|FG003|Stage 2|Withdrawal by Subject|0|||
144707574|NCT03193190|521781557|FG004|Stage 2|Withdrawal by Subject|0|||
144707575|NCT03193190|521781558|FG005|Stage 2|Withdrawal by Subject|0|||
144707576|NCT03193190|521781559|FG006|Stage 2|Withdrawal by Subject|0|||
144707577|NCT03193190|521781560|FG007|Stage 2|Withdrawal by Subject|0|||
144707578|NCT03193190|521781561|FG008|Stage 2|Withdrawal by Subject|0|||
144707579|NCT03193190|521781562|FG009|Stage 2|Withdrawal by Subject|0|||
144707580|NCT03193190|521781563|FG010|Stage 2|Withdrawal by Subject|0|||
144707581|NCT03193190|521781564|FG011|Stage 2|Withdrawal by Subject|0|||
144707582|NCT03193190|521781565|FG012|Stage 2|Withdrawal by Subject|0|||
144707583|NCT03193190|521781566|FG013|Stage 2|Withdrawal by Subject|1|||
144707584|NCT03193190|521781567|FG014|Stage 2|Withdrawal by Subject|1|||
144707585|NCT03193190|521781568|FG015|Stage 2|Withdrawal by Subject|0|||
144707586|NCT03532295|521781569|FG000|Overall Study|Did not start treatment|0|||
144707587|NCT03532295|521781570|FG001|Overall Study|Did not start treatment|2|||
144707588|NCT03732677|521781574|FG000|Overall Study|Terminated the study|154|||
144707589|NCT03732677|521781575|FG001|Overall Study|Terminated the study|197|||
144707590|NCT03732677|521781574|FG000|Overall Study|Continuing study off treatment|379|||
144707591|NCT03732677|521781575|FG001|Overall Study|Continuing study off treatment|333|||
144707592|NCT04644237|521781576|FG000|Overall Study|Death|4|||
144707593|NCT04644237|521781577|FG001|Overall Study|Death|2|||
144707594|NCT04644237|521781576|FG000|Overall Study|Adverse Event|18|||
144707595|NCT04644237|521781577|FG001|Overall Study|Adverse Event|19|||
144707596|NCT04644237|521781576|FG000|Overall Study|Progressive Disease|61|||
144707597|NCT04644237|521781577|FG001|Overall Study|Progressive Disease|23|||
144707598|NCT04644237|521781576|FG000|Overall Study|Clinical Progression|4|||
144707599|NCT04644237|521781577|FG001|Overall Study|Clinical Progression|1|||
144707600|NCT04644237|521781576|FG000|Overall Study|Withdrawal by Subject|4|||
144707601|NCT04644237|521781577|FG001|Overall Study|Withdrawal by Subject|2|||
144707602|NCT04644237|521781576|FG000|Overall Study|Physician Decision|4|||
144707603|NCT04644237|521781577|FG001|Overall Study|Physician Decision|0|||
144707604|NCT04644237|521781576|FG000|Overall Study|Other|6|||
144707605|NCT04644237|521781577|FG001|Overall Study|Other|3|||
144707606|NCT04644237|521781576|FG000|Overall Study|Randomized but not Treated|1|||
144707607|NCT04644237|521781577|FG001|Overall Study|Randomized but not Treated|0|||
144707608|NCT03131817|521781578|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
144707609|NCT05838755|521781590|FG000|Overall Study|Adverse Event|1|||
144707610|NCT05838755|521781591|FG001|Overall Study|Adverse Event|0|||
144707611|NCT05838755|521781592|FG002|Overall Study|Adverse Event|0|||
144707612|NCT05838755|521781590|FG000|Overall Study|Lack of Efficacy|1|||
144707613|NCT05838755|521781591|FG001|Overall Study|Lack of Efficacy|0|||
144707614|NCT05838755|521781592|FG002|Overall Study|Lack of Efficacy|1|||
144707615|NCT05838755|521781590|FG000|Overall Study|Lost to Follow-up|0|||
144707616|NCT05838755|521781591|FG001|Overall Study|Lost to Follow-up|1|||
144707617|NCT05838755|521781592|FG002|Overall Study|Lost to Follow-up|4|||
144707618|NCT05838755|521781590|FG000|Overall Study|Withdrawal by Subject|0|||
144707619|NCT05838755|521781591|FG001|Overall Study|Withdrawal by Subject|2|||
144707620|NCT05838755|521781592|FG002|Overall Study|Withdrawal by Subject|0|||
144707621|NCT05838755|521781590|FG000|Overall Study|Study terminated by sponsor|26|||
144707622|NCT05838755|521781591|FG001|Overall Study|Study terminated by sponsor|27|||
144707623|NCT05838755|521781592|FG002|Overall Study|Study terminated by sponsor|26|||
144707624|NCT05838755|521781590|FG000|Overall Study|Randomized, not treated|2|||
144707625|NCT05838755|521781591|FG001|Overall Study|Randomized, not treated|0|||
144707626|NCT05838755|521781592|FG002|Overall Study|Randomized, not treated|1|||
144707627|NCT05838755|521781590|FG000|Overall Study|Pregnancy|0|||
144707628|NCT05838755|521781591|FG001|Overall Study|Pregnancy|1|||
144707629|NCT05838755|521781592|FG002|Overall Study|Pregnancy|0|||
144707630|NCT04439110|521781593|FG000|Overall Study|Ineligible|2|||
144707631|NCT04439110|521781593|FG000|Overall Study|Adverse Event|4|||
144707632|NCT04439110|521781593|FG000|Overall Study|Death|2|||
144707633|NCT04439110|521781593|FG000|Overall Study|Disease proression|25|||
144707634|NCT04439110|521781593|FG000|Overall Study|Withdrawal by Subject|1|||
144707635|NCT04439110|521781593|FG000|Overall Study|Alternative therapy|1|||
144707636|NCT04439110|521781593|FG000|Overall Study|Other complicating disease|1|||
144707637|NCT04439110|521781593|FG000|Overall Study|Personal reasons|1|||
144707638|NCT04439110|521781593|FG000|Overall Study|Still on treatment|1|||
144707639|NCT04647253|521781600|FG000|Overall Study|Death ≤ 365 Days|16|||
144707640|NCT04647253|521781601|FG001|Overall Study|Death ≤ 365 Days|7|||
144707641|NCT04647253|521781600|FG000|Overall Study|Physician Decision|0|||
144707642|NCT04647253|521781601|FG001|Overall Study|Physician Decision|1|||
144707643|NCT04647253|521781600|FG000|Overall Study|Withdrawal by Subject|7|||
144707644|NCT04647253|521781601|FG001|Overall Study|Withdrawal by Subject|2|||
144707645|NCT04647253|521781600|FG000|Overall Study|Missed 12-Month Visit|9|||
144707646|NCT04647253|521781601|FG001|Overall Study|Missed 12-Month Visit|7|||
144707647|NCT04647253|521781600|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
144707648|NCT04647253|521781601|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
144707649|NCT04071366|521782224|FG000|Part 1: Open-label (29 Days)|Death|4|||
144707650|NCT04071366|521782225|FG001|Part 1: Open-label (29 Days)|Death|2|||
144707651|NCT04071366|521782226|FG002|Part 1: Open-label (29 Days)|Death|8|||
144707652|NCT04071366|521782227|FG003|Part 1: Open-label (29 Days)|Death|0|||
144707653|NCT04071366|521782228|FG004|Part 1: Open-label (29 Days)|Death|0|||
144707654|NCT04071366|521782224|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
144707655|NCT04071366|521782225|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
144707656|NCT04071366|521782226|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
144707657|NCT04071366|521782227|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
144707658|NCT04071366|521782228|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
144707659|NCT04071366|521782224|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
144707660|NCT04071366|521782225|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
144707661|NCT04071366|521782226|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
144707662|NCT04071366|521782227|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
144707663|NCT04071366|521782228|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
144707664|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Death|0|||
144707665|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Death|0|||
144707666|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Death|0|||
144707667|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Death|2|||
144707668|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Death|2|||
144707669|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
144707670|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
144707671|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
144707672|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
144707673|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
144707674|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
144707675|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
144707676|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
144707677|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
144707678|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
144707679|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
144707680|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
144707681|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
144707682|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
144707683|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
144707684|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
144707685|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
144707686|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
144707687|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
144707688|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
144707689|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
144707690|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
144707691|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
144707692|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
144707693|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
144707694|NCT04071366|521782224|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
144707695|NCT04071366|521782225|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
144707696|NCT04071366|521782226|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
144707697|NCT04071366|521782227|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
144707698|NCT04071366|521782228|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
144707699|NCT02239692|521782229|FG000|Overall Study|Incomplete colonoscopy|1|||
144707700|NCT02239692|521782230|FG001|Overall Study|Incomplete colonoscopy|2|||
144707701|NCT02239692|521782229|FG000|Overall Study|Adverse Event|0|||
144707702|NCT02239692|521782230|FG001|Overall Study|Adverse Event|1|||
144707703|NCT02239692|521782229|FG000|Overall Study|Physician Decision|0|||
144707704|NCT02239692|521782230|FG001|Overall Study|Physician Decision|1|||
144707705|NCT02239692|521782229|FG000|Overall Study|Lost to Follow-up|1|||
144707706|NCT02239692|521782230|FG001|Overall Study|Lost to Follow-up|4|||
144707707|NCT02239692|521782229|FG000|Overall Study|Withdrawal by Subject|3|||
144707708|NCT02239692|521782230|FG001|Overall Study|Withdrawal by Subject|5|||
144707709|NCT02239692|521782229|FG000|Overall Study|Other reason|1|||
144707710|NCT02239692|521782230|FG001|Overall Study|Other reason|0|||
144707711|NCT01678924|521782231|FG000|Overall Study|Adverse Event|1|||
144707712|NCT01678924|521782232|FG001|Overall Study|Adverse Event|1|||
144707713|NCT01678924|521782233|FG002|Overall Study|Adverse Event|0|||
144707714|NCT01678924|521782234|FG003|Overall Study|Adverse Event|1|||
144707715|NCT01678924|521782231|FG000|Overall Study|Lack of Efficacy|7|||
144707716|NCT01678924|521782232|FG001|Overall Study|Lack of Efficacy|2|||
144707717|NCT01678924|521782233|FG002|Overall Study|Lack of Efficacy|0|||
144707718|NCT01678924|521782234|FG003|Overall Study|Lack of Efficacy|5|||
144707719|NCT01678924|521782231|FG000|Overall Study|Lost to Follow-up|0|||
144707720|NCT01678924|521782232|FG001|Overall Study|Lost to Follow-up|4|||
144707721|NCT01678924|521782233|FG002|Overall Study|Lost to Follow-up|0|||
144707722|NCT01678924|521782234|FG003|Overall Study|Lost to Follow-up|2|||
144707723|NCT01678924|521782231|FG000|Overall Study|Personal Reasons|2|||
144707724|NCT01678924|521782232|FG001|Overall Study|Personal Reasons|2|||
144707725|NCT01678924|521782233|FG002|Overall Study|Personal Reasons|2|||
144707726|NCT01678924|521782234|FG003|Overall Study|Personal Reasons|7|||
144707727|NCT01678924|521782231|FG000|Overall Study|Withdrawal by Subject|0|||
144707728|NCT01678924|521782232|FG001|Overall Study|Withdrawal by Subject|3|||
144707729|NCT01678924|521782233|FG002|Overall Study|Withdrawal by Subject|0|||
144707730|NCT01678924|521782234|FG003|Overall Study|Withdrawal by Subject|2|||
144707731|NCT01678924|521782231|FG000|Overall Study|Unable to attend scheduled visits|0|||
144707732|NCT01678924|521782232|FG001|Overall Study|Unable to attend scheduled visits|0|||
144707733|NCT01678924|521782233|FG002|Overall Study|Unable to attend scheduled visits|0|||
144707734|NCT01678924|521782234|FG003|Overall Study|Unable to attend scheduled visits|1|||
144707735|NCT00080288|521782235|FG000|Overall Study|Adverse Event|7|||
144707736|NCT00080288|521782236|FG001|Overall Study|Adverse Event|4|||
144707737|NCT00080288|521782235|FG000|Overall Study|Lost to Follow-up|3|||
144707738|NCT00080288|521782236|FG001|Overall Study|Lost to Follow-up|5|||
144479931|NCT00244374|520957666|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
144479932|NCT00244374|520957667|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
144479933|NCT00244374|520957668|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
144479934|NCT00244374|520957664|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
144479935|NCT00244374|520957665|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
144479936|NCT00244374|520957666|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
144479937|NCT00244374|520957667|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
144479938|NCT00244374|520957668|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
144479939|NCT02105636|520957673|FG000|Pre-Treatment|Disease Progression|1|||
144479940|NCT02105636|520957674|FG001|Pre-Treatment|Disease Progression|0|||
144479941|NCT02105636|520957673|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
144479942|NCT02105636|520957674|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
144367637|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367638|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367639|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367640|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144479943|NCT02105636|520957673|FG000|Pre-Treatment|Participant withdrew consent|0|||
144479944|NCT02105636|520957674|FG001|Pre-Treatment|Participant withdrew consent|6|||
144479945|NCT02105636|520957673|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
144479946|NCT02105636|520957674|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
144479947|NCT02105636|520957673|FG000|Treatment|Study Drug Toxicity|14|||
144479948|NCT02105636|520957674|FG001|Treatment|Study Drug Toxicity|10|||
144479949|NCT02105636|520957673|FG000|Treatment|Adverse event unrelated to study drug|19|||
144707739|NCT00080288|521782235|FG000|Overall Study|Physician Decision|6|||
144707740|NCT00080288|521782236|FG001|Overall Study|Physician Decision|2|||
144707741|NCT00080288|521782235|FG000|Overall Study|Withdrawal by Subject|3|||
144707742|NCT00080288|521782236|FG001|Overall Study|Withdrawal by Subject|16|||
144367641|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367642|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367643|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
144367644|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367645|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
144367646|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367647|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367648|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367649|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
144367650|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367651|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367652|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367653|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367654|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367655|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367656|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367657|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
144367658|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367659|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367660|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367661|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367662|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367663|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
144367664|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Transplant|0|||
144367665|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Transplant|0|||
144367666|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Transplant|0|||
144367667|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Transplant|0|||
144367668|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Transplant|0|||
144367669|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Transplant|0|||
144367670|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Transplant|0|||
144367671|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Transplant|0|||
144367672|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Transplant|0|||
144367673|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Transplant|4|||
144367674|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Transplant|2|||
144367675|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Transplant|0|||
144367676|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Transplant|0|||
144367677|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Transplant|0|||
144479950|NCT02105636|520957674|FG001|Treatment|Adverse event unrelated to study drug|3|||
144479951|NCT02105636|520957673|FG000|Treatment|Participant request to discontinue study treatment|8|||
144538205|NCT00146172|521174126|FG004|Overall Study|Disease Progression|2|||
144707743|NCT00080288|521782235|FG000|Overall Study|Miscellaneous|11|||
144367678|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
144367679|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
144367680|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
144367681|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
144367682|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
144367683|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
144367684|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
144367685|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
144479952|NCT02105636|520957674|FG001|Treatment|Participant request to discontinue study treatment|6|||
144479953|NCT02105636|520957673|FG000|Treatment|Participant withdrew consent|5|||
144479954|NCT02105636|520957674|FG001|Treatment|Participant withdrew consent|1|||
144479955|NCT02105636|520957673|FG000|Treatment|Lost to Follow-up|1|||
144479956|NCT02105636|520957674|FG001|Treatment|Lost to Follow-up|0|||
144479957|NCT02105636|520957673|FG000|Treatment|Maximum Clinical Benefit|1|||
144479958|NCT02105636|520957674|FG001|Treatment|Maximum Clinical Benefit|3|||
144479959|NCT02105636|520957673|FG000|Treatment|Poor/Non-compliance|0|||
144479960|NCT02105636|520957674|FG001|Treatment|Poor/Non-compliance|1|||
144479961|NCT02105636|520957673|FG000|Treatment|Participant no longer meets study criteria|1|||
144479962|NCT02105636|520957674|FG001|Treatment|Participant no longer meets study criteria|0|||
144479963|NCT02105636|520957673|FG000|Treatment|Other reasons|1|||
144479964|NCT02105636|520957674|FG001|Treatment|Other reasons|0|||
144479965|NCT02105636|520957673|FG000|Treatment|Disease Progression|185|||
144479966|NCT02105636|520957674|FG001|Treatment|Disease Progression|87|||
144479967|NCT02802319|520957678|FG000|Overall Study|Physician Decision|2|||
144479968|NCT02802319|520957679|FG001|Overall Study|Physician Decision|1|||
144479969|NCT02802319|520957678|FG000|Overall Study|Lost to Follow-up|0|||
144479970|NCT02802319|520957679|FG001|Overall Study|Lost to Follow-up|4|||
144479971|NCT04651114|520957680|FG000|Overall Study|Withdrawal by Subject|8|||
144479972|NCT01923896|520957685|FG000|Overall Study|Adverse Event|1|||
144479973|NCT01923896|520957686|FG001|Overall Study|Adverse Event|0|||
144479974|NCT03545113|520957689|FG000|Overall Study|Surgery Cancelled|1|||
144479975|NCT03545113|520957690|FG001|Overall Study|Surgery Cancelled|0|||
144479976|NCT03545113|520957689|FG000|Overall Study|Death|1|||
144479977|NCT03545113|520957690|FG001|Overall Study|Death|0|||
144479978|NCT03545113|520957689|FG000|Overall Study|Adverse Event|2|||
144479979|NCT03545113|520957690|FG001|Overall Study|Adverse Event|0|||
144479980|NCT03545113|520957689|FG000|Overall Study|Received different surgery|1|||
144479981|NCT03545113|520957690|FG001|Overall Study|Received different surgery|0|||
144479982|NCT00235443|520957691|FG000|Overall Study|Adverse Event|4|||
144479983|NCT00235443|520957692|FG001|Overall Study|Adverse Event|12|||
144479984|NCT00235443|520957693|FG002|Overall Study|Adverse Event|17|||
144479985|NCT00235443|520957694|FG003|Overall Study|Adverse Event|44|||
144479986|NCT00235443|520957695|FG004|Overall Study|Adverse Event|10|||
144479987|NCT00235443|520957696|FG005|Overall Study|Adverse Event|15|||
144479988|NCT00235443|520957691|FG000|Overall Study|Lack of Efficacy|0|||
144479989|NCT00235443|520957692|FG001|Overall Study|Lack of Efficacy|1|||
144479990|NCT00235443|520957693|FG002|Overall Study|Lack of Efficacy|5|||
144479991|NCT00235443|520957694|FG003|Overall Study|Lack of Efficacy|12|||
144479992|NCT00235443|520957695|FG004|Overall Study|Lack of Efficacy|2|||
144479993|NCT00235443|520957696|FG005|Overall Study|Lack of Efficacy|9|||
144479994|NCT00235443|520957691|FG000|Overall Study|Withdrawal by Subject|3|||
144479995|NCT00235443|520957692|FG001|Overall Study|Withdrawal by Subject|9|||
144479996|NCT00235443|520957693|FG002|Overall Study|Withdrawal by Subject|25|||
144479997|NCT00235443|520957694|FG003|Overall Study|Withdrawal by Subject|24|||
144479998|NCT00235443|520957695|FG004|Overall Study|Withdrawal by Subject|10|||
144479999|NCT00235443|520957696|FG005|Overall Study|Withdrawal by Subject|12|||
144480000|NCT00235443|520957691|FG000|Overall Study|Lost to Follow-up|0|||
144480001|NCT00235443|520957692|FG001|Overall Study|Lost to Follow-up|8|||
144480002|NCT00235443|520957693|FG002|Overall Study|Lost to Follow-up|6|||
144480003|NCT00235443|520957694|FG003|Overall Study|Lost to Follow-up|6|||
144480004|NCT00235443|520957695|FG004|Overall Study|Lost to Follow-up|4|||
144480005|NCT00235443|520957696|FG005|Overall Study|Lost to Follow-up|3|||
144480006|NCT00235443|520957691|FG000|Overall Study|Unsatisfactory compliance|0|||
144480007|NCT00235443|520957692|FG001|Overall Study|Unsatisfactory compliance|2|||
144480008|NCT00235443|520957693|FG002|Overall Study|Unsatisfactory compliance|3|||
144480009|NCT00235443|520957694|FG003|Overall Study|Unsatisfactory compliance|4|||
144480010|NCT00235443|520957695|FG004|Overall Study|Unsatisfactory compliance|1|||
144480011|NCT00235443|520957696|FG005|Overall Study|Unsatisfactory compliance|0|||
144480012|NCT00235443|520957691|FG000|Overall Study|Other reasons for premature termination|1|||
144480013|NCT00235443|520957692|FG001|Overall Study|Other reasons for premature termination|6|||
144480014|NCT00235443|520957693|FG002|Overall Study|Other reasons for premature termination|6|||
144480015|NCT00235443|520957694|FG003|Overall Study|Other reasons for premature termination|7|||
144480016|NCT00235443|520957695|FG004|Overall Study|Other reasons for premature termination|3|||
144480017|NCT00235443|520957696|FG005|Overall Study|Other reasons for premature termination|6|||
144480018|NCT02032173|520957697|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
144480019|NCT00474929|520957698|FG000|Overall Study|Withdrawal by Subject|0|||
144480020|NCT00474929|520957699|FG001|Overall Study|Withdrawal by Subject|1|||
144480021|NCT00474929|520957700|FG002|Overall Study|Withdrawal by Subject|0|||
144480022|NCT00474929|520957701|FG003|Overall Study|Withdrawal by Subject|0|||
144480023|NCT00474929|520957702|FG004|Overall Study|Withdrawal by Subject|0|||
144480024|NCT00474929|520957698|FG000|Overall Study|Unrelated medical condition|0|||
144480025|NCT00474929|520957699|FG001|Overall Study|Unrelated medical condition|0|||
144480026|NCT00474929|520957700|FG002|Overall Study|Unrelated medical condition|1|||
144480027|NCT00474929|520957701|FG003|Overall Study|Unrelated medical condition|0|||
144480028|NCT00474929|520957702|FG004|Overall Study|Unrelated medical condition|0|||
144480029|NCT00474929|520957698|FG000|Overall Study|Physician Decision|0|||
144480030|NCT00474929|520957699|FG001|Overall Study|Physician Decision|0|||
144480031|NCT00474929|520957700|FG002|Overall Study|Physician Decision|1|||
144480032|NCT00474929|520957701|FG003|Overall Study|Physician Decision|2|||
144480033|NCT00474929|520957702|FG004|Overall Study|Physician Decision|0|||
144480034|NCT03661996|520957705|FG000|Overall Study|Adverse Event|0|||
144480035|NCT03661996|520957706|FG001|Overall Study|Adverse Event|0|||
144480036|NCT03661996|520957707|FG002|Overall Study|Adverse Event|1|||
144480037|NCT03661996|520957708|FG003|Overall Study|Adverse Event|1|||
144480038|NCT03661996|520957709|FG004|Overall Study|Adverse Event|0|||
144480039|NCT03661996|520957705|FG000|Overall Study|Lost to Follow-up|5|||
144480040|NCT03661996|520957706|FG001|Overall Study|Lost to Follow-up|1|||
144480041|NCT03661996|520957707|FG002|Overall Study|Lost to Follow-up|2|||
144480042|NCT03661996|520957708|FG003|Overall Study|Lost to Follow-up|2|||
144480043|NCT03661996|520957709|FG004|Overall Study|Lost to Follow-up|6|||
144480044|NCT03661996|520957705|FG000|Overall Study|Physician Decision|1|||
144480045|NCT03661996|520957706|FG001|Overall Study|Physician Decision|1|||
144480046|NCT03661996|520957707|FG002|Overall Study|Physician Decision|1|||
144480047|NCT03661996|520957708|FG003|Overall Study|Physician Decision|2|||
144480048|NCT03661996|520957709|FG004|Overall Study|Physician Decision|0|||
144480049|NCT03661996|520957705|FG000|Overall Study|Protocol Violation|0|||
144480050|NCT03661996|520957706|FG001|Overall Study|Protocol Violation|0|||
144480051|NCT03661996|520957707|FG002|Overall Study|Protocol Violation|0|||
144480052|NCT03661996|520957708|FG003|Overall Study|Protocol Violation|0|||
144480053|NCT03661996|520957709|FG004|Overall Study|Protocol Violation|1|||
144480054|NCT03661996|520957705|FG000|Overall Study|Withdrawal by Subject|3|||
144480055|NCT03661996|520957706|FG001|Overall Study|Withdrawal by Subject|5|||
144480056|NCT03661996|520957707|FG002|Overall Study|Withdrawal by Subject|1|||
144480057|NCT03661996|520957708|FG003|Overall Study|Withdrawal by Subject|7|||
144480058|NCT03661996|520957709|FG004|Overall Study|Withdrawal by Subject|7|||
144480059|NCT03661996|520957705|FG000|Overall Study|Sponsors Decision|2|||
144480060|NCT03661996|520957706|FG001|Overall Study|Sponsors Decision|0|||
144707744|NCT00080288|521782236|FG001|Overall Study|Miscellaneous|11|||
144707745|NCT02253654|521782237|FG000|Overall Study|Withdrawal by Subject|12|||
144707746|NCT02253654|521782238|FG001|Overall Study|Withdrawal by Subject|4|||
144707747|NCT02253654|521782237|FG000|Overall Study|Decision by Sponsor|1|||
144707748|NCT02253654|521782238|FG001|Overall Study|Decision by Sponsor|1|||
144707749|NCT02253654|521782237|FG000|Overall Study|Lost to Follow-up|2|||
144707750|NCT02253654|521782238|FG001|Overall Study|Lost to Follow-up|5|||
144707751|NCT02253654|521782237|FG000|Overall Study|Death|4|||
144707752|NCT02253654|521782238|FG001|Overall Study|Death|7|||
144707753|NCT02253654|521782237|FG000|Overall Study|Did Not Receive Study Treatment|4|||
144707754|NCT02253654|521782238|FG001|Overall Study|Did Not Receive Study Treatment|1|||
144707755|NCT03044431|521782241|FG000|Overall Study|Lost to Follow-up|59|||
144707756|NCT03456726|521782242|FG000|Overall Study|Disease Progression|6|||
144707757|NCT03456726|521782243|FG001|Overall Study|Disease Progression|1|||
144707758|NCT03456726|521782242|FG000|Overall Study|Adverse Event|4|||
144707759|NCT03456726|521782243|FG001|Overall Study|Adverse Event|2|||
144707760|NCT03456726|521782242|FG000|Overall Study|Withdrawal by Subject|1|||
144707761|NCT03456726|521782243|FG001|Overall Study|Withdrawal by Subject|0|||
144707762|NCT03456726|521782242|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
144707763|NCT03456726|521782243|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
144707764|NCT00399490|521782244|FG000|Overall Study|Adverse Event|19|||
144707765|NCT00399490|521782244|FG000|Overall Study|Lack of Efficacy|31|||
144707766|NCT00399490|521782244|FG000|Overall Study|Lost to Follow-up|5|||
144707767|NCT00399490|521782244|FG000|Overall Study|Withdrawal by Subject|18|||
144707768|NCT00399490|521782244|FG000|Overall Study|Other|25|||
144707769|NCT02576054|521782248|FG000|Overall Study|Withdrawal by Subject|1|||
144707770|NCT02706353|521782249|FG000|Dose Level 1|Disease Progression|1|||
144480061|NCT03661996|520957707|FG002|Overall Study|Sponsors Decision|0|||
144480062|NCT03661996|520957708|FG003|Overall Study|Sponsors Decision|0|||
144480063|NCT03661996|520957709|FG004|Overall Study|Sponsors Decision|0|||
144480064|NCT03661996|520957705|FG000|Overall Study|Other|1|||
144480065|NCT03661996|520957706|FG001|Overall Study|Other|1|||
144480066|NCT03661996|520957707|FG002|Overall Study|Other|1|||
144480067|NCT03661996|520957708|FG003|Overall Study|Other|1|||
144480068|NCT03661996|520957709|FG004|Overall Study|Other|0|||
144480069|NCT03321513|520957710|FG000|Overall Study|Death|11|||
144707771|NCT02706353|521782250|FG001|Dose Level 1|Disease Progression|0|||
144480070|NCT03321513|520957711|FG001|Overall Study|Death|5|||
144480071|NCT03321513|520957710|FG000|Overall Study|Withdrawal by Subject|5|||
144480072|NCT03321513|520957711|FG001|Overall Study|Withdrawal by Subject|10|||
144480073|NCT03321513|520957710|FG000|Overall Study|Lost to Follow-up|10|||
144480074|NCT03321513|520957711|FG001|Overall Study|Lost to Follow-up|11|||
144480075|NCT03029247|520957712|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
144480076|NCT03029247|520957713|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
144480077|NCT03029247|520957712|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
144480078|NCT03029247|520957713|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
144480079|NCT03029247|520957712|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
144480080|NCT03029247|520957713|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
144480081|NCT03029247|520957712|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
144480082|NCT03029247|520957713|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
144480083|NCT02593305|520957714|FG000|Post 1|Comparison only group. No intervention.|0|||
144480084|NCT02593305|520957715|FG001|Post 1|Comparison only group. No intervention.|0|||
144480085|NCT02593305|520957716|FG002|Post 1|Comparison only group. No intervention.|10|||
144480086|NCT00068380|520957717|FG000|Overall Study|Withdrawal by Subject|3|||
144480087|NCT00068380|520957717|FG000|Overall Study|Adverse Event|2|||
144480088|NCT01976364|520957718|FG000|Main Study (36 Months)|Adverse Event|63|||
144480089|NCT01976364|520957719|FG001|Main Study (36 Months)|Adverse Event|0|||
144480090|NCT01976364|520957720|FG002|Main Study (36 Months)|Adverse Event|0|||
144480091|NCT01976364|520957718|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
144480092|NCT01976364|520957719|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
144480093|NCT01976364|520957720|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
144480094|NCT01976364|520957718|FG000|Main Study (36 Months)|Other|13|||
144480095|NCT01976364|520957719|FG001|Main Study (36 Months)|Other|0|||
144480096|NCT01976364|520957720|FG002|Main Study (36 Months)|Other|0|||
144480097|NCT01976364|520957718|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
144480098|NCT01976364|520957719|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
144480099|NCT01976364|520957720|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
144480100|NCT01976364|520957718|FG000|Main Study (36 Months)|Medication error|1|||
144480101|NCT01976364|520957719|FG001|Main Study (36 Months)|Medication error|0|||
144480102|NCT01976364|520957720|FG002|Main Study (36 Months)|Medication error|0|||
144480103|NCT01976364|520957718|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
144480104|NCT01976364|520957719|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
144480105|NCT01976364|520957720|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
144480106|NCT01976364|520957718|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
144480107|NCT01976364|520957719|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
144707772|NCT02706353|521782251|FG002|Dose Level 1|Disease Progression|0|||
144707773|NCT02706353|521782252|FG003|Dose Level 1|Disease Progression|0|||
144707774|NCT02706353|521782253|FG004|Dose Level 1|Disease Progression|0|||
144707775|NCT02706353|521782254|FG005|Dose Level 1|Disease Progression|0|||
144707776|NCT02706353|521782249|FG000|Dose Level 3|Disease Progression|0|||
144707777|NCT02706353|521782250|FG001|Dose Level 3|Disease Progression|0|||
144707778|NCT02706353|521782251|FG002|Dose Level 3|Disease Progression|2|||
144707779|NCT02706353|521782252|FG003|Dose Level 3|Disease Progression|0|||
144707780|NCT02706353|521782253|FG004|Dose Level 3|Disease Progression|0|||
144707781|NCT02706353|521782254|FG005|Dose Level 3|Disease Progression|0|||
144707782|NCT02706353|521782249|FG000|Dose Level 4|Disease Progression|0|||
144707783|NCT02706353|521782250|FG001|Dose Level 4|Disease Progression|0|||
144707784|NCT02706353|521782251|FG002|Dose Level 4|Disease Progression|0|||
144707785|NCT02706353|521782252|FG003|Dose Level 4|Disease Progression|1|||
144707786|NCT02706353|521782253|FG004|Dose Level 4|Disease Progression|0|||
144707787|NCT02706353|521782254|FG005|Dose Level 4|Disease Progression|0|||
144707788|NCT02706353|521782249|FG000|Dose Level 4|Toxicity|0|||
144707789|NCT02706353|521782250|FG001|Dose Level 4|Toxicity|0|||
144707790|NCT02706353|521782251|FG002|Dose Level 4|Toxicity|0|||
144707791|NCT02706353|521782252|FG003|Dose Level 4|Toxicity|1|||
144707792|NCT02706353|521782253|FG004|Dose Level 4|Toxicity|0|||
144707793|NCT02706353|521782254|FG005|Dose Level 4|Toxicity|0|||
144707794|NCT02706353|521782249|FG000|Dose Level 4|Death|0|||
144480108|NCT01976364|520957720|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
144480109|NCT01976364|520957718|FG000|Main Study (36 Months)|Protocol Violation|13|||
144480110|NCT01976364|520957719|FG001|Main Study (36 Months)|Protocol Violation|0|||
144707795|NCT02706353|521782250|FG001|Dose Level 4|Death|0|||
144707796|NCT02706353|521782251|FG002|Dose Level 4|Death|0|||
144480111|NCT01976364|520957720|FG002|Main Study (36 Months)|Protocol Violation|0|||
144480112|NCT01976364|520957718|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
144480113|NCT01976364|520957719|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
144707797|NCT02706353|521782252|FG003|Dose Level 4|Death|1|||
144707798|NCT02706353|521782253|FG004|Dose Level 4|Death|0|||
144707799|NCT02706353|521782254|FG005|Dose Level 4|Death|0|||
144480114|NCT01976364|520957720|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
144707800|NCT02706353|521782249|FG000|Dose Level 5|Toxicity|0|||
144707801|NCT02706353|521782250|FG001|Dose Level 5|Toxicity|0|||
144707802|NCT02706353|521782251|FG002|Dose Level 5|Toxicity|0|||
144707803|NCT02706353|521782252|FG003|Dose Level 5|Toxicity|0|||
144480115|NCT01976364|520957718|FG000|Main Study (36 Months)|Death|5|||
144480116|NCT01976364|520957719|FG001|Main Study (36 Months)|Death|0|||
144480117|NCT01976364|520957720|FG002|Main Study (36 Months)|Death|0|||
144480118|NCT01976364|520957718|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
144480119|NCT01976364|520957719|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
144480120|NCT01976364|520957720|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
144480121|NCT01976364|520957718|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
144480122|NCT01976364|520957719|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
144480123|NCT01976364|520957720|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
144480124|NCT01976364|520957718|FG000|Sub-study (12 Months)|Protocol Violation|0|||
144480125|NCT01976364|520957719|FG001|Sub-study (12 Months)|Protocol Violation|1|||
144480126|NCT01976364|520957720|FG002|Sub-study (12 Months)|Protocol Violation|1|||
144480127|NCT01976364|520957718|FG000|Sub-study (12 Months)|Adverse Event|0|||
144480128|NCT01976364|520957719|FG001|Sub-study (12 Months)|Adverse Event|4|||
144480129|NCT01976364|520957720|FG002|Sub-study (12 Months)|Adverse Event|3|||
144480130|NCT02757521|520957721|FG000|Overall Study|Adverse Event|1|||
144480131|NCT02757521|520957722|FG001|Overall Study|Adverse Event|0|||
144480132|NCT01190215|520957723|FG000|Up to Month 6|Lost to Follow-up|2|||
144480133|NCT01190215|520957724|FG001|Up to Month 6|Lost to Follow-up|0|||
144480134|NCT00003511|520957725|FG000|Overall Study|Not evaluable|4|||
144480135|NCT01642602|520957731|FG000|Overall Study|Adverse Event|2|||
144480136|NCT00641719|520957739|FG000|Overall Study|Lack of Efficacy|1|||
144480137|NCT00641719|520957740|FG001|Overall Study|Lack of Efficacy|2|||
144480138|NCT00641719|520957739|FG000|Overall Study|Adverse Event|24|||
144480139|NCT00641719|520957740|FG001|Overall Study|Adverse Event|29|||
144480140|NCT00641719|520957739|FG000|Overall Study|Withdrawal by Subject|4|||
144480141|NCT00641719|520957740|FG001|Overall Study|Withdrawal by Subject|4|||
144480142|NCT00641719|520957739|FG000|Overall Study|Reason Not Specified|1|||
144480143|NCT00641719|520957740|FG001|Overall Study|Reason Not Specified|2|||
144480144|NCT03321006|520957741|FG000|Overall Study|Death|1|||
144480145|NCT03321006|520957742|FG001|Overall Study|Death|0|||
144480146|NCT03321006|520957741|FG000|Overall Study|Lack of Efficacy|1|||
144480147|NCT03321006|520957742|FG001|Overall Study|Lack of Efficacy|0|||
144480148|NCT03303469|520957743|FG000|Overall Study|Lost to Follow-up|2|||
144480149|NCT03101241|520957749|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
144480150|NCT03101241|520957750|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
144480151|NCT03101241|520957749|FG000|Overall Study|Participant withdrew consent|3|||
144480152|NCT03101241|520957750|FG001|Overall Study|Participant withdrew consent|1|||
144480153|NCT03101241|520957749|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
144480154|NCT03101241|520957750|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
144480155|NCT03101241|520957749|FG000|Overall Study|Lost to Follow-up|2|||
144480156|NCT03101241|520957750|FG001|Overall Study|Lost to Follow-up|0|||
144480157|NCT03101241|520957749|FG000|Overall Study|Lack of Efficacy|0|||
144480158|NCT03101241|520957750|FG001|Overall Study|Lack of Efficacy|1|||
144480159|NCT03101241|520957749|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
144480160|NCT03101241|520957750|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
144480161|NCT04498247|520957751|FG000|Overall Study|Lost to Follow-up|0|||
144480162|NCT04498247|520957752|FG001|Overall Study|Lost to Follow-up|0|||
144480163|NCT04498247|520957753|FG002|Overall Study|Lost to Follow-up|0|||
144480164|NCT04498247|520957754|FG003|Overall Study|Lost to Follow-up|1|||
144480165|NCT04498247|520957755|FG004|Overall Study|Lost to Follow-up|0|||
144480166|NCT04498247|520957756|FG005|Overall Study|Lost to Follow-up|0|||
144480167|NCT04498247|520957757|FG006|Overall Study|Lost to Follow-up|0|||
144480168|NCT04498247|520957758|FG007|Overall Study|Lost to Follow-up|0|||
144480169|NCT04498247|520957751|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
144480170|NCT04498247|520957752|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480171|NCT04498247|520957753|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480172|NCT04498247|520957754|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480173|NCT04498247|520957755|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480174|NCT04498247|520957756|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480175|NCT04498247|520957757|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480176|NCT04498247|520957758|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
144480177|NCT04498247|520957751|FG000|Overall Study|Withdrawal by Subject|0|||
144480178|NCT04498247|520957752|FG001|Overall Study|Withdrawal by Subject|8|||
144480179|NCT04498247|520957753|FG002|Overall Study|Withdrawal by Subject|0|||
144480180|NCT04498247|520957754|FG003|Overall Study|Withdrawal by Subject|7|||
144480181|NCT04498247|520957755|FG004|Overall Study|Withdrawal by Subject|0|||
144480182|NCT04498247|520957756|FG005|Overall Study|Withdrawal by Subject|0|||
144480183|NCT04498247|520957757|FG006|Overall Study|Withdrawal by Subject|1|||
144480184|NCT04498247|520957758|FG007|Overall Study|Withdrawal by Subject|0|||
144480185|NCT04498247|520957751|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
144480186|NCT04498247|520957752|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
144480187|NCT04498247|520957753|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
144480188|NCT04498247|520957754|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
144480189|NCT04498247|520957755|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
144480190|NCT04498247|520957756|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
144480191|NCT04498247|520957757|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
144480192|NCT04498247|520957758|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
144480193|NCT00192023|520957759|FG000|Period III - Double-Blind|Adverse Event|3|||
144480194|NCT00192023|520957760|FG001|Period III - Double-Blind|Adverse Event|0|||
144480195|NCT00192023|520957759|FG000|Period III - Double-Blind|Physician Decision|2|||
144480196|NCT00192023|520957760|FG001|Period III - Double-Blind|Physician Decision|0|||
144480197|NCT00192023|520957759|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
144480198|NCT00192023|520957760|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
144480199|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
144480200|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
144480201|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
144480202|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
144480203|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
144480204|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
144480205|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
144480206|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
144480207|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
144480208|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
144480209|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
144480210|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
144480211|NCT00192023|520957759|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
144480212|NCT00192023|520957760|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
144480213|NCT00669903|520957761|FG000|Overall Study|Adverse Event|0|||
144480214|NCT00669903|520957762|FG001|Overall Study|Adverse Event|1|||
144480215|NCT00669903|520957763|FG002|Overall Study|Adverse Event|3|||
144480216|NCT00669903|520957764|FG003|Overall Study|Adverse Event|1|||
144480217|NCT00669903|520957761|FG000|Overall Study|Withdrawal by Subject|0|||
144480218|NCT00669903|520957762|FG001|Overall Study|Withdrawal by Subject|2|||
144480219|NCT00669903|520957763|FG002|Overall Study|Withdrawal by Subject|2|||
144480220|NCT00669903|520957764|FG003|Overall Study|Withdrawal by Subject|2|||
144480221|NCT00669903|520957761|FG000|Overall Study|Lost to Follow-up|1|||
144480222|NCT00669903|520957762|FG001|Overall Study|Lost to Follow-up|1|||
144480223|NCT00669903|520957763|FG002|Overall Study|Lost to Follow-up|0|||
144480224|NCT00669903|520957764|FG003|Overall Study|Lost to Follow-up|1|||
144480225|NCT00669903|520957761|FG000|Overall Study|Protocol Violation|0|||
144480226|NCT00669903|520957762|FG001|Overall Study|Protocol Violation|1|||
144480227|NCT00669903|520957763|FG002|Overall Study|Protocol Violation|0|||
144480228|NCT00669903|520957764|FG003|Overall Study|Protocol Violation|0|||
144480229|NCT00245856|520957765|FG000|Period Two|Withdrawal by Subject|0|||
144480230|NCT00245856|520957766|FG001|Period Two|Withdrawal by Subject|1|||
144480231|NCT01003184|520957767|FG000|Overall Study|Adverse Event|12|||
144480232|NCT01003184|520957768|FG001|Overall Study|Adverse Event|5|||
144480233|NCT01003184|520957767|FG000|Overall Study|Lost to Follow-up|1|||
144480234|NCT01003184|520957768|FG001|Overall Study|Lost to Follow-up|0|||
144480235|NCT01003184|520957767|FG000|Overall Study|Loss of glucose control|1|||
144480236|NCT01003184|520957768|FG001|Overall Study|Loss of glucose control|1|||
144480237|NCT01003184|520957767|FG000|Overall Study|Protocol Violation|3|||
144480238|NCT01003184|520957768|FG001|Overall Study|Protocol Violation|0|||
144480239|NCT01003184|520957767|FG000|Overall Study|Withdrawal by Subject|1|||
144480240|NCT01003184|520957768|FG001|Overall Study|Withdrawal by Subject|6|||
144480241|NCT01003184|520957767|FG000|Overall Study|Physician Decision|1|||
144480242|NCT01003184|520957768|FG001|Overall Study|Physician Decision|0|||
144480243|NCT04848662|520957769|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
144480244|NCT04848662|520957770|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
144480245|NCT03662997|520957777|FG000|Overall Study|Adverse Event|0|||
144480246|NCT03662997|520957778|FG001|Overall Study|Adverse Event|2|||
144480247|NCT03662997|520957779|FG002|Overall Study|Adverse Event|0|||
144480248|NCT03662997|520957780|FG003|Overall Study|Adverse Event|0|||
144480249|NCT00007475|520957781|FG000|Overall Study|Withdrawal by Subject|1|||
144707804|NCT02706353|521782253|FG004|Dose Level 5|Toxicity|1|||
144480250|NCT00007475|520957782|FG001|Overall Study|Withdrawal by Subject|0|||
144480251|NCT00007475|520957783|FG002|Overall Study|Withdrawal by Subject|0|||
144480252|NCT00007475|520957784|FG003|Overall Study|Withdrawal by Subject|0|||
144480253|NCT00007475|520957781|FG000|Overall Study|Adverse Event|3|||
144480254|NCT00007475|520957782|FG001|Overall Study|Adverse Event|0|||
144480255|NCT00007475|520957783|FG002|Overall Study|Adverse Event|0|||
144480256|NCT00007475|520957784|FG003|Overall Study|Adverse Event|0|||
144707805|NCT02706353|521782254|FG005|Dose Level 5|Toxicity|0|||
144707806|NCT02706353|521782249|FG000|Dose Level 5|Disease Progression|0|||
144480257|NCT01719224|520957785|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
144480258|NCT01719224|520957786|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
144707807|NCT02706353|521782250|FG001|Dose Level 5|Disease Progression|0|||
144480259|NCT03000673|520957787|FG000|Overall Study|Withdrawal by Subject|1|||
144480260|NCT03000673|520957788|FG001|Overall Study|Withdrawal by Subject|0|||
144480261|NCT03000673|520957789|FG002|Overall Study|Withdrawal by Subject|0|||
144480262|NCT03000673|520957790|FG003|Overall Study|Withdrawal by Subject|0|||
144480263|NCT01121484|520957792|FG000|Overall Study|Adverse Event|12|||
144480264|NCT01121484|520957793|FG001|Overall Study|Adverse Event|5|||
144480265|NCT01121484|520957792|FG000|Overall Study|Lack of Efficacy|3|||
144480266|NCT01121484|520957793|FG001|Overall Study|Lack of Efficacy|11|||
144480267|NCT01121484|520957792|FG000|Overall Study|Lost to Follow-up|5|||
144480268|NCT01121484|520957793|FG001|Overall Study|Lost to Follow-up|9|||
144480269|NCT01121484|520957792|FG000|Overall Study|Physician Decision|0|||
144480270|NCT01121484|520957793|FG001|Overall Study|Physician Decision|3|||
144480271|NCT01121484|520957792|FG000|Overall Study|Protocol Violation|1|||
144480272|NCT01121484|520957793|FG001|Overall Study|Protocol Violation|0|||
144480273|NCT01121484|520957792|FG000|Overall Study|Withdrawal by Subject|8|||
144480274|NCT01121484|520957793|FG001|Overall Study|Withdrawal by Subject|7|||
144480275|NCT01121484|520957792|FG000|Overall Study|Discontinuation of study by sponsor|0|||
144480276|NCT01121484|520957793|FG001|Overall Study|Discontinuation of study by sponsor|1|||
144480277|NCT01121484|520957792|FG000|Overall Study|Other|3|||
144480278|NCT01121484|520957793|FG001|Overall Study|Other|3|||
144480279|NCT01121484|520957792|FG000|Overall Study|Randomized, not treated|1|||
144480280|NCT01121484|520957793|FG001|Overall Study|Randomized, not treated|4|||
144480281|NCT00562978|520957794|FG000|Overall Study|Patient had imaging dose only|1|||
144480282|NCT00562978|520957795|FG001|Overall Study|Patient had imaging dose only|11|||
144480283|NCT00152971|520957796|FG000|Overall Study|Adverse Event|12|||
144480284|NCT00152971|520957797|FG001|Overall Study|Adverse Event|10|||
144480285|NCT00152971|520957798|FG002|Overall Study|Adverse Event|9|||
144480286|NCT00152971|520957796|FG000|Overall Study|Protocol Violation|10|||
144480287|NCT00152971|520957797|FG001|Overall Study|Protocol Violation|11|||
144480288|NCT00152971|520957798|FG002|Overall Study|Protocol Violation|8|||
144480289|NCT00152971|520957796|FG000|Overall Study|Lost to Follow-up|17|||
144480290|NCT00152971|520957797|FG001|Overall Study|Lost to Follow-up|14|||
144480291|NCT00152971|520957798|FG002|Overall Study|Lost to Follow-up|13|||
144480292|NCT00152971|520957796|FG000|Overall Study|Withdrawal by Subject|9|||
144480293|NCT00152971|520957797|FG001|Overall Study|Withdrawal by Subject|8|||
144480294|NCT00152971|520957798|FG002|Overall Study|Withdrawal by Subject|14|||
144480295|NCT00152971|520957796|FG000|Overall Study|Other|3|||
144480296|NCT00152971|520957797|FG001|Overall Study|Other|5|||
144480297|NCT00152971|520957798|FG002|Overall Study|Other|5|||
144480298|NCT00152971|520957796|FG000|Treatment|Adverse Event|49|||
144480299|NCT00152971|520957797|FG001|Treatment|Adverse Event|40|||
144480300|NCT00152971|520957798|FG002|Treatment|Adverse Event|54|||
144480301|NCT00152971|520957796|FG000|Treatment|Protocol Violation|8|||
144480302|NCT00152971|520957797|FG001|Treatment|Protocol Violation|6|||
144480303|NCT00152971|520957798|FG002|Treatment|Protocol Violation|10|||
144480304|NCT00152971|520957796|FG000|Treatment|Lost to Follow-up|1|||
144480305|NCT00152971|520957797|FG001|Treatment|Lost to Follow-up|2|||
144480306|NCT00152971|520957798|FG002|Treatment|Lost to Follow-up|1|||
144480307|NCT00152971|520957796|FG000|Treatment|Withdrawal by Subject|4|||
144480308|NCT00152971|520957797|FG001|Treatment|Withdrawal by Subject|4|||
144480309|NCT00152971|520957798|FG002|Treatment|Withdrawal by Subject|5|||
144480310|NCT00152971|520957796|FG000|Treatment|Other|9|||
144480311|NCT00152971|520957797|FG001|Treatment|Other|11|||
144480312|NCT00152971|520957798|FG002|Treatment|Other|10|||
144480313|NCT00675506|520957799|FG000|Overall Study|Lost to Follow-up|1|||
144480314|NCT00675506|520957800|FG001|Overall Study|Lost to Follow-up|5|||
144480315|NCT00675506|520957799|FG000|Overall Study|Lost interest|3|||
144707808|NCT02706353|521782251|FG002|Dose Level 5|Disease Progression|0|||
144707809|NCT02706353|521782252|FG003|Dose Level 5|Disease Progression|0|||
144707810|NCT02706353|521782253|FG004|Dose Level 5|Disease Progression|3|||
144707811|NCT02706353|521782254|FG005|Dose Level 5|Disease Progression|2|||
144707812|NCT02706353|521782249|FG000|Dose Level 5|Death|0|||
144707813|NCT02706353|521782250|FG001|Dose Level 5|Death|0|||
144707814|NCT02706353|521782251|FG002|Dose Level 5|Death|0|||
144707815|NCT02706353|521782252|FG003|Dose Level 5|Death|0|||
144480316|NCT00675506|520957800|FG001|Overall Study|Lost interest|5|||
144480317|NCT00675506|520957799|FG000|Overall Study|Elevated fasting glucose|2|||
144707816|NCT02706353|521782253|FG004|Dose Level 5|Death|1|||
144480318|NCT00675506|520957800|FG001|Overall Study|Elevated fasting glucose|1|||
144480319|NCT00675506|520957799|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
144480320|NCT00675506|520957800|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
144480321|NCT00675506|520957799|FG000|Overall Study|Elevated IGF-1|2|||
144480322|NCT00675506|520957800|FG001|Overall Study|Elevated IGF-1|0|||
144480323|NCT00675506|520957799|FG000|Overall Study|Hypersensitivity Reaction|1|||
144480324|NCT00675506|520957800|FG001|Overall Study|Hypersensitivity Reaction|0|||
144707817|NCT02706353|521782254|FG005|Dose Level 5|Death|6|||
144707818|NCT02706353|521782249|FG000|Dose Level 5|Withdrawal by Subject|0|||
144707819|NCT02706353|521782250|FG001|Dose Level 5|Withdrawal by Subject|0|||
144707820|NCT02706353|521782251|FG002|Dose Level 5|Withdrawal by Subject|0|||
144707821|NCT02706353|521782252|FG003|Dose Level 5|Withdrawal by Subject|0|||
144707822|NCT02706353|521782253|FG004|Dose Level 5|Withdrawal by Subject|0|||
144707823|NCT02706353|521782254|FG005|Dose Level 5|Withdrawal by Subject|2|||
144707824|NCT03560466|521782255|FG000|Overall Study|Adverse Event|1|||
144707825|NCT03560466|521782256|FG001|Overall Study|Adverse Event|2|||
144707826|NCT03560466|521782257|FG002|Overall Study|Adverse Event|0|||
144707827|NCT03560466|521782255|FG000|Overall Study|Poor Compliance to Protocol|0|||
144707828|NCT03560466|521782256|FG001|Overall Study|Poor Compliance to Protocol|2|||
144707829|NCT03560466|521782257|FG002|Overall Study|Poor Compliance to Protocol|0|||
144707830|NCT03560466|521782255|FG000|Overall Study|Other|6|||
144707831|NCT03560466|521782256|FG001|Overall Study|Other|8|||
144707832|NCT03560466|521782257|FG002|Overall Study|Other|1|||
144707833|NCT03703297|521782258|FG000|Overall Study|Death|115|||
144707834|NCT03703297|521782259|FG001|Overall Study|Death|0|||
144707835|NCT03703297|521782260|FG002|Overall Study|Death|144|||
144707836|NCT03703297|521782258|FG000|Overall Study|Withdrawal by Subject|9|||
144707837|NCT03703297|521782259|FG001|Overall Study|Withdrawal by Subject|0|||
144707838|NCT03703297|521782260|FG002|Overall Study|Withdrawal by Subject|11|||
144707839|NCT03703297|521782258|FG000|Overall Study|Ongoing at the time of DCO|140|||
144707840|NCT03703297|521782259|FG001|Overall Study|Ongoing at the time of DCO|200|||
144707841|NCT03703297|521782260|FG002|Overall Study|Ongoing at the time of DCO|111|||
144707842|NCT02038959|521783721|FG000|Overall Study|Withdrawal by Subject|6|||
144707843|NCT02038959|521783722|FG001|Overall Study|Withdrawal by Subject|8|||
144707844|NCT00819091|521783723|FG000|Overall Study|Adverse Event|3|||
144707845|NCT00819091|521783724|FG001|Overall Study|Adverse Event|5|||
144707846|NCT00819091|521783723|FG000|Overall Study|Protocol Violation|0|||
144707847|NCT00819091|521783724|FG001|Overall Study|Protocol Violation|1|||
144707848|NCT00819091|521783723|FG000|Overall Study|Lost to Follow-up|2|||
144707849|NCT00819091|521783724|FG001|Overall Study|Lost to Follow-up|0|||
144707850|NCT00819091|521783723|FG000|Overall Study|Withdrawal by Subject|1|||
144707851|NCT00819091|521783724|FG001|Overall Study|Withdrawal by Subject|2|||
144707852|NCT00819091|521783723|FG000|Overall Study|Other|1|||
144707853|NCT00819091|521783724|FG001|Overall Study|Other|2|||
144707854|NCT03911960|521783725|FG000|Overall Study|Lost to Follow-up|5|||
144707855|NCT03911960|521783726|FG001|Overall Study|Lost to Follow-up|3|||
144707856|NCT00391092|521783727|FG000|Overall Study|Death|78|||
144707857|NCT00391092|521783728|FG001|Overall Study|Death|81|||
144707858|NCT00391092|521783727|FG000|Overall Study|Lost to Follow-up|13|||
144707859|NCT00391092|521783728|FG001|Overall Study|Lost to Follow-up|18|||
144707860|NCT00391092|521783727|FG000|Overall Study|Alive on treatment|29|||
144707861|NCT00391092|521783728|FG001|Overall Study|Alive on treatment|33|||
144707862|NCT00391092|521783727|FG000|Overall Study|Alive in follow-up|88|||
144707863|NCT00391092|521783728|FG001|Overall Study|Alive in follow-up|84|||
144707864|NCT00424515|521783731|FG000|Overall Study|Progressive Disease|10|||
144707865|NCT00424515|521783732|FG001|Overall Study|Progressive Disease|11|||
144707866|NCT00424515|521783731|FG000|Overall Study|Adverse Event|0|||
144707867|NCT00424515|521783732|FG001|Overall Study|Adverse Event|1|||
144707868|NCT00424515|521783731|FG000|Overall Study|Intercurrent Illness|0|||
144707869|NCT00424515|521783732|FG001|Overall Study|Intercurrent Illness|1|||
144707870|NCT00424515|521783731|FG000|Overall Study|Withdrawal by Subject|1|||
144707871|NCT00424515|521783732|FG001|Overall Study|Withdrawal by Subject|0|||
144707872|NCT00858234|521783733|FG000|Overall Study|Adverse Event|6|||
144707873|NCT00858234|521783733|FG000|Overall Study|Progressive disease|2|||
144707874|NCT00858234|521783733|FG000|Overall Study|Status unknown|1|||
144707875|NCT04318535|521783734|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
144707876|NCT04318535|521783735|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
144707877|NCT04318535|521783736|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
144707878|NCT02675426|521783741|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
144707879|NCT02675426|521783742|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
144707880|NCT02675426|521783743|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
144707881|NCT02675426|521783744|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
144707882|NCT02675426|521783741|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
144707883|NCT02675426|521783742|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
144707884|NCT02675426|521783743|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
144707885|NCT02675426|521783744|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
144707886|NCT02675426|521783741|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
144707887|NCT02675426|521783742|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
144707888|NCT02675426|521783743|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
144707889|NCT02675426|521783744|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
144707890|NCT02675426|521783741|FG000|Period 1: Week 1 to Week 12|Other|2|||
144707891|NCT02675426|521783742|FG001|Period 1: Week 1 to Week 12|Other|1|||
144707892|NCT02675426|521783743|FG002|Period 1: Week 1 to Week 12|Other|0|||
144707893|NCT02675426|521783744|FG003|Period 1: Week 1 to Week 12|Other|2|||
144707894|NCT02675426|521783741|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
144707895|NCT02675426|521783742|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
144707896|NCT02675426|521783743|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
144707897|NCT02675426|521783744|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
144707898|NCT02675426|521783741|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
144707899|NCT02675426|521783742|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
144707900|NCT02675426|521783743|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
144707901|NCT02675426|521783744|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
144707902|NCT02675426|521783741|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
144707903|NCT02675426|521783742|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
144707904|NCT02675426|521783743|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
144707905|NCT02675426|521783744|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
144707906|NCT02675426|521783741|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
144707907|NCT02675426|521783742|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
144707908|NCT02675426|521783743|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
144707909|NCT02675426|521783744|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
144707910|NCT02675426|521783741|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
144707911|NCT02675426|521783742|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
144707912|NCT02675426|521783743|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
144707913|NCT02675426|521783744|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
144707914|NCT02675426|521783741|FG000|Period 2: Week 12 to Week 260|Other|8|||
144707915|NCT02675426|521783742|FG001|Period 2: Week 12 to Week 260|Other|12|||
144707916|NCT02675426|521783743|FG002|Period 2: Week 12 to Week 260|Other|23|||
144707917|NCT02675426|521783744|FG003|Period 2: Week 12 to Week 260|Other|15|||
144707918|NCT02428231|521783747|FG000|Overall Study|Other|10|||
144707919|NCT02428231|521783748|FG001|Overall Study|Other|16|||
144707920|NCT02428231|521783747|FG000|Overall Study|Required Symptomatic Therapy|0|||
144707921|NCT02428231|521783748|FG001|Overall Study|Required Symptomatic Therapy|1|||
144707922|NCT02428231|521783747|FG000|Overall Study|Adverse Event|3|||
144707923|NCT02428231|521783748|FG001|Overall Study|Adverse Event|0|||
144707924|NCT02156466|521783751|FG000|Overall Study|Adverse Event|0|||
144707925|NCT02156466|521783752|FG001|Overall Study|Adverse Event|0|||
144707926|NCT02156466|521783753|FG002|Overall Study|Adverse Event|1|||
144707927|NCT02156466|521783754|FG003|Overall Study|Adverse Event|1|||
144707928|NCT02156466|521783755|FG004|Overall Study|Adverse Event|0|||
144707929|NCT02156466|521783751|FG000|Overall Study|Quantiferon Positivity|0|||
144707930|NCT02156466|521783752|FG001|Overall Study|Quantiferon Positivity|0|||
144707931|NCT02156466|521783753|FG002|Overall Study|Quantiferon Positivity|0|||
144707932|NCT02156466|521783754|FG003|Overall Study|Quantiferon Positivity|1|||
144707933|NCT02156466|521783755|FG004|Overall Study|Quantiferon Positivity|0|||
144707934|NCT02237118|521783756|FG000|Overall Study|Protocol Violation|0|||
144707935|NCT02237118|521783757|FG001|Overall Study|Protocol Violation|1|||
144707936|NCT02237118|521783756|FG000|Overall Study|consent withdrawn|1|||
144707937|NCT02237118|521783757|FG001|Overall Study|consent withdrawn|0|||
144707938|NCT04470622|521783758|FG000|Overall Study|Withdrawal by Subject|0|||
144707939|NCT04470622|521783759|FG001|Overall Study|Withdrawal by Subject|1|||
144707940|NCT04470622|521783758|FG000|Overall Study|Screen Failure|0|||
144707941|NCT04470622|521783759|FG001|Overall Study|Screen Failure|1|||
144707942|NCT04470622|521783758|FG000|Overall Study|Death|0|||
144707943|NCT04470622|521783759|FG001|Overall Study|Death|1|||
144707944|NCT01586624|521783761|FG000|Overall Study|Adverse Event|3|||
144707945|NCT01586624|521783762|FG001|Overall Study|Adverse Event|0|||
144707946|NCT01586624|521783763|FG002|Overall Study|Adverse Event|2|||
144707947|NCT01586624|521783764|FG003|Overall Study|Adverse Event|1|||
144707948|NCT01586624|521783765|FG004|Overall Study|Adverse Event|3|||
144707949|NCT01586624|521783766|FG005|Overall Study|Adverse Event|3|||
144707950|NCT01586624|521783767|FG006|Overall Study|Adverse Event|2|||
144707951|NCT01586624|521783768|FG007|Overall Study|Adverse Event|3|||
144707952|NCT01586624|521783761|FG000|Overall Study|Physician Decision|0|||
144707953|NCT01586624|521783762|FG001|Overall Study|Physician Decision|1|||
144707954|NCT01586624|521783763|FG002|Overall Study|Physician Decision|1|||
144707955|NCT01586624|521783764|FG003|Overall Study|Physician Decision|0|||
144707956|NCT01586624|521783765|FG004|Overall Study|Physician Decision|2|||
144707957|NCT01586624|521783766|FG005|Overall Study|Physician Decision|0|||
144707958|NCT01586624|521783767|FG006|Overall Study|Physician Decision|1|||
144707959|NCT01586624|521783768|FG007|Overall Study|Physician Decision|1|||
144707960|NCT01586624|521783761|FG000|Overall Study|Withdrawal by Subject|0|||
144707961|NCT01586624|521783762|FG001|Overall Study|Withdrawal by Subject|0|||
144707962|NCT01586624|521783763|FG002|Overall Study|Withdrawal by Subject|0|||
144707963|NCT01586624|521783764|FG003|Overall Study|Withdrawal by Subject|1|||
144707964|NCT01586624|521783765|FG004|Overall Study|Withdrawal by Subject|0|||
144707965|NCT01586624|521783766|FG005|Overall Study|Withdrawal by Subject|0|||
144707966|NCT01586624|521783767|FG006|Overall Study|Withdrawal by Subject|0|||
144707967|NCT01586624|521783768|FG007|Overall Study|Withdrawal by Subject|0|||
144707968|NCT01586624|521783761|FG000|Overall Study|Evidence of disease progression|1|||
144707969|NCT01586624|521783762|FG001|Overall Study|Evidence of disease progression|3|||
144707970|NCT01586624|521783763|FG002|Overall Study|Evidence of disease progression|2|||
144707971|NCT01586624|521783764|FG003|Overall Study|Evidence of disease progression|5|||
144707972|NCT01586624|521783765|FG004|Overall Study|Evidence of disease progression|3|||
144707973|NCT01586624|521783766|FG005|Overall Study|Evidence of disease progression|5|||
144707974|NCT01586624|521783767|FG006|Overall Study|Evidence of disease progression|4|||
144707975|NCT01586624|521783768|FG007|Overall Study|Evidence of disease progression|6|||
144707976|NCT01586624|521783761|FG000|Overall Study|Screen failure (no treatment received)|0|||
144707977|NCT01586624|521783762|FG001|Overall Study|Screen failure (no treatment received)|0|||
144707978|NCT01586624|521783763|FG002|Overall Study|Screen failure (no treatment received)|0|||
144707979|NCT01586624|521783764|FG003|Overall Study|Screen failure (no treatment received)|0|||
144707980|NCT01586624|521783765|FG004|Overall Study|Screen failure (no treatment received)|0|||
144707981|NCT01586624|521783766|FG005|Overall Study|Screen failure (no treatment received)|0|||
144707982|NCT01586624|521783767|FG006|Overall Study|Screen failure (no treatment received)|1|||
144707983|NCT01586624|521783768|FG007|Overall Study|Screen failure (no treatment received)|0|||
144707984|NCT00953927|521783769|FG000|Overall Study|Lost to Follow-up|61|||
144707985|NCT00953927|521783770|FG001|Overall Study|Lost to Follow-up|65|||
144707986|NCT00953927|521783769|FG000|Overall Study|Withdrawal by Subject|36|||
144707987|NCT00953927|521783770|FG001|Overall Study|Withdrawal by Subject|25|||
144707988|NCT00953927|521783769|FG000|Overall Study|Death|7|||
144707989|NCT00953927|521783770|FG001|Overall Study|Death|4|||
144707990|NCT00953927|521783769|FG000|Overall Study|Other study discontinuation|1|||
144707991|NCT00953927|521783770|FG001|Overall Study|Other study discontinuation|1|||
144707992|NCT01396161|521783771|FG000|Overall Study|Withdrawal by Subject|0|||
144707993|NCT01396161|521783772|FG001|Overall Study|Withdrawal by Subject|0|||
144707994|NCT01396161|521783773|FG002|Overall Study|Withdrawal by Subject|0|||
144707995|NCT01396161|521783774|FG003|Overall Study|Withdrawal by Subject|0|||
144707996|NCT01396161|521783775|FG004|Overall Study|Withdrawal by Subject|1|||
144707997|NCT01396161|521783776|FG005|Overall Study|Withdrawal by Subject|0|||
144707998|NCT01396161|521783777|FG006|Overall Study|Withdrawal by Subject|0|||
144707999|NCT01396161|521783771|FG000|Overall Study|Other|0|||
144708000|NCT01396161|521783772|FG001|Overall Study|Other|0|||
144708001|NCT01396161|521783773|FG002|Overall Study|Other|0|||
144708002|NCT01396161|521783774|FG003|Overall Study|Other|0|||
144708003|NCT01396161|521783775|FG004|Overall Study|Other|0|||
144708004|NCT01396161|521783776|FG005|Overall Study|Other|0|||
144708005|NCT01396161|521783777|FG006|Overall Study|Other|1|||
144708006|NCT02962739|521783782|FG000|Overall Study|Withdrawal by Subject|0|||
144708007|NCT02962739|521783783|FG001|Overall Study|Withdrawal by Subject|1|||
144708008|NCT02962739|521783784|FG002|Overall Study|Withdrawal by Subject|0|||
144708009|NCT02962739|521783785|FG003|Overall Study|Withdrawal by Subject|0|||
144708010|NCT02962739|521783786|FG004|Overall Study|Withdrawal by Subject|0|||
144708011|NCT02962739|521783787|FG005|Overall Study|Withdrawal by Subject|0|||
144708012|NCT02962739|521783782|FG000|Overall Study|Protocol Violation|0|||
144708013|NCT02962739|521783783|FG001|Overall Study|Protocol Violation|0|||
144708014|NCT02962739|521783784|FG002|Overall Study|Protocol Violation|1|||
144708015|NCT02962739|521783785|FG003|Overall Study|Protocol Violation|0|||
144708016|NCT02962739|521783786|FG004|Overall Study|Protocol Violation|1|||
144708017|NCT02962739|521783787|FG005|Overall Study|Protocol Violation|0|||
144708018|NCT00817778|521783791|FG000|Overall Study|Adverse Event|1|||
144708019|NCT00817778|521783792|FG001|Overall Study|Adverse Event|0|||
144708020|NCT00817778|521783791|FG000|Overall Study|Withdrawal by Subject|1|||
144708021|NCT00817778|521783792|FG001|Overall Study|Withdrawal by Subject|1|||
144708022|NCT00817778|521783791|FG000|Overall Study|Protocol Violation|0|||
144708023|NCT00817778|521783792|FG001|Overall Study|Protocol Violation|1|||
144708024|NCT00817778|521783791|FG000|Overall Study|Study-specific discontinuation criteria|0|||
144708025|NCT00817778|521783792|FG001|Overall Study|Study-specific discontinuation criteria|1|||
144708026|NCT00817778|521783791|FG000|Overall Study|Poor venous access|1|||
144480325|NCT00675506|520957799|FG000|Overall Study|Disclosed history of cancer|1|||
144480326|NCT00675506|520957800|FG001|Overall Study|Disclosed history of cancer|0|||
144708027|NCT00817778|521783792|FG001|Overall Study|Poor venous access|0|||
144708028|NCT03343054|521783793|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
144708029|NCT03343054|521783794|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
144708030|NCT03343054|521783795|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
144708031|NCT03343054|521783793|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
144708032|NCT03343054|521783794|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
144708033|NCT03343054|521783795|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
144708034|NCT03343054|521783793|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
144708035|NCT03343054|521783794|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
144708036|NCT03343054|521783795|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
144708037|NCT03343054|521783793|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
144708038|NCT03343054|521783794|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
144708039|NCT03343054|521783795|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
144708040|NCT03578276|521783796|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
144708041|NCT03578276|521783797|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
144708042|NCT02360397|521783800|FG000|Overall Study|Incomplete screening|3|||
144708043|NCT02360397|521783800|FG000|Overall Study|Adverse Event|1|||
144708044|NCT01537549|521783801|FG000|Overall Study|Lost to Follow-up|1|||
144708045|NCT01537549|521783801|FG000|Overall Study|Withdrawal by Subject|2|||
144708046|NCT01286207|521783806|FG000|Overall Study|Adverse Event|27|||
144708047|NCT01286207|521783807|FG001|Overall Study|Adverse Event|41|||
144708048|NCT01286207|521783808|FG002|Overall Study|Adverse Event|8|||
144708049|NCT01286207|521783806|FG000|Overall Study|Lost to Follow-up|49|||
144708050|NCT01286207|521783807|FG001|Overall Study|Lost to Follow-up|43|||
144708051|NCT01286207|521783808|FG002|Overall Study|Lost to Follow-up|20|||
144708052|NCT01286207|521783806|FG000|Overall Study|Withdrawal by Subject|93|||
144708053|NCT01286207|521783807|FG001|Overall Study|Withdrawal by Subject|79|||
144708054|NCT01286207|521783808|FG002|Overall Study|Withdrawal by Subject|41|||
144708055|NCT01286207|521783806|FG000|Overall Study|Lack of Response|92|||
144708056|NCT01286207|521783807|FG001|Overall Study|Lack of Response|38|||
144708057|NCT01286207|521783808|FG002|Overall Study|Lack of Response|8|||
144708058|NCT01286207|521783806|FG000|Overall Study|Other|37|||
144708059|NCT01286207|521783807|FG001|Overall Study|Other|47|||
144708060|NCT01286207|521783808|FG002|Overall Study|Other|13|||
144480327|NCT00675506|520957799|FG000|Overall Study|Declined participation|1|||
144480328|NCT00675506|520957800|FG001|Overall Study|Declined participation|0|||
144480329|NCT00675506|520957799|FG000|Overall Study|Schedule conflict|0|||
144708061|NCT00981409|521783809|FG000|Overall Study|Adverse Event|4|||
144708062|NCT00981409|521783810|FG001|Overall Study|Adverse Event|0|||
144480330|NCT00675506|520957800|FG001|Overall Study|Schedule conflict|1|||
144480331|NCT01003639|520957803|FG000|Overall Study|Lost to Follow-up|6|||
144708063|NCT00981409|521783809|FG000|Overall Study|Protocol Violation|0|||
144708064|NCT00981409|521783810|FG001|Overall Study|Protocol Violation|1|||
144708065|NCT00981409|521783809|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
144708066|NCT00981409|521783810|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
144708067|NCT00450177|521783811|FG000|Overall Study|Adverse Event|7|||
144708068|NCT00450177|521783812|FG001|Overall Study|Adverse Event|4|||
144708069|NCT00450177|521783811|FG000|Overall Study|Withdrawal by Subject|1|||
144708070|NCT00450177|521783812|FG001|Overall Study|Withdrawal by Subject|6|||
144708071|NCT00450177|521783811|FG000|Overall Study|Withdrawal by Primary Team|1|||
144708072|NCT00450177|521783812|FG001|Overall Study|Withdrawal by Primary Team|1|||
144708073|NCT02923115|521783813|FG000|Overall Study|Lost to Follow-up|0|||
144708074|NCT02923115|521783814|FG001|Overall Study|Lost to Follow-up|0|||
144708075|NCT02923115|521783815|FG002|Overall Study|Lost to Follow-up|0|||
144708076|NCT02923115|521783816|FG003|Overall Study|Lost to Follow-up|1|||
144708077|NCT02923115|521783817|FG004|Overall Study|Lost to Follow-up|0|||
144708078|NCT02923115|521783818|FG005|Overall Study|Lost to Follow-up|0|||
144708079|NCT02923115|521783813|FG000|Overall Study|Withdrawal by Subject|0|||
144708080|NCT02923115|521783814|FG001|Overall Study|Withdrawal by Subject|1|||
144708081|NCT02923115|521783815|FG002|Overall Study|Withdrawal by Subject|0|||
144708082|NCT02923115|521783816|FG003|Overall Study|Withdrawal by Subject|0|||
144708083|NCT02923115|521783817|FG004|Overall Study|Withdrawal by Subject|0|||
144708084|NCT02923115|521783818|FG005|Overall Study|Withdrawal by Subject|0|||
144708085|NCT02923115|521783813|FG000|Overall Study|Randomized, but not dosed|0|||
144480332|NCT01003639|520957804|FG001|Overall Study|Lost to Follow-up|9|||
144708086|NCT02923115|521783814|FG001|Overall Study|Randomized, but not dosed|0|||
144708087|NCT02923115|521783815|FG002|Overall Study|Randomized, but not dosed|3|||
144708088|NCT02923115|521783816|FG003|Overall Study|Randomized, but not dosed|1|||
144708089|NCT02923115|521783817|FG004|Overall Study|Randomized, but not dosed|5|||
144708090|NCT02923115|521783818|FG005|Overall Study|Randomized, but not dosed|0|||
144708091|NCT03869684|521783821|FG000|Overall Study|Adverse Event|0|||
144708092|NCT03869684|521783822|FG001|Overall Study|Adverse Event|3|||
144708093|NCT03869684|521783823|FG002|Overall Study|Adverse Event|1|||
144708094|NCT03869684|521783821|FG000|Overall Study|Withdrawal by Subject|1|||
144708095|NCT03869684|521783822|FG001|Overall Study|Withdrawal by Subject|0|||
144708096|NCT03869684|521783823|FG002|Overall Study|Withdrawal by Subject|0|||
144708097|NCT03869684|521783821|FG000|Overall Study|Lost to Follow-up|1|||
144708098|NCT03869684|521783822|FG001|Overall Study|Lost to Follow-up|0|||
144708099|NCT03869684|521783823|FG002|Overall Study|Lost to Follow-up|0|||
144708100|NCT03869684|521783821|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
144708101|NCT03869684|521783822|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
144708102|NCT03869684|521783823|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
144708103|NCT04056299|521783824|FG000|Overall Study|Sponsor discontinued study|3|||
144708104|NCT04056299|521783825|FG001|Overall Study|Sponsor discontinued study|3|||
144708105|NCT01296152|521783832|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
144708106|NCT04840901|521783833|FG000|Overall Study|Lost to Follow-up|3|||
144708107|NCT04840901|521783834|FG001|Overall Study|Lost to Follow-up|1|||
144708108|NCT04840901|521783833|FG000|Overall Study|Moved|1|||
144708109|NCT04840901|521783834|FG001|Overall Study|Moved|0|||
144708110|NCT04840901|521783833|FG000|Overall Study|Unable to comply with study schedule|0|||
144708111|NCT04840901|521783834|FG001|Overall Study|Unable to comply with study schedule|1|||
144708112|NCT04840901|521783833|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
144708113|NCT04840901|521783834|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
144708114|NCT01268683|521783835|FG000|Overall Study|Lost to Follow-up|1|||
144367686|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
144367687|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
144367688|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
144367689|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
144367690|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
144367691|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
144367692|NCT02113982|520557327|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
144367693|NCT02113982|520557328|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
144367694|NCT02113982|520557329|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
144367695|NCT02113982|520557330|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
144367696|NCT02113982|520557331|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
144367697|NCT02113982|520557332|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
144367698|NCT02113982|520557333|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
144367699|NCT02113982|520557334|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
144708115|NCT01268683|521783835|FG000|Overall Study|Death|1|||
144367700|NCT02113982|520557335|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
144367701|NCT02113982|520557336|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
144708116|NCT01988493|521783836|FG000|Overall Study|Randomized but not treated|0|||
144708117|NCT01988493|521783837|FG001|Overall Study|Randomized but not treated|0|||
144708118|NCT01988493|521783838|FG002|Overall Study|Randomized but not treated|0|||
144708119|NCT01988493|521783839|FG003|Overall Study|Randomized but not treated|0|||
144708120|NCT01988493|521783840|FG004|Overall Study|Randomized but not treated|1|||
144708121|NCT03891875|521783843|FG000|Overall Study|Withdrawal by Subject|20|||
144708122|NCT03891875|521783844|FG001|Overall Study|Withdrawal by Subject|3|||
144708123|NCT03891875|521783843|FG000|Overall Study|Adverse Event|10|||
144708124|NCT03891875|521783844|FG001|Overall Study|Adverse Event|4|||
144708125|NCT03891875|521783843|FG000|Overall Study|Physician Decision|1|||
144708126|NCT03891875|521783844|FG001|Overall Study|Physician Decision|1|||
144708127|NCT03891875|521783843|FG000|Overall Study|Protocol Violation|1|||
144708128|NCT03891875|521783844|FG001|Overall Study|Protocol Violation|0|||
144708129|NCT03891875|521783843|FG000|Overall Study|Lost to Follow-up|1|||
144708130|NCT03891875|521783844|FG001|Overall Study|Lost to Follow-up|0|||
144708131|NCT03891875|521783843|FG000|Overall Study|COVID-19 infection|1|||
144708132|NCT03891875|521783844|FG001|Overall Study|COVID-19 infection|0|||
144708133|NCT02756078|521783845|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
144708134|NCT02756078|521783846|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
144708135|NCT02756078|521783845|FG000|Period 1|Lost to Follow-up|0|||
144708136|NCT02756078|521783846|FG001|Period 1|Lost to Follow-up|2|||
144708137|NCT02756078|521783845|FG000|Period 1|Protocol Violation|0|||
144708138|NCT02756078|521783846|FG001|Period 1|Protocol Violation|1|||
144708139|NCT02756078|521783845|FG000|Period 1|Adverse Event|1|||
144708140|NCT02756078|521783846|FG001|Period 1|Adverse Event|10|||
144708141|NCT02756078|521783845|FG000|Period 1|Withdrawal by Subject|6|||
144708142|NCT02756078|521783846|FG001|Period 1|Withdrawal by Subject|6|||
144708143|NCT02756078|521783845|FG000|Period 1|Lens Discomfort|2|||
144708144|NCT02756078|521783846|FG001|Period 1|Lens Discomfort|2|||
144708145|NCT02756078|521783845|FG000|Period 2|Adverse Event|3|||
144708146|NCT02756078|521783846|FG001|Period 2|Adverse Event|5|||
144708147|NCT02756078|521783845|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
144708148|NCT02756078|521783846|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
144708149|NCT02756078|521783845|FG000|Period 2|Withdrawal by Subject|3|||
144708150|NCT02756078|521783846|FG001|Period 2|Withdrawal by Subject|1|||
144708151|NCT05349188|521783847|FG000|Overall Study|Withdrawal by Subject|1|||
144708152|NCT05349188|521783848|FG001|Overall Study|Withdrawal by Subject|0|||
144708153|NCT02268045|521783849|FG000|Overall Study|Death|4|||
144708154|NCT02268045|521783850|FG001|Overall Study|Death|4|||
144708155|NCT02268045|521783849|FG000|Overall Study|Disease Progression|2|||
144708156|NCT02268045|521783850|FG001|Overall Study|Disease Progression|1|||
144708157|NCT02268045|521783849|FG000|Overall Study|Adverse Event|7|||
144708158|NCT02268045|521783850|FG001|Overall Study|Adverse Event|7|||
144708159|NCT02268045|521783849|FG000|Overall Study|Withdrawal by Subject|2|||
144708160|NCT02268045|521783850|FG001|Overall Study|Withdrawal by Subject|6|||
144708161|NCT02268045|521783849|FG000|Overall Study|Physician Decision|0|||
144708162|NCT02268045|521783850|FG001|Overall Study|Physician Decision|1|||
144708163|NCT02268045|521783849|FG000|Overall Study|Protocol Violation|1|||
144708164|NCT02268045|521783850|FG001|Overall Study|Protocol Violation|1|||
144708165|NCT00481871|521783853|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
144708166|NCT00481871|521783854|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
144708167|NCT00481871|521783855|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
144708168|NCT00481871|521783856|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
144708169|NCT00481871|521783857|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
144708170|NCT03332212|521783858|FG000|Overall Study|Not treated|0|||
144708171|NCT03332212|521783859|FG001|Overall Study|Not treated|1|||
144708172|NCT03332212|521783860|FG002|Overall Study|Not treated|0|||
144708173|NCT03332212|521783861|FG003|Overall Study|Not treated|0|||
144708174|NCT03332212|521783858|FG000|Overall Study|Adverse Event|0|||
144708175|NCT03332212|521783859|FG001|Overall Study|Adverse Event|0|||
144708176|NCT03332212|521783860|FG002|Overall Study|Adverse Event|0|||
144708177|NCT03332212|521783861|FG003|Overall Study|Adverse Event|1|||
144708178|NCT03332212|521783858|FG000|Overall Study|worsening of disease under study|1|||
144708179|NCT03332212|521783859|FG001|Overall Study|worsening of disease under study|1|||
144708180|NCT03332212|521783860|FG002|Overall Study|worsening of disease under study|0|||
144708181|NCT03332212|521783861|FG003|Overall Study|worsening of disease under study|0|||
144708182|NCT01308762|521783865|FG000|Overall Study|Protocol Violation|0|||
144708183|NCT01308762|521783866|FG001|Overall Study|Protocol Violation|1|||
144708184|NCT01308762|521783867|FG002|Overall Study|Protocol Violation|0|||
144708185|NCT02058368|521783868|FG000|Overall Study|Adverse Event|15|||
144708186|NCT02058368|521783869|FG001|Overall Study|Adverse Event|20|||
144708187|NCT02058368|521783868|FG000|Overall Study|Lack of Efficacy|0|||
144708188|NCT02058368|521783869|FG001|Overall Study|Lack of Efficacy|1|||
144708189|NCT02058368|521783868|FG000|Overall Study|Protocol Violation|0|||
144708190|NCT02058368|521783869|FG001|Overall Study|Protocol Violation|4|||
144708191|NCT02058368|521783868|FG000|Overall Study|Lost to Follow-up|2|||
144708192|NCT02058368|521783869|FG001|Overall Study|Lost to Follow-up|0|||
144708193|NCT02058368|521783868|FG000|Overall Study|Physician Decision|2|||
144708194|NCT02058368|521783869|FG001|Overall Study|Physician Decision|3|||
144708195|NCT02058368|521783868|FG000|Overall Study|Withdrawal by Subject|22|||
144708196|NCT02058368|521783869|FG001|Overall Study|Withdrawal by Subject|26|||
144708197|NCT01652872|521783870|FG000|Overall Study|Death|36|||
144708198|NCT01652872|521783871|FG001|Overall Study|Death|39|||
144708199|NCT01652872|521783870|FG000|Overall Study|Lost to Follow-up|28|||
144708200|NCT01652872|521783871|FG001|Overall Study|Lost to Follow-up|23|||
144708201|NCT01652872|521783870|FG000|Overall Study|Decision by sponsor|5|||
144708202|NCT01652872|521783871|FG001|Overall Study|Decision by sponsor|7|||
144708203|NCT01652872|521783870|FG000|Overall Study|Withdrawal by Subject|76|||
144708204|NCT01652872|521783871|FG001|Overall Study|Withdrawal by Subject|84|||
144708205|NCT05899218|521783872|FG000|Overall Study|Lost to Follow-up|2|||
144708206|NCT05899218|521783873|FG001|Overall Study|Lost to Follow-up|2|||
144708207|NCT05899218|521783872|FG000|Overall Study|deemed ineligible out of country|1|||
144708208|NCT05899218|521783873|FG001|Overall Study|deemed ineligible out of country|0|||
144708209|NCT03594175|521783874|FG000|Overall Study|Not treated|8|||
144708210|NCT03594175|521783875|FG001|Overall Study|Not treated|1|||
144708211|NCT03594175|521783876|FG002|Overall Study|Not treated|5|||
144708212|NCT03594175|521783874|FG000|Overall Study|Adverse Event|3|||
144708213|NCT03594175|521783875|FG001|Overall Study|Adverse Event|0|||
144708214|NCT03594175|521783876|FG002|Overall Study|Adverse Event|0|||
144708215|NCT03594175|521783874|FG000|Overall Study|Withdrawal by Subject|3|||
144708216|NCT03594175|521783875|FG001|Overall Study|Withdrawal by Subject|0|||
144708217|NCT03594175|521783876|FG002|Overall Study|Withdrawal by Subject|0|||
144708218|NCT03594175|521783874|FG000|Overall Study|Protocol Violation|2|||
144708219|NCT03594175|521783875|FG001|Overall Study|Protocol Violation|2|||
144708220|NCT03594175|521783876|FG002|Overall Study|Protocol Violation|2|||
144708221|NCT01020773|521786143|FG000|Overall Study|Withdrawal by Subject|4|||
144708222|NCT01020773|521786144|FG001|Overall Study|Withdrawal by Subject|3|||
144708223|NCT03853213|521786145|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
144708224|NCT03853213|521786146|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
144708225|NCT03853213|521786145|FG000|Overall Study|Other (e.g., too busy)|0|||
144708226|NCT03853213|521786146|FG001|Overall Study|Other (e.g., too busy)|2|||
144708227|NCT01788163|521786147|FG000|Overall Study|Other|53|||
144708228|NCT01788163|521786148|FG001|Overall Study|Other|0|||
144708229|NCT01788163|521786149|FG002|Overall Study|Other|0|||
144708230|NCT01788163|521786150|FG003|Overall Study|Other|0|||
144708231|NCT01788163|521786151|FG004|Overall Study|Other|0|||
144708232|NCT01788163|521786152|FG005|Overall Study|Other|7|||
144708233|NCT01788163|521786153|FG006|Overall Study|Other|1|||
144708234|NCT01788163|521786154|FG007|Overall Study|Other|48|||
144708235|NCT01788163|521786155|FG008|Overall Study|Other|15|||
144708236|NCT01788163|521786147|FG000|Overall Study|Withdrawal by Subject|2|||
144708237|NCT01788163|521786148|FG001|Overall Study|Withdrawal by Subject|0|||
144708238|NCT01788163|521786149|FG002|Overall Study|Withdrawal by Subject|0|||
144708239|NCT01788163|521786150|FG003|Overall Study|Withdrawal by Subject|0|||
144708240|NCT01788163|521786151|FG004|Overall Study|Withdrawal by Subject|0|||
144708241|NCT01788163|521786152|FG005|Overall Study|Withdrawal by Subject|0|||
144708242|NCT01788163|521786153|FG006|Overall Study|Withdrawal by Subject|0|||
144708243|NCT01788163|521786154|FG007|Overall Study|Withdrawal by Subject|0|||
144708244|NCT01788163|521786155|FG008|Overall Study|Withdrawal by Subject|1|||
144708245|NCT00545441|521786156|FG000|Overall Study|Fistula draining at 6 months|2|||
144708246|NCT00545441|521786157|FG001|Overall Study|Fistula draining at 6 months|4|||
144708247|NCT00545441|521786156|FG000|Overall Study|Lost to Follow-up|9|||
144708248|NCT00545441|521786157|FG001|Overall Study|Lost to Follow-up|5|||
144708249|NCT00545441|521786156|FG000|Overall Study|Technical failure|0|||
144708250|NCT00545441|521786157|FG001|Overall Study|Technical failure|1|||
144708251|NCT00545441|521786156|FG000|Overall Study|Withdrawal by Subject|1|||
144708252|NCT00545441|521786157|FG001|Overall Study|Withdrawal by Subject|1|||
144708253|NCT00545441|521786156|FG000|Overall Study|Persistence or recurrence of fistula|5|||
144708254|NCT00545441|521786157|FG001|Overall Study|Persistence or recurrence of fistula|2|||
144708255|NCT00545441|521786156|FG000|Overall Study|Patients were not treated|1|||
144708256|NCT00545441|521786157|FG001|Overall Study|Patients were not treated|3|||
144708257|NCT00265239|521786158|FG000|Overall Study|Adverse Event|2|||
144708258|NCT00265239|521786159|FG001|Overall Study|Adverse Event|1|||
144708259|NCT02803138|521786160|FG000|Overall Study|Failure to return|38|||
144708260|NCT02803138|521786160|FG000|Overall Study|Insufficient virological response|2|||
144708261|NCT02803138|521786160|FG000|Overall Study|Withdrawn consent|1|||
144708262|NCT02803138|521786160|FG000|Overall Study|Death|1|||
144708263|NCT02803138|521786160|FG000|Overall Study|Other, not specified|28|||
144708264|NCT00021229|521786161|FG000|Overall Study|Adverse Event|10|||
144708265|NCT00021229|521786162|FG001|Overall Study|Adverse Event|5|||
144708266|NCT00021229|521786163|FG002|Overall Study|Adverse Event|2|||
144708267|NCT00021229|521786161|FG000|Overall Study|Death|0|||
144708268|NCT00021229|521786162|FG001|Overall Study|Death|1|||
144708269|NCT00021229|521786163|FG002|Overall Study|Death|0|||
144708270|NCT00021229|521786161|FG000|Overall Study|Withdrawal by Subject|7|||
144708271|NCT00021229|521786162|FG001|Overall Study|Withdrawal by Subject|7|||
144708272|NCT00021229|521786163|FG002|Overall Study|Withdrawal by Subject|1|||
144708273|NCT00021229|521786161|FG000|Overall Study|Progressive Disease|15|||
144708274|NCT00021229|521786162|FG001|Overall Study|Progressive Disease|19|||
144708275|NCT00021229|521786163|FG002|Overall Study|Progressive Disease|12|||
144708276|NCT00021229|521786161|FG000|Overall Study|Protocol Violation|1|||
144708277|NCT00021229|521786162|FG001|Overall Study|Protocol Violation|1|||
144708278|NCT00021229|521786163|FG002|Overall Study|Protocol Violation|0|||
144480333|NCT01003639|520957803|FG000|Overall Study|Withdrawal by Subject|9|||
144708279|NCT00021229|521786161|FG000|Overall Study|Physician Decision|0|||
144708280|NCT00021229|521786162|FG001|Overall Study|Physician Decision|0|||
144708281|NCT00021229|521786163|FG002|Overall Study|Physician Decision|1|||
144708282|NCT00021229|521786161|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
144708283|NCT00021229|521786162|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
144708284|NCT00021229|521786163|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
144708285|NCT01858558|521786167|FG000|Overall Study|Death|1|||
144708286|NCT01858558|521786168|FG001|Overall Study|Death|1|||
144708287|NCT01858558|521786167|FG000|Overall Study|Lost to Follow-up|1|||
144708288|NCT01858558|521786168|FG001|Overall Study|Lost to Follow-up|0|||
144708289|NCT01858558|521786167|FG000|Overall Study|Disease progression|3|||
144708290|NCT01858558|521786168|FG001|Overall Study|Disease progression|1|||
144708291|NCT01858558|521786167|FG000|Overall Study|Product contamination|2|||
144708292|NCT01858558|521786168|FG001|Overall Study|Product contamination|0|||
144708293|NCT01858558|521786167|FG000|Overall Study|Failed expansion of cell product|2|||
144708294|NCT01858558|521786168|FG001|Overall Study|Failed expansion of cell product|0|||
144708295|NCT01784419|521786169|FG000|Overall Study|Adverse Event|3|||
144708296|NCT02328547|521786170|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
144708297|NCT02328547|521786171|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
144708298|NCT02328547|521786170|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
144708299|NCT02328547|521786171|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
144708300|NCT00414011|521786172|FG000|Overall Study|Physician Decision|3|||
144708301|NCT00414011|521786172|FG000|Overall Study|Withdrawal by Subject|2|||
144708302|NCT00306852|521786175|FG000|Overall Study|Death|14|||
144708303|NCT00306852|521786176|FG001|Overall Study|Death|14|||
144708304|NCT00306852|521786175|FG000|Overall Study|Lost to Follow-up|15|||
144708305|NCT00306852|521786176|FG001|Overall Study|Lost to Follow-up|24|||
144708306|NCT00883740|521786177|FG000|First Intervention|Lost to Follow-up|1|||
144708307|NCT00883740|521786178|FG001|First Intervention|Lost to Follow-up|0|||
144708308|NCT00883740|521786177|FG000|First Intervention|No longer willing to participate|2|||
144708309|NCT00883740|521786178|FG001|First Intervention|No longer willing to participate|0|||
144708310|NCT00883740|521786177|FG000|First Intervention|Protocol Violation|3|||
144708311|NCT00883740|521786178|FG001|First Intervention|Protocol Violation|6|||
144708312|NCT00883740|521786177|FG000|First Intervention|Adverse Event|1|||
144708313|NCT00883740|521786178|FG001|First Intervention|Adverse Event|2|||
144708314|NCT00883740|521786177|FG000|Second Intervention|Protocol Violation|1|||
144708315|NCT00883740|521786178|FG001|Second Intervention|Protocol Violation|0|||
144708316|NCT00883740|521786177|FG000|Second Intervention|No longer willing to participate|0|||
144708317|NCT00883740|521786178|FG001|Second Intervention|No longer willing to participate|1|||
144708318|NCT01227954|521786181|FG000|Overall Study|Protocol Violation|6|||
144708319|NCT01227954|521786181|FG000|Overall Study|No protocol treatment|7|||
144708320|NCT00078312|521786184|FG000|Overall Study|Adverse Event|43|||
144708321|NCT00078312|521786184|FG000|Overall Study|Lack of Efficacy|15|||
144708322|NCT00078312|521786184|FG000|Overall Study|Lost to Follow-up|41|||
144708323|NCT00078312|521786184|FG000|Overall Study|Physician Decision|9|||
144708324|NCT00078312|521786184|FG000|Overall Study|Protocol Violation|3|||
144708325|NCT00078312|521786184|FG000|Overall Study|Withdrawal by Subject|33|||
144708326|NCT00078312|521786184|FG000|Overall Study|Miscellaneous|33|||
144708327|NCT02216214|521786185|FG000|Overall Study|Randomized Never Received Study Drug|1|||
144708328|NCT02216214|521786186|FG001|Overall Study|Randomized Never Received Study Drug|0|||
144708329|NCT02216214|521786185|FG000|Overall Study|Adverse Event|10|||
144708330|NCT02216214|521786186|FG001|Overall Study|Adverse Event|8|||
144708331|NCT02216214|521786185|FG000|Overall Study|Lack of Efficacy|2|||
144708332|NCT02216214|521786186|FG001|Overall Study|Lack of Efficacy|2|||
144708333|NCT02216214|521786185|FG000|Overall Study|Lost to Follow-up|3|||
144708334|NCT02216214|521786186|FG001|Overall Study|Lost to Follow-up|2|||
144708335|NCT02216214|521786185|FG000|Overall Study|Protocol Violation|4|||
144708336|NCT02216214|521786186|FG001|Overall Study|Protocol Violation|2|||
144480334|NCT01003639|520957804|FG001|Overall Study|Withdrawal by Subject|5|||
144480335|NCT01003639|520957803|FG000|Overall Study|Lack of Efficacy|1|||
144480336|NCT01003639|520957804|FG001|Overall Study|Lack of Efficacy|6|||
144708337|NCT02216214|521786185|FG000|Overall Study|Withdrawal by Subject|22|||
144480337|NCT01003639|520957803|FG000|Overall Study|Adverse Event|0|||
144708338|NCT02216214|521786186|FG001|Overall Study|Withdrawal by Subject|20|||
144708339|NCT02216214|521786185|FG000|Overall Study|Study Terminated By Sponsor|0|||
144708340|NCT02216214|521786186|FG001|Overall Study|Study Terminated By Sponsor|1|||
144480338|NCT01003639|520957804|FG001|Overall Study|Adverse Event|1|||
144480339|NCT01003639|520957803|FG000|Overall Study|Protocol Violation|0|||
144480340|NCT01003639|520957804|FG001|Overall Study|Protocol Violation|1|||
144480341|NCT01003639|520957803|FG000|Overall Study|Physician Decision|1|||
144708341|NCT02216214|521786185|FG000|Overall Study|Miscellaneous|1|||
144708342|NCT02216214|521786186|FG001|Overall Study|Miscellaneous|1|||
144708343|NCT01414062|521786187|FG000|Overall Study|Lost to Follow-up|3|||
144708344|NCT01414062|521786188|FG001|Overall Study|Lost to Follow-up|2|||
144708345|NCT01414062|521786187|FG000|Overall Study|Left Country|1|||
144480342|NCT01003639|520957804|FG001|Overall Study|Physician Decision|0|||
144708346|NCT01414062|521786188|FG001|Overall Study|Left Country|1|||
144708347|NCT01414062|521786187|FG000|Overall Study|Family Disapproval|1|||
144708348|NCT01414062|521786188|FG001|Overall Study|Family Disapproval|0|||
144708349|NCT01414062|521786187|FG000|Overall Study|Withdrawal by Subject|0|||
144708350|NCT01414062|521786188|FG001|Overall Study|Withdrawal by Subject|1|||
144708351|NCT04285983|521786189|FG000|Overall Study|Protocol Violation|6|||
144708352|NCT00103259|521786192|FG000|Overall Study|Death|3|||
144708353|NCT00103259|521786193|FG001|Overall Study|Death|2|||
144708354|NCT00103259|521786192|FG000|Overall Study|Withdrawal by Subject|2|||
144708355|NCT00103259|521786193|FG001|Overall Study|Withdrawal by Subject|3|||
144708356|NCT00103259|521786192|FG000|Overall Study|alternative therapy|1|||
144708357|NCT00103259|521786193|FG001|Overall Study|alternative therapy|0|||
144708358|NCT00103259|521786192|FG000|Overall Study|other (reasons were not specified)|2|||
144480343|NCT00284089|520957805|FG000|Multiple Dose Phase|Adverse Event|1|||
144480344|NCT00284089|520957806|FG001|Multiple Dose Phase|Adverse Event|0|||
144480345|NCT00284089|520957807|FG002|Multiple Dose Phase|Adverse Event|1|||
144708359|NCT00103259|521786193|FG001|Overall Study|other (reasons were not specified)|1|||
144708360|NCT00103259|521786192|FG000|Overall Study|ineligible/no protocol therapy|4|||
144708361|NCT00103259|521786193|FG001|Overall Study|ineligible/no protocol therapy|6|||
144708362|NCT02610842|521786196|FG000|Overall Study|Lost to Follow-up|5|||
144708363|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
144708364|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
144708365|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
144708366|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
144708367|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
144708368|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
144708369|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
144708370|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
144708371|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
144708372|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
144708373|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
144708374|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
144708375|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
144708376|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
144708377|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
144708378|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
144708379|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
144708380|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
144708381|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
144708382|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
144708383|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
144708384|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
144708385|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
144708386|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
144708387|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
144708388|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
144708389|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
144708390|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
144708391|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
144708392|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
144708393|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
144708394|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
144708395|NCT03747939|521786197|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
144708396|NCT03747939|521786198|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
144708397|NCT03747939|521786199|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
144708398|NCT03747939|521786200|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
144708399|NCT03747939|521786197|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
144708400|NCT03747939|521786198|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
144708401|NCT03747939|521786199|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
144708402|NCT03747939|521786200|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
144708403|NCT03747939|521786197|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
144708404|NCT03747939|521786198|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
144708405|NCT03747939|521786199|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
144708406|NCT03747939|521786200|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
144708407|NCT03747939|521786197|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
144708408|NCT03747939|521786198|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
144708409|NCT03747939|521786199|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
144708410|NCT03747939|521786200|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
144708411|NCT03747939|521786197|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
144708412|NCT03747939|521786198|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
144708413|NCT03747939|521786199|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
144708414|NCT03747939|521786200|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
144708415|NCT03747939|521786197|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
144708416|NCT03747939|521786198|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
144708417|NCT03747939|521786199|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
144708418|NCT03747939|521786200|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
144708419|NCT01447628|521786201|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
144708420|NCT01447628|521786202|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
144708421|NCT01447628|521786203|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
144708422|NCT01447628|521786204|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
144708423|NCT00185731|521786205|FG000|Overall Study|Withdrawal by Subject|1|||
144708424|NCT00185731|521786205|FG000|Overall Study|Not Eligible|1|||
144708425|NCT03087773|521786206|FG000|Overall Study|Withdrawal by Subject|8|||
144708426|NCT03087773|521786207|FG001|Overall Study|Withdrawal by Subject|4|||
144708427|NCT03087773|521786206|FG000|Overall Study|Lost to Follow-up|12|||
144708428|NCT03087773|521786207|FG001|Overall Study|Lost to Follow-up|8|||
144708429|NCT02494583|521786210|FG000|Overall Study|Death|224|||
144708430|NCT02494583|521786211|FG001|Overall Study|Death|214|||
144708431|NCT02494583|521786212|FG002|Overall Study|Death|225|||
144708432|NCT02494583|521786210|FG000|Overall Study|Lost to Follow-up|1|||
144708433|NCT02494583|521786211|FG001|Overall Study|Lost to Follow-up|0|||
144708434|NCT02494583|521786212|FG002|Overall Study|Lost to Follow-up|0|||
144708435|NCT02494583|521786210|FG000|Overall Study|Protocol Violation|1|||
144708436|NCT02494583|521786211|FG001|Overall Study|Protocol Violation|2|||
144708437|NCT02494583|521786212|FG002|Overall Study|Protocol Violation|0|||
144708438|NCT02494583|521786210|FG000|Overall Study|Screen Failure|0|||
144708439|NCT02494583|521786211|FG001|Overall Study|Screen Failure|1|||
144708440|NCT02494583|521786212|FG002|Overall Study|Screen Failure|0|||
144708441|NCT02494583|521786210|FG000|Overall Study|Transferred to Extension Study|15|||
144708442|NCT02494583|521786211|FG001|Overall Study|Transferred to Extension Study|15|||
144708443|NCT02494583|521786212|FG002|Overall Study|Transferred to Extension Study|6|||
144708444|NCT02494583|521786210|FG000|Overall Study|Did Not Continue on Extension Study|8|||
144708445|NCT02494583|521786211|FG001|Overall Study|Did Not Continue on Extension Study|10|||
144708446|NCT02494583|521786212|FG002|Overall Study|Did Not Continue on Extension Study|4|||
144708447|NCT02494583|521786210|FG000|Overall Study|Withdrawal by Subject|7|||
144708448|NCT02494583|521786211|FG001|Overall Study|Withdrawal by Subject|15|||
144708449|NCT02494583|521786212|FG002|Overall Study|Withdrawal by Subject|15|||
144708450|NCT00627458|521786219|FG000|Overall Study|Migrated from study area|1|||
144708451|NCT00627458|521786220|FG001|Overall Study|Migrated from study area|0|||
144708452|NCT00627458|521786221|FG002|Overall Study|Migrated from study area|1|||
144708453|NCT00627458|521786219|FG000|Overall Study|Withdrawal by Subject|2|||
144708454|NCT00627458|521786220|FG001|Overall Study|Withdrawal by Subject|6|||
144708455|NCT00627458|521786221|FG002|Overall Study|Withdrawal by Subject|5|||
144708456|NCT00627458|521786219|FG000|Overall Study|Lost to Follow-up|1|||
144708457|NCT00627458|521786220|FG001|Overall Study|Lost to Follow-up|1|||
144708458|NCT00627458|521786221|FG002|Overall Study|Lost to Follow-up|0|||
144708459|NCT01556490|521786224|FG000|Randomized Patients Summary|Protocol Violation|22|||
144708460|NCT01556490|521786225|FG001|Randomized Patients Summary|Protocol Violation|23|||
144708461|NCT01556490|521786224|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
144708462|NCT01556490|521786225|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
144708463|NCT03985293|521786240|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
144708464|NCT03985293|521786241|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
144708465|NCT03985293|521786242|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
144708466|NCT03985293|521786243|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
144708467|NCT03985293|521786244|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
144708468|NCT03985293|521786245|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
144708469|NCT03985293|521786240|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
144708470|NCT03985293|521786241|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
144708471|NCT03985293|521786242|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
144708472|NCT03985293|521786243|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
144708473|NCT03985293|521786244|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
144708474|NCT03985293|521786245|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
144708475|NCT03985293|521786240|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
144708476|NCT03985293|521786241|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
144708477|NCT03985293|521786242|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
144708478|NCT03985293|521786243|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
144708479|NCT03985293|521786244|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
144708480|NCT03985293|521786245|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
144708481|NCT03985293|521786240|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
144708482|NCT03985293|521786241|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
144708483|NCT03985293|521786242|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
144708484|NCT03985293|521786243|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
144708485|NCT03985293|521786244|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
144708486|NCT03985293|521786245|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
144708487|NCT03985293|521786240|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
144708488|NCT03985293|521786241|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
144708489|NCT03985293|521786242|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
144708490|NCT03985293|521786243|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
144708491|NCT03985293|521786244|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
144708492|NCT03985293|521786245|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
144708493|NCT03985293|521786240|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
144708494|NCT03985293|521786241|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
144708495|NCT03985293|521786242|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
144708496|NCT03985293|521786243|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
144708497|NCT03985293|521786244|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
144708498|NCT03985293|521786245|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
144708499|NCT03985293|521786240|FG000|FOLLOW-UP|Lost to Follow-up|0|||
144480346|NCT00284089|520957808|FG003|Multiple Dose Phase|Adverse Event|1|||
144480347|NCT00284089|520957805|FG000|Multiple Dose Phase|Protocol Violation|0|||
144480348|NCT00284089|520957806|FG001|Multiple Dose Phase|Protocol Violation|0|||
144480349|NCT00284089|520957807|FG002|Multiple Dose Phase|Protocol Violation|1|||
144480350|NCT00284089|520957808|FG003|Multiple Dose Phase|Protocol Violation|0|||
144480351|NCT00284089|520957805|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
144480352|NCT00284089|520957806|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
144480353|NCT00284089|520957807|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
144480354|NCT00284089|520957808|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
144480355|NCT00284089|520957805|FG000|Multiple Dose Phase|Death|0|||
144708500|NCT03985293|521786241|FG001|FOLLOW-UP|Lost to Follow-up|0|||
144708501|NCT03985293|521786242|FG002|FOLLOW-UP|Lost to Follow-up|1|||
144708502|NCT03985293|521786243|FG003|FOLLOW-UP|Lost to Follow-up|0|||
144708503|NCT03985293|521786244|FG004|FOLLOW-UP|Lost to Follow-up|0|||
144708504|NCT03985293|521786245|FG005|FOLLOW-UP|Lost to Follow-up|0|||
144708505|NCT01488071|521786246|FG000|Overall Study|Adverse Event|15|||
144708506|NCT01488071|521786247|FG001|Overall Study|Adverse Event|23|||
144708507|NCT01488071|521786246|FG000|Overall Study|Lack of Efficacy|11|||
144708508|NCT01488071|521786247|FG001|Overall Study|Lack of Efficacy|17|||
144708509|NCT01488071|521786246|FG000|Overall Study|Non-compliance with study drug|2|||
144708510|NCT01488071|521786247|FG001|Overall Study|Non-compliance with study drug|0|||
144708511|NCT01488071|521786246|FG000|Overall Study|Protocol Violation|5|||
144708512|NCT01488071|521786247|FG001|Overall Study|Protocol Violation|7|||
144708513|NCT01488071|521786246|FG000|Overall Study|Withdrawal of Consent|14|||
144708514|NCT01488071|521786247|FG001|Overall Study|Withdrawal of Consent|12|||
144708515|NCT01488071|521786246|FG000|Overall Study|Lost to Follow-up|1|||
144708516|NCT01488071|521786247|FG001|Overall Study|Lost to Follow-up|0|||
144708517|NCT01488071|521786246|FG000|Overall Study|Administrative or Other Reason(s)|5|||
144708518|NCT01488071|521786247|FG001|Overall Study|Administrative or Other Reason(s)|4|||
144708519|NCT02139306|521786248|FG000|Overall Study|Withdrawal by Subject|4|||
144708520|NCT02139306|521786249|FG001|Overall Study|Withdrawal by Subject|6|||
144708521|NCT02139306|521786248|FG000|Overall Study|Adverse Event|3|||
144708522|NCT02139306|521786249|FG001|Overall Study|Adverse Event|4|||
144708523|NCT02139306|521786248|FG000|Overall Study|Physician Decision|0|||
144708524|NCT02139306|521786249|FG001|Overall Study|Physician Decision|1|||
144708525|NCT02139306|521786248|FG000|Overall Study|Other Unspecified|2|||
144708526|NCT02139306|521786249|FG001|Overall Study|Other Unspecified|3|||
144708527|NCT02139306|521786248|FG000|Overall Study|Protocol Violation|4|||
144708528|NCT02139306|521786249|FG001|Overall Study|Protocol Violation|0|||
144708529|NCT02587325|521786250|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
144708530|NCT02587325|521786251|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
144708531|NCT02587325|521786252|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
144708532|NCT02587325|521786253|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
144708533|NCT02587325|521786254|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
144708534|NCT02587325|521786250|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
144708535|NCT02587325|521786251|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
144708536|NCT02587325|521786252|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
144708537|NCT02587325|521786253|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
144708538|NCT02587325|521786254|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
144708539|NCT02587325|521786250|FG000|32-Week Optional Extension Part|Adverse Event|0|||
144708540|NCT02587325|521786251|FG001|32-Week Optional Extension Part|Adverse Event|0|||
144708541|NCT02587325|521786252|FG002|32-Week Optional Extension Part|Adverse Event|1|||
144708542|NCT02587325|521786253|FG003|32-Week Optional Extension Part|Adverse Event|0|||
144708543|NCT02587325|521786254|FG004|32-Week Optional Extension Part|Adverse Event|0|||
144708544|NCT02587325|521786250|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
144708545|NCT02587325|521786251|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
144708546|NCT02587325|521786252|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
144708547|NCT02587325|521786253|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
144708548|NCT02587325|521786254|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
144708549|NCT00390572|521786255|FG000|Overall Study|Lost to Follow-up|8|||
144708550|NCT00390572|521786256|FG001|Overall Study|Lost to Follow-up|4|||
144708551|NCT00390572|521786255|FG000|Overall Study|health condition|0|||
144708552|NCT00390572|521786256|FG001|Overall Study|health condition|1|||
144480356|NCT00284089|520957806|FG001|Multiple Dose Phase|Death|0|||
144708553|NCT00391118|521786259|FG000|Overall Study|Adverse Event|3|||
144708554|NCT00391118|521786260|FG001|Overall Study|Adverse Event|10|||
144708555|NCT00391118|521786261|FG002|Overall Study|Adverse Event|7|||
144708556|NCT00391118|521786259|FG000|Overall Study|Lost to Follow-up|0|||
144708557|NCT00391118|521786260|FG001|Overall Study|Lost to Follow-up|2|||
144708558|NCT00391118|521786261|FG002|Overall Study|Lost to Follow-up|3|||
144708559|NCT00391118|521786259|FG000|Overall Study|Withdrawal by Subject|0|||
144708560|NCT00391118|521786260|FG001|Overall Study|Withdrawal by Subject|9|||
144708561|NCT00391118|521786261|FG002|Overall Study|Withdrawal by Subject|1|||
144708562|NCT00391118|521786259|FG000|Overall Study|Death|0|||
144708563|NCT00391118|521786260|FG001|Overall Study|Death|1|||
144480357|NCT00284089|520957807|FG002|Multiple Dose Phase|Death|1|||
144480358|NCT00284089|520957808|FG003|Multiple Dose Phase|Death|1|||
144708564|NCT00391118|521786261|FG002|Overall Study|Death|0|||
144708565|NCT00391118|521786259|FG000|Overall Study|Physician Decision|0|||
144708566|NCT00391118|521786260|FG001|Overall Study|Physician Decision|3|||
144708567|NCT00391118|521786261|FG002|Overall Study|Physician Decision|0|||
144708568|NCT00391118|521786259|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
144708569|NCT00391118|521786260|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
144708570|NCT00391118|521786261|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
144708571|NCT00391118|521786259|FG000|Overall Study|Progressive Disease|7|||
144708572|NCT00391118|521786260|FG001|Overall Study|Progressive Disease|26|||
144708573|NCT00391118|521786261|FG002|Overall Study|Progressive Disease|43|||
144708574|NCT00391118|521786259|FG000|Overall Study|Sponsor Decision|0|||
144708575|NCT00391118|521786260|FG001|Overall Study|Sponsor Decision|1|||
144708576|NCT00391118|521786261|FG002|Overall Study|Sponsor Decision|3|||
144708577|NCT00391118|521786259|FG000|Overall Study|Protocol Violation|1|||
144708578|NCT00391118|521786260|FG001|Overall Study|Protocol Violation|0|||
144708579|NCT00391118|521786261|FG002|Overall Study|Protocol Violation|0|||
144708580|NCT01892020|521786262|FG000|Period 1|Adverse Event|1|||
144708581|NCT01892020|521786263|FG001|Period 1|Adverse Event|1|||
144708582|NCT01892020|521786262|FG000|Period 1|Protocol Violation|2|||
144708583|NCT01892020|521786263|FG001|Period 1|Protocol Violation|4|||
144708584|NCT01892020|521786262|FG000|Period 1|Unclassified|0|||
144708585|NCT01892020|521786263|FG001|Period 1|Unclassified|1|||
144708586|NCT01892020|521786262|FG000|Period 2|Protocol Violation|1|||
144708587|NCT01892020|521786263|FG001|Period 2|Protocol Violation|0|||
144708588|NCT03078192|521786268|FG000|Overall Study|Withdrawal by Subject|2|||
144708589|NCT03078192|521786269|FG001|Overall Study|Withdrawal by Subject|1|||
144708590|NCT03078192|521786268|FG000|Overall Study|screen failure|0|||
144708591|NCT03078192|521786269|FG001|Overall Study|screen failure|3|||
144708592|NCT02873195|521786270|FG000|Overall Study|Ineligible|5|||
144367702|NCT02113982|520557337|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
144367703|NCT02113982|520557338|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
144367704|NCT02113982|520557339|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
144367705|NCT02113982|520557340|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
144367706|NCT02113982|520557327|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367707|NCT02113982|520557328|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367708|NCT02113982|520557329|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367709|NCT02113982|520557330|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367710|NCT02113982|520557331|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367711|NCT02113982|520557332|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367712|NCT02113982|520557333|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367713|NCT02113982|520557334|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367714|NCT02113982|520557335|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367715|NCT02113982|520557336|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367716|NCT02113982|520557337|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367717|NCT02113982|520557338|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
144367718|NCT02113982|520557339|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367719|NCT02113982|520557340|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
144367720|NCT02113982|520557327|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367721|NCT02113982|520557328|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367722|NCT02113982|520557329|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367723|NCT02113982|520557330|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367724|NCT02113982|520557331|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367725|NCT02113982|520557332|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367726|NCT02113982|520557333|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367727|NCT02113982|520557334|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367728|NCT02113982|520557335|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367729|NCT02113982|520557336|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367730|NCT02113982|520557337|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367731|NCT02113982|520557338|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
144367732|NCT02113982|520557339|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
144480359|NCT00284089|520957805|FG000|Extension Phase|Adverse Event|0|||
144708593|NCT02873195|521786271|FG001|Overall Study|Ineligible|0|||
144708594|NCT03107715|521786272|FG000|Overall Study|did not deliver at the home hospital|4|||
144708595|NCT03107715|521786273|FG001|Overall Study|did not deliver at the home hospital|6|||
144708596|NCT03107715|521786272|FG000|Overall Study|infant stillborn|0|||
144708597|NCT03107715|521786273|FG001|Overall Study|infant stillborn|1|||
144708598|NCT02508649|521786274|FG000|Overall Study|Withdrawal by Subject|4|||
144708599|NCT02508649|521786275|FG001|Overall Study|Withdrawal by Subject|6|||
144708600|NCT02508649|521786276|FG002|Overall Study|Withdrawal by Subject|5|||
144708601|NCT02508649|521786277|FG003|Overall Study|Withdrawal by Subject|6|||
144708602|NCT02508649|521786274|FG000|Overall Study|Investigator withdrew the subject|1|||
144708603|NCT02508649|521786275|FG001|Overall Study|Investigator withdrew the subject|2|||
144708604|NCT02508649|521786276|FG002|Overall Study|Investigator withdrew the subject|1|||
144708605|NCT02508649|521786277|FG003|Overall Study|Investigator withdrew the subject|0|||
144708606|NCT02508649|521786274|FG000|Overall Study|Post randomization screening failure|12|||
144708607|NCT02508649|521786275|FG001|Overall Study|Post randomization screening failure|4|||
144708608|NCT02508649|521786276|FG002|Overall Study|Post randomization screening failure|9|||
144708609|NCT02508649|521786277|FG003|Overall Study|Post randomization screening failure|3|||
144708610|NCT02508649|521786274|FG000|Overall Study|Lost to Follow-up|1|||
144708611|NCT02508649|521786275|FG001|Overall Study|Lost to Follow-up|1|||
144708612|NCT02508649|521786276|FG002|Overall Study|Lost to Follow-up|0|||
144708613|NCT02508649|521786277|FG003|Overall Study|Lost to Follow-up|1|||
144708614|NCT03252756|521786279|FG000|Overall Study|Protocol Violation|2|||
144708615|NCT03252756|521786280|FG001|Overall Study|Protocol Violation|4|||
144708616|NCT03252756|521786279|FG000|Overall Study|COVID-19 Pandemic|1|||
144708617|NCT03252756|521786280|FG001|Overall Study|COVID-19 Pandemic|1|||
144708618|NCT03252756|521786279|FG000|Overall Study|Study Drug Expiration|0|||
144708619|NCT03252756|521786280|FG001|Overall Study|Study Drug Expiration|1|||
144708620|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708621|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708622|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708623|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
144708624|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
144708625|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708626|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708627|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708628|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708629|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
144708630|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708631|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708632|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
144708633|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
144708634|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
144708635|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
144708636|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
144708637|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
144708638|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
144708639|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708640|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708641|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708642|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708643|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708644|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
144708645|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708646|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708647|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708648|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
144708649|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708650|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708651|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708652|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
144708653|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
144708654|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
144708655|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
144708656|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
144708657|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
144708658|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
144708659|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708660|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708661|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708662|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708663|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
144708664|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708665|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708666|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708667|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708668|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708669|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708670|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708671|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708672|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
144708673|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708674|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708675|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
144708676|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
144708677|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708678|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708679|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708680|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708681|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708682|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708683|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708684|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144480360|NCT00284089|520957806|FG001|Extension Phase|Adverse Event|0|||
144708685|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708686|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708687|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
144708688|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708689|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708690|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
144708691|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708692|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708693|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
144708694|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
144708695|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
144708696|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
144708697|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
144708698|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708699|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
144708700|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708701|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708702|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
144708703|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708704|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708705|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708706|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
144708707|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708708|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
144708709|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
144708710|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
144708711|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
144708712|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
144480361|NCT00284089|520957807|FG002|Extension Phase|Adverse Event|2|||
144480362|NCT00284089|520957808|FG003|Extension Phase|Adverse Event|2|||
144480363|NCT00284089|520957805|FG000|Extension Phase|condition no longer requires study drug|2|||
144480364|NCT00284089|520957806|FG001|Extension Phase|condition no longer requires study drug|0|||
144480365|NCT00284089|520957807|FG002|Extension Phase|condition no longer requires study drug|2|||
144480366|NCT00284089|520957808|FG003|Extension Phase|condition no longer requires study drug|7|||
144480367|NCT00284089|520957805|FG000|Extension Phase|Protocol Violation|0|||
144480368|NCT00284089|520957806|FG001|Extension Phase|Protocol Violation|0|||
144480369|NCT00284089|520957807|FG002|Extension Phase|Protocol Violation|1|||
144480370|NCT00284089|520957808|FG003|Extension Phase|Protocol Violation|0|||
144480371|NCT00284089|520957805|FG000|Extension Phase|Withdrawal by Subject|0|||
144480372|NCT00284089|520957806|FG001|Extension Phase|Withdrawal by Subject|0|||
144708713|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
144708714|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
144708715|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708716|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708717|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
144708718|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708719|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708720|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708721|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708722|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708723|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708724|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708725|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708726|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708727|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708728|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708729|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708730|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
144708731|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
144708732|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
144708733|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
144708734|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708735|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708736|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708737|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708738|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
144708739|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708740|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708741|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708742|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144480373|NCT00284089|520957807|FG002|Extension Phase|Withdrawal by Subject|1|||
144480374|NCT00284089|520957808|FG003|Extension Phase|Withdrawal by Subject|3|||
144480375|NCT04986982|520957812|FG000|Overall Study|Withdrawal by Subject|3|||
144480376|NCT04986982|520957813|FG001|Overall Study|Withdrawal by Subject|1|||
144480377|NCT04986982|520957812|FG000|Overall Study|Lack of Efficacy|0|||
144480378|NCT04986982|520957813|FG001|Overall Study|Lack of Efficacy|2|||
144480379|NCT04986982|520957812|FG000|Overall Study|Ineligibility|3|||
144480380|NCT04986982|520957813|FG001|Overall Study|Ineligibility|0|||
144480381|NCT04986982|520957812|FG000|Overall Study|Adverse Event|4|||
144480382|NCT04986982|520957813|FG001|Overall Study|Adverse Event|4|||
144708743|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
144708744|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708745|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708746|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708747|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708748|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708749|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708750|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708751|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708752|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
144708753|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
144708754|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
144708755|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
144708756|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
144708757|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
144708758|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
144708759|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
144708760|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
144708761|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
144708762|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
144708763|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
144708764|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
144708765|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
144708766|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
144708767|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
144708768|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
144708769|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
144480383|NCT04986982|520957812|FG000|Overall Study|Lost to Follow-up|0|||
144708770|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
144708771|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
144480384|NCT04986982|520957813|FG001|Overall Study|Lost to Follow-up|1|||
144480385|NCT04986982|520957812|FG000|Overall Study|Sponsor's discretion|1|||
144480386|NCT04986982|520957813|FG001|Overall Study|Sponsor's discretion|0|||
144480387|NCT01407354|520957815|FG000|First Intervention|Withdrawal by Subject|0|||
144480388|NCT01407354|520957816|FG001|First Intervention|Withdrawal by Subject|2|||
144480389|NCT01407354|520957815|FG000|First Intervention|Adverse Event|1|||
144480390|NCT01407354|520957816|FG001|First Intervention|Adverse Event|0|||
144480391|NCT01407354|520957815|FG000|First Intervention|Physician Decision|1|||
144480392|NCT01407354|520957816|FG001|First Intervention|Physician Decision|0|||
144480393|NCT02204579|520957818|FG000|Overall Study|Screen failures|2|||
144480394|NCT02778399|520957819|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
144480395|NCT02778399|520957820|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
144480396|NCT02778399|520957821|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
144480397|NCT02778399|520957822|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
144480398|NCT02778399|520957823|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
144480399|NCT02778399|520957824|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
144480400|NCT02778399|520957819|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
144480401|NCT02778399|520957820|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
144480402|NCT02778399|520957821|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
144708772|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708773|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708774|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708775|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708776|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708777|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708778|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708779|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708780|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708781|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708782|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
144708783|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708784|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708785|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708786|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708787|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708788|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708789|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708790|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
144708791|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
144708792|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
144708793|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708794|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708795|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
144708796|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
144708797|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708798|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
144708799|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708800|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
144708801|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708802|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708803|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
144708804|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
144708805|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
144708806|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
144708807|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
144708808|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
144708809|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
144708810|NCT01915498|521786281|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
144708811|NCT01915498|521786282|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
144708812|NCT01915498|521786283|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
144708813|NCT01915498|521786284|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
144708814|NCT01915498|521786285|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
144708815|NCT01915498|521786286|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
144708816|NCT01915498|521786287|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
144480403|NCT02778399|520957822|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
144708817|NCT01915498|521786288|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
144538206|NCT00146172|521174127|FG005|Overall Study|Disease Progression|2|||
144708818|NCT01915498|521786289|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
144367733|NCT02113982|520557340|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
144367734|NCT02113982|520557327|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367735|NCT02113982|520557328|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367736|NCT02113982|520557329|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367737|NCT02113982|520557330|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367738|NCT02113982|520557331|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367739|NCT02113982|520557332|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367740|NCT02113982|520557333|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367741|NCT02113982|520557334|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367742|NCT02113982|520557335|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367743|NCT02113982|520557336|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367744|NCT02113982|520557337|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367745|NCT02113982|520557338|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
144367746|NCT02113982|520557339|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367747|NCT02113982|520557340|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
144367748|NCT02113982|520557327|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
144367749|NCT02113982|520557328|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
144367750|NCT02113982|520557329|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
144367751|NCT02113982|520557330|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
144367752|NCT02113982|520557331|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
144367753|NCT02113982|520557332|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
144367754|NCT02113982|520557333|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
144367755|NCT02113982|520557334|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
144367756|NCT02113982|520557335|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
144367757|NCT02113982|520557336|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
144367758|NCT02113982|520557337|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
144367759|NCT02113982|520557338|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
144367760|NCT02113982|520557339|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
144367761|NCT02113982|520557340|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
144367762|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367763|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367764|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367765|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367766|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367767|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367768|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367769|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367770|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367771|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367772|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367773|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367774|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
144367775|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
144367776|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367777|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367778|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367779|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367780|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367781|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367782|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367783|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367784|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367785|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367786|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367787|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
144367788|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
144367789|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
144367790|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367791|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367792|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367793|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367794|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367795|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367796|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367797|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367798|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367799|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367800|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144367801|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
144708819|NCT01915498|521786290|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
144708820|NCT01915498|521786291|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
144708821|NCT01915498|521786292|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
144708822|NCT01915498|521786293|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
144708823|NCT01915498|521786294|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
144708824|NCT01915498|521786295|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
144708825|NCT01915498|521786296|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
144708826|NCT01915498|521786297|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
144708827|NCT01915498|521786298|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
144708828|NCT01915498|521786299|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
144708829|NCT01915498|521786281|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708830|NCT01915498|521786282|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708831|NCT01915498|521786283|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708832|NCT01915498|521786284|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708833|NCT01915498|521786285|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708834|NCT01915498|521786286|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708835|NCT01915498|521786287|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708836|NCT01915498|521786288|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708837|NCT01915498|521786289|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708838|NCT01915498|521786290|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708839|NCT01915498|521786291|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708840|NCT01915498|521786292|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708841|NCT01915498|521786293|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708842|NCT01915498|521786294|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708843|NCT01915498|521786295|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708844|NCT01915498|521786296|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708845|NCT01915498|521786297|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708846|NCT01915498|521786298|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
144708847|NCT01915498|521786299|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
144708848|NCT01915498|521786281|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708849|NCT01915498|521786282|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708850|NCT01915498|521786283|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708851|NCT01915498|521786284|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708852|NCT01915498|521786285|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708853|NCT01915498|521786286|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708854|NCT01915498|521786287|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708855|NCT01915498|521786288|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708856|NCT01915498|521786289|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708857|NCT01915498|521786290|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708858|NCT01915498|521786291|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708859|NCT01915498|521786292|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708860|NCT01915498|521786293|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708861|NCT01915498|521786294|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708862|NCT01915498|521786295|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708863|NCT01915498|521786296|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144367802|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
144367803|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
144367804|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367805|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367806|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367807|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367808|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367809|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367810|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367811|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367812|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367813|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367814|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367815|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
144367816|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
144708864|NCT01915498|521786297|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708865|NCT01915498|521786298|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
144708866|NCT01915498|521786299|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
144708867|NCT01915498|521786281|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144480404|NCT02778399|520957823|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
144480405|NCT02778399|520957824|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
144480406|NCT02778399|520957819|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
144480407|NCT02778399|520957820|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
144708868|NCT01915498|521786282|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708869|NCT01915498|521786283|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708870|NCT01915498|521786284|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708871|NCT01915498|521786285|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708872|NCT01915498|521786286|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708873|NCT01915498|521786287|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708874|NCT01915498|521786288|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708875|NCT01915498|521786289|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708876|NCT01915498|521786290|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708877|NCT01915498|521786291|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708878|NCT01915498|521786292|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708879|NCT01915498|521786293|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708880|NCT01915498|521786294|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708881|NCT01915498|521786295|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708882|NCT01915498|521786296|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708883|NCT01915498|521786297|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708884|NCT01915498|521786298|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
144708885|NCT01915498|521786299|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
144708886|NCT01907516|521786300|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
144708887|NCT01907516|521786301|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
144708888|NCT01907516|521786300|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
144708889|NCT01907516|521786301|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
144708890|NCT01907516|521786300|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
144708891|NCT01907516|521786301|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
144708892|NCT01907516|521786300|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
144708893|NCT01907516|521786301|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
144708894|NCT00131937|521786303|FG000|Overall Study|Adverse Event|3|||
144708895|NCT00131937|521786303|FG000|Overall Study|Withdrawal by Subject|2|||
144708896|NCT00131937|521786303|FG000|Overall Study|Physician Decision|1|||
144708897|NCT00131937|521786303|FG000|Overall Study|Disease Progression|7|||
144708898|NCT00131937|521786303|FG000|Overall Study|Alternative therapy|1|||
144708899|NCT01211613|521787983|FG000|Overall Study|Lost to Follow-up|2|||
144708900|NCT01211613|521787984|FG001|Overall Study|Lost to Follow-up|2|||
144708901|NCT01211613|521787985|FG002|Overall Study|Lost to Follow-up|2|||
144708902|NCT01211613|521787983|FG000|Overall Study|Withdrawal by Subject|1|||
144708903|NCT01211613|521787984|FG001|Overall Study|Withdrawal by Subject|0|||
144708904|NCT01211613|521787985|FG002|Overall Study|Withdrawal by Subject|0|||
144708905|NCT03302299|521787986|FG000|Overall Study|Protocol Violation|1|||
144708906|NCT01458132|521787987|FG000|Overall Study|Other|15|||
144708907|NCT01458132|521787988|FG001|Overall Study|Other|3|||
144708908|NCT03543046|521788000|FG000|Overall Study|Adverse Event|1|||
144708909|NCT03543046|521788001|FG001|Overall Study|Adverse Event|1|||
144708910|NCT03543046|521788000|FG000|Overall Study|Physician Decision|1|||
144708911|NCT03543046|521788001|FG001|Overall Study|Physician Decision|1|||
144708912|NCT03543046|521788000|FG000|Overall Study|Protocol Violation|1|||
144708913|NCT03543046|521788001|FG001|Overall Study|Protocol Violation|0|||
144480408|NCT02778399|520957821|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
144480409|NCT02778399|520957822|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
144480410|NCT02778399|520957823|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
144480411|NCT02778399|520957824|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
144480412|NCT02778399|520957819|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
144480413|NCT02778399|520957820|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
144480414|NCT02778399|520957821|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
144480415|NCT02778399|520957822|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
144480416|NCT02778399|520957823|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
144480417|NCT02778399|520957824|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
144480418|NCT02778399|520957819|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
144480419|NCT02778399|520957820|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
144480420|NCT02778399|520957821|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
144708914|NCT00520494|521788011|FG000|Overall Study|Withdrawal by Subject|1|||
144708915|NCT04247594|521788012|FG000|Overall Study|Withdrawal by Subject|4|||
144708916|NCT05354206|521788014|FG000|Overall Study|Withdrawal by Subject|1|||
144708917|NCT05354206|521788015|FG001|Overall Study|Withdrawal by Subject|0|||
144480421|NCT02778399|520957822|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
144480422|NCT02778399|520957823|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
144480423|NCT02778399|520957824|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
144480424|NCT02778399|520957819|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
144480425|NCT02778399|520957820|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
144480426|NCT02778399|520957821|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
144480427|NCT02778399|520957822|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
144480428|NCT02778399|520957823|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
144480429|NCT02778399|520957824|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
144480430|NCT02778399|520957819|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
144480431|NCT02778399|520957820|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
144480432|NCT02778399|520957821|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
144480433|NCT02778399|520957822|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
144480434|NCT02778399|520957823|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
144480435|NCT02778399|520957824|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
144480436|NCT02778399|520957819|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
144480437|NCT02778399|520957820|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
144480438|NCT02778399|520957821|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
144480439|NCT02778399|520957822|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
144480440|NCT02778399|520957823|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
144480441|NCT02778399|520957824|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
144480442|NCT02778399|520957819|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
144480443|NCT02778399|520957820|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
144708918|NCT04936334|521788016|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
144708919|NCT00422058|521788017|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
144708920|NCT00422058|521788018|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
144708921|NCT00422058|521788019|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
144708922|NCT00422058|521788020|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
144708923|NCT00422058|521788021|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
144708924|NCT00422058|521788022|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
144708925|NCT00422058|521788017|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
144708926|NCT00422058|521788018|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
144708927|NCT00422058|521788019|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
144708928|NCT00422058|521788020|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
144708929|NCT00422058|521788021|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
144708930|NCT00422058|521788022|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
144708931|NCT00422058|521788017|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
144708932|NCT00422058|521788018|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
144708933|NCT00422058|521788019|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
144708934|NCT00422058|521788020|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
144708935|NCT00422058|521788021|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
144708936|NCT00422058|521788022|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
144708937|NCT00422058|521788017|FG000|Double-Blind, Week 0-20|Other|11|||
144708938|NCT00422058|521788018|FG001|Double-Blind, Week 0-20|Other|3|||
144708939|NCT00422058|521788019|FG002|Double-Blind, Week 0-20|Other|8|||
144708940|NCT00422058|521788020|FG003|Double-Blind, Week 0-20|Other|8|||
144708941|NCT00422058|521788021|FG004|Double-Blind, Week 0-20|Other|4|||
144708942|NCT00422058|521788022|FG005|Double-Blind, Week 0-20|Other|10|||
144708943|NCT00422058|521788017|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
144708944|NCT00422058|521788018|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
144367817|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
144367818|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367819|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367820|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367821|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367822|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367823|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367824|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367825|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367826|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367827|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367828|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367829|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144367830|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
144367831|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
144480444|NCT02778399|520957821|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
144480445|NCT02778399|520957822|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
144708945|NCT00422058|521788019|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
144708946|NCT00422058|521788020|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
144708947|NCT00422058|521788021|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
144708948|NCT00422058|521788022|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
144708949|NCT00422058|521788017|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
144708950|NCT00422058|521788018|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
144708951|NCT00422058|521788019|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
144708952|NCT00422058|521788020|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
144708953|NCT00422058|521788021|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
144708954|NCT00422058|521788022|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
144708955|NCT00422058|521788017|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
144708956|NCT00422058|521788018|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
144708957|NCT00422058|521788019|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
144708958|NCT00422058|521788020|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
144708959|NCT00422058|521788021|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
144708960|NCT00422058|521788022|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
144708961|NCT00422058|521788017|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
144708962|NCT00422058|521788018|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
144708963|NCT00422058|521788019|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
144708964|NCT00422058|521788020|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
144708965|NCT00422058|521788021|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
144708966|NCT00422058|521788022|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
144708967|NCT00422058|521788017|FG000|Open-Label Extension, Week 20-104|Other|13|||
144708968|NCT00422058|521788018|FG001|Open-Label Extension, Week 20-104|Other|14|||
144708969|NCT00422058|521788019|FG002|Open-Label Extension, Week 20-104|Other|6|||
144708970|NCT00422058|521788020|FG003|Open-Label Extension, Week 20-104|Other|13|||
144708971|NCT00422058|521788021|FG004|Open-Label Extension, Week 20-104|Other|16|||
144708972|NCT00422058|521788022|FG005|Open-Label Extension, Week 20-104|Other|18|||
144708973|NCT00713830|521788023|FG000|Overall Study|Adverse Event|23|||
144708974|NCT00713830|521788024|FG001|Overall Study|Adverse Event|71|||
144708975|NCT00713830|521788023|FG000|Overall Study|Lack of Efficacy|24|||
144708976|NCT00713830|521788024|FG001|Overall Study|Lack of Efficacy|16|||
144708977|NCT00713830|521788023|FG000|Overall Study|Lost to Follow-up|2|||
144708978|NCT00713830|521788024|FG001|Overall Study|Lost to Follow-up|9|||
144708979|NCT00713830|521788023|FG000|Overall Study|Withdrawal by Subject|13|||
144708980|NCT00713830|521788024|FG001|Overall Study|Withdrawal by Subject|23|||
144708981|NCT00713830|521788023|FG000|Overall Study|Poor Compliance to Protocol|7|||
144708982|NCT00713830|521788024|FG001|Overall Study|Poor Compliance to Protocol|14|||
144708983|NCT00713830|521788023|FG000|Overall Study|Familial and Personal Reasons|9|||
144708984|NCT00713830|521788024|FG001|Overall Study|Familial and Personal Reasons|34|||
144708985|NCT00713830|521788023|FG000|Overall Study|Sponsor Decision|4|||
144708986|NCT00713830|521788024|FG001|Overall Study|Sponsor Decision|10|||
144708987|NCT02787785|521788029|FG000|Overall Study|Death|3|||
144708988|NCT02787785|521788030|FG001|Overall Study|Death|4|||
144708989|NCT02787785|521788029|FG000|Overall Study|Lost to Follow-up|1|||
144708990|NCT02787785|521788030|FG001|Overall Study|Lost to Follow-up|1|||
144708991|NCT02787785|521788029|FG000|Overall Study|Withdrawal by Subject|0|||
144708992|NCT02787785|521788030|FG001|Overall Study|Withdrawal by Subject|5|||
144708993|NCT00902265|521788031|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
144708994|NCT00902265|521788031|FG000|Overall Study|Adverse Event|2|||
144708995|NCT00902265|521788031|FG000|Overall Study|Lack of Efficacy|2|||
144708996|NCT00902265|521788031|FG000|Overall Study|Protocol Violation|1|||
144708997|NCT02866695|521788034|FG000|Overall Study|Adverse Event|1|||
144708998|NCT02866695|521788034|FG000|Overall Study|Lost to Follow-up|1|||
144708999|NCT03224234|521788035|FG000|Main Study|Lost to Follow-up|5|||
144709000|NCT03224234|521788036|FG001|Main Study|Lost to Follow-up|5|||
144709001|NCT05016765|521788037|FG000|Overall Study|Lost to Follow-up|4|||
144709002|NCT05144477|521788040|FG000|Overall Study|Withdrawal by Subject|1|||
144709003|NCT05144477|521788041|FG001|Overall Study|Withdrawal by Subject|1|||
144709004|NCT01766310|521788044|FG000|Overall Study|Lost to Follow-up|1|||
144709005|NCT01766310|521788045|FG001|Overall Study|Lost to Follow-up|3|||
144709006|NCT03151707|521788046|FG000|Overall Study|Lost to Follow-up|6|||
144709007|NCT02125734|521788048|FG000|Period 2|Adverse Event|0|||
144709008|NCT02125734|521788049|FG001|Period 2|Adverse Event|1|||
144709009|NCT01591499|521788050|FG000|Baseline Visit|Withdrawal by Subject|0|||
144709010|NCT01591499|521788051|FG001|Baseline Visit|Withdrawal by Subject|2|||
144709011|NCT01591499|521788052|FG002|Baseline Visit|Withdrawal by Subject|0|||
144709012|NCT01591499|521788053|FG003|Baseline Visit|Withdrawal by Subject|2|||
144709013|NCT01591499|521788050|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
144709014|NCT01591499|521788051|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
144709015|NCT01591499|521788052|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
144709016|NCT01591499|521788053|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
144480446|NCT02778399|520957823|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
144709017|NCT01591499|521788050|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
144709018|NCT01591499|521788051|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
144709019|NCT01591499|521788052|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
144709020|NCT01591499|521788053|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
144709021|NCT00646282|521788054|FG000|Overall Study|Protocol terminated|4|||
144709022|NCT00646282|521788055|FG001|Overall Study|Protocol terminated|4|||
144709023|NCT02617446|521788056|FG000|Overall Study|Withdrawal by Subject|0|||
144709024|NCT02617446|521788057|FG001|Overall Study|Withdrawal by Subject|2|||
144709025|NCT02617446|521788058|FG002|Overall Study|Withdrawal by Subject|0|||
144709026|NCT02617446|521788056|FG000|Overall Study|Adverse Event|1|||
144709027|NCT02617446|521788057|FG001|Overall Study|Adverse Event|0|||
144480447|NCT02778399|520957824|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
144480448|NCT02778399|520957819|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
144480449|NCT02778399|520957820|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
144480450|NCT02778399|520957821|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
144480451|NCT02778399|520957822|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
144480452|NCT02778399|520957823|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
144480453|NCT02778399|520957824|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
144480454|NCT02778399|520957819|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
144480455|NCT02778399|520957820|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
144480456|NCT02778399|520957821|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
144480457|NCT02778399|520957822|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
144480458|NCT02778399|520957823|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
144480459|NCT02778399|520957824|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
144480460|NCT03556358|520957830|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
144480461|NCT03556358|520957831|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
144480462|NCT03556358|520957830|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
144480463|NCT03556358|520957831|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
144480464|NCT03556358|520957830|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
144480465|NCT03556358|520957831|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
144480466|NCT03556358|520957830|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
144480467|NCT03556358|520957831|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
144480468|NCT03556358|520957830|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
144480469|NCT03556358|520957831|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
144480470|NCT03556358|520957830|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
144480471|NCT03556358|520957831|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
144480472|NCT03556358|520957830|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
144480473|NCT03556358|520957831|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
144480474|NCT01351025|520957835|FG000|Week 0 - 20|Lost to Follow-up|2|||
144480475|NCT01351025|520957836|FG001|Week 0 - 20|Lost to Follow-up|1|||
144480476|NCT01351025|520957835|FG000|Week 0 - 20|Withdrawal by Subject|1|||
144480477|NCT01351025|520957836|FG001|Week 0 - 20|Withdrawal by Subject|0|||
144480478|NCT01351025|520957835|FG000|Week 24 - 44|Lost to Follow-up|0|||
144480479|NCT01351025|520957836|FG001|Week 24 - 44|Lost to Follow-up|2|||
144480480|NCT01351025|520957835|FG000|Week 24 - 44|Site closed|0|||
144480481|NCT01351025|520957836|FG001|Week 24 - 44|Site closed|1|||
144480482|NCT01351025|520957835|FG000|Week 24 - 44|unable to get to clinic|1|||
144480483|NCT01351025|520957836|FG001|Week 24 - 44|unable to get to clinic|1|||
144480484|NCT05067933|520957840|FG000|Overall Study|Withdrawal by Subject|2|||
144480485|NCT05067933|520957841|FG001|Overall Study|Withdrawal by Subject|0|||
144480486|NCT05067933|520957842|FG002|Overall Study|Withdrawal by Subject|0|||
144480487|NCT05067933|520957843|FG003|Overall Study|Withdrawal by Subject|0|||
144480488|NCT05067933|520957844|FG004|Overall Study|Withdrawal by Subject|0|||
144480489|NCT05067933|520957845|FG005|Overall Study|Withdrawal by Subject|0|||
144480490|NCT05067933|520957840|FG000|Overall Study|Lost to Follow-up|1|||
144480491|NCT05067933|520957841|FG001|Overall Study|Lost to Follow-up|1|||
144480492|NCT05067933|520957842|FG002|Overall Study|Lost to Follow-up|1|||
144480493|NCT05067933|520957843|FG003|Overall Study|Lost to Follow-up|2|||
144480494|NCT05067933|520957844|FG004|Overall Study|Lost to Follow-up|1|||
144480495|NCT05067933|520957845|FG005|Overall Study|Lost to Follow-up|0|||
144480496|NCT05067933|520957840|FG000|Overall Study|Miscellaneous|1|||
144480497|NCT05067933|520957841|FG001|Overall Study|Miscellaneous|0|||
144480498|NCT05067933|520957842|FG002|Overall Study|Miscellaneous|0|||
144480499|NCT05067933|520957843|FG003|Overall Study|Miscellaneous|0|||
144709028|NCT02617446|521788058|FG002|Overall Study|Adverse Event|5|||
144709029|NCT02617446|521788056|FG000|Overall Study|Lost to Follow-up|3|||
144480500|NCT05067933|520957844|FG004|Overall Study|Miscellaneous|0|||
144709030|NCT02617446|521788057|FG001|Overall Study|Lost to Follow-up|0|||
144709031|NCT02617446|521788058|FG002|Overall Study|Lost to Follow-up|0|||
144480501|NCT05067933|520957845|FG005|Overall Study|Miscellaneous|0|||
144480502|NCT05067933|520957840|FG000|Overall Study|Death|0|||
144709032|NCT02617446|521788056|FG000|Overall Study|Death|0|||
144480503|NCT05067933|520957841|FG001|Overall Study|Death|0|||
144480504|NCT05067933|520957842|FG002|Overall Study|Death|0|||
144709033|NCT02617446|521788057|FG001|Overall Study|Death|0|||
144709034|NCT02617446|521788058|FG002|Overall Study|Death|2|||
144709035|NCT00530088|521788067|FG000|Overall Study|Disease Progression|4|||
144709036|NCT00530088|521788067|FG000|Overall Study|Physician Decision|4|||
144709037|NCT00530088|521788067|FG000|Overall Study|Other Not Specified|2|||
144709038|NCT00902278|521788068|FG000|Overall Study|Physician Decision|1|||
144709039|NCT00902278|521788069|FG001|Overall Study|Physician Decision|0|||
144709040|NCT00902278|521788070|FG002|Overall Study|Physician Decision|2|||
144709041|NCT00902278|521788071|FG003|Overall Study|Physician Decision|0|||
144709042|NCT00902278|521788072|FG004|Overall Study|Physician Decision|1|||
144709043|NCT00902278|521788068|FG000|Overall Study|Lost to Follow-up|3|||
144709044|NCT00902278|521788069|FG001|Overall Study|Lost to Follow-up|2|||
144709045|NCT00902278|521788070|FG002|Overall Study|Lost to Follow-up|3|||
144709046|NCT00902278|521788071|FG003|Overall Study|Lost to Follow-up|0|||
144709047|NCT00902278|521788072|FG004|Overall Study|Lost to Follow-up|1|||
144709048|NCT02181842|521788079|FG000|Overall Study|Case Report Forms Uncollected|2|||
144709049|NCT04529096|521788080|FG000|Overall Study|Adverse Event|6|||
144709050|NCT04529096|521788081|FG001|Overall Study|Adverse Event|1|||
144709051|NCT04529096|521788080|FG000|Overall Study|Lack of Efficacy|1|||
144709052|NCT04529096|521788081|FG001|Overall Study|Lack of Efficacy|0|||
144709053|NCT04529096|521788080|FG000|Overall Study|Lost to Follow-up|1|||
144709054|NCT04529096|521788081|FG001|Overall Study|Lost to Follow-up|1|||
144709055|NCT04529096|521788080|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144709056|NCT04529096|521788081|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144709057|NCT04529096|521788080|FG000|Overall Study|Physician Decision|1|||
144709058|NCT04529096|521788081|FG001|Overall Study|Physician Decision|3|||
144709059|NCT04529096|521788080|FG000|Overall Study|Withdrawal by Subject|5|||
144709060|NCT04529096|521788081|FG001|Overall Study|Withdrawal by Subject|0|||
144709061|NCT00758706|521788082|FG000|Overall Study|Adverse Event|4|||
144709062|NCT00758706|521788083|FG001|Overall Study|Adverse Event|4|||
144709063|NCT03454672|521788084|FG000|Overall Study|Adverse Event|1|||
144709064|NCT03454672|521788085|FG001|Overall Study|Adverse Event|1|||
144709065|NCT03454672|521788084|FG000|Overall Study|Lost to Follow-up|1|||
144709066|NCT03454672|521788085|FG001|Overall Study|Lost to Follow-up|3|||
144709067|NCT03454672|521788084|FG000|Overall Study|painful|1|||
144709068|NCT03454672|521788085|FG001|Overall Study|painful|2|||
144709069|NCT03454672|521788084|FG000|Overall Study|Non-compliance|2|||
144709070|NCT03454672|521788085|FG001|Overall Study|Non-compliance|4|||
144709071|NCT03454672|521788084|FG000|Overall Study|personal reasons|3|||
144709072|NCT03454672|521788085|FG001|Overall Study|personal reasons|2|||
144709073|NCT03454672|521788084|FG000|Overall Study|Withdrawal by Subject|1|||
144709074|NCT03454672|521788085|FG001|Overall Study|Withdrawal by Subject|0|||
144709075|NCT04449354|521788086|FG000|Overall Study|Withdrawal by Subject|1|||
144367832|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367833|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367834|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367835|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367836|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367837|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367838|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367839|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367840|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367841|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367842|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367843|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367844|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
144367845|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
144367846|NCT02113982|520557327|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367847|NCT02113982|520557328|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367848|NCT02113982|520557329|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367849|NCT02113982|520557330|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367850|NCT02113982|520557331|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367851|NCT02113982|520557332|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367852|NCT02113982|520557333|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144709076|NCT02913261|521788093|FG000|Overall Study|Technical problems|0|||
144709077|NCT02913261|521788094|FG001|Overall Study|Technical problems|1|||
144367853|NCT02113982|520557334|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144709078|NCT02913261|521788093|FG000|Overall Study|Lack of Efficacy|32|||
144709079|NCT02913261|521788094|FG001|Overall Study|Lack of Efficacy|69|||
144709080|NCT02913261|521788093|FG000|Overall Study|Adverse Event|27|||
144709081|NCT02913261|521788094|FG001|Overall Study|Adverse Event|5|||
144709082|NCT02913261|521788093|FG000|Overall Study|Death|25|||
144709083|NCT02913261|521788094|FG001|Overall Study|Death|22|||
144709084|NCT02913261|521788093|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
144709085|NCT02913261|521788094|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
144709086|NCT02913261|521788093|FG000|Overall Study|Disease relapse|8|||
144709087|NCT02913261|521788094|FG001|Overall Study|Disease relapse|13|||
144709088|NCT02913261|521788093|FG000|Overall Study|Physician Decision|8|||
144709089|NCT02913261|521788094|FG001|Overall Study|Physician Decision|9|||
144709090|NCT02913261|521788093|FG000|Overall Study|Subject/guardian decision|4|||
144709091|NCT02913261|521788094|FG001|Overall Study|Subject/guardian decision|6|||
144709092|NCT02913261|521788093|FG000|Overall Study|Graft loss|2|||
144709093|NCT02913261|521788094|FG001|Overall Study|Graft loss|0|||
144709094|NCT02304302|521788117|FG000|Overall Study|Adverse Event|2|||
144709095|NCT02304302|521788118|FG001|Overall Study|Adverse Event|3|||
144709096|NCT02304302|521788117|FG000|Overall Study|Lost to Follow-up|1|||
144709097|NCT02304302|521788118|FG001|Overall Study|Lost to Follow-up|4|||
144709098|NCT02304302|521788117|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
144709099|NCT02304302|521788118|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
144709100|NCT02149199|521788124|FG000|Overall Study|Study specific withdrawal criteria|4|||
144709101|NCT02149199|521788125|FG001|Overall Study|Study specific withdrawal criteria|21|||
144709102|NCT02149199|521788126|FG002|Overall Study|Study specific withdrawal criteria|6|||
144709103|NCT02149199|521788124|FG000|Overall Study|Other|20|||
144709104|NCT02149199|521788125|FG001|Overall Study|Other|25|||
144480505|NCT05067933|520957843|FG003|Overall Study|Death|1|||
144480506|NCT05067933|520957844|FG004|Overall Study|Death|0|||
144480507|NCT05067933|520957845|FG005|Overall Study|Death|0|||
144480508|NCT01065350|520957846|FG000|Overall Study|Received incorrect drug allocation|0|||
144480509|NCT01065350|520957847|FG001|Overall Study|Received incorrect drug allocation|1|||
144480510|NCT00386308|520959208|FG000|Overall Study|Adverse Event|3|||
144480511|NCT00386308|520959209|FG001|Overall Study|Adverse Event|3|||
144480512|NCT00386308|520959208|FG000|Overall Study|Protocol Violation|2|||
144480513|NCT00386308|520959209|FG001|Overall Study|Protocol Violation|5|||
144480514|NCT00386308|520959208|FG000|Overall Study|Lack of Efficacy|0|||
144480515|NCT00386308|520959209|FG001|Overall Study|Lack of Efficacy|2|||
144480516|NCT00386308|520959208|FG000|Overall Study|Lost to Follow-up|10|||
144480517|NCT00386308|520959209|FG001|Overall Study|Lost to Follow-up|6|||
144480518|NCT00386308|520959208|FG000|Overall Study|Withdrawal by Subject|6|||
144480519|NCT00386308|520959209|FG001|Overall Study|Withdrawal by Subject|2|||
144480520|NCT00386308|520959208|FG000|Overall Study|Other Event|8|||
144480521|NCT00386308|520959209|FG001|Overall Study|Other Event|1|||
144480522|NCT03518658|520959210|FG000|Overall Study|Other|51|||
144480523|NCT03518658|520959211|FG001|Overall Study|Other|0|||
144480524|NCT00649389|520959212|FG000|Overall Study|Adverse Event|22|||
144480525|NCT00649389|520959213|FG001|Overall Study|Adverse Event|46|||
144480526|NCT00649389|520959214|FG002|Overall Study|Adverse Event|38|||
144480527|NCT00649389|520959215|FG003|Overall Study|Adverse Event|48|||
144480528|NCT00649389|520959212|FG000|Overall Study|Lost to Follow-up|15|||
144480529|NCT00649389|520959213|FG001|Overall Study|Lost to Follow-up|17|||
144480530|NCT00649389|520959214|FG002|Overall Study|Lost to Follow-up|21|||
144480531|NCT00649389|520959215|FG003|Overall Study|Lost to Follow-up|26|||
144480532|NCT00649389|520959212|FG000|Overall Study|Protocol Violation|11|||
144480533|NCT00649389|520959213|FG001|Overall Study|Protocol Violation|13|||
144480534|NCT00649389|520959214|FG002|Overall Study|Protocol Violation|9|||
144480535|NCT00649389|520959215|FG003|Overall Study|Protocol Violation|8|||
144480536|NCT00649389|520959212|FG000|Overall Study|Withdrawal by Subject|20|||
144480537|NCT00649389|520959213|FG001|Overall Study|Withdrawal by Subject|21|||
144480538|NCT00649389|520959214|FG002|Overall Study|Withdrawal by Subject|19|||
144480539|NCT00649389|520959215|FG003|Overall Study|Withdrawal by Subject|23|||
144480540|NCT00649389|520959212|FG000|Overall Study|Other|3|||
144480541|NCT00649389|520959213|FG001|Overall Study|Other|9|||
144480542|NCT00649389|520959214|FG002|Overall Study|Other|1|||
144480543|NCT00649389|520959215|FG003|Overall Study|Other|6|||
144480544|NCT00453310|520959216|FG000|Overall Study|Progression of Disease|10|||
144480545|NCT01993017|520959222|FG000|Overall Study|Death|23|||
144480546|NCT01993017|520959223|FG001|Overall Study|Death|26|||
144480547|NCT01993017|520959224|FG002|Overall Study|Death|18|||
144480548|NCT01993017|520959222|FG000|Overall Study|Could not be contacted|43|||
144480549|NCT01993017|520959223|FG001|Overall Study|Could not be contacted|42|||
144480550|NCT01993017|520959224|FG002|Overall Study|Could not be contacted|38|||
144480551|NCT01993017|520959222|FG000|Overall Study|Dropped out|19|||
144709105|NCT02149199|521788126|FG002|Overall Study|Other|20|||
144709106|NCT02149199|521788124|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
144480552|NCT01993017|520959223|FG001|Overall Study|Dropped out|6|||
144480553|NCT01993017|520959224|FG002|Overall Study|Dropped out|11|||
144480554|NCT01993017|520959222|FG000|Overall Study|Other reasons|17|||
144480555|NCT01993017|520959223|FG001|Overall Study|Other reasons|11|||
144480556|NCT01993017|520959224|FG002|Overall Study|Other reasons|7|||
144480557|NCT01993017|520959222|FG000|Overall Study|Ineligible after randomization|4|||
144480558|NCT01993017|520959223|FG001|Overall Study|Ineligible after randomization|5|||
144709107|NCT02149199|521788125|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
144709108|NCT02149199|521788126|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
144709109|NCT02149199|521788124|FG000|Overall Study|Withdrawal by Subject|75|||
144709110|NCT02149199|521788125|FG001|Overall Study|Withdrawal by Subject|93|||
144709111|NCT02149199|521788126|FG002|Overall Study|Withdrawal by Subject|77|||
144709112|NCT02149199|521788124|FG000|Overall Study|Protocol Violation|16|||
144709113|NCT02149199|521788125|FG001|Overall Study|Protocol Violation|13|||
144709114|NCT02149199|521788126|FG002|Overall Study|Protocol Violation|15|||
144709115|NCT02149199|521788124|FG000|Overall Study|Lost to Follow-up|3|||
144709116|NCT02149199|521788125|FG001|Overall Study|Lost to Follow-up|12|||
144709117|NCT02149199|521788126|FG002|Overall Study|Lost to Follow-up|11|||
144709118|NCT02149199|521788124|FG000|Overall Study|Death|0|||
144709119|NCT02149199|521788125|FG001|Overall Study|Death|0|||
144709120|NCT02149199|521788126|FG002|Overall Study|Death|1|||
144709121|NCT02149199|521788124|FG000|Overall Study|Adverse Event|6|||
144709122|NCT02149199|521788125|FG001|Overall Study|Adverse Event|15|||
144709123|NCT02149199|521788126|FG002|Overall Study|Adverse Event|9|||
144709124|NCT01966107|521788127|FG000|Overall Study|excluded from FAS|21|||
144709125|NCT01966107|521788128|FG001|Overall Study|excluded from FAS|20|||
144709126|NCT01966107|521788127|FG000|Overall Study|discontinued treatment|345|||
144709127|NCT01966107|521788128|FG001|Overall Study|discontinued treatment|372|||
144709128|NCT01966107|521788127|FG000|Overall Study|due to study closure|164|||
144709129|NCT01966107|521788128|FG001|Overall Study|due to study closure|186|||
144709130|NCT01966107|521788127|FG000|Overall Study|withdrew from the study|272|||
144709131|NCT01966107|521788128|FG001|Overall Study|withdrew from the study|303|||
144709132|NCT00532779|521788129|FG000|Overall Study|Adverse Event|122|||
144709133|NCT00532779|521788130|FG001|Overall Study|Adverse Event|112|||
144709134|NCT00532779|521788131|FG002|Overall Study|Adverse Event|56|||
144709135|NCT00532779|521788129|FG000|Overall Study|Lost to Follow-up|76|||
144709136|NCT00532779|521788130|FG001|Overall Study|Lost to Follow-up|65|||
144709137|NCT00532779|521788131|FG002|Overall Study|Lost to Follow-up|66|||
144709138|NCT00532779|521788129|FG000|Overall Study|Withdrawal by Subject|63|||
144709139|NCT00532779|521788130|FG001|Overall Study|Withdrawal by Subject|60|||
144709140|NCT00532779|521788131|FG002|Overall Study|Withdrawal by Subject|90|||
144709141|NCT00532779|521788129|FG000|Overall Study|Lack of Efficacy|12|||
144709142|NCT00532779|521788130|FG001|Overall Study|Lack of Efficacy|12|||
144709143|NCT00532779|521788131|FG002|Overall Study|Lack of Efficacy|40|||
144709144|NCT00532779|521788129|FG000|Overall Study|Protocol Violation|5|||
144709145|NCT00532779|521788130|FG001|Overall Study|Protocol Violation|9|||
144709146|NCT00532779|521788131|FG002|Overall Study|Protocol Violation|7|||
144709147|NCT00532779|521788129|FG000|Overall Study|Pregnancy|2|||
144709148|NCT00532779|521788130|FG001|Overall Study|Pregnancy|5|||
144709149|NCT00532779|521788131|FG002|Overall Study|Pregnancy|3|||
144709150|NCT00532779|521788129|FG000|Overall Study|Death|0|||
144709151|NCT00532779|521788130|FG001|Overall Study|Death|1|||
144709152|NCT00532779|521788131|FG002|Overall Study|Death|0|||
144709153|NCT00532779|521788129|FG000|Overall Study|Drug noncompliance, moved, other|14|||
144709154|NCT00532779|521788130|FG001|Overall Study|Drug noncompliance, moved, other|23|||
144709155|NCT00532779|521788131|FG002|Overall Study|Drug noncompliance, moved, other|29|||
144709156|NCT02662556|521788132|FG000|Overall Study|Adverse Event|4|||
144709157|NCT02662556|521788132|FG000|Overall Study|Lack of Efficacy|4|||
144709158|NCT00689273|521788135|FG000|Overall Study|Adverse Event|3|||
144709159|NCT00689273|521788136|FG001|Overall Study|Adverse Event|1|||
144709160|NCT00689273|521788135|FG000|Overall Study|Lack of Efficacy|3|||
144709161|NCT00689273|521788136|FG001|Overall Study|Lack of Efficacy|0|||
144709162|NCT00689273|521788135|FG000|Overall Study|Lost to Follow-up|0|||
144709163|NCT00689273|521788136|FG001|Overall Study|Lost to Follow-up|2|||
144480559|NCT01993017|520959224|FG002|Overall Study|Ineligible after randomization|5|||
144480560|NCT01863043|520959225|FG000|Overall Study|Death|6|||
144709164|NCT00689273|521788135|FG000|Overall Study|Other|6|||
144709165|NCT00689273|521788136|FG001|Overall Study|Other|2|||
144709166|NCT00689273|521788135|FG000|Overall Study|Randomized but not Treated|1|||
144709167|NCT00689273|521788136|FG001|Overall Study|Randomized but not Treated|0|||
144709168|NCT01901146|521790010|FG000|Neoadjuvant Phase|Death|1|||
144709169|NCT01901146|521790011|FG001|Neoadjuvant Phase|Death|2|||
144709170|NCT01901146|521790012|FG002|Neoadjuvant Phase|Death|0|||
144709171|NCT01901146|521790013|FG003|Neoadjuvant Phase|Death|0|||
144709172|NCT01901146|521790014|FG004|Neoadjuvant Phase|Death|0|||
144709173|NCT01901146|521790010|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
144709174|NCT01901146|521790011|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
144709175|NCT01901146|521790012|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
144709176|NCT01901146|521790013|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
144709177|NCT01901146|521790014|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
144709178|NCT01901146|521790010|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
144709179|NCT01901146|521790011|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
144709180|NCT01901146|521790012|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
144709181|NCT01901146|521790013|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
144709182|NCT01901146|521790014|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
144709183|NCT01901146|521790010|FG000|Neoadjuvant Phase|Physician Decision|1|||
144709184|NCT01901146|521790011|FG001|Neoadjuvant Phase|Physician Decision|2|||
144709185|NCT01901146|521790012|FG002|Neoadjuvant Phase|Physician Decision|0|||
144709186|NCT01901146|521790013|FG003|Neoadjuvant Phase|Physician Decision|0|||
144709187|NCT01901146|521790014|FG004|Neoadjuvant Phase|Physician Decision|0|||
144367854|NCT02113982|520557335|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367855|NCT02113982|520557336|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367856|NCT02113982|520557337|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367857|NCT02113982|520557338|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367858|NCT02113982|520557339|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
144367859|NCT02113982|520557340|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
144367860|NCT01759446|520557343|FG000|Overall Study|Protocol Violation|1|||
144367861|NCT01759446|520557344|FG001|Overall Study|Protocol Violation|0|||
144367862|NCT01759446|520557345|FG002|Overall Study|Protocol Violation|1|||
144367863|NCT01759446|520557346|FG003|Overall Study|Protocol Violation|0|||
144367864|NCT01759446|520557347|FG004|Overall Study|Protocol Violation|0|||
144367865|NCT01759446|520557343|FG000|Overall Study|Withdrawal by Subject|0|||
144367866|NCT01759446|520557344|FG001|Overall Study|Withdrawal by Subject|1|||
144367867|NCT01759446|520557345|FG002|Overall Study|Withdrawal by Subject|0|||
144367868|NCT01759446|520557346|FG003|Overall Study|Withdrawal by Subject|1|||
144367869|NCT01759446|520557347|FG004|Overall Study|Withdrawal by Subject|0|||
144367870|NCT01760733|520557348|FG000|Waiting List|Death|18|||
144367871|NCT01760733|520557348|FG000|Waiting List|Removed from waiting list|41|||
144367872|NCT01760733|520557348|FG000|Waiting List|Not received a transplant yet|13|||
144367873|NCT01760733|520557348|FG000|Transplanted|Not reached 10 years post transplant|184|||
144367874|NCT01760733|520557348|FG000|Transplanted|Death|26|||
144367875|NCT01760733|520557348|FG000|Transplanted|Graft loss|7|||
144367876|NCT00815659|520557349|FG000|Overall Study|Adverse Event|9|||
144367877|NCT00815659|520557349|FG000|Overall Study|Withdrawal by Subject|9|||
144367878|NCT00815659|520557349|FG000|Overall Study|Lost to Follow-up|4|||
144367879|NCT00815659|520557349|FG000|Overall Study|Protocol Violation|1|||
144367880|NCT02395471|520557350|FG000|Overall Study|Lost to Follow-up|2|||
144367881|NCT02395471|520557351|FG001|Overall Study|Lost to Follow-up|0|||
144367882|NCT02395471|520557350|FG000|Overall Study|Withdrawal by Subject|2|||
144367883|NCT02395471|520557351|FG001|Overall Study|Withdrawal by Subject|1|||
144367884|NCT02395471|520557350|FG000|Overall Study|Physician Decision|1|||
144367885|NCT02395471|520557351|FG001|Overall Study|Physician Decision|0|||
144367886|NCT02395471|520557350|FG000|Overall Study|Protocol Violation|0|||
144367887|NCT02395471|520557351|FG001|Overall Study|Protocol Violation|1|||
144367888|NCT02395471|520557350|FG000|Overall Study|Failure to swollow sponge twice|1|||
144367889|NCT02395471|520557351|FG001|Overall Study|Failure to swollow sponge twice|0|||
144367890|NCT02395471|520557350|FG000|Overall Study|Patient did not return for procedure|0|||
144367891|NCT02395471|520557351|FG001|Overall Study|Patient did not return for procedure|1|||
144367892|NCT02395471|520557350|FG000|Overall Study|Subject not eligible|1|||
144367893|NCT02395471|520557351|FG001|Overall Study|Subject not eligible|0|||
144367894|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
144367895|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
144367896|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Adverse Event|31|||
144367897|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Adverse Event|21|||
144367898|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
144367899|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
144367900|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
144367901|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
144367902|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
144367903|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
144367904|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
144367905|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
144367906|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Administrative problems|3|||
144367907|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Administrative problems|3|||
144367908|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Death|5|||
144367909|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Death|8|||
144367910|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Disease progression|139|||
144367911|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Disease progression|119|||
144367912|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
144367913|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
144367914|NCT00785785|520557352|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
144367915|NCT00785785|520557353|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
144367916|NCT00785785|520557352|FG000|Optional Extension Phase|Adverse Event|4|||
144367917|NCT00785785|520557353|FG001|Optional Extension Phase|Adverse Event|5|||
144367918|NCT00785785|520557352|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
144367919|NCT00785785|520557353|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
144367920|NCT00785785|520557352|FG000|Optional Extension Phase|Lost to Follow-up|1|||
144367921|NCT00785785|520557353|FG001|Optional Extension Phase|Lost to Follow-up|0|||
144367922|NCT00785785|520557352|FG000|Optional Extension Phase|Administrative problems|2|||
144367923|NCT00785785|520557353|FG001|Optional Extension Phase|Administrative problems|0|||
144367924|NCT00785785|520557352|FG000|Optional Extension Phase|Death|1|||
144480561|NCT01863043|520959226|FG001|Overall Study|Death|1|||
144480562|NCT01863043|520959225|FG000|Overall Study|Withdrawal by Subject|0|||
144480563|NCT01863043|520959226|FG001|Overall Study|Withdrawal by Subject|2|||
144480564|NCT01863043|520959225|FG000|Overall Study|Adverse Event|7|||
144480565|NCT01863043|520959226|FG001|Overall Study|Adverse Event|8|||
144480566|NCT01863043|520959225|FG000|Overall Study|exclusion criteria found after enrollment|0|||
144480567|NCT01863043|520959226|FG001|Overall Study|exclusion criteria found after enrollment|1|||
144480568|NCT01987596|520959227|FG000|Overall Study|Physician Decision|1|||
144480569|NCT01987596|520959228|FG001|Overall Study|Physician Decision|0|||
144480570|NCT01987596|520959227|FG000|Overall Study|Progressive Disease; missing all period|0|||
144480571|NCT01987596|520959228|FG001|Overall Study|Progressive Disease; missing all period|1|||
144480572|NCT02632786|520959229|FG000|Overall Study|Adverse Event|2|||
144480573|NCT02632786|520959230|FG001|Overall Study|Adverse Event|1|||
144480574|NCT02632786|520959229|FG000|Overall Study|Death|3|||
144480575|NCT02632786|520959230|FG001|Overall Study|Death|2|||
144480576|NCT02632786|520959229|FG000|Overall Study|Physician Decision|5|||
144480577|NCT02632786|520959230|FG001|Overall Study|Physician Decision|4|||
144480578|NCT02632786|520959229|FG000|Overall Study|Withdrawal by Subject|1|||
144480579|NCT02632786|520959230|FG001|Overall Study|Withdrawal by Subject|0|||
144480580|NCT01928225|520959231|FG000|Overall Study|Pregnancy|1|||
144480581|NCT01928225|520959232|FG001|Overall Study|Pregnancy|0|||
144480582|NCT01928225|520959231|FG000|Overall Study|basaloid cervical cancer|1|||
144480583|NCT01928225|520959232|FG001|Overall Study|basaloid cervical cancer|0|||
144480584|NCT01928225|520959231|FG000|Overall Study|Lost to Follow-up|1|||
144480585|NCT01928225|520959232|FG001|Overall Study|Lost to Follow-up|3|||
144480586|NCT00854295|520959233|FG000|Overall Study|Death|7|||
144480587|NCT00854295|520959234|FG001|Overall Study|Death|0|||
144480588|NCT00854295|520959235|FG002|Overall Study|Death|1|||
144480589|NCT00854295|520959236|FG003|Overall Study|Death|1|||
144480590|NCT00854295|520959233|FG000|Overall Study|Adverse Event|6|||
144480591|NCT00854295|520959234|FG001|Overall Study|Adverse Event|1|||
144480592|NCT00854295|520959235|FG002|Overall Study|Adverse Event|1|||
144480593|NCT00854295|520959236|FG003|Overall Study|Adverse Event|3|||
144480594|NCT00854295|520959233|FG000|Overall Study|Lost to Follow-up|18|||
144480595|NCT00854295|520959234|FG001|Overall Study|Lost to Follow-up|5|||
144367925|NCT00785785|520557353|FG001|Optional Extension Phase|Death|5|||
144367926|NCT00785785|520557352|FG000|Optional Extension Phase|Disease progression|22|||
144367927|NCT00785785|520557353|FG001|Optional Extension Phase|Disease progression|70|||
144367928|NCT00785785|520557352|FG000|Optional Extension Phase|Protocol deviation|0|||
144367929|NCT00785785|520557353|FG001|Optional Extension Phase|Protocol deviation|2|||
144367930|NCT00785785|520557352|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
144367931|NCT00785785|520557353|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
144367932|NCT01244893|520557354|FG000|Baseline|Protocol Violation|0|||
144367933|NCT01244893|520557355|FG001|Baseline|Protocol Violation|1|||
144367934|NCT01244893|520557354|FG000|1-Week Follow Up|Lost to Follow-up|1|||
144367935|NCT01244893|520557355|FG001|1-Week Follow Up|Lost to Follow-up|0|||
144367936|NCT00357552|520557356|FG000|Screening|Did not meet eligibility criteria|84|||
144367937|NCT00357552|520557356|FG000|Weeks 0 to 24|Death|1|||
144367938|NCT00357552|520557356|FG000|Weeks 24 to 104|Death|3|||
144367939|NCT00357552|520557356|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
144367940|NCT00882557|520557364|FG000|Overall Study|Withdrawal by Subject|1|||
144367941|NCT00882557|520557365|FG001|Overall Study|Withdrawal by Subject|0|||
144367942|NCT00882557|520557364|FG000|Overall Study|Trouble with Vein Access|1|||
144367943|NCT00882557|520557365|FG001|Overall Study|Trouble with Vein Access|0|||
144367944|NCT00882557|520557364|FG000|Overall Study|Randomized Not Treated|0|||
144367945|NCT00882557|520557365|FG001|Overall Study|Randomized Not Treated|1|||
144367946|NCT00823615|520557367|FG000|Period 2|Lost to Follow-up|2|||
144367947|NCT00823615|520557368|FG001|Period 2|Lost to Follow-up|0|||
144367948|NCT00823615|520557367|FG000|Period 2|Time/Job Conflict|1|||
144367949|NCT00823615|520557368|FG001|Period 2|Time/Job Conflict|2|||
144367950|NCT00084136|520557372|FG000|PI Comparison|Death|10|||
144367951|NCT00084136|520557373|FG001|PI Comparison|Death|9|||
144367952|NCT00084136|520557374|FG002|PI Comparison|Death|0|||
144367953|NCT00084136|520557372|FG000|PI Comparison|Lost to Follow-up|11|||
144367954|NCT00084136|520557373|FG001|PI Comparison|Lost to Follow-up|8|||
144367955|NCT00084136|520557374|FG002|PI Comparison|Lost to Follow-up|0|||
144367956|NCT00084136|520557372|FG000|PI Comparison|Withdrawal by Subject|33|||
144367957|NCT00084136|520557373|FG001|PI Comparison|Withdrawal by Subject|30|||
144367958|NCT00084136|520557374|FG002|PI Comparison|Withdrawal by Subject|0|||
144367959|NCT00084136|520557372|FG000|PI Comparison|Clinic site closed|1|||
144367960|NCT00084136|520557373|FG001|PI Comparison|Clinic site closed|0|||
144480596|NCT00854295|520959235|FG002|Overall Study|Lost to Follow-up|21|||
144480597|NCT00854295|520959236|FG003|Overall Study|Lost to Follow-up|21|||
144480598|NCT00854295|520959233|FG000|Overall Study|Physician Decision|10|||
144480599|NCT00854295|520959234|FG001|Overall Study|Physician Decision|0|||
144480600|NCT00854295|520959235|FG002|Overall Study|Physician Decision|0|||
144367961|NCT00084136|520557374|FG002|PI Comparison|Clinic site closed|0|||
144480601|NCT00854295|520959236|FG003|Overall Study|Physician Decision|0|||
144709188|NCT01901146|521790010|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
144709189|NCT01901146|521790011|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
144709190|NCT01901146|521790012|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
144709191|NCT01901146|521790013|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
144709192|NCT01901146|521790014|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
144709193|NCT01901146|521790010|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
144709194|NCT01901146|521790011|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
144709195|NCT01901146|521790012|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
144709196|NCT01901146|521790013|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
144709197|NCT01901146|521790014|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
144709198|NCT01901146|521790010|FG000|Adjuvant Phase|Other|0|||
144709199|NCT01901146|521790011|FG001|Adjuvant Phase|Other|0|||
144709200|NCT01901146|521790012|FG002|Adjuvant Phase|Other|1|||
144709201|NCT01901146|521790013|FG003|Adjuvant Phase|Other|0|||
144709202|NCT01901146|521790014|FG004|Adjuvant Phase|Other|0|||
144480602|NCT00709592|520959237|FG000|Overall Study|Unable to proceed to transplant|0|||
144480603|NCT00709592|520959238|FG001|Overall Study|Unable to proceed to transplant|1|||
144480604|NCT02440594|520959241|FG000|Overall Study|Lost to Follow-up|34|||
144709203|NCT01901146|521790010|FG000|Adjuvant Phase|Death|0|||
144709204|NCT01901146|521790011|FG001|Adjuvant Phase|Death|0|||
144709205|NCT01901146|521790012|FG002|Adjuvant Phase|Death|0|||
144709206|NCT01901146|521790013|FG003|Adjuvant Phase|Death|0|||
144709207|NCT01901146|521790014|FG004|Adjuvant Phase|Death|3|||
144709208|NCT01901146|521790010|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
144709209|NCT01901146|521790011|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
144709210|NCT01901146|521790012|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
144709211|NCT01901146|521790013|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
144709212|NCT01901146|521790014|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
144709213|NCT01901146|521790010|FG000|Adjuvant Phase|Physician Decision|0|||
144709214|NCT01901146|521790011|FG001|Adjuvant Phase|Physician Decision|0|||
144709215|NCT01901146|521790012|FG002|Adjuvant Phase|Physician Decision|9|||
144709216|NCT01901146|521790013|FG003|Adjuvant Phase|Physician Decision|2|||
144709217|NCT01901146|521790014|FG004|Adjuvant Phase|Physician Decision|4|||
144709218|NCT01901146|521790010|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
144709219|NCT01901146|521790011|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
144709220|NCT01901146|521790012|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
144709221|NCT01901146|521790013|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
144709222|NCT01901146|521790014|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
144709223|NCT00297492|521790015|FG000|Set Quit Date|Lost to Follow-up|7|||
144709224|NCT00297492|521790016|FG001|Set Quit Date|Lost to Follow-up|13|||
144709225|NCT00297492|521790017|FG002|Set Quit Date|Lost to Follow-up|5|||
144709226|NCT00297492|521790015|FG000|6 Month Follow-up|Lost to Follow-up|63|||
144709227|NCT00297492|521790016|FG001|6 Month Follow-up|Lost to Follow-up|49|||
144709228|NCT00297492|521790017|FG002|6 Month Follow-up|Lost to Follow-up|27|||
144709229|NCT03724968|521790018|FG000|Overall Study|Insurance issues|0|||
144709230|NCT03724968|521790019|FG001|Overall Study|Insurance issues|1|||
144709231|NCT03724968|521790018|FG000|Overall Study|Study closed|0|||
144709232|NCT03724968|521790019|FG001|Overall Study|Study closed|1|||
144480605|NCT02440594|520959242|FG001|Overall Study|Lost to Follow-up|33|||
144480606|NCT02440594|520959243|FG002|Overall Study|Lost to Follow-up|54|||
144480607|NCT02440594|520959244|FG003|Overall Study|Lost to Follow-up|47|||
144480608|NCT02440594|520959245|FG004|Overall Study|Lost to Follow-up|5|||
144480609|NCT02440594|520959246|FG005|Overall Study|Lost to Follow-up|4|||
144480610|NCT02440594|520959247|FG006|Overall Study|Lost to Follow-up|28|||
144480611|NCT02440594|520959248|FG007|Overall Study|Lost to Follow-up|48|||
144480612|NCT02440594|520959241|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
144480613|NCT02440594|520959242|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
144480614|NCT02440594|520959243|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
144480615|NCT02440594|520959244|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
144480616|NCT02440594|520959245|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
144709233|NCT01336608|521790020|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
144709234|NCT01336608|521790021|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144709235|NCT01336608|521790022|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144709236|NCT01336608|521790023|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144709237|NCT01336608|521790020|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
144480617|NCT02440594|520959246|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
144480618|NCT02440594|520959247|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
144709238|NCT01336608|521790021|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144709239|NCT01336608|521790022|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144709240|NCT01336608|521790023|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144480619|NCT02440594|520959248|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
144480620|NCT02440594|520959241|FG000|Overall Study|Withdrawal by Subject|81|||
144480621|NCT02440594|520959242|FG001|Overall Study|Withdrawal by Subject|67|||
144709241|NCT01336608|521790020|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
144709242|NCT01336608|521790021|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
144709243|NCT01336608|521790022|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
144709244|NCT01336608|521790023|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
144709245|NCT01336608|521790020|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
144709246|NCT01336608|521790021|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
144709247|NCT01336608|521790022|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
144709248|NCT01336608|521790023|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
144709249|NCT01336608|521790020|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
144709250|NCT01336608|521790021|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144709251|NCT01336608|521790022|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144709252|NCT01336608|521790023|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144709253|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
144709254|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
144709255|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
144709256|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
144709257|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144709258|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
144709259|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144709260|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144709261|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
144709262|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
144709263|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
144709264|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
144709265|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
144709266|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
144709267|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
144709268|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
144709269|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
144709270|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
144709271|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
144709272|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
144709273|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144709274|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
144709275|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144709276|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144709277|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
144709278|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
144709279|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
144709280|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
144709281|NCT01336608|521790020|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144709282|NCT01336608|521790021|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
144709283|NCT01336608|521790022|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
144709284|NCT01336608|521790023|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
144709285|NCT00569231|521790024|FG000|Overall Study|Study unrelated surgery|1|||
144709286|NCT00569231|521790024|FG000|Overall Study|Airfare expense|2|||
144709287|NCT00569231|521790024|FG000|Overall Study|Withdrawal by Subject|1|||
144709288|NCT00569231|521790024|FG000|Overall Study|Car accident injury|1|||
144709289|NCT00569231|521790024|FG000|Overall Study|Non-compliance|2|||
144709290|NCT01614925|521790025|FG000|Overall Study|Withdrawal by Subject|1|||
144709291|NCT01614925|521790026|FG001|Overall Study|Withdrawal by Subject|0|||
144709292|NCT01614925|521790025|FG000|Overall Study|Protocol Violation|3|||
144709293|NCT01614925|521790026|FG001|Overall Study|Protocol Violation|2|||
144709294|NCT02437890|521790031|FG000|Overall Study|Non-compliance to study drug|0|||
144709295|NCT02437890|521790032|FG001|Overall Study|Non-compliance to study drug|1|||
144709296|NCT02437890|521790033|FG002|Overall Study|Non-compliance to study drug|0|||
144709297|NCT02437890|521790034|FG003|Overall Study|Non-compliance to study drug|0|||
144709298|NCT02437890|521790035|FG004|Overall Study|Non-compliance to study drug|1|||
144709299|NCT02437890|521790031|FG000|Overall Study|Sponsor's decision|1|||
144709300|NCT02437890|521790032|FG001|Overall Study|Sponsor's decision|1|||
144709301|NCT02437890|521790033|FG002|Overall Study|Sponsor's decision|4|||
144709302|NCT02437890|521790034|FG003|Overall Study|Sponsor's decision|0|||
144709303|NCT02437890|521790035|FG004|Overall Study|Sponsor's decision|2|||
144709304|NCT02437890|521790031|FG000|Overall Study|Physician Decision|0|||
144709305|NCT02437890|521790032|FG001|Overall Study|Physician Decision|0|||
144709306|NCT02437890|521790033|FG002|Overall Study|Physician Decision|0|||
144709307|NCT02437890|521790034|FG003|Overall Study|Physician Decision|1|||
144709308|NCT02437890|521790035|FG004|Overall Study|Physician Decision|0|||
144709309|NCT02437890|521790031|FG000|Overall Study|Unable to attend visit(s)|1|||
144709310|NCT02437890|521790032|FG001|Overall Study|Unable to attend visit(s)|0|||
144709311|NCT02437890|521790033|FG002|Overall Study|Unable to attend visit(s)|0|||
144709312|NCT02437890|521790034|FG003|Overall Study|Unable to attend visit(s)|0|||
144709313|NCT02437890|521790035|FG004|Overall Study|Unable to attend visit(s)|0|||
144709314|NCT02437890|521790031|FG000|Overall Study|Lack of Efficacy|1|||
144709315|NCT02437890|521790032|FG001|Overall Study|Lack of Efficacy|3|||
144709316|NCT02437890|521790033|FG002|Overall Study|Lack of Efficacy|0|||
144709317|NCT02437890|521790034|FG003|Overall Study|Lack of Efficacy|3|||
144709318|NCT02437890|521790035|FG004|Overall Study|Lack of Efficacy|1|||
144709319|NCT02437890|521790031|FG000|Overall Study|Adverse Event|4|||
144709320|NCT02437890|521790032|FG001|Overall Study|Adverse Event|9|||
144709321|NCT02437890|521790033|FG002|Overall Study|Adverse Event|5|||
144709322|NCT02437890|521790034|FG003|Overall Study|Adverse Event|11|||
144709323|NCT02437890|521790035|FG004|Overall Study|Adverse Event|7|||
144709324|NCT02437890|521790031|FG000|Overall Study|Withdrawal by Subject|1|||
144709325|NCT02437890|521790032|FG001|Overall Study|Withdrawal by Subject|2|||
144709326|NCT02437890|521790033|FG002|Overall Study|Withdrawal by Subject|6|||
144709327|NCT02437890|521790034|FG003|Overall Study|Withdrawal by Subject|5|||
144709328|NCT02437890|521790035|FG004|Overall Study|Withdrawal by Subject|5|||
144709329|NCT02437890|521790031|FG000|Overall Study|Death|0|||
144709330|NCT02437890|521790032|FG001|Overall Study|Death|0|||
144709331|NCT02437890|521790033|FG002|Overall Study|Death|0|||
144709332|NCT02437890|521790034|FG003|Overall Study|Death|2|||
144709333|NCT02437890|521790035|FG004|Overall Study|Death|0|||
144709334|NCT01190098|521790036|FG000|Overall Study|Adverse Event|2|||
144709335|NCT01190098|521790037|FG001|Overall Study|Adverse Event|0|||
144709336|NCT01190098|521790036|FG000|Overall Study|Patient coomorbidity|0|||
144709337|NCT01190098|521790037|FG001|Overall Study|Patient coomorbidity|1|||
144709338|NCT01190098|521790036|FG000|Overall Study|Lack of transportation|1|||
144709339|NCT01190098|521790037|FG001|Overall Study|Lack of transportation|0|||
144709340|NCT01190098|521790036|FG000|Overall Study|Other|0|||
144709341|NCT01190098|521790037|FG001|Overall Study|Other|1|||
144709342|NCT00344305|521790038|FG000|Overall Study|Lost to Follow-up|2|||
144709343|NCT00344305|521790039|FG001|Overall Study|Lost to Follow-up|0|||
144709344|NCT00344305|521790038|FG000|Overall Study|Participant was not contacted in window|0|||
144709345|NCT00344305|521790039|FG001|Overall Study|Participant was not contacted in window|1|||
144709346|NCT04723173|521790044|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
144709347|NCT02996448|521790045|FG000|Overall Study|Study terminated due to adverse effects|3|||
144709348|NCT01422720|521790046|FG000|Overall Study|Adverse Event|16|||
144709349|NCT01422720|521790046|FG000|Overall Study|Lack of Efficacy|1|||
144709350|NCT01422720|521790046|FG000|Overall Study|Withdrawal by Subject|4|||
144709351|NCT01422720|521790046|FG000|Overall Study|Ineligibility|1|||
144709352|NCT00303316|521790051|FG000|Overall Study|Protocol Violation|1|||
144709353|NCT00303316|521790052|FG001|Overall Study|Protocol Violation|0|||
144367962|NCT00084136|520557372|FG000|NRTI Comparison|Death|20|||
144367963|NCT00084136|520557373|FG001|NRTI Comparison|Death|0|||
144367964|NCT00084136|520557374|FG002|NRTI Comparison|Death|18|||
144367965|NCT00084136|520557372|FG000|NRTI Comparison|Lost to Follow-up|14|||
144367966|NCT00084136|520557373|FG001|NRTI Comparison|Lost to Follow-up|0|||
144367967|NCT00084136|520557374|FG002|NRTI Comparison|Lost to Follow-up|12|||
144367968|NCT00084136|520557372|FG000|NRTI Comparison|Withdrawal by Subject|54|||
144367969|NCT00084136|520557373|FG001|NRTI Comparison|Withdrawal by Subject|0|||
144367970|NCT00084136|520557374|FG002|NRTI Comparison|Withdrawal by Subject|38|||
144367971|NCT00084136|520557372|FG000|NRTI Comparison|Clinic site closed|12|||
144367972|NCT00084136|520557373|FG001|NRTI Comparison|Clinic site closed|0|||
144367973|NCT00084136|520557374|FG002|NRTI Comparison|Clinic site closed|14|||
144367974|NCT00084136|520557372|FG000|NRTI Comparison|Not reason above|1|||
144367975|NCT00084136|520557373|FG001|NRTI Comparison|Not reason above|0|||
144367976|NCT00084136|520557374|FG002|NRTI Comparison|Not reason above|0|||
144480622|NCT02440594|520959243|FG002|Overall Study|Withdrawal by Subject|59|||
144480623|NCT02440594|520959244|FG003|Overall Study|Withdrawal by Subject|38|||
144480624|NCT02440594|520959245|FG004|Overall Study|Withdrawal by Subject|2|||
144709354|NCT00303316|521790051|FG000|Overall Study|Lost to Follow-up|0|||
144709355|NCT00303316|521790052|FG001|Overall Study|Lost to Follow-up|1|||
144709356|NCT00303316|521790051|FG000|Overall Study|Withdrawal by Subject|1|||
144709357|NCT00303316|521790052|FG001|Overall Study|Withdrawal by Subject|2|||
144367977|NCT02230670|520557375|FG000|Overall Study|Adverse Event|1|||
144367978|NCT02230670|520557376|FG001|Overall Study|Adverse Event|2|||
144367979|NCT02230670|520557375|FG000|Overall Study|Withdrawal by Subject|2|||
144367980|NCT02230670|520557376|FG001|Overall Study|Withdrawal by Subject|2|||
144480625|NCT02440594|520959246|FG005|Overall Study|Withdrawal by Subject|2|||
144480626|NCT02440594|520959247|FG006|Overall Study|Withdrawal by Subject|7|||
144709358|NCT01726335|521790053|FG000|Overall Study|Lost to Follow-up|2|||
144709359|NCT01726335|521790053|FG000|Overall Study|Withdrawal by Subject|15|||
144709360|NCT01726335|521790053|FG000|Overall Study|Adverse Event|4|||
144367981|NCT02230670|520557375|FG000|Overall Study|Physician Decision|0|||
144709361|NCT01726335|521790053|FG000|Overall Study|Lost to Follow-up|2|||
144709362|NCT01726335|521790053|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
144709363|NCT01074307|521790058|FG000|Overall Study|No primary endpoint evaluation|14|||
144709364|NCT01074307|521790059|FG001|Overall Study|No primary endpoint evaluation|6|||
144709365|NCT01074307|521790058|FG000|Overall Study|Exclusion criterion|0|||
144709366|NCT01074307|521790059|FG001|Overall Study|Exclusion criterion|1|||
144709367|NCT01074307|521790058|FG000|Overall Study|Protocol Violation|8|||
144709368|NCT01074307|521790059|FG001|Overall Study|Protocol Violation|5|||
144709369|NCT02162511|521790065|FG000|Overall Study|Lack of Efficacy|0|||
144709370|NCT02162511|521790066|FG001|Overall Study|Lack of Efficacy|0|||
144709371|NCT02162511|521790067|FG002|Overall Study|Lack of Efficacy|2|||
144709372|NCT01160198|521790068|FG000|Overall Study|Withdrawal by Subject|2|||
144709373|NCT01160198|521790069|FG001|Overall Study|Withdrawal by Subject|1|||
144709374|NCT01160198|521790070|FG002|Overall Study|Withdrawal by Subject|0|||
144709375|NCT01160198|521790068|FG000|Overall Study|Adverse Event|0|||
144709376|NCT01160198|521790069|FG001|Overall Study|Adverse Event|1|||
144709377|NCT01160198|521790070|FG002|Overall Study|Adverse Event|0|||
144709378|NCT01160198|521790068|FG000|Overall Study|Lost to Follow-up|0|||
144709379|NCT01160198|521790069|FG001|Overall Study|Lost to Follow-up|1|||
144709380|NCT01160198|521790070|FG002|Overall Study|Lost to Follow-up|0|||
144709381|NCT01160198|521790068|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
144709382|NCT01160198|521790069|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
144709383|NCT01160198|521790070|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
144709384|NCT00563524|521790072|FG000|Overall Study|Adverse Event|0|||
144709385|NCT00563524|521790073|FG001|Overall Study|Adverse Event|1|||
144709386|NCT00563524|521790074|FG002|Overall Study|Adverse Event|0|||
144709387|NCT00563524|521790075|FG003|Overall Study|Adverse Event|0|||
144709388|NCT00563524|521790076|FG004|Overall Study|Adverse Event|2|||
144709389|NCT00563524|521790077|FG005|Overall Study|Adverse Event|0|||
144709390|NCT00563524|521790072|FG000|Overall Study|Lost to Follow-up|1|||
144709391|NCT00563524|521790073|FG001|Overall Study|Lost to Follow-up|0|||
144709392|NCT00563524|521790074|FG002|Overall Study|Lost to Follow-up|0|||
144709393|NCT00563524|521790075|FG003|Overall Study|Lost to Follow-up|0|||
144709394|NCT00563524|521790076|FG004|Overall Study|Lost to Follow-up|0|||
144709395|NCT00563524|521790077|FG005|Overall Study|Lost to Follow-up|0|||
144709396|NCT00563524|521790072|FG000|Overall Study|Protocol Violation|0|||
144709397|NCT00563524|521790073|FG001|Overall Study|Protocol Violation|1|||
144709398|NCT00563524|521790074|FG002|Overall Study|Protocol Violation|0|||
144709399|NCT00563524|521790075|FG003|Overall Study|Protocol Violation|0|||
144709400|NCT00563524|521790076|FG004|Overall Study|Protocol Violation|0|||
144709401|NCT00563524|521790077|FG005|Overall Study|Protocol Violation|0|||
144709402|NCT00563524|521790072|FG000|Overall Study|Withdrawal by Subject|1|||
144709403|NCT00563524|521790073|FG001|Overall Study|Withdrawal by Subject|1|||
144709404|NCT00563524|521790074|FG002|Overall Study|Withdrawal by Subject|3|||
144709405|NCT00563524|521790075|FG003|Overall Study|Withdrawal by Subject|0|||
144709406|NCT00563524|521790076|FG004|Overall Study|Withdrawal by Subject|0|||
144709407|NCT00563524|521790077|FG005|Overall Study|Withdrawal by Subject|1|||
144709408|NCT02748616|521790085|FG000|Overall Study|Lost to Follow-up|1|||
144709409|NCT02748616|521790085|FG000|Overall Study|Withdrawal by Subject|2|||
144709410|NCT02748616|521790085|FG000|Overall Study|Physician Decision|2|||
144709411|NCT02748616|521790085|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
144709412|NCT01875991|521790089|FG000|Overall Study|Withdrawal by Subject|6|||
144709413|NCT01875991|521790090|FG001|Overall Study|Withdrawal by Subject|6|||
144709414|NCT01875991|521790089|FG000|Overall Study|Sponsor Decision|1|||
144367982|NCT02230670|520557376|FG001|Overall Study|Physician Decision|1|||
144367983|NCT02230670|520557375|FG000|Overall Study|Protocol Violation|0|||
144367984|NCT02230670|520557376|FG001|Overall Study|Protocol Violation|1|||
144367985|NCT02230670|520557375|FG000|Overall Study|Progression to Child-Pugh C|1|||
144367986|NCT02230670|520557376|FG001|Overall Study|Progression to Child-Pugh C|2|||
144367987|NCT03938259|520557379|FG000|Overall Study|unable to establish baseline for ventilation|1|||
144367988|NCT03938259|520557380|FG001|Overall Study|unable to establish baseline for ventilation|1|||
144367989|NCT01907854|520557381|FG000|Overall Study|Protocol Violation|1|||
144709415|NCT01875991|521790090|FG001|Overall Study|Sponsor Decision|0|||
144709416|NCT02030834|521790091|FG000|Overall Study|Death|4|||
144709417|NCT02030834|521790092|FG001|Overall Study|Death|0|||
144709418|NCT02030834|521790093|FG002|Overall Study|Death|0|||
144367990|NCT01907854|520557382|FG001|Overall Study|Protocol Violation|1|||
144709419|NCT02030834|521790091|FG000|Overall Study|Manufacturing failure|2|||
144709420|NCT02030834|521790092|FG001|Overall Study|Manufacturing failure|0|||
144709421|NCT02030834|521790093|FG002|Overall Study|Manufacturing failure|1|||
144709422|NCT02030834|521790091|FG000|Overall Study|Disease progression|2|||
144709423|NCT02030834|521790092|FG001|Overall Study|Disease progression|0|||
144709424|NCT02030834|521790093|FG002|Overall Study|Disease progression|2|||
144709425|NCT02030834|521790091|FG000|Overall Study|Lost to Follow-up|1|||
144709426|NCT02030834|521790092|FG001|Overall Study|Lost to Follow-up|0|||
144709427|NCT02030834|521790093|FG002|Overall Study|Lost to Follow-up|0|||
144709428|NCT02030834|521790091|FG000|Overall Study|Withdrawal by Subject|1|||
144709429|NCT02030834|521790092|FG001|Overall Study|Withdrawal by Subject|0|||
144709430|NCT02030834|521790093|FG002|Overall Study|Withdrawal by Subject|0|||
144709431|NCT02030834|521790091|FG000|Overall Study|Lack of funding|1|||
144709432|NCT02030834|521790092|FG001|Overall Study|Lack of funding|0|||
144709433|NCT02030834|521790093|FG002|Overall Study|Lack of funding|0|||
144709434|NCT03959137|521790095|FG000|Overall Study|Protocol Violation|6|||
144709435|NCT01289990|521790097|FG000|Overall Study|Death|0|||
144709436|NCT01289990|521790098|FG001|Overall Study|Death|0|||
144709437|NCT01289990|521790099|FG002|Overall Study|Death|0|||
144709438|NCT01289990|521790100|FG003|Overall Study|Death|1|||
144709439|NCT01289990|521790101|FG004|Overall Study|Death|2|||
144709440|NCT01289990|521790102|FG005|Overall Study|Death|1|||
144709441|NCT01289990|521790103|FG006|Overall Study|Death|0|||
144709442|NCT01289990|521790104|FG007|Overall Study|Death|0|||
144709443|NCT01289990|521790105|FG008|Overall Study|Death|0|||
144709444|NCT01289990|521790106|FG009|Overall Study|Death|0|||
144709445|NCT01289990|521790107|FG010|Overall Study|Death|0|||
144709446|NCT01289990|521790108|FG011|Overall Study|Death|1|||
144709447|NCT01289990|521790109|FG012|Overall Study|Death|0|||
144709448|NCT01289990|521790097|FG000|Overall Study|Lost to Follow-up|3|||
144709449|NCT01289990|521790098|FG001|Overall Study|Lost to Follow-up|2|||
144709450|NCT01289990|521790099|FG002|Overall Study|Lost to Follow-up|5|||
144709451|NCT01289990|521790100|FG003|Overall Study|Lost to Follow-up|5|||
144709452|NCT01289990|521790101|FG004|Overall Study|Lost to Follow-up|3|||
144709453|NCT01289990|521790102|FG005|Overall Study|Lost to Follow-up|4|||
144709454|NCT01289990|521790103|FG006|Overall Study|Lost to Follow-up|2|||
144709455|NCT01289990|521790104|FG007|Overall Study|Lost to Follow-up|2|||
144709456|NCT01289990|521790105|FG008|Overall Study|Lost to Follow-up|1|||
144709457|NCT01289990|521790106|FG009|Overall Study|Lost to Follow-up|4|||
144709458|NCT01289990|521790107|FG010|Overall Study|Lost to Follow-up|2|||
144709459|NCT01289990|521790108|FG011|Overall Study|Lost to Follow-up|1|||
144709460|NCT01289990|521790109|FG012|Overall Study|Lost to Follow-up|2|||
144709461|NCT01289990|521790097|FG000|Overall Study|Withdrawal by Subject|15|||
144709462|NCT01289990|521790098|FG001|Overall Study|Withdrawal by Subject|14|||
144709463|NCT01289990|521790099|FG002|Overall Study|Withdrawal by Subject|12|||
144709464|NCT01289990|521790100|FG003|Overall Study|Withdrawal by Subject|13|||
144709465|NCT01289990|521790101|FG004|Overall Study|Withdrawal by Subject|8|||
144709466|NCT01289990|521790102|FG005|Overall Study|Withdrawal by Subject|7|||
144709467|NCT01289990|521790103|FG006|Overall Study|Withdrawal by Subject|13|||
144709468|NCT01289990|521790104|FG007|Overall Study|Withdrawal by Subject|9|||
144709469|NCT01289990|521790105|FG008|Overall Study|Withdrawal by Subject|12|||
144709470|NCT01289990|521790106|FG009|Overall Study|Withdrawal by Subject|13|||
144709471|NCT01289990|521790107|FG010|Overall Study|Withdrawal by Subject|11|||
144709472|NCT01289990|521790108|FG011|Overall Study|Withdrawal by Subject|13|||
144709473|NCT01289990|521790109|FG012|Overall Study|Withdrawal by Subject|16|||
144709474|NCT01289990|521790097|FG000|Overall Study|discontinued in preceding trial|18|||
144709475|NCT01289990|521790098|FG001|Overall Study|discontinued in preceding trial|20|||
144709476|NCT01289990|521790099|FG002|Overall Study|discontinued in preceding trial|41|||
144709477|NCT01289990|521790100|FG003|Overall Study|discontinued in preceding trial|17|||
144709478|NCT01289990|521790101|FG004|Overall Study|discontinued in preceding trial|11|||
144709479|NCT01289990|521790102|FG005|Overall Study|discontinued in preceding trial|12|||
144709480|NCT01289990|521790103|FG006|Overall Study|discontinued in preceding trial|18|||
144709481|NCT01289990|521790104|FG007|Overall Study|discontinued in preceding trial|8|||
144709482|NCT01289990|521790105|FG008|Overall Study|discontinued in preceding trial|17|||
144709483|NCT01289990|521790106|FG009|Overall Study|discontinued in preceding trial|21|||
144709484|NCT01289990|521790107|FG010|Overall Study|discontinued in preceding trial|17|||
144709485|NCT01289990|521790108|FG011|Overall Study|discontinued in preceding trial|17|||
144709486|NCT01289990|521790109|FG012|Overall Study|discontinued in preceding trial|24|||
144709487|NCT01289990|521790097|FG000|Overall Study|did not continue in extension|41|||
144709488|NCT01289990|521790098|FG001|Overall Study|did not continue in extension|45|||
144709489|NCT01289990|521790099|FG002|Overall Study|did not continue in extension|51|||
144709490|NCT01289990|521790100|FG003|Overall Study|did not continue in extension|51|||
144709491|NCT01289990|521790101|FG004|Overall Study|did not continue in extension|48|||
144709492|NCT01289990|521790102|FG005|Overall Study|did not continue in extension|50|||
144709493|NCT01289990|521790103|FG006|Overall Study|did not continue in extension|54|||
144709494|NCT01289990|521790104|FG007|Overall Study|did not continue in extension|36|||
144709495|NCT01289990|521790105|FG008|Overall Study|did not continue in extension|44|||
144709496|NCT01289990|521790106|FG009|Overall Study|did not continue in extension|48|||
144709497|NCT01289990|521790107|FG010|Overall Study|did not continue in extension|45|||
144709498|NCT01289990|521790108|FG011|Overall Study|did not continue in extension|34|||
144709499|NCT01289990|521790109|FG012|Overall Study|did not continue in extension|56|||
144709500|NCT01289990|521790097|FG000|Overall Study|Not treated|0|||
144709501|NCT01289990|521790098|FG001|Overall Study|Not treated|0|||
144709502|NCT01289990|521790099|FG002|Overall Study|Not treated|0|||
144709503|NCT01289990|521790100|FG003|Overall Study|Not treated|0|||
144709504|NCT01289990|521790101|FG004|Overall Study|Not treated|0|||
144709505|NCT01289990|521790102|FG005|Overall Study|Not treated|0|||
144709506|NCT01289990|521790103|FG006|Overall Study|Not treated|1|||
144709507|NCT01289990|521790104|FG007|Overall Study|Not treated|0|||
144709508|NCT01289990|521790105|FG008|Overall Study|Not treated|1|||
144709509|NCT01289990|521790106|FG009|Overall Study|Not treated|0|||
144709510|NCT01289990|521790107|FG010|Overall Study|Not treated|1|||
144709511|NCT01289990|521790108|FG011|Overall Study|Not treated|2|||
144709512|NCT01289990|521790109|FG012|Overall Study|Not treated|0|||
144709513|NCT01220128|521790110|FG000|Overall Study|Progressive disease|0|||
144709514|NCT01220128|521790111|FG001|Overall Study|Progressive disease|0|||
144709515|NCT01220128|521790112|FG002|Overall Study|Progressive disease|2|||
144709516|NCT01220128|521790113|FG003|Overall Study|Progressive disease|0|||
144709517|NCT01220128|521790114|FG004|Overall Study|Progressive disease|0|||
144709518|NCT01220128|521790115|FG005|Overall Study|Progressive disease|0|||
144709519|NCT01220128|521790116|FG006|Overall Study|Progressive disease|0|||
144709520|NCT01220128|521790110|FG000|Overall Study|Sponsor study termination|0|||
144709521|NCT01220128|521790111|FG001|Overall Study|Sponsor study termination|1|||
144709522|NCT01220128|521790112|FG002|Overall Study|Sponsor study termination|0|||
144709523|NCT01220128|521790113|FG003|Overall Study|Sponsor study termination|0|||
144709524|NCT01220128|521790114|FG004|Overall Study|Sponsor study termination|0|||
144709525|NCT01220128|521790115|FG005|Overall Study|Sponsor study termination|0|||
144709526|NCT01220128|521790116|FG006|Overall Study|Sponsor study termination|1|||
144709527|NCT01220128|521790110|FG000|Overall Study|Adverse event, serious fatal|2|||
144709528|NCT01220128|521790111|FG001|Overall Study|Adverse event, serious fatal|0|||
144709529|NCT01220128|521790112|FG002|Overall Study|Adverse event, serious fatal|0|||
144709530|NCT01220128|521790113|FG003|Overall Study|Adverse event, serious fatal|0|||
144709531|NCT01220128|521790114|FG004|Overall Study|Adverse event, serious fatal|0|||
144709532|NCT01220128|521790115|FG005|Overall Study|Adverse event, serious fatal|0|||
144709533|NCT01220128|521790116|FG006|Overall Study|Adverse event, serious fatal|1|||
144709534|NCT01220128|521790110|FG000|Overall Study|Adverse event, non-fatal|1|||
144709535|NCT01220128|521790111|FG001|Overall Study|Adverse event, non-fatal|0|||
144709536|NCT01220128|521790112|FG002|Overall Study|Adverse event, non-fatal|0|||
144709537|NCT01220128|521790113|FG003|Overall Study|Adverse event, non-fatal|0|||
144709538|NCT01220128|521790114|FG004|Overall Study|Adverse event, non-fatal|0|||
144709539|NCT01220128|521790115|FG005|Overall Study|Adverse event, non-fatal|0|||
144709540|NCT01220128|521790116|FG006|Overall Study|Adverse event, non-fatal|3|||
144709541|NCT01220128|521790110|FG000|Overall Study|Other|0|||
144709542|NCT01220128|521790111|FG001|Overall Study|Other|0|||
144709543|NCT01220128|521790112|FG002|Overall Study|Other|1|||
144709544|NCT01220128|521790113|FG003|Overall Study|Other|0|||
144709545|NCT01220128|521790114|FG004|Overall Study|Other|0|||
144709546|NCT01220128|521790115|FG005|Overall Study|Other|0|||
144709547|NCT01220128|521790116|FG006|Overall Study|Other|0|||
144709548|NCT01220128|521790110|FG000|Overall Study|Consent withdrawn by subject|1|||
144709549|NCT01220128|521790111|FG001|Overall Study|Consent withdrawn by subject|0|||
144709550|NCT01220128|521790112|FG002|Overall Study|Consent withdrawn by subject|0|||
144709551|NCT01220128|521790113|FG003|Overall Study|Consent withdrawn by subject|0|||
144709552|NCT01220128|521790114|FG004|Overall Study|Consent withdrawn by subject|0|||
144709553|NCT01220128|521790115|FG005|Overall Study|Consent withdrawn by subject|0|||
144709554|NCT01220128|521790116|FG006|Overall Study|Consent withdrawn by subject|0|||
144709555|NCT02392559|521790117|FG000|Overall Study|Withdrawal by Subject|0|||
144709556|NCT02392559|521790118|FG001|Overall Study|Withdrawal by Subject|1|||
144709557|NCT01500434|521790122|FG000|Overall Study|Death|1|||
144709558|NCT01500434|521790122|FG000|Overall Study|Withdrawal by Subject|1|||
144709559|NCT01500434|521790122|FG000|Overall Study|Missed 12-month follow-up|5|||
144709560|NCT00752895|521790126|FG000|Overall Study|Withdrawal by Subject|8|||
144709561|NCT00752895|521790127|FG001|Overall Study|Withdrawal by Subject|3|||
144709562|NCT00633217|521790128|FG000|Overall Study|Adverse Event|5|||
144709563|NCT00633217|521790129|FG001|Overall Study|Adverse Event|9|||
144709564|NCT00633217|521790128|FG000|Overall Study|Lack of Efficacy|0|||
144367991|NCT01907854|520557381|FG000|Overall Study|Withdrawal by Subject|9|||
144709565|NCT00633217|521790129|FG001|Overall Study|Lack of Efficacy|2|||
144538207|NCT00146172|521174128|FG006|Overall Study|Disease Progression|1|||
144709566|NCT00633217|521790128|FG000|Overall Study|Protocol Violation|3|||
144709567|NCT00633217|521790129|FG001|Overall Study|Protocol Violation|7|||
144709568|NCT00633217|521790128|FG000|Overall Study|Lost to Follow-up|2|||
144709569|NCT00633217|521790129|FG001|Overall Study|Lost to Follow-up|2|||
144709570|NCT00633217|521790128|FG000|Overall Study|Investigator Discretion|2|||
144709571|NCT00633217|521790129|FG001|Overall Study|Investigator Discretion|0|||
144709572|NCT00633217|521790128|FG000|Overall Study|Withdrew Consent|3|||
144709573|NCT00633217|521790129|FG001|Overall Study|Withdrew Consent|3|||
144709574|NCT00314262|521790130|FG000|Overall Study|Adverse Event|2|||
144709575|NCT00314262|521790130|FG000|Overall Study|Withdrawal by Subject|2|||
144709576|NCT00314262|521790130|FG000|Overall Study|Physician Decision|1|||
144709577|NCT04881448|521790131|FG000|Overall Study|Study cancelled by sponsor|220|||
144709578|NCT04881448|521790131|FG000|Overall Study|Withdrawal by Subject|2|||
144709579|NCT04881448|521790131|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
144709580|NCT02531698|521790137|FG000|Overall Study|Adverse Event|2|||
144709581|NCT02531698|521790138|FG001|Overall Study|Adverse Event|1|||
144709582|NCT02531698|521790137|FG000|Overall Study|Withdrawal by Subject|6|||
144709583|NCT02531698|521790138|FG001|Overall Study|Withdrawal by Subject|1|||
144709584|NCT02531698|521790137|FG000|Overall Study|Protocol Violation|2|||
144709585|NCT02531698|521790138|FG001|Overall Study|Protocol Violation|0|||
144709586|NCT02531698|521790137|FG000|Overall Study|Lost to Follow-up|1|||
144709587|NCT02531698|521790138|FG001|Overall Study|Lost to Follow-up|0|||
144709588|NCT02395536|521790139|FG000|Overall Study|Lost to Follow-up|4|||
144709589|NCT02395536|521790140|FG001|Overall Study|Lost to Follow-up|4|||
144709590|NCT02395536|521790139|FG000|Overall Study|Death|2|||
144709591|NCT02395536|521790140|FG001|Overall Study|Death|0|||
144709592|NCT02395536|521790139|FG000|Overall Study|Physician Decision|4|||
144709593|NCT02395536|521790140|FG001|Overall Study|Physician Decision|6|||
144709594|NCT02395536|521790139|FG000|Overall Study|Withdrawal by Subject|9|||
144709595|NCT02395536|521790140|FG001|Overall Study|Withdrawal by Subject|17|||
144709596|NCT02395536|521790139|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
144709597|NCT02395536|521790140|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
144709598|NCT02395536|521790139|FG000|Overall Study|Insurance issue|0|||
144709599|NCT02395536|521790140|FG001|Overall Study|Insurance issue|1|||
144709600|NCT00701558|521790141|FG000|Overall Study|Death|7|||
144709601|NCT00701558|521790141|FG000|Overall Study|Lost to Follow-up|8|||
144709602|NCT02787746|521790142|FG000|Overall Study|Adverse Event|42|||
144709603|NCT02787746|521790142|FG000|Overall Study|Withdrawal by Subject|65|||
144709604|NCT02787746|521790142|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
144709605|NCT00606801|521791936|FG000|Intervention|Protocol Violation|3|||
144709606|NCT00606801|521791937|FG001|Intervention|Protocol Violation|3|||
144709607|NCT02082262|521791938|FG000|Overall Study|Withdrawal by Subject|3|||
144709608|NCT02082262|521791938|FG000|Overall Study|Adverse Event|48|||
144709609|NCT01796860|521791940|FG000|Overall Study|Withdrawal by Subject|3|||
144709610|NCT01408576|521791942|FG000|Overall Study|Lack of Efficacy|17|||
144709611|NCT01408576|521791943|FG001|Overall Study|Lack of Efficacy|30|||
144709612|NCT01408576|521791944|FG002|Overall Study|Lack of Efficacy|48|||
144709613|NCT01408576|521791942|FG000|Overall Study|Protocol Violation|1|||
144709614|NCT01408576|521791943|FG001|Overall Study|Protocol Violation|2|||
144709615|NCT01408576|521791944|FG002|Overall Study|Protocol Violation|2|||
144709616|NCT01408576|521791942|FG000|Overall Study|Lost to Follow-up|10|||
144709617|NCT01408576|521791943|FG001|Overall Study|Lost to Follow-up|9|||
144709618|NCT01408576|521791944|FG002|Overall Study|Lost to Follow-up|17|||
144709619|NCT01408576|521791942|FG000|Overall Study|Withdrawal by Subject|34|||
144709620|NCT01408576|521791943|FG001|Overall Study|Withdrawal by Subject|60|||
144709621|NCT01408576|521791944|FG002|Overall Study|Withdrawal by Subject|66|||
144709622|NCT01408576|521791942|FG000|Overall Study|Sponsor terminated study|89|||
144709623|NCT01408576|521791943|FG001|Overall Study|Sponsor terminated study|333|||
144709624|NCT01408576|521791944|FG002|Overall Study|Sponsor terminated study|330|||
144709625|NCT01408576|521791942|FG000|Overall Study|AE, serious fatal|4|||
144709626|NCT01408576|521791943|FG001|Overall Study|AE, serious fatal|4|||
144709627|NCT01408576|521791944|FG002|Overall Study|AE, serious fatal|1|||
144709628|NCT01408576|521791942|FG000|Overall Study|SAE, non-fatal|11|||
144709629|NCT01408576|521791943|FG001|Overall Study|SAE, non-fatal|23|||
144709630|NCT01408576|521791944|FG002|Overall Study|SAE, non-fatal|14|||
144709631|NCT01408576|521791942|FG000|Overall Study|AE, non-serious non-fatal|12|||
144709632|NCT01408576|521791943|FG001|Overall Study|AE, non-serious non-fatal|19|||
144709633|NCT01408576|521791944|FG002|Overall Study|AE, non-serious non-fatal|11|||
144709634|NCT01408576|521791942|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
144709635|NCT01408576|521791943|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144709636|NCT01408576|521791944|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144709637|NCT01408576|521791942|FG000|Overall Study|AE, unknown type|0|||
144709638|NCT01408576|521791943|FG001|Overall Study|AE, unknown type|1|||
144709639|NCT01408576|521791944|FG002|Overall Study|AE, unknown type|0|||
144367992|NCT01907854|520557382|FG001|Overall Study|Withdrawal by Subject|7|||
144709640|NCT01408576|521791942|FG000|Overall Study|Other|10|||
144709641|NCT01408576|521791943|FG001|Overall Study|Other|16|||
144709642|NCT01408576|521791944|FG002|Overall Study|Other|18|||
144709643|NCT00802529|521791945|FG000|Overall Study|Lost to Follow-up|0|||
144709644|NCT00802529|521791946|FG001|Overall Study|Lost to Follow-up|1|||
144709645|NCT02703454|521791950|FG000|Overall Study|Not treated|1|||
144709646|NCT02703454|521791951|FG001|Overall Study|Not treated|3|||
144709647|NCT02703454|521791950|FG000|Overall Study|Withdrawal by Subject|4|||
144709648|NCT02703454|521791951|FG001|Overall Study|Withdrawal by Subject|3|||
144709649|NCT02703454|521791950|FG000|Overall Study|Lost to Follow-up|1|||
144709650|NCT02703454|521791951|FG001|Overall Study|Lost to Follow-up|2|||
144709651|NCT02703454|521791950|FG000|Overall Study|Study discontinuation|5|||
144709652|NCT02703454|521791951|FG001|Overall Study|Study discontinuation|8|||
144709653|NCT02284373|521791952|FG000|Overall Study|Withdrawal by Subject|0|||
144709654|NCT02284373|521791953|FG001|Overall Study|Withdrawal by Subject|1|||
144709655|NCT02284373|521791954|FG002|Overall Study|Withdrawal by Subject|0|||
144709656|NCT02284373|521791952|FG000|Overall Study|Other|0|||
144709657|NCT02284373|521791953|FG001|Overall Study|Other|1|||
144709658|NCT02284373|521791954|FG002|Overall Study|Other|0|||
144709659|NCT02284373|521791952|FG000|Overall Study|Lost to Follow-up|0|||
144709660|NCT02284373|521791953|FG001|Overall Study|Lost to Follow-up|1|||
144709661|NCT02284373|521791954|FG002|Overall Study|Lost to Follow-up|0|||
144709662|NCT02016755|521791956|FG000|Overall Study|Major amputation of index limb|2|||
144709663|NCT02016755|521791956|FG000|Overall Study|Adverse Event|2|||
144709664|NCT02016755|521791956|FG000|Overall Study|Physician Decision|1|||
144709665|NCT02016755|521791956|FG000|Overall Study|Death|2|||
144709666|NCT02499406|521791958|FG000|Overall Study|missed 3 treatment sessions|4|||
144709667|NCT00552617|521791962|FG000|Overall Study|Not Treated|0|||
144709668|NCT00552617|521791963|FG001|Overall Study|Not Treated|0|||
144709669|NCT00552617|521791964|FG002|Overall Study|Not Treated|1|||
144709670|NCT00552617|521791965|FG003|Overall Study|Not Treated|0|||
144709671|NCT00552617|521791966|FG004|Overall Study|Not Treated|0|||
144709672|NCT00552617|521791967|FG005|Overall Study|Not Treated|0|||
144709673|NCT00552617|521791968|FG006|Overall Study|Not Treated|0|||
144709674|NCT00552617|521791969|FG007|Overall Study|Not Treated|0|||
144709675|NCT00552617|521791970|FG008|Overall Study|Not Treated|0|||
144709676|NCT00552617|521791971|FG009|Overall Study|Not Treated|1|||
144709677|NCT00552617|521791962|FG000|Overall Study|Lost to Follow-up|0|||
144709678|NCT00552617|521791963|FG001|Overall Study|Lost to Follow-up|0|||
144709679|NCT00552617|521791964|FG002|Overall Study|Lost to Follow-up|0|||
144367993|NCT01907854|520557381|FG000|Overall Study|Lost to Follow-up|2|||
144367994|NCT01907854|520557382|FG001|Overall Study|Lost to Follow-up|2|||
144367995|NCT01907854|520557381|FG000|Overall Study|Unclassified|4|||
144367996|NCT01907854|520557382|FG001|Overall Study|Unclassified|3|||
144367997|NCT01657019|520557383|FG000|Overall Study|Withdrawal by Subject|65|||
144367998|NCT01657019|520557383|FG000|Overall Study|Adverse Event|55|||
144367999|NCT01657019|520557383|FG000|Overall Study|Lost to Follow-up|48|||
144368000|NCT01657019|520557383|FG000|Overall Study|Protocol Violation|6|||
144368001|NCT01657019|520557383|FG000|Overall Study|Lack of Efficacy|3|||
144368002|NCT01657019|520557383|FG000|Overall Study|Other|58|||
144368003|NCT01285323|520557384|FG000|Overall Study|Adverse Event|9|||
144368004|NCT01285323|520557385|FG001|Overall Study|Adverse Event|8|||
144368005|NCT01285323|520557384|FG000|Overall Study|Lack of Efficacy|4|||
144368006|NCT01285323|520557385|FG001|Overall Study|Lack of Efficacy|2|||
144368007|NCT01285323|520557384|FG000|Overall Study|Withdrawal by Subject|15|||
144368008|NCT01285323|520557385|FG001|Overall Study|Withdrawal by Subject|11|||
144368009|NCT01285323|520557384|FG000|Overall Study|Protocol Violation|1|||
144368010|NCT01285323|520557385|FG001|Overall Study|Protocol Violation|2|||
144368011|NCT01285323|520557384|FG000|Overall Study|Non-compliance with study procedures|2|||
144368012|NCT01285323|520557385|FG001|Overall Study|Non-compliance with study procedures|3|||
144368013|NCT01285323|520557384|FG000|Overall Study|Lost to Follow-up|1|||
144368014|NCT01285323|520557385|FG001|Overall Study|Lost to Follow-up|1|||
144368015|NCT01285323|520557384|FG000|Overall Study|Other|1|||
144368016|NCT01285323|520557385|FG001|Overall Study|Other|3|||
144368017|NCT02606643|520557386|FG000|Overall Study|did not meet inclusion criteria|1|||
144368018|NCT02606643|520557387|FG001|Overall Study|did not meet inclusion criteria|3|||
144368019|NCT00803569|520557390|FG000|Overall Study|Progressive Disease|3|||
144368020|NCT00803569|520557390|FG000|Overall Study|Noncompliance|1|||
144709680|NCT00552617|521791965|FG003|Overall Study|Lost to Follow-up|1|||
144368021|NCT02900378|520557393|FG000|Randomization (Visit 2)|Adverse Event|14|||
144368022|NCT02900378|520557394|FG001|Randomization (Visit 2)|Adverse Event|11|||
144709681|NCT00552617|521791966|FG004|Overall Study|Lost to Follow-up|0|||
144368023|NCT02900378|520557393|FG000|Randomization (Visit 2)|Death|1|||
144368024|NCT02900378|520557394|FG001|Randomization (Visit 2)|Death|4|||
144368025|NCT02900378|520557393|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
144368026|NCT02900378|520557394|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
144480627|NCT02440594|520959248|FG007|Overall Study|Withdrawal by Subject|7|||
144480628|NCT02440594|520959241|FG000|Overall Study|Administratively w/drawn|3|||
144709682|NCT00552617|521791967|FG005|Overall Study|Lost to Follow-up|2|||
144709683|NCT00552617|521791968|FG006|Overall Study|Lost to Follow-up|0|||
144709684|NCT00552617|521791969|FG007|Overall Study|Lost to Follow-up|0|||
144709685|NCT00552617|521791970|FG008|Overall Study|Lost to Follow-up|2|||
144709686|NCT00552617|521791971|FG009|Overall Study|Lost to Follow-up|0|||
144709687|NCT04651218|521791972|FG000|Overall Study|Withdrawal by Subject|0|||
144709688|NCT04651218|521791973|FG001|Overall Study|Withdrawal by Subject|2|||
144709689|NCT02476851|521791974|FG000|Overall Study|Protocol Violation|1|||
144709690|NCT02476851|521791975|FG001|Overall Study|Protocol Violation|1|||
144709691|NCT01399125|521791987|FG000|Overall Study|Adverse Event|32|||
144709692|NCT01399125|521791988|FG001|Overall Study|Adverse Event|30|||
144709693|NCT01399125|521791987|FG000|Overall Study|Abnormal Lab values|0|||
144709694|NCT01399125|521791988|FG001|Overall Study|Abnormal Lab values|1|||
144709695|NCT01399125|521791987|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144709696|NCT01399125|521791988|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
144709697|NCT01399125|521791987|FG000|Overall Study|Withdrawal by Subject|5|||
144709698|NCT01399125|521791988|FG001|Overall Study|Withdrawal by Subject|8|||
144709699|NCT01399125|521791987|FG000|Overall Study|Lost to Follow-up|2|||
144709700|NCT01399125|521791988|FG001|Overall Study|Lost to Follow-up|3|||
144709701|NCT01399125|521791987|FG000|Overall Study|Administrative Problems|7|||
144709702|NCT01399125|521791988|FG001|Overall Study|Administrative Problems|11|||
144709703|NCT01399125|521791987|FG000|Overall Study|Death|0|||
144709704|NCT01399125|521791988|FG001|Overall Study|Death|1|||
144709705|NCT01399125|521791987|FG000|Overall Study|Protocol Deviation|5|||
144709706|NCT01399125|521791988|FG001|Overall Study|Protocol Deviation|2|||
144709707|NCT04333199|521792001|FG000|Evaluated Patients|Lost to Follow-up|0|||
144709708|NCT04333199|521792002|FG001|Evaluated Patients|Lost to Follow-up|1|||
144709709|NCT04333199|521792003|FG002|Evaluated Patients|Lost to Follow-up|2|||
144709710|NCT00854607|521792004|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
144709711|NCT00965263|521792012|FG000|Overall Study|Physician Decision|2|||
144709712|NCT00965263|521792013|FG001|Overall Study|Physician Decision|0|||
144709713|NCT00965263|521792012|FG000|Overall Study|Family emergency|0|||
144709714|NCT00965263|521792013|FG001|Overall Study|Family emergency|1|||
144709715|NCT00965263|521792012|FG000|Overall Study|Protocol Violation|0|||
144709716|NCT00965263|521792013|FG001|Overall Study|Protocol Violation|2|||
144709717|NCT00995488|521792014|FG000|Overall Study|Withdrawal by Subject|1|||
144709718|NCT00683904|521792015|FG000|Dose Level 1|Disease progression|2|||
144709719|NCT00683904|521792016|FG001|Dose Level 1|Disease progression|0|||
144709720|NCT00683904|521792015|FG000|Dose Level 1|Adverse Event|1|||
144709721|NCT00683904|521792016|FG001|Dose Level 1|Adverse Event|0|||
144709722|NCT00683904|521792015|FG000|Dose Level 2|Adverse Event|0|||
144709723|NCT00683904|521792016|FG001|Dose Level 2|Adverse Event|2|||
144709724|NCT05789420|521792017|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
144709725|NCT05789420|521792017|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
144709726|NCT05473247|521792018|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
144709727|NCT02340078|521792024|FG000|Overall Study|Protocol Violation|1|||
144709728|NCT01311505|521792025|FG000|First Intervention Period|Protocol Violation|0|||
144709729|NCT01311505|521792026|FG001|First Intervention Period|Protocol Violation|1|||
144709730|NCT00446134|521792027|FG000|Overall Study|Adverse Event|7|||
144709731|NCT00446134|521792028|FG001|Overall Study|Adverse Event|17|||
144709732|NCT00446134|521792029|FG002|Overall Study|Adverse Event|13|||
144709733|NCT00446134|521792030|FG003|Overall Study|Adverse Event|18|||
144709734|NCT00446134|521792027|FG000|Overall Study|Lack of Efficacy|19|||
144709735|NCT00446134|521792028|FG001|Overall Study|Lack of Efficacy|19|||
144709736|NCT00446134|521792029|FG002|Overall Study|Lack of Efficacy|24|||
144709737|NCT00446134|521792030|FG003|Overall Study|Lack of Efficacy|19|||
144709738|NCT00446134|521792027|FG000|Overall Study|Protocol Violation|0|||
144709739|NCT00446134|521792028|FG001|Overall Study|Protocol Violation|2|||
144709740|NCT00446134|521792029|FG002|Overall Study|Protocol Violation|1|||
144709741|NCT00446134|521792030|FG003|Overall Study|Protocol Violation|0|||
144709742|NCT00446134|521792027|FG000|Overall Study|Lost to Follow-up|1|||
144709743|NCT00446134|521792028|FG001|Overall Study|Lost to Follow-up|3|||
144709744|NCT00446134|521792029|FG002|Overall Study|Lost to Follow-up|1|||
144709745|NCT00446134|521792030|FG003|Overall Study|Lost to Follow-up|1|||
144709746|NCT00446134|521792027|FG000|Overall Study|Withdrawal by Subject|3|||
144709747|NCT00446134|521792028|FG001|Overall Study|Withdrawal by Subject|3|||
144709748|NCT00446134|521792029|FG002|Overall Study|Withdrawal by Subject|1|||
144709749|NCT00446134|521792030|FG003|Overall Study|Withdrawal by Subject|3|||
144709750|NCT00446134|521792027|FG000|Overall Study|Physician Decision|0|||
144709751|NCT00446134|521792028|FG001|Overall Study|Physician Decision|0|||
144709752|NCT00446134|521792029|FG002|Overall Study|Physician Decision|0|||
144709753|NCT00446134|521792030|FG003|Overall Study|Physician Decision|2|||
144709754|NCT00446134|521792027|FG000|Overall Study|Adverse Event-Diarrhea|1|||
144709755|NCT00446134|521792028|FG001|Overall Study|Adverse Event-Diarrhea|1|||
144709756|NCT00446134|521792029|FG002|Overall Study|Adverse Event-Diarrhea|2|||
144709757|NCT00446134|521792030|FG003|Overall Study|Adverse Event-Diarrhea|0|||
144709758|NCT00446134|521792027|FG000|Overall Study|Reason Not Completed|3|||
144709759|NCT00446134|521792028|FG001|Overall Study|Reason Not Completed|0|||
144709760|NCT00446134|521792029|FG002|Overall Study|Reason Not Completed|1|||
144709761|NCT00446134|521792030|FG003|Overall Study|Reason Not Completed|2|||
144709762|NCT00567996|521792034|FG000|Overall Study|Adverse Event|18|||
144709763|NCT00567996|521792035|FG001|Overall Study|Adverse Event|16|||
144709764|NCT00567996|521792036|FG002|Overall Study|Adverse Event|13|||
144709765|NCT00567996|521792034|FG000|Overall Study|Protocol Deviation|9|||
144709766|NCT00567996|521792035|FG001|Overall Study|Protocol Deviation|11|||
144709767|NCT00567996|521792036|FG002|Overall Study|Protocol Deviation|13|||
144709768|NCT00567996|521792034|FG000|Overall Study|Withdrawal by Subject|8|||
144709769|NCT00567996|521792035|FG001|Overall Study|Withdrawal by Subject|12|||
144709770|NCT00567996|521792036|FG002|Overall Study|Withdrawal by Subject|22|||
144709771|NCT00567996|521792034|FG000|Overall Study|Abnormal Lab value(s)|2|||
144709772|NCT00567996|521792035|FG001|Overall Study|Abnormal Lab value(s)|1|||
144709773|NCT00567996|521792036|FG002|Overall Study|Abnormal Lab value(s)|2|||
144709774|NCT00567996|521792034|FG000|Overall Study|Abnormal test procedure result(s)|2|||
144709775|NCT00567996|521792035|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144709776|NCT00567996|521792036|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144709777|NCT00567996|521792034|FG000|Overall Study|Lost to Follow-up|2|||
144709778|NCT00567996|521792035|FG001|Overall Study|Lost to Follow-up|5|||
144709779|NCT00567996|521792036|FG002|Overall Study|Lost to Follow-up|2|||
144709780|NCT00567996|521792034|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144709781|NCT00567996|521792035|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144709782|NCT00567996|521792036|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
144709783|NCT00567996|521792034|FG000|Overall Study|Administrative problems|1|||
144709784|NCT00567996|521792035|FG001|Overall Study|Administrative problems|1|||
144709785|NCT00567996|521792036|FG002|Overall Study|Administrative problems|0|||
144709786|NCT00567996|521792034|FG000|Overall Study|Death|1|||
144709787|NCT00567996|521792035|FG001|Overall Study|Death|0|||
144709788|NCT00567996|521792036|FG002|Overall Study|Death|2|||
144709789|NCT00567996|521792034|FG000|Overall Study|Patient's inability to use the device|0|||
144709790|NCT00567996|521792035|FG001|Overall Study|Patient's inability to use the device|1|||
144709791|NCT00567996|521792036|FG002|Overall Study|Patient's inability to use the device|0|||
144709792|NCT02956005|521792037|FG000|Overall Study|Not eligible|1|||
144709793|NCT02956005|521792037|FG000|Overall Study|Withdrawal by Subject|3|||
144709794|NCT02956005|521792037|FG000|Overall Study|Physician Decision|12|||
144709795|NCT02524665|521792040|FG000|Overall Study|Lost to Follow-up|1|||
144709796|NCT02602080|521792043|FG000|Overall Study|Protocol Violation|6|||
144709797|NCT02602080|521792044|FG001|Overall Study|Protocol Violation|1|||
144709798|NCT02602080|521792045|FG002|Overall Study|Protocol Violation|3|||
144709799|NCT01066039|521792048|FG000|Overall Study|Adverse Event|6|||
144709800|NCT01066039|521792048|FG000|Overall Study|Withdrawal by Subject|17|||
144709801|NCT01066039|521792048|FG000|Overall Study|Protocol Violation|2|||
144709802|NCT01066039|521792048|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
144709803|NCT01066039|521792048|FG000|Overall Study|Investigator's Request|1|||
144709804|NCT01066039|521792048|FG000|Overall Study|Dropout due to Insulin Administration|1|||
144709805|NCT01066039|521792048|FG000|Overall Study|Additional Antihypertensive Required|4|||
144709806|NCT01066039|521792048|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
144709807|NCT01066039|521792048|FG000|Overall Study|Failure to Control Blood Pressure|1|||
144709808|NCT01066039|521792048|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
144709809|NCT02574260|521792049|FG000|Overall Study|Disease Progression|1|||
144709810|NCT03022799|521792056|FG000|Overall Study|Adverse Event|0|||
144709811|NCT03022799|521792057|FG001|Overall Study|Adverse Event|0|||
144709812|NCT03022799|521792058|FG002|Overall Study|Adverse Event|0|||
144709813|NCT03022799|521792059|FG003|Overall Study|Adverse Event|0|||
144709814|NCT03022799|521792060|FG004|Overall Study|Adverse Event|0|||
144709815|NCT03022799|521792061|FG005|Overall Study|Adverse Event|0|||
144709816|NCT03022799|521792062|FG006|Overall Study|Adverse Event|0|||
144709817|NCT03022799|521792063|FG007|Overall Study|Adverse Event|0|||
144709818|NCT03022799|521792064|FG008|Overall Study|Adverse Event|0|||
144709819|NCT03022799|521792065|FG009|Overall Study|Adverse Event|1|||
144709820|NCT03022799|521792066|FG010|Overall Study|Adverse Event|1|||
144709821|NCT03022799|521792067|FG011|Overall Study|Adverse Event|0|||
144709822|NCT03022799|521792068|FG012|Overall Study|Adverse Event|0|||
144709823|NCT00883129|521792072|FG000|Overall Study|Adverse Event|7|||
144709824|NCT00883129|521792073|FG001|Overall Study|Adverse Event|15|||
144709825|NCT00883129|521792072|FG000|Overall Study|Withdrawal by Subject|8|||
144709826|NCT00883129|521792073|FG001|Overall Study|Withdrawal by Subject|9|||
144709827|NCT00883129|521792072|FG000|Overall Study|Non-compliance|3|||
144709828|NCT00883129|521792073|FG001|Overall Study|Non-compliance|6|||
144709829|NCT00883129|521792072|FG000|Overall Study|Lost to Follow-up|1|||
144709830|NCT00883129|521792073|FG001|Overall Study|Lost to Follow-up|2|||
144709831|NCT00883129|521792072|FG000|Overall Study|Death|1|||
144709832|NCT00883129|521792073|FG001|Overall Study|Death|2|||
144709833|NCT00883129|521792072|FG000|Overall Study|Defined Treatment Failure|0|||
144709834|NCT00883129|521792073|FG001|Overall Study|Defined Treatment Failure|2|||
144709835|NCT03273257|521792074|FG000|Overall Study|Death|0|||
144368027|NCT02900378|520557393|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
144709836|NCT03273257|521792075|FG001|Overall Study|Death|1|||
144709837|NCT03273257|521792074|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
144709838|NCT03273257|521792075|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
144709839|NCT03273257|521792074|FG000|Overall Study|Study terminated|3|||
144709840|NCT03273257|521792075|FG001|Overall Study|Study terminated|2|||
144709841|NCT01185639|521792077|FG000|Overall Study|Progressed and didn't receive therapy|2|||
144709842|NCT02200614|521792078|FG000|Double Blind Treatment|Adverse Event|86|||
144709843|NCT02200614|521792079|FG001|Double Blind Treatment|Adverse Event|48|||
144709844|NCT02200614|521792078|FG000|Double Blind Treatment|Confirmed metastasis|120|||
144709845|NCT02200614|521792079|FG001|Double Blind Treatment|Confirmed metastasis|140|||
144709846|NCT02200614|521792078|FG000|Double Blind Treatment|Judgment of the investigator|59|||
144709847|NCT02200614|521792079|FG001|Double Blind Treatment|Judgment of the investigator|99|||
144709848|NCT02200614|521792078|FG000|Double Blind Treatment|Metastasis by local reading|1|||
144709849|NCT02200614|521792079|FG001|Double Blind Treatment|Metastasis by local reading|3|||
144709850|NCT02200614|521792078|FG000|Double Blind Treatment|Other reason|6|||
144709851|NCT02200614|521792079|FG001|Double Blind Treatment|Other reason|2|||
144709852|NCT02200614|521792078|FG000|Double Blind Treatment|Personal reason|77|||
144709853|NCT02200614|521792079|FG001|Double Blind Treatment|Personal reason|85|||
144709854|NCT02200614|521792078|FG000|Double Blind Treatment|Protocol deviation|14|||
144709855|NCT02200614|521792079|FG001|Double Blind Treatment|Protocol deviation|7|||
144709856|NCT02200614|521792078|FG000|Double Blind Treatment|Not treated|1|||
144709857|NCT02200614|521792079|FG001|Double Blind Treatment|Not treated|0|||
144709858|NCT02200614|521792078|FG000|Open Label|Adverse Event|41|||
144709859|NCT02200614|521792079|FG001|Open Label|Adverse Event|11|||
144709860|NCT02200614|521792078|FG000|Open Label|Confirmed metastasis|1|||
144709861|NCT02200614|521792079|FG001|Open Label|Confirmed metastasis|0|||
144709862|NCT02200614|521792078|FG000|Open Label|Judgment of the investigator|29|||
144709863|NCT02200614|521792079|FG001|Open Label|Judgment of the investigator|2|||
144709864|NCT02200614|521792078|FG000|Open Label|Metastasis by local reading|138|||
144709865|NCT02200614|521792079|FG001|Open Label|Metastasis by local reading|27|||
144709866|NCT02200614|521792078|FG000|Open Label|Other reason|22|||
144709867|NCT02200614|521792079|FG001|Open Label|Other reason|4|||
144709868|NCT02200614|521792078|FG000|Open Label|Personal reason|60|||
144709869|NCT02200614|521792079|FG001|Open Label|Personal reason|8|||
144709870|NCT02200614|521792078|FG000|Open Label|Protocol deviation|3|||
144709871|NCT02200614|521792079|FG001|Open Label|Protocol deviation|2|||
144709872|NCT02200614|521792078|FG000|Open Label|Missing|2|||
144709873|NCT02200614|521792079|FG001|Open Label|Missing|2|||
144709874|NCT01898884|521792080|FG000|Multiple Dose Period|Adverse Event|0|||
144368028|NCT02900378|520557394|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
144368029|NCT02900378|520557393|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
144368030|NCT02900378|520557394|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
144368031|NCT02900378|520557393|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
144368032|NCT02900378|520557394|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
144368033|NCT02900378|520557393|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
144368034|NCT02900378|520557394|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
144368035|NCT03818321|520557395|FG000|Overall Study|Withdrawal by Subject|1|||
144368036|NCT03818321|520557396|FG001|Overall Study|Withdrawal by Subject|2|||
144368037|NCT05038982|520557397|FG000|Overall Study|Withdrawal by Subject|0|||
144368038|NCT05038982|520557398|FG001|Overall Study|Withdrawal by Subject|2|||
144368039|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
144368040|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
144368041|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
144368042|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
144368043|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144368044|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
144368045|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
144368046|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
144368047|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
144368048|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
144368049|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
144368050|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
144368051|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
144368052|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
144368053|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
144368054|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
144368055|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
144368056|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
144368057|NCT03739203|520557399|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
144368058|NCT03739203|520557400|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
144368059|NCT03739203|520557401|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
144368060|NCT03739203|520557399|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
144368061|NCT03739203|520557400|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
144368062|NCT03739203|520557401|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
144368063|NCT03739203|520557399|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
144368064|NCT03739203|520557400|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
144709875|NCT01898884|521792081|FG001|Multiple Dose Period|Adverse Event|0|||
144709876|NCT01898884|521792082|FG002|Multiple Dose Period|Adverse Event|0|||
144709877|NCT01898884|521792083|FG003|Multiple Dose Period|Adverse Event|0|||
144368065|NCT03739203|520557401|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
144709878|NCT01898884|521792084|FG004|Multiple Dose Period|Adverse Event|0|||
144709879|NCT01898884|521792085|FG005|Multiple Dose Period|Adverse Event|0|||
144709880|NCT01898884|521792086|FG006|Multiple Dose Period|Adverse Event|1|||
144709881|NCT01898884|521792087|FG007|Multiple Dose Period|Adverse Event|0|||
144709882|NCT01898884|521792088|FG008|Multiple Dose Period|Adverse Event|0|||
144709883|NCT01898884|521792080|FG000|Multiple Dose Period|Randomized Not Treated|0|||
144709884|NCT01898884|521792081|FG001|Multiple Dose Period|Randomized Not Treated|0|||
144709885|NCT01898884|521792082|FG002|Multiple Dose Period|Randomized Not Treated|0|||
144709886|NCT01898884|521792083|FG003|Multiple Dose Period|Randomized Not Treated|0|||
144709887|NCT01898884|521792084|FG004|Multiple Dose Period|Randomized Not Treated|0|||
144709888|NCT01898884|521792085|FG005|Multiple Dose Period|Randomized Not Treated|0|||
144709889|NCT01898884|521792086|FG006|Multiple Dose Period|Randomized Not Treated|0|||
144709890|NCT01898884|521792087|FG007|Multiple Dose Period|Randomized Not Treated|0|||
144709891|NCT01898884|521792088|FG008|Multiple Dose Period|Randomized Not Treated|1|||
144709892|NCT00759759|521792089|FG000|Overall Study|didn't return for period 2|1|||
144709893|NCT00759759|521792090|FG001|Overall Study|didn't return for period 2|0|||
144709894|NCT00759759|521792089|FG000|Overall Study|Didn't receive drug in period 2|1|||
144709895|NCT00759759|521792090|FG001|Overall Study|Didn't receive drug in period 2|0|||
144709896|NCT00759759|521792089|FG000|Overall Study|Withdrawal by Subject|2|||
144709897|NCT00759759|521792090|FG001|Overall Study|Withdrawal by Subject|1|||
144709898|NCT00828516|521792100|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
144709899|NCT01556165|521792101|FG000|Overall Study|Adverse Event|5|||
144709900|NCT01556165|521792102|FG001|Overall Study|Adverse Event|3|||
144709901|NCT01556165|521792101|FG000|Overall Study|Protocol Violation|0|||
144709902|NCT01556165|521792102|FG001|Overall Study|Protocol Violation|3|||
144709903|NCT01556165|521792101|FG000|Overall Study|Withdrawal of Consent|7|||
144709904|NCT01556165|521792102|FG001|Overall Study|Withdrawal of Consent|1|||
144709905|NCT01640964|521792110|FG000|Overall Study|Lost to Follow-up|0|||
144709906|NCT01640964|521792111|FG001|Overall Study|Lost to Follow-up|0|||
144709907|NCT01640964|521792112|FG002|Overall Study|Lost to Follow-up|1|||
144709908|NCT01640964|521792110|FG000|Overall Study|Protocol Deviation|1|||
144709909|NCT01640964|521792111|FG001|Overall Study|Protocol Deviation|1|||
144709910|NCT01640964|521792112|FG002|Overall Study|Protocol Deviation|2|||
144709911|NCT04822701|521792116|FG000|Overall Study|Not treated|2|||
144709912|NCT04822701|521792117|FG001|Overall Study|Not treated|0|||
144709913|NCT04822701|521792116|FG000|Overall Study|Lost to Follow-up|1|||
144480629|NCT02440594|520959242|FG001|Overall Study|Administratively w/drawn|2|||
144480630|NCT02440594|520959243|FG002|Overall Study|Administratively w/drawn|0|||
144480631|NCT02440594|520959244|FG003|Overall Study|Administratively w/drawn|0|||
144709914|NCT04822701|521792117|FG001|Overall Study|Lost to Follow-up|0|||
144709915|NCT04822701|521792116|FG000|Overall Study|Withdrawal by Subject|1|||
144709916|NCT04822701|521792117|FG001|Overall Study|Withdrawal by Subject|0|||
144709917|NCT00700310|521793790|FG000|Overall Study|Adverse Event|6|||
144709918|NCT00700310|521793791|FG001|Overall Study|Adverse Event|10|||
144709919|NCT00700310|521793792|FG002|Overall Study|Adverse Event|5|||
144709920|NCT00700310|521793793|FG003|Overall Study|Adverse Event|11|||
144709921|NCT00700310|521793790|FG000|Overall Study|Lost to Follow-up|4|||
144709922|NCT00700310|521793791|FG001|Overall Study|Lost to Follow-up|1|||
144709923|NCT00700310|521793792|FG002|Overall Study|Lost to Follow-up|0|||
144709924|NCT00700310|521793793|FG003|Overall Study|Lost to Follow-up|1|||
144709925|NCT00700310|521793790|FG000|Overall Study|Withdrawal by Subject|8|||
144709926|NCT00700310|521793791|FG001|Overall Study|Withdrawal by Subject|9|||
144709927|NCT00700310|521793792|FG002|Overall Study|Withdrawal by Subject|8|||
144709928|NCT00700310|521793793|FG003|Overall Study|Withdrawal by Subject|8|||
144709929|NCT00700310|521793790|FG000|Overall Study|Lack of Efficacy|0|||
144709930|NCT00700310|521793791|FG001|Overall Study|Lack of Efficacy|3|||
144709931|NCT00700310|521793792|FG002|Overall Study|Lack of Efficacy|0|||
144709932|NCT00700310|521793793|FG003|Overall Study|Lack of Efficacy|1|||
144709933|NCT00700310|521793790|FG000|Overall Study|Administrative/Other|1|||
144709934|NCT00700310|521793791|FG001|Overall Study|Administrative/Other|3|||
144709935|NCT00700310|521793792|FG002|Overall Study|Administrative/Other|1|||
144709936|NCT00700310|521793793|FG003|Overall Study|Administrative/Other|3|||
144709937|NCT00700310|521793790|FG000|Overall Study|Randomized, Not Treated|2|||
144709938|NCT00700310|521793791|FG001|Overall Study|Randomized, Not Treated|0|||
144709939|NCT00700310|521793792|FG002|Overall Study|Randomized, Not Treated|2|||
144709940|NCT00700310|521793793|FG003|Overall Study|Randomized, Not Treated|2|||
144709941|NCT00337129|521793794|FG000|Overall Study|Adverse Event|4|||
144368066|NCT03739203|520557399|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
144368067|NCT03739203|520557400|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
144368068|NCT03739203|520557401|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
144368069|NCT03739203|520557399|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
144368070|NCT03739203|520557400|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
144368071|NCT03739203|520557401|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
144368072|NCT01663103|520557404|FG000|Overall Study|Withdrawal by Subject|1|||
144368073|NCT01663103|520557405|FG001|Overall Study|Withdrawal by Subject|2|||
144368074|NCT01663103|520557404|FG000|Overall Study|Adverse Event|1|||
144368075|NCT01663103|520557405|FG001|Overall Study|Adverse Event|0|||
144368076|NCT01663103|520557404|FG000|Overall Study|dog bite|1|||
144368077|NCT01663103|520557405|FG001|Overall Study|dog bite|0|||
144368078|NCT01656408|520557406|FG000|Overall Study|Adverse Event|0|||
144368079|NCT01656408|520557407|FG001|Overall Study|Adverse Event|0|||
144709942|NCT00337129|521793794|FG000|Overall Study|Withdrawal by Subject|1|||
144709943|NCT00337129|521793794|FG000|Overall Study|Lack of Efficacy|32|||
144709944|NCT00337129|521793794|FG000|Overall Study|Death|2|||
144709945|NCT00337129|521793794|FG000|Overall Study|not protocol specified|1|||
144709946|NCT00647426|521793795|FG000|Overall Study|Withdrawal by Subject|2|||
144709947|NCT01467570|521793797|FG000|Overall Study|Lost to Follow-up|8|||
144709948|NCT01467570|521793798|FG001|Overall Study|Lost to Follow-up|9|||
144709949|NCT02626182|521793801|FG000|Overall Study|Adverse Event|2|||
144709950|NCT02626182|521793802|FG001|Overall Study|Adverse Event|0|||
144709951|NCT01084603|521793807|FG000|Baseline|Withdrawal by Subject|2|||
144709952|NCT01084603|521793807|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
144709953|NCT01084603|521793807|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
144709954|NCT01084603|521793807|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
144709955|NCT01084603|521793807|FG000|Washout Period 4|Adverse Event|1|||
144709956|NCT02766088|521793816|FG000|Overall Study|Sponsor study termination|498|||
144709957|NCT02766088|521793816|FG000|Overall Study|Migrated/moved from the study area|1|||
144709958|NCT02766088|521793816|FG000|Overall Study|Lost to Follow-up|5|||
144709959|NCT02766088|521793816|FG000|Overall Study|Other|1|||
144709960|NCT02766088|521793816|FG000|Overall Study|Death|1|||
144709961|NCT01222715|521793817|FG000|Overall Study|Adverse Event|0|||
144709962|NCT01222715|521793818|FG001|Overall Study|Adverse Event|4|||
144709963|NCT01222715|521793817|FG000|Overall Study|Death|0|||
144709964|NCT01222715|521793818|FG001|Overall Study|Death|1|||
144709965|NCT01222715|521793817|FG000|Overall Study|Lack of Efficacy|22|||
144709966|NCT01222715|521793818|FG001|Overall Study|Lack of Efficacy|14|||
144709967|NCT01222715|521793817|FG000|Overall Study|Physician Decision|12|||
144709968|NCT01222715|521793818|FG001|Overall Study|Physician Decision|2|||
144709969|NCT01222715|521793817|FG000|Overall Study|Refusal of further protocol therapy|0|||
144709970|NCT01222715|521793818|FG001|Overall Study|Refusal of further protocol therapy|4|||
144709971|NCT01222715|521793817|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
144709972|NCT01222715|521793818|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
144709973|NCT01222715|521793817|FG000|Overall Study|Ineligible|0|||
144709974|NCT01222715|521793818|FG001|Overall Study|Ineligible|1|||
144709975|NCT01222715|521793817|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
144709976|NCT01222715|521793818|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
144709977|NCT03836729|521793821|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
144709978|NCT00948025|521793823|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
144709979|NCT00948025|521793824|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
144709980|NCT00948025|521793823|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
144709981|NCT00948025|521793824|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
144709982|NCT00948025|521793823|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
144709983|NCT00948025|521793824|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
144709984|NCT03555890|521793833|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144709985|NCT03555890|521793834|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144709986|NCT03555890|521793835|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144709987|NCT03555890|521793836|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
144709988|NCT03372369|521793837|FG000|Qualification Period|Withdrawal by Subject|16|||
144709989|NCT03372369|521793838|FG001|Qualification Period|Withdrawal by Subject|13|||
144709990|NCT03372369|521793837|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
144709991|NCT03372369|521793838|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
144709992|NCT03372369|521793837|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
144368080|NCT01656408|520557408|FG002|Overall Study|Adverse Event|1|||
144368081|NCT01656408|520557409|FG003|Overall Study|Adverse Event|0|||
144368082|NCT01656408|520557410|FG004|Overall Study|Adverse Event|0|||
144368083|NCT01656408|520557411|FG005|Overall Study|Adverse Event|1|||
144368084|NCT01656408|520557412|FG006|Overall Study|Adverse Event|1|||
144709993|NCT03372369|521793838|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
144709994|NCT02239601|521793839|FG000|Overall Study|Withdrawal by Subject|3|||
144709995|NCT02239601|521793840|FG001|Overall Study|Withdrawal by Subject|4|||
144709996|NCT02239601|521793839|FG000|Overall Study|Protocol Violation|4|||
144709997|NCT02239601|521793840|FG001|Overall Study|Protocol Violation|2|||
144709998|NCT01508325|521793841|FG000|Overall Study|Withdrawal by Subject|8|||
144709999|NCT01508325|521793842|FG001|Overall Study|Withdrawal by Subject|9|||
144710000|NCT01508325|521793841|FG000|Overall Study|Protocol Violation|0|||
144368085|NCT01656408|520557413|FG007|Overall Study|Adverse Event|0|||
144368086|NCT01656408|520557414|FG008|Overall Study|Adverse Event|1|||
144368087|NCT01656408|520557415|FG009|Overall Study|Adverse Event|0|||
144368088|NCT01656408|520557406|FG000|Overall Study|Physician Decision|1|||
144710001|NCT01508325|521793842|FG001|Overall Study|Protocol Violation|3|||
144710002|NCT01508325|521793841|FG000|Overall Study|Physician Decision|2|||
144710003|NCT01508325|521793842|FG001|Overall Study|Physician Decision|1|||
144710004|NCT01508325|521793841|FG000|Overall Study|Adverse Event|1|||
144710005|NCT01508325|521793842|FG001|Overall Study|Adverse Event|0|||
144710006|NCT01508325|521793841|FG000|Overall Study|Lost to Follow-up|5|||
144710007|NCT01508325|521793842|FG001|Overall Study|Lost to Follow-up|6|||
144710008|NCT01508325|521793841|FG000|Overall Study|Other|2|||
144710009|NCT01508325|521793842|FG001|Overall Study|Other|2|||
144710010|NCT04682639|521793843|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
144710011|NCT04682639|521793844|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
144710012|NCT04682639|521793845|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
144710013|NCT04682639|521793846|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
144710014|NCT04682639|521793847|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
144710015|NCT04682639|521793843|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
144710016|NCT04682639|521793844|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
144710017|NCT04682639|521793845|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
144710018|NCT04682639|521793846|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144710019|NCT04682639|521793847|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144710020|NCT04682639|521793843|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
144710021|NCT04682639|521793844|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144710022|NCT04682639|521793845|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144710023|NCT04682639|521793846|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144710024|NCT04682639|521793847|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144710025|NCT04682639|521793843|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
144710026|NCT04682639|521793844|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
144710027|NCT04682639|521793845|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
144710028|NCT04682639|521793846|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
144710029|NCT04682639|521793847|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
144710030|NCT04682639|521793843|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
144710031|NCT04682639|521793844|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
144710032|NCT04682639|521793845|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
144710033|NCT04682639|521793846|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
144710034|NCT04682639|521793847|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
144710035|NCT04682639|521793843|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
144710036|NCT04682639|521793844|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
144710037|NCT04682639|521793845|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
144710038|NCT04682639|521793846|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144710039|NCT04682639|521793847|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144710040|NCT04682639|521793843|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
144710041|NCT04682639|521793844|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
144710042|NCT04682639|521793845|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
144710043|NCT04682639|521793846|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
144710044|NCT04682639|521793847|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
144710045|NCT04682639|521793843|FG000|OLE Period (28 Weeks)|Other|1|||
144710046|NCT04682639|521793844|FG001|OLE Period (28 Weeks)|Other|2|||
144710047|NCT04682639|521793845|FG002|OLE Period (28 Weeks)|Other|0|||
144710048|NCT04682639|521793846|FG003|OLE Period (28 Weeks)|Other|0|||
144710049|NCT04682639|521793847|FG004|OLE Period (28 Weeks)|Other|1|||
144710050|NCT04682639|521793843|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
144710051|NCT04682639|521793844|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
144710052|NCT04682639|521793845|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
144710053|NCT04682639|521793846|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
144710054|NCT04682639|521793847|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
144710055|NCT04682639|521793843|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
144710056|NCT04682639|521793844|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
144710057|NCT04682639|521793845|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144710058|NCT04682639|521793846|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144710059|NCT04682639|521793847|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144710060|NCT04682639|521793843|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
144710061|NCT04682639|521793844|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
144710062|NCT04682639|521793845|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144710063|NCT04682639|521793846|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144710064|NCT04682639|521793847|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144710065|NCT04682639|521793843|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
144710066|NCT04682639|521793844|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
144710067|NCT04682639|521793845|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
144710068|NCT04682639|521793846|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
144710069|NCT04682639|521793847|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
144710070|NCT01392170|521793848|FG000|Overall Study|Withdrawal by Subject|1|||
144710071|NCT01392170|521793848|FG000|Overall Study|Ineligible|1|||
144710072|NCT01383954|521793849|FG000|Overall Study|Lack of Efficacy|2|||
144710073|NCT01383954|521793849|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
144710074|NCT01383954|521793849|FG000|Overall Study|Adverse Event|1|||
144368089|NCT01656408|520557407|FG001|Overall Study|Physician Decision|0|||
144368090|NCT01656408|520557408|FG002|Overall Study|Physician Decision|1|||
144710075|NCT01383954|521793849|FG000|Overall Study|Reason Not Specified|9|||
144710076|NCT00763269|521793858|FG000|Overall Study|Lost to Follow-up|12|||
144480632|NCT02440594|520959245|FG004|Overall Study|Administratively w/drawn|0|||
144480633|NCT02440594|520959246|FG005|Overall Study|Administratively w/drawn|0|||
144480634|NCT02440594|520959247|FG006|Overall Study|Administratively w/drawn|2|||
144480635|NCT02440594|520959248|FG007|Overall Study|Administratively w/drawn|1|||
144710077|NCT00763269|521793859|FG001|Overall Study|Lost to Follow-up|13|||
144710078|NCT03174925|521793860|FG000|Overall Study|Elastographic images not retrievable|2|||
144710079|NCT03174925|521793860|FG000|Overall Study|Elastography image not interpretable|1|||
144710080|NCT01791127|521793863|FG000|Overall Study|Death|356|||
144480636|NCT03154359|520959249|FG000|Overall Study|Adverse Event|1|||
144480637|NCT03154359|520959249|FG000|Overall Study|Lack of Efficacy|2|||
144480638|NCT03154359|520959249|FG000|Overall Study|Lost to Follow-up|3|||
144480639|NCT03154359|520959249|FG000|Overall Study|Physician Decision|3|||
144480640|NCT03154359|520959249|FG000|Overall Study|Protocol Violation|4|||
144480641|NCT03154359|520959249|FG000|Overall Study|Withdrawal by Subject|5|||
144480642|NCT03154359|520959249|FG000|Overall Study|Disruption of study due to COVID-19|4|||
144480643|NCT04250337|520959250|FG000|Overall Study|Adverse Event|0|||
144480644|NCT04250337|520959251|FG001|Overall Study|Adverse Event|3|||
144480645|NCT04250337|520959250|FG000|Overall Study|Lack of Efficacy|1|||
144480646|NCT04250337|520959251|FG001|Overall Study|Lack of Efficacy|3|||
144480647|NCT04250337|520959250|FG000|Overall Study|Physician Decision|1|||
144480648|NCT04250337|520959251|FG001|Overall Study|Physician Decision|0|||
144480649|NCT04250337|520959250|FG000|Overall Study|Protocol Deviation|2|||
144480650|NCT04250337|520959251|FG001|Overall Study|Protocol Deviation|2|||
144480651|NCT04250337|520959250|FG000|Overall Study|Withdrawal by Subject|4|||
144480652|NCT04250337|520959251|FG001|Overall Study|Withdrawal by Subject|3|||
144710081|NCT01791127|521793863|FG000|Overall Study|Patient has withdrawn from study|293|||
144710082|NCT01791127|521793863|FG000|Overall Study|Lost to Follow-up|42|||
144710083|NCT01791127|521793863|FG000|Overall Study|All Siello leads are explanted|31|||
144710084|NCT01791127|521793863|FG000|Overall Study|Completion of 30 day safety registry|1|||
144710085|NCT01791127|521793863|FG000|Overall Study|Study terminated for EP Passion|749|||
144710086|NCT03471182|521793864|FG000|Overall Study|Withdrawal by Subject|1|||
144710087|NCT03471182|521793865|FG001|Overall Study|Withdrawal by Subject|1|||
144710088|NCT03471182|521793866|FG002|Overall Study|Withdrawal by Subject|0|||
144710089|NCT03471182|521793864|FG000|Overall Study|Technical failure|2|||
144710090|NCT03471182|521793865|FG001|Overall Study|Technical failure|0|||
144710091|NCT03471182|521793866|FG002|Overall Study|Technical failure|0|||
144710092|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
144710093|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
144710094|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
144710095|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
144710096|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
144710097|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
144710098|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
144710099|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
144710100|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
144710101|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
144710102|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
144710103|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
144710104|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
144710105|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
144710106|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
144710107|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
144710108|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
144710109|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
144710110|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
144710111|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
144710112|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
144710113|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
144710114|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
144710115|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
144710116|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
144480653|NCT04668989|520959255|FG000|First Intervention|Covid-19 related self-isolation|0|||
144480654|NCT04668989|520959256|FG001|First Intervention|Covid-19 related self-isolation|1|||
144480655|NCT04668989|520959255|FG000|Second Intervention|Adverse Event|0|||
144480656|NCT04668989|520959256|FG001|Second Intervention|Adverse Event|1|||
144480657|NCT01993823|520959257|FG000|Overall Study|Requested by the patient|6|||
144480658|NCT01993823|520959258|FG001|Overall Study|Requested by the patient|11|||
144710117|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
144710118|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
144710119|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
144710120|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
144710121|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
144710122|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
144710123|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
144710124|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
144710125|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
144710126|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
144710127|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
144710128|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
144710129|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
144710130|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
144710131|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
144710132|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
144710133|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
144710134|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
144710135|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
144710136|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
144710137|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
144710138|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
144710139|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
144710140|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
144710141|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
144710142|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
144710143|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
144710144|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
144710145|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
144710146|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
144710147|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
144710148|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
144710149|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
144710150|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
144710151|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
144710152|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
144710153|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
144710154|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
144710155|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
144710156|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
144710157|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
144710158|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
144710159|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
144710160|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
144710161|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
144710162|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
144710163|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
144710164|NCT04440163|521793869|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
144710165|NCT04440163|521793870|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
144710166|NCT04440163|521793871|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
144710167|NCT04440163|521793872|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
144710168|NCT04440163|521793873|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
144710169|NCT04440163|521793874|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
144710170|NCT04440163|521793875|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
144710171|NCT04440163|521793876|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
144710172|NCT04440163|521793869|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
144710173|NCT04440163|521793870|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
144710174|NCT04440163|521793871|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
144710175|NCT04440163|521793872|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
144710176|NCT04440163|521793873|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
144710177|NCT04440163|521793874|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
144710178|NCT04440163|521793875|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
144710179|NCT04440163|521793876|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
144710180|NCT04440163|521793869|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710181|NCT04440163|521793870|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710182|NCT04440163|521793871|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710183|NCT04440163|521793872|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
144710184|NCT04440163|521793873|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710185|NCT04440163|521793874|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710186|NCT04440163|521793875|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710187|NCT04440163|521793876|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
144710188|NCT00068406|521793879|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
144710189|NCT00068406|521793879|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
144710190|NCT02018042|521793880|FG000|Overall Study|Withdrawal by Subject|1|||
144710191|NCT00589693|521793881|FG000|Overall Study|randomized in error|12|||
144710192|NCT00589693|521793882|FG001|Overall Study|randomized in error|6|||
144710193|NCT00589693|521793881|FG000|Overall Study|Adverse Event|4|||
144710194|NCT00589693|521793882|FG001|Overall Study|Adverse Event|4|||
144710195|NCT00589693|521793881|FG000|Overall Study|Death|26|||
144710196|NCT00589693|521793882|FG001|Overall Study|Death|16|||
144710197|NCT00589693|521793881|FG000|Overall Study|Lack of Efficacy|0|||
144710198|NCT00589693|521793882|FG001|Overall Study|Lack of Efficacy|1|||
144710199|NCT00589693|521793881|FG000|Overall Study|Lost to Follow-up|1|||
144710200|NCT00589693|521793882|FG001|Overall Study|Lost to Follow-up|0|||
144710201|NCT00589693|521793881|FG000|Overall Study|Physician Decision|0|||
144710202|NCT00589693|521793882|FG001|Overall Study|Physician Decision|1|||
144710203|NCT00589693|521793881|FG000|Overall Study|Protocol Violation|1|||
144710204|NCT00589693|521793882|FG001|Overall Study|Protocol Violation|1|||
144710205|NCT03231709|521793883|FG000|Treatment Period 1|Reason not Specified|0|||
144710206|NCT03231709|521793884|FG001|Treatment Period 1|Reason not Specified|1|||
144710207|NCT03231709|521793883|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
144710208|NCT03231709|521793884|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
144710209|NCT02609178|521793885|FG000|First Crown|Withdrawal by Subject|0|||
144710210|NCT02609178|521793886|FG001|First Crown|Withdrawal by Subject|0|||
144710211|NCT02609178|521793887|FG002|First Crown|Withdrawal by Subject|1|||
144710212|NCT02609178|521793888|FG003|First Crown|Withdrawal by Subject|1|||
144710213|NCT02609178|521793889|FG004|First Crown|Withdrawal by Subject|0|||
144710214|NCT02609178|521793890|FG005|First Crown|Withdrawal by Subject|0|||
144710215|NCT01128153|521793891|FG000|Overall Study|Adverse Event|1|||
144710216|NCT01128153|521793892|FG001|Overall Study|Adverse Event|3|||
144710217|NCT01128153|521793891|FG000|Overall Study|Condition under investigation worsened|8|||
144710218|NCT01128153|521793892|FG001|Overall Study|Condition under investigation worsened|7|||
144710219|NCT01128153|521793891|FG000|Overall Study|Withdrawal by Subject|2|||
144710220|NCT01128153|521793892|FG001|Overall Study|Withdrawal by Subject|3|||
144710221|NCT01128153|521793891|FG000|Overall Study|Incorrect enrolment to study|2|||
144710222|NCT01128153|521793892|FG001|Overall Study|Incorrect enrolment to study|1|||
144710223|NCT01128153|521793891|FG000|Overall Study|Protocol Violation|2|||
144710224|NCT01128153|521793892|FG001|Overall Study|Protocol Violation|0|||
144710225|NCT01128153|521793891|FG000|Overall Study|Developed discontinuation criteria|1|||
144480659|NCT01993823|520959257|FG000|Overall Study|Protocol Violation|0|||
144480660|NCT01993823|520959258|FG001|Overall Study|Protocol Violation|1|||
144710226|NCT01128153|521793892|FG001|Overall Study|Developed discontinuation criteria|1|||
144710227|NCT01954082|521793893|FG000|Overall Study|Study Suspension|42|||
144710228|NCT01954082|521793894|FG001|Overall Study|Study Suspension|36|||
144368091|NCT01656408|520557409|FG003|Overall Study|Physician Decision|0|||
144368092|NCT01656408|520557410|FG004|Overall Study|Physician Decision|1|||
144368093|NCT01656408|520557411|FG005|Overall Study|Physician Decision|1|||
144368094|NCT01656408|520557412|FG006|Overall Study|Physician Decision|0|||
144368095|NCT01656408|520557413|FG007|Overall Study|Physician Decision|1|||
144368096|NCT01656408|520557414|FG008|Overall Study|Physician Decision|1|||
144368097|NCT01656408|520557415|FG009|Overall Study|Physician Decision|3|||
144368098|NCT01646125|520559781|FG000|Overall Study|Untreated|2|||
144368099|NCT01646125|520559782|FG001|Overall Study|Untreated|5|||
144368100|NCT01646125|520559781|FG000|Overall Study|Adverse Event|2|||
144368101|NCT01646125|520559782|FG001|Overall Study|Adverse Event|1|||
144368102|NCT01646125|520559781|FG000|Overall Study|Death|1|||
144710229|NCT01954082|521793893|FG000|Overall Study|Adverse Event|10|||
144710230|NCT01954082|521793894|FG001|Overall Study|Adverse Event|4|||
144368103|NCT01646125|520559782|FG001|Overall Study|Death|1|||
144368104|NCT01646125|520559781|FG000|Overall Study|Physician Decision|1|||
144710231|NCT01954082|521793893|FG000|Overall Study|Intolerance|0|||
144368105|NCT01646125|520559782|FG001|Overall Study|Physician Decision|3|||
144710232|NCT01954082|521793894|FG001|Overall Study|Intolerance|1|||
144710233|NCT01954082|521793893|FG000|Overall Study|Non-compliance|6|||
144710234|NCT01954082|521793894|FG001|Overall Study|Non-compliance|4|||
144710235|NCT01954082|521793893|FG000|Overall Study|Physician Decision|2|||
144710236|NCT01954082|521793894|FG001|Overall Study|Physician Decision|0|||
144710237|NCT01954082|521793893|FG000|Overall Study|Parent Decision|1|||
144368106|NCT01646125|520559781|FG000|Overall Study|Progressive disease|22|||
144480661|NCT01993823|520959257|FG000|Overall Study|Lost to Follow-up|1|||
144368107|NCT01646125|520559782|FG001|Overall Study|Progressive disease|16|||
144480662|NCT01993823|520959258|FG001|Overall Study|Lost to Follow-up|4|||
144710238|NCT01954082|521793894|FG001|Overall Study|Parent Decision|0|||
144710239|NCT01954082|521793893|FG000|Overall Study|Withdrawal by Subject|0|||
144710240|NCT01954082|521793894|FG001|Overall Study|Withdrawal by Subject|1|||
144710241|NCT01954082|521793893|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
144710242|NCT01954082|521793894|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
144710243|NCT01954082|521793893|FG000|Overall Study|Redirection of Care|0|||
144710244|NCT01954082|521793894|FG001|Overall Study|Redirection of Care|2|||
144710245|NCT01954082|521793893|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
144710246|NCT01954082|521793894|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
144710247|NCT01954082|521793893|FG000|Overall Study|Comfort Care|0|||
144710248|NCT01954082|521793894|FG001|Overall Study|Comfort Care|1|||
144368108|NCT01646125|520559781|FG000|Overall Study|Study terminated by sponsor|2|||
144368109|NCT01646125|520559782|FG001|Overall Study|Study terminated by sponsor|1|||
144368110|NCT01646125|520559781|FG000|Overall Study|Subject/Guardian decision|1|||
144368111|NCT01646125|520559782|FG001|Overall Study|Subject/Guardian decision|1|||
144368112|NCT00918255|520559787|FG000|Overall Study|Adverse Event|1|||
144368113|NCT00918255|520559788|FG001|Overall Study|Adverse Event|0|||
144368114|NCT00918255|520559789|FG002|Overall Study|Adverse Event|0|||
144368115|NCT00918255|520559787|FG000|Overall Study|Withdrawal by Subject|1|||
144368116|NCT00918255|520559788|FG001|Overall Study|Withdrawal by Subject|0|||
144368117|NCT00918255|520559789|FG002|Overall Study|Withdrawal by Subject|2|||
144368118|NCT00918255|520559787|FG000|Overall Study|Lack of Efficacy|1|||
144368119|NCT00918255|520559788|FG001|Overall Study|Lack of Efficacy|0|||
144368120|NCT00918255|520559789|FG002|Overall Study|Lack of Efficacy|0|||
144368121|NCT00918255|520559787|FG000|Overall Study|Lost to Follow-up|1|||
144368122|NCT00918255|520559788|FG001|Overall Study|Lost to Follow-up|0|||
144368123|NCT00918255|520559789|FG002|Overall Study|Lost to Follow-up|2|||
144368124|NCT00918255|520559787|FG000|Overall Study|Exceeded allowed number of interventions|0|||
144368125|NCT00918255|520559788|FG001|Overall Study|Exceeded allowed number of interventions|0|||
144368126|NCT00918255|520559789|FG002|Overall Study|Exceeded allowed number of interventions|1|||
144368127|NCT00918255|520559787|FG000|Overall Study|Non-compliance|1|||
144368128|NCT00918255|520559788|FG001|Overall Study|Non-compliance|0|||
144368129|NCT00918255|520559789|FG002|Overall Study|Non-compliance|0|||
144368130|NCT00918255|520559787|FG000|Overall Study|Investigator discretion|1|||
144368131|NCT00918255|520559788|FG001|Overall Study|Investigator discretion|0|||
144368132|NCT00918255|520559789|FG002|Overall Study|Investigator discretion|0|||
144368133|NCT00068692|520559791|FG000|Step 1: Registration|Disese progression/relapse|5|||
144368134|NCT00068692|520559792|FG001|Step 1: Registration|Disese progression/relapse|0|||
144368135|NCT00068692|520559793|FG002|Step 1: Registration|Disese progression/relapse|0|||
144368136|NCT00068692|520559794|FG003|Step 1: Registration|Disese progression/relapse|0|||
144368137|NCT00068692|520559795|FG004|Step 1: Registration|Disese progression/relapse|0|||
144368138|NCT00068692|520559796|FG005|Step 1: Registration|Disese progression/relapse|0|||
144368139|NCT00068692|520559797|FG006|Step 1: Registration|Disese progression/relapse|0|||
144368140|NCT00068692|520559798|FG007|Step 1: Registration|Disese progression/relapse|0|||
144368141|NCT00068692|520559791|FG000|Step 1: Registration|Adverse Event|7|||
144368142|NCT00068692|520559792|FG001|Step 1: Registration|Adverse Event|0|||
144368143|NCT00068692|520559793|FG002|Step 1: Registration|Adverse Event|0|||
144368144|NCT00068692|520559794|FG003|Step 1: Registration|Adverse Event|0|||
144368145|NCT00068692|520559795|FG004|Step 1: Registration|Adverse Event|0|||
144368146|NCT00068692|520559796|FG005|Step 1: Registration|Adverse Event|0|||
144368147|NCT00068692|520559797|FG006|Step 1: Registration|Adverse Event|0|||
144368148|NCT00068692|520559798|FG007|Step 1: Registration|Adverse Event|0|||
144368149|NCT00068692|520559791|FG000|Step 1: Registration|Death|1|||
144368150|NCT00068692|520559792|FG001|Step 1: Registration|Death|0|||
144368151|NCT00068692|520559793|FG002|Step 1: Registration|Death|0|||
144368152|NCT00068692|520559794|FG003|Step 1: Registration|Death|0|||
144368153|NCT00068692|520559795|FG004|Step 1: Registration|Death|0|||
144368154|NCT00068692|520559796|FG005|Step 1: Registration|Death|0|||
144368155|NCT00068692|520559797|FG006|Step 1: Registration|Death|0|||
144368156|NCT00068692|520559798|FG007|Step 1: Registration|Death|0|||
144368157|NCT00068692|520559791|FG000|Step 1: Registration|Withdrawal by Subject|11|||
144368158|NCT00068692|520559792|FG001|Step 1: Registration|Withdrawal by Subject|0|||
144710249|NCT01954082|521793893|FG000|Overall Study|Infant Moved|0|||
144710250|NCT01954082|521793894|FG001|Overall Study|Infant Moved|1|||
144710251|NCT01954082|521793893|FG000|Overall Study|Randomized not Treated|4|||
144368159|NCT00068692|520559793|FG002|Step 1: Registration|Withdrawal by Subject|0|||
144368160|NCT00068692|520559794|FG003|Step 1: Registration|Withdrawal by Subject|0|||
144368161|NCT00068692|520559795|FG004|Step 1: Registration|Withdrawal by Subject|0|||
144368162|NCT00068692|520559796|FG005|Step 1: Registration|Withdrawal by Subject|0|||
144368163|NCT00068692|520559797|FG006|Step 1: Registration|Withdrawal by Subject|0|||
144368164|NCT00068692|520559798|FG007|Step 1: Registration|Withdrawal by Subject|0|||
144368165|NCT00068692|520559791|FG000|Step 1: Registration|Alternative therapy|2|||
144368166|NCT00068692|520559792|FG001|Step 1: Registration|Alternative therapy|0|||
144710252|NCT01954082|521793894|FG001|Overall Study|Randomized not Treated|2|||
144710253|NCT02419469|521793895|FG000|Overall Study|Withdrawal by Subject|1|||
144710254|NCT01682512|521793896|FG000|Overall Study|Adverse Event|6|||
144710255|NCT01682512|521793897|FG001|Overall Study|Adverse Event|5|||
144710256|NCT01682512|521793898|FG002|Overall Study|Adverse Event|2|||
144710257|NCT01682512|521793896|FG000|Overall Study|Withdrawal by Subject|2|||
144710258|NCT01682512|521793897|FG001|Overall Study|Withdrawal by Subject|6|||
144710259|NCT01682512|521793898|FG002|Overall Study|Withdrawal by Subject|3|||
144710260|NCT01682512|521793896|FG000|Overall Study|Physician Decision|0|||
144710261|NCT01682512|521793897|FG001|Overall Study|Physician Decision|2|||
144710262|NCT01682512|521793898|FG002|Overall Study|Physician Decision|0|||
144710263|NCT01682512|521793896|FG000|Overall Study|Study terminated by sponsor|46|||
144710264|NCT01682512|521793897|FG001|Overall Study|Study terminated by sponsor|43|||
144710265|NCT01682512|521793898|FG002|Overall Study|Study terminated by sponsor|0|||
144710266|NCT01682512|521793896|FG000|Overall Study|Lost to Follow-up|3|||
144710267|NCT01682512|521793897|FG001|Overall Study|Lost to Follow-up|0|||
144710268|NCT01682512|521793898|FG002|Overall Study|Lost to Follow-up|2|||
144368167|NCT00068692|520559793|FG002|Step 1: Registration|Alternative therapy|0|||
144368168|NCT00068692|520559794|FG003|Step 1: Registration|Alternative therapy|0|||
144368169|NCT00068692|520559795|FG004|Step 1: Registration|Alternative therapy|0|||
144368170|NCT00068692|520559796|FG005|Step 1: Registration|Alternative therapy|0|||
144368171|NCT00068692|520559797|FG006|Step 1: Registration|Alternative therapy|0|||
144368172|NCT00068692|520559798|FG007|Step 1: Registration|Alternative therapy|0|||
144368173|NCT00068692|520559791|FG000|Step 1: Registration|Complicating disease|2|||
144368174|NCT00068692|520559792|FG001|Step 1: Registration|Complicating disease|0|||
144368175|NCT00068692|520559793|FG002|Step 1: Registration|Complicating disease|0|||
144368176|NCT00068692|520559794|FG003|Step 1: Registration|Complicating disease|0|||
144368177|NCT00068692|520559795|FG004|Step 1: Registration|Complicating disease|0|||
144368178|NCT00068692|520559796|FG005|Step 1: Registration|Complicating disease|0|||
144368179|NCT00068692|520559797|FG006|Step 1: Registration|Complicating disease|0|||
144368180|NCT00068692|520559798|FG007|Step 1: Registration|Complicating disease|0|||
144368181|NCT00068692|520559791|FG000|Step 1: Registration|Protocol Violation|1|||
144368182|NCT00068692|520559792|FG001|Step 1: Registration|Protocol Violation|0|||
144368183|NCT00068692|520559793|FG002|Step 1: Registration|Protocol Violation|0|||
144368184|NCT00068692|520559794|FG003|Step 1: Registration|Protocol Violation|0|||
144368185|NCT00068692|520559795|FG004|Step 1: Registration|Protocol Violation|0|||
144368186|NCT00068692|520559796|FG005|Step 1: Registration|Protocol Violation|0|||
144368187|NCT00068692|520559797|FG006|Step 1: Registration|Protocol Violation|0|||
144368188|NCT00068692|520559798|FG007|Step 1: Registration|Protocol Violation|0|||
144368189|NCT00068692|520559791|FG000|Step 1: Registration|Not eligible|6|||
144368190|NCT00068692|520559792|FG001|Step 1: Registration|Not eligible|0|||
144368191|NCT00068692|520559793|FG002|Step 1: Registration|Not eligible|0|||
144368192|NCT00068692|520559794|FG003|Step 1: Registration|Not eligible|0|||
144368193|NCT00068692|520559795|FG004|Step 1: Registration|Not eligible|0|||
144368194|NCT00068692|520559796|FG005|Step 1: Registration|Not eligible|0|||
144368195|NCT00068692|520559797|FG006|Step 1: Registration|Not eligible|0|||
144368196|NCT00068692|520559798|FG007|Step 1: Registration|Not eligible|0|||
144368197|NCT00068692|520559791|FG000|Step 1: Registration|Other|2|||
144368198|NCT00068692|520559792|FG001|Step 1: Registration|Other|0|||
144368199|NCT00068692|520559793|FG002|Step 1: Registration|Other|0|||
144368200|NCT00068692|520559794|FG003|Step 1: Registration|Other|0|||
144368201|NCT00068692|520559795|FG004|Step 1: Registration|Other|0|||
144368202|NCT00068692|520559796|FG005|Step 1: Registration|Other|0|||
144368203|NCT00068692|520559797|FG006|Step 1: Registration|Other|0|||
144368204|NCT00068692|520559798|FG007|Step 1: Registration|Other|0|||
144368205|NCT00068692|520559791|FG000|Step 1: Registration|Not start protocol therapy|3|||
144368206|NCT00068692|520559792|FG001|Step 1: Registration|Not start protocol therapy|0|||
144368207|NCT00068692|520559793|FG002|Step 1: Registration|Not start protocol therapy|0|||
144368208|NCT00068692|520559794|FG003|Step 1: Registration|Not start protocol therapy|0|||
144368209|NCT00068692|520559795|FG004|Step 1: Registration|Not start protocol therapy|0|||
144368210|NCT00068692|520559796|FG005|Step 1: Registration|Not start protocol therapy|0|||
144368211|NCT00068692|520559797|FG006|Step 1: Registration|Not start protocol therapy|0|||
144368212|NCT00068692|520559798|FG007|Step 1: Registration|Not start protocol therapy|0|||
144368213|NCT00068692|520559791|FG000|Step 1: Registration|Registered but not randomized|0|||
144480663|NCT01235975|520959261|FG000|Overall Study|Serious Adverse Event|0|||
144710269|NCT01682512|521793896|FG000|Overall Study|Protocol Violation|2|||
144710270|NCT01682512|521793897|FG001|Overall Study|Protocol Violation|3|||
144710271|NCT01682512|521793898|FG002|Overall Study|Protocol Violation|2|||
144368214|NCT00068692|520559792|FG001|Step 1: Registration|Registered but not randomized|1|||
144368215|NCT00068692|520559793|FG002|Step 1: Registration|Registered but not randomized|0|||
144368216|NCT00068692|520559794|FG003|Step 1: Registration|Registered but not randomized|0|||
144368217|NCT00068692|520559795|FG004|Step 1: Registration|Registered but not randomized|0|||
144368218|NCT00068692|520559796|FG005|Step 1: Registration|Registered but not randomized|0|||
144368219|NCT00068692|520559797|FG006|Step 1: Registration|Registered but not randomized|0|||
144368220|NCT00068692|520559798|FG007|Step 1: Registration|Registered but not randomized|0|||
144368221|NCT00068692|520559791|FG000|Step 2: Randomization|Disesae progression/replase|0|||
144710272|NCT01682512|521793896|FG000|Overall Study|Primary lack of efficacy|10|||
144710273|NCT01682512|521793897|FG001|Overall Study|Primary lack of efficacy|7|||
144710274|NCT01682512|521793898|FG002|Overall Study|Primary lack of efficacy|7|||
144710275|NCT01682512|521793896|FG000|Overall Study|Secondary lack of efficacy|1|||
144710276|NCT01682512|521793897|FG001|Overall Study|Secondary lack of efficacy|1|||
144710277|NCT01682512|521793898|FG002|Overall Study|Secondary lack of efficacy|0|||
144710278|NCT01682512|521793896|FG000|Overall Study|Other than stated above|2|||
144710279|NCT01682512|521793897|FG001|Overall Study|Other than stated above|4|||
144710280|NCT01682512|521793898|FG002|Overall Study|Other than stated above|2|||
144710281|NCT01377233|521793899|FG000|Open-label|Adverse Event|1|||
144710282|NCT01377233|521793900|FG001|Open-label|Adverse Event|0|||
144710283|NCT01377233|521793901|FG002|Open-label|Adverse Event|0|||
144710284|NCT01377233|521793902|FG003|Open-label|Adverse Event|0|||
144710285|NCT01377233|521793903|FG004|Open-label|Adverse Event|0|||
144710286|NCT01377233|521793899|FG000|Open-label|Withdrawal by Subject|3|||
144710287|NCT01377233|521793900|FG001|Open-label|Withdrawal by Subject|0|||
144710288|NCT01377233|521793901|FG002|Open-label|Withdrawal by Subject|0|||
144710289|NCT01377233|521793902|FG003|Open-label|Withdrawal by Subject|0|||
144710290|NCT01377233|521793903|FG004|Open-label|Withdrawal by Subject|0|||
144710291|NCT01377233|521793899|FG000|Double-blind|Adverse Event|0|||
144710292|NCT01377233|521793900|FG001|Double-blind|Adverse Event|1|||
144710293|NCT01377233|521793901|FG002|Double-blind|Adverse Event|2|||
144710294|NCT01377233|521793902|FG003|Double-blind|Adverse Event|2|||
144710295|NCT01377233|521793903|FG004|Double-blind|Adverse Event|0|||
144710296|NCT01377233|521793899|FG000|Double-blind|Protocol Violation|0|||
144710297|NCT01377233|521793900|FG001|Double-blind|Protocol Violation|0|||
144710298|NCT01377233|521793901|FG002|Double-blind|Protocol Violation|0|||
144710299|NCT01377233|521793902|FG003|Double-blind|Protocol Violation|0|||
144710300|NCT01377233|521793903|FG004|Double-blind|Protocol Violation|1|||
144710301|NCT01377233|521793899|FG000|Double-blind|Withdrawal by Subject|0|||
144710302|NCT01377233|521793900|FG001|Double-blind|Withdrawal by Subject|0|||
144710303|NCT01377233|521793901|FG002|Double-blind|Withdrawal by Subject|0|||
144710304|NCT01377233|521793902|FG003|Double-blind|Withdrawal by Subject|1|||
144710305|NCT01377233|521793903|FG004|Double-blind|Withdrawal by Subject|0|||
144710306|NCT01377233|521793899|FG000|Double-blind|Administrative or other|0|||
144710307|NCT01377233|521793900|FG001|Double-blind|Administrative or other|0|||
144710308|NCT01377233|521793901|FG002|Double-blind|Administrative or other|0|||
144710309|NCT01377233|521793902|FG003|Double-blind|Administrative or other|1|||
144710310|NCT01377233|521793903|FG004|Double-blind|Administrative or other|1|||
144710311|NCT01785875|521793904|FG000|Overall Study|Withdrawal by Subject|41|||
144710312|NCT01785875|521793905|FG001|Overall Study|Withdrawal by Subject|34|||
144710313|NCT01785875|521793906|FG002|Overall Study|Withdrawal by Subject|36|||
144710314|NCT01785875|521793904|FG000|Overall Study|Lost to Follow-up|19|||
144710315|NCT01785875|521793905|FG001|Overall Study|Lost to Follow-up|22|||
144710316|NCT01785875|521793906|FG002|Overall Study|Lost to Follow-up|6|||
144710317|NCT01785875|521793904|FG000|Overall Study|Death|27|||
144710318|NCT01785875|521793905|FG001|Overall Study|Death|16|||
144710319|NCT01785875|521793906|FG002|Overall Study|Death|7|||
144710320|NCT01785875|521793904|FG000|Overall Study|Sponsor Decision|0|||
144710321|NCT01785875|521793905|FG001|Overall Study|Sponsor Decision|2|||
144710322|NCT01785875|521793906|FG002|Overall Study|Sponsor Decision|0|||
144710323|NCT01785875|521793904|FG000|Overall Study|Protocol Specified Criteria|207|||
144710324|NCT01785875|521793905|FG001|Overall Study|Protocol Specified Criteria|214|||
144710325|NCT01785875|521793906|FG002|Overall Study|Protocol Specified Criteria|55|||
144710326|NCT01785875|521793904|FG000|Overall Study|Missing|0|||
144710327|NCT01785875|521793905|FG001|Overall Study|Missing|1|||
144710328|NCT01785875|521793906|FG002|Overall Study|Missing|3|||
144710329|NCT03137082|521793909|FG000|Overall Study|Withdrawal by Subject|1|||
144710330|NCT03137082|521793910|FG001|Overall Study|Withdrawal by Subject|1|||
144710331|NCT03137082|521793909|FG000|Overall Study|Lost to Follow-up|1|||
144710332|NCT03137082|521793910|FG001|Overall Study|Lost to Follow-up|0|||
144710333|NCT00417027|521793911|FG000|Overall Study|Protocol Violation|0|||
144710334|NCT00417027|521793912|FG001|Overall Study|Protocol Violation|5|||
144710335|NCT00417027|521793913|FG002|Overall Study|Protocol Violation|5|||
144710336|NCT00707174|521793914|FG000|Overall Study|Adverse Event|1|||
144710337|NCT00707174|521793915|FG001|Overall Study|Adverse Event|6|||
144710338|NCT00707174|521793914|FG000|Overall Study|Withdrawal by Subject|4|||
144710339|NCT00707174|521793915|FG001|Overall Study|Withdrawal by Subject|1|||
144710340|NCT00544557|521793916|FG000|Overall Study|Adverse Event|140|||
144710341|NCT00544557|521793916|FG000|Overall Study|Lack of Efficacy|196|||
144710342|NCT00544557|521793916|FG000|Overall Study|Other|98|||
144710343|NCT04057118|521793919|FG000|Overall Study|Adverse Event|1|||
144710344|NCT04057118|521793920|FG001|Overall Study|Adverse Event|0|||
144710345|NCT04057118|521793921|FG002|Overall Study|Adverse Event|1|||
144710346|NCT04057118|521793922|FG003|Overall Study|Adverse Event|1|||
144710347|NCT04057118|521793919|FG000|Overall Study|Physician Decision|0|||
144710348|NCT04057118|521793920|FG001|Overall Study|Physician Decision|0|||
144710349|NCT04057118|521793921|FG002|Overall Study|Physician Decision|1|||
144710350|NCT04057118|521793922|FG003|Overall Study|Physician Decision|1|||
144710351|NCT04057118|521793919|FG000|Overall Study|Withdrawal by Subject|2|||
144710352|NCT04057118|521793920|FG001|Overall Study|Withdrawal by Subject|2|||
144710353|NCT04057118|521793921|FG002|Overall Study|Withdrawal by Subject|0|||
144710354|NCT04057118|521793922|FG003|Overall Study|Withdrawal by Subject|2|||
144710355|NCT04057118|521793919|FG000|Overall Study|Not Specific|0|||
144710356|NCT04057118|521793920|FG001|Overall Study|Not Specific|0|||
144710357|NCT04057118|521793921|FG002|Overall Study|Not Specific|1|||
144710358|NCT04057118|521793922|FG003|Overall Study|Not Specific|1|||
144710359|NCT01850108|521793928|FG000|Overall Study|Lost to Follow-up|4|||
144710360|NCT01850108|521793928|FG000|Overall Study|Not eligible|1|||
144710361|NCT01850108|521793928|FG000|Overall Study|Failed engraftment|2|||
144710362|NCT01850108|521793928|FG000|Overall Study|Physician Decision|1|||
144710363|NCT03273712|521793932|FG000|Overall Study|Death|5|||
144710364|NCT03273712|521793932|FG000|Overall Study|Adverse Event|1|||
144710365|NCT03273712|521793932|FG000|Overall Study|Disease Progression|1|||
144710366|NCT00886782|521793940|FG000|Overall Study|Disease progression|3|||
144710367|NCT00886782|521793941|FG001|Overall Study|Disease progression|3|||
144710368|NCT00886782|521793942|FG002|Overall Study|Disease progression|3|||
144710369|NCT00886782|521793940|FG000|Overall Study|Study drug toxicity|0|||
144710370|NCT00886782|521793941|FG001|Overall Study|Study drug toxicity|0|||
144710371|NCT00886782|521793942|FG002|Overall Study|Study drug toxicity|1|||
144710372|NCT00886782|521793940|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
144710373|NCT00886782|521793941|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
144710374|NCT00886782|521793942|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
144710375|NCT01494649|521793945|FG000|Overall Study|Lost to Follow-up|0|||
144710376|NCT01494649|521793946|FG001|Overall Study|Lost to Follow-up|1|||
144710377|NCT03467971|521793947|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144368222|NCT00068692|520559792|FG001|Step 2: Randomization|Disesae progression/replase|0|||
144710378|NCT03467971|521793948|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144710379|NCT01656967|521793949|FG000|Overall Study|faulty monitor|1|||
144710380|NCT01656967|521793950|FG001|Overall Study|faulty monitor|0|||
144710381|NCT01656967|521793949|FG000|Overall Study|unsuccessful ETT insertion|3|||
144710382|NCT01656967|521793950|FG001|Overall Study|unsuccessful ETT insertion|2|||
144710383|NCT05166512|521793951|FG000|Randomized|Lost to Follow-up|2|||
144710384|NCT05166512|521793952|FG001|Randomized|Lost to Follow-up|0|||
144710385|NCT05166512|521793951|FG000|Randomized|Withdrawal by Subject|1|||
144710386|NCT05166512|521793952|FG001|Randomized|Withdrawal by Subject|0|||
144368223|NCT00068692|520559793|FG002|Step 2: Randomization|Disesae progression/replase|1|||
144368224|NCT00068692|520559794|FG003|Step 2: Randomization|Disesae progression/replase|1|||
144368225|NCT00068692|520559795|FG004|Step 2: Randomization|Disesae progression/replase|0|||
144368226|NCT00068692|520559796|FG005|Step 2: Randomization|Disesae progression/replase|0|||
144368227|NCT00068692|520559797|FG006|Step 2: Randomization|Disesae progression/replase|0|||
144368228|NCT00068692|520559798|FG007|Step 2: Randomization|Disesae progression/replase|0|||
144368229|NCT00068692|520559791|FG000|Step 2: Randomization|Adverse Event|0|||
144368230|NCT00068692|520559792|FG001|Step 2: Randomization|Adverse Event|0|||
144538208|NCT00146172|521174129|FG007|Overall Study|Disease Progression|22|||
144710387|NCT05166512|521793951|FG000|Baseline Data Collection|Lost to Follow-up|0|||
144710388|NCT05166512|521793952|FG001|Baseline Data Collection|Lost to Follow-up|3|||
144710389|NCT05166512|521793951|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
144710390|NCT05166512|521793952|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
144710391|NCT05166512|521793951|FG000|Baseline Data Collection|Protocol Violation|2|||
144710392|NCT05166512|521793952|FG001|Baseline Data Collection|Protocol Violation|0|||
144710393|NCT05166512|521793951|FG000|4 Month Data Collection|Lost to Follow-up|1|||
144710394|NCT05166512|521793952|FG001|4 Month Data Collection|Lost to Follow-up|0|||
144710395|NCT05166512|521793951|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
144368231|NCT00068692|520559793|FG002|Step 2: Randomization|Adverse Event|4|||
144710396|NCT05166512|521793952|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
144710397|NCT05166512|521793951|FG000|12 Month Data Collection|Lost to Follow-up|3|||
144710398|NCT05166512|521793952|FG001|12 Month Data Collection|Lost to Follow-up|1|||
144710399|NCT05166512|521793951|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
144480664|NCT01235975|520959262|FG001|Overall Study|Serious Adverse Event|1|||
144480665|NCT01235975|520959261|FG000|Overall Study|Withdrawal by Subject|8|||
144480666|NCT01235975|520959262|FG001|Overall Study|Withdrawal by Subject|2|||
144480667|NCT01235975|520959261|FG000|Overall Study|Migrated/moved from study area|2|||
144480668|NCT01235975|520959262|FG001|Overall Study|Migrated/moved from study area|1|||
144480669|NCT01235975|520959261|FG000|Overall Study|Lost to Follow-up|7|||
144480670|NCT01235975|520959262|FG001|Overall Study|Lost to Follow-up|3|||
144480671|NCT05033743|520959265|FG000|Overall Study|Lost to Follow-up|1|||
144480672|NCT05033743|520959265|FG000|Overall Study|Protocol Violation|2|||
144480673|NCT05033743|520959265|FG000|Overall Study|Withdrawal by Subject|1|||
144480674|NCT00791921|520959268|FG000|Overall Study|Protocol planed|24|||
144480675|NCT00791921|520959269|FG001|Overall Study|Protocol planed|88|||
144480676|NCT00791921|520959268|FG000|Overall Study|Withdrawal by Subject|1|||
144480677|NCT00791921|520959269|FG001|Overall Study|Withdrawal by Subject|2|||
144480678|NCT00791921|520959268|FG000|Overall Study|Adverse Event|8|||
144480679|NCT00791921|520959269|FG001|Overall Study|Adverse Event|2|||
144710400|NCT05166512|521793952|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
144710401|NCT00420849|521793953|FG000|Overall Study|Lack of Efficacy|154|||
144710402|NCT00420849|521793953|FG000|Overall Study|Adverse Event|107|||
144710403|NCT00420849|521793953|FG000|Overall Study|Withdrawal by Subject|28|||
144480680|NCT00791921|520959268|FG000|Overall Study|Lack of Efficacy|0|||
144480681|NCT00791921|520959269|FG001|Overall Study|Lack of Efficacy|2|||
144480682|NCT00791921|520959268|FG000|Overall Study|Lack of study drug administration|1|||
144710404|NCT00420849|521793953|FG000|Overall Study|Death|18|||
144710405|NCT00420849|521793953|FG000|Overall Study|Other|14|||
144710406|NCT00420849|521793953|FG000|Overall Study|Transplant|8|||
144710407|NCT00420849|521793953|FG000|Overall Study|Protocol Violation|1|||
144710408|NCT00420849|521793953|FG000|Overall Study|Lost to Follow-up|1|||
144710409|NCT01345058|521793954|FG000|Overall Study|Withdrawal by Subject|1|||
144710410|NCT01345058|521793955|FG001|Overall Study|Withdrawal by Subject|0|||
144710411|NCT01345058|521793954|FG000|Overall Study|Participant Reported Increase in Events|1|||
144710412|NCT01345058|521793955|FG001|Overall Study|Participant Reported Increase in Events|0|||
144710413|NCT01345058|521793954|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
144710414|NCT01345058|521793955|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
144710415|NCT01345058|521793954|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
144710416|NCT01345058|521793955|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
144710417|NCT01345058|521793954|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
144710418|NCT01345058|521793955|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
144710419|NCT00000135|521793956|FG000|Overall Study|Death|27|||
144710420|NCT00000135|521793957|FG001|Overall Study|Death|14|||
144710421|NCT01831596|521793958|FG000|Overall Study|Other|8|||
144710422|NCT01999322|521793959|FG000|Overall Study|Adverse Event|1|||
144710423|NCT01999322|521793960|FG001|Overall Study|Adverse Event|0|||
144710424|NCT00434148|521793961|FG000|Overall Study|Adverse Event|18|||
144710425|NCT00434148|521793962|FG001|Overall Study|Adverse Event|18|||
144710426|NCT00434148|521793961|FG000|Overall Study|Lack of Efficacy|25|||
144710427|NCT00434148|521793962|FG001|Overall Study|Lack of Efficacy|28|||
144710428|NCT00434148|521793961|FG000|Overall Study|Withdrawal by Subject|15|||
144710429|NCT00434148|521793962|FG001|Overall Study|Withdrawal by Subject|15|||
144710430|NCT00434148|521793961|FG000|Overall Study|Protocol Violation|4|||
144710431|NCT00434148|521793962|FG001|Overall Study|Protocol Violation|0|||
144710432|NCT00434148|521793961|FG000|Overall Study|Administrative problems|6|||
144710433|NCT00434148|521793962|FG001|Overall Study|Administrative problems|10|||
144710434|NCT00434148|521793961|FG000|Overall Study|Lost to Follow-up|0|||
144710435|NCT00434148|521793962|FG001|Overall Study|Lost to Follow-up|1|||
144710436|NCT00434148|521793961|FG000|Overall Study|Condition no longer requires study drug|1|||
144710437|NCT00434148|521793962|FG001|Overall Study|Condition no longer requires study drug|0|||
144710438|NCT00434148|521793961|FG000|Overall Study|Abnormal test procedure result|0|||
144710439|NCT00434148|521793962|FG001|Overall Study|Abnormal test procedure result|1|||
144710440|NCT00833976|521795623|FG000|Overall Study|Withdrawal by Subject|5|||
144710441|NCT00833976|521795623|FG000|Overall Study|Lost to Follow-up|4|||
144710442|NCT00833976|521795623|FG000|Overall Study|Did not meet eligibility criteria|41|||
144710443|NCT00833976|521795623|FG000|Overall Study|Physician Decision|1|||
144710444|NCT01142466|521795627|FG000|Overall Study|Adverse Event|2|||
144710445|NCT01142466|521795628|FG001|Overall Study|Adverse Event|1|||
144710446|NCT01142466|521795627|FG000|Overall Study|Withdrawal by Subject|1|||
144480683|NCT00791921|520959269|FG001|Overall Study|Lack of study drug administration|1|||
144480684|NCT00791921|520959268|FG000|Overall Study|Reason other than those above|0|||
144480685|NCT00791921|520959269|FG001|Overall Study|Reason other than those above|1|||
144480686|NCT01592695|520959271|FG000|Overall Study|Lost to Follow-up|8|||
144710447|NCT01142466|521795628|FG001|Overall Study|Withdrawal by Subject|1|||
144710448|NCT02414854|521795633|FG000|Overall Study|Adverse Event|9|||
144710449|NCT02414854|521795634|FG001|Overall Study|Adverse Event|7|||
144710450|NCT02414854|521795635|FG002|Overall Study|Adverse Event|1|||
144710451|NCT02414854|521795636|FG003|Overall Study|Adverse Event|12|||
144710452|NCT02414854|521795633|FG000|Overall Study|Poor compliance to protocol|1|||
144368232|NCT00068692|520559794|FG003|Step 2: Randomization|Adverse Event|2|||
144368233|NCT00068692|520559795|FG004|Step 2: Randomization|Adverse Event|2|||
144368234|NCT00068692|520559796|FG005|Step 2: Randomization|Adverse Event|3|||
144368235|NCT00068692|520559797|FG006|Step 2: Randomization|Adverse Event|4|||
144368236|NCT00068692|520559798|FG007|Step 2: Randomization|Adverse Event|4|||
144368237|NCT00068692|520559791|FG000|Step 2: Randomization|Death|0|||
144368238|NCT00068692|520559792|FG001|Step 2: Randomization|Death|0|||
144368239|NCT00068692|520559793|FG002|Step 2: Randomization|Death|0|||
144368240|NCT00068692|520559794|FG003|Step 2: Randomization|Death|0|||
144368241|NCT00068692|520559795|FG004|Step 2: Randomization|Death|1|||
144368242|NCT00068692|520559796|FG005|Step 2: Randomization|Death|0|||
144368243|NCT00068692|520559797|FG006|Step 2: Randomization|Death|0|||
144368244|NCT00068692|520559798|FG007|Step 2: Randomization|Death|1|||
144368245|NCT00068692|520559791|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
144368246|NCT00068692|520559792|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
144368247|NCT00068692|520559793|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
144368248|NCT00068692|520559794|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
144368249|NCT00068692|520559795|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
144368250|NCT00068692|520559796|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
144368251|NCT00068692|520559797|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
144368252|NCT00068692|520559798|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
144368253|NCT00068692|520559791|FG000|Step 2: Randomization|alternative therapy|0|||
144368254|NCT00068692|520559792|FG001|Step 2: Randomization|alternative therapy|0|||
144368255|NCT00068692|520559793|FG002|Step 2: Randomization|alternative therapy|0|||
144368256|NCT00068692|520559794|FG003|Step 2: Randomization|alternative therapy|1|||
144368257|NCT00068692|520559795|FG004|Step 2: Randomization|alternative therapy|1|||
144368258|NCT00068692|520559796|FG005|Step 2: Randomization|alternative therapy|0|||
144368259|NCT00068692|520559797|FG006|Step 2: Randomization|alternative therapy|0|||
144368260|NCT00068692|520559798|FG007|Step 2: Randomization|alternative therapy|0|||
144368261|NCT00068692|520559791|FG000|Step 2: Randomization|Physician Decision|0|||
144368262|NCT00068692|520559792|FG001|Step 2: Randomization|Physician Decision|0|||
144368263|NCT00068692|520559793|FG002|Step 2: Randomization|Physician Decision|0|||
144368264|NCT00068692|520559794|FG003|Step 2: Randomization|Physician Decision|1|||
144368265|NCT00068692|520559795|FG004|Step 2: Randomization|Physician Decision|1|||
144368266|NCT00068692|520559796|FG005|Step 2: Randomization|Physician Decision|0|||
144368267|NCT00068692|520559797|FG006|Step 2: Randomization|Physician Decision|0|||
144368268|NCT00068692|520559798|FG007|Step 2: Randomization|Physician Decision|0|||
144368269|NCT00068692|520559791|FG000|Step 2: Randomization|Other|0|||
144368270|NCT00068692|520559792|FG001|Step 2: Randomization|Other|0|||
144368271|NCT00068692|520559793|FG002|Step 2: Randomization|Other|0|||
144368272|NCT00068692|520559794|FG003|Step 2: Randomization|Other|1|||
144368273|NCT00068692|520559795|FG004|Step 2: Randomization|Other|0|||
144368274|NCT00068692|520559796|FG005|Step 2: Randomization|Other|1|||
144368275|NCT00068692|520559797|FG006|Step 2: Randomization|Other|0|||
144368276|NCT00068692|520559798|FG007|Step 2: Randomization|Other|0|||
144368277|NCT00068692|520559791|FG000|Step 2: Randomization|never start protocol therapy|0|||
144368278|NCT00068692|520559792|FG001|Step 2: Randomization|never start protocol therapy|0|||
144368279|NCT00068692|520559793|FG002|Step 2: Randomization|never start protocol therapy|1|||
144368280|NCT00068692|520559794|FG003|Step 2: Randomization|never start protocol therapy|0|||
144368281|NCT00068692|520559795|FG004|Step 2: Randomization|never start protocol therapy|1|||
144368282|NCT00068692|520559796|FG005|Step 2: Randomization|never start protocol therapy|0|||
144368283|NCT00068692|520559797|FG006|Step 2: Randomization|never start protocol therapy|0|||
144368284|NCT00068692|520559798|FG007|Step 2: Randomization|never start protocol therapy|0|||
144368285|NCT00248040|520559800|FG000|Overall Study|transplantectomy|2|||
144368286|NCT00248040|520559801|FG001|Overall Study|transplantectomy|1|||
144368287|NCT00248040|520559802|FG002|Overall Study|transplantectomy|3|||
144368288|NCT00248040|520559800|FG000|Overall Study|transplant cancelled post treat start|1|||
144368289|NCT00248040|520559801|FG001|Overall Study|transplant cancelled post treat start|0|||
144368290|NCT00248040|520559802|FG002|Overall Study|transplant cancelled post treat start|0|||
144368291|NCT00248040|520559800|FG000|Overall Study|Death|0|||
144368292|NCT00248040|520559801|FG001|Overall Study|Death|0|||
144368293|NCT00248040|520559802|FG002|Overall Study|Death|1|||
144710453|NCT02414854|521795634|FG001|Overall Study|Poor compliance to protocol|1|||
144710454|NCT02414854|521795635|FG002|Overall Study|Poor compliance to protocol|2|||
144710455|NCT02414854|521795636|FG003|Overall Study|Poor compliance to protocol|2|||
144710456|NCT02414854|521795633|FG000|Overall Study|Other than specified above|12|||
144710457|NCT02414854|521795634|FG001|Overall Study|Other than specified above|37|||
144368294|NCT03557034|520559805|FG000|Overall Study|Withdrawal by Subject|1|||
144368295|NCT03557034|520559806|FG001|Overall Study|Withdrawal by Subject|0|||
144368296|NCT00865566|520559807|FG000|Overall Study|Death|1|||
144368297|NCT00865566|520559808|FG001|Overall Study|Death|11|||
144368298|NCT00865566|520559807|FG000|Overall Study|Lost to Follow-up|314|||
144368299|NCT00865566|520559808|FG001|Overall Study|Lost to Follow-up|315|||
144368300|NCT00865566|520559807|FG000|Overall Study|Withdrawal by Subject|45|||
144368301|NCT00865566|520559808|FG001|Overall Study|Withdrawal by Subject|65|||
144480687|NCT01592695|520959272|FG001|Overall Study|Lost to Follow-up|4|||
144480688|NCT00422799|520959273|FG000|Overall Study|Withdrawal by Subject|6|||
144480689|NCT00422799|520959273|FG000|Overall Study|Adverse Event|7|||
144480690|NCT01965158|520959274|FG000|Overall Study|Adverse Event|14|||
144480691|NCT01965158|520959275|FG001|Overall Study|Adverse Event|5|||
144480692|NCT01965158|520959274|FG000|Overall Study|Withdrawal by Subject|16|||
144480693|NCT01965158|520959275|FG001|Overall Study|Withdrawal by Subject|24|||
144710458|NCT02414854|521795635|FG002|Overall Study|Other than specified above|17|||
144710459|NCT02414854|521795636|FG003|Overall Study|Other than specified above|37|||
144710460|NCT03724916|521795637|FG000|Overall Study|Withdrawal by Subject|0|||
144710461|NCT03724916|521795638|FG001|Overall Study|Withdrawal by Subject|1|||
144710462|NCT03724916|521795639|FG002|Overall Study|Withdrawal by Subject|1|||
144710463|NCT03724916|521795640|FG003|Overall Study|Withdrawal by Subject|2|||
144710464|NCT03724916|521795637|FG000|Overall Study|Randomized but not Treated|1|||
144710465|NCT03724916|521795638|FG001|Overall Study|Randomized but not Treated|0|||
144710466|NCT03724916|521795639|FG002|Overall Study|Randomized but not Treated|0|||
144710467|NCT03724916|521795640|FG003|Overall Study|Randomized but not Treated|0|||
144710468|NCT01355523|521795641|FG000|Overall Study|Withdrawal by Subject|1|||
144710469|NCT01355523|521795642|FG001|Overall Study|Withdrawal by Subject|4|||
144710470|NCT01355523|521795641|FG000|Overall Study|Lost to Follow-up|0|||
144710471|NCT01355523|521795642|FG001|Overall Study|Lost to Follow-up|2|||
144710472|NCT01355523|521795641|FG000|Overall Study|Protocol Violation|0|||
144710473|NCT01355523|521795642|FG001|Overall Study|Protocol Violation|2|||
144710474|NCT01355523|521795641|FG000|Overall Study|Adverse Event|0|||
144710475|NCT01355523|521795642|FG001|Overall Study|Adverse Event|2|||
144710476|NCT04575038|521795643|FG000|Overall Study|Withdrawal by Subject|1|||
144710477|NCT04575038|521795644|FG001|Overall Study|Withdrawal by Subject|1|||
144710478|NCT00190684|521795650|FG000|Overall Study|Adverse Event|86|||
144710479|NCT00190684|521795650|FG000|Overall Study|Satisfactory response|80|||
144710480|NCT00190684|521795650|FG000|Overall Study|Lack of efficacy|204|||
144710481|NCT00190684|521795650|FG000|Overall Study|Lost to Follow-up|232|||
144710482|NCT00190684|521795650|FG000|Overall Study|Patient moved|60|||
144710483|NCT00190684|521795650|FG000|Overall Study|Patient Decision|432|||
144710484|NCT00190684|521795650|FG000|Overall Study|Clinical relapse|67|||
144710485|NCT00190684|521795650|FG000|Overall Study|Sponsor's decision|17|||
144710486|NCT00190684|521795650|FG000|Overall Study|Physician Decision|84|||
144710487|NCT00190684|521795650|FG000|Overall Study|Protocol Violation|123|||
144710488|NCT00190684|521795650|FG000|Overall Study|Study Period III Completed|103|||
144710489|NCT00190684|521795650|FG000|Overall Study|Study Period V Completed|1|||
144710490|NCT03496207|521795651|FG000|Base Study|Adverse Event|0|||
144710491|NCT03496207|521795652|FG001|Base Study|Adverse Event|0|||
144710492|NCT03496207|521795653|FG002|Base Study|Adverse Event|1|||
144710493|NCT03496207|521795654|FG003|Base Study|Adverse Event|1|||
144710494|NCT03496207|521795655|FG004|Base Study|Adverse Event|4|||
144710495|NCT03496207|521795651|FG000|Base Study|Death|0|||
144710496|NCT03496207|521795652|FG001|Base Study|Death|0|||
144710497|NCT03496207|521795653|FG002|Base Study|Death|0|||
144710498|NCT03496207|521795654|FG003|Base Study|Death|0|||
144710499|NCT03496207|521795655|FG004|Base Study|Death|1|||
144710500|NCT03496207|521795651|FG000|Base Study|Withdrawal by Subject|0|||
144710501|NCT03496207|521795652|FG001|Base Study|Withdrawal by Subject|0|||
144710502|NCT03496207|521795653|FG002|Base Study|Withdrawal by Subject|1|||
144710503|NCT03496207|521795654|FG003|Base Study|Withdrawal by Subject|0|||
144710504|NCT03496207|521795655|FG004|Base Study|Withdrawal by Subject|1|||
144710505|NCT03496207|521795651|FG000|Extension Period|Adverse Event|0|||
144710506|NCT03496207|521795652|FG001|Extension Period|Adverse Event|0|||
144710507|NCT03496207|521795653|FG002|Extension Period|Adverse Event|0|||
144710508|NCT03496207|521795654|FG003|Extension Period|Adverse Event|1|||
144710509|NCT03496207|521795655|FG004|Extension Period|Adverse Event|1|||
144710510|NCT03496207|521795651|FG000|Extension Period|Death|1|||
144710511|NCT03496207|521795652|FG001|Extension Period|Death|0|||
144710512|NCT03496207|521795653|FG002|Extension Period|Death|0|||
144710513|NCT03496207|521795654|FG003|Extension Period|Death|1|||
144710514|NCT03496207|521795655|FG004|Extension Period|Death|2|||
144710515|NCT03496207|521795651|FG000|Extension Period|Withdrawal by Subject|1|||
144710516|NCT03496207|521795652|FG001|Extension Period|Withdrawal by Subject|0|||
144710517|NCT03496207|521795653|FG002|Extension Period|Withdrawal by Subject|0|||
144710518|NCT03496207|521795654|FG003|Extension Period|Withdrawal by Subject|1|||
144710519|NCT03496207|521795655|FG004|Extension Period|Withdrawal by Subject|1|||
144710520|NCT03496207|521795651|FG000|Extension Period|Elevated hemoglobin levels|0|||
144710521|NCT03496207|521795652|FG001|Extension Period|Elevated hemoglobin levels|0|||
144710522|NCT03496207|521795653|FG002|Extension Period|Elevated hemoglobin levels|0|||
144710523|NCT03496207|521795654|FG003|Extension Period|Elevated hemoglobin levels|0|||
144710524|NCT03496207|521795655|FG004|Extension Period|Elevated hemoglobin levels|1|||
144710525|NCT00810615|521795661|FG000|Overall Study|Withdrawal by Subject|1|||
144710526|NCT00810615|521795662|FG001|Overall Study|Withdrawal by Subject|1|||
144480694|NCT01965158|520959274|FG000|Overall Study|Lost to Follow-up|7|||
144480695|NCT01965158|520959275|FG001|Overall Study|Lost to Follow-up|5|||
144480696|NCT01965158|520959274|FG000|Overall Study|Protocol Violation|1|||
144480697|NCT01965158|520959275|FG001|Overall Study|Protocol Violation|1|||
144480698|NCT01965158|520959274|FG000|Overall Study|Other - Miscellaneous|3|||
144480699|NCT01965158|520959275|FG001|Overall Study|Other - Miscellaneous|0|||
144480700|NCT00474175|520959276|FG000|Overall Study|Lack of Efficacy|0|||
144480701|NCT00474175|520959277|FG001|Overall Study|Lack of Efficacy|0|||
144710527|NCT02567266|521795663|FG000|Overall Study|Withdrawal by Subject|10|||
144710528|NCT02567266|521795664|FG001|Overall Study|Withdrawal by Subject|7|||
144710529|NCT02567266|521795665|FG002|Overall Study|Withdrawal by Subject|6|||
144710530|NCT02567266|521795663|FG000|Overall Study|Lost to Follow-up|13|||
144710531|NCT02567266|521795664|FG001|Overall Study|Lost to Follow-up|8|||
144710532|NCT02567266|521795665|FG002|Overall Study|Lost to Follow-up|10|||
144710533|NCT00068445|521795669|FG000|Randomization|Cancel|1|||
144710534|NCT00068445|521795670|FG001|Randomization|Cancel|3|||
144710535|NCT00068445|521795669|FG000|Randomization|Ineligible|1|||
144710536|NCT00068445|521795670|FG001|Randomization|Ineligible|1|||
144710537|NCT00068445|521795669|FG000|Treatment|Refused Further Treatment|13|||
144710538|NCT00068445|521795670|FG001|Treatment|Refused Further Treatment|10|||
144710539|NCT00068445|521795669|FG000|Treatment|Adverse Event|7|||
144710540|NCT00068445|521795670|FG001|Treatment|Adverse Event|1|||
144710541|NCT00068445|521795669|FG000|Treatment|Other (Specifics not available)|9|||
144710542|NCT00068445|521795670|FG001|Treatment|Other (Specifics not available)|5|||
144710543|NCT01155284|521795671|FG000|Overall Study|Withdrawal by Subject|4|||
144710544|NCT01155284|521795672|FG001|Overall Study|Withdrawal by Subject|3|||
144710545|NCT01155284|521795671|FG000|Overall Study|Lost to Follow-up|1|||
144710546|NCT01155284|521795672|FG001|Overall Study|Lost to Follow-up|2|||
144710547|NCT01155284|521795671|FG000|Overall Study|Physician Decision|1|||
144710548|NCT01155284|521795672|FG001|Overall Study|Physician Decision|0|||
144710549|NCT01155284|521795671|FG000|Overall Study|Adverse Event|1|||
144710550|NCT01155284|521795672|FG001|Overall Study|Adverse Event|0|||
144710551|NCT01896700|521795673|FG000|Overall Study|Adverse Event|4|||
144710552|NCT01896700|521795674|FG001|Overall Study|Adverse Event|5|||
144710553|NCT01896700|521795673|FG000|Overall Study|Withdrawal by Subject|0|||
144710554|NCT01896700|521795674|FG001|Overall Study|Withdrawal by Subject|1|||
144710555|NCT00423488|521795677|FG000|Overall Study|No evidence of study drug intake|2|||
144710556|NCT00423488|521795678|FG001|Overall Study|No evidence of study drug intake|1|||
144710557|NCT00423488|521795677|FG000|Overall Study|No post baseline data|3|||
144710558|NCT00423488|521795678|FG001|Overall Study|No post baseline data|0|||
144710559|NCT01255722|521795679|FG000|Overall Study|Adverse Event|0|||
144710560|NCT01255722|521795680|FG001|Overall Study|Adverse Event|1|||
144710561|NCT01255722|521795681|FG002|Overall Study|Adverse Event|1|||
144710562|NCT01255722|521795679|FG000|Overall Study|asymptomatic patient|1|||
144710563|NCT01255722|521795680|FG001|Overall Study|asymptomatic patient|0|||
144710564|NCT01255722|521795681|FG002|Overall Study|asymptomatic patient|0|||
144710565|NCT01255722|521795679|FG000|Overall Study|beta-blocker contraindicated|2|||
144710566|NCT01255722|521795680|FG001|Overall Study|beta-blocker contraindicated|0|||
144710567|NCT01255722|521795681|FG002|Overall Study|beta-blocker contraindicated|0|||
144710568|NCT03835975|521795682|FG000|Overall Study|Lost to Follow-up|1|||
144710569|NCT03835975|521795683|FG001|Overall Study|Lost to Follow-up|1|||
144710570|NCT03835975|521795684|FG002|Overall Study|Lost to Follow-up|0|||
144710571|NCT03835975|521795685|FG003|Overall Study|Lost to Follow-up|0|||
144710572|NCT03835975|521795686|FG004|Overall Study|Lost to Follow-up|0|||
144710573|NCT03835975|521795682|FG000|Overall Study|No longer met eligibility criteria|0|||
144710574|NCT03835975|521795683|FG001|Overall Study|No longer met eligibility criteria|1|||
144710575|NCT03835975|521795684|FG002|Overall Study|No longer met eligibility criteria|0|||
144710576|NCT03835975|521795685|FG003|Overall Study|No longer met eligibility criteria|0|||
144710577|NCT03835975|521795686|FG004|Overall Study|No longer met eligibility criteria|0|||
144710578|NCT03835975|521795682|FG000|Overall Study|Protocol Violation|1|||
144710579|NCT03835975|521795683|FG001|Overall Study|Protocol Violation|1|||
144710580|NCT03835975|521795684|FG002|Overall Study|Protocol Violation|2|||
144710581|NCT03835975|521795685|FG003|Overall Study|Protocol Violation|0|||
144710582|NCT03835975|521795686|FG004|Overall Study|Protocol Violation|0|||
144710583|NCT03835975|521795682|FG000|Overall Study|Withdrawal by Subject|1|||
144710584|NCT03835975|521795683|FG001|Overall Study|Withdrawal by Subject|0|||
144710585|NCT03835975|521795684|FG002|Overall Study|Withdrawal by Subject|1|||
144710586|NCT03835975|521795685|FG003|Overall Study|Withdrawal by Subject|1|||
144710587|NCT03835975|521795686|FG004|Overall Study|Withdrawal by Subject|0|||
144710588|NCT00370396|521795687|FG000|Overall Study|Withdrawal by Subject|0|||
144710589|NCT00370396|521795688|FG001|Overall Study|Withdrawal by Subject|0|||
144710590|NCT00370396|521795689|FG002|Overall Study|Withdrawal by Subject|1|||
144710591|NCT00370396|521795687|FG000|Overall Study|Lost to Follow-up|11|||
144710592|NCT00370396|521795688|FG001|Overall Study|Lost to Follow-up|1|||
144710593|NCT00370396|521795689|FG002|Overall Study|Lost to Follow-up|0|||
144710594|NCT04529499|521795690|FG000|Overall Study|Withdrawal by Subject|9|||
144710595|NCT04529499|521795691|FG001|Overall Study|Withdrawal by Subject|11|||
144710596|NCT04529499|521795690|FG000|Overall Study|Physician Decision|1|||
144710597|NCT04529499|521795691|FG001|Overall Study|Physician Decision|2|||
144710598|NCT04529499|521795690|FG000|Overall Study|Adverse Event|4|||
144710599|NCT04529499|521795691|FG001|Overall Study|Adverse Event|4|||
144710600|NCT04529499|521795690|FG000|Overall Study|Death|14|||
144710601|NCT04529499|521795691|FG001|Overall Study|Death|11|||
144710602|NCT04529499|521795690|FG000|Overall Study|Lost to Follow-up|1|||
144710603|NCT04529499|521795691|FG001|Overall Study|Lost to Follow-up|1|||
144710604|NCT04529499|521795690|FG000|Overall Study|Others|7|||
144710605|NCT04529499|521795691|FG001|Overall Study|Others|11|||
144710606|NCT02441179|521795692|FG000|Overall Study|Withdrawal by Subject|1|||
144710607|NCT02441179|521795693|FG001|Overall Study|Withdrawal by Subject|1|||
144710608|NCT02702271|521795695|FG000|Overall Study|Death|36|||
144710609|NCT02702271|521795696|FG001|Overall Study|Death|7|||
144710610|NCT02702271|521795695|FG000|Overall Study|Lost to Follow-up|12|||
144710611|NCT02702271|521795696|FG001|Overall Study|Lost to Follow-up|0|||
144710612|NCT02702271|521795695|FG000|Overall Study|Withdrawal by Subject|8|||
144710613|NCT02702271|521795696|FG001|Overall Study|Withdrawal by Subject|1|||
144710614|NCT02702271|521795695|FG000|Overall Study|Physician Decision|2|||
144710615|NCT02702271|521795696|FG001|Overall Study|Physician Decision|0|||
144710616|NCT02702271|521795695|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
144710617|NCT02702271|521795696|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
144710618|NCT03091400|521795697|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
144710619|NCT03091400|521795698|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
144710620|NCT00975884|521795699|FG000|Overall Study|Adverse Event|1|||
144710621|NCT00975884|521795700|FG001|Overall Study|Adverse Event|0|||
144710622|NCT00975884|521795699|FG000|Overall Study|Lost to Follow-up|5|||
144710623|NCT00975884|521795700|FG001|Overall Study|Lost to Follow-up|3|||
144710624|NCT00975884|521795699|FG000|Overall Study|Withdrawal by Subject|9|||
144710625|NCT00975884|521795700|FG001|Overall Study|Withdrawal by Subject|9|||
144710626|NCT00975884|521795699|FG000|Overall Study|Other|1|||
144710627|NCT00975884|521795700|FG001|Overall Study|Other|3|||
144710628|NCT00051636|521795701|FG000|Period 1 - Core|Adverse Event|2|||
144710629|NCT00051636|521795702|FG001|Period 1 - Core|Adverse Event|2|||
144710630|NCT00051636|521795701|FG000|Period 1 - Core|Protocol Violation|1|||
144710631|NCT00051636|521795702|FG001|Period 1 - Core|Protocol Violation|0|||
144710632|NCT00051636|521795701|FG000|Period 1 - Core|Withdrawal by Subject|1|||
144710633|NCT00051636|521795702|FG001|Period 1 - Core|Withdrawal by Subject|2|||
144710634|NCT00051636|521795701|FG000|Period 1 - Core|Lost to Follow-up|0|||
144710635|NCT00051636|521795702|FG001|Period 1 - Core|Lost to Follow-up|2|||
144710636|NCT00051636|521795701|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
144710637|NCT00051636|521795702|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
144710638|NCT00051636|521795701|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
144710639|NCT00051636|521795702|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
144710640|NCT00051636|521795701|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
144710641|NCT00051636|521795702|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
144710642|NCT00051636|521795701|FG000|Period 2- Extended Observation Period|Death|4|||
144710643|NCT00051636|521795702|FG001|Period 2- Extended Observation Period|Death|5|||
144710644|NCT00051636|521795701|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
144710645|NCT00051636|521795702|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
144710646|NCT01174368|521795703|FG000|Overall Study|Withdrawal by Subject|1|||
144710647|NCT00479765|521795704|FG000|Overall Study|study terminated|4|||
144368302|NCT00865566|520559807|FG000|Overall Study|Physician Decision|0|||
144368303|NCT00865566|520559808|FG001|Overall Study|Physician Decision|1|||
144368304|NCT00865566|520559807|FG000|Overall Study|Participant relocated|78|||
144368305|NCT00865566|520559808|FG001|Overall Study|Participant relocated|107|||
144368306|NCT00865566|520559807|FG000|Overall Study|Participant unable to adhere|27|||
144710648|NCT00725725|521795709|FG000|Overall Study|Adverse Event|1|||
144368307|NCT00865566|520559808|FG001|Overall Study|Participant unable to adhere|42|||
144710649|NCT00725725|521795710|FG001|Overall Study|Adverse Event|3|||
144710650|NCT00725725|521795711|FG002|Overall Study|Adverse Event|2|||
144710651|NCT00725725|521795709|FG000|Overall Study|Lost to Follow-up|2|||
144710652|NCT00725725|521795710|FG001|Overall Study|Lost to Follow-up|0|||
144710653|NCT00725725|521795711|FG002|Overall Study|Lost to Follow-up|2|||
144710654|NCT00725725|521795709|FG000|Overall Study|Withdrawal by Subject|1|||
144710655|NCT00725725|521795710|FG001|Overall Study|Withdrawal by Subject|0|||
144710656|NCT00725725|521795711|FG002|Overall Study|Withdrawal by Subject|1|||
144480702|NCT00474175|520959278|FG002|Overall Study|Lack of Efficacy|1|||
144480703|NCT00474175|520959276|FG000|Overall Study|Withdrawal by Subject|0|||
144480704|NCT00474175|520959277|FG001|Overall Study|Withdrawal by Subject|1|||
144480705|NCT00474175|520959278|FG002|Overall Study|Withdrawal by Subject|1|||
144480706|NCT00474175|520959276|FG000|Overall Study|Ineligible|1|||
144480707|NCT00474175|520959277|FG001|Overall Study|Ineligible|3|||
144480708|NCT00474175|520959278|FG002|Overall Study|Ineligible|1|||
144480709|NCT00474175|520959276|FG000|Overall Study|Protocol Violation|0|||
144480710|NCT00474175|520959277|FG001|Overall Study|Protocol Violation|2|||
144480711|NCT00474175|520959278|FG002|Overall Study|Protocol Violation|1|||
144480712|NCT00474175|520959276|FG000|Overall Study|Administrative|0|||
144480713|NCT00474175|520959277|FG001|Overall Study|Administrative|1|||
144480714|NCT00474175|520959278|FG002|Overall Study|Administrative|0|||
144480715|NCT01619787|520959280|FG000|Overall Study|Lost to Follow-up|5|||
144480716|NCT03066622|520959284|FG000|Overall Study|Lost to Follow-up|24|||
144480717|NCT03066622|520959285|FG001|Overall Study|Lost to Follow-up|25|||
144480718|NCT03066622|520959284|FG000|Overall Study|Withdrawal by Subject|2|||
144480719|NCT03066622|520959285|FG001|Overall Study|Withdrawal by Subject|1|||
144480720|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
144480721|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
144480722|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
144480723|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
144480724|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
144480725|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
144480726|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
144480727|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
144480728|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
144480729|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
144480730|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
144480731|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
144710657|NCT00725725|521795709|FG000|Overall Study|Protocol Violation|0|||
144710658|NCT00725725|521795710|FG001|Overall Study|Protocol Violation|1|||
144480732|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
144480733|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
144480734|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
144480735|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
144480736|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
144480737|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
144480738|NCT00365378|520959286|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
144480739|NCT00365378|520959287|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
144480740|NCT00365378|520959288|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
144480741|NCT00365378|520959286|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
144480742|NCT00365378|520959287|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
144480743|NCT00365378|520959288|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
144480744|NCT00365378|520959286|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
144480745|NCT00365378|520959287|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
144480746|NCT00365378|520959288|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
144480747|NCT00365378|520959286|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
144480748|NCT00365378|520959287|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
144710659|NCT00725725|521795711|FG002|Overall Study|Protocol Violation|0|||
144710660|NCT01619085|521795712|FG000|Overall Study|Adverse Event|231|||
144710661|NCT01619085|521795712|FG000|Overall Study|Protocol Violation|4|||
144710662|NCT01619085|521795712|FG000|Overall Study|Lost to Follow-up|3|||
144710663|NCT01619085|521795712|FG000|Overall Study|Withdrawal by Subject|45|||
144480749|NCT00365378|520959288|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
144480750|NCT00365378|520959286|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
144480751|NCT00365378|520959287|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
144480752|NCT00365378|520959288|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
144480753|NCT00365378|520959286|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
144710664|NCT01619085|521795712|FG000|Overall Study|Other than specified|96|||
144480754|NCT00365378|520959287|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
144480755|NCT00365378|520959288|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
144480756|NCT00365378|520959286|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
144480757|NCT00365378|520959287|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
144480758|NCT00365378|520959288|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
144480759|NCT00365378|520959286|FG000|Extension|Adverse Event|0|||
144710665|NCT01619085|521795712|FG000|Overall Study|Not treated|1|||
144710666|NCT01619085|521795712|FG000|Overall Study|Death|145|||
144710667|NCT00944125|521795715|FG000|3 to 6 Months|Withdrawal by Subject|0|||
144710668|NCT00944125|521795716|FG001|3 to 6 Months|Withdrawal by Subject|2|||
144710669|NCT00944125|521795715|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
144710670|NCT00944125|521795716|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
144710671|NCT03125629|521795717|FG000|Overall Study|Withdrawal by Subject|2|||
144710672|NCT03125629|521795717|FG000|Overall Study|Equipment malfunction|1|||
144710673|NCT00743119|521795718|FG000|Overall Study|unreliable|3|||
144710674|NCT00743119|521795718|FG000|Overall Study|Withdrawal by Subject|1|||
144710675|NCT04816877|521795719|FG000|Overall Study|Withdrawal by Subject|1|||
144710676|NCT04816877|521795720|FG001|Overall Study|Withdrawal by Subject|0|||
144710677|NCT02176642|521795723|FG000|Overall Study|Withdrawal by Subject|0|||
144710678|NCT02176642|521795724|FG001|Overall Study|Withdrawal by Subject|1|||
144710679|NCT00295620|521795726|FG000|Overall Study|Lost to Follow-up|9|||
144710680|NCT00295620|521795727|FG001|Overall Study|Lost to Follow-up|5|||
144710681|NCT00295620|521795726|FG000|Overall Study|Withdrawal by Subject|37|||
144710682|NCT00295620|521795727|FG001|Overall Study|Withdrawal by Subject|50|||
144710683|NCT00295620|521795726|FG000|Overall Study|Death|206|||
144710684|NCT00295620|521795727|FG001|Overall Study|Death|207|||
144710685|NCT00295620|521795726|FG000|Overall Study|Other reasons|10|||
144710686|NCT00295620|521795727|FG001|Overall Study|Other reasons|9|||
144710687|NCT00295620|521795726|FG000|Overall Study|Discontinuation by sponsor|580|||
144710688|NCT00295620|521795727|FG001|Overall Study|Discontinuation by sponsor|593|||
144710689|NCT00295620|521795726|FG000|Overall Study|Protocol Violation|30|||
144710690|NCT00295620|521795727|FG001|Overall Study|Protocol Violation|32|||
144710691|NCT02989610|521795728|FG000|Overall Study|Withdrawal by Subject|20|||
144710692|NCT02989610|521795728|FG000|Overall Study|Departure of PI from Site|8|||
144710693|NCT02989610|521795728|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
144710694|NCT02989610|521795728|FG000|Overall Study|Lost to Follow-up|3|||
144710695|NCT02989610|521795728|FG000|Overall Study|Death|3|||
144710696|NCT02989610|521795728|FG000|Overall Study|System Explant|3|||
144710697|NCT02989610|521795728|FG000|Overall Study|Subject Non-Compliance|2|||
144710698|NCT02989610|521795728|FG000|Overall Study|System Revision|2|||
144368308|NCT00865566|520559807|FG000|Overall Study|Other; N=245 due to early study closure|154|||
144368309|NCT00865566|520559808|FG001|Overall Study|Other; N=245 due to early study closure|139|||
144368310|NCT00865566|520559807|FG000|Overall Study|HIV infection|5|||
144368311|NCT00865566|520559808|FG001|Overall Study|HIV infection|7|||
144368312|NCT00118417|520559811|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
144368313|NCT00118417|520559812|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
144368314|NCT00118417|520559811|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
144368315|NCT00118417|520559812|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
144368316|NCT00118417|520559811|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
144368317|NCT00118417|520559812|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
144368318|NCT00118417|520559811|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
144368319|NCT00118417|520559812|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
144368320|NCT00118417|520559811|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
144368321|NCT00118417|520559812|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
144368322|NCT02978781|520559813|FG000|Part A|Adverse Event|1|||
144368323|NCT02978781|520559814|FG001|Part A|Adverse Event|1|||
144368324|NCT02978781|520559815|FG002|Part A|Adverse Event|0|||
144368325|NCT02978781|520559816|FG003|Part A|Adverse Event|0|||
144368326|NCT02978781|520559817|FG004|Part A|Adverse Event|0|||
144368327|NCT02978781|520559813|FG000|Part A|Withdrawal by Subject|0|||
144368328|NCT02978781|520559814|FG001|Part A|Withdrawal by Subject|1|||
144368329|NCT02978781|520559815|FG002|Part A|Withdrawal by Subject|0|||
144368330|NCT02978781|520559816|FG003|Part A|Withdrawal by Subject|0|||
144368331|NCT02978781|520559817|FG004|Part A|Withdrawal by Subject|0|||
144368332|NCT02978781|520559813|FG000|Part B|Withdrawal by Subject|0|||
144368333|NCT02978781|520559814|FG001|Part B|Withdrawal by Subject|0|||
144368334|NCT02978781|520559815|FG002|Part B|Withdrawal by Subject|0|||
144368335|NCT02978781|520559816|FG003|Part B|Withdrawal by Subject|1|||
144368336|NCT02978781|520559817|FG004|Part B|Withdrawal by Subject|0|||
144710699|NCT02989610|521795728|FG000|Overall Study|PI Left, Study Closing|1|||
144710700|NCT02989610|521795728|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
144710701|NCT02989610|521795728|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
144710702|NCT04508621|521795733|FG000|Overall Study|Adverse Event|39|||
144710703|NCT04508621|521795734|FG001|Overall Study|Adverse Event|16|||
144710704|NCT04508621|521795733|FG000|Overall Study|Lack of Efficacy|2|||
144710705|NCT04508621|521795734|FG001|Overall Study|Lack of Efficacy|8|||
144710706|NCT04508621|521795733|FG000|Overall Study|Physician Decision|0|||
144710707|NCT04508621|521795734|FG001|Overall Study|Physician Decision|1|||
144710708|NCT04508621|521795733|FG000|Overall Study|Withdrawal by Subject|10|||
144710709|NCT04508621|521795734|FG001|Overall Study|Withdrawal by Subject|14|||
144710710|NCT04508621|521795733|FG000|Overall Study|Lost to Follow-up|12|||
144368337|NCT02978781|520559813|FG000|Part C|Adverse Event|0|||
144368338|NCT02978781|520559814|FG001|Part C|Adverse Event|0|||
144368339|NCT02978781|520559815|FG002|Part C|Adverse Event|0|||
144368340|NCT02978781|520559816|FG003|Part C|Adverse Event|0|||
144710711|NCT04508621|521795734|FG001|Overall Study|Lost to Follow-up|9|||
144710712|NCT04508621|521795733|FG000|Overall Study|COVID-19 related crisis|3|||
144710713|NCT04508621|521795734|FG001|Overall Study|COVID-19 related crisis|0|||
144710714|NCT04508621|521795733|FG000|Overall Study|Subject non-compliance|1|||
144710715|NCT04508621|521795734|FG001|Overall Study|Subject non-compliance|0|||
144710716|NCT00084617|521795735|FG000|Overall Study|Withdrawal by Subject|7|||
144710717|NCT00084617|521795735|FG000|Overall Study|Lack of Efficacy|1|||
144710718|NCT00084617|521795735|FG000|Overall Study|Protocol Violation|1|||
144710719|NCT01625286|521795736|FG000|Overall Study|Adverse Event|0|||
144710720|NCT01625286|521795737|FG001|Overall Study|Adverse Event|0|||
144710721|NCT01625286|521795738|FG002|Overall Study|Adverse Event|0|||
144710722|NCT01625286|521795739|FG003|Overall Study|Adverse Event|0|||
144710723|NCT01625286|521795740|FG004|Overall Study|Adverse Event|1|||
144710724|NCT01625286|521795741|FG005|Overall Study|Adverse Event|2|||
144710725|NCT01625286|521795742|FG006|Overall Study|Adverse Event|1|||
144710726|NCT01625286|521795736|FG000|Overall Study|Death|0|||
144710727|NCT01625286|521795737|FG001|Overall Study|Death|0|||
144710728|NCT01625286|521795738|FG002|Overall Study|Death|1|||
144710729|NCT01625286|521795739|FG003|Overall Study|Death|1|||
144710730|NCT01625286|521795740|FG004|Overall Study|Death|0|||
144710731|NCT01625286|521795741|FG005|Overall Study|Death|11|||
144480760|NCT00365378|520959287|FG001|Extension|Adverse Event|0|||
144480761|NCT00365378|520959288|FG002|Extension|Adverse Event|1|||
144480762|NCT00365378|520959286|FG000|Extension|Moved|0|||
144480763|NCT00365378|520959287|FG001|Extension|Moved|0|||
144480764|NCT00365378|520959288|FG002|Extension|Moved|8|||
144480765|NCT00365378|520959286|FG000|Extension|Lost to Follow-up|0|||
144480766|NCT00365378|520959287|FG001|Extension|Lost to Follow-up|0|||
144480767|NCT00365378|520959288|FG002|Extension|Lost to Follow-up|57|||
144480768|NCT00365378|520959286|FG000|Extension|Protocol Violation|0|||
144480769|NCT00365378|520959287|FG001|Extension|Protocol Violation|0|||
144480770|NCT00365378|520959288|FG002|Extension|Protocol Violation|2|||
144480771|NCT00365378|520959286|FG000|Extension|Withdrawal by Subject|0|||
144480772|NCT00365378|520959287|FG001|Extension|Withdrawal by Subject|0|||
144480773|NCT00365378|520959288|FG002|Extension|Withdrawal by Subject|98|||
144480774|NCT00365378|520959286|FG000|Extension|Other|0|||
144480775|NCT00365378|520959287|FG001|Extension|Other|0|||
144480776|NCT00365378|520959288|FG002|Extension|Other|31|||
144480777|NCT01737996|520959294|FG000|Overall Study|Adverse Event|0|||
144480778|NCT01737996|520959295|FG001|Overall Study|Adverse Event|1|||
144480779|NCT01737996|520959296|FG002|Overall Study|Adverse Event|1|||
144480780|NCT01737996|520959294|FG000|Overall Study|Withdrawal by Subject|0|||
144480781|NCT01737996|520959295|FG001|Overall Study|Withdrawal by Subject|0|||
144480782|NCT01737996|520959296|FG002|Overall Study|Withdrawal by Subject|1|||
144480783|NCT02693834|520959305|FG000|Baseline Measurement|Withdrawal by Subject|1|||
144480784|NCT02693834|520959306|FG001|Baseline Measurement|Withdrawal by Subject|0|||
144480785|NCT02693834|520959305|FG000|Baseline Measurement|Adverse Event|1|||
144480786|NCT02693834|520959306|FG001|Baseline Measurement|Adverse Event|0|||
144480787|NCT02693834|520959305|FG000|Week 2 Practice|Adverse Event|0|||
144480788|NCT02693834|520959306|FG001|Week 2 Practice|Adverse Event|1|||
144480789|NCT02765490|520959309|FG000|Overall Study|Lost to Follow-up|1|||
144480790|NCT02765490|520959310|FG001|Overall Study|Lost to Follow-up|1|||
144480791|NCT02765490|520959309|FG000|Overall Study|Other|0|||
144480792|NCT02765490|520959310|FG001|Overall Study|Other|1|||
144480793|NCT02765490|520959309|FG000|Overall Study|Death|0|||
144480794|NCT02765490|520959310|FG001|Overall Study|Death|1|||
144480795|NCT01468922|520959311|FG000|Overall Study|Screening failure|0|||
144480796|NCT01468922|520959312|FG001|Overall Study|Screening failure|0|||
144480797|NCT01468922|520959313|FG002|Overall Study|Screening failure|0|||
144480798|NCT01468922|520959314|FG003|Overall Study|Screening failure|0|||
144480799|NCT01468922|520959315|FG004|Overall Study|Screening failure|0|||
144710732|NCT01625286|521795742|FG006|Overall Study|Death|16|||
144710733|NCT01625286|521795736|FG000|Overall Study|Withdrawal by Subject|0|||
144710734|NCT01625286|521795737|FG001|Overall Study|Withdrawal by Subject|1|||
144480800|NCT01468922|520959316|FG005|Overall Study|Screening failure|0|||
144480801|NCT01468922|520959317|FG006|Overall Study|Screening failure|0|||
144480802|NCT01468922|520959318|FG007|Overall Study|Screening failure|0|||
144710735|NCT01625286|521795738|FG002|Overall Study|Withdrawal by Subject|0|||
144710736|NCT01625286|521795739|FG003|Overall Study|Withdrawal by Subject|1|||
144480803|NCT01468922|520959319|FG008|Overall Study|Screening failure|1|||
144710737|NCT01625286|521795740|FG004|Overall Study|Withdrawal by Subject|0|||
144480804|NCT01468922|520959311|FG000|Overall Study|Per patient choice|1|||
144710738|NCT01625286|521795741|FG005|Overall Study|Withdrawal by Subject|0|||
144710739|NCT01625286|521795742|FG006|Overall Study|Withdrawal by Subject|1|||
144480805|NCT01468922|520959312|FG001|Overall Study|Per patient choice|0|||
144480806|NCT01468922|520959313|FG002|Overall Study|Per patient choice|0|||
144480807|NCT01468922|520959314|FG003|Overall Study|Per patient choice|0|||
144480808|NCT01468922|520959315|FG004|Overall Study|Per patient choice|0|||
144710740|NCT01625286|521795736|FG000|Overall Study|Any reason not specifically recorded|0|||
144710741|NCT01625286|521795737|FG001|Overall Study|Any reason not specifically recorded|0|||
144710742|NCT01625286|521795738|FG002|Overall Study|Any reason not specifically recorded|0|||
144710743|NCT01625286|521795739|FG003|Overall Study|Any reason not specifically recorded|0|||
144710744|NCT01625286|521795740|FG004|Overall Study|Any reason not specifically recorded|0|||
144710745|NCT01625286|521795741|FG005|Overall Study|Any reason not specifically recorded|1|||
144710746|NCT01625286|521795742|FG006|Overall Study|Any reason not specifically recorded|0|||
144710747|NCT01625286|521795736|FG000|Overall Study|Progressive disease|6|||
144710748|NCT01625286|521795737|FG001|Overall Study|Progressive disease|3|||
144710749|NCT01625286|521795738|FG002|Overall Study|Progressive disease|4|||
144710750|NCT01625286|521795739|FG003|Overall Study|Progressive disease|5|||
144710751|NCT01625286|521795740|FG004|Overall Study|Progressive disease|5|||
144710752|NCT01625286|521795741|FG005|Overall Study|Progressive disease|0|||
144710753|NCT01625286|521795742|FG006|Overall Study|Progressive disease|0|||
144710754|NCT01625286|521795736|FG000|Overall Study|Lost to Follow-up|0|||
144710755|NCT01625286|521795737|FG001|Overall Study|Lost to Follow-up|0|||
144710756|NCT01625286|521795738|FG002|Overall Study|Lost to Follow-up|0|||
144710757|NCT01625286|521795739|FG003|Overall Study|Lost to Follow-up|0|||
144710758|NCT01625286|521795740|FG004|Overall Study|Lost to Follow-up|0|||
144710759|NCT01625286|521795741|FG005|Overall Study|Lost to Follow-up|0|||
144710760|NCT01625286|521795742|FG006|Overall Study|Lost to Follow-up|1|||
144710761|NCT04355767|521795743|FG000|Overall Study|Withdrawal by Subject|2|||
144710762|NCT04355767|521795744|FG001|Overall Study|Withdrawal by Subject|2|||
144710763|NCT04355767|521795743|FG000|Overall Study|Death|5|||
144710764|NCT04355767|521795744|FG001|Overall Study|Death|1|||
144710765|NCT01861717|521795747|FG000|Overall Study|Lost to Follow-up|1|||
144710766|NCT01861717|521795747|FG000|Overall Study|Withdrawal by Subject|1|||
144710767|NCT00681824|521797514|FG000|Overall Study|withdrawn by investigator|0|||
144710768|NCT00681824|521797515|FG001|Overall Study|withdrawn by investigator|0|||
144710769|NCT00681824|521797516|FG002|Overall Study|withdrawn by investigator|1|||
144710770|NCT00681824|521797514|FG000|Overall Study|scheduling conflict|1|||
144710771|NCT00681824|521797515|FG001|Overall Study|scheduling conflict|0|||
144710772|NCT00681824|521797516|FG002|Overall Study|scheduling conflict|0|||
144710773|NCT00681824|521797514|FG000|Overall Study|Death|0|||
144710774|NCT00681824|521797515|FG001|Overall Study|Death|1|||
144710775|NCT00681824|521797516|FG002|Overall Study|Death|0|||
144710776|NCT02464059|521797517|FG000|Overall Study|Lost to Follow-up|6|||
144710777|NCT03591107|521797518|FG000|Overall Study|Same patient in both arms|1|||
144710778|NCT03591107|521797519|FG001|Overall Study|Same patient in both arms|1|||
144710779|NCT03591107|521797518|FG000|Overall Study|Sought care at other clinics|0|||
144710780|NCT03591107|521797519|FG001|Overall Study|Sought care at other clinics|2|||
144710781|NCT03591107|521797518|FG000|Overall Study|Discharged from clinic|0|||
144710782|NCT03591107|521797519|FG001|Overall Study|Discharged from clinic|1|||
144710783|NCT03591107|521797518|FG000|Overall Study|Withdrawal by Subject|0|||
144710784|NCT03591107|521797519|FG001|Overall Study|Withdrawal by Subject|1|||
144710785|NCT01902134|521797520|FG000|Overall Study|Adverse Event|3|||
144710786|NCT01902134|521797521|FG001|Overall Study|Adverse Event|1|||
144710787|NCT01902134|521797522|FG002|Overall Study|Adverse Event|2|||
144710788|NCT01902134|521797523|FG003|Overall Study|Adverse Event|1|||
144710789|NCT01902134|521797524|FG004|Overall Study|Adverse Event|1|||
144710790|NCT01902134|521797525|FG005|Overall Study|Adverse Event|3|||
144710791|NCT01902134|521797520|FG000|Overall Study|Lack of Efficacy|0|||
144710792|NCT01902134|521797521|FG001|Overall Study|Lack of Efficacy|0|||
144710793|NCT01902134|521797522|FG002|Overall Study|Lack of Efficacy|2|||
144710794|NCT01902134|521797523|FG003|Overall Study|Lack of Efficacy|0|||
144710795|NCT01902134|521797524|FG004|Overall Study|Lack of Efficacy|0|||
144710796|NCT01902134|521797525|FG005|Overall Study|Lack of Efficacy|1|||
144710797|NCT01902134|521797520|FG000|Overall Study|Physician Decision|0|||
144710798|NCT01902134|521797521|FG001|Overall Study|Physician Decision|1|||
144710799|NCT01902134|521797522|FG002|Overall Study|Physician Decision|0|||
144710800|NCT01902134|521797523|FG003|Overall Study|Physician Decision|0|||
144710801|NCT01902134|521797524|FG004|Overall Study|Physician Decision|0|||
144710802|NCT01902134|521797525|FG005|Overall Study|Physician Decision|0|||
144710803|NCT01902134|521797520|FG000|Overall Study|Protocol Violation|0|||
144710804|NCT01902134|521797521|FG001|Overall Study|Protocol Violation|0|||
144710805|NCT01902134|521797522|FG002|Overall Study|Protocol Violation|0|||
144710806|NCT01902134|521797523|FG003|Overall Study|Protocol Violation|0|||
144710807|NCT01902134|521797524|FG004|Overall Study|Protocol Violation|0|||
144710808|NCT01902134|521797525|FG005|Overall Study|Protocol Violation|1|||
144710809|NCT01902134|521797520|FG000|Overall Study|Withdrawal by Subject|4|||
144710810|NCT01902134|521797521|FG001|Overall Study|Withdrawal by Subject|8|||
144710811|NCT01902134|521797522|FG002|Overall Study|Withdrawal by Subject|9|||
144710812|NCT01902134|521797523|FG003|Overall Study|Withdrawal by Subject|1|||
144710813|NCT01902134|521797524|FG004|Overall Study|Withdrawal by Subject|5|||
144710814|NCT01902134|521797525|FG005|Overall Study|Withdrawal by Subject|4|||
144710815|NCT01902134|521797520|FG000|Overall Study|no compliance|1|||
144710816|NCT01902134|521797521|FG001|Overall Study|no compliance|0|||
144710817|NCT01902134|521797522|FG002|Overall Study|no compliance|0|||
144710818|NCT01902134|521797523|FG003|Overall Study|no compliance|0|||
144710819|NCT01902134|521797524|FG004|Overall Study|no compliance|0|||
144710820|NCT01902134|521797525|FG005|Overall Study|no compliance|0|||
144710821|NCT01902134|521797520|FG000|Overall Study|Other|0|||
144710822|NCT01902134|521797521|FG001|Overall Study|Other|1|||
144710823|NCT01902134|521797522|FG002|Overall Study|Other|2|||
144710824|NCT01902134|521797523|FG003|Overall Study|Other|0|||
144710825|NCT01902134|521797524|FG004|Overall Study|Other|1|||
144710826|NCT01902134|521797525|FG005|Overall Study|Other|0|||
144710827|NCT01272193|521797528|FG000|Overall Study|Adverse Event|1|||
144710828|NCT01272193|521797529|FG001|Overall Study|Adverse Event|1|||
144710829|NCT01272193|521797528|FG000|Overall Study|Lack of Efficacy|0|||
144710830|NCT01272193|521797529|FG001|Overall Study|Lack of Efficacy|3|||
144710831|NCT01272193|521797528|FG000|Overall Study|Withdrawal Criteria|1|||
144710832|NCT01272193|521797529|FG001|Overall Study|Withdrawal Criteria|1|||
144710833|NCT01272193|521797528|FG000|Overall Study|Unclassified|8|||
144710834|NCT01272193|521797529|FG001|Overall Study|Unclassified|7|||
144710835|NCT01440647|521797532|FG000|Overall Study|Death|2|||
144710836|NCT01440647|521797533|FG001|Overall Study|Death|3|||
144710837|NCT04335110|521797542|FG000|Overall Study|Withdrawal by Subject|1|||
144710838|NCT04335110|521797543|FG001|Overall Study|Withdrawal by Subject|1|||
144710839|NCT04335110|521797542|FG000|Overall Study|Death|0|||
144710840|NCT04335110|521797543|FG001|Overall Study|Death|1|||
144710841|NCT00350519|521797544|FG000|Overall Study|Death|0|||
144710842|NCT00350519|521797545|FG001|Overall Study|Death|1|||
144710843|NCT00350519|521797544|FG000|Overall Study|Physician Decision|0|||
144710844|NCT00350519|521797545|FG001|Overall Study|Physician Decision|1|||
144710845|NCT00350519|521797544|FG000|Overall Study|Protocol Violation|1|||
144710846|NCT00350519|521797545|FG001|Overall Study|Protocol Violation|2|||
144710847|NCT00350519|521797544|FG000|Overall Study|Withdrawal by Subject|3|||
144710848|NCT00350519|521797545|FG001|Overall Study|Withdrawal by Subject|2|||
144710849|NCT01637961|521797546|FG000|Overall Study|Ineligible: wrong primary|1|||
144710850|NCT01637961|521797546|FG000|Overall Study|Ineligible: inadequate pathology|1|||
144710851|NCT04388527|521797547|FG000|Overall Study|Death|14|||
144710852|NCT04388527|521797547|FG000|Overall Study|Withdrawal by Subject|2|||
144710853|NCT04388527|521797547|FG000|Overall Study|Lost to Follow-up|1|||
144710854|NCT03451331|521797556|FG000|Overall Study|Withdrawal by Subject|1|||
144710855|NCT03451331|521797557|FG001|Overall Study|Withdrawal by Subject|0|||
144710856|NCT03451331|521797556|FG000|Overall Study|Unable to start treatment.|1|||
144710857|NCT03451331|521797557|FG001|Overall Study|Unable to start treatment.|1|||
144710858|NCT02773446|521797558|FG000|First Admission|Withdrawal by Subject|0|||
144710859|NCT02773446|521797559|FG001|First Admission|Withdrawal by Subject|0|||
144710860|NCT02773446|521797560|FG002|First Admission|Withdrawal by Subject|0|||
144710861|NCT02773446|521797561|FG003|First Admission|Withdrawal by Subject|1|||
144710862|NCT02773446|521797562|FG004|First Admission|Withdrawal by Subject|0|||
144710863|NCT02773446|521797563|FG005|First Admission|Withdrawal by Subject|0|||
144710864|NCT02773446|521797558|FG000|First Admission|Lost to Follow-up|1|||
144710865|NCT02773446|521797559|FG001|First Admission|Lost to Follow-up|0|||
144710866|NCT02773446|521797560|FG002|First Admission|Lost to Follow-up|0|||
144710867|NCT02773446|521797561|FG003|First Admission|Lost to Follow-up|0|||
144710868|NCT02773446|521797562|FG004|First Admission|Lost to Follow-up|0|||
144710869|NCT02773446|521797563|FG005|First Admission|Lost to Follow-up|0|||
144710870|NCT00289731|521797564|FG000|Overall Study|Adverse Event|1|||
144710871|NCT00289731|521797565|FG001|Overall Study|Adverse Event|2|||
144710872|NCT00289731|521797566|FG002|Overall Study|Adverse Event|2|||
144710873|NCT00289731|521797564|FG000|Overall Study|Other|1|||
144710874|NCT00289731|521797565|FG001|Overall Study|Other|0|||
144710875|NCT00289731|521797566|FG002|Overall Study|Other|0|||
144710876|NCT04023994|521797567|FG000|Overall Study|Lost to Follow-up|0|||
144710877|NCT04023994|521797568|FG001|Overall Study|Lost to Follow-up|1|||
144710878|NCT04023994|521797569|FG002|Overall Study|Lost to Follow-up|2|||
144710879|NCT04023994|521797570|FG003|Overall Study|Lost to Follow-up|0|||
144710880|NCT04023994|521797571|FG004|Overall Study|Lost to Follow-up|0|||
144710881|NCT04023994|521797572|FG005|Overall Study|Lost to Follow-up|0|||
144710882|NCT04023994|521797567|FG000|Overall Study|Withdrawal by Subject|0|||
144710883|NCT04023994|521797568|FG001|Overall Study|Withdrawal by Subject|0|||
144710884|NCT04023994|521797569|FG002|Overall Study|Withdrawal by Subject|0|||
144710885|NCT04023994|521797570|FG003|Overall Study|Withdrawal by Subject|1|||
144710886|NCT04023994|521797571|FG004|Overall Study|Withdrawal by Subject|0|||
144710887|NCT04023994|521797572|FG005|Overall Study|Withdrawal by Subject|0|||
144710888|NCT01613131|521797573|FG000|Overall Study|Withdrawal by Subject|3|||
144710889|NCT01613131|521797574|FG001|Overall Study|Withdrawal by Subject|5|||
144710890|NCT01020305|521797575|FG000|Overall Study|Adverse Event|2|||
144710891|NCT00467818|521797576|FG000|Overall Study|Adverse Event|1|||
144710892|NCT00467818|521797577|FG001|Overall Study|Adverse Event|0|||
144710893|NCT00467818|521797576|FG000|Overall Study|Lost to Follow-up|2|||
144710894|NCT00467818|521797577|FG001|Overall Study|Lost to Follow-up|2|||
144710895|NCT00618774|521797578|FG000|Overall Study|Adverse Event|5|||
144710896|NCT00618774|521797579|FG001|Overall Study|Adverse Event|3|||
144710897|NCT00618774|521797578|FG000|Overall Study|Withdrawal by Subject|1|||
144710898|NCT00618774|521797579|FG001|Overall Study|Withdrawal by Subject|0|||
144710899|NCT02753400|521797580|FG000|Overall Study|Adverse Event|3|||
144710900|NCT02753400|521797581|FG001|Overall Study|Adverse Event|0|||
144710901|NCT02753400|521797580|FG000|Overall Study|Withdrawal by Subject|2|||
144710902|NCT02753400|521797581|FG001|Overall Study|Withdrawal by Subject|1|||
144710903|NCT01830920|521797584|FG000|Overall Study|Adverse Event|1|||
144710904|NCT01830920|521797585|FG001|Overall Study|Adverse Event|0|||
144710905|NCT01830920|521797586|FG002|Overall Study|Adverse Event|1|||
144710906|NCT01830920|521797587|FG003|Overall Study|Adverse Event|0|||
144710907|NCT01830920|521797588|FG004|Overall Study|Adverse Event|0|||
144710908|NCT01830920|521797584|FG000|Overall Study|Withdrawal by Subject|2|||
144710909|NCT01830920|521797585|FG001|Overall Study|Withdrawal by Subject|2|||
144710910|NCT01830920|521797586|FG002|Overall Study|Withdrawal by Subject|1|||
144710911|NCT01830920|521797587|FG003|Overall Study|Withdrawal by Subject|7|||
144710912|NCT01830920|521797588|FG004|Overall Study|Withdrawal by Subject|1|||
144710913|NCT01830920|521797584|FG000|Overall Study|Death|3|||
144710914|NCT01830920|521797585|FG001|Overall Study|Death|3|||
144710915|NCT01830920|521797586|FG002|Overall Study|Death|5|||
144710916|NCT01830920|521797587|FG003|Overall Study|Death|4|||
144710917|NCT01830920|521797588|FG004|Overall Study|Death|4|||
144710918|NCT01830920|521797584|FG000|Overall Study|Other|15|||
144710919|NCT01830920|521797585|FG001|Overall Study|Other|1|||
144710920|NCT01830920|521797586|FG002|Overall Study|Other|1|||
144710921|NCT01830920|521797587|FG003|Overall Study|Other|5|||
144710922|NCT01830920|521797588|FG004|Overall Study|Other|3|||
144710923|NCT01313728|521797589|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
144710924|NCT00736333|521797590|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
144710925|NCT00736333|521797590|FG000|Overall Study|Data Missing|2|||
144710926|NCT00736333|521797590|FG000|Overall Study|Tumor Progression|75|||
144710927|NCT00736333|521797590|FG000|Overall Study|Toxicity|6|||
144710928|NCT00736333|521797590|FG000|Overall Study|Withdrawal by Subject|10|||
144480809|NCT01468922|520959316|FG005|Overall Study|Per patient choice|0|||
144480810|NCT01468922|520959317|FG006|Overall Study|Per patient choice|0|||
144480811|NCT01468922|520959318|FG007|Overall Study|Per patient choice|0|||
144480812|NCT01468922|520959319|FG008|Overall Study|Per patient choice|0|||
144480813|NCT01468922|520959311|FG000|Overall Study|Switched to alternative treatment|1|||
144480814|NCT01468922|520959312|FG001|Overall Study|Switched to alternative treatment|0|||
144480815|NCT01468922|520959313|FG002|Overall Study|Switched to alternative treatment|0|||
144710929|NCT00736333|521797590|FG000|Overall Study|Death|7|||
144710930|NCT00736333|521797590|FG000|Overall Study|Other|4|||
144710931|NCT00572156|521797598|FG000|Overall Study|Adverse Event|3|||
144710932|NCT00572156|521797599|FG001|Overall Study|Adverse Event|1|||
144710933|NCT00572156|521797600|FG002|Overall Study|Adverse Event|5|||
144710934|NCT00572156|521797601|FG003|Overall Study|Adverse Event|1|||
144710935|NCT00572156|521797598|FG000|Overall Study|Lost to Follow-up|1|||
144710936|NCT00572156|521797599|FG001|Overall Study|Lost to Follow-up|1|||
144710937|NCT00572156|521797600|FG002|Overall Study|Lost to Follow-up|1|||
144710938|NCT00572156|521797601|FG003|Overall Study|Lost to Follow-up|0|||
144710939|NCT00572156|521797598|FG000|Overall Study|Protocol Violation|1|||
144710940|NCT00572156|521797599|FG001|Overall Study|Protocol Violation|2|||
144710941|NCT00572156|521797600|FG002|Overall Study|Protocol Violation|0|||
144710942|NCT00572156|521797601|FG003|Overall Study|Protocol Violation|2|||
144710943|NCT00572156|521797598|FG000|Overall Study|Patient/Parent Decision|1|||
144710944|NCT00572156|521797599|FG001|Overall Study|Patient/Parent Decision|6|||
144710945|NCT00572156|521797600|FG002|Overall Study|Patient/Parent Decision|4|||
144480816|NCT01468922|520959314|FG003|Overall Study|Switched to alternative treatment|0|||
144480817|NCT01468922|520959315|FG004|Overall Study|Switched to alternative treatment|1|||
144480818|NCT01468922|520959316|FG005|Overall Study|Switched to alternative treatment|0|||
144480819|NCT01468922|520959317|FG006|Overall Study|Switched to alternative treatment|0|||
144710946|NCT00572156|521797601|FG003|Overall Study|Patient/Parent Decision|3|||
144710947|NCT00572156|521797598|FG000|Overall Study|Sponsor Decision|20|||
144710948|NCT00572156|521797599|FG001|Overall Study|Sponsor Decision|16|||
144710949|NCT00572156|521797600|FG002|Overall Study|Sponsor Decision|17|||
144710950|NCT00572156|521797601|FG003|Overall Study|Sponsor Decision|19|||
144710951|NCT02261974|521797602|FG000|Overall Study|Withdrawal by Subject|3|||
144710952|NCT02261974|521797603|FG001|Overall Study|Withdrawal by Subject|2|||
144710953|NCT02261974|521797602|FG000|Overall Study|Pregnancy|0|||
144710954|NCT02261974|521797603|FG001|Overall Study|Pregnancy|1|||
144710955|NCT02261974|521797602|FG000|Overall Study|Missed treatment cut-off date|6|||
144710956|NCT02261974|521797603|FG001|Overall Study|Missed treatment cut-off date|3|||
144710957|NCT02261974|521797602|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
144710958|NCT02261974|521797603|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
144710959|NCT02261974|521797602|FG000|Overall Study|Lost to Follow-up|2|||
144710960|NCT02261974|521797603|FG001|Overall Study|Lost to Follow-up|0|||
144710961|NCT02261974|521797602|FG000|Overall Study|Adverse Event|1|||
144710962|NCT02261974|521797603|FG001|Overall Study|Adverse Event|0|||
144480820|NCT01468922|520959318|FG007|Overall Study|Switched to alternative treatment|0|||
144480821|NCT01468922|520959319|FG008|Overall Study|Switched to alternative treatment|0|||
144480822|NCT01468922|520959311|FG000|Overall Study|Enrolled on new protocol|0|||
144480823|NCT01468922|520959312|FG001|Overall Study|Enrolled on new protocol|0|||
144480824|NCT01468922|520959313|FG002|Overall Study|Enrolled on new protocol|0|||
144480825|NCT01468922|520959314|FG003|Overall Study|Enrolled on new protocol|0|||
144480826|NCT01468922|520959315|FG004|Overall Study|Enrolled on new protocol|1|||
144480827|NCT01468922|520959316|FG005|Overall Study|Enrolled on new protocol|0|||
144480828|NCT01468922|520959317|FG006|Overall Study|Enrolled on new protocol|0|||
144480829|NCT01468922|520959318|FG007|Overall Study|Enrolled on new protocol|0|||
144480830|NCT01468922|520959319|FG008|Overall Study|Enrolled on new protocol|0|||
144480831|NCT01468922|520959311|FG000|Overall Study|Adverse Event|0|||
144480832|NCT01468922|520959312|FG001|Overall Study|Adverse Event|0|||
144480833|NCT01468922|520959313|FG002|Overall Study|Adverse Event|0|||
144480834|NCT01468922|520959314|FG003|Overall Study|Adverse Event|0|||
144480835|NCT01468922|520959315|FG004|Overall Study|Adverse Event|0|||
144480836|NCT01468922|520959316|FG005|Overall Study|Adverse Event|0|||
144480837|NCT01468922|520959317|FG006|Overall Study|Adverse Event|0|||
144480838|NCT01468922|520959318|FG007|Overall Study|Adverse Event|1|||
144480839|NCT01468922|520959319|FG008|Overall Study|Adverse Event|0|||
144480840|NCT01468922|520959311|FG000|Overall Study|Infection of blood|0|||
144480841|NCT01468922|520959312|FG001|Overall Study|Infection of blood|0|||
144480842|NCT01468922|520959313|FG002|Overall Study|Infection of blood|0|||
144480843|NCT01468922|520959314|FG003|Overall Study|Infection of blood|0|||
144480844|NCT01468922|520959315|FG004|Overall Study|Infection of blood|0|||
144480845|NCT01468922|520959316|FG005|Overall Study|Infection of blood|0|||
144480846|NCT01468922|520959317|FG006|Overall Study|Infection of blood|0|||
144480847|NCT01468922|520959318|FG007|Overall Study|Infection of blood|1|||
144480848|NCT01468922|520959319|FG008|Overall Study|Infection of blood|0|||
144480849|NCT01468922|520959311|FG000|Overall Study|Patient choice - surgery|0|||
144480850|NCT01468922|520959312|FG001|Overall Study|Patient choice - surgery|0|||
144480851|NCT01468922|520959313|FG002|Overall Study|Patient choice - surgery|0|||
144480852|NCT01468922|520959314|FG003|Overall Study|Patient choice - surgery|0|||
144480853|NCT01468922|520959315|FG004|Overall Study|Patient choice - surgery|0|||
144480854|NCT01468922|520959316|FG005|Overall Study|Patient choice - surgery|0|||
144480855|NCT01468922|520959317|FG006|Overall Study|Patient choice - surgery|0|||
144480856|NCT01468922|520959318|FG007|Overall Study|Patient choice - surgery|1|||
144480857|NCT01468922|520959319|FG008|Overall Study|Patient choice - surgery|0|||
144480858|NCT01468922|520959311|FG000|Overall Study|Refused further treatment|0|||
144480859|NCT01468922|520959312|FG001|Overall Study|Refused further treatment|0|||
144480860|NCT01468922|520959313|FG002|Overall Study|Refused further treatment|0|||
144480861|NCT01468922|520959314|FG003|Overall Study|Refused further treatment|0|||
144480862|NCT01468922|520959315|FG004|Overall Study|Refused further treatment|0|||
144480863|NCT01468922|520959316|FG005|Overall Study|Refused further treatment|0|||
144480864|NCT01468922|520959317|FG006|Overall Study|Refused further treatment|0|||
144480865|NCT01468922|520959318|FG007|Overall Study|Refused further treatment|1|||
144480866|NCT01468922|520959319|FG008|Overall Study|Refused further treatment|0|||
144480867|NCT01923389|520959320|FG000|Overall Study|Protocol Violation|1|||
144480868|NCT01923389|520959321|FG001|Overall Study|Protocol Violation|0|||
144480869|NCT02761629|520959327|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
144480870|NCT02761629|520959328|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
144480871|NCT02761629|520959327|FG000|Overall Study|Insufficient Therapeutic Response|2|||
144480872|NCT02761629|520959328|FG001|Overall Study|Insufficient Therapeutic Response|7|||
144480873|NCT02761629|520959327|FG000|Overall Study|Failure to Return|2|||
144480874|NCT02761629|520959328|FG001|Overall Study|Failure to Return|4|||
144480875|NCT02761629|520959327|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
144480876|NCT02761629|520959328|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
144480877|NCT02761629|520959327|FG000|Overall Study|Protocol Violation|2|||
144480878|NCT02761629|520959328|FG001|Overall Study|Protocol Violation|2|||
144480879|NCT02761629|520959327|FG000|Overall Study|Withdrawal by Subject|0|||
144480880|NCT02761629|520959328|FG001|Overall Study|Withdrawal by Subject|3|||
144480881|NCT02761629|520959327|FG000|Overall Study|Other|0|||
144480882|NCT02761629|520959328|FG001|Overall Study|Other|2|||
144480883|NCT02761629|520959327|FG000|Overall Study|Lost to Follow-up|4|||
144480884|NCT02761629|520959328|FG001|Overall Study|Lost to Follow-up|1|||
144480885|NCT02761629|520959327|FG000|Overall Study|Randomized But Not Treated|8|||
144710963|NCT01440595|521797604|FG000|Overall Study|Lost to Follow-up|0|||
144710964|NCT01440595|521797605|FG001|Overall Study|Lost to Follow-up|1|||
144480886|NCT02761629|520959328|FG001|Overall Study|Randomized But Not Treated|4|||
144480887|NCT01348776|520959332|FG000|Overall Study|Lost to Follow-up|3|||
144480888|NCT02340520|520959338|FG000|Overall Study|Lost to Follow-up|1|||
144710965|NCT01440595|521797606|FG002|Overall Study|Lost to Follow-up|0|||
144480889|NCT02340520|520959338|FG000|Overall Study|Patient did not take drug as specified|1|||
144480890|NCT02340520|520959338|FG000|Overall Study|Withdrawal by Subject|1|||
144480891|NCT04362137|520959339|FG000|Overall Study|Death|9|||
144480892|NCT04362137|520959340|FG001|Overall Study|Death|3|||
144480893|NCT04362137|520959339|FG000|Overall Study|Patient decision|6|||
144710966|NCT01440595|521797604|FG000|Overall Study|Study terminated by sponsor.|1|||
144710967|NCT01440595|521797605|FG001|Overall Study|Study terminated by sponsor.|2|||
144710968|NCT01440595|521797606|FG002|Overall Study|Study terminated by sponsor.|1|||
144710969|NCT01347879|521797607|FG000|Overall Study|Adverse Event|0|||
144710970|NCT01347879|521797608|FG001|Overall Study|Adverse Event|12|||
144710971|NCT01347879|521797607|FG000|Overall Study|Lost to Follow-up|2|||
144710972|NCT01347879|521797608|FG001|Overall Study|Lost to Follow-up|0|||
144710973|NCT01347879|521797607|FG000|Overall Study|Withdrawal by Subject|3|||
144710974|NCT01347879|521797608|FG001|Overall Study|Withdrawal by Subject|2|||
144710975|NCT01347879|521797607|FG000|Overall Study|Other|2|||
144710976|NCT01347879|521797608|FG001|Overall Study|Other|3|||
144710977|NCT04736576|521797613|FG000|Overall Study|Progressive disease|3|||
144710978|NCT04736576|521797614|FG001|Overall Study|Progressive disease|1|||
144710979|NCT04736576|521797613|FG000|Overall Study|Death|1|||
144710980|NCT04736576|521797614|FG001|Overall Study|Death|0|||
144710981|NCT00720304|521797615|FG000|Overall Study|Withdrawal by Subject|14|||
144710982|NCT00720304|521797616|FG001|Overall Study|Withdrawal by Subject|1|||
144710983|NCT00720304|521797615|FG000|Overall Study|Death|1|||
144710984|NCT00720304|521797616|FG001|Overall Study|Death|0|||
144710985|NCT00720304|521797615|FG000|Overall Study|Physician Decision|5|||
144710986|NCT00720304|521797616|FG001|Overall Study|Physician Decision|2|||
144710987|NCT00720304|521797615|FG000|Overall Study|Adverse Event|3|||
144710988|NCT00720304|521797616|FG001|Overall Study|Adverse Event|1|||
144710989|NCT00720304|521797615|FG000|Overall Study|Disease progression|6|||
144710990|NCT00720304|521797616|FG001|Overall Study|Disease progression|1|||
144710991|NCT04330482|521797619|FG000|Overall Study|Lost to Follow-up|2|||
144710992|NCT04330482|521797620|FG001|Overall Study|Lost to Follow-up|1|||
144710993|NCT04330482|521797619|FG000|Overall Study|Withdrawal by Subject|0|||
144710994|NCT04330482|521797620|FG001|Overall Study|Withdrawal by Subject|3|||
144710995|NCT00996918|521797621|FG000|Overall Study|Lack of Efficacy|1|||
144710996|NCT00996918|521797622|FG001|Overall Study|Lack of Efficacy|1|||
144710997|NCT00996918|521797623|FG002|Overall Study|Lack of Efficacy|2|||
144710998|NCT00996918|521797624|FG003|Overall Study|Lack of Efficacy|2|||
144710999|NCT00996918|521797625|FG004|Overall Study|Lack of Efficacy|0|||
144711000|NCT00996918|521797621|FG000|Overall Study|Adverse Event|2|||
144711001|NCT00996918|521797622|FG001|Overall Study|Adverse Event|5|||
144711002|NCT00996918|521797623|FG002|Overall Study|Adverse Event|2|||
144711003|NCT00996918|521797624|FG003|Overall Study|Adverse Event|6|||
144711004|NCT00996918|521797625|FG004|Overall Study|Adverse Event|0|||
144711005|NCT00996918|521797621|FG000|Overall Study|Withdrawal by Subject|1|||
144711006|NCT00996918|521797622|FG001|Overall Study|Withdrawal by Subject|4|||
144711007|NCT00996918|521797623|FG002|Overall Study|Withdrawal by Subject|3|||
144711008|NCT00996918|521797624|FG003|Overall Study|Withdrawal by Subject|3|||
144711009|NCT00996918|521797625|FG004|Overall Study|Withdrawal by Subject|2|||
144711010|NCT00996918|521797621|FG000|Overall Study|Physician Decision|1|||
144711011|NCT00996918|521797622|FG001|Overall Study|Physician Decision|0|||
144711012|NCT00996918|521797623|FG002|Overall Study|Physician Decision|0|||
144711013|NCT00996918|521797624|FG003|Overall Study|Physician Decision|0|||
144711014|NCT00996918|521797625|FG004|Overall Study|Physician Decision|0|||
144711015|NCT00996918|521797621|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
144711016|NCT00996918|521797622|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
144711017|NCT00996918|521797623|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
144711018|NCT00996918|521797624|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
144711019|NCT00996918|521797625|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
144711020|NCT00996918|521797621|FG000|Overall Study|Loss of Caregiver|0|||
144711021|NCT00996918|521797622|FG001|Overall Study|Loss of Caregiver|1|||
144711022|NCT00996918|521797623|FG002|Overall Study|Loss of Caregiver|0|||
144711023|NCT00996918|521797624|FG003|Overall Study|Loss of Caregiver|0|||
144711024|NCT00996918|521797625|FG004|Overall Study|Loss of Caregiver|0|||
144711025|NCT00996918|521797621|FG000|Overall Study|Other|3|||
144711026|NCT00996918|521797622|FG001|Overall Study|Other|1|||
144711027|NCT00996918|521797623|FG002|Overall Study|Other|0|||
144368341|NCT02978781|520559817|FG004|Part C|Adverse Event|2|||
144711028|NCT00996918|521797624|FG003|Overall Study|Other|0|||
144711029|NCT00996918|521797625|FG004|Overall Study|Other|0|||
144711030|NCT01333475|521797628|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
144368342|NCT02978781|520559813|FG000|Part C|Withdrawal by Subject|0|||
144711031|NCT01333475|521797629|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
144711032|NCT01333475|521797628|FG000|Overall Study|Toxicity|1|||
144711033|NCT01333475|521797629|FG001|Overall Study|Toxicity|3|||
144711034|NCT04440007|521797630|FG000|Overall Study|Adverse Event|0|||
144711035|NCT04440007|521797631|FG001|Overall Study|Adverse Event|1|||
144711036|NCT04440007|521797630|FG000|Overall Study|Lost to Follow-up|1|||
144711037|NCT04440007|521797631|FG001|Overall Study|Lost to Follow-up|3|||
144711038|NCT04440007|521797630|FG000|Overall Study|Death|7|||
144711039|NCT04440007|521797631|FG001|Overall Study|Death|2|||
144711040|NCT04440007|521797630|FG000|Overall Study|Physician Decision|1|||
144711041|NCT04440007|521797631|FG001|Overall Study|Physician Decision|1|||
144711042|NCT04440007|521797630|FG000|Overall Study|Withdrawal by Subject|2|||
144711043|NCT04440007|521797631|FG001|Overall Study|Withdrawal by Subject|1|||
144711044|NCT04440007|521797630|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
144711045|NCT04440007|521797631|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
144711046|NCT04440007|521797630|FG000|Overall Study|Discontinued prior to dosing|0|||
144711047|NCT04440007|521797631|FG001|Overall Study|Discontinued prior to dosing|2|||
144711048|NCT01466673|521797632|FG000|Overall Study|Non-compliance with study treatment|2|||
144711049|NCT01466673|521797633|FG001|Overall Study|Non-compliance with study treatment|0|||
144711050|NCT01466673|521797632|FG000|Overall Study|Lost to Follow-up|3|||
144711051|NCT01466673|521797633|FG001|Overall Study|Lost to Follow-up|5|||
144711052|NCT01466673|521797632|FG000|Overall Study|Adverse Event|2|||
144711053|NCT01466673|521797633|FG001|Overall Study|Adverse Event|1|||
144711054|NCT02981602|521797634|FG000|Overall Study|Adverse Event|0|||
144711055|NCT02981602|521797635|FG001|Overall Study|Adverse Event|0|||
144711056|NCT02981602|521797636|FG002|Overall Study|Adverse Event|0|||
144711057|NCT02981602|521797637|FG003|Overall Study|Adverse Event|1|||
144711058|NCT02981602|521797638|FG004|Overall Study|Adverse Event|0|||
144711059|NCT02725671|521797639|FG000|Overall Study|Lost to Follow-up|1|||
144711060|NCT00666718|521797640|FG000|Overall Study|Adverse Event|0|||
144711061|NCT00666718|521797641|FG001|Overall Study|Adverse Event|1|||
144711062|NCT00666718|521797640|FG000|Overall Study|Death|1|||
144711063|NCT00666718|521797641|FG001|Overall Study|Death|0|||
144711064|NCT00666718|521797640|FG000|Overall Study|Lost to Follow-up|1|||
144711065|NCT00666718|521797641|FG001|Overall Study|Lost to Follow-up|0|||
144711066|NCT00666718|521797640|FG000|Overall Study|Entry Criteria Not Met|2|||
144711067|NCT00666718|521797641|FG001|Overall Study|Entry Criteria Not Met|0|||
144711068|NCT00666718|521797640|FG000|Overall Study|Protocol Violation|1|||
144711069|NCT00666718|521797641|FG001|Overall Study|Protocol Violation|3|||
144711070|NCT00666718|521797640|FG000|Overall Study|Withdrawal by Subject|7|||
144711071|NCT00666718|521797641|FG001|Overall Study|Withdrawal by Subject|12|||
144711072|NCT00666718|521797640|FG000|Overall Study|Physician Decision|0|||
144711073|NCT00666718|521797641|FG001|Overall Study|Physician Decision|2|||
144711074|NCT00963599|521797642|FG000|Overall Study|Adverse Event|2|||
144711075|NCT00963599|521797643|FG001|Overall Study|Adverse Event|0|||
144711076|NCT00963599|521797644|FG002|Overall Study|Adverse Event|1|||
144711077|NCT00963599|521797645|FG003|Overall Study|Adverse Event|2|||
144711078|NCT00963599|521797642|FG000|Overall Study|Lack of Efficacy|0|||
144711079|NCT00963599|521797643|FG001|Overall Study|Lack of Efficacy|2|||
144711080|NCT00963599|521797644|FG002|Overall Study|Lack of Efficacy|1|||
144711081|NCT00963599|521797645|FG003|Overall Study|Lack of Efficacy|4|||
144711082|NCT00963599|521797642|FG000|Overall Study|Lost to Follow-up|0|||
144711083|NCT00963599|521797643|FG001|Overall Study|Lost to Follow-up|1|||
144711084|NCT00963599|521797644|FG002|Overall Study|Lost to Follow-up|1|||
144711085|NCT00963599|521797645|FG003|Overall Study|Lost to Follow-up|1|||
144711086|NCT00963599|521797642|FG000|Overall Study|Protocol Violation|2|||
144711087|NCT00963599|521797643|FG001|Overall Study|Protocol Violation|2|||
144711088|NCT00963599|521797644|FG002|Overall Study|Protocol Violation|3|||
144711089|NCT00963599|521797645|FG003|Overall Study|Protocol Violation|4|||
144711090|NCT00963599|521797642|FG000|Overall Study|Withdrawal by Subject|2|||
144711091|NCT00963599|521797643|FG001|Overall Study|Withdrawal by Subject|1|||
144711092|NCT00963599|521797644|FG002|Overall Study|Withdrawal by Subject|3|||
144711093|NCT00963599|521797645|FG003|Overall Study|Withdrawal by Subject|3|||
144711094|NCT01706770|521797646|FG000|Overall Study|Lost to Follow-up|1|||
144711095|NCT01706770|521797647|FG001|Overall Study|Lost to Follow-up|0|||
144711096|NCT01706770|521797646|FG000|Overall Study|Physician Decision|1|||
144711097|NCT01706770|521797647|FG001|Overall Study|Physician Decision|0|||
144711098|NCT00123487|521797648|FG000|Randomized|Death prior to starting treatment|0|||
144711099|NCT00123487|521797649|FG001|Randomized|Death prior to starting treatment|1|||
144711100|NCT00123487|521797648|FG000|Randomized|SAE prior to starting treatment|1|||
144711101|NCT00123487|521797649|FG001|Randomized|SAE prior to starting treatment|0|||
144711102|NCT00123487|521797648|FG000|Treated With Study Drug|Adverse Event|23|||
144711103|NCT00123487|521797649|FG001|Treated With Study Drug|Adverse Event|22|||
144711104|NCT00123487|521797648|FG000|Treated With Study Drug|Disease Progression|141|||
144711105|NCT00123487|521797649|FG001|Treated With Study Drug|Disease Progression|122|||
144711106|NCT00123487|521797648|FG000|Treated With Study Drug|Physician Decision|8|||
144711107|NCT00123487|521797649|FG001|Treated With Study Drug|Physician Decision|9|||
144711108|NCT00123487|521797648|FG000|Treated With Study Drug|Other|59|||
144711109|NCT00123487|521797649|FG001|Treated With Study Drug|Other|58|||
144711110|NCT00123487|521797648|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
144711111|NCT00123487|521797649|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
144711112|NCT00123487|521797648|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
144711113|NCT00123487|521797649|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
144711114|NCT00123487|521797648|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
144711115|NCT00123487|521797649|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
144711116|NCT01783483|521797654|FG000|Overall Study|Death|3|||
144711117|NCT01783483|521797655|FG001|Overall Study|Death|3|||
144711118|NCT01783483|521797654|FG000|Overall Study|Lost to Follow-up|14|||
144711119|NCT01783483|521797655|FG001|Overall Study|Lost to Follow-up|10|||
144711120|NCT01783483|521797654|FG000|Overall Study|Withdrawal by Subject|2|||
144711121|NCT01783483|521797655|FG001|Overall Study|Withdrawal by Subject|1|||
144711122|NCT01783483|521797654|FG000|Overall Study|Physician Decision|1|||
144480894|NCT04362137|520959340|FG001|Overall Study|Patient decision|3|||
144711123|NCT01783483|521797655|FG001|Overall Study|Physician Decision|1|||
144711124|NCT02065791|521797661|FG000|Overall Study|Closed Site|1|||
144711125|NCT02065791|521797662|FG001|Overall Study|Closed Site|1|||
144711126|NCT02065791|521797661|FG000|Overall Study|Withdrawal by Subject|11|||
144711127|NCT02065791|521797662|FG001|Overall Study|Withdrawal by Subject|5|||
144711128|NCT02065791|521797661|FG000|Overall Study|Lost to Follow-up|13|||
144711129|NCT02065791|521797662|FG001|Overall Study|Lost to Follow-up|9|||
144711130|NCT00363129|521797663|FG000|Overall Study|Withdrawal by Subject|11|||
144711131|NCT00363129|521797664|FG001|Overall Study|Withdrawal by Subject|18|||
144480895|NCT04362137|520959339|FG000|Overall Study|Adverse Event|1|||
144480896|NCT04362137|520959340|FG001|Overall Study|Adverse Event|0|||
144480897|NCT04362137|520959339|FG000|Overall Study|Lost to Follow-up|1|||
144480898|NCT04362137|520959340|FG001|Overall Study|Lost to Follow-up|0|||
144480899|NCT04362137|520959339|FG000|Overall Study|Protocol deviation|1|||
144480900|NCT04362137|520959340|FG001|Overall Study|Protocol deviation|0|||
144480901|NCT00447954|520959341|FG000|Overall Study|Adverse Event|0|||
144480902|NCT00447954|520959342|FG001|Overall Study|Adverse Event|2|||
144480903|NCT00447954|520959343|FG002|Overall Study|Adverse Event|0|||
144480904|NCT00447954|520959341|FG000|Overall Study|Withdrawal by Subject|0|||
144480905|NCT00447954|520959342|FG001|Overall Study|Withdrawal by Subject|1|||
144480906|NCT00447954|520959343|FG002|Overall Study|Withdrawal by Subject|1|||
144480907|NCT00447954|520959341|FG000|Overall Study|Lost to Follow-up|0|||
144480908|NCT00447954|520959342|FG001|Overall Study|Lost to Follow-up|1|||
144480909|NCT00447954|520959343|FG002|Overall Study|Lost to Follow-up|0|||
144480910|NCT00447954|520959341|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
144480911|NCT00447954|520959342|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
144480912|NCT00447954|520959343|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
144480913|NCT03176238|520959346|FG000|Overall Study|Unacceptable AEs|15|||
144480914|NCT03176238|520959347|FG001|Overall Study|Unacceptable AEs|8|||
144480915|NCT03176238|520959346|FG000|Overall Study|Abnormal lab value(s)|2|||
144711132|NCT00363129|521797663|FG000|Overall Study|Adverse Event|8|||
144711133|NCT00363129|521797664|FG001|Overall Study|Adverse Event|3|||
144711134|NCT00363129|521797663|FG000|Overall Study|Alternate Treatment|2|||
144711135|NCT00363129|521797664|FG001|Overall Study|Alternate Treatment|4|||
144711136|NCT00363129|521797663|FG000|Overall Study|Other Medical Problems|2|||
144711137|NCT00363129|521797664|FG001|Overall Study|Other Medical Problems|4|||
144711138|NCT00363129|521797663|FG000|Overall Study|Death|0|||
144711139|NCT00363129|521797664|FG001|Overall Study|Death|1|||
144711140|NCT00363129|521797663|FG000|Overall Study|Other Reasons|6|||
144711141|NCT00363129|521797664|FG001|Overall Study|Other Reasons|3|||
144711142|NCT01021137|521797665|FG000|Overall Study|Lost to Follow-up|9|||
144711143|NCT01021137|521797666|FG001|Overall Study|Lost to Follow-up|4|||
144368343|NCT02978781|520559814|FG001|Part C|Withdrawal by Subject|0|||
144368344|NCT02978781|520559815|FG002|Part C|Withdrawal by Subject|0|||
144368345|NCT02978781|520559816|FG003|Part C|Withdrawal by Subject|0|||
144368346|NCT02978781|520559817|FG004|Part C|Withdrawal by Subject|1|||
144368347|NCT02978781|520559813|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
144368348|NCT02978781|520559814|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
144368349|NCT02978781|520559815|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
144368350|NCT02978781|520559816|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
144368351|NCT02978781|520559817|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
144368352|NCT01528969|520559818|FG000|Overall Study|absent from the school at baseline|2|||
144368353|NCT01528969|520559819|FG001|Overall Study|absent from the school at baseline|0|||
144368354|NCT02282605|520559820|FG000|Overall Study|negative SA result on Day -1|3|||
144368355|NCT02282605|520559821|FG001|Overall Study|negative SA result on Day -1|0|||
144368356|NCT02282605|520559822|FG002|Overall Study|negative SA result on Day -1|0|||
144368357|NCT01383356|520559825|FG000|Period 1|Adverse Event|5|||
144368358|NCT01383356|520559826|FG001|Period 1|Adverse Event|3|||
144368359|NCT01383356|520559825|FG000|Period 1|Non-compliance|3|||
144368360|NCT01383356|520559826|FG001|Period 1|Non-compliance|0|||
144368361|NCT01383356|520559825|FG000|Period 1|Out of Range Mid-study-Test|0|||
144368362|NCT01383356|520559826|FG001|Period 1|Out of Range Mid-study-Test|1|||
144368363|NCT01383356|520559825|FG000|Period 1|Personal|0|||
144480916|NCT03176238|520959347|FG001|Overall Study|Abnormal lab value(s)|0|||
144480917|NCT03176238|520959346|FG000|Overall Study|Inter-current illness|0|||
144711144|NCT01021137|521797667|FG002|Overall Study|Lost to Follow-up|2|||
144711145|NCT01021137|521797668|FG003|Overall Study|Lost to Follow-up|6|||
144711146|NCT01021137|521797665|FG000|Overall Study|Withdrawal by Subject|1|||
144368364|NCT01383356|520559826|FG001|Period 1|Personal|2|||
144368365|NCT03584789|520559827|FG000|Overall Study|refused EHR permission|19|||
144480918|NCT03176238|520959347|FG001|Overall Study|Inter-current illness|1|||
144711147|NCT01021137|521797666|FG001|Overall Study|Withdrawal by Subject|0|||
144711148|NCT01021137|521797667|FG002|Overall Study|Withdrawal by Subject|0|||
144711149|NCT01021137|521797668|FG003|Overall Study|Withdrawal by Subject|3|||
144711150|NCT00659581|521797669|FG000|Overall Study|Adverse Event|1006|||
144711151|NCT00659581|521797669|FG000|Overall Study|Lack of Efficacy|1183|||
144711152|NCT00659581|521797669|FG000|Overall Study|Other|6393|||
144711153|NCT03125915|521797677|FG000|1 Month Follow up|Lost to Follow-up|3|||
144711154|NCT03125915|521797678|FG001|1 Month Follow up|Lost to Follow-up|3|||
144711155|NCT03125915|521797679|FG002|1 Month Follow up|Lost to Follow-up|2|||
144711156|NCT03125915|521797680|FG003|1 Month Follow up|Lost to Follow-up|3|||
144711157|NCT03125915|521797677|FG000|3 Month Follow-up|Lost to Follow-up|6|||
144711158|NCT03125915|521797678|FG001|3 Month Follow-up|Lost to Follow-up|4|||
144711159|NCT03125915|521797679|FG002|3 Month Follow-up|Lost to Follow-up|4|||
144711160|NCT03125915|521797680|FG003|3 Month Follow-up|Lost to Follow-up|2|||
144711161|NCT03125915|521797677|FG000|6 Month Follow-up|Lost to Follow-up|7|||
144711162|NCT03125915|521797678|FG001|6 Month Follow-up|Lost to Follow-up|3|||
144711163|NCT03125915|521797679|FG002|6 Month Follow-up|Lost to Follow-up|6|||
144711164|NCT03125915|521797680|FG003|6 Month Follow-up|Lost to Follow-up|3|||
144711165|NCT01309828|521797683|FG000|Overall Study|Adverse Event|10|||
144711166|NCT01309828|521797684|FG001|Overall Study|Adverse Event|11|||
144711167|NCT01309828|521797683|FG000|Overall Study|Voluntary Withdrawal|5|||
144711168|NCT01309828|521797684|FG001|Overall Study|Voluntary Withdrawal|4|||
144711169|NCT01309828|521797683|FG000|Overall Study|Major Protocol Deviation|0|||
144711170|NCT01309828|521797684|FG001|Overall Study|Major Protocol Deviation|1|||
144711171|NCT01309828|521797683|FG000|Overall Study|Other|1|||
144711172|NCT01309828|521797684|FG001|Overall Study|Other|0|||
144711173|NCT00928135|521797694|FG000|Overall Study|Withdrawal by Subject|1|||
144711174|NCT00928135|521797695|FG001|Overall Study|Withdrawal by Subject|0|||
144711175|NCT02598622|521799233|FG000|Overall Study|Withdrawal by Subject|3|||
144711176|NCT02598622|521799234|FG001|Overall Study|Withdrawal by Subject|0|||
144711177|NCT02598622|521799233|FG000|Overall Study|Physician Decision|3|||
144711178|NCT02598622|521799234|FG001|Overall Study|Physician Decision|0|||
144711179|NCT00305110|521799240|FG000|Overall Study|Missing data|29|||
144711180|NCT03101293|521799241|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
144711181|NCT03101293|521799242|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
144711182|NCT01017029|521799243|FG000|Overall Study|Lost to Follow-up|1|||
144711183|NCT01017029|521799244|FG001|Overall Study|Lost to Follow-up|0|||
144711184|NCT01017029|521799243|FG000|Overall Study|Administrative problem|0|||
144711185|NCT01017029|521799244|FG001|Overall Study|Administrative problem|1|||
144711186|NCT01017029|521799243|FG000|Overall Study|Death|3|||
144711187|NCT01017029|521799244|FG001|Overall Study|Death|1|||
144711188|NCT02770716|521799247|FG000|Overall Study|Death|101|||
144711189|NCT02770716|521799248|FG001|Overall Study|Death|45|||
144711190|NCT02770716|521799247|FG000|Overall Study|Withdrawal by Subject|4|||
144711191|NCT02770716|521799248|FG001|Overall Study|Withdrawal by Subject|2|||
144711192|NCT02770716|521799247|FG000|Overall Study|Lost to Follow-up|1|||
144711193|NCT02770716|521799248|FG001|Overall Study|Lost to Follow-up|0|||
144711194|NCT02770716|521799247|FG000|Overall Study|Various reasons|6|||
144711195|NCT02770716|521799248|FG001|Overall Study|Various reasons|2|||
144711196|NCT03989115|521799250|FG000|Overall Study|Withdrawal by Subject|2|||
144711197|NCT03989115|521799251|FG001|Overall Study|Withdrawal by Subject|1|||
144711198|NCT03989115|521799252|FG002|Overall Study|Withdrawal by Subject|3|||
144711199|NCT03989115|521799253|FG003|Overall Study|Withdrawal by Subject|0|||
144711200|NCT03989115|521799254|FG004|Overall Study|Withdrawal by Subject|17|||
144711201|NCT03989115|521799255|FG005|Overall Study|Withdrawal by Subject|1|||
144711202|NCT03989115|521799256|FG006|Overall Study|Withdrawal by Subject|0|||
144711203|NCT03989115|521799257|FG007|Overall Study|Withdrawal by Subject|0|||
144711204|NCT03989115|521799250|FG000|Overall Study|Sponsor decision to terminate the study|1|||
144711205|NCT03989115|521799251|FG001|Overall Study|Sponsor decision to terminate the study|1|||
144368366|NCT03584789|520559828|FG001|Overall Study|refused EHR permission|28|||
144711206|NCT03989115|521799252|FG002|Overall Study|Sponsor decision to terminate the study|0|||
144711207|NCT03989115|521799253|FG003|Overall Study|Sponsor decision to terminate the study|1|||
144711208|NCT03989115|521799254|FG004|Overall Study|Sponsor decision to terminate the study|11|||
144711209|NCT03989115|521799255|FG005|Overall Study|Sponsor decision to terminate the study|0|||
144711210|NCT03989115|521799256|FG006|Overall Study|Sponsor decision to terminate the study|2|||
144711211|NCT03989115|521799257|FG007|Overall Study|Sponsor decision to terminate the study|1|||
144711212|NCT03989115|521799250|FG000|Overall Study|Lost to Follow-up|2|||
144480919|NCT03176238|520959346|FG000|Overall Study|Consent withdrawal|14|||
144480920|NCT03176238|520959347|FG001|Overall Study|Consent withdrawal|2|||
144480921|NCT03176238|520959346|FG000|Overall Study|Lost to Follow-up|3|||
144480922|NCT03176238|520959347|FG001|Overall Study|Lost to Follow-up|0|||
144480923|NCT03176238|520959346|FG000|Overall Study|Administrative problems|1|||
144480924|NCT03176238|520959347|FG001|Overall Study|Administrative problems|0|||
144480925|NCT03176238|520959346|FG000|Overall Study|Death|3|||
144480926|NCT03176238|520959347|FG001|Overall Study|Death|0|||
144480927|NCT03176238|520959346|FG000|Overall Study|Disease Progression|133|||
144480928|NCT03176238|520959347|FG001|Overall Study|Disease Progression|22|||
144480929|NCT03176238|520959346|FG000|Overall Study|Tx duration completed per EAP|0|||
144711213|NCT03989115|521799251|FG001|Overall Study|Lost to Follow-up|0|||
144711214|NCT03989115|521799252|FG002|Overall Study|Lost to Follow-up|0|||
144711215|NCT03989115|521799253|FG003|Overall Study|Lost to Follow-up|0|||
144711216|NCT03989115|521799254|FG004|Overall Study|Lost to Follow-up|1|||
144711217|NCT03989115|521799255|FG005|Overall Study|Lost to Follow-up|0|||
144711218|NCT03989115|521799256|FG006|Overall Study|Lost to Follow-up|0|||
144711219|NCT03989115|521799257|FG007|Overall Study|Lost to Follow-up|0|||
144711220|NCT03989115|521799250|FG000|Overall Study|Death|2|||
144711221|NCT03989115|521799251|FG001|Overall Study|Death|2|||
144711222|NCT03989115|521799252|FG002|Overall Study|Death|9|||
144711223|NCT03989115|521799253|FG003|Overall Study|Death|6|||
144711224|NCT03989115|521799254|FG004|Overall Study|Death|31|||
144711225|NCT03989115|521799255|FG005|Overall Study|Death|6|||
144711226|NCT03989115|521799256|FG006|Overall Study|Death|2|||
144711227|NCT03989115|521799257|FG007|Overall Study|Death|3|||
144711228|NCT03989115|521799250|FG000|Overall Study|Other|1|||
144711229|NCT03989115|521799251|FG001|Overall Study|Other|2|||
144711230|NCT03989115|521799252|FG002|Overall Study|Other|0|||
144711231|NCT03989115|521799253|FG003|Overall Study|Other|0|||
144711232|NCT03989115|521799254|FG004|Overall Study|Other|5|||
144711233|NCT03989115|521799255|FG005|Overall Study|Other|0|||
144711234|NCT03989115|521799256|FG006|Overall Study|Other|0|||
144711235|NCT03989115|521799257|FG007|Overall Study|Other|0|||
144711236|NCT01453374|521799258|FG000|Overall Study|Adverse Event|7|||
144711237|NCT01453374|521799258|FG000|Overall Study|Lack of Efficacy|1|||
144711238|NCT01453374|521799258|FG000|Overall Study|Lost to Follow-up|3|||
144711239|NCT01453374|521799258|FG000|Overall Study|Withdrawal by Subject|5|||
144711240|NCT01453374|521799258|FG000|Overall Study|Incarcerated|2|||
144711241|NCT01238822|521799261|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
144711242|NCT02525562|521799273|FG000|Overall Study|Death|9|||
144480930|NCT03176238|520959347|FG001|Overall Study|Tx duration completed per EAP|1|||
144538209|NCT00146172|521174122|FG000|Overall Study|Death|0|||
144711243|NCT02525562|521799274|FG001|Overall Study|Death|0|||
144711244|NCT02525562|521799275|FG002|Overall Study|Death|0|||
144711245|NCT02525562|521799273|FG000|Overall Study|Lost to Follow-up|19|||
144711246|NCT02525562|521799274|FG001|Overall Study|Lost to Follow-up|0|||
144711247|NCT02525562|521799275|FG002|Overall Study|Lost to Follow-up|0|||
144711248|NCT02525562|521799273|FG000|Overall Study|Withdrawal by Subject|37|||
144711249|NCT02525562|521799274|FG001|Overall Study|Withdrawal by Subject|0|||
144711250|NCT02525562|521799275|FG002|Overall Study|Withdrawal by Subject|0|||
144711251|NCT02525562|521799273|FG000|Overall Study|Revision/Removal of Study Device|4|||
144711252|NCT02525562|521799274|FG001|Overall Study|Revision/Removal of Study Device|0|||
144711253|NCT02525562|521799275|FG002|Overall Study|Revision/Removal of Study Device|0|||
144711254|NCT02525562|521799273|FG000|Overall Study|Study Closed by Sponsor|154|||
144711255|NCT02525562|521799274|FG001|Overall Study|Study Closed by Sponsor|0|||
144711256|NCT02525562|521799275|FG002|Overall Study|Study Closed by Sponsor|0|||
144711257|NCT02983227|521799276|FG000|Overall Study|Adverse Event|21|||
144711258|NCT02983227|521799277|FG001|Overall Study|Adverse Event|3|||
144711259|NCT02983227|521799276|FG000|Overall Study|Death|3|||
144711260|NCT02983227|521799277|FG001|Overall Study|Death|0|||
144711261|NCT02983227|521799276|FG000|Overall Study|Lack of Efficacy|8|||
144711262|NCT02983227|521799277|FG001|Overall Study|Lack of Efficacy|1|||
144711263|NCT02983227|521799276|FG000|Overall Study|Lost to Follow-up|3|||
144711264|NCT02983227|521799277|FG001|Overall Study|Lost to Follow-up|0|||
144711265|NCT02983227|521799276|FG000|Overall Study|Multiple Reasons|2|||
144711266|NCT02983227|521799277|FG001|Overall Study|Multiple Reasons|1|||
144711267|NCT02983227|521799276|FG000|Overall Study|Physician Decision|3|||
144711268|NCT02983227|521799277|FG001|Overall Study|Physician Decision|1|||
144711269|NCT02983227|521799276|FG000|Overall Study|Withdrawal by Subject|19|||
144711270|NCT02983227|521799277|FG001|Overall Study|Withdrawal by Subject|8|||
144711271|NCT02354976|521799278|FG000|Overall Study|Other - reason not specified|1|||
144711272|NCT02354976|521799279|FG001|Overall Study|Other - reason not specified|0|||
144711273|NCT02354976|521799280|FG002|Overall Study|Other - reason not specified|1|||
144711274|NCT02354976|521799278|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
144711275|NCT02354976|521799279|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
144711276|NCT02354976|521799280|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
144711277|NCT02354976|521799278|FG000|Overall Study|Adverse Event|1|||
144711278|NCT02354976|521799279|FG001|Overall Study|Adverse Event|0|||
144711279|NCT02354976|521799280|FG002|Overall Study|Adverse Event|2|||
144711280|NCT03118765|521799281|FG000|Overall Study|Withdrawal by Subject|0|||
144711281|NCT03118765|521799282|FG001|Overall Study|Withdrawal by Subject|0|||
144711282|NCT03118765|521799283|FG002|Overall Study|Withdrawal by Subject|1|||
144711283|NCT03118765|521799284|FG003|Overall Study|Withdrawal by Subject|0|||
144711284|NCT03118765|521799285|FG004|Overall Study|Withdrawal by Subject|0|||
144711285|NCT03118765|521799281|FG000|Overall Study|Adverse Event|1|||
144711286|NCT03118765|521799282|FG001|Overall Study|Adverse Event|1|||
144711287|NCT03118765|521799283|FG002|Overall Study|Adverse Event|1|||
144711288|NCT03118765|521799284|FG003|Overall Study|Adverse Event|1|||
144711289|NCT03118765|521799285|FG004|Overall Study|Adverse Event|1|||
144711290|NCT03118765|521799281|FG000|Overall Study|Non compliance with Study Procedures|0|||
144711291|NCT03118765|521799282|FG001|Overall Study|Non compliance with Study Procedures|0|||
144711292|NCT03118765|521799283|FG002|Overall Study|Non compliance with Study Procedures|0|||
144711293|NCT03118765|521799284|FG003|Overall Study|Non compliance with Study Procedures|1|||
144711294|NCT03118765|521799285|FG004|Overall Study|Non compliance with Study Procedures|0|||
144711295|NCT03118765|521799281|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
144711296|NCT03118765|521799282|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
144711297|NCT03118765|521799283|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
144711298|NCT03118765|521799284|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
144711299|NCT03118765|521799285|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
144711300|NCT03118765|521799281|FG000|Overall Study|COPD Exacerbation|1|||
144711301|NCT03118765|521799282|FG001|Overall Study|COPD Exacerbation|0|||
144711302|NCT03118765|521799283|FG002|Overall Study|COPD Exacerbation|0|||
144711303|NCT03118765|521799284|FG003|Overall Study|COPD Exacerbation|1|||
144711304|NCT03118765|521799285|FG004|Overall Study|COPD Exacerbation|0|||
144711305|NCT03118765|521799281|FG000|Overall Study|Lost to Follow-up|1|||
144711306|NCT03118765|521799282|FG001|Overall Study|Lost to Follow-up|0|||
144711307|NCT03118765|521799283|FG002|Overall Study|Lost to Follow-up|1|||
144711308|NCT03118765|521799284|FG003|Overall Study|Lost to Follow-up|0|||
144711309|NCT03118765|521799285|FG004|Overall Study|Lost to Follow-up|0|||
144711310|NCT03118765|521799281|FG000|Overall Study|Sponsor Decision|1|||
144711311|NCT03118765|521799282|FG001|Overall Study|Sponsor Decision|0|||
144711312|NCT03118765|521799283|FG002|Overall Study|Sponsor Decision|1|||
144711313|NCT03118765|521799284|FG003|Overall Study|Sponsor Decision|0|||
144711314|NCT03118765|521799285|FG004|Overall Study|Sponsor Decision|1|||
144711315|NCT02164539|521799286|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
144711316|NCT02164539|521799287|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
144711317|NCT02164539|521799288|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
144711318|NCT02164539|521799289|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
144711319|NCT02164539|521799290|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
144711320|NCT02164539|521799291|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
144711321|NCT02164539|521799292|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
144711322|NCT02164539|521799286|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
144711323|NCT02164539|521799287|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
144711324|NCT02164539|521799288|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
144711325|NCT02164539|521799289|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
144711326|NCT02164539|521799290|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
144711327|NCT02164539|521799291|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
144711328|NCT02164539|521799292|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
144711329|NCT02164539|521799286|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
144711330|NCT02164539|521799287|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
144711331|NCT02164539|521799288|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
144711332|NCT02164539|521799289|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
144711333|NCT02164539|521799290|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
144711334|NCT02164539|521799291|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
144711335|NCT02164539|521799292|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
144711336|NCT02164539|521799286|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
144711337|NCT02164539|521799287|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
144711338|NCT02164539|521799288|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
144711339|NCT02164539|521799289|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
144711340|NCT02164539|521799290|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
144711341|NCT02164539|521799291|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
144711342|NCT02164539|521799292|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
144711343|NCT02164539|521799286|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
144711344|NCT02164539|521799287|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
144711345|NCT02164539|521799288|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
144711346|NCT02164539|521799289|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
144711347|NCT02164539|521799290|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
144711348|NCT02164539|521799291|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
144711349|NCT02164539|521799292|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
144711350|NCT02164539|521799286|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
144711351|NCT02164539|521799287|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
144711352|NCT02164539|521799288|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
144711353|NCT02164539|521799289|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
144711354|NCT02164539|521799290|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
144711355|NCT02164539|521799291|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
144711356|NCT02164539|521799292|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
144711357|NCT02643966|521799293|FG000|First Screening Round|ineligible|1|||
144711358|NCT02643966|521799293|FG000|First Screening Round|excluded from analysis|2|||
144711359|NCT02643966|521799293|FG000|First Screening Round|Lost to Follow-up|56|||
144711360|NCT02643966|521799293|FG000|First Screening Round|Withdrawal by Subject|28|||
144711361|NCT02643966|521799293|FG000|First Screening Round|Death|1|||
144711362|NCT02643966|521799293|FG000|Between First and Second Screening|Lost to Follow-up|65|||
144711363|NCT02643966|521799293|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
144711364|NCT02643966|521799293|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
144711365|NCT02643966|521799293|FG000|Second Screening Round|Withdrawal by Subject|20|||
144711366|NCT02643966|521799293|FG000|Second Screening Round|Lost to Follow-up|57|||
144711367|NCT02643966|521799293|FG000|Second Screening Round|Physician Decision|2|||
144711368|NCT02643966|521799293|FG000|Second Screening Round|Death|4|||
144711369|NCT02643966|521799293|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
144711370|NCT02643966|521799293|FG000|Between Second and Third Screening|Death|1|||
144711371|NCT02643966|521799293|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
144711372|NCT02643966|521799293|FG000|Third Screening Round|PI excluded|2|||
144711373|NCT02643966|521799293|FG000|Third Screening Round|Lost to Follow-up|241|||
144711374|NCT01612702|521799294|FG000|Overall Study|Protocol Violation|11|||
144711375|NCT01612702|521799295|FG001|Overall Study|Protocol Violation|11|||
144711376|NCT03636542|521799296|FG000|Overall Study|Lost to Follow-up|1|||
144711377|NCT03636542|521799297|FG001|Overall Study|Lost to Follow-up|1|||
144711378|NCT03636542|521799296|FG000|Overall Study|Physician Decision|0|||
144711379|NCT03636542|521799297|FG001|Overall Study|Physician Decision|1|||
144711380|NCT03636542|521799296|FG000|Overall Study|Withdrawal by Subject|1|||
144711381|NCT03636542|521799297|FG001|Overall Study|Withdrawal by Subject|0|||
144711382|NCT03070431|521799298|FG000|Overall Study|Withdrawal by Subject|2|||
144711383|NCT03070431|521799298|FG000|Overall Study|Lost to Follow-up|2|||
144711384|NCT01542736|521799299|FG000|Overall Study|Death|1|||
144711385|NCT03674827|521799300|FG000|Treatment Phase|Adverse Event|0|||
144711386|NCT03674827|521799301|FG001|Treatment Phase|Adverse Event|0|||
144711387|NCT03674827|521799302|FG002|Treatment Phase|Adverse Event|0|||
144711388|NCT03674827|521799303|FG003|Treatment Phase|Adverse Event|0|||
144711389|NCT03674827|521799304|FG004|Treatment Phase|Adverse Event|0|||
144711390|NCT03674827|521799305|FG005|Treatment Phase|Adverse Event|2|||
144711391|NCT03674827|521799300|FG000|Treatment Phase|Death|2|||
144711392|NCT03674827|521799301|FG001|Treatment Phase|Death|0|||
144711393|NCT03674827|521799302|FG002|Treatment Phase|Death|0|||
144711394|NCT03674827|521799303|FG003|Treatment Phase|Death|0|||
144711395|NCT03674827|521799304|FG004|Treatment Phase|Death|1|||
144711396|NCT03674827|521799305|FG005|Treatment Phase|Death|0|||
144711397|NCT03674827|521799300|FG000|Treatment Phase|Progressive Disease|0|||
144711398|NCT03674827|521799301|FG001|Treatment Phase|Progressive Disease|4|||
144711399|NCT03674827|521799302|FG002|Treatment Phase|Progressive Disease|3|||
144711400|NCT03674827|521799303|FG003|Treatment Phase|Progressive Disease|4|||
144711401|NCT03674827|521799304|FG004|Treatment Phase|Progressive Disease|4|||
144711402|NCT03674827|521799305|FG005|Treatment Phase|Progressive Disease|9|||
144711403|NCT03674827|521799300|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
144711404|NCT03674827|521799301|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
144711405|NCT03674827|521799302|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
144711406|NCT03674827|521799303|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
144711407|NCT03674827|521799304|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
144711408|NCT03674827|521799305|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
144711409|NCT03674827|521799300|FG000|Treatment Phase|Withdrawal by Subject|0|||
144711410|NCT03674827|521799301|FG001|Treatment Phase|Withdrawal by Subject|0|||
144711411|NCT03674827|521799302|FG002|Treatment Phase|Withdrawal by Subject|0|||
144711412|NCT03674827|521799303|FG003|Treatment Phase|Withdrawal by Subject|0|||
144711413|NCT03674827|521799304|FG004|Treatment Phase|Withdrawal by Subject|0|||
144711414|NCT03674827|521799305|FG005|Treatment Phase|Withdrawal by Subject|1|||
144711415|NCT03674827|521799300|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
144711416|NCT03674827|521799301|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
144711417|NCT03674827|521799302|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
144711418|NCT03674827|521799303|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
144711419|NCT03674827|521799304|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
144711420|NCT03674827|521799305|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
144711421|NCT03674827|521799300|FG000|Treatment Phase|Other|0|||
144711422|NCT03674827|521799301|FG001|Treatment Phase|Other|1|||
144711423|NCT03674827|521799302|FG002|Treatment Phase|Other|0|||
144711424|NCT03674827|521799303|FG003|Treatment Phase|Other|0|||
144711425|NCT03674827|521799304|FG004|Treatment Phase|Other|0|||
144711426|NCT03674827|521799305|FG005|Treatment Phase|Other|1|||
144711427|NCT03674827|521799300|FG000|Long-Term Follow-up Phase|Death|2|||
144711428|NCT03674827|521799301|FG001|Long-Term Follow-up Phase|Death|4|||
144711429|NCT03674827|521799302|FG002|Long-Term Follow-up Phase|Death|2|||
144711430|NCT03674827|521799303|FG003|Long-Term Follow-up Phase|Death|3|||
144711431|NCT03674827|521799304|FG004|Long-Term Follow-up Phase|Death|2|||
144711432|NCT03674827|521799305|FG005|Long-Term Follow-up Phase|Death|6|||
144711433|NCT03674827|521799300|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
144711434|NCT03674827|521799301|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
144711435|NCT03674827|521799302|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
144711436|NCT03674827|521799303|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
144711437|NCT03674827|521799304|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
144711438|NCT03674827|521799305|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
144711439|NCT03674827|521799300|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
144711440|NCT03674827|521799301|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
144711441|NCT03674827|521799302|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
144711442|NCT03674827|521799303|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
144711443|NCT03674827|521799304|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
144711444|NCT03674827|521799305|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
144711445|NCT00527397|521799306|FG000|Overall Study|Adverse Event|3|||
144711446|NCT00527397|521799306|FG000|Overall Study|Lack of Efficacy|1|||
144711447|NCT00527397|521799306|FG000|Overall Study|Protocol Violation|1|||
144711448|NCT00527397|521799306|FG000|Overall Study|Withdrawal by Subject|6|||
144711449|NCT00527397|521799306|FG000|Overall Study|Study terminated by sponsor|13|||
144711450|NCT04130919|521799309|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
144711451|NCT04130919|521799310|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
144711452|NCT04130919|521799311|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
144711453|NCT04130919|521799312|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
144711454|NCT04130919|521799313|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
144711455|NCT04130919|521799314|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
144711456|NCT04130919|521799309|FG000|Blinded Treatment Phase|Adverse Event|0|||
144711457|NCT04130919|521799310|FG001|Blinded Treatment Phase|Adverse Event|0|||
144711458|NCT04130919|521799311|FG002|Blinded Treatment Phase|Adverse Event|1|||
144711459|NCT04130919|521799312|FG003|Blinded Treatment Phase|Adverse Event|0|||
144711460|NCT04130919|521799313|FG004|Blinded Treatment Phase|Adverse Event|0|||
144711461|NCT04130919|521799314|FG005|Blinded Treatment Phase|Adverse Event|0|||
144711462|NCT04130919|521799309|FG000|Blinded Treatment Phase|Disease worsening|0|||
144711463|NCT04130919|521799310|FG001|Blinded Treatment Phase|Disease worsening|0|||
144711464|NCT04130919|521799311|FG002|Blinded Treatment Phase|Disease worsening|1|||
144711465|NCT04130919|521799312|FG003|Blinded Treatment Phase|Disease worsening|0|||
144538210|NCT00146172|521174123|FG001|Overall Study|Death|0|||
144711466|NCT04130919|521799313|FG004|Blinded Treatment Phase|Disease worsening|0|||
144711467|NCT04130919|521799314|FG005|Blinded Treatment Phase|Disease worsening|0|||
144711468|NCT04130919|521799309|FG000|Blinded Treatment Phase|Investigator's decision|0|||
144711469|NCT04130919|521799310|FG001|Blinded Treatment Phase|Investigator's decision|1|||
144711470|NCT04130919|521799311|FG002|Blinded Treatment Phase|Investigator's decision|0|||
144711471|NCT04130919|521799312|FG003|Blinded Treatment Phase|Investigator's decision|0|||
144711472|NCT04130919|521799313|FG004|Blinded Treatment Phase|Investigator's decision|0|||
144711473|NCT04130919|521799314|FG005|Blinded Treatment Phase|Investigator's decision|0|||
144711474|NCT04130919|521799309|FG000|Blinded Treatment Phase|Withdrew consent|1|||
144711475|NCT04130919|521799310|FG001|Blinded Treatment Phase|Withdrew consent|0|||
144711476|NCT04130919|521799311|FG002|Blinded Treatment Phase|Withdrew consent|0|||
144711477|NCT04130919|521799312|FG003|Blinded Treatment Phase|Withdrew consent|0|||
144711478|NCT04130919|521799313|FG004|Blinded Treatment Phase|Withdrew consent|0|||
144711479|NCT04130919|521799314|FG005|Blinded Treatment Phase|Withdrew consent|0|||
144711480|NCT04130919|521799309|FG000|Open-label Treatment Phase|Withdrew consent|0|||
144711481|NCT04130919|521799310|FG001|Open-label Treatment Phase|Withdrew consent|0|||
144711482|NCT04130919|521799311|FG002|Open-label Treatment Phase|Withdrew consent|0|||
144711483|NCT04130919|521799312|FG003|Open-label Treatment Phase|Withdrew consent|1|||
144711484|NCT04130919|521799313|FG004|Open-label Treatment Phase|Withdrew consent|1|||
144711485|NCT04130919|521799314|FG005|Open-label Treatment Phase|Withdrew consent|1|||
144711486|NCT04130919|521799309|FG000|Open-label Treatment Phase|Disease worsening|0|||
144711487|NCT04130919|521799310|FG001|Open-label Treatment Phase|Disease worsening|0|||
144711488|NCT04130919|521799311|FG002|Open-label Treatment Phase|Disease worsening|0|||
144711489|NCT04130919|521799312|FG003|Open-label Treatment Phase|Disease worsening|1|||
144711490|NCT04130919|521799313|FG004|Open-label Treatment Phase|Disease worsening|0|||
144711491|NCT04130919|521799314|FG005|Open-label Treatment Phase|Disease worsening|1|||
144711492|NCT04130919|521799309|FG000|Open-label Treatment Phase|Investigator's decision|0|||
144711493|NCT04130919|521799310|FG001|Open-label Treatment Phase|Investigator's decision|0|||
144711494|NCT04130919|521799311|FG002|Open-label Treatment Phase|Investigator's decision|0|||
144711495|NCT04130919|521799312|FG003|Open-label Treatment Phase|Investigator's decision|1|||
144711496|NCT04130919|521799313|FG004|Open-label Treatment Phase|Investigator's decision|0|||
144711497|NCT04130919|521799314|FG005|Open-label Treatment Phase|Investigator's decision|0|||
144711498|NCT04130919|521799309|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
144711499|NCT04130919|521799310|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
144711500|NCT04130919|521799311|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
144711501|NCT04130919|521799312|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
144711502|NCT04130919|521799313|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
144711503|NCT04130919|521799314|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
144711504|NCT04130919|521799309|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
144711505|NCT04130919|521799310|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
144711506|NCT04130919|521799311|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
144711507|NCT04130919|521799312|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
144711508|NCT04130919|521799313|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
144711509|NCT04130919|521799314|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
144711510|NCT02624518|521799315|FG000|Overall Study|Physician Decision|1|||
144711511|NCT02400905|521799316|FG000|Overall Study|Death|24|||
144711512|NCT02400905|521799316|FG000|Overall Study|Lost to Follow-up|18|||
144711513|NCT02400905|521799316|FG000|Overall Study|Withdrawal by Subject|16|||
144711514|NCT02400905|521799316|FG000|Overall Study|Physician Decision|4|||
144711515|NCT02400905|521799316|FG000|Overall Study|Other|1|||
144711516|NCT00061945|521799319|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
144711517|NCT00061945|521799320|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
144711518|NCT00061945|521799319|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
144711519|NCT00061945|521799320|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
144711520|NCT00061945|521799319|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
144711521|NCT00061945|521799320|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
144711522|NCT00061945|521799319|FG000|Course IV: Alemtuzumab|Early exits|6|||
144711523|NCT00061945|521799320|FG001|Course IV: Alemtuzumab|Early exits|15|||
144711524|NCT01039584|521799321|FG000|Overall Study|Withdrawal by Subject|4|||
144711525|NCT01039584|521799322|FG001|Overall Study|Withdrawal by Subject|2|||
144711526|NCT01039584|521799323|FG002|Overall Study|Withdrawal by Subject|1|||
144711527|NCT01039584|521799321|FG000|Overall Study|Protocol Violation|10|||
144711528|NCT01039584|521799322|FG001|Overall Study|Protocol Violation|4|||
144711529|NCT01039584|521799323|FG002|Overall Study|Protocol Violation|6|||
144711530|NCT01039584|521799321|FG000|Overall Study|Lost to Follow-up|5|||
144711531|NCT01039584|521799322|FG001|Overall Study|Lost to Follow-up|3|||
144711532|NCT01039584|521799323|FG002|Overall Study|Lost to Follow-up|4|||
144711533|NCT01039584|521799321|FG000|Overall Study|Negative Baseline culture for Candida|59|||
144711534|NCT01039584|521799322|FG001|Overall Study|Negative Baseline culture for Candida|59|||
144711535|NCT01039584|521799323|FG002|Overall Study|Negative Baseline culture for Candida|24|||
144711536|NCT01039584|521799321|FG000|Overall Study|Lack of Efficacy|7|||
144711537|NCT01039584|521799322|FG001|Overall Study|Lack of Efficacy|6|||
144711538|NCT01039584|521799323|FG002|Overall Study|Lack of Efficacy|10|||
144711539|NCT01039584|521799321|FG000|Overall Study|other|1|||
144711540|NCT01039584|521799322|FG001|Overall Study|other|3|||
144711541|NCT01039584|521799323|FG002|Overall Study|other|1|||
144711542|NCT01039584|521799321|FG000|Overall Study|Pap smear with significant pathology|10|||
144711543|NCT01039584|521799322|FG001|Overall Study|Pap smear with significant pathology|10|||
144711544|NCT01039584|521799323|FG002|Overall Study|Pap smear with significant pathology|3|||
144711545|NCT01039584|521799321|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
144711546|NCT01039584|521799322|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
144711547|NCT01039584|521799323|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
144711548|NCT03672396|521799326|FG000|Overall Study|Withdrawal by Subject|4|||
144711549|NCT03672396|521799326|FG000|Overall Study|Physician Decision|1|||
144711550|NCT03672396|521799326|FG000|Overall Study|Adverse Event|1|||
144711551|NCT03707522|521799329|FG000|Overall Study|Lost to Follow-up|24|||
144711552|NCT03707522|521799330|FG001|Overall Study|Lost to Follow-up|27|||
144711553|NCT03707522|521799331|FG002|Overall Study|Lost to Follow-up|41|||
144711554|NCT03707522|521799332|FG003|Overall Study|Lost to Follow-up|36|||
144711555|NCT03001011|521799333|FG000|Overall Study|Adverse Event|9|||
144711556|NCT03001011|521799334|FG001|Overall Study|Adverse Event|3|||
144711557|NCT03001011|521799333|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
144711558|NCT03001011|521799334|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
144711559|NCT03001011|521799333|FG000|Overall Study|Other than specified above|3|||
144711560|NCT03001011|521799334|FG001|Overall Study|Other than specified above|8|||
144711561|NCT00383019|521799335|FG000|Overall Study|Adverse Event|5|||
144711562|NCT00383019|521799336|FG001|Overall Study|Adverse Event|1|||
144711563|NCT00383019|521799335|FG000|Overall Study|Withdrawal by Subject|0|||
144711564|NCT00383019|521799336|FG001|Overall Study|Withdrawal by Subject|1|||
144711565|NCT02278952|521799337|FG000|Overall Study|Insufficient Sample|6|||
144711566|NCT00217971|521799340|FG000|Overall Study|Adverse Event|1|||
144711567|NCT00217971|521799341|FG001|Overall Study|Adverse Event|1|||
144711568|NCT00217971|521799340|FG000|Overall Study|Lost to Follow-up|15|||
144711569|NCT00217971|521799341|FG001|Overall Study|Lost to Follow-up|19|||
144711570|NCT00217971|521799340|FG000|Overall Study|Physician Decision|0|||
144711571|NCT00217971|521799341|FG001|Overall Study|Physician Decision|1|||
144711572|NCT00217971|521799340|FG000|Overall Study|Withdrawal by Subject|7|||
144711573|NCT00217971|521799341|FG001|Overall Study|Withdrawal by Subject|12|||
144711574|NCT00217971|521799340|FG000|Overall Study|non compliant|1|||
144711575|NCT00217971|521799341|FG001|Overall Study|non compliant|0|||
144711576|NCT02556632|521799342|FG000|Overall Study|Lost to Follow-up|1|||
144711577|NCT02556632|521799343|FG001|Overall Study|Lost to Follow-up|0|||
144711578|NCT02556632|521799344|FG002|Overall Study|Lost to Follow-up|0|||
144711579|NCT02556632|521799342|FG000|Overall Study|Disliked Intervention|1|||
144711580|NCT02556632|521799343|FG001|Overall Study|Disliked Intervention|1|||
144711581|NCT02556632|521799344|FG002|Overall Study|Disliked Intervention|1|||
144711582|NCT02556632|521799342|FG000|Overall Study|No Reason|1|||
144711583|NCT02556632|521799343|FG001|Overall Study|No Reason|0|||
144711584|NCT02556632|521799344|FG002|Overall Study|No Reason|1|||
144711585|NCT02556632|521799342|FG000|Overall Study|Personal Issues|0|||
144711586|NCT02556632|521799343|FG001|Overall Study|Personal Issues|1|||
144711587|NCT02556632|521799344|FG002|Overall Study|Personal Issues|1|||
144711588|NCT02556632|521799342|FG000|Overall Study|Changed Mind|0|||
144711589|NCT02556632|521799343|FG001|Overall Study|Changed Mind|1|||
144711590|NCT02556632|521799344|FG002|Overall Study|Changed Mind|0|||
144711591|NCT02556632|521799342|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
144711592|NCT02556632|521799343|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
144711593|NCT02556632|521799344|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
144711594|NCT02556632|521799342|FG000|Overall Study|Unrelated Adverse Event|1|||
144711595|NCT02556632|521799343|FG001|Overall Study|Unrelated Adverse Event|0|||
144711596|NCT02556632|521799344|FG002|Overall Study|Unrelated Adverse Event|3|||
144711597|NCT02556632|521799342|FG000|Overall Study|Related Adverse Event|0|||
144711598|NCT02556632|521799343|FG001|Overall Study|Related Adverse Event|1|||
144711599|NCT02556632|521799344|FG002|Overall Study|Related Adverse Event|0|||
144711600|NCT02556632|521799342|FG000|Overall Study|Possibly Related Adverse Event|0|||
144711601|NCT02556632|521799343|FG001|Overall Study|Possibly Related Adverse Event|0|||
144711602|NCT02556632|521799344|FG002|Overall Study|Possibly Related Adverse Event|1|||
144711603|NCT02556632|521799342|FG000|Overall Study|Did Not Start RT|0|||
144711604|NCT02556632|521799343|FG001|Overall Study|Did Not Start RT|1|||
144711605|NCT02556632|521799344|FG002|Overall Study|Did Not Start RT|0|||
144711606|NCT02556632|521799342|FG000|Overall Study|Ineligible|0|||
144711607|NCT02556632|521799343|FG001|Overall Study|Ineligible|1|||
144711608|NCT02556632|521799344|FG002|Overall Study|Ineligible|0|||
144711609|NCT02556632|521799342|FG000|Overall Study|Disliked Study Procedures|0|||
144711610|NCT02556632|521799343|FG001|Overall Study|Disliked Study Procedures|0|||
144711611|NCT02556632|521799344|FG002|Overall Study|Disliked Study Procedures|1|||
144711612|NCT02556632|521799342|FG000|Overall Study|Treatment or Change Delay|0|||
144538211|NCT00146172|521174124|FG002|Overall Study|Death|0|||
144711613|NCT02556632|521799343|FG001|Overall Study|Treatment or Change Delay|0|||
144711614|NCT02556632|521799344|FG002|Overall Study|Treatment or Change Delay|1|||
144711615|NCT00808015|521799345|FG000|Overall Study|Death|1|||
144711616|NCT00808015|521799345|FG000|Overall Study|Lack of Efficacy|58|||
144711617|NCT00808015|521799345|FG000|Overall Study|Lost to Follow-up|76|||
144711618|NCT00808015|521799345|FG000|Overall Study|Participants not willing to participate|158|||
144711619|NCT00808015|521799345|FG000|Overall Study|Adverse Event|22|||
144711620|NCT00808015|521799345|FG000|Overall Study|Other|25|||
144711621|NCT00808015|521799345|FG000|Overall Study|Enrolled but not treated|4|||
144711622|NCT03338673|521799348|FG000|Overall Study|Lost to Follow-up|1|||
144711623|NCT03338673|521799349|FG001|Overall Study|Lost to Follow-up|1|||
144711624|NCT04523831|521799354|FG000|Overall Study|Lost to Follow-up|15|||
144711625|NCT04523831|521799355|FG001|Overall Study|Lost to Follow-up|17|||
144711626|NCT04523831|521799354|FG000|Overall Study|Death|0|||
144711627|NCT04523831|521799355|FG001|Overall Study|Death|3|||
144711628|NCT04523831|521799354|FG000|Overall Study|Adverse Event|2|||
144711629|NCT04523831|521799355|FG001|Overall Study|Adverse Event|0|||
144711630|NCT04556838|521799356|FG000|Overall Study|Withdrawal by Subject|3|||
144711631|NCT04556838|521799357|FG001|Overall Study|Withdrawal by Subject|1|||
144711632|NCT04556838|521799358|FG002|Overall Study|Withdrawal by Subject|2|||
144711633|NCT04556838|521799356|FG000|Overall Study|Adverse Event|0|||
144711634|NCT04556838|521799357|FG001|Overall Study|Adverse Event|1|||
144711635|NCT04556838|521799358|FG002|Overall Study|Adverse Event|1|||
144711636|NCT04556838|521799356|FG000|Overall Study|Lost to Follow-up|0|||
144711637|NCT04556838|521799357|FG001|Overall Study|Lost to Follow-up|0|||
144711638|NCT04556838|521799358|FG002|Overall Study|Lost to Follow-up|2|||
144711639|NCT04556838|521799356|FG000|Overall Study|Subject travel|0|||
144711640|NCT04556838|521799357|FG001|Overall Study|Subject travel|1|||
144711641|NCT04556838|521799358|FG002|Overall Study|Subject travel|0|||
144711642|NCT04556838|521799356|FG000|Overall Study|Physician Decision|1|||
144711643|NCT04556838|521799357|FG001|Overall Study|Physician Decision|0|||
144711644|NCT04556838|521799358|FG002|Overall Study|Physician Decision|0|||
144711645|NCT03033069|521799359|FG000|Overall Study|Adverse Event|6|||
144711646|NCT03033069|521799360|FG001|Overall Study|Adverse Event|7|||
144711647|NCT03033069|521799361|FG002|Overall Study|Adverse Event|4|||
144711648|NCT03033069|521799362|FG003|Overall Study|Adverse Event|6|||
144711649|NCT03033069|521799359|FG000|Overall Study|Lack of Efficacy|0|||
144711650|NCT03033069|521799360|FG001|Overall Study|Lack of Efficacy|0|||
144711651|NCT03033069|521799361|FG002|Overall Study|Lack of Efficacy|1|||
144711652|NCT03033069|521799362|FG003|Overall Study|Lack of Efficacy|0|||
144711653|NCT03033069|521799359|FG000|Overall Study|Lost to Follow-up|6|||
144711654|NCT03033069|521799360|FG001|Overall Study|Lost to Follow-up|5|||
144711655|NCT03033069|521799361|FG002|Overall Study|Lost to Follow-up|5|||
144711656|NCT03033069|521799362|FG003|Overall Study|Lost to Follow-up|6|||
144711657|NCT03033069|521799359|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144711658|NCT03033069|521799360|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144711659|NCT03033069|521799361|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144711660|NCT03033069|521799362|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144711661|NCT03033069|521799359|FG000|Overall Study|Protocol Deviation|0|||
144711662|NCT03033069|521799360|FG001|Overall Study|Protocol Deviation|1|||
144711663|NCT03033069|521799361|FG002|Overall Study|Protocol Deviation|0|||
144711664|NCT03033069|521799362|FG003|Overall Study|Protocol Deviation|0|||
144711665|NCT03033069|521799359|FG000|Overall Study|Withdrawal by Subject|10|||
144711666|NCT03033069|521799360|FG001|Overall Study|Withdrawal by Subject|10|||
144711667|NCT03033069|521799361|FG002|Overall Study|Withdrawal by Subject|11|||
144711668|NCT03033069|521799362|FG003|Overall Study|Withdrawal by Subject|6|||
144711669|NCT03033069|521799359|FG000|Overall Study|Withdrawal By Caregiver|1|||
144711670|NCT03033069|521799360|FG001|Overall Study|Withdrawal By Caregiver|0|||
144711671|NCT03033069|521799361|FG002|Overall Study|Withdrawal By Caregiver|0|||
144711672|NCT03033069|521799362|FG003|Overall Study|Withdrawal By Caregiver|0|||
144711673|NCT03033069|521799359|FG000|Overall Study|Reason not Specified|0|||
144711674|NCT03033069|521799360|FG001|Overall Study|Reason not Specified|1|||
144711675|NCT03033069|521799361|FG002|Overall Study|Reason not Specified|0|||
144711676|NCT03033069|521799362|FG003|Overall Study|Reason not Specified|1|||
144711677|NCT02623426|521799363|FG000|Overall Study|Lost to Follow-up|0|||
144711678|NCT02623426|521799364|FG001|Overall Study|Lost to Follow-up|0|||
144711679|NCT02623426|521799365|FG002|Overall Study|Lost to Follow-up|1|||
144711680|NCT02623426|521799363|FG000|Overall Study|Withdrawal by Subject|1|||
144480931|NCT03176238|520959346|FG000|Overall Study|Patient is switched to commercial drug|16|||
144711681|NCT02623426|521799364|FG001|Overall Study|Withdrawal by Subject|2|||
144711682|NCT02623426|521799365|FG002|Overall Study|Withdrawal by Subject|2|||
144711683|NCT03751124|521799366|FG000|Overall Study|Adverse Event|4|||
144711684|NCT03751124|521799367|FG001|Overall Study|Adverse Event|3|||
144711685|NCT03751124|521799366|FG000|Overall Study|Protocol Deviation|0|||
144711686|NCT03751124|521799367|FG001|Overall Study|Protocol Deviation|1|||
144711687|NCT03751124|521799366|FG000|Overall Study|Lost to Follow-up|6|||
144711688|NCT03751124|521799367|FG001|Overall Study|Lost to Follow-up|4|||
144711689|NCT03751124|521799366|FG000|Overall Study|Withdrawal by Subject|6|||
144711690|NCT03751124|521799367|FG001|Overall Study|Withdrawal by Subject|8|||
144711691|NCT03751124|521799366|FG000|Overall Study|Lack of Efficacy|1|||
144711692|NCT03751124|521799367|FG001|Overall Study|Lack of Efficacy|1|||
144711693|NCT03751124|521799366|FG000|Overall Study|Pregnancy|0|||
144711694|NCT03751124|521799367|FG001|Overall Study|Pregnancy|1|||
144711695|NCT03751124|521799366|FG000|Overall Study|Other|9|||
144711696|NCT03751124|521799367|FG001|Overall Study|Other|9|||
144711697|NCT03751124|521799366|FG000|Overall Study|Participants who did not receive any study drug|0|||
144711698|NCT03751124|521799367|FG001|Overall Study|Participants who did not receive any study drug|1|||
144711699|NCT00555399|521799378|FG000|Overall Study|Withdrawal by Subject|0|||
144711700|NCT00555399|521799379|FG001|Overall Study|Withdrawal by Subject|0|||
144711701|NCT00555399|521799380|FG002|Overall Study|Withdrawal by Subject|1|||
144711702|NCT00555399|521799381|FG003|Overall Study|Withdrawal by Subject|0|||
144711703|NCT00555399|521799382|FG004|Overall Study|Withdrawal by Subject|0|||
144711704|NCT00555399|521799383|FG005|Overall Study|Withdrawal by Subject|0|||
144711705|NCT00555399|521799384|FG006|Overall Study|Withdrawal by Subject|0|||
144711706|NCT00555399|521799385|FG007|Overall Study|Withdrawal by Subject|0|||
144711707|NCT00555399|521799386|FG008|Overall Study|Withdrawal by Subject|0|||
144711708|NCT00555399|521799387|FG009|Overall Study|Withdrawal by Subject|0|||
144711709|NCT00555399|521799388|FG010|Overall Study|Withdrawal by Subject|0|||
144711710|NCT00555399|521799389|FG011|Overall Study|Withdrawal by Subject|1|||
144711711|NCT00555399|521799378|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
144711712|NCT00555399|521799379|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
144711713|NCT00555399|521799380|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
144711714|NCT00555399|521799381|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
144711715|NCT00555399|521799382|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
144711716|NCT00555399|521799383|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
144711717|NCT00555399|521799384|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
144711718|NCT00555399|521799385|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
144711719|NCT00555399|521799386|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
144711720|NCT00555399|521799387|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
144711721|NCT00555399|521799388|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
144711722|NCT00555399|521799389|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
144711723|NCT05458895|521799390|FG000|Overall Study|Withdrawal by Subject|8|||
144711724|NCT05458895|521799390|FG000|Overall Study|Lost to Follow-up|17|||
144711725|NCT05458895|521799390|FG000|Overall Study|Pregnancy|2|||
144711726|NCT05458895|521799390|FG000|Overall Study|Withdrawal by Study Team|1|||
144711727|NCT04639310|521799391|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
144711728|NCT04639310|521799392|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
144711729|NCT03053622|521801322|FG000|Overall Study|Lost to Follow-up|0|||
144711730|NCT03053622|521801323|FG001|Overall Study|Lost to Follow-up|0|||
144711731|NCT03053622|521801324|FG002|Overall Study|Lost to Follow-up|0|||
144711732|NCT03053622|521801325|FG003|Overall Study|Lost to Follow-up|1|||
144711733|NCT01416142|521801326|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
144711734|NCT01416142|521801327|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
144711735|NCT01416142|521801328|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
144711736|NCT00678379|521801329|FG000|Overall Study|Injection performed after tonsillectomy|2|||
144711737|NCT00678379|521801330|FG001|Overall Study|Injection performed after tonsillectomy|0|||
144711738|NCT00678379|521801331|FG002|Overall Study|Injection performed after tonsillectomy|1|||
144711739|NCT00678379|521801329|FG000|Overall Study|Incomplete Data|4|||
144711740|NCT00678379|521801330|FG001|Overall Study|Incomplete Data|3|||
144711741|NCT00678379|521801331|FG002|Overall Study|Incomplete Data|3|||
144711742|NCT00736099|521801345|FG000|Overall Study|Adverse Event|61|||
144711743|NCT00736099|521801346|FG001|Overall Study|Adverse Event|18|||
144711744|NCT00736099|521801345|FG000|Overall Study|Protocol Violation|10|||
144711745|NCT00736099|521801346|FG001|Overall Study|Protocol Violation|4|||
144711746|NCT00736099|521801345|FG000|Overall Study|Lost to Follow-up|12|||
144368367|NCT03584789|520559829|FG002|Overall Study|refused EHR permission|23|||
144368368|NCT03584789|520559827|FG000|Overall Study|patients tied to a provider who retired|0|||
144368369|NCT03584789|520559828|FG001|Overall Study|patients tied to a provider who retired|0|||
144368370|NCT03584789|520559829|FG002|Overall Study|patients tied to a provider who retired|3|||
144368371|NCT02035267|520559830|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
144368372|NCT02035267|520559831|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
144368373|NCT02035267|520559832|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
144368374|NCT02035267|520559833|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
144711747|NCT00736099|521801346|FG001|Overall Study|Lost to Follow-up|5|||
144711748|NCT00736099|521801345|FG000|Overall Study|Withdrawal by Subject|42|||
144711749|NCT00736099|521801346|FG001|Overall Study|Withdrawal by Subject|13|||
144711750|NCT00736099|521801345|FG000|Overall Study|Lack of Efficacy|15|||
144711751|NCT00736099|521801346|FG001|Overall Study|Lack of Efficacy|8|||
144368375|NCT02035267|520559830|FG000|Overall Study|Adverse Event|0|||
144711752|NCT00736099|521801345|FG000|Overall Study|Other reason|43|||
144711753|NCT00736099|521801346|FG001|Overall Study|Other reason|10|||
144368376|NCT02035267|520559831|FG001|Overall Study|Adverse Event|0|||
144368377|NCT02035267|520559832|FG002|Overall Study|Adverse Event|1|||
144368378|NCT02035267|520559833|FG003|Overall Study|Adverse Event|0|||
144368379|NCT02035267|520559830|FG000|Overall Study|Lost to Follow-up|0|||
144368380|NCT02035267|520559831|FG001|Overall Study|Lost to Follow-up|0|||
144368381|NCT02035267|520559832|FG002|Overall Study|Lost to Follow-up|0|||
144368382|NCT02035267|520559833|FG003|Overall Study|Lost to Follow-up|1|||
144368383|NCT02035267|520559830|FG000|Overall Study|Other unspecified|0|||
144368384|NCT02035267|520559831|FG001|Overall Study|Other unspecified|1|||
144368385|NCT02035267|520559832|FG002|Overall Study|Other unspecified|0|||
144368386|NCT02035267|520559833|FG003|Overall Study|Other unspecified|0|||
144368387|NCT00602472|520559834|FG000|Overall Study|Adverse Event|5|||
144368388|NCT00602472|520559835|FG001|Overall Study|Adverse Event|23|||
144368389|NCT00602472|520559834|FG000|Overall Study|Protocol Violation|4|||
144368390|NCT00602472|520559835|FG001|Overall Study|Protocol Violation|19|||
144368391|NCT00602472|520559834|FG000|Overall Study|Withdrawal by Subject|8|||
144368392|NCT00602472|520559835|FG001|Overall Study|Withdrawal by Subject|14|||
144368393|NCT00602472|520559834|FG000|Overall Study|Other incl. lack of efficacy|4|||
144368394|NCT00602472|520559835|FG001|Overall Study|Other incl. lack of efficacy|2|||
144368395|NCT00098813|520559842|FG000|Overall Study|Death|8|||
144368396|NCT00098813|520559842|FG000|Overall Study|Protocol Violation|1|||
144368397|NCT00098813|520559842|FG000|Overall Study|Withdrawal by Subject|7|||
144368398|NCT00098813|520559842|FG000|Overall Study|Progression of Disease|1|||
144368399|NCT00098813|520559842|FG000|Overall Study|Other complicating disease|1|||
144368400|NCT00098813|520559842|FG000|Overall Study|Reversal of RAI resistance|1|||
144368401|NCT03926611|520559843|FG000|Overall Study|Adverse Event|0|||
144368402|NCT03926611|520559844|FG001|Overall Study|Adverse Event|0|||
144368403|NCT03926611|520559845|FG002|Overall Study|Adverse Event|0|||
144368404|NCT03926611|520559846|FG003|Overall Study|Adverse Event|3|||
144368405|NCT03926611|520559847|FG004|Overall Study|Adverse Event|1|||
144368406|NCT03926611|520559848|FG005|Overall Study|Adverse Event|3|||
144368407|NCT03926611|520559849|FG006|Overall Study|Adverse Event|0|||
144368408|NCT03926611|520559843|FG000|Overall Study|Lack of Efficacy|1|||
144368409|NCT03926611|520559844|FG001|Overall Study|Lack of Efficacy|2|||
144368410|NCT03926611|520559845|FG002|Overall Study|Lack of Efficacy|0|||
144368411|NCT03926611|520559846|FG003|Overall Study|Lack of Efficacy|0|||
144368412|NCT03926611|520559847|FG004|Overall Study|Lack of Efficacy|1|||
144368413|NCT03926611|520559848|FG005|Overall Study|Lack of Efficacy|0|||
144368414|NCT03926611|520559849|FG006|Overall Study|Lack of Efficacy|1|||
144368415|NCT03926611|520559843|FG000|Overall Study|Physician Decision|0|||
144368416|NCT03926611|520559844|FG001|Overall Study|Physician Decision|0|||
144368417|NCT03926611|520559845|FG002|Overall Study|Physician Decision|0|||
144368418|NCT03926611|520559846|FG003|Overall Study|Physician Decision|0|||
144368419|NCT03926611|520559847|FG004|Overall Study|Physician Decision|0|||
144368420|NCT03926611|520559848|FG005|Overall Study|Physician Decision|1|||
144368421|NCT03926611|520559849|FG006|Overall Study|Physician Decision|0|||
144368422|NCT03926611|520559843|FG000|Overall Study|Protocol Violation|1|||
144368423|NCT03926611|520559844|FG001|Overall Study|Protocol Violation|0|||
144368424|NCT03926611|520559845|FG002|Overall Study|Protocol Violation|0|||
144368425|NCT03926611|520559846|FG003|Overall Study|Protocol Violation|1|||
144368426|NCT03926611|520559847|FG004|Overall Study|Protocol Violation|1|||
144368427|NCT03926611|520559848|FG005|Overall Study|Protocol Violation|1|||
144368428|NCT03926611|520559849|FG006|Overall Study|Protocol Violation|1|||
144368429|NCT03926611|520559843|FG000|Overall Study|Technical problems|0|||
144368430|NCT03926611|520559844|FG001|Overall Study|Technical problems|0|||
144538212|NCT00146172|521174125|FG003|Overall Study|Death|0|||
144368431|NCT03926611|520559845|FG002|Overall Study|Technical problems|0|||
144368432|NCT03926611|520559846|FG003|Overall Study|Technical problems|0|||
144368433|NCT03926611|520559847|FG004|Overall Study|Technical problems|0|||
144368434|NCT03926611|520559848|FG005|Overall Study|Technical problems|1|||
144368435|NCT03926611|520559849|FG006|Overall Study|Technical problems|0|||
144368436|NCT03926611|520559843|FG000|Overall Study|Withdrawal by Subject|1|||
144368437|NCT03926611|520559844|FG001|Overall Study|Withdrawal by Subject|1|||
144368438|NCT03926611|520559845|FG002|Overall Study|Withdrawal by Subject|1|||
144368439|NCT03926611|520559846|FG003|Overall Study|Withdrawal by Subject|0|||
144368440|NCT03926611|520559847|FG004|Overall Study|Withdrawal by Subject|0|||
144711754|NCT04006847|521801349|FG000|Overall Study|Product issue|1|||
144711755|NCT03862625|521801359|FG000|Overall Study|Lost to Follow-up|0|||
144711756|NCT03862625|521801360|FG001|Overall Study|Lost to Follow-up|1|||
144711757|NCT01814761|521801361|FG000|Overall Study|Other Reasons|1|||
144711758|NCT01814761|521801362|FG001|Overall Study|Other Reasons|10|||
144711759|NCT01814761|521801361|FG000|Overall Study|Ocular Adverse Event|6|||
144711760|NCT01814761|521801362|FG001|Overall Study|Ocular Adverse Event|15|||
144711761|NCT01814761|521801361|FG000|Overall Study|Lost to Follow-up|1|||
144711762|NCT01814761|521801362|FG001|Overall Study|Lost to Follow-up|5|||
144711763|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
144711764|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
144711765|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
144711766|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
144711767|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
144711768|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
144711769|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
144711770|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
144711771|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
144711772|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
144711773|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
144711774|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
144711775|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
144711776|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
144711777|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
144711778|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
144711779|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
144711780|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
144711781|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
144711782|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
144711783|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
144711784|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
144711785|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
144711786|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
144711787|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
144711788|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
144711789|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
144711790|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
144711791|NCT01872689|521801363|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
144711792|NCT01872689|521801364|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
144711793|NCT01872689|521801365|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
144711794|NCT01872689|521801366|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
144711795|NCT01872689|521801363|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
144711796|NCT01872689|521801364|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
144711797|NCT01872689|521801365|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
144711798|NCT01872689|521801366|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
144711799|NCT01872689|521801363|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
144711800|NCT01872689|521801364|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
144711801|NCT01872689|521801365|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
144711802|NCT01872689|521801366|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
144711803|NCT01872689|521801363|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
144711804|NCT01872689|521801364|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
144711805|NCT01872689|521801365|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
144711806|NCT01872689|521801366|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
144711807|NCT01872689|521801363|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
144711808|NCT01872689|521801364|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
144711809|NCT01872689|521801365|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
144711810|NCT01872689|521801366|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
144711811|NCT01872689|521801363|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
144711812|NCT01872689|521801364|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
144711813|NCT01872689|521801365|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
144711814|NCT01872689|521801366|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
144711815|NCT01872689|521801363|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
144711816|NCT01872689|521801364|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
144711817|NCT01872689|521801365|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
144711818|NCT01872689|521801366|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
144711819|NCT01070966|521801370|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
144711820|NCT01070966|521801370|FG000|Participants for Safety Evaluation|Off-label use|9|||
144711821|NCT01070966|521801370|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
144711822|NCT01070966|521801370|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
144711823|NCT01070966|521801370|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
144711824|NCT01070966|521801370|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
144711825|NCT01070966|521801370|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
144711826|NCT01070966|521801370|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
144711827|NCT01415921|521801373|FG000|Overall Study|Adverse Event|0|||
144711828|NCT01415921|521801374|FG001|Overall Study|Adverse Event|1|||
144711829|NCT01415921|521801373|FG000|Overall Study|Physician Decision|1|||
144711830|NCT01415921|521801374|FG001|Overall Study|Physician Decision|1|||
144711831|NCT01415921|521801373|FG000|Overall Study|Withdrawal by Subject|0|||
144711832|NCT01415921|521801374|FG001|Overall Study|Withdrawal by Subject|1|||
144711833|NCT01415921|521801373|FG000|Overall Study|Other|2|||
144711834|NCT01415921|521801374|FG001|Overall Study|Other|0|||
144711835|NCT01244815|521801375|FG000|Overall Study|Not Treated|0|||
144711836|NCT01244815|521801376|FG001|Overall Study|Not Treated|1|||
144711837|NCT01244815|521801377|FG002|Overall Study|Not Treated|0|||
144711838|NCT01244815|521801378|FG003|Overall Study|Not Treated|0|||
144711839|NCT01244815|521801375|FG000|Overall Study|Adverse Event|4|||
144711840|NCT01244815|521801376|FG001|Overall Study|Adverse Event|7|||
144711841|NCT01244815|521801377|FG002|Overall Study|Adverse Event|5|||
144711842|NCT01244815|521801378|FG003|Overall Study|Adverse Event|5|||
144711843|NCT01244815|521801375|FG000|Overall Study|Treatment Failure|0|||
144711844|NCT01244815|521801376|FG001|Overall Study|Treatment Failure|0|||
144711845|NCT01244815|521801377|FG002|Overall Study|Treatment Failure|0|||
144711846|NCT01244815|521801378|FG003|Overall Study|Treatment Failure|1|||
144711847|NCT01244815|521801375|FG000|Overall Study|Lost to Follow-up|3|||
144711848|NCT01244815|521801376|FG001|Overall Study|Lost to Follow-up|2|||
144711849|NCT01244815|521801377|FG002|Overall Study|Lost to Follow-up|3|||
144711850|NCT01244815|521801378|FG003|Overall Study|Lost to Follow-up|2|||
144711851|NCT01244815|521801375|FG000|Overall Study|Withdrawal by Subject|0|||
144711852|NCT01244815|521801376|FG001|Overall Study|Withdrawal by Subject|2|||
144711853|NCT01244815|521801377|FG002|Overall Study|Withdrawal by Subject|0|||
144711854|NCT01244815|521801378|FG003|Overall Study|Withdrawal by Subject|3|||
144711855|NCT01244815|521801375|FG000|Overall Study|Protocol Violation|7|||
144711856|NCT01244815|521801376|FG001|Overall Study|Protocol Violation|4|||
144711857|NCT01244815|521801377|FG002|Overall Study|Protocol Violation|3|||
144711858|NCT01244815|521801378|FG003|Overall Study|Protocol Violation|1|||
144711859|NCT01244815|521801375|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
144711860|NCT01244815|521801376|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
144711861|NCT01244815|521801377|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
144711862|NCT01244815|521801378|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
144711863|NCT01808209|521801380|FG000|Overall Study|Lost to Follow-up|0|||
144711864|NCT01808209|521801381|FG001|Overall Study|Lost to Follow-up|1|||
144711865|NCT04991311|521801384|FG000|Overall Study|Adverse Event|1|||
144711866|NCT03876873|521801387|FG000|Overall Study|Physician Decision|0|||
144711867|NCT03876873|521801388|FG001|Overall Study|Physician Decision|1|||
144711868|NCT02117479|521801390|FG000|Overall Study|Death|13|||
144711869|NCT02117479|521801391|FG001|Overall Study|Death|8|||
144711870|NCT02117479|521801390|FG000|Overall Study|Adverse Event|8|||
144711871|NCT02117479|521801391|FG001|Overall Study|Adverse Event|16|||
144711872|NCT02117479|521801390|FG000|Overall Study|Subject decision|8|||
144711873|NCT02117479|521801391|FG001|Overall Study|Subject decision|9|||
144711874|NCT02117479|521801390|FG000|Overall Study|Disease progression|104|||
144711875|NCT02117479|521801391|FG001|Overall Study|Disease progression|108|||
144711876|NCT02117479|521801390|FG000|Overall Study|Noncompliance with study treatment|1|||
144711877|NCT02117479|521801391|FG001|Overall Study|Noncompliance with study treatment|0|||
144711878|NCT02117479|521801390|FG000|Overall Study|Study terminated by the sponsor|4|||
144711879|NCT02117479|521801391|FG001|Overall Study|Study terminated by the sponsor|6|||
144711880|NCT02117479|521801390|FG000|Overall Study|Physician Decision|7|||
144711881|NCT02117479|521801391|FG001|Overall Study|Physician Decision|2|||
144711882|NCT02117479|521801390|FG000|Overall Study|Other unspecified|11|||
144711883|NCT02117479|521801391|FG001|Overall Study|Other unspecified|7|||
144711884|NCT02629133|521801395|FG000|Overall Study|Lost to Follow-up|3|||
144711885|NCT02629133|521801396|FG001|Overall Study|Lost to Follow-up|1|||
144711886|NCT02629133|521801395|FG000|Overall Study|Withdrawal by Subject|1|||
144711887|NCT02629133|521801396|FG001|Overall Study|Withdrawal by Subject|1|||
144711888|NCT01223196|521801397|FG000|Overall Study|Lost to Follow-up|2|||
144711889|NCT01223196|521801398|FG001|Overall Study|Lost to Follow-up|0|||
144711890|NCT01223196|521801397|FG000|Overall Study|Physician Decision|1|||
144711891|NCT01223196|521801398|FG001|Overall Study|Physician Decision|0|||
144711892|NCT01223196|521801397|FG000|Overall Study|Withdrawal by Subject|1|||
144711893|NCT01223196|521801398|FG001|Overall Study|Withdrawal by Subject|0|||
144711894|NCT03216954|521801399|FG000|Overall Study|Adverse Event|0|||
144711895|NCT03216954|521801400|FG001|Overall Study|Adverse Event|0|||
144711896|NCT03216954|521801401|FG002|Overall Study|Adverse Event|1|||
144711897|NCT03216954|521801402|FG003|Overall Study|Adverse Event|0|||
144711898|NCT03216954|521801403|FG004|Overall Study|Adverse Event|1|||
144711899|NCT03216954|521801399|FG000|Overall Study|Withdrawal by Subject|2|||
144711900|NCT03216954|521801400|FG001|Overall Study|Withdrawal by Subject|0|||
144711901|NCT03216954|521801401|FG002|Overall Study|Withdrawal by Subject|0|||
144711902|NCT03216954|521801402|FG003|Overall Study|Withdrawal by Subject|0|||
144711903|NCT03216954|521801403|FG004|Overall Study|Withdrawal by Subject|0|||
144711904|NCT03216954|521801399|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
144711905|NCT03216954|521801400|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
144711906|NCT03216954|521801401|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
144711907|NCT03216954|521801402|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
144711908|NCT03216954|521801403|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
144711909|NCT05180630|521801404|FG000|First Intervention|Physician Decision|0|||
144711910|NCT05180630|521801405|FG001|First Intervention|Physician Decision|0|||
144711911|NCT05180630|521801406|FG002|First Intervention|Physician Decision|3|||
144711912|NCT00447694|521801409|FG000|Overall Study|Adverse Event|2|||
144711913|NCT00447694|521801409|FG000|Overall Study|Abnormal laboratory value|1|||
144711914|NCT00447694|521801409|FG000|Overall Study|Abnormal test procedure result|1|||
144711915|NCT00447694|521801409|FG000|Overall Study|Withdrawal by Subject|2|||
144711916|NCT00709735|521801410|FG000|Overall Study|Lost to Follow-up|1|||
144711917|NCT00709735|521801411|FG001|Overall Study|Lost to Follow-up|1|||
144711918|NCT00709735|521801410|FG000|Overall Study|Relapse into Opioid Abuse|0|||
144711919|NCT00709735|521801411|FG001|Overall Study|Relapse into Opioid Abuse|1|||
144711920|NCT00709735|521801410|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
144711921|NCT00709735|521801411|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
144711922|NCT01169987|521801412|FG000|Overall Study|Withdrawal by Subject|3|||
144711923|NCT01169987|521801412|FG000|Overall Study|Lost to Follow-up|24|||
144711924|NCT01169987|521801412|FG000|Overall Study|Other|4|||
144711925|NCT00829439|521801413|FG000|Overall Study|Adverse Event|0|||
144711926|NCT00829439|521801414|FG001|Overall Study|Adverse Event|0|||
144711927|NCT00829439|521801415|FG002|Overall Study|Adverse Event|1|||
144711928|NCT00829439|521801416|FG003|Overall Study|Adverse Event|0|||
144711929|NCT00386100|521801417|FG000|Overall Study|Did not receive study medication|6|||
144711930|NCT00386100|521801418|FG001|Overall Study|Did not receive study medication|4|||
144711931|NCT00386100|521801417|FG000|Overall Study|Adverse Event|15|||
144711932|NCT00386100|521801418|FG001|Overall Study|Adverse Event|25|||
144711933|NCT00386100|521801417|FG000|Overall Study|Death|0|||
144711934|NCT00386100|521801418|FG001|Overall Study|Death|1|||
144711935|NCT00386100|521801417|FG000|Overall Study|Insufficient therapeutic effect|30|||
144711936|NCT00386100|521801418|FG001|Overall Study|Insufficient therapeutic effect|6|||
144711937|NCT00386100|521801417|FG000|Overall Study|Lost to Follow-up|29|||
144711938|NCT00386100|521801418|FG001|Overall Study|Lost to Follow-up|29|||
144711939|NCT00386100|521801417|FG000|Overall Study|Non-compliance|18|||
144711940|NCT00386100|521801418|FG001|Overall Study|Non-compliance|19|||
144711941|NCT00386100|521801417|FG000|Overall Study|Protocol Violation|5|||
144711942|NCT00386100|521801418|FG001|Overall Study|Protocol Violation|3|||
144711943|NCT00386100|521801417|FG000|Overall Study|Withdrawal by Subject|32|||
144711944|NCT00386100|521801418|FG001|Overall Study|Withdrawal by Subject|31|||
144711945|NCT00386100|521801417|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
144711946|NCT00386100|521801418|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
144711947|NCT00386100|521801417|FG000|Overall Study|BMD <2.5|1|||
144711948|NCT00386100|521801418|FG001|Overall Study|BMD <2.5|0|||
144711949|NCT00386100|521801417|FG000|Overall Study|Consecutive elevated Hba1C|1|||
144368441|NCT03926611|520559848|FG005|Overall Study|Withdrawal by Subject|1|||
144368442|NCT03926611|520559849|FG006|Overall Study|Withdrawal by Subject|3|||
144368443|NCT03926611|520559843|FG000|Overall Study|Covid-19 pandemic|0|||
144368444|NCT03926611|520559844|FG001|Overall Study|Covid-19 pandemic|0|||
144368445|NCT03926611|520559845|FG002|Overall Study|Covid-19 pandemic|1|||
144368446|NCT03926611|520559846|FG003|Overall Study|Covid-19 pandemic|0|||
144368447|NCT03926611|520559847|FG004|Overall Study|Covid-19 pandemic|1|||
144368448|NCT03926611|520559848|FG005|Overall Study|Covid-19 pandemic|2|||
144368449|NCT03926611|520559849|FG006|Overall Study|Covid-19 pandemic|0|||
144368450|NCT02215252|520559850|FG000|Overall Study|Adverse Event|1|||
144368451|NCT02215252|520559851|FG001|Overall Study|Adverse Event|5|||
144368452|NCT02215252|520559852|FG002|Overall Study|Adverse Event|2|||
144368453|NCT02215252|520559850|FG000|Overall Study|Lost to Follow-up|0|||
144368454|NCT02215252|520559851|FG001|Overall Study|Lost to Follow-up|0|||
144711950|NCT00386100|521801418|FG001|Overall Study|Consecutive elevated Hba1C|0|||
144711951|NCT00386100|521801417|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
144711952|NCT00386100|521801418|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
144711953|NCT00386100|521801417|FG000|Overall Study|Laboratory findings|1|||
144711954|NCT00386100|521801418|FG001|Overall Study|Laboratory findings|0|||
144368455|NCT02215252|520559852|FG002|Overall Study|Lost to Follow-up|1|||
144368456|NCT02215252|520559850|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
144711955|NCT00386100|521801417|FG000|Overall Study|Participant's concern due to CPK levels|1|||
144711956|NCT00386100|521801418|FG001|Overall Study|Participant's concern due to CPK levels|0|||
144711957|NCT00386100|521801417|FG000|Overall Study|Participant moving out of state|2|||
144711958|NCT00386100|521801418|FG001|Overall Study|Participant moving out of state|0|||
144711959|NCT00386100|521801417|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
144711960|NCT00386100|521801418|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
144711961|NCT00386100|521801417|FG000|Overall Study|Didn't meet entry criteria|1|||
144711962|NCT00386100|521801418|FG001|Overall Study|Didn't meet entry criteria|1|||
144711963|NCT00386100|521801417|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
144711964|NCT00386100|521801418|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
144711965|NCT00386100|521801417|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
144711966|NCT00386100|521801418|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
144711967|NCT00386100|521801417|FG000|Overall Study|Bad metabolic control & patient security|1|||
144711968|NCT00386100|521801418|FG001|Overall Study|Bad metabolic control & patient security|0|||
144711969|NCT00386100|521801417|FG000|Overall Study|Bone loss by DXA bone scan|1|||
144711970|NCT00386100|521801418|FG001|Overall Study|Bone loss by DXA bone scan|0|||
144711971|NCT00386100|521801417|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
144711972|NCT00386100|521801418|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
144711973|NCT00386100|521801417|FG000|Overall Study|7.6% bone loss|1|||
144711974|NCT00386100|521801418|FG001|Overall Study|7.6% bone loss|0|||
144711975|NCT00386100|521801417|FG000|Overall Study|Osteoporosis|0|||
144711976|NCT00386100|521801418|FG001|Overall Study|Osteoporosis|1|||
144711977|NCT00386100|521801417|FG000|Overall Study|Positive pregnancy test|1|||
144711978|NCT00386100|521801418|FG001|Overall Study|Positive pregnancy test|3|||
144711979|NCT00386100|521801417|FG000|Overall Study|Out of country for 5 months|1|||
144711980|NCT00386100|521801418|FG001|Overall Study|Out of country for 5 months|0|||
144711981|NCT00386100|521801417|FG000|Overall Study|Hb1Ac >8%|0|||
144711982|NCT00386100|521801418|FG001|Overall Study|Hb1Ac >8%|1|||
144711983|NCT00386100|521801417|FG000|Overall Study|Participant randomized in error|1|||
144711984|NCT00386100|521801418|FG001|Overall Study|Participant randomized in error|0|||
144711985|NCT00849524|521801424|FG000|Overall Study|Lack of Efficacy|3|||
144711986|NCT01027884|521801427|FG000|Overall Study|Adverse Event|2|||
144711987|NCT01027884|521801428|FG001|Overall Study|Adverse Event|1|||
144711988|NCT01027884|521801427|FG000|Overall Study|Protocol Violation|1|||
144711989|NCT01027884|521801428|FG001|Overall Study|Protocol Violation|0|||
144711990|NCT01027884|521801427|FG000|Overall Study|Non-compliance|1|||
144711991|NCT01027884|521801428|FG001|Overall Study|Non-compliance|1|||
144711992|NCT01027884|521801427|FG000|Overall Study|Withdrawal by Subject|0|||
144711993|NCT01027884|521801428|FG001|Overall Study|Withdrawal by Subject|1|||
144711994|NCT01027884|521801427|FG000|Overall Study|Lost to Follow-up|0|||
144711995|NCT01027884|521801428|FG001|Overall Study|Lost to Follow-up|1|||
144711996|NCT01027884|521801427|FG000|Overall Study|Spinal fixation surgery|0|||
144711997|NCT01027884|521801428|FG001|Overall Study|Spinal fixation surgery|3|||
144711998|NCT02059187|521801429|FG000|Overall Study|Adverse Event|0|||
144711999|NCT02059187|521801430|FG001|Overall Study|Adverse Event|3|||
144712000|NCT02059187|521801429|FG000|Overall Study|Death|1|||
144712001|NCT02059187|521801430|FG001|Overall Study|Death|1|||
144712002|NCT02059187|521801429|FG000|Overall Study|Lost to Follow-up|9|||
144712003|NCT02059187|521801430|FG001|Overall Study|Lost to Follow-up|8|||
144712004|NCT02059187|521801429|FG000|Overall Study|Non-compliance with study drug|1|||
144712005|NCT02059187|521801430|FG001|Overall Study|Non-compliance with study drug|0|||
144712006|NCT02059187|521801429|FG000|Overall Study|Physician Decision|1|||
144712007|NCT02059187|521801430|FG001|Overall Study|Physician Decision|2|||
144712008|NCT02059187|521801429|FG000|Overall Study|Protocol Violation|1|||
144712009|NCT02059187|521801430|FG001|Overall Study|Protocol Violation|0|||
144712010|NCT02059187|521801429|FG000|Overall Study|Withdrawal by Subject|12|||
144712011|NCT02059187|521801430|FG001|Overall Study|Withdrawal by Subject|8|||
144712012|NCT02729194|521801431|FG000|Overall Study|Withdrawal by Subject|3|||
144712013|NCT00845026|521801432|FG000|Study Period III|Adverse Event|23|||
144712014|NCT00845026|521801433|FG001|Study Period III|Adverse Event|19|||
144712015|NCT00845026|521801432|FG000|Study Period III|Perceived lack of efficacy|27|||
144712016|NCT00845026|521801433|FG001|Study Period III|Perceived lack of efficacy|15|||
144712017|NCT00845026|521801432|FG000|Study Period III|Withdrawal by Subject|19|||
144712018|NCT00845026|521801433|FG001|Study Period III|Withdrawal by Subject|15|||
144712019|NCT00845026|521801432|FG000|Study Period III|Entry Criteria not met|8|||
144712020|NCT00845026|521801433|FG001|Study Period III|Entry Criteria not met|11|||
144712021|NCT00845026|521801432|FG000|Study Period III|Lost to Follow-up|4|||
144712022|NCT00845026|521801433|FG001|Study Period III|Lost to Follow-up|5|||
144712023|NCT00845026|521801432|FG000|Study Period III|Protocol Violation|8|||
144712024|NCT00845026|521801433|FG001|Study Period III|Protocol Violation|1|||
144712025|NCT00845026|521801432|FG000|Study Period III|Scheduled conflict|3|||
144712026|NCT00845026|521801433|FG001|Study Period III|Scheduled conflict|1|||
144712027|NCT00845026|521801432|FG000|Study Period III|Subject is moving or has moved|2|||
144712028|NCT00845026|521801433|FG001|Study Period III|Subject is moving or has moved|4|||
144712029|NCT00845026|521801432|FG000|Study Period III|Transportation issues|1|||
144712030|NCT00845026|521801433|FG001|Study Period III|Transportation issues|1|||
144712031|NCT00845026|521801432|FG000|Study Period IV|Adverse Event|4|||
144712032|NCT00845026|521801433|FG001|Study Period IV|Adverse Event|0|||
144712033|NCT00845026|521801432|FG000|Study Period IV|Perceived lack of efficacy|2|||
144712034|NCT00845026|521801433|FG001|Study Period IV|Perceived lack of efficacy|1|||
144712035|NCT00845026|521801432|FG000|Study Period IV|Protocol Violation|3|||
144712036|NCT00845026|521801433|FG001|Study Period IV|Protocol Violation|1|||
144712037|NCT00845026|521801432|FG000|Study Period IV|Lost to Follow-up|1|||
144712038|NCT00845026|521801433|FG001|Study Period IV|Lost to Follow-up|0|||
144712039|NCT00845026|521801432|FG000|Study Period IV|Withdrawal by Subject|4|||
144712040|NCT00845026|521801433|FG001|Study Period IV|Withdrawal by Subject|1|||
144712041|NCT00845026|521801432|FG000|Study Period IV|Entry Criteria Not Met|1|||
144712042|NCT00845026|521801433|FG001|Study Period IV|Entry Criteria Not Met|0|||
144712043|NCT00845026|521801432|FG000|Study Period IV|Subject is moving or has moved|0|||
144712044|NCT00845026|521801433|FG001|Study Period IV|Subject is moving or has moved|1|||
144712045|NCT00845026|521801432|FG000|Study Period IV|Scheduling conflict|1|||
144712046|NCT00845026|521801433|FG001|Study Period IV|Scheduling conflict|0|||
144712047|NCT03012815|521801434|FG000|Overall Study|Lost to Follow-up|1|||
144712048|NCT03012815|521801435|FG001|Overall Study|Lost to Follow-up|0|||
144712049|NCT03012815|521801434|FG000|Overall Study|Physician Decision|3|||
144712050|NCT03012815|521801435|FG001|Overall Study|Physician Decision|2|||
144712051|NCT03012815|521801434|FG000|Overall Study|Adverse Event|1|||
144712052|NCT03012815|521801435|FG001|Overall Study|Adverse Event|0|||
144712053|NCT01462695|521801436|FG000|Overall Study|Adverse Event|1|||
144712054|NCT01462695|521801437|FG001|Overall Study|Adverse Event|1|||
144712055|NCT01462695|521801436|FG000|Overall Study|Death|2|||
144712056|NCT01462695|521801437|FG001|Overall Study|Death|0|||
144712057|NCT01462695|521801436|FG000|Overall Study|Lack of Efficacy|6|||
144712058|NCT01462695|521801437|FG001|Overall Study|Lack of Efficacy|12|||
144712059|NCT01462695|521801436|FG000|Overall Study|Physician Decision|5|||
144712060|NCT01462695|521801437|FG001|Overall Study|Physician Decision|0|||
144712061|NCT01462695|521801436|FG000|Overall Study|Withdrawal by Subject|2|||
144712062|NCT01462695|521801437|FG001|Overall Study|Withdrawal by Subject|0|||
144712063|NCT01462695|521801436|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
144712064|NCT01462695|521801437|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
144712065|NCT00879970|521801438|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
144712066|NCT00879970|521801439|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
144712067|NCT00879970|521801440|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
144712068|NCT00879970|521801441|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
144712069|NCT00879970|521801442|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
144712070|NCT00879970|521801438|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
144712071|NCT00879970|521801439|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
144712072|NCT00879970|521801440|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
144712073|NCT00879970|521801441|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
144712074|NCT00879970|521801442|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
144712075|NCT00879970|521801438|FG000|Period 1 TZD Randomization|Death|2|||
144712076|NCT00879970|521801439|FG001|Period 1 TZD Randomization|Death|1|||
144712077|NCT00879970|521801440|FG002|Period 1 TZD Randomization|Death|0|||
144712078|NCT00879970|521801441|FG003|Period 1 TZD Randomization|Death|0|||
144712079|NCT00879970|521801442|FG004|Period 1 TZD Randomization|Death|0|||
144712080|NCT00879970|521801438|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
144712081|NCT00879970|521801439|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
144712082|NCT00879970|521801440|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
144712083|NCT00879970|521801441|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
144712084|NCT00879970|521801442|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
144712085|NCT00879970|521801438|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
144712086|NCT00879970|521801439|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
144712087|NCT00879970|521801440|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
144712088|NCT00879970|521801441|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
144712089|NCT00879970|521801442|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
144712090|NCT00879970|521801438|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
144712091|NCT00879970|521801439|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
144712092|NCT00879970|521801440|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
144712093|NCT00879970|521801441|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
144712094|NCT00879970|521801442|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
144712095|NCT00879970|521801438|FG000|Period 2 Vitamin D Randomization|Death|0|||
144712096|NCT00879970|521801439|FG001|Period 2 Vitamin D Randomization|Death|0|||
144712097|NCT00879970|521801440|FG002|Period 2 Vitamin D Randomization|Death|0|||
144712098|NCT00879970|521801441|FG003|Period 2 Vitamin D Randomization|Death|2|||
144712099|NCT00879970|521801442|FG004|Period 2 Vitamin D Randomization|Death|0|||
144712100|NCT04380701|521801443|FG000|Overall Study|Pregnancy|0|||
144712101|NCT04380701|521801444|FG001|Overall Study|Pregnancy|0|||
144712102|NCT04380701|521801445|FG002|Overall Study|Pregnancy|0|||
144712103|NCT04380701|521801446|FG003|Overall Study|Pregnancy|0|||
144712104|NCT04380701|521801447|FG004|Overall Study|Pregnancy|0|||
144712105|NCT04380701|521801448|FG005|Overall Study|Pregnancy|0|||
144712106|NCT04380701|521801449|FG006|Overall Study|Pregnancy|0|||
144712107|NCT04380701|521801450|FG007|Overall Study|Pregnancy|0|||
144712108|NCT04380701|521801451|FG008|Overall Study|Pregnancy|0|||
144712109|NCT04380701|521801452|FG009|Overall Study|Pregnancy|0|||
144712110|NCT04380701|521801453|FG010|Overall Study|Pregnancy|0|||
144712111|NCT04380701|521801454|FG011|Overall Study|Pregnancy|0|||
144712112|NCT04380701|521801455|FG012|Overall Study|Pregnancy|0|||
144712113|NCT04380701|521801456|FG013|Overall Study|Pregnancy|0|||
144712114|NCT04380701|521801457|FG014|Overall Study|Pregnancy|0|||
144368457|NCT02215252|520559851|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
144368458|NCT02215252|520559852|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
144368459|NCT02215252|520559850|FG000|Overall Study|Protocol Violation|0|||
144368460|NCT02215252|520559851|FG001|Overall Study|Protocol Violation|1|||
144368461|NCT02215252|520559852|FG002|Overall Study|Protocol Violation|0|||
144368462|NCT02215252|520559850|FG000|Overall Study|Withdrawal by Subject|1|||
144368463|NCT02215252|520559851|FG001|Overall Study|Withdrawal by Subject|0|||
144368464|NCT02215252|520559852|FG002|Overall Study|Withdrawal by Subject|0|||
144368465|NCT02215252|520559850|FG000|Overall Study|Other|0|||
144368466|NCT02215252|520559851|FG001|Overall Study|Other|1|||
144368467|NCT02215252|520559852|FG002|Overall Study|Other|1|||
144368468|NCT00956007|520559853|FG000|Overall Study|Protocol Violation|27|||
144368469|NCT00956007|520559854|FG001|Overall Study|Protocol Violation|23|||
144368470|NCT01750229|520559855|FG000|Randomized Crossover Phase|Adverse Event|1|||
144368471|NCT01750229|520559855|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
144368472|NCT01750229|520559855|FG000|Long-term Follow-up Phase|Adverse Event|2|||
144368473|NCT01750229|520559855|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
144368474|NCT01208207|520559859|FG000|Part I|Adverse Event|19|||
144368475|NCT01208207|520559860|FG001|Part I|Adverse Event|2|||
144368476|NCT01208207|520559861|FG002|Part I|Adverse Event|6|||
144368477|NCT01208207|520559862|FG003|Part I|Adverse Event|0|||
144368478|NCT01208207|520559863|FG004|Part I|Adverse Event|0|||
144368479|NCT01208207|520559864|FG005|Part I|Adverse Event|0|||
144368480|NCT01208207|520559865|FG006|Part I|Adverse Event|0|||
144368481|NCT01208207|520559859|FG000|Part I|Lack of Efficacy|21|||
144368482|NCT01208207|520559860|FG001|Part I|Lack of Efficacy|3|||
144368483|NCT01208207|520559861|FG002|Part I|Lack of Efficacy|2|||
144368484|NCT01208207|520559862|FG003|Part I|Lack of Efficacy|0|||
144368485|NCT01208207|520559863|FG004|Part I|Lack of Efficacy|0|||
144368486|NCT01208207|520559864|FG005|Part I|Lack of Efficacy|0|||
144368487|NCT01208207|520559865|FG006|Part I|Lack of Efficacy|0|||
144368488|NCT01208207|520559859|FG000|Part I|Lost to Follow-up|6|||
144368489|NCT01208207|520559860|FG001|Part I|Lost to Follow-up|1|||
144368490|NCT01208207|520559861|FG002|Part I|Lost to Follow-up|0|||
144368491|NCT01208207|520559862|FG003|Part I|Lost to Follow-up|0|||
144368492|NCT01208207|520559863|FG004|Part I|Lost to Follow-up|0|||
144368493|NCT01208207|520559864|FG005|Part I|Lost to Follow-up|0|||
144368494|NCT01208207|520559865|FG006|Part I|Lost to Follow-up|0|||
144368495|NCT01208207|520559859|FG000|Part I|Non-Compliance With Study Drug|1|||
144368496|NCT01208207|520559860|FG001|Part I|Non-Compliance With Study Drug|0|||
144368497|NCT01208207|520559861|FG002|Part I|Non-Compliance With Study Drug|1|||
144368498|NCT01208207|520559862|FG003|Part I|Non-Compliance With Study Drug|0|||
144368499|NCT01208207|520559863|FG004|Part I|Non-Compliance With Study Drug|0|||
144368500|NCT01208207|520559864|FG005|Part I|Non-Compliance With Study Drug|0|||
144368501|NCT01208207|520559865|FG006|Part I|Non-Compliance With Study Drug|0|||
144368502|NCT01208207|520559859|FG000|Part I|Physician Decision|0|||
144368503|NCT01208207|520559860|FG001|Part I|Physician Decision|1|||
144368504|NCT01208207|520559861|FG002|Part I|Physician Decision|0|||
144368505|NCT01208207|520559862|FG003|Part I|Physician Decision|0|||
144368506|NCT01208207|520559863|FG004|Part I|Physician Decision|0|||
144712115|NCT04380701|521801458|FG015|Overall Study|Pregnancy|0|||
144712116|NCT04380701|521801459|FG016|Overall Study|Pregnancy|0|||
144712117|NCT04380701|521801460|FG017|Overall Study|Pregnancy|0|||
144368507|NCT01208207|520559864|FG005|Part I|Physician Decision|0|||
144712118|NCT04380701|521801461|FG018|Overall Study|Pregnancy|0|||
144368508|NCT01208207|520559865|FG006|Part I|Physician Decision|0|||
144368509|NCT01208207|520559859|FG000|Part I|Progressive Disease|1|||
144368510|NCT01208207|520559860|FG001|Part I|Progressive Disease|0|||
144368511|NCT01208207|520559861|FG002|Part I|Progressive Disease|0|||
144368512|NCT01208207|520559862|FG003|Part I|Progressive Disease|0|||
144368513|NCT01208207|520559863|FG004|Part I|Progressive Disease|0|||
144368514|NCT01208207|520559864|FG005|Part I|Progressive Disease|0|||
144368515|NCT01208207|520559865|FG006|Part I|Progressive Disease|0|||
144368516|NCT01208207|520559859|FG000|Part I|Protocol Violation|8|||
144368517|NCT01208207|520559860|FG001|Part I|Protocol Violation|0|||
144368518|NCT01208207|520559861|FG002|Part I|Protocol Violation|2|||
144368519|NCT01208207|520559862|FG003|Part I|Protocol Violation|0|||
144712119|NCT04380701|521801462|FG019|Overall Study|Pregnancy|0|||
144712120|NCT04380701|521801463|FG020|Overall Study|Pregnancy|0|||
144712121|NCT04380701|521801464|FG021|Overall Study|Pregnancy|0|||
144712122|NCT04380701|521801465|FG022|Overall Study|Pregnancy|0|||
144712123|NCT04380701|521801466|FG023|Overall Study|Pregnancy|0|||
144712124|NCT04380701|521801467|FG024|Overall Study|Pregnancy|0|||
144712125|NCT04380701|521801468|FG025|Overall Study|Pregnancy|0|||
144712126|NCT04380701|521801469|FG026|Overall Study|Pregnancy|0|||
144712127|NCT04380701|521801470|FG027|Overall Study|Pregnancy|0|||
144712128|NCT04380701|521801471|FG028|Overall Study|Pregnancy|0|||
144712129|NCT04380701|521801472|FG029|Overall Study|Pregnancy|0|||
144712130|NCT04380701|521801473|FG030|Overall Study|Pregnancy|0|||
144712131|NCT04380701|521801474|FG031|Overall Study|Pregnancy|0|||
144712132|NCT04380701|521801475|FG032|Overall Study|Pregnancy|1|||
144712133|NCT04380701|521801476|FG033|Overall Study|Pregnancy|0|||
144712134|NCT04380701|521801443|FG000|Overall Study|Lost to Follow-up|0|||
144712135|NCT04380701|521801444|FG001|Overall Study|Lost to Follow-up|0|||
144712136|NCT04380701|521801445|FG002|Overall Study|Lost to Follow-up|0|||
144712137|NCT04380701|521801446|FG003|Overall Study|Lost to Follow-up|0|||
144712138|NCT04380701|521801447|FG004|Overall Study|Lost to Follow-up|0|||
144712139|NCT04380701|521801448|FG005|Overall Study|Lost to Follow-up|0|||
144712140|NCT04380701|521801449|FG006|Overall Study|Lost to Follow-up|0|||
144712141|NCT04380701|521801450|FG007|Overall Study|Lost to Follow-up|0|||
144712142|NCT04380701|521801451|FG008|Overall Study|Lost to Follow-up|0|||
144712143|NCT04380701|521801452|FG009|Overall Study|Lost to Follow-up|0|||
144712144|NCT04380701|521801453|FG010|Overall Study|Lost to Follow-up|0|||
144712145|NCT04380701|521801454|FG011|Overall Study|Lost to Follow-up|0|||
144712146|NCT04380701|521801455|FG012|Overall Study|Lost to Follow-up|0|||
144712147|NCT04380701|521801456|FG013|Overall Study|Lost to Follow-up|0|||
144712148|NCT04380701|521801457|FG014|Overall Study|Lost to Follow-up|0|||
144712149|NCT04380701|521801458|FG015|Overall Study|Lost to Follow-up|0|||
144712150|NCT04380701|521801459|FG016|Overall Study|Lost to Follow-up|0|||
144712151|NCT04380701|521801460|FG017|Overall Study|Lost to Follow-up|0|||
144712152|NCT04380701|521801461|FG018|Overall Study|Lost to Follow-up|0|||
144712153|NCT04380701|521801462|FG019|Overall Study|Lost to Follow-up|0|||
144712154|NCT04380701|521801463|FG020|Overall Study|Lost to Follow-up|1|||
144712155|NCT04380701|521801464|FG021|Overall Study|Lost to Follow-up|0|||
144712156|NCT04380701|521801465|FG022|Overall Study|Lost to Follow-up|0|||
144712157|NCT04380701|521801466|FG023|Overall Study|Lost to Follow-up|1|||
144712158|NCT04380701|521801467|FG024|Overall Study|Lost to Follow-up|0|||
144712159|NCT04380701|521801468|FG025|Overall Study|Lost to Follow-up|0|||
144712160|NCT04380701|521801469|FG026|Overall Study|Lost to Follow-up|0|||
144712161|NCT04380701|521801470|FG027|Overall Study|Lost to Follow-up|0|||
144712162|NCT04380701|521801471|FG028|Overall Study|Lost to Follow-up|0|||
144712163|NCT04380701|521801472|FG029|Overall Study|Lost to Follow-up|1|||
144712164|NCT04380701|521801473|FG030|Overall Study|Lost to Follow-up|0|||
144712165|NCT04380701|521801474|FG031|Overall Study|Lost to Follow-up|0|||
144712166|NCT04380701|521801475|FG032|Overall Study|Lost to Follow-up|0|||
144712167|NCT04380701|521801476|FG033|Overall Study|Lost to Follow-up|1|||
144712168|NCT04380701|521801443|FG000|Overall Study|Private reason(s)|0|||
144712169|NCT04380701|521801444|FG001|Overall Study|Private reason(s)|0|||
144712170|NCT04380701|521801445|FG002|Overall Study|Private reason(s)|0|||
144712171|NCT04380701|521801446|FG003|Overall Study|Private reason(s)|0|||
144712172|NCT04380701|521801447|FG004|Overall Study|Private reason(s)|0|||
144712173|NCT04380701|521801448|FG005|Overall Study|Private reason(s)|0|||
144712174|NCT04380701|521801449|FG006|Overall Study|Private reason(s)|1|||
144712175|NCT04380701|521801450|FG007|Overall Study|Private reason(s)|0|||
144712176|NCT04380701|521801451|FG008|Overall Study|Private reason(s)|1|||
144712177|NCT04380701|521801452|FG009|Overall Study|Private reason(s)|1|||
144712178|NCT04380701|521801453|FG010|Overall Study|Private reason(s)|0|||
144712179|NCT04380701|521801454|FG011|Overall Study|Private reason(s)|0|||
144712180|NCT04380701|521801455|FG012|Overall Study|Private reason(s)|0|||
144712181|NCT04380701|521801456|FG013|Overall Study|Private reason(s)|0|||
144712182|NCT04380701|521801457|FG014|Overall Study|Private reason(s)|0|||
144712183|NCT04380701|521801458|FG015|Overall Study|Private reason(s)|0|||
144712184|NCT04380701|521801459|FG016|Overall Study|Private reason(s)|0|||
144712185|NCT04380701|521801460|FG017|Overall Study|Private reason(s)|0|||
144712186|NCT04380701|521801461|FG018|Overall Study|Private reason(s)|0|||
144712187|NCT04380701|521801462|FG019|Overall Study|Private reason(s)|0|||
144712188|NCT04380701|521801463|FG020|Overall Study|Private reason(s)|0|||
144712189|NCT04380701|521801464|FG021|Overall Study|Private reason(s)|0|||
144712190|NCT04380701|521801465|FG022|Overall Study|Private reason(s)|0|||
144712191|NCT04380701|521801466|FG023|Overall Study|Private reason(s)|1|||
144712192|NCT04380701|521801467|FG024|Overall Study|Private reason(s)|0|||
144712193|NCT04380701|521801468|FG025|Overall Study|Private reason(s)|0|||
144712194|NCT04380701|521801469|FG026|Overall Study|Private reason(s)|0|||
144712195|NCT04380701|521801470|FG027|Overall Study|Private reason(s)|0|||
144712196|NCT04380701|521801471|FG028|Overall Study|Private reason(s)|0|||
144712197|NCT04380701|521801472|FG029|Overall Study|Private reason(s)|1|||
144712198|NCT04380701|521801473|FG030|Overall Study|Private reason(s)|0|||
144712199|NCT04380701|521801474|FG031|Overall Study|Private reason(s)|0|||
144712200|NCT04380701|521801475|FG032|Overall Study|Private reason(s)|0|||
144712201|NCT04380701|521801476|FG033|Overall Study|Private reason(s)|0|||
144712202|NCT04380701|521801443|FG000|Overall Study|Withdrawal by Subject|0|||
144712203|NCT04380701|521801444|FG001|Overall Study|Withdrawal by Subject|0|||
144712204|NCT04380701|521801445|FG002|Overall Study|Withdrawal by Subject|0|||
144712205|NCT04380701|521801446|FG003|Overall Study|Withdrawal by Subject|0|||
144712206|NCT04380701|521801447|FG004|Overall Study|Withdrawal by Subject|0|||
144712207|NCT04380701|521801448|FG005|Overall Study|Withdrawal by Subject|0|||
144712208|NCT04380701|521801449|FG006|Overall Study|Withdrawal by Subject|1|||
144712209|NCT04380701|521801450|FG007|Overall Study|Withdrawal by Subject|1|||
144712210|NCT04380701|521801451|FG008|Overall Study|Withdrawal by Subject|0|||
144712211|NCT04380701|521801452|FG009|Overall Study|Withdrawal by Subject|0|||
144712212|NCT04380701|521801453|FG010|Overall Study|Withdrawal by Subject|0|||
144712213|NCT04380701|521801454|FG011|Overall Study|Withdrawal by Subject|1|||
144712214|NCT04380701|521801455|FG012|Overall Study|Withdrawal by Subject|0|||
144712215|NCT04380701|521801456|FG013|Overall Study|Withdrawal by Subject|1|||
144712216|NCT04380701|521801457|FG014|Overall Study|Withdrawal by Subject|0|||
144712217|NCT04380701|521801458|FG015|Overall Study|Withdrawal by Subject|0|||
144712218|NCT04380701|521801459|FG016|Overall Study|Withdrawal by Subject|1|||
144712219|NCT04380701|521801460|FG017|Overall Study|Withdrawal by Subject|0|||
144712220|NCT04380701|521801461|FG018|Overall Study|Withdrawal by Subject|0|||
144712221|NCT04380701|521801462|FG019|Overall Study|Withdrawal by Subject|0|||
144712222|NCT04380701|521801463|FG020|Overall Study|Withdrawal by Subject|0|||
144712223|NCT04380701|521801464|FG021|Overall Study|Withdrawal by Subject|0|||
144712224|NCT04380701|521801465|FG022|Overall Study|Withdrawal by Subject|2|||
144712225|NCT04380701|521801466|FG023|Overall Study|Withdrawal by Subject|2|||
144712226|NCT04380701|521801467|FG024|Overall Study|Withdrawal by Subject|1|||
144712227|NCT04380701|521801468|FG025|Overall Study|Withdrawal by Subject|1|||
144712228|NCT04380701|521801469|FG026|Overall Study|Withdrawal by Subject|0|||
144712229|NCT04380701|521801470|FG027|Overall Study|Withdrawal by Subject|0|||
144712230|NCT04380701|521801471|FG028|Overall Study|Withdrawal by Subject|0|||
144712231|NCT04380701|521801472|FG029|Overall Study|Withdrawal by Subject|0|||
144712232|NCT04380701|521801473|FG030|Overall Study|Withdrawal by Subject|0|||
144712233|NCT04380701|521801474|FG031|Overall Study|Withdrawal by Subject|0|||
144712234|NCT04380701|521801475|FG032|Overall Study|Withdrawal by Subject|0|||
144712235|NCT04380701|521801476|FG033|Overall Study|Withdrawal by Subject|0|||
144712236|NCT04380701|521801443|FG000|Overall Study|Adverse Event|0|||
144712237|NCT04380701|521801444|FG001|Overall Study|Adverse Event|0|||
144712238|NCT04380701|521801445|FG002|Overall Study|Adverse Event|0|||
144712239|NCT04380701|521801446|FG003|Overall Study|Adverse Event|0|||
144712240|NCT04380701|521801447|FG004|Overall Study|Adverse Event|0|||
144712241|NCT04380701|521801448|FG005|Overall Study|Adverse Event|1|||
144712242|NCT04380701|521801449|FG006|Overall Study|Adverse Event|0|||
144712243|NCT04380701|521801450|FG007|Overall Study|Adverse Event|0|||
144712244|NCT04380701|521801451|FG008|Overall Study|Adverse Event|0|||
144712245|NCT04380701|521801452|FG009|Overall Study|Adverse Event|0|||
144712246|NCT04380701|521801453|FG010|Overall Study|Adverse Event|0|||
144712247|NCT04380701|521801454|FG011|Overall Study|Adverse Event|0|||
144712248|NCT04380701|521801455|FG012|Overall Study|Adverse Event|0|||
144712249|NCT04380701|521801456|FG013|Overall Study|Adverse Event|0|||
144712250|NCT04380701|521801457|FG014|Overall Study|Adverse Event|0|||
144712251|NCT04380701|521801458|FG015|Overall Study|Adverse Event|1|||
144712252|NCT04380701|521801459|FG016|Overall Study|Adverse Event|0|||
144712253|NCT04380701|521801460|FG017|Overall Study|Adverse Event|0|||
144712254|NCT04380701|521801461|FG018|Overall Study|Adverse Event|0|||
144712255|NCT04380701|521801462|FG019|Overall Study|Adverse Event|1|||
144712256|NCT04380701|521801463|FG020|Overall Study|Adverse Event|0|||
144712257|NCT04380701|521801464|FG021|Overall Study|Adverse Event|0|||
144712258|NCT04380701|521801465|FG022|Overall Study|Adverse Event|0|||
144712259|NCT04380701|521801466|FG023|Overall Study|Adverse Event|0|||
144712260|NCT04380701|521801467|FG024|Overall Study|Adverse Event|0|||
144712261|NCT04380701|521801468|FG025|Overall Study|Adverse Event|0|||
144712262|NCT04380701|521801469|FG026|Overall Study|Adverse Event|0|||
144712263|NCT04380701|521801470|FG027|Overall Study|Adverse Event|0|||
144712264|NCT04380701|521801471|FG028|Overall Study|Adverse Event|0|||
144712265|NCT04380701|521801472|FG029|Overall Study|Adverse Event|0|||
144712266|NCT04380701|521801473|FG030|Overall Study|Adverse Event|0|||
144712267|NCT04380701|521801474|FG031|Overall Study|Adverse Event|0|||
144712268|NCT04380701|521801475|FG032|Overall Study|Adverse Event|0|||
144712269|NCT04380701|521801476|FG033|Overall Study|Adverse Event|0|||
144712270|NCT04380701|521801443|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
144712271|NCT04380701|521801444|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
144712272|NCT04380701|521801445|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
144712273|NCT04380701|521801446|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
144712274|NCT04380701|521801447|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
144712275|NCT04380701|521801448|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
144712276|NCT04380701|521801449|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
144712277|NCT04380701|521801450|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
144712278|NCT04380701|521801451|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
144712279|NCT04380701|521801452|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
144712280|NCT04380701|521801453|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
144712281|NCT04380701|521801454|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
144712282|NCT04380701|521801455|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
144712283|NCT04380701|521801456|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
144712284|NCT04380701|521801457|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
144712285|NCT04380701|521801458|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
144712286|NCT04380701|521801459|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
144712287|NCT04380701|521801460|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
144712288|NCT04380701|521801461|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
144712289|NCT04380701|521801462|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
144712290|NCT04380701|521801463|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
144712291|NCT04380701|521801464|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
144712292|NCT04380701|521801465|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
144712293|NCT04380701|521801466|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
144712294|NCT04380701|521801467|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
144712295|NCT04380701|521801468|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
144712296|NCT04380701|521801469|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
144712297|NCT04380701|521801470|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
144712298|NCT04380701|521801471|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
144712299|NCT04380701|521801472|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
144712300|NCT04380701|521801473|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
144712301|NCT04380701|521801474|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
144712302|NCT04380701|521801475|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
144712303|NCT04380701|521801476|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
144712304|NCT04380701|521801443|FG000|Overall Study|Physician Decision|0|||
144712305|NCT04380701|521801444|FG001|Overall Study|Physician Decision|0|||
144712306|NCT04380701|521801445|FG002|Overall Study|Physician Decision|0|||
144712307|NCT04380701|521801446|FG003|Overall Study|Physician Decision|0|||
144712308|NCT04380701|521801447|FG004|Overall Study|Physician Decision|0|||
144712309|NCT04380701|521801448|FG005|Overall Study|Physician Decision|0|||
144712310|NCT04380701|521801449|FG006|Overall Study|Physician Decision|0|||
144712311|NCT04380701|521801450|FG007|Overall Study|Physician Decision|0|||
144712312|NCT04380701|521801451|FG008|Overall Study|Physician Decision|0|||
144712313|NCT04380701|521801452|FG009|Overall Study|Physician Decision|0|||
144712314|NCT04380701|521801453|FG010|Overall Study|Physician Decision|0|||
144712315|NCT04380701|521801454|FG011|Overall Study|Physician Decision|0|||
144712316|NCT04380701|521801455|FG012|Overall Study|Physician Decision|0|||
144712317|NCT04380701|521801456|FG013|Overall Study|Physician Decision|0|||
144712318|NCT04380701|521801457|FG014|Overall Study|Physician Decision|0|||
144712319|NCT04380701|521801458|FG015|Overall Study|Physician Decision|0|||
144712320|NCT04380701|521801459|FG016|Overall Study|Physician Decision|0|||
144712321|NCT04380701|521801460|FG017|Overall Study|Physician Decision|0|||
144712322|NCT04380701|521801461|FG018|Overall Study|Physician Decision|0|||
144712323|NCT04380701|521801462|FG019|Overall Study|Physician Decision|0|||
144712324|NCT04380701|521801463|FG020|Overall Study|Physician Decision|0|||
144712325|NCT04380701|521801464|FG021|Overall Study|Physician Decision|0|||
144712326|NCT04380701|521801465|FG022|Overall Study|Physician Decision|0|||
144712327|NCT04380701|521801466|FG023|Overall Study|Physician Decision|0|||
144712328|NCT04380701|521801467|FG024|Overall Study|Physician Decision|2|||
144712329|NCT04380701|521801468|FG025|Overall Study|Physician Decision|0|||
144712330|NCT04380701|521801469|FG026|Overall Study|Physician Decision|0|||
144712331|NCT04380701|521801470|FG027|Overall Study|Physician Decision|0|||
144538213|NCT00146172|521174126|FG004|Overall Study|Death|0|||
144712332|NCT04380701|521801471|FG028|Overall Study|Physician Decision|0|||
144712333|NCT04380701|521801472|FG029|Overall Study|Physician Decision|0|||
144712334|NCT04380701|521801473|FG030|Overall Study|Physician Decision|0|||
144712335|NCT04380701|521801474|FG031|Overall Study|Physician Decision|0|||
144712336|NCT04380701|521801475|FG032|Overall Study|Physician Decision|0|||
144712337|NCT04380701|521801476|FG033|Overall Study|Physician Decision|0|||
144712338|NCT04380701|521801443|FG000|Overall Study|Death|0|||
144712339|NCT04380701|521801444|FG001|Overall Study|Death|0|||
144712340|NCT04380701|521801445|FG002|Overall Study|Death|0|||
144712341|NCT04380701|521801446|FG003|Overall Study|Death|0|||
144712342|NCT04380701|521801447|FG004|Overall Study|Death|0|||
144712343|NCT04380701|521801448|FG005|Overall Study|Death|0|||
144712344|NCT04380701|521801449|FG006|Overall Study|Death|0|||
144712345|NCT04380701|521801450|FG007|Overall Study|Death|0|||
144712346|NCT04380701|521801451|FG008|Overall Study|Death|0|||
144712347|NCT04380701|521801452|FG009|Overall Study|Death|0|||
144712348|NCT04380701|521801453|FG010|Overall Study|Death|0|||
144712349|NCT04380701|521801454|FG011|Overall Study|Death|0|||
144712350|NCT04380701|521801455|FG012|Overall Study|Death|0|||
144712351|NCT04380701|521801456|FG013|Overall Study|Death|0|||
144712352|NCT04380701|521801457|FG014|Overall Study|Death|0|||
144712353|NCT04380701|521801458|FG015|Overall Study|Death|0|||
144712354|NCT04380701|521801459|FG016|Overall Study|Death|0|||
144712355|NCT04380701|521801460|FG017|Overall Study|Death|0|||
144712356|NCT04380701|521801461|FG018|Overall Study|Death|0|||
144712357|NCT04380701|521801462|FG019|Overall Study|Death|0|||
144712358|NCT04380701|521801463|FG020|Overall Study|Death|0|||
144712359|NCT04380701|521801464|FG021|Overall Study|Death|0|||
144712360|NCT04380701|521801465|FG022|Overall Study|Death|0|||
144712361|NCT04380701|521801466|FG023|Overall Study|Death|0|||
144712362|NCT04380701|521801467|FG024|Overall Study|Death|1|||
144712363|NCT04380701|521801468|FG025|Overall Study|Death|0|||
144712364|NCT04380701|521801469|FG026|Overall Study|Death|0|||
144712365|NCT04380701|521801470|FG027|Overall Study|Death|0|||
144712366|NCT04380701|521801471|FG028|Overall Study|Death|0|||
144712367|NCT04380701|521801472|FG029|Overall Study|Death|0|||
144712368|NCT04380701|521801473|FG030|Overall Study|Death|0|||
144712369|NCT04380701|521801474|FG031|Overall Study|Death|0|||
144712370|NCT04380701|521801475|FG032|Overall Study|Death|0|||
144712371|NCT04380701|521801476|FG033|Overall Study|Death|0|||
144712372|NCT04380701|521801443|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712373|NCT04380701|521801444|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712374|NCT04380701|521801445|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712375|NCT04380701|521801446|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712376|NCT04380701|521801447|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712377|NCT04380701|521801448|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712378|NCT04380701|521801449|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712379|NCT04380701|521801450|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712380|NCT04380701|521801451|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144480932|NCT03176238|520959347|FG001|Overall Study|Patient is switched to commercial drug|1|||
144480933|NCT03176238|520959346|FG000|Overall Study|Protocol Violation|1|||
144712381|NCT04380701|521801452|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712382|NCT04380701|521801453|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712383|NCT04380701|521801454|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712384|NCT04380701|521801455|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712385|NCT04380701|521801456|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712386|NCT04380701|521801457|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712387|NCT04380701|521801458|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712388|NCT04380701|521801459|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712389|NCT04380701|521801460|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712390|NCT04380701|521801461|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712391|NCT04380701|521801462|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712392|NCT04380701|521801463|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712393|NCT04380701|521801464|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
144712394|NCT04380701|521801465|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
144712395|NCT04380701|521801466|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
144712396|NCT04380701|521801467|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
144712397|NCT04380701|521801468|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712398|NCT04380701|521801469|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712399|NCT04380701|521801470|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712400|NCT04380701|521801471|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712401|NCT04380701|521801472|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712402|NCT04380701|521801473|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712403|NCT04380701|521801474|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712404|NCT04380701|521801475|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712405|NCT04380701|521801476|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
144712406|NCT00558519|521801477|FG000|Overall Study|Ph+|20|||
144712407|NCT00558519|521801477|FG000|Overall Study|Ineligible|1|||
144712408|NCT00558519|521801477|FG000|Overall Study|Insufficient data|1|||
144712409|NCT00558519|521801477|FG000|Overall Study|Never received treatment|1|||
144712410|NCT00995930|521801484|FG000|Overall Study|Protocol deviation|2|||
144712411|NCT00995930|521801485|FG001|Overall Study|Protocol deviation|5|||
144712412|NCT00995930|521801484|FG000|Overall Study|Death|0|||
144712413|NCT00995930|521801485|FG001|Overall Study|Death|1|||
144712414|NCT00995930|521801484|FG000|Overall Study|Administrative problems|4|||
144712415|NCT00995930|521801485|FG001|Overall Study|Administrative problems|2|||
144712416|NCT00995930|521801484|FG000|Overall Study|Lost to Follow-up|1|||
144712417|NCT00995930|521801485|FG001|Overall Study|Lost to Follow-up|2|||
144712418|NCT00995930|521801484|FG000|Overall Study|Withdrawal by Subject|3|||
144712419|NCT00995930|521801485|FG001|Overall Study|Withdrawal by Subject|4|||
144712420|NCT00995930|521801484|FG000|Overall Study|Adverse Event|11|||
144712421|NCT00995930|521801485|FG001|Overall Study|Adverse Event|14|||
144712422|NCT01458119|521801486|FG000|Overall Study|Physician Decision|4|||
144712423|NCT01458119|521801486|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
144712424|NCT01458119|521801486|FG000|Overall Study|Pregnancy|1|||
144712425|NCT01458119|521801486|FG000|Overall Study|Death|2|||
144712426|NCT01458119|521801486|FG000|Overall Study|Adverse Event|1|||
144712427|NCT01458119|521801486|FG000|Overall Study|Consent Withdrawn by Participant|8|||
144712428|NCT01458119|521801486|FG000|Overall Study|Non-compliance With Study Drug|3|||
144712429|NCT02094937|521801491|FG000|8 Weeks in Period 1|Adverse Event|9|||
144712430|NCT02094937|521801492|FG001|8 Weeks in Period 1|Adverse Event|0|||
144712431|NCT02094937|521801493|FG002|8 Weeks in Period 1|Adverse Event|0|||
144712432|NCT02094937|521801494|FG003|8 Weeks in Period 1|Adverse Event|0|||
144712433|NCT02094937|521801491|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
144712434|NCT02094937|521801492|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
144712435|NCT02094937|521801493|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
144712436|NCT02094937|521801494|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
144712437|NCT02094937|521801491|FG000|8 Weeks in Period 1|Protocol Violation|2|||
144712438|NCT02094937|521801492|FG001|8 Weeks in Period 1|Protocol Violation|0|||
144712439|NCT02094937|521801493|FG002|8 Weeks in Period 1|Protocol Violation|0|||
144712440|NCT02094937|521801494|FG003|8 Weeks in Period 1|Protocol Violation|0|||
144712441|NCT02094937|521801491|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
144712442|NCT02094937|521801492|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
144712443|NCT02094937|521801493|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
144712444|NCT02094937|521801494|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
144712445|NCT02094937|521801491|FG000|8 Weeks in Period 1|Physician Decision|1|||
144480934|NCT03176238|520959347|FG001|Overall Study|Protocol Violation|0|||
144712446|NCT02094937|521801492|FG001|8 Weeks in Period 1|Physician Decision|0|||
144712447|NCT02094937|521801493|FG002|8 Weeks in Period 1|Physician Decision|0|||
144712448|NCT02094937|521801494|FG003|8 Weeks in Period 1|Physician Decision|0|||
144712449|NCT02094937|521801491|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
144712450|NCT02094937|521801492|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
144712451|NCT02094937|521801493|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
144712452|NCT02094937|521801494|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
144712453|NCT02094937|521801491|FG000|12 Weeks in Period 2|Adverse Event|0|||
144712454|NCT02094937|521801492|FG001|12 Weeks in Period 2|Adverse Event|2|||
144712455|NCT02094937|521801493|FG002|12 Weeks in Period 2|Adverse Event|4|||
144712456|NCT02094937|521801494|FG003|12 Weeks in Period 2|Adverse Event|1|||
144712457|NCT02094937|521801491|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
144712458|NCT02094937|521801492|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
144712459|NCT02094937|521801493|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
144712460|NCT02094937|521801494|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
144368520|NCT01208207|520559863|FG004|Part I|Protocol Violation|0|||
144368521|NCT01208207|520559864|FG005|Part I|Protocol Violation|0|||
144368522|NCT01208207|520559865|FG006|Part I|Protocol Violation|0|||
144368523|NCT01208207|520559859|FG000|Part I|Withdrawal by Subject|14|||
144368524|NCT01208207|520559860|FG001|Part I|Withdrawal by Subject|4|||
144368525|NCT01208207|520559861|FG002|Part I|Withdrawal by Subject|4|||
144368526|NCT01208207|520559862|FG003|Part I|Withdrawal by Subject|0|||
144368527|NCT01208207|520559863|FG004|Part I|Withdrawal by Subject|0|||
144368528|NCT01208207|520559864|FG005|Part I|Withdrawal by Subject|0|||
144368529|NCT01208207|520559865|FG006|Part I|Withdrawal by Subject|0|||
144368530|NCT01208207|520559859|FG000|Part II|Withdrawal by Subject|0|||
144368531|NCT01208207|520559860|FG001|Part II|Withdrawal by Subject|0|||
144368532|NCT01208207|520559861|FG002|Part II|Withdrawal by Subject|0|||
144368533|NCT01208207|520559862|FG003|Part II|Withdrawal by Subject|10|||
144368534|NCT01208207|520559863|FG004|Part II|Withdrawal by Subject|9|||
144368535|NCT01208207|520559864|FG005|Part II|Withdrawal by Subject|3|||
144368536|NCT01208207|520559865|FG006|Part II|Withdrawal by Subject|5|||
144368537|NCT01208207|520559859|FG000|Part II|Adverse Event|0|||
144368538|NCT01208207|520559860|FG001|Part II|Adverse Event|0|||
144368539|NCT01208207|520559861|FG002|Part II|Adverse Event|0|||
144368540|NCT01208207|520559862|FG003|Part II|Adverse Event|5|||
144368541|NCT01208207|520559863|FG004|Part II|Adverse Event|9|||
144368542|NCT01208207|520559864|FG005|Part II|Adverse Event|4|||
144368543|NCT01208207|520559865|FG006|Part II|Adverse Event|2|||
144368544|NCT01208207|520559859|FG000|Part II|Lack of Efficacy|0|||
144368545|NCT01208207|520559860|FG001|Part II|Lack of Efficacy|0|||
144368546|NCT01208207|520559861|FG002|Part II|Lack of Efficacy|0|||
144368547|NCT01208207|520559862|FG003|Part II|Lack of Efficacy|6|||
144368548|NCT01208207|520559863|FG004|Part II|Lack of Efficacy|4|||
144368549|NCT01208207|520559864|FG005|Part II|Lack of Efficacy|3|||
144368550|NCT01208207|520559865|FG006|Part II|Lack of Efficacy|3|||
144368551|NCT01208207|520559859|FG000|Part II|Lost to Follow-up|0|||
144368552|NCT01208207|520559860|FG001|Part II|Lost to Follow-up|0|||
144368553|NCT01208207|520559861|FG002|Part II|Lost to Follow-up|0|||
144368554|NCT01208207|520559862|FG003|Part II|Lost to Follow-up|4|||
144368555|NCT01208207|520559863|FG004|Part II|Lost to Follow-up|0|||
144368556|NCT01208207|520559864|FG005|Part II|Lost to Follow-up|2|||
144368557|NCT01208207|520559865|FG006|Part II|Lost to Follow-up|1|||
144368558|NCT01208207|520559859|FG000|Part II|Non-Compliance With Study Drug|0|||
144368559|NCT01208207|520559860|FG001|Part II|Non-Compliance With Study Drug|0|||
144368560|NCT01208207|520559861|FG002|Part II|Non-Compliance With Study Drug|0|||
144368561|NCT01208207|520559862|FG003|Part II|Non-Compliance With Study Drug|4|||
144368562|NCT01208207|520559863|FG004|Part II|Non-Compliance With Study Drug|1|||
144368563|NCT01208207|520559864|FG005|Part II|Non-Compliance With Study Drug|1|||
144368564|NCT01208207|520559865|FG006|Part II|Non-Compliance With Study Drug|0|||
144368565|NCT01208207|520559859|FG000|Part II|Physician Decision|0|||
144368566|NCT01208207|520559860|FG001|Part II|Physician Decision|0|||
144368567|NCT01208207|520559861|FG002|Part II|Physician Decision|0|||
144368568|NCT01208207|520559862|FG003|Part II|Physician Decision|1|||
144368569|NCT01208207|520559863|FG004|Part II|Physician Decision|0|||
144368570|NCT01208207|520559864|FG005|Part II|Physician Decision|2|||
144368571|NCT01208207|520559865|FG006|Part II|Physician Decision|0|||
144368572|NCT01208207|520559859|FG000|Part II|Protocol Violation|0|||
144368573|NCT01208207|520559860|FG001|Part II|Protocol Violation|0|||
144368574|NCT01208207|520559861|FG002|Part II|Protocol Violation|0|||
144368575|NCT01208207|520559862|FG003|Part II|Protocol Violation|1|||
144368576|NCT01208207|520559863|FG004|Part II|Protocol Violation|0|||
144368577|NCT01208207|520559864|FG005|Part II|Protocol Violation|0|||
144368578|NCT01208207|520559865|FG006|Part II|Protocol Violation|0|||
144368579|NCT01208207|520559859|FG000|Part II|Technical Problems|0|||
144368580|NCT01208207|520559860|FG001|Part II|Technical Problems|0|||
144368581|NCT01208207|520559861|FG002|Part II|Technical Problems|0|||
144368582|NCT01208207|520559862|FG003|Part II|Technical Problems|1|||
144368583|NCT01208207|520559863|FG004|Part II|Technical Problems|0|||
144368584|NCT01208207|520559864|FG005|Part II|Technical Problems|1|||
144368585|NCT01208207|520559865|FG006|Part II|Technical Problems|0|||
144368586|NCT01134055|520559873|FG000|Overall Study|Adverse Event|5|||
144368587|NCT01134055|520559874|FG001|Overall Study|Adverse Event|2|||
144368588|NCT01134055|520559875|FG002|Overall Study|Adverse Event|2|||
144368589|NCT01134055|520559876|FG003|Overall Study|Adverse Event|2|||
144368590|NCT01134055|520559877|FG004|Overall Study|Adverse Event|5|||
144712461|NCT02094937|521801491|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
144712462|NCT02094937|521801492|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
144712463|NCT02094937|521801493|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
144712464|NCT02094937|521801494|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
144712465|NCT02094937|521801491|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
144712466|NCT02094937|521801492|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
144712467|NCT02094937|521801493|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
144712468|NCT02094937|521801494|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
144712469|NCT02094937|521801491|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
144712470|NCT02094937|521801492|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
144712471|NCT02094937|521801493|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
144712472|NCT02094937|521801494|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
144712473|NCT03185949|521801497|FG000|ITT Analysis|Withdrawal by Subject|4|||
144712474|NCT03185949|521801498|FG001|ITT Analysis|Withdrawal by Subject|3|||
144712475|NCT03185949|521801497|FG000|PP Analysis|Protocol Violation|2|||
144712476|NCT03185949|521801498|FG001|PP Analysis|Protocol Violation|2|||
144712477|NCT03185949|521801497|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
144712478|NCT03185949|521801498|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
144712479|NCT05788237|521801504|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
144712480|NCT05788237|521801505|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
144712481|NCT05788237|521801506|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
144712482|NCT05788237|521801507|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
144712483|NCT05788237|521801504|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
144712484|NCT05788237|521801505|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
144712485|NCT05788237|521801506|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
144712486|NCT05788237|521801507|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
144712487|NCT05788237|521801504|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
144712488|NCT05788237|521801505|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
144712489|NCT05788237|521801506|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
144712490|NCT05788237|521801507|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
144712491|NCT05788237|521801504|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
144712492|NCT05788237|521801505|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
144712493|NCT05788237|521801506|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
144712494|NCT05788237|521801507|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
144712495|NCT05788237|521801504|FG000|SSA (Approximately 2 Months)|Death|0|||
144712496|NCT05788237|521801505|FG001|SSA (Approximately 2 Months)|Death|1|||
144712497|NCT05788237|521801506|FG002|SSA (Approximately 2 Months)|Death|0|||
144712498|NCT05788237|521801507|FG003|SSA (Approximately 2 Months)|Death|0|||
144712499|NCT05788237|521801504|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
144712500|NCT05788237|521801505|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
144712501|NCT05788237|521801506|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
144712502|NCT05788237|521801507|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
144712503|NCT05788237|521801504|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
144368591|NCT01134055|520559878|FG005|Overall Study|Adverse Event|7|||
144368592|NCT01134055|520559879|FG006|Overall Study|Adverse Event|2|||
144368593|NCT01134055|520559873|FG000|Overall Study|Lost to Follow-up|0|||
144368594|NCT01134055|520559874|FG001|Overall Study|Lost to Follow-up|1|||
144368595|NCT01134055|520559875|FG002|Overall Study|Lost to Follow-up|0|||
144368596|NCT01134055|520559876|FG003|Overall Study|Lost to Follow-up|1|||
144368597|NCT01134055|520559877|FG004|Overall Study|Lost to Follow-up|0|||
144368598|NCT01134055|520559878|FG005|Overall Study|Lost to Follow-up|0|||
144368599|NCT01134055|520559879|FG006|Overall Study|Lost to Follow-up|0|||
144368600|NCT01134055|520559873|FG000|Overall Study|Withdrawal by Subject|3|||
144368601|NCT01134055|520559874|FG001|Overall Study|Withdrawal by Subject|3|||
144368602|NCT01134055|520559875|FG002|Overall Study|Withdrawal by Subject|1|||
144368603|NCT01134055|520559876|FG003|Overall Study|Withdrawal by Subject|2|||
144368604|NCT01134055|520559877|FG004|Overall Study|Withdrawal by Subject|0|||
144368605|NCT01134055|520559878|FG005|Overall Study|Withdrawal by Subject|0|||
144368606|NCT01134055|520559879|FG006|Overall Study|Withdrawal by Subject|8|||
144368607|NCT01134055|520559873|FG000|Overall Study|Protocol Violation|0|||
144368608|NCT01134055|520559874|FG001|Overall Study|Protocol Violation|0|||
144368609|NCT01134055|520559875|FG002|Overall Study|Protocol Violation|0|||
144368610|NCT01134055|520559876|FG003|Overall Study|Protocol Violation|1|||
144368611|NCT01134055|520559877|FG004|Overall Study|Protocol Violation|1|||
144368612|NCT01134055|520559878|FG005|Overall Study|Protocol Violation|0|||
144368613|NCT01134055|520559879|FG006|Overall Study|Protocol Violation|0|||
144368614|NCT01134055|520559873|FG000|Overall Study|Physician Decision|0|||
144368615|NCT01134055|520559874|FG001|Overall Study|Physician Decision|0|||
144368616|NCT01134055|520559875|FG002|Overall Study|Physician Decision|0|||
144368617|NCT01134055|520559876|FG003|Overall Study|Physician Decision|0|||
144368618|NCT01134055|520559877|FG004|Overall Study|Physician Decision|0|||
144368619|NCT01134055|520559878|FG005|Overall Study|Physician Decision|0|||
144368620|NCT01134055|520559879|FG006|Overall Study|Physician Decision|1|||
144368621|NCT01454102|520559884|FG000|Overall Study|Continuing in the treatment period|0|||
144712504|NCT05788237|521801505|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
144712505|NCT05788237|521801506|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
144199219|NCT02935686|519928861|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
144368622|NCT01454102|520559885|FG001|Overall Study|Continuing in the treatment period|0|||
144368623|NCT01454102|520559886|FG002|Overall Study|Continuing in the treatment period|0|||
144368624|NCT01454102|520559887|FG003|Overall Study|Continuing in the treatment period|0|||
144368625|NCT01454102|520559888|FG004|Overall Study|Continuing in the treatment period|3|||
144368626|NCT01454102|520559889|FG005|Overall Study|Continuing in the treatment period|3|||
144712506|NCT05788237|521801507|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
144712507|NCT05788237|521801504|FG000|SSB (Approximately 1 Month)|Other|0|||
144712508|NCT05788237|521801505|FG001|SSB (Approximately 1 Month)|Other|0|||
144712509|NCT05788237|521801506|FG002|SSB (Approximately 1 Month)|Other|0|||
144712510|NCT05788237|521801507|FG003|SSB (Approximately 1 Month)|Other|1|||
144712511|NCT01326702|521803300|FG000|Overall Study|Other|1|||
144712512|NCT01326702|521803301|FG001|Overall Study|Other|0|||
144712513|NCT01326702|521803302|FG002|Overall Study|Other|0|||
144712514|NCT01326702|521803303|FG003|Overall Study|Other|0|||
144712515|NCT01326702|521803304|FG004|Overall Study|Other|0|||
144712516|NCT01326702|521803305|FG005|Overall Study|Other|1|||
144712517|NCT01326702|521803306|FG006|Overall Study|Other|0|||
144712518|NCT01326702|521803300|FG000|Overall Study|progressive disease|1|||
144712519|NCT01326702|521803301|FG001|Overall Study|progressive disease|1|||
144712520|NCT01326702|521803302|FG002|Overall Study|progressive disease|3|||
144712521|NCT01326702|521803303|FG003|Overall Study|progressive disease|1|||
144712522|NCT01326702|521803304|FG004|Overall Study|progressive disease|3|||
144712523|NCT01326702|521803305|FG005|Overall Study|progressive disease|2|||
144712524|NCT01326702|521803306|FG006|Overall Study|progressive disease|3|||
144712525|NCT01326702|521803300|FG000|Overall Study|Death|0|||
144712526|NCT01326702|521803301|FG001|Overall Study|Death|1|||
144712527|NCT01326702|521803302|FG002|Overall Study|Death|0|||
144712528|NCT01326702|521803303|FG003|Overall Study|Death|0|||
144712529|NCT01326702|521803304|FG004|Overall Study|Death|0|||
144712530|NCT01326702|521803305|FG005|Overall Study|Death|0|||
144712531|NCT01326702|521803306|FG006|Overall Study|Death|0|||
144712532|NCT01326702|521803300|FG000|Overall Study|Adverse Event|0|||
144712533|NCT01326702|521803301|FG001|Overall Study|Adverse Event|0|||
144712534|NCT01326702|521803302|FG002|Overall Study|Adverse Event|1|||
144712535|NCT01326702|521803303|FG003|Overall Study|Adverse Event|1|||
144712536|NCT01326702|521803304|FG004|Overall Study|Adverse Event|0|||
144712537|NCT01326702|521803305|FG005|Overall Study|Adverse Event|3|||
144712538|NCT01326702|521803306|FG006|Overall Study|Adverse Event|1|||
144712539|NCT01326702|521803300|FG000|Overall Study|Withdrawal by Subject|0|||
144712540|NCT01326702|521803301|FG001|Overall Study|Withdrawal by Subject|0|||
144712541|NCT01326702|521803302|FG002|Overall Study|Withdrawal by Subject|1|||
144712542|NCT01326702|521803303|FG003|Overall Study|Withdrawal by Subject|0|||
144712543|NCT01326702|521803304|FG004|Overall Study|Withdrawal by Subject|1|||
144712544|NCT01326702|521803305|FG005|Overall Study|Withdrawal by Subject|1|||
144712545|NCT01326702|521803306|FG006|Overall Study|Withdrawal by Subject|3|||
144712546|NCT01326702|521803300|FG000|Overall Study|Not Treated|0|||
144712547|NCT01326702|521803301|FG001|Overall Study|Not Treated|0|||
144712548|NCT01326702|521803302|FG002|Overall Study|Not Treated|0|||
144712549|NCT01326702|521803303|FG003|Overall Study|Not Treated|1|||
144712550|NCT01326702|521803304|FG004|Overall Study|Not Treated|0|||
144712551|NCT01326702|521803305|FG005|Overall Study|Not Treated|1|||
144712552|NCT01326702|521803306|FG006|Overall Study|Not Treated|0|||
144712553|NCT02082912|521803307|FG000|Overall Study|Physician Decision|0|||
144712554|NCT02082912|521803308|FG001|Overall Study|Physician Decision|1|||
144712555|NCT01835132|521803315|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
144712556|NCT00856778|521803316|FG000|Overall Study|Adverse Event|7|||
144712557|NCT00856778|521803316|FG000|Overall Study|Withdrawal by Subject|10|||
144712558|NCT00856778|521803316|FG000|Overall Study|Study deviation|2|||
144712559|NCT00856778|521803316|FG000|Overall Study|Lost to Follow-up|5|||
144712560|NCT00265083|521803317|FG000|Overall Study|Adverse Event|5|||
144712561|NCT00265083|521803318|FG001|Overall Study|Adverse Event|13|||
144712562|NCT00265083|521803319|FG002|Overall Study|Adverse Event|15|||
144712563|NCT00265083|521803317|FG000|Overall Study|Lost to Follow-up|3|||
144712564|NCT00265083|521803318|FG001|Overall Study|Lost to Follow-up|4|||
144712565|NCT00265083|521803319|FG002|Overall Study|Lost to Follow-up|4|||
144712566|NCT00265083|521803317|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
144712567|NCT00265083|521803318|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
144712568|NCT00265083|521803319|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
144712569|NCT00265083|521803317|FG000|Overall Study|Other|1|||
144712570|NCT00265083|521803318|FG001|Overall Study|Other|12|||
144712571|NCT00265083|521803319|FG002|Overall Study|Other|9|||
144712572|NCT03208933|521803320|FG000|Overall Study|Death|3|||
144712573|NCT03208933|521803320|FG000|Overall Study|Withdrawal by Subject|3|||
144712574|NCT03208933|521803320|FG000|Overall Study|Adverse Event|1|||
144712575|NCT03208933|521803320|FG000|Overall Study|Lost to Follow-up|2|||
144712576|NCT03208933|521803320|FG000|Overall Study|Physician Decision|3|||
144712577|NCT03208933|521803320|FG000|Overall Study|Protocol Violation|1|||
144712578|NCT03333382|521803325|FG000|Overall Study|Lost to Follow-up|1|||
144712579|NCT03333382|521803326|FG001|Overall Study|Lost to Follow-up|0|||
144712580|NCT00550420|521803327|FG000|Overall Study|Adverse Event|28|||
144712581|NCT00550420|521803327|FG000|Overall Study|Lost to Follow-up|8|||
144712582|NCT00550420|521803327|FG000|Overall Study|Protocol Violation|11|||
144712583|NCT00550420|521803327|FG000|Overall Study|Withdrawal by Subject|30|||
144712584|NCT00550420|521803327|FG000|Overall Study|Still in study at termination|206|||
144712585|NCT00550420|521803327|FG000|Overall Study|Missing|2|||
144712586|NCT00550420|521803327|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
144712587|NCT00550420|521803327|FG000|Overall Study|Investigators opinion|1|||
144712588|NCT00550420|521803327|FG000|Overall Study|Lack of curative effect|1|||
144712589|NCT00550420|521803327|FG000|Overall Study|Unethical stop of enrollment|2|||
144712590|NCT00550420|521803327|FG000|Overall Study|Caregiver's decision to withdraw|1|||
144712591|NCT00550420|521803327|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
144712592|NCT00550420|521803327|FG000|Overall Study|Exclusion criteria|1|||
144712593|NCT00550420|521803327|FG000|Overall Study|Prohibited medicine|1|||
144712594|NCT00782275|521803328|FG000|Overall Study|Adverse Event|11|||
144712595|NCT00782275|521803328|FG000|Overall Study|Withdrawal by Subject|1|||
144712596|NCT00782275|521803328|FG000|Overall Study|Progressive Disease|21|||
144712597|NCT00782275|521803328|FG000|Overall Study|Physician Decision|4|||
144712598|NCT00782275|521803328|FG000|Overall Study|Not started treatment|1|||
144712599|NCT00782275|521803328|FG000|Overall Study|Other|3|||
144712600|NCT04378010|521803329|FG000|Overall Study|Adverse Event|8|||
144712601|NCT04378010|521803330|FG001|Overall Study|Adverse Event|14|||
144712602|NCT04378010|521803331|FG002|Overall Study|Adverse Event|4|||
144712603|NCT04378010|521803329|FG000|Overall Study|Withdrawal by Subject|0|||
144712604|NCT04378010|521803330|FG001|Overall Study|Withdrawal by Subject|2|||
144712605|NCT04378010|521803331|FG002|Overall Study|Withdrawal by Subject|1|||
144712606|NCT04378010|521803329|FG000|Overall Study|Protocol Violation|2|||
144712607|NCT04378010|521803330|FG001|Overall Study|Protocol Violation|1|||
144712608|NCT04378010|521803331|FG002|Overall Study|Protocol Violation|4|||
144712609|NCT04378010|521803329|FG000|Overall Study|Study terminated by Sponsor|22|||
144712610|NCT04378010|521803330|FG001|Overall Study|Study terminated by Sponsor|16|||
144712611|NCT04378010|521803331|FG002|Overall Study|Study terminated by Sponsor|22|||
144712612|NCT04378010|521803329|FG000|Overall Study|Subject inability to complete study visit|0|||
144712613|NCT04378010|521803330|FG001|Overall Study|Subject inability to complete study visit|0|||
144712614|NCT04378010|521803331|FG002|Overall Study|Subject inability to complete study visit|1|||
144712615|NCT04378010|521803329|FG000|Overall Study|Subject never dosed|0|||
144712616|NCT04378010|521803330|FG001|Overall Study|Subject never dosed|1|||
144712617|NCT04378010|521803331|FG002|Overall Study|Subject never dosed|0|||
144712618|NCT02019979|521803332|FG000|Overall Study|study terminated|14|||
144712619|NCT02513459|521803333|FG000|Overall Study|Adverse Event|7|||
144712620|NCT02513459|521803333|FG000|Overall Study|Withdrew consent|5|||
144712621|NCT02513459|521803333|FG000|Overall Study|Loss of efficacy|2|||
144712622|NCT02513459|521803333|FG000|Overall Study|Pregnancy|2|||
144712623|NCT02513459|521803333|FG000|Overall Study|Subject decision|2|||
144712624|NCT02513459|521803333|FG000|Overall Study|Lack of response|1|||
144368627|NCT01454102|520559890|FG006|Overall Study|Continuing in the treatment period|2|||
144368628|NCT01454102|520559891|FG007|Overall Study|Continuing in the treatment period|0|||
144368629|NCT01454102|520559892|FG008|Overall Study|Continuing in the treatment period|1|||
144368630|NCT01454102|520559893|FG009|Overall Study|Continuing in the treatment period|0|||
144368631|NCT01454102|520559894|FG010|Overall Study|Continuing in the treatment period|0|||
144368632|NCT01454102|520559895|FG011|Overall Study|Continuing in the treatment period|4|||
144368633|NCT01454102|520559896|FG012|Overall Study|Continuing in the treatment period|7|||
144368634|NCT01454102|520559897|FG013|Overall Study|Continuing in the treatment period|4|||
144368635|NCT01454102|520559898|FG014|Overall Study|Continuing in the treatment period|3|||
144368636|NCT01454102|520559899|FG015|Overall Study|Continuing in the treatment period|1|||
144368637|NCT01782378|520559904|FG000|First Series|Lost to Follow-up|7|||
144368638|NCT01782378|520559905|FG001|First Series|Lost to Follow-up|8|||
144368639|NCT01782378|520559904|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
144368640|NCT01782378|520559905|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
144368641|NCT01782378|520559904|FG000|Second Series|Lost to Follow-up|8|||
144368642|NCT01782378|520559905|FG001|Second Series|Lost to Follow-up|7|||
144368643|NCT01782378|520559904|FG000|Second Series|Did not choose to complete S2 Optional|18|||
144368644|NCT01782378|520559905|FG001|Second Series|Did not choose to complete S2 Optional|0|||
144368645|NCT00830440|520559906|FG000|Overall Study|Protocol Violation|1|||
144368646|NCT00830440|520559907|FG001|Overall Study|Protocol Violation|0|||
144368647|NCT00830440|520559906|FG000|Overall Study|Withdrawal by Subject|1|||
144368648|NCT00830440|520559907|FG001|Overall Study|Withdrawal by Subject|0|||
144368649|NCT00830440|520559906|FG000|Overall Study|unsuccessful procedure|4|||
144368650|NCT00830440|520559907|FG001|Overall Study|unsuccessful procedure|0|||
144368651|NCT00830440|520559906|FG000|Overall Study|Adverse Event|2|||
144368652|NCT00830440|520559907|FG001|Overall Study|Adverse Event|0|||
144368653|NCT00942604|520559908|FG000|Overall Study|Protocol Violation|1|||
144368654|NCT00942604|520559909|FG001|Overall Study|Protocol Violation|1|||
144368655|NCT00942604|520559908|FG000|Overall Study|Adverse Event|0|||
144368656|NCT00942604|520559909|FG001|Overall Study|Adverse Event|1|||
144368657|NCT00942604|520559908|FG000|Overall Study|Withdrawal by Subject|0|||
144368658|NCT00942604|520559909|FG001|Overall Study|Withdrawal by Subject|1|||
144368659|NCT00942604|520559908|FG000|Overall Study|Patient relocation|1|||
144368660|NCT00942604|520559909|FG001|Overall Study|Patient relocation|1|||
144368661|NCT01143246|520559910|FG000|Overall Study|Adverse Event|24|||
144368662|NCT01143246|520559911|FG001|Overall Study|Adverse Event|28|||
144368663|NCT01143246|520559910|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
144368664|NCT01143246|520559911|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
144368665|NCT01143246|520559910|FG000|Overall Study|Lost to Follow-up|0|||
144368666|NCT01143246|520559911|FG001|Overall Study|Lost to Follow-up|1|||
144368667|NCT01143246|520559910|FG000|Overall Study|Death|16|||
144368668|NCT01143246|520559911|FG001|Overall Study|Death|15|||
144368669|NCT01143246|520559910|FG000|Overall Study|Reason not Specified|3|||
144368670|NCT01143246|520559911|FG001|Overall Study|Reason not Specified|5|||
144368671|NCT03987503|520559912|FG000|Overall Study|Lost to Follow-up|20|||
144368672|NCT03987503|520559912|FG000|Overall Study|Withdrawal by Subject|2|||
144368673|NCT03486834|520559918|FG000|Overall Study|Withdrawal by Subject|46|||
144368674|NCT03486834|520559919|FG001|Overall Study|Withdrawal by Subject|46|||
144368675|NCT03486834|520559920|FG002|Overall Study|Withdrawal by Subject|52|||
144368676|NCT03486834|520559918|FG000|Overall Study|Adverse Event|8|||
144368677|NCT03486834|520559919|FG001|Overall Study|Adverse Event|7|||
144368678|NCT03486834|520559920|FG002|Overall Study|Adverse Event|0|||
144368679|NCT03486834|520559918|FG000|Overall Study|Lost to Follow-up|41|||
144368680|NCT03486834|520559919|FG001|Overall Study|Lost to Follow-up|24|||
144368681|NCT03486834|520559920|FG002|Overall Study|Lost to Follow-up|39|||
144368682|NCT03486834|520559918|FG000|Overall Study|Non-compliance with Study Drug|2|||
144368683|NCT03486834|520559919|FG001|Overall Study|Non-compliance with Study Drug|2|||
144368684|NCT03486834|520559920|FG002|Overall Study|Non-compliance with Study Drug|0|||
144368685|NCT03486834|520559918|FG000|Overall Study|Physician Decision|5|||
144368686|NCT03486834|520559919|FG001|Overall Study|Physician Decision|2|||
144368687|NCT03486834|520559920|FG002|Overall Study|Physician Decision|3|||
144368688|NCT03486834|520559918|FG000|Overall Study|Pregnancy|10|||
144368689|NCT03486834|520559919|FG001|Overall Study|Pregnancy|12|||
144368690|NCT03486834|520559920|FG002|Overall Study|Pregnancy|12|||
144368691|NCT03486834|520559918|FG000|Overall Study|Protocol Deviation|2|||
144368692|NCT03486834|520559919|FG001|Overall Study|Protocol Deviation|3|||
144368693|NCT03486834|520559920|FG002|Overall Study|Protocol Deviation|3|||
144368694|NCT03486834|520559918|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144368695|NCT03486834|520559919|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
144368696|NCT03486834|520559920|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
144368697|NCT03486834|520559918|FG000|Overall Study|Randomized but not treated|4|||
144368698|NCT03486834|520559919|FG001|Overall Study|Randomized but not treated|4|||
144368699|NCT03486834|520559920|FG002|Overall Study|Randomized but not treated|1|||
144368700|NCT00888940|520559924|FG000|Overall Study|Adverse Event|12|||
144712625|NCT02513459|521803333|FG000|Overall Study|Reproductive plans|1|||
144712626|NCT02513459|521803333|FG000|Overall Study|Surgery planned-- not done|1|||
144712627|NCT03237611|521803334|FG000|Overall Study|Withdrawal by Subject|1|||
144712628|NCT03237611|521803334|FG000|Overall Study|Ineligible|1|||
144712629|NCT00923195|521803338|FG000|Overall Study|Death|0|||
144712630|NCT00923195|521803339|FG001|Overall Study|Death|1|||
144712631|NCT00525031|521803340|FG000|Overall Study|Disease Progression|1|||
144712632|NCT00525031|521803341|FG001|Overall Study|Disease Progression|1|||
144712633|NCT02454972|521803346|FG000|Overall Study|Progressive disease|17|||
144712634|NCT02454972|521803347|FG001|Overall Study|Progressive disease|16|||
144712635|NCT02454972|521803348|FG002|Overall Study|Progressive disease|59|||
144712636|NCT02454972|521803349|FG003|Overall Study|Progressive disease|23|||
144712637|NCT02454972|521803350|FG004|Overall Study|Progressive disease|16|||
144712638|NCT02454972|521803351|FG005|Overall Study|Progressive disease|12|||
144712639|NCT02454972|521803352|FG006|Overall Study|Progressive disease|19|||
144368701|NCT00888940|520559925|FG001|Overall Study|Adverse Event|3|||
144368702|NCT00888940|520559924|FG000|Overall Study|Lost to Follow-up|5|||
144368703|NCT00888940|520559925|FG001|Overall Study|Lost to Follow-up|5|||
144368704|NCT00888940|520559924|FG000|Overall Study|Randomized Not Treated|11|||
144368705|NCT00888940|520559925|FG001|Overall Study|Randomized Not Treated|13|||
144368706|NCT03815929|520559930|FG000|Overall Study|Lost to Follow-up|2|||
144368707|NCT03815929|520559931|FG001|Overall Study|Lost to Follow-up|1|||
144368708|NCT03815929|520559932|FG002|Overall Study|Lost to Follow-up|0|||
144368709|NCT03815929|520559930|FG000|Overall Study|Physician Decision|2|||
144368710|NCT03815929|520559931|FG001|Overall Study|Physician Decision|2|||
144368711|NCT03815929|520559932|FG002|Overall Study|Physician Decision|0|||
144368712|NCT03815929|520559930|FG000|Overall Study|Withdrawal by Subject|0|||
144368713|NCT03815929|520559931|FG001|Overall Study|Withdrawal by Subject|0|||
144368714|NCT03815929|520559932|FG002|Overall Study|Withdrawal by Subject|1|||
144368715|NCT03313037|520559933|FG000|Overall Study|Protocol Violation|4|||
144368716|NCT03313037|520559934|FG001|Overall Study|Protocol Violation|1|||
144368717|NCT03313037|520559933|FG000|Overall Study|Other|1|||
144368718|NCT03313037|520559934|FG001|Overall Study|Other|1|||
144368719|NCT03313037|520559933|FG000|Overall Study|Withdrawal by Subject|4|||
144368720|NCT03313037|520559934|FG001|Overall Study|Withdrawal by Subject|3|||
144368721|NCT03313037|520559933|FG000|Overall Study|No longer meets eligibility criteria|1|||
144368722|NCT03313037|520559934|FG001|Overall Study|No longer meets eligibility criteria|7|||
144368723|NCT03313037|520559933|FG000|Overall Study|Lost to Follow-up|9|||
144368724|NCT03313037|520559934|FG001|Overall Study|Lost to Follow-up|8|||
144368725|NCT03313037|520559933|FG000|Overall Study|Randomized but not treated|1|||
144368726|NCT03313037|520559934|FG001|Overall Study|Randomized but not treated|0|||
144368727|NCT02760498|520559935|FG000|Overall Study|Adverse Event|3|||
144368728|NCT02760498|520559936|FG001|Overall Study|Adverse Event|3|||
144368729|NCT02760498|520559937|FG002|Overall Study|Adverse Event|1|||
144368730|NCT02760498|520559938|FG003|Overall Study|Adverse Event|1|||
144368731|NCT02760498|520559939|FG004|Overall Study|Adverse Event|0|||
144368732|NCT02760498|520559940|FG005|Overall Study|Adverse Event|6|||
144368733|NCT02760498|520559935|FG000|Overall Study|Death|7|||
144368734|NCT02760498|520559936|FG001|Overall Study|Death|5|||
144368735|NCT02760498|520559937|FG002|Overall Study|Death|5|||
144368736|NCT02760498|520559938|FG003|Overall Study|Death|7|||
144368737|NCT02760498|520559939|FG004|Overall Study|Death|0|||
144368738|NCT02760498|520559940|FG005|Overall Study|Death|23|||
144368739|NCT02760498|520559935|FG000|Overall Study|Lost to Follow-up|0|||
144368740|NCT02760498|520559936|FG001|Overall Study|Lost to Follow-up|0|||
144368741|NCT02760498|520559937|FG002|Overall Study|Lost to Follow-up|0|||
144368742|NCT02760498|520559938|FG003|Overall Study|Lost to Follow-up|0|||
144368743|NCT02760498|520559939|FG004|Overall Study|Lost to Follow-up|0|||
144368744|NCT02760498|520559940|FG005|Overall Study|Lost to Follow-up|3|||
144368745|NCT02760498|520559935|FG000|Overall Study|Non-compliance with study drug|0|||
144368746|NCT02760498|520559936|FG001|Overall Study|Non-compliance with study drug|2|||
144368747|NCT02760498|520559937|FG002|Overall Study|Non-compliance with study drug|0|||
144368748|NCT02760498|520559938|FG003|Overall Study|Non-compliance with study drug|0|||
144368749|NCT02760498|520559939|FG004|Overall Study|Non-compliance with study drug|0|||
144712640|NCT02454972|521803353|FG007|Overall Study|Progressive disease|27|||
144712641|NCT02454972|521803354|FG008|Overall Study|Progressive disease|0|||
144712642|NCT02454972|521803346|FG000|Overall Study|Death|0|||
144368750|NCT02760498|520559940|FG005|Overall Study|Non-compliance with study drug|0|||
144368751|NCT02760498|520559935|FG000|Overall Study|Participant decision|1|||
144368752|NCT02760498|520559936|FG001|Overall Study|Participant decision|4|||
144368753|NCT02760498|520559937|FG002|Overall Study|Participant decision|2|||
144368754|NCT02760498|520559938|FG003|Overall Study|Participant decision|2|||
144368755|NCT02760498|520559939|FG004|Overall Study|Participant decision|1|||
144368756|NCT02760498|520559940|FG005|Overall Study|Participant decision|6|||
144368757|NCT02760498|520559935|FG000|Overall Study|Sponsor decision|0|||
144368758|NCT02760498|520559936|FG001|Overall Study|Sponsor decision|0|||
144712643|NCT02454972|521803347|FG001|Overall Study|Death|0|||
144712644|NCT02454972|521803348|FG002|Overall Study|Death|5|||
144712645|NCT02454972|521803349|FG003|Overall Study|Death|1|||
144712646|NCT02454972|521803350|FG004|Overall Study|Death|0|||
144712647|NCT02454972|521803351|FG005|Overall Study|Death|0|||
144712648|NCT02454972|521803352|FG006|Overall Study|Death|0|||
144712649|NCT02454972|521803353|FG007|Overall Study|Death|0|||
144712650|NCT02454972|521803354|FG008|Overall Study|Death|95|||
144368759|NCT02760498|520559937|FG002|Overall Study|Sponsor decision|0|||
144368760|NCT02760498|520559938|FG003|Overall Study|Sponsor decision|3|||
144712651|NCT02454972|521803346|FG000|Overall Study|Physician Decision|0|||
144368761|NCT02760498|520559939|FG004|Overall Study|Sponsor decision|0|||
144368762|NCT02760498|520559940|FG005|Overall Study|Sponsor decision|0|||
144368763|NCT02760498|520559935|FG000|Overall Study|Physician Decision|3|||
144368764|NCT02760498|520559936|FG001|Overall Study|Physician Decision|4|||
144368765|NCT02760498|520559937|FG002|Overall Study|Physician Decision|1|||
144368766|NCT02760498|520559938|FG003|Overall Study|Physician Decision|4|||
144368767|NCT02760498|520559939|FG004|Overall Study|Physician Decision|0|||
144712652|NCT02454972|521803347|FG001|Overall Study|Physician Decision|1|||
144712653|NCT02454972|521803348|FG002|Overall Study|Physician Decision|2|||
144368768|NCT02760498|520559940|FG005|Overall Study|Physician Decision|2|||
144368769|NCT02760498|520559935|FG000|Overall Study|Disease progression|21|||
144712654|NCT02454972|521803349|FG003|Overall Study|Physician Decision|1|||
144368770|NCT02760498|520559936|FG001|Overall Study|Disease progression|19|||
144368771|NCT02760498|520559937|FG002|Overall Study|Disease progression|20|||
144368772|NCT02760498|520559938|FG003|Overall Study|Disease progression|18|||
144368773|NCT02760498|520559939|FG004|Overall Study|Disease progression|4|||
144368774|NCT02760498|520559940|FG005|Overall Study|Disease progression|55|||
144368775|NCT02760498|520559935|FG000|Overall Study|Withdrawal by Subject|4|||
144368776|NCT02760498|520559936|FG001|Overall Study|Withdrawal by Subject|7|||
144368777|NCT02760498|520559937|FG002|Overall Study|Withdrawal by Subject|5|||
144368778|NCT02760498|520559938|FG003|Overall Study|Withdrawal by Subject|1|||
144368779|NCT02760498|520559939|FG004|Overall Study|Withdrawal by Subject|0|||
144368780|NCT02760498|520559940|FG005|Overall Study|Withdrawal by Subject|6|||
144368781|NCT02760498|520559935|FG000|Overall Study|Other than specified|1|||
144368782|NCT02760498|520559936|FG001|Overall Study|Other than specified|6|||
144368783|NCT02760498|520559937|FG002|Overall Study|Other than specified|0|||
144368784|NCT02760498|520559938|FG003|Overall Study|Other than specified|3|||
144368785|NCT02760498|520559939|FG004|Overall Study|Other than specified|1|||
144368786|NCT02760498|520559940|FG005|Overall Study|Other than specified|0|||
144368787|NCT02760498|520559935|FG000|Overall Study|Not treated|0|||
144368788|NCT02760498|520559936|FG001|Overall Study|Not treated|0|||
144368789|NCT02760498|520559937|FG002|Overall Study|Not treated|0|||
144368790|NCT02760498|520559938|FG003|Overall Study|Not treated|0|||
144368791|NCT02760498|520559939|FG004|Overall Study|Not treated|0|||
144368792|NCT02760498|520559940|FG005|Overall Study|Not treated|2|||
144368793|NCT02205736|520559941|FG000|Overall Study|Lost to Follow-up|106|||
144368794|NCT03326713|520559942|FG000|Overall Study|Death|2|||
144368795|NCT03326713|520559943|FG001|Overall Study|Death|1|||
144368796|NCT03326713|520559944|FG002|Overall Study|Death|0|||
144368797|NCT03326713|520559942|FG000|Overall Study|Lost to Follow-up|20|||
144368798|NCT03326713|520559943|FG001|Overall Study|Lost to Follow-up|21|||
144368799|NCT03326713|520559944|FG002|Overall Study|Lost to Follow-up|33|||
144368800|NCT03326713|520559942|FG000|Overall Study|Withdrawal by Subject|1|||
144368801|NCT03326713|520559943|FG001|Overall Study|Withdrawal by Subject|2|||
144368802|NCT03326713|520559944|FG002|Overall Study|Withdrawal by Subject|11|||
144368803|NCT03326713|520559942|FG000|Overall Study|Found Ineligible|11|||
144368804|NCT03326713|520559943|FG001|Overall Study|Found Ineligible|11|||
144368805|NCT03326713|520559944|FG002|Overall Study|Found Ineligible|8|||
144368806|NCT00771758|520559945|FG000|Overall Study|Adverse Event|2|||
144368807|NCT00771758|520559946|FG001|Overall Study|Adverse Event|8|||
144368808|NCT00771758|520559947|FG002|Overall Study|Adverse Event|1|||
144368809|NCT00771758|520559945|FG000|Overall Study|Lack of Efficacy|0|||
144712655|NCT02454972|521803350|FG004|Overall Study|Physician Decision|2|||
144712656|NCT02454972|521803351|FG005|Overall Study|Physician Decision|0|||
144712657|NCT02454972|521803352|FG006|Overall Study|Physician Decision|0|||
144712658|NCT02454972|521803353|FG007|Overall Study|Physician Decision|1|||
144712659|NCT02454972|521803354|FG008|Overall Study|Physician Decision|0|||
144712660|NCT02454972|521803346|FG000|Overall Study|Non treatment-related adverse event|2|||
144712661|NCT02454972|521803347|FG001|Overall Study|Non treatment-related adverse event|0|||
144712662|NCT02454972|521803348|FG002|Overall Study|Non treatment-related adverse event|1|||
144712663|NCT02454972|521803349|FG003|Overall Study|Non treatment-related adverse event|0|||
144712664|NCT02454972|521803350|FG004|Overall Study|Non treatment-related adverse event|0|||
144712665|NCT02454972|521803351|FG005|Overall Study|Non treatment-related adverse event|1|||
144712666|NCT02454972|521803352|FG006|Overall Study|Non treatment-related adverse event|0|||
144712667|NCT02454972|521803353|FG007|Overall Study|Non treatment-related adverse event|1|||
144712668|NCT02454972|521803354|FG008|Overall Study|Non treatment-related adverse event|0|||
144712669|NCT02454972|521803346|FG000|Overall Study|Treatment-related adverse events|0|||
144712670|NCT02454972|521803347|FG001|Overall Study|Treatment-related adverse events|1|||
144712671|NCT02454972|521803348|FG002|Overall Study|Treatment-related adverse events|1|||
144712672|NCT02454972|521803349|FG003|Overall Study|Treatment-related adverse events|0|||
144712673|NCT02454972|521803350|FG004|Overall Study|Treatment-related adverse events|2|||
144712674|NCT02454972|521803351|FG005|Overall Study|Treatment-related adverse events|0|||
144712675|NCT02454972|521803352|FG006|Overall Study|Treatment-related adverse events|0|||
144712676|NCT02454972|521803353|FG007|Overall Study|Treatment-related adverse events|2|||
144368810|NCT00771758|520559946|FG001|Overall Study|Lack of Efficacy|2|||
144368811|NCT00771758|520559947|FG002|Overall Study|Lack of Efficacy|1|||
144368812|NCT00771758|520559945|FG000|Overall Study|Lost to Follow-up|1|||
144368813|NCT00771758|520559946|FG001|Overall Study|Lost to Follow-up|0|||
144368814|NCT00771758|520559947|FG002|Overall Study|Lost to Follow-up|0|||
144368815|NCT00771758|520559945|FG000|Overall Study|Protocol Violation|1|||
144368816|NCT00771758|520559946|FG001|Overall Study|Protocol Violation|0|||
144368817|NCT00771758|520559947|FG002|Overall Study|Protocol Violation|0|||
144368818|NCT00771758|520559945|FG000|Overall Study|Withdrawal by Subject|1|||
144368819|NCT00771758|520559946|FG001|Overall Study|Withdrawal by Subject|0|||
144368820|NCT00771758|520559947|FG002|Overall Study|Withdrawal by Subject|0|||
144368821|NCT00771758|520559945|FG000|Overall Study|Other|3|||
144368822|NCT00771758|520559946|FG001|Overall Study|Other|2|||
144712677|NCT02454972|521803354|FG008|Overall Study|Treatment-related adverse events|0|||
144712678|NCT02454972|521803346|FG000|Overall Study|Patient moves to compassionate use|0|||
144368823|NCT00771758|520559947|FG002|Overall Study|Other|0|||
144712679|NCT02454972|521803347|FG001|Overall Study|Patient moves to compassionate use|0|||
144712680|NCT02454972|521803348|FG002|Overall Study|Patient moves to compassionate use|0|||
144712681|NCT02454972|521803349|FG003|Overall Study|Patient moves to compassionate use|0|||
144712682|NCT02454972|521803350|FG004|Overall Study|Patient moves to compassionate use|0|||
144712683|NCT02454972|521803351|FG005|Overall Study|Patient moves to compassionate use|0|||
144712684|NCT02454972|521803352|FG006|Overall Study|Patient moves to compassionate use|2|||
144712685|NCT02454972|521803353|FG007|Overall Study|Patient moves to compassionate use|0|||
144712686|NCT02454972|521803354|FG008|Overall Study|Patient moves to compassionate use|0|||
144712687|NCT02454972|521803346|FG000|Overall Study|Withdrawal by Subject|0|||
144712688|NCT02454972|521803347|FG001|Overall Study|Withdrawal by Subject|1|||
144712689|NCT02454972|521803348|FG002|Overall Study|Withdrawal by Subject|5|||
144712690|NCT02454972|521803349|FG003|Overall Study|Withdrawal by Subject|2|||
144712691|NCT02454972|521803350|FG004|Overall Study|Withdrawal by Subject|3|||
144712692|NCT02454972|521803351|FG005|Overall Study|Withdrawal by Subject|2|||
144712693|NCT02454972|521803352|FG006|Overall Study|Withdrawal by Subject|0|||
144712694|NCT02454972|521803353|FG007|Overall Study|Withdrawal by Subject|1|||
144712695|NCT02454972|521803354|FG008|Overall Study|Withdrawal by Subject|2|||
144712696|NCT02454972|521803346|FG000|Overall Study|Multiple delay/holds on treatment|0|||
144712697|NCT02454972|521803347|FG001|Overall Study|Multiple delay/holds on treatment|0|||
144712698|NCT02454972|521803348|FG002|Overall Study|Multiple delay/holds on treatment|0|||
144712699|NCT02454972|521803349|FG003|Overall Study|Multiple delay/holds on treatment|1|||
144712700|NCT02454972|521803350|FG004|Overall Study|Multiple delay/holds on treatment|0|||
144712701|NCT02454972|521803351|FG005|Overall Study|Multiple delay/holds on treatment|0|||
144712702|NCT02454972|521803352|FG006|Overall Study|Multiple delay/holds on treatment|0|||
144712703|NCT02454972|521803353|FG007|Overall Study|Multiple delay/holds on treatment|0|||
144712704|NCT02454972|521803354|FG008|Overall Study|Multiple delay/holds on treatment|0|||
144712705|NCT02454972|521803346|FG000|Overall Study|Never treated|0|||
144712706|NCT02454972|521803347|FG001|Overall Study|Never treated|0|||
144712707|NCT02454972|521803348|FG002|Overall Study|Never treated|3|||
144712708|NCT02454972|521803349|FG003|Overall Study|Never treated|1|||
144712709|NCT02454972|521803350|FG004|Overall Study|Never treated|1|||
144712710|NCT02454972|521803351|FG005|Overall Study|Never treated|0|||
144712711|NCT02454972|521803352|FG006|Overall Study|Never treated|0|||
144712712|NCT02454972|521803353|FG007|Overall Study|Never treated|0|||
144712713|NCT02454972|521803354|FG008|Overall Study|Never treated|5|||
144712714|NCT02454972|521803346|FG000|Overall Study|Lost to Follow-up|0|||
144712715|NCT02454972|521803347|FG001|Overall Study|Lost to Follow-up|0|||
144712716|NCT02454972|521803348|FG002|Overall Study|Lost to Follow-up|0|||
144712717|NCT02454972|521803349|FG003|Overall Study|Lost to Follow-up|0|||
144712718|NCT02454972|521803350|FG004|Overall Study|Lost to Follow-up|0|||
144712719|NCT02454972|521803351|FG005|Overall Study|Lost to Follow-up|0|||
144712720|NCT02454972|521803352|FG006|Overall Study|Lost to Follow-up|0|||
144712721|NCT02454972|521803353|FG007|Overall Study|Lost to Follow-up|0|||
144712722|NCT02454972|521803354|FG008|Overall Study|Lost to Follow-up|2|||
144712723|NCT02454972|521803346|FG000|Overall Study|Study termination|0|||
144712724|NCT02454972|521803347|FG001|Overall Study|Study termination|0|||
144712725|NCT02454972|521803348|FG002|Overall Study|Study termination|0|||
144712726|NCT02454972|521803349|FG003|Overall Study|Study termination|0|||
144712727|NCT02454972|521803350|FG004|Overall Study|Study termination|0|||
144712728|NCT02454972|521803351|FG005|Overall Study|Study termination|0|||
144712729|NCT02454972|521803352|FG006|Overall Study|Study termination|0|||
144712730|NCT02454972|521803353|FG007|Overall Study|Study termination|0|||
144712731|NCT02454972|521803354|FG008|Overall Study|Study termination|6|||
144712732|NCT00830063|521803355|FG000|Overall Study|Adverse Event|7|||
144712733|NCT00830063|521803356|FG001|Overall Study|Adverse Event|13|||
144712734|NCT00830063|521803357|FG002|Overall Study|Adverse Event|16|||
144712735|NCT00830063|521803358|FG003|Overall Study|Adverse Event|13|||
144712736|NCT00830063|521803355|FG000|Overall Study|Death|1|||
144712737|NCT00830063|521803356|FG001|Overall Study|Death|0|||
144712738|NCT00830063|521803357|FG002|Overall Study|Death|0|||
144712739|NCT00830063|521803358|FG003|Overall Study|Death|0|||
144712740|NCT00830063|521803355|FG000|Overall Study|Lost to Follow-up|0|||
144712741|NCT00830063|521803356|FG001|Overall Study|Lost to Follow-up|0|||
144712742|NCT00830063|521803357|FG002|Overall Study|Lost to Follow-up|3|||
144712743|NCT00830063|521803358|FG003|Overall Study|Lost to Follow-up|1|||
144712744|NCT00830063|521803355|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
144712745|NCT00830063|521803356|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
144712746|NCT00830063|521803357|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
144712747|NCT00830063|521803358|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
144712748|NCT00830063|521803355|FG000|Overall Study|Lack of Efficacy|51|||
144712749|NCT00830063|521803356|FG001|Overall Study|Lack of Efficacy|23|||
144712750|NCT00830063|521803357|FG002|Overall Study|Lack of Efficacy|25|||
144712751|NCT00830063|521803358|FG003|Overall Study|Lack of Efficacy|32|||
144712752|NCT00830063|521803355|FG000|Overall Study|Other|5|||
144712753|NCT00830063|521803356|FG001|Overall Study|Other|5|||
144712754|NCT00830063|521803357|FG002|Overall Study|Other|8|||
144712755|NCT00830063|521803358|FG003|Overall Study|Other|6|||
144712756|NCT00830063|521803355|FG000|Overall Study|Withdrawal by Subject|16|||
144712757|NCT00830063|521803356|FG001|Overall Study|Withdrawal by Subject|10|||
144712758|NCT00830063|521803357|FG002|Overall Study|Withdrawal by Subject|16|||
144712759|NCT00830063|521803358|FG003|Overall Study|Withdrawal by Subject|13|||
144712760|NCT00830063|521803355|FG000|Overall Study|Protocol Violation|1|||
144712761|NCT00830063|521803356|FG001|Overall Study|Protocol Violation|0|||
144712762|NCT00830063|521803357|FG002|Overall Study|Protocol Violation|3|||
144712763|NCT00830063|521803358|FG003|Overall Study|Protocol Violation|2|||
144712764|NCT00830063|521803355|FG000|Overall Study|Randomized But Not Treated|0|||
144712765|NCT00830063|521803356|FG001|Overall Study|Randomized But Not Treated|2|||
144712766|NCT00830063|521803357|FG002|Overall Study|Randomized But Not Treated|0|||
144712767|NCT00830063|521803358|FG003|Overall Study|Randomized But Not Treated|2|||
144712768|NCT00787566|521803361|FG000|Overall Study|AE related to chemotherapy|0|||
144712769|NCT00787566|521803362|FG001|Overall Study|AE related to chemotherapy|1|||
144712770|NCT00787566|521803363|FG002|Overall Study|AE related to chemotherapy|0|||
144712771|NCT02140164|521803364|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
144712772|NCT00660790|521803385|FG000|Baseline to 3 Months|Death|1|||
144712773|NCT00660790|521803385|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
144712774|NCT00660790|521803385|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
144712775|NCT00686374|521803390|FG000|Overall Study|Lack of Efficacy|10|||
144712776|NCT00686374|521803390|FG000|Overall Study|Adverse Event|8|||
144712777|NCT00686374|521803390|FG000|Overall Study|Withdrew consent|5|||
144712778|NCT00686374|521803390|FG000|Overall Study|Lost to Follow-up|1|||
144712779|NCT00686374|521803390|FG000|Overall Study|Missing reason|33|||
144712780|NCT00686374|521803390|FG000|Overall Study|Other, not specified|4|||
144712781|NCT01725113|521803391|FG000|Overall Study|Kidney Transplant|1|||
144712782|NCT01725113|521803392|FG001|Overall Study|Kidney Transplant|1|||
144712783|NCT01725113|521803391|FG000|Overall Study|Withdrawal by Subject|0|||
144712784|NCT01725113|521803392|FG001|Overall Study|Withdrawal by Subject|1|||
144712785|NCT02143947|521803393|FG000|Overall Study|Lost to Follow-up|4|||
144712786|NCT02143947|521803394|FG001|Overall Study|Lost to Follow-up|2|||
144712787|NCT00697112|521803397|FG000|Overall Study|Adverse Event|8|||
144712788|NCT00697112|521803397|FG000|Overall Study|Lost to Follow-up|1|||
144712789|NCT00697112|521803397|FG000|Overall Study|Did not meet inclusion criteria|1|||
144712790|NCT01427920|521803402|FG000|Overall Study|Adverse Event|1|||
144712791|NCT01427920|521803403|FG001|Overall Study|Adverse Event|2|||
144712792|NCT01427920|521803402|FG000|Overall Study|Lack of Efficacy|1|||
144712793|NCT01427920|521803403|FG001|Overall Study|Lack of Efficacy|0|||
144712794|NCT01427920|521803402|FG000|Overall Study|Protocol Violation|1|||
144712795|NCT01427920|521803403|FG001|Overall Study|Protocol Violation|3|||
144712796|NCT01427920|521803402|FG000|Overall Study|Withdrawal Criteria|4|||
144712797|NCT01427920|521803403|FG001|Overall Study|Withdrawal Criteria|4|||
144712798|NCT01427920|521803402|FG000|Overall Study|Unclassified|2|||
144712799|NCT01427920|521803403|FG001|Overall Study|Unclassified|8|||
144712800|NCT04228302|521803404|FG000|Overall Study|Adverse Event|0|||
144712801|NCT04228302|521803405|FG001|Overall Study|Adverse Event|0|||
144712802|NCT04228302|521803406|FG002|Overall Study|Adverse Event|0|||
144712803|NCT04228302|521803407|FG003|Overall Study|Adverse Event|0|||
144712804|NCT04228302|521803408|FG004|Overall Study|Adverse Event|1|||
144712805|NCT04228302|521803409|FG005|Overall Study|Adverse Event|0|||
144712806|NCT03066440|521803412|FG000|Overall Study|Physician Decision|1|||
144712807|NCT03066440|521803413|FG001|Overall Study|Physician Decision|1|||
144712808|NCT03066440|521803412|FG000|Overall Study|Protocol Violation|0|||
144712809|NCT03066440|521803413|FG001|Overall Study|Protocol Violation|2|||
144712810|NCT00054275|521803416|FG000|Overall Study|Withdrawal by Subject|4|||
144712811|NCT00054275|521803416|FG000|Overall Study|Adverse Event|5|||
144712812|NCT00054275|521803416|FG000|Overall Study|Progressive disease in cycle 1|1|||
144712813|NCT00054275|521803416|FG000|Overall Study|Physician Decision|1|||
144712814|NCT00755937|521803417|FG000|Recruitment|Unknown if infliximab received|164|||
144712815|NCT00755937|521803417|FG000|Observational Follow-up|Lost to Follow-up|148|||
144712816|NCT01106352|521803418|FG000|Overall Study|Subjects untreated|0|||
144712817|NCT01106352|521803419|FG001|Overall Study|Subjects untreated|0|||
144712818|NCT01106352|521803420|FG002|Overall Study|Subjects untreated|0|||
144712819|NCT01106352|521803421|FG003|Overall Study|Subjects untreated|3|||
144712820|NCT01106352|521803422|FG004|Overall Study|Subjects untreated|4|||
144712821|NCT01106352|521803418|FG000|Overall Study|Sponsor Decision|1|||
144712822|NCT01106352|521803419|FG001|Overall Study|Sponsor Decision|0|||
144712823|NCT01106352|521803420|FG002|Overall Study|Sponsor Decision|0|||
144712824|NCT01106352|521803421|FG003|Overall Study|Sponsor Decision|0|||
144712825|NCT01106352|521803422|FG004|Overall Study|Sponsor Decision|0|||
144712826|NCT01106352|521803418|FG000|Overall Study|Too ill to come in for the visit|0|||
144712827|NCT01106352|521803419|FG001|Overall Study|Too ill to come in for the visit|0|||
144712828|NCT01106352|521803420|FG002|Overall Study|Too ill to come in for the visit|1|||
144712829|NCT01106352|521803421|FG003|Overall Study|Too ill to come in for the visit|0|||
144712830|NCT01106352|521803422|FG004|Overall Study|Too ill to come in for the visit|0|||
144712831|NCT01106352|521803418|FG000|Overall Study|Lost to Follow-up|0|||
144712832|NCT01106352|521803419|FG001|Overall Study|Lost to Follow-up|0|||
144712833|NCT01106352|521803420|FG002|Overall Study|Lost to Follow-up|0|||
144712834|NCT01106352|521803421|FG003|Overall Study|Lost to Follow-up|0|||
144712835|NCT01106352|521803422|FG004|Overall Study|Lost to Follow-up|1|||
144712836|NCT01106352|521803418|FG000|Overall Study|Death|0|||
144712837|NCT01106352|521803419|FG001|Overall Study|Death|0|||
144712838|NCT01106352|521803420|FG002|Overall Study|Death|1|||
144712839|NCT01106352|521803421|FG003|Overall Study|Death|3|||
144712840|NCT01106352|521803422|FG004|Overall Study|Death|1|||
144712841|NCT01106352|521803418|FG000|Overall Study|Disease progression|0|||
144712842|NCT01106352|521803419|FG001|Overall Study|Disease progression|0|||
144712843|NCT01106352|521803420|FG002|Overall Study|Disease progression|0|||
144712844|NCT01106352|521803421|FG003|Overall Study|Disease progression|1|||
144712845|NCT01106352|521803422|FG004|Overall Study|Disease progression|0|||
144712846|NCT01106352|521803418|FG000|Overall Study|Withdrawal by Subject|0|||
144712847|NCT01106352|521803419|FG001|Overall Study|Withdrawal by Subject|0|||
144712848|NCT01106352|521803420|FG002|Overall Study|Withdrawal by Subject|0|||
144712849|NCT01106352|521803421|FG003|Overall Study|Withdrawal by Subject|3|||
144712850|NCT01106352|521803422|FG004|Overall Study|Withdrawal by Subject|2|||
144712851|NCT01106352|521803418|FG000|Overall Study|Went on hospice|0|||
144712852|NCT01106352|521803419|FG001|Overall Study|Went on hospice|0|||
144712853|NCT01106352|521803420|FG002|Overall Study|Went on hospice|0|||
144712854|NCT01106352|521803421|FG003|Overall Study|Went on hospice|1|||
144712855|NCT01106352|521803422|FG004|Overall Study|Went on hospice|0|||
144712856|NCT01106352|521803418|FG000|Overall Study|Subject entered hospice|0|||
144712857|NCT01106352|521803419|FG001|Overall Study|Subject entered hospice|0|||
144712858|NCT01106352|521803420|FG002|Overall Study|Subject entered hospice|0|||
144712859|NCT01106352|521803421|FG003|Overall Study|Subject entered hospice|1|||
144712860|NCT01106352|521803422|FG004|Overall Study|Subject entered hospice|0|||
144712861|NCT01106352|521803418|FG000|Overall Study|Home hospice since July 2013|0|||
144712862|NCT01106352|521803419|FG001|Overall Study|Home hospice since July 2013|0|||
144712863|NCT01106352|521803420|FG002|Overall Study|Home hospice since July 2013|0|||
144712864|NCT01106352|521803421|FG003|Overall Study|Home hospice since July 2013|1|||
144712865|NCT01106352|521803422|FG004|Overall Study|Home hospice since July 2013|0|||
144712866|NCT03547531|521803423|FG000|Overall Study|not coming in data collection : sick|2|||
144712867|NCT03547531|521803424|FG001|Overall Study|not coming in data collection : sick|2|||
144712868|NCT03547531|521803423|FG000|Overall Study|having family occasion|0|||
144712869|NCT03547531|521803424|FG001|Overall Study|having family occasion|2|||
144712870|NCT03944707|521803425|FG000|Overall Study|Adverse Event|0|||
144712871|NCT03944707|521803426|FG001|Overall Study|Adverse Event|2|||
144712872|NCT03944707|521803425|FG000|Overall Study|Study terminated by sponsor|12|||
144712873|NCT03944707|521803426|FG001|Overall Study|Study terminated by sponsor|7|||
144712874|NCT03944707|521803425|FG000|Overall Study|Subject decision|0|||
144712875|NCT03944707|521803426|FG001|Overall Study|Subject decision|1|||
144712876|NCT03402126|521803434|FG000|Overall Study|Lost to Follow-up|6|||
144712877|NCT03402126|521803434|FG000|Overall Study|Protocol Violation|10|||
144712878|NCT03402126|521803434|FG000|Overall Study|Sponsor request/Study termination|29|||
144712879|NCT03402126|521803434|FG000|Overall Study|Study product no longer in use|1|||
144712880|NCT03402126|521803434|FG000|Overall Study|Technical problems|1|||
144712881|NCT03402126|521803434|FG000|Overall Study|Withdrawal by Subject|6|||
144712882|NCT03402126|521803434|FG000|Overall Study|Physician Decision|2|||
144712883|NCT03402126|521803434|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
144712884|NCT03402126|521803434|FG000|Overall Study|Death|4|||
144712885|NCT02444182|521803435|FG000|Overall Study|non-compliance|2|||
144712886|NCT02444182|521803436|FG001|Overall Study|non-compliance|1|||
144712887|NCT02444182|521803435|FG000|Overall Study|Lost to Follow-up|0|||
144712888|NCT02444182|521803436|FG001|Overall Study|Lost to Follow-up|4|||
144712889|NCT01959230|521803439|FG000|Overall Study|Failure to follow study procedures|0|||
144712890|NCT01959230|521803440|FG001|Overall Study|Failure to follow study procedures|1|||
144712891|NCT01959230|521803439|FG000|Overall Study|Administrative reasons|2|||
144712892|NCT01959230|521803440|FG001|Overall Study|Administrative reasons|0|||
144712893|NCT01959230|521803439|FG000|Overall Study|Withdrawal by Subject|2|||
144712894|NCT01959230|521803440|FG001|Overall Study|Withdrawal by Subject|0|||
144712895|NCT00751998|521803441|FG000|Overall Study|Lost to Follow-up|7|||
144712896|NCT00751998|521803441|FG000|Overall Study|Death|11|||
144712897|NCT00751998|521803441|FG000|Overall Study|Withdrawal by Subject|2|||
144712898|NCT04126733|521803442|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
144712899|NCT04126733|521803442|FG000|Treatment Period|Adverse Event|8|||
144712900|NCT04126733|521803442|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
144712901|NCT04126733|521803442|FG000|Treatment Period|Physician Decision|5|||
144712902|NCT04126733|521803442|FG000|Treatment Period|Death|1|||
144712903|NCT04126733|521803442|FG000|Treatment Period|Other Reasons|2|||
144712904|NCT04126733|521803442|FG000|Active Follow-up Period|Death|13|||
144712905|NCT04126733|521803442|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
144712906|NCT04126733|521803442|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
144712907|NCT04126733|521803442|FG000|Active Follow-up Period|Other Reasons|1|||
144712908|NCT04126733|521803442|FG000|Long-term Follow-up Period|Death|22|||
144712909|NCT04126733|521803442|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
144712910|NCT04126733|521803442|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
144712911|NCT02598193|521803443|FG000|Overall Study|Adverse Event|13|||
144712912|NCT02598193|521803443|FG000|Overall Study|Withdrawal by Subject|1|||
144712913|NCT02598193|521803443|FG000|Overall Study|Listed in active lung transplant list|1|||
144712914|NCT02598193|521803443|FG000|Overall Study|Does not want to take Nintedanib|1|||
144712915|NCT02487979|521803444|FG000|Overall Study|Physician Decision|2|||
144712916|NCT02487979|521803444|FG000|Overall Study|Withdrawal by Subject|2|||
144712917|NCT02487979|521803444|FG000|Overall Study|Progressive Disease|17|||
144368824|NCT03067077|520559948|FG000|Overall Study|Did not receive surgery|4|||
144368825|NCT03067077|520559949|FG001|Overall Study|Did not receive surgery|5|||
144368826|NCT03067077|520559948|FG000|Overall Study|Lost to Follow-up|3|||
144368827|NCT03067077|520559949|FG001|Overall Study|Lost to Follow-up|2|||
144368828|NCT00935584|520559952|FG000|Overall Study|Withdrawal by Subject|9|||
144368829|NCT00935584|520559953|FG001|Overall Study|Withdrawal by Subject|0|||
144712918|NCT01493531|521803449|FG000|Overall Study|Adverse Event|4|||
144712919|NCT01493531|521803450|FG001|Overall Study|Adverse Event|12|||
144712920|NCT01493531|521803451|FG002|Overall Study|Adverse Event|9|||
144712921|NCT01493531|521803449|FG000|Overall Study|Gout flare|3|||
144712922|NCT01493531|521803450|FG001|Overall Study|Gout flare|0|||
144712923|NCT01493531|521803451|FG002|Overall Study|Gout flare|2|||
144368830|NCT00935584|520559952|FG000|Overall Study|Death|3|||
144368831|NCT00935584|520559953|FG001|Overall Study|Death|0|||
144368832|NCT00935584|520559952|FG000|Overall Study|Lost to Follow-up|8|||
144368833|NCT00935584|520559953|FG001|Overall Study|Lost to Follow-up|0|||
144368834|NCT00935584|520559952|FG000|Overall Study|No show|9|||
144712924|NCT01493531|521803449|FG000|Overall Study|Protocol Violation|8|||
144712925|NCT01493531|521803450|FG001|Overall Study|Protocol Violation|15|||
144712926|NCT01493531|521803451|FG002|Overall Study|Protocol Violation|12|||
144712927|NCT01493531|521803449|FG000|Overall Study|Sponsor terminated study|5|||
144712928|NCT01493531|521803450|FG001|Overall Study|Sponsor terminated study|2|||
144712929|NCT01493531|521803451|FG002|Overall Study|Sponsor terminated study|3|||
144712930|NCT01493531|521803449|FG000|Overall Study|Lost to Follow-up|5|||
144712931|NCT01493531|521803450|FG001|Overall Study|Lost to Follow-up|7|||
144712932|NCT01493531|521803451|FG002|Overall Study|Lost to Follow-up|11|||
144712933|NCT01493531|521803449|FG000|Overall Study|Withdrawal by Subject|16|||
144712934|NCT01493531|521803450|FG001|Overall Study|Withdrawal by Subject|13|||
144712935|NCT01493531|521803451|FG002|Overall Study|Withdrawal by Subject|11|||
144712936|NCT01493531|521803449|FG000|Overall Study|Death|0|||
144712937|NCT01493531|521803450|FG001|Overall Study|Death|1|||
144712938|NCT01493531|521803451|FG002|Overall Study|Death|0|||
144712939|NCT01946282|521803452|FG000|Year 1|Did not return FIT kit|4186|||
144712940|NCT01946282|521803453|FG001|Year 1|Did not return FIT kit|608|||
144712941|NCT01946282|521803454|FG002|Year 1|Did not return FIT kit|654|||
144712942|NCT01946282|521803452|FG000|Year 2|Did not return FIT kit|803|||
144712943|NCT01946282|521803453|FG001|Year 2|Did not return FIT kit|131|||
144712944|NCT01946282|521803454|FG002|Year 2|Did not return FIT kit|115|||
144712945|NCT01946282|521803452|FG000|Year 3|Did not return FIT kit|288|||
144712946|NCT01946282|521803453|FG001|Year 3|Did not return FIT kit|43|||
144712947|NCT01946282|521803454|FG002|Year 3|Did not return FIT kit|30|||
144712948|NCT03031431|521803455|FG000|Overall Study|Infant removed by maternal request|1|||
144712949|NCT03670537|521803460|FG000|Overall Study|Protocol Violation|1|||
144712950|NCT04133519|521803461|FG000|Overall Study|Withdrawal by Subject|5|||
144712951|NCT04133519|521803462|FG001|Overall Study|Withdrawal by Subject|4|||
144712952|NCT04133519|521803461|FG000|Overall Study|Protocol Violation|0|||
144712953|NCT04133519|521803462|FG001|Overall Study|Protocol Violation|1|||
144712954|NCT04133519|521803461|FG000|Overall Study|Never started treatment|1|||
144712955|NCT04133519|521803462|FG001|Overall Study|Never started treatment|1|||
144712956|NCT02217345|521803463|FG000|Overall Study|Lost to Follow-up|2|||
144712957|NCT02217345|521803464|FG001|Overall Study|Lost to Follow-up|1|||
144712958|NCT02217345|521803463|FG000|Overall Study|Withdrawal by Subject|3|||
144712959|NCT02217345|521803464|FG001|Overall Study|Withdrawal by Subject|2|||
144712960|NCT02217345|521803463|FG000|Overall Study|Adverse Event|2|||
144712961|NCT02217345|521803464|FG001|Overall Study|Adverse Event|1|||
144712962|NCT02217345|521803463|FG000|Overall Study|Physician Decision|0|||
144712963|NCT02217345|521803464|FG001|Overall Study|Physician Decision|1|||
144712964|NCT01280981|521803471|FG000|Overall Study|Withdrawal by Subject|11|||
144712965|NCT01280981|521803471|FG000|Overall Study|Protocol Violation|2|||
144712966|NCT01280981|521803471|FG000|Overall Study|Lack of Efficacy|13|||
144712967|NCT01280981|521803471|FG000|Overall Study|Lost to Follow-up|3|||
144712968|NCT01280981|521803471|FG000|Overall Study|Adverse Event|6|||
144712969|NCT01280981|521803471|FG000|Overall Study|Irregular or discontinued menses|3|||
144712970|NCT01280981|521803471|FG000|Overall Study|Failed to return|45|||
144712971|NCT01280981|521803471|FG000|Overall Study|Non-compliance with protocol|3|||
144712972|NCT01280981|521803471|FG000|Overall Study|Withdrawal of consent|3|||
144712973|NCT01280981|521803471|FG000|Overall Study|Elective surgery|2|||
144712974|NCT01280981|521803471|FG000|Overall Study|Study site closure|1|||
144712975|NCT01256398|521803472|FG000|Overall Study|Withdrawal by Subject|1|||
144712976|NCT03439293|521803474|FG000|Overall Study|Death|22|||
144712977|NCT03439293|521803474|FG000|Overall Study|Withdrawal by Subject|8|||
144712978|NCT03439293|521803474|FG000|Overall Study|Lost to Follow-up|2|||
144712979|NCT03439293|521803474|FG000|Overall Study|Reason Not Specified|28|||
144712980|NCT03439293|521803474|FG000|Overall Study|Missing|1|||
144712981|NCT04288115|521803481|FG000|Overall Study|Withdrawal by Subject|0|||
144712982|NCT04288115|521803482|FG001|Overall Study|Withdrawal by Subject|1|||
144712983|NCT04288115|521803481|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
144712984|NCT04288115|521803482|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
144712985|NCT00729365|521803484|FG000|Overall Study|Physician Decision|33|||
144712986|NCT00729365|521803485|FG001|Overall Study|Physician Decision|6|||
144712987|NCT00729365|521803486|FG002|Overall Study|Physician Decision|7|||
144712988|NCT00869089|521803489|FG000|Overall Study|Lost to Follow-up|1|||
144712989|NCT00869089|521803489|FG000|Overall Study|Withdrawal by Subject|1|||
144712990|NCT00869089|521803489|FG000|Overall Study|Screen Fail|1|||
144712991|NCT01374906|521803490|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144712992|NCT01374906|521803491|FG001|Overall Study|Abnormal laboratory value(s)|3|||
144712993|NCT01374906|521803490|FG000|Overall Study|Administrative problems|2|||
144712994|NCT01374906|521803491|FG001|Overall Study|Administrative problems|2|||
144712995|NCT01374906|521803490|FG000|Overall Study|Adverse Event|10|||
144712996|NCT01374906|521803491|FG001|Overall Study|Adverse Event|11|||
144712997|NCT01374906|521803490|FG000|Overall Study|Death|0|||
144712998|NCT01374906|521803491|FG001|Overall Study|Death|2|||
144712999|NCT01374906|521803490|FG000|Overall Study|Protocol Violation|2|||
144713000|NCT01374906|521803491|FG001|Overall Study|Protocol Violation|2|||
144713001|NCT01374906|521803490|FG000|Overall Study|Withdrawal by Subject|15|||
144713002|NCT01374906|521803491|FG001|Overall Study|Withdrawal by Subject|9|||
144713003|NCT01374906|521803490|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
144713004|NCT01374906|521803491|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
144713005|NCT05166421|521803494|FG000|Overall Study|Other|3|||
144713006|NCT05166421|521803495|FG001|Overall Study|Other|1|||
144713007|NCT05166421|521803496|FG002|Overall Study|Other|1|||
144713008|NCT05166421|521803494|FG000|Overall Study|Withdrawal by Subject|5|||
144713009|NCT05166421|521803495|FG001|Overall Study|Withdrawal by Subject|3|||
144713010|NCT05166421|521803496|FG002|Overall Study|Withdrawal by Subject|6|||
144713011|NCT05166421|521803494|FG000|Overall Study|Lost to Follow-up|4|||
144713012|NCT05166421|521803495|FG001|Overall Study|Lost to Follow-up|1|||
144713013|NCT05166421|521803496|FG002|Overall Study|Lost to Follow-up|7|||
144713014|NCT01246973|521804637|FG000|Overall Study|Other|38|||
144713015|NCT01246973|521804638|FG001|Overall Study|Other|25|||
144713016|NCT01246973|521804637|FG000|Overall Study|Adverse Event|16|||
144713017|NCT01246973|521804638|FG001|Overall Study|Adverse Event|9|||
144713018|NCT01246973|521804637|FG000|Overall Study|Withdrawal by Subject|7|||
144713019|NCT01246973|521804638|FG001|Overall Study|Withdrawal by Subject|13|||
144713020|NCT01335399|521804639|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
144713021|NCT01335399|521804640|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
144713022|NCT01335399|521804639|FG000|Pre-treatment Period|Participant request to discontinue|0|||
144713023|NCT01335399|521804640|FG001|Pre-treatment Period|Participant request to discontinue|1|||
144713024|NCT01335399|521804639|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
144713025|NCT01335399|521804640|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
144713026|NCT01335399|521804639|FG000|Pre-treatment Period|Consent withdrawal|3|||
144713027|NCT01335399|521804640|FG001|Pre-treatment Period|Consent withdrawal|0|||
144713028|NCT01335399|521804639|FG000|Treatment Period|Disease progression|117|||
144713029|NCT01335399|521804640|FG001|Treatment Period|Disease progression|145|||
144713030|NCT01335399|521804639|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
144713031|NCT01335399|521804640|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
144713032|NCT01335399|521804639|FG000|Treatment Period|Study drug toxicity|52|||
144713033|NCT01335399|521804640|FG001|Treatment Period|Study drug toxicity|64|||
144713034|NCT01335399|521804639|FG000|Treatment Period|Participant request to discontinue|30|||
144713035|NCT01335399|521804640|FG001|Treatment Period|Participant request to discontinue|22|||
144713036|NCT01335399|521804639|FG000|Treatment Period|Other reasons|30|||
144713037|NCT01335399|521804640|FG001|Treatment Period|Other reasons|30|||
144713038|NCT01335399|521804639|FG000|Treatment Period|Consent withdrawal|10|||
144713039|NCT01335399|521804640|FG001|Treatment Period|Consent withdrawal|7|||
144713040|NCT01335399|521804639|FG000|Treatment Period|Death|7|||
144713041|NCT01335399|521804640|FG001|Treatment Period|Death|6|||
144713042|NCT01335399|521804639|FG000|Treatment Period|Poor/Non-compliance|3|||
144713043|NCT01335399|521804640|FG001|Treatment Period|Poor/Non-compliance|4|||
144713044|NCT01335399|521804639|FG000|Treatment Period|Lost to Follow-up|2|||
144713045|NCT01335399|521804640|FG001|Treatment Period|Lost to Follow-up|2|||
144713046|NCT01335399|521804639|FG000|Treatment Period|Maximum clinical benefit|1|||
144713047|NCT01335399|521804640|FG001|Treatment Period|Maximum clinical benefit|1|||
144713048|NCT01335399|521804639|FG000|Treatment Period|No longer meet study criteria|1|||
144713049|NCT01335399|521804640|FG001|Treatment Period|No longer meet study criteria|1|||
144713050|NCT01335399|521804639|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
144713051|NCT01335399|521804640|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
144713052|NCT01835470|521804645|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
144713053|NCT01835470|521804645|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
144713054|NCT01011907|521804646|FG000|Overall Study|Withdrawal by Subject|13|||
144713055|NCT01011907|521804647|FG001|Overall Study|Withdrawal by Subject|11|||
144713056|NCT01011907|521804646|FG000|Overall Study|Adverse Event|1|||
144713057|NCT01011907|521804647|FG001|Overall Study|Adverse Event|4|||
144713058|NCT00304954|521804648|FG000|Overall Study|Withdrawal by Subject|0|||
144713059|NCT00304954|521804649|FG001|Overall Study|Withdrawal by Subject|0|||
144713060|NCT00304954|521804650|FG002|Overall Study|Withdrawal by Subject|1|||
144713061|NCT00304954|521804651|FG003|Overall Study|Withdrawal by Subject|0|||
144713062|NCT00304954|521804648|FG000|Overall Study|Adverse Event|1|||
144713063|NCT00304954|521804649|FG001|Overall Study|Adverse Event|0|||
144713064|NCT00304954|521804650|FG002|Overall Study|Adverse Event|0|||
144713065|NCT00304954|521804651|FG003|Overall Study|Adverse Event|0|||
144713066|NCT01406873|521804656|FG000|Overall Study|Withdrawal by Subject|1|||
144713067|NCT01406873|521804657|FG001|Overall Study|Withdrawal by Subject|1|||
144713068|NCT00207714|521804658|FG000|Overall Study|Adverse Event|6|||
144713069|NCT00207714|521804659|FG001|Overall Study|Adverse Event|2|||
144713070|NCT00207714|521804660|FG002|Overall Study|Adverse Event|4|||
144713071|NCT00207714|521804661|FG003|Overall Study|Adverse Event|3|||
144713072|NCT00207714|521804662|FG004|Overall Study|Adverse Event|1|||
144713073|NCT00207714|521804658|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
144713074|NCT00207714|521804659|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144713075|NCT00207714|521804660|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
144713076|NCT00207714|521804661|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
144713077|NCT00207714|521804662|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
144713078|NCT00207714|521804658|FG000|Overall Study|Other|3|||
144713079|NCT00207714|521804659|FG001|Overall Study|Other|2|||
144713080|NCT00207714|521804660|FG002|Overall Study|Other|5|||
144713081|NCT00207714|521804661|FG003|Overall Study|Other|1|||
144713082|NCT00207714|521804662|FG004|Overall Study|Other|0|||
144713083|NCT03627195|521804663|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
144713084|NCT03627195|521804664|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
144713085|NCT03627195|521804665|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
144713086|NCT03627195|521804666|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
144713087|NCT03627195|521804667|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
144713088|NCT03627195|521804668|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
144713089|NCT02290028|521804673|FG000|Overall Study|Death|217|||
144713090|NCT02290028|521804673|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
144713091|NCT02290028|521804673|FG000|Overall Study|No longer under care of study physician|76|||
144713092|NCT02290028|521804673|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
144713093|NCT02290028|521804673|FG000|Overall Study|Withdrawal by Subject|52|||
144713094|NCT02290028|521804673|FG000|Overall Study|Study site closure|44|||
144713095|NCT02290028|521804673|FG000|Overall Study|Lost to Follow-up|34|||
144713096|NCT02290028|521804673|FG000|Overall Study|Miscellaneous|10|||
144713097|NCT02290028|521804673|FG000|Overall Study|Transition to EP PASSION|1295|||
144713098|NCT02290028|521804673|FG000|Overall Study|Planned study completion at 12 months|257|||
144713099|NCT01270841|521804674|FG000|Overall Study|Adverse Event|0|||
144713100|NCT01270841|521804675|FG001|Overall Study|Adverse Event|1|||
144713101|NCT01270841|521804676|FG002|Overall Study|Adverse Event|0|||
144713102|NCT01270841|521804677|FG003|Overall Study|Adverse Event|3|||
144713103|NCT01270841|521804674|FG000|Overall Study|Withdrawal by Subject|3|||
144713104|NCT01270841|521804675|FG001|Overall Study|Withdrawal by Subject|2|||
144713105|NCT01270841|521804676|FG002|Overall Study|Withdrawal by Subject|3|||
144713106|NCT01270841|521804677|FG003|Overall Study|Withdrawal by Subject|3|||
144713107|NCT01270841|521804674|FG000|Overall Study|Lost to Follow-up|3|||
144713108|NCT01270841|521804675|FG001|Overall Study|Lost to Follow-up|1|||
144713109|NCT01270841|521804676|FG002|Overall Study|Lost to Follow-up|4|||
144713110|NCT01270841|521804677|FG003|Overall Study|Lost to Follow-up|2|||
144713111|NCT01270841|521804674|FG000|Overall Study|Physician Decision|0|||
144713112|NCT01270841|521804675|FG001|Overall Study|Physician Decision|1|||
144713113|NCT01270841|521804676|FG002|Overall Study|Physician Decision|0|||
144713114|NCT01270841|521804677|FG003|Overall Study|Physician Decision|0|||
144247704|NCT02407054|520104197|FG002|Overall Study|Withdrawal by Subject|2|||
144247705|NCT00415597|520104198|FG000|Enrollment|Withdrawal by Subject|1|||
144247706|NCT00415597|520104198|FG000|Enrollment|Protocol Violation|1|||
144247707|NCT00415597|520104198|FG000|Treatment|Adverse Event|110|||
144247708|NCT00415597|520104198|FG000|Treatment|Lack of Efficacy|39|||
144247709|NCT00415597|520104198|FG000|Treatment|Protocol Violation|67|||
144247710|NCT00415597|520104198|FG000|Treatment|Physician Decision|3|||
144247711|NCT00415597|520104198|FG000|Treatment|Withdrawal by Subject|51|||
144247712|NCT00415597|520104198|FG000|Treatment|Lost to Follow-up|28|||
144247713|NCT00415597|520104198|FG000|Treatment|Drug Screen|2|||
144247714|NCT00415597|520104198|FG000|Treatment|Administrative|3|||
144247715|NCT00415597|520104198|FG000|Treatment|Sponsor Decision|1|||
144247716|NCT00415597|520104198|FG000|Treatment|Multiple Reasons|1|||
144247717|NCT04102865|520104200|FG000|Overall Study|Adverse Event|4|||
144247718|NCT04102865|520104201|FG001|Overall Study|Adverse Event|0|||
144247719|NCT04102865|520104200|FG000|Overall Study|Lost to Follow-up|1|||
144247720|NCT04102865|520104201|FG001|Overall Study|Lost to Follow-up|0|||
144247721|NCT04102865|520104200|FG000|Overall Study|Withdrawal by Subject|2|||
144247722|NCT04102865|520104201|FG001|Overall Study|Withdrawal by Subject|0|||
144247723|NCT01764997|520104202|FG000|Run-in Period|Adverse Event|15|||
144247724|NCT01764997|520104203|FG001|Run-in Period|Adverse Event|0|||
144247725|NCT01764997|520104204|FG002|Run-in Period|Adverse Event|0|||
144247726|NCT01764997|520104205|FG003|Run-in Period|Adverse Event|0|||
144247727|NCT01764997|520104206|FG004|Run-in Period|Adverse Event|0|||
144247728|NCT01764997|520104202|FG000|Run-in Period|Lack of Efficacy|5|||
144247729|NCT01764997|520104203|FG001|Run-in Period|Lack of Efficacy|0|||
144247730|NCT01764997|520104204|FG002|Run-in Period|Lack of Efficacy|0|||
144247731|NCT01764997|520104205|FG003|Run-in Period|Lack of Efficacy|0|||
144247732|NCT01764997|520104206|FG004|Run-in Period|Lack of Efficacy|0|||
144247733|NCT01764997|520104202|FG000|Run-in Period|Poor compliance to protocol|1|||
144247734|NCT01764997|520104203|FG001|Run-in Period|Poor compliance to protocol|0|||
144247735|NCT01764997|520104204|FG002|Run-in Period|Poor compliance to protocol|0|||
144247736|NCT01764997|520104205|FG003|Run-in Period|Poor compliance to protocol|0|||
144713115|NCT01270841|521804674|FG000|Overall Study|Did not qualify|6|||
144713116|NCT01270841|521804675|FG001|Overall Study|Did not qualify|3|||
144713117|NCT01270841|521804676|FG002|Overall Study|Did not qualify|4|||
144713118|NCT01270841|521804677|FG003|Overall Study|Did not qualify|5|||
144713119|NCT01270841|521804674|FG000|Overall Study|Protocol Violation|1|||
144713120|NCT01270841|521804675|FG001|Overall Study|Protocol Violation|5|||
144713121|NCT01270841|521804676|FG002|Overall Study|Protocol Violation|0|||
144713122|NCT01270841|521804677|FG003|Overall Study|Protocol Violation|0|||
144713123|NCT01270841|521804674|FG000|Overall Study|Enrolled in error|0|||
144713124|NCT01270841|521804675|FG001|Overall Study|Enrolled in error|1|||
144713125|NCT01270841|521804676|FG002|Overall Study|Enrolled in error|0|||
144713126|NCT01270841|521804677|FG003|Overall Study|Enrolled in error|0|||
144713127|NCT04242186|521804688|FG000|Overall Study|Death|5|||
144713128|NCT04356573|521804694|FG000|Overall Study|Didn't Qualify|1|||
144713129|NCT04356573|521804695|FG001|Overall Study|Didn't Qualify|0|||
144713130|NCT03650400|521804696|FG000|Overall Study|Study terminated by sponsor|0|||
144713131|NCT03650400|521804697|FG001|Overall Study|Study terminated by sponsor|5|||
144713132|NCT01965535|521804704|FG000|Overall Study|Lack of Efficacy|2|||
144713133|NCT01965535|521804705|FG001|Overall Study|Lack of Efficacy|1|||
144713134|NCT01889862|521804706|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
144713135|NCT01889862|521804707|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
144713136|NCT01889862|521804708|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
144713137|NCT01889862|521804709|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
144713138|NCT01889862|521804710|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
144713139|NCT01889862|521804706|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
144713140|NCT01889862|521804707|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
144713141|NCT01889862|521804708|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
144713142|NCT01889862|521804709|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
144713143|NCT01889862|521804710|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
144713144|NCT01889862|521804706|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
144713145|NCT01889862|521804707|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
144713146|NCT01889862|521804708|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
144713147|NCT01889862|521804709|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
144713148|NCT01889862|521804710|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
144713149|NCT01889862|521804706|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
144713150|NCT01889862|521804707|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
144713151|NCT01889862|521804708|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
144713152|NCT01889862|521804709|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
144713153|NCT01889862|521804710|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
144713154|NCT01889862|521804706|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
144713155|NCT01889862|521804707|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
144713156|NCT01889862|521804708|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
144713157|NCT01889862|521804709|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
144713158|NCT01889862|521804710|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
144713159|NCT01889862|521804706|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
144713160|NCT01889862|521804707|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
144713161|NCT01889862|521804708|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
144713162|NCT01889862|521804709|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
144713163|NCT01889862|521804710|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
144713164|NCT01889862|521804706|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
144713165|NCT01889862|521804707|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
144713166|NCT01889862|521804708|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
144713167|NCT01889862|521804709|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
144713168|NCT01889862|521804710|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
144713169|NCT01889862|521804706|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
144713170|NCT01889862|521804707|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
144713171|NCT01889862|521804708|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
144713172|NCT01889862|521804709|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
144713173|NCT01889862|521804710|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
144713174|NCT01889862|521804706|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
144713175|NCT01889862|521804707|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
144713176|NCT01889862|521804708|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
144713177|NCT01889862|521804709|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
144713178|NCT01889862|521804710|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
144713179|NCT01889862|521804706|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
144713180|NCT01889862|521804707|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
144713181|NCT01889862|521804708|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
144713182|NCT01889862|521804709|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
144713183|NCT01889862|521804710|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
144713184|NCT01325532|521804711|FG000|Overall Study|Withdrawal by Subject|2|||
144713185|NCT01325532|521804712|FG001|Overall Study|Withdrawal by Subject|0|||
144713186|NCT01749033|521804717|FG000|Overall Study|Did not receive allocated intervention|3|||
144713187|NCT01749033|521804718|FG001|Overall Study|Did not receive allocated intervention|3|||
144713188|NCT01749033|521804719|FG002|Overall Study|Did not receive allocated intervention|0|||
144713189|NCT01749033|521804717|FG000|Overall Study|Lost to Follow-up|0|||
144713190|NCT01749033|521804718|FG001|Overall Study|Lost to Follow-up|2|||
144713191|NCT01749033|521804719|FG002|Overall Study|Lost to Follow-up|1|||
144713192|NCT03056001|521804720|FG000|Overall Study|Death|24|||
144713193|NCT01364298|521804723|FG000|Overall Study|Adverse Event|3|||
144713194|NCT01364298|521804724|FG001|Overall Study|Adverse Event|4|||
144713195|NCT01364298|521804723|FG000|Overall Study|Lack of adherence to treatment|1|||
144713196|NCT01364298|521804724|FG001|Overall Study|Lack of adherence to treatment|3|||
144713197|NCT01364298|521804723|FG000|Overall Study|Lack of Efficacy|1|||
144713198|NCT01364298|521804724|FG001|Overall Study|Lack of Efficacy|0|||
144713199|NCT01364298|521804723|FG000|Overall Study|Lost to Follow-up|5|||
144713200|NCT01364298|521804724|FG001|Overall Study|Lost to Follow-up|10|||
144713201|NCT01364298|521804723|FG000|Overall Study|Withdrawal by Subject|3|||
144713202|NCT01364298|521804724|FG001|Overall Study|Withdrawal by Subject|3|||
144713203|NCT01364298|521804723|FG000|Overall Study|Other|1|||
144713204|NCT01364298|521804724|FG001|Overall Study|Other|3|||
144713205|NCT01864525|521804725|FG000|Overall Study|Adverse Event|1|||
144713206|NCT01864525|521804726|FG001|Overall Study|Adverse Event|0|||
144713207|NCT03296553|521804728|FG000|Overall Study|Withdrawal by Subject|1|||
144713208|NCT03296553|521804729|FG001|Overall Study|Withdrawal by Subject|1|||
144713209|NCT03296553|521804728|FG000|Overall Study|Death|1|||
144713210|NCT03296553|521804729|FG001|Overall Study|Death|0|||
144713211|NCT02295280|521804730|FG000|Overall Study|Adverse Event|0|||
144713212|NCT02295280|521804731|FG001|Overall Study|Adverse Event|1|||
144713213|NCT02875067|521804732|FG000|Overall Study|Withdrawal by Subject|1|||
144713214|NCT02875067|521804732|FG000|Overall Study|Withdrawal by Termination of Study|5|||
144713215|NCT00065065|521804733|FG000|Overall Study|Adverse Event|3|||
144713216|NCT00065065|521804734|FG001|Overall Study|Adverse Event|2|||
144713217|NCT00065065|521804733|FG000|Overall Study|Withdrawal by Subject|1|||
144713218|NCT00065065|521804734|FG001|Overall Study|Withdrawal by Subject|5|||
144713219|NCT00065065|521804733|FG000|Overall Study|Lack of Efficacy|4|||
144713220|NCT00065065|521804734|FG001|Overall Study|Lack of Efficacy|11|||
144713221|NCT00065065|521804733|FG000|Overall Study|Other|2|||
144713222|NCT00065065|521804734|FG001|Overall Study|Other|2|||
144713223|NCT04363736|521804736|FG000|Overall Study|Withdrawal by Subject|1|||
144713224|NCT04363736|521804737|FG001|Overall Study|Withdrawal by Subject|0|||
144713225|NCT04363736|521804736|FG000|Overall Study|Lost to Follow-up|10|||
144713226|NCT04363736|521804737|FG001|Overall Study|Lost to Follow-up|7|||
144713227|NCT04363736|521804736|FG000|Overall Study|Death|8|||
144713228|NCT04363736|521804737|FG001|Overall Study|Death|6|||
144713229|NCT01050673|521804738|FG000|Overall Study|Physician Decision|4|||
144713230|NCT01050673|521804739|FG001|Overall Study|Physician Decision|5|||
144713231|NCT03056352|521804740|FG000|Overall Study|Lost to Follow-up|1|||
144713232|NCT01254045|521804741|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
144713233|NCT01254045|521804742|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
144713234|NCT01254045|521804743|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
144713235|NCT01254045|521804744|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
144713236|NCT01254045|521804745|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
144713237|NCT01254045|521804746|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
144713238|NCT02971605|521804747|FG000|Overall Study|Withdrawal by Subject|1|||
144368835|NCT00935584|520559953|FG001|Overall Study|No show|0|||
144368836|NCT00935584|520559952|FG000|Overall Study|Relocated|3|||
144713239|NCT00597207|521804748|FG000|Overall Study|Lost to Follow-up|5|||
144713240|NCT00597207|521804749|FG001|Overall Study|Lost to Follow-up|7|||
144713241|NCT00520351|521804750|FG000|First Intervention|Withdrawal by Subject|1|||
144713242|NCT00520351|521804751|FG001|First Intervention|Withdrawal by Subject|1|||
144713243|NCT03797222|521804755|FG000|Overall Study|Withdrawal by Subject|1|||
144713244|NCT03077828|521804757|FG000|Treatment Cycles|Death|1|||
144713245|NCT03077828|521804757|FG000|Treatment Cycles|Withdrawal by Subject|1|||
144713246|NCT03077828|521804757|FG000|Treatment Cycles|Screen Fail|2|||
144713247|NCT03077828|521804757|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
144713248|NCT03077828|521804757|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
144713249|NCT03077828|521804757|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
144713250|NCT03077828|521804757|FG000|Follow-up|Patients still in follow-up|15|||
144713251|NCT00435825|521804762|FG000|Overall Study|Abnormality of Laboratory Test|0|||
144713252|NCT00435825|521804763|FG001|Overall Study|Abnormality of Laboratory Test|1|||
144713253|NCT00435825|521804764|FG002|Overall Study|Abnormality of Laboratory Test|0|||
144713254|NCT00435825|521804765|FG003|Overall Study|Abnormality of Laboratory Test|0|||
144713255|NCT00435825|521804762|FG000|Overall Study|Insufficient Therapeutic Response|3|||
144713256|NCT00435825|521804763|FG001|Overall Study|Insufficient Therapeutic Response|1|||
144368837|NCT00935584|520559953|FG001|Overall Study|Relocated|0|||
144368838|NCT00935584|520559952|FG000|Overall Study|Patient changed provider|3|||
144538214|NCT00146172|521174127|FG005|Overall Study|Death|0|||
144368839|NCT00935584|520559953|FG001|Overall Study|Patient changed provider|0|||
144713257|NCT00435825|521804764|FG002|Overall Study|Insufficient Therapeutic Response|0|||
144713258|NCT00435825|521804765|FG003|Overall Study|Insufficient Therapeutic Response|3|||
144713259|NCT00435825|521804762|FG000|Overall Study|Other Protocol Violation|1|||
144713260|NCT00435825|521804763|FG001|Overall Study|Other Protocol Violation|0|||
144713261|NCT00435825|521804764|FG002|Overall Study|Other Protocol Violation|0|||
144713262|NCT00435825|521804765|FG003|Overall Study|Other Protocol Violation|0|||
144713263|NCT00435825|521804762|FG000|Overall Study|Refused treatment|2|||
144713264|NCT00435825|521804763|FG001|Overall Study|Refused treatment|0|||
144713265|NCT00435825|521804764|FG002|Overall Study|Refused treatment|0|||
144713266|NCT00435825|521804765|FG003|Overall Study|Refused treatment|5|||
144713267|NCT00435825|521804762|FG000|Overall Study|Failure to return|5|||
144713268|NCT00435825|521804763|FG001|Overall Study|Failure to return|0|||
144713269|NCT00435825|521804764|FG002|Overall Study|Failure to return|4|||
144713270|NCT00435825|521804765|FG003|Overall Study|Failure to return|0|||
144713271|NCT00435825|521804762|FG000|Overall Study|Did not receive study drug|1|||
144713272|NCT00435825|521804763|FG001|Overall Study|Did not receive study drug|0|||
144713273|NCT00435825|521804764|FG002|Overall Study|Did not receive study drug|2|||
144713274|NCT00435825|521804765|FG003|Overall Study|Did not receive study drug|0|||
144713275|NCT00435825|521804762|FG000|Overall Study|Did not enter follow-up|0|||
144713276|NCT00435825|521804763|FG001|Overall Study|Did not enter follow-up|4|||
144713277|NCT00435825|521804764|FG002|Overall Study|Did not enter follow-up|1|||
144713278|NCT00435825|521804765|FG003|Overall Study|Did not enter follow-up|3|||
144713279|NCT00435825|521804762|FG000|Overall Study|Did not complete full follow-up period|6|||
144713280|NCT00435825|521804763|FG001|Overall Study|Did not complete full follow-up period|6|||
144713281|NCT00435825|521804764|FG002|Overall Study|Did not complete full follow-up period|4|||
144713282|NCT00435825|521804765|FG003|Overall Study|Did not complete full follow-up period|5|||
144713283|NCT00430638|521804766|FG000|Overall Study|Adverse Event|15|||
144713284|NCT00430638|521804767|FG001|Overall Study|Adverse Event|15|||
144713285|NCT00430638|521804766|FG000|Overall Study|Uncontrolled blood pressure|48|||
144713286|NCT00430638|521804767|FG001|Overall Study|Uncontrolled blood pressure|13|||
144713287|NCT00430638|521804766|FG000|Overall Study|Lost to Follow-up|1|||
144713288|NCT00430638|521804767|FG001|Overall Study|Lost to Follow-up|7|||
144713289|NCT00430638|521804766|FG000|Overall Study|Protocol Violation|6|||
144713290|NCT00430638|521804767|FG001|Overall Study|Protocol Violation|4|||
144713291|NCT00430638|521804766|FG000|Overall Study|Withdrawal by Subject|4|||
144713292|NCT00430638|521804767|FG001|Overall Study|Withdrawal by Subject|6|||
144713293|NCT00430638|521804766|FG000|Overall Study|Non-compliant|2|||
144713294|NCT00430638|521804767|FG001|Overall Study|Non-compliant|1|||
144713295|NCT00430638|521804766|FG000|Overall Study|Other|2|||
144713296|NCT00430638|521804767|FG001|Overall Study|Other|2|||
144713297|NCT02367781|521804768|FG000|Overall Study|Withdrawal by Subject|20|||
144713298|NCT02367781|521804769|FG001|Overall Study|Withdrawal by Subject|13|||
144713299|NCT02367781|521804768|FG000|Overall Study|Protocol Violation|0|||
144713300|NCT02367781|521804769|FG001|Overall Study|Protocol Violation|1|||
144713301|NCT02367781|521804768|FG000|Overall Study|Physician Decision|7|||
144713302|NCT02367781|521804769|FG001|Overall Study|Physician Decision|0|||
144713303|NCT02367781|521804768|FG000|Overall Study|Randomized in Error|5|||
144713304|NCT02367781|521804769|FG001|Overall Study|Randomized in Error|4|||
144713305|NCT02367781|521804768|FG000|Overall Study|Non-Compliance|1|||
144713306|NCT02367781|521804769|FG001|Overall Study|Non-Compliance|0|||
144713307|NCT02367781|521804768|FG000|Overall Study|Lost to Follow-up|1|||
144713308|NCT02367781|521804769|FG001|Overall Study|Lost to Follow-up|2|||
144713309|NCT02367781|521804768|FG000|Overall Study|Death|330|||
144713310|NCT02367781|521804769|FG001|Overall Study|Death|176|||
144713311|NCT02367781|521804768|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
144713312|NCT02367781|521804769|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
144713313|NCT02367781|521804768|FG000|Overall Study|Prolonged Hospitalization|1|||
144713314|NCT02367781|521804769|FG001|Overall Study|Prolonged Hospitalization|0|||
144713315|NCT02367781|521804768|FG000|Overall Study|Death Prior First Dose|1|||
144713316|NCT02367781|521804769|FG001|Overall Study|Death Prior First Dose|0|||
144713317|NCT02367781|521804768|FG000|Overall Study|Administrative-Change Facility|1|||
144713318|NCT02367781|521804769|FG001|Overall Study|Administrative-Change Facility|0|||
144713319|NCT02367781|521804768|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
144713320|NCT02367781|521804769|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
144713321|NCT02367781|521804768|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
144713322|NCT02367781|521804769|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
144713323|NCT02367781|521804768|FG000|Overall Study|Study Terminated by Sponsor|3|||
144713324|NCT02367781|521804769|FG001|Overall Study|Study Terminated by Sponsor|1|||
144713325|NCT02367781|521804768|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
144713326|NCT02367781|521804769|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
144713327|NCT02367781|521804768|FG000|Overall Study|Sponsor Decision|2|||
144713328|NCT02367781|521804769|FG001|Overall Study|Sponsor Decision|0|||
144713329|NCT02367781|521804768|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
144538215|NCT00146172|521174128|FG006|Overall Study|Death|1|||
144713330|NCT02367781|521804769|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
144713331|NCT01529749|521804770|FG000|Overall Study|Lost to Follow-up|0|||
144713332|NCT01529749|521804771|FG001|Overall Study|Lost to Follow-up|1|||
144713333|NCT01529749|521804772|FG002|Overall Study|Lost to Follow-up|1|||
144713334|NCT01529749|521804773|FG003|Overall Study|Lost to Follow-up|0|||
144713335|NCT01529749|521804770|FG000|Overall Study|Physician Decision|0|||
144713336|NCT01529749|521804771|FG001|Overall Study|Physician Decision|0|||
144713337|NCT01529749|521804772|FG002|Overall Study|Physician Decision|0|||
144713338|NCT01529749|521804773|FG003|Overall Study|Physician Decision|1|||
144713339|NCT01529749|521804770|FG000|Overall Study|Withdrawal by Subject|0|||
144713340|NCT01529749|521804771|FG001|Overall Study|Withdrawal by Subject|1|||
144713341|NCT01529749|521804772|FG002|Overall Study|Withdrawal by Subject|1|||
144713342|NCT01529749|521804773|FG003|Overall Study|Withdrawal by Subject|0|||
144713343|NCT01529749|521804770|FG000|Overall Study|Protocol Violation|0|||
144713344|NCT01529749|521804771|FG001|Overall Study|Protocol Violation|0|||
144713345|NCT01529749|521804772|FG002|Overall Study|Protocol Violation|0|||
144713346|NCT01529749|521804773|FG003|Overall Study|Protocol Violation|1|||
144713347|NCT00789828|521804774|FG000|Core Period (48 Weeks)|Administrative problems|0|||
144713348|NCT00789828|521804775|FG001|Core Period (48 Weeks)|Administrative problems|1|||
144713349|NCT00789828|521804774|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
144713350|NCT00789828|521804775|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
144713351|NCT00789828|521804774|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
144713352|NCT00789828|521804775|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
144713353|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
144713354|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
144713355|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
144713356|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
144713357|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
144713358|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
144713359|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
144713360|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
144713361|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|Death|1|||
144713362|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|Death|0|||
144713363|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
144713364|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
144713365|NCT00789828|521804774|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
144713366|NCT00789828|521804775|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
144713367|NCT01133392|521804776|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
144713368|NCT01133392|521804777|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
144713369|NCT01133392|521804776|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
144713370|NCT01133392|521804777|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
144713371|NCT00378482|521804778|FG000|Overall Study|Lost to Follow-up|1|||
144713372|NCT00378482|521804778|FG000|Overall Study|Lack of Efficacy|8|||
144368840|NCT00935584|520559952|FG000|Overall Study|Provider dropped out of study|14|||
144368841|NCT00935584|520559953|FG001|Overall Study|Provider dropped out of study|4|||
144368842|NCT00687193|520559960|FG000|Overall Study|Adverse Event|0|||
144368843|NCT00687193|520559961|FG001|Overall Study|Adverse Event|1|||
144368844|NCT00687193|520559962|FG002|Overall Study|Adverse Event|2|||
144368845|NCT00687193|520559963|FG003|Overall Study|Adverse Event|3|||
144368846|NCT00687193|520559964|FG004|Overall Study|Adverse Event|0|||
144368847|NCT00687193|520559965|FG005|Overall Study|Adverse Event|2|||
144368848|NCT00687193|520559960|FG000|Overall Study|Lack of Efficacy|1|||
144368849|NCT00687193|520559961|FG001|Overall Study|Lack of Efficacy|1|||
144368850|NCT00687193|520559962|FG002|Overall Study|Lack of Efficacy|0|||
144368851|NCT00687193|520559963|FG003|Overall Study|Lack of Efficacy|0|||
144368852|NCT00687193|520559964|FG004|Overall Study|Lack of Efficacy|0|||
144368853|NCT00687193|520559965|FG005|Overall Study|Lack of Efficacy|2|||
144368854|NCT00687193|520559960|FG000|Overall Study|Protocol Violation|1|||
144368855|NCT00687193|520559961|FG001|Overall Study|Protocol Violation|2|||
144368856|NCT00687193|520559962|FG002|Overall Study|Protocol Violation|0|||
144368857|NCT00687193|520559963|FG003|Overall Study|Protocol Violation|1|||
144368858|NCT00687193|520559964|FG004|Overall Study|Protocol Violation|2|||
144368859|NCT00687193|520559965|FG005|Overall Study|Protocol Violation|0|||
144368860|NCT01394016|520559966|FG000|Overall Study|Progressive Disease|2|||
144368861|NCT01394016|520559967|FG001|Overall Study|Progressive Disease|0|||
144368862|NCT01394016|520559968|FG002|Overall Study|Progressive Disease|0|||
144368863|NCT01394016|520559969|FG003|Overall Study|Progressive Disease|0|||
144368864|NCT01394016|520559970|FG004|Overall Study|Progressive Disease|0|||
144368865|NCT01394016|520559971|FG005|Overall Study|Progressive Disease|0|||
144368866|NCT01394016|520559972|FG006|Overall Study|Progressive Disease|0|||
144368867|NCT01394016|520559973|FG007|Overall Study|Progressive Disease|0|||
144368868|NCT01394016|520559974|FG008|Overall Study|Progressive Disease|0|||
144368869|NCT01394016|520559975|FG009|Overall Study|Progressive Disease|0|||
144368870|NCT01394016|520559976|FG010|Overall Study|Progressive Disease|0|||
144368871|NCT01394016|520559977|FG011|Overall Study|Progressive Disease|0|||
144368872|NCT01394016|520559978|FG012|Overall Study|Progressive Disease|0|||
144713373|NCT00378482|521804778|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
144713374|NCT00378482|521804778|FG000|Overall Study|Withdrawal by Subject|4|||
144713375|NCT00378482|521804778|FG000|Overall Study|Adverse Event|9|||
144713376|NCT03202511|521806343|FG000|Overall Study|Withdrawal by Subject|1|||
144713377|NCT03202511|521806344|FG001|Overall Study|Withdrawal by Subject|0|||
144713378|NCT00686790|521806345|FG000|Overall Study|Adverse Event|2|||
144713379|NCT00686790|521806345|FG000|Overall Study|Withdrawal by Subject|1|||
144368873|NCT01394016|520559979|FG013|Overall Study|Progressive Disease|0|||
144368874|NCT01394016|520559980|FG014|Overall Study|Progressive Disease|0|||
144368875|NCT01394016|520559981|FG015|Overall Study|Progressive Disease|0|||
144368876|NCT01394016|520559982|FG016|Overall Study|Progressive Disease|0|||
144368877|NCT01394016|520559983|FG017|Overall Study|Progressive Disease|0|||
144368878|NCT01394016|520559984|FG018|Overall Study|Progressive Disease|0|||
144368879|NCT01394016|520559966|FG000|Overall Study|Withdrawal by Subject|0|||
144368880|NCT01394016|520559967|FG001|Overall Study|Withdrawal by Subject|0|||
144368881|NCT01394016|520559968|FG002|Overall Study|Withdrawal by Subject|0|||
144368882|NCT01394016|520559969|FG003|Overall Study|Withdrawal by Subject|0|||
144368883|NCT01394016|520559970|FG004|Overall Study|Withdrawal by Subject|0|||
144368884|NCT01394016|520559971|FG005|Overall Study|Withdrawal by Subject|0|||
144368885|NCT01394016|520559972|FG006|Overall Study|Withdrawal by Subject|0|||
144368886|NCT01394016|520559973|FG007|Overall Study|Withdrawal by Subject|1|||
144368887|NCT01394016|520559974|FG008|Overall Study|Withdrawal by Subject|1|||
144368888|NCT01394016|520559975|FG009|Overall Study|Withdrawal by Subject|1|||
144368889|NCT01394016|520559976|FG010|Overall Study|Withdrawal by Subject|4|||
144368890|NCT01394016|520559977|FG011|Overall Study|Withdrawal by Subject|0|||
144368891|NCT01394016|520559978|FG012|Overall Study|Withdrawal by Subject|0|||
144368892|NCT01394016|520559979|FG013|Overall Study|Withdrawal by Subject|3|||
144368893|NCT01394016|520559980|FG014|Overall Study|Withdrawal by Subject|1|||
144368894|NCT01394016|520559981|FG015|Overall Study|Withdrawal by Subject|3|||
144368895|NCT01394016|520559982|FG016|Overall Study|Withdrawal by Subject|1|||
144368896|NCT01394016|520559983|FG017|Overall Study|Withdrawal by Subject|1|||
144368897|NCT01394016|520559984|FG018|Overall Study|Withdrawal by Subject|2|||
144368898|NCT01394016|520559966|FG000|Overall Study|Adverse Event|0|||
144368899|NCT01394016|520559967|FG001|Overall Study|Adverse Event|0|||
144368900|NCT01394016|520559968|FG002|Overall Study|Adverse Event|0|||
144368901|NCT01394016|520559969|FG003|Overall Study|Adverse Event|0|||
144368902|NCT01394016|520559970|FG004|Overall Study|Adverse Event|0|||
144368903|NCT01394016|520559971|FG005|Overall Study|Adverse Event|0|||
144368904|NCT01394016|520559972|FG006|Overall Study|Adverse Event|0|||
144368905|NCT01394016|520559973|FG007|Overall Study|Adverse Event|0|||
144368906|NCT01394016|520559974|FG008|Overall Study|Adverse Event|0|||
144368907|NCT01394016|520559975|FG009|Overall Study|Adverse Event|1|||
144368908|NCT01394016|520559976|FG010|Overall Study|Adverse Event|0|||
144368909|NCT01394016|520559977|FG011|Overall Study|Adverse Event|0|||
144368910|NCT01394016|520559978|FG012|Overall Study|Adverse Event|0|||
144368911|NCT01394016|520559979|FG013|Overall Study|Adverse Event|0|||
144368912|NCT01394016|520559980|FG014|Overall Study|Adverse Event|0|||
144368913|NCT01394016|520559981|FG015|Overall Study|Adverse Event|0|||
144368914|NCT01394016|520559982|FG016|Overall Study|Adverse Event|1|||
144368915|NCT01394016|520559983|FG017|Overall Study|Adverse Event|1|||
144368916|NCT01394016|520559984|FG018|Overall Study|Adverse Event|0|||
144368917|NCT01394016|520559966|FG000|Overall Study|Sponsor Decision|0|||
144368918|NCT01394016|520559967|FG001|Overall Study|Sponsor Decision|0|||
144368919|NCT01394016|520559968|FG002|Overall Study|Sponsor Decision|0|||
144368920|NCT01394016|520559969|FG003|Overall Study|Sponsor Decision|0|||
144368921|NCT01394016|520559970|FG004|Overall Study|Sponsor Decision|0|||
144368922|NCT01394016|520559971|FG005|Overall Study|Sponsor Decision|0|||
144368923|NCT01394016|520559972|FG006|Overall Study|Sponsor Decision|0|||
144368924|NCT01394016|520559973|FG007|Overall Study|Sponsor Decision|0|||
144368925|NCT01394016|520559974|FG008|Overall Study|Sponsor Decision|0|||
144368926|NCT01394016|520559975|FG009|Overall Study|Sponsor Decision|0|||
144368927|NCT01394016|520559976|FG010|Overall Study|Sponsor Decision|0|||
144368928|NCT01394016|520559977|FG011|Overall Study|Sponsor Decision|0|||
144368929|NCT01394016|520559978|FG012|Overall Study|Sponsor Decision|1|||
144368930|NCT01394016|520559979|FG013|Overall Study|Sponsor Decision|0|||
144368931|NCT01394016|520559980|FG014|Overall Study|Sponsor Decision|0|||
144368932|NCT01394016|520559981|FG015|Overall Study|Sponsor Decision|0|||
144368933|NCT01394016|520559982|FG016|Overall Study|Sponsor Decision|0|||
144368934|NCT01394016|520559983|FG017|Overall Study|Sponsor Decision|0|||
144368935|NCT01394016|520559984|FG018|Overall Study|Sponsor Decision|0|||
144368936|NCT01394016|520559966|FG000|Overall Study|Lost to Follow-up|0|||
144368937|NCT01394016|520559967|FG001|Overall Study|Lost to Follow-up|0|||
144368938|NCT01394016|520559968|FG002|Overall Study|Lost to Follow-up|0|||
144368939|NCT01394016|520559969|FG003|Overall Study|Lost to Follow-up|0|||
144368940|NCT01394016|520559970|FG004|Overall Study|Lost to Follow-up|0|||
144368941|NCT01394016|520559971|FG005|Overall Study|Lost to Follow-up|0|||
144368942|NCT01394016|520559972|FG006|Overall Study|Lost to Follow-up|0|||
144368943|NCT01394016|520559973|FG007|Overall Study|Lost to Follow-up|0|||
144368944|NCT01394016|520559974|FG008|Overall Study|Lost to Follow-up|0|||
144713380|NCT00686790|521806345|FG000|Overall Study|Death|1|||
144713381|NCT00686790|521806345|FG000|Overall Study|Lost to Follow-up|12|||
144713382|NCT00096382|521806346|FG000|Overall Study|Not treated|1|||
144713383|NCT00096382|521806347|FG001|Overall Study|Not treated|0|||
144713384|NCT00096382|521806346|FG000|Overall Study|Death during treatment|1|||
144713385|NCT00096382|521806347|FG001|Overall Study|Death during treatment|0|||
144713386|NCT01375010|521806348|FG000|Overall Study|Lost to Follow-up|8|||
144713387|NCT01375010|521806349|FG001|Overall Study|Lost to Follow-up|2|||
144713388|NCT01375010|521806348|FG000|Overall Study|Withdrawal by Subject|4|||
144713389|NCT01375010|521806349|FG001|Overall Study|Withdrawal by Subject|2|||
144713390|NCT02614703|521806350|FG000|Overall Study|Withdrawal by Subject|7|||
144713391|NCT02614703|521806351|FG001|Overall Study|Withdrawal by Subject|1|||
144713392|NCT01681771|521806352|FG000|Overall Study|Lost to Follow-up|4|||
144713393|NCT01681771|521806353|FG001|Overall Study|Lost to Follow-up|2|||
144713394|NCT00331773|521806354|FG000|Overall Study|Withdrawal by Subject|6|||
144713395|NCT00331773|521806355|FG001|Overall Study|Withdrawal by Subject|4|||
144713396|NCT00331773|521806354|FG000|Overall Study|Protocol Violation|10|||
144713397|NCT00331773|521806355|FG001|Overall Study|Protocol Violation|3|||
144713398|NCT01792284|521806356|FG000|Lead-in Period|Adverse Event|15|||
144713399|NCT01792284|521806357|FG001|Lead-in Period|Adverse Event|0|||
144713400|NCT01792284|521806358|FG002|Lead-in Period|Adverse Event|0|||
144713401|NCT01792284|521806356|FG000|Lead-in Period|Lost to Follow-up|2|||
144713402|NCT01792284|521806357|FG001|Lead-in Period|Lost to Follow-up|0|||
144713403|NCT01792284|521806358|FG002|Lead-in Period|Lost to Follow-up|0|||
144713404|NCT01792284|521806356|FG000|Lead-in Period|Protocol Violation|1|||
144713405|NCT01792284|521806357|FG001|Lead-in Period|Protocol Violation|0|||
144713406|NCT01792284|521806358|FG002|Lead-in Period|Protocol Violation|0|||
144713407|NCT01792284|521806356|FG000|Lead-in Period|Withdrawal by Subject|10|||
144713408|NCT01792284|521806357|FG001|Lead-in Period|Withdrawal by Subject|0|||
144713409|NCT01792284|521806358|FG002|Lead-in Period|Withdrawal by Subject|0|||
144713410|NCT01792284|521806356|FG000|Lead-in Period|Physician Decision|1|||
144713411|NCT01792284|521806357|FG001|Lead-in Period|Physician Decision|0|||
144713412|NCT01792284|521806358|FG002|Lead-in Period|Physician Decision|0|||
144713413|NCT01792284|521806356|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
144713414|NCT01792284|521806357|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
144713415|NCT01792284|521806358|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
144713416|NCT01792284|521806356|FG000|Randomization Period 1|Withdrawal by Subject|0|||
144713417|NCT01792284|521806357|FG001|Randomization Period 1|Withdrawal by Subject|1|||
144713418|NCT01792284|521806358|FG002|Randomization Period 1|Withdrawal by Subject|1|||
144713419|NCT01792284|521806356|FG000|Randomization Period 1|Physician Decision|0|||
144713420|NCT01792284|521806357|FG001|Randomization Period 1|Physician Decision|1|||
144713421|NCT01792284|521806358|FG002|Randomization Period 1|Physician Decision|1|||
144713422|NCT01792284|521806356|FG000|Randomization Period 1|Adverse Event|0|||
144713423|NCT01792284|521806357|FG001|Randomization Period 1|Adverse Event|0|||
144713424|NCT01792284|521806358|FG002|Randomization Period 1|Adverse Event|2|||
144713425|NCT01792284|521806356|FG000|Randomization Period 1|Lost to Follow-up|0|||
144713426|NCT01792284|521806357|FG001|Randomization Period 1|Lost to Follow-up|0|||
144713427|NCT01792284|521806358|FG002|Randomization Period 1|Lost to Follow-up|1|||
144713428|NCT01792284|521806356|FG000|Randomization Period 2|Protocol Violation|0|||
144713429|NCT01792284|521806357|FG001|Randomization Period 2|Protocol Violation|1|||
144713430|NCT01792284|521806358|FG002|Randomization Period 2|Protocol Violation|0|||
144713431|NCT01792284|521806356|FG000|Randomization Period 2|Withdrawal by Subject|0|||
144713432|NCT01792284|521806357|FG001|Randomization Period 2|Withdrawal by Subject|2|||
144713433|NCT01792284|521806358|FG002|Randomization Period 2|Withdrawal by Subject|0|||
144713434|NCT00379587|521806364|FG000|Overall Study|Lost to Follow-up|2|||
144713435|NCT00775983|521806365|FG000|Overall Study|Protocol Violation|1|||
144713436|NCT00775983|521806366|FG001|Overall Study|Protocol Violation|2|||
144713437|NCT01059071|521806367|FG000|Overall Study|Lack of Efficacy|1|||
144713438|NCT01059071|521806368|FG001|Overall Study|Lack of Efficacy|4|||
144713439|NCT01059071|521806369|FG002|Overall Study|Lack of Efficacy|2|||
144713440|NCT01059071|521806370|FG003|Overall Study|Lack of Efficacy|3|||
144713441|NCT01059071|521806367|FG000|Overall Study|Withdrawal by Subject|1|||
144713442|NCT01059071|521806368|FG001|Overall Study|Withdrawal by Subject|0|||
144713443|NCT01059071|521806369|FG002|Overall Study|Withdrawal by Subject|0|||
144713444|NCT01059071|521806370|FG003|Overall Study|Withdrawal by Subject|2|||
144713445|NCT01059071|521806367|FG000|Overall Study|Physician Decision|0|||
144713446|NCT01059071|521806368|FG001|Overall Study|Physician Decision|0|||
144713447|NCT01059071|521806369|FG002|Overall Study|Physician Decision|0|||
144713448|NCT01059071|521806370|FG003|Overall Study|Physician Decision|1|||
144713449|NCT01314703|521806371|FG000|Overall Study|screen failure and closed enrollment|8|||
144713450|NCT00597584|521806372|FG000|Overall Study|Adverse Event|4|||
144713451|NCT00597584|521806373|FG001|Overall Study|Adverse Event|2|||
144713452|NCT00597584|521806372|FG000|Overall Study|Death|53|||
144713453|NCT00597584|521806373|FG001|Overall Study|Death|30|||
144713454|NCT00597584|521806372|FG000|Overall Study|Lack of Efficacy|1|||
144713455|NCT00597584|521806373|FG001|Overall Study|Lack of Efficacy|0|||
144713456|NCT00597584|521806372|FG000|Overall Study|Lost to Follow-up|2|||
144713457|NCT00597584|521806373|FG001|Overall Study|Lost to Follow-up|4|||
144713458|NCT00597584|521806372|FG000|Overall Study|Physician Decision|3|||
144713459|NCT00597584|521806373|FG001|Overall Study|Physician Decision|0|||
144713460|NCT00597584|521806372|FG000|Overall Study|Pregnancy|2|||
144713461|NCT00597584|521806373|FG001|Overall Study|Pregnancy|0|||
144713462|NCT00597584|521806372|FG000|Overall Study|Withdrawal by Subject|44|||
144713463|NCT00597584|521806373|FG001|Overall Study|Withdrawal by Subject|12|||
144713464|NCT00597584|521806372|FG000|Overall Study|Discontinued Dialysis|0|||
144713465|NCT00597584|521806373|FG001|Overall Study|Discontinued Dialysis|1|||
144713466|NCT00597584|521806372|FG000|Overall Study|Lost ability to consent|1|||
144713467|NCT00597584|521806373|FG001|Overall Study|Lost ability to consent|1|||
144713468|NCT00597584|521806372|FG000|Overall Study|Never dosed|1|||
144368945|NCT01394016|520559975|FG009|Overall Study|Lost to Follow-up|0|||
144368946|NCT01394016|520559976|FG010|Overall Study|Lost to Follow-up|0|||
144368947|NCT01394016|520559977|FG011|Overall Study|Lost to Follow-up|0|||
144368948|NCT01394016|520559978|FG012|Overall Study|Lost to Follow-up|0|||
144368949|NCT01394016|520559979|FG013|Overall Study|Lost to Follow-up|0|||
144368950|NCT01394016|520559980|FG014|Overall Study|Lost to Follow-up|0|||
144368951|NCT01394016|520559981|FG015|Overall Study|Lost to Follow-up|0|||
144368952|NCT01394016|520559982|FG016|Overall Study|Lost to Follow-up|0|||
144368953|NCT01394016|520559983|FG017|Overall Study|Lost to Follow-up|0|||
144368954|NCT01394016|520559984|FG018|Overall Study|Lost to Follow-up|1|||
144368955|NCT03534804|520559985|FG000|Overall Study|Withdrawal by Subject|1|||
144368956|NCT00174187|520559989|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
144368957|NCT00174187|520559990|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
144713469|NCT00597584|521806373|FG001|Overall Study|Never dosed|0|||
144713470|NCT00597584|521806372|FG000|Overall Study|Relocation|8|||
144713471|NCT00597584|521806373|FG001|Overall Study|Relocation|6|||
144713472|NCT00597584|521806372|FG000|Overall Study|Renal transplant|9|||
144713473|NCT00597584|521806373|FG001|Overall Study|Renal transplant|7|||
144713474|NCT00515073|521806380|FG000|Overall Study|Withdrawal by Subject|1|||
144713475|NCT00515073|521806380|FG000|Overall Study|Physician Decision|1|||
144713476|NCT02791659|521806381|FG000|Overall Study|Protocol Violation|0|||
144713477|NCT02791659|521806382|FG001|Overall Study|Protocol Violation|1|||
144713478|NCT00881959|521806383|FG000|Overall Study|Lost to Follow-up|2|||
144713479|NCT00881959|521806384|FG001|Overall Study|Lost to Follow-up|4|||
144713480|NCT01456052|521806385|FG000|Overall Study|Adverse Event|1|||
144713481|NCT01456052|521806386|FG001|Overall Study|Adverse Event|1|||
144713482|NCT01456052|521806387|FG002|Overall Study|Adverse Event|2|||
144713483|NCT01456052|521806385|FG000|Overall Study|Consent withdrawn|0|||
144713484|NCT01456052|521806386|FG001|Overall Study|Consent withdrawn|2|||
144713485|NCT01456052|521806387|FG002|Overall Study|Consent withdrawn|1|||
144713486|NCT01456052|521806385|FG000|Overall Study|Protocol Violation|0|||
144713487|NCT01456052|521806386|FG001|Overall Study|Protocol Violation|1|||
144713488|NCT01456052|521806387|FG002|Overall Study|Protocol Violation|0|||
144713489|NCT01456052|521806385|FG000|Overall Study|Physician Decision|1|||
144713490|NCT01456052|521806386|FG001|Overall Study|Physician Decision|0|||
144713491|NCT01456052|521806387|FG002|Overall Study|Physician Decision|1|||
144713492|NCT01456052|521806385|FG000|Overall Study|Treatment Failure|0|||
144713493|NCT01456052|521806386|FG001|Overall Study|Treatment Failure|1|||
144713494|NCT01456052|521806387|FG002|Overall Study|Treatment Failure|1|||
144713495|NCT03840811|521806388|FG000|Overall Study|Lost to Follow-up|0|||
144713496|NCT03840811|521806389|FG001|Overall Study|Lost to Follow-up|0|||
144713497|NCT03840811|521806390|FG002|Overall Study|Lost to Follow-up|1|||
144713498|NCT01904383|521806391|FG000|Overall Study|CRF not collected|117|||
144713499|NCT01904383|521806391|FG000|Overall Study|Reason not listed|147|||
144713500|NCT01904383|521806391|FG000|Overall Study|Lost to Follow-up|674|||
144713501|NCT01904383|521806391|FG000|Overall Study|Lack of Efficacy|370|||
144713502|NCT01904383|521806391|FG000|Overall Study|Improvement|141|||
144713503|NCT01904383|521806391|FG000|Overall Study|Adverse Event|271|||
144713504|NCT01904383|521806391|FG000|Overall Study|No patient visit after entry|54|||
144713505|NCT01703741|521806392|FG000|Overall Study|Withdrawal by Subject|6|||
144713506|NCT01703741|521806392|FG000|Overall Study|Adverse Event|2|||
144713507|NCT01703741|521806392|FG000|Overall Study|Physician Decision|2|||
144713508|NCT01703741|521806392|FG000|Overall Study|Protocol Violation|1|||
144713509|NCT01703741|521806392|FG000|Overall Study|Lost to Follow-up|3|||
144713510|NCT01703741|521806392|FG000|Overall Study|Subject did not want to continue|2|||
144713511|NCT01703741|521806392|FG000|Overall Study|Subject cannot comply with study visits|1|||
144713512|NCT01703741|521806392|FG000|Overall Study|Subject started testosterone injections|1|||
144713513|NCT01368276|521806393|FG000|Overall Study|Death|1|||
144713514|NCT01368276|521806394|FG001|Overall Study|Death|10|||
144480935|NCT03176238|520959346|FG000|Overall Study|Changes in the patient's condition|2|||
144480936|NCT03176238|520959347|FG001|Overall Study|Changes in the patient's condition|1|||
144480937|NCT03176238|520959346|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
144480938|NCT03176238|520959347|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
144480939|NCT00550550|520959348|FG000|Overall Study|Adverse Event|13|||
144480940|NCT00550550|520959349|FG001|Overall Study|Adverse Event|5|||
144480941|NCT00550550|520959348|FG000|Overall Study|Treatment Failure|0|||
144480942|NCT00550550|520959349|FG001|Overall Study|Treatment Failure|1|||
144480943|NCT00550550|520959348|FG000|Overall Study|Lost to Follow-up|4|||
144480944|NCT00550550|520959349|FG001|Overall Study|Lost to Follow-up|0|||
144480945|NCT00550550|520959348|FG000|Overall Study|Withdrawal by Subject|10|||
144480946|NCT00550550|520959349|FG001|Overall Study|Withdrawal by Subject|8|||
144480947|NCT00550550|520959348|FG000|Overall Study|Protocol Violation|5|||
144480948|NCT00550550|520959349|FG001|Overall Study|Protocol Violation|14|||
144480949|NCT00550550|520959348|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
144538216|NCT00146172|521174129|FG007|Overall Study|Death|0|||
144713515|NCT03341273|521806395|FG000|Overall Study|Lost to Follow-up|7|||
144368958|NCT00174187|520559991|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
144368959|NCT00174187|520559989|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
144713516|NCT03341273|521806396|FG001|Overall Study|Lost to Follow-up|7|||
144713517|NCT03341273|521806395|FG000|Overall Study|Withdrawal by Subject|4|||
144713518|NCT03341273|521806396|FG001|Overall Study|Withdrawal by Subject|2|||
144713519|NCT03341273|521806395|FG000|Overall Study|Physician Decision|1|||
144713520|NCT03341273|521806396|FG001|Overall Study|Physician Decision|0|||
144713521|NCT03341273|521806395|FG000|Overall Study|Protocol Violation|0|||
144713522|NCT03341273|521806396|FG001|Overall Study|Protocol Violation|1|||
144713523|NCT03341273|521806395|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
144713524|NCT03341273|521806396|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
144713525|NCT03341273|521806395|FG000|Overall Study|Became ineligible after enrollment|1|||
144713526|NCT03341273|521806396|FG001|Overall Study|Became ineligible after enrollment|0|||
144713527|NCT03341273|521806395|FG000|Overall Study|Not Eligible at Enrollment|0|||
144713528|NCT03341273|521806396|FG001|Overall Study|Not Eligible at Enrollment|1|||
144713529|NCT03341273|521806395|FG000|Overall Study|Participant incarcerated|1|||
144713530|NCT03341273|521806396|FG001|Overall Study|Participant incarcerated|0|||
144713531|NCT02041494|521806397|FG000|Overall Study|Death|1|||
144713532|NCT02041494|521806398|FG001|Overall Study|Death|3|||
144713533|NCT02041494|521806397|FG000|Overall Study|Lost to Follow-up|2|||
144713534|NCT02041494|521806398|FG001|Overall Study|Lost to Follow-up|6|||
144713535|NCT02041494|521806397|FG000|Overall Study|study terminated|16|||
144713536|NCT02041494|521806398|FG001|Overall Study|study terminated|11|||
144713537|NCT01717456|521806399|FG000|End of Treatment|Physician Decision|0|||
144713538|NCT01717456|521806400|FG001|End of Treatment|Physician Decision|1|||
144713539|NCT01717456|521806399|FG000|End of Treatment|Lost to Follow-up|0|||
144713540|NCT01717456|521806400|FG001|End of Treatment|Lost to Follow-up|1|||
144713541|NCT01717456|521806399|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
144713542|NCT01717456|521806400|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
144713543|NCT02410837|521806401|FG000|Overall Study|Death|387|||
144713544|NCT02410837|521806401|FG000|Overall Study|Lost to Follow-up|50|||
144713545|NCT02410837|521806401|FG000|Overall Study|Withdrawal by Subject|44|||
144713546|NCT02410837|521806401|FG000|Overall Study|Physician Decision|6|||
144713547|NCT02410837|521806401|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
144713548|NCT01825876|521806403|FG000|Period 2|Withdrawal by Subject|0|||
144713549|NCT01825876|521806404|FG001|Period 2|Withdrawal by Subject|1|||
144713550|NCT03751020|521806407|FG000|Overall Study|Withdrawal by Subject|2|||
144713551|NCT03751020|521806408|FG001|Overall Study|Withdrawal by Subject|0|||
144713552|NCT03751020|521806409|FG002|Overall Study|Withdrawal by Subject|0|||
144713553|NCT03751020|521806407|FG000|Overall Study|Lost to Follow-up|7|||
144713554|NCT03751020|521806408|FG001|Overall Study|Lost to Follow-up|4|||
144713555|NCT03751020|521806409|FG002|Overall Study|Lost to Follow-up|10|||
144713556|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
144713557|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
144713558|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
144713559|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
144713560|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
144713561|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
144713562|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
144713563|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
144713564|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
144713565|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
144713566|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
144713567|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
144713568|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
144713569|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
144713570|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
144713571|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
144713572|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
144713573|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
144713574|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
144713575|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
144713576|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
144713577|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
144713578|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
144713579|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
144368960|NCT00174187|520559990|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
144480950|NCT00550550|520959349|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
144480951|NCT00550550|520959348|FG000|Overall Study|Randomized But Not Treated|1|||
144480952|NCT00550550|520959349|FG001|Overall Study|Randomized But Not Treated|0|||
144480953|NCT03311230|520959353|FG000|Overall Study|Withdrawal by Subject|1|||
144480954|NCT03311230|520959354|FG001|Overall Study|Withdrawal by Subject|4|||
144480955|NCT03311230|520959355|FG002|Overall Study|Withdrawal by Subject|2|||
144480956|NCT03311230|520959356|FG003|Overall Study|Withdrawal by Subject|7|||
144480957|NCT03311230|520959353|FG000|Overall Study|Unrelated injury|0|||
144480958|NCT03311230|520959354|FG001|Overall Study|Unrelated injury|1|||
144480959|NCT03311230|520959355|FG002|Overall Study|Unrelated injury|0|||
144480960|NCT03311230|520959356|FG003|Overall Study|Unrelated injury|0|||
144480961|NCT01302938|520959357|FG000|Overall Study|Withdrawal by Subject|1|||
144480962|NCT01302938|520959358|FG001|Overall Study|Withdrawal by Subject|0|||
144480963|NCT01302938|520959357|FG000|Overall Study|Adverse Event|1|||
144480964|NCT01302938|520959358|FG001|Overall Study|Adverse Event|0|||
144480965|NCT00171873|520959359|FG000|Overall Study|Withdrawal by Subject|4|||
144480966|NCT00171873|520959360|FG001|Overall Study|Withdrawal by Subject|2|||
144480967|NCT00171873|520959359|FG000|Overall Study|Adverse Event|5|||
144480968|NCT00171873|520959360|FG001|Overall Study|Adverse Event|0|||
144480969|NCT00171873|520959359|FG000|Overall Study|Switched to Octreotide|0|||
144480970|NCT00171873|520959360|FG001|Overall Study|Switched to Octreotide|1|||
144480971|NCT05200936|520959361|FG000|Overall Study|Withdrawal by Subject|2|||
144480972|NCT05200936|520959362|FG001|Overall Study|Withdrawal by Subject|2|||
144480973|NCT05200936|520959361|FG000|Overall Study|Lost to Follow-up|2|||
144480974|NCT05200936|520959362|FG001|Overall Study|Lost to Follow-up|0|||
144480975|NCT05200936|520959361|FG000|Overall Study|Pregnancy|0|||
144480976|NCT05200936|520959362|FG001|Overall Study|Pregnancy|1|||
144480977|NCT02906683|520960726|FG000|Overall Study|Adverse Event|0|||
144480978|NCT02906683|520960727|FG001|Overall Study|Adverse Event|1|||
144480979|NCT02906683|520960728|FG002|Overall Study|Adverse Event|0|||
144480980|NCT02906683|520960726|FG000|Overall Study|Physician Decision|0|||
144480981|NCT02906683|520960727|FG001|Overall Study|Physician Decision|1|||
144480982|NCT02906683|520960728|FG002|Overall Study|Physician Decision|1|||
144480983|NCT02906683|520960726|FG000|Overall Study|Withdrawal by Subject|0|||
144480984|NCT02906683|520960727|FG001|Overall Study|Withdrawal by Subject|2|||
144480985|NCT02906683|520960728|FG002|Overall Study|Withdrawal by Subject|1|||
144480986|NCT02906683|520960726|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
144480987|NCT02906683|520960727|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
144480988|NCT02906683|520960728|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
144480989|NCT02906683|520960726|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
144480990|NCT02906683|520960727|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
144480991|NCT02906683|520960728|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
144480992|NCT02781506|520960729|FG000|Overall Study|Adverse Event|5|||
144480993|NCT01340482|520960731|FG000|Overall Study|Adverse Event|2|||
144480994|NCT01340482|520960732|FG001|Overall Study|Adverse Event|0|||
144480995|NCT01340482|520960733|FG002|Overall Study|Adverse Event|0|||
144480996|NCT02593539|520960734|FG000|Overall Study|Adverse Event|1|||
144480997|NCT01282476|520960735|FG000|Overall Study|Death|11|||
144480998|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
144480999|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
144481000|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
144481001|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
144481002|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
144481003|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
144481004|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Death|0|||
144481005|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Death|1|||
144481006|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Adverse Event|11|||
144481007|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Adverse Event|11|||
144713580|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
144713581|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
144713582|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
144713583|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
144713584|NCT00528879|521806410|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
144481008|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
144481009|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
144481010|NCT02936037|520960738|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144481011|NCT02936037|520960739|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
144481012|NCT02936037|520960738|FG000|Open Label Extension|Adverse Event|0|||
144481013|NCT02936037|520960739|FG001|Open Label Extension|Adverse Event|3|||
144481014|NCT02936037|520960738|FG000|Open Label Extension|Other|0|||
144481015|NCT02936037|520960739|FG001|Open Label Extension|Other|3|||
144713585|NCT00528879|521806411|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
144481016|NCT02936037|520960738|FG000|Open Label Extension|Withdrawal by Subject|0|||
144481017|NCT02936037|520960739|FG001|Open Label Extension|Withdrawal by Subject|4|||
144481018|NCT00077636|520960742|FG000|Overall Study|Refused Treatment|9|||
144481019|NCT00077636|520960743|FG001|Overall Study|Refused Treatment|31|||
144481020|NCT00077636|520960742|FG000|Overall Study|Admin|3|||
144481021|NCT00077636|520960743|FG001|Overall Study|Admin|3|||
144481022|NCT00077636|520960742|FG000|Overall Study|Withdrawal by Subject|2|||
144481023|NCT00077636|520960743|FG001|Overall Study|Withdrawal by Subject|2|||
144481024|NCT00077636|520960742|FG000|Overall Study|Adverse Event|17|||
144481025|NCT00077636|520960743|FG001|Overall Study|Adverse Event|34|||
144481026|NCT00077636|520960742|FG000|Overall Study|Protocol Violation|0|||
144481027|NCT00077636|520960743|FG001|Overall Study|Protocol Violation|2|||
144481028|NCT00077636|520960742|FG000|Overall Study|Lost to Follow-up|10|||
144481029|NCT00077636|520960743|FG001|Overall Study|Lost to Follow-up|18|||
144481030|NCT00077636|520960742|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
144481031|NCT00077636|520960743|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
144481032|NCT00592319|520960744|FG000|Overall Study|Lost to Follow-up|0|||
144481033|NCT00592319|520960745|FG001|Overall Study|Lost to Follow-up|3|||
144481034|NCT01017120|520960751|FG000|Overall Study|Adverse Event|9|||
144481035|NCT01017120|520960752|FG001|Overall Study|Adverse Event|0|||
144481036|NCT01017120|520960751|FG000|Overall Study|Lost to Follow-up|13|||
144481037|NCT01017120|520960752|FG001|Overall Study|Lost to Follow-up|11|||
144481038|NCT01017120|520960751|FG000|Overall Study|Lack of Efficacy|1|||
144481039|NCT01017120|520960752|FG001|Overall Study|Lack of Efficacy|0|||
144481040|NCT01017120|520960751|FG000|Overall Study|Withdrawal by Subject|39|||
144481041|NCT01017120|520960752|FG001|Overall Study|Withdrawal by Subject|21|||
144481042|NCT01017120|520960751|FG000|Overall Study|Pregnancy|1|||
144481043|NCT01017120|520960752|FG001|Overall Study|Pregnancy|1|||
144481044|NCT01017120|520960751|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
144481045|NCT01017120|520960752|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
144481046|NCT01017120|520960751|FG000|Overall Study|Relocated Out of Town|0|||
144481047|NCT01017120|520960752|FG001|Overall Study|Relocated Out of Town|2|||
144481048|NCT01017120|520960751|FG000|Overall Study|Protocol Violation|1|||
144481049|NCT01017120|520960752|FG001|Overall Study|Protocol Violation|0|||
144481050|NCT01017120|520960751|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
144481051|NCT01017120|520960752|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
144481052|NCT01087723|520960754|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
144481053|NCT01087723|520960755|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
144481054|NCT01087723|520960754|FG000|Overall Study|Withdrawal by Subject|10|||
144481055|NCT01087723|520960755|FG001|Overall Study|Withdrawal by Subject|13|||
144481056|NCT01087723|520960754|FG000|Overall Study|Physician Decision|2|||
144481057|NCT01087723|520960755|FG001|Overall Study|Physician Decision|0|||
144481058|NCT01087723|520960754|FG000|Overall Study|Lost to Follow-up|1|||
144481059|NCT01087723|520960755|FG001|Overall Study|Lost to Follow-up|4|||
144481060|NCT01087723|520960754|FG000|Overall Study|Reason Not Specified|1|||
144481061|NCT01087723|520960755|FG001|Overall Study|Reason Not Specified|2|||
144481062|NCT01868035|520960756|FG000|Overall Study|Lost to Follow-up|3|||
144481063|NCT01868035|520960756|FG000|Overall Study|Withdrawal by Subject|1|||
144481064|NCT01868035|520960756|FG000|Overall Study|Progressive Disease|2|||
144481065|NCT01868035|520960756|FG000|Overall Study|Non-compliance|1|||
144481066|NCT00806624|520960757|FG000|Overall Study|Adverse Event|2|||
144481067|NCT00806624|520960758|FG001|Overall Study|Adverse Event|8|||
144481068|NCT00806624|520960759|FG002|Overall Study|Adverse Event|0|||
144481069|NCT00806624|520960757|FG000|Overall Study|Death|0|||
144481070|NCT00806624|520960758|FG001|Overall Study|Death|1|||
144481071|NCT00806624|520960759|FG002|Overall Study|Death|1|||
144481072|NCT00806624|520960757|FG000|Overall Study|Lost to Follow-up|1|||
144481073|NCT00806624|520960758|FG001|Overall Study|Lost to Follow-up|0|||
144713586|NCT00528879|521806412|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
144713587|NCT00528879|521806413|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
144713588|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
144713589|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
144713590|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
144713591|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
144481074|NCT00806624|520960759|FG002|Overall Study|Lost to Follow-up|1|||
144481075|NCT00806624|520960757|FG000|Overall Study|Withdrawal by Subject|6|||
144481076|NCT00806624|520960758|FG001|Overall Study|Withdrawal by Subject|3|||
144481077|NCT00806624|520960759|FG002|Overall Study|Withdrawal by Subject|3|||
144481078|NCT00806624|520960757|FG000|Overall Study|discontinued before start of treatment|0|||
144481079|NCT00806624|520960758|FG001|Overall Study|discontinued before start of treatment|0|||
144481080|NCT00806624|520960759|FG002|Overall Study|discontinued before start of treatment|1|||
144481081|NCT01804673|520960763|FG000|Overall Study|Adverse Event|4|||
144481082|NCT01804673|520960763|FG000|Overall Study|Withdrawal by Subject|1|||
144481083|NCT01804673|520960763|FG000|Overall Study|Lack of Efficacy|9|||
144481084|NCT01804673|520960763|FG000|Overall Study|Change to Oral Therapy|37|||
144481085|NCT01804673|520960763|FG000|Overall Study|No Further Therapy Required|84|||
144368961|NCT00174187|520559991|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
144368962|NCT00174187|520559989|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
144368963|NCT00174187|520559990|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
144368964|NCT00174187|520559991|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
144368965|NCT00174187|520559989|FG000|Period 1 (up to 3 Years)|Other|0|||
144368966|NCT00174187|520559990|FG001|Period 1 (up to 3 Years)|Other|1|||
144368967|NCT00174187|520559991|FG002|Period 1 (up to 3 Years)|Other|0|||
144368968|NCT00174187|520559989|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
144368969|NCT00174187|520559990|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
144368970|NCT00174187|520559991|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
144368971|NCT00174187|520559989|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
144368972|NCT00174187|520559990|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
144368973|NCT00174187|520559991|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
144368974|NCT00174187|520559989|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
144368975|NCT00174187|520559990|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
144368976|NCT00174187|520559991|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
144368977|NCT00174187|520559989|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
144368978|NCT00174187|520559990|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
144368979|NCT00174187|520559991|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
144368980|NCT00174187|520559989|FG000|Period 2 (After 3 Years)|Other|0|||
144368981|NCT00174187|520559990|FG001|Period 2 (After 3 Years)|Other|0|||
144368982|NCT00174187|520559991|FG002|Period 2 (After 3 Years)|Other|5|||
144368983|NCT01198977|520559993|FG000|Overall Study|Lost to Follow-up|1|||
144368984|NCT01198977|520559994|FG001|Overall Study|Lost to Follow-up|0|||
144368985|NCT03863080|520559995|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
144368986|NCT03863080|520559996|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
144368987|NCT03863080|520559997|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
144368988|NCT03863080|520559998|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
144368989|NCT03863080|520559995|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
144368990|NCT03863080|520559996|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
144368991|NCT03863080|520559997|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
144368992|NCT03863080|520559998|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
144368993|NCT03863080|520559995|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
144368994|NCT03863080|520559996|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
144368995|NCT03863080|520559997|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
144368996|NCT03863080|520559998|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
144368997|NCT01285557|520559999|FG000|Overall Study|Death|173|||
144368998|NCT01285557|520560000|FG001|Overall Study|Death|90|||
144368999|NCT01285557|520559999|FG000|Overall Study|Lost to Follow-up|6|||
144369000|NCT01285557|520560000|FG001|Overall Study|Lost to Follow-up|2|||
144369001|NCT01285557|520559999|FG000|Overall Study|Withdrew Consent|6|||
144369002|NCT01285557|520560000|FG001|Overall Study|Withdrew Consent|1|||
144369003|NCT01285557|520559999|FG000|Overall Study|Sponsor Study Termination|23|||
144369004|NCT01285557|520560000|FG001|Overall Study|Sponsor Study Termination|13|||
144369005|NCT01285557|520559999|FG000|Overall Study|Randomized but not treated|1|||
144369006|NCT01285557|520560000|FG001|Overall Study|Randomized but not treated|1|||
144369007|NCT01285557|520559999|FG000|Overall Study|Study follow-up ongoing|28|||
144369008|NCT01285557|520560000|FG001|Overall Study|Study follow-up ongoing|14|||
144369009|NCT01285557|520559999|FG000|Overall Study|Sponsor Decision|2|||
144369010|NCT01285557|520560000|FG001|Overall Study|Sponsor Decision|1|||
144369011|NCT01648751|520560006|FG000|Overall Study|Withdrawal by Subject|2|||
144369012|NCT01648751|520560007|FG001|Overall Study|Withdrawal by Subject|3|||
144369013|NCT02484391|520560008|FG000|Overall Study|Lack of Efficacy|15|||
144369014|NCT02484391|520560009|FG001|Overall Study|Lack of Efficacy|14|||
144369015|NCT02484391|520560010|FG002|Overall Study|Lack of Efficacy|3|||
144369016|NCT02484391|520560008|FG000|Overall Study|Lost to Follow-up|0|||
144369017|NCT02484391|520560009|FG001|Overall Study|Lost to Follow-up|0|||
144369018|NCT02484391|520560010|FG002|Overall Study|Lost to Follow-up|2|||
144369019|NCT02484391|520560008|FG000|Overall Study|Physician Decision|1|||
144369020|NCT02484391|520560009|FG001|Overall Study|Physician Decision|3|||
144369021|NCT02484391|520560010|FG002|Overall Study|Physician Decision|0|||
144369022|NCT02484391|520560008|FG000|Overall Study|Went to Transplant|5|||
144369023|NCT02484391|520560009|FG001|Overall Study|Went to Transplant|3|||
144369024|NCT02484391|520560010|FG002|Overall Study|Went to Transplant|2|||
144369025|NCT04922216|520560011|FG000|Overall Study|Withdrawal by Subject|0|||
144369026|NCT04922216|520560012|FG001|Overall Study|Withdrawal by Subject|1|||
144369027|NCT04922216|520560013|FG002|Overall Study|Withdrawal by Subject|0|||
144369028|NCT04922216|520560014|FG003|Overall Study|Withdrawal by Subject|0|||
144369029|NCT04922216|520560015|FG004|Overall Study|Withdrawal by Subject|0|||
144369030|NCT04922216|520560016|FG005|Overall Study|Withdrawal by Subject|0|||
144369031|NCT04922216|520560017|FG006|Overall Study|Withdrawal by Subject|0|||
144369032|NCT04922216|520560018|FG007|Overall Study|Withdrawal by Subject|2|||
144713592|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
144369033|NCT04922216|520560019|FG008|Overall Study|Withdrawal by Subject|0|||
144369034|NCT04922216|520560020|FG009|Overall Study|Withdrawal by Subject|0|||
144369035|NCT04922216|520560021|FG010|Overall Study|Withdrawal by Subject|0|||
144369036|NCT04922216|520560022|FG011|Overall Study|Withdrawal by Subject|0|||
144369037|NCT04922216|520560023|FG012|Overall Study|Withdrawal by Subject|1|||
144369038|NCT04922216|520560024|FG013|Overall Study|Withdrawal by Subject|1|||
144369039|NCT04922216|520560025|FG014|Overall Study|Withdrawal by Subject|1|||
144369040|NCT04922216|520560026|FG015|Overall Study|Withdrawal by Subject|0|||
144369041|NCT04922216|520560027|FG016|Overall Study|Withdrawal by Subject|0|||
144369042|NCT04922216|520560028|FG017|Overall Study|Withdrawal by Subject|1|||
144369043|NCT04922216|520560029|FG018|Overall Study|Withdrawal by Subject|1|||
144369044|NCT04922216|520560030|FG019|Overall Study|Withdrawal by Subject|1|||
144369045|NCT04922216|520560031|FG020|Overall Study|Withdrawal by Subject|1|||
144369046|NCT04922216|520560032|FG021|Overall Study|Withdrawal by Subject|0|||
144369047|NCT04922216|520560033|FG022|Overall Study|Withdrawal by Subject|0|||
144369048|NCT04922216|520560034|FG023|Overall Study|Withdrawal by Subject|2|||
144369049|NCT04922216|520560035|FG024|Overall Study|Withdrawal by Subject|0|||
144369050|NCT04922216|520560036|FG025|Overall Study|Withdrawal by Subject|0|||
144369051|NCT04922216|520560037|FG026|Overall Study|Withdrawal by Subject|1|||
144369052|NCT04922216|520560038|FG027|Overall Study|Withdrawal by Subject|0|||
144369053|NCT04922216|520560039|FG028|Overall Study|Withdrawal by Subject|0|||
144369054|NCT04922216|520560040|FG029|Overall Study|Withdrawal by Subject|0|||
144369055|NCT04922216|520560041|FG030|Overall Study|Withdrawal by Subject|1|||
144369056|NCT04922216|520560042|FG031|Overall Study|Withdrawal by Subject|0|||
144369057|NCT04922216|520560011|FG000|Overall Study|Lost to Follow-up|1|||
144369058|NCT04922216|520560012|FG001|Overall Study|Lost to Follow-up|0|||
144369059|NCT04922216|520560013|FG002|Overall Study|Lost to Follow-up|2|||
144369060|NCT04922216|520560014|FG003|Overall Study|Lost to Follow-up|0|||
144369061|NCT04922216|520560015|FG004|Overall Study|Lost to Follow-up|0|||
144369062|NCT04922216|520560016|FG005|Overall Study|Lost to Follow-up|2|||
144369063|NCT04922216|520560017|FG006|Overall Study|Lost to Follow-up|0|||
144369064|NCT04922216|520560018|FG007|Overall Study|Lost to Follow-up|1|||
144369065|NCT04922216|520560019|FG008|Overall Study|Lost to Follow-up|1|||
144369066|NCT04922216|520560020|FG009|Overall Study|Lost to Follow-up|2|||
144369067|NCT04922216|520560021|FG010|Overall Study|Lost to Follow-up|2|||
144369068|NCT04922216|520560022|FG011|Overall Study|Lost to Follow-up|1|||
144481086|NCT01804673|520960763|FG000|Overall Study|Use of Prohibited Medication|1|||
144481087|NCT01804673|520960763|FG000|Overall Study|Other|4|||
144481088|NCT00313911|520960771|FG000|Overall Study|Serious adverse event|6|||
144481089|NCT00313911|520960772|FG001|Overall Study|Serious adverse event|1|||
144481090|NCT00313911|520960771|FG000|Overall Study|Adverse Event|2|||
144713593|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
144713594|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
144713595|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
144713596|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
144713597|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
144713598|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
144713599|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
144713600|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
144713601|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
144713602|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
144713603|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
144713604|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
144713605|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
144713606|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
144713607|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
144713608|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
144713609|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
144713610|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
144713611|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
144713612|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
144713613|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
144713614|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
144713615|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
144713616|NCT00528879|521806410|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
144713617|NCT00528879|521806411|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
144369069|NCT04922216|520560023|FG012|Overall Study|Lost to Follow-up|1|||
144369070|NCT04922216|520560024|FG013|Overall Study|Lost to Follow-up|0|||
144369071|NCT04922216|520560025|FG014|Overall Study|Lost to Follow-up|1|||
144369072|NCT04922216|520560026|FG015|Overall Study|Lost to Follow-up|0|||
144369073|NCT04922216|520560027|FG016|Overall Study|Lost to Follow-up|0|||
144369074|NCT04922216|520560028|FG017|Overall Study|Lost to Follow-up|2|||
144369075|NCT04922216|520560029|FG018|Overall Study|Lost to Follow-up|1|||
144481091|NCT00313911|520960772|FG001|Overall Study|Adverse Event|3|||
144481092|NCT00313911|520960771|FG000|Overall Study|Protocol Violation|19|||
144481093|NCT00313911|520960772|FG001|Overall Study|Protocol Violation|10|||
144481094|NCT00313911|520960771|FG000|Overall Study|Lost to Follow-up|27|||
144481095|NCT00313911|520960772|FG001|Overall Study|Lost to Follow-up|14|||
144481096|NCT00313911|520960771|FG000|Overall Study|Withdrawal by Subject|39|||
144481097|NCT00313911|520960772|FG001|Overall Study|Withdrawal by Subject|12|||
144481098|NCT00313911|520960771|FG000|Overall Study|Did not meet age criteria|1|||
144481099|NCT00313911|520960772|FG001|Overall Study|Did not meet age criteria|1|||
144481100|NCT01912781|520960775|FG000|Overall Study|Withdrawal by Subject|2|||
144481101|NCT01912781|520960776|FG001|Overall Study|Withdrawal by Subject|0|||
144481102|NCT00569803|520960777|FG000|Overall Study|Lost to Follow-up|1|||
144481103|NCT00569803|520960778|FG001|Overall Study|Lost to Follow-up|0|||
144481104|NCT00569803|520960779|FG002|Overall Study|Lost to Follow-up|0|||
144481105|NCT00569803|520960780|FG003|Overall Study|Lost to Follow-up|0|||
144481106|NCT00569803|520960781|FG004|Overall Study|Lost to Follow-up|0|||
144481107|NCT00569803|520960782|FG005|Overall Study|Lost to Follow-up|0|||
144481108|NCT00569803|520960783|FG006|Overall Study|Lost to Follow-up|0|||
144481109|NCT00569803|520960784|FG007|Overall Study|Lost to Follow-up|0|||
144481110|NCT00569803|520960777|FG000|Overall Study|injection syringe leaked during dosing|0|||
144481111|NCT00569803|520960778|FG001|Overall Study|injection syringe leaked during dosing|0|||
144481112|NCT00569803|520960779|FG002|Overall Study|injection syringe leaked during dosing|0|||
144481113|NCT00569803|520960780|FG003|Overall Study|injection syringe leaked during dosing|1|||
144481114|NCT00569803|520960781|FG004|Overall Study|injection syringe leaked during dosing|0|||
144481115|NCT00569803|520960782|FG005|Overall Study|injection syringe leaked during dosing|0|||
144481116|NCT00569803|520960783|FG006|Overall Study|injection syringe leaked during dosing|0|||
144481117|NCT00569803|520960784|FG007|Overall Study|injection syringe leaked during dosing|0|||
144481118|NCT00569803|520960777|FG000|Overall Study|Withdrawal by Subject|0|||
144481119|NCT00569803|520960778|FG001|Overall Study|Withdrawal by Subject|0|||
144713618|NCT00528879|521806412|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
144713619|NCT00528879|521806413|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
144713620|NCT00078819|521806416|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
144713621|NCT00078819|521806417|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
144713622|NCT00078819|521806418|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
144713623|NCT00078819|521806419|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
144713624|NCT00078819|521806416|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
144713625|NCT00078819|521806417|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
144713626|NCT00078819|521806418|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
144713627|NCT00078819|521806419|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
144713628|NCT00078819|521806416|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
144713629|NCT00078819|521806417|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
144713630|NCT00078819|521806418|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
144369076|NCT04922216|520560030|FG019|Overall Study|Lost to Follow-up|0|||
144369077|NCT04922216|520560031|FG020|Overall Study|Lost to Follow-up|1|||
144369078|NCT04922216|520560032|FG021|Overall Study|Lost to Follow-up|0|||
144369079|NCT04922216|520560033|FG022|Overall Study|Lost to Follow-up|2|||
144369080|NCT04922216|520560034|FG023|Overall Study|Lost to Follow-up|1|||
144369081|NCT04922216|520560035|FG024|Overall Study|Lost to Follow-up|0|||
144369082|NCT04922216|520560036|FG025|Overall Study|Lost to Follow-up|2|||
144369083|NCT04922216|520560037|FG026|Overall Study|Lost to Follow-up|0|||
144369084|NCT04922216|520560038|FG027|Overall Study|Lost to Follow-up|0|||
144369085|NCT04922216|520560039|FG028|Overall Study|Lost to Follow-up|1|||
144369086|NCT04922216|520560040|FG029|Overall Study|Lost to Follow-up|0|||
144369087|NCT04922216|520560041|FG030|Overall Study|Lost to Follow-up|2|||
144369088|NCT04922216|520560042|FG031|Overall Study|Lost to Follow-up|1|||
144369089|NCT02864394|520560043|FG000|Overall Study|Death|184|||
144369090|NCT02864394|520560044|FG001|Overall Study|Death|189|||
144369091|NCT02864394|520560043|FG000|Overall Study|Lost to Follow-up|0|||
144369092|NCT02864394|520560044|FG001|Overall Study|Lost to Follow-up|2|||
144369093|NCT02864394|520560043|FG000|Overall Study|Sponsor Decision|26|||
144369094|NCT02864394|520560044|FG001|Overall Study|Sponsor Decision|11|||
144369095|NCT02864394|520560043|FG000|Overall Study|Withdrawal by Subject|3|||
144369096|NCT02864394|520560044|FG001|Overall Study|Withdrawal by Subject|10|||
144369097|NCT00904033|520561572|FG000|Overall Study|Withdrawal by Subject|1|||
144369098|NCT00904033|520561573|FG001|Overall Study|Withdrawal by Subject|1|||
144369099|NCT00904033|520561574|FG002|Overall Study|Withdrawal by Subject|0|||
144369100|NCT00904033|520561575|FG003|Overall Study|Withdrawal by Subject|0|||
144369101|NCT00904033|520561572|FG000|Overall Study|Physician Decision|0|||
144369102|NCT00904033|520561573|FG001|Overall Study|Physician Decision|0|||
144369103|NCT00904033|520561574|FG002|Overall Study|Physician Decision|1|||
144369104|NCT00904033|520561575|FG003|Overall Study|Physician Decision|0|||
144369105|NCT00904033|520561572|FG000|Overall Study|Unable to obtain final blood draw|0|||
144369106|NCT00904033|520561573|FG001|Overall Study|Unable to obtain final blood draw|0|||
144481120|NCT00569803|520960779|FG002|Overall Study|Withdrawal by Subject|0|||
144481121|NCT00569803|520960780|FG003|Overall Study|Withdrawal by Subject|0|||
144481122|NCT00569803|520960781|FG004|Overall Study|Withdrawal by Subject|0|||
144481123|NCT00569803|520960782|FG005|Overall Study|Withdrawal by Subject|0|||
144481124|NCT00569803|520960783|FG006|Overall Study|Withdrawal by Subject|0|||
144481125|NCT00569803|520960784|FG007|Overall Study|Withdrawal by Subject|1|||
144481126|NCT01622348|520960786|FG000|Overall Study|Withdrawal by Subject|1|||
144481127|NCT01622348|520960787|FG001|Overall Study|Withdrawal by Subject|0|||
144481128|NCT01622348|520960788|FG002|Overall Study|Withdrawal by Subject|1|||
144481129|NCT00467142|520960791|FG000|Overall Study|Withdrawal by Subject|1|||
144481130|NCT00467142|520960791|FG000|Overall Study|Adverse Event|1|||
144481131|NCT00467142|520960791|FG000|Overall Study|Protocol Violation|1|||
144481132|NCT04537897|520960792|FG000|Overall Study|Other than listed|0|||
144481133|NCT04537897|520960793|FG001|Overall Study|Other than listed|0|||
144481134|NCT04537897|520960794|FG002|Overall Study|Other than listed|0|||
144481135|NCT04537897|520960795|FG003|Overall Study|Other than listed|0|||
144481136|NCT04537897|520960796|FG004|Overall Study|Other than listed|0|||
144481137|NCT04537897|520960797|FG005|Overall Study|Other than listed|0|||
144481138|NCT04537897|520960798|FG006|Overall Study|Other than listed|1|||
144481139|NCT04537897|520960799|FG007|Overall Study|Other than listed|0|||
144481140|NCT04537897|520960800|FG008|Overall Study|Other than listed|0|||
144481141|NCT04537897|520960792|FG000|Overall Study|Adverse Event|0|||
144481142|NCT04537897|520960793|FG001|Overall Study|Adverse Event|0|||
144481143|NCT04537897|520960794|FG002|Overall Study|Adverse Event|0|||
144481144|NCT04537897|520960795|FG003|Overall Study|Adverse Event|1|||
144481145|NCT04537897|520960796|FG004|Overall Study|Adverse Event|0|||
144481146|NCT04537897|520960797|FG005|Overall Study|Adverse Event|0|||
144481147|NCT04537897|520960798|FG006|Overall Study|Adverse Event|0|||
144481148|NCT04537897|520960799|FG007|Overall Study|Adverse Event|0|||
144481149|NCT04537897|520960800|FG008|Overall Study|Adverse Event|0|||
144481150|NCT04537897|520960792|FG000|Overall Study|Withdrawal by Subject|0|||
144481151|NCT04537897|520960793|FG001|Overall Study|Withdrawal by Subject|1|||
144481152|NCT04537897|520960794|FG002|Overall Study|Withdrawal by Subject|0|||
144481153|NCT04537897|520960795|FG003|Overall Study|Withdrawal by Subject|0|||
144481154|NCT04537897|520960796|FG004|Overall Study|Withdrawal by Subject|0|||
144481155|NCT04537897|520960797|FG005|Overall Study|Withdrawal by Subject|0|||
144481156|NCT04537897|520960798|FG006|Overall Study|Withdrawal by Subject|0|||
144481157|NCT04537897|520960799|FG007|Overall Study|Withdrawal by Subject|0|||
144481158|NCT04537897|520960800|FG008|Overall Study|Withdrawal by Subject|0|||
144481159|NCT00919893|520960801|FG000|Overall Study|Protocol Violation|19|||
144481160|NCT00919893|520960802|FG001|Overall Study|Protocol Violation|9|||
144481161|NCT03029780|520960808|FG000|Overall Study|Disease Progression|20|||
144481162|NCT03029780|520960809|FG001|Overall Study|Disease Progression|22|||
144481163|NCT03029780|520960808|FG000|Overall Study|Study Drug Toxicity|15|||
144481164|NCT03029780|520960809|FG001|Overall Study|Study Drug Toxicity|11|||
144481165|NCT03029780|520960808|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
144481166|NCT03029780|520960809|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
144481167|NCT03029780|520960808|FG000|Overall Study|Participant request to discontinue study treatment|4|||
144481168|NCT03029780|520960809|FG001|Overall Study|Participant request to discontinue study treatment|1|||
144481169|NCT03029780|520960808|FG000|Overall Study|Maximum clinical benefit|1|||
144481170|NCT03029780|520960809|FG001|Overall Study|Maximum clinical benefit|0|||
144481171|NCT03029780|520960808|FG000|Overall Study|Participant no longer meets study criteria|0|||
144481172|NCT03029780|520960809|FG001|Overall Study|Participant no longer meets study criteria|1|||
144481173|NCT03029780|520960808|FG000|Overall Study|Other reasons|6|||
144481174|NCT03029780|520960809|FG001|Overall Study|Other reasons|6|||
144713631|NCT00078819|521806419|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
144713632|NCT00078819|521806416|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
144713633|NCT00078819|521806417|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
144713634|NCT00078819|521806418|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
144481175|NCT03029780|520960808|FG000|Overall Study|Not reported|1|||
144481176|NCT03029780|520960809|FG001|Overall Study|Not reported|1|||
144481177|NCT03029780|520960808|FG000|Overall Study|Death|2|||
144481178|NCT03029780|520960809|FG001|Overall Study|Death|6|||
144481179|NCT00197028|520960810|FG000|Overall Study|Adverse Event|2|||
144713635|NCT00078819|521806419|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
144713636|NCT00078819|521806416|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
144713637|NCT00078819|521806417|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
144713638|NCT00078819|521806418|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
144713639|NCT00078819|521806419|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
144481180|NCT00197028|520960811|FG001|Overall Study|Adverse Event|2|||
144481181|NCT00197028|520960810|FG000|Overall Study|Protocol Violation|2|||
144481182|NCT00197028|520960811|FG001|Overall Study|Protocol Violation|1|||
144481183|NCT00197028|520960810|FG000|Overall Study|Withdrawal by Subject|8|||
144481184|NCT00197028|520960811|FG001|Overall Study|Withdrawal by Subject|12|||
144481185|NCT00197028|520960810|FG000|Overall Study|Lost to Follow-up|1|||
144481186|NCT00197028|520960811|FG001|Overall Study|Lost to Follow-up|0|||
144481187|NCT00197028|520960810|FG000|Overall Study|Other|3|||
144481188|NCT00197028|520960811|FG001|Overall Study|Other|6|||
144481189|NCT00178256|520960812|FG000|Overall Study|Adverse Event|2|||
144481190|NCT00178256|520960813|FG001|Overall Study|Adverse Event|0|||
144481191|NCT00178256|520960814|FG002|Overall Study|Adverse Event|0|||
144481192|NCT00178256|520960815|FG003|Overall Study|Adverse Event|0|||
144481193|NCT00178256|520960812|FG000|Overall Study|Death|0|||
144481194|NCT00178256|520960813|FG001|Overall Study|Death|1|||
144481195|NCT00178256|520960814|FG002|Overall Study|Death|0|||
144481196|NCT00178256|520960815|FG003|Overall Study|Death|1|||
144481197|NCT00178256|520960812|FG000|Overall Study|Cancer progression|2|||
144481198|NCT00178256|520960813|FG001|Overall Study|Cancer progression|0|||
144481199|NCT00178256|520960814|FG002|Overall Study|Cancer progression|0|||
144481200|NCT00178256|520960815|FG003|Overall Study|Cancer progression|1|||
144481201|NCT01763788|520960818|FG000|Overall Study|Lost to Follow-up|0|||
144481202|NCT01763788|520960819|FG001|Overall Study|Lost to Follow-up|0|||
144481203|NCT01763788|520960820|FG002|Overall Study|Lost to Follow-up|1|||
144481204|NCT01763788|520960821|FG003|Overall Study|Lost to Follow-up|0|||
144481205|NCT00885352|520960826|FG000|Overall Study|Adverse Event|2|||
144481206|NCT00885352|520960827|FG001|Overall Study|Adverse Event|3|||
144481207|NCT00885352|520960826|FG000|Overall Study|Lost to Follow-up|2|||
144481208|NCT00885352|520960827|FG001|Overall Study|Lost to Follow-up|2|||
144713640|NCT00078819|521806416|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
144713641|NCT00078819|521806417|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
144481209|NCT00885352|520960826|FG000|Overall Study|Physician Decision|0|||
144713642|NCT00078819|521806418|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
144713643|NCT00078819|521806419|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
144713644|NCT00078819|521806416|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
144713645|NCT00078819|521806417|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
144713646|NCT00078819|521806418|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
144713647|NCT00078819|521806419|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
144713648|NCT00078819|521806416|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
144713649|NCT00078819|521806417|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
144713650|NCT00078819|521806418|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
144713651|NCT00078819|521806419|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
144713652|NCT02555618|521806420|FG000|Overall Study|Sponsor's Circumstances|1|||
144713653|NCT02555618|521806421|FG001|Overall Study|Sponsor's Circumstances|0|||
144713654|NCT01252238|521806424|FG000|Overall Study|Sponsor terminated study|4|||
144713655|NCT01252238|521806425|FG001|Overall Study|Sponsor terminated study|4|||
144713656|NCT01252238|521806426|FG002|Overall Study|Sponsor terminated study|4|||
144713657|NCT00272961|521806427|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
144713658|NCT00272961|521806428|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
144713659|NCT00272961|521806429|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
144713660|NCT00272961|521806430|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
144713661|NCT00272961|521806431|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
144713662|NCT00272961|521806427|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
144713663|NCT00272961|521806428|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
144713664|NCT00272961|521806429|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
144713665|NCT00272961|521806430|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
144713666|NCT00272961|521806431|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
144713667|NCT00272961|521806427|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
144713668|NCT00272961|521806428|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
144713669|NCT00272961|521806429|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
144713670|NCT00272961|521806430|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
144713671|NCT00272961|521806431|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
144713672|NCT00272961|521806427|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
144713673|NCT00272961|521806428|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
144713674|NCT00272961|521806429|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
144481210|NCT00885352|520960827|FG001|Overall Study|Physician Decision|3|||
144481211|NCT00885352|520960826|FG000|Overall Study|Protocol Violation|0|||
144481212|NCT00885352|520960827|FG001|Overall Study|Protocol Violation|2|||
144481213|NCT00885352|520960826|FG000|Overall Study|Withdrawal by Subject|1|||
144713675|NCT00272961|521806430|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
144713676|NCT00272961|521806431|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
144481214|NCT00885352|520960827|FG001|Overall Study|Withdrawal by Subject|5|||
144538217|NCT00146172|521174122|FG000|Overall Study|Physician Decision|0|||
144481215|NCT00885352|520960826|FG000|Overall Study|Contradiction to study medication|0|||
144481216|NCT00885352|520960827|FG001|Overall Study|Contradiction to study medication|2|||
144481217|NCT00885352|520960826|FG000|Overall Study|Excluded medication|2|||
144481218|NCT00885352|520960827|FG001|Overall Study|Excluded medication|2|||
144481219|NCT00885352|520960826|FG000|Overall Study|Lab abnormalities|1|||
144481220|NCT00885352|520960827|FG001|Overall Study|Lab abnormalities|1|||
144481221|NCT03560258|520960828|FG000|Overall Study|Lost to Follow-up|3|||
144481222|NCT03560258|520960829|FG001|Overall Study|Lost to Follow-up|0|||
144481223|NCT03560258|520960830|FG002|Overall Study|Lost to Follow-up|0|||
144481224|NCT03560258|520960828|FG000|Overall Study|Protocol Violation|0|||
144481225|NCT03560258|520960829|FG001|Overall Study|Protocol Violation|1|||
144481226|NCT03560258|520960830|FG002|Overall Study|Protocol Violation|0|||
144481227|NCT03560258|520960828|FG000|Overall Study|Withdrawal by Subject|0|||
144481228|NCT03560258|520960829|FG001|Overall Study|Withdrawal by Subject|0|||
144481229|NCT03560258|520960830|FG002|Overall Study|Withdrawal by Subject|1|||
144481230|NCT01460160|520960831|FG000|Treatment Phase|Lack of Efficacy|3|||
144481231|NCT01460160|520960831|FG000|Treatment Phase|Study Drug Toxicity|2|||
144481232|NCT01460160|520960831|FG000|Treatment Phase|Adverse Event|8|||
144481233|NCT01460160|520960831|FG000|Treatment Phase|Withdrawal by Subject|4|||
144481234|NCT01460160|520960831|FG000|Treatment Phase|Death|2|||
144481235|NCT01460160|520960831|FG000|Treatment Phase|Other reasons|9|||
144481236|NCT01460160|520960831|FG000|Follow-up Phase|Withdrawal by Subject|4|||
144481237|NCT01460160|520960831|FG000|Follow-up Phase|Death|14|||
144481238|NCT01460160|520960831|FG000|Follow-up Phase|Lost to Follow-up|7|||
144481239|NCT01460160|520960831|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
144481240|NCT01460160|520960831|FG000|Follow-up Phase|Other and not reported reasons|5|||
144481241|NCT03893825|520960832|FG000|Overall Study|Death|2|||
144481242|NCT03893825|520960833|FG001|Overall Study|Death|1|||
144481243|NCT03893825|520960832|FG000|Overall Study|Adverse Event|0|||
144481244|NCT03893825|520960833|FG001|Overall Study|Adverse Event|2|||
144481245|NCT03893825|520960832|FG000|Overall Study|Withdrawal by Subject|19|||
144481246|NCT03893825|520960833|FG001|Overall Study|Withdrawal by Subject|21|||
144481247|NCT03893825|520960832|FG000|Overall Study|Protocol deviation|1|||
144481248|NCT03893825|520960833|FG001|Overall Study|Protocol deviation|0|||
144481249|NCT03893825|520960832|FG000|Overall Study|Lost to Follow-up|10|||
144481250|NCT03893825|520960833|FG001|Overall Study|Lost to Follow-up|10|||
144481251|NCT03893825|520960832|FG000|Overall Study|Other than specified|7|||
144481252|NCT03893825|520960833|FG001|Overall Study|Other than specified|6|||
144481253|NCT04161807|520960837|FG000|Overall Study|Withdrawal by Subject|2|||
144481254|NCT04161807|520960837|FG000|Overall Study|Performed only 1 treatment|2|||
144481255|NCT02006121|520960838|FG000|Double Blind Phase|Adverse Event|6|||
144481256|NCT02006121|520960839|FG001|Double Blind Phase|Adverse Event|0|||
144481257|NCT02006121|520960838|FG000|Double Blind Phase|Lack of Efficacy|1|||
144713677|NCT00272961|521806427|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
144713678|NCT00272961|521806428|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
144713679|NCT00272961|521806429|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
144713680|NCT00272961|521806430|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
144713681|NCT00272961|521806431|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
144713682|NCT00272961|521806427|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
144713683|NCT00272961|521806428|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
144713684|NCT00272961|521806429|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
144713685|NCT00272961|521806430|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
144713686|NCT00272961|521806431|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
144713687|NCT00272961|521806427|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
144713688|NCT00272961|521806428|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
144713689|NCT00272961|521806429|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
144713690|NCT00272961|521806430|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
144713691|NCT00272961|521806431|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
144713692|NCT00272961|521806427|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
144713693|NCT00272961|521806428|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
144713694|NCT00272961|521806429|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
144713695|NCT00272961|521806430|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
144481258|NCT02006121|520960839|FG001|Double Blind Phase|Lack of Efficacy|16|||
144481259|NCT02006121|520960838|FG000|Double Blind Phase|Withdrawal by Subject|3|||
144481260|NCT02006121|520960839|FG001|Double Blind Phase|Withdrawal by Subject|4|||
144481261|NCT02006121|520960838|FG000|Double Blind Phase|Non-compliance with study drug|1|||
144481262|NCT02006121|520960839|FG001|Double Blind Phase|Non-compliance with study drug|3|||
144481263|NCT02006121|520960838|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
144481264|NCT02006121|520960839|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
144481265|NCT02006121|520960838|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
144481266|NCT02006121|520960839|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
144481267|NCT02006121|520960838|FG000|Open Label Phase|Adverse Event|15|||
144713696|NCT00272961|521806431|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
144481268|NCT02006121|520960839|FG001|Open Label Phase|Adverse Event|0|||
144481269|NCT02006121|520960838|FG000|Open Label Phase|Lack of Efficacy|2|||
144481270|NCT02006121|520960839|FG001|Open Label Phase|Lack of Efficacy|0|||
144481271|NCT02006121|520960838|FG000|Open Label Phase|Protocol Violation|2|||
144713697|NCT01507831|521806432|FG000|Overall Study|Randomized but not treated|0|||
144713698|NCT01507831|521806433|FG001|Overall Study|Randomized but not treated|3|||
144713699|NCT01507831|521806432|FG000|Overall Study|Adverse Event|48|||
144713700|NCT01507831|521806433|FG001|Overall Study|Adverse Event|113|||
144713701|NCT01507831|521806432|FG000|Overall Study|Death|6|||
144713702|NCT01507831|521806433|FG001|Overall Study|Death|2|||
144713703|NCT01507831|521806432|FG000|Overall Study|Poor compliance to protocol|38|||
144713704|NCT01507831|521806433|FG001|Overall Study|Poor compliance to protocol|60|||
144713705|NCT01507831|521806432|FG000|Overall Study|Physician Decision|0|||
144713706|NCT01507831|521806433|FG001|Overall Study|Physician Decision|4|||
144713707|NCT01507831|521806432|FG000|Overall Study|Participant moved|5|||
144713708|NCT01507831|521806433|FG001|Overall Study|Participant moved|19|||
144713709|NCT01507831|521806432|FG000|Overall Study|Consent withdrawn by participant|34|||
144713710|NCT01507831|521806433|FG001|Overall Study|Consent withdrawn by participant|72|||
144713711|NCT01507831|521806432|FG000|Overall Study|Related to study drug administration|5|||
144713712|NCT01507831|521806433|FG001|Overall Study|Related to study drug administration|14|||
144713713|NCT01507831|521806432|FG000|Overall Study|Last visit outside protocol visit window|51|||
144713714|NCT01507831|521806433|FG001|Overall Study|Last visit outside protocol visit window|143|||
144713715|NCT01507831|521806432|FG000|Overall Study|Selection criteria finally not met|0|||
144713716|NCT01507831|521806433|FG001|Overall Study|Selection criteria finally not met|1|||
144713717|NCT01507831|521806432|FG000|Overall Study|Site closure|0|||
144713718|NCT01507831|521806433|FG001|Overall Study|Site closure|3|||
144713719|NCT01507831|521806432|FG000|Overall Study|Potential lost to follow-up|3|||
144713720|NCT01507831|521806433|FG001|Overall Study|Potential lost to follow-up|0|||
144713721|NCT01507831|521806432|FG000|Overall Study|Other|3|||
144713722|NCT01507831|521806433|FG001|Overall Study|Other|6|||
144713723|NCT03196791|521806434|FG000|Overall Study|Protocol Violation|7|||
144713724|NCT03196791|521806435|FG001|Overall Study|Protocol Violation|3|||
144713725|NCT03196791|521806434|FG000|Overall Study|Withdrawal by Subject|3|||
144713726|NCT03196791|521806435|FG001|Overall Study|Withdrawal by Subject|2|||
144713727|NCT00068237|521806438|FG000|Overall Study|Ineligible|3|||
144713728|NCT00068237|521806438|FG000|Overall Study|No protocol treatment received|2|||
144713729|NCT03276962|521806444|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
144713730|NCT03276962|521806445|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
144713731|NCT03276962|521806446|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
144713732|NCT03276962|521806447|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
144713733|NCT03276962|521806448|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
144713734|NCT03276962|521806444|FG000|Overall Study|Protocol Deviation|2|||
144713735|NCT03276962|521806445|FG001|Overall Study|Protocol Deviation|0|||
144713736|NCT03276962|521806446|FG002|Overall Study|Protocol Deviation|1|||
144713737|NCT03276962|521806447|FG003|Overall Study|Protocol Deviation|2|||
144713738|NCT03276962|521806448|FG004|Overall Study|Protocol Deviation|1|||
144713739|NCT03276962|521806444|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
144713740|NCT03276962|521806445|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
144713741|NCT03276962|521806446|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
144713742|NCT03276962|521806447|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
144713743|NCT03276962|521806448|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
144713744|NCT03276962|521806444|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
144713745|NCT03276962|521806445|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
144713746|NCT03276962|521806446|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
144713747|NCT03276962|521806447|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
144713748|NCT03276962|521806448|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
144713749|NCT03276962|521806444|FG000|Overall Study|Lost to Follow-up|10|||
144713750|NCT03276962|521806445|FG001|Overall Study|Lost to Follow-up|10|||
144713751|NCT03276962|521806446|FG002|Overall Study|Lost to Follow-up|4|||
144713752|NCT03276962|521806447|FG003|Overall Study|Lost to Follow-up|6|||
144713753|NCT03276962|521806448|FG004|Overall Study|Lost to Follow-up|10|||
144713754|NCT03276962|521806444|FG000|Overall Study|Other|0|||
144713755|NCT03276962|521806445|FG001|Overall Study|Other|2|||
144713756|NCT03276962|521806446|FG002|Overall Study|Other|0|||
144481272|NCT02006121|520960839|FG001|Open Label Phase|Protocol Violation|0|||
144481273|NCT02006121|520960838|FG000|Open Label Phase|Withdrawal by Subject|3|||
144713757|NCT03276962|521806447|FG003|Overall Study|Other|2|||
144713758|NCT03276962|521806448|FG004|Overall Study|Other|1|||
144713759|NCT01238211|521806449|FG000|Overall Study|Continues active treatment|31|||
144713760|NCT01238211|521806449|FG000|Overall Study|Adverse Event|7|||
144713761|NCT01238211|521806449|FG000|Overall Study|Death|4|||
144481274|NCT02006121|520960839|FG001|Open Label Phase|Withdrawal by Subject|0|||
144481275|NCT02006121|520960838|FG000|Open Label Phase|Non-compliance with study drug|3|||
144369107|NCT00904033|520561574|FG002|Overall Study|Unable to obtain final blood draw|0|||
144369108|NCT00904033|520561575|FG003|Overall Study|Unable to obtain final blood draw|2|||
144369109|NCT03252925|520561576|FG000|Overall Study|Withdrawal by Subject|1|||
144713762|NCT01238211|521806449|FG000|Overall Study|Relapse/Progression|2|||
144713763|NCT01238211|521806449|FG000|Overall Study|Withdrawal by Subject|7|||
144713764|NCT01238211|521806449|FG000|Overall Study|Non-protocol treatment|4|||
144713765|NCT01238211|521806449|FG000|Overall Study|Investigator/Patient Decision|3|||
144713766|NCT01358708|521806450|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
144713767|NCT01358708|521806451|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144369110|NCT03252925|520561577|FG001|Overall Study|Withdrawal by Subject|0|||
144369111|NCT03252925|520561576|FG000|Overall Study|Protocol Violation|6|||
144369112|NCT03252925|520561577|FG001|Overall Study|Protocol Violation|0|||
144369113|NCT03252925|520561576|FG000|Overall Study|Adverse Event|1|||
144369114|NCT03252925|520561577|FG001|Overall Study|Adverse Event|0|||
144369115|NCT03252925|520561576|FG000|Overall Study|Lost to Follow-up|6|||
144369116|NCT03252925|520561577|FG001|Overall Study|Lost to Follow-up|6|||
144369117|NCT00521404|520561578|FG000|Overall Study|Adverse Event|13|||
144369118|NCT00521404|520561578|FG000|Overall Study|Disease Progression|33|||
144369119|NCT00521404|520561578|FG000|Overall Study|Investigator decision|5|||
144369120|NCT00521404|520561578|FG000|Overall Study|Withdrawal of consent|3|||
144369121|NCT00521404|520561578|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
144369122|NCT00521404|520561578|FG000|Overall Study|Other|7|||
144369123|NCT01908803|520561579|FG000|Overall Study|Adverse Event|1|||
144369124|NCT01908803|520561580|FG001|Overall Study|Adverse Event|0|||
144369125|NCT01908803|520561579|FG000|Overall Study|Physician Decision|0|||
144369126|NCT01908803|520561580|FG001|Overall Study|Physician Decision|1|||
144369127|NCT01908803|520561579|FG000|Overall Study|Withdrawal by Subject|1|||
144369128|NCT01908803|520561580|FG001|Overall Study|Withdrawal by Subject|0|||
144369129|NCT01908803|520561579|FG000|Overall Study|Randomization Error|1|||
144369130|NCT01908803|520561580|FG001|Overall Study|Randomization Error|0|||
144369131|NCT01908803|520561579|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
144369132|NCT01908803|520561580|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
144369133|NCT01524796|520561581|FG000|Overall Study|Adverse Event|13|||
144369134|NCT01524796|520561581|FG000|Overall Study|Lack of Efficacy|3|||
144369135|NCT01524796|520561581|FG000|Overall Study|Lost to Follow-up|1|||
144369136|NCT01524796|520561581|FG000|Overall Study|The price|1|||
144369137|NCT01524796|520561581|FG000|Overall Study|Withdrawal by Subject|4|||
144369138|NCT01524796|520561581|FG000|Overall Study|Move|1|||
144369139|NCT01524796|520561581|FG000|Overall Study|Deterioration of pains|1|||
144369140|NCT01524796|520561581|FG000|Overall Study|Gall stone surgery|1|||
144369141|NCT01524796|520561581|FG000|Overall Study|Nervous about confidentiality|1|||
144369142|NCT01524796|520561581|FG000|Overall Study|Switch to carbamazapine|1|||
144369143|NCT01524796|520561581|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
144369144|NCT00836693|520561584|FG000|Overall Study|Adverse Event|4|||
144369145|NCT00836693|520561585|FG001|Overall Study|Adverse Event|1|||
144369146|NCT00836693|520561584|FG000|Overall Study|Sponsor Decision|0|||
144369147|NCT00836693|520561585|FG001|Overall Study|Sponsor Decision|1|||
144369148|NCT00836693|520561584|FG000|Overall Study|Physician Decision|2|||
144369149|NCT00836693|520561585|FG001|Overall Study|Physician Decision|0|||
144369150|NCT00836693|520561584|FG000|Overall Study|Withdrawal by Subject|9|||
144369151|NCT00836693|520561585|FG001|Overall Study|Withdrawal by Subject|4|||
144369152|NCT00836693|520561584|FG000|Overall Study|Protocol Violation|1|||
144369153|NCT00836693|520561585|FG001|Overall Study|Protocol Violation|0|||
144369154|NCT00836693|520561584|FG000|Overall Study|Lost to Follow-up|1|||
144713768|NCT01358708|521806450|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
144538218|NCT00146172|521174123|FG001|Overall Study|Physician Decision|0|||
144713769|NCT01358708|521806451|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
144713770|NCT03550794|521806456|FG000|Overall Study|No longer met inclusion criteria|1|||
144369155|NCT00836693|520561585|FG001|Overall Study|Lost to Follow-up|0|||
144369156|NCT02612779|520561586|FG000|Overall Study|Administrative reason by sponsor|4|||
144369157|NCT02612779|520561587|FG001|Overall Study|Administrative reason by sponsor|1|||
144369158|NCT02612779|520561586|FG000|Overall Study|No longer meet study criteria|0|||
144369159|NCT02612779|520561587|FG001|Overall Study|No longer meet study criteria|1|||
144369160|NCT02612779|520561586|FG000|Overall Study|Disease progression|29|||
144369161|NCT02612779|520561587|FG001|Overall Study|Disease progression|2|||
144369162|NCT02612779|520561586|FG000|Overall Study|Study drug toxicity|10|||
144369163|NCT02612779|520561587|FG001|Overall Study|Study drug toxicity|1|||
144369164|NCT02612779|520561586|FG000|Overall Study|Death|1|||
144713771|NCT03550794|521806457|FG001|Overall Study|No longer met inclusion criteria|2|||
144713772|NCT03550794|521806456|FG000|Overall Study|Goals of care changed|1|||
144713773|NCT03550794|521806457|FG001|Overall Study|Goals of care changed|0|||
144713774|NCT03550794|521806456|FG000|Overall Study|Withdrawal by Subject|2|||
144713775|NCT03550794|521806457|FG001|Overall Study|Withdrawal by Subject|0|||
144713776|NCT03550794|521806456|FG000|Overall Study|Death|0|||
144713777|NCT03550794|521806457|FG001|Overall Study|Death|1|||
144713778|NCT01890785|521806458|FG000|Third Intervention|Withdrawal by Subject|0|||
144713779|NCT01890785|521806459|FG001|Third Intervention|Withdrawal by Subject|1|||
144713780|NCT01890785|521806460|FG002|Third Intervention|Withdrawal by Subject|0|||
144713781|NCT01890785|521806461|FG003|Third Intervention|Withdrawal by Subject|0|||
144713782|NCT01890785|521806462|FG004|Third Intervention|Withdrawal by Subject|0|||
144713783|NCT01890785|521806463|FG005|Third Intervention|Withdrawal by Subject|0|||
144713784|NCT02713243|521806464|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
144713785|NCT02713243|521806465|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
144713786|NCT02713243|521806464|FG000|Overall Study|Administrative problems|0|||
144713787|NCT02713243|521806465|FG001|Overall Study|Administrative problems|1|||
144713788|NCT02713243|521806464|FG000|Overall Study|Protocol deviation|0|||
144713789|NCT02713243|521806465|FG001|Overall Study|Protocol deviation|1|||
144481276|NCT02006121|520960839|FG001|Open Label Phase|Non-compliance with study drug|0|||
144481277|NCT00452413|520960842|FG000|Overall Study|Progressive Disease|4|||
144481278|NCT00452413|520960843|FG001|Overall Study|Progressive Disease|11|||
144481279|NCT00452413|520960844|FG002|Overall Study|Progressive Disease|30|||
144481280|NCT00452413|520960842|FG000|Overall Study|Withdrawal by Subject|0|||
144481281|NCT00452413|520960843|FG001|Overall Study|Withdrawal by Subject|1|||
144481282|NCT00452413|520960844|FG002|Overall Study|Withdrawal by Subject|4|||
144713790|NCT02766400|521806469|FG000|Overall Study|Death|1|||
144713791|NCT02766400|521806470|FG001|Overall Study|Death|2|||
144481283|NCT00452413|520960842|FG000|Overall Study|Adverse Event|0|||
144713792|NCT02766400|521806469|FG000|Overall Study|Withdrawal by Subject|1|||
144713793|NCT02766400|521806470|FG001|Overall Study|Withdrawal by Subject|0|||
144713794|NCT05037409|521806471|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
144713795|NCT05037409|521806472|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
144481284|NCT00452413|520960843|FG001|Overall Study|Adverse Event|0|||
144481285|NCT00452413|520960844|FG002|Overall Study|Adverse Event|5|||
144713796|NCT05037409|521806473|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
144713797|NCT03499249|521806474|FG000|Overall Study|Physician Decision|1|||
144713798|NCT02475980|521806479|FG000|Overall Study|Lost to Follow-up|4|||
144713799|NCT02475980|521806479|FG000|Overall Study|Withdrawal by Subject|1|||
144713800|NCT00990093|521806480|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
144713801|NCT00990093|521806481|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
144713802|NCT00990093|521806480|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
144713803|NCT00990093|521806481|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
144481286|NCT00452413|520960842|FG000|Overall Study|Physician Decision|0|||
144481287|NCT00452413|520960843|FG001|Overall Study|Physician Decision|0|||
144481288|NCT00452413|520960844|FG002|Overall Study|Physician Decision|4|||
144481289|NCT00452413|520960842|FG000|Overall Study|Death due to study disease|0|||
144481290|NCT00452413|520960843|FG001|Overall Study|Death due to study disease|0|||
144481291|NCT00452413|520960844|FG002|Overall Study|Death due to study disease|2|||
144481292|NCT00452413|520960842|FG000|Overall Study|Death due to adverse event (AE)|0|||
144481293|NCT00452413|520960843|FG001|Overall Study|Death due to adverse event (AE)|0|||
144481294|NCT00452413|520960844|FG002|Overall Study|Death due to adverse event (AE)|1|||
144481295|NCT00452413|520960842|FG000|Overall Study|On treatment|0|||
144481296|NCT00452413|520960843|FG001|Overall Study|On treatment|0|||
144481297|NCT00452413|520960844|FG002|Overall Study|On treatment|3|||
144481298|NCT01518946|520960862|FG000|Open-label Phase|Other|4|||
144481299|NCT01518946|520960863|FG001|Open-label Phase|Other|0|||
144481300|NCT01518946|520960864|FG002|Open-label Phase|Other|0|||
144713804|NCT00990093|521806480|FG000|Test Period 1 (1-14 Days)|Other|1|||
144713805|NCT00990093|521806481|FG001|Test Period 1 (1-14 Days)|Other|0|||
144713806|NCT00990093|521806480|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
144713807|NCT00990093|521806481|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
144713808|NCT00990093|521806480|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
144713809|NCT00990093|521806481|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
144713810|NCT00990093|521806480|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
144713811|NCT00990093|521806481|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
144713812|NCT00990093|521806480|FG000|Test Period 2 (15-28 Days)|Other|0|||
144713813|NCT00990093|521806481|FG001|Test Period 2 (15-28 Days)|Other|1|||
144481301|NCT01518946|520960862|FG000|Randomized Phase (First Intervention)|Other|0|||
144481302|NCT01518946|520960863|FG001|Randomized Phase (First Intervention)|Other|1|||
144481303|NCT01518946|520960864|FG002|Randomized Phase (First Intervention)|Other|0|||
144481304|NCT03857841|520960865|FG000|Overall Study|Death|1|||
144481305|NCT03857841|520960866|FG001|Overall Study|Death|0|||
144481306|NCT03857841|520960867|FG002|Overall Study|Death|0|||
144481307|NCT03857841|520960868|FG003|Overall Study|Death|0|||
144713814|NCT00766506|521807874|FG000|Overall Study|Use rescue medication after 3 hours|3|||
144481308|NCT03857841|520960865|FG000|Overall Study|Study Terminated by Sponsor|1|||
144481309|NCT03857841|520960866|FG001|Overall Study|Study Terminated by Sponsor|0|||
144481310|NCT03857841|520960867|FG002|Overall Study|Study Terminated by Sponsor|0|||
144481311|NCT03857841|520960868|FG003|Overall Study|Study Terminated by Sponsor|0|||
144481312|NCT00384059|520960869|FG000|Infant Series|Not consented|2|||
144481313|NCT00384059|520960870|FG001|Infant Series|Not consented|6|||
144481314|NCT00384059|520960869|FG000|Infant Series|Withdrawal by Subject|2|||
144481315|NCT00384059|520960870|FG001|Infant Series|Withdrawal by Subject|2|||
144481316|NCT00384059|520960869|FG000|Infant Series|Adverse Event|1|||
144481317|NCT00384059|520960870|FG001|Infant Series|Adverse Event|2|||
144481318|NCT00384059|520960869|FG000|Infant Series|Protocol Violation|1|||
144481319|NCT00384059|520960870|FG001|Infant Series|Protocol Violation|2|||
144481320|NCT00384059|520960869|FG000|Infant Series|Lost to Follow-up|0|||
144481321|NCT00384059|520960870|FG001|Infant Series|Lost to Follow-up|1|||
144481322|NCT00384059|520960869|FG000|After Infant Series|Protocol Violation|2|||
144481323|NCT00384059|520960870|FG001|After Infant Series|Protocol Violation|3|||
144481324|NCT00384059|520960869|FG000|After Infant Series|Withdrawal by Subject|2|||
144481325|NCT00384059|520960870|FG001|After Infant Series|Withdrawal by Subject|2|||
144481326|NCT00384059|520960869|FG000|After Infant Series|Failed to Return|0|||
144481327|NCT00384059|520960870|FG001|After Infant Series|Failed to Return|2|||
144481328|NCT00384059|520960869|FG000|After Infant Series|Adverse Event|0|||
144481329|NCT00384059|520960870|FG001|After Infant Series|Adverse Event|1|||
144481330|NCT00384059|520960869|FG000|After Infant Series|Physician Decision|0|||
144481331|NCT00384059|520960870|FG001|After Infant Series|Physician Decision|1|||
144481332|NCT00384059|520960869|FG000|After Infant Series|Lost to Follow-up|0|||
144481333|NCT00384059|520960870|FG001|After Infant Series|Lost to Follow-up|1|||
144481334|NCT00384059|520960869|FG000|Toddler Dose|Lost to Follow-up|1|||
144481335|NCT00384059|520960870|FG001|Toddler Dose|Lost to Follow-up|1|||
144481336|NCT00384059|520960869|FG000|Toddler Dose|Failed to return|0|||
144481337|NCT00384059|520960870|FG001|Toddler Dose|Failed to return|1|||
144481338|NCT00381641|520960874|FG000|Overall Study|Withdrawal by Subject|0|||
144481339|NCT00381641|520960875|FG001|Overall Study|Withdrawal by Subject|2|||
144481340|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
144481341|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
144481342|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
144481343|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
144481344|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
144481345|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
144481346|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
144481347|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
144481348|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144481349|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144481350|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144481351|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144481352|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144481353|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144481354|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
144481355|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
144481356|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
144481357|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144481358|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144481359|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144481360|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144481361|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
144481362|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
144713815|NCT00766506|521807875|FG001|Overall Study|Use rescue medication after 3 hours|0|||
144713816|NCT00766506|521807874|FG000|Overall Study|Other|2|||
144713817|NCT00766506|521807875|FG001|Overall Study|Other|2|||
144713818|NCT01246986|521807876|FG000|Overall Study|Lost to Follow-up|0|||
144713819|NCT01246986|521807877|FG001|Overall Study|Lost to Follow-up|1|||
144713820|NCT01246986|521807878|FG002|Overall Study|Lost to Follow-up|3|||
144481363|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
144481364|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
144481365|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
144481366|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
144481367|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
144481368|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
144481369|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
144481370|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
144481371|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
144713821|NCT01246986|521807879|FG003|Overall Study|Lost to Follow-up|0|||
144713822|NCT01246986|521807880|FG004|Overall Study|Lost to Follow-up|0|||
144713823|NCT01246986|521807881|FG005|Overall Study|Lost to Follow-up|1|||
144713824|NCT01246986|521807882|FG006|Overall Study|Lost to Follow-up|0|||
144713825|NCT01246986|521807876|FG000|Overall Study|Withdrawal by Subject|3|||
144713826|NCT01246986|521807877|FG001|Overall Study|Withdrawal by Subject|4|||
144713827|NCT01246986|521807878|FG002|Overall Study|Withdrawal by Subject|3|||
144713828|NCT01246986|521807879|FG003|Overall Study|Withdrawal by Subject|0|||
144713829|NCT01246986|521807880|FG004|Overall Study|Withdrawal by Subject|4|||
144713830|NCT01246986|521807881|FG005|Overall Study|Withdrawal by Subject|0|||
144713831|NCT01246986|521807882|FG006|Overall Study|Withdrawal by Subject|0|||
144713832|NCT02496221|521807884|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
144713833|NCT02496221|521807885|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
144713834|NCT02496221|521807884|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
144713835|NCT02496221|521807885|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
144713836|NCT02496221|521807884|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
144713837|NCT02496221|521807885|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
144713838|NCT03262233|521807886|FG000|Overall Study|Withdrawal by Subject|12|||
144713839|NCT03262233|521807887|FG001|Overall Study|Withdrawal by Subject|8|||
144713840|NCT03262233|521807888|FG002|Overall Study|Withdrawal by Subject|21|||
144713841|NCT03262233|521807889|FG003|Overall Study|Withdrawal by Subject|13|||
144713842|NCT03262233|521807886|FG000|Overall Study|Declined due to shock|1|||
144713843|NCT03262233|521807887|FG001|Overall Study|Declined due to shock|2|||
144713844|NCT03262233|521807888|FG002|Overall Study|Declined due to shock|2|||
144713845|NCT03262233|521807889|FG003|Overall Study|Declined due to shock|3|||
144713846|NCT03262233|521807886|FG000|Overall Study|Protocol Violation|5|||
144713847|NCT03262233|521807887|FG001|Overall Study|Protocol Violation|10|||
144713848|NCT03262233|521807888|FG002|Overall Study|Protocol Violation|2|||
144713849|NCT03262233|521807889|FG003|Overall Study|Protocol Violation|13|||
144369165|NCT02612779|520561587|FG001|Overall Study|Death|0|||
144369166|NCT02612779|520561586|FG000|Overall Study|Adverse event unrelated to study drug|5|||
144369167|NCT02612779|520561587|FG001|Overall Study|Adverse event unrelated to study drug|0|||
144369168|NCT02612779|520561586|FG000|Overall Study|Participant withdrew consent|4|||
144369169|NCT02612779|520561587|FG001|Overall Study|Participant withdrew consent|0|||
144369170|NCT02612779|520561586|FG000|Overall Study|Lost to Follow-up|1|||
144369171|NCT02612779|520561587|FG001|Overall Study|Lost to Follow-up|0|||
144713850|NCT03262233|521807886|FG000|Overall Study|data collection artifact|0|||
144713851|NCT03262233|521807887|FG001|Overall Study|data collection artifact|1|||
144713852|NCT03262233|521807888|FG002|Overall Study|data collection artifact|0|||
144713853|NCT03262233|521807889|FG003|Overall Study|data collection artifact|0|||
144713854|NCT01120600|521807892|FG000|Overall Study|Adverse Event|7|||
144713855|NCT01120600|521807893|FG001|Overall Study|Adverse Event|7|||
144713856|NCT01120600|521807892|FG000|Overall Study|Excessive Bone Loss|0|||
144713857|NCT01120600|521807893|FG001|Overall Study|Excessive Bone Loss|4|||
144713858|NCT01120600|521807892|FG000|Overall Study|Lost to Follow-up|1|||
144713859|NCT01120600|521807893|FG001|Overall Study|Lost to Follow-up|3|||
144713860|NCT01120600|521807892|FG000|Overall Study|Physician Decision|1|||
144713861|NCT01120600|521807893|FG001|Overall Study|Physician Decision|3|||
144713862|NCT01120600|521807892|FG000|Overall Study|Protocol Violation|0|||
144713863|NCT01120600|521807893|FG001|Overall Study|Protocol Violation|4|||
144713864|NCT01120600|521807892|FG000|Overall Study|Withdrawal by Subject|10|||
144713865|NCT01120600|521807893|FG001|Overall Study|Withdrawal by Subject|11|||
144369172|NCT02612779|520561586|FG000|Overall Study|Maximum clinical benefit|10|||
144713866|NCT03990389|521807894|FG000|Overall Study|Lost to Follow-up|3|||
144713867|NCT03990389|521807895|FG001|Overall Study|Lost to Follow-up|0|||
144713868|NCT03770000|521807896|FG000|Overall Study|Premature discontinuation due to PD|0|||
144713869|NCT03770000|521807897|FG001|Overall Study|Premature discontinuation due to PD|0|||
144713870|NCT03770000|521807898|FG002|Overall Study|Premature discontinuation due to PD|1|||
144713871|NCT03770000|521807899|FG003|Overall Study|Premature discontinuation due to PD|3|||
144713872|NCT03770000|521807900|FG004|Overall Study|Premature discontinuation due to PD|2|||
144713873|NCT02595528|521807901|FG000|Overall Study|Withdrawal by Subject|1|||
144369173|NCT02612779|520561587|FG001|Overall Study|Maximum clinical benefit|1|||
144369174|NCT02612779|520561586|FG000|Overall Study|Other reasons|4|||
144369175|NCT02612779|520561587|FG001|Overall Study|Other reasons|0|||
144369176|NCT01002339|520561588|FG000|Overall Study|Withdrawal by Subject|0|||
144713874|NCT02595528|521807902|FG001|Overall Study|Withdrawal by Subject|2|||
144713875|NCT02595528|521807903|FG002|Overall Study|Withdrawal by Subject|1|||
144713876|NCT02595528|521807904|FG003|Overall Study|Withdrawal by Subject|3|||
144713877|NCT02595528|521807901|FG000|Overall Study|Lost to Follow-up|1|||
144713878|NCT02595528|521807902|FG001|Overall Study|Lost to Follow-up|1|||
144713879|NCT02595528|521807903|FG002|Overall Study|Lost to Follow-up|0|||
144713880|NCT02595528|521807904|FG003|Overall Study|Lost to Follow-up|1|||
144713881|NCT00833547|521807905|FG000|Overall Study|Withdrawal by Subject|2|||
144713882|NCT00833547|521807906|FG001|Overall Study|Withdrawal by Subject|2|||
144713883|NCT01690520|521807909|FG000|Overall Study|Death|25|||
144713884|NCT01690520|521807910|FG001|Overall Study|Death|21|||
144713885|NCT01690520|521807909|FG000|Overall Study|Lost to Follow-up|2|||
144713886|NCT01690520|521807910|FG001|Overall Study|Lost to Follow-up|3|||
144713887|NCT01690520|521807909|FG000|Overall Study|Withdrawal by Subject|2|||
144713888|NCT01690520|521807910|FG001|Overall Study|Withdrawal by Subject|0|||
144713889|NCT01690520|521807909|FG000|Overall Study|Relapse|0|||
144538219|NCT00146172|521174124|FG002|Overall Study|Physician Decision|0|||
144713890|NCT01690520|521807910|FG001|Overall Study|Relapse|1|||
144713891|NCT01690520|521807909|FG000|Overall Study|Other|0|||
144713892|NCT01690520|521807910|FG001|Overall Study|Other|1|||
144713893|NCT01690520|521807909|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
144713894|NCT01690520|521807910|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
144713895|NCT00382291|521807911|FG000|Overall Study|Adverse Event|1|||
144713896|NCT00382291|521807912|FG001|Overall Study|Adverse Event|2|||
144713897|NCT00382291|521807913|FG002|Overall Study|Adverse Event|2|||
144713898|NCT00382291|521807911|FG000|Overall Study|Protocol Violation|1|||
144713899|NCT00382291|521807912|FG001|Overall Study|Protocol Violation|0|||
144713900|NCT00382291|521807913|FG002|Overall Study|Protocol Violation|0|||
144713901|NCT00382291|521807911|FG000|Overall Study|Temporary study suspension|2|||
144713902|NCT00382291|521807912|FG001|Overall Study|Temporary study suspension|2|||
144713903|NCT00382291|521807913|FG002|Overall Study|Temporary study suspension|5|||
144713904|NCT00382291|521807911|FG000|Overall Study|Withdrawal by Subject|0|||
144713905|NCT00382291|521807912|FG001|Overall Study|Withdrawal by Subject|2|||
144713906|NCT00382291|521807913|FG002|Overall Study|Withdrawal by Subject|0|||
144713907|NCT00382291|521807911|FG000|Overall Study|Physician Decision|0|||
144713908|NCT00382291|521807912|FG001|Overall Study|Physician Decision|1|||
144713909|NCT00382291|521807913|FG002|Overall Study|Physician Decision|0|||
144713910|NCT00382291|521807911|FG000|Overall Study|Lack of Efficacy|0|||
144713911|NCT00382291|521807912|FG001|Overall Study|Lack of Efficacy|0|||
144713912|NCT00382291|521807913|FG002|Overall Study|Lack of Efficacy|1|||
144713913|NCT02266706|521807914|FG000|Overall Study|Withdrawal by Subject|0|||
144713914|NCT02266706|521807915|FG001|Overall Study|Withdrawal by Subject|1|||
144713915|NCT02266706|521807916|FG002|Overall Study|Withdrawal by Subject|1|||
144713916|NCT02266706|521807917|FG003|Overall Study|Withdrawal by Subject|0|||
144713917|NCT02266706|521807918|FG004|Overall Study|Withdrawal by Subject|0|||
144713918|NCT02266706|521807919|FG005|Overall Study|Withdrawal by Subject|1|||
144713919|NCT02266706|521807920|FG006|Overall Study|Withdrawal by Subject|0|||
144713920|NCT02266706|521807921|FG007|Overall Study|Withdrawal by Subject|0|||
144713921|NCT02266706|521807922|FG008|Overall Study|Withdrawal by Subject|0|||
144713922|NCT02266706|521807914|FG000|Overall Study|Screen failure|0|||
144713923|NCT02266706|521807915|FG001|Overall Study|Screen failure|0|||
144713924|NCT02266706|521807916|FG002|Overall Study|Screen failure|0|||
144713925|NCT02266706|521807917|FG003|Overall Study|Screen failure|0|||
144247737|NCT01764997|520104206|FG004|Run-in Period|Poor compliance to protocol|0|||
144247738|NCT01764997|520104202|FG000|Run-in Period|Other than specified above|17|||
144247739|NCT01764997|520104203|FG001|Run-in Period|Other than specified above|0|||
144247740|NCT01764997|520104204|FG002|Run-in Period|Other than specified above|0|||
144247741|NCT01764997|520104205|FG003|Run-in Period|Other than specified above|0|||
144247742|NCT01764997|520104206|FG004|Run-in Period|Other than specified above|0|||
144247743|NCT01764997|520104202|FG000|Study Drug Treatment Period|Adverse Event|0|||
144247744|NCT01764997|520104203|FG001|Study Drug Treatment Period|Adverse Event|1|||
144247745|NCT01764997|520104204|FG002|Study Drug Treatment Period|Adverse Event|0|||
144247746|NCT01764997|520104205|FG003|Study Drug Treatment Period|Adverse Event|0|||
144247747|NCT01764997|520104206|FG004|Study Drug Treatment Period|Adverse Event|24|||
144247748|NCT01764997|520104202|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
144247749|NCT01764997|520104203|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
144247750|NCT01764997|520104204|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
144713926|NCT02266706|521807918|FG004|Overall Study|Screen failure|0|||
144713927|NCT02266706|521807919|FG005|Overall Study|Screen failure|1|||
144713928|NCT02266706|521807920|FG006|Overall Study|Screen failure|1|||
144713929|NCT02266706|521807921|FG007|Overall Study|Screen failure|0|||
144713930|NCT02266706|521807922|FG008|Overall Study|Screen failure|0|||
144713931|NCT02266706|521807914|FG000|Overall Study|Enrollment in another study|0|||
144713932|NCT02266706|521807915|FG001|Overall Study|Enrollment in another study|0|||
144713933|NCT02266706|521807916|FG002|Overall Study|Enrollment in another study|0|||
144369177|NCT01002339|520561589|FG001|Overall Study|Withdrawal by Subject|1|||
144369178|NCT01002339|520561590|FG002|Overall Study|Withdrawal by Subject|0|||
144713934|NCT02266706|521807917|FG003|Overall Study|Enrollment in another study|1|||
144713935|NCT02266706|521807918|FG004|Overall Study|Enrollment in another study|0|||
144713936|NCT02266706|521807919|FG005|Overall Study|Enrollment in another study|0|||
144713937|NCT02266706|521807920|FG006|Overall Study|Enrollment in another study|0|||
144713938|NCT02266706|521807921|FG007|Overall Study|Enrollment in another study|0|||
144713939|NCT02266706|521807922|FG008|Overall Study|Enrollment in another study|0|||
144713940|NCT02402933|521807923|FG000|Overall Study|Withdrawal by Subject|4|||
144713941|NCT02402933|521807923|FG000|Overall Study|Discontinued; Site Termination|10|||
144713942|NCT01977352|521807924|FG000|Overall Study|Lost to Follow-up|1|||
144713943|NCT01977352|521807925|FG001|Overall Study|Lost to Follow-up|2|||
144713944|NCT00409188|521807926|FG000|Overall Study|Ongoing at data cut-off|383|||
144713945|NCT00409188|521807927|FG001|Overall Study|Ongoing at data cut-off|175|||
144713946|NCT00854620|521807934|FG000|Overall Study|Adverse Event|1|||
144713947|NCT01169649|521807940|FG000|Overall Study|Patient Not Treated|3|||
144713948|NCT00534092|521807941|FG000|Overall Study|Lost to Follow-up|1|||
144713949|NCT00534092|521807942|FG001|Overall Study|Lost to Follow-up|0|||
144713950|NCT00534092|521807941|FG000|Overall Study|personal reasons/family concerns|1|||
144713951|NCT00534092|521807942|FG001|Overall Study|personal reasons/family concerns|0|||
144713952|NCT02919475|521807943|FG000|Overall Study|Adverse Event|3|||
144713953|NCT02919475|521807944|FG001|Overall Study|Adverse Event|3|||
144713954|NCT02919475|521807945|FG002|Overall Study|Adverse Event|3|||
144713955|NCT02919475|521807946|FG003|Overall Study|Adverse Event|9|||
144713956|NCT02919475|521807947|FG004|Overall Study|Adverse Event|2|||
144713957|NCT02919475|521807943|FG000|Overall Study|Death|0|||
144713958|NCT02919475|521807944|FG001|Overall Study|Death|1|||
144713959|NCT02919475|521807945|FG002|Overall Study|Death|0|||
144713960|NCT02919475|521807946|FG003|Overall Study|Death|0|||
144713961|NCT02919475|521807947|FG004|Overall Study|Death|0|||
144713962|NCT02919475|521807943|FG000|Overall Study|Lost to Follow-up|0|||
144713963|NCT02919475|521807944|FG001|Overall Study|Lost to Follow-up|0|||
144713964|NCT02919475|521807945|FG002|Overall Study|Lost to Follow-up|0|||
144713965|NCT02919475|521807946|FG003|Overall Study|Lost to Follow-up|1|||
144713966|NCT02919475|521807947|FG004|Overall Study|Lost to Follow-up|0|||
144713967|NCT02919475|521807943|FG000|Overall Study|Withdrawal by Subject|2|||
144713968|NCT02919475|521807944|FG001|Overall Study|Withdrawal by Subject|3|||
144713969|NCT02919475|521807945|FG002|Overall Study|Withdrawal by Subject|1|||
144713970|NCT02919475|521807946|FG003|Overall Study|Withdrawal by Subject|2|||
144713971|NCT02919475|521807947|FG004|Overall Study|Withdrawal by Subject|2|||
144713972|NCT02919475|521807943|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
144713973|NCT02919475|521807944|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
144713974|NCT02919475|521807945|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
144713975|NCT02919475|521807946|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
144713976|NCT02919475|521807947|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144369179|NCT01002339|520561588|FG000|Overall Study|Incorrect treatment assignment|0|||
144713977|NCT02323295|521807951|FG000|Overall Study|Adverse Event|0|||
144713978|NCT02323295|521807952|FG001|Overall Study|Adverse Event|1|||
144713979|NCT02323295|521807951|FG000|Overall Study|Withdrawal by Subject|0|||
144713980|NCT02323295|521807952|FG001|Overall Study|Withdrawal by Subject|1|||
144713981|NCT02323295|521807951|FG000|Overall Study|Patient did not have surgery as planned.|0|||
144713982|NCT02323295|521807952|FG001|Overall Study|Patient did not have surgery as planned.|1|||
144713983|NCT02370784|521807953|FG000|Overall Study|Patient started prohibited medication|0|||
144713984|NCT02370784|521807954|FG001|Overall Study|Patient started prohibited medication|1|||
144713985|NCT02962882|521807956|FG000|Overall Study|Adverse Event|2|||
144713986|NCT02962882|521807956|FG000|Overall Study|Withdrawal by Subject|2|||
144713987|NCT02962882|521807956|FG000|Overall Study|Transfer from ICU|32|||
144713988|NCT03763331|521807957|FG000|Overall Study|Lost to Follow-up|1|||
144713989|NCT03763331|521807958|FG001|Overall Study|Lost to Follow-up|0|||
144713990|NCT03763331|521807957|FG000|Overall Study|Withdrawal by Subject|1|||
144713991|NCT03763331|521807958|FG001|Overall Study|Withdrawal by Subject|0|||
144713992|NCT03763331|521807957|FG000|Overall Study|Non-compliance|0|||
144713993|NCT03763331|521807958|FG001|Overall Study|Non-compliance|3|||
144713994|NCT01155063|521807959|FG000|Overall Study|Adverse Event|1|||
144369180|NCT01002339|520561589|FG001|Overall Study|Incorrect treatment assignment|0|||
144369181|NCT01002339|520561590|FG002|Overall Study|Incorrect treatment assignment|1|||
144369182|NCT01002339|520561588|FG000|Overall Study|Protocol Violation|0|||
144369183|NCT01002339|520561589|FG001|Overall Study|Protocol Violation|0|||
144369184|NCT01002339|520561590|FG002|Overall Study|Protocol Violation|2|||
144369185|NCT01002339|520561588|FG000|Overall Study|Lung cancer detected before transplant|0|||
144369186|NCT01002339|520561589|FG001|Overall Study|Lung cancer detected before transplant|0|||
144369187|NCT01002339|520561590|FG002|Overall Study|Lung cancer detected before transplant|1|||
144369188|NCT01002339|520561588|FG000|Overall Study|Randomized. Not transplanted|0|||
144369189|NCT01002339|520561589|FG001|Overall Study|Randomized. Not transplanted|0|||
144369190|NCT01002339|520561590|FG002|Overall Study|Randomized. Not transplanted|1|||
144369191|NCT00892099|520561591|FG000|Overall Study|Death|1|||
144369192|NCT00892099|520561592|FG001|Overall Study|Death|0|||
144369193|NCT00892099|520561593|FG002|Overall Study|Death|1|||
144369194|NCT00892099|520561591|FG000|Overall Study|Adverse Event|1|||
144369195|NCT00892099|520561592|FG001|Overall Study|Adverse Event|0|||
144369196|NCT00892099|520561593|FG002|Overall Study|Adverse Event|0|||
144369197|NCT00892099|520561591|FG000|Overall Study|replocated|1|||
144369198|NCT00892099|520561592|FG001|Overall Study|replocated|0|||
144369199|NCT00892099|520561593|FG002|Overall Study|replocated|2|||
144369200|NCT00892099|520561591|FG000|Overall Study|Prolonged hospitalization|1|||
144369201|NCT00892099|520561592|FG001|Overall Study|Prolonged hospitalization|0|||
144369202|NCT00892099|520561593|FG002|Overall Study|Prolonged hospitalization|1|||
144369203|NCT00892099|520561591|FG000|Overall Study|no further details|1|||
144369204|NCT00892099|520561592|FG001|Overall Study|no further details|0|||
144369205|NCT00892099|520561593|FG002|Overall Study|no further details|1|||
144369206|NCT00892099|520561591|FG000|Overall Study|kidney function recovered|0|||
144369207|NCT00892099|520561592|FG001|Overall Study|kidney function recovered|1|||
144369208|NCT00892099|520561593|FG002|Overall Study|kidney function recovered|0|||
144369209|NCT00892099|520561591|FG000|Overall Study|investigator decision|0|||
144369210|NCT00892099|520561592|FG001|Overall Study|investigator decision|0|||
144369211|NCT00892099|520561593|FG002|Overall Study|investigator decision|1|||
144369212|NCT00892099|520561591|FG000|Overall Study|Lost to Follow-up|0|||
144369213|NCT00892099|520561592|FG001|Overall Study|Lost to Follow-up|0|||
144369214|NCT00892099|520561593|FG002|Overall Study|Lost to Follow-up|1|||
144369215|NCT02346721|520561594|FG000|Overall Study|Withdrew Consent|3|||
144369216|NCT02346721|520561594|FG000|Overall Study|Lack of Efficacy|1|||
144369217|NCT00790842|520561595|FG000|Dose Level 1|Adverse Event|1|||
144369218|NCT00790842|520561596|FG001|Dose Level 1|Adverse Event|0|||
144369219|NCT00790842|520561597|FG002|Dose Level 1|Adverse Event|0|||
144369220|NCT00790842|520561598|FG003|Dose Level 1|Adverse Event|2|||
144369221|NCT00790842|520561599|FG004|Dose Level 1|Adverse Event|0|||
144369222|NCT00790842|520561600|FG005|Dose Level 1|Adverse Event|0|||
144369223|NCT00790842|520561601|FG006|Dose Level 1|Adverse Event|0|||
144369224|NCT00790842|520561602|FG007|Dose Level 1|Adverse Event|1|||
144369225|NCT00790842|520561603|FG008|Dose Level 1|Adverse Event|0|||
144369226|NCT00790842|520561604|FG009|Dose Level 1|Adverse Event|0|||
144369227|NCT00790842|520561605|FG010|Dose Level 1|Adverse Event|0|||
144369228|NCT00790842|520561595|FG000|Dose Level 1|Physician Decision|1|||
144369229|NCT00790842|520561596|FG001|Dose Level 1|Physician Decision|0|||
144481372|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
144481373|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
144713995|NCT01155063|521807959|FG000|Overall Study|Withdrawal by Subject|1|||
144369230|NCT00790842|520561597|FG002|Dose Level 1|Physician Decision|0|||
144369231|NCT00790842|520561598|FG003|Dose Level 1|Physician Decision|0|||
144369232|NCT00790842|520561599|FG004|Dose Level 1|Physician Decision|0|||
144369233|NCT00790842|520561600|FG005|Dose Level 1|Physician Decision|0|||
144369234|NCT00790842|520561601|FG006|Dose Level 1|Physician Decision|0|||
144369235|NCT00790842|520561602|FG007|Dose Level 1|Physician Decision|1|||
144369236|NCT00790842|520561603|FG008|Dose Level 1|Physician Decision|0|||
144369237|NCT00790842|520561604|FG009|Dose Level 1|Physician Decision|0|||
144369238|NCT00790842|520561605|FG010|Dose Level 1|Physician Decision|0|||
144369239|NCT00790842|520561595|FG000|Dose Level 1|Withdrawal by Subject|1|||
144369240|NCT00790842|520561596|FG001|Dose Level 1|Withdrawal by Subject|0|||
144369241|NCT00790842|520561597|FG002|Dose Level 1|Withdrawal by Subject|0|||
144713996|NCT01155063|521807959|FG000|Overall Study|Study terminated by sponsor|87|||
144713997|NCT04741503|521807960|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
144713998|NCT04741503|521807961|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
144713999|NCT04741503|521807962|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
144714000|NCT04741503|521807960|FG000|Initial Enrollment|Overquotas removed|0|||
144714001|NCT04741503|521807961|FG001|Initial Enrollment|Overquotas removed|0|||
144714002|NCT04741503|521807962|FG002|Initial Enrollment|Overquotas removed|186|||
144714003|NCT04741503|521807960|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
144714004|NCT04741503|521807961|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
144714005|NCT04741503|521807962|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
144714006|NCT01663714|521807963|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
144714007|NCT01663714|521807963|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
144714008|NCT01663714|521807963|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
144714009|NCT01663714|521807963|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
144714010|NCT01663714|521807963|FG000|Long-Term Follow-Up|Death|4|||
144714011|NCT01663714|521807963|FG000|Long-Term Follow-Up|Non-compliance|1|||
144714012|NCT00623623|521807964|FG000|Overall Study|Previous enrolment into this study|1|||
144714013|NCT00623623|521807965|FG001|Overall Study|Previous enrolment into this study|1|||
144714014|NCT00693784|521807966|FG000|Overall Study|Lost to Follow-up|2|||
144714015|NCT00693784|521807966|FG000|Overall Study|Withdrawal by Subject|2|||
144714016|NCT02265952|521807967|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
144714017|NCT02265952|521807968|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
144714018|NCT02265952|521807967|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
144714019|NCT02265952|521807968|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
144714020|NCT00326885|521807972|FG000|Overall Study|Adverse Event|1|||
144714021|NCT00326885|521807972|FG000|Overall Study|Withdrawal by Subject|3|||
144714022|NCT00326885|521807972|FG000|Overall Study|Physician Decision|1|||
144714023|NCT00326885|521807972|FG000|Overall Study|Hospice withdrew consent|2|||
144714024|NCT01042977|521807973|FG000|Overall Study|Adverse Event|4|||
144714025|NCT01042977|521807974|FG001|Overall Study|Adverse Event|12|||
144714026|NCT01042977|521807973|FG000|Overall Study|Death|2|||
144714027|NCT01042977|521807974|FG001|Overall Study|Death|1|||
144714028|NCT01042977|521807973|FG000|Overall Study|Withdrawal by Subject|8|||
144714029|NCT01042977|521807974|FG001|Overall Study|Withdrawal by Subject|16|||
144714030|NCT01042977|521807973|FG000|Overall Study|Lost to Follow-up|0|||
144714031|NCT01042977|521807974|FG001|Overall Study|Lost to Follow-up|2|||
144714032|NCT01042977|521807973|FG000|Overall Study|Poor/non-compliance|3|||
144714033|NCT01042977|521807974|FG001|Overall Study|Poor/non-compliance|4|||
144714034|NCT01042977|521807973|FG000|Overall Study|Subject no longer meets study criteria|15|||
144714035|NCT01042977|521807974|FG001|Overall Study|Subject no longer meets study criteria|13|||
144714036|NCT01042977|521807973|FG000|Overall Study|Incorrect enrollment|6|||
144714037|NCT01042977|521807974|FG001|Overall Study|Incorrect enrollment|4|||
144714038|NCT01042977|521807973|FG000|Overall Study|Safety|0|||
144714039|NCT01042977|521807974|FG001|Overall Study|Safety|2|||
144714040|NCT01042977|521807973|FG000|Overall Study|Administrative reason by sponsor|0|||
144481374|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
144481375|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
144481376|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
144481377|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
144481378|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144481379|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144481380|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144481381|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144481382|NCT04921969|520960876|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
144481383|NCT04921969|520960877|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
144481384|NCT04921969|520960878|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
144481385|NCT04921969|520960879|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
144481386|NCT04921969|520960880|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
144481387|NCT04921969|520960881|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
144481388|NCT04921969|520960882|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
144481389|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
144481390|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
144481391|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
144481392|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
144481393|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
144481394|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
144481395|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
144481396|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144481397|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144481398|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144481399|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
144481400|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144481401|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
144481402|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
144481403|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144481404|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144481405|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144481406|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
144481407|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
144481408|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
144481409|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
144481410|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
144481411|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
144481412|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
144481413|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
144481414|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
144481415|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
144481416|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
144481417|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144481418|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144481419|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144481420|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
144481421|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
144481422|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
144481423|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
144481424|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
144481425|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
144481426|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
144481427|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
144481428|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
144481429|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
144481430|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
144481431|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
144481432|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
144481433|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
144714041|NCT01042977|521807974|FG001|Overall Study|Administrative reason by sponsor|1|||
144714042|NCT01042977|521807973|FG000|Overall Study|Various|3|||
144714043|NCT01042977|521807974|FG001|Overall Study|Various|0|||
144714044|NCT02499354|521807975|FG000|Overall Study|Withdrawal by Subject|1|||
144714045|NCT02499354|521807976|FG001|Overall Study|Withdrawal by Subject|0|||
144714046|NCT02424565|521807978|FG000|Period 1 (D0)|Protocol Violation|0|||
144714047|NCT02424565|521807979|FG001|Period 1 (D0)|Protocol Violation|1|||
144714048|NCT01677910|521807980|FG000|Double-Blind Treatment Period|Adverse Event|6|||
144714049|NCT01677910|521807981|FG001|Double-Blind Treatment Period|Adverse Event|2|||
144481434|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
144481435|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
144481436|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
144481437|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
144481438|NCT04921969|520960876|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
144481439|NCT04921969|520960877|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
144481440|NCT04921969|520960878|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
144481441|NCT04921969|520960879|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
144481442|NCT04921969|520960880|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
144481443|NCT04921969|520960881|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
144481444|NCT04921969|520960882|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
144481445|NCT04287868|520960883|FG000|Overall Study|Screening fail|1|||
144481446|NCT04287868|520960884|FG001|Overall Study|Screening fail|0|||
144481447|NCT01811563|520962298|FG000|Overall Study|Lost to Follow-up|5|||
144481448|NCT01811563|520962299|FG001|Overall Study|Lost to Follow-up|2|||
144481449|NCT01811563|520962298|FG000|Overall Study|Incorrect Randomization procedure|0|||
144481450|NCT01811563|520962299|FG001|Overall Study|Incorrect Randomization procedure|1|||
144481451|NCT04424290|520962300|FG000|Overall Study|Not treated|0|||
144481452|NCT04424290|520962301|FG001|Overall Study|Not treated|0|||
144481453|NCT04424290|520962302|FG002|Overall Study|Not treated|1|||
144481454|NCT04424290|520962303|FG003|Overall Study|Not treated|0|||
144481455|NCT04424290|520962304|FG004|Overall Study|Not treated|1|||
144481456|NCT04424290|520962300|FG000|Overall Study|Adverse Event|0|||
144481457|NCT04424290|520962301|FG001|Overall Study|Adverse Event|0|||
144481458|NCT04424290|520962302|FG002|Overall Study|Adverse Event|0|||
144481459|NCT04424290|520962303|FG003|Overall Study|Adverse Event|2|||
144481460|NCT04424290|520962304|FG004|Overall Study|Adverse Event|0|||
144481461|NCT04424290|520962300|FG000|Overall Study|Withdrawal by Subject|0|||
144481462|NCT04424290|520962301|FG001|Overall Study|Withdrawal by Subject|0|||
144481463|NCT04424290|520962302|FG002|Overall Study|Withdrawal by Subject|0|||
144481464|NCT04424290|520962303|FG003|Overall Study|Withdrawal by Subject|0|||
144481465|NCT04424290|520962304|FG004|Overall Study|Withdrawal by Subject|1|||
144481466|NCT04424290|520962300|FG000|Overall Study|Other than listed|0|||
144481467|NCT04424290|520962301|FG001|Overall Study|Other than listed|0|||
144481468|NCT04424290|520962302|FG002|Overall Study|Other than listed|0|||
144481469|NCT04424290|520962303|FG003|Overall Study|Other than listed|1|||
144481470|NCT04424290|520962304|FG004|Overall Study|Other than listed|0|||
144481471|NCT01267825|520962305|FG000|Overall Study|study terminated. no data collected.|1|||
144481472|NCT01267825|520962306|FG001|Overall Study|study terminated. no data collected.|0|||
144481473|NCT02791490|520962308|FG000|Overall Study|Lost to Follow-up|1|||
144481474|NCT02791490|520962309|FG001|Overall Study|Lost to Follow-up|2|||
144481475|NCT02791490|520962308|FG000|Overall Study|Withdrawal by Subject|2|||
144481476|NCT02791490|520962309|FG001|Overall Study|Withdrawal by Subject|6|||
144481477|NCT01189890|520962310|FG000|Overall Study|Adverse Event|3|||
144481478|NCT01189890|520962311|FG001|Overall Study|Adverse Event|4|||
144481479|NCT01189890|520962310|FG000|Overall Study|Lack of Efficacy|7|||
144481480|NCT01189890|520962311|FG001|Overall Study|Lack of Efficacy|2|||
144481481|NCT01189890|520962310|FG000|Overall Study|Lost to Follow-up|1|||
144481482|NCT01189890|520962311|FG001|Overall Study|Lost to Follow-up|7|||
144481483|NCT01189890|520962310|FG000|Overall Study|Protocol Violation|1|||
144481484|NCT01189890|520962311|FG001|Overall Study|Protocol Violation|5|||
144481485|NCT01189890|520962310|FG000|Overall Study|Withdrawal by Subject|15|||
144481486|NCT01189890|520962311|FG001|Overall Study|Withdrawal by Subject|11|||
144481487|NCT01189890|520962310|FG000|Overall Study|Non Compliance|0|||
144481488|NCT01189890|520962311|FG001|Overall Study|Non Compliance|1|||
144481489|NCT01189890|520962310|FG000|Overall Study|Physician Decision|5|||
144481490|NCT01189890|520962311|FG001|Overall Study|Physician Decision|4|||
144481491|NCT01189890|520962310|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
144481492|NCT01189890|520962311|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
144481493|NCT01912222|520962315|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
144481494|NCT01912222|520962316|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
144481495|NCT01912222|520962317|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
144481496|NCT01912222|520962315|FG000|Part B: Treatment Period|Progressive disease|10|||
144481497|NCT01912222|520962316|FG001|Part B: Treatment Period|Progressive disease|12|||
144481498|NCT01912222|520962317|FG002|Part B: Treatment Period|Progressive disease|15|||
144481499|NCT01912222|520962315|FG000|Part B: Treatment Period|Adverse Event|1|||
144481500|NCT01912222|520962316|FG001|Part B: Treatment Period|Adverse Event|2|||
144481501|NCT01912222|520962317|FG002|Part B: Treatment Period|Adverse Event|3|||
144481502|NCT01912222|520962315|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
144481503|NCT01912222|520962316|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
144481504|NCT01912222|520962317|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
144481505|NCT01024959|520962318|FG000|Overall Study|ineligible|12|||
144481506|NCT01024959|520962318|FG000|Overall Study|results not evaluable|12|||
144481507|NCT01024959|520962318|FG000|Overall Study|missing results required for analysis|17|||
144481508|NCT00636792|520962319|FG000|Overall Study|Adverse Event|16|||
144481509|NCT00636792|520962319|FG000|Overall Study|Physician Decision|7|||
144481510|NCT00636792|520962319|FG000|Overall Study|Progressive Disease|4|||
144481511|NCT00636792|520962319|FG000|Overall Study|Withdrawal by Subject|3|||
144481512|NCT00636792|520962319|FG000|Overall Study|Other|3|||
144369242|NCT00790842|520561598|FG003|Dose Level 1|Withdrawal by Subject|0|||
144369243|NCT00790842|520561599|FG004|Dose Level 1|Withdrawal by Subject|0|||
144369244|NCT00790842|520561600|FG005|Dose Level 1|Withdrawal by Subject|0|||
144369245|NCT00790842|520561601|FG006|Dose Level 1|Withdrawal by Subject|0|||
144369246|NCT00790842|520561602|FG007|Dose Level 1|Withdrawal by Subject|0|||
144369247|NCT00790842|520561603|FG008|Dose Level 1|Withdrawal by Subject|0|||
144369248|NCT00790842|520561604|FG009|Dose Level 1|Withdrawal by Subject|0|||
144369249|NCT00790842|520561605|FG010|Dose Level 1|Withdrawal by Subject|0|||
144369250|NCT00790842|520561595|FG000|Dose Level 2|Death|0|||
144369251|NCT00790842|520561596|FG001|Dose Level 2|Death|1|||
144369252|NCT00790842|520561597|FG002|Dose Level 2|Death|0|||
144369253|NCT00790842|520561598|FG003|Dose Level 2|Death|0|||
144369254|NCT00790842|520561599|FG004|Dose Level 2|Death|1|||
144369255|NCT00790842|520561600|FG005|Dose Level 2|Death|0|||
144369256|NCT00790842|520561601|FG006|Dose Level 2|Death|0|||
144481513|NCT00451217|520962323|FG000|Overall Study|Lost to Follow-up|0|||
144481514|NCT00451217|520962324|FG001|Overall Study|Lost to Follow-up|1|||
144481515|NCT00451217|520962325|FG002|Overall Study|Lost to Follow-up|1|||
144481516|NCT00451217|520962326|FG003|Overall Study|Lost to Follow-up|1|||
144481517|NCT00451217|520962323|FG000|Overall Study|Withdrawal by Subject|1|||
144481518|NCT00451217|520962324|FG001|Overall Study|Withdrawal by Subject|0|||
144369257|NCT00790842|520561602|FG007|Dose Level 2|Death|0|||
144369258|NCT00790842|520561603|FG008|Dose Level 2|Death|0|||
144369259|NCT00790842|520561604|FG009|Dose Level 2|Death|0|||
144369260|NCT00790842|520561605|FG010|Dose Level 2|Death|0|||
144369261|NCT00790842|520561595|FG000|Dose Level 2|Physician Decision|0|||
144369262|NCT00790842|520561596|FG001|Dose Level 2|Physician Decision|1|||
144369263|NCT00790842|520561597|FG002|Dose Level 2|Physician Decision|0|||
144714050|NCT01677910|521807982|FG002|Double-Blind Treatment Period|Adverse Event|3|||
144481519|NCT00451217|520962325|FG002|Overall Study|Withdrawal by Subject|0|||
144481520|NCT00451217|520962326|FG003|Overall Study|Withdrawal by Subject|0|||
144481521|NCT00451217|520962323|FG000|Overall Study|Not Treated|1|||
144369264|NCT00790842|520561598|FG003|Dose Level 2|Physician Decision|0|||
144369265|NCT00790842|520561599|FG004|Dose Level 2|Physician Decision|0|||
144369266|NCT00790842|520561600|FG005|Dose Level 2|Physician Decision|0|||
144369267|NCT00790842|520561601|FG006|Dose Level 2|Physician Decision|0|||
144369268|NCT00790842|520561602|FG007|Dose Level 2|Physician Decision|0|||
144369269|NCT00790842|520561603|FG008|Dose Level 2|Physician Decision|0|||
144369270|NCT00790842|520561604|FG009|Dose Level 2|Physician Decision|0|||
144369271|NCT00790842|520561605|FG010|Dose Level 2|Physician Decision|0|||
144369272|NCT00790842|520561595|FG000|Dose Level 2|Withdrawal by Subject|0|||
144714051|NCT01677910|521807983|FG003|Double-Blind Treatment Period|Adverse Event|0|||
144714052|NCT01677910|521807980|FG000|Double-Blind Treatment Period|Physician Decision|0|||
144714053|NCT01677910|521807981|FG001|Double-Blind Treatment Period|Physician Decision|0|||
144714054|NCT01677910|521807982|FG002|Double-Blind Treatment Period|Physician Decision|1|||
144714055|NCT01677910|521807983|FG003|Double-Blind Treatment Period|Physician Decision|0|||
144714056|NCT01677910|521807980|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
144714057|NCT01677910|521807981|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
144714058|NCT01677910|521807982|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
144714059|NCT01677910|521807983|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
144714060|NCT01677910|521807980|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
144369273|NCT00790842|520561596|FG001|Dose Level 2|Withdrawal by Subject|1|||
144369274|NCT00790842|520561597|FG002|Dose Level 2|Withdrawal by Subject|0|||
144369275|NCT00790842|520561598|FG003|Dose Level 2|Withdrawal by Subject|0|||
144369276|NCT00790842|520561599|FG004|Dose Level 2|Withdrawal by Subject|0|||
144369277|NCT00790842|520561600|FG005|Dose Level 2|Withdrawal by Subject|0|||
144369278|NCT00790842|520561601|FG006|Dose Level 2|Withdrawal by Subject|0|||
144369279|NCT00790842|520561602|FG007|Dose Level 2|Withdrawal by Subject|0|||
144369280|NCT00790842|520561603|FG008|Dose Level 2|Withdrawal by Subject|0|||
144369281|NCT00790842|520561604|FG009|Dose Level 2|Withdrawal by Subject|0|||
144369282|NCT00790842|520561605|FG010|Dose Level 2|Withdrawal by Subject|0|||
144369283|NCT00790842|520561595|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369284|NCT00790842|520561596|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369285|NCT00790842|520561597|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369286|NCT00790842|520561598|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369287|NCT00790842|520561599|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369288|NCT00790842|520561600|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369289|NCT00790842|520561601|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369290|NCT00790842|520561602|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369291|NCT00790842|520561603|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
144369292|NCT00790842|520561604|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369293|NCT00790842|520561605|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
144369294|NCT00790842|520561595|FG000|Dose Level 3|Adverse Event|0|||
144369295|NCT00790842|520561596|FG001|Dose Level 3|Adverse Event|0|||
144369296|NCT00790842|520561597|FG002|Dose Level 3|Adverse Event|1|||
144369297|NCT00790842|520561598|FG003|Dose Level 3|Adverse Event|0|||
144369298|NCT00790842|520561599|FG004|Dose Level 3|Adverse Event|0|||
144369299|NCT00790842|520561600|FG005|Dose Level 3|Adverse Event|0|||
144369300|NCT00790842|520561601|FG006|Dose Level 3|Adverse Event|0|||
144369301|NCT00790842|520561602|FG007|Dose Level 3|Adverse Event|0|||
144369302|NCT00790842|520561603|FG008|Dose Level 3|Adverse Event|0|||
144369303|NCT00790842|520561604|FG009|Dose Level 3|Adverse Event|0|||
144369304|NCT00790842|520561605|FG010|Dose Level 3|Adverse Event|0|||
144369305|NCT00790842|520561595|FG000|Dose Level 3|Withdrawal by Subject|0|||
144369306|NCT00790842|520561596|FG001|Dose Level 3|Withdrawal by Subject|0|||
144369307|NCT00790842|520561597|FG002|Dose Level 3|Withdrawal by Subject|3|||
144369308|NCT00790842|520561598|FG003|Dose Level 3|Withdrawal by Subject|0|||
144369309|NCT00790842|520561599|FG004|Dose Level 3|Withdrawal by Subject|0|||
144369310|NCT00790842|520561600|FG005|Dose Level 3|Withdrawal by Subject|0|||
144369311|NCT00790842|520561601|FG006|Dose Level 3|Withdrawal by Subject|0|||
144369312|NCT00790842|520561602|FG007|Dose Level 3|Withdrawal by Subject|0|||
144369313|NCT00790842|520561603|FG008|Dose Level 3|Withdrawal by Subject|0|||
144369314|NCT00790842|520561604|FG009|Dose Level 3|Withdrawal by Subject|2|||
144369315|NCT00790842|520561605|FG010|Dose Level 3|Withdrawal by Subject|0|||
144369316|NCT00790842|520561595|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369317|NCT00790842|520561596|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369318|NCT00790842|520561597|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369319|NCT00790842|520561598|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369320|NCT00790842|520561599|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369321|NCT00790842|520561600|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
144369322|NCT00790842|520561601|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144481522|NCT00451217|520962324|FG001|Overall Study|Not Treated|1|||
144481523|NCT00451217|520962325|FG002|Overall Study|Not Treated|3|||
144481524|NCT00451217|520962326|FG003|Overall Study|Not Treated|4|||
144481525|NCT01129336|520962327|FG000|Overall Study|Protocol Violation|1|||
144481526|NCT01129336|520962328|FG001|Overall Study|Protocol Violation|0|||
144481527|NCT01129336|520962327|FG000|Overall Study|Disease Progression|1|||
144481528|NCT01129336|520962328|FG001|Overall Study|Disease Progression|4|||
144481529|NCT01129336|520962327|FG000|Overall Study|Lost to Follow-up|1|||
144481530|NCT01129336|520962328|FG001|Overall Study|Lost to Follow-up|0|||
144481531|NCT01129336|520962327|FG000|Overall Study|Withdrawal by Subject|7|||
144481532|NCT01129336|520962328|FG001|Overall Study|Withdrawal by Subject|4|||
144481533|NCT01129336|520962327|FG000|Overall Study|Adverse Event|0|||
144481534|NCT01129336|520962328|FG001|Overall Study|Adverse Event|1|||
144481535|NCT01129336|520962327|FG000|Overall Study|Missing Study Completion Status|2|||
144481536|NCT01129336|520962328|FG001|Overall Study|Missing Study Completion Status|3|||
144481537|NCT01129336|520962327|FG000|Overall Study|Death|0|||
144481538|NCT01129336|520962328|FG001|Overall Study|Death|4|||
144481539|NCT00708305|520962341|FG000|Period 1|Protocol Violation|1|||
144481540|NCT00708305|520962342|FG001|Period 1|Protocol Violation|0|||
144481541|NCT00708305|520962343|FG002|Period 1|Protocol Violation|1|||
144481542|NCT00708305|520962344|FG003|Period 1|Protocol Violation|0|||
144481543|NCT00708305|520962341|FG000|Period 1|Other Reason|0|||
144481544|NCT00708305|520962342|FG001|Period 1|Other Reason|0|||
144481545|NCT00708305|520962343|FG002|Period 1|Other Reason|0|||
144481546|NCT00708305|520962344|FG003|Period 1|Other Reason|2|||
144481547|NCT00708305|520962341|FG000|Period 2|Lost to Follow-up|0|||
144481548|NCT00708305|520962342|FG001|Period 2|Lost to Follow-up|1|||
144481549|NCT00708305|520962343|FG002|Period 2|Lost to Follow-up|0|||
144481550|NCT00708305|520962344|FG003|Period 2|Lost to Follow-up|0|||
144481551|NCT00708305|520962341|FG000|Period 2|Protocol Violation|0|||
144481552|NCT00708305|520962342|FG001|Period 2|Protocol Violation|1|||
144481553|NCT00708305|520962343|FG002|Period 2|Protocol Violation|0|||
144481554|NCT00708305|520962344|FG003|Period 2|Protocol Violation|0|||
144481555|NCT00708305|520962341|FG000|Period 2|Other Reason|1|||
144481556|NCT00708305|520962342|FG001|Period 2|Other Reason|0|||
144481557|NCT00708305|520962343|FG002|Period 2|Other Reason|0|||
144481558|NCT00708305|520962344|FG003|Period 2|Other Reason|1|||
144481559|NCT00708305|520962341|FG000|Period 3|Protocol Violation|0|||
144481560|NCT00708305|520962342|FG001|Period 3|Protocol Violation|2|||
144481561|NCT00708305|520962343|FG002|Period 3|Protocol Violation|0|||
144481562|NCT00708305|520962344|FG003|Period 3|Protocol Violation|0|||
144481563|NCT00708305|520962341|FG000|Period 3|Other Reason|1|||
144481564|NCT00708305|520962342|FG001|Period 3|Other Reason|0|||
144481565|NCT00708305|520962343|FG002|Period 3|Other Reason|0|||
144481566|NCT00708305|520962344|FG003|Period 3|Other Reason|0|||
144481567|NCT00734214|520962350|FG000|Overall Study|Withdrawal by Subject|3|||
144481568|NCT00734214|520962351|FG001|Overall Study|Withdrawal by Subject|4|||
144481569|NCT00734214|520962350|FG000|Overall Study|MD withdrawal|1|||
144481570|NCT00734214|520962351|FG001|Overall Study|MD withdrawal|0|||
144481571|NCT00582491|520962352|FG000|Overall Study|Withdrawal by Subject|1|||
144481572|NCT00582491|520962353|FG001|Overall Study|Withdrawal by Subject|0|||
144481573|NCT01193582|520962354|FG000|Vaccination Series|Withdrawal by Subject|11|||
144481574|NCT01193582|520962355|FG001|Vaccination Series|Withdrawal by Subject|13|||
144481575|NCT01193582|520962356|FG002|Vaccination Series|Withdrawal by Subject|8|||
144481576|NCT01193582|520962357|FG003|Vaccination Series|Withdrawal by Subject|3|||
144481577|NCT01193582|520962354|FG000|12 Month Follow-up|Death|0|||
144481578|NCT01193582|520962355|FG001|12 Month Follow-up|Death|0|||
144481579|NCT01193582|520962356|FG002|12 Month Follow-up|Death|1|||
144481580|NCT01193582|520962357|FG003|12 Month Follow-up|Death|0|||
144481581|NCT01193582|520962354|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
144481582|NCT01193582|520962355|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
144481583|NCT01193582|520962356|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
144481584|NCT01193582|520962357|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
144481585|NCT01425632|520962358|FG000|Overall Study|Adverse Event|0|||
144481586|NCT01425632|520962359|FG001|Overall Study|Adverse Event|1|||
144481587|NCT01425632|520962360|FG002|Overall Study|Adverse Event|1|||
144481588|NCT01425632|520962358|FG000|Overall Study|Physician Decision|1|||
144481589|NCT01425632|520962359|FG001|Overall Study|Physician Decision|0|||
144481590|NCT01425632|520962360|FG002|Overall Study|Physician Decision|0|||
144481591|NCT01425632|520962358|FG000|Overall Study|Protocol Violation|0|||
144481592|NCT01425632|520962359|FG001|Overall Study|Protocol Violation|0|||
144481593|NCT01425632|520962360|FG002|Overall Study|Protocol Violation|2|||
144481594|NCT01425632|520962358|FG000|Overall Study|Withdrawal by Subject|0|||
144481595|NCT01425632|520962359|FG001|Overall Study|Withdrawal by Subject|0|||
144481596|NCT01425632|520962360|FG002|Overall Study|Withdrawal by Subject|1|||
144481597|NCT00406419|520962367|FG000|Overall Study|Death|3|||
144481598|NCT00406419|520962368|FG001|Overall Study|Death|1|||
144481599|NCT00406419|520962369|FG002|Overall Study|Death|4|||
144481600|NCT00406419|520962367|FG000|Overall Study|Protocol Violation|6|||
144481601|NCT00406419|520962368|FG001|Overall Study|Protocol Violation|2|||
144481602|NCT00406419|520962369|FG002|Overall Study|Protocol Violation|5|||
144481603|NCT00406419|520962367|FG000|Overall Study|Study Terminated by Sponsor|260|||
144481604|NCT00406419|520962368|FG001|Overall Study|Study Terminated by Sponsor|288|||
144481605|NCT00406419|520962369|FG002|Overall Study|Study Terminated by Sponsor|282|||
144481606|NCT00406419|520962367|FG000|Overall Study|Withdrawal by Subject|17|||
144481607|NCT00406419|520962368|FG001|Overall Study|Withdrawal by Subject|24|||
144481608|NCT00406419|520962369|FG002|Overall Study|Withdrawal by Subject|26|||
144481609|NCT00406419|520962367|FG000|Overall Study|Lack of Efficacy|12|||
144481610|NCT00406419|520962368|FG001|Overall Study|Lack of Efficacy|1|||
144481611|NCT00406419|520962369|FG002|Overall Study|Lack of Efficacy|6|||
144481612|NCT00406419|520962367|FG000|Overall Study|Non-Compliance with Study Drug|5|||
144481613|NCT00406419|520962368|FG001|Overall Study|Non-Compliance with Study Drug|6|||
144481614|NCT00406419|520962369|FG002|Overall Study|Non-Compliance with Study Drug|3|||
144481615|NCT00406419|520962367|FG000|Overall Study|Adverse Event|10|||
144481616|NCT00406419|520962368|FG001|Overall Study|Adverse Event|12|||
144481617|NCT00406419|520962369|FG002|Overall Study|Adverse Event|16|||
144481618|NCT00406419|520962367|FG000|Overall Study|Lost to Follow-up|11|||
144481619|NCT00406419|520962368|FG001|Overall Study|Lost to Follow-up|10|||
144481620|NCT00406419|520962369|FG002|Overall Study|Lost to Follow-up|5|||
144481621|NCT01775930|520962370|FG000|Overall Study|Futility stopping boundary met|1|||
144481622|NCT01208415|520962373|FG000|Overall Study|Death|1|||
144481623|NCT01208415|520962373|FG000|Overall Study|Lost to Follow-up|2|||
144481624|NCT01208415|520962373|FG000|Overall Study|Withdrawal by Subject|3|||
144481625|NCT01208415|520962373|FG000|Overall Study|Device not placed|1|||
144481626|NCT01208415|520962373|FG000|Overall Study|Still be eligible for follow-up|33|||
144481627|NCT03856996|520962374|FG000|Overall Study|Withdrawal by Subject|1|||
144481628|NCT03856996|520962375|FG001|Overall Study|Withdrawal by Subject|0|||
144481629|NCT03856996|520962374|FG000|Overall Study|Lost to Follow-up|0|||
144481630|NCT03856996|520962375|FG001|Overall Study|Lost to Follow-up|1|||
144481631|NCT03856996|520962374|FG000|Overall Study|Adverse Event|1|||
144481632|NCT03856996|520962375|FG001|Overall Study|Adverse Event|1|||
144481633|NCT03856996|520962374|FG000|Overall Study|Other|1|||
144481634|NCT03856996|520962375|FG001|Overall Study|Other|0|||
144481635|NCT01155661|520962381|FG000|Overall Study|Adverse Event|101|||
144481636|NCT01155661|520962381|FG000|Overall Study|Death|1|||
144481637|NCT01155661|520962381|FG000|Overall Study|Lack of Efficacy|32|||
144481638|NCT01155661|520962381|FG000|Overall Study|Lost to Follow-up|22|||
144481639|NCT01155661|520962381|FG000|Overall Study|Physician Decision|3|||
144481640|NCT01155661|520962381|FG000|Overall Study|Protocol Violation|35|||
144481641|NCT01155661|520962381|FG000|Overall Study|Withdrawal by Subject|73|||
144481642|NCT01155661|520962381|FG000|Overall Study|Sponsor Decision|13|||
144481643|NCT01396395|520962382|FG000|Overall Study|Withdrawal by Subject|10|||
144481644|NCT01396395|520962383|FG001|Overall Study|Withdrawal by Subject|12|||
144481645|NCT01396395|520962382|FG000|Overall Study|Protocol Violation|3|||
144481646|NCT01396395|520962383|FG001|Overall Study|Protocol Violation|1|||
144481647|NCT01396395|520962382|FG000|Overall Study|Adverse Event|10|||
144481648|NCT01396395|520962383|FG001|Overall Study|Adverse Event|2|||
144481649|NCT01396395|520962382|FG000|Overall Study|Lost to Follow-up|17|||
144481650|NCT01396395|520962383|FG001|Overall Study|Lost to Follow-up|11|||
144481651|NCT01396395|520962382|FG000|Overall Study|Other|0|||
144481652|NCT01396395|520962383|FG001|Overall Study|Other|1|||
144481653|NCT00882921|520962384|FG000|Overall Study|Death|2|||
144714061|NCT01677910|521807981|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
144714062|NCT01677910|521807982|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
144714063|NCT01677910|521807983|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
144714064|NCT01677910|521807980|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
144714065|NCT01677910|521807981|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
144714066|NCT01677910|521807982|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
144588131|NCT00153062|521352288|FG001|Overall Study|No disposition data available|1|||
144588132|NCT00153062|521352289|FG002|Overall Study|No disposition data available|1|||
144588133|NCT00153062|521352290|FG003|Overall Study|No disposition data available|1|||
144481654|NCT00882921|520962384|FG000|Overall Study|Other|3|||
144481655|NCT00882921|520962384|FG000|Overall Study|Lost to Follow-up|2|||
144481656|NCT00882921|520962384|FG000|Overall Study|Termination By Investigator|3|||
144714067|NCT01677910|521807983|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
144714068|NCT01677910|521807980|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
144714069|NCT01677910|521807981|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
144481657|NCT00882921|520962384|FG000|Overall Study|Withdrawal Of Consent|1|||
144481658|NCT01370005|520962385|FG000|Overall Study|Not treated|1|||
144481659|NCT01370005|520962386|FG001|Overall Study|Not treated|0|||
144481660|NCT01370005|520962387|FG002|Overall Study|Not treated|0|||
144481661|NCT01370005|520962385|FG000|Overall Study|Adverse Event|5|||
144481662|NCT01370005|520962386|FG001|Overall Study|Adverse Event|5|||
144481663|NCT01370005|520962387|FG002|Overall Study|Adverse Event|6|||
144481664|NCT01370005|520962385|FG000|Overall Study|Lack of Efficacy|1|||
144481665|NCT01370005|520962386|FG001|Overall Study|Lack of Efficacy|0|||
144481666|NCT01370005|520962387|FG002|Overall Study|Lack of Efficacy|0|||
144588134|NCT00153062|521352287|FG000|Overall Study|Other|0|||
144481667|NCT01370005|520962385|FG000|Overall Study|Non compliant with protocol|0|||
144481668|NCT01370005|520962386|FG001|Overall Study|Non compliant with protocol|1|||
144481669|NCT01370005|520962387|FG002|Overall Study|Non compliant with protocol|2|||
144481670|NCT01370005|520962385|FG000|Overall Study|Lost to Follow-up|1|||
144481671|NCT01370005|520962386|FG001|Overall Study|Lost to Follow-up|1|||
144481672|NCT01370005|520962387|FG002|Overall Study|Lost to Follow-up|1|||
144481673|NCT01370005|520962385|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
144481674|NCT01370005|520962386|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
144481675|NCT01370005|520962387|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
144481676|NCT01370005|520962385|FG000|Overall Study|Other reason not defined above|3|||
144481677|NCT01370005|520962386|FG001|Overall Study|Other reason not defined above|0|||
144481678|NCT01370005|520962387|FG002|Overall Study|Other reason not defined above|2|||
144481679|NCT03691948|520962388|FG000|Overall Study|Lost to Follow-up|1|||
144481680|NCT03691948|520962389|FG001|Overall Study|Lost to Follow-up|3|||
144481681|NCT02009696|520962390|FG000|Overall Study|Withdrawal by Subject|2|||
144481682|NCT02120664|520962391|FG000|Overall Study|Withdrawal by Subject|0|||
144481683|NCT02120664|520962392|FG001|Overall Study|Withdrawal by Subject|0|||
144481684|NCT02120664|520962393|FG002|Overall Study|Withdrawal by Subject|0|||
144481685|NCT02120664|520962394|FG003|Overall Study|Withdrawal by Subject|1|||
144481686|NCT02120664|520962395|FG004|Overall Study|Withdrawal by Subject|0|||
144481687|NCT03916744|520962396|FG000|Overall Study|Withdrawal by Subject|0|||
144481688|NCT03916744|520962397|FG001|Overall Study|Withdrawal by Subject|1|||
144481689|NCT03916744|520962398|FG002|Overall Study|Withdrawal by Subject|2|||
144481690|NCT02460263|520962399|FG000|Transition Period|Withdrawal by Subject|1|||
144481691|NCT02460263|520962399|FG000|Transition Period|Death|1|||
144481692|NCT04524598|520962400|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
144481693|NCT04524598|520962401|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
144481694|NCT04524598|520962402|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
144481695|NCT04524598|520962403|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
144481696|NCT04524598|520962404|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
144481697|NCT04524598|520962400|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
144481698|NCT04524598|520962401|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
144481699|NCT04524598|520962402|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481700|NCT04524598|520962403|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481701|NCT04524598|520962404|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481702|NCT04524598|520962400|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
144481703|NCT04524598|520962401|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
144481704|NCT04524598|520962402|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
144481705|NCT04524598|520962403|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
144481706|NCT04524598|520962404|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
144481707|NCT04524598|520962400|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
144481708|NCT04524598|520962401|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
144481709|NCT04524598|520962402|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
144481710|NCT04524598|520962403|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
144481711|NCT04524598|520962404|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
144481712|NCT04524598|520962400|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481713|NCT04524598|520962401|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481714|NCT04524598|520962402|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
144481715|NCT04524598|520962403|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
144481716|NCT04524598|520962404|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481717|NCT04524598|520962400|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
144481718|NCT04524598|520962401|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
144481719|NCT04524598|520962402|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
144481720|NCT04524598|520962403|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
144481721|NCT04524598|520962404|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
144481722|NCT04524598|520962400|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481723|NCT04524598|520962401|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481724|NCT04524598|520962402|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481725|NCT04524598|520962403|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
144481726|NCT04524598|520962404|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
144481727|NCT02301156|520962405|FG000|Overall Study|Adverse Event|13|||
144481728|NCT02301156|520962406|FG001|Overall Study|Adverse Event|14|||
144481729|NCT02301156|520962405|FG000|Overall Study|Death|1|||
144481730|NCT02301156|520962406|FG001|Overall Study|Death|5|||
144481731|NCT02301156|520962405|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
144481732|NCT02301156|520962406|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
144481733|NCT02301156|520962405|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
144369323|NCT00790842|520561602|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369324|NCT00790842|520561603|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369325|NCT00790842|520561604|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369326|NCT00790842|520561605|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
144369327|NCT00790842|520561595|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369328|NCT00790842|520561596|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369329|NCT00790842|520561597|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
144369330|NCT00790842|520561598|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369331|NCT00790842|520561599|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369332|NCT00790842|520561600|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369333|NCT00790842|520561601|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369334|NCT00790842|520561602|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369335|NCT00790842|520561603|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369336|NCT00790842|520561604|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369337|NCT00790842|520561605|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
144369338|NCT00790842|520561595|FG000|Dose Level 4|Adverse Event|0|||
144369339|NCT00790842|520561596|FG001|Dose Level 4|Adverse Event|0|||
144369340|NCT00790842|520561597|FG002|Dose Level 4|Adverse Event|0|||
144369341|NCT00790842|520561598|FG003|Dose Level 4|Adverse Event|0|||
144369342|NCT00790842|520561599|FG004|Dose Level 4|Adverse Event|0|||
144369343|NCT00790842|520561600|FG005|Dose Level 4|Adverse Event|0|||
144369344|NCT00790842|520561601|FG006|Dose Level 4|Adverse Event|1|||
144369345|NCT00790842|520561602|FG007|Dose Level 4|Adverse Event|0|||
144369346|NCT00790842|520561603|FG008|Dose Level 4|Adverse Event|0|||
144369347|NCT00790842|520561604|FG009|Dose Level 4|Adverse Event|0|||
144369348|NCT00790842|520561605|FG010|Dose Level 4|Adverse Event|0|||
144369349|NCT00790842|520561595|FG000|Dose Level 4|Physician Decision|0|||
144369350|NCT00790842|520561596|FG001|Dose Level 4|Physician Decision|0|||
144369351|NCT00790842|520561597|FG002|Dose Level 4|Physician Decision|0|||
144369352|NCT00790842|520561598|FG003|Dose Level 4|Physician Decision|0|||
144369353|NCT00790842|520561599|FG004|Dose Level 4|Physician Decision|0|||
144369354|NCT00790842|520561600|FG005|Dose Level 4|Physician Decision|0|||
144369355|NCT00790842|520561601|FG006|Dose Level 4|Physician Decision|1|||
144369356|NCT00790842|520561602|FG007|Dose Level 4|Physician Decision|0|||
144369357|NCT00790842|520561603|FG008|Dose Level 4|Physician Decision|0|||
144369358|NCT00790842|520561604|FG009|Dose Level 4|Physician Decision|0|||
144369359|NCT00790842|520561605|FG010|Dose Level 4|Physician Decision|1|||
144369360|NCT00790842|520561595|FG000|Dose Level 4|Withdrawal by Subject|0|||
144369361|NCT00790842|520561596|FG001|Dose Level 4|Withdrawal by Subject|0|||
144369362|NCT00790842|520561597|FG002|Dose Level 4|Withdrawal by Subject|0|||
144369363|NCT00790842|520561598|FG003|Dose Level 4|Withdrawal by Subject|0|||
144369364|NCT00790842|520561599|FG004|Dose Level 4|Withdrawal by Subject|0|||
144369365|NCT00790842|520561600|FG005|Dose Level 4|Withdrawal by Subject|0|||
144369366|NCT00790842|520561601|FG006|Dose Level 4|Withdrawal by Subject|0|||
144369367|NCT00790842|520561602|FG007|Dose Level 4|Withdrawal by Subject|0|||
144369368|NCT00790842|520561603|FG008|Dose Level 4|Withdrawal by Subject|0|||
144369369|NCT00790842|520561604|FG009|Dose Level 4|Withdrawal by Subject|0|||
144369370|NCT00790842|520561605|FG010|Dose Level 4|Withdrawal by Subject|1|||
144369371|NCT00790842|520561595|FG000|Expansion Cohort|Adverse Event|0|||
144369372|NCT00790842|520561596|FG001|Expansion Cohort|Adverse Event|0|||
144369373|NCT00790842|520561597|FG002|Expansion Cohort|Adverse Event|0|||
144369374|NCT00790842|520561598|FG003|Expansion Cohort|Adverse Event|0|||
144369375|NCT00790842|520561599|FG004|Expansion Cohort|Adverse Event|0|||
144369376|NCT00790842|520561600|FG005|Expansion Cohort|Adverse Event|0|||
144369377|NCT00790842|520561601|FG006|Expansion Cohort|Adverse Event|1|||
144369378|NCT00790842|520561602|FG007|Expansion Cohort|Adverse Event|0|||
144369379|NCT00790842|520561603|FG008|Expansion Cohort|Adverse Event|0|||
144369380|NCT00790842|520561604|FG009|Expansion Cohort|Adverse Event|0|||
144369381|NCT00790842|520561605|FG010|Expansion Cohort|Adverse Event|0|||
144369382|NCT00790842|520561595|FG000|Expansion Cohort|Death|0|||
144369383|NCT00790842|520561596|FG001|Expansion Cohort|Death|0|||
144369384|NCT00790842|520561597|FG002|Expansion Cohort|Death|2|||
144369385|NCT00790842|520561598|FG003|Expansion Cohort|Death|0|||
144369386|NCT00790842|520561599|FG004|Expansion Cohort|Death|0|||
144369387|NCT00790842|520561600|FG005|Expansion Cohort|Death|0|||
144369388|NCT00790842|520561601|FG006|Expansion Cohort|Death|0|||
144369389|NCT00790842|520561602|FG007|Expansion Cohort|Death|0|||
144369390|NCT00790842|520561603|FG008|Expansion Cohort|Death|0|||
144369391|NCT00790842|520561604|FG009|Expansion Cohort|Death|0|||
144369392|NCT00790842|520561605|FG010|Expansion Cohort|Death|0|||
144369393|NCT00790842|520561595|FG000|Expansion Cohort|Physician Decision|0|||
144369394|NCT00790842|520561596|FG001|Expansion Cohort|Physician Decision|0|||
144369395|NCT00790842|520561597|FG002|Expansion Cohort|Physician Decision|1|||
144369396|NCT00790842|520561598|FG003|Expansion Cohort|Physician Decision|0|||
144369397|NCT00790842|520561599|FG004|Expansion Cohort|Physician Decision|0|||
144369398|NCT00790842|520561600|FG005|Expansion Cohort|Physician Decision|0|||
144369399|NCT00790842|520561601|FG006|Expansion Cohort|Physician Decision|0|||
144369400|NCT00790842|520561602|FG007|Expansion Cohort|Physician Decision|0|||
144481734|NCT02301156|520962406|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
144481735|NCT02301156|520962405|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
144481736|NCT02301156|520962406|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
144481737|NCT02301156|520962405|FG000|Overall Study|Reason not Specified|6|||
144481738|NCT02301156|520962406|FG001|Overall Study|Reason not Specified|3|||
144481739|NCT02638623|520962407|FG000|Overall Study|Surgery timing|5|||
144481740|NCT02638623|520962408|FG001|Overall Study|Surgery timing|6|||
144481741|NCT02638623|520962407|FG000|Overall Study|Not given intervention|2|||
144481742|NCT02638623|520962408|FG001|Overall Study|Not given intervention|0|||
144481743|NCT02322814|520962411|FG000|Overall Study|Death|7|||
144481744|NCT02322814|520962412|FG001|Overall Study|Death|29|||
144481745|NCT02322814|520962413|FG002|Overall Study|Death|32|||
144481746|NCT02322814|520962414|FG003|Overall Study|Death|23|||
144481747|NCT02322814|520962415|FG004|Overall Study|Death|14|||
144481748|NCT02322814|520962411|FG000|Overall Study|Lost to Follow-up|1|||
144481749|NCT02322814|520962412|FG001|Overall Study|Lost to Follow-up|3|||
144481750|NCT02322814|520962413|FG002|Overall Study|Lost to Follow-up|3|||
144481751|NCT02322814|520962414|FG003|Overall Study|Lost to Follow-up|1|||
144481752|NCT02322814|520962415|FG004|Overall Study|Lost to Follow-up|0|||
144481753|NCT02322814|520962411|FG000|Overall Study|Various Reasons|2|||
144481754|NCT02322814|520962412|FG001|Overall Study|Various Reasons|0|||
144481755|NCT02322814|520962413|FG002|Overall Study|Various Reasons|1|||
144481756|NCT02322814|520962414|FG003|Overall Study|Various Reasons|1|||
144481757|NCT02322814|520962415|FG004|Overall Study|Various Reasons|0|||
144481758|NCT02322814|520962411|FG000|Overall Study|Progressive Disease|0|||
144481759|NCT02322814|520962412|FG001|Overall Study|Progressive Disease|0|||
144481760|NCT02322814|520962413|FG002|Overall Study|Progressive Disease|0|||
144481761|NCT02322814|520962414|FG003|Overall Study|Progressive Disease|1|||
144481762|NCT02322814|520962415|FG004|Overall Study|Progressive Disease|1|||
144481763|NCT02322814|520962411|FG000|Overall Study|Protocol Violation|1|||
144481764|NCT02322814|520962412|FG001|Overall Study|Protocol Violation|0|||
144481765|NCT02322814|520962413|FG002|Overall Study|Protocol Violation|0|||
144481766|NCT02322814|520962414|FG003|Overall Study|Protocol Violation|0|||
144481767|NCT02322814|520962415|FG004|Overall Study|Protocol Violation|0|||
144481768|NCT02322814|520962411|FG000|Overall Study|Study Terminated by Sponsor|0|||
144481769|NCT02322814|520962412|FG001|Overall Study|Study Terminated by Sponsor|7|||
144481770|NCT02322814|520962413|FG002|Overall Study|Study Terminated by Sponsor|9|||
144481771|NCT02322814|520962414|FG003|Overall Study|Study Terminated by Sponsor|5|||
144481772|NCT02322814|520962415|FG004|Overall Study|Study Terminated by Sponsor|13|||
144481773|NCT02322814|520962411|FG000|Overall Study|Withdrawal by Subject|5|||
144481774|NCT02322814|520962412|FG001|Overall Study|Withdrawal by Subject|4|||
144481775|NCT02322814|520962413|FG002|Overall Study|Withdrawal by Subject|2|||
144481776|NCT02322814|520962414|FG003|Overall Study|Withdrawal by Subject|1|||
144481777|NCT02322814|520962415|FG004|Overall Study|Withdrawal by Subject|3|||
144481778|NCT04152343|520962416|FG000|Overall Study|Transplanted|5|||
144481779|NCT04152343|520962416|FG000|Overall Study|Death|20|||
144481780|NCT04152343|520962416|FG000|Overall Study|Lost to Follow-up|3|||
144481781|NCT00591864|520962417|FG000|Overall Study|Incomplete Imaging|5|||
144481782|NCT02459093|520962422|FG000|Overall Study|Protocol Violation|6|||
144481783|NCT02459093|520962423|FG001|Overall Study|Protocol Violation|11|||
144481784|NCT02459093|520962422|FG000|Overall Study|Lost to Follow-up|6|||
144481785|NCT02459093|520962423|FG001|Overall Study|Lost to Follow-up|7|||
144481786|NCT00118092|520962424|FG000|Overall Study|Withdrawal by Subject|1|||
144481787|NCT00118092|520962424|FG000|Overall Study|Protocol Violation|1|||
144481788|NCT01164228|520962425|FG000|Overall Study|Progression|24|||
144481789|NCT01164228|520962426|FG001|Overall Study|Progression|25|||
144481790|NCT01164228|520962425|FG000|Overall Study|Adverse Event|13|||
144481791|NCT01164228|520962426|FG001|Overall Study|Adverse Event|7|||
144481792|NCT01164228|520962425|FG000|Overall Study|Death|1|||
144481793|NCT01164228|520962426|FG001|Overall Study|Death|1|||
144481794|NCT01164228|520962425|FG000|Overall Study|Withdrawal by Subject|2|||
144481795|NCT01164228|520962426|FG001|Overall Study|Withdrawal by Subject|0|||
144481796|NCT01164228|520962425|FG000|Overall Study|Physician Decision|1|||
144481797|NCT01164228|520962426|FG001|Overall Study|Physician Decision|2|||
144481798|NCT01164228|520962425|FG000|Overall Study|Symptomatic deterioration|1|||
144481799|NCT01164228|520962426|FG001|Overall Study|Symptomatic deterioration|0|||
144481800|NCT01164228|520962425|FG000|Overall Study|Never started treatment|1|||
144481801|NCT01164228|520962426|FG001|Overall Study|Never started treatment|3|||
144481802|NCT01164228|520962425|FG000|Overall Study|Ineligible|1|||
144481803|NCT01164228|520962426|FG001|Overall Study|Ineligible|0|||
144481804|NCT02090634|520962427|FG000|Overall Study|Lost to Follow-up|0|||
144481805|NCT02090634|520962428|FG001|Overall Study|Lost to Follow-up|1|||
144714070|NCT01677910|521807982|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
144481806|NCT02090634|520962427|FG000|Overall Study|Death|0|||
144481807|NCT02090634|520962428|FG001|Overall Study|Death|1|||
144481808|NCT02090634|520962427|FG000|Overall Study|Protocol Violation|3|||
144481809|NCT02090634|520962428|FG001|Overall Study|Protocol Violation|1|||
144481810|NCT02090634|520962427|FG000|Overall Study|Adverse Event|2|||
144481811|NCT02090634|520962428|FG001|Overall Study|Adverse Event|0|||
144714071|NCT01677910|521807983|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
144481812|NCT01965938|520962429|FG000|Overall Study|Withdrawal by Subject|1|||
144481813|NCT01965938|520962430|FG001|Overall Study|Withdrawal by Subject|0|||
144481814|NCT03757234|520962431|FG000|Overall Study|Adverse Event|0|||
144481815|NCT03757234|520962432|FG001|Overall Study|Adverse Event|0|||
144481816|NCT03757234|520962433|FG002|Overall Study|Adverse Event|0|||
144481817|NCT03757234|520962434|FG003|Overall Study|Adverse Event|0|||
144481818|NCT03757234|520962435|FG004|Overall Study|Adverse Event|1|||
144481819|NCT03757234|520962431|FG000|Overall Study|Lost to Follow-up|1|||
144481820|NCT03757234|520962432|FG001|Overall Study|Lost to Follow-up|0|||
144481821|NCT03757234|520962433|FG002|Overall Study|Lost to Follow-up|0|||
144481822|NCT03757234|520962434|FG003|Overall Study|Lost to Follow-up|0|||
144481823|NCT03757234|520962435|FG004|Overall Study|Lost to Follow-up|1|||
144481824|NCT03757234|520962431|FG000|Overall Study|Withdrawal by Subject|1|||
144481825|NCT03757234|520962432|FG001|Overall Study|Withdrawal by Subject|1|||
144481826|NCT03757234|520962433|FG002|Overall Study|Withdrawal by Subject|0|||
144481827|NCT03757234|520962434|FG003|Overall Study|Withdrawal by Subject|1|||
144481828|NCT03757234|520962435|FG004|Overall Study|Withdrawal by Subject|2|||
144481829|NCT03757234|520962431|FG000|Overall Study|Other|1|||
144481830|NCT03757234|520962432|FG001|Overall Study|Other|1|||
144481831|NCT03757234|520962433|FG002|Overall Study|Other|0|||
144481832|NCT03757234|520962434|FG003|Overall Study|Other|0|||
144481833|NCT03757234|520962435|FG004|Overall Study|Other|0|||
144481834|NCT03342053|520962440|FG000|Overall Study|Adverse Event|2|||
144481835|NCT03342053|520962441|FG001|Overall Study|Adverse Event|0|||
144481836|NCT03342053|520962440|FG000|Overall Study|Withdrawal by Subject|0|||
144481837|NCT03342053|520962441|FG001|Overall Study|Withdrawal by Subject|1|||
144481838|NCT00735644|520962442|FG000|Overall Study|Did not receive study vaccine|0|||
144481839|NCT00735644|520962443|FG001|Overall Study|Did not receive study vaccine|1|||
144481840|NCT00735644|520962444|FG002|Overall Study|Did not receive study vaccine|0|||
144481841|NCT00735644|520962445|FG003|Overall Study|Did not receive study vaccine|0|||
144481842|NCT00735644|520962446|FG004|Overall Study|Did not receive study vaccine|0|||
144481843|NCT00735644|520962442|FG000|Overall Study|Withdrawal by Subject|0|||
144481844|NCT00735644|520962443|FG001|Overall Study|Withdrawal by Subject|1|||
144481845|NCT00735644|520962444|FG002|Overall Study|Withdrawal by Subject|1|||
144481846|NCT00735644|520962445|FG003|Overall Study|Withdrawal by Subject|1|||
144481847|NCT00735644|520962446|FG004|Overall Study|Withdrawal by Subject|0|||
144481848|NCT02041923|520962449|FG000|Overall Study|Lost to Follow-up|26|||
144481849|NCT02041923|520962450|FG001|Overall Study|Lost to Follow-up|30|||
144481850|NCT00621296|520962455|FG000|Overall Study|Adverse Event|2|||
144481851|NCT00621296|520962455|FG000|Overall Study|Lack of Efficacy|1|||
144481852|NCT00621296|520962455|FG000|Overall Study|Physician Decision|7|||
144481853|NCT00621296|520962455|FG000|Overall Study|Unmatch Criteria|1|||
144481854|NCT00621296|520962455|FG000|Overall Study|Stopping Criteria|3|||
144481855|NCT00251927|520964367|FG000|Overall Study|Adverse Event|3|||
144481856|NCT00251927|520964368|FG001|Overall Study|Adverse Event|15|||
144481857|NCT00251927|520964367|FG000|Overall Study|Lack of Efficacy|22|||
144481858|NCT00251927|520964368|FG001|Overall Study|Lack of Efficacy|16|||
144481859|NCT00251927|520964367|FG000|Overall Study|Lost to Follow-up|22|||
144481860|NCT00251927|520964368|FG001|Overall Study|Lost to Follow-up|8|||
144481861|NCT00251927|520964367|FG000|Overall Study|Protocol Violation|1|||
144481862|NCT00251927|520964368|FG001|Overall Study|Protocol Violation|2|||
144481863|NCT00251927|520964367|FG000|Overall Study|Pregnancy|2|||
144481864|NCT00251927|520964368|FG001|Overall Study|Pregnancy|0|||
144481865|NCT00251927|520964367|FG000|Overall Study|Withdrawal by Subject|40|||
144481866|NCT00251927|520964368|FG001|Overall Study|Withdrawal by Subject|25|||
144481867|NCT00251927|520964367|FG000|Overall Study|Study-specific discont. achieved|13|||
144481868|NCT00251927|520964368|FG001|Overall Study|Study-specific discont. achieved|2|||
144481869|NCT00251927|520964367|FG000|Overall Study|Study procedure non-compliance|5|||
144714072|NCT01677910|521807980|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
144714073|NCT01677910|521807981|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
144714074|NCT01677910|521807982|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
144714075|NCT01677910|521807983|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
144714076|NCT01677910|521807980|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
144714077|NCT01677910|521807981|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
144714078|NCT01677910|521807982|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
144714079|NCT01677910|521807983|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
144714080|NCT01677910|521807980|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
144714081|NCT01677910|521807981|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
144714082|NCT01677910|521807982|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
144714083|NCT01677910|521807983|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
144714084|NCT01677910|521807980|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
144481870|NCT00251927|520964368|FG001|Overall Study|Study procedure non-compliance|6|||
144481871|NCT04789577|520964372|FG000|Overall Study|Withdrawal by Subject|1|||
144481872|NCT04789577|520964373|FG001|Overall Study|Withdrawal by Subject|1|||
144481873|NCT04789577|520964374|FG002|Overall Study|Withdrawal by Subject|1|||
144481874|NCT04789577|520964375|FG003|Overall Study|Withdrawal by Subject|3|||
144481875|NCT04789577|520964376|FG004|Overall Study|Withdrawal by Subject|1|||
144481876|NCT04789577|520964377|FG005|Overall Study|Withdrawal by Subject|7|||
144714085|NCT01677910|521807981|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
144714086|NCT01677910|521807982|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
144714087|NCT01677910|521807983|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
144481877|NCT04789577|520964378|FG006|Overall Study|Withdrawal by Subject|1|||
144481878|NCT04789577|520964372|FG000|Overall Study|Lost to Follow-up|7|||
144481879|NCT04789577|520964373|FG001|Overall Study|Lost to Follow-up|12|||
144481880|NCT04789577|520964374|FG002|Overall Study|Lost to Follow-up|7|||
144481881|NCT04789577|520964375|FG003|Overall Study|Lost to Follow-up|10|||
144481882|NCT04789577|520964376|FG004|Overall Study|Lost to Follow-up|8|||
144481883|NCT04789577|520964377|FG005|Overall Study|Lost to Follow-up|6|||
144481884|NCT04789577|520964378|FG006|Overall Study|Lost to Follow-up|10|||
144481885|NCT04789577|520964372|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
144481886|NCT04789577|520964373|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
144481887|NCT04789577|520964374|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
144481888|NCT04789577|520964375|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
144481889|NCT04789577|520964376|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
144481890|NCT04789577|520964377|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
144481891|NCT04789577|520964378|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
144481892|NCT04789577|520964372|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
144481893|NCT04789577|520964373|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
144481894|NCT04789577|520964374|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
144481895|NCT04789577|520964375|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
144481896|NCT04789577|520964376|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
144481897|NCT04789577|520964377|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
144481898|NCT04789577|520964378|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
144481899|NCT01275196|520964380|FG000|Overall Study|Adverse Event|3|||
144481900|NCT01275196|520964381|FG001|Overall Study|Adverse Event|5|||
144481901|NCT01275196|520964380|FG000|Overall Study|Withdrawal by Subject|4|||
144481902|NCT01275196|520964381|FG001|Overall Study|Withdrawal by Subject|5|||
144481903|NCT01275196|520964380|FG000|Overall Study|Lost to Follow-up|1|||
144481904|NCT01275196|520964381|FG001|Overall Study|Lost to Follow-up|0|||
144481905|NCT01275196|520964380|FG000|Overall Study|Disease Progression|6|||
144481906|NCT01275196|520964381|FG001|Overall Study|Disease Progression|5|||
144481907|NCT01275196|520964380|FG000|Overall Study|Protocol Violation|1|||
144481908|NCT01275196|520964381|FG001|Overall Study|Protocol Violation|0|||
144481909|NCT01275196|520964380|FG000|Overall Study|Suboptimal response/treatment failure|5|||
144481910|NCT01275196|520964381|FG001|Overall Study|Suboptimal response/treatment failure|6|||
144481911|NCT01027364|520964382|FG000|Overall Study|Adverse Event|1|||
144481912|NCT01027364|520964383|FG001|Overall Study|Adverse Event|0|||
144481913|NCT01027364|520964384|FG002|Overall Study|Adverse Event|1|||
144481914|NCT01027364|520964385|FG003|Overall Study|Adverse Event|0|||
144481915|NCT01027364|520964382|FG000|Overall Study|Lost to Follow-up|1|||
144714088|NCT03568500|521807984|FG000|Overall Study|Lost to Follow-up|1|||
144714089|NCT03568500|521807985|FG001|Overall Study|Lost to Follow-up|1|||
144714090|NCT03568500|521807986|FG002|Overall Study|Lost to Follow-up|2|||
144714091|NCT03568500|521807984|FG000|Overall Study|Adverse Event|1|||
144714092|NCT03568500|521807985|FG001|Overall Study|Adverse Event|1|||
144714093|NCT03568500|521807986|FG002|Overall Study|Adverse Event|2|||
144714094|NCT03568500|521807984|FG000|Overall Study|Physician Decision|1|||
144714095|NCT03568500|521807985|FG001|Overall Study|Physician Decision|0|||
144714096|NCT03568500|521807986|FG002|Overall Study|Physician Decision|0|||
144714097|NCT03568500|521807984|FG000|Overall Study|Withdrawal by Subject|4|||
144714098|NCT03568500|521807985|FG001|Overall Study|Withdrawal by Subject|2|||
144714099|NCT03568500|521807986|FG002|Overall Study|Withdrawal by Subject|0|||
144714100|NCT03568500|521807984|FG000|Overall Study|Technical Problems|2|||
144714101|NCT03568500|521807985|FG001|Overall Study|Technical Problems|1|||
144714102|NCT03568500|521807986|FG002|Overall Study|Technical Problems|0|||
144714103|NCT03568500|521807984|FG000|Overall Study|Participant Noncompliance|1|||
144714104|NCT03568500|521807985|FG001|Overall Study|Participant Noncompliance|1|||
144714105|NCT03568500|521807986|FG002|Overall Study|Participant Noncompliance|0|||
144714106|NCT00685919|521807996|FG000|Overall Study|Withdrawal by Subject|0|||
144714107|NCT00685919|521807997|FG001|Overall Study|Withdrawal by Subject|0|||
144714108|NCT00685919|521807998|FG002|Overall Study|Withdrawal by Subject|1|||
144714109|NCT00685919|521807999|FG003|Overall Study|Withdrawal by Subject|0|||
144481916|NCT01027364|520964383|FG001|Overall Study|Lost to Follow-up|0|||
144481917|NCT01027364|520964384|FG002|Overall Study|Lost to Follow-up|0|||
144481918|NCT01027364|520964385|FG003|Overall Study|Lost to Follow-up|0|||
144481919|NCT01027364|520964382|FG000|Overall Study|Protocol Violation|1|||
144714110|NCT00685919|521807996|FG000|Overall Study|Physician Decision|1|||
144714111|NCT00685919|521807997|FG001|Overall Study|Physician Decision|0|||
144714112|NCT00685919|521807998|FG002|Overall Study|Physician Decision|0|||
144714113|NCT00685919|521807999|FG003|Overall Study|Physician Decision|0|||
144481920|NCT01027364|520964383|FG001|Overall Study|Protocol Violation|0|||
144481921|NCT01027364|520964384|FG002|Overall Study|Protocol Violation|0|||
144481922|NCT01027364|520964385|FG003|Overall Study|Protocol Violation|1|||
144481923|NCT01027364|520964382|FG000|Overall Study|Withdrawal by Subject|1|||
144481924|NCT01027364|520964383|FG001|Overall Study|Withdrawal by Subject|2|||
144481925|NCT01027364|520964384|FG002|Overall Study|Withdrawal by Subject|0|||
144481926|NCT01027364|520964385|FG003|Overall Study|Withdrawal by Subject|0|||
144481927|NCT03119610|520964386|FG000|Overall Study|Adverse Event|1|||
144481928|NCT03119610|520964387|FG001|Overall Study|Adverse Event|0|||
144481929|NCT03119610|520964386|FG000|Overall Study|Lost to Follow-up|0|||
144481930|NCT03119610|520964387|FG001|Overall Study|Lost to Follow-up|1|||
144481931|NCT00114634|520964388|FG000|Overall Study|failure to return forms|3|||
144481932|NCT03283696|520964413|FG000|Overall Study|Physician Decision|5|||
144481933|NCT03283696|520964414|FG001|Overall Study|Physician Decision|6|||
144481934|NCT03283696|520964413|FG000|Overall Study|Withdrawal by Subject|2|||
144481935|NCT03283696|520964414|FG001|Overall Study|Withdrawal by Subject|0|||
144481936|NCT00684762|520964417|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
144481937|NCT00684762|520964418|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
144481938|NCT03237013|520964428|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
144369401|NCT00790842|520561603|FG008|Expansion Cohort|Physician Decision|0|||
144369402|NCT00790842|520561604|FG009|Expansion Cohort|Physician Decision|0|||
144369403|NCT00790842|520561605|FG010|Expansion Cohort|Physician Decision|0|||
144369404|NCT00790842|520561595|FG000|Expansion Cohort|Withdrawal by Subject|0|||
144369405|NCT00790842|520561596|FG001|Expansion Cohort|Withdrawal by Subject|0|||
144369406|NCT00790842|520561597|FG002|Expansion Cohort|Withdrawal by Subject|3|||
144369407|NCT00790842|520561598|FG003|Expansion Cohort|Withdrawal by Subject|0|||
144369408|NCT00790842|520561599|FG004|Expansion Cohort|Withdrawal by Subject|0|||
144369409|NCT00790842|520561600|FG005|Expansion Cohort|Withdrawal by Subject|0|||
144369410|NCT00790842|520561601|FG006|Expansion Cohort|Withdrawal by Subject|0|||
144369411|NCT00790842|520561602|FG007|Expansion Cohort|Withdrawal by Subject|0|||
144481939|NCT03237013|520964429|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
144481940|NCT03237013|520964430|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
144481941|NCT00258440|520964435|FG000|Overall Study|Withdrawal by Subject|0|||
144481942|NCT00258440|520964436|FG001|Overall Study|Withdrawal by Subject|0|||
144481943|NCT00258440|520964437|FG002|Overall Study|Withdrawal by Subject|1|||
144481944|NCT00737061|520964438|FG000|Waiting Period|Lost to Follow-up|6|||
144481945|NCT00737061|520964438|FG000|Waiting Period|Withdrawal by Subject|1|||
144481946|NCT00737061|520964438|FG000|Waiting Period|Bilateral placement failure|34|||
144481947|NCT00737061|520964438|FG000|Waiting Period|Deemed patent following HSG|26|||
144481948|NCT00737061|520964438|FG000|Waiting Period|Alternative contraception failure|3|||
144481949|NCT00737061|520964438|FG000|Waiting Period|Elected surgical tubal ligation|5|||
144481950|NCT00737061|520964438|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
144481951|NCT00737061|520964438|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
144481952|NCT00737061|520964438|FG000|1 Year Wearing Period|Discontinued reilance|3|||
144481953|NCT00737061|520964438|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
144481954|NCT06173570|520964445|FG000|Overall Study|Adverse Event|1|||
144481955|NCT06173570|520964446|FG001|Overall Study|Adverse Event|0|||
144481956|NCT06173570|520964447|FG002|Overall Study|Adverse Event|0|||
144481957|NCT06173570|520964448|FG003|Overall Study|Adverse Event|2|||
144369412|NCT00790842|520561603|FG008|Expansion Cohort|Withdrawal by Subject|0|||
144369413|NCT00790842|520561604|FG009|Expansion Cohort|Withdrawal by Subject|0|||
144369414|NCT00790842|520561605|FG010|Expansion Cohort|Withdrawal by Subject|0|||
144369415|NCT00790842|520561595|FG000|Expansion Cohort|Study Closure|0|||
144481958|NCT06173570|520964449|FG004|Overall Study|Adverse Event|0|||
144481959|NCT06173570|520964445|FG000|Overall Study|Lost to Follow-up|1|||
144481960|NCT06173570|520964446|FG001|Overall Study|Lost to Follow-up|0|||
144481961|NCT06173570|520964447|FG002|Overall Study|Lost to Follow-up|0|||
144481962|NCT06173570|520964448|FG003|Overall Study|Lost to Follow-up|0|||
144481963|NCT06173570|520964449|FG004|Overall Study|Lost to Follow-up|2|||
144481964|NCT06173570|520964445|FG000|Overall Study|Protocol Violation|0|||
144481965|NCT06173570|520964446|FG001|Overall Study|Protocol Violation|2|||
144481966|NCT06173570|520964447|FG002|Overall Study|Protocol Violation|0|||
144481967|NCT06173570|520964448|FG003|Overall Study|Protocol Violation|0|||
144481968|NCT06173570|520964449|FG004|Overall Study|Protocol Violation|1|||
144481969|NCT06173570|520964445|FG000|Overall Study|Withdrawal by Subject|0|||
144481970|NCT06173570|520964446|FG001|Overall Study|Withdrawal by Subject|1|||
144481971|NCT06173570|520964447|FG002|Overall Study|Withdrawal by Subject|1|||
144481972|NCT06173570|520964448|FG003|Overall Study|Withdrawal by Subject|1|||
144481973|NCT06173570|520964449|FG004|Overall Study|Withdrawal by Subject|1|||
144481974|NCT06173570|520964445|FG000|Overall Study|Non-compliance with Study Drug|1|||
144481975|NCT06173570|520964446|FG001|Overall Study|Non-compliance with Study Drug|0|||
144481976|NCT06173570|520964447|FG002|Overall Study|Non-compliance with Study Drug|0|||
144481977|NCT06173570|520964448|FG003|Overall Study|Non-compliance with Study Drug|0|||
144481978|NCT06173570|520964449|FG004|Overall Study|Non-compliance with Study Drug|0|||
144481979|NCT06173570|520964445|FG000|Overall Study|Screen Failure|0|||
144481980|NCT06173570|520964446|FG001|Overall Study|Screen Failure|0|||
144481981|NCT06173570|520964447|FG002|Overall Study|Screen Failure|0|||
144481982|NCT06173570|520964448|FG003|Overall Study|Screen Failure|0|||
144481983|NCT06173570|520964449|FG004|Overall Study|Screen Failure|1|||
144481984|NCT06173570|520964445|FG000|Overall Study|Other|2|||
144481985|NCT06173570|520964446|FG001|Overall Study|Other|1|||
144481986|NCT06173570|520964447|FG002|Overall Study|Other|0|||
144481987|NCT06173570|520964448|FG003|Overall Study|Other|2|||
144481988|NCT06173570|520964449|FG004|Overall Study|Other|0|||
144481989|NCT00545363|520964452|FG000|Overall Study|Adverse Event|6|||
144481990|NCT00545363|520964453|FG001|Overall Study|Adverse Event|7|||
144481991|NCT00545363|520964452|FG000|Overall Study|Withdrawal by Subject|6|||
144481992|NCT00545363|520964453|FG001|Overall Study|Withdrawal by Subject|5|||
144481993|NCT00545363|520964452|FG000|Overall Study|Non-compliance|3|||
144481994|NCT00545363|520964453|FG001|Overall Study|Non-compliance|1|||
144481995|NCT00545363|520964452|FG000|Overall Study|Did not meet entry criteria|1|||
144481996|NCT00545363|520964453|FG001|Overall Study|Did not meet entry criteria|1|||
144481997|NCT00545363|520964452|FG000|Overall Study|Lost to Follow-up|2|||
144481998|NCT00545363|520964453|FG001|Overall Study|Lost to Follow-up|0|||
144481999|NCT00545363|520964452|FG000|Overall Study|Other|1|||
144482000|NCT00545363|520964453|FG001|Overall Study|Other|1|||
144482001|NCT00366301|520964454|FG000|Overall Study|Lost to Follow-up|4|||
144482002|NCT00366301|520964455|FG001|Overall Study|Lost to Follow-up|4|||
144369416|NCT00790842|520561596|FG001|Expansion Cohort|Study Closure|0|||
144369417|NCT00790842|520561597|FG002|Expansion Cohort|Study Closure|1|||
144369418|NCT00790842|520561598|FG003|Expansion Cohort|Study Closure|0|||
144369419|NCT00790842|520561599|FG004|Expansion Cohort|Study Closure|0|||
144369420|NCT00790842|520561600|FG005|Expansion Cohort|Study Closure|0|||
144369421|NCT00790842|520561601|FG006|Expansion Cohort|Study Closure|0|||
144369422|NCT00790842|520561602|FG007|Expansion Cohort|Study Closure|0|||
144369423|NCT00790842|520561603|FG008|Expansion Cohort|Study Closure|0|||
144369424|NCT00790842|520561604|FG009|Expansion Cohort|Study Closure|0|||
144369425|NCT00790842|520561605|FG010|Expansion Cohort|Study Closure|0|||
144369426|NCT02968004|520561606|FG000|Main Study Phase|Adverse Event|1|||
144369427|NCT02968004|520561607|FG001|Main Study Phase|Adverse Event|0|||
144369428|NCT02968004|520561606|FG000|Main Study Phase|Withdrawal by Subject|0|||
144369429|NCT02968004|520561607|FG001|Main Study Phase|Withdrawal by Subject|1|||
144369430|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
144369431|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
144369432|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
144369433|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
144369434|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
144369435|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
144369436|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
144369437|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
144369438|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
144482003|NCT00366301|520964456|FG002|Overall Study|Lost to Follow-up|3|||
144482004|NCT00366301|520964457|FG003|Overall Study|Lost to Follow-up|7|||
144369439|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
144369440|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
144369441|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
144369442|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
144482005|NCT00366301|520964454|FG000|Overall Study|Withdrawal by Subject|4|||
144482006|NCT00366301|520964455|FG001|Overall Study|Withdrawal by Subject|2|||
144482007|NCT00366301|520964456|FG002|Overall Study|Withdrawal by Subject|1|||
144714114|NCT03870997|521808004|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
144714115|NCT03870997|521808005|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
144714116|NCT03870997|521808006|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
144714117|NCT03870997|521808007|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
144714118|NCT03870997|521808008|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
144714119|NCT03870997|521808009|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
144714120|NCT00837577|521808010|FG000|Double-blind Period|Clinical Adverse Event|1|||
144369443|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
144369444|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
144369445|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
144369446|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
144369447|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
144369448|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
144369449|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
144369450|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
144369451|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
144369452|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
144369453|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
144369454|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
144369455|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
144369456|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
144369457|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
144369458|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
144369459|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
144369460|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
144369461|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
144369462|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
144369463|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
144369464|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
144369465|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
144369466|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
144369467|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
144369468|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
144369469|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
144369470|NCT02968004|520561606|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
144369471|NCT02968004|520561607|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
144369472|NCT05029362|520561608|FG000|Overall Study|Lost to Follow-up|9|||
144369473|NCT00419952|520561609|FG000|Overall Study|Adverse Event|8|||
144369474|NCT00419952|520561610|FG001|Overall Study|Adverse Event|10|||
144369475|NCT00419952|520561609|FG000|Overall Study|Withdrawal by Subject|44|||
144369476|NCT00419952|520561610|FG001|Overall Study|Withdrawal by Subject|43|||
144369477|NCT00419952|520561609|FG000|Overall Study|Lost to Follow-up|43|||
144369478|NCT00419952|520561610|FG001|Overall Study|Lost to Follow-up|34|||
144369479|NCT00419952|520561609|FG000|Overall Study|Protocol Violation|32|||
144369480|NCT00419952|520561610|FG001|Overall Study|Protocol Violation|24|||
144369481|NCT00419952|520561609|FG000|Overall Study|Pregnancy|4|||
144369482|NCT00419952|520561610|FG001|Overall Study|Pregnancy|2|||
144369483|NCT00419952|520561609|FG000|Overall Study|Physician Decision|1|||
144369484|NCT00419952|520561610|FG001|Overall Study|Physician Decision|3|||
144369485|NCT00419952|520561609|FG000|Overall Study|Incorrectly enrolled|10|||
144369486|NCT00419952|520561610|FG001|Overall Study|Incorrectly enrolled|3|||
144369487|NCT00419952|520561609|FG000|Overall Study|Intake of prohibited medication|2|||
144369488|NCT00419952|520561610|FG001|Overall Study|Intake of prohibited medication|2|||
144369489|NCT00419952|520561609|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
144369490|NCT00419952|520561610|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
144369491|NCT00419952|520561609|FG000|Overall Study|Diary or medication non-compliance|2|||
144369492|NCT00419952|520561610|FG001|Overall Study|Diary or medication non-compliance|4|||
144369493|NCT00419952|520561609|FG000|Overall Study|Abnormal ECG|1|||
144369494|NCT00419952|520561610|FG001|Overall Study|Abnormal ECG|0|||
144369495|NCT03126591|520561611|FG000|Overall Study|Death|6|||
144369496|NCT03126591|520561612|FG001|Overall Study|Death|3|||
144369497|NCT03126591|520561613|FG002|Overall Study|Death|17|||
144369498|NCT03126591|520561611|FG000|Overall Study|Progressive Disease|0|||
144369499|NCT03126591|520561612|FG001|Overall Study|Progressive Disease|1|||
144369500|NCT03126591|520561613|FG002|Overall Study|Progressive Disease|2|||
144369501|NCT03126591|520561611|FG000|Overall Study|Terminated by Sponsor|0|||
144369502|NCT03126591|520561612|FG001|Overall Study|Terminated by Sponsor|1|||
144369503|NCT03126591|520561613|FG002|Overall Study|Terminated by Sponsor|4|||
144369504|NCT03126591|520561611|FG000|Overall Study|Withdrawal by Subject|1|||
144369505|NCT03126591|520561612|FG001|Overall Study|Withdrawal by Subject|1|||
144369506|NCT03126591|520561613|FG002|Overall Study|Withdrawal by Subject|4|||
144482008|NCT00366301|520964457|FG003|Overall Study|Withdrawal by Subject|1|||
144482009|NCT01372605|520964458|FG000|Overall Study|Death|1|||
144482010|NCT01372605|520964459|FG001|Overall Study|Death|2|||
144482011|NCT01372605|520964458|FG000|Overall Study|Lost to Follow-up|2|||
144482012|NCT01372605|520964459|FG001|Overall Study|Lost to Follow-up|1|||
144482013|NCT01372605|520964458|FG000|Overall Study|Withdrawal by Subject|4|||
144482014|NCT01372605|520964459|FG001|Overall Study|Withdrawal by Subject|7|||
144482015|NCT01372605|520964458|FG000|Overall Study|Moved|3|||
144482016|NCT01372605|520964459|FG001|Overall Study|Moved|0|||
144482017|NCT01372605|520964458|FG000|Overall Study|Changed medical home|2|||
144482018|NCT01372605|520964459|FG001|Overall Study|Changed medical home|0|||
144482019|NCT01108510|520964460|FG000|Overall Study|Randomized but Not Treated|5|||
144482020|NCT01108510|520964461|FG001|Overall Study|Randomized but Not Treated|1|||
144482021|NCT01108510|520964460|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
144482022|NCT01108510|520964461|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
144482023|NCT01108510|520964460|FG000|Overall Study|Adverse Event|26|||
144482024|NCT01108510|520964461|FG001|Overall Study|Adverse Event|19|||
144482025|NCT01108510|520964460|FG000|Overall Study|Lost to Follow-up|20|||
144482026|NCT01108510|520964461|FG001|Overall Study|Lost to Follow-up|17|||
144482027|NCT01108510|520964460|FG000|Overall Study|Withdrew Consent|21|||
144482028|NCT01108510|520964461|FG001|Overall Study|Withdrew Consent|15|||
144482029|NCT01108510|520964460|FG000|Overall Study|Investigator's Discretion|12|||
144482030|NCT01108510|520964461|FG001|Overall Study|Investigator's Discretion|10|||
144482031|NCT01108510|520964460|FG000|Overall Study|Participant Noncompliance|5|||
144482032|NCT01108510|520964461|FG001|Overall Study|Participant Noncompliance|7|||
144482033|NCT01108510|520964460|FG000|Overall Study|Lack of Efficacy|3|||
144482034|NCT01108510|520964461|FG001|Overall Study|Lack of Efficacy|0|||
144482035|NCT01108510|520964460|FG000|Overall Study|Pregnancy|0|||
144482036|NCT01108510|520964461|FG001|Overall Study|Pregnancy|3|||
144482037|NCT01108510|520964460|FG000|Overall Study|Death|1|||
144482038|NCT01108510|520964461|FG001|Overall Study|Death|1|||
144482039|NCT00210119|520964462|FG000|Overall Study|Protocol Violation|1|||
144482040|NCT00210119|520964462|FG000|Overall Study|Withdrawal by Subject|1|||
144482041|NCT00951509|520964463|FG000|Overall Study|Withdrawal by Subject|2|||
144482042|NCT01830881|520964465|FG000|Overall Study|Changed decision to have an abortion|0|||
144482043|NCT01830881|520964466|FG001|Overall Study|Changed decision to have an abortion|1|||
144482044|NCT01258660|520964467|FG000|Overall Study|Adverse Event|2|||
144482045|NCT01258660|520964468|FG001|Overall Study|Adverse Event|4|||
144482046|NCT01258660|520964467|FG000|Overall Study|Withdrawal by Subject|3|||
144482047|NCT01258660|520964468|FG001|Overall Study|Withdrawal by Subject|0|||
144482048|NCT01258660|520964467|FG000|Overall Study|due to relocation|2|||
144482049|NCT01258660|520964468|FG001|Overall Study|due to relocation|0|||
144482050|NCT01258660|520964467|FG000|Overall Study|Protocol Violation|0|||
144482051|NCT01258660|520964468|FG001|Overall Study|Protocol Violation|1|||
144482052|NCT01258660|520964467|FG000|Overall Study|Invalid for primary analysis data set|4|||
144482053|NCT01258660|520964468|FG001|Overall Study|Invalid for primary analysis data set|6|||
144482054|NCT03125941|520964469|FG000|Overall Study|did not receive intervention|1|||
144482055|NCT03125941|520964470|FG001|Overall Study|did not receive intervention|2|||
144482056|NCT04192630|520964471|FG000|Overall Study|Discontinued before surgery|2|||
144482057|NCT04192630|520964472|FG001|Overall Study|Discontinued before surgery|0|||
144482058|NCT04192630|520964471|FG000|Overall Study|Discontinued after surgery|5|||
144482059|NCT04192630|520964472|FG001|Overall Study|Discontinued after surgery|3|||
144482060|NCT01586338|520964474|FG000|Overall Study|Adverse Event|3|||
144482061|NCT01586338|520964474|FG000|Overall Study|Lost to Follow-up|1|||
144482062|NCT01586338|520964474|FG000|Overall Study|Withdrawal by participant|3|||
144482063|NCT01586338|520964474|FG000|Overall Study|Other|1|||
144482064|NCT03306043|520964477|FG000|Overall Study|Adverse Event|1|||
144482065|NCT03306043|520964477|FG000|Overall Study|Lost to Follow-up|1|||
144482066|NCT03306043|520964477|FG000|Overall Study|Withdrawal by Subject|2|||
144482067|NCT01544491|520964478|FG000|Overall Study|Withdrawal by Subject|3|||
144482068|NCT01544491|520964479|FG001|Overall Study|Withdrawal by Subject|2|||
144369507|NCT03722238|520561616|FG000|Overall Study|Protocol Violation|1|||
144482069|NCT01544491|520964478|FG000|Overall Study|Lost to Follow-up|0|||
144482070|NCT01544491|520964479|FG001|Overall Study|Lost to Follow-up|1|||
144482071|NCT01544491|520964478|FG000|Overall Study|administrative problems|2|||
144482072|NCT01544491|520964479|FG001|Overall Study|administrative problems|0|||
144482073|NCT01799720|520964480|FG000|Overall Study|Withdrawal by Subject|3|||
144482074|NCT01799720|520964481|FG001|Overall Study|Withdrawal by Subject|0|||
144482075|NCT01799720|520964482|FG002|Overall Study|Withdrawal by Subject|0|||
144482076|NCT01799720|520964480|FG000|Overall Study|Protocol Violation|0|||
144369508|NCT03722238|520561617|FG001|Overall Study|Protocol Violation|0|||
144482077|NCT01799720|520964481|FG001|Overall Study|Protocol Violation|1|||
144482078|NCT01799720|520964482|FG002|Overall Study|Protocol Violation|0|||
144482079|NCT01799720|520964480|FG000|Overall Study|Pregnancy|0|||
144482080|NCT01799720|520964481|FG001|Overall Study|Pregnancy|0|||
144482081|NCT01799720|520964482|FG002|Overall Study|Pregnancy|1|||
144482082|NCT01234649|520964484|FG000|Overall Study|Withdrawal by Subject|32|||
144482083|NCT01234649|520964485|FG001|Overall Study|Withdrawal by Subject|26|||
144482084|NCT01234649|520964484|FG000|Overall Study|Pregnancy|6|||
144482085|NCT01234649|520964485|FG001|Overall Study|Pregnancy|6|||
144482086|NCT01234649|520964484|FG000|Overall Study|intolerant to side effects|4|||
144482087|NCT01234649|520964485|FG001|Overall Study|intolerant to side effects|3|||
144482088|NCT01234649|520964484|FG000|Overall Study|Allergic reaction|1|||
144482089|NCT01234649|520964485|FG001|Overall Study|Allergic reaction|0|||
144482090|NCT01234649|520964484|FG000|Overall Study|Lack of Efficacy|0|||
144482091|NCT01234649|520964485|FG001|Overall Study|Lack of Efficacy|3|||
144482092|NCT00896454|520964486|FG000|Overall Study|Death|10|||
144482093|NCT00896454|520964486|FG000|Overall Study|Adverse Event|8|||
144482094|NCT00896454|520964486|FG000|Overall Study|Disease Progression|5|||
144482095|NCT00896454|520964486|FG000|Overall Study|Other|4|||
144482096|NCT00896454|520964486|FG000|Overall Study|Requirement for alternative therapy|3|||
144482097|NCT00896454|520964486|FG000|Overall Study|Ongoing in study|2|||
144482098|NCT00896454|520964486|FG000|Overall Study|Withdrawal by Subject|1|||
144482099|NCT01461993|520964491|FG000|Overall Study|Withdrawal by Subject|60|||
144482100|NCT01461993|520964492|FG001|Overall Study|Withdrawal by Subject|53|||
144482101|NCT01461993|520964493|FG002|Overall Study|Withdrawal by Subject|16|||
144482102|NCT01461993|520964491|FG000|Overall Study|Lost to Follow-up|44|||
144482103|NCT01461993|520964492|FG001|Overall Study|Lost to Follow-up|48|||
144482104|NCT01461993|520964493|FG002|Overall Study|Lost to Follow-up|22|||
144482105|NCT01461993|520964491|FG000|Overall Study|Protocol Violation|10|||
144482106|NCT01461993|520964492|FG001|Overall Study|Protocol Violation|9|||
144482107|NCT01461993|520964493|FG002|Overall Study|Protocol Violation|7|||
144482108|NCT01461993|520964491|FG000|Overall Study|Adverse Event|9|||
144482109|NCT01461993|520964492|FG001|Overall Study|Adverse Event|11|||
144482110|NCT01461993|520964493|FG002|Overall Study|Adverse Event|3|||
144482111|NCT01461993|520964491|FG000|Overall Study|No longer met eligibility criteria|13|||
144482112|NCT01461993|520964492|FG001|Overall Study|No longer met eligibility criteria|18|||
144482113|NCT01461993|520964493|FG002|Overall Study|No longer met eligibility criteria|10|||
144482114|NCT01461993|520964491|FG000|Overall Study|Did not meet entrance criteria|2|||
144482115|NCT01461993|520964492|FG001|Overall Study|Did not meet entrance criteria|3|||
144482116|NCT01461993|520964493|FG002|Overall Study|Did not meet entrance criteria|0|||
144482117|NCT01461993|520964491|FG000|Overall Study|Other|13|||
144482118|NCT01461993|520964492|FG001|Overall Study|Other|15|||
144482119|NCT01461993|520964493|FG002|Overall Study|Other|6|||
144482120|NCT00680056|520964495|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
144482121|NCT00680056|520964496|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
144482122|NCT00680056|520964495|FG000|Second Intervention|Protocol Violation|3|||
144482123|NCT00680056|520964496|FG001|Second Intervention|Protocol Violation|1|||
144482124|NCT02733042|520964497|FG000|Overall Study|Adverse Event|1|||
144482125|NCT02733042|520964498|FG001|Overall Study|Adverse Event|0|||
144482126|NCT02733042|520964499|FG002|Overall Study|Adverse Event|1|||
144482127|NCT02733042|520964500|FG003|Overall Study|Adverse Event|1|||
144482128|NCT02733042|520964501|FG004|Overall Study|Adverse Event|0|||
144482129|NCT02733042|520964502|FG005|Overall Study|Adverse Event|0|||
144482130|NCT02733042|520964503|FG006|Overall Study|Adverse Event|0|||
144482131|NCT02733042|520964504|FG007|Overall Study|Adverse Event|0|||
144482132|NCT02733042|520964505|FG008|Overall Study|Adverse Event|0|||
144482133|NCT02733042|520964506|FG009|Overall Study|Adverse Event|0|||
144482134|NCT02733042|520964507|FG010|Overall Study|Adverse Event|2|||
144482135|NCT02733042|520964508|FG011|Overall Study|Adverse Event|2|||
144482136|NCT02733042|520964509|FG012|Overall Study|Adverse Event|0|||
144482137|NCT02733042|520964510|FG013|Overall Study|Adverse Event|2|||
144482138|NCT02733042|520964511|FG014|Overall Study|Adverse Event|0|||
144482139|NCT02733042|520964512|FG015|Overall Study|Adverse Event|0|||
144482140|NCT02733042|520964513|FG016|Overall Study|Adverse Event|0|||
144482141|NCT02733042|520964514|FG017|Overall Study|Adverse Event|1|||
144482142|NCT02733042|520964515|FG018|Overall Study|Adverse Event|0|||
144482143|NCT02733042|520964497|FG000|Overall Study|Progressive Disease|2|||
144482144|NCT02733042|520964498|FG001|Overall Study|Progressive Disease|1|||
144482145|NCT02733042|520964499|FG002|Overall Study|Progressive Disease|3|||
144482146|NCT02733042|520964500|FG003|Overall Study|Progressive Disease|1|||
144482147|NCT02733042|520964501|FG004|Overall Study|Progressive Disease|2|||
144482148|NCT02733042|520964502|FG005|Overall Study|Progressive Disease|3|||
144482149|NCT02733042|520964503|FG006|Overall Study|Progressive Disease|0|||
144482150|NCT02733042|520964504|FG007|Overall Study|Progressive Disease|3|||
144482151|NCT02733042|520964505|FG008|Overall Study|Progressive Disease|3|||
144482152|NCT02733042|520964506|FG009|Overall Study|Progressive Disease|2|||
144482153|NCT02733042|520964507|FG010|Overall Study|Progressive Disease|2|||
144482154|NCT02733042|520964508|FG011|Overall Study|Progressive Disease|2|||
144482155|NCT02733042|520964509|FG012|Overall Study|Progressive Disease|8|||
144482156|NCT02733042|520964510|FG013|Overall Study|Progressive Disease|1|||
144482157|NCT02733042|520964511|FG014|Overall Study|Progressive Disease|4|||
144482158|NCT02733042|520964512|FG015|Overall Study|Progressive Disease|7|||
144482159|NCT02733042|520964513|FG016|Overall Study|Progressive Disease|2|||
144482160|NCT02733042|520964514|FG017|Overall Study|Progressive Disease|3|||
144482161|NCT02733042|520964515|FG018|Overall Study|Progressive Disease|4|||
144482162|NCT02733042|520964497|FG000|Overall Study|Withdrawal by Subject|0|||
144482163|NCT02733042|520964498|FG001|Overall Study|Withdrawal by Subject|1|||
144482164|NCT02733042|520964499|FG002|Overall Study|Withdrawal by Subject|2|||
144482165|NCT02733042|520964500|FG003|Overall Study|Withdrawal by Subject|1|||
144482166|NCT02733042|520964501|FG004|Overall Study|Withdrawal by Subject|1|||
144482167|NCT02733042|520964502|FG005|Overall Study|Withdrawal by Subject|0|||
144482168|NCT02733042|520964503|FG006|Overall Study|Withdrawal by Subject|0|||
144482169|NCT02733042|520964504|FG007|Overall Study|Withdrawal by Subject|0|||
144482170|NCT02733042|520964505|FG008|Overall Study|Withdrawal by Subject|1|||
144482171|NCT02733042|520964506|FG009|Overall Study|Withdrawal by Subject|1|||
144482172|NCT02733042|520964507|FG010|Overall Study|Withdrawal by Subject|0|||
144482173|NCT02733042|520964508|FG011|Overall Study|Withdrawal by Subject|2|||
144482174|NCT02733042|520964509|FG012|Overall Study|Withdrawal by Subject|1|||
144482175|NCT02733042|520964510|FG013|Overall Study|Withdrawal by Subject|1|||
144482176|NCT02733042|520964511|FG014|Overall Study|Withdrawal by Subject|0|||
144482177|NCT02733042|520964512|FG015|Overall Study|Withdrawal by Subject|0|||
144482178|NCT02733042|520964513|FG016|Overall Study|Withdrawal by Subject|0|||
144482179|NCT02733042|520964514|FG017|Overall Study|Withdrawal by Subject|0|||
144482180|NCT02733042|520964515|FG018|Overall Study|Withdrawal by Subject|0|||
144482181|NCT02733042|520964497|FG000|Overall Study|Other Reasons|0|||
144482182|NCT02733042|520964498|FG001|Overall Study|Other Reasons|0|||
144482183|NCT02733042|520964499|FG002|Overall Study|Other Reasons|1|||
144482184|NCT02733042|520964500|FG003|Overall Study|Other Reasons|0|||
144482185|NCT02733042|520964501|FG004|Overall Study|Other Reasons|0|||
144482186|NCT02733042|520964502|FG005|Overall Study|Other Reasons|0|||
144482187|NCT02733042|520964503|FG006|Overall Study|Other Reasons|0|||
144482188|NCT02733042|520964504|FG007|Overall Study|Other Reasons|0|||
144482189|NCT02733042|520964505|FG008|Overall Study|Other Reasons|0|||
144482190|NCT02733042|520964506|FG009|Overall Study|Other Reasons|1|||
144482191|NCT02733042|520964507|FG010|Overall Study|Other Reasons|1|||
144482192|NCT02733042|520964508|FG011|Overall Study|Other Reasons|0|||
144482193|NCT02733042|520964509|FG012|Overall Study|Other Reasons|0|||
144482194|NCT02733042|520964510|FG013|Overall Study|Other Reasons|0|||
144482195|NCT02733042|520964511|FG014|Overall Study|Other Reasons|0|||
144482196|NCT02733042|520964512|FG015|Overall Study|Other Reasons|1|||
144482197|NCT02733042|520964513|FG016|Overall Study|Other Reasons|0|||
144482198|NCT02733042|520964514|FG017|Overall Study|Other Reasons|1|||
144482199|NCT02733042|520964515|FG018|Overall Study|Other Reasons|0|||
144482200|NCT02733042|520964497|FG000|Overall Study|Death|0|||
144482201|NCT02733042|520964498|FG001|Overall Study|Death|0|||
144482202|NCT02733042|520964499|FG002|Overall Study|Death|0|||
144482203|NCT02733042|520964500|FG003|Overall Study|Death|0|||
144482204|NCT02733042|520964501|FG004|Overall Study|Death|0|||
144482205|NCT02733042|520964502|FG005|Overall Study|Death|0|||
144482206|NCT02733042|520964503|FG006|Overall Study|Death|1|||
144482207|NCT02733042|520964504|FG007|Overall Study|Death|0|||
144482208|NCT02733042|520964505|FG008|Overall Study|Death|1|||
144482209|NCT02733042|520964506|FG009|Overall Study|Death|0|||
144482210|NCT02733042|520964507|FG010|Overall Study|Death|1|||
144482211|NCT02733042|520964508|FG011|Overall Study|Death|0|||
144482212|NCT02733042|520964509|FG012|Overall Study|Death|0|||
144482213|NCT02733042|520964510|FG013|Overall Study|Death|0|||
144482214|NCT02733042|520964511|FG014|Overall Study|Death|1|||
144482215|NCT02733042|520964512|FG015|Overall Study|Death|2|||
144482216|NCT02733042|520964513|FG016|Overall Study|Death|0|||
144482217|NCT02733042|520964514|FG017|Overall Study|Death|0|||
144482218|NCT02733042|520964515|FG018|Overall Study|Death|0|||
144482219|NCT02838628|520964517|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
144482220|NCT02838628|520964518|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
144482221|NCT02838628|520964517|FG000|Recurrence Follow-up Period|Adverse Event|1|||
144482222|NCT02838628|520964518|FG001|Recurrence Follow-up Period|Adverse Event|0|||
144482223|NCT02838628|520964517|FG000|Recurrence Follow-up Period|Non-compliance|0|||
144482224|NCT02838628|520964518|FG001|Recurrence Follow-up Period|Non-compliance|1|||
144482225|NCT02838628|520964517|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
144482226|NCT02838628|520964518|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
144482227|NCT02838628|520964517|FG000|Recurrence Follow-up Period|Other un-specified|1|||
144482228|NCT02838628|520964518|FG001|Recurrence Follow-up Period|Other un-specified|1|||
144482229|NCT01821898|520964519|FG000|Overall Study|Withdrawal by Subject|2|||
144482230|NCT01821898|520964520|FG001|Overall Study|Withdrawal by Subject|1|||
144482231|NCT00337662|520964522|FG000|Study Period II|Lost to Follow-up|0|||
144482232|NCT00337662|520964523|FG001|Study Period II|Lost to Follow-up|0|||
144482233|NCT00337662|520964524|FG002|Study Period II|Lost to Follow-up|0|||
144482234|NCT00337662|520964525|FG003|Study Period II|Lost to Follow-up|35|||
144482235|NCT00337662|520964522|FG000|Study Period II|Withdrawal by Subject|0|||
144482236|NCT00337662|520964523|FG001|Study Period II|Withdrawal by Subject|0|||
144482237|NCT00337662|520964524|FG002|Study Period II|Withdrawal by Subject|0|||
144482238|NCT00337662|520964525|FG003|Study Period II|Withdrawal by Subject|20|||
144482239|NCT00337662|520964522|FG000|Study Period II|Adverse Event|0|||
144482240|NCT00337662|520964523|FG001|Study Period II|Adverse Event|0|||
144482241|NCT00337662|520964524|FG002|Study Period II|Adverse Event|0|||
144482242|NCT00337662|520964525|FG003|Study Period II|Adverse Event|16|||
144482243|NCT00337662|520964522|FG000|Study Period II|Physician Decision|0|||
144482244|NCT00337662|520964523|FG001|Study Period II|Physician Decision|0|||
144482245|NCT00337662|520964524|FG002|Study Period II|Physician Decision|0|||
144482246|NCT00337662|520964525|FG003|Study Period II|Physician Decision|13|||
144482247|NCT00337662|520964522|FG000|Study Period II|Entry Criteria Not Met|0|||
144482248|NCT00337662|520964523|FG001|Study Period II|Entry Criteria Not Met|0|||
144482249|NCT00337662|520964524|FG002|Study Period II|Entry Criteria Not Met|0|||
144482250|NCT00337662|520964525|FG003|Study Period II|Entry Criteria Not Met|6|||
144482251|NCT00337662|520964522|FG000|Study Period II|Protocol Violation|0|||
144482252|NCT00337662|520964523|FG001|Study Period II|Protocol Violation|0|||
144482253|NCT00337662|520964524|FG002|Study Period II|Protocol Violation|0|||
144482254|NCT00337662|520964525|FG003|Study Period II|Protocol Violation|6|||
144482255|NCT00337662|520964522|FG000|Study Period II|Lack of Efficacy|0|||
144482256|NCT00337662|520964523|FG001|Study Period II|Lack of Efficacy|0|||
144482257|NCT00337662|520964524|FG002|Study Period II|Lack of Efficacy|0|||
144482258|NCT00337662|520964525|FG003|Study Period II|Lack of Efficacy|7|||
144482259|NCT00337662|520964522|FG000|Study Period II|Sponsor Decision|0|||
144482260|NCT00337662|520964523|FG001|Study Period II|Sponsor Decision|0|||
144482261|NCT00337662|520964524|FG002|Study Period II|Sponsor Decision|0|||
144482262|NCT00337662|520964525|FG003|Study Period II|Sponsor Decision|2|||
144482263|NCT00337662|520964522|FG000|Study Period II|Parent/Caregiver Decision|0|||
144482264|NCT00337662|520964523|FG001|Study Period II|Parent/Caregiver Decision|0|||
144482265|NCT00337662|520964524|FG002|Study Period II|Parent/Caregiver Decision|0|||
144482266|NCT00337662|520964525|FG003|Study Period II|Parent/Caregiver Decision|1|||
144482267|NCT00337662|520964522|FG000|Study Period III|Lost to Follow-up|14|||
144482268|NCT00337662|520964523|FG001|Study Period III|Lost to Follow-up|16|||
144482269|NCT00337662|520964524|FG002|Study Period III|Lost to Follow-up|14|||
144482270|NCT00337662|520964525|FG003|Study Period III|Lost to Follow-up|0|||
144482271|NCT00337662|520964522|FG000|Study Period III|Withdrawal by Subject|18|||
144482272|NCT00337662|520964523|FG001|Study Period III|Withdrawal by Subject|14|||
144482273|NCT00337662|520964524|FG002|Study Period III|Withdrawal by Subject|12|||
144482274|NCT00337662|520964525|FG003|Study Period III|Withdrawal by Subject|0|||
144482275|NCT00337662|520964522|FG000|Study Period III|Adverse Event|9|||
144482276|NCT00337662|520964523|FG001|Study Period III|Adverse Event|10|||
144482277|NCT00337662|520964524|FG002|Study Period III|Adverse Event|8|||
144482278|NCT00337662|520964525|FG003|Study Period III|Adverse Event|0|||
144482279|NCT00337662|520964522|FG000|Study Period III|Protocol Violation|3|||
144482280|NCT00337662|520964523|FG001|Study Period III|Protocol Violation|8|||
144482281|NCT00337662|520964524|FG002|Study Period III|Protocol Violation|2|||
144482282|NCT00337662|520964525|FG003|Study Period III|Protocol Violation|0|||
144482283|NCT00337662|520964522|FG000|Study Period III|Physician Decision|6|||
144482284|NCT00337662|520964523|FG001|Study Period III|Physician Decision|5|||
144482285|NCT00337662|520964524|FG002|Study Period III|Physician Decision|0|||
144482286|NCT00337662|520964525|FG003|Study Period III|Physician Decision|0|||
144482287|NCT00337662|520964522|FG000|Study Period III|Entry Criteria Not Met|4|||
144482288|NCT00337662|520964523|FG001|Study Period III|Entry Criteria Not Met|1|||
144482289|NCT00337662|520964524|FG002|Study Period III|Entry Criteria Not Met|3|||
144482290|NCT00337662|520964525|FG003|Study Period III|Entry Criteria Not Met|0|||
144482291|NCT00337662|520964522|FG000|Study Period III|Lack of Efficacy|4|||
144482292|NCT00337662|520964523|FG001|Study Period III|Lack of Efficacy|4|||
144482293|NCT00337662|520964524|FG002|Study Period III|Lack of Efficacy|2|||
144482294|NCT00337662|520964525|FG003|Study Period III|Lack of Efficacy|0|||
144482295|NCT00337662|520964522|FG000|Study Period III|Parent/Caregiver Decision|0|||
144482296|NCT00337662|520964523|FG001|Study Period III|Parent/Caregiver Decision|0|||
144482297|NCT00337662|520964524|FG002|Study Period III|Parent/Caregiver Decision|2|||
144482298|NCT00337662|520964525|FG003|Study Period III|Parent/Caregiver Decision|0|||
144482299|NCT00337662|520964522|FG000|Study Period III|Sponsor Decision|1|||
144482300|NCT00337662|520964523|FG001|Study Period III|Sponsor Decision|0|||
144482301|NCT00337662|520964524|FG002|Study Period III|Sponsor Decision|1|||
144482302|NCT00337662|520964525|FG003|Study Period III|Sponsor Decision|0|||
144482303|NCT00337662|520964522|FG000|Study Period III|Clinical Relapse|1|||
144482304|NCT00337662|520964523|FG001|Study Period III|Clinical Relapse|0|||
144482305|NCT00337662|520964524|FG002|Study Period III|Clinical Relapse|0|||
144482306|NCT00337662|520964525|FG003|Study Period III|Clinical Relapse|0|||
144482307|NCT03734991|520964530|FG000|Overall Study|Adverse Event|4|||
144482308|NCT03734991|520964531|FG001|Overall Study|Adverse Event|0|||
144482309|NCT03734991|520964530|FG000|Overall Study|Lost to Follow-up|4|||
144482310|NCT03734991|520964531|FG001|Overall Study|Lost to Follow-up|0|||
144482311|NCT03734991|520964530|FG000|Overall Study|Physician Decision|0|||
144482312|NCT03734991|520964531|FG001|Overall Study|Physician Decision|1|||
144482313|NCT03734991|520964530|FG000|Overall Study|Pregnancy|1|||
144482314|NCT03734991|520964531|FG001|Overall Study|Pregnancy|0|||
144482315|NCT03734991|520964530|FG000|Overall Study|Withdrawal by Subject|6|||
144482316|NCT03734991|520964531|FG001|Overall Study|Withdrawal by Subject|3|||
144482317|NCT03734991|520964530|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
144482318|NCT03734991|520964531|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
144482319|NCT03734991|520964530|FG000|Overall Study|Other|2|||
144482320|NCT03734991|520964531|FG001|Overall Study|Other|2|||
144482321|NCT00180713|520964532|FG000|Overall Study|Withdrawal by Subject|2|||
144482322|NCT00180713|520964533|FG001|Overall Study|Withdrawal by Subject|0|||
144482323|NCT00180713|520964532|FG000|Overall Study|Adverse Event|3|||
144482324|NCT00180713|520964533|FG001|Overall Study|Adverse Event|3|||
144482325|NCT03012061|520964536|FG000|Overall Study|Withdrawal by Subject|1|||
144482326|NCT03012061|520964537|FG001|Overall Study|Withdrawal by Subject|5|||
144482327|NCT03012061|520964538|FG002|Overall Study|Withdrawal by Subject|4|||
144482328|NCT03012061|520964536|FG000|Overall Study|Investigator Site Closed|1|||
144482329|NCT03012061|520964537|FG001|Overall Study|Investigator Site Closed|2|||
144482330|NCT03012061|520964538|FG002|Overall Study|Investigator Site Closed|0|||
144482331|NCT03012061|520964536|FG000|Overall Study|Lost to Follow-up|2|||
144482332|NCT03012061|520964537|FG001|Overall Study|Lost to Follow-up|1|||
144482333|NCT03012061|520964538|FG002|Overall Study|Lost to Follow-up|0|||
144482334|NCT03012061|520964536|FG000|Overall Study|Study closed/ Terminated|0|||
144482335|NCT03012061|520964537|FG001|Overall Study|Study closed/ Terminated|0|||
144482336|NCT03012061|520964538|FG002|Overall Study|Study closed/ Terminated|1|||
144482337|NCT03012061|520964536|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
144482338|NCT03012061|520964537|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
144482339|NCT03012061|520964538|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
144482340|NCT03012061|520964536|FG000|Overall Study|Protocol Violation|0|||
144482341|NCT03012061|520964537|FG001|Overall Study|Protocol Violation|0|||
144482342|NCT03012061|520964538|FG002|Overall Study|Protocol Violation|2|||
144482343|NCT03012061|520964536|FG000|Overall Study|Lack of Efficacy|0|||
144482344|NCT03012061|520964537|FG001|Overall Study|Lack of Efficacy|1|||
144482345|NCT03012061|520964538|FG002|Overall Study|Lack of Efficacy|0|||
144482346|NCT03012061|520964536|FG000|Overall Study|Adverse Event|2|||
144482347|NCT03012061|520964537|FG001|Overall Study|Adverse Event|0|||
144482348|NCT03012061|520964538|FG002|Overall Study|Adverse Event|0|||
144482349|NCT02736968|520964542|FG000|Overall Study|Lost to Follow-up|0|||
144482350|NCT02736968|520964543|FG001|Overall Study|Lost to Follow-up|0|||
144482351|NCT02736968|520964544|FG002|Overall Study|Lost to Follow-up|0|||
144482352|NCT02736968|520964545|FG003|Overall Study|Lost to Follow-up|0|||
144482353|NCT02736968|520964546|FG004|Overall Study|Lost to Follow-up|0|||
144482354|NCT02736968|520964547|FG005|Overall Study|Lost to Follow-up|0|||
144714121|NCT00837577|521808011|FG001|Double-blind Period|Clinical Adverse Event|0|||
144714122|NCT00837577|521808010|FG000|Double-blind Period|Withdrawal by Subject|1|||
144714123|NCT00837577|521808011|FG001|Double-blind Period|Withdrawal by Subject|0|||
144714124|NCT00837577|521808010|FG000|Open-label Period|Clinical Adverse Event|2|||
144714125|NCT00837577|521808011|FG001|Open-label Period|Clinical Adverse Event|2|||
144714126|NCT00837577|521808010|FG000|Open-label Period|Laboratory Adverse Event|0|||
144714127|NCT00837577|521808011|FG001|Open-label Period|Laboratory Adverse Event|1|||
144714128|NCT00837577|521808010|FG000|Open-label Period|Lack of Efficacy|4|||
144714129|NCT00837577|521808011|FG001|Open-label Period|Lack of Efficacy|3|||
144714130|NCT00837577|521808010|FG000|Open-label Period|Withdrawal by Subject|1|||
144714131|NCT00837577|521808011|FG001|Open-label Period|Withdrawal by Subject|2|||
144714132|NCT00837577|521808010|FG000|Open-label Period|Other Reason|1|||
144714133|NCT00837577|521808011|FG001|Open-label Period|Other Reason|1|||
144714134|NCT00986154|521808012|FG000|Overall Study|Death|136|||
144714135|NCT00986154|521808013|FG001|Overall Study|Death|127|||
144714136|NCT00986154|521808012|FG000|Overall Study|Lost to Follow-up|7|||
144714137|NCT00986154|521808013|FG001|Overall Study|Lost to Follow-up|4|||
144714138|NCT00986154|521808012|FG000|Overall Study|Withdrawal by Subject|32|||
144714139|NCT00986154|521808013|FG001|Overall Study|Withdrawal by Subject|33|||
144714140|NCT00986154|521808012|FG000|Overall Study|investigator/subject decide not continue|6|||
144714141|NCT00986154|521808013|FG001|Overall Study|investigator/subject decide not continue|3|||
144714142|NCT00986154|521808012|FG000|Overall Study|never received study drug|25|||
144714143|NCT00986154|521808013|FG001|Overall Study|never received study drug|27|||
144714144|NCT00033631|521808019|FG000|Overall Study|Protocol Violation|14|||
144482355|NCT02736968|520964548|FG006|Overall Study|Lost to Follow-up|5|||
144482356|NCT02736968|520964549|FG007|Overall Study|Lost to Follow-up|2|||
144482357|NCT02736968|520964542|FG000|Overall Study|COVID-19 Pandemic|0|||
144482358|NCT02736968|520964543|FG001|Overall Study|COVID-19 Pandemic|0|||
144482359|NCT02736968|520964544|FG002|Overall Study|COVID-19 Pandemic|0|||
144482360|NCT02736968|520964545|FG003|Overall Study|COVID-19 Pandemic|0|||
144482361|NCT02736968|520964546|FG004|Overall Study|COVID-19 Pandemic|0|||
144482362|NCT02736968|520964547|FG005|Overall Study|COVID-19 Pandemic|0|||
144714145|NCT00033631|521808020|FG001|Overall Study|Protocol Violation|11|||
144714146|NCT00033631|521808019|FG000|Overall Study|Withdrawal by Subject|4|||
144714147|NCT00033631|521808020|FG001|Overall Study|Withdrawal by Subject|4|||
144482363|NCT02736968|520964548|FG006|Overall Study|COVID-19 Pandemic|2|||
144482364|NCT02736968|520964549|FG007|Overall Study|COVID-19 Pandemic|0|||
144369509|NCT03722238|520561616|FG000|Overall Study|Physician Decision|1|||
144482365|NCT02736968|520964542|FG000|Overall Study|Withdrawal by Subject|0|||
144482366|NCT02736968|520964543|FG001|Overall Study|Withdrawal by Subject|0|||
144482367|NCT02736968|520964544|FG002|Overall Study|Withdrawal by Subject|0|||
144482368|NCT02736968|520964545|FG003|Overall Study|Withdrawal by Subject|0|||
144482369|NCT02736968|520964546|FG004|Overall Study|Withdrawal by Subject|0|||
144482370|NCT02736968|520964547|FG005|Overall Study|Withdrawal by Subject|0|||
144482371|NCT02736968|520964548|FG006|Overall Study|Withdrawal by Subject|1|||
144482372|NCT02736968|520964549|FG007|Overall Study|Withdrawal by Subject|0|||
144482373|NCT02961374|520964550|FG000|Overall Study|Adverse Event|4|||
144482374|NCT00309608|520964551|FG000|Overall Study|Adverse Event|1|||
144482375|NCT00309608|520964552|FG001|Overall Study|Adverse Event|5|||
144482376|NCT00309608|520964553|FG002|Overall Study|Adverse Event|3|||
144482377|NCT00309608|520964554|FG003|Overall Study|Adverse Event|2|||
144482378|NCT00309608|520964555|FG004|Overall Study|Adverse Event|3|||
144482379|NCT00309608|520964551|FG000|Overall Study|Protocol Violation|2|||
144482380|NCT00309608|520964552|FG001|Overall Study|Protocol Violation|0|||
144482381|NCT00309608|520964553|FG002|Overall Study|Protocol Violation|0|||
144482382|NCT00309608|520964554|FG003|Overall Study|Protocol Violation|0|||
144482383|NCT00309608|520964555|FG004|Overall Study|Protocol Violation|0|||
144482384|NCT00309608|520964551|FG000|Overall Study|Lost to Follow-up|0|||
144482385|NCT00309608|520964552|FG001|Overall Study|Lost to Follow-up|0|||
144482386|NCT00309608|520964553|FG002|Overall Study|Lost to Follow-up|2|||
144482387|NCT00309608|520964554|FG003|Overall Study|Lost to Follow-up|0|||
144482388|NCT00309608|520964555|FG004|Overall Study|Lost to Follow-up|1|||
144482389|NCT00309608|520964551|FG000|Overall Study|Withdrawal by Subject|1|||
144482390|NCT00309608|520964552|FG001|Overall Study|Withdrawal by Subject|4|||
144482391|NCT00309608|520964553|FG002|Overall Study|Withdrawal by Subject|2|||
144482392|NCT00309608|520964554|FG003|Overall Study|Withdrawal by Subject|0|||
144482393|NCT00309608|520964555|FG004|Overall Study|Withdrawal by Subject|0|||
144482394|NCT00309608|520964551|FG000|Overall Study|Other incl. Lack of efficacy|10|||
144369510|NCT03722238|520561617|FG001|Overall Study|Physician Decision|0|||
144369511|NCT03722238|520561616|FG000|Overall Study|Death|1|||
144369512|NCT03722238|520561617|FG001|Overall Study|Death|0|||
144369513|NCT03722238|520561616|FG000|Overall Study|Lost to Follow-up|6|||
144369514|NCT03722238|520561617|FG001|Overall Study|Lost to Follow-up|0|||
144369515|NCT03722238|520561616|FG000|Overall Study|Partial missing data|44|||
144369516|NCT03722238|520561617|FG001|Overall Study|Partial missing data|1|||
144369517|NCT03722238|520561616|FG000|Overall Study|Withdrawal by Subject|2|||
144369518|NCT03722238|520561617|FG001|Overall Study|Withdrawal by Subject|0|||
144482395|NCT00309608|520964552|FG001|Overall Study|Other incl. Lack of efficacy|4|||
144482396|NCT00309608|520964553|FG002|Overall Study|Other incl. Lack of efficacy|3|||
144369519|NCT03722238|520561616|FG000|Overall Study|Other|4|||
144369520|NCT03722238|520561617|FG001|Overall Study|Other|0|||
144369521|NCT03722238|520561616|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
144482397|NCT00309608|520964554|FG003|Overall Study|Other incl. Lack of efficacy|4|||
144482398|NCT00309608|520964555|FG004|Overall Study|Other incl. Lack of efficacy|0|||
144482399|NCT00874432|520964557|FG000|Overall Study|Withdrawal by Subject|1|||
144482400|NCT00874432|520964558|FG001|Overall Study|Withdrawal by Subject|0|||
144482401|NCT00874432|520964559|FG002|Overall Study|Withdrawal by Subject|0|||
144482402|NCT00874432|520964560|FG003|Overall Study|Withdrawal by Subject|0|||
144482403|NCT00874432|520964557|FG000|Overall Study|Physician Decision|1|||
144482404|NCT00874432|520964558|FG001|Overall Study|Physician Decision|0|||
144482405|NCT00874432|520964559|FG002|Overall Study|Physician Decision|0|||
144482406|NCT00874432|520964560|FG003|Overall Study|Physician Decision|0|||
144482407|NCT00874432|520964557|FG000|Overall Study|Other|1|||
144482408|NCT00874432|520964558|FG001|Overall Study|Other|2|||
144482409|NCT00874432|520964559|FG002|Overall Study|Other|8|||
144482410|NCT00874432|520964560|FG003|Overall Study|Other|3|||
144482411|NCT04249336|520966399|FG000|Overall Study|Lost to Follow-up|3|||
144482412|NCT04249336|520966400|FG001|Overall Study|Lost to Follow-up|3|||
144482413|NCT04249336|520966401|FG002|Overall Study|Lost to Follow-up|3|||
144482414|NCT04249336|520966402|FG003|Overall Study|Lost to Follow-up|3|||
144482415|NCT01242176|520966403|FG000|Washout Period of 7 Days|Adverse Event|0|||
144482416|NCT01242176|520966404|FG001|Washout Period of 7 Days|Adverse Event|2|||
144482417|NCT01242176|520966403|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
144482418|NCT01242176|520966404|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
144482419|NCT00871351|520966405|FG000|Overall Study|Withdrawal by Subject|1|||
144482420|NCT00871351|520966406|FG001|Overall Study|Withdrawal by Subject|0|||
144482421|NCT00871351|520966407|FG002|Overall Study|Withdrawal by Subject|0|||
144482422|NCT00871351|520966405|FG000|Overall Study|Adverse Event|3|||
144482423|NCT00871351|520966406|FG001|Overall Study|Adverse Event|1|||
144482424|NCT00871351|520966407|FG002|Overall Study|Adverse Event|0|||
144482425|NCT02291289|520966409|FG000|Induction Treatment|Withdrawal by Subject|0|||
144482426|NCT02291289|520966410|FG001|Induction Treatment|Withdrawal by Subject|0|||
144482427|NCT02291289|520966411|FG002|Induction Treatment|Withdrawal by Subject|0|||
144482428|NCT02291289|520966412|FG003|Induction Treatment|Withdrawal by Subject|24|||
144482429|NCT02291289|520966413|FG004|Induction Treatment|Withdrawal by Subject|0|||
144482430|NCT02291289|520966414|FG005|Induction Treatment|Withdrawal by Subject|0|||
144482431|NCT02291289|520966415|FG006|Induction Treatment|Withdrawal by Subject|0|||
144482432|NCT02291289|520966416|FG007|Induction Treatment|Withdrawal by Subject|0|||
144482433|NCT02291289|520966417|FG008|Induction Treatment|Withdrawal by Subject|0|||
144482434|NCT02291289|520966418|FG009|Induction Treatment|Withdrawal by Subject|18|||
144482435|NCT02291289|520966419|FG010|Induction Treatment|Withdrawal by Subject|0|||
144482436|NCT02291289|520966420|FG011|Induction Treatment|Withdrawal by Subject|0|||
144482437|NCT02291289|520966421|FG012|Induction Treatment|Withdrawal by Subject|0|||
144482438|NCT02291289|520966409|FG000|Induction Treatment|Adverse Event|0|||
144482439|NCT02291289|520966410|FG001|Induction Treatment|Adverse Event|0|||
144482440|NCT02291289|520966411|FG002|Induction Treatment|Adverse Event|0|||
144482441|NCT02291289|520966412|FG003|Induction Treatment|Adverse Event|3|||
144482442|NCT02291289|520966413|FG004|Induction Treatment|Adverse Event|0|||
144482443|NCT02291289|520966414|FG005|Induction Treatment|Adverse Event|0|||
144482444|NCT02291289|520966415|FG006|Induction Treatment|Adverse Event|0|||
144482445|NCT02291289|520966416|FG007|Induction Treatment|Adverse Event|0|||
144482446|NCT02291289|520966417|FG008|Induction Treatment|Adverse Event|0|||
144482447|NCT02291289|520966418|FG009|Induction Treatment|Adverse Event|1|||
144482448|NCT02291289|520966419|FG010|Induction Treatment|Adverse Event|0|||
144482449|NCT02291289|520966420|FG011|Induction Treatment|Adverse Event|0|||
144482450|NCT02291289|520966421|FG012|Induction Treatment|Adverse Event|0|||
144482451|NCT02291289|520966409|FG000|Induction Treatment|Death|25|||
144482452|NCT02291289|520966410|FG001|Induction Treatment|Death|0|||
144482453|NCT02291289|520966411|FG002|Induction Treatment|Death|0|||
144482454|NCT02291289|520966412|FG003|Induction Treatment|Death|111|||
144482455|NCT02291289|520966413|FG004|Induction Treatment|Death|0|||
144482456|NCT02291289|520966414|FG005|Induction Treatment|Death|0|||
144482457|NCT02291289|520966415|FG006|Induction Treatment|Death|1|||
144482458|NCT02291289|520966416|FG007|Induction Treatment|Death|0|||
144482459|NCT02291289|520966417|FG008|Induction Treatment|Death|0|||
144482460|NCT02291289|520966418|FG009|Induction Treatment|Death|82|||
144482461|NCT02291289|520966419|FG010|Induction Treatment|Death|0|||
144482462|NCT02291289|520966420|FG011|Induction Treatment|Death|0|||
144482463|NCT02291289|520966421|FG012|Induction Treatment|Death|0|||
144482464|NCT02291289|520966409|FG000|Induction Treatment|Lost to Follow-up|1|||
144482465|NCT02291289|520966410|FG001|Induction Treatment|Lost to Follow-up|0|||
144482466|NCT02291289|520966411|FG002|Induction Treatment|Lost to Follow-up|0|||
144482467|NCT02291289|520966412|FG003|Induction Treatment|Lost to Follow-up|12|||
144482468|NCT02291289|520966413|FG004|Induction Treatment|Lost to Follow-up|0|||
144482469|NCT02291289|520966414|FG005|Induction Treatment|Lost to Follow-up|0|||
144482470|NCT02291289|520966415|FG006|Induction Treatment|Lost to Follow-up|0|||
144482471|NCT02291289|520966416|FG007|Induction Treatment|Lost to Follow-up|0|||
144714148|NCT00971204|521808021|FG000|Overall Study|Did not meet all criteria-not treated|14|||
144714149|NCT00971204|521808021|FG000|Overall Study|Lost to Follow-up|10|||
144714150|NCT01361607|521808025|FG000|Overall Study|Adverse Event|38|||
144714151|NCT01361607|521808026|FG001|Overall Study|Adverse Event|29|||
144482472|NCT02291289|520966417|FG008|Induction Treatment|Lost to Follow-up|0|||
144482473|NCT02291289|520966418|FG009|Induction Treatment|Lost to Follow-up|9|||
144482474|NCT02291289|520966419|FG010|Induction Treatment|Lost to Follow-up|0|||
144369522|NCT03722238|520561617|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
144369523|NCT03722238|520561616|FG000|Overall Study|Did not meet risk classification group criteria|90|||
144369524|NCT03722238|520561617|FG001|Overall Study|Did not meet risk classification group criteria|0|||
144369525|NCT03722238|520561616|FG000|Overall Study|Did not sign consent|17|||
144482475|NCT02291289|520966420|FG011|Induction Treatment|Lost to Follow-up|0|||
144482476|NCT02291289|520966421|FG012|Induction Treatment|Lost to Follow-up|0|||
144482477|NCT02291289|520966409|FG000|Induction Treatment|Non-Compliance|0|||
144482478|NCT02291289|520966410|FG001|Induction Treatment|Non-Compliance|0|||
144482479|NCT02291289|520966411|FG002|Induction Treatment|Non-Compliance|0|||
144369526|NCT03722238|520561617|FG001|Overall Study|Did not sign consent|0|||
144482480|NCT02291289|520966412|FG003|Induction Treatment|Non-Compliance|1|||
144482481|NCT02291289|520966413|FG004|Induction Treatment|Non-Compliance|0|||
144482482|NCT02291289|520966414|FG005|Induction Treatment|Non-Compliance|0|||
144482483|NCT02291289|520966415|FG006|Induction Treatment|Non-Compliance|0|||
144482484|NCT02291289|520966416|FG007|Induction Treatment|Non-Compliance|0|||
144482485|NCT02291289|520966417|FG008|Induction Treatment|Non-Compliance|0|||
144482486|NCT02291289|520966418|FG009|Induction Treatment|Non-Compliance|1|||
144482487|NCT02291289|520966419|FG010|Induction Treatment|Non-Compliance|0|||
144482488|NCT02291289|520966420|FG011|Induction Treatment|Non-Compliance|0|||
144482489|NCT02291289|520966421|FG012|Induction Treatment|Non-Compliance|0|||
144482490|NCT02291289|520966409|FG000|Induction Treatment|Reason Not Specified|0|||
144482491|NCT02291289|520966410|FG001|Induction Treatment|Reason Not Specified|0|||
144482492|NCT02291289|520966411|FG002|Induction Treatment|Reason Not Specified|0|||
144482493|NCT02291289|520966412|FG003|Induction Treatment|Reason Not Specified|4|||
144482494|NCT02291289|520966413|FG004|Induction Treatment|Reason Not Specified|0|||
144482495|NCT02291289|520966414|FG005|Induction Treatment|Reason Not Specified|0|||
144482496|NCT02291289|520966415|FG006|Induction Treatment|Reason Not Specified|0|||
144482497|NCT02291289|520966416|FG007|Induction Treatment|Reason Not Specified|0|||
144482498|NCT02291289|520966417|FG008|Induction Treatment|Reason Not Specified|0|||
144482499|NCT02291289|520966418|FG009|Induction Treatment|Reason Not Specified|7|||
144482500|NCT02291289|520966419|FG010|Induction Treatment|Reason Not Specified|0|||
144482501|NCT02291289|520966420|FG011|Induction Treatment|Reason Not Specified|0|||
144482502|NCT02291289|520966421|FG012|Induction Treatment|Reason Not Specified|0|||
144482503|NCT02291289|520966409|FG000|Induction Treatment|Physician Decision|0|||
144714152|NCT01361607|521808025|FG000|Overall Study|Withdrawal by Subject|19|||
144714153|NCT01361607|521808026|FG001|Overall Study|Withdrawal by Subject|8|||
144714154|NCT01361607|521808025|FG000|Overall Study|Withdrawal by Investigator|5|||
144714155|NCT01361607|521808026|FG001|Overall Study|Withdrawal by Investigator|3|||
144714156|NCT01361607|521808025|FG000|Overall Study|Lost to Follow-up|1|||
144714157|NCT01361607|521808026|FG001|Overall Study|Lost to Follow-up|0|||
144714158|NCT01361607|521808025|FG000|Overall Study|Met Withdrawal Criteria|1|||
144714159|NCT01361607|521808026|FG001|Overall Study|Met Withdrawal Criteria|1|||
144714160|NCT00373685|521808027|FG000|Overall Study|Death|2|||
144714161|NCT00373685|521808028|FG001|Overall Study|Death|1|||
144714162|NCT00373685|521808027|FG000|Overall Study|Adverse Event|278|||
144714163|NCT00373685|521808028|FG001|Overall Study|Adverse Event|253|||
144714164|NCT00373685|521808027|FG000|Overall Study|Insufficient clinical response|169|||
144714165|NCT00373685|521808028|FG001|Overall Study|Insufficient clinical response|119|||
144714166|NCT00373685|521808027|FG000|Overall Study|Did not meet entrance criteria|167|||
144714167|NCT00373685|521808028|FG001|Overall Study|Did not meet entrance criteria|184|||
144714168|NCT00373685|521808027|FG000|Overall Study|Lost to follow up|83|||
144714169|NCT00373685|521808028|FG001|Overall Study|Lost to follow up|103|||
144714170|NCT00373685|521808027|FG000|Overall Study|No longer willing to participate|337|||
144714171|NCT00373685|521808028|FG001|Overall Study|No longer willing to participate|352|||
144714172|NCT00373685|521808027|FG000|Overall Study|Other|149|||
144714173|NCT00373685|521808028|FG001|Overall Study|Other|146|||
144714174|NCT00373685|521808027|FG000|Overall Study|Protocol Violation|191|||
144714175|NCT00373685|521808028|FG001|Overall Study|Protocol Violation|182|||
144714176|NCT00373685|521808027|FG000|Overall Study|Final Status Unknown|12|||
144714177|NCT00373685|521808028|FG001|Overall Study|Final Status Unknown|4|||
144714178|NCT00373685|521808027|FG000|Overall Study|Randomized, not treated|51|||
144714179|NCT00373685|521808028|FG001|Overall Study|Randomized, not treated|77|||
144714180|NCT02570165|521808029|FG000|Overall Study|Adverse Event|1|||
144714181|NCT02570165|521808030|FG001|Overall Study|Adverse Event|0|||
144714182|NCT02570165|521808031|FG002|Overall Study|Adverse Event|2|||
144714183|NCT02570165|521808032|FG003|Overall Study|Adverse Event|0|||
144714184|NCT02570165|521808033|FG004|Overall Study|Adverse Event|0|||
144714185|NCT02570165|521808034|FG005|Overall Study|Adverse Event|0|||
144714186|NCT02570165|521808035|FG006|Overall Study|Adverse Event|0|||
144482504|NCT02291289|520966410|FG001|Induction Treatment|Physician Decision|0|||
144482505|NCT02291289|520966411|FG002|Induction Treatment|Physician Decision|0|||
144482506|NCT02291289|520966412|FG003|Induction Treatment|Physician Decision|3|||
144482507|NCT02291289|520966413|FG004|Induction Treatment|Physician Decision|0|||
144482508|NCT02291289|520966414|FG005|Induction Treatment|Physician Decision|0|||
144482509|NCT02291289|520966415|FG006|Induction Treatment|Physician Decision|0|||
144482510|NCT02291289|520966416|FG007|Induction Treatment|Physician Decision|0|||
144714187|NCT02570165|521808029|FG000|Overall Study|Lack of Efficacy|0|||
144714188|NCT02570165|521808030|FG001|Overall Study|Lack of Efficacy|1|||
144714189|NCT02570165|521808031|FG002|Overall Study|Lack of Efficacy|0|||
144714190|NCT02570165|521808032|FG003|Overall Study|Lack of Efficacy|0|||
144714191|NCT02570165|521808033|FG004|Overall Study|Lack of Efficacy|4|||
144714192|NCT02570165|521808034|FG005|Overall Study|Lack of Efficacy|0|||
144714193|NCT02570165|521808035|FG006|Overall Study|Lack of Efficacy|0|||
144714194|NCT02570165|521808029|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
144714195|NCT02570165|521808030|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
144482511|NCT02291289|520966417|FG008|Induction Treatment|Physician Decision|0|||
144482512|NCT02291289|520966418|FG009|Induction Treatment|Physician Decision|1|||
144482513|NCT02291289|520966419|FG010|Induction Treatment|Physician Decision|0|||
144482514|NCT02291289|520966420|FG011|Induction Treatment|Physician Decision|0|||
144482515|NCT02291289|520966421|FG012|Induction Treatment|Physician Decision|0|||
144482516|NCT02291289|520966409|FG000|Induction Treatment|Protocol Violation|0|||
144482517|NCT02291289|520966410|FG001|Induction Treatment|Protocol Violation|0|||
144482518|NCT02291289|520966411|FG002|Induction Treatment|Protocol Violation|0|||
144482519|NCT02291289|520966412|FG003|Induction Treatment|Protocol Violation|3|||
144482520|NCT02291289|520966413|FG004|Induction Treatment|Protocol Violation|0|||
144482521|NCT02291289|520966414|FG005|Induction Treatment|Protocol Violation|0|||
144482522|NCT02291289|520966415|FG006|Induction Treatment|Protocol Violation|0|||
144482523|NCT02291289|520966416|FG007|Induction Treatment|Protocol Violation|0|||
144482524|NCT02291289|520966417|FG008|Induction Treatment|Protocol Violation|0|||
144482525|NCT02291289|520966418|FG009|Induction Treatment|Protocol Violation|2|||
144482526|NCT02291289|520966419|FG010|Induction Treatment|Protocol Violation|0|||
144482527|NCT02291289|520966420|FG011|Induction Treatment|Protocol Violation|0|||
144482528|NCT02291289|520966421|FG012|Induction Treatment|Protocol Violation|0|||
144482529|NCT02291289|520966409|FG000|Induction Treatment|Missing|4|||
144482530|NCT02291289|520966410|FG001|Induction Treatment|Missing|0|||
144482531|NCT02291289|520966411|FG002|Induction Treatment|Missing|0|||
144482532|NCT02291289|520966412|FG003|Induction Treatment|Missing|14|||
144482533|NCT02291289|520966413|FG004|Induction Treatment|Missing|0|||
144482534|NCT02291289|520966414|FG005|Induction Treatment|Missing|0|||
144482535|NCT02291289|520966415|FG006|Induction Treatment|Missing|0|||
144482536|NCT02291289|520966416|FG007|Induction Treatment|Missing|0|||
144482537|NCT02291289|520966417|FG008|Induction Treatment|Missing|0|||
144482538|NCT02291289|520966418|FG009|Induction Treatment|Missing|54|||
144482539|NCT02291289|520966419|FG010|Induction Treatment|Missing|0|||
144482540|NCT02291289|520966420|FG011|Induction Treatment|Missing|0|||
144482541|NCT02291289|520966421|FG012|Induction Treatment|Missing|0|||
144482542|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482543|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482544|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482545|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482546|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
144482547|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
144482548|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482549|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482550|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482551|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482552|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
144482553|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
144482554|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144482555|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Death|0|||
144482556|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Death|29|||
144482557|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Death|16|||
144482558|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Death|0|||
144482559|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Death|188|||
144482560|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Death|107|||
144482561|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Death|0|||
144482562|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Death|1|||
144482563|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Death|1|||
144482564|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Death|0|||
144482565|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Death|46|||
144482566|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Death|19|||
144482567|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Death|0|||
144482568|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Adverse Event|0|||
144482569|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Adverse Event|0|||
144482570|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Adverse Event|0|||
144482571|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Adverse Event|0|||
144482572|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Adverse Event|1|||
144482573|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Adverse Event|1|||
144482574|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Adverse Event|0|||
144482575|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Adverse Event|0|||
144482576|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Adverse Event|0|||
144482577|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Adverse Event|0|||
144482578|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Adverse Event|0|||
144482579|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Adverse Event|0|||
144482580|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Adverse Event|0|||
144482581|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482582|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
144482583|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482584|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482585|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
144482586|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
144482587|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482588|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
144482589|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482590|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482591|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
144482592|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
144482593|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
144482594|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
144482595|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
144482596|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
144482597|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
144482598|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
144482599|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
144482600|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
144482601|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
144482602|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
144482603|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
144482604|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
144482605|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
144482606|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
144482607|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Physician Decision|0|||
144482608|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Physician Decision|2|||
144482609|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Physician Decision|0|||
144482610|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Physician Decision|0|||
144482611|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Physician Decision|3|||
144482612|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Physician Decision|0|||
144482613|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Physician Decision|0|||
144482614|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Physician Decision|0|||
144482615|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Physician Decision|0|||
144482616|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Physician Decision|0|||
144482617|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Physician Decision|1|||
144482618|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Physician Decision|3|||
144482619|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Physician Decision|0|||
144482620|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Not Treated|0|||
144482621|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Not Treated|0|||
144482622|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Not Treated|2|||
144482623|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Not Treated|0|||
144482624|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Not Treated|0|||
144482625|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Not Treated|0|||
144482626|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Not Treated|0|||
144482627|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Not Treated|0|||
144482628|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Not Treated|0|||
144482629|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Not Treated|0|||
144482630|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Not Treated|0|||
144482631|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Not Treated|0|||
144482632|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Not Treated|0|||
144482633|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482634|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
144482635|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482636|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144369527|NCT03722238|520561616|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
144369528|NCT03722238|520561617|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
144369529|NCT03722238|520561616|FG000|Overall Study|Not willing to purchase study medication|142|||
144369530|NCT03722238|520561617|FG001|Overall Study|Not willing to purchase study medication|0|||
144369531|NCT03722238|520561616|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
144369532|NCT03722238|520561617|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
144369533|NCT02158546|520561624|FG000|Overall Study|Physician Decision|0|||
144369534|NCT02158546|520561625|FG001|Overall Study|Physician Decision|1|||
144369535|NCT02158546|520561626|FG002|Overall Study|Physician Decision|0|||
144369536|NCT02158546|520561627|FG003|Overall Study|Physician Decision|0|||
144369537|NCT02158546|520561624|FG000|Overall Study|Non-compliance|0|||
144369538|NCT02158546|520561625|FG001|Overall Study|Non-compliance|1|||
144369539|NCT02158546|520561626|FG002|Overall Study|Non-compliance|0|||
144369540|NCT02158546|520561627|FG003|Overall Study|Non-compliance|1|||
144369541|NCT02158546|520561624|FG000|Overall Study|Failure to meet eligibility criteria|0|||
144369542|NCT02158546|520561625|FG001|Overall Study|Failure to meet eligibility criteria|1|||
144482637|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482638|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482639|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144369543|NCT02158546|520561626|FG002|Overall Study|Failure to meet eligibility criteria|0|||
144369544|NCT02158546|520561627|FG003|Overall Study|Failure to meet eligibility criteria|0|||
144482640|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482641|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482642|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482643|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482644|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482645|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
144482646|NCT02291289|520966409|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
144482647|NCT02291289|520966410|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
144482648|NCT02291289|520966411|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
144482649|NCT02291289|520966412|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
144482650|NCT02291289|520966413|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
144482651|NCT02291289|520966414|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
144482652|NCT02291289|520966415|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
144482653|NCT02291289|520966416|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
144482654|NCT02291289|520966417|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
144482655|NCT02291289|520966418|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
144714196|NCT02570165|521808031|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
144714197|NCT02570165|521808032|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
144714198|NCT02570165|521808033|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
144714199|NCT02570165|521808034|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
144714200|NCT02570165|521808035|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
144714201|NCT02570165|521808029|FG000|Overall Study|Lost to Follow-up|0|||
144714202|NCT02570165|521808030|FG001|Overall Study|Lost to Follow-up|0|||
144714203|NCT02570165|521808031|FG002|Overall Study|Lost to Follow-up|1|||
144714204|NCT02570165|521808032|FG003|Overall Study|Lost to Follow-up|1|||
144714205|NCT02570165|521808033|FG004|Overall Study|Lost to Follow-up|0|||
144714206|NCT02570165|521808034|FG005|Overall Study|Lost to Follow-up|0|||
144714207|NCT02570165|521808035|FG006|Overall Study|Lost to Follow-up|0|||
144714208|NCT02570165|521808029|FG000|Overall Study|Physician Decision|0|||
144714209|NCT02570165|521808030|FG001|Overall Study|Physician Decision|1|||
144714210|NCT02570165|521808031|FG002|Overall Study|Physician Decision|0|||
144714211|NCT02570165|521808032|FG003|Overall Study|Physician Decision|0|||
144714212|NCT02570165|521808033|FG004|Overall Study|Physician Decision|0|||
144714213|NCT02570165|521808034|FG005|Overall Study|Physician Decision|0|||
144714214|NCT02570165|521808035|FG006|Overall Study|Physician Decision|0|||
144714215|NCT02570165|521808029|FG000|Overall Study|Withdrawal by Subject|0|||
144714216|NCT02570165|521808030|FG001|Overall Study|Withdrawal by Subject|0|||
144714217|NCT02570165|521808031|FG002|Overall Study|Withdrawal by Subject|0|||
144714218|NCT02570165|521808032|FG003|Overall Study|Withdrawal by Subject|2|||
144714219|NCT02570165|521808033|FG004|Overall Study|Withdrawal by Subject|1|||
144714220|NCT02570165|521808034|FG005|Overall Study|Withdrawal by Subject|0|||
144714221|NCT02570165|521808035|FG006|Overall Study|Withdrawal by Subject|0|||
144714222|NCT02570165|521808029|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
144714223|NCT02570165|521808030|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
144714224|NCT02570165|521808031|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
144714225|NCT02570165|521808032|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
144714226|NCT02570165|521808033|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
144714227|NCT02570165|521808034|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
144714228|NCT02570165|521808035|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
144714229|NCT02570165|521808029|FG000|Overall Study|Withdrawal Request by GSK|0|||
144482656|NCT02291289|520966419|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
144482657|NCT02291289|520966420|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
144482658|NCT02291289|520966421|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
144482659|NCT02291289|520966409|FG000|Early Disease Progression|Death|0|||
144482660|NCT02291289|520966410|FG001|Early Disease Progression|Death|0|||
144482661|NCT02291289|520966411|FG002|Early Disease Progression|Death|0|||
144482662|NCT02291289|520966412|FG003|Early Disease Progression|Death|0|||
144482663|NCT02291289|520966413|FG004|Early Disease Progression|Death|0|||
144482664|NCT02291289|520966414|FG005|Early Disease Progression|Death|0|||
144482665|NCT02291289|520966415|FG006|Early Disease Progression|Death|0|||
144482666|NCT02291289|520966416|FG007|Early Disease Progression|Death|0|||
144482667|NCT02291289|520966417|FG008|Early Disease Progression|Death|0|||
144482668|NCT02291289|520966418|FG009|Early Disease Progression|Death|0|||
144482669|NCT02291289|520966419|FG010|Early Disease Progression|Death|0|||
144482670|NCT02291289|520966420|FG011|Early Disease Progression|Death|0|||
144482671|NCT02291289|520966421|FG012|Early Disease Progression|Death|10|||
144482672|NCT02291289|520966409|FG000|Early Disease Progression|Lost to Follow-up|0|||
144482673|NCT02291289|520966410|FG001|Early Disease Progression|Lost to Follow-up|0|||
144482674|NCT02291289|520966411|FG002|Early Disease Progression|Lost to Follow-up|0|||
144714230|NCT02570165|521808030|FG001|Overall Study|Withdrawal Request by GSK|0|||
144714231|NCT02570165|521808031|FG002|Overall Study|Withdrawal Request by GSK|2|||
144714232|NCT02570165|521808032|FG003|Overall Study|Withdrawal Request by GSK|0|||
144714233|NCT02570165|521808033|FG004|Overall Study|Withdrawal Request by GSK|0|||
144714234|NCT02570165|521808034|FG005|Overall Study|Withdrawal Request by GSK|0|||
144369545|NCT02158546|520561624|FG000|Overall Study|Lack of Efficacy|1|||
144369546|NCT02158546|520561625|FG001|Overall Study|Lack of Efficacy|1|||
144369547|NCT02158546|520561626|FG002|Overall Study|Lack of Efficacy|0|||
144369548|NCT02158546|520561627|FG003|Overall Study|Lack of Efficacy|0|||
144369549|NCT02158546|520561624|FG000|Overall Study|Adverse Event|2|||
144369550|NCT02158546|520561625|FG001|Overall Study|Adverse Event|2|||
144369551|NCT02158546|520561626|FG002|Overall Study|Adverse Event|0|||
144369552|NCT02158546|520561627|FG003|Overall Study|Adverse Event|0|||
144369553|NCT02158546|520561624|FG000|Overall Study|Withdrawal by Subject|6|||
144369554|NCT02158546|520561625|FG001|Overall Study|Withdrawal by Subject|2|||
144369555|NCT02158546|520561626|FG002|Overall Study|Withdrawal by Subject|1|||
144369556|NCT02158546|520561627|FG003|Overall Study|Withdrawal by Subject|0|||
144369557|NCT02158546|520561624|FG000|Overall Study|Lost to Follow-up|5|||
144369558|NCT02158546|520561625|FG001|Overall Study|Lost to Follow-up|4|||
144369559|NCT02158546|520561626|FG002|Overall Study|Lost to Follow-up|0|||
144369560|NCT02158546|520561627|FG003|Overall Study|Lost to Follow-up|1|||
144369561|NCT02158546|520561624|FG000|Overall Study|Site Excluded|5|||
144369562|NCT02158546|520561625|FG001|Overall Study|Site Excluded|5|||
144369563|NCT02158546|520561626|FG002|Overall Study|Site Excluded|3|||
144369564|NCT02158546|520561627|FG003|Overall Study|Site Excluded|4|||
144369565|NCT02351817|520561628|FG000|Period 1|Adverse Event|1|||
144369566|NCT02351817|520561629|FG001|Period 1|Adverse Event|2|||
144369567|NCT02351817|520561628|FG000|Period 1|Lack of Efficacy|0|||
144369568|NCT02351817|520561629|FG001|Period 1|Lack of Efficacy|1|||
144369569|NCT02351817|520561628|FG000|Period 2|Adverse Event|0|||
144369570|NCT02351817|520561629|FG001|Period 2|Adverse Event|2|||
144369571|NCT02351817|520561628|FG000|Period 2|Protocol Violation|1|||
144369572|NCT02351817|520561629|FG001|Period 2|Protocol Violation|0|||
144369573|NCT02488915|520561632|FG000|Overall Study|Death|21|||
144369574|NCT02488915|520561632|FG000|Overall Study|Lost to Follow-up|4|||
144369575|NCT02488915|520561632|FG000|Overall Study|Withdrawal by Subject|1|||
144369576|NCT00885170|520561635|FG000|Overall Study|Adverse Event|12|||
144369577|NCT00885170|520561636|FG001|Overall Study|Adverse Event|4|||
144369578|NCT00885170|520561635|FG000|Overall Study|Excessive bone loss|6|||
144369579|NCT00885170|520561636|FG001|Overall Study|Excessive bone loss|3|||
144369580|NCT00885170|520561635|FG000|Overall Study|Lost to Follow-up|2|||
144369581|NCT00885170|520561636|FG001|Overall Study|Lost to Follow-up|1|||
144369582|NCT00885170|520561635|FG000|Overall Study|Physician Decision|2|||
144369583|NCT00885170|520561636|FG001|Overall Study|Physician Decision|1|||
144369584|NCT00885170|520561635|FG000|Overall Study|Protocol Violation|3|||
144369585|NCT00885170|520561636|FG001|Overall Study|Protocol Violation|1|||
144369586|NCT00885170|520561635|FG000|Overall Study|Withdrawal by Subject|13|||
144369587|NCT00885170|520561636|FG001|Overall Study|Withdrawal by Subject|13|||
144369588|NCT03771664|520561637|FG000|Overall Study|Adverse Event|1|||
144369589|NCT03771664|520561638|FG001|Overall Study|Adverse Event|0|||
144369590|NCT03771664|520561637|FG000|Overall Study|Lost to Follow-up|1|||
144369591|NCT03771664|520561638|FG001|Overall Study|Lost to Follow-up|0|||
144369592|NCT03771664|520561637|FG000|Overall Study|Withdrawal by Participant|1|||
144369593|NCT03771664|520561638|FG001|Overall Study|Withdrawal by Participant|4|||
144369594|NCT03771664|520561637|FG000|Overall Study|Randomized but not Treated|0|||
144369595|NCT03771664|520561638|FG001|Overall Study|Randomized but not Treated|1|||
144369596|NCT00561925|520561640|FG000|14 Day Lead-In Period|Adverse Event|38|||
144369597|NCT00561925|520561641|FG001|14 Day Lead-In Period|Adverse Event|0|||
144369598|NCT00561925|520561642|FG002|14 Day Lead-In Period|Adverse Event|0|||
144369599|NCT00561925|520561643|FG003|14 Day Lead-In Period|Adverse Event|0|||
144369600|NCT00561925|520561644|FG004|14 Day Lead-In Period|Adverse Event|0|||
144369601|NCT00561925|520561640|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
144369602|NCT00561925|520561641|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
144369603|NCT00561925|520561642|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
144369604|NCT00561925|520561643|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
144369605|NCT00561925|520561644|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
144369606|NCT00561925|520561640|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
144369607|NCT00561925|520561641|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
144369608|NCT00561925|520561642|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
144369609|NCT00561925|520561643|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
144369610|NCT00561925|520561644|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
144369611|NCT00561925|520561640|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
144369612|NCT00561925|520561641|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
144369613|NCT00561925|520561642|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
144369614|NCT00561925|520561643|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
144369615|NCT00561925|520561644|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
144369616|NCT00561925|520561640|FG000|14 Day Lead-In Period|Other|5|||
144482675|NCT02291289|520966412|FG003|Early Disease Progression|Lost to Follow-up|0|||
144369617|NCT00561925|520561641|FG001|14 Day Lead-In Period|Other|0|||
144369618|NCT00561925|520561642|FG002|14 Day Lead-In Period|Other|0|||
144369619|NCT00561925|520561643|FG003|14 Day Lead-In Period|Other|0|||
144369620|NCT00561925|520561644|FG004|14 Day Lead-In Period|Other|0|||
144369621|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
144369622|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
144369623|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
144369624|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
144369625|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
144369626|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
144369627|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
144369628|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
144369629|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
144369630|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
144369631|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
144369632|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
144714235|NCT02570165|521808035|FG006|Overall Study|Withdrawal Request by GSK|0|||
144714236|NCT05003167|521808042|FG000|Overall Study|Withdrawal by Subject|1|||
144714237|NCT01123980|521808043|FG000|Overall Study|Adverse Event|1|||
144714238|NCT01123980|521808044|FG001|Overall Study|Adverse Event|1|||
144714239|NCT01123980|521808043|FG000|Overall Study|Lack of Efficacy|1|||
144714240|NCT01123980|521808044|FG001|Overall Study|Lack of Efficacy|0|||
144714241|NCT01123980|521808043|FG000|Overall Study|Physician Decision|0|||
144714242|NCT01123980|521808044|FG001|Overall Study|Physician Decision|1|||
144714243|NCT01123980|521808043|FG000|Overall Study|Lost to Follow-up|0|||
144714244|NCT01123980|521808044|FG001|Overall Study|Lost to Follow-up|6|||
144714245|NCT01123980|521808043|FG000|Overall Study|Protocol Violation|6|||
144714246|NCT01123980|521808044|FG001|Overall Study|Protocol Violation|6|||
144714247|NCT01123980|521808043|FG000|Overall Study|Withdrawal by Subject|5|||
144714248|NCT01123980|521808044|FG001|Overall Study|Withdrawal by Subject|3|||
144714249|NCT01123980|521808043|FG000|Overall Study|Unclassified|6|||
144714250|NCT01123980|521808044|FG001|Overall Study|Unclassified|7|||
144714251|NCT01225991|521808045|FG000|Overall Study|Withdrawal by Subject|6|||
144714252|NCT00343642|521809442|FG000|Overall Study|Lost to Follow-up|0|||
144714253|NCT00343642|521809443|FG001|Overall Study|Lost to Follow-up|1|||
144714254|NCT00343642|521809444|FG002|Overall Study|Lost to Follow-up|0|||
144714255|NCT00343642|521809442|FG000|Overall Study|Pregnancy|1|||
144714256|NCT00343642|521809443|FG001|Overall Study|Pregnancy|0|||
144714257|NCT00343642|521809444|FG002|Overall Study|Pregnancy|2|||
144714258|NCT00343642|521809442|FG000|Overall Study|Withdrawal by Subject|2|||
144714259|NCT00343642|521809443|FG001|Overall Study|Withdrawal by Subject|3|||
144714260|NCT00343642|521809444|FG002|Overall Study|Withdrawal by Subject|4|||
144714261|NCT00343642|521809442|FG000|Overall Study|Adverse Event|0|||
144714262|NCT00343642|521809443|FG001|Overall Study|Adverse Event|0|||
144714263|NCT00343642|521809444|FG002|Overall Study|Adverse Event|1|||
144714264|NCT00343642|521809442|FG000|Overall Study|Flare up|6|||
144714265|NCT00343642|521809443|FG001|Overall Study|Flare up|4|||
144714266|NCT00343642|521809444|FG002|Overall Study|Flare up|0|||
144714267|NCT01963676|521809445|FG000|Overall Study|Withdrawal by Subject|1|||
144714268|NCT01963676|521809446|FG001|Overall Study|Withdrawal by Subject|0|||
144714269|NCT00860574|521809447|FG000|Overall Study|Death|2|||
144714270|NCT00860574|521809447|FG000|Overall Study|Relapse|1|||
144714271|NCT01165242|521809448|FG000|Overall Study|Unreachable Subjects|1|||
144714272|NCT01165242|521809449|FG001|Overall Study|Unreachable Subjects|0|||
144714273|NCT01165242|521809450|FG002|Overall Study|Unreachable Subjects|0|||
144714274|NCT01165242|521809448|FG000|Overall Study|Incarcerated Subjects|0|||
144714275|NCT01165242|521809449|FG001|Overall Study|Incarcerated Subjects|1|||
144714276|NCT01165242|521809450|FG002|Overall Study|Incarcerated Subjects|0|||
144714277|NCT01165242|521809448|FG000|Overall Study|Visit 2 Declined by Subject|0|||
144714278|NCT01165242|521809449|FG001|Overall Study|Visit 2 Declined by Subject|0|||
144714279|NCT01165242|521809450|FG002|Overall Study|Visit 2 Declined by Subject|1|||
144714280|NCT01165242|521809448|FG000|Overall Study|Withdrawal by Subject|0|||
144714281|NCT01165242|521809449|FG001|Overall Study|Withdrawal by Subject|2|||
144714282|NCT01165242|521809450|FG002|Overall Study|Withdrawal by Subject|2|||
144714283|NCT01165242|521809448|FG000|Overall Study|Extended Holiday|0|||
144714284|NCT01165242|521809449|FG001|Overall Study|Extended Holiday|0|||
144714285|NCT01165242|521809450|FG002|Overall Study|Extended Holiday|1|||
144714286|NCT01165242|521809448|FG000|Overall Study|Lost to Follow-up|9|||
144714287|NCT01165242|521809449|FG001|Overall Study|Lost to Follow-up|7|||
144714288|NCT01165242|521809450|FG002|Overall Study|Lost to Follow-up|10|||
144714289|NCT03877237|521809451|FG000|Overall Study|Adverse Event|1|||
144714290|NCT03877237|521809452|FG001|Overall Study|Adverse Event|2|||
144369633|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
144714291|NCT03877237|521809451|FG000|Overall Study|Death|3|||
144714292|NCT03877237|521809452|FG001|Overall Study|Death|2|||
144714293|NCT03877237|521809451|FG000|Overall Study|Physician Decision|1|||
144714294|NCT03877237|521809452|FG001|Overall Study|Physician Decision|0|||
144714295|NCT03877237|521809451|FG000|Overall Study|Withdrawal by Subject|0|||
144714296|NCT03877237|521809452|FG001|Overall Study|Withdrawal by Subject|2|||
144714297|NCT03372083|521809454|FG000|Overall Study|Adverse Event|3|||
144714298|NCT03372083|521809454|FG000|Overall Study|Physician Decision|1|||
144714299|NCT03372083|521809454|FG000|Overall Study|Withdrawal by Subject|1|||
144482676|NCT02291289|520966413|FG004|Early Disease Progression|Lost to Follow-up|0|||
144482677|NCT02291289|520966414|FG005|Early Disease Progression|Lost to Follow-up|0|||
144482678|NCT02291289|520966415|FG006|Early Disease Progression|Lost to Follow-up|0|||
144482679|NCT02291289|520966416|FG007|Early Disease Progression|Lost to Follow-up|0|||
144482680|NCT02291289|520966417|FG008|Early Disease Progression|Lost to Follow-up|0|||
144482681|NCT02291289|520966418|FG009|Early Disease Progression|Lost to Follow-up|0|||
144482682|NCT02291289|520966419|FG010|Early Disease Progression|Lost to Follow-up|0|||
144482683|NCT02291289|520966420|FG011|Early Disease Progression|Lost to Follow-up|0|||
144482684|NCT02291289|520966421|FG012|Early Disease Progression|Lost to Follow-up|1|||
144482685|NCT00154063|520966422|FG000|Overall Study|Adverse Event|4|||
144482686|NCT00154063|520966423|FG001|Overall Study|Adverse Event|8|||
144482687|NCT00154063|520966422|FG000|Overall Study|Protocol Violation|1|||
144482688|NCT00154063|520966423|FG001|Overall Study|Protocol Violation|1|||
144482689|NCT00154063|520966422|FG000|Overall Study|Investigator or Sponsor Request|0|||
144482690|NCT00154063|520966423|FG001|Overall Study|Investigator or Sponsor Request|1|||
144482691|NCT00154063|520966422|FG000|Overall Study|Withdrawal by Subject|4|||
144482692|NCT00154063|520966423|FG001|Overall Study|Withdrawal by Subject|9|||
144714300|NCT00566098|521809456|FG000|Collection of MILs|Withdrawal by Subject|1|||
144714301|NCT00566098|521809456|FG000|Collection of MILs|Relapsed|1|||
144714302|NCT00566098|521809456|FG000|Generation of MILs Product|Relapsed|1|||
144714303|NCT00566098|521809456|FG000|Administration of ASCT+MILs|Death|10|||
144714304|NCT00566098|521809456|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
144714305|NCT02236754|521809457|FG000|Overall Study|Withdrawal by Subject|1|||
144714306|NCT02236754|521809458|FG001|Overall Study|Withdrawal by Subject|0|||
144714307|NCT02544633|521809459|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
144714308|NCT02544633|521809460|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
144714309|NCT02544633|521809461|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
144714310|NCT02544633|521809462|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
144714311|NCT02544633|521809459|FG000|Treatment Period|Adverse Event|7|||
144714312|NCT02544633|521809460|FG001|Treatment Period|Adverse Event|4|||
144714313|NCT02544633|521809461|FG002|Treatment Period|Adverse Event|0|||
144714314|NCT02544633|521809462|FG003|Treatment Period|Adverse Event|5|||
144714315|NCT02544633|521809459|FG000|Treatment Period|Lack of Efficacy|17|||
144714316|NCT02544633|521809460|FG001|Treatment Period|Lack of Efficacy|11|||
144714317|NCT02544633|521809461|FG002|Treatment Period|Lack of Efficacy|5|||
144714318|NCT02544633|521809462|FG003|Treatment Period|Lack of Efficacy|5|||
144714319|NCT02544633|521809459|FG000|Treatment Period|Global Deterioration of Health|3|||
144714320|NCT02544633|521809460|FG001|Treatment Period|Global Deterioration of Health|3|||
144714321|NCT02544633|521809461|FG002|Treatment Period|Global Deterioration of Health|0|||
144714322|NCT02544633|521809462|FG003|Treatment Period|Global Deterioration of Health|1|||
144714323|NCT02544633|521809459|FG000|Treatment Period|Withdrawal by Subject|1|||
144714324|NCT02544633|521809460|FG001|Treatment Period|Withdrawal by Subject|0|||
144714325|NCT02544633|521809461|FG002|Treatment Period|Withdrawal by Subject|0|||
144714326|NCT02544633|521809462|FG003|Treatment Period|Withdrawal by Subject|0|||
144714327|NCT02544633|521809459|FG000|Treatment Period|Lost to Follow-up|0|||
144714328|NCT02544633|521809460|FG001|Treatment Period|Lost to Follow-up|1|||
144714329|NCT02544633|521809461|FG002|Treatment Period|Lost to Follow-up|0|||
144714330|NCT02544633|521809462|FG003|Treatment Period|Lost to Follow-up|0|||
144714331|NCT02544633|521809459|FG000|Treatment Period|Death|0|||
144714332|NCT02544633|521809460|FG001|Treatment Period|Death|0|||
144714333|NCT02544633|521809461|FG002|Treatment Period|Death|1|||
144714334|NCT02544633|521809462|FG003|Treatment Period|Death|0|||
144714335|NCT02544633|521809459|FG000|Treatment Period|Non-compliance|0|||
144714336|NCT02544633|521809460|FG001|Treatment Period|Non-compliance|0|||
144482693|NCT00154063|520966422|FG000|Overall Study|Other|3|||
144482694|NCT00154063|520966423|FG001|Overall Study|Other|3|||
144482695|NCT01857934|520966431|FG000|Overall Study|Relapse or progression|2|||
144482696|NCT01857934|520966431|FG000|Overall Study|Unacceptable toxicity|3|||
144538220|NCT00146172|521174125|FG003|Overall Study|Physician Decision|0|||
144714337|NCT02544633|521809461|FG002|Treatment Period|Non-compliance|1|||
144714338|NCT02544633|521809462|FG003|Treatment Period|Non-compliance|0|||
144714339|NCT02544633|521809459|FG000|Treatment Period|Clinical Disease Progression|0|||
144714340|NCT02544633|521809460|FG001|Treatment Period|Clinical Disease Progression|0|||
144714341|NCT02544633|521809461|FG002|Treatment Period|Clinical Disease Progression|0|||
144714342|NCT02544633|521809462|FG003|Treatment Period|Clinical Disease Progression|1|||
144714343|NCT02544633|521809459|FG000|Survival Follow-up Period|Death|12|||
144714344|NCT02544633|521809460|FG001|Survival Follow-up Period|Death|14|||
144714345|NCT02544633|521809461|FG002|Survival Follow-up Period|Death|3|||
144714346|NCT02544633|521809462|FG003|Survival Follow-up Period|Death|9|||
144714347|NCT02544633|521809459|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
144714348|NCT02544633|521809460|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
144714349|NCT02544633|521809461|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
144714350|NCT02544633|521809462|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
144714351|NCT02544633|521809459|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
144714352|NCT02544633|521809460|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
144482697|NCT01857934|520966431|FG000|Overall Study|Unwillingness or inability to comply|2|||
144482698|NCT01857934|520966431|FG000|Overall Study|Physician Decision|3|||
144482699|NCT00439179|520966432|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
144482700|NCT00439179|520966433|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
144482701|NCT00439179|520966434|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
144482702|NCT00439179|520966435|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
144482703|NCT01844115|520966436|FG000|Overall Study|Adverse Event|4|||
144482704|NCT01844115|520966437|FG001|Overall Study|Adverse Event|22|||
144482705|NCT01844115|520966436|FG000|Overall Study|Lack of Efficacy|1|||
144482706|NCT01844115|520966437|FG001|Overall Study|Lack of Efficacy|4|||
144482707|NCT01844115|520966436|FG000|Overall Study|Protocol Violation|12|||
144482708|NCT01844115|520966437|FG001|Overall Study|Protocol Violation|10|||
144482709|NCT01844115|520966436|FG000|Overall Study|Withdrawal by Subject|11|||
144482710|NCT01844115|520966437|FG001|Overall Study|Withdrawal by Subject|11|||
144482711|NCT01844115|520966436|FG000|Overall Study|Lost to Follow-up|11|||
144482712|NCT01844115|520966437|FG001|Overall Study|Lost to Follow-up|10|||
144482713|NCT01844115|520966436|FG000|Overall Study|Pregnancy|0|||
144482714|NCT01844115|520966437|FG001|Overall Study|Pregnancy|1|||
144482715|NCT00758160|520966438|FG000|Overall Study|No Longer Requires Study Medication|4|||
144482716|NCT00758160|520966438|FG000|Overall Study|Administration Problems|3|||
144482717|NCT00758160|520966438|FG000|Overall Study|Adverse Event|15|||
144482718|NCT00758160|520966438|FG000|Overall Study|Lack of Efficacy|10|||
144482719|NCT00758160|520966438|FG000|Overall Study|Lost to Follow-up|14|||
144482720|NCT00758160|520966438|FG000|Overall Study|Protocol Violation|12|||
144482721|NCT00758160|520966438|FG000|Overall Study|Withdrawal by Subject|8|||
144482722|NCT01463293|520966441|FG000|Overall Study|Lost to Follow-up|1|||
144482723|NCT01463293|520966442|FG001|Overall Study|Lost to Follow-up|4|||
144482724|NCT01463293|520966443|FG002|Overall Study|Lost to Follow-up|5|||
144482725|NCT01463293|520966441|FG000|Overall Study|Adverse Event|1|||
144482726|NCT01463293|520966442|FG001|Overall Study|Adverse Event|2|||
144482727|NCT01463293|520966443|FG002|Overall Study|Adverse Event|0|||
144482728|NCT01463293|520966441|FG000|Overall Study|Withdrawal by Subject|4|||
144482729|NCT01463293|520966442|FG001|Overall Study|Withdrawal by Subject|10|||
144482730|NCT01463293|520966443|FG002|Overall Study|Withdrawal by Subject|5|||
144482731|NCT01463293|520966441|FG000|Overall Study|Other|0|||
144482732|NCT01463293|520966442|FG001|Overall Study|Other|0|||
144482733|NCT01463293|520966443|FG002|Overall Study|Other|2|||
144482734|NCT00119262|520966447|FG000|Overall Study|Lack of Efficacy|0|||
144482735|NCT00119262|520966448|FG001|Overall Study|Lack of Efficacy|3|||
144482736|NCT00119262|520966447|FG000|Overall Study|Withdrawal by Subject|12|||
144482737|NCT00119262|520966448|FG001|Overall Study|Withdrawal by Subject|11|||
144482738|NCT00119262|520966447|FG000|Overall Study|Adverse Event|33|||
144482739|NCT00119262|520966448|FG001|Overall Study|Adverse Event|35|||
144482740|NCT00119262|520966447|FG000|Overall Study|other disease|0|||
144482741|NCT00119262|520966448|FG001|Overall Study|other disease|2|||
144482742|NCT00119262|520966447|FG000|Overall Study|ineligble|1|||
144482743|NCT00119262|520966448|FG001|Overall Study|ineligble|2|||
144482744|NCT00119262|520966447|FG000|Overall Study|others|0|||
144482745|NCT00119262|520966448|FG001|Overall Study|others|5|||
144482746|NCT03853317|520966449|FG000|Overall Study|Progressive Disease|5|||
144482747|NCT03853317|520966449|FG000|Overall Study|Adverse Event|1|||
144482748|NCT03853317|520966449|FG000|Overall Study|Death|1|||
144482749|NCT03853317|520966449|FG000|Overall Study|other event|2|||
144482750|NCT00779584|520966452|FG000|Overall Study|Protocol Violation|0|||
144482751|NCT00779584|520966453|FG001|Overall Study|Protocol Violation|0|||
144482752|NCT00779584|520966454|FG002|Overall Study|Protocol Violation|0|||
144482753|NCT00779584|520966455|FG003|Overall Study|Protocol Violation|0|||
144482754|NCT00779584|520966456|FG004|Overall Study|Protocol Violation|0|||
144482755|NCT00779584|520966457|FG005|Overall Study|Protocol Violation|1|||
144482756|NCT00779584|520966458|FG006|Overall Study|Protocol Violation|0|||
144482757|NCT00779584|520966459|FG007|Overall Study|Protocol Violation|0|||
144482758|NCT00779584|520966460|FG008|Overall Study|Protocol Violation|0|||
144482759|NCT00779584|520966452|FG000|Overall Study|Withdrawal by Subject|1|||
144482760|NCT00779584|520966453|FG001|Overall Study|Withdrawal by Subject|1|||
144482761|NCT00779584|520966454|FG002|Overall Study|Withdrawal by Subject|2|||
144482762|NCT00779584|520966455|FG003|Overall Study|Withdrawal by Subject|0|||
144482763|NCT00779584|520966456|FG004|Overall Study|Withdrawal by Subject|0|||
144482764|NCT00779584|520966457|FG005|Overall Study|Withdrawal by Subject|2|||
144482765|NCT00779584|520966458|FG006|Overall Study|Withdrawal by Subject|1|||
144482766|NCT00779584|520966459|FG007|Overall Study|Withdrawal by Subject|0|||
144482767|NCT00779584|520966460|FG008|Overall Study|Withdrawal by Subject|0|||
144482768|NCT00779584|520966452|FG000|Overall Study|Lost to Follow-up|0|||
144482769|NCT00779584|520966453|FG001|Overall Study|Lost to Follow-up|0|||
144482770|NCT00779584|520966454|FG002|Overall Study|Lost to Follow-up|0|||
144482771|NCT00779584|520966455|FG003|Overall Study|Lost to Follow-up|0|||
144482772|NCT00779584|520966456|FG004|Overall Study|Lost to Follow-up|1|||
144482773|NCT00779584|520966457|FG005|Overall Study|Lost to Follow-up|0|||
144482774|NCT00779584|520966458|FG006|Overall Study|Lost to Follow-up|0|||
144482775|NCT00779584|520966459|FG007|Overall Study|Lost to Follow-up|0|||
144482776|NCT00779584|520966460|FG008|Overall Study|Lost to Follow-up|0|||
144482777|NCT00779584|520966452|FG000|Overall Study|Progression of Disease|0|||
144482778|NCT00779584|520966453|FG001|Overall Study|Progression of Disease|1|||
144482779|NCT00779584|520966454|FG002|Overall Study|Progression of Disease|2|||
144482780|NCT00779584|520966455|FG003|Overall Study|Progression of Disease|6|||
144482781|NCT00779584|520966456|FG004|Overall Study|Progression of Disease|5|||
144482782|NCT00779584|520966457|FG005|Overall Study|Progression of Disease|1|||
144482783|NCT00779584|520966458|FG006|Overall Study|Progression of Disease|4|||
144482784|NCT00779584|520966459|FG007|Overall Study|Progression of Disease|2|||
144482785|NCT00779584|520966460|FG008|Overall Study|Progression of Disease|1|||
144482786|NCT00779584|520966452|FG000|Overall Study|Adverse Event|1|||
144482787|NCT00779584|520966453|FG001|Overall Study|Adverse Event|0|||
144482788|NCT00779584|520966454|FG002|Overall Study|Adverse Event|2|||
144482789|NCT00779584|520966455|FG003|Overall Study|Adverse Event|0|||
144482790|NCT00779584|520966456|FG004|Overall Study|Adverse Event|0|||
144482791|NCT00779584|520966457|FG005|Overall Study|Adverse Event|0|||
144482792|NCT00779584|520966458|FG006|Overall Study|Adverse Event|2|||
144482793|NCT00779584|520966459|FG007|Overall Study|Adverse Event|1|||
144482794|NCT00779584|520966460|FG008|Overall Study|Adverse Event|1|||
144482795|NCT00779584|520966452|FG000|Overall Study|Symptomatic Deterioration|1|||
144482796|NCT00779584|520966453|FG001|Overall Study|Symptomatic Deterioration|1|||
144482797|NCT00779584|520966454|FG002|Overall Study|Symptomatic Deterioration|1|||
144482798|NCT00779584|520966455|FG003|Overall Study|Symptomatic Deterioration|0|||
144482799|NCT00779584|520966456|FG004|Overall Study|Symptomatic Deterioration|0|||
144482800|NCT00779584|520966457|FG005|Overall Study|Symptomatic Deterioration|1|||
144482801|NCT00779584|520966458|FG006|Overall Study|Symptomatic Deterioration|1|||
144482802|NCT00779584|520966459|FG007|Overall Study|Symptomatic Deterioration|0|||
144482803|NCT00779584|520966460|FG008|Overall Study|Symptomatic Deterioration|0|||
144482804|NCT00779584|520966452|FG000|Overall Study|Ongoing in Study|0|||
144482805|NCT00779584|520966453|FG001|Overall Study|Ongoing in Study|0|||
144482806|NCT00779584|520966454|FG002|Overall Study|Ongoing in Study|0|||
144714353|NCT02544633|521809461|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
144482807|NCT00779584|520966455|FG003|Overall Study|Ongoing in Study|0|||
144482808|NCT00779584|520966456|FG004|Overall Study|Ongoing in Study|1|||
144482809|NCT00779584|520966457|FG005|Overall Study|Ongoing in Study|1|||
144714354|NCT02544633|521809462|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
144714355|NCT02544633|521809459|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
144714356|NCT02544633|521809460|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
144714357|NCT02544633|521809461|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
144714358|NCT02544633|521809462|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
144714359|NCT02092961|521809463|FG000|Overall Study|Not reported|1|||
144714360|NCT02092961|521809464|FG001|Overall Study|Not reported|0|||
144714361|NCT02092961|521809465|FG002|Overall Study|Not reported|1|||
144714362|NCT02092961|521809463|FG000|Overall Study|Study stopped|13|||
144714363|NCT02092961|521809464|FG001|Overall Study|Study stopped|9|||
144714364|NCT02092961|521809465|FG002|Overall Study|Study stopped|12|||
144714365|NCT02092961|521809463|FG000|Overall Study|Lack of therapeutic response|2|||
144714366|NCT02092961|521809464|FG001|Overall Study|Lack of therapeutic response|1|||
144714367|NCT02092961|521809465|FG002|Overall Study|Lack of therapeutic response|3|||
144714368|NCT02092961|521809463|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
144714369|NCT02092961|521809464|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
144714370|NCT02092961|521809465|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
144714371|NCT02092961|521809463|FG000|Overall Study|Adverse Event|2|||
144714372|NCT02092961|521809464|FG001|Overall Study|Adverse Event|4|||
144714373|NCT02092961|521809465|FG002|Overall Study|Adverse Event|0|||
144714374|NCT02270983|521809466|FG000|Overall Study|Adverse Event|3|||
144714375|NCT02270983|521809467|FG001|Overall Study|Adverse Event|2|||
144714376|NCT02270983|521809468|FG002|Overall Study|Adverse Event|6|||
144714377|NCT02270983|521809466|FG000|Overall Study|Lack of Efficacy|2|||
144714378|NCT02270983|521809467|FG001|Overall Study|Lack of Efficacy|1|||
144714379|NCT02270983|521809468|FG002|Overall Study|Lack of Efficacy|1|||
144714380|NCT02270983|521809466|FG000|Overall Study|Withdrawal by Subject|1|||
144714381|NCT02270983|521809467|FG001|Overall Study|Withdrawal by Subject|0|||
144482810|NCT00779584|520966458|FG006|Overall Study|Ongoing in Study|0|||
144482811|NCT00779584|520966459|FG007|Overall Study|Ongoing in Study|0|||
144482812|NCT00779584|520966460|FG008|Overall Study|Ongoing in Study|0|||
144482813|NCT03632434|520966463|FG000|Overall Study|Withdrawal by Subject|2|||
144482814|NCT01115491|520966464|FG000|Overall Study|Death|22|||
144482815|NCT01115491|520966464|FG000|Overall Study|Adverse Event|3|||
144482816|NCT01115491|520966464|FG000|Overall Study|Lost to Follow-up|3|||
144482817|NCT01115491|520966464|FG000|Overall Study|Withdrawal by Subject|1|||
144482818|NCT01115491|520966464|FG000|Overall Study|Physician Decision|1|||
144714382|NCT02270983|521809468|FG002|Overall Study|Withdrawal by Subject|2|||
144714383|NCT02270983|521809466|FG000|Overall Study|Lost to Follow-up|1|||
144714384|NCT02270983|521809467|FG001|Overall Study|Lost to Follow-up|1|||
144714385|NCT02270983|521809468|FG002|Overall Study|Lost to Follow-up|2|||
144714386|NCT02270983|521809466|FG000|Overall Study|Protocol Violation|1|||
144714387|NCT02270983|521809467|FG001|Overall Study|Protocol Violation|1|||
144714388|NCT02270983|521809468|FG002|Overall Study|Protocol Violation|1|||
144714389|NCT02270983|521809466|FG000|Overall Study|family emergency|0|||
144714390|NCT02270983|521809467|FG001|Overall Study|family emergency|1|||
144714391|NCT02270983|521809468|FG002|Overall Study|family emergency|0|||
144714392|NCT02270983|521809466|FG000|Overall Study|study procedure non-compliance|1|||
144714393|NCT02270983|521809467|FG001|Overall Study|study procedure non-compliance|0|||
144714394|NCT02270983|521809468|FG002|Overall Study|study procedure non-compliance|0|||
144714395|NCT02270983|521809466|FG000|Overall Study|moved away from study site|0|||
144714396|NCT02270983|521809467|FG001|Overall Study|moved away from study site|1|||
144714397|NCT02270983|521809468|FG002|Overall Study|moved away from study site|0|||
144714398|NCT00928252|521809471|FG000|Overall Study|Physician Decision|3|||
144714399|NCT01605461|521809472|FG000|Overall Study|Lost to Follow-up|3|||
144714400|NCT01605461|521809472|FG000|Overall Study|Withdrawal by Subject|1|||
144714401|NCT02024698|521809473|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
144714402|NCT02024698|521809474|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
144714403|NCT00275028|521809475|FG000|Overall Study|Withdrew consent before treatment began|1|||
144714404|NCT00275028|521809475|FG000|Overall Study|Withdrawal by Subject|5|||
144714405|NCT00275028|521809475|FG000|Overall Study|Adverse Event|9|||
144714406|NCT00275028|521809475|FG000|Overall Study|Progressive Disease|30|||
144714407|NCT00275028|521809475|FG000|Overall Study|Physician Decision|2|||
144714408|NCT01847313|521809478|FG000|Overall Study|Death|0|||
144714409|NCT01847313|521809479|FG001|Overall Study|Death|1|||
144714410|NCT01847313|521809478|FG000|Overall Study|Withdrawal by Subject|0|||
144714411|NCT01847313|521809479|FG001|Overall Study|Withdrawal by Subject|1|||
144714412|NCT00598559|521809481|FG000|Overall Study|Adverse Event|11|||
144714413|NCT00598559|521809482|FG001|Overall Study|Adverse Event|7|||
144714414|NCT00598559|521809483|FG002|Overall Study|Adverse Event|0|||
144714415|NCT00598559|521809481|FG000|Overall Study|Withdrawal by Subject|2|||
144714416|NCT00598559|521809482|FG001|Overall Study|Withdrawal by Subject|2|||
144714417|NCT00598559|521809483|FG002|Overall Study|Withdrawal by Subject|0|||
144714418|NCT00598559|521809481|FG000|Overall Study|Protocol Non-compliance|1|||
144714419|NCT00598559|521809482|FG001|Overall Study|Protocol Non-compliance|0|||
144714420|NCT00598559|521809483|FG002|Overall Study|Protocol Non-compliance|0|||
144714421|NCT00598559|521809481|FG000|Overall Study|Early discharge from hospital|9|||
144714422|NCT00598559|521809482|FG001|Overall Study|Early discharge from hospital|12|||
144714423|NCT00598559|521809483|FG002|Overall Study|Early discharge from hospital|3|||
144714424|NCT00598559|521809481|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
144714425|NCT00598559|521809482|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
144714426|NCT00598559|521809483|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
144714427|NCT00936884|521809488|FG000|Double-blind|Withdrawal by Subject|6|||
144714428|NCT00936884|521809489|FG001|Double-blind|Withdrawal by Subject|4|||
144714429|NCT00936884|521809490|FG002|Double-blind|Withdrawal by Subject|0|||
144714430|NCT00936884|521809488|FG000|Double-blind|Death|2|||
144714431|NCT00936884|521809489|FG001|Double-blind|Death|1|||
144714432|NCT00936884|521809490|FG002|Double-blind|Death|0|||
144714433|NCT00936884|521809488|FG000|Double-blind|Lack of Efficacy|1|||
144714434|NCT00936884|521809489|FG001|Double-blind|Lack of Efficacy|1|||
144714435|NCT00936884|521809490|FG002|Double-blind|Lack of Efficacy|0|||
144714436|NCT00936884|521809488|FG000|Double-blind|Adverse Event|1|||
144714437|NCT00936884|521809489|FG001|Double-blind|Adverse Event|0|||
144714438|NCT00936884|521809490|FG002|Double-blind|Adverse Event|0|||
144714439|NCT00936884|521809488|FG000|Double-blind|Physician Decision|1|||
144714440|NCT00936884|521809489|FG001|Double-blind|Physician Decision|0|||
144714441|NCT00936884|521809490|FG002|Double-blind|Physician Decision|0|||
144714442|NCT00936884|521809488|FG000|Double-blind|No post baseline diary entry|1|||
144714443|NCT00936884|521809489|FG001|Double-blind|No post baseline diary entry|0|||
144714444|NCT00936884|521809490|FG002|Double-blind|No post baseline diary entry|0|||
144714445|NCT00936884|521809488|FG000|Double-blind|Did not receive study drug|0|||
144714446|NCT00936884|521809489|FG001|Double-blind|Did not receive study drug|1|||
144714447|NCT00936884|521809490|FG002|Double-blind|Did not receive study drug|0|||
144714448|NCT02280421|521809493|FG000|Washout (2 Weeks)|Adverse Event|0|||
144714449|NCT02280421|521809494|FG001|Washout (2 Weeks)|Adverse Event|1|||
144714450|NCT02280421|521809493|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
144714451|NCT02280421|521809494|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
144714452|NCT02764489|521809495|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
144714453|NCT02764489|521809496|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
144714454|NCT02764489|521809495|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
144714455|NCT02764489|521809496|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
144714456|NCT02764489|521809495|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
144714457|NCT02764489|521809496|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
144714458|NCT02764489|521809495|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
144714459|NCT02764489|521809496|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
144714460|NCT01625845|521809497|FG000|Overall Study|Adverse Event|1|||
144714461|NCT01625845|521809498|FG001|Overall Study|Adverse Event|2|||
144714462|NCT01625845|521809497|FG000|Overall Study|Lost to Follow-up|2|||
144714463|NCT01625845|521809498|FG001|Overall Study|Lost to Follow-up|1|||
144482819|NCT04297241|520966465|FG000|Overall Study|Withdrawal by Subject|1|||
144482820|NCT04297241|520966465|FG000|Overall Study|Adverse Event|1|||
144482821|NCT04297241|520966465|FG000|Overall Study|Physician Decision|3|||
144482822|NCT03688711|520966476|FG000|Overall Study|Withdrawal by Subject|0|||
144482823|NCT03688711|520966477|FG001|Overall Study|Withdrawal by Subject|1|||
144482824|NCT04654468|520966481|FG000|Overall Study|Death|1|||
144482825|NCT04654468|520966481|FG000|Overall Study|Ongoing in the Study|50|||
144482826|NCT04159415|520966491|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482827|NCT04159415|520966492|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482828|NCT04159415|520966493|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482829|NCT04159415|520966494|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482830|NCT04159415|520966495|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482831|NCT04159415|520966496|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482832|NCT04159415|520966497|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
144482833|NCT04159415|520966498|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
144482834|NCT04159415|520966499|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482835|NCT04159415|520966500|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
144482836|NCT04159415|520966491|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482837|NCT04159415|520966492|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482838|NCT04159415|520966493|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482839|NCT04159415|520966494|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482840|NCT04159415|520966495|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482841|NCT04159415|520966496|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482842|NCT04159415|520966497|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482843|NCT04159415|520966498|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
144482844|NCT04159415|520966499|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482845|NCT04159415|520966500|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
144482846|NCT04159415|520966491|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482847|NCT04159415|520966492|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482848|NCT04159415|520966493|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482849|NCT04159415|520966494|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482850|NCT04159415|520966495|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482851|NCT04159415|520966496|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482852|NCT04159415|520966497|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482853|NCT04159415|520966498|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
144482854|NCT04159415|520966499|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482855|NCT04159415|520966500|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
144482856|NCT04159415|520966491|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482857|NCT04159415|520966492|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482858|NCT04159415|520966493|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482859|NCT04159415|520966494|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482860|NCT04159415|520966495|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482861|NCT04159415|520966496|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482862|NCT04159415|520966497|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482863|NCT04159415|520966498|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482864|NCT04159415|520966499|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
144482865|NCT04159415|520966500|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
144482866|NCT05064735|520966501|FG000|Overall Study|Withdrawal by Subject|7|||
144482867|NCT05064735|520966502|FG001|Overall Study|Withdrawal by Subject|8|||
144482868|NCT05064735|520966501|FG000|Overall Study|Lost to Follow-up|7|||
144482869|NCT05064735|520966502|FG001|Overall Study|Lost to Follow-up|2|||
144482870|NCT05064735|520966501|FG000|Overall Study|Physician Decision|2|||
144482871|NCT05064735|520966502|FG001|Overall Study|Physician Decision|1|||
144482872|NCT05064735|520966501|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
144482873|NCT05064735|520966502|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
144482874|NCT05064735|520966501|FG000|Overall Study|Site Closure|7|||
144482875|NCT05064735|520966502|FG001|Overall Study|Site Closure|2|||
144482876|NCT01018563|520966507|FG000|Overall Study|Termination of the study by Sponsor|2|||
144482877|NCT01018563|520966508|FG001|Overall Study|Termination of the study by Sponsor|1|||
144482878|NCT02344537|520966511|FG000|Overall Study|Protocol Violation|1|||
144482879|NCT02344537|520966512|FG001|Overall Study|Protocol Violation|1|||
144482880|NCT02344537|520966511|FG000|Overall Study|Subject started another treatment after wk 6|1|||
144482881|NCT02344537|520966512|FG001|Overall Study|Subject started another treatment after wk 6|0|||
144482882|NCT02344537|520966511|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
144482883|NCT02344537|520966512|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
144482884|NCT00960752|520966521|FG000|Overall Study|Adverse Event|0|||
144482885|NCT00960752|520966522|FG001|Overall Study|Adverse Event|0|||
144482886|NCT00960752|520966523|FG002|Overall Study|Adverse Event|1|||
144482887|NCT00960752|520966521|FG000|Overall Study|Progression|0|||
144482888|NCT00960752|520966522|FG001|Overall Study|Progression|0|||
144482889|NCT00960752|520966523|FG002|Overall Study|Progression|1|||
144482890|NCT04844970|520966524|FG000|Overall Study|Adverse Event|0|||
144482891|NCT04844970|520966525|FG001|Overall Study|Adverse Event|1|||
144482892|NCT04844970|520966524|FG000|Overall Study|Withdrawal by Subject|2|||
144482893|NCT04844970|520966525|FG001|Overall Study|Withdrawal by Subject|0|||
144482894|NCT05490329|520966526|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
144482895|NCT05490329|520966527|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
144482896|NCT05490329|520966526|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
144482897|NCT05490329|520966527|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
144482898|NCT05490329|520966526|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
144482899|NCT05490329|520966527|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
144482900|NCT05027074|520966528|FG000|Overall Study|Death|47|||
144482901|NCT05027074|520966529|FG001|Overall Study|Death|42|||
144482902|NCT05027074|520966530|FG002|Overall Study|Death|39|||
144482903|NCT05027074|520966528|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144482904|NCT05027074|520966529|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144482905|NCT05027074|520966530|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144482906|NCT05027074|520966528|FG000|Overall Study|Site Terminated By Sponsor|3|||
144482907|NCT05027074|520966529|FG001|Overall Study|Site Terminated By Sponsor|0|||
144369634|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
144714464|NCT01625845|521809497|FG000|Overall Study|Withdrawal by Subject|2|||
144714465|NCT01625845|521809498|FG001|Overall Study|Withdrawal by Subject|0|||
144714466|NCT02853929|521809499|FG000|Overall Study|Lost to Follow-up|3|||
144714467|NCT02853929|521809500|FG001|Overall Study|Lost to Follow-up|0|||
144714468|NCT02853929|521809499|FG000|Overall Study|Withdrawal by Subject|1|||
144714469|NCT02853929|521809500|FG001|Overall Study|Withdrawal by Subject|0|||
144714470|NCT02853929|521809499|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
144714471|NCT02853929|521809500|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
144714472|NCT01294592|521809501|FG000|Overall Study|Adverse Event|28|||
144714473|NCT01294592|521809502|FG001|Overall Study|Adverse Event|13|||
144714474|NCT01294592|521809501|FG000|Overall Study|Lack of Efficacy|7|||
144714475|NCT01294592|521809502|FG001|Overall Study|Lack of Efficacy|5|||
144714476|NCT01294592|521809501|FG000|Overall Study|Protocol Violation|1|||
144714477|NCT01294592|521809502|FG001|Overall Study|Protocol Violation|7|||
144714478|NCT01294592|521809501|FG000|Overall Study|Lost to Follow-up|7|||
144714479|NCT01294592|521809502|FG001|Overall Study|Lost to Follow-up|9|||
144714480|NCT01294592|521809501|FG000|Overall Study|Physician Decision|6|||
144714481|NCT01294592|521809502|FG001|Overall Study|Physician Decision|11|||
144714482|NCT01294592|521809501|FG000|Overall Study|Withdrawal by Subject|28|||
144714483|NCT01294592|521809502|FG001|Overall Study|Withdrawal by Subject|28|||
144714484|NCT02762565|521809503|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
144714485|NCT03549130|521809504|FG000|Overall Study|Adverse Event|0|||
144714486|NCT03549130|521809505|FG001|Overall Study|Adverse Event|1|||
144714487|NCT03549130|521809504|FG000|Overall Study|Lost to Follow-up|0|||
144714488|NCT03549130|521809505|FG001|Overall Study|Lost to Follow-up|1|||
144714489|NCT01113710|521809506|FG000|Overall Study|Adverse Event|64|||
144714490|NCT01113710|521809506|FG000|Overall Study|Lack of Efficacy|41|||
144714491|NCT01113710|521809506|FG000|Overall Study|No Information Available|40|||
144714492|NCT01113710|521809506|FG000|Overall Study|Withdrawal by Subject|28|||
144714493|NCT01113710|521809506|FG000|Overall Study|Lost to Follow-up|20|||
144714494|NCT01113710|521809506|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
144714495|NCT01113710|521809506|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
144714496|NCT01113710|521809506|FG000|Overall Study|Lack of Patient's Compliance|8|||
144714497|NCT01113710|521809506|FG000|Overall Study|Other|7|||
144714498|NCT01113710|521809506|FG000|Overall Study|Adverse Event/Other|5|||
144714499|NCT01113710|521809506|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
144714500|NCT01113710|521809506|FG000|Overall Study|Lack of Efficacy/Other|4|||
144714501|NCT01113710|521809506|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
144714502|NCT01113710|521809506|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
144714503|NCT01113710|521809506|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
144714504|NCT01113710|521809506|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
144714505|NCT01113710|521809506|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
144714506|NCT01113710|521809506|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
144714507|NCT01113710|521809506|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
144714508|NCT01113710|521809506|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
144714509|NCT01113710|521809506|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
144714510|NCT01113710|521809506|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
144714511|NCT01113710|521809506|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
144714512|NCT01113710|521809506|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
144714513|NCT01113710|521809506|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
144714514|NCT01078623|521809508|FG000|Treatment Period 1|Adverse Event|1|||
144714515|NCT01078623|521809509|FG001|Treatment Period 1|Adverse Event|1|||
144714516|NCT01078623|521809510|FG002|Treatment Period 1|Adverse Event|1|||
144714517|NCT01078623|521809511|FG003|Treatment Period 1|Adverse Event|0|||
144714518|NCT01078623|521809512|FG004|Treatment Period 1|Adverse Event|0|||
144714519|NCT01078623|521809513|FG005|Treatment Period 1|Adverse Event|0|||
144714520|NCT01078623|521809514|FG006|Treatment Period 1|Adverse Event|1|||
144714521|NCT01078623|521809515|FG007|Treatment Period 1|Adverse Event|0|||
144714522|NCT01078623|521809516|FG008|Treatment Period 1|Adverse Event|1|||
144714523|NCT01078623|521809517|FG009|Treatment Period 1|Adverse Event|1|||
144714524|NCT01078623|521809518|FG010|Treatment Period 1|Adverse Event|0|||
144714525|NCT01078623|521809519|FG011|Treatment Period 1|Adverse Event|0|||
144714526|NCT01078623|521809520|FG012|Treatment Period 1|Adverse Event|0|||
144714527|NCT01078623|521809521|FG013|Treatment Period 1|Adverse Event|0|||
144714528|NCT01078623|521809522|FG014|Treatment Period 1|Adverse Event|0|||
144714529|NCT01078623|521809523|FG015|Treatment Period 1|Adverse Event|0|||
144714530|NCT01078623|521809524|FG016|Treatment Period 1|Adverse Event|0|||
144714531|NCT01078623|521809525|FG017|Treatment Period 1|Adverse Event|0|||
144714532|NCT01078623|521809526|FG018|Treatment Period 1|Adverse Event|0|||
144714533|NCT01078623|521809527|FG019|Treatment Period 1|Adverse Event|0|||
144714534|NCT01078623|521809508|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144714535|NCT01078623|521809509|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144714536|NCT01078623|521809510|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144714537|NCT01078623|521809511|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144714538|NCT01078623|521809512|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144714539|NCT01078623|521809513|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144482908|NCT05027074|520966530|FG002|Overall Study|Site Terminated By Sponsor|2|||
144482909|NCT05027074|520966528|FG000|Overall Study|Withdrawal by Subject|13|||
144482910|NCT05027074|520966529|FG001|Overall Study|Withdrawal by Subject|8|||
144482911|NCT05027074|520966530|FG002|Overall Study|Withdrawal by Subject|10|||
144482912|NCT05027074|520966528|FG000|Overall Study|Lost to Follow-up|2|||
144482913|NCT05027074|520966529|FG001|Overall Study|Lost to Follow-up|4|||
144482914|NCT05027074|520966530|FG002|Overall Study|Lost to Follow-up|3|||
144482915|NCT05027074|520966528|FG000|Overall Study|Status Not Recorded|0|||
144482916|NCT05027074|520966529|FG001|Overall Study|Status Not Recorded|0|||
144482917|NCT05027074|520966530|FG002|Overall Study|Status Not Recorded|1|||
144482918|NCT03169881|520966531|FG000|Overall Study|Incomplete Follow-up|10|||
144482919|NCT03169881|520966532|FG001|Overall Study|Incomplete Follow-up|15|||
144482920|NCT03169881|520966531|FG000|Overall Study|Lost to Follow-up|18|||
144482921|NCT03169881|520966532|FG001|Overall Study|Lost to Follow-up|20|||
144482922|NCT03169881|520966531|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
144482923|NCT03169881|520966532|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
144482924|NCT00856661|520966533|FG000|Overall Study|Death|15|||
144482925|NCT00856661|520966534|FG001|Overall Study|Death|18|||
144482926|NCT00856661|520966533|FG000|Overall Study|Protocol Violation|2|||
144482927|NCT00856661|520966534|FG001|Overall Study|Protocol Violation|1|||
144369635|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
144369636|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
144369637|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
144369638|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
144369639|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
144369640|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
144369641|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
144369642|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
144369643|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
144369644|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
144369645|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
144369646|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
144369647|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
144369648|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
144369649|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
144369650|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
144369651|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Death|0|||
144369652|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Death|6|||
144369653|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Death|3|||
144369654|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Death|0|||
144369655|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Death|0|||
144369656|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
144369657|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
144369658|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
144369659|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
144369660|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
144369661|NCT00561925|520561640|FG000|144-week Double-blind, Double-dummy|Other|0|||
144369662|NCT00561925|520561641|FG001|144-week Double-blind, Double-dummy|Other|8|||
144369663|NCT00561925|520561642|FG002|144-week Double-blind, Double-dummy|Other|11|||
144369664|NCT00561925|520561643|FG003|144-week Double-blind, Double-dummy|Other|0|||
144369665|NCT00561925|520561644|FG004|144-week Double-blind, Double-dummy|Other|0|||
144369666|NCT00561925|520561640|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
144369667|NCT00561925|520561641|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
144369668|NCT00561925|520561642|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
144369669|NCT00561925|520561643|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
144369670|NCT00561925|520561644|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
144369671|NCT00684021|520561647|FG000|Overall Study|MRI Contraindicated|1|||
144369672|NCT00684021|520561648|FG001|Overall Study|MRI Contraindicated|1|||
144369673|NCT00684021|520561649|FG002|Overall Study|MRI Contraindicated|1|||
144369674|NCT00684021|520561650|FG003|Overall Study|MRI Contraindicated|0|||
144369675|NCT00684021|520561647|FG000|Overall Study|MRI not performed|0|||
144369676|NCT00684021|520561648|FG001|Overall Study|MRI not performed|1|||
144369677|NCT00684021|520561649|FG002|Overall Study|MRI not performed|1|||
144369678|NCT00684021|520561650|FG003|Overall Study|MRI not performed|2|||
144482928|NCT00856661|520966533|FG000|Overall Study|Withdrawal by Subject|1|||
144482929|NCT00856661|520966534|FG001|Overall Study|Withdrawal by Subject|2|||
144482930|NCT00856661|520966533|FG000|Overall Study|Lost to Follow-up|1|||
144482931|NCT00856661|520966534|FG001|Overall Study|Lost to Follow-up|3|||
144482932|NCT00856661|520966533|FG000|Overall Study|Physician Judgement|8|||
144482933|NCT00856661|520966534|FG001|Overall Study|Physician Judgement|5|||
144482934|NCT03936777|520966535|FG000|Overall Study|Adverse Event|3|||
144482935|NCT03936777|520966535|FG000|Overall Study|Death|3|||
144482936|NCT03936777|520966535|FG000|Overall Study|Lack of Efficacy|24|||
144482937|NCT03936777|520966535|FG000|Overall Study|Lost to Follow-up|3|||
144482938|NCT03936777|520966535|FG000|Overall Study|Physician Decision|1|||
144482939|NCT03936777|520966535|FG000|Overall Study|Withdrawal by Subject|11|||
144482940|NCT03936777|520966535|FG000|Overall Study|Subjected Weaned of ZX008|1|||
144482941|NCT03936777|520966535|FG000|Overall Study|Missing|6|||
144482942|NCT02306122|520966536|FG000|Initial Physician Randomization|Physician Decision|0|||
144482943|NCT02306122|520966537|FG001|Initial Physician Randomization|Physician Decision|0|||
144482944|NCT02306122|520966538|FG002|Initial Physician Randomization|Physician Decision|0|||
144482945|NCT02306122|520966539|FG003|Initial Physician Randomization|Physician Decision|0|||
144482946|NCT02306122|520966540|FG004|Initial Physician Randomization|Physician Decision|0|||
144482947|NCT02306122|520966541|FG005|Initial Physician Randomization|Physician Decision|0|||
144482948|NCT02306122|520966542|FG006|Initial Physician Randomization|Physician Decision|0|||
144482949|NCT02306122|520966543|FG007|Initial Physician Randomization|Physician Decision|0|||
144482950|NCT02306122|520966544|FG008|Initial Physician Randomization|Physician Decision|1|||
144482951|NCT02306122|520966545|FG009|Initial Physician Randomization|Physician Decision|0|||
144482952|NCT02306122|520966546|FG010|Initial Physician Randomization|Physician Decision|0|||
144482953|NCT05295732|520966550|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
144482954|NCT05295732|520966551|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
144482955|NCT05295732|520966552|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
144482956|NCT05295732|520966553|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
144482957|NCT05295732|520966554|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
144482958|NCT05295732|520966550|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
144482959|NCT05295732|520966551|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
144482960|NCT05295732|520966552|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
144482961|NCT05295732|520966553|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
144482962|NCT05295732|520966554|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
144482963|NCT04150029|520966555|FG000|Overall Study|Disease Relapse|0|||
144482964|NCT04150029|520966556|FG001|Overall Study|Disease Relapse|18|||
144482965|NCT04150029|520966555|FG000|Overall Study|Progressive Disease|2|||
144482966|NCT04150029|520966556|FG001|Overall Study|Progressive Disease|16|||
144482967|NCT04150029|520966555|FG000|Overall Study|Adverse Event|1|||
144482968|NCT04150029|520966556|FG001|Overall Study|Adverse Event|11|||
144482969|NCT04150029|520966555|FG000|Overall Study|Physician Decision|0|||
144482970|NCT04150029|520966556|FG001|Overall Study|Physician Decision|10|||
144482971|NCT04150029|520966555|FG000|Overall Study|Study Terminated by Sponsor|1|||
144482972|NCT04150029|520966556|FG001|Overall Study|Study Terminated by Sponsor|10|||
144482973|NCT04150029|520966555|FG000|Overall Study|Death|0|||
144482974|NCT04150029|520966556|FG001|Overall Study|Death|8|||
144482975|NCT04150029|520966555|FG000|Overall Study|Participant Decision|0|||
144482976|NCT04150029|520966556|FG001|Overall Study|Participant Decision|7|||
144482977|NCT04150029|520966555|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
144482978|NCT04150029|520966556|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
144482979|NCT02364713|520966557|FG000|Overall Study|Ineligible|2|||
144714540|NCT01078623|521809514|FG006|Treatment Period 1|Withdrawal by Subject|0|||
144714541|NCT01078623|521809515|FG007|Treatment Period 1|Withdrawal by Subject|1|||
144714542|NCT01078623|521809516|FG008|Treatment Period 1|Withdrawal by Subject|0|||
144714543|NCT01078623|521809517|FG009|Treatment Period 1|Withdrawal by Subject|0|||
144714544|NCT01078623|521809518|FG010|Treatment Period 1|Withdrawal by Subject|1|||
144714545|NCT01078623|521809519|FG011|Treatment Period 1|Withdrawal by Subject|0|||
144714546|NCT01078623|521809520|FG012|Treatment Period 1|Withdrawal by Subject|0|||
144714547|NCT01078623|521809521|FG013|Treatment Period 1|Withdrawal by Subject|0|||
144714548|NCT01078623|521809522|FG014|Treatment Period 1|Withdrawal by Subject|0|||
144714549|NCT01078623|521809523|FG015|Treatment Period 1|Withdrawal by Subject|0|||
144714550|NCT01078623|521809524|FG016|Treatment Period 1|Withdrawal by Subject|0|||
144714551|NCT01078623|521809525|FG017|Treatment Period 1|Withdrawal by Subject|0|||
144714552|NCT01078623|521809526|FG018|Treatment Period 1|Withdrawal by Subject|0|||
144714553|NCT01078623|521809527|FG019|Treatment Period 1|Withdrawal by Subject|0|||
144714554|NCT01078623|521809508|FG000|Treatment Period 1|Protocol Violation|0|||
144714555|NCT01078623|521809509|FG001|Treatment Period 1|Protocol Violation|0|||
144714556|NCT01078623|521809510|FG002|Treatment Period 1|Protocol Violation|0|||
144714557|NCT01078623|521809511|FG003|Treatment Period 1|Protocol Violation|0|||
144714558|NCT01078623|521809512|FG004|Treatment Period 1|Protocol Violation|0|||
144714559|NCT01078623|521809513|FG005|Treatment Period 1|Protocol Violation|1|||
144714560|NCT01078623|521809514|FG006|Treatment Period 1|Protocol Violation|0|||
144714561|NCT01078623|521809515|FG007|Treatment Period 1|Protocol Violation|0|||
144714562|NCT01078623|521809516|FG008|Treatment Period 1|Protocol Violation|0|||
144714563|NCT01078623|521809517|FG009|Treatment Period 1|Protocol Violation|0|||
144714564|NCT01078623|521809518|FG010|Treatment Period 1|Protocol Violation|0|||
144714565|NCT01078623|521809519|FG011|Treatment Period 1|Protocol Violation|0|||
144714566|NCT01078623|521809520|FG012|Treatment Period 1|Protocol Violation|0|||
144714567|NCT01078623|521809521|FG013|Treatment Period 1|Protocol Violation|0|||
144714568|NCT01078623|521809522|FG014|Treatment Period 1|Protocol Violation|0|||
144714569|NCT01078623|521809523|FG015|Treatment Period 1|Protocol Violation|0|||
144714570|NCT01078623|521809524|FG016|Treatment Period 1|Protocol Violation|0|||
144714571|NCT01078623|521809525|FG017|Treatment Period 1|Protocol Violation|0|||
144714572|NCT01078623|521809526|FG018|Treatment Period 1|Protocol Violation|0|||
144714573|NCT01078623|521809527|FG019|Treatment Period 1|Protocol Violation|0|||
144714574|NCT01078623|521809508|FG000|Treatment Period 2|Adverse Event|0|||
144714575|NCT01078623|521809509|FG001|Treatment Period 2|Adverse Event|0|||
144714576|NCT01078623|521809510|FG002|Treatment Period 2|Adverse Event|0|||
144714577|NCT01078623|521809511|FG003|Treatment Period 2|Adverse Event|0|||
144714578|NCT01078623|521809512|FG004|Treatment Period 2|Adverse Event|0|||
144714579|NCT01078623|521809513|FG005|Treatment Period 2|Adverse Event|0|||
144714580|NCT01078623|521809514|FG006|Treatment Period 2|Adverse Event|1|||
144714581|NCT01078623|521809515|FG007|Treatment Period 2|Adverse Event|0|||
144714582|NCT01078623|521809516|FG008|Treatment Period 2|Adverse Event|0|||
144714583|NCT01078623|521809517|FG009|Treatment Period 2|Adverse Event|0|||
144714584|NCT01078623|521809518|FG010|Treatment Period 2|Adverse Event|0|||
144714585|NCT01078623|521809519|FG011|Treatment Period 2|Adverse Event|0|||
144714586|NCT01078623|521809520|FG012|Treatment Period 2|Adverse Event|0|||
144714587|NCT01078623|521809521|FG013|Treatment Period 2|Adverse Event|0|||
144714588|NCT01078623|521809522|FG014|Treatment Period 2|Adverse Event|0|||
144714589|NCT01078623|521809523|FG015|Treatment Period 2|Adverse Event|0|||
144714590|NCT01078623|521809524|FG016|Treatment Period 2|Adverse Event|0|||
144714591|NCT01078623|521809525|FG017|Treatment Period 2|Adverse Event|0|||
144714592|NCT01078623|521809526|FG018|Treatment Period 2|Adverse Event|1|||
144714593|NCT01078623|521809527|FG019|Treatment Period 2|Adverse Event|0|||
144714594|NCT01078623|521809508|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144714595|NCT01078623|521809509|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144714596|NCT01078623|521809510|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144714597|NCT01078623|521809511|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144714598|NCT01078623|521809512|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144714599|NCT01078623|521809513|FG005|Treatment Period 2|Withdrawal by Subject|1|||
144714600|NCT01078623|521809514|FG006|Treatment Period 2|Withdrawal by Subject|0|||
144714601|NCT01078623|521809515|FG007|Treatment Period 2|Withdrawal by Subject|0|||
144714602|NCT01078623|521809516|FG008|Treatment Period 2|Withdrawal by Subject|0|||
144714603|NCT01078623|521809517|FG009|Treatment Period 2|Withdrawal by Subject|0|||
144714604|NCT01078623|521809518|FG010|Treatment Period 2|Withdrawal by Subject|0|||
144714605|NCT01078623|521809519|FG011|Treatment Period 2|Withdrawal by Subject|0|||
144714606|NCT01078623|521809520|FG012|Treatment Period 2|Withdrawal by Subject|0|||
144714607|NCT01078623|521809521|FG013|Treatment Period 2|Withdrawal by Subject|0|||
144714608|NCT01078623|521809522|FG014|Treatment Period 2|Withdrawal by Subject|0|||
144714609|NCT01078623|521809523|FG015|Treatment Period 2|Withdrawal by Subject|0|||
144714610|NCT01078623|521809524|FG016|Treatment Period 2|Withdrawal by Subject|0|||
144714611|NCT01078623|521809525|FG017|Treatment Period 2|Withdrawal by Subject|0|||
144714612|NCT01078623|521809526|FG018|Treatment Period 2|Withdrawal by Subject|0|||
144714613|NCT01078623|521809527|FG019|Treatment Period 2|Withdrawal by Subject|0|||
144714614|NCT01078623|521809508|FG000|Treatment Period 3|Adverse Event|0|||
144714615|NCT01078623|521809509|FG001|Treatment Period 3|Adverse Event|0|||
144714616|NCT01078623|521809510|FG002|Treatment Period 3|Adverse Event|0|||
144714617|NCT01078623|521809511|FG003|Treatment Period 3|Adverse Event|0|||
144714618|NCT01078623|521809512|FG004|Treatment Period 3|Adverse Event|1|||
144714619|NCT01078623|521809513|FG005|Treatment Period 3|Adverse Event|0|||
144714620|NCT01078623|521809514|FG006|Treatment Period 3|Adverse Event|0|||
144714621|NCT01078623|521809515|FG007|Treatment Period 3|Adverse Event|0|||
144714622|NCT01078623|521809516|FG008|Treatment Period 3|Adverse Event|0|||
144714623|NCT01078623|521809517|FG009|Treatment Period 3|Adverse Event|0|||
144714624|NCT01078623|521809518|FG010|Treatment Period 3|Adverse Event|0|||
144714625|NCT01078623|521809519|FG011|Treatment Period 3|Adverse Event|0|||
144714626|NCT01078623|521809520|FG012|Treatment Period 3|Adverse Event|0|||
144482980|NCT02364713|520966558|FG001|Overall Study|Ineligible|2|||
144714627|NCT01078623|521809521|FG013|Treatment Period 3|Adverse Event|1|||
144714628|NCT01078623|521809522|FG014|Treatment Period 3|Adverse Event|0|||
144714629|NCT01078623|521809523|FG015|Treatment Period 3|Adverse Event|0|||
144714630|NCT01078623|521809524|FG016|Treatment Period 3|Adverse Event|0|||
144369679|NCT00684021|520561647|FG000|Overall Study|Death|1|||
144714631|NCT01078623|521809525|FG017|Treatment Period 3|Adverse Event|0|||
144714632|NCT01078623|521809526|FG018|Treatment Period 3|Adverse Event|0|||
144714633|NCT01078623|521809527|FG019|Treatment Period 3|Adverse Event|0|||
144714634|NCT01078623|521809508|FG000|Treatment Period 4|Adverse Event|0|||
144714635|NCT01078623|521809509|FG001|Treatment Period 4|Adverse Event|0|||
144482981|NCT01032044|520966559|FG000|Overall Study|Protocol Violation|14|||
144714636|NCT01078623|521809510|FG002|Treatment Period 4|Adverse Event|1|||
144714637|NCT01078623|521809511|FG003|Treatment Period 4|Adverse Event|0|||
144714638|NCT01078623|521809512|FG004|Treatment Period 4|Adverse Event|0|||
144714639|NCT01078623|521809513|FG005|Treatment Period 4|Adverse Event|0|||
144369680|NCT00684021|520561648|FG001|Overall Study|Death|0|||
144369681|NCT00684021|520561649|FG002|Overall Study|Death|0|||
144369682|NCT00684021|520561650|FG003|Overall Study|Death|0|||
144369683|NCT00724698|520561651|FG000|Overall Study|Adverse Event|9|||
144369684|NCT00724698|520561651|FG000|Overall Study|Failure of Therapy|4|||
144369685|NCT00724698|520561651|FG000|Overall Study|Poor Compliance|16|||
144714640|NCT01078623|521809514|FG006|Treatment Period 4|Adverse Event|0|||
144714641|NCT01078623|521809515|FG007|Treatment Period 4|Adverse Event|0|||
144714642|NCT01078623|521809516|FG008|Treatment Period 4|Adverse Event|0|||
144714643|NCT01078623|521809517|FG009|Treatment Period 4|Adverse Event|0|||
144714644|NCT01078623|521809518|FG010|Treatment Period 4|Adverse Event|0|||
144714645|NCT01078623|521809519|FG011|Treatment Period 4|Adverse Event|0|||
144714646|NCT01078623|521809520|FG012|Treatment Period 4|Adverse Event|0|||
144714647|NCT01078623|521809521|FG013|Treatment Period 4|Adverse Event|0|||
144714648|NCT01078623|521809522|FG014|Treatment Period 4|Adverse Event|0|||
144714649|NCT01078623|521809523|FG015|Treatment Period 4|Adverse Event|0|||
144714650|NCT01078623|521809524|FG016|Treatment Period 4|Adverse Event|0|||
144714651|NCT01078623|521809525|FG017|Treatment Period 4|Adverse Event|0|||
144714652|NCT01078623|521809526|FG018|Treatment Period 4|Adverse Event|0|||
144714653|NCT01078623|521809527|FG019|Treatment Period 4|Adverse Event|0|||
144714654|NCT01078623|521809508|FG000|Treatment Period 4|Withdrawal by Subject|0|||
144714655|NCT01078623|521809509|FG001|Treatment Period 4|Withdrawal by Subject|0|||
144714656|NCT01078623|521809510|FG002|Treatment Period 4|Withdrawal by Subject|0|||
144714657|NCT01078623|521809511|FG003|Treatment Period 4|Withdrawal by Subject|0|||
144714658|NCT01078623|521809512|FG004|Treatment Period 4|Withdrawal by Subject|0|||
144714659|NCT01078623|521809513|FG005|Treatment Period 4|Withdrawal by Subject|0|||
144714660|NCT01078623|521809514|FG006|Treatment Period 4|Withdrawal by Subject|0|||
144714661|NCT01078623|521809515|FG007|Treatment Period 4|Withdrawal by Subject|0|||
144714662|NCT01078623|521809516|FG008|Treatment Period 4|Withdrawal by Subject|0|||
144714663|NCT01078623|521809517|FG009|Treatment Period 4|Withdrawal by Subject|0|||
144714664|NCT01078623|521809518|FG010|Treatment Period 4|Withdrawal by Subject|0|||
144714665|NCT01078623|521809519|FG011|Treatment Period 4|Withdrawal by Subject|0|||
144714666|NCT01078623|521809520|FG012|Treatment Period 4|Withdrawal by Subject|0|||
144714667|NCT01078623|521809521|FG013|Treatment Period 4|Withdrawal by Subject|0|||
144714668|NCT01078623|521809522|FG014|Treatment Period 4|Withdrawal by Subject|0|||
144714669|NCT01078623|521809523|FG015|Treatment Period 4|Withdrawal by Subject|1|||
144714670|NCT01078623|521809524|FG016|Treatment Period 4|Withdrawal by Subject|0|||
144714671|NCT01078623|521809525|FG017|Treatment Period 4|Withdrawal by Subject|0|||
144714672|NCT01078623|521809526|FG018|Treatment Period 4|Withdrawal by Subject|0|||
144714673|NCT01078623|521809527|FG019|Treatment Period 4|Withdrawal by Subject|0|||
144714674|NCT00463866|521809528|FG000|Overall Study|Adverse Event|70|||
144714675|NCT00463866|521809529|FG001|Overall Study|Adverse Event|93|||
144714676|NCT00463866|521809528|FG000|Overall Study|Withdrawal by Subject|81|||
144714677|NCT00463866|521809529|FG001|Overall Study|Withdrawal by Subject|79|||
144714678|NCT00463866|521809528|FG000|Overall Study|Lost to Follow-up|46|||
144714679|NCT00463866|521809529|FG001|Overall Study|Lost to Follow-up|55|||
144714680|NCT00463866|521809528|FG000|Overall Study|Incorrect Enrolment|64|||
144714681|NCT00463866|521809529|FG001|Overall Study|Incorrect Enrolment|66|||
144714682|NCT00463866|521809528|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
144714683|NCT00463866|521809529|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
144714684|NCT00463866|521809528|FG000|Overall Study|Safety Reason|1|||
144714685|NCT00463866|521809529|FG001|Overall Study|Safety Reason|3|||
144714686|NCT00463866|521809528|FG000|Overall Study|Mis-Randomization of subject|0|||
144714687|NCT00463866|521809529|FG001|Overall Study|Mis-Randomization of subject|1|||
144714688|NCT00463866|521809528|FG000|Overall Study|Other|22|||
144714689|NCT00463866|521809529|FG001|Overall Study|Other|22|||
144714690|NCT01170364|521809540|FG000|Overall Study|Protocol Violation|4|||
144714691|NCT01170364|521809541|FG001|Overall Study|Protocol Violation|1|||
144714692|NCT04132232|521809542|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
144714693|NCT04132232|521809543|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
144714694|NCT04132232|521809542|FG000|Overall Study|Lost to Follow-up|6|||
144714695|NCT04132232|521809543|FG001|Overall Study|Lost to Follow-up|7|||
144714696|NCT00368537|521809545|FG000|Randomization|No study drug dosed|13|||
144714697|NCT00368537|521809546|FG001|Randomization|No study drug dosed|6|||
144714698|NCT00368537|521809545|FG000|Baseline Participants|Lost to Follow-up|16|||
144714699|NCT00368537|521809546|FG001|Baseline Participants|Lost to Follow-up|17|||
144714700|NCT00368537|521809545|FG000|Baseline Participants|Withdrawal by Subject|6|||
144714701|NCT00368537|521809546|FG001|Baseline Participants|Withdrawal by Subject|4|||
144714702|NCT00368537|521809545|FG000|Baseline Participants|Death|1|||
144714703|NCT00368537|521809546|FG001|Baseline Participants|Death|2|||
144714704|NCT00368537|521809545|FG000|Baseline Participants|No susceptibility|1|||
144369686|NCT00724698|520561651|FG000|Overall Study|Lost to Follow-up|36|||
144714705|NCT00368537|521809546|FG001|Baseline Participants|No susceptibility|0|||
144714706|NCT00368537|521809545|FG000|Baseline Participants|Patient uncompliant|0|||
144714707|NCT00368537|521809546|FG001|Baseline Participants|Patient uncompliant|1|||
144714708|NCT02732561|521809562|FG000|Overall Study|Lost to Follow-up|1|||
144714709|NCT02732561|521809563|FG001|Overall Study|Lost to Follow-up|1|||
144369687|NCT00724698|520561651|FG000|Overall Study|No Info|25|||
144482982|NCT01032044|520966560|FG001|Overall Study|Protocol Violation|8|||
144482983|NCT01032044|520966559|FG000|Overall Study|Adverse Event|0|||
144482984|NCT01032044|520966560|FG001|Overall Study|Adverse Event|1|||
144482985|NCT01032044|520966559|FG000|Overall Study|Lost to Follow-up|11|||
144482986|NCT01032044|520966560|FG001|Overall Study|Lost to Follow-up|11|||
144482987|NCT01233609|520966561|FG000|Overall Study|Death|1|||
144482988|NCT01233609|520966562|FG001|Overall Study|Death|0|||
144482989|NCT01233609|520966561|FG000|Overall Study|Lost to Follow-up|3|||
144482990|NCT01233609|520966562|FG001|Overall Study|Lost to Follow-up|1|||
144482991|NCT01233609|520966561|FG000|Overall Study|Adverse Event|2|||
144482992|NCT01233609|520966562|FG001|Overall Study|Adverse Event|1|||
144482993|NCT01233609|520966561|FG000|Overall Study|Withdrawal by Subject|3|||
144482994|NCT01233609|520966562|FG001|Overall Study|Withdrawal by Subject|0|||
144482995|NCT01051063|520966567|FG000|Overall Study|Death|2|||
144482996|NCT01051063|520966568|FG001|Overall Study|Death|2|||
144482997|NCT01051063|520966567|FG000|Overall Study|Withdrawal by Subject|1|||
144482998|NCT01051063|520966568|FG001|Overall Study|Withdrawal by Subject|1|||
144482999|NCT01051063|520966567|FG000|Overall Study|Termination of the study|5|||
144483000|NCT01051063|520966568|FG001|Overall Study|Termination of the study|0|||
144483001|NCT01051063|520966567|FG000|Overall Study|Moved from the study site area|1|||
144483002|NCT01051063|520966568|FG001|Overall Study|Moved from the study site area|0|||
144483003|NCT01051063|520966567|FG000|Overall Study|Other|1|||
144483004|NCT01051063|520966568|FG001|Overall Study|Other|0|||
144483005|NCT01051063|520966567|FG000|Overall Study|Lost to Follow-up|0|||
144483006|NCT01051063|520966568|FG001|Overall Study|Lost to Follow-up|1|||
144483007|NCT03713021|520966569|FG000|Overall Study|Did not have CT sim scan available|6|||
144483008|NCT03713021|520966569|FG000|Overall Study|Not eligible|4|||
144483009|NCT03713021|520966569|FG000|Overall Study|Issues with TraceIT markers|5|||
144483010|NCT05256381|520966570|FG000|Overall Study|Withdrawal by Subject|4|||
144483011|NCT05256381|520966571|FG001|Overall Study|Withdrawal by Subject|0|||
144483012|NCT05256381|520966572|FG002|Overall Study|Withdrawal by Subject|2|||
144483013|NCT05256381|520966573|FG003|Overall Study|Withdrawal by Subject|2|||
144483014|NCT05256381|520966574|FG004|Overall Study|Withdrawal by Subject|8|||
144483015|NCT05256381|520966575|FG005|Overall Study|Withdrawal by Subject|6|||
144483016|NCT05256381|520966570|FG000|Overall Study|Physician Decision|0|||
144483017|NCT05256381|520966571|FG001|Overall Study|Physician Decision|0|||
144483018|NCT05256381|520966572|FG002|Overall Study|Physician Decision|1|||
144483019|NCT05256381|520966573|FG003|Overall Study|Physician Decision|0|||
144483020|NCT05256381|520966574|FG004|Overall Study|Physician Decision|2|||
144483021|NCT05256381|520966575|FG005|Overall Study|Physician Decision|0|||
144483022|NCT05256381|520966570|FG000|Overall Study|Death|17|||
144483023|NCT05256381|520966571|FG001|Overall Study|Death|3|||
144483024|NCT05256381|520966572|FG002|Overall Study|Death|4|||
144483025|NCT05256381|520966573|FG003|Overall Study|Death|5|||
144483026|NCT05256381|520966574|FG004|Overall Study|Death|24|||
144483027|NCT05256381|520966575|FG005|Overall Study|Death|21|||
144483028|NCT05256381|520966570|FG000|Overall Study|Other, not specified|0|||
144483029|NCT05256381|520966571|FG001|Overall Study|Other, not specified|0|||
144483030|NCT05256381|520966572|FG002|Overall Study|Other, not specified|0|||
144483031|NCT05256381|520966573|FG003|Overall Study|Other, not specified|0|||
144483032|NCT05256381|520966574|FG004|Overall Study|Other, not specified|2|||
144483033|NCT05256381|520966575|FG005|Overall Study|Other, not specified|1|||
144483034|NCT05256381|520966570|FG000|Overall Study|Study terminated by sponsor|18|||
144483035|NCT05256381|520966571|FG001|Overall Study|Study terminated by sponsor|5|||
144483036|NCT05256381|520966572|FG002|Overall Study|Study terminated by sponsor|5|||
144483037|NCT05256381|520966573|FG003|Overall Study|Study terminated by sponsor|5|||
144483038|NCT05256381|520966574|FG004|Overall Study|Study terminated by sponsor|18|||
144483039|NCT05256381|520966575|FG005|Overall Study|Study terminated by sponsor|11|||
144483040|NCT05256381|520966570|FG000|Overall Study|Lost to Follow-up|1|||
144483041|NCT05256381|520966571|FG001|Overall Study|Lost to Follow-up|0|||
144483042|NCT05256381|520966572|FG002|Overall Study|Lost to Follow-up|0|||
144483043|NCT05256381|520966573|FG003|Overall Study|Lost to Follow-up|0|||
144483044|NCT05256381|520966574|FG004|Overall Study|Lost to Follow-up|1|||
144483045|NCT05256381|520966575|FG005|Overall Study|Lost to Follow-up|0|||
144483046|NCT06017999|520967461|FG000|Overall Study|Withdrawal by Subject|0|||
144483047|NCT06017999|520967462|FG001|Overall Study|Withdrawal by Subject|4|||
144483048|NCT06017999|520967463|FG002|Overall Study|Withdrawal by Subject|3|||
144483049|NCT06017999|520967461|FG000|Overall Study|Adverse Event|2|||
144483050|NCT06017999|520967462|FG001|Overall Study|Adverse Event|1|||
144483051|NCT06017999|520967463|FG002|Overall Study|Adverse Event|1|||
144483052|NCT06017999|520967461|FG000|Overall Study|Lost to Follow-up|0|||
144483053|NCT06017999|520967462|FG001|Overall Study|Lost to Follow-up|0|||
144483054|NCT06017999|520967463|FG002|Overall Study|Lost to Follow-up|1|||
144483055|NCT06017999|520967461|FG000|Overall Study|Physician Decision|1|||
144483056|NCT06017999|520967462|FG001|Overall Study|Physician Decision|1|||
144483057|NCT06017999|520967463|FG002|Overall Study|Physician Decision|0|||
144483058|NCT06017999|520967461|FG000|Overall Study|Non-Compliance|0|||
144483059|NCT06017999|520967462|FG001|Overall Study|Non-Compliance|0|||
144483060|NCT06017999|520967463|FG002|Overall Study|Non-Compliance|1|||
144483061|NCT06017999|520967461|FG000|Overall Study|Lack of Efficacy|1|||
144483062|NCT06017999|520967462|FG001|Overall Study|Lack of Efficacy|0|||
144483063|NCT06017999|520967463|FG002|Overall Study|Lack of Efficacy|7|||
144483064|NCT06017999|520967461|FG000|Overall Study|COVID Positive|0|||
144483065|NCT06017999|520967462|FG001|Overall Study|COVID Positive|1|||
144483066|NCT06017999|520967463|FG002|Overall Study|COVID Positive|0|||
144483067|NCT06017999|520967461|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
144483068|NCT06017999|520967462|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
144483069|NCT06017999|520967463|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
144483070|NCT04338581|520967464|FG000|Overall Study|Lack of Efficacy|1|||
144483071|NCT04338581|520967465|FG001|Overall Study|Lack of Efficacy|0|||
144483072|NCT04338581|520967464|FG000|Overall Study|Withdrawal by Subject|4|||
144483073|NCT04338581|520967465|FG001|Overall Study|Withdrawal by Subject|4|||
144483074|NCT04338581|520967464|FG000|Overall Study|Prohibited Medication|1|||
144483075|NCT04338581|520967465|FG001|Overall Study|Prohibited Medication|0|||
144483076|NCT01757665|520967466|FG000|Overall Study|Still on Study - Visit Completed|240|||
144483077|NCT01757665|520967467|FG001|Overall Study|Still on Study - Visit Completed|30|||
144483078|NCT01757665|520967466|FG000|Overall Study|Still on Study - Visit Pending|398|||
144483079|NCT01757665|520967467|FG001|Overall Study|Still on Study - Visit Pending|40|||
144483080|NCT01757665|520967466|FG000|Overall Study|Still on Study - Missed Visit|14|||
144483081|NCT01757665|520967467|FG001|Overall Study|Still on Study - Missed Visit|1|||
144483082|NCT01757665|520967466|FG000|Overall Study|Death|25|||
144483083|NCT01757665|520967467|FG001|Overall Study|Death|8|||
144483084|NCT01757665|520967466|FG000|Overall Study|Explant|1|||
144483085|NCT01757665|520967467|FG001|Overall Study|Explant|2|||
144483086|NCT01757665|520967466|FG000|Overall Study|Withdrawal by Subject|10|||
144483087|NCT01757665|520967467|FG001|Overall Study|Withdrawal by Subject|0|||
144483088|NCT01757665|520967466|FG000|Overall Study|Lost to Follow-up|1|||
144483089|NCT01757665|520967467|FG001|Overall Study|Lost to Follow-up|1|||
144483090|NCT01757665|520967466|FG000|Overall Study|Not Implanted with Device|5|||
144483091|NCT01757665|520967467|FG001|Overall Study|Not Implanted with Device|1|||
144483092|NCT02572817|520967472|FG000|Overall Study|Death|6|||
144483093|NCT02572817|520967473|FG001|Overall Study|Death|3|||
144483094|NCT02572817|520967472|FG000|Overall Study|Lost to Follow-up|3|||
144483095|NCT02572817|520967473|FG001|Overall Study|Lost to Follow-up|3|||
144483096|NCT01394250|520967474|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
144483097|NCT01394250|520967475|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
144483098|NCT01394250|520967474|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
144483099|NCT01394250|520967475|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
144483100|NCT02310126|520967476|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
144483101|NCT02310126|520967477|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
144483102|NCT02310126|520967476|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
144483103|NCT02310126|520967477|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
144483104|NCT02222896|520967481|FG000|Abdomen|Did not qualify|34|||
144483105|NCT02222896|520967482|FG001|Abdomen|Did not qualify|10|||
144483106|NCT02222896|520967483|FG002|Abdomen|Did not qualify|32|||
144483107|NCT02222896|520967481|FG000|Groin|Did not qualify|43|||
144483108|NCT02222896|520967482|FG001|Groin|Did not qualify|9|||
144483109|NCT02222896|520967483|FG002|Groin|Did not qualify|40|||
144483110|NCT02441946|520967484|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
144483111|NCT02441946|520967485|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
144483112|NCT02441946|520967486|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
144483113|NCT02441946|520967484|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
144483114|NCT02441946|520967485|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
144483115|NCT02441946|520967486|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
144483116|NCT02441946|520967484|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
144483117|NCT02441946|520967485|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
144483118|NCT02441946|520967486|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
144483119|NCT02441946|520967484|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
144483120|NCT02441946|520967485|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
144483121|NCT02441946|520967486|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
144483122|NCT02441946|520967484|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
144483123|NCT02441946|520967485|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
144483124|NCT02441946|520967486|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
144483125|NCT02441946|520967484|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
144483126|NCT02441946|520967485|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
144483127|NCT02441946|520967486|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
144483128|NCT02441946|520967484|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
144483129|NCT02441946|520967485|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
144483130|NCT02441946|520967486|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
144483131|NCT02441946|520967484|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
144483132|NCT02441946|520967485|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
144483133|NCT02441946|520967486|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
144483134|NCT02441946|520967484|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
144483135|NCT02441946|520967485|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
144483136|NCT02441946|520967486|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
144483137|NCT02441946|520967484|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
144483138|NCT02441946|520967485|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
144483139|NCT02441946|520967486|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
144483140|NCT02441946|520967484|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
144483141|NCT02441946|520967485|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144483142|NCT02441946|520967486|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144483143|NCT04267614|520967487|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
144483144|NCT04267614|520967487|FG000|Overall Study|Lost to Follow-up|115|||
144714710|NCT02732561|521809562|FG000|Overall Study|Withdrawal by Subject|1|||
144714711|NCT02732561|521809563|FG001|Overall Study|Withdrawal by Subject|0|||
144714712|NCT01886300|521809564|FG000|Overall Study|Trial terminated by sponsor|16|||
144714713|NCT02622074|521809565|FG000|Overall Study|Death|4|||
144714714|NCT02622074|521809566|FG001|Overall Study|Death|0|||
144714715|NCT02622074|521809567|FG002|Overall Study|Death|0|||
144714716|NCT02622074|521809568|FG003|Overall Study|Death|1|||
144714717|NCT02622074|521809569|FG004|Overall Study|Death|1|||
144714718|NCT02622074|521809570|FG005|Overall Study|Death|0|||
144714719|NCT02622074|521809565|FG000|Overall Study|Withdrawal by Subject|0|||
144714720|NCT02622074|521809566|FG001|Overall Study|Withdrawal by Subject|1|||
144714721|NCT02622074|521809567|FG002|Overall Study|Withdrawal by Subject|0|||
144714722|NCT02622074|521809568|FG003|Overall Study|Withdrawal by Subject|0|||
144483145|NCT00786474|520967494|FG000|Overall Study|Death|5|||
144483146|NCT00786474|520967495|FG001|Overall Study|Death|4|||
144714723|NCT02622074|521809569|FG004|Overall Study|Withdrawal by Subject|0|||
144714724|NCT02622074|521809570|FG005|Overall Study|Withdrawal by Subject|0|||
144483147|NCT00786474|520967494|FG000|Overall Study|Withdrawal by Subject|23|||
144369688|NCT04041414|520561654|FG000|Overall Study|Lost to Follow-up|1|||
144369689|NCT04041414|520561655|FG001|Overall Study|Lost to Follow-up|2|||
144369690|NCT02177032|520561656|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
144483148|NCT00786474|520967495|FG001|Overall Study|Withdrawal by Subject|31|||
144483149|NCT00786474|520967494|FG000|Overall Study|Lost to Follow-up|3|||
144483150|NCT00786474|520967495|FG001|Overall Study|Lost to Follow-up|3|||
144483151|NCT00786474|520967494|FG000|Overall Study|Physician Decision|2|||
144483152|NCT00786474|520967495|FG001|Overall Study|Physician Decision|1|||
144483153|NCT00786474|520967494|FG000|Overall Study|Other|4|||
144483154|NCT00786474|520967495|FG001|Overall Study|Other|4|||
144483155|NCT01868074|520967496|FG000|Overall Study|Lost to Follow-up|3|||
144483156|NCT01868074|520967497|FG001|Overall Study|Lost to Follow-up|2|||
144483157|NCT01868074|520967496|FG000|Overall Study|Withdrawal by Subject|4|||
144483158|NCT01868074|520967497|FG001|Overall Study|Withdrawal by Subject|2|||
144483159|NCT03904693|520967499|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
144483160|NCT03904693|520967500|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
144483161|NCT03904693|520967501|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
144483162|NCT03904693|520967502|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
144483163|NCT03904693|520967503|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
144483164|NCT03904693|520967504|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
144483165|NCT03904693|520967499|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144483166|NCT03904693|520967500|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144483167|NCT03904693|520967501|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
144483168|NCT03904693|520967502|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144483169|NCT03904693|520967503|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144483170|NCT03904693|520967504|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144483171|NCT03904693|520967499|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
144483172|NCT03904693|520967500|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
144483173|NCT03904693|520967501|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
144483174|NCT03904693|520967502|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
144483175|NCT03904693|520967503|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
144483176|NCT03904693|520967504|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
144483177|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
144483178|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
144483179|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
144538221|NCT00146172|521174126|FG004|Overall Study|Physician Decision|0|||
144369691|NCT02177032|520561657|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
144369692|NCT02177032|520561658|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
144369693|NCT02177032|520561659|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
144483180|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
144483181|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
144483182|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
144483183|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
144483184|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
144483185|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
144483186|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
144483187|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
144483188|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
144483189|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
144483190|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
144483191|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
144483192|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
144483193|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
144483194|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
144483195|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
144483196|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
144483197|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
144483198|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
144483199|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
144483200|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
144483201|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
144483202|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
144483203|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
144483204|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
144483205|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
144483206|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
144483207|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
144483208|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
144483209|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
144483210|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
144483211|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
144483212|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
144483213|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
144483214|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
144483215|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
144483216|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
144483217|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
144483218|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
144483219|NCT03904693|520967499|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
144483220|NCT03904693|520967500|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
144483221|NCT03904693|520967501|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
144483222|NCT03904693|520967502|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
144483223|NCT03904693|520967503|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
144483224|NCT03904693|520967504|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
144483225|NCT04175912|520967505|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
144483226|NCT04175912|520967506|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
144483227|NCT04175912|520967505|FG000|Overall Study|Adverse Event|0|||
144483228|NCT04175912|520967506|FG001|Overall Study|Adverse Event|3|||
144483229|NCT04175912|520967505|FG000|Overall Study|Never started treatment|3|||
144483230|NCT04175912|520967506|FG001|Overall Study|Never started treatment|3|||
144483231|NCT04175912|520967505|FG000|Overall Study|Death|0|||
144483232|NCT04175912|520967506|FG001|Overall Study|Death|1|||
144483233|NCT06390826|520967507|FG000|Overall Study|Never Start Protocol Therapy|1|||
144483234|NCT06390826|520967507|FG000|Overall Study|Adverse Event|1|||
144483235|NCT06390826|520967507|FG000|Overall Study|Disease Progression|8|||
144483236|NCT02303626|520967510|FG000|Overall Study|Lack of Efficacy|1|||
144483237|NCT02303626|520967511|FG001|Overall Study|Lack of Efficacy|0|||
144483238|NCT02303626|520967512|FG002|Overall Study|Lack of Efficacy|1|||
144483239|NCT02303626|520967510|FG000|Overall Study|Adverse Event|0|||
144483240|NCT02303626|520967511|FG001|Overall Study|Adverse Event|2|||
144483241|NCT02303626|520967512|FG002|Overall Study|Adverse Event|0|||
144483242|NCT02303626|520967510|FG000|Overall Study|Protocol Violation|0|||
144483243|NCT02303626|520967511|FG001|Overall Study|Protocol Violation|1|||
144483244|NCT02303626|520967512|FG002|Overall Study|Protocol Violation|0|||
144483245|NCT02303626|520967510|FG000|Overall Study|Pregnancy|0|||
144483246|NCT02303626|520967511|FG001|Overall Study|Pregnancy|0|||
144483247|NCT02303626|520967512|FG002|Overall Study|Pregnancy|1|||
144483248|NCT02303626|520967510|FG000|Overall Study|Subject Non-Compliance|0|||
144483249|NCT02303626|520967511|FG001|Overall Study|Subject Non-Compliance|0|||
144483250|NCT02303626|520967512|FG002|Overall Study|Subject Non-Compliance|1|||
144483251|NCT03698019|520967513|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
144483252|NCT03698019|520967514|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
144483253|NCT03698019|520967513|FG000|Step 1: Registration|Withdrawal by Subject|7|||
144483254|NCT03698019|520967514|FG001|Step 1: Registration|Withdrawal by Subject|2|||
144483255|NCT03698019|520967513|FG000|Step 1: Registration|Toxicity|0|||
144483256|NCT03698019|520967514|FG001|Step 1: Registration|Toxicity|1|||
144483257|NCT03698019|520967513|FG000|Step 1: Registration|Disease Progression|0|||
144483258|NCT03698019|520967514|FG001|Step 1: Registration|Disease Progression|12|||
144483259|NCT03698019|520967513|FG000|Step 1: Registration|Co-morbidities|0|||
144483260|NCT03698019|520967514|FG001|Step 1: Registration|Co-morbidities|1|||
144483261|NCT03698019|520967513|FG000|Step 1: Registration|Scheduling Issues|1|||
144483262|NCT03698019|520967514|FG001|Step 1: Registration|Scheduling Issues|0|||
144483263|NCT03698019|520967513|FG000|Step 1: Registration|Participant Refusal|0|||
144483264|NCT03698019|520967514|FG001|Step 1: Registration|Participant Refusal|1|||
144483265|NCT03698019|520967513|FG000|Step 2: Surgery|Participant Refusal|2|||
144483266|NCT03698019|520967514|FG001|Step 2: Surgery|Participant Refusal|1|||
144483267|NCT03698019|520967513|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
144483268|NCT03698019|520967514|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
144483269|NCT03698019|520967513|FG000|Step 2: Surgery|Metastatic Disease|16|||
144483270|NCT03698019|520967514|FG001|Step 2: Surgery|Metastatic Disease|9|||
144483271|NCT03698019|520967513|FG000|Step 2: Surgery|Residual Disease|2|||
144483272|NCT03698019|520967514|FG001|Step 2: Surgery|Residual Disease|1|||
144483273|NCT03698019|520967513|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
144483274|NCT03698019|520967514|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
144483275|NCT03698019|520967513|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
144483276|NCT03698019|520967514|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
144483277|NCT03698019|520967513|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
144483278|NCT03698019|520967514|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
144483279|NCT03698019|520967513|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
144483280|NCT03698019|520967514|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
144483281|NCT03698019|520967513|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
144483282|NCT03698019|520967514|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
144483283|NCT03698019|520967513|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
144483284|NCT03698019|520967514|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
144483285|NCT03698019|520967513|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
144483286|NCT03698019|520967514|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
144483287|NCT03698019|520967513|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
144483288|NCT03698019|520967514|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
144483289|NCT03915951|520967515|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
144483290|NCT03915951|520967516|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
144483291|NCT03915951|520967515|FG000|Overall Study|Adverse Event|12|||
144483292|NCT03915951|520967516|FG001|Overall Study|Adverse Event|6|||
144483293|NCT03915951|520967515|FG000|Overall Study|Disease progression (radiological)|17|||
144483294|NCT03915951|520967516|FG001|Overall Study|Disease progression (radiological)|15|||
144483295|NCT03915951|520967515|FG000|Overall Study|Disease progression (clinical)|4|||
144483296|NCT03915951|520967516|FG001|Overall Study|Disease progression (clinical)|1|||
144483297|NCT03915951|520967515|FG000|Overall Study|Patient decision|0|||
144483298|NCT03915951|520967516|FG001|Overall Study|Patient decision|4|||
144483299|NCT03915951|520967515|FG000|Overall Study|Investigator decision|0|||
144483300|NCT03915951|520967516|FG001|Overall Study|Investigator decision|1|||
144483301|NCT03915951|520967515|FG000|Overall Study|Consent withdrawn|1|||
144483302|NCT03915951|520967516|FG001|Overall Study|Consent withdrawn|1|||
144483303|NCT03915951|520967515|FG000|Overall Study|Death|0|||
144483304|NCT03915951|520967516|FG001|Overall Study|Death|3|||
144483305|NCT05832437|520967517|FG000|Overall Study|time off work|1|||
144483306|NCT05832437|520967518|FG001|Overall Study|time off work|0|||
144483307|NCT05832437|520967519|FG002|Overall Study|time off work|0|||
144483308|NCT05832437|520967520|FG003|Overall Study|time off work|0|||
144483309|NCT05376371|520967521|FG000|Overall Study|change in release date|10|||
144483310|NCT05407311|520967522|FG000|Overall Study|Withdrawal by Subject|5|||
144483311|NCT05407311|520967522|FG000|Overall Study|Protocol Violation|3|||
144483312|NCT05407311|520967522|FG000|Overall Study|Physician Decision|1|||
144483313|NCT05407311|520967522|FG000|Overall Study|Non-compliance|1|||
144483314|NCT03797326|520967527|FG000|Overall Study|Lost to Follow-up|1|||
144483315|NCT03797326|520967528|FG001|Overall Study|Lost to Follow-up|0|||
144483316|NCT03797326|520967529|FG002|Overall Study|Lost to Follow-up|0|||
144483317|NCT03797326|520967530|FG003|Overall Study|Lost to Follow-up|1|||
144483318|NCT03797326|520967531|FG004|Overall Study|Lost to Follow-up|0|||
144483319|NCT03797326|520967532|FG005|Overall Study|Lost to Follow-up|0|||
144483320|NCT03797326|520967533|FG006|Overall Study|Lost to Follow-up|0|||
144483321|NCT03797326|520967534|FG007|Overall Study|Lost to Follow-up|0|||
144483322|NCT03797326|520967527|FG000|Overall Study|Withdrawal by Subject|0|||
144483323|NCT03797326|520967528|FG001|Overall Study|Withdrawal by Subject|0|||
144483324|NCT03797326|520967529|FG002|Overall Study|Withdrawal by Subject|1|||
144483325|NCT03797326|520967530|FG003|Overall Study|Withdrawal by Subject|3|||
144483326|NCT03797326|520967531|FG004|Overall Study|Withdrawal by Subject|0|||
144483327|NCT03797326|520967532|FG005|Overall Study|Withdrawal by Subject|2|||
144483328|NCT03797326|520967533|FG006|Overall Study|Withdrawal by Subject|2|||
144483329|NCT03797326|520967534|FG007|Overall Study|Withdrawal by Subject|3|||
144483330|NCT03797326|520967527|FG000|Overall Study|Sponsor Decision|3|||
144483331|NCT03797326|520967528|FG001|Overall Study|Sponsor Decision|3|||
144483332|NCT03797326|520967529|FG002|Overall Study|Sponsor Decision|3|||
144483333|NCT03797326|520967530|FG003|Overall Study|Sponsor Decision|6|||
144483334|NCT03797326|520967531|FG004|Overall Study|Sponsor Decision|0|||
144483335|NCT03797326|520967532|FG005|Overall Study|Sponsor Decision|3|||
144483336|NCT03797326|520967533|FG006|Overall Study|Sponsor Decision|3|||
144483337|NCT03797326|520967534|FG007|Overall Study|Sponsor Decision|2|||
144483338|NCT03797326|520967527|FG000|Overall Study|Death|27|||
144483339|NCT03797326|520967528|FG001|Overall Study|Death|28|||
144483340|NCT03797326|520967529|FG002|Overall Study|Death|95|||
144483341|NCT03797326|520967530|FG003|Overall Study|Death|95|||
144483342|NCT03797326|520967531|FG004|Overall Study|Death|30|||
144483343|NCT03797326|520967532|FG005|Overall Study|Death|96|||
144483344|NCT03797326|520967533|FG006|Overall Study|Death|97|||
144483345|NCT03797326|520967534|FG007|Overall Study|Death|98|||
144483346|NCT03797326|520967527|FG000|Overall Study|Enrolled in error|0|||
144483347|NCT03797326|520967528|FG001|Overall Study|Enrolled in error|0|||
144483348|NCT03797326|520967529|FG002|Overall Study|Enrolled in error|3|||
144483349|NCT03797326|520967530|FG003|Overall Study|Enrolled in error|2|||
144483350|NCT03797326|520967531|FG004|Overall Study|Enrolled in error|2|||
144483351|NCT03797326|520967532|FG005|Overall Study|Enrolled in error|1|||
144483352|NCT03797326|520967533|FG006|Overall Study|Enrolled in error|1|||
144483353|NCT03797326|520967534|FG007|Overall Study|Enrolled in error|0|||
144483354|NCT00127413|520967535|FG000|Overall Study|Lost to Follow-up|6|||
144483355|NCT00127413|520967536|FG001|Overall Study|Lost to Follow-up|4|||
144483356|NCT00127413|520967537|FG002|Overall Study|Lost to Follow-up|8|||
144483357|NCT00127413|520967538|FG003|Overall Study|Lost to Follow-up|2|||
144483358|NCT04213989|520968178|FG000|Overall Study|Withdrawal by Subject|3|||
144483359|NCT04213989|520968179|FG001|Overall Study|Withdrawal by Subject|2|||
144483360|NCT04213989|520968178|FG000|Overall Study|Physician Decision|1|||
144483361|NCT04213989|520968179|FG001|Overall Study|Physician Decision|0|||
144483362|NCT04213989|520968178|FG000|Overall Study|Lost to Follow-up|0|||
144483363|NCT04213989|520968179|FG001|Overall Study|Lost to Follow-up|4|||
144483364|NCT01327547|520968180|FG000|Overall Study|Adverse Event|4|||
144483365|NCT01327547|520968181|FG001|Overall Study|Adverse Event|1|||
144483366|NCT01327547|520968180|FG000|Overall Study|Death|1|||
144483367|NCT01327547|520968181|FG001|Overall Study|Death|2|||
144483368|NCT01327547|520968180|FG000|Overall Study|Lost to Follow-up|6|||
144483369|NCT01327547|520968181|FG001|Overall Study|Lost to Follow-up|6|||
144483370|NCT01327547|520968180|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
144483371|NCT01327547|520968181|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
144483372|NCT01327547|520968180|FG000|Overall Study|Withdrawal by Subject|3|||
144483373|NCT01327547|520968181|FG001|Overall Study|Withdrawal by Subject|7|||
144483374|NCT01327547|520968180|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
144483375|NCT01327547|520968181|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
144483376|NCT01327547|520968180|FG000|Overall Study|Protocol Violation|1|||
144483377|NCT01327547|520968181|FG001|Overall Study|Protocol Violation|0|||
144483378|NCT01327547|520968180|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
144483379|NCT01327547|520968181|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
144483380|NCT01327547|520968180|FG000|Overall Study|Required prohibited medication|2|||
144483381|NCT01327547|520968181|FG001|Overall Study|Required prohibited medication|0|||
144483382|NCT01327547|520968180|FG000|Overall Study|Non-compliance with study procedures|1|||
144483383|NCT01327547|520968181|FG001|Overall Study|Non-compliance with study procedures|0|||
144483384|NCT01327547|520968180|FG000|Overall Study|By investigator in subject's interest|0|||
144483385|NCT01327547|520968181|FG001|Overall Study|By investigator in subject's interest|1|||
144483386|NCT02930122|520968185|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
144483387|NCT02930122|520968186|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
144483388|NCT03390036|520968189|FG000|Overall Study|Lost to Follow-up|1|||
144483389|NCT03390036|520968190|FG001|Overall Study|Lost to Follow-up|0|||
144483390|NCT03390036|520968191|FG002|Overall Study|Lost to Follow-up|0|||
144483391|NCT03390036|520968189|FG000|Overall Study|Lack of Efficacy|1|||
144483392|NCT03390036|520968190|FG001|Overall Study|Lack of Efficacy|0|||
144483393|NCT03390036|520968191|FG002|Overall Study|Lack of Efficacy|0|||
144483394|NCT00744237|520968194|FG000|Overall Study|Lack of Efficacy|1|||
144483395|NCT00744237|520968195|FG001|Overall Study|Lack of Efficacy|1|||
144483396|NCT00744237|520968196|FG002|Overall Study|Lack of Efficacy|0|||
144483397|NCT00744237|520968194|FG000|Overall Study|Withdrawal by Subject|9|||
144483398|NCT00744237|520968195|FG001|Overall Study|Withdrawal by Subject|5|||
144483399|NCT00744237|520968196|FG002|Overall Study|Withdrawal by Subject|3|||
144483400|NCT00744237|520968194|FG000|Overall Study|Lost to Follow-up|1|||
144483401|NCT00744237|520968195|FG001|Overall Study|Lost to Follow-up|1|||
144483402|NCT00744237|520968196|FG002|Overall Study|Lost to Follow-up|1|||
144483403|NCT00744237|520968194|FG000|Overall Study|Protocol Violation|3|||
144483404|NCT00744237|520968195|FG001|Overall Study|Protocol Violation|4|||
144483405|NCT00744237|520968196|FG002|Overall Study|Protocol Violation|3|||
144483406|NCT00744237|520968194|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
144483407|NCT00744237|520968195|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
144483408|NCT00744237|520968196|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
144483409|NCT00744237|520968194|FG000|Overall Study|Dosing Error|1|||
144483410|NCT00744237|520968195|FG001|Overall Study|Dosing Error|0|||
144483411|NCT00744237|520968196|FG002|Overall Study|Dosing Error|1|||
144483412|NCT00744237|520968194|FG000|Overall Study|Study Drug Error|1|||
144483413|NCT00744237|520968195|FG001|Overall Study|Study Drug Error|0|||
144483414|NCT00744237|520968196|FG002|Overall Study|Study Drug Error|0|||
144483415|NCT00744237|520968194|FG000|Overall Study|Prohibited Concomitant Medication|0|||
144483416|NCT00744237|520968195|FG001|Overall Study|Prohibited Concomitant Medication|0|||
144483417|NCT00744237|520968196|FG002|Overall Study|Prohibited Concomitant Medication|1|||
144483418|NCT00744237|520968194|FG000|Overall Study|Poor Compliance|0|||
144483419|NCT00744237|520968195|FG001|Overall Study|Poor Compliance|2|||
144483420|NCT00744237|520968196|FG002|Overall Study|Poor Compliance|0|||
144483421|NCT00744237|520968194|FG000|Overall Study|Administrative. Site Closed|1|||
144483422|NCT00744237|520968195|FG001|Overall Study|Administrative. Site Closed|1|||
144483423|NCT00744237|520968196|FG002|Overall Study|Administrative. Site Closed|1|||
144483424|NCT00744237|520968194|FG000|Overall Study|Adverse Event|9|||
144483425|NCT00744237|520968195|FG001|Overall Study|Adverse Event|13|||
144483426|NCT00744237|520968196|FG002|Overall Study|Adverse Event|5|||
144483427|NCT02091869|520968199|FG000|Overall Study|Withdrawal by Subject|0|||
144483428|NCT02091869|520968200|FG001|Overall Study|Withdrawal by Subject|3|||
144483429|NCT01375959|520968205|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
144483430|NCT01375959|520968206|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
144483431|NCT01375959|520968205|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
144483432|NCT01375959|520968206|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
144483433|NCT01375959|520968205|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
144483434|NCT01375959|520968206|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
144483435|NCT02771210|520968207|FG000|Period 1|Adverse Event|5|||
144483436|NCT02771210|520968208|FG001|Period 1|Adverse Event|3|||
144483437|NCT02771210|520968207|FG000|Period 1|Lack of Efficacy|3|||
144483438|NCT02771210|520968208|FG001|Period 1|Lack of Efficacy|6|||
144483439|NCT02771210|520968207|FG000|Period 1|Lost to Follow-up|2|||
144483440|NCT02771210|520968208|FG001|Period 1|Lost to Follow-up|0|||
144369694|NCT02177032|520561656|FG000|Overall Study|Lost to Follow-up|0|||
144483441|NCT02771210|520968207|FG000|Period 1|Physician Decision|0|||
144483442|NCT02771210|520968208|FG001|Period 1|Physician Decision|1|||
144483443|NCT02771210|520968207|FG000|Period 1|Withdrawal by Subject|0|||
144483444|NCT02771210|520968208|FG001|Period 1|Withdrawal by Subject|3|||
144483445|NCT02771210|520968207|FG000|Period 1|Withdrawal of informed consent|1|||
144483446|NCT02771210|520968208|FG001|Period 1|Withdrawal of informed consent|5|||
144483447|NCT02771210|520968207|FG000|Period 2|Adverse Event|1|||
144483448|NCT02771210|520968208|FG001|Period 2|Adverse Event|0|||
144483449|NCT02771210|520968207|FG000|Period 2|Lack of Efficacy|0|||
144483450|NCT02771210|520968208|FG001|Period 2|Lack of Efficacy|1|||
144483451|NCT02771210|520968207|FG000|Period 2|Withdrawal by Subject|1|||
144483452|NCT02771210|520968208|FG001|Period 2|Withdrawal by Subject|0|||
144483453|NCT02771210|520968207|FG000|Period 2|Withdrawal of informed consent|0|||
144483454|NCT02771210|520968208|FG001|Period 2|Withdrawal of informed consent|2|||
144483455|NCT04422639|520968215|FG000|Overall Study|Death|1|||
144483456|NCT04422639|520968216|FG001|Overall Study|Death|0|||
144483457|NCT04422639|520968215|FG000|Overall Study|study closed prior to completion of FU visits|0|||
144483458|NCT04422639|520968216|FG001|Overall Study|study closed prior to completion of FU visits|2|||
144483459|NCT01964521|520968217|FG000|Overall Study|Lost to Follow-up|4|||
144483460|NCT01551303|520968223|FG000|Overall Study|failed awareness check on vision test|4|||
144483461|NCT01551303|520968224|FG001|Overall Study|failed awareness check on vision test|7|||
144483462|NCT02878213|520968225|FG000|Overall Study|Withdrawal by Subject|2|||
144483463|NCT02878213|520968225|FG000|Overall Study|Adverse Event|1|||
144483464|NCT04908449|520968226|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
144483465|NCT04908449|520968227|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
144483466|NCT04908449|520968226|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
144483467|NCT04908449|520968227|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
144483468|NCT00147225|520968228|FG000|Overall Study|Withdrawal by Subject|1|||
144483469|NCT00147225|520968229|FG001|Overall Study|Withdrawal by Subject|0|||
144483470|NCT00147225|520968230|FG002|Overall Study|Withdrawal by Subject|1|||
144483471|NCT00147225|520968231|FG003|Overall Study|Withdrawal by Subject|0|||
144483472|NCT00147225|520968232|FG004|Overall Study|Withdrawal by Subject|0|||
144483473|NCT00147225|520968233|FG005|Overall Study|Withdrawal by Subject|1|||
144483474|NCT00147225|520968228|FG000|Overall Study|Adverse Event|0|||
144483475|NCT00147225|520968229|FG001|Overall Study|Adverse Event|0|||
144483476|NCT00147225|520968230|FG002|Overall Study|Adverse Event|1|||
144483477|NCT00147225|520968231|FG003|Overall Study|Adverse Event|1|||
144483478|NCT00147225|520968232|FG004|Overall Study|Adverse Event|0|||
144483479|NCT00147225|520968233|FG005|Overall Study|Adverse Event|0|||
144483480|NCT00147225|520968228|FG000|Overall Study|Screen Failure|0|||
144483481|NCT00147225|520968229|FG001|Overall Study|Screen Failure|0|||
144483482|NCT00147225|520968230|FG002|Overall Study|Screen Failure|0|||
144483483|NCT00147225|520968231|FG003|Overall Study|Screen Failure|0|||
144483484|NCT00147225|520968232|FG004|Overall Study|Screen Failure|1|||
144483485|NCT00147225|520968233|FG005|Overall Study|Screen Failure|0|||
144483486|NCT00147225|520968228|FG000|Overall Study|Chemotherapy Changed|0|||
144483487|NCT00147225|520968229|FG001|Overall Study|Chemotherapy Changed|0|||
144483488|NCT00147225|520968230|FG002|Overall Study|Chemotherapy Changed|0|||
144483489|NCT00147225|520968231|FG003|Overall Study|Chemotherapy Changed|0|||
144483490|NCT00147225|520968232|FG004|Overall Study|Chemotherapy Changed|0|||
144483491|NCT00147225|520968233|FG005|Overall Study|Chemotherapy Changed|1|||
144483492|NCT01567865|520968234|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
144483493|NCT01567865|520968235|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
144483494|NCT01567865|520968236|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
144483495|NCT01567865|520968237|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
144483496|NCT01567865|520968234|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
144483497|NCT01567865|520968235|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
144483498|NCT01567865|520968236|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
144483499|NCT01567865|520968237|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
144483500|NCT02023879|520968238|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
144483501|NCT02023879|520968239|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
144483502|NCT02023879|520968240|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
144483503|NCT02023879|520968238|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
144483504|NCT02023879|520968239|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
144483505|NCT02023879|520968240|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
144483506|NCT02023879|520968238|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
144483507|NCT02023879|520968239|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
144483508|NCT02023879|520968240|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
144483509|NCT02023879|520968238|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
144483510|NCT02023879|520968239|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
144483511|NCT02023879|520968240|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
144483512|NCT02023879|520968238|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
144483513|NCT02023879|520968239|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
144483514|NCT02023879|520968240|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
144483515|NCT02023879|520968238|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
144483516|NCT02023879|520968239|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
144483517|NCT02023879|520968240|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
144483518|NCT02023879|520968238|FG000|Extension Open Label Treatment|Adverse Event|1|||
144483519|NCT02023879|520968239|FG001|Extension Open Label Treatment|Adverse Event|7|||
144483520|NCT02023879|520968240|FG002|Extension Open Label Treatment|Adverse Event|3|||
144483521|NCT02023879|520968238|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
144483522|NCT02023879|520968239|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
144483523|NCT02023879|520968240|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
144483524|NCT02023879|520968238|FG000|Extension Open Label Treatment|Participant moved|1|||
144483525|NCT02023879|520968239|FG001|Extension Open Label Treatment|Participant moved|2|||
144483526|NCT02023879|520968240|FG002|Extension Open Label Treatment|Participant moved|0|||
144483527|NCT02023879|520968238|FG000|Extension Open Label Treatment|Other than specified above|2|||
144483528|NCT02023879|520968239|FG001|Extension Open Label Treatment|Other than specified above|7|||
144483529|NCT02023879|520968240|FG002|Extension Open Label Treatment|Other than specified above|2|||
144483530|NCT06385483|520968241|FG000|Overall Study|Withdrawal by Subject|2|||
144483531|NCT06385483|520968241|FG000|Overall Study|Never start protocol therapy|2|||
144483532|NCT06385483|520968241|FG000|Overall Study|Disease progression|15|||
144483533|NCT05569954|520968242|FG000|Overall Study|Lost to Follow-up|3|||
144483534|NCT05569954|520968243|FG001|Overall Study|Lost to Follow-up|4|||
144483535|NCT05569954|520968242|FG000|Overall Study|Protocol Violation|1|||
144483536|NCT05569954|520968243|FG001|Overall Study|Protocol Violation|2|||
144483537|NCT05569954|520968242|FG000|Overall Study|Withdrawal by Subject|4|||
144483538|NCT05569954|520968243|FG001|Overall Study|Withdrawal by Subject|2|||
144483539|NCT01040780|520970393|FG000|Overall Study|Protocol Violation|1|||
144483540|NCT01040780|520970394|FG001|Overall Study|Protocol Violation|3|||
144483541|NCT03864926|520970397|FG000|Overall Study|Death|0|||
144483542|NCT03864926|520970398|FG001|Overall Study|Death|2|||
144483543|NCT00445601|520970399|FG000|Overall Study|Withdrawal by Subject|11|||
144483544|NCT00445601|520970400|FG001|Overall Study|Withdrawal by Subject|11|||
144483545|NCT00445601|520970399|FG000|Overall Study|TURBT Complication|12|||
144483546|NCT00445601|520970400|FG001|Overall Study|TURBT Complication|8|||
144483547|NCT00445601|520970399|FG000|Overall Study|Incorrect Disease Status|6|||
144483548|NCT00445601|520970400|FG001|Overall Study|Incorrect Disease Status|6|||
144483549|NCT00445601|520970399|FG000|Overall Study|Drug Delivery Issue|2|||
144483550|NCT00445601|520970400|FG001|Overall Study|Drug Delivery Issue|2|||
144483551|NCT00445601|520970399|FG000|Overall Study|Adverse Event|2|||
144483552|NCT00445601|520970400|FG001|Overall Study|Adverse Event|0|||
144483553|NCT00445601|520970399|FG000|Overall Study|Death prior to TURBT|0|||
144483554|NCT00445601|520970400|FG001|Overall Study|Death prior to TURBT|1|||
144483555|NCT01091428|520970401|FG000|Phase 1|Progressive Disease|24|||
144483556|NCT01091428|520970402|FG001|Phase 1|Progressive Disease|8|||
144483557|NCT01091428|520970403|FG002|Phase 1|Progressive Disease|0|||
144483558|NCT01091428|520970404|FG003|Phase 1|Progressive Disease|0|||
144483559|NCT01091428|520970401|FG000|Phase 1|Symptomatic Deterioration|3|||
144483560|NCT01091428|520970402|FG001|Phase 1|Symptomatic Deterioration|2|||
144483561|NCT01091428|520970403|FG002|Phase 1|Symptomatic Deterioration|0|||
144483562|NCT01091428|520970404|FG003|Phase 1|Symptomatic Deterioration|0|||
144483563|NCT01091428|520970401|FG000|Phase 1|Adverse Event|2|||
144483564|NCT01091428|520970402|FG001|Phase 1|Adverse Event|0|||
144483565|NCT01091428|520970403|FG002|Phase 1|Adverse Event|0|||
144483566|NCT01091428|520970404|FG003|Phase 1|Adverse Event|0|||
144483567|NCT01091428|520970401|FG000|Phase 1|Withdrawal by Subject|7|||
144483568|NCT01091428|520970402|FG001|Phase 1|Withdrawal by Subject|0|||
144483569|NCT01091428|520970403|FG002|Phase 1|Withdrawal by Subject|0|||
144483570|NCT01091428|520970404|FG003|Phase 1|Withdrawal by Subject|0|||
144483571|NCT01091428|520970401|FG000|Phase 1|Reason not specified|0|||
144483572|NCT01091428|520970402|FG001|Phase 1|Reason not specified|1|||
144483573|NCT01091428|520970403|FG002|Phase 1|Reason not specified|0|||
144483574|NCT01091428|520970404|FG003|Phase 1|Reason not specified|0|||
144483575|NCT01091428|520970401|FG000|Phase 1|Single-Patient IND|2|||
144483576|NCT01091428|520970402|FG001|Phase 1|Single-Patient IND|0|||
144483577|NCT01091428|520970403|FG002|Phase 1|Single-Patient IND|0|||
144483578|NCT01091428|520970404|FG003|Phase 1|Single-Patient IND|0|||
144483579|NCT01091428|520970401|FG000|Phase 2|Progressive Disease|0|||
144483580|NCT01091428|520970402|FG001|Phase 2|Progressive Disease|0|||
144483581|NCT01091428|520970403|FG002|Phase 2|Progressive Disease|44|||
144483582|NCT01091428|520970404|FG003|Phase 2|Progressive Disease|46|||
144483583|NCT01091428|520970401|FG000|Phase 2|Symptomatic Deterioration|0|||
144483584|NCT01091428|520970402|FG001|Phase 2|Symptomatic Deterioration|0|||
144483585|NCT01091428|520970403|FG002|Phase 2|Symptomatic Deterioration|1|||
144483586|NCT01091428|520970404|FG003|Phase 2|Symptomatic Deterioration|6|||
144483587|NCT01091428|520970401|FG000|Phase 2|Adverse Event|0|||
144483588|NCT01091428|520970402|FG001|Phase 2|Adverse Event|0|||
144483589|NCT01091428|520970403|FG002|Phase 2|Adverse Event|12|||
144483590|NCT01091428|520970404|FG003|Phase 2|Adverse Event|5|||
144483591|NCT01091428|520970401|FG000|Phase 2|Withdrawal by Subject|0|||
144483592|NCT01091428|520970402|FG001|Phase 2|Withdrawal by Subject|0|||
144483593|NCT01091428|520970403|FG002|Phase 2|Withdrawal by Subject|9|||
144483594|NCT01091428|520970404|FG003|Phase 2|Withdrawal by Subject|8|||
144483595|NCT01091428|520970401|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
144483596|NCT01091428|520970402|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
144483597|NCT01091428|520970403|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
144483598|NCT01091428|520970404|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
144483599|NCT01091428|520970401|FG000|Phase 2|Reason not specified|0|||
144483600|NCT01091428|520970402|FG001|Phase 2|Reason not specified|0|||
144483601|NCT01091428|520970403|FG002|Phase 2|Reason not specified|4|||
144483602|NCT01091428|520970404|FG003|Phase 2|Reason not specified|3|||
144483603|NCT01091428|520970401|FG000|Phase 2|Physician Decision|0|||
144483604|NCT01091428|520970402|FG001|Phase 2|Physician Decision|0|||
144483605|NCT01091428|520970403|FG002|Phase 2|Physician Decision|2|||
144483606|NCT01091428|520970404|FG003|Phase 2|Physician Decision|0|||
144483607|NCT02959138|520970411|FG000|Overall Study|Enrolled but Never Treated|0|||
144483608|NCT02959138|520970412|FG001|Overall Study|Enrolled but Never Treated|1|||
144483609|NCT02959138|520970413|FG002|Overall Study|Enrolled but Never Treated|0|||
144483610|NCT02391038|520970414|FG000|Overall Study|Progressive disease|3|||
144483611|NCT02391038|520970415|FG001|Overall Study|Progressive disease|3|||
144483612|NCT02391038|520970416|FG002|Overall Study|Progressive disease|6|||
144483613|NCT00329719|520970422|FG000|Overall Study|Lost to Follow-up|0|||
144483614|NCT00329719|520970423|FG001|Overall Study|Lost to Follow-up|0|||
144483615|NCT00329719|520970424|FG002|Overall Study|Lost to Follow-up|0|||
144483616|NCT00329719|520970425|FG003|Overall Study|Lost to Follow-up|1|||
144483617|NCT03918239|520970426|FG000|Overall Study|Lost to Follow-up|3|||
144483618|NCT03918239|520970427|FG001|Overall Study|Lost to Follow-up|1|||
144483619|NCT03918239|520970426|FG000|Overall Study|Pregnancy|0|||
144483620|NCT03918239|520970427|FG001|Overall Study|Pregnancy|2|||
144483621|NCT03918239|520970426|FG000|Overall Study|Withdrawal by Subject|3|||
144483622|NCT03918239|520970427|FG001|Overall Study|Withdrawal by Subject|3|||
144483623|NCT03918239|520970426|FG000|Overall Study|positive urine drug screening results|4|||
144483624|NCT03918239|520970427|FG001|Overall Study|positive urine drug screening results|1|||
144483625|NCT01984424|520970428|FG000|Overall Study|Withdrawal by Subject|3|||
144483626|NCT01984424|520970429|FG001|Overall Study|Withdrawal by Subject|5|||
144483627|NCT01984424|520970428|FG000|Overall Study|Sponsor Decision|0|||
144483628|NCT01984424|520970429|FG001|Overall Study|Sponsor Decision|1|||
144483629|NCT01984424|520970428|FG000|Overall Study|Lost to Follow-up|0|||
144483630|NCT01984424|520970429|FG001|Overall Study|Lost to Follow-up|1|||
144483631|NCT01807221|520970430|FG000|Overall Study|Progressive disease|1|||
144483632|NCT01807221|520970431|FG001|Overall Study|Progressive disease|0|||
144483633|NCT01807221|520970432|FG002|Overall Study|Progressive disease|1|||
144483634|NCT01807221|520970433|FG003|Overall Study|Progressive disease|0|||
144483635|NCT01807221|520970434|FG004|Overall Study|Progressive disease|0|||
144483636|NCT01807221|520970435|FG005|Overall Study|Progressive disease|0|||
144483637|NCT01807221|520970430|FG000|Overall Study|Death|7|||
144483638|NCT01807221|520970431|FG001|Overall Study|Death|9|||
144483639|NCT01807221|520970432|FG002|Overall Study|Death|4|||
144483640|NCT01807221|520970433|FG003|Overall Study|Death|2|||
144483641|NCT01807221|520970434|FG004|Overall Study|Death|1|||
144483642|NCT01807221|520970435|FG005|Overall Study|Death|6|||
144483643|NCT01807221|520970430|FG000|Overall Study|Physician Decision|2|||
144483644|NCT01807221|520970431|FG001|Overall Study|Physician Decision|1|||
144483645|NCT01807221|520970432|FG002|Overall Study|Physician Decision|0|||
144483646|NCT01807221|520970433|FG003|Overall Study|Physician Decision|0|||
144483647|NCT01807221|520970434|FG004|Overall Study|Physician Decision|0|||
144483648|NCT01807221|520970435|FG005|Overall Study|Physician Decision|0|||
144483649|NCT01807221|520970430|FG000|Overall Study|Adverse Event|33|||
144483650|NCT01807221|520970431|FG001|Overall Study|Adverse Event|22|||
144483651|NCT01807221|520970432|FG002|Overall Study|Adverse Event|26|||
144483652|NCT01807221|520970433|FG003|Overall Study|Adverse Event|25|||
144483653|NCT01807221|520970434|FG004|Overall Study|Adverse Event|18|||
144483654|NCT01807221|520970435|FG005|Overall Study|Adverse Event|21|||
144483655|NCT01807221|520970430|FG000|Overall Study|Protocol Violation|0|||
144483656|NCT01807221|520970431|FG001|Overall Study|Protocol Violation|2|||
144483657|NCT01807221|520970432|FG002|Overall Study|Protocol Violation|1|||
144483658|NCT01807221|520970433|FG003|Overall Study|Protocol Violation|2|||
144483659|NCT01807221|520970434|FG004|Overall Study|Protocol Violation|0|||
144483660|NCT01807221|520970435|FG005|Overall Study|Protocol Violation|1|||
144483661|NCT01807221|520970430|FG000|Overall Study|Non-compliance|1|||
144483662|NCT01807221|520970431|FG001|Overall Study|Non-compliance|2|||
144483663|NCT01807221|520970432|FG002|Overall Study|Non-compliance|0|||
144483664|NCT01807221|520970433|FG003|Overall Study|Non-compliance|1|||
144483665|NCT01807221|520970434|FG004|Overall Study|Non-compliance|0|||
144483666|NCT01807221|520970435|FG005|Overall Study|Non-compliance|0|||
144483667|NCT01807221|520970430|FG000|Overall Study|Logistical difficulties|0|||
144483668|NCT01807221|520970431|FG001|Overall Study|Logistical difficulties|1|||
144483669|NCT01807221|520970432|FG002|Overall Study|Logistical difficulties|0|||
144483670|NCT01807221|520970433|FG003|Overall Study|Logistical difficulties|0|||
144483671|NCT01807221|520970434|FG004|Overall Study|Logistical difficulties|1|||
144483672|NCT01807221|520970435|FG005|Overall Study|Logistical difficulties|0|||
144483673|NCT01807221|520970430|FG000|Overall Study|Withdrawal by Subject|33|||
144483674|NCT01807221|520970431|FG001|Overall Study|Withdrawal by Subject|15|||
144483675|NCT01807221|520970432|FG002|Overall Study|Withdrawal by Subject|8|||
144483676|NCT01807221|520970433|FG003|Overall Study|Withdrawal by Subject|14|||
144483677|NCT01807221|520970434|FG004|Overall Study|Withdrawal by Subject|16|||
144483678|NCT01807221|520970435|FG005|Overall Study|Withdrawal by Subject|13|||
144483679|NCT01807221|520970430|FG000|Overall Study|Sponsor decision|2|||
144483680|NCT01807221|520970431|FG001|Overall Study|Sponsor decision|0|||
144483681|NCT01807221|520970432|FG002|Overall Study|Sponsor decision|1|||
144483682|NCT01807221|520970433|FG003|Overall Study|Sponsor decision|1|||
144483683|NCT01807221|520970434|FG004|Overall Study|Sponsor decision|0|||
144483684|NCT01807221|520970435|FG005|Overall Study|Sponsor decision|0|||
144483685|NCT01807221|520970430|FG000|Overall Study|Lost to Follow-up|1|||
144483686|NCT01807221|520970431|FG001|Overall Study|Lost to Follow-up|0|||
144483687|NCT01807221|520970432|FG002|Overall Study|Lost to Follow-up|2|||
144483688|NCT01807221|520970433|FG003|Overall Study|Lost to Follow-up|1|||
144483689|NCT01807221|520970434|FG004|Overall Study|Lost to Follow-up|0|||
144483690|NCT01807221|520970435|FG005|Overall Study|Lost to Follow-up|0|||
144483691|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
144483692|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
144483693|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
144483694|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
144483695|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
144483696|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
144483697|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
144483698|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
144483699|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
144483700|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
144483701|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
144483702|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
144483703|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
144483704|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
144483705|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
144483706|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
144483707|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
144483708|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
144483709|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
144483710|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
144483711|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
144483712|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
144483713|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
144483714|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
144483715|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
144483716|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
144483717|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
144483718|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
144483719|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
144483720|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
144483721|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
144483722|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
144483723|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
144483724|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
144483725|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
144483726|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
144483727|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
144483728|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
144483729|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
144483730|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
144483731|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
144483732|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
144483733|NCT01089556|520970443|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
144483734|NCT01089556|520970444|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
144483735|NCT01089556|520970445|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
144483736|NCT01089556|520970446|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
144483737|NCT01089556|520970447|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
144483738|NCT01089556|520970448|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
144483739|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
144483740|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
144483741|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
144483742|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
144483743|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
144483744|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
144483745|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
144483746|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
144483747|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
144483748|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
144483749|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
144483750|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
144483751|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
144483752|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
144483753|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
144483754|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
144483755|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
144483756|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
144483757|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
144483758|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
144483759|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
144483760|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
144483761|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
144483762|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
144483763|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
144483764|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
144483765|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
144483766|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
144483767|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
144483768|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
144483769|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
144483770|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
144483771|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
144483772|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
144483773|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
144483774|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
144483775|NCT01089556|520970443|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
144483776|NCT01089556|520970444|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
144483777|NCT01089556|520970445|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
144483778|NCT01089556|520970446|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
144483779|NCT01089556|520970447|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
144483780|NCT01089556|520970448|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
144483781|NCT01238575|520970449|FG000|Overall Study|Lack of Efficacy|2|||
144483782|NCT01238575|520970450|FG001|Overall Study|Lack of Efficacy|4|||
144483783|NCT01238575|520970449|FG000|Overall Study|Adverse Event|2|||
144483784|NCT01238575|520970450|FG001|Overall Study|Adverse Event|0|||
144483785|NCT01702428|520970453|FG000|Overall Study|Adverse Event|2|||
144483786|NCT01702428|520970454|FG001|Overall Study|Adverse Event|0|||
144483787|NCT01702428|520970455|FG002|Overall Study|Adverse Event|0|||
144483788|NCT01702428|520970456|FG003|Overall Study|Adverse Event|0|||
144483789|NCT01702428|520970453|FG000|Overall Study|Lost to Follow-up|33|||
144483790|NCT01702428|520970454|FG001|Overall Study|Lost to Follow-up|41|||
144483791|NCT01702428|520970455|FG002|Overall Study|Lost to Follow-up|37|||
144483792|NCT01702428|520970456|FG003|Overall Study|Lost to Follow-up|44|||
144483793|NCT01702428|520970453|FG000|Overall Study|Parents cannot assist to site|1|||
144483794|NCT01702428|520970454|FG001|Overall Study|Parents cannot assist to site|0|||
144483795|NCT01702428|520970455|FG002|Overall Study|Parents cannot assist to site|1|||
144483796|NCT01702428|520970456|FG003|Overall Study|Parents cannot assist to site|0|||
144483797|NCT01702428|520970453|FG000|Overall Study|Lost Coverage|0|||
144483798|NCT01702428|520970454|FG001|Overall Study|Lost Coverage|0|||
144483799|NCT01702428|520970455|FG002|Overall Study|Lost Coverage|0|||
144483800|NCT01702428|520970456|FG003|Overall Study|Lost Coverage|1|||
144483801|NCT01702428|520970453|FG000|Overall Study|Lost Health Plan|3|||
144483802|NCT01702428|520970454|FG001|Overall Study|Lost Health Plan|5|||
144483803|NCT01702428|520970455|FG002|Overall Study|Lost Health Plan|0|||
144483804|NCT01702428|520970456|FG003|Overall Study|Lost Health Plan|2|||
144483805|NCT01702428|520970453|FG000|Overall Study|Mother transferred care|0|||
144483806|NCT01702428|520970454|FG001|Overall Study|Mother transferred care|1|||
144483807|NCT01702428|520970455|FG002|Overall Study|Mother transferred care|0|||
144483808|NCT01702428|520970456|FG003|Overall Study|Mother transferred care|0|||
144483809|NCT01702428|520970453|FG000|Overall Study|Parents too busy|1|||
144483810|NCT01702428|520970454|FG001|Overall Study|Parents too busy|0|||
144483811|NCT01702428|520970455|FG002|Overall Study|Parents too busy|0|||
144483812|NCT01702428|520970456|FG003|Overall Study|Parents too busy|0|||
144483813|NCT01702428|520970453|FG000|Overall Study|Protocol Violation|3|||
144483814|NCT01702428|520970454|FG001|Overall Study|Protocol Violation|0|||
144483815|NCT01702428|520970455|FG002|Overall Study|Protocol Violation|1|||
144483816|NCT01702428|520970456|FG003|Overall Study|Protocol Violation|0|||
144483817|NCT01702428|520970453|FG000|Overall Study|Withdrawal by Subject|21|||
144483818|NCT01702428|520970454|FG001|Overall Study|Withdrawal by Subject|23|||
144483819|NCT01702428|520970455|FG002|Overall Study|Withdrawal by Subject|14|||
144483820|NCT01702428|520970456|FG003|Overall Study|Withdrawal by Subject|10|||
144483821|NCT00594906|520970457|FG000|Overall Study|Physician Decision|1|||
144483822|NCT00594906|520970458|FG001|Overall Study|Physician Decision|0|||
144483823|NCT00594906|520970457|FG000|Overall Study|Physician Decision|0|||
144483824|NCT00594906|520970458|FG001|Overall Study|Physician Decision|1|||
144483825|NCT00594906|520970457|FG000|Overall Study|Death|0|||
144483826|NCT00594906|520970458|FG001|Overall Study|Death|1|||
144483827|NCT01533714|520970460|FG000|Overall Study|Adverse Event|0|||
144483828|NCT01533714|520970461|FG001|Overall Study|Adverse Event|1|||
144483829|NCT01533714|520970462|FG002|Overall Study|Adverse Event|2|||
144483830|NCT01533714|520970463|FG003|Overall Study|Adverse Event|2|||
144483831|NCT01533714|520970464|FG004|Overall Study|Adverse Event|2|||
144483832|NCT01533714|520970465|FG005|Overall Study|Adverse Event|1|||
144483833|NCT01533714|520970460|FG000|Overall Study|Lack of Efficacy|0|||
144483834|NCT01533714|520970461|FG001|Overall Study|Lack of Efficacy|0|||
144483835|NCT01533714|520970462|FG002|Overall Study|Lack of Efficacy|0|||
144483836|NCT01533714|520970463|FG003|Overall Study|Lack of Efficacy|0|||
144483837|NCT01533714|520970464|FG004|Overall Study|Lack of Efficacy|0|||
144483838|NCT01533714|520970465|FG005|Overall Study|Lack of Efficacy|1|||
144483839|NCT01533714|520970460|FG000|Overall Study|Withdrawal by Subject|0|||
144483840|NCT01533714|520970461|FG001|Overall Study|Withdrawal by Subject|1|||
144483841|NCT01533714|520970462|FG002|Overall Study|Withdrawal by Subject|0|||
144483842|NCT01533714|520970463|FG003|Overall Study|Withdrawal by Subject|1|||
144483843|NCT01533714|520970464|FG004|Overall Study|Withdrawal by Subject|1|||
144483844|NCT01533714|520970465|FG005|Overall Study|Withdrawal by Subject|0|||
144483845|NCT01533714|520970460|FG000|Overall Study|Exclusion criteria|0|||
144483846|NCT01533714|520970461|FG001|Overall Study|Exclusion criteria|1|||
144483847|NCT01533714|520970462|FG002|Overall Study|Exclusion criteria|0|||
144483848|NCT01533714|520970463|FG003|Overall Study|Exclusion criteria|0|||
144483849|NCT01533714|520970464|FG004|Overall Study|Exclusion criteria|0|||
144483850|NCT01533714|520970465|FG005|Overall Study|Exclusion criteria|0|||
144483851|NCT01533714|520970460|FG000|Overall Study|Positive for purified protein derivative|0|||
144483852|NCT01533714|520970461|FG001|Overall Study|Positive for purified protein derivative|0|||
144483853|NCT01533714|520970462|FG002|Overall Study|Positive for purified protein derivative|1|||
144483854|NCT01533714|520970463|FG003|Overall Study|Positive for purified protein derivative|0|||
144483855|NCT01533714|520970464|FG004|Overall Study|Positive for purified protein derivative|1|||
144483856|NCT01533714|520970465|FG005|Overall Study|Positive for purified protein derivative|0|||
144483857|NCT01533714|520970460|FG000|Overall Study|Withdrawal criteria|0|||
144483858|NCT01533714|520970461|FG001|Overall Study|Withdrawal criteria|0|||
144483859|NCT01533714|520970462|FG002|Overall Study|Withdrawal criteria|1|||
144483860|NCT01533714|520970463|FG003|Overall Study|Withdrawal criteria|0|||
144483861|NCT01533714|520970464|FG004|Overall Study|Withdrawal criteria|3|||
144483862|NCT01533714|520970465|FG005|Overall Study|Withdrawal criteria|1|||
144483863|NCT01533714|520970460|FG000|Overall Study|Ineligibility reason|0|||
144483864|NCT01533714|520970461|FG001|Overall Study|Ineligibility reason|0|||
144483865|NCT01533714|520970462|FG002|Overall Study|Ineligibility reason|0|||
144483866|NCT01533714|520970463|FG003|Overall Study|Ineligibility reason|1|||
144483867|NCT01533714|520970464|FG004|Overall Study|Ineligibility reason|0|||
144483868|NCT01533714|520970465|FG005|Overall Study|Ineligibility reason|0|||
144483869|NCT02564055|520970466|FG000|Overall Study|Adverse Event|1|||
144483870|NCT02564055|520970467|FG001|Overall Study|Adverse Event|0|||
144483871|NCT02564055|520970468|FG002|Overall Study|Adverse Event|4|||
144483872|NCT02564055|520970469|FG003|Overall Study|Adverse Event|1|||
144483873|NCT02564055|520970470|FG004|Overall Study|Adverse Event|4|||
144483874|NCT02564055|520970471|FG005|Overall Study|Adverse Event|1|||
144483875|NCT02564055|520970466|FG000|Overall Study|Protocol Violation|1|||
144483876|NCT02564055|520970467|FG001|Overall Study|Protocol Violation|0|||
144483877|NCT02564055|520970468|FG002|Overall Study|Protocol Violation|0|||
144483878|NCT02564055|520970469|FG003|Overall Study|Protocol Violation|0|||
144483879|NCT02564055|520970470|FG004|Overall Study|Protocol Violation|0|||
144483880|NCT02564055|520970471|FG005|Overall Study|Protocol Violation|0|||
144483881|NCT02564055|520970466|FG000|Overall Study|Reached stopping criteria|0|||
144483882|NCT02564055|520970467|FG001|Overall Study|Reached stopping criteria|0|||
144483883|NCT02564055|520970468|FG002|Overall Study|Reached stopping criteria|0|||
144483884|NCT02564055|520970469|FG003|Overall Study|Reached stopping criteria|0|||
144483885|NCT02564055|520970470|FG004|Overall Study|Reached stopping criteria|0|||
144483886|NCT02564055|520970471|FG005|Overall Study|Reached stopping criteria|1|||
144483887|NCT02564055|520970466|FG000|Overall Study|Lost to Follow-up|0|||
144483888|NCT02564055|520970467|FG001|Overall Study|Lost to Follow-up|1|||
144483889|NCT02564055|520970468|FG002|Overall Study|Lost to Follow-up|4|||
144483890|NCT02564055|520970469|FG003|Overall Study|Lost to Follow-up|2|||
144483891|NCT02564055|520970470|FG004|Overall Study|Lost to Follow-up|1|||
144483892|NCT02564055|520970471|FG005|Overall Study|Lost to Follow-up|0|||
144483893|NCT02564055|520970466|FG000|Overall Study|Physician Decision|0|||
144483894|NCT02564055|520970467|FG001|Overall Study|Physician Decision|0|||
144483895|NCT02564055|520970468|FG002|Overall Study|Physician Decision|1|||
144483896|NCT02564055|520970469|FG003|Overall Study|Physician Decision|0|||
144483897|NCT02564055|520970470|FG004|Overall Study|Physician Decision|0|||
144483898|NCT02564055|520970471|FG005|Overall Study|Physician Decision|0|||
144483899|NCT02564055|520970466|FG000|Overall Study|Withdrawal by Subject|4|||
144483900|NCT02564055|520970467|FG001|Overall Study|Withdrawal by Subject|4|||
144483901|NCT02564055|520970468|FG002|Overall Study|Withdrawal by Subject|3|||
144483902|NCT02564055|520970469|FG003|Overall Study|Withdrawal by Subject|3|||
144483903|NCT02564055|520970470|FG004|Overall Study|Withdrawal by Subject|10|||
144483904|NCT02564055|520970471|FG005|Overall Study|Withdrawal by Subject|10|||
144483905|NCT04012814|520970472|FG000|Overall Study|Lost to Follow-up|4|||
144483906|NCT04012814|520970472|FG000|Overall Study|Withdrawal by Subject|2|||
144483907|NCT04012814|520970472|FG000|Overall Study|Protocol Violation|1|||
144483908|NCT04012814|520970472|FG000|Overall Study|Adverse Event|1|||
144483909|NCT04397523|520970473|FG000|Overall Study|Lost to Follow-up|3|||
144483910|NCT04397523|520970473|FG000|Overall Study|Transfer from/to other hospital|8|||
144483911|NCT02111213|520970479|FG000|Overall Study|Withdrawal by Subject|3|||
144483912|NCT02111213|520970480|FG001|Overall Study|Withdrawal by Subject|2|||
144483913|NCT02111213|520970479|FG000|Overall Study|Lost to Follow-up|3|||
144483914|NCT02111213|520970480|FG001|Overall Study|Lost to Follow-up|4|||
144483915|NCT02226172|520970483|FG000|Overall Study|Participant refused further follow-up|4|||
144483916|NCT02226172|520970483|FG000|Overall Study|Other|5|||
144483917|NCT02226172|520970483|FG000|Overall Study|Death|1|||
144483918|NCT02226172|520970483|FG000|Overall Study|Study terminated by sponsor|1|||
144483919|NCT02226172|520970483|FG000|Overall Study|Adverse Event|6|||
144483920|NCT01865617|520970484|FG000|Overall Study|Death|27|||
144483921|NCT01865617|520970485|FG001|Overall Study|Death|3|||
144483922|NCT01865617|520970486|FG002|Overall Study|Death|1|||
144483923|NCT01865617|520970487|FG003|Overall Study|Death|1|||
144483924|NCT01865617|520970488|FG004|Overall Study|Death|5|||
144483925|NCT01865617|520970489|FG005|Overall Study|Death|1|||
144483926|NCT01865617|520970490|FG006|Overall Study|Death|11|||
144483927|NCT01865617|520970491|FG007|Overall Study|Death|1|||
144483928|NCT01865617|520970492|FG008|Overall Study|Death|11|||
144483929|NCT01865617|520970493|FG009|Overall Study|Death|3|||
144369695|NCT02177032|520561657|FG001|Overall Study|Lost to Follow-up|2|||
144483930|NCT01865617|520970494|FG010|Overall Study|Death|32|||
144369696|NCT02177032|520561658|FG002|Overall Study|Lost to Follow-up|0|||
144369697|NCT02177032|520561659|FG003|Overall Study|Lost to Follow-up|0|||
144369698|NCT02177032|520561656|FG000|Overall Study|OTHER|2|||
144369699|NCT02177032|520561657|FG001|Overall Study|OTHER|0|||
144369700|NCT02177032|520561658|FG002|Overall Study|OTHER|1|||
144369701|NCT02177032|520561659|FG003|Overall Study|OTHER|0|||
144369702|NCT02177032|520561656|FG000|Overall Study|Withdrawal by Subject|1|||
144369703|NCT02177032|520561657|FG001|Overall Study|Withdrawal by Subject|0|||
144369704|NCT02177032|520561658|FG002|Overall Study|Withdrawal by Subject|1|||
144369705|NCT02177032|520561659|FG003|Overall Study|Withdrawal by Subject|0|||
144369706|NCT00665652|520561660|FG000|Overall Study|Adverse Event|4|||
144369707|NCT00665652|520561660|FG000|Overall Study|Death|1|||
144369708|NCT00665652|520561660|FG000|Overall Study|No longer met inclusion criteria.|1|||
144369709|NCT02161016|520561662|FG000|Overall Study|withdrawn by IRB|1|||
144369710|NCT02556177|520561664|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
144369711|NCT02556177|520561665|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
144369712|NCT00380367|520561674|FG000|Overall Study|Lost to Follow-up|1|||
144369713|NCT00380367|520561674|FG000|Overall Study|Withdrawal by Subject|1|||
144369714|NCT01605799|520561675|FG000|Overall Study|Withdrawal by Subject|2|||
144369715|NCT01605799|520561676|FG001|Overall Study|Withdrawal by Subject|1|||
144369716|NCT00734539|520561679|FG000|Main Study|Death|33|||
144369717|NCT00734539|520561680|FG001|Main Study|Death|32|||
144369718|NCT00734539|520561679|FG000|Main Study|Physician Decision|2|||
144369719|NCT00734539|520561680|FG001|Main Study|Physician Decision|0|||
144369720|NCT00734539|520561679|FG000|Main Study|Withdrawal by Subject|1|||
144369721|NCT00734539|520561680|FG001|Main Study|Withdrawal by Subject|3|||
144369722|NCT00734539|520561679|FG000|Main Study|Enrolled in error; ineligible|1|||
144369723|NCT00734539|520561680|FG001|Main Study|Enrolled in error; ineligible|0|||
144369724|NCT02592798|520561687|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
144369725|NCT02592798|520561688|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
144369726|NCT02592798|520561687|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
144369727|NCT02592798|520561688|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
144369728|NCT02592798|520561687|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
144369729|NCT02592798|520561688|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
144369730|NCT02592798|520561687|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
144369731|NCT02592798|520561688|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
144369732|NCT02592798|520561687|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
144369733|NCT02592798|520561688|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
144369734|NCT02592798|520561687|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
144369735|NCT02592798|520561688|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
144369736|NCT02592798|520561687|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
144369737|NCT02592798|520561688|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
144369738|NCT02592798|520561687|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
144369739|NCT02592798|520561688|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
144369740|NCT02592798|520561687|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
144369741|NCT02592798|520561688|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
144369742|NCT02592798|520561687|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
144369743|NCT02592798|520561688|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
144369744|NCT02592798|520561687|FG000|Transition From DB2 to OLE|Other reasons|1|||
144369745|NCT02592798|520561688|FG001|Transition From DB2 to OLE|Other reasons|0|||
144369746|NCT02592798|520561687|FG000|Open Label Period (OLE)|Other reasons|0|||
144369747|NCT02592798|520561688|FG001|Open Label Period (OLE)|Other reasons|2|||
144369748|NCT02592798|520561687|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
144369749|NCT02592798|520561688|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
144369750|NCT02592798|520561687|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
144369751|NCT02592798|520561688|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
144369752|NCT02592798|520561687|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
144369753|NCT02592798|520561688|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
144369754|NCT02592798|520561687|FG000|Open Label Period (OLE)|Adverse Event|0|||
144369755|NCT02592798|520561688|FG001|Open Label Period (OLE)|Adverse Event|1|||
144369756|NCT01188343|520561689|FG000|Overall Study|Not vaccinated|0|||
144369757|NCT01188343|520561690|FG001|Overall Study|Not vaccinated|2|||
144369758|NCT01188343|520561691|FG002|Overall Study|Not vaccinated|1|||
144369759|NCT01188343|520561689|FG000|Overall Study|Withdrawal by Subject|1|||
144369760|NCT01188343|520561690|FG001|Overall Study|Withdrawal by Subject|24|||
144369761|NCT01188343|520561691|FG002|Overall Study|Withdrawal by Subject|0|||
144369762|NCT02745119|520561693|FG000|Overall Study|Adverse Event|1|||
144369763|NCT02745119|520561694|FG001|Overall Study|Adverse Event|0|||
144369764|NCT02745119|520561695|FG002|Overall Study|Adverse Event|1|||
144369765|NCT02745119|520561696|FG003|Overall Study|Adverse Event|3|||
144369766|NCT02745119|520561693|FG000|Overall Study|Death|3|||
144369767|NCT02745119|520561694|FG001|Overall Study|Death|3|||
144369768|NCT02745119|520561695|FG002|Overall Study|Death|0|||
144369769|NCT02745119|520561696|FG003|Overall Study|Death|4|||
144483931|NCT01865617|520970495|FG011|Overall Study|Death|6|||
144483932|NCT01865617|520970496|FG012|Overall Study|Death|13|||
144483933|NCT01865617|520970484|FG000|Overall Study|Lost to Follow-up|2|||
144483934|NCT01865617|520970485|FG001|Overall Study|Lost to Follow-up|0|||
144483935|NCT01865617|520970486|FG002|Overall Study|Lost to Follow-up|0|||
144483936|NCT01865617|520970487|FG003|Overall Study|Lost to Follow-up|0|||
144483937|NCT01865617|520970488|FG004|Overall Study|Lost to Follow-up|0|||
144483938|NCT01865617|520970489|FG005|Overall Study|Lost to Follow-up|0|||
144483939|NCT01865617|520970490|FG006|Overall Study|Lost to Follow-up|0|||
144483940|NCT01865617|520970491|FG007|Overall Study|Lost to Follow-up|0|||
144483941|NCT01865617|520970492|FG008|Overall Study|Lost to Follow-up|0|||
144483942|NCT01865617|520970493|FG009|Overall Study|Lost to Follow-up|0|||
144483943|NCT01865617|520970494|FG010|Overall Study|Lost to Follow-up|0|||
144483944|NCT01865617|520970495|FG011|Overall Study|Lost to Follow-up|0|||
144483945|NCT01865617|520970496|FG012|Overall Study|Lost to Follow-up|0|||
144483946|NCT01865617|520970484|FG000|Overall Study|Withdrawal by Subject|1|||
144483947|NCT01865617|520970485|FG001|Overall Study|Withdrawal by Subject|0|||
144483948|NCT01865617|520970486|FG002|Overall Study|Withdrawal by Subject|0|||
144483949|NCT01865617|520970487|FG003|Overall Study|Withdrawal by Subject|0|||
144483950|NCT01865617|520970488|FG004|Overall Study|Withdrawal by Subject|0|||
144483951|NCT01865617|520970489|FG005|Overall Study|Withdrawal by Subject|0|||
144483952|NCT01865617|520970490|FG006|Overall Study|Withdrawal by Subject|0|||
144483953|NCT01865617|520970491|FG007|Overall Study|Withdrawal by Subject|0|||
144483954|NCT01865617|520970492|FG008|Overall Study|Withdrawal by Subject|0|||
144483955|NCT01865617|520970493|FG009|Overall Study|Withdrawal by Subject|0|||
144483956|NCT01865617|520970494|FG010|Overall Study|Withdrawal by Subject|0|||
144483957|NCT01865617|520970495|FG011|Overall Study|Withdrawal by Subject|0|||
144483958|NCT01865617|520970496|FG012|Overall Study|Withdrawal by Subject|0|||
144483959|NCT01865617|520970484|FG000|Overall Study|Patient proceeded to new therapy|0|||
144483960|NCT01865617|520970485|FG001|Overall Study|Patient proceeded to new therapy|0|||
144483961|NCT01865617|520970486|FG002|Overall Study|Patient proceeded to new therapy|0|||
144483962|NCT01865617|520970487|FG003|Overall Study|Patient proceeded to new therapy|0|||
144483963|NCT01865617|520970488|FG004|Overall Study|Patient proceeded to new therapy|2|||
144483964|NCT01865617|520970489|FG005|Overall Study|Patient proceeded to new therapy|0|||
144483965|NCT01865617|520970490|FG006|Overall Study|Patient proceeded to new therapy|0|||
144483966|NCT01865617|520970491|FG007|Overall Study|Patient proceeded to new therapy|0|||
144483967|NCT01865617|520970492|FG008|Overall Study|Patient proceeded to new therapy|0|||
144483968|NCT01865617|520970493|FG009|Overall Study|Patient proceeded to new therapy|0|||
144483969|NCT01865617|520970494|FG010|Overall Study|Patient proceeded to new therapy|0|||
144483970|NCT01865617|520970495|FG011|Overall Study|Patient proceeded to new therapy|0|||
144483971|NCT01865617|520970496|FG012|Overall Study|Patient proceeded to new therapy|0|||
144483972|NCT01865617|520970484|FG000|Overall Study|Other|0|||
144483973|NCT01865617|520970485|FG001|Overall Study|Other|0|||
144483974|NCT01865617|520970486|FG002|Overall Study|Other|0|||
144483975|NCT01865617|520970487|FG003|Overall Study|Other|0|||
144483976|NCT01865617|520970488|FG004|Overall Study|Other|0|||
144483977|NCT01865617|520970489|FG005|Overall Study|Other|0|||
144483978|NCT01865617|520970490|FG006|Overall Study|Other|1|||
144483979|NCT01865617|520970491|FG007|Overall Study|Other|0|||
144483980|NCT01865617|520970492|FG008|Overall Study|Other|0|||
144483981|NCT01865617|520970493|FG009|Overall Study|Other|0|||
144483982|NCT01865617|520970494|FG010|Overall Study|Other|0|||
144483983|NCT01865617|520970495|FG011|Overall Study|Other|0|||
144483984|NCT01865617|520970496|FG012|Overall Study|Other|0|||
144483985|NCT00502996|520970497|FG000|Overall Study|Lost to Follow-up|9|||
144483986|NCT00502996|520970497|FG000|Overall Study|Protocol Violation|2|||
144483987|NCT00502996|520970497|FG000|Overall Study|Treatment failure|25|||
144483988|NCT00502996|520970497|FG000|Overall Study|Withdrawal Informed Consent|6|||
144483989|NCT00502996|520970497|FG000|Overall Study|Adverse Event|2|||
144483990|NCT02500979|520970498|FG000|Period 1|Hyperglycemia|1|||
144483991|NCT02500979|520970499|FG001|Period 1|Hyperglycemia|0|||
144483992|NCT02500979|520970498|FG000|Period 1|Severe non-compliance to protocol|0|||
144483993|NCT02500979|520970499|FG001|Period 1|Severe non-compliance to protocol|1|||
144483994|NCT02500979|520970498|FG000|Period 1|Adverse Event|1|||
144483995|NCT02500979|520970499|FG001|Period 1|Adverse Event|0|||
144483996|NCT02500979|520970498|FG000|Period 1|Subject decision|2|||
144483997|NCT02500979|520970499|FG001|Period 1|Subject decision|0|||
144483998|NCT02500979|520970498|FG000|Period 2|Change in risk|1|||
144483999|NCT02500979|520970499|FG001|Period 2|Change in risk|0|||
144484000|NCT01613027|520970502|FG000|Overall Study|Lost to Follow-up|5|||
144484001|NCT01613027|520970502|FG000|Overall Study|Switched Physician|1|||
144484002|NCT01613027|520970502|FG000|Overall Study|Lack of Efficacy|1|||
144484003|NCT01613027|520970502|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
144484004|NCT02153359|520970503|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
144484005|NCT02153359|520970504|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
144484006|NCT02796963|520970505|FG000|Overall Study|Lost to Follow-up|89|||
144484007|NCT02796963|520970506|FG001|Overall Study|Lost to Follow-up|76|||
144484008|NCT02796963|520970507|FG002|Overall Study|Lost to Follow-up|69|||
144484009|NCT02796963|520970508|FG003|Overall Study|Lost to Follow-up|72|||
144484010|NCT00988351|520970512|FG000|Overall Study|Withdrawal by Subject|8|||
144484011|NCT00988351|520970513|FG001|Overall Study|Withdrawal by Subject|0|||
144484012|NCT00988351|520970512|FG000|Overall Study|Lost to Follow-up|6|||
144484013|NCT00988351|520970513|FG001|Overall Study|Lost to Follow-up|9|||
144484014|NCT00988351|520970512|FG000|Overall Study|not using CPAP|5|||
144484015|NCT00988351|520970513|FG001|Overall Study|not using CPAP|3|||
144484016|NCT02471404|520970527|FG000|Overall Study|Adverse Event|7|||
144484017|NCT02471404|520970528|FG001|Overall Study|Adverse Event|1|||
144484018|NCT02471404|520970529|FG002|Overall Study|Adverse Event|2|||
144484019|NCT02471404|520970527|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
144484020|NCT02471404|520970528|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
144484021|NCT02471404|520970529|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
144484022|NCT02471404|520970527|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
144484023|NCT02471404|520970528|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
144484024|NCT02471404|520970529|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
144484025|NCT02471404|520970527|FG000|Overall Study|Lost to Follow-up|1|||
144484026|NCT02471404|520970528|FG001|Overall Study|Lost to Follow-up|1|||
144484027|NCT02471404|520970529|FG002|Overall Study|Lost to Follow-up|3|||
144484028|NCT02471404|520970527|FG000|Overall Study|Protocol Violation|1|||
144484029|NCT02471404|520970528|FG001|Overall Study|Protocol Violation|0|||
144484030|NCT02471404|520970529|FG002|Overall Study|Protocol Violation|0|||
144484031|NCT02471404|520970527|FG000|Overall Study|Withdrawal by Subject|8|||
144484032|NCT02471404|520970528|FG001|Overall Study|Withdrawal by Subject|4|||
144484033|NCT02471404|520970529|FG002|Overall Study|Withdrawal by Subject|5|||
144484034|NCT02471404|520970527|FG000|Overall Study|Other reasons not specified|10|||
144484035|NCT02471404|520970528|FG001|Overall Study|Other reasons not specified|7|||
144484036|NCT02471404|520970529|FG002|Overall Study|Other reasons not specified|12|||
144484037|NCT01927731|520970530|FG000|Overall Study|Graft Failure|1|||
144484038|NCT01927731|520970531|FG001|Overall Study|Graft Failure|2|||
144484039|NCT01927731|520970530|FG000|Overall Study|Physician Decision|2|||
144484040|NCT01927731|520970531|FG001|Overall Study|Physician Decision|3|||
144484041|NCT01927731|520970530|FG000|Overall Study|Withdrawal by Subject|0|||
144484042|NCT01927731|520970531|FG001|Overall Study|Withdrawal by Subject|2|||
144484043|NCT01927731|520970530|FG000|Overall Study|Death|0|||
144484044|NCT01927731|520970531|FG001|Overall Study|Death|3|||
144484045|NCT01464255|520970532|FG000|Overall Study|unresolve corneal staining|0|||
144484046|NCT01464255|520970533|FG001|Overall Study|unresolve corneal staining|1|||
144484047|NCT00785538|520970534|FG000|Treatment Period|Adverse Event|1|||
144484048|NCT00785538|520970535|FG001|Treatment Period|Adverse Event|2|||
144484049|NCT00785538|520970536|FG002|Treatment Period|Adverse Event|2|||
144484050|NCT00785538|520970537|FG003|Treatment Period|Adverse Event|0|||
144484051|NCT00785538|520970534|FG000|Treatment Period|Withdrawal by Subject|0|||
144484052|NCT00785538|520970535|FG001|Treatment Period|Withdrawal by Subject|0|||
144484053|NCT00785538|520970536|FG002|Treatment Period|Withdrawal by Subject|0|||
144484054|NCT00785538|520970537|FG003|Treatment Period|Withdrawal by Subject|1|||
144484055|NCT02066532|520970540|FG000|Phase II|Withdrawal by Subject|1|||
144484056|NCT02066532|520970541|FG001|Phase II|Withdrawal by Subject|0|||
144484057|NCT02066532|520970542|FG002|Phase II|Withdrawal by Subject|0|||
144484058|NCT02066532|520970543|FG003|Phase II|Withdrawal by Subject|0|||
144484059|NCT05033080|520970544|FG000|Overall Study|Adverse Event|4|||
144484060|NCT05033080|520970545|FG001|Overall Study|Adverse Event|4|||
144484061|NCT05033080|520970544|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
144484062|NCT05033080|520970545|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
144484063|NCT05033080|520970544|FG000|Overall Study|Lost to Follow-up|1|||
144484064|NCT05033080|520970545|FG001|Overall Study|Lost to Follow-up|0|||
144484065|NCT05033080|520970544|FG000|Overall Study|Other non-compliance|0|||
144484066|NCT05033080|520970545|FG001|Overall Study|Other non-compliance|1|||
144484067|NCT05033080|520970544|FG000|Overall Study|Physician Decision|0|||
144484068|NCT05033080|520970545|FG001|Overall Study|Physician Decision|1|||
144484069|NCT05033080|520970544|FG000|Overall Study|Other|1|||
144484070|NCT05033080|520970545|FG001|Overall Study|Other|1|||
144484071|NCT03560245|520970546|FG000|Overall Study|Withdrawal by Subject|3|||
144484072|NCT03560245|520970547|FG001|Overall Study|Withdrawal by Subject|2|||
144484073|NCT03560245|520970546|FG000|Overall Study|Adverse Event|1|||
144484074|NCT03560245|520970547|FG001|Overall Study|Adverse Event|1|||
144484075|NCT03560245|520970546|FG000|Overall Study|Protocol Violation|1|||
144484076|NCT03560245|520970547|FG001|Overall Study|Protocol Violation|0|||
144484077|NCT03560245|520970546|FG000|Overall Study|Death|0|||
144484078|NCT03560245|520970547|FG001|Overall Study|Death|1|||
144484079|NCT03560245|520970546|FG000|Overall Study|Lost to Follow-up|0|||
144484080|NCT03560245|520970547|FG001|Overall Study|Lost to Follow-up|1|||
144484081|NCT03560245|520970546|FG000|Overall Study|Physician Decision|0|||
144484082|NCT03560245|520970547|FG001|Overall Study|Physician Decision|1|||
144484083|NCT03560245|520970546|FG000|Overall Study|Other|0|||
144484084|NCT03560245|520970547|FG001|Overall Study|Other|1|||
144484085|NCT01265823|520970548|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
144484086|NCT01265823|520970548|FG000|Overall Study|Failure to Return|4|||
144484087|NCT01265823|520970548|FG000|Overall Study|Protocol Violation|1|||
144484088|NCT01265823|520970548|FG000|Overall Study|Participant Request|1|||
144484089|NCT01263106|520970549|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
144484090|NCT01263106|520970550|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
144484091|NCT01794117|520970554|FG000|Overall Study|Adverse Event|1|||
144484092|NCT01794117|520970555|FG001|Overall Study|Adverse Event|0|||
144484093|NCT01794117|520970556|FG002|Overall Study|Adverse Event|0|||
144484094|NCT01794117|520970557|FG003|Overall Study|Adverse Event|0|||
144484095|NCT01794117|520970554|FG000|Overall Study|Participant noncompliance|0|||
144484096|NCT01794117|520970555|FG001|Overall Study|Participant noncompliance|1|||
144484097|NCT01794117|520970556|FG002|Overall Study|Participant noncompliance|0|||
144484098|NCT01794117|520970557|FG003|Overall Study|Participant noncompliance|0|||
144484099|NCT01794117|520970554|FG000|Overall Study|Refused further treatment|0|||
144484100|NCT01794117|520970555|FG001|Overall Study|Refused further treatment|2|||
144484101|NCT01794117|520970556|FG002|Overall Study|Refused further treatment|0|||
144484102|NCT01794117|520970557|FG003|Overall Study|Refused further treatment|0|||
144484103|NCT02401308|520970559|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
144484104|NCT02401308|520970560|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
144484105|NCT02998021|520970561|FG000|Overall Study|Withdrawal by Subject|3|||
144484106|NCT02998021|520970562|FG001|Overall Study|Withdrawal by Subject|1|||
144484107|NCT02998021|520970561|FG000|Overall Study|unsafe home|0|||
144484108|NCT02998021|520970562|FG001|Overall Study|unsafe home|1|||
144484109|NCT00514046|520970563|FG000|Overall Study|transferred to another protocol|2|||
144484110|NCT00514046|520970564|FG001|Overall Study|transferred to another protocol|1|||
144484111|NCT00514046|520970565|FG002|Overall Study|transferred to another protocol|3|||
144484112|NCT00514046|520970566|FG003|Overall Study|transferred to another protocol|0|||
144484113|NCT00514046|520970567|FG004|Overall Study|transferred to another protocol|1|||
144484114|NCT00514046|520970568|FG005|Overall Study|transferred to another protocol|0|||
144484115|NCT00514046|520970569|FG006|Overall Study|transferred to another protocol|0|||
144484116|NCT00514046|520970570|FG007|Overall Study|transferred to another protocol|0|||
144484117|NCT00514046|520970571|FG008|Overall Study|transferred to another protocol|0|||
144484118|NCT00514046|520970563|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
144484119|NCT00514046|520970564|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
144484120|NCT00514046|520970565|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
144484121|NCT00514046|520970566|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
144484122|NCT00514046|520970567|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
144484123|NCT00514046|520970568|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
144484124|NCT00514046|520970569|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
144484125|NCT00514046|520970570|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
144484126|NCT00514046|520970571|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
144484127|NCT00514046|520970563|FG000|Overall Study|Disease progression on study|0|||
144714725|NCT03726437|521809571|FG000|Overall Study|Lost to Follow-up|85|||
144714726|NCT03726437|521809572|FG001|Overall Study|Lost to Follow-up|76|||
144714727|NCT00267007|521809573|FG000|Overall Study|Withdrawal by Subject|6|||
144714728|NCT00267007|521809574|FG001|Overall Study|Withdrawal by Subject|0|||
144714729|NCT00267007|521809573|FG000|Overall Study|Lost to Follow-up|1|||
144714730|NCT00267007|521809574|FG001|Overall Study|Lost to Follow-up|0|||
144714731|NCT00267007|521809573|FG000|Overall Study|Non-compliance|0|||
144714732|NCT00267007|521809574|FG001|Overall Study|Non-compliance|1|||
144714733|NCT00267007|521809573|FG000|Overall Study|Adverse Event|1|||
144714734|NCT00267007|521809574|FG001|Overall Study|Adverse Event|0|||
144714735|NCT01205529|521809575|FG000|Overall Study|Procedure Cancelled|4|||
144714736|NCT01205529|521809575|FG000|Overall Study|Withdrawal by Subject|2|||
144714737|NCT01205529|521809575|FG000|Overall Study|Physician Decision|4|||
144714738|NCT01205529|521809575|FG000|Overall Study|Unstable post op|15|||
144714739|NCT01205529|521809575|FG000|Overall Study|No longer met criteria|30|||
144714740|NCT01610167|521809576|FG000|Overall Study|Scheduling conflict.|0|||
144714741|NCT01610167|521809577|FG001|Overall Study|Scheduling conflict.|0|||
144714742|NCT01610167|521809578|FG002|Overall Study|Scheduling conflict.|2|||
144714743|NCT04428502|521809579|FG000|Overall Study|Did not meet entrance criteria|14|||
144714744|NCT05288673|521809580|FG000|Overall Study|Consent withdrawn by subject|0|||
144714745|NCT05288673|521809581|FG001|Overall Study|Consent withdrawn by subject|0|||
144714746|NCT05288673|521809582|FG002|Overall Study|Consent withdrawn by subject|1|||
144714747|NCT00811070|521809586|FG000|Overall Study|Death|0|||
144714748|NCT00811070|521809587|FG001|Overall Study|Death|0|||
144714749|NCT00811070|521809588|FG002|Overall Study|Death|0|||
144714750|NCT00811070|521809589|FG003|Overall Study|Death|2|||
144714751|NCT00811070|521809590|FG004|Overall Study|Death|5|||
144714752|NCT00811070|521809591|FG005|Overall Study|Death|0|||
144714753|NCT00811070|521809586|FG000|Overall Study|Other|1|||
144714754|NCT00811070|521809587|FG001|Overall Study|Other|0|||
144714755|NCT00811070|521809588|FG002|Overall Study|Other|0|||
144714756|NCT00811070|521809589|FG003|Overall Study|Other|0|||
144714757|NCT00811070|521809590|FG004|Overall Study|Other|0|||
144714758|NCT00811070|521809591|FG005|Overall Study|Other|0|||
144714759|NCT00811070|521809586|FG000|Overall Study|Withdrawal by Subject|0|||
144714760|NCT00811070|521809587|FG001|Overall Study|Withdrawal by Subject|1|||
144714761|NCT00811070|521809588|FG002|Overall Study|Withdrawal by Subject|0|||
144714762|NCT00811070|521809589|FG003|Overall Study|Withdrawal by Subject|0|||
144714763|NCT00811070|521809590|FG004|Overall Study|Withdrawal by Subject|0|||
144714764|NCT00811070|521809591|FG005|Overall Study|Withdrawal by Subject|0|||
144714765|NCT00811070|521809586|FG000|Overall Study|Physician Decision|0|||
144714766|NCT00811070|521809587|FG001|Overall Study|Physician Decision|0|||
144714767|NCT00811070|521809588|FG002|Overall Study|Physician Decision|0|||
144714768|NCT00811070|521809589|FG003|Overall Study|Physician Decision|0|||
144714769|NCT00811070|521809590|FG004|Overall Study|Physician Decision|0|||
144714770|NCT00811070|521809591|FG005|Overall Study|Physician Decision|1|||
144714771|NCT00585039|521809593|FG000|Overall Study|medication spilled|2|||
144714772|NCT00585039|521809594|FG001|Overall Study|medication spilled|0|||
144714773|NCT04147611|521809595|FG000|Overall Study|Physician Decision|0|||
144714774|NCT04147611|521809596|FG001|Overall Study|Physician Decision|1|||
144714775|NCT01010230|521809597|FG000|Overall Study|Withdrawal by Subject|6|||
144714776|NCT01010230|521809598|FG001|Overall Study|Withdrawal by Subject|5|||
144714777|NCT01010230|521809597|FG000|Overall Study|Lost to Follow-up|4|||
144714778|NCT01010230|521809598|FG001|Overall Study|Lost to Follow-up|2|||
144714779|NCT01585831|521809605|FG000|Overall Study|Physician Decision|0|||
144714780|NCT01585831|521809606|FG001|Overall Study|Physician Decision|1|||
144714781|NCT01585831|521809605|FG000|Overall Study|Withdrawal by Subject|2|||
144714782|NCT01585831|521809606|FG001|Overall Study|Withdrawal by Subject|1|||
144714783|NCT04444752|521809607|FG000|Overall Study|Adverse Event|1|||
144714784|NCT04444752|521809608|FG001|Overall Study|Adverse Event|0|||
144714785|NCT04444752|521809609|FG002|Overall Study|Adverse Event|0|||
144714786|NCT04444752|521809610|FG003|Overall Study|Adverse Event|2|||
144714787|NCT04444752|521809607|FG000|Overall Study|Lost to Follow-up|2|||
144484128|NCT00514046|520970564|FG001|Overall Study|Disease progression on study|0|||
144484129|NCT00514046|520970565|FG002|Overall Study|Disease progression on study|2|||
144484130|NCT00514046|520970566|FG003|Overall Study|Disease progression on study|0|||
144484131|NCT00514046|520970567|FG004|Overall Study|Disease progression on study|0|||
144484132|NCT00514046|520970568|FG005|Overall Study|Disease progression on study|1|||
144484133|NCT00514046|520970569|FG006|Overall Study|Disease progression on study|0|||
144484134|NCT00514046|520970570|FG007|Overall Study|Disease progression on study|0|||
144484135|NCT00514046|520970571|FG008|Overall Study|Disease progression on study|0|||
144484136|NCT00655551|520970572|FG000|All Periods Combined|Adverse Event|0|||
144484137|NCT00655551|520970573|FG001|All Periods Combined|Adverse Event|3|||
144484138|NCT00655551|520970574|FG002|All Periods Combined|Adverse Event|4|||
144484139|NCT00655551|520970572|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
144484140|NCT00655551|520970573|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
144484141|NCT00655551|520970574|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
144484142|NCT00655551|520970572|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
144484143|NCT00655551|520970573|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
144484144|NCT00655551|520970574|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
144484145|NCT00655551|520970572|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
144484146|NCT00655551|520970573|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
144484147|NCT00655551|520970574|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
144484148|NCT01734434|520970575|FG000|Overall Study|Death Infant|3|||
144484149|NCT01734434|520970576|FG001|Overall Study|Death Infant|1|||
144484150|NCT01734434|520970577|FG002|Overall Study|Death Infant|17|||
144484151|NCT01734434|520970578|FG003|Overall Study|Death Infant|5|||
144484152|NCT01734434|520970575|FG000|Overall Study|Lost to Follow-up|2|||
144484153|NCT01734434|520970576|FG001|Overall Study|Lost to Follow-up|9|||
144484154|NCT01734434|520970577|FG002|Overall Study|Lost to Follow-up|67|||
144484155|NCT01734434|520970578|FG003|Overall Study|Lost to Follow-up|11|||
144484156|NCT01734434|520970575|FG000|Overall Study|No Live Birth|1|||
144484157|NCT01734434|520970576|FG001|Overall Study|No Live Birth|2|||
144484158|NCT01734434|520970577|FG002|Overall Study|No Live Birth|32|||
144484159|NCT01734434|520970578|FG003|Overall Study|No Live Birth|6|||
144484160|NCT01734434|520970575|FG000|Overall Study|Withdrawal by Subject|4|||
144484161|NCT01734434|520970576|FG001|Overall Study|Withdrawal by Subject|0|||
144484162|NCT01734434|520970577|FG002|Overall Study|Withdrawal by Subject|8|||
144484163|NCT01734434|520970578|FG003|Overall Study|Withdrawal by Subject|1|||
144484164|NCT01734434|520970575|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
144484165|NCT01734434|520970576|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
144484166|NCT01734434|520970577|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
144484167|NCT01734434|520970578|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
144484168|NCT01734434|520970575|FG000|Overall Study|Subject Not Reachable|0|||
144484169|NCT01734434|520970576|FG001|Overall Study|Subject Not Reachable|0|||
144484170|NCT01734434|520970577|FG002|Overall Study|Subject Not Reachable|1|||
144484171|NCT01734434|520970578|FG003|Overall Study|Subject Not Reachable|0|||
144484172|NCT01734434|520970575|FG000|Overall Study|Treatment Defaulter|0|||
144484173|NCT01734434|520970576|FG001|Overall Study|Treatment Defaulter|0|||
144484174|NCT01734434|520970577|FG002|Overall Study|Treatment Defaulter|1|||
144484175|NCT01734434|520970578|FG003|Overall Study|Treatment Defaulter|0|||
144484176|NCT01734434|520970575|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
144484177|NCT01734434|520970576|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
144484178|NCT01734434|520970577|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
144484179|NCT01734434|520970578|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
144484180|NCT01734434|520970575|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
144484181|NCT01734434|520970576|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
144484182|NCT01734434|520970577|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
144484183|NCT01734434|520970578|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
144484184|NCT03681639|520972256|FG000|Overall Study|Death|4|||
144484185|NCT03681639|520972256|FG000|Overall Study|Lost to Follow-up|2|||
144484186|NCT03681639|520972256|FG000|Overall Study|Withdrawal by Subject|1|||
144484187|NCT03681639|520972256|FG000|Overall Study|Adverse Event|2|||
144484188|NCT00802737|520972257|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
144484189|NCT00802737|520972258|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
144484190|NCT00802737|520972259|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
144484191|NCT00802737|520972257|FG000|Overall Study|Death|6|||
144484192|NCT00802737|520972258|FG001|Overall Study|Death|5|||
144484193|NCT00802737|520972259|FG002|Overall Study|Death|1|||
144484194|NCT00802737|520972257|FG000|Overall Study|Adverse Event|1|||
144484195|NCT00802737|520972258|FG001|Overall Study|Adverse Event|0|||
144484196|NCT00802737|520972259|FG002|Overall Study|Adverse Event|0|||
144484197|NCT00802737|520972257|FG000|Overall Study|Received Prohibited Therapy|1|||
144484198|NCT00802737|520972258|FG001|Overall Study|Received Prohibited Therapy|0|||
144484199|NCT00802737|520972259|FG002|Overall Study|Received Prohibited Therapy|0|||
144484200|NCT00802737|520972257|FG000|Overall Study|Ongoing CLL-Treatment|0|||
144484201|NCT00802737|520972258|FG001|Overall Study|Ongoing CLL-Treatment|1|||
144484202|NCT00802737|520972259|FG002|Overall Study|Ongoing CLL-Treatment|0|||
144484203|NCT00802737|520972257|FG000|Overall Study|Participant too Unwell|0|||
144484204|NCT00802737|520972258|FG001|Overall Study|Participant too Unwell|2|||
144484205|NCT00802737|520972259|FG002|Overall Study|Participant too Unwell|0|||
144484206|NCT01625910|520972265|FG000|Overall Study|Lost to Follow-up|3|||
144484207|NCT01625910|520972266|FG001|Overall Study|Lost to Follow-up|4|||
144484208|NCT00358215|520972267|FG000|Overall Study|Ineligibility determined|4|||
144484209|NCT00358215|520972268|FG001|Overall Study|Ineligibility determined|3|||
144484210|NCT00358215|520972267|FG000|Overall Study|Adverse Event|83|||
144484211|NCT00358215|520972268|FG001|Overall Study|Adverse Event|65|||
144484212|NCT00358215|520972267|FG000|Overall Study|Withdrawal by Subject|111|||
144484213|NCT00358215|520972268|FG001|Overall Study|Withdrawal by Subject|102|||
144484214|NCT00358215|520972267|FG000|Overall Study|Participant request|65|||
144484215|NCT00358215|520972268|FG001|Overall Study|Participant request|64|||
144484216|NCT00358215|520972267|FG000|Overall Study|Physician Decision|47|||
144484217|NCT00358215|520972268|FG001|Overall Study|Physician Decision|39|||
144484218|NCT00358215|520972267|FG000|Overall Study|Lost to Follow-up|16|||
144484219|NCT00358215|520972268|FG001|Overall Study|Lost to Follow-up|22|||
144484220|NCT00358215|520972267|FG000|Overall Study|Death|265|||
144484221|NCT00358215|520972268|FG001|Overall Study|Death|281|||
144484222|NCT00358215|520972267|FG000|Overall Study|Protocol Violation|64|||
144484223|NCT00358215|520972268|FG001|Overall Study|Protocol Violation|59|||
144484224|NCT00358215|520972267|FG000|Overall Study|Pregnancy|1|||
144484225|NCT00358215|520972268|FG001|Overall Study|Pregnancy|0|||
144484226|NCT00358215|520972267|FG000|Overall Study|Other|21|||
144484227|NCT00358215|520972268|FG001|Overall Study|Other|14|||
144484228|NCT00358215|520972267|FG000|Overall Study|Did not receive investigational product|2|||
144484229|NCT00358215|520972268|FG001|Overall Study|Did not receive investigational product|3|||
144484230|NCT01681368|520972271|FG000|Overall Study|Refused further treatment|1|||
144484231|NCT01681368|520972271|FG000|Overall Study|Refused further follow up|1|||
144484232|NCT00373295|520972274|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
144484233|NCT00373295|520972275|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
144484234|NCT00373295|520972276|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
144484235|NCT00373295|520972277|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
144484236|NCT00373295|520972278|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
144484237|NCT00373295|520972279|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
144484238|NCT00962585|520972286|FG000|Overall Study|Adverse Event|0|||
144484239|NCT00962585|520972287|FG001|Overall Study|Adverse Event|2|||
144484240|NCT00962585|520972288|FG002|Overall Study|Adverse Event|1|||
144484241|NCT00962585|520972289|FG003|Overall Study|Adverse Event|0|||
144484242|NCT00962585|520972286|FG000|Overall Study|Lost to Follow-up|3|||
144484243|NCT00962585|520972287|FG001|Overall Study|Lost to Follow-up|0|||
144484244|NCT00962585|520972288|FG002|Overall Study|Lost to Follow-up|1|||
144484245|NCT00962585|520972289|FG003|Overall Study|Lost to Follow-up|0|||
144484246|NCT00962585|520972286|FG000|Overall Study|Protocol Violation|0|||
144484247|NCT00962585|520972287|FG001|Overall Study|Protocol Violation|0|||
144484248|NCT00962585|520972288|FG002|Overall Study|Protocol Violation|1|||
144484249|NCT00962585|520972289|FG003|Overall Study|Protocol Violation|0|||
144484250|NCT00962585|520972286|FG000|Overall Study|Withdrawal by Subject|1|||
144484251|NCT00962585|520972287|FG001|Overall Study|Withdrawal by Subject|0|||
144484252|NCT00962585|520972288|FG002|Overall Study|Withdrawal by Subject|0|||
144484253|NCT00962585|520972289|FG003|Overall Study|Withdrawal by Subject|0|||
144484254|NCT00962585|520972286|FG000|Overall Study|Withdrew Consent|2|||
144484255|NCT00962585|520972287|FG001|Overall Study|Withdrew Consent|0|||
144484256|NCT00962585|520972288|FG002|Overall Study|Withdrew Consent|0|||
144484257|NCT00962585|520972289|FG003|Overall Study|Withdrew Consent|0|||
144484258|NCT02254421|520972290|FG000|Overall Study|Randomized but Not Treated|1|||
144484259|NCT02254421|520972291|FG001|Overall Study|Randomized but Not Treated|0|||
144484260|NCT02254421|520972290|FG000|Overall Study|Death|0|||
144484261|NCT02254421|520972291|FG001|Overall Study|Death|2|||
144484262|NCT02254421|520972290|FG000|Overall Study|Withdrew Consent|1|||
144484263|NCT02254421|520972291|FG001|Overall Study|Withdrew Consent|1|||
144484264|NCT01729728|520972298|FG000|Overall Study|Adverse Event|0|||
144484265|NCT01729728|520972299|FG001|Overall Study|Adverse Event|6|||
144484266|NCT01729728|520972300|FG002|Overall Study|Adverse Event|0|||
144484267|NCT01729728|520972298|FG000|Overall Study|Protocol Violation|1|||
144484268|NCT01729728|520972299|FG001|Overall Study|Protocol Violation|0|||
144484269|NCT01729728|520972300|FG002|Overall Study|Protocol Violation|1|||
144484270|NCT01009047|520972303|FG000|Overall Study|Adverse Event|5|||
144484271|NCT01009047|520972304|FG001|Overall Study|Adverse Event|0|||
144484272|NCT01009047|520972303|FG000|Overall Study|Lost to Follow-up|0|||
144484273|NCT01009047|520972304|FG001|Overall Study|Lost to Follow-up|2|||
144484274|NCT01009047|520972303|FG000|Overall Study|Lack of Efficacy|4|||
144484275|NCT01009047|520972304|FG001|Overall Study|Lack of Efficacy|11|||
144484276|NCT01009047|520972303|FG000|Overall Study|Withdrawal by consent|16|||
144484277|NCT01009047|520972304|FG001|Overall Study|Withdrawal by consent|11|||
144484278|NCT01009047|520972303|FG000|Overall Study|Other|3|||
144484279|NCT01009047|520972304|FG001|Overall Study|Other|2|||
144484280|NCT01630590|520972306|FG000|Overall Study|Adverse Event|9|||
144484281|NCT01630590|520972306|FG000|Overall Study|Lack of Efficacy|37|||
144484282|NCT01630590|520972306|FG000|Overall Study|Withdrawal by Subject|4|||
144484283|NCT01630590|520972306|FG000|Overall Study|2nd primary tumor|2|||
144484284|NCT01630590|520972306|FG000|Overall Study|Automobile accident|1|||
144484285|NCT01630590|520972306|FG000|Overall Study|Maximum benefit|4|||
144484286|NCT02366936|520972307|FG000|Overall Study|Withdrawal by Subject|2|||
144484287|NCT02366936|520972307|FG000|Overall Study|Lost to Follow-up|4|||
144484288|NCT02366936|520972307|FG000|Overall Study|Physician Decision|2|||
144484289|NCT01751113|520972310|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
144484290|NCT01751113|520972311|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
144484291|NCT01751113|520972312|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
144484292|NCT01751113|520972313|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
144484293|NCT01751113|520972314|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
144484294|NCT01751113|520972315|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
144484295|NCT01751113|520972310|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
144484296|NCT01751113|520972311|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
144484297|NCT01751113|520972312|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
144484298|NCT01751113|520972313|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
144484299|NCT01751113|520972314|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
144484300|NCT01751113|520972315|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
144484301|NCT01558674|520972316|FG000|Part 1|Study Terminated by Sponsor|10|||
144484302|NCT01558674|520972317|FG001|Part 1|Study Terminated by Sponsor|0|||
144484303|NCT01558674|520972316|FG000|Part 1|Withdrawal by Subject|1|||
144484304|NCT01558674|520972317|FG001|Part 1|Withdrawal by Subject|0|||
144484305|NCT00924469|520972318|FG000|Overall Study|Adverse Event|2|||
144484306|NCT00924469|520972319|FG001|Overall Study|Adverse Event|0|||
144484307|NCT00924469|520972318|FG000|Overall Study|Withdrawal by Subject|0|||
144484308|NCT00924469|520972319|FG001|Overall Study|Withdrawal by Subject|1|||
144484309|NCT00924469|520972318|FG000|Overall Study|Lost to Follow-up|0|||
144484310|NCT00924469|520972319|FG001|Overall Study|Lost to Follow-up|1|||
144484311|NCT00630058|520972320|FG000|Overall Study|Adverse Event|1|||
144484312|NCT00630058|520972321|FG001|Overall Study|Adverse Event|1|||
144484313|NCT00630058|520972320|FG000|Overall Study|Withdrawal by Subject|0|||
144484314|NCT00630058|520972321|FG001|Overall Study|Withdrawal by Subject|1|||
144484315|NCT00630058|520972320|FG000|Overall Study|stopping criteria|3|||
144484316|NCT00630058|520972321|FG001|Overall Study|stopping criteria|2|||
144484317|NCT01146574|520972322|FG000|Overall Study|Death|0|||
144484318|NCT01146574|520972323|FG001|Overall Study|Death|1|||
144484319|NCT01146574|520972324|FG002|Overall Study|Death|1|||
144484320|NCT01146574|520972325|FG003|Overall Study|Death|0|||
144484321|NCT01146574|520972326|FG004|Overall Study|Death|0|||
144484322|NCT01146574|520972327|FG005|Overall Study|Death|0|||
144484323|NCT01146574|520972328|FG006|Overall Study|Death|0|||
144484324|NCT01146574|520972322|FG000|Overall Study|Other reasons|0|||
144484325|NCT01146574|520972323|FG001|Overall Study|Other reasons|0|||
144484326|NCT01146574|520972324|FG002|Overall Study|Other reasons|3|||
144484327|NCT01146574|520972325|FG003|Overall Study|Other reasons|0|||
144484328|NCT01146574|520972326|FG004|Overall Study|Other reasons|0|||
144484329|NCT01146574|520972327|FG005|Overall Study|Other reasons|0|||
144484330|NCT01146574|520972328|FG006|Overall Study|Other reasons|0|||
144484331|NCT01146574|520972322|FG000|Overall Study|Kidney transplant|0|||
144484332|NCT01146574|520972323|FG001|Overall Study|Kidney transplant|0|||
144484333|NCT01146574|520972324|FG002|Overall Study|Kidney transplant|1|||
144484334|NCT01146574|520972325|FG003|Overall Study|Kidney transplant|1|||
144484335|NCT01146574|520972326|FG004|Overall Study|Kidney transplant|0|||
144484336|NCT01146574|520972327|FG005|Overall Study|Kidney transplant|0|||
144484337|NCT01146574|520972328|FG006|Overall Study|Kidney transplant|0|||
144484338|NCT01146574|520972322|FG000|Overall Study|Withdrew consent|0|||
144484339|NCT01146574|520972323|FG001|Overall Study|Withdrew consent|0|||
144484340|NCT01146574|520972324|FG002|Overall Study|Withdrew consent|1|||
144484341|NCT01146574|520972325|FG003|Overall Study|Withdrew consent|1|||
144484342|NCT01146574|520972326|FG004|Overall Study|Withdrew consent|2|||
144484343|NCT01146574|520972327|FG005|Overall Study|Withdrew consent|1|||
144484344|NCT01146574|520972328|FG006|Overall Study|Withdrew consent|1|||
144484345|NCT00849680|520972333|FG000|Overall Study|Adverse Event|0|||
144484346|NCT00849680|520972334|FG001|Overall Study|Adverse Event|0|||
144484347|NCT00849680|520972335|FG002|Overall Study|Adverse Event|0|||
144484348|NCT00849680|520972336|FG003|Overall Study|Adverse Event|0|||
144484349|NCT00849680|520972337|FG004|Overall Study|Adverse Event|0|||
144484350|NCT00849680|520972338|FG005|Overall Study|Adverse Event|0|||
144484351|NCT00849680|520972339|FG006|Overall Study|Adverse Event|2|||
144484352|NCT00849680|520972340|FG007|Overall Study|Adverse Event|0|||
144484353|NCT00849680|520972333|FG000|Overall Study|Lost to Follow-up|7|||
144484354|NCT00849680|520972334|FG001|Overall Study|Lost to Follow-up|3|||
144484355|NCT00849680|520972335|FG002|Overall Study|Lost to Follow-up|12|||
144484356|NCT00849680|520972336|FG003|Overall Study|Lost to Follow-up|11|||
144484357|NCT00849680|520972337|FG004|Overall Study|Lost to Follow-up|8|||
144484358|NCT00849680|520972338|FG005|Overall Study|Lost to Follow-up|11|||
144484359|NCT00849680|520972339|FG006|Overall Study|Lost to Follow-up|12|||
144484360|NCT00849680|520972340|FG007|Overall Study|Lost to Follow-up|5|||
144484361|NCT00849680|520972333|FG000|Overall Study|Subject moved|1|||
144484362|NCT00849680|520972334|FG001|Overall Study|Subject moved|0|||
144484363|NCT00849680|520972335|FG002|Overall Study|Subject moved|3|||
144484364|NCT00849680|520972336|FG003|Overall Study|Subject moved|1|||
144484365|NCT00849680|520972337|FG004|Overall Study|Subject moved|0|||
144484366|NCT00849680|520972338|FG005|Overall Study|Subject moved|2|||
144484367|NCT00849680|520972339|FG006|Overall Study|Subject moved|2|||
144484368|NCT00849680|520972340|FG007|Overall Study|Subject moved|2|||
144484369|NCT00849680|520972333|FG000|Overall Study|Withdrawal by Subject|2|||
144484370|NCT00849680|520972334|FG001|Overall Study|Withdrawal by Subject|0|||
144484371|NCT00849680|520972335|FG002|Overall Study|Withdrawal by Subject|0|||
144484372|NCT00849680|520972336|FG003|Overall Study|Withdrawal by Subject|2|||
144484373|NCT00849680|520972337|FG004|Overall Study|Withdrawal by Subject|2|||
144484374|NCT00849680|520972338|FG005|Overall Study|Withdrawal by Subject|2|||
144484375|NCT00849680|520972339|FG006|Overall Study|Withdrawal by Subject|1|||
144484376|NCT00849680|520972340|FG007|Overall Study|Withdrawal by Subject|1|||
144484377|NCT00849680|520972333|FG000|Overall Study|Subject unable to comply with protocol|1|||
144484378|NCT00849680|520972334|FG001|Overall Study|Subject unable to comply with protocol|0|||
144484379|NCT00849680|520972335|FG002|Overall Study|Subject unable to comply with protocol|0|||
144484380|NCT00849680|520972336|FG003|Overall Study|Subject unable to comply with protocol|0|||
144484381|NCT00849680|520972337|FG004|Overall Study|Subject unable to comply with protocol|0|||
144484382|NCT00849680|520972338|FG005|Overall Study|Subject unable to comply with protocol|0|||
144484383|NCT00849680|520972339|FG006|Overall Study|Subject unable to comply with protocol|0|||
144484384|NCT00849680|520972340|FG007|Overall Study|Subject unable to comply with protocol|0|||
144484385|NCT03053492|520972341|FG000|Overall Study|Adverse Event|1|||
144484386|NCT03053492|520972342|FG001|Overall Study|Adverse Event|1|||
144484387|NCT03053492|520972341|FG000|Overall Study|Withdrawal by Subject|7|||
144484388|NCT03053492|520972342|FG001|Overall Study|Withdrawal by Subject|5|||
144484389|NCT03382600|520972344|FG000|Overall Study|Adverse Event|3|||
144484390|NCT03382600|520972345|FG001|Overall Study|Adverse Event|3|||
144484391|NCT03382600|520972344|FG000|Overall Study|Clinical Disease Progression|2|||
144484392|NCT03382600|520972345|FG001|Overall Study|Clinical Disease Progression|4|||
144484393|NCT03382600|520972344|FG000|Overall Study|Radiological Progression|40|||
144484394|NCT03382600|520972345|FG001|Overall Study|Radiological Progression|31|||
144484395|NCT03382600|520972344|FG000|Overall Study|Withdrawal by Subject|0|||
144484396|NCT03382600|520972345|FG001|Overall Study|Withdrawal by Subject|1|||
144484397|NCT03382600|520972344|FG000|Overall Study|Other|9|||
144484398|NCT03382600|520972345|FG001|Overall Study|Other|7|||
144484399|NCT00967018|520972346|FG000|Overall Study|Adverse Event|2|||
144484400|NCT00967018|520972346|FG000|Overall Study|Physician Decision|7|||
144484401|NCT00967018|520972346|FG000|Overall Study|Lost to Follow-up|2|||
144484402|NCT00967018|520972346|FG000|Overall Study|Withdrawal by Subject|1|||
144484403|NCT00967018|520972346|FG000|Overall Study|Miscellaneous Reasons|9|||
144484404|NCT04276090|520972349|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
144484405|NCT04276090|520972350|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
144484406|NCT04642469|520972351|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
144484407|NCT04642469|520972352|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
144484408|NCT04642469|520972351|FG000|Overall Study|Death|1|||
144484409|NCT04642469|520972352|FG001|Overall Study|Death|2|||
144484410|NCT04642469|520972351|FG000|Overall Study|Study/site closed following amendment 1|11|||
144484411|NCT04642469|520972352|FG001|Overall Study|Study/site closed following amendment 1|11|||
144484412|NCT04642469|520972351|FG000|Overall Study|Other|1|||
144484413|NCT04642469|520972352|FG001|Overall Study|Other|1|||
144714788|NCT04444752|521809608|FG001|Overall Study|Lost to Follow-up|6|||
144714789|NCT04444752|521809609|FG002|Overall Study|Lost to Follow-up|2|||
144714790|NCT04444752|521809610|FG003|Overall Study|Lost to Follow-up|5|||
144714791|NCT04444752|521809607|FG000|Overall Study|Physician Decision|0|||
144714792|NCT04444752|521809608|FG001|Overall Study|Physician Decision|0|||
144714793|NCT04444752|521809609|FG002|Overall Study|Physician Decision|0|||
144714794|NCT04444752|521809610|FG003|Overall Study|Physician Decision|2|||
144714795|NCT04444752|521809607|FG000|Overall Study|Pregnancy|0|||
144714796|NCT04444752|521809608|FG001|Overall Study|Pregnancy|0|||
144714797|NCT04444752|521809609|FG002|Overall Study|Pregnancy|0|||
144714798|NCT04444752|521809610|FG003|Overall Study|Pregnancy|1|||
144714799|NCT04444752|521809607|FG000|Overall Study|Withdrawal by Subject|6|||
144714800|NCT04444752|521809608|FG001|Overall Study|Withdrawal by Subject|5|||
144714801|NCT04444752|521809609|FG002|Overall Study|Withdrawal by Subject|3|||
144714802|NCT04444752|521809610|FG003|Overall Study|Withdrawal by Subject|4|||
144714803|NCT04444752|521809607|FG000|Overall Study|Protocol Violation|1|||
144714804|NCT04444752|521809608|FG001|Overall Study|Protocol Violation|1|||
144714805|NCT04444752|521809609|FG002|Overall Study|Protocol Violation|0|||
144714806|NCT04444752|521809610|FG003|Overall Study|Protocol Violation|0|||
144714807|NCT04444752|521809607|FG000|Overall Study|Patient moving out of town|1|||
144714808|NCT04444752|521809608|FG001|Overall Study|Patient moving out of town|0|||
144714809|NCT04444752|521809609|FG002|Overall Study|Patient moving out of town|0|||
144714810|NCT04444752|521809610|FG003|Overall Study|Patient moving out of town|1|||
144714811|NCT04444752|521809607|FG000|Overall Study|Lack of Efficacy|0|||
144714812|NCT04444752|521809608|FG001|Overall Study|Lack of Efficacy|0|||
144714813|NCT04444752|521809609|FG002|Overall Study|Lack of Efficacy|0|||
144714814|NCT04444752|521809610|FG003|Overall Study|Lack of Efficacy|1|||
144714815|NCT04444752|521809607|FG000|Overall Study|Death|0|||
144714816|NCT04444752|521809608|FG001|Overall Study|Death|0|||
144714817|NCT04444752|521809609|FG002|Overall Study|Death|1|||
144714818|NCT04444752|521809610|FG003|Overall Study|Death|0|||
144714819|NCT00579254|521809611|FG000|Overall Study|Lost to Follow-up|39|||
144714820|NCT00579254|521809611|FG000|Overall Study|Discontinued when study terminated|73|||
144714821|NCT02557672|521809612|FG000|Overall Study|Withdrawal by Subject|4|||
144714822|NCT02557672|521809613|FG001|Overall Study|Withdrawal by Subject|2|||
144484414|NCT04642469|520972351|FG000|Overall Study|Withdrawal by Subject|1|||
144484415|NCT04642469|520972352|FG001|Overall Study|Withdrawal by Subject|0|||
144714823|NCT01623830|521811301|FG000|Overall Study|Withdrawal by Subject|6|||
144714824|NCT01623830|521811302|FG001|Overall Study|Withdrawal by Subject|7|||
144714825|NCT01623830|521811301|FG000|Overall Study|Exclusion from Study|1|||
144484416|NCT01680458|520972358|FG000|Overall Study|Protocol Violation|3|||
144484417|NCT02302066|520972359|FG000|Overall Study|Adverse Event|1|||
144484418|NCT02302066|520972360|FG001|Overall Study|Adverse Event|1|||
144484419|NCT02302066|520972361|FG002|Overall Study|Adverse Event|3|||
144484420|NCT02302066|520972362|FG003|Overall Study|Adverse Event|0|||
144484421|NCT02302066|520972359|FG000|Overall Study|Lost to Follow-up|4|||
144484422|NCT02302066|520972360|FG001|Overall Study|Lost to Follow-up|5|||
144484423|NCT02302066|520972361|FG002|Overall Study|Lost to Follow-up|24|||
144484424|NCT02302066|520972362|FG003|Overall Study|Lost to Follow-up|7|||
144484425|NCT02302066|520972359|FG000|Overall Study|Withdrawal by Subject|25|||
144484426|NCT02302066|520972360|FG001|Overall Study|Withdrawal by Subject|58|||
144484427|NCT02302066|520972361|FG002|Overall Study|Withdrawal by Subject|124|||
144484428|NCT02302066|520972362|FG003|Overall Study|Withdrawal by Subject|33|||
144484429|NCT02302066|520972359|FG000|Overall Study|Pregnancy|2|||
144484430|NCT02302066|520972360|FG001|Overall Study|Pregnancy|10|||
144484431|NCT02302066|520972361|FG002|Overall Study|Pregnancy|12|||
144484432|NCT02302066|520972362|FG003|Overall Study|Pregnancy|0|||
144484433|NCT02302066|520972359|FG000|Overall Study|Reason Not Specified|1|||
144484434|NCT02302066|520972360|FG001|Overall Study|Reason Not Specified|1|||
144484435|NCT02302066|520972361|FG002|Overall Study|Reason Not Specified|9|||
144484436|NCT02302066|520972362|FG003|Overall Study|Reason Not Specified|1|||
144484437|NCT02180438|520972378|FG000|Overall Study|Lost to Follow-up|1|||
144714826|NCT01623830|521811302|FG001|Overall Study|Exclusion from Study|2|||
144714827|NCT01797120|521811307|FG000|Overall Study|Disesae progression|37|||
144714828|NCT01797120|521811308|FG001|Overall Study|Disesae progression|49|||
144714829|NCT01797120|521811307|FG000|Overall Study|Adverse Event|13|||
144714830|NCT01797120|521811308|FG001|Overall Study|Adverse Event|5|||
144714831|NCT01797120|521811307|FG000|Overall Study|Withdrawal by Subject|6|||
144714832|NCT01797120|521811308|FG001|Overall Study|Withdrawal by Subject|6|||
144714833|NCT01797120|521811307|FG000|Overall Study|Symptomatic progression|2|||
144714834|NCT01797120|521811308|FG001|Overall Study|Symptomatic progression|1|||
144714835|NCT01797120|521811307|FG000|Overall Study|Non-compliance|1|||
144714836|NCT01797120|521811308|FG001|Overall Study|Non-compliance|0|||
144714837|NCT01797120|521811307|FG000|Overall Study|Physician Decision|3|||
144714838|NCT01797120|521811308|FG001|Overall Study|Physician Decision|0|||
144714839|NCT01797120|521811307|FG000|Overall Study|still on treatment|2|||
144714840|NCT01797120|521811308|FG001|Overall Study|still on treatment|4|||
144714841|NCT01797120|521811307|FG000|Overall Study|never start protocol therapy|2|||
144714842|NCT01797120|521811308|FG001|Overall Study|never start protocol therapy|0|||
144714843|NCT04120194|521811318|FG000|Overall Study|Lost to Follow-up|11|||
144714844|NCT04120194|521811319|FG001|Overall Study|Lost to Follow-up|8|||
144714845|NCT04120194|521811318|FG000|Overall Study|Adverse Event|4|||
144714846|NCT04120194|521811319|FG001|Overall Study|Adverse Event|5|||
144714847|NCT04120194|521811318|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
144714848|NCT04120194|521811319|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
144714849|NCT04120194|521811318|FG000|Overall Study|Miscellaneous|4|||
144714850|NCT04120194|521811319|FG001|Overall Study|Miscellaneous|5|||
144714851|NCT00553540|521811320|FG000|Overall Study|discharged after first visit|2|||
144714852|NCT00553540|521811321|FG001|Overall Study|discharged after first visit|5|||
144714853|NCT02114931|521811331|FG000|Overall Study|Withdrawal by Subject|15|||
144714854|NCT02114931|521811332|FG001|Overall Study|Withdrawal by Subject|18|||
144714855|NCT02114931|521811331|FG000|Overall Study|Adverse Event|4|||
144714856|NCT02114931|521811332|FG001|Overall Study|Adverse Event|6|||
144714857|NCT02114931|521811331|FG000|Overall Study|Lost to Follow-up|3|||
144714858|NCT02114931|521811332|FG001|Overall Study|Lost to Follow-up|3|||
144714859|NCT02114931|521811331|FG000|Overall Study|Physician Decision|1|||
144714860|NCT02114931|521811332|FG001|Overall Study|Physician Decision|2|||
144714861|NCT02114931|521811331|FG000|Overall Study|Other|2|||
144714862|NCT02114931|521811332|FG001|Overall Study|Other|1|||
144714863|NCT03565211|521811336|FG000|Overall Study|Withdrawal by Subject|2|||
144714864|NCT03565211|521811336|FG000|Overall Study|Lost to Follow-up|1|||
144714865|NCT03565211|521811336|FG000|Overall Study|Adverse Event|44|||
144484438|NCT02058290|520972379|FG000|Overall Study|Protocol Violation|2|||
144484439|NCT02058290|520972380|FG001|Overall Study|Protocol Violation|1|||
144484440|NCT02058290|520972379|FG000|Overall Study|Physician Decision|1|||
144484441|NCT02058290|520972380|FG001|Overall Study|Physician Decision|0|||
144484442|NCT02058290|520972379|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
144714866|NCT03565211|521811336|FG000|Overall Study|Personal issues|1|||
144714867|NCT00667719|521811340|FG000|Overall Study|Adverse Event|39|||
144714868|NCT00667719|521811340|FG000|Overall Study|Abnormal Test Procedure|1|||
144714869|NCT00667719|521811340|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144714870|NCT00667719|521811340|FG000|Overall Study|Protocol Violation|3|||
144714871|NCT00667719|521811340|FG000|Overall Study|Withdrawal by Subject|17|||
144484443|NCT02058290|520972380|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
144484444|NCT02058290|520972379|FG000|Overall Study|Withdrawal by Subject|0|||
144484445|NCT02058290|520972380|FG001|Overall Study|Withdrawal by Subject|1|||
144714872|NCT00667719|521811340|FG000|Overall Study|Lost to Follow-up|8|||
144714873|NCT03840135|521811341|FG000|Overall Study|Protocol Violation|6|||
144484446|NCT00785707|520972382|FG000|Overall Study|Lost to Follow-up|7|||
144484447|NCT00105586|520972385|FG000|Overall Study|Adverse Event|4|||
144484448|NCT00105586|520972386|FG001|Overall Study|Adverse Event|3|||
144484449|NCT00105586|520972385|FG000|Overall Study|Physician Decision|13|||
144484450|NCT00105586|520972386|FG001|Overall Study|Physician Decision|13|||
144484451|NCT02262260|520972387|FG000|Overall Study|Adverse Event|4|||
144484452|NCT02262260|520972388|FG001|Overall Study|Adverse Event|1|||
144484453|NCT02262260|520972387|FG000|Overall Study|Withdrawal of consent|4|||
144484454|NCT02262260|520972388|FG001|Overall Study|Withdrawal of consent|2|||
144484455|NCT02262260|520972387|FG000|Overall Study|Lost to Follow-up|1|||
144484456|NCT02262260|520972388|FG001|Overall Study|Lost to Follow-up|2|||
144484457|NCT02262260|520972387|FG000|Overall Study|Protocol deviation|2|||
144484458|NCT02262260|520972388|FG001|Overall Study|Protocol deviation|5|||
144484459|NCT02696902|520972393|FG000|Overall Study|Lost to Follow-up|0|||
144484460|NCT02696902|520972394|FG001|Overall Study|Lost to Follow-up|1|||
144484461|NCT02696902|520972395|FG002|Overall Study|Lost to Follow-up|1|||
144484462|NCT02696902|520972393|FG000|Overall Study|Withdrawal by Subject|0|||
144484463|NCT02696902|520972394|FG001|Overall Study|Withdrawal by Subject|0|||
144484464|NCT02696902|520972395|FG002|Overall Study|Withdrawal by Subject|1|||
144484465|NCT02696902|520972393|FG000|Overall Study|Death|19|||
144484466|NCT02696902|520972394|FG001|Overall Study|Death|3|||
144484467|NCT02696902|520972395|FG002|Overall Study|Death|24|||
144484468|NCT02696902|520972393|FG000|Overall Study|Participant not fit post-randomization|0|||
144484469|NCT02696902|520972394|FG001|Overall Study|Participant not fit post-randomization|0|||
144484470|NCT02696902|520972395|FG002|Overall Study|Participant not fit post-randomization|1|||
144484471|NCT02696902|520972393|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
144484472|NCT02696902|520972394|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
144484473|NCT02696902|520972395|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
144484474|NCT02696902|520972393|FG000|Overall Study|Principal investigator's decision|1|||
144484475|NCT02696902|520972394|FG001|Overall Study|Principal investigator's decision|0|||
144484476|NCT02696902|520972395|FG002|Overall Study|Principal investigator's decision|0|||
144484477|NCT02696902|520972393|FG000|Overall Study|Sponsor's decision|1|||
144484478|NCT02696902|520972394|FG001|Overall Study|Sponsor's decision|0|||
144484479|NCT02696902|520972395|FG002|Overall Study|Sponsor's decision|0|||
144484480|NCT02696902|520972393|FG000|Overall Study|Transferred to other hospital|1|||
144484481|NCT02696902|520972394|FG001|Overall Study|Transferred to other hospital|0|||
144484482|NCT02696902|520972395|FG002|Overall Study|Transferred to other hospital|0|||
144484483|NCT03406702|520972400|FG000|Overall Study|Missed Day 27 Dosing|1|||
144484484|NCT00383240|520972410|FG000|Overall Study|Adverse Event|4|||
144484485|NCT00383240|520972411|FG001|Overall Study|Adverse Event|6|||
144484486|NCT00383240|520972412|FG002|Overall Study|Adverse Event|9|||
144484487|NCT00383240|520972413|FG003|Overall Study|Adverse Event|7|||
144484488|NCT00383240|520972410|FG000|Overall Study|Treatment Failure|8|||
144484489|NCT00383240|520972411|FG001|Overall Study|Treatment Failure|13|||
144484490|NCT00383240|520972412|FG002|Overall Study|Treatment Failure|47|||
144484491|NCT00383240|520972413|FG003|Overall Study|Treatment Failure|46|||
144484492|NCT00383240|520972410|FG000|Overall Study|Lost to Follow-up|3|||
144484493|NCT00383240|520972411|FG001|Overall Study|Lost to Follow-up|0|||
144484494|NCT00383240|520972412|FG002|Overall Study|Lost to Follow-up|0|||
144484495|NCT00383240|520972413|FG003|Overall Study|Lost to Follow-up|2|||
144484496|NCT00383240|520972410|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
144484497|NCT00383240|520972411|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
144484498|NCT00383240|520972412|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
144484499|NCT00383240|520972413|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
144484500|NCT00383240|520972410|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
144484501|NCT00383240|520972411|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
144484502|NCT00383240|520972412|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
144484503|NCT00383240|520972413|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
144484504|NCT00383240|520972410|FG000|Overall Study|Protocol Violation|4|||
144484505|NCT00383240|520972411|FG001|Overall Study|Protocol Violation|5|||
144484506|NCT00383240|520972412|FG002|Overall Study|Protocol Violation|9|||
144484507|NCT00383240|520972413|FG003|Overall Study|Protocol Violation|6|||
144484508|NCT00383240|520972410|FG000|Overall Study|Did not meet protocol eligibility|9|||
144484509|NCT00383240|520972411|FG001|Overall Study|Did not meet protocol eligibility|4|||
144484510|NCT00383240|520972412|FG002|Overall Study|Did not meet protocol eligibility|9|||
144484511|NCT00383240|520972413|FG003|Overall Study|Did not meet protocol eligibility|3|||
144484512|NCT00383240|520972410|FG000|Overall Study|Administrative|1|||
144484513|NCT00383240|520972411|FG001|Overall Study|Administrative|1|||
144484514|NCT00383240|520972412|FG002|Overall Study|Administrative|0|||
144484515|NCT00383240|520972413|FG003|Overall Study|Administrative|0|||
144484516|NCT02049710|520972414|FG000|Overall Study|Lost to Follow-up|319|||
144484517|NCT02049710|520972415|FG001|Overall Study|Lost to Follow-up|324|||
144484518|NCT03391960|520972416|FG000|Overall Study|Protocol Violation|0|||
144484519|NCT03391960|520972417|FG001|Overall Study|Protocol Violation|0|||
144484520|NCT02924389|520972419|FG000|Overall Study|Lost to Follow-up|1|||
144484521|NCT02924389|520972420|FG001|Overall Study|Lost to Follow-up|0|||
144484522|NCT02924389|520972419|FG000|Overall Study|Physician Decision|2|||
144484523|NCT02924389|520972420|FG001|Overall Study|Physician Decision|0|||
144484524|NCT02924389|520972419|FG000|Overall Study|Withdrawal by Subject|3|||
144484525|NCT02924389|520972420|FG001|Overall Study|Withdrawal by Subject|0|||
144484526|NCT02924389|520972419|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
144484527|NCT02924389|520972420|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
144484528|NCT00654940|520974454|FG000|Period 1|Adverse Event|0|||
144484529|NCT00654940|520974455|FG001|Period 1|Adverse Event|1|||
144484530|NCT00654940|520974454|FG000|Period 1|Intolerable Pain Level|1|||
144484531|NCT00654940|520974455|FG001|Period 1|Intolerable Pain Level|0|||
144484532|NCT00581113|520974456|FG000|Overall Study|Withdrawal by Subject|0|||
144484533|NCT00581113|520974457|FG001|Overall Study|Withdrawal by Subject|1|||
144484534|NCT00619476|520974458|FG000|Overall Study|Adverse Event|12|||
144484535|NCT00619476|520974459|FG001|Overall Study|Adverse Event|6|||
144484536|NCT00619476|520974460|FG002|Overall Study|Adverse Event|12|||
144484537|NCT00619476|520974461|FG003|Overall Study|Adverse Event|16|||
144484538|NCT00619476|520974458|FG000|Overall Study|Lack of Efficacy|6|||
144484539|NCT00619476|520974459|FG001|Overall Study|Lack of Efficacy|1|||
144484540|NCT00619476|520974460|FG002|Overall Study|Lack of Efficacy|1|||
144484541|NCT00619476|520974461|FG003|Overall Study|Lack of Efficacy|4|||
144484542|NCT00619476|520974458|FG000|Overall Study|Protocol Violation|5|||
144484543|NCT00619476|520974459|FG001|Overall Study|Protocol Violation|4|||
144484544|NCT00619476|520974460|FG002|Overall Study|Protocol Violation|4|||
144484545|NCT00619476|520974461|FG003|Overall Study|Protocol Violation|9|||
144484546|NCT00619476|520974458|FG000|Overall Study|Lost to Follow-up|1|||
144484547|NCT00619476|520974459|FG001|Overall Study|Lost to Follow-up|2|||
144484548|NCT00619476|520974460|FG002|Overall Study|Lost to Follow-up|0|||
144484549|NCT00619476|520974461|FG003|Overall Study|Lost to Follow-up|1|||
144484550|NCT00619476|520974458|FG000|Overall Study|Investigator Discretion|2|||
144484551|NCT00619476|520974459|FG001|Overall Study|Investigator Discretion|2|||
144484552|NCT00619476|520974460|FG002|Overall Study|Investigator Discretion|2|||
144484553|NCT00619476|520974461|FG003|Overall Study|Investigator Discretion|0|||
144484554|NCT00619476|520974458|FG000|Overall Study|Withdrawal by Subject|5|||
144484555|NCT00619476|520974459|FG001|Overall Study|Withdrawal by Subject|7|||
144484556|NCT00619476|520974460|FG002|Overall Study|Withdrawal by Subject|5|||
144484557|NCT00619476|520974461|FG003|Overall Study|Withdrawal by Subject|4|||
144484558|NCT02169830|520974467|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
144484559|NCT02169830|520974468|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
144484560|NCT02169830|520974469|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
144484561|NCT02169830|520974467|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
144484562|NCT02169830|520974468|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
144484563|NCT02169830|520974469|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
144484564|NCT02169830|520974467|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
144484565|NCT02169830|520974468|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
144484566|NCT02169830|520974469|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
144484567|NCT02169830|520974467|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
144484568|NCT02169830|520974468|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
144484569|NCT02169830|520974469|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
144484570|NCT02169830|520974467|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
144484571|NCT02169830|520974468|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
144484572|NCT02169830|520974469|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
144484573|NCT03204695|520974470|FG000|Overall Study|Death|1|||
144484574|NCT03204695|520974470|FG000|Overall Study|Participant was treated with another device|1|||
144484575|NCT03204695|520974470|FG000|Overall Study|Physician Decision|2|||
144484576|NCT04834362|520974471|FG000|Overall Study|Death|1|||
144484577|NCT04834362|520974472|FG001|Overall Study|Death|2|||
144484578|NCT02555371|520974473|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
144484579|NCT02555371|520974474|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
144714874|NCT03840135|521811342|FG001|Overall Study|Protocol Violation|1|||
144714875|NCT03840135|521811341|FG000|Overall Study|Withdrawal by Subject|1|||
144714876|NCT03840135|521811342|FG001|Overall Study|Withdrawal by Subject|0|||
144714877|NCT01159769|521811343|FG000|Overall Study|Adverse Event|1|||
144714878|NCT01827371|521811344|FG000|Overall Study|Adverse Event|0|||
144714879|NCT01827371|521811345|FG001|Overall Study|Adverse Event|0|||
144714880|NCT01827371|521811346|FG002|Overall Study|Adverse Event|4|||
144714881|NCT01827371|521811347|FG003|Overall Study|Adverse Event|2|||
144714882|NCT01827371|521811344|FG000|Overall Study|Lost to Follow-up|0|||
144714883|NCT01827371|521811345|FG001|Overall Study|Lost to Follow-up|2|||
144714884|NCT01827371|521811346|FG002|Overall Study|Lost to Follow-up|0|||
144714885|NCT01827371|521811347|FG003|Overall Study|Lost to Follow-up|4|||
144714886|NCT01827371|521811344|FG000|Overall Study|Protocol Violation|1|||
144714887|NCT01827371|521811345|FG001|Overall Study|Protocol Violation|0|||
144714888|NCT01827371|521811346|FG002|Overall Study|Protocol Violation|0|||
144714889|NCT01827371|521811347|FG003|Overall Study|Protocol Violation|0|||
144714890|NCT01827371|521811344|FG000|Overall Study|Withdrawal by Subject|1|||
144714891|NCT01827371|521811345|FG001|Overall Study|Withdrawal by Subject|2|||
144714892|NCT01827371|521811346|FG002|Overall Study|Withdrawal by Subject|2|||
144714893|NCT01827371|521811347|FG003|Overall Study|Withdrawal by Subject|3|||
144714894|NCT01827371|521811344|FG000|Overall Study|Physician Decision|0|||
144714895|NCT01827371|521811345|FG001|Overall Study|Physician Decision|1|||
144714896|NCT01827371|521811346|FG002|Overall Study|Physician Decision|0|||
144714897|NCT01827371|521811347|FG003|Overall Study|Physician Decision|1|||
144714898|NCT01827371|521811344|FG000|Overall Study|Temporary study halt to vaccinations|11|||
144714899|NCT01827371|521811345|FG001|Overall Study|Temporary study halt to vaccinations|2|||
144714900|NCT01827371|521811346|FG002|Overall Study|Temporary study halt to vaccinations|5|||
144714901|NCT01827371|521811347|FG003|Overall Study|Temporary study halt to vaccinations|13|||
144714902|NCT03063632|521811348|FG000|Overall Study|Death|4|||
144714903|NCT03063632|521811349|FG001|Overall Study|Death|6|||
144714904|NCT03063632|521811348|FG000|Overall Study|Lost to Follow-up|0|||
144714905|NCT03063632|521811349|FG001|Overall Study|Lost to Follow-up|1|||
144714906|NCT03063632|521811348|FG000|Overall Study|Withdrawal by Subject|0|||
144714907|NCT03063632|521811349|FG001|Overall Study|Withdrawal by Subject|2|||
144714908|NCT03063632|521811348|FG000|Overall Study|Physician Decision|2|||
144714909|NCT03063632|521811349|FG001|Overall Study|Physician Decision|0|||
144714910|NCT03063632|521811348|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
144714911|NCT03063632|521811349|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
144714912|NCT00106028|521811352|FG000|Overall Study|Adverse Event|3|||
144714913|NCT00106028|521811353|FG001|Overall Study|Adverse Event|2|||
144369770|NCT02745119|520561693|FG000|Overall Study|Lost to Follow-up|0|||
144484580|NCT02555371|520974475|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
144714914|NCT00106028|521811352|FG000|Overall Study|Protocol Violation|1|||
144714915|NCT00106028|521811353|FG001|Overall Study|Protocol Violation|1|||
144714916|NCT00106028|521811352|FG000|Overall Study|Withdrawal by Subject|2|||
144714917|NCT00106028|521811353|FG001|Overall Study|Withdrawal by Subject|8|||
144714918|NCT00106028|521811352|FG000|Overall Study|Lost to Follow-up|0|||
144714919|NCT00106028|521811353|FG001|Overall Study|Lost to Follow-up|1|||
144714920|NCT00947011|521811355|FG000|Overall Study|Study was terminated,PI left institution|12|||
144714921|NCT00814658|521811356|FG000|Overall Study|Lost to Follow-up|0|||
144484581|NCT02555371|520974476|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
144484582|NCT02555371|520974477|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
144484583|NCT02555371|520974473|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
144484584|NCT02555371|520974474|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
144484585|NCT02555371|520974475|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
144484586|NCT02555371|520974476|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
144484587|NCT02555371|520974477|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
144484588|NCT02555371|520974473|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
144484589|NCT02555371|520974474|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
144714922|NCT00814658|521811357|FG001|Overall Study|Lost to Follow-up|1|||
144714923|NCT00814658|521811356|FG000|Overall Study|Physician Decision|1|||
144714924|NCT00814658|521811357|FG001|Overall Study|Physician Decision|0|||
144714925|NCT00814658|521811356|FG000|Overall Study|Adverse Event|3|||
144714926|NCT00814658|521811357|FG001|Overall Study|Adverse Event|3|||
144714927|NCT05266456|521811358|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
144714928|NCT05266456|521811359|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
144714929|NCT05266456|521811360|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
144714930|NCT05266456|521811361|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
144714931|NCT05266456|521811358|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
144714932|NCT05266456|521811359|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
144714933|NCT05266456|521811360|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
144714934|NCT05266456|521811361|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
144714935|NCT05266456|521811358|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
144714936|NCT05266456|521811359|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
144714937|NCT05266456|521811360|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
144714938|NCT05266456|521811361|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
144714939|NCT05266456|521811358|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
144714940|NCT05266456|521811359|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
144714941|NCT05266456|521811360|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
144714942|NCT05266456|521811361|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
144714943|NCT05266456|521811358|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
144714944|NCT05266456|521811359|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
144714945|NCT05266456|521811360|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
144714946|NCT05266456|521811361|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
144714947|NCT06371079|521811364|FG000|Overall Study|Missing data|88|||
144714948|NCT06371079|521811365|FG001|Overall Study|Missing data|247|||
144714949|NCT00411762|521811366|FG000|Overall Study|Withdrawal by Subject|5|||
144714950|NCT03712228|521811370|FG000|Treatment Period 1|Lack of Efficacy|0|||
144714951|NCT03712228|521811371|FG001|Treatment Period 1|Lack of Efficacy|0|||
144714952|NCT03712228|521811372|FG002|Treatment Period 1|Lack of Efficacy|0|||
144714953|NCT03712228|521811373|FG003|Treatment Period 1|Lack of Efficacy|0|||
144714954|NCT03712228|521811374|FG004|Treatment Period 1|Lack of Efficacy|0|||
144714955|NCT03712228|521811375|FG005|Treatment Period 1|Lack of Efficacy|1|||
144714956|NCT03712228|521811370|FG000|Treatment Period 2|Pregnancy|0|||
144714957|NCT03712228|521811371|FG001|Treatment Period 2|Pregnancy|0|||
144714958|NCT03712228|521811372|FG002|Treatment Period 2|Pregnancy|0|||
144714959|NCT03712228|521811373|FG003|Treatment Period 2|Pregnancy|1|||
144714960|NCT03712228|521811374|FG004|Treatment Period 2|Pregnancy|0|||
144714961|NCT03712228|521811375|FG005|Treatment Period 2|Pregnancy|0|||
144714962|NCT03712228|521811370|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144714963|NCT03712228|521811371|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144714964|NCT03712228|521811372|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144714965|NCT03712228|521811373|FG003|Treatment Period 2|Withdrawal by Subject|1|||
144714966|NCT03712228|521811374|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144714967|NCT03712228|521811375|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144714968|NCT02746705|521811376|FG000|Overall Study|Physician Decision|1|||
144714969|NCT02746705|521811377|FG001|Overall Study|Physician Decision|1|||
144714970|NCT02746705|521811376|FG000|Overall Study|Lost to Follow-up|1|||
144714971|NCT02746705|521811377|FG001|Overall Study|Lost to Follow-up|0|||
144714972|NCT02746705|521811376|FG000|Overall Study|outlier scores deemed not valid|0|||
144714973|NCT02746705|521811377|FG001|Overall Study|outlier scores deemed not valid|1|||
144714974|NCT01964105|521811378|FG000|Overall Study|Lost to Follow-up|2|||
144714975|NCT01964105|521811379|FG001|Overall Study|Lost to Follow-up|13|||
144714976|NCT01964105|521811380|FG002|Overall Study|Lost to Follow-up|0|||
144714977|NCT00575328|521811381|FG000|Overall Study|Adverse Event|1|||
144714978|NCT00575328|521811382|FG001|Overall Study|Adverse Event|1|||
144714979|NCT00575328|521811381|FG000|Overall Study|Lost to Follow-up|2|||
144714980|NCT00575328|521811382|FG001|Overall Study|Lost to Follow-up|1|||
144714981|NCT01430104|521811383|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
144714982|NCT00124449|521811388|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
144714983|NCT00124449|521811389|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
144714984|NCT00124449|521811388|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
144484590|NCT02555371|520974475|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
144484591|NCT02555371|520974476|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
144484592|NCT02555371|520974477|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
144484593|NCT02555371|520974473|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
144484594|NCT02555371|520974474|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
144484595|NCT02555371|520974475|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
144484596|NCT02555371|520974476|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
144484597|NCT02555371|520974477|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
144484598|NCT02555371|520974473|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
144484599|NCT02555371|520974474|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
144484600|NCT02555371|520974475|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
144484601|NCT02555371|520974476|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
144484602|NCT02555371|520974477|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
144484603|NCT02555371|520974473|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
144484604|NCT02555371|520974474|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
144484605|NCT02555371|520974475|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
144484606|NCT02555371|520974476|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
144484607|NCT02555371|520974477|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
144484608|NCT02555371|520974473|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
144484609|NCT02555371|520974474|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
144484610|NCT02555371|520974475|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
144484611|NCT02555371|520974476|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
144484612|NCT02555371|520974477|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
144484613|NCT02555371|520974473|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
144484614|NCT02555371|520974474|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
144484615|NCT02555371|520974475|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
144484616|NCT02555371|520974476|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
144484617|NCT02555371|520974477|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
144199220|NCT02935686|519928862|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
144199221|NCT02935686|519928863|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
144199222|NCT02935686|519928864|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
144199223|NCT02935686|519928865|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
144199224|NCT02935686|519928861|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
144199225|NCT02935686|519928862|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
144199226|NCT02935686|519928863|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
144199227|NCT02935686|519928864|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
144199228|NCT02935686|519928865|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
144199229|NCT02935686|519928861|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
144199230|NCT02935686|519928862|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
144199231|NCT02935686|519928863|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
144199232|NCT02935686|519928864|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
144199233|NCT02935686|519928865|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
144199234|NCT02935686|519928861|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
144199235|NCT02935686|519928862|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
144199236|NCT02935686|519928863|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
144199237|NCT02935686|519928864|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
144199238|NCT02935686|519928865|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
144199239|NCT02935686|519928861|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
144199240|NCT02935686|519928862|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
144199241|NCT02935686|519928863|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
144199242|NCT02935686|519928864|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
144199243|NCT02935686|519928865|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
144199244|NCT02935686|519928861|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
144199245|NCT02935686|519928862|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
144199246|NCT02935686|519928863|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
144199247|NCT02935686|519928864|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
144199248|NCT02935686|519928865|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
144199249|NCT02935686|519928861|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
144199250|NCT02935686|519928862|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
144484618|NCT02555371|520974473|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
144484619|NCT02555371|520974474|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
144484620|NCT02555371|520974475|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
144369771|NCT02745119|520561694|FG001|Overall Study|Lost to Follow-up|0|||
144484621|NCT02555371|520974476|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
144484622|NCT02555371|520974477|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
144484623|NCT02555371|520974473|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
144484624|NCT02555371|520974474|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
144484625|NCT02555371|520974475|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
144484626|NCT02555371|520974476|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
144484627|NCT02555371|520974477|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
144484628|NCT02555371|520974473|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
144484629|NCT02555371|520974474|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
144484630|NCT02555371|520974475|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
144484631|NCT02555371|520974476|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
144484632|NCT02555371|520974477|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
144484633|NCT02555371|520974473|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
144484634|NCT02555371|520974474|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
144484635|NCT02555371|520974475|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
144484636|NCT02555371|520974476|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
144484637|NCT02555371|520974477|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
144484638|NCT02555371|520974473|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
144484639|NCT02555371|520974474|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
144484640|NCT02555371|520974475|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
144484641|NCT02555371|520974476|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
144484642|NCT02555371|520974477|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
144484643|NCT02555371|520974473|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
144484644|NCT02555371|520974474|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
144484645|NCT02555371|520974475|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
144484646|NCT02555371|520974476|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
144484647|NCT02555371|520974477|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
144484648|NCT03095599|520974478|FG000|Overall Study|Withdrawal by Subject|1|||
144484649|NCT03095599|520974479|FG001|Overall Study|Withdrawal by Subject|0|||
144484650|NCT03095599|520974478|FG000|Overall Study|Lost to Follow-up|1|||
144484651|NCT03095599|520974479|FG001|Overall Study|Lost to Follow-up|0|||
144484652|NCT03095599|520974478|FG000|Overall Study|Withdrawal prior to vaccination|1|||
144484653|NCT03095599|520974479|FG001|Overall Study|Withdrawal prior to vaccination|0|||
144484654|NCT00742885|520974483|FG000|Overall Study|Lost to Follow-up|1|||
144484655|NCT00742885|520974484|FG001|Overall Study|Lost to Follow-up|0|||
144484656|NCT04781647|520974485|FG000|Overall Study|Study terminated by Sponsor|11|||
144484657|NCT04781647|520974486|FG001|Overall Study|Study terminated by Sponsor|9|||
144484658|NCT04781647|520974487|FG002|Overall Study|Study terminated by Sponsor|9|||
144484659|NCT04781647|520974485|FG000|Overall Study|Withdrawal by Subject|1|||
144484660|NCT04781647|520974486|FG001|Overall Study|Withdrawal by Subject|2|||
144484661|NCT04781647|520974487|FG002|Overall Study|Withdrawal by Subject|0|||
144484662|NCT04781647|520974485|FG000|Overall Study|Adverse Event|0|||
144484663|NCT04781647|520974486|FG001|Overall Study|Adverse Event|1|||
144484664|NCT04781647|520974487|FG002|Overall Study|Adverse Event|1|||
144484665|NCT04781647|520974485|FG000|Overall Study|Protocol Violation|1|||
144484666|NCT04781647|520974486|FG001|Overall Study|Protocol Violation|0|||
144484667|NCT04781647|520974487|FG002|Overall Study|Protocol Violation|0|||
144484668|NCT04781647|520974485|FG000|Overall Study|Pregnancy|0|||
144484669|NCT04781647|520974486|FG001|Overall Study|Pregnancy|0|||
144484670|NCT04781647|520974487|FG002|Overall Study|Pregnancy|1|||
144484671|NCT04781647|520974485|FG000|Overall Study|Virology rebounded|1|||
144484672|NCT04781647|520974486|FG001|Overall Study|Virology rebounded|0|||
144484673|NCT04781647|520974487|FG002|Overall Study|Virology rebounded|0|||
144484674|NCT01755689|520974488|FG000|Overall Study|Withdrawal by Subject|1|||
144484675|NCT01755689|520974489|FG001|Overall Study|Withdrawal by Subject|3|||
144484676|NCT01755689|520974490|FG002|Overall Study|Withdrawal by Subject|2|||
144484677|NCT01755689|520974491|FG003|Overall Study|Withdrawal by Subject|1|||
144484678|NCT01755689|520974492|FG004|Overall Study|Withdrawal by Subject|1|||
144484679|NCT01755689|520974488|FG000|Overall Study|Migrated/moved from study area|0|||
144484680|NCT01755689|520974489|FG001|Overall Study|Migrated/moved from study area|1|||
144484681|NCT01755689|520974490|FG002|Overall Study|Migrated/moved from study area|1|||
144484682|NCT01755689|520974491|FG003|Overall Study|Migrated/moved from study area|1|||
144484683|NCT01755689|520974492|FG004|Overall Study|Migrated/moved from study area|1|||
144484684|NCT01755689|520974488|FG000|Overall Study|Lost to Follow-up|1|||
144484685|NCT01755689|520974489|FG001|Overall Study|Lost to Follow-up|0|||
144484686|NCT01755689|520974490|FG002|Overall Study|Lost to Follow-up|1|||
144484687|NCT01755689|520974491|FG003|Overall Study|Lost to Follow-up|0|||
144484688|NCT01755689|520974492|FG004|Overall Study|Lost to Follow-up|2|||
144484689|NCT01755689|520974488|FG000|Overall Study|Pregnancy|1|||
144484690|NCT01755689|520974489|FG001|Overall Study|Pregnancy|1|||
144484691|NCT01755689|520974490|FG002|Overall Study|Pregnancy|2|||
144484692|NCT01755689|520974491|FG003|Overall Study|Pregnancy|4|||
144484693|NCT01755689|520974492|FG004|Overall Study|Pregnancy|2|||
144484694|NCT01155388|520974499|FG000|Overall Study|Adverse Event|1|||
144484695|NCT01155388|520974500|FG001|Overall Study|Adverse Event|0|||
144484696|NCT01004250|520974501|FG000|Induction Therapy Period|Adverse Event|10|||
144484697|NCT01004250|520974501|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
144484698|NCT01004250|520974501|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
144484699|NCT01004250|520974501|FG000|Induction Therapy Period|Physician Decision|2|||
144484700|NCT01004250|520974501|FG000|Maintenance Therapy Period|Adverse Event|15|||
144484701|NCT01004250|520974501|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
144484702|NCT01004250|520974501|FG000|Maintenance Therapy Period|Protocol Violation|1|||
144484703|NCT01004250|520974501|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
144714985|NCT00124449|521811389|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
144714986|NCT00124449|521811388|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
144714987|NCT00124449|521811389|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
144714988|NCT00124449|521811388|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
144714989|NCT00124449|521811389|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
144714990|NCT00124449|521811388|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
144714991|NCT00124449|521811389|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
144714992|NCT00124449|521811388|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
144714993|NCT00124449|521811389|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
144714994|NCT00124449|521811388|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
144714995|NCT00124449|521811389|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
144714996|NCT00124449|521811388|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
144714997|NCT00124449|521811389|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
144714998|NCT00124449|521811388|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
144714999|NCT00124449|521811389|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
144715000|NCT00124449|521811388|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
144715001|NCT00124449|521811389|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
144715002|NCT00124449|521811388|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
144715003|NCT00124449|521811389|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
144715004|NCT00124449|521811388|FG000|18-Month Untreated Observation Period|Relocated|1|||
144715005|NCT00124449|521811389|FG001|18-Month Untreated Observation Period|Relocated|0|||
144715006|NCT03124381|521811395|FG000|Overall Study|Lost to Follow-up|1|||
144715007|NCT03124381|521811396|FG001|Overall Study|Lost to Follow-up|1|||
144715008|NCT03124381|521811395|FG000|Overall Study|Withdrawal by Subject|6|||
144715009|NCT03124381|521811396|FG001|Overall Study|Withdrawal by Subject|3|||
144715010|NCT03124381|521811395|FG000|Overall Study|Protocol Violation|0|||
144715011|NCT03124381|521811396|FG001|Overall Study|Protocol Violation|1|||
144715012|NCT03124381|521811395|FG000|Overall Study|Adverse Event|1|||
144715013|NCT03124381|521811396|FG001|Overall Study|Adverse Event|1|||
144715014|NCT03124381|521811395|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
144715015|NCT03124381|521811396|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
144715016|NCT03940586|521811400|FG000|Overall Study|Death|3|||
144715017|NCT03940586|521811401|FG001|Overall Study|Death|2|||
144715018|NCT03940586|521811402|FG002|Overall Study|Death|0|||
144715019|NCT03940586|521811400|FG000|Overall Study|Physician Decision|1|||
144715020|NCT03940586|521811401|FG001|Overall Study|Physician Decision|0|||
144715021|NCT03940586|521811402|FG002|Overall Study|Physician Decision|1|||
144715022|NCT03940586|521811400|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
144715023|NCT03940586|521811401|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
144715024|NCT03940586|521811402|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
144715025|NCT03940586|521811400|FG000|Overall Study|Not Treated|0|||
144715026|NCT03940586|521811401|FG001|Overall Study|Not Treated|2|||
144715027|NCT03940586|521811402|FG002|Overall Study|Not Treated|0|||
144715028|NCT00964223|521811403|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
144715029|NCT01559818|521811405|FG000|Overall Study|Physician Decision|1|||
144715030|NCT01559818|521811405|FG000|Overall Study|Pregnancy|1|||
144715031|NCT01559818|521811405|FG000|Overall Study|Study terminated by Sponsor|4|||
144715032|NCT01559818|521811405|FG000|Overall Study|Withdrawal by Subject|1|||
144715033|NCT04071626|521811406|FG000|Overall Study|Withdrawal by Subject|1|||
144715034|NCT04071626|521811407|FG001|Overall Study|Withdrawal by Subject|1|||
144715035|NCT04071626|521811406|FG000|Overall Study|Protocol Violation|0|||
144715036|NCT04071626|521811407|FG001|Overall Study|Protocol Violation|1|||
144715037|NCT00931385|521811408|FG000|Overall Study|Adverse Event|2|||
144715038|NCT00931385|521811409|FG001|Overall Study|Adverse Event|1|||
144715039|NCT00931385|521811410|FG002|Overall Study|Adverse Event|0|||
144715040|NCT00931385|521811411|FG003|Overall Study|Adverse Event|3|||
144715041|NCT00931385|521811408|FG000|Overall Study|Protocol Violation|0|||
144715042|NCT00931385|521811409|FG001|Overall Study|Protocol Violation|0|||
144715043|NCT00931385|521811410|FG002|Overall Study|Protocol Violation|1|||
144715044|NCT00931385|521811411|FG003|Overall Study|Protocol Violation|0|||
144715045|NCT00931385|521811408|FG000|Overall Study|Withdrawal by Subject|0|||
144715046|NCT00931385|521811409|FG001|Overall Study|Withdrawal by Subject|1|||
144715047|NCT00931385|521811410|FG002|Overall Study|Withdrawal by Subject|0|||
144484704|NCT01004250|520974501|FG000|Maintenance Therapy Period|Physician Decision|4|||
144484705|NCT01004250|520974501|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
144484706|NCT03943589|520974502|FG000|Overall Study|Death|1|||
144484707|NCT03943589|520974502|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
144484708|NCT04329104|520974503|FG000|Efficacy Study|Withdrawal by Subject|0|||
144484709|NCT04329104|520974504|FG001|Efficacy Study|Withdrawal by Subject|0|||
144484710|NCT04329104|520974505|FG002|Efficacy Study|Withdrawal by Subject|0|||
144484711|NCT04329104|520974506|FG003|Efficacy Study|Withdrawal by Subject|5|||
144484712|NCT04329104|520974507|FG004|Efficacy Study|Withdrawal by Subject|6|||
144484713|NCT04329104|520974508|FG005|Efficacy Study|Withdrawal by Subject|8|||
144484714|NCT03884231|520974509|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
144484715|NCT03884231|520974509|FG000|Overall Study|Subject Withdrew Consent|1|||
144484716|NCT03884231|520974509|FG000|Overall Study|MRI Scan Not Performed|1|||
144484717|NCT00900627|520974510|FG000|Overall Study|Condition under investigation worsened|4|||
144484718|NCT00900627|520974511|FG001|Overall Study|Condition under investigation worsened|0|||
144484719|NCT00900627|520974512|FG002|Overall Study|Condition under investigation worsened|5|||
144484720|NCT00900627|520974513|FG003|Overall Study|Condition under investigation worsened|3|||
144484721|NCT00900627|520974514|FG004|Overall Study|Condition under investigation worsened|0|||
144484722|NCT00900627|520974515|FG005|Overall Study|Condition under investigation worsened|0|||
144484723|NCT00900627|520974510|FG000|Overall Study|Withdrawal by Subject|1|||
144484724|NCT00900627|520974511|FG001|Overall Study|Withdrawal by Subject|0|||
144484725|NCT00900627|520974512|FG002|Overall Study|Withdrawal by Subject|1|||
144484726|NCT00900627|520974513|FG003|Overall Study|Withdrawal by Subject|0|||
144484727|NCT00900627|520974514|FG004|Overall Study|Withdrawal by Subject|1|||
144484728|NCT00900627|520974515|FG005|Overall Study|Withdrawal by Subject|2|||
144484729|NCT00900627|520974510|FG000|Overall Study|Adverse Event|1|||
144484730|NCT00900627|520974511|FG001|Overall Study|Adverse Event|2|||
144484731|NCT00900627|520974512|FG002|Overall Study|Adverse Event|0|||
144484732|NCT00900627|520974513|FG003|Overall Study|Adverse Event|3|||
144484733|NCT00900627|520974514|FG004|Overall Study|Adverse Event|0|||
144484734|NCT00900627|520974515|FG005|Overall Study|Adverse Event|0|||
144484735|NCT00900627|520974510|FG000|Overall Study|Death|0|||
144484736|NCT00900627|520974511|FG001|Overall Study|Death|0|||
144484737|NCT00900627|520974512|FG002|Overall Study|Death|0|||
144484738|NCT00900627|520974513|FG003|Overall Study|Death|0|||
144484739|NCT00900627|520974514|FG004|Overall Study|Death|28|||
144484740|NCT00900627|520974515|FG005|Overall Study|Death|24|||
144484741|NCT00830947|520974516|FG000|Overall Study|Lost to Follow-up|4|||
144484742|NCT00830947|520974517|FG001|Overall Study|Lost to Follow-up|4|||
144484743|NCT00867490|520974519|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
144484744|NCT00867490|520974519|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
144484745|NCT00867490|520974519|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
144484746|NCT00867490|520974519|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
144484747|NCT00867490|520974519|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
144484748|NCT00358150|520974520|FG000|Overall Study|Adverse Event|3|||
144484749|NCT00358150|520974520|FG000|Overall Study|Withdrawal by Subject|1|||
144484750|NCT00358150|520974520|FG000|Overall Study|Undefined|3|||
144484751|NCT03685708|520974521|FG000|Overall Study|Withdrawal by Subject|0|||
144484752|NCT03685708|520974522|FG001|Overall Study|Withdrawal by Subject|0|||
144484753|NCT03685708|520974523|FG002|Overall Study|Withdrawal by Subject|1|||
144484754|NCT03685708|520974521|FG000|Overall Study|Screen Fail|0|||
144484755|NCT03685708|520974522|FG001|Overall Study|Screen Fail|1|||
144484756|NCT03685708|520974523|FG002|Overall Study|Screen Fail|1|||
144484757|NCT03685708|520974521|FG000|Overall Study|COVID 19 Pandemic|1|||
144484758|NCT03685708|520974522|FG001|Overall Study|COVID 19 Pandemic|1|||
144484759|NCT03685708|520974523|FG002|Overall Study|COVID 19 Pandemic|6|||
144484760|NCT03685708|520974521|FG000|Overall Study|Disease Progression|0|||
144484761|NCT03685708|520974522|FG001|Overall Study|Disease Progression|0|||
144484762|NCT03685708|520974523|FG002|Overall Study|Disease Progression|1|||
144484763|NCT00179010|520974524|FG000|Overall Study|Muscle probe defective|1|||
144484764|NCT00179010|520974525|FG001|Overall Study|Muscle probe defective|1|||
144484765|NCT00179010|520974524|FG000|Overall Study|Failure to place arterial line|0|||
144484766|NCT00179010|520974525|FG001|Overall Study|Failure to place arterial line|1|||
144484767|NCT02823964|520974545|FG000|Overall Study|Adverse Event|2|||
144484768|NCT02823964|520974545|FG000|Overall Study|Physician Decision|1|||
144484769|NCT02823964|520974545|FG000|Overall Study|Lack of Efficacy|1|||
144484770|NCT02823964|520974545|FG000|Overall Study|Withdrawal by Subject|1|||
144484771|NCT01744496|520974556|FG000|Titration Period|Adverse Event|2|||
144484772|NCT01744496|520974557|FG001|Titration Period|Adverse Event|1|||
144484773|NCT01744496|520974556|FG000|Titration Period|Personal reasons|0|||
144484774|NCT01744496|520974557|FG001|Titration Period|Personal reasons|1|||
144484775|NCT01744496|520974556|FG000|Maintenance Period|Adverse Event|1|||
144484776|NCT01744496|520974557|FG001|Maintenance Period|Adverse Event|3|||
144484777|NCT01744496|520974556|FG000|Maintenance Period|Protocol Violation|1|||
144484778|NCT01744496|520974557|FG001|Maintenance Period|Protocol Violation|0|||
144484779|NCT01744496|520974556|FG000|Maintenance Period|Withdrawal by Subject|1|||
144484780|NCT01744496|520974557|FG001|Maintenance Period|Withdrawal by Subject|1|||
144484781|NCT01744496|520974556|FG000|Maintenance Period|Subject left town|1|||
144484782|NCT01744496|520974557|FG001|Maintenance Period|Subject left town|0|||
144484783|NCT03537261|520974558|FG000|Overall Study|Lost to Follow-up|4|||
144484784|NCT03537261|520974559|FG001|Overall Study|Lost to Follow-up|5|||
144484785|NCT03537261|520974558|FG000|Overall Study|Withdrawal by Subject|4|||
144484786|NCT03537261|520974559|FG001|Overall Study|Withdrawal by Subject|6|||
144484787|NCT03537261|520974558|FG000|Overall Study|Did not return study questionnaires|0|||
144484788|NCT03537261|520974559|FG001|Overall Study|Did not return study questionnaires|1|||
144484789|NCT01177813|520974562|FG000|Overall Study|Adverse Event|8|||
144484790|NCT01177813|520974563|FG001|Overall Study|Adverse Event|2|||
144484791|NCT01177813|520974564|FG002|Overall Study|Adverse Event|4|||
144484792|NCT01177813|520974565|FG003|Overall Study|Adverse Event|6|||
144484793|NCT01177813|520974566|FG004|Overall Study|Adverse Event|3|||
144484794|NCT01177813|520974562|FG000|Overall Study|Lack of Efficacy|1|||
144484795|NCT01177813|520974563|FG001|Overall Study|Lack of Efficacy|0|||
144484796|NCT01177813|520974564|FG002|Overall Study|Lack of Efficacy|0|||
144484797|NCT01177813|520974565|FG003|Overall Study|Lack of Efficacy|0|||
144484798|NCT01177813|520974566|FG004|Overall Study|Lack of Efficacy|0|||
144484799|NCT01177813|520974562|FG000|Overall Study|Protocol Violation|3|||
144484800|NCT01177813|520974563|FG001|Overall Study|Protocol Violation|2|||
144484801|NCT01177813|520974564|FG002|Overall Study|Protocol Violation|2|||
144484802|NCT01177813|520974565|FG003|Overall Study|Protocol Violation|0|||
144484803|NCT01177813|520974566|FG004|Overall Study|Protocol Violation|1|||
144484804|NCT01177813|520974562|FG000|Overall Study|Lost to Follow-up|12|||
144484805|NCT01177813|520974563|FG001|Overall Study|Lost to Follow-up|5|||
144484806|NCT01177813|520974564|FG002|Overall Study|Lost to Follow-up|6|||
144484807|NCT01177813|520974565|FG003|Overall Study|Lost to Follow-up|3|||
144484808|NCT01177813|520974566|FG004|Overall Study|Lost to Follow-up|0|||
144484809|NCT01177813|520974562|FG000|Overall Study|Withdrawal by Subject|12|||
144484810|NCT01177813|520974563|FG001|Overall Study|Withdrawal by Subject|7|||
144484811|NCT01177813|520974564|FG002|Overall Study|Withdrawal by Subject|6|||
144484812|NCT01177813|520974565|FG003|Overall Study|Withdrawal by Subject|5|||
144484813|NCT01177813|520974566|FG004|Overall Study|Withdrawal by Subject|3|||
144484814|NCT01177813|520974562|FG000|Overall Study|Other reason not defined above|5|||
144484815|NCT01177813|520974563|FG001|Overall Study|Other reason not defined above|2|||
144484816|NCT01177813|520974564|FG002|Overall Study|Other reason not defined above|2|||
144484817|NCT01177813|520974565|FG003|Overall Study|Other reason not defined above|3|||
144484818|NCT01177813|520974566|FG004|Overall Study|Other reason not defined above|2|||
144484819|NCT03772314|520974575|FG000|Overall Study|Adverse Event|7|||
144484820|NCT03772314|520974576|FG001|Overall Study|Adverse Event|2|||
144484821|NCT02001974|520974577|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
144484822|NCT02001974|520974578|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
144484823|NCT02001974|520974579|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
144484824|NCT02001974|520974577|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
144484825|NCT02001974|520974578|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
144484826|NCT02001974|520974579|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
144484827|NCT02001974|520974577|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
144484828|NCT02001974|520974578|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
144484829|NCT02001974|520974579|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
144484830|NCT02001974|520974577|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
144484831|NCT02001974|520974578|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
144484832|NCT02001974|520974579|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
144484833|NCT00993317|520974580|FG000|Overall Study|Adverse Event|2|||
144484834|NCT00993317|520974581|FG001|Overall Study|Adverse Event|4|||
144484835|NCT00993317|520974580|FG000|Overall Study|Lack of Efficacy|18|||
144484836|NCT00993317|520974581|FG001|Overall Study|Lack of Efficacy|18|||
144484837|NCT00993317|520974580|FG000|Overall Study|Withdrawal by Subject|0|||
144484838|NCT00993317|520974581|FG001|Overall Study|Withdrawal by Subject|2|||
144484839|NCT00993317|520974580|FG000|Overall Study|Investigator's opinion|0|||
144484840|NCT00993317|520974581|FG001|Overall Study|Investigator's opinion|1|||
144484841|NCT00993317|520974580|FG000|Overall Study|Early study termination at the site|1|||
144484842|NCT00993317|520974581|FG001|Overall Study|Early study termination at the site|0|||
144484843|NCT01380990|520974582|FG000|Overall Study|Treatment Failure|1|||
144484844|NCT01380990|520974583|FG001|Overall Study|Treatment Failure|0|||
144484845|NCT01380990|520974582|FG000|Overall Study|Death|0|||
144484846|NCT01380990|520974583|FG001|Overall Study|Death|1|||
144484847|NCT02038764|520974584|FG000|Overall Study|Adverse Event|0|||
144484848|NCT02038764|520974585|FG001|Overall Study|Adverse Event|0|||
144484849|NCT02038764|520974586|FG002|Overall Study|Adverse Event|1|||
144484850|NCT02038764|520974587|FG003|Overall Study|Adverse Event|0|||
144484851|NCT02038764|520974588|FG004|Overall Study|Adverse Event|0|||
144484852|NCT02038764|520974584|FG000|Overall Study|Lost to Follow-up|0|||
144484853|NCT02038764|520974585|FG001|Overall Study|Lost to Follow-up|1|||
144484854|NCT02038764|520974586|FG002|Overall Study|Lost to Follow-up|0|||
144484855|NCT02038764|520974587|FG003|Overall Study|Lost to Follow-up|0|||
144484856|NCT02038764|520974588|FG004|Overall Study|Lost to Follow-up|0|||
144484857|NCT02038764|520974584|FG000|Overall Study|Withdrawal by Subject|0|||
144484858|NCT02038764|520974585|FG001|Overall Study|Withdrawal by Subject|0|||
144484859|NCT02038764|520974586|FG002|Overall Study|Withdrawal by Subject|0|||
144484860|NCT02038764|520974587|FG003|Overall Study|Withdrawal by Subject|0|||
144484861|NCT02038764|520974588|FG004|Overall Study|Withdrawal by Subject|1|||
144484862|NCT02038764|520974584|FG000|Overall Study|Other|1|||
144484863|NCT02038764|520974585|FG001|Overall Study|Other|0|||
144484864|NCT02038764|520974586|FG002|Overall Study|Other|1|||
144484865|NCT02038764|520974587|FG003|Overall Study|Other|0|||
144484866|NCT02038764|520974588|FG004|Overall Study|Other|0|||
144484867|NCT01651936|520974591|FG000|Base Study|Adverse Event|3|||
144484868|NCT01651936|520974592|FG001|Base Study|Adverse Event|0|||
144484869|NCT01651936|520974593|FG002|Base Study|Adverse Event|0|||
144484870|NCT01651936|520974591|FG000|Base Study|Withdrawal by Subject|1|||
144484871|NCT01651936|520974592|FG001|Base Study|Withdrawal by Subject|1|||
144484872|NCT01651936|520974593|FG002|Base Study|Withdrawal by Subject|0|||
144484873|NCT01651936|520974591|FG000|Base Study|Early Escape|2|||
144484874|NCT01651936|520974592|FG001|Base Study|Early Escape|8|||
144715048|NCT00931385|521811411|FG003|Overall Study|Withdrawal by Subject|1|||
144715049|NCT00931385|521811408|FG000|Overall Study|Lost to Follow-up|0|||
144715050|NCT00931385|521811409|FG001|Overall Study|Lost to Follow-up|0|||
144715051|NCT00931385|521811410|FG002|Overall Study|Lost to Follow-up|0|||
144715052|NCT00931385|521811411|FG003|Overall Study|Lost to Follow-up|1|||
144715053|NCT00665626|521811416|FG000|Overall Study|Lack of Efficacy|8|||
144715054|NCT00665626|521811417|FG001|Overall Study|Lack of Efficacy|5|||
144715055|NCT00665626|521811416|FG000|Overall Study|Lost to Follow-up|0|||
144715056|NCT00665626|521811417|FG001|Overall Study|Lost to Follow-up|2|||
144715057|NCT00665626|521811416|FG000|Overall Study|Withdrawal by Subject|0|||
144715058|NCT00665626|521811417|FG001|Overall Study|Withdrawal by Subject|1|||
144715059|NCT00665626|521811416|FG000|Overall Study|Protocol Violation|0|||
144715060|NCT00665626|521811417|FG001|Overall Study|Protocol Violation|2|||
144715061|NCT00665626|521811416|FG000|Overall Study|Adverse Event|1|||
144715062|NCT00665626|521811417|FG001|Overall Study|Adverse Event|9|||
144715063|NCT00665626|521811416|FG000|Overall Study|Due to exclusion criteria|0|||
144715064|NCT00665626|521811417|FG001|Overall Study|Due to exclusion criteria|1|||
144715065|NCT00665626|521811416|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
144715066|NCT00665626|521811417|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
144715067|NCT00665626|521811416|FG000|Overall Study|Unably to comply with dosing regimen|0|||
144715068|NCT00665626|521811417|FG001|Overall Study|Unably to comply with dosing regimen|1|||
144715069|NCT00665626|521811416|FG000|Overall Study|Death|1|||
144715070|NCT00665626|521811417|FG001|Overall Study|Death|0|||
144715071|NCT00530439|521811418|FG000|Overall Study|GDM|9|||
144715072|NCT00530439|521811419|FG001|Overall Study|GDM|3|||
144484875|NCT01651936|520974593|FG002|Base Study|Early Escape|0|||
144484876|NCT01651936|520974591|FG000|Base Study|Study terminated by sponsor|21|||
144484877|NCT01651936|520974592|FG001|Base Study|Study terminated by sponsor|16|||
144484878|NCT01651936|520974593|FG002|Base Study|Study terminated by sponsor|0|||
144484879|NCT01651936|520974591|FG000|Extension Study|Lack of Efficacy|0|||
144484880|NCT01651936|520974592|FG001|Extension Study|Lack of Efficacy|0|||
144484881|NCT01651936|520974593|FG002|Extension Study|Lack of Efficacy|1|||
144484882|NCT01651936|520974591|FG000|Extension Study|Study terminated by sponsor|0|||
144484883|NCT01651936|520974592|FG001|Extension Study|Study terminated by sponsor|0|||
144484884|NCT01651936|520974593|FG002|Extension Study|Study terminated by sponsor|13|||
144715073|NCT00530439|521811418|FG000|Overall Study|Withdraw|18|||
144484885|NCT03044353|520974594|FG000|Overall Study|Adverse Event|0|||
144484886|NCT03044353|520974595|FG001|Overall Study|Adverse Event|1|||
144484887|NCT03044353|520974596|FG002|Overall Study|Adverse Event|0|||
144715074|NCT00530439|521811419|FG001|Overall Study|Withdraw|14|||
144715075|NCT00530439|521811418|FG000|Overall Study|Missed abortion|1|||
144484888|NCT02141659|520974606|FG000|Overall Study|Major Protocol Deviation|0|||
144484889|NCT02141659|520974607|FG001|Overall Study|Major Protocol Deviation|1|||
144484890|NCT02141659|520974608|FG002|Overall Study|Major Protocol Deviation|0|||
144484891|NCT02141659|520974609|FG003|Overall Study|Major Protocol Deviation|0|||
144484892|NCT02141659|520974610|FG004|Overall Study|Major Protocol Deviation|0|||
144484893|NCT02141659|520974611|FG005|Overall Study|Major Protocol Deviation|0|||
144484894|NCT02141659|520974606|FG000|Overall Study|Lack of Efficacy|0|||
144484895|NCT02141659|520974607|FG001|Overall Study|Lack of Efficacy|0|||
144484896|NCT02141659|520974608|FG002|Overall Study|Lack of Efficacy|0|||
144484897|NCT02141659|520974609|FG003|Overall Study|Lack of Efficacy|0|||
144484898|NCT02141659|520974610|FG004|Overall Study|Lack of Efficacy|0|||
144484899|NCT02141659|520974611|FG005|Overall Study|Lack of Efficacy|1|||
144484900|NCT02141659|520974606|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
144484901|NCT02141659|520974607|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
144484902|NCT02141659|520974608|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
144484903|NCT02141659|520974609|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
144484904|NCT02141659|520974610|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
144484905|NCT02141659|520974611|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
144484906|NCT00305864|520974618|FG000|Overall Study|Ineligible / No protocol treatment|0|||
144484907|NCT00305864|520974619|FG001|Overall Study|Ineligible / No protocol treatment|1|||
144484908|NCT00305864|520974620|FG002|Overall Study|Ineligible / No protocol treatment|1|||
144484909|NCT00305864|520974621|FG003|Overall Study|Ineligible / No protocol treatment|13|||
144484910|NCT02836613|520974624|FG000|Overall Study|Accidental drowning|1|||
144484911|NCT02836613|520974625|FG001|Overall Study|Accidental drowning|0|||
144484912|NCT02836613|520974624|FG000|Overall Study|Lost to Follow-up|0|||
144484913|NCT02836613|520974625|FG001|Overall Study|Lost to Follow-up|1|||
144484914|NCT02836613|520974624|FG000|Overall Study|Withdrawal by Subject|0|||
144484915|NCT02836613|520974625|FG001|Overall Study|Withdrawal by Subject|2|||
144484916|NCT03881059|520974626|FG000|Treatment Period - Part A|Adverse Event|1|||
144484917|NCT03881059|520974627|FG001|Treatment Period - Part A|Adverse Event|3|||
144484918|NCT03881059|520974628|FG002|Treatment Period - Part A|Adverse Event|4|||
144484919|NCT03881059|520974626|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
144484920|NCT03881059|520974627|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
144484921|NCT03881059|520974628|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
144484922|NCT03881059|520974626|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
144484923|NCT03881059|520974627|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
144484924|NCT03881059|520974628|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
144484925|NCT03881059|520974626|FG000|Treatment Period - Part A|Other reasons|2|||
144484926|NCT03881059|520974627|FG001|Treatment Period - Part A|Other reasons|1|||
144484927|NCT03881059|520974628|FG002|Treatment Period - Part A|Other reasons|0|||
144484928|NCT03881059|520974626|FG000|Treatment Period - Part B|Adverse Event|0|||
144484929|NCT03881059|520974627|FG001|Treatment Period - Part B|Adverse Event|0|||
144484930|NCT03881059|520974628|FG002|Treatment Period - Part B|Adverse Event|3|||
144484931|NCT03881059|520974626|FG000|Treatment Period - Part B|Death|0|||
144715076|NCT00530439|521811419|FG001|Overall Study|Missed abortion|4|||
144715077|NCT00530439|521811418|FG000|Overall Study|Misclassification|2|||
144715078|NCT00530439|521811419|FG001|Overall Study|Misclassification|0|||
144715079|NCT00530439|521811418|FG000|Overall Study|Twin pregnancy|0|||
144715080|NCT00530439|521811419|FG001|Overall Study|Twin pregnancy|2|||
144715081|NCT00530439|521811418|FG000|Overall Study|Severe malformation/abortion|0|||
144715082|NCT00530439|521811419|FG001|Overall Study|Severe malformation/abortion|3|||
144715083|NCT01629693|521811422|FG000|Overall Study|Lost to Follow-up|2|||
144715084|NCT01629693|521811423|FG001|Overall Study|Lost to Follow-up|4|||
144715085|NCT01629693|521811422|FG000|Overall Study|Withdrawal by Subject|2|||
144715086|NCT01629693|521811423|FG001|Overall Study|Withdrawal by Subject|2|||
144715087|NCT01629693|521811422|FG000|Overall Study|Adverse Event|1|||
144715088|NCT01629693|521811423|FG001|Overall Study|Adverse Event|0|||
144715089|NCT01629693|521811422|FG000|Overall Study|Investigator decision|0|||
144715090|NCT01629693|521811423|FG001|Overall Study|Investigator decision|1|||
144715091|NCT01629693|521811422|FG000|Overall Study|Poor comfort of study lenses|0|||
144715092|NCT01629693|521811423|FG001|Overall Study|Poor comfort of study lenses|2|||
144715093|NCT01629693|521811422|FG000|Overall Study|Subject decision unrelated to AE|0|||
144715094|NCT01629693|521811423|FG001|Overall Study|Subject decision unrelated to AE|1|||
144715095|NCT04385199|521811424|FG000|Overall Study|Withdrawal by Subject|1|||
144484932|NCT03881059|520974627|FG001|Treatment Period - Part B|Death|1|||
144484933|NCT03881059|520974628|FG002|Treatment Period - Part B|Death|1|||
144484934|NCT03881059|520974626|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
144484935|NCT03881059|520974627|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
144715096|NCT04385199|521811425|FG001|Overall Study|Withdrawal by Subject|0|||
144715097|NCT01025193|521811427|FG000|Overall Study|Protocol Violation|1|||
144715098|NCT01025193|521811427|FG000|Overall Study|Adverse Event|3|||
144484936|NCT03881059|520974628|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
144484937|NCT03881059|520974626|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
144484938|NCT03881059|520974627|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
144484939|NCT03881059|520974628|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
144484940|NCT03881059|520974626|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
144484941|NCT03881059|520974627|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
144484942|NCT03881059|520974628|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
144484943|NCT03881059|520974626|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
144484944|NCT03881059|520974627|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
144484945|NCT03881059|520974628|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
144484946|NCT03881059|520974626|FG000|Treatment Period - Part B|Other reasons|4|||
144484947|NCT03881059|520974627|FG001|Treatment Period - Part B|Other reasons|3|||
144484948|NCT03881059|520974628|FG002|Treatment Period - Part B|Other reasons|3|||
144484949|NCT05284019|520974629|FG000|Overall Study|Study terminated|2|||
144484950|NCT05284019|520974630|FG001|Overall Study|Study terminated|2|||
144484951|NCT05284019|520974631|FG002|Overall Study|Study terminated|2|||
144484952|NCT05284019|520974632|FG003|Overall Study|Study terminated|5|||
144484953|NCT05284019|520974633|FG004|Overall Study|Study terminated|15|||
144484954|NCT05284019|520974629|FG000|Overall Study|Withdrawal by Subject|0|||
144484955|NCT05284019|520974630|FG001|Overall Study|Withdrawal by Subject|0|||
144484956|NCT05284019|520974631|FG002|Overall Study|Withdrawal by Subject|0|||
144484957|NCT05284019|520974632|FG003|Overall Study|Withdrawal by Subject|1|||
144484958|NCT05284019|520974633|FG004|Overall Study|Withdrawal by Subject|1|||
144484959|NCT05284019|520974629|FG000|Overall Study|Lost to Follow-up|1|||
144484960|NCT05284019|520974630|FG001|Overall Study|Lost to Follow-up|0|||
144484961|NCT05284019|520974631|FG002|Overall Study|Lost to Follow-up|0|||
144484962|NCT05284019|520974632|FG003|Overall Study|Lost to Follow-up|2|||
144484963|NCT05284019|520974633|FG004|Overall Study|Lost to Follow-up|1|||
144484964|NCT02743793|520974634|FG000|Overall Study|Death|1|||
144484965|NCT02743793|520974635|FG001|Overall Study|Death|1|||
144484966|NCT02743793|520974634|FG000|Overall Study|Withdrawal by Subject|0|||
144484967|NCT02743793|520974635|FG001|Overall Study|Withdrawal by Subject|1|||
144484968|NCT02743793|520974634|FG000|Overall Study|Screen Failure|4|||
144484969|NCT02743793|520974635|FG001|Overall Study|Screen Failure|0|||
144484970|NCT02743793|520974634|FG000|Overall Study|No Primary Care Physician|0|||
144484971|NCT02743793|520974635|FG001|Overall Study|No Primary Care Physician|1|||
144484972|NCT02743793|520974634|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
144484973|NCT02743793|520974635|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
144484974|NCT02743793|520974634|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
144484975|NCT02743793|520974635|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
144484976|NCT02065570|520974636|FG000|Induction Study|Adverse Event|5|||
144484977|NCT02065570|520974637|FG001|Induction Study|Adverse Event|12|||
144484978|NCT02065570|520974638|FG002|Induction Study|Adverse Event|0|||
144484979|NCT02065570|520974639|FG003|Induction Study|Adverse Event|0|||
144484980|NCT02065570|520974636|FG000|Induction Study|Withdrawal by Subject|2|||
144484981|NCT02065570|520974637|FG001|Induction Study|Withdrawal by Subject|3|||
144484982|NCT02065570|520974638|FG002|Induction Study|Withdrawal by Subject|0|||
144484983|NCT02065570|520974639|FG003|Induction Study|Withdrawal by Subject|0|||
144484984|NCT02065570|520974636|FG000|Induction Study|Lost to Follow-up|1|||
144484985|NCT02065570|520974637|FG001|Induction Study|Lost to Follow-up|1|||
144484986|NCT02065570|520974638|FG002|Induction Study|Lost to Follow-up|0|||
144484987|NCT02065570|520974639|FG003|Induction Study|Lost to Follow-up|0|||
144484988|NCT02065570|520974636|FG000|Induction Study|Other, Not Specified|6|||
144484989|NCT02065570|520974637|FG001|Induction Study|Other, Not Specified|5|||
144484990|NCT02065570|520974638|FG002|Induction Study|Other, Not Specified|0|||
144484991|NCT02065570|520974639|FG003|Induction Study|Other, Not Specified|0|||
144484992|NCT02065570|520974636|FG000|Maintenance Study|Adverse Event|0|||
144484993|NCT02065570|520974637|FG001|Maintenance Study|Adverse Event|0|||
144484994|NCT02065570|520974638|FG002|Maintenance Study|Adverse Event|8|||
144484995|NCT02065570|520974639|FG003|Maintenance Study|Adverse Event|8|||
144484996|NCT02065570|520974636|FG000|Maintenance Study|Withdrawal by Subject|0|||
144484997|NCT02065570|520974637|FG001|Maintenance Study|Withdrawal by Subject|0|||
144484998|NCT02065570|520974638|FG002|Maintenance Study|Withdrawal by Subject|1|||
144484999|NCT02065570|520974639|FG003|Maintenance Study|Withdrawal by Subject|4|||
144485000|NCT02065570|520974636|FG000|Maintenance Study|Lost to Follow-up|0|||
144485001|NCT02065570|520974637|FG001|Maintenance Study|Lost to Follow-up|0|||
144485002|NCT02065570|520974638|FG002|Maintenance Study|Lost to Follow-up|2|||
144485003|NCT02065570|520974639|FG003|Maintenance Study|Lost to Follow-up|2|||
144485004|NCT02065570|520974636|FG000|Maintenance Study|Other, Not Specified|0|||
144485005|NCT02065570|520974637|FG001|Maintenance Study|Other, Not Specified|0|||
144485006|NCT02065570|520974638|FG002|Maintenance Study|Other, Not Specified|11|||
144485007|NCT02065570|520974639|FG003|Maintenance Study|Other, Not Specified|5|||
144485008|NCT01231503|520974640|FG000|Overall Study|Adverse Event|0|||
144485009|NCT01231503|520974641|FG001|Overall Study|Adverse Event|0|||
144485010|NCT01231503|520974642|FG002|Overall Study|Adverse Event|0|||
144485011|NCT01231503|520974643|FG003|Overall Study|Adverse Event|0|||
144485012|NCT01231503|520974644|FG004|Overall Study|Adverse Event|0|||
144485013|NCT01231503|520974645|FG005|Overall Study|Adverse Event|1|||
144485014|NCT01231503|520974646|FG006|Overall Study|Adverse Event|0|||
144485015|NCT01231503|520974647|FG007|Overall Study|Adverse Event|0|||
144485016|NCT01231503|520974640|FG000|Overall Study|Adverse event, serious fatal|0|||
144485017|NCT01231503|520974641|FG001|Overall Study|Adverse event, serious fatal|0|||
144485018|NCT01231503|520974642|FG002|Overall Study|Adverse event, serious fatal|1|||
144485019|NCT01231503|520974643|FG003|Overall Study|Adverse event, serious fatal|1|||
144715099|NCT04079842|521811428|FG000|Overall Study|Request of subject|2|||
144715100|NCT04079842|521811428|FG000|Overall Study|Unable to draw Arterial samples|1|||
144715101|NCT02904200|521811429|FG000|Overall Study|Withdrawal by Subject|1|||
144715102|NCT02904200|521811430|FG001|Overall Study|Withdrawal by Subject|0|||
144715103|NCT02133352|521811433|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
144715104|NCT03705169|521811434|FG000|Overall Study|Lost to Follow-up|0|||
144715105|NCT03705169|521811435|FG001|Overall Study|Lost to Follow-up|0|||
144715106|NCT03705169|521811436|FG002|Overall Study|Lost to Follow-up|0|||
144715107|NCT03705169|521811437|FG003|Overall Study|Lost to Follow-up|2|||
144715108|NCT03705169|521811438|FG004|Overall Study|Lost to Follow-up|0|||
144715109|NCT03705169|521811439|FG005|Overall Study|Lost to Follow-up|2|||
144715110|NCT03705169|521811440|FG006|Overall Study|Lost to Follow-up|1|||
144715111|NCT03705169|521811441|FG007|Overall Study|Lost to Follow-up|0|||
144715112|NCT03705169|521811442|FG008|Overall Study|Lost to Follow-up|0|||
144715113|NCT03705169|521811443|FG009|Overall Study|Lost to Follow-up|1|||
144715114|NCT03705169|521811434|FG000|Overall Study|Adverse Event|0|||
144715115|NCT03705169|521811435|FG001|Overall Study|Adverse Event|0|||
144715116|NCT03705169|521811436|FG002|Overall Study|Adverse Event|0|||
144715117|NCT03705169|521811437|FG003|Overall Study|Adverse Event|1|||
144485020|NCT01231503|520974644|FG004|Overall Study|Adverse event, serious fatal|0|||
144485021|NCT01231503|520974645|FG005|Overall Study|Adverse event, serious fatal|1|||
144485022|NCT01231503|520974646|FG006|Overall Study|Adverse event, serious fatal|0|||
144485023|NCT01231503|520974647|FG007|Overall Study|Adverse event, serious fatal|0|||
144485024|NCT01231503|520974640|FG000|Overall Study|Withdrawal by Subject|6|||
144485025|NCT01231503|520974641|FG001|Overall Study|Withdrawal by Subject|3|||
144485026|NCT01231503|520974642|FG002|Overall Study|Withdrawal by Subject|3|||
144485027|NCT01231503|520974643|FG003|Overall Study|Withdrawal by Subject|1|||
144715118|NCT03705169|521811438|FG004|Overall Study|Adverse Event|0|||
144715119|NCT03705169|521811439|FG005|Overall Study|Adverse Event|0|||
144715120|NCT03705169|521811440|FG006|Overall Study|Adverse Event|0|||
144715121|NCT03705169|521811441|FG007|Overall Study|Adverse Event|0|||
144715122|NCT03705169|521811442|FG008|Overall Study|Adverse Event|0|||
144485028|NCT01231503|520974644|FG004|Overall Study|Withdrawal by Subject|3|||
144485029|NCT01231503|520974645|FG005|Overall Study|Withdrawal by Subject|5|||
144485030|NCT01231503|520974646|FG006|Overall Study|Withdrawal by Subject|1|||
144485031|NCT01231503|520974647|FG007|Overall Study|Withdrawal by Subject|2|||
144485032|NCT01231503|520974640|FG000|Overall Study|Lost to Follow-up|8|||
144485033|NCT01231503|520974641|FG001|Overall Study|Lost to Follow-up|10|||
144485034|NCT01231503|520974642|FG002|Overall Study|Lost to Follow-up|8|||
144485035|NCT01231503|520974643|FG003|Overall Study|Lost to Follow-up|5|||
144485036|NCT01231503|520974644|FG004|Overall Study|Lost to Follow-up|7|||
144485037|NCT01231503|520974645|FG005|Overall Study|Lost to Follow-up|9|||
144485038|NCT01231503|520974646|FG006|Overall Study|Lost to Follow-up|6|||
144485039|NCT01231503|520974647|FG007|Overall Study|Lost to Follow-up|6|||
144485040|NCT01231503|520974640|FG000|Overall Study|Protocol Violation|0|||
144485041|NCT01231503|520974641|FG001|Overall Study|Protocol Violation|0|||
144485042|NCT01231503|520974642|FG002|Overall Study|Protocol Violation|0|||
144485043|NCT01231503|520974643|FG003|Overall Study|Protocol Violation|1|||
144485044|NCT01231503|520974644|FG004|Overall Study|Protocol Violation|0|||
144485045|NCT01231503|520974645|FG005|Overall Study|Protocol Violation|0|||
144485046|NCT01231503|520974646|FG006|Overall Study|Protocol Violation|0|||
144485047|NCT01231503|520974647|FG007|Overall Study|Protocol Violation|0|||
144485048|NCT01088529|520974650|FG000|Overall Study|Did not receive study treatment|0|||
144485049|NCT01088529|520974651|FG001|Overall Study|Did not receive study treatment|1|||
144485050|NCT02044458|520974655|FG000|Overall Study|Protocol Violation|3|||
144485051|NCT02044458|520974656|FG001|Overall Study|Protocol Violation|8|||
144485052|NCT01818141|520976540|FG000|Overall Study|Withdrawal by Subject|2|||
144485053|NCT01818141|520976541|FG001|Overall Study|Withdrawal by Subject|0|||
144485054|NCT01818141|520976540|FG000|Overall Study|No baseline C.diff colonies|1|||
144485055|NCT01818141|520976541|FG001|Overall Study|No baseline C.diff colonies|1|||
144485056|NCT01818141|520976540|FG000|Overall Study|Lost to Follow-up|0|||
144485057|NCT01818141|520976541|FG001|Overall Study|Lost to Follow-up|2|||
144485058|NCT00513019|520976542|FG000|Overall Study|Adverse Event|1|||
144485059|NCT00513019|520976543|FG001|Overall Study|Adverse Event|0|||
144485060|NCT00513019|520976542|FG000|Overall Study|Withdrawal by Subject|4|||
144485061|NCT00513019|520976543|FG001|Overall Study|Withdrawal by Subject|5|||
144485062|NCT02609659|520976544|FG000|Overall Study|Adverse Event|1|||
144485063|NCT02609659|520976544|FG000|Overall Study|Lost to Follow-up|6|||
144485064|NCT02609659|520976544|FG000|Overall Study|Other|1|||
144485065|NCT01853254|520976545|FG000|Overall Study|Abnormal Laboratory Test|1|||
144485066|NCT01853254|520976545|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
144485067|NCT01853254|520976545|FG000|Overall Study|Death|1|||
144485068|NCT01853254|520976545|FG000|Overall Study|Failure to Return|43|||
144485069|NCT01853254|520976545|FG000|Overall Study|Insufficient Therapeutic Response|22|||
144485070|NCT01853254|520976545|FG000|Overall Study|Refusal of Treatment|1|||
144485071|NCT01853254|520976545|FG000|Overall Study|Other Protocol Violation|1|||
144485072|NCT01853254|520976545|FG000|Overall Study|Withdrawal of Consent|16|||
144485073|NCT01853254|520976545|FG000|Overall Study|Administrative/Other|16|||
144485074|NCT02462083|520976546|FG000|Overall Study|Sponsor request|39|||
144485075|NCT02462083|520976546|FG000|Overall Study|Withdrawal by Subject|87|||
144485076|NCT02462083|520976546|FG000|Overall Study|Lost to Follow-up|41|||
144485077|NCT02462083|520976546|FG000|Overall Study|Lack of Efficacy|151|||
144485078|NCT02462083|520976546|FG000|Overall Study|Pregnancy|1|||
144485079|NCT02462083|520976546|FG000|Overall Study|Protocol Violation|6|||
144485080|NCT02462083|520976546|FG000|Overall Study|Adverse Event|33|||
144485081|NCT02462083|520976546|FG000|Overall Study|Worsening condition|16|||
144485082|NCT02462083|520976546|FG000|Overall Study|Other than specified|45|||
144485083|NCT01642186|520976547|FG000|Overall Study|Death|0|||
144485084|NCT01642186|520976548|FG001|Overall Study|Death|2|||
144485085|NCT01642186|520976549|FG002|Overall Study|Death|2|||
144485086|NCT01642186|520976547|FG000|Overall Study|Lost to Follow-up|0|||
144485087|NCT01642186|520976548|FG001|Overall Study|Lost to Follow-up|0|||
144485088|NCT01642186|520976549|FG002|Overall Study|Lost to Follow-up|1|||
144485089|NCT01668147|520976550|FG000|Overall Study|Withdrawal by Subject|6|||
144485090|NCT01474512|520976552|FG000|Induction Period|Adverse Event|6|||
144485091|NCT01474512|520976553|FG001|Induction Period|Adverse Event|10|||
144485092|NCT01474512|520976554|FG002|Induction Period|Adverse Event|10|||
144485093|NCT01474512|520976555|FG003|Induction Period|Adverse Event|0|||
144485094|NCT01474512|520976556|FG004|Induction Period|Adverse Event|0|||
144485095|NCT01474512|520976557|FG005|Induction Period|Adverse Event|0|||
144485096|NCT01474512|520976558|FG006|Induction Period|Adverse Event|0|||
144485097|NCT01474512|520976559|FG007|Induction Period|Adverse Event|0|||
144485098|NCT01474512|520976560|FG008|Induction Period|Adverse Event|0|||
144485099|NCT01474512|520976561|FG009|Induction Period|Adverse Event|0|||
144485100|NCT01474512|520976562|FG010|Induction Period|Adverse Event|0|||
144485101|NCT01474512|520976563|FG011|Induction Period|Adverse Event|0|||
144485102|NCT01474512|520976564|FG012|Induction Period|Adverse Event|0|||
144485103|NCT01474512|520976565|FG013|Induction Period|Adverse Event|0|||
144485104|NCT01474512|520976566|FG014|Induction Period|Adverse Event|0|||
144485105|NCT01474512|520976567|FG015|Induction Period|Adverse Event|0|||
144485106|NCT01474512|520976568|FG016|Induction Period|Adverse Event|0|||
144485107|NCT01474512|520976569|FG017|Induction Period|Adverse Event|0|||
144485108|NCT01474512|520976552|FG000|Induction Period|Lack of Efficacy|7|||
144485109|NCT01474512|520976553|FG001|Induction Period|Lack of Efficacy|1|||
144485110|NCT01474512|520976554|FG002|Induction Period|Lack of Efficacy|0|||
144485111|NCT01474512|520976555|FG003|Induction Period|Lack of Efficacy|0|||
144485112|NCT01474512|520976556|FG004|Induction Period|Lack of Efficacy|0|||
144485113|NCT01474512|520976557|FG005|Induction Period|Lack of Efficacy|0|||
144485114|NCT01474512|520976558|FG006|Induction Period|Lack of Efficacy|0|||
144485115|NCT01474512|520976559|FG007|Induction Period|Lack of Efficacy|0|||
144485116|NCT01474512|520976560|FG008|Induction Period|Lack of Efficacy|0|||
144485117|NCT01474512|520976561|FG009|Induction Period|Lack of Efficacy|0|||
144485118|NCT01474512|520976562|FG010|Induction Period|Lack of Efficacy|0|||
144485119|NCT01474512|520976563|FG011|Induction Period|Lack of Efficacy|0|||
144485120|NCT01474512|520976564|FG012|Induction Period|Lack of Efficacy|0|||
144485121|NCT01474512|520976565|FG013|Induction Period|Lack of Efficacy|0|||
144485122|NCT01474512|520976566|FG014|Induction Period|Lack of Efficacy|0|||
144485123|NCT01474512|520976567|FG015|Induction Period|Lack of Efficacy|0|||
144485124|NCT01474512|520976568|FG016|Induction Period|Lack of Efficacy|0|||
144485125|NCT01474512|520976569|FG017|Induction Period|Lack of Efficacy|0|||
144485126|NCT01474512|520976552|FG000|Induction Period|Withdrawal by Subject|6|||
144485127|NCT01474512|520976553|FG001|Induction Period|Withdrawal by Subject|6|||
144485128|NCT01474512|520976554|FG002|Induction Period|Withdrawal by Subject|5|||
144485129|NCT01474512|520976555|FG003|Induction Period|Withdrawal by Subject|0|||
144485130|NCT01474512|520976556|FG004|Induction Period|Withdrawal by Subject|0|||
144715123|NCT03705169|521811443|FG009|Overall Study|Adverse Event|0|||
144715124|NCT03705169|521811434|FG000|Overall Study|Site Closure|0|||
144715125|NCT03705169|521811435|FG001|Overall Study|Site Closure|0|||
144715126|NCT03705169|521811436|FG002|Overall Study|Site Closure|0|||
144715127|NCT03705169|521811437|FG003|Overall Study|Site Closure|1|||
144715128|NCT03705169|521811438|FG004|Overall Study|Site Closure|0|||
144715129|NCT03705169|521811439|FG005|Overall Study|Site Closure|0|||
144715130|NCT03705169|521811440|FG006|Overall Study|Site Closure|0|||
144715131|NCT03705169|521811441|FG007|Overall Study|Site Closure|0|||
144715132|NCT03705169|521811442|FG008|Overall Study|Site Closure|0|||
144715133|NCT03705169|521811443|FG009|Overall Study|Site Closure|0|||
144715134|NCT03705169|521811434|FG000|Overall Study|Did not receive study treatment|0|||
144715135|NCT03705169|521811435|FG001|Overall Study|Did not receive study treatment|0|||
144715136|NCT03705169|521811436|FG002|Overall Study|Did not receive study treatment|0|||
144715137|NCT03705169|521811437|FG003|Overall Study|Did not receive study treatment|1|||
144715138|NCT03705169|521811438|FG004|Overall Study|Did not receive study treatment|0|||
144485131|NCT01474512|520976557|FG005|Induction Period|Withdrawal by Subject|0|||
144485132|NCT01474512|520976558|FG006|Induction Period|Withdrawal by Subject|0|||
144485133|NCT01474512|520976559|FG007|Induction Period|Withdrawal by Subject|0|||
144485134|NCT01474512|520976560|FG008|Induction Period|Withdrawal by Subject|0|||
144485135|NCT01474512|520976561|FG009|Induction Period|Withdrawal by Subject|0|||
144485136|NCT01474512|520976562|FG010|Induction Period|Withdrawal by Subject|0|||
144485137|NCT01474512|520976563|FG011|Induction Period|Withdrawal by Subject|0|||
144485138|NCT01474512|520976564|FG012|Induction Period|Withdrawal by Subject|0|||
144485139|NCT01474512|520976565|FG013|Induction Period|Withdrawal by Subject|0|||
144715139|NCT03705169|521811439|FG005|Overall Study|Did not receive study treatment|0|||
144715140|NCT03705169|521811440|FG006|Overall Study|Did not receive study treatment|0|||
144715141|NCT03705169|521811441|FG007|Overall Study|Did not receive study treatment|0|||
144485140|NCT01474512|520976566|FG014|Induction Period|Withdrawal by Subject|0|||
144715142|NCT03705169|521811442|FG008|Overall Study|Did not receive study treatment|0|||
144485141|NCT01474512|520976567|FG015|Induction Period|Withdrawal by Subject|0|||
144485142|NCT01474512|520976568|FG016|Induction Period|Withdrawal by Subject|0|||
144485143|NCT01474512|520976569|FG017|Induction Period|Withdrawal by Subject|0|||
144485144|NCT01474512|520976552|FG000|Induction Period|Protocol Violation|3|||
144485145|NCT01474512|520976553|FG001|Induction Period|Protocol Violation|6|||
144485146|NCT01474512|520976554|FG002|Induction Period|Protocol Violation|0|||
144485147|NCT01474512|520976555|FG003|Induction Period|Protocol Violation|0|||
144485148|NCT01474512|520976556|FG004|Induction Period|Protocol Violation|0|||
144485149|NCT01474512|520976557|FG005|Induction Period|Protocol Violation|0|||
144485150|NCT01474512|520976558|FG006|Induction Period|Protocol Violation|0|||
144485151|NCT01474512|520976559|FG007|Induction Period|Protocol Violation|0|||
144485152|NCT01474512|520976560|FG008|Induction Period|Protocol Violation|0|||
144485153|NCT01474512|520976561|FG009|Induction Period|Protocol Violation|0|||
144485154|NCT01474512|520976562|FG010|Induction Period|Protocol Violation|0|||
144485155|NCT01474512|520976563|FG011|Induction Period|Protocol Violation|0|||
144485156|NCT01474512|520976564|FG012|Induction Period|Protocol Violation|0|||
144485157|NCT01474512|520976565|FG013|Induction Period|Protocol Violation|0|||
144485158|NCT01474512|520976566|FG014|Induction Period|Protocol Violation|0|||
144485159|NCT01474512|520976567|FG015|Induction Period|Protocol Violation|0|||
144485160|NCT01474512|520976568|FG016|Induction Period|Protocol Violation|0|||
144485161|NCT01474512|520976569|FG017|Induction Period|Protocol Violation|0|||
144485162|NCT01474512|520976552|FG000|Induction Period|Sponsor Decision|1|||
144485163|NCT01474512|520976553|FG001|Induction Period|Sponsor Decision|1|||
144485164|NCT01474512|520976554|FG002|Induction Period|Sponsor Decision|1|||
144485165|NCT01474512|520976555|FG003|Induction Period|Sponsor Decision|0|||
144485166|NCT01474512|520976556|FG004|Induction Period|Sponsor Decision|0|||
144485167|NCT01474512|520976557|FG005|Induction Period|Sponsor Decision|0|||
144485168|NCT01474512|520976558|FG006|Induction Period|Sponsor Decision|0|||
144485169|NCT01474512|520976559|FG007|Induction Period|Sponsor Decision|0|||
144485170|NCT01474512|520976560|FG008|Induction Period|Sponsor Decision|0|||
144485171|NCT01474512|520976561|FG009|Induction Period|Sponsor Decision|0|||
144485172|NCT01474512|520976562|FG010|Induction Period|Sponsor Decision|0|||
144485173|NCT01474512|520976563|FG011|Induction Period|Sponsor Decision|0|||
144485174|NCT01474512|520976564|FG012|Induction Period|Sponsor Decision|0|||
144485175|NCT01474512|520976565|FG013|Induction Period|Sponsor Decision|0|||
144485176|NCT01474512|520976566|FG014|Induction Period|Sponsor Decision|0|||
144485177|NCT01474512|520976567|FG015|Induction Period|Sponsor Decision|0|||
144485178|NCT01474512|520976568|FG016|Induction Period|Sponsor Decision|0|||
144485179|NCT01474512|520976569|FG017|Induction Period|Sponsor Decision|0|||
144485180|NCT01474512|520976552|FG000|Induction Period|Lost to Follow-up|1|||
144485181|NCT01474512|520976553|FG001|Induction Period|Lost to Follow-up|0|||
144485182|NCT01474512|520976554|FG002|Induction Period|Lost to Follow-up|2|||
144485183|NCT01474512|520976555|FG003|Induction Period|Lost to Follow-up|0|||
144485184|NCT01474512|520976556|FG004|Induction Period|Lost to Follow-up|0|||
144485185|NCT01474512|520976557|FG005|Induction Period|Lost to Follow-up|0|||
144485186|NCT01474512|520976558|FG006|Induction Period|Lost to Follow-up|0|||
144485187|NCT01474512|520976559|FG007|Induction Period|Lost to Follow-up|0|||
144485188|NCT01474512|520976560|FG008|Induction Period|Lost to Follow-up|0|||
144485189|NCT01474512|520976561|FG009|Induction Period|Lost to Follow-up|0|||
144485190|NCT01474512|520976562|FG010|Induction Period|Lost to Follow-up|0|||
144485191|NCT01474512|520976563|FG011|Induction Period|Lost to Follow-up|0|||
144485192|NCT01474512|520976564|FG012|Induction Period|Lost to Follow-up|0|||
144485193|NCT01474512|520976565|FG013|Induction Period|Lost to Follow-up|0|||
144485194|NCT01474512|520976566|FG014|Induction Period|Lost to Follow-up|0|||
144485195|NCT01474512|520976567|FG015|Induction Period|Lost to Follow-up|0|||
144485196|NCT01474512|520976568|FG016|Induction Period|Lost to Follow-up|0|||
144485197|NCT01474512|520976569|FG017|Induction Period|Lost to Follow-up|0|||
144485198|NCT01474512|520976552|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485199|NCT01474512|520976553|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485200|NCT01474512|520976554|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485201|NCT01474512|520976555|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
144715143|NCT03705169|521811443|FG009|Overall Study|Did not receive study treatment|0|||
144715144|NCT03705169|521811434|FG000|Overall Study|Concerns about study visit compliance|0|||
144485202|NCT01474512|520976556|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
144485203|NCT01474512|520976557|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
144485204|NCT01474512|520976558|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
144485205|NCT01474512|520976559|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485206|NCT01474512|520976560|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485207|NCT01474512|520976561|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485208|NCT01474512|520976562|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485209|NCT01474512|520976563|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485210|NCT01474512|520976564|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485211|NCT01474512|520976565|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485212|NCT01474512|520976566|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485213|NCT01474512|520976567|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485214|NCT01474512|520976568|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485215|NCT01474512|520976569|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
144485216|NCT01474512|520976552|FG000|Maintenance Period|Adverse Event|0|||
144485217|NCT01474512|520976553|FG001|Maintenance Period|Adverse Event|0|||
144485218|NCT01474512|520976554|FG002|Maintenance Period|Adverse Event|0|||
144485219|NCT01474512|520976555|FG003|Maintenance Period|Adverse Event|4|||
144485220|NCT01474512|520976556|FG004|Maintenance Period|Adverse Event|2|||
144485221|NCT01474512|520976557|FG005|Maintenance Period|Adverse Event|7|||
144485222|NCT01474512|520976558|FG006|Maintenance Period|Adverse Event|0|||
144485223|NCT01474512|520976559|FG007|Maintenance Period|Adverse Event|19|||
144485224|NCT01474512|520976560|FG008|Maintenance Period|Adverse Event|1|||
144485225|NCT01474512|520976561|FG009|Maintenance Period|Adverse Event|3|||
144485226|NCT01474512|520976562|FG010|Maintenance Period|Adverse Event|0|||
144485227|NCT01474512|520976563|FG011|Maintenance Period|Adverse Event|0|||
144485228|NCT01474512|520976564|FG012|Maintenance Period|Adverse Event|0|||
144485229|NCT01474512|520976565|FG013|Maintenance Period|Adverse Event|0|||
144485230|NCT01474512|520976566|FG014|Maintenance Period|Adverse Event|0|||
144485231|NCT01474512|520976567|FG015|Maintenance Period|Adverse Event|0|||
144485232|NCT01474512|520976568|FG016|Maintenance Period|Adverse Event|0|||
144485233|NCT01474512|520976569|FG017|Maintenance Period|Adverse Event|0|||
144485234|NCT01474512|520976552|FG000|Maintenance Period|Withdrawal by Subject|0|||
144485235|NCT01474512|520976553|FG001|Maintenance Period|Withdrawal by Subject|0|||
144485236|NCT01474512|520976554|FG002|Maintenance Period|Withdrawal by Subject|0|||
144485237|NCT01474512|520976555|FG003|Maintenance Period|Withdrawal by Subject|6|||
144485238|NCT01474512|520976556|FG004|Maintenance Period|Withdrawal by Subject|2|||
144485239|NCT01474512|520976557|FG005|Maintenance Period|Withdrawal by Subject|3|||
144485240|NCT01474512|520976558|FG006|Maintenance Period|Withdrawal by Subject|1|||
144485241|NCT01474512|520976559|FG007|Maintenance Period|Withdrawal by Subject|6|||
144485242|NCT01474512|520976560|FG008|Maintenance Period|Withdrawal by Subject|3|||
144485243|NCT01474512|520976561|FG009|Maintenance Period|Withdrawal by Subject|1|||
144485244|NCT01474512|520976562|FG010|Maintenance Period|Withdrawal by Subject|0|||
144485245|NCT01474512|520976563|FG011|Maintenance Period|Withdrawal by Subject|0|||
144485246|NCT01474512|520976564|FG012|Maintenance Period|Withdrawal by Subject|0|||
144485247|NCT01474512|520976565|FG013|Maintenance Period|Withdrawal by Subject|0|||
144485248|NCT01474512|520976566|FG014|Maintenance Period|Withdrawal by Subject|0|||
144485249|NCT01474512|520976567|FG015|Maintenance Period|Withdrawal by Subject|0|||
144485250|NCT01474512|520976568|FG016|Maintenance Period|Withdrawal by Subject|0|||
144485251|NCT01474512|520976569|FG017|Maintenance Period|Withdrawal by Subject|0|||
144485252|NCT01474512|520976552|FG000|Maintenance Period|Lost to Follow-up|0|||
144485253|NCT01474512|520976553|FG001|Maintenance Period|Lost to Follow-up|0|||
144485254|NCT01474512|520976554|FG002|Maintenance Period|Lost to Follow-up|0|||
144485255|NCT01474512|520976555|FG003|Maintenance Period|Lost to Follow-up|3|||
144485256|NCT01474512|520976556|FG004|Maintenance Period|Lost to Follow-up|3|||
144485257|NCT01474512|520976557|FG005|Maintenance Period|Lost to Follow-up|0|||
144485258|NCT01474512|520976558|FG006|Maintenance Period|Lost to Follow-up|0|||
144485259|NCT01474512|520976559|FG007|Maintenance Period|Lost to Follow-up|2|||
144485260|NCT01474512|520976560|FG008|Maintenance Period|Lost to Follow-up|1|||
144485261|NCT01474512|520976561|FG009|Maintenance Period|Lost to Follow-up|1|||
144485262|NCT01474512|520976562|FG010|Maintenance Period|Lost to Follow-up|0|||
144485263|NCT01474512|520976563|FG011|Maintenance Period|Lost to Follow-up|0|||
144485264|NCT01474512|520976564|FG012|Maintenance Period|Lost to Follow-up|0|||
144485265|NCT01474512|520976565|FG013|Maintenance Period|Lost to Follow-up|0|||
144485266|NCT01474512|520976566|FG014|Maintenance Period|Lost to Follow-up|0|||
144485267|NCT01474512|520976567|FG015|Maintenance Period|Lost to Follow-up|0|||
144485268|NCT01474512|520976568|FG016|Maintenance Period|Lost to Follow-up|0|||
144485269|NCT01474512|520976569|FG017|Maintenance Period|Lost to Follow-up|0|||
144485270|NCT01474512|520976552|FG000|Maintenance Period|Death|0|||
144485271|NCT01474512|520976553|FG001|Maintenance Period|Death|0|||
144485272|NCT01474512|520976554|FG002|Maintenance Period|Death|0|||
144485273|NCT01474512|520976555|FG003|Maintenance Period|Death|0|||
144485274|NCT01474512|520976556|FG004|Maintenance Period|Death|0|||
144485275|NCT01474512|520976557|FG005|Maintenance Period|Death|2|||
144485276|NCT01474512|520976558|FG006|Maintenance Period|Death|0|||
144485277|NCT01474512|520976559|FG007|Maintenance Period|Death|0|||
144485278|NCT01474512|520976560|FG008|Maintenance Period|Death|0|||
144485279|NCT01474512|520976561|FG009|Maintenance Period|Death|0|||
144485280|NCT01474512|520976562|FG010|Maintenance Period|Death|0|||
144485281|NCT01474512|520976563|FG011|Maintenance Period|Death|0|||
144485282|NCT01474512|520976564|FG012|Maintenance Period|Death|0|||
144485283|NCT01474512|520976565|FG013|Maintenance Period|Death|0|||
144485284|NCT01474512|520976566|FG014|Maintenance Period|Death|0|||
144485285|NCT01474512|520976567|FG015|Maintenance Period|Death|0|||
144485286|NCT01474512|520976568|FG016|Maintenance Period|Death|0|||
144485287|NCT01474512|520976569|FG017|Maintenance Period|Death|0|||
144485288|NCT01474512|520976552|FG000|Maintenance Period|Physician Decision|0|||
144485289|NCT01474512|520976553|FG001|Maintenance Period|Physician Decision|0|||
144485290|NCT01474512|520976554|FG002|Maintenance Period|Physician Decision|0|||
144485291|NCT01474512|520976555|FG003|Maintenance Period|Physician Decision|0|||
144485292|NCT01474512|520976556|FG004|Maintenance Period|Physician Decision|0|||
144485293|NCT01474512|520976557|FG005|Maintenance Period|Physician Decision|1|||
144485294|NCT01474512|520976558|FG006|Maintenance Period|Physician Decision|0|||
144485295|NCT01474512|520976559|FG007|Maintenance Period|Physician Decision|2|||
144485296|NCT01474512|520976560|FG008|Maintenance Period|Physician Decision|0|||
144485297|NCT01474512|520976561|FG009|Maintenance Period|Physician Decision|0|||
144485298|NCT01474512|520976562|FG010|Maintenance Period|Physician Decision|0|||
144485299|NCT01474512|520976563|FG011|Maintenance Period|Physician Decision|0|||
144485300|NCT01474512|520976564|FG012|Maintenance Period|Physician Decision|0|||
144485301|NCT01474512|520976565|FG013|Maintenance Period|Physician Decision|0|||
144485302|NCT01474512|520976566|FG014|Maintenance Period|Physician Decision|0|||
144485303|NCT01474512|520976567|FG015|Maintenance Period|Physician Decision|0|||
144485304|NCT01474512|520976568|FG016|Maintenance Period|Physician Decision|0|||
144485305|NCT01474512|520976569|FG017|Maintenance Period|Physician Decision|0|||
144485306|NCT01474512|520976552|FG000|Maintenance Period|Clinical Relapse|0|||
144485307|NCT01474512|520976553|FG001|Maintenance Period|Clinical Relapse|0|||
144485308|NCT01474512|520976554|FG002|Maintenance Period|Clinical Relapse|0|||
144485309|NCT01474512|520976555|FG003|Maintenance Period|Clinical Relapse|1|||
144485310|NCT01474512|520976556|FG004|Maintenance Period|Clinical Relapse|0|||
144485311|NCT01474512|520976557|FG005|Maintenance Period|Clinical Relapse|0|||
144485312|NCT01474512|520976558|FG006|Maintenance Period|Clinical Relapse|0|||
144485313|NCT01474512|520976559|FG007|Maintenance Period|Clinical Relapse|0|||
144485314|NCT01474512|520976560|FG008|Maintenance Period|Clinical Relapse|0|||
144485315|NCT01474512|520976561|FG009|Maintenance Period|Clinical Relapse|0|||
144485316|NCT01474512|520976562|FG010|Maintenance Period|Clinical Relapse|0|||
144485317|NCT01474512|520976563|FG011|Maintenance Period|Clinical Relapse|0|||
144485318|NCT01474512|520976564|FG012|Maintenance Period|Clinical Relapse|0|||
144485319|NCT01474512|520976565|FG013|Maintenance Period|Clinical Relapse|0|||
144485320|NCT01474512|520976566|FG014|Maintenance Period|Clinical Relapse|0|||
144485321|NCT01474512|520976567|FG015|Maintenance Period|Clinical Relapse|0|||
144485322|NCT01474512|520976568|FG016|Maintenance Period|Clinical Relapse|0|||
144485323|NCT01474512|520976569|FG017|Maintenance Period|Clinical Relapse|0|||
144485324|NCT01474512|520976552|FG000|Maintenance Period|Lack of Efficacy|0|||
144485325|NCT01474512|520976553|FG001|Maintenance Period|Lack of Efficacy|0|||
144485326|NCT01474512|520976554|FG002|Maintenance Period|Lack of Efficacy|0|||
144485327|NCT01474512|520976555|FG003|Maintenance Period|Lack of Efficacy|1|||
144485328|NCT01474512|520976556|FG004|Maintenance Period|Lack of Efficacy|0|||
144485329|NCT01474512|520976557|FG005|Maintenance Period|Lack of Efficacy|0|||
144485330|NCT01474512|520976558|FG006|Maintenance Period|Lack of Efficacy|0|||
144485331|NCT01474512|520976559|FG007|Maintenance Period|Lack of Efficacy|11|||
144485332|NCT01474512|520976560|FG008|Maintenance Period|Lack of Efficacy|11|||
144485333|NCT01474512|520976561|FG009|Maintenance Period|Lack of Efficacy|12|||
144485334|NCT01474512|520976562|FG010|Maintenance Period|Lack of Efficacy|0|||
144485335|NCT01474512|520976563|FG011|Maintenance Period|Lack of Efficacy|0|||
144485336|NCT01474512|520976564|FG012|Maintenance Period|Lack of Efficacy|0|||
144485337|NCT01474512|520976565|FG013|Maintenance Period|Lack of Efficacy|0|||
144485338|NCT01474512|520976566|FG014|Maintenance Period|Lack of Efficacy|0|||
144485339|NCT01474512|520976567|FG015|Maintenance Period|Lack of Efficacy|0|||
144485340|NCT01474512|520976568|FG016|Maintenance Period|Lack of Efficacy|0|||
144485341|NCT01474512|520976569|FG017|Maintenance Period|Lack of Efficacy|0|||
144485342|NCT01474512|520976552|FG000|Maintenance Period|Protocol Violation|0|||
144485343|NCT01474512|520976553|FG001|Maintenance Period|Protocol Violation|0|||
144485344|NCT01474512|520976554|FG002|Maintenance Period|Protocol Violation|0|||
144485345|NCT01474512|520976555|FG003|Maintenance Period|Protocol Violation|1|||
144485346|NCT01474512|520976556|FG004|Maintenance Period|Protocol Violation|0|||
144485347|NCT01474512|520976557|FG005|Maintenance Period|Protocol Violation|0|||
144485348|NCT01474512|520976558|FG006|Maintenance Period|Protocol Violation|0|||
144485349|NCT01474512|520976559|FG007|Maintenance Period|Protocol Violation|1|||
144485350|NCT01474512|520976560|FG008|Maintenance Period|Protocol Violation|0|||
144485351|NCT01474512|520976561|FG009|Maintenance Period|Protocol Violation|1|||
144485352|NCT01474512|520976562|FG010|Maintenance Period|Protocol Violation|0|||
144485353|NCT01474512|520976563|FG011|Maintenance Period|Protocol Violation|0|||
144485354|NCT01474512|520976564|FG012|Maintenance Period|Protocol Violation|0|||
144485355|NCT01474512|520976565|FG013|Maintenance Period|Protocol Violation|0|||
144485356|NCT01474512|520976566|FG014|Maintenance Period|Protocol Violation|0|||
144485357|NCT01474512|520976567|FG015|Maintenance Period|Protocol Violation|0|||
144485358|NCT01474512|520976568|FG016|Maintenance Period|Protocol Violation|0|||
144485359|NCT01474512|520976569|FG017|Maintenance Period|Protocol Violation|0|||
144485360|NCT01474512|520976552|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
144485361|NCT01474512|520976553|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
144485362|NCT01474512|520976554|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
144485363|NCT01474512|520976555|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
144485364|NCT01474512|520976556|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
144485365|NCT01474512|520976557|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
144485366|NCT01474512|520976558|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
144485367|NCT01474512|520976559|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
144485368|NCT01474512|520976560|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
144485369|NCT01474512|520976561|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
144485370|NCT01474512|520976562|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
144715145|NCT03705169|521811435|FG001|Overall Study|Concerns about study visit compliance|0|||
144715146|NCT03705169|521811436|FG002|Overall Study|Concerns about study visit compliance|0|||
144715147|NCT03705169|521811437|FG003|Overall Study|Concerns about study visit compliance|1|||
144715148|NCT03705169|521811438|FG004|Overall Study|Concerns about study visit compliance|0|||
144715149|NCT03705169|521811439|FG005|Overall Study|Concerns about study visit compliance|0|||
144715150|NCT03705169|521811440|FG006|Overall Study|Concerns about study visit compliance|0|||
144715151|NCT03705169|521811441|FG007|Overall Study|Concerns about study visit compliance|0|||
144715152|NCT03705169|521811442|FG008|Overall Study|Concerns about study visit compliance|0|||
144715153|NCT03705169|521811443|FG009|Overall Study|Concerns about study visit compliance|0|||
144715154|NCT00185211|521811444|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
144715155|NCT00185211|521811445|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
144715156|NCT00185211|521811444|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
144715157|NCT00185211|521811445|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
144715158|NCT00185211|521811444|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
144715159|NCT00185211|521811445|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
144715160|NCT00185211|521811444|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
144715161|NCT00185211|521811445|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
144715162|NCT00185211|521811444|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
144715163|NCT00185211|521811445|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
144715164|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
144715165|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
144715166|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
144715167|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
144715168|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
144715169|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
144715170|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
144715171|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
144715172|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
144715173|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
144715174|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
144715175|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
144715176|NCT00185211|521811444|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
144715177|NCT00185211|521811445|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
144715178|NCT01759537|521811446|FG000|Overall Study|Death|1|||
144715179|NCT01759537|521811447|FG001|Overall Study|Death|1|||
144715180|NCT01759537|521811446|FG000|Overall Study|Pregnancy|1|||
144715181|NCT01759537|521811447|FG001|Overall Study|Pregnancy|1|||
144715182|NCT01759537|521811446|FG000|Overall Study|Lost to Follow-up|9|||
144715183|NCT01759537|521811447|FG001|Overall Study|Lost to Follow-up|9|||
144715184|NCT01759537|521811446|FG000|Overall Study|Accident involving jaw fracture|1|||
144715185|NCT01759537|521811447|FG001|Overall Study|Accident involving jaw fracture|1|||
144715186|NCT01759537|521811446|FG000|Overall Study|Subcrestal implant too coronal|1|||
144715187|NCT01759537|521811447|FG001|Overall Study|Subcrestal implant too coronal|1|||
144715188|NCT00420290|521811448|FG000|Overall Study|Adverse Event|3|||
144715189|NCT00420290|521811449|FG001|Overall Study|Adverse Event|1|||
144715190|NCT00420290|521811448|FG000|Overall Study|Withdrawal by Subject|0|||
144715191|NCT00420290|521811449|FG001|Overall Study|Withdrawal by Subject|2|||
144715192|NCT00420290|521811448|FG000|Overall Study|did not meet inclusion/exclusion|1|||
144715193|NCT00420290|521811449|FG001|Overall Study|did not meet inclusion/exclusion|1|||
144715194|NCT01859390|521813294|FG000|Overall Study|Insufficient Sputum Collected|1|||
144715195|NCT01859390|521813295|FG001|Overall Study|Insufficient Sputum Collected|3|||
144715196|NCT01859390|521813294|FG000|Overall Study|Sample Missing Collection Date|0|||
144715197|NCT01859390|521813295|FG001|Overall Study|Sample Missing Collection Date|1|||
144715198|NCT01859390|521813294|FG000|Overall Study|Tube Cracked|0|||
144715199|NCT01859390|521813295|FG001|Overall Study|Tube Cracked|2|||
144715200|NCT01859390|521813294|FG000|Overall Study|Shipment Error|0|||
144715201|NCT01859390|521813295|FG001|Overall Study|Shipment Error|1|||
144715202|NCT01706198|521813297|FG000|Overall Study|Adverse Event|12|||
144715203|NCT01706198|521813298|FG001|Overall Study|Adverse Event|15|||
144715204|NCT01706198|521813297|FG000|Overall Study|Protocol Violation|7|||
144715205|NCT01706198|521813298|FG001|Overall Study|Protocol Violation|5|||
144715206|NCT01706198|521813297|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
144715207|NCT01706198|521813298|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
144485371|NCT01474512|520976563|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
144485372|NCT01474512|520976564|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
144485373|NCT01474512|520976565|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
144485374|NCT01474512|520976566|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
144485375|NCT01474512|520976567|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
144485376|NCT01474512|520976568|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
144485377|NCT01474512|520976569|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
144485378|NCT01474512|520976552|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
144485379|NCT01474512|520976553|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
144485380|NCT01474512|520976554|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
144485381|NCT01474512|520976555|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
144485382|NCT01474512|520976556|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
144485383|NCT01474512|520976557|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
144485384|NCT01474512|520976558|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
144485385|NCT01474512|520976559|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
144485386|NCT01474512|520976560|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
144485387|NCT01474512|520976561|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
144485388|NCT01474512|520976562|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
144485389|NCT01474512|520976563|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
144485390|NCT01474512|520976564|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
144485391|NCT01474512|520976565|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
144485392|NCT01474512|520976566|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
144485393|NCT01474512|520976567|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
144485394|NCT01474512|520976568|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
144485395|NCT01474512|520976569|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
144485396|NCT01474512|520976552|FG000|Long-Term Extension Period|Adverse Event|0|||
144485397|NCT01474512|520976553|FG001|Long-Term Extension Period|Adverse Event|0|||
144485398|NCT01474512|520976554|FG002|Long-Term Extension Period|Adverse Event|0|||
144485399|NCT01474512|520976555|FG003|Long-Term Extension Period|Adverse Event|0|||
144485400|NCT01474512|520976556|FG004|Long-Term Extension Period|Adverse Event|0|||
144485401|NCT01474512|520976557|FG005|Long-Term Extension Period|Adverse Event|0|||
144485402|NCT01474512|520976558|FG006|Long-Term Extension Period|Adverse Event|0|||
144485403|NCT01474512|520976559|FG007|Long-Term Extension Period|Adverse Event|0|||
144485404|NCT01474512|520976560|FG008|Long-Term Extension Period|Adverse Event|0|||
144485405|NCT01474512|520976561|FG009|Long-Term Extension Period|Adverse Event|0|||
144485406|NCT01474512|520976562|FG010|Long-Term Extension Period|Adverse Event|0|||
144485407|NCT01474512|520976563|FG011|Long-Term Extension Period|Adverse Event|1|||
144485408|NCT01474512|520976564|FG012|Long-Term Extension Period|Adverse Event|57|||
144485409|NCT01474512|520976565|FG013|Long-Term Extension Period|Adverse Event|58|||
144485410|NCT01474512|520976566|FG014|Long-Term Extension Period|Adverse Event|0|||
144485411|NCT01474512|520976567|FG015|Long-Term Extension Period|Adverse Event|0|||
144485412|NCT01474512|520976568|FG016|Long-Term Extension Period|Adverse Event|0|||
144715208|NCT01706198|521813297|FG000|Overall Study|Lost to Follow-up|97|||
144715209|NCT01706198|521813298|FG001|Overall Study|Lost to Follow-up|93|||
144715210|NCT01706198|521813297|FG000|Overall Study|Physician Decision|23|||
144715211|NCT01706198|521813298|FG001|Overall Study|Physician Decision|37|||
144715212|NCT01706198|521813297|FG000|Overall Study|Withdrawal by Subject|23|||
144715213|NCT01706198|521813298|FG001|Overall Study|Withdrawal by Subject|31|||
144715214|NCT04313283|521813299|FG000|Overall Study|did not complete intervention|4|||
144715215|NCT01084005|521813300|FG000|Overall Study|Adverse Event|1|||
144715216|NCT01084005|521813301|FG001|Overall Study|Adverse Event|8|||
144715217|NCT01084005|521813300|FG000|Overall Study|Protocol Violation|3|||
144715218|NCT01084005|521813301|FG001|Overall Study|Protocol Violation|7|||
144715219|NCT01084005|521813300|FG000|Overall Study|Withdrawal by Subject|1|||
144715220|NCT01084005|521813301|FG001|Overall Study|Withdrawal by Subject|1|||
144715221|NCT03377556|521813307|FG000|Overall Study|Adverse Event|5|||
144715222|NCT03377556|521813307|FG000|Overall Study|Refusal unrelated to adverse events|1|||
144715223|NCT03377556|521813307|FG000|Overall Study|Progression/relapse|38|||
144715224|NCT03377556|521813307|FG000|Overall Study|Death|3|||
144715225|NCT00472446|521813308|FG000|Overall Study|Protocol Violation|0|||
144715226|NCT00472446|521813309|FG001|Overall Study|Protocol Violation|0|||
144715227|NCT00472446|521813310|FG002|Overall Study|Protocol Violation|0|||
144715228|NCT00472446|521813311|FG003|Overall Study|Protocol Violation|1|||
144715229|NCT00472446|521813308|FG000|Overall Study|Reintervention|0|||
144715230|NCT00472446|521813309|FG001|Overall Study|Reintervention|0|||
144715231|NCT00472446|521813310|FG002|Overall Study|Reintervention|1|||
144715232|NCT00472446|521813311|FG003|Overall Study|Reintervention|1|||
144715233|NCT00472446|521813308|FG000|Overall Study|Questionnaires not returned|5|||
144715234|NCT00472446|521813309|FG001|Overall Study|Questionnaires not returned|6|||
144715235|NCT00472446|521813310|FG002|Overall Study|Questionnaires not returned|6|||
144715236|NCT00472446|521813311|FG003|Overall Study|Questionnaires not returned|4|||
144715237|NCT02008721|521813314|FG000|Overall Study|Withdrawal by Subject|5|||
144715238|NCT02008721|521813315|FG001|Overall Study|Withdrawal by Subject|1|||
144485413|NCT01474512|520976569|FG017|Long-Term Extension Period|Adverse Event|0|||
144485414|NCT01474512|520976552|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
144485415|NCT01474512|520976553|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
144485416|NCT01474512|520976554|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
144485417|NCT01474512|520976555|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
144485418|NCT01474512|520976556|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
144485419|NCT01474512|520976557|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
144485420|NCT01474512|520976558|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
144485421|NCT01474512|520976559|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
144485422|NCT01474512|520976560|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
144485423|NCT01474512|520976561|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
144485424|NCT01474512|520976562|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
144485425|NCT01474512|520976563|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
144485426|NCT01474512|520976564|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
144485427|NCT01474512|520976565|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
144485428|NCT01474512|520976566|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
144485429|NCT01474512|520976567|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
144485430|NCT01474512|520976568|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
144485431|NCT01474512|520976569|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
144485432|NCT01474512|520976552|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
144485433|NCT01474512|520976553|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
144485434|NCT01474512|520976554|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
144485435|NCT01474512|520976555|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
144485436|NCT01474512|520976556|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
144485437|NCT01474512|520976557|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
144485438|NCT01474512|520976558|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
144485439|NCT01474512|520976559|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
144485440|NCT01474512|520976560|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
144485441|NCT01474512|520976561|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
144485442|NCT01474512|520976562|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
144485443|NCT01474512|520976563|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
144485444|NCT01474512|520976564|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
144485445|NCT01474512|520976565|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
144485446|NCT01474512|520976566|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
144485447|NCT01474512|520976567|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
144485448|NCT01474512|520976568|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
144485449|NCT01474512|520976569|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
144485450|NCT01474512|520976552|FG000|Long-Term Extension Period|Physician Decision|0|||
144485451|NCT01474512|520976553|FG001|Long-Term Extension Period|Physician Decision|0|||
144485452|NCT01474512|520976554|FG002|Long-Term Extension Period|Physician Decision|0|||
144485453|NCT01474512|520976555|FG003|Long-Term Extension Period|Physician Decision|0|||
144485454|NCT01474512|520976556|FG004|Long-Term Extension Period|Physician Decision|0|||
144485455|NCT01474512|520976557|FG005|Long-Term Extension Period|Physician Decision|0|||
144485456|NCT01474512|520976558|FG006|Long-Term Extension Period|Physician Decision|0|||
144485457|NCT01474512|520976559|FG007|Long-Term Extension Period|Physician Decision|0|||
144485458|NCT01474512|520976560|FG008|Long-Term Extension Period|Physician Decision|0|||
144485459|NCT01474512|520976561|FG009|Long-Term Extension Period|Physician Decision|0|||
144485460|NCT01474512|520976562|FG010|Long-Term Extension Period|Physician Decision|0|||
144485461|NCT01474512|520976563|FG011|Long-Term Extension Period|Physician Decision|0|||
144485462|NCT01474512|520976564|FG012|Long-Term Extension Period|Physician Decision|21|||
144485463|NCT01474512|520976565|FG013|Long-Term Extension Period|Physician Decision|21|||
144485464|NCT01474512|520976566|FG014|Long-Term Extension Period|Physician Decision|0|||
144485465|NCT01474512|520976567|FG015|Long-Term Extension Period|Physician Decision|0|||
144485466|NCT01474512|520976568|FG016|Long-Term Extension Period|Physician Decision|0|||
144485467|NCT01474512|520976569|FG017|Long-Term Extension Period|Physician Decision|0|||
144485468|NCT01474512|520976552|FG000|Long-Term Extension Period|Clinical Relapse|0|||
144485469|NCT01474512|520976553|FG001|Long-Term Extension Period|Clinical Relapse|0|||
144485470|NCT01474512|520976554|FG002|Long-Term Extension Period|Clinical Relapse|0|||
144485471|NCT01474512|520976555|FG003|Long-Term Extension Period|Clinical Relapse|0|||
144485472|NCT01474512|520976556|FG004|Long-Term Extension Period|Clinical Relapse|0|||
144485473|NCT01474512|520976557|FG005|Long-Term Extension Period|Clinical Relapse|0|||
144485474|NCT01474512|520976558|FG006|Long-Term Extension Period|Clinical Relapse|0|||
144485475|NCT01474512|520976559|FG007|Long-Term Extension Period|Clinical Relapse|0|||
144485476|NCT01474512|520976560|FG008|Long-Term Extension Period|Clinical Relapse|0|||
144485477|NCT01474512|520976561|FG009|Long-Term Extension Period|Clinical Relapse|0|||
144485478|NCT01474512|520976562|FG010|Long-Term Extension Period|Clinical Relapse|0|||
144485479|NCT01474512|520976563|FG011|Long-Term Extension Period|Clinical Relapse|0|||
144485480|NCT01474512|520976564|FG012|Long-Term Extension Period|Clinical Relapse|9|||
144485481|NCT01474512|520976565|FG013|Long-Term Extension Period|Clinical Relapse|9|||
144485482|NCT01474512|520976566|FG014|Long-Term Extension Period|Clinical Relapse|0|||
144485483|NCT01474512|520976567|FG015|Long-Term Extension Period|Clinical Relapse|0|||
144485484|NCT01474512|520976568|FG016|Long-Term Extension Period|Clinical Relapse|0|||
144485485|NCT01474512|520976569|FG017|Long-Term Extension Period|Clinical Relapse|0|||
144485486|NCT01474512|520976552|FG000|Long-Term Extension Period|Death|0|||
144485487|NCT01474512|520976553|FG001|Long-Term Extension Period|Death|0|||
144485488|NCT01474512|520976554|FG002|Long-Term Extension Period|Death|0|||
144485489|NCT01474512|520976555|FG003|Long-Term Extension Period|Death|0|||
144485490|NCT01474512|520976556|FG004|Long-Term Extension Period|Death|0|||
144485491|NCT01474512|520976557|FG005|Long-Term Extension Period|Death|0|||
144485492|NCT01474512|520976558|FG006|Long-Term Extension Period|Death|0|||
144485493|NCT01474512|520976559|FG007|Long-Term Extension Period|Death|0|||
144485494|NCT01474512|520976560|FG008|Long-Term Extension Period|Death|0|||
144485495|NCT01474512|520976561|FG009|Long-Term Extension Period|Death|0|||
144485496|NCT01474512|520976562|FG010|Long-Term Extension Period|Death|0|||
144485497|NCT01474512|520976563|FG011|Long-Term Extension Period|Death|0|||
144485498|NCT01474512|520976564|FG012|Long-Term Extension Period|Death|9|||
144485499|NCT01474512|520976565|FG013|Long-Term Extension Period|Death|9|||
144485500|NCT01474512|520976566|FG014|Long-Term Extension Period|Death|0|||
144485501|NCT01474512|520976567|FG015|Long-Term Extension Period|Death|0|||
144485502|NCT01474512|520976568|FG016|Long-Term Extension Period|Death|0|||
144485503|NCT01474512|520976569|FG017|Long-Term Extension Period|Death|0|||
144485504|NCT01474512|520976552|FG000|Long-Term Extension Period|Sponsor Decision|0|||
144485505|NCT01474512|520976553|FG001|Long-Term Extension Period|Sponsor Decision|0|||
144485506|NCT01474512|520976554|FG002|Long-Term Extension Period|Sponsor Decision|0|||
144485507|NCT01474512|520976555|FG003|Long-Term Extension Period|Sponsor Decision|0|||
144485508|NCT01474512|520976556|FG004|Long-Term Extension Period|Sponsor Decision|0|||
144485509|NCT01474512|520976557|FG005|Long-Term Extension Period|Sponsor Decision|0|||
144485510|NCT01474512|520976558|FG006|Long-Term Extension Period|Sponsor Decision|0|||
144485511|NCT01474512|520976559|FG007|Long-Term Extension Period|Sponsor Decision|0|||
144485512|NCT01474512|520976560|FG008|Long-Term Extension Period|Sponsor Decision|0|||
144485513|NCT01474512|520976561|FG009|Long-Term Extension Period|Sponsor Decision|0|||
144485514|NCT01474512|520976562|FG010|Long-Term Extension Period|Sponsor Decision|0|||
144485515|NCT01474512|520976563|FG011|Long-Term Extension Period|Sponsor Decision|0|||
144485516|NCT01474512|520976564|FG012|Long-Term Extension Period|Sponsor Decision|6|||
144485517|NCT01474512|520976565|FG013|Long-Term Extension Period|Sponsor Decision|6|||
144485518|NCT01474512|520976566|FG014|Long-Term Extension Period|Sponsor Decision|0|||
144485519|NCT01474512|520976567|FG015|Long-Term Extension Period|Sponsor Decision|0|||
144485520|NCT01474512|520976568|FG016|Long-Term Extension Period|Sponsor Decision|0|||
144485521|NCT01474512|520976569|FG017|Long-Term Extension Period|Sponsor Decision|0|||
144485522|NCT01474512|520976552|FG000|Long-Term Extension Period|Protocol Violation|0|||
144485523|NCT01474512|520976553|FG001|Long-Term Extension Period|Protocol Violation|0|||
144485524|NCT01474512|520976554|FG002|Long-Term Extension Period|Protocol Violation|0|||
144485525|NCT01474512|520976555|FG003|Long-Term Extension Period|Protocol Violation|0|||
144485526|NCT01474512|520976556|FG004|Long-Term Extension Period|Protocol Violation|0|||
144485527|NCT01474512|520976557|FG005|Long-Term Extension Period|Protocol Violation|0|||
144485528|NCT01474512|520976558|FG006|Long-Term Extension Period|Protocol Violation|0|||
144485529|NCT01474512|520976559|FG007|Long-Term Extension Period|Protocol Violation|0|||
144485530|NCT01474512|520976560|FG008|Long-Term Extension Period|Protocol Violation|0|||
144485531|NCT01474512|520976561|FG009|Long-Term Extension Period|Protocol Violation|0|||
144485532|NCT01474512|520976562|FG010|Long-Term Extension Period|Protocol Violation|0|||
144485533|NCT01474512|520976563|FG011|Long-Term Extension Period|Protocol Violation|0|||
144485534|NCT01474512|520976564|FG012|Long-Term Extension Period|Protocol Violation|5|||
144485535|NCT01474512|520976565|FG013|Long-Term Extension Period|Protocol Violation|5|||
144485536|NCT01474512|520976566|FG014|Long-Term Extension Period|Protocol Violation|0|||
144485537|NCT01474512|520976567|FG015|Long-Term Extension Period|Protocol Violation|0|||
144485538|NCT01474512|520976568|FG016|Long-Term Extension Period|Protocol Violation|0|||
144485539|NCT01474512|520976569|FG017|Long-Term Extension Period|Protocol Violation|0|||
144485540|NCT01474512|520976552|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485541|NCT01474512|520976553|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485542|NCT01474512|520976554|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485543|NCT01474512|520976555|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485544|NCT01474512|520976556|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485545|NCT01474512|520976557|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485546|NCT01474512|520976558|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485547|NCT01474512|520976559|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485548|NCT01474512|520976560|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485549|NCT01474512|520976561|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485550|NCT01474512|520976562|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485551|NCT01474512|520976563|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485552|NCT01474512|520976564|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
144485553|NCT01474512|520976565|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
144485554|NCT01474512|520976566|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485555|NCT01474512|520976567|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485556|NCT01474512|520976568|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485557|NCT01474512|520976569|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
144485558|NCT01474512|520976552|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485559|NCT01474512|520976553|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485560|NCT01474512|520976554|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485561|NCT01474512|520976555|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485562|NCT01474512|520976556|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485563|NCT01474512|520976557|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485564|NCT01474512|520976558|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485565|NCT01474512|520976559|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485566|NCT01474512|520976560|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485567|NCT01474512|520976561|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485568|NCT01474512|520976562|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485569|NCT01474512|520976563|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
144485570|NCT01474512|520976564|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485571|NCT01474512|520976565|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485572|NCT01474512|520976566|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485573|NCT01474512|520976567|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485574|NCT01474512|520976568|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485575|NCT01474512|520976569|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
144485576|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
144485577|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
144485578|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
144485579|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
144485580|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
144485581|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
144485582|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
144485583|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
144485584|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
144485585|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
144485586|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
144485587|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
144485588|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
144485589|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
144485590|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
144485591|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
144485592|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
144485593|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
144485594|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485595|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485596|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485597|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485598|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485599|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485600|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485601|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485602|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485603|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485604|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485605|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485606|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485607|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
144485608|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
144485609|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
144485610|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
144485611|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
144485612|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485613|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485614|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485615|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485616|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485617|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485618|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485619|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485620|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485621|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485622|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485623|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485624|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485625|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
144485626|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
144485627|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
144485628|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
144485629|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
144715239|NCT02008721|521813314|FG000|Overall Study|Death|4|||
144715240|NCT02008721|521813315|FG001|Overall Study|Death|2|||
144715241|NCT02008721|521813314|FG000|Overall Study|Adverse Event|3|||
144715242|NCT02008721|521813315|FG001|Overall Study|Adverse Event|5|||
144715243|NCT02008721|521813314|FG000|Overall Study|Protocol Violation|3|||
144715244|NCT02008721|521813315|FG001|Overall Study|Protocol Violation|2|||
144715245|NCT00295854|521813318|FG000|Overall Study|Adverse Event|7|||
144715246|NCT00295854|521813319|FG001|Overall Study|Adverse Event|7|||
144485630|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144715247|NCT00295854|521813320|FG002|Overall Study|Adverse Event|6|||
144485631|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485632|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485633|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485634|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485635|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485636|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485637|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485638|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485639|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485640|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485641|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485642|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485643|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485644|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485645|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
144485646|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
144485647|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
144485648|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
144485649|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
144485650|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
144485651|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
144485652|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
144485653|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
144485654|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
144485655|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
144485656|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
144485657|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
144485658|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
144485659|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
144485660|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
144485661|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
144485662|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
144485663|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
144485664|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
144485665|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
144485666|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485667|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485668|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485669|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485670|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485671|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485672|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485673|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485674|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485675|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485676|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485677|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485678|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485679|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485680|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
144485681|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
144715248|NCT00295854|521813318|FG000|Overall Study|Protocol Violation|1|||
144715249|NCT00295854|521813319|FG001|Overall Study|Protocol Violation|1|||
144715250|NCT00295854|521813320|FG002|Overall Study|Protocol Violation|1|||
144715251|NCT00295854|521813318|FG000|Overall Study|Lost to Follow-up|2|||
144715252|NCT00295854|521813319|FG001|Overall Study|Lost to Follow-up|0|||
144715253|NCT00295854|521813320|FG002|Overall Study|Lost to Follow-up|1|||
144715254|NCT00295854|521813318|FG000|Overall Study|Withdrawal by Subject|3|||
144715255|NCT00295854|521813319|FG001|Overall Study|Withdrawal by Subject|7|||
144715256|NCT00295854|521813320|FG002|Overall Study|Withdrawal by Subject|4|||
144715257|NCT00295854|521813318|FG000|Overall Study|did not continue to meet criteria|1|||
144715258|NCT00295854|521813319|FG001|Overall Study|did not continue to meet criteria|1|||
144715259|NCT00295854|521813320|FG002|Overall Study|did not continue to meet criteria|2|||
144715260|NCT00295854|521813318|FG000|Overall Study|required a prohibited medication|1|||
144715261|NCT00295854|521813319|FG001|Overall Study|required a prohibited medication|0|||
144715262|NCT00295854|521813320|FG002|Overall Study|required a prohibited medication|0|||
144715263|NCT00295854|521813318|FG000|Overall Study|Other|3|||
144715264|NCT00295854|521813319|FG001|Overall Study|Other|5|||
144369772|NCT02745119|520561695|FG002|Overall Study|Lost to Follow-up|0|||
144485682|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
144485683|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
144485684|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
144538222|NCT00146172|521174127|FG005|Overall Study|Physician Decision|0|||
144485685|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
144485686|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
144485687|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
144485688|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
144485689|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
144485690|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
144485691|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
144485692|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
144485693|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
144485694|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
144485695|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
144485696|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
144485697|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
144485698|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
144485699|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
144485700|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
144485701|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
144485702|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485703|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485704|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485705|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485706|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485707|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485708|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485709|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485710|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485711|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485712|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485713|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485714|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485715|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485716|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
144485717|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485718|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
144485719|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
144485720|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485721|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485722|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485723|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485724|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485725|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485726|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485727|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485728|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485729|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485730|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485731|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485732|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485733|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485734|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
144485735|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485736|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
144485737|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
144485738|NCT01474512|520976552|FG000|Post-Treatment Follow-Up|Death|0|||
144485739|NCT01474512|520976553|FG001|Post-Treatment Follow-Up|Death|0|||
144485740|NCT01474512|520976554|FG002|Post-Treatment Follow-Up|Death|0|||
144485741|NCT01474512|520976555|FG003|Post-Treatment Follow-Up|Death|0|||
144485742|NCT01474512|520976556|FG004|Post-Treatment Follow-Up|Death|0|||
144485743|NCT01474512|520976557|FG005|Post-Treatment Follow-Up|Death|0|||
144485744|NCT01474512|520976558|FG006|Post-Treatment Follow-Up|Death|0|||
144485745|NCT01474512|520976559|FG007|Post-Treatment Follow-Up|Death|0|||
144485746|NCT01474512|520976560|FG008|Post-Treatment Follow-Up|Death|0|||
144485747|NCT01474512|520976561|FG009|Post-Treatment Follow-Up|Death|0|||
144485748|NCT01474512|520976562|FG010|Post-Treatment Follow-Up|Death|0|||
144485749|NCT01474512|520976563|FG011|Post-Treatment Follow-Up|Death|0|||
144485750|NCT01474512|520976564|FG012|Post-Treatment Follow-Up|Death|0|||
144485751|NCT01474512|520976565|FG013|Post-Treatment Follow-Up|Death|0|||
144485752|NCT01474512|520976566|FG014|Post-Treatment Follow-Up|Death|0|||
144485753|NCT01474512|520976567|FG015|Post-Treatment Follow-Up|Death|0|||
144485754|NCT01474512|520976568|FG016|Post-Treatment Follow-Up|Death|1|||
144485755|NCT01474512|520976569|FG017|Post-Treatment Follow-Up|Death|0|||
144485756|NCT01118962|520976572|FG000|Overall Study|Adverse Event|2|||
144485757|NCT01118962|520976572|FG000|Overall Study|Lack of Efficacy|1|||
144485758|NCT01118962|520976572|FG000|Overall Study|Protocol Violation|1|||
144485759|NCT01118962|520976572|FG000|Overall Study|Withdrawal by Subject|4|||
144485760|NCT01118962|520976572|FG000|Overall Study|Pregnancy|1|||
144485761|NCT01118962|520976572|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
144485762|NCT00506285|520976575|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
144485763|NCT00506285|520976576|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
144485764|NCT00506285|520976575|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
144485765|NCT00506285|520976576|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
144485766|NCT00506285|520976575|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
144485767|NCT00506285|520976576|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
144485768|NCT00506285|520976575|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
144485769|NCT00506285|520976576|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
144485770|NCT00506285|520976575|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
144485771|NCT00506285|520976576|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
144485772|NCT00531011|520976584|FG000|Overall Study|Withdrawal by Subject|2|||
144485773|NCT00531011|520976585|FG001|Overall Study|Withdrawal by Subject|4|||
144485774|NCT00531011|520976584|FG000|Overall Study|Death|1|||
144485775|NCT00531011|520976585|FG001|Overall Study|Death|0|||
144485776|NCT00531011|520976584|FG000|Overall Study|Lost to Follow-up|1|||
144485777|NCT00531011|520976585|FG001|Overall Study|Lost to Follow-up|0|||
144485778|NCT00531011|520976584|FG000|Overall Study|Physician Decision|0|||
144485779|NCT00531011|520976585|FG001|Overall Study|Physician Decision|3|||
144485780|NCT02206152|520976612|FG000|Pre-Randomization|Withdrawal by Subject|2|||
144485781|NCT00390455|520976614|FG000|Overall Study|Adverse Event|17|||
144485782|NCT00390455|520976615|FG001|Overall Study|Adverse Event|3|||
144485783|NCT00390455|520976614|FG000|Overall Study|Withdrawal by Subject|8|||
144485784|NCT00390455|520976615|FG001|Overall Study|Withdrawal by Subject|8|||
144485785|NCT00390455|520976614|FG000|Overall Study|Alternate Treatment|0|||
144485786|NCT00390455|520976615|FG001|Overall Study|Alternate Treatment|1|||
144485787|NCT00390455|520976614|FG000|Overall Study|Other Medical Reasons|7|||
144485788|NCT00390455|520976615|FG001|Overall Study|Other Medical Reasons|11|||
144485789|NCT00794820|520976618|FG000|Overall Study|Adverse Event|11|||
144715265|NCT00295854|521813320|FG002|Overall Study|Other|1|||
144715266|NCT00772577|521813321|FG000|Overall Study|Adverse Event|6|||
144715267|NCT00772577|521813322|FG001|Overall Study|Adverse Event|3|||
144715268|NCT00772577|521813321|FG000|Overall Study|Abnormal laboratory values|0|||
144715269|NCT00772577|521813322|FG001|Overall Study|Abnormal laboratory values|1|||
144715270|NCT00772577|521813321|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144715271|NCT00772577|521813322|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
144715272|NCT00772577|521813321|FG000|Overall Study|Patient withdrew consent|8|||
144715273|NCT00772577|521813322|FG001|Overall Study|Patient withdrew consent|5|||
144715274|NCT00772577|521813321|FG000|Overall Study|Lost to Follow-up|4|||
144715275|NCT00772577|521813322|FG001|Overall Study|Lost to Follow-up|3|||
144715276|NCT00772577|521813321|FG000|Overall Study|Administrative problems|2|||
144715277|NCT00772577|521813322|FG001|Overall Study|Administrative problems|1|||
144715278|NCT00772577|521813321|FG000|Overall Study|Protocol Deviation|3|||
144715279|NCT00772577|521813322|FG001|Overall Study|Protocol Deviation|2|||
144715280|NCT00672620|521813323|FG000|Overall Study|Adverse Event|7|||
144715281|NCT00672620|521813324|FG001|Overall Study|Adverse Event|7|||
144715282|NCT00672620|521813325|FG002|Overall Study|Adverse Event|12|||
144715283|NCT00672620|521813326|FG003|Overall Study|Adverse Event|17|||
144715284|NCT00672620|521813323|FG000|Overall Study|Lack of Efficacy|1|||
144715285|NCT00672620|521813324|FG001|Overall Study|Lack of Efficacy|2|||
144715286|NCT00672620|521813325|FG002|Overall Study|Lack of Efficacy|2|||
144715287|NCT00672620|521813326|FG003|Overall Study|Lack of Efficacy|0|||
144715288|NCT00672620|521813323|FG000|Overall Study|Noncompliance with Study Drug|3|||
144715289|NCT00672620|521813324|FG001|Overall Study|Noncompliance with Study Drug|4|||
144715290|NCT00672620|521813325|FG002|Overall Study|Noncompliance with Study Drug|0|||
144715291|NCT00672620|521813326|FG003|Overall Study|Noncompliance with Study Drug|2|||
144715292|NCT00672620|521813323|FG000|Overall Study|Protocol Deviations|5|||
144715293|NCT00672620|521813324|FG001|Overall Study|Protocol Deviations|7|||
144715294|NCT00672620|521813325|FG002|Overall Study|Protocol Deviations|2|||
144715295|NCT00672620|521813326|FG003|Overall Study|Protocol Deviations|5|||
144715296|NCT00672620|521813323|FG000|Overall Study|Withdrawal of Consent|6|||
144715297|NCT00672620|521813324|FG001|Overall Study|Withdrawal of Consent|12|||
144715298|NCT00672620|521813325|FG002|Overall Study|Withdrawal of Consent|5|||
144715299|NCT00672620|521813326|FG003|Overall Study|Withdrawal of Consent|6|||
144715300|NCT00672620|521813323|FG000|Overall Study|Lost to Follow-up|8|||
144485790|NCT00794820|520976618|FG000|Overall Study|Secondary Malignancies|2|||
144485791|NCT00794820|520976618|FG000|Overall Study|Resistant Disease|2|||
144485792|NCT00794820|520976618|FG000|Overall Study|Ineligible/Screen Failure|1|||
144715301|NCT00672620|521813324|FG001|Overall Study|Lost to Follow-up|19|||
144485793|NCT04076020|520976619|FG000|Overall Study|Death|4|||
144485794|NCT04076020|520976620|FG001|Overall Study|Death|6|||
144715302|NCT00672620|521813325|FG002|Overall Study|Lost to Follow-up|8|||
144715303|NCT00672620|521813326|FG003|Overall Study|Lost to Follow-up|11|||
144715304|NCT00672620|521813323|FG000|Overall Study|Reason not Specified|3|||
144485795|NCT04076020|520976619|FG000|Overall Study|Withdrawal by Subject|12|||
144485796|NCT04076020|520976620|FG001|Overall Study|Withdrawal by Subject|8|||
144485797|NCT02406261|520976622|FG000|Period 1|Lost to Follow-up|2|||
144485798|NCT02406261|520976623|FG001|Period 1|Lost to Follow-up|0|||
144485799|NCT02406261|520976622|FG000|Period 1|Adverse Event|1|||
144485800|NCT02406261|520976623|FG001|Period 1|Adverse Event|0|||
144485801|NCT02406261|520976622|FG000|Period 2|Physician Decision|0|||
144485802|NCT02406261|520976623|FG001|Period 2|Physician Decision|1|||
144485803|NCT02406261|520976622|FG000|Period 2|Protocol Violation|0|||
144485804|NCT02406261|520976623|FG001|Period 2|Protocol Violation|1|||
144485805|NCT02406261|520976622|FG000|Period 2|Withdrawal by Subject|0|||
144485806|NCT02406261|520976623|FG001|Period 2|Withdrawal by Subject|1|||
144485807|NCT01591460|520976624|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
144485808|NCT01591460|520976624|FG000|Overall Study|Futility Rule (Week 12)|7|||
144485809|NCT01591460|520976624|FG000|Overall Study|Futility Rule (Week 24)|3|||
144485810|NCT01591460|520976624|FG000|Overall Study|Rebound or Breakthrough|3|||
144485811|NCT01591460|520976624|FG000|Overall Study|Treatment Discontinued by Error|1|||
144485812|NCT01591460|520976624|FG000|Overall Study|Lost to Follow-up|1|||
144485813|NCT01591460|520976624|FG000|Overall Study|Noncompliance|1|||
144485814|NCT01591460|520976624|FG000|Overall Study|Participant Refusal|3|||
144485815|NCT01591460|520976624|FG000|Overall Study|Withdrawal by Subject|1|||
144485816|NCT01591460|520976624|FG000|Overall Study|Protocol Violation|1|||
144485817|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
144485818|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
144485819|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
144485820|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
144485821|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
144485822|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
144485823|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
144485824|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
144485825|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
144485826|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
144485827|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
144485828|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
144485829|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
144485830|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
144485831|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
144485832|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
144485833|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
144485834|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
144485835|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
144485836|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
144485837|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
144485838|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
144485839|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
144485840|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
144485841|NCT03230864|520976625|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
144485842|NCT03230864|520976626|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
144485843|NCT03230864|520976627|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
144485844|NCT03230864|520976628|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
144485845|NCT03230864|520976625|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
144485846|NCT03230864|520976626|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
144485847|NCT03230864|520976627|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
144485848|NCT03230864|520976628|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
144485849|NCT03230864|520976625|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144485850|NCT03230864|520976626|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144485851|NCT03230864|520976627|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
144485852|NCT03230864|520976628|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
144485853|NCT03230864|520976625|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
144485854|NCT03230864|520976626|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
144485855|NCT03230864|520976627|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
144485856|NCT03230864|520976628|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
144485857|NCT00610675|520976635|FG000|Overall Study|Untreated|4|||
144485858|NCT00610675|520976635|FG000|Overall Study|Adverse Event|67|||
144485859|NCT00610675|520976635|FG000|Overall Study|Insufficient Effect|31|||
144485860|NCT00610675|520976635|FG000|Overall Study|Withdrawal by Subject|28|||
144485861|NCT00610675|520976635|FG000|Overall Study|Reasons unrelated to trial|27|||
144485862|NCT00610675|520976635|FG000|Overall Study|Lack of Compliance|7|||
144485863|NCT00610675|520976635|FG000|Overall Study|Lost to Follow-up|31|||
144485864|NCT00610675|520976635|FG000|Overall Study|Other reason (not specified)|25|||
144485865|NCT04011384|520976638|FG000|Overall Study|Withdrawal by Subject|2|||
144485866|NCT04011384|520976639|FG001|Overall Study|Withdrawal by Subject|0|||
144485867|NCT00672958|520976640|FG000|Overall Study|Adverse Event|11|||
144485868|NCT00672958|520976641|FG001|Overall Study|Adverse Event|9|||
144485869|NCT00672958|520976640|FG000|Overall Study|Lack of Efficacy|6|||
144485870|NCT00672958|520976641|FG001|Overall Study|Lack of Efficacy|11|||
144485871|NCT00672958|520976640|FG000|Overall Study|Non-compliance with study drug|2|||
144485872|NCT00672958|520976641|FG001|Overall Study|Non-compliance with study drug|3|||
144485873|NCT00672958|520976640|FG000|Overall Study|Protocol deviations|11|||
144485874|NCT00672958|520976641|FG001|Overall Study|Protocol deviations|5|||
144485875|NCT00672958|520976640|FG000|Overall Study|Voluntary withdrawal|12|||
144485876|NCT00672958|520976641|FG001|Overall Study|Voluntary withdrawal|8|||
144485877|NCT00672958|520976640|FG000|Overall Study|Lost to Follow-up|22|||
144485878|NCT00672958|520976641|FG001|Overall Study|Lost to Follow-up|17|||
144485879|NCT00672958|520976640|FG000|Overall Study|Reason not specified|0|||
144485880|NCT00672958|520976641|FG001|Overall Study|Reason not specified|3|||
144485881|NCT02374593|520976642|FG000|Overall Study|non-compliant|2|||
144485882|NCT02374593|520976643|FG001|Overall Study|non-compliant|0|||
144485883|NCT00579982|520976644|FG000|Overall Study|Adverse Event|4|||
144485884|NCT00579982|520976644|FG000|Overall Study|Protocol Violation|4|||
144485885|NCT03192215|520976645|FG000|Overall Study|Death|28|||
144485886|NCT03192215|520976646|FG001|Overall Study|Death|23|||
144485887|NCT03192215|520976645|FG000|Overall Study|Lost to Follow-up|10|||
144485888|NCT03192215|520976646|FG001|Overall Study|Lost to Follow-up|15|||
144485889|NCT03192215|520976645|FG000|Overall Study|Withdrawal by Subject|49|||
144485890|NCT03192215|520976646|FG001|Overall Study|Withdrawal by Subject|48|||
144485891|NCT03192215|520976645|FG000|Overall Study|Other as reported in analysis|4|||
144485892|NCT03192215|520976646|FG001|Overall Study|Other as reported in analysis|1|||
144485893|NCT04844918|520976648|FG000|Overall Study|Adverse Event|7|||
144485894|NCT04844918|520976649|FG001|Overall Study|Adverse Event|8|||
144485895|NCT04844918|520976650|FG002|Overall Study|Adverse Event|5|||
144485896|NCT04844918|520976648|FG000|Overall Study|Physician Decision|0|||
144485897|NCT04844918|520976649|FG001|Overall Study|Physician Decision|1|||
144485898|NCT04844918|520976650|FG002|Overall Study|Physician Decision|0|||
144485899|NCT04844918|520976648|FG000|Overall Study|Withdrawal by Subject|6|||
144485900|NCT04844918|520976649|FG001|Overall Study|Withdrawal by Subject|3|||
144485901|NCT04844918|520976650|FG002|Overall Study|Withdrawal by Subject|3|||
144485902|NCT04844918|520976648|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
144485903|NCT04844918|520976649|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
144485904|NCT04844918|520976650|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
144485905|NCT04716881|520976652|FG000|Overall Study|Adverse Event|1|||
144485906|NCT04716881|520976652|FG000|Overall Study|Lost to Follow-up|1|||
144485907|NCT00363896|520976654|FG000|Overall Study|Withdrawal by Subject|29|||
144485908|NCT00363896|520976655|FG001|Overall Study|Withdrawal by Subject|16|||
144485909|NCT00363896|520976654|FG000|Overall Study|Adverse Event|24|||
144485910|NCT00363896|520976655|FG001|Overall Study|Adverse Event|13|||
144485911|NCT00363896|520976654|FG000|Overall Study|COPD exacerbation|13|||
144485912|NCT00363896|520976655|FG001|Overall Study|COPD exacerbation|7|||
144485913|NCT00363896|520976654|FG000|Overall Study|Lack of Efficacy|12|||
144485914|NCT00363896|520976655|FG001|Overall Study|Lack of Efficacy|8|||
144485915|NCT00363896|520976654|FG000|Overall Study|Protocol Violation|6|||
144485916|NCT00363896|520976655|FG001|Overall Study|Protocol Violation|1|||
144485917|NCT00363896|520976654|FG000|Overall Study|Lost to Follow-up|3|||
144485918|NCT00363896|520976655|FG001|Overall Study|Lost to Follow-up|0|||
144485919|NCT00363896|520976654|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
144485920|NCT00363896|520976655|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
144485921|NCT00363896|520976654|FG000|Overall Study|Other|1|||
144485922|NCT00363896|520976655|FG001|Overall Study|Other|2|||
144485923|NCT01076088|520976660|FG000|Overall Study|Adverse Event|1|||
144485924|NCT01076088|520976661|FG001|Overall Study|Adverse Event|6|||
144485925|NCT01076088|520976662|FG002|Overall Study|Adverse Event|3|||
144485926|NCT01076088|520976663|FG003|Overall Study|Adverse Event|2|||
144485927|NCT01076088|520976664|FG004|Overall Study|Adverse Event|3|||
144485928|NCT01076088|520976665|FG005|Overall Study|Adverse Event|3|||
144485929|NCT01076088|520976660|FG000|Overall Study|Lost to Follow-up|1|||
144485930|NCT01076088|520976661|FG001|Overall Study|Lost to Follow-up|1|||
144485931|NCT01076088|520976662|FG002|Overall Study|Lost to Follow-up|0|||
144485932|NCT01076088|520976663|FG003|Overall Study|Lost to Follow-up|1|||
144485933|NCT01076088|520976664|FG004|Overall Study|Lost to Follow-up|1|||
144485934|NCT01076088|520976665|FG005|Overall Study|Lost to Follow-up|2|||
144485935|NCT01076088|520976660|FG000|Overall Study|Non-compliance with study drug|0|||
144485936|NCT01076088|520976661|FG001|Overall Study|Non-compliance with study drug|0|||
144485937|NCT01076088|520976662|FG002|Overall Study|Non-compliance with study drug|0|||
144485938|NCT01076088|520976663|FG003|Overall Study|Non-compliance with study drug|1|||
144485939|NCT01076088|520976664|FG004|Overall Study|Non-compliance with study drug|0|||
144485940|NCT01076088|520976665|FG005|Overall Study|Non-compliance with study drug|0|||
144485941|NCT01076088|520976660|FG000|Overall Study|Physician Decision|1|||
144485942|NCT01076088|520976661|FG001|Overall Study|Physician Decision|3|||
144485943|NCT01076088|520976662|FG002|Overall Study|Physician Decision|0|||
144485944|NCT01076088|520976663|FG003|Overall Study|Physician Decision|1|||
144485945|NCT01076088|520976664|FG004|Overall Study|Physician Decision|1|||
144485946|NCT01076088|520976665|FG005|Overall Study|Physician Decision|0|||
144485947|NCT01076088|520976660|FG000|Overall Study|Withdrawal by Subject|8|||
144485948|NCT01076088|520976661|FG001|Overall Study|Withdrawal by Subject|8|||
144485949|NCT01076088|520976662|FG002|Overall Study|Withdrawal by Subject|14|||
144485950|NCT01076088|520976663|FG003|Overall Study|Withdrawal by Subject|10|||
144485951|NCT01076088|520976664|FG004|Overall Study|Withdrawal by Subject|11|||
144485952|NCT01076088|520976665|FG005|Overall Study|Withdrawal by Subject|17|||
144485953|NCT01076088|520976660|FG000|Overall Study|Other protocol specified criteria|0|||
144485954|NCT01076088|520976661|FG001|Overall Study|Other protocol specified criteria|0|||
144485955|NCT01076088|520976662|FG002|Overall Study|Other protocol specified criteria|0|||
144485956|NCT01076088|520976663|FG003|Overall Study|Other protocol specified criteria|0|||
144485957|NCT01076088|520976664|FG004|Overall Study|Other protocol specified criteria|0|||
144485958|NCT01076088|520976665|FG005|Overall Study|Other protocol specified criteria|1|||
144485959|NCT03285113|520976666|FG000|Overall Study|Unable to implant leads|2|||
144485960|NCT02207374|520976670|FG000|Overall Study|Withdrawal by Subject|5|||
144485961|NCT02207374|520976671|FG001|Overall Study|Withdrawal by Subject|9|||
144485962|NCT02207374|520976672|FG002|Overall Study|Withdrawal by Subject|4|||
144485963|NCT02207374|520976670|FG000|Overall Study|Death|1|||
144485964|NCT02207374|520976671|FG001|Overall Study|Death|0|||
144485965|NCT02207374|520976672|FG002|Overall Study|Death|1|||
144485966|NCT02207374|520976670|FG000|Overall Study|Missing follow-up information|0|||
144485967|NCT02207374|520976671|FG001|Overall Study|Missing follow-up information|1|||
144485968|NCT02207374|520976672|FG002|Overall Study|Missing follow-up information|1|||
144485969|NCT01000376|520976674|FG000|Cycle 1 Day 1|Adverse Event|1|||
144485970|NCT01000376|520976675|FG001|Cycle 1 Day 1|Adverse Event|0|||
144485971|NCT01000376|520976674|FG000|Cycle 1 Day 1|Progressive Disease|1|||
144485972|NCT01000376|520976675|FG001|Cycle 1 Day 1|Progressive Disease|0|||
144485973|NCT00318149|520976676|FG000|Overall Study|Adverse Event|0|||
144485974|NCT00318149|520976677|FG001|Overall Study|Adverse Event|0|||
144485975|NCT00318149|520976678|FG002|Overall Study|Adverse Event|0|||
144485976|NCT00318149|520976679|FG003|Overall Study|Adverse Event|0|||
144485977|NCT00318149|520976680|FG004|Overall Study|Adverse Event|0|||
144485978|NCT00318149|520976681|FG005|Overall Study|Adverse Event|2|||
144485979|NCT00219141|520976682|FG000|Overall Study|Adverse Event|4|||
144485980|NCT00219141|520976683|FG001|Overall Study|Adverse Event|10|||
144485981|NCT00219141|520976684|FG002|Overall Study|Adverse Event|5|||
144485982|NCT00219141|520976682|FG000|Overall Study|Lack of Efficacy|3|||
144485983|NCT00219141|520976683|FG001|Overall Study|Lack of Efficacy|2|||
144485984|NCT00219141|520976684|FG002|Overall Study|Lack of Efficacy|0|||
144485985|NCT00219141|520976682|FG000|Overall Study|Administrative problems|0|||
144485986|NCT00219141|520976683|FG001|Overall Study|Administrative problems|1|||
144485987|NCT00219141|520976684|FG002|Overall Study|Administrative problems|0|||
144485988|NCT00219141|520976682|FG000|Overall Study|Lost to Follow-up|2|||
144485989|NCT00219141|520976683|FG001|Overall Study|Lost to Follow-up|4|||
144485990|NCT00219141|520976684|FG002|Overall Study|Lost to Follow-up|1|||
144485991|NCT00219141|520976682|FG000|Overall Study|Protocol Violation|3|||
144485992|NCT00219141|520976683|FG001|Overall Study|Protocol Violation|1|||
144485993|NCT00219141|520976684|FG002|Overall Study|Protocol Violation|1|||
144485994|NCT00219141|520976682|FG000|Overall Study|Withdrawal by Subject|1|||
144485995|NCT00219141|520976683|FG001|Overall Study|Withdrawal by Subject|3|||
144485996|NCT00219141|520976684|FG002|Overall Study|Withdrawal by Subject|5|||
144485997|NCT00219141|520976682|FG000|Overall Study|Condition no longer requires study drug|1|||
144485998|NCT00219141|520976683|FG001|Overall Study|Condition no longer requires study drug|0|||
144485999|NCT00219141|520976684|FG002|Overall Study|Condition no longer requires study drug|0|||
144486000|NCT01994720|520976685|FG000|Overall Study|Withdrawal by Subject|46|||
144486001|NCT01994720|520976686|FG001|Overall Study|Withdrawal by Subject|56|||
144486002|NCT00903786|520976694|FG000|Overall Study|Physician Decision|6|||
144486003|NCT00903786|520976694|FG000|Overall Study|Lack of Efficacy|5|||
144486004|NCT00903786|520976694|FG000|Overall Study|Reason other than lack of efficacy|4|||
144486005|NCT00845871|520976697|FG000|Assessment Period|Adverse Event|2|||
144486006|NCT00845871|520976697|FG000|Assessment Period|Abnormal laboratory values|1|||
144486007|NCT00845871|520976697|FG000|Assessment Period|Abnormal test procedure results|1|||
144486008|NCT00845871|520976697|FG000|Assessment Period|Patient withdrew consent|3|||
144486009|NCT01857622|520976698|FG000|Overall Study|Adverse Event|5|||
144486010|NCT01857622|520976699|FG001|Overall Study|Adverse Event|0|||
144486011|NCT01857622|520976700|FG002|Overall Study|Adverse Event|2|||
144486012|NCT01857622|520976698|FG000|Overall Study|Physician Decision|1|||
144486013|NCT01857622|520976699|FG001|Overall Study|Physician Decision|0|||
144486014|NCT01857622|520976700|FG002|Overall Study|Physician Decision|0|||
144486015|NCT01857622|520976698|FG000|Overall Study|Protocol Violation|4|||
144486016|NCT01857622|520976699|FG001|Overall Study|Protocol Violation|1|||
144486017|NCT01857622|520976700|FG002|Overall Study|Protocol Violation|0|||
144486018|NCT01857622|520976698|FG000|Overall Study|Withdrawal by Subject|1|||
144486019|NCT01857622|520976699|FG001|Overall Study|Withdrawal by Subject|0|||
144486020|NCT01857622|520976700|FG002|Overall Study|Withdrawal by Subject|0|||
144486021|NCT01291225|520976704|FG000|Overall Study|Lost to Follow-up|85|||
144486022|NCT01291225|520976705|FG001|Overall Study|Lost to Follow-up|39|||
144486023|NCT01267253|520976706|FG000|Overall Study|Ineligible - required test not done|1|||
144486024|NCT01267253|520976706|FG000|Overall Study|Inevaluable-never received study treatme|2|||
144486025|NCT04318093|520976707|FG000|Overall Study|Adverse Event|2|||
144486026|NCT04318093|520976708|FG001|Overall Study|Adverse Event|2|||
144486027|NCT04318093|520976707|FG000|Overall Study|Participant withdrew consent|1|||
144486028|NCT04318093|520976708|FG001|Overall Study|Participant withdrew consent|0|||
144486029|NCT04318093|520976707|FG000|Overall Study|Other reasons|0|||
144486030|NCT04318093|520976708|FG001|Overall Study|Other reasons|1|||
144486031|NCT02855164|520976716|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
144486032|NCT02855164|520976717|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
144486033|NCT02855164|520976718|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
144486034|NCT02855164|520976719|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
144486035|NCT02855164|520976720|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
144486036|NCT02855164|520976721|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
144486037|NCT02855164|520976722|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
144486038|NCT02855164|520976723|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
144486039|NCT02855164|520976716|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
144486040|NCT02855164|520976717|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
144486041|NCT02855164|520976718|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
144486042|NCT02855164|520976719|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
144486043|NCT02855164|520976720|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
144486044|NCT02855164|520976721|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
144486045|NCT02855164|520976722|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
144486046|NCT02855164|520976723|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
144486047|NCT02855164|520976716|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
144486048|NCT02855164|520976717|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
144486049|NCT02855164|520976718|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
144486050|NCT02855164|520976719|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
144486051|NCT02855164|520976720|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
144486052|NCT02855164|520976721|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
144486053|NCT02855164|520976722|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
144486054|NCT02855164|520976723|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
144486055|NCT02855164|520976716|FG000|Part C (Randomized Set)|Adverse Event|0|||
144486056|NCT02855164|520976717|FG001|Part C (Randomized Set)|Adverse Event|0|||
144486057|NCT02855164|520976718|FG002|Part C (Randomized Set)|Adverse Event|0|||
144486058|NCT02855164|520976719|FG003|Part C (Randomized Set)|Adverse Event|0|||
144486059|NCT02855164|520976720|FG004|Part C (Randomized Set)|Adverse Event|0|||
144486060|NCT02855164|520976721|FG005|Part C (Randomized Set)|Adverse Event|5|||
144486061|NCT02855164|520976722|FG006|Part C (Randomized Set)|Adverse Event|9|||
144486062|NCT02855164|520976723|FG007|Part C (Randomized Set)|Adverse Event|2|||
144486063|NCT02855164|520976716|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
144486064|NCT02855164|520976717|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
144486065|NCT02855164|520976718|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
144486066|NCT02855164|520976719|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
144486067|NCT02855164|520976720|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
144486068|NCT02855164|520976721|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
144486069|NCT02855164|520976722|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
144486070|NCT02855164|520976723|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
144486071|NCT02855164|520976716|FG000|Part C (Randomized Set)|Physician Decision|0|||
144486072|NCT02855164|520976717|FG001|Part C (Randomized Set)|Physician Decision|0|||
144486073|NCT02855164|520976718|FG002|Part C (Randomized Set)|Physician Decision|0|||
144486074|NCT02855164|520976719|FG003|Part C (Randomized Set)|Physician Decision|0|||
144486075|NCT02855164|520976720|FG004|Part C (Randomized Set)|Physician Decision|0|||
144486076|NCT02855164|520976721|FG005|Part C (Randomized Set)|Physician Decision|1|||
144486077|NCT02855164|520976722|FG006|Part C (Randomized Set)|Physician Decision|0|||
144486078|NCT02855164|520976723|FG007|Part C (Randomized Set)|Physician Decision|1|||
144486079|NCT02855164|520976716|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
144486080|NCT02855164|520976717|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
144486081|NCT02855164|520976718|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
144486082|NCT02855164|520976719|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
144486083|NCT02855164|520976720|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
144486084|NCT02855164|520976721|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
144486085|NCT02855164|520976722|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
144486086|NCT02855164|520976723|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
144486087|NCT00876460|520976724|FG000|Combination Therapy Phase|Progressive disease|2|||
144486088|NCT00876460|520976725|FG001|Combination Therapy Phase|Progressive disease|3|||
144486089|NCT00876460|520976726|FG002|Combination Therapy Phase|Progressive disease|3|||
144486090|NCT00876460|520976727|FG003|Combination Therapy Phase|Progressive disease|3|||
144486091|NCT00876460|520976728|FG004|Combination Therapy Phase|Progressive disease|3|||
144486092|NCT00876460|520976729|FG005|Combination Therapy Phase|Progressive disease|1|||
144486093|NCT00876460|520976730|FG006|Combination Therapy Phase|Progressive disease|1|||
144486094|NCT00876460|520976731|FG007|Combination Therapy Phase|Progressive disease|1|||
144486095|NCT00876460|520976724|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
144486096|NCT00876460|520976725|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
144715305|NCT00672620|521813324|FG001|Overall Study|Reason not Specified|3|||
144715306|NCT00672620|521813325|FG002|Overall Study|Reason not Specified|2|||
144715307|NCT00672620|521813326|FG003|Overall Study|Reason not Specified|1|||
144715308|NCT03211156|521813327|FG000|Overall Study|Withdrawal by Subject|0|||
144715309|NCT03211156|521813328|FG001|Overall Study|Withdrawal by Subject|2|||
144715310|NCT03211156|521813327|FG000|Overall Study|Lost to Follow-up|1|||
144715311|NCT03211156|521813328|FG001|Overall Study|Lost to Follow-up|1|||
144715312|NCT03211156|521813327|FG000|Overall Study|Adverse Event|1|||
144715313|NCT03211156|521813328|FG001|Overall Study|Adverse Event|0|||
144715314|NCT02736227|521813334|FG000|Overall Study|Withdrawal by Subject|0|||
144715315|NCT02736227|521813335|FG001|Overall Study|Withdrawal by Subject|0|||
144715316|NCT02736227|521813336|FG002|Overall Study|Withdrawal by Subject|1|||
144715317|NCT02736227|521813334|FG000|Overall Study|Physician Decision|0|||
144715318|NCT02736227|521813335|FG001|Overall Study|Physician Decision|0|||
144715319|NCT02736227|521813336|FG002|Overall Study|Physician Decision|5|||
144715320|NCT02736227|521813334|FG000|Overall Study|Non Compliant|0|||
144715321|NCT02736227|521813335|FG001|Overall Study|Non Compliant|0|||
144715322|NCT02736227|521813336|FG002|Overall Study|Non Compliant|2|||
144715323|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715324|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715325|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144486097|NCT00876460|520976726|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
144486098|NCT00876460|520976727|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
144486099|NCT00876460|520976728|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
144486100|NCT00876460|520976729|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
144715326|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
144486101|NCT00876460|520976730|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
144715327|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144486102|NCT00876460|520976731|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
144486103|NCT00876460|520976724|FG000|Combination Therapy Phase|Adverse Event|0|||
144486104|NCT00876460|520976725|FG001|Combination Therapy Phase|Adverse Event|2|||
144486105|NCT00876460|520976726|FG002|Combination Therapy Phase|Adverse Event|0|||
144486106|NCT00876460|520976727|FG003|Combination Therapy Phase|Adverse Event|2|||
144486107|NCT00876460|520976728|FG004|Combination Therapy Phase|Adverse Event|2|||
144486108|NCT00876460|520976729|FG005|Combination Therapy Phase|Adverse Event|0|||
144486109|NCT00876460|520976730|FG006|Combination Therapy Phase|Adverse Event|3|||
144486110|NCT00876460|520976731|FG007|Combination Therapy Phase|Adverse Event|2|||
144486111|NCT00876460|520976724|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
144486112|NCT00876460|520976725|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
144486113|NCT00876460|520976726|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
144486114|NCT00876460|520976727|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
144486115|NCT00876460|520976728|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
144486116|NCT00876460|520976729|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
144486117|NCT00876460|520976730|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
144486118|NCT00876460|520976731|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
144486119|NCT00876460|520976724|FG000|Combination Therapy Phase|Other reason not defined above|0|||
144486120|NCT00876460|520976725|FG001|Combination Therapy Phase|Other reason not defined above|0|||
144486121|NCT00876460|520976726|FG002|Combination Therapy Phase|Other reason not defined above|0|||
144486122|NCT00876460|520976727|FG003|Combination Therapy Phase|Other reason not defined above|0|||
144486123|NCT00876460|520976728|FG004|Combination Therapy Phase|Other reason not defined above|0|||
144486124|NCT00876460|520976729|FG005|Combination Therapy Phase|Other reason not defined above|0|||
144486125|NCT00876460|520976730|FG006|Combination Therapy Phase|Other reason not defined above|1|||
144486126|NCT00876460|520976731|FG007|Combination Therapy Phase|Other reason not defined above|2|||
144486127|NCT00876460|520976724|FG000|Combination Therapy Phase|Not treated|0|||
144486128|NCT00876460|520976725|FG001|Combination Therapy Phase|Not treated|0|||
144486129|NCT00876460|520976726|FG002|Combination Therapy Phase|Not treated|0|||
144486130|NCT00876460|520976727|FG003|Combination Therapy Phase|Not treated|0|||
144486131|NCT00876460|520976728|FG004|Combination Therapy Phase|Not treated|0|||
144486132|NCT00876460|520976729|FG005|Combination Therapy Phase|Not treated|0|||
144486133|NCT00876460|520976730|FG006|Combination Therapy Phase|Not treated|1|||
144486134|NCT00876460|520976731|FG007|Combination Therapy Phase|Not treated|0|||
144486135|NCT00876460|520976724|FG000|Mono Therapy Phase|Progressive disease|0|||
144486136|NCT00876460|520976725|FG001|Mono Therapy Phase|Progressive disease|0|||
144486137|NCT00876460|520976726|FG002|Mono Therapy Phase|Progressive disease|0|||
144486138|NCT00876460|520976727|FG003|Mono Therapy Phase|Progressive disease|0|||
144486139|NCT00876460|520976728|FG004|Mono Therapy Phase|Progressive disease|2|||
144486140|NCT00876460|520976729|FG005|Mono Therapy Phase|Progressive disease|0|||
144486141|NCT00876460|520976730|FG006|Mono Therapy Phase|Progressive disease|1|||
144486142|NCT00876460|520976731|FG007|Mono Therapy Phase|Progressive disease|3|||
144486143|NCT00876460|520976724|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
144486144|NCT00876460|520976725|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
144486145|NCT00876460|520976726|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
144486146|NCT00876460|520976727|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
144486147|NCT00876460|520976728|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
144486148|NCT00876460|520976729|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
144486149|NCT00876460|520976730|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
144486150|NCT00876460|520976731|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
144486151|NCT00876460|520976724|FG000|Mono Therapy Phase|Adverse Event|0|||
144486152|NCT00876460|520976725|FG001|Mono Therapy Phase|Adverse Event|0|||
144486153|NCT00876460|520976726|FG002|Mono Therapy Phase|Adverse Event|0|||
144486154|NCT00876460|520976727|FG003|Mono Therapy Phase|Adverse Event|1|||
144486155|NCT00876460|520976728|FG004|Mono Therapy Phase|Adverse Event|0|||
144486156|NCT00876460|520976729|FG005|Mono Therapy Phase|Adverse Event|0|||
144486157|NCT00876460|520976730|FG006|Mono Therapy Phase|Adverse Event|0|||
144486158|NCT00876460|520976731|FG007|Mono Therapy Phase|Adverse Event|0|||
144486159|NCT00064025|520976732|FG000|Overall Study|Ineligible|4|||
144486160|NCT00064025|520976732|FG000|Overall Study|Inevaluable|3|||
144486161|NCT02468934|520976735|FG000|Overall Study|Withdrawal by Subject|4|||
144486162|NCT02468934|520976735|FG000|Overall Study|Screen Failure|3|||
144486163|NCT00547911|520976742|FG000|Overall Study|Adverse Event|0|||
144486164|NCT00547911|520976743|FG001|Overall Study|Adverse Event|0|||
144486165|NCT00547911|520976744|FG002|Overall Study|Adverse Event|0|||
144486166|NCT00547911|520976745|FG003|Overall Study|Adverse Event|1|||
144486167|NCT00547911|520976746|FG004|Overall Study|Adverse Event|0|||
144486168|NCT00547911|520976747|FG005|Overall Study|Adverse Event|0|||
144486169|NCT02133924|520976748|FG000|Overall Study|Death|38|||
144486170|NCT02133924|520976748|FG000|Overall Study|Physician Decision|1|||
144486171|NCT02133924|520976748|FG000|Overall Study|Withdrawal by Subject|3|||
144486172|NCT01644474|520976750|FG000|Overall Study|Poor compliance to protocol|1|||
144486173|NCT01644474|520976751|FG001|Overall Study|Poor compliance to protocol|0|||
144486174|NCT01644474|520976750|FG000|Overall Study|Consent withdrawn by participant|0|||
144486175|NCT01644474|520976751|FG001|Overall Study|Consent withdrawn by participant|1|||
144486176|NCT01644474|520976750|FG000|Overall Study|Participant moved|0|||
144486177|NCT01644474|520976751|FG001|Overall Study|Participant moved|1|||
144715328|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715329|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715330|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715331|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715332|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
144715333|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144715334|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144715335|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Adverse Event|1|||
144715336|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Adverse Event|1|||
144715337|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Adverse Event|1|||
144715338|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Adverse Event|1|||
144715339|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Adverse Event|0|||
144715340|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Adverse Event|0|||
144715341|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Adverse Event|0|||
144715342|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Adverse Event|0|||
144715343|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
144715344|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
144715345|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
144715346|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
144715347|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
144715348|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
144715349|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
144715350|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
144715351|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
144715352|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
144715353|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144715354|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
144715355|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
144715356|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
144715357|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
144715358|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
144715359|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
144715360|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
144715361|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
144715362|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
144715363|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
144715364|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
144715365|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715366|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715367|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715368|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715369|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715370|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
144715371|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715372|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
144715373|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715374|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715375|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715376|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715377|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
144715378|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
144715379|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715380|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715381|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715382|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
144715383|NCT00950599|521813341|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
144715384|NCT00950599|521813342|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
144715385|NCT00950599|521813343|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
144715386|NCT00950599|521813344|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
144715387|NCT00950599|521813345|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
144715388|NCT00950599|521813346|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
144715389|NCT00950599|521813347|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
144715390|NCT00950599|521813348|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
144715391|NCT00950599|521813349|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
144715392|NCT00950599|521813350|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
144715393|NCT00950599|521813341|FG000|Follow-Up Period|Adverse Event|0|||
144486178|NCT01644474|520976750|FG000|Overall Study|Adverse Event|4|||
144486179|NCT01644474|520976751|FG001|Overall Study|Adverse Event|5|||
144486180|NCT01644474|520976750|FG000|Overall Study|Site scheduling error|1|||
144486181|NCT01644474|520976751|FG001|Overall Study|Site scheduling error|1|||
144486182|NCT01644474|520976750|FG000|Overall Study|Protocol Violation|1|||
144486183|NCT01644474|520976751|FG001|Overall Study|Protocol Violation|0|||
144486184|NCT00551213|520978411|FG000|Overall Study|Adverse Event|6|||
144486185|NCT00551213|520978412|FG001|Overall Study|Adverse Event|3|||
144486186|NCT00551213|520978411|FG000|Overall Study|Progressive Disease|41|||
144486187|NCT00551213|520978412|FG001|Overall Study|Progressive Disease|12|||
144486188|NCT00551213|520978411|FG000|Overall Study|Withdrawal by Subject|2|||
144486189|NCT00551213|520978412|FG001|Overall Study|Withdrawal by Subject|0|||
144486190|NCT00551213|520978411|FG000|Overall Study|Not Treated|1|||
144486191|NCT00551213|520978412|FG001|Overall Study|Not Treated|2|||
144486192|NCT00593554|520978413|FG000|Overall Study|Death|1|||
144486193|NCT00593554|520978414|FG001|Overall Study|Death|2|||
144486194|NCT00593554|520978413|FG000|Overall Study|Physician Decision|0|||
144486195|NCT00593554|520978414|FG001|Overall Study|Physician Decision|1|||
144486196|NCT00593554|520978413|FG000|Overall Study|Withdrawal by Subject|1|||
144486197|NCT00593554|520978414|FG001|Overall Study|Withdrawal by Subject|0|||
144486198|NCT00593554|520978413|FG000|Overall Study|Disease Progression|1|||
144486199|NCT00593554|520978414|FG001|Overall Study|Disease Progression|2|||
144486200|NCT01254565|520978415|FG000|Overall Study|Non-compliance to Study Procedures|0|||
144486201|NCT01254565|520978416|FG001|Overall Study|Non-compliance to Study Procedures|0|||
144486202|NCT01254565|520978417|FG002|Overall Study|Non-compliance to Study Procedures|0|||
144486203|NCT01254565|520978418|FG003|Overall Study|Non-compliance to Study Procedures|0|||
144486204|NCT01254565|520978419|FG004|Overall Study|Non-compliance to Study Procedures|1|||
144486205|NCT01254565|520978420|FG005|Overall Study|Non-compliance to Study Procedures|0|||
144486206|NCT01254565|520978415|FG000|Overall Study|Did not Receive Treatment|1|||
144486207|NCT01254565|520978416|FG001|Overall Study|Did not Receive Treatment|1|||
144486208|NCT01254565|520978417|FG002|Overall Study|Did not Receive Treatment|0|||
144486209|NCT01254565|520978418|FG003|Overall Study|Did not Receive Treatment|0|||
144486210|NCT01254565|520978419|FG004|Overall Study|Did not Receive Treatment|3|||
144486211|NCT01254565|520978420|FG005|Overall Study|Did not Receive Treatment|4|||
144486212|NCT01254565|520978415|FG000|Overall Study|Other|0|||
144486213|NCT01254565|520978416|FG001|Overall Study|Other|0|||
144486214|NCT01254565|520978417|FG002|Overall Study|Other|0|||
144486215|NCT01254565|520978418|FG003|Overall Study|Other|1|||
144486216|NCT01254565|520978419|FG004|Overall Study|Other|0|||
144486217|NCT01254565|520978420|FG005|Overall Study|Other|0|||
144486218|NCT02726399|520978421|FG000|Overall Study|Participant Non-Compliance|1|||
144486219|NCT02726399|520978421|FG000|Overall Study|Adverse Event|2|||
144486220|NCT02726399|520978421|FG000|Overall Study|Progression of disease|4|||
144486221|NCT04747275|520978422|FG000|Overall Study|Study terminated|0|||
144486222|NCT04747275|520978423|FG001|Overall Study|Study terminated|1|||
144486223|NCT03268590|520978426|FG000|Overall Study|Previously unknown exclusion criteria|1|||
144486224|NCT04254679|520978429|FG000|Overall Study|Protocol Violation|1|||
144486225|NCT04254679|520978430|FG001|Overall Study|Protocol Violation|1|||
144486226|NCT04254679|520978429|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
144486227|NCT04254679|520978430|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
144486228|NCT02086552|520978431|FG000|Overall Study|Withdrawal by Subject|1|||
144486229|NCT00478608|520978436|FG000|Overall Study|Adverse Event|1|||
144486230|NCT00478608|520978436|FG000|Overall Study|Serious Adverse Event|14|||
144486231|NCT00478608|520978436|FG000|Overall Study|Withdrawal by Subject|2|||
144486232|NCT00478608|520978436|FG000|Overall Study|Protocol Violation|3|||
144486233|NCT02080520|520978437|FG000|Overall Study|Self-reported symptoms|5|||
144486234|NCT02080520|520978438|FG001|Overall Study|Self-reported symptoms|6|||
144486235|NCT02080520|520978437|FG000|Overall Study|Unable to contact|2|||
144486236|NCT02080520|520978438|FG001|Overall Study|Unable to contact|1|||
144486237|NCT02080520|520978437|FG000|Overall Study|Initiated aspirin|2|||
144486238|NCT02080520|520978438|FG001|Overall Study|Initiated aspirin|0|||
144486239|NCT02080520|520978437|FG000|Overall Study|Atrial fibrillation|1|||
144486240|NCT02080520|520978438|FG001|Overall Study|Atrial fibrillation|1|||
144486241|NCT02080520|520978437|FG000|Overall Study|Cancer|1|||
144486242|NCT02080520|520978438|FG001|Overall Study|Cancer|2|||
144486243|NCT02080520|520978437|FG000|Overall Study|Not interested in study|1|||
144486244|NCT02080520|520978438|FG001|Overall Study|Not interested in study|3|||
144486245|NCT02080520|520978437|FG000|Overall Study|Too busy|1|||
144486246|NCT02080520|520978438|FG001|Overall Study|Too busy|1|||
144486247|NCT02080520|520978437|FG000|Overall Study|Work-related injury|1|||
144486248|NCT02080520|520978438|FG001|Overall Study|Work-related injury|0|||
144486249|NCT02080520|520978437|FG000|Overall Study|Personal reasons|0|||
144486250|NCT02080520|520978438|FG001|Overall Study|Personal reasons|3|||
144486251|NCT00432679|520978443|FG000|Overall Study|Adverse Event|2|||
144486252|NCT00432679|520978444|FG001|Overall Study|Adverse Event|1|||
144486253|NCT00432679|520978443|FG000|Overall Study|Withdrawal by Subject|3|||
144486254|NCT00432679|520978444|FG001|Overall Study|Withdrawal by Subject|2|||
144486255|NCT01316692|520978449|FG000|Overall Study|Adverse Event|5|||
144486256|NCT01316692|520978449|FG000|Overall Study|Disease Progression|7|||
144486257|NCT01686932|520978452|FG000|Period 1|Adverse Event|1|||
144486258|NCT01686932|520978453|FG001|Period 1|Adverse Event|1|||
144486259|NCT01284140|520978455|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
144486260|NCT01284140|520978456|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
144486261|NCT01284140|520978455|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
144486262|NCT01284140|520978456|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
144486263|NCT04147260|520978458|FG000|Overall Study|Adverse Event|1|||
144486264|NCT04147260|520978459|FG001|Overall Study|Adverse Event|0|||
144486265|NCT04147260|520978460|FG002|Overall Study|Adverse Event|1|||
144486266|NCT04147260|520978461|FG003|Overall Study|Adverse Event|2|||
144486267|NCT04147260|520978462|FG004|Overall Study|Adverse Event|0|||
144486268|NCT04147260|520978458|FG000|Overall Study|Withdrawal by Subject|0|||
144486269|NCT04147260|520978459|FG001|Overall Study|Withdrawal by Subject|0|||
144486270|NCT04147260|520978460|FG002|Overall Study|Withdrawal by Subject|1|||
144486271|NCT04147260|520978461|FG003|Overall Study|Withdrawal by Subject|1|||
144486272|NCT04147260|520978462|FG004|Overall Study|Withdrawal by Subject|0|||
144486273|NCT01555021|520978463|FG000|Overall Study|Lost to Follow-up|1|||
144486274|NCT01555021|520978464|FG001|Overall Study|Lost to Follow-up|2|||
144486275|NCT03358329|520978468|FG000|Overall Study|Lost to Follow-up|2|||
144486276|NCT03358329|520978468|FG000|Overall Study|Withdrawal by Subject|2|||
144486277|NCT01313923|520978469|FG000|Overall Study|Physician Decision|3|||
144486278|NCT01388530|520978470|FG000|Overall Study|Lost to Follow-up|5|||
144486279|NCT02420327|520978471|FG000|Overall Study|Adverse Event|7|||
144486280|NCT02420327|520978471|FG000|Overall Study|Pregnancy|1|||
144486281|NCT02420327|520978471|FG000|Overall Study|Withdrawal by Subject|6|||
144486282|NCT02420327|520978471|FG000|Overall Study|Lost to Follow-up|1|||
144486283|NCT02420327|520978471|FG000|Overall Study|Protocol Violation|1|||
144486284|NCT02204293|520978472|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
144486285|NCT02204293|520978473|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
144486286|NCT02204293|520978474|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
144486287|NCT02204293|520978475|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
144486288|NCT02204293|520978476|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
144486289|NCT02204293|520978477|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
144486290|NCT02204293|520978472|FG000|Core Study Part I|Adverse Event|1|||
144486291|NCT02204293|520978473|FG001|Core Study Part I|Adverse Event|0|||
144486292|NCT02204293|520978474|FG002|Core Study Part I|Adverse Event|0|||
144486293|NCT02204293|520978475|FG003|Core Study Part I|Adverse Event|0|||
144486294|NCT02204293|520978476|FG004|Core Study Part I|Adverse Event|0|||
144486295|NCT02204293|520978477|FG005|Core Study Part I|Adverse Event|0|||
144486296|NCT02204293|520978472|FG000|Core Study Part I|Physician Decision|0|||
144486297|NCT02204293|520978473|FG001|Core Study Part I|Physician Decision|3|||
144486298|NCT02204293|520978474|FG002|Core Study Part I|Physician Decision|0|||
144486299|NCT02204293|520978475|FG003|Core Study Part I|Physician Decision|0|||
144486300|NCT02204293|520978476|FG004|Core Study Part I|Physician Decision|0|||
144486301|NCT02204293|520978477|FG005|Core Study Part I|Physician Decision|0|||
144486302|NCT02204293|520978472|FG000|LTE Phase|Study Suspended|0|||
144486303|NCT02204293|520978473|FG001|LTE Phase|Study Suspended|0|||
144486304|NCT02204293|520978474|FG002|LTE Phase|Study Suspended|0|||
144486305|NCT02204293|520978475|FG003|LTE Phase|Study Suspended|0|||
144486306|NCT02204293|520978476|FG004|LTE Phase|Study Suspended|0|||
144486307|NCT02204293|520978477|FG005|LTE Phase|Study Suspended|7|||
144486308|NCT01990300|520978478|FG000|Overall Study|Case Report Forms Uncollected|89|||
144486309|NCT01990300|520978478|FG000|Overall Study|Protocol Deviation|53|||
144588135|NCT00153062|521352288|FG001|Overall Study|Other|0|||
144588136|NCT00153062|521352289|FG002|Overall Study|Other|1|||
144588137|NCT00153062|521352290|FG003|Overall Study|Other|0|||
144588138|NCT02594163|521352301|FG000|Treatment Period|Progressive disease|2|||
144588139|NCT02594163|521352302|FG001|Treatment Period|Progressive disease|3|||
144588140|NCT02594163|521352301|FG000|Treatment Period|Adverse Event|1|||
144588141|NCT02594163|521352302|FG001|Treatment Period|Adverse Event|5|||
144588142|NCT02594163|521352301|FG000|Treatment Period|Physician Decision|1|||
144588143|NCT02594163|521352302|FG001|Treatment Period|Physician Decision|3|||
144588144|NCT02594163|521352301|FG000|Treatment Period|Study termination by sponsor|2|||
144588145|NCT02594163|521352302|FG001|Treatment Period|Study termination by sponsor|1|||
144588146|NCT02594163|521352301|FG000|Treatment Period|Other, Non-AE|1|||
144588147|NCT02594163|521352302|FG001|Treatment Period|Other, Non-AE|0|||
144588148|NCT02594163|521352301|FG000|Follow-up Period|Withdrawal by Subject|0|||
144588149|NCT02594163|521352302|FG001|Follow-up Period|Withdrawal by Subject|1|||
144588150|NCT02594163|521352301|FG000|Follow-up Period|Study Termination by Sponsor|6|||
144588151|NCT02594163|521352302|FG001|Follow-up Period|Study Termination by Sponsor|4|||
144588152|NCT02594163|521352301|FG000|Follow-up Period|Lost to Follow-up|1|||
144588153|NCT02594163|521352302|FG001|Follow-up Period|Lost to Follow-up|0|||
144588154|NCT02594163|521352301|FG000|Follow-up Period|Death|2|||
144486310|NCT00287469|520978481|FG000|Overall Study|serious adverse event|1|||
144588155|NCT02594163|521352302|FG001|Follow-up Period|Death|5|||
144588156|NCT02594163|521352301|FG000|Follow-up Period|Adverse Event|0|||
144486311|NCT00287469|520978482|FG001|Overall Study|serious adverse event|6|||
144715394|NCT00950599|521813342|FG001|Follow-Up Period|Adverse Event|0|||
144715395|NCT00950599|521813343|FG002|Follow-Up Period|Adverse Event|0|||
144715396|NCT00950599|521813344|FG003|Follow-Up Period|Adverse Event|0|||
144715397|NCT00950599|521813345|FG004|Follow-Up Period|Adverse Event|0|||
144715398|NCT00950599|521813346|FG005|Follow-Up Period|Adverse Event|0|||
144715399|NCT00950599|521813347|FG006|Follow-Up Period|Adverse Event|0|||
144715400|NCT00950599|521813348|FG007|Follow-Up Period|Adverse Event|0|||
144715401|NCT00950599|521813349|FG008|Follow-Up Period|Adverse Event|1|||
144715402|NCT00950599|521813350|FG009|Follow-Up Period|Adverse Event|0|||
144715403|NCT00950599|521813341|FG000|Follow-Up Period|Lack of Efficacy|0|||
144715404|NCT00950599|521813342|FG001|Follow-Up Period|Lack of Efficacy|0|||
144715405|NCT00950599|521813343|FG002|Follow-Up Period|Lack of Efficacy|0|||
144715406|NCT00950599|521813344|FG003|Follow-Up Period|Lack of Efficacy|0|||
144715407|NCT00950599|521813345|FG004|Follow-Up Period|Lack of Efficacy|0|||
144715408|NCT00950599|521813346|FG005|Follow-Up Period|Lack of Efficacy|0|||
144715409|NCT00950599|521813347|FG006|Follow-Up Period|Lack of Efficacy|0|||
144715410|NCT00950599|521813348|FG007|Follow-Up Period|Lack of Efficacy|0|||
144715411|NCT00950599|521813349|FG008|Follow-Up Period|Lack of Efficacy|3|||
144715412|NCT00950599|521813350|FG009|Follow-Up Period|Lack of Efficacy|0|||
144715413|NCT00950599|521813341|FG000|Follow-Up Period|Lost to Follow-up|0|||
144715414|NCT00950599|521813342|FG001|Follow-Up Period|Lost to Follow-up|0|||
144715415|NCT00950599|521813343|FG002|Follow-Up Period|Lost to Follow-up|0|||
144715416|NCT00950599|521813344|FG003|Follow-Up Period|Lost to Follow-up|0|||
144715417|NCT00950599|521813345|FG004|Follow-Up Period|Lost to Follow-up|0|||
144715418|NCT00950599|521813346|FG005|Follow-Up Period|Lost to Follow-up|0|||
144715419|NCT00950599|521813347|FG006|Follow-Up Period|Lost to Follow-up|0|||
144715420|NCT00950599|521813348|FG007|Follow-Up Period|Lost to Follow-up|0|||
144715421|NCT00950599|521813349|FG008|Follow-Up Period|Lost to Follow-up|5|||
144715422|NCT00950599|521813350|FG009|Follow-Up Period|Lost to Follow-up|1|||
144715423|NCT00950599|521813341|FG000|Follow-Up Period|Physician Decision|0|||
144715424|NCT00950599|521813342|FG001|Follow-Up Period|Physician Decision|0|||
144715425|NCT00950599|521813343|FG002|Follow-Up Period|Physician Decision|0|||
144715426|NCT00950599|521813344|FG003|Follow-Up Period|Physician Decision|0|||
144715427|NCT00950599|521813345|FG004|Follow-Up Period|Physician Decision|0|||
144715428|NCT00950599|521813346|FG005|Follow-Up Period|Physician Decision|0|||
144715429|NCT00950599|521813347|FG006|Follow-Up Period|Physician Decision|0|||
144715430|NCT00950599|521813348|FG007|Follow-Up Period|Physician Decision|0|||
144715431|NCT00950599|521813349|FG008|Follow-Up Period|Physician Decision|1|||
144715432|NCT00950599|521813350|FG009|Follow-Up Period|Physician Decision|0|||
144715433|NCT00950599|521813341|FG000|Follow-Up Period|Poor/Noncompliance|0|||
144715434|NCT00950599|521813342|FG001|Follow-Up Period|Poor/Noncompliance|0|||
144715435|NCT00950599|521813343|FG002|Follow-Up Period|Poor/Noncompliance|0|||
144715436|NCT00950599|521813344|FG003|Follow-Up Period|Poor/Noncompliance|0|||
144715437|NCT00950599|521813345|FG004|Follow-Up Period|Poor/Noncompliance|0|||
144715438|NCT00950599|521813346|FG005|Follow-Up Period|Poor/Noncompliance|0|||
144715439|NCT00950599|521813347|FG006|Follow-Up Period|Poor/Noncompliance|0|||
144715440|NCT00950599|521813348|FG007|Follow-Up Period|Poor/Noncompliance|0|||
144715441|NCT00950599|521813349|FG008|Follow-Up Period|Poor/Noncompliance|1|||
144715442|NCT00950599|521813350|FG009|Follow-Up Period|Poor/Noncompliance|0|||
144715443|NCT00950599|521813341|FG000|Follow-Up Period|Subject withdrew Consent|0|||
144715444|NCT00950599|521813342|FG001|Follow-Up Period|Subject withdrew Consent|0|||
144715445|NCT00950599|521813343|FG002|Follow-Up Period|Subject withdrew Consent|0|||
144715446|NCT00950599|521813344|FG003|Follow-Up Period|Subject withdrew Consent|0|||
144715447|NCT00950599|521813345|FG004|Follow-Up Period|Subject withdrew Consent|0|||
144715448|NCT00950599|521813346|FG005|Follow-Up Period|Subject withdrew Consent|0|||
144715449|NCT00950599|521813347|FG006|Follow-Up Period|Subject withdrew Consent|0|||
144715450|NCT00950599|521813348|FG007|Follow-Up Period|Subject withdrew Consent|0|||
144715451|NCT00950599|521813349|FG008|Follow-Up Period|Subject withdrew Consent|2|||
144715452|NCT00950599|521813350|FG009|Follow-Up Period|Subject withdrew Consent|1|||
144715453|NCT01684722|521813351|FG000|Overall Study|Lost to Follow-up|78|||
144715454|NCT01684722|521813352|FG001|Overall Study|Lost to Follow-up|56|||
144715455|NCT01684722|521813353|FG002|Overall Study|Lost to Follow-up|75|||
144715456|NCT01684722|521813354|FG003|Overall Study|Lost to Follow-up|89|||
144715457|NCT01684722|521813351|FG000|Overall Study|Death|19|||
144715458|NCT01684722|521813352|FG001|Overall Study|Death|21|||
144715459|NCT01684722|521813353|FG002|Overall Study|Death|19|||
144715460|NCT01684722|521813354|FG003|Overall Study|Death|21|||
144715461|NCT00219557|521813355|FG000|Phase 1|Lack of Efficacy|3|||
144715462|NCT00219557|521813356|FG001|Phase 1|Lack of Efficacy|0|||
144715463|NCT00219557|521813357|FG002|Phase 1|Lack of Efficacy|0|||
144715464|NCT00219557|521813355|FG000|Phase 1|Adverse Event|2|||
144715465|NCT00219557|521813356|FG001|Phase 1|Adverse Event|0|||
144715466|NCT00219557|521813357|FG002|Phase 1|Adverse Event|0|||
144715467|NCT00219557|521813355|FG000|Phase 1|Withdrawal by Subject|1|||
144715468|NCT00219557|521813356|FG001|Phase 1|Withdrawal by Subject|0|||
144715469|NCT00219557|521813357|FG002|Phase 1|Withdrawal by Subject|0|||
144715470|NCT00219557|521813355|FG000|Phase 1|Started chemotherapy at other institute|1|||
144486312|NCT00287469|520978481|FG000|Overall Study|Adverse Event|1|||
144486313|NCT00287469|520978482|FG001|Overall Study|Adverse Event|1|||
144486314|NCT00287469|520978481|FG000|Overall Study|moved from area|144|||
144486315|NCT00287469|520978482|FG001|Overall Study|moved from area|138|||
144486316|NCT00287469|520978481|FG000|Overall Study|Lost to Follow-up|74|||
144486317|NCT00287469|520978482|FG001|Overall Study|Lost to Follow-up|69|||
144486318|NCT00065468|520978483|FG000|Overall Study|Death|172|||
144486319|NCT00065468|520978484|FG001|Overall Study|Death|169|||
144486320|NCT00065468|520978485|FG002|Overall Study|Death|171|||
144486321|NCT00065468|520978483|FG000|Overall Study|Withdrawal by Subject|3|||
144486322|NCT00065468|520978484|FG001|Overall Study|Withdrawal by Subject|4|||
144486323|NCT00065468|520978485|FG002|Overall Study|Withdrawal by Subject|5|||
144486324|NCT00065468|520978483|FG000|Overall Study|Lost to Follow-up|5|||
144486325|NCT00065468|520978484|FG001|Overall Study|Lost to Follow-up|3|||
144486326|NCT00065468|520978485|FG002|Overall Study|Lost to Follow-up|2|||
144486327|NCT00065468|520978483|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
144486328|NCT00065468|520978484|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
144486329|NCT00065468|520978485|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
144486330|NCT00065468|520978483|FG000|Overall Study|Disease progression|0|||
144486331|NCT00065468|520978484|FG001|Overall Study|Disease progression|0|||
144486332|NCT00065468|520978485|FG002|Overall Study|Disease progression|1|||
144486333|NCT00065468|520978483|FG000|Overall Study|Other|14|||
144486334|NCT00065468|520978484|FG001|Overall Study|Other|24|||
144486335|NCT00065468|520978485|FG002|Overall Study|Other|18|||
144486336|NCT01225835|520978486|FG000|Overall Study|Completed protocol|2|||
144486337|NCT01225835|520978487|FG001|Overall Study|Completed protocol|1|||
144486338|NCT01225835|520978486|FG000|Overall Study|Did not meet hCG criterion|2|||
144486339|NCT01225835|520978487|FG001|Overall Study|Did not meet hCG criterion|0|||
144486340|NCT01225835|520978486|FG000|Overall Study|Adverse Event|2|||
144486341|NCT01225835|520978487|FG001|Overall Study|Adverse Event|1|||
144486342|NCT01225835|520978486|FG000|Overall Study|Other|1|||
144486343|NCT01225835|520978487|FG001|Overall Study|Other|1|||
144486344|NCT02589392|520978488|FG000|Overall Study|Adverse Event|1|||
144486345|NCT02589392|520978489|FG001|Overall Study|Adverse Event|1|||
144486346|NCT02589392|520978488|FG000|Overall Study|Withdrawal by Subject|1|||
144486347|NCT02589392|520978489|FG001|Overall Study|Withdrawal by Subject|2|||
144486348|NCT02589392|520978488|FG000|Overall Study|Protocol Violation|1|||
144486349|NCT02589392|520978489|FG001|Overall Study|Protocol Violation|1|||
144486350|NCT02589392|520978488|FG000|Overall Study|Lost to Follow-up|2|||
144486351|NCT02589392|520978489|FG001|Overall Study|Lost to Follow-up|2|||
144486352|NCT02589392|520978488|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
144486353|NCT02589392|520978489|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
144486354|NCT01266993|520978490|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
144486355|NCT01266993|520978491|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
144486356|NCT01266993|520978490|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
144486357|NCT01266993|520978491|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
144486358|NCT03051659|520978492|FG000|Treatment Period|Withdrawal by Subject|0|||
144486359|NCT03051659|520978493|FG001|Treatment Period|Withdrawal by Subject|2|||
144486360|NCT03051659|520978492|FG000|Survival Follow-up|Lost to Follow-up|23|||
144486361|NCT03051659|520978493|FG001|Survival Follow-up|Lost to Follow-up|22|||
144486362|NCT02293837|520978494|FG000|Overall Study|Lost to Follow-up|0|||
144486363|NCT02293837|520978495|FG001|Overall Study|Lost to Follow-up|2|||
144486364|NCT02293837|520978496|FG002|Overall Study|Lost to Follow-up|1|||
144486365|NCT02293837|520978497|FG003|Overall Study|Lost to Follow-up|0|||
144486366|NCT02293837|520978494|FG000|Overall Study|Withdrawal by Subject|2|||
144486367|NCT02293837|520978495|FG001|Overall Study|Withdrawal by Subject|1|||
144486368|NCT02293837|520978496|FG002|Overall Study|Withdrawal by Subject|2|||
144486369|NCT02293837|520978497|FG003|Overall Study|Withdrawal by Subject|1|||
144486370|NCT02293837|520978494|FG000|Overall Study|COVID-19 Related|1|||
144486371|NCT02293837|520978495|FG001|Overall Study|COVID-19 Related|1|||
144486372|NCT02293837|520978496|FG002|Overall Study|COVID-19 Related|0|||
144486373|NCT02293837|520978497|FG003|Overall Study|COVID-19 Related|0|||
144486374|NCT02293837|520978494|FG000|Overall Study|Participant ill and could not be infused|0|||
144486375|NCT02293837|520978495|FG001|Overall Study|Participant ill and could not be infused|0|||
144486376|NCT02293837|520978496|FG002|Overall Study|Participant ill and could not be infused|1|||
144486377|NCT02293837|520978497|FG003|Overall Study|Participant ill and could not be infused|0|||
144486378|NCT04779242|520978498|FG000|Overall Study|Adverse Event|1|||
144486379|NCT04779242|520978499|FG001|Overall Study|Adverse Event|1|||
144486380|NCT04779242|520978498|FG000|Overall Study|Lost to Follow-up|2|||
144486381|NCT04779242|520978499|FG001|Overall Study|Lost to Follow-up|4|||
144486382|NCT04779242|520978498|FG000|Overall Study|Withdrawal by Subject|7|||
144486383|NCT04779242|520978499|FG001|Overall Study|Withdrawal by Subject|9|||
144486384|NCT04779242|520978498|FG000|Overall Study|Death|6|||
144486385|NCT04779242|520978499|FG001|Overall Study|Death|6|||
144486386|NCT04779242|520978498|FG000|Overall Study|COVID-19 related reasons|2|||
144486387|NCT04779242|520978499|FG001|Overall Study|COVID-19 related reasons|1|||
144486388|NCT04779242|520978498|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
144538223|NCT00146172|521174128|FG006|Overall Study|Physician Decision|0|||
144486389|NCT04779242|520978499|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
144486390|NCT04779242|520978498|FG000|Overall Study|Martial Law in Ukraine|2|||
144486391|NCT04779242|520978499|FG001|Overall Study|Martial Law in Ukraine|3|||
144486392|NCT02087150|520978500|FG000|Overall Study|Death|0|||
144486393|NCT02087150|520978501|FG001|Overall Study|Death|1|||
144486394|NCT02087150|520978502|FG002|Overall Study|Death|0|||
144486395|NCT02087150|520978500|FG000|Overall Study|Lost to Follow-up|6|||
144486396|NCT02087150|520978501|FG001|Overall Study|Lost to Follow-up|13|||
144486397|NCT02087150|520978502|FG002|Overall Study|Lost to Follow-up|7|||
144486398|NCT02087150|520978500|FG000|Overall Study|Withdrawal by Subject|2|||
144486399|NCT02087150|520978501|FG001|Overall Study|Withdrawal by Subject|5|||
144486400|NCT02087150|520978502|FG002|Overall Study|Withdrawal by Subject|3|||
144715471|NCT00219557|521813356|FG001|Phase 1|Started chemotherapy at other institute|0|||
144715472|NCT00219557|521813357|FG002|Phase 1|Started chemotherapy at other institute|0|||
144715473|NCT00219557|521813355|FG000|Phase 2|Lack of Efficacy|0|||
144715474|NCT00219557|521813356|FG001|Phase 2|Lack of Efficacy|21|||
144715475|NCT00219557|521813357|FG002|Phase 2|Lack of Efficacy|15|||
144715476|NCT00219557|521813355|FG000|Phase 2|Adverse Event|0|||
144715477|NCT00219557|521813356|FG001|Phase 2|Adverse Event|22|||
144715478|NCT00219557|521813357|FG002|Phase 2|Adverse Event|2|||
144715479|NCT00219557|521813355|FG000|Phase 2|Death|0|||
144715480|NCT00219557|521813356|FG001|Phase 2|Death|8|||
144715481|NCT00219557|521813357|FG002|Phase 2|Death|2|||
144715482|NCT00219557|521813355|FG000|Phase 2|Other|0|||
144715483|NCT00219557|521813356|FG001|Phase 2|Other|8|||
144715484|NCT00219557|521813357|FG002|Phase 2|Other|6|||
144715485|NCT00219557|521813355|FG000|Phase 2|Withdrawal by Subject|0|||
144715486|NCT00219557|521813356|FG001|Phase 2|Withdrawal by Subject|9|||
144715487|NCT00219557|521813357|FG002|Phase 2|Withdrawal by Subject|5|||
144715488|NCT00219557|521813355|FG000|Phase 2|Treatment not received|0|||
144715489|NCT00219557|521813356|FG001|Phase 2|Treatment not received|1|||
144715490|NCT00219557|521813357|FG002|Phase 2|Treatment not received|3|||
144715491|NCT02741271|521813368|FG000|Overall Study|Lost to Follow-up|2|||
144715492|NCT02741271|521813369|FG001|Overall Study|Lost to Follow-up|0|||
144715493|NCT02741271|521813368|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144715494|NCT02741271|521813369|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
144715495|NCT03652961|521813370|FG000|Overall Study|Lost to Follow-up|3|||
144715496|NCT03652961|521813370|FG000|Overall Study|Screen Failure|1|||
144715497|NCT00410410|521813371|FG000|Induction Period (IP)|Death|1|||
144715498|NCT00410410|521813372|FG001|Induction Period (IP)|Death|0|||
144715499|NCT00410410|521813373|FG002|Induction Period (IP)|Death|0|||
144715500|NCT00410410|521813374|FG003|Induction Period (IP)|Death|0|||
144715501|NCT00410410|521813375|FG004|Induction Period (IP)|Death|0|||
144715502|NCT00410410|521813376|FG005|Induction Period (IP)|Death|0|||
144715503|NCT00410410|521813377|FG006|Induction Period (IP)|Death|0|||
144715504|NCT00410410|521813378|FG007|Induction Period (IP)|Death|0|||
144715505|NCT00410410|521813379|FG008|Induction Period (IP)|Death|0|||
144715506|NCT00410410|521813371|FG000|Induction Period (IP)|Adverse Event|3|||
144715507|NCT00410410|521813372|FG001|Induction Period (IP)|Adverse Event|4|||
144715508|NCT00410410|521813373|FG002|Induction Period (IP)|Adverse Event|2|||
144715509|NCT00410410|521813374|FG003|Induction Period (IP)|Adverse Event|4|||
144715510|NCT00410410|521813375|FG004|Induction Period (IP)|Adverse Event|1|||
144715511|NCT00410410|521813376|FG005|Induction Period (IP)|Adverse Event|0|||
144715512|NCT00410410|521813377|FG006|Induction Period (IP)|Adverse Event|0|||
144715513|NCT00410410|521813378|FG007|Induction Period (IP)|Adverse Event|0|||
144715514|NCT00410410|521813379|FG008|Induction Period (IP)|Adverse Event|0|||
144715515|NCT00410410|521813371|FG000|Induction Period (IP)|Lack of Efficacy|26|||
144715516|NCT00410410|521813372|FG001|Induction Period (IP)|Lack of Efficacy|24|||
144715517|NCT00410410|521813373|FG002|Induction Period (IP)|Lack of Efficacy|8|||
144715518|NCT00410410|521813374|FG003|Induction Period (IP)|Lack of Efficacy|8|||
144715519|NCT00410410|521813375|FG004|Induction Period (IP)|Lack of Efficacy|7|||
144715520|NCT00410410|521813376|FG005|Induction Period (IP)|Lack of Efficacy|7|||
144715521|NCT00410410|521813377|FG006|Induction Period (IP)|Lack of Efficacy|0|||
144486401|NCT02087150|520978500|FG000|Overall Study|Physician Decision|0|||
144715522|NCT00410410|521813378|FG007|Induction Period (IP)|Lack of Efficacy|0|||
144715523|NCT00410410|521813379|FG008|Induction Period (IP)|Lack of Efficacy|0|||
144715524|NCT00410410|521813371|FG000|Induction Period (IP)|Lost to Follow-up|2|||
144715525|NCT00410410|521813372|FG001|Induction Period (IP)|Lost to Follow-up|2|||
144715526|NCT00410410|521813373|FG002|Induction Period (IP)|Lost to Follow-up|2|||
144715527|NCT00410410|521813374|FG003|Induction Period (IP)|Lost to Follow-up|3|||
144715528|NCT00410410|521813375|FG004|Induction Period (IP)|Lost to Follow-up|0|||
144715529|NCT00410410|521813376|FG005|Induction Period (IP)|Lost to Follow-up|1|||
144715530|NCT00410410|521813377|FG006|Induction Period (IP)|Lost to Follow-up|0|||
144715531|NCT00410410|521813378|FG007|Induction Period (IP)|Lost to Follow-up|0|||
144715532|NCT00410410|521813379|FG008|Induction Period (IP)|Lost to Follow-up|0|||
144486402|NCT02087150|520978501|FG001|Overall Study|Physician Decision|1|||
144486403|NCT02087150|520978502|FG002|Overall Study|Physician Decision|0|||
144715533|NCT00410410|521813371|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
144715534|NCT00410410|521813372|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
144486404|NCT02087150|520978500|FG000|Overall Study|Procedure not done|1|||
144486405|NCT02087150|520978501|FG001|Overall Study|Procedure not done|13|||
144486406|NCT02087150|520978502|FG002|Overall Study|Procedure not done|0|||
144486407|NCT02087150|520978500|FG000|Overall Study|F/U not completed w/in study window|0|||
144486408|NCT02087150|520978501|FG001|Overall Study|F/U not completed w/in study window|0|||
144486409|NCT02087150|520978502|FG002|Overall Study|F/U not completed w/in study window|1|||
144486410|NCT02087150|520978500|FG000|Overall Study|Other|1|||
144486411|NCT02087150|520978501|FG001|Overall Study|Other|0|||
144486412|NCT02087150|520978502|FG002|Overall Study|Other|0|||
144486413|NCT02087150|520978500|FG000|Overall Study|Pt moved out of town|0|||
144486414|NCT02087150|520978501|FG001|Overall Study|Pt moved out of town|1|||
144486415|NCT02087150|520978502|FG002|Overall Study|Pt moved out of town|0|||
144486416|NCT00322374|520978504|FG000|Starting Dose|Physician Decision|2|||
144486417|NCT00322374|520978505|FG001|Starting Dose|Physician Decision|0|||
144486418|NCT00322374|520978506|FG002|Starting Dose|Physician Decision|0|||
144486419|NCT00322374|520978507|FG003|Starting Dose|Physician Decision|0|||
144486420|NCT00322374|520978504|FG000|Starting Dose|Study Drug Toxicity|4|||
144486421|NCT00322374|520978505|FG001|Starting Dose|Study Drug Toxicity|0|||
144486422|NCT00322374|520978506|FG002|Starting Dose|Study Drug Toxicity|0|||
144486423|NCT00322374|520978507|FG003|Starting Dose|Study Drug Toxicity|0|||
144486424|NCT00322374|520978504|FG000|First Escalation|Documented Disease Progression|0|||
144486425|NCT00322374|520978505|FG001|First Escalation|Documented Disease Progression|6|||
144486426|NCT00322374|520978506|FG002|First Escalation|Documented Disease Progression|0|||
144486427|NCT00322374|520978507|FG003|First Escalation|Documented Disease Progression|0|||
144486428|NCT00322374|520978504|FG000|First Escalation|Physician Decision|0|||
144486429|NCT00322374|520978505|FG001|First Escalation|Physician Decision|12|||
144486430|NCT00322374|520978506|FG002|First Escalation|Physician Decision|0|||
144486431|NCT00322374|520978507|FG003|First Escalation|Physician Decision|0|||
144486432|NCT00322374|520978504|FG000|First Escalation|Study Drug Toxicity|0|||
144486433|NCT00322374|520978505|FG001|First Escalation|Study Drug Toxicity|11|||
144486434|NCT00322374|520978506|FG002|First Escalation|Study Drug Toxicity|0|||
144486435|NCT00322374|520978507|FG003|First Escalation|Study Drug Toxicity|0|||
144486436|NCT00322374|520978504|FG000|First Escalation|Participant Request|0|||
144486437|NCT00322374|520978505|FG001|First Escalation|Participant Request|1|||
144486438|NCT00322374|520978506|FG002|First Escalation|Participant Request|0|||
144486439|NCT00322374|520978507|FG003|First Escalation|Participant Request|0|||
144486440|NCT00322374|520978504|FG000|Second Escalation|Physician Decision|0|||
144486441|NCT00322374|520978505|FG001|Second Escalation|Physician Decision|0|||
144486442|NCT00322374|520978506|FG002|Second Escalation|Physician Decision|5|||
144486443|NCT00322374|520978507|FG003|Second Escalation|Physician Decision|0|||
144486444|NCT00322374|520978504|FG000|Second Escalation|Study Drug Toxicity|0|||
144486445|NCT00322374|520978505|FG001|Second Escalation|Study Drug Toxicity|0|||
144486446|NCT00322374|520978506|FG002|Second Escalation|Study Drug Toxicity|1|||
144486447|NCT00322374|520978507|FG003|Second Escalation|Study Drug Toxicity|0|||
144486448|NCT01448044|520978510|FG000|Treatment Period|Adverse Event|4|||
144486449|NCT01448044|520978511|FG001|Treatment Period|Adverse Event|3|||
144486450|NCT01448044|520978510|FG000|Treatment Period|Lack of Efficacy|5|||
144486451|NCT01448044|520978511|FG001|Treatment Period|Lack of Efficacy|12|||
144486452|NCT01448044|520978510|FG000|Treatment Period|Subject requested discontinue study drug|1|||
144486453|NCT01448044|520978511|FG001|Treatment Period|Subject requested discontinue study drug|0|||
144486454|NCT01448044|520978510|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
144486455|NCT01448044|520978511|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
144486456|NCT01448044|520978510|FG000|Treatment Period|Participant does not meet study criteria|1|||
144486457|NCT01448044|520978511|FG001|Treatment Period|Participant does not meet study criteria|0|||
144486458|NCT01448044|520978510|FG000|Treatment Period|Lost to Follow-up|2|||
144486459|NCT01448044|520978511|FG001|Treatment Period|Lost to Follow-up|1|||
144486460|NCT01448044|520978510|FG000|Treatment Period|Other reason|2|||
144486461|NCT01448044|520978511|FG001|Treatment Period|Other reason|0|||
144486462|NCT01448044|520978510|FG000|Follow Up Period|Withdrawal by Subject|1|||
144486463|NCT01448044|520978511|FG001|Follow Up Period|Withdrawal by Subject|1|||
144486464|NCT01448044|520978510|FG000|Follow Up Period|Lost to Follow-up|6|||
144486465|NCT01448044|520978511|FG001|Follow Up Period|Lost to Follow-up|2|||
144486466|NCT01448044|520978510|FG000|Follow Up Period|Other|5|||
144486467|NCT01448044|520978511|FG001|Follow Up Period|Other|11|||
144486468|NCT04230980|520978514|FG000|Overall Study|Lost to Follow-up|1|||
144486469|NCT04230980|520978515|FG001|Overall Study|Lost to Follow-up|2|||
144486470|NCT04230980|520978514|FG000|Overall Study|Adverse Event|0|||
144486471|NCT04230980|520978515|FG001|Overall Study|Adverse Event|1|||
144486472|NCT02372058|520978516|FG000|Overall Study|Withdrawal by Subject|3|||
144486473|NCT00972179|520978517|FG000|Overall Study|Noncompliance|1|||
144486474|NCT00972179|520978518|FG001|Overall Study|Noncompliance|0|||
144486475|NCT00972179|520978519|FG002|Overall Study|Noncompliance|0|||
144486476|NCT00972179|520978520|FG003|Overall Study|Noncompliance|0|||
144486477|NCT00972179|520978521|FG004|Overall Study|Noncompliance|1|||
144486478|NCT00972179|520978522|FG005|Overall Study|Noncompliance|0|||
144486479|NCT00972179|520978523|FG006|Overall Study|Noncompliance|1|||
144486480|NCT00972179|520978517|FG000|Overall Study|Withdrawal by Subject|0|||
144486481|NCT00972179|520978518|FG001|Overall Study|Withdrawal by Subject|3|||
144486482|NCT00972179|520978519|FG002|Overall Study|Withdrawal by Subject|0|||
144486483|NCT00972179|520978520|FG003|Overall Study|Withdrawal by Subject|1|||
144486484|NCT00972179|520978521|FG004|Overall Study|Withdrawal by Subject|0|||
144486485|NCT00972179|520978522|FG005|Overall Study|Withdrawal by Subject|0|||
144486486|NCT00972179|520978523|FG006|Overall Study|Withdrawal by Subject|2|||
144486487|NCT00972179|520978517|FG000|Overall Study|Administrative Decision|0|||
144486488|NCT00972179|520978518|FG001|Overall Study|Administrative Decision|0|||
144486489|NCT00972179|520978519|FG002|Overall Study|Administrative Decision|0|||
144486490|NCT00972179|520978520|FG003|Overall Study|Administrative Decision|0|||
144486491|NCT00972179|520978521|FG004|Overall Study|Administrative Decision|1|||
144486492|NCT00972179|520978522|FG005|Overall Study|Administrative Decision|0|||
144486493|NCT00972179|520978523|FG006|Overall Study|Administrative Decision|0|||
144486494|NCT00972179|520978517|FG000|Overall Study|Lost to Follow-up|0|||
144486495|NCT00972179|520978518|FG001|Overall Study|Lost to Follow-up|0|||
144486496|NCT00972179|520978519|FG002|Overall Study|Lost to Follow-up|1|||
144486497|NCT00972179|520978520|FG003|Overall Study|Lost to Follow-up|0|||
144486498|NCT00972179|520978521|FG004|Overall Study|Lost to Follow-up|0|||
144486499|NCT00972179|520978522|FG005|Overall Study|Lost to Follow-up|3|||
144486500|NCT00972179|520978523|FG006|Overall Study|Lost to Follow-up|1|||
144486501|NCT02061761|520978527|FG000|Overall Study|Disease progression|2|||
144486502|NCT02061761|520978528|FG001|Overall Study|Disease progression|8|||
144486503|NCT02061761|520978529|FG002|Overall Study|Disease progression|4|||
144486504|NCT02061761|520978530|FG003|Overall Study|Disease progression|5|||
144486505|NCT02061761|520978531|FG004|Overall Study|Disease progression|9|||
144486506|NCT02061761|520978532|FG005|Overall Study|Disease progression|3|||
144486507|NCT02061761|520978533|FG006|Overall Study|Disease progression|1|||
144486508|NCT02061761|520978534|FG007|Overall Study|Disease progression|2|||
144486509|NCT02061761|520978535|FG008|Overall Study|Disease progression|28|||
144486510|NCT02061761|520978527|FG000|Overall Study|Study Drug toxicity|0|||
144486511|NCT02061761|520978528|FG001|Overall Study|Study Drug toxicity|0|||
144486512|NCT02061761|520978529|FG002|Overall Study|Study Drug toxicity|0|||
144486513|NCT02061761|520978530|FG003|Overall Study|Study Drug toxicity|0|||
144486514|NCT02061761|520978531|FG004|Overall Study|Study Drug toxicity|0|||
144486515|NCT02061761|520978532|FG005|Overall Study|Study Drug toxicity|1|||
144486516|NCT02061761|520978533|FG006|Overall Study|Study Drug toxicity|0|||
144486517|NCT02061761|520978534|FG007|Overall Study|Study Drug toxicity|2|||
144486518|NCT02061761|520978535|FG008|Overall Study|Study Drug toxicity|6|||
144486519|NCT02061761|520978527|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
144486520|NCT02061761|520978528|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
144486521|NCT02061761|520978529|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
144486522|NCT02061761|520978530|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
144486523|NCT02061761|520978531|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
144486524|NCT02061761|520978532|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
144486525|NCT02061761|520978533|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
144486526|NCT02061761|520978534|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
144486527|NCT02061761|520978535|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
144486528|NCT02061761|520978527|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144486529|NCT02061761|520978528|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144486530|NCT02061761|520978529|FG002|Overall Study|Participant request to discontinue study treatment|2|||
144486531|NCT02061761|520978530|FG003|Overall Study|Participant request to discontinue study treatment|2|||
144486532|NCT02061761|520978531|FG004|Overall Study|Participant request to discontinue study treatment|0|||
144486533|NCT02061761|520978532|FG005|Overall Study|Participant request to discontinue study treatment|1|||
144486534|NCT02061761|520978533|FG006|Overall Study|Participant request to discontinue study treatment|0|||
144486535|NCT02061761|520978534|FG007|Overall Study|Participant request to discontinue study treatment|0|||
144486536|NCT02061761|520978535|FG008|Overall Study|Participant request to discontinue study treatment|2|||
144486537|NCT02061761|520978527|FG000|Overall Study|Withdrawal by Subject|0|||
144486538|NCT02061761|520978528|FG001|Overall Study|Withdrawal by Subject|0|||
144486539|NCT02061761|520978529|FG002|Overall Study|Withdrawal by Subject|0|||
144486540|NCT02061761|520978530|FG003|Overall Study|Withdrawal by Subject|0|||
144486541|NCT02061761|520978531|FG004|Overall Study|Withdrawal by Subject|0|||
144486542|NCT02061761|520978532|FG005|Overall Study|Withdrawal by Subject|0|||
144486543|NCT02061761|520978533|FG006|Overall Study|Withdrawal by Subject|0|||
144486544|NCT02061761|520978534|FG007|Overall Study|Withdrawal by Subject|0|||
144486545|NCT02061761|520978535|FG008|Overall Study|Withdrawal by Subject|2|||
144486546|NCT02061761|520978527|FG000|Overall Study|Maximum clinical benefit|0|||
144486547|NCT02061761|520978528|FG001|Overall Study|Maximum clinical benefit|0|||
144486548|NCT02061761|520978529|FG002|Overall Study|Maximum clinical benefit|0|||
144486549|NCT02061761|520978530|FG003|Overall Study|Maximum clinical benefit|1|||
144486550|NCT02061761|520978531|FG004|Overall Study|Maximum clinical benefit|0|||
144486551|NCT02061761|520978532|FG005|Overall Study|Maximum clinical benefit|0|||
144486552|NCT02061761|520978533|FG006|Overall Study|Maximum clinical benefit|0|||
144486553|NCT02061761|520978534|FG007|Overall Study|Maximum clinical benefit|0|||
144486554|NCT02061761|520978535|FG008|Overall Study|Maximum clinical benefit|6|||
144486555|NCT02061761|520978527|FG000|Overall Study|Participant no longer meets study criteria|0|||
144486556|NCT02061761|520978528|FG001|Overall Study|Participant no longer meets study criteria|0|||
144486557|NCT02061761|520978529|FG002|Overall Study|Participant no longer meets study criteria|0|||
144486558|NCT02061761|520978530|FG003|Overall Study|Participant no longer meets study criteria|0|||
144486559|NCT02061761|520978531|FG004|Overall Study|Participant no longer meets study criteria|0|||
144486560|NCT02061761|520978532|FG005|Overall Study|Participant no longer meets study criteria|0|||
144486561|NCT02061761|520978533|FG006|Overall Study|Participant no longer meets study criteria|0|||
144486562|NCT02061761|520978534|FG007|Overall Study|Participant no longer meets study criteria|0|||
144486563|NCT02061761|520978535|FG008|Overall Study|Participant no longer meets study criteria|1|||
144486564|NCT02061761|520978527|FG000|Overall Study|Other reasons|0|||
144486565|NCT02061761|520978528|FG001|Overall Study|Other reasons|0|||
144486566|NCT02061761|520978529|FG002|Overall Study|Other reasons|0|||
144486567|NCT02061761|520978530|FG003|Overall Study|Other reasons|0|||
144486568|NCT02061761|520978531|FG004|Overall Study|Other reasons|2|||
144486569|NCT02061761|520978532|FG005|Overall Study|Other reasons|0|||
144486570|NCT02061761|520978533|FG006|Overall Study|Other reasons|0|||
144486571|NCT02061761|520978534|FG007|Overall Study|Other reasons|0|||
144486572|NCT02061761|520978535|FG008|Overall Study|Other reasons|6|||
144486573|NCT00195715|520978545|FG000|Overall Study|Adverse Event|122|||
144486574|NCT00195715|520978545|FG000|Overall Study|Withdrawal by Subject|58|||
144486575|NCT00195715|520978545|FG000|Overall Study|Lost to Follow-up|27|||
144486576|NCT00195715|520978545|FG000|Overall Study|Protocol Violation|13|||
144486577|NCT00195715|520978545|FG000|Overall Study|Lack of Efficacy|93|||
144486578|NCT00195715|520978545|FG000|Overall Study|Pregnancy|14|||
144486579|NCT00195715|520978545|FG000|Overall Study|Investigative site closure|8|||
144486580|NCT00195715|520978545|FG000|Overall Study|Subject moved/relocated|7|||
144486581|NCT00195715|520978545|FG000|Overall Study|Subject non-compliance|6|||
144486582|NCT00195715|520978545|FG000|Overall Study|Subject started commercial Humira|5|||
144486583|NCT00195715|520978545|FG000|Overall Study|Subject choice|3|||
144486584|NCT00195715|520978545|FG000|Overall Study|Loss of response/no improvement|3|||
144486585|NCT00195715|520978545|FG000|Overall Study|Sponsor stopped study|1|||
144486586|NCT00195715|520978545|FG000|Overall Study|Administrative reasons|2|||
144486587|NCT00195715|520978545|FG000|Overall Study|Investigator's decision|2|||
144486588|NCT00195715|520978545|FG000|Overall Study|Subject wants to get pregnant|4|||
144486589|NCT00195715|520978545|FG000|Overall Study|Use of prohibited medication|2|||
144486590|NCT00195715|520978545|FG000|Overall Study|Planned surgery|2|||
144486591|NCT00195715|520978545|FG000|Overall Study|Increased infection rate|1|||
144486592|NCT00195715|520978545|FG000|Overall Study|Ineligible|1|||
144486593|NCT00195715|520978545|FG000|Overall Study|Colonic stricture|1|||
144486594|NCT00195715|520978545|FG000|Overall Study|Sponsor discontinued trial|1|||
144486595|NCT00195715|520978545|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
144715535|NCT00410410|521813373|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
144715536|NCT00410410|521813374|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
144715537|NCT00410410|521813375|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
144715538|NCT00410410|521813376|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
144715539|NCT00410410|521813377|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
144715540|NCT00410410|521813378|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
144715541|NCT00410410|521813379|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
144715542|NCT00410410|521813371|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715543|NCT00410410|521813372|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715544|NCT00410410|521813373|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
144715545|NCT00410410|521813374|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715546|NCT00410410|521813375|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715547|NCT00410410|521813376|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715548|NCT00410410|521813377|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715549|NCT00410410|521813378|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715550|NCT00410410|521813379|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
144715551|NCT00410410|521813371|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715552|NCT00410410|521813372|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715553|NCT00410410|521813373|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715554|NCT00410410|521813374|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715555|NCT00410410|521813375|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
144715556|NCT00410410|521813376|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
144715557|NCT00410410|521813377|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715558|NCT00410410|521813378|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715559|NCT00410410|521813379|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
144715560|NCT00410410|521813371|FG000|Induction Period (IP)|Other|0|||
144715561|NCT00410410|521813372|FG001|Induction Period (IP)|Other|0|||
144715562|NCT00410410|521813373|FG002|Induction Period (IP)|Other|1|||
144715563|NCT00410410|521813374|FG003|Induction Period (IP)|Other|0|||
144715564|NCT00410410|521813375|FG004|Induction Period (IP)|Other|0|||
144486596|NCT01370603|520978548|FG000|Period 1|Adverse Event|5|||
144486597|NCT01370603|520978549|FG001|Period 1|Adverse Event|3|||
144486598|NCT01370603|520978548|FG000|Period 1|Lost to Follow-up|2|||
144486599|NCT01370603|520978549|FG001|Period 1|Lost to Follow-up|0|||
144486600|NCT01370603|520978548|FG000|Period 1|Protocol Violation|2|||
144486601|NCT01370603|520978549|FG001|Period 1|Protocol Violation|2|||
144486602|NCT01370603|520978548|FG000|Period 1|Withdrawal by Subject|5|||
144486603|NCT01370603|520978549|FG001|Period 1|Withdrawal by Subject|5|||
144486604|NCT01370603|520978548|FG000|Crossover Washout|Adverse Event|2|||
144486605|NCT01370603|520978549|FG001|Crossover Washout|Adverse Event|1|||
144486606|NCT01370603|520978548|FG000|Crossover Washout|Lost to Follow-up|2|||
144486607|NCT01370603|520978549|FG001|Crossover Washout|Lost to Follow-up|0|||
144486608|NCT01370603|520978548|FG000|Crossover Washout|Protocol Violation|1|||
144486609|NCT01370603|520978549|FG001|Crossover Washout|Protocol Violation|0|||
144486610|NCT01370603|520978548|FG000|Crossover Washout|Withdrawal by Subject|4|||
144486611|NCT01370603|520978549|FG001|Crossover Washout|Withdrawal by Subject|1|||
144486612|NCT01370603|520978548|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
144486613|NCT01370603|520978549|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
144486614|NCT01370603|520978548|FG000|Period 2|Adverse Event|1|||
144486615|NCT01370603|520978549|FG001|Period 2|Adverse Event|4|||
144486616|NCT01370603|520978548|FG000|Period 2|Lost to Follow-up|1|||
144486617|NCT01370603|520978549|FG001|Period 2|Lost to Follow-up|0|||
144486618|NCT01370603|520978548|FG000|Period 2|Withdrawal by Subject|1|||
144486619|NCT01370603|520978549|FG001|Period 2|Withdrawal by Subject|0|||
144486620|NCT00003458|520978554|FG000|Overall Study|Not evaluable|4|||
144486621|NCT01216293|520978559|FG000|Main Study|Adverse Event|1|||
144486622|NCT01216293|520978560|FG001|Main Study|Adverse Event|4|||
144486623|NCT01216293|520978561|FG002|Main Study|Adverse Event|2|||
144486624|NCT01216293|520978559|FG000|Main Study|Major Protocol Deviation|1|||
144486625|NCT01216293|520978560|FG001|Main Study|Major Protocol Deviation|0|||
144486626|NCT01216293|520978561|FG002|Main Study|Major Protocol Deviation|1|||
144486627|NCT01216293|520978559|FG000|Main Study|Lost to Follow-up|3|||
144486628|NCT01216293|520978560|FG001|Main Study|Lost to Follow-up|1|||
144486629|NCT01216293|520978561|FG002|Main Study|Lost to Follow-up|0|||
144486630|NCT01216293|520978559|FG000|Main Study|Voluntary Withdrawal|2|||
144486631|NCT01216293|520978560|FG001|Main Study|Voluntary Withdrawal|2|||
144486632|NCT01216293|520978561|FG002|Main Study|Voluntary Withdrawal|2|||
144486633|NCT01216293|520978559|FG000|Main Study|Other Reason Not Specified|0|||
144486634|NCT01216293|520978560|FG001|Main Study|Other Reason Not Specified|1|||
144486635|NCT01216293|520978561|FG002|Main Study|Other Reason Not Specified|1|||
144486636|NCT01216293|520978559|FG000|Main Study|Randomized, Not Treated|1|||
144486637|NCT01216293|520978560|FG001|Main Study|Randomized, Not Treated|0|||
144486638|NCT01216293|520978561|FG002|Main Study|Randomized, Not Treated|0|||
144486639|NCT01216293|520978559|FG000|Calcium Absorption Substudy|Adverse Event|0|||
144486640|NCT01216293|520978560|FG001|Calcium Absorption Substudy|Adverse Event|2|||
144486641|NCT01216293|520978561|FG002|Calcium Absorption Substudy|Adverse Event|0|||
144486642|NCT01216293|520978559|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
144486643|NCT01216293|520978560|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
144486644|NCT01216293|520978561|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
144486645|NCT01216293|520978559|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
144486646|NCT01216293|520978560|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
144486647|NCT01216293|520978561|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
144486648|NCT04129580|520980635|FG000|Overall Study|Lost to Follow-up|14|||
144486649|NCT04129580|520980636|FG001|Overall Study|Lost to Follow-up|25|||
144486650|NCT01500226|520980639|FG000|Overall Study|Adverse Event|31|||
144486651|NCT01500226|520980640|FG001|Overall Study|Adverse Event|38|||
144486652|NCT01500226|520980639|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
144486653|NCT01500226|520980640|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
144486654|NCT01500226|520980639|FG000|Overall Study|Withdrawal by Subject|93|||
144486655|NCT01500226|520980640|FG001|Overall Study|Withdrawal by Subject|96|||
144486656|NCT01500226|520980639|FG000|Overall Study|Death|12|||
144486657|NCT01500226|520980640|FG001|Overall Study|Death|4|||
144486658|NCT01500226|520980639|FG000|Overall Study|Disease Progression|16|||
144486659|NCT01500226|520980640|FG001|Overall Study|Disease Progression|14|||
144486660|NCT01500226|520980639|FG000|Overall Study|Protocol Violation|53|||
144369773|NCT02745119|520561696|FG003|Overall Study|Lost to Follow-up|1|||
144486661|NCT01500226|520980640|FG001|Overall Study|Protocol Violation|39|||
144486662|NCT01500226|520980639|FG000|Overall Study|Physician Decision|17|||
144486663|NCT01500226|520980640|FG001|Overall Study|Physician Decision|15|||
144486664|NCT01500226|520980639|FG000|Overall Study|Lack of Efficacy|14|||
144486665|NCT01500226|520980640|FG001|Overall Study|Lack of Efficacy|30|||
144486666|NCT01500226|520980639|FG000|Overall Study|Lost to Follow-up|9|||
144486667|NCT01500226|520980640|FG001|Overall Study|Lost to Follow-up|5|||
144486668|NCT01500226|520980639|FG000|Overall Study|Other Reasons|19|||
144486669|NCT01500226|520980640|FG001|Overall Study|Other Reasons|16|||
144486670|NCT04212169|520980641|FG000|Overall Study|Adverse Event|0|||
144486671|NCT04212169|520980642|FG001|Overall Study|Adverse Event|0|||
144486672|NCT04212169|520980643|FG002|Overall Study|Adverse Event|0|||
144486673|NCT04212169|520980644|FG003|Overall Study|Adverse Event|2|||
144486674|NCT04212169|520980641|FG000|Overall Study|Lost to Follow-up|1|||
144486675|NCT04212169|520980642|FG001|Overall Study|Lost to Follow-up|0|||
144486676|NCT04212169|520980643|FG002|Overall Study|Lost to Follow-up|0|||
144486677|NCT04212169|520980644|FG003|Overall Study|Lost to Follow-up|2|||
144486678|NCT04212169|520980641|FG000|Overall Study|Withdrawal by Subject|10|||
144486679|NCT04212169|520980642|FG001|Overall Study|Withdrawal by Subject|2|||
144486680|NCT04212169|520980643|FG002|Overall Study|Withdrawal by Subject|5|||
144486681|NCT04212169|520980644|FG003|Overall Study|Withdrawal by Subject|7|||
144486682|NCT04212169|520980641|FG000|Overall Study|Other reason, unspecified|3|||
144486683|NCT04212169|520980642|FG001|Overall Study|Other reason, unspecified|1|||
144486684|NCT04212169|520980643|FG002|Overall Study|Other reason, unspecified|0|||
144486685|NCT04212169|520980644|FG003|Overall Study|Other reason, unspecified|2|||
144486686|NCT02176928|520980645|FG000|Overall Study|Lost to Follow-up|2|||
144486687|NCT02176928|520980646|FG001|Overall Study|Lost to Follow-up|4|||
144486688|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
144486689|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
144486690|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
144486691|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
144486692|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
144486693|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
144486694|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
144486695|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
144486696|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
144486697|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
144486698|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486699|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486700|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486701|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
144486702|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
144486703|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486704|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486705|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486706|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486707|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
144486708|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
144486709|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
144486710|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
144486711|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
144486712|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
144486713|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
144486714|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
144486715|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
144486716|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
144486717|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
144486718|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
144486719|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486720|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486721|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
144486722|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
144486723|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486724|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486725|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486726|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486727|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
144486728|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486729|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486730|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
144486731|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
144486732|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486733|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486734|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486735|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486736|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486737|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
144486738|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486739|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486740|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486741|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486742|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
144486743|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486744|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486745|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486746|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486747|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
144486748|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486749|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486750|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486751|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
144486752|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
144486753|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
144486754|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486755|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486756|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486757|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
144486758|NCT02018861|520980654|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486759|NCT02018861|520980655|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486760|NCT02018861|520980656|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486761|NCT02018861|520980657|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
144486762|NCT02018861|520980658|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
144486763|NCT02018861|520980659|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486764|NCT02018861|520980660|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486765|NCT02018861|520980661|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486766|NCT02018861|520980662|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486767|NCT02018861|520980663|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
144486768|NCT02018861|520980654|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486769|NCT02018861|520980655|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486770|NCT02018861|520980656|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486771|NCT02018861|520980657|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486772|NCT02018861|520980658|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486773|NCT02018861|520980659|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486774|NCT02018861|520980660|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
144486775|NCT02018861|520980661|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
144486776|NCT02018861|520980662|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486777|NCT02018861|520980663|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
144486778|NCT02018861|520980654|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486779|NCT02018861|520980655|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486780|NCT02018861|520980656|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486781|NCT02018861|520980657|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486782|NCT02018861|520980658|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486783|NCT02018861|520980659|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486784|NCT02018861|520980660|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
144486785|NCT02018861|520980661|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
144486786|NCT02018861|520980662|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486787|NCT02018861|520980663|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
144486788|NCT02018861|520980654|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486789|NCT02018861|520980655|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486790|NCT02018861|520980656|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486791|NCT02018861|520980657|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486792|NCT02018861|520980658|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486793|NCT02018861|520980659|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486794|NCT02018861|520980660|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486795|NCT02018861|520980661|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486796|NCT02018861|520980662|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
144486797|NCT02018861|520980663|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
144486798|NCT02018861|520980654|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486799|NCT02018861|520980655|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486800|NCT02018861|520980656|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486801|NCT02018861|520980657|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486802|NCT02018861|520980658|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486803|NCT02018861|520980659|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486804|NCT02018861|520980660|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486805|NCT02018861|520980661|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486806|NCT02018861|520980662|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
144486807|NCT02018861|520980663|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
144486808|NCT02018861|520980654|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486809|NCT02018861|520980655|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486810|NCT02018861|520980656|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486811|NCT02018861|520980657|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486812|NCT02018861|520980658|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486813|NCT02018861|520980659|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486814|NCT02018861|520980660|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486815|NCT02018861|520980661|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486816|NCT02018861|520980662|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
144486817|NCT02018861|520980663|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
144486818|NCT00504348|520980667|FG000|Overall Study|Adverse Event|3|||
144486819|NCT00504348|520980667|FG000|Overall Study|Lack of Efficacy|4|||
144486820|NCT00504348|520980667|FG000|Overall Study|Physician Decision|1|||
144486821|NCT00224133|520980668|FG000|Overall Study|Adverse Event|93|||
144486822|NCT00224133|520980668|FG000|Overall Study|Protocol Violation|6|||
144486823|NCT00224133|520980668|FG000|Overall Study|Withdrawal by Subject|33|||
144486824|NCT00224133|520980668|FG000|Overall Study|Lack of Efficacy|58|||
144486825|NCT00224133|520980668|FG000|Overall Study|Lost to Follow-up|21|||
144486826|NCT00224133|520980668|FG000|Overall Study|Physician Decision|1|||
144486827|NCT00224133|520980668|FG000|Overall Study|Other|14|||
144486828|NCT03699124|520980670|FG000|Overall Study|Adverse Event|6|||
144486829|NCT03699124|520980671|FG001|Overall Study|Adverse Event|5|||
144486830|NCT03699124|520980672|FG002|Overall Study|Adverse Event|2|||
144486831|NCT03699124|520980670|FG000|Overall Study|Death|0|||
144486832|NCT03699124|520980671|FG001|Overall Study|Death|2|||
144486833|NCT03699124|520980672|FG002|Overall Study|Death|0|||
144486834|NCT03699124|520980670|FG000|Overall Study|Lost to Follow-up|20|||
144486835|NCT03699124|520980671|FG001|Overall Study|Lost to Follow-up|16|||
144486836|NCT03699124|520980672|FG002|Overall Study|Lost to Follow-up|15|||
144486837|NCT03699124|520980670|FG000|Overall Study|Protocol Violation|1|||
144486838|NCT03699124|520980671|FG001|Overall Study|Protocol Violation|0|||
144486839|NCT03699124|520980672|FG002|Overall Study|Protocol Violation|0|||
144486840|NCT03699124|520980670|FG000|Overall Study|Withdrawal by Subject|13|||
144486841|NCT03699124|520980671|FG001|Overall Study|Withdrawal by Subject|14|||
144486842|NCT03699124|520980672|FG002|Overall Study|Withdrawal by Subject|13|||
144486843|NCT03699124|520980670|FG000|Overall Study|Other reasons|5|||
144486844|NCT03699124|520980671|FG001|Overall Study|Other reasons|3|||
144486845|NCT03699124|520980672|FG002|Overall Study|Other reasons|10|||
144486846|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
144486847|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
144486848|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
144486849|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
144486850|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
144486851|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
144486852|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
144486853|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
144486854|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
144486855|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
144486856|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
144486857|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
144486858|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
144486859|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
144486860|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
144486861|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
144486862|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
144486863|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
144486864|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
144486865|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
144486866|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
144486867|NCT02718417|520980674|FG000|Chemotherapy Phase (CP)|Other|2|||
144486868|NCT02718417|520980675|FG001|Chemotherapy Phase (CP)|Other|0|||
144486869|NCT02718417|520980676|FG002|Chemotherapy Phase (CP)|Other|1|||
144486870|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Adverse Event|21|||
144486871|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Adverse Event|26|||
144486872|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Adverse Event|0|||
144486873|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
144486874|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
144486875|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
144486876|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
144486877|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
144486878|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
144486879|NCT02718417|520980674|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
144486880|NCT02718417|520980675|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
144486881|NCT02718417|520980676|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
144486882|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Physician's decision|6|||
144486883|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Physician's decision|7|||
144486884|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Physician's decision|0|||
144486885|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Progressive disease|100|||
144486886|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Progressive disease|88|||
144486887|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Progressive disease|0|||
144486888|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Other|2|||
144486889|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Other|1|||
144486890|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Other|0|||
144486891|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
144486892|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
144486893|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
144486894|NCT02718417|520980674|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
144486895|NCT02718417|520980675|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
144486896|NCT02718417|520980676|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
144486897|NCT02718417|520980674|FG000|Observation Phase (OP)|Adverse Event|0|||
144486898|NCT02718417|520980675|FG001|Observation Phase (OP)|Adverse Event|0|||
144486899|NCT02718417|520980676|FG002|Observation Phase (OP)|Adverse Event|1|||
144486900|NCT02718417|520980674|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
144486901|NCT02718417|520980675|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
144486902|NCT02718417|520980676|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
144486903|NCT02718417|520980674|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
144486904|NCT02718417|520980675|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
144486905|NCT02718417|520980676|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
144486906|NCT02718417|520980674|FG000|Observation Phase (OP)|Physician Decision|0|||
144486907|NCT02718417|520980675|FG001|Observation Phase (OP)|Physician Decision|0|||
144486908|NCT02718417|520980676|FG002|Observation Phase (OP)|Physician Decision|9|||
144486909|NCT02718417|520980674|FG000|Observation Phase (OP)|Progressive disease|0|||
144486910|NCT02718417|520980675|FG001|Observation Phase (OP)|Progressive disease|0|||
144486911|NCT02718417|520980676|FG002|Observation Phase (OP)|Progressive disease|92|||
144486912|NCT02718417|520980674|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
144486913|NCT02718417|520980675|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
144486914|NCT02718417|520980676|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
144486915|NCT02718417|520980674|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
144486916|NCT02718417|520980675|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
144486917|NCT02718417|520980676|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
144486918|NCT02718417|520980674|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
144486919|NCT02718417|520980675|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
144486920|NCT02718417|520980676|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
144486921|NCT02718417|520980674|FG000|Observation Phase (OP)|Other|0|||
144486922|NCT02718417|520980675|FG001|Observation Phase (OP)|Other|0|||
144486923|NCT02718417|520980676|FG002|Observation Phase (OP)|Other|7|||
144486924|NCT02718417|520980674|FG000|Follow-up Phase|Adverse Event|3|||
144486925|NCT02718417|520980675|FG001|Follow-up Phase|Adverse Event|1|||
144486926|NCT02718417|520980676|FG002|Follow-up Phase|Adverse Event|1|||
144486927|NCT02718417|520980674|FG000|Follow-up Phase|Other|4|||
144486928|NCT02718417|520980675|FG001|Follow-up Phase|Other|6|||
144486929|NCT02718417|520980676|FG002|Follow-up Phase|Other|4|||
144486930|NCT02718417|520980674|FG000|Follow-up Phase|Withdrawal by Subject|19|||
144486931|NCT02718417|520980675|FG001|Follow-up Phase|Withdrawal by Subject|17|||
144486932|NCT02718417|520980676|FG002|Follow-up Phase|Withdrawal by Subject|5|||
144486933|NCT02718417|520980674|FG000|Follow-up Phase|Study terminated by sponsor|100|||
144486934|NCT02718417|520980675|FG001|Follow-up Phase|Study terminated by sponsor|138|||
144486935|NCT02718417|520980676|FG002|Follow-up Phase|Study terminated by sponsor|6|||
144486936|NCT02718417|520980674|FG000|Follow-up Phase|Lost to Follow-up|2|||
144486937|NCT02718417|520980675|FG001|Follow-up Phase|Lost to Follow-up|3|||
144486938|NCT02718417|520980676|FG002|Follow-up Phase|Lost to Follow-up|0|||
144486939|NCT02718417|520980674|FG000|Follow-up Phase|Death leading to discontinuation|7|||
144486940|NCT02718417|520980675|FG001|Follow-up Phase|Death leading to discontinuation|7|||
144486941|NCT02718417|520980676|FG002|Follow-up Phase|Death leading to discontinuation|3|||
144486942|NCT02718417|520980674|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
144486943|NCT02718417|520980675|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
144486944|NCT02718417|520980676|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
144486945|NCT02718417|520980674|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
144486946|NCT02718417|520980675|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
144486947|NCT02718417|520980676|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
144486948|NCT02718417|520980674|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
144486949|NCT02718417|520980675|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
144486950|NCT02718417|520980676|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
144486951|NCT02718417|520980674|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
144486952|NCT02718417|520980675|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
144486953|NCT02718417|520980676|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
144486954|NCT02718417|520980674|FG000|Long-term Follow-up Phase|Other|0|||
144486955|NCT02718417|520980675|FG001|Long-term Follow-up Phase|Other|2|||
144486956|NCT02718417|520980676|FG002|Long-term Follow-up Phase|Other|0|||
144486957|NCT01023308|520980677|FG000|Overall Study|Abnormal test proceedure results|3|||
144486958|NCT01023308|520980678|FG001|Overall Study|Abnormal test proceedure results|8|||
144486959|NCT01023308|520980677|FG000|Overall Study|Administrative problems|2|||
144486960|NCT01023308|520980678|FG001|Overall Study|Administrative problems|1|||
144486961|NCT01023308|520980677|FG000|Overall Study|Adverse Event|130|||
144486962|NCT01023308|520980678|FG001|Overall Study|Adverse Event|66|||
144486963|NCT01023308|520980677|FG000|Overall Study|Death|21|||
144486964|NCT01023308|520980678|FG001|Overall Study|Death|17|||
144486965|NCT01023308|520980677|FG000|Overall Study|Disease progression|82|||
144486966|NCT01023308|520980678|FG001|Overall Study|Disease progression|153|||
144486967|NCT01023308|520980677|FG000|Overall Study|New Cancer therapy|4|||
144486968|NCT01023308|520980678|FG001|Overall Study|New Cancer therapy|7|||
144486969|NCT01023308|520980677|FG000|Overall Study|Protocol Violation|3|||
144486970|NCT01023308|520980678|FG001|Overall Study|Protocol Violation|4|||
144486971|NCT01023308|520980677|FG000|Overall Study|Untreated|5|||
144486972|NCT01023308|520980678|FG001|Overall Study|Untreated|5|||
144486973|NCT01023308|520980677|FG000|Overall Study|Lost to Follow-up|1|||
144486974|NCT01023308|520980678|FG001|Overall Study|Lost to Follow-up|0|||
144486975|NCT01023308|520980677|FG000|Overall Study|Withdrawal by Subject|34|||
144486976|NCT01023308|520980678|FG001|Overall Study|Withdrawal by Subject|18|||
144486977|NCT01890967|520980679|FG000|Overall Study|Adverse Event|3|||
144486978|NCT01890967|520980680|FG001|Overall Study|Adverse Event|3|||
144486979|NCT01890967|520980681|FG002|Overall Study|Adverse Event|3|||
144486980|NCT01890967|520980682|FG003|Overall Study|Adverse Event|2|||
144486981|NCT01890967|520980683|FG004|Overall Study|Adverse Event|1|||
144486982|NCT01890967|520980684|FG005|Overall Study|Adverse Event|7|||
144486983|NCT01890967|520980679|FG000|Overall Study|Death|1|||
144486984|NCT01890967|520980680|FG001|Overall Study|Death|0|||
144486985|NCT01890967|520980681|FG002|Overall Study|Death|0|||
144486986|NCT01890967|520980682|FG003|Overall Study|Death|0|||
144486987|NCT01890967|520980683|FG004|Overall Study|Death|0|||
144486988|NCT01890967|520980684|FG005|Overall Study|Death|0|||
144486989|NCT01890967|520980679|FG000|Overall Study|Lost to Follow-up|1|||
144486990|NCT01890967|520980680|FG001|Overall Study|Lost to Follow-up|1|||
144486991|NCT01890967|520980681|FG002|Overall Study|Lost to Follow-up|1|||
144486992|NCT01890967|520980682|FG003|Overall Study|Lost to Follow-up|1|||
144486993|NCT01890967|520980683|FG004|Overall Study|Lost to Follow-up|0|||
144486994|NCT01890967|520980684|FG005|Overall Study|Lost to Follow-up|1|||
144486995|NCT01890967|520980679|FG000|Overall Study|Protocol Violation|0|||
144486996|NCT01890967|520980680|FG001|Overall Study|Protocol Violation|3|||
144486997|NCT01890967|520980681|FG002|Overall Study|Protocol Violation|3|||
144486998|NCT01890967|520980682|FG003|Overall Study|Protocol Violation|2|||
144486999|NCT01890967|520980683|FG004|Overall Study|Protocol Violation|4|||
144487000|NCT01890967|520980684|FG005|Overall Study|Protocol Violation|1|||
144487001|NCT01890967|520980679|FG000|Overall Study|Sponsor Decision|2|||
144487002|NCT01890967|520980680|FG001|Overall Study|Sponsor Decision|0|||
144487003|NCT01890967|520980681|FG002|Overall Study|Sponsor Decision|1|||
144487004|NCT01890967|520980682|FG003|Overall Study|Sponsor Decision|3|||
144487005|NCT01890967|520980683|FG004|Overall Study|Sponsor Decision|2|||
144487006|NCT01890967|520980684|FG005|Overall Study|Sponsor Decision|3|||
144487007|NCT01890967|520980679|FG000|Overall Study|Withdrawal by Subject|3|||
144487008|NCT01890967|520980680|FG001|Overall Study|Withdrawal by Subject|4|||
144487009|NCT01890967|520980681|FG002|Overall Study|Withdrawal by Subject|2|||
144487010|NCT01890967|520980682|FG003|Overall Study|Withdrawal by Subject|3|||
144715565|NCT00410410|521813376|FG005|Induction Period (IP)|Other|0|||
144715566|NCT00410410|521813377|FG006|Induction Period (IP)|Other|0|||
144715567|NCT00410410|521813378|FG007|Induction Period (IP)|Other|0|||
144715568|NCT00410410|521813379|FG008|Induction Period (IP)|Other|0|||
144715569|NCT00410410|521813371|FG000|Maintenance Period (MP)|Death|0|||
144715570|NCT00410410|521813372|FG001|Maintenance Period (MP)|Death|0|||
144715571|NCT00410410|521813373|FG002|Maintenance Period (MP)|Death|0|||
144487011|NCT01890967|520980683|FG004|Overall Study|Withdrawal by Subject|3|||
144487012|NCT01890967|520980684|FG005|Overall Study|Withdrawal by Subject|1|||
144487013|NCT01383993|520980687|FG000|Overall Study|Adverse Event|1|||
144487014|NCT01383993|520980688|FG001|Overall Study|Adverse Event|1|||
144487015|NCT01383993|520980689|FG002|Overall Study|Adverse Event|0|||
144487016|NCT01383993|520980687|FG000|Overall Study|Withdrawal by Subject|0|||
144487017|NCT01383993|520980688|FG001|Overall Study|Withdrawal by Subject|0|||
144487018|NCT01383993|520980689|FG002|Overall Study|Withdrawal by Subject|1|||
144487019|NCT01383993|520980687|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
144487020|NCT01383993|520980688|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
144487021|NCT01383993|520980689|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
144487022|NCT00795132|520980693|FG000|Overall Study|Death|1|||
144487023|NCT00795132|520980693|FG000|Overall Study|Relapse|2|||
144487024|NCT02561455|520980694|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
144487025|NCT02561455|520980695|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
144487026|NCT02561455|520980696|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
144487027|NCT02561455|520980697|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
144487028|NCT02561455|520980694|FG000|Overall Study|Withdrawal by Subject|1|||
144487029|NCT02561455|520980695|FG001|Overall Study|Withdrawal by Subject|0|||
144487030|NCT02561455|520980696|FG002|Overall Study|Withdrawal by Subject|1|||
144487031|NCT02561455|520980697|FG003|Overall Study|Withdrawal by Subject|0|||
144487032|NCT02561455|520980694|FG000|Overall Study|Disease Progression|0|||
144487033|NCT02561455|520980695|FG001|Overall Study|Disease Progression|1|||
144487034|NCT02561455|520980696|FG002|Overall Study|Disease Progression|0|||
144487035|NCT02561455|520980697|FG003|Overall Study|Disease Progression|0|||
144487036|NCT02451930|520980701|FG000|Overall Study|Death|0|||
144487037|NCT02451930|520980702|FG001|Overall Study|Death|15|||
144487038|NCT02451930|520980701|FG000|Overall Study|Lost to Follow-up|0|||
144487039|NCT02451930|520980702|FG001|Overall Study|Lost to Follow-up|3|||
144487040|NCT02451930|520980701|FG000|Overall Study|Sponsor Decision|2|||
144487041|NCT02451930|520980702|FG001|Overall Study|Sponsor Decision|10|||
144487042|NCT02451930|520980701|FG000|Overall Study|Withdrawal by Subject|0|||
144487043|NCT02451930|520980702|FG001|Overall Study|Withdrawal by Subject|1|||
144487044|NCT02451930|520980701|FG000|Overall Study|Other|0|||
144487045|NCT02451930|520980702|FG001|Overall Study|Other|1|||
144487046|NCT00262743|520980703|FG000|Overall Study|Adverse Event|0|||
144487047|NCT00262743|520980704|FG001|Overall Study|Adverse Event|9|||
144487048|NCT00262743|520980703|FG000|Overall Study|Disease progression|0|||
144487049|NCT00262743|520980704|FG001|Overall Study|Disease progression|3|||
144487050|NCT01950273|520980714|FG000|Overall Study|Protocol Violation|1|||
144487051|NCT01950273|520980715|FG001|Overall Study|Protocol Violation|0|||
144487052|NCT01950273|520980714|FG000|Overall Study|Withdrawal by Subject|2|||
144487053|NCT01950273|520980715|FG001|Overall Study|Withdrawal by Subject|0|||
144487054|NCT01950273|520980714|FG000|Overall Study|Other not defined above|1|||
144487055|NCT01950273|520980715|FG001|Overall Study|Other not defined above|0|||
144487056|NCT00472186|520980716|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
144487057|NCT00472186|520980717|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
144487058|NCT03354637|520980722|FG000|Double-blind Period|Protocol Violation|2|||
144487059|NCT03354637|520980723|FG001|Double-blind Period|Protocol Violation|0|||
144487060|NCT03354637|520980724|FG002|Double-blind Period|Protocol Violation|0|||
144487061|NCT03354637|520980722|FG000|Double-blind Period|Adverse Event|1|||
144487062|NCT03354637|520980723|FG001|Double-blind Period|Adverse Event|2|||
144487063|NCT03354637|520980724|FG002|Double-blind Period|Adverse Event|0|||
144487064|NCT03354637|520980722|FG000|Double-blind Period|Lost to Follow-up|3|||
144487065|NCT03354637|520980723|FG001|Double-blind Period|Lost to Follow-up|4|||
144487066|NCT03354637|520980724|FG002|Double-blind Period|Lost to Follow-up|3|||
144487067|NCT03354637|520980722|FG000|Double-blind Period|Withdrawal by Subject|10|||
144487068|NCT03354637|520980723|FG001|Double-blind Period|Withdrawal by Subject|6|||
144487069|NCT03354637|520980724|FG002|Double-blind Period|Withdrawal by Subject|4|||
144487070|NCT03354637|520980722|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
144487071|NCT03354637|520980723|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
144487072|NCT03354637|520980724|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
144487073|NCT03354637|520980722|FG000|Open Label Extension|Adverse Event|0|||
144487074|NCT03354637|520980723|FG001|Open Label Extension|Adverse Event|0|||
144487075|NCT03354637|520980724|FG002|Open Label Extension|Adverse Event|1|||
144487076|NCT03354637|520980722|FG000|Open Label Extension|Lost to Follow-up|0|||
144487077|NCT03354637|520980723|FG001|Open Label Extension|Lost to Follow-up|0|||
144487078|NCT03354637|520980724|FG002|Open Label Extension|Lost to Follow-up|2|||
144487079|NCT03354637|520980722|FG000|Open Label Extension|Withdrawal by Subject|0|||
144487080|NCT03354637|520980723|FG001|Open Label Extension|Withdrawal by Subject|0|||
144487081|NCT03354637|520980724|FG002|Open Label Extension|Withdrawal by Subject|5|||
144487082|NCT03354637|520980722|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
144487083|NCT03354637|520980723|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
144487084|NCT03354637|520980724|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
144487085|NCT03354637|520980722|FG000|Open Label Extension|Subject Noncompliance|0|||
144487086|NCT03354637|520980723|FG001|Open Label Extension|Subject Noncompliance|0|||
144487087|NCT03354637|520980724|FG002|Open Label Extension|Subject Noncompliance|1|||
144487088|NCT03354637|520980722|FG000|Open Label Extension|Lack of Efficacy|0|||
144487089|NCT03354637|520980723|FG001|Open Label Extension|Lack of Efficacy|0|||
144487090|NCT03354637|520980724|FG002|Open Label Extension|Lack of Efficacy|1|||
144487091|NCT03354637|520980722|FG000|Open Label Extension|Physician Decision|0|||
144487092|NCT03354637|520980723|FG001|Open Label Extension|Physician Decision|0|||
144487093|NCT03354637|520980724|FG002|Open Label Extension|Physician Decision|1|||
144487094|NCT01154036|520980731|FG000|Phase I|Physician Decision|0|||
144487095|NCT01154036|520980732|FG001|Phase I|Physician Decision|1|||
144487096|NCT01154036|520980733|FG002|Phase I|Physician Decision|0|||
144487097|NCT01154036|520980734|FG003|Phase I|Physician Decision|0|||
144487098|NCT01154036|520980735|FG004|Phase I|Physician Decision|0|||
144487099|NCT01154036|520980736|FG005|Phase I|Physician Decision|0|||
144487100|NCT01154036|520980737|FG006|Phase I|Physician Decision|0|||
144487101|NCT01154036|520980738|FG007|Phase I|Physician Decision|0|||
144487102|NCT01154036|520980731|FG000|Phase I|Lost to Follow-up|0|||
144487103|NCT01154036|520980732|FG001|Phase I|Lost to Follow-up|3|||
144487104|NCT01154036|520980733|FG002|Phase I|Lost to Follow-up|6|||
144487105|NCT01154036|520980734|FG003|Phase I|Lost to Follow-up|0|||
144487106|NCT01154036|520980735|FG004|Phase I|Lost to Follow-up|0|||
144487107|NCT01154036|520980736|FG005|Phase I|Lost to Follow-up|0|||
144487108|NCT01154036|520980737|FG006|Phase I|Lost to Follow-up|0|||
144487109|NCT01154036|520980738|FG007|Phase I|Lost to Follow-up|0|||
144487110|NCT01154036|520980731|FG000|Phase I|Protocol Violation|0|||
144487111|NCT01154036|520980732|FG001|Phase I|Protocol Violation|3|||
144487112|NCT01154036|520980733|FG002|Phase I|Protocol Violation|9|||
144487113|NCT01154036|520980734|FG003|Phase I|Protocol Violation|0|||
144487114|NCT01154036|520980735|FG004|Phase I|Protocol Violation|0|||
144487115|NCT01154036|520980736|FG005|Phase I|Protocol Violation|0|||
144487116|NCT01154036|520980737|FG006|Phase I|Protocol Violation|0|||
144487117|NCT01154036|520980738|FG007|Phase I|Protocol Violation|0|||
144487118|NCT01154036|520980731|FG000|Phase I|Withdrawal by Subject|2|||
144487119|NCT01154036|520980732|FG001|Phase I|Withdrawal by Subject|10|||
144487120|NCT01154036|520980733|FG002|Phase I|Withdrawal by Subject|29|||
144487121|NCT01154036|520980734|FG003|Phase I|Withdrawal by Subject|0|||
144487122|NCT01154036|520980735|FG004|Phase I|Withdrawal by Subject|0|||
144487123|NCT01154036|520980736|FG005|Phase I|Withdrawal by Subject|0|||
144487124|NCT01154036|520980737|FG006|Phase I|Withdrawal by Subject|0|||
144487125|NCT01154036|520980738|FG007|Phase I|Withdrawal by Subject|0|||
144487126|NCT01154036|520980731|FG000|Phase I|Adverse Event|1|||
144487127|NCT01154036|520980732|FG001|Phase I|Adverse Event|11|||
144487128|NCT01154036|520980733|FG002|Phase I|Adverse Event|12|||
144487129|NCT01154036|520980734|FG003|Phase I|Adverse Event|0|||
144487130|NCT01154036|520980735|FG004|Phase I|Adverse Event|0|||
144487131|NCT01154036|520980736|FG005|Phase I|Adverse Event|0|||
144487132|NCT01154036|520980737|FG006|Phase I|Adverse Event|0|||
144487133|NCT01154036|520980738|FG007|Phase I|Adverse Event|0|||
144487134|NCT01154036|520980731|FG000|Phase II|Adverse Event|0|||
144487135|NCT01154036|520980732|FG001|Phase II|Adverse Event|0|||
144487136|NCT01154036|520980733|FG002|Phase II|Adverse Event|0|||
144487137|NCT01154036|520980734|FG003|Phase II|Adverse Event|0|||
144487138|NCT01154036|520980735|FG004|Phase II|Adverse Event|1|||
144487139|NCT01154036|520980736|FG005|Phase II|Adverse Event|1|||
144487140|NCT01154036|520980737|FG006|Phase II|Adverse Event|1|||
144487141|NCT01154036|520980738|FG007|Phase II|Adverse Event|1|||
144487142|NCT01154036|520980731|FG000|Phase II|Physician Decision|0|||
144487143|NCT01154036|520980732|FG001|Phase II|Physician Decision|0|||
144487144|NCT01154036|520980733|FG002|Phase II|Physician Decision|0|||
144487145|NCT01154036|520980734|FG003|Phase II|Physician Decision|0|||
144487146|NCT01154036|520980735|FG004|Phase II|Physician Decision|0|||
144487147|NCT01154036|520980736|FG005|Phase II|Physician Decision|0|||
144487148|NCT01154036|520980737|FG006|Phase II|Physician Decision|1|||
144487149|NCT01154036|520980738|FG007|Phase II|Physician Decision|0|||
144487150|NCT01154036|520980731|FG000|Phase II|Lost to Follow-up|0|||
144487151|NCT01154036|520980732|FG001|Phase II|Lost to Follow-up|0|||
144487152|NCT01154036|520980733|FG002|Phase II|Lost to Follow-up|0|||
144487153|NCT01154036|520980734|FG003|Phase II|Lost to Follow-up|1|||
144487154|NCT01154036|520980735|FG004|Phase II|Lost to Follow-up|2|||
144487155|NCT01154036|520980736|FG005|Phase II|Lost to Follow-up|0|||
144487156|NCT01154036|520980737|FG006|Phase II|Lost to Follow-up|2|||
144487157|NCT01154036|520980738|FG007|Phase II|Lost to Follow-up|1|||
144487158|NCT01154036|520980731|FG000|Phase II|Protocol Violation|0|||
144487159|NCT01154036|520980732|FG001|Phase II|Protocol Violation|0|||
144487160|NCT01154036|520980733|FG002|Phase II|Protocol Violation|0|||
144487161|NCT01154036|520980734|FG003|Phase II|Protocol Violation|0|||
144487162|NCT01154036|520980735|FG004|Phase II|Protocol Violation|1|||
144487163|NCT01154036|520980736|FG005|Phase II|Protocol Violation|2|||
144487164|NCT01154036|520980737|FG006|Phase II|Protocol Violation|0|||
144487165|NCT01154036|520980738|FG007|Phase II|Protocol Violation|0|||
144487166|NCT01154036|520980731|FG000|Phase II|Withdrawal by Subject|0|||
144487167|NCT01154036|520980732|FG001|Phase II|Withdrawal by Subject|0|||
144487168|NCT01154036|520980733|FG002|Phase II|Withdrawal by Subject|0|||
144487169|NCT01154036|520980734|FG003|Phase II|Withdrawal by Subject|0|||
144487170|NCT01154036|520980735|FG004|Phase II|Withdrawal by Subject|4|||
144487171|NCT01154036|520980736|FG005|Phase II|Withdrawal by Subject|2|||
144487172|NCT01154036|520980737|FG006|Phase II|Withdrawal by Subject|5|||
144487173|NCT01154036|520980738|FG007|Phase II|Withdrawal by Subject|4|||
144487174|NCT02264574|520980739|FG000|Overall Study|Death|21|||
144487175|NCT02264574|520980740|FG001|Overall Study|Death|21|||
144487176|NCT02264574|520980739|FG000|Overall Study|Withdrawal by Subject|8|||
144487177|NCT02264574|520980740|FG001|Overall Study|Withdrawal by Subject|6|||
144487178|NCT02264574|520980739|FG000|Overall Study|Other, Not Specified|0|||
144487179|NCT02264574|520980740|FG001|Overall Study|Other, Not Specified|3|||
144487180|NCT03405662|520980743|FG000|Overall Study|COVID-19 restriction|1|||
144487181|NCT03405662|520980744|FG001|Overall Study|COVID-19 restriction|0|||
144487182|NCT03405662|520980743|FG000|Overall Study|unblinding|0|||
144487183|NCT03405662|520980744|FG001|Overall Study|unblinding|1|||
144487184|NCT03405662|520980743|FG000|Overall Study|placement in memory care facility|0|||
144487185|NCT03405662|520980744|FG001|Overall Study|placement in memory care facility|2|||
144487186|NCT00280293|520980745|FG000|Overall Study|Protocol Violation|3|||
144487187|NCT00280293|520980746|FG001|Overall Study|Protocol Violation|0|||
144487188|NCT00280293|520980745|FG000|Overall Study|Physician Decision|5|||
144487189|NCT00280293|520980746|FG001|Overall Study|Physician Decision|4|||
144487190|NCT00280293|520980745|FG000|Overall Study|Lost to Follow-up|14|||
144487191|NCT00280293|520980746|FG001|Overall Study|Lost to Follow-up|12|||
144487192|NCT00280293|520980745|FG000|Overall Study|Withdrawal by Subject|3|||
144487193|NCT00280293|520980746|FG001|Overall Study|Withdrawal by Subject|5|||
144487194|NCT00280293|520980745|FG000|Overall Study|Incarceration/Legal Reasons|1|||
144487195|NCT00280293|520980746|FG001|Overall Study|Incarceration/Legal Reasons|1|||
144487196|NCT00280293|520980745|FG000|Overall Study|Adverse Event|0|||
144487197|NCT00280293|520980746|FG001|Overall Study|Adverse Event|1|||
144487198|NCT02056119|520980747|FG000|Overall Study|Death|1|||
144487199|NCT02056119|520980748|FG001|Overall Study|Death|2|||
144487200|NCT02056119|520980747|FG000|Overall Study|Intubated for less than 24 hrs|2|||
144487201|NCT02056119|520980748|FG001|Overall Study|Intubated for less than 24 hrs|7|||
144487202|NCT02056119|520980747|FG000|Overall Study|No aerosol treatments were given.|3|||
144487203|NCT02056119|520980748|FG001|Overall Study|No aerosol treatments were given.|2|||
144487204|NCT02056119|520980747|FG000|Overall Study|Received Metaneb treatment|0|||
144487205|NCT02056119|520980748|FG001|Overall Study|Received Metaneb treatment|2|||
144487206|NCT02056119|520980747|FG000|Overall Study|Protocol Violation|4|||
144487207|NCT02056119|520980748|FG001|Overall Study|Protocol Violation|7|||
144487208|NCT02443103|520980758|FG000|Overall Study|Adverse Event|2|||
144487209|NCT02443103|520980758|FG000|Overall Study|Noncompliance|1|||
144487210|NCT02982720|520980759|FG000|Overall Study|Adverse Event|3|||
144487211|NCT02982720|520980759|FG000|Overall Study|Death|1|||
144487212|NCT00507026|520980765|FG000|Overall Study|Lack of Efficacy|6|||
144487213|NCT00507026|520980766|FG001|Overall Study|Lack of Efficacy|4|||
144487214|NCT00507026|520980767|FG002|Overall Study|Lack of Efficacy|21|||
144487215|NCT00507026|520980765|FG000|Overall Study|Withdrawal by Subject|2|||
144487216|NCT00507026|520980766|FG001|Overall Study|Withdrawal by Subject|0|||
144487217|NCT00507026|520980767|FG002|Overall Study|Withdrawal by Subject|0|||
144487218|NCT00507026|520980765|FG000|Overall Study|Investigator Decision|1|||
144487219|NCT00507026|520980766|FG001|Overall Study|Investigator Decision|0|||
144487220|NCT00507026|520980767|FG002|Overall Study|Investigator Decision|0|||
144487221|NCT00507026|520980765|FG000|Overall Study|Adverse Event|2|||
144487222|NCT00507026|520980766|FG001|Overall Study|Adverse Event|0|||
144487223|NCT00507026|520980767|FG002|Overall Study|Adverse Event|0|||
144487224|NCT00507026|520980765|FG000|Overall Study|Protocol Violation|1|||
144487225|NCT00507026|520980766|FG001|Overall Study|Protocol Violation|0|||
144487226|NCT00507026|520980767|FG002|Overall Study|Protocol Violation|0|||
144487227|NCT00507026|520980765|FG000|Overall Study|Other|1|||
144487228|NCT00507026|520980766|FG001|Overall Study|Other|0|||
144487229|NCT00507026|520980767|FG002|Overall Study|Other|0|||
144487230|NCT03523871|520980770|FG000|Overall Study|Death|1|||
144487231|NCT03619174|520980772|FG000|Overall Study|Lost to Follow-up|3|||
144487232|NCT03619174|520980773|FG001|Overall Study|Lost to Follow-up|0|||
144487233|NCT03619174|520980772|FG000|Overall Study|Withdrawal by Subject|4|||
144487234|NCT03619174|520980773|FG001|Overall Study|Withdrawal by Subject|3|||
144487235|NCT03619174|520980772|FG000|Overall Study|Pregnancy|1|||
144369774|NCT02745119|520561693|FG000|Overall Study|Protocol Deviation|0|||
144487236|NCT03619174|520980773|FG001|Overall Study|Pregnancy|1|||
144487237|NCT03619174|520980772|FG000|Overall Study|Discomfort during treatment|1|||
144487238|NCT03619174|520980773|FG001|Overall Study|Discomfort during treatment|0|||
144487239|NCT01991197|520980774|FG000|Overall Study|Lost to Follow-up|1|||
144487240|NCT01991197|520980775|FG001|Overall Study|Lost to Follow-up|1|||
144487241|NCT01991197|520980774|FG000|Overall Study|Physician Decision|0|||
144487242|NCT01991197|520980775|FG001|Overall Study|Physician Decision|2|||
144487243|NCT01991197|520980774|FG000|Overall Study|Withdrawal by Subject|2|||
144487244|NCT01991197|520980775|FG001|Overall Study|Withdrawal by Subject|0|||
144487245|NCT01010217|520980780|FG000|Overall Study|Lost to Follow-up|4|||
144487246|NCT01010217|520980781|FG001|Overall Study|Lost to Follow-up|5|||
144487247|NCT01010217|520980782|FG002|Overall Study|Lost to Follow-up|1|||
144487248|NCT01010217|520980783|FG003|Overall Study|Lost to Follow-up|0|||
144487249|NCT01010217|520980784|FG004|Overall Study|Lost to Follow-up|0|||
144487250|NCT01010217|520980780|FG000|Overall Study|Withdrawal by Subject|1|||
144487251|NCT01010217|520980781|FG001|Overall Study|Withdrawal by Subject|0|||
144487252|NCT01010217|520980782|FG002|Overall Study|Withdrawal by Subject|0|||
144487253|NCT01010217|520980783|FG003|Overall Study|Withdrawal by Subject|0|||
144487254|NCT01010217|520980784|FG004|Overall Study|Withdrawal by Subject|0|||
144487255|NCT01010217|520980780|FG000|Overall Study|Physician Decision|0|||
144487256|NCT01010217|520980781|FG001|Overall Study|Physician Decision|0|||
144487257|NCT01010217|520980782|FG002|Overall Study|Physician Decision|0|||
144487258|NCT01010217|520980783|FG003|Overall Study|Physician Decision|6|||
144487259|NCT01010217|520980784|FG004|Overall Study|Physician Decision|3|||
144487260|NCT04285229|520980785|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144487261|NCT04285229|520980786|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144487262|NCT04285229|520980787|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144487263|NCT04285229|520980788|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144487264|NCT04285229|520980789|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144487265|NCT04285229|520980790|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144487266|NCT04285229|520980785|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
144487267|NCT04285229|520980786|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
144487268|NCT04285229|520980787|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
144487269|NCT04285229|520980788|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
144487270|NCT04285229|520980789|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
144487271|NCT04285229|520980790|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
144487272|NCT04285229|520980785|FG000|Extended Treatment Period|Adverse Event|0|||
144487273|NCT04285229|520980786|FG001|Extended Treatment Period|Adverse Event|0|||
144487274|NCT04285229|520980787|FG002|Extended Treatment Period|Adverse Event|0|||
144487275|NCT04285229|520980788|FG003|Extended Treatment Period|Adverse Event|1|||
144487276|NCT04285229|520980789|FG004|Extended Treatment Period|Adverse Event|0|||
144487277|NCT04285229|520980790|FG005|Extended Treatment Period|Adverse Event|0|||
144487278|NCT04285229|520980785|FG000|Extended Treatment Period|Physician Decision|0|||
144487279|NCT04285229|520980786|FG001|Extended Treatment Period|Physician Decision|0|||
144487280|NCT04285229|520980787|FG002|Extended Treatment Period|Physician Decision|1|||
144487281|NCT04285229|520980788|FG003|Extended Treatment Period|Physician Decision|0|||
144487282|NCT04285229|520980789|FG004|Extended Treatment Period|Physician Decision|0|||
144487283|NCT04285229|520980790|FG005|Extended Treatment Period|Physician Decision|0|||
144487284|NCT04285229|520980785|FG000|Follow-up Period|Adverse Event|0|||
144487285|NCT04285229|520980786|FG001|Follow-up Period|Adverse Event|0|||
144487286|NCT04285229|520980787|FG002|Follow-up Period|Adverse Event|0|||
144487287|NCT04285229|520980788|FG003|Follow-up Period|Adverse Event|0|||
144487288|NCT04285229|520980789|FG004|Follow-up Period|Adverse Event|1|||
144487289|NCT04285229|520980790|FG005|Follow-up Period|Adverse Event|4|||
144487290|NCT04285229|520980785|FG000|Follow-up Period|Withdrawal by Subject|0|||
144487291|NCT04285229|520980786|FG001|Follow-up Period|Withdrawal by Subject|0|||
144487292|NCT04285229|520980787|FG002|Follow-up Period|Withdrawal by Subject|0|||
144487293|NCT04285229|520980788|FG003|Follow-up Period|Withdrawal by Subject|0|||
144487294|NCT04285229|520980789|FG004|Follow-up Period|Withdrawal by Subject|0|||
144487295|NCT04285229|520980790|FG005|Follow-up Period|Withdrawal by Subject|5|||
144487296|NCT04285229|520980785|FG000|Follow-up Period|Covid-19|0|||
144487297|NCT04285229|520980786|FG001|Follow-up Period|Covid-19|0|||
144487298|NCT04285229|520980787|FG002|Follow-up Period|Covid-19|0|||
144487299|NCT04285229|520980788|FG003|Follow-up Period|Covid-19|0|||
144487300|NCT04285229|520980789|FG004|Follow-up Period|Covid-19|0|||
144487301|NCT04285229|520980790|FG005|Follow-up Period|Covid-19|2|||
144487302|NCT04285229|520980785|FG000|Follow-up Period|Physician Decision|0|||
144487303|NCT04285229|520980786|FG001|Follow-up Period|Physician Decision|0|||
144487304|NCT04285229|520980787|FG002|Follow-up Period|Physician Decision|0|||
144487305|NCT04285229|520980788|FG003|Follow-up Period|Physician Decision|0|||
144487306|NCT04285229|520980789|FG004|Follow-up Period|Physician Decision|0|||
144487307|NCT04285229|520980790|FG005|Follow-up Period|Physician Decision|1|||
144487308|NCT01012973|520980791|FG000|Overall Study|Adverse Event|5|||
144487309|NCT01012973|520980792|FG001|Overall Study|Adverse Event|5|||
144487310|NCT01012973|520980791|FG000|Overall Study|Lack of Efficacy|0|||
144487311|NCT01012973|520980792|FG001|Overall Study|Lack of Efficacy|5|||
144487312|NCT01012973|520980791|FG000|Overall Study|Lost to Follow-up|1|||
144487313|NCT01012973|520980792|FG001|Overall Study|Lost to Follow-up|0|||
144487314|NCT01012973|520980791|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
144487315|NCT01012973|520980792|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
144487316|NCT01012973|520980791|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
144369775|NCT02745119|520561694|FG001|Overall Study|Protocol Deviation|0|||
144487317|NCT01012973|520980792|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
144487318|NCT01012973|520980791|FG000|Overall Study|Protocol Violation|5|||
144487319|NCT01012973|520980792|FG001|Overall Study|Protocol Violation|2|||
144487320|NCT01012973|520980791|FG000|Overall Study|Withdrawal by Subject|4|||
144487321|NCT01012973|520980792|FG001|Overall Study|Withdrawal by Subject|6|||
144487322|NCT01556763|520980795|FG000|Overall Study|Withdrawal by Subject|0|||
144487323|NCT01556763|520980796|FG001|Overall Study|Withdrawal by Subject|1|||
144487324|NCT01556763|520980797|FG002|Overall Study|Withdrawal by Subject|0|||
144487325|NCT02258464|520980798|FG000|Overall Study|Progressive disease (PD)|9|||
144487326|NCT02258464|520980799|FG001|Overall Study|Progressive disease (PD)|17|||
144487327|NCT02258464|520980798|FG000|Overall Study|Study drug never administered|1|||
144487328|NCT02258464|520980799|FG001|Overall Study|Study drug never administered|1|||
144487329|NCT02258464|520980798|FG000|Overall Study|AE not related to clinical PD|1|||
144487330|NCT02258464|520980799|FG001|Overall Study|AE not related to clinical PD|3|||
144487331|NCT02258464|520980798|FG000|Overall Study|Withdrawal by Subject|5|||
144487332|NCT02258464|520980799|FG001|Overall Study|Withdrawal by Subject|4|||
144487333|NCT02258464|520980798|FG000|Overall Study|AE related to clinical PD|1|||
144487334|NCT02258464|520980799|FG001|Overall Study|AE related to clinical PD|0|||
144487335|NCT04170296|520980800|FG000|Overall Study|Adverse Event|1|||
144487336|NCT04170296|520980801|FG001|Overall Study|Adverse Event|0|||
144487337|NCT04170296|520980800|FG000|Overall Study|Withdrawal by Subject|3|||
144487338|NCT04170296|520980801|FG001|Overall Study|Withdrawal by Subject|2|||
144487339|NCT04170296|520980800|FG000|Overall Study|Lost to Follow-up|4|||
144487340|NCT04170296|520980801|FG001|Overall Study|Lost to Follow-up|2|||
144487341|NCT00932646|520980802|FG000|Overall Study|Adverse Event|2|||
144487342|NCT00932646|520980803|FG001|Overall Study|Adverse Event|1|||
144487343|NCT00932646|520980804|FG002|Overall Study|Adverse Event|1|||
144487344|NCT00932646|520980805|FG003|Overall Study|Adverse Event|1|||
144487345|NCT00932646|520980802|FG000|Overall Study|Lost to Follow-up|2|||
144487346|NCT00932646|520980803|FG001|Overall Study|Lost to Follow-up|1|||
144487347|NCT00932646|520980804|FG002|Overall Study|Lost to Follow-up|0|||
144487348|NCT00932646|520980805|FG003|Overall Study|Lost to Follow-up|0|||
144487349|NCT00932646|520980802|FG000|Overall Study|Withdrawal by Subject|1|||
144487350|NCT00932646|520980803|FG001|Overall Study|Withdrawal by Subject|1|||
144487351|NCT00932646|520980804|FG002|Overall Study|Withdrawal by Subject|3|||
144487352|NCT00932646|520980805|FG003|Overall Study|Withdrawal by Subject|0|||
144487353|NCT02138747|520980806|FG000|Treatment Period 1|Adverse Event|10|||
144487354|NCT02138747|520980807|FG001|Treatment Period 1|Adverse Event|14|||
144487355|NCT02138747|520980808|FG002|Treatment Period 1|Adverse Event|2|||
144487356|NCT02138747|520980809|FG003|Treatment Period 1|Adverse Event|1|||
144487357|NCT02138747|520980806|FG000|Treatment Period 1|Lost to Follow-up|0|||
144487358|NCT02138747|520980807|FG001|Treatment Period 1|Lost to Follow-up|1|||
144487359|NCT02138747|520980808|FG002|Treatment Period 1|Lost to Follow-up|1|||
144487360|NCT02138747|520980809|FG003|Treatment Period 1|Lost to Follow-up|0|||
144487361|NCT02138747|520980806|FG000|Treatment Period 1|Protocol Violation|0|||
144487362|NCT02138747|520980807|FG001|Treatment Period 1|Protocol Violation|2|||
144487363|NCT02138747|520980808|FG002|Treatment Period 1|Protocol Violation|0|||
144487364|NCT02138747|520980809|FG003|Treatment Period 1|Protocol Violation|0|||
144487365|NCT02138747|520980806|FG000|Treatment Period 1|Withdrawal by Subject|8|||
144487366|NCT02138747|520980807|FG001|Treatment Period 1|Withdrawal by Subject|4|||
144487367|NCT02138747|520980808|FG002|Treatment Period 1|Withdrawal by Subject|1|||
144487368|NCT02138747|520980809|FG003|Treatment Period 1|Withdrawal by Subject|3|||
144487369|NCT02138747|520980806|FG000|Treatment Period 1|Other - Miscellaneous|2|||
144487370|NCT02138747|520980807|FG001|Treatment Period 1|Other - Miscellaneous|4|||
144487371|NCT02138747|520980808|FG002|Treatment Period 1|Other - Miscellaneous|0|||
144487372|NCT02138747|520980809|FG003|Treatment Period 1|Other - Miscellaneous|0|||
144487373|NCT02138747|520980806|FG000|Treatment Period 2|Adverse Event|6|||
144487374|NCT02138747|520980807|FG001|Treatment Period 2|Adverse Event|3|||
144487375|NCT02138747|520980808|FG002|Treatment Period 2|Adverse Event|1|||
144487376|NCT02138747|520980809|FG003|Treatment Period 2|Adverse Event|1|||
144487377|NCT02138747|520980806|FG000|Treatment Period 2|Lost to Follow-up|2|||
144487378|NCT02138747|520980807|FG001|Treatment Period 2|Lost to Follow-up|0|||
144487379|NCT02138747|520980808|FG002|Treatment Period 2|Lost to Follow-up|0|||
144487380|NCT02138747|520980809|FG003|Treatment Period 2|Lost to Follow-up|0|||
144487381|NCT02138747|520980806|FG000|Treatment Period 2|Protocol Violation|1|||
144487382|NCT02138747|520980807|FG001|Treatment Period 2|Protocol Violation|0|||
144487383|NCT02138747|520980808|FG002|Treatment Period 2|Protocol Violation|0|||
144487384|NCT02138747|520980809|FG003|Treatment Period 2|Protocol Violation|0|||
144487385|NCT02138747|520980806|FG000|Treatment Period 2|Withdrawal by Subject|5|||
144487386|NCT02138747|520980807|FG001|Treatment Period 2|Withdrawal by Subject|4|||
144487387|NCT02138747|520980808|FG002|Treatment Period 2|Withdrawal by Subject|1|||
144487388|NCT02138747|520980809|FG003|Treatment Period 2|Withdrawal by Subject|2|||
144487389|NCT02138747|520980806|FG000|Treatment Period 2|Other - Miscellaneous|3|||
144487390|NCT02138747|520980807|FG001|Treatment Period 2|Other - Miscellaneous|0|||
144487391|NCT02138747|520980808|FG002|Treatment Period 2|Other - Miscellaneous|0|||
144487392|NCT02138747|520980809|FG003|Treatment Period 2|Other - Miscellaneous|0|||
144487393|NCT00653263|520980810|FG000|Overall Study|Withdrawal by Subject|1|||
144487394|NCT00653263|520980810|FG000|Overall Study|Physician Decision|1|||
144487395|NCT02611830|520980811|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
144369776|NCT02745119|520561695|FG002|Overall Study|Protocol Deviation|0|||
144487396|NCT02611830|520980812|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
144369777|NCT02745119|520561696|FG003|Overall Study|Protocol Deviation|1|||
144487397|NCT02611830|520980813|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
144487398|NCT02611830|520980814|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
144487399|NCT02611830|520980811|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
144487400|NCT02611830|520980812|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
144487401|NCT02611830|520980813|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
144487402|NCT02611830|520980814|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
144487403|NCT02611830|520980811|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
144487404|NCT02611830|520980812|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
144487405|NCT02611830|520980813|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
144487406|NCT02611830|520980814|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
144487407|NCT02611830|520980811|FG000|OL Induction Phase|Lack of Efficacy|9|||
144487408|NCT02611830|520980812|FG001|OL Induction Phase|Lack of Efficacy|0|||
144487409|NCT02611830|520980813|FG002|OL Induction Phase|Lack of Efficacy|0|||
144487410|NCT02611830|520980814|FG003|OL Induction Phase|Lack of Efficacy|0|||
144487411|NCT02611830|520980811|FG000|OL Induction Phase|Reason not specified|3|||
144487412|NCT02611830|520980812|FG001|OL Induction Phase|Reason not specified|0|||
144487413|NCT02611830|520980813|FG002|OL Induction Phase|Reason not specified|0|||
144487414|NCT02611830|520980814|FG003|OL Induction Phase|Reason not specified|0|||
144487415|NCT02611830|520980811|FG000|Maintenance Phase|Lack of Efficacy|0|||
144487416|NCT02611830|520980812|FG001|Maintenance Phase|Lack of Efficacy|29|||
144487417|NCT02611830|520980813|FG002|Maintenance Phase|Lack of Efficacy|18|||
144487418|NCT02611830|520980814|FG003|Maintenance Phase|Lack of Efficacy|6|||
144487419|NCT02611830|520980811|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
144487420|NCT02611830|520980812|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
144487421|NCT02611830|520980813|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
144487422|NCT02611830|520980814|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
144487423|NCT02611830|520980811|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
144487424|NCT02611830|520980812|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
144487425|NCT02611830|520980813|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
144487426|NCT02611830|520980814|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
144487427|NCT02611830|520980811|FG000|Maintenance Phase|Lost to Follow-up|0|||
144487428|NCT02611830|520980812|FG001|Maintenance Phase|Lost to Follow-up|0|||
144487429|NCT02611830|520980813|FG002|Maintenance Phase|Lost to Follow-up|0|||
144487430|NCT02611830|520980814|FG003|Maintenance Phase|Lost to Follow-up|1|||
144487431|NCT02611830|520980811|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
144487432|NCT02611830|520980812|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
144487433|NCT02611830|520980813|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
144487434|NCT02611830|520980814|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
144487435|NCT02611830|520980811|FG000|Maintenance Phase|Pregnancy|0|||
144487436|NCT02611830|520980812|FG001|Maintenance Phase|Pregnancy|0|||
144487437|NCT02611830|520980813|FG002|Maintenance Phase|Pregnancy|1|||
144487438|NCT02611830|520980814|FG003|Maintenance Phase|Pregnancy|0|||
144487439|NCT02611830|520980811|FG000|Maintenance Phase|Reason not specified|0|||
144487440|NCT02611830|520980812|FG001|Maintenance Phase|Reason not specified|1|||
144487441|NCT02611830|520980813|FG002|Maintenance Phase|Reason not specified|4|||
144487442|NCT02611830|520980814|FG003|Maintenance Phase|Reason not specified|0|||
144487443|NCT00776100|520980815|FG000|Overall Study|Disease Progression|1|||
144487444|NCT00776100|520980816|FG001|Overall Study|Disease Progression|0|||
144487445|NCT03567993|520980819|FG000|Overall Study|Lost to Follow-up|4|||
144487446|NCT03567993|520980820|FG001|Overall Study|Lost to Follow-up|2|||
144487447|NCT03567993|520980819|FG000|Overall Study|Death|1|||
144487448|NCT03567993|520980820|FG001|Overall Study|Death|1|||
144487449|NCT03567993|520980819|FG000|Overall Study|Withdrawal by Subject|1|||
144487450|NCT03567993|520980820|FG001|Overall Study|Withdrawal by Subject|0|||
144487451|NCT04793464|520980821|FG000|Overall Study|Lost to Follow-up|458|||
144487452|NCT04793464|520980822|FG001|Overall Study|Lost to Follow-up|168|||
144487453|NCT04793464|520980823|FG002|Overall Study|Lost to Follow-up|5|||
144487454|NCT04793464|520980821|FG000|Overall Study|Withdrawal by Subject|43|||
144487455|NCT04793464|520980822|FG001|Overall Study|Withdrawal by Subject|15|||
144487456|NCT04793464|520980823|FG002|Overall Study|Withdrawal by Subject|0|||
144487457|NCT05822921|520980826|FG000|Overall Study|Lost to Follow-up|1|||
144487458|NCT05822921|520980827|FG001|Overall Study|Lost to Follow-up|1|||
144487459|NCT01163747|520980829|FG000|Overall Study|Adverse Event|0|||
144487460|NCT01163747|520980830|FG001|Overall Study|Adverse Event|5|||
144487461|NCT01163747|520980829|FG000|Overall Study|Insufficient Therapeutic Response|0|||
144487462|NCT01163747|520980830|FG001|Overall Study|Insufficient Therapeutic Response|1|||
144487463|NCT01163747|520980829|FG000|Overall Study|Protocol Violation|0|||
144487464|NCT01163747|520980830|FG001|Overall Study|Protocol Violation|1|||
144487465|NCT01163747|520980829|FG000|Overall Study|Refused Treatment|6|||
144487466|NCT01163747|520980830|FG001|Overall Study|Refused Treatment|4|||
144487467|NCT01671748|520980831|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
144487468|NCT01671748|520980832|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
144487469|NCT01671748|520980831|FG000|4 Week run-in Phase|Adverse Event|1|||
144487470|NCT01671748|520980832|FG001|4 Week run-in Phase|Adverse Event|0|||
144487471|NCT01671748|520980831|FG000|4 Week run-in Phase|Not eligible|9|||
144487472|NCT01671748|520980832|FG001|4 Week run-in Phase|Not eligible|0|||
144487473|NCT04714216|520982603|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
144487474|NCT04714216|520982603|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
144487475|NCT01349829|520982606|FG000|Overall Study|Lost to Follow-up|4|||
144487476|NCT01349829|520982607|FG001|Overall Study|Lost to Follow-up|8|||
144487477|NCT01349829|520982606|FG000|Overall Study|Consent withdrawal|3|||
144487478|NCT01349829|520982607|FG001|Overall Study|Consent withdrawal|8|||
144487479|NCT01349829|520982606|FG000|Overall Study|Migrated/moved|2|||
144487480|NCT01349829|520982607|FG001|Overall Study|Migrated/moved|7|||
144487481|NCT00777803|520982608|FG000|Overall Study|Lost to Follow-up|12|||
144487482|NCT00777803|520982609|FG001|Overall Study|Lost to Follow-up|5|||
144487483|NCT00777803|520982608|FG000|Overall Study|Adverse Event|1|||
144487484|NCT00777803|520982609|FG001|Overall Study|Adverse Event|0|||
144487485|NCT00777803|520982608|FG000|Overall Study|Non-compliance|2|||
144487486|NCT00777803|520982609|FG001|Overall Study|Non-compliance|2|||
144487487|NCT01995357|520982612|FG000|Period 5|Lack of Efficacy|1|||
144487488|NCT01995357|520982613|FG001|Period 5|Lack of Efficacy|0|||
144487489|NCT01995357|520982614|FG002|Period 5|Lack of Efficacy|0|||
144487490|NCT01995357|520982615|FG003|Period 5|Lack of Efficacy|0|||
144487491|NCT01995357|520982616|FG004|Period 5|Lack of Efficacy|0|||
144487492|NCT01995357|520982617|FG005|Period 5|Lack of Efficacy|0|||
144487493|NCT01995357|520982612|FG000|Period 5|Adverse Event|1|||
144487494|NCT01995357|520982613|FG001|Period 5|Adverse Event|0|||
144487495|NCT01995357|520982614|FG002|Period 5|Adverse Event|1|||
144487496|NCT01995357|520982615|FG003|Period 5|Adverse Event|0|||
144487497|NCT01995357|520982616|FG004|Period 5|Adverse Event|0|||
144487498|NCT01995357|520982617|FG005|Period 5|Adverse Event|0|||
144487499|NCT01809210|520982624|FG000|Overall Study|Withdrawal by Subject|0|||
144487500|NCT01809210|520982625|FG001|Overall Study|Withdrawal by Subject|0|||
144487501|NCT01809210|520982626|FG002|Overall Study|Withdrawal by Subject|1|||
144487502|NCT01809210|520982627|FG003|Overall Study|Withdrawal by Subject|1|||
144487503|NCT01809210|520982628|FG004|Overall Study|Withdrawal by Subject|1|||
144487504|NCT01809210|520982629|FG005|Overall Study|Withdrawal by Subject|0|||
144487505|NCT01809210|520982630|FG006|Overall Study|Withdrawal by Subject|4|||
144487506|NCT01809210|520982624|FG000|Overall Study|Death|1|||
144487507|NCT01809210|520982625|FG001|Overall Study|Death|1|||
144487508|NCT01809210|520982626|FG002|Overall Study|Death|2|||
144487509|NCT01809210|520982627|FG003|Overall Study|Death|0|||
144487510|NCT01809210|520982628|FG004|Overall Study|Death|1|||
144487511|NCT01809210|520982629|FG005|Overall Study|Death|3|||
144487512|NCT01809210|520982630|FG006|Overall Study|Death|1|||
144487513|NCT00590980|520982631|FG000|Overall Study|Did not meet all inclusion criteria|10|||
144487514|NCT04006366|520982640|FG000|Overall Study|Withdrawal by Subject|1|||
144487515|NCT04430335|520982642|FG000|Overall Study|Withdrawal by Subject|1|||
144487516|NCT03249376|520982645|FG000|Overall Study|Adverse Event|11|||
144487517|NCT03249376|520982646|FG001|Overall Study|Adverse Event|5|||
144487518|NCT03249376|520982645|FG000|Overall Study|Lack of Efficacy|2|||
144487519|NCT03249376|520982646|FG001|Overall Study|Lack of Efficacy|4|||
144487520|NCT03249376|520982645|FG000|Overall Study|Protocol Violation|3|||
144487521|NCT03249376|520982646|FG001|Overall Study|Protocol Violation|2|||
144487522|NCT03249376|520982645|FG000|Overall Study|Physician Decision|0|||
144487523|NCT03249376|520982646|FG001|Overall Study|Physician Decision|2|||
144487524|NCT03249376|520982645|FG000|Overall Study|Withdrawal by Subject|3|||
144487525|NCT03249376|520982646|FG001|Overall Study|Withdrawal by Subject|9|||
144487526|NCT03249376|520982645|FG000|Overall Study|LTFU|2|||
144487527|NCT03249376|520982646|FG001|Overall Study|LTFU|1|||
144487528|NCT00627042|520982647|FG000|Overall Study|Withdrawal by Subject|2|||
144487529|NCT04102540|520982657|FG000|Overall Study|Withdrawn by PI|2|||
144487530|NCT04102540|520982657|FG000|Overall Study|Lost to Follow-up|6|||
144487531|NCT01567163|520982659|FG000|Overall Study|Progressive Disease|2|||
144487532|NCT01567163|520982659|FG000|Overall Study|Lost to Follow-up|2|||
144487533|NCT01458249|520982663|FG000|Overall Study|Not treated|1|||
144487534|NCT01458249|520982663|FG000|Overall Study|Adverse Event|4|||
144487535|NCT01458249|520982663|FG000|Overall Study|Other|2|||
144487536|NCT01458249|520982663|FG000|Overall Study|Ongoing|1|||
144487537|NCT01348854|520982664|FG000|Overall Study|Lost to Follow-up|2|||
144487538|NCT01348854|520982665|FG001|Overall Study|Lost to Follow-up|1|||
144487539|NCT01348854|520982664|FG000|Overall Study|Withdrawal by Subject|1|||
144487540|NCT01348854|520982665|FG001|Overall Study|Withdrawal by Subject|0|||
144487541|NCT03220737|520982666|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
144487542|NCT03220737|520982667|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
144487543|NCT03220737|520982668|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
144487544|NCT03220737|520982669|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
144487545|NCT03220737|520982670|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
144487546|NCT03220737|520982671|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
144487547|NCT03220737|520982672|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
144487548|NCT03220737|520982666|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
144487549|NCT03220737|520982667|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
144487550|NCT03220737|520982668|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
144487551|NCT03220737|520982669|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
144487552|NCT03220737|520982670|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
144487553|NCT03220737|520982671|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
144487554|NCT03220737|520982672|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
144487555|NCT03220737|520982666|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
144487556|NCT03220737|520982667|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
144487557|NCT03220737|520982668|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
144487558|NCT03220737|520982669|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
144487559|NCT03220737|520982670|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
144487560|NCT03220737|520982671|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
144487561|NCT03220737|520982672|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
144487562|NCT03220737|520982666|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
144487563|NCT03220737|520982667|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
144487564|NCT03220737|520982668|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
144487565|NCT03220737|520982669|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
144487566|NCT03220737|520982670|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
144487567|NCT03220737|520982671|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
144487568|NCT03220737|520982672|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
144487569|NCT03220737|520982666|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
144487570|NCT03220737|520982667|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
144487571|NCT03220737|520982668|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
144487572|NCT03220737|520982669|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
144487573|NCT03220737|520982670|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
144487574|NCT03220737|520982671|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
144487575|NCT03220737|520982672|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
144487576|NCT03220737|520982666|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
144487577|NCT03220737|520982667|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
144487578|NCT03220737|520982668|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
144487579|NCT03220737|520982669|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
144487580|NCT03220737|520982670|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
144487581|NCT03220737|520982671|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
144487582|NCT03220737|520982672|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
144487583|NCT03220737|520982666|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
144487584|NCT03220737|520982667|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
144487585|NCT03220737|520982668|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
144487586|NCT03220737|520982669|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
144487587|NCT03220737|520982670|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
144487588|NCT03220737|520982671|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
144487589|NCT03220737|520982672|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
144487590|NCT03220737|520982666|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
144487591|NCT03220737|520982667|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
144487592|NCT03220737|520982668|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
144487593|NCT03220737|520982669|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
144487594|NCT03220737|520982670|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
144487595|NCT03220737|520982671|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
144487596|NCT03220737|520982672|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
144487597|NCT01720797|520982673|FG000|Overall Study|Withdrawal by Subject|3|||
144487598|NCT01720797|520982674|FG001|Overall Study|Withdrawal by Subject|0|||
144487599|NCT00983619|520982681|FG000|Overall Study|Lost to Follow-up|0|||
144487600|NCT00983619|520982682|FG001|Overall Study|Lost to Follow-up|1|||
144487601|NCT00983619|520982683|FG002|Overall Study|Lost to Follow-up|0|||
144487602|NCT00983619|520982684|FG003|Overall Study|Lost to Follow-up|0|||
144487603|NCT00983619|520982685|FG004|Overall Study|Lost to Follow-up|0|||
144487604|NCT00983619|520982686|FG005|Overall Study|Lost to Follow-up|2|||
144487605|NCT00983619|520982687|FG006|Overall Study|Lost to Follow-up|0|||
144487606|NCT00983619|520982688|FG007|Overall Study|Lost to Follow-up|0|||
144487607|NCT00983619|520982689|FG008|Overall Study|Lost to Follow-up|0|||
144487608|NCT00983619|520982690|FG009|Overall Study|Lost to Follow-up|0|||
144487609|NCT00983619|520982691|FG010|Overall Study|Lost to Follow-up|0|||
144487610|NCT00983619|520982692|FG011|Overall Study|Lost to Follow-up|2|||
144487611|NCT00983619|520982681|FG000|Overall Study|Withdrawal by Subject|2|||
144487612|NCT00983619|520982682|FG001|Overall Study|Withdrawal by Subject|1|||
144487613|NCT00983619|520982683|FG002|Overall Study|Withdrawal by Subject|1|||
144487614|NCT00983619|520982684|FG003|Overall Study|Withdrawal by Subject|3|||
144487615|NCT00983619|520982685|FG004|Overall Study|Withdrawal by Subject|1|||
144487616|NCT00983619|520982686|FG005|Overall Study|Withdrawal by Subject|23|||
144487617|NCT00983619|520982687|FG006|Overall Study|Withdrawal by Subject|0|||
144715572|NCT00410410|521813374|FG003|Maintenance Period (MP)|Death|0|||
144487618|NCT00983619|520982688|FG007|Overall Study|Withdrawal by Subject|0|||
144487619|NCT00983619|520982689|FG008|Overall Study|Withdrawal by Subject|0|||
144487620|NCT00983619|520982690|FG009|Overall Study|Withdrawal by Subject|0|||
144487621|NCT00983619|520982691|FG010|Overall Study|Withdrawal by Subject|1|||
144487622|NCT00983619|520982692|FG011|Overall Study|Withdrawal by Subject|1|||
144487623|NCT00983619|520982681|FG000|Overall Study|Death|0|||
144487624|NCT00983619|520982682|FG001|Overall Study|Death|2|||
144487625|NCT00983619|520982683|FG002|Overall Study|Death|2|||
144487626|NCT00983619|520982684|FG003|Overall Study|Death|1|||
144487627|NCT00983619|520982685|FG004|Overall Study|Death|2|||
144487628|NCT00983619|520982686|FG005|Overall Study|Death|30|||
144487629|NCT00983619|520982687|FG006|Overall Study|Death|1|||
144487630|NCT00983619|520982688|FG007|Overall Study|Death|0|||
144487631|NCT00983619|520982689|FG008|Overall Study|Death|1|||
144487632|NCT00983619|520982690|FG009|Overall Study|Death|2|||
144487633|NCT00983619|520982691|FG010|Overall Study|Death|9|||
144487634|NCT00983619|520982692|FG011|Overall Study|Death|8|||
144487635|NCT00983619|520982681|FG000|Overall Study|Other|1|||
144487636|NCT00983619|520982682|FG001|Overall Study|Other|0|||
144487637|NCT00983619|520982683|FG002|Overall Study|Other|0|||
144487638|NCT00983619|520982684|FG003|Overall Study|Other|1|||
144487639|NCT00983619|520982685|FG004|Overall Study|Other|0|||
144487640|NCT00983619|520982686|FG005|Overall Study|Other|12|||
144487641|NCT00983619|520982687|FG006|Overall Study|Other|2|||
144487642|NCT00983619|520982688|FG007|Overall Study|Other|2|||
144487643|NCT00983619|520982689|FG008|Overall Study|Other|0|||
144487644|NCT00983619|520982690|FG009|Overall Study|Other|1|||
144487645|NCT00983619|520982691|FG010|Overall Study|Other|1|||
144487646|NCT00983619|520982692|FG011|Overall Study|Other|0|||
144487647|NCT04827134|520982693|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
144487648|NCT04827134|520982694|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
144487649|NCT04827134|520982695|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
144487650|NCT04827134|520982696|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
144487651|NCT03875911|520982701|FG000|Overall Study|Lost to Follow-up|3|||
144487652|NCT03875911|520982702|FG001|Overall Study|Lost to Follow-up|6|||
144487653|NCT03875911|520982703|FG002|Overall Study|Lost to Follow-up|2|||
144487654|NCT03875911|520982701|FG000|Overall Study|Surgery cancelled|1|||
144487655|NCT03875911|520982702|FG001|Overall Study|Surgery cancelled|0|||
144487656|NCT03875911|520982703|FG002|Overall Study|Surgery cancelled|1|||
144487657|NCT03875911|520982701|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
144487658|NCT03875911|520982702|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
144487659|NCT03875911|520982703|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
144487660|NCT03824938|520982708|FG000|Overall Study|Withdrawal by Subject|2|||
144487661|NCT03824938|520982709|FG001|Overall Study|Withdrawal by Subject|1|||
144487662|NCT03824938|520982710|FG002|Overall Study|Withdrawal by Subject|0|||
144487663|NCT03824938|520982711|FG003|Overall Study|Withdrawal by Subject|2|||
144487664|NCT03824938|520982712|FG004|Overall Study|Withdrawal by Subject|0|||
144487665|NCT03824938|520982713|FG005|Overall Study|Withdrawal by Subject|1|||
144487666|NCT03824938|520982708|FG000|Overall Study|Lost to Follow-up|0|||
144487667|NCT03824938|520982709|FG001|Overall Study|Lost to Follow-up|1|||
144487668|NCT03824938|520982710|FG002|Overall Study|Lost to Follow-up|0|||
144487669|NCT03824938|520982711|FG003|Overall Study|Lost to Follow-up|0|||
144487670|NCT03824938|520982712|FG004|Overall Study|Lost to Follow-up|1|||
144487671|NCT03824938|520982713|FG005|Overall Study|Lost to Follow-up|0|||
144487672|NCT02019602|520982719|FG000|Screening Period|Ineligibility|4|||
144487673|NCT02019602|520982720|FG001|Screening Period|Ineligibility|0|||
144487674|NCT02019602|520982719|FG000|Screening Period|Adverse Event|1|||
144487675|NCT02019602|520982720|FG001|Screening Period|Adverse Event|0|||
144487676|NCT00683449|520982721|FG000|Overall Study|Lost to Follow-up|0|||
144487677|NCT00683449|520982722|FG001|Overall Study|Lost to Follow-up|1|||
144487678|NCT00683449|520982723|FG002|Overall Study|Lost to Follow-up|0|||
144487679|NCT00683449|520982724|FG003|Overall Study|Lost to Follow-up|0|||
144487680|NCT00683449|520982725|FG004|Overall Study|Lost to Follow-up|0|||
144487681|NCT01058863|520982726|FG000|Overall Study|Lost to Follow-up|1|||
144487682|NCT01058863|520982726|FG000|Overall Study|Withdrawal by Subject|1|||
144487683|NCT01058863|520982726|FG000|Overall Study|Sponsor requested withdrawal|1|||
144487684|NCT01058863|520982726|FG000|Overall Study|Randomized in error|1|||
144487685|NCT00681187|520982727|FG000|Overall Study|Withdrawal by Subject|1|||
144487686|NCT00681187|520982728|FG001|Overall Study|Withdrawal by Subject|0|||
144487687|NCT00681187|520982727|FG000|Overall Study|Death|0|||
144487688|NCT00681187|520982728|FG001|Overall Study|Death|1|||
144487689|NCT00681187|520982727|FG000|Overall Study|Adverse Event|0|||
144487690|NCT00681187|520982728|FG001|Overall Study|Adverse Event|1|||
144487691|NCT03653416|520982729|FG000|Overall Study|Protocol Violation|6|||
144487692|NCT03653416|520982730|FG001|Overall Study|Protocol Violation|1|||
144487693|NCT02788006|520982734|FG000|Overall Study|Patient not treated|1|||
144487694|NCT02269943|520982737|FG000|Treatment Period|Death|0|||
144487695|NCT02269943|520982738|FG001|Treatment Period|Death|1|||
144487696|NCT02269943|520982737|FG000|Treatment Period|Adverse Event|1|||
144487697|NCT02269943|520982738|FG001|Treatment Period|Adverse Event|10|||
144487698|NCT02269943|520982737|FG000|Treatment Period|Progressive Disease|5|||
144487699|NCT02269943|520982738|FG001|Treatment Period|Progressive Disease|17|||
144487700|NCT02269943|520982737|FG000|Treatment Period|Symptomatic Deterioration|0|||
144487701|NCT02269943|520982738|FG001|Treatment Period|Symptomatic Deterioration|2|||
144487702|NCT02269943|520982737|FG000|Follow-Up Survival Period|Death|3|||
144487703|NCT02269943|520982738|FG001|Follow-Up Survival Period|Death|16|||
144487704|NCT02269943|520982737|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
144487705|NCT02269943|520982738|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
144487706|NCT02269943|520982737|FG000|Follow-Up Survival Period|Alive|2|||
144487707|NCT02269943|520982738|FG001|Follow-Up Survival Period|Alive|8|||
144487708|NCT03541642|520982739|FG000|Overall Study|Withdrawal by Subject|1|||
144487709|NCT03541642|520982740|FG001|Overall Study|Withdrawal by Subject|2|||
144487710|NCT03541642|520982739|FG000|Overall Study|Lost to Follow-up|16|||
144487711|NCT03541642|520982740|FG001|Overall Study|Lost to Follow-up|12|||
144487712|NCT03541642|520982739|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
144487713|NCT03541642|520982740|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
144487714|NCT03050398|520982743|FG000|Overall Study|Study terminated by sponsor|8|||
144487715|NCT03055832|520982744|FG000|Week 2|Withdrawal by Subject|1|||
144487716|NCT03055832|520982745|FG001|Week 2|Withdrawal by Subject|0|||
144487717|NCT04242875|520982746|FG000|Overall Study|Adverse Event|2|||
144487718|NCT02397460|520982747|FG000|Treatment Period 2|Adverse Event|0|||
144487719|NCT02397460|520982748|FG001|Treatment Period 2|Adverse Event|0|||
144487720|NCT02397460|520982749|FG002|Treatment Period 2|Adverse Event|0|||
144487721|NCT02397460|520982750|FG003|Treatment Period 2|Adverse Event|0|||
144487722|NCT02397460|520982751|FG004|Treatment Period 2|Adverse Event|0|||
144487723|NCT02397460|520982752|FG005|Treatment Period 2|Adverse Event|0|||
144487724|NCT02397460|520982753|FG006|Treatment Period 2|Adverse Event|0|||
144487725|NCT02397460|520982754|FG007|Treatment Period 2|Adverse Event|1|||
144487726|NCT02397460|520982747|FG000|Treatment Period 4|Adverse Event|0|||
144487727|NCT02397460|520982748|FG001|Treatment Period 4|Adverse Event|1|||
144487728|NCT02397460|520982749|FG002|Treatment Period 4|Adverse Event|0|||
144487729|NCT02397460|520982750|FG003|Treatment Period 4|Adverse Event|0|||
144487730|NCT02397460|520982751|FG004|Treatment Period 4|Adverse Event|0|||
144487731|NCT02397460|520982752|FG005|Treatment Period 4|Adverse Event|0|||
144487732|NCT02397460|520982753|FG006|Treatment Period 4|Adverse Event|0|||
144487733|NCT02397460|520982754|FG007|Treatment Period 4|Adverse Event|0|||
144487734|NCT02397460|520982747|FG000|Treatment Period 4|Physician Decision|0|||
144487735|NCT02397460|520982748|FG001|Treatment Period 4|Physician Decision|0|||
144487736|NCT02397460|520982749|FG002|Treatment Period 4|Physician Decision|0|||
144487737|NCT02397460|520982750|FG003|Treatment Period 4|Physician Decision|0|||
144487738|NCT02397460|520982751|FG004|Treatment Period 4|Physician Decision|1|||
144487739|NCT02397460|520982752|FG005|Treatment Period 4|Physician Decision|0|||
144487740|NCT02397460|520982753|FG006|Treatment Period 4|Physician Decision|0|||
144487741|NCT02397460|520982754|FG007|Treatment Period 4|Physician Decision|0|||
144487742|NCT02285595|520982763|FG000|Overall Study|Lost to Follow-up|14|||
144487743|NCT02285595|520982763|FG000|Overall Study|Withdrawal by Subject|1|||
144487744|NCT01960790|520982764|FG000|Overall Study|Survey forms could not be recovered|3|||
144487745|NCT01960790|520982764|FG000|Overall Study|Treat with Humira outside survey period|3|||
144487746|NCT01960790|520982764|FG000|Overall Study|Transferred to another hospital|4|||
144487747|NCT01960790|520982764|FG000|Overall Study|Unevaluable for safety|1|||
144487748|NCT00544544|520982765|FG000|Overall Study|Withdrawal by Subject|1|||
144487749|NCT00544544|520982765|FG000|Overall Study|Adverse Event|1|||
144487750|NCT00544544|520982765|FG000|Overall Study|Lost to Follow-up|1|||
144487751|NCT02711995|520984330|FG000|Washout (90 Days)|Conflicting medication|1|||
144487752|NCT00322868|520984331|FG000|Overall Study|disease progression|1|||
144487753|NCT03615482|520984332|FG000|Overall Study|Death|1|||
144487754|NCT03615482|520984333|FG001|Overall Study|Death|0|||
144487755|NCT03615482|520984332|FG000|Overall Study|Lost to Follow-up|7|||
144487756|NCT03615482|520984333|FG001|Overall Study|Lost to Follow-up|7|||
144487757|NCT03615482|520984332|FG000|Overall Study|Physician Decision|2|||
144487758|NCT03615482|520984333|FG001|Overall Study|Physician Decision|3|||
144487759|NCT03615482|520984332|FG000|Overall Study|Withdrawal by Subject|7|||
144487760|NCT03615482|520984333|FG001|Overall Study|Withdrawal by Subject|7|||
144487761|NCT01852162|520984334|FG000|Overall Study|Adverse Event|1|||
144487762|NCT01852162|520984335|FG001|Overall Study|Adverse Event|0|||
144487763|NCT01852162|520984334|FG000|Overall Study|Withdrawal by Subject|3|||
144487764|NCT01852162|520984335|FG001|Overall Study|Withdrawal by Subject|1|||
144487765|NCT02955277|520984336|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
144487766|NCT02955277|520984337|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
144487767|NCT02955277|520984336|FG000|Post to Follow-up|Lost to Follow-up|8|||
144487768|NCT02955277|520984337|FG001|Post to Follow-up|Lost to Follow-up|11|||
144487769|NCT00163215|520984345|FG000|Overall Study|Lack of Efficacy|3|||
144487770|NCT00163215|520984345|FG000|Overall Study|Withdrawal by Subject|5|||
144487771|NCT00163215|520984345|FG000|Overall Study|Other|7|||
144487772|NCT01115998|520984347|FG000|Overall Study|Lost to Follow-up|6|||
144487773|NCT01115998|520984348|FG001|Overall Study|Lost to Follow-up|6|||
144487774|NCT02819479|520984349|FG000|Overall Study|Adverse Event|2|||
144487775|NCT01646320|520984354|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
144487776|NCT01646320|520984355|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
144487777|NCT01646320|520984354|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
144487778|NCT01646320|520984355|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
144487779|NCT01646320|520984354|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
144487780|NCT01646320|520984355|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
144487781|NCT01646320|520984354|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
144487782|NCT01646320|520984355|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
144487783|NCT01646320|520984354|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
144487784|NCT01646320|520984355|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
144487785|NCT01646320|520984354|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
144487786|NCT01646320|520984355|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
144487787|NCT01646320|520984354|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
144487788|NCT01646320|520984355|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
144487789|NCT01646320|520984354|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
144487790|NCT01646320|520984355|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
144487791|NCT01646320|520984354|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
144487792|NCT01646320|520984355|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
144487793|NCT01646320|520984354|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
144487794|NCT01646320|520984355|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
144487795|NCT01646320|520984354|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
144487796|NCT01646320|520984355|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
144487797|NCT02485353|520984356|FG000|Overall Study|Death|1|||
144487798|NCT02485353|520984356|FG000|Overall Study|Disease Progression|1|||
144487799|NCT00839917|520984357|FG000|Overall Study|Lost to Follow-up|1|||
144487800|NCT00839917|520984358|FG001|Overall Study|Lost to Follow-up|0|||
144487801|NCT00839917|520984357|FG000|Overall Study|Did not receive vaccine|0|||
144487802|NCT00839917|520984358|FG001|Overall Study|Did not receive vaccine|1|||
144487803|NCT00724061|520984359|FG000|Dose Escalation Phase|Adverse Event|2|||
144487804|NCT00724061|520984359|FG000|Dose Escalation Phase|Disease Progression|3|||
144487805|NCT00594932|520984364|FG000|First 3 Months|Withdrawal by Subject|1|||
144487806|NCT00594932|520984365|FG001|First 3 Months|Withdrawal by Subject|3|||
144487807|NCT00594932|520984364|FG000|Final 3 Months|Withdrawal by Subject|4|||
144487808|NCT00594932|520984365|FG001|Final 3 Months|Withdrawal by Subject|3|||
144487809|NCT01094171|520984366|FG000|Overall Study|Lost to Follow-up|2|||
144487810|NCT01094171|520984366|FG000|Overall Study|Informed consent withdrawal|4|||
144487811|NCT01094171|520984366|FG000|Overall Study|Migration from the study area|3|||
144487812|NCT01094171|520984366|FG000|Overall Study|Other|1|||
144487813|NCT01536145|520984367|FG000|Overall Study|Progressive disease|3|||
144487814|NCT01536145|520984368|FG001|Overall Study|Progressive disease|4|||
144487815|NCT01536145|520984369|FG002|Overall Study|Progressive disease|1|||
144487816|NCT01536145|520984370|FG003|Overall Study|Progressive disease|2|||
144487817|NCT01536145|520984371|FG004|Overall Study|Progressive disease|1|||
144487818|NCT01536145|520984372|FG005|Overall Study|Progressive disease|2|||
144487819|NCT01536145|520984373|FG006|Overall Study|Progressive disease|1|||
144487820|NCT01536145|520984374|FG007|Overall Study|Progressive disease|2|||
144487821|NCT01536145|520984375|FG008|Overall Study|Progressive disease|1|||
144487822|NCT01536145|520984376|FG009|Overall Study|Progressive disease|3|||
144487823|NCT01536145|520984377|FG010|Overall Study|Progressive disease|3|||
144487824|NCT01536145|520984367|FG000|Overall Study|Withdrawal by Subject|0|||
144487825|NCT01536145|520984368|FG001|Overall Study|Withdrawal by Subject|0|||
144487826|NCT01536145|520984369|FG002|Overall Study|Withdrawal by Subject|1|||
144487827|NCT01536145|520984370|FG003|Overall Study|Withdrawal by Subject|0|||
144487828|NCT01536145|520984371|FG004|Overall Study|Withdrawal by Subject|0|||
144487829|NCT01536145|520984372|FG005|Overall Study|Withdrawal by Subject|1|||
144487830|NCT01536145|520984373|FG006|Overall Study|Withdrawal by Subject|0|||
144487831|NCT01536145|520984374|FG007|Overall Study|Withdrawal by Subject|0|||
144487832|NCT01536145|520984375|FG008|Overall Study|Withdrawal by Subject|2|||
144487833|NCT01536145|520984376|FG009|Overall Study|Withdrawal by Subject|0|||
144487834|NCT01536145|520984377|FG010|Overall Study|Withdrawal by Subject|2|||
144487835|NCT01536145|520984367|FG000|Overall Study|Other|0|||
144487836|NCT01536145|520984368|FG001|Overall Study|Other|0|||
144487837|NCT01536145|520984369|FG002|Overall Study|Other|0|||
144487838|NCT01536145|520984370|FG003|Overall Study|Other|0|||
144487839|NCT01536145|520984371|FG004|Overall Study|Other|1|||
144487840|NCT01536145|520984372|FG005|Overall Study|Other|0|||
144487841|NCT01536145|520984373|FG006|Overall Study|Other|0|||
144487842|NCT01536145|520984374|FG007|Overall Study|Other|0|||
144487843|NCT01536145|520984375|FG008|Overall Study|Other|0|||
144487844|NCT01536145|520984376|FG009|Overall Study|Other|3|||
144487845|NCT01536145|520984377|FG010|Overall Study|Other|2|||
144487846|NCT01536145|520984367|FG000|Overall Study|Death|0|||
144487847|NCT01536145|520984368|FG001|Overall Study|Death|0|||
144487848|NCT01536145|520984369|FG002|Overall Study|Death|0|||
144487849|NCT01536145|520984370|FG003|Overall Study|Death|0|||
144487850|NCT01536145|520984371|FG004|Overall Study|Death|0|||
144487851|NCT01536145|520984372|FG005|Overall Study|Death|0|||
144487852|NCT01536145|520984373|FG006|Overall Study|Death|1|||
144487853|NCT01536145|520984374|FG007|Overall Study|Death|0|||
144487854|NCT01536145|520984375|FG008|Overall Study|Death|0|||
144487855|NCT01536145|520984376|FG009|Overall Study|Death|0|||
144487856|NCT01536145|520984377|FG010|Overall Study|Death|0|||
144487857|NCT01536145|520984367|FG000|Overall Study|Adverse Event|0|||
144487858|NCT01536145|520984368|FG001|Overall Study|Adverse Event|0|||
144487859|NCT01536145|520984369|FG002|Overall Study|Adverse Event|0|||
144487860|NCT01536145|520984370|FG003|Overall Study|Adverse Event|0|||
144487861|NCT01536145|520984371|FG004|Overall Study|Adverse Event|0|||
144487862|NCT01536145|520984372|FG005|Overall Study|Adverse Event|0|||
144487863|NCT01536145|520984373|FG006|Overall Study|Adverse Event|0|||
144487864|NCT01536145|520984374|FG007|Overall Study|Adverse Event|2|||
144487865|NCT01536145|520984375|FG008|Overall Study|Adverse Event|0|||
144487866|NCT01536145|520984376|FG009|Overall Study|Adverse Event|0|||
144487867|NCT01536145|520984377|FG010|Overall Study|Adverse Event|3|||
144487868|NCT00088205|520984380|FG000|Overall Study|Adverse Event|4|||
144487869|NCT00088205|520984380|FG000|Overall Study|Progressive Disease|51|||
144487870|NCT00088205|520984380|FG000|Overall Study|Physician Decision|1|||
144487871|NCT00088205|520984380|FG000|Overall Study|Death Due to Study Disease|4|||
144487872|NCT05199233|520984381|FG000|Overall Study|Lack of Efficacy|1|||
144487873|NCT01364727|520984386|FG000|Overall Study|Not Eligible|2|||
144487874|NCT00688259|520984387|FG000|Overall Study|Lost to Follow-up|2|||
144487875|NCT00688259|520984388|FG001|Overall Study|Lost to Follow-up|4|||
144487876|NCT00688259|520984387|FG000|Overall Study|Physician Decision|1|||
144487877|NCT00688259|520984388|FG001|Overall Study|Physician Decision|0|||
144487878|NCT00688259|520984387|FG000|Overall Study|Withdrawal by Subject|2|||
144487879|NCT00688259|520984388|FG001|Overall Study|Withdrawal by Subject|0|||
144487880|NCT00688259|520984387|FG000|Overall Study|Declined Interview|2|||
144487881|NCT00688259|520984388|FG001|Overall Study|Declined Interview|3|||
144487882|NCT00688259|520984387|FG000|Overall Study|Hospitalized at Follow-up|0|||
144487883|NCT00688259|520984388|FG001|Overall Study|Hospitalized at Follow-up|1|||
144487884|NCT01676220|520984390|FG000|Overall Study|Randomized But Not Treated|4|||
144487885|NCT01676220|520984391|FG001|Overall Study|Randomized But Not Treated|1|||
144487886|NCT01676220|520984390|FG000|Overall Study|Adverse Event|10|||
144487887|NCT01676220|520984391|FG001|Overall Study|Adverse Event|8|||
144487888|NCT01676220|520984390|FG000|Overall Study|Lack of Efficacy|2|||
144487889|NCT01676220|520984391|FG001|Overall Study|Lack of Efficacy|5|||
144487890|NCT01676220|520984390|FG000|Overall Study|Protocol Violation|11|||
144487891|NCT01676220|520984391|FG001|Overall Study|Protocol Violation|12|||
144487892|NCT01676220|520984390|FG000|Overall Study|Received Rescue Therapy|14|||
144487893|NCT01676220|520984391|FG001|Overall Study|Received Rescue Therapy|22|||
144487894|NCT01676220|520984390|FG000|Overall Study|Personal Reason|34|||
144487895|NCT01676220|520984391|FG001|Overall Study|Personal Reason|45|||
144487896|NCT01676220|520984390|FG000|Overall Study|Lost to Follow-up|11|||
144487897|NCT01676220|520984391|FG001|Overall Study|Lost to Follow-up|18|||
144487898|NCT01676220|520984390|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
144487899|NCT01676220|520984391|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
144487900|NCT01676220|520984390|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
144487901|NCT01676220|520984391|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
144487902|NCT01676220|520984390|FG000|Overall Study|Perceived Lack of Efficacy|3|||
144487903|NCT01676220|520984391|FG001|Overall Study|Perceived Lack of Efficacy|1|||
144487904|NCT01676220|520984390|FG000|Overall Study|Non Serious Hypoglycemia|2|||
144487905|NCT01676220|520984391|FG001|Overall Study|Non Serious Hypoglycemia|0|||
144487906|NCT01676220|520984390|FG000|Overall Study|No More Need of Insulin|1|||
144487907|NCT01676220|520984391|FG001|Overall Study|No More Need of Insulin|0|||
144487908|NCT02213055|520984395|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
144487909|NCT02213055|520984396|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
144487910|NCT02213055|520984395|FG000|Overall Study|Protocol was not Followed during Study|1|||
144487911|NCT02213055|520984396|FG001|Overall Study|Protocol was not Followed during Study|0|||
144487912|NCT02213055|520984395|FG000|Overall Study|Documentation Issue at Enrollment|1|||
144487913|NCT02213055|520984396|FG001|Overall Study|Documentation Issue at Enrollment|0|||
144487914|NCT02213055|520984395|FG000|Overall Study|Documentation Issue during Study|10|||
144487915|NCT02213055|520984396|FG001|Overall Study|Documentation Issue during Study|0|||
144487916|NCT02213055|520984395|FG000|Overall Study|Did not have Live Lice|8|||
144487917|NCT02213055|520984396|FG001|Overall Study|Did not have Live Lice|0|||
144487918|NCT02213055|520984395|FG000|Overall Study|Had another Treatment during the Study|3|||
144487919|NCT02213055|520984396|FG001|Overall Study|Had another Treatment during the Study|0|||
144487920|NCT02213055|520984395|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
144487921|NCT02213055|520984396|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
144487922|NCT02213055|520984395|FG000|Overall Study|Did not Return to School|5|||
144487923|NCT02213055|520984396|FG001|Overall Study|Did not Return to School|0|||
144487924|NCT00231894|520984397|FG000|Overall Study|Withdrawal by Subject|1|||
144487925|NCT00231894|520984398|FG001|Overall Study|Withdrawal by Subject|1|||
144487926|NCT02025205|520984400|FG000|Overall Study|Withdrawal by Subject|1|||
144487927|NCT02025205|520984401|FG001|Overall Study|Withdrawal by Subject|1|||
144487928|NCT02025205|520984400|FG000|Overall Study|Protocol Violation|2|||
144487929|NCT02025205|520984401|FG001|Overall Study|Protocol Violation|1|||
144487930|NCT02025205|520984400|FG000|Overall Study|Death|0|||
144487931|NCT02025205|520984401|FG001|Overall Study|Death|1|||
144487932|NCT01767129|520984402|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
144487933|NCT01767129|520984403|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
144487934|NCT01024751|520984404|FG000|Enrolled Participants|Ineligible at baseline|3|||
144487935|NCT01024751|520984405|FG001|Enrolled Participants|Ineligible at baseline|4|||
144487936|NCT01024751|520984404|FG000|Eligible Participants|Withdrawal by Subject|0|||
144487937|NCT01024751|520984405|FG001|Eligible Participants|Withdrawal by Subject|1|||
144487938|NCT01024751|520984404|FG000|Eligible Participants|Lost to Follow-up|0|||
144487939|NCT01024751|520984405|FG001|Eligible Participants|Lost to Follow-up|1|||
144487940|NCT01024751|520984404|FG000|Eligible Participants|Ineligible|0|||
144487941|NCT01024751|520984405|FG001|Eligible Participants|Ineligible|1|||
144487942|NCT03246672|520984407|FG000|Overall Study|Lost to Follow-up|2|||
144487943|NCT02500316|520984408|FG000|Overall Study|Adverse Event|3|||
144487944|NCT02500316|520984408|FG000|Overall Study|Lost to Follow-up|2|||
144487945|NCT02500316|520984408|FG000|Overall Study|Protocol Violation|1|||
144487946|NCT02500316|520984408|FG000|Overall Study|Withdrawal by Subject|15|||
144487947|NCT02500316|520984408|FG000|Overall Study|Final height achieved|5|||
144487948|NCT02500316|520984408|FG000|Overall Study|Due to war activity|1|||
144487949|NCT01406717|520984409|FG000|Overall Study|Subject non-compliance|4|||
144487950|NCT01406717|520984410|FG001|Overall Study|Subject non-compliance|3|||
144487951|NCT01406717|520984409|FG000|Overall Study|Protocol Violation|5|||
144487952|NCT01406717|520984410|FG001|Overall Study|Protocol Violation|1|||
144487953|NCT01406717|520984409|FG000|Overall Study|Lost to Follow-up|14|||
144487954|NCT01406717|520984410|FG001|Overall Study|Lost to Follow-up|8|||
144487955|NCT01406717|520984409|FG000|Overall Study|Withdrawal by Subject|19|||
144487956|NCT01406717|520984410|FG001|Overall Study|Withdrawal by Subject|15|||
144487957|NCT01406717|520984409|FG000|Overall Study|Adverse Event|1|||
144487958|NCT01406717|520984410|FG001|Overall Study|Adverse Event|2|||
144487959|NCT01406717|520984409|FG000|Overall Study|Lack of Efficacy|0|||
144487960|NCT01406717|520984410|FG001|Overall Study|Lack of Efficacy|1|||
144487961|NCT01406717|520984409|FG000|Overall Study|Non-completion of visit activity|0|||
144487962|NCT01406717|520984410|FG001|Overall Study|Non-completion of visit activity|1|||
144487963|NCT03257995|520984411|FG000|Overall Study|Adverse Event|0|||
144487964|NCT03257995|520984412|FG001|Overall Study|Adverse Event|1|||
144487965|NCT03257995|520984413|FG002|Overall Study|Adverse Event|0|||
144487966|NCT03257995|520984414|FG003|Overall Study|Adverse Event|0|||
144487967|NCT03257995|520984415|FG004|Overall Study|Adverse Event|0|||
144487968|NCT03257995|520984416|FG005|Overall Study|Adverse Event|0|||
144487969|NCT03257995|520984411|FG000|Overall Study|Protocol deviation|0|||
144487970|NCT03257995|520984412|FG001|Overall Study|Protocol deviation|0|||
144487971|NCT03257995|520984413|FG002|Overall Study|Protocol deviation|0|||
144487972|NCT03257995|520984414|FG003|Overall Study|Protocol deviation|0|||
144487973|NCT03257995|520984415|FG004|Overall Study|Protocol deviation|0|||
144487974|NCT03257995|520984416|FG005|Overall Study|Protocol deviation|2|||
144487975|NCT01987830|520984423|FG000|Overall Study|Never received baseline scan|1|||
144487976|NCT00057811|520984432|FG000|Overall Study|Lack of Efficacy|1|||
144487977|NCT00057811|520984433|FG001|Overall Study|Lack of Efficacy|4|||
144487978|NCT00057811|520984432|FG000|Overall Study|Physician Decision|1|||
144487979|NCT00057811|520984433|FG001|Overall Study|Physician Decision|0|||
144487980|NCT00057811|520984432|FG000|Overall Study|Withdrawal by Subject|3|||
144487981|NCT00057811|520984433|FG001|Overall Study|Withdrawal by Subject|4|||
144487982|NCT00057811|520984432|FG000|Overall Study|Ineligible|4|||
144487983|NCT00057811|520984433|FG001|Overall Study|Ineligible|2|||
144487984|NCT00057811|520984432|FG000|Overall Study|Inevaluable|1|||
144487985|NCT00057811|520984433|FG001|Overall Study|Inevaluable|2|||
144487986|NCT00556374|520984434|FG000|Overall Study|Withdrawal by Subject|235|||
144487987|NCT00556374|520984435|FG001|Overall Study|Withdrawal by Subject|205|||
144487988|NCT00556374|520984434|FG000|Overall Study|Death|158|||
144487989|NCT00556374|520984435|FG001|Overall Study|Death|127|||
144487990|NCT00556374|520984434|FG000|Overall Study|Lost to Follow-up|24|||
144487991|NCT00556374|520984435|FG001|Overall Study|Lost to Follow-up|17|||
144487992|NCT00556374|520984434|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
144487993|NCT00556374|520984435|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
144487994|NCT02036515|520984436|FG000|Overall Study|Adverse Event|1|||
144487995|NCT02036515|520984437|FG001|Overall Study|Adverse Event|1|||
144487996|NCT02036515|520984438|FG002|Overall Study|Adverse Event|2|||
144487997|NCT02036515|520984436|FG000|Overall Study|Lost to Follow-up|0|||
144487998|NCT02036515|520984437|FG001|Overall Study|Lost to Follow-up|2|||
144487999|NCT02036515|520984438|FG002|Overall Study|Lost to Follow-up|0|||
144488000|NCT02036515|520984436|FG000|Overall Study|Non-compliance with study drug|0|||
144488001|NCT02036515|520984437|FG001|Overall Study|Non-compliance with study drug|0|||
144488002|NCT02036515|520984438|FG002|Overall Study|Non-compliance with study drug|2|||
144488003|NCT02036515|520984436|FG000|Overall Study|Screen failure|0|||
144488004|NCT02036515|520984437|FG001|Overall Study|Screen failure|2|||
144488005|NCT02036515|520984438|FG002|Overall Study|Screen failure|0|||
144488006|NCT02036515|520984436|FG000|Overall Study|Withdrawal by Subject|4|||
144488007|NCT02036515|520984437|FG001|Overall Study|Withdrawal by Subject|7|||
144488008|NCT02036515|520984438|FG002|Overall Study|Withdrawal by Subject|9|||
144488009|NCT02036515|520984436|FG000|Overall Study|Hyperglycemia|0|||
144488010|NCT02036515|520984437|FG001|Overall Study|Hyperglycemia|0|||
144488011|NCT02036515|520984438|FG002|Overall Study|Hyperglycemia|1|||
144488012|NCT02218489|520984441|FG000|Overall Study|Withdrawal by Subject|4|||
144488013|NCT02218489|520984442|FG001|Overall Study|Withdrawal by Subject|3|||
144488014|NCT02218489|520984441|FG000|Overall Study|Lost to Follow-up|1|||
144488015|NCT02218489|520984442|FG001|Overall Study|Lost to Follow-up|0|||
144488016|NCT02404493|520984443|FG000|Overall Study|Adverse Event|1|||
144488017|NCT02404493|520984444|FG001|Overall Study|Adverse Event|1|||
144488018|NCT01700348|520984445|FG000|Overall Study|Withdrawal by Subject|22|||
144488019|NCT01700348|520984445|FG000|Overall Study|Lost to Follow-up|1|||
144488020|NCT02388074|520984446|FG000|Overall Study|Lost in Transit|2|||
144488021|NCT02388074|520984446|FG000|Overall Study|Sample Not Returned|1|||
144488022|NCT03958630|520984451|FG000|Overall Study|Withdrawal by Subject|0|||
144488023|NCT03958630|520984452|FG001|Overall Study|Withdrawal by Subject|0|||
144488024|NCT03958630|520984453|FG002|Overall Study|Withdrawal by Subject|1|||
144488025|NCT03958630|520984451|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
144488026|NCT03958630|520984452|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
144488027|NCT03958630|520984453|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
144488028|NCT01254890|520984456|FG000|Overall Study|Ineligible|0|||
144488029|NCT01254890|520984457|FG001|Overall Study|Ineligible|3|||
144488030|NCT01254890|520984456|FG000|Overall Study|Withdrawal by Subject|1|||
144488031|NCT01254890|520984457|FG001|Overall Study|Withdrawal by Subject|2|||
144488032|NCT01254890|520984456|FG000|Overall Study|Disease Progression|0|||
144488033|NCT01254890|520984457|FG001|Overall Study|Disease Progression|5|||
144488034|NCT04157686|520984460|FG000|Overall Study|Adverse Event|1|||
144488035|NCT04157686|520984461|FG001|Overall Study|Adverse Event|0|||
144488036|NCT04157686|520984462|FG002|Overall Study|Adverse Event|1|||
144488037|NCT04157686|520984463|FG003|Overall Study|Adverse Event|0|||
144488038|NCT04157686|520984464|FG004|Overall Study|Adverse Event|1|||
144488039|NCT04157686|520984465|FG005|Overall Study|Adverse Event|0|||
144488040|NCT04157686|520984466|FG006|Overall Study|Adverse Event|0|||
144488041|NCT04157686|520984467|FG007|Overall Study|Adverse Event|0|||
144488042|NCT04157686|520984460|FG000|Overall Study|Pregnancy|0|||
144488043|NCT04157686|520984461|FG001|Overall Study|Pregnancy|1|||
144488044|NCT04157686|520984462|FG002|Overall Study|Pregnancy|3|||
144488045|NCT04157686|520984463|FG003|Overall Study|Pregnancy|0|||
144488046|NCT04157686|520984464|FG004|Overall Study|Pregnancy|0|||
144488047|NCT04157686|520984465|FG005|Overall Study|Pregnancy|0|||
144488048|NCT04157686|520984466|FG006|Overall Study|Pregnancy|3|||
144488049|NCT04157686|520984467|FG007|Overall Study|Pregnancy|0|||
144488050|NCT04157686|520984460|FG000|Overall Study|Lost to Follow-up|1|||
144488051|NCT04157686|520984461|FG001|Overall Study|Lost to Follow-up|2|||
144488052|NCT04157686|520984462|FG002|Overall Study|Lost to Follow-up|8|||
144488053|NCT04157686|520984463|FG003|Overall Study|Lost to Follow-up|6|||
144488054|NCT04157686|520984464|FG004|Overall Study|Lost to Follow-up|6|||
144488055|NCT04157686|520984465|FG005|Overall Study|Lost to Follow-up|3|||
144488056|NCT04157686|520984466|FG006|Overall Study|Lost to Follow-up|7|||
144488057|NCT04157686|520984467|FG007|Overall Study|Lost to Follow-up|9|||
144488058|NCT04157686|520984460|FG000|Overall Study|Lack of Efficacy|0|||
144488059|NCT04157686|520984461|FG001|Overall Study|Lack of Efficacy|0|||
144488060|NCT04157686|520984462|FG002|Overall Study|Lack of Efficacy|0|||
144488061|NCT04157686|520984463|FG003|Overall Study|Lack of Efficacy|0|||
144488062|NCT04157686|520984464|FG004|Overall Study|Lack of Efficacy|0|||
144488063|NCT04157686|520984465|FG005|Overall Study|Lack of Efficacy|2|||
144488064|NCT04157686|520984466|FG006|Overall Study|Lack of Efficacy|0|||
144488065|NCT04157686|520984467|FG007|Overall Study|Lack of Efficacy|1|||
144488066|NCT04157686|520984460|FG000|Overall Study|Withdrawal by Subject|10|||
144488067|NCT04157686|520984461|FG001|Overall Study|Withdrawal by Subject|10|||
144488068|NCT04157686|520984462|FG002|Overall Study|Withdrawal by Subject|12|||
144488069|NCT04157686|520984463|FG003|Overall Study|Withdrawal by Subject|20|||
144488070|NCT04157686|520984464|FG004|Overall Study|Withdrawal by Subject|12|||
144488071|NCT04157686|520984465|FG005|Overall Study|Withdrawal by Subject|11|||
144488072|NCT04157686|520984466|FG006|Overall Study|Withdrawal by Subject|18|||
144488073|NCT04157686|520984467|FG007|Overall Study|Withdrawal by Subject|24|||
144488074|NCT04157686|520984460|FG000|Overall Study|Physician Decision|0|||
144488075|NCT04157686|520984461|FG001|Overall Study|Physician Decision|0|||
144488076|NCT04157686|520984462|FG002|Overall Study|Physician Decision|1|||
144488077|NCT04157686|520984463|FG003|Overall Study|Physician Decision|0|||
144488078|NCT04157686|520984464|FG004|Overall Study|Physician Decision|1|||
144488079|NCT04157686|520984465|FG005|Overall Study|Physician Decision|0|||
144488080|NCT04157686|520984466|FG006|Overall Study|Physician Decision|3|||
144488081|NCT04157686|520984467|FG007|Overall Study|Physician Decision|0|||
144488082|NCT04157686|520984460|FG000|Overall Study|Death|0|||
144488083|NCT04157686|520984461|FG001|Overall Study|Death|0|||
144488084|NCT04157686|520984462|FG002|Overall Study|Death|0|||
144488085|NCT04157686|520984463|FG003|Overall Study|Death|2|||
144488086|NCT04157686|520984464|FG004|Overall Study|Death|0|||
144488087|NCT04157686|520984465|FG005|Overall Study|Death|0|||
144488088|NCT04157686|520984466|FG006|Overall Study|Death|0|||
144488089|NCT04157686|520984467|FG007|Overall Study|Death|0|||
144488090|NCT04157686|520984460|FG000|Overall Study|Protocol Violation|0|||
144488091|NCT04157686|520984461|FG001|Overall Study|Protocol Violation|0|||
144488092|NCT04157686|520984462|FG002|Overall Study|Protocol Violation|0|||
144488093|NCT04157686|520984463|FG003|Overall Study|Protocol Violation|0|||
144488094|NCT04157686|520984464|FG004|Overall Study|Protocol Violation|1|||
144488095|NCT04157686|520984465|FG005|Overall Study|Protocol Violation|0|||
144488096|NCT04157686|520984466|FG006|Overall Study|Protocol Violation|0|||
144488097|NCT04157686|520984467|FG007|Overall Study|Protocol Violation|0|||
144488098|NCT04157686|520984460|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
144488099|NCT04157686|520984461|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
144488100|NCT04157686|520984462|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
144488101|NCT04157686|520984463|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
144488102|NCT04157686|520984464|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
144488103|NCT04157686|520984465|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
144488104|NCT04157686|520984466|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
144488105|NCT04157686|520984467|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
144488106|NCT03872388|520984468|FG000|Overall Study|Disease Progression|0|||
144488107|NCT03872388|520984469|FG001|Overall Study|Disease Progression|0|||
144488108|NCT03872388|520984470|FG002|Overall Study|Disease Progression|0|||
144488109|NCT03872388|520984471|FG003|Overall Study|Disease Progression|0|||
144488110|NCT03872388|520984472|FG004|Overall Study|Disease Progression|0|||
144488111|NCT03872388|520984473|FG005|Overall Study|Disease Progression|0|||
144488112|NCT03872388|520984474|FG006|Overall Study|Disease Progression|1|||
144488113|NCT03872388|520984475|FG007|Overall Study|Disease Progression|1|||
144488114|NCT04423393|520986456|FG000|Overall Study|Withdrawal by Subject|0|||
144488115|NCT04423393|520986457|FG001|Overall Study|Withdrawal by Subject|0|||
144488116|NCT04423393|520986458|FG002|Overall Study|Withdrawal by Subject|0|||
144488117|NCT04423393|520986459|FG003|Overall Study|Withdrawal by Subject|0|||
144488118|NCT04423393|520986460|FG004|Overall Study|Withdrawal by Subject|0|||
144488119|NCT04423393|520986461|FG005|Overall Study|Withdrawal by Subject|1|||
144488120|NCT04423393|520986462|FG006|Overall Study|Withdrawal by Subject|0|||
144488121|NCT04423393|520986463|FG007|Overall Study|Withdrawal by Subject|0|||
144488122|NCT04423393|520986464|FG008|Overall Study|Withdrawal by Subject|0|||
144488123|NCT04423393|520986465|FG009|Overall Study|Withdrawal by Subject|0|||
144488124|NCT04423393|520986466|FG010|Overall Study|Withdrawal by Subject|0|||
144488125|NCT04423393|520986467|FG011|Overall Study|Withdrawal by Subject|0|||
144488126|NCT04423393|520986468|FG012|Overall Study|Withdrawal by Subject|0|||
144488127|NCT04423393|520986469|FG013|Overall Study|Withdrawal by Subject|1|||
144488128|NCT04423393|520986470|FG014|Overall Study|Withdrawal by Subject|0|||
144488129|NCT04423393|520986471|FG015|Overall Study|Withdrawal by Subject|0|||
144488130|NCT04423393|520986472|FG016|Overall Study|Withdrawal by Subject|0|||
144488131|NCT04423393|520986473|FG017|Overall Study|Withdrawal by Subject|0|||
144488132|NCT04423393|520986456|FG000|Overall Study|Sponsor Decision|0|||
144488133|NCT04423393|520986457|FG001|Overall Study|Sponsor Decision|0|||
144488134|NCT04423393|520986458|FG002|Overall Study|Sponsor Decision|0|||
144488135|NCT04423393|520986459|FG003|Overall Study|Sponsor Decision|0|||
144488136|NCT04423393|520986460|FG004|Overall Study|Sponsor Decision|0|||
144488137|NCT04423393|520986461|FG005|Overall Study|Sponsor Decision|0|||
144488138|NCT04423393|520986462|FG006|Overall Study|Sponsor Decision|0|||
144488139|NCT04423393|520986463|FG007|Overall Study|Sponsor Decision|0|||
144488140|NCT04423393|520986464|FG008|Overall Study|Sponsor Decision|0|||
144488141|NCT04423393|520986465|FG009|Overall Study|Sponsor Decision|0|||
144488142|NCT04423393|520986466|FG010|Overall Study|Sponsor Decision|0|||
144488143|NCT04423393|520986467|FG011|Overall Study|Sponsor Decision|0|||
144488144|NCT04423393|520986468|FG012|Overall Study|Sponsor Decision|0|||
144488145|NCT04423393|520986469|FG013|Overall Study|Sponsor Decision|1|||
144488146|NCT04423393|520986470|FG014|Overall Study|Sponsor Decision|0|||
144488147|NCT04423393|520986471|FG015|Overall Study|Sponsor Decision|0|||
144488148|NCT04423393|520986472|FG016|Overall Study|Sponsor Decision|0|||
144488149|NCT04423393|520986473|FG017|Overall Study|Sponsor Decision|0|||
144488150|NCT00107380|520986477|FG000|Overall Study|Adverse Event|7|||
144488151|NCT00107380|520986477|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
144488152|NCT00107380|520986477|FG000|Overall Study|Progression/relapse|4|||
144488153|NCT00107380|520986477|FG000|Overall Study|Death|3|||
144488154|NCT00107380|520986477|FG000|Overall Study|Other - not protocol specified|7|||
144488155|NCT00107380|520986477|FG000|Overall Study|Ineligible|2|||
144488156|NCT03531905|520986478|FG000|Overall Study|Withdrawal by Subject|3|||
144488157|NCT03531905|520986479|FG001|Overall Study|Withdrawal by Subject|3|||
144488158|NCT03531905|520986480|FG002|Overall Study|Withdrawal by Subject|2|||
144488159|NCT03531905|520986478|FG000|Overall Study|Lost to Follow-up|2|||
144488160|NCT03531905|520986479|FG001|Overall Study|Lost to Follow-up|2|||
144488161|NCT03531905|520986480|FG002|Overall Study|Lost to Follow-up|1|||
144488162|NCT03531905|520986478|FG000|Overall Study|Participant was out of town|1|||
144488163|NCT03531905|520986479|FG001|Overall Study|Participant was out of town|0|||
144488164|NCT03531905|520986480|FG002|Overall Study|Participant was out of town|0|||
144488165|NCT03531905|520986478|FG000|Overall Study|Could not speak with the participant|1|||
144488166|NCT03531905|520986479|FG001|Overall Study|Could not speak with the participant|0|||
144488167|NCT03531905|520986480|FG002|Overall Study|Could not speak with the participant|0|||
144488168|NCT01489020|520986483|FG000|Overall Study|Withdrawal by Subject|1|||
144488169|NCT01489020|520986484|FG001|Overall Study|Withdrawal by Subject|0|||
144488170|NCT01489020|520986485|FG002|Overall Study|Withdrawal by Subject|0|||
144488171|NCT01489020|520986486|FG003|Overall Study|Withdrawal by Subject|0|||
144488172|NCT01489020|520986487|FG004|Overall Study|Withdrawal by Subject|0|||
144488173|NCT01489020|520986488|FG005|Overall Study|Withdrawal by Subject|0|||
144488174|NCT01489020|520986483|FG000|Overall Study|Adverse Event|0|||
144488175|NCT01489020|520986484|FG001|Overall Study|Adverse Event|0|||
144488176|NCT01489020|520986485|FG002|Overall Study|Adverse Event|3|||
144488177|NCT01489020|520986486|FG003|Overall Study|Adverse Event|0|||
144488178|NCT01489020|520986487|FG004|Overall Study|Adverse Event|3|||
144488179|NCT01489020|520986488|FG005|Overall Study|Adverse Event|0|||
144488180|NCT01489020|520986483|FG000|Overall Study|Concomitant disease|0|||
144488181|NCT01489020|520986484|FG001|Overall Study|Concomitant disease|0|||
144488182|NCT01489020|520986485|FG002|Overall Study|Concomitant disease|0|||
144488183|NCT01489020|520986486|FG003|Overall Study|Concomitant disease|0|||
144488184|NCT01489020|520986487|FG004|Overall Study|Concomitant disease|3|||
144488185|NCT01489020|520986488|FG005|Overall Study|Concomitant disease|0|||
144488186|NCT01174550|520986489|FG000|Overall Study|Death|75|||
144488187|NCT01174550|520986490|FG001|Overall Study|Death|74|||
144488188|NCT01174550|520986489|FG000|Overall Study|Lost to Follow-up|652|||
144488189|NCT01174550|520986490|FG001|Overall Study|Lost to Follow-up|510|||
144488190|NCT01174550|520986489|FG000|Overall Study|Withdrawal by Subject|543|||
144488191|NCT01174550|520986490|FG001|Overall Study|Withdrawal by Subject|289|||
144488192|NCT05343455|520986493|FG000|Overall Study|Withdrawal by Subject|4|||
144488193|NCT05343455|520986494|FG001|Overall Study|Withdrawal by Subject|9|||
144488194|NCT05343455|520986495|FG002|Overall Study|Withdrawal by Subject|7|||
144488195|NCT05343455|520986493|FG000|Overall Study|Adverse Event|2|||
144488196|NCT05343455|520986494|FG001|Overall Study|Adverse Event|1|||
144488197|NCT05343455|520986495|FG002|Overall Study|Adverse Event|2|||
144488198|NCT05343455|520986493|FG000|Overall Study|Lost to Follow-up|1|||
144488199|NCT05343455|520986494|FG001|Overall Study|Lost to Follow-up|1|||
144488200|NCT05343455|520986495|FG002|Overall Study|Lost to Follow-up|3|||
144488201|NCT05343455|520986493|FG000|Overall Study|Pregnancy|1|||
144488202|NCT05343455|520986494|FG001|Overall Study|Pregnancy|0|||
144488203|NCT05343455|520986495|FG002|Overall Study|Pregnancy|0|||
144488204|NCT05343455|520986493|FG000|Overall Study|Physician Decision|0|||
144488205|NCT05343455|520986494|FG001|Overall Study|Physician Decision|0|||
144488206|NCT05343455|520986495|FG002|Overall Study|Physician Decision|1|||
144488207|NCT05343455|520986493|FG000|Overall Study|Protocol Violation|0|||
144488208|NCT05343455|520986494|FG001|Overall Study|Protocol Violation|1|||
144488209|NCT05343455|520986495|FG002|Overall Study|Protocol Violation|1|||
144488210|NCT01440049|520986498|FG000|Overall Study|Adverse Event|5|||
144488211|NCT02268552|520986499|FG000|Part 1|Death|1|||
144488212|NCT02268552|520986500|FG001|Part 1|Death|1|||
144488213|NCT02268552|520986501|FG002|Part 1|Death|1|||
144488214|NCT02268552|520986502|FG003|Part 1|Death|2|||
144488215|NCT02268552|520986503|FG004|Part 1|Death|0|||
144488216|NCT02268552|520986504|FG005|Part 1|Death|0|||
144488217|NCT02268552|520986505|FG006|Part 1|Death|0|||
144488218|NCT02268552|520986499|FG000|Part 1|Subject/guardian decision|0|||
144488219|NCT02268552|520986500|FG001|Part 1|Subject/guardian decision|0|||
144488220|NCT02268552|520986501|FG002|Part 1|Subject/guardian decision|0|||
144488221|NCT02268552|520986502|FG003|Part 1|Subject/guardian decision|1|||
144488222|NCT02268552|520986503|FG004|Part 1|Subject/guardian decision|0|||
144488223|NCT02268552|520986504|FG005|Part 1|Subject/guardian decision|0|||
144488224|NCT02268552|520986505|FG006|Part 1|Subject/guardian decision|0|||
144488225|NCT02268552|520986499|FG000|Part 2|Death|0|||
144488226|NCT02268552|520986500|FG001|Part 2|Death|0|||
144488227|NCT02268552|520986501|FG002|Part 2|Death|0|||
144488228|NCT02268552|520986502|FG003|Part 2|Death|0|||
144488229|NCT02268552|520986503|FG004|Part 2|Death|0|||
144488230|NCT02268552|520986504|FG005|Part 2|Death|0|||
144488231|NCT02268552|520986505|FG006|Part 2|Death|2|||
144488232|NCT02268552|520986499|FG000|Part 2|Subject/guardian decision|0|||
144488233|NCT02268552|520986500|FG001|Part 2|Subject/guardian decision|0|||
144488234|NCT02268552|520986501|FG002|Part 2|Subject/guardian decision|0|||
144488235|NCT02268552|520986502|FG003|Part 2|Subject/guardian decision|0|||
144488236|NCT02268552|520986503|FG004|Part 2|Subject/guardian decision|0|||
144488237|NCT02268552|520986504|FG005|Part 2|Subject/guardian decision|0|||
144488238|NCT02268552|520986505|FG006|Part 2|Subject/guardian decision|1|||
144488239|NCT02268552|520986499|FG000|Part 3 Extension|Death|0|||
144488240|NCT02268552|520986500|FG001|Part 3 Extension|Death|1|||
144488241|NCT02268552|520986501|FG002|Part 3 Extension|Death|1|||
144488242|NCT02268552|520986502|FG003|Part 3 Extension|Death|1|||
144488243|NCT02268552|520986503|FG004|Part 3 Extension|Death|1|||
144488244|NCT02268552|520986504|FG005|Part 3 Extension|Death|1|||
144488245|NCT02268552|520986505|FG006|Part 3 Extension|Death|0|||
144488246|NCT02268552|520986499|FG000|Part 3 Extension|Early termination of trial|1|||
144488247|NCT02268552|520986500|FG001|Part 3 Extension|Early termination of trial|0|||
144488248|NCT02268552|520986501|FG002|Part 3 Extension|Early termination of trial|0|||
144488249|NCT02268552|520986502|FG003|Part 3 Extension|Early termination of trial|0|||
144488250|NCT02268552|520986503|FG004|Part 3 Extension|Early termination of trial|2|||
144488251|NCT02268552|520986504|FG005|Part 3 Extension|Early termination of trial|9|||
144488252|NCT02268552|520986505|FG006|Part 3 Extension|Early termination of trial|11|||
144488253|NCT02268552|520986499|FG000|Part 3 Extension|Subject/guardian decision|0|||
144488254|NCT02268552|520986500|FG001|Part 3 Extension|Subject/guardian decision|0|||
144488255|NCT02268552|520986501|FG002|Part 3 Extension|Subject/guardian decision|0|||
144488256|NCT02268552|520986502|FG003|Part 3 Extension|Subject/guardian decision|0|||
144488257|NCT02268552|520986503|FG004|Part 3 Extension|Subject/guardian decision|0|||
144488258|NCT02268552|520986504|FG005|Part 3 Extension|Subject/guardian decision|0|||
144488259|NCT02268552|520986505|FG006|Part 3 Extension|Subject/guardian decision|1|||
144488260|NCT02139982|520986507|FG000|Overall Study|Lack of Efficacy|0|||
144488261|NCT02139982|520986508|FG001|Overall Study|Lack of Efficacy|1|||
144488262|NCT02139982|520986509|FG002|Overall Study|Lack of Efficacy|0|||
144488263|NCT02139982|520986510|FG003|Overall Study|Lack of Efficacy|1|||
144488264|NCT02139982|520986511|FG004|Overall Study|Lack of Efficacy|0|||
144488265|NCT02139982|520986512|FG005|Overall Study|Lack of Efficacy|0|||
144488266|NCT02139982|520986513|FG006|Overall Study|Lack of Efficacy|0|||
144488267|NCT02139982|520986514|FG007|Overall Study|Lack of Efficacy|0|||
144488268|NCT02139982|520986515|FG008|Overall Study|Lack of Efficacy|0|||
144488269|NCT02139982|520986516|FG009|Overall Study|Lack of Efficacy|0|||
144488270|NCT02748512|520986519|FG000|Overall Study|Lost to Follow-up|1|||
144488271|NCT02748512|520986520|FG001|Overall Study|Lost to Follow-up|1|||
144488272|NCT00997243|520986522|FG000|Overall Study|Early termination of study by sponsor|7|||
144488273|NCT03415022|520986525|FG000|Overall Study|Withdrawal by Subject|1|||
144488274|NCT03415022|520986526|FG001|Overall Study|Withdrawal by Subject|2|||
144488275|NCT03415022|520986525|FG000|Overall Study|COVID-19 Suspension|2|||
144488276|NCT03415022|520986526|FG001|Overall Study|COVID-19 Suspension|3|||
144488277|NCT03415022|520986525|FG000|Overall Study|Lost to Follow-up|2|||
144488278|NCT03415022|520986526|FG001|Overall Study|Lost to Follow-up|0|||
144488279|NCT04466618|520986527|FG000|Overall Study|Withdrawal by Subject|0|||
144488280|NCT04466618|520986528|FG001|Overall Study|Withdrawal by Subject|1|||
144488281|NCT01349907|520986529|FG000|Overall Study|Adverse Event|37|||
144488282|NCT01349907|520986530|FG001|Overall Study|Adverse Event|11|||
144488283|NCT01349907|520986529|FG000|Overall Study|Treatment failure|13|||
144488284|NCT01349907|520986530|FG001|Overall Study|Treatment failure|4|||
144488285|NCT01349907|520986529|FG000|Overall Study|Lost to Follow-up|25|||
144488286|NCT01349907|520986530|FG001|Overall Study|Lost to Follow-up|6|||
144488287|NCT01349907|520986529|FG000|Overall Study|Withdrawal by Subject|30|||
144488288|NCT01349907|520986530|FG001|Overall Study|Withdrawal by Subject|8|||
144488289|NCT01349907|520986529|FG000|Overall Study|Protocol Violation|33|||
144488290|NCT01349907|520986530|FG001|Overall Study|Protocol Violation|13|||
144488291|NCT01349907|520986529|FG000|Overall Study|Administrative|1|||
144488292|NCT01349907|520986530|FG001|Overall Study|Administrative|1|||
144488293|NCT03583541|520986536|FG000|Overall Study|Lost to Follow-up|31|||
144488294|NCT03583541|520986537|FG001|Overall Study|Lost to Follow-up|65|||
144488295|NCT00884286|520986538|FG000|Overall Study|Progressive disease|21|||
144488296|NCT00884286|520986539|FG001|Overall Study|Progressive disease|28|||
144488297|NCT00884286|520986538|FG000|Overall Study|Toxicity|4|||
144488298|NCT00884286|520986539|FG001|Overall Study|Toxicity|1|||
144488299|NCT00884286|520986538|FG000|Overall Study|Death|2|||
144488300|NCT00884286|520986539|FG001|Overall Study|Death|2|||
144488301|NCT00884286|520986538|FG000|Overall Study|Physician Decision|1|||
144488302|NCT00884286|520986539|FG001|Overall Study|Physician Decision|0|||
144488303|NCT00884286|520986538|FG000|Overall Study|Septic shock|1|||
144488304|NCT00884286|520986539|FG001|Overall Study|Septic shock|0|||
144488305|NCT00884286|520986538|FG000|Overall Study|Thrombus in right auricle|1|||
144488306|NCT00884286|520986539|FG001|Overall Study|Thrombus in right auricle|0|||
144488307|NCT00884286|520986538|FG000|Overall Study|Not treated|2|||
144488308|NCT00884286|520986539|FG001|Overall Study|Not treated|1|||
144488309|NCT00884286|520986538|FG000|Overall Study|Comprised lung carcinoma|0|||
144488310|NCT00884286|520986539|FG001|Overall Study|Comprised lung carcinoma|1|||
144488311|NCT00109928|520986540|FG000|Overall Study|Adverse Event|2|||
144488312|NCT00109928|520986540|FG000|Overall Study|Progression|6|||
144488313|NCT00109928|520986540|FG000|Overall Study|Death|2|||
144488314|NCT00109928|520986540|FG000|Overall Study|not protocol specified|2|||
144488315|NCT00109928|520986540|FG000|Overall Study|not eligible|1|||
144488316|NCT01196104|520986541|FG000|Overall Study|Lost to Follow-up|1|||
144488317|NCT01196104|520986542|FG001|Overall Study|Lost to Follow-up|0|||
144488318|NCT01196104|520986541|FG000|Overall Study|Physician Decision|0|||
144488319|NCT01196104|520986542|FG001|Overall Study|Physician Decision|1|||
144488320|NCT01196104|520986541|FG000|Overall Study|Withdrawal by Subject|3|||
144488321|NCT01196104|520986542|FG001|Overall Study|Withdrawal by Subject|3|||
144488322|NCT01196104|520986541|FG000|Overall Study|Various|0|||
144488323|NCT01196104|520986542|FG001|Overall Study|Various|1|||
144488324|NCT02411591|520986547|FG000|Overall Study|Adverse Event|0|||
144488325|NCT02411591|520986548|FG001|Overall Study|Adverse Event|4|||
144488326|NCT02411591|520986549|FG002|Overall Study|Adverse Event|2|||
144488327|NCT02411591|520986547|FG000|Overall Study|Withdrawal by Subject|0|||
144488328|NCT02411591|520986548|FG001|Overall Study|Withdrawal by Subject|3|||
144488329|NCT02411591|520986549|FG002|Overall Study|Withdrawal by Subject|0|||
144488330|NCT02411591|520986547|FG000|Overall Study|Physician Decision|0|||
144488331|NCT02411591|520986548|FG001|Overall Study|Physician Decision|3|||
144488332|NCT02411591|520986549|FG002|Overall Study|Physician Decision|1|||
144488333|NCT02491892|520986550|FG000|Overall Study|Adverse Event|1|||
144488334|NCT02491892|520986551|FG001|Overall Study|Adverse Event|1|||
144488335|NCT02491892|520986550|FG000|Overall Study|Death|1|||
144488336|NCT02491892|520986551|FG001|Overall Study|Death|1|||
144488337|NCT02491892|520986550|FG000|Overall Study|Lack of Efficacy|37|||
144488338|NCT02491892|520986551|FG001|Overall Study|Lack of Efficacy|36|||
144488339|NCT02491892|520986550|FG000|Overall Study|Refused Treatment|1|||
144488340|NCT02491892|520986551|FG001|Overall Study|Refused Treatment|0|||
144488341|NCT02491892|520986550|FG000|Overall Study|Lost to Follow-up|1|||
144488342|NCT02491892|520986551|FG001|Overall Study|Lost to Follow-up|0|||
144488343|NCT04227340|520986552|FG000|Overall Study|Withdrawal by Subject|3|||
144488344|NCT01734850|520986553|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
144488345|NCT01734850|520986554|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
144488346|NCT01734850|520986555|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
144488347|NCT01734850|520986553|FG000|Overall Study|Not infused due to manufacturing failure|0|||
144488348|NCT01734850|520986554|FG001|Overall Study|Not infused due to manufacturing failure|0|||
144488349|NCT01734850|520986555|FG002|Overall Study|Not infused due to manufacturing failure|1|||
144488350|NCT00750893|520986556|FG000|Overall Study|Adverse Event|5|||
144488351|NCT00750893|520986556|FG000|Overall Study|Withdrawal by Subject|10|||
144488352|NCT00750893|520986556|FG000|Overall Study|Lost to Follow-up|510|||
144488353|NCT00750893|520986556|FG000|Overall Study|Other|17|||
144488354|NCT00661258|520986558|FG000|Overall Study|Death|1|||
144488355|NCT00661258|520986559|FG001|Overall Study|Death|0|||
144488356|NCT00661258|520986558|FG000|Overall Study|caught by police and in detox center|2|||
144488357|NCT00661258|520986559|FG001|Overall Study|caught by police and in detox center|1|||
144488358|NCT00393094|520986560|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
144488359|NCT00393094|520986560|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
144488360|NCT04496167|520986561|FG000|Overall Study|Adverse Event|6|||
144488361|NCT04496167|520986562|FG001|Overall Study|Adverse Event|2|||
144488362|NCT04496167|520986561|FG000|Overall Study|Withdrawal by Subject|7|||
144488363|NCT04496167|520986562|FG001|Overall Study|Withdrawal by Subject|6|||
144488364|NCT04496167|520986561|FG000|Overall Study|Lost to Follow-up|3|||
144488365|NCT04496167|520986562|FG001|Overall Study|Lost to Follow-up|5|||
144488366|NCT04496167|520986561|FG000|Overall Study|Not Treated|1|||
144488367|NCT04496167|520986562|FG001|Overall Study|Not Treated|2|||
144488368|NCT04496167|520986561|FG000|Overall Study|Other Than Specified|1|||
144488369|NCT04496167|520986562|FG001|Overall Study|Other Than Specified|1|||
144488370|NCT00598481|520986565|FG000|Treatment|Physician Decision|1|||
144369778|NCT02745119|520561693|FG000|Overall Study|Withdrawal by Subject|7|||
144369779|NCT02745119|520561694|FG001|Overall Study|Withdrawal by Subject|15|||
144369780|NCT02745119|520561695|FG002|Overall Study|Withdrawal by Subject|8|||
144369781|NCT02745119|520561696|FG003|Overall Study|Withdrawal by Subject|14|||
144369782|NCT02745119|520561693|FG000|Overall Study|Study Terminated by Sponsor|134|||
144369783|NCT02745119|520561694|FG001|Overall Study|Study Terminated by Sponsor|252|||
144369784|NCT02745119|520561695|FG002|Overall Study|Study Terminated by Sponsor|135|||
144369785|NCT02745119|520561696|FG003|Overall Study|Study Terminated by Sponsor|251|||
144369786|NCT02745119|520561693|FG000|Overall Study|Physician Decision|0|||
144369787|NCT02745119|520561694|FG001|Overall Study|Physician Decision|2|||
144369788|NCT02745119|520561695|FG002|Overall Study|Physician Decision|2|||
144369789|NCT02745119|520561696|FG003|Overall Study|Physician Decision|2|||
144369790|NCT02745119|520561693|FG000|Overall Study|Reason Not Specified|0|||
144369791|NCT02745119|520561694|FG001|Overall Study|Reason Not Specified|2|||
144369792|NCT02745119|520561695|FG002|Overall Study|Reason Not Specified|0|||
144488371|NCT01083160|520986566|FG000|Overall Study|Adverse Event|1|||
144488372|NCT00918749|520986569|FG000|Overall Study|Adverse Event|1|||
144369793|NCT02745119|520561696|FG003|Overall Study|Reason Not Specified|1|||
144369794|NCT02447003|520561699|FG000|Overall Study|Other|0|||
144369795|NCT02447003|520561700|FG001|Overall Study|Other|4|||
144488373|NCT00918749|520986570|FG001|Overall Study|Adverse Event|0|||
144488374|NCT00918749|520986571|FG002|Overall Study|Adverse Event|1|||
144488375|NCT00918749|520986569|FG000|Overall Study|Lost to Follow-up|0|||
144488376|NCT00918749|520986570|FG001|Overall Study|Lost to Follow-up|0|||
144488377|NCT00918749|520986571|FG002|Overall Study|Lost to Follow-up|1|||
144488378|NCT00918749|520986569|FG000|Overall Study|Withdrawal by Subject|5|||
144369796|NCT02447003|520561699|FG000|Overall Study|Site discontinued|0|||
144538224|NCT00146172|521174129|FG007|Overall Study|Physician Decision|1|||
144369797|NCT02447003|520561700|FG001|Overall Study|Site discontinued|2|||
144488379|NCT00918749|520986570|FG001|Overall Study|Withdrawal by Subject|3|||
144488380|NCT00918749|520986571|FG002|Overall Study|Withdrawal by Subject|5|||
144488381|NCT00918749|520986569|FG000|Overall Study|No Study Medication Taken|1|||
144488382|NCT00918749|520986570|FG001|Overall Study|No Study Medication Taken|0|||
144488383|NCT00918749|520986571|FG002|Overall Study|No Study Medication Taken|0|||
144488384|NCT01951092|520986572|FG000|Overall Study|Lost to Follow-up|10|||
144488385|NCT01951092|520986572|FG000|Overall Study|Incarceration|1|||
144488386|NCT01951092|520986572|FG000|Overall Study|Transfer of Care|1|||
144488387|NCT01712789|520986573|FG000|Overall Study|Lack of Efficacy|2|||
144488388|NCT01712789|520986573|FG000|Overall Study|Lost to Follow-up|1|||
144488389|NCT01712789|520986573|FG000|Overall Study|Progressive Disease|504|||
144488390|NCT01712789|520986573|FG000|Overall Study|Death|57|||
144488391|NCT01712789|520986573|FG000|Overall Study|Adverse Event|52|||
144488392|NCT01712789|520986573|FG000|Overall Study|Miscellaneous|31|||
144488393|NCT01712789|520986573|FG000|Overall Study|Withdrawal by Subject|21|||
144488394|NCT01712789|520986573|FG000|Overall Study|Transition to Commercial Treatment|8|||
144488395|NCT01712789|520986573|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
144488396|NCT01708187|520986574|FG000|Overall Study|Lost to Follow-up|0|||
144488397|NCT01708187|520986575|FG001|Overall Study|Lost to Follow-up|1|||
144488398|NCT03018106|520986577|FG000|Overall Study|Lost to Follow-up|0|||
144488399|NCT03018106|520986578|FG001|Overall Study|Lost to Follow-up|1|||
144488400|NCT00136916|520986579|FG000|Overall Study|Never received study treatment|3|||
144488401|NCT00136916|520986580|FG001|Overall Study|Never received study treatment|5|||
144488402|NCT00136916|520986579|FG000|Overall Study|Death|1|||
144488403|NCT00136916|520986580|FG001|Overall Study|Death|3|||
144488404|NCT00136916|520986579|FG000|Overall Study|Adverse Event|27|||
144488405|NCT00136916|520986580|FG001|Overall Study|Adverse Event|8|||
144488406|NCT00136916|520986579|FG000|Overall Study|Laboratory abnormality|0|||
144488407|NCT00136916|520986580|FG001|Overall Study|Laboratory abnormality|1|||
144488408|NCT00136916|520986579|FG000|Overall Study|Lack of Efficacy|13|||
144488409|NCT00136916|520986580|FG001|Overall Study|Lack of Efficacy|3|||
144488410|NCT00136916|520986579|FG000|Overall Study|Lost to Follow-up|12|||
144488411|NCT00136916|520986580|FG001|Overall Study|Lost to Follow-up|14|||
144488412|NCT00136916|520986579|FG000|Overall Study|Withdrawal by Subject|44|||
144488413|NCT00136916|520986580|FG001|Overall Study|Withdrawal by Subject|46|||
144488414|NCT00136916|520986579|FG000|Overall Study|Other|22|||
144488415|NCT00136916|520986580|FG001|Overall Study|Other|24|||
144488416|NCT00136916|520986579|FG000|Overall Study|Discontinued in follow up period|3|||
144488417|NCT00136916|520986580|FG001|Overall Study|Discontinued in follow up period|0|||
144488418|NCT01439711|520986581|FG000|Overall Study|Ineligible|13|||
144488419|NCT01439711|520986581|FG000|Overall Study|Cancel|3|||
144488420|NCT01439711|520986581|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
144488421|NCT01439711|520986581|FG000|Overall Study|Adverse Event|5|||
144488422|NCT01439711|520986581|FG000|Overall Study|Withdrawal by Subject|3|||
144488423|NCT01439711|520986581|FG000|Overall Study|Progression During Active Tx|3|||
144488424|NCT01439711|520986581|FG000|Overall Study|Noncompliance|3|||
144488425|NCT01439711|520986581|FG000|Overall Study|No MRI|9|||
144488426|NCT01603121|520986588|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
144488427|NCT01603121|520986589|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
144488428|NCT01656759|520986590|FG000|Overall Study|Protocol Violation|2|||
144488429|NCT01656759|520986591|FG001|Overall Study|Protocol Violation|3|||
144488430|NCT04707391|520986592|FG000|Overall Study|Adverse Event|5|||
144488431|NCT04707391|520986593|FG001|Overall Study|Adverse Event|8|||
144488432|NCT04707391|520986592|FG000|Overall Study|Lost to Follow-up|44|||
144488433|NCT04707391|520986593|FG001|Overall Study|Lost to Follow-up|31|||
144488434|NCT04707391|520986592|FG000|Overall Study|Protocol Violation|1|||
144488435|NCT04707391|520986593|FG001|Overall Study|Protocol Violation|5|||
144488436|NCT04707391|520986592|FG000|Overall Study|Withdrawal by Subject|27|||
144488437|NCT04707391|520986593|FG001|Overall Study|Withdrawal by Subject|25|||
144488438|NCT04707391|520986592|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
144488439|NCT04707391|520986593|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
144488440|NCT04707391|520986592|FG000|Overall Study|Other|0|||
144488441|NCT04707391|520986593|FG001|Overall Study|Other|2|||
144369798|NCT02447003|520561699|FG000|Overall Study|Physician Decision|0|||
144488442|NCT01932996|520986594|FG000|Overall Study|Protocol Violation|2|||
144488443|NCT01932996|520986595|FG001|Overall Study|Protocol Violation|0|||
144488444|NCT02584855|520986603|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
144488445|NCT02584855|520986604|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
144488446|NCT02584855|520986605|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
144488447|NCT02584855|520986606|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
144488448|NCT02584855|520986607|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
144488449|NCT02584855|520986608|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
144488450|NCT02584855|520986603|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
144488451|NCT02584855|520986604|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
144488452|NCT02584855|520986605|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
144488453|NCT02584855|520986606|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
144488454|NCT02584855|520986607|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
144488455|NCT02584855|520986608|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
144488456|NCT02584855|520986603|FG000|Open-Label Treatment Period|Adverse Event|14|||
144488457|NCT02584855|520986604|FG001|Open-Label Treatment Period|Adverse Event|0|||
144488458|NCT02584855|520986605|FG002|Open-Label Treatment Period|Adverse Event|0|||
144488459|NCT02584855|520986606|FG003|Open-Label Treatment Period|Adverse Event|0|||
144488460|NCT02584855|520986607|FG004|Open-Label Treatment Period|Adverse Event|0|||
144488461|NCT02584855|520986608|FG005|Open-Label Treatment Period|Adverse Event|0|||
144488462|NCT02584855|520986603|FG000|Open-Label Treatment Period|Death|2|||
144488463|NCT02584855|520986604|FG001|Open-Label Treatment Period|Death|0|||
144488464|NCT02584855|520986605|FG002|Open-Label Treatment Period|Death|0|||
144488465|NCT02584855|520986606|FG003|Open-Label Treatment Period|Death|0|||
144488466|NCT02584855|520986607|FG004|Open-Label Treatment Period|Death|0|||
144488467|NCT02584855|520986608|FG005|Open-Label Treatment Period|Death|0|||
144488468|NCT02584855|520986603|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
144488469|NCT02584855|520986604|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
144488470|NCT02584855|520986605|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
144488471|NCT02584855|520986606|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
144488472|NCT02584855|520986607|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
144488473|NCT02584855|520986608|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
144488474|NCT02584855|520986603|FG000|Open-Label Treatment Period|Protocol Violation|1|||
144488475|NCT02584855|520986604|FG001|Open-Label Treatment Period|Protocol Violation|0|||
144488476|NCT02584855|520986605|FG002|Open-Label Treatment Period|Protocol Violation|0|||
144488477|NCT02584855|520986606|FG003|Open-Label Treatment Period|Protocol Violation|0|||
144488478|NCT02584855|520986607|FG004|Open-Label Treatment Period|Protocol Violation|0|||
144488479|NCT02584855|520986608|FG005|Open-Label Treatment Period|Protocol Violation|0|||
144488480|NCT02584855|520986603|FG000|Open-Label Treatment Period|No PI Available|2|||
144488481|NCT02584855|520986604|FG001|Open-Label Treatment Period|No PI Available|0|||
144488482|NCT02584855|520986605|FG002|Open-Label Treatment Period|No PI Available|0|||
144488483|NCT02584855|520986606|FG003|Open-Label Treatment Period|No PI Available|0|||
144488484|NCT02584855|520986607|FG004|Open-Label Treatment Period|No PI Available|0|||
144488485|NCT02584855|520986608|FG005|Open-Label Treatment Period|No PI Available|0|||
144488486|NCT02584855|520986603|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
144488487|NCT02584855|520986604|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
144488488|NCT02584855|520986605|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
144488489|NCT02584855|520986606|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
144488490|NCT02584855|520986607|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
144488491|NCT02584855|520986608|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
144488492|NCT02584855|520986603|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
144488493|NCT02584855|520986604|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
144488494|NCT02584855|520986605|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
144488495|NCT02584855|520986606|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
144488496|NCT02584855|520986607|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
144488497|NCT02584855|520986608|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
144488498|NCT02584855|520986603|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
144488499|NCT02584855|520986604|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
144488500|NCT02584855|520986605|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
144488501|NCT02584855|520986606|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
144488502|NCT02584855|520986607|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
144488503|NCT02584855|520986608|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
144488504|NCT02584855|520986603|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
144488505|NCT02584855|520986604|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
144488506|NCT02584855|520986605|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
144488507|NCT02584855|520986606|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
144488508|NCT02584855|520986607|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
144488509|NCT02584855|520986608|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
144488510|NCT02584855|520986603|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
144488511|NCT02584855|520986604|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
144488512|NCT02584855|520986605|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
144488513|NCT02584855|520986606|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
144488514|NCT02584855|520986607|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
144488515|NCT02584855|520986608|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
144488516|NCT02584855|520986603|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144488517|NCT02584855|520986604|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144488518|NCT02584855|520986605|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144488519|NCT02584855|520986606|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144488520|NCT02584855|520986607|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
144488521|NCT02584855|520986608|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
144488522|NCT02584855|520986603|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
144488523|NCT02584855|520986604|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
144488524|NCT02584855|520986605|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
144488525|NCT02584855|520986606|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
144488526|NCT02584855|520986607|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
144488527|NCT02584855|520986608|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
144488528|NCT02337478|520986609|FG000|Overall Study|Lack of Efficacy|5|||
144488529|NCT00895843|520986610|FG000|Overall Study|Protocol Violation|12|||
144488530|NCT00895843|520986611|FG001|Overall Study|Protocol Violation|12|||
144488531|NCT04963062|520986615|FG000|Overall Study|withdrew by the study team|4|||
144488532|NCT04963062|520986616|FG001|Overall Study|withdrew by the study team|2|||
144488533|NCT01513967|520986621|FG000|Overall Study|Pregnancy|0|||
144488534|NCT01513967|520986622|FG001|Overall Study|Pregnancy|0|||
144488535|NCT01513967|520986623|FG002|Overall Study|Pregnancy|0|||
144488536|NCT01513967|520986624|FG003|Overall Study|Pregnancy|0|||
144488537|NCT01513967|520986625|FG004|Overall Study|Pregnancy|0|||
144488538|NCT01513967|520986626|FG005|Overall Study|Pregnancy|0|||
144488539|NCT01513967|520986627|FG006|Overall Study|Pregnancy|1|||
144488540|NCT01513967|520986628|FG007|Overall Study|Pregnancy|0|||
144488541|NCT01513967|520986621|FG000|Overall Study|missed a study visit|0|||
144488542|NCT01513967|520986622|FG001|Overall Study|missed a study visit|0|||
144488543|NCT01513967|520986623|FG002|Overall Study|missed a study visit|0|||
144488544|NCT01513967|520986624|FG003|Overall Study|missed a study visit|0|||
144488545|NCT01513967|520986625|FG004|Overall Study|missed a study visit|0|||
144488546|NCT01513967|520986626|FG005|Overall Study|missed a study visit|0|||
144488547|NCT01513967|520986627|FG006|Overall Study|missed a study visit|1|||
144488548|NCT01513967|520986628|FG007|Overall Study|missed a study visit|0|||
144488549|NCT01513967|520986621|FG000|Overall Study|excluded due to positive drug screen|0|||
144488550|NCT01513967|520986622|FG001|Overall Study|excluded due to positive drug screen|0|||
144488551|NCT01513967|520986623|FG002|Overall Study|excluded due to positive drug screen|0|||
144488552|NCT01513967|520986624|FG003|Overall Study|excluded due to positive drug screen|0|||
144488553|NCT01513967|520986625|FG004|Overall Study|excluded due to positive drug screen|0|||
144488554|NCT01513967|520986626|FG005|Overall Study|excluded due to positive drug screen|0|||
144488555|NCT01513967|520986627|FG006|Overall Study|excluded due to positive drug screen|0|||
144488556|NCT01513967|520986628|FG007|Overall Study|excluded due to positive drug screen|2|||
144488557|NCT01513967|520986621|FG000|Overall Study|Physician Decision|0|||
144488558|NCT01513967|520986622|FG001|Overall Study|Physician Decision|0|||
144488559|NCT01513967|520986623|FG002|Overall Study|Physician Decision|0|||
144488560|NCT01513967|520986624|FG003|Overall Study|Physician Decision|0|||
144488561|NCT01513967|520986625|FG004|Overall Study|Physician Decision|0|||
144488562|NCT01513967|520986626|FG005|Overall Study|Physician Decision|1|||
144488563|NCT01513967|520986627|FG006|Overall Study|Physician Decision|0|||
144488564|NCT01513967|520986628|FG007|Overall Study|Physician Decision|0|||
144488565|NCT02906202|520986629|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
144488566|NCT04131907|520986630|FG000|Overall Study|Adverse Event|2|||
144488567|NCT04131907|520986631|FG001|Overall Study|Adverse Event|0|||
144488568|NCT04131907|520986632|FG002|Overall Study|Adverse Event|0|||
144488569|NCT04131907|520986630|FG000|Overall Study|Physician Decision|4|||
144488570|NCT04131907|520986631|FG001|Overall Study|Physician Decision|22|||
144488571|NCT04131907|520986632|FG002|Overall Study|Physician Decision|0|||
144488572|NCT04131907|520986630|FG000|Overall Study|Withdrawal by Subject|2|||
144488573|NCT04131907|520986631|FG001|Overall Study|Withdrawal by Subject|0|||
144488574|NCT04131907|520986632|FG002|Overall Study|Withdrawal by Subject|1|||
144488575|NCT04131907|520986630|FG000|Overall Study|Treatment failure|2|||
144488576|NCT04131907|520986631|FG001|Overall Study|Treatment failure|0|||
144488577|NCT04131907|520986632|FG002|Overall Study|Treatment failure|1|||
144488578|NCT00847301|520986633|FG000|Overall Study|Adverse Event|35|||
144488579|NCT00847301|520986633|FG000|Overall Study|Switch to other anticoagulants|16|||
144488580|NCT00847301|520986633|FG000|Overall Study|Lost to Follow-up|1|||
144488581|NCT00847301|520986633|FG000|Overall Study|No prescription after hospital discharge|1|||
144588157|NCT02594163|521352302|FG001|Follow-up Period|Adverse Event|1|||
144369799|NCT02447003|520561700|FG001|Overall Study|Physician Decision|1|||
144369800|NCT02447003|520561699|FG000|Overall Study|Withdrawal by Subject|4|||
144369801|NCT02447003|520561700|FG001|Overall Study|Withdrawal by Subject|3|||
144488582|NCT00847301|520986633|FG000|Overall Study|Other reason not defined above|1|||
144488583|NCT03428815|520986637|FG000|Overall Study|Lost to Follow-up|2|||
144488584|NCT03428815|520986638|FG001|Overall Study|Lost to Follow-up|2|||
144488585|NCT03428815|520986637|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
144488586|NCT03428815|520986638|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
144488587|NCT03428815|520986637|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
144488588|NCT03428815|520986638|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
144488589|NCT05221749|520986639|FG000|Overall Study|Lost to Follow-up|2|||
144488590|NCT05221749|520986640|FG001|Overall Study|Lost to Follow-up|3|||
144488591|NCT00519636|520986641|FG000|Treatment Period 1|Adverse Event|1|||
144488592|NCT00519636|520986642|FG001|Treatment Period 1|Adverse Event|0|||
144488593|NCT00519636|520986643|FG002|Treatment Period 1|Adverse Event|1|||
144488594|NCT00519636|520986644|FG003|Treatment Period 1|Adverse Event|0|||
144488595|NCT00519636|520986641|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
144488596|NCT00519636|520986642|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
144488597|NCT00519636|520986643|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
144488598|NCT00519636|520986644|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
144488599|NCT00519636|520986641|FG000|Washout Period|Adverse Event|2|||
144488600|NCT00519636|520986642|FG001|Washout Period|Adverse Event|1|||
144488601|NCT00519636|520986643|FG002|Washout Period|Adverse Event|1|||
144488602|NCT00519636|520986644|FG003|Washout Period|Adverse Event|0|||
144488603|NCT00519636|520986641|FG000|Washout Period|Lost to Follow-up|1|||
144488604|NCT00519636|520986642|FG001|Washout Period|Lost to Follow-up|0|||
144488605|NCT00519636|520986643|FG002|Washout Period|Lost to Follow-up|0|||
144488606|NCT00519636|520986644|FG003|Washout Period|Lost to Follow-up|0|||
144488607|NCT00519636|520986641|FG000|Washout Period|Protocol Violation|0|||
144488608|NCT00519636|520986642|FG001|Washout Period|Protocol Violation|0|||
144488609|NCT00519636|520986643|FG002|Washout Period|Protocol Violation|1|||
144488610|NCT00519636|520986644|FG003|Washout Period|Protocol Violation|2|||
144488611|NCT00519636|520986641|FG000|Washout Period|Withdrawal by Subject|1|||
144488612|NCT00519636|520986642|FG001|Washout Period|Withdrawal by Subject|0|||
144488613|NCT00519636|520986643|FG002|Washout Period|Withdrawal by Subject|1|||
144488614|NCT00519636|520986644|FG003|Washout Period|Withdrawal by Subject|0|||
144488615|NCT00519636|520986641|FG000|Washout Period|Failed to meet continuation criteria|14|||
144488616|NCT00519636|520986642|FG001|Washout Period|Failed to meet continuation criteria|11|||
144488617|NCT00519636|520986643|FG002|Washout Period|Failed to meet continuation criteria|9|||
144488618|NCT00519636|520986644|FG003|Washout Period|Failed to meet continuation criteria|3|||
144488619|NCT00519636|520986641|FG000|Washout Period|Out of pollen area > 48 hours|1|||
144488620|NCT00519636|520986642|FG001|Washout Period|Out of pollen area > 48 hours|0|||
144488621|NCT00519636|520986643|FG002|Washout Period|Out of pollen area > 48 hours|0|||
144488622|NCT00519636|520986644|FG003|Washout Period|Out of pollen area > 48 hours|0|||
144488623|NCT00519636|520986641|FG000|Washout Period|Participating in study at another site|1|||
144488624|NCT00519636|520986642|FG001|Washout Period|Participating in study at another site|0|||
144488625|NCT00519636|520986643|FG002|Washout Period|Participating in study at another site|0|||
144488626|NCT00519636|520986644|FG003|Washout Period|Participating in study at another site|0|||
144488627|NCT00519636|520986641|FG000|Washout Period|Non-compliant|0|||
144488628|NCT00519636|520986642|FG001|Washout Period|Non-compliant|1|||
144488629|NCT00519636|520986643|FG002|Washout Period|Non-compliant|0|||
144488630|NCT00519636|520986644|FG003|Washout Period|Non-compliant|0|||
144488631|NCT00519636|520986641|FG000|Washout Period|Per doctors request|0|||
144488632|NCT00519636|520986642|FG001|Washout Period|Per doctors request|1|||
144488633|NCT00519636|520986643|FG002|Washout Period|Per doctors request|0|||
144488634|NCT00519636|520986644|FG003|Washout Period|Per doctors request|0|||
144488635|NCT00519636|520986641|FG000|Washout Period|Subject randomized in error|0|||
144488636|NCT00519636|520986642|FG001|Washout Period|Subject randomized in error|0|||
144488637|NCT00519636|520986643|FG002|Washout Period|Subject randomized in error|1|||
144488638|NCT00519636|520986644|FG003|Washout Period|Subject randomized in error|0|||
144488639|NCT00519636|520986641|FG000|Washout Period|Prohibited medications|0|||
144488640|NCT00519636|520986642|FG001|Washout Period|Prohibited medications|0|||
144488641|NCT00519636|520986643|FG002|Washout Period|Prohibited medications|1|||
144488642|NCT00519636|520986644|FG003|Washout Period|Prohibited medications|0|||
144488643|NCT00519636|520986641|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
144488644|NCT00519636|520986642|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
144488645|NCT00519636|520986643|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
144488646|NCT00519636|520986644|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
144488647|NCT00519636|520986641|FG000|Treatment Period 2|Subject randomized in error|0|||
144488648|NCT00519636|520986642|FG001|Treatment Period 2|Subject randomized in error|1|||
144488649|NCT00519636|520986643|FG002|Treatment Period 2|Subject randomized in error|0|||
144488650|NCT00519636|520986644|FG003|Treatment Period 2|Subject randomized in error|0|||
144488651|NCT00519636|520986641|FG000|Treatment Period 2|Per doctors request|0|||
144488652|NCT00519636|520986642|FG001|Treatment Period 2|Per doctors request|0|||
144488653|NCT00519636|520986643|FG002|Treatment Period 2|Per doctors request|1|||
144488654|NCT00519636|520986644|FG003|Treatment Period 2|Per doctors request|0|||
144488655|NCT00519636|520986641|FG000|Treatment Period 2|Subject misrandomized|0|||
144488656|NCT00519636|520986642|FG001|Treatment Period 2|Subject misrandomized|0|||
144488657|NCT00519636|520986643|FG002|Treatment Period 2|Subject misrandomized|0|||
144369802|NCT02447003|520561699|FG000|Overall Study|Sponsor Decision|6|||
144488658|NCT00519636|520986644|FG003|Treatment Period 2|Subject misrandomized|1|||
144488659|NCT00519636|520986641|FG000|Post Study Period|Subject randomized in error|0|||
144488660|NCT00519636|520986642|FG001|Post Study Period|Subject randomized in error|0|||
144488661|NCT00519636|520986643|FG002|Post Study Period|Subject randomized in error|0|||
144488662|NCT00519636|520986644|FG003|Post Study Period|Subject randomized in error|1|||
144488663|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
144488664|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
144488665|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
144488666|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
144488667|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
144488668|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
144488669|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
144488670|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
144488671|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
144488672|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
144488673|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
144488674|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
144488675|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
144488676|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
144488677|NCT01815736|520986645|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
144488678|NCT01815736|520986646|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
144488679|NCT01815736|520986645|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
144488680|NCT01815736|520986646|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
144488681|NCT01815736|520986645|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
144488682|NCT01815736|520986646|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
144488683|NCT01815736|520986645|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
144488684|NCT01815736|520986646|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
144488685|NCT01815736|520986645|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
144488686|NCT01815736|520986646|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
144488687|NCT01815736|520986645|FG000|Extension Treatment Phase- After Week 96|Death|1|||
144488688|NCT01815736|520986646|FG001|Extension Treatment Phase- After Week 96|Death|0|||
144488689|NCT04039503|520986647|FG000|Overall Study|Adverse Event|3|||
144488690|NCT04039503|520986648|FG001|Overall Study|Adverse Event|0|||
144488691|NCT04039503|520986649|FG002|Overall Study|Adverse Event|2|||
144488692|NCT04039503|520986650|FG003|Overall Study|Adverse Event|0|||
144488693|NCT04039503|520986647|FG000|Overall Study|Lost to Follow-up|0|||
144488694|NCT04039503|520986648|FG001|Overall Study|Lost to Follow-up|0|||
144488695|NCT04039503|520986649|FG002|Overall Study|Lost to Follow-up|1|||
144488696|NCT04039503|520986650|FG003|Overall Study|Lost to Follow-up|0|||
144488697|NCT04039503|520986647|FG000|Overall Study|Protocol Violation|0|||
144488698|NCT04039503|520986648|FG001|Overall Study|Protocol Violation|1|||
144488699|NCT04039503|520986649|FG002|Overall Study|Protocol Violation|2|||
144488700|NCT04039503|520986650|FG003|Overall Study|Protocol Violation|1|||
144488701|NCT04039503|520986647|FG000|Overall Study|Withdrawal by Subject|4|||
144488702|NCT04039503|520986648|FG001|Overall Study|Withdrawal by Subject|3|||
144488703|NCT04039503|520986649|FG002|Overall Study|Withdrawal by Subject|5|||
144488704|NCT04039503|520986650|FG003|Overall Study|Withdrawal by Subject|2|||
144488705|NCT03363659|520986661|FG000|Overall Study|Adverse Event|1|||
144488706|NCT03363659|520986661|FG000|Overall Study|Screen fail|1|||
144488707|NCT03363659|520986661|FG000|Overall Study|Withdrawal by Subject|1|||
144488708|NCT00904150|520986662|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
144488709|NCT00904150|520986663|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
144488710|NCT00904150|520986662|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
144488711|NCT00904150|520986663|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
144488712|NCT02601937|520986664|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488713|NCT02601937|520986665|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488714|NCT02601937|520986666|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488715|NCT02601937|520986667|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488716|NCT02601937|520986668|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488717|NCT02601937|520986669|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
144488718|NCT02601937|520986670|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488719|NCT02601937|520986671|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488720|NCT02601937|520986672|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488721|NCT02601937|520986673|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488722|NCT02601937|520986674|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
144488723|NCT02601937|520986664|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
144488724|NCT02601937|520986665|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488725|NCT02601937|520986666|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488726|NCT02601937|520986667|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488727|NCT02601937|520986668|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488728|NCT02601937|520986669|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488729|NCT02601937|520986670|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
144488730|NCT02601937|520986671|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488731|NCT02601937|520986672|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144715573|NCT00410410|521813375|FG004|Maintenance Period (MP)|Death|0|||
144488732|NCT02601937|520986673|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488733|NCT02601937|520986674|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
144488734|NCT02601937|520986664|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488735|NCT02601937|520986665|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488736|NCT02601937|520986666|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
144488737|NCT02601937|520986667|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488738|NCT02601937|520986668|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488739|NCT02601937|520986669|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488740|NCT02601937|520986670|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488741|NCT02601937|520986671|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488742|NCT02601937|520986672|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488743|NCT02601937|520986673|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488744|NCT02601937|520986674|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
144488745|NCT02601937|520986664|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
144488746|NCT02601937|520986665|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
144488747|NCT02601937|520986666|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
144488748|NCT02601937|520986667|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
144488749|NCT02601937|520986668|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
144488750|NCT02601937|520986669|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
144488751|NCT02601937|520986670|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
144488752|NCT02601937|520986671|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
144488753|NCT02601937|520986672|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
144488754|NCT02601937|520986673|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
144488755|NCT02601937|520986674|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
144488756|NCT02601937|520986664|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488757|NCT02601937|520986665|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488758|NCT02601937|520986666|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488759|NCT02601937|520986667|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488760|NCT02601937|520986668|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488761|NCT02601937|520986669|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488762|NCT02601937|520986670|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488763|NCT02601937|520986671|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488764|NCT02601937|520986672|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488765|NCT02601937|520986673|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
144488766|NCT02601937|520986674|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
144488767|NCT02601937|520986664|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488768|NCT02601937|520986665|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488769|NCT02601937|520986666|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488770|NCT02601937|520986667|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488771|NCT02601937|520986668|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488772|NCT02601937|520986669|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488773|NCT02601937|520986670|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488774|NCT02601937|520986671|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
144488775|NCT02601937|520986672|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488776|NCT02601937|520986673|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488777|NCT02601937|520986674|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
144488778|NCT02601937|520986664|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488779|NCT02601937|520986665|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488780|NCT02601937|520986666|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488781|NCT02601937|520986667|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488782|NCT02601937|520986668|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488783|NCT02601937|520986669|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488784|NCT02601937|520986670|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488785|NCT02601937|520986671|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488786|NCT02601937|520986672|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
144488787|NCT02601937|520986673|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
144488788|NCT02601937|520986674|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
144488789|NCT02601937|520986664|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488790|NCT02601937|520986665|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488791|NCT02601937|520986666|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488792|NCT02601937|520986667|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488793|NCT02601937|520986668|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488794|NCT02601937|520986669|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488795|NCT02601937|520986670|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
144488796|NCT02601937|520986671|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
144488797|NCT02601937|520986672|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
144488798|NCT02601937|520986673|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
144488799|NCT02601937|520986674|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
144488800|NCT02601937|520986664|FG000|Period 2: Dose Expansion Cohort|Other|0|||
144488801|NCT02601937|520986665|FG001|Period 2: Dose Expansion Cohort|Other|0|||
144488802|NCT02601937|520986666|FG002|Period 2: Dose Expansion Cohort|Other|0|||
144488803|NCT02601937|520986667|FG003|Period 2: Dose Expansion Cohort|Other|0|||
144488804|NCT02601937|520986668|FG004|Period 2: Dose Expansion Cohort|Other|0|||
144488805|NCT02601937|520986669|FG005|Period 2: Dose Expansion Cohort|Other|0|||
144488806|NCT02601937|520986670|FG006|Period 2: Dose Expansion Cohort|Other|0|||
144488807|NCT02601937|520986671|FG007|Period 2: Dose Expansion Cohort|Other|0|||
144488808|NCT02601937|520986672|FG008|Period 2: Dose Expansion Cohort|Other|2|||
144488809|NCT02601937|520986673|FG009|Period 2: Dose Expansion Cohort|Other|2|||
144488810|NCT02601937|520986674|FG010|Period 2: Dose Expansion Cohort|Other|0|||
144488811|NCT02601937|520986664|FG000|Period 2: Dose Expansion Cohort|Death|0|||
144488812|NCT02601937|520986665|FG001|Period 2: Dose Expansion Cohort|Death|0|||
144488813|NCT02601937|520986666|FG002|Period 2: Dose Expansion Cohort|Death|0|||
144488814|NCT02601937|520986667|FG003|Period 2: Dose Expansion Cohort|Death|0|||
144488815|NCT02601937|520986668|FG004|Period 2: Dose Expansion Cohort|Death|0|||
144488816|NCT02601937|520986669|FG005|Period 2: Dose Expansion Cohort|Death|0|||
144488817|NCT02601937|520986670|FG006|Period 2: Dose Expansion Cohort|Death|0|||
144488818|NCT02601937|520986671|FG007|Period 2: Dose Expansion Cohort|Death|0|||
144488819|NCT02601937|520986672|FG008|Period 2: Dose Expansion Cohort|Death|1|||
144488820|NCT02601937|520986673|FG009|Period 2: Dose Expansion Cohort|Death|0|||
144488821|NCT02601937|520986674|FG010|Period 2: Dose Expansion Cohort|Death|0|||
144488822|NCT02692235|520988122|FG000|Overall Study|Withdrawal by Subject|2|||
144488823|NCT02692235|520988123|FG001|Overall Study|Withdrawal by Subject|1|||
144488824|NCT02692235|520988122|FG000|Overall Study|Adverse Event|1|||
144488825|NCT02692235|520988123|FG001|Overall Study|Adverse Event|2|||
144488826|NCT01929993|520988125|FG000|Overall Study|Protocol Violation|4|||
144488827|NCT01929993|520988126|FG001|Overall Study|Protocol Violation|6|||
144488828|NCT01929993|520988125|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
144488829|NCT01929993|520988126|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
144488830|NCT03673098|520988127|FG000|Overall Study|Lost to Follow-up|2|||
144488831|NCT03673098|520988128|FG001|Overall Study|Lost to Follow-up|3|||
144488832|NCT03673098|520988127|FG000|Overall Study|Withdrawal by Subject|6|||
144488833|NCT03673098|520988128|FG001|Overall Study|Withdrawal by Subject|1|||
144488834|NCT03673098|520988127|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
144488835|NCT03673098|520988128|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
144488836|NCT01268059|520988132|FG000|Overall Study|Lost to Follow-up|0|||
144488837|NCT01268059|520988133|FG001|Overall Study|Lost to Follow-up|1|||
144488838|NCT01268059|520988134|FG002|Overall Study|Lost to Follow-up|0|||
144488839|NCT01268059|520988135|FG003|Overall Study|Lost to Follow-up|0|||
144488840|NCT01268059|520988132|FG000|Overall Study|Withdrawal by Subject|7|||
144488841|NCT01268059|520988133|FG001|Overall Study|Withdrawal by Subject|4|||
144488842|NCT01268059|520988134|FG002|Overall Study|Withdrawal by Subject|0|||
144488843|NCT01268059|520988135|FG003|Overall Study|Withdrawal by Subject|0|||
144488844|NCT01268059|520988132|FG000|Overall Study|Death|20|||
144488845|NCT01268059|520988133|FG001|Overall Study|Death|30|||
144488846|NCT01268059|520988134|FG002|Overall Study|Death|3|||
144488847|NCT01268059|520988135|FG003|Overall Study|Death|5|||
144488848|NCT01268059|520988132|FG000|Overall Study|Progression of disease|1|||
144488849|NCT01268059|520988133|FG001|Overall Study|Progression of disease|0|||
144488850|NCT01268059|520988134|FG002|Overall Study|Progression of disease|0|||
144488851|NCT01268059|520988135|FG003|Overall Study|Progression of disease|0|||
144488852|NCT03660943|520988136|FG000|Overall Study|Adverse Event|5|||
144488853|NCT03660943|520988137|FG001|Overall Study|Adverse Event|3|||
144488854|NCT03660943|520988136|FG000|Overall Study|Death|0|||
144488855|NCT03660943|520988137|FG001|Overall Study|Death|2|||
144488856|NCT03660943|520988136|FG000|Overall Study|Lost to Follow-up|7|||
144488857|NCT03660943|520988137|FG001|Overall Study|Lost to Follow-up|3|||
144488858|NCT03660943|520988136|FG000|Overall Study|Protocol Violation|3|||
144488859|NCT03660943|520988137|FG001|Overall Study|Protocol Violation|5|||
144488860|NCT03660943|520988136|FG000|Overall Study|Withdrawal by Subject|8|||
144488861|NCT03660943|520988137|FG001|Overall Study|Withdrawal by Subject|15|||
144488862|NCT03660943|520988136|FG000|Overall Study|Lack of Efficacy|9|||
144488863|NCT03660943|520988137|FG001|Overall Study|Lack of Efficacy|12|||
144488864|NCT03660943|520988136|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
144488865|NCT03660943|520988137|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
144488866|NCT03850444|520988138|FG000|Overall Study|Adverse Event|16|||
144488867|NCT03850444|520988139|FG001|Overall Study|Adverse Event|10|||
144488868|NCT03850444|520988138|FG000|Overall Study|Death|87|||
144488869|NCT03850444|520988139|FG001|Overall Study|Death|107|||
144488870|NCT03850444|520988138|FG000|Overall Study|Lost to Follow-up|1|||
144488871|NCT03850444|520988139|FG001|Overall Study|Lost to Follow-up|1|||
144488872|NCT03850444|520988138|FG000|Overall Study|Withdrawal by Subject|1|||
144488873|NCT03850444|520988139|FG001|Overall Study|Withdrawal by Subject|5|||
144488874|NCT03850444|520988138|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
144488875|NCT03850444|520988139|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
144488876|NCT01036087|520988140|FG000|Overall Study|Adverse Event|2|||
144488877|NCT01036087|520988140|FG000|Overall Study|Lack of Efficacy|1|||
144488878|NCT01021878|520988141|FG000|Overall Study|Lost to Follow-up|4|||
144488879|NCT01021878|520988142|FG001|Overall Study|Lost to Follow-up|3|||
144488880|NCT01021878|520988141|FG000|Overall Study|Death|0|||
144488881|NCT01021878|520988142|FG001|Overall Study|Death|1|||
144488882|NCT01021878|520988141|FG000|Overall Study|Adverse Event|6|||
144488883|NCT01021878|520988142|FG001|Overall Study|Adverse Event|5|||
144488884|NCT01021878|520988141|FG000|Overall Study|Transplantation|6|||
144488885|NCT01021878|520988142|FG001|Overall Study|Transplantation|1|||
144488886|NCT01155726|520988145|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
144488887|NCT01155726|520988146|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
144488888|NCT01155726|520988147|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
144488889|NCT01155726|520988148|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
144488890|NCT02892409|520988149|FG000|Overall Study|Adverse Event|1|||
144488891|NCT02892409|520988150|FG001|Overall Study|Adverse Event|0|||
144488892|NCT02892409|520988149|FG000|Overall Study|Withdrawal by Subject|2|||
144488893|NCT02892409|520988150|FG001|Overall Study|Withdrawal by Subject|1|||
144488894|NCT05305040|520988151|FG000|Overall Study|Not Dosed|37|||
144488895|NCT05305040|520988152|FG001|Overall Study|Not Dosed|37|||
144488896|NCT05305040|520988151|FG000|Overall Study|Study Closure|34|||
144488897|NCT05305040|520988152|FG001|Overall Study|Study Closure|46|||
144488898|NCT05305040|520988151|FG000|Overall Study|Death|14|||
144488899|NCT05305040|520988152|FG001|Overall Study|Death|13|||
144488900|NCT05305040|520988151|FG000|Overall Study|Withdrawal by Subject|15|||
144488901|NCT05305040|520988152|FG001|Overall Study|Withdrawal by Subject|10|||
144488902|NCT05305040|520988151|FG000|Overall Study|Other|13|||
144488903|NCT05305040|520988152|FG001|Overall Study|Other|10|||
144488904|NCT05305040|520988151|FG000|Overall Study|Primary Malignancy Relapse|3|||
144488905|NCT05305040|520988152|FG001|Overall Study|Primary Malignancy Relapse|4|||
144488906|NCT05305040|520988151|FG000|Overall Study|Adverse Event|3|||
144488907|NCT05305040|520988152|FG001|Overall Study|Adverse Event|3|||
144488908|NCT05305040|520988151|FG000|Overall Study|Lost to Follow-up|2|||
144488909|NCT05305040|520988152|FG001|Overall Study|Lost to Follow-up|1|||
144488910|NCT05305040|520988151|FG000|Overall Study|Graft versus host disease|2|||
144488911|NCT05305040|520988152|FG001|Overall Study|Graft versus host disease|0|||
144488912|NCT05305040|520988151|FG000|Overall Study|Investigator's Decision|1|||
144488913|NCT05305040|520988152|FG001|Overall Study|Investigator's Decision|1|||
144488914|NCT05305040|520988151|FG000|Overall Study|COVID-19 Reasons|1|||
144488915|NCT05305040|520988152|FG001|Overall Study|COVID-19 Reasons|0|||
144488916|NCT01195675|520988156|FG000|Overall Study|Adverse Event|1|||
144488917|NCT01195675|520988156|FG000|Overall Study|Withdrawal by Subject|2|||
144488918|NCT02424344|520988157|FG000|Overall Study|Lack of Efficacy|0|||
144488919|NCT02424344|520988158|FG001|Overall Study|Lack of Efficacy|1|||
144488920|NCT02424344|520988157|FG000|Overall Study|Withdrawal by Subject|2|||
144488921|NCT02424344|520988158|FG001|Overall Study|Withdrawal by Subject|1|||
144488922|NCT02424344|520988157|FG000|Overall Study|Lost to Follow-up|1|||
144488923|NCT02424344|520988158|FG001|Overall Study|Lost to Follow-up|0|||
144488924|NCT02424344|520988157|FG000|Overall Study|Adverse Event|4|||
144488925|NCT02424344|520988158|FG001|Overall Study|Adverse Event|8|||
144488926|NCT01536262|520988159|FG000|Overall Study|Adverse Event|6|||
144488927|NCT01536262|520988160|FG001|Overall Study|Adverse Event|1|||
144488928|NCT01536262|520988161|FG002|Overall Study|Adverse Event|2|||
144488929|NCT01536262|520988159|FG000|Overall Study|Withdrawal by Subject|1|||
144488930|NCT01536262|520988160|FG001|Overall Study|Withdrawal by Subject|1|||
144488931|NCT01536262|520988161|FG002|Overall Study|Withdrawal by Subject|0|||
144488932|NCT01536262|520988159|FG000|Overall Study|Other than stated above|1|||
144488933|NCT01536262|520988160|FG001|Overall Study|Other than stated above|0|||
144488934|NCT01536262|520988161|FG002|Overall Study|Other than stated above|0|||
144488935|NCT05257837|520988165|FG000|Overall Study|Excluded (did not find the guns)|4|||
144488936|NCT05257837|520988166|FG001|Overall Study|Excluded (did not find the guns)|2|||
144488937|NCT05257837|520988167|FG002|Overall Study|Excluded (did not find the guns)|4|||
144488938|NCT05257837|520988168|FG003|Overall Study|Excluded (did not find the guns)|0|||
144488939|NCT01781611|520988169|FG000|Overall Study|Adverse Event|4|||
144488940|NCT01781611|520988170|FG001|Overall Study|Adverse Event|0|||
144488941|NCT01625338|520988171|FG000|Overall Study|Enrolled but not Treated|0|||
144488942|NCT01625338|520988172|FG001|Overall Study|Enrolled but not Treated|0|||
144488943|NCT01625338|520988173|FG002|Overall Study|Enrolled but not Treated|1|||
144488944|NCT01625338|520988171|FG000|Overall Study|Efficacy Failure|27|||
144488945|NCT01625338|520988172|FG001|Overall Study|Efficacy Failure|39|||
144488946|NCT01625338|520988173|FG002|Overall Study|Efficacy Failure|31|||
144488947|NCT01625338|520988171|FG000|Overall Study|Lost to Follow-up|3|||
144488948|NCT01625338|520988172|FG001|Overall Study|Lost to Follow-up|3|||
144488949|NCT01625338|520988173|FG002|Overall Study|Lost to Follow-up|2|||
144488950|NCT01625338|520988171|FG000|Overall Study|Investigator Decision|0|||
144488951|NCT01625338|520988172|FG001|Overall Study|Investigator Decision|2|||
144488952|NCT01625338|520988173|FG002|Overall Study|Investigator Decision|1|||
144488953|NCT01625338|520988171|FG000|Overall Study|Subject Withdrew Consent|1|||
144488954|NCT01625338|520988172|FG001|Overall Study|Subject Withdrew Consent|0|||
144488955|NCT01625338|520988173|FG002|Overall Study|Subject Withdrew Consent|2|||
144488956|NCT01625338|520988171|FG000|Overall Study|Adverse Event|1|||
144488957|NCT01625338|520988172|FG001|Overall Study|Adverse Event|0|||
144488958|NCT01625338|520988173|FG002|Overall Study|Adverse Event|1|||
144488959|NCT01625338|520988171|FG000|Overall Study|Study Discontinued by Sponsor|0|||
144488960|NCT01625338|520988172|FG001|Overall Study|Study Discontinued by Sponsor|0|||
144488961|NCT01625338|520988173|FG002|Overall Study|Study Discontinued by Sponsor|1|||
144488962|NCT03639675|520988174|FG000|Overall Study|Withdrawal by Subject|1|||
144488963|NCT02459587|520988175|FG000|3-Month Follow-up Assessment|Death|0|||
144488964|NCT02459587|520988176|FG001|3-Month Follow-up Assessment|Death|2|||
144488965|NCT02459587|520988175|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
144488966|NCT02459587|520988176|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
144488967|NCT02459587|520988175|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
144488968|NCT02459587|520988176|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
144488969|NCT02459587|520988175|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
144488970|NCT02459587|520988176|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
144488971|NCT02459587|520988175|FG000|6-month Follow-up Assessment|Death|2|||
144488972|NCT02459587|520988176|FG001|6-month Follow-up Assessment|Death|1|||
144488973|NCT02459587|520988175|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
144488974|NCT02459587|520988176|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
144488975|NCT02459587|520988175|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
144488976|NCT02459587|520988176|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
144488977|NCT02459587|520988175|FG000|12-month Follow-up Assessment|Death|2|||
144488978|NCT02459587|520988176|FG001|12-month Follow-up Assessment|Death|0|||
144488979|NCT02459587|520988175|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
144488980|NCT02459587|520988176|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
144488981|NCT02459587|520988175|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
144488982|NCT02459587|520988176|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
144488983|NCT02459587|520988175|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
144488984|NCT02459587|520988176|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
144488985|NCT01473420|520988179|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
144488986|NCT01473420|520988180|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
144488987|NCT01473420|520988179|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
144488988|NCT01473420|520988180|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
144488989|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
144488990|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
144488991|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
144488992|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
144488993|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
144488994|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
144488995|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
144488996|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
144488997|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
144488998|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
144488999|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
144489000|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
144489001|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
144489002|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
144489003|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
144489004|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
144489005|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
144489006|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
144489007|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
144489008|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
144489009|NCT01473420|520988179|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
144489010|NCT01473420|520988180|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
144489011|NCT04172987|520988184|FG000|Lead In Period|Adverse Event|1|||
144489012|NCT04172987|520988184|FG000|Lead In Period|Protocol Violation|1|||
144369803|NCT02447003|520561700|FG001|Overall Study|Sponsor Decision|11|||
144489013|NCT04172987|520988184|FG000|Period 1|Physician Decision|1|||
144489014|NCT04172987|520988184|FG000|Period 2|Adverse Event|5|||
144489015|NCT04172987|520988184|FG000|Period 2|Dosing Termination by Sponsor|4|||
144489016|NCT00577720|520988189|FG000|Overall Study|Adverse Event|2|||
144489017|NCT00577720|520988190|FG001|Overall Study|Adverse Event|1|||
144489018|NCT00577720|520988191|FG002|Overall Study|Adverse Event|0|||
144489019|NCT00577720|520988192|FG003|Overall Study|Adverse Event|4|||
144489020|NCT00577720|520988189|FG000|Overall Study|Lost to Follow-up|0|||
144489021|NCT00577720|520988190|FG001|Overall Study|Lost to Follow-up|0|||
144489022|NCT00577720|520988191|FG002|Overall Study|Lost to Follow-up|1|||
144489023|NCT00577720|520988192|FG003|Overall Study|Lost to Follow-up|0|||
144489024|NCT00577720|520988189|FG000|Overall Study|Protocol Violation|0|||
144489025|NCT00577720|520988190|FG001|Overall Study|Protocol Violation|0|||
144489026|NCT00577720|520988191|FG002|Overall Study|Protocol Violation|0|||
144489027|NCT00577720|520988192|FG003|Overall Study|Protocol Violation|1|||
144489028|NCT00577720|520988189|FG000|Overall Study|Withdrawal by Subject|2|||
144489029|NCT00577720|520988190|FG001|Overall Study|Withdrawal by Subject|0|||
144489030|NCT00577720|520988191|FG002|Overall Study|Withdrawal by Subject|0|||
144489031|NCT00577720|520988192|FG003|Overall Study|Withdrawal by Subject|2|||
144489032|NCT00738530|520988196|FG000|Overall Study|Death|220|||
144489033|NCT00738530|520988197|FG001|Overall Study|Death|224|||
144489034|NCT00738530|520988196|FG000|Overall Study|Lost to Follow-up|8|||
144489035|NCT00738530|520988197|FG001|Overall Study|Lost to Follow-up|6|||
144489036|NCT00738530|520988196|FG000|Overall Study|Withdrawal by Subject|6|||
144489037|NCT00738530|520988197|FG001|Overall Study|Withdrawal by Subject|8|||
144489038|NCT01628510|520988198|FG000|Overall Study|Withdrawal by Subject|0|||
144489039|NCT01628510|520988199|FG001|Overall Study|Withdrawal by Subject|4|||
144489040|NCT01628510|520988198|FG000|Overall Study|Death|3|||
144489041|NCT01628510|520988199|FG001|Overall Study|Death|1|||
144489042|NCT03100838|520988200|FG000|Overall Study|Adverse Event|1|||
144489043|NCT03100838|520988201|FG001|Overall Study|Adverse Event|0|||
144489044|NCT03100838|520988202|FG002|Overall Study|Adverse Event|0|||
144489045|NCT03100838|520988203|FG003|Overall Study|Adverse Event|0|||
144489046|NCT03100838|520988200|FG000|Overall Study|Physician Decision|1|||
144489047|NCT03100838|520988201|FG001|Overall Study|Physician Decision|1|||
144489048|NCT03100838|520988202|FG002|Overall Study|Physician Decision|1|||
144489049|NCT03100838|520988203|FG003|Overall Study|Physician Decision|1|||
144489050|NCT03100838|520988200|FG000|Overall Study|Pregnancy|0|||
144489051|NCT03100838|520988201|FG001|Overall Study|Pregnancy|1|||
144489052|NCT03100838|520988202|FG002|Overall Study|Pregnancy|0|||
144489053|NCT03100838|520988203|FG003|Overall Study|Pregnancy|0|||
144489054|NCT03100838|520988200|FG000|Overall Study|Lost to Follow-up|0|||
144489055|NCT03100838|520988201|FG001|Overall Study|Lost to Follow-up|0|||
144489056|NCT03100838|520988202|FG002|Overall Study|Lost to Follow-up|1|||
144489057|NCT03100838|520988203|FG003|Overall Study|Lost to Follow-up|0|||
144489058|NCT02040090|520988207|FG000|Overall Study|Adverse Event|2|||
144489059|NCT02040090|520988208|FG001|Overall Study|Adverse Event|0|||
144489060|NCT02040090|520988207|FG000|Overall Study|Physician Decision|1|||
144489061|NCT02040090|520988208|FG001|Overall Study|Physician Decision|0|||
144489062|NCT02040090|520988207|FG000|Overall Study|Withdrawal by Subject|0|||
144489063|NCT02040090|520988208|FG001|Overall Study|Withdrawal by Subject|1|||
144489064|NCT02040090|520988207|FG000|Overall Study|Lost to Follow-up|0|||
144489065|NCT02040090|520988208|FG001|Overall Study|Lost to Follow-up|1|||
144489066|NCT03259373|520988209|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
144489067|NCT03259373|520988210|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
144489068|NCT03259373|520988209|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
144489069|NCT03259373|520988210|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
144489070|NCT03259373|520988209|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
144489071|NCT03259373|520988210|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
144489072|NCT03259373|520988209|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
144489073|NCT03259373|520988210|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
144489074|NCT03259373|520988209|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
144489075|NCT03259373|520988210|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
144489076|NCT03259373|520988209|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
144715574|NCT00410410|521813376|FG005|Maintenance Period (MP)|Death|0|||
144715575|NCT00410410|521813377|FG006|Maintenance Period (MP)|Death|1|||
144715576|NCT00410410|521813378|FG007|Maintenance Period (MP)|Death|0|||
144715577|NCT00410410|521813379|FG008|Maintenance Period (MP)|Death|0|||
144715578|NCT00410410|521813371|FG000|Maintenance Period (MP)|Adverse Event|0|||
144369804|NCT02447003|520561699|FG000|Overall Study|Progressive Disease|1|||
144489077|NCT03259373|520988210|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
144489078|NCT00885495|520988214|FG000|Overall Study|Adverse Event|1|||
144489079|NCT00885495|520988215|FG001|Overall Study|Adverse Event|2|||
144489080|NCT00885495|520988214|FG000|Overall Study|Protocol Violation|0|||
144489081|NCT00885495|520988215|FG001|Overall Study|Protocol Violation|1|||
144489082|NCT00885495|520988214|FG000|Overall Study|Withdrawal by Subject|1|||
144489083|NCT00885495|520988215|FG001|Overall Study|Withdrawal by Subject|0|||
144489084|NCT04504916|520988219|FG000|Overall Study|Study terminated|7|||
144489085|NCT04504916|520988220|FG001|Overall Study|Study terminated|8|||
144715579|NCT00410410|521813372|FG001|Maintenance Period (MP)|Adverse Event|0|||
144489086|NCT04504916|520988219|FG000|Overall Study|Death|54|||
144489087|NCT04504916|520988220|FG001|Overall Study|Death|18|||
144489088|NCT04504916|520988219|FG000|Overall Study|Lost to Follow-up|1|||
144489089|NCT04504916|520988220|FG001|Overall Study|Lost to Follow-up|1|||
144489090|NCT04504916|520988219|FG000|Overall Study|Withdrawal by Subject|8|||
144489091|NCT04504916|520988220|FG001|Overall Study|Withdrawal by Subject|4|||
144489092|NCT04504916|520988219|FG000|Overall Study|Did not agree to follow-up|0|||
144489093|NCT04504916|520988220|FG001|Overall Study|Did not agree to follow-up|1|||
144489094|NCT01368211|520988221|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
144489095|NCT01368211|520988222|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
144489096|NCT01349660|520988226|FG000|Overall Study|Still Receiving Study Treatment|0|||
144489097|NCT01349660|520988227|FG001|Overall Study|Still Receiving Study Treatment|0|||
144489098|NCT01349660|520988228|FG002|Overall Study|Still Receiving Study Treatment|1|||
144489099|NCT01349660|520988226|FG000|Overall Study|Disease Progression|2|||
144489100|NCT01349660|520988227|FG001|Overall Study|Disease Progression|4|||
144489101|NCT01349660|520988228|FG002|Overall Study|Disease Progression|50|||
144489102|NCT01349660|520988226|FG000|Overall Study|Adverse Event|1|||
144489103|NCT01349660|520988227|FG001|Overall Study|Adverse Event|1|||
144489104|NCT01349660|520988228|FG002|Overall Study|Adverse Event|12|||
144489105|NCT01349660|520988226|FG000|Overall Study|Withdrawal by Subject|2|||
144489106|NCT01349660|520988227|FG001|Overall Study|Withdrawal by Subject|0|||
144489107|NCT01349660|520988228|FG002|Overall Study|Withdrawal by Subject|9|||
144489108|NCT01349660|520988226|FG000|Overall Study|Death|1|||
144489109|NCT01349660|520988227|FG001|Overall Study|Death|1|||
144489110|NCT01349660|520988228|FG002|Overall Study|Death|0|||
144489111|NCT01349660|520988226|FG000|Overall Study|Non-Permitted Interventions|0|||
144489112|NCT01349660|520988227|FG001|Overall Study|Non-Permitted Interventions|0|||
144489113|NCT01349660|520988228|FG002|Overall Study|Non-Permitted Interventions|2|||
144489114|NCT01349660|520988226|FG000|Overall Study|Study Compliance|0|||
144489115|NCT01349660|520988227|FG001|Overall Study|Study Compliance|0|||
144489116|NCT01349660|520988228|FG002|Overall Study|Study Compliance|1|||
144489117|NCT01349660|520988226|FG000|Overall Study|Declining Performance Status|0|||
144489118|NCT01349660|520988227|FG001|Overall Study|Declining Performance Status|0|||
144489119|NCT01349660|520988228|FG002|Overall Study|Declining Performance Status|1|||
144489120|NCT01563978|520988229|FG000|Overall Study|Physician Decision|1|||
144489121|NCT01563978|520988230|FG001|Overall Study|Physician Decision|0|||
144489122|NCT01563978|520988229|FG000|Overall Study|Lost to Follow-up|1|||
144489123|NCT01563978|520988230|FG001|Overall Study|Lost to Follow-up|0|||
144489124|NCT01563978|520988229|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
144489125|NCT01563978|520988230|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
144489126|NCT01563978|520988229|FG000|Overall Study|Adverse Event|1|||
144489127|NCT01563978|520988230|FG001|Overall Study|Adverse Event|2|||
144489128|NCT05764239|520988231|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
144489129|NCT05764239|520988231|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
144489130|NCT05764239|520988231|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
144489131|NCT05764239|520988231|FG000|DEP (Part 1)|Adverse Event|1|||
144489132|NCT05764239|520988231|FG000|DEP (Part 1)|Lost to Follow-up|1|||
144489133|NCT05764239|520988231|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
144489134|NCT05764239|520988231|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
144489135|NCT05764239|520988231|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
144489136|NCT05764239|520988231|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
144489137|NCT05593211|520988234|FG000|Overall Study|Withdrawal by Subject|1|||
144489138|NCT03225846|520988235|FG000|Overall Study|Adverse Event|0|||
144489139|NCT03225846|520988236|FG001|Overall Study|Adverse Event|0|||
144489140|NCT03225846|520988237|FG002|Overall Study|Adverse Event|0|||
144489141|NCT03225846|520988238|FG003|Overall Study|Adverse Event|0|||
144489142|NCT03225846|520988239|FG004|Overall Study|Adverse Event|0|||
144489143|NCT03225846|520988240|FG005|Overall Study|Adverse Event|0|||
144489144|NCT03225846|520988241|FG006|Overall Study|Adverse Event|6|||
144489145|NCT03225846|520988235|FG000|Overall Study|Withdrawal by Subject|0|||
144489146|NCT03225846|520988236|FG001|Overall Study|Withdrawal by Subject|1|||
144489147|NCT03225846|520988237|FG002|Overall Study|Withdrawal by Subject|0|||
144489148|NCT03225846|520988238|FG003|Overall Study|Withdrawal by Subject|0|||
144489149|NCT03225846|520988239|FG004|Overall Study|Withdrawal by Subject|0|||
144489150|NCT03225846|520988240|FG005|Overall Study|Withdrawal by Subject|0|||
144489151|NCT03225846|520988241|FG006|Overall Study|Withdrawal by Subject|0|||
144489152|NCT03225846|520988235|FG000|Overall Study|Death|0|||
144489153|NCT03225846|520988236|FG001|Overall Study|Death|1|||
144489154|NCT03225846|520988237|FG002|Overall Study|Death|0|||
144489155|NCT03225846|520988238|FG003|Overall Study|Death|0|||
144489156|NCT03225846|520988239|FG004|Overall Study|Death|0|||
144489157|NCT03225846|520988240|FG005|Overall Study|Death|0|||
144489158|NCT03225846|520988241|FG006|Overall Study|Death|0|||
144489159|NCT03225846|520988235|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
144489160|NCT03225846|520988236|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
144489161|NCT03225846|520988237|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
144489162|NCT03225846|520988238|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
144489163|NCT03225846|520988239|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
144489164|NCT03225846|520988240|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
144489165|NCT03225846|520988241|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
144489166|NCT03225846|520988235|FG000|Overall Study|Patient decision|0|||
144489167|NCT03225846|520988236|FG001|Overall Study|Patient decision|0|||
144489168|NCT03225846|520988237|FG002|Overall Study|Patient decision|0|||
144489169|NCT03225846|520988238|FG003|Overall Study|Patient decision|0|||
144489170|NCT03225846|520988239|FG004|Overall Study|Patient decision|0|||
144489171|NCT03225846|520988240|FG005|Overall Study|Patient decision|0|||
144489172|NCT03225846|520988241|FG006|Overall Study|Patient decision|1|||
144489173|NCT00996580|520988242|FG000|Overall Study|Adverse Event|466|||
144489174|NCT00996580|520988242|FG000|Overall Study|Lost to Follow-up|480|||
144489175|NCT00996580|520988242|FG000|Overall Study|Noncompliance with the protocol|137|||
144489176|NCT00996580|520988242|FG000|Overall Study|Physician Decision|5|||
144489177|NCT00996580|520988242|FG000|Overall Study|Pregnancy|68|||
144489178|NCT00996580|520988242|FG000|Overall Study|Protocol Violation|16|||
144489179|NCT00996580|520988242|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
144489180|NCT00996580|520988242|FG000|Overall Study|Withdrawal by Subject|217|||
144489181|NCT00996580|520988242|FG000|Overall Study|Other|29|||
144489182|NCT04248465|520988243|FG000|Randomized-Controlled Period|Death|12|||
144489183|NCT04248465|520988244|FG001|Randomized-Controlled Period|Death|5|||
144489184|NCT04248465|520988243|FG000|Randomized-Controlled Period|Adverse Event|2|||
144489185|NCT04248465|520988244|FG001|Randomized-Controlled Period|Adverse Event|0|||
144489186|NCT04248465|520988243|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
144489187|NCT04248465|520988244|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
144489188|NCT04248465|520988243|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
144489189|NCT04248465|520988244|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
144489190|NCT04248465|520988243|FG000|Randomized-Controlled Period|Physician Decision|1|||
144489191|NCT04248465|520988244|FG001|Randomized-Controlled Period|Physician Decision|1|||
144489192|NCT04248465|520988243|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
144489193|NCT04248465|520988244|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
144489194|NCT04248465|520988243|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
144489195|NCT04248465|520988244|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
144489196|NCT04248465|520988243|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
144489197|NCT04248465|520988244|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
144489198|NCT05708846|520988245|FG000|Overall Study|Death|5|||
144489199|NCT05708846|520988245|FG000|Overall Study|Withdrawal by Subject|20|||
144489200|NCT00238420|520988246|FG000|Overall Study|Protocol Violation|1|||
144489201|NCT00238420|520988247|FG001|Overall Study|Protocol Violation|1|||
144489202|NCT00442286|520988248|FG000|Overall Study|Death|2|||
144489203|NCT00442286|520988249|FG001|Overall Study|Death|2|||
144489204|NCT00442286|520988248|FG000|Overall Study|Lost to Follow-up|1|||
144489205|NCT00442286|520988249|FG001|Overall Study|Lost to Follow-up|0|||
144489206|NCT00442286|520988248|FG000|Overall Study|Withdrawal by Subject|2|||
144489207|NCT00442286|520988249|FG001|Overall Study|Withdrawal by Subject|0|||
144489208|NCT00442286|520988248|FG000|Overall Study|System explanted|1|||
144489209|NCT00442286|520988249|FG001|Overall Study|System explanted|0|||
144489210|NCT00442286|520988248|FG000|Overall Study|Patient Injury|1|||
144489211|NCT00442286|520988249|FG001|Overall Study|Patient Injury|0|||
144489212|NCT00641186|520988250|FG000|Overall Study|Adverse Event|3|||
144489213|NCT04140890|520988255|FG000|Overall Study|Withdrawal by Subject|0|||
144489214|NCT04140890|520988256|FG001|Overall Study|Withdrawal by Subject|1|||
144489215|NCT02102464|520988257|FG000|Randomized Study|Withdrawal by Subject|0|||
144489216|NCT02102464|520988258|FG001|Randomized Study|Withdrawal by Subject|1|||
144489217|NCT02102464|520988259|FG002|Randomized Study|Withdrawal by Subject|0|||
144489218|NCT01778062|520988260|FG000|Overall Study|Adverse Event|1|||
144489219|NCT01778062|520988261|FG001|Overall Study|Adverse Event|3|||
144489220|NCT01778062|520988260|FG000|Overall Study|Consent Withdrawal|1|||
144489221|NCT01778062|520988261|FG001|Overall Study|Consent Withdrawal|5|||
144489222|NCT01778062|520988260|FG000|Overall Study|major protocol deviation|4|||
144489223|NCT01778062|520988261|FG001|Overall Study|major protocol deviation|3|||
144489224|NCT01824472|520988262|FG000|Overall Study|Lost to Follow-up|0|||
144489225|NCT01824472|520988263|FG001|Overall Study|Lost to Follow-up|0|||
144489226|NCT01824472|520988264|FG002|Overall Study|Lost to Follow-up|1|||
144489227|NCT01824472|520988262|FG000|Overall Study|Withdrawal by Subject|1|||
144489228|NCT01824472|520988263|FG001|Overall Study|Withdrawal by Subject|5|||
144489229|NCT01824472|520988264|FG002|Overall Study|Withdrawal by Subject|3|||
144489230|NCT01824472|520988262|FG000|Overall Study|Ineligible post randomization&screening|0|||
144489231|NCT01824472|520988263|FG001|Overall Study|Ineligible post randomization&screening|2|||
144489232|NCT01824472|520988264|FG002|Overall Study|Ineligible post randomization&screening|0|||
144489233|NCT03387514|520988265|FG000|Overall Study|Withdrawal by Subject|2|||
144369805|NCT02447003|520561700|FG001|Overall Study|Progressive Disease|0|||
144489234|NCT03387514|520988265|FG000|Overall Study|Physician Decision|1|||
144489235|NCT03387514|520988265|FG000|Overall Study|Lost to Follow-up|2|||
144489236|NCT02846558|520988274|FG000|Overall Study|Adverse Event|1|||
144489237|NCT02846558|520988275|FG001|Overall Study|Adverse Event|0|||
144489238|NCT02846558|520988276|FG002|Overall Study|Adverse Event|0|||
144489239|NCT02846558|520988277|FG003|Overall Study|Adverse Event|0|||
144489240|NCT02846558|520988274|FG000|Overall Study|Withdrawal by Subject|5|||
144489241|NCT02846558|520988275|FG001|Overall Study|Withdrawal by Subject|4|||
144489242|NCT02846558|520988276|FG002|Overall Study|Withdrawal by Subject|2|||
144489243|NCT02846558|520988277|FG003|Overall Study|Withdrawal by Subject|2|||
144489244|NCT02846558|520988274|FG000|Overall Study|Lost to Follow-up|2|||
144489245|NCT02846558|520988275|FG001|Overall Study|Lost to Follow-up|0|||
144489246|NCT02846558|520988276|FG002|Overall Study|Lost to Follow-up|0|||
144489247|NCT02846558|520988277|FG003|Overall Study|Lost to Follow-up|0|||
144489248|NCT04445155|520988278|FG000|Overall Study|Lost to Follow-up|11|||
144489249|NCT04445155|520988279|FG001|Overall Study|Lost to Follow-up|2|||
144489250|NCT04445155|520988280|FG002|Overall Study|Lost to Follow-up|3|||
144489251|NCT04445155|520988281|FG003|Overall Study|Lost to Follow-up|0|||
144489252|NCT04445155|520988278|FG000|Overall Study|Withdrawal by Subject|8|||
144489253|NCT04445155|520988279|FG001|Overall Study|Withdrawal by Subject|0|||
144489254|NCT04445155|520988280|FG002|Overall Study|Withdrawal by Subject|0|||
144489255|NCT04445155|520988281|FG003|Overall Study|Withdrawal by Subject|0|||
144489256|NCT04445155|520988278|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
144489257|NCT04445155|520988279|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
144489258|NCT04445155|520988280|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
144489259|NCT04445155|520988281|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
144489260|NCT04445155|520988278|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
144489261|NCT04445155|520988279|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
144489262|NCT04445155|520988280|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
144489263|NCT04445155|520988281|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
144489264|NCT02253316|520988283|FG000|Consolidation|Progression|4|||
144489265|NCT02253316|520988284|FG001|Consolidation|Progression|0|||
144489266|NCT02253316|520988285|FG002|Consolidation|Progression|0|||
144489267|NCT02253316|520988283|FG000|Consolidation|Non-Compliance|1|||
144489268|NCT02253316|520988284|FG001|Consolidation|Non-Compliance|0|||
144489269|NCT02253316|520988285|FG002|Consolidation|Non-Compliance|0|||
144489270|NCT02253316|520988283|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
144489271|NCT02253316|520988284|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
144489272|NCT02253316|520988285|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
144489273|NCT02253316|520988283|FG000|Consolidation|Secondary Malignancy|2|||
144489274|NCT02253316|520988284|FG001|Consolidation|Secondary Malignancy|0|||
144489275|NCT02253316|520988285|FG002|Consolidation|Secondary Malignancy|0|||
144489276|NCT02253316|520988283|FG000|Consolidation|Adverse Event|7|||
144489277|NCT02253316|520988284|FG001|Consolidation|Adverse Event|0|||
144489278|NCT02253316|520988285|FG002|Consolidation|Adverse Event|0|||
144489279|NCT02253316|520988283|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
144489280|NCT02253316|520988284|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
144489281|NCT02253316|520988285|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
144489282|NCT02253316|520988283|FG000|Maintenance|Physician Decision|0|||
144489283|NCT02253316|520988284|FG001|Maintenance|Physician Decision|7|||
144489284|NCT02253316|520988285|FG002|Maintenance|Physician Decision|16|||
144489285|NCT02253316|520988283|FG000|Maintenance|Non-Compliance|0|||
144489286|NCT02253316|520988284|FG001|Maintenance|Non-Compliance|1|||
144489287|NCT02253316|520988285|FG002|Maintenance|Non-Compliance|1|||
144489288|NCT02253316|520988283|FG000|Maintenance|Secondary Malignancy|0|||
144489289|NCT02253316|520988284|FG001|Maintenance|Secondary Malignancy|2|||
144489290|NCT02253316|520988285|FG002|Maintenance|Secondary Malignancy|6|||
144489291|NCT02253316|520988283|FG000|Maintenance|Adverse Event|0|||
144489292|NCT02253316|520988284|FG001|Maintenance|Adverse Event|8|||
144489293|NCT02253316|520988285|FG002|Maintenance|Adverse Event|12|||
144489294|NCT02253316|520988283|FG000|Maintenance|Still receiving active treatment|0|||
144489295|NCT02253316|520988284|FG001|Maintenance|Still receiving active treatment|4|||
144489296|NCT02253316|520988285|FG002|Maintenance|Still receiving active treatment|0|||
144489297|NCT04213846|520990209|FG000|Overall Study|Withdrawal by Subject|7|||
144489298|NCT04213846|520990210|FG001|Overall Study|Withdrawal by Subject|6|||
144489299|NCT04213846|520990209|FG000|Overall Study|Lost to Follow-up|15|||
144489300|NCT04213846|520990210|FG001|Overall Study|Lost to Follow-up|21|||
144489301|NCT03038672|520990211|FG000|Initial Treatment|Unacceptable chemistry|0|||
144489302|NCT03038672|520990212|FG001|Initial Treatment|Unacceptable chemistry|1|||
144369806|NCT02447003|520561699|FG000|Overall Study|Lost to Follow-up|5|||
144489303|NCT03038672|520990211|FG000|Initial Treatment|Progression prior to treatment|1|||
144489304|NCT03038672|520990212|FG001|Initial Treatment|Progression prior to treatment|0|||
144369807|NCT02447003|520561700|FG001|Overall Study|Lost to Follow-up|0|||
144369808|NCT02447003|520561699|FG000|Overall Study|Death|154|||
144369809|NCT02447003|520561700|FG001|Overall Study|Death|63|||
144369810|NCT04161157|520561701|FG000|Overall Study|Lost to Follow-up|4|||
144369811|NCT04161157|520561701|FG000|Overall Study|Death|3|||
144489305|NCT03038672|520990211|FG000|Initial Treatment|No treatment per protocol|1|||
144489306|NCT03038672|520990212|FG001|Initial Treatment|No treatment per protocol|0|||
144489307|NCT05220501|520990213|FG000|Overall Study|Withdrawal by Subject|11|||
144489308|NCT05220501|520990214|FG001|Overall Study|Withdrawal by Subject|21|||
144489309|NCT05220501|520990215|FG002|Overall Study|Withdrawal by Subject|32|||
144489310|NCT05220501|520990213|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
144489311|NCT05220501|520990214|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
144489312|NCT05220501|520990215|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
144489313|NCT03468426|520990222|FG000|Overall Study|Progressive disease|3|||
144489314|NCT03468426|520990223|FG001|Overall Study|Progressive disease|0|||
144489315|NCT03468426|520990224|FG002|Overall Study|Progressive disease|4|||
144489316|NCT03468426|520990225|FG003|Overall Study|Progressive disease|20|||
144489317|NCT03468426|520990226|FG004|Overall Study|Progressive disease|23|||
144489318|NCT03468426|520990227|FG005|Overall Study|Progressive disease|15|||
144489319|NCT03468426|520990228|FG006|Overall Study|Progressive disease|24|||
144489320|NCT03468426|520990229|FG007|Overall Study|Progressive disease|27|||
144489321|NCT03468426|520990230|FG008|Overall Study|Progressive disease|13|||
144489322|NCT03468426|520990231|FG009|Overall Study|Progressive disease|13|||
144489323|NCT03468426|520990232|FG010|Overall Study|Progressive disease|0|||
144489324|NCT03468426|520990222|FG000|Overall Study|Other adverse event or clinical progression|0|||
144489325|NCT03468426|520990223|FG001|Overall Study|Other adverse event or clinical progression|1|||
144489326|NCT03468426|520990224|FG002|Overall Study|Other adverse event or clinical progression|3|||
144489327|NCT03468426|520990225|FG003|Overall Study|Other adverse event or clinical progression|14|||
144489328|NCT03468426|520990226|FG004|Overall Study|Other adverse event or clinical progression|10|||
144489329|NCT03468426|520990227|FG005|Overall Study|Other adverse event or clinical progression|8|||
144489330|NCT03468426|520990228|FG006|Overall Study|Other adverse event or clinical progression|5|||
144489331|NCT03468426|520990229|FG007|Overall Study|Other adverse event or clinical progression|4|||
144489332|NCT03468426|520990230|FG008|Overall Study|Other adverse event or clinical progression|6|||
144489333|NCT03468426|520990231|FG009|Overall Study|Other adverse event or clinical progression|11|||
144489334|NCT03468426|520990232|FG010|Overall Study|Other adverse event or clinical progression|0|||
144489335|NCT03468426|520990222|FG000|Overall Study|Refused to continue taking trial medication|0|||
144489336|NCT03468426|520990223|FG001|Overall Study|Refused to continue taking trial medication|0|||
144489337|NCT03468426|520990224|FG002|Overall Study|Refused to continue taking trial medication|0|||
144489338|NCT03468426|520990225|FG003|Overall Study|Refused to continue taking trial medication|2|||
144489339|NCT03468426|520990226|FG004|Overall Study|Refused to continue taking trial medication|0|||
144489340|NCT03468426|520990227|FG005|Overall Study|Refused to continue taking trial medication|3|||
144489341|NCT03468426|520990228|FG006|Overall Study|Refused to continue taking trial medication|0|||
144489342|NCT03468426|520990229|FG007|Overall Study|Refused to continue taking trial medication|0|||
144489343|NCT03468426|520990230|FG008|Overall Study|Refused to continue taking trial medication|1|||
144489344|NCT03468426|520990231|FG009|Overall Study|Refused to continue taking trial medication|0|||
144489345|NCT03468426|520990232|FG010|Overall Study|Refused to continue taking trial medication|0|||
144489346|NCT03468426|520990222|FG000|Overall Study|Other than listed|0|||
144489347|NCT03468426|520990223|FG001|Overall Study|Other than listed|1|||
144489348|NCT03468426|520990224|FG002|Overall Study|Other than listed|0|||
144489349|NCT03468426|520990225|FG003|Overall Study|Other than listed|0|||
144489350|NCT03468426|520990226|FG004|Overall Study|Other than listed|2|||
144489351|NCT03468426|520990227|FG005|Overall Study|Other than listed|2|||
144489352|NCT03468426|520990228|FG006|Overall Study|Other than listed|0|||
144489353|NCT03468426|520990229|FG007|Overall Study|Other than listed|0|||
144489354|NCT03468426|520990230|FG008|Overall Study|Other than listed|4|||
144489355|NCT03468426|520990231|FG009|Overall Study|Other than listed|4|||
144489356|NCT03468426|520990232|FG010|Overall Study|Other than listed|1|||
144489357|NCT03468426|520990222|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489358|NCT03468426|520990223|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489359|NCT03468426|520990224|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144489360|NCT03468426|520990225|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489361|NCT03468426|520990226|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489362|NCT03468426|520990227|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489363|NCT03468426|520990228|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489364|NCT03468426|520990229|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489365|NCT03468426|520990230|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489366|NCT03468426|520990231|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489367|NCT03468426|520990232|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144489368|NCT03468426|520990222|FG000|Overall Study|missing reason|0|||
144489369|NCT03468426|520990223|FG001|Overall Study|missing reason|0|||
144489370|NCT03468426|520990224|FG002|Overall Study|missing reason|0|||
144489371|NCT03468426|520990225|FG003|Overall Study|missing reason|0|||
144489372|NCT03468426|520990226|FG004|Overall Study|missing reason|0|||
144489373|NCT03468426|520990227|FG005|Overall Study|missing reason|0|||
144489374|NCT03468426|520990228|FG006|Overall Study|missing reason|0|||
144489375|NCT03468426|520990229|FG007|Overall Study|missing reason|0|||
144489376|NCT03468426|520990230|FG008|Overall Study|missing reason|0|||
144489377|NCT03468426|520990231|FG009|Overall Study|missing reason|1|||
144489378|NCT03468426|520990232|FG010|Overall Study|missing reason|0|||
144489379|NCT04004208|520990239|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144489380|NCT04004208|520990240|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144489381|NCT04004208|520990239|FG000|Overall Study|Death|3|||
144489382|NCT04004208|520990240|FG001|Overall Study|Death|0|||
144489383|NCT04004208|520990239|FG000|Overall Study|COVID-19 pandemic|1|||
144489384|NCT04004208|520990240|FG001|Overall Study|COVID-19 pandemic|0|||
144489385|NCT04004208|520990239|FG000|Overall Study|Physician Decision|1|||
144489386|NCT04004208|520990240|FG001|Overall Study|Physician Decision|0|||
144489387|NCT04004208|520990239|FG000|Overall Study|Adverse Event|1|||
144489388|NCT04004208|520990240|FG001|Overall Study|Adverse Event|1|||
144489389|NCT01310868|520990246|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
144489390|NCT01628874|520990253|FG000|Overall Study|Physician Decision|1|||
144489391|NCT01628874|520990254|FG001|Overall Study|Physician Decision|1|||
144489392|NCT01628874|520990253|FG000|Overall Study|Age >4 months|4|||
144489393|NCT01628874|520990254|FG001|Overall Study|Age >4 months|2|||
144489394|NCT00873093|520990255|FG000|Overall Study|Adverse Event|0|||
144489395|NCT00873093|520990256|FG001|Overall Study|Adverse Event|2|||
144489396|NCT00873093|520990257|FG002|Overall Study|Adverse Event|0|||
144489397|NCT00873093|520990258|FG003|Overall Study|Adverse Event|0|||
144489398|NCT00873093|520990259|FG004|Overall Study|Adverse Event|0|||
144489399|NCT00873093|520990255|FG000|Overall Study|Death|0|||
144489400|NCT00873093|520990256|FG001|Overall Study|Death|3|||
144489401|NCT00873093|520990257|FG002|Overall Study|Death|2|||
144489402|NCT00873093|520990258|FG003|Overall Study|Death|0|||
144489403|NCT00873093|520990259|FG004|Overall Study|Death|0|||
144489404|NCT00873093|520990255|FG000|Overall Study|Physician Decision|0|||
144489405|NCT00873093|520990256|FG001|Overall Study|Physician Decision|17|||
144489406|NCT00873093|520990257|FG002|Overall Study|Physician Decision|10|||
144489407|NCT00873093|520990258|FG003|Overall Study|Physician Decision|10|||
144489408|NCT00873093|520990259|FG004|Overall Study|Physician Decision|2|||
144489409|NCT00873093|520990255|FG000|Overall Study|Withdrawal by Subject|1|||
144489410|NCT00873093|520990256|FG001|Overall Study|Withdrawal by Subject|4|||
144489411|NCT00873093|520990257|FG002|Overall Study|Withdrawal by Subject|4|||
144489412|NCT00873093|520990258|FG003|Overall Study|Withdrawal by Subject|0|||
144489413|NCT00873093|520990259|FG004|Overall Study|Withdrawal by Subject|0|||
144489414|NCT00873093|520990255|FG000|Overall Study|Ineligible|0|||
144489415|NCT00873093|520990256|FG001|Overall Study|Ineligible|1|||
144489416|NCT00873093|520990257|FG002|Overall Study|Ineligible|0|||
144489417|NCT00873093|520990258|FG003|Overall Study|Ineligible|1|||
144489418|NCT00873093|520990259|FG004|Overall Study|Ineligible|0|||
144489419|NCT01152554|520990260|FG000|Overall Study|Withdrawal by Subject|73|||
144489420|NCT01152554|520990261|FG001|Overall Study|Withdrawal by Subject|28|||
144489421|NCT01152554|520990260|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
144489422|NCT01152554|520990261|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
144489423|NCT01152554|520990260|FG000|Overall Study|Adverse Event|67|||
144489424|NCT01152554|520990261|FG001|Overall Study|Adverse Event|14|||
144489425|NCT01152554|520990260|FG000|Overall Study|Severe non-compliance to protocol|36|||
144489426|NCT01152554|520990261|FG001|Overall Study|Severe non-compliance to protocol|14|||
144489427|NCT01152554|520990260|FG000|Overall Study|Condition under investigation worsened|5|||
144489428|NCT01152554|520990261|FG001|Overall Study|Condition under investigation worsened|2|||
144489429|NCT01152554|520990260|FG000|Overall Study|Lack of Efficacy|20|||
144489430|NCT01152554|520990261|FG001|Overall Study|Lack of Efficacy|3|||
144489431|NCT01152554|520990260|FG000|Overall Study|Study-specific withdrawal criteria|17|||
144489432|NCT01152554|520990261|FG001|Overall Study|Study-specific withdrawal criteria|8|||
144489433|NCT01152554|520990260|FG000|Overall Study|Lost to Follow-up|87|||
144489434|NCT01152554|520990261|FG001|Overall Study|Lost to Follow-up|32|||
144489435|NCT01152554|520990260|FG000|Overall Study|Other|28|||
144489436|NCT01152554|520990261|FG001|Overall Study|Other|8|||
144489437|NCT01152554|520990260|FG000|Overall Study|Death|1|||
144489438|NCT01152554|520990261|FG001|Overall Study|Death|1|||
144489439|NCT02117544|520990262|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
144489440|NCT02117544|520990263|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
144489441|NCT03486899|520990264|FG000|Overall Study|Lost to Follow-up|4|||
144489442|NCT03486899|520990265|FG001|Overall Study|Lost to Follow-up|1|||
144489443|NCT03486899|520990266|FG002|Overall Study|Lost to Follow-up|4|||
144489444|NCT03486899|520990267|FG003|Overall Study|Lost to Follow-up|3|||
144489445|NCT03486899|520990264|FG000|Overall Study|Death|1|||
144489446|NCT03486899|520990265|FG001|Overall Study|Death|0|||
144489447|NCT03486899|520990266|FG002|Overall Study|Death|0|||
144489448|NCT03486899|520990267|FG003|Overall Study|Death|1|||
144489449|NCT03486899|520990264|FG000|Overall Study|Adverse Event|0|||
144489450|NCT03486899|520990265|FG001|Overall Study|Adverse Event|2|||
144489451|NCT03486899|520990266|FG002|Overall Study|Adverse Event|0|||
144489452|NCT03486899|520990267|FG003|Overall Study|Adverse Event|2|||
144489453|NCT03486899|520990264|FG000|Overall Study|Withdrawal by Subject|3|||
144489454|NCT03486899|520990265|FG001|Overall Study|Withdrawal by Subject|7|||
144489455|NCT03486899|520990266|FG002|Overall Study|Withdrawal by Subject|4|||
144489456|NCT03486899|520990267|FG003|Overall Study|Withdrawal by Subject|3|||
144369812|NCT04161157|520561701|FG000|Overall Study|Ineligible|2|||
144369813|NCT04161157|520561701|FG000|Overall Study|Withdrawal by Subject|4|||
144369814|NCT04721977|520561716|FG000|Overall Study|Death|15|||
144369815|NCT04721977|520561716|FG000|Overall Study|Ongoing|51|||
144369816|NCT03278249|520561717|FG000|Overall Study|Withdrawal by Subject|2|||
144369817|NCT03278249|520561717|FG000|Overall Study|Lost to Follow-up|1|||
144369818|NCT02017405|520561718|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
144369819|NCT02017405|520561719|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
144369820|NCT02017405|520561720|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
144369821|NCT02017405|520561721|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
144369822|NCT02017405|520561722|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
144369823|NCT02017405|520561723|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
144369824|NCT02017405|520561718|FG000|Open-label Phase|Adverse Event|1|||
144369825|NCT02017405|520561719|FG001|Open-label Phase|Adverse Event|1|||
144369826|NCT02017405|520561720|FG002|Open-label Phase|Adverse Event|0|||
144369827|NCT02017405|520561721|FG003|Open-label Phase|Adverse Event|0|||
144369828|NCT02017405|520561722|FG004|Open-label Phase|Adverse Event|0|||
144369829|NCT02017405|520561723|FG005|Open-label Phase|Adverse Event|0|||
144369830|NCT02374450|520561725|FG000|Overall Study|Protocol Violation|0|||
144369831|NCT02374450|520561726|FG001|Overall Study|Protocol Violation|1|||
144369832|NCT02374450|520561727|FG002|Overall Study|Protocol Violation|0|||
144369833|NCT02374450|520561725|FG000|Overall Study|Withdrawal by Subject|91|||
144369834|NCT02374450|520561726|FG001|Overall Study|Withdrawal by Subject|110|||
144369835|NCT02374450|520561727|FG002|Overall Study|Withdrawal by Subject|4|||
144369836|NCT02374450|520561725|FG000|Overall Study|Lost to Follow-up|168|||
144369837|NCT02374450|520561726|FG001|Overall Study|Lost to Follow-up|194|||
144369838|NCT02374450|520561727|FG002|Overall Study|Lost to Follow-up|138|||
144369839|NCT02374450|520561725|FG000|Overall Study|Death|173|||
144369840|NCT02374450|520561726|FG001|Overall Study|Death|185|||
144369841|NCT02374450|520561727|FG002|Overall Study|Death|81|||
144369842|NCT02374450|520561725|FG000|Overall Study|Migrated from the study area|538|||
144369843|NCT02374450|520561726|FG001|Overall Study|Migrated from the study area|648|||
144369844|NCT02374450|520561727|FG002|Overall Study|Migrated from the study area|181|||
144369845|NCT02374450|520561725|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
144369846|NCT02374450|520561726|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
144369847|NCT02374450|520561727|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
144369848|NCT02374450|520561725|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
144369849|NCT02374450|520561726|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
144369850|NCT02374450|520561727|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
144369851|NCT02374450|520561725|FG000|Overall Study|Other|0|||
144369852|NCT02374450|520561726|FG001|Overall Study|Other|21|||
144369853|NCT02374450|520561727|FG002|Overall Study|Other|79|||
144369854|NCT04730804|520561728|FG000|Overall Study|Physician Decision|0|||
144369855|NCT04730804|520561729|FG001|Overall Study|Physician Decision|0|||
144369856|NCT04730804|520561730|FG002|Overall Study|Physician Decision|0|||
144369857|NCT04730804|520561731|FG003|Overall Study|Physician Decision|0|||
144369858|NCT04730804|520561732|FG004|Overall Study|Physician Decision|0|||
144369859|NCT04730804|520561733|FG005|Overall Study|Physician Decision|1|||
144369860|NCT04730804|520561728|FG000|Overall Study|Withdrawal by Subject|0|||
144369861|NCT04730804|520561729|FG001|Overall Study|Withdrawal by Subject|0|||
144369862|NCT04730804|520561730|FG002|Overall Study|Withdrawal by Subject|0|||
144369863|NCT04730804|520561731|FG003|Overall Study|Withdrawal by Subject|0|||
144369864|NCT04730804|520561732|FG004|Overall Study|Withdrawal by Subject|1|||
144369865|NCT04730804|520561733|FG005|Overall Study|Withdrawal by Subject|2|||
144369866|NCT02202759|520562724|FG000|Overall Study|Study Terminated by Sponsor|3|||
144369867|NCT02202759|520562725|FG001|Overall Study|Study Terminated by Sponsor|3|||
144369868|NCT02202759|520562726|FG002|Overall Study|Study Terminated by Sponsor|3|||
144369869|NCT02202759|520562724|FG000|Overall Study|Withdrawal by Subject|2|||
144369870|NCT02202759|520562725|FG001|Overall Study|Withdrawal by Subject|1|||
144369871|NCT02202759|520562726|FG002|Overall Study|Withdrawal by Subject|1|||
144369872|NCT02202759|520562724|FG000|Overall Study|Reason not Specified|4|||
144369873|NCT02202759|520562725|FG001|Overall Study|Reason not Specified|11|||
144369874|NCT02202759|520562726|FG002|Overall Study|Reason not Specified|10|||
144369875|NCT01590888|520562727|FG000|Overall Study|Adverse Event|3|||
144369876|NCT01590888|520562728|FG001|Overall Study|Adverse Event|0|||
144369877|NCT01590888|520562729|FG002|Overall Study|Adverse Event|1|||
144369878|NCT01590888|520562727|FG000|Overall Study|Lost to Follow-up|1|||
144369879|NCT01590888|520562728|FG001|Overall Study|Lost to Follow-up|0|||
144369880|NCT01590888|520562729|FG002|Overall Study|Lost to Follow-up|0|||
144369881|NCT04953728|520562730|FG000|Overall Study|Withdrawal by Subject|3|||
144369882|NCT04953728|520562730|FG000|Overall Study|Physician Decision|1|||
144369883|NCT02331277|520562733|FG000|Overall Study|Withdrawal by Subject|1|||
144369884|NCT02331277|520562734|FG001|Overall Study|Withdrawal by Subject|0|||
144369885|NCT00990704|520562737|FG000|Overall Study|Adverse Event|1|||
144369886|NCT00990704|520562738|FG001|Overall Study|Adverse Event|1|||
144369887|NCT00990704|520562737|FG000|Overall Study|Physician Decision|0|||
144489457|NCT03486899|520990264|FG000|Overall Study|Other Reasons|0|||
144489458|NCT03486899|520990265|FG001|Overall Study|Other Reasons|1|||
144489459|NCT03486899|520990266|FG002|Overall Study|Other Reasons|0|||
144489460|NCT03486899|520990267|FG003|Overall Study|Other Reasons|1|||
144489461|NCT02408549|520990268|FG000|Overall Study|Adverse Event|15|||
144489462|NCT02408549|520990268|FG000|Overall Study|Death|4|||
144489463|NCT02408549|520990268|FG000|Overall Study|Lack of Efficacy|17|||
144489464|NCT02408549|520990268|FG000|Overall Study|Protocol Violation|4|||
144489465|NCT02408549|520990268|FG000|Overall Study|Lost to Follow-up|6|||
144489466|NCT02408549|520990268|FG000|Overall Study|Consent withdrawn|30|||
144489467|NCT02408549|520990268|FG000|Overall Study|Neurology research program closing at site|1|||
144489468|NCT02408549|520990268|FG000|Overall Study|Site closure|1|||
144489469|NCT02408549|520990268|FG000|Overall Study|Pregnancy|1|||
144489470|NCT02408549|520990268|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
144489471|NCT02408549|520990268|FG000|Overall Study|Subject moved to another place, far from site|1|||
144489472|NCT02408549|520990268|FG000|Overall Study|Study terminated at site|1|||
144489473|NCT02559817|520990269|FG000|Treatment Period|Adverse Event|1|||
144489474|NCT02559817|520990270|FG001|Treatment Period|Adverse Event|0|||
144489475|NCT02559817|520990271|FG002|Treatment Period|Adverse Event|1|||
144489476|NCT02559817|520990272|FG003|Treatment Period|Adverse Event|0|||
144489477|NCT02559817|520990273|FG004|Treatment Period|Adverse Event|0|||
144489478|NCT02559817|520990269|FG000|Treatment Period|Lack of Efficacy|0|||
144489479|NCT02559817|520990270|FG001|Treatment Period|Lack of Efficacy|1|||
144489480|NCT02559817|520990271|FG002|Treatment Period|Lack of Efficacy|0|||
144489481|NCT02559817|520990272|FG003|Treatment Period|Lack of Efficacy|0|||
144489482|NCT02559817|520990273|FG004|Treatment Period|Lack of Efficacy|0|||
144489483|NCT02559817|520990269|FG000|Treatment Period|Lost to Follow-up|0|||
144489484|NCT02559817|520990270|FG001|Treatment Period|Lost to Follow-up|1|||
144489485|NCT02559817|520990271|FG002|Treatment Period|Lost to Follow-up|0|||
144489486|NCT02559817|520990272|FG003|Treatment Period|Lost to Follow-up|1|||
144489487|NCT02559817|520990273|FG004|Treatment Period|Lost to Follow-up|0|||
144489488|NCT02559817|520990269|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
144489489|NCT02559817|520990270|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
144489490|NCT02559817|520990271|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
144489491|NCT02559817|520990272|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
144489492|NCT02559817|520990273|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
144489493|NCT02559817|520990269|FG000|Treatment Period|Protocol Violation|0|||
144489494|NCT02559817|520990270|FG001|Treatment Period|Protocol Violation|0|||
144489495|NCT02559817|520990271|FG002|Treatment Period|Protocol Violation|0|||
144489496|NCT02559817|520990272|FG003|Treatment Period|Protocol Violation|1|||
144489497|NCT02559817|520990273|FG004|Treatment Period|Protocol Violation|0|||
144489498|NCT03389893|520990274|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
144489499|NCT03389893|520990275|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
144489500|NCT03389893|520990276|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
144489501|NCT03389893|520990277|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
144489502|NCT03389893|520990274|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
144489503|NCT03389893|520990275|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
144489504|NCT03389893|520990276|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
144489505|NCT03389893|520990277|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
144489506|NCT03389893|520990274|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
144489507|NCT03389893|520990275|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
144489508|NCT03389893|520990276|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
144489509|NCT03389893|520990277|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
144489510|NCT03389893|520990274|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
144489511|NCT03389893|520990275|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
144489512|NCT03389893|520990276|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
144489513|NCT03389893|520990277|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
144489514|NCT02448719|520990278|FG000|Overall Study|Withdrawal by Subject|0|||
144489515|NCT02448719|520990279|FG001|Overall Study|Withdrawal by Subject|0|||
144489516|NCT02448719|520990280|FG002|Overall Study|Withdrawal by Subject|0|||
144489517|NCT02448719|520990281|FG003|Overall Study|Withdrawal by Subject|0|||
144489518|NCT02448719|520990282|FG004|Overall Study|Withdrawal by Subject|1|||
144489519|NCT02448719|520990283|FG005|Overall Study|Withdrawal by Subject|0|||
144489520|NCT02448719|520990284|FG006|Overall Study|Withdrawal by Subject|0|||
144489521|NCT02448719|520990285|FG007|Overall Study|Withdrawal by Subject|0|||
144715580|NCT00410410|521813373|FG002|Maintenance Period (MP)|Adverse Event|0|||
144715581|NCT00410410|521813374|FG003|Maintenance Period (MP)|Adverse Event|0|||
144489522|NCT02448719|520990286|FG008|Overall Study|Withdrawal by Subject|0|||
144489523|NCT02448719|520990287|FG009|Overall Study|Withdrawal by Subject|0|||
144489524|NCT02448719|520990288|FG010|Overall Study|Withdrawal by Subject|0|||
144489525|NCT01232556|520990289|FG000|Overall Study|Withdrawal by Subject|21|||
144489526|NCT01232556|520990290|FG001|Overall Study|Withdrawal by Subject|17|||
144489527|NCT01232556|520990289|FG000|Overall Study|Death|97|||
144489528|NCT01232556|520990290|FG001|Overall Study|Death|97|||
144489529|NCT01232556|520990289|FG000|Overall Study|Lost to Follow-up|0|||
144489530|NCT01232556|520990290|FG001|Overall Study|Lost to Follow-up|2|||
144489531|NCT01232556|520990289|FG000|Overall Study|Terminated by Sponsor|35|||
144489532|NCT01232556|520990290|FG001|Overall Study|Terminated by Sponsor|51|||
144489533|NCT01232556|520990289|FG000|Overall Study|Other|6|||
144489534|NCT01232556|520990290|FG001|Overall Study|Other|4|||
144489535|NCT04179461|520990292|FG000|Overall Study|Lost to Follow-up|4|||
144489536|NCT00184028|520990295|FG000|Overall Study|Death|1|||
144489537|NCT00184028|520990295|FG000|Overall Study|Lack of Efficacy|4|||
144489538|NCT00184028|520990295|FG000|Overall Study|Adverse Event|2|||
144489539|NCT00184028|520990295|FG000|Overall Study|Withdrawal by Subject|1|||
144489540|NCT00184028|520990295|FG000|Overall Study|Non-compliance|2|||
144489541|NCT01141660|520990296|FG000|Overall Study|Physician Decision|0|||
144489542|NCT01141660|520990297|FG001|Overall Study|Physician Decision|12|||
144489543|NCT00209027|520990299|FG000|Overall Study|study terminated|10|||
144489544|NCT00209027|520990300|FG001|Overall Study|study terminated|0|||
144489545|NCT03785340|520990301|FG000|Overall Study|Lost to Follow-up|2|||
144489546|NCT03785340|520990302|FG001|Overall Study|Lost to Follow-up|0|||
144489547|NCT03785340|520990301|FG000|Overall Study|Adverse Event|1|||
144489548|NCT03785340|520990302|FG001|Overall Study|Adverse Event|0|||
144489549|NCT04894903|520990311|FG000|Overall Study|Death|1|||
144489550|NCT04894903|520990312|FG001|Overall Study|Death|0|||
144489551|NCT04894903|520990311|FG000|Overall Study|Pregnancy|1|||
144489552|NCT04894903|520990312|FG001|Overall Study|Pregnancy|0|||
144489553|NCT04894903|520990311|FG000|Overall Study|Withdrawal by Subject|1|||
144489554|NCT04894903|520990312|FG001|Overall Study|Withdrawal by Subject|1|||
144489555|NCT04894903|520990311|FG000|Overall Study|moved or exited health system|1|||
144489556|NCT04894903|520990312|FG001|Overall Study|moved or exited health system|3|||
144489557|NCT01923428|520990314|FG000|Overall Study|Adverse Event|8|||
144489558|NCT01923428|520990315|FG001|Overall Study|Adverse Event|6|||
144489559|NCT01923428|520990316|FG002|Overall Study|Adverse Event|3|||
144489560|NCT01923428|520990317|FG003|Overall Study|Adverse Event|3|||
144489561|NCT01923428|520990314|FG000|Overall Study|Withdrawal by Subject|5|||
144489562|NCT01923428|520990315|FG001|Overall Study|Withdrawal by Subject|3|||
144489563|NCT01923428|520990316|FG002|Overall Study|Withdrawal by Subject|0|||
144489564|NCT01923428|520990317|FG003|Overall Study|Withdrawal by Subject|4|||
144489565|NCT01923428|520990314|FG000|Overall Study|Lost to Follow-up|2|||
144489566|NCT01923428|520990315|FG001|Overall Study|Lost to Follow-up|1|||
144489567|NCT01923428|520990316|FG002|Overall Study|Lost to Follow-up|5|||
144489568|NCT01923428|520990317|FG003|Overall Study|Lost to Follow-up|0|||
144489569|NCT01923428|520990314|FG000|Overall Study|Protocol Violation|3|||
144489570|NCT01923428|520990315|FG001|Overall Study|Protocol Violation|0|||
144489571|NCT01923428|520990316|FG002|Overall Study|Protocol Violation|2|||
144489572|NCT01923428|520990317|FG003|Overall Study|Protocol Violation|1|||
144489573|NCT01923428|520990314|FG000|Overall Study|Non Compliance to treatment|1|||
144489574|NCT01923428|520990315|FG001|Overall Study|Non Compliance to treatment|2|||
144489575|NCT01923428|520990316|FG002|Overall Study|Non Compliance to treatment|0|||
144489576|NCT01923428|520990317|FG003|Overall Study|Non Compliance to treatment|1|||
144489577|NCT01923428|520990314|FG000|Overall Study|Lack of Efficacy|0|||
144489578|NCT01923428|520990315|FG001|Overall Study|Lack of Efficacy|0|||
144489579|NCT01923428|520990316|FG002|Overall Study|Lack of Efficacy|1|||
144489580|NCT01923428|520990317|FG003|Overall Study|Lack of Efficacy|1|||
144489581|NCT01822353|520990318|FG000|Overall Study|Adverse Event|1|||
144489582|NCT01822353|520990319|FG001|Overall Study|Adverse Event|3|||
144489583|NCT01822353|520990320|FG002|Overall Study|Adverse Event|1|||
144489584|NCT01822353|520990318|FG000|Overall Study|Pregnancy|0|||
144489585|NCT01822353|520990319|FG001|Overall Study|Pregnancy|1|||
144489586|NCT01822353|520990320|FG002|Overall Study|Pregnancy|0|||
144489587|NCT01822353|520990318|FG000|Overall Study|Withdrawal by Subject|3|||
144489588|NCT01822353|520990319|FG001|Overall Study|Withdrawal by Subject|1|||
144489589|NCT01822353|520990320|FG002|Overall Study|Withdrawal by Subject|0|||
144369888|NCT00990704|520562738|FG001|Overall Study|Physician Decision|1|||
144489590|NCT02550873|520990321|FG000|Randomized Double Blind|Adverse Event|3|||
144489591|NCT02550873|520990322|FG001|Randomized Double Blind|Adverse Event|1|||
144489592|NCT02550873|520990323|FG002|Randomized Double Blind|Adverse Event|0|||
144489593|NCT02550873|520990321|FG000|Randomized Double Blind|Disease progression|1|||
144489594|NCT02550873|520990322|FG001|Randomized Double Blind|Disease progression|1|||
144489595|NCT02550873|520990323|FG002|Randomized Double Blind|Disease progression|0|||
144489596|NCT02550873|520990321|FG000|Open Label Extension|Study ongoing|0|||
144489597|NCT02550873|520990322|FG001|Open Label Extension|Study ongoing|0|||
144489598|NCT02550873|520990323|FG002|Open Label Extension|Study ongoing|111|||
144489599|NCT03873246|520990324|FG000|Overall Study|Adverse Event|1|||
144489600|NCT03873246|520990325|FG001|Overall Study|Adverse Event|3|||
144489601|NCT03873246|520990326|FG002|Overall Study|Adverse Event|3|||
144489602|NCT03873246|520990324|FG000|Overall Study|Lost to Follow-up|4|||
144489603|NCT03873246|520990325|FG001|Overall Study|Lost to Follow-up|4|||
144489604|NCT03873246|520990326|FG002|Overall Study|Lost to Follow-up|5|||
144489605|NCT03873246|520990324|FG000|Overall Study|Protocol Violation|0|||
144489606|NCT03873246|520990325|FG001|Overall Study|Protocol Violation|1|||
144489607|NCT03873246|520990326|FG002|Overall Study|Protocol Violation|0|||
144489608|NCT03873246|520990324|FG000|Overall Study|Withdrawal by Subject|0|||
144489609|NCT03873246|520990325|FG001|Overall Study|Withdrawal by Subject|4|||
144489610|NCT03873246|520990326|FG002|Overall Study|Withdrawal by Subject|1|||
144489611|NCT04630756|520990327|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
144489612|NCT04630756|520990328|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
144489613|NCT04630756|520990329|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
144489614|NCT03621982|520990330|FG000|Overall Study|Withdrawal by Subject|1|||
144489615|NCT03621982|520990331|FG001|Overall Study|Withdrawal by Subject|0|||
144489616|NCT03621982|520990332|FG002|Overall Study|Withdrawal by Subject|0|||
144489617|NCT03621982|520990333|FG003|Overall Study|Withdrawal by Subject|1|||
144489618|NCT03621982|520990334|FG004|Overall Study|Withdrawal by Subject|0|||
144489619|NCT03621982|520990335|FG005|Overall Study|Withdrawal by Subject|1|||
144489620|NCT03621982|520990336|FG006|Overall Study|Withdrawal by Subject|1|||
144489621|NCT03621982|520990337|FG007|Overall Study|Withdrawal by Subject|0|||
144489622|NCT03621982|520990338|FG008|Overall Study|Withdrawal by Subject|1|||
144489623|NCT03621982|520990339|FG009|Overall Study|Withdrawal by Subject|0|||
144489624|NCT03621982|520990340|FG010|Overall Study|Withdrawal by Subject|2|||
144489625|NCT03621982|520990341|FG011|Overall Study|Withdrawal by Subject|1|||
144489626|NCT03621982|520990342|FG012|Overall Study|Withdrawal by Subject|2|||
144489627|NCT03621982|520990343|FG013|Overall Study|Withdrawal by Subject|2|||
144489628|NCT03621982|520990330|FG000|Overall Study|Investigator/Sponsor decision|0|||
144489629|NCT03621982|520990331|FG001|Overall Study|Investigator/Sponsor decision|0|||
144489630|NCT03621982|520990332|FG002|Overall Study|Investigator/Sponsor decision|0|||
144489631|NCT03621982|520990333|FG003|Overall Study|Investigator/Sponsor decision|0|||
144489632|NCT03621982|520990334|FG004|Overall Study|Investigator/Sponsor decision|0|||
144489633|NCT03621982|520990335|FG005|Overall Study|Investigator/Sponsor decision|0|||
144489634|NCT03621982|520990336|FG006|Overall Study|Investigator/Sponsor decision|0|||
144489635|NCT03621982|520990337|FG007|Overall Study|Investigator/Sponsor decision|0|||
144489636|NCT03621982|520990338|FG008|Overall Study|Investigator/Sponsor decision|0|||
144489637|NCT03621982|520990339|FG009|Overall Study|Investigator/Sponsor decision|0|||
144489638|NCT03621982|520990340|FG010|Overall Study|Investigator/Sponsor decision|0|||
144489639|NCT03621982|520990341|FG011|Overall Study|Investigator/Sponsor decision|4|||
144489640|NCT03621982|520990342|FG012|Overall Study|Investigator/Sponsor decision|0|||
144489641|NCT03621982|520990343|FG013|Overall Study|Investigator/Sponsor decision|2|||
144489642|NCT03621982|520990330|FG000|Overall Study|Death|2|||
144489643|NCT03621982|520990331|FG001|Overall Study|Death|4|||
144489644|NCT03621982|520990332|FG002|Overall Study|Death|4|||
144489645|NCT03621982|520990333|FG003|Overall Study|Death|3|||
144489646|NCT03621982|520990334|FG004|Overall Study|Death|8|||
144489647|NCT03621982|520990335|FG005|Overall Study|Death|4|||
144489648|NCT03621982|520990336|FG006|Overall Study|Death|6|||
144489649|NCT03621982|520990337|FG007|Overall Study|Death|3|||
144489650|NCT03621982|520990338|FG008|Overall Study|Death|0|||
144489651|NCT03621982|520990339|FG009|Overall Study|Death|3|||
144489652|NCT03621982|520990340|FG010|Overall Study|Death|8|||
144489653|NCT03621982|520990341|FG011|Overall Study|Death|4|||
144489654|NCT03621982|520990342|FG012|Overall Study|Death|2|||
144489655|NCT03621982|520990343|FG013|Overall Study|Death|2|||
144489656|NCT03621982|520990330|FG000|Overall Study|Lost to Follow-up|0|||
144489657|NCT03621982|520990331|FG001|Overall Study|Lost to Follow-up|0|||
144489658|NCT03621982|520990332|FG002|Overall Study|Lost to Follow-up|1|||
144489659|NCT03621982|520990333|FG003|Overall Study|Lost to Follow-up|0|||
144489660|NCT03621982|520990334|FG004|Overall Study|Lost to Follow-up|0|||
144489661|NCT03621982|520990335|FG005|Overall Study|Lost to Follow-up|0|||
144489662|NCT03621982|520990336|FG006|Overall Study|Lost to Follow-up|1|||
144489663|NCT03621982|520990337|FG007|Overall Study|Lost to Follow-up|0|||
144489664|NCT03621982|520990338|FG008|Overall Study|Lost to Follow-up|0|||
144489665|NCT03621982|520990339|FG009|Overall Study|Lost to Follow-up|1|||
144489666|NCT03621982|520990340|FG010|Overall Study|Lost to Follow-up|0|||
144489667|NCT03621982|520990341|FG011|Overall Study|Lost to Follow-up|0|||
144489668|NCT03621982|520990342|FG012|Overall Study|Lost to Follow-up|0|||
144489669|NCT03621982|520990343|FG013|Overall Study|Lost to Follow-up|0|||
144489670|NCT00245011|520990344|FG000|Overall Study|Lack of Efficacy|1|||
144489671|NCT03317379|520990349|FG000|Overall Study|Lost to Follow-up|0|||
144489672|NCT03317379|520990350|FG001|Overall Study|Lost to Follow-up|3|||
144489673|NCT03317379|520990351|FG002|Overall Study|Lost to Follow-up|2|||
144489674|NCT03040687|520990352|FG000|Overall Study|Withdrawal by Subject|1|||
144489675|NCT03040687|520990353|FG001|Overall Study|Withdrawal by Subject|0|||
144489676|NCT03040687|520990354|FG002|Overall Study|Withdrawal by Subject|0|||
144489677|NCT00550173|520990355|FG000|Overall Study|Death|45|||
144489678|NCT00550173|520990356|FG001|Overall Study|Death|38|||
144489679|NCT00550173|520990357|FG002|Overall Study|Death|50|||
144489680|NCT00550173|520990355|FG000|Overall Study|Physician Decision|1|||
144489681|NCT00550173|520990356|FG001|Overall Study|Physician Decision|2|||
144489682|NCT00550173|520990357|FG002|Overall Study|Physician Decision|2|||
144489683|NCT00550173|520990355|FG000|Overall Study|Withdrawal by Subject|9|||
144489684|NCT00550173|520990356|FG001|Overall Study|Withdrawal by Subject|12|||
144489685|NCT00550173|520990357|FG002|Overall Study|Withdrawal by Subject|17|||
144489686|NCT00550173|520990355|FG000|Overall Study|Sponsor Decision|13|||
144489687|NCT00550173|520990356|FG001|Overall Study|Sponsor Decision|7|||
144489688|NCT00550173|520990357|FG002|Overall Study|Sponsor Decision|1|||
144489689|NCT00550173|520990355|FG000|Overall Study|Lost to Follow-up|4|||
144489690|NCT00550173|520990356|FG001|Overall Study|Lost to Follow-up|4|||
144489691|NCT00550173|520990357|FG002|Overall Study|Lost to Follow-up|3|||
144489692|NCT00810641|520990366|FG000|Overall Study|Withdrawal by Subject|0|||
144489693|NCT00810641|520990367|FG001|Overall Study|Withdrawal by Subject|1|||
144489694|NCT00810641|520990368|FG002|Overall Study|Withdrawal by Subject|2|||
144489695|NCT01556243|520990369|FG000|Overall Study|Ineligible|34|||
144489696|NCT01556243|520990369|FG000|Overall Study|Converted to mastectomy|14|||
144489697|NCT01556243|520990369|FG000|Overall Study|Unable to achieve negative margins|2|||
144489698|NCT01556243|520990369|FG000|Overall Study|Withdrawal by Subject|16|||
144489699|NCT01388543|520990370|FG000|Day 14|Adverse Event|1|||
144489700|NCT01388543|520990371|FG001|Day 14|Adverse Event|4|||
144489701|NCT02325713|520990374|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489702|NCT02325713|520990375|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489703|NCT02325713|520990376|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489704|NCT02325713|520990377|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489705|NCT02325713|520990378|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489706|NCT02325713|520990379|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489707|NCT02325713|520990380|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489708|NCT02325713|520990381|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489709|NCT02325713|520990382|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489710|NCT02325713|520990383|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489711|NCT02325713|520990384|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
144489712|NCT02325713|520990385|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489713|NCT02325713|520990386|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489714|NCT02325713|520990387|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489715|NCT02325713|520990388|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489716|NCT02325713|520990389|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
144489717|NCT02325713|520990374|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
144489718|NCT02325713|520990375|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489719|NCT02325713|520990376|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489720|NCT02325713|520990377|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489721|NCT02325713|520990378|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489722|NCT02325713|520990379|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489723|NCT02325713|520990380|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489724|NCT02325713|520990381|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489725|NCT02325713|520990382|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489726|NCT02325713|520990383|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489727|NCT02325713|520990384|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489728|NCT02325713|520990385|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489729|NCT02325713|520990386|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489730|NCT02325713|520990387|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489731|NCT02325713|520990388|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489732|NCT02325713|520990389|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
144489733|NCT02325713|520990374|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489734|NCT02325713|520990375|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489735|NCT02325713|520990376|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489736|NCT02325713|520990377|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489737|NCT02325713|520990378|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489738|NCT02325713|520990379|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489739|NCT02325713|520990380|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489740|NCT02325713|520990381|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489741|NCT02325713|520990382|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144369889|NCT01376804|520562739|FG000|Treatment Period|Withdrawal by Subject|1|||
144489742|NCT02325713|520990383|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
144489743|NCT02325713|520990384|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489744|NCT02325713|520990385|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489745|NCT02325713|520990386|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489746|NCT02325713|520990387|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489747|NCT02325713|520990388|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489748|NCT02325713|520990389|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
144489749|NCT01213173|520990390|FG000|Overall Study|Protocol Violation|2|||
144489750|NCT01213173|520990391|FG001|Overall Study|Protocol Violation|0|||
144489751|NCT01213173|520990390|FG000|Overall Study|Adverse Event|4|||
144489752|NCT01213173|520990391|FG001|Overall Study|Adverse Event|8|||
144489753|NCT01213173|520990390|FG000|Overall Study|Withdrawal by Subject|5|||
144489754|NCT01213173|520990391|FG001|Overall Study|Withdrawal by Subject|5|||
144489755|NCT01213173|520990390|FG000|Overall Study|Incorrect Enrollment|1|||
144489756|NCT01213173|520990391|FG001|Overall Study|Incorrect Enrollment|3|||
144489757|NCT02353832|520990392|FG000|Overall Study|Ineligible after enrollment|1|||
144489758|NCT02353832|520990392|FG000|Overall Study|Lost to Follow-up|1|||
144489759|NCT02684903|520990393|FG000|Overall Study|COVID-19 shutdown of lab|4|||
144489760|NCT02684903|520990394|FG001|Overall Study|COVID-19 shutdown of lab|6|||
144489761|NCT02684903|520990393|FG000|Overall Study|Lost to Follow-up|31|||
144489762|NCT02684903|520990394|FG001|Overall Study|Lost to Follow-up|41|||
144489763|NCT03280563|520991548|FG000|Stage 1|Death|2|||
144489764|NCT03280563|520991549|FG001|Stage 1|Death|1|||
144489765|NCT03280563|520991550|FG002|Stage 1|Death|0|||
144489766|NCT03280563|520991551|FG003|Stage 1|Death|0|||
144489767|NCT03280563|520991552|FG004|Stage 1|Death|0|||
144489768|NCT03280563|520991553|FG005|Stage 1|Death|3|||
144489769|NCT03280563|520991554|FG006|Stage 1|Death|0|||
144489770|NCT03280563|520991555|FG007|Stage 1|Death|0|||
144489771|NCT03280563|520991556|FG008|Stage 1|Death|0|||
144489772|NCT03280563|520991548|FG000|Stage 1|Study Ended by Sponsor|0|||
144489773|NCT03280563|520991549|FG001|Stage 1|Study Ended by Sponsor|0|||
144489774|NCT03280563|520991550|FG002|Stage 1|Study Ended by Sponsor|1|||
144489775|NCT03280563|520991551|FG003|Stage 1|Study Ended by Sponsor|0|||
144489776|NCT03280563|520991552|FG004|Stage 1|Study Ended by Sponsor|0|||
144489777|NCT03280563|520991553|FG005|Stage 1|Study Ended by Sponsor|1|||
144489778|NCT03280563|520991554|FG006|Stage 1|Study Ended by Sponsor|0|||
144489779|NCT03280563|520991555|FG007|Stage 1|Study Ended by Sponsor|0|||
144489780|NCT03280563|520991556|FG008|Stage 1|Study Ended by Sponsor|0|||
144489781|NCT03280563|520991548|FG000|Stage 1|Withdrawal by Subject|5|||
144489782|NCT03280563|520991549|FG001|Stage 1|Withdrawal by Subject|1|||
144489783|NCT03280563|520991550|FG002|Stage 1|Withdrawal by Subject|2|||
144489784|NCT03280563|520991551|FG003|Stage 1|Withdrawal by Subject|0|||
144489785|NCT03280563|520991552|FG004|Stage 1|Withdrawal by Subject|0|||
144489786|NCT03280563|520991553|FG005|Stage 1|Withdrawal by Subject|2|||
144489787|NCT03280563|520991554|FG006|Stage 1|Withdrawal by Subject|0|||
144489788|NCT03280563|520991555|FG007|Stage 1|Withdrawal by Subject|0|||
144489789|NCT03280563|520991556|FG008|Stage 1|Withdrawal by Subject|0|||
144489790|NCT03280563|520991548|FG000|Stage 1|Reason Not Specified|0|||
144489791|NCT03280563|520991549|FG001|Stage 1|Reason Not Specified|0|||
144489792|NCT03280563|520991550|FG002|Stage 1|Reason Not Specified|0|||
144489793|NCT03280563|520991551|FG003|Stage 1|Reason Not Specified|0|||
144489794|NCT03280563|520991552|FG004|Stage 1|Reason Not Specified|0|||
144489795|NCT03280563|520991553|FG005|Stage 1|Reason Not Specified|1|||
144489796|NCT03280563|520991554|FG006|Stage 1|Reason Not Specified|0|||
144489797|NCT03280563|520991555|FG007|Stage 1|Reason Not Specified|0|||
144489798|NCT03280563|520991556|FG008|Stage 1|Reason Not Specified|0|||
144489799|NCT03280563|520991548|FG000|Stage 1|Physician Decision|0|||
144489800|NCT03280563|520991549|FG001|Stage 1|Physician Decision|1|||
144489801|NCT03280563|520991550|FG002|Stage 1|Physician Decision|0|||
144489802|NCT03280563|520991551|FG003|Stage 1|Physician Decision|0|||
144489803|NCT03280563|520991552|FG004|Stage 1|Physician Decision|0|||
144489804|NCT03280563|520991553|FG005|Stage 1|Physician Decision|0|||
144489805|NCT03280563|520991554|FG006|Stage 1|Physician Decision|0|||
144489806|NCT03280563|520991555|FG007|Stage 1|Physician Decision|0|||
144489807|NCT03280563|520991556|FG008|Stage 1|Physician Decision|0|||
144489808|NCT03280563|520991548|FG000|Stage 2|Death|0|||
144489809|NCT03280563|520991549|FG001|Stage 2|Death|0|||
144489810|NCT03280563|520991550|FG002|Stage 2|Death|0|||
144489811|NCT03280563|520991551|FG003|Stage 2|Death|0|||
144489812|NCT03280563|520991552|FG004|Stage 2|Death|0|||
144489813|NCT03280563|520991553|FG005|Stage 2|Death|0|||
144489814|NCT03280563|520991554|FG006|Stage 2|Death|0|||
144489815|NCT03280563|520991555|FG007|Stage 2|Death|1|||
144489816|NCT03280563|520991556|FG008|Stage 2|Death|0|||
144489817|NCT03280563|520991548|FG000|Stage 2|Progressive Disease|0|||
144489818|NCT03280563|520991549|FG001|Stage 2|Progressive Disease|0|||
144489819|NCT03280563|520991550|FG002|Stage 2|Progressive Disease|0|||
144489820|NCT03280563|520991551|FG003|Stage 2|Progressive Disease|0|||
144489821|NCT03280563|520991552|FG004|Stage 2|Progressive Disease|0|||
144489822|NCT03280563|520991553|FG005|Stage 2|Progressive Disease|0|||
144489823|NCT03280563|520991554|FG006|Stage 2|Progressive Disease|2|||
144489824|NCT03280563|520991555|FG007|Stage 2|Progressive Disease|0|||
144489825|NCT03280563|520991556|FG008|Stage 2|Progressive Disease|0|||
144489826|NCT03280563|520991548|FG000|Long-term Survival Follow-up|Death|10|||
144489827|NCT03280563|520991549|FG001|Long-term Survival Follow-up|Death|14|||
144489828|NCT03280563|520991550|FG002|Long-term Survival Follow-up|Death|15|||
144489829|NCT03280563|520991551|FG003|Long-term Survival Follow-up|Death|3|||
144489830|NCT03280563|520991552|FG004|Long-term Survival Follow-up|Death|6|||
144489831|NCT03280563|520991553|FG005|Long-term Survival Follow-up|Death|18|||
144489832|NCT03280563|520991554|FG006|Long-term Survival Follow-up|Death|11|||
144489833|NCT03280563|520991555|FG007|Long-term Survival Follow-up|Death|1|||
144489834|NCT03280563|520991556|FG008|Long-term Survival Follow-up|Death|3|||
144489835|NCT03280563|520991548|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
144489836|NCT03280563|520991549|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
144489837|NCT03280563|520991550|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
144489838|NCT03280563|520991551|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
144489839|NCT03280563|520991552|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
144489840|NCT03280563|520991553|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
144489841|NCT03280563|520991554|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
144489842|NCT03280563|520991555|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
144489843|NCT03280563|520991556|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
144489844|NCT03280563|520991548|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
144489845|NCT03280563|520991549|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
144489846|NCT03280563|520991550|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
144489847|NCT03280563|520991551|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
144489848|NCT03280563|520991552|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
144489849|NCT03280563|520991553|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
144489850|NCT03280563|520991554|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
144489851|NCT03280563|520991555|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
144489852|NCT03280563|520991556|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
144489853|NCT03280563|520991548|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
144489854|NCT03280563|520991549|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
144489855|NCT03280563|520991550|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
144489856|NCT03280563|520991551|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
144489857|NCT03280563|520991552|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
144489858|NCT03280563|520991553|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
144489859|NCT03280563|520991554|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
144489860|NCT03280563|520991555|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
144489861|NCT03280563|520991556|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
144489862|NCT00802841|520991557|FG000|Overall Study|Administrative problems|1|||
144489863|NCT00802841|520991558|FG001|Overall Study|Administrative problems|0|||
144489864|NCT00802841|520991557|FG000|Overall Study|Lost to Follow-up|2|||
144489865|NCT00802841|520991558|FG001|Overall Study|Lost to Follow-up|1|||
144489866|NCT00802841|520991557|FG000|Overall Study|Death|1|||
144489867|NCT00802841|520991558|FG001|Overall Study|Death|2|||
144489868|NCT00802841|520991557|FG000|Overall Study|Adverse Event|8|||
144489869|NCT00802841|520991558|FG001|Overall Study|Adverse Event|2|||
144489870|NCT00802841|520991557|FG000|Overall Study|Disease progression|7|||
144489871|NCT00802841|520991558|FG001|Overall Study|Disease progression|3|||
144489872|NCT00802841|520991557|FG000|Overall Study|Withdrawal by Subject|9|||
144489873|NCT00802841|520991558|FG001|Overall Study|Withdrawal by Subject|5|||
144489874|NCT00802841|520991557|FG000|Overall Study|Protocol deviation|2|||
144489875|NCT00802841|520991558|FG001|Overall Study|Protocol deviation|6|||
144489876|NCT00802841|520991557|FG000|Overall Study|Treatment duration completed|66|||
144489877|NCT00802841|520991558|FG001|Overall Study|Treatment duration completed|76|||
144489878|NCT04096365|520991561|FG000|Overall Study|Adverse Event|1|||
144489879|NCT00354029|520991566|FG000|Overall Study|Protocol Violation|4|||
144489880|NCT00354029|520991567|FG001|Overall Study|Protocol Violation|2|||
144489881|NCT03930186|520991568|FG000|Weeks 0 to 16|Adverse Event|6|||
144489882|NCT03930186|520991568|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
144489883|NCT03930186|520991568|FG000|Weeks 16 to 32|Adverse Event|1|||
144489884|NCT03930186|520991568|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
144489885|NCT01477749|520991577|FG000|Overall Study|Physician Decision|4|||
144489886|NCT01782326|520991581|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
144489887|NCT01782326|520991582|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
144489888|NCT01782326|520991581|FG000|Planned Treatment Epoch|Death|29|||
144489889|NCT01782326|520991582|FG001|Planned Treatment Epoch|Death|30|||
144489890|NCT01782326|520991581|FG000|Planned Treatment Epoch|Physician Decision|18|||
144489891|NCT01782326|520991582|FG001|Planned Treatment Epoch|Physician Decision|16|||
144489892|NCT01782326|520991581|FG000|Planned Treatment Epoch|Protocol deviation|2|||
144489893|NCT01782326|520991582|FG001|Planned Treatment Epoch|Protocol deviation|3|||
144489894|NCT01782326|520991581|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
144489895|NCT01782326|520991582|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
144489896|NCT01782326|520991581|FG000|Planned Treatment Epoch|Technical problems|0|||
144489897|NCT01782326|520991582|FG001|Planned Treatment Epoch|Technical problems|4|||
144489898|NCT01782326|520991581|FG000|Double-blind Treatment|Adverse Event|129|||
144489899|NCT01782326|520991582|FG001|Double-blind Treatment|Adverse Event|145|||
144489900|NCT01782326|520991581|FG000|Double-blind Treatment|Subject/guardian decision|111|||
144489901|NCT01782326|520991582|FG001|Double-blind Treatment|Subject/guardian decision|125|||
144489902|NCT01782326|520991581|FG000|Double-blind Treatment|Lack of Efficacy|17|||
144489903|NCT01782326|520991582|FG001|Double-blind Treatment|Lack of Efficacy|22|||
144489904|NCT01782326|520991581|FG000|Double-blind Treatment|Physician Decision|13|||
144489905|NCT01782326|520991582|FG001|Double-blind Treatment|Physician Decision|16|||
144489906|NCT01782326|520991581|FG000|Double-blind Treatment|Protocol deviation|8|||
144489907|NCT01782326|520991582|FG001|Double-blind Treatment|Protocol deviation|7|||
144489908|NCT01782326|520991581|FG000|Double-blind Treatment|Technical problems|0|||
144489909|NCT01782326|520991582|FG001|Double-blind Treatment|Technical problems|5|||
144489910|NCT01347645|520991583|FG000|Overall Study|Death|1|||
144489911|NCT01347645|520991584|FG001|Overall Study|Death|5|||
144489912|NCT01347645|520991585|FG002|Overall Study|Death|2|||
144489913|NCT01347645|520991586|FG003|Overall Study|Death|7|||
144489914|NCT01347645|520991587|FG004|Overall Study|Death|7|||
144489915|NCT01347645|520991583|FG000|Overall Study|Lost to Follow-up|1|||
144489916|NCT01347645|520991584|FG001|Overall Study|Lost to Follow-up|1|||
144489917|NCT01347645|520991585|FG002|Overall Study|Lost to Follow-up|0|||
144489918|NCT01347645|520991586|FG003|Overall Study|Lost to Follow-up|1|||
144489919|NCT01347645|520991587|FG004|Overall Study|Lost to Follow-up|1|||
144489920|NCT01347645|520991583|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
144489921|NCT01347645|520991584|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
144489922|NCT01347645|520991585|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
144489923|NCT01347645|520991586|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
144489924|NCT01347645|520991587|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
144489925|NCT01347645|520991583|FG000|Overall Study|Other|1|||
144489926|NCT01347645|520991584|FG001|Overall Study|Other|0|||
144489927|NCT01347645|520991585|FG002|Overall Study|Other|0|||
144489928|NCT01347645|520991586|FG003|Overall Study|Other|0|||
144489929|NCT01347645|520991587|FG004|Overall Study|Other|1|||
144489930|NCT01347645|520991583|FG000|Overall Study|Withdrawal by Subject|0|||
144489931|NCT01347645|520991584|FG001|Overall Study|Withdrawal by Subject|0|||
144489932|NCT01347645|520991585|FG002|Overall Study|Withdrawal by Subject|0|||
144489933|NCT01347645|520991586|FG003|Overall Study|Withdrawal by Subject|3|||
144489934|NCT01347645|520991587|FG004|Overall Study|Withdrawal by Subject|3|||
144489935|NCT01347645|520991583|FG000|Overall Study|Physician Decision|0|||
144489936|NCT01347645|520991584|FG001|Overall Study|Physician Decision|0|||
144489937|NCT01347645|520991585|FG002|Overall Study|Physician Decision|0|||
144489938|NCT01347645|520991586|FG003|Overall Study|Physician Decision|0|||
144489939|NCT01347645|520991587|FG004|Overall Study|Physician Decision|1|||
144489940|NCT01347645|520991583|FG000|Overall Study|Adverse Event|0|||
144489941|NCT01347645|520991584|FG001|Overall Study|Adverse Event|0|||
144489942|NCT01347645|520991585|FG002|Overall Study|Adverse Event|0|||
144489943|NCT01347645|520991586|FG003|Overall Study|Adverse Event|1|||
144489944|NCT01347645|520991587|FG004|Overall Study|Adverse Event|1|||
144489945|NCT03160079|520991588|FG000|Overall Study|Adverse Event|2|||
144489946|NCT03160079|520991589|FG001|Overall Study|Adverse Event|0|||
144489947|NCT03160079|520991588|FG000|Overall Study|Disease Progression|1|||
144489948|NCT03160079|520991589|FG001|Overall Study|Disease Progression|0|||
144489949|NCT03160079|520991588|FG000|Overall Study|Physician Decision|1|||
144489950|NCT03160079|520991589|FG001|Overall Study|Physician Decision|0|||
144489951|NCT02003222|520991590|FG000|Induction|Never started treatment|0|||
144489952|NCT02003222|520991591|FG001|Induction|Never started treatment|0|||
144489953|NCT02003222|520991592|FG002|Induction|Never started treatment|0|||
144489954|NCT02003222|520991593|FG003|Induction|Never started treatment|0|||
144489955|NCT02003222|520991594|FG004|Induction|Never started treatment|8|||
144489956|NCT02003222|520991590|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
144489957|NCT02003222|520991591|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
144489958|NCT02003222|520991592|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
144489959|NCT02003222|520991593|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
144489960|NCT02003222|520991594|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
144489961|NCT02003222|520991590|FG000|Induction|Adverse Event|0|||
144489962|NCT02003222|520991591|FG001|Induction|Adverse Event|0|||
144489963|NCT02003222|520991592|FG002|Induction|Adverse Event|0|||
144489964|NCT02003222|520991593|FG003|Induction|Adverse Event|0|||
144489965|NCT02003222|520991594|FG004|Induction|Adverse Event|13|||
144489966|NCT02003222|520991590|FG000|Induction|Alternative therapy|0|||
144489967|NCT02003222|520991591|FG001|Induction|Alternative therapy|0|||
144489968|NCT02003222|520991592|FG002|Induction|Alternative therapy|0|||
144489969|NCT02003222|520991593|FG003|Induction|Alternative therapy|0|||
144489970|NCT02003222|520991594|FG004|Induction|Alternative therapy|12|||
144489971|NCT02003222|520991590|FG000|Induction|Disease progression|0|||
144489972|NCT02003222|520991591|FG001|Induction|Disease progression|0|||
144489973|NCT02003222|520991592|FG002|Induction|Disease progression|0|||
144489974|NCT02003222|520991593|FG003|Induction|Disease progression|0|||
144489975|NCT02003222|520991594|FG004|Induction|Disease progression|22|||
144489976|NCT02003222|520991590|FG000|Induction|Death|0|||
144489977|NCT02003222|520991591|FG001|Induction|Death|0|||
144489978|NCT02003222|520991592|FG002|Induction|Death|0|||
144489979|NCT02003222|520991593|FG003|Induction|Death|0|||
144489980|NCT02003222|520991594|FG004|Induction|Death|3|||
144489981|NCT02003222|520991590|FG000|Induction|Withdrawal by Subject|0|||
144489982|NCT02003222|520991591|FG001|Induction|Withdrawal by Subject|0|||
144489983|NCT02003222|520991592|FG002|Induction|Withdrawal by Subject|0|||
144489984|NCT02003222|520991593|FG003|Induction|Withdrawal by Subject|0|||
144489985|NCT02003222|520991594|FG004|Induction|Withdrawal by Subject|8|||
144489986|NCT02003222|520991590|FG000|Induction|Other reasons|0|||
144489987|NCT02003222|520991591|FG001|Induction|Other reasons|0|||
144489988|NCT02003222|520991592|FG002|Induction|Other reasons|0|||
144489989|NCT02003222|520991593|FG003|Induction|Other reasons|0|||
144489990|NCT02003222|520991594|FG004|Induction|Other reasons|22|||
144489991|NCT02003222|520991590|FG000|Intensification|Never started treatment|0|||
144489992|NCT02003222|520991591|FG001|Intensification|Never started treatment|0|||
144489993|NCT02003222|520991592|FG002|Intensification|Never started treatment|0|||
144489994|NCT02003222|520991593|FG003|Intensification|Never started treatment|0|||
144489995|NCT02003222|520991594|FG004|Intensification|Never started treatment|2|||
144489996|NCT02003222|520991590|FG000|Intensification|Adverse Event|0|||
144489997|NCT02003222|520991591|FG001|Intensification|Adverse Event|0|||
144489998|NCT02003222|520991592|FG002|Intensification|Adverse Event|0|||
144489999|NCT02003222|520991593|FG003|Intensification|Adverse Event|0|||
144490000|NCT02003222|520991594|FG004|Intensification|Adverse Event|6|||
144490001|NCT02003222|520991590|FG000|Intensification|Alternative therapy|0|||
144490002|NCT02003222|520991591|FG001|Intensification|Alternative therapy|0|||
144490003|NCT02003222|520991592|FG002|Intensification|Alternative therapy|0|||
144490004|NCT02003222|520991593|FG003|Intensification|Alternative therapy|0|||
144490005|NCT02003222|520991594|FG004|Intensification|Alternative therapy|8|||
144490006|NCT02003222|520991590|FG000|Intensification|Disease progression|0|||
144490007|NCT02003222|520991591|FG001|Intensification|Disease progression|0|||
144490008|NCT02003222|520991592|FG002|Intensification|Disease progression|0|||
144490009|NCT02003222|520991593|FG003|Intensification|Disease progression|0|||
144490010|NCT02003222|520991594|FG004|Intensification|Disease progression|18|||
144490011|NCT02003222|520991590|FG000|Intensification|Withdrawal by Subject|0|||
144490012|NCT02003222|520991591|FG001|Intensification|Withdrawal by Subject|0|||
144490013|NCT02003222|520991592|FG002|Intensification|Withdrawal by Subject|0|||
144490014|NCT02003222|520991593|FG003|Intensification|Withdrawal by Subject|0|||
144490015|NCT02003222|520991594|FG004|Intensification|Withdrawal by Subject|5|||
144490016|NCT02003222|520991590|FG000|Intensification|Other reasons|0|||
144490017|NCT02003222|520991591|FG001|Intensification|Other reasons|0|||
144490018|NCT02003222|520991592|FG002|Intensification|Other reasons|0|||
144490019|NCT02003222|520991593|FG003|Intensification|Other reasons|0|||
144490020|NCT02003222|520991594|FG004|Intensification|Other reasons|8|||
144490021|NCT01848834|520991595|FG000|Overall Study|Adverse Event|3|||
144490022|NCT01848834|520991596|FG001|Overall Study|Adverse Event|11|||
144490023|NCT01848834|520991597|FG002|Overall Study|Adverse Event|3|||
144490024|NCT01848834|520991598|FG003|Overall Study|Adverse Event|5|||
144490025|NCT01848834|520991599|FG004|Overall Study|Adverse Event|9|||
144490026|NCT01848834|520991595|FG000|Overall Study|Death|2|||
144490027|NCT01848834|520991596|FG001|Overall Study|Death|11|||
144490028|NCT01848834|520991597|FG002|Overall Study|Death|1|||
144490029|NCT01848834|520991598|FG003|Overall Study|Death|8|||
144490030|NCT01848834|520991599|FG004|Overall Study|Death|27|||
144490031|NCT01848834|520991595|FG000|Overall Study|Excluded Medication|5|||
144715582|NCT00410410|521813375|FG004|Maintenance Period (MP)|Adverse Event|0|||
144715583|NCT00410410|521813376|FG005|Maintenance Period (MP)|Adverse Event|0|||
144715584|NCT00410410|521813377|FG006|Maintenance Period (MP)|Adverse Event|1|||
144715585|NCT00410410|521813378|FG007|Maintenance Period (MP)|Adverse Event|3|||
144715586|NCT00410410|521813379|FG008|Maintenance Period (MP)|Adverse Event|0|||
144715587|NCT00410410|521813371|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
144715588|NCT00410410|521813372|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
144715589|NCT00410410|521813373|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
144715590|NCT00410410|521813374|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
144369890|NCT01376804|520562739|FG000|Treatment Period|Adverse Event|6|||
144490032|NCT01848834|520991596|FG001|Overall Study|Excluded Medication|4|||
144490033|NCT01848834|520991597|FG002|Overall Study|Excluded Medication|3|||
144490034|NCT01848834|520991598|FG003|Overall Study|Excluded Medication|6|||
144490035|NCT01848834|520991599|FG004|Overall Study|Excluded Medication|6|||
144490036|NCT01848834|520991595|FG000|Overall Study|Lost to Follow-up|5|||
144490037|NCT01848834|520991596|FG001|Overall Study|Lost to Follow-up|5|||
144490038|NCT01848834|520991597|FG002|Overall Study|Lost to Follow-up|3|||
144490039|NCT01848834|520991598|FG003|Overall Study|Lost to Follow-up|0|||
144490040|NCT01848834|520991599|FG004|Overall Study|Lost to Follow-up|3|||
144490041|NCT01848834|520991595|FG000|Overall Study|Physician Decision|1|||
144490042|NCT01848834|520991596|FG001|Overall Study|Physician Decision|3|||
144490043|NCT01848834|520991597|FG002|Overall Study|Physician Decision|4|||
144490044|NCT01848834|520991598|FG003|Overall Study|Physician Decision|0|||
144490045|NCT01848834|520991599|FG004|Overall Study|Physician Decision|11|||
144490046|NCT01848834|520991595|FG000|Overall Study|Protocol Violation|0|||
144490047|NCT01848834|520991596|FG001|Overall Study|Protocol Violation|0|||
144490048|NCT01848834|520991597|FG002|Overall Study|Protocol Violation|0|||
144490049|NCT01848834|520991598|FG003|Overall Study|Protocol Violation|0|||
144490050|NCT01848834|520991599|FG004|Overall Study|Protocol Violation|1|||
144490051|NCT01848834|520991595|FG000|Overall Study|Sponsor Decision|1|||
144490052|NCT01848834|520991596|FG001|Overall Study|Sponsor Decision|1|||
144490053|NCT01848834|520991597|FG002|Overall Study|Sponsor Decision|0|||
144490054|NCT01848834|520991598|FG003|Overall Study|Sponsor Decision|1|||
144490055|NCT01848834|520991599|FG004|Overall Study|Sponsor Decision|1|||
144490056|NCT01848834|520991595|FG000|Overall Study|Withdrawal by Subject|2|||
144490057|NCT01848834|520991596|FG001|Overall Study|Withdrawal by Subject|13|||
144490058|NCT01848834|520991597|FG002|Overall Study|Withdrawal by Subject|10|||
144490059|NCT01848834|520991598|FG003|Overall Study|Withdrawal by Subject|6|||
144490060|NCT01848834|520991599|FG004|Overall Study|Withdrawal by Subject|36|||
144490061|NCT01886872|520991602|FG000|Overall Study|Ineligible|7|||
144490062|NCT01886872|520991603|FG001|Overall Study|Ineligible|4|||
144490063|NCT01886872|520991604|FG002|Overall Study|Ineligible|12|||
144490064|NCT01670500|520991608|FG000|Overall Study|Withdrawal by Subject|1|||
144490065|NCT01670500|520991609|FG001|Overall Study|Withdrawal by Subject|0|||
144490066|NCT01857323|520991611|FG000|Overall Study|Adverse Event|1|||
144490067|NCT01857323|520991611|FG000|Overall Study|Withdrawal by Subject|3|||
144490068|NCT01857323|520991611|FG000|Overall Study|Non-compliance|1|||
144490069|NCT01857323|520991611|FG000|Overall Study|Protocol Violation|6|||
144490070|NCT01857323|520991611|FG000|Overall Study|Lost to Follow-up|1|||
144490071|NCT01857323|520991611|FG000|Overall Study|Other|4|||
144490072|NCT01857323|520991611|FG000|Overall Study|Did not complete 180 doses|48|||
144490073|NCT03658811|520991612|FG000|Overall Study|Lost to Follow-up|3|||
144490074|NCT02107443|520991613|FG000|Overall Study|Death|42|||
144490075|NCT02107443|520991614|FG001|Overall Study|Death|30|||
144490076|NCT02107443|520991613|FG000|Overall Study|Study Protocol Violation|3|||
144490077|NCT02107443|520991614|FG001|Overall Study|Study Protocol Violation|1|||
144490078|NCT02107443|520991613|FG000|Overall Study|Registered but Not Eligible|0|||
144490079|NCT02107443|520991614|FG001|Overall Study|Registered but Not Eligible|1|||
144490080|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
144490081|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
144490082|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
144490083|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
144490084|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Changed Mind|2|||
144490085|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Changed Mind|0|||
144490086|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
144490087|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
144490088|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
144490089|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
144490090|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
144490091|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
144490092|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
144490093|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
144490094|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Other Medical|9|||
144490095|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Other Medical|5|||
144490096|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Disease Progression|4|||
144490097|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Disease Progression|2|||
144490098|NCT02107443|520991613|FG000|Overall Study|Withdrawal: Personal Issues|0|||
144490099|NCT02107443|520991614|FG001|Overall Study|Withdrawal: Personal Issues|3|||
144490100|NCT01400893|520991615|FG000|Overall Study|Death|27|||
144490101|NCT01400893|520991616|FG001|Overall Study|Death|21|||
144490102|NCT01400893|520991615|FG000|Overall Study|Lost to Follow-up|0|||
144490103|NCT01400893|520991616|FG001|Overall Study|Lost to Follow-up|6|||
144490104|NCT00946647|520991617|FG000|Phase 1 Part|Adverse Event|2|||
144490105|NCT00946647|520991618|FG001|Phase 1 Part|Adverse Event|5|||
144490106|NCT00946647|520991619|FG002|Phase 1 Part|Adverse Event|3|||
144490107|NCT00946647|520991620|FG003|Phase 1 Part|Adverse Event|0|||
144490108|NCT00946647|520991621|FG004|Phase 1 Part|Adverse Event|0|||
144490109|NCT00946647|520991617|FG000|Phase 1 Part|Disease progression|3|||
144490110|NCT00946647|520991618|FG001|Phase 1 Part|Disease progression|6|||
144490111|NCT00946647|520991619|FG002|Phase 1 Part|Disease progression|1|||
144490112|NCT00946647|520991620|FG003|Phase 1 Part|Disease progression|0|||
144490113|NCT00946647|520991621|FG004|Phase 1 Part|Disease progression|0|||
144490114|NCT00946647|520991617|FG000|Phase 1 Part|Withdrawal by Subject|1|||
144490115|NCT00946647|520991618|FG001|Phase 1 Part|Withdrawal by Subject|4|||
144490116|NCT00946647|520991619|FG002|Phase 1 Part|Withdrawal by Subject|3|||
144490117|NCT00946647|520991620|FG003|Phase 1 Part|Withdrawal by Subject|0|||
144490118|NCT00946647|520991621|FG004|Phase 1 Part|Withdrawal by Subject|0|||
144490119|NCT00946647|520991617|FG000|Phase 1 Part|Abnormal values|0|||
144490120|NCT00946647|520991618|FG001|Phase 1 Part|Abnormal values|2|||
144490121|NCT00946647|520991619|FG002|Phase 1 Part|Abnormal values|0|||
144490122|NCT00946647|520991620|FG003|Phase 1 Part|Abnormal values|0|||
144490123|NCT00946647|520991621|FG004|Phase 1 Part|Abnormal values|0|||
144490124|NCT00946647|520991617|FG000|Phase 1 Part|Reason missing|0|||
144490125|NCT00946647|520991618|FG001|Phase 1 Part|Reason missing|1|||
144490126|NCT00946647|520991619|FG002|Phase 1 Part|Reason missing|0|||
144490127|NCT00946647|520991620|FG003|Phase 1 Part|Reason missing|0|||
144490128|NCT00946647|520991621|FG004|Phase 1 Part|Reason missing|0|||
144490129|NCT00946647|520991617|FG000|Phase ll Part|Untreated|0|||
144490130|NCT00946647|520991618|FG001|Phase ll Part|Untreated|0|||
144490131|NCT00946647|520991619|FG002|Phase ll Part|Untreated|0|||
144490132|NCT00946647|520991620|FG003|Phase ll Part|Untreated|0|||
144490133|NCT00946647|520991621|FG004|Phase ll Part|Untreated|2|||
144490134|NCT00946647|520991617|FG000|Phase ll Part|Adverse Event|0|||
144490135|NCT00946647|520991618|FG001|Phase ll Part|Adverse Event|0|||
144490136|NCT00946647|520991619|FG002|Phase ll Part|Adverse Event|0|||
144490137|NCT00946647|520991620|FG003|Phase ll Part|Adverse Event|10|||
144490138|NCT00946647|520991621|FG004|Phase ll Part|Adverse Event|6|||
144490139|NCT00946647|520991617|FG000|Phase ll Part|Withdrawal by Subject|0|||
144490140|NCT00946647|520991618|FG001|Phase ll Part|Withdrawal by Subject|0|||
144490141|NCT00946647|520991619|FG002|Phase ll Part|Withdrawal by Subject|0|||
144490142|NCT00946647|520991620|FG003|Phase ll Part|Withdrawal by Subject|8|||
144490143|NCT00946647|520991621|FG004|Phase ll Part|Withdrawal by Subject|6|||
144490144|NCT00946647|520991617|FG000|Phase ll Part|Administrative problems|0|||
144490145|NCT00946647|520991618|FG001|Phase ll Part|Administrative problems|0|||
144490146|NCT00946647|520991619|FG002|Phase ll Part|Administrative problems|0|||
144490147|NCT00946647|520991620|FG003|Phase ll Part|Administrative problems|3|||
144490148|NCT00946647|520991621|FG004|Phase ll Part|Administrative problems|8|||
144490149|NCT00946647|520991617|FG000|Phase ll Part|Death|0|||
144490150|NCT00946647|520991618|FG001|Phase ll Part|Death|0|||
144490151|NCT00946647|520991619|FG002|Phase ll Part|Death|0|||
144490152|NCT00946647|520991620|FG003|Phase ll Part|Death|7|||
144490153|NCT00946647|520991621|FG004|Phase ll Part|Death|4|||
144490154|NCT00946647|520991617|FG000|Phase ll Part|Disease progression|0|||
144490155|NCT00946647|520991618|FG001|Phase ll Part|Disease progression|0|||
144490156|NCT00946647|520991619|FG002|Phase ll Part|Disease progression|0|||
144490157|NCT00946647|520991620|FG003|Phase ll Part|Disease progression|6|||
144490158|NCT00946647|520991621|FG004|Phase ll Part|Disease progression|14|||
144490159|NCT00946647|520991617|FG000|Phase ll Part|Protocol Violation|0|||
144490160|NCT00946647|520991618|FG001|Phase ll Part|Protocol Violation|0|||
144490161|NCT00946647|520991619|FG002|Phase ll Part|Protocol Violation|0|||
144490162|NCT00946647|520991620|FG003|Phase ll Part|Protocol Violation|4|||
144490163|NCT00946647|520991621|FG004|Phase ll Part|Protocol Violation|2|||
144490164|NCT00946647|520991617|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
144490165|NCT00946647|520991618|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
144490166|NCT00946647|520991619|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
144490167|NCT00946647|520991620|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
144490168|NCT00946647|520991621|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
144490169|NCT04209790|520991622|FG000|Overall Study|Physician Decision|1|||
144490170|NCT03057834|520991623|FG000|Overall Study|Withdrawal by Subject|25|||
144490171|NCT03057834|520991624|FG001|Overall Study|Withdrawal by Subject|29|||
144490172|NCT03706690|520991628|FG000|Overall Study|Withdrawal by Subject|8|||
144490173|NCT03706690|520991629|FG001|Overall Study|Withdrawal by Subject|8|||
144490174|NCT03706690|520991628|FG000|Overall Study|Death|143|||
144490175|NCT03706690|520991629|FG001|Overall Study|Death|75|||
144490176|NCT03706690|520991628|FG000|Overall Study|Ongoing at DCO|121|||
144490177|NCT03706690|520991629|FG001|Overall Study|Ongoing at DCO|52|||
144490178|NCT03803774|520991630|FG000|Dose Escalation|Withdrawal by Subject|0|||
144490179|NCT03803774|520991631|FG001|Dose Escalation|Withdrawal by Subject|0|||
144490180|NCT03803774|520991632|FG002|Dose Escalation|Withdrawal by Subject|0|||
144490181|NCT03803774|520991633|FG003|Dose Escalation|Withdrawal by Subject|1|||
144490182|NCT03803774|520991634|FG004|Dose Escalation|Withdrawal by Subject|0|||
144490183|NCT05617040|520991635|FG000|Overall Study|Adverse Event|0|||
144490184|NCT05617040|520991636|FG001|Overall Study|Adverse Event|1|||
144490185|NCT05617040|520991637|FG002|Overall Study|Adverse Event|0|||
144490186|NCT05617040|520991635|FG000|Overall Study|Death|0|||
144490187|NCT05617040|520991636|FG001|Overall Study|Death|0|||
144490188|NCT05617040|520991637|FG002|Overall Study|Death|1|||
144490189|NCT02711826|520991638|FG000|Overall Study|Physician Decision|0|||
144490190|NCT02711826|520991639|FG001|Overall Study|Physician Decision|0|||
144490191|NCT02711826|520991640|FG002|Overall Study|Physician Decision|0|||
144490192|NCT02711826|520991641|FG003|Overall Study|Physician Decision|1|||
144490193|NCT02711826|520991642|FG004|Overall Study|Physician Decision|0|||
144490194|NCT02711826|520991638|FG000|Overall Study|Withdrawal by Subject|0|||
144490195|NCT02711826|520991639|FG001|Overall Study|Withdrawal by Subject|1|||
144490196|NCT02711826|520991640|FG002|Overall Study|Withdrawal by Subject|0|||
144490197|NCT02711826|520991641|FG003|Overall Study|Withdrawal by Subject|4|||
144490198|NCT02711826|520991642|FG004|Overall Study|Withdrawal by Subject|0|||
144490199|NCT02711826|520991638|FG000|Overall Study|Failure to manufacture cellular product|0|||
144490200|NCT02711826|520991639|FG001|Overall Study|Failure to manufacture cellular product|0|||
144490201|NCT02711826|520991640|FG002|Overall Study|Failure to manufacture cellular product|5|||
144490202|NCT02711826|520991641|FG003|Overall Study|Failure to manufacture cellular product|0|||
144490203|NCT02711826|520991642|FG004|Overall Study|Failure to manufacture cellular product|0|||
144490204|NCT02711826|520991638|FG000|Overall Study|Infusion canceled for active infection|0|||
144490205|NCT02711826|520991639|FG001|Overall Study|Infusion canceled for active infection|1|||
144490206|NCT02711826|520991640|FG002|Overall Study|Infusion canceled for active infection|0|||
144490207|NCT02711826|520991641|FG003|Overall Study|Infusion canceled for active infection|0|||
144490208|NCT02711826|520991642|FG004|Overall Study|Infusion canceled for active infection|0|||
144490209|NCT02711826|520991638|FG000|Overall Study|Screen failures|0|||
144490210|NCT02711826|520991639|FG001|Overall Study|Screen failures|0|||
144490211|NCT02711826|520991640|FG002|Overall Study|Screen failures|0|||
144490212|NCT02711826|520991641|FG003|Overall Study|Screen failures|4|||
144490213|NCT02711826|520991642|FG004|Overall Study|Screen failures|0|||
144490214|NCT03990363|520991643|FG000|Overall Study|Withdrawal by Subject|10|||
144490215|NCT03990363|520991644|FG001|Overall Study|Withdrawal by Subject|9|||
144490216|NCT03990363|520991645|FG002|Overall Study|Withdrawal by Subject|18|||
144490217|NCT03990363|520991646|FG003|Overall Study|Withdrawal by Subject|11|||
144490218|NCT03990363|520991647|FG004|Overall Study|Withdrawal by Subject|9|||
144490219|NCT03990363|520991643|FG000|Overall Study|Physician Decision|1|||
144490220|NCT03990363|520991644|FG001|Overall Study|Physician Decision|0|||
144369891|NCT01376804|520562739|FG000|Treatment Period|Patient did not receive study drug|1|||
144490221|NCT03990363|520991645|FG002|Overall Study|Physician Decision|0|||
144490222|NCT03990363|520991646|FG003|Overall Study|Physician Decision|0|||
144490223|NCT03990363|520991647|FG004|Overall Study|Physician Decision|0|||
144490224|NCT03990363|520991643|FG000|Overall Study|Adverse Event|1|||
144490225|NCT03990363|520991644|FG001|Overall Study|Adverse Event|3|||
144490226|NCT03990363|520991645|FG002|Overall Study|Adverse Event|2|||
144490227|NCT03990363|520991646|FG003|Overall Study|Adverse Event|2|||
144490228|NCT03990363|520991647|FG004|Overall Study|Adverse Event|0|||
144490229|NCT03990363|520991643|FG000|Overall Study|Death|14|||
144490230|NCT03990363|520991644|FG001|Overall Study|Death|8|||
144490231|NCT03990363|520991645|FG002|Overall Study|Death|14|||
144490232|NCT03990363|520991646|FG003|Overall Study|Death|10|||
144490233|NCT03990363|520991647|FG004|Overall Study|Death|11|||
144490234|NCT03990363|520991643|FG000|Overall Study|Failure to meet randomization criteria|0|||
144715591|NCT00410410|521813375|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
144715592|NCT00410410|521813376|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
144715593|NCT00410410|521813377|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
144715594|NCT00410410|521813378|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
144715595|NCT00410410|521813379|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
144715596|NCT00410410|521813371|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
144715597|NCT00410410|521813372|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
144715598|NCT00410410|521813373|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
144715599|NCT00410410|521813374|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
144715600|NCT00410410|521813375|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
144715601|NCT00410410|521813376|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
144715602|NCT00410410|521813377|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
144715603|NCT00410410|521813378|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
144715604|NCT00410410|521813379|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
144715605|NCT00410410|521813371|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715606|NCT00410410|521813372|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715607|NCT00410410|521813373|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715608|NCT00410410|521813374|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715609|NCT00410410|521813375|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715610|NCT00410410|521813376|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715611|NCT00410410|521813377|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
144715612|NCT00410410|521813378|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
144715613|NCT00410410|521813379|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
144715614|NCT00410410|521813371|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715615|NCT00410410|521813372|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715616|NCT00410410|521813373|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715617|NCT00410410|521813374|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715618|NCT00410410|521813375|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715619|NCT00410410|521813376|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715620|NCT00410410|521813377|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
144715621|NCT00410410|521813378|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
144715622|NCT00410410|521813379|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
144715623|NCT00410410|521813371|FG000|Open-Label Period (OL)|Death|0|||
144715624|NCT00410410|521813372|FG001|Open-Label Period (OL)|Death|0|||
144715625|NCT00410410|521813373|FG002|Open-Label Period (OL)|Death|0|||
144715626|NCT00410410|521813374|FG003|Open-Label Period (OL)|Death|0|||
144715627|NCT00410410|521813375|FG004|Open-Label Period (OL)|Death|0|||
144490235|NCT03990363|520991644|FG001|Overall Study|Failure to meet randomization criteria|1|||
144490236|NCT03990363|520991645|FG002|Overall Study|Failure to meet randomization criteria|1|||
144490237|NCT03990363|520991646|FG003|Overall Study|Failure to meet randomization criteria|0|||
144715628|NCT00410410|521813376|FG005|Open-Label Period (OL)|Death|0|||
144490238|NCT03990363|520991647|FG004|Overall Study|Failure to meet randomization criteria|0|||
144490239|NCT03990363|520991643|FG000|Overall Study|Lost to Follow-up|0|||
144490240|NCT03990363|520991644|FG001|Overall Study|Lost to Follow-up|0|||
144490241|NCT03990363|520991645|FG002|Overall Study|Lost to Follow-up|0|||
144490242|NCT03990363|520991646|FG003|Overall Study|Lost to Follow-up|1|||
144490243|NCT03990363|520991647|FG004|Overall Study|Lost to Follow-up|2|||
144490244|NCT03990363|520991643|FG000|Overall Study|Non-compliance with study drug|2|||
144490245|NCT03990363|520991644|FG001|Overall Study|Non-compliance with study drug|1|||
144490246|NCT03990363|520991645|FG002|Overall Study|Non-compliance with study drug|2|||
144490247|NCT03990363|520991646|FG003|Overall Study|Non-compliance with study drug|0|||
144490248|NCT03990363|520991647|FG004|Overall Study|Non-compliance with study drug|0|||
144490249|NCT03990363|520991643|FG000|Overall Study|Study terminated by sponsor|0|||
144490250|NCT03990363|520991644|FG001|Overall Study|Study terminated by sponsor|1|||
144490251|NCT03990363|520991645|FG002|Overall Study|Study terminated by sponsor|0|||
144490252|NCT03990363|520991646|FG003|Overall Study|Study terminated by sponsor|0|||
144490253|NCT03990363|520991647|FG004|Overall Study|Study terminated by sponsor|0|||
144490254|NCT03990363|520991643|FG000|Overall Study|Site terminated by sponsor|2|||
144490255|NCT03990363|520991644|FG001|Overall Study|Site terminated by sponsor|1|||
144490256|NCT03990363|520991645|FG002|Overall Study|Site terminated by sponsor|2|||
144490257|NCT03990363|520991646|FG003|Overall Study|Site terminated by sponsor|0|||
144490258|NCT03990363|520991647|FG004|Overall Study|Site terminated by sponsor|2|||
144490259|NCT03990363|520991643|FG000|Overall Study|Not categorized|5|||
144490260|NCT03990363|520991644|FG001|Overall Study|Not categorized|5|||
144490261|NCT03990363|520991645|FG002|Overall Study|Not categorized|3|||
144490262|NCT03990363|520991646|FG003|Overall Study|Not categorized|2|||
144490263|NCT03990363|520991647|FG004|Overall Study|Not categorized|2|||
144490264|NCT02169219|520991650|FG000|Overall Study|Lack of Efficacy|6|||
144490265|NCT02886936|520991651|FG000|Overall Study|Lost to Follow-up|4|||
144490266|NCT02886936|520991652|FG001|Overall Study|Lost to Follow-up|3|||
144490267|NCT02886936|520991653|FG002|Overall Study|Lost to Follow-up|0|||
144490268|NCT04562779|520991654|FG000|Overall Study|Lost to Follow-up|7|||
144490269|NCT04562779|520991655|FG001|Overall Study|Lost to Follow-up|5|||
144490270|NCT04562779|520991656|FG002|Overall Study|Lost to Follow-up|10|||
144490271|NCT04562779|520991654|FG000|Overall Study|Protocol Violation|2|||
144490272|NCT04562779|520991655|FG001|Overall Study|Protocol Violation|2|||
144490273|NCT04562779|520991656|FG002|Overall Study|Protocol Violation|0|||
144490274|NCT02320721|520991657|FG000|Overall Study|Adverse Event|6|||
144490275|NCT02320721|520991658|FG001|Overall Study|Adverse Event|6|||
144490276|NCT02320721|520991657|FG000|Overall Study|Lack of Efficacy|2|||
144490277|NCT02320721|520991658|FG001|Overall Study|Lack of Efficacy|0|||
144490278|NCT02320721|520991657|FG000|Overall Study|Poor compliance to protocol|3|||
144490279|NCT02320721|520991658|FG001|Overall Study|Poor compliance to protocol|7|||
144490280|NCT02320721|520991657|FG000|Overall Study|Randomized but not treated|0|||
144490281|NCT02320721|520991658|FG001|Overall Study|Randomized but not treated|1|||
144490282|NCT02320721|520991657|FG000|Overall Study|Hypoglycemia|1|||
144490283|NCT02320721|520991658|FG001|Overall Study|Hypoglycemia|0|||
144490284|NCT02320721|520991657|FG000|Overall Study|Other than specified above|15|||
144490285|NCT02320721|520991658|FG001|Overall Study|Other than specified above|20|||
144490286|NCT03173248|520991659|FG000|Overall Study|Death|28|||
144490287|NCT03173248|520991660|FG001|Overall Study|Death|46|||
144490288|NCT03173248|520991659|FG000|Overall Study|Lost to Follow-up|0|||
144490289|NCT03173248|520991660|FG001|Overall Study|Lost to Follow-up|1|||
144490290|NCT03173248|520991659|FG000|Overall Study|Withdrawal by Subject|6|||
144490291|NCT03173248|520991660|FG001|Overall Study|Withdrawal by Subject|4|||
144490292|NCT03173248|520991659|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
144490293|NCT03173248|520991660|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
144490294|NCT03077620|520991662|FG000|Overall Study|Unable to place lumbar catheter|1|||
144490295|NCT03077620|520991663|FG001|Overall Study|Unable to place lumbar catheter|0|||
144490296|NCT03077620|520991664|FG002|Overall Study|Unable to place lumbar catheter|1|||
144490297|NCT03077620|520991665|FG003|Overall Study|Unable to place lumbar catheter|0|||
144490298|NCT03077620|520991662|FG000|Overall Study|Withdrawal by Subject|0|||
144490299|NCT03077620|520991663|FG001|Overall Study|Withdrawal by Subject|1|||
144490300|NCT03077620|520991664|FG002|Overall Study|Withdrawal by Subject|0|||
144490301|NCT03077620|520991665|FG003|Overall Study|Withdrawal by Subject|0|||
144490302|NCT03077620|520991662|FG000|Overall Study|Physician Decision|0|||
144490303|NCT03077620|520991663|FG001|Overall Study|Physician Decision|0|||
144490304|NCT03077620|520991664|FG002|Overall Study|Physician Decision|1|||
144490305|NCT03077620|520991665|FG003|Overall Study|Physician Decision|0|||
144490306|NCT05397470|520991666|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
144490307|NCT05397470|520991667|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
144490308|NCT05397470|520991668|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
144490309|NCT05397470|520991666|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
144490310|NCT05397470|520991667|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
144490311|NCT05397470|520991668|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
144490312|NCT05397470|520991666|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
144490313|NCT05397470|520991667|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
144490314|NCT05397470|520991668|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
144490315|NCT05397470|520991666|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
144490316|NCT05397470|520991667|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
144490317|NCT05397470|520991668|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
144490318|NCT05397470|520991666|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
144490319|NCT05397470|520991667|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
144490320|NCT05397470|520991668|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
144490321|NCT05397470|520991666|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
144490322|NCT05397470|520991667|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
144490323|NCT05397470|520991668|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
144490324|NCT05397470|520991666|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
144490325|NCT05397470|520991667|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
144490326|NCT05397470|520991668|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
144490327|NCT05567952|520993191|FG000|Overall Study|Lost to Follow-up|3|||
144490328|NCT05567952|520993192|FG001|Overall Study|Lost to Follow-up|2|||
144490329|NCT05567952|520993191|FG000|Overall Study|Withdrawal by Subject|6|||
144490330|NCT05567952|520993192|FG001|Overall Study|Withdrawal by Subject|3|||
144490331|NCT05567952|520993191|FG000|Overall Study|Other|3|||
144490332|NCT05567952|520993192|FG001|Overall Study|Other|1|||
144490333|NCT05194735|520993193|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
144490334|NCT05194735|520993194|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
144490335|NCT05194735|520993195|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
144490336|NCT05194735|520993193|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
144490337|NCT05194735|520993194|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
144490338|NCT05194735|520993195|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
144490339|NCT05194735|520993193|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
144490340|NCT05194735|520993194|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
144490341|NCT05194735|520993195|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
144490342|NCT05194735|520993193|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
144490343|NCT05194735|520993194|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
144490344|NCT05194735|520993195|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
144490345|NCT00731042|520993196|FG000|Second Intervention|Did not meet inclusion criteria|0|||
144490346|NCT00731042|520993197|FG001|Second Intervention|Did not meet inclusion criteria|2|||
144490347|NCT00432159|520993206|FG000|Overall Study|Death|0|||
144490348|NCT00432159|520993207|FG001|Overall Study|Death|1|||
144490349|NCT00432159|520993208|FG002|Overall Study|Death|0|||
144490350|NCT00432159|520993209|FG003|Overall Study|Death|0|||
144490351|NCT00432159|520993210|FG004|Overall Study|Death|0|||
144490352|NCT00432159|520993206|FG000|Overall Study|Failure|9|||
144490353|NCT00432159|520993207|FG001|Overall Study|Failure|5|||
144490354|NCT00432159|520993208|FG002|Overall Study|Failure|3|||
144490355|NCT00432159|520993209|FG003|Overall Study|Failure|2|||
144490356|NCT00432159|520993210|FG004|Overall Study|Failure|3|||
144490357|NCT00432159|520993206|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
144490358|NCT00432159|520993207|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
144490359|NCT00432159|520993208|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
144490360|NCT00432159|520993209|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
144490361|NCT00432159|520993210|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
144490362|NCT05310084|520993212|FG000|Overall Study|Withdrawal by Subject|2|||
144490363|NCT05310084|520993213|FG001|Overall Study|Withdrawal by Subject|3|||
144490364|NCT05310084|520993212|FG000|Overall Study|Participant availability|0|||
144490365|NCT05310084|520993213|FG001|Overall Study|Participant availability|4|||
144490366|NCT05310084|520993212|FG000|Overall Study|Lost to Follow-up|1|||
144490367|NCT05310084|520993213|FG001|Overall Study|Lost to Follow-up|1|||
144490368|NCT05310084|520993212|FG000|Overall Study|Adverse Event|1|||
144490369|NCT05310084|520993213|FG001|Overall Study|Adverse Event|1|||
144490370|NCT05310084|520993212|FG000|Overall Study|Randomized but not vaccinated|4|||
144490371|NCT05310084|520993213|FG001|Overall Study|Randomized but not vaccinated|2|||
144490372|NCT02107274|520993215|FG000|Treatment vs. Placebo|Adverse Event|3|||
144490373|NCT02107274|520993216|FG001|Treatment vs. Placebo|Adverse Event|0|||
144490374|NCT02107274|520993215|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
144490375|NCT02107274|520993216|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
144490376|NCT02107274|520993215|FG000|Control Phase|Lost to Follow-up|1|||
144490377|NCT02107274|520993216|FG001|Control Phase|Lost to Follow-up|1|||
144490378|NCT02107274|520993215|FG000|Control Phase|Death|2|||
144490379|NCT02107274|520993216|FG001|Control Phase|Death|0|||
144490380|NCT02107274|520993215|FG000|Control Phase|Adverse Event|0|||
144490381|NCT02107274|520993216|FG001|Control Phase|Adverse Event|1|||
144490382|NCT03158948|520993220|FG000|Overall Study|Death|1|||
144490383|NCT03158948|520993221|FG001|Overall Study|Death|1|||
144490384|NCT03158948|520993222|FG002|Overall Study|Death|3|||
144490385|NCT03158948|520993223|FG003|Overall Study|Death|2|||
144490386|NCT03158948|520993220|FG000|Overall Study|Physician Decision|0|||
144490387|NCT03158948|520993221|FG001|Overall Study|Physician Decision|0|||
144490388|NCT03158948|520993222|FG002|Overall Study|Physician Decision|0|||
144490389|NCT03158948|520993223|FG003|Overall Study|Physician Decision|1|||
144490390|NCT04730947|520993224|FG000|Overall Study|Withdrawal by Subject|0|||
144490391|NCT04730947|520993225|FG001|Overall Study|Withdrawal by Subject|1|||
144490392|NCT03527277|520993228|FG000|Overall Study|Withdrawal by Subject|5|||
144490393|NCT03527277|520993229|FG001|Overall Study|Withdrawal by Subject|0|||
144490394|NCT03527277|520993228|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
144490395|NCT03527277|520993229|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
144490396|NCT03527277|520993228|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
144490397|NCT03527277|520993229|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
144490398|NCT02118714|520993234|FG000|Overall Study|Lost to Follow-up|2|||
144490399|NCT02118714|520993234|FG000|Overall Study|Protocol Violation|1|||
144490400|NCT01627340|520993235|FG000|Overall Study|Adverse Event|1|||
144490401|NCT01627340|520993236|FG001|Overall Study|Adverse Event|0|||
144490402|NCT01627340|520993235|FG000|Overall Study|Lost to Follow-up|8|||
144490403|NCT01627340|520993236|FG001|Overall Study|Lost to Follow-up|4|||
144490404|NCT01627340|520993235|FG000|Overall Study|Pregnancy|1|||
144490405|NCT01627340|520993236|FG001|Overall Study|Pregnancy|0|||
144490406|NCT01627340|520993235|FG000|Overall Study|Withdrawal by Subject|2|||
144490407|NCT01627340|520993236|FG001|Overall Study|Withdrawal by Subject|0|||
144490408|NCT02013687|520993237|FG000|Overall Study|Lost to Follow-up|0|||
144490409|NCT02013687|520993238|FG001|Overall Study|Lost to Follow-up|0|||
144490410|NCT02013687|520993239|FG002|Overall Study|Lost to Follow-up|1|||
144490411|NCT02013687|520993240|FG003|Overall Study|Lost to Follow-up|0|||
144490412|NCT02013687|520993237|FG000|Overall Study|Protocol Violation|0|||
144490413|NCT02013687|520993238|FG001|Overall Study|Protocol Violation|0|||
144490414|NCT02013687|520993239|FG002|Overall Study|Protocol Violation|0|||
144490415|NCT02013687|520993240|FG003|Overall Study|Protocol Violation|1|||
144490416|NCT02013687|520993237|FG000|Overall Study|Withdrawal by Subject|0|||
144490417|NCT02013687|520993238|FG001|Overall Study|Withdrawal by Subject|0|||
144490418|NCT02013687|520993239|FG002|Overall Study|Withdrawal by Subject|0|||
144490419|NCT02013687|520993240|FG003|Overall Study|Withdrawal by Subject|1|||
144490420|NCT02013687|520993237|FG000|Overall Study|Missed visits due to patient travel|0|||
144490421|NCT02013687|520993238|FG001|Overall Study|Missed visits due to patient travel|0|||
144490422|NCT02013687|520993239|FG002|Overall Study|Missed visits due to patient travel|1|||
144490423|NCT02013687|520993240|FG003|Overall Study|Missed visits due to patient travel|0|||
144369892|NCT01532986|520562745|FG000|Overall Study|Death|9|||
144490424|NCT01653847|520993241|FG000|Overall Study|Withdrawal by Subject|1|||
144490425|NCT01653847|520993242|FG001|Overall Study|Withdrawal by Subject|0|||
144490426|NCT02554513|520993243|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
144490427|NCT02554513|520993244|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
144490428|NCT00388362|520993245|FG000|Enrolled|Ineligible|1|||
144490429|NCT00388362|520993245|FG000|Enrolled|Adverse Event|9|||
144490430|NCT00388362|520993245|FG000|Enrolled|Death|1|||
144490431|NCT00388362|520993245|FG000|Enrolled|Loss insurance|1|||
144490432|NCT00388362|520993245|FG000|Enrolled|Withdrawal by Subject|1|||
144490433|NCT00388362|520993245|FG000|Remained on Study Median of 514 Days|Death|2|||
144490434|NCT02335268|520993246|FG000|Overall Study|Physician Decision|5|||
144490435|NCT02335268|520993247|FG001|Overall Study|Physician Decision|1|||
144490436|NCT02335268|520993246|FG000|Overall Study|Lack of Efficacy|2|||
144490437|NCT02335268|520993247|FG001|Overall Study|Lack of Efficacy|1|||
144490438|NCT02335268|520993246|FG000|Overall Study|Adverse Event|5|||
144490439|NCT02335268|520993247|FG001|Overall Study|Adverse Event|2|||
144490440|NCT02335268|520993246|FG000|Overall Study|increase blasts|2|||
144490441|NCT02335268|520993247|FG001|Overall Study|increase blasts|0|||
144490442|NCT02335268|520993246|FG000|Overall Study|Withdrawal by Subject|3|||
144490443|NCT02335268|520993247|FG001|Overall Study|Withdrawal by Subject|2|||
144490444|NCT01856192|520993252|FG000|Overall Study|Adverse Event|12|||
144490445|NCT01856192|520993253|FG001|Overall Study|Adverse Event|4|||
144490446|NCT01856192|520993252|FG000|Overall Study|Alternative therapy|0|||
144490447|NCT01856192|520993253|FG001|Overall Study|Alternative therapy|3|||
144490448|NCT01856192|520993252|FG000|Overall Study|Death|3|||
144490449|NCT01856192|520993253|FG001|Overall Study|Death|5|||
144490450|NCT01856192|520993252|FG000|Overall Study|Lack of Efficacy|0|||
144490451|NCT01856192|520993253|FG001|Overall Study|Lack of Efficacy|5|||
144490452|NCT01856192|520993252|FG000|Overall Study|Withdrawal by Subject|1|||
144490453|NCT01856192|520993253|FG001|Overall Study|Withdrawal by Subject|1|||
144490454|NCT01856192|520993252|FG000|Overall Study|Other diseases|1|||
144490455|NCT01856192|520993253|FG001|Overall Study|Other diseases|0|||
144490456|NCT01856192|520993252|FG000|Overall Study|Never started treatment|7|||
144490457|NCT01856192|520993253|FG001|Overall Study|Never started treatment|5|||
144490458|NCT01856192|520993252|FG000|Overall Study|Path ineligible|20|||
144490459|NCT01856192|520993253|FG001|Overall Study|Path ineligible|34|||
144490460|NCT01856192|520993252|FG000|Overall Study|Non-path ineligible|2|||
144490461|NCT01856192|520993253|FG001|Overall Study|Non-path ineligible|2|||
144490462|NCT01856192|520993252|FG000|Overall Study|Physician Decision|1|||
144490463|NCT01856192|520993253|FG001|Overall Study|Physician Decision|1|||
144490464|NCT01856192|520993252|FG000|Overall Study|Suspicion of progressive disease|1|||
144490465|NCT01856192|520993253|FG001|Overall Study|Suspicion of progressive disease|0|||
144490466|NCT01856192|520993252|FG000|Overall Study|Non-compliance|1|||
144490467|NCT01856192|520993253|FG001|Overall Study|Non-compliance|0|||
144490468|NCT05893797|520993254|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
144490469|NCT05893797|520993254|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
144490470|NCT05893797|520993254|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
144490471|NCT05893797|520993254|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
144490472|NCT04770220|520993255|FG000|Overall Study|Adverse Event|2|||
144490473|NCT04770220|520993256|FG001|Overall Study|Adverse Event|11|||
144490474|NCT04770220|520993255|FG000|Overall Study|Withdrawal by Subject|5|||
144490475|NCT04770220|520993256|FG001|Overall Study|Withdrawal by Subject|11|||
144715629|NCT00410410|521813377|FG006|Open-Label Period (OL)|Death|0|||
144715630|NCT00410410|521813378|FG007|Open-Label Period (OL)|Death|0|||
144715631|NCT00410410|521813379|FG008|Open-Label Period (OL)|Death|1|||
144715632|NCT00410410|521813371|FG000|Open-Label Period (OL)|Adverse Event|0|||
144715633|NCT00410410|521813372|FG001|Open-Label Period (OL)|Adverse Event|0|||
144715634|NCT00410410|521813373|FG002|Open-Label Period (OL)|Adverse Event|0|||
144715635|NCT00410410|521813374|FG003|Open-Label Period (OL)|Adverse Event|0|||
144715636|NCT00410410|521813375|FG004|Open-Label Period (OL)|Adverse Event|0|||
144715637|NCT00410410|521813376|FG005|Open-Label Period (OL)|Adverse Event|0|||
144715638|NCT00410410|521813377|FG006|Open-Label Period (OL)|Adverse Event|0|||
144715639|NCT00410410|521813378|FG007|Open-Label Period (OL)|Adverse Event|0|||
144715640|NCT00410410|521813379|FG008|Open-Label Period (OL)|Adverse Event|10|||
144715641|NCT00410410|521813371|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
144715642|NCT00410410|521813372|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
144715643|NCT00410410|521813373|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
144715644|NCT00410410|521813374|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
144715645|NCT00410410|521813375|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
144715646|NCT00410410|521813376|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
144715647|NCT00410410|521813377|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
144715648|NCT00410410|521813378|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
144715649|NCT00410410|521813379|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
144715650|NCT00410410|521813371|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
144715651|NCT00410410|521813372|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
144715652|NCT00410410|521813373|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
144715653|NCT00410410|521813374|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
144715654|NCT00410410|521813375|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
144715655|NCT00410410|521813376|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
144715656|NCT00410410|521813377|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
144715657|NCT00410410|521813378|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
144715658|NCT00410410|521813379|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
144715659|NCT00410410|521813371|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715660|NCT00410410|521813372|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715661|NCT00410410|521813373|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715662|NCT00410410|521813374|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715663|NCT00410410|521813375|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715664|NCT00410410|521813376|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715665|NCT00410410|521813377|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715666|NCT00410410|521813378|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
144715667|NCT00410410|521813379|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
144715668|NCT00410410|521813371|FG000|Open-Label Period (OL)|Pregnancy|0|||
144715669|NCT00410410|521813372|FG001|Open-Label Period (OL)|Pregnancy|0|||
144715670|NCT00410410|521813373|FG002|Open-Label Period (OL)|Pregnancy|0|||
144715671|NCT00410410|521813374|FG003|Open-Label Period (OL)|Pregnancy|0|||
144715672|NCT00410410|521813375|FG004|Open-Label Period (OL)|Pregnancy|0|||
144715673|NCT00410410|521813376|FG005|Open-Label Period (OL)|Pregnancy|0|||
144715674|NCT00410410|521813377|FG006|Open-Label Period (OL)|Pregnancy|0|||
144715675|NCT00410410|521813378|FG007|Open-Label Period (OL)|Pregnancy|0|||
144715676|NCT00410410|521813379|FG008|Open-Label Period (OL)|Pregnancy|1|||
144715677|NCT00410410|521813371|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715678|NCT00410410|521813372|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715679|NCT00410410|521813373|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715680|NCT00410410|521813374|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715681|NCT00410410|521813375|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715682|NCT00410410|521813376|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715683|NCT00410410|521813377|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715684|NCT00410410|521813378|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
144715685|NCT00410410|521813379|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
144490476|NCT04770220|520993255|FG000|Overall Study|Lost to Follow-up|4|||
144490477|NCT04770220|520993256|FG001|Overall Study|Lost to Follow-up|3|||
144490478|NCT04770220|520993255|FG000|Overall Study|not otherwise specified|2|||
144490479|NCT04770220|520993256|FG001|Overall Study|not otherwise specified|3|||
144490480|NCT04770220|520993255|FG000|Overall Study|Physician Decision|1|||
144490481|NCT04770220|520993256|FG001|Overall Study|Physician Decision|3|||
144490482|NCT04955626|520993257|FG000|Blinded Period|Lost to Follow-up|28|||
144490483|NCT04955626|520993258|FG001|Blinded Period|Lost to Follow-up|28|||
144490484|NCT04955626|520993259|FG002|Blinded Period|Lost to Follow-up|7|||
144490485|NCT04955626|520993260|FG003|Blinded Period|Lost to Follow-up|14|||
144490486|NCT04955626|520993261|FG004|Blinded Period|Lost to Follow-up|3|||
144490487|NCT04955626|520993262|FG005|Blinded Period|Lost to Follow-up|2|||
144490488|NCT04955626|520993263|FG006|Blinded Period|Lost to Follow-up|6|||
144490489|NCT04955626|520993264|FG007|Blinded Period|Lost to Follow-up|4|||
144490490|NCT04955626|520993265|FG008|Blinded Period|Lost to Follow-up|5|||
144490491|NCT04955626|520993266|FG009|Blinded Period|Lost to Follow-up|8|||
144490492|NCT04955626|520993267|FG010|Blinded Period|Lost to Follow-up|10|||
144490493|NCT04955626|520993268|FG011|Blinded Period|Lost to Follow-up|32|||
144490494|NCT04955626|520993269|FG012|Blinded Period|Lost to Follow-up|0|||
144490495|NCT04955626|520993270|FG013|Blinded Period|Lost to Follow-up|0|||
144490496|NCT04955626|520993271|FG014|Blinded Period|Lost to Follow-up|0|||
144490497|NCT04955626|520993272|FG015|Blinded Period|Lost to Follow-up|12|||
144490498|NCT04955626|520993273|FG016|Blinded Period|Lost to Follow-up|2|||
144490499|NCT04955626|520993274|FG017|Blinded Period|Lost to Follow-up|5|||
144490500|NCT04955626|520993275|FG018|Blinded Period|Lost to Follow-up|0|||
144490501|NCT04955626|520993276|FG019|Blinded Period|Lost to Follow-up|0|||
144490502|NCT04955626|520993277|FG020|Blinded Period|Lost to Follow-up|0|||
144490503|NCT04955626|520993278|FG021|Blinded Period|Lost to Follow-up|0|||
144490504|NCT04955626|520993279|FG022|Blinded Period|Lost to Follow-up|0|||
144490505|NCT04955626|520993280|FG023|Blinded Period|Lost to Follow-up|0|||
144490506|NCT04955626|520993281|FG024|Blinded Period|Lost to Follow-up|3|||
144490507|NCT04955626|520993282|FG025|Blinded Period|Lost to Follow-up|1|||
144490508|NCT04955626|520993283|FG026|Blinded Period|Lost to Follow-up|2|||
144490509|NCT04955626|520993284|FG027|Blinded Period|Lost to Follow-up|2|||
144490510|NCT04955626|520993285|FG028|Blinded Period|Lost to Follow-up|2|||
144490511|NCT04955626|520993286|FG029|Blinded Period|Lost to Follow-up|0|||
144490512|NCT04955626|520993287|FG030|Blinded Period|Lost to Follow-up|0|||
144490513|NCT04955626|520993288|FG031|Blinded Period|Lost to Follow-up|0|||
144490514|NCT04955626|520993289|FG032|Blinded Period|Lost to Follow-up|0|||
144490515|NCT04955626|520993290|FG033|Blinded Period|Lost to Follow-up|0|||
144490516|NCT04955626|520993291|FG034|Blinded Period|Lost to Follow-up|0|||
144490517|NCT04955626|520993292|FG035|Blinded Period|Lost to Follow-up|0|||
144490518|NCT04955626|520993257|FG000|Blinded Period|Protocol Violation|5|||
144490519|NCT04955626|520993258|FG001|Blinded Period|Protocol Violation|14|||
144490520|NCT04955626|520993259|FG002|Blinded Period|Protocol Violation|0|||
144490521|NCT04955626|520993260|FG003|Blinded Period|Protocol Violation|1|||
144490522|NCT04955626|520993261|FG004|Blinded Period|Protocol Violation|2|||
144490523|NCT04955626|520993262|FG005|Blinded Period|Protocol Violation|2|||
144490524|NCT04955626|520993263|FG006|Blinded Period|Protocol Violation|0|||
144490525|NCT04955626|520993264|FG007|Blinded Period|Protocol Violation|0|||
144490526|NCT04955626|520993265|FG008|Blinded Period|Protocol Violation|0|||
144490527|NCT04955626|520993266|FG009|Blinded Period|Protocol Violation|4|||
144490528|NCT04955626|520993267|FG010|Blinded Period|Protocol Violation|6|||
144490529|NCT04955626|520993268|FG011|Blinded Period|Protocol Violation|1|||
144490530|NCT04955626|520993269|FG012|Blinded Period|Protocol Violation|0|||
144490531|NCT04955626|520993270|FG013|Blinded Period|Protocol Violation|0|||
144490532|NCT04955626|520993271|FG014|Blinded Period|Protocol Violation|2|||
144490533|NCT04955626|520993272|FG015|Blinded Period|Protocol Violation|6|||
144490534|NCT04955626|520993273|FG016|Blinded Period|Protocol Violation|4|||
144490535|NCT04955626|520993274|FG017|Blinded Period|Protocol Violation|6|||
144490536|NCT04955626|520993275|FG018|Blinded Period|Protocol Violation|0|||
144490537|NCT04955626|520993276|FG019|Blinded Period|Protocol Violation|1|||
144490538|NCT04955626|520993277|FG020|Blinded Period|Protocol Violation|0|||
144490539|NCT04955626|520993278|FG021|Blinded Period|Protocol Violation|1|||
144490540|NCT04955626|520993279|FG022|Blinded Period|Protocol Violation|0|||
144490541|NCT04955626|520993280|FG023|Blinded Period|Protocol Violation|0|||
144490542|NCT04955626|520993281|FG024|Blinded Period|Protocol Violation|4|||
144490543|NCT04955626|520993282|FG025|Blinded Period|Protocol Violation|6|||
144490544|NCT04955626|520993283|FG026|Blinded Period|Protocol Violation|5|||
144490545|NCT04955626|520993284|FG027|Blinded Period|Protocol Violation|3|||
144490546|NCT04955626|520993285|FG028|Blinded Period|Protocol Violation|4|||
144490547|NCT04955626|520993286|FG029|Blinded Period|Protocol Violation|3|||
144490548|NCT04955626|520993287|FG030|Blinded Period|Protocol Violation|0|||
144490549|NCT04955626|520993288|FG031|Blinded Period|Protocol Violation|0|||
144490550|NCT04955626|520993289|FG032|Blinded Period|Protocol Violation|0|||
144369893|NCT01532986|520562746|FG001|Overall Study|Death|9|||
144369894|NCT01532986|520562745|FG000|Overall Study|Withdrawal by Subject|7|||
144490551|NCT04955626|520993290|FG033|Blinded Period|Protocol Violation|0|||
144490552|NCT04955626|520993291|FG034|Blinded Period|Protocol Violation|0|||
144490553|NCT04955626|520993292|FG035|Blinded Period|Protocol Violation|0|||
144490554|NCT04955626|520993257|FG000|Blinded Period|Death|0|||
144490555|NCT04955626|520993258|FG001|Blinded Period|Death|2|||
144490556|NCT04955626|520993259|FG002|Blinded Period|Death|0|||
144490557|NCT04955626|520993260|FG003|Blinded Period|Death|0|||
144490558|NCT04955626|520993261|FG004|Blinded Period|Death|0|||
144490559|NCT04955626|520993262|FG005|Blinded Period|Death|0|||
144490560|NCT04955626|520993263|FG006|Blinded Period|Death|0|||
144490561|NCT04955626|520993264|FG007|Blinded Period|Death|2|||
144490562|NCT04955626|520993265|FG008|Blinded Period|Death|1|||
144490563|NCT04955626|520993266|FG009|Blinded Period|Death|1|||
144490564|NCT04955626|520993267|FG010|Blinded Period|Death|0|||
144490565|NCT04955626|520993268|FG011|Blinded Period|Death|2|||
144490566|NCT04955626|520993269|FG012|Blinded Period|Death|0|||
144490567|NCT04955626|520993270|FG013|Blinded Period|Death|0|||
144490568|NCT04955626|520993271|FG014|Blinded Period|Death|0|||
144490569|NCT04955626|520993272|FG015|Blinded Period|Death|0|||
144490570|NCT04955626|520993273|FG016|Blinded Period|Death|0|||
144490571|NCT04955626|520993274|FG017|Blinded Period|Death|0|||
144490572|NCT04955626|520993275|FG018|Blinded Period|Death|0|||
144490573|NCT04955626|520993276|FG019|Blinded Period|Death|0|||
144490574|NCT04955626|520993277|FG020|Blinded Period|Death|0|||
144490575|NCT04955626|520993278|FG021|Blinded Period|Death|0|||
144490576|NCT04955626|520993279|FG022|Blinded Period|Death|0|||
144490577|NCT04955626|520993280|FG023|Blinded Period|Death|1|||
144490578|NCT04955626|520993281|FG024|Blinded Period|Death|0|||
144490579|NCT04955626|520993282|FG025|Blinded Period|Death|0|||
144490580|NCT04955626|520993283|FG026|Blinded Period|Death|1|||
144490581|NCT04955626|520993284|FG027|Blinded Period|Death|1|||
144490582|NCT04955626|520993285|FG028|Blinded Period|Death|0|||
144490583|NCT04955626|520993286|FG029|Blinded Period|Death|1|||
144490584|NCT04955626|520993287|FG030|Blinded Period|Death|0|||
144490585|NCT04955626|520993288|FG031|Blinded Period|Death|0|||
144490586|NCT04955626|520993289|FG032|Blinded Period|Death|0|||
144490587|NCT04955626|520993290|FG033|Blinded Period|Death|0|||
144490588|NCT04955626|520993291|FG034|Blinded Period|Death|0|||
144490589|NCT04955626|520993292|FG035|Blinded Period|Death|0|||
144490590|NCT04955626|520993257|FG000|Blinded Period|Adverse Event|0|||
144490591|NCT04955626|520993258|FG001|Blinded Period|Adverse Event|1|||
144490592|NCT04955626|520993259|FG002|Blinded Period|Adverse Event|1|||
144490593|NCT04955626|520993260|FG003|Blinded Period|Adverse Event|1|||
144490594|NCT04955626|520993261|FG004|Blinded Period|Adverse Event|0|||
144490595|NCT04955626|520993262|FG005|Blinded Period|Adverse Event|0|||
144490596|NCT04955626|520993263|FG006|Blinded Period|Adverse Event|0|||
144490597|NCT04955626|520993264|FG007|Blinded Period|Adverse Event|0|||
144490598|NCT04955626|520993265|FG008|Blinded Period|Adverse Event|0|||
144490599|NCT04955626|520993266|FG009|Blinded Period|Adverse Event|1|||
144490600|NCT04955626|520993267|FG010|Blinded Period|Adverse Event|1|||
144490601|NCT04955626|520993268|FG011|Blinded Period|Adverse Event|0|||
144490602|NCT04955626|520993269|FG012|Blinded Period|Adverse Event|0|||
144490603|NCT04955626|520993270|FG013|Blinded Period|Adverse Event|0|||
144490604|NCT04955626|520993271|FG014|Blinded Period|Adverse Event|0|||
144490605|NCT04955626|520993272|FG015|Blinded Period|Adverse Event|0|||
144490606|NCT04955626|520993273|FG016|Blinded Period|Adverse Event|0|||
144490607|NCT04955626|520993274|FG017|Blinded Period|Adverse Event|0|||
144490608|NCT04955626|520993275|FG018|Blinded Period|Adverse Event|1|||
144490609|NCT04955626|520993276|FG019|Blinded Period|Adverse Event|0|||
144490610|NCT04955626|520993277|FG020|Blinded Period|Adverse Event|0|||
144490611|NCT04955626|520993278|FG021|Blinded Period|Adverse Event|0|||
144490612|NCT04955626|520993279|FG022|Blinded Period|Adverse Event|0|||
144490613|NCT04955626|520993280|FG023|Blinded Period|Adverse Event|0|||
144490614|NCT04955626|520993281|FG024|Blinded Period|Adverse Event|0|||
144490615|NCT04955626|520993282|FG025|Blinded Period|Adverse Event|0|||
144490616|NCT04955626|520993283|FG026|Blinded Period|Adverse Event|1|||
144490617|NCT04955626|520993284|FG027|Blinded Period|Adverse Event|0|||
144490618|NCT04955626|520993285|FG028|Blinded Period|Adverse Event|0|||
144490619|NCT04955626|520993286|FG029|Blinded Period|Adverse Event|0|||
144490620|NCT04955626|520993287|FG030|Blinded Period|Adverse Event|0|||
144490621|NCT04955626|520993288|FG031|Blinded Period|Adverse Event|0|||
144490622|NCT04955626|520993289|FG032|Blinded Period|Adverse Event|0|||
144490623|NCT04955626|520993290|FG033|Blinded Period|Adverse Event|0|||
144490624|NCT04955626|520993291|FG034|Blinded Period|Adverse Event|0|||
144490625|NCT04955626|520993292|FG035|Blinded Period|Adverse Event|0|||
144490626|NCT04955626|520993257|FG000|Blinded Period|No longer meets eligibility criteria|1|||
144490627|NCT04955626|520993258|FG001|Blinded Period|No longer meets eligibility criteria|2|||
144490628|NCT04955626|520993259|FG002|Blinded Period|No longer meets eligibility criteria|0|||
144490629|NCT04955626|520993260|FG003|Blinded Period|No longer meets eligibility criteria|1|||
144490630|NCT04955626|520993261|FG004|Blinded Period|No longer meets eligibility criteria|0|||
144490631|NCT04955626|520993262|FG005|Blinded Period|No longer meets eligibility criteria|0|||
144490632|NCT04955626|520993263|FG006|Blinded Period|No longer meets eligibility criteria|0|||
144490633|NCT04955626|520993264|FG007|Blinded Period|No longer meets eligibility criteria|0|||
144490634|NCT04955626|520993265|FG008|Blinded Period|No longer meets eligibility criteria|1|||
144490635|NCT04955626|520993266|FG009|Blinded Period|No longer meets eligibility criteria|0|||
144490636|NCT04955626|520993267|FG010|Blinded Period|No longer meets eligibility criteria|1|||
144490637|NCT04955626|520993268|FG011|Blinded Period|No longer meets eligibility criteria|1|||
144490638|NCT04955626|520993269|FG012|Blinded Period|No longer meets eligibility criteria|0|||
144490639|NCT04955626|520993270|FG013|Blinded Period|No longer meets eligibility criteria|0|||
144490640|NCT04955626|520993271|FG014|Blinded Period|No longer meets eligibility criteria|0|||
144490641|NCT04955626|520993272|FG015|Blinded Period|No longer meets eligibility criteria|3|||
144490642|NCT04955626|520993273|FG016|Blinded Period|No longer meets eligibility criteria|0|||
144490643|NCT04955626|520993274|FG017|Blinded Period|No longer meets eligibility criteria|2|||
144490644|NCT04955626|520993275|FG018|Blinded Period|No longer meets eligibility criteria|0|||
144490645|NCT04955626|520993276|FG019|Blinded Period|No longer meets eligibility criteria|0|||
144490646|NCT04955626|520993277|FG020|Blinded Period|No longer meets eligibility criteria|0|||
144490647|NCT04955626|520993278|FG021|Blinded Period|No longer meets eligibility criteria|0|||
144490648|NCT04955626|520993279|FG022|Blinded Period|No longer meets eligibility criteria|0|||
144490649|NCT04955626|520993280|FG023|Blinded Period|No longer meets eligibility criteria|0|||
144490650|NCT04955626|520993281|FG024|Blinded Period|No longer meets eligibility criteria|1|||
144490651|NCT04955626|520993282|FG025|Blinded Period|No longer meets eligibility criteria|0|||
144490652|NCT04955626|520993283|FG026|Blinded Period|No longer meets eligibility criteria|0|||
144490653|NCT04955626|520993284|FG027|Blinded Period|No longer meets eligibility criteria|1|||
144490654|NCT04955626|520993285|FG028|Blinded Period|No longer meets eligibility criteria|0|||
144490655|NCT04955626|520993286|FG029|Blinded Period|No longer meets eligibility criteria|0|||
144490656|NCT04955626|520993287|FG030|Blinded Period|No longer meets eligibility criteria|0|||
144490657|NCT04955626|520993288|FG031|Blinded Period|No longer meets eligibility criteria|0|||
144490658|NCT04955626|520993289|FG032|Blinded Period|No longer meets eligibility criteria|0|||
144490659|NCT04955626|520993290|FG033|Blinded Period|No longer meets eligibility criteria|0|||
144490660|NCT04955626|520993291|FG034|Blinded Period|No longer meets eligibility criteria|0|||
144490661|NCT04955626|520993292|FG035|Blinded Period|No longer meets eligibility criteria|0|||
144490662|NCT04955626|520993257|FG000|Blinded Period|Other|54|||
144490663|NCT04955626|520993258|FG001|Blinded Period|Other|3|||
144490664|NCT04955626|520993259|FG002|Blinded Period|Other|4|||
144490665|NCT04955626|520993260|FG003|Blinded Period|Other|2|||
144490666|NCT04955626|520993261|FG004|Blinded Period|Other|0|||
144490667|NCT04955626|520993262|FG005|Blinded Period|Other|0|||
144490668|NCT04955626|520993263|FG006|Blinded Period|Other|2|||
144490669|NCT04955626|520993264|FG007|Blinded Period|Other|2|||
144490670|NCT04955626|520993265|FG008|Blinded Period|Other|1|||
144490671|NCT04955626|520993266|FG009|Blinded Period|Other|0|||
144490672|NCT04955626|520993267|FG010|Blinded Period|Other|1|||
144490673|NCT04955626|520993268|FG011|Blinded Period|Other|1|||
144490674|NCT04955626|520993269|FG012|Blinded Period|Other|0|||
144490675|NCT04955626|520993270|FG013|Blinded Period|Other|0|||
144490676|NCT04955626|520993271|FG014|Blinded Period|Other|0|||
144490677|NCT04955626|520993272|FG015|Blinded Period|Other|0|||
144490678|NCT04955626|520993273|FG016|Blinded Period|Other|0|||
144490679|NCT04955626|520993274|FG017|Blinded Period|Other|1|||
144490680|NCT04955626|520993275|FG018|Blinded Period|Other|0|||
144490681|NCT04955626|520993276|FG019|Blinded Period|Other|0|||
144490682|NCT04955626|520993277|FG020|Blinded Period|Other|0|||
144490683|NCT04955626|520993278|FG021|Blinded Period|Other|0|||
144490684|NCT04955626|520993279|FG022|Blinded Period|Other|0|||
144490685|NCT04955626|520993280|FG023|Blinded Period|Other|0|||
144490686|NCT04955626|520993281|FG024|Blinded Period|Other|0|||
144490687|NCT04955626|520993282|FG025|Blinded Period|Other|0|||
144490688|NCT04955626|520993283|FG026|Blinded Period|Other|2|||
144490689|NCT04955626|520993284|FG027|Blinded Period|Other|0|||
144490690|NCT04955626|520993285|FG028|Blinded Period|Other|0|||
144490691|NCT04955626|520993286|FG029|Blinded Period|Other|0|||
144490692|NCT04955626|520993287|FG030|Blinded Period|Other|0|||
144490693|NCT04955626|520993288|FG031|Blinded Period|Other|0|||
144490694|NCT04955626|520993289|FG032|Blinded Period|Other|0|||
144490695|NCT04955626|520993290|FG033|Blinded Period|Other|0|||
144490696|NCT04955626|520993291|FG034|Blinded Period|Other|0|||
144490697|NCT04955626|520993292|FG035|Blinded Period|Other|0|||
144490698|NCT04955626|520993257|FG000|Blinded Period|Physician Decision|1|||
144490699|NCT04955626|520993258|FG001|Blinded Period|Physician Decision|1|||
144490700|NCT04955626|520993259|FG002|Blinded Period|Physician Decision|0|||
144490701|NCT04955626|520993260|FG003|Blinded Period|Physician Decision|3|||
144490702|NCT04955626|520993261|FG004|Blinded Period|Physician Decision|0|||
144490703|NCT04955626|520993262|FG005|Blinded Period|Physician Decision|0|||
144490704|NCT04955626|520993263|FG006|Blinded Period|Physician Decision|1|||
144490705|NCT04955626|520993264|FG007|Blinded Period|Physician Decision|1|||
144490706|NCT04955626|520993265|FG008|Blinded Period|Physician Decision|0|||
144490707|NCT04955626|520993266|FG009|Blinded Period|Physician Decision|0|||
144490708|NCT04955626|520993267|FG010|Blinded Period|Physician Decision|0|||
144490709|NCT04955626|520993268|FG011|Blinded Period|Physician Decision|5|||
144490710|NCT04955626|520993269|FG012|Blinded Period|Physician Decision|0|||
144490711|NCT04955626|520993270|FG013|Blinded Period|Physician Decision|0|||
144490712|NCT04955626|520993271|FG014|Blinded Period|Physician Decision|0|||
144490713|NCT04955626|520993272|FG015|Blinded Period|Physician Decision|0|||
144490714|NCT04955626|520993273|FG016|Blinded Period|Physician Decision|0|||
144490715|NCT04955626|520993274|FG017|Blinded Period|Physician Decision|0|||
144490716|NCT04955626|520993275|FG018|Blinded Period|Physician Decision|0|||
144490717|NCT04955626|520993276|FG019|Blinded Period|Physician Decision|0|||
144490718|NCT04955626|520993277|FG020|Blinded Period|Physician Decision|0|||
144490719|NCT04955626|520993278|FG021|Blinded Period|Physician Decision|0|||
144490720|NCT04955626|520993279|FG022|Blinded Period|Physician Decision|0|||
144490721|NCT04955626|520993280|FG023|Blinded Period|Physician Decision|0|||
144490722|NCT04955626|520993281|FG024|Blinded Period|Physician Decision|0|||
144490723|NCT04955626|520993282|FG025|Blinded Period|Physician Decision|0|||
144490724|NCT04955626|520993283|FG026|Blinded Period|Physician Decision|0|||
144490725|NCT04955626|520993284|FG027|Blinded Period|Physician Decision|0|||
144490726|NCT04955626|520993285|FG028|Blinded Period|Physician Decision|0|||
144490727|NCT04955626|520993286|FG029|Blinded Period|Physician Decision|0|||
144490728|NCT04955626|520993287|FG030|Blinded Period|Physician Decision|0|||
144490729|NCT04955626|520993288|FG031|Blinded Period|Physician Decision|0|||
144490730|NCT04955626|520993289|FG032|Blinded Period|Physician Decision|0|||
144490731|NCT04955626|520993290|FG033|Blinded Period|Physician Decision|0|||
144490732|NCT04955626|520993291|FG034|Blinded Period|Physician Decision|0|||
144490733|NCT04955626|520993292|FG035|Blinded Period|Physician Decision|0|||
144490734|NCT04955626|520993257|FG000|Blinded Period|Withdrawal by Subject|26|||
144490735|NCT04955626|520993258|FG001|Blinded Period|Withdrawal by Subject|62|||
144490736|NCT04955626|520993259|FG002|Blinded Period|Withdrawal by Subject|14|||
144490737|NCT04955626|520993260|FG003|Blinded Period|Withdrawal by Subject|16|||
144490738|NCT04955626|520993261|FG004|Blinded Period|Withdrawal by Subject|1|||
144490739|NCT04955626|520993262|FG005|Blinded Period|Withdrawal by Subject|2|||
144490740|NCT04955626|520993263|FG006|Blinded Period|Withdrawal by Subject|9|||
144490741|NCT04955626|520993264|FG007|Blinded Period|Withdrawal by Subject|5|||
144490742|NCT04955626|520993265|FG008|Blinded Period|Withdrawal by Subject|3|||
144490743|NCT04955626|520993266|FG009|Blinded Period|Withdrawal by Subject|15|||
144490744|NCT04955626|520993267|FG010|Blinded Period|Withdrawal by Subject|11|||
144490745|NCT04955626|520993268|FG011|Blinded Period|Withdrawal by Subject|7|||
144490746|NCT04955626|520993269|FG012|Blinded Period|Withdrawal by Subject|2|||
144490747|NCT04955626|520993270|FG013|Blinded Period|Withdrawal by Subject|0|||
144490748|NCT04955626|520993271|FG014|Blinded Period|Withdrawal by Subject|1|||
144490749|NCT04955626|520993272|FG015|Blinded Period|Withdrawal by Subject|11|||
144490750|NCT04955626|520993273|FG016|Blinded Period|Withdrawal by Subject|2|||
144490751|NCT04955626|520993274|FG017|Blinded Period|Withdrawal by Subject|5|||
144490752|NCT04955626|520993275|FG018|Blinded Period|Withdrawal by Subject|0|||
144490753|NCT04955626|520993276|FG019|Blinded Period|Withdrawal by Subject|0|||
144490754|NCT04955626|520993277|FG020|Blinded Period|Withdrawal by Subject|1|||
144490755|NCT04955626|520993278|FG021|Blinded Period|Withdrawal by Subject|0|||
144490756|NCT04955626|520993279|FG022|Blinded Period|Withdrawal by Subject|0|||
144490757|NCT04955626|520993280|FG023|Blinded Period|Withdrawal by Subject|0|||
144490758|NCT04955626|520993281|FG024|Blinded Period|Withdrawal by Subject|5|||
144490759|NCT04955626|520993282|FG025|Blinded Period|Withdrawal by Subject|1|||
144490760|NCT04955626|520993283|FG026|Blinded Period|Withdrawal by Subject|5|||
144490761|NCT04955626|520993284|FG027|Blinded Period|Withdrawal by Subject|1|||
144490762|NCT04955626|520993285|FG028|Blinded Period|Withdrawal by Subject|4|||
144490763|NCT04955626|520993286|FG029|Blinded Period|Withdrawal by Subject|2|||
144490764|NCT04955626|520993287|FG030|Blinded Period|Withdrawal by Subject|0|||
144490765|NCT04955626|520993288|FG031|Blinded Period|Withdrawal by Subject|0|||
144490766|NCT04955626|520993289|FG032|Blinded Period|Withdrawal by Subject|0|||
144490767|NCT04955626|520993290|FG033|Blinded Period|Withdrawal by Subject|0|||
144490768|NCT04955626|520993291|FG034|Blinded Period|Withdrawal by Subject|0|||
144490769|NCT04955626|520993292|FG035|Blinded Period|Withdrawal by Subject|0|||
144490770|NCT04955626|520993257|FG000|Blinded Period|Refused further study procedures|0|||
144490771|NCT04955626|520993258|FG001|Blinded Period|Refused further study procedures|0|||
144490772|NCT04955626|520993259|FG002|Blinded Period|Refused further study procedures|0|||
144490773|NCT04955626|520993260|FG003|Blinded Period|Refused further study procedures|0|||
144490774|NCT04955626|520993261|FG004|Blinded Period|Refused further study procedures|0|||
144490775|NCT04955626|520993262|FG005|Blinded Period|Refused further study procedures|0|||
144490776|NCT04955626|520993263|FG006|Blinded Period|Refused further study procedures|1|||
144490777|NCT04955626|520993264|FG007|Blinded Period|Refused further study procedures|0|||
144490778|NCT04955626|520993265|FG008|Blinded Period|Refused further study procedures|0|||
144490779|NCT04955626|520993266|FG009|Blinded Period|Refused further study procedures|0|||
144490780|NCT04955626|520993267|FG010|Blinded Period|Refused further study procedures|0|||
144490781|NCT04955626|520993268|FG011|Blinded Period|Refused further study procedures|2|||
144490782|NCT04955626|520993269|FG012|Blinded Period|Refused further study procedures|0|||
144490783|NCT04955626|520993270|FG013|Blinded Period|Refused further study procedures|0|||
144490784|NCT04955626|520993271|FG014|Blinded Period|Refused further study procedures|0|||
144490785|NCT04955626|520993272|FG015|Blinded Period|Refused further study procedures|0|||
144490786|NCT04955626|520993273|FG016|Blinded Period|Refused further study procedures|0|||
144490787|NCT04955626|520993274|FG017|Blinded Period|Refused further study procedures|0|||
144490788|NCT04955626|520993275|FG018|Blinded Period|Refused further study procedures|0|||
144490789|NCT04955626|520993276|FG019|Blinded Period|Refused further study procedures|0|||
144490790|NCT04955626|520993277|FG020|Blinded Period|Refused further study procedures|0|||
144490791|NCT04955626|520993278|FG021|Blinded Period|Refused further study procedures|0|||
144490792|NCT04955626|520993279|FG022|Blinded Period|Refused further study procedures|0|||
144490793|NCT04955626|520993280|FG023|Blinded Period|Refused further study procedures|0|||
144490794|NCT04955626|520993281|FG024|Blinded Period|Refused further study procedures|0|||
144490795|NCT04955626|520993282|FG025|Blinded Period|Refused further study procedures|0|||
144490796|NCT04955626|520993283|FG026|Blinded Period|Refused further study procedures|0|||
144490797|NCT04955626|520993284|FG027|Blinded Period|Refused further study procedures|0|||
144490798|NCT04955626|520993285|FG028|Blinded Period|Refused further study procedures|0|||
144490799|NCT04955626|520993286|FG029|Blinded Period|Refused further study procedures|0|||
144490800|NCT04955626|520993287|FG030|Blinded Period|Refused further study procedures|0|||
144490801|NCT04955626|520993288|FG031|Blinded Period|Refused further study procedures|0|||
144490802|NCT04955626|520993289|FG032|Blinded Period|Refused further study procedures|0|||
144490803|NCT04955626|520993290|FG033|Blinded Period|Refused further study procedures|0|||
144490804|NCT04955626|520993291|FG034|Blinded Period|Refused further study procedures|0|||
144490805|NCT04955626|520993292|FG035|Blinded Period|Refused further study procedures|0|||
144490806|NCT04955626|520993257|FG000|Blinded Period|Participants entered open label period|4544|||
144490807|NCT04955626|520993258|FG001|Blinded Period|Participants entered open label period|4906|||
144490808|NCT04955626|520993259|FG002|Blinded Period|Participants entered open label period|0|||
144490809|NCT04955626|520993260|FG003|Blinded Period|Participants entered open label period|0|||
144490810|NCT04955626|520993261|FG004|Blinded Period|Participants entered open label period|0|||
144490811|NCT04955626|520993262|FG005|Blinded Period|Participants entered open label period|0|||
144490812|NCT04955626|520993263|FG006|Blinded Period|Participants entered open label period|0|||
144490813|NCT04955626|520993264|FG007|Blinded Period|Participants entered open label period|0|||
144490814|NCT04955626|520993265|FG008|Blinded Period|Participants entered open label period|0|||
144490815|NCT04955626|520993266|FG009|Blinded Period|Participants entered open label period|0|||
144490816|NCT04955626|520993267|FG010|Blinded Period|Participants entered open label period|0|||
144490817|NCT04955626|520993268|FG011|Blinded Period|Participants entered open label period|0|||
144490818|NCT04955626|520993269|FG012|Blinded Period|Participants entered open label period|0|||
144490819|NCT04955626|520993270|FG013|Blinded Period|Participants entered open label period|0|||
144715686|NCT00410410|521813371|FG000|Open-Label Period (OL)|Other|0|||
144715687|NCT00410410|521813372|FG001|Open-Label Period (OL)|Other|0|||
144715688|NCT00410410|521813373|FG002|Open-Label Period (OL)|Other|0|||
144715689|NCT00410410|521813374|FG003|Open-Label Period (OL)|Other|0|||
144715690|NCT00410410|521813375|FG004|Open-Label Period (OL)|Other|0|||
144715691|NCT00410410|521813376|FG005|Open-Label Period (OL)|Other|0|||
144715692|NCT00410410|521813377|FG006|Open-Label Period (OL)|Other|0|||
144715693|NCT00410410|521813378|FG007|Open-Label Period (OL)|Other|0|||
144715694|NCT00410410|521813379|FG008|Open-Label Period (OL)|Other|7|||
144715695|NCT01783496|521813380|FG000|Overall Study|Lost to Follow-up|0|||
144715696|NCT01783496|521813381|FG001|Overall Study|Lost to Follow-up|0|||
144715697|NCT01783496|521813382|FG002|Overall Study|Lost to Follow-up|0|||
144715698|NCT01783496|521813383|FG003|Overall Study|Lost to Follow-up|2|||
144715699|NCT01783496|521813384|FG004|Overall Study|Lost to Follow-up|0|||
144715700|NCT01783496|521813385|FG005|Overall Study|Lost to Follow-up|1|||
144715701|NCT01783496|521813380|FG000|Overall Study|Withdrawal by Subject|1|||
144715702|NCT01783496|521813381|FG001|Overall Study|Withdrawal by Subject|0|||
144715703|NCT01783496|521813382|FG002|Overall Study|Withdrawal by Subject|0|||
144715704|NCT01783496|521813383|FG003|Overall Study|Withdrawal by Subject|0|||
144715705|NCT01783496|521813384|FG004|Overall Study|Withdrawal by Subject|0|||
144715706|NCT01783496|521813385|FG005|Overall Study|Withdrawal by Subject|0|||
144715707|NCT01789281|521813386|FG000|Overall Study|Disease progression|15|||
144715708|NCT01789281|521813387|FG001|Overall Study|Disease progression|4|||
144715709|NCT01789281|521813386|FG000|Overall Study|Adverse Event|5|||
144715710|NCT01789281|521813387|FG001|Overall Study|Adverse Event|5|||
144715711|NCT01789281|521813386|FG000|Overall Study|Withdrawal by Subject|1|||
144715712|NCT01789281|521813387|FG001|Overall Study|Withdrawal by Subject|0|||
144715713|NCT01789281|521813386|FG000|Overall Study|Lost to Follow-up|1|||
144490820|NCT04955626|520993271|FG014|Blinded Period|Participants entered open label period|0|||
144490821|NCT04955626|520993272|FG015|Blinded Period|Participants entered open label period|0|||
144490822|NCT04955626|520993273|FG016|Blinded Period|Participants entered open label period|0|||
144490823|NCT04955626|520993274|FG017|Blinded Period|Participants entered open label period|0|||
144490824|NCT04955626|520993275|FG018|Blinded Period|Participants entered open label period|0|||
144490825|NCT04955626|520993276|FG019|Blinded Period|Participants entered open label period|0|||
144490826|NCT04955626|520993277|FG020|Blinded Period|Participants entered open label period|0|||
144490827|NCT04955626|520993278|FG021|Blinded Period|Participants entered open label period|0|||
144490828|NCT04955626|520993279|FG022|Blinded Period|Participants entered open label period|0|||
144490829|NCT04955626|520993280|FG023|Blinded Period|Participants entered open label period|0|||
144490830|NCT04955626|520993281|FG024|Blinded Period|Participants entered open label period|0|||
144490831|NCT04955626|520993282|FG025|Blinded Period|Participants entered open label period|0|||
144490832|NCT04955626|520993283|FG026|Blinded Period|Participants entered open label period|0|||
144490833|NCT04955626|520993284|FG027|Blinded Period|Participants entered open label period|0|||
144490834|NCT04955626|520993285|FG028|Blinded Period|Participants entered open label period|0|||
144490835|NCT04955626|520993286|FG029|Blinded Period|Participants entered open label period|0|||
144490836|NCT04955626|520993287|FG030|Blinded Period|Participants entered open label period|0|||
144490837|NCT04955626|520993288|FG031|Blinded Period|Participants entered open label period|0|||
144490838|NCT04955626|520993289|FG032|Blinded Period|Participants entered open label period|0|||
144490839|NCT04955626|520993290|FG033|Blinded Period|Participants entered open label period|0|||
144490840|NCT04955626|520993291|FG034|Blinded Period|Participants entered open label period|0|||
144490841|NCT04955626|520993292|FG035|Blinded Period|Participants entered open label period|0|||
144490842|NCT04955626|520993257|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
144490843|NCT04955626|520993258|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
144490844|NCT04955626|520993259|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
144490845|NCT04955626|520993260|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
144490846|NCT04955626|520993261|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
144490847|NCT04955626|520993262|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
144490848|NCT04955626|520993263|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
144490849|NCT04955626|520993264|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
144490850|NCT04955626|520993265|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
144490851|NCT04955626|520993266|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
144490852|NCT04955626|520993267|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
144490853|NCT04955626|520993268|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
144490854|NCT04955626|520993269|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
144490855|NCT04955626|520993270|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
144490856|NCT04955626|520993271|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
144490857|NCT04955626|520993272|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
144490858|NCT04955626|520993273|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
144490859|NCT04955626|520993274|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
144490860|NCT04955626|520993275|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
144490861|NCT04955626|520993276|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
144490862|NCT04955626|520993277|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
144490863|NCT04955626|520993278|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
144369895|NCT01532986|520562746|FG001|Overall Study|Withdrawal by Subject|10|||
144369896|NCT01532986|520562745|FG000|Overall Study|Physician Decision|7|||
144490864|NCT04955626|520993279|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
144490865|NCT04955626|520993280|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
144490866|NCT04955626|520993281|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
144490867|NCT04955626|520993282|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
144490868|NCT04955626|520993283|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
144490869|NCT04955626|520993284|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
144490870|NCT04955626|520993285|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
144490871|NCT04955626|520993286|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
144490872|NCT04955626|520993287|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
144490873|NCT04955626|520993288|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
144490874|NCT04955626|520993289|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
144490875|NCT04955626|520993290|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
144490876|NCT04955626|520993291|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
144490877|NCT04955626|520993292|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
144490878|NCT04955626|520993257|FG000|Blinded Period|Medication error|0|||
144369897|NCT01532986|520562746|FG001|Overall Study|Physician Decision|5|||
144490879|NCT04955626|520993258|FG001|Blinded Period|Medication error|0|||
144490880|NCT04955626|520993259|FG002|Blinded Period|Medication error|0|||
144490881|NCT04955626|520993260|FG003|Blinded Period|Medication error|0|||
144490882|NCT04955626|520993261|FG004|Blinded Period|Medication error|0|||
144490883|NCT04955626|520993262|FG005|Blinded Period|Medication error|0|||
144490884|NCT04955626|520993263|FG006|Blinded Period|Medication error|0|||
144490885|NCT04955626|520993264|FG007|Blinded Period|Medication error|0|||
144490886|NCT04955626|520993265|FG008|Blinded Period|Medication error|0|||
144490887|NCT04955626|520993266|FG009|Blinded Period|Medication error|0|||
144490888|NCT04955626|520993267|FG010|Blinded Period|Medication error|2|||
144490889|NCT04955626|520993268|FG011|Blinded Period|Medication error|0|||
144490890|NCT04955626|520993269|FG012|Blinded Period|Medication error|0|||
144490891|NCT04955626|520993270|FG013|Blinded Period|Medication error|0|||
144490892|NCT04955626|520993271|FG014|Blinded Period|Medication error|0|||
144490893|NCT04955626|520993272|FG015|Blinded Period|Medication error|0|||
144490894|NCT04955626|520993273|FG016|Blinded Period|Medication error|0|||
144490895|NCT04955626|520993274|FG017|Blinded Period|Medication error|0|||
144490896|NCT04955626|520993275|FG018|Blinded Period|Medication error|0|||
144490897|NCT04955626|520993276|FG019|Blinded Period|Medication error|0|||
144490898|NCT04955626|520993277|FG020|Blinded Period|Medication error|0|||
144490899|NCT04955626|520993278|FG021|Blinded Period|Medication error|0|||
144490900|NCT04955626|520993279|FG022|Blinded Period|Medication error|0|||
144490901|NCT04955626|520993280|FG023|Blinded Period|Medication error|0|||
144490902|NCT04955626|520993281|FG024|Blinded Period|Medication error|0|||
144490903|NCT04955626|520993282|FG025|Blinded Period|Medication error|0|||
144490904|NCT04955626|520993283|FG026|Blinded Period|Medication error|0|||
144490905|NCT04955626|520993284|FG027|Blinded Period|Medication error|0|||
144490906|NCT04955626|520993285|FG028|Blinded Period|Medication error|4|||
144490907|NCT04955626|520993286|FG029|Blinded Period|Medication error|0|||
144490908|NCT04955626|520993287|FG030|Blinded Period|Medication error|0|||
144490909|NCT04955626|520993288|FG031|Blinded Period|Medication error|0|||
144490910|NCT04955626|520993289|FG032|Blinded Period|Medication error|0|||
144490911|NCT04955626|520993290|FG033|Blinded Period|Medication error|0|||
144490912|NCT04955626|520993291|FG034|Blinded Period|Medication error|0|||
144490913|NCT04955626|520993292|FG035|Blinded Period|Medication error|0|||
144490914|NCT04955626|520993257|FG000|Open-Label Period|Lost to Follow-up|109|||
144490915|NCT04955626|520993258|FG001|Open-Label Period|Lost to Follow-up|41|||
144369898|NCT02120898|520562747|FG000|Overall Study|Withdrawal by Subject|4|||
144369899|NCT02120898|520562748|FG001|Overall Study|Withdrawal by Subject|2|||
144490916|NCT04955626|520993259|FG002|Open-Label Period|Lost to Follow-up|0|||
144490917|NCT04955626|520993260|FG003|Open-Label Period|Lost to Follow-up|0|||
144490918|NCT04955626|520993261|FG004|Open-Label Period|Lost to Follow-up|0|||
144490919|NCT04955626|520993262|FG005|Open-Label Period|Lost to Follow-up|0|||
144490920|NCT04955626|520993263|FG006|Open-Label Period|Lost to Follow-up|0|||
144490921|NCT04955626|520993264|FG007|Open-Label Period|Lost to Follow-up|0|||
144490922|NCT04955626|520993265|FG008|Open-Label Period|Lost to Follow-up|0|||
144369900|NCT02120898|520562749|FG002|Overall Study|Withdrawal by Subject|2|||
144369901|NCT02120898|520562747|FG000|Overall Study|Non-compliance with study drug|3|||
144490923|NCT04955626|520993266|FG009|Open-Label Period|Lost to Follow-up|0|||
144490924|NCT04955626|520993267|FG010|Open-Label Period|Lost to Follow-up|0|||
144490925|NCT04955626|520993268|FG011|Open-Label Period|Lost to Follow-up|0|||
144490926|NCT04955626|520993269|FG012|Open-Label Period|Lost to Follow-up|0|||
144490927|NCT04955626|520993270|FG013|Open-Label Period|Lost to Follow-up|0|||
144490928|NCT04955626|520993271|FG014|Open-Label Period|Lost to Follow-up|0|||
144490929|NCT04955626|520993272|FG015|Open-Label Period|Lost to Follow-up|0|||
144490930|NCT04955626|520993273|FG016|Open-Label Period|Lost to Follow-up|0|||
144490931|NCT04955626|520993274|FG017|Open-Label Period|Lost to Follow-up|0|||
144490932|NCT04955626|520993275|FG018|Open-Label Period|Lost to Follow-up|0|||
144490933|NCT04955626|520993276|FG019|Open-Label Period|Lost to Follow-up|0|||
144490934|NCT04955626|520993277|FG020|Open-Label Period|Lost to Follow-up|0|||
144490935|NCT04955626|520993278|FG021|Open-Label Period|Lost to Follow-up|0|||
144490936|NCT04955626|520993279|FG022|Open-Label Period|Lost to Follow-up|0|||
144490937|NCT04955626|520993280|FG023|Open-Label Period|Lost to Follow-up|0|||
144490938|NCT04955626|520993281|FG024|Open-Label Period|Lost to Follow-up|0|||
144490939|NCT04955626|520993282|FG025|Open-Label Period|Lost to Follow-up|0|||
144490940|NCT04955626|520993283|FG026|Open-Label Period|Lost to Follow-up|0|||
144490941|NCT04955626|520993284|FG027|Open-Label Period|Lost to Follow-up|0|||
144490942|NCT04955626|520993285|FG028|Open-Label Period|Lost to Follow-up|0|||
144490943|NCT04955626|520993286|FG029|Open-Label Period|Lost to Follow-up|0|||
144490944|NCT04955626|520993287|FG030|Open-Label Period|Lost to Follow-up|0|||
144490945|NCT04955626|520993288|FG031|Open-Label Period|Lost to Follow-up|0|||
144490946|NCT04955626|520993289|FG032|Open-Label Period|Lost to Follow-up|0|||
144490947|NCT04955626|520993290|FG033|Open-Label Period|Lost to Follow-up|0|||
144490948|NCT04955626|520993291|FG034|Open-Label Period|Lost to Follow-up|0|||
144490949|NCT04955626|520993292|FG035|Open-Label Period|Lost to Follow-up|0|||
144490950|NCT04955626|520993257|FG000|Open-Label Period|Protocol Violation|377|||
144490951|NCT04955626|520993258|FG001|Open-Label Period|Protocol Violation|48|||
144490952|NCT04955626|520993259|FG002|Open-Label Period|Protocol Violation|0|||
144490953|NCT04955626|520993260|FG003|Open-Label Period|Protocol Violation|0|||
144490954|NCT04955626|520993261|FG004|Open-Label Period|Protocol Violation|0|||
144490955|NCT04955626|520993262|FG005|Open-Label Period|Protocol Violation|0|||
144490956|NCT04955626|520993263|FG006|Open-Label Period|Protocol Violation|0|||
144490957|NCT04955626|520993264|FG007|Open-Label Period|Protocol Violation|0|||
144490958|NCT04955626|520993265|FG008|Open-Label Period|Protocol Violation|0|||
144490959|NCT04955626|520993266|FG009|Open-Label Period|Protocol Violation|0|||
144490960|NCT04955626|520993267|FG010|Open-Label Period|Protocol Violation|0|||
144490961|NCT04955626|520993268|FG011|Open-Label Period|Protocol Violation|0|||
144490962|NCT04955626|520993269|FG012|Open-Label Period|Protocol Violation|0|||
144490963|NCT04955626|520993270|FG013|Open-Label Period|Protocol Violation|0|||
144490964|NCT04955626|520993271|FG014|Open-Label Period|Protocol Violation|0|||
144490965|NCT04955626|520993272|FG015|Open-Label Period|Protocol Violation|0|||
144490966|NCT04955626|520993273|FG016|Open-Label Period|Protocol Violation|0|||
144490967|NCT04955626|520993274|FG017|Open-Label Period|Protocol Violation|0|||
144490968|NCT04955626|520993275|FG018|Open-Label Period|Protocol Violation|0|||
144490969|NCT04955626|520993276|FG019|Open-Label Period|Protocol Violation|0|||
144490970|NCT04955626|520993277|FG020|Open-Label Period|Protocol Violation|0|||
144490971|NCT04955626|520993278|FG021|Open-Label Period|Protocol Violation|0|||
144490972|NCT04955626|520993279|FG022|Open-Label Period|Protocol Violation|0|||
144490973|NCT04955626|520993280|FG023|Open-Label Period|Protocol Violation|0|||
144490974|NCT04955626|520993281|FG024|Open-Label Period|Protocol Violation|0|||
144490975|NCT04955626|520993282|FG025|Open-Label Period|Protocol Violation|0|||
144490976|NCT04955626|520993283|FG026|Open-Label Period|Protocol Violation|0|||
144490977|NCT04955626|520993284|FG027|Open-Label Period|Protocol Violation|0|||
144490978|NCT04955626|520993285|FG028|Open-Label Period|Protocol Violation|0|||
144490979|NCT04955626|520993286|FG029|Open-Label Period|Protocol Violation|0|||
144490980|NCT04955626|520993287|FG030|Open-Label Period|Protocol Violation|0|||
144490981|NCT04955626|520993288|FG031|Open-Label Period|Protocol Violation|0|||
144490982|NCT04955626|520993289|FG032|Open-Label Period|Protocol Violation|0|||
144490983|NCT04955626|520993290|FG033|Open-Label Period|Protocol Violation|0|||
144490984|NCT04955626|520993291|FG034|Open-Label Period|Protocol Violation|0|||
144490985|NCT04955626|520993292|FG035|Open-Label Period|Protocol Violation|0|||
144490986|NCT04955626|520993257|FG000|Open-Label Period|Death|5|||
144490987|NCT04955626|520993258|FG001|Open-Label Period|Death|5|||
144490988|NCT04955626|520993259|FG002|Open-Label Period|Death|0|||
144490989|NCT04955626|520993260|FG003|Open-Label Period|Death|0|||
144490990|NCT04955626|520993261|FG004|Open-Label Period|Death|0|||
144490991|NCT04955626|520993262|FG005|Open-Label Period|Death|0|||
144490992|NCT04955626|520993263|FG006|Open-Label Period|Death|0|||
144490993|NCT04955626|520993264|FG007|Open-Label Period|Death|0|||
144490994|NCT04955626|520993265|FG008|Open-Label Period|Death|0|||
144490995|NCT04955626|520993266|FG009|Open-Label Period|Death|0|||
144490996|NCT04955626|520993267|FG010|Open-Label Period|Death|0|||
144490997|NCT04955626|520993268|FG011|Open-Label Period|Death|0|||
144490998|NCT04955626|520993269|FG012|Open-Label Period|Death|0|||
144490999|NCT04955626|520993270|FG013|Open-Label Period|Death|0|||
144491000|NCT04955626|520993271|FG014|Open-Label Period|Death|0|||
144491001|NCT04955626|520993272|FG015|Open-Label Period|Death|0|||
144491002|NCT04955626|520993273|FG016|Open-Label Period|Death|0|||
144491003|NCT04955626|520993274|FG017|Open-Label Period|Death|0|||
144491004|NCT04955626|520993275|FG018|Open-Label Period|Death|0|||
144491005|NCT04955626|520993276|FG019|Open-Label Period|Death|0|||
144491006|NCT04955626|520993277|FG020|Open-Label Period|Death|0|||
144491007|NCT04955626|520993278|FG021|Open-Label Period|Death|0|||
144491008|NCT04955626|520993279|FG022|Open-Label Period|Death|0|||
144491009|NCT04955626|520993280|FG023|Open-Label Period|Death|0|||
144491010|NCT04955626|520993281|FG024|Open-Label Period|Death|0|||
144491011|NCT04955626|520993282|FG025|Open-Label Period|Death|0|||
144491012|NCT04955626|520993283|FG026|Open-Label Period|Death|0|||
144491013|NCT04955626|520993284|FG027|Open-Label Period|Death|0|||
144491014|NCT04955626|520993285|FG028|Open-Label Period|Death|0|||
144491015|NCT04955626|520993286|FG029|Open-Label Period|Death|0|||
144491016|NCT04955626|520993287|FG030|Open-Label Period|Death|0|||
144491017|NCT04955626|520993288|FG031|Open-Label Period|Death|0|||
144491018|NCT04955626|520993289|FG032|Open-Label Period|Death|0|||
144491019|NCT04955626|520993290|FG033|Open-Label Period|Death|0|||
144491020|NCT04955626|520993291|FG034|Open-Label Period|Death|0|||
144491021|NCT04955626|520993292|FG035|Open-Label Period|Death|0|||
144491022|NCT04955626|520993257|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
144491023|NCT04955626|520993258|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
144491024|NCT04955626|520993259|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
144491025|NCT04955626|520993260|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
144491026|NCT04955626|520993261|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
144491027|NCT04955626|520993262|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
144491028|NCT04955626|520993263|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
144491029|NCT04955626|520993264|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
144491030|NCT04955626|520993265|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
144491031|NCT04955626|520993266|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
144491032|NCT04955626|520993267|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
144491033|NCT04955626|520993268|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
144491034|NCT04955626|520993269|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
144491035|NCT04955626|520993270|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
144491036|NCT04955626|520993271|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
144491037|NCT04955626|520993272|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
144491038|NCT04955626|520993273|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
144491039|NCT04955626|520993274|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
144491040|NCT04955626|520993275|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
144491041|NCT04955626|520993276|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
144491042|NCT04955626|520993277|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
144491043|NCT04955626|520993278|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
144491044|NCT04955626|520993279|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
144491045|NCT04955626|520993280|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
144491046|NCT04955626|520993281|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
144491047|NCT04955626|520993282|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
144491048|NCT04955626|520993283|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
144715714|NCT01789281|521813387|FG001|Overall Study|Lost to Follow-up|0|||
144715715|NCT01789281|521813386|FG000|Overall Study|Administrative problems|0|||
144715716|NCT01789281|521813387|FG001|Overall Study|Administrative problems|1|||
144715717|NCT00686920|521813388|FG000|Overall Study|Death|45|||
144715718|NCT00686920|521813389|FG001|Overall Study|Death|14|||
144715719|NCT00686920|521813388|FG000|Overall Study|Liver Transplant|23|||
144715720|NCT00686920|521813389|FG001|Overall Study|Liver Transplant|8|||
144715721|NCT00686920|521813388|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
144715722|NCT00686920|521813389|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
144715723|NCT00686920|521813388|FG000|Overall Study|Withdrawal by Subject|23|||
144715724|NCT00686920|521813389|FG001|Overall Study|Withdrawal by Subject|5|||
144715725|NCT00686920|521813388|FG000|Overall Study|Protocol Violation|2|||
144715726|NCT00686920|521813389|FG001|Overall Study|Protocol Violation|1|||
144715727|NCT00686920|521813388|FG000|Overall Study|Adverse Event|10|||
144715728|NCT00686920|521813389|FG001|Overall Study|Adverse Event|2|||
144715729|NCT00686920|521813388|FG000|Overall Study|Personal Reason|0|||
144715730|NCT00686920|521813389|FG001|Overall Study|Personal Reason|1|||
144715731|NCT00686920|521813388|FG000|Overall Study|Lost to Follow-up|15|||
144715732|NCT00686920|521813389|FG001|Overall Study|Lost to Follow-up|3|||
144715733|NCT00686920|521813388|FG000|Overall Study|Moved to Another State|1|||
144715734|NCT00686920|521813389|FG001|Overall Study|Moved to Another State|0|||
144715735|NCT00686920|521813388|FG000|Overall Study|Transferred to Nursing Home|1|||
144715736|NCT00686920|521813389|FG001|Overall Study|Transferred to Nursing Home|0|||
144715737|NCT00686920|521813388|FG000|Overall Study|Noncompliance|9|||
144715738|NCT00686920|521813389|FG001|Overall Study|Noncompliance|0|||
144715739|NCT00686920|521813388|FG000|Overall Study|Principal Investigator Decision|2|||
144715740|NCT00686920|521813389|FG001|Overall Study|Principal Investigator Decision|0|||
144715741|NCT01141283|521813390|FG000|Overall Study|Adverse Event|56|||
144715742|NCT01141283|521813390|FG000|Overall Study|Lost to Follow-up|4|||
144715743|NCT01141283|521813390|FG000|Overall Study|Withdrawal by Subject|14|||
144715744|NCT01141283|521813390|FG000|Overall Study|Administrative|4|||
144715745|NCT01141283|521813390|FG000|Overall Study|Lack of Efficacy|10|||
144715746|NCT00449930|521813393|FG000|Overall Study|Adverse Event|9|||
144715747|NCT00449930|521813394|FG001|Overall Study|Adverse Event|19|||
144715748|NCT00449930|521813393|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
144715749|NCT00449930|521813394|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
144715750|NCT00449930|521813393|FG000|Overall Study|Lack of Efficacy|10|||
144715751|NCT00449930|521813394|FG001|Overall Study|Lack of Efficacy|1|||
144715752|NCT00449930|521813393|FG000|Overall Study|Lost to Follow-up|9|||
144715753|NCT00449930|521813394|FG001|Overall Study|Lost to Follow-up|14|||
144715754|NCT00449930|521813393|FG000|Overall Study|Physician Decision|1|||
144715755|NCT00449930|521813394|FG001|Overall Study|Physician Decision|2|||
144715756|NCT00449930|521813393|FG000|Overall Study|Protocol Violation|14|||
144715757|NCT00449930|521813394|FG001|Overall Study|Protocol Violation|15|||
144715758|NCT00449930|521813393|FG000|Overall Study|Withdrawal by Subject|16|||
144715759|NCT00449930|521813394|FG001|Overall Study|Withdrawal by Subject|23|||
144715760|NCT00449930|521813393|FG000|Overall Study|Glycemic discontinuation criteria|1|||
144715761|NCT00449930|521813394|FG001|Overall Study|Glycemic discontinuation criteria|1|||
144715762|NCT02124746|521813395|FG000|Overall Study|Adverse Event|2|||
144715763|NCT02124746|521813396|FG001|Overall Study|Adverse Event|1|||
144715764|NCT02124746|521813397|FG002|Overall Study|Adverse Event|2|||
144715765|NCT02124746|521813395|FG000|Overall Study|Death|2|||
144715766|NCT02124746|521813396|FG001|Overall Study|Death|1|||
144715767|NCT02124746|521813397|FG002|Overall Study|Death|3|||
144715768|NCT02124746|521813395|FG000|Overall Study|Lack of Efficacy|3|||
144715769|NCT02124746|521813396|FG001|Overall Study|Lack of Efficacy|2|||
144715770|NCT02124746|521813397|FG002|Overall Study|Lack of Efficacy|2|||
144715771|NCT02124746|521813395|FG000|Overall Study|Physician Decision|6|||
144715772|NCT02124746|521813396|FG001|Overall Study|Physician Decision|4|||
144715773|NCT02124746|521813397|FG002|Overall Study|Physician Decision|5|||
144715774|NCT02124746|521813395|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144715775|NCT02124746|521813396|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144491049|NCT04955626|520993284|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
144491050|NCT04955626|520993285|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
144491051|NCT04955626|520993286|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
144715776|NCT02124746|521813397|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144715777|NCT02124746|521813395|FG000|Overall Study|Withdrawal by Subject|3|||
144715778|NCT02124746|521813396|FG001|Overall Study|Withdrawal by Subject|3|||
144491052|NCT04955626|520993287|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
144491053|NCT04955626|520993288|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
144491054|NCT04955626|520993289|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
144491055|NCT04955626|520993290|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
144491056|NCT04955626|520993291|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
144491057|NCT04955626|520993292|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
144491058|NCT04955626|520993257|FG000|Open-Label Period|Other|621|||
144491059|NCT04955626|520993258|FG001|Open-Label Period|Other|429|||
144491060|NCT04955626|520993259|FG002|Open-Label Period|Other|0|||
144491061|NCT04955626|520993260|FG003|Open-Label Period|Other|0|||
144491062|NCT04955626|520993261|FG004|Open-Label Period|Other|0|||
144491063|NCT04955626|520993262|FG005|Open-Label Period|Other|0|||
144491064|NCT04955626|520993263|FG006|Open-Label Period|Other|0|||
144491065|NCT04955626|520993264|FG007|Open-Label Period|Other|0|||
144491066|NCT04955626|520993265|FG008|Open-Label Period|Other|0|||
144491067|NCT04955626|520993266|FG009|Open-Label Period|Other|0|||
144491068|NCT04955626|520993267|FG010|Open-Label Period|Other|0|||
144491069|NCT04955626|520993268|FG011|Open-Label Period|Other|0|||
144491070|NCT04955626|520993269|FG012|Open-Label Period|Other|0|||
144491071|NCT04955626|520993270|FG013|Open-Label Period|Other|0|||
144491072|NCT04955626|520993271|FG014|Open-Label Period|Other|0|||
144491073|NCT04955626|520993272|FG015|Open-Label Period|Other|0|||
144491074|NCT04955626|520993273|FG016|Open-Label Period|Other|0|||
144491075|NCT04955626|520993274|FG017|Open-Label Period|Other|0|||
144491076|NCT04955626|520993275|FG018|Open-Label Period|Other|0|||
144491077|NCT04955626|520993276|FG019|Open-Label Period|Other|0|||
144491078|NCT04955626|520993277|FG020|Open-Label Period|Other|0|||
144491079|NCT04955626|520993278|FG021|Open-Label Period|Other|0|||
144491080|NCT04955626|520993279|FG022|Open-Label Period|Other|0|||
144491081|NCT04955626|520993280|FG023|Open-Label Period|Other|0|||
144491082|NCT04955626|520993281|FG024|Open-Label Period|Other|0|||
144491083|NCT04955626|520993282|FG025|Open-Label Period|Other|0|||
144491084|NCT04955626|520993283|FG026|Open-Label Period|Other|0|||
144491085|NCT04955626|520993284|FG027|Open-Label Period|Other|0|||
144491086|NCT04955626|520993285|FG028|Open-Label Period|Other|0|||
144491087|NCT04955626|520993286|FG029|Open-Label Period|Other|0|||
144491088|NCT04955626|520993287|FG030|Open-Label Period|Other|0|||
144491089|NCT04955626|520993288|FG031|Open-Label Period|Other|0|||
144491090|NCT04955626|520993289|FG032|Open-Label Period|Other|0|||
144491091|NCT04955626|520993290|FG033|Open-Label Period|Other|0|||
144491092|NCT04955626|520993291|FG034|Open-Label Period|Other|0|||
144491093|NCT04955626|520993292|FG035|Open-Label Period|Other|0|||
144491094|NCT04955626|520993257|FG000|Open-Label Period|Physician Decision|2|||
144491095|NCT04955626|520993258|FG001|Open-Label Period|Physician Decision|0|||
144491096|NCT04955626|520993259|FG002|Open-Label Period|Physician Decision|0|||
144491097|NCT04955626|520993260|FG003|Open-Label Period|Physician Decision|0|||
144491098|NCT04955626|520993261|FG004|Open-Label Period|Physician Decision|0|||
144491099|NCT04955626|520993262|FG005|Open-Label Period|Physician Decision|0|||
144491100|NCT04955626|520993263|FG006|Open-Label Period|Physician Decision|0|||
144491101|NCT04955626|520993264|FG007|Open-Label Period|Physician Decision|0|||
144491102|NCT04955626|520993265|FG008|Open-Label Period|Physician Decision|0|||
144491103|NCT04955626|520993266|FG009|Open-Label Period|Physician Decision|0|||
144491104|NCT04955626|520993267|FG010|Open-Label Period|Physician Decision|0|||
144491105|NCT04955626|520993268|FG011|Open-Label Period|Physician Decision|0|||
144491106|NCT04955626|520993269|FG012|Open-Label Period|Physician Decision|0|||
144491107|NCT04955626|520993270|FG013|Open-Label Period|Physician Decision|0|||
144491108|NCT04955626|520993271|FG014|Open-Label Period|Physician Decision|0|||
144491109|NCT04955626|520993272|FG015|Open-Label Period|Physician Decision|0|||
144491110|NCT04955626|520993273|FG016|Open-Label Period|Physician Decision|0|||
144491111|NCT04955626|520993274|FG017|Open-Label Period|Physician Decision|0|||
144491112|NCT04955626|520993275|FG018|Open-Label Period|Physician Decision|0|||
144369902|NCT02120898|520562748|FG001|Overall Study|Non-compliance with study drug|0|||
144369903|NCT02120898|520562749|FG002|Overall Study|Non-compliance with study drug|0|||
144491113|NCT04955626|520993276|FG019|Open-Label Period|Physician Decision|0|||
144491114|NCT04955626|520993277|FG020|Open-Label Period|Physician Decision|0|||
144491115|NCT04955626|520993278|FG021|Open-Label Period|Physician Decision|0|||
144491116|NCT04955626|520993279|FG022|Open-Label Period|Physician Decision|0|||
144491117|NCT04955626|520993280|FG023|Open-Label Period|Physician Decision|0|||
144491118|NCT04955626|520993281|FG024|Open-Label Period|Physician Decision|0|||
144491119|NCT04955626|520993282|FG025|Open-Label Period|Physician Decision|0|||
144491120|NCT04955626|520993283|FG026|Open-Label Period|Physician Decision|0|||
144491121|NCT04955626|520993284|FG027|Open-Label Period|Physician Decision|0|||
144491122|NCT04955626|520993285|FG028|Open-Label Period|Physician Decision|0|||
144491123|NCT04955626|520993286|FG029|Open-Label Period|Physician Decision|0|||
144491124|NCT04955626|520993287|FG030|Open-Label Period|Physician Decision|0|||
144491125|NCT04955626|520993288|FG031|Open-Label Period|Physician Decision|0|||
144369904|NCT02120898|520562747|FG000|Overall Study|Adverse Event|1|||
144491126|NCT04955626|520993289|FG032|Open-Label Period|Physician Decision|0|||
144491127|NCT04955626|520993290|FG033|Open-Label Period|Physician Decision|0|||
144491128|NCT04955626|520993291|FG034|Open-Label Period|Physician Decision|0|||
144491129|NCT04955626|520993292|FG035|Open-Label Period|Physician Decision|0|||
144491130|NCT04955626|520993257|FG000|Open-Label Period|Withdrawal by Subject|135|||
144491131|NCT04955626|520993258|FG001|Open-Label Period|Withdrawal by Subject|25|||
144491132|NCT04955626|520993259|FG002|Open-Label Period|Withdrawal by Subject|0|||
144491133|NCT04955626|520993260|FG003|Open-Label Period|Withdrawal by Subject|0|||
144491134|NCT04955626|520993261|FG004|Open-Label Period|Withdrawal by Subject|0|||
144491135|NCT04955626|520993262|FG005|Open-Label Period|Withdrawal by Subject|0|||
144491136|NCT04955626|520993263|FG006|Open-Label Period|Withdrawal by Subject|0|||
144491137|NCT04955626|520993264|FG007|Open-Label Period|Withdrawal by Subject|0|||
144491138|NCT04955626|520993265|FG008|Open-Label Period|Withdrawal by Subject|0|||
144491139|NCT04955626|520993266|FG009|Open-Label Period|Withdrawal by Subject|0|||
144491140|NCT04955626|520993267|FG010|Open-Label Period|Withdrawal by Subject|0|||
144491141|NCT04955626|520993268|FG011|Open-Label Period|Withdrawal by Subject|0|||
144491142|NCT04955626|520993269|FG012|Open-Label Period|Withdrawal by Subject|0|||
144491143|NCT04955626|520993270|FG013|Open-Label Period|Withdrawal by Subject|0|||
144491144|NCT04955626|520993271|FG014|Open-Label Period|Withdrawal by Subject|0|||
144491145|NCT04955626|520993272|FG015|Open-Label Period|Withdrawal by Subject|0|||
144491146|NCT04955626|520993273|FG016|Open-Label Period|Withdrawal by Subject|0|||
144491147|NCT04955626|520993274|FG017|Open-Label Period|Withdrawal by Subject|0|||
144491148|NCT04955626|520993275|FG018|Open-Label Period|Withdrawal by Subject|0|||
144491149|NCT04955626|520993276|FG019|Open-Label Period|Withdrawal by Subject|0|||
144491150|NCT04955626|520993277|FG020|Open-Label Period|Withdrawal by Subject|0|||
144491151|NCT04955626|520993278|FG021|Open-Label Period|Withdrawal by Subject|0|||
144491152|NCT04955626|520993279|FG022|Open-Label Period|Withdrawal by Subject|0|||
144491153|NCT04955626|520993280|FG023|Open-Label Period|Withdrawal by Subject|0|||
144491154|NCT04955626|520993281|FG024|Open-Label Period|Withdrawal by Subject|0|||
144491155|NCT04955626|520993282|FG025|Open-Label Period|Withdrawal by Subject|0|||
144491156|NCT04955626|520993283|FG026|Open-Label Period|Withdrawal by Subject|0|||
144491157|NCT04955626|520993284|FG027|Open-Label Period|Withdrawal by Subject|0|||
144491158|NCT04955626|520993285|FG028|Open-Label Period|Withdrawal by Subject|0|||
144491159|NCT04955626|520993286|FG029|Open-Label Period|Withdrawal by Subject|0|||
144491160|NCT04955626|520993287|FG030|Open-Label Period|Withdrawal by Subject|0|||
144491161|NCT04955626|520993288|FG031|Open-Label Period|Withdrawal by Subject|0|||
144491162|NCT04955626|520993289|FG032|Open-Label Period|Withdrawal by Subject|0|||
144491163|NCT04955626|520993290|FG033|Open-Label Period|Withdrawal by Subject|0|||
144491164|NCT04955626|520993291|FG034|Open-Label Period|Withdrawal by Subject|0|||
144491165|NCT04955626|520993292|FG035|Open-Label Period|Withdrawal by Subject|0|||
144491166|NCT04955626|520993257|FG000|Open-Label Period|Refused further study procedures|1|||
144491167|NCT04955626|520993258|FG001|Open-Label Period|Refused further study procedures|0|||
144491168|NCT04955626|520993259|FG002|Open-Label Period|Refused further study procedures|0|||
144491169|NCT04955626|520993260|FG003|Open-Label Period|Refused further study procedures|0|||
144491170|NCT04955626|520993261|FG004|Open-Label Period|Refused further study procedures|0|||
144491171|NCT04955626|520993262|FG005|Open-Label Period|Refused further study procedures|0|||
144491172|NCT04955626|520993263|FG006|Open-Label Period|Refused further study procedures|0|||
144715779|NCT02124746|521813397|FG002|Overall Study|Withdrawal by Subject|0|||
144715780|NCT02124746|521813395|FG000|Overall Study|Study Terminated by Sponsor|0|||
144715781|NCT02124746|521813396|FG001|Overall Study|Study Terminated by Sponsor|0|||
144715782|NCT02124746|521813397|FG002|Overall Study|Study Terminated by Sponsor|6|||
144715783|NCT02124746|521813395|FG000|Overall Study|Disease Progression|3|||
144715784|NCT02124746|521813396|FG001|Overall Study|Disease Progression|6|||
144715785|NCT02124746|521813397|FG002|Overall Study|Disease Progression|4|||
144491173|NCT04955626|520993264|FG007|Open-Label Period|Refused further study procedures|0|||
144491174|NCT04955626|520993265|FG008|Open-Label Period|Refused further study procedures|0|||
144491175|NCT04955626|520993266|FG009|Open-Label Period|Refused further study procedures|0|||
144491176|NCT04955626|520993267|FG010|Open-Label Period|Refused further study procedures|0|||
144491177|NCT04955626|520993268|FG011|Open-Label Period|Refused further study procedures|0|||
144491178|NCT04955626|520993269|FG012|Open-Label Period|Refused further study procedures|0|||
144491179|NCT04955626|520993270|FG013|Open-Label Period|Refused further study procedures|0|||
144491180|NCT04955626|520993271|FG014|Open-Label Period|Refused further study procedures|0|||
144491181|NCT04955626|520993272|FG015|Open-Label Period|Refused further study procedures|0|||
144491182|NCT04955626|520993273|FG016|Open-Label Period|Refused further study procedures|0|||
144491183|NCT04955626|520993274|FG017|Open-Label Period|Refused further study procedures|0|||
144491184|NCT04955626|520993275|FG018|Open-Label Period|Refused further study procedures|0|||
144491185|NCT04955626|520993276|FG019|Open-Label Period|Refused further study procedures|0|||
144491186|NCT04955626|520993277|FG020|Open-Label Period|Refused further study procedures|0|||
144491187|NCT04955626|520993278|FG021|Open-Label Period|Refused further study procedures|0|||
144491188|NCT04955626|520993279|FG022|Open-Label Period|Refused further study procedures|0|||
144491189|NCT04955626|520993280|FG023|Open-Label Period|Refused further study procedures|0|||
144491190|NCT04955626|520993281|FG024|Open-Label Period|Refused further study procedures|0|||
144491191|NCT04955626|520993282|FG025|Open-Label Period|Refused further study procedures|0|||
144491192|NCT04955626|520993283|FG026|Open-Label Period|Refused further study procedures|0|||
144491193|NCT04955626|520993284|FG027|Open-Label Period|Refused further study procedures|0|||
144491194|NCT04955626|520993285|FG028|Open-Label Period|Refused further study procedures|0|||
144491195|NCT04955626|520993286|FG029|Open-Label Period|Refused further study procedures|0|||
144491196|NCT04955626|520993287|FG030|Open-Label Period|Refused further study procedures|0|||
144491197|NCT04955626|520993288|FG031|Open-Label Period|Refused further study procedures|0|||
144491198|NCT04955626|520993289|FG032|Open-Label Period|Refused further study procedures|0|||
144491199|NCT04955626|520993290|FG033|Open-Label Period|Refused further study procedures|0|||
144491200|NCT04955626|520993291|FG034|Open-Label Period|Refused further study procedures|0|||
144491201|NCT04955626|520993292|FG035|Open-Label Period|Refused further study procedures|0|||
144491202|NCT04955626|520993257|FG000|Open-Label Period|Adverse Event|1|||
144491203|NCT04955626|520993258|FG001|Open-Label Period|Adverse Event|0|||
144491204|NCT04955626|520993259|FG002|Open-Label Period|Adverse Event|0|||
144491205|NCT04955626|520993260|FG003|Open-Label Period|Adverse Event|0|||
144491206|NCT04955626|520993261|FG004|Open-Label Period|Adverse Event|0|||
144491207|NCT04955626|520993262|FG005|Open-Label Period|Adverse Event|0|||
144491208|NCT04955626|520993263|FG006|Open-Label Period|Adverse Event|0|||
144491209|NCT04955626|520993264|FG007|Open-Label Period|Adverse Event|0|||
144491210|NCT04955626|520993265|FG008|Open-Label Period|Adverse Event|0|||
144491211|NCT04955626|520993266|FG009|Open-Label Period|Adverse Event|0|||
144491212|NCT04955626|520993267|FG010|Open-Label Period|Adverse Event|0|||
144491213|NCT04955626|520993268|FG011|Open-Label Period|Adverse Event|0|||
144491214|NCT04955626|520993269|FG012|Open-Label Period|Adverse Event|0|||
144491215|NCT04955626|520993270|FG013|Open-Label Period|Adverse Event|0|||
144491216|NCT04955626|520993271|FG014|Open-Label Period|Adverse Event|0|||
144491217|NCT04955626|520993272|FG015|Open-Label Period|Adverse Event|0|||
144491218|NCT04955626|520993273|FG016|Open-Label Period|Adverse Event|0|||
144715786|NCT03811249|521813400|FG000|Overall Study|Withdrawal by Subject|44|||
144369905|NCT02120898|520562748|FG001|Overall Study|Adverse Event|2|||
144715787|NCT03811249|521813400|FG000|Overall Study|Missed Visit|24|||
144715788|NCT00571922|521813401|FG000|Overall Study|Completion unknown|36|||
144715789|NCT00571922|521813402|FG001|Overall Study|Completion unknown|36|||
144715790|NCT05017493|521813410|FG000|Overall Study|Withdrawal by Subject|26|||
144715791|NCT05017493|521813411|FG001|Overall Study|Withdrawal by Subject|0|||
144715792|NCT05017493|521813410|FG000|Overall Study|Physician Decision|15|||
144715793|NCT05017493|521813411|FG001|Overall Study|Physician Decision|0|||
144715794|NCT05017493|521813410|FG000|Overall Study|Protocol Violation|81|||
144715795|NCT05017493|521813411|FG001|Overall Study|Protocol Violation|0|||
144715796|NCT04304950|521813421|FG000|Overall Study|Lost to Follow-up|1|||
144715797|NCT04304950|521813422|FG001|Overall Study|Lost to Follow-up|1|||
144715798|NCT00345683|521813429|FG000|Overall Study|Lost to Follow-up|19|||
144715799|NCT00345683|521813430|FG001|Overall Study|Lost to Follow-up|7|||
144715800|NCT00345683|521813429|FG000|Overall Study|Other|6|||
144715801|NCT00345683|521813430|FG001|Overall Study|Other|2|||
144715802|NCT03634488|521813431|FG000|Overall Study|Death|1|||
144715803|NCT03634488|521813432|FG001|Overall Study|Death|0|||
144715804|NCT03634488|521813433|FG002|Overall Study|Death|0|||
144715805|NCT03634488|521813431|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
144715806|NCT03634488|521813432|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
144715807|NCT03634488|521813433|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
144715808|NCT01697449|521813440|FG000|Overall Study|Disease progression|47|||
144715809|NCT01697449|521813440|FG000|Overall Study|Adverse Event|7|||
144715810|NCT01697449|521813440|FG000|Overall Study|Lost to Follow-up|5|||
144715811|NCT01697449|521813440|FG000|Overall Study|Withdrawal by Subject|2|||
144715812|NCT01697449|521813440|FG000|Overall Study|Physician Decision|1|||
144715813|NCT01697449|521813440|FG000|Overall Study|Death|2|||
144715814|NCT01697449|521813440|FG000|Overall Study|Other|1|||
144715815|NCT01697449|521813440|FG000|Overall Study|Missing|25|||
144715816|NCT00529568|521813441|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
144715817|NCT00529568|521813442|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
144715818|NCT00529568|521813443|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
144715819|NCT00529568|521813441|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
144715820|NCT00529568|521813442|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
144715821|NCT00529568|521813443|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
144715822|NCT00529568|521813441|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
144715823|NCT00529568|521813442|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
144715824|NCT00529568|521813443|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
144715825|NCT00529568|521813441|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
144715826|NCT00529568|521813442|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
144715827|NCT00529568|521813443|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
144715828|NCT00529568|521813441|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
144715829|NCT00529568|521813442|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
144715830|NCT00529568|521813443|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
144715831|NCT00529568|521813441|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
144715832|NCT00529568|521813442|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
144715833|NCT00529568|521813443|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
144715834|NCT00529568|521813441|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
144715835|NCT00529568|521813442|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
144715836|NCT00529568|521813443|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
144715837|NCT00529568|521813441|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
144715838|NCT00529568|521813442|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
144715839|NCT00529568|521813443|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
144715840|NCT00529568|521813441|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
144715841|NCT00529568|521813442|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
144715842|NCT00529568|521813443|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
144715843|NCT00529568|521813441|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
144715844|NCT00529568|521813442|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
144715845|NCT00529568|521813443|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
144715846|NCT00529568|521813441|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
144715847|NCT00529568|521813442|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
144715848|NCT00529568|521813443|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
144715849|NCT01201356|521813444|FG000|Overall Study|Adverse Event|170|||
144715850|NCT01201356|521813444|FG000|Overall Study|Abnormal laboratory value(s)|51|||
144715851|NCT01201356|521813444|FG000|Overall Study|Abnormal test procedure result(s)|3|||
144715852|NCT01201356|521813444|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
144715853|NCT01201356|521813444|FG000|Overall Study|Condition no longer requires study drug|12|||
144715854|NCT01201356|521813444|FG000|Overall Study|Withdrawal by Subject|144|||
144715855|NCT01201356|521813444|FG000|Overall Study|Lost to Follow-up|50|||
144491219|NCT04955626|520993274|FG017|Open-Label Period|Adverse Event|0|||
144491220|NCT04955626|520993275|FG018|Open-Label Period|Adverse Event|0|||
144491221|NCT04955626|520993276|FG019|Open-Label Period|Adverse Event|0|||
144491222|NCT04955626|520993277|FG020|Open-Label Period|Adverse Event|0|||
144491223|NCT04955626|520993278|FG021|Open-Label Period|Adverse Event|0|||
144491224|NCT04955626|520993279|FG022|Open-Label Period|Adverse Event|0|||
144491225|NCT04955626|520993280|FG023|Open-Label Period|Adverse Event|0|||
144491226|NCT04955626|520993281|FG024|Open-Label Period|Adverse Event|0|||
144491227|NCT04955626|520993282|FG025|Open-Label Period|Adverse Event|0|||
144491228|NCT04955626|520993283|FG026|Open-Label Period|Adverse Event|0|||
144491229|NCT04955626|520993284|FG027|Open-Label Period|Adverse Event|0|||
144491230|NCT04955626|520993285|FG028|Open-Label Period|Adverse Event|0|||
144491231|NCT04955626|520993286|FG029|Open-Label Period|Adverse Event|0|||
144491232|NCT04955626|520993287|FG030|Open-Label Period|Adverse Event|0|||
144491233|NCT04955626|520993288|FG031|Open-Label Period|Adverse Event|0|||
144491234|NCT04955626|520993289|FG032|Open-Label Period|Adverse Event|0|||
144491235|NCT04955626|520993290|FG033|Open-Label Period|Adverse Event|0|||
144491236|NCT04955626|520993291|FG034|Open-Label Period|Adverse Event|0|||
144491237|NCT04955626|520993292|FG035|Open-Label Period|Adverse Event|0|||
144491238|NCT04955626|520993257|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
144491239|NCT04955626|520993258|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
144491240|NCT04955626|520993259|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
144491241|NCT04955626|520993260|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
144491242|NCT04955626|520993261|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
144491243|NCT04955626|520993262|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
144491244|NCT04955626|520993263|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
144491245|NCT04955626|520993264|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
144491246|NCT04955626|520993265|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
144491247|NCT04955626|520993266|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
144491248|NCT04955626|520993267|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
144491249|NCT04955626|520993268|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
144491250|NCT04955626|520993269|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
144491251|NCT04955626|520993270|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
144491252|NCT04955626|520993271|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
144491253|NCT04955626|520993272|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
144491254|NCT04955626|520993273|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
144491255|NCT04955626|520993274|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
144491256|NCT04955626|520993275|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
144491257|NCT04955626|520993276|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
144491258|NCT04955626|520993277|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
144491259|NCT04955626|520993278|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
144491260|NCT04955626|520993279|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
144491261|NCT04955626|520993280|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
144491262|NCT04955626|520993281|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
144491263|NCT04955626|520993282|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
144491264|NCT04955626|520993283|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
144491265|NCT04955626|520993284|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
144491266|NCT04955626|520993285|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
144491267|NCT04955626|520993286|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
144491268|NCT04955626|520993287|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
144491269|NCT04955626|520993288|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
144491270|NCT04955626|520993289|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
144491271|NCT04955626|520993290|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
144491272|NCT04955626|520993291|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
144491273|NCT04955626|520993292|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
144491274|NCT04955626|520993257|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491275|NCT04955626|520993258|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
144491276|NCT04955626|520993259|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491277|NCT04955626|520993260|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491278|NCT04955626|520993261|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491279|NCT04955626|520993262|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491280|NCT04955626|520993263|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491281|NCT04955626|520993264|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144369906|NCT02120898|520562749|FG002|Overall Study|Adverse Event|1|||
144369907|NCT02120898|520562747|FG000|Overall Study|Protocol Violation|1|||
144491282|NCT04955626|520993265|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491283|NCT04955626|520993266|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491284|NCT04955626|520993267|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491285|NCT04955626|520993268|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491286|NCT04955626|520993269|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144369908|NCT02120898|520562748|FG001|Overall Study|Protocol Violation|2|||
144491287|NCT04955626|520993270|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491288|NCT04955626|520993271|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491289|NCT04955626|520993272|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491290|NCT04955626|520993273|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491291|NCT04955626|520993274|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491292|NCT04955626|520993275|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491293|NCT04955626|520993276|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491294|NCT04955626|520993277|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491295|NCT04955626|520993278|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491296|NCT04955626|520993279|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491297|NCT04955626|520993280|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491298|NCT04955626|520993281|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491299|NCT04955626|520993282|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491300|NCT04955626|520993283|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491301|NCT04955626|520993284|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491302|NCT04955626|520993285|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491303|NCT04955626|520993286|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491304|NCT04955626|520993287|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491305|NCT04955626|520993288|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491306|NCT04955626|520993289|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491307|NCT04955626|520993290|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491308|NCT04955626|520993291|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491309|NCT04955626|520993292|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
144491310|NCT04320615|520993293|FG000|Overall Study|Withdrawal by Subject|4|||
144491311|NCT04320615|520993294|FG001|Overall Study|Withdrawal by Subject|10|||
144491312|NCT04320615|520993293|FG000|Overall Study|Physician Decision|2|||
144491313|NCT04320615|520993294|FG001|Overall Study|Physician Decision|0|||
144491314|NCT04320615|520993293|FG000|Overall Study|Other|2|||
144491315|NCT04320615|520993294|FG001|Overall Study|Other|0|||
144491316|NCT04320615|520993293|FG000|Overall Study|Lost to Follow-up|5|||
144491317|NCT04320615|520993294|FG001|Overall Study|Lost to Follow-up|23|||
144491318|NCT04320615|520993293|FG000|Overall Study|Death|35|||
144491319|NCT04320615|520993294|FG001|Overall Study|Death|71|||
144491320|NCT00003509|520993295|FG000|Overall Study|Not evaluable|5|||
144491321|NCT04060680|520993297|FG000|Overall Study|Unsuccessful implant|17|||
144491322|NCT04060680|520993298|FG001|Overall Study|Unsuccessful implant|2|||
144491323|NCT04060680|520993297|FG000|Overall Study|Adverse Event|3|||
144491324|NCT04060680|520993298|FG001|Overall Study|Adverse Event|0|||
144491325|NCT04060680|520993297|FG000|Overall Study|Death|2|||
144491326|NCT04060680|520993298|FG001|Overall Study|Death|0|||
144491327|NCT04060680|520993297|FG000|Overall Study|Study product no longer in use|1|||
144491328|NCT04060680|520993298|FG001|Overall Study|Study product no longer in use|0|||
144491329|NCT04060680|520993297|FG000|Overall Study|Withdrawal by Subject|1|||
144491330|NCT04060680|520993298|FG001|Overall Study|Withdrawal by Subject|0|||
144491331|NCT02507219|520993299|FG000|Overall Study|Physician Decision|1|||
144491332|NCT02507219|520993300|FG001|Overall Study|Physician Decision|0|||
144491333|NCT02507219|520993301|FG002|Overall Study|Physician Decision|0|||
144491334|NCT02507219|520993302|FG003|Overall Study|Physician Decision|0|||
144491335|NCT02507219|520993303|FG004|Overall Study|Physician Decision|0|||
144491336|NCT02507219|520993304|FG005|Overall Study|Physician Decision|0|||
144491337|NCT02507219|520993299|FG000|Overall Study|Withdrawal by Subject|0|||
144491338|NCT02507219|520993300|FG001|Overall Study|Withdrawal by Subject|0|||
144491339|NCT02507219|520993301|FG002|Overall Study|Withdrawal by Subject|0|||
144491340|NCT02507219|520993302|FG003|Overall Study|Withdrawal by Subject|0|||
144491341|NCT02507219|520993303|FG004|Overall Study|Withdrawal by Subject|1|||
144491342|NCT02507219|520993304|FG005|Overall Study|Withdrawal by Subject|0|||
144491343|NCT01544582|520993305|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
144491344|NCT01544582|520993306|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
144491345|NCT01544582|520993307|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
144491346|NCT01544582|520993308|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
144491347|NCT01544582|520993305|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
144491348|NCT01544582|520993306|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
144491349|NCT01544582|520993307|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
144491350|NCT01544582|520993308|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
144491351|NCT01544582|520993305|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
144491352|NCT01544582|520993306|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
144491353|NCT01544582|520993307|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
144491354|NCT01544582|520993308|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
144491355|NCT01544582|520993305|FG000|Analysis Population|Physician Decision|0|||
144491356|NCT01544582|520993306|FG001|Analysis Population|Physician Decision|13|||
144491357|NCT01544582|520993307|FG002|Analysis Population|Physician Decision|10|||
144491358|NCT01544582|520993308|FG003|Analysis Population|Physician Decision|9|||
144491359|NCT01544582|520993305|FG000|Analysis Population|Safety Reason|0|||
144491360|NCT01544582|520993306|FG001|Analysis Population|Safety Reason|33|||
144491361|NCT01544582|520993307|FG002|Analysis Population|Safety Reason|31|||
144491362|NCT01544582|520993308|FG003|Analysis Population|Safety Reason|8|||
144491363|NCT01544582|520993305|FG000|Analysis Population|Effectiveness Reason|0|||
144491364|NCT01544582|520993306|FG001|Analysis Population|Effectiveness Reason|48|||
144491365|NCT01544582|520993307|FG002|Analysis Population|Effectiveness Reason|29|||
144491366|NCT01544582|520993308|FG003|Analysis Population|Effectiveness Reason|12|||
144491367|NCT01544582|520993305|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
144491368|NCT01544582|520993306|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
144491369|NCT01544582|520993307|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
144491370|NCT01544582|520993308|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
144491371|NCT01544582|520993305|FG000|Analysis Population|Lost to Follow-up|0|||
144491372|NCT01544582|520993306|FG001|Analysis Population|Lost to Follow-up|6|||
144491373|NCT01544582|520993307|FG002|Analysis Population|Lost to Follow-up|6|||
144491374|NCT01544582|520993308|FG003|Analysis Population|Lost to Follow-up|5|||
144491375|NCT01544582|520993305|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
144491376|NCT01544582|520993306|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
144491377|NCT01544582|520993307|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
144491378|NCT01544582|520993308|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
144491379|NCT01544582|520993305|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
144491380|NCT01544582|520993306|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
144491381|NCT01544582|520993307|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
144491382|NCT01544582|520993308|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
144491383|NCT01544582|520993305|FG000|Analysis Population|Intolerance|0|||
144491384|NCT01544582|520993306|FG001|Analysis Population|Intolerance|1|||
144491385|NCT01544582|520993307|FG002|Analysis Population|Intolerance|0|||
144491386|NCT01544582|520993308|FG003|Analysis Population|Intolerance|0|||
144491387|NCT01544582|520993305|FG000|Analysis Population|Liver Transplantation|0|||
144491388|NCT01544582|520993306|FG001|Analysis Population|Liver Transplantation|0|||
144491389|NCT01544582|520993307|FG002|Analysis Population|Liver Transplantation|1|||
144491390|NCT01544582|520993308|FG003|Analysis Population|Liver Transplantation|0|||
144491391|NCT01544582|520993305|FG000|Analysis Population|No Social Insurance|0|||
144491392|NCT01544582|520993306|FG001|Analysis Population|No Social Insurance|0|||
144491393|NCT01544582|520993307|FG002|Analysis Population|No Social Insurance|1|||
144491394|NCT01544582|520993308|FG003|Analysis Population|No Social Insurance|0|||
144491395|NCT01544582|520993305|FG000|Analysis Population|Poor Adherence|0|||
144491396|NCT01544582|520993306|FG001|Analysis Population|Poor Adherence|0|||
144491397|NCT01544582|520993307|FG002|Analysis Population|Poor Adherence|1|||
144491398|NCT01544582|520993308|FG003|Analysis Population|Poor Adherence|0|||
144491399|NCT01544582|520993305|FG000|Analysis Population|Poor Participant Compliance|0|||
144491400|NCT01544582|520993306|FG001|Analysis Population|Poor Participant Compliance|1|||
144491401|NCT01544582|520993307|FG002|Analysis Population|Poor Participant Compliance|0|||
144491402|NCT01544582|520993308|FG003|Analysis Population|Poor Participant Compliance|0|||
144491403|NCT01544582|520993305|FG000|Analysis Population|Programmed Surgery|0|||
144491404|NCT01544582|520993306|FG001|Analysis Population|Programmed Surgery|1|||
144491405|NCT01544582|520993307|FG002|Analysis Population|Programmed Surgery|0|||
144491406|NCT01544582|520993308|FG003|Analysis Population|Programmed Surgery|0|||
144491407|NCT01544582|520993305|FG000|Analysis Population|Participant in Jail|0|||
144491408|NCT01544582|520993306|FG001|Analysis Population|Participant in Jail|0|||
144491409|NCT01544582|520993307|FG002|Analysis Population|Participant in Jail|1|||
144491410|NCT01544582|520993308|FG003|Analysis Population|Participant in Jail|0|||
144491411|NCT02419755|520993311|FG000|Overall Study|Death|1|||
144491412|NCT02419755|520993312|FG001|Overall Study|Death|3|||
144491413|NCT02419755|520993311|FG000|Overall Study|Relapse|0|||
144491414|NCT02419755|520993312|FG001|Overall Study|Relapse|1|||
144491415|NCT02419755|520993311|FG000|Overall Study|Ineligible|1|||
144491416|NCT02419755|520993312|FG001|Overall Study|Ineligible|0|||
144491417|NCT02419755|520993311|FG000|Overall Study|Withdrawal by Subject|1|||
144491418|NCT02419755|520993312|FG001|Overall Study|Withdrawal by Subject|0|||
144491419|NCT06403605|520993315|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
144491420|NCT06403605|520993316|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
144491421|NCT06403605|520993315|FG000|Follow-up|Adverse Event|4|||
144491422|NCT06403605|520993316|FG001|Follow-up|Adverse Event|2|||
144491423|NCT06403605|520993315|FG000|Follow-up|Withdrawal by Subject|2|||
144491424|NCT06403605|520993316|FG001|Follow-up|Withdrawal by Subject|3|||
144491425|NCT06403605|520993315|FG000|Follow-up|Lost to Follow-up|1|||
144491426|NCT06403605|520993316|FG001|Follow-up|Lost to Follow-up|0|||
144491427|NCT06403605|520993315|FG000|Follow-up|Death|1|||
144491428|NCT06403605|520993316|FG001|Follow-up|Death|0|||
144491429|NCT06403605|520993315|FG000|Follow-up|Other reasons|0|||
144491430|NCT06403605|520993316|FG001|Follow-up|Other reasons|4|||
144491431|NCT01950390|520993317|FG000|Overall Study|Never started treatment|3|||
144491432|NCT01950390|520993318|FG001|Overall Study|Never started treatment|2|||
144491433|NCT01950390|520993317|FG000|Overall Study|Disease progression|45|||
144491434|NCT01950390|520993318|FG001|Overall Study|Disease progression|52|||
144491435|NCT01950390|520993317|FG000|Overall Study|Adverse Event|22|||
144491436|NCT01950390|520993318|FG001|Overall Study|Adverse Event|16|||
144491437|NCT01950390|520993317|FG000|Overall Study|Death|5|||
144491438|NCT01950390|520993318|FG001|Overall Study|Death|3|||
144491439|NCT01950390|520993317|FG000|Overall Study|Withdrawal by Subject|5|||
144491440|NCT01950390|520993318|FG001|Overall Study|Withdrawal by Subject|1|||
144491441|NCT01950390|520993317|FG000|Overall Study|Alternative therapy|0|||
144491442|NCT01950390|520993318|FG001|Overall Study|Alternative therapy|3|||
144491443|NCT01950390|520993317|FG000|Overall Study|Complicating disease|1|||
144491444|NCT01950390|520993318|FG001|Overall Study|Complicating disease|0|||
144491445|NCT01950390|520993317|FG000|Overall Study|On treatment|1|||
144491446|NCT01950390|520993318|FG001|Overall Study|On treatment|0|||
144491447|NCT01950390|520993317|FG000|Overall Study|Symptomatic deterioration|2|||
144491448|NCT01950390|520993318|FG001|Overall Study|Symptomatic deterioration|1|||
144491449|NCT01950390|520993317|FG000|Overall Study|Physician Decision|0|||
144491450|NCT01950390|520993318|FG001|Overall Study|Physician Decision|4|||
144491451|NCT01950390|520993317|FG000|Overall Study|Lack of clinical benefit|0|||
144491452|NCT01950390|520993318|FG001|Overall Study|Lack of clinical benefit|1|||
144491453|NCT01950390|520993317|FG000|Overall Study|Maintained PR and moved to observation only|0|||
144491454|NCT01950390|520993318|FG001|Overall Study|Maintained PR and moved to observation only|1|||
144491455|NCT01939158|520995147|FG000|Overall Study|Adverse Event|1|||
144491456|NCT01939158|520995148|FG001|Overall Study|Adverse Event|0|||
144491457|NCT01939158|520995149|FG002|Overall Study|Adverse Event|0|||
144491458|NCT01939158|520995150|FG003|Overall Study|Adverse Event|0|||
144491459|NCT01939158|520995147|FG000|Overall Study|Withdrawal by Subject|22|||
144491460|NCT01939158|520995148|FG001|Overall Study|Withdrawal by Subject|25|||
144491461|NCT01939158|520995149|FG002|Overall Study|Withdrawal by Subject|15|||
144491462|NCT01939158|520995150|FG003|Overall Study|Withdrawal by Subject|17|||
144491463|NCT01939158|520995147|FG000|Overall Study|Migrated/moved from study area|5|||
144491464|NCT01939158|520995148|FG001|Overall Study|Migrated/moved from study area|7|||
144491465|NCT01939158|520995149|FG002|Overall Study|Migrated/moved from study area|3|||
144491466|NCT01939158|520995150|FG003|Overall Study|Migrated/moved from study area|6|||
144491467|NCT01939158|520995147|FG000|Overall Study|Lost to Follow-up|18|||
144491468|NCT01939158|520995148|FG001|Overall Study|Lost to Follow-up|17|||
144491469|NCT01939158|520995149|FG002|Overall Study|Lost to Follow-up|17|||
144491470|NCT01939158|520995150|FG003|Overall Study|Lost to Follow-up|17|||
144491471|NCT01939158|520995147|FG000|Overall Study|Death|0|||
144491472|NCT01939158|520995148|FG001|Overall Study|Death|0|||
144491473|NCT01939158|520995149|FG002|Overall Study|Death|1|||
144491474|NCT01939158|520995150|FG003|Overall Study|Death|1|||
144491475|NCT01939158|520995147|FG000|Overall Study|No longer meets eligibility criteria|0|||
144491476|NCT01939158|520995148|FG001|Overall Study|No longer meets eligibility criteria|0|||
144491477|NCT01939158|520995149|FG002|Overall Study|No longer meets eligibility criteria|1|||
144491478|NCT01939158|520995150|FG003|Overall Study|No longer meets eligibility criteria|0|||
144491479|NCT01939158|520995147|FG000|Overall Study|Other|1|||
144491480|NCT01939158|520995148|FG001|Overall Study|Other|3|||
144491481|NCT01939158|520995149|FG002|Overall Study|Other|4|||
144491482|NCT01939158|520995150|FG003|Overall Study|Other|3|||
144491483|NCT02065245|520995151|FG000|Infusion 1|Lost to Follow-up|0|||
144491484|NCT02065245|520995152|FG001|Infusion 1|Lost to Follow-up|0|||
144491485|NCT02065245|520995153|FG002|Infusion 1|Lost to Follow-up|0|||
144491486|NCT02065245|520995154|FG003|Infusion 1|Lost to Follow-up|0|||
144491487|NCT02065245|520995155|FG004|Infusion 1|Lost to Follow-up|0|||
144491488|NCT02065245|520995156|FG005|Infusion 1|Lost to Follow-up|0|||
144491489|NCT02065245|520995157|FG006|Infusion 1|Lost to Follow-up|1|||
144491490|NCT02065245|520995151|FG000|Infusion 1|Death|0|||
144491491|NCT02065245|520995152|FG001|Infusion 1|Death|0|||
144369909|NCT02120898|520562749|FG002|Overall Study|Protocol Violation|0|||
144369910|NCT02120898|520562747|FG000|Overall Study|Lost to Follow-up|0|||
144369911|NCT02120898|520562748|FG001|Overall Study|Lost to Follow-up|0|||
144491492|NCT02065245|520995153|FG002|Infusion 1|Death|1|||
144491493|NCT02065245|520995154|FG003|Infusion 1|Death|0|||
144491494|NCT02065245|520995155|FG004|Infusion 1|Death|1|||
144491495|NCT02065245|520995156|FG005|Infusion 1|Death|0|||
144491496|NCT02065245|520995157|FG006|Infusion 1|Death|0|||
144491497|NCT02065245|520995151|FG000|Infusion 2|Death|0|||
144715856|NCT01201356|521813444|FG000|Overall Study|administrative problems|74|||
144715857|NCT01201356|521813444|FG000|Overall Study|Death|16|||
144715858|NCT01201356|521813444|FG000|Overall Study|Protocol Violation|12|||
144715859|NCT00738920|521813447|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
144715860|NCT00738920|521813448|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
144715861|NCT00738920|521813449|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
144715862|NCT00738920|521813447|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
144715863|NCT00738920|521813448|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
144715864|NCT00738920|521813449|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
144715865|NCT00738920|521813447|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
144715866|NCT00738920|521813448|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
144715867|NCT00738920|521813449|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
144715868|NCT00738920|521813447|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
144715869|NCT00738920|521813448|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
144715870|NCT00738920|521813449|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
144715871|NCT00738920|521813447|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
144715872|NCT00738920|521813448|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
144715873|NCT00738920|521813449|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
144715874|NCT00738920|521813447|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
144715875|NCT00738920|521813448|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
144715876|NCT00738920|521813449|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
144715877|NCT00738920|521813447|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
144715878|NCT00738920|521813448|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
144715879|NCT00738920|521813449|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
144715880|NCT00738920|521813447|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
144715881|NCT00738920|521813448|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
144715882|NCT00738920|521813449|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
144715883|NCT00738920|521813447|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
144715884|NCT00738920|521813448|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
144715885|NCT00738920|521813449|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
144715886|NCT00738920|521813447|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
144715887|NCT00738920|521813448|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
144715888|NCT00738920|521813449|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
144715889|NCT02046369|521813450|FG000|Overall Study|Adverse Event|3|||
144715890|NCT02046369|521813451|FG001|Overall Study|Adverse Event|3|||
144715891|NCT02046369|521813450|FG000|Overall Study|Lack of Efficacy|3|||
144715892|NCT02046369|521813451|FG001|Overall Study|Lack of Efficacy|3|||
144715893|NCT02046369|521813450|FG000|Overall Study|Lost to Follow-up|3|||
144715894|NCT02046369|521813451|FG001|Overall Study|Lost to Follow-up|3|||
144715895|NCT02046369|521813450|FG000|Overall Study|Protocol Violation|1|||
144715896|NCT02046369|521813451|FG001|Overall Study|Protocol Violation|2|||
144715897|NCT02046369|521813450|FG000|Overall Study|Withdrawal by Subject|3|||
144715898|NCT02046369|521813451|FG001|Overall Study|Withdrawal by Subject|6|||
144715899|NCT02046369|521813450|FG000|Overall Study|never received study drug|0|||
144715900|NCT02046369|521813451|FG001|Overall Study|never received study drug|1|||
144715901|NCT02046369|521813450|FG000|Overall Study|non compliance|1|||
144715902|NCT02046369|521813451|FG001|Overall Study|non compliance|0|||
144715903|NCT00549198|521814984|FG000|Overall Study|Adverse Event|28|||
144715904|NCT00549198|521814985|FG001|Overall Study|Adverse Event|26|||
144715905|NCT00549198|521814984|FG000|Overall Study|Insufficient Viral Load Response|4|||
144715906|NCT00549198|521814985|FG001|Overall Study|Insufficient Viral Load Response|2|||
144715907|NCT00549198|521814984|FG000|Overall Study|Protocol-defined Virological Failure|7|||
144715908|NCT00549198|521814985|FG001|Overall Study|Protocol-defined Virological Failure|0|||
144715909|NCT00549198|521814984|FG000|Overall Study|Non-compliance|2|||
144715910|NCT00549198|521814985|FG001|Overall Study|Non-compliance|4|||
144715911|NCT00549198|521814984|FG000|Overall Study|Lost to Follow-up|7|||
144715912|NCT00549198|521814985|FG001|Overall Study|Lost to Follow-up|8|||
144715913|NCT00549198|521814984|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
144715914|NCT00549198|521814985|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144715915|NCT00549198|521814984|FG000|Overall Study|Protocol Violation|7|||
144715916|NCT00549198|521814985|FG001|Overall Study|Protocol Violation|2|||
144715917|NCT00549198|521814984|FG000|Overall Study|Investigator Decision|4|||
144715918|NCT00549198|521814985|FG001|Overall Study|Investigator Decision|3|||
144715919|NCT00549198|521814984|FG000|Overall Study|Withdrawal by Subject|7|||
144715920|NCT00549198|521814985|FG001|Overall Study|Withdrawal by Subject|7|||
144715921|NCT00549198|521814984|FG000|Overall Study|Disease Progression|1|||
144715922|NCT00549198|521814985|FG001|Overall Study|Disease Progression|0|||
144715923|NCT00549198|521814984|FG000|Overall Study|Participant Moved|2|||
144715924|NCT00549198|521814985|FG001|Overall Study|Participant Moved|0|||
144715925|NCT00549198|521814984|FG000|Overall Study|Participant not able to perform Week 96|1|||
144369912|NCT02120898|520562749|FG002|Overall Study|Lost to Follow-up|1|||
144369913|NCT04313244|520562750|FG000|Overall Study|Withdrawal of Consent|3|||
144369914|NCT04313244|520562751|FG001|Overall Study|Withdrawal of Consent|3|||
144369915|NCT04313244|520562750|FG000|Overall Study|Met Exclusion Criteria|1|||
144369916|NCT04313244|520562751|FG001|Overall Study|Met Exclusion Criteria|0|||
144369917|NCT04313244|520562750|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
144491498|NCT02065245|520995152|FG001|Infusion 2|Death|0|||
144491499|NCT02065245|520995153|FG002|Infusion 2|Death|0|||
144491500|NCT02065245|520995154|FG003|Infusion 2|Death|0|||
144715926|NCT00549198|521814985|FG001|Overall Study|Participant not able to perform Week 96|0|||
144715927|NCT00549198|521814984|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
144715928|NCT00549198|521814985|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
144715929|NCT00549198|521814984|FG000|Overall Study|Prohibited Medication|1|||
144715930|NCT00549198|521814985|FG001|Overall Study|Prohibited Medication|2|||
144715931|NCT00549198|521814984|FG000|Overall Study|Participant planning pregnancy|1|||
144715932|NCT00549198|521814985|FG001|Overall Study|Participant planning pregnancy|0|||
144715933|NCT00549198|521814984|FG000|Overall Study|Participant overweight, no scan possible|1|||
144715934|NCT00549198|521814985|FG001|Overall Study|Participant overweight, no scan possible|0|||
144715935|NCT00549198|521814984|FG000|Overall Study|No scan facilities|0|||
144715936|NCT00549198|521814985|FG001|Overall Study|No scan facilities|2|||
144715937|NCT00549198|521814984|FG000|Overall Study|Pregnancy|0|||
144715938|NCT00549198|521814985|FG001|Overall Study|Pregnancy|3|||
144715939|NCT00549198|521814984|FG000|Overall Study|Not Exposed to Study Drug|3|||
144715940|NCT00549198|521814985|FG001|Overall Study|Not Exposed to Study Drug|4|||
144715941|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
144715942|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
144715943|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
144715944|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
144715945|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
144715946|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
144715947|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
144715948|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
144715949|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
144491501|NCT02065245|520995155|FG004|Infusion 2|Death|0|||
144491502|NCT02065245|520995156|FG005|Infusion 2|Death|0|||
144491503|NCT02065245|520995157|FG006|Infusion 2|Death|1|||
144491504|NCT02065245|520995151|FG000|Infusion 3|Lost to Follow-up|1|||
144491505|NCT02065245|520995152|FG001|Infusion 3|Lost to Follow-up|1|||
144715950|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
144715951|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
144715952|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
144715953|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
144715954|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
144715955|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
144715956|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
144715957|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
144715958|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
144715959|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
144715960|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
144715961|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
144715962|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
144715963|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
144715964|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
144715965|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
144715966|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
144715967|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
144715968|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
144715969|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
144715970|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
144715971|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
144715972|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
144715973|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
144715974|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
144715975|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
144715976|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
144715977|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
144715978|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
144715979|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
144715980|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
144715981|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
144715982|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
144715983|NCT00606684|521814986|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
144715984|NCT00606684|521814987|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
144715985|NCT00606684|521814988|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
144715986|NCT00606684|521814989|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
144715987|NCT00606684|521814990|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
144715988|NCT00606684|521814991|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
144715989|NCT00606684|521814992|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
144715990|NCT00606684|521814986|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144715991|NCT00606684|521814987|FG001|Double-Blind Treatment Period|Adverse Event|3|||
144715992|NCT00606684|521814988|FG002|Double-Blind Treatment Period|Adverse Event|2|||
144715993|NCT00606684|521814989|FG003|Double-Blind Treatment Period|Adverse Event|4|||
144715994|NCT00606684|521814990|FG004|Double-Blind Treatment Period|Adverse Event|2|||
144715995|NCT00606684|521814991|FG005|Double-Blind Treatment Period|Adverse Event|0|||
144715996|NCT00606684|521814992|FG006|Double-Blind Treatment Period|Adverse Event|1|||
144715997|NCT00606684|521814986|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
144715998|NCT00606684|521814987|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
144715999|NCT00606684|521814988|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
144716000|NCT00606684|521814989|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
144716001|NCT00606684|521814990|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
144716002|NCT00606684|521814991|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
144716003|NCT00606684|521814992|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
144716004|NCT00606684|521814986|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
144716005|NCT00606684|521814987|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
144716006|NCT00606684|521814988|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
144716007|NCT00606684|521814989|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
144716008|NCT00606684|521814990|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
144716009|NCT00606684|521814991|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
144716010|NCT00606684|521814992|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
144716011|NCT00606684|521814986|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
144716012|NCT00606684|521814987|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
144716013|NCT00606684|521814988|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
144716014|NCT00606684|521814989|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
144716015|NCT00606684|521814990|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
144716016|NCT00606684|521814991|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
144716017|NCT00606684|521814992|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
144716018|NCT00606684|521814986|FG000|Double-Blind Treatment Period|Physician Decision|0|||
144716019|NCT00606684|521814987|FG001|Double-Blind Treatment Period|Physician Decision|5|||
144716020|NCT00606684|521814988|FG002|Double-Blind Treatment Period|Physician Decision|1|||
144716021|NCT00606684|521814989|FG003|Double-Blind Treatment Period|Physician Decision|0|||
144716022|NCT00606684|521814990|FG004|Double-Blind Treatment Period|Physician Decision|3|||
144716023|NCT00606684|521814991|FG005|Double-Blind Treatment Period|Physician Decision|1|||
144716024|NCT00606684|521814992|FG006|Double-Blind Treatment Period|Physician Decision|2|||
144716025|NCT00606684|521814986|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144716026|NCT00606684|521814987|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144716027|NCT00606684|521814988|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144716028|NCT00606684|521814989|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144716029|NCT00606684|521814990|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144716030|NCT00606684|521814991|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144716031|NCT00606684|521814992|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144716032|NCT01759381|521814995|FG000|Overall Study|Death|1|||
144716033|NCT01759381|521814996|FG001|Overall Study|Death|0|||
144716034|NCT01907737|521815001|FG000|Overall Study|Withdrawal by Subject|1|||
144716035|NCT02965820|521815004|FG000|Period 2, Second 30 Days|Adverse Event|1|||
144716036|NCT02965820|521815005|FG001|Period 2, Second 30 Days|Adverse Event|1|||
144716037|NCT01967888|521815006|FG000|Overall Study|Lost to Follow-up|6|||
144716038|NCT01967888|521815007|FG001|Overall Study|Lost to Follow-up|4|||
144716039|NCT01967888|521815006|FG000|Overall Study|Withdrawal by Subject|1|||
144716040|NCT01967888|521815007|FG001|Overall Study|Withdrawal by Subject|1|||
144716041|NCT01967888|521815006|FG000|Overall Study|Did Not Have Transplant|1|||
144716042|NCT01967888|521815007|FG001|Overall Study|Did Not Have Transplant|0|||
144716043|NCT01967888|521815006|FG000|Overall Study|Research visit not done, data recorded|1|||
144716044|NCT01967888|521815007|FG001|Overall Study|Research visit not done, data recorded|0|||
144716045|NCT01967888|521815006|FG000|Overall Study|Subject excluded after randomization|1|||
144716046|NCT01967888|521815007|FG001|Overall Study|Subject excluded after randomization|0|||
144716047|NCT01967888|521815006|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
144716048|NCT01967888|521815007|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
144716049|NCT01967888|521815006|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
144716050|NCT01967888|521815007|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
144716051|NCT01894984|521815010|FG000|Overall Study|Other|314|||
144716052|NCT01894984|521815011|FG001|Overall Study|Other|175|||
144716053|NCT00827359|521815012|FG000|Overall Study|Progressive Diseas|19|||
144716054|NCT00827359|521815012|FG000|Overall Study|Unacceptable Toxicity|5|||
144716055|NCT00827359|521815012|FG000|Overall Study|Ineligible|1|||
144716056|NCT00323609|521815013|FG000|Overall Study|Death|16|||
144716057|NCT00323609|521815014|FG001|Overall Study|Death|21|||
144716058|NCT00323609|521815015|FG002|Overall Study|Death|0|||
144716059|NCT00323609|521815016|FG003|Overall Study|Death|0|||
144716060|NCT00323609|521815013|FG000|Overall Study|Lost to Follow-up|9|||
144716061|NCT00323609|521815014|FG001|Overall Study|Lost to Follow-up|10|||
144716062|NCT00323609|521815015|FG002|Overall Study|Lost to Follow-up|0|||
144716063|NCT00323609|521815016|FG003|Overall Study|Lost to Follow-up|0|||
144716064|NCT00323609|521815013|FG000|Overall Study|Physician Decision|2|||
144716065|NCT00323609|521815014|FG001|Overall Study|Physician Decision|0|||
144716066|NCT00323609|521815015|FG002|Overall Study|Physician Decision|0|||
144716067|NCT00323609|521815016|FG003|Overall Study|Physician Decision|1|||
144716068|NCT00323609|521815013|FG000|Overall Study|Withdrawal by Subject|11|||
144716069|NCT00323609|521815014|FG001|Overall Study|Withdrawal by Subject|23|||
144716070|NCT00323609|521815015|FG002|Overall Study|Withdrawal by Subject|4|||
144716071|NCT00323609|521815016|FG003|Overall Study|Withdrawal by Subject|4|||
144716072|NCT00323609|521815013|FG000|Overall Study|Other non-VCF-related medical condition|3|||
144716073|NCT00323609|521815014|FG001|Overall Study|Other non-VCF-related medical condition|2|||
144716074|NCT00323609|521815015|FG002|Overall Study|Other non-VCF-related medical condition|0|||
144716075|NCT00323609|521815016|FG003|Overall Study|Other non-VCF-related medical condition|0|||
144716076|NCT00323609|521815013|FG000|Overall Study|Sponsor discontinued trial|29|||
144716077|NCT00323609|521815014|FG001|Overall Study|Sponsor discontinued trial|29|||
144716078|NCT00323609|521815015|FG002|Overall Study|Sponsor discontinued trial|0|||
144716079|NCT00323609|521815016|FG003|Overall Study|Sponsor discontinued trial|0|||
144716080|NCT00323609|521815013|FG000|Overall Study|Unrelenting or severe back pain|1|||
144716081|NCT00323609|521815014|FG001|Overall Study|Unrelenting or severe back pain|1|||
144716082|NCT00323609|521815015|FG002|Overall Study|Unrelenting or severe back pain|0|||
144716083|NCT00323609|521815016|FG003|Overall Study|Unrelenting or severe back pain|0|||
144716084|NCT00323609|521815013|FG000|Overall Study|Logistical withdrawal|9|||
144716085|NCT00323609|521815014|FG001|Overall Study|Logistical withdrawal|5|||
144716086|NCT00323609|521815015|FG002|Overall Study|Logistical withdrawal|0|||
144716087|NCT00323609|521815016|FG003|Overall Study|Logistical withdrawal|1|||
144716088|NCT00323609|521815013|FG000|Overall Study|Other reason|11|||
144716089|NCT00323609|521815014|FG001|Overall Study|Other reason|8|||
144716090|NCT00323609|521815015|FG002|Overall Study|Other reason|4|||
144491506|NCT02065245|520995153|FG002|Infusion 3|Lost to Follow-up|0|||
144716091|NCT00323609|521815016|FG003|Overall Study|Other reason|9|||
144716092|NCT02436135|521815019|FG000|Overall Study|Progressive Disease|3|||
144716093|NCT02436135|521815020|FG001|Overall Study|Progressive Disease|1|||
144716094|NCT02436135|521815019|FG000|Overall Study|Investigator Discretion|1|||
144716095|NCT02436135|521815020|FG001|Overall Study|Investigator Discretion|2|||
144716096|NCT02436135|521815019|FG000|Overall Study|Adverse Event|1|||
144716097|NCT02436135|521815020|FG001|Overall Study|Adverse Event|0|||
144716098|NCT02436135|521815019|FG000|Overall Study|Withdrawal by Participant|1|||
144716099|NCT02436135|521815020|FG001|Overall Study|Withdrawal by Participant|0|||
144716100|NCT02436135|521815019|FG000|Overall Study|Study Terminated By Sponsor|0|||
144716101|NCT02436135|521815020|FG001|Overall Study|Study Terminated By Sponsor|1|||
144716102|NCT00475852|521815021|FG000|Overall Study|Death|444|||
144716103|NCT00475852|521815022|FG001|Overall Study|Death|456|||
144716104|NCT00475852|521815021|FG000|Overall Study|Withdrawal by Subject|19|||
144716105|NCT00475852|521815022|FG001|Overall Study|Withdrawal by Subject|24|||
144716106|NCT00475852|521815021|FG000|Overall Study|Lost to Follow-up|54|||
144716107|NCT00475852|521815022|FG001|Overall Study|Lost to Follow-up|68|||
144716108|NCT02063698|521815023|FG000|Overall Study|did not complete booklet for days 2-8|1|||
144716109|NCT02063698|521815024|FG001|Overall Study|did not complete booklet for days 2-8|2|||
144716110|NCT00297479|521815025|FG000|Overall Study|Lost to Follow-up|37|||
144716111|NCT00297479|521815026|FG001|Overall Study|Lost to Follow-up|54|||
144716112|NCT00297479|521815027|FG002|Overall Study|Lost to Follow-up|51|||
144716113|NCT01664494|521815028|FG000|Overall Study|Withdrawal by Subject|27|||
144716114|NCT01664494|521815028|FG000|Overall Study|Death|18|||
144716115|NCT01664494|521815028|FG000|Overall Study|Other|49|||
144716116|NCT01664494|521815028|FG000|Overall Study|Lost to Follow-up|99|||
144716117|NCT01427803|521815029|FG000|Overall Study|Lost to Follow-up|32|||
144716118|NCT01427803|521815030|FG001|Overall Study|Lost to Follow-up|26|||
144716119|NCT01427803|521815029|FG000|Overall Study|Withdrawal by Subject|20|||
144716120|NCT01427803|521815030|FG001|Overall Study|Withdrawal by Subject|0|||
144716121|NCT01427803|521815029|FG000|Overall Study|Unable to complete full treatment period|6|||
144716122|NCT01427803|521815030|FG001|Overall Study|Unable to complete full treatment period|0|||
144716123|NCT01427803|521815029|FG000|Overall Study|Protocol Violation|1|||
144716124|NCT01427803|521815030|FG001|Overall Study|Protocol Violation|0|||
144716125|NCT01427803|521815029|FG000|Overall Study|Physician Decision|3|||
144716126|NCT01427803|521815030|FG001|Overall Study|Physician Decision|0|||
144716127|NCT01427803|521815029|FG000|Overall Study|did not take product|1|||
144716128|NCT01427803|521815030|FG001|Overall Study|did not take product|0|||
144716129|NCT03412019|521815033|FG000|Overall Study|Withdrawal by Subject|1|||
144716130|NCT03412019|521815034|FG001|Overall Study|Withdrawal by Subject|1|||
144716131|NCT01612156|521815038|FG000|Overall Study|Protocol Violation|2|||
144716132|NCT01612156|521815039|FG001|Overall Study|Protocol Violation|0|||
144716133|NCT01023269|521815040|FG000|Overall Study|early termination of the study|2|||
144716134|NCT01023269|521815041|FG001|Overall Study|early termination of the study|0|||
144716135|NCT01953783|521815042|FG000|Overall Study|Progressive disease|2|||
144716136|NCT02974114|521815052|FG000|Overall Study|Other (Not specified)|0|||
144716137|NCT02974114|521815053|FG001|Overall Study|Other (Not specified)|1|||
144716138|NCT02974114|521815054|FG002|Overall Study|Other (Not specified)|2|||
144716139|NCT00545233|521815055|FG000|Overall Study|Adverse Event|10|||
144716140|NCT00545233|521815056|FG001|Overall Study|Adverse Event|5|||
144716141|NCT00545233|521815055|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
144716142|NCT00545233|521815056|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
144716143|NCT00545233|521815055|FG000|Overall Study|Protocol Violation|2|||
144716144|NCT00545233|521815056|FG001|Overall Study|Protocol Violation|0|||
144716145|NCT00545233|521815055|FG000|Overall Study|Refused Treatment|9|||
144716146|NCT00545233|521815056|FG001|Overall Study|Refused Treatment|7|||
144716147|NCT00545233|521815055|FG000|Overall Study|Failure to Return|4|||
144716148|NCT00545233|521815056|FG001|Overall Study|Failure to Return|6|||
144716149|NCT00545233|521815055|FG000|Overall Study|Insufficient response|14|||
144716150|NCT00545233|521815056|FG001|Overall Study|Insufficient response|15|||
144716151|NCT00545233|521815055|FG000|Overall Study|Physician Decision|2|||
144716152|NCT00545233|521815056|FG001|Overall Study|Physician Decision|1|||
144716153|NCT00479401|521815060|FG000|Overall Study|Adverse Event|24|||
144716154|NCT00479401|521815061|FG001|Overall Study|Adverse Event|20|||
144716155|NCT00479401|521815062|FG002|Overall Study|Adverse Event|4|||
144716156|NCT00479401|521815060|FG000|Overall Study|Lack of Efficacy|2|||
144716157|NCT00479401|521815061|FG001|Overall Study|Lack of Efficacy|2|||
144716158|NCT00479401|521815062|FG002|Overall Study|Lack of Efficacy|4|||
144716159|NCT00479401|521815060|FG000|Overall Study|Protocol Violation|2|||
144716160|NCT00479401|521815061|FG001|Overall Study|Protocol Violation|1|||
144716161|NCT00479401|521815062|FG002|Overall Study|Protocol Violation|1|||
144716162|NCT00479401|521815060|FG000|Overall Study|Lost to Follow-up|1|||
144716163|NCT00479401|521815061|FG001|Overall Study|Lost to Follow-up|1|||
144491507|NCT02065245|520995154|FG003|Infusion 3|Lost to Follow-up|0|||
144716164|NCT00479401|521815062|FG002|Overall Study|Lost to Follow-up|1|||
144716165|NCT00479401|521815060|FG000|Overall Study|Withdrawal by Subject|16|||
144716166|NCT00479401|521815061|FG001|Overall Study|Withdrawal by Subject|10|||
144716167|NCT00479401|521815062|FG002|Overall Study|Withdrawal by Subject|2|||
144716168|NCT00479401|521815060|FG000|Overall Study|Exclusion criteria, relocation|4|||
144716169|NCT00479401|521815061|FG001|Overall Study|Exclusion criteria, relocation|3|||
144716170|NCT00479401|521815062|FG002|Overall Study|Exclusion criteria, relocation|0|||
144716171|NCT02868281|521815065|FG000|Overall Study|Adverse Event|2|||
144716172|NCT02868281|521815066|FG001|Overall Study|Adverse Event|2|||
144716173|NCT02868281|521815065|FG000|Overall Study|Protocol Violation|13|||
144716174|NCT02868281|521815066|FG001|Overall Study|Protocol Violation|10|||
144716175|NCT02868281|521815065|FG000|Overall Study|Lost to Follow-up|3|||
144716176|NCT02868281|521815066|FG001|Overall Study|Lost to Follow-up|6|||
144716177|NCT02868281|521815065|FG000|Overall Study|Withdrawal by Subject|11|||
144716178|NCT02868281|521815066|FG001|Overall Study|Withdrawal by Subject|15|||
144716179|NCT02868281|521815065|FG000|Overall Study|Physician Decision|2|||
144716180|NCT02868281|521815066|FG001|Overall Study|Physician Decision|0|||
144716181|NCT02868281|521815065|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
144716182|NCT02868281|521815066|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
144716183|NCT02868281|521815065|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
144716184|NCT02868281|521815066|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
144716185|NCT02868281|521815065|FG000|Overall Study|Long journey/moving away|1|||
144716186|NCT02868281|521815066|FG001|Overall Study|Long journey/moving away|1|||
144716187|NCT01722266|521815067|FG000|Overall Study|Withdrawal by Subject|1|||
144716188|NCT01722266|521815068|FG001|Overall Study|Withdrawal by Subject|2|||
144716189|NCT01722266|521815069|FG002|Overall Study|Withdrawal by Subject|0|||
144716190|NCT01722266|521815070|FG003|Overall Study|Withdrawal by Subject|0|||
144716191|NCT01722266|521815067|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
144716192|NCT01722266|521815068|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
144716193|NCT01722266|521815069|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
144716194|NCT01722266|521815070|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
144716195|NCT01722266|521815067|FG000|Overall Study|Dropped out due to Nausea|0|||
144716196|NCT01722266|521815068|FG001|Overall Study|Dropped out due to Nausea|0|||
144716197|NCT01722266|521815069|FG002|Overall Study|Dropped out due to Nausea|2|||
144716198|NCT01722266|521815070|FG003|Overall Study|Dropped out due to Nausea|0|||
144716199|NCT01504867|521815074|FG000|Overall Study|Inclusion criteria not met|2|||
144716200|NCT01504867|521815075|FG001|Overall Study|Inclusion criteria not met|2|||
144716201|NCT01504867|521815074|FG000|Overall Study|Consent revoked|5|||
144716202|NCT01504867|521815075|FG001|Overall Study|Consent revoked|1|||
144716203|NCT02533999|521815079|FG000|Overall Study|Lost to Follow-up|3|||
144716204|NCT02533999|521815080|FG001|Overall Study|Lost to Follow-up|5|||
144716205|NCT02533999|521815079|FG000|Overall Study|Protocol Violation|3|||
144716206|NCT02533999|521815080|FG001|Overall Study|Protocol Violation|0|||
144716207|NCT02533999|521815079|FG000|Overall Study|Adverse Event|0|||
144716208|NCT02533999|521815080|FG001|Overall Study|Adverse Event|1|||
144716209|NCT02533999|521815079|FG000|Overall Study|Randomized but intervention not received|0|||
144716210|NCT02533999|521815080|FG001|Overall Study|Randomized but intervention not received|1|||
144716211|NCT03210259|521815081|FG000|12-Week Run-in Period|Adverse Event|1|||
144716212|NCT03210259|521815082|FG001|12-Week Run-in Period|Adverse Event|0|||
144716213|NCT03210259|521815083|FG002|12-Week Run-in Period|Adverse Event|0|||
144716214|NCT03210259|521815081|FG000|12-Week Run-in Period|Death|1|||
144716215|NCT03210259|521815082|FG001|12-Week Run-in Period|Death|0|||
144716216|NCT03210259|521815083|FG002|12-Week Run-in Period|Death|0|||
144716217|NCT03210259|521815081|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
144716218|NCT03210259|521815082|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
144716219|NCT03210259|521815083|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
144716220|NCT03210259|521815081|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
144716221|NCT03210259|521815082|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
144716222|NCT03210259|521815083|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
144716223|NCT03210259|521815081|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
144716224|NCT03210259|521815082|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
144716225|NCT03210259|521815083|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
144491508|NCT02065245|520995155|FG004|Infusion 3|Lost to Follow-up|0|||
144716226|NCT03210259|521815081|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
144716227|NCT03210259|521815082|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
144716228|NCT03210259|521815083|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
144716229|NCT03210259|521815081|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
144716230|NCT03210259|521815082|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
144716231|NCT03210259|521815083|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
144716232|NCT03210259|521815081|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
144716233|NCT03210259|521815082|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
144716234|NCT03210259|521815083|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
144716235|NCT03210259|521815081|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
144491509|NCT02065245|520995156|FG005|Infusion 3|Lost to Follow-up|0|||
144491510|NCT02065245|520995157|FG006|Infusion 3|Lost to Follow-up|0|||
144491511|NCT01518257|520995158|FG000|Overall Study|Lost to Follow-up|1|||
144491512|NCT01518257|520995159|FG001|Overall Study|Lost to Follow-up|0|||
144491513|NCT01518257|520995158|FG000|Overall Study|Other Miscellaneous Reason|1|||
144491514|NCT01518257|520995159|FG001|Overall Study|Other Miscellaneous Reason|0|||
144491515|NCT00924664|520995160|FG000|Overall Study|Adverse Event|23|||
144491516|NCT00924664|520995161|FG001|Overall Study|Adverse Event|39|||
144491517|NCT00924664|520995160|FG000|Overall Study|Lack of Efficacy|10|||
144491518|NCT00924664|520995161|FG001|Overall Study|Lack of Efficacy|15|||
144491519|NCT00924664|520995160|FG000|Overall Study|Lost to Follow-up|10|||
144491520|NCT00924664|520995161|FG001|Overall Study|Lost to Follow-up|12|||
144716236|NCT03210259|521815082|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
144716237|NCT03210259|521815083|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
144716238|NCT03210259|521815081|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
144716239|NCT03210259|521815082|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
144716240|NCT03210259|521815083|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
144716241|NCT03210259|521815081|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
144716242|NCT03210259|521815082|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
144716243|NCT03210259|521815083|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
144716244|NCT01154153|521815084|FG000|Overall Study|Poor compliance to protocol|2|||
144716245|NCT01154153|521815085|FG001|Overall Study|Poor compliance to protocol|0|||
144716246|NCT01154153|521815084|FG000|Overall Study|Unable to use labs|2|||
144716247|NCT01154153|521815085|FG001|Overall Study|Unable to use labs|3|||
144716248|NCT01154153|521815084|FG000|Overall Study|Withdrew consent|1|||
144716249|NCT01154153|521815085|FG001|Overall Study|Withdrew consent|0|||
144716250|NCT02473510|521815086|FG000|Overall Study|Lost to Follow-up|1|||
144716251|NCT02473510|521815087|FG001|Overall Study|Lost to Follow-up|2|||
144716252|NCT02191579|521815088|FG000|Treatment 1|Multiple Reasons Specified|27|||
144716253|NCT02191579|521815089|FG001|Treatment 1|Multiple Reasons Specified|58|||
144716254|NCT02191579|521815088|FG000|Treatment 2|Multiple Reasons Specified|0|||
144716255|NCT02191579|521815089|FG001|Treatment 2|Multiple Reasons Specified|25|||
144716256|NCT02006147|521815090|FG000|Overall Study|Protocol Violation|1|||
144716257|NCT02006147|521815091|FG001|Overall Study|Protocol Violation|1|||
144716258|NCT02006147|521815092|FG002|Overall Study|Protocol Violation|0|||
144716259|NCT02006147|521815093|FG003|Overall Study|Protocol Violation|0|||
144716260|NCT02006147|521815090|FG000|Overall Study|Withdrawal by Subject|0|||
144716261|NCT02006147|521815091|FG001|Overall Study|Withdrawal by Subject|1|||
144716262|NCT02006147|521815092|FG002|Overall Study|Withdrawal by Subject|0|||
144716263|NCT02006147|521815093|FG003|Overall Study|Withdrawal by Subject|0|||
144716264|NCT02006147|521815090|FG000|Overall Study|Withdrawal by Sponsor|1|||
144716265|NCT02006147|521815091|FG001|Overall Study|Withdrawal by Sponsor|0|||
144716266|NCT02006147|521815092|FG002|Overall Study|Withdrawal by Sponsor|0|||
144716267|NCT02006147|521815093|FG003|Overall Study|Withdrawal by Sponsor|0|||
144716268|NCT00408876|521815094|FG000|Overall Study|Adverse Event|9|||
144716269|NCT00408876|521815095|FG001|Overall Study|Adverse Event|17|||
144716270|NCT00408876|521815096|FG002|Overall Study|Adverse Event|27|||
144716271|NCT00408876|521815097|FG003|Overall Study|Adverse Event|10|||
144716272|NCT00408876|521815094|FG000|Overall Study|Withdrawal by Subject|3|||
144716273|NCT00408876|521815095|FG001|Overall Study|Withdrawal by Subject|6|||
144716274|NCT00408876|521815096|FG002|Overall Study|Withdrawal by Subject|6|||
144716275|NCT00408876|521815097|FG003|Overall Study|Withdrawal by Subject|14|||
144716276|NCT00408876|521815094|FG000|Overall Study|Lack of Efficacy|2|||
144716277|NCT00408876|521815095|FG001|Overall Study|Lack of Efficacy|4|||
144716278|NCT00408876|521815096|FG002|Overall Study|Lack of Efficacy|5|||
144716279|NCT00408876|521815097|FG003|Overall Study|Lack of Efficacy|6|||
144716280|NCT00408876|521815094|FG000|Overall Study|Lost to Follow-up|1|||
144716281|NCT00408876|521815095|FG001|Overall Study|Lost to Follow-up|6|||
144716282|NCT00408876|521815096|FG002|Overall Study|Lost to Follow-up|5|||
144716283|NCT00408876|521815097|FG003|Overall Study|Lost to Follow-up|2|||
144716284|NCT00408876|521815094|FG000|Overall Study|Protocol Violation|0|||
144716285|NCT00408876|521815095|FG001|Overall Study|Protocol Violation|3|||
144716286|NCT00408876|521815096|FG002|Overall Study|Protocol Violation|4|||
144716287|NCT00408876|521815097|FG003|Overall Study|Protocol Violation|3|||
144716288|NCT00408876|521815094|FG000|Overall Study|Physician Decision|1|||
144716289|NCT00408876|521815095|FG001|Overall Study|Physician Decision|0|||
144716290|NCT00408876|521815096|FG002|Overall Study|Physician Decision|3|||
144716291|NCT00408876|521815097|FG003|Overall Study|Physician Decision|0|||
144716292|NCT03404206|521815098|FG000|Overall Study|Withdrawal by Subject|1|||
144716293|NCT03404206|521815099|FG001|Overall Study|Withdrawal by Subject|1|||
144716294|NCT03404206|521815100|FG002|Overall Study|Withdrawal by Subject|0|||
144716295|NCT03404206|521815098|FG000|Overall Study|Lost to Follow-up|3|||
144716296|NCT03404206|521815099|FG001|Overall Study|Lost to Follow-up|1|||
144716297|NCT03404206|521815100|FG002|Overall Study|Lost to Follow-up|0|||
144716298|NCT05478603|521815101|FG000|Overall Study|Withdrawal by Subject|0|||
144716299|NCT05478603|521815102|FG001|Overall Study|Withdrawal by Subject|1|||
144716300|NCT05478603|521815103|FG002|Overall Study|Withdrawal by Subject|0|||
144716301|NCT05478603|521815104|FG003|Overall Study|Withdrawal by Subject|0|||
144716302|NCT03182686|521815107|FG000|Overall Study|Lost to Follow-up|2|||
144716303|NCT03182686|521815108|FG001|Overall Study|Lost to Follow-up|0|||
144716304|NCT03182686|521815107|FG000|Overall Study|Adverse Event|2|||
144716305|NCT03182686|521815108|FG001|Overall Study|Adverse Event|0|||
144716306|NCT03182686|521815107|FG000|Overall Study|Withdrawal by Subject|3|||
144716307|NCT03182686|521815108|FG001|Overall Study|Withdrawal by Subject|0|||
144716308|NCT01154127|521815109|FG000|Period 1 (21 Days)|Adverse Event|3|||
144716309|NCT01154127|521815110|FG001|Period 1 (21 Days)|Adverse Event|4|||
144716310|NCT01154127|521815109|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
144716311|NCT01154127|521815110|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
144716312|NCT01154127|521815109|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
144491521|NCT00924664|520995160|FG000|Overall Study|Withdrawal by Subject|47|||
144491522|NCT00924664|520995161|FG001|Overall Study|Withdrawal by Subject|71|||
144491523|NCT00924664|520995160|FG000|Overall Study|Protocol Violation|2|||
144491524|NCT00924664|520995161|FG001|Overall Study|Protocol Violation|5|||
144491525|NCT00924664|520995160|FG000|Overall Study|Pregnancy|1|||
144491526|NCT00924664|520995161|FG001|Overall Study|Pregnancy|1|||
144491527|NCT00924664|520995160|FG000|Overall Study|Death|0|||
144491528|NCT00924664|520995161|FG001|Overall Study|Death|2|||
144491529|NCT00924664|520995160|FG000|Overall Study|Study terminated by sponsor|199|||
144491530|NCT00924664|520995161|FG001|Overall Study|Study terminated by sponsor|330|||
144491531|NCT00924664|520995160|FG000|Overall Study|Other|29|||
144491532|NCT00924664|520995161|FG001|Overall Study|Other|52|||
144716313|NCT01154127|521815110|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
144716314|NCT01154127|521815109|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
144716315|NCT01154127|521815110|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
144716316|NCT01154127|521815109|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
144716317|NCT01154127|521815110|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
144716318|NCT01169844|521815111|FG000|Overall Study|Adverse Event|0|||
144716319|NCT01169844|521815112|FG001|Overall Study|Adverse Event|1|||
144716320|NCT01169844|521815111|FG000|Overall Study|Patient withdrew consent|4|||
144716321|NCT01169844|521815112|FG001|Overall Study|Patient withdrew consent|0|||
144716322|NCT01169844|521815111|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144716323|NCT01169844|521815112|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144716324|NCT01337050|521815116|FG000|Overall Study|Death|0|||
144716325|NCT01337050|521815117|FG001|Overall Study|Death|0|||
144716326|NCT01337050|521815118|FG002|Overall Study|Death|4|||
144716327|NCT01337050|521815116|FG000|Overall Study|Other|4|||
144716328|NCT01337050|521815117|FG001|Overall Study|Other|6|||
144716329|NCT01337050|521815118|FG002|Overall Study|Other|8|||
144716330|NCT01337050|521815116|FG000|Overall Study|Participants refused further follow-up|0|||
144716331|NCT01337050|521815117|FG001|Overall Study|Participants refused further follow-up|7|||
144716332|NCT01337050|521815118|FG002|Overall Study|Participants refused further follow-up|7|||
144716333|NCT00003102|521815119|FG000|Overall Study|Physician Decision|1|||
144716334|NCT00003102|521815120|FG001|Overall Study|Physician Decision|1|||
144716335|NCT00003102|521815121|FG002|Overall Study|Physician Decision|0|||
144716336|NCT00003102|521815119|FG000|Overall Study|Progressive Disease|0|||
144716337|NCT00003102|521815120|FG001|Overall Study|Progressive Disease|1|||
144716338|NCT00003102|521815121|FG002|Overall Study|Progressive Disease|0|||
144716339|NCT00003102|521815119|FG000|Overall Study|Adverse Event|0|||
144716340|NCT00003102|521815120|FG001|Overall Study|Adverse Event|1|||
144716341|NCT00003102|521815121|FG002|Overall Study|Adverse Event|1|||
144716342|NCT00003102|521815119|FG000|Overall Study|Death|0|||
144716343|NCT00003102|521815120|FG001|Overall Study|Death|0|||
144716344|NCT00003102|521815121|FG002|Overall Study|Death|1|||
144716345|NCT00096486|521815122|FG000|Overall Study|Withdrawal by Subject|0|||
144716346|NCT00096486|521815123|FG001|Overall Study|Withdrawal by Subject|0|||
144716347|NCT00096486|521815124|FG002|Overall Study|Withdrawal by Subject|1|||
144716348|NCT00096486|521815125|FG003|Overall Study|Withdrawal by Subject|1|||
144716349|NCT00096486|521815122|FG000|Overall Study|Not Treated|0|||
144716350|NCT00096486|521815123|FG001|Overall Study|Not Treated|0|||
144716351|NCT00096486|521815124|FG002|Overall Study|Not Treated|1|||
144716352|NCT00096486|521815125|FG003|Overall Study|Not Treated|1|||
144716353|NCT01512979|521815126|FG000|Overall Study|Adverse Event|2|||
144716354|NCT01512979|521815127|FG001|Overall Study|Adverse Event|2|||
144716355|NCT01512979|521815126|FG000|Overall Study|Protocol Violation|1|||
144716356|NCT01512979|521815127|FG001|Overall Study|Protocol Violation|4|||
144716357|NCT01512979|521815126|FG000|Overall Study|Lost to Follow-up|2|||
144716358|NCT01512979|521815127|FG001|Overall Study|Lost to Follow-up|5|||
144716359|NCT01512979|521815126|FG000|Overall Study|Withdrawal by Subject|1|||
144491533|NCT00924664|520995160|FG000|Overall Study|Randomized but not Treated|1|||
144491534|NCT00924664|520995161|FG001|Overall Study|Randomized but not Treated|0|||
144716360|NCT01512979|521815127|FG001|Overall Study|Withdrawal by Subject|2|||
144716361|NCT01512979|521815126|FG000|Overall Study|Reason other than stated above|13|||
144491535|NCT01460381|520995163|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
144491536|NCT01460381|520995164|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
144716362|NCT01512979|521815127|FG001|Overall Study|Reason other than stated above|9|||
144716363|NCT04049552|521815128|FG000|Overall Study|Lost to Follow-up|1|||
144716364|NCT02196506|521815129|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
144716365|NCT02196506|521815130|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
144716366|NCT02196506|521815131|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
144716367|NCT02196506|521815132|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
144716368|NCT02196506|521815129|FG000|Phase A|Withdrawal by Subject|34|||
144716369|NCT02196506|521815130|FG001|Phase A|Withdrawal by Subject|0|||
144716370|NCT02196506|521815131|FG002|Phase A|Withdrawal by Subject|0|||
144716371|NCT02196506|521815132|FG003|Phase A|Withdrawal by Subject|0|||
144716372|NCT02196506|521815129|FG000|Phase A|Adverse Event|22|||
144716373|NCT02196506|521815130|FG001|Phase A|Adverse Event|0|||
144491537|NCT01097655|520995165|FG000|Overall Study|Withdrawal by Subject|1|||
144491538|NCT01097655|520995165|FG000|Overall Study|Subject Documented Twice|1|||
144491539|NCT01097655|520995165|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
144491540|NCT02652130|520995166|FG000|Overall Study|Death|1|||
144491541|NCT01021332|520995167|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
144716374|NCT02196506|521815131|FG002|Phase A|Adverse Event|0|||
144716375|NCT02196506|521815132|FG003|Phase A|Adverse Event|0|||
144716376|NCT02196506|521815129|FG000|Phase A|Lost to Follow-up|9|||
144716377|NCT02196506|521815130|FG001|Phase A|Lost to Follow-up|0|||
144716378|NCT02196506|521815131|FG002|Phase A|Lost to Follow-up|0|||
144716379|NCT02196506|521815132|FG003|Phase A|Lost to Follow-up|0|||
144716380|NCT02196506|521815129|FG000|Phase A|Protocol deviation|12|||
144716381|NCT02196506|521815130|FG001|Phase A|Protocol deviation|0|||
144716382|NCT02196506|521815131|FG002|Phase A|Protocol deviation|0|||
144716383|NCT02196506|521815132|FG003|Phase A|Protocol deviation|0|||
144716384|NCT02196506|521815129|FG000|Phase A|Participant withdrawn by investigator|10|||
144716385|NCT02196506|521815130|FG001|Phase A|Participant withdrawn by investigator|0|||
144716386|NCT02196506|521815131|FG002|Phase A|Participant withdrawn by investigator|0|||
144716387|NCT02196506|521815132|FG003|Phase A|Participant withdrawn by investigator|0|||
144716388|NCT02196506|521815129|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
144716389|NCT02196506|521815130|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
144716390|NCT02196506|521815131|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
144716391|NCT02196506|521815132|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
144716392|NCT02196506|521815129|FG000|Phase B|Lack of Efficacy|0|||
144716393|NCT02196506|521815130|FG001|Phase B|Lack of Efficacy|1|||
144716394|NCT02196506|521815131|FG002|Phase B|Lack of Efficacy|2|||
144716395|NCT02196506|521815132|FG003|Phase B|Lack of Efficacy|0|||
144716396|NCT02196506|521815129|FG000|Phase B|Withdrawal by Participant|0|||
144716397|NCT02196506|521815130|FG001|Phase B|Withdrawal by Participant|8|||
144716398|NCT02196506|521815131|FG002|Phase B|Withdrawal by Participant|1|||
144716399|NCT02196506|521815132|FG003|Phase B|Withdrawal by Participant|0|||
144716400|NCT02196506|521815129|FG000|Phase B|Adverse Event|0|||
144491542|NCT01021332|520995167|FG000|Overall Study|Adverse Event|43|||
144491543|NCT01021332|520995167|FG000|Overall Study|Lack of Efficacy|19|||
144716401|NCT02196506|521815130|FG001|Phase B|Adverse Event|4|||
144716402|NCT02196506|521815131|FG002|Phase B|Adverse Event|1|||
144716403|NCT02196506|521815132|FG003|Phase B|Adverse Event|0|||
144716404|NCT02196506|521815129|FG000|Phase B|Lost to Follow-up|0|||
144716405|NCT02196506|521815130|FG001|Phase B|Lost to Follow-up|2|||
144716406|NCT02196506|521815131|FG002|Phase B|Lost to Follow-up|1|||
144716407|NCT02196506|521815132|FG003|Phase B|Lost to Follow-up|0|||
144716408|NCT02196506|521815129|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
144716409|NCT02196506|521815130|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
144716410|NCT02196506|521815131|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
144716411|NCT02196506|521815132|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
144716412|NCT02196506|521815129|FG000|Phase A+|Withdrawal by Participant|0|||
144716413|NCT02196506|521815130|FG001|Phase A+|Withdrawal by Participant|0|||
144716414|NCT02196506|521815131|FG002|Phase A+|Withdrawal by Participant|0|||
144716415|NCT02196506|521815132|FG003|Phase A+|Withdrawal by Participant|5|||
144716416|NCT02196506|521815129|FG000|Phase A+|Adverse Event|0|||
144716417|NCT02196506|521815130|FG001|Phase A+|Adverse Event|0|||
144716418|NCT02196506|521815131|FG002|Phase A+|Adverse Event|0|||
144716419|NCT02196506|521815132|FG003|Phase A+|Adverse Event|1|||
144716420|NCT02196506|521815129|FG000|Phase A+|Lost to Follow-up|0|||
144716421|NCT02196506|521815130|FG001|Phase A+|Lost to Follow-up|0|||
144716422|NCT02196506|521815131|FG002|Phase A+|Lost to Follow-up|0|||
144716423|NCT02196506|521815132|FG003|Phase A+|Lost to Follow-up|6|||
144716424|NCT02196506|521815129|FG000|Phase A+|Participant withdrawn by investigator|0|||
144716425|NCT02196506|521815130|FG001|Phase A+|Participant withdrawn by investigator|0|||
144716426|NCT02196506|521815131|FG002|Phase A+|Participant withdrawn by investigator|0|||
144716427|NCT02196506|521815132|FG003|Phase A+|Participant withdrawn by investigator|1|||
144716428|NCT02257632|521817681|FG000|Overall Study|Withdrawal by Subject|0|||
144716429|NCT02257632|521817682|FG001|Overall Study|Withdrawal by Subject|1|||
144716430|NCT02257632|521817681|FG000|Overall Study|Adverse Event|1|||
144716431|NCT02257632|521817682|FG001|Overall Study|Adverse Event|2|||
144716432|NCT02468557|521817683|FG000|Overall Study|Adverse Event|1|||
144716433|NCT02468557|521817683|FG000|Overall Study|Death|1|||
144716434|NCT02468557|521817683|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
144716435|NCT02468557|521817683|FG000|Overall Study|All Enrolled but Never Dosed|4|||
144716436|NCT01393990|521817685|FG000|Overall Study|Adverse Event|0|||
144716437|NCT01393990|521817686|FG001|Overall Study|Adverse Event|0|||
144716438|NCT01393990|521817687|FG002|Overall Study|Adverse Event|0|||
144716439|NCT01393990|521817688|FG003|Overall Study|Adverse Event|0|||
144716440|NCT01393990|521817689|FG004|Overall Study|Adverse Event|0|||
144716441|NCT01393990|521817690|FG005|Overall Study|Adverse Event|0|||
144716442|NCT01393990|521817691|FG006|Overall Study|Adverse Event|0|||
144716443|NCT01393990|521817692|FG007|Overall Study|Adverse Event|0|||
144716444|NCT01393990|521817693|FG008|Overall Study|Adverse Event|0|||
144716445|NCT01393990|521817694|FG009|Overall Study|Adverse Event|0|||
144716446|NCT01393990|521817695|FG010|Overall Study|Adverse Event|0|||
144716447|NCT01393990|521817696|FG011|Overall Study|Adverse Event|0|||
144716448|NCT01393990|521817697|FG012|Overall Study|Adverse Event|0|||
144716449|NCT01393990|521817698|FG013|Overall Study|Adverse Event|0|||
144716450|NCT01393990|521817699|FG014|Overall Study|Adverse Event|1|||
144716451|NCT01393990|521817700|FG015|Overall Study|Adverse Event|1|||
144716452|NCT01393990|521817701|FG016|Overall Study|Adverse Event|0|||
144716453|NCT01393990|521817702|FG017|Overall Study|Adverse Event|0|||
144716454|NCT01393990|521817685|FG000|Overall Study|Progressive Disease|1|||
144716455|NCT01393990|521817686|FG001|Overall Study|Progressive Disease|0|||
144716456|NCT01393990|521817687|FG002|Overall Study|Progressive Disease|0|||
144716457|NCT01393990|521817688|FG003|Overall Study|Progressive Disease|1|||
144716458|NCT01393990|521817689|FG004|Overall Study|Progressive Disease|1|||
144716459|NCT01393990|521817690|FG005|Overall Study|Progressive Disease|1|||
144716460|NCT01393990|521817691|FG006|Overall Study|Progressive Disease|1|||
144716461|NCT01393990|521817692|FG007|Overall Study|Progressive Disease|1|||
144716462|NCT01393990|521817693|FG008|Overall Study|Progressive Disease|3|||
144716463|NCT01393990|521817694|FG009|Overall Study|Progressive Disease|1|||
144716464|NCT01393990|521817695|FG010|Overall Study|Progressive Disease|0|||
144716465|NCT01393990|521817696|FG011|Overall Study|Progressive Disease|0|||
144716466|NCT01393990|521817697|FG012|Overall Study|Progressive Disease|0|||
144716467|NCT01393990|521817698|FG013|Overall Study|Progressive Disease|1|||
144716468|NCT01393990|521817699|FG014|Overall Study|Progressive Disease|6|||
144716469|NCT01393990|521817700|FG015|Overall Study|Progressive Disease|1|||
144716470|NCT01393990|521817701|FG016|Overall Study|Progressive Disease|0|||
144716471|NCT01393990|521817702|FG017|Overall Study|Progressive Disease|0|||
144716472|NCT01393990|521817685|FG000|Overall Study|Death|0|||
144716473|NCT01393990|521817686|FG001|Overall Study|Death|0|||
144716474|NCT01393990|521817687|FG002|Overall Study|Death|0|||
144716475|NCT01393990|521817688|FG003|Overall Study|Death|0|||
144716476|NCT01393990|521817689|FG004|Overall Study|Death|1|||
144716477|NCT01393990|521817690|FG005|Overall Study|Death|0|||
144716478|NCT01393990|521817691|FG006|Overall Study|Death|0|||
144716479|NCT01393990|521817692|FG007|Overall Study|Death|0|||
144716480|NCT01393990|521817693|FG008|Overall Study|Death|0|||
144716481|NCT01393990|521817694|FG009|Overall Study|Death|0|||
144716482|NCT01393990|521817695|FG010|Overall Study|Death|0|||
144716483|NCT01393990|521817696|FG011|Overall Study|Death|0|||
144716484|NCT01393990|521817697|FG012|Overall Study|Death|0|||
144716485|NCT01393990|521817698|FG013|Overall Study|Death|1|||
144716486|NCT01393990|521817699|FG014|Overall Study|Death|1|||
144716487|NCT01393990|521817700|FG015|Overall Study|Death|0|||
144716488|NCT01393990|521817701|FG016|Overall Study|Death|0|||
144716489|NCT01393990|521817702|FG017|Overall Study|Death|0|||
144716490|NCT01393990|521817685|FG000|Overall Study|Withdrawal by Subject|0|||
144716491|NCT01393990|521817686|FG001|Overall Study|Withdrawal by Subject|0|||
144716492|NCT01393990|521817687|FG002|Overall Study|Withdrawal by Subject|0|||
144716493|NCT01393990|521817688|FG003|Overall Study|Withdrawal by Subject|0|||
144716494|NCT01393990|521817689|FG004|Overall Study|Withdrawal by Subject|0|||
144716495|NCT01393990|521817690|FG005|Overall Study|Withdrawal by Subject|0|||
144716496|NCT01393990|521817691|FG006|Overall Study|Withdrawal by Subject|0|||
144716497|NCT01393990|521817692|FG007|Overall Study|Withdrawal by Subject|0|||
144716498|NCT01393990|521817693|FG008|Overall Study|Withdrawal by Subject|0|||
144716499|NCT01393990|521817694|FG009|Overall Study|Withdrawal by Subject|0|||
144369918|NCT04313244|520562751|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
144369919|NCT00891904|520562752|FG000|Overall Study|Death|1|||
144369920|NCT00891904|520562752|FG000|Overall Study|Adverse Event|1|||
144369921|NCT00927953|520562753|FG000|Overall Study|Death|2|||
144369922|NCT00927953|520562754|FG001|Overall Study|Death|1|||
144369923|NCT02976038|520562755|FG000|Overall Study|Physician Decision|22|||
144369924|NCT02976038|520562755|FG000|Overall Study|Withdrawal by Subject|3|||
144369925|NCT02976038|520562755|FG000|Overall Study|Lost to Follow-up|2|||
144491544|NCT01021332|520995167|FG000|Overall Study|Withdrawal of Consent|23|||
144369926|NCT02976038|520562755|FG000|Overall Study|Adverse Event|1|||
144369927|NCT01046396|520562756|FG000|Overall Study|Withdrawal by Subject|5|||
144491545|NCT01021332|520995167|FG000|Overall Study|Lost to Follow-up|4|||
144491546|NCT01021332|520995167|FG000|Overall Study|Protocol Violation|9|||
144491547|NCT01021332|520995167|FG000|Overall Study|Miscellaneous|3|||
144491548|NCT03487666|520995168|FG000|Overall Study|Disease progression|4|||
144491549|NCT03487666|520995169|FG001|Overall Study|Disease progression|2|||
144491550|NCT03487666|520995170|FG002|Overall Study|Disease progression|0|||
144491551|NCT03487666|520995168|FG000|Overall Study|Adverse Event|0|||
144491552|NCT03487666|520995169|FG001|Overall Study|Adverse Event|0|||
144491553|NCT03487666|520995170|FG002|Overall Study|Adverse Event|1|||
144491554|NCT03201757|520995171|FG000|Overall Study|Withdrawal by Subject|133|||
144491555|NCT03201757|520995171|FG000|Overall Study|Adverse Event|44|||
144491556|NCT03201757|520995171|FG000|Overall Study|Lost to Follow-up|37|||
144491557|NCT03201757|520995171|FG000|Overall Study|Pregnancy|2|||
144491558|NCT03201757|520995171|FG000|Overall Study|Lack of Efficacy|1|||
144491559|NCT03201757|520995171|FG000|Overall Study|Protocol Violation|20|||
144491560|NCT03201757|520995171|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
144491561|NCT03201757|520995171|FG000|Overall Study|Not Yet Determined|5|||
144491562|NCT03201757|520995171|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
144491563|NCT03201757|520995171|FG000|Overall Study|Other|20|||
144491564|NCT00765362|520995173|FG000|Overall Study|Death|9|||
144491565|NCT00765362|520995173|FG000|Overall Study|Adverse Event|2|||
144491566|NCT00765362|520995173|FG000|Overall Study|Protocol Violation|18|||
144491567|NCT00765362|520995173|FG000|Overall Study|Withdrawal by Subject|13|||
144491568|NCT00765362|520995173|FG000|Overall Study|Lost to Follow-up|95|||
144491569|NCT00557505|520995175|FG000|Overall Study|Death|0|||
144491570|NCT00557505|520995176|FG001|Overall Study|Death|0|||
144491571|NCT00557505|520995177|FG002|Overall Study|Death|0|||
144491572|NCT00557505|520995178|FG003|Overall Study|Death|0|||
144491573|NCT00557505|520995179|FG004|Overall Study|Death|0|||
144491574|NCT00557505|520995180|FG005|Overall Study|Death|0|||
144491575|NCT00557505|520995181|FG006|Overall Study|Death|0|||
144491576|NCT00557505|520995182|FG007|Overall Study|Death|0|||
144491577|NCT00557505|520995183|FG008|Overall Study|Death|1|||
144491578|NCT00557505|520995175|FG000|Overall Study|Adverse Event|0|||
144491579|NCT00557505|520995176|FG001|Overall Study|Adverse Event|0|||
144491580|NCT00557505|520995177|FG002|Overall Study|Adverse Event|1|||
144491581|NCT00557505|520995178|FG003|Overall Study|Adverse Event|0|||
144491582|NCT00557505|520995179|FG004|Overall Study|Adverse Event|0|||
144491583|NCT00557505|520995180|FG005|Overall Study|Adverse Event|0|||
144491584|NCT00557505|520995181|FG006|Overall Study|Adverse Event|1|||
144491585|NCT00557505|520995182|FG007|Overall Study|Adverse Event|0|||
144491586|NCT00557505|520995183|FG008|Overall Study|Adverse Event|0|||
144491587|NCT00557505|520995175|FG000|Overall Study|Global deterioration of health|1|||
144491588|NCT00557505|520995176|FG001|Overall Study|Global deterioration of health|0|||
144491589|NCT00557505|520995177|FG002|Overall Study|Global deterioration of health|0|||
144491590|NCT00557505|520995178|FG003|Overall Study|Global deterioration of health|0|||
144491591|NCT00557505|520995179|FG004|Overall Study|Global deterioration of health|0|||
144491592|NCT00557505|520995180|FG005|Overall Study|Global deterioration of health|0|||
144491593|NCT00557505|520995181|FG006|Overall Study|Global deterioration of health|0|||
144491594|NCT00557505|520995182|FG007|Overall Study|Global deterioration of health|0|||
144491595|NCT00557505|520995183|FG008|Overall Study|Global deterioration of health|0|||
144491596|NCT00557505|520995175|FG000|Overall Study|Objective progression or relapse|2|||
144491597|NCT00557505|520995176|FG001|Overall Study|Objective progression or relapse|3|||
144491598|NCT00557505|520995177|FG002|Overall Study|Objective progression or relapse|3|||
144491599|NCT00557505|520995178|FG003|Overall Study|Objective progression or relapse|2|||
144491600|NCT00557505|520995179|FG004|Overall Study|Objective progression or relapse|2|||
144491601|NCT00557505|520995180|FG005|Overall Study|Objective progression or relapse|3|||
144491602|NCT00557505|520995181|FG006|Overall Study|Objective progression or relapse|2|||
144491603|NCT00557505|520995182|FG007|Overall Study|Objective progression or relapse|5|||
144491604|NCT00557505|520995183|FG008|Overall Study|Objective progression or relapse|15|||
144491605|NCT00557505|520995175|FG000|Overall Study|Withdrawal by Subject|0|||
144491606|NCT00557505|520995176|FG001|Overall Study|Withdrawal by Subject|0|||
144491607|NCT00557505|520995177|FG002|Overall Study|Withdrawal by Subject|0|||
144491608|NCT00557505|520995178|FG003|Overall Study|Withdrawal by Subject|1|||
144491609|NCT00557505|520995179|FG004|Overall Study|Withdrawal by Subject|0|||
144491610|NCT00557505|520995180|FG005|Overall Study|Withdrawal by Subject|0|||
144491611|NCT00557505|520995181|FG006|Overall Study|Withdrawal by Subject|0|||
144491612|NCT00557505|520995182|FG007|Overall Study|Withdrawal by Subject|0|||
144491613|NCT00557505|520995183|FG008|Overall Study|Withdrawal by Subject|1|||
144491614|NCT00031447|520995184|FG000|Overall Study|Lost to Follow-up|0|||
144491615|NCT00031447|520995185|FG001|Overall Study|Lost to Follow-up|1|||
144491616|NCT00031447|520995184|FG000|Overall Study|Non-compliant|1|||
144491617|NCT00031447|520995185|FG001|Overall Study|Non-compliant|1|||
144491618|NCT00031447|520995184|FG000|Overall Study|Re-activation of Disease|2|||
144491619|NCT00031447|520995185|FG001|Overall Study|Re-activation of Disease|1|||
144491620|NCT00031447|520995184|FG000|Overall Study|Disruption of blinded study drug supply|7|||
144491621|NCT00031447|520995185|FG001|Overall Study|Disruption of blinded study drug supply|4|||
144491622|NCT01636362|520995186|FG000|Overall Study|Physician Decision|6|||
144491623|NCT01636362|520995186|FG000|Overall Study|Subject healed, not returning|1|||
144491624|NCT01636362|520995186|FG000|Overall Study|Withdrawal by Subject|1|||
144491625|NCT00519779|520995187|FG000|Overall Study|Withdrawal by Subject|0|||
144491626|NCT00519779|520995188|FG001|Overall Study|Withdrawal by Subject|1|||
144491627|NCT01323660|520995196|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
144716500|NCT01393990|521817695|FG010|Overall Study|Withdrawal by Subject|0|||
144716501|NCT01393990|521817696|FG011|Overall Study|Withdrawal by Subject|0|||
144491628|NCT01323660|520995197|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
144491629|NCT01323660|520995198|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
144491630|NCT01323660|520995199|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
144491631|NCT01323660|520995200|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
144491632|NCT01323660|520995201|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
144491633|NCT01323660|520995196|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
144491634|NCT01323660|520995197|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
144491635|NCT01323660|520995198|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
144491636|NCT01323660|520995199|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
144716502|NCT01393990|521817697|FG012|Overall Study|Withdrawal by Subject|0|||
144716503|NCT01393990|521817698|FG013|Overall Study|Withdrawal by Subject|0|||
144716504|NCT01393990|521817699|FG014|Overall Study|Withdrawal by Subject|1|||
144716505|NCT01393990|521817700|FG015|Overall Study|Withdrawal by Subject|1|||
144716506|NCT01393990|521817701|FG016|Overall Study|Withdrawal by Subject|0|||
144716507|NCT01393990|521817702|FG017|Overall Study|Withdrawal by Subject|0|||
144716508|NCT00331630|521817704|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
144716509|NCT00331630|521817704|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
144716510|NCT00331630|521817704|FG000|Follow up for 5 Years|Death|5|||
144716511|NCT00331630|521817704|FG000|Follow up for 5 Years|Data collection was stopped|24|||
144716512|NCT01312779|521817705|FG000|Overall Study|Withdrawal by Subject|2|||
144716513|NCT01312779|521817705|FG000|Overall Study|Death|3|||
144716514|NCT01312779|521817705|FG000|Overall Study|Not Implanted with Device|27|||
144716515|NCT01473758|521817709|FG000|Cycle 1|Adverse Event|10|||
144716516|NCT01473758|521817710|FG001|Cycle 1|Adverse Event|2|||
144716517|NCT01473758|521817711|FG002|Cycle 1|Adverse Event|0|||
144716518|NCT01473758|521817712|FG003|Cycle 1|Adverse Event|0|||
144716519|NCT01473758|521817709|FG000|Cycle 1|Withdrawal by Subject|1|||
144716520|NCT01473758|521817710|FG001|Cycle 1|Withdrawal by Subject|1|||
144716521|NCT01473758|521817711|FG002|Cycle 1|Withdrawal by Subject|0|||
144716522|NCT01473758|521817712|FG003|Cycle 1|Withdrawal by Subject|0|||
144716523|NCT01473758|521817709|FG000|Cycle 2|Adverse Event|0|||
144716524|NCT01473758|521817710|FG001|Cycle 2|Adverse Event|0|||
144716525|NCT01473758|521817711|FG002|Cycle 2|Adverse Event|5|||
144716526|NCT01473758|521817712|FG003|Cycle 2|Adverse Event|0|||
144716527|NCT02480010|521817713|FG000|Overall Study|Adverse Event|3|||
144716528|NCT02480010|521817714|FG001|Overall Study|Adverse Event|1|||
144716529|NCT02480010|521817713|FG000|Overall Study|Death|1|||
144716530|NCT02480010|521817714|FG001|Overall Study|Death|0|||
144716531|NCT02480010|521817713|FG000|Overall Study|Insufficient therapeutic response|31|||
144716532|NCT02480010|521817714|FG001|Overall Study|Insufficient therapeutic response|29|||
144716533|NCT02480010|521817713|FG000|Overall Study|Refused Treatment|0|||
144716534|NCT02480010|521817714|FG001|Overall Study|Refused Treatment|3|||
144716535|NCT02763579|521817724|FG000|Global Period|Death|167|||
144716536|NCT02763579|521817725|FG001|Global Period|Death|151|||
144716537|NCT02763579|521817726|FG002|Global Period|Death|0|||
144716538|NCT02763579|521817727|FG003|Global Period|Death|0|||
144716539|NCT02763579|521817724|FG000|Global Period|Lost to Follow-up|2|||
144716540|NCT02763579|521817725|FG001|Global Period|Lost to Follow-up|4|||
144716541|NCT02763579|521817726|FG002|Global Period|Lost to Follow-up|0|||
144716542|NCT02763579|521817727|FG003|Global Period|Lost to Follow-up|0|||
144716543|NCT02763579|521817724|FG000|Global Period|Physician Decision|0|||
144716544|NCT02763579|521817725|FG001|Global Period|Physician Decision|2|||
144716545|NCT02763579|521817726|FG002|Global Period|Physician Decision|0|||
144716546|NCT02763579|521817727|FG003|Global Period|Physician Decision|0|||
144716547|NCT02763579|521817724|FG000|Global Period|Study Terminated By Sponsor|21|||
144716548|NCT02763579|521817725|FG001|Global Period|Study Terminated By Sponsor|26|||
144716549|NCT02763579|521817726|FG002|Global Period|Study Terminated By Sponsor|0|||
144716550|NCT02763579|521817727|FG003|Global Period|Study Terminated By Sponsor|0|||
144716551|NCT02763579|521817724|FG000|Global Period|Withdrawal by Subject|12|||
144716552|NCT02763579|521817725|FG001|Global Period|Withdrawal by Subject|18|||
144716553|NCT02763579|521817726|FG002|Global Period|Withdrawal by Subject|0|||
144716554|NCT02763579|521817727|FG003|Global Period|Withdrawal by Subject|0|||
144716555|NCT02763579|521817724|FG000|China Period|Death|0|||
144716556|NCT02763579|521817725|FG001|China Period|Death|0|||
144716557|NCT02763579|521817726|FG002|China Period|Death|46|||
144491637|NCT01323660|520995200|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
144491638|NCT01323660|520995201|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
144491639|NCT01323660|520995196|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
144491640|NCT01323660|520995197|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
144491641|NCT01323660|520995198|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
144491642|NCT01323660|520995199|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
144491643|NCT01323660|520995200|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
144491644|NCT01323660|520995201|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
144491645|NCT01323660|520995196|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144491646|NCT01323660|520995197|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144491647|NCT01323660|520995198|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144491648|NCT01323660|520995199|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144491649|NCT01323660|520995200|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
144491650|NCT01323660|520995201|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144716558|NCT02763579|521817727|FG003|China Period|Death|48|||
144716559|NCT02763579|521817724|FG000|China Period|Lost to Follow-up|0|||
144716560|NCT02763579|521817725|FG001|China Period|Lost to Follow-up|0|||
144716561|NCT02763579|521817726|FG002|China Period|Lost to Follow-up|1|||
144716562|NCT02763579|521817727|FG003|China Period|Lost to Follow-up|1|||
144716563|NCT02763579|521817724|FG000|China Period|Physician Decision|0|||
144716564|NCT02763579|521817725|FG001|China Period|Physician Decision|0|||
144716565|NCT02763579|521817726|FG002|China Period|Physician Decision|0|||
144716566|NCT02763579|521817727|FG003|China Period|Physician Decision|1|||
144716567|NCT02763579|521817724|FG000|China Period|Study Terminated By Sponsor|0|||
144716568|NCT02763579|521817725|FG001|China Period|Study Terminated By Sponsor|0|||
144716569|NCT02763579|521817726|FG002|China Period|Study Terminated By Sponsor|3|||
144716570|NCT02763579|521817727|FG003|China Period|Study Terminated By Sponsor|4|||
144716571|NCT02763579|521817724|FG000|China Period|Withdrawal by Subject|0|||
144716572|NCT02763579|521817725|FG001|China Period|Withdrawal by Subject|0|||
144716573|NCT02763579|521817726|FG002|China Period|Withdrawal by Subject|3|||
144716574|NCT02763579|521817727|FG003|China Period|Withdrawal by Subject|3|||
144716575|NCT01764854|521817730|FG000|Overall Study|Adverse Event|0|||
144716576|NCT01764854|521817731|FG001|Overall Study|Adverse Event|0|||
144716577|NCT01764854|521817732|FG002|Overall Study|Adverse Event|2|||
144716578|NCT01764854|521817733|FG003|Overall Study|Adverse Event|0|||
144716579|NCT01764854|521817730|FG000|Overall Study|Withdrawal by Subject|0|||
144716580|NCT01764854|521817731|FG001|Overall Study|Withdrawal by Subject|0|||
144716581|NCT01764854|521817732|FG002|Overall Study|Withdrawal by Subject|1|||
144716582|NCT01764854|521817733|FG003|Overall Study|Withdrawal by Subject|0|||
144716583|NCT01764854|521817730|FG000|Overall Study|relocation|0|||
144716584|NCT01764854|521817731|FG001|Overall Study|relocation|0|||
144716585|NCT01764854|521817732|FG002|Overall Study|relocation|2|||
144716586|NCT01764854|521817733|FG003|Overall Study|relocation|0|||
144716587|NCT01764854|521817730|FG000|Overall Study|Protocol Violation|0|||
144716588|NCT01764854|521817731|FG001|Overall Study|Protocol Violation|0|||
144716589|NCT01764854|521817732|FG002|Overall Study|Protocol Violation|1|||
144716590|NCT01764854|521817733|FG003|Overall Study|Protocol Violation|2|||
144716591|NCT00910858|521817742|FG000|Pharmacokinetic Phase|Adverse Event|1|||
144716592|NCT00910858|521817743|FG001|Pharmacokinetic Phase|Adverse Event|0|||
144716593|NCT00910858|521817744|FG002|Pharmacokinetic Phase|Adverse Event|0|||
144716594|NCT00910858|521817742|FG000|Monotherapy Phase|Adverse Event|3|||
144716595|NCT00910858|521817743|FG001|Monotherapy Phase|Adverse Event|2|||
144716596|NCT00910858|521817744|FG002|Monotherapy Phase|Adverse Event|0|||
144716597|NCT00910858|521817742|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
144716598|NCT00910858|521817743|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
144716599|NCT00910858|521817744|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
144716600|NCT00910858|521817742|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
144716601|NCT00910858|521817743|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
144716602|NCT00910858|521817744|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
144716603|NCT00910858|521817742|FG000|Monotherapy Phase|Protocol Violation|1|||
144716604|NCT00910858|521817743|FG001|Monotherapy Phase|Protocol Violation|0|||
144716605|NCT00910858|521817744|FG002|Monotherapy Phase|Protocol Violation|0|||
144716606|NCT00910858|521817742|FG000|Monotherapy Phase|Other|3|||
144716607|NCT00910858|521817743|FG001|Monotherapy Phase|Other|4|||
144716608|NCT00910858|521817744|FG002|Monotherapy Phase|Other|2|||
144716609|NCT00910858|521817742|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
144369928|NCT00658359|520562757|FG000|Overall Study|Death|3|||
144716610|NCT00910858|521817743|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
144716611|NCT00910858|521817744|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
144716612|NCT00910858|521817742|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
144716613|NCT00910858|521817743|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
144369929|NCT00658359|520562758|FG001|Overall Study|Death|1|||
144716614|NCT00910858|521817744|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
144716615|NCT00910858|521817742|FG000|Combined Treatment Phase|Protocol Violation|1|||
144716616|NCT00910858|521817743|FG001|Combined Treatment Phase|Protocol Violation|0|||
144491651|NCT01323660|520995196|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144491652|NCT01323660|520995197|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144491653|NCT01323660|520995198|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144491654|NCT01323660|520995199|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144491655|NCT01323660|520995200|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144491656|NCT01323660|520995201|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144491657|NCT01323660|520995196|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
144491658|NCT01323660|520995197|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144491659|NCT01323660|520995198|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
144491660|NCT01323660|520995199|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
144491661|NCT01323660|520995200|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
144491662|NCT01323660|520995201|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144491663|NCT01323660|520995196|FG000|Washout Period (14 Days)|Adverse Event|0|||
144491664|NCT01323660|520995197|FG001|Washout Period (14 Days)|Adverse Event|0|||
144491665|NCT01323660|520995198|FG002|Washout Period (14 Days)|Adverse Event|0|||
144491666|NCT01323660|520995199|FG003|Washout Period (14 Days)|Adverse Event|0|||
144491667|NCT01323660|520995200|FG004|Washout Period (14 Days)|Adverse Event|1|||
144491668|NCT01323660|520995201|FG005|Washout Period (14 Days)|Adverse Event|0|||
144491669|NCT01323660|520995196|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
144491670|NCT01323660|520995197|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
144491671|NCT01323660|520995198|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
144716617|NCT00910858|521817744|FG002|Combined Treatment Phase|Protocol Violation|0|||
144716618|NCT00910858|521817742|FG000|Combined Treatment Phase|Other|0|||
144716619|NCT00910858|521817743|FG001|Combined Treatment Phase|Other|2|||
144716620|NCT00910858|521817744|FG002|Combined Treatment Phase|Other|1|||
144716621|NCT00827827|521817745|FG000|Overall Study|Lost to Follow-up|3|||
144716622|NCT00827827|521817746|FG001|Overall Study|Lost to Follow-up|0|||
144716623|NCT00827827|521817745|FG000|Overall Study|Fall at home- hospitalization|1|||
144716624|NCT00827827|521817746|FG001|Overall Study|Fall at home- hospitalization|0|||
144716625|NCT00827827|521817745|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
144716626|NCT00827827|521817746|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
144716627|NCT00827827|521817745|FG000|Overall Study|Gout|1|||
144716628|NCT00827827|521817746|FG001|Overall Study|Gout|0|||
144716629|NCT00827827|521817745|FG000|Overall Study|Transportation issues|1|||
144716630|NCT00827827|521817746|FG001|Overall Study|Transportation issues|0|||
144716631|NCT00827827|521817745|FG000|Overall Study|Burned with water at home|1|||
144716632|NCT00827827|521817746|FG001|Overall Study|Burned with water at home|0|||
144716633|NCT00447603|521817751|FG000|Screening|Withdrawal by Subject|1|||
144716634|NCT00447603|521817752|FG001|Screening|Withdrawal by Subject|0|||
144716635|NCT00447603|521817753|FG002|Screening|Withdrawal by Subject|0|||
144716636|NCT00447603|521817751|FG000|Screening|Protocol Violation|1|||
144716637|NCT00447603|521817752|FG001|Screening|Protocol Violation|0|||
144716638|NCT00447603|521817753|FG002|Screening|Protocol Violation|0|||
144716639|NCT00447603|521817751|FG000|Screening|Screen Failure|4|||
144716640|NCT00447603|521817752|FG001|Screening|Screen Failure|0|||
144716641|NCT00447603|521817753|FG002|Screening|Screen Failure|0|||
144716642|NCT00447603|521817751|FG000|Screening|Study Terminated by Sponsor|15|||
144716643|NCT00447603|521817752|FG001|Screening|Study Terminated by Sponsor|0|||
144716644|NCT00447603|521817753|FG002|Screening|Study Terminated by Sponsor|0|||
144716645|NCT00447603|521817751|FG000|Filter Period|Adverse Event|0|||
144716646|NCT00447603|521817752|FG001|Filter Period|Adverse Event|0|||
144716647|NCT00447603|521817753|FG002|Filter Period|Adverse Event|1|||
144716648|NCT00447603|521817751|FG000|Filter Period|Screen Failure|0|||
144716649|NCT00447603|521817752|FG001|Filter Period|Screen Failure|3|||
144716650|NCT00447603|521817753|FG002|Filter Period|Screen Failure|4|||
144716651|NCT00447603|521817751|FG000|Filter Period|Study terminated by Sponsor|0|||
144716652|NCT00447603|521817752|FG001|Filter Period|Study terminated by Sponsor|1|||
144716653|NCT00447603|521817753|FG002|Filter Period|Study terminated by Sponsor|10|||
144716654|NCT01165684|521817760|FG000|Overall Study|Adverse Event|1|||
144716655|NCT01165684|521817761|FG001|Overall Study|Adverse Event|1|||
144716656|NCT01165684|521817760|FG000|Overall Study|Lack of Efficacy|2|||
144716657|NCT01165684|521817761|FG001|Overall Study|Lack of Efficacy|1|||
144716658|NCT01165684|521817760|FG000|Overall Study|Protocol Violation|7|||
144716659|NCT01165684|521817761|FG001|Overall Study|Protocol Violation|15|||
144716660|NCT01165684|521817760|FG000|Overall Study|Withdrawal Criteria|2|||
144716661|NCT01165684|521817761|FG001|Overall Study|Withdrawal Criteria|13|||
144716662|NCT01165684|521817760|FG000|Overall Study|Unclassified|16|||
144716663|NCT01165684|521817761|FG001|Overall Study|Unclassified|22|||
144716664|NCT00901628|521817780|FG000|Overall Study|disconnection of catheter|4|||
144716665|NCT00901628|521817781|FG001|Overall Study|disconnection of catheter|8|||
144716666|NCT00901628|521817780|FG000|Overall Study|disconnection of drain|0|||
144716667|NCT00901628|521817781|FG001|Overall Study|disconnection of drain|1|||
144716668|NCT00901628|521817780|FG000|Overall Study|peroneal nerve palsy|0|||
144716669|NCT00901628|521817781|FG001|Overall Study|peroneal nerve palsy|1|||
144716670|NCT00608205|521817784|FG000|Overall Study|Adverse Event|3|||
144716671|NCT00608205|521817785|FG001|Overall Study|Adverse Event|2|||
144716672|NCT00608205|521817784|FG000|Overall Study|Patient non-compliant|0|||
144716673|NCT00608205|521817785|FG001|Overall Study|Patient non-compliant|1|||
144716674|NCT00909727|521817791|FG000|Overall Study|Adverse Event|1|||
144716675|NCT00909727|521817792|FG001|Overall Study|Adverse Event|0|||
144716676|NCT00909727|521817791|FG000|Overall Study|Wrong Genotype|1|||
144716677|NCT00909727|521817792|FG001|Overall Study|Wrong Genotype|0|||
144716678|NCT00909727|521817791|FG000|Overall Study|Withdrawal of Consent|1|||
144716679|NCT00909727|521817792|FG001|Overall Study|Withdrawal of Consent|0|||
144491672|NCT01323660|520995199|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
144491673|NCT01323660|520995200|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
144491674|NCT01323660|520995201|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
144491675|NCT01323660|520995196|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
144491676|NCT01323660|520995197|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
144491677|NCT01323660|520995198|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
144491678|NCT01323660|520995199|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
144491679|NCT01323660|520995200|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
144491680|NCT01323660|520995201|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
144491681|NCT01323660|520995196|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
144491682|NCT01323660|520995197|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
144491683|NCT01323660|520995198|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
144491684|NCT01323660|520995199|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
144491685|NCT01323660|520995200|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
144491686|NCT01323660|520995201|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
144491687|NCT01323660|520995196|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
144491688|NCT01323660|520995197|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
144491689|NCT01323660|520995198|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
144491690|NCT01323660|520995199|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
144491691|NCT01323660|520995200|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
144491692|NCT01323660|520995201|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
144491693|NCT01323660|520995196|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
144491694|NCT01323660|520995197|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
144491695|NCT01323660|520995198|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
144491696|NCT01323660|520995199|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
144491697|NCT01323660|520995200|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
144491698|NCT01323660|520995201|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
144491699|NCT01323660|520995196|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144491700|NCT01323660|520995197|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144491701|NCT01323660|520995198|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144491702|NCT01323660|520995199|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144491703|NCT01323660|520995200|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
144491704|NCT01323660|520995201|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144491705|NCT02800928|520995202|FG000|Overall Study|Withdrawal by Subject|1|||
144369930|NCT00658359|520562759|FG002|Overall Study|Death|2|||
144491706|NCT02800928|520995203|FG001|Overall Study|Withdrawal by Subject|1|||
144491707|NCT02800928|520995202|FG000|Overall Study|Protocol Violation|1|||
144369931|NCT00658359|520562757|FG000|Overall Study|Adverse Event|13|||
144491708|NCT02800928|520995203|FG001|Overall Study|Protocol Violation|1|||
144491709|NCT02886728|520995210|FG000|Overall Study|Withdrew Consent|31|||
144491710|NCT02886728|520995211|FG001|Overall Study|Withdrew Consent|13|||
144491711|NCT02886728|520995212|FG002|Overall Study|Withdrew Consent|11|||
144491712|NCT02886728|520995213|FG003|Overall Study|Withdrew Consent|47|||
144491713|NCT02886728|520995210|FG000|Overall Study|Lost to Follow-up|12|||
144491714|NCT02886728|520995211|FG001|Overall Study|Lost to Follow-up|6|||
144491715|NCT02886728|520995212|FG002|Overall Study|Lost to Follow-up|13|||
144491716|NCT02886728|520995213|FG003|Overall Study|Lost to Follow-up|12|||
144491717|NCT02886728|520995210|FG000|Overall Study|Adverse Event|13|||
144491718|NCT02886728|520995211|FG001|Overall Study|Adverse Event|5|||
144491719|NCT02886728|520995212|FG002|Overall Study|Adverse Event|5|||
144491720|NCT02886728|520995213|FG003|Overall Study|Adverse Event|11|||
144491721|NCT02886728|520995210|FG000|Overall Study|Investigator's Discretion|11|||
144491722|NCT02886728|520995211|FG001|Overall Study|Investigator's Discretion|7|||
144491723|NCT02886728|520995212|FG002|Overall Study|Investigator's Discretion|5|||
144491724|NCT02886728|520995213|FG003|Overall Study|Investigator's Discretion|11|||
144491725|NCT02886728|520995210|FG000|Overall Study|Death|3|||
144491726|NCT02886728|520995211|FG001|Overall Study|Death|1|||
144491727|NCT02886728|520995212|FG002|Overall Study|Death|0|||
144491728|NCT02886728|520995213|FG003|Overall Study|Death|0|||
144491729|NCT02886728|520995210|FG000|Overall Study|Protocol Violation|0|||
144491730|NCT02886728|520995211|FG001|Overall Study|Protocol Violation|0|||
144491731|NCT02886728|520995212|FG002|Overall Study|Protocol Violation|0|||
144491732|NCT02886728|520995213|FG003|Overall Study|Protocol Violation|4|||
144491733|NCT02886728|520995210|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144491734|NCT02886728|520995211|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144491735|NCT02886728|520995212|FG002|Overall Study|Non-Compliance with Study Drug|1|||
144491736|NCT02886728|520995213|FG003|Overall Study|Non-Compliance with Study Drug|0|||
144491737|NCT02886728|520995210|FG000|Overall Study|Pregnancy|0|||
144491738|NCT02886728|520995211|FG001|Overall Study|Pregnancy|0|||
144491739|NCT02886728|520995212|FG002|Overall Study|Pregnancy|1|||
144491740|NCT02886728|520995213|FG003|Overall Study|Pregnancy|0|||
144491741|NCT02886728|520995210|FG000|Overall Study|Randomized but Not Dosed|1|||
144491742|NCT02886728|520995211|FG001|Overall Study|Randomized but Not Dosed|0|||
144491743|NCT02886728|520995212|FG002|Overall Study|Randomized but Not Dosed|0|||
144491744|NCT02886728|520995213|FG003|Overall Study|Randomized but Not Dosed|2|||
144491745|NCT04990440|520995220|FG000|Overall Study|Sponsor's Decision|0|||
144491746|NCT04990440|520995221|FG001|Overall Study|Sponsor's Decision|0|||
144491747|NCT04990440|520995222|FG002|Overall Study|Sponsor's Decision|1|||
144491748|NCT03712098|520995223|FG000|Overall Study|Lost to Follow-up|3|||
144491749|NCT03712098|520995224|FG001|Overall Study|Lost to Follow-up|7|||
144491750|NCT03712098|520995223|FG000|Overall Study|Withdrawal by Subject|9|||
144491751|NCT03712098|520995224|FG001|Overall Study|Withdrawal by Subject|4|||
144491752|NCT03712098|520995223|FG000|Overall Study|Protocol Violation|2|||
144491753|NCT03712098|520995224|FG001|Overall Study|Protocol Violation|1|||
144491754|NCT02954575|520995229|FG000|Overall Study|Withdrawal by Subject|2|||
144491755|NCT02954575|520995229|FG000|Overall Study|Adverse Event|1|||
144491756|NCT00570661|520995231|FG000|Overall Study|Disease worsening|5|||
144716680|NCT00909727|521817791|FG000|Overall Study|Prohibited Medication|1|||
144716681|NCT00909727|521817792|FG001|Overall Study|Prohibited Medication|0|||
144716682|NCT01909466|521817794|FG000|Overall Study|Lost to Follow-up|5|||
144716683|NCT01909466|521817795|FG001|Overall Study|Lost to Follow-up|7|||
144716684|NCT01909466|521817794|FG000|Overall Study|Adverse Event|3|||
144716685|NCT01909466|521817795|FG001|Overall Study|Adverse Event|4|||
144716686|NCT01909466|521817794|FG000|Overall Study|Met Withdrawal Criteria|0|||
144716687|NCT01909466|521817795|FG001|Overall Study|Met Withdrawal Criteria|3|||
144369932|NCT00658359|520562758|FG001|Overall Study|Adverse Event|6|||
144491757|NCT00570661|520995231|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
144491758|NCT00570661|520995231|FG000|Overall Study|Adverse Event|1|||
144491759|NCT01066156|520995232|FG000|Overall Study|ineligible|2|||
144491760|NCT01066156|520995232|FG000|Overall Study|Lost to Follow-up|7|||
144491761|NCT01066156|520995232|FG000|Overall Study|Withdrawal by Subject|1|||
144491762|NCT01734382|520995236|FG000|Part 1|Adverse Event|2|||
144491763|NCT01734382|520995237|FG001|Part 1|Adverse Event|0|||
144491764|NCT01734382|520995238|FG002|Part 1|Adverse Event|0|||
144491765|NCT01734382|520995236|FG000|Part 2|Adverse Event|0|||
144491766|NCT01734382|520995237|FG001|Part 2|Adverse Event|0|||
144491767|NCT01734382|520995238|FG002|Part 2|Adverse Event|1|||
144491768|NCT01734382|520995236|FG000|Part 2|Lack of Efficacy|0|||
144491769|NCT01734382|520995237|FG001|Part 2|Lack of Efficacy|1|||
144491770|NCT01734382|520995238|FG002|Part 2|Lack of Efficacy|1|||
144716688|NCT01909466|521817794|FG000|Overall Study|Physician Decision|2|||
144716689|NCT01909466|521817795|FG001|Overall Study|Physician Decision|0|||
144491771|NCT01734382|520995236|FG000|Part 2|Other|0|||
144491772|NCT01734382|520995237|FG001|Part 2|Other|0|||
144491773|NCT01734382|520995238|FG002|Part 2|Other|1|||
144491774|NCT01734382|520995236|FG000|Part 2|Physician Decision|0|||
144491775|NCT01734382|520995237|FG001|Part 2|Physician Decision|0|||
144491776|NCT01734382|520995238|FG002|Part 2|Physician Decision|3|||
144716690|NCT01909466|521817794|FG000|Overall Study|Withdrawal by Subject|11|||
144369933|NCT00658359|520562759|FG002|Overall Study|Adverse Event|9|||
144369934|NCT00658359|520562757|FG000|Overall Study|Protocol Violation|1|||
144369935|NCT00658359|520562758|FG001|Overall Study|Protocol Violation|0|||
144369936|NCT00658359|520562759|FG002|Overall Study|Protocol Violation|0|||
144369937|NCT00658359|520562757|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
144369938|NCT00658359|520562758|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
144369939|NCT00658359|520562759|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
144369940|NCT00658359|520562757|FG000|Overall Study|Withdrawal by Subject|7|||
144369941|NCT00658359|520562758|FG001|Overall Study|Withdrawal by Subject|4|||
144369942|NCT00658359|520562759|FG002|Overall Study|Withdrawal by Subject|2|||
144369943|NCT00658359|520562757|FG000|Overall Study|Lost to Follow-up|2|||
144369944|NCT00658359|520562758|FG001|Overall Study|Lost to Follow-up|2|||
144369945|NCT00658359|520562759|FG002|Overall Study|Lost to Follow-up|4|||
144369946|NCT00658359|520562757|FG000|Overall Study|Lack of Efficacy|0|||
144369947|NCT00658359|520562758|FG001|Overall Study|Lack of Efficacy|1|||
144369948|NCT00658359|520562759|FG002|Overall Study|Lack of Efficacy|0|||
144369949|NCT02558296|520562760|FG000|Completed the Study Through Week 24|Adverse Event|9|||
144369950|NCT02558296|520562761|FG001|Completed the Study Through Week 24|Adverse Event|3|||
144369951|NCT02558296|520562760|FG000|Completed the Study Through Week 24|Death|7|||
144369952|NCT02558296|520562761|FG001|Completed the Study Through Week 24|Death|7|||
144369953|NCT02558296|520562760|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
144369954|NCT02558296|520562761|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
144369955|NCT02558296|520562760|FG000|Completed the Study Through Week 24|Physician Decision|1|||
144369956|NCT02558296|520562761|FG001|Completed the Study Through Week 24|Physician Decision|0|||
144369957|NCT02558296|520562760|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
144369958|NCT02558296|520562761|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
144369959|NCT02558296|520562760|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
144491777|NCT01734382|520995236|FG000|Part 2|Protocol Violation|0|||
144491778|NCT01734382|520995237|FG001|Part 2|Protocol Violation|1|||
144491779|NCT01734382|520995238|FG002|Part 2|Protocol Violation|0|||
144491780|NCT01734382|520995236|FG000|Part 2|Withdrawal by Subject|0|||
144369960|NCT02558296|520562761|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
144369961|NCT02558296|520562760|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
144716691|NCT01909466|521817795|FG001|Overall Study|Withdrawal by Subject|9|||
144716692|NCT01909466|521817794|FG000|Overall Study|Lack of Efficacy|1|||
144716693|NCT01909466|521817795|FG001|Overall Study|Lack of Efficacy|0|||
144716694|NCT01339910|521817796|FG000|Overall Study|Withdrawal by Subject|1|||
144716695|NCT01339910|521817797|FG001|Overall Study|Withdrawal by Subject|0|||
144716696|NCT01339910|521817796|FG000|Overall Study|Physician Decision|1|||
144716697|NCT01339910|521817797|FG001|Overall Study|Physician Decision|0|||
144716698|NCT01339910|521817796|FG000|Overall Study|Disease relapse|1|||
144716699|NCT01339910|521817797|FG001|Overall Study|Disease relapse|4|||
144716700|NCT01567306|521817799|FG000|Overall Study|Protocol Violation|2|||
144716701|NCT01567306|521817800|FG001|Overall Study|Protocol Violation|2|||
144716702|NCT01567306|521817801|FG002|Overall Study|Protocol Violation|0|||
144716703|NCT01567306|521817802|FG003|Overall Study|Protocol Violation|3|||
144716704|NCT01567306|521817803|FG004|Overall Study|Protocol Violation|1|||
144716705|NCT01567306|521817804|FG005|Overall Study|Protocol Violation|1|||
144716706|NCT01567306|521817799|FG000|Overall Study|Change site living|1|||
144716707|NCT01567306|521817800|FG001|Overall Study|Change site living|0|||
144716708|NCT01567306|521817801|FG002|Overall Study|Change site living|0|||
144716709|NCT01567306|521817802|FG003|Overall Study|Change site living|0|||
144716710|NCT01567306|521817803|FG004|Overall Study|Change site living|0|||
144716711|NCT01567306|521817804|FG005|Overall Study|Change site living|0|||
144716712|NCT01567306|521817799|FG000|Overall Study|Adverse Event|0|||
144716713|NCT01567306|521817800|FG001|Overall Study|Adverse Event|0|||
144716714|NCT01567306|521817801|FG002|Overall Study|Adverse Event|0|||
144716715|NCT01567306|521817802|FG003|Overall Study|Adverse Event|2|||
144716716|NCT01567306|521817803|FG004|Overall Study|Adverse Event|4|||
144716717|NCT01567306|521817804|FG005|Overall Study|Adverse Event|1|||
144716718|NCT01567306|521817799|FG000|Overall Study|Lost to Follow-up|0|||
144716719|NCT01567306|521817800|FG001|Overall Study|Lost to Follow-up|0|||
144716720|NCT01567306|521817801|FG002|Overall Study|Lost to Follow-up|0|||
144716721|NCT01567306|521817802|FG003|Overall Study|Lost to Follow-up|0|||
144716722|NCT01567306|521817803|FG004|Overall Study|Lost to Follow-up|2|||
144716723|NCT01567306|521817804|FG005|Overall Study|Lost to Follow-up|0|||
144716724|NCT01567306|521817799|FG000|Overall Study|Withdrawal by Subject|0|||
144716725|NCT01567306|521817800|FG001|Overall Study|Withdrawal by Subject|0|||
144716726|NCT01567306|521817801|FG002|Overall Study|Withdrawal by Subject|0|||
144716727|NCT01567306|521817802|FG003|Overall Study|Withdrawal by Subject|0|||
144716728|NCT01567306|521817803|FG004|Overall Study|Withdrawal by Subject|0|||
144716729|NCT01567306|521817804|FG005|Overall Study|Withdrawal by Subject|1|||
144716730|NCT00829413|521817809|FG000|Overall Study|No study drug admimnistered|13|||
144716731|NCT00829413|521817809|FG000|Overall Study|Training Patients|67|||
144716732|NCT00829413|521817809|FG000|Overall Study|No truth standard procedure available|9|||
144716733|NCT00829413|521817809|FG000|Overall Study|Technically inadequate truth standard|2|||
144716734|NCT00829413|521817809|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
144716735|NCT04272775|521817811|FG000|Overall Study|Study Terminated by Sponsor|1|||
144716736|NCT04272775|521817812|FG001|Overall Study|Study Terminated by Sponsor|0|||
144716737|NCT04272775|521817811|FG000|Overall Study|Protocol Violation|0|||
144716738|NCT04272775|521817812|FG001|Overall Study|Protocol Violation|1|||
144716739|NCT04272775|521817811|FG000|Overall Study|Symptomatic Deterioration|1|||
144716740|NCT04272775|521817812|FG001|Overall Study|Symptomatic Deterioration|1|||
144716741|NCT04272775|521817811|FG000|Overall Study|Withdrawal by Subject|1|||
144716742|NCT04272775|521817812|FG001|Overall Study|Withdrawal by Subject|2|||
144716743|NCT04272775|521817811|FG000|Overall Study|Adverse Event|1|||
144716744|NCT04272775|521817812|FG001|Overall Study|Adverse Event|2|||
144716745|NCT04272775|521817811|FG000|Overall Study|Progressive Disease|3|||
144716746|NCT04272775|521817812|FG001|Overall Study|Progressive Disease|1|||
144716747|NCT00738673|521817813|FG000|Overall Study|Adverse Event|1|||
144716748|NCT00738673|521817814|FG001|Overall Study|Adverse Event|0|||
144716749|NCT00738673|521817813|FG000|Overall Study|Lack of Efficacy|19|||
144716750|NCT00738673|521817814|FG001|Overall Study|Lack of Efficacy|8|||
144716751|NCT00738673|521817813|FG000|Overall Study|Protocol Violation|1|||
144716752|NCT00738673|521817814|FG001|Overall Study|Protocol Violation|2|||
144716753|NCT00738673|521817813|FG000|Overall Study|Withdrawal by Subject|3|||
144716754|NCT00738673|521817814|FG001|Overall Study|Withdrawal by Subject|1|||
144716755|NCT00891774|521817815|FG000|Overall Study|Lost to Follow-up|5|||
144716756|NCT00891774|521817815|FG000|Overall Study|Illness (Self/Mother)|3|||
144716757|NCT00891774|521817815|FG000|Overall Study|Withdrawal by Subject|2|||
144716758|NCT00891774|521817815|FG000|Overall Study|Protocol Violation|4|||
144716759|NCT03175120|521817817|FG000|Overall Study|Adverse Event|2|||
144716760|NCT03175120|521817818|FG001|Overall Study|Adverse Event|2|||
144716761|NCT03175120|521817817|FG000|Overall Study|Protocol Violation|5|||
144716762|NCT03175120|521817818|FG001|Overall Study|Protocol Violation|2|||
144716763|NCT03175120|521817817|FG000|Overall Study|Lost to Follow-up|1|||
144716764|NCT03175120|521817818|FG001|Overall Study|Lost to Follow-up|0|||
144716765|NCT03175120|521817817|FG000|Overall Study|Withdrawal by Subject|2|||
144716766|NCT03175120|521817818|FG001|Overall Study|Withdrawal by Subject|5|||
144491781|NCT01734382|520995237|FG001|Part 2|Withdrawal by Subject|0|||
144491782|NCT01734382|520995238|FG002|Part 2|Withdrawal by Subject|1|||
144491783|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
144491784|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
144716767|NCT03175120|521817817|FG000|Overall Study|Other|2|||
144716768|NCT03175120|521817818|FG001|Overall Study|Other|3|||
144716769|NCT03263819|521817820|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
144716770|NCT03263819|521817821|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
144716771|NCT00863057|521817823|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
144716772|NCT00863057|521817824|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
144716773|NCT00863057|521817825|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
144716774|NCT00863057|521817826|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
144716775|NCT00863057|521817823|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
144716776|NCT00863057|521817824|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
144716777|NCT00863057|521817825|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
144716778|NCT00863057|521817826|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
144716779|NCT00863057|521817823|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
144716780|NCT00863057|521817824|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
144716781|NCT00863057|521817825|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
144716782|NCT00863057|521817826|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
144716783|NCT00863057|521817823|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
144716784|NCT00863057|521817824|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
144716785|NCT00863057|521817825|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
144716786|NCT00863057|521817826|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
144716787|NCT01698320|521817830|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
144716788|NCT01698320|521817831|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
144716789|NCT01698320|521817832|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
144716790|NCT01698320|521817830|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
144716791|NCT01698320|521817831|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
144716792|NCT01698320|521817832|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
144716793|NCT01698320|521817830|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
144716794|NCT01698320|521817831|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
144716795|NCT01698320|521817832|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
144716796|NCT01698320|521817830|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
144716797|NCT01698320|521817831|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
144716798|NCT01698320|521817832|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
144716799|NCT01698320|521817830|FG000|12-Week Double-Blind Period|Adverse Event|0|||
144716800|NCT01698320|521817831|FG001|12-Week Double-Blind Period|Adverse Event|1|||
144716801|NCT01698320|521817832|FG002|12-Week Double-Blind Period|Adverse Event|1|||
144716802|NCT01698320|521817830|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
144716803|NCT01698320|521817831|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
144716804|NCT01698320|521817832|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
144716805|NCT01698320|521817830|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
144716806|NCT01698320|521817831|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
144716807|NCT01698320|521817832|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
144716808|NCT01698320|521817830|FG000|12-Week Double-Blind Period|Pregnancy|0|||
144716809|NCT01698320|521817831|FG001|12-Week Double-Blind Period|Pregnancy|1|||
144716810|NCT01698320|521817832|FG002|12-Week Double-Blind Period|Pregnancy|1|||
144716811|NCT01698320|521817830|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
144716812|NCT01698320|521817831|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
144716813|NCT01698320|521817832|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
144716814|NCT01698320|521817830|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
144716815|NCT01698320|521817831|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
144716816|NCT01698320|521817832|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
144716817|NCT01698320|521817830|FG000|40-Week Open-Label Period|Adverse Event|0|||
144716818|NCT01698320|521817831|FG001|40-Week Open-Label Period|Adverse Event|3|||
144716819|NCT01698320|521817832|FG002|40-Week Open-Label Period|Adverse Event|2|||
144716820|NCT01698320|521817830|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
144716821|NCT01698320|521817831|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
144716822|NCT01698320|521817832|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
144716823|NCT01698320|521817830|FG000|40-Week Open-Label Period|Pregnancy|0|||
144716824|NCT01698320|521817831|FG001|40-Week Open-Label Period|Pregnancy|2|||
144716825|NCT01698320|521817832|FG002|40-Week Open-Label Period|Pregnancy|1|||
144716826|NCT01698320|521817830|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
144716827|NCT01698320|521817831|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
144716828|NCT01698320|521817832|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
144716829|NCT01698320|521817830|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
144491785|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
144491786|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
144491787|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
144491788|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
144491789|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
144491790|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
144491791|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
144491792|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
144491793|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
144491794|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
144491795|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
144491796|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
144491797|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
144491798|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
144491799|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
144491800|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
144491801|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
144491802|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
144491803|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
144491804|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
144491805|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
144491806|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
144491807|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
144491808|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
144491809|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
144491810|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
144491811|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
144491812|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
144491813|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
144491814|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
144491815|NCT03890120|520995239|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
144491816|NCT03890120|520995240|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
144491817|NCT03890120|520995241|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
144491818|NCT03890120|520995242|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
144491819|NCT03890120|520995239|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
144491820|NCT03890120|520995240|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
144491821|NCT03890120|520995241|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
144491822|NCT03890120|520995242|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
144491823|NCT03890120|520995239|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
144491824|NCT03890120|520995240|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
144491825|NCT03890120|520995241|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
144491826|NCT03890120|520995242|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
144491827|NCT03890120|520995239|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
144716830|NCT01698320|521817831|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
144716831|NCT01698320|521817832|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
144716832|NCT02040766|521817836|FG000|Overall Study|Adverse Event|1|||
144716833|NCT02040766|521817837|FG001|Overall Study|Adverse Event|1|||
144716834|NCT02040766|521817838|FG002|Overall Study|Adverse Event|1|||
144716835|NCT02040766|521817839|FG003|Overall Study|Adverse Event|0|||
144716836|NCT02040766|521817840|FG004|Overall Study|Adverse Event|2|||
144716837|NCT02040766|521817836|FG000|Overall Study|Withdrawal by Subject|4|||
144716838|NCT02040766|521817837|FG001|Overall Study|Withdrawal by Subject|3|||
144716839|NCT02040766|521817838|FG002|Overall Study|Withdrawal by Subject|2|||
144716840|NCT02040766|521817839|FG003|Overall Study|Withdrawal by Subject|3|||
144716841|NCT02040766|521817840|FG004|Overall Study|Withdrawal by Subject|2|||
144716842|NCT02040766|521817836|FG000|Overall Study|Non-compliance|0|||
144716843|NCT02040766|521817837|FG001|Overall Study|Non-compliance|1|||
144716844|NCT02040766|521817838|FG002|Overall Study|Non-compliance|0|||
144716845|NCT02040766|521817839|FG003|Overall Study|Non-compliance|0|||
144716846|NCT02040766|521817840|FG004|Overall Study|Non-compliance|0|||
144716847|NCT02040766|521817836|FG000|Overall Study|Protocol Violation|2|||
144716848|NCT02040766|521817837|FG001|Overall Study|Protocol Violation|1|||
144716849|NCT02040766|521817838|FG002|Overall Study|Protocol Violation|2|||
144716850|NCT02040766|521817839|FG003|Overall Study|Protocol Violation|3|||
144716851|NCT02040766|521817840|FG004|Overall Study|Protocol Violation|0|||
144716852|NCT02040766|521817836|FG000|Overall Study|Lost to Follow-up|4|||
144716853|NCT02040766|521817837|FG001|Overall Study|Lost to Follow-up|1|||
144716854|NCT02040766|521817838|FG002|Overall Study|Lost to Follow-up|3|||
144716855|NCT02040766|521817839|FG003|Overall Study|Lost to Follow-up|1|||
144716856|NCT02040766|521817840|FG004|Overall Study|Lost to Follow-up|4|||
144716857|NCT02040766|521817836|FG000|Overall Study|Not reported|1|||
144716858|NCT02040766|521817837|FG001|Overall Study|Not reported|0|||
144716859|NCT02040766|521817838|FG002|Overall Study|Not reported|0|||
144716860|NCT02040766|521817839|FG003|Overall Study|Not reported|0|||
144716861|NCT02040766|521817840|FG004|Overall Study|Not reported|0|||
144716862|NCT02040766|521817836|FG000|Overall Study|Lack of Efficacy|6|||
144716863|NCT02040766|521817837|FG001|Overall Study|Lack of Efficacy|3|||
144716864|NCT02040766|521817838|FG002|Overall Study|Lack of Efficacy|4|||
144716865|NCT02040766|521817839|FG003|Overall Study|Lack of Efficacy|6|||
144716866|NCT02040766|521817840|FG004|Overall Study|Lack of Efficacy|5|||
144716867|NCT01271933|521817843|FG000|Single-Blind Phase|Lack of Efficacy|37|||
144716868|NCT01271933|521817844|FG001|Single-Blind Phase|Lack of Efficacy|0|||
144716869|NCT01271933|521817845|FG002|Single-Blind Phase|Lack of Efficacy|0|||
144716870|NCT01271933|521817843|FG000|Single-Blind Phase|Lost to Follow-up|10|||
144716871|NCT01271933|521817844|FG001|Single-Blind Phase|Lost to Follow-up|0|||
144716872|NCT01271933|521817845|FG002|Single-Blind Phase|Lost to Follow-up|0|||
144716873|NCT01271933|521817843|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
144716874|NCT01271933|521817844|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
144716875|NCT01271933|521817845|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
144716876|NCT01271933|521817843|FG000|Single-Blind Phase|Protocol Violation|3|||
144716877|NCT01271933|521817844|FG001|Single-Blind Phase|Protocol Violation|0|||
144716878|NCT01271933|521817845|FG002|Single-Blind Phase|Protocol Violation|0|||
144716879|NCT01271933|521817843|FG000|Single-Blind Phase|Adverse Event|52|||
144716880|NCT01271933|521817844|FG001|Single-Blind Phase|Adverse Event|0|||
144716881|NCT01271933|521817845|FG002|Single-Blind Phase|Adverse Event|0|||
144716882|NCT01271933|521817843|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
144716883|NCT01271933|521817844|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
144716884|NCT01271933|521817845|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
144716885|NCT01271933|521817843|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
144716886|NCT01271933|521817844|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
144716887|NCT01271933|521817845|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
144716888|NCT01271933|521817843|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
144716889|NCT01271933|521817844|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
144716890|NCT01271933|521817845|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
144716891|NCT01271933|521817843|FG000|Double-Blind Phase|Randomized but not treated|0|||
144491828|NCT03890120|520995240|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
144716892|NCT01271933|521817844|FG001|Double-Blind Phase|Randomized but not treated|0|||
144716893|NCT01271933|521817845|FG002|Double-Blind Phase|Randomized but not treated|1|||
144716894|NCT01271933|521817843|FG000|Double-Blind Phase|Lack of Efficacy|0|||
144716895|NCT01271933|521817844|FG001|Double-Blind Phase|Lack of Efficacy|6|||
144716896|NCT01271933|521817845|FG002|Double-Blind Phase|Lack of Efficacy|9|||
144716897|NCT01271933|521817843|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144716898|NCT01271933|521817844|FG001|Double-Blind Phase|Lost to Follow-up|1|||
144716899|NCT01271933|521817845|FG002|Double-Blind Phase|Lost to Follow-up|1|||
144716900|NCT01271933|521817843|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
144716901|NCT01271933|521817844|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
144369962|NCT02558296|520562761|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
144491829|NCT03890120|520995241|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
144491830|NCT03890120|520995242|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
144491831|NCT03890120|520995239|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
144491832|NCT03890120|520995240|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
144491833|NCT03890120|520995241|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
144491834|NCT03890120|520995242|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
144491835|NCT02015663|520995244|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
144491836|NCT02015663|520995245|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
144491837|NCT02015663|520995244|FG000|Overall Study|Withdrawal by Subject|1|||
144491838|NCT02015663|520995245|FG001|Overall Study|Withdrawal by Subject|0|||
144491839|NCT02015663|520995244|FG000|Overall Study|Protocol Violation|0|||
144491840|NCT02015663|520995245|FG001|Overall Study|Protocol Violation|1|||
144491841|NCT02015663|520995244|FG000|Overall Study|Adverse Event|3|||
144491842|NCT02015663|520995245|FG001|Overall Study|Adverse Event|0|||
144491843|NCT02015663|520995244|FG000|Overall Study|Administrative problems|10|||
144491844|NCT02015663|520995245|FG001|Overall Study|Administrative problems|11|||
144491845|NCT00479674|520995247|FG000|Overall Study|Adverse Event|18|||
144491846|NCT00479674|520995247|FG000|Overall Study|Withdrawal by Subject|6|||
144491847|NCT00479674|520995247|FG000|Overall Study|Physician Decision|14|||
144491848|NCT00479674|520995247|FG000|Overall Study|none provided|3|||
144491849|NCT00146640|520995253|FG000|Overall Study|Adverse Event|12|||
144491850|NCT00146640|520995254|FG001|Overall Study|Adverse Event|10|||
144716902|NCT01271933|521817845|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
144716903|NCT01271933|521817843|FG000|Double-Blind Phase|Adverse Event|0|||
144716904|NCT01271933|521817844|FG001|Double-Blind Phase|Adverse Event|3|||
144716905|NCT01271933|521817845|FG002|Double-Blind Phase|Adverse Event|0|||
144716906|NCT01271933|521817843|FG000|Double-Blind Phase|Participant request-personal reason|0|||
144716907|NCT01271933|521817844|FG001|Double-Blind Phase|Participant request-personal reason|1|||
144716908|NCT01271933|521817845|FG002|Double-Blind Phase|Participant request-personal reason|0|||
144716909|NCT01138150|521817846|FG000|Overall Study|blood unable to be processed|0|||
144716910|NCT01138150|521817847|FG001|Overall Study|blood unable to be processed|1|||
144716911|NCT01138150|521817846|FG000|Overall Study|Physician Decision|1|||
144716912|NCT01138150|521817847|FG001|Overall Study|Physician Decision|0|||
144716913|NCT01620983|521817848|FG000|Overall Study|Lost to Follow-up|8|||
144716914|NCT01620983|521817849|FG001|Overall Study|Lost to Follow-up|4|||
144716915|NCT01620983|521817850|FG002|Overall Study|Lost to Follow-up|9|||
144716916|NCT01620983|521817848|FG000|Overall Study|Withdrawal by Subject|6|||
144716917|NCT01620983|521817849|FG001|Overall Study|Withdrawal by Subject|8|||
144716918|NCT01620983|521817850|FG002|Overall Study|Withdrawal by Subject|1|||
144716919|NCT01620983|521817848|FG000|Overall Study|Death|2|||
144716920|NCT01620983|521817849|FG001|Overall Study|Death|0|||
144716921|NCT01620983|521817850|FG002|Overall Study|Death|0|||
144716922|NCT01620983|521817848|FG000|Overall Study|Physician Decision|3|||
144716923|NCT01620983|521817849|FG001|Overall Study|Physician Decision|10|||
144369963|NCT02558296|520562760|FG000|Completed the Study|Adverse Event|14|||
144369964|NCT02558296|520562761|FG001|Completed the Study|Adverse Event|5|||
144491851|NCT00146640|520995253|FG000|Overall Study|Medical Reasons|3|||
144491852|NCT00146640|520995254|FG001|Overall Study|Medical Reasons|0|||
144491853|NCT00146640|520995253|FG000|Overall Study|Non-Medical Reasons|8|||
144716924|NCT01620983|521817850|FG002|Overall Study|Physician Decision|5|||
144716925|NCT01724359|521817851|FG000|Overall Study|Adverse Event|10|||
144716926|NCT01724359|521817851|FG000|Overall Study|Death|1|||
144716927|NCT01724359|521817851|FG000|Overall Study|Other|20|||
144716928|NCT01208402|521817852|FG000|Overall Study|Withdrawal by Subject|1|||
144716929|NCT01208402|521817853|FG001|Overall Study|Withdrawal by Subject|0|||
144369965|NCT02558296|520562760|FG000|Completed the Study|Death|39|||
144369966|NCT02558296|520562761|FG001|Completed the Study|Death|25|||
144491854|NCT00146640|520995254|FG001|Overall Study|Non-Medical Reasons|4|||
144369967|NCT02558296|520562760|FG000|Completed the Study|Lost to Follow-up|31|||
144369968|NCT02558296|520562761|FG001|Completed the Study|Lost to Follow-up|23|||
144491855|NCT02059161|520995255|FG000|Overall Study|Pregnancy|0|||
144491856|NCT02059161|520995256|FG001|Overall Study|Pregnancy|2|||
144491857|NCT02059161|520995255|FG000|Overall Study|Adverse Event|2|||
144491858|NCT02059161|520995256|FG001|Overall Study|Adverse Event|6|||
144491859|NCT02059161|520995255|FG000|Overall Study|Lost to Follow-up|20|||
144491860|NCT02059161|520995256|FG001|Overall Study|Lost to Follow-up|12|||
144491861|NCT02059161|520995255|FG000|Overall Study|Physician Decision|4|||
144491862|NCT02059161|520995256|FG001|Overall Study|Physician Decision|4|||
144491863|NCT02059161|520995255|FG000|Overall Study|Protocol Violation|1|||
144491864|NCT02059161|520995256|FG001|Overall Study|Protocol Violation|1|||
144491865|NCT02059161|520995255|FG000|Overall Study|Withdrawal by Subject|16|||
144491866|NCT02059161|520995256|FG001|Overall Study|Withdrawal by Subject|13|||
144491867|NCT02059161|520995255|FG000|Overall Study|Randomized in error, no study drug|0|||
144491868|NCT02059161|520995256|FG001|Overall Study|Randomized in error, no study drug|1|||
144491869|NCT02059161|520995255|FG000|Overall Study|Non-compliance with study drug|6|||
144491870|NCT02059161|520995256|FG001|Overall Study|Non-compliance with study drug|2|||
144369969|NCT02558296|520562760|FG000|Completed the Study|Physician Decision|6|||
144369970|NCT02558296|520562761|FG001|Completed the Study|Physician Decision|0|||
144369971|NCT02558296|520562760|FG000|Completed the Study|Protocol Violation|2|||
144369972|NCT02558296|520562761|FG001|Completed the Study|Protocol Violation|1|||
144369973|NCT02558296|520562760|FG000|Completed the Study|Withdrawal by Subject|53|||
144369974|NCT02558296|520562761|FG001|Completed the Study|Withdrawal by Subject|31|||
144369975|NCT02558296|520562760|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
144716930|NCT01571635|521817854|FG000|Overall Study|Adverse Event|3|||
144716931|NCT01571635|521817855|FG001|Overall Study|Adverse Event|0|||
144716932|NCT01571635|521817856|FG002|Overall Study|Adverse Event|2|||
144716933|NCT01571635|521817857|FG003|Overall Study|Adverse Event|3|||
144716934|NCT01571635|521817858|FG004|Overall Study|Adverse Event|5|||
144716935|NCT01571635|521817854|FG000|Overall Study|Other reasons|2|||
144716936|NCT01571635|521817855|FG001|Overall Study|Other reasons|1|||
144716937|NCT01571635|521817856|FG002|Overall Study|Other reasons|2|||
144716938|NCT01571635|521817857|FG003|Overall Study|Other reasons|2|||
144716939|NCT01571635|521817858|FG004|Overall Study|Other reasons|1|||
144716940|NCT01571635|521817854|FG000|Overall Study|Study terminated by sponsor|0|||
144716941|NCT01571635|521817855|FG001|Overall Study|Study terminated by sponsor|4|||
144716942|NCT01571635|521817856|FG002|Overall Study|Study terminated by sponsor|1|||
144716943|NCT01571635|521817857|FG003|Overall Study|Study terminated by sponsor|3|||
144716944|NCT01571635|521817858|FG004|Overall Study|Study terminated by sponsor|1|||
144716945|NCT01571635|521817854|FG000|Overall Study|Withdrew consent|1|||
144491871|NCT03293485|520995257|FG000|Overall Study|Death|1|||
144716946|NCT01571635|521817855|FG001|Overall Study|Withdrew consent|1|||
144716947|NCT01571635|521817856|FG002|Overall Study|Withdrew consent|2|||
144716948|NCT01571635|521817857|FG003|Overall Study|Withdrew consent|3|||
144716949|NCT01571635|521817858|FG004|Overall Study|Withdrew consent|0|||
144716950|NCT01571635|521817854|FG000|Overall Study|Lack of Efficacy|0|||
144716951|NCT01571635|521817855|FG001|Overall Study|Lack of Efficacy|2|||
144716952|NCT01571635|521817856|FG002|Overall Study|Lack of Efficacy|0|||
144716953|NCT01571635|521817857|FG003|Overall Study|Lack of Efficacy|1|||
144716954|NCT01571635|521817858|FG004|Overall Study|Lack of Efficacy|2|||
144716955|NCT01335464|521817859|FG000|Overall Study|Adverse Event|15|||
144716956|NCT01335464|521817860|FG001|Overall Study|Adverse Event|25|||
144716957|NCT01335464|521817859|FG000|Overall Study|Non compliant with protocol|2|||
144716958|NCT01335464|521817860|FG001|Overall Study|Non compliant with protocol|0|||
144716959|NCT01335464|521817859|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
144716960|NCT01335464|521817860|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
144716961|NCT01335464|521817859|FG000|Overall Study|Not treated|2|||
144716962|NCT01335464|521817860|FG001|Overall Study|Not treated|0|||
144716963|NCT01335464|521817859|FG000|Overall Study|Reason other than those stated above|1|||
144716964|NCT01335464|521817860|FG001|Overall Study|Reason other than those stated above|1|||
144716965|NCT01783730|521817863|FG000|Overall Study|Failed to meet inclusion criteria|6|||
144716966|NCT02151461|521817864|FG000|Overall Study|Adverse Event|5|||
144716967|NCT02151461|521817865|FG001|Overall Study|Adverse Event|1|||
144716968|NCT02151461|521817866|FG002|Overall Study|Adverse Event|0|||
144716969|NCT02151461|521817867|FG003|Overall Study|Adverse Event|2|||
144716970|NCT02151461|521817864|FG000|Overall Study|Lost to Follow-up|0|||
144716971|NCT02151461|521817865|FG001|Overall Study|Lost to Follow-up|0|||
144716972|NCT02151461|521817866|FG002|Overall Study|Lost to Follow-up|1|||
144716973|NCT02151461|521817867|FG003|Overall Study|Lost to Follow-up|1|||
144716974|NCT02151461|521817864|FG000|Overall Study|Withdrawal by Subject|1|||
144716975|NCT02151461|521817865|FG001|Overall Study|Withdrawal by Subject|0|||
144716976|NCT02151461|521817866|FG002|Overall Study|Withdrawal by Subject|1|||
144716977|NCT02151461|521817867|FG003|Overall Study|Withdrawal by Subject|1|||
144716978|NCT02151461|521817864|FG000|Overall Study|Treatment discontinuation|0|||
144716979|NCT02151461|521817865|FG001|Overall Study|Treatment discontinuation|0|||
144716980|NCT02151461|521817866|FG002|Overall Study|Treatment discontinuation|1|||
144716981|NCT02151461|521817867|FG003|Overall Study|Treatment discontinuation|0|||
144716982|NCT00871169|521817868|FG000|Overall Study|Protocol Violation|1|||
144716983|NCT00871169|521817868|FG000|Overall Study|Patient did not receive study treatment|2|||
144716984|NCT00252187|521817869|FG000|Overall Study|Adverse Event|3|||
144716985|NCT00252187|521817870|FG001|Overall Study|Adverse Event|1|||
144716986|NCT00252187|521817869|FG000|Overall Study|Withdrawal by Subject|1|||
144716987|NCT00252187|521817870|FG001|Overall Study|Withdrawal by Subject|0|||
144716988|NCT00706706|521817871|FG000|Overall Study|Death|53|||
144716989|NCT00706706|521817871|FG000|Overall Study|Lost to Follow-up|7|||
144716990|NCT00706706|521817871|FG000|Overall Study|Study endpoint had reached|45|||
144716991|NCT02280356|521817883|FG000|Overall Study|Not Treated|2|||
144716992|NCT02280356|521817883|FG000|Overall Study|Withdrawal by Subject|1|||
144716993|NCT02280356|521817883|FG000|Overall Study|Not evaluable|2|||
144716994|NCT03493698|521817884|FG000|Treatment Period C|Adverse Event|1|||
144716995|NCT03493698|521817884|FG000|Treatment Period C|Withdrawal by Subject|1|||
144716996|NCT03361956|521817885|FG000|Overall Study|Adverse Event|1|||
144716997|NCT03361956|521817886|FG001|Overall Study|Adverse Event|0|||
144716998|NCT03361956|521817887|FG002|Overall Study|Adverse Event|1|||
144716999|NCT03361956|521817888|FG003|Overall Study|Adverse Event|1|||
144717000|NCT03361956|521817889|FG004|Overall Study|Adverse Event|0|||
144717001|NCT03361956|521817885|FG000|Overall Study|Other|0|||
144717002|NCT03361956|521817886|FG001|Overall Study|Other|0|||
144491872|NCT03293485|520995257|FG000|Overall Study|Screen Failure|2|||
144491873|NCT03293485|520995257|FG000|Overall Study|Withdrawal by Subject|2|||
144717003|NCT03361956|521817887|FG002|Overall Study|Other|0|||
144717004|NCT03361956|521817888|FG003|Overall Study|Other|1|||
144717005|NCT03361956|521817889|FG004|Overall Study|Other|0|||
144717006|NCT03361956|521817885|FG000|Overall Study|Withdrawal by Subject|2|||
144717007|NCT03361956|521817886|FG001|Overall Study|Withdrawal by Subject|2|||
144717008|NCT03361956|521817887|FG002|Overall Study|Withdrawal by Subject|2|||
144717009|NCT03361956|521817888|FG003|Overall Study|Withdrawal by Subject|0|||
144717010|NCT03361956|521817889|FG004|Overall Study|Withdrawal by Subject|3|||
144717011|NCT03361956|521817885|FG000|Overall Study|Disease Relapse|0|||
144717012|NCT03361956|521817886|FG001|Overall Study|Disease Relapse|0|||
144717013|NCT03361956|521817887|FG002|Overall Study|Disease Relapse|1|||
144717014|NCT03361956|521817888|FG003|Overall Study|Disease Relapse|0|||
144717015|NCT03361956|521817889|FG004|Overall Study|Disease Relapse|0|||
144717016|NCT03361956|521817885|FG000|Overall Study|Physician Decision|0|||
144717017|NCT03361956|521817886|FG001|Overall Study|Physician Decision|2|||
144717018|NCT03361956|521817887|FG002|Overall Study|Physician Decision|0|||
144717019|NCT03361956|521817888|FG003|Overall Study|Physician Decision|1|||
144717020|NCT03361956|521817889|FG004|Overall Study|Physician Decision|0|||
144717021|NCT03361956|521817885|FG000|Overall Study|Lost to Follow-up|0|||
144717022|NCT03361956|521817886|FG001|Overall Study|Lost to Follow-up|0|||
144717023|NCT03361956|521817887|FG002|Overall Study|Lost to Follow-up|1|||
144717024|NCT03361956|521817888|FG003|Overall Study|Lost to Follow-up|1|||
144717025|NCT03361956|521817889|FG004|Overall Study|Lost to Follow-up|2|||
144717026|NCT02173301|521817891|FG000|Overall Study|Adverse Event|7|||
144717027|NCT02173301|521817892|FG001|Overall Study|Adverse Event|8|||
144717028|NCT02173301|521817893|FG002|Overall Study|Adverse Event|13|||
144717029|NCT02173301|521817894|FG003|Overall Study|Adverse Event|5|||
144717030|NCT02173301|521817891|FG000|Overall Study|Withdrawal by Subject|8|||
144717031|NCT02173301|521817892|FG001|Overall Study|Withdrawal by Subject|10|||
144717032|NCT02173301|521817893|FG002|Overall Study|Withdrawal by Subject|4|||
144717033|NCT02173301|521817894|FG003|Overall Study|Withdrawal by Subject|8|||
144717034|NCT02173301|521817891|FG000|Overall Study|Lost to Follow-up|4|||
144717035|NCT02173301|521817892|FG001|Overall Study|Lost to Follow-up|4|||
144717036|NCT02173301|521817893|FG002|Overall Study|Lost to Follow-up|2|||
144717037|NCT02173301|521817894|FG003|Overall Study|Lost to Follow-up|2|||
144717038|NCT02173301|521817891|FG000|Overall Study|Protocol Violation|0|||
144717039|NCT02173301|521817892|FG001|Overall Study|Protocol Violation|1|||
144717040|NCT02173301|521817893|FG002|Overall Study|Protocol Violation|0|||
144717041|NCT02173301|521817894|FG003|Overall Study|Protocol Violation|0|||
144717042|NCT02173301|521817891|FG000|Overall Study|Physician Decision|0|||
144717043|NCT02173301|521817892|FG001|Overall Study|Physician Decision|0|||
144717044|NCT02173301|521817893|FG002|Overall Study|Physician Decision|1|||
144717045|NCT02173301|521817894|FG003|Overall Study|Physician Decision|0|||
144717046|NCT02173301|521817891|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
144717047|NCT02173301|521817892|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
144717048|NCT02173301|521817893|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
144717049|NCT02173301|521817894|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
144717050|NCT01606137|521817895|FG000|Overall Study|Adverse Event|85|||
144717051|NCT01606137|521817895|FG000|Overall Study|Withdrawal by Subject|74|||
144717052|NCT01606137|521817895|FG000|Overall Study|Lack of Efficacy|56|||
144717053|NCT01606137|521817895|FG000|Overall Study|Lost to Follow-up|15|||
144717054|NCT01606137|521817895|FG000|Overall Study|Protocol Violation|1|||
144717055|NCT01606137|521817895|FG000|Overall Study|Patient non-compliance|9|||
144717056|NCT01606137|521817895|FG000|Overall Study|Death|1|||
144717057|NCT01606137|521817895|FG000|Overall Study|Decreased/no pain|4|||
144717058|NCT01606137|521817895|FG000|Overall Study|Issues with driving|4|||
144717059|NCT01606137|521817895|FG000|Overall Study|multiple sclerosis less stable|1|||
144717060|NCT01606137|521817895|FG000|Overall Study|Increased bilirubin|1|||
144717061|NCT01606137|521817895|FG000|Overall Study|Spray causes nausea|1|||
144717062|NCT01606137|521817895|FG000|Overall Study|Not enough improvement|4|||
144717063|NCT01606137|521817895|FG000|Overall Study|Wanted to try another treatment|1|||
144717064|NCT01606137|521817895|FG000|Overall Study|Patient leaving country|1|||
144717065|NCT01606137|521817895|FG000|Overall Study|Personal reasons|1|||
144717066|NCT01606137|521817895|FG000|Overall Study|Unable to tolerate study med. taste|1|||
144717067|NCT01606137|521817895|FG000|Overall Study|Patient moving|1|||
144717068|NCT01606137|521817895|FG000|Overall Study|Unable to collect consistent data|1|||
144717069|NCT00254397|521817896|FG000|Overall Study|Disease Progression|4|||
144717070|NCT00254397|521817897|FG001|Overall Study|Disease Progression|1|||
144717071|NCT00254397|521817898|FG002|Overall Study|Disease Progression|16|||
144717072|NCT00254397|521817899|FG003|Overall Study|Disease Progression|23|||
144717073|NCT00254397|521817896|FG000|Overall Study|Non-Compliant|0|||
144717074|NCT00254397|521817897|FG001|Overall Study|Non-Compliant|0|||
144717075|NCT00254397|521817898|FG002|Overall Study|Non-Compliant|0|||
144717076|NCT00254397|521817899|FG003|Overall Study|Non-Compliant|1|||
144717077|NCT00254397|521817896|FG000|Overall Study|Adverse Event|2|||
144717078|NCT00254397|521817897|FG001|Overall Study|Adverse Event|0|||
144717079|NCT00254397|521817898|FG002|Overall Study|Adverse Event|3|||
144717080|NCT00254397|521817899|FG003|Overall Study|Adverse Event|1|||
144717081|NCT00066807|521817900|FG000|Overall Study|Study was terminated early|14|||
144717082|NCT00066807|521817901|FG001|Overall Study|Study was terminated early|15|||
144717083|NCT05028751|521817902|FG000|Overall Study|Study Terminated by Sponsor|3|||
144717084|NCT05028751|521817903|FG001|Overall Study|Study Terminated by Sponsor|0|||
144717085|NCT05028751|521817904|FG002|Overall Study|Study Terminated by Sponsor|0|||
144717086|NCT05028751|521817905|FG003|Overall Study|Study Terminated by Sponsor|0|||
144717087|NCT05028751|521817902|FG000|Overall Study|Death|9|||
144717088|NCT05028751|521817903|FG001|Overall Study|Death|3|||
144717089|NCT05028751|521817904|FG002|Overall Study|Death|2|||
144717090|NCT05028751|521817905|FG003|Overall Study|Death|4|||
144717091|NCT05028751|521817902|FG000|Overall Study|Withdrawal by Subject|0|||
144717092|NCT05028751|521817903|FG001|Overall Study|Withdrawal by Subject|0|||
144717093|NCT05028751|521817904|FG002|Overall Study|Withdrawal by Subject|1|||
144717094|NCT05028751|521817905|FG003|Overall Study|Withdrawal by Subject|0|||
144717095|NCT05028751|521817902|FG000|Overall Study|Miscellaneous|2|||
144717096|NCT05028751|521817903|FG001|Overall Study|Miscellaneous|0|||
144717097|NCT05028751|521817904|FG002|Overall Study|Miscellaneous|0|||
144717098|NCT05028751|521817905|FG003|Overall Study|Miscellaneous|0|||
144717099|NCT04578548|521817906|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
144717100|NCT04578548|521817907|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
144717101|NCT04578548|521817906|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
144717102|NCT04578548|521817907|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
144717103|NCT04578548|521817906|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
144717104|NCT04578548|521817907|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
144717105|NCT04578548|521817906|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
144717106|NCT04578548|521817907|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
144717107|NCT04578548|521817906|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
144717108|NCT04578548|521817907|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
144717109|NCT04578548|521817906|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
144717110|NCT04578548|521817907|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
144717111|NCT00972153|521817910|FG000|Overall Study|Equipment malfunction during case|0|||
144717112|NCT00972153|521817911|FG001|Overall Study|Equipment malfunction during case|1|||
144717113|NCT00972153|521817912|FG002|Overall Study|Equipment malfunction during case|0|||
144717114|NCT01077713|521817913|FG000|Overall Study|Withdrawal by Subject|1|||
144717115|NCT01077713|521817914|FG001|Overall Study|Withdrawal by Subject|2|||
144717116|NCT01077713|521817913|FG000|Overall Study|Progressive Disease (PD)|0|||
144717117|NCT01077713|521817914|FG001|Overall Study|Progressive Disease (PD)|1|||
144717118|NCT01077713|521817913|FG000|Overall Study|Death|28|||
144717119|NCT01077713|521817914|FG001|Overall Study|Death|29|||
144717120|NCT01077713|521817913|FG000|Overall Study|Lost to Follow-up|1|||
144717121|NCT01077713|521817914|FG001|Overall Study|Lost to Follow-up|1|||
144717122|NCT01077713|521817913|FG000|Overall Study|Adverse Event|2|||
144717123|NCT01077713|521817914|FG001|Overall Study|Adverse Event|1|||
144717124|NCT01077713|521817913|FG000|Overall Study|Other|4|||
144717125|NCT01077713|521817914|FG001|Overall Study|Other|2|||
144471680|NCT00246337|520925258|FG006|Overall Study|Reported as completing trial in error|0|||
144491874|NCT01723826|520995261|FG000|Overall Study|Adverse Event|4|||
144491875|NCT01723826|520995262|FG001|Overall Study|Adverse Event|1|||
144491876|NCT01723826|520995263|FG002|Overall Study|Adverse Event|4|||
144491877|NCT01723826|520995264|FG003|Overall Study|Adverse Event|5|||
144491878|NCT01723826|520995261|FG000|Overall Study|Death according to AE eCRF|2|||
144491879|NCT01723826|520995262|FG001|Overall Study|Death according to AE eCRF|3|||
144491880|NCT01723826|520995263|FG002|Overall Study|Death according to AE eCRF|3|||
144491881|NCT01723826|520995264|FG003|Overall Study|Death according to AE eCRF|7|||
144491882|NCT01723826|520995261|FG000|Overall Study|Lost to Follow-up|1|||
144491883|NCT01723826|520995262|FG001|Overall Study|Lost to Follow-up|3|||
144491884|NCT01723826|520995263|FG002|Overall Study|Lost to Follow-up|1|||
144491885|NCT01723826|520995264|FG003|Overall Study|Lost to Follow-up|1|||
144491886|NCT01723826|520995261|FG000|Overall Study|Non-compliance|0|||
144491887|NCT01723826|520995262|FG001|Overall Study|Non-compliance|1|||
144491888|NCT01723826|520995263|FG002|Overall Study|Non-compliance|3|||
144491889|NCT01723826|520995264|FG003|Overall Study|Non-compliance|3|||
144491890|NCT01723826|520995261|FG000|Overall Study|Non-compliance With Study Drug|0|||
144491891|NCT01723826|520995262|FG001|Overall Study|Non-compliance With Study Drug|1|||
144491892|NCT01723826|520995263|FG002|Overall Study|Non-compliance With Study Drug|0|||
144491893|NCT01723826|520995264|FG003|Overall Study|Non-compliance With Study Drug|0|||
144491894|NCT01723826|520995261|FG000|Overall Study|Other Reason|8|||
144491895|NCT01723826|520995262|FG001|Overall Study|Other Reason|6|||
144491896|NCT01723826|520995263|FG002|Overall Study|Other Reason|12|||
144491897|NCT01723826|520995264|FG003|Overall Study|Other Reason|14|||
144491898|NCT01723826|520995261|FG000|Overall Study|Physician Decision|1|||
144491899|NCT01723826|520995262|FG001|Overall Study|Physician Decision|3|||
144491900|NCT01723826|520995263|FG002|Overall Study|Physician Decision|4|||
144491901|NCT01723826|520995264|FG003|Overall Study|Physician Decision|11|||
144471681|NCT00246337|520925259|FG007|Overall Study|Reported as completing trial in error|1|||
144491902|NCT01723826|520995261|FG000|Overall Study|Protocol Violation|1|||
144491903|NCT01723826|520995262|FG001|Overall Study|Protocol Violation|1|||
144491904|NCT01723826|520995263|FG002|Overall Study|Protocol Violation|3|||
144491905|NCT01723826|520995264|FG003|Overall Study|Protocol Violation|1|||
144491906|NCT01723826|520995261|FG000|Overall Study|Withdrawal by Subject|10|||
144717126|NCT00628745|521817915|FG000|Overall Study|Withdrawal by Subject|63|||
144717127|NCT00628745|521817916|FG001|Overall Study|Withdrawal by Subject|3|||
144717128|NCT00628745|521817917|FG002|Overall Study|Withdrawal by Subject|9|||
144717129|NCT00628745|521817918|FG003|Overall Study|Withdrawal by Subject|2|||
144717130|NCT00628745|521817919|FG004|Overall Study|Withdrawal by Subject|69|||
144717131|NCT00628745|521817915|FG000|Overall Study|Does not meet inclusion criteria|0|||
144717132|NCT00628745|521817916|FG001|Overall Study|Does not meet inclusion criteria|12|||
144717133|NCT00628745|521817917|FG002|Overall Study|Does not meet inclusion criteria|0|||
144717134|NCT00628745|521817918|FG003|Overall Study|Does not meet inclusion criteria|0|||
144717135|NCT00628745|521817919|FG004|Overall Study|Does not meet inclusion criteria|18|||
144717136|NCT00628745|521817915|FG000|Overall Study|Participation in an interventional clinical trial|81|||
144717137|NCT00628745|521817916|FG001|Overall Study|Participation in an interventional clinical trial|4|||
144717138|NCT00628745|521817917|FG002|Overall Study|Participation in an interventional clinical trial|7|||
144717139|NCT00628745|521817918|FG003|Overall Study|Participation in an interventional clinical trial|0|||
144717140|NCT00628745|521817919|FG004|Overall Study|Participation in an interventional clinical trial|63|||
144717141|NCT00628745|521817915|FG000|Overall Study|Physician Decision|8|||
144717142|NCT00628745|521817916|FG001|Overall Study|Physician Decision|4|||
144717143|NCT00628745|521817917|FG002|Overall Study|Physician Decision|3|||
144717144|NCT00628745|521817918|FG003|Overall Study|Physician Decision|0|||
144717145|NCT00628745|521817919|FG004|Overall Study|Physician Decision|30|||
144717146|NCT00628745|521817915|FG000|Overall Study|Lost to Follow-up|109|||
144717147|NCT00628745|521817916|FG001|Overall Study|Lost to Follow-up|7|||
144717148|NCT00628745|521817917|FG002|Overall Study|Lost to Follow-up|7|||
144717149|NCT00628745|521817918|FG003|Overall Study|Lost to Follow-up|0|||
144717150|NCT00628745|521817919|FG004|Overall Study|Lost to Follow-up|498|||
144717151|NCT00628745|521817915|FG000|Overall Study|Death|197|||
144717152|NCT00628745|521817916|FG001|Overall Study|Death|81|||
144717153|NCT00628745|521817917|FG002|Overall Study|Death|12|||
144717154|NCT00628745|521817918|FG003|Overall Study|Death|4|||
144717155|NCT00628745|521817919|FG004|Overall Study|Death|939|||
144717156|NCT00628745|521817915|FG000|Overall Study|Participant transferred to another THAOS site|6|||
144717157|NCT00628745|521817916|FG001|Overall Study|Participant transferred to another THAOS site|0|||
144717158|NCT00628745|521817917|FG002|Overall Study|Participant transferred to another THAOS site|0|||
144717159|NCT00628745|521817918|FG003|Overall Study|Participant transferred to another THAOS site|0|||
144717160|NCT00628745|521817919|FG004|Overall Study|Participant transferred to another THAOS site|7|||
144717161|NCT00628745|521817915|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
144717162|NCT00628745|521817916|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
144717163|NCT00628745|521817917|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
144717164|NCT00628745|521817918|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
144717165|NCT00628745|521817919|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
144717166|NCT00628745|521817915|FG000|Overall Study|Site closure|152|||
144717167|NCT00628745|521817916|FG001|Overall Study|Site closure|146|||
144717168|NCT00628745|521817917|FG002|Overall Study|Site closure|6|||
144717169|NCT00628745|521817918|FG003|Overall Study|Site closure|8|||
144717170|NCT00628745|521817919|FG004|Overall Study|Site closure|691|||
144717171|NCT00628745|521817915|FG000|Overall Study|Duplicate participant|0|||
144717172|NCT00628745|521817916|FG001|Overall Study|Duplicate participant|0|||
144717173|NCT00628745|521817917|FG002|Overall Study|Duplicate participant|0|||
144717174|NCT00628745|521817918|FG003|Overall Study|Duplicate participant|0|||
144717175|NCT00628745|521817919|FG004|Overall Study|Duplicate participant|1|||
144717176|NCT00628745|521817915|FG000|Overall Study|Missing|4|||
144717177|NCT00628745|521817916|FG001|Overall Study|Missing|3|||
144717178|NCT00628745|521817917|FG002|Overall Study|Missing|0|||
144717179|NCT00628745|521817918|FG003|Overall Study|Missing|0|||
144717180|NCT00628745|521817919|FG004|Overall Study|Missing|10|||
144717181|NCT00628745|521817915|FG000|Overall Study|Othe reasons|987|||
144717182|NCT00628745|521817916|FG001|Overall Study|Othe reasons|373|||
144717183|NCT00628745|521817917|FG002|Overall Study|Othe reasons|105|||
144717184|NCT00628745|521817918|FG003|Overall Study|Othe reasons|1|||
144717185|NCT00628745|521817919|FG004|Overall Study|Othe reasons|1772|||
144717186|NCT03322462|521819936|FG000|Overall Study|Technical difficulties|2|||
144717187|NCT03322462|521819936|FG000|Overall Study|Other|1|||
144717188|NCT00720798|521819942|FG000|Overall Study|Adverse Event|304|||
144717189|NCT00720798|521819942|FG000|Overall Study|Death|39|||
144717190|NCT00720798|521819942|FG000|Overall Study|Insufficient Therapeutic Response|129|||
144717191|NCT00720798|521819942|FG000|Overall Study|Protocol Violation|4|||
144717192|NCT00720798|521819942|FG000|Overall Study|Refused Treatment|151|||
144717193|NCT00720798|521819942|FG000|Overall Study|Failure to Return|46|||
144717194|NCT00720798|521819942|FG000|Overall Study|Reason not Specified|83|||
144717195|NCT00433381|521819943|FG000|Overall Study|Ineligible / no protocol treatment|3|||
144491907|NCT01723826|520995262|FG001|Overall Study|Withdrawal by Subject|17|||
144491908|NCT01723826|520995263|FG002|Overall Study|Withdrawal by Subject|27|||
144491909|NCT01723826|520995264|FG003|Overall Study|Withdrawal by Subject|48|||
144491910|NCT03633903|520995267|FG000|Overall Study|Withdrawal by Subject|1|||
144491911|NCT03633903|520995268|FG001|Overall Study|Withdrawal by Subject|2|||
144491912|NCT03633903|520995267|FG000|Overall Study|Lost to Follow-up|5|||
144491913|NCT03633903|520995268|FG001|Overall Study|Lost to Follow-up|5|||
144491914|NCT00419003|520995279|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
144491915|NCT00419003|520995280|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
144491916|NCT00419003|520995279|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
144491917|NCT00419003|520995280|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
144491918|NCT02687919|520995281|FG000|Overall Study|Withdrawal by Subject|6|||
144491919|NCT02687919|520995282|FG001|Overall Study|Withdrawal by Subject|6|||
144491920|NCT02687919|520995281|FG000|Overall Study|Protocol Violation|2|||
144491921|NCT02687919|520995282|FG001|Overall Study|Protocol Violation|0|||
144491922|NCT00131911|520995283|FG000|Overall Study|Withdrawal by Subject|1|||
144491923|NCT00131911|520995284|FG001|Overall Study|Withdrawal by Subject|0|||
144491924|NCT01606189|520995287|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
144369976|NCT02558296|520562761|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
144491925|NCT01606189|520995288|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
144491926|NCT01606189|520995289|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
144491927|NCT01606189|520995290|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
144717196|NCT00433381|521819944|FG001|Overall Study|Ineligible / no protocol treatment|3|||
144717197|NCT00434161|521819945|FG000|Overall Study|Adverse Event|5|||
144717198|NCT00434161|521819946|FG001|Overall Study|Adverse Event|1|||
144717199|NCT00434161|521819947|FG002|Overall Study|Adverse Event|4|||
144717200|NCT00434161|521819945|FG000|Overall Study|Lost to Follow-up|0|||
144717201|NCT00434161|521819946|FG001|Overall Study|Lost to Follow-up|1|||
144717202|NCT00434161|521819947|FG002|Overall Study|Lost to Follow-up|0|||
144717203|NCT00434161|521819945|FG000|Overall Study|Death|1|||
144491928|NCT01606189|520995291|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
144717204|NCT00434161|521819946|FG001|Overall Study|Death|0|||
144717205|NCT00434161|521819947|FG002|Overall Study|Death|1|||
144717206|NCT00434161|521819945|FG000|Overall Study|Non-Compliance|1|||
144717207|NCT00434161|521819946|FG001|Overall Study|Non-Compliance|1|||
144491929|NCT01606189|520995292|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
144491930|NCT01606189|520995287|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
144491931|NCT01606189|520995288|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
144491932|NCT01606189|520995289|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
144491933|NCT01606189|520995290|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
144491934|NCT01606189|520995291|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
144491935|NCT01606189|520995292|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
144491936|NCT01354938|520995293|FG000|Overall Study|Lost to Follow-up|1|||
144491937|NCT01167023|520995294|FG000|Overall Study|Lost to Follow-up|0|||
144491938|NCT01167023|520995295|FG001|Overall Study|Lost to Follow-up|1|||
144491939|NCT01167023|520995296|FG002|Overall Study|Lost to Follow-up|1|||
144491940|NCT01167023|520995294|FG000|Overall Study|Screen Failure|0|||
144491941|NCT01167023|520995295|FG001|Overall Study|Screen Failure|1|||
144491942|NCT01167023|520995296|FG002|Overall Study|Screen Failure|0|||
144491943|NCT01167023|520995294|FG000|Overall Study|Sponsor Decision|0|||
144717208|NCT00434161|521819947|FG002|Overall Study|Non-Compliance|0|||
144717209|NCT00434161|521819945|FG000|Overall Study|Withdrawal by Subject|2|||
144717210|NCT00434161|521819946|FG001|Overall Study|Withdrawal by Subject|0|||
144717211|NCT00434161|521819947|FG002|Overall Study|Withdrawal by Subject|3|||
144717212|NCT00434161|521819945|FG000|Overall Study|Logistical error study assessments|1|||
144717213|NCT00434161|521819946|FG001|Overall Study|Logistical error study assessments|0|||
144717214|NCT00434161|521819947|FG002|Overall Study|Logistical error study assessments|3|||
144717215|NCT01003886|521819948|FG000|Overall Study|Lack of Efficacy|5|||
144717216|NCT01003886|521819948|FG000|Overall Study|Lost to Follow-up|169|||
144717217|NCT01003886|521819948|FG000|Overall Study|Withdrawal by Subject|39|||
144717218|NCT01003886|521819948|FG000|Overall Study|Other|14|||
144717219|NCT01003886|521819948|FG000|Overall Study|Adverse Event|3|||
144717220|NCT04467697|521819965|FG000|Overall Study|Adverse Event|2|||
144717221|NCT04467697|521819965|FG000|Overall Study|Lost to Follow-up|6|||
144717222|NCT04467697|521819965|FG000|Overall Study|Withdrawal by Subject|9|||
144717223|NCT04467697|521819965|FG000|Overall Study|Protocol Violation|3|||
144717224|NCT05751629|521819966|FG000|Overall Study|Withdrawal by Subject|6|||
144717225|NCT05751629|521819966|FG000|Overall Study|Death|25|||
144491944|NCT01167023|520995295|FG001|Overall Study|Sponsor Decision|1|||
144491945|NCT01167023|520995296|FG002|Overall Study|Sponsor Decision|0|||
144717226|NCT05751629|521819966|FG000|Overall Study|Study Site Closed|9|||
144717227|NCT05751629|521819966|FG000|Overall Study|Physician Decision|1|||
144717228|NCT00673361|521819972|FG000|Overall Study|Screen Failure|2|||
144717229|NCT03038113|521819977|FG000|Overall Study|Withdrawal by Subject|0|||
144717230|NCT03038113|521819978|FG001|Overall Study|Withdrawal by Subject|0|||
144491946|NCT01167023|520995294|FG000|Overall Study|Withdrawal by Subject|0|||
144491947|NCT01167023|520995295|FG001|Overall Study|Withdrawal by Subject|0|||
144491948|NCT01167023|520995296|FG002|Overall Study|Withdrawal by Subject|1|||
144491949|NCT01708954|520995301|FG000|Step 1|Disease progression|26|||
144491950|NCT01708954|520995302|FG001|Step 1|Disease progression|17|||
144491951|NCT01708954|520995303|FG002|Step 1|Disease progression|14|||
144491952|NCT01708954|520995301|FG000|Step 1|Adverse Event|3|||
144491953|NCT01708954|520995302|FG001|Step 1|Adverse Event|11|||
144491954|NCT01708954|520995303|FG002|Step 1|Adverse Event|13|||
144491955|NCT01708954|520995301|FG000|Step 1|Death|3|||
144491956|NCT01708954|520995302|FG001|Step 1|Death|2|||
144491957|NCT01708954|520995303|FG002|Step 1|Death|3|||
144491958|NCT01708954|520995301|FG000|Step 1|Withdrawal by Subject|2|||
144491959|NCT01708954|520995302|FG001|Step 1|Withdrawal by Subject|5|||
144491960|NCT01708954|520995303|FG002|Step 1|Withdrawal by Subject|3|||
144491961|NCT01708954|520995301|FG000|Step 1|Other complicating disease|0|||
144491962|NCT01708954|520995302|FG001|Step 1|Other complicating disease|2|||
144491963|NCT01708954|520995303|FG002|Step 1|Other complicating disease|0|||
144369977|NCT02919995|520562765|FG000|Overall Study|Adverse Event|0|||
144491964|NCT01708954|520995301|FG000|Step 1|Crossed over to Step 2|2|||
144491965|NCT01708954|520995302|FG001|Step 1|Crossed over to Step 2|0|||
144369978|NCT02919995|520562766|FG001|Overall Study|Adverse Event|0|||
144491966|NCT01708954|520995303|FG002|Step 1|Crossed over to Step 2|0|||
144491967|NCT01708954|520995301|FG000|Step 1|Symptomatic deterioration|1|||
144491968|NCT01708954|520995302|FG001|Step 1|Symptomatic deterioration|0|||
144491969|NCT01708954|520995303|FG002|Step 1|Symptomatic deterioration|1|||
144491970|NCT01708954|520995301|FG000|Step 1|Off-treatment reason not submitted|1|||
144491971|NCT01708954|520995302|FG001|Step 1|Off-treatment reason not submitted|1|||
144491972|NCT01708954|520995303|FG002|Step 1|Off-treatment reason not submitted|1|||
144491973|NCT01708954|520995301|FG000|Step 1|Ineligible or never received treatment|4|||
144491974|NCT01708954|520995302|FG001|Step 1|Ineligible or never received treatment|2|||
144491975|NCT01708954|520995303|FG002|Step 1|Ineligible or never received treatment|8|||
144491976|NCT01708954|520995301|FG000|Step 2|Disease progression|9|||
144491977|NCT01708954|520995302|FG001|Step 2|Disease progression|4|||
144491978|NCT01708954|520995303|FG002|Step 2|Disease progression|0|||
144491979|NCT01708954|520995301|FG000|Step 2|Adverse Event|3|||
144491980|NCT01708954|520995302|FG001|Step 2|Adverse Event|2|||
144491981|NCT01708954|520995303|FG002|Step 2|Adverse Event|0|||
144491982|NCT01708954|520995301|FG000|Step 2|Withdrawal by Subject|1|||
144491983|NCT01708954|520995302|FG001|Step 2|Withdrawal by Subject|1|||
144491984|NCT01708954|520995303|FG002|Step 2|Withdrawal by Subject|0|||
144491985|NCT00114959|520995314|FG000|Overall Study|Lack of Efficacy|6|||
144491986|NCT00114959|520995314|FG000|Overall Study|Physician Decision|1|||
144491987|NCT00114959|520995314|FG000|Overall Study|Death|1|||
144491988|NCT04951479|520995315|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
144491989|NCT00729690|520995316|FG000|Overall Study|IT Catheter Malfunction|0|||
144491990|NCT00729690|520995317|FG001|Overall Study|IT Catheter Malfunction|2|||
144491991|NCT00729690|520995318|FG002|Overall Study|IT Catheter Malfunction|2|||
144491992|NCT00394095|520996957|FG000|Screening|Withdrawal by Subject|1|||
144491993|NCT00394095|520996958|FG001|Screening|Withdrawal by Subject|0|||
144491994|NCT00394095|520996957|FG000|Randomized|Withdrawal by Subject|5|||
144491995|NCT00394095|520996958|FG001|Randomized|Withdrawal by Subject|1|||
144491996|NCT00394095|520996957|FG000|Randomized|Adverse Event|1|||
144491997|NCT00394095|520996958|FG001|Randomized|Adverse Event|1|||
144491998|NCT00394095|520996957|FG000|Randomized|Overdose|1|||
144491999|NCT00394095|520996958|FG001|Randomized|Overdose|0|||
144492000|NCT00394095|520996957|FG000|Randomized|Lost to Follow-up|1|||
144492001|NCT00394095|520996958|FG001|Randomized|Lost to Follow-up|2|||
144492002|NCT01256476|520996960|FG000|Overall Study|Adverse Event|2|||
144492003|NCT01256476|520996961|FG001|Overall Study|Adverse Event|1|||
144492004|NCT01256476|520996960|FG000|Overall Study|Withdrawal by Subject|2|||
144492005|NCT01256476|520996961|FG001|Overall Study|Withdrawal by Subject|1|||
144492006|NCT01256476|520996960|FG000|Overall Study|Lost to Follow-up|1|||
144492007|NCT01256476|520996961|FG001|Overall Study|Lost to Follow-up|2|||
144492008|NCT01256476|520996960|FG000|Overall Study|Persistent ALT or AST elevation|1|||
144492009|NCT01256476|520996961|FG001|Overall Study|Persistent ALT or AST elevation|0|||
144492010|NCT01256476|520996960|FG000|Overall Study|Physician Decision|0|||
144492011|NCT01256476|520996961|FG001|Overall Study|Physician Decision|1|||
144492012|NCT01256476|520996960|FG000|Overall Study|Subject non-compliance|0|||
144492013|NCT01256476|520996961|FG001|Overall Study|Subject non-compliance|1|||
144492014|NCT01256476|520996960|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
144492015|NCT01256476|520996961|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
144492016|NCT02401529|520996962|FG000|Overall Study|Lost to Follow-up|2|||
144492017|NCT02401529|520996963|FG001|Overall Study|Lost to Follow-up|1|||
144492018|NCT02401529|520996962|FG000|Overall Study|Physician Decision|2|||
144492019|NCT02401529|520996963|FG001|Overall Study|Physician Decision|6|||
144492020|NCT02401529|520996962|FG000|Overall Study|Protocol Violation|5|||
144492021|NCT02401529|520996963|FG001|Overall Study|Protocol Violation|0|||
144492022|NCT01616563|520996965|FG000|Overall Study|Lost to Follow-up|40|||
144492023|NCT01106287|520996966|FG000|Overall Study|Adverse Event|1|||
144492024|NCT01106287|520996967|FG001|Overall Study|Adverse Event|0|||
144492025|NCT01106287|520996968|FG002|Overall Study|Adverse Event|0|||
144492026|NCT01106287|520996969|FG003|Overall Study|Adverse Event|0|||
144492027|NCT00072475|520996970|FG000|Overall Study|Adverse Event|44|||
144492028|NCT00072475|520996970|FG000|Overall Study|Death|3|||
144492029|NCT00072475|520996970|FG000|Overall Study|Withdrawal by Subject|46|||
144492030|NCT00072475|520996970|FG000|Overall Study|Patient/Investigator Decision|4|||
144492031|NCT02123966|520996971|FG000|Overall Study|Intercurrent Illness|1|||
144492032|NCT01033643|520996975|FG000|Overall Study|Withdrew Consent|0|||
144492033|NCT01033643|520996976|FG001|Overall Study|Withdrew Consent|3|||
144492034|NCT01033643|520996977|FG002|Overall Study|Withdrew Consent|0|||
144492035|NCT01033643|520996978|FG003|Overall Study|Withdrew Consent|0|||
144492036|NCT01033643|520996979|FG004|Overall Study|Withdrew Consent|0|||
144492037|NCT01033643|520996980|FG005|Overall Study|Withdrew Consent|1|||
144492038|NCT02028884|520996987|FG000|Double-blind Period|Adverse Event|5|||
144492039|NCT02028884|520996988|FG001|Double-blind Period|Adverse Event|3|||
144492040|NCT02028884|520996989|FG002|Double-blind Period|Adverse Event|0|||
144492041|NCT02028884|520996987|FG000|Double-blind Period|Eligibility Violation|1|||
144492042|NCT02028884|520996988|FG001|Double-blind Period|Eligibility Violation|0|||
144492043|NCT02028884|520996989|FG002|Double-blind Period|Eligibility Violation|0|||
144717231|NCT03038113|521819979|FG002|Overall Study|Withdrawal by Subject|1|||
144717232|NCT03038113|521819980|FG003|Overall Study|Withdrawal by Subject|0|||
144717233|NCT03038113|521819981|FG004|Overall Study|Withdrawal by Subject|0|||
144717234|NCT03038113|521819982|FG005|Overall Study|Withdrawal by Subject|0|||
144717235|NCT03038113|521819983|FG006|Overall Study|Withdrawal by Subject|0|||
144717236|NCT03038113|521819984|FG007|Overall Study|Withdrawal by Subject|0|||
144717237|NCT03038113|521819985|FG008|Overall Study|Withdrawal by Subject|0|||
144717238|NCT03038113|521819986|FG009|Overall Study|Withdrawal by Subject|0|||
144717239|NCT03038113|521819987|FG010|Overall Study|Withdrawal by Subject|0|||
144717240|NCT03038113|521819988|FG011|Overall Study|Withdrawal by Subject|0|||
144717241|NCT03038113|521819989|FG012|Overall Study|Withdrawal by Subject|0|||
144717242|NCT03038113|521819990|FG013|Overall Study|Withdrawal by Subject|1|||
144717243|NCT03038113|521819977|FG000|Overall Study|Lost to Follow-up|0|||
144717244|NCT03038113|521819978|FG001|Overall Study|Lost to Follow-up|0|||
144717245|NCT03038113|521819979|FG002|Overall Study|Lost to Follow-up|0|||
144717246|NCT03038113|521819980|FG003|Overall Study|Lost to Follow-up|0|||
144717247|NCT03038113|521819981|FG004|Overall Study|Lost to Follow-up|0|||
144717248|NCT03038113|521819982|FG005|Overall Study|Lost to Follow-up|0|||
144717249|NCT03038113|521819983|FG006|Overall Study|Lost to Follow-up|1|||
144717250|NCT03038113|521819984|FG007|Overall Study|Lost to Follow-up|0|||
144717251|NCT03038113|521819985|FG008|Overall Study|Lost to Follow-up|0|||
144717252|NCT03038113|521819986|FG009|Overall Study|Lost to Follow-up|0|||
144717253|NCT03038113|521819987|FG010|Overall Study|Lost to Follow-up|0|||
144717254|NCT03038113|521819988|FG011|Overall Study|Lost to Follow-up|0|||
144717255|NCT03038113|521819989|FG012|Overall Study|Lost to Follow-up|0|||
144717256|NCT03038113|521819990|FG013|Overall Study|Lost to Follow-up|0|||
144717257|NCT03882047|521819992|FG000|Overall Study|Adverse Event|0|||
144717258|NCT03882047|521819993|FG001|Overall Study|Adverse Event|2|||
144717259|NCT03882047|521819994|FG002|Overall Study|Adverse Event|2|||
144717260|NCT03882047|521819992|FG000|Overall Study|Treatment Failure|3|||
144717261|NCT03882047|521819993|FG001|Overall Study|Treatment Failure|3|||
144717262|NCT03882047|521819994|FG002|Overall Study|Treatment Failure|12|||
144717263|NCT03882047|521819992|FG000|Overall Study|Lost to Follow-up|0|||
144717264|NCT03882047|521819993|FG001|Overall Study|Lost to Follow-up|1|||
144717265|NCT03882047|521819994|FG002|Overall Study|Lost to Follow-up|0|||
144717266|NCT03882047|521819992|FG000|Overall Study|Did Not Wish to Continue|1|||
144717267|NCT03882047|521819993|FG001|Overall Study|Did Not Wish to Continue|4|||
144717268|NCT03882047|521819994|FG002|Overall Study|Did Not Wish to Continue|1|||
144717269|NCT03882047|521819992|FG000|Overall Study|Noncompliance With Protocol|2|||
144717270|NCT03882047|521819993|FG001|Overall Study|Noncompliance With Protocol|0|||
144717271|NCT03882047|521819994|FG002|Overall Study|Noncompliance With Protocol|0|||
144717272|NCT03882047|521819992|FG000|Overall Study|Did Not Meet Eligibility|0|||
144717273|NCT03882047|521819993|FG001|Overall Study|Did Not Meet Eligibility|0|||
144717274|NCT03882047|521819994|FG002|Overall Study|Did Not Meet Eligibility|1|||
144717275|NCT00723554|521819995|FG000|Overall Study|Adverse Event|12|||
144717276|NCT00723554|521819995|FG000|Overall Study|Investigator's judgement|5|||
144717277|NCT00723554|521819995|FG000|Overall Study|Inhaled medication other than iloprost|4|||
144717278|NCT00723554|521819995|FG000|Overall Study|Withdrawal of consent|3|||
144717279|NCT00723554|521819995|FG000|Overall Study|Other|3|||
144717280|NCT00723554|521819995|FG000|Overall Study|Lost to Follow-up|1|||
144717281|NCT00723554|521819995|FG000|Overall Study|Non-compliance|1|||
144717282|NCT03255031|521820000|FG000|Overall Study|Adverse Event|5|||
144717283|NCT03255031|521820001|FG001|Overall Study|Adverse Event|3|||
144717284|NCT03255031|521820000|FG000|Overall Study|Physician Decision|2|||
144717285|NCT03255031|521820001|FG001|Overall Study|Physician Decision|1|||
144492044|NCT02028884|520996987|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
144492045|NCT02028884|520996988|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
144717286|NCT03255031|521820000|FG000|Overall Study|Withdrawal by Subject|9|||
144717287|NCT03255031|521820001|FG001|Overall Study|Withdrawal by Subject|3|||
144717288|NCT01809314|521820002|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
144717289|NCT01809314|521820002|FG000|Overall Study|Adverse Event|6|||
144717290|NCT01809314|521820002|FG000|Overall Study|Insufficient Therapeutic Response|14|||
144717291|NCT01809314|521820002|FG000|Overall Study|Lost to Follow-up|724|||
144717292|NCT01092702|521820003|FG000|Overall Study|Withdrawal by Subject|7|||
144717293|NCT01092702|521820003|FG000|Overall Study|Lost to Follow-up|2|||
144717294|NCT03567057|521820004|FG000|Overall Study|Adverse Event|56|||
144717295|NCT03567057|521820005|FG001|Overall Study|Adverse Event|53|||
144717296|NCT03567057|521820006|FG002|Overall Study|Adverse Event|28|||
144717297|NCT03567057|521820004|FG000|Overall Study|Withdrawal by Subject|22|||
144492046|NCT02028884|520996989|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
144492047|NCT02028884|520996987|FG000|Double-blind Period|Withdrawal by Subject|2|||
144492048|NCT02028884|520996988|FG001|Double-blind Period|Withdrawal by Subject|0|||
144717298|NCT03567057|521820005|FG001|Overall Study|Withdrawal by Subject|24|||
144717299|NCT03567057|521820006|FG002|Overall Study|Withdrawal by Subject|13|||
144717300|NCT03567057|521820004|FG000|Overall Study|Lost to Follow-up|3|||
144717301|NCT03567057|521820005|FG001|Overall Study|Lost to Follow-up|5|||
144717302|NCT03567057|521820006|FG002|Overall Study|Lost to Follow-up|2|||
144717303|NCT03567057|521820004|FG000|Overall Study|COVID-19 pandemic|4|||
144717304|NCT03567057|521820005|FG001|Overall Study|COVID-19 pandemic|3|||
144717305|NCT03567057|521820006|FG002|Overall Study|COVID-19 pandemic|0|||
144717306|NCT03567057|521820004|FG000|Overall Study|Non-compliance with study drug|4|||
144717307|NCT03567057|521820005|FG001|Overall Study|Non-compliance with study drug|2|||
144717308|NCT03567057|521820006|FG002|Overall Study|Non-compliance with study drug|0|||
144717309|NCT03567057|521820004|FG000|Overall Study|Lack of Efficacy|3|||
144717310|NCT03567057|521820005|FG001|Overall Study|Lack of Efficacy|0|||
144717311|NCT03567057|521820006|FG002|Overall Study|Lack of Efficacy|1|||
144717312|NCT03567057|521820004|FG000|Overall Study|Death|1|||
144717313|NCT03567057|521820005|FG001|Overall Study|Death|0|||
144717314|NCT03567057|521820006|FG002|Overall Study|Death|0|||
144717315|NCT03567057|521820004|FG000|Overall Study|Physician Decision|1|||
144717316|NCT03567057|521820005|FG001|Overall Study|Physician Decision|0|||
144717317|NCT03567057|521820006|FG002|Overall Study|Physician Decision|0|||
144717318|NCT03567057|521820004|FG000|Overall Study|Unstable medical condition|1|||
144717319|NCT03567057|521820005|FG001|Overall Study|Unstable medical condition|0|||
144717320|NCT03567057|521820006|FG002|Overall Study|Unstable medical condition|0|||
144717321|NCT03567057|521820004|FG000|Overall Study|Medical history event|0|||
144717322|NCT03567057|521820005|FG001|Overall Study|Medical history event|0|||
144717323|NCT03567057|521820006|FG002|Overall Study|Medical history event|1|||
144717324|NCT03567057|521820004|FG000|Overall Study|Other|0|||
144717325|NCT03567057|521820005|FG001|Overall Study|Other|0|||
144717326|NCT03567057|521820006|FG002|Overall Study|Other|1|||
144717327|NCT00490061|521820007|FG000|Overall Study|Physician Decision|1|||
144717328|NCT01580020|521820008|FG000|Overall Study|Lack of Efficacy|0|||
144717329|NCT01580020|521820009|FG001|Overall Study|Lack of Efficacy|5|||
144717330|NCT01580020|521820010|FG002|Overall Study|Lack of Efficacy|0|||
144717331|NCT01580020|521820011|FG003|Overall Study|Lack of Efficacy|1|||
144717332|NCT01580020|521820008|FG000|Overall Study|Withdrawal by Subject|0|||
144717333|NCT01580020|521820009|FG001|Overall Study|Withdrawal by Subject|1|||
144717334|NCT01580020|521820010|FG002|Overall Study|Withdrawal by Subject|1|||
144717335|NCT01580020|521820011|FG003|Overall Study|Withdrawal by Subject|0|||
144717336|NCT01580020|521820008|FG000|Overall Study|Adverse Event|1|||
144717337|NCT01580020|521820009|FG001|Overall Study|Adverse Event|1|||
144717338|NCT01580020|521820010|FG002|Overall Study|Adverse Event|1|||
144717339|NCT01580020|521820011|FG003|Overall Study|Adverse Event|1|||
144717340|NCT01580020|521820008|FG000|Overall Study|Administrative Problems|0|||
144717341|NCT01580020|521820009|FG001|Overall Study|Administrative Problems|0|||
144717342|NCT01580020|521820010|FG002|Overall Study|Administrative Problems|1|||
144717343|NCT01580020|521820011|FG003|Overall Study|Administrative Problems|0|||
144717344|NCT01580020|521820008|FG000|Overall Study|Lost to Follow-up|0|||
144717345|NCT01580020|521820009|FG001|Overall Study|Lost to Follow-up|0|||
144717346|NCT01580020|521820010|FG002|Overall Study|Lost to Follow-up|1|||
144717347|NCT01580020|521820011|FG003|Overall Study|Lost to Follow-up|0|||
144717348|NCT00591253|521820013|FG000|Overall Study|Adverse Event|3|||
144717349|NCT00591253|521820014|FG001|Overall Study|Adverse Event|3|||
144717350|NCT00591253|521820015|FG002|Overall Study|Adverse Event|1|||
144717351|NCT00591253|521820013|FG000|Overall Study|Protocol Violation|2|||
144717352|NCT00591253|521820014|FG001|Overall Study|Protocol Violation|2|||
144717353|NCT00591253|521820015|FG002|Overall Study|Protocol Violation|2|||
144717354|NCT00591253|521820013|FG000|Overall Study|Lost to Follow-up|2|||
144717355|NCT00591253|521820014|FG001|Overall Study|Lost to Follow-up|4|||
144717356|NCT00591253|521820015|FG002|Overall Study|Lost to Follow-up|0|||
144717357|NCT00591253|521820013|FG000|Overall Study|Withdrawal by Subject|1|||
144717358|NCT00591253|521820014|FG001|Overall Study|Withdrawal by Subject|7|||
144717359|NCT00591253|521820015|FG002|Overall Study|Withdrawal by Subject|6|||
144492049|NCT02028884|520996989|FG002|Double-blind Period|Withdrawal by Subject|0|||
144717360|NCT00591253|521820013|FG000|Overall Study|Lack of Efficacy|1|||
144717361|NCT00591253|521820014|FG001|Overall Study|Lack of Efficacy|0|||
144717362|NCT00591253|521820015|FG002|Overall Study|Lack of Efficacy|3|||
144717363|NCT00591253|521820013|FG000|Overall Study|Other|5|||
144717364|NCT00591253|521820014|FG001|Overall Study|Other|5|||
144717365|NCT00591253|521820015|FG002|Overall Study|Other|3|||
144717366|NCT01841359|521820016|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
144717367|NCT01841359|521820016|FG000|Overall Study|Concommitant medical issues|2|||
144717368|NCT01841359|521820016|FG000|Overall Study|Adverse Event|3|||
144717369|NCT01841359|521820016|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
144717370|NCT01875445|521820019|FG000|Overall Study|Lost to Follow-up|5|||
144717371|NCT01875445|521820020|FG001|Overall Study|Lost to Follow-up|0|||
144492050|NCT02028884|520996987|FG000|Open-label Extension Period|Adverse Event|3|||
144492051|NCT02028884|520996988|FG001|Open-label Extension Period|Adverse Event|1|||
144492052|NCT02028884|520996989|FG002|Open-label Extension Period|Adverse Event|0|||
144492053|NCT02028884|520996987|FG000|Open-label Extension Period|Lack of Efficacy|3|||
144492054|NCT02028884|520996988|FG001|Open-label Extension Period|Lack of Efficacy|0|||
144492055|NCT02028884|520996989|FG002|Open-label Extension Period|Lack of Efficacy|0|||
144492056|NCT02028884|520996987|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
144492057|NCT02028884|520996988|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
144492058|NCT02028884|520996989|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
144492059|NCT02028884|520996987|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
144492060|NCT02028884|520996988|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
144492061|NCT02028884|520996989|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
144492062|NCT02028884|520996987|FG000|Open-label Extension Period|Switched to another treatment option|3|||
144492063|NCT02028884|520996988|FG001|Open-label Extension Period|Switched to another treatment option|0|||
144492064|NCT02028884|520996989|FG002|Open-label Extension Period|Switched to another treatment option|0|||
144492065|NCT02403674|520996990|FG000|Base Study|Death|1|||
144492066|NCT02403674|520996991|FG001|Base Study|Death|4|||
144492067|NCT02403674|520996990|FG000|Base Study|Adverse Event|11|||
144492068|NCT02403674|520996991|FG001|Base Study|Adverse Event|26|||
144492069|NCT02403674|520996990|FG000|Base Study|Lack of Efficacy|31|||
144492070|NCT02403674|520996991|FG001|Base Study|Lack of Efficacy|23|||
144492071|NCT02403674|520996990|FG000|Base Study|Lost to Follow-up|6|||
144492072|NCT02403674|520996991|FG001|Base Study|Lost to Follow-up|8|||
144492073|NCT02403674|520996990|FG000|Base Study|Withdrawal by Subject|10|||
144492074|NCT02403674|520996991|FG001|Base Study|Withdrawal by Subject|17|||
144492075|NCT02403674|520996990|FG000|Base Study|Physician Decision|2|||
144492076|NCT02403674|520996991|FG001|Base Study|Physician Decision|2|||
144492077|NCT02403674|520996990|FG000|Base Study|Pregnancy|2|||
144492078|NCT02403674|520996991|FG001|Base Study|Pregnancy|2|||
144492079|NCT02403674|520996990|FG000|Base Study|Protocol Violation|8|||
144492080|NCT02403674|520996991|FG001|Base Study|Protocol Violation|4|||
144492081|NCT02403674|520996990|FG000|Base Study|Non-Compliance with study drug|1|||
144492082|NCT02403674|520996991|FG001|Base Study|Non-Compliance with study drug|4|||
144492083|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
144492084|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
144492085|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
144492086|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
144492087|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
144492088|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
144492089|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
144492090|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
144492091|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
144492092|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
144492093|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
144492094|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
144492095|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Death|1|||
144492096|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Death|0|||
144492097|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
144492098|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
144492099|NCT02403674|520996990|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
144492100|NCT02403674|520996991|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
144492101|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
144492102|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
144492103|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
144492104|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
144492105|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
144492106|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
144492107|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
144492108|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
144492109|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
144492110|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
144492111|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Death|2|||
144492112|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Death|2|||
144492113|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
144492114|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
144492115|NCT02403674|520996990|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
144492116|NCT02403674|520996991|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
144492117|NCT02403674|520996990|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
144492118|NCT02403674|520996991|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
144492119|NCT02403674|520996990|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
144492120|NCT02403674|520996991|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
144492121|NCT02403674|520996990|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
144492122|NCT02403674|520996991|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
144492123|NCT02403674|520996990|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
144492124|NCT02403674|520996991|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
144492125|NCT02403674|520996990|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
144492126|NCT02403674|520996991|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
144492127|NCT00826280|520996992|FG000|Overall Study|Randomized but drug not received|1|||
144492128|NCT00826280|520996993|FG001|Overall Study|Randomized but drug not received|0|||
144492129|NCT00826280|520996994|FG002|Overall Study|Randomized but drug not received|1|||
144492130|NCT00826280|520996992|FG000|Overall Study|Adverse Event|1|||
144492131|NCT00826280|520996993|FG001|Overall Study|Adverse Event|3|||
144717372|NCT01875445|521820019|FG000|Overall Study|Withdrawal by Subject|2|||
144717373|NCT01875445|521820020|FG001|Overall Study|Withdrawal by Subject|0|||
144717374|NCT01102777|521820021|FG000|Overall Study|Death|2|||
144717375|NCT01102777|521820022|FG001|Overall Study|Death|6|||
144717376|NCT01102777|521820021|FG000|Overall Study|Lost to Follow-up|7|||
144717377|NCT01102777|521820022|FG001|Overall Study|Lost to Follow-up|10|||
144717378|NCT01752920|521820027|FG000|Overall Study|Adverse Event|1|||
144717379|NCT01752920|521820028|FG001|Overall Study|Adverse Event|0|||
144717380|NCT01752920|521820029|FG002|Overall Study|Adverse Event|5|||
144717381|NCT01752920|521820030|FG003|Overall Study|Adverse Event|10|||
144717382|NCT01752920|521820027|FG000|Overall Study|Clinical Disease Progression|6|||
144717383|NCT01752920|521820028|FG001|Overall Study|Clinical Disease Progression|4|||
144717384|NCT01752920|521820029|FG002|Overall Study|Clinical Disease Progression|1|||
144717385|NCT01752920|521820030|FG003|Overall Study|Clinical Disease Progression|13|||
144717386|NCT01752920|521820027|FG000|Overall Study|Physician Decision|1|||
144717387|NCT01752920|521820028|FG001|Overall Study|Physician Decision|0|||
144717388|NCT01752920|521820029|FG002|Overall Study|Physician Decision|0|||
144717389|NCT01752920|521820030|FG003|Overall Study|Physician Decision|3|||
144717390|NCT01752920|521820027|FG000|Overall Study|Radiographic Disease Progression|20|||
144717391|NCT01752920|521820028|FG001|Overall Study|Radiographic Disease Progression|7|||
144717392|NCT01752920|521820029|FG002|Overall Study|Radiographic Disease Progression|12|||
144717393|NCT01752920|521820030|FG003|Overall Study|Radiographic Disease Progression|29|||
144717394|NCT01752920|521820027|FG000|Overall Study|Study Terminated by Sponsor|0|||
144717395|NCT01752920|521820028|FG001|Overall Study|Study Terminated by Sponsor|0|||
144717396|NCT01752920|521820029|FG002|Overall Study|Study Terminated by Sponsor|0|||
144717397|NCT01752920|521820030|FG003|Overall Study|Study Terminated by Sponsor|1|||
144717398|NCT01752920|521820027|FG000|Overall Study|Withdrawal by Subject|0|||
144717399|NCT01752920|521820028|FG001|Overall Study|Withdrawal by Subject|1|||
144717400|NCT01752920|521820029|FG002|Overall Study|Withdrawal by Subject|0|||
144717401|NCT01752920|521820030|FG003|Overall Study|Withdrawal by Subject|1|||
144717402|NCT01752920|521820027|FG000|Overall Study|Lack of clinical benefit|1|||
144717403|NCT01752920|521820028|FG001|Overall Study|Lack of clinical benefit|1|||
144717404|NCT01752920|521820029|FG002|Overall Study|Lack of clinical benefit|1|||
144717405|NCT01752920|521820030|FG003|Overall Study|Lack of clinical benefit|1|||
144717406|NCT01738581|521820031|FG000|Overall Study|Lost to Follow-up|1|||
144717407|NCT01738581|521820032|FG001|Overall Study|Lost to Follow-up|0|||
144717408|NCT00210626|521820033|FG000|Overall Study|Adverse Event|1|||
144717409|NCT00210626|521820034|FG001|Overall Study|Adverse Event|2|||
144717410|NCT00210626|521820033|FG000|Overall Study|Protocol Violation|1|||
144717411|NCT00210626|521820034|FG001|Overall Study|Protocol Violation|5|||
144717412|NCT00210626|521820033|FG000|Overall Study|Lost to Follow-up|11|||
144717413|NCT00210626|521820034|FG001|Overall Study|Lost to Follow-up|11|||
144717414|NCT00210626|521820033|FG000|Overall Study|Death|1|||
144717415|NCT00210626|521820034|FG001|Overall Study|Death|0|||
144717416|NCT00210626|521820033|FG000|Overall Study|Withdrawal by Subject|29|||
144717417|NCT00210626|521820034|FG001|Overall Study|Withdrawal by Subject|20|||
144717418|NCT00210626|521820033|FG000|Overall Study|Physician Decision|0|||
144717419|NCT00210626|521820034|FG001|Overall Study|Physician Decision|2|||
144717420|NCT00210626|521820033|FG000|Overall Study|Sponser Request|1|||
144717421|NCT00210626|521820034|FG001|Overall Study|Sponser Request|0|||
144717422|NCT00210626|521820033|FG000|Overall Study|Other|4|||
144717423|NCT00210626|521820034|FG001|Overall Study|Other|5|||
144717424|NCT00771901|521820035|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
144717425|NCT00771901|521820036|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
144717426|NCT00771901|521820037|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
144717427|NCT02862535|521820038|FG000|Overall Study|Death|7|||
144717428|NCT02862535|521820039|FG001|Overall Study|Death|3|||
144717429|NCT02862535|521820040|FG002|Overall Study|Death|2|||
144717430|NCT02862535|521820041|FG003|Overall Study|Death|5|||
144717431|NCT02862535|521820038|FG000|Overall Study|Study Terminated by Sponsor|1|||
144717432|NCT02862535|521820039|FG001|Overall Study|Study Terminated by Sponsor|3|||
144717433|NCT02862535|521820040|FG002|Overall Study|Study Terminated by Sponsor|8|||
144717434|NCT02862535|521820041|FG003|Overall Study|Study Terminated by Sponsor|5|||
144717435|NCT02862535|521820038|FG000|Overall Study|Enrolled, not Treated|1|||
144717436|NCT02862535|521820039|FG001|Overall Study|Enrolled, not Treated|0|||
144717437|NCT02862535|521820040|FG002|Overall Study|Enrolled, not Treated|0|||
144717438|NCT02862535|521820041|FG003|Overall Study|Enrolled, not Treated|1|||
144492132|NCT00826280|520996994|FG002|Overall Study|Adverse Event|0|||
144717439|NCT04147715|521820042|FG000|Overall Study|Adverse Event|0|||
144492133|NCT00826280|520996992|FG000|Overall Study|Lost to Follow-up|0|||
144492134|NCT00826280|520996993|FG001|Overall Study|Lost to Follow-up|1|||
144492135|NCT00826280|520996994|FG002|Overall Study|Lost to Follow-up|0|||
144492136|NCT00826280|520996992|FG000|Overall Study|Sponsor discontinued subject or study|1|||
144492137|NCT00826280|520996993|FG001|Overall Study|Sponsor discontinued subject or study|0|||
144492138|NCT00826280|520996994|FG002|Overall Study|Sponsor discontinued subject or study|0|||
144492139|NCT00826280|520996992|FG000|Overall Study|Reversible ischemic defect not present|43|||
144717440|NCT04147715|521820043|FG001|Overall Study|Adverse Event|0|||
144717441|NCT04147715|521820044|FG002|Overall Study|Adverse Event|0|||
144717442|NCT04147715|521820045|FG003|Overall Study|Adverse Event|0|||
144717443|NCT04147715|521820046|FG004|Overall Study|Adverse Event|0|||
144717444|NCT04147715|521820047|FG005|Overall Study|Adverse Event|0|||
144717445|NCT04147715|521820048|FG006|Overall Study|Adverse Event|0|||
144717446|NCT04147715|521820049|FG007|Overall Study|Adverse Event|2|||
144717447|NCT04147715|521820050|FG008|Overall Study|Adverse Event|1|||
144717448|NCT04147715|521820051|FG009|Overall Study|Adverse Event|0|||
144717449|NCT04147715|521820052|FG010|Overall Study|Adverse Event|0|||
144717450|NCT04147715|521820053|FG011|Overall Study|Adverse Event|0|||
144717451|NCT02418910|521820057|FG000|Overall Study|Lost to Follow-up|3|||
144717452|NCT02418910|521820057|FG000|Overall Study|Withdrawal by Subject|4|||
144717453|NCT02472977|521820058|FG000|Overall Study|Disease progression|4|||
144717454|NCT02472977|521820059|FG001|Overall Study|Disease progression|25|||
144717455|NCT02472977|521820060|FG002|Overall Study|Disease progression|6|||
144717456|NCT02472977|521820058|FG000|Overall Study|Withdrawal by Subject|0|||
144717457|NCT02472977|521820059|FG001|Overall Study|Withdrawal by Subject|1|||
144717458|NCT02472977|521820060|FG002|Overall Study|Withdrawal by Subject|0|||
144717459|NCT02472977|521820058|FG000|Overall Study|Study drug toxicity|2|||
144717460|NCT02472977|521820059|FG001|Overall Study|Study drug toxicity|0|||
144717461|NCT02472977|521820060|FG002|Overall Study|Study drug toxicity|2|||
144717462|NCT02472977|521820058|FG000|Overall Study|Subject request to discontinue treatment|0|||
144717463|NCT02472977|521820059|FG001|Overall Study|Subject request to discontinue treatment|1|||
144717464|NCT02472977|521820060|FG002|Overall Study|Subject request to discontinue treatment|0|||
144717465|NCT00291330|521820062|FG000|Overall Study|Adverse Event|47|||
144717466|NCT00291330|521820063|FG001|Overall Study|Adverse Event|40|||
144717467|NCT00291330|521820062|FG000|Overall Study|Protocol Violation|13|||
144717468|NCT00291330|521820063|FG001|Overall Study|Protocol Violation|20|||
144717469|NCT00291330|521820062|FG000|Overall Study|Lost to Follow-up|16|||
144717470|NCT00291330|521820063|FG001|Overall Study|Lost to Follow-up|11|||
144717471|NCT00291330|521820062|FG000|Overall Study|Withdrawal by Subject|22|||
144717472|NCT00291330|521820063|FG001|Overall Study|Withdrawal by Subject|25|||
144717473|NCT00291330|521820062|FG000|Overall Study|Other|3|||
144717474|NCT00291330|521820063|FG001|Overall Study|Other|1|||
144717475|NCT00566709|521820066|FG000|Overall Study|Protocol Violation|5|||
144717476|NCT00566709|521820067|FG001|Overall Study|Protocol Violation|0|||
144717477|NCT01829295|521820068|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
144717478|NCT01829295|521820069|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
144717479|NCT01829295|521820070|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
144717480|NCT01829295|521820071|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
144717481|NCT01829295|521820068|FG000|6-12 Months|Adverse Event|0|||
144717482|NCT01829295|521820069|FG001|6-12 Months|Adverse Event|0|||
144717483|NCT01829295|521820070|FG002|6-12 Months|Adverse Event|3|||
144717484|NCT01829295|521820071|FG003|6-12 Months|Adverse Event|2|||
144492140|NCT00826280|520996993|FG001|Overall Study|Reversible ischemic defect not present|40|||
144492141|NCT00826280|520996994|FG002|Overall Study|Reversible ischemic defect not present|44|||
144492142|NCT00826280|520996992|FG000|Overall Study|Interpretation Failure|1|||
144492143|NCT00826280|520996993|FG001|Overall Study|Interpretation Failure|0|||
144492144|NCT00826280|520996994|FG002|Overall Study|Interpretation Failure|0|||
144492145|NCT00826280|520996992|FG000|Overall Study|Machine Failure|1|||
144492146|NCT00826280|520996993|FG001|Overall Study|Machine Failure|1|||
144492147|NCT00826280|520996994|FG002|Overall Study|Machine Failure|0|||
144492148|NCT00826280|520996992|FG000|Overall Study|One or more non-interpretable scan|0|||
144492149|NCT00826280|520996993|FG001|Overall Study|One or more non-interpretable scan|1|||
144492150|NCT00826280|520996994|FG002|Overall Study|One or more non-interpretable scan|1|||
144492151|NCT03019458|520996997|FG000|Overall Study|Death|0|||
144492152|NCT03019458|520996998|FG001|Overall Study|Death|1|||
144492153|NCT03330119|520996999|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
144492154|NCT03330119|520997000|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
144492155|NCT01561079|520997001|FG000|Overall Study|Physician Decision|17|||
144717485|NCT01829295|521820068|FG000|6-12 Months|Lost to Follow-up|2|||
144717486|NCT01829295|521820069|FG001|6-12 Months|Lost to Follow-up|0|||
144717487|NCT01829295|521820070|FG002|6-12 Months|Lost to Follow-up|0|||
144717488|NCT01829295|521820071|FG003|6-12 Months|Lost to Follow-up|0|||
144717489|NCT01829295|521820068|FG000|6-12 Months|Withdrawal by Subject|2|||
144717490|NCT01829295|521820069|FG001|6-12 Months|Withdrawal by Subject|2|||
144717491|NCT01829295|521820070|FG002|6-12 Months|Withdrawal by Subject|0|||
144717492|NCT01829295|521820071|FG003|6-12 Months|Withdrawal by Subject|0|||
144717493|NCT02629965|521820074|FG000|Period 1|Adverse Event|1|||
144717494|NCT02629965|521820075|FG001|Period 1|Adverse Event|0|||
144717495|NCT02629965|521820074|FG000|Period 1|Unexpected worsening of disease|2|||
144717496|NCT02629965|521820075|FG001|Period 1|Unexpected worsening of disease|0|||
144717497|NCT02629965|521820074|FG000|Period 1|Other than listed above|1|||
144717498|NCT02629965|521820075|FG001|Period 1|Other than listed above|2|||
144717499|NCT02629965|521820074|FG000|Period 2|Adverse Event|1|||
144717500|NCT02629965|521820075|FG001|Period 2|Adverse Event|0|||
144717501|NCT03443869|521820076|FG000|Overall Study|Death|3|||
144717502|NCT03443869|521820077|FG001|Overall Study|Death|3|||
144717503|NCT03443869|521820076|FG000|Overall Study|Withdrawal by Subject|34|||
144717504|NCT03443869|521820077|FG001|Overall Study|Withdrawal by Subject|22|||
144717505|NCT03443869|521820076|FG000|Overall Study|Lost to Follow-up|1|||
144717506|NCT03443869|521820077|FG001|Overall Study|Lost to Follow-up|2|||
144717507|NCT03443869|521820076|FG000|Overall Study|Physician Decision|3|||
144717508|NCT03443869|521820077|FG001|Overall Study|Physician Decision|3|||
144717509|NCT03443869|521820076|FG000|Overall Study|Other|4|||
144717510|NCT03443869|521820077|FG001|Overall Study|Other|4|||
144717511|NCT02390219|521820078|FG000|Overall Study|Death|1|||
144717512|NCT02390219|521820078|FG000|Overall Study|Physician Decision|1|||
144717513|NCT02390219|521820078|FG000|Overall Study|Adverse Event|6|||
144717514|NCT02390219|521820078|FG000|Overall Study|Withdrawal by Subject|1|||
144717515|NCT02390219|521820078|FG000|Overall Study|Lost to Follow-up|2|||
144717516|NCT02390219|521820078|FG000|Overall Study|Other|2|||
144717517|NCT00299728|521820079|FG000|Overall Study|Lost to Follow-up|0|||
144717518|NCT00299728|521820080|FG001|Overall Study|Lost to Follow-up|1|||
144717519|NCT00299728|521820079|FG000|Overall Study|Withdrawal by Subject|0|||
144717520|NCT00299728|521820080|FG001|Overall Study|Withdrawal by Subject|1|||
144717521|NCT00299728|521820079|FG000|Overall Study|Progressive disease|0|||
144717522|NCT00299728|521820080|FG001|Overall Study|Progressive disease|1|||
144717523|NCT02230085|521820081|FG000|Overall Study|Physician Decision|1|||
144717524|NCT02230085|521820081|FG000|Overall Study|Withdrawal by Subject|3|||
144717525|NCT00580983|521820082|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
144717526|NCT01360632|521820083|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
144717527|NCT01360632|521820084|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
144717528|NCT01360632|521820085|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
144717529|NCT01360632|521820086|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
144717530|NCT01360632|521820087|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
144717531|NCT01360632|521820083|FG000|Phase A (8 Weeks)|Adverse Event|60|||
144717532|NCT01360632|521820084|FG001|Phase A (8 Weeks)|Adverse Event|0|||
144717533|NCT01360632|521820085|FG002|Phase A (8 Weeks)|Adverse Event|0|||
144717534|NCT01360632|521820086|FG003|Phase A (8 Weeks)|Adverse Event|0|||
144717535|NCT01360632|521820087|FG004|Phase A (8 Weeks)|Adverse Event|0|||
144717536|NCT01360632|521820083|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
144717537|NCT01360632|521820084|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
144717538|NCT01360632|521820085|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
144717539|NCT01360632|521820086|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
144717540|NCT01360632|521820087|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
144717541|NCT01360632|521820083|FG000|Phase A (8 Weeks)|Physician Decision|10|||
144717542|NCT01360632|521820084|FG001|Phase A (8 Weeks)|Physician Decision|0|||
144717543|NCT01360632|521820085|FG002|Phase A (8 Weeks)|Physician Decision|0|||
144717544|NCT01360632|521820086|FG003|Phase A (8 Weeks)|Physician Decision|0|||
144717545|NCT01360632|521820087|FG004|Phase A (8 Weeks)|Physician Decision|0|||
144717546|NCT01360632|521820083|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
144717547|NCT01360632|521820084|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
144717548|NCT01360632|521820085|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
144717549|NCT01360632|521820086|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
144717550|NCT01360632|521820087|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
144717551|NCT01360632|521820083|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
144717552|NCT01360632|521820084|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
144717553|NCT01360632|521820085|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
144717554|NCT01360632|521820086|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
144717555|NCT01360632|521820087|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
144717556|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
144717557|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
144717558|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
144717559|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
144717560|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
144717561|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Adverse Event|0|||
144717562|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Adverse Event|3|||
144717563|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Adverse Event|9|||
144717564|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Adverse Event|3|||
144369979|NCT02919995|520562767|FG002|Overall Study|Adverse Event|0|||
144717565|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Adverse Event|0|||
144717566|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
144717567|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
144492156|NCT01561079|520997001|FG000|Overall Study|Withdrawal by Subject|59|||
144492157|NCT01561079|520997001|FG000|Overall Study|Protocol Violation|2|||
144492158|NCT00664521|520997004|FG000|Overall Study|Adverse Event|4|||
144492159|NCT00664521|520997005|FG001|Overall Study|Adverse Event|1|||
144492160|NCT00664521|520997004|FG000|Overall Study|Lost to Follow-up|1|||
144492161|NCT00664521|520997005|FG001|Overall Study|Lost to Follow-up|0|||
144492162|NCT00664521|520997004|FG000|Overall Study|Other|1|||
144492163|NCT00664521|520997005|FG001|Overall Study|Other|0|||
144492164|NCT00953160|520997012|FG000|Overall Study|Lost to Follow-up|23|||
144492165|NCT00953160|520997012|FG000|Overall Study|Withdrawal by Subject|4|||
144492166|NCT00425503|520997013|FG000|Overall Study|Adverse Event|2|||
144492167|NCT00425503|520997013|FG000|Overall Study|Protocol Violation|1|||
144492168|NCT02179918|520997014|FG000|Overall Study|Death|0|||
144492169|NCT02179918|520997015|FG001|Overall Study|Death|0|||
144492170|NCT02179918|520997016|FG002|Overall Study|Death|0|||
144492171|NCT02179918|520997017|FG003|Overall Study|Death|1|||
144492172|NCT02179918|520997018|FG004|Overall Study|Death|0|||
144492173|NCT02179918|520997014|FG000|Overall Study|Lost to Follow-up|0|||
144492174|NCT02179918|520997015|FG001|Overall Study|Lost to Follow-up|0|||
144492175|NCT02179918|520997016|FG002|Overall Study|Lost to Follow-up|1|||
144492176|NCT02179918|520997017|FG003|Overall Study|Lost to Follow-up|0|||
144492177|NCT02179918|520997018|FG004|Overall Study|Lost to Follow-up|0|||
144492178|NCT02179918|520997014|FG000|Overall Study|Progressive Disease|4|||
144492179|NCT02179918|520997015|FG001|Overall Study|Progressive Disease|1|||
144492180|NCT02179918|520997016|FG002|Overall Study|Progressive Disease|1|||
144492181|NCT02179918|520997017|FG003|Overall Study|Progressive Disease|2|||
144492182|NCT02179918|520997018|FG004|Overall Study|Progressive Disease|6|||
144492183|NCT02179918|520997014|FG000|Overall Study|Other|0|||
144492184|NCT02179918|520997015|FG001|Overall Study|Other|1|||
144492185|NCT02179918|520997016|FG002|Overall Study|Other|0|||
144492186|NCT02179918|520997017|FG003|Overall Study|Other|0|||
144492187|NCT02179918|520997018|FG004|Overall Study|Other|1|||
144492188|NCT02179918|520997014|FG000|Overall Study|Subject refused further follow-up|0|||
144492189|NCT02179918|520997015|FG001|Overall Study|Subject refused further follow-up|1|||
144492190|NCT02179918|520997016|FG002|Overall Study|Subject refused further follow-up|0|||
144492191|NCT02179918|520997017|FG003|Overall Study|Subject refused further follow-up|0|||
144492192|NCT02179918|520997018|FG004|Overall Study|Subject refused further follow-up|1|||
144492193|NCT04003974|520997022|FG000|Overall Study|Missing|1|||
144492194|NCT04003974|520997023|FG001|Overall Study|Missing|0|||
144492195|NCT04003974|520997022|FG000|Overall Study|Withdrawal by Subject|0|||
144492196|NCT04003974|520997023|FG001|Overall Study|Withdrawal by Subject|2|||
144492197|NCT02400307|520997024|FG000|Overall Study|Enrolled and Never Dosed|1|||
144492198|NCT02400307|520997025|FG001|Overall Study|Enrolled and Never Dosed|0|||
144492199|NCT01052662|520997028|FG000|Overall Study|Lost to Follow-up|15|||
144492200|NCT01052662|520997029|FG001|Overall Study|Lost to Follow-up|13|||
144492201|NCT01052662|520997030|FG002|Overall Study|Lost to Follow-up|18|||
144492202|NCT01052662|520997028|FG000|Overall Study|Withdrawal by Subject|3|||
144492203|NCT01052662|520997029|FG001|Overall Study|Withdrawal by Subject|2|||
144492204|NCT01052662|520997030|FG002|Overall Study|Withdrawal by Subject|1|||
144492205|NCT01052662|520997028|FG000|Overall Study|Pharmacy issue|1|||
144492206|NCT01052662|520997029|FG001|Overall Study|Pharmacy issue|3|||
144717568|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
144717569|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
144717570|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
144717571|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Physician Decision|0|||
144717572|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Physician Decision|0|||
144717573|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Physician Decision|0|||
144717574|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Physician Decision|1|||
144717575|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Physician Decision|0|||
144717576|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
144717577|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
144717578|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
144717579|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
144717580|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
144717581|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
144717582|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
144717583|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
144717584|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
144717585|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
144717586|NCT01360632|521820083|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
144717587|NCT01360632|521820084|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
144717588|NCT01360632|521820085|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
144717589|NCT01360632|521820086|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
144717590|NCT01360632|521820087|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
144717591|NCT01360632|521820083|FG000|Phase A+|Lost to Follow-up|0|||
144717592|NCT01360632|521820084|FG001|Phase A+|Lost to Follow-up|0|||
144717593|NCT01360632|521820085|FG002|Phase A+|Lost to Follow-up|0|||
144717594|NCT01360632|521820086|FG003|Phase A+|Lost to Follow-up|0|||
144717595|NCT01360632|521820087|FG004|Phase A+|Lost to Follow-up|2|||
144717596|NCT01360632|521820083|FG000|Phase A+|Adverse Event|0|||
144717597|NCT01360632|521820084|FG001|Phase A+|Adverse Event|0|||
144717598|NCT01360632|521820085|FG002|Phase A+|Adverse Event|0|||
144717599|NCT01360632|521820086|FG003|Phase A+|Adverse Event|0|||
144717600|NCT01360632|521820087|FG004|Phase A+|Adverse Event|2|||
144717601|NCT01360632|521820083|FG000|Phase A+|Met Withdrawal Criteria|0|||
144717602|NCT01360632|521820084|FG001|Phase A+|Met Withdrawal Criteria|0|||
144717603|NCT01360632|521820085|FG002|Phase A+|Met Withdrawal Criteria|0|||
144717604|NCT01360632|521820086|FG003|Phase A+|Met Withdrawal Criteria|0|||
144717605|NCT01360632|521820087|FG004|Phase A+|Met Withdrawal Criteria|7|||
144717606|NCT01360632|521820083|FG000|Phase A+|Physician Decision|0|||
144717607|NCT01360632|521820084|FG001|Phase A+|Physician Decision|0|||
144717608|NCT01360632|521820085|FG002|Phase A+|Physician Decision|0|||
144717609|NCT01360632|521820086|FG003|Phase A+|Physician Decision|0|||
144717610|NCT01360632|521820087|FG004|Phase A+|Physician Decision|3|||
144717611|NCT01360632|521820083|FG000|Phase A+|Withdrawal by Subject|0|||
144717612|NCT01360632|521820084|FG001|Phase A+|Withdrawal by Subject|0|||
144717613|NCT01360632|521820085|FG002|Phase A+|Withdrawal by Subject|0|||
144717614|NCT01360632|521820086|FG003|Phase A+|Withdrawal by Subject|0|||
144717615|NCT01360632|521820087|FG004|Phase A+|Withdrawal by Subject|8|||
144717616|NCT01360632|521820083|FG000|Phase A+|Protocol Deviation|0|||
144717617|NCT01360632|521820084|FG001|Phase A+|Protocol Deviation|0|||
144717618|NCT01360632|521820085|FG002|Phase A+|Protocol Deviation|0|||
144717619|NCT01360632|521820086|FG003|Phase A+|Protocol Deviation|0|||
144717620|NCT01360632|521820087|FG004|Phase A+|Protocol Deviation|3|||
144717621|NCT01298596|521820088|FG000|Overall Study|Withdrawal by Subject|1|||
144717622|NCT01298596|521820089|FG001|Overall Study|Withdrawal by Subject|1|||
144717623|NCT01298596|521820088|FG000|Overall Study|Death|5|||
144717624|NCT01298596|521820089|FG001|Overall Study|Death|3|||
144717625|NCT01298596|521820088|FG000|Overall Study|Lost to Follow-up|6|||
144717626|NCT01298596|521820089|FG001|Overall Study|Lost to Follow-up|14|||
144717627|NCT01298596|521820088|FG000|Overall Study|Referred for further management|16|||
144717628|NCT01298596|521820089|FG001|Overall Study|Referred for further management|15|||
144717629|NCT04128696|521820090|FG000|Overall Study|Lost to Follow-up|3|||
144717630|NCT04128696|521820091|FG001|Overall Study|Lost to Follow-up|7|||
144717631|NCT04128696|521820090|FG000|Overall Study|Withdrawal by Subject|12|||
144717632|NCT04128696|521820091|FG001|Overall Study|Withdrawal by Subject|11|||
144717633|NCT04128696|521820090|FG000|Overall Study|Study Closed/Terminated|26|||
144717634|NCT04128696|521820091|FG001|Overall Study|Study Closed/Terminated|38|||
144717635|NCT04128696|521820090|FG000|Overall Study|Physician Decision|2|||
144717636|NCT04128696|521820091|FG001|Overall Study|Physician Decision|3|||
144717637|NCT03740100|521820092|FG000|Overall Study|Adverse Event|1|||
144717638|NCT03740100|521820092|FG000|Overall Study|Death|1|||
144717639|NCT03120520|521820093|FG000|Overall Study|Lost to Follow-up|1|||
144492207|NCT01052662|520997030|FG002|Overall Study|Pharmacy issue|3|||
144492208|NCT01052662|520997028|FG000|Overall Study|Adverse Event|1|||
144717640|NCT03120520|521820094|FG001|Overall Study|Lost to Follow-up|1|||
144717641|NCT03120520|521820095|FG002|Overall Study|Lost to Follow-up|1|||
144717642|NCT03120520|521820096|FG003|Overall Study|Lost to Follow-up|1|||
144492209|NCT01052662|520997029|FG001|Overall Study|Adverse Event|1|||
144492210|NCT01052662|520997030|FG002|Overall Study|Adverse Event|0|||
144492211|NCT01052662|520997028|FG000|Overall Study|Legal Problem|2|||
144492212|NCT01052662|520997029|FG001|Overall Study|Legal Problem|0|||
144492213|NCT01052662|520997030|FG002|Overall Study|Legal Problem|0|||
144492214|NCT01052662|520997028|FG000|Overall Study|Administrative|0|||
144492215|NCT01052662|520997029|FG001|Overall Study|Administrative|3|||
144492216|NCT01052662|520997030|FG002|Overall Study|Administrative|0|||
144492217|NCT03023332|520997031|FG000|Overall Study|Withdrawal by Subject|10|||
144492218|NCT03023332|520997032|FG001|Overall Study|Withdrawal by Subject|5|||
144492219|NCT03023332|520997033|FG002|Overall Study|Withdrawal by Subject|4|||
144492220|NCT03023332|520997034|FG003|Overall Study|Withdrawal by Subject|7|||
144492221|NCT03023332|520997031|FG000|Overall Study|Lost to Follow-up|13|||
144492222|NCT03023332|520997032|FG001|Overall Study|Lost to Follow-up|16|||
144492223|NCT03023332|520997033|FG002|Overall Study|Lost to Follow-up|8|||
144492224|NCT03023332|520997034|FG003|Overall Study|Lost to Follow-up|13|||
144492225|NCT03023332|520997031|FG000|Overall Study|Death|1|||
144492226|NCT03023332|520997032|FG001|Overall Study|Death|0|||
144492227|NCT03023332|520997033|FG002|Overall Study|Death|0|||
144492228|NCT03023332|520997034|FG003|Overall Study|Death|0|||
144492229|NCT01272011|520997037|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
144492230|NCT01272011|520997038|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
144492231|NCT01272011|520997039|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
144492232|NCT02240680|520997040|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
144492233|NCT02240680|520997041|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
144492234|NCT02240680|520997042|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
144492235|NCT02240680|520997043|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
144492236|NCT02240680|520997040|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
144492237|NCT02240680|520997041|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
144492238|NCT02240680|520997042|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
144492239|NCT02240680|520997043|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
144492240|NCT02240680|520997040|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
144492241|NCT02240680|520997041|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
144492242|NCT02240680|520997042|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
144492243|NCT02240680|520997043|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
144492244|NCT02240680|520997040|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
144492245|NCT02240680|520997041|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
144492246|NCT02240680|520997042|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
144492247|NCT02240680|520997043|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
144492248|NCT02240680|520997040|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
144492249|NCT02240680|520997041|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
144492250|NCT02240680|520997042|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
144492251|NCT02240680|520997043|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
144492252|NCT02240680|520997040|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
144492253|NCT02240680|520997041|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
144492254|NCT02240680|520997042|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
144492255|NCT02240680|520997043|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
144492256|NCT02240680|520997040|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
144492257|NCT02240680|520997041|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
144492258|NCT02240680|520997042|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
144492259|NCT02240680|520997043|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
144492260|NCT02240680|520997040|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
144492261|NCT02240680|520997041|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
144492262|NCT02240680|520997042|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
144492263|NCT02240680|520997043|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
144492264|NCT01657032|520997044|FG000|Overall Study|Lost to Follow-up|0|||
144492265|NCT01657032|520997045|FG001|Overall Study|Lost to Follow-up|7|||
144492266|NCT05968482|520997046|FG000|First Crossover Period|Withdrawal by Subject|0|||
144492267|NCT05968482|520997047|FG001|First Crossover Period|Withdrawal by Subject|0|||
144492268|NCT05968482|520997048|FG002|First Crossover Period|Withdrawal by Subject|1|||
144492269|NCT05968482|520997049|FG003|First Crossover Period|Withdrawal by Subject|0|||
144492270|NCT05968482|520997050|FG004|First Crossover Period|Withdrawal by Subject|0|||
144492271|NCT05968482|520997051|FG005|First Crossover Period|Withdrawal by Subject|0|||
144492272|NCT05968482|520997046|FG000|First Crossover Period|Adverse Event|0|||
144492273|NCT05968482|520997047|FG001|First Crossover Period|Adverse Event|0|||
144492274|NCT05968482|520997048|FG002|First Crossover Period|Adverse Event|0|||
144492275|NCT05968482|520997049|FG003|First Crossover Period|Adverse Event|0|||
144492276|NCT05968482|520997050|FG004|First Crossover Period|Adverse Event|0|||
144492277|NCT05968482|520997051|FG005|First Crossover Period|Adverse Event|1|||
144492278|NCT05968482|520997046|FG000|Second Crossover Period|Withdrawal by Subject|0|||
144492279|NCT05968482|520997047|FG001|Second Crossover Period|Withdrawal by Subject|0|||
144492280|NCT05968482|520997048|FG002|Second Crossover Period|Withdrawal by Subject|0|||
144717643|NCT03120520|521820093|FG000|Overall Study|Withdrawal by Subject|3|||
144717644|NCT03120520|521820094|FG001|Overall Study|Withdrawal by Subject|2|||
144717645|NCT03120520|521820095|FG002|Overall Study|Withdrawal by Subject|3|||
144717646|NCT03120520|521820096|FG003|Overall Study|Withdrawal by Subject|2|||
144717647|NCT03120520|521820093|FG000|Overall Study|Other|0|||
144717648|NCT03120520|521820094|FG001|Overall Study|Other|1|||
144717649|NCT03120520|521820095|FG002|Overall Study|Other|0|||
144717650|NCT03120520|521820096|FG003|Overall Study|Other|0|||
144717651|NCT02123459|521820100|FG000|Washout Period (1 Day)|Adverse Event|1|||
144717652|NCT02123459|521820101|FG001|Washout Period (1 Day)|Adverse Event|0|||
144717653|NCT03387059|521820106|FG000|Overall Study|Study termination|5|||
144717654|NCT03387059|521820107|FG001|Overall Study|Study termination|4|||
144717655|NCT00395083|521820109|FG000|Overall Study|Withdrawal by Subject|6|||
144717656|NCT00395083|521820110|FG001|Overall Study|Withdrawal by Subject|5|||
144717657|NCT00395083|521820109|FG000|Overall Study|Developed another disease|4|||
144717658|NCT00395083|521820110|FG001|Overall Study|Developed another disease|3|||
144717659|NCT04136626|521820111|FG000|Treatment Phase|Withdrawal by Subject|1|||
144717660|NCT04136626|521820112|FG001|Treatment Phase|Withdrawal by Subject|9|||
144717661|NCT04136626|521820111|FG000|Treatment Phase|Adverse Event|1|||
144492281|NCT05968482|520997049|FG003|Second Crossover Period|Withdrawal by Subject|0|||
144492282|NCT05968482|520997050|FG004|Second Crossover Period|Withdrawal by Subject|1|||
144717662|NCT04136626|521820112|FG001|Treatment Phase|Adverse Event|0|||
144717663|NCT04136626|521820111|FG000|Treatment Phase|Lost to Follow-up|1|||
144717664|NCT04136626|521820112|FG001|Treatment Phase|Lost to Follow-up|5|||
144492283|NCT05968482|520997051|FG005|Second Crossover Period|Withdrawal by Subject|0|||
144492284|NCT05968482|520997046|FG000|Third Crossover Period|Adverse Event|0|||
144492285|NCT05968482|520997047|FG001|Third Crossover Period|Adverse Event|0|||
144492286|NCT05968482|520997048|FG002|Third Crossover Period|Adverse Event|0|||
144369980|NCT02919995|520562768|FG003|Overall Study|Adverse Event|0|||
144369981|NCT02919995|520562769|FG004|Overall Study|Adverse Event|0|||
144492287|NCT05968482|520997049|FG003|Third Crossover Period|Adverse Event|0|||
144492288|NCT05968482|520997050|FG004|Third Crossover Period|Adverse Event|1|||
144492289|NCT05968482|520997051|FG005|Third Crossover Period|Adverse Event|0|||
144492290|NCT05968482|520997046|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
144492291|NCT05968482|520997047|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
144492292|NCT05968482|520997048|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
144492293|NCT05968482|520997049|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
144492294|NCT05968482|520997050|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
144492295|NCT05968482|520997051|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
144492296|NCT01925170|520997054|FG000|Overall Study|Unverified cancer status|53|||
144492297|NCT01077024|520997055|FG000|Overall Study|Lost to Follow-up|20|||
144492298|NCT01077024|520997056|FG001|Overall Study|Lost to Follow-up|14|||
144492299|NCT01077024|520997055|FG000|Overall Study|Withdrawal by Subject|0|||
144492300|NCT01077024|520997056|FG001|Overall Study|Withdrawal by Subject|2|||
144492301|NCT01077024|520997055|FG000|Overall Study|Incarcerated|7|||
144492302|NCT01077024|520997056|FG001|Overall Study|Incarcerated|8|||
144492303|NCT01077024|520997055|FG000|Overall Study|Other|4|||
144492304|NCT01077024|520997056|FG001|Overall Study|Other|4|||
144492305|NCT02034435|520997057|FG000|Overall Study|Withdrawal by Subject|1|||
144492306|NCT02034435|520997058|FG001|Overall Study|Withdrawal by Subject|0|||
144717665|NCT04136626|521820111|FG000|12-month Follow-up|Lost to Follow-up|8|||
144717666|NCT04136626|521820112|FG001|12-month Follow-up|Lost to Follow-up|7|||
144717667|NCT02806232|521822080|FG000|Overall Study|Lost to Follow-up|1|||
144717668|NCT02806232|521822081|FG001|Overall Study|Lost to Follow-up|2|||
144717669|NCT02806232|521822082|FG002|Overall Study|Lost to Follow-up|1|||
144717670|NCT02806232|521822083|FG003|Overall Study|Lost to Follow-up|0|||
144717671|NCT02806232|521822084|FG004|Overall Study|Lost to Follow-up|0|||
144717672|NCT02806232|521822085|FG005|Overall Study|Lost to Follow-up|1|||
144369982|NCT02919995|520562770|FG005|Overall Study|Adverse Event|1|||
144717673|NCT02806232|521822086|FG006|Overall Study|Lost to Follow-up|0|||
144717674|NCT02806232|521822087|FG007|Overall Study|Lost to Follow-up|0|||
144717675|NCT02806232|521822088|FG008|Overall Study|Lost to Follow-up|0|||
144717676|NCT02806232|521822080|FG000|Overall Study|Withdrawal by Subject|0|||
144717677|NCT02806232|521822081|FG001|Overall Study|Withdrawal by Subject|2|||
144717678|NCT02806232|521822082|FG002|Overall Study|Withdrawal by Subject|0|||
144717679|NCT02806232|521822083|FG003|Overall Study|Withdrawal by Subject|0|||
144717680|NCT02806232|521822084|FG004|Overall Study|Withdrawal by Subject|2|||
144717681|NCT02806232|521822085|FG005|Overall Study|Withdrawal by Subject|1|||
144717682|NCT02806232|521822086|FG006|Overall Study|Withdrawal by Subject|0|||
144717683|NCT02806232|521822087|FG007|Overall Study|Withdrawal by Subject|0|||
144717684|NCT02806232|521822088|FG008|Overall Study|Withdrawal by Subject|0|||
144717685|NCT01133821|521822089|FG000|Overall Study|Lost to Follow-up|8|||
144717686|NCT01133821|521822090|FG001|Overall Study|Lost to Follow-up|11|||
144717687|NCT01133821|521822089|FG000|Overall Study|Withdrawal by Subject|8|||
144717688|NCT01133821|521822090|FG001|Overall Study|Withdrawal by Subject|3|||
144717689|NCT01133821|521822089|FG000|Overall Study|preferred other treatment|1|||
144717690|NCT01133821|521822090|FG001|Overall Study|preferred other treatment|1|||
144717691|NCT01133821|521822089|FG000|Overall Study|Protocol Violation|0|||
144717692|NCT01133821|521822090|FG001|Overall Study|Protocol Violation|1|||
144717693|NCT01133821|521822089|FG000|Overall Study|Refused participation|1|||
144717694|NCT01133821|521822090|FG001|Overall Study|Refused participation|3|||
144717695|NCT03342898|521822093|FG000|Overall Study|Adverse Event|3|||
144717696|NCT03342898|521822094|FG001|Overall Study|Adverse Event|1|||
144717697|NCT03342898|521822095|FG002|Overall Study|Adverse Event|0|||
144717698|NCT03342898|521822093|FG000|Overall Study|Lost to Follow-up|44|||
144717699|NCT03342898|521822094|FG001|Overall Study|Lost to Follow-up|40|||
144717700|NCT03342898|521822095|FG002|Overall Study|Lost to Follow-up|42|||
144717701|NCT03342898|521822093|FG000|Overall Study|Withdrawal of Consent|5|||
144717702|NCT03342898|521822094|FG001|Overall Study|Withdrawal of Consent|9|||
144717703|NCT03342898|521822095|FG002|Overall Study|Withdrawal of Consent|11|||
144717704|NCT03342898|521822093|FG000|Overall Study|Death|0|||
144717705|NCT03342898|521822094|FG001|Overall Study|Death|1|||
144717706|NCT03342898|521822095|FG002|Overall Study|Death|1|||
144717707|NCT03342898|521822093|FG000|Overall Study|Reason not Specified|2|||
144717708|NCT03342898|521822094|FG001|Overall Study|Reason not Specified|2|||
144717709|NCT03342898|521822095|FG002|Overall Study|Reason not Specified|0|||
144717710|NCT01387282|521822096|FG000|Overall Study|Death|47|||
144717711|NCT01387282|521822097|FG001|Overall Study|Death|16|||
144717712|NCT01387282|521822096|FG000|Overall Study|Other|5|||
144717713|NCT01387282|521822097|FG001|Overall Study|Other|1|||
144717714|NCT01387282|521822096|FG000|Overall Study|Unrelated AE|6|||
144717715|NCT01387282|521822097|FG001|Overall Study|Unrelated AE|4|||
144717716|NCT01387282|521822096|FG000|Overall Study|Withdrawal by patient|33|||
144717717|NCT01387282|521822097|FG001|Overall Study|Withdrawal by patient|23|||
144717718|NCT01387282|521822096|FG000|Overall Study|Study drug-related AE|2|||
144717719|NCT01387282|521822097|FG001|Overall Study|Study drug-related AE|2|||
144717720|NCT01387282|521822096|FG000|Overall Study|Lost to Follow-up|4|||
144717721|NCT01387282|521822097|FG001|Overall Study|Lost to Follow-up|1|||
144492307|NCT02034435|520997059|FG002|Overall Study|Withdrawal by Subject|0|||
144492308|NCT02034435|520997060|FG003|Overall Study|Withdrawal by Subject|0|||
144492309|NCT02034435|520997057|FG000|Overall Study|Illness|0|||
144492310|NCT02034435|520997058|FG001|Overall Study|Illness|2|||
144492311|NCT02034435|520997059|FG002|Overall Study|Illness|0|||
144492312|NCT02034435|520997060|FG003|Overall Study|Illness|0|||
144492313|NCT02034435|520997057|FG000|Overall Study|Inadequate IV access|1|||
144492314|NCT02034435|520997058|FG001|Overall Study|Inadequate IV access|0|||
144492315|NCT02034435|520997059|FG002|Overall Study|Inadequate IV access|0|||
144492316|NCT02034435|520997060|FG003|Overall Study|Inadequate IV access|1|||
144492317|NCT02300311|520997063|FG000|Overall Study|Other than the reason specified|1|||
144492318|NCT02300311|520997064|FG001|Overall Study|Other than the reason specified|0|||
144492319|NCT02300311|520997063|FG000|Overall Study|Refused to continue taking medication|18|||
144492320|NCT02300311|520997064|FG001|Overall Study|Refused to continue taking medication|0|||
144492321|NCT02839681|520997065|FG000|Overall Study|Death|2|||
144492322|NCT00772928|520997066|FG000|Overall Study|Lost to Follow-up|9|||
144492323|NCT00772928|520997067|FG001|Overall Study|Lost to Follow-up|6|||
144492324|NCT00772928|520997066|FG000|Overall Study|Protocol Violation|10|||
144492325|NCT00772928|520997067|FG001|Overall Study|Protocol Violation|12|||
144492326|NCT00772928|520997066|FG000|Overall Study|Withdrawal by Subject|25|||
144492327|NCT00772928|520997067|FG001|Overall Study|Withdrawal by Subject|22|||
144492328|NCT00772928|520997066|FG000|Overall Study|Did not receive vaccine|0|||
144492329|NCT00772928|520997067|FG001|Overall Study|Did not receive vaccine|1|||
144492330|NCT00801242|520997072|FG000|Overall Study|Adverse Event|10|||
144492331|NCT00801242|520997072|FG000|Overall Study|Withdrawal by Subject|13|||
144492332|NCT00801242|520997072|FG000|Overall Study|Protocol Violation|5|||
144492333|NCT00801242|520997072|FG000|Overall Study|Physician Decision|3|||
144492334|NCT00801242|520997072|FG000|Overall Study|Lost to Follow-up|1|||
144492335|NCT00801242|520997072|FG000|Overall Study|Miscellaneous reasons|20|||
144492336|NCT02015195|520997074|FG000|Overall Study|Adverse Event|0|||
144492337|NCT02015195|520997075|FG001|Overall Study|Adverse Event|0|||
144492338|NCT02015195|520997076|FG002|Overall Study|Adverse Event|0|||
144492339|NCT02015195|520997077|FG003|Overall Study|Adverse Event|1|||
144492340|NCT02015195|520997078|FG004|Overall Study|Adverse Event|0|||
144492341|NCT02015195|520997079|FG005|Overall Study|Adverse Event|0|||
144492342|NCT02015195|520997080|FG006|Overall Study|Adverse Event|0|||
144492343|NCT01318811|520997081|FG000|Overall Study|Physician Decision|1|||
144492344|NCT01318811|520997082|FG001|Overall Study|Physician Decision|1|||
144492345|NCT01318811|520997081|FG000|Overall Study|CRRT stopped for head CT|0|||
144492346|NCT01318811|520997082|FG001|Overall Study|CRRT stopped for head CT|1|||
144492347|NCT01318811|520997081|FG000|Overall Study|Death|0|||
144492348|NCT01318811|520997082|FG001|Overall Study|Death|1|||
144492349|NCT01318811|520997081|FG000|Overall Study|CRRT stopped for head MRI|0|||
144492350|NCT01318811|520997082|FG001|Overall Study|CRRT stopped for head MRI|1|||
144492351|NCT00811187|520997083|FG000|Overall Study|Unable to place device / procedure abort|3|||
144492352|NCT00811187|520997084|FG001|Overall Study|Unable to place device / procedure abort|3|||
144492353|NCT00329303|520997085|FG000|Overall Study|Lack of Efficacy|1|||
144492354|NCT00329303|520997086|FG001|Overall Study|Lack of Efficacy|0|||
144492355|NCT00329303|520997085|FG000|Overall Study|Decision of the sponsor|0|||
144369983|NCT01821118|520562772|FG000|Overall Study|Death|0|||
144492356|NCT00329303|520997086|FG001|Overall Study|Decision of the sponsor|1|||
144492357|NCT00329303|520997085|FG000|Overall Study|Patient no longer available|1|||
144369984|NCT01821118|520562773|FG001|Overall Study|Death|1|||
144492358|NCT00329303|520997086|FG001|Overall Study|Patient no longer available|0|||
144492359|NCT00329303|520997085|FG000|Overall Study|Patient relocated|0|||
144492360|NCT00329303|520997086|FG001|Overall Study|Patient relocated|1|||
144492361|NCT00162942|520997089|FG000|Overall Study|Adverse Event|10|||
144492362|NCT00162942|520997090|FG001|Overall Study|Adverse Event|6|||
144492363|NCT00162942|520997089|FG000|Overall Study|Death|1|||
144492364|NCT00162942|520997090|FG001|Overall Study|Death|0|||
144492365|NCT00162942|520997089|FG000|Overall Study|Withdrawal by Subject|3|||
144492366|NCT00162942|520997090|FG001|Overall Study|Withdrawal by Subject|6|||
144492367|NCT00162942|520997089|FG000|Overall Study|Physician Decision|1|||
144492368|NCT00162942|520997090|FG001|Overall Study|Physician Decision|0|||
144492369|NCT00162942|520997089|FG000|Overall Study|Enter Open-Label Study|76|||
144492370|NCT00162942|520997090|FG001|Overall Study|Enter Open-Label Study|35|||
144492371|NCT00162942|520997089|FG000|Overall Study|Alternate Therapy|6|||
144492372|NCT00162942|520997090|FG001|Overall Study|Alternate Therapy|2|||
144492373|NCT00162942|520997089|FG000|Overall Study|Lack of Efficacy|1|||
144492374|NCT00162942|520997090|FG001|Overall Study|Lack of Efficacy|0|||
144492375|NCT00162942|520997089|FG000|Overall Study|Flare During Active Treatment|7|||
144492376|NCT00162942|520997090|FG001|Overall Study|Flare During Active Treatment|3|||
144492377|NCT00162942|520997089|FG000|Overall Study|2 or more consecutive treatments missed|1|||
144492378|NCT00162942|520997090|FG001|Overall Study|2 or more consecutive treatments missed|0|||
144492379|NCT01192295|520997091|FG000|Overall Study|Adverse Event|3|||
144492380|NCT01192295|520997092|FG001|Overall Study|Adverse Event|7|||
144492381|NCT01192295|520997091|FG000|Overall Study|Withdrawal by Subject|3|||
144492382|NCT01192295|520997092|FG001|Overall Study|Withdrawal by Subject|4|||
144492383|NCT01192295|520997091|FG000|Overall Study|Lost to Follow-up|0|||
144492384|NCT01192295|520997092|FG001|Overall Study|Lost to Follow-up|1|||
144492385|NCT01192295|520997091|FG000|Overall Study|Lack of Efficacy|0|||
144492386|NCT01192295|520997092|FG001|Overall Study|Lack of Efficacy|5|||
144492387|NCT01192295|520997091|FG000|Overall Study|Administrative|4|||
144492388|NCT01192295|520997092|FG001|Overall Study|Administrative|6|||
144492389|NCT01700530|520997093|FG000|Overall Study|Withdrawal by Subject|0|||
144492390|NCT01700530|520997094|FG001|Overall Study|Withdrawal by Subject|3|||
144492391|NCT01700530|520997095|FG002|Overall Study|Withdrawal by Subject|1|||
144492392|NCT00577629|520997096|FG000|Treatment Period|Death|1|||
144492393|NCT00577629|520997096|FG000|Long Term Follow-Up|Death|15|||
144492394|NCT00577629|520997096|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
144492395|NCT00577629|520997096|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
144492396|NCT00577629|520997096|FG000|Long Term Follow-Up|Physician Decision|1|||
144492397|NCT01449721|520997098|FG000|Overall Study|Physician Decision|0|||
144492398|NCT01449721|520997099|FG001|Overall Study|Physician Decision|1|||
144492399|NCT01449721|520997098|FG000|Overall Study|Physician Decision|0|||
144492400|NCT01449721|520997099|FG001|Overall Study|Physician Decision|1|||
144492401|NCT03212365|520997106|FG000|Overall Study|Discharged prior to Xa level|12|||
144492402|NCT03212365|520997107|FG001|Overall Study|Discharged prior to Xa level|8|||
144492403|NCT03212365|520997106|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
144717722|NCT03997448|521822098|FG000|Study Treatment|Disease Progression|1|||
144717723|NCT03997448|521822098|FG000|Study Treatment|Symptomatic Deterioration|1|||
144717724|NCT03997448|521822098|FG000|Follow up|Death|2|||
144717725|NCT03997448|521822098|FG000|Follow up|study terminated|1|||
144717726|NCT01621490|521822101|FG000|Overall Study|Subject no longer meets study criteria|0|||
144717727|NCT01621490|521822102|FG001|Overall Study|Subject no longer meets study criteria|0|||
144717728|NCT01621490|521822103|FG002|Overall Study|Subject no longer meets study criteria|0|||
144717729|NCT01621490|521822104|FG003|Overall Study|Subject no longer meets study criteria|0|||
144717730|NCT01621490|521822105|FG004|Overall Study|Subject no longer meets study criteria|1|||
144717731|NCT01621490|521822106|FG005|Overall Study|Subject no longer meets study criteria|0|||
144717732|NCT01621490|521822107|FG006|Overall Study|Subject no longer meets study criteria|0|||
144717733|NCT01621490|521822108|FG007|Overall Study|Subject no longer meets study criteria|0|||
144717734|NCT01621490|521822109|FG008|Overall Study|Subject no longer meets study criteria|0|||
144717735|NCT01621490|521822110|FG009|Overall Study|Subject no longer meets study criteria|0|||
144717736|NCT01621490|521822111|FG010|Overall Study|Subject no longer meets study criteria|0|||
144717737|NCT01621490|521822101|FG000|Overall Study|Maximum clinical benefit|3|||
144717738|NCT01621490|521822102|FG001|Overall Study|Maximum clinical benefit|2|||
144717739|NCT01621490|521822103|FG002|Overall Study|Maximum clinical benefit|0|||
144717740|NCT01621490|521822104|FG003|Overall Study|Maximum clinical benefit|0|||
144717741|NCT01621490|521822105|FG004|Overall Study|Maximum clinical benefit|0|||
144717742|NCT01621490|521822106|FG005|Overall Study|Maximum clinical benefit|0|||
144717743|NCT01621490|521822107|FG006|Overall Study|Maximum clinical benefit|1|||
144717744|NCT01621490|521822108|FG007|Overall Study|Maximum clinical benefit|2|||
144717745|NCT01621490|521822109|FG008|Overall Study|Maximum clinical benefit|2|||
144717746|NCT01621490|521822110|FG009|Overall Study|Maximum clinical benefit|0|||
144717747|NCT01621490|521822111|FG010|Overall Study|Maximum clinical benefit|0|||
144717748|NCT01621490|521822101|FG000|Overall Study|Withdrawal by Subject|1|||
144717749|NCT01621490|521822102|FG001|Overall Study|Withdrawal by Subject|0|||
144717750|NCT01621490|521822103|FG002|Overall Study|Withdrawal by Subject|0|||
144717751|NCT01621490|521822104|FG003|Overall Study|Withdrawal by Subject|0|||
144717752|NCT01621490|521822105|FG004|Overall Study|Withdrawal by Subject|0|||
144369985|NCT02504151|520562774|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
144492404|NCT03212365|520997107|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
144492405|NCT03212365|520997106|FG000|Overall Study|Refused study medication|3|||
144492406|NCT03212365|520997107|FG001|Overall Study|Refused study medication|0|||
144492407|NCT03212365|520997106|FG000|Overall Study|Initiated heparin infusion on floor|1|||
144492408|NCT03212365|520997107|FG001|Overall Study|Initiated heparin infusion on floor|1|||
144492409|NCT03212365|520997106|FG000|Overall Study|Unexpected return to OR|1|||
144492410|NCT03212365|520997107|FG001|Overall Study|Unexpected return to OR|1|||
144492411|NCT03212365|520997106|FG000|Overall Study|Medication distribution error|1|||
144492412|NCT03212365|520997107|FG001|Overall Study|Medication distribution error|0|||
144492413|NCT03212365|520997106|FG000|Overall Study|Required epidural placement|1|||
144492414|NCT03212365|520997107|FG001|Overall Study|Required epidural placement|0|||
144492415|NCT03212365|520997106|FG000|Overall Study|Withdrawal by Subject|0|||
144492416|NCT03212365|520997107|FG001|Overall Study|Withdrawal by Subject|1|||
144492417|NCT03212365|520997106|FG000|Overall Study|developed acute renal failure|0|||
144492418|NCT03212365|520997107|FG001|Overall Study|developed acute renal failure|1|||
144492419|NCT00333138|520997109|FG000|Core Study (6 Months)|Adverse Event|4|||
144492420|NCT00333138|520997110|FG001|Core Study (6 Months)|Adverse Event|5|||
144492421|NCT00333138|520997111|FG002|Core Study (6 Months)|Adverse Event|8|||
144492422|NCT00333138|520997109|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
144492423|NCT00333138|520997110|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
144492424|NCT00333138|520997111|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
144492425|NCT00333138|520997109|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
144492426|NCT00333138|520997110|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
144492427|NCT00333138|520997111|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
144492428|NCT00333138|520997109|FG000|Core Study (6 Months)|Protocol Violation|1|||
144492429|NCT00333138|520997110|FG001|Core Study (6 Months)|Protocol Violation|0|||
144492430|NCT00333138|520997111|FG002|Core Study (6 Months)|Protocol Violation|1|||
144492431|NCT00333138|520997109|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
144492432|NCT00333138|520997110|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
144492433|NCT00333138|520997111|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
144492434|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
144492435|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
144492436|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
144492437|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
144492438|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
144492439|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
144492440|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
144492441|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
144492442|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
144717753|NCT01621490|521822106|FG005|Overall Study|Withdrawal by Subject|1|||
144717754|NCT01621490|521822107|FG006|Overall Study|Withdrawal by Subject|0|||
144717755|NCT01621490|521822108|FG007|Overall Study|Withdrawal by Subject|0|||
144717756|NCT01621490|521822109|FG008|Overall Study|Withdrawal by Subject|0|||
144717757|NCT01621490|521822110|FG009|Overall Study|Withdrawal by Subject|0|||
144717758|NCT01621490|521822111|FG010|Overall Study|Withdrawal by Subject|0|||
144717759|NCT01621490|521822101|FG000|Overall Study|Subject request to discontinue study|1|||
144717760|NCT01621490|521822102|FG001|Overall Study|Subject request to discontinue study|3|||
144717761|NCT01621490|521822103|FG002|Overall Study|Subject request to discontinue study|1|||
144717762|NCT01621490|521822104|FG003|Overall Study|Subject request to discontinue study|1|||
144717763|NCT01621490|521822105|FG004|Overall Study|Subject request to discontinue study|0|||
144717764|NCT01621490|521822106|FG005|Overall Study|Subject request to discontinue study|2|||
144717765|NCT01621490|521822107|FG006|Overall Study|Subject request to discontinue study|1|||
144717766|NCT01621490|521822108|FG007|Overall Study|Subject request to discontinue study|0|||
144717767|NCT01621490|521822109|FG008|Overall Study|Subject request to discontinue study|1|||
144717768|NCT01621490|521822110|FG009|Overall Study|Subject request to discontinue study|0|||
144717769|NCT01621490|521822111|FG010|Overall Study|Subject request to discontinue study|0|||
144717770|NCT01621490|521822101|FG000|Overall Study|Adverse event unrelated to study drug|1|||
144717771|NCT01621490|521822102|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144717772|NCT01621490|521822103|FG002|Overall Study|Adverse event unrelated to study drug|0|||
144717773|NCT01621490|521822104|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144717774|NCT01621490|521822105|FG004|Overall Study|Adverse event unrelated to study drug|0|||
144717775|NCT01621490|521822106|FG005|Overall Study|Adverse event unrelated to study drug|0|||
144717776|NCT01621490|521822107|FG006|Overall Study|Adverse event unrelated to study drug|0|||
144717777|NCT01621490|521822108|FG007|Overall Study|Adverse event unrelated to study drug|2|||
144717778|NCT01621490|521822109|FG008|Overall Study|Adverse event unrelated to study drug|0|||
144717779|NCT01621490|521822110|FG009|Overall Study|Adverse event unrelated to study drug|0|||
144492443|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
144717780|NCT01621490|521822111|FG010|Overall Study|Adverse event unrelated to study drug|0|||
144717781|NCT01621490|521822101|FG000|Overall Study|Disease progression|27|||
144492444|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
144492445|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
144492446|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
144492447|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
144492448|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
144492449|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
144492450|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
144492451|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
144492452|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
144492453|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
144492454|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
144492455|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
144492456|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
144492457|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
144492458|NCT00333138|520997109|FG000|Extension Study (Month6 to End of Study)|Death|0|||
144492459|NCT00333138|520997110|FG001|Extension Study (Month6 to End of Study)|Death|1|||
144492460|NCT00333138|520997111|FG002|Extension Study (Month6 to End of Study)|Death|0|||
144492461|NCT01342887|520997112|FG000|Overall Study|Death|2|||
144492462|NCT04880161|520997114|FG000|Overall Study|Withdrawal by Subject|1|||
144492463|NCT04880161|520997115|FG001|Overall Study|Withdrawal by Subject|0|||
144492464|NCT04880161|520997114|FG000|Overall Study|Lack of Compliance|1|||
144492465|NCT04880161|520997115|FG001|Overall Study|Lack of Compliance|1|||
144492466|NCT04880161|520997114|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
144492467|NCT04880161|520997115|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
144492468|NCT04880161|520997114|FG000|Overall Study|Screen Failure|0|||
144492469|NCT04880161|520997115|FG001|Overall Study|Screen Failure|1|||
144492470|NCT01354106|520997116|FG000|Overall Study|Withdrawal by Subject|2|||
144492471|NCT02491411|520998953|FG000|Overall Study|Physician Decision|4|||
144492472|NCT04034238|520998954|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
144492473|NCT04034238|520998955|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
144492474|NCT04034238|520998956|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
144492475|NCT04034238|520998957|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144492476|NCT04034238|520998954|FG000|Dose Escalation Phase|Screen failures|0|||
144492477|NCT04034238|520998955|FG001|Dose Escalation Phase|Screen failures|0|||
144492478|NCT04034238|520998956|FG002|Dose Escalation Phase|Screen failures|0|||
144492479|NCT04034238|520998957|FG003|Dose Escalation Phase|Screen failures|2|||
144492480|NCT04034238|520998954|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
144492481|NCT04034238|520998955|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
144492482|NCT04034238|520998956|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
144492483|NCT04034238|520998957|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
144492484|NCT04034238|520998954|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
144492485|NCT04034238|520998955|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
144492486|NCT04034238|520998956|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
144492487|NCT04034238|520998957|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
144492488|NCT01598987|520998958|FG000|Baseline to Month 12|Administrative problems|2|||
144492489|NCT01598987|520998958|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
144492490|NCT01598987|520998958|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
144492491|NCT01598987|520998958|FG000|Baseline to 24 Month|Administrative problems|2|||
144492492|NCT01598987|520998958|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
144492493|NCT01450943|520998961|FG000|Overall Study|Screen failure, loss to follow-up|2|||
144492494|NCT01450943|520998962|FG001|Overall Study|Screen failure, loss to follow-up|7|||
144492495|NCT01450943|520998963|FG002|Overall Study|Screen failure, loss to follow-up|6|||
144492496|NCT03303105|520998964|FG000|Overall Study|Adverse Event|0|||
144492497|NCT03303105|520998965|FG001|Overall Study|Adverse Event|2|||
144492498|NCT03303105|520998964|FG000|Overall Study|Lack of Efficacy|1|||
144492499|NCT03303105|520998965|FG001|Overall Study|Lack of Efficacy|0|||
144492500|NCT03303105|520998964|FG000|Overall Study|Protocol Violation|1|||
144492501|NCT03303105|520998965|FG001|Overall Study|Protocol Violation|0|||
144492502|NCT03303105|520998964|FG000|Overall Study|Withdrawal by Subject|0|||
144492503|NCT03303105|520998965|FG001|Overall Study|Withdrawal by Subject|2|||
144492504|NCT04822298|520998968|FG000|Overall Study|Death|3|||
144492505|NCT01333943|520998972|FG000|Overall Study|Known neuropathy|1|||
144492506|NCT01333943|520998973|FG001|Overall Study|Known neuropathy|0|||
144492507|NCT01789203|520998974|FG000|Overall Study|Adverse Event|2|||
144492508|NCT01789203|520998975|FG001|Overall Study|Adverse Event|2|||
144492509|NCT01789203|520998974|FG000|Overall Study|Withdrawal by Subject|1|||
144492510|NCT01789203|520998975|FG001|Overall Study|Withdrawal by Subject|0|||
144492511|NCT01789203|520998974|FG000|Overall Study|Death|1|||
144492512|NCT01789203|520998975|FG001|Overall Study|Death|0|||
144492513|NCT01789203|520998974|FG000|Overall Study|Protocol Violation|2|||
144492514|NCT01789203|520998975|FG001|Overall Study|Protocol Violation|1|||
144492515|NCT01789203|520998974|FG000|Overall Study|Other|1|||
144492516|NCT01789203|520998975|FG001|Overall Study|Other|1|||
144492517|NCT01789203|520998974|FG000|Overall Study|patient non-adherent|2|||
144492518|NCT01789203|520998975|FG001|Overall Study|patient non-adherent|0|||
144492519|NCT01254305|520998982|FG000|Overall Study|Adverse Event|6|||
144492520|NCT01254305|520998983|FG001|Overall Study|Adverse Event|3|||
144492521|NCT01254305|520998984|FG002|Overall Study|Adverse Event|2|||
144492522|NCT01254305|520998982|FG000|Overall Study|Lack of Efficacy|1|||
144492523|NCT01254305|520998983|FG001|Overall Study|Lack of Efficacy|0|||
144492524|NCT01254305|520998984|FG002|Overall Study|Lack of Efficacy|1|||
144492525|NCT01254305|520998982|FG000|Overall Study|Protocol Violation|1|||
144492526|NCT01254305|520998983|FG001|Overall Study|Protocol Violation|7|||
144492527|NCT01254305|520998984|FG002|Overall Study|Protocol Violation|3|||
144492528|NCT01254305|520998982|FG000|Overall Study|Withdrawal by Subject|4|||
144492529|NCT01254305|520998983|FG001|Overall Study|Withdrawal by Subject|2|||
144492530|NCT01254305|520998984|FG002|Overall Study|Withdrawal by Subject|4|||
144492531|NCT01254305|520998982|FG000|Overall Study|Lost to Follow-up|10|||
144492532|NCT01254305|520998983|FG001|Overall Study|Lost to Follow-up|6|||
144492533|NCT01254305|520998984|FG002|Overall Study|Lost to Follow-up|5|||
144492534|NCT01254305|520998982|FG000|Overall Study|Other Reasons|0|||
144492535|NCT01254305|520998983|FG001|Overall Study|Other Reasons|0|||
144492536|NCT01254305|520998984|FG002|Overall Study|Other Reasons|2|||
144492537|NCT02297503|520998985|FG000|Overall Study|Withdrawal by Subject|1|||
144492538|NCT02297503|520998986|FG001|Overall Study|Withdrawal by Subject|1|||
144492539|NCT02297503|520998985|FG000|Overall Study|Protocol Violation|1|||
144492540|NCT02297503|520998986|FG001|Overall Study|Protocol Violation|0|||
144492541|NCT02297503|520998985|FG000|Overall Study|Pregnancy|0|||
144492542|NCT02297503|520998986|FG001|Overall Study|Pregnancy|1|||
144492543|NCT02297503|520998985|FG000|Overall Study|Lost to Follow-up|0|||
144492544|NCT02297503|520998986|FG001|Overall Study|Lost to Follow-up|1|||
144492545|NCT02297503|520998985|FG000|Overall Study|Medical reason|0|||
144492546|NCT02297503|520998986|FG001|Overall Study|Medical reason|1|||
144492547|NCT03169361|520998987|FG000|Overall Study|Protocol Violation|32|||
144492548|NCT02788656|520998988|FG000|Overall Study|Withdrawal by Subject|1|||
144492549|NCT02788656|520998989|FG001|Overall Study|Withdrawal by Subject|0|||
144492550|NCT00550732|520998994|FG000|Overall Study|Death|4|||
144492551|NCT00550732|520998994|FG000|Overall Study|Withdrawal by Subject|2|||
144492552|NCT00550732|520998994|FG000|Overall Study|Physician Decision|2|||
144492553|NCT00550732|520998994|FG000|Overall Study|Lost to Follow-up|1|||
144492554|NCT00550732|520998994|FG000|Overall Study|Palliative care|1|||
144492555|NCT00550732|520998994|FG000|Overall Study|Adverse Event|1|||
144492556|NCT03302910|520999000|FG000|Overall Study|Protocol Violation|1|||
144492557|NCT03302910|520999001|FG001|Overall Study|Protocol Violation|0|||
144492558|NCT02724020|520999008|FG000|Overall Study|Death|16|||
144492559|NCT02724020|520999009|FG001|Overall Study|Death|18|||
144492560|NCT02724020|520999010|FG002|Overall Study|Death|19|||
144492561|NCT02724020|520999008|FG000|Overall Study|Lost to Follow-up|0|||
144492562|NCT02724020|520999009|FG001|Overall Study|Lost to Follow-up|3|||
144492563|NCT02724020|520999010|FG002|Overall Study|Lost to Follow-up|0|||
144492564|NCT02724020|520999008|FG000|Overall Study|Site Terminated by Sponsor|15|||
144492565|NCT02724020|520999009|FG001|Overall Study|Site Terminated by Sponsor|8|||
144492566|NCT02724020|520999010|FG002|Overall Study|Site Terminated by Sponsor|8|||
144492567|NCT02724020|520999008|FG000|Overall Study|Withdrawal by Subject|1|||
144492568|NCT02724020|520999009|FG001|Overall Study|Withdrawal by Subject|3|||
144492569|NCT02724020|520999010|FG002|Overall Study|Withdrawal by Subject|5|||
144492570|NCT04537949|520999014|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
144492571|NCT04537949|520999015|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
144492572|NCT04537949|520999016|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
144492573|NCT04537949|520999017|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
144492574|NCT04537949|520999018|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
144492575|NCT04537949|520999019|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
144492576|NCT04537949|520999020|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
144492577|NCT04537949|520999021|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
144492578|NCT04537949|520999014|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
144492579|NCT04537949|520999015|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
144492580|NCT04537949|520999016|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
144492581|NCT04537949|520999017|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
144492582|NCT04537949|520999018|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
144492583|NCT04537949|520999019|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
144492584|NCT04537949|520999020|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
144492585|NCT04537949|520999021|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
144492586|NCT04537949|520999014|FG000|Follow-up Phase|Lost to Follow-up|0|||
144492587|NCT04537949|520999015|FG001|Follow-up Phase|Lost to Follow-up|3|||
144492588|NCT04537949|520999016|FG002|Follow-up Phase|Lost to Follow-up|0|||
144492589|NCT04537949|520999017|FG003|Follow-up Phase|Lost to Follow-up|0|||
144492590|NCT04537949|520999018|FG004|Follow-up Phase|Lost to Follow-up|0|||
144492591|NCT04537949|520999019|FG005|Follow-up Phase|Lost to Follow-up|0|||
144492592|NCT04537949|520999020|FG006|Follow-up Phase|Lost to Follow-up|0|||
144492593|NCT04537949|520999021|FG007|Follow-up Phase|Lost to Follow-up|0|||
144492594|NCT04537949|520999014|FG000|Follow-up Phase|personal reasons|0|||
144492595|NCT04537949|520999015|FG001|Follow-up Phase|personal reasons|0|||
144492596|NCT04537949|520999016|FG002|Follow-up Phase|personal reasons|0|||
144492597|NCT04537949|520999017|FG003|Follow-up Phase|personal reasons|1|||
144492598|NCT04537949|520999018|FG004|Follow-up Phase|personal reasons|1|||
144492599|NCT04537949|520999019|FG005|Follow-up Phase|personal reasons|0|||
144492600|NCT04537949|520999020|FG006|Follow-up Phase|personal reasons|0|||
144492601|NCT04537949|520999021|FG007|Follow-up Phase|personal reasons|0|||
144492602|NCT04537949|520999014|FG000|Follow-up Phase|Withdrawal by Subject|0|||
144492603|NCT04537949|520999015|FG001|Follow-up Phase|Withdrawal by Subject|0|||
144492604|NCT04537949|520999016|FG002|Follow-up Phase|Withdrawal by Subject|0|||
144492605|NCT04537949|520999017|FG003|Follow-up Phase|Withdrawal by Subject|0|||
144492606|NCT04537949|520999018|FG004|Follow-up Phase|Withdrawal by Subject|1|||
144492607|NCT04537949|520999019|FG005|Follow-up Phase|Withdrawal by Subject|0|||
144492608|NCT04537949|520999020|FG006|Follow-up Phase|Withdrawal by Subject|0|||
144369986|NCT02504151|520562775|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
144492609|NCT04537949|520999021|FG007|Follow-up Phase|Withdrawal by Subject|0|||
144492610|NCT00087490|520999026|FG000|Overall Study|Death|6|||
144492611|NCT00087490|520999027|FG001|Overall Study|Death|4|||
144492612|NCT00087490|520999026|FG000|Overall Study|Adverse Event|3|||
144492613|NCT00087490|520999027|FG001|Overall Study|Adverse Event|8|||
144492614|NCT00087490|520999026|FG000|Overall Study|Lack of Efficacy|0|||
144492615|NCT00087490|520999027|FG001|Overall Study|Lack of Efficacy|2|||
144492616|NCT00087490|520999026|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
144492617|NCT00087490|520999027|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
144492618|NCT00087490|520999026|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
144492619|NCT00087490|520999027|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
144492620|NCT00087490|520999026|FG000|Overall Study|Randomized but not treated|7|||
144492621|NCT00087490|520999027|FG001|Overall Study|Randomized but not treated|18|||
144492622|NCT00761774|520999028|FG000|Overall Study|Adverse Event|17|||
144492623|NCT00761774|520999028|FG000|Overall Study|Lack of Efficacy|37|||
144492624|NCT00761774|520999028|FG000|Overall Study|Lost to Follow-up|2|||
144492625|NCT00761774|520999028|FG000|Overall Study|Withdrawal by Subject|9|||
144492626|NCT00761774|520999028|FG000|Overall Study|Non-compliance|4|||
144492627|NCT00761774|520999028|FG000|Overall Study|End of study|2|||
144492628|NCT00761774|520999028|FG000|Overall Study|Reclassification of seizures|1|||
144492629|NCT00761774|520999028|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
144492630|NCT00761774|520999028|FG000|Overall Study|Sponsor decision|1|||
144492631|NCT00761774|520999028|FG000|Overall Study|Investigator clinical judgement|1|||
144492632|NCT00761774|520999028|FG000|Overall Study|Patient moved out of study area|1|||
144492633|NCT00761774|520999028|FG000|Overall Study|Coordinator leaving site|1|||
144492634|NCT00761774|520999028|FG000|Overall Study|Subject IP non-compliance|1|||
144492635|NCT00761774|520999028|FG000|Overall Study|IP stopped by hospital physician|1|||
144492636|NCT02825043|520999030|FG000|Overall Study|Lost to Follow-up|4|||
144492637|NCT03582137|520999034|FG000|Overall Study|Adverse Event|1|||
144492638|NCT03582137|520999035|FG001|Overall Study|Adverse Event|0|||
144492639|NCT03704298|520999039|FG000|Overall Study|Death|3|||
144492640|NCT03704298|520999040|FG001|Overall Study|Death|1|||
144492641|NCT03704298|520999041|FG002|Overall Study|Death|1|||
144492642|NCT03704298|520999042|FG003|Overall Study|Death|0|||
144492643|NCT03704298|520999039|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
144492644|NCT03704298|520999040|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
144369987|NCT02504151|520562774|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
144492645|NCT03704298|520999041|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
144492646|NCT03704298|520999042|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
144492647|NCT03704298|520999039|FG000|Overall Study|Withdrawal by Subject|1|||
144492648|NCT03704298|520999040|FG001|Overall Study|Withdrawal by Subject|0|||
144492649|NCT03704298|520999041|FG002|Overall Study|Withdrawal by Subject|0|||
144492650|NCT03704298|520999042|FG003|Overall Study|Withdrawal by Subject|0|||
144492651|NCT03704298|520999039|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
144492652|NCT03704298|520999040|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
144492653|NCT03704298|520999041|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
144492654|NCT03704298|520999042|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
144492655|NCT02303574|520999045|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492656|NCT02303574|520999046|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492657|NCT02303574|520999047|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
144492658|NCT02303574|520999048|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492659|NCT02303574|520999049|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492660|NCT02303574|520999050|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492661|NCT02303574|520999051|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492662|NCT02303574|520999052|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492663|NCT02303574|520999053|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492664|NCT02303574|520999054|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
144492665|NCT02303574|520999045|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492666|NCT02303574|520999046|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492667|NCT02303574|520999047|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492668|NCT02303574|520999048|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492669|NCT02303574|520999049|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492670|NCT02303574|520999050|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492671|NCT02303574|520999051|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492672|NCT02303574|520999052|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
144492673|NCT02303574|520999053|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492674|NCT02303574|520999054|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
144492675|NCT00994279|520999059|FG000|Overall Study|Withdrawal by Subject|2|||
144492676|NCT00994279|520999060|FG001|Overall Study|Withdrawal by Subject|2|||
144492677|NCT00994279|520999059|FG000|Overall Study|Toxicity|1|||
144492678|NCT00994279|520999060|FG001|Overall Study|Toxicity|0|||
144492679|NCT00994279|520999059|FG000|Overall Study|Multiple reasons|1|||
144492680|NCT00994279|520999060|FG001|Overall Study|Multiple reasons|3|||
144492681|NCT00859014|520999061|FG000|Overall Study|Death|4|||
144492682|NCT00859014|520999061|FG000|Overall Study|Lost to Follow-up|1|||
144492683|NCT01163149|520999065|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
144492684|NCT01163149|520999066|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
144492685|NCT01163149|520999067|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
144492686|NCT01163149|520999065|FG000|Extension Treatment Period|Adverse Event|0|||
144492687|NCT01163149|520999066|FG001|Extension Treatment Period|Adverse Event|1|||
144492688|NCT01163149|520999067|FG002|Extension Treatment Period|Adverse Event|0|||
144492689|NCT01163149|520999065|FG000|Extension Treatment Period|Noncompliance|0|||
144717782|NCT01621490|521822102|FG001|Overall Study|Disease progression|28|||
144717783|NCT01621490|521822103|FG002|Overall Study|Disease progression|1|||
144717784|NCT01621490|521822104|FG003|Overall Study|Disease progression|5|||
144717785|NCT01621490|521822105|FG004|Overall Study|Disease progression|3|||
144717786|NCT01621490|521822106|FG005|Overall Study|Disease progression|8|||
144717787|NCT01621490|521822107|FG006|Overall Study|Disease progression|7|||
144717788|NCT01621490|521822108|FG007|Overall Study|Disease progression|1|||
144717789|NCT01621490|521822109|FG008|Overall Study|Disease progression|4|||
144717790|NCT01621490|521822110|FG009|Overall Study|Disease progression|1|||
144717791|NCT01621490|521822111|FG010|Overall Study|Disease progression|1|||
144717792|NCT01621490|521822101|FG000|Overall Study|Study drug toxicity|1|||
144717793|NCT01621490|521822102|FG001|Overall Study|Study drug toxicity|4|||
144717794|NCT01621490|521822103|FG002|Overall Study|Study drug toxicity|5|||
144717795|NCT01621490|521822104|FG003|Overall Study|Study drug toxicity|3|||
144717796|NCT01621490|521822105|FG004|Overall Study|Study drug toxicity|1|||
144717797|NCT01621490|521822106|FG005|Overall Study|Study drug toxicity|10|||
144717798|NCT01621490|521822107|FG006|Overall Study|Study drug toxicity|1|||
144717799|NCT01621490|521822108|FG007|Overall Study|Study drug toxicity|4|||
144717800|NCT01621490|521822109|FG008|Overall Study|Study drug toxicity|1|||
144717801|NCT01621490|521822110|FG009|Overall Study|Study drug toxicity|0|||
144717802|NCT01621490|521822111|FG010|Overall Study|Study drug toxicity|0|||
144717803|NCT01621490|521822101|FG000|Overall Study|Death|0|||
144717804|NCT01621490|521822102|FG001|Overall Study|Death|0|||
144717805|NCT01621490|521822103|FG002|Overall Study|Death|0|||
144717806|NCT01621490|521822104|FG003|Overall Study|Death|0|||
144717807|NCT01621490|521822105|FG004|Overall Study|Death|0|||
144717808|NCT01621490|521822106|FG005|Overall Study|Death|0|||
144717809|NCT01621490|521822107|FG006|Overall Study|Death|0|||
144492690|NCT01163149|520999066|FG001|Extension Treatment Period|Noncompliance|0|||
144492691|NCT01163149|520999067|FG002|Extension Treatment Period|Noncompliance|1|||
144492692|NCT00630539|520999068|FG000|Overall Study|Adverse Event|1|||
144492693|NCT00630539|520999069|FG001|Overall Study|Adverse Event|3|||
144492694|NCT00630539|520999070|FG002|Overall Study|Adverse Event|1|||
144492695|NCT00630539|520999071|FG003|Overall Study|Adverse Event|2|||
144492696|NCT00630539|520999068|FG000|Overall Study|Withdrawal by Subject|0|||
144492697|NCT00630539|520999069|FG001|Overall Study|Withdrawal by Subject|1|||
144492698|NCT00630539|520999070|FG002|Overall Study|Withdrawal by Subject|0|||
144492699|NCT00630539|520999071|FG003|Overall Study|Withdrawal by Subject|1|||
144492700|NCT02806336|520999084|FG000|Overall Study|Physician Decision|1|||
144492701|NCT02806336|520999085|FG001|Overall Study|Physician Decision|0|||
144492702|NCT02806336|520999084|FG000|Overall Study|Withdrawal by Subject|2|||
144492703|NCT02806336|520999085|FG001|Overall Study|Withdrawal by Subject|4|||
144492704|NCT02806336|520999084|FG000|Overall Study|COVID-19 research shut down|3|||
144492705|NCT02806336|520999085|FG001|Overall Study|COVID-19 research shut down|4|||
144492706|NCT02806336|520999084|FG000|Overall Study|Lack of Efficacy|0|||
144492707|NCT02806336|520999085|FG001|Overall Study|Lack of Efficacy|1|||
144492708|NCT04159896|520999086|FG000|Overall Study|Lack of Efficacy|7|||
144492709|NCT04159896|520999086|FG000|Overall Study|Withdrawal by Subject|1|||
144492710|NCT04159896|520999086|FG000|Overall Study|Adverse Event|1|||
144492711|NCT04159896|520999086|FG000|Overall Study|A transient ischaemic attack|1|||
144492712|NCT05705167|520999087|FG000|Overall Study|Randomised but not Treated|0|||
144492713|NCT05705167|520999088|FG001|Overall Study|Randomised but not Treated|2|||
144492714|NCT05705167|520999089|FG002|Overall Study|Randomised but not Treated|0|||
144492715|NCT05705167|520999090|FG003|Overall Study|Randomised but not Treated|7|||
144492716|NCT05705167|520999091|FG004|Overall Study|Randomised but not Treated|0|||
144492717|NCT05705167|520999092|FG005|Overall Study|Randomised but not Treated|0|||
144492718|NCT05705167|520999093|FG006|Overall Study|Randomised but not Treated|0|||
144492719|NCT05705167|520999087|FG000|Overall Study|Death|0|||
144492720|NCT05705167|520999088|FG001|Overall Study|Death|0|||
144492721|NCT05705167|520999089|FG002|Overall Study|Death|3|||
144492722|NCT05705167|520999090|FG003|Overall Study|Death|0|||
144492723|NCT05705167|520999091|FG004|Overall Study|Death|1|||
144492724|NCT05705167|520999092|FG005|Overall Study|Death|1|||
144492725|NCT05705167|520999093|FG006|Overall Study|Death|1|||
144492726|NCT05705167|520999087|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
144492727|NCT05705167|520999088|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
144492728|NCT05705167|520999089|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
144492729|NCT05705167|520999090|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
144492730|NCT05705167|520999091|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
144492731|NCT05705167|520999092|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
144492732|NCT05705167|520999093|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
144492733|NCT04529538|520999094|FG000|Overall Study|Lost to Follow-up|3|||
144492734|NCT04529538|520999095|FG001|Overall Study|Lost to Follow-up|2|||
144492735|NCT04529538|520999096|FG002|Overall Study|Lost to Follow-up|1|||
144492736|NCT04529538|520999097|FG003|Overall Study|Lost to Follow-up|0|||
144492737|NCT04529538|520999098|FG004|Overall Study|Lost to Follow-up|1|||
144492738|NCT04529538|520999099|FG005|Overall Study|Lost to Follow-up|1|||
144492739|NCT04529538|520999100|FG006|Overall Study|Lost to Follow-up|2|||
144492740|NCT04529538|520999101|FG007|Overall Study|Lost to Follow-up|0|||
144492741|NCT04529538|520999094|FG000|Overall Study|Not eligible at enrollment|0|||
144492742|NCT04529538|520999095|FG001|Overall Study|Not eligible at enrollment|1|||
144492743|NCT04529538|520999096|FG002|Overall Study|Not eligible at enrollment|2|||
144492744|NCT04529538|520999097|FG003|Overall Study|Not eligible at enrollment|1|||
144492745|NCT04529538|520999098|FG004|Overall Study|Not eligible at enrollment|0|||
144492746|NCT04529538|520999099|FG005|Overall Study|Not eligible at enrollment|0|||
144492747|NCT04529538|520999100|FG006|Overall Study|Not eligible at enrollment|0|||
144492748|NCT04529538|520999101|FG007|Overall Study|Not eligible at enrollment|1|||
144492749|NCT04529538|520999094|FG000|Overall Study|Withdrawal by Subject|0|||
144717810|NCT01621490|521822108|FG007|Overall Study|Death|0|||
144717811|NCT01621490|521822109|FG008|Overall Study|Death|1|||
144717812|NCT01621490|521822110|FG009|Overall Study|Death|0|||
144717813|NCT01621490|521822111|FG010|Overall Study|Death|0|||
144717814|NCT01621490|521822101|FG000|Overall Study|Other reasons|7|||
144717815|NCT01621490|521822102|FG001|Overall Study|Other reasons|6|||
144717816|NCT01621490|521822103|FG002|Overall Study|Other reasons|4|||
144717817|NCT01621490|521822104|FG003|Overall Study|Other reasons|1|||
144717818|NCT01621490|521822105|FG004|Overall Study|Other reasons|1|||
144717819|NCT01621490|521822106|FG005|Overall Study|Other reasons|3|||
144717820|NCT01621490|521822107|FG006|Overall Study|Other reasons|1|||
144717821|NCT01621490|521822108|FG007|Overall Study|Other reasons|1|||
144717822|NCT01621490|521822109|FG008|Overall Study|Other reasons|1|||
144717823|NCT01621490|521822110|FG009|Overall Study|Other reasons|0|||
144717824|NCT01621490|521822111|FG010|Overall Study|Other reasons|0|||
144717825|NCT00506753|521822112|FG000|Overall Study|Lost to Follow-up|21|||
144717826|NCT00506753|521822113|FG001|Overall Study|Lost to Follow-up|15|||
144717827|NCT00125359|521822114|FG000|Overall Study|Death|4|||
144717828|NCT00125359|521822114|FG000|Overall Study|Adverse Event|5|||
144717829|NCT00125359|521822114|FG000|Overall Study|Physician Decision|14|||
144717830|NCT02451670|521822115|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
144717831|NCT02451670|521822116|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
144717832|NCT00461500|521822117|FG000|Overall Study|Adverse Event|1|||
144717833|NCT00461500|521822118|FG001|Overall Study|Adverse Event|0|||
144717834|NCT00461500|521822117|FG000|Overall Study|Lack of Efficacy|0|||
144717835|NCT00461500|521822118|FG001|Overall Study|Lack of Efficacy|1|||
144717836|NCT00461500|521822117|FG000|Overall Study|Expired Drug Treatment|1|||
144717837|NCT00461500|521822118|FG001|Overall Study|Expired Drug Treatment|1|||
144717838|NCT00461500|521822117|FG000|Overall Study|Study Stopped|1|||
144717839|NCT00461500|521822118|FG001|Overall Study|Study Stopped|2|||
144717840|NCT00461500|521822117|FG000|Overall Study|Drug Treatment Misuse|1|||
144717841|NCT00461500|521822118|FG001|Overall Study|Drug Treatment Misuse|0|||
144717842|NCT00461500|521822117|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
144717843|NCT00461500|521822118|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
144717844|NCT00461500|521822117|FG000|Overall Study|Lost to Follow-up|2|||
144717845|NCT00461500|521822118|FG001|Overall Study|Lost to Follow-up|2|||
144717846|NCT01513551|521822123|FG000|Overall Study|Death|0|||
144717847|NCT01513551|521822124|FG001|Overall Study|Death|1|||
144717848|NCT01513551|521822125|FG002|Overall Study|Death|0|||
144717849|NCT01513551|521822123|FG000|Overall Study|Lost to Follow-up|3|||
144717850|NCT01513551|521822124|FG001|Overall Study|Lost to Follow-up|5|||
144717851|NCT01513551|521822125|FG002|Overall Study|Lost to Follow-up|2|||
144717852|NCT01513551|521822123|FG000|Overall Study|Withdrawal by Subject|1|||
144717853|NCT01513551|521822124|FG001|Overall Study|Withdrawal by Subject|0|||
144717854|NCT01513551|521822125|FG002|Overall Study|Withdrawal by Subject|2|||
144717855|NCT01513551|521822123|FG000|Overall Study|Randomized but not vaccinated|0|||
144717856|NCT01513551|521822124|FG001|Overall Study|Randomized but not vaccinated|0|||
144717857|NCT01513551|521822125|FG002|Overall Study|Randomized but not vaccinated|1|||
144717858|NCT02482805|521822126|FG000|Overall Study|Lost to Follow-up|4|||
144717859|NCT02482805|521822127|FG001|Overall Study|Lost to Follow-up|4|||
144717860|NCT02482805|521822128|FG002|Overall Study|Lost to Follow-up|0|||
144717861|NCT01806597|521822131|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
144717862|NCT01806597|521822132|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
144717863|NCT01806597|521822133|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
144717864|NCT01806597|521822134|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
144717865|NCT01806597|521822135|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
144717866|NCT01806597|521822136|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
144717867|NCT01806597|521822131|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
144717868|NCT01806597|521822132|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
144717869|NCT01806597|521822133|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
144717870|NCT01806597|521822134|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
144717871|NCT01806597|521822135|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
144717872|NCT01806597|521822136|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
144717873|NCT01806597|521822131|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
144717874|NCT01806597|521822132|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
144717875|NCT01806597|521822133|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
144717876|NCT01806597|521822134|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
144717877|NCT01806597|521822135|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
144717878|NCT01806597|521822136|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
144717879|NCT01806597|521822131|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
144717880|NCT01806597|521822132|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
144717881|NCT01806597|521822133|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
144717882|NCT01806597|521822134|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
144717883|NCT01806597|521822135|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
144717884|NCT01806597|521822136|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
144492750|NCT04529538|520999095|FG001|Overall Study|Withdrawal by Subject|1|||
144492751|NCT04529538|520999096|FG002|Overall Study|Withdrawal by Subject|1|||
144492752|NCT04529538|520999097|FG003|Overall Study|Withdrawal by Subject|2|||
144492753|NCT04529538|520999098|FG004|Overall Study|Withdrawal by Subject|0|||
144492754|NCT04529538|520999099|FG005|Overall Study|Withdrawal by Subject|2|||
144492755|NCT04529538|520999100|FG006|Overall Study|Withdrawal by Subject|3|||
144492756|NCT04529538|520999101|FG007|Overall Study|Withdrawal by Subject|0|||
144492757|NCT04529538|520999094|FG000|Overall Study|Other|0|||
144492758|NCT04529538|520999095|FG001|Overall Study|Other|1|||
144492759|NCT04529538|520999096|FG002|Overall Study|Other|0|||
144492760|NCT04529538|520999097|FG003|Overall Study|Other|0|||
144492761|NCT04529538|520999098|FG004|Overall Study|Other|0|||
144492762|NCT04529538|520999099|FG005|Overall Study|Other|0|||
144717885|NCT01806597|521822131|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
144717886|NCT01806597|521822132|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
144717887|NCT01806597|521822133|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
144717888|NCT01806597|521822134|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
144717889|NCT01806597|521822135|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
144717890|NCT01806597|521822136|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
144717891|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
144717892|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
144717893|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
144717894|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
144717895|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
144717896|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
144717897|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
144717898|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
144717899|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
144717900|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
144717901|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
144717902|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
144717903|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
144717904|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
144717905|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
144717906|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
144717907|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
144717908|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
144717909|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
144717910|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
144717911|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
144717912|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
144717913|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
144717914|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
144717915|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
144717916|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
144717917|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
144717918|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
144717919|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
144717920|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
144717921|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
144717922|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
144717923|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
144717924|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
144588158|NCT02594163|521352301|FG000|Follow-up Period|Progressive Disease|2|||
144588159|NCT02594163|521352302|FG001|Follow-up Period|Progressive Disease|0|||
144717925|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
144717926|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
144717927|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
144717928|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
144717929|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
144717930|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
144717931|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
144717932|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
144717933|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
144492763|NCT04529538|520999100|FG006|Overall Study|Other|0|||
144492764|NCT04529538|520999101|FG007|Overall Study|Other|0|||
144492765|NCT04529538|520999094|FG000|Overall Study|Adverse Event|0|||
144492766|NCT04529538|520999095|FG001|Overall Study|Adverse Event|0|||
144492767|NCT04529538|520999096|FG002|Overall Study|Adverse Event|0|||
144492768|NCT04529538|520999097|FG003|Overall Study|Adverse Event|1|||
144492769|NCT04529538|520999098|FG004|Overall Study|Adverse Event|0|||
144492770|NCT04529538|520999099|FG005|Overall Study|Adverse Event|0|||
144492771|NCT04529538|520999100|FG006|Overall Study|Adverse Event|0|||
144492772|NCT04529538|520999101|FG007|Overall Study|Adverse Event|0|||
144492773|NCT04529538|520999094|FG000|Overall Study|Protocol Deviation|0|||
144492774|NCT04529538|520999095|FG001|Overall Study|Protocol Deviation|0|||
144492775|NCT04529538|520999096|FG002|Overall Study|Protocol Deviation|0|||
144492776|NCT04529538|520999097|FG003|Overall Study|Protocol Deviation|1|||
144492777|NCT04529538|520999098|FG004|Overall Study|Protocol Deviation|0|||
144492778|NCT04529538|520999099|FG005|Overall Study|Protocol Deviation|0|||
144492779|NCT04529538|520999100|FG006|Overall Study|Protocol Deviation|0|||
144717934|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
144717935|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
144717936|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
144717937|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
144717938|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
144717939|NCT01806597|521822131|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
144717940|NCT01806597|521822132|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
144717941|NCT01806597|521822133|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
144717942|NCT01806597|521822134|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
144717943|NCT01806597|521822135|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
144717944|NCT01806597|521822136|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
144717945|NCT01806597|521822131|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
144717946|NCT01806597|521822132|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
144717947|NCT01806597|521822133|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
144717948|NCT01806597|521822134|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
144717949|NCT01806597|521822135|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
144717950|NCT01806597|521822136|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
144717951|NCT01806597|521822131|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
144717952|NCT01806597|521822132|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
144717953|NCT01806597|521822133|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
144717954|NCT01806597|521822134|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
144717955|NCT01806597|521822135|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
144717956|NCT01806597|521822136|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
144717957|NCT01806597|521822131|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
144717958|NCT01806597|521822132|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
144717959|NCT01806597|521822133|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
144717960|NCT01806597|521822134|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
144717961|NCT01806597|521822135|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
144717962|NCT01806597|521822136|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
144717963|NCT01806597|521822131|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
144717964|NCT01806597|521822132|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
144717965|NCT01806597|521822133|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
144717966|NCT01806597|521822134|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
144717967|NCT01806597|521822135|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
144717968|NCT01806597|521822136|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
144717969|NCT01806597|521822131|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
144717970|NCT01806597|521822132|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
144717971|NCT01806597|521822133|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
144717972|NCT01806597|521822134|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
144717973|NCT01806597|521822135|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
144717974|NCT01806597|521822136|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
144717975|NCT01144663|521822137|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
144717976|NCT01144663|521822138|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
144717977|NCT01144663|521822139|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
144717978|NCT01144663|521822140|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
144717979|NCT01144663|521822137|FG000|Primary Vaccination Phase|Adverse Event|1|||
144717980|NCT01144663|521822138|FG001|Primary Vaccination Phase|Adverse Event|0|||
144717981|NCT01144663|521822139|FG002|Primary Vaccination Phase|Adverse Event|0|||
144717982|NCT01144663|521822140|FG003|Primary Vaccination Phase|Adverse Event|1|||
144717983|NCT01144663|521822137|FG000|Primary Vaccination Phase|Protocol Violation|2|||
144717984|NCT01144663|521822138|FG001|Primary Vaccination Phase|Protocol Violation|0|||
144717985|NCT01144663|521822139|FG002|Primary Vaccination Phase|Protocol Violation|1|||
144717986|NCT01144663|521822140|FG003|Primary Vaccination Phase|Protocol Violation|0|||
144717987|NCT01144663|521822137|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
144717988|NCT01144663|521822138|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
144717989|NCT01144663|521822139|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
144717990|NCT01144663|521822140|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
144717991|NCT01144663|521822137|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
144492780|NCT04529538|520999101|FG007|Overall Study|Protocol Deviation|0|||
144492781|NCT04529538|520999094|FG000|Overall Study|Physician Decision|0|||
144492782|NCT04529538|520999095|FG001|Overall Study|Physician Decision|0|||
144492783|NCT04529538|520999096|FG002|Overall Study|Physician Decision|0|||
144492784|NCT04529538|520999097|FG003|Overall Study|Physician Decision|0|||
144492785|NCT04529538|520999098|FG004|Overall Study|Physician Decision|0|||
144492786|NCT04529538|520999099|FG005|Overall Study|Physician Decision|1|||
144492787|NCT04529538|520999100|FG006|Overall Study|Physician Decision|0|||
144492788|NCT04529538|520999101|FG007|Overall Study|Physician Decision|1|||
144492789|NCT02223182|520999102|FG000|Double-Blind Period|Adverse Event|0|||
144492790|NCT02223182|520999103|FG001|Double-Blind Period|Adverse Event|2|||
144492791|NCT02223182|520999104|FG002|Double-Blind Period|Adverse Event|1|||
144492792|NCT02223182|520999105|FG003|Double-Blind Period|Adverse Event|0|||
144492793|NCT02223182|520999102|FG000|Double-Blind Period|Withdrawal by Subject|1|||
144492794|NCT02223182|520999103|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144492795|NCT02223182|520999104|FG002|Double-Blind Period|Withdrawal by Subject|1|||
144717992|NCT01144663|521822138|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
144717993|NCT01144663|521822139|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
144717994|NCT01144663|521822140|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
144717995|NCT01144663|521822137|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
144717996|NCT01144663|521822138|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
144717997|NCT01144663|521822139|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
144717998|NCT01144663|521822140|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
144717999|NCT01144663|521822137|FG000|Primary Vaccination Phase|Other|0|||
144718000|NCT01144663|521822138|FG001|Primary Vaccination Phase|Other|1|||
144718001|NCT01144663|521822139|FG002|Primary Vaccination Phase|Other|0|||
144718002|NCT01144663|521822140|FG003|Primary Vaccination Phase|Other|2|||
144718003|NCT01144663|521822137|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
144718004|NCT01144663|521822138|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
144718005|NCT01144663|521822139|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
144718006|NCT01144663|521822140|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
144718007|NCT01144663|521822137|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
144718008|NCT01144663|521822138|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
144718009|NCT01144663|521822139|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
144718010|NCT01144663|521822140|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
144718011|NCT01144663|521822137|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
144718012|NCT01144663|521822138|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
144718013|NCT01144663|521822139|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
144718014|NCT01144663|521822140|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
144718015|NCT01144663|521822137|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
144718016|NCT01144663|521822138|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
144718017|NCT01144663|521822139|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
144718018|NCT01144663|521822140|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
144718019|NCT01144663|521822137|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
144718020|NCT01144663|521822138|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
144718021|NCT01144663|521822139|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
144718022|NCT01144663|521822140|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
144718023|NCT01144663|521822137|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
144718024|NCT01144663|521822138|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
144718025|NCT01144663|521822139|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
144718026|NCT01144663|521822140|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
144718027|NCT01267266|521822143|FG000|Enrollment Phase|Withdrawal by Subject|2|||
144718028|NCT01267266|521822144|FG001|Enrollment Phase|Withdrawal by Subject|0|||
144718029|NCT01267266|521822143|FG000|Lead-in Phase|Lack of Efficacy|20|||
144718030|NCT01267266|521822144|FG001|Lead-in Phase|Lack of Efficacy|0|||
144718031|NCT01267266|521822143|FG000|Lead-in Phase|Adverse Event|2|||
144718032|NCT01267266|521822144|FG001|Lead-in Phase|Adverse Event|0|||
144718033|NCT01267266|521822143|FG000|Lead-in Phase|Withdrawal by Subject|1|||
144718034|NCT01267266|521822144|FG001|Lead-in Phase|Withdrawal by Subject|0|||
144718035|NCT01335477|521822146|FG000|Overall Study|Adverse Event|30|||
144718036|NCT01335477|521822147|FG001|Overall Study|Adverse Event|42|||
144718037|NCT01335477|521822146|FG000|Overall Study|Non compliant with protocol|0|||
144718038|NCT01335477|521822147|FG001|Overall Study|Non compliant with protocol|2|||
144718039|NCT01335477|521822146|FG000|Overall Study|Lost to Follow-up|1|||
144718040|NCT01335477|521822147|FG001|Overall Study|Lost to Follow-up|2|||
144718041|NCT01335477|521822146|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
144718042|NCT01335477|521822147|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
144718043|NCT01335477|521822146|FG000|Overall Study|Not treated|1|||
144718044|NCT01335477|521822147|FG001|Overall Study|Not treated|2|||
144718045|NCT01335477|521822146|FG000|Overall Study|Reason other than those stated above|2|||
144718046|NCT01335477|521822147|FG001|Overall Study|Reason other than those stated above|2|||
144718047|NCT02038634|521822149|FG000|Overall Study|Lost to Follow-up|0|||
144718048|NCT02038634|521822150|FG001|Overall Study|Lost to Follow-up|1|||
144718049|NCT01034137|521822152|FG000|Overall Study|Adverse Event|9|||
144718050|NCT01034137|521822153|FG001|Overall Study|Adverse Event|10|||
144718051|NCT01034137|521822154|FG002|Overall Study|Adverse Event|8|||
144718052|NCT01034137|521822152|FG000|Overall Study|Withdrawal by Subject|4|||
144718053|NCT01034137|521822153|FG001|Overall Study|Withdrawal by Subject|3|||
144718054|NCT01034137|521822154|FG002|Overall Study|Withdrawal by Subject|3|||
144718055|NCT01034137|521822152|FG000|Overall Study|Lack of Efficacy|9|||
144718056|NCT01034137|521822153|FG001|Overall Study|Lack of Efficacy|4|||
144718057|NCT01034137|521822154|FG002|Overall Study|Lack of Efficacy|13|||
144718058|NCT01034137|521822152|FG000|Overall Study|Protocol Violation|2|||
144718059|NCT01034137|521822153|FG001|Overall Study|Protocol Violation|2|||
144718060|NCT01034137|521822154|FG002|Overall Study|Protocol Violation|1|||
144492796|NCT02223182|520999105|FG003|Double-Blind Period|Withdrawal by Subject|0|||
144492797|NCT02223182|520999102|FG000|Double-Blind Period|Lost to Follow-up|0|||
144492798|NCT02223182|520999103|FG001|Double-Blind Period|Lost to Follow-up|1|||
144492799|NCT02223182|520999104|FG002|Double-Blind Period|Lost to Follow-up|0|||
144492800|NCT02223182|520999105|FG003|Double-Blind Period|Lost to Follow-up|0|||
144492801|NCT02223182|520999102|FG000|Double-Blind Period|Non Compliance|0|||
144492802|NCT02223182|520999103|FG001|Double-Blind Period|Non Compliance|0|||
144492803|NCT02223182|520999104|FG002|Double-Blind Period|Non Compliance|0|||
144492804|NCT02223182|520999105|FG003|Double-Blind Period|Non Compliance|1|||
144492805|NCT02223182|520999102|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
144492806|NCT02223182|520999103|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
144492807|NCT02223182|520999104|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
144492808|NCT02223182|520999105|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
144492809|NCT02223182|520999102|FG000|Open-Label 500 Period|Adverse Event|1|||
144492810|NCT02223182|520999103|FG001|Open-Label 500 Period|Adverse Event|0|||
144492811|NCT02223182|520999104|FG002|Open-Label 500 Period|Adverse Event|2|||
144492812|NCT02223182|520999105|FG003|Open-Label 500 Period|Adverse Event|1|||
144492813|NCT02223182|520999102|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
144492814|NCT02223182|520999103|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
144492815|NCT02223182|520999104|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
144492816|NCT02223182|520999105|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
144492817|NCT02223182|520999102|FG000|Open-Label 500 Period|Physician Decision|0|||
144492818|NCT02223182|520999103|FG001|Open-Label 500 Period|Physician Decision|0|||
144492819|NCT02223182|520999104|FG002|Open-Label 500 Period|Physician Decision|0|||
144492820|NCT02223182|520999105|FG003|Open-Label 500 Period|Physician Decision|1|||
144492821|NCT02223182|520999102|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
144492822|NCT02223182|520999103|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
144492823|NCT02223182|520999104|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
144492824|NCT02223182|520999105|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
144492825|NCT02223182|520999102|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
144492826|NCT02223182|520999103|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
144492827|NCT02223182|520999104|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
144492828|NCT02223182|520999105|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
144492829|NCT02223182|520999102|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
144492830|NCT02223182|520999103|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
144492831|NCT02223182|520999104|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
144492832|NCT02223182|520999105|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
144492833|NCT02223182|520999102|FG000|Open-Label 300 Period|Non Compliance|0|||
144492834|NCT02223182|520999103|FG001|Open-Label 300 Period|Non Compliance|2|||
144492835|NCT02223182|520999104|FG002|Open-Label 300 Period|Non Compliance|1|||
144492836|NCT02223182|520999105|FG003|Open-Label 300 Period|Non Compliance|0|||
144492837|NCT02099539|520999110|FG000|Overall Study|Progressive Disease|3|||
144492838|NCT02099539|520999111|FG001|Overall Study|Progressive Disease|2|||
144492839|NCT02099539|520999112|FG002|Overall Study|Progressive Disease|2|||
144492840|NCT02099539|520999113|FG003|Overall Study|Progressive Disease|1|||
144492841|NCT02099539|520999114|FG004|Overall Study|Progressive Disease|4|||
144492842|NCT02099539|520999115|FG005|Overall Study|Progressive Disease|2|||
144492843|NCT02099539|520999116|FG006|Overall Study|Progressive Disease|0|||
144492844|NCT02099539|520999110|FG000|Overall Study|Adverse Event|0|||
144492845|NCT02099539|520999111|FG001|Overall Study|Adverse Event|0|||
144492846|NCT02099539|520999112|FG002|Overall Study|Adverse Event|1|||
144492847|NCT02099539|520999113|FG003|Overall Study|Adverse Event|1|||
144492848|NCT02099539|520999114|FG004|Overall Study|Adverse Event|0|||
144492849|NCT02099539|520999115|FG005|Overall Study|Adverse Event|0|||
144492850|NCT02099539|520999116|FG006|Overall Study|Adverse Event|0|||
144492851|NCT02099539|520999110|FG000|Overall Study|Physician Decision|0|||
144492852|NCT02099539|520999111|FG001|Overall Study|Physician Decision|0|||
144492853|NCT02099539|520999112|FG002|Overall Study|Physician Decision|0|||
144492854|NCT02099539|520999113|FG003|Overall Study|Physician Decision|0|||
144492855|NCT02099539|520999114|FG004|Overall Study|Physician Decision|0|||
144492856|NCT02099539|520999115|FG005|Overall Study|Physician Decision|1|||
144492857|NCT02099539|520999116|FG006|Overall Study|Physician Decision|0|||
144492858|NCT03473756|520999118|FG000|Overall Study|Withdrawal by Subject|1|||
144492859|NCT03473756|520999119|FG001|Overall Study|Withdrawal by Subject|4|||
144492860|NCT03473756|520999118|FG000|Overall Study|Adverse Event|6|||
144492861|NCT03473756|520999119|FG001|Overall Study|Adverse Event|7|||
144492862|NCT03473756|520999118|FG000|Overall Study|Lack of Efficacy|3|||
144492863|NCT03473756|520999119|FG001|Overall Study|Lack of Efficacy|10|||
144492864|NCT03473756|520999118|FG000|Overall Study|Physician Decision|0|||
144492865|NCT03473756|520999119|FG001|Overall Study|Physician Decision|2|||
144492866|NCT03473756|520999118|FG000|Overall Study|End of study treatment|0|||
144492867|NCT03473756|520999119|FG001|Overall Study|End of study treatment|2|||
144492868|NCT03473756|520999118|FG000|Overall Study|Lost to Follow-up|0|||
144492869|NCT03473756|520999119|FG001|Overall Study|Lost to Follow-up|1|||
144492870|NCT03714022|520999120|FG000|Overall Study|Adverse Event|1|||
144369988|NCT02504151|520562775|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
144492871|NCT03714022|520999121|FG001|Overall Study|Adverse Event|0|||
144492872|NCT03714022|520999120|FG000|Overall Study|Consent withdrawal|0|||
144492873|NCT03714022|520999121|FG001|Overall Study|Consent withdrawal|1|||
144492874|NCT03714022|520999120|FG000|Overall Study|Lost to Follow-up|3|||
144492875|NCT03714022|520999121|FG001|Overall Study|Lost to Follow-up|2|||
144492876|NCT01007552|520999122|FG000|Overall Study|Withdrawal by Subject|1|||
144492877|NCT00465361|521000994|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
144492878|NCT01511536|521000995|FG000|Phase 1|Other|0|||
144492879|NCT01511536|521000996|FG001|Phase 1|Other|1|||
144492880|NCT01511536|521000997|FG002|Phase 1|Other|0|||
144492881|NCT01511536|521000995|FG000|Phase 2|Other|0|||
144492882|NCT01511536|521000996|FG001|Phase 2|Other|0|||
144492883|NCT01511536|521000997|FG002|Phase 2|Other|9|||
144492884|NCT02703532|521001002|FG000|Overall Study|Withdrawal by Subject|0|||
144492885|NCT02703532|521001003|FG001|Overall Study|Withdrawal by Subject|1|||
144492886|NCT02703532|521001004|FG002|Overall Study|Withdrawal by Subject|0|||
144492887|NCT02703532|521001005|FG003|Overall Study|Withdrawal by Subject|1|||
144492888|NCT02703532|521001002|FG000|Overall Study|Lost to Follow-up|2|||
144492889|NCT02703532|521001003|FG001|Overall Study|Lost to Follow-up|0|||
144492890|NCT02703532|521001004|FG002|Overall Study|Lost to Follow-up|2|||
144492891|NCT02703532|521001005|FG003|Overall Study|Lost to Follow-up|0|||
144492892|NCT03738241|521001009|FG000|Overall Study|Withdrawal by Subject|0|||
144492893|NCT03738241|521001010|FG001|Overall Study|Withdrawal by Subject|0|||
144492894|NCT03738241|521001011|FG002|Overall Study|Withdrawal by Subject|0|||
144492895|NCT03738241|521001012|FG003|Overall Study|Withdrawal by Subject|0|||
144492896|NCT03738241|521001013|FG004|Overall Study|Withdrawal by Subject|0|||
144492897|NCT03738241|521001014|FG005|Overall Study|Withdrawal by Subject|0|||
144492898|NCT03738241|521001015|FG006|Overall Study|Withdrawal by Subject|0|||
144492899|NCT03738241|521001016|FG007|Overall Study|Withdrawal by Subject|0|||
144492900|NCT03738241|521001017|FG008|Overall Study|Withdrawal by Subject|0|||
144492901|NCT03738241|521001018|FG009|Overall Study|Withdrawal by Subject|1|||
144492902|NCT03738241|521001009|FG000|Overall Study|Physician Decision|0|||
144492903|NCT03738241|521001010|FG001|Overall Study|Physician Decision|0|||
144492904|NCT03738241|521001011|FG002|Overall Study|Physician Decision|0|||
144492905|NCT03738241|521001012|FG003|Overall Study|Physician Decision|0|||
144492906|NCT03738241|521001013|FG004|Overall Study|Physician Decision|0|||
144492907|NCT03738241|521001014|FG005|Overall Study|Physician Decision|0|||
144492908|NCT03738241|521001015|FG006|Overall Study|Physician Decision|0|||
144492909|NCT03738241|521001016|FG007|Overall Study|Physician Decision|0|||
144492910|NCT03738241|521001017|FG008|Overall Study|Physician Decision|1|||
144492911|NCT03738241|521001018|FG009|Overall Study|Physician Decision|0|||
144492912|NCT03738241|521001009|FG000|Overall Study|Adverse Event|1|||
144492913|NCT03738241|521001010|FG001|Overall Study|Adverse Event|0|||
144718061|NCT01034137|521822152|FG000|Overall Study|Refused treatment or did not cooperate|2|||
144718062|NCT01034137|521822153|FG001|Overall Study|Refused treatment or did not cooperate|0|||
144718063|NCT01034137|521822154|FG002|Overall Study|Refused treatment or did not cooperate|1|||
144718064|NCT01034137|521822152|FG000|Overall Study|Administrative or other|2|||
144718065|NCT01034137|521822153|FG001|Overall Study|Administrative or other|3|||
144718066|NCT01034137|521822154|FG002|Overall Study|Administrative or other|4|||
144718067|NCT03572933|521822155|FG000|Overall Study|Adverse Event|4|||
144718068|NCT03572933|521822156|FG001|Overall Study|Adverse Event|1|||
144718069|NCT03572933|521822155|FG000|Overall Study|Withdrawal by Subject|0|||
144718070|NCT03572933|521822156|FG001|Overall Study|Withdrawal by Subject|1|||
144718071|NCT04633837|521822160|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
144718072|NCT04633837|521822161|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
144718073|NCT00112489|521822162|FG000|Overall Study|Refused further treatment|8|||
144718074|NCT00112489|521822162|FG000|Overall Study|Adverse Event|12|||
144718075|NCT00112489|521822162|FG000|Overall Study|Death|2|||
144718076|NCT00112489|521822162|FG000|Overall Study|Other, Not Specified|9|||
144718077|NCT00112489|521822162|FG000|Overall Study|Patient never treated|2|||
144718078|NCT00112489|521822162|FG000|Overall Study|Ineligible|7|||
144718079|NCT00268346|521822163|FG000|Overall Study|Adverse Event|0|||
144718080|NCT00268346|521822164|FG001|Overall Study|Adverse Event|1|||
144718081|NCT00268346|521822163|FG000|Overall Study|Death|0|||
144718082|NCT00268346|521822164|FG001|Overall Study|Death|1|||
144718083|NCT00268346|521822163|FG000|Overall Study|Withdrawal by Subject|0|||
144718084|NCT00268346|521822164|FG001|Overall Study|Withdrawal by Subject|1|||
144718085|NCT01799590|521822165|FG000|Overall Study|Adverse Event|13|||
144718086|NCT01799590|521822166|FG001|Overall Study|Adverse Event|7|||
144718087|NCT01799590|521822167|FG002|Overall Study|Adverse Event|5|||
144718088|NCT01799590|521822165|FG000|Overall Study|Pregnancy|2|||
144718089|NCT01799590|521822166|FG001|Overall Study|Pregnancy|0|||
144718090|NCT01799590|521822167|FG002|Overall Study|Pregnancy|0|||
144718091|NCT01799590|521822165|FG000|Overall Study|Lack of Efficacy|3|||
144492914|NCT03738241|521001011|FG002|Overall Study|Adverse Event|0|||
144492915|NCT03738241|521001012|FG003|Overall Study|Adverse Event|0|||
144492916|NCT03738241|521001013|FG004|Overall Study|Adverse Event|0|||
144492917|NCT03738241|521001014|FG005|Overall Study|Adverse Event|0|||
144492918|NCT03738241|521001015|FG006|Overall Study|Adverse Event|0|||
144492919|NCT03738241|521001016|FG007|Overall Study|Adverse Event|0|||
144492920|NCT03738241|521001017|FG008|Overall Study|Adverse Event|0|||
144492921|NCT03738241|521001018|FG009|Overall Study|Adverse Event|0|||
144492922|NCT01244763|521001019|FG000|Overall Study|Adverse Event|1|||
144492923|NCT01244763|521001020|FG001|Overall Study|Adverse Event|0|||
144492924|NCT01244763|521001021|FG002|Overall Study|Adverse Event|0|||
144492925|NCT01244763|521001022|FG003|Overall Study|Adverse Event|0|||
144492926|NCT01244763|521001023|FG004|Overall Study|Adverse Event|0|||
144492927|NCT01244763|521001024|FG005|Overall Study|Adverse Event|1|||
144492928|NCT01244763|521001019|FG000|Overall Study|Death|1|||
144492929|NCT01244763|521001020|FG001|Overall Study|Death|0|||
144492930|NCT01244763|521001021|FG002|Overall Study|Death|1|||
144492931|NCT01244763|521001022|FG003|Overall Study|Death|0|||
144492932|NCT01244763|521001023|FG004|Overall Study|Death|2|||
144492933|NCT01244763|521001024|FG005|Overall Study|Death|0|||
144492934|NCT01244763|521001019|FG000|Overall Study|Physician Decision|0|||
144492935|NCT01244763|521001020|FG001|Overall Study|Physician Decision|0|||
144492936|NCT01244763|521001021|FG002|Overall Study|Physician Decision|1|||
144492937|NCT01244763|521001022|FG003|Overall Study|Physician Decision|0|||
144492938|NCT01244763|521001023|FG004|Overall Study|Physician Decision|0|||
144492939|NCT01244763|521001024|FG005|Overall Study|Physician Decision|0|||
144492940|NCT01244763|521001019|FG000|Overall Study|Withdrawal by Subject|1|||
144492941|NCT01244763|521001020|FG001|Overall Study|Withdrawal by Subject|2|||
144492942|NCT01244763|521001021|FG002|Overall Study|Withdrawal by Subject|0|||
144492943|NCT01244763|521001022|FG003|Overall Study|Withdrawal by Subject|1|||
144492944|NCT01244763|521001023|FG004|Overall Study|Withdrawal by Subject|1|||
144492945|NCT01244763|521001024|FG005|Overall Study|Withdrawal by Subject|2|||
144492946|NCT01244763|521001019|FG000|Overall Study|Lost to Follow-up|0|||
144492947|NCT01244763|521001020|FG001|Overall Study|Lost to Follow-up|1|||
144492948|NCT01244763|521001021|FG002|Overall Study|Lost to Follow-up|0|||
144492949|NCT01244763|521001022|FG003|Overall Study|Lost to Follow-up|0|||
144492950|NCT01244763|521001023|FG004|Overall Study|Lost to Follow-up|0|||
144492951|NCT01244763|521001024|FG005|Overall Study|Lost to Follow-up|0|||
144492952|NCT01244763|521001019|FG000|Overall Study|Enrolled into the Extension Study|0|||
144492953|NCT01244763|521001020|FG001|Overall Study|Enrolled into the Extension Study|0|||
144492954|NCT01244763|521001021|FG002|Overall Study|Enrolled into the Extension Study|0|||
144492955|NCT01244763|521001022|FG003|Overall Study|Enrolled into the Extension Study|0|||
144492956|NCT01244763|521001023|FG004|Overall Study|Enrolled into the Extension Study|0|||
144492957|NCT01244763|521001024|FG005|Overall Study|Enrolled into the Extension Study|1|||
144492958|NCT02263885|521001025|FG000|Overall Study|Withdrawal by Subject|7|||
144492959|NCT02263885|521001025|FG000|Overall Study|Alternative Treatment|3|||
144492960|NCT02459964|521001032|FG000|Overall Study|Withdrawal by Subject|0|||
144492961|NCT02459964|521001033|FG001|Overall Study|Withdrawal by Subject|0|||
144492962|NCT02459964|521001034|FG002|Overall Study|Withdrawal by Subject|1|||
144492963|NCT02459964|521001032|FG000|Overall Study|Abnormal EKG changes|0|||
144492964|NCT02459964|521001033|FG001|Overall Study|Abnormal EKG changes|0|||
144492965|NCT02459964|521001034|FG002|Overall Study|Abnormal EKG changes|1|||
144492966|NCT00751790|521001035|FG000|Overall Study|Lost to Follow-up|1|||
144718092|NCT01799590|521822166|FG001|Overall Study|Lack of Efficacy|1|||
144718093|NCT01799590|521822167|FG002|Overall Study|Lack of Efficacy|3|||
144718094|NCT01799590|521822165|FG000|Overall Study|Participants convenience|4|||
144718095|NCT01799590|521822166|FG001|Overall Study|Participants convenience|4|||
144718096|NCT01799590|521822167|FG002|Overall Study|Participants convenience|2|||
144718097|NCT01799590|521822165|FG000|Overall Study|Aggravation of complications|0|||
144718098|NCT01799590|521822166|FG001|Overall Study|Aggravation of complications|1|||
144718099|NCT01799590|521822167|FG002|Overall Study|Aggravation of complications|1|||
144718100|NCT01799590|521822165|FG000|Overall Study|Using drugs with restricted days of use|0|||
144718101|NCT01799590|521822166|FG001|Overall Study|Using drugs with restricted days of use|3|||
144718102|NCT01799590|521822167|FG002|Overall Study|Using drugs with restricted days of use|2|||
144718103|NCT01799590|521822165|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
144718104|NCT01799590|521822166|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
144718105|NCT01799590|521822167|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
144718106|NCT01799590|521822165|FG000|Overall Study|Other|3|||
144718107|NCT01799590|521822166|FG001|Overall Study|Other|0|||
144718108|NCT01799590|521822167|FG002|Overall Study|Other|1|||
144718109|NCT00294723|521822170|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
144718110|NCT00294723|521822171|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
144718111|NCT00294723|521822172|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
144718112|NCT00294723|521822170|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
144718113|NCT00294723|521822171|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
144718114|NCT00294723|521822172|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
144718115|NCT00294723|521822170|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
144718116|NCT00294723|521822171|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
144718117|NCT00294723|521822172|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
144718118|NCT00294723|521822170|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
144718119|NCT00294723|521822171|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
144718120|NCT00294723|521822172|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
144718121|NCT00294723|521822170|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
144718122|NCT00294723|521822171|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
144718123|NCT00294723|521822172|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
144718124|NCT00294723|521822170|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
144718125|NCT00294723|521822171|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
144718126|NCT00294723|521822172|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
144718127|NCT00294723|521822170|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
144718128|NCT00294723|521822171|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
144718129|NCT00294723|521822172|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
144718130|NCT00294723|521822170|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
144718131|NCT00294723|521822171|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
144718132|NCT00294723|521822172|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
144718133|NCT00294723|521822170|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
144718134|NCT00294723|521822171|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
144718135|NCT00294723|521822172|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
144718136|NCT00294723|521822170|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
144718137|NCT00294723|521822171|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
144718138|NCT00294723|521822172|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
144718139|NCT00294723|521822170|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
144718140|NCT00294723|521822171|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
144718141|NCT00294723|521822172|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
144718142|NCT00294723|521822170|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
144718143|NCT00294723|521822171|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
144718144|NCT00294723|521822172|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
144718145|NCT00752791|521822173|FG000|Overall Study|Adverse Event|7|||
144718146|NCT00752791|521822173|FG000|Overall Study|Withdrawal by Subject|1|||
144718147|NCT00752791|521822173|FG000|Overall Study|Physician Decision|1|||
144492967|NCT00751790|521001035|FG000|Overall Study|Death|3|||
144492968|NCT00751790|521001035|FG000|Overall Study|Withdrawal by Subject|1|||
144492969|NCT04170023|521001036|FG000|LTE Period|Withdrawal by Subject|1|||
144492970|NCT04170023|521001037|FG001|LTE Period|Withdrawal by Subject|0|||
144492971|NCT04170023|521001038|FG002|LTE Period|Withdrawal by Subject|0|||
144492972|NCT04170023|521001036|FG000|LTE Period|Study Termination|11|||
144492973|NCT04170023|521001037|FG001|LTE Period|Study Termination|11|||
144492974|NCT04170023|521001038|FG002|LTE Period|Study Termination|5|||
144492975|NCT03836664|521001041|FG000|Overall Study|Didn't complete forms and lost drug|3|||
144492976|NCT03836664|521001042|FG001|Overall Study|Didn't complete forms and lost drug|3|||
144492977|NCT03566680|521001043|FG000|Overall Study|Pregnancy|1|||
144492978|NCT03566680|521001043|FG000|Overall Study|Lost to Follow-up|13|||
144492979|NCT03566680|521001043|FG000|Overall Study|Withdrawal by Subject|3|||
144492980|NCT04337489|521001044|FG000|Overall Study|Withdrawal by Subject|1|||
144492981|NCT01113463|521001047|FG000|Overall Study|Physician Decision|5|||
144492982|NCT00562965|521001048|FG000|Overall Study|Withdrawal by Subject|0|||
144492983|NCT00562965|521001049|FG001|Overall Study|Withdrawal by Subject|1|||
144492984|NCT00562965|521001048|FG000|Overall Study|Death|2|||
144492985|NCT00562965|521001049|FG001|Overall Study|Death|4|||
144492986|NCT00562965|521001048|FG000|Overall Study|Lost to Follow-up|1|||
144492987|NCT00562965|521001049|FG001|Overall Study|Lost to Follow-up|0|||
144492988|NCT00562965|521001048|FG000|Overall Study|Other|0|||
144492989|NCT00562965|521001049|FG001|Overall Study|Other|1|||
144492990|NCT01657682|521001050|FG000|Overall Study|Lost to Follow-up|1|||
144492991|NCT01657682|521001051|FG001|Overall Study|Lost to Follow-up|0|||
144492992|NCT01657682|521001052|FG002|Overall Study|Lost to Follow-up|0|||
144492993|NCT01657682|521001050|FG000|Overall Study|Withdrawal by Subject|0|||
144492994|NCT01657682|521001051|FG001|Overall Study|Withdrawal by Subject|1|||
144492995|NCT01657682|521001052|FG002|Overall Study|Withdrawal by Subject|1|||
144492996|NCT01657682|521001050|FG000|Overall Study|Adverse Event|0|||
144492997|NCT01657682|521001051|FG001|Overall Study|Adverse Event|1|||
144492998|NCT01657682|521001052|FG002|Overall Study|Adverse Event|0|||
144492999|NCT03379233|521001054|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
144493000|NCT03379233|521001055|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
144493001|NCT00965484|521001056|FG000|Overall Study|Protocol Violation|1|||
144493002|NCT00965484|521001056|FG000|Overall Study|Withdrawal by Subject|1|||
144493003|NCT00848211|521001057|FG000|Overall Study|Protocol Violation|0|||
144493004|NCT00848211|521001058|FG001|Overall Study|Protocol Violation|1|||
144493005|NCT00848211|521001059|FG002|Overall Study|Protocol Violation|1|||
144493006|NCT00848211|521001060|FG003|Overall Study|Protocol Violation|0|||
144493007|NCT00848211|521001057|FG000|Overall Study|Adverse Event|0|||
144493008|NCT00848211|521001058|FG001|Overall Study|Adverse Event|0|||
144493009|NCT00848211|521001059|FG002|Overall Study|Adverse Event|0|||
144493010|NCT00848211|521001060|FG003|Overall Study|Adverse Event|0|||
144493011|NCT02531438|521001061|FG000|Overall Study|Adverse Event|7|||
144493012|NCT02531438|521001062|FG001|Overall Study|Adverse Event|9|||
144493013|NCT02531438|521001061|FG000|Overall Study|Lost to Follow-up|0|||
144493014|NCT02531438|521001062|FG001|Overall Study|Lost to Follow-up|3|||
144493015|NCT02531438|521001061|FG000|Overall Study|Withdrawal by Subject|7|||
144493016|NCT02531438|521001062|FG001|Overall Study|Withdrawal by Subject|8|||
144493017|NCT02531438|521001061|FG000|Overall Study|Physician Decision|0|||
144493018|NCT02531438|521001062|FG001|Overall Study|Physician Decision|1|||
144493019|NCT02531438|521001061|FG000|Overall Study|Death|6|||
144493020|NCT02531438|521001062|FG001|Overall Study|Death|3|||
144493021|NCT02531438|521001061|FG000|Overall Study|Randomized, but Not Treated|4|||
144493022|NCT02531438|521001062|FG001|Overall Study|Randomized, but Not Treated|0|||
144493023|NCT02531438|521001061|FG000|Overall Study|Missed EOT/PTE Visit|5|||
144493024|NCT02531438|521001062|FG001|Overall Study|Missed EOT/PTE Visit|2|||
144493025|NCT02531438|521001061|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
144493026|NCT02531438|521001062|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
144493027|NCT01124617|521001063|FG000|Overall Study|Adverse Event|5|||
144493028|NCT01124617|521001064|FG001|Overall Study|Adverse Event|2|||
144493029|NCT01124617|521001063|FG000|Overall Study|Lack of Efficacy|2|||
144493030|NCT01124617|521001064|FG001|Overall Study|Lack of Efficacy|1|||
144493031|NCT01124617|521001063|FG000|Overall Study|Protocol Violation|1|||
144493032|NCT01124617|521001064|FG001|Overall Study|Protocol Violation|1|||
144493033|NCT01124617|521001063|FG000|Overall Study|Withdrawal by Subject|9|||
144493034|NCT01124617|521001064|FG001|Overall Study|Withdrawal by Subject|1|||
144493035|NCT01124617|521001063|FG000|Overall Study|Other|2|||
144493036|NCT01124617|521001064|FG001|Overall Study|Other|1|||
144493037|NCT00945477|521001065|FG000|Overall Study|Adverse Event|3|||
144493038|NCT00945477|521001065|FG000|Overall Study|Lack of Efficacy|2|||
144493039|NCT00945477|521001065|FG000|Overall Study|Withdrawal by Subject|1|||
144493040|NCT01653743|521001066|FG000|Overall Study|Withdrawal by Subject|1|||
144718148|NCT00752791|521822173|FG000|Overall Study|Death|1|||
144718149|NCT00752791|521822173|FG000|Overall Study|Renal transplant|3|||
144718150|NCT00752791|521822173|FG000|Overall Study|Switched to hemodialysis|2|||
144718151|NCT00752791|521822173|FG000|Overall Study|Protocol deviation|1|||
144718152|NCT01977092|521822174|FG000|Overall Study|Death|3|||
144718153|NCT01977092|521822175|FG001|Overall Study|Death|4|||
144718154|NCT01977092|521822174|FG000|Overall Study|Lost to Follow-up|23|||
144718155|NCT01977092|521822175|FG001|Overall Study|Lost to Follow-up|14|||
144718156|NCT01977092|521822174|FG000|Overall Study|Withdrawal by Subject|2|||
144718157|NCT01977092|521822175|FG001|Overall Study|Withdrawal by Subject|1|||
144718158|NCT01977092|521822174|FG000|Overall Study|In prison|3|||
144718159|NCT01977092|521822175|FG001|Overall Study|In prison|11|||
144718160|NCT00678392|521822176|FG000|Overall Study|Adverse Event|0|||
144718161|NCT00678392|521822177|FG001|Overall Study|Adverse Event|6|||
144718162|NCT00678392|521822176|FG000|Overall Study|Death|280|||
144718163|NCT00678392|521822177|FG001|Overall Study|Death|269|||
144718164|NCT00678392|521822176|FG000|Overall Study|Lost to Follow-up|15|||
144718165|NCT00678392|521822177|FG001|Overall Study|Lost to Follow-up|13|||
144718166|NCT00678392|521822176|FG000|Overall Study|Objective Progression or Relapse|3|||
144718167|NCT00678392|521822177|FG001|Overall Study|Objective Progression or Relapse|8|||
144718168|NCT00678392|521822176|FG000|Overall Study|Sponsor's Decision|1|||
144718169|NCT00678392|521822177|FG001|Overall Study|Sponsor's Decision|2|||
144718170|NCT00678392|521822176|FG000|Overall Study|Withdrawal by Subject|4|||
144718171|NCT00678392|521822177|FG001|Overall Study|Withdrawal by Subject|4|||
144718172|NCT00678392|521822176|FG000|Overall Study|Randomized But Not Treated|2|||
144718173|NCT00678392|521822177|FG001|Overall Study|Randomized But Not Treated|7|||
144718174|NCT00678392|521822176|FG000|Overall Study|Other|56|||
144718175|NCT00678392|521822177|FG001|Overall Study|Other|53|||
144718176|NCT01958281|521822178|FG000|Overall Study|Lack of Efficacy|5|||
144718177|NCT01958281|521822179|FG001|Overall Study|Lack of Efficacy|2|||
144718178|NCT01958281|521822180|FG002|Overall Study|Lack of Efficacy|0|||
144718179|NCT01958281|521822178|FG000|Overall Study|Adverse Event|0|||
144718180|NCT01958281|521822179|FG001|Overall Study|Adverse Event|2|||
144718181|NCT01958281|521822180|FG002|Overall Study|Adverse Event|0|||
144718182|NCT01958281|521822178|FG000|Overall Study|Withdrew Consent|1|||
144718183|NCT01958281|521822179|FG001|Overall Study|Withdrew Consent|0|||
144718184|NCT01958281|521822180|FG002|Overall Study|Withdrew Consent|0|||
144718185|NCT02927847|521822183|FG000|Overall Study|Lost to Follow-up|1|||
144718186|NCT02927847|521822184|FG001|Overall Study|Lost to Follow-up|0|||
144718187|NCT02927847|521822183|FG000|Overall Study|Withdrawal by Subject|4|||
144718188|NCT02927847|521822184|FG001|Overall Study|Withdrawal by Subject|2|||
144718189|NCT02927847|521822183|FG000|Overall Study|PI withdrawn due to missed visits|1|||
144718190|NCT02927847|521822184|FG001|Overall Study|PI withdrawn due to missed visits|1|||
144718191|NCT01418352|521822187|FG000|Overall Study|Lost to Follow-up|2|||
144718192|NCT01418352|521822188|FG001|Overall Study|Lost to Follow-up|0|||
144718193|NCT01418352|521822189|FG002|Overall Study|Lost to Follow-up|0|||
144718194|NCT01418352|521822190|FG003|Overall Study|Lost to Follow-up|0|||
144718195|NCT01418352|521822187|FG000|Overall Study|Adverse Event|0|||
144718196|NCT01418352|521822188|FG001|Overall Study|Adverse Event|1|||
144718197|NCT01418352|521822189|FG002|Overall Study|Adverse Event|0|||
144718198|NCT01418352|521822190|FG003|Overall Study|Adverse Event|0|||
144718199|NCT01418352|521822187|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
144718200|NCT01418352|521822188|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
144718201|NCT01418352|521822189|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
144718202|NCT01418352|521822190|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
144718203|NCT01418352|521822187|FG000|Overall Study|Subject Withdrew Consent|0|||
144718204|NCT01418352|521822188|FG001|Overall Study|Subject Withdrew Consent|1|||
144493041|NCT01653743|521001067|FG001|Overall Study|Withdrawal by Subject|0|||
144493042|NCT01653743|521001066|FG000|Overall Study|Investigator discretion|3|||
144718205|NCT01418352|521822189|FG002|Overall Study|Subject Withdrew Consent|2|||
144718206|NCT01418352|521822190|FG003|Overall Study|Subject Withdrew Consent|1|||
144718207|NCT01418352|521822187|FG000|Overall Study|Protocol Deviation|0|||
144718208|NCT01418352|521822188|FG001|Overall Study|Protocol Deviation|0|||
144718209|NCT01418352|521822189|FG002|Overall Study|Protocol Deviation|1|||
144718210|NCT01418352|521822190|FG003|Overall Study|Protocol Deviation|0|||
144718211|NCT01418352|521822187|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
144718212|NCT01418352|521822188|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
144718213|NCT01418352|521822189|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
144493043|NCT01653743|521001067|FG001|Overall Study|Investigator discretion|0|||
144493044|NCT04796935|521001068|FG000|Overall Study|Withdrawal by Subject|0|||
144718214|NCT01418352|521822190|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
144718215|NCT01401478|521822192|FG000|Overall Study|Study drug not available|6|||
144718216|NCT01401478|521822192|FG000|Overall Study|Adverse Event|5|||
144718217|NCT01401478|521822192|FG000|Overall Study|Hyperphosphatemia|5|||
144718218|NCT01401478|521822192|FG000|Overall Study|Lost to Follow-up|5|||
144718219|NCT01401478|521822192|FG000|Overall Study|Kidney transplantation|3|||
144718220|NCT01401478|521822192|FG000|Overall Study|Withdrawal by Subject|3|||
144718221|NCT01401478|521822192|FG000|Overall Study|Blood samples not available|1|||
144718222|NCT01401478|521822192|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
144718223|NCT01401478|521822192|FG000|Overall Study|Low intact parathyroid hormone|1|||
144718224|NCT01401478|521822192|FG000|Overall Study|Serious adverse event|1|||
144718225|NCT01814137|521822193|FG000|Overall Study|Adverse Event|0|||
144718226|NCT01814137|521822194|FG001|Overall Study|Adverse Event|1|||
144718227|NCT01814137|521822193|FG000|Overall Study|Withdrawal by Subject|2|||
144718228|NCT01814137|521822194|FG001|Overall Study|Withdrawal by Subject|2|||
144718229|NCT01814137|521822193|FG000|Overall Study|Physician Decision|1|||
144718230|NCT01814137|521822194|FG001|Overall Study|Physician Decision|1|||
144718231|NCT01814137|521822193|FG000|Overall Study|Unclassified|2|||
144718232|NCT01814137|521822194|FG001|Overall Study|Unclassified|1|||
144718233|NCT00886483|521822200|FG000|Overall Study|Lost to Follow-up|0|||
144718234|NCT00886483|521822201|FG001|Overall Study|Lost to Follow-up|1|||
144718235|NCT00886483|521822200|FG000|Overall Study|Pursue medications|1|||
144718236|NCT00886483|521822201|FG001|Overall Study|Pursue medications|2|||
144718237|NCT00886483|521822200|FG000|Overall Study|Distance to center, poor grades|1|||
144718238|NCT00886483|521822201|FG001|Overall Study|Distance to center, poor grades|0|||
144718239|NCT02168270|521822203|FG000|Overall Study|Lack of Efficacy|4|||
144718240|NCT02175966|521822204|FG000|Follow-up Period|Lack of Efficacy|10|||
144718241|NCT02175966|521822205|FG001|Follow-up Period|Lack of Efficacy|6|||
144718242|NCT01086215|521822210|FG000|Overall Study|Death|14|||
144718243|NCT01086215|521822211|FG001|Overall Study|Death|8|||
144718244|NCT01086215|521822212|FG002|Overall Study|Death|8|||
144718245|NCT01086215|521822213|FG003|Overall Study|Death|1|||
144718246|NCT01086215|521822210|FG000|Overall Study|Lost to Follow-up|22|||
144718247|NCT01086215|521822211|FG001|Overall Study|Lost to Follow-up|39|||
144718248|NCT01086215|521822212|FG002|Overall Study|Lost to Follow-up|18|||
144718249|NCT01086215|521822213|FG003|Overall Study|Lost to Follow-up|2|||
144718250|NCT01965652|521822214|FG000|Overall Study|Adverse Event|40|||
144718251|NCT01965652|521822215|FG001|Overall Study|Adverse Event|37|||
144718252|NCT01965652|521822214|FG000|Overall Study|Withdrawal by Subject|62|||
144718253|NCT01965652|521822215|FG001|Overall Study|Withdrawal by Subject|69|||
144718254|NCT01965652|521822214|FG000|Overall Study|Lost to Follow-up|53|||
144718255|NCT01965652|521822215|FG001|Overall Study|Lost to Follow-up|40|||
144718256|NCT01965652|521822214|FG000|Overall Study|Protocol Violation|34|||
144718257|NCT01965652|521822215|FG001|Overall Study|Protocol Violation|38|||
144718258|NCT01965652|521822214|FG000|Overall Study|Death|3|||
144718259|NCT01965652|521822215|FG001|Overall Study|Death|4|||
144718260|NCT01965652|521822214|FG000|Overall Study|Other - Miscellaneous|18|||
144718261|NCT01965652|521822215|FG001|Overall Study|Other - Miscellaneous|21|||
144718262|NCT01965652|521822214|FG000|Overall Study|Pregnancy|0|||
144718263|NCT01965652|521822215|FG001|Overall Study|Pregnancy|1|||
144718264|NCT01121900|521822218|FG000|First Intervention Period|Adverse Event|1|||
144718265|NCT01121900|521822219|FG001|First Intervention Period|Adverse Event|1|||
144718266|NCT01121900|521822218|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
144718267|NCT01121900|521822219|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144718268|NCT03469271|521822220|FG000|Overall Study|Withdrawal by Subject|2|||
144718269|NCT03469271|521822221|FG001|Overall Study|Withdrawal by Subject|0|||
144718270|NCT03469271|521822222|FG002|Overall Study|Withdrawal by Subject|0|||
144718271|NCT03469271|521822223|FG003|Overall Study|Withdrawal by Subject|1|||
144718272|NCT01328054|521822226|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
144718273|NCT01328054|521822227|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
144718274|NCT01328054|521822226|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
144718275|NCT01328054|521822227|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
144718276|NCT01328054|521822226|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
144718277|NCT01328054|521822227|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
144718278|NCT03760510|521822228|FG000|Overall Study|Not ventilated for 24 hours|105|||
144718279|NCT03760510|521822229|FG001|Overall Study|Not ventilated for 24 hours|97|||
144718280|NCT00871728|521822230|FG000|Overall Study|Adverse Event|1|||
144718281|NCT00871728|521822230|FG000|Overall Study|Protocol Violation|7|||
144718282|NCT00871728|521822230|FG000|Overall Study|Lost to Follow-up|2|||
144718283|NCT00871728|521822230|FG000|Overall Study|Failed to Visit Hospital|4|||
144718284|NCT00871728|521822230|FG000|Overall Study|Participant Non-compliance|1|||
144718285|NCT00871728|521822230|FG000|Overall Study|Withdrawal of Informed Consent|5|||
144718286|NCT03016078|521822236|FG000|Overall Study|Protocol Violation|1|||
144718287|NCT03016078|521822236|FG000|Overall Study|Protocol Violation|1|||
144718288|NCT02378506|521822237|FG000|Overall Study|Lack of Efficacy|3|||
144718289|NCT02378506|521822237|FG000|Overall Study|Withdrawal by Subject|4|||
144718290|NCT02378506|521822237|FG000|Overall Study|Protocol Violation|2|||
144718291|NCT02378506|521822237|FG000|Overall Study|Death|1|||
144718292|NCT02378506|521822237|FG000|Overall Study|Adverse Event|14|||
144718293|NCT02378506|521822237|FG000|Overall Study|Randomized But Not Treated|1|||
144718294|NCT01070394|521822239|FG000|Overall Study|Adverse Event|6|||
144718295|NCT01070394|521822239|FG000|Overall Study|Withdrawal by Subject|1|||
144718296|NCT01715415|521822251|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
144718297|NCT01715415|521822252|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
144718298|NCT01715415|521822251|FG000|Double-blind Treatment|Adverse Event|3|||
144718299|NCT01715415|521822252|FG001|Double-blind Treatment|Adverse Event|0|||
144718300|NCT01715415|521822251|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
144718301|NCT01715415|521822252|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
144718302|NCT01715415|521822251|FG000|Double-blind Treatment|Other|1|||
144718303|NCT01715415|521822252|FG001|Double-blind Treatment|Other|0|||
144718304|NCT01715415|521822251|FG000|Open-label Treatment|Adverse Event|0|||
144718305|NCT01715415|521822252|FG001|Open-label Treatment|Adverse Event|1|||
144718306|NCT01715415|521822251|FG000|Open-label Treatment|Subject Noncompliant|0|||
144718307|NCT01715415|521822252|FG001|Open-label Treatment|Subject Noncompliant|1|||
144718308|NCT01015612|521822253|FG000|Overall Study|Death|113|||
144718309|NCT01015612|521822253|FG000|Overall Study|Withdrawal by Subject|40|||
144718310|NCT03586830|521822254|FG000|Overall Study|Site terminated by Sponsor|1|||
144718311|NCT03586830|521822255|FG001|Overall Study|Site terminated by Sponsor|4|||
144718312|NCT03586830|521822256|FG002|Overall Study|Site terminated by Sponsor|3|||
144718313|NCT03586830|521822257|FG003|Overall Study|Site terminated by Sponsor|3|||
144718314|NCT03586830|521822254|FG000|Overall Study|Lost to Follow-up|0|||
144718315|NCT03586830|521822255|FG001|Overall Study|Lost to Follow-up|2|||
144718316|NCT03586830|521822256|FG002|Overall Study|Lost to Follow-up|2|||
144718317|NCT03586830|521822257|FG003|Overall Study|Lost to Follow-up|1|||
144718318|NCT03586830|521822254|FG000|Overall Study|Withdrawal by Subject|1|||
144718319|NCT03586830|521822255|FG001|Overall Study|Withdrawal by Subject|0|||
144718320|NCT03586830|521822256|FG002|Overall Study|Withdrawal by Subject|3|||
144718321|NCT03586830|521822257|FG003|Overall Study|Withdrawal by Subject|1|||
144718322|NCT02497391|521823760|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
144718323|NCT02497391|521823761|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
144718324|NCT02497391|521823762|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
144718325|NCT02497391|521823763|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
144718326|NCT02497391|521823764|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
144718327|NCT02497391|521823765|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
144718328|NCT02497391|521823760|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
144718329|NCT02497391|521823761|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
144718330|NCT02497391|521823762|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
144718331|NCT02497391|521823763|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
144718332|NCT02497391|521823764|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
144718333|NCT02497391|521823765|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
144718334|NCT02497391|521823760|FG000|Period 3 (14 Days)|Adverse Event|0|||
144718335|NCT02497391|521823761|FG001|Period 3 (14 Days)|Adverse Event|1|||
144718336|NCT02497391|521823762|FG002|Period 3 (14 Days)|Adverse Event|0|||
144718337|NCT02497391|521823763|FG003|Period 3 (14 Days)|Adverse Event|0|||
144718338|NCT02497391|521823764|FG004|Period 3 (14 Days)|Adverse Event|0|||
144718339|NCT02497391|521823765|FG005|Period 3 (14 Days)|Adverse Event|0|||
144718340|NCT02497391|521823760|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
144718341|NCT02497391|521823761|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
144718342|NCT02497391|521823762|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
144718343|NCT02497391|521823763|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
144718344|NCT02497391|521823764|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
144718345|NCT02497391|521823765|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
144718346|NCT02497391|521823760|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
144718347|NCT02497391|521823761|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
144718348|NCT02497391|521823762|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
144718349|NCT02497391|521823763|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
144718350|NCT02497391|521823764|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
144718351|NCT02497391|521823765|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
144718352|NCT01664052|521823766|FG000|Phase 1|No device placement|6|||
144718353|NCT01664052|521823767|FG001|Phase 1|No device placement|0|||
144718354|NCT01664052|521823766|FG000|Phase 1|No HSG 1 hr post placement|1|||
144718355|NCT01664052|521823767|FG001|Phase 1|No HSG 1 hr post placement|0|||
144718356|NCT01664052|521823766|FG000|Phase 2|No device placement|0|||
144718357|NCT01664052|521823767|FG001|Phase 2|No device placement|4|||
144718358|NCT03740698|521823769|FG000|Overall Study|Physician Decision|0|||
144718359|NCT03740698|521823770|FG001|Overall Study|Physician Decision|1|||
144718360|NCT03740698|521823771|FG002|Overall Study|Physician Decision|1|||
144718361|NCT01466686|521823784|FG000|Overall Study|Withdrawal by Subject|1|||
144718362|NCT02049359|521823793|FG000|Overall Study|Lost to Follow-up|26|||
144718363|NCT02049359|521823794|FG001|Overall Study|Lost to Follow-up|19|||
144718364|NCT01405950|521823795|FG000|Overall Study|Withdrawal by Subject|1|||
144718365|NCT01405950|521823796|FG001|Overall Study|Withdrawal by Subject|0|||
144718366|NCT01405950|521823797|FG002|Overall Study|Withdrawal by Subject|0|||
144718367|NCT01405950|521823798|FG003|Overall Study|Withdrawal by Subject|0|||
144493045|NCT04796935|521001069|FG001|Overall Study|Withdrawal by Subject|1|||
144493046|NCT04796935|521001068|FG000|Overall Study|Physician Decision|0|||
144493047|NCT04796935|521001069|FG001|Overall Study|Physician Decision|1|||
144493048|NCT04796935|521001068|FG000|Overall Study|Device not available|1|||
144493049|NCT04796935|521001069|FG001|Overall Study|Device not available|0|||
144493050|NCT04796935|521001068|FG000|Overall Study|Trained provider not available|1|||
144493051|NCT04796935|521001069|FG001|Overall Study|Trained provider not available|0|||
144493052|NCT00410384|521001070|FG000|Overall Study|Withdrawal by Subject|28|||
144493053|NCT00410384|521001071|FG001|Overall Study|Withdrawal by Subject|17|||
144718368|NCT01381900|521823805|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
144718369|NCT01381900|521823806|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
144718370|NCT01381900|521823807|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
144718371|NCT01381900|521823805|FG000|Overall Study|Adverse Event|4|||
144718372|NCT01381900|521823806|FG001|Overall Study|Adverse Event|6|||
144718373|NCT01381900|521823807|FG002|Overall Study|Adverse Event|7|||
144718374|NCT01381900|521823805|FG000|Overall Study|Noncompliance with study drug|0|||
144718375|NCT01381900|521823806|FG001|Overall Study|Noncompliance with study drug|0|||
144718376|NCT01381900|521823807|FG002|Overall Study|Noncompliance with study drug|1|||
144718377|NCT01381900|521823805|FG000|Overall Study|Physician Decision|0|||
144718378|NCT01381900|521823806|FG001|Overall Study|Physician Decision|1|||
144718379|NCT01381900|521823807|FG002|Overall Study|Physician Decision|1|||
144718380|NCT01381900|521823805|FG000|Overall Study|Protocol Violation|0|||
144718381|NCT01381900|521823806|FG001|Overall Study|Protocol Violation|1|||
144718382|NCT01381900|521823807|FG002|Overall Study|Protocol Violation|1|||
144718383|NCT01381900|521823805|FG000|Overall Study|Withdrawal by Subject|0|||
144718384|NCT01381900|521823806|FG001|Overall Study|Withdrawal by Subject|0|||
144718385|NCT01381900|521823807|FG002|Overall Study|Withdrawal by Subject|1|||
144718386|NCT01381900|521823805|FG000|Overall Study|Early withdraw|3|||
144718387|NCT01381900|521823806|FG001|Overall Study|Early withdraw|1|||
144718388|NCT01381900|521823807|FG002|Overall Study|Early withdraw|1|||
144718389|NCT00387712|521823808|FG000|Overall Study|Physician Decision|6|||
144718390|NCT00387712|521823809|FG001|Overall Study|Physician Decision|4|||
144718391|NCT00387712|521823808|FG000|Overall Study|Lost to Follow-up|17|||
144718392|NCT00387712|521823809|FG001|Overall Study|Lost to Follow-up|20|||
144718393|NCT00387712|521823808|FG000|Overall Study|Withdrawal by Subject|6|||
144718394|NCT00387712|521823809|FG001|Overall Study|Withdrawal by Subject|12|||
144718395|NCT02040428|521823810|FG000|Overall Study|Death|4|||
144493054|NCT00410384|521001072|FG002|Overall Study|Withdrawal by Subject|20|||
144493055|NCT00410384|521001070|FG000|Overall Study|Adverse Event|23|||
144493056|NCT00410384|521001071|FG001|Overall Study|Adverse Event|18|||
144493057|NCT00410384|521001072|FG002|Overall Study|Adverse Event|23|||
144493058|NCT00410384|521001070|FG000|Overall Study|Lack of Efficacy|20|||
144493059|NCT00410384|521001071|FG001|Overall Study|Lack of Efficacy|12|||
144493060|NCT00410384|521001072|FG002|Overall Study|Lack of Efficacy|17|||
144493061|NCT00410384|521001070|FG000|Overall Study|Lack of Compliance|2|||
144493062|NCT00410384|521001071|FG001|Overall Study|Lack of Compliance|2|||
144493063|NCT00410384|521001072|FG002|Overall Study|Lack of Compliance|2|||
144493064|NCT00410384|521001070|FG000|Overall Study|Lost to Follow-up|4|||
144493065|NCT00410384|521001071|FG001|Overall Study|Lost to Follow-up|6|||
144493066|NCT00410384|521001072|FG002|Overall Study|Lost to Follow-up|6|||
144493067|NCT00410384|521001070|FG000|Overall Study|Protocol Violation|6|||
144493068|NCT00410384|521001071|FG001|Overall Study|Protocol Violation|6|||
144493069|NCT00410384|521001072|FG002|Overall Study|Protocol Violation|6|||
144493070|NCT00410384|521001070|FG000|Overall Study|Physician Decision|3|||
144493071|NCT00410384|521001071|FG001|Overall Study|Physician Decision|3|||
144493072|NCT00410384|521001072|FG002|Overall Study|Physician Decision|4|||
144493073|NCT00410384|521001070|FG000|Overall Study|Other|3|||
144493074|NCT00410384|521001071|FG001|Overall Study|Other|8|||
144493075|NCT00410384|521001072|FG002|Overall Study|Other|4|||
144493076|NCT01253200|521001073|FG000|Overall Study|Death|1|||
144493077|NCT01253200|521001074|FG001|Overall Study|Death|0|||
144493078|NCT01253200|521001075|FG002|Overall Study|Death|0|||
144493079|NCT01253200|521001076|FG003|Overall Study|Death|0|||
144493080|NCT01253200|521001077|FG004|Overall Study|Death|0|||
144493081|NCT01253200|521001073|FG000|Overall Study|Lost to Follow-up|1|||
144718396|NCT02040428|521823811|FG001|Overall Study|Death|3|||
144718397|NCT02040428|521823810|FG000|Overall Study|Withdrawal by Subject|1|||
144718398|NCT02040428|521823811|FG001|Overall Study|Withdrawal by Subject|1|||
144718399|NCT01772368|521823813|FG000|Overall Study|Adverse Event|1|||
144718400|NCT01772368|521823813|FG000|Overall Study|Withdrawal by Subject|3|||
144718401|NCT01772368|521823813|FG000|Overall Study|Protocol Violation|2|||
144718402|NCT01772368|521823813|FG000|Overall Study|Other|1|||
144718403|NCT03347695|521823827|FG000|Overall Study|Death|0|||
144718404|NCT03347695|521823828|FG001|Overall Study|Death|4|||
144718405|NCT03347695|521823827|FG000|Overall Study|Lost to Follow-up|0|||
144718406|NCT03347695|521823828|FG001|Overall Study|Lost to Follow-up|1|||
144718407|NCT00671879|521823831|FG000|Overall Study|Withdrawal by Subject|0|||
144718408|NCT00671879|521823832|FG001|Overall Study|Withdrawal by Subject|4|||
144718409|NCT00671879|521823833|FG002|Overall Study|Withdrawal by Subject|6|||
144718410|NCT02668783|521823834|FG000|Overall Study|Pregnancy|0|||
144718411|NCT02668783|521823835|FG001|Overall Study|Pregnancy|1|||
144718412|NCT02668783|521823834|FG000|Overall Study|Protocol Violation|2|||
144718413|NCT02668783|521823835|FG001|Overall Study|Protocol Violation|1|||
144718414|NCT02668783|521823834|FG000|Overall Study|Study terminated by sponsor|9|||
144718415|NCT02668783|521823835|FG001|Overall Study|Study terminated by sponsor|10|||
144718416|NCT02668783|521823834|FG000|Overall Study|Subject moved|1|||
144718417|NCT02668783|521823835|FG001|Overall Study|Subject moved|0|||
144718418|NCT02668783|521823834|FG000|Overall Study|Withdrawal by Subject|1|||
144718419|NCT02668783|521823835|FG001|Overall Study|Withdrawal by Subject|0|||
144718420|NCT02884206|521823836|FG000|Valsartan Run-in Period|Death|1|||
144718421|NCT02884206|521823837|FG001|Valsartan Run-in Period|Death|0|||
144718422|NCT02884206|521823838|FG002|Valsartan Run-in Period|Death|0|||
144718423|NCT02884206|521823836|FG000|Valsartan Run-in Period|Adverse Event|31|||
144718424|NCT02884206|521823837|FG001|Valsartan Run-in Period|Adverse Event|0|||
144718425|NCT02884206|521823838|FG002|Valsartan Run-in Period|Adverse Event|0|||
144718426|NCT02884206|521823836|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
144718427|NCT02884206|521823837|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
144718428|NCT02884206|521823838|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
144718429|NCT02884206|521823836|FG000|Valsartan Run-in Period|Protocol deviation|4|||
144718430|NCT02884206|521823837|FG001|Valsartan Run-in Period|Protocol deviation|0|||
144718431|NCT02884206|521823838|FG002|Valsartan Run-in Period|Protocol deviation|0|||
144718432|NCT02884206|521823836|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
144718433|NCT02884206|521823837|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
144718434|NCT02884206|521823838|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
144718435|NCT02884206|521823836|FG000|Valsartan Run-in Period|Physician Decision|1|||
144718436|NCT02884206|521823837|FG001|Valsartan Run-in Period|Physician Decision|0|||
144718437|NCT02884206|521823838|FG002|Valsartan Run-in Period|Physician Decision|0|||
144718438|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Adverse Event|38|||
144718439|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Adverse Event|0|||
144718440|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Adverse Event|0|||
144718441|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Death|2|||
144718442|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Death|0|||
144718443|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Death|0|||
144718444|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
144718445|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
144718446|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
144718447|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
144718448|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
144718449|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
144718450|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
144718451|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
144718452|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
144718453|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Physician Decision|1|||
144718454|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Physician Decision|0|||
144718455|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Physician Decision|0|||
144718456|NCT02884206|521823836|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
144718457|NCT02884206|521823837|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
144718458|NCT02884206|521823838|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
144718459|NCT02884206|521823836|FG000|Double-Blind Period|Death|0|||
144718460|NCT02884206|521823837|FG001|Double-Blind Period|Death|28|||
144718461|NCT02884206|521823838|FG002|Double-Blind Period|Death|39|||
144718462|NCT02884206|521823836|FG000|Double-Blind Period|Patient/guardian decision|0|||
144718463|NCT02884206|521823837|FG001|Double-Blind Period|Patient/guardian decision|10|||
144718464|NCT02884206|521823838|FG002|Double-Blind Period|Patient/guardian decision|13|||
144718465|NCT02884206|521823836|FG000|Double-Blind Period|Lost to Follow-up|0|||
144718466|NCT02884206|521823837|FG001|Double-Blind Period|Lost to Follow-up|4|||
144718467|NCT02884206|521823838|FG002|Double-Blind Period|Lost to Follow-up|4|||
144718468|NCT02884206|521823836|FG000|Double-Blind Period|Physician Decision|0|||
144718469|NCT02884206|521823837|FG001|Double-Blind Period|Physician Decision|2|||
144718470|NCT02884206|521823838|FG002|Double-Blind Period|Physician Decision|0|||
144493082|NCT01253200|521001074|FG001|Overall Study|Lost to Follow-up|1|||
144493083|NCT01253200|521001075|FG002|Overall Study|Lost to Follow-up|0|||
144493084|NCT01253200|521001076|FG003|Overall Study|Lost to Follow-up|0|||
144493085|NCT01253200|521001077|FG004|Overall Study|Lost to Follow-up|0|||
144493086|NCT01253200|521001073|FG000|Overall Study|Withdrawal by Subject|2|||
144493087|NCT01253200|521001074|FG001|Overall Study|Withdrawal by Subject|0|||
144493088|NCT01253200|521001075|FG002|Overall Study|Withdrawal by Subject|0|||
144493089|NCT01253200|521001076|FG003|Overall Study|Withdrawal by Subject|0|||
144493090|NCT01253200|521001077|FG004|Overall Study|Withdrawal by Subject|0|||
144493091|NCT01253200|521001073|FG000|Overall Study|Protocol Violation|1|||
144493092|NCT01253200|521001074|FG001|Overall Study|Protocol Violation|4|||
144493093|NCT01253200|521001075|FG002|Overall Study|Protocol Violation|0|||
144493094|NCT01253200|521001076|FG003|Overall Study|Protocol Violation|0|||
144493095|NCT01253200|521001077|FG004|Overall Study|Protocol Violation|5|||
144493096|NCT01253200|521001073|FG000|Overall Study|intents|10|||
144493097|NCT01253200|521001074|FG001|Overall Study|intents|10|||
144493098|NCT01253200|521001075|FG002|Overall Study|intents|1|||
144493099|NCT01253200|521001076|FG003|Overall Study|intents|3|||
144493100|NCT01253200|521001077|FG004|Overall Study|intents|0|||
144493101|NCT01253200|521001073|FG000|Overall Study|Attempts|6|||
144493102|NCT01253200|521001074|FG001|Overall Study|Attempts|4|||
144493103|NCT01253200|521001075|FG002|Overall Study|Attempts|1|||
144493104|NCT01253200|521001076|FG003|Overall Study|Attempts|2|||
144493105|NCT01253200|521001077|FG004|Overall Study|Attempts|0|||
144493106|NCT02049437|521001078|FG000|Period 1|Adverse Event|1|||
144493107|NCT02049437|521001079|FG001|Period 1|Adverse Event|1|||
144493108|NCT02049437|521001078|FG000|Period 1|Adverse Event|1|||
144493109|NCT02049437|521001079|FG001|Period 1|Adverse Event|0|||
144493110|NCT00783718|521001080|FG000|Induction Phase|Adverse Event|4|||
144493111|NCT00783718|521001081|FG001|Induction Phase|Adverse Event|0|||
144493112|NCT00783718|521001082|FG002|Induction Phase|Adverse Event|7|||
144493113|NCT00783718|521001083|FG003|Induction Phase|Adverse Event|0|||
144493114|NCT00783718|521001084|FG004|Induction Phase|Adverse Event|0|||
144493115|NCT00783718|521001085|FG005|Induction Phase|Adverse Event|0|||
144493116|NCT00783718|521001086|FG006|Induction Phase|Adverse Event|0|||
144493117|NCT00783718|521001080|FG000|Induction Phase|Protocol Violation|1|||
144493118|NCT00783718|521001081|FG001|Induction Phase|Protocol Violation|1|||
144493119|NCT00783718|521001082|FG002|Induction Phase|Protocol Violation|6|||
144493120|NCT00783718|521001083|FG003|Induction Phase|Protocol Violation|0|||
144493121|NCT00783718|521001084|FG004|Induction Phase|Protocol Violation|0|||
144718471|NCT02884206|521823836|FG000|Double-Blind Period|Adverse Event|0|||
144718472|NCT02884206|521823837|FG001|Double-Blind Period|Adverse Event|0|||
144718473|NCT02884206|521823838|FG002|Double-Blind Period|Adverse Event|3|||
144718474|NCT02884206|521823836|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
144718475|NCT02884206|521823837|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
144718476|NCT02884206|521823838|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
144718477|NCT03907280|521823839|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
144718478|NCT03907280|521823840|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
144718479|NCT03907280|521823841|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
144718480|NCT02231710|521823842|FG000|Overall Study|Physician Decision|1|||
144718481|NCT01399723|521823843|FG000|Overall Study|Lost to Follow-up|0|||
144718482|NCT01399723|521823844|FG001|Overall Study|Lost to Follow-up|1|||
144718483|NCT00124020|521823845|FG000|Overall Study|Death|67|||
144718484|NCT00124020|521823846|FG001|Overall Study|Death|71|||
144718485|NCT00124020|521823845|FG000|Overall Study|Withdrawal by Subject|13|||
144718486|NCT00124020|521823846|FG001|Overall Study|Withdrawal by Subject|11|||
144718487|NCT00124020|521823845|FG000|Overall Study|Lost to Follow-up|5|||
144718488|NCT00124020|521823846|FG001|Overall Study|Lost to Follow-up|8|||
144718489|NCT00124020|521823845|FG000|Overall Study|Other|1|||
144718490|NCT00124020|521823846|FG001|Overall Study|Other|1|||
144718491|NCT00124020|521823845|FG000|Overall Study|Transfer to another hospital|2|||
144718492|NCT00124020|521823846|FG001|Overall Study|Transfer to another hospital|0|||
144718493|NCT04604184|521823850|FG000|Overall Study|Adverse Event|5|||
144493122|NCT00783718|521001085|FG005|Induction Phase|Protocol Violation|0|||
144493123|NCT00783718|521001086|FG006|Induction Phase|Protocol Violation|0|||
144493124|NCT00783718|521001080|FG000|Induction Phase|Lack of Efficacy|5|||
144718494|NCT04604184|521823851|FG001|Overall Study|Adverse Event|5|||
144493125|NCT00783718|521001081|FG001|Induction Phase|Lack of Efficacy|2|||
144493126|NCT00783718|521001082|FG002|Induction Phase|Lack of Efficacy|14|||
144493127|NCT00783718|521001083|FG003|Induction Phase|Lack of Efficacy|0|||
144493128|NCT00783718|521001084|FG004|Induction Phase|Lack of Efficacy|0|||
144493129|NCT00783718|521001085|FG005|Induction Phase|Lack of Efficacy|0|||
144493130|NCT00783718|521001086|FG006|Induction Phase|Lack of Efficacy|0|||
144493131|NCT00783718|521001080|FG000|Induction Phase|Withdrawal by Subject|3|||
144493132|NCT00783718|521001081|FG001|Induction Phase|Withdrawal by Subject|4|||
144493133|NCT00783718|521001082|FG002|Induction Phase|Withdrawal by Subject|8|||
144493134|NCT00783718|521001083|FG003|Induction Phase|Withdrawal by Subject|0|||
144493135|NCT00783718|521001084|FG004|Induction Phase|Withdrawal by Subject|0|||
144493136|NCT00783718|521001085|FG005|Induction Phase|Withdrawal by Subject|0|||
144493137|NCT00783718|521001086|FG006|Induction Phase|Withdrawal by Subject|0|||
144493138|NCT00783718|521001080|FG000|Induction Phase|Lost to Follow-up|1|||
144493139|NCT00783718|521001081|FG001|Induction Phase|Lost to Follow-up|0|||
144493140|NCT00783718|521001082|FG002|Induction Phase|Lost to Follow-up|1|||
144493141|NCT00783718|521001083|FG003|Induction Phase|Lost to Follow-up|0|||
144493142|NCT00783718|521001084|FG004|Induction Phase|Lost to Follow-up|0|||
144493143|NCT00783718|521001085|FG005|Induction Phase|Lost to Follow-up|0|||
144493144|NCT00783718|521001086|FG006|Induction Phase|Lost to Follow-up|0|||
144493145|NCT00783718|521001080|FG000|Maintenance Phase|Adverse Event|12|||
144493146|NCT00783718|521001081|FG001|Maintenance Phase|Adverse Event|0|||
144493147|NCT00783718|521001082|FG002|Maintenance Phase|Adverse Event|0|||
144493148|NCT00783718|521001083|FG003|Maintenance Phase|Adverse Event|15|||
144493149|NCT00783718|521001084|FG004|Maintenance Phase|Adverse Event|7|||
144493150|NCT00783718|521001085|FG005|Maintenance Phase|Adverse Event|6|||
144718495|NCT04604184|521823850|FG000|Overall Study|Death|2|||
144718496|NCT04604184|521823851|FG001|Overall Study|Death|1|||
144718497|NCT04604184|521823850|FG000|Overall Study|Withdrawal by Subject|1|||
144718498|NCT04604184|521823851|FG001|Overall Study|Withdrawal by Subject|3|||
144718499|NCT04604184|521823850|FG000|Overall Study|Not treated|2|||
144718500|NCT04604184|521823851|FG001|Overall Study|Not treated|2|||
144718501|NCT04604184|521823850|FG000|Overall Study|Due to sponsor decision|9|||
144718502|NCT04604184|521823851|FG001|Overall Study|Due to sponsor decision|7|||
144718503|NCT04604184|521823850|FG000|Overall Study|Physician Decision|0|||
144718504|NCT04604184|521823851|FG001|Overall Study|Physician Decision|1|||
144718505|NCT04604184|521823850|FG000|Overall Study|Transfer to healthcare|1|||
144718506|NCT04604184|521823851|FG001|Overall Study|Transfer to healthcare|0|||
144718507|NCT05487456|521823852|FG000|Overall Study|Withdrawal by Subject|0|||
144718508|NCT05487456|521823853|FG001|Overall Study|Withdrawal by Subject|0|||
144718509|NCT05487456|521823854|FG002|Overall Study|Withdrawal by Subject|1|||
144718510|NCT05487456|521823855|FG003|Overall Study|Withdrawal by Subject|0|||
144718511|NCT01625377|521823858|FG000|Overall Study|Death|1|||
144718512|NCT01625377|521823859|FG001|Overall Study|Death|1|||
144718513|NCT01625377|521823858|FG000|Overall Study|Administrative Problem|1|||
144718514|NCT01625377|521823859|FG001|Overall Study|Administrative Problem|1|||
144718515|NCT01625377|521823858|FG000|Overall Study|Protocol Violation|0|||
144718516|NCT01625377|521823859|FG001|Overall Study|Protocol Violation|3|||
144718517|NCT01625377|521823858|FG000|Overall Study|Adverse Event|3|||
144718518|NCT01625377|521823859|FG001|Overall Study|Adverse Event|16|||
144718519|NCT01625377|521823858|FG000|Overall Study|Graft loss|1|||
144718520|NCT01625377|521823859|FG001|Overall Study|Graft loss|0|||
144718521|NCT01625377|521823858|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144718522|NCT01625377|521823859|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144718523|NCT01625377|521823858|FG000|Overall Study|Abnormal laboratory values|1|||
144718524|NCT01625377|521823859|FG001|Overall Study|Abnormal laboratory values|0|||
144718525|NCT02043366|521823860|FG000|Overall Study|Lost to Follow-up|2|||
144718526|NCT02043366|521823861|FG001|Overall Study|Lost to Follow-up|2|||
144718527|NCT02043366|521823862|FG002|Overall Study|Lost to Follow-up|2|||
144718528|NCT02043366|521823863|FG003|Overall Study|Lost to Follow-up|2|||
144718529|NCT02043366|521823864|FG004|Overall Study|Lost to Follow-up|2|||
144718530|NCT02043366|521823865|FG005|Overall Study|Lost to Follow-up|2|||
144718531|NCT01489956|521823866|FG000|Overall Study|Lost to Follow-up|1|||
144718532|NCT01489956|521823867|FG001|Overall Study|Lost to Follow-up|0|||
144718533|NCT01489956|521823868|FG002|Overall Study|Lost to Follow-up|0|||
144718534|NCT01489956|521823866|FG000|Overall Study|Withdrawal by Subject|0|||
144718535|NCT01489956|521823867|FG001|Overall Study|Withdrawal by Subject|0|||
144718536|NCT01489956|521823868|FG002|Overall Study|Withdrawal by Subject|1|||
144718537|NCT02784106|521823869|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
144718538|NCT02784106|521823870|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
144718539|NCT02784106|521823871|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
144718540|NCT02784106|521823872|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
144718541|NCT02784106|521823869|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
144718542|NCT02784106|521823870|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
144718543|NCT02784106|521823871|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144718544|NCT02784106|521823872|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144718545|NCT02784106|521823869|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
144718546|NCT02784106|521823870|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
144493151|NCT00783718|521001086|FG006|Maintenance Phase|Adverse Event|16|||
144493152|NCT00783718|521001080|FG000|Maintenance Phase|Protocol Violation|1|||
144493153|NCT00783718|521001081|FG001|Maintenance Phase|Protocol Violation|0|||
144718547|NCT02784106|521823871|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
144718548|NCT02784106|521823872|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
144718549|NCT02784106|521823869|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
144718550|NCT02784106|521823870|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
144493154|NCT00783718|521001082|FG002|Maintenance Phase|Protocol Violation|0|||
144493155|NCT00783718|521001083|FG003|Maintenance Phase|Protocol Violation|0|||
144493156|NCT00783718|521001084|FG004|Maintenance Phase|Protocol Violation|0|||
144493157|NCT00783718|521001085|FG005|Maintenance Phase|Protocol Violation|0|||
144369989|NCT02504151|520562774|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
144493158|NCT00783718|521001086|FG006|Maintenance Phase|Protocol Violation|2|||
144493159|NCT00783718|521001080|FG000|Maintenance Phase|Lack of Efficacy|83|||
144493160|NCT00783718|521001081|FG001|Maintenance Phase|Lack of Efficacy|0|||
144493161|NCT00783718|521001082|FG002|Maintenance Phase|Lack of Efficacy|0|||
144493162|NCT00783718|521001083|FG003|Maintenance Phase|Lack of Efficacy|61|||
144493163|NCT00783718|521001084|FG004|Maintenance Phase|Lack of Efficacy|31|||
144493164|NCT00783718|521001085|FG005|Maintenance Phase|Lack of Efficacy|33|||
144493165|NCT00783718|521001086|FG006|Maintenance Phase|Lack of Efficacy|155|||
144493166|NCT00783718|521001080|FG000|Maintenance Phase|Withdrawal by Subject|6|||
144493167|NCT00783718|521001081|FG001|Maintenance Phase|Withdrawal by Subject|0|||
144493168|NCT00783718|521001082|FG002|Maintenance Phase|Withdrawal by Subject|0|||
144493169|NCT00783718|521001083|FG003|Maintenance Phase|Withdrawal by Subject|2|||
144493170|NCT00783718|521001084|FG004|Maintenance Phase|Withdrawal by Subject|5|||
144493171|NCT00783718|521001085|FG005|Maintenance Phase|Withdrawal by Subject|2|||
144493172|NCT00783718|521001086|FG006|Maintenance Phase|Withdrawal by Subject|20|||
144493173|NCT00783718|521001080|FG000|Maintenance Phase|Lost to Follow-up|3|||
144493174|NCT00783718|521001081|FG001|Maintenance Phase|Lost to Follow-up|0|||
144493175|NCT00783718|521001082|FG002|Maintenance Phase|Lost to Follow-up|0|||
144493176|NCT00783718|521001083|FG003|Maintenance Phase|Lost to Follow-up|0|||
144493177|NCT00783718|521001084|FG004|Maintenance Phase|Lost to Follow-up|2|||
144493178|NCT00783718|521001085|FG005|Maintenance Phase|Lost to Follow-up|0|||
144493179|NCT00783718|521001086|FG006|Maintenance Phase|Lost to Follow-up|2|||
144493180|NCT01605136|521001089|FG000|Study Period|Withdrawal by Subject|2|||
144493181|NCT01605136|521001090|FG001|Study Period|Withdrawal by Subject|0|||
144718551|NCT02784106|521823871|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
144718552|NCT02784106|521823872|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
144718553|NCT02784106|521823869|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
144718554|NCT02784106|521823870|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
144718555|NCT02784106|521823871|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
144718556|NCT02784106|521823872|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
144718557|NCT02784106|521823869|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
144718558|NCT02784106|521823870|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
144718559|NCT02784106|521823871|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
144718560|NCT02784106|521823872|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
144718561|NCT03341507|521823873|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
144718562|NCT00718159|521823874|FG000|Overall Study|Progressive Disease|3|||
144718563|NCT00718159|521823875|FG001|Overall Study|Progressive Disease|3|||
144718564|NCT00718159|521823876|FG002|Overall Study|Progressive Disease|2|||
144718565|NCT00718159|521823877|FG003|Overall Study|Progressive Disease|0|||
144718566|NCT00718159|521823878|FG004|Overall Study|Progressive Disease|6|||
144718567|NCT00718159|521823879|FG005|Overall Study|Progressive Disease|0|||
144718568|NCT00718159|521823880|FG006|Overall Study|Progressive Disease|0|||
144718569|NCT00718159|521823874|FG000|Overall Study|Death due to Adverse Event|0|||
144718570|NCT00718159|521823875|FG001|Overall Study|Death due to Adverse Event|0|||
144718571|NCT00718159|521823876|FG002|Overall Study|Death due to Adverse Event|0|||
144718572|NCT00718159|521823877|FG003|Overall Study|Death due to Adverse Event|2|||
144718573|NCT00718159|521823878|FG004|Overall Study|Death due to Adverse Event|2|||
144718574|NCT00718159|521823879|FG005|Overall Study|Death due to Adverse Event|0|||
144718575|NCT00718159|521823880|FG006|Overall Study|Death due to Adverse Event|0|||
144718576|NCT00718159|521823874|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
144718577|NCT00718159|521823875|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
144718578|NCT00718159|521823876|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
144718579|NCT00718159|521823877|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
144718580|NCT00718159|521823878|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
144718581|NCT00718159|521823879|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
144718582|NCT00718159|521823880|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
144718583|NCT00718159|521823874|FG000|Overall Study|Investigator Decision|0|||
144718584|NCT00718159|521823875|FG001|Overall Study|Investigator Decision|0|||
144718585|NCT00718159|521823876|FG002|Overall Study|Investigator Decision|0|||
144718586|NCT00718159|521823877|FG003|Overall Study|Investigator Decision|0|||
144718587|NCT00718159|521823878|FG004|Overall Study|Investigator Decision|0|||
144718588|NCT00718159|521823879|FG005|Overall Study|Investigator Decision|1|||
144718589|NCT00718159|521823880|FG006|Overall Study|Investigator Decision|1|||
144718590|NCT01405820|521823881|FG000|Randomized Treatment Period|Adverse Event|3|||
144718591|NCT01405820|521823882|FG001|Randomized Treatment Period|Adverse Event|3|||
144718592|NCT01405820|521823883|FG002|Randomized Treatment Period|Adverse Event|3|||
144718593|NCT01405820|521823884|FG003|Randomized Treatment Period|Adverse Event|0|||
144718594|NCT01405820|521823885|FG004|Randomized Treatment Period|Adverse Event|2|||
144718595|NCT01405820|521823886|FG005|Randomized Treatment Period|Adverse Event|1|||
144493182|NCT01605136|521001089|FG000|Study Period|Physician Decision|1|||
144493183|NCT01605136|521001090|FG001|Study Period|Physician Decision|1|||
144493184|NCT01605136|521001089|FG000|Study Period|Lost to Follow-up|0|||
144718596|NCT01405820|521823881|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
144718597|NCT01405820|521823882|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
144718598|NCT01405820|521823883|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
144718599|NCT01405820|521823884|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
144718600|NCT01405820|521823885|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
144718601|NCT01405820|521823886|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
144718602|NCT01405820|521823881|FG000|Randomized Treatment Period|Other|2|||
144718603|NCT01405820|521823882|FG001|Randomized Treatment Period|Other|2|||
144718604|NCT01405820|521823883|FG002|Randomized Treatment Period|Other|1|||
144718605|NCT01405820|521823884|FG003|Randomized Treatment Period|Other|1|||
144718606|NCT01405820|521823885|FG004|Randomized Treatment Period|Other|0|||
144718607|NCT01405820|521823886|FG005|Randomized Treatment Period|Other|0|||
144718608|NCT01405820|521823881|FG000|Randomized Treatment Period|Physician Decision|0|||
144718609|NCT01405820|521823882|FG001|Randomized Treatment Period|Physician Decision|2|||
144718610|NCT01405820|521823883|FG002|Randomized Treatment Period|Physician Decision|1|||
144718611|NCT01405820|521823884|FG003|Randomized Treatment Period|Physician Decision|0|||
144718612|NCT01405820|521823885|FG004|Randomized Treatment Period|Physician Decision|0|||
144718613|NCT01405820|521823886|FG005|Randomized Treatment Period|Physician Decision|0|||
144718614|NCT01405820|521823881|FG000|Randomized Treatment Period|Rescue|0|||
144718615|NCT01405820|521823882|FG001|Randomized Treatment Period|Rescue|1|||
144718616|NCT01405820|521823883|FG002|Randomized Treatment Period|Rescue|13|||
144718617|NCT01405820|521823884|FG003|Randomized Treatment Period|Rescue|10|||
144718618|NCT01405820|521823885|FG004|Randomized Treatment Period|Rescue|8|||
144718619|NCT01405820|521823886|FG005|Randomized Treatment Period|Rescue|8|||
144718620|NCT01405820|521823881|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
144718621|NCT01405820|521823882|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
144718622|NCT01405820|521823883|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
144718623|NCT01405820|521823884|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
144718624|NCT01405820|521823885|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
144718625|NCT01405820|521823886|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
144718626|NCT01405820|521823881|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
144718627|NCT01405820|521823882|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
144718628|NCT01405820|521823883|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
144718629|NCT01405820|521823884|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
144718630|NCT01405820|521823885|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
144718631|NCT01405820|521823886|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
144718632|NCT01405820|521823881|FG000|Randomized Treatment Period|Death|0|||
144718633|NCT01405820|521823882|FG001|Randomized Treatment Period|Death|0|||
144718634|NCT01405820|521823883|FG002|Randomized Treatment Period|Death|0|||
144718635|NCT01405820|521823884|FG003|Randomized Treatment Period|Death|1|||
144718636|NCT01405820|521823885|FG004|Randomized Treatment Period|Death|0|||
144718637|NCT01405820|521823886|FG005|Randomized Treatment Period|Death|0|||
144718638|NCT01405820|521823881|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
144718639|NCT01405820|521823882|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
144718640|NCT01405820|521823883|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
144718641|NCT01405820|521823884|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
144718642|NCT01405820|521823885|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
144718643|NCT01405820|521823886|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
144718644|NCT01405820|521823881|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
144718645|NCT01405820|521823882|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
144718646|NCT01405820|521823883|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
144718647|NCT01405820|521823884|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
144718648|NCT01405820|521823885|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
144718649|NCT01405820|521823886|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
144718650|NCT01405820|521823881|FG000|Open-Label Treatment Period|Other|1|||
144718651|NCT01405820|521823882|FG001|Open-Label Treatment Period|Other|1|||
144718652|NCT01405820|521823883|FG002|Open-Label Treatment Period|Other|1|||
144718653|NCT01405820|521823884|FG003|Open-Label Treatment Period|Other|1|||
144718654|NCT01405820|521823885|FG004|Open-Label Treatment Period|Other|1|||
144718655|NCT01405820|521823886|FG005|Open-Label Treatment Period|Other|1|||
144718656|NCT01405820|521823881|FG000|Open-Label Treatment Period|Physician Decision|0|||
144718657|NCT01405820|521823882|FG001|Open-Label Treatment Period|Physician Decision|0|||
144718658|NCT01405820|521823883|FG002|Open-Label Treatment Period|Physician Decision|1|||
144718659|NCT01405820|521823884|FG003|Open-Label Treatment Period|Physician Decision|2|||
144718660|NCT01405820|521823885|FG004|Open-Label Treatment Period|Physician Decision|1|||
144718661|NCT01405820|521823886|FG005|Open-Label Treatment Period|Physician Decision|0|||
144718662|NCT01405820|521823881|FG000|Open-Label Treatment Period|Adverse Event|0|||
144718663|NCT01405820|521823882|FG001|Open-Label Treatment Period|Adverse Event|0|||
144718664|NCT01405820|521823883|FG002|Open-Label Treatment Period|Adverse Event|0|||
144369990|NCT02504151|520562775|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144493185|NCT01605136|521001090|FG001|Study Period|Lost to Follow-up|2|||
144493186|NCT01605136|521001089|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
144493187|NCT01605136|521001090|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
144493188|NCT01072929|521001091|FG000|Overall Study|Adverse Event|8|||
144493189|NCT01072929|521001092|FG001|Overall Study|Adverse Event|11|||
144493190|NCT01072929|521001093|FG002|Overall Study|Adverse Event|2|||
144493191|NCT01072929|521001091|FG000|Overall Study|Lack of Efficacy|7|||
144493192|NCT01072929|521001092|FG001|Overall Study|Lack of Efficacy|4|||
144493193|NCT01072929|521001093|FG002|Overall Study|Lack of Efficacy|0|||
144493194|NCT01072929|521001091|FG000|Overall Study|Withdrawal by Subject|7|||
144493195|NCT01072929|521001092|FG001|Overall Study|Withdrawal by Subject|15|||
144493196|NCT01072929|521001093|FG002|Overall Study|Withdrawal by Subject|3|||
144493197|NCT01072929|521001091|FG000|Overall Study|Protocol Violation|13|||
144493198|NCT01072929|521001092|FG001|Overall Study|Protocol Violation|11|||
144493199|NCT01072929|521001093|FG002|Overall Study|Protocol Violation|2|||
144493200|NCT01072929|521001091|FG000|Overall Study|Lost to Follow-up|8|||
144493201|NCT01072929|521001092|FG001|Overall Study|Lost to Follow-up|4|||
144493202|NCT01072929|521001093|FG002|Overall Study|Lost to Follow-up|1|||
144493203|NCT01072929|521001091|FG000|Overall Study|Noncompliance with study medication|0|||
144493204|NCT01072929|521001092|FG001|Overall Study|Noncompliance with study medication|3|||
144493205|NCT01072929|521001093|FG002|Overall Study|Noncompliance with study medication|0|||
144493206|NCT01072929|521001091|FG000|Overall Study|Noncompliance with study procedures|1|||
144493207|NCT01072929|521001092|FG001|Overall Study|Noncompliance with study procedures|0|||
144493208|NCT01072929|521001093|FG002|Overall Study|Noncompliance with study procedures|1|||
144493209|NCT01072929|521001091|FG000|Overall Study|Other|0|||
144493210|NCT01072929|521001092|FG001|Overall Study|Other|3|||
144493211|NCT01072929|521001093|FG002|Overall Study|Other|0|||
144493212|NCT01027871|521001094|FG000|Overall Study|Physician Decision|1|||
144493213|NCT01027871|521001095|FG001|Overall Study|Physician Decision|5|||
144493214|NCT01027871|521001096|FG002|Overall Study|Physician Decision|0|||
144493215|NCT01027871|521001094|FG000|Overall Study|Protocol Violation|0|||
144493216|NCT01027871|521001095|FG001|Overall Study|Protocol Violation|2|||
144493217|NCT01027871|521001096|FG002|Overall Study|Protocol Violation|2|||
144493218|NCT01027871|521001094|FG000|Overall Study|Withdrawal by Subject|1|||
144493219|NCT01027871|521001095|FG001|Overall Study|Withdrawal by Subject|2|||
144493220|NCT01027871|521001096|FG002|Overall Study|Withdrawal by Subject|2|||
144493221|NCT01027871|521001094|FG000|Overall Study|Adverse Event|0|||
144493222|NCT01027871|521001095|FG001|Overall Study|Adverse Event|2|||
144493223|NCT01027871|521001096|FG002|Overall Study|Adverse Event|2|||
144493224|NCT01027871|521001094|FG000|Overall Study|Sponsor Decision|0|||
144493225|NCT01027871|521001095|FG001|Overall Study|Sponsor Decision|2|||
144493226|NCT01027871|521001096|FG002|Overall Study|Sponsor Decision|0|||
144493227|NCT01027871|521001094|FG000|Overall Study|Discontinued Prior to Treatment|0|||
144493228|NCT01027871|521001095|FG001|Overall Study|Discontinued Prior to Treatment|0|||
144493229|NCT01027871|521001096|FG002|Overall Study|Discontinued Prior to Treatment|1|||
144493230|NCT04833855|521001097|FG000|Overall Study|Decision by sponsor|0|||
144493231|NCT04833855|521001098|FG001|Overall Study|Decision by sponsor|1|||
144493232|NCT04833855|521001099|FG002|Overall Study|Decision by sponsor|0|||
144493233|NCT04833855|521001100|FG003|Overall Study|Decision by sponsor|0|||
144493234|NCT04833855|521001097|FG000|Overall Study|Withdrawal by Subject|4|||
144493235|NCT04833855|521001098|FG001|Overall Study|Withdrawal by Subject|1|||
144493236|NCT04833855|521001099|FG002|Overall Study|Withdrawal by Subject|3|||
144718665|NCT01405820|521823884|FG003|Open-Label Treatment Period|Adverse Event|1|||
144718666|NCT01405820|521823885|FG004|Open-Label Treatment Period|Adverse Event|0|||
144718667|NCT01405820|521823886|FG005|Open-Label Treatment Period|Adverse Event|0|||
144718668|NCT03222141|521823887|FG000|Overall Study|Death|15|||
144718669|NCT03222141|521823887|FG000|Overall Study|Lost to Follow-up|3|||
144718670|NCT00441584|521823888|FG000|Overall Study|Lack of Efficacy|79|||
144718671|NCT00441584|521823888|FG000|Overall Study|Withdrawal by Subject|8|||
144718672|NCT00441584|521823888|FG000|Overall Study|Adverse Event|6|||
144718673|NCT00441584|521823888|FG000|Overall Study|Protocol Violation|5|||
144718674|NCT00441584|521823888|FG000|Overall Study|Lost to Follow-up|4|||
144718675|NCT00441584|521823888|FG000|Overall Study|Failure to meet eligibility criteria|3|||
144718676|NCT00619619|521823891|FG000|Overall Study|Physician Decision|0|||
144718677|NCT00619619|521823892|FG001|Overall Study|Physician Decision|0|||
144718678|NCT00619619|521823893|FG002|Overall Study|Physician Decision|1|||
144718679|NCT00619619|521823894|FG003|Overall Study|Physician Decision|0|||
144493237|NCT04833855|521001100|FG003|Overall Study|Withdrawal by Subject|1|||
144493238|NCT04833855|521001097|FG000|Overall Study|Lost to Follow-up|1|||
144493239|NCT04833855|521001098|FG001|Overall Study|Lost to Follow-up|0|||
144718680|NCT00619619|521823895|FG004|Overall Study|Physician Decision|0|||
144493240|NCT04833855|521001099|FG002|Overall Study|Lost to Follow-up|2|||
144718681|NCT00619619|521823896|FG005|Overall Study|Physician Decision|0|||
144718682|NCT00619619|521823897|FG006|Overall Study|Physician Decision|0|||
144718683|NCT00619619|521823898|FG007|Overall Study|Physician Decision|0|||
144493241|NCT04833855|521001100|FG003|Overall Study|Lost to Follow-up|2|||
144493242|NCT04833855|521001097|FG000|Overall Study|Protocol specified criteria|0|||
144718684|NCT00619619|521823891|FG000|Overall Study|Protocol Violation|0|||
144493243|NCT04833855|521001098|FG001|Overall Study|Protocol specified criteria|0|||
144493244|NCT04833855|521001099|FG002|Overall Study|Protocol specified criteria|2|||
144493245|NCT04833855|521001100|FG003|Overall Study|Protocol specified criteria|1|||
144493246|NCT03782727|521001101|FG000|Overall Study|Lost to Follow-up|32|||
144493247|NCT03008122|521001105|FG000|Overall Study|Physician Decision|3|||
144493248|NCT03008122|521001106|FG001|Overall Study|Physician Decision|2|||
144493249|NCT03008122|521001107|FG002|Overall Study|Physician Decision|0|||
144493250|NCT03008122|521001105|FG000|Overall Study|Withdrawal by Subject|1|||
144493251|NCT03008122|521001106|FG001|Overall Study|Withdrawal by Subject|3|||
144493252|NCT03008122|521001107|FG002|Overall Study|Withdrawal by Subject|0|||
144493253|NCT03008122|521001105|FG000|Overall Study|Lost to Follow-up|4|||
144493254|NCT03008122|521001106|FG001|Overall Study|Lost to Follow-up|8|||
144493255|NCT03008122|521001107|FG002|Overall Study|Lost to Follow-up|3|||
144493256|NCT03008122|521001105|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
144493257|NCT03008122|521001106|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
144493258|NCT03008122|521001107|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
144493259|NCT03008122|521001105|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
144493260|NCT03008122|521001106|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
144493261|NCT03008122|521001107|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
144493262|NCT03008122|521001105|FG000|Overall Study|Death|0|||
144493263|NCT03008122|521001106|FG001|Overall Study|Death|0|||
144493264|NCT03008122|521001107|FG002|Overall Study|Death|1|||
144493265|NCT02338609|521001110|FG000|Overall Study|Physician Decision|1|||
144493266|NCT02338609|521001110|FG000|Overall Study|Death|1|||
144493267|NCT04736056|521001112|FG000|Overall Study|Death|0|||
144493268|NCT04736056|521001113|FG001|Overall Study|Death|0|||
144493269|NCT04736056|521001114|FG002|Overall Study|Death|0|||
144493270|NCT04736056|521001115|FG003|Overall Study|Death|1|||
144493271|NCT04736056|521001112|FG000|Overall Study|Lost to Follow-up|1|||
144493272|NCT04736056|521001113|FG001|Overall Study|Lost to Follow-up|0|||
144493273|NCT04736056|521001114|FG002|Overall Study|Lost to Follow-up|1|||
144493274|NCT04736056|521001115|FG003|Overall Study|Lost to Follow-up|1|||
144493275|NCT04736056|521001112|FG000|Overall Study|Withdrawal by Subject|2|||
144493276|NCT04736056|521001113|FG001|Overall Study|Withdrawal by Subject|0|||
144493277|NCT04736056|521001114|FG002|Overall Study|Withdrawal by Subject|0|||
144493278|NCT04736056|521001115|FG003|Overall Study|Withdrawal by Subject|0|||
144493279|NCT04736056|521001112|FG000|Overall Study|Physician Decision|1|||
144493280|NCT04736056|521001113|FG001|Overall Study|Physician Decision|0|||
144493281|NCT04736056|521001114|FG002|Overall Study|Physician Decision|1|||
144493282|NCT04736056|521001115|FG003|Overall Study|Physician Decision|0|||
144493283|NCT02148718|521001116|FG000|Overall Study|Protocol Violation|26|||
144493284|NCT02148718|521001116|FG000|Overall Study|Discontinued Study Prematurely|5|||
144493285|NCT00333788|521001117|FG000|Overall Study|Adverse Event|44|||
144493286|NCT00333788|521001117|FG000|Overall Study|Lack of Efficacy|80|||
144718685|NCT00619619|521823892|FG001|Overall Study|Protocol Violation|0|||
144718686|NCT00619619|521823893|FG002|Overall Study|Protocol Violation|0|||
144718687|NCT00619619|521823894|FG003|Overall Study|Protocol Violation|1|||
144718688|NCT00619619|521823895|FG004|Overall Study|Protocol Violation|0|||
144718689|NCT00619619|521823896|FG005|Overall Study|Protocol Violation|0|||
144718690|NCT00619619|521823897|FG006|Overall Study|Protocol Violation|1|||
144718691|NCT00619619|521823898|FG007|Overall Study|Protocol Violation|1|||
144718692|NCT00619619|521823891|FG000|Overall Study|Adverse Event|0|||
144718693|NCT00619619|521823892|FG001|Overall Study|Adverse Event|0|||
144718694|NCT00619619|521823893|FG002|Overall Study|Adverse Event|0|||
144718695|NCT00619619|521823894|FG003|Overall Study|Adverse Event|0|||
144718696|NCT00619619|521823895|FG004|Overall Study|Adverse Event|2|||
144718697|NCT00619619|521823896|FG005|Overall Study|Adverse Event|0|||
144718698|NCT00619619|521823897|FG006|Overall Study|Adverse Event|0|||
144718699|NCT00619619|521823898|FG007|Overall Study|Adverse Event|2|||
144718700|NCT00415532|521823900|FG000|Treatment Period|Adverse Event|2|||
144718701|NCT00415532|521823901|FG001|Treatment Period|Adverse Event|3|||
144718702|NCT00415532|521823900|FG000|Treatment Period|Death|2|||
144718703|NCT00415532|521823901|FG001|Treatment Period|Death|1|||
144718704|NCT00415532|521823900|FG000|Treatment Period|Lost to Follow-up|1|||
144718705|NCT00415532|521823901|FG001|Treatment Period|Lost to Follow-up|1|||
144718706|NCT00415532|521823900|FG000|Treatment Period|Protocol Violation|1|||
144718707|NCT00415532|521823901|FG001|Treatment Period|Protocol Violation|0|||
144718708|NCT00415532|521823900|FG000|Treatment Period|Withdrawal by Subject|6|||
144718709|NCT00415532|521823901|FG001|Treatment Period|Withdrawal by Subject|6|||
144718710|NCT00415532|521823900|FG000|Treatment Period|Other|2|||
144718711|NCT00415532|521823901|FG001|Treatment Period|Other|2|||
144718712|NCT00415532|521823900|FG000|Treatment Period|Ineligibility determined|1|||
144718713|NCT00415532|521823901|FG001|Treatment Period|Ineligibility determined|1|||
144718714|NCT00415532|521823900|FG000|Treatment Period|Noncompliance|1|||
144718715|NCT00415532|521823901|FG001|Treatment Period|Noncompliance|1|||
144718716|NCT00415532|521823900|FG000|Treatment Period|Requirement for alternative therapy|1|||
144718717|NCT00415532|521823901|FG001|Treatment Period|Requirement for alternative therapy|0|||
144718718|NCT00415532|521823900|FG000|Safety Follow Up Period|Adverse Event|1|||
144718719|NCT00415532|521823901|FG001|Safety Follow Up Period|Adverse Event|3|||
144718720|NCT00415532|521823900|FG000|Safety Follow Up Period|Death|3|||
144718721|NCT00415532|521823901|FG001|Safety Follow Up Period|Death|0|||
144718722|NCT00415532|521823900|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
144718723|NCT00415532|521823901|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
144718724|NCT00415532|521823900|FG000|Safety Follow Up Period|Other|1|||
144718725|NCT00415532|521823901|FG001|Safety Follow Up Period|Other|4|||
144718726|NCT00415532|521823900|FG000|Safety Follow Up Period|Ineligibility determined|1|||
144718727|NCT00415532|521823901|FG001|Safety Follow Up Period|Ineligibility determined|1|||
144718728|NCT00415532|521823900|FG000|Safety Follow Up Period|Noncompliance|1|||
144718729|NCT00415532|521823901|FG001|Safety Follow Up Period|Noncompliance|0|||
144718730|NCT00415532|521823900|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
144718731|NCT00415532|521823901|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
144718732|NCT01798485|521823902|FG000|Overall Study|Adverse Event|32|||
144718733|NCT01798485|521823903|FG001|Overall Study|Adverse Event|40|||
144718734|NCT01798485|521823902|FG000|Overall Study|Withdrawal by Subject|27|||
144718735|NCT01798485|521823903|FG001|Overall Study|Withdrawal by Subject|31|||
144718736|NCT01798485|521823902|FG000|Overall Study|Lost to Follow-up|0|||
144718737|NCT01798485|521823903|FG001|Overall Study|Lost to Follow-up|3|||
144718738|NCT01798485|521823902|FG000|Overall Study|Physician Decision|14|||
144718739|NCT01798485|521823903|FG001|Overall Study|Physician Decision|10|||
144718740|NCT01798485|521823902|FG000|Overall Study|Objective Disease Progression|152|||
144718741|NCT01798485|521823903|FG001|Overall Study|Objective Disease Progression|106|||
144718742|NCT01798485|521823902|FG000|Overall Study|Death|25|||
144718743|NCT01798485|521823903|FG001|Overall Study|Death|22|||
144493287|NCT00333788|521001117|FG000|Overall Study|Lost to Follow-up|2|||
144493288|NCT00333788|521001117|FG000|Overall Study|Withdrawal by Subject|24|||
144493289|NCT00333788|521001117|FG000|Overall Study|Other: Non-compliance|2|||
144493290|NCT00333788|521001117|FG000|Overall Study|Other: Moved|2|||
144718744|NCT01798485|521823902|FG000|Overall Study|Sponsor Decision|61|||
144718745|NCT01798485|521823903|FG001|Overall Study|Sponsor Decision|54|||
144718746|NCT01798485|521823902|FG000|Overall Study|Clinical Progression|35|||
144718747|NCT01798485|521823903|FG001|Overall Study|Clinical Progression|24|||
144718748|NCT01952574|521823904|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
144718749|NCT01952574|521823905|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
144718750|NCT01952574|521823906|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
144493291|NCT00333788|521001117|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
144493292|NCT00333788|521001117|FG000|Overall Study|Other: Investigator decision|1|||
144369991|NCT02504151|520562774|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
144493293|NCT00333788|521001117|FG000|Overall Study|Other: Quality of life concern|1|||
144493294|NCT00333788|521001117|FG000|Overall Study|Other: Sponsor decision|1|||
144493295|NCT00333788|521001117|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
144493296|NCT00333788|521001117|FG000|Overall Study|Other: Medical monitor decision|1|||
144493297|NCT00333788|521001117|FG000|Overall Study|Other: Physician decision|1|||
144493298|NCT00333788|521001117|FG000|Overall Study|Other: Signed consent for another study|1|||
144493299|NCT00663962|521001120|FG000|Overall Study|somnolence|1|||
144493300|NCT00663962|521001121|FG001|Overall Study|somnolence|0|||
144493301|NCT00604786|521001122|FG000|Overall Study|Lost to Follow-up|2|||
144493302|NCT00604786|521001123|FG001|Overall Study|Lost to Follow-up|0|||
144493303|NCT02337361|521001124|FG000|3-month Follow-up|Lost to Follow-up|19|||
144493304|NCT02337361|521001125|FG001|3-month Follow-up|Lost to Follow-up|14|||
144493305|NCT02337361|521001124|FG000|6-month Follow-up|Lost to Follow-up|2|||
144493306|NCT02337361|521001125|FG001|6-month Follow-up|Lost to Follow-up|4|||
144493307|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Adverse Event|5|||
144493308|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Adverse Event|13|||
144493309|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Adverse Event|0|||
144493310|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
144493311|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
144493312|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
144493313|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
144493314|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
144493315|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
144493316|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
144493317|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
144493318|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
144493319|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
144493320|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
144493321|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
144493322|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
144493323|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
144493324|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
144493325|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Physician Decision|2|||
144493326|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Physician Decision|3|||
144493327|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Physician Decision|0|||
144493328|NCT01449929|521001126|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
144718751|NCT01952574|521823907|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
144718752|NCT01952574|521823908|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144718753|NCT01952574|521823909|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144718754|NCT01952574|521823910|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144718755|NCT01952574|521823904|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
144718756|NCT01952574|521823905|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
144718757|NCT01952574|521823906|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
144718758|NCT01952574|521823907|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
144718759|NCT01952574|521823908|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
144718760|NCT01952574|521823909|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
144718761|NCT01952574|521823910|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
144718762|NCT01952574|521823904|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
144718763|NCT01952574|521823905|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
144718764|NCT01952574|521823906|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
144718765|NCT01952574|521823907|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
144718766|NCT01952574|521823908|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
144718767|NCT01952574|521823909|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
144718768|NCT01952574|521823910|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
144718769|NCT01952574|521823904|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
144718770|NCT01952574|521823905|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
144718771|NCT01952574|521823906|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
144718772|NCT01952574|521823907|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
144718773|NCT01952574|521823908|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
144718774|NCT01952574|521823909|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
144718775|NCT01952574|521823910|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
144718776|NCT01952574|521823904|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
144718777|NCT01952574|521823905|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
144718778|NCT01952574|521823906|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
144718779|NCT01952574|521823907|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
144369992|NCT02504151|520562775|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
144493329|NCT01449929|521001127|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
144493330|NCT01449929|521001128|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
144493331|NCT01449929|521001126|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
144493332|NCT01449929|521001127|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
144493333|NCT01449929|521001128|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
144493334|NCT01449929|521001126|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
144493335|NCT01449929|521001127|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
144493336|NCT01449929|521001128|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
144493337|NCT01449929|521001126|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
144493338|NCT01449929|521001127|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
144493339|NCT01449929|521001128|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
144493340|NCT03015740|521001129|FG000|Overall Study|Adverse Event|1|||
144493341|NCT03015740|521001130|FG001|Overall Study|Adverse Event|0|||
144493342|NCT03015740|521001131|FG002|Overall Study|Adverse Event|0|||
144493343|NCT03015740|521001129|FG000|Overall Study|Death|3|||
144493344|NCT03015740|521001130|FG001|Overall Study|Death|5|||
144493345|NCT03015740|521001131|FG002|Overall Study|Death|0|||
144493346|NCT03015740|521001129|FG000|Overall Study|Withdrawal by Subject|2|||
144493347|NCT03015740|521001130|FG001|Overall Study|Withdrawal by Subject|0|||
144493348|NCT03015740|521001131|FG002|Overall Study|Withdrawal by Subject|0|||
144493349|NCT03253653|521001136|FG000|Overall Study|Withdrawal by Subject|4|||
144493350|NCT03253653|521001137|FG001|Overall Study|Withdrawal by Subject|1|||
144493351|NCT03253653|521001136|FG000|Overall Study|Protocol Violation|0|||
144493352|NCT03253653|521001137|FG001|Overall Study|Protocol Violation|5|||
144493353|NCT02206685|521002997|FG000|Overall Study|Surgery cancelled/changed|2|||
144493354|NCT02206685|521002998|FG001|Overall Study|Surgery cancelled/changed|3|||
144493355|NCT02206685|521002997|FG000|Overall Study|Withdrawal by Subject|1|||
144493356|NCT02206685|521002998|FG001|Overall Study|Withdrawal by Subject|2|||
144493357|NCT02206685|521002997|FG000|Overall Study|Protocol Violation|2|||
144493358|NCT02206685|521002998|FG001|Overall Study|Protocol Violation|2|||
144493359|NCT02271594|521003006|FG000|Overall Study|Study closed; recruiting failure|19|||
144493360|NCT02271594|521003007|FG001|Overall Study|Study closed; recruiting failure|12|||
144493361|NCT00495469|521003008|FG000|Overall Study|Adverse Event|0|||
144493362|NCT00495469|521003009|FG001|Overall Study|Adverse Event|1|||
144493363|NCT00495469|521003010|FG002|Overall Study|Adverse Event|3|||
144493364|NCT00495469|521003011|FG003|Overall Study|Adverse Event|0|||
144493365|NCT00495469|521003012|FG004|Overall Study|Adverse Event|1|||
144493366|NCT00495469|521003013|FG005|Overall Study|Adverse Event|1|||
144493367|NCT00495469|521003014|FG006|Overall Study|Adverse Event|1|||
144493368|NCT00495469|521003008|FG000|Overall Study|Lost to Follow-up|1|||
144493369|NCT00495469|521003009|FG001|Overall Study|Lost to Follow-up|1|||
144493370|NCT00495469|521003010|FG002|Overall Study|Lost to Follow-up|3|||
144493371|NCT00495469|521003011|FG003|Overall Study|Lost to Follow-up|1|||
144493372|NCT00495469|521003012|FG004|Overall Study|Lost to Follow-up|0|||
144493373|NCT00495469|521003013|FG005|Overall Study|Lost to Follow-up|0|||
144493374|NCT00495469|521003014|FG006|Overall Study|Lost to Follow-up|0|||
144493375|NCT00495469|521003008|FG000|Overall Study|Protocol Violation|0|||
144493376|NCT00495469|521003009|FG001|Overall Study|Protocol Violation|0|||
144493377|NCT00495469|521003010|FG002|Overall Study|Protocol Violation|0|||
144493378|NCT00495469|521003011|FG003|Overall Study|Protocol Violation|0|||
144493379|NCT00495469|521003012|FG004|Overall Study|Protocol Violation|1|||
144493380|NCT00495469|521003013|FG005|Overall Study|Protocol Violation|2|||
144493381|NCT00495469|521003014|FG006|Overall Study|Protocol Violation|0|||
144493382|NCT00495469|521003008|FG000|Overall Study|Withdrawal by Subject|5|||
144493383|NCT00495469|521003009|FG001|Overall Study|Withdrawal by Subject|3|||
144493384|NCT00495469|521003010|FG002|Overall Study|Withdrawal by Subject|1|||
144493385|NCT00495469|521003011|FG003|Overall Study|Withdrawal by Subject|3|||
144493386|NCT00495469|521003012|FG004|Overall Study|Withdrawal by Subject|3|||
144493387|NCT00495469|521003013|FG005|Overall Study|Withdrawal by Subject|2|||
144493388|NCT00495469|521003014|FG006|Overall Study|Withdrawal by Subject|3|||
144493389|NCT00495469|521003008|FG000|Overall Study|Lack of Efficacy|0|||
144493390|NCT00495469|521003009|FG001|Overall Study|Lack of Efficacy|0|||
144493391|NCT00495469|521003010|FG002|Overall Study|Lack of Efficacy|0|||
144493392|NCT00495469|521003011|FG003|Overall Study|Lack of Efficacy|0|||
144718780|NCT01952574|521823908|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
144718781|NCT01952574|521823909|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
144718782|NCT01952574|521823910|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
144718783|NCT01952574|521823904|FG000|Open-label Treatment Phase|Missing|0|||
144718784|NCT01952574|521823905|FG001|Open-label Treatment Phase|Missing|0|||
144718785|NCT01952574|521823906|FG002|Open-label Treatment Phase|Missing|0|||
144493393|NCT00495469|521003012|FG004|Overall Study|Lack of Efficacy|0|||
144493394|NCT00495469|521003013|FG005|Overall Study|Lack of Efficacy|0|||
144718786|NCT01952574|521823907|FG003|Open-label Treatment Phase|Missing|0|||
144718787|NCT01952574|521823908|FG004|Open-label Treatment Phase|Missing|4|||
144493395|NCT00495469|521003014|FG006|Overall Study|Lack of Efficacy|1|||
144493396|NCT00495469|521003008|FG000|Overall Study|Liver function test abnormality|0|||
144493397|NCT00495469|521003009|FG001|Overall Study|Liver function test abnormality|1|||
144493398|NCT00495469|521003010|FG002|Overall Study|Liver function test abnormality|0|||
144493399|NCT00495469|521003011|FG003|Overall Study|Liver function test abnormality|0|||
144493400|NCT00495469|521003012|FG004|Overall Study|Liver function test abnormality|0|||
144493401|NCT00495469|521003013|FG005|Overall Study|Liver function test abnormality|0|||
144493402|NCT00495469|521003014|FG006|Overall Study|Liver function test abnormality|0|||
144493403|NCT00495469|521003008|FG000|Overall Study|ST depression at randomisation in ECG|0|||
144718788|NCT01952574|521823909|FG005|Open-label Treatment Phase|Missing|0|||
144493404|NCT00495469|521003009|FG001|Overall Study|ST depression at randomisation in ECG|1|||
144493405|NCT00495469|521003010|FG002|Overall Study|ST depression at randomisation in ECG|0|||
144493406|NCT00495469|521003011|FG003|Overall Study|ST depression at randomisation in ECG|0|||
144493407|NCT00495469|521003012|FG004|Overall Study|ST depression at randomisation in ECG|0|||
144493408|NCT00495469|521003013|FG005|Overall Study|ST depression at randomisation in ECG|0|||
144493409|NCT00495469|521003014|FG006|Overall Study|ST depression at randomisation in ECG|0|||
144493410|NCT00367237|521003019|FG000|Overall Study|Adverse Event|7|||
144493411|NCT00367237|521003020|FG001|Overall Study|Adverse Event|2|||
144493412|NCT00367237|521003019|FG000|Overall Study|Lost to Follow-up|1|||
144493413|NCT00367237|521003020|FG001|Overall Study|Lost to Follow-up|0|||
144493414|NCT00367237|521003019|FG000|Overall Study|Withdrawal by Subject|0|||
144493415|NCT00367237|521003020|FG001|Overall Study|Withdrawal by Subject|4|||
144493416|NCT00367237|521003019|FG000|Overall Study|Protocol Violation|2|||
144493417|NCT00367237|521003020|FG001|Overall Study|Protocol Violation|5|||
144493418|NCT01175707|521003021|FG000|Overall Study|Adverse Event|4|||
144493419|NCT01175707|521003022|FG001|Overall Study|Adverse Event|6|||
144493420|NCT00180674|521003031|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
144493421|NCT00180674|521003031|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
144493422|NCT01106976|521003032|FG000|Overall Study|Lost to Follow-up|8|||
144493423|NCT00051311|521003036|FG000|Overall Study|Starting new study|0|||
144493424|NCT00051311|521003037|FG001|Overall Study|Starting new study|1|||
144493425|NCT00051311|521003036|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
144493426|NCT00051311|521003037|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
144493427|NCT00051311|521003036|FG000|Overall Study|Death of recipient|8|||
144493428|NCT00051311|521003037|FG001|Overall Study|Death of recipient|8|||
144493429|NCT00051311|521003036|FG000|Overall Study|Recipient taken off study|4|||
144493430|NCT00051311|521003037|FG001|Overall Study|Recipient taken off study|4|||
144493431|NCT01427907|521003041|FG000|Overall Study|Withdrawal by Subject|3|||
144493432|NCT01427907|521003042|FG001|Overall Study|Withdrawal by Subject|4|||
144493433|NCT02374957|521003043|FG000|Overall Study|Patient did not complete forms correctly|1|||
144493434|NCT02374957|521003044|FG001|Overall Study|Patient did not complete forms correctly|0|||
144493435|NCT00972543|521003045|FG000|Overall Study|Adverse Event|1|||
144493436|NCT00972543|521003046|FG001|Overall Study|Adverse Event|0|||
144493437|NCT00972543|521003045|FG000|Overall Study|Early study termination by sponsor|4|||
144493438|NCT00972543|521003046|FG001|Overall Study|Early study termination by sponsor|1|||
144493439|NCT00335153|521003047|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
144493440|NCT00335153|521003047|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
144493441|NCT00335153|521003047|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
144493442|NCT00335153|521003047|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
144493443|NCT00335153|521003047|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
144493444|NCT00335153|521003047|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
144493445|NCT00335153|521003047|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
144493446|NCT00335153|521003047|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
144493447|NCT00335153|521003047|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
144493448|NCT00335153|521003047|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
144493449|NCT02478359|521003050|FG000|Overall Study|Disenrolled from health plan|106|||
144493450|NCT02478359|521003051|FG001|Overall Study|Disenrolled from health plan|65|||
144493451|NCT02412761|521003052|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144493452|NCT02412761|521003053|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144493453|NCT02412761|521003054|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144493454|NCT02412761|521003055|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144493455|NCT02412761|521003056|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144493456|NCT02412761|521003057|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144493457|NCT01818700|521003058|FG000|Overall Study|Adverse Event|67|||
144493458|NCT01818700|521003058|FG000|Overall Study|Lack of Efficacy|2|||
144493459|NCT01818700|521003058|FG000|Overall Study|Lost to Follow-up|5|||
144493460|NCT01818700|521003058|FG000|Overall Study|Withdrawal by Subject|27|||
144493461|NCT01818700|521003058|FG000|Overall Study|Protocol Violation|2|||
144493462|NCT01818700|521003058|FG000|Overall Study|Other|1|||
144493463|NCT01417000|521003059|FG000|Overall Study|Death|59|||
144493464|NCT01417000|521003060|FG001|Overall Study|Death|28|||
144493465|NCT01417000|521003059|FG000|Overall Study|Lost to Follow-up|1|||
144493466|NCT01417000|521003060|FG001|Overall Study|Lost to Follow-up|0|||
144493467|NCT01417000|521003059|FG000|Overall Study|Study Terminated by Sponsor|1|||
144493468|NCT01417000|521003060|FG001|Overall Study|Study Terminated by Sponsor|1|||
144493469|NCT01719861|521003068|FG000|Cycle 1|Death|4|||
144493470|NCT01719861|521003068|FG000|Cycle 2|Death|1|||
144493471|NCT00958009|521003069|FG000|Overall Study|Adverse Event|1|||
144493472|NCT00958009|521003069|FG000|Overall Study|Subject found device difficult to use|1|||
144493473|NCT01813422|521003076|FG000|Overall Study|Withdrawal by Subject|14|||
144493474|NCT01813422|521003077|FG001|Overall Study|Withdrawal by Subject|8|||
144493475|NCT01813422|521003076|FG000|Overall Study|Death|2|||
144493476|NCT01813422|521003077|FG001|Overall Study|Death|3|||
144493477|NCT01813422|521003076|FG000|Overall Study|Sponsor Decision|2|||
144493478|NCT01813422|521003077|FG001|Overall Study|Sponsor Decision|1|||
144493479|NCT01813422|521003076|FG000|Overall Study|Lost to Follow-up|2|||
144493480|NCT01813422|521003077|FG001|Overall Study|Lost to Follow-up|4|||
144493481|NCT00558753|521003082|FG000|Overall Study|Lost to Follow-up|5|||
144493482|NCT00558753|521003083|FG001|Overall Study|Lost to Follow-up|7|||
144493483|NCT01414166|521003087|FG000|Overall Study|Adverse Event|10|||
144493484|NCT01414166|521003088|FG001|Overall Study|Adverse Event|2|||
144493485|NCT01414166|521003087|FG000|Overall Study|Lost to Follow-up|4|||
144493486|NCT01414166|521003088|FG001|Overall Study|Lost to Follow-up|1|||
144493487|NCT01414166|521003087|FG000|Overall Study|Non-compliance with study drug|2|||
144493488|NCT01414166|521003088|FG001|Overall Study|Non-compliance with study drug|0|||
144493489|NCT01414166|521003087|FG000|Overall Study|Physician Decision|2|||
144493490|NCT01414166|521003088|FG001|Overall Study|Physician Decision|0|||
144493491|NCT01414166|521003087|FG000|Overall Study|Protocol Violation|2|||
144493492|NCT01414166|521003088|FG001|Overall Study|Protocol Violation|0|||
144493493|NCT01414166|521003087|FG000|Overall Study|Study terminated by Sponsor|68|||
144493494|NCT01414166|521003088|FG001|Overall Study|Study terminated by Sponsor|75|||
144493495|NCT01414166|521003087|FG000|Overall Study|Withdrawal by Subject|3|||
144493496|NCT01414166|521003088|FG001|Overall Study|Withdrawal by Subject|5|||
144493497|NCT03682536|521003089|FG000|Randomization|Withdrawal by Subject|0|||
144493498|NCT03682536|521003090|FG001|Randomization|Withdrawal by Subject|2|||
144493499|NCT03682536|521003089|FG000|Treatment|Other Reasons|8|||
144493500|NCT03682536|521003090|FG001|Treatment|Other Reasons|7|||
144493501|NCT03682536|521003089|FG000|Treatment|Physician Decision|5|||
144493502|NCT03682536|521003090|FG001|Treatment|Physician Decision|5|||
144493503|NCT03682536|521003089|FG000|Treatment|Protocol Violation|1|||
144493504|NCT03682536|521003090|FG001|Treatment|Protocol Violation|0|||
144493505|NCT03682536|521003089|FG000|Treatment|Study Terminated by Sponsor|1|||
144493506|NCT03682536|521003090|FG001|Treatment|Study Terminated by Sponsor|2|||
144493507|NCT03682536|521003089|FG000|Treatment|Lost to Follow-up|0|||
144493508|NCT03682536|521003090|FG001|Treatment|Lost to Follow-up|1|||
144493509|NCT03682536|521003089|FG000|Treatment|Withdrawal by Subject|16|||
144493510|NCT03682536|521003090|FG001|Treatment|Withdrawal by Subject|18|||
144493511|NCT03682536|521003089|FG000|Treatment|Lack of Efficacy|41|||
144493512|NCT03682536|521003090|FG001|Treatment|Lack of Efficacy|68|||
144493513|NCT03682536|521003089|FG000|Treatment|Disease Progression|9|||
144493514|NCT03682536|521003090|FG001|Treatment|Disease Progression|7|||
144493515|NCT03682536|521003089|FG000|Treatment|Adverse Event|9|||
144493516|NCT03682536|521003090|FG001|Treatment|Adverse Event|5|||
144493517|NCT03682536|521003089|FG000|Treatment|Death|14|||
144493518|NCT03682536|521003090|FG001|Treatment|Death|13|||
144493519|NCT04824131|521003091|FG000|CAB LA Oral Phase|Adverse Event|1|||
144493520|NCT04824131|521003091|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
144493521|NCT04824131|521003091|FG000|Step 3|Withdrawal by Subject|2|||
144493522|NCT05489224|521003092|FG000|Treatment Period I|Withdrawal by Subject|6|||
144493523|NCT05489224|521003093|FG001|Treatment Period I|Withdrawal by Subject|5|||
144493524|NCT05489224|521003094|FG002|Treatment Period I|Withdrawal by Subject|0|||
144493525|NCT05489224|521003092|FG000|Treatment Period I|Adverse Event|3|||
144493526|NCT05489224|521003093|FG001|Treatment Period I|Adverse Event|11|||
144493527|NCT05489224|521003094|FG002|Treatment Period I|Adverse Event|0|||
144493528|NCT05489224|521003092|FG000|Treatment Period I|Lost to Follow-up|0|||
144493529|NCT05489224|521003093|FG001|Treatment Period I|Lost to Follow-up|1|||
144493530|NCT05489224|521003094|FG002|Treatment Period I|Lost to Follow-up|0|||
144493531|NCT05489224|521003092|FG000|Treatment Period I|Physician Decision|0|||
144493532|NCT05489224|521003093|FG001|Treatment Period I|Physician Decision|1|||
144493533|NCT05489224|521003094|FG002|Treatment Period I|Physician Decision|0|||
144493534|NCT05489224|521003092|FG000|Treatment Period II up to Week 32|Ongoing|222|||
144493535|NCT05489224|521003093|FG001|Treatment Period II up to Week 32|Ongoing|107|||
144493536|NCT05489224|521003094|FG002|Treatment Period II up to Week 32|Ongoing|107|||
144493537|NCT05489224|521003092|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
144493538|NCT05489224|521003093|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
144493539|NCT05489224|521003094|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
144493540|NCT05489224|521003092|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
144493541|NCT05489224|521003093|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
144493542|NCT05489224|521003094|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
144493543|NCT03686384|521003095|FG000|Overall Study|Lack of Efficacy|4|||
144493544|NCT03686384|521003096|FG001|Overall Study|Lack of Efficacy|13|||
144493545|NCT03686384|521003095|FG000|Overall Study|Lost to Follow-up|3|||
144493546|NCT03686384|521003096|FG001|Overall Study|Lost to Follow-up|0|||
144493547|NCT03686384|521003095|FG000|Overall Study|Physician Decision|0|||
144493548|NCT03686384|521003096|FG001|Overall Study|Physician Decision|1|||
144493549|NCT03686384|521003095|FG000|Overall Study|Took prohibited medication|0|||
144493550|NCT03686384|521003096|FG001|Overall Study|Took prohibited medication|1|||
144493551|NCT04887285|521003097|FG000|Overall Study|Lost to Follow-up|0|||
144493552|NCT04887285|521003098|FG001|Overall Study|Lost to Follow-up|2|||
144493553|NCT04887285|521003099|FG002|Overall Study|Lost to Follow-up|3|||
144493554|NCT04640571|521003100|FG000|Overall Study|Withdrawal by Subject|0|||
144493555|NCT04640571|521003101|FG001|Overall Study|Withdrawal by Subject|0|||
144493556|NCT04640571|521003102|FG002|Overall Study|Withdrawal by Subject|0|||
144493557|NCT04640571|521003103|FG003|Overall Study|Withdrawal by Subject|0|||
144493558|NCT04640571|521003104|FG004|Overall Study|Withdrawal by Subject|0|||
144493559|NCT04640571|521003105|FG005|Overall Study|Withdrawal by Subject|2|||
144493560|NCT02820051|521003107|FG000|Overall Study|Lost to Follow-up|7|||
144493561|NCT02820051|521003108|FG001|Overall Study|Lost to Follow-up|4|||
144493562|NCT01222247|521003113|FG000|Overall Study|Lost to Follow-up|2|||
144493563|NCT01222247|521003114|FG001|Overall Study|Lost to Follow-up|2|||
144493564|NCT03289455|521003115|FG000|Overall Study|Death|1|||
144493565|NCT03289455|521003116|FG001|Overall Study|Death|0|||
144493566|NCT03289455|521003117|FG002|Overall Study|Death|0|||
144493567|NCT03289455|521003115|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
144493568|NCT03289455|521003116|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
144493569|NCT03289455|521003117|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
144493570|NCT03289455|521003115|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
144493571|NCT03289455|521003116|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
144493572|NCT03289455|521003117|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
144493573|NCT03289455|521003115|FG000|Overall Study|Progressive disease|3|||
144493574|NCT03289455|521003116|FG001|Overall Study|Progressive disease|4|||
144493575|NCT03289455|521003117|FG002|Overall Study|Progressive disease|5|||
144493576|NCT02956967|521003121|FG000|Overall Study|Adverse Event|3|||
144493577|NCT02956967|521003121|FG000|Overall Study|Reason non-related to neutropenia|10|||
144493578|NCT02956967|521003121|FG000|Overall Study|Lost to Follow-up|5|||
144493579|NCT02956967|521003121|FG000|Overall Study|Missing|1|||
144493580|NCT02956967|521003121|FG000|Overall Study|Termination of Nivestim administration|29|||
144493581|NCT02322775|521003122|FG000|Overall Study|Adverse Event|1|||
144493582|NCT02322775|521003123|FG001|Overall Study|Adverse Event|0|||
144493583|NCT02322775|521003122|FG000|Overall Study|Lost to Follow-up|0|||
144493584|NCT02322775|521003123|FG001|Overall Study|Lost to Follow-up|1|||
144493585|NCT02322775|521003122|FG000|Overall Study|Protocol Violation|1|||
144493586|NCT02322775|521003123|FG001|Overall Study|Protocol Violation|0|||
144493587|NCT02322775|521003122|FG000|Overall Study|Withdrawal by Subject|3|||
144493588|NCT02322775|521003123|FG001|Overall Study|Withdrawal by Subject|4|||
144493589|NCT02322775|521003122|FG000|Overall Study|Not willing to perform all FU visits|0|||
144493590|NCT02322775|521003123|FG001|Overall Study|Not willing to perform all FU visits|1|||
144493591|NCT04482855|521003124|FG000|Overall Study|Lost to Follow-up|1|||
144493592|NCT04482855|521003125|FG001|Overall Study|Lost to Follow-up|0|||
144493593|NCT04482855|521003124|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
144493594|NCT04482855|521003125|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
144493595|NCT04482855|521003124|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
144493596|NCT04482855|521003125|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
144493597|NCT00764868|521003126|FG000|Overall Study|Adverse Event|18|||
144493598|NCT00764868|521003126|FG000|Overall Study|Withdrawal by Subject|31|||
144493599|NCT00764868|521003126|FG000|Overall Study|Non-compliance|16|||
144493600|NCT00764868|521003126|FG000|Overall Study|Lost to Follow-up|25|||
144493601|NCT00764868|521003126|FG000|Overall Study|Lack of Efficacy|5|||
144493602|NCT00764868|521003126|FG000|Overall Study|Subject moved|7|||
144493603|NCT00764868|521003126|FG000|Overall Study|Pregnancy|3|||
144493604|NCT00764868|521003126|FG000|Overall Study|Prohibited medication|1|||
144493605|NCT00764868|521003126|FG000|Overall Study|Out of town|1|||
144493606|NCT00764868|521003126|FG000|Overall Study|Misuse and compliance of study drug|1|||
144493607|NCT00764868|521003126|FG000|Overall Study|Subject sent to boarding school|1|||
144493608|NCT00764868|521003126|FG000|Overall Study|Met an exclusion criteria|1|||
144493609|NCT00764868|521003126|FG000|Overall Study|Positive drug screen|2|||
144493610|NCT00764868|521003126|FG000|Overall Study|Sponsor requested withdrawal|1|||
144493611|NCT00819234|521003135|FG000|Overall Study|Withdrawal by Subject|8|||
144493612|NCT00819234|521003136|FG001|Overall Study|Withdrawal by Subject|13|||
144493613|NCT00819234|521003137|FG002|Overall Study|Withdrawal by Subject|6|||
144493614|NCT00819234|521003138|FG003|Overall Study|Withdrawal by Subject|3|||
144493615|NCT00819234|521003139|FG004|Overall Study|Withdrawal by Subject|0|||
144493616|NCT00819234|521003140|FG005|Overall Study|Withdrawal by Subject|4|||
144493617|NCT00819234|521003141|FG006|Overall Study|Withdrawal by Subject|4|||
144493618|NCT00819234|521003142|FG007|Overall Study|Withdrawal by Subject|8|||
144493619|NCT00819234|521003143|FG008|Overall Study|Withdrawal by Subject|5|||
144493620|NCT00819234|521003144|FG009|Overall Study|Withdrawal by Subject|3|||
144493621|NCT00819234|521003135|FG000|Overall Study|Adverse Event|0|||
144493622|NCT00819234|521003136|FG001|Overall Study|Adverse Event|0|||
144493623|NCT00819234|521003137|FG002|Overall Study|Adverse Event|1|||
144493624|NCT00819234|521003138|FG003|Overall Study|Adverse Event|0|||
144493625|NCT00819234|521003139|FG004|Overall Study|Adverse Event|0|||
144493626|NCT00819234|521003140|FG005|Overall Study|Adverse Event|2|||
144493627|NCT00819234|521003141|FG006|Overall Study|Adverse Event|0|||
144493628|NCT00819234|521003142|FG007|Overall Study|Adverse Event|0|||
144493629|NCT00819234|521003143|FG008|Overall Study|Adverse Event|0|||
144493630|NCT00819234|521003144|FG009|Overall Study|Adverse Event|0|||
144493631|NCT00819234|521003135|FG000|Overall Study|Physician Decision|0|||
144493632|NCT00819234|521003136|FG001|Overall Study|Physician Decision|0|||
144493633|NCT00819234|521003137|FG002|Overall Study|Physician Decision|0|||
144493634|NCT00819234|521003138|FG003|Overall Study|Physician Decision|1|||
144493635|NCT00819234|521003139|FG004|Overall Study|Physician Decision|0|||
144493636|NCT00819234|521003140|FG005|Overall Study|Physician Decision|0|||
144493637|NCT00819234|521003141|FG006|Overall Study|Physician Decision|0|||
144493638|NCT00819234|521003142|FG007|Overall Study|Physician Decision|0|||
144493639|NCT00819234|521003143|FG008|Overall Study|Physician Decision|0|||
144493640|NCT00819234|521003144|FG009|Overall Study|Physician Decision|2|||
144493641|NCT00819234|521003135|FG000|Overall Study|Protocol Violation|0|||
144493642|NCT00819234|521003136|FG001|Overall Study|Protocol Violation|0|||
144493643|NCT00819234|521003137|FG002|Overall Study|Protocol Violation|1|||
144493644|NCT00819234|521003138|FG003|Overall Study|Protocol Violation|0|||
144493645|NCT00819234|521003139|FG004|Overall Study|Protocol Violation|0|||
144493646|NCT00819234|521003140|FG005|Overall Study|Protocol Violation|0|||
144493647|NCT00819234|521003141|FG006|Overall Study|Protocol Violation|0|||
144493648|NCT00819234|521003142|FG007|Overall Study|Protocol Violation|0|||
144493649|NCT00819234|521003143|FG008|Overall Study|Protocol Violation|0|||
144493650|NCT00819234|521003144|FG009|Overall Study|Protocol Violation|0|||
144493651|NCT00819234|521003135|FG000|Overall Study|Lost to Follow-up|2|||
144493652|NCT00819234|521003136|FG001|Overall Study|Lost to Follow-up|2|||
144493653|NCT00819234|521003137|FG002|Overall Study|Lost to Follow-up|0|||
144493654|NCT00819234|521003138|FG003|Overall Study|Lost to Follow-up|2|||
144493655|NCT00819234|521003139|FG004|Overall Study|Lost to Follow-up|1|||
144493656|NCT00819234|521003140|FG005|Overall Study|Lost to Follow-up|1|||
144493657|NCT00819234|521003141|FG006|Overall Study|Lost to Follow-up|1|||
144493658|NCT00819234|521003142|FG007|Overall Study|Lost to Follow-up|1|||
144493659|NCT00819234|521003143|FG008|Overall Study|Lost to Follow-up|1|||
144493660|NCT00819234|521003144|FG009|Overall Study|Lost to Follow-up|2|||
144493661|NCT04438785|521003145|FG000|Overall Study|change of weight, give up intervention|2|||
144493662|NCT04438785|521003146|FG001|Overall Study|change of weight, give up intervention|10|||
144493663|NCT04011033|521003147|FG000|Overall Study|Physician Decision|2|||
144493664|NCT04011033|521003148|FG001|Overall Study|Physician Decision|3|||
144493665|NCT04011033|521003147|FG000|Overall Study|Withdrawal by Subject|1|||
144493666|NCT04011033|521003148|FG001|Overall Study|Withdrawal by Subject|0|||
144493667|NCT01823341|521003149|FG000|Overall Study|Failed run-in|7|||
144493668|NCT01823341|521003149|FG000|Overall Study|Withdrawal by Subject|7|||
144493669|NCT01823341|521003149|FG000|Overall Study|Adverse Event|1|||
144493670|NCT02027935|521003150|FG000|Overall Study|Death|1|||
144493671|NCT02027935|521003150|FG000|Overall Study|Lack of Efficacy|5|||
144493672|NCT02027935|521003150|FG000|Overall Study|Study Closure|1|||
144493673|NCT00689104|521003151|FG000|Overall Study|Eligibility criterion not met|5|||
144493674|NCT00689104|521003152|FG001|Overall Study|Eligibility criterion not met|8|||
144493675|NCT00689104|521003153|FG002|Overall Study|Eligibility criterion not met|0|||
144493676|NCT00689104|521003154|FG003|Overall Study|Eligibility criterion not met|4|||
144493677|NCT00689104|521003151|FG000|Overall Study|Adverse Event|13|||
144493678|NCT00689104|521003152|FG001|Overall Study|Adverse Event|25|||
144493679|NCT00689104|521003153|FG002|Overall Study|Adverse Event|16|||
144493680|NCT00689104|521003154|FG003|Overall Study|Adverse Event|24|||
144493681|NCT00689104|521003151|FG000|Overall Study|Lack of Efficacy|5|||
144493682|NCT00689104|521003152|FG001|Overall Study|Lack of Efficacy|6|||
144493683|NCT00689104|521003153|FG002|Overall Study|Lack of Efficacy|2|||
144493684|NCT00689104|521003154|FG003|Overall Study|Lack of Efficacy|3|||
144493685|NCT00689104|521003151|FG000|Overall Study|Withdrawal by Subject|12|||
144493686|NCT00689104|521003152|FG001|Overall Study|Withdrawal by Subject|11|||
144493687|NCT00689104|521003153|FG002|Overall Study|Withdrawal by Subject|18|||
144493688|NCT00689104|521003154|FG003|Overall Study|Withdrawal by Subject|11|||
144493689|NCT00689104|521003151|FG000|Overall Study|Lost to Follow-up|4|||
144493690|NCT00689104|521003152|FG001|Overall Study|Lost to Follow-up|3|||
144493691|NCT00689104|521003153|FG002|Overall Study|Lost to Follow-up|2|||
144493692|NCT00689104|521003154|FG003|Overall Study|Lost to Follow-up|5|||
144493693|NCT00689104|521003151|FG000|Overall Study|Protocol Violation|2|||
144493694|NCT00689104|521003152|FG001|Overall Study|Protocol Violation|3|||
144493695|NCT00689104|521003153|FG002|Overall Study|Protocol Violation|5|||
144493696|NCT00689104|521003154|FG003|Overall Study|Protocol Violation|3|||
144493697|NCT00689104|521003151|FG000|Overall Study|Randomized but never received study drug|2|||
144493698|NCT00689104|521003152|FG001|Overall Study|Randomized but never received study drug|1|||
144493699|NCT00689104|521003153|FG002|Overall Study|Randomized but never received study drug|1|||
144493700|NCT00689104|521003154|FG003|Overall Study|Randomized but never received study drug|0|||
144493701|NCT00689104|521003151|FG000|Overall Study|Physician Decision|1|||
144493702|NCT00689104|521003152|FG001|Overall Study|Physician Decision|0|||
144493703|NCT00689104|521003153|FG002|Overall Study|Physician Decision|0|||
144493704|NCT00689104|521003154|FG003|Overall Study|Physician Decision|0|||
144493705|NCT00689104|521003151|FG000|Overall Study|Non-compliance with study procedures|0|||
144493706|NCT00689104|521003152|FG001|Overall Study|Non-compliance with study procedures|0|||
144493707|NCT00689104|521003153|FG002|Overall Study|Non-compliance with study procedures|1|||
144493708|NCT00689104|521003154|FG003|Overall Study|Non-compliance with study procedures|0|||
144493709|NCT04873817|521003155|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
144493710|NCT04873817|521003155|FG000|Overall Study|Lost to Follow-up|4|||
144493711|NCT04873817|521003155|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
144718789|NCT01952574|521823910|FG006|Open-label Treatment Phase|Missing|0|||
144718790|NCT01952574|521823904|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
144718791|NCT01952574|521823905|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
144718792|NCT01952574|521823906|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
144718793|NCT01952574|521823907|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
144718794|NCT01952574|521823908|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
144718795|NCT01952574|521823909|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
144718796|NCT01952574|521823910|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
144718797|NCT01952574|521823904|FG000|Open-label Treatment Phase|Death|0|||
144718798|NCT01952574|521823905|FG001|Open-label Treatment Phase|Death|0|||
144718799|NCT01952574|521823906|FG002|Open-label Treatment Phase|Death|0|||
144718800|NCT01952574|521823907|FG003|Open-label Treatment Phase|Death|0|||
144718801|NCT01952574|521823908|FG004|Open-label Treatment Phase|Death|1|||
144718802|NCT01952574|521823909|FG005|Open-label Treatment Phase|Death|0|||
144718803|NCT01952574|521823910|FG006|Open-label Treatment Phase|Death|0|||
144718804|NCT01952574|521823904|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
144718805|NCT01952574|521823905|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
144718806|NCT01952574|521823906|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
144718807|NCT01952574|521823907|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
144718808|NCT01952574|521823908|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
144718809|NCT01952574|521823909|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
144718810|NCT01952574|521823910|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
144718811|NCT01952574|521823904|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
144718812|NCT01952574|521823905|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
144718813|NCT01952574|521823906|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
144718814|NCT01952574|521823907|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
144718815|NCT01952574|521823908|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
144718816|NCT01952574|521823909|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
144718817|NCT01952574|521823910|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
144718818|NCT01107535|521823911|FG000|Overall Study|Death|5|||
144718819|NCT05085964|521823912|FG000|Overall Study|Premature termination of study|21|||
144718820|NCT05085964|521823913|FG001|Overall Study|Premature termination of study|0|||
144718821|NCT03156270|521823918|FG000|Overall Study|Failed pre-treatment screening|1|||
144718822|NCT03156270|521823918|FG000|Overall Study|Lost to Follow-up|1|||
144718823|NCT00446654|521823919|FG000|Overall Study|Withdrawal by Subject|1|||
144718824|NCT00446654|521823920|FG001|Overall Study|Withdrawal by Subject|0|||
144718825|NCT00446654|521823919|FG000|Overall Study|Adverse Event|1|||
144718826|NCT00446654|521823920|FG001|Overall Study|Adverse Event|0|||
144718827|NCT02087059|521823922|FG000|Overall Study|Disease Progression|1|||
144718828|NCT02087059|521823922|FG000|Overall Study|Adverse Event|5|||
144718829|NCT02087059|521823922|FG000|Overall Study|Lost to Follow-up|1|||
144718830|NCT00593333|521823923|FG000|Overall Study|Lost to Follow-up|10|||
144718831|NCT00593333|521823924|FG001|Overall Study|Lost to Follow-up|11|||
144718832|NCT01261325|521823925|FG000|Overall Study|Lack of Efficacy|1|||
144718833|NCT01261325|521823926|FG001|Overall Study|Lack of Efficacy|1|||
144718834|NCT01261325|521823927|FG002|Overall Study|Lack of Efficacy|0|||
144718835|NCT01261325|521823925|FG000|Overall Study|Withdrawal by Subject|2|||
144718836|NCT01261325|521823926|FG001|Overall Study|Withdrawal by Subject|2|||
144718837|NCT01261325|521823927|FG002|Overall Study|Withdrawal by Subject|4|||
144718838|NCT01261325|521823925|FG000|Overall Study|SAE, non-fatal|1|||
144718839|NCT01261325|521823926|FG001|Overall Study|SAE, non-fatal|5|||
144718840|NCT01261325|521823927|FG002|Overall Study|SAE, non-fatal|1|||
144718841|NCT01261325|521823925|FG000|Overall Study|AE, non-serious non-fatal|9|||
144718842|NCT01261325|521823926|FG001|Overall Study|AE, non-serious non-fatal|15|||
144718843|NCT01261325|521823927|FG002|Overall Study|AE, non-serious non-fatal|13|||
144718844|NCT01261325|521823925|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
144718845|NCT01261325|521823926|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144718846|NCT01261325|521823927|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144718847|NCT01261325|521823925|FG000|Overall Study|Non Compliance|2|||
144718848|NCT01261325|521823926|FG001|Overall Study|Non Compliance|0|||
144718849|NCT01261325|521823927|FG002|Overall Study|Non Compliance|0|||
144718850|NCT01261325|521823925|FG000|Overall Study|Patient Randomized by Mistake|0|||
144718851|NCT01261325|521823926|FG001|Overall Study|Patient Randomized by Mistake|1|||
144718852|NCT01261325|521823927|FG002|Overall Study|Patient Randomized by Mistake|0|||
144718853|NCT01261325|521823925|FG000|Overall Study|Erroneously Randomized|1|||
144718854|NCT01261325|521823926|FG001|Overall Study|Erroneously Randomized|0|||
144718855|NCT01261325|521823927|FG002|Overall Study|Erroneously Randomized|0|||
144718856|NCT01261325|521823925|FG000|Overall Study|Screen Failure|1|||
144718857|NCT01261325|521823926|FG001|Overall Study|Screen Failure|0|||
144718858|NCT01261325|521823927|FG002|Overall Study|Screen Failure|0|||
144718859|NCT01261325|521823925|FG000|Overall Study|Randomized in Error|0|||
144718860|NCT01261325|521823926|FG001|Overall Study|Randomized in Error|0|||
144718861|NCT01261325|521823927|FG002|Overall Study|Randomized in Error|1|||
144718862|NCT01261325|521823925|FG000|Overall Study|Protocol Violation|0|||
144718863|NCT01261325|521823926|FG001|Overall Study|Protocol Violation|3|||
144493712|NCT04873817|521003155|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
144493713|NCT04873817|521003155|FG000|Overall Study|Other Reasons|3|||
144493714|NCT00924560|521003159|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
144718864|NCT01261325|521823927|FG002|Overall Study|Protocol Violation|1|||
144718865|NCT01261325|521823925|FG000|Overall Study|Lost to Follow-up|0|||
144718866|NCT01261325|521823926|FG001|Overall Study|Lost to Follow-up|1|||
144718867|NCT01261325|521823927|FG002|Overall Study|Lost to Follow-up|3|||
144718868|NCT01261325|521823925|FG000|Overall Study|AE, serious fatal|0|||
144718869|NCT01261325|521823926|FG001|Overall Study|AE, serious fatal|0|||
144718870|NCT01261325|521823927|FG002|Overall Study|AE, serious fatal|2|||
144718871|NCT02330081|521823936|FG000|Overall Study|Adverse Event|1|||
144718872|NCT02330081|521823936|FG000|Overall Study|Donation did not meet criteria|1|||
144718873|NCT02330081|521823936|FG000|Overall Study|Protocol Violation|6|||
144718874|NCT02668302|521823944|FG000|Overall Study|Withdrawal by Subject|1|||
144718875|NCT02668302|521823945|FG001|Overall Study|Withdrawal by Subject|0|||
144718876|NCT03775681|521823946|FG000|Overall Study|Physician Decision|3|||
144718877|NCT00616928|521823947|FG000|Overall Study|Adverse Event|6|||
144718878|NCT00616928|521823948|FG001|Overall Study|Adverse Event|3|||
144718879|NCT00616928|521823949|FG002|Overall Study|Adverse Event|2|||
144718880|NCT00616928|521823950|FG003|Overall Study|Adverse Event|2|||
144718881|NCT00616928|521823947|FG000|Overall Study|Other|51|||
144718882|NCT00616928|521823948|FG001|Overall Study|Other|8|||
144718883|NCT00616928|521823949|FG002|Overall Study|Other|15|||
144718884|NCT00616928|521823950|FG003|Overall Study|Other|5|||
144718885|NCT00616928|521823947|FG000|Overall Study|Lost to Follow-up|5|||
144718886|NCT00616928|521823948|FG001|Overall Study|Lost to Follow-up|7|||
144718887|NCT00616928|521823949|FG002|Overall Study|Lost to Follow-up|0|||
144718888|NCT00616928|521823950|FG003|Overall Study|Lost to Follow-up|0|||
144718889|NCT00895583|521823951|FG000|Overall Study|Adverse Event|28|||
144718890|NCT00895583|521823952|FG001|Overall Study|Adverse Event|4|||
144718891|NCT00895583|521823951|FG000|Overall Study|Death|2|||
144718892|NCT00895583|521823952|FG001|Overall Study|Death|1|||
144718893|NCT00895583|521823951|FG000|Overall Study|Physician Decision|3|||
144718894|NCT00895583|521823952|FG001|Overall Study|Physician Decision|1|||
144718895|NCT00895583|521823951|FG000|Overall Study|Lost to Follow-up|1|||
144718896|NCT00895583|521823952|FG001|Overall Study|Lost to Follow-up|3|||
144718897|NCT00895583|521823951|FG000|Overall Study|Protocol Violation|1|||
144718898|NCT00895583|521823952|FG001|Overall Study|Protocol Violation|0|||
144718899|NCT00895583|521823951|FG000|Overall Study|Withdrawal by Subject|4|||
144718900|NCT00895583|521823952|FG001|Overall Study|Withdrawal by Subject|2|||
144718901|NCT00895583|521823951|FG000|Overall Study|Lack of Efficacy|5|||
144718902|NCT00895583|521823952|FG001|Overall Study|Lack of Efficacy|0|||
144718903|NCT00895583|521823951|FG000|Overall Study|Other|0|||
144718904|NCT00895583|521823952|FG001|Overall Study|Other|1|||
144718905|NCT03529955|521823953|FG000|Overall Study|Adverse Event|1|||
144718906|NCT03529955|521823953|FG000|Overall Study|Lack of Efficacy|1|||
144718907|NCT02034799|521825738|FG000|Overall Study|Withdrawal by Subject|0|||
144718908|NCT02034799|521825739|FG001|Overall Study|Withdrawal by Subject|2|||
144718909|NCT02034799|521825738|FG000|Overall Study|Lost to Follow-up|0|||
144718910|NCT02034799|521825739|FG001|Overall Study|Lost to Follow-up|1|||
144718911|NCT02034799|521825738|FG000|Overall Study|Death|2|||
144718912|NCT02034799|521825739|FG001|Overall Study|Death|1|||
144718913|NCT00633152|521825748|FG000|Overall Study|Adverse Event|1|||
144718914|NCT00633152|521825749|FG001|Overall Study|Adverse Event|0|||
144718915|NCT00633152|521825748|FG000|Overall Study|Randomized, did not receive study drug|5|||
144718916|NCT00633152|521825749|FG001|Overall Study|Randomized, did not receive study drug|2|||
144718917|NCT00633152|521825748|FG000|Overall Study|Withdrawal by Subject|1|||
144718918|NCT00633152|521825749|FG001|Overall Study|Withdrawal by Subject|1|||
144718919|NCT00633152|521825748|FG000|Overall Study|Lost to Follow-up|4|||
144718920|NCT00633152|521825749|FG001|Overall Study|Lost to Follow-up|1|||
144718921|NCT00633152|521825748|FG000|Overall Study|Miscellaneous Other|3|||
144718922|NCT00633152|521825749|FG001|Overall Study|Miscellaneous Other|2|||
144718923|NCT03273387|521825751|FG000|Overall Study|Death|2|||
144718924|NCT03273387|521825752|FG001|Overall Study|Death|2|||
144718925|NCT03273387|521825751|FG000|Overall Study|Withdrawal by Subject|1|||
144718926|NCT03273387|521825752|FG001|Overall Study|Withdrawal by Subject|1|||
144493715|NCT00924560|521003160|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
144718927|NCT05216978|521825753|FG000|Overall Study|Withdrawal by Subject|3|||
144718928|NCT05216978|521825753|FG000|Overall Study|Lost to Follow-up|5|||
144718929|NCT00658320|521825755|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
144718930|NCT00658320|521825756|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
144718931|NCT00658320|521825755|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
144718932|NCT00658320|521825756|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
144718933|NCT00658320|521825755|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
144718934|NCT00658320|521825756|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
144718935|NCT00658320|521825755|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
144718936|NCT00658320|521825756|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
144493716|NCT00924560|521003161|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
144493717|NCT00924560|521003159|FG000|Overall Study|Non Compliance with the Protocol|20|||
144493718|NCT00924560|521003160|FG001|Overall Study|Non Compliance with the Protocol|15|||
144493719|NCT00924560|521003161|FG002|Overall Study|Non Compliance with the Protocol|4|||
144493720|NCT00924560|521003159|FG000|Overall Study|Physician Decision|2|||
144493721|NCT00924560|521003160|FG001|Overall Study|Physician Decision|3|||
144493722|NCT00924560|521003161|FG002|Overall Study|Physician Decision|4|||
144493723|NCT00924560|521003159|FG000|Overall Study|Withdrawal by Subject|50|||
144493724|NCT00924560|521003160|FG001|Overall Study|Withdrawal by Subject|44|||
144493725|NCT00924560|521003161|FG002|Overall Study|Withdrawal by Subject|18|||
144493726|NCT00924560|521003159|FG000|Overall Study|Adverse Event|39|||
144493727|NCT00924560|521003160|FG001|Overall Study|Adverse Event|33|||
144493728|NCT00924560|521003161|FG002|Overall Study|Adverse Event|0|||
144493729|NCT00924560|521003159|FG000|Overall Study|Pregnancy|5|||
144493730|NCT00924560|521003160|FG001|Overall Study|Pregnancy|7|||
144493731|NCT00924560|521003161|FG002|Overall Study|Pregnancy|1|||
144493732|NCT00924560|521003159|FG000|Overall Study|Lost to Follow-up|78|||
144493733|NCT00924560|521003160|FG001|Overall Study|Lost to Follow-up|94|||
144493734|NCT00924560|521003161|FG002|Overall Study|Lost to Follow-up|45|||
144493735|NCT00924560|521003159|FG000|Overall Study|Miscellaneous Reasons|13|||
144493736|NCT00924560|521003160|FG001|Overall Study|Miscellaneous Reasons|10|||
144493737|NCT00924560|521003161|FG002|Overall Study|Miscellaneous Reasons|10|||
144493738|NCT00665561|521003166|FG000|Overall Study|Death recorded on subject summary pages|75|||
144493739|NCT00665561|521003167|FG001|Overall Study|Death recorded on subject summary pages|75|||
144493740|NCT00665561|521003166|FG000|Overall Study|Does not meet entrance criteria|19|||
144493741|NCT00665561|521003167|FG001|Overall Study|Does not meet entrance criteria|21|||
144493742|NCT00665561|521003166|FG000|Overall Study|Lost to Follow-up|203|||
144493743|NCT00665561|521003167|FG001|Overall Study|Lost to Follow-up|264|||
144493744|NCT00665561|521003166|FG000|Overall Study|Withdrawal by Subject|74|||
144493745|NCT00665561|521003167|FG001|Overall Study|Withdrawal by Subject|65|||
144493746|NCT00665561|521003166|FG000|Overall Study|Other|123|||
144493747|NCT00665561|521003167|FG001|Overall Study|Other|108|||
144493748|NCT00665561|521003166|FG000|Overall Study|Site closed|8|||
144493749|NCT00665561|521003167|FG001|Overall Study|Site closed|0|||
144493750|NCT00665561|521003166|FG000|Overall Study|Withdrawn due to pregnancy|0|||
144493751|NCT00665561|521003167|FG001|Overall Study|Withdrawn due to pregnancy|1|||
144493752|NCT01101542|521003168|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
144493753|NCT01101542|521003168|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
144493754|NCT01101542|521003168|FG000|Year 4 Surveillance Period|Other|287|||
144493755|NCT01101542|521003168|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
144493756|NCT01101542|521003168|FG000|Year 5 Surveillance Period|Pregnancy|1|||
144493757|NCT01101542|521003168|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
144493758|NCT01101542|521003168|FG000|Year 6 Surveillance Period|Pregnancy|1|||
144493759|NCT01101542|521003168|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
144493760|NCT00701311|521003169|FG000|Overall Study|Lack of Efficacy|3|||
144493761|NCT00701311|521003169|FG000|Overall Study|Adverse Event|3|||
144493762|NCT00701311|521003169|FG000|Overall Study|Withdrawal by Subject|2|||
144493763|NCT00231179|521004989|FG000|Overall Study|Lost to Follow-up|21|||
144493764|NCT00231179|521004990|FG001|Overall Study|Lost to Follow-up|21|||
144493765|NCT00231179|521004989|FG000|Overall Study|Withdrawal by Subject|3|||
144493766|NCT00231179|521004990|FG001|Overall Study|Withdrawal by Subject|3|||
144493767|NCT01345292|521004991|FG000|Overall Study|Withdrawal by Subject|2|||
144493768|NCT01345292|521004992|FG001|Overall Study|Withdrawal by Subject|0|||
144493769|NCT01345292|521004993|FG002|Overall Study|Withdrawal by Subject|1|||
144493770|NCT05406791|521004995|FG000|Overall Study|Lost to Follow-up|13|||
144493771|NCT05406791|521004996|FG001|Overall Study|Lost to Follow-up|10|||
144493772|NCT00515086|521004997|FG000|Overall Study|Adverse Event|1|||
144493773|NCT00515086|521004998|FG001|Overall Study|Adverse Event|1|||
144493774|NCT00515086|521004999|FG002|Overall Study|Adverse Event|2|||
144493775|NCT00515086|521005000|FG003|Overall Study|Adverse Event|3|||
144493776|NCT00515086|521004997|FG000|Overall Study|Administrative|1|||
144493777|NCT00515086|521004998|FG001|Overall Study|Administrative|1|||
144493778|NCT00515086|521004999|FG002|Overall Study|Administrative|0|||
144493779|NCT00515086|521005000|FG003|Overall Study|Administrative|0|||
144493780|NCT00515086|521004997|FG000|Overall Study|Withdrawal by Subject|1|||
144493781|NCT00515086|521004998|FG001|Overall Study|Withdrawal by Subject|0|||
144493782|NCT00515086|521004999|FG002|Overall Study|Withdrawal by Subject|0|||
144493783|NCT00515086|521005000|FG003|Overall Study|Withdrawal by Subject|1|||
144493784|NCT00515086|521004997|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
144493785|NCT00515086|521004998|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144493786|NCT00515086|521004999|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
144493787|NCT00515086|521005000|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
144493788|NCT00515086|521004997|FG000|Overall Study|Lost to Follow-up|1|||
144493789|NCT00515086|521004998|FG001|Overall Study|Lost to Follow-up|0|||
144493790|NCT00515086|521004999|FG002|Overall Study|Lost to Follow-up|0|||
144493791|NCT00515086|521005000|FG003|Overall Study|Lost to Follow-up|0|||
144493792|NCT00515086|521004997|FG000|Overall Study|Study drug no longer required|0|||
144493793|NCT00515086|521004998|FG001|Overall Study|Study drug no longer required|1|||
144493794|NCT00515086|521004999|FG002|Overall Study|Study drug no longer required|0|||
144493795|NCT00515086|521005000|FG003|Overall Study|Study drug no longer required|0|||
144493796|NCT00515086|521004997|FG000|Overall Study|Death|2|||
144493797|NCT00515086|521004998|FG001|Overall Study|Death|0|||
144493798|NCT00515086|521004999|FG002|Overall Study|Death|0|||
144493799|NCT00515086|521005000|FG003|Overall Study|Death|0|||
144493800|NCT02373813|521005001|FG000|Run-In Period|Other, Not Specified|5|||
144493801|NCT02373813|521005002|FG001|Run-In Period|Other, Not Specified|0|||
144493802|NCT02373813|521005003|FG002|Run-In Period|Other, Not Specified|0|||
144493803|NCT02373813|521005004|FG003|Run-In Period|Other, Not Specified|0|||
144493804|NCT02373813|521005001|FG000|Run-In Period|Withdrawal by Subject|16|||
144493805|NCT02373813|521005002|FG001|Run-In Period|Withdrawal by Subject|0|||
144493806|NCT02373813|521005003|FG002|Run-In Period|Withdrawal by Subject|0|||
144493807|NCT02373813|521005004|FG003|Run-In Period|Withdrawal by Subject|0|||
144493808|NCT02373813|521005001|FG000|Run-In Period|Decision by Sponsor|11|||
144493809|NCT02373813|521005002|FG001|Run-In Period|Decision by Sponsor|0|||
144493810|NCT02373813|521005003|FG002|Run-In Period|Decision by Sponsor|0|||
144493811|NCT02373813|521005004|FG003|Run-In Period|Decision by Sponsor|0|||
144493812|NCT02373813|521005001|FG000|Run-In Period|Protocol Violation|75|||
144493813|NCT02373813|521005002|FG001|Run-In Period|Protocol Violation|0|||
144493814|NCT02373813|521005003|FG002|Run-In Period|Protocol Violation|0|||
144493815|NCT02373813|521005004|FG003|Run-In Period|Protocol Violation|0|||
144493816|NCT02373813|521005001|FG000|Run-In Period|Lost to Follow-up|2|||
144493817|NCT02373813|521005002|FG001|Run-In Period|Lost to Follow-up|0|||
144493818|NCT02373813|521005003|FG002|Run-In Period|Lost to Follow-up|0|||
144493819|NCT02373813|521005004|FG003|Run-In Period|Lost to Follow-up|0|||
144493820|NCT02373813|521005001|FG000|Run-In Period|Adverse Event|3|||
144493821|NCT02373813|521005002|FG001|Run-In Period|Adverse Event|0|||
144493822|NCT02373813|521005003|FG002|Run-In Period|Adverse Event|0|||
144493823|NCT02373813|521005004|FG003|Run-In Period|Adverse Event|0|||
144493824|NCT02373813|521005001|FG000|Run-In Period|Noncompliance|1|||
144493825|NCT02373813|521005002|FG001|Run-In Period|Noncompliance|0|||
144493826|NCT02373813|521005003|FG002|Run-In Period|Noncompliance|0|||
144493827|NCT02373813|521005004|FG003|Run-In Period|Noncompliance|0|||
144493828|NCT02373813|521005001|FG000|Run-In Period|Ineligibility Determined|3|||
144493829|NCT02373813|521005002|FG001|Run-In Period|Ineligibility Determined|0|||
144493830|NCT02373813|521005003|FG002|Run-In Period|Ineligibility Determined|0|||
144493831|NCT02373813|521005004|FG003|Run-In Period|Ineligibility Determined|0|||
144493832|NCT02373813|521005001|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
144493833|NCT02373813|521005002|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
144493834|NCT02373813|521005003|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
144493835|NCT02373813|521005004|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
144493836|NCT02373813|521005001|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
144493837|NCT02373813|521005002|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
144493838|NCT02373813|521005003|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
144493839|NCT02373813|521005004|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
144493840|NCT02373813|521005001|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144493841|NCT02373813|521005002|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
144493842|NCT02373813|521005003|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
144493843|NCT02373813|521005004|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
144493844|NCT02373813|521005001|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144493845|NCT02373813|521005002|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
144493846|NCT02373813|521005003|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
144493847|NCT02373813|521005004|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
144493848|NCT01764386|521005007|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
144493849|NCT01764386|521005008|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
144493850|NCT01764386|521005007|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
144493851|NCT01764386|521005008|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
144493852|NCT01764386|521005007|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
144493853|NCT01764386|521005008|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
144493854|NCT01764386|521005007|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
144493855|NCT01764386|521005008|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
144493856|NCT01764386|521005007|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
144493857|NCT01764386|521005008|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
144493858|NCT01764386|521005007|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
144493859|NCT01764386|521005008|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
144493860|NCT01764386|521005007|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
144493861|NCT01764386|521005008|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
144493862|NCT01764386|521005007|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
144493863|NCT01764386|521005008|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
144493864|NCT04454567|521005009|FG000|Overall Study|Study Terminated by Sponsor|1|||
144493865|NCT04454567|521005010|FG001|Overall Study|Study Terminated by Sponsor|1|||
144493866|NCT01123161|521005011|FG000|Overall Study|Lost to Follow-up|1|||
144493867|NCT01123161|521005012|FG001|Overall Study|Lost to Follow-up|0|||
144493868|NCT01123161|521005011|FG000|Overall Study|Withdrawal by Subject|1|||
144493869|NCT01123161|521005012|FG001|Overall Study|Withdrawal by Subject|0|||
144493870|NCT03239210|521005014|FG000|Overall Study|Lost to Follow-up|2|||
144493871|NCT03239210|521005015|FG001|Overall Study|Lost to Follow-up|2|||
144493872|NCT03239210|521005014|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
144493873|NCT03239210|521005015|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
144493874|NCT03239210|521005014|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
144493875|NCT03239210|521005015|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
144493876|NCT01403987|521005016|FG000|Overall Study|Residents forgot their secret PIN|18|||
144493877|NCT01403987|521005017|FG001|Overall Study|Residents forgot their secret PIN|17|||
144493878|NCT01403987|521005018|FG002|Overall Study|Residents forgot their secret PIN|18|||
144493879|NCT01094743|521005019|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
144493880|NCT02851511|521005020|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
144493881|NCT02851511|521005021|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
144493882|NCT02851511|521005022|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
144493883|NCT02851511|521005023|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
144493884|NCT02851511|521005020|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
144493885|NCT02851511|521005021|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
144493886|NCT02851511|521005022|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
144493887|NCT02851511|521005023|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
144493888|NCT02851511|521005020|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
144493889|NCT02851511|521005021|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
144493890|NCT02851511|521005022|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
144493891|NCT02851511|521005023|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
144493892|NCT02851511|521005020|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
144493893|NCT02851511|521005021|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
144493894|NCT02851511|521005022|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
144493895|NCT02851511|521005023|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
144493896|NCT02851511|521005020|FG000|Phase I|Physician Decision|0|||
144493897|NCT02851511|521005021|FG001|Phase I|Physician Decision|0|||
144493898|NCT02851511|521005022|FG002|Phase I|Physician Decision|0|||
144493899|NCT02851511|521005023|FG003|Phase I|Physician Decision|1|||
144493900|NCT02851511|521005020|FG000|Phase I|Withdrawal by Subject|2|||
144493901|NCT02851511|521005021|FG001|Phase I|Withdrawal by Subject|1|||
144493902|NCT02851511|521005022|FG002|Phase I|Withdrawal by Subject|0|||
144493903|NCT02851511|521005023|FG003|Phase I|Withdrawal by Subject|3|||
144493904|NCT02851511|521005020|FG000|Phase II|Physician Decision|18|||
144493905|NCT02851511|521005021|FG001|Phase II|Physician Decision|16|||
144493906|NCT02851511|521005022|FG002|Phase II|Physician Decision|0|||
144493907|NCT02851511|521005023|FG003|Phase II|Physician Decision|0|||
144493908|NCT02851511|521005020|FG000|Phase II|Withdrawal by Subject|18|||
144493909|NCT02851511|521005021|FG001|Phase II|Withdrawal by Subject|16|||
144493910|NCT02851511|521005022|FG002|Phase II|Withdrawal by Subject|0|||
144493911|NCT02851511|521005023|FG003|Phase II|Withdrawal by Subject|0|||
144493912|NCT02851511|521005020|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
144493913|NCT02851511|521005021|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
144718937|NCT02410252|521825760|FG000|Overall Study|Withdrawal by Subject|4|||
144718938|NCT02410252|521825760|FG000|Overall Study|Physician Decision|2|||
144718939|NCT03433001|521825772|FG000|Overall Study|Lack of Efficacy|109|||
144718940|NCT03433001|521825772|FG000|Overall Study|Adverse Event|69|||
144718941|NCT03433001|521825772|FG000|Overall Study|Withdrawal by Subject|10|||
144718942|NCT03433001|521825772|FG000|Overall Study|Death|12|||
144718943|NCT03433001|521825772|FG000|Overall Study|Lost to Follow-up|4|||
144718944|NCT03433001|521825772|FG000|Overall Study|Other|25|||
144718945|NCT01007916|521825773|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
144718946|NCT01007916|521825774|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
144718947|NCT01007916|521825773|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
144718948|NCT01007916|521825774|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
144718949|NCT02961920|521825780|FG000|Overall Study|did not achive stydy protocol schedule|1|||
144718950|NCT02961920|521825781|FG001|Overall Study|did not achive stydy protocol schedule|1|||
144493914|NCT02851511|521005022|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
144493915|NCT02851511|521005023|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
144493916|NCT02851511|521005020|FG000|Phase II|Lost to Follow-up|0|||
144493917|NCT02851511|521005021|FG001|Phase II|Lost to Follow-up|1|||
144493918|NCT02851511|521005022|FG002|Phase II|Lost to Follow-up|0|||
144493919|NCT02851511|521005023|FG003|Phase II|Lost to Follow-up|0|||
144493920|NCT00303303|521005024|FG000|Overall Study|Withdrawal by Subject|0|||
144493921|NCT00303303|521005025|FG001|Overall Study|Withdrawal by Subject|0|||
144493922|NCT00303303|521005026|FG002|Overall Study|Withdrawal by Subject|1|||
144493923|NCT03255941|521005028|FG000|Overall Study|Not eligible or refused injection|37|||
144493924|NCT03255941|521005029|FG001|Overall Study|Not eligible or refused injection|44|||
144493925|NCT03255941|521005030|FG002|Overall Study|Not eligible or refused injection|5|||
144493926|NCT03255941|521005031|FG003|Overall Study|Not eligible or refused injection|6|||
144493927|NCT03255941|521005028|FG000|Overall Study|Did not complete exit interview|1|||
144493928|NCT03255941|521005029|FG001|Overall Study|Did not complete exit interview|2|||
144493929|NCT03255941|521005030|FG002|Overall Study|Did not complete exit interview|0|||
144493930|NCT03255941|521005031|FG003|Overall Study|Did not complete exit interview|0|||
144493931|NCT01004263|521005032|FG000|Overall Study|Adverse Event|15|||
144493932|NCT01004263|521005032|FG000|Overall Study|Withdrawal by Subject|58|||
144493933|NCT01004263|521005032|FG000|Overall Study|Protocol Violation|10|||
144493934|NCT01004263|521005032|FG000|Overall Study|Lost to Follow-up|64|||
144493935|NCT01004263|521005032|FG000|Overall Study|Lack of Efficacy|13|||
144493936|NCT01004263|521005032|FG000|Overall Study|Pregnancy|2|||
144493937|NCT01004263|521005032|FG000|Overall Study|Physician Decision|15|||
144493938|NCT01004263|521005032|FG000|Overall Study|Lack of Qualifying Event|2|||
144493939|NCT00372528|521005033|FG000|Overall Study|Lack of Efficacy|1|||
144493940|NCT00372528|521005033|FG000|Overall Study|Adverse Event|1|||
144493941|NCT00372528|521005033|FG000|Overall Study|Study Terminated by Sponsor|18|||
144493942|NCT00372528|521005033|FG000|Overall Study|Other|1|||
144493943|NCT05124899|521005034|FG000|Overall Study|Lost to Follow-up|3|||
144493944|NCT03432533|521005035|FG000|Overall Study|Lost to Follow-up|1|||
144493945|NCT03432533|521005036|FG001|Overall Study|Lost to Follow-up|2|||
144493946|NCT03432533|521005035|FG000|Overall Study|Withdrawal by Subject|14|||
144493947|NCT03432533|521005036|FG001|Overall Study|Withdrawal by Subject|9|||
144493948|NCT00797225|521005039|FG000|Weeks 1 to 12|Adverse Event|0|||
144493949|NCT00797225|521005040|FG001|Weeks 1 to 12|Adverse Event|0|||
144493950|NCT00797225|521005041|FG002|Weeks 1 to 12|Adverse Event|1|||
144493951|NCT00797225|521005042|FG003|Weeks 1 to 12|Adverse Event|0|||
144493952|NCT00797225|521005043|FG004|Weeks 1 to 12|Adverse Event|0|||
144493953|NCT00797225|521005044|FG005|Weeks 1 to 12|Adverse Event|0|||
144493954|NCT00797225|521005045|FG006|Weeks 1 to 12|Adverse Event|0|||
144493955|NCT00797225|521005046|FG007|Weeks 1 to 12|Adverse Event|0|||
144493956|NCT00797225|521005039|FG000|Weeks 1 to 12|Non-compliance|0|||
144493957|NCT00797225|521005040|FG001|Weeks 1 to 12|Non-compliance|1|||
144493958|NCT00797225|521005041|FG002|Weeks 1 to 12|Non-compliance|0|||
144493959|NCT00797225|521005042|FG003|Weeks 1 to 12|Non-compliance|0|||
144493960|NCT00797225|521005043|FG004|Weeks 1 to 12|Non-compliance|0|||
144493961|NCT00797225|521005044|FG005|Weeks 1 to 12|Non-compliance|0|||
144493962|NCT00797225|521005045|FG006|Weeks 1 to 12|Non-compliance|0|||
144493963|NCT00797225|521005046|FG007|Weeks 1 to 12|Non-compliance|0|||
144493964|NCT00797225|521005039|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
144493965|NCT00797225|521005040|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
144493966|NCT00797225|521005041|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
144493967|NCT00797225|521005042|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
144493968|NCT00797225|521005043|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
144493969|NCT00797225|521005044|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
144493970|NCT00797225|521005045|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
144493971|NCT00797225|521005046|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
144493972|NCT00797225|521005039|FG000|Weeks 1 to 12|Sponsor Decision|1|||
144493973|NCT00797225|521005040|FG001|Weeks 1 to 12|Sponsor Decision|0|||
144493974|NCT00797225|521005041|FG002|Weeks 1 to 12|Sponsor Decision|0|||
144493975|NCT00797225|521005042|FG003|Weeks 1 to 12|Sponsor Decision|0|||
144493976|NCT00797225|521005043|FG004|Weeks 1 to 12|Sponsor Decision|0|||
144493977|NCT00797225|521005044|FG005|Weeks 1 to 12|Sponsor Decision|0|||
144493978|NCT00797225|521005045|FG006|Weeks 1 to 12|Sponsor Decision|0|||
144493979|NCT00797225|521005046|FG007|Weeks 1 to 12|Sponsor Decision|0|||
144493980|NCT00797225|521005039|FG000|Weeks 13 to 24|Non-compliance|0|||
144493981|NCT00797225|521005040|FG001|Weeks 13 to 24|Non-compliance|2|||
144493982|NCT00797225|521005041|FG002|Weeks 13 to 24|Non-compliance|0|||
144493983|NCT00797225|521005042|FG003|Weeks 13 to 24|Non-compliance|0|||
144493984|NCT00797225|521005043|FG004|Weeks 13 to 24|Non-compliance|0|||
144493985|NCT00797225|521005044|FG005|Weeks 13 to 24|Non-compliance|0|||
144493986|NCT00797225|521005045|FG006|Weeks 13 to 24|Non-compliance|0|||
144493987|NCT00797225|521005046|FG007|Weeks 13 to 24|Non-compliance|0|||
144493988|NCT00797225|521005039|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
144493989|NCT00797225|521005040|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
144493990|NCT00797225|521005041|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
144493991|NCT00797225|521005042|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
144493992|NCT00797225|521005043|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
144493993|NCT00797225|521005044|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
144493994|NCT00797225|521005045|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
144493995|NCT00797225|521005046|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
144493996|NCT00797225|521005039|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
144493997|NCT00797225|521005040|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
144493998|NCT00797225|521005041|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
144493999|NCT00797225|521005042|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
144494000|NCT00797225|521005043|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
144494001|NCT00797225|521005044|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
144494002|NCT00797225|521005045|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
144494003|NCT00797225|521005046|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
144494004|NCT00797225|521005039|FG000|Weeks 13 to 24|Adverse Event|0|||
144494005|NCT00797225|521005040|FG001|Weeks 13 to 24|Adverse Event|1|||
144494006|NCT00797225|521005041|FG002|Weeks 13 to 24|Adverse Event|0|||
144494007|NCT00797225|521005042|FG003|Weeks 13 to 24|Adverse Event|0|||
144494008|NCT00797225|521005043|FG004|Weeks 13 to 24|Adverse Event|0|||
144494009|NCT00797225|521005044|FG005|Weeks 13 to 24|Adverse Event|0|||
144494010|NCT00797225|521005045|FG006|Weeks 13 to 24|Adverse Event|1|||
144494011|NCT00797225|521005046|FG007|Weeks 13 to 24|Adverse Event|0|||
144494012|NCT00797225|521005039|FG000|Weeks 13 to 24|Sponsor Decision|0|||
144494013|NCT00797225|521005040|FG001|Weeks 13 to 24|Sponsor Decision|0|||
144494014|NCT00797225|521005041|FG002|Weeks 13 to 24|Sponsor Decision|0|||
144494015|NCT00797225|521005042|FG003|Weeks 13 to 24|Sponsor Decision|0|||
144494016|NCT00797225|521005043|FG004|Weeks 13 to 24|Sponsor Decision|0|||
144494017|NCT00797225|521005044|FG005|Weeks 13 to 24|Sponsor Decision|0|||
144494018|NCT00797225|521005045|FG006|Weeks 13 to 24|Sponsor Decision|1|||
144494019|NCT00797225|521005046|FG007|Weeks 13 to 24|Sponsor Decision|0|||
144494020|NCT00578227|521005047|FG000|Overall Study|Lost to Follow-up|0|||
144494021|NCT00578227|521005048|FG001|Overall Study|Lost to Follow-up|1|||
144494022|NCT00578227|521005049|FG002|Overall Study|Lost to Follow-up|1|||
144494023|NCT00578227|521005047|FG000|Overall Study|Withdrawal by Subject|5|||
144494024|NCT00578227|521005048|FG001|Overall Study|Withdrawal by Subject|1|||
144494025|NCT00578227|521005049|FG002|Overall Study|Withdrawal by Subject|3|||
144494026|NCT02929108|521005055|FG000|Overall Study|Hospice patient death|100|||
144494027|NCT02929108|521005056|FG001|Overall Study|Hospice patient death|64|||
144494028|NCT02929108|521005057|FG002|Overall Study|Hospice patient death|28|||
144494029|NCT02929108|521005058|FG003|Overall Study|Hospice patient death|46|||
144494030|NCT02929108|521005059|FG004|Overall Study|Hospice patient death|55|||
144494031|NCT02929108|521005060|FG005|Overall Study|Hospice patient death|28|||
144494032|NCT02929108|521005061|FG006|Overall Study|Hospice patient death|78|||
144494033|NCT00052962|521005062|FG000|Overall Study|Not evaluable|0|||
144494034|NCT00052962|521005063|FG001|Overall Study|Not evaluable|2|||
144494035|NCT00052962|521005062|FG000|Overall Study|Not randomized/not evaluable|1|||
144494036|NCT00052962|521005063|FG001|Overall Study|Not randomized/not evaluable|0|||
144494037|NCT02084082|521005065|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
144494038|NCT02084082|521005066|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
144494039|NCT02084082|521005067|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
144494040|NCT02084082|521005068|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
144494041|NCT02084082|521005065|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
144494042|NCT02084082|521005066|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
144494043|NCT02084082|521005067|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
144494044|NCT02084082|521005068|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
144494045|NCT01767909|521005071|FG000|Overall Study|Withdrawal by Subject|4|||
144494046|NCT01767909|521005072|FG001|Overall Study|Withdrawal by Subject|7|||
144494047|NCT01767909|521005071|FG000|Overall Study|Adverse Event|3|||
144494048|NCT01767909|521005072|FG001|Overall Study|Adverse Event|1|||
144494049|NCT01767909|521005071|FG000|Overall Study|Withdrawal by Study Partner|3|||
144494050|NCT01767909|521005072|FG001|Overall Study|Withdrawal by Study Partner|1|||
144494051|NCT01767909|521005071|FG000|Overall Study|Non-Compliance|2|||
144494052|NCT01767909|521005072|FG001|Overall Study|Non-Compliance|0|||
144494053|NCT01767909|521005071|FG000|Overall Study|Perceived Lack of Efficacy|1|||
144494054|NCT01767909|521005072|FG001|Overall Study|Perceived Lack of Efficacy|0|||
144494055|NCT01767909|521005071|FG000|Overall Study|Investigator Recommendation|0|||
144494056|NCT01767909|521005072|FG001|Overall Study|Investigator Recommendation|1|||
144494057|NCT01767909|521005071|FG000|Overall Study|Lost to Follow-up|0|||
144494058|NCT01767909|521005072|FG001|Overall Study|Lost to Follow-up|1|||
144494059|NCT01767909|521005071|FG000|Overall Study|LP uncessessful|0|||
144494060|NCT01767909|521005072|FG001|Overall Study|LP uncessessful|1|||
144494061|NCT01723774|521005073|FG000|Neoadjuvant|Ki67 > 10%|4|||
144494062|NCT01723774|521005074|FG001|Neoadjuvant|Ki67 > 10%|0|||
144494063|NCT01723774|521005075|FG002|Neoadjuvant|Ki67 > 10%|10|||
144494064|NCT01723774|521005076|FG003|Neoadjuvant|Ki67 > 10%|0|||
144494065|NCT01723774|521005073|FG000|Neoadjuvant|Withdrawal by Subject|3|||
144494066|NCT01723774|521005074|FG001|Neoadjuvant|Withdrawal by Subject|1|||
144494067|NCT01723774|521005075|FG002|Neoadjuvant|Withdrawal by Subject|0|||
144494068|NCT01723774|521005076|FG003|Neoadjuvant|Withdrawal by Subject|0|||
144494069|NCT01723774|521005073|FG000|Neoadjuvant|Disease progression|0|||
144494070|NCT01723774|521005074|FG001|Neoadjuvant|Disease progression|1|||
144494071|NCT01723774|521005075|FG002|Neoadjuvant|Disease progression|1|||
144494072|NCT01723774|521005076|FG003|Neoadjuvant|Disease progression|0|||
144494073|NCT01723774|521005073|FG000|Neoadjuvant|Adverse Event|0|||
144494074|NCT01723774|521005074|FG001|Neoadjuvant|Adverse Event|1|||
144494075|NCT01723774|521005075|FG002|Neoadjuvant|Adverse Event|2|||
144494076|NCT01723774|521005076|FG003|Neoadjuvant|Adverse Event|0|||
144494077|NCT01723774|521005073|FG000|Neoadjuvant|High estradiol|0|||
144494078|NCT01723774|521005074|FG001|Neoadjuvant|High estradiol|1|||
144494079|NCT01723774|521005075|FG002|Neoadjuvant|High estradiol|0|||
144494080|NCT01723774|521005076|FG003|Neoadjuvant|High estradiol|0|||
144494081|NCT04956692|521005084|FG000|Overall Study|Death|115|||
144494082|NCT04956692|521005085|FG001|Overall Study|Death|47|||
144494083|NCT04956692|521005084|FG000|Overall Study|Lost to Follow-up|0|||
144494084|NCT04956692|521005085|FG001|Overall Study|Lost to Follow-up|1|||
144494085|NCT04956692|521005084|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144494086|NCT04956692|521005085|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144494087|NCT04956692|521005084|FG000|Overall Study|Withdrawal by Subject|5|||
144494088|NCT04956692|521005085|FG001|Overall Study|Withdrawal by Subject|2|||
144494089|NCT04956692|521005084|FG000|Overall Study|Ongoing in Study|236|||
144494090|NCT04956692|521005085|FG001|Overall Study|Ongoing in Study|123|||
144494091|NCT04639947|521005086|FG000|Overall Study|Screen fail|1|||
144494092|NCT03285711|521005089|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
144494093|NCT03285711|521005090|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
144494094|NCT03285711|521005091|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
144494095|NCT03285711|521005092|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
144494096|NCT03285711|521005089|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
144494097|NCT03285711|521005090|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
144494098|NCT03285711|521005091|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
144494099|NCT03285711|521005092|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
144494100|NCT03285711|521005089|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
144494101|NCT03285711|521005090|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
144494102|NCT03285711|521005091|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
144494103|NCT03285711|521005092|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
144494104|NCT03285711|521005089|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
144494105|NCT03285711|521005090|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
144494106|NCT03285711|521005091|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
144494107|NCT03285711|521005092|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
144494108|NCT02431533|521005096|FG000|Overall Study|Withdrawal by Subject|1|||
144494109|NCT02431533|521005097|FG001|Overall Study|Withdrawal by Subject|3|||
144494110|NCT02431533|521005096|FG000|Overall Study|Developed Exclusionary criteria|1|||
144494111|NCT02431533|521005097|FG001|Overall Study|Developed Exclusionary criteria|0|||
144494112|NCT00235495|521005100|FG000|Overall Study|Death|52|||
144494113|NCT00235495|521005101|FG001|Overall Study|Death|42|||
144494114|NCT00235495|521005100|FG000|Overall Study|Withdrawal by Subject|5|||
144494115|NCT00235495|521005101|FG001|Overall Study|Withdrawal by Subject|3|||
144494116|NCT00235495|521005100|FG000|Overall Study|Lost to Follow-up|11|||
144494117|NCT00235495|521005101|FG001|Overall Study|Lost to Follow-up|13|||
144494118|NCT00235495|521005100|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
144494119|NCT00235495|521005101|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
144494120|NCT02234310|521005102|FG000|Overall Study|Physician Decision|1|||
144494121|NCT02234310|521005102|FG000|Overall Study|Adverse Event|1|||
144494122|NCT02234310|521005102|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
144494123|NCT02234310|521005102|FG000|Overall Study|Withdrawal by Subject|2|||
144494124|NCT03251378|521005105|FG000|Overall Study|Death|3|||
144494125|NCT03251378|521005106|FG001|Overall Study|Death|2|||
144494126|NCT03251378|521005107|FG002|Overall Study|Death|3|||
144494127|NCT03251378|521005108|FG003|Overall Study|Death|30|||
144494128|NCT03251378|521005109|FG004|Overall Study|Death|24|||
144494129|NCT03251378|521005110|FG005|Overall Study|Death|12|||
144494130|NCT03251378|521005111|FG006|Overall Study|Death|12|||
144494131|NCT03251378|521005105|FG000|Overall Study|Lost to Follow-up|0|||
144494132|NCT03251378|521005106|FG001|Overall Study|Lost to Follow-up|0|||
144494133|NCT03251378|521005107|FG002|Overall Study|Lost to Follow-up|1|||
144494134|NCT03251378|521005108|FG003|Overall Study|Lost to Follow-up|3|||
144494135|NCT03251378|521005109|FG004|Overall Study|Lost to Follow-up|0|||
144494136|NCT03251378|521005110|FG005|Overall Study|Lost to Follow-up|0|||
144494137|NCT03251378|521005111|FG006|Overall Study|Lost to Follow-up|0|||
144494138|NCT03251378|521005105|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
144494139|NCT03251378|521005106|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
144494140|NCT03251378|521005107|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
144494141|NCT03251378|521005108|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
144494142|NCT03251378|521005109|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
144494143|NCT03251378|521005110|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
144494144|NCT03251378|521005111|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
144494145|NCT03251378|521005105|FG000|Overall Study|Progressive disease|2|||
144494146|NCT03251378|521005106|FG001|Overall Study|Progressive disease|0|||
144494147|NCT03251378|521005107|FG002|Overall Study|Progressive disease|0|||
144494148|NCT03251378|521005108|FG003|Overall Study|Progressive disease|1|||
144494149|NCT03251378|521005109|FG004|Overall Study|Progressive disease|0|||
144494150|NCT03251378|521005110|FG005|Overall Study|Progressive disease|0|||
144494151|NCT03251378|521005111|FG006|Overall Study|Progressive disease|0|||
144494152|NCT03251378|521005105|FG000|Overall Study|Physician Decision|0|||
144494153|NCT03251378|521005106|FG001|Overall Study|Physician Decision|2|||
144494154|NCT03251378|521005107|FG002|Overall Study|Physician Decision|0|||
144494155|NCT03251378|521005108|FG003|Overall Study|Physician Decision|0|||
144494156|NCT03251378|521005109|FG004|Overall Study|Physician Decision|0|||
144494157|NCT03251378|521005110|FG005|Overall Study|Physician Decision|0|||
144494158|NCT03251378|521005111|FG006|Overall Study|Physician Decision|0|||
144494159|NCT03251378|521005105|FG000|Overall Study|Other|2|||
144494160|NCT03251378|521005106|FG001|Overall Study|Other|3|||
144494161|NCT03251378|521005107|FG002|Overall Study|Other|2|||
144494162|NCT03251378|521005108|FG003|Overall Study|Other|0|||
144494163|NCT03251378|521005109|FG004|Overall Study|Other|1|||
144494164|NCT03251378|521005110|FG005|Overall Study|Other|1|||
144494165|NCT03251378|521005111|FG006|Overall Study|Other|1|||
144494166|NCT03251378|521005105|FG000|Overall Study|Other|0|||
144494167|NCT03251378|521005106|FG001|Overall Study|Other|0|||
144494168|NCT03251378|521005107|FG002|Overall Study|Other|0|||
144494169|NCT03251378|521005108|FG003|Overall Study|Other|4|||
144494170|NCT03251378|521005109|FG004|Overall Study|Other|13|||
144494171|NCT03251378|521005110|FG005|Overall Study|Other|0|||
144494172|NCT03251378|521005111|FG006|Overall Study|Other|0|||
144494173|NCT04739423|521005118|FG000|Overall Study|Protocol Violation|0|||
144494174|NCT04739423|521005119|FG001|Overall Study|Protocol Violation|1|||
144494175|NCT04739423|521005120|FG002|Overall Study|Protocol Violation|0|||
144494176|NCT04739423|521005121|FG003|Overall Study|Protocol Violation|0|||
144494177|NCT04739423|521005122|FG004|Overall Study|Protocol Violation|0|||
144494178|NCT04739423|521005123|FG005|Overall Study|Protocol Violation|0|||
144494179|NCT04739423|521005118|FG000|Overall Study|Adverse Event|0|||
144494180|NCT04739423|521005119|FG001|Overall Study|Adverse Event|0|||
144494181|NCT04739423|521005120|FG002|Overall Study|Adverse Event|1|||
144494182|NCT04739423|521005121|FG003|Overall Study|Adverse Event|0|||
144494183|NCT04739423|521005122|FG004|Overall Study|Adverse Event|1|||
144494184|NCT04739423|521005123|FG005|Overall Study|Adverse Event|0|||
144494185|NCT04739423|521005118|FG000|Overall Study|Withdrawal by Subject|0|||
144494186|NCT04739423|521005119|FG001|Overall Study|Withdrawal by Subject|0|||
144494187|NCT04739423|521005120|FG002|Overall Study|Withdrawal by Subject|0|||
144494188|NCT04739423|521005121|FG003|Overall Study|Withdrawal by Subject|0|||
144494189|NCT04739423|521005122|FG004|Overall Study|Withdrawal by Subject|0|||
144494190|NCT04739423|521005123|FG005|Overall Study|Withdrawal by Subject|1|||
144494191|NCT05174065|521005130|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
144494192|NCT05174065|521005131|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
144494193|NCT05174065|521005132|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
144494194|NCT05174065|521005130|FG000|Placebo-controlled Period|Other|0|||
144494195|NCT05174065|521005131|FG001|Placebo-controlled Period|Other|1|||
144494196|NCT05174065|521005132|FG002|Placebo-controlled Period|Other|0|||
144494197|NCT05174065|521005130|FG000|Placebo-controlled Period|Adverse Event|1|||
144494198|NCT05174065|521005131|FG001|Placebo-controlled Period|Adverse Event|1|||
144494199|NCT05174065|521005132|FG002|Placebo-controlled Period|Adverse Event|0|||
144494200|NCT05174065|521005130|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
144494201|NCT05174065|521005131|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
144494202|NCT05174065|521005132|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
144494203|NCT05174065|521005130|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
144494204|NCT05174065|521005131|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
144494205|NCT05174065|521005132|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
144494206|NCT05174065|521005130|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
144494207|NCT05174065|521005131|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
144494208|NCT05174065|521005132|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
144494209|NCT01641861|521005133|FG000|Overall Study|Lost to Follow-up|21|||
144494210|NCT01641861|521005134|FG001|Overall Study|Lost to Follow-up|16|||
144494211|NCT01641861|521005133|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
144494212|NCT01641861|521005134|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
144494213|NCT01641861|521005133|FG000|Overall Study|Died due to drowning|0|||
144494214|NCT01641861|521005134|FG001|Overall Study|Died due to drowning|1|||
144494215|NCT00814489|521005160|FG000|Overall Study|Other|2|||
144494216|NCT00814489|521005161|FG001|Overall Study|Other|0|||
144494217|NCT00814489|521005162|FG002|Overall Study|Other|1|||
144494218|NCT01515319|521005163|FG000|Overall Study|Withdrawal by Subject|0|||
144494219|NCT01515319|521005164|FG001|Overall Study|Withdrawal by Subject|0|||
144494220|NCT01515319|521005165|FG002|Overall Study|Withdrawal by Subject|0|||
144494221|NCT01515319|521005166|FG003|Overall Study|Withdrawal by Subject|0|||
144494222|NCT01515319|521005167|FG004|Overall Study|Withdrawal by Subject|0|||
144494223|NCT01515319|521005168|FG005|Overall Study|Withdrawal by Subject|0|||
144494224|NCT01515319|521005169|FG006|Overall Study|Withdrawal by Subject|1|||
144494225|NCT01515319|521005170|FG007|Overall Study|Withdrawal by Subject|0|||
144494226|NCT01515319|521005171|FG008|Overall Study|Withdrawal by Subject|0|||
144494227|NCT01515319|521005172|FG009|Overall Study|Withdrawal by Subject|0|||
144494228|NCT01515319|521005163|FG000|Overall Study|Adverse Event|0|||
144494229|NCT01515319|521005164|FG001|Overall Study|Adverse Event|0|||
144494230|NCT01515319|521005165|FG002|Overall Study|Adverse Event|0|||
144494231|NCT01515319|521005166|FG003|Overall Study|Adverse Event|0|||
144494232|NCT01515319|521005167|FG004|Overall Study|Adverse Event|0|||
144494233|NCT01515319|521005168|FG005|Overall Study|Adverse Event|0|||
144494234|NCT01515319|521005169|FG006|Overall Study|Adverse Event|0|||
144494235|NCT01515319|521005170|FG007|Overall Study|Adverse Event|0|||
144494236|NCT01515319|521005171|FG008|Overall Study|Adverse Event|3|||
144494237|NCT01515319|521005172|FG009|Overall Study|Adverse Event|0|||
144494238|NCT01515319|521005163|FG000|Overall Study|Protocol Violation|0|||
144494239|NCT01515319|521005164|FG001|Overall Study|Protocol Violation|0|||
144494240|NCT01515319|521005165|FG002|Overall Study|Protocol Violation|0|||
144494241|NCT01515319|521005166|FG003|Overall Study|Protocol Violation|0|||
144494242|NCT01515319|521005167|FG004|Overall Study|Protocol Violation|0|||
144494243|NCT01515319|521005168|FG005|Overall Study|Protocol Violation|0|||
144494244|NCT01515319|521005169|FG006|Overall Study|Protocol Violation|0|||
144494245|NCT01515319|521005170|FG007|Overall Study|Protocol Violation|0|||
144494246|NCT01515319|521005171|FG008|Overall Study|Protocol Violation|2|||
144494247|NCT01515319|521005172|FG009|Overall Study|Protocol Violation|0|||
144494248|NCT02624778|521007076|FG000|Overall Study|Lost to Follow-up|0|||
144494249|NCT02624778|521007077|FG001|Overall Study|Lost to Follow-up|0|||
144494250|NCT02624778|521007078|FG002|Overall Study|Lost to Follow-up|1|||
144494251|NCT02624778|521007079|FG003|Overall Study|Lost to Follow-up|0|||
144494252|NCT02624778|521007080|FG004|Overall Study|Lost to Follow-up|0|||
144494253|NCT02624778|521007081|FG005|Overall Study|Lost to Follow-up|0|||
144494254|NCT02624778|521007082|FG006|Overall Study|Lost to Follow-up|0|||
144494255|NCT02624778|521007083|FG007|Overall Study|Lost to Follow-up|0|||
144494256|NCT02624778|521007084|FG008|Overall Study|Lost to Follow-up|0|||
144494257|NCT02624778|521007076|FG000|Overall Study|Withdrawal by Subject|0|||
144494258|NCT02624778|521007077|FG001|Overall Study|Withdrawal by Subject|1|||
144494259|NCT02624778|521007078|FG002|Overall Study|Withdrawal by Subject|0|||
144494260|NCT02624778|521007079|FG003|Overall Study|Withdrawal by Subject|0|||
144494261|NCT02624778|521007080|FG004|Overall Study|Withdrawal by Subject|0|||
144494262|NCT02624778|521007081|FG005|Overall Study|Withdrawal by Subject|1|||
144494263|NCT02624778|521007082|FG006|Overall Study|Withdrawal by Subject|1|||
144494264|NCT02624778|521007083|FG007|Overall Study|Withdrawal by Subject|1|||
144494265|NCT02624778|521007084|FG008|Overall Study|Withdrawal by Subject|1|||
144494266|NCT02624778|521007076|FG000|Overall Study|Adverse Event|0|||
144494267|NCT02624778|521007077|FG001|Overall Study|Adverse Event|0|||
144494268|NCT02624778|521007078|FG002|Overall Study|Adverse Event|0|||
144494269|NCT02624778|521007079|FG003|Overall Study|Adverse Event|0|||
144494270|NCT02624778|521007080|FG004|Overall Study|Adverse Event|0|||
144494271|NCT02624778|521007081|FG005|Overall Study|Adverse Event|0|||
144494272|NCT02624778|521007082|FG006|Overall Study|Adverse Event|0|||
144494273|NCT02624778|521007083|FG007|Overall Study|Adverse Event|0|||
144494274|NCT02624778|521007084|FG008|Overall Study|Adverse Event|2|||
144494275|NCT02624778|521007076|FG000|Overall Study|Death|0|||
144494276|NCT02624778|521007077|FG001|Overall Study|Death|0|||
144494277|NCT02624778|521007078|FG002|Overall Study|Death|0|||
144494278|NCT02624778|521007079|FG003|Overall Study|Death|0|||
144494279|NCT02624778|521007080|FG004|Overall Study|Death|0|||
144494280|NCT02624778|521007081|FG005|Overall Study|Death|0|||
144494281|NCT02624778|521007082|FG006|Overall Study|Death|1|||
144494282|NCT02624778|521007083|FG007|Overall Study|Death|0|||
144494283|NCT02624778|521007084|FG008|Overall Study|Death|0|||
144494284|NCT02624778|521007076|FG000|Overall Study|Physician Decision|0|||
144494285|NCT02624778|521007077|FG001|Overall Study|Physician Decision|0|||
144494286|NCT02624778|521007078|FG002|Overall Study|Physician Decision|0|||
144494287|NCT02624778|521007079|FG003|Overall Study|Physician Decision|0|||
144494288|NCT02624778|521007080|FG004|Overall Study|Physician Decision|0|||
144494289|NCT02624778|521007081|FG005|Overall Study|Physician Decision|0|||
144494290|NCT02624778|521007082|FG006|Overall Study|Physician Decision|0|||
144494291|NCT02624778|521007083|FG007|Overall Study|Physician Decision|3|||
144494292|NCT02624778|521007084|FG008|Overall Study|Physician Decision|3|||
144494293|NCT04091672|521007085|FG000|Overall Study|Death|6|||
144494294|NCT04091672|521007086|FG001|Overall Study|Death|6|||
144494295|NCT04091672|521007085|FG000|Overall Study|Lost to Follow-up|7|||
144494296|NCT04091672|521007086|FG001|Overall Study|Lost to Follow-up|7|||
144494297|NCT04091672|521007085|FG000|Overall Study|Withdrawal by Subject|3|||
144494298|NCT04091672|521007086|FG001|Overall Study|Withdrawal by Subject|3|||
144494299|NCT04091672|521007085|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
144494300|NCT04091672|521007086|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
144494301|NCT05296629|521007087|FG000|Overall Study|Withdrawal by Subject|3|||
144494302|NCT05296629|521007088|FG001|Overall Study|Withdrawal by Subject|10|||
144494303|NCT05296629|521007089|FG002|Overall Study|Withdrawal by Subject|4|||
144494304|NCT05296629|521007087|FG000|Overall Study|Lost to Follow-up|2|||
144494305|NCT05296629|521007088|FG001|Overall Study|Lost to Follow-up|7|||
144494306|NCT05296629|521007089|FG002|Overall Study|Lost to Follow-up|1|||
144494307|NCT05296629|521007087|FG000|Overall Study|Adverse Event|0|||
144494308|NCT05296629|521007088|FG001|Overall Study|Adverse Event|4|||
144494309|NCT05296629|521007089|FG002|Overall Study|Adverse Event|2|||
144494310|NCT05296629|521007087|FG000|Overall Study|Protocol Violation|0|||
144494311|NCT05296629|521007088|FG001|Overall Study|Protocol Violation|2|||
144494312|NCT05296629|521007089|FG002|Overall Study|Protocol Violation|0|||
144494313|NCT02268396|521007090|FG000|Overall Study|Adverse Event|3|||
144494314|NCT02268396|521007090|FG000|Overall Study|Administrative|2|||
144494315|NCT02268396|521007090|FG000|Overall Study|Withdrawal by Subject|1|||
144494316|NCT02268396|521007090|FG000|Overall Study|Lost to Follow-up|2|||
144494317|NCT02268396|521007090|FG000|Overall Study|Protocol-Specified Criteria|2|||
144494318|NCT02268396|521007090|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
144494319|NCT04610684|521007093|FG000|Study Treatment|Withdrawal by Subject|1|||
144494320|NCT04610684|521007093|FG000|Study Treatment|Disease Progression|2|||
144494321|NCT04610684|521007093|FG000|Follow up|Death|2|||
144494322|NCT04610684|521007093|FG000|Follow up|Withdrawal by Subject|1|||
144494323|NCT02153788|521007097|FG000|Overall Study|Physician Decision|2|||
144494324|NCT02153788|521007098|FG001|Overall Study|Physician Decision|1|||
144494325|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
144494326|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
144494327|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
144494328|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
144494329|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
144494330|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
144494331|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
144494332|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
144494333|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
144718951|NCT01452529|521825782|FG000|Run-in Period|Adverse Event|96|||
144718952|NCT01452529|521825783|FG001|Run-in Period|Adverse Event|0|||
144718953|NCT01452529|521825784|FG002|Run-in Period|Adverse Event|0|||
144718954|NCT01452529|521825782|FG000|Run-in Period|Withdrawal by Subject|49|||
144718955|NCT01452529|521825783|FG001|Run-in Period|Withdrawal by Subject|0|||
144718956|NCT01452529|521825784|FG002|Run-in Period|Withdrawal by Subject|0|||
144718957|NCT01452529|521825782|FG000|Run-in Period|Lost to Follow-up|19|||
144718958|NCT01452529|521825783|FG001|Run-in Period|Lost to Follow-up|0|||
144718959|NCT01452529|521825784|FG002|Run-in Period|Lost to Follow-up|0|||
144718960|NCT01452529|521825782|FG000|Run-in Period|Lack of Efficacy|46|||
144718961|NCT01452529|521825783|FG001|Run-in Period|Lack of Efficacy|0|||
144718962|NCT01452529|521825784|FG002|Run-in Period|Lack of Efficacy|0|||
144718963|NCT01452529|521825782|FG000|Run-in Period|Confirmed or suspected diversion|23|||
144718964|NCT01452529|521825783|FG001|Run-in Period|Confirmed or suspected diversion|0|||
144718965|NCT01452529|521825784|FG002|Run-in Period|Confirmed or suspected diversion|0|||
144718966|NCT01452529|521825782|FG000|Run-in Period|Administrative|21|||
144718967|NCT01452529|521825783|FG001|Run-in Period|Administrative|0|||
144718968|NCT01452529|521825784|FG002|Run-in Period|Administrative|0|||
144718969|NCT01452529|521825782|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
144718970|NCT01452529|521825783|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
144718971|NCT01452529|521825784|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
144494334|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
144494335|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
144494336|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
144494337|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
144494338|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
144494339|NCT04672460|521007099|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
144494340|NCT04672460|521007100|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
144494341|NCT04672460|521007099|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
144494342|NCT04672460|521007100|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
144494343|NCT04672460|521007099|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
144494344|NCT04672460|521007100|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
144494345|NCT04672460|521007099|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
144494346|NCT04672460|521007100|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
144494347|NCT04672460|521007099|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
144494348|NCT04672460|521007100|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
144494349|NCT04672460|521007099|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
144494350|NCT04672460|521007100|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
144494351|NCT04672460|521007099|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
144494352|NCT04672460|521007100|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
144494353|NCT04672460|521007099|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
144494354|NCT04672460|521007100|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
144494355|NCT04672460|521007099|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
144494356|NCT04672460|521007100|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
144494357|NCT04672460|521007099|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
144494358|NCT04672460|521007100|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
144494359|NCT01876043|521007103|FG000|Overall Study|Death|1|||
144494360|NCT01876043|521007103|FG000|Overall Study|Withdrawal by Subject|1|||
144494361|NCT00079937|521007104|FG000|Overall Study|Adverse Event|2|||
144494362|NCT00079937|521007105|FG001|Overall Study|Adverse Event|1|||
144494363|NCT00079937|521007104|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144494364|NCT00079937|521007105|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144494365|NCT00079937|521007104|FG000|Overall Study|Subject no longer requires study drug|3|||
144494366|NCT00079937|521007105|FG001|Overall Study|Subject no longer requires study drug|0|||
144494367|NCT00079937|521007104|FG000|Overall Study|Protocol Violation|8|||
144494368|NCT00079937|521007105|FG001|Overall Study|Protocol Violation|6|||
144494369|NCT00079937|521007104|FG000|Overall Study|Withdrawal by Subject|21|||
144494370|NCT00079937|521007105|FG001|Overall Study|Withdrawal by Subject|7|||
144494371|NCT00079937|521007104|FG000|Overall Study|Lost to Follow-up|12|||
144494372|NCT00079937|521007105|FG001|Overall Study|Lost to Follow-up|5|||
144494373|NCT00079937|521007104|FG000|Overall Study|Administrative problems|22|||
144494374|NCT00079937|521007105|FG001|Overall Study|Administrative problems|11|||
144494375|NCT02949271|521007106|FG000|Overall Study|Lack of Efficacy|5|||
144494376|NCT02949271|521007107|FG001|Overall Study|Lack of Efficacy|4|||
144494377|NCT02949271|521007106|FG000|Overall Study|Lost to Follow-up|3|||
144494378|NCT02949271|521007107|FG001|Overall Study|Lost to Follow-up|6|||
144494379|NCT02949271|521007106|FG000|Overall Study|Physician Decision|5|||
144494380|NCT02949271|521007107|FG001|Overall Study|Physician Decision|5|||
144494381|NCT02949271|521007106|FG000|Overall Study|Protocol Violation|6|||
144494382|NCT02949271|521007107|FG001|Overall Study|Protocol Violation|3|||
144494383|NCT02949271|521007106|FG000|Overall Study|Withdrawal by Subject|1|||
144494384|NCT02949271|521007107|FG001|Overall Study|Withdrawal by Subject|0|||
144494385|NCT02949271|521007106|FG000|Overall Study|Delivered prior to intervention|7|||
144494386|NCT02949271|521007107|FG001|Overall Study|Delivered prior to intervention|9|||
144494387|NCT02949271|521007106|FG000|Overall Study|Outside the window for cervical dilation|2|||
144494388|NCT02949271|521007107|FG001|Overall Study|Outside the window for cervical dilation|3|||
144494389|NCT05458102|521007110|FG000|Overall Study|Withdrew consent|2|||
144494390|NCT05458102|521007111|FG001|Overall Study|Withdrew consent|0|||
144494391|NCT05458102|521007110|FG000|Overall Study|Adverse Event|1|||
144494392|NCT05458102|521007111|FG001|Overall Study|Adverse Event|0|||
144494393|NCT05458102|521007110|FG000|Overall Study|Enrolled but never treated|1|||
144494394|NCT05458102|521007111|FG001|Overall Study|Enrolled but never treated|0|||
144494395|NCT05458102|521007110|FG000|Overall Study|Protocol Violation|1|||
144494396|NCT05458102|521007111|FG001|Overall Study|Protocol Violation|0|||
144494397|NCT00852475|521007120|FG000|Overall Study|Lost to Follow-up|3|||
144494398|NCT00852475|521007121|FG001|Overall Study|Lost to Follow-up|4|||
144494399|NCT04531540|521007129|FG000|Overall Study|Adverse Event|1|||
144494400|NCT04531540|521007129|FG000|Overall Study|Protocol Violation|3|||
144494401|NCT04531540|521007129|FG000|Overall Study|Withdrawal by Subject|4|||
144494402|NCT04531540|521007129|FG000|Overall Study|Found to be Ineligible|1|||
144494403|NCT00926393|521007130|FG000|Overall Study|Withdrawal by Subject|1|||
144494404|NCT00926393|521007131|FG001|Overall Study|Withdrawal by Subject|2|||
144494405|NCT00926393|521007130|FG000|Overall Study|Adverse Event|1|||
144494406|NCT00926393|521007131|FG001|Overall Study|Adverse Event|1|||
144494407|NCT00278564|521007134|FG000|Overall Study|Lack of Efficacy|4|||
144494408|NCT03606460|521007135|FG000|Overall Study|Lost to Follow-up|1|||
144494409|NCT03606460|521007136|FG001|Overall Study|Lost to Follow-up|8|||
144494410|NCT00003377|521007137|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
144494411|NCT00003377|521007138|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
144494412|NCT00003377|521007139|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
144494413|NCT00003377|521007140|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
144494414|NCT00003377|521007141|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
144494415|NCT00003377|521007137|FG000|Period II|Ureteral stent complications|0|||
144494416|NCT00003377|521007138|FG001|Period II|Ureteral stent complications|0|||
144494417|NCT00003377|521007139|FG002|Period II|Ureteral stent complications|0|||
144494418|NCT00003377|521007140|FG003|Period II|Ureteral stent complications|0|||
144494419|NCT00003377|521007141|FG004|Period II|Ureteral stent complications|1|||
144494420|NCT04541186|521007142|FG000|Main Study|Adverse Event|0|||
144494421|NCT04541186|521007143|FG001|Main Study|Adverse Event|0|||
144494422|NCT04541186|521007144|FG002|Main Study|Adverse Event|4|||
144494423|NCT04541186|521007145|FG003|Main Study|Adverse Event|0|||
144494424|NCT04541186|521007146|FG004|Main Study|Adverse Event|0|||
144494425|NCT04541186|521007142|FG000|Main Study|Investigator Decision|0|||
144494426|NCT04541186|521007143|FG001|Main Study|Investigator Decision|0|||
144494427|NCT04541186|521007144|FG002|Main Study|Investigator Decision|1|||
144494428|NCT04541186|521007145|FG003|Main Study|Investigator Decision|1|||
144494429|NCT04541186|521007146|FG004|Main Study|Investigator Decision|0|||
144494430|NCT04541186|521007142|FG000|Main Study|Withdrawal by Subject|1|||
144494431|NCT04541186|521007143|FG001|Main Study|Withdrawal by Subject|1|||
144494432|NCT04541186|521007144|FG002|Main Study|Withdrawal by Subject|0|||
144494433|NCT04541186|521007145|FG003|Main Study|Withdrawal by Subject|0|||
144494434|NCT04541186|521007146|FG004|Main Study|Withdrawal by Subject|0|||
144494435|NCT04541186|521007142|FG000|Main Study|COVID-19-related Dose Interruption|0|||
144494436|NCT04541186|521007143|FG001|Main Study|COVID-19-related Dose Interruption|0|||
144494437|NCT04541186|521007144|FG002|Main Study|COVID-19-related Dose Interruption|0|||
144494438|NCT04541186|521007145|FG003|Main Study|COVID-19-related Dose Interruption|0|||
144494439|NCT04541186|521007146|FG004|Main Study|COVID-19-related Dose Interruption|1|||
144494440|NCT04541186|521007142|FG000|Main Study|Randomized in Error Not Treated|0|||
144494441|NCT04541186|521007143|FG001|Main Study|Randomized in Error Not Treated|0|||
144494442|NCT04541186|521007144|FG002|Main Study|Randomized in Error Not Treated|1|||
144494443|NCT04541186|521007145|FG003|Main Study|Randomized in Error Not Treated|0|||
144494444|NCT04541186|521007146|FG004|Main Study|Randomized in Error Not Treated|0|||
144494445|NCT04541186|521007142|FG000|Fibrate Expansion Study|Other than Specified|0|||
144494446|NCT04541186|521007143|FG001|Fibrate Expansion Study|Other than Specified|0|||
144494447|NCT04541186|521007144|FG002|Fibrate Expansion Study|Other than Specified|0|||
144494448|NCT04541186|521007145|FG003|Fibrate Expansion Study|Other than Specified|0|||
144494449|NCT04541186|521007146|FG004|Fibrate Expansion Study|Other than Specified|1|||
144494450|NCT02256969|521007147|FG000|Overall Study|Screenfailed or withdrew|2|||
144494451|NCT02256969|521007148|FG001|Overall Study|Screenfailed or withdrew|1|||
144494452|NCT02256969|521007149|FG002|Overall Study|Screenfailed or withdrew|1|||
144494453|NCT00058058|521007153|FG000|Overall Study|Withdrawal by Subject|4|||
144494454|NCT00058058|521007153|FG000|Overall Study|Ineligible|20|||
144494455|NCT00058058|521007153|FG000|Overall Study|Claustrophobic|5|||
144494456|NCT00058058|521007153|FG000|Overall Study|technical issues|6|||
144494457|NCT00058058|521007153|FG000|Overall Study|Poor positioning, illness,pain|3|||
144494458|NCT03085017|521007154|FG000|Overall Study|Death|0|||
144494459|NCT03085017|521007155|FG001|Overall Study|Death|3|||
144494460|NCT00748969|521007159|FG000|Overall Study|Withdrawal by Subject|1|||
144494461|NCT00748969|521007160|FG001|Overall Study|Withdrawal by Subject|0|||
144494462|NCT00748969|521007159|FG000|Overall Study|Withdrawal by Subject|0|||
144494463|NCT00748969|521007160|FG001|Overall Study|Withdrawal by Subject|1|||
144494464|NCT02390557|521007161|FG000|Wave 2|Survey non-respondent|72|||
144494465|NCT02390557|521007162|FG001|Wave 2|Survey non-respondent|41|||
144494466|NCT02390557|521007163|FG002|Wave 2|Survey non-respondent|23|||
144494467|NCT03278028|521007166|FG000|Overall Study|Lost to Follow-up|1|||
144718972|NCT01452529|521825782|FG000|Double-blind (DB) Period|Adverse Event|0|||
144718973|NCT01452529|521825783|FG001|Double-blind (DB) Period|Adverse Event|18|||
144718974|NCT01452529|521825784|FG002|Double-blind (DB) Period|Adverse Event|11|||
144718975|NCT01452529|521825782|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
144718976|NCT01452529|521825783|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
144718977|NCT01452529|521825784|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
144718978|NCT01452529|521825782|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
144718979|NCT01452529|521825783|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
144718980|NCT01452529|521825784|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
144718981|NCT01452529|521825782|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
144718982|NCT01452529|521825783|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
144718983|NCT01452529|521825784|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
144718984|NCT01452529|521825782|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
144718985|NCT01452529|521825783|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
144718986|NCT01452529|521825784|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
144718987|NCT01452529|521825782|FG000|Double-blind (DB) Period|Administrative|0|||
144718988|NCT01452529|521825783|FG001|Double-blind (DB) Period|Administrative|11|||
144718989|NCT01452529|521825784|FG002|Double-blind (DB) Period|Administrative|7|||
144718990|NCT03551730|521825785|FG000|Overall Study|Adverse Event|1|||
144718991|NCT03551730|521825786|FG001|Overall Study|Adverse Event|0|||
144718992|NCT03551730|521825787|FG002|Overall Study|Adverse Event|0|||
144718993|NCT03551730|521825788|FG003|Overall Study|Adverse Event|0|||
144718994|NCT02891200|521825794|FG000|Overall Study|Lost to Follow-up|31|||
144718995|NCT02891200|521825795|FG001|Overall Study|Lost to Follow-up|36|||
144718996|NCT02891200|521825794|FG000|Overall Study|Death|10|||
144718997|NCT02891200|521825795|FG001|Overall Study|Death|9|||
144718998|NCT02891200|521825794|FG000|Overall Study|Withdrawal by Subject|1|||
144718999|NCT02891200|521825795|FG001|Overall Study|Withdrawal by Subject|4|||
144719000|NCT01927757|521825798|FG000|Overall Study|Withdrawal by Subject|14|||
144719001|NCT01927757|521825798|FG000|Overall Study|Lost to Follow-up|2|||
144719002|NCT01927757|521825798|FG000|Overall Study|Decision by Sponsor|2|||
144719003|NCT01927757|521825798|FG000|Overall Study|Other|1|||
144719004|NCT01927757|521825798|FG000|Overall Study|Ethical Reasons|4|||
144719005|NCT04480463|521825801|FG000|Overall Study|Death|0|||
144719006|NCT04480463|521825802|FG001|Overall Study|Death|1|||
144719007|NCT04480463|521825801|FG000|Overall Study|Adverse Event|6|||
144719008|NCT04480463|521825802|FG001|Overall Study|Adverse Event|8|||
144719009|NCT04480463|521825801|FG000|Overall Study|Lost to Follow-up|3|||
144719010|NCT04480463|521825802|FG001|Overall Study|Lost to Follow-up|2|||
144719011|NCT04480463|521825801|FG000|Overall Study|Physician Decision|2|||
144719012|NCT04480463|521825802|FG001|Overall Study|Physician Decision|5|||
144719013|NCT04480463|521825801|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
144719014|NCT04480463|521825802|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
144719015|NCT04480463|521825801|FG000|Overall Study|Protocol Violation|2|||
144719016|NCT04480463|521825802|FG001|Overall Study|Protocol Violation|1|||
144719017|NCT04480463|521825801|FG000|Overall Study|Withdrawal by Subject|6|||
144719018|NCT04480463|521825802|FG001|Overall Study|Withdrawal by Subject|7|||
144719019|NCT04480463|521825801|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
144719020|NCT04480463|521825802|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
144719021|NCT04480463|521825801|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
144719022|NCT04480463|521825802|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
144719023|NCT04480463|521825801|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
144719024|NCT04480463|521825802|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
144719025|NCT04480463|521825801|FG000|Overall Study|Other|6|||
144719026|NCT04480463|521825802|FG001|Overall Study|Other|4|||
144719027|NCT00444795|521825803|FG000|Overall Study|Not Treated|1|||
144719028|NCT00444795|521825803|FG000|Overall Study|Treated Prior to the Contract Date|2|||
144719029|NCT00988169|521825804|FG000|Overall Study|Withdrawal by Subject|1|||
144719030|NCT02322879|521825805|FG000|First Intervention|Physician Decision|1|||
144719031|NCT02322879|521825806|FG001|First Intervention|Physician Decision|0|||
144494468|NCT03278028|521007167|FG001|Overall Study|Lost to Follow-up|0|||
144494469|NCT03278028|521007166|FG000|Overall Study|Withdrawal by Subject|3|||
144494470|NCT03278028|521007167|FG001|Overall Study|Withdrawal by Subject|1|||
144494471|NCT03278028|521007166|FG000|Overall Study|Pregnancy|0|||
144494472|NCT03278028|521007167|FG001|Overall Study|Pregnancy|1|||
144494473|NCT00463151|521007168|FG000|Overall Study|Adverse Event|0|||
144494474|NCT00463151|521007169|FG001|Overall Study|Adverse Event|0|||
144494475|NCT00463151|521007170|FG002|Overall Study|Adverse Event|1|||
144494476|NCT00463151|521007171|FG003|Overall Study|Adverse Event|0|||
144494477|NCT00463151|521007168|FG000|Overall Study|Lack of Efficacy|2|||
144494478|NCT00463151|521007169|FG001|Overall Study|Lack of Efficacy|5|||
144494479|NCT00463151|521007170|FG002|Overall Study|Lack of Efficacy|2|||
144494480|NCT00463151|521007171|FG003|Overall Study|Lack of Efficacy|5|||
144494481|NCT00463151|521007168|FG000|Overall Study|Protocol Violation|0|||
144494482|NCT00463151|521007169|FG001|Overall Study|Protocol Violation|0|||
144494483|NCT00463151|521007170|FG002|Overall Study|Protocol Violation|0|||
144494484|NCT00463151|521007171|FG003|Overall Study|Protocol Violation|1|||
144494485|NCT00463151|521007168|FG000|Overall Study|Withdrawal by Subject|0|||
144494486|NCT00463151|521007169|FG001|Overall Study|Withdrawal by Subject|0|||
144494487|NCT00463151|521007170|FG002|Overall Study|Withdrawal by Subject|0|||
144494488|NCT00463151|521007171|FG003|Overall Study|Withdrawal by Subject|1|||
144494489|NCT05349084|521007172|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
144494490|NCT00293462|521007173|FG000|Overall Study|Withdrawal by Subject|4|||
144494491|NCT00293462|521007174|FG001|Overall Study|Withdrawal by Subject|3|||
144494492|NCT00293462|521007175|FG002|Overall Study|Withdrawal by Subject|8|||
144494493|NCT00293462|521007173|FG000|Overall Study|Death|1|||
144494494|NCT00293462|521007174|FG001|Overall Study|Death|0|||
144494495|NCT00293462|521007175|FG002|Overall Study|Death|0|||
144494496|NCT00293462|521007173|FG000|Overall Study|Lost to Follow-up|0|||
144494497|NCT00293462|521007174|FG001|Overall Study|Lost to Follow-up|1|||
144494498|NCT00293462|521007175|FG002|Overall Study|Lost to Follow-up|0|||
144494499|NCT00293462|521007173|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
144494500|NCT00293462|521007174|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
144494501|NCT00293462|521007175|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
144494502|NCT00293462|521007173|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
144494503|NCT00293462|521007174|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
144494504|NCT00293462|521007175|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
144494505|NCT00293462|521007173|FG000|Overall Study|Refuse Radiation Treatment|1|||
144494506|NCT00293462|521007174|FG001|Overall Study|Refuse Radiation Treatment|0|||
144494507|NCT00293462|521007175|FG002|Overall Study|Refuse Radiation Treatment|0|||
144494508|NCT00293462|521007173|FG000|Overall Study|No Show|0|||
144494509|NCT00293462|521007174|FG001|Overall Study|No Show|0|||
144494510|NCT00293462|521007175|FG002|Overall Study|No Show|1|||
144494511|NCT00293462|521007173|FG000|Overall Study|Went back to his home country|0|||
144494512|NCT00293462|521007174|FG001|Overall Study|Went back to his home country|0|||
144494513|NCT00293462|521007175|FG002|Overall Study|Went back to his home country|1|||
144494514|NCT00293462|521007173|FG000|Overall Study|Blood clot after chemotherapy|0|||
144494515|NCT00293462|521007174|FG001|Overall Study|Blood clot after chemotherapy|0|||
144494516|NCT00293462|521007175|FG002|Overall Study|Blood clot after chemotherapy|1|||
144494517|NCT00293462|521007173|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
144494518|NCT00293462|521007174|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
144494519|NCT00293462|521007175|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
144494520|NCT00293462|521007173|FG000|Overall Study|Possible Tracheostomy leakage|0|||
144494521|NCT00293462|521007174|FG001|Overall Study|Possible Tracheostomy leakage|1|||
144494522|NCT00293462|521007175|FG002|Overall Study|Possible Tracheostomy leakage|0|||
144494523|NCT00293462|521007173|FG000|Overall Study|Low radiation dose in oral cavity|0|||
144494524|NCT00293462|521007174|FG001|Overall Study|Low radiation dose in oral cavity|1|||
144494525|NCT00293462|521007175|FG002|Overall Study|Low radiation dose in oral cavity|0|||
144494526|NCT00293462|521007173|FG000|Overall Study|Physician Decision|0|||
144494527|NCT00293462|521007174|FG001|Overall Study|Physician Decision|1|||
144494528|NCT00293462|521007175|FG002|Overall Study|Physician Decision|0|||
144494529|NCT00688688|521007176|FG000|Overall Study|Eligibility criterion not met|7|||
144494530|NCT00688688|521007177|FG001|Overall Study|Eligibility criterion not met|7|||
144494531|NCT00688688|521007178|FG002|Overall Study|Eligibility criterion not met|10|||
144494532|NCT00688688|521007176|FG000|Overall Study|Adverse Event|52|||
144494533|NCT00688688|521007177|FG001|Overall Study|Adverse Event|51|||
144494534|NCT00688688|521007178|FG002|Overall Study|Adverse Event|50|||
144494535|NCT00688688|521007176|FG000|Overall Study|Lack of Efficacy|34|||
144494536|NCT00688688|521007177|FG001|Overall Study|Lack of Efficacy|25|||
144494537|NCT00688688|521007178|FG002|Overall Study|Lack of Efficacy|45|||
144494538|NCT00688688|521007176|FG000|Overall Study|Withdrawal by Subject|66|||
144494539|NCT00688688|521007177|FG001|Overall Study|Withdrawal by Subject|75|||
144494540|NCT00688688|521007178|FG002|Overall Study|Withdrawal by Subject|65|||
144494541|NCT00688688|521007176|FG000|Overall Study|Lost to Follow-up|14|||
144494542|NCT00688688|521007177|FG001|Overall Study|Lost to Follow-up|7|||
144494543|NCT00688688|521007178|FG002|Overall Study|Lost to Follow-up|7|||
144494544|NCT00688688|521007176|FG000|Overall Study|Protocol Violation|6|||
144494545|NCT00688688|521007177|FG001|Overall Study|Protocol Violation|9|||
144494546|NCT00688688|521007178|FG002|Overall Study|Protocol Violation|11|||
144494547|NCT00688688|521007176|FG000|Overall Study|Randomized but never received study drug|1|||
144494548|NCT00688688|521007177|FG001|Overall Study|Randomized but never received study drug|0|||
144494549|NCT00688688|521007178|FG002|Overall Study|Randomized but never received study drug|0|||
144494550|NCT00688688|521007176|FG000|Overall Study|Non-compliance with study procedures|5|||
144494551|NCT00688688|521007177|FG001|Overall Study|Non-compliance with study procedures|3|||
144494552|NCT00688688|521007178|FG002|Overall Study|Non-compliance with study procedures|4|||
144494553|NCT00688688|521007176|FG000|Overall Study|Taking exclusionary medications|1|||
144494554|NCT00688688|521007177|FG001|Overall Study|Taking exclusionary medications|0|||
144494555|NCT00688688|521007178|FG002|Overall Study|Taking exclusionary medications|0|||
144494556|NCT00688688|521007176|FG000|Overall Study|Site closure|0|||
144494557|NCT00688688|521007177|FG001|Overall Study|Site closure|1|||
144494558|NCT00688688|521007178|FG002|Overall Study|Site closure|0|||
144494559|NCT00688688|521007176|FG000|Overall Study|Violation of exclusion criterion|0|||
144494560|NCT00688688|521007177|FG001|Overall Study|Violation of exclusion criterion|1|||
144494561|NCT00688688|521007178|FG002|Overall Study|Violation of exclusion criterion|0|||
144494562|NCT03283553|521007182|FG000|Patient Participant Flow|Death|5|||
144494563|NCT03283553|521007183|FG001|Patient Participant Flow|Death|10|||
144494564|NCT03283553|521007182|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
144494565|NCT03283553|521007183|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
144494566|NCT03283553|521007182|FG000|Patient Participant Flow|Lost to Follow-up|1|||
144494567|NCT03283553|521007183|FG001|Patient Participant Flow|Lost to Follow-up|1|||
144494568|NCT03283553|521007182|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
144494569|NCT03283553|521007183|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
144494570|NCT03283553|521007182|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
144494571|NCT03283553|521007183|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
144494572|NCT03283553|521007182|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
144494573|NCT03283553|521007183|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
144494574|NCT03686683|521007184|FG000|Overall Study|Withdrawal by Subject|52|||
144494575|NCT03686683|521007185|FG001|Overall Study|Withdrawal by Subject|32|||
144494576|NCT03686683|521007184|FG000|Overall Study|Lost to Follow-up|23|||
144494577|NCT03686683|521007185|FG001|Overall Study|Lost to Follow-up|19|||
144494578|NCT03686683|521007184|FG000|Overall Study|Adverse Event|1|||
144494579|NCT03686683|521007185|FG001|Overall Study|Adverse Event|0|||
144494580|NCT03686683|521007184|FG000|Overall Study|Death|10|||
144494581|NCT03686683|521007185|FG001|Overall Study|Death|5|||
144494582|NCT03686683|521007184|FG000|Overall Study|Progressive Disease|1|||
144494583|NCT03686683|521007185|FG001|Overall Study|Progressive Disease|1|||
144494584|NCT03686683|521007184|FG000|Overall Study|Noncompliance|1|||
144494585|NCT03686683|521007185|FG001|Overall Study|Noncompliance|0|||
144494586|NCT03686683|521007184|FG000|Overall Study|Physician Decision|1|||
144494587|NCT03686683|521007185|FG001|Overall Study|Physician Decision|1|||
144494588|NCT03686683|521007184|FG000|Overall Study|Screen fail post-randomization|1|||
144494589|NCT03686683|521007185|FG001|Overall Study|Screen fail post-randomization|0|||
144494590|NCT03686683|521007184|FG000|Overall Study|Protocol Violation|3|||
144494591|NCT03686683|521007185|FG001|Overall Study|Protocol Violation|0|||
144494592|NCT03686683|521007184|FG000|Overall Study|No data available|1|||
144494593|NCT03686683|521007185|FG001|Overall Study|No data available|0|||
144494594|NCT00372060|521007186|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
144494595|NCT00372060|521007187|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
144494596|NCT00372060|521007186|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
144494597|NCT00372060|521007187|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
144494598|NCT00372060|521007186|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
144494599|NCT00372060|521007187|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
144494600|NCT00372060|521007186|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
144494601|NCT00372060|521007187|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
144494602|NCT00372060|521007186|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
144494603|NCT00372060|521007187|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
144494604|NCT00372060|521007186|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
144494605|NCT00372060|521007187|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
144494606|NCT01579578|521007199|FG000|Overall Study|Death|4|||
144494607|NCT01579578|521007200|FG001|Overall Study|Death|1|||
144494608|NCT01579578|521007199|FG000|Overall Study|Lost to Follow-up|1|||
144494609|NCT01579578|521007200|FG001|Overall Study|Lost to Follow-up|1|||
144494610|NCT01579578|521007199|FG000|Overall Study|Withdrawal by Subject|2|||
144494611|NCT01579578|521007200|FG001|Overall Study|Withdrawal by Subject|1|||
144494612|NCT01579578|521007199|FG000|Overall Study|Eligibility criteria|3|||
144494613|NCT01579578|521007200|FG001|Overall Study|Eligibility criteria|9|||
144494614|NCT01579578|521007199|FG000|Overall Study|Ongoing|3|||
144494615|NCT01579578|521007200|FG001|Overall Study|Ongoing|0|||
144494616|NCT01770860|521007201|FG000|Overall Study|Withdrawal by Subject|4|||
144494617|NCT01770860|521007201|FG000|Overall Study|Lost to Follow-up|1|||
144494618|NCT01770860|521007201|FG000|Overall Study|Administrative decision made by the PI|1|||
144494619|NCT01528709|521007202|FG000|Overall Study|Death|2|||
144494620|NCT01528709|521007203|FG001|Overall Study|Death|0|||
144494621|NCT01528709|521007202|FG000|Overall Study|Withdrawal by Subject|10|||
144494622|NCT01528709|521007203|FG001|Overall Study|Withdrawal by Subject|15|||
144494623|NCT01528709|521007202|FG000|Overall Study|allergy|1|||
144494624|NCT01528709|521007203|FG001|Overall Study|allergy|0|||
144494625|NCT01237678|521007204|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
144494626|NCT01237678|521007205|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
144494627|NCT01237678|521007206|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
144494628|NCT01237678|521007204|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
144494629|NCT01237678|521007205|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
144494630|NCT01237678|521007206|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
144494631|NCT01237678|521007204|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
144494632|NCT01237678|521007205|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
144494633|NCT01237678|521007206|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
144494634|NCT01237678|521007204|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
144494635|NCT01237678|521007205|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
144494636|NCT01237678|521007206|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
144494637|NCT01237678|521007204|FG000|Phase II|Adverse Event|0|||
144494638|NCT01237678|521007205|FG001|Phase II|Adverse Event|39|||
144494639|NCT01237678|521007206|FG002|Phase II|Adverse Event|9|||
144494640|NCT01237678|521007204|FG000|Phase II|Death|0|||
144494641|NCT01237678|521007205|FG001|Phase II|Death|0|||
144494642|NCT01237678|521007206|FG002|Phase II|Death|2|||
144494643|NCT01237678|521007204|FG000|Phase II|Lack of Efficacy|0|||
144494644|NCT01237678|521007205|FG001|Phase II|Lack of Efficacy|25|||
144494645|NCT01237678|521007206|FG002|Phase II|Lack of Efficacy|3|||
144369993|NCT00705016|520562778|FG000|Overall Study|Adverse Event|6|||
144369994|NCT00705016|520562779|FG001|Overall Study|Adverse Event|11|||
144494646|NCT01237678|521007204|FG000|Phase II|Withdrawal by Subject|0|||
144494647|NCT01237678|521007205|FG001|Phase II|Withdrawal by Subject|1|||
144494648|NCT01237678|521007206|FG002|Phase II|Withdrawal by Subject|5|||
144494649|NCT01237678|521007204|FG000|Phase II|Completed Cycles 4-6|0|||
144494650|NCT01237678|521007205|FG001|Phase II|Completed Cycles 4-6|11|||
144494651|NCT01237678|521007206|FG002|Phase II|Completed Cycles 4-6|21|||
144494652|NCT01237678|521007204|FG000|Phase II|Sponsor Decision/Study Closed|0|||
144494653|NCT01237678|521007205|FG001|Phase II|Sponsor Decision/Study Closed|18|||
144494654|NCT01237678|521007206|FG002|Phase II|Sponsor Decision/Study Closed|7|||
144494655|NCT01237678|521007204|FG000|Phase II|Randomized but were not treated|0|||
144494656|NCT01237678|521007205|FG001|Phase II|Randomized but were not treated|4|||
144494657|NCT01237678|521007206|FG002|Phase II|Randomized but were not treated|3|||
144494658|NCT01648283|521007212|FG000|Overall Study|Withdrawal by Subject|14|||
144494659|NCT03005288|521007222|FG000|Overall Study|Withdrawal by Subject|7|||
144494660|NCT03005288|521007223|FG001|Overall Study|Withdrawal by Subject|5|||
144494661|NCT03005288|521007222|FG000|Overall Study|Lost to Follow-up|0|||
144494662|NCT03005288|521007223|FG001|Overall Study|Lost to Follow-up|1|||
144494663|NCT03005288|521007222|FG000|Overall Study|Adverse Event|5|||
144494664|NCT03005288|521007223|FG001|Overall Study|Adverse Event|0|||
144494665|NCT03005288|521007222|FG000|Overall Study|Protocol deviation|0|||
144494666|NCT03005288|521007223|FG001|Overall Study|Protocol deviation|1|||
144494667|NCT03005288|521007222|FG000|Overall Study|Physician Decision|0|||
144494668|NCT03005288|521007223|FG001|Overall Study|Physician Decision|1|||
144494669|NCT03590743|521007227|FG000|Overall Study|Withdrawal by Subject|0|||
144494670|NCT03590743|521007228|FG001|Overall Study|Withdrawal by Subject|1|||
144494671|NCT01221181|521007236|FG000|Overall Study|Lost to Follow-up|1|||
144494672|NCT00429793|521007237|FG000|Overall Study|Improper pre-protocol treatment|3|||
144494673|NCT00429793|521007237|FG000|Overall Study|Required test not done|1|||
144494674|NCT00429793|521007237|FG000|Overall Study|Never treated|1|||
144494675|NCT00429793|521007237|FG000|Overall Study|Non-measurable|1|||
144494676|NCT01394991|521007238|FG000|Overall Study|Adverse Event|0|||
144494677|NCT01394991|521007239|FG001|Overall Study|Adverse Event|4|||
144494678|NCT01394991|521007238|FG000|Overall Study|Lack of Efficacy|5|||
144494679|NCT01394991|521007239|FG001|Overall Study|Lack of Efficacy|7|||
144494680|NCT01394991|521007238|FG000|Overall Study|Lost to Follow-up|6|||
144494681|NCT01394991|521007239|FG001|Overall Study|Lost to Follow-up|8|||
144719032|NCT04081337|521825807|FG000|Overall Study|Adverse Event|0|||
144719033|NCT04081337|521825808|FG001|Overall Study|Adverse Event|1|||
144719034|NCT04081337|521825807|FG000|Overall Study|Withdrawal by Subject|2|||
144719035|NCT04081337|521825808|FG001|Overall Study|Withdrawal by Subject|0|||
144719036|NCT04081337|521825807|FG000|Overall Study|Physician Decision|1|||
144719037|NCT04081337|521825808|FG001|Overall Study|Physician Decision|2|||
144719038|NCT04081337|521825807|FG000|Overall Study|Lost to Follow-up|1|||
144719039|NCT04081337|521825808|FG001|Overall Study|Lost to Follow-up|0|||
144719040|NCT02637076|521825809|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
144719041|NCT02637076|521825810|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
144719042|NCT02637076|521825809|FG000|Overall Study|Withdrawal by Subject|0|||
144719043|NCT02637076|521825810|FG001|Overall Study|Withdrawal by Subject|4|||
144719044|NCT01464827|521825812|FG000|Overall Study|Adverse Event|0|||
144719045|NCT01464827|521825813|FG001|Overall Study|Adverse Event|0|||
144719046|NCT01464827|521825814|FG002|Overall Study|Adverse Event|0|||
144719047|NCT01464827|521825815|FG003|Overall Study|Adverse Event|0|||
144719048|NCT01464827|521825816|FG004|Overall Study|Adverse Event|0|||
144719049|NCT01464827|521825817|FG005|Overall Study|Adverse Event|0|||
144719050|NCT01464827|521825818|FG006|Overall Study|Adverse Event|0|||
144719051|NCT01464827|521825819|FG007|Overall Study|Adverse Event|0|||
144719052|NCT01464827|521825820|FG008|Overall Study|Adverse Event|0|||
144719053|NCT01464827|521825821|FG009|Overall Study|Adverse Event|0|||
144719054|NCT01464827|521825822|FG010|Overall Study|Adverse Event|0|||
144719055|NCT01464827|521825823|FG011|Overall Study|Adverse Event|0|||
144719056|NCT01464827|521825824|FG012|Overall Study|Adverse Event|1|||
144719057|NCT01464827|521825825|FG013|Overall Study|Adverse Event|0|||
144719058|NCT01464827|521825812|FG000|Overall Study|Withdrawal by Subject|1|||
144719059|NCT01464827|521825813|FG001|Overall Study|Withdrawal by Subject|0|||
144719060|NCT01464827|521825814|FG002|Overall Study|Withdrawal by Subject|0|||
144719061|NCT01464827|521825815|FG003|Overall Study|Withdrawal by Subject|0|||
144719062|NCT01464827|521825816|FG004|Overall Study|Withdrawal by Subject|1|||
144719063|NCT01464827|521825817|FG005|Overall Study|Withdrawal by Subject|0|||
144719064|NCT01464827|521825818|FG006|Overall Study|Withdrawal by Subject|0|||
144719065|NCT01464827|521825819|FG007|Overall Study|Withdrawal by Subject|1|||
144719066|NCT01464827|521825820|FG008|Overall Study|Withdrawal by Subject|0|||
144719067|NCT01464827|521825821|FG009|Overall Study|Withdrawal by Subject|0|||
144494682|NCT01394991|521007238|FG000|Overall Study|Physician Decision|1|||
144719068|NCT01464827|521825822|FG010|Overall Study|Withdrawal by Subject|0|||
144494683|NCT01394991|521007239|FG001|Overall Study|Physician Decision|3|||
144494684|NCT01394991|521007238|FG000|Overall Study|Protocol Violation|1|||
144494685|NCT01394991|521007239|FG001|Overall Study|Protocol Violation|1|||
144494686|NCT01394991|521007238|FG000|Overall Study|Withdrawal by Subject|20|||
144494687|NCT01394991|521007239|FG001|Overall Study|Withdrawal by Subject|17|||
144494688|NCT01394991|521007238|FG000|Overall Study|Chemotherapy Termination|10|||
144494689|NCT01394991|521007239|FG001|Overall Study|Chemotherapy Termination|15|||
144494690|NCT01394991|521007238|FG000|Overall Study|Disease Progression|7|||
144494691|NCT01394991|521007239|FG001|Overall Study|Disease Progression|7|||
144494692|NCT01394991|521007238|FG000|Overall Study|Prematurely Termination of Trial|9|||
144494693|NCT01394991|521007239|FG001|Overall Study|Prematurely Termination of Trial|10|||
144494694|NCT03073005|521007240|FG000|Overall Study|Death|6|||
144494695|NCT03073005|521007241|FG001|Overall Study|Death|0|||
144494696|NCT03073005|521007242|FG002|Overall Study|Death|7|||
144494697|NCT03073005|521007243|FG003|Overall Study|Death|0|||
144494698|NCT03073005|521007240|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
144494699|NCT03073005|521007241|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
144494700|NCT03073005|521007242|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
144494701|NCT03073005|521007243|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
144494702|NCT03073005|521007240|FG000|Overall Study|Lost to Follow-up|2|||
144494703|NCT03073005|521007241|FG001|Overall Study|Lost to Follow-up|2|||
144494704|NCT03073005|521007242|FG002|Overall Study|Lost to Follow-up|1|||
144494705|NCT03073005|521007243|FG003|Overall Study|Lost to Follow-up|2|||
144494706|NCT03073005|521007240|FG000|Overall Study|Withdrawal by Subject|0|||
144494707|NCT03073005|521007241|FG001|Overall Study|Withdrawal by Subject|4|||
144494708|NCT03073005|521007242|FG002|Overall Study|Withdrawal by Subject|4|||
144494709|NCT03073005|521007243|FG003|Overall Study|Withdrawal by Subject|4|||
144494710|NCT02427646|521007244|FG000|Overall Study|Lack of Efficacy|2|||
144494711|NCT02427646|521007245|FG001|Overall Study|Lack of Efficacy|3|||
144494712|NCT02427646|521007244|FG000|Overall Study|Physician Decision|1|||
144494713|NCT02427646|521007245|FG001|Overall Study|Physician Decision|4|||
144494714|NCT02427646|521007244|FG000|Overall Study|Protocol Violation|3|||
144494715|NCT02427646|521007245|FG001|Overall Study|Protocol Violation|3|||
144494716|NCT02427646|521007244|FG000|Overall Study|Bothersome hand weakness|2|||
144494717|NCT02427646|521007245|FG001|Overall Study|Bothersome hand weakness|4|||
144494718|NCT01734811|521007246|FG000|Overall Study|Lost to Follow-up|2|||
144494719|NCT01734811|521007247|FG001|Overall Study|Lost to Follow-up|3|||
144494720|NCT01734811|521007246|FG000|Overall Study|Withdrawal by Subject|2|||
144494721|NCT01734811|521007247|FG001|Overall Study|Withdrawal by Subject|0|||
144494722|NCT03824236|521007248|FG000|Overall Study|Lost to Follow-up|0|||
144494723|NCT03824236|521007249|FG001|Overall Study|Lost to Follow-up|0|||
144494724|NCT03824236|521007250|FG002|Overall Study|Lost to Follow-up|1|||
144494725|NCT01290094|521007251|FG000|Overall Study|Withdrawal by Subject|1|||
144494726|NCT01290094|521007251|FG000|Overall Study|Lost to Follow-up|5|||
144494727|NCT01712685|521007262|FG000|Overall Study|pt declined to participate before trmt|1|||
144494728|NCT01866917|521007263|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
144494729|NCT01866917|521007264|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
144494730|NCT01140347|521007265|FG000|Overall Study|Lost to Follow-up|5|||
144494731|NCT01140347|521007266|FG001|Overall Study|Lost to Follow-up|6|||
144494732|NCT01140347|521007265|FG000|Overall Study|Withdrawal by Subject|13|||
144494733|NCT01140347|521007266|FG001|Overall Study|Withdrawal by Subject|8|||
144494734|NCT00901485|521007267|FG000|Overall Study|Lack of Efficacy|0|||
144494735|NCT00901485|521007268|FG001|Overall Study|Lack of Efficacy|2|||
144494736|NCT00901485|521007267|FG000|Overall Study|Withdrawal by Subject|1|||
144494737|NCT00901485|521007268|FG001|Overall Study|Withdrawal by Subject|2|||
144494738|NCT01871285|521007269|FG000|First Intervention (1 Day)|Adverse Event|1|||
144494739|NCT01871285|521007270|FG001|First Intervention (1 Day)|Adverse Event|0|||
144494740|NCT01871285|521007271|FG002|First Intervention (1 Day)|Adverse Event|0|||
144494741|NCT01871285|521007272|FG003|First Intervention (1 Day)|Adverse Event|0|||
144494742|NCT01871285|521007269|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
144494743|NCT01871285|521007270|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
144494744|NCT01871285|521007271|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
144494745|NCT01871285|521007272|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
144494746|NCT01959880|521007273|FG000|Overall Study|Withdrawal by Subject|11|||
144494747|NCT01959880|521007274|FG001|Overall Study|Withdrawal by Subject|13|||
144494748|NCT01959880|521007275|FG002|Overall Study|Withdrawal by Subject|8|||
144494749|NCT01959880|521007276|FG003|Overall Study|Withdrawal by Subject|7|||
144494750|NCT01959880|521007273|FG000|Overall Study|Death|1|||
144494751|NCT01959880|521007274|FG001|Overall Study|Death|10|||
144494752|NCT01959880|521007275|FG002|Overall Study|Death|1|||
144494753|NCT01959880|521007276|FG003|Overall Study|Death|2|||
144494754|NCT01959880|521007273|FG000|Overall Study|Lost to Follow-up|95|||
144494755|NCT01959880|521007274|FG001|Overall Study|Lost to Follow-up|18|||
144494756|NCT01959880|521007275|FG002|Overall Study|Lost to Follow-up|15|||
144494757|NCT01959880|521007276|FG003|Overall Study|Lost to Follow-up|8|||
144494758|NCT01959880|521007273|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
144494759|NCT01959880|521007274|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
144494760|NCT01959880|521007275|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
144494761|NCT01959880|521007276|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
144494762|NCT01959880|521007273|FG000|Overall Study|Study completed early-FDA approved|1003|||
144494763|NCT01959880|521007274|FG001|Overall Study|Study completed early-FDA approved|311|||
144494764|NCT01959880|521007275|FG002|Overall Study|Study completed early-FDA approved|179|||
144494765|NCT01959880|521007276|FG003|Overall Study|Study completed early-FDA approved|152|||
144494766|NCT01919619|521007277|FG000|Overall Study|Physician Decision|1|||
144494767|NCT01919619|521007278|FG001|Overall Study|Physician Decision|1|||
144494768|NCT04978363|521009235|FG000|Overall Study|Other medical issues unrelated to the study|0|||
144494769|NCT04978363|521009236|FG001|Overall Study|Other medical issues unrelated to the study|0|||
144494770|NCT04978363|521009237|FG002|Overall Study|Other medical issues unrelated to the study|0|||
144494771|NCT04978363|521009238|FG003|Overall Study|Other medical issues unrelated to the study|0|||
144494772|NCT04978363|521009239|FG004|Overall Study|Other medical issues unrelated to the study|1|||
144494773|NCT04978363|521009240|FG005|Overall Study|Other medical issues unrelated to the study|0|||
144494774|NCT04978363|521009241|FG006|Overall Study|Other medical issues unrelated to the study|0|||
144494775|NCT04978363|521009242|FG007|Overall Study|Other medical issues unrelated to the study|0|||
144494776|NCT04978363|521009243|FG008|Overall Study|Other medical issues unrelated to the study|0|||
144494777|NCT04978363|521009244|FG009|Overall Study|Other medical issues unrelated to the study|0|||
144494778|NCT04978363|521009245|FG010|Overall Study|Other medical issues unrelated to the study|0|||
144494779|NCT04978363|521009235|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
144494780|NCT04978363|521009236|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
144494781|NCT04978363|521009237|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
144494782|NCT04978363|521009238|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
144494783|NCT04978363|521009239|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
144494784|NCT04978363|521009240|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
144494785|NCT04978363|521009241|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
144494786|NCT04978363|521009242|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
144494787|NCT04978363|521009243|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
144494788|NCT04978363|521009244|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
144494789|NCT04978363|521009245|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
144494790|NCT04978363|521009235|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494791|NCT04978363|521009236|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
144494792|NCT04978363|521009237|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494793|NCT04978363|521009238|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494794|NCT04978363|521009239|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494795|NCT04978363|521009240|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494796|NCT04978363|521009241|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494797|NCT04978363|521009242|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494798|NCT04978363|521009243|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494799|NCT04978363|521009244|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494800|NCT04978363|521009245|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
144494801|NCT00049517|521009247|FG000|Induction|Disease progression|0|||
144494802|NCT00049517|521009248|FG001|Induction|Disease progression|0|||
144494803|NCT00049517|521009249|FG002|Induction|Disease progression|0|||
144494804|NCT00049517|521009250|FG003|Induction|Disease progression|0|||
144494805|NCT00049517|521009251|FG004|Induction|Disease progression|18|||
144494806|NCT00049517|521009252|FG005|Induction|Disease progression|11|||
144369995|NCT00705016|520562780|FG002|Overall Study|Adverse Event|10|||
144494807|NCT00049517|521009247|FG000|Induction|Adverse Event|0|||
144494808|NCT00049517|521009248|FG001|Induction|Adverse Event|0|||
144494809|NCT00049517|521009249|FG002|Induction|Adverse Event|0|||
144494810|NCT00049517|521009250|FG003|Induction|Adverse Event|0|||
144494811|NCT00049517|521009251|FG004|Induction|Adverse Event|5|||
144369996|NCT00705016|520562778|FG000|Overall Study|Death|5|||
144494812|NCT00049517|521009252|FG005|Induction|Adverse Event|7|||
144494813|NCT00049517|521009247|FG000|Induction|Death|0|||
144494814|NCT00049517|521009248|FG001|Induction|Death|0|||
144494815|NCT00049517|521009249|FG002|Induction|Death|0|||
144494816|NCT00049517|521009250|FG003|Induction|Death|0|||
144494817|NCT00049517|521009251|FG004|Induction|Death|9|||
144494818|NCT00049517|521009252|FG005|Induction|Death|6|||
144494819|NCT00049517|521009247|FG000|Induction|Withdrawal by Subject|0|||
144494820|NCT00049517|521009248|FG001|Induction|Withdrawal by Subject|0|||
144494821|NCT00049517|521009249|FG002|Induction|Withdrawal by Subject|0|||
144494822|NCT00049517|521009250|FG003|Induction|Withdrawal by Subject|0|||
144494823|NCT00049517|521009251|FG004|Induction|Withdrawal by Subject|1|||
144494824|NCT00049517|521009252|FG005|Induction|Withdrawal by Subject|3|||
144494825|NCT00049517|521009247|FG000|Induction|Alternative therapy|0|||
144494826|NCT00049517|521009248|FG001|Induction|Alternative therapy|0|||
144494827|NCT00049517|521009249|FG002|Induction|Alternative therapy|0|||
144494828|NCT00049517|521009250|FG003|Induction|Alternative therapy|0|||
144494829|NCT00049517|521009251|FG004|Induction|Alternative therapy|2|||
144494830|NCT00049517|521009252|FG005|Induction|Alternative therapy|2|||
144494831|NCT00049517|521009247|FG000|Induction|Other complicating disease|0|||
144494832|NCT00049517|521009248|FG001|Induction|Other complicating disease|0|||
144494833|NCT00049517|521009249|FG002|Induction|Other complicating disease|0|||
144494834|NCT00049517|521009250|FG003|Induction|Other complicating disease|0|||
144494835|NCT00049517|521009251|FG004|Induction|Other complicating disease|3|||
144494836|NCT00049517|521009252|FG005|Induction|Other complicating disease|0|||
144494837|NCT00049517|521009247|FG000|Induction|Reasons not reported|0|||
144494838|NCT00049517|521009248|FG001|Induction|Reasons not reported|0|||
144494839|NCT00049517|521009249|FG002|Induction|Reasons not reported|0|||
144494840|NCT00049517|521009250|FG003|Induction|Reasons not reported|0|||
144494841|NCT00049517|521009251|FG004|Induction|Reasons not reported|22|||
144494842|NCT00049517|521009252|FG005|Induction|Reasons not reported|25|||
144494843|NCT00049517|521009247|FG000|Conditioning/Transplant|Disease progression|14|||
144494844|NCT00049517|521009248|FG001|Conditioning/Transplant|Disease progression|6|||
144494845|NCT00049517|521009249|FG002|Conditioning/Transplant|Disease progression|10|||
144494846|NCT00049517|521009250|FG003|Conditioning/Transplant|Disease progression|6|||
144494847|NCT00049517|521009251|FG004|Conditioning/Transplant|Disease progression|0|||
144494848|NCT00049517|521009252|FG005|Conditioning/Transplant|Disease progression|0|||
144494849|NCT00049517|521009247|FG000|Conditioning/Transplant|Adverse Event|2|||
144494850|NCT00049517|521009248|FG001|Conditioning/Transplant|Adverse Event|1|||
144494851|NCT00049517|521009249|FG002|Conditioning/Transplant|Adverse Event|4|||
144494852|NCT00049517|521009250|FG003|Conditioning/Transplant|Adverse Event|8|||
144494853|NCT00049517|521009251|FG004|Conditioning/Transplant|Adverse Event|0|||
144494854|NCT00049517|521009252|FG005|Conditioning/Transplant|Adverse Event|0|||
144494855|NCT00049517|521009247|FG000|Conditioning/Transplant|Death|1|||
144494856|NCT00049517|521009248|FG001|Conditioning/Transplant|Death|0|||
144494857|NCT00049517|521009249|FG002|Conditioning/Transplant|Death|0|||
144494858|NCT00049517|521009250|FG003|Conditioning/Transplant|Death|2|||
144494859|NCT00049517|521009251|FG004|Conditioning/Transplant|Death|0|||
144494860|NCT00049517|521009252|FG005|Conditioning/Transplant|Death|0|||
144494861|NCT00049517|521009247|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
144494862|NCT00049517|521009248|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
144494863|NCT00049517|521009249|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
144494864|NCT00049517|521009250|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
144494865|NCT00049517|521009251|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
144494866|NCT00049517|521009252|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
144494867|NCT00049517|521009247|FG000|Conditioning/Transplant|Alternative therapy|4|||
144494868|NCT00049517|521009248|FG001|Conditioning/Transplant|Alternative therapy|4|||
144494869|NCT00049517|521009249|FG002|Conditioning/Transplant|Alternative therapy|2|||
144494870|NCT00049517|521009250|FG003|Conditioning/Transplant|Alternative therapy|1|||
144494871|NCT00049517|521009251|FG004|Conditioning/Transplant|Alternative therapy|1|||
144494872|NCT00049517|521009252|FG005|Conditioning/Transplant|Alternative therapy|0|||
144494873|NCT00049517|521009247|FG000|Conditioning/Transplant|Other complicating disease|2|||
144494874|NCT00049517|521009248|FG001|Conditioning/Transplant|Other complicating disease|0|||
144494875|NCT00049517|521009249|FG002|Conditioning/Transplant|Other complicating disease|0|||
144494876|NCT00049517|521009250|FG003|Conditioning/Transplant|Other complicating disease|4|||
144494877|NCT00049517|521009251|FG004|Conditioning/Transplant|Other complicating disease|0|||
144494878|NCT00049517|521009252|FG005|Conditioning/Transplant|Other complicating disease|1|||
144494879|NCT00049517|521009247|FG000|Conditioning/Transplant|Reasons not reported|25|||
144494880|NCT00049517|521009248|FG001|Conditioning/Transplant|Reasons not reported|31|||
144494881|NCT00049517|521009249|FG002|Conditioning/Transplant|Reasons not reported|18|||
144494882|NCT00049517|521009250|FG003|Conditioning/Transplant|Reasons not reported|15|||
144494883|NCT00049517|521009251|FG004|Conditioning/Transplant|Reasons not reported|5|||
144494884|NCT00049517|521009252|FG005|Conditioning/Transplant|Reasons not reported|5|||
144494885|NCT00940017|521009253|FG000|Overall Study|did not meet entrance criteria|3|||
144494886|NCT00940017|521009253|FG000|Overall Study|Adverse Event|1|||
144494887|NCT01684046|521009256|FG000|Period 1, First 30 Days|Adverse Event|0|||
144494888|NCT01684046|521009257|FG001|Period 1, First 30 Days|Adverse Event|2|||
144494889|NCT01575860|521009258|FG000|Overall Study|Withdrawal by Subject|1|||
144494890|NCT01575860|521009258|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
144494891|NCT00582790|521009268|FG000|Overall Study|Rapid progression of disease|1|||
144494892|NCT03681691|521009269|FG000|Overall Study|COVID|1|||
144494893|NCT03681691|521009270|FG001|Overall Study|COVID|0|||
144494894|NCT03681691|521009269|FG000|Overall Study|prolonged bleeding|1|||
144494895|NCT03681691|521009270|FG001|Overall Study|prolonged bleeding|0|||
144494896|NCT03681691|521009269|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
144494897|NCT03681691|521009270|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
144494898|NCT02334306|521009271|FG000|Double-blind Period|Adverse Event|0|||
144494899|NCT02334306|521009272|FG001|Double-blind Period|Adverse Event|1|||
144494900|NCT02334306|521009271|FG000|Double-blind Period|Withdrawal by Subject|1|||
144494901|NCT02334306|521009272|FG001|Double-blind Period|Withdrawal by Subject|1|||
144494902|NCT01687270|521009273|FG000|Overall Study|Lack of Efficacy|11|||
144494903|NCT01687270|521009273|FG000|Overall Study|Lost to Follow-up|1|||
144494904|NCT00465985|521009274|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
144494905|NCT00465985|521009275|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
144494906|NCT00465985|521009274|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
144494907|NCT00465985|521009275|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
144494908|NCT00465985|521009274|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
144494909|NCT00465985|521009275|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
144494910|NCT00465985|521009274|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
144494911|NCT00465985|521009275|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
144494912|NCT03302156|521009276|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
144494913|NCT03302156|521009277|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
144494914|NCT03302156|521009278|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
144494915|NCT03532178|521009279|FG000|First Period|Withdrawal by Subject|1|||
144494916|NCT03532178|521009280|FG001|First Period|Withdrawal by Subject|3|||
144494917|NCT03532178|521009279|FG000|First Period|technical issues in data collection Technical issues|0|||
144494918|NCT03532178|521009280|FG001|First Period|technical issues in data collection Technical issues|1|||
144494919|NCT03532178|521009279|FG000|Second Period|Withdrawal by Subject|1|||
144494920|NCT03532178|521009280|FG001|Second Period|Withdrawal by Subject|1|||
144494921|NCT03532178|521009279|FG000|Second Period|Technical issues|0|||
144494922|NCT03532178|521009280|FG001|Second Period|Technical issues|1|||
144494923|NCT03635112|521009281|FG000|Overall Study|Adverse Event|5|||
144494924|NCT03635112|521009282|FG001|Overall Study|Adverse Event|9|||
144494925|NCT03635112|521009283|FG002|Overall Study|Adverse Event|14|||
144494926|NCT03635112|521009281|FG000|Overall Study|Lost to Follow-up|1|||
144719069|NCT01464827|521825823|FG011|Overall Study|Withdrawal by Subject|0|||
144719070|NCT01464827|521825824|FG012|Overall Study|Withdrawal by Subject|0|||
144719071|NCT01464827|521825825|FG013|Overall Study|Withdrawal by Subject|0|||
144719072|NCT01464827|521825812|FG000|Overall Study|Lost to Follow-up|0|||
144719073|NCT01464827|521825813|FG001|Overall Study|Lost to Follow-up|2|||
144719074|NCT01464827|521825814|FG002|Overall Study|Lost to Follow-up|0|||
144719075|NCT01464827|521825815|FG003|Overall Study|Lost to Follow-up|2|||
144719076|NCT01464827|521825816|FG004|Overall Study|Lost to Follow-up|3|||
144719077|NCT01464827|521825817|FG005|Overall Study|Lost to Follow-up|1|||
144719078|NCT01464827|521825818|FG006|Overall Study|Lost to Follow-up|2|||
144719079|NCT01464827|521825819|FG007|Overall Study|Lost to Follow-up|2|||
144719080|NCT01464827|521825820|FG008|Overall Study|Lost to Follow-up|0|||
144719081|NCT01464827|521825821|FG009|Overall Study|Lost to Follow-up|0|||
144719082|NCT01464827|521825822|FG010|Overall Study|Lost to Follow-up|0|||
144719083|NCT01464827|521825823|FG011|Overall Study|Lost to Follow-up|1|||
144719084|NCT01464827|521825824|FG012|Overall Study|Lost to Follow-up|0|||
144719085|NCT01464827|521825825|FG013|Overall Study|Lost to Follow-up|1|||
144719086|NCT01464827|521825812|FG000|Overall Study|Other|2|||
144719087|NCT01464827|521825813|FG001|Overall Study|Other|3|||
144719088|NCT01464827|521825814|FG002|Overall Study|Other|0|||
144719089|NCT01464827|521825815|FG003|Overall Study|Other|2|||
144719090|NCT01464827|521825816|FG004|Overall Study|Other|3|||
144719091|NCT01464827|521825817|FG005|Overall Study|Other|0|||
144719092|NCT01464827|521825818|FG006|Overall Study|Other|1|||
144719093|NCT01464827|521825819|FG007|Overall Study|Other|0|||
144719094|NCT01464827|521825820|FG008|Overall Study|Other|3|||
144719095|NCT01464827|521825821|FG009|Overall Study|Other|1|||
144719096|NCT01464827|521825822|FG010|Overall Study|Other|2|||
144719097|NCT01464827|521825823|FG011|Overall Study|Other|0|||
144719098|NCT01464827|521825824|FG012|Overall Study|Other|1|||
144719099|NCT01464827|521825825|FG013|Overall Study|Other|0|||
144719100|NCT01464827|521825812|FG000|Overall Study|Not Treated|0|||
144719101|NCT01464827|521825813|FG001|Overall Study|Not Treated|2|||
144719102|NCT01464827|521825814|FG002|Overall Study|Not Treated|0|||
144719103|NCT01464827|521825815|FG003|Overall Study|Not Treated|0|||
144719104|NCT01464827|521825816|FG004|Overall Study|Not Treated|1|||
144719105|NCT01464827|521825817|FG005|Overall Study|Not Treated|0|||
144719106|NCT01464827|521825818|FG006|Overall Study|Not Treated|1|||
144719107|NCT01464827|521825819|FG007|Overall Study|Not Treated|0|||
144719108|NCT01464827|521825820|FG008|Overall Study|Not Treated|0|||
144719109|NCT01464827|521825821|FG009|Overall Study|Not Treated|2|||
144719110|NCT01464827|521825822|FG010|Overall Study|Not Treated|0|||
144719111|NCT01464827|521825823|FG011|Overall Study|Not Treated|1|||
144719112|NCT01464827|521825824|FG012|Overall Study|Not Treated|0|||
144719113|NCT01464827|521825825|FG013|Overall Study|Not Treated|2|||
144719114|NCT03487796|521825826|FG000|Overall Study|Lost to Follow-up|18|||
144719115|NCT03487796|521825827|FG001|Overall Study|Lost to Follow-up|6|||
144719116|NCT00613574|521825836|FG000|Overall Study|Adverse Event|3|||
144719117|NCT00613574|521825836|FG000|Overall Study|Lost to Follow-up|2|||
144719118|NCT00613574|521825836|FG000|Overall Study|Other|1|||
144719119|NCT02711956|521825838|FG000|Overall Study|Adverse Event|0|||
144719120|NCT02711956|521825839|FG001|Overall Study|Adverse Event|0|||
144719121|NCT02711956|521825840|FG002|Overall Study|Adverse Event|0|||
144719122|NCT02711956|521825841|FG003|Overall Study|Adverse Event|1|||
144719123|NCT02711956|521825842|FG004|Overall Study|Adverse Event|2|||
144719124|NCT02711956|521825843|FG005|Overall Study|Adverse Event|0|||
144719125|NCT02711956|521825844|FG006|Overall Study|Adverse Event|0|||
144719126|NCT02711956|521825845|FG007|Overall Study|Adverse Event|1|||
144719127|NCT02711956|521825846|FG008|Overall Study|Adverse Event|1|||
144719128|NCT02711956|521825847|FG009|Overall Study|Adverse Event|1|||
144719129|NCT02711956|521825848|FG010|Overall Study|Adverse Event|1|||
144719130|NCT02711956|521825849|FG011|Overall Study|Adverse Event|0|||
144719131|NCT02711956|521825850|FG012|Overall Study|Adverse Event|0|||
144719132|NCT02711956|521825851|FG013|Overall Study|Adverse Event|0|||
144719133|NCT02711956|521825852|FG014|Overall Study|Adverse Event|2|||
144719134|NCT02711956|521825838|FG000|Overall Study|Physician Decision|0|||
144494927|NCT03635112|521009282|FG001|Overall Study|Lost to Follow-up|0|||
144719135|NCT02711956|521825839|FG001|Overall Study|Physician Decision|0|||
144719136|NCT02711956|521825840|FG002|Overall Study|Physician Decision|0|||
144719137|NCT02711956|521825841|FG003|Overall Study|Physician Decision|2|||
144719138|NCT02711956|521825842|FG004|Overall Study|Physician Decision|0|||
144719139|NCT02711956|521825843|FG005|Overall Study|Physician Decision|0|||
144719140|NCT02711956|521825844|FG006|Overall Study|Physician Decision|0|||
144719141|NCT02711956|521825845|FG007|Overall Study|Physician Decision|0|||
144719142|NCT02711956|521825846|FG008|Overall Study|Physician Decision|0|||
144719143|NCT02711956|521825847|FG009|Overall Study|Physician Decision|0|||
144494928|NCT03635112|521009283|FG002|Overall Study|Lost to Follow-up|1|||
144494929|NCT03635112|521009281|FG000|Overall Study|Physician Decision|5|||
144494930|NCT03635112|521009282|FG001|Overall Study|Physician Decision|7|||
144494931|NCT03635112|521009283|FG002|Overall Study|Physician Decision|5|||
144494932|NCT03635112|521009281|FG000|Overall Study|Protocol Violation|0|||
144494933|NCT03635112|521009282|FG001|Overall Study|Protocol Violation|0|||
144494934|NCT03635112|521009283|FG002|Overall Study|Protocol Violation|1|||
144494935|NCT03635112|521009281|FG000|Overall Study|Study Terminated by Sponsor|11|||
144494936|NCT03635112|521009282|FG001|Overall Study|Study Terminated by Sponsor|17|||
144494937|NCT03635112|521009283|FG002|Overall Study|Study Terminated by Sponsor|21|||
144494938|NCT03635112|521009281|FG000|Overall Study|Withdrawal by Subject|4|||
144494939|NCT03635112|521009282|FG001|Overall Study|Withdrawal by Subject|9|||
144494940|NCT03635112|521009283|FG002|Overall Study|Withdrawal by Subject|7|||
144494941|NCT03635112|521009281|FG000|Overall Study|Miscellaneous|0|||
144494942|NCT03635112|521009282|FG001|Overall Study|Miscellaneous|0|||
144494943|NCT03635112|521009283|FG002|Overall Study|Miscellaneous|1|||
144494944|NCT04296942|521009284|FG000|Overall Study|Study closure by sponsor|1|||
144494945|NCT04296942|521009285|FG001|Overall Study|Study closure by sponsor|0|||
144494946|NCT04296942|521009286|FG002|Overall Study|Study closure by sponsor|0|||
144494947|NCT03398356|521009287|FG000|Before Treatment|Lost to Follow-up|1|||
144494948|NCT03398356|521009288|FG001|Before Treatment|Lost to Follow-up|2|||
144494949|NCT03398356|521009289|FG002|Before Treatment|Lost to Follow-up|0|||
144494950|NCT03398356|521009287|FG000|Before Treatment|drug intolerance|2|||
144494951|NCT03398356|521009288|FG001|Before Treatment|drug intolerance|1|||
144494952|NCT03398356|521009289|FG002|Before Treatment|drug intolerance|0|||
144494953|NCT03398356|521009287|FG000|Before Treatment|Withdrawal by Subject|0|||
144494954|NCT03398356|521009288|FG001|Before Treatment|Withdrawal by Subject|5|||
144494955|NCT03398356|521009289|FG002|Before Treatment|Withdrawal by Subject|0|||
144494956|NCT03398356|521009287|FG000|Before Treatment|Physician Decision|0|||
144494957|NCT03398356|521009288|FG001|Before Treatment|Physician Decision|0|||
144494958|NCT03398356|521009289|FG002|Before Treatment|Physician Decision|11|||
144494959|NCT03398356|521009287|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
144494960|NCT03398356|521009288|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
144494961|NCT03398356|521009289|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
144494962|NCT02096003|521009296|FG000|Overall Study|Protocol Violation|0|||
144494963|NCT02096003|521009297|FG001|Overall Study|Protocol Violation|2|||
144494964|NCT02096003|521009296|FG000|Overall Study|additional surgery|2|||
144494965|NCT02096003|521009297|FG001|Overall Study|additional surgery|1|||
144494966|NCT01511250|521009298|FG000|Overall Study|Withdrawal of Consent|1|||
144494967|NCT01511250|521009299|FG001|Overall Study|Withdrawal of Consent|0|||
144494968|NCT01511250|521009300|FG002|Overall Study|Withdrawal of Consent|0|||
144494969|NCT01511250|521009301|FG003|Overall Study|Withdrawal of Consent|0|||
144494970|NCT01511250|521009302|FG004|Overall Study|Withdrawal of Consent|0|||
144494971|NCT01511250|521009303|FG005|Overall Study|Withdrawal of Consent|0|||
144494972|NCT01511250|521009304|FG006|Overall Study|Withdrawal of Consent|0|||
144494973|NCT01511250|521009305|FG007|Overall Study|Withdrawal of Consent|1|||
144494974|NCT01511250|521009306|FG008|Overall Study|Withdrawal of Consent|1|||
144494975|NCT01511250|521009307|FG009|Overall Study|Withdrawal of Consent|0|||
144494976|NCT01511250|521009298|FG000|Overall Study|Sponsor/Investigator Decision|1|||
144494977|NCT01511250|521009299|FG001|Overall Study|Sponsor/Investigator Decision|0|||
144494978|NCT01511250|521009300|FG002|Overall Study|Sponsor/Investigator Decision|0|||
144494979|NCT01511250|521009301|FG003|Overall Study|Sponsor/Investigator Decision|0|||
144494980|NCT01511250|521009302|FG004|Overall Study|Sponsor/Investigator Decision|0|||
144494981|NCT01511250|521009303|FG005|Overall Study|Sponsor/Investigator Decision|0|||
144494982|NCT01511250|521009304|FG006|Overall Study|Sponsor/Investigator Decision|0|||
144494983|NCT01511250|521009305|FG007|Overall Study|Sponsor/Investigator Decision|0|||
144494984|NCT01511250|521009306|FG008|Overall Study|Sponsor/Investigator Decision|0|||
144494985|NCT01511250|521009307|FG009|Overall Study|Sponsor/Investigator Decision|0|||
144494986|NCT01511250|521009298|FG000|Overall Study|Lost to Follow-up|7|||
144494987|NCT01511250|521009299|FG001|Overall Study|Lost to Follow-up|3|||
144494988|NCT01511250|521009300|FG002|Overall Study|Lost to Follow-up|3|||
144494989|NCT01511250|521009301|FG003|Overall Study|Lost to Follow-up|3|||
144494990|NCT01511250|521009302|FG004|Overall Study|Lost to Follow-up|0|||
144494991|NCT01511250|521009303|FG005|Overall Study|Lost to Follow-up|0|||
144494992|NCT01511250|521009304|FG006|Overall Study|Lost to Follow-up|2|||
144719144|NCT02711956|521825848|FG010|Overall Study|Physician Decision|0|||
144719145|NCT02711956|521825849|FG011|Overall Study|Physician Decision|0|||
144719146|NCT02711956|521825850|FG012|Overall Study|Physician Decision|0|||
144719147|NCT02711956|521825851|FG013|Overall Study|Physician Decision|0|||
144719148|NCT02711956|521825852|FG014|Overall Study|Physician Decision|0|||
144494993|NCT01511250|521009305|FG007|Overall Study|Lost to Follow-up|3|||
144494994|NCT01511250|521009306|FG008|Overall Study|Lost to Follow-up|13|||
144494995|NCT01511250|521009307|FG009|Overall Study|Lost to Follow-up|5|||
144494996|NCT01511250|521009298|FG000|Overall Study|Protocol Violation|0|||
144494997|NCT01511250|521009299|FG001|Overall Study|Protocol Violation|2|||
144494998|NCT01511250|521009300|FG002|Overall Study|Protocol Violation|1|||
144719149|NCT02711956|521825838|FG000|Overall Study|Withdrawal by Subject|0|||
144369997|NCT00705016|520562779|FG001|Overall Study|Death|7|||
144369998|NCT00705016|520562780|FG002|Overall Study|Death|5|||
144369999|NCT00705016|520562778|FG000|Overall Study|Protocol Violation|0|||
144370000|NCT00705016|520562779|FG001|Overall Study|Protocol Violation|1|||
144370001|NCT00705016|520562780|FG002|Overall Study|Protocol Violation|1|||
144370002|NCT00705016|520562778|FG000|Overall Study|Withdrawal by Subject|4|||
144370003|NCT00705016|520562779|FG001|Overall Study|Withdrawal by Subject|3|||
144370004|NCT00705016|520562780|FG002|Overall Study|Withdrawal by Subject|2|||
144370005|NCT00705016|520562778|FG000|Overall Study|Progressive Disease|33|||
144370006|NCT00705016|520562779|FG001|Overall Study|Progressive Disease|29|||
144370007|NCT00705016|520562780|FG002|Overall Study|Progressive Disease|33|||
144370008|NCT00705016|520562778|FG000|Overall Study|Symptomatic Deterioration|3|||
144370009|NCT00705016|520562779|FG001|Overall Study|Symptomatic Deterioration|1|||
144370010|NCT00705016|520562780|FG002|Overall Study|Symptomatic Deterioration|1|||
144370011|NCT00705016|520562778|FG000|Overall Study|Other|9|||
144370012|NCT00705016|520562779|FG001|Overall Study|Other|6|||
144370013|NCT00705016|520562780|FG002|Overall Study|Other|6|||
144370014|NCT00363480|520562781|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
144370015|NCT00363480|520562781|FG000|Overall Study|Adverse Event|4|||
144370016|NCT00363480|520562781|FG000|Overall Study|Lost to Follow-up|5|||
144370017|NCT00363480|520562781|FG000|Overall Study|Withdrawal by Subject|5|||
144370018|NCT00363480|520562781|FG000|Overall Study|Non-compliance of subject|1|||
144370019|NCT00363480|520562781|FG000|Overall Study|Participant discontinued on its own|1|||
144494999|NCT01511250|521009301|FG003|Overall Study|Protocol Violation|0|||
144495000|NCT01511250|521009302|FG004|Overall Study|Protocol Violation|0|||
144495001|NCT01511250|521009303|FG005|Overall Study|Protocol Violation|0|||
144495002|NCT01511250|521009304|FG006|Overall Study|Protocol Violation|0|||
144495003|NCT01511250|521009305|FG007|Overall Study|Protocol Violation|0|||
144495004|NCT01511250|521009306|FG008|Overall Study|Protocol Violation|0|||
144495005|NCT01511250|521009307|FG009|Overall Study|Protocol Violation|0|||
144495006|NCT03178201|521009308|FG000|Overall Study|Off study|5|||
144495007|NCT04668144|521009309|FG000|Overall Study|Protocol Violation|0|||
144495008|NCT04668144|521009310|FG001|Overall Study|Protocol Violation|1|||
144495009|NCT04668144|521009311|FG002|Overall Study|Protocol Violation|2|||
144495010|NCT01763047|521009312|FG000|Period 1|Test Article Not Available|4|||
144495011|NCT01763047|521009313|FG001|Period 1|Test Article Not Available|1|||
144495012|NCT01763047|521009312|FG000|Period 1|Protocol Violation|4|||
144495013|NCT01763047|521009313|FG001|Period 1|Protocol Violation|4|||
144495014|NCT01763047|521009312|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
144495015|NCT01763047|521009313|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
144495016|NCT01763047|521009312|FG000|Period 1|Adverse Event|0|||
144495017|NCT01763047|521009313|FG001|Period 1|Adverse Event|1|||
144495018|NCT01763047|521009312|FG000|Period 1|Unsatisfactory Visual Response|0|||
144495019|NCT01763047|521009313|FG001|Period 1|Unsatisfactory Visual Response|3|||
144495020|NCT01763047|521009312|FG000|Period 1|Lens Power Not Available|0|||
144495021|NCT01763047|521009313|FG001|Period 1|Lens Power Not Available|1|||
144495022|NCT01763047|521009312|FG000|Period 1|Study Site office Closed|0|||
144719150|NCT02711956|521825839|FG001|Overall Study|Withdrawal by Subject|0|||
144719151|NCT02711956|521825840|FG002|Overall Study|Withdrawal by Subject|0|||
144719152|NCT02711956|521825841|FG003|Overall Study|Withdrawal by Subject|0|||
144719153|NCT02711956|521825842|FG004|Overall Study|Withdrawal by Subject|0|||
144719154|NCT02711956|521825843|FG005|Overall Study|Withdrawal by Subject|0|||
144719155|NCT02711956|521825844|FG006|Overall Study|Withdrawal by Subject|1|||
144719156|NCT02711956|521825845|FG007|Overall Study|Withdrawal by Subject|0|||
144719157|NCT02711956|521825846|FG008|Overall Study|Withdrawal by Subject|0|||
144719158|NCT02711956|521825847|FG009|Overall Study|Withdrawal by Subject|0|||
144719159|NCT02711956|521825848|FG010|Overall Study|Withdrawal by Subject|0|||
144719160|NCT02711956|521825849|FG011|Overall Study|Withdrawal by Subject|1|||
144719161|NCT02711956|521825850|FG012|Overall Study|Withdrawal by Subject|6|||
144719162|NCT02711956|521825851|FG013|Overall Study|Withdrawal by Subject|0|||
144719163|NCT02711956|521825852|FG014|Overall Study|Withdrawal by Subject|1|||
144719164|NCT02711956|521825838|FG000|Overall Study|Clinical progression|1|||
144719165|NCT02711956|521825839|FG001|Overall Study|Clinical progression|0|||
144719166|NCT02711956|521825840|FG002|Overall Study|Clinical progression|0|||
144719167|NCT02711956|521825841|FG003|Overall Study|Clinical progression|0|||
144719168|NCT02711956|521825842|FG004|Overall Study|Clinical progression|0|||
144719169|NCT02711956|521825843|FG005|Overall Study|Clinical progression|0|||
144719170|NCT02711956|521825844|FG006|Overall Study|Clinical progression|1|||
144719171|NCT02711956|521825845|FG007|Overall Study|Clinical progression|0|||
144719172|NCT02711956|521825846|FG008|Overall Study|Clinical progression|1|||
144719173|NCT02711956|521825847|FG009|Overall Study|Clinical progression|0|||
144719174|NCT02711956|521825848|FG010|Overall Study|Clinical progression|0|||
144370020|NCT00432172|520562789|FG000|Overall Study|Physician Decision|0|||
144370021|NCT00432172|520562790|FG001|Overall Study|Physician Decision|0|||
144495023|NCT01763047|521009313|FG001|Period 1|Study Site office Closed|1|||
144495024|NCT01763047|521009312|FG000|Period 2|Lens Discomfort|1|||
144495025|NCT01763047|521009313|FG001|Period 2|Lens Discomfort|0|||
144495026|NCT01763047|521009312|FG000|Period 2|No longer meets Eligibility Criteria|1|||
144495027|NCT01763047|521009313|FG001|Period 2|No longer meets Eligibility Criteria|0|||
144495028|NCT01763047|521009312|FG000|Period 2|Study Site office Closed|1|||
144495029|NCT01763047|521009313|FG001|Period 2|Study Site office Closed|1|||
144495030|NCT01763047|521009312|FG000|Period 2|Unsatisfactory Visual Response|1|||
144495031|NCT01763047|521009313|FG001|Period 2|Unsatisfactory Visual Response|1|||
144495032|NCT01763047|521009312|FG000|Period 2|Protocol Violation|0|||
144495033|NCT01763047|521009313|FG001|Period 2|Protocol Violation|2|||
144495034|NCT01763047|521009312|FG000|Period 2|Unsatisfactory lens Fitting|0|||
144495035|NCT01763047|521009313|FG001|Period 2|Unsatisfactory lens Fitting|1|||
144495036|NCT00916006|521009316|FG000|Overall Study|Adverse Event|1|||
144495037|NCT00916006|521009317|FG001|Overall Study|Adverse Event|1|||
144495038|NCT00916006|521009316|FG000|Overall Study|Withdrawal by Subject|2|||
144495039|NCT00916006|521009317|FG001|Overall Study|Withdrawal by Subject|5|||
144495040|NCT00916006|521009316|FG000|Overall Study|Protocol Violation|0|||
144495041|NCT00916006|521009317|FG001|Overall Study|Protocol Violation|1|||
144495042|NCT01008748|521009322|FG000|Overall Study|Lost to Follow-up|80|||
144495043|NCT01008748|521009322|FG000|Overall Study|Other|1|||
144495044|NCT00832780|521009325|FG000|Overall Study|Death|16|||
144495045|NCT00832780|521009325|FG000|Overall Study|Lost to Follow-up|4|||
144495046|NCT00832780|521009325|FG000|Overall Study|no reason given|2|||
144495047|NCT00832780|521009325|FG000|Overall Study|other complicating condition|2|||
144495048|NCT00832780|521009325|FG000|Overall Study|Physician Decision|1|||
144495049|NCT02696785|521009336|FG000|Blinded Treatment Period|Adverse Event|0|||
144495050|NCT02696785|521009337|FG001|Blinded Treatment Period|Adverse Event|1|||
144495051|NCT02696785|521009338|FG002|Blinded Treatment Period|Adverse Event|3|||
144495052|NCT02696785|521009339|FG003|Blinded Treatment Period|Adverse Event|0|||
144495053|NCT02696785|521009336|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
144495054|NCT02696785|521009337|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
144495055|NCT02696785|521009338|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
144495056|NCT02696785|521009339|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
144495057|NCT02696785|521009336|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
144495058|NCT02696785|521009337|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
144495059|NCT02696785|521009338|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
144495060|NCT02696785|521009339|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
144495061|NCT02696785|521009336|FG000|Blinded Treatment Period|Screen Failure|1|||
144495062|NCT02696785|521009337|FG001|Blinded Treatment Period|Screen Failure|0|||
144495063|NCT02696785|521009338|FG002|Blinded Treatment Period|Screen Failure|0|||
144495064|NCT02696785|521009339|FG003|Blinded Treatment Period|Screen Failure|0|||
144495065|NCT02696785|521009336|FG000|Washout Period|Withdrawal by Subject|0|||
144495066|NCT02696785|521009337|FG001|Washout Period|Withdrawal by Subject|1|||
144495067|NCT02696785|521009338|FG002|Washout Period|Withdrawal by Subject|0|||
144495068|NCT02696785|521009339|FG003|Washout Period|Withdrawal by Subject|0|||
144495069|NCT02696785|521009336|FG000|Washout Period|Lack of Efficacy|0|||
144495070|NCT02696785|521009337|FG001|Washout Period|Lack of Efficacy|1|||
144495071|NCT02696785|521009338|FG002|Washout Period|Lack of Efficacy|0|||
144495072|NCT02696785|521009339|FG003|Washout Period|Lack of Efficacy|0|||
144495073|NCT02696785|521009336|FG000|Extended Treatment Period|Adverse Event|2|||
144495074|NCT02696785|521009337|FG001|Extended Treatment Period|Adverse Event|3|||
144495075|NCT02696785|521009338|FG002|Extended Treatment Period|Adverse Event|2|||
144495076|NCT02696785|521009339|FG003|Extended Treatment Period|Adverse Event|1|||
144495077|NCT02696785|521009336|FG000|Extended Treatment Period|Lack of Efficacy|0|||
144495078|NCT02696785|521009337|FG001|Extended Treatment Period|Lack of Efficacy|1|||
144495079|NCT02696785|521009338|FG002|Extended Treatment Period|Lack of Efficacy|0|||
144495080|NCT02696785|521009339|FG003|Extended Treatment Period|Lack of Efficacy|0|||
144495081|NCT02696785|521009336|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
144495082|NCT02696785|521009337|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
144495083|NCT02696785|521009338|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
144495084|NCT02696785|521009339|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
144495085|NCT02696785|521009336|FG000|Follow-up Period|Adverse Event|0|||
144495086|NCT02696785|521009337|FG001|Follow-up Period|Adverse Event|0|||
144495087|NCT02696785|521009338|FG002|Follow-up Period|Adverse Event|8|||
144495088|NCT02696785|521009339|FG003|Follow-up Period|Adverse Event|2|||
144495089|NCT02696785|521009336|FG000|Follow-up Period|Lost to Follow-up|0|||
144495090|NCT02696785|521009337|FG001|Follow-up Period|Lost to Follow-up|0|||
144495091|NCT02696785|521009338|FG002|Follow-up Period|Lost to Follow-up|0|||
144495092|NCT02696785|521009339|FG003|Follow-up Period|Lost to Follow-up|1|||
144495093|NCT02696785|521009336|FG000|Follow-up Period|Lack of Efficacy|0|||
144495094|NCT02696785|521009337|FG001|Follow-up Period|Lack of Efficacy|0|||
144495095|NCT02696785|521009338|FG002|Follow-up Period|Lack of Efficacy|0|||
144495096|NCT02696785|521009339|FG003|Follow-up Period|Lack of Efficacy|1|||
144495097|NCT02696785|521009336|FG000|Follow-up Period|Withdrawal by Subject|1|||
144495098|NCT02696785|521009337|FG001|Follow-up Period|Withdrawal by Subject|0|||
144495099|NCT02696785|521009338|FG002|Follow-up Period|Withdrawal by Subject|5|||
144495100|NCT02696785|521009339|FG003|Follow-up Period|Withdrawal by Subject|4|||
144495101|NCT04863898|521009343|FG000|Overall Study|Away from study clinic during intervention training period|2|||
144495102|NCT04863898|521009343|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
144495103|NCT04863898|521009343|FG000|Overall Study|Lost to Follow-up|3|||
144495104|NCT04863898|521009343|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
144495105|NCT04863898|521009343|FG000|Overall Study|No longer employed at clinic|3|||
144495106|NCT02487446|521009351|FG000|Period 1|Physician Decision|0|||
144495107|NCT02487446|521009352|FG001|Period 1|Physician Decision|1|||
144495108|NCT02487446|521009351|FG000|Period 1|Lack of Efficacy|1|||
144495109|NCT02487446|521009352|FG001|Period 1|Lack of Efficacy|0|||
144495110|NCT02487446|521009351|FG000|Period 1|Protocol deviation|3|||
144495111|NCT02487446|521009352|FG001|Period 1|Protocol deviation|2|||
144495112|NCT02487446|521009351|FG000|Period 1|Lost to Follow-up|2|||
144495113|NCT02487446|521009352|FG001|Period 1|Lost to Follow-up|0|||
144495114|NCT02487446|521009351|FG000|Period 1|Withdrawal by Subject|2|||
144495115|NCT02487446|521009352|FG001|Period 1|Withdrawal by Subject|0|||
144495116|NCT02487446|521009351|FG000|Period 1|Adverse Event|5|||
144495117|NCT02487446|521009352|FG001|Period 1|Adverse Event|5|||
144495118|NCT02487446|521009351|FG000|Washout|Lost to Follow-up|0|||
144495119|NCT02487446|521009352|FG001|Washout|Lost to Follow-up|2|||
144495120|NCT02487446|521009351|FG000|Washout|Withdrawal by Subject|1|||
144495121|NCT02487446|521009352|FG001|Washout|Withdrawal by Subject|4|||
144495122|NCT02487446|521009351|FG000|Washout|Adverse Event|2|||
144495123|NCT02487446|521009352|FG001|Washout|Adverse Event|2|||
144495124|NCT02487446|521009351|FG000|Period 2|Protocol deviation|0|||
144495125|NCT02487446|521009352|FG001|Period 2|Protocol deviation|1|||
144495126|NCT02487446|521009351|FG000|Period 2|Lost to Follow-up|1|||
144495127|NCT02487446|521009352|FG001|Period 2|Lost to Follow-up|1|||
144495128|NCT02487446|521009351|FG000|Period 2|Withdrawal by Subject|1|||
144495129|NCT02487446|521009352|FG001|Period 2|Withdrawal by Subject|1|||
144495130|NCT02487446|521009351|FG000|Period 2|Adverse Event|6|||
144495131|NCT02487446|521009352|FG001|Period 2|Adverse Event|2|||
144495132|NCT01822821|521009353|FG000|Overall Study|Eligible surgery cancelled|1|||
144495133|NCT01822821|521009354|FG001|Overall Study|Eligible surgery cancelled|1|||
144495134|NCT01822821|521009353|FG000|Overall Study|Other reasons|1|||
144495135|NCT01822821|521009354|FG001|Overall Study|Other reasons|0|||
144495136|NCT02320253|521009355|FG000|Overall Study|Withdrawal by Subject|3|||
144495137|NCT02320253|521009356|FG001|Overall Study|Withdrawal by Subject|0|||
144495138|NCT02320253|521009357|FG002|Overall Study|Withdrawal by Subject|0|||
144495139|NCT02320253|521009355|FG000|Overall Study|Lost to Follow-up|2|||
144495140|NCT02320253|521009356|FG001|Overall Study|Lost to Follow-up|2|||
144495141|NCT02320253|521009357|FG002|Overall Study|Lost to Follow-up|1|||
144495142|NCT02320253|521009355|FG000|Overall Study|Death|1|||
144495143|NCT02320253|521009356|FG001|Overall Study|Death|0|||
144719175|NCT02711956|521825849|FG011|Overall Study|Clinical progression|2|||
144719176|NCT02711956|521825850|FG012|Overall Study|Clinical progression|4|||
144719177|NCT02711956|521825851|FG013|Overall Study|Clinical progression|1|||
144719178|NCT02711956|521825852|FG014|Overall Study|Clinical progression|1|||
144719179|NCT02711956|521825838|FG000|Overall Study|Radiographic progression|1|||
144719180|NCT02711956|521825839|FG001|Overall Study|Radiographic progression|1|||
144719181|NCT02711956|521825840|FG002|Overall Study|Radiographic progression|2|||
144495144|NCT02320253|521009357|FG002|Overall Study|Death|1|||
144495145|NCT05750745|521009358|FG000|Overall Study|Adverse Event|1|||
144495146|NCT05750745|521009359|FG001|Overall Study|Adverse Event|0|||
144495147|NCT05750745|521009360|FG002|Overall Study|Adverse Event|0|||
144719182|NCT02711956|521825841|FG003|Overall Study|Radiographic progression|0|||
144495148|NCT05750745|521009358|FG000|Overall Study|Protocol Violation|1|||
144495149|NCT05750745|521009359|FG001|Overall Study|Protocol Violation|0|||
144495150|NCT05750745|521009360|FG002|Overall Study|Protocol Violation|0|||
144495151|NCT05750745|521009358|FG000|Overall Study|Withdrawal by Subject|0|||
144495152|NCT05750745|521009359|FG001|Overall Study|Withdrawal by Subject|1|||
144495153|NCT05750745|521009360|FG002|Overall Study|Withdrawal by Subject|0|||
144495154|NCT05780047|521009362|FG000|Overall Study|Did not submit baseline urine test kit|226|||
144495155|NCT05780047|521009362|FG000|Overall Study|Lost to Follow-up|34|||
144495156|NCT05780047|521009362|FG000|Overall Study|Did not submit second urine test kit|124|||
144495157|NCT00783692|521009372|FG000|Induction Phase|Adverse Event|7|||
144495158|NCT00783692|521009373|FG001|Induction Phase|Adverse Event|9|||
144495159|NCT00783692|521009374|FG002|Induction Phase|Adverse Event|24|||
144495160|NCT00783692|521009375|FG003|Induction Phase|Adverse Event|0|||
144495161|NCT00783692|521009376|FG004|Induction Phase|Adverse Event|0|||
144495162|NCT00783692|521009377|FG005|Induction Phase|Adverse Event|0|||
144495163|NCT00783692|521009378|FG006|Induction Phase|Adverse Event|0|||
144495164|NCT00783692|521009372|FG000|Induction Phase|Protocol Violation|0|||
144495165|NCT00783692|521009373|FG001|Induction Phase|Protocol Violation|0|||
144495166|NCT00783692|521009374|FG002|Induction Phase|Protocol Violation|1|||
144495167|NCT00783692|521009375|FG003|Induction Phase|Protocol Violation|0|||
144495168|NCT00783692|521009376|FG004|Induction Phase|Protocol Violation|0|||
144495169|NCT00783692|521009377|FG005|Induction Phase|Protocol Violation|0|||
144495170|NCT00783692|521009378|FG006|Induction Phase|Protocol Violation|0|||
144495171|NCT00783692|521009372|FG000|Induction Phase|Lack of Efficacy|1|||
144495172|NCT00783692|521009373|FG001|Induction Phase|Lack of Efficacy|3|||
144495173|NCT00783692|521009374|FG002|Induction Phase|Lack of Efficacy|28|||
144495174|NCT00783692|521009375|FG003|Induction Phase|Lack of Efficacy|0|||
144495175|NCT00783692|521009376|FG004|Induction Phase|Lack of Efficacy|0|||
144495176|NCT00783692|521009377|FG005|Induction Phase|Lack of Efficacy|0|||
144495177|NCT00783692|521009378|FG006|Induction Phase|Lack of Efficacy|0|||
144495178|NCT00783692|521009372|FG000|Induction Phase|Withdrawal by Subject|3|||
144495179|NCT00783692|521009373|FG001|Induction Phase|Withdrawal by Subject|9|||
144495180|NCT00783692|521009374|FG002|Induction Phase|Withdrawal by Subject|16|||
144495181|NCT00783692|521009375|FG003|Induction Phase|Withdrawal by Subject|0|||
144495182|NCT00783692|521009376|FG004|Induction Phase|Withdrawal by Subject|0|||
144495183|NCT00783692|521009377|FG005|Induction Phase|Withdrawal by Subject|0|||
144495184|NCT00783692|521009378|FG006|Induction Phase|Withdrawal by Subject|0|||
144495185|NCT00783692|521009372|FG000|Induction Phase|Lost to Follow-up|0|||
144495186|NCT00783692|521009373|FG001|Induction Phase|Lost to Follow-up|0|||
144495187|NCT00783692|521009374|FG002|Induction Phase|Lost to Follow-up|3|||
144495188|NCT00783692|521009375|FG003|Induction Phase|Lost to Follow-up|0|||
144495189|NCT00783692|521009376|FG004|Induction Phase|Lost to Follow-up|0|||
144495190|NCT00783692|521009377|FG005|Induction Phase|Lost to Follow-up|0|||
144495191|NCT00783692|521009378|FG006|Induction Phase|Lost to Follow-up|0|||
144495192|NCT00783692|521009372|FG000|Induction Phase|Other|0|||
144495193|NCT00783692|521009373|FG001|Induction Phase|Other|0|||
144495194|NCT00783692|521009374|FG002|Induction Phase|Other|2|||
144495195|NCT00783692|521009375|FG003|Induction Phase|Other|0|||
144495196|NCT00783692|521009376|FG004|Induction Phase|Other|0|||
144495197|NCT00783692|521009377|FG005|Induction Phase|Other|0|||
144495198|NCT00783692|521009378|FG006|Induction Phase|Other|0|||
144495199|NCT00783692|521009372|FG000|Maintenance Phase|Adverse Event|7|||
144495200|NCT00783692|521009373|FG001|Maintenance Phase|Adverse Event|0|||
144495201|NCT00783692|521009374|FG002|Maintenance Phase|Adverse Event|0|||
144495202|NCT00783692|521009375|FG003|Maintenance Phase|Adverse Event|15|||
144495203|NCT00783692|521009376|FG004|Maintenance Phase|Adverse Event|12|||
144719183|NCT02711956|521825842|FG004|Overall Study|Radiographic progression|1|||
144719184|NCT02711956|521825843|FG005|Overall Study|Radiographic progression|0|||
144719185|NCT02711956|521825844|FG006|Overall Study|Radiographic progression|0|||
144719186|NCT02711956|521825845|FG007|Overall Study|Radiographic progression|0|||
144719187|NCT02711956|521825846|FG008|Overall Study|Radiographic progression|2|||
144719188|NCT02711956|521825847|FG009|Overall Study|Radiographic progression|1|||
144719189|NCT02711956|521825848|FG010|Overall Study|Radiographic progression|0|||
144719190|NCT02711956|521825849|FG011|Overall Study|Radiographic progression|5|||
144719191|NCT02711956|521825850|FG012|Overall Study|Radiographic progression|3|||
144719192|NCT02711956|521825851|FG013|Overall Study|Radiographic progression|0|||
144719193|NCT02711956|521825852|FG014|Overall Study|Radiographic progression|1|||
144495204|NCT00783692|521009377|FG005|Maintenance Phase|Adverse Event|9|||
144495205|NCT00783692|521009378|FG006|Maintenance Phase|Adverse Event|38|||
144495206|NCT00783692|521009372|FG000|Maintenance Phase|Protocol Violation|0|||
144495207|NCT00783692|521009373|FG001|Maintenance Phase|Protocol Violation|0|||
144495208|NCT00783692|521009374|FG002|Maintenance Phase|Protocol Violation|0|||
144495209|NCT00783692|521009375|FG003|Maintenance Phase|Protocol Violation|1|||
144495210|NCT00783692|521009376|FG004|Maintenance Phase|Protocol Violation|2|||
144495211|NCT00783692|521009377|FG005|Maintenance Phase|Protocol Violation|3|||
144495212|NCT00783692|521009378|FG006|Maintenance Phase|Protocol Violation|4|||
144495213|NCT00783692|521009372|FG000|Maintenance Phase|Lack of Efficacy|79|||
144495214|NCT00783692|521009373|FG001|Maintenance Phase|Lack of Efficacy|0|||
144495215|NCT00783692|521009374|FG002|Maintenance Phase|Lack of Efficacy|0|||
144495216|NCT00783692|521009375|FG003|Maintenance Phase|Lack of Efficacy|64|||
144495217|NCT00783692|521009376|FG004|Maintenance Phase|Lack of Efficacy|58|||
144495218|NCT00783692|521009377|FG005|Maintenance Phase|Lack of Efficacy|48|||
144495219|NCT00783692|521009378|FG006|Maintenance Phase|Lack of Efficacy|177|||
144495220|NCT00783692|521009372|FG000|Maintenance Phase|Withdrawal by Subject|7|||
144495221|NCT00783692|521009373|FG001|Maintenance Phase|Withdrawal by Subject|0|||
144495222|NCT00783692|521009374|FG002|Maintenance Phase|Withdrawal by Subject|0|||
144495223|NCT00783692|521009375|FG003|Maintenance Phase|Withdrawal by Subject|7|||
144495224|NCT00783692|521009376|FG004|Maintenance Phase|Withdrawal by Subject|6|||
144495225|NCT00783692|521009377|FG005|Maintenance Phase|Withdrawal by Subject|9|||
144495226|NCT00783692|521009378|FG006|Maintenance Phase|Withdrawal by Subject|24|||
144495227|NCT00783692|521009372|FG000|Maintenance Phase|Lost to Follow-up|2|||
144495228|NCT00783692|521009373|FG001|Maintenance Phase|Lost to Follow-up|0|||
144495229|NCT00783692|521009374|FG002|Maintenance Phase|Lost to Follow-up|0|||
144495230|NCT00783692|521009375|FG003|Maintenance Phase|Lost to Follow-up|1|||
144495231|NCT00783692|521009376|FG004|Maintenance Phase|Lost to Follow-up|3|||
144495232|NCT00783692|521009377|FG005|Maintenance Phase|Lost to Follow-up|2|||
144495233|NCT00783692|521009378|FG006|Maintenance Phase|Lost to Follow-up|5|||
144495234|NCT00783692|521009372|FG000|Maintenance Phase|Other|0|||
144495235|NCT00783692|521009373|FG001|Maintenance Phase|Other|0|||
144495236|NCT00783692|521009374|FG002|Maintenance Phase|Other|0|||
144495237|NCT00783692|521009375|FG003|Maintenance Phase|Other|1|||
144495238|NCT00783692|521009376|FG004|Maintenance Phase|Other|0|||
144495239|NCT00783692|521009377|FG005|Maintenance Phase|Other|1|||
144495240|NCT00783692|521009378|FG006|Maintenance Phase|Other|1|||
144495241|NCT00209274|521009381|FG000|Overall Study|Missed visit|3|||
144495242|NCT00209274|521009382|FG001|Overall Study|Missed visit|2|||
144495243|NCT00209274|521009381|FG000|Overall Study|Death|32|||
144495244|NCT00209274|521009382|FG001|Overall Study|Death|15|||
144495245|NCT00209274|521009381|FG000|Overall Study|Withdrawal by Subject|30|||
144495246|NCT00209274|521009382|FG001|Overall Study|Withdrawal by Subject|15|||
144495247|NCT00209274|521009381|FG000|Overall Study|Randomized not treated (RNT)|6|||
144719194|NCT02711956|521825838|FG000|Overall Study|PSA progression with clinical progression|0|||
144719195|NCT02711956|521825839|FG001|Overall Study|PSA progression with clinical progression|0|||
144719196|NCT02711956|521825840|FG002|Overall Study|PSA progression with clinical progression|0|||
144719197|NCT02711956|521825841|FG003|Overall Study|PSA progression with clinical progression|0|||
144719198|NCT02711956|521825842|FG004|Overall Study|PSA progression with clinical progression|1|||
144719199|NCT02711956|521825843|FG005|Overall Study|PSA progression with clinical progression|0|||
144719200|NCT02711956|521825844|FG006|Overall Study|PSA progression with clinical progression|0|||
144719201|NCT02711956|521825845|FG007|Overall Study|PSA progression with clinical progression|0|||
144719202|NCT02711956|521825846|FG008|Overall Study|PSA progression with clinical progression|0|||
144719203|NCT02711956|521825847|FG009|Overall Study|PSA progression with clinical progression|0|||
144719204|NCT02711956|521825848|FG010|Overall Study|PSA progression with clinical progression|0|||
144719205|NCT02711956|521825849|FG011|Overall Study|PSA progression with clinical progression|0|||
144719206|NCT02711956|521825850|FG012|Overall Study|PSA progression with clinical progression|1|||
144719207|NCT02711956|521825851|FG013|Overall Study|PSA progression with clinical progression|1|||
144719208|NCT02711956|521825852|FG014|Overall Study|PSA progression with clinical progression|0|||
144719209|NCT02711956|521825838|FG000|Overall Study|PSA progression with radiographic progression|0|||
144719210|NCT02711956|521825839|FG001|Overall Study|PSA progression with radiographic progression|1|||
144719211|NCT02711956|521825840|FG002|Overall Study|PSA progression with radiographic progression|0|||
144719212|NCT02711956|521825841|FG003|Overall Study|PSA progression with radiographic progression|0|||
144719213|NCT02711956|521825842|FG004|Overall Study|PSA progression with radiographic progression|0|||
144719214|NCT02711956|521825843|FG005|Overall Study|PSA progression with radiographic progression|2|||
144719215|NCT02711956|521825844|FG006|Overall Study|PSA progression with radiographic progression|2|||
144719216|NCT02711956|521825845|FG007|Overall Study|PSA progression with radiographic progression|1|||
144719217|NCT02711956|521825846|FG008|Overall Study|PSA progression with radiographic progression|0|||
144719218|NCT02711956|521825847|FG009|Overall Study|PSA progression with radiographic progression|1|||
144719219|NCT02711956|521825848|FG010|Overall Study|PSA progression with radiographic progression|0|||
144719220|NCT02711956|521825849|FG011|Overall Study|PSA progression with radiographic progression|1|||
144719221|NCT02711956|521825850|FG012|Overall Study|PSA progression with radiographic progression|2|||
144719222|NCT02711956|521825851|FG013|Overall Study|PSA progression with radiographic progression|3|||
144495248|NCT00209274|521009382|FG001|Overall Study|Randomized not treated (RNT)|15|||
144495249|NCT02753530|521009383|FG000|Overall Study|Adverse Event|7|||
144495250|NCT02753530|521009384|FG001|Overall Study|Adverse Event|1|||
144495251|NCT02753530|521009383|FG000|Overall Study|Death|0|||
144495252|NCT02753530|521009384|FG001|Overall Study|Death|1|||
144495253|NCT02753530|521009383|FG000|Overall Study|Physician Decision|0|||
144495254|NCT02753530|521009384|FG001|Overall Study|Physician Decision|1|||
144495255|NCT02753530|521009383|FG000|Overall Study|Protocol Violation|1|||
144495256|NCT02753530|521009384|FG001|Overall Study|Protocol Violation|0|||
144495257|NCT02753530|521009383|FG000|Overall Study|Withdrawal by Subject|4|||
144495258|NCT02753530|521009384|FG001|Overall Study|Withdrawal by Subject|3|||
144495259|NCT02696226|521009385|FG000|Overall Study|Study terminated - lack of enrollment|1|||
144495260|NCT02696226|521009386|FG001|Overall Study|Study terminated - lack of enrollment|0|||
144495261|NCT02696226|521009387|FG002|Overall Study|Study terminated - lack of enrollment|2|||
144495262|NCT02696226|521009388|FG003|Overall Study|Study terminated - lack of enrollment|0|||
144495263|NCT02909101|521009389|FG000|Overall Study|Lost to Follow-up|1|||
144495264|NCT02909101|521009390|FG001|Overall Study|Lost to Follow-up|1|||
144495265|NCT02698436|521009395|FG000|Overall Study|Adverse Event|1|||
144495266|NCT02698436|521009396|FG001|Overall Study|Adverse Event|0|||
144495267|NCT02698436|521009395|FG000|Overall Study|Withdrawal by Subject|3|||
144495268|NCT02698436|521009396|FG001|Overall Study|Withdrawal by Subject|3|||
144495269|NCT02698436|521009395|FG000|Overall Study|Lost to Follow-up|2|||
144495270|NCT02698436|521009396|FG001|Overall Study|Lost to Follow-up|4|||
144495271|NCT02698436|521009395|FG000|Overall Study|Non-compliance with study regimen|1|||
144495272|NCT02698436|521009396|FG001|Overall Study|Non-compliance with study regimen|0|||
144495273|NCT00097370|521009397|FG000|Stage 1|Adverse Event|3|||
144495274|NCT00097370|521009397|FG000|Stage 1|Withdrawal by Subject|1|||
144495275|NCT00097370|521009397|FG000|Stage 1|Lack of Efficacy|2|||
144495276|NCT00097370|521009397|FG000|Stage 2|Adverse Event|5|||
144495277|NCT00097370|521009397|FG000|Stage 2|Withdrawal by Subject|1|||
144495278|NCT00097370|521009397|FG000|Stage 2|Lack of Efficacy|3|||
144495279|NCT00097370|521009397|FG000|Stage 2|Pregnancy|1|||
144495280|NCT00097370|521009397|FG000|Stage 2|Sponsor Terminated Study|2|||
144495281|NCT00097370|521009397|FG000|Stage 2|Lost to Follow-up|1|||
144495282|NCT00097370|521009397|FG000|Stage 3|Adverse Event|2|||
144495283|NCT00097370|521009397|FG000|Stage 3|Withdrawal by Subject|3|||
144495284|NCT00097370|521009397|FG000|Stage 3|Lack of Efficacy|1|||
144495285|NCT00097370|521009397|FG000|Stage 3|Sponsor Terminated Study|52|||
144495286|NCT00097370|521009397|FG000|Stage 3|Lost to Follow-up|1|||
144495287|NCT00062868|521009407|FG000|Dose Level 1|Death|2|||
144495288|NCT00062868|521009408|FG001|Dose Level 1|Death|0|||
144495289|NCT00062868|521009409|FG002|Dose Level 1|Death|0|||
144495290|NCT00062868|521009410|FG003|Dose Level 1|Death|2|||
144495291|NCT00062868|521009411|FG004|Dose Level 1|Death|0|||
144495292|NCT00062868|521009412|FG005|Dose Level 1|Death|0|||
144495293|NCT00062868|521009413|FG006|Dose Level 1|Death|3|||
144495294|NCT00062868|521009414|FG007|Dose Level 1|Death|0|||
144495295|NCT00062868|521009415|FG008|Dose Level 1|Death|0|||
144495296|NCT00062868|521009416|FG009|Dose Level 1|Death|0|||
144495297|NCT00062868|521009417|FG010|Dose Level 1|Death|0|||
144495298|NCT00062868|521009418|FG011|Dose Level 1|Death|0|||
144495299|NCT00062868|521009419|FG012|Dose Level 1|Death|0|||
144495300|NCT00062868|521009420|FG013|Dose Level 1|Death|0|||
144495301|NCT00062868|521009421|FG014|Dose Level 1|Death|0|||
144495302|NCT00062868|521009422|FG015|Dose Level 1|Death|0|||
144495303|NCT00062868|521009423|FG016|Dose Level 1|Death|0|||
144495304|NCT00062868|521009424|FG017|Dose Level 1|Death|0|||
144495305|NCT00062868|521009425|FG018|Dose Level 1|Death|7|||
144495306|NCT00062868|521009426|FG019|Dose Level 1|Death|0|||
144495307|NCT00062868|521009427|FG020|Dose Level 1|Death|1|||
144495308|NCT00062868|521009407|FG000|Dose Level 1|Lost to Follow-up|0|||
144495309|NCT00062868|521009408|FG001|Dose Level 1|Lost to Follow-up|0|||
144719223|NCT02711956|521825852|FG014|Overall Study|PSA progression with radiographic progression|3|||
144719224|NCT03294538|521825855|FG000|Overall Study|Adverse Event|0|||
144719225|NCT03294538|521825856|FG001|Overall Study|Adverse Event|1|||
144719226|NCT03294538|521825857|FG002|Overall Study|Adverse Event|1|||
144370022|NCT00432172|520562791|FG002|Overall Study|Physician Decision|2|||
144370023|NCT00432172|520562792|FG003|Overall Study|Physician Decision|0|||
144370024|NCT00432172|520562789|FG000|Overall Study|Adverse Event|4|||
144370025|NCT00432172|520562790|FG001|Overall Study|Adverse Event|2|||
144370026|NCT00432172|520562791|FG002|Overall Study|Adverse Event|4|||
144370027|NCT00432172|520562792|FG003|Overall Study|Adverse Event|3|||
144370028|NCT00432172|520562789|FG000|Overall Study|Disease progression|0|||
144370029|NCT00432172|520562790|FG001|Overall Study|Disease progression|2|||
144719227|NCT03294538|521825855|FG000|Overall Study|Lost to Follow-up|1|||
144719228|NCT03294538|521825856|FG001|Overall Study|Lost to Follow-up|0|||
144719229|NCT03294538|521825857|FG002|Overall Study|Lost to Follow-up|0|||
144719230|NCT03294538|521825855|FG000|Overall Study|Outside of Visit Window|4|||
144719231|NCT03294538|521825856|FG001|Overall Study|Outside of Visit Window|4|||
144719232|NCT03294538|521825857|FG002|Overall Study|Outside of Visit Window|1|||
144719233|NCT01769378|521825861|FG000|Overall Study|Adverse Event|10|||
144719234|NCT01769378|521825862|FG001|Overall Study|Adverse Event|0|||
144719235|NCT01769378|521825861|FG000|Overall Study|Entry criteria not met|1|||
144370030|NCT00432172|520562791|FG002|Overall Study|Disease progression|5|||
144370031|NCT00432172|520562792|FG003|Overall Study|Disease progression|1|||
144370032|NCT00432172|520562789|FG000|Overall Study|Withdrawal by Subject|0|||
144370033|NCT00432172|520562790|FG001|Overall Study|Withdrawal by Subject|1|||
144370034|NCT00432172|520562791|FG002|Overall Study|Withdrawal by Subject|0|||
144370035|NCT00432172|520562792|FG003|Overall Study|Withdrawal by Subject|2|||
144370036|NCT00432172|520562789|FG000|Overall Study|No treatment received|2|||
144370037|NCT00432172|520562790|FG001|Overall Study|No treatment received|2|||
144370038|NCT00432172|520562791|FG002|Overall Study|No treatment received|0|||
144370039|NCT00432172|520562792|FG003|Overall Study|No treatment received|1|||
144370040|NCT02536963|520562793|FG000|Overall Study|Withdrawal by Subject|18|||
144370041|NCT02141204|520562794|FG000|Overall Study|Lost to Follow-up|2|||
144370042|NCT02141204|520562795|FG001|Overall Study|Lost to Follow-up|1|||
144370043|NCT02141204|520562794|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
144370044|NCT02141204|520562795|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
144370045|NCT02141204|520562794|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
144370046|NCT02141204|520562795|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
144370047|NCT02141204|520562794|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
144370048|NCT02141204|520562795|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
144370049|NCT00515619|520562800|FG000|Overall Study|Adverse Event|34|||
144495310|NCT00062868|521009409|FG002|Dose Level 1|Lost to Follow-up|0|||
144495311|NCT00062868|521009410|FG003|Dose Level 1|Lost to Follow-up|0|||
144495312|NCT00062868|521009411|FG004|Dose Level 1|Lost to Follow-up|0|||
144495313|NCT00062868|521009412|FG005|Dose Level 1|Lost to Follow-up|0|||
144495314|NCT00062868|521009413|FG006|Dose Level 1|Lost to Follow-up|0|||
144495315|NCT00062868|521009414|FG007|Dose Level 1|Lost to Follow-up|0|||
144495316|NCT00062868|521009415|FG008|Dose Level 1|Lost to Follow-up|0|||
144495317|NCT00062868|521009416|FG009|Dose Level 1|Lost to Follow-up|0|||
144495318|NCT00062868|521009417|FG010|Dose Level 1|Lost to Follow-up|0|||
144495319|NCT00062868|521009418|FG011|Dose Level 1|Lost to Follow-up|0|||
144495320|NCT00062868|521009419|FG012|Dose Level 1|Lost to Follow-up|1|||
144495321|NCT00062868|521009420|FG013|Dose Level 1|Lost to Follow-up|0|||
144495322|NCT00062868|521009421|FG014|Dose Level 1|Lost to Follow-up|0|||
144495323|NCT00062868|521009422|FG015|Dose Level 1|Lost to Follow-up|0|||
144495324|NCT00062868|521009423|FG016|Dose Level 1|Lost to Follow-up|0|||
144719236|NCT01769378|521825862|FG001|Overall Study|Entry criteria not met|0|||
144719237|NCT01769378|521825861|FG000|Overall Study|Protocol Violation|1|||
144719238|NCT01769378|521825862|FG001|Overall Study|Protocol Violation|1|||
144719239|NCT01769378|521825861|FG000|Overall Study|Withdrawal by Subject|10|||
144719240|NCT01769378|521825862|FG001|Overall Study|Withdrawal by Subject|3|||
144719241|NCT01769378|521825861|FG000|Overall Study|Sponsor Decision|1|||
144370050|NCT00515619|520562800|FG000|Overall Study|Lack of Efficacy|92|||
144495325|NCT00062868|521009424|FG017|Dose Level 1|Lost to Follow-up|0|||
144495326|NCT00062868|521009425|FG018|Dose Level 1|Lost to Follow-up|2|||
144495327|NCT00062868|521009426|FG019|Dose Level 1|Lost to Follow-up|0|||
144495328|NCT00062868|521009427|FG020|Dose Level 1|Lost to Follow-up|1|||
144495329|NCT00062868|521009407|FG000|Dose Level 2|Death|0|||
144495330|NCT00062868|521009408|FG001|Dose Level 2|Death|3|||
144495331|NCT00062868|521009409|FG002|Dose Level 2|Death|0|||
144495332|NCT00062868|521009410|FG003|Dose Level 2|Death|0|||
144495333|NCT00062868|521009411|FG004|Dose Level 2|Death|2|||
144495334|NCT00062868|521009412|FG005|Dose Level 2|Death|0|||
144495335|NCT00062868|521009413|FG006|Dose Level 2|Death|0|||
144495336|NCT00062868|521009414|FG007|Dose Level 2|Death|0|||
144495337|NCT00062868|521009415|FG008|Dose Level 2|Death|0|||
144495338|NCT00062868|521009416|FG009|Dose Level 2|Death|0|||
144495339|NCT00062868|521009417|FG010|Dose Level 2|Death|1|||
144495340|NCT00062868|521009418|FG011|Dose Level 2|Death|0|||
144495341|NCT00062868|521009419|FG012|Dose Level 2|Death|0|||
144495342|NCT00062868|521009420|FG013|Dose Level 2|Death|0|||
144495343|NCT00062868|521009421|FG014|Dose Level 2|Death|0|||
144495344|NCT00062868|521009422|FG015|Dose Level 2|Death|0|||
144495345|NCT00062868|521009423|FG016|Dose Level 2|Death|2|||
144495346|NCT00062868|521009424|FG017|Dose Level 2|Death|0|||
144495347|NCT00062868|521009425|FG018|Dose Level 2|Death|0|||
144495348|NCT00062868|521009426|FG019|Dose Level 2|Death|0|||
144495349|NCT00062868|521009427|FG020|Dose Level 2|Death|0|||
144495350|NCT00062868|521009407|FG000|Dose Level 2|Lost to Follow-up|0|||
144495351|NCT00062868|521009408|FG001|Dose Level 2|Lost to Follow-up|0|||
144495352|NCT00062868|521009409|FG002|Dose Level 2|Lost to Follow-up|0|||
144495353|NCT00062868|521009410|FG003|Dose Level 2|Lost to Follow-up|0|||
144495354|NCT00062868|521009411|FG004|Dose Level 2|Lost to Follow-up|0|||
144495355|NCT00062868|521009412|FG005|Dose Level 2|Lost to Follow-up|0|||
144495356|NCT00062868|521009413|FG006|Dose Level 2|Lost to Follow-up|0|||
144495357|NCT00062868|521009414|FG007|Dose Level 2|Lost to Follow-up|0|||
144495358|NCT00062868|521009415|FG008|Dose Level 2|Lost to Follow-up|0|||
144495359|NCT00062868|521009416|FG009|Dose Level 2|Lost to Follow-up|0|||
144495360|NCT00062868|521009417|FG010|Dose Level 2|Lost to Follow-up|0|||
144495361|NCT00062868|521009418|FG011|Dose Level 2|Lost to Follow-up|0|||
144495362|NCT00062868|521009419|FG012|Dose Level 2|Lost to Follow-up|0|||
144495363|NCT00062868|521009420|FG013|Dose Level 2|Lost to Follow-up|1|||
144495364|NCT00062868|521009421|FG014|Dose Level 2|Lost to Follow-up|0|||
144495365|NCT00062868|521009422|FG015|Dose Level 2|Lost to Follow-up|0|||
144495366|NCT00062868|521009423|FG016|Dose Level 2|Lost to Follow-up|1|||
144495367|NCT00062868|521009424|FG017|Dose Level 2|Lost to Follow-up|0|||
144495368|NCT00062868|521009425|FG018|Dose Level 2|Lost to Follow-up|0|||
144495369|NCT00062868|521009426|FG019|Dose Level 2|Lost to Follow-up|0|||
144495370|NCT00062868|521009427|FG020|Dose Level 2|Lost to Follow-up|0|||
144495371|NCT00062868|521009407|FG000|Dose Level 3|Death|0|||
144495372|NCT00062868|521009408|FG001|Dose Level 3|Death|0|||
144495373|NCT00062868|521009409|FG002|Dose Level 3|Death|0|||
144495374|NCT00062868|521009410|FG003|Dose Level 3|Death|0|||
144495375|NCT00062868|521009411|FG004|Dose Level 3|Death|0|||
144495376|NCT00062868|521009412|FG005|Dose Level 3|Death|0|||
144495377|NCT00062868|521009413|FG006|Dose Level 3|Death|0|||
144495378|NCT00062868|521009414|FG007|Dose Level 3|Death|0|||
144495379|NCT00062868|521009415|FG008|Dose Level 3|Death|0|||
144495380|NCT00062868|521009416|FG009|Dose Level 3|Death|0|||
144495381|NCT00062868|521009417|FG010|Dose Level 3|Death|0|||
144495382|NCT00062868|521009418|FG011|Dose Level 3|Death|1|||
144495383|NCT00062868|521009419|FG012|Dose Level 3|Death|0|||
144495384|NCT00062868|521009420|FG013|Dose Level 3|Death|0|||
144495385|NCT00062868|521009421|FG014|Dose Level 3|Death|0|||
144495386|NCT00062868|521009422|FG015|Dose Level 3|Death|0|||
144495387|NCT00062868|521009423|FG016|Dose Level 3|Death|0|||
144495388|NCT00062868|521009424|FG017|Dose Level 3|Death|1|||
144495389|NCT00062868|521009425|FG018|Dose Level 3|Death|0|||
144495390|NCT00062868|521009426|FG019|Dose Level 3|Death|0|||
144495391|NCT00062868|521009427|FG020|Dose Level 3|Death|0|||
144495392|NCT00062868|521009407|FG000|Dose Level 3|Lost to Follow-up|0|||
144495393|NCT00062868|521009408|FG001|Dose Level 3|Lost to Follow-up|0|||
144495394|NCT00062868|521009409|FG002|Dose Level 3|Lost to Follow-up|0|||
144495395|NCT00062868|521009410|FG003|Dose Level 3|Lost to Follow-up|0|||
144495396|NCT00062868|521009411|FG004|Dose Level 3|Lost to Follow-up|0|||
144495397|NCT00062868|521009412|FG005|Dose Level 3|Lost to Follow-up|0|||
144495398|NCT00062868|521009413|FG006|Dose Level 3|Lost to Follow-up|0|||
144495399|NCT00062868|521009414|FG007|Dose Level 3|Lost to Follow-up|0|||
144495400|NCT00062868|521009415|FG008|Dose Level 3|Lost to Follow-up|0|||
144495401|NCT00062868|521009416|FG009|Dose Level 3|Lost to Follow-up|0|||
144495402|NCT00062868|521009417|FG010|Dose Level 3|Lost to Follow-up|0|||
144495403|NCT00062868|521009418|FG011|Dose Level 3|Lost to Follow-up|0|||
144495404|NCT00062868|521009419|FG012|Dose Level 3|Lost to Follow-up|0|||
144495405|NCT00062868|521009420|FG013|Dose Level 3|Lost to Follow-up|0|||
144495406|NCT00062868|521009421|FG014|Dose Level 3|Lost to Follow-up|1|||
144495407|NCT00062868|521009422|FG015|Dose Level 3|Lost to Follow-up|0|||
144495408|NCT00062868|521009423|FG016|Dose Level 3|Lost to Follow-up|0|||
144495409|NCT00062868|521009424|FG017|Dose Level 3|Lost to Follow-up|0|||
144495410|NCT00062868|521009425|FG018|Dose Level 3|Lost to Follow-up|0|||
144495411|NCT00062868|521009426|FG019|Dose Level 3|Lost to Follow-up|0|||
144495412|NCT00062868|521009427|FG020|Dose Level 3|Lost to Follow-up|0|||
144495413|NCT00062868|521009407|FG000|Dose Level 3|Withdrew|0|||
144495414|NCT00062868|521009408|FG001|Dose Level 3|Withdrew|0|||
144495415|NCT00062868|521009409|FG002|Dose Level 3|Withdrew|2|||
144495416|NCT00062868|521009410|FG003|Dose Level 3|Withdrew|0|||
144495417|NCT00062868|521009411|FG004|Dose Level 3|Withdrew|0|||
144495418|NCT00062868|521009412|FG005|Dose Level 3|Withdrew|0|||
144495419|NCT00062868|521009413|FG006|Dose Level 3|Withdrew|0|||
144495420|NCT00062868|521009414|FG007|Dose Level 3|Withdrew|0|||
144495421|NCT00062868|521009415|FG008|Dose Level 3|Withdrew|0|||
144495422|NCT00062868|521009416|FG009|Dose Level 3|Withdrew|0|||
144495423|NCT00062868|521009417|FG010|Dose Level 3|Withdrew|0|||
144495424|NCT00062868|521009418|FG011|Dose Level 3|Withdrew|0|||
144495425|NCT00062868|521009419|FG012|Dose Level 3|Withdrew|0|||
144495426|NCT00062868|521009420|FG013|Dose Level 3|Withdrew|0|||
144495427|NCT00062868|521009421|FG014|Dose Level 3|Withdrew|0|||
144495428|NCT00062868|521009422|FG015|Dose Level 3|Withdrew|0|||
144495429|NCT00062868|521009423|FG016|Dose Level 3|Withdrew|0|||
144495430|NCT00062868|521009424|FG017|Dose Level 3|Withdrew|0|||
144495431|NCT00062868|521009425|FG018|Dose Level 3|Withdrew|0|||
144495432|NCT00062868|521009426|FG019|Dose Level 3|Withdrew|0|||
144495433|NCT00062868|521009427|FG020|Dose Level 3|Withdrew|0|||
144495434|NCT04949399|521009430|FG000|Overall Study|Lost to Follow-up|11|||
144495435|NCT04949399|521009431|FG001|Overall Study|Lost to Follow-up|6|||
144495436|NCT04949399|521009430|FG000|Overall Study|Withdrawal by Subject|2|||
144495437|NCT04949399|521009431|FG001|Overall Study|Withdrawal by Subject|3|||
144495438|NCT00670540|521009432|FG000|Overall Study|ineligible|17|||
144495439|NCT00670540|521009432|FG000|Overall Study|not living in France|348|||
144495440|NCT00670540|521009432|FG000|Overall Study|refused to participate|189|||
144495441|NCT00670540|521009432|FG000|Overall Study|controls randomised for no follow up|2770|||
144495442|NCT00670540|521009432|FG000|Overall Study|missing information inclusion criteria|1|||
144495443|NCT01304706|521010760|FG000|Overall Study|Adverse Event|2|||
144495444|NCT01304706|521010760|FG000|Overall Study|Lack of Efficacy|1|||
144495445|NCT01304706|521010760|FG000|Overall Study|Death|3|||
144495446|NCT01304706|521010760|FG000|Overall Study|Withdrawal by Subject|3|||
144495447|NCT01304706|521010760|FG000|Overall Study|Lost to Follow-up|7|||
144495448|NCT01304706|521010760|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
144495449|NCT01251614|521010763|FG000|Overall Study|Adverse Event|1|||
144495450|NCT01251614|521010764|FG001|Overall Study|Adverse Event|0|||
144495451|NCT01251614|521010765|FG002|Overall Study|Adverse Event|1|||
144495452|NCT01251614|521010763|FG000|Overall Study|Lack of Efficacy|1|||
144495453|NCT01251614|521010764|FG001|Overall Study|Lack of Efficacy|9|||
144495454|NCT01251614|521010765|FG002|Overall Study|Lack of Efficacy|4|||
144495455|NCT01251614|521010763|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
144495456|NCT01251614|521010764|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
144495457|NCT01251614|521010765|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
144495458|NCT01251614|521010763|FG000|Overall Study|Pregnancy|0|||
144495459|NCT01251614|521010764|FG001|Overall Study|Pregnancy|0|||
144495460|NCT01251614|521010765|FG002|Overall Study|Pregnancy|2|||
144495461|NCT01251614|521010763|FG000|Overall Study|Loss of Disease Control|0|||
144495462|NCT01251614|521010764|FG001|Overall Study|Loss of Disease Control|1|||
144495463|NCT01251614|521010765|FG002|Overall Study|Loss of Disease Control|0|||
144495464|NCT01251614|521010763|FG000|Overall Study|Withdrawal by Subject|0|||
144495465|NCT01251614|521010764|FG001|Overall Study|Withdrawal by Subject|2|||
144495466|NCT01251614|521010765|FG002|Overall Study|Withdrawal by Subject|1|||
144495467|NCT01251614|521010763|FG000|Overall Study|Lost to Follow-up|0|||
144495468|NCT01251614|521010764|FG001|Overall Study|Lost to Follow-up|1|||
144495469|NCT01251614|521010765|FG002|Overall Study|Lost to Follow-up|0|||
144495470|NCT00093795|521010766|FG000|Overall Study|No follow up data|20|||
144495471|NCT00093795|521010767|FG001|Overall Study|No follow up data|16|||
144495472|NCT00093795|521010768|FG002|Overall Study|No follow up data|17|||
144495473|NCT02790606|521010776|FG000|Overall Study|Death|27|||
144495474|NCT02790606|521010776|FG000|Overall Study|Lost to Follow-up|4|||
144495475|NCT02790606|521010776|FG000|Overall Study|Physician Decision|3|||
144495476|NCT02790606|521010776|FG000|Overall Study|Withdrawal by Subject|1|||
144495477|NCT02735915|521010777|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
144495478|NCT02735915|521010777|FG000|Overall Study|Withdrawal following SAE|2|||
144495479|NCT02735915|521010777|FG000|Overall Study|Withdrawal by Subject|1|||
144495480|NCT05328973|521010778|FG000|Overall Study|Withdrawal by Subject|0|||
144495481|NCT05328973|521010779|FG001|Overall Study|Withdrawal by Subject|1|||
144495482|NCT00409708|521010784|FG000|Treatment|Abnormal test procedure result(s)|1|||
144495483|NCT00409708|521010785|FG001|Treatment|Abnormal test procedure result(s)|0|||
144495484|NCT00409708|521010784|FG000|Treatment|Lack of Efficacy|0|||
144495485|NCT00409708|521010785|FG001|Treatment|Lack of Efficacy|1|||
144495486|NCT00409708|521010784|FG000|Treatment|Protocol Violation|6|||
144495487|NCT00409708|521010785|FG001|Treatment|Protocol Violation|2|||
144495488|NCT00409708|521010784|FG000|Treatment|Withdrawal by Subject|3|||
144495489|NCT00409708|521010785|FG001|Treatment|Withdrawal by Subject|8|||
144495490|NCT00409708|521010784|FG000|Treatment|Lost to Follow-up|0|||
144495491|NCT00409708|521010785|FG001|Treatment|Lost to Follow-up|6|||
144495492|NCT00409708|521010784|FG000|Treatment|Administrative problems|5|||
144495493|NCT00409708|521010785|FG001|Treatment|Administrative problems|0|||
144495494|NCT00409708|521010784|FG000|Washout|Lack of Efficacy|9|||
144495495|NCT00409708|521010785|FG001|Washout|Lack of Efficacy|1|||
144495496|NCT00409708|521010784|FG000|Washout|Protocol Violation|0|||
144495497|NCT00409708|521010785|FG001|Washout|Protocol Violation|1|||
144495498|NCT00409708|521010784|FG000|Washout|Withdrawal by Subject|11|||
144495499|NCT00409708|521010785|FG001|Washout|Withdrawal by Subject|5|||
144495500|NCT00409708|521010784|FG000|Washout|Lost to Follow-up|1|||
144495501|NCT00409708|521010785|FG001|Washout|Lost to Follow-up|3|||
144495502|NCT00498186|521010786|FG000|Overall Study|Protocol Violation|10|||
144495503|NCT00498186|521010786|FG000|Overall Study|Lack of Efficacy|31|||
144495504|NCT00498186|521010786|FG000|Overall Study|Adverse Event|89|||
144495505|NCT00498186|521010786|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
144495506|NCT00498186|521010786|FG000|Overall Study|Withdrawal by Subject|18|||
144495507|NCT00498186|521010786|FG000|Overall Study|Lost to Follow-up|3|||
144495508|NCT00498186|521010786|FG000|Overall Study|Other|10|||
144495509|NCT03929302|521010787|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
144495510|NCT03929302|521010788|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
144495511|NCT03929302|521010789|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
144495512|NCT03929302|521010787|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
144495513|NCT03929302|521010788|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
144495514|NCT03929302|521010789|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
144495515|NCT03929302|521010787|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
144495516|NCT03929302|521010788|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
144495517|NCT03929302|521010789|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
144495518|NCT00984282|521010790|FG000|Double Blind Treatment|Adverse Event|40|||
144495519|NCT00984282|521010791|FG001|Double Blind Treatment|Adverse Event|6|||
144495520|NCT00984282|521010790|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
144495521|NCT00984282|521010791|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
144495522|NCT00984282|521010790|FG000|Double Blind Treatment|Physician Decision|1|||
144495523|NCT00984282|521010791|FG001|Double Blind Treatment|Physician Decision|2|||
144495524|NCT00984282|521010790|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
144495525|NCT00984282|521010791|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
144495526|NCT00984282|521010790|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
144495527|NCT00984282|521010791|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
144495528|NCT00984282|521010790|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
144495529|NCT00984282|521010791|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
144495530|NCT00984282|521010790|FG000|Double Blind Treatment|Lost to Follow-up|3|||
144495531|NCT00984282|521010791|FG001|Double Blind Treatment|Lost to Follow-up|0|||
144495532|NCT00984282|521010790|FG000|Double Blind Treatment|Death|8|||
144495533|NCT00984282|521010791|FG001|Double Blind Treatment|Death|4|||
144495534|NCT00984282|521010790|FG000|Double Blind Treatment|Not treated|0|||
144495535|NCT00984282|521010791|FG001|Double Blind Treatment|Not treated|1|||
144495536|NCT00984282|521010790|FG000|Double Blind Treatment|Switched to commercial drug|6|||
144495537|NCT00984282|521010791|FG001|Double Blind Treatment|Switched to commercial drug|1|||
144495538|NCT00984282|521010790|FG000|Double Blind Treatment|protocol driven decision point|1|||
144495539|NCT00984282|521010791|FG001|Double Blind Treatment|protocol driven decision point|1|||
144495540|NCT00984282|521010790|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
144495541|NCT00984282|521010791|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
144495542|NCT00984282|521010790|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
144495543|NCT00984282|521010791|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
144495544|NCT00984282|521010790|FG000|Open-label Treatment|Adverse Event|20|||
144495545|NCT00984282|521010791|FG001|Open-label Treatment|Adverse Event|30|||
144495546|NCT00984282|521010790|FG000|Open-label Treatment|Withdrawal by Subject|6|||
144495547|NCT00984282|521010791|FG001|Open-label Treatment|Withdrawal by Subject|21|||
144495548|NCT00984282|521010790|FG000|Open-label Treatment|Death|7|||
144495549|NCT00984282|521010791|FG001|Open-label Treatment|Death|15|||
144495550|NCT00984282|521010790|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
144495551|NCT00984282|521010791|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
144495552|NCT00984282|521010790|FG000|Open-label Treatment|Lost to Follow-up|1|||
144719242|NCT01769378|521825862|FG001|Overall Study|Sponsor Decision|0|||
144719243|NCT01769378|521825861|FG000|Overall Study|Lost to Follow-up|2|||
144719244|NCT01769378|521825862|FG001|Overall Study|Lost to Follow-up|0|||
144719245|NCT01090765|521825863|FG000|Overall Study|Patient withdrew consent|0|||
144719246|NCT01090765|521825864|FG001|Overall Study|Patient withdrew consent|0|||
144719247|NCT01090765|521825865|FG002|Overall Study|Patient withdrew consent|0|||
144719248|NCT01090765|521825866|FG003|Overall Study|Patient withdrew consent|0|||
144719249|NCT01090765|521825867|FG004|Overall Study|Patient withdrew consent|1|||
144719250|NCT01090765|521825868|FG005|Overall Study|Patient withdrew consent|1|||
144495553|NCT00984282|521010791|FG001|Open-label Treatment|Lost to Follow-up|1|||
144495554|NCT00984282|521010790|FG000|Open-label Treatment|Patient convenience|1|||
144495555|NCT00984282|521010791|FG001|Open-label Treatment|Patient convenience|0|||
144495556|NCT00984282|521010790|FG000|Open-label Treatment|Non-compliant with study medication|1|||
144495557|NCT00984282|521010791|FG001|Open-label Treatment|Non-compliant with study medication|0|||
144495558|NCT00984282|521010790|FG000|Open-label Treatment|Target lesion removed|0|||
144495559|NCT00984282|521010791|FG001|Open-label Treatment|Target lesion removed|1|||
144495560|NCT00984282|521010790|FG000|Open-label Treatment|Protocol driven decision point|1|||
144495561|NCT00984282|521010791|FG001|Open-label Treatment|Protocol driven decision point|1|||
144495562|NCT00984282|521010790|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
144495563|NCT00984282|521010791|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
144495564|NCT00984282|521010790|FG000|Open-label Treatment|Switched to commercial drug|6|||
144495565|NCT00984282|521010791|FG001|Open-label Treatment|Switched to commercial drug|7|||
144495566|NCT00984282|521010790|FG000|Open-label Treatment|Physician Decision|1|||
144495567|NCT00984282|521010791|FG001|Open-label Treatment|Physician Decision|0|||
144495568|NCT00984282|521010790|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
144495569|NCT00984282|521010791|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
144495570|NCT00984282|521010790|FG000|Long Term Follow-up|Death|27|||
144495571|NCT00984282|521010791|FG001|Long Term Follow-up|Death|68|||
144495572|NCT00984282|521010790|FG000|Long Term Follow-up|Lost to Follow-up|3|||
144495573|NCT00984282|521010791|FG001|Long Term Follow-up|Lost to Follow-up|6|||
144495574|NCT00984282|521010790|FG000|Long Term Follow-up|Protocol driven decision point|25|||
144495575|NCT00984282|521010791|FG001|Long Term Follow-up|Protocol driven decision point|26|||
144495576|NCT00984282|521010790|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
144495577|NCT00984282|521010791|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
144495578|NCT00984282|521010790|FG000|Long Term Follow-up|Switched to commercial drug|4|||
144495579|NCT00984282|521010791|FG001|Long Term Follow-up|Switched to commercial drug|2|||
144495580|NCT00984282|521010790|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
144495581|NCT00984282|521010791|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
144495582|NCT02321540|521010792|FG000|Overall Study|Death|0|||
144495583|NCT02321540|521010793|FG001|Overall Study|Death|1|||
144495584|NCT02321540|521010792|FG000|Overall Study|Progression|3|||
144495585|NCT02321540|521010793|FG001|Overall Study|Progression|9|||
144495586|NCT00372567|521010796|FG000|Phase 3 Study|Adverse Event|5|||
144495587|NCT00372567|521010797|FG001|Phase 3 Study|Adverse Event|1|||
144495588|NCT00372567|521010798|FG002|Phase 3 Study|Adverse Event|1|||
144495589|NCT00372567|521010796|FG000|Phase 3 Study|Death|1|||
144495590|NCT00372567|521010797|FG001|Phase 3 Study|Death|1|||
144495591|NCT00372567|521010798|FG002|Phase 3 Study|Death|0|||
144495592|NCT00372567|521010796|FG000|Phase 3 Study|Protocol Violation|0|||
144495593|NCT00372567|521010797|FG001|Phase 3 Study|Protocol Violation|0|||
144495594|NCT00372567|521010798|FG002|Phase 3 Study|Protocol Violation|1|||
144495595|NCT00372567|521010796|FG000|Phase 3 Study|Objective progression or relapse|10|||
144495596|NCT00372567|521010797|FG001|Phase 3 Study|Objective progression or relapse|13|||
144495597|NCT00372567|521010798|FG002|Phase 3 Study|Objective progression or relapse|4|||
144495598|NCT00372567|521010796|FG000|Phase 3 Study|Global deterioration of health status|0|||
144495599|NCT00372567|521010797|FG001|Phase 3 Study|Global deterioration of health status|1|||
144495600|NCT00372567|521010798|FG002|Phase 3 Study|Global deterioration of health status|0|||
144495601|NCT00372567|521010796|FG000|Phase 3 Study|Other|2|||
144495602|NCT00372567|521010797|FG001|Phase 3 Study|Other|2|||
144495603|NCT00372567|521010798|FG002|Phase 3 Study|Other|1|||
144495604|NCT00372567|521010796|FG000|Phase 3 Study|study terminated by sponsor|13|||
144495605|NCT00372567|521010797|FG001|Phase 3 Study|study terminated by sponsor|8|||
144495606|NCT00372567|521010798|FG002|Phase 3 Study|study terminated by sponsor|5|||
144495607|NCT02347943|521010799|FG000|Overall Study|Study was cancelled|140|||
144495608|NCT02347943|521010800|FG001|Overall Study|Study was cancelled|67|||
144495609|NCT02347943|521010801|FG002|Overall Study|Study was cancelled|45|||
144495610|NCT00691028|521010802|FG000|Open-label Period|Adverse Event|0|||
144495611|NCT00691028|521010803|FG001|Open-label Period|Adverse Event|0|||
144495612|NCT00691028|521010804|FG002|Open-label Period|Adverse Event|0|||
144495613|NCT00691028|521010805|FG003|Open-label Period|Adverse Event|16|||
144495614|NCT00691028|521010802|FG000|Open-label Period|Withdrawal by Subject|0|||
144495615|NCT00691028|521010803|FG001|Open-label Period|Withdrawal by Subject|0|||
144495616|NCT00691028|521010804|FG002|Open-label Period|Withdrawal by Subject|0|||
144495617|NCT00691028|521010805|FG003|Open-label Period|Withdrawal by Subject|3|||
144495618|NCT00691028|521010802|FG000|Open-label Period|not come to a hospital|0|||
144495619|NCT00691028|521010803|FG001|Open-label Period|not come to a hospital|0|||
144495620|NCT00691028|521010804|FG002|Open-label Period|not come to a hospital|0|||
144495621|NCT00691028|521010805|FG003|Open-label Period|not come to a hospital|1|||
144495622|NCT00691028|521010802|FG000|Double-blind Period|Adverse Event|8|||
144495623|NCT00691028|521010803|FG001|Double-blind Period|Adverse Event|9|||
144495624|NCT00691028|521010804|FG002|Double-blind Period|Adverse Event|6|||
144495625|NCT00691028|521010805|FG003|Double-blind Period|Adverse Event|0|||
144495626|NCT00691028|521010802|FG000|Double-blind Period|Lack of Efficacy|4|||
144495627|NCT00691028|521010803|FG001|Double-blind Period|Lack of Efficacy|3|||
144495628|NCT00691028|521010804|FG002|Double-blind Period|Lack of Efficacy|2|||
144495629|NCT00691028|521010805|FG003|Double-blind Period|Lack of Efficacy|0|||
144495630|NCT00691028|521010802|FG000|Double-blind Period|Withdrawal by Subject|1|||
144495631|NCT00691028|521010803|FG001|Double-blind Period|Withdrawal by Subject|0|||
144495632|NCT00691028|521010804|FG002|Double-blind Period|Withdrawal by Subject|1|||
144495633|NCT00691028|521010805|FG003|Double-blind Period|Withdrawal by Subject|0|||
144495634|NCT00691028|521010802|FG000|Double-blind Period|not come to a hospital.|0|||
144495635|NCT00691028|521010803|FG001|Double-blind Period|not come to a hospital.|1|||
144495636|NCT00691028|521010804|FG002|Double-blind Period|not come to a hospital.|0|||
144495637|NCT00691028|521010805|FG003|Double-blind Period|not come to a hospital.|0|||
144495638|NCT02072226|521010813|FG000|Overall Study|Lost to Follow-up|11|||
144495639|NCT02072226|521010814|FG001|Overall Study|Lost to Follow-up|7|||
144719251|NCT01090765|521825863|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
144719252|NCT01090765|521825864|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
144719253|NCT01090765|521825865|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
144719254|NCT01090765|521825866|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
144719255|NCT01090765|521825867|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
144719256|NCT01090765|521825868|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
144719257|NCT01090765|521825863|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
144719258|NCT01090765|521825864|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
144719259|NCT01090765|521825865|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
144719260|NCT01090765|521825866|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
144719261|NCT01090765|521825867|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
144719262|NCT01090765|521825868|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
144719263|NCT01755858|521825872|FG000|Overall Study|Adverse Event|1|||
144719264|NCT01755858|521825873|FG001|Overall Study|Adverse Event|1|||
144719265|NCT00782509|521825874|FG000|Overall Study|Adverse Event|20|||
144719266|NCT00782509|521825875|FG001|Overall Study|Adverse Event|10|||
144719267|NCT00782509|521825876|FG002|Overall Study|Adverse Event|20|||
144719268|NCT00782509|521825874|FG000|Overall Study|Lost to Follow-up|1|||
144719269|NCT00782509|521825875|FG001|Overall Study|Lost to Follow-up|2|||
144719270|NCT00782509|521825876|FG002|Overall Study|Lost to Follow-up|3|||
144719271|NCT00782509|521825874|FG000|Overall Study|Withdrawal by Subject|3|||
144719272|NCT00782509|521825875|FG001|Overall Study|Withdrawal by Subject|5|||
144719273|NCT00782509|521825876|FG002|Overall Study|Withdrawal by Subject|8|||
144719274|NCT00782509|521825874|FG000|Overall Study|Non compliance with protocol|2|||
144719275|NCT00782509|521825875|FG001|Overall Study|Non compliance with protocol|0|||
144719276|NCT00782509|521825876|FG002|Overall Study|Non compliance with protocol|0|||
144719277|NCT00782509|521825874|FG000|Overall Study|Other reasons not stated above|5|||
144719278|NCT00782509|521825875|FG001|Overall Study|Other reasons not stated above|2|||
144719279|NCT00782509|521825876|FG002|Overall Study|Other reasons not stated above|3|||
144719280|NCT00782509|521825874|FG000|Overall Study|Lack of Efficacy|10|||
144719281|NCT00782509|521825875|FG001|Overall Study|Lack of Efficacy|5|||
144719282|NCT00782509|521825876|FG002|Overall Study|Lack of Efficacy|2|||
144719283|NCT00175019|521825878|FG000|Overall Study|Adverse Event|54|||
144719284|NCT00175019|521825879|FG001|Overall Study|Adverse Event|22|||
144719285|NCT00175019|521825880|FG002|Overall Study|Adverse Event|2|||
144719286|NCT00175019|521825878|FG000|Overall Study|Protocol Violation|6|||
144719287|NCT00175019|521825879|FG001|Overall Study|Protocol Violation|3|||
144719288|NCT00175019|521825880|FG002|Overall Study|Protocol Violation|3|||
144719289|NCT00175019|521825878|FG000|Overall Study|Lost to Follow-up|42|||
144719290|NCT00175019|521825879|FG001|Overall Study|Lost to Follow-up|39|||
144719291|NCT00175019|521825880|FG002|Overall Study|Lost to Follow-up|9|||
144719292|NCT00175019|521825878|FG000|Overall Study|Did not continue under Amendment 4|1|||
144719293|NCT00175019|521825879|FG001|Overall Study|Did not continue under Amendment 4|1|||
144719294|NCT00175019|521825880|FG002|Overall Study|Did not continue under Amendment 4|2|||
144719295|NCT00175019|521825878|FG000|Overall Study|Personal Reason(s)|39|||
144719296|NCT00175019|521825879|FG001|Overall Study|Personal Reason(s)|31|||
144719297|NCT00175019|521825880|FG002|Overall Study|Personal Reason(s)|8|||
144719298|NCT00175019|521825878|FG000|Overall Study|Therapeutic Failure|10|||
144719299|NCT00175019|521825879|FG001|Overall Study|Therapeutic Failure|38|||
144719300|NCT00175019|521825880|FG002|Overall Study|Therapeutic Failure|22|||
144719301|NCT00175019|521825878|FG000|Overall Study|Gout Flare|2|||
144719302|NCT00175019|521825879|FG001|Overall Study|Gout Flare|3|||
144719303|NCT00175019|521825880|FG002|Overall Study|Gout Flare|0|||
144719304|NCT00175019|521825878|FG000|Overall Study|Reason Not Specified|40|||
144719305|NCT00175019|521825879|FG001|Overall Study|Reason Not Specified|34|||
144719306|NCT00175019|521825880|FG002|Overall Study|Reason Not Specified|11|||
144719307|NCT00770991|521825893|FG000|Overall Study|Physician Decision|2|||
144719308|NCT00770991|521825894|FG001|Overall Study|Physician Decision|0|||
144719309|NCT00770991|521825893|FG000|Overall Study|Withdrawal by Subject|1|||
144719310|NCT00770991|521825894|FG001|Overall Study|Withdrawal by Subject|0|||
144719311|NCT00770991|521825893|FG000|Overall Study|Adverse Event|1|||
144719312|NCT00770991|521825894|FG001|Overall Study|Adverse Event|5|||
144719313|NCT00770991|521825893|FG000|Overall Study|Pregnancy|1|||
144719314|NCT00770991|521825894|FG001|Overall Study|Pregnancy|0|||
144719315|NCT02087046|521825895|FG000|Overall Study|Adverse Event|4|||
144719316|NCT02087046|521825895|FG000|Overall Study|Death|1|||
144719317|NCT02087046|521825895|FG000|Overall Study|Lost to Follow-up|3|||
144719318|NCT02087046|521825895|FG000|Overall Study|Withdrawal by Subject|2|||
144719319|NCT02087046|521825895|FG000|Overall Study|Physician Decision|1|||
144719320|NCT02444533|521825896|FG000|Overall Study|Not able to complete forms|0|||
144719321|NCT02444533|521825897|FG001|Overall Study|Not able to complete forms|2|||
144719322|NCT02444533|521825896|FG000|Overall Study|Only gave post-procedure complications|2|||
144719323|NCT02444533|521825897|FG001|Overall Study|Only gave post-procedure complications|2|||
144719324|NCT01155583|521825898|FG000|Phase I|Screen failure - did not start treatment|0|||
144719325|NCT01155583|521825899|FG001|Phase I|Screen failure - did not start treatment|0|||
144719326|NCT01155583|521825900|FG002|Phase I|Screen failure - did not start treatment|0|||
144495640|NCT02072226|521010813|FG000|Overall Study|Patient Non-compliance|2|||
144495641|NCT02072226|521010814|FG001|Overall Study|Patient Non-compliance|3|||
144495642|NCT02072226|521010813|FG000|Overall Study|Death|1|||
144495643|NCT02072226|521010814|FG001|Overall Study|Death|0|||
144495644|NCT02072226|521010813|FG000|Overall Study|Patient Withdrawal of Consent|1|||
144495645|NCT02072226|521010814|FG001|Overall Study|Patient Withdrawal of Consent|0|||
144495646|NCT03255018|521010822|FG000|Overall Study|Death on study|0|||
144495647|NCT03255018|521010823|FG001|Overall Study|Death on study|5|||
144495648|NCT03255018|521010822|FG000|Overall Study|Withdrawal by Subject|0|||
144495649|NCT03255018|521010823|FG001|Overall Study|Withdrawal by Subject|2|||
144495650|NCT02680756|521010825|FG000|Overall Study|Adverse Event|10|||
144495651|NCT02680756|521010826|FG001|Overall Study|Adverse Event|2|||
144495652|NCT02680756|521010825|FG000|Overall Study|Lost to Follow-up|7|||
144495653|NCT02680756|521010826|FG001|Overall Study|Lost to Follow-up|6|||
144495654|NCT02680756|521010825|FG000|Overall Study|Withdrawal by Subject|5|||
144495655|NCT02680756|521010826|FG001|Overall Study|Withdrawal by Subject|5|||
144495656|NCT02680756|521010825|FG000|Overall Study|Physician Decision|4|||
144495657|NCT02680756|521010826|FG001|Overall Study|Physician Decision|1|||
144495658|NCT02680756|521010825|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
144495659|NCT02680756|521010826|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
144495660|NCT02680756|521010825|FG000|Overall Study|Blood transfusion for any reason|0|||
144495661|NCT02680756|521010826|FG001|Overall Study|Blood transfusion for any reason|1|||
144495662|NCT02680756|521010825|FG000|Overall Study|Death|1|||
144495663|NCT02680756|521010826|FG001|Overall Study|Death|0|||
144495664|NCT02680756|521010825|FG000|Overall Study|Protocol Violation|1|||
144495665|NCT02680756|521010826|FG001|Overall Study|Protocol Violation|0|||
144495666|NCT02680756|521010825|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
144495667|NCT02680756|521010826|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
144495668|NCT02680756|521010825|FG000|Overall Study|None of above or not recorded|3|||
144495669|NCT02680756|521010826|FG001|Overall Study|None of above or not recorded|2|||
144495670|NCT00480441|521010827|FG000|Screening|Not Eligible|37|||
144495671|NCT00480441|521010828|FG001|Screening|Not Eligible|0|||
144495672|NCT00480441|521010829|FG002|Screening|Not Eligible|0|||
144495673|NCT00480441|521010827|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
144495674|NCT00480441|521010828|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
144495675|NCT00480441|521010829|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
144495676|NCT00480441|521010827|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
144495677|NCT00480441|521010828|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
144495678|NCT00480441|521010829|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
144495679|NCT00480441|521010827|FG000|Baseline Functional MRI|physical contraindication|4|||
144495680|NCT00480441|521010828|FG001|Baseline Functional MRI|physical contraindication|0|||
144495681|NCT00480441|521010829|FG002|Baseline Functional MRI|physical contraindication|0|||
144495682|NCT00480441|521010827|FG000|Randomization|Lost to Follow-up|0|||
144495683|NCT00480441|521010828|FG001|Randomization|Lost to Follow-up|7|||
144495684|NCT00480441|521010829|FG002|Randomization|Lost to Follow-up|2|||
144495685|NCT01360840|521010832|FG000|Overall Study|Ongoing at data cut-off|10|||
144495686|NCT01360840|521010833|FG001|Overall Study|Ongoing at data cut-off|10|||
144495687|NCT01360840|521010834|FG002|Overall Study|Ongoing at data cut-off|9|||
144495688|NCT02950545|521010837|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
144495689|NCT02950545|521010838|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
144495690|NCT02950545|521010839|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
144495691|NCT02950545|521010840|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
144495692|NCT02950545|521010841|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
144495693|NCT02950545|521010842|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
144495694|NCT02950545|521010837|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
144495695|NCT02950545|521010838|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
144495696|NCT02950545|521010839|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
144495697|NCT02950545|521010840|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
144495698|NCT02950545|521010841|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
144495699|NCT02950545|521010842|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
144495700|NCT02950545|521010837|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
144495701|NCT02950545|521010838|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
144495702|NCT02950545|521010839|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
144495703|NCT02950545|521010840|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
144495704|NCT02950545|521010841|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
144495705|NCT02950545|521010842|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
144495706|NCT02950545|521010837|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
144495707|NCT02950545|521010838|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
144495708|NCT02950545|521010839|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
144495709|NCT02950545|521010840|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
144495710|NCT02950545|521010841|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
144495711|NCT02950545|521010842|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
144495712|NCT02950545|521010837|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
144495713|NCT02950545|521010838|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
144495714|NCT02950545|521010839|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
144495715|NCT02950545|521010840|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
144495716|NCT02950545|521010841|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
144495717|NCT02950545|521010842|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
144495718|NCT00647348|521010844|FG000|Overall Study|Lost to Follow-up|3|||
144495719|NCT00647348|521010845|FG001|Overall Study|Lost to Follow-up|6|||
144495720|NCT00619151|521010846|FG000|Overall Study|Study terminated prior to followup|1|||
144495721|NCT00619151|521010847|FG001|Overall Study|Study terminated prior to followup|0|||
144495722|NCT04889118|521010848|FG000|Overall Study|Death|33|||
144495723|NCT04889118|521010849|FG001|Overall Study|Death|37|||
144495724|NCT04889118|521010848|FG000|Overall Study|Ongoing in Study|31|||
144495725|NCT04889118|521010849|FG001|Overall Study|Ongoing in Study|30|||
144495726|NCT01982760|521010850|FG000|Overall Study|Physician Decision|1|||
144495727|NCT01982760|521010851|FG001|Overall Study|Physician Decision|0|||
144495728|NCT00821236|521010852|FG000|Overall Study|Lost to Follow-up|3|||
144495729|NCT00530777|521010854|FG000|Overall Study|Lost to Follow-up|0|||
144495730|NCT00530777|521010855|FG001|Overall Study|Lost to Follow-up|1|||
144495731|NCT00530777|521010854|FG000|Overall Study|Death|1|||
144495732|NCT00530777|521010855|FG001|Overall Study|Death|2|||
144495733|NCT00530777|521010854|FG000|Overall Study|Physician Decision|1|||
144495734|NCT00530777|521010855|FG001|Overall Study|Physician Decision|0|||
144495735|NCT00530777|521010854|FG000|Overall Study|Withdrawal by Subject|0|||
144495736|NCT00530777|521010855|FG001|Overall Study|Withdrawal by Subject|1|||
144495737|NCT00530777|521010854|FG000|Overall Study|Unable to adhere to visit schedule|5|||
144495738|NCT00530777|521010855|FG001|Overall Study|Unable to adhere to visit schedule|1|||
144495739|NCT01582243|521010860|FG000|Overall Study|Withdrawal by Subject|1|||
144495740|NCT01582243|521010860|FG000|Overall Study|Adverse Event|1|||
144495741|NCT01582243|521010860|FG000|Overall Study|Lost to Follow-up|1|||
144495742|NCT03382821|521010861|FG000|Overall Study|Did not receive allocated intervention.|0|||
144495743|NCT03382821|521010862|FG001|Overall Study|Did not receive allocated intervention.|3|||
144495744|NCT00282438|521010864|FG000|Overall Study|Lack of Efficacy|1|||
144495745|NCT00282438|521010865|FG001|Overall Study|Lack of Efficacy|0|||
144495746|NCT00282438|521010864|FG000|Overall Study|Death|0|||
144495747|NCT00282438|521010865|FG001|Overall Study|Death|1|||
144495748|NCT02397889|521010866|FG000|Overall Study|Physician Decision|1|||
144495749|NCT02397889|521010867|FG001|Overall Study|Physician Decision|0|||
144495750|NCT01928940|521010877|FG000|Overall Study|Adverse Event|0|||
144495751|NCT01928940|521010878|FG001|Overall Study|Adverse Event|1|||
144495752|NCT02954055|521010879|FG000|Overall Study|Did not initiate therapy|6|||
144495753|NCT02954055|521010880|FG001|Overall Study|Did not initiate therapy|1|||
144495754|NCT01352507|521010889|FG000|Treatment Period 1|Adverse Event|3|||
144495755|NCT01352507|521010890|FG001|Treatment Period 1|Adverse Event|0|||
144495756|NCT01352507|521010889|FG000|Treatment Period 1|Lost to Follow-up|3|||
144495757|NCT01352507|521010890|FG001|Treatment Period 1|Lost to Follow-up|4|||
144495758|NCT01352507|521010889|FG000|Treatment Period 1|Withdrawal by Subject|7|||
144495759|NCT01352507|521010890|FG001|Treatment Period 1|Withdrawal by Subject|5|||
144495760|NCT01352507|521010889|FG000|Treatment Period 1|Physician Decision|1|||
144495761|NCT01352507|521010890|FG001|Treatment Period 1|Physician Decision|0|||
144495762|NCT01352507|521010889|FG000|Washout Period|Withdrawal by Subject|0|||
144495763|NCT01352507|521010890|FG001|Washout Period|Withdrawal by Subject|1|||
144495764|NCT01352507|521010889|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
144495765|NCT01352507|521010890|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
144495766|NCT01352507|521010889|FG000|Treatment Period 2|Withdrawal by Subject|4|||
144719327|NCT01155583|521825901|FG003|Phase I|Screen failure - did not start treatment|0|||
144719328|NCT01155583|521825902|FG004|Phase I|Screen failure - did not start treatment|1|||
144719329|NCT01155583|521825903|FG005|Phase I|Screen failure - did not start treatment|0|||
144719330|NCT01155583|521825904|FG006|Phase I|Screen failure - did not start treatment|0|||
144495767|NCT01352507|521010890|FG001|Treatment Period 2|Withdrawal by Subject|3|||
144495768|NCT01352507|521010889|FG000|Treatment Period 2|Lack of Efficacy|1|||
144495769|NCT01352507|521010890|FG001|Treatment Period 2|Lack of Efficacy|0|||
144495770|NCT01119703|521010891|FG000|Overall Study|Adverse Event|0|||
144495771|NCT01119703|521010892|FG001|Overall Study|Adverse Event|1|||
144495772|NCT02095158|521010896|FG000|Overall Study|Adverse Event|14|||
144495773|NCT02095158|521010896|FG000|Overall Study|Lack of Efficacy|3|||
144495774|NCT02095158|521010896|FG000|Overall Study|Pregnancy|1|||
144495775|NCT02095158|521010896|FG000|Overall Study|Lost to Follow-up|20|||
144495776|NCT02095158|521010896|FG000|Overall Study|Personal Reasons|35|||
144495777|NCT02095158|521010896|FG000|Overall Study|Protocol Violation|1|||
144495778|NCT02095158|521010896|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144495779|NCT02282527|521010899|FG000|Overall Study|Lost to Follow-up|0|||
144495780|NCT02282527|521010900|FG001|Overall Study|Lost to Follow-up|1|||
144495781|NCT02282527|521010899|FG000|Overall Study|Lack of home health aid|1|||
144495782|NCT02282527|521010900|FG001|Overall Study|Lack of home health aid|0|||
144495783|NCT00941031|521010901|FG000|Induction Period|Lack of Efficacy|2|||
144495784|NCT00941031|521010902|FG001|Induction Period|Lack of Efficacy|1|||
144495785|NCT00941031|521010903|FG002|Induction Period|Lack of Efficacy|0|||
144495786|NCT00941031|521010904|FG003|Induction Period|Lack of Efficacy|5|||
144495787|NCT00941031|521010905|FG004|Induction Period|Lack of Efficacy|0|||
144495788|NCT00941031|521010906|FG005|Induction Period|Lack of Efficacy|0|||
144495789|NCT00941031|521010907|FG006|Induction Period|Lack of Efficacy|0|||
144719331|NCT01155583|521825905|FG007|Phase I|Screen failure - did not start treatment|2|||
144719332|NCT01155583|521825906|FG008|Phase I|Screen failure - did not start treatment|0|||
144719333|NCT01155583|521825898|FG000|Phase I|Withdrawal by Subject|0|||
144719334|NCT01155583|521825899|FG001|Phase I|Withdrawal by Subject|0|||
144719335|NCT01155583|521825900|FG002|Phase I|Withdrawal by Subject|0|||
144719336|NCT01155583|521825901|FG003|Phase I|Withdrawal by Subject|0|||
144719337|NCT01155583|521825902|FG004|Phase I|Withdrawal by Subject|0|||
144719338|NCT01155583|521825903|FG005|Phase I|Withdrawal by Subject|0|||
144719339|NCT01155583|521825904|FG006|Phase I|Withdrawal by Subject|0|||
144719340|NCT01155583|521825905|FG007|Phase I|Withdrawal by Subject|1|||
144719341|NCT01155583|521825906|FG008|Phase I|Withdrawal by Subject|0|||
144719342|NCT00585351|521825907|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
144719343|NCT00585351|521825908|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
144719344|NCT00585351|521825909|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
144719345|NCT00585351|521825910|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
144719346|NCT00585351|521825911|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
144719347|NCT00585351|521825912|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
144719348|NCT00585351|521825913|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
144719349|NCT00585351|521825914|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
144719350|NCT00585351|521825907|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
144719351|NCT00585351|521825908|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
144719352|NCT00585351|521825909|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
144719353|NCT00585351|521825910|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
144719354|NCT00585351|521825911|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
144719355|NCT00585351|521825912|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
144719356|NCT00585351|521825913|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
144719357|NCT00585351|521825914|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
144719358|NCT00585351|521825907|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
144719359|NCT00585351|521825908|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
144719360|NCT00585351|521825909|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
144719361|NCT00585351|521825910|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
144719362|NCT00585351|521825911|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
144719363|NCT00585351|521825912|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
144719364|NCT00585351|521825913|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
144719365|NCT00585351|521825914|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
144719366|NCT00585351|521825907|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
144719367|NCT00585351|521825908|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
144719368|NCT00585351|521825909|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
144719369|NCT00585351|521825910|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
144719370|NCT00585351|521825911|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
144719371|NCT00585351|521825912|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
144719372|NCT00585351|521825913|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
144719373|NCT00585351|521825914|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
144719374|NCT00585351|521825907|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
144719375|NCT00585351|521825908|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
144719376|NCT00585351|521825909|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
144719377|NCT00585351|521825910|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
144719378|NCT00585351|521825911|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
144719379|NCT00585351|521825912|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
144719380|NCT00585351|521825913|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
144719381|NCT00585351|521825914|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
144719382|NCT00585351|521825907|FG000|Enrollment Period (Intervention)|Death|0|||
144719383|NCT00585351|521825908|FG001|Enrollment Period (Intervention)|Death|0|||
144719384|NCT00585351|521825909|FG002|Enrollment Period (Intervention)|Death|0|||
144719385|NCT00585351|521825910|FG003|Enrollment Period (Intervention)|Death|0|||
144719386|NCT00585351|521825911|FG004|Enrollment Period (Intervention)|Death|1|||
144719387|NCT00585351|521825912|FG005|Enrollment Period (Intervention)|Death|0|||
144495790|NCT00941031|521010901|FG000|Induction Period|Withdrawal by Subject|1|||
144495791|NCT00941031|521010902|FG001|Induction Period|Withdrawal by Subject|2|||
144495792|NCT00941031|521010903|FG002|Induction Period|Withdrawal by Subject|2|||
144495793|NCT00941031|521010904|FG003|Induction Period|Withdrawal by Subject|2|||
144495794|NCT00941031|521010905|FG004|Induction Period|Withdrawal by Subject|0|||
144495795|NCT00941031|521010906|FG005|Induction Period|Withdrawal by Subject|0|||
144495796|NCT00941031|521010907|FG006|Induction Period|Withdrawal by Subject|0|||
144495797|NCT00941031|521010901|FG000|Induction Period|Adminstative Problems|1|||
144495798|NCT00941031|521010902|FG001|Induction Period|Adminstative Problems|1|||
144495799|NCT00941031|521010903|FG002|Induction Period|Adminstative Problems|1|||
144495800|NCT00941031|521010904|FG003|Induction Period|Adminstative Problems|0|||
144495801|NCT00941031|521010905|FG004|Induction Period|Adminstative Problems|0|||
144495802|NCT00941031|521010906|FG005|Induction Period|Adminstative Problems|0|||
144495803|NCT00941031|521010907|FG006|Induction Period|Adminstative Problems|0|||
144495804|NCT00941031|521010901|FG000|Induction Period|Adverse Event|1|||
144495805|NCT00941031|521010902|FG001|Induction Period|Adverse Event|0|||
144495806|NCT00941031|521010903|FG002|Induction Period|Adverse Event|3|||
144495807|NCT00941031|521010904|FG003|Induction Period|Adverse Event|2|||
144495808|NCT00941031|521010905|FG004|Induction Period|Adverse Event|0|||
144495809|NCT00941031|521010906|FG005|Induction Period|Adverse Event|0|||
144495810|NCT00941031|521010907|FG006|Induction Period|Adverse Event|0|||
144495811|NCT00941031|521010901|FG000|Maintenance Period|Withdrawal by Subject|0|||
144495812|NCT00941031|521010902|FG001|Maintenance Period|Withdrawal by Subject|0|||
144495813|NCT00941031|521010903|FG002|Maintenance Period|Withdrawal by Subject|0|||
144495814|NCT00941031|521010904|FG003|Maintenance Period|Withdrawal by Subject|0|||
144495815|NCT00941031|521010905|FG004|Maintenance Period|Withdrawal by Subject|6|||
144495816|NCT00941031|521010906|FG005|Maintenance Period|Withdrawal by Subject|2|||
144495817|NCT00941031|521010907|FG006|Maintenance Period|Withdrawal by Subject|13|||
144495818|NCT00941031|521010901|FG000|Maintenance Period|Administrative Problems|0|||
144495819|NCT00941031|521010902|FG001|Maintenance Period|Administrative Problems|0|||
144495820|NCT00941031|521010903|FG002|Maintenance Period|Administrative Problems|0|||
144495821|NCT00941031|521010904|FG003|Maintenance Period|Administrative Problems|0|||
144495822|NCT00941031|521010905|FG004|Maintenance Period|Administrative Problems|1|||
144495823|NCT00941031|521010906|FG005|Maintenance Period|Administrative Problems|0|||
144495824|NCT00941031|521010907|FG006|Maintenance Period|Administrative Problems|1|||
144495825|NCT00941031|521010901|FG000|Maintenance Period|Protocol Violation|0|||
144495826|NCT00941031|521010902|FG001|Maintenance Period|Protocol Violation|0|||
144495827|NCT00941031|521010903|FG002|Maintenance Period|Protocol Violation|0|||
144495828|NCT00941031|521010904|FG003|Maintenance Period|Protocol Violation|0|||
144495829|NCT00941031|521010905|FG004|Maintenance Period|Protocol Violation|0|||
144495830|NCT00941031|521010906|FG005|Maintenance Period|Protocol Violation|0|||
144495831|NCT00941031|521010907|FG006|Maintenance Period|Protocol Violation|1|||
144495832|NCT00941031|521010901|FG000|Maintenance Period|Adverse Event|0|||
144495833|NCT00941031|521010902|FG001|Maintenance Period|Adverse Event|0|||
144495834|NCT00941031|521010903|FG002|Maintenance Period|Adverse Event|0|||
144495835|NCT00941031|521010904|FG003|Maintenance Period|Adverse Event|0|||
144495836|NCT00941031|521010905|FG004|Maintenance Period|Adverse Event|0|||
144495837|NCT00941031|521010906|FG005|Maintenance Period|Adverse Event|2|||
144495838|NCT00941031|521010907|FG006|Maintenance Period|Adverse Event|8|||
144495839|NCT00941031|521010901|FG000|Maintenance Period|Lost to Follow-up|0|||
144495840|NCT00941031|521010902|FG001|Maintenance Period|Lost to Follow-up|0|||
144495841|NCT00941031|521010903|FG002|Maintenance Period|Lost to Follow-up|0|||
144495842|NCT00941031|521010904|FG003|Maintenance Period|Lost to Follow-up|0|||
144495843|NCT00941031|521010905|FG004|Maintenance Period|Lost to Follow-up|2|||
144495844|NCT00941031|521010906|FG005|Maintenance Period|Lost to Follow-up|2|||
144495845|NCT00941031|521010907|FG006|Maintenance Period|Lost to Follow-up|7|||
144495846|NCT00941031|521010901|FG000|Maintenance Period|Lack of Efficacy|0|||
144495847|NCT00941031|521010902|FG001|Maintenance Period|Lack of Efficacy|0|||
144495848|NCT00941031|521010903|FG002|Maintenance Period|Lack of Efficacy|0|||
144495849|NCT00941031|521010904|FG003|Maintenance Period|Lack of Efficacy|0|||
144495850|NCT00941031|521010905|FG004|Maintenance Period|Lack of Efficacy|0|||
144495851|NCT00941031|521010906|FG005|Maintenance Period|Lack of Efficacy|0|||
144495852|NCT00941031|521010907|FG006|Maintenance Period|Lack of Efficacy|13|||
144495853|NCT01872611|521010908|FG000|Overall Study|Adverse Event|3|||
144495854|NCT01872611|521010909|FG001|Overall Study|Adverse Event|1|||
144495855|NCT01872611|521010908|FG000|Overall Study|Adverse Event, prior to treatment|0|||
144495856|NCT01872611|521010909|FG001|Overall Study|Adverse Event, prior to treatment|1|||
144495857|NCT01872611|521010908|FG000|Overall Study|Death|0|||
144495858|NCT01872611|521010909|FG001|Overall Study|Death|1|||
144495859|NCT01872611|521010908|FG000|Overall Study|Death, prior to treatment|0|||
144495860|NCT01872611|521010909|FG001|Overall Study|Death, prior to treatment|1|||
144495861|NCT01872611|521010908|FG000|Overall Study|Lost to Follow-up|8|||
144495862|NCT01872611|521010909|FG001|Overall Study|Lost to Follow-up|1|||
144495863|NCT01872611|521010908|FG000|Overall Study|Physician Decision|1|||
144495864|NCT01872611|521010909|FG001|Overall Study|Physician Decision|0|||
144495865|NCT01872611|521010908|FG000|Overall Study|Withdrawal by Subject|6|||
144495866|NCT01872611|521010909|FG001|Overall Study|Withdrawal by Subject|1|||
144495867|NCT01872611|521010908|FG000|Overall Study|Reason not provided|6|||
144495868|NCT01872611|521010909|FG001|Overall Study|Reason not provided|6|||
144495869|NCT03537651|521010910|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
144495870|NCT03537651|521010910|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
144495871|NCT03537651|521010910|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
144495872|NCT03537651|521010910|FG000|Part A (Up to 96 Weeks)|Other|1|||
144495873|NCT03537651|521010910|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
144495874|NCT03537651|521010910|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
144495875|NCT03537651|521010910|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
144495876|NCT03537651|521010910|FG000|Part B (Up to 192 Weeks)|Other|1|||
144495877|NCT05487703|521010911|FG000|Overall Study|Other|19|||
144495878|NCT05487703|521010911|FG000|Overall Study|Participant not well|5|||
144495879|NCT05487703|521010911|FG000|Overall Study|Insurance Reasons|6|||
144495880|NCT05487703|521010911|FG000|Overall Study|Physician Decision|19|||
144495881|NCT05487703|521010911|FG000|Overall Study|Lack of Efficacy|60|||
144495882|NCT00359619|521012381|FG000|Overall Study|Adverse Event|0|||
144495883|NCT00359619|521012382|FG001|Overall Study|Adverse Event|0|||
144495884|NCT00359619|521012383|FG002|Overall Study|Adverse Event|1|||
144495885|NCT00359619|521012384|FG003|Overall Study|Adverse Event|0|||
144495886|NCT00359619|521012385|FG004|Overall Study|Adverse Event|0|||
144495887|NCT00359619|521012386|FG005|Overall Study|Adverse Event|0|||
144495888|NCT00359619|521012387|FG006|Overall Study|Adverse Event|1|||
144495889|NCT00359619|521012381|FG000|Overall Study|Withdrawal by Subject|3|||
144495890|NCT00359619|521012382|FG001|Overall Study|Withdrawal by Subject|1|||
144495891|NCT00359619|521012383|FG002|Overall Study|Withdrawal by Subject|4|||
144495892|NCT00359619|521012384|FG003|Overall Study|Withdrawal by Subject|2|||
144495893|NCT00359619|521012385|FG004|Overall Study|Withdrawal by Subject|2|||
144495894|NCT00359619|521012386|FG005|Overall Study|Withdrawal by Subject|0|||
144495895|NCT00359619|521012387|FG006|Overall Study|Withdrawal by Subject|3|||
144495896|NCT00359619|521012381|FG000|Overall Study|Other|1|||
144495897|NCT00359619|521012382|FG001|Overall Study|Other|0|||
144495898|NCT00359619|521012383|FG002|Overall Study|Other|0|||
144495899|NCT00359619|521012384|FG003|Overall Study|Other|0|||
144495900|NCT00359619|521012385|FG004|Overall Study|Other|0|||
144495901|NCT00359619|521012386|FG005|Overall Study|Other|0|||
144495902|NCT00359619|521012387|FG006|Overall Study|Other|0|||
144495903|NCT00359619|521012381|FG000|Overall Study|Lost to Follow-up|4|||
144495904|NCT00359619|521012382|FG001|Overall Study|Lost to Follow-up|4|||
144495905|NCT00359619|521012383|FG002|Overall Study|Lost to Follow-up|2|||
144495906|NCT00359619|521012384|FG003|Overall Study|Lost to Follow-up|1|||
144495907|NCT00359619|521012385|FG004|Overall Study|Lost to Follow-up|1|||
144495908|NCT00359619|521012386|FG005|Overall Study|Lost to Follow-up|5|||
144495909|NCT00359619|521012387|FG006|Overall Study|Lost to Follow-up|0|||
144495910|NCT01419717|521012388|FG000|Overall Study|Protocol-specified Criteria|62|||
144495911|NCT01419717|521012388|FG000|Overall Study|Adverse Event|19|||
144495912|NCT01419717|521012388|FG000|Overall Study|Death|17|||
144495913|NCT01419717|521012388|FG000|Overall Study|Withdrawal by Subject|10|||
144495914|NCT01419717|521012388|FG000|Overall Study|Disease Progression|9|||
144495915|NCT01419717|521012388|FG000|Overall Study|Other|4|||
144495916|NCT01419717|521012388|FG000|Overall Study|Lost to Follow-up|2|||
144495917|NCT01419717|521012388|FG000|Overall Study|Administrative Decision|1|||
144495918|NCT01419717|521012388|FG000|Overall Study|Noncompliance|1|||
144495919|NCT02857283|521012389|FG000|First Exposure|Withdrawal by Subject|1|||
144495920|NCT02857283|521012390|FG001|First Exposure|Withdrawal by Subject|0|||
144495921|NCT00613301|521012391|FG000|Overall Study|Adverse Event|49|||
144495922|NCT00613301|521012391|FG000|Overall Study|Lost to Follow-up|88|||
144495923|NCT00613301|521012391|FG000|Overall Study|Withdrawal by Subject|5|||
144495924|NCT00613301|521012391|FG000|Overall Study|Death|6|||
144495925|NCT00613301|521012391|FG000|Overall Study|Lack of Efficacy|13|||
144495926|NCT00613301|521012391|FG000|Overall Study|Physician Decision|2|||
144495927|NCT00613301|521012391|FG000|Overall Study|No data was collected|53|||
144495928|NCT00613301|521012391|FG000|Overall Study|Irregularly enrolled patients|12|||
144495929|NCT00587288|521012392|FG000|Overall Study|Adverse Event|0|||
144495930|NCT00587288|521012393|FG001|Overall Study|Adverse Event|1|||
144495931|NCT00587288|521012392|FG000|Overall Study|Lack of Efficacy|2|||
144495932|NCT00587288|521012393|FG001|Overall Study|Lack of Efficacy|8|||
144495933|NCT00587288|521012392|FG000|Overall Study|Protocol Violation|1|||
144495934|NCT00587288|521012393|FG001|Overall Study|Protocol Violation|0|||
144495935|NCT00946114|521012396|FG000|Overall Study|Death|5|||
144495936|NCT00946114|521012397|FG001|Overall Study|Death|2|||
144495937|NCT00946114|521012396|FG000|Overall Study|Other|1|||
144495938|NCT00946114|521012397|FG001|Overall Study|Other|0|||
144495939|NCT00946114|521012396|FG000|Overall Study|Withdrawal by Subject|2|||
144719388|NCT00585351|521825913|FG006|Enrollment Period (Intervention)|Death|1|||
144719389|NCT00585351|521825914|FG007|Enrollment Period (Intervention)|Death|0|||
144719390|NCT00585351|521825907|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
144719391|NCT00585351|521825908|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
144719392|NCT00585351|521825909|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
144719393|NCT00585351|521825910|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
144495940|NCT00946114|521012397|FG001|Overall Study|Withdrawal by Subject|0|||
144495941|NCT00723294|521012398|FG000|Overall Study|Lobular histology|2|||
144719394|NCT00585351|521825911|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
144719395|NCT00585351|521825912|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
144495942|NCT00723294|521012398|FG000|Overall Study|>25% intraductal component|1|||
144495943|NCT00723294|521012398|FG000|Overall Study|No MRI tumor enhancement|1|||
144495944|NCT00723294|521012398|FG000|Overall Study|1.0-Tesla MRI|1|||
144495945|NCT00723294|521012398|FG000|Overall Study|No cryoabalation|2|||
144495946|NCT00723294|521012398|FG000|Overall Study|Did not undergo surgery|1|||
144495947|NCT00723294|521012398|FG000|Overall Study|Treated prior to registration|1|||
144495948|NCT00723294|521012398|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
144495949|NCT00723294|521012398|FG000|Overall Study|Benign lesion|1|||
144495950|NCT00723294|521012398|FG000|Overall Study|Withdrawal by Subject|1|||
144495951|NCT00723294|521012398|FG000|Overall Study|No treatment due to probe failure|1|||
144495952|NCT01211665|521012399|FG000|Overall Study|Withdrawal by Subject|1|||
144495953|NCT01211665|521012400|FG001|Overall Study|Withdrawal by Subject|0|||
144495954|NCT01211665|521012399|FG000|Overall Study|Death|1|||
144495955|NCT01211665|521012400|FG001|Overall Study|Death|0|||
144495956|NCT00088465|521012405|FG000|Overall Study|Withdrawal by Subject|290|||
144495957|NCT00088465|521012405|FG000|Overall Study|Adverse Event|77|||
144495958|NCT00088465|521012405|FG000|Overall Study|Lost to Follow-up|57|||
144495959|NCT00088465|521012405|FG000|Overall Study|Physician Decision|45|||
144495960|NCT00088465|521012405|FG000|Overall Study|Sponsor Decision|37|||
144495961|NCT00088465|521012405|FG000|Overall Study|Lack of Efficacy|27|||
144495962|NCT00088465|521012405|FG000|Overall Study|Protocol Violation|17|||
144495963|NCT00088465|521012405|FG000|Overall Study|Death|11|||
144495964|NCT00448864|521012406|FG000|Overall Study|Death|1|||
144495965|NCT00448864|521012407|FG001|Overall Study|Death|0|||
144495966|NCT00448864|521012408|FG002|Overall Study|Death|0|||
144495967|NCT00448864|521012406|FG000|Overall Study|Lost to Follow-up|3|||
144495968|NCT00448864|521012407|FG001|Overall Study|Lost to Follow-up|1|||
144495969|NCT00448864|521012408|FG002|Overall Study|Lost to Follow-up|0|||
144495970|NCT00448864|521012406|FG000|Overall Study|Physician Decision|1|||
144495971|NCT00448864|521012407|FG001|Overall Study|Physician Decision|0|||
144495972|NCT00448864|521012408|FG002|Overall Study|Physician Decision|1|||
144495973|NCT00448864|521012406|FG000|Overall Study|Withdrawal by Subject|0|||
144495974|NCT00448864|521012407|FG001|Overall Study|Withdrawal by Subject|2|||
144495975|NCT00448864|521012408|FG002|Overall Study|Withdrawal by Subject|0|||
144495976|NCT00448864|521012406|FG000|Overall Study|Protocol Violation|0|||
144495977|NCT00448864|521012407|FG001|Overall Study|Protocol Violation|2|||
144495978|NCT00448864|521012408|FG002|Overall Study|Protocol Violation|0|||
144495979|NCT01390857|521012409|FG000|Overall Study|Protocol Violation|2|||
144495980|NCT01390857|521012409|FG000|Overall Study|Lost to Follow-up|1|||
144495981|NCT01390857|521012409|FG000|Overall Study|No Visit after the First Visit|7|||
144495982|NCT02757885|521012410|FG000|Overall Study|Screen Failures|4|||
144495983|NCT01456780|521012412|FG000|Overall Study|Lost to Follow-up|3|||
144495984|NCT01456780|521012413|FG001|Overall Study|Lost to Follow-up|3|||
144495985|NCT01456780|521012414|FG002|Overall Study|Lost to Follow-up|0|||
144495986|NCT02688621|521012415|FG000|Overall Study|Pregnancy|1|||
144495987|NCT02688621|521012416|FG001|Overall Study|Pregnancy|3|||
144495988|NCT02688621|521012415|FG000|Overall Study|Lost to Follow-up|38|||
144495989|NCT02688621|521012416|FG001|Overall Study|Lost to Follow-up|15|||
144495990|NCT02688621|521012415|FG000|Overall Study|Withdrawal by Subject|1|||
144495991|NCT02688621|521012416|FG001|Overall Study|Withdrawal by Subject|0|||
144495992|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
144495993|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
144495994|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
144495995|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Death|3|||
144495996|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Death|0|||
144495997|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Death|0|||
144495998|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
144495999|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
144496000|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
144496001|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
144496002|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
144496003|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
144496004|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
144496005|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
144496006|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
144496007|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
144496008|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
144496009|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
144496010|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
144496011|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
144496012|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
144496013|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Other|1|||
144496014|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Other|0|||
144496015|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Other|0|||
144496016|NCT02403323|521012419|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
144496017|NCT02403323|521012420|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
144496018|NCT02403323|521012421|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
144496019|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
144496020|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
144719396|NCT00585351|521825913|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
144719397|NCT00585351|521825914|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
144719398|NCT01001169|521825915|FG000|Overall Study|Withdrawal by Subject|2|||
144719399|NCT01001169|521825916|FG001|Overall Study|Withdrawal by Subject|1|||
144719400|NCT02536378|521825921|FG000|Overall Study|Physician Decision|0|||
144719401|NCT02536378|521825922|FG001|Overall Study|Physician Decision|2|||
144719402|NCT02536378|521825921|FG000|Overall Study|Withdrawal by Subject|0|||
144719403|NCT02536378|521825922|FG001|Overall Study|Withdrawal by Subject|1|||
144719404|NCT02536378|521825921|FG000|Overall Study|Death|1|||
144719405|NCT02536378|521825922|FG001|Overall Study|Death|2|||
144719406|NCT02536378|521825921|FG000|Overall Study|Patient refused further follow up|6|||
144719407|NCT02536378|521825922|FG001|Overall Study|Patient refused further follow up|2|||
144719408|NCT00602030|521825923|FG000|Lead-in Phase|Disease Progression|2|||
144719409|NCT00602030|521825924|FG001|Lead-in Phase|Disease Progression|3|||
144719410|NCT00602030|521825925|FG002|Lead-in Phase|Disease Progression|0|||
144719411|NCT00602030|521825926|FG003|Lead-in Phase|Disease Progression|0|||
144719412|NCT00602030|521825927|FG004|Lead-in Phase|Disease Progression|0|||
144719413|NCT00602030|521825923|FG000|Lead-in Phase|Adverse Event|0|||
144719414|NCT00602030|521825924|FG001|Lead-in Phase|Adverse Event|2|||
144719415|NCT00602030|521825925|FG002|Lead-in Phase|Adverse Event|0|||
144719416|NCT00602030|521825926|FG003|Lead-in Phase|Adverse Event|0|||
144719417|NCT00602030|521825927|FG004|Lead-in Phase|Adverse Event|0|||
144719418|NCT00602030|521825923|FG000|Double-blind Phase|Disease progression|0|||
144719419|NCT00602030|521825924|FG001|Double-blind Phase|Disease progression|0|||
144719420|NCT00602030|521825925|FG002|Double-blind Phase|Disease progression|33|||
144719421|NCT00602030|521825926|FG003|Double-blind Phase|Disease progression|30|||
144719422|NCT00602030|521825927|FG004|Double-blind Phase|Disease progression|0|||
144719423|NCT00602030|521825923|FG000|Double-blind Phase|Adverse Event|0|||
144719424|NCT00602030|521825924|FG001|Double-blind Phase|Adverse Event|0|||
144719425|NCT00602030|521825925|FG002|Double-blind Phase|Adverse Event|9|||
144719426|NCT00602030|521825926|FG003|Double-blind Phase|Adverse Event|18|||
144719427|NCT00602030|521825927|FG004|Double-blind Phase|Adverse Event|0|||
144719428|NCT00602030|521825923|FG000|Double-blind Phase|Consent withdrawal|0|||
144719429|NCT00602030|521825924|FG001|Double-blind Phase|Consent withdrawal|0|||
144719430|NCT00602030|521825925|FG002|Double-blind Phase|Consent withdrawal|4|||
144719431|NCT00602030|521825926|FG003|Double-blind Phase|Consent withdrawal|3|||
144719432|NCT00602030|521825927|FG004|Double-blind Phase|Consent withdrawal|0|||
144719433|NCT00602030|521825923|FG000|Double-blind Phase|Death|0|||
144719434|NCT00602030|521825924|FG001|Double-blind Phase|Death|0|||
144719435|NCT00602030|521825925|FG002|Double-blind Phase|Death|3|||
144719436|NCT00602030|521825926|FG003|Double-blind Phase|Death|3|||
144719437|NCT00602030|521825927|FG004|Double-blind Phase|Death|0|||
144719438|NCT00602030|521825923|FG000|Double-blind Phase|Administrative decision|0|||
144719439|NCT00602030|521825924|FG001|Double-blind Phase|Administrative decision|0|||
144719440|NCT00602030|521825925|FG002|Double-blind Phase|Administrative decision|0|||
144719441|NCT00602030|521825926|FG003|Double-blind Phase|Administrative decision|2|||
144719442|NCT00602030|521825927|FG004|Double-blind Phase|Administrative decision|0|||
144719443|NCT00602030|521825923|FG000|Double-blind Phase|Ineligibility|0|||
144719444|NCT00602030|521825924|FG001|Double-blind Phase|Ineligibility|0|||
144719445|NCT00602030|521825925|FG002|Double-blind Phase|Ineligibility|0|||
144719446|NCT00602030|521825926|FG003|Double-blind Phase|Ineligibility|1|||
144719447|NCT00602030|521825927|FG004|Double-blind Phase|Ineligibility|0|||
144719448|NCT00602030|521825923|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
144719449|NCT00602030|521825924|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
144719450|NCT00602030|521825925|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
144719451|NCT00602030|521825926|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
144719452|NCT00602030|521825927|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
144719453|NCT00602030|521825923|FG000|Double-blind Phase|Reason not specified|0|||
144719454|NCT00602030|521825924|FG001|Double-blind Phase|Reason not specified|0|||
144719455|NCT00602030|521825925|FG002|Double-blind Phase|Reason not specified|4|||
144719456|NCT00602030|521825926|FG003|Double-blind Phase|Reason not specified|2|||
144719457|NCT00602030|521825927|FG004|Double-blind Phase|Reason not specified|0|||
144719458|NCT00602030|521825923|FG000|Crossover Phase|Disease Progression|0|||
144719459|NCT00602030|521825924|FG001|Crossover Phase|Disease Progression|0|||
144719460|NCT00602030|521825925|FG002|Crossover Phase|Disease Progression|0|||
144719461|NCT00602030|521825926|FG003|Crossover Phase|Disease Progression|0|||
144719462|NCT00602030|521825927|FG004|Crossover Phase|Disease Progression|11|||
144719463|NCT00602030|521825923|FG000|Crossover Phase|Adverse Event|0|||
144719464|NCT00602030|521825924|FG001|Crossover Phase|Adverse Event|0|||
144719465|NCT00602030|521825925|FG002|Crossover Phase|Adverse Event|0|||
144719466|NCT00602030|521825926|FG003|Crossover Phase|Adverse Event|0|||
144719467|NCT00602030|521825927|FG004|Crossover Phase|Adverse Event|3|||
144719468|NCT00602030|521825923|FG000|Crossover Phase|Consent withdrawal|0|||
144719469|NCT00602030|521825924|FG001|Crossover Phase|Consent withdrawal|0|||
144719470|NCT00602030|521825925|FG002|Crossover Phase|Consent withdrawal|0|||
144719471|NCT00602030|521825926|FG003|Crossover Phase|Consent withdrawal|0|||
144496021|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
144496022|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
144496023|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
144496024|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
144496025|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
144496026|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
144496027|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
144496028|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
144496029|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
144496030|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
144496031|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
144496032|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
144496033|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
144496034|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
144496035|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
144496036|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
144496037|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
144496038|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
144496039|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
144496040|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
144496041|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
144496042|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
144496043|NCT02403323|521012419|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
144496044|NCT02403323|521012420|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
144496045|NCT02403323|521012421|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
144496046|NCT00197236|521012422|FG000|Overall Study|Adverse Event|1|||
144496047|NCT00197236|521012423|FG001|Overall Study|Adverse Event|0|||
144496048|NCT00197236|521012424|FG002|Overall Study|Adverse Event|1|||
144496049|NCT00197236|521012422|FG000|Overall Study|Lost to Follow-up|5|||
144496050|NCT00197236|521012423|FG001|Overall Study|Lost to Follow-up|14|||
144496051|NCT00197236|521012424|FG002|Overall Study|Lost to Follow-up|6|||
144496052|NCT00197236|521012422|FG000|Overall Study|Protocol Violation|0|||
144496053|NCT00197236|521012423|FG001|Overall Study|Protocol Violation|0|||
144496054|NCT00197236|521012424|FG002|Overall Study|Protocol Violation|1|||
144496055|NCT00197236|521012422|FG000|Overall Study|Withdrawal by Subject|7|||
144496056|NCT00197236|521012423|FG001|Overall Study|Withdrawal by Subject|3|||
144496057|NCT00197236|521012424|FG002|Overall Study|Withdrawal by Subject|11|||
144496058|NCT00197236|521012422|FG000|Overall Study|Study drug/medication expiration|1|||
144496059|NCT00197236|521012423|FG001|Overall Study|Study drug/medication expiration|0|||
144496060|NCT00197236|521012424|FG002|Overall Study|Study drug/medication expiration|3|||
144496061|NCT00197236|521012422|FG000|Overall Study|Returned out of specified time window|0|||
144496062|NCT00197236|521012423|FG001|Overall Study|Returned out of specified time window|0|||
144496063|NCT00197236|521012424|FG002|Overall Study|Returned out of specified time window|1|||
144496064|NCT03885596|521012425|FG000|Overall Study|Withdrawal by Subject|2|||
144496065|NCT03885596|521012426|FG001|Overall Study|Withdrawal by Subject|1|||
144496066|NCT03885596|521012427|FG002|Overall Study|Withdrawal by Subject|0|||
144496067|NCT03885596|521012428|FG003|Overall Study|Withdrawal by Subject|0|||
144496068|NCT01076335|521012429|FG000|Overall Study|Withdrawal by Subject|3|||
144496069|NCT01076335|521012429|FG000|Overall Study|Withdrawal without treatment|1|||
144496070|NCT02616263|521012430|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
144496071|NCT02616263|521012431|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
144496072|NCT02616263|521012430|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
144496073|NCT02616263|521012431|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
144496074|NCT02616263|521012430|FG000|6 Month to 1.5 Year|Death|1|||
144496075|NCT02616263|521012431|FG001|6 Month to 1.5 Year|Death|0|||
144496076|NCT02616263|521012430|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
144496077|NCT02616263|521012431|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
144496078|NCT02616263|521012430|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
144496079|NCT02616263|521012431|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
144496080|NCT02616263|521012430|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
144496081|NCT02616263|521012431|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
144496082|NCT02939183|521012432|FG000|Overall Study|Death|0|||
144496083|NCT02939183|521012433|FG001|Overall Study|Death|0|||
144496084|NCT02939183|521012434|FG002|Overall Study|Death|1|||
144496085|NCT02939183|521012435|FG003|Overall Study|Death|0|||
144496086|NCT02939183|521012436|FG004|Overall Study|Death|0|||
144496087|NCT02939183|521012437|FG005|Overall Study|Death|2|||
144496088|NCT02939183|521012438|FG006|Overall Study|Death|1|||
144496089|NCT02939183|521012439|FG007|Overall Study|Death|0|||
144496090|NCT02939183|521012440|FG008|Overall Study|Death|0|||
144719472|NCT00602030|521825927|FG004|Crossover Phase|Consent withdrawal|2|||
144496091|NCT02939183|521012432|FG000|Overall Study|Sponsor decision|0|||
144370051|NCT00515619|520562800|FG000|Overall Study|Withdrawal by Subject|66|||
144496092|NCT02939183|521012433|FG001|Overall Study|Sponsor decision|1|||
144496093|NCT02939183|521012434|FG002|Overall Study|Sponsor decision|0|||
144496094|NCT02939183|521012435|FG003|Overall Study|Sponsor decision|1|||
144496095|NCT02939183|521012436|FG004|Overall Study|Sponsor decision|2|||
144496096|NCT02939183|521012437|FG005|Overall Study|Sponsor decision|0|||
144370052|NCT00515619|520562800|FG000|Overall Study|Protocol Violation|3|||
144370053|NCT00515619|520562800|FG000|Overall Study|Lost to Follow-up|4|||
144370054|NCT00515619|520562800|FG000|Overall Study|Unsatisfactory compliance|6|||
144370055|NCT00515619|520562800|FG000|Overall Study|Other: Site discontinuing trials|2|||
144370056|NCT00515619|520562800|FG000|Overall Study|Other: Subject cannot attend visits|2|||
144370057|NCT00515619|520562800|FG000|Overall Study|Other: Subject required surgery|1|||
144370058|NCT00515619|520562800|FG000|Overall Study|Other: Subject moved to another country|1|||
144370059|NCT00515619|520562800|FG000|Overall Study|Other: Investigator decision|1|||
144370060|NCT00515619|520562800|FG000|Overall Study|Other: Subject became pregnant|1|||
144370061|NCT00515619|520562800|FG000|Overall Study|Other: Request from sponsor|1|||
144370062|NCT00515619|520562800|FG000|Overall Study|Other: Drug available on license|1|||
144370063|NCT00515619|520562800|FG000|Overall Study|Other: Subject interested in other AED|1|||
144370064|NCT02379091|520562801|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144370065|NCT02379091|520562802|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
144370066|NCT02379091|520562803|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144370067|NCT02379091|520562804|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
144370068|NCT02379091|520562801|FG000|Overall Study|Principal Investigator Discretion|0|||
144370069|NCT02379091|520562802|FG001|Overall Study|Principal Investigator Discretion|1|||
144496097|NCT02939183|521012438|FG006|Overall Study|Sponsor decision|3|||
144496098|NCT02939183|521012439|FG007|Overall Study|Sponsor decision|1|||
144496099|NCT02939183|521012440|FG008|Overall Study|Sponsor decision|4|||
144496100|NCT02939183|521012432|FG000|Overall Study|Withdrawal by Subject|0|||
144496101|NCT02939183|521012433|FG001|Overall Study|Withdrawal by Subject|2|||
144496102|NCT02939183|521012434|FG002|Overall Study|Withdrawal by Subject|0|||
144496103|NCT02939183|521012435|FG003|Overall Study|Withdrawal by Subject|1|||
144496104|NCT02939183|521012436|FG004|Overall Study|Withdrawal by Subject|0|||
144496105|NCT02939183|521012437|FG005|Overall Study|Withdrawal by Subject|0|||
144496106|NCT02939183|521012438|FG006|Overall Study|Withdrawal by Subject|2|||
144496107|NCT02939183|521012439|FG007|Overall Study|Withdrawal by Subject|2|||
144496108|NCT02939183|521012440|FG008|Overall Study|Withdrawal by Subject|2|||
144496109|NCT02939183|521012432|FG000|Overall Study|Not treated due to adverse event|0|||
144496110|NCT02939183|521012433|FG001|Overall Study|Not treated due to adverse event|0|||
144496111|NCT02939183|521012434|FG002|Overall Study|Not treated due to adverse event|0|||
144496112|NCT02939183|521012435|FG003|Overall Study|Not treated due to adverse event|1|||
144496113|NCT02939183|521012436|FG004|Overall Study|Not treated due to adverse event|0|||
144496114|NCT02939183|521012437|FG005|Overall Study|Not treated due to adverse event|0|||
144496115|NCT02939183|521012438|FG006|Overall Study|Not treated due to adverse event|1|||
144496116|NCT02939183|521012439|FG007|Overall Study|Not treated due to adverse event|0|||
144496117|NCT02939183|521012440|FG008|Overall Study|Not treated due to adverse event|0|||
144496118|NCT00654238|521012445|FG000|Overall Study|Screen Failures|4|||
144496119|NCT00614744|521012446|FG000|Overall Study|Lost to Follow-up|5|||
144496120|NCT00614744|521012447|FG001|Overall Study|Lost to Follow-up|4|||
144496121|NCT00614744|521012446|FG000|Overall Study|Incomplete for Behavior Issues|0|||
144496122|NCT00614744|521012447|FG001|Overall Study|Incomplete for Behavior Issues|2|||
144496123|NCT01446003|521012448|FG000|Period 1|Protocol Violation|2|||
144496124|NCT01446003|521012449|FG001|Period 1|Protocol Violation|0|||
144496125|NCT01446003|521012448|FG000|Period 2|Adverse Event|1|||
144496126|NCT01446003|521012449|FG001|Period 2|Adverse Event|0|||
144496127|NCT00490555|521012451|FG000|Overall Study|noncompliant with drug administration|0|||
144496128|NCT00490555|521012452|FG001|Overall Study|noncompliant with drug administration|0|||
144496129|NCT00490555|521012453|FG002|Overall Study|noncompliant with drug administration|2|||
144496130|NCT00490555|521012454|FG003|Overall Study|noncompliant with drug administration|0|||
144496131|NCT02042443|521012457|FG000|Overall Study|Adverse Event|2|||
144496132|NCT02042443|521012458|FG001|Overall Study|Adverse Event|1|||
144496133|NCT02042443|521012457|FG000|Overall Study|Withdrawal by Subject|0|||
144496134|NCT02042443|521012458|FG001|Overall Study|Withdrawal by Subject|1|||
144496135|NCT02042443|521012457|FG000|Overall Study|Progression|21|||
144496136|NCT02042443|521012458|FG001|Overall Study|Progression|17|||
144496137|NCT02042443|521012457|FG000|Overall Study|not protocol specified|1|||
144496138|NCT02042443|521012458|FG001|Overall Study|not protocol specified|1|||
144496139|NCT02042443|521012457|FG000|Overall Study|Not eligible/not analyzable|3|||
144496140|NCT02042443|521012458|FG001|Overall Study|Not eligible/not analyzable|6|||
144496141|NCT01007149|521012461|FG000|Overall Study|Administrative problems|0|||
144496142|NCT01007149|521012462|FG001|Overall Study|Administrative problems|1|||
144496143|NCT02784704|521012463|FG000|Overall Study|Adverse Event|4|||
144496144|NCT02784704|521012464|FG001|Overall Study|Adverse Event|2|||
144496145|NCT02784704|521012463|FG000|Overall Study|Lost to Follow-up|6|||
144496146|NCT02784704|521012464|FG001|Overall Study|Lost to Follow-up|4|||
144496147|NCT02784704|521012463|FG000|Overall Study|Withdrawal by Subject|1|||
144496148|NCT02784704|521012464|FG001|Overall Study|Withdrawal by Subject|3|||
144496149|NCT02784704|521012463|FG000|Overall Study|Subject Non Compliance|2|||
144496150|NCT02784704|521012464|FG001|Overall Study|Subject Non Compliance|0|||
144496151|NCT01913340|521012465|FG000|Overall Study|Death|2|||
144496152|NCT01913340|521012466|FG001|Overall Study|Death|5|||
144496153|NCT01913340|521012465|FG000|Overall Study|Lost to Follow-up|1|||
144496154|NCT01913340|521012466|FG001|Overall Study|Lost to Follow-up|1|||
144496155|NCT00603538|521012467|FG000|Overall Study|Adverse Event|0|||
144496156|NCT00603538|521012468|FG001|Overall Study|Adverse Event|4|||
144496157|NCT00603538|521012469|FG002|Overall Study|Adverse Event|2|||
144496158|NCT00603538|521012467|FG000|Overall Study|Objective progression or relapse|3|||
144496159|NCT00603538|521012468|FG001|Overall Study|Objective progression or relapse|0|||
144496160|NCT00603538|521012469|FG002|Overall Study|Objective progression or relapse|0|||
144496161|NCT05096884|521012471|FG000|Overall Study|Excluded based on negative tilt table test|4|||
144496162|NCT04794179|521012472|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
144496163|NCT04794179|521012473|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
144496164|NCT01096056|521012474|FG000|Overall Study|Lost to Follow-up|0|||
144496165|NCT01096056|521012475|FG001|Overall Study|Lost to Follow-up|1|||
144496166|NCT03568162|521012476|FG000|Overall Study|Adverse Event|0|||
144496167|NCT03568162|521012477|FG001|Overall Study|Adverse Event|1|||
144496168|NCT03568162|521012478|FG002|Overall Study|Adverse Event|2|||
144496169|NCT03568162|521012479|FG003|Overall Study|Adverse Event|0|||
144496170|NCT03568162|521012480|FG004|Overall Study|Adverse Event|0|||
144496171|NCT03568162|521012481|FG005|Overall Study|Adverse Event|1|||
144496172|NCT03568162|521012476|FG000|Overall Study|Death|0|||
144496173|NCT03568162|521012477|FG001|Overall Study|Death|0|||
144496174|NCT03568162|521012478|FG002|Overall Study|Death|0|||
144496175|NCT03568162|521012479|FG003|Overall Study|Death|0|||
144370070|NCT02379091|520562803|FG002|Overall Study|Principal Investigator Discretion|0|||
144496176|NCT03568162|521012480|FG004|Overall Study|Death|1|||
144496177|NCT03568162|521012481|FG005|Overall Study|Death|0|||
144496178|NCT03568162|521012476|FG000|Overall Study|Lost to Follow-up|3|||
144496179|NCT03568162|521012477|FG001|Overall Study|Lost to Follow-up|2|||
144496180|NCT03568162|521012478|FG002|Overall Study|Lost to Follow-up|4|||
144496181|NCT03568162|521012479|FG003|Overall Study|Lost to Follow-up|2|||
144496182|NCT03568162|521012480|FG004|Overall Study|Lost to Follow-up|3|||
144496183|NCT03568162|521012481|FG005|Overall Study|Lost to Follow-up|2|||
144496184|NCT03568162|521012476|FG000|Overall Study|Physician Decision|0|||
144496185|NCT03568162|521012477|FG001|Overall Study|Physician Decision|1|||
144496186|NCT03568162|521012478|FG002|Overall Study|Physician Decision|1|||
144496187|NCT03568162|521012479|FG003|Overall Study|Physician Decision|0|||
144496188|NCT03568162|521012480|FG004|Overall Study|Physician Decision|1|||
144496189|NCT03568162|521012481|FG005|Overall Study|Physician Decision|0|||
144496190|NCT03568162|521012476|FG000|Overall Study|Pregnancy|0|||
144496191|NCT03568162|521012477|FG001|Overall Study|Pregnancy|0|||
144496192|NCT03568162|521012478|FG002|Overall Study|Pregnancy|0|||
144496193|NCT03568162|521012479|FG003|Overall Study|Pregnancy|1|||
144496194|NCT03568162|521012480|FG004|Overall Study|Pregnancy|0|||
144496195|NCT03568162|521012481|FG005|Overall Study|Pregnancy|0|||
144496196|NCT03568162|521012476|FG000|Overall Study|Protocol Violation|1|||
144496197|NCT03568162|521012477|FG001|Overall Study|Protocol Violation|0|||
144496198|NCT03568162|521012478|FG002|Overall Study|Protocol Violation|1|||
144496199|NCT03568162|521012479|FG003|Overall Study|Protocol Violation|1|||
144496200|NCT03568162|521012480|FG004|Overall Study|Protocol Violation|1|||
144496201|NCT03568162|521012481|FG005|Overall Study|Protocol Violation|1|||
144496202|NCT03568162|521012476|FG000|Overall Study|Withdrawal by Subject|15|||
144496203|NCT03568162|521012477|FG001|Overall Study|Withdrawal by Subject|15|||
144496204|NCT03568162|521012478|FG002|Overall Study|Withdrawal by Subject|26|||
144496205|NCT03568162|521012479|FG003|Overall Study|Withdrawal by Subject|22|||
144719473|NCT00798889|521825928|FG000|Overall Study|Adverse Event|53|||
144719474|NCT00798889|521825928|FG000|Overall Study|Protocol Violation|2|||
144719475|NCT00798889|521825928|FG000|Overall Study|Withdrawal by Subject|31|||
144719476|NCT00798889|521825928|FG000|Overall Study|Lost to Follow-up|1|||
144719477|NCT00798889|521825928|FG000|Overall Study|Lack of Efficacy|213|||
144719478|NCT00798889|521825928|FG000|Overall Study|Decision of Sponsor|11|||
144719479|NCT00798889|521825928|FG000|Overall Study|Enrolled, Not treated|3|||
144719480|NCT03558997|521825931|FG000|Overall Study|Adverse Event|0|||
144719481|NCT03558997|521825932|FG001|Overall Study|Adverse Event|2|||
144719482|NCT03558997|521825933|FG002|Overall Study|Adverse Event|5|||
144719483|NCT03558997|521825934|FG003|Overall Study|Adverse Event|1|||
144719484|NCT03558997|521825931|FG000|Overall Study|Physician Decision|0|||
144719485|NCT03558997|521825932|FG001|Overall Study|Physician Decision|0|||
144719486|NCT03558997|521825933|FG002|Overall Study|Physician Decision|1|||
144719487|NCT03558997|521825934|FG003|Overall Study|Physician Decision|0|||
144719488|NCT03558997|521825931|FG000|Overall Study|Withdrawal by Subject|1|||
144719489|NCT03558997|521825932|FG001|Overall Study|Withdrawal by Subject|0|||
144719490|NCT03558997|521825933|FG002|Overall Study|Withdrawal by Subject|1|||
144719491|NCT03558997|521825934|FG003|Overall Study|Withdrawal by Subject|1|||
144719492|NCT03558997|521825931|FG000|Overall Study|Lost to Follow-up|0|||
144719493|NCT03558997|521825932|FG001|Overall Study|Lost to Follow-up|0|||
144719494|NCT03558997|521825933|FG002|Overall Study|Lost to Follow-up|1|||
144719495|NCT03558997|521825934|FG003|Overall Study|Lost to Follow-up|0|||
144719496|NCT01859702|521825937|FG000|Overall Study|Protocol deviation|3|||
144719497|NCT01859702|521825937|FG000|Overall Study|Adverse Event|2|||
144719498|NCT00130520|521827405|FG000|Overall Study|Adverse Event|11|||
144719499|NCT00130520|521827405|FG000|Overall Study|Death|1|||
144719500|NCT00130520|521827405|FG000|Overall Study|Physician Decision|1|||
144719501|NCT00130520|521827405|FG000|Overall Study|Withdrawal by Subject|1|||
144719502|NCT00130520|521827405|FG000|Overall Study|Disease Progression|23|||
144719503|NCT00130520|521827405|FG000|Overall Study|Protocol non-compliance|1|||
144719504|NCT00130520|521827405|FG000|Overall Study|Did not meet re-treatment criteria|1|||
144719505|NCT02295774|521827406|FG000|Overall Study|Physician Decision|1|||
144719506|NCT02295774|521827406|FG000|Overall Study|Withdrawal by Subject|2|||
144719507|NCT01075763|521827407|FG000|Overall Study|Lost to Follow-up|2|||
144719508|NCT01075763|521827408|FG001|Overall Study|Lost to Follow-up|1|||
144496206|NCT03568162|521012480|FG004|Overall Study|Withdrawal by Subject|6|||
144496207|NCT03568162|521012481|FG005|Overall Study|Withdrawal by Subject|9|||
144496208|NCT03568162|521012476|FG000|Overall Study|Others|3|||
144496209|NCT03568162|521012477|FG001|Overall Study|Others|4|||
144496210|NCT03568162|521012478|FG002|Overall Study|Others|1|||
144496211|NCT03568162|521012479|FG003|Overall Study|Others|4|||
144496212|NCT03568162|521012480|FG004|Overall Study|Others|2|||
144496213|NCT03568162|521012481|FG005|Overall Study|Others|1|||
144496214|NCT04678830|521012483|FG000|Overall Study|Lack of Efficacy|2|||
144496215|NCT04678830|521012484|FG001|Overall Study|Lack of Efficacy|0|||
144719509|NCT01075763|521827407|FG000|Overall Study|Lack of Efficacy|0|||
144719510|NCT01075763|521827408|FG001|Overall Study|Lack of Efficacy|1|||
144719511|NCT01075763|521827407|FG000|Overall Study|Withdrawal by Subject|2|||
144719512|NCT01075763|521827408|FG001|Overall Study|Withdrawal by Subject|2|||
144719513|NCT03083483|521827410|FG000|Overall Study|Adverse Event|1|||
144719514|NCT03083483|521827411|FG001|Overall Study|Adverse Event|1|||
144719515|NCT03083483|521827412|FG002|Overall Study|Adverse Event|1|||
144496216|NCT04678830|521012483|FG000|Overall Study|Withdrawal by Subject|0|||
144496217|NCT04678830|521012484|FG001|Overall Study|Withdrawal by Subject|1|||
144496218|NCT05550337|521012485|FG000|Overall Study|Lack of Efficacy|0|||
144496219|NCT05550337|521012486|FG001|Overall Study|Lack of Efficacy|0|||
144496220|NCT05550337|521012487|FG002|Overall Study|Lack of Efficacy|1|||
144496221|NCT05550337|521012485|FG000|Overall Study|Adverse Event|1|||
144496222|NCT05550337|521012486|FG001|Overall Study|Adverse Event|5|||
144496223|NCT05550337|521012487|FG002|Overall Study|Adverse Event|0|||
144496224|NCT05550337|521012485|FG000|Overall Study|Withdrawal by Subject|8|||
144496225|NCT05550337|521012486|FG001|Overall Study|Withdrawal by Subject|14|||
144496226|NCT05550337|521012487|FG002|Overall Study|Withdrawal by Subject|10|||
144496227|NCT05550337|521012485|FG000|Overall Study|Pregnancy|0|||
144496228|NCT05550337|521012486|FG001|Overall Study|Pregnancy|0|||
144496229|NCT05550337|521012487|FG002|Overall Study|Pregnancy|1|||
144496230|NCT05550337|521012485|FG000|Overall Study|Protocol Violation|1|||
144496231|NCT05550337|521012486|FG001|Overall Study|Protocol Violation|3|||
144496232|NCT05550337|521012487|FG002|Overall Study|Protocol Violation|4|||
144496233|NCT05550337|521012485|FG000|Overall Study|Physician Decision|2|||
144496234|NCT05550337|521012486|FG001|Overall Study|Physician Decision|1|||
144496235|NCT05550337|521012487|FG002|Overall Study|Physician Decision|1|||
144496236|NCT05550337|521012485|FG000|Overall Study|Lost to Follow-up|16|||
144496237|NCT05550337|521012486|FG001|Overall Study|Lost to Follow-up|11|||
144496238|NCT05550337|521012487|FG002|Overall Study|Lost to Follow-up|11|||
144496239|NCT03115346|521012489|FG000|Overall Study|Did not have AAA surgery|28|||
144496240|NCT03115346|521012490|FG001|Overall Study|Did not have AAA surgery|15|||
144496241|NCT03115346|521012489|FG000|Overall Study|Death|3|||
144496242|NCT03115346|521012490|FG001|Overall Study|Death|1|||
144496243|NCT03115346|521012489|FG000|Overall Study|Withdrawal by Subject|0|||
144496244|NCT03115346|521012490|FG001|Overall Study|Withdrawal by Subject|3|||
144496245|NCT03115346|521012489|FG000|Overall Study|Lost to Follow-up|0|||
144496246|NCT03115346|521012490|FG001|Overall Study|Lost to Follow-up|3|||
144496247|NCT01737268|521012493|FG000|Overall Study|Adverse Event|6|||
144496248|NCT01737268|521012493|FG000|Overall Study|Worsening of Target Disease|2|||
144496249|NCT01737268|521012493|FG000|Overall Study|In consideration of the patient's safety|1|||
144496250|NCT01190176|521012496|FG000|Overall Study|Withdrawal by Subject|1|||
144496251|NCT01190176|521012496|FG000|Overall Study|Lost to Follow-up|1|||
144496252|NCT02189863|521012497|FG000|First 2 Weeks|Motion Sickness|4|||
144496253|NCT02189863|521012498|FG001|First 2 Weeks|Motion Sickness|2|||
144496254|NCT03697460|521012499|FG000|Overall Study|Withdrawal by Subject|3|||
144496255|NCT03369951|521012500|FG000|Overall Study|Withdrawal by Subject|3|||
144496256|NCT03369951|521012500|FG000|Overall Study|Death|1|||
144496257|NCT03369951|521012500|FG000|Overall Study|Lost to Follow-up|1|||
144496258|NCT03369951|521012500|FG000|Overall Study|Protocol Violation|1|||
144496259|NCT00725010|521012510|FG000|Overall Study|Toxicity|9|||
144496260|NCT00725010|521012510|FG000|Overall Study|Tumor Progression|7|||
144496261|NCT00725010|521012510|FG000|Overall Study|Withdrawal by Subject|2|||
144496262|NCT00725010|521012510|FG000|Overall Study|Death|1|||
144496263|NCT00725010|521012510|FG000|Overall Study|Lost to Follow-up|1|||
144496264|NCT00725010|521012510|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
144496265|NCT00725010|521012510|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
144496266|NCT00725010|521012510|FG000|Overall Study|No further documentation|1|||
144496267|NCT00725010|521012510|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
144496268|NCT03499600|521012511|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
144496269|NCT03499600|521012512|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
144496270|NCT02414828|521012513|FG000|Overall Study|Lost to Follow-up|0|||
144496271|NCT02414828|521012514|FG001|Overall Study|Lost to Follow-up|1|||
144496272|NCT02414828|521012515|FG002|Overall Study|Lost to Follow-up|1|||
144496273|NCT02414828|521012516|FG003|Overall Study|Lost to Follow-up|2|||
144496274|NCT00389519|521012520|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
144496275|NCT00389519|521012521|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
144496276|NCT00389519|521012522|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
144496277|NCT00389519|521012523|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
144496278|NCT00389519|521012520|FG000|Placebo Run-In|Withdrawal by Subject|19|||
144496279|NCT00389519|521012521|FG001|Placebo Run-In|Withdrawal by Subject|0|||
144496280|NCT00389519|521012522|FG002|Placebo Run-In|Withdrawal by Subject|0|||
144496281|NCT00389519|521012523|FG003|Placebo Run-In|Withdrawal by Subject|0|||
144496282|NCT00389519|521012520|FG000|Placebo Run-In|Reason not specified|40|||
144496283|NCT00389519|521012521|FG001|Placebo Run-In|Reason not specified|0|||
144496284|NCT00389519|521012522|FG002|Placebo Run-In|Reason not specified|0|||
144496285|NCT00389519|521012523|FG003|Placebo Run-In|Reason not specified|0|||
144496286|NCT00389519|521012520|FG000|Randomized|Did not receive study drug|2|||
144496287|NCT00389519|521012521|FG001|Randomized|Did not receive study drug|0|||
144496288|NCT00389519|521012522|FG002|Randomized|Did not receive study drug|0|||
144496289|NCT00389519|521012523|FG003|Randomized|Did not receive study drug|0|||
144496290|NCT00389519|521012520|FG000|Treated|Adverse Event|1|||
144496291|NCT00389519|521012521|FG001|Treated|Adverse Event|0|||
144496292|NCT00389519|521012522|FG002|Treated|Adverse Event|0|||
144496293|NCT00389519|521012523|FG003|Treated|Adverse Event|2|||
144496294|NCT00389519|521012520|FG000|Treated|Reason not specified|1|||
144496295|NCT00389519|521012521|FG001|Treated|Reason not specified|1|||
144496296|NCT00389519|521012522|FG002|Treated|Reason not specified|0|||
144496297|NCT00389519|521012523|FG003|Treated|Reason not specified|2|||
144496298|NCT01474538|521014272|FG000|Treatment Period 1|Death|1|||
144496299|NCT01474538|521014273|FG001|Treatment Period 1|Death|0|||
144496300|NCT01474538|521014272|FG000|Treatment Period 1|Physician Decision|1|||
144496301|NCT01474538|521014273|FG001|Treatment Period 1|Physician Decision|0|||
144496302|NCT01474538|521014272|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144496303|NCT01474538|521014273|FG001|Treatment Period 1|Withdrawal by Subject|3|||
144496304|NCT01474538|521014272|FG000|Treatment Period 1|Protocol Violation|0|||
144496305|NCT01474538|521014273|FG001|Treatment Period 1|Protocol Violation|1|||
144496306|NCT01474538|521014272|FG000|Treatment Period 2|Death|1|||
144496307|NCT01474538|521014273|FG001|Treatment Period 2|Death|0|||
144496308|NCT01474538|521014272|FG000|Treatment Period 2|Adverse Event|1|||
144496309|NCT01474538|521014273|FG001|Treatment Period 2|Adverse Event|1|||
144496310|NCT01474538|521014272|FG000|Treatment Period 2|Withdrawal by Subject|2|||
144496311|NCT01474538|521014273|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144496312|NCT01474538|521014272|FG000|Treatment Period 2|Sponsor decision|1|||
144496313|NCT01474538|521014273|FG001|Treatment Period 2|Sponsor decision|0|||
144496314|NCT01474538|521014272|FG000|Treatment Period 2|Physician Decision|0|||
144496315|NCT01474538|521014273|FG001|Treatment Period 2|Physician Decision|1|||
144496316|NCT01474538|521014272|FG000|Treatment Period 2|Protocol Violation|1|||
144496317|NCT01474538|521014273|FG001|Treatment Period 2|Protocol Violation|0|||
144496318|NCT04565249|521014276|FG000|Overall Study|Death|0|||
144496319|NCT04565249|521014277|FG001|Overall Study|Death|0|||
144496320|NCT04565249|521014278|FG002|Overall Study|Death|0|||
144496321|NCT04565249|521014279|FG003|Overall Study|Death|1|||
144496322|NCT00886613|521014284|FG000|Overall Study|Protocol deviation (Part B)|1|||
144496323|NCT00886613|521014285|FG001|Overall Study|Protocol deviation (Part B)|0|||
144496324|NCT00886613|521014286|FG002|Overall Study|Protocol deviation (Part B)|0|||
144496325|NCT00886613|521014284|FG000|Overall Study|Lost to follow-up (Part B)|1|||
144496326|NCT00886613|521014285|FG001|Overall Study|Lost to follow-up (Part B)|0|||
144496327|NCT00886613|521014286|FG002|Overall Study|Lost to follow-up (Part B)|1|||
144496328|NCT00886613|521014284|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
144496329|NCT00886613|521014285|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
144496330|NCT00886613|521014286|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
144496331|NCT02333630|521014291|FG000|Overall Study|Lost to Follow-up|5|||
144496332|NCT02333630|521014292|FG001|Overall Study|Lost to Follow-up|2|||
144496333|NCT05349864|521014293|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
144496334|NCT05349864|521014294|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
144496335|NCT02223793|521014295|FG000|Overall Study|Lost to Follow-up|10|||
144496336|NCT02223793|521014296|FG001|Overall Study|Lost to Follow-up|1|||
144496337|NCT02223793|521014297|FG002|Overall Study|Lost to Follow-up|2|||
144496338|NCT02223793|521014295|FG000|Overall Study|Withdrawal by Subject|3|||
144496339|NCT02223793|521014296|FG001|Overall Study|Withdrawal by Subject|2|||
144496340|NCT02223793|521014297|FG002|Overall Study|Withdrawal by Subject|3|||
144496341|NCT02223793|521014295|FG000|Overall Study|Moved/studycenter unable to participate|4|||
144496342|NCT02223793|521014296|FG001|Overall Study|Moved/studycenter unable to participate|6|||
144496343|NCT02223793|521014297|FG002|Overall Study|Moved/studycenter unable to participate|8|||
144496344|NCT02359435|521014298|FG000|Overall Study|Lost to Follow-up|4|||
144496345|NCT02359435|521014299|FG001|Overall Study|Lost to Follow-up|4|||
144496346|NCT00315055|521014300|FG000|Overall Study|Protocol Violation|2|||
144496347|NCT00315055|521014301|FG001|Overall Study|Protocol Violation|4|||
144496348|NCT00315055|521014300|FG000|Overall Study|Lost to Follow-up|1|||
144496349|NCT00315055|521014301|FG001|Overall Study|Lost to Follow-up|1|||
144496350|NCT01289119|521014305|FG000|Overall Study|Adverse Event|2|||
144496351|NCT01289119|521014306|FG001|Overall Study|Adverse Event|1|||
144496352|NCT01289119|521014307|FG002|Overall Study|Adverse Event|0|||
144496353|NCT01289119|521014308|FG003|Overall Study|Adverse Event|2|||
144496354|NCT01289119|521014309|FG004|Overall Study|Adverse Event|1|||
144496355|NCT01289119|521014310|FG005|Overall Study|Adverse Event|0|||
144496356|NCT01289119|521014305|FG000|Overall Study|Major Protocol Deviation|2|||
144496357|NCT01289119|521014306|FG001|Overall Study|Major Protocol Deviation|1|||
144496358|NCT01289119|521014307|FG002|Overall Study|Major Protocol Deviation|3|||
144496359|NCT01289119|521014308|FG003|Overall Study|Major Protocol Deviation|0|||
144496360|NCT01289119|521014309|FG004|Overall Study|Major Protocol Deviation|2|||
144496361|NCT01289119|521014310|FG005|Overall Study|Major Protocol Deviation|1|||
144496362|NCT01289119|521014305|FG000|Overall Study|Lost to Follow-up|0|||
144496363|NCT01289119|521014306|FG001|Overall Study|Lost to Follow-up|3|||
144496364|NCT01289119|521014307|FG002|Overall Study|Lost to Follow-up|0|||
144496365|NCT01289119|521014308|FG003|Overall Study|Lost to Follow-up|0|||
144496366|NCT01289119|521014309|FG004|Overall Study|Lost to Follow-up|0|||
144496367|NCT01289119|521014310|FG005|Overall Study|Lost to Follow-up|1|||
144496368|NCT01289119|521014305|FG000|Overall Study|Withdrawal by Subject|4|||
144496369|NCT01289119|521014306|FG001|Overall Study|Withdrawal by Subject|2|||
144496370|NCT01289119|521014307|FG002|Overall Study|Withdrawal by Subject|4|||
144496371|NCT01289119|521014308|FG003|Overall Study|Withdrawal by Subject|3|||
144496372|NCT01289119|521014309|FG004|Overall Study|Withdrawal by Subject|1|||
144496373|NCT01289119|521014310|FG005|Overall Study|Withdrawal by Subject|1|||
144496374|NCT01289119|521014305|FG000|Overall Study|Pregnancy|0|||
144496375|NCT01289119|521014306|FG001|Overall Study|Pregnancy|1|||
144496376|NCT01289119|521014307|FG002|Overall Study|Pregnancy|0|||
144496377|NCT01289119|521014308|FG003|Overall Study|Pregnancy|0|||
144496378|NCT01289119|521014309|FG004|Overall Study|Pregnancy|0|||
144496379|NCT01289119|521014310|FG005|Overall Study|Pregnancy|0|||
144496380|NCT01289119|521014305|FG000|Overall Study|Lack of Efficacy|0|||
144496381|NCT01289119|521014306|FG001|Overall Study|Lack of Efficacy|1|||
144496382|NCT01289119|521014307|FG002|Overall Study|Lack of Efficacy|1|||
144496383|NCT01289119|521014308|FG003|Overall Study|Lack of Efficacy|1|||
144496384|NCT01289119|521014309|FG004|Overall Study|Lack of Efficacy|1|||
144496385|NCT01289119|521014310|FG005|Overall Study|Lack of Efficacy|1|||
144496386|NCT01289119|521014305|FG000|Overall Study|Other|1|||
144496387|NCT01289119|521014306|FG001|Overall Study|Other|0|||
144496388|NCT01289119|521014307|FG002|Overall Study|Other|1|||
144496389|NCT01289119|521014308|FG003|Overall Study|Other|0|||
144496390|NCT01289119|521014309|FG004|Overall Study|Other|0|||
144496391|NCT01289119|521014310|FG005|Overall Study|Other|0|||
144496392|NCT01704846|521014311|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144496393|NCT01704846|521014312|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144496394|NCT00530335|521014315|FG000|Overall Study|Adverse Event|3|||
144496395|NCT00530335|521014315|FG000|Overall Study|Protocol Violation|1|||
144496396|NCT00530335|521014315|FG000|Overall Study|Withdrawal by Subject|1|||
144496397|NCT00530335|521014315|FG000|Overall Study|Physician Decision|1|||
144496398|NCT01244984|521014316|FG000|Overall Study|Adverse Event|2|||
144496399|NCT01244984|521014317|FG001|Overall Study|Adverse Event|11|||
144496400|NCT01244984|521014318|FG002|Overall Study|Adverse Event|2|||
144496401|NCT01244984|521014316|FG000|Overall Study|Protocol Violation|1|||
144496402|NCT01244984|521014317|FG001|Overall Study|Protocol Violation|0|||
144496403|NCT01244984|521014318|FG002|Overall Study|Protocol Violation|0|||
144496404|NCT01244984|521014316|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
144496405|NCT01244984|521014317|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
144496406|NCT01244984|521014318|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
144496407|NCT01244984|521014316|FG000|Overall Study|Withdrawal by Subject|1|||
144496408|NCT01244984|521014317|FG001|Overall Study|Withdrawal by Subject|2|||
144496409|NCT01244984|521014318|FG002|Overall Study|Withdrawal by Subject|2|||
144496410|NCT04577183|521014319|FG000|Overall Study|Death|1|||
144496411|NCT04577183|521014319|FG000|Overall Study|Withdrawal by Subject|3|||
144496412|NCT04577183|521014319|FG000|Overall Study|Early termination|2|||
144496413|NCT01168401|521014320|FG000|Overall Study|Lost to Follow-up|1|||
144496414|NCT01168401|521014321|FG001|Overall Study|Lost to Follow-up|1|||
144496415|NCT01168401|521014322|FG002|Overall Study|Lost to Follow-up|2|||
144496416|NCT01168401|521014323|FG003|Overall Study|Lost to Follow-up|1|||
144496417|NCT01168401|521014324|FG004|Overall Study|Lost to Follow-up|0|||
144496418|NCT01168401|521014325|FG005|Overall Study|Lost to Follow-up|0|||
144496419|NCT01168401|521014326|FG006|Overall Study|Lost to Follow-up|0|||
144496420|NCT01168401|521014327|FG007|Overall Study|Lost to Follow-up|0|||
144496421|NCT01168401|521014328|FG008|Overall Study|Lost to Follow-up|0|||
144496422|NCT01168401|521014329|FG009|Overall Study|Lost to Follow-up|0|||
144496423|NCT01168401|521014330|FG010|Overall Study|Lost to Follow-up|0|||
144496424|NCT01168401|521014320|FG000|Overall Study|Withdrawal by Subject|0|||
144496425|NCT01168401|521014321|FG001|Overall Study|Withdrawal by Subject|0|||
144496426|NCT01168401|521014322|FG002|Overall Study|Withdrawal by Subject|0|||
144496427|NCT01168401|521014323|FG003|Overall Study|Withdrawal by Subject|1|||
144496428|NCT01168401|521014324|FG004|Overall Study|Withdrawal by Subject|0|||
144496429|NCT01168401|521014325|FG005|Overall Study|Withdrawal by Subject|0|||
144496430|NCT01168401|521014326|FG006|Overall Study|Withdrawal by Subject|0|||
144496431|NCT01168401|521014327|FG007|Overall Study|Withdrawal by Subject|0|||
144496432|NCT01168401|521014328|FG008|Overall Study|Withdrawal by Subject|0|||
144496433|NCT01168401|521014329|FG009|Overall Study|Withdrawal by Subject|0|||
144496434|NCT01168401|521014330|FG010|Overall Study|Withdrawal by Subject|0|||
144496435|NCT00672256|521014331|FG000|Overall Study|PI dropped, bad data|44|||
144496436|NCT01801930|521014333|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
144496437|NCT01801930|521014334|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
144496438|NCT01801930|521014335|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
144496439|NCT01801930|521014336|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
144496440|NCT01801930|521014333|FG000|Overall Study|DLT occurs|0|||
144496441|NCT01801930|521014334|FG001|Overall Study|DLT occurs|1|||
144496442|NCT01801930|521014335|FG002|Overall Study|DLT occurs|0|||
144496443|NCT01801930|521014336|FG003|Overall Study|DLT occurs|0|||
144496444|NCT01720043|521014348|FG000|Overall Study|Withdrawal by Subject|1|||
144496445|NCT01688973|521014349|FG000|Overall Study|Ineligible|2|||
144496446|NCT01688973|521014350|FG001|Overall Study|Ineligible|3|||
144496447|NCT01124162|521014353|FG000|First Intervention|Adverse Event|2|||
144496448|NCT01124162|521014354|FG001|First Intervention|Adverse Event|0|||
144719516|NCT03083483|521827410|FG000|Overall Study|Lost to Follow-up|2|||
144719517|NCT03083483|521827411|FG001|Overall Study|Lost to Follow-up|1|||
144719518|NCT03083483|521827412|FG002|Overall Study|Lost to Follow-up|1|||
144719519|NCT03083483|521827410|FG000|Overall Study|technological issues|1|||
144719520|NCT03083483|521827411|FG001|Overall Study|technological issues|0|||
144719521|NCT03083483|521827412|FG002|Overall Study|technological issues|1|||
144719522|NCT01751412|521827415|FG000|Overall Study|Disease Progression Before Treatment|1|||
144719523|NCT00582036|521827416|FG000|Overall Study|Withdrawal by Subject|0|||
144496449|NCT01124162|521014353|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144496450|NCT01124162|521014354|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144496451|NCT01516892|521014357|FG000|Overall Study|Adverse Event|25|||
144496452|NCT01516892|521014357|FG000|Overall Study|Lack of Efficacy|35|||
144496453|NCT01516892|521014357|FG000|Overall Study|Pregnancy|5|||
144496454|NCT01516892|521014357|FG000|Overall Study|Lost to Follow-up|82|||
144719524|NCT00582036|521827417|FG001|Overall Study|Withdrawal by Subject|1|||
144719525|NCT03734237|521827418|FG000|Overall Study|Lost to Follow-up|1|||
144496455|NCT01516892|521014357|FG000|Overall Study|Subject Withdrew Consent|92|||
144496456|NCT01516892|521014357|FG000|Overall Study|Protocol Violation|60|||
144496457|NCT01516892|521014357|FG000|Overall Study|Other Miscellaneous Reasons|43|||
144496458|NCT01516892|521014357|FG000|Overall Study|Missing|1|||
144496459|NCT00711646|521014358|FG000|Overall Study|Adverse Event|6|||
144496460|NCT00711646|521014359|FG001|Overall Study|Adverse Event|1|||
144496461|NCT00711646|521014358|FG000|Overall Study|Withdrawal by Subject|4|||
144496462|NCT00711646|521014359|FG001|Overall Study|Withdrawal by Subject|0|||
144496463|NCT00711646|521014358|FG000|Overall Study|Protocol Violation|0|||
144496464|NCT00711646|521014359|FG001|Overall Study|Protocol Violation|1|||
144496465|NCT00711646|521014358|FG000|Overall Study|Lost to Follow-up|1|||
144496466|NCT00711646|521014359|FG001|Overall Study|Lost to Follow-up|0|||
144496467|NCT00711646|521014358|FG000|Overall Study|administrative decision|0|||
144496468|NCT00711646|521014359|FG001|Overall Study|administrative decision|1|||
144496469|NCT00711646|521014358|FG000|Overall Study|patient non-compliance|1|||
144496470|NCT00711646|521014359|FG001|Overall Study|patient non-compliance|0|||
144496471|NCT04381494|521014360|FG000|Overall Study|Early termination of trial|19|||
144496472|NCT04381494|521014360|FG000|Overall Study|Investigator's discretion|1|||
144496473|NCT04381494|521014360|FG000|Overall Study|Withdrawal by Subject|9|||
144496474|NCT04381494|521014360|FG000|Overall Study|NSCLC disease progression|4|||
144496475|NCT04381494|521014360|FG000|Overall Study|Device-Related Adverse Event|2|||
144496476|NCT01451814|521014361|FG000|Overall Study|Withdrawal by Subject|1|||
144496477|NCT01451814|521014362|FG001|Overall Study|Withdrawal by Subject|1|||
144496478|NCT01451814|521014361|FG000|Overall Study|Lost to Follow-up|5|||
144496479|NCT01451814|521014362|FG001|Overall Study|Lost to Follow-up|4|||
144496480|NCT03439124|521014363|FG000|Overall Study|Adverse Event|2|||
144496481|NCT03439124|521014364|FG001|Overall Study|Adverse Event|0|||
144496482|NCT03439124|521014363|FG000|Overall Study|Lost to Follow-up|1|||
144496483|NCT03439124|521014364|FG001|Overall Study|Lost to Follow-up|0|||
144496484|NCT03439124|521014363|FG000|Overall Study|Other reasons|1|||
144496485|NCT03439124|521014364|FG001|Overall Study|Other reasons|0|||
144496486|NCT02993471|521014366|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
144496487|NCT02993471|521014366|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
144496488|NCT03006341|521014368|FG000|Overall Study|Not linked in the EMR|25069|||
144496489|NCT03006341|521014369|FG001|Overall Study|Not linked in the EMR|67505|||
144496490|NCT03006341|521014370|FG002|Overall Study|Not linked in the EMR|30993|||
144496491|NCT03006341|521014371|FG003|Overall Study|Not linked in the EMR|10685|||
144496492|NCT03101592|521014374|FG000|Overall Study|participant files could not be located|111|||
144496493|NCT03101592|521014375|FG001|Overall Study|participant files could not be located|170|||
144496494|NCT03101592|521014376|FG002|Overall Study|participant files could not be located|118|||
144496495|NCT03124108|521014381|FG000|Overall Study|Adverse Event|0|||
144496496|NCT03124108|521014382|FG001|Overall Study|Adverse Event|1|||
144496497|NCT03124108|521014383|FG002|Overall Study|Adverse Event|0|||
144496498|NCT00631917|521014384|FG000|Overall Study|Adverse Event|34|||
144496499|NCT00631917|521014385|FG001|Overall Study|Adverse Event|45|||
144496500|NCT00631917|521014384|FG000|Overall Study|Abnormal laboratory value(s)|2|||
144496501|NCT00631917|521014385|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144496502|NCT00631917|521014384|FG000|Overall Study|Abnormal test procedure result(s)|3|||
144496503|NCT00631917|521014385|FG001|Overall Study|Abnormal test procedure result(s)|2|||
144496504|NCT00631917|521014384|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
144496505|NCT00631917|521014385|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
144496506|NCT00631917|521014384|FG000|Overall Study|No longer required study drug|0|||
144496507|NCT00631917|521014385|FG001|Overall Study|No longer required study drug|1|||
144496508|NCT00631917|521014384|FG000|Overall Study|Protocol deviation|6|||
144496509|NCT00631917|521014385|FG001|Overall Study|Protocol deviation|5|||
144496510|NCT00631917|521014384|FG000|Overall Study|Subject withdrew consent|25|||
144496511|NCT00631917|521014385|FG001|Overall Study|Subject withdrew consent|33|||
144496512|NCT00631917|521014384|FG000|Overall Study|Lost to Follow-up|7|||
144719526|NCT03734237|521827419|FG001|Overall Study|Lost to Follow-up|3|||
144719527|NCT03734237|521827420|FG002|Overall Study|Lost to Follow-up|0|||
144719528|NCT03734237|521827418|FG000|Overall Study|Withdrawal by Subject|7|||
144719529|NCT03734237|521827419|FG001|Overall Study|Withdrawal by Subject|9|||
144719530|NCT03734237|521827420|FG002|Overall Study|Withdrawal by Subject|10|||
144719531|NCT02623959|521827422|FG000|Overall Study|Progression|0|||
144719532|NCT02623959|521827423|FG001|Overall Study|Progression|1|||
144719533|NCT03687125|521827424|FG000|Overall Study|Progressive Disease|2|||
144719534|NCT03687125|521827425|FG001|Overall Study|Progressive Disease|1|||
144496513|NCT00631917|521014385|FG001|Overall Study|Lost to Follow-up|7|||
144496514|NCT00631917|521014384|FG000|Overall Study|Administrative problems|2|||
144496515|NCT00631917|521014385|FG001|Overall Study|Administrative problems|0|||
144496516|NCT00631917|521014384|FG000|Overall Study|Death|1|||
144496517|NCT00631917|521014385|FG001|Overall Study|Death|0|||
144496518|NCT05650333|521014388|FG000|Treatment Period (7 Days)|Adverse Event|1|||
144496519|NCT01835899|521014390|FG000|Overall Study|Adverse Event|0|||
144719535|NCT03687125|521827424|FG000|Overall Study|Protocol Violation|1|||
144719536|NCT03687125|521827425|FG001|Overall Study|Protocol Violation|0|||
144496520|NCT01835899|521014391|FG001|Overall Study|Adverse Event|0|||
144496521|NCT01835899|521014392|FG002|Overall Study|Adverse Event|1|||
144496522|NCT01835899|521014390|FG000|Overall Study|Other than stated above|0|||
144496523|NCT01835899|521014391|FG001|Overall Study|Other than stated above|1|||
144496524|NCT01835899|521014392|FG002|Overall Study|Other than stated above|0|||
144496525|NCT05015478|521014395|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
144496526|NCT05015478|521014396|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
144496527|NCT05015478|521014397|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
144496528|NCT05015478|521014398|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
144496529|NCT04939428|521014399|FG000|Overall Study|Death|0|||
144496530|NCT04939428|521014400|FG001|Overall Study|Death|1|||
144496531|NCT04939428|521014401|FG002|Overall Study|Death|0|||
144496532|NCT04939428|521014399|FG000|Overall Study|Lost to Follow-up|0|||
144496533|NCT04939428|521014400|FG001|Overall Study|Lost to Follow-up|5|||
144496534|NCT04939428|521014401|FG002|Overall Study|Lost to Follow-up|0|||
144496535|NCT04939428|521014399|FG000|Overall Study|Physician Decision|1|||
144496536|NCT04939428|521014400|FG001|Overall Study|Physician Decision|0|||
144496537|NCT04939428|521014401|FG002|Overall Study|Physician Decision|0|||
144496538|NCT04939428|521014399|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144496539|NCT04939428|521014400|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144496540|NCT04939428|521014401|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144496541|NCT04939428|521014399|FG000|Overall Study|Withdrawal by Subject|10|||
144496542|NCT04939428|521014400|FG001|Overall Study|Withdrawal by Subject|11|||
144496543|NCT04939428|521014401|FG002|Overall Study|Withdrawal by Subject|0|||
144496544|NCT04939428|521014399|FG000|Overall Study|Unkown|6|||
144496545|NCT04939428|521014400|FG001|Overall Study|Unkown|3|||
144496546|NCT04939428|521014401|FG002|Overall Study|Unkown|0|||
144496547|NCT04939428|521014399|FG000|Overall Study|Discotinued per protocol|0|||
144496548|NCT04939428|521014400|FG001|Overall Study|Discotinued per protocol|0|||
144496549|NCT04939428|521014401|FG002|Overall Study|Discotinued per protocol|902|||
144496550|NCT04319094|521014402|FG000|Baseline|Lost to Follow-up|4|||
144496551|NCT04319094|521014403|FG001|Baseline|Lost to Follow-up|5|||
144496552|NCT04319094|521014402|FG000|Baseline|Protocol Violation|0|||
144496553|NCT04319094|521014403|FG001|Baseline|Protocol Violation|3|||
144496554|NCT04319094|521014402|FG000|Baseline|Withdrawal by Subject|2|||
144496555|NCT04319094|521014403|FG001|Baseline|Withdrawal by Subject|1|||
144496556|NCT04319094|521014402|FG000|Post-Intervention|Death|0|||
144496557|NCT04319094|521014403|FG001|Post-Intervention|Death|1|||
144496558|NCT04319094|521014402|FG000|Post-Intervention|Lost to Follow-up|4|||
144496559|NCT04319094|521014403|FG001|Post-Intervention|Lost to Follow-up|4|||
144496560|NCT04319094|521014402|FG000|Post-Intervention|Withdrawal by Subject|8|||
144496561|NCT04319094|521014403|FG001|Post-Intervention|Withdrawal by Subject|5|||
144496562|NCT04319094|521014402|FG000|Post-Intervention|Incomplete Data Collection|1|||
144496563|NCT04319094|521014403|FG001|Post-Intervention|Incomplete Data Collection|3|||
144496564|NCT04319094|521014402|FG000|3-month|Death|1|||
144496565|NCT04319094|521014403|FG001|3-month|Death|0|||
144496566|NCT04319094|521014402|FG000|3-month|Lost to Follow-up|2|||
144496567|NCT04319094|521014403|FG001|3-month|Lost to Follow-up|2|||
144496568|NCT04319094|521014402|FG000|3-month|Withdrawal by Subject|0|||
144496569|NCT04319094|521014403|FG001|3-month|Withdrawal by Subject|3|||
144496570|NCT04319094|521014402|FG000|3-month|Incomplete data collection|9|||
144496571|NCT04319094|521014403|FG001|3-month|Incomplete data collection|7|||
144496572|NCT04319094|521014402|FG000|6-month|Lost to Follow-up|1|||
144496573|NCT04319094|521014403|FG001|6-month|Lost to Follow-up|1|||
144496574|NCT04319094|521014402|FG000|6-month|Withdrawal by Subject|0|||
144496575|NCT04319094|521014403|FG001|6-month|Withdrawal by Subject|3|||
144496576|NCT04319094|521014402|FG000|6-month|Incomplete data collection|14|||
144496577|NCT04319094|521014403|FG001|6-month|Incomplete data collection|9|||
144496578|NCT04319094|521014402|FG000|9-month|Lost to Follow-up|8|||
144719537|NCT01992107|521827426|FG000|Overall Study|Administrative reasons|2|||
144719538|NCT01992107|521827427|FG001|Overall Study|Administrative reasons|0|||
144719539|NCT01992107|521827428|FG002|Overall Study|Administrative reasons|0|||
144719540|NCT01992107|521827426|FG000|Overall Study|Adverse Event|0|||
144719541|NCT01992107|521827427|FG001|Overall Study|Adverse Event|1|||
144719542|NCT01992107|521827428|FG002|Overall Study|Adverse Event|0|||
144719543|NCT01992107|521827426|FG000|Overall Study|Lost to Follow-up|46|||
144719544|NCT01992107|521827427|FG001|Overall Study|Lost to Follow-up|22|||
144719545|NCT01992107|521827428|FG002|Overall Study|Lost to Follow-up|26|||
144719546|NCT01992107|521827426|FG000|Overall Study|noncompliance and were unavailable|7|||
144496579|NCT04319094|521014403|FG001|9-month|Lost to Follow-up|4|||
144496580|NCT04319094|521014402|FG000|9-month|Withdrawal by Subject|0|||
144496581|NCT04319094|521014403|FG001|9-month|Withdrawal by Subject|1|||
144496582|NCT04319094|521014402|FG000|9-month|Incomplete data collection|8|||
144496583|NCT04319094|521014403|FG001|9-month|Incomplete data collection|5|||
144496584|NCT04319094|521014402|FG000|12-month|Lost to Follow-up|11|||
144496585|NCT04319094|521014403|FG001|12-month|Lost to Follow-up|8|||
144496586|NCT00877851|521014404|FG000|Overall Study|Lost to Follow-up|5|||
144496587|NCT00877851|521014405|FG001|Overall Study|Lost to Follow-up|5|||
144496588|NCT00877851|521014404|FG000|Overall Study|computer problem|3|||
144496589|NCT00877851|521014405|FG001|Overall Study|computer problem|0|||
144496590|NCT00877851|521014404|FG000|Overall Study|no longer interested in participating|1|||
144496591|NCT00877851|521014405|FG001|Overall Study|no longer interested in participating|0|||
144496592|NCT03424239|521014406|FG000|Overall Study|Withdrawal by Subject|2|||
144496593|NCT00770211|521014407|FG000|Overall Study|Lost to Follow-up|1|||
144496594|NCT00770211|521014408|FG001|Overall Study|Lost to Follow-up|0|||
144496595|NCT00770211|521014407|FG000|Overall Study|Withdrawal by Subject|0|||
144496596|NCT00770211|521014408|FG001|Overall Study|Withdrawal by Subject|2|||
144496597|NCT00318656|521014409|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
144496598|NCT00318656|521014410|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
144496599|NCT00318656|521014409|FG000|Overall Study|Did not receive any treatment|0|||
144496600|NCT00318656|521014410|FG001|Overall Study|Did not receive any treatment|1|||
144496601|NCT03905135|521014411|FG000|Dose Escalation|Adverse Event|1|||
144496602|NCT03905135|521014412|FG001|Dose Escalation|Adverse Event|1|||
144496603|NCT03905135|521014411|FG000|Dose Escalation|Progressive disease|3|||
144496604|NCT03905135|521014412|FG001|Dose Escalation|Progressive disease|1|||
144496605|NCT03905135|521014411|FG000|Dose Escalation|Intercurrent illness|1|||
144496606|NCT03905135|521014412|FG001|Dose Escalation|Intercurrent illness|0|||
144496607|NCT01740557|521014413|FG000|Overall Study|Ineligible|1|||
144496608|NCT01740557|521014413|FG000|Overall Study|Screen failure|1|||
144496609|NCT03781804|521014414|FG000|Overall Study|Adverse Event|2|||
144496610|NCT03781804|521014415|FG001|Overall Study|Adverse Event|2|||
144496611|NCT03781804|521014416|FG002|Overall Study|Adverse Event|3|||
144496612|NCT03781804|521014414|FG000|Overall Study|Lost to Follow-up|1|||
144496613|NCT03781804|521014415|FG001|Overall Study|Lost to Follow-up|1|||
144496614|NCT03781804|521014416|FG002|Overall Study|Lost to Follow-up|2|||
144496615|NCT03781804|521014414|FG000|Overall Study|Lack of Efficacy|4|||
144496616|NCT03781804|521014415|FG001|Overall Study|Lack of Efficacy|2|||
144496617|NCT03781804|521014416|FG002|Overall Study|Lack of Efficacy|9|||
144496618|NCT03781804|521014414|FG000|Overall Study|Protocol Violation|0|||
144496619|NCT03781804|521014415|FG001|Overall Study|Protocol Violation|0|||
144496620|NCT03781804|521014416|FG002|Overall Study|Protocol Violation|1|||
144496621|NCT03781804|521014414|FG000|Overall Study|Withdrawal by Subject|0|||
144496622|NCT03781804|521014415|FG001|Overall Study|Withdrawal by Subject|1|||
144496623|NCT03781804|521014416|FG002|Overall Study|Withdrawal by Subject|1|||
144496624|NCT03781804|521014414|FG000|Overall Study|Reason not provided|2|||
144496625|NCT03781804|521014415|FG001|Overall Study|Reason not provided|2|||
144496626|NCT03781804|521014416|FG002|Overall Study|Reason not provided|0|||
144496627|NCT00768066|521014417|FG000|Overall Study|Did not receive study product injection.|3|||
144496628|NCT00768066|521014418|FG001|Overall Study|Did not receive study product injection.|3|||
144496629|NCT00768066|521014419|FG002|Overall Study|Did not receive study product injection.|0|||
144496630|NCT04831775|521014420|FG000|Overall Study|Lost to Follow-up|11|||
144496631|NCT04831775|521014421|FG001|Overall Study|Lost to Follow-up|13|||
144496632|NCT00337818|521014422|FG000|Overall Study|Lost to Follow-up|289|||
144496633|NCT00337818|521014423|FG001|Overall Study|Lost to Follow-up|91|||
144496634|NCT00337818|521014424|FG002|Overall Study|Lost to Follow-up|107|||
144496635|NCT01560949|521014426|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
144496636|NCT01560949|521014426|FG000|Surgery Phase|Physician Decision|3|||
144496637|NCT05526911|521016434|FG000|Overall Study|Adverse Event|2|||
144496638|NCT05025449|521016435|FG000|Overall Study|Withdrawal by Subject|1|||
144496639|NCT05025449|521016435|FG000|Overall Study|Patient emergently taken to operating room|1|||
144496640|NCT00256308|521016436|FG000|Overall Study|Death|2|||
144496641|NCT01537133|521016437|FG000|Overall Study|Withdrawal by Subject|2|||
144496642|NCT01537133|521016438|FG001|Overall Study|Withdrawal by Subject|0|||
144496643|NCT01537133|521016439|FG002|Overall Study|Withdrawal by Subject|0|||
144496644|NCT01537133|521016440|FG003|Overall Study|Withdrawal by Subject|0|||
144496645|NCT01537133|521016437|FG000|Overall Study|Lost to Follow-up|1|||
144496646|NCT01537133|521016438|FG001|Overall Study|Lost to Follow-up|0|||
144496647|NCT01537133|521016439|FG002|Overall Study|Lost to Follow-up|0|||
144496648|NCT01537133|521016440|FG003|Overall Study|Lost to Follow-up|0|||
144496649|NCT00569946|521016441|FG000|Overall Study|Adverse Event|16|||
144496650|NCT00569946|521016441|FG000|Overall Study|Objective Progression or Relapse|42|||
144496651|NCT00569946|521016441|FG000|Overall Study|Global Deterioration of Health Status|1|||
144496652|NCT00762463|521016443|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
144496653|NCT00762463|521016444|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
144496654|NCT00762463|521016445|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
144496655|NCT00762463|521016446|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
144496656|NCT00762463|521016443|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
144496657|NCT00762463|521016444|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
144496658|NCT00762463|521016445|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
144496659|NCT00762463|521016446|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
144496660|NCT00762463|521016443|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
144496661|NCT00762463|521016444|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
144496662|NCT00762463|521016445|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
144496663|NCT00762463|521016446|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
144496664|NCT00762463|521016443|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
144496665|NCT00762463|521016444|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
144496666|NCT00762463|521016445|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
144496667|NCT00762463|521016446|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
144496668|NCT00762463|521016443|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
144496669|NCT00762463|521016444|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
144496670|NCT00762463|521016445|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
144496671|NCT00762463|521016446|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
144496672|NCT00762463|521016443|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
144496673|NCT00762463|521016444|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
144496674|NCT00762463|521016445|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
144496675|NCT00762463|521016446|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
144496676|NCT00762463|521016443|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
144496677|NCT00762463|521016444|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
144496678|NCT00762463|521016445|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
144496679|NCT00762463|521016446|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
144496680|NCT00762463|521016443|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
144496681|NCT00762463|521016444|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
144496682|NCT00762463|521016445|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
144496683|NCT00762463|521016446|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
144496684|NCT00797862|521016447|FG000|Overall Study|Adverse Event|86|||
144496685|NCT00797862|521016448|FG001|Overall Study|Adverse Event|44|||
144496686|NCT00797862|521016449|FG002|Overall Study|Adverse Event|58|||
144496687|NCT00797862|521016447|FG000|Overall Study|Abnormal Test Procedure Result|0|||
144496688|NCT00797862|521016448|FG001|Overall Study|Abnormal Test Procedure Result|1|||
144496689|NCT00797862|521016449|FG002|Overall Study|Abnormal Test Procedure Result|1|||
144496690|NCT00797862|521016447|FG000|Overall Study|Lack of Efficacy|1|||
144496691|NCT00797862|521016448|FG001|Overall Study|Lack of Efficacy|7|||
144496692|NCT00797862|521016449|FG002|Overall Study|Lack of Efficacy|6|||
144496693|NCT00797862|521016447|FG000|Overall Study|No longer required study medication|1|||
144496694|NCT00797862|521016448|FG001|Overall Study|No longer required study medication|0|||
144496695|NCT00797862|521016449|FG002|Overall Study|No longer required study medication|0|||
144496696|NCT00797862|521016447|FG000|Overall Study|Withdrawal by Subject|14|||
144496697|NCT00797862|521016448|FG001|Overall Study|Withdrawal by Subject|7|||
144496698|NCT00797862|521016449|FG002|Overall Study|Withdrawal by Subject|7|||
144496699|NCT00797862|521016447|FG000|Overall Study|Lost to Follow-up|11|||
144496700|NCT00797862|521016448|FG001|Overall Study|Lost to Follow-up|0|||
144496701|NCT00797862|521016449|FG002|Overall Study|Lost to Follow-up|5|||
144496702|NCT00797862|521016447|FG000|Overall Study|Administrative Problem|4|||
144496703|NCT00797862|521016448|FG001|Overall Study|Administrative Problem|0|||
144496704|NCT00797862|521016449|FG002|Overall Study|Administrative Problem|0|||
144496705|NCT00797862|521016447|FG000|Overall Study|Protocol Violation|4|||
144496706|NCT00797862|521016448|FG001|Overall Study|Protocol Violation|6|||
144496707|NCT00797862|521016449|FG002|Overall Study|Protocol Violation|8|||
144496708|NCT00797862|521016447|FG000|Overall Study|Mis-randomized|3|||
144496709|NCT00797862|521016448|FG001|Overall Study|Mis-randomized|3|||
144496710|NCT00797862|521016449|FG002|Overall Study|Mis-randomized|1|||
144719547|NCT01992107|521827427|FG001|Overall Study|noncompliance and were unavailable|3|||
144719548|NCT01992107|521827428|FG002|Overall Study|noncompliance and were unavailable|2|||
144719549|NCT01992107|521827426|FG000|Overall Study|Withdrawal by Subject|13|||
144719550|NCT01992107|521827427|FG001|Overall Study|Withdrawal by Subject|7|||
144719551|NCT01992107|521827428|FG002|Overall Study|Withdrawal by Subject|8|||
144719552|NCT02022007|521827429|FG000|Overall Study|Withdrawal by Subject|1|||
144719553|NCT02022007|521827430|FG001|Overall Study|Withdrawal by Subject|1|||
144719554|NCT02022007|521827431|FG002|Overall Study|Withdrawal by Subject|1|||
144496711|NCT00531479|521016450|FG000|Overall Study|Death|68|||
144496712|NCT00531479|521016451|FG001|Overall Study|Death|71|||
144496713|NCT00531479|521016450|FG000|Overall Study|Lost to Follow-up|0|||
144496714|NCT00531479|521016451|FG001|Overall Study|Lost to Follow-up|2|||
144496715|NCT00531479|521016450|FG000|Overall Study|Other|0|||
144496716|NCT00531479|521016451|FG001|Overall Study|Other|1|||
144496717|NCT00531479|521016450|FG000|Overall Study|Withdrawal by Subject|6|||
144496718|NCT00531479|521016451|FG001|Overall Study|Withdrawal by Subject|6|||
144496719|NCT00531479|521016450|FG000|Overall Study|Did not receive treatment|2|||
144496720|NCT00531479|521016451|FG001|Overall Study|Did not receive treatment|3|||
144496721|NCT05074498|521016454|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
144496722|NCT05074498|521016455|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
144496723|NCT05074498|521016456|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
144496724|NCT05074498|521016457|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
144496725|NCT05074498|521016458|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
144496726|NCT05074498|521016459|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
144496727|NCT05074498|521016454|FG000|Part 1 (Upto Day 104)|Other|1|||
144496728|NCT05074498|521016455|FG001|Part 1 (Upto Day 104)|Other|0|||
144496729|NCT05074498|521016456|FG002|Part 1 (Upto Day 104)|Other|0|||
144496730|NCT05074498|521016457|FG003|Part 1 (Upto Day 104)|Other|0|||
144496731|NCT05074498|521016458|FG004|Part 1 (Upto Day 104)|Other|0|||
144496732|NCT05074498|521016459|FG005|Part 1 (Upto Day 104)|Other|0|||
144496733|NCT05074498|521016454|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
144496734|NCT05074498|521016455|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
144496735|NCT05074498|521016456|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
144496736|NCT05074498|521016457|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
144496737|NCT05074498|521016458|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
144496738|NCT05074498|521016459|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
144496739|NCT05074498|521016454|FG000|Part 2 (Upto Day 104)|Death|0|||
144496740|NCT05074498|521016455|FG001|Part 2 (Upto Day 104)|Death|0|||
144496741|NCT05074498|521016456|FG002|Part 2 (Upto Day 104)|Death|0|||
144496742|NCT05074498|521016457|FG003|Part 2 (Upto Day 104)|Death|0|||
144496743|NCT05074498|521016458|FG004|Part 2 (Upto Day 104)|Death|1|||
144496744|NCT05074498|521016459|FG005|Part 2 (Upto Day 104)|Death|0|||
144496745|NCT05074498|521016454|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
144496746|NCT05074498|521016455|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
144496747|NCT05074498|521016456|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
144496748|NCT05074498|521016457|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
144496749|NCT05074498|521016458|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
144496750|NCT05074498|521016459|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
144496751|NCT05074498|521016454|FG000|Part 2 (Upto Day 104)|Other|0|||
144496752|NCT05074498|521016455|FG001|Part 2 (Upto Day 104)|Other|0|||
144496753|NCT05074498|521016456|FG002|Part 2 (Upto Day 104)|Other|0|||
144496754|NCT05074498|521016457|FG003|Part 2 (Upto Day 104)|Other|0|||
144496755|NCT05074498|521016458|FG004|Part 2 (Upto Day 104)|Other|1|||
144496756|NCT05074498|521016459|FG005|Part 2 (Upto Day 104)|Other|0|||
144496757|NCT01240356|521016460|FG000|Overall Study|Withdrawal by Subject|2|||
144496758|NCT01240356|521016461|FG001|Overall Study|Withdrawal by Subject|0|||
144496759|NCT01240356|521016460|FG000|Overall Study|MRI contraindication|1|||
144496760|NCT01240356|521016461|FG001|Overall Study|MRI contraindication|0|||
144496761|NCT01306331|521016462|FG000|Overall Study|Adverse Event|28|||
144496762|NCT01306331|521016463|FG001|Overall Study|Adverse Event|25|||
144496763|NCT01306331|521016462|FG000|Overall Study|Lost to Follow-up|321|||
144496764|NCT01306331|521016463|FG001|Overall Study|Lost to Follow-up|323|||
144496765|NCT01306331|521016462|FG000|Overall Study|Physician Decision|26|||
144496766|NCT01306331|521016463|FG001|Overall Study|Physician Decision|22|||
144496767|NCT01306331|521016462|FG000|Overall Study|Pregnancy|136|||
144496768|NCT01306331|521016463|FG001|Overall Study|Pregnancy|151|||
144496769|NCT01306331|521016462|FG000|Overall Study|Protocol Violation|154|||
144496770|NCT01306331|521016463|FG001|Overall Study|Protocol Violation|124|||
144496771|NCT01306331|521016462|FG000|Overall Study|Withdrawal by Subject|163|||
144496772|NCT01306331|521016463|FG001|Overall Study|Withdrawal by Subject|152|||
144496773|NCT01306331|521016462|FG000|Overall Study|Not sexually active|29|||
144496774|NCT01306331|521016463|FG001|Overall Study|Not sexually active|28|||
144496775|NCT01306331|521016462|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
144496776|NCT01306331|521016463|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
144496777|NCT01306331|521016462|FG000|Overall Study|Other|34|||
144496778|NCT01306331|521016463|FG001|Overall Study|Other|32|||
144496779|NCT00172185|521016469|FG000|Overall Study|Adverse Event|0|||
144496780|NCT00172185|521016470|FG001|Overall Study|Adverse Event|1|||
144496781|NCT00172185|521016471|FG002|Overall Study|Adverse Event|3|||
144496782|NCT00172185|521016472|FG003|Overall Study|Adverse Event|4|||
144496783|NCT00172185|521016469|FG000|Overall Study|Physician Decision|0|||
144496784|NCT00172185|521016470|FG001|Overall Study|Physician Decision|0|||
144496785|NCT00172185|521016471|FG002|Overall Study|Physician Decision|1|||
144496786|NCT00172185|521016472|FG003|Overall Study|Physician Decision|0|||
144496787|NCT00172185|521016469|FG000|Overall Study|SPONSOR Decision|0|||
144496788|NCT00172185|521016470|FG001|Overall Study|SPONSOR Decision|1|||
144496789|NCT00172185|521016471|FG002|Overall Study|SPONSOR Decision|0|||
144496790|NCT00172185|521016472|FG003|Overall Study|SPONSOR Decision|0|||
144496791|NCT00172185|521016469|FG000|Overall Study|Withdrawal by Subject|0|||
144496792|NCT00172185|521016470|FG001|Overall Study|Withdrawal by Subject|0|||
144496793|NCT00172185|521016471|FG002|Overall Study|Withdrawal by Subject|1|||
144496794|NCT00172185|521016472|FG003|Overall Study|Withdrawal by Subject|0|||
144496795|NCT04048135|521016473|FG000|Overall Study|Withdrawal by Subject|1|||
144496796|NCT04048135|521016474|FG001|Overall Study|Withdrawal by Subject|1|||
144496797|NCT04048135|521016475|FG002|Overall Study|Withdrawal by Subject|1|||
144496798|NCT04048135|521016476|FG003|Overall Study|Withdrawal by Subject|2|||
144496799|NCT04048135|521016477|FG004|Overall Study|Withdrawal by Subject|0|||
144496800|NCT04048135|521016478|FG005|Overall Study|Withdrawal by Subject|0|||
144496801|NCT04048135|521016479|FG006|Overall Study|Withdrawal by Subject|1|||
144496802|NCT04048135|521016480|FG007|Overall Study|Withdrawal by Subject|1|||
144496803|NCT04048135|521016473|FG000|Overall Study|Adverse Event|0|||
144496804|NCT04048135|521016474|FG001|Overall Study|Adverse Event|0|||
144496805|NCT04048135|521016475|FG002|Overall Study|Adverse Event|0|||
144496806|NCT04048135|521016476|FG003|Overall Study|Adverse Event|1|||
144496807|NCT04048135|521016477|FG004|Overall Study|Adverse Event|1|||
144496808|NCT04048135|521016478|FG005|Overall Study|Adverse Event|0|||
144496809|NCT04048135|521016479|FG006|Overall Study|Adverse Event|0|||
144496810|NCT04048135|521016480|FG007|Overall Study|Adverse Event|0|||
144496811|NCT04048135|521016473|FG000|Overall Study|Protocol Violation|0|||
144496812|NCT04048135|521016474|FG001|Overall Study|Protocol Violation|0|||
144496813|NCT04048135|521016475|FG002|Overall Study|Protocol Violation|0|||
144496814|NCT04048135|521016476|FG003|Overall Study|Protocol Violation|0|||
144496815|NCT04048135|521016477|FG004|Overall Study|Protocol Violation|0|||
144496816|NCT04048135|521016478|FG005|Overall Study|Protocol Violation|1|||
144496817|NCT04048135|521016479|FG006|Overall Study|Protocol Violation|0|||
144496818|NCT04048135|521016480|FG007|Overall Study|Protocol Violation|0|||
144496819|NCT01677936|521016481|FG000|Overall Study|Lost to Follow-up|4|||
144496820|NCT01677936|521016482|FG001|Overall Study|Lost to Follow-up|1|||
144496821|NCT01677936|521016481|FG000|Overall Study|Protocol Violation|3|||
144496822|NCT01677936|521016482|FG001|Overall Study|Protocol Violation|0|||
144496823|NCT01677936|521016481|FG000|Overall Study|Adverse Event|1|||
144496824|NCT01677936|521016482|FG001|Overall Study|Adverse Event|0|||
144496825|NCT01677936|521016481|FG000|Overall Study|Lost to Follow-up|1|||
144496826|NCT01677936|521016482|FG001|Overall Study|Lost to Follow-up|0|||
144496827|NCT01677936|521016481|FG000|Overall Study|Protocol Violation|0|||
144496828|NCT01677936|521016482|FG001|Overall Study|Protocol Violation|4|||
144496829|NCT04358549|521016485|FG000|Overall Study|Adverse Event|0|||
144496830|NCT04358549|521016486|FG001|Overall Study|Adverse Event|1|||
144496831|NCT04358549|521016485|FG000|Overall Study|Death|1|||
144496832|NCT04358549|521016486|FG001|Overall Study|Death|0|||
144496833|NCT04358549|521016485|FG000|Overall Study|Lost to Follow-up|2|||
144496834|NCT04358549|521016486|FG001|Overall Study|Lost to Follow-up|1|||
144496835|NCT04358549|521016485|FG000|Overall Study|Withdrawal by Subject|6|||
144496836|NCT04358549|521016486|FG001|Overall Study|Withdrawal by Subject|6|||
144496837|NCT04358549|521016485|FG000|Overall Study|Start remdesivir|1|||
144496838|NCT04358549|521016486|FG001|Overall Study|Start remdesivir|0|||
144496839|NCT03837028|521016490|FG000|Overall Study|Lost to Follow-up|4|||
144496840|NCT03837028|521016491|FG001|Overall Study|Lost to Follow-up|0|||
144496841|NCT03837028|521016492|FG002|Overall Study|Lost to Follow-up|2|||
144496842|NCT03837028|521016493|FG003|Overall Study|Lost to Follow-up|0|||
144496843|NCT03837028|521016490|FG000|Overall Study|Withdrawal by Subject|12|||
144496844|NCT03837028|521016491|FG001|Overall Study|Withdrawal by Subject|11|||
144496845|NCT03837028|521016492|FG002|Overall Study|Withdrawal by Subject|11|||
144496846|NCT03837028|521016493|FG003|Overall Study|Withdrawal by Subject|7|||
144496847|NCT00157014|521016494|FG000|Overall Study|Death|4|||
144496848|NCT00157014|521016495|FG001|Overall Study|Death|2|||
144496849|NCT00157014|521016496|FG002|Overall Study|Death|1|||
144496850|NCT00157014|521016497|FG003|Overall Study|Death|1|||
144496851|NCT00157014|521016494|FG000|Overall Study|Physician Decision|0|||
144719555|NCT02022007|521827429|FG000|Overall Study|Noncompliant|0|||
144719556|NCT02022007|521827430|FG001|Overall Study|Noncompliant|0|||
144719557|NCT02022007|521827431|FG002|Overall Study|Noncompliant|1|||
144719558|NCT01214603|521827432|FG000|Overall Study|Adverse Event|0|||
144719559|NCT01214603|521827433|FG001|Overall Study|Adverse Event|0|||
144496852|NCT00157014|521016495|FG001|Overall Study|Physician Decision|1|||
144496853|NCT00157014|521016496|FG002|Overall Study|Physician Decision|0|||
144496854|NCT00157014|521016497|FG003|Overall Study|Physician Decision|0|||
144496855|NCT00157014|521016494|FG000|Overall Study|Medications withdrawn on family request|0|||
144496856|NCT00157014|521016495|FG001|Overall Study|Medications withdrawn on family request|1|||
144496857|NCT00157014|521016496|FG002|Overall Study|Medications withdrawn on family request|0|||
144719560|NCT01214603|521827434|FG002|Overall Study|Adverse Event|1|||
144496858|NCT00157014|521016497|FG003|Overall Study|Medications withdrawn on family request|0|||
144496859|NCT00157014|521016494|FG000|Overall Study|Patient withdrawn by investigator|1|||
144496860|NCT00157014|521016495|FG001|Overall Study|Patient withdrawn by investigator|0|||
144496861|NCT00157014|521016496|FG002|Overall Study|Patient withdrawn by investigator|0|||
144719561|NCT01214603|521827432|FG000|Overall Study|Death|1|||
144496862|NCT00157014|521016497|FG003|Overall Study|Patient withdrawn by investigator|0|||
144496863|NCT00157014|521016494|FG000|Overall Study|Patient unable to return in nursing home|1|||
144496864|NCT00157014|521016495|FG001|Overall Study|Patient unable to return in nursing home|0|||
144496865|NCT00157014|521016496|FG002|Overall Study|Patient unable to return in nursing home|0|||
144496866|NCT00157014|521016497|FG003|Overall Study|Patient unable to return in nursing home|0|||
144496867|NCT00157014|521016494|FG000|Overall Study|Patient would not receive transplant|0|||
144496868|NCT00157014|521016495|FG001|Overall Study|Patient would not receive transplant|1|||
144496869|NCT00157014|521016496|FG002|Overall Study|Patient would not receive transplant|0|||
144496870|NCT00157014|521016497|FG003|Overall Study|Patient would not receive transplant|0|||
144496871|NCT00157014|521016494|FG000|Overall Study|Withdrawal by Subject|1|||
144496872|NCT00157014|521016495|FG001|Overall Study|Withdrawal by Subject|0|||
144496873|NCT00157014|521016496|FG002|Overall Study|Withdrawal by Subject|0|||
144496874|NCT00157014|521016497|FG003|Overall Study|Withdrawal by Subject|0|||
144496875|NCT01362491|521016498|FG000|Overall Study|Ineligible|1|||
144496876|NCT01362491|521016499|FG001|Overall Study|Ineligible|0|||
144496877|NCT01362491|521016500|FG002|Overall Study|Ineligible|0|||
144496878|NCT01257503|521016501|FG000|Overall Study|Lost to Follow-up|7|||
144496879|NCT01257503|521016502|FG001|Overall Study|Lost to Follow-up|10|||
144496880|NCT01257503|521016501|FG000|Overall Study|Over 5 years old at enrollment|0|||
144496881|NCT01257503|521016502|FG001|Overall Study|Over 5 years old at enrollment|1|||
144496882|NCT01257503|521016501|FG000|Overall Study|strep culture positive at enrollment|1|||
144496883|NCT01257503|521016502|FG001|Overall Study|strep culture positive at enrollment|0|||
144496884|NCT04867902|521016503|FG000|Overall Study|Lost to Follow-up|1|||
144496885|NCT04867902|521016503|FG000|Overall Study|Withdrawal by Subject|2|||
144496886|NCT04867902|521016503|FG000|Overall Study|Protocol Violation|1|||
144496887|NCT05355116|521016504|FG000|Overall Study|Withdrawal by Subject|2|||
144496888|NCT02501629|521016505|FG000|Overall Study|Death|0|||
144496889|NCT02501629|521016506|FG001|Overall Study|Death|1|||
144496890|NCT02501629|521016505|FG000|Overall Study|Withdrawn from study by sponsor|1|||
144496891|NCT02501629|521016506|FG001|Overall Study|Withdrawn from study by sponsor|0|||
144496892|NCT02501629|521016505|FG000|Overall Study|Early termination by sponsor|1|||
144496893|NCT02501629|521016506|FG001|Overall Study|Early termination by sponsor|0|||
144496894|NCT02501629|521016505|FG000|Overall Study|Withdrawal by Subject|3|||
144496895|NCT02501629|521016506|FG001|Overall Study|Withdrawal by Subject|5|||
144496896|NCT02501629|521016505|FG000|Overall Study|Subject did not return to site|0|||
144496897|NCT02501629|521016506|FG001|Overall Study|Subject did not return to site|1|||
144496898|NCT00868231|521016509|FG000|Treatment Period 1|Adverse Event|0|||
144496899|NCT00868231|521016510|FG001|Treatment Period 1|Adverse Event|0|||
144496900|NCT00868231|521016511|FG002|Treatment Period 1|Adverse Event|0|||
144496901|NCT00868231|521016512|FG003|Treatment Period 1|Adverse Event|0|||
144496902|NCT00868231|521016513|FG004|Treatment Period 1|Adverse Event|1|||
144496903|NCT00868231|521016514|FG005|Treatment Period 1|Adverse Event|0|||
144496904|NCT00868231|521016509|FG000|Treatment Period 2|Adverse Event|1|||
144496905|NCT00868231|521016510|FG001|Treatment Period 2|Adverse Event|0|||
144496906|NCT00868231|521016511|FG002|Treatment Period 2|Adverse Event|0|||
144496907|NCT00868231|521016512|FG003|Treatment Period 2|Adverse Event|0|||
144496908|NCT00868231|521016513|FG004|Treatment Period 2|Adverse Event|0|||
144496909|NCT00868231|521016514|FG005|Treatment Period 2|Adverse Event|0|||
144496910|NCT00868231|521016509|FG000|Treatment Period 3|Adverse Event|0|||
144496911|NCT00868231|521016510|FG001|Treatment Period 3|Adverse Event|0|||
144496912|NCT00868231|521016511|FG002|Treatment Period 3|Adverse Event|1|||
144496913|NCT00868231|521016512|FG003|Treatment Period 3|Adverse Event|0|||
144496914|NCT00868231|521016513|FG004|Treatment Period 3|Adverse Event|0|||
144496915|NCT00868231|521016514|FG005|Treatment Period 3|Adverse Event|0|||
144496916|NCT03120676|521016515|FG000|Overall Study|Not treated|1|||
144496917|NCT03396835|521016516|FG000|Overall Study|Withdrawn prior to completion|1|||
144496918|NCT03396835|521016516|FG000|Overall Study|Did not meet criteria for data analysis|1|||
144496919|NCT00742274|521016523|FG000|Overall Study|Death|1|||
144496920|NCT00742274|521016524|FG001|Overall Study|Death|0|||
144496921|NCT00742274|521016523|FG000|Overall Study|Withdrawal by Subject|1|||
144496922|NCT00742274|521016524|FG001|Overall Study|Withdrawal by Subject|2|||
144496923|NCT00742274|521016523|FG000|Overall Study|Removed for medical reasons|1|||
144496924|NCT00742274|521016524|FG001|Overall Study|Removed for medical reasons|1|||
144496925|NCT01649427|521016529|FG000|Overall Study|Adverse Event|1|||
144496926|NCT01649427|521016530|FG001|Overall Study|Adverse Event|1|||
144496927|NCT01649427|521016529|FG000|Overall Study|Withdrawal by Subject|8|||
144496928|NCT01649427|521016530|FG001|Overall Study|Withdrawal by Subject|7|||
144496929|NCT01649427|521016529|FG000|Overall Study|Lost to Follow-up|0|||
144496930|NCT01649427|521016530|FG001|Overall Study|Lost to Follow-up|1|||
144496931|NCT01649427|521016529|FG000|Overall Study|Graft loss|0|||
144496932|NCT01649427|521016530|FG001|Overall Study|Graft loss|1|||
144496933|NCT01649427|521016529|FG000|Overall Study|Surgical problems during nephrectomy|2|||
144496934|NCT01649427|521016530|FG001|Overall Study|Surgical problems during nephrectomy|2|||
144496935|NCT03717194|521016531|FG000|Overall Study|Withdrawal by Subject|2|||
144496936|NCT03717194|521016532|FG001|Overall Study|Withdrawal by Subject|4|||
144496937|NCT03717194|521016531|FG000|Overall Study|Adverse Event|1|||
144496938|NCT03717194|521016532|FG001|Overall Study|Adverse Event|1|||
144496939|NCT01836458|521016533|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
144496940|NCT01836458|521016534|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144496941|NCT01836458|521016535|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
144496942|NCT01836458|521016536|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
144496943|NCT03425539|521016541|FG000|Overall Study|Randomized but not treated|0|||
144496944|NCT03425539|521016542|FG001|Overall Study|Randomized but not treated|1|||
144496945|NCT03425539|521016541|FG000|Overall Study|Adverse Event|2|||
144496946|NCT03425539|521016542|FG001|Overall Study|Adverse Event|2|||
144496947|NCT03425539|521016541|FG000|Overall Study|Withdrawal by Subject|3|||
144496948|NCT03425539|521016542|FG001|Overall Study|Withdrawal by Subject|0|||
144496949|NCT03425539|521016541|FG000|Overall Study|Lost to Follow-up|0|||
144496950|NCT03425539|521016542|FG001|Overall Study|Lost to Follow-up|1|||
144496951|NCT00946192|521016543|FG000|Overall Study|Lost to Follow-up|6|||
144496952|NCT00946192|521016544|FG001|Overall Study|Lost to Follow-up|11|||
144496953|NCT00946192|521016545|FG002|Overall Study|Lost to Follow-up|9|||
144496954|NCT00946192|521016543|FG000|Overall Study|Withdrawal by Subject|10|||
144496955|NCT00946192|521016544|FG001|Overall Study|Withdrawal by Subject|7|||
144496956|NCT00946192|521016545|FG002|Overall Study|Withdrawal by Subject|3|||
144496957|NCT00946192|521016543|FG000|Overall Study|Did not start medication|2|||
144496958|NCT00946192|521016544|FG001|Overall Study|Did not start medication|0|||
144496959|NCT00946192|521016545|FG002|Overall Study|Did not start medication|0|||
144496960|NCT01080131|521016546|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
144496961|NCT01080131|521016547|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
144496962|NCT01080131|521016546|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
144496963|NCT01080131|521016547|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
144496964|NCT01080131|521016546|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
144496965|NCT01080131|521016547|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
144496966|NCT01080131|521016546|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
144496967|NCT01080131|521016547|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
144496968|NCT01080131|521016546|FG000|Core Study (0- 12 Weeks)|Death|1|||
144496969|NCT01080131|521016547|FG001|Core Study (0- 12 Weeks)|Death|0|||
144496970|NCT01080131|521016546|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
144496971|NCT01080131|521016547|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
144496972|NCT01080131|521016546|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
144496973|NCT01080131|521016547|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
144496974|NCT01080131|521016546|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
144496975|NCT01080131|521016547|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
144496976|NCT01080131|521016546|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
144496977|NCT01080131|521016547|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
144496978|NCT01080131|521016546|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
144496979|NCT01080131|521016547|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
144496980|NCT01080131|521016546|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
144496981|NCT01080131|521016547|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
144496982|NCT01080131|521016546|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
144496983|NCT01080131|521016547|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
144496984|NCT01080131|521016546|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
144496985|NCT01080131|521016547|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
144496986|NCT02014558|521016548|FG000|Overall Study|Never Received Study Drug|0|||
144496987|NCT02014558|521016549|FG001|Overall Study|Never Received Study Drug|0|||
144496988|NCT02014558|521016550|FG002|Overall Study|Never Received Study Drug|0|||
144496989|NCT02014558|521016551|FG003|Overall Study|Never Received Study Drug|0|||
144496990|NCT02014558|521016552|FG004|Overall Study|Never Received Study Drug|1|||
144496991|NCT02014558|521016553|FG005|Overall Study|Never Received Study Drug|0|||
144719562|NCT01214603|521827433|FG001|Overall Study|Death|0|||
144719563|NCT01214603|521827434|FG002|Overall Study|Death|0|||
144719564|NCT01214603|521827432|FG000|Overall Study|Progressive Disease|4|||
144719565|NCT01214603|521827433|FG001|Overall Study|Progressive Disease|1|||
144719566|NCT01214603|521827434|FG002|Overall Study|Progressive Disease|3|||
144719567|NCT01507896|521827435|FG000|Overall Study|Withdrawal by Subject|1|||
144719568|NCT01507896|521827435|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
144719569|NCT00617461|521827446|FG000|First Treatment Intervention Period|Adverse Event|2|||
144719570|NCT00617461|521827447|FG001|First Treatment Intervention Period|Adverse Event|0|||
144719571|NCT00617461|521827446|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
144719572|NCT00617461|521827447|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
144719573|NCT00617461|521827446|FG000|First Treatment Intervention Period|Protocol Violation|2|||
144719574|NCT00617461|521827447|FG001|First Treatment Intervention Period|Protocol Violation|1|||
144719575|NCT00617461|521827446|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
144719576|NCT00617461|521827447|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
144719577|NCT00617461|521827446|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
144719578|NCT00617461|521827447|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
144719579|NCT00617461|521827446|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
144719580|NCT00617461|521827447|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
144719581|NCT00617461|521827446|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
144719582|NCT00617461|521827447|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
144719583|NCT00617461|521827446|FG000|Second Treatment Intervention Period|Adverse Event|0|||
144719584|NCT00617461|521827447|FG001|Second Treatment Intervention Period|Adverse Event|1|||
144719585|NCT00617461|521827446|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
144719586|NCT00617461|521827447|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
144719587|NCT00617461|521827446|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
144719588|NCT00617461|521827447|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
144719589|NCT00617461|521827446|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
144719590|NCT00617461|521827447|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
144719591|NCT00358826|521827448|FG000|Core Study|Adverse Event|1|||
144719592|NCT00358826|521827449|FG001|Core Study|Adverse Event|3|||
144719593|NCT00358826|521827450|FG002|Core Study|Adverse Event|1|||
144719594|NCT00358826|521827451|FG003|Core Study|Adverse Event|1|||
144719595|NCT00358826|521827452|FG004|Core Study|Adverse Event|0|||
144719596|NCT00358826|521827453|FG005|Core Study|Adverse Event|0|||
144719597|NCT00358826|521827454|FG006|Core Study|Adverse Event|0|||
144719598|NCT00358826|521827455|FG007|Core Study|Adverse Event|0|||
144719599|NCT00358826|521827448|FG000|Core Study|Withdrawal by Subject|2|||
144719600|NCT00358826|521827449|FG001|Core Study|Withdrawal by Subject|2|||
144719601|NCT00358826|521827450|FG002|Core Study|Withdrawal by Subject|0|||
144719602|NCT00358826|521827451|FG003|Core Study|Withdrawal by Subject|0|||
144719603|NCT00358826|521827452|FG004|Core Study|Withdrawal by Subject|0|||
144719604|NCT00358826|521827453|FG005|Core Study|Withdrawal by Subject|0|||
144719605|NCT00358826|521827454|FG006|Core Study|Withdrawal by Subject|0|||
144719606|NCT00358826|521827455|FG007|Core Study|Withdrawal by Subject|0|||
144719607|NCT00358826|521827448|FG000|Core Study|Lost to Follow-up|0|||
144719608|NCT00358826|521827449|FG001|Core Study|Lost to Follow-up|0|||
144719609|NCT00358826|521827450|FG002|Core Study|Lost to Follow-up|0|||
144719610|NCT00358826|521827451|FG003|Core Study|Lost to Follow-up|1|||
144719611|NCT00358826|521827452|FG004|Core Study|Lost to Follow-up|0|||
144719612|NCT00358826|521827453|FG005|Core Study|Lost to Follow-up|0|||
144719613|NCT00358826|521827454|FG006|Core Study|Lost to Follow-up|0|||
144719614|NCT00358826|521827455|FG007|Core Study|Lost to Follow-up|0|||
144719615|NCT00358826|521827448|FG000|Core Study|Physician Decision|0|||
144719616|NCT00358826|521827449|FG001|Core Study|Physician Decision|0|||
144719617|NCT00358826|521827450|FG002|Core Study|Physician Decision|1|||
144719618|NCT00358826|521827451|FG003|Core Study|Physician Decision|0|||
144719619|NCT00358826|521827452|FG004|Core Study|Physician Decision|0|||
144719620|NCT00358826|521827453|FG005|Core Study|Physician Decision|0|||
144719621|NCT00358826|521827454|FG006|Core Study|Physician Decision|0|||
144719622|NCT00358826|521827455|FG007|Core Study|Physician Decision|0|||
144719623|NCT00358826|521827448|FG000|MDCT Substudy|Adverse Event|0|||
144719624|NCT00358826|521827449|FG001|MDCT Substudy|Adverse Event|0|||
144496992|NCT02014558|521016554|FG006|Overall Study|Never Received Study Drug|1|||
144496993|NCT02014558|521016555|FG007|Overall Study|Never Received Study Drug|0|||
144719625|NCT00358826|521827450|FG002|MDCT Substudy|Adverse Event|0|||
144496994|NCT02014558|521016556|FG008|Overall Study|Never Received Study Drug|2|||
144496995|NCT02014558|521016557|FG009|Overall Study|Never Received Study Drug|0|||
144496996|NCT02014558|521016558|FG010|Overall Study|Never Received Study Drug|2|||
144496997|NCT02014558|521016559|FG011|Overall Study|Never Received Study Drug|2|||
144496998|NCT02014558|521016560|FG012|Overall Study|Never Received Study Drug|0|||
144496999|NCT02014558|521016548|FG000|Overall Study|Adverse Event|0|||
144497000|NCT02014558|521016549|FG001|Overall Study|Adverse Event|0|||
144497001|NCT02014558|521016550|FG002|Overall Study|Adverse Event|0|||
144497002|NCT02014558|521016551|FG003|Overall Study|Adverse Event|0|||
144497003|NCT02014558|521016552|FG004|Overall Study|Adverse Event|1|||
144497004|NCT02014558|521016553|FG005|Overall Study|Adverse Event|0|||
144497005|NCT02014558|521016554|FG006|Overall Study|Adverse Event|0|||
144497006|NCT02014558|521016555|FG007|Overall Study|Adverse Event|0|||
144497007|NCT02014558|521016556|FG008|Overall Study|Adverse Event|2|||
144497008|NCT02014558|521016557|FG009|Overall Study|Adverse Event|2|||
144497009|NCT02014558|521016558|FG010|Overall Study|Adverse Event|5|||
144497010|NCT02014558|521016559|FG011|Overall Study|Adverse Event|21|||
144497011|NCT02014558|521016560|FG012|Overall Study|Adverse Event|3|||
144497012|NCT02014558|521016548|FG000|Overall Study|Death|1|||
144497013|NCT02014558|521016549|FG001|Overall Study|Death|0|||
144497014|NCT02014558|521016550|FG002|Overall Study|Death|0|||
144497015|NCT02014558|521016551|FG003|Overall Study|Death|0|||
144497016|NCT02014558|521016552|FG004|Overall Study|Death|0|||
144497017|NCT02014558|521016553|FG005|Overall Study|Death|0|||
144497018|NCT02014558|521016554|FG006|Overall Study|Death|1|||
144497019|NCT02014558|521016555|FG007|Overall Study|Death|1|||
144497020|NCT02014558|521016556|FG008|Overall Study|Death|2|||
144497021|NCT02014558|521016557|FG009|Overall Study|Death|5|||
144497022|NCT02014558|521016558|FG010|Overall Study|Death|5|||
144497023|NCT02014558|521016559|FG011|Overall Study|Death|19|||
144497024|NCT02014558|521016560|FG012|Overall Study|Death|2|||
144497025|NCT02014558|521016548|FG000|Overall Study|Lack of Efficacy|1|||
144497026|NCT02014558|521016549|FG001|Overall Study|Lack of Efficacy|2|||
144497027|NCT02014558|521016550|FG002|Overall Study|Lack of Efficacy|1|||
144497028|NCT02014558|521016551|FG003|Overall Study|Lack of Efficacy|1|||
144497029|NCT02014558|521016552|FG004|Overall Study|Lack of Efficacy|0|||
144497030|NCT02014558|521016553|FG005|Overall Study|Lack of Efficacy|0|||
144497031|NCT02014558|521016554|FG006|Overall Study|Lack of Efficacy|1|||
144497032|NCT02014558|521016555|FG007|Overall Study|Lack of Efficacy|3|||
144497033|NCT02014558|521016556|FG008|Overall Study|Lack of Efficacy|3|||
144497034|NCT02014558|521016557|FG009|Overall Study|Lack of Efficacy|3|||
144497035|NCT02014558|521016558|FG010|Overall Study|Lack of Efficacy|16|||
144497036|NCT02014558|521016559|FG011|Overall Study|Lack of Efficacy|8|||
144497037|NCT02014558|521016560|FG012|Overall Study|Lack of Efficacy|5|||
144497038|NCT02014558|521016548|FG000|Overall Study|Lost to Follow-up|0|||
144497039|NCT02014558|521016549|FG001|Overall Study|Lost to Follow-up|0|||
144497040|NCT02014558|521016550|FG002|Overall Study|Lost to Follow-up|0|||
144497041|NCT02014558|521016551|FG003|Overall Study|Lost to Follow-up|0|||
144497042|NCT02014558|521016552|FG004|Overall Study|Lost to Follow-up|0|||
144497043|NCT02014558|521016553|FG005|Overall Study|Lost to Follow-up|0|||
144497044|NCT02014558|521016554|FG006|Overall Study|Lost to Follow-up|0|||
144497045|NCT02014558|521016555|FG007|Overall Study|Lost to Follow-up|0|||
144719626|NCT00358826|521827451|FG003|MDCT Substudy|Adverse Event|0|||
144719627|NCT00358826|521827452|FG004|MDCT Substudy|Adverse Event|1|||
144719628|NCT00358826|521827453|FG005|MDCT Substudy|Adverse Event|0|||
144719629|NCT00358826|521827454|FG006|MDCT Substudy|Adverse Event|0|||
144719630|NCT00358826|521827455|FG007|MDCT Substudy|Adverse Event|0|||
144719631|NCT00358826|521827448|FG000|MDCT Substudy|Lost to Follow-up|0|||
144719632|NCT00358826|521827449|FG001|MDCT Substudy|Lost to Follow-up|0|||
144719633|NCT00358826|521827450|FG002|MDCT Substudy|Lost to Follow-up|0|||
144719634|NCT00358826|521827451|FG003|MDCT Substudy|Lost to Follow-up|0|||
144719635|NCT00358826|521827452|FG004|MDCT Substudy|Lost to Follow-up|0|||
144719636|NCT00358826|521827453|FG005|MDCT Substudy|Lost to Follow-up|1|||
144719637|NCT00358826|521827454|FG006|MDCT Substudy|Lost to Follow-up|0|||
144719638|NCT00358826|521827455|FG007|MDCT Substudy|Lost to Follow-up|0|||
144719639|NCT00358826|521827448|FG000|MDCT Substudy|Withdrawal by Subject|0|||
144719640|NCT00358826|521827449|FG001|MDCT Substudy|Withdrawal by Subject|0|||
144719641|NCT00358826|521827450|FG002|MDCT Substudy|Withdrawal by Subject|0|||
144719642|NCT00358826|521827451|FG003|MDCT Substudy|Withdrawal by Subject|0|||
144719643|NCT00358826|521827452|FG004|MDCT Substudy|Withdrawal by Subject|0|||
144719644|NCT00358826|521827453|FG005|MDCT Substudy|Withdrawal by Subject|1|||
144719645|NCT00358826|521827454|FG006|MDCT Substudy|Withdrawal by Subject|0|||
144719646|NCT00358826|521827455|FG007|MDCT Substudy|Withdrawal by Subject|0|||
144719647|NCT01821625|521827457|FG000|Overall Study|Withdrawal by Subject|2|||
144719648|NCT01821625|521827457|FG000|Overall Study|Lack of Efficacy|2|||
144497046|NCT02014558|521016556|FG008|Overall Study|Lost to Follow-up|0|||
144719649|NCT01821625|521827457|FG000|Overall Study|Adverse Event|1|||
144497047|NCT02014558|521016557|FG009|Overall Study|Lost to Follow-up|0|||
144719650|NCT01821625|521827457|FG000|Overall Study|Medical contraindication|1|||
144497048|NCT02014558|521016558|FG010|Overall Study|Lost to Follow-up|1|||
144497049|NCT02014558|521016559|FG011|Overall Study|Lost to Follow-up|0|||
144497050|NCT02014558|521016560|FG012|Overall Study|Lost to Follow-up|0|||
144497051|NCT02014558|521016548|FG000|Overall Study|Progressive Disease|1|||
144497052|NCT02014558|521016549|FG001|Overall Study|Progressive Disease|0|||
144497053|NCT02014558|521016550|FG002|Overall Study|Progressive Disease|1|||
144497054|NCT02014558|521016551|FG003|Overall Study|Progressive Disease|1|||
144497055|NCT02014558|521016552|FG004|Overall Study|Progressive Disease|1|||
144497056|NCT02014558|521016553|FG005|Overall Study|Progressive Disease|2|||
144497057|NCT02014558|521016554|FG006|Overall Study|Progressive Disease|1|||
144497058|NCT02014558|521016555|FG007|Overall Study|Progressive Disease|6|||
144497059|NCT02014558|521016556|FG008|Overall Study|Progressive Disease|5|||
144497060|NCT02014558|521016557|FG009|Overall Study|Progressive Disease|6|||
144497061|NCT02014558|521016558|FG010|Overall Study|Progressive Disease|22|||
144497062|NCT02014558|521016559|FG011|Overall Study|Progressive Disease|31|||
144497063|NCT02014558|521016560|FG012|Overall Study|Progressive Disease|6|||
144497064|NCT02014558|521016548|FG000|Overall Study|Withdrawal by Subject|0|||
144497065|NCT02014558|521016549|FG001|Overall Study|Withdrawal by Subject|0|||
144497066|NCT02014558|521016550|FG002|Overall Study|Withdrawal by Subject|0|||
144497067|NCT02014558|521016551|FG003|Overall Study|Withdrawal by Subject|0|||
144497068|NCT02014558|521016552|FG004|Overall Study|Withdrawal by Subject|1|||
144497069|NCT02014558|521016553|FG005|Overall Study|Withdrawal by Subject|0|||
144497070|NCT02014558|521016554|FG006|Overall Study|Withdrawal by Subject|0|||
144497071|NCT02014558|521016555|FG007|Overall Study|Withdrawal by Subject|0|||
144497072|NCT02014558|521016556|FG008|Overall Study|Withdrawal by Subject|0|||
144497073|NCT02014558|521016557|FG009|Overall Study|Withdrawal by Subject|2|||
144497074|NCT02014558|521016558|FG010|Overall Study|Withdrawal by Subject|6|||
144497075|NCT02014558|521016559|FG011|Overall Study|Withdrawal by Subject|10|||
144497076|NCT02014558|521016560|FG012|Overall Study|Withdrawal by Subject|0|||
144497077|NCT02014558|521016548|FG000|Overall Study|Miscellaneous|2|||
144497078|NCT02014558|521016549|FG001|Overall Study|Miscellaneous|1|||
144497079|NCT02014558|521016550|FG002|Overall Study|Miscellaneous|1|||
144497080|NCT02014558|521016551|FG003|Overall Study|Miscellaneous|1|||
144497081|NCT02014558|521016552|FG004|Overall Study|Miscellaneous|0|||
144497082|NCT02014558|521016553|FG005|Overall Study|Miscellaneous|1|||
144497083|NCT02014558|521016554|FG006|Overall Study|Miscellaneous|0|||
144497084|NCT02014558|521016555|FG007|Overall Study|Miscellaneous|1|||
144497085|NCT02014558|521016556|FG008|Overall Study|Miscellaneous|1|||
144497086|NCT02014558|521016557|FG009|Overall Study|Miscellaneous|3|||
144497087|NCT02014558|521016558|FG010|Overall Study|Miscellaneous|12|||
144497088|NCT02014558|521016559|FG011|Overall Study|Miscellaneous|11|||
144497089|NCT02014558|521016560|FG012|Overall Study|Miscellaneous|1|||
144497090|NCT00299702|521016563|FG000|Overall Study|Death|1|||
144497091|NCT00299702|521016564|FG001|Overall Study|Death|0|||
144497092|NCT00299702|521016563|FG000|Overall Study|Adverse Event|0|||
144497093|NCT00299702|521016564|FG001|Overall Study|Adverse Event|4|||
144497094|NCT00299702|521016563|FG000|Overall Study|Lost to Follow-up|18|||
144497095|NCT00299702|521016564|FG001|Overall Study|Lost to Follow-up|10|||
144497096|NCT00299702|521016563|FG000|Overall Study|Withdrawal by Subject|25|||
144497097|NCT00299702|521016564|FG001|Overall Study|Withdrawal by Subject|23|||
144497098|NCT00299702|521016563|FG000|Overall Study|Pregnancy|0|||
144497099|NCT00299702|521016564|FG001|Overall Study|Pregnancy|1|||
144497100|NCT00299702|521016563|FG000|Overall Study|Insufficient Response|4|||
144497101|NCT00299702|521016564|FG001|Overall Study|Insufficient Response|3|||
144497102|NCT00299702|521016563|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
144497103|NCT00299702|521016564|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
144497104|NCT00751036|521016565|FG000|Overall Study|Disease Progression|28|||
144497105|NCT00751036|521016566|FG001|Overall Study|Disease Progression|29|||
144497106|NCT00751036|521016565|FG000|Overall Study|Adverse Event|6|||
144497107|NCT00751036|521016566|FG001|Overall Study|Adverse Event|4|||
144497108|NCT00751036|521016565|FG000|Overall Study|Administrative Problems|3|||
144497109|NCT00751036|521016566|FG001|Overall Study|Administrative Problems|4|||
144497110|NCT00751036|521016565|FG000|Overall Study|Withdrawal by Subject|5|||
144497111|NCT00751036|521016566|FG001|Overall Study|Withdrawal by Subject|2|||
144497112|NCT00751036|521016565|FG000|Overall Study|Death|3|||
144497113|NCT00751036|521016566|FG001|Overall Study|Death|3|||
144497114|NCT00751036|521016565|FG000|Overall Study|Lost to Follow-up|0|||
144497115|NCT00751036|521016566|FG001|Overall Study|Lost to Follow-up|1|||
144497116|NCT00751036|521016565|FG000|Overall Study|Protocol Violation|1|||
144497117|NCT00751036|521016566|FG001|Overall Study|Protocol Violation|0|||
144497118|NCT00751036|521016565|FG000|Overall Study|Missing end of Treatment Page|2|||
144497119|NCT00751036|521016566|FG001|Overall Study|Missing end of Treatment Page|3|||
144719651|NCT00457665|521827462|FG000|12 Months|Drug allergy|1|||
144719652|NCT00457665|521827463|FG001|12 Months|Drug allergy|1|||
144719653|NCT00457665|521827462|FG000|12 Months|High HIV viral load|5|||
144719654|NCT00457665|521827463|FG001|12 Months|High HIV viral load|1|||
144719655|NCT00457665|521827462|FG000|12 Months|Lipodystrophy|2|||
144719656|NCT00457665|521827463|FG001|12 Months|Lipodystrophy|0|||
144719657|NCT00457665|521827462|FG000|12 Months|Withdrawal by Subject|0|||
144719658|NCT00457665|521827463|FG001|12 Months|Withdrawal by Subject|2|||
144719659|NCT00457665|521827462|FG000|12 Months|Abnormal Liver function tests|0|||
144497120|NCT04580407|521016567|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
144497121|NCT02068885|521016572|FG000|Overall Study|Withdrew|3|||
144497122|NCT02068885|521016573|FG001|Overall Study|Withdrew|5|||
144497123|NCT02068885|521016574|FG002|Overall Study|Withdrew|8|||
144497124|NCT00681811|521016575|FG000|Overall Study|Adverse Event|1|||
144497125|NCT00681811|521016576|FG001|Overall Study|Adverse Event|1|||
144497126|NCT00681811|521016575|FG000|Overall Study|Withdrawal by Subject|2|||
144497127|NCT00681811|521016576|FG001|Overall Study|Withdrawal by Subject|2|||
144719660|NCT00457665|521827463|FG001|12 Months|Abnormal Liver function tests|5|||
144719661|NCT00457665|521827462|FG000|24 Months|Withdrawal by Subject|3|||
144719662|NCT00457665|521827463|FG001|24 Months|Withdrawal by Subject|2|||
144719663|NCT00457665|521827462|FG000|24 Months|Lipodystrophy|1|||
144719664|NCT00457665|521827463|FG001|24 Months|Lipodystrophy|1|||
144719665|NCT00457665|521827462|FG000|24 Months|Abnormal liver function tests|1|||
144719666|NCT00457665|521827463|FG001|24 Months|Abnormal liver function tests|5|||
144719667|NCT02535000|521827465|FG000|Overall Study|Cancellation of surgery.|1|||
144497128|NCT00681811|521016575|FG000|Overall Study|Non-compliance|0|||
144497129|NCT00681811|521016576|FG001|Overall Study|Non-compliance|1|||
144497130|NCT01562743|521016584|FG000|Overall Study|Adverse Event|29|||
144497131|NCT01562743|521016584|FG000|Overall Study|Lack of Efficacy|3|||
144497132|NCT01562743|521016584|FG000|Overall Study|Withdrawal by Subject|13|||
144497133|NCT01562743|521016584|FG000|Overall Study|Protocol Violation|1|||
144497134|NCT01562743|521016584|FG000|Overall Study|Discontinuation criteria|2|||
144497135|NCT01562743|521016584|FG000|Overall Study|Lost to Follow-up|2|||
144497136|NCT01562743|521016584|FG000|Overall Study|Physician Decision|2|||
144497137|NCT04155424|521016586|FG000|Overall Study|Other than specified|3|||
144497138|NCT04155424|521016586|FG000|Overall Study|Withdrawal by Subject|1|||
144497139|NCT04155424|521016586|FG000|Overall Study|Adverse Event|1|||
144497140|NCT04159506|521016587|FG000|Overall Study|Lost to Follow-up|2|||
144497141|NCT04159506|521016588|FG001|Overall Study|Lost to Follow-up|5|||
144497142|NCT02449044|521016589|FG000|Overall Study|Lost to Follow-up|2|||
144497143|NCT02449044|521016589|FG000|Overall Study|Withdrawal by Subject|13|||
144497144|NCT02449044|521016589|FG000|Overall Study|Adverse Event|30|||
144497145|NCT02449044|521016589|FG000|Overall Study|Met Withdrawal Criteria|7|||
144497146|NCT02449044|521016589|FG000|Overall Study|Physician Decision|9|||
144497147|NCT02449044|521016589|FG000|Overall Study|Sponsor Discontinued Trial|3|||
144497148|NCT00662909|521016591|FG000|Overall Study|Adverse Event|17|||
144497149|NCT00662909|521016592|FG001|Overall Study|Adverse Event|18|||
144719668|NCT02535000|521827466|FG001|Overall Study|Cancellation of surgery.|2|||
144719669|NCT01620489|521827472|FG000|Overall Study|Adverse Event|17|||
144719670|NCT01620489|521827473|FG001|Overall Study|Adverse Event|4|||
144719671|NCT01620489|521827472|FG000|Overall Study|Protocol Violation|0|||
144719672|NCT01620489|521827473|FG001|Overall Study|Protocol Violation|3|||
144497150|NCT00662909|521016593|FG002|Overall Study|Adverse Event|19|||
144497151|NCT00662909|521016591|FG000|Overall Study|Lack of Efficacy|9|||
144497152|NCT00662909|521016592|FG001|Overall Study|Lack of Efficacy|1|||
144497153|NCT00662909|521016593|FG002|Overall Study|Lack of Efficacy|5|||
144719673|NCT01620489|521827472|FG000|Overall Study|Withdrawal Criteria|17|||
144719674|NCT01620489|521827473|FG001|Overall Study|Withdrawal Criteria|25|||
144719675|NCT01620489|521827472|FG000|Overall Study|Unclassified|1|||
144497154|NCT00662909|521016591|FG000|Overall Study|Withdrawal by Subject|29|||
144497155|NCT00662909|521016592|FG001|Overall Study|Withdrawal by Subject|22|||
144497156|NCT00662909|521016593|FG002|Overall Study|Withdrawal by Subject|16|||
144497157|NCT00662909|521016591|FG000|Overall Study|Lost to Follow-up|2|||
144497158|NCT00662909|521016592|FG001|Overall Study|Lost to Follow-up|9|||
144497159|NCT00662909|521016593|FG002|Overall Study|Lost to Follow-up|3|||
144497160|NCT00662909|521016591|FG000|Overall Study|Protocol Violation|7|||
144497161|NCT00662909|521016592|FG001|Overall Study|Protocol Violation|4|||
144497162|NCT00662909|521016593|FG002|Overall Study|Protocol Violation|5|||
144497163|NCT00662909|521016591|FG000|Overall Study|Randomized- never received study drug|1|||
144497164|NCT00662909|521016592|FG001|Overall Study|Randomized- never received study drug|0|||
144497165|NCT00662909|521016593|FG002|Overall Study|Randomized- never received study drug|0|||
144497166|NCT00662909|521016591|FG000|Overall Study|Non-compliance with study procedures|3|||
144497167|NCT00662909|521016592|FG001|Overall Study|Non-compliance with study procedures|3|||
144497168|NCT00662909|521016593|FG002|Overall Study|Non-compliance with study procedures|2|||
144497169|NCT00662909|521016591|FG000|Overall Study|Physician Decision|1|||
144497170|NCT00662909|521016592|FG001|Overall Study|Physician Decision|1|||
144497171|NCT00662909|521016593|FG002|Overall Study|Physician Decision|2|||
144497172|NCT00662909|521016591|FG000|Overall Study|Eligibility criterion not met|0|||
144497173|NCT00662909|521016592|FG001|Overall Study|Eligibility criterion not met|1|||
144497174|NCT00662909|521016593|FG002|Overall Study|Eligibility criterion not met|1|||
144497175|NCT03613129|521018266|FG000|Pre-treatment Assessment|Protocol Violation|2|||
144497176|NCT03613129|521018267|FG001|Pre-treatment Assessment|Protocol Violation|0|||
144497177|NCT03613129|521018268|FG002|Pre-treatment Assessment|Protocol Violation|0|||
144497178|NCT03613129|521018269|FG003|Pre-treatment Assessment|Protocol Violation|0|||
144497179|NCT03613129|521018270|FG004|Pre-treatment Assessment|Protocol Violation|0|||
144497180|NCT03613129|521018266|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
144497181|NCT03613129|521018267|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
144497182|NCT03613129|521018268|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
144497183|NCT03613129|521018269|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
144497184|NCT03613129|521018270|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
144497185|NCT00938340|521018271|FG000|Overall Study|Withdrawal by Subject|3|||
144497186|NCT00938340|521018271|FG000|Overall Study|Protocol Violation|1|||
144497187|NCT00938340|521018271|FG000|Overall Study|Adverse Event|1|||
144497188|NCT02534896|521018272|FG000|Overall Study|Adverse Event|2|||
144497189|NCT02534896|521018273|FG001|Overall Study|Adverse Event|1|||
144497190|NCT02534896|521018274|FG002|Overall Study|Adverse Event|1|||
144497191|NCT02534896|521018272|FG000|Overall Study|Insufficient therapeutic response|2|||
144497192|NCT02534896|521018273|FG001|Overall Study|Insufficient therapeutic response|0|||
144497193|NCT02534896|521018274|FG002|Overall Study|Insufficient therapeutic response|0|||
144497194|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
144497195|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
144497196|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
144497197|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
144497198|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Adverse Event|198|||
144497199|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Adverse Event|0|||
144497200|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Adverse Event|0|||
144497201|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Adverse Event|0|||
144497202|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Death|62|||
144497203|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Death|0|||
144497204|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Death|0|||
144497205|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Death|0|||
144497206|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
144497207|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
144497208|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
144497209|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
144497210|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Complicating disease|13|||
144497211|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Complicating disease|0|||
144497212|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Complicating disease|0|||
144497213|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Complicating disease|0|||
144497214|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
144497215|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
144497216|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
144497217|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
144497218|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
144497219|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
144497220|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
144497221|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
144497222|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Non-compliance|4|||
144497223|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Non-compliance|0|||
144497224|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Non-compliance|0|||
144497225|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Non-compliance|0|||
144497226|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Pain|4|||
144497227|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Pain|0|||
144497228|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Pain|0|||
144497229|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Pain|0|||
144497230|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
144497231|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
144497232|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
144497233|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
144497234|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Hospice care|1|||
144497235|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Hospice care|0|||
144497236|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Hospice care|0|||
144497237|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Hospice care|0|||
144497238|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Physician Decision|1|||
144497239|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Physician Decision|0|||
144497240|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Physician Decision|0|||
144497241|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Physician Decision|0|||
144497242|NCT01107626|521018279|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
144497243|NCT01107626|521018280|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
144497244|NCT01107626|521018281|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
144497245|NCT01107626|521018282|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
144497246|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
144497247|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
144497248|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
144497249|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
144497250|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
144497251|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
144497252|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
144497253|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
144497254|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Death|0|||
144497255|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Death|8|||
144497256|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Death|2|||
144497257|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Death|13|||
144497258|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
144497259|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
144497260|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
144497261|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
144497262|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
144497263|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
144497264|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
144497265|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
144497266|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
144497267|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
144497268|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
144497269|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
144497270|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
144497271|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
144497272|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
144497273|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
144497274|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
144497275|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
144497276|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
144497277|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
144719676|NCT01620489|521827473|FG001|Overall Study|Unclassified|2|||
144719677|NCT01851590|521827476|FG000|Overall Study|Withdrawal by Subject|0|||
144719678|NCT01851590|521827477|FG001|Overall Study|Withdrawal by Subject|0|||
144497278|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
144497279|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
144497280|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
144497281|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
144497282|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
144497283|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
144497284|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
144497285|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
144497286|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
144497287|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
144497288|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
144497289|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
144497290|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
144497291|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
144497292|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
144497293|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
144497294|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
144497295|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
144497296|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
144497297|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
144497298|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Pain|0|||
144497299|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Pain|0|||
144497300|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Pain|0|||
144497301|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Pain|1|||
144497302|NCT01107626|521018279|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
144497303|NCT01107626|521018280|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
144497304|NCT01107626|521018281|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
144497305|NCT01107626|521018282|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
144497306|NCT03441360|521018283|FG000|Overall Study|Radiological disease progression|5|||
144497307|NCT03441360|521018284|FG001|Overall Study|Radiological disease progression|6|||
144497308|NCT03441360|521018285|FG002|Overall Study|Radiological disease progression|4|||
144497309|NCT03441360|521018283|FG000|Overall Study|Clinical disease progression|2|||
144497310|NCT03441360|521018284|FG001|Overall Study|Clinical disease progression|2|||
144497311|NCT03441360|521018285|FG002|Overall Study|Clinical disease progression|0|||
144497312|NCT03441360|521018283|FG000|Overall Study|Adverse Event|1|||
144497313|NCT03441360|521018284|FG001|Overall Study|Adverse Event|0|||
144497314|NCT03441360|521018285|FG002|Overall Study|Adverse Event|1|||
144497315|NCT00269399|521018286|FG000|Overall Study|Lack of Efficacy|27|||
144497316|NCT00269399|521018287|FG001|Overall Study|Lack of Efficacy|10|||
144497317|NCT00269399|521018286|FG000|Overall Study|Adverse Event|10|||
144497318|NCT00269399|521018287|FG001|Overall Study|Adverse Event|4|||
144497319|NCT00269399|521018286|FG000|Overall Study|Withdrawal by Subject|2|||
144497320|NCT00269399|521018287|FG001|Overall Study|Withdrawal by Subject|5|||
144497321|NCT00269399|521018286|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
144497322|NCT00269399|521018287|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
144497323|NCT00269399|521018286|FG000|Overall Study|Other|0|||
144497324|NCT00269399|521018287|FG001|Overall Study|Other|4|||
144497325|NCT00269399|521018286|FG000|Overall Study|Development of exclusion criteria|0|||
144497326|NCT00269399|521018287|FG001|Overall Study|Development of exclusion criteria|1|||
144497327|NCT04310579|521018289|FG000|Overall Study|Adverse Event|0|||
144497328|NCT04310579|521018290|FG001|Overall Study|Adverse Event|0|||
144497329|NCT04310579|521018291|FG002|Overall Study|Adverse Event|0|||
144497330|NCT04310579|521018292|FG003|Overall Study|Adverse Event|0|||
144497331|NCT04310579|521018293|FG004|Overall Study|Adverse Event|0|||
144497332|NCT04310579|521018294|FG005|Overall Study|Adverse Event|0|||
144497333|NCT04310579|521018295|FG006|Overall Study|Adverse Event|2|||
144497334|NCT04310579|521018296|FG007|Overall Study|Adverse Event|0|||
144497335|NCT04310579|521018297|FG008|Overall Study|Adverse Event|1|||
144497336|NCT04310579|521018298|FG009|Overall Study|Adverse Event|1|||
144497337|NCT04310579|521018299|FG010|Overall Study|Adverse Event|0|||
144497338|NCT04310579|521018289|FG000|Overall Study|Withdrawal by Subject|0|||
144497339|NCT04310579|521018290|FG001|Overall Study|Withdrawal by Subject|0|||
144497340|NCT04310579|521018291|FG002|Overall Study|Withdrawal by Subject|0|||
144497341|NCT04310579|521018292|FG003|Overall Study|Withdrawal by Subject|0|||
144497342|NCT04310579|521018293|FG004|Overall Study|Withdrawal by Subject|0|||
144497343|NCT04310579|521018294|FG005|Overall Study|Withdrawal by Subject|1|||
144497344|NCT04310579|521018295|FG006|Overall Study|Withdrawal by Subject|0|||
144497345|NCT04310579|521018296|FG007|Overall Study|Withdrawal by Subject|0|||
144497346|NCT04310579|521018297|FG008|Overall Study|Withdrawal by Subject|0|||
144497347|NCT04310579|521018298|FG009|Overall Study|Withdrawal by Subject|0|||
144497348|NCT04310579|521018299|FG010|Overall Study|Withdrawal by Subject|0|||
144497349|NCT04310579|521018289|FG000|Overall Study|Positive COVID-19 test|0|||
144497350|NCT04310579|521018290|FG001|Overall Study|Positive COVID-19 test|0|||
144497351|NCT04310579|521018291|FG002|Overall Study|Positive COVID-19 test|0|||
144497352|NCT04310579|521018292|FG003|Overall Study|Positive COVID-19 test|0|||
144497353|NCT04310579|521018293|FG004|Overall Study|Positive COVID-19 test|0|||
144497354|NCT04310579|521018294|FG005|Overall Study|Positive COVID-19 test|0|||
144497355|NCT04310579|521018295|FG006|Overall Study|Positive COVID-19 test|0|||
144497356|NCT04310579|521018296|FG007|Overall Study|Positive COVID-19 test|0|||
144497357|NCT04310579|521018297|FG008|Overall Study|Positive COVID-19 test|0|||
144497358|NCT04310579|521018298|FG009|Overall Study|Positive COVID-19 test|0|||
144497359|NCT04310579|521018299|FG010|Overall Study|Positive COVID-19 test|1|||
144497360|NCT03467724|521018300|FG000|Overall Study|Lost to Follow-up|5|||
144497361|NCT03467724|521018300|FG000|Overall Study|Withdrawal by Subject|1|||
144497362|NCT03467724|521018300|FG000|Overall Study|Protocol Violation|1|||
144497363|NCT03467724|521018300|FG000|Overall Study|Adverse Event|1|||
144497364|NCT02236559|521018310|FG000|Overall Study|Met Exclusion|3|||
144497365|NCT02236559|521018311|FG001|Overall Study|Met Exclusion|6|||
144497366|NCT02236559|521018310|FG000|Overall Study|Did not Meet Inclusion|3|||
144497367|NCT02236559|521018311|FG001|Overall Study|Did not Meet Inclusion|3|||
144497368|NCT02236559|521018310|FG000|Overall Study|Subject Did Not Consent|4|||
144497369|NCT02236559|521018311|FG001|Overall Study|Subject Did Not Consent|2|||
144497370|NCT02236559|521018310|FG000|Overall Study|Physician Decision|1|||
144497371|NCT02236559|521018311|FG001|Overall Study|Physician Decision|1|||
144497372|NCT02236559|521018310|FG000|Overall Study|Withdrawal by Subject|1|||
144497373|NCT02236559|521018311|FG001|Overall Study|Withdrawal by Subject|0|||
144497374|NCT02049866|521018312|FG000|Overall Study|Withdrawal by Subject|1|||
144497375|NCT01117480|521018313|FG000|Overall Study|Protocol Violation|8|||
144497376|NCT01117480|521018313|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
144497377|NCT03721016|521018314|FG000|Overall Study|Adverse Event|0|||
144497378|NCT03721016|521018315|FG001|Overall Study|Adverse Event|1|||
144497379|NCT03721016|521018316|FG002|Overall Study|Adverse Event|1|||
144497380|NCT03721016|521018314|FG000|Overall Study|Withdrawal by Subject|8|||
144497381|NCT03721016|521018315|FG001|Overall Study|Withdrawal by Subject|16|||
144497382|NCT03721016|521018316|FG002|Overall Study|Withdrawal by Subject|13|||
144497383|NCT03721016|521018314|FG000|Overall Study|Lost to Follow-up|4|||
144497384|NCT03721016|521018315|FG001|Overall Study|Lost to Follow-up|6|||
144497385|NCT03721016|521018316|FG002|Overall Study|Lost to Follow-up|5|||
144497386|NCT03721016|521018314|FG000|Overall Study|Physician Decision|0|||
144497387|NCT03721016|521018315|FG001|Overall Study|Physician Decision|1|||
144497388|NCT03721016|521018316|FG002|Overall Study|Physician Decision|2|||
144497389|NCT03721016|521018314|FG000|Overall Study|Protocol Violation|0|||
144497390|NCT03721016|521018315|FG001|Overall Study|Protocol Violation|1|||
144497391|NCT03721016|521018316|FG002|Overall Study|Protocol Violation|0|||
144497392|NCT03721016|521018314|FG000|Overall Study|Site terminated by sponsor|3|||
144497393|NCT03721016|521018315|FG001|Overall Study|Site terminated by sponsor|7|||
144497394|NCT03721016|521018316|FG002|Overall Study|Site terminated by sponsor|6|||
144497395|NCT03721016|521018314|FG000|Overall Study|Subject exited early due to COVID-19|1|||
144497396|NCT03721016|521018315|FG001|Overall Study|Subject exited early due to COVID-19|0|||
144497397|NCT03721016|521018316|FG002|Overall Study|Subject exited early due to COVID-19|0|||
144497398|NCT04353037|521018318|FG000|Overall Study|Lost to Follow-up|0|||
144497399|NCT04353037|521018319|FG001|Overall Study|Lost to Follow-up|1|||
144497400|NCT04353037|521018320|FG002|Overall Study|Lost to Follow-up|2|||
144497401|NCT04353037|521018321|FG003|Overall Study|Lost to Follow-up|3|||
144497402|NCT04353037|521018318|FG000|Overall Study|Withdrawal by Subject|0|||
144497403|NCT04353037|521018319|FG001|Overall Study|Withdrawal by Subject|2|||
144497404|NCT04353037|521018320|FG002|Overall Study|Withdrawal by Subject|3|||
144497405|NCT04353037|521018321|FG003|Overall Study|Withdrawal by Subject|5|||
144497406|NCT04353037|521018318|FG000|Overall Study|Adverse Event|0|||
144497407|NCT04353037|521018319|FG001|Overall Study|Adverse Event|0|||
144497408|NCT04353037|521018320|FG002|Overall Study|Adverse Event|2|||
144497409|NCT04353037|521018321|FG003|Overall Study|Adverse Event|0|||
144497410|NCT04353037|521018318|FG000|Overall Study|Exposure Change|0|||
144497411|NCT04353037|521018319|FG001|Overall Study|Exposure Change|0|||
144497412|NCT04353037|521018320|FG002|Overall Study|Exposure Change|0|||
144497413|NCT04353037|521018321|FG003|Overall Study|Exposure Change|2|||
144497414|NCT00817635|521018322|FG000|Overall Study|Adverse Event|1|||
144497415|NCT00817635|521018323|FG001|Overall Study|Adverse Event|0|||
144497416|NCT00817635|521018324|FG002|Overall Study|Adverse Event|0|||
144497417|NCT00817635|521018325|FG003|Overall Study|Adverse Event|1|||
144497418|NCT00817635|521018326|FG004|Overall Study|Adverse Event|1|||
144497419|NCT00817635|521018322|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
144497420|NCT00817635|521018323|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
144497421|NCT00817635|521018324|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
144497422|NCT00817635|521018325|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
144497423|NCT00817635|521018326|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
144497424|NCT00817635|521018322|FG000|Overall Study|Withdrawal by Subject|2|||
144497425|NCT00817635|521018323|FG001|Overall Study|Withdrawal by Subject|1|||
144497426|NCT00817635|521018324|FG002|Overall Study|Withdrawal by Subject|0|||
144497427|NCT00817635|521018325|FG003|Overall Study|Withdrawal by Subject|1|||
144497428|NCT00817635|521018326|FG004|Overall Study|Withdrawal by Subject|2|||
144497429|NCT00817635|521018322|FG000|Overall Study|Lost to Follow-up|0|||
144497430|NCT00817635|521018323|FG001|Overall Study|Lost to Follow-up|1|||
144497431|NCT00817635|521018324|FG002|Overall Study|Lost to Follow-up|0|||
144497432|NCT00817635|521018325|FG003|Overall Study|Lost to Follow-up|1|||
144497433|NCT00817635|521018326|FG004|Overall Study|Lost to Follow-up|0|||
144497434|NCT00817635|521018322|FG000|Overall Study|Administrative Problems|0|||
144497435|NCT00817635|521018323|FG001|Overall Study|Administrative Problems|0|||
144497436|NCT00817635|521018324|FG002|Overall Study|Administrative Problems|0|||
144497437|NCT00817635|521018325|FG003|Overall Study|Administrative Problems|0|||
144497438|NCT00817635|521018326|FG004|Overall Study|Administrative Problems|1|||
144497439|NCT00817635|521018322|FG000|Overall Study|Protocol Violation|5|||
144497440|NCT00817635|521018323|FG001|Overall Study|Protocol Violation|1|||
144497441|NCT00817635|521018324|FG002|Overall Study|Protocol Violation|3|||
144497442|NCT00817635|521018325|FG003|Overall Study|Protocol Violation|2|||
144497443|NCT00817635|521018326|FG004|Overall Study|Protocol Violation|3|||
144497444|NCT03710564|521018327|FG000|Overall Study|Study Terminated by Sponsor|104|||
144497445|NCT03710564|521018328|FG001|Overall Study|Study Terminated by Sponsor|55|||
144497446|NCT03710564|521018327|FG000|Overall Study|Withdrawal by Subject|57|||
144497447|NCT03710564|521018328|FG001|Overall Study|Withdrawal by Subject|25|||
144497448|NCT03710564|521018327|FG000|Overall Study|Death|10|||
144497449|NCT03710564|521018328|FG001|Overall Study|Death|4|||
144497450|NCT03710564|521018327|FG000|Overall Study|Lost to Follow-up|5|||
144497451|NCT03710564|521018328|FG001|Overall Study|Lost to Follow-up|4|||
144497452|NCT03710564|521018327|FG000|Overall Study|Protocol Violation|3|||
144497453|NCT03710564|521018328|FG001|Overall Study|Protocol Violation|2|||
144497454|NCT03710564|521018327|FG000|Overall Study|Adverse Event|3|||
144497455|NCT03710564|521018328|FG001|Overall Study|Adverse Event|0|||
144497456|NCT03710564|521018327|FG000|Overall Study|Physician Decision|2|||
144497457|NCT03710564|521018328|FG001|Overall Study|Physician Decision|3|||
144497458|NCT01167426|521018329|FG000|Overall Study|Lost to Follow-up|6|||
144497459|NCT01167426|521018329|FG000|Overall Study|Protocol Violation|1|||
144497460|NCT01167426|521018329|FG000|Overall Study|Withdrawal by Subject|2|||
144497461|NCT01167426|521018329|FG000|Overall Study|Sponsor Decision|1|||
144497462|NCT02219490|521018333|FG000|Overall Study|Adverse Event|24|||
144497463|NCT02219490|521018333|FG000|Overall Study|Withdrew consent|96|||
144497464|NCT02219490|521018333|FG000|Overall Study|Lost to Follow-up|126|||
144497465|NCT02219490|521018333|FG000|Overall Study|COVID-19 infection|2|||
144497466|NCT02219490|521018333|FG000|Overall Study|COVID-19 logistical restrictions|33|||
144497467|NCT02219490|521018333|FG000|Overall Study|Other, not specified|57|||
144497468|NCT00335556|521018334|FG000|Overall Study|Death|0|||
144497469|NCT00335556|521018335|FG001|Overall Study|Death|5|||
144497470|NCT00335556|521018336|FG002|Overall Study|Death|0|||
144497471|NCT00335556|521018337|FG003|Overall Study|Death|0|||
144497472|NCT00335556|521018338|FG004|Overall Study|Death|1|||
144497473|NCT00335556|521018339|FG005|Overall Study|Death|0|||
144497474|NCT00335556|521018334|FG000|Overall Study|Lack of Efficacy|0|||
144497475|NCT00335556|521018335|FG001|Overall Study|Lack of Efficacy|19|||
144497476|NCT00335556|521018336|FG002|Overall Study|Lack of Efficacy|3|||
144497477|NCT00335556|521018337|FG003|Overall Study|Lack of Efficacy|3|||
144497478|NCT00335556|521018338|FG004|Overall Study|Lack of Efficacy|0|||
144497479|NCT00335556|521018339|FG005|Overall Study|Lack of Efficacy|1|||
144497480|NCT00335556|521018334|FG000|Overall Study|Physician Decision|0|||
144497481|NCT00335556|521018335|FG001|Overall Study|Physician Decision|6|||
144497482|NCT00335556|521018336|FG002|Overall Study|Physician Decision|2|||
144497483|NCT00335556|521018337|FG003|Overall Study|Physician Decision|1|||
144497484|NCT00335556|521018338|FG004|Overall Study|Physician Decision|0|||
144497485|NCT00335556|521018339|FG005|Overall Study|Physician Decision|0|||
144497486|NCT00335556|521018334|FG000|Overall Study|Ineligible|2|||
144497487|NCT00335556|521018335|FG001|Overall Study|Ineligible|0|||
144497488|NCT00335556|521018336|FG002|Overall Study|Ineligible|0|||
144497489|NCT00335556|521018337|FG003|Overall Study|Ineligible|0|||
144497490|NCT00335556|521018338|FG004|Overall Study|Ineligible|0|||
144497491|NCT00335556|521018339|FG005|Overall Study|Ineligible|0|||
144497492|NCT00335556|521018334|FG000|Overall Study|Refusal of further protocol therapy|0|||
144497493|NCT00335556|521018335|FG001|Overall Study|Refusal of further protocol therapy|4|||
144497494|NCT00335556|521018336|FG002|Overall Study|Refusal of further protocol therapy|0|||
144497495|NCT00335556|521018337|FG003|Overall Study|Refusal of further protocol therapy|1|||
144497496|NCT00335556|521018338|FG004|Overall Study|Refusal of further protocol therapy|0|||
144497497|NCT00335556|521018339|FG005|Overall Study|Refusal of further protocol therapy|0|||
144497498|NCT02365298|521018341|FG000|Period 2|incorrect Rx dispensed|1|||
144497499|NCT02365298|521018342|FG001|Period 2|incorrect Rx dispensed|0|||
144497500|NCT02365298|521018341|FG000|Period 2|Discontinued at request of Sponsor|1|||
144497501|NCT02365298|521018342|FG001|Period 2|Discontinued at request of Sponsor|0|||
144497502|NCT02365298|521018341|FG000|Period 2|Test Article longer available|0|||
144497503|NCT02365298|521018342|FG001|Period 2|Test Article longer available|1|||
144497504|NCT02365298|521018341|FG000|Period 2|Protocol Violation|0|||
144497505|NCT02365298|521018342|FG001|Period 2|Protocol Violation|1|||
144497506|NCT02974010|521018345|FG000|Overall Study|Lost to Follow-up|3|||
144497507|NCT02974010|521018346|FG001|Overall Study|Lost to Follow-up|1|||
144497508|NCT02974010|521018347|FG002|Overall Study|Lost to Follow-up|0|||
144497509|NCT02974010|521018348|FG003|Overall Study|Lost to Follow-up|0|||
144497510|NCT02974010|521018345|FG000|Overall Study|Withdrawal by Subject|2|||
144497511|NCT02974010|521018346|FG001|Overall Study|Withdrawal by Subject|1|||
144497512|NCT02974010|521018347|FG002|Overall Study|Withdrawal by Subject|0|||
144497513|NCT02974010|521018348|FG003|Overall Study|Withdrawal by Subject|0|||
144497514|NCT02974010|521018345|FG000|Overall Study|Adverse Event|0|||
144497515|NCT02974010|521018346|FG001|Overall Study|Adverse Event|1|||
144497516|NCT02974010|521018347|FG002|Overall Study|Adverse Event|0|||
144497517|NCT02974010|521018348|FG003|Overall Study|Adverse Event|0|||
144497518|NCT02974010|521018345|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
144497519|NCT02974010|521018346|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
144497520|NCT02974010|521018347|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
144497521|NCT02974010|521018348|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
144497522|NCT02974010|521018345|FG000|Overall Study|Lack of Efficacy|0|||
144497523|NCT02974010|521018346|FG001|Overall Study|Lack of Efficacy|0|||
144719679|NCT01851590|521827478|FG002|Overall Study|Withdrawal by Subject|1|||
144719680|NCT01851590|521827476|FG000|Overall Study|Adverse Event|0|||
144719681|NCT01851590|521827477|FG001|Overall Study|Adverse Event|0|||
144719682|NCT01851590|521827478|FG002|Overall Study|Adverse Event|2|||
144719683|NCT01851590|521827476|FG000|Overall Study|Lack of Efficacy|0|||
144719684|NCT01851590|521827477|FG001|Overall Study|Lack of Efficacy|1|||
144719685|NCT01851590|521827478|FG002|Overall Study|Lack of Efficacy|0|||
144719686|NCT00696709|521827479|FG000|Overall Study|Withdrawal by Subject|1|||
144719687|NCT00696709|521827480|FG001|Overall Study|Withdrawal by Subject|2|||
144719688|NCT00696709|521827481|FG002|Overall Study|Withdrawal by Subject|1|||
144719689|NCT00696709|521827482|FG003|Overall Study|Withdrawal by Subject|4|||
144719690|NCT00696709|521827483|FG004|Overall Study|Withdrawal by Subject|3|||
144719691|NCT00696709|521827479|FG000|Overall Study|Protocol Violation|1|||
144719692|NCT00696709|521827480|FG001|Overall Study|Protocol Violation|0|||
144719693|NCT00696709|521827481|FG002|Overall Study|Protocol Violation|0|||
144719694|NCT00696709|521827482|FG003|Overall Study|Protocol Violation|0|||
144719695|NCT00696709|521827483|FG004|Overall Study|Protocol Violation|0|||
144497524|NCT02974010|521018347|FG002|Overall Study|Lack of Efficacy|1|||
144497525|NCT02974010|521018348|FG003|Overall Study|Lack of Efficacy|0|||
144719696|NCT00696709|521827479|FG000|Overall Study|Lost to Follow-up|1|||
144719697|NCT00696709|521827480|FG001|Overall Study|Lost to Follow-up|1|||
144719698|NCT00696709|521827481|FG002|Overall Study|Lost to Follow-up|0|||
144719699|NCT00696709|521827482|FG003|Overall Study|Lost to Follow-up|0|||
144719700|NCT00696709|521827483|FG004|Overall Study|Lost to Follow-up|0|||
144497526|NCT01941316|521018349|FG000|Overall Study|Adverse Event|0|||
144497527|NCT01941316|521018350|FG001|Overall Study|Adverse Event|1|||
144497528|NCT01941316|521018351|FG002|Overall Study|Adverse Event|0|||
144497529|NCT01941316|521018352|FG003|Overall Study|Adverse Event|7|||
144497530|NCT01941316|521018349|FG000|Overall Study|Progressive Disease|3|||
144497531|NCT01941316|521018350|FG001|Overall Study|Progressive Disease|6|||
144497532|NCT01941316|521018351|FG002|Overall Study|Progressive Disease|2|||
144497533|NCT01941316|521018352|FG003|Overall Study|Progressive Disease|29|||
144497534|NCT01941316|521018349|FG000|Overall Study|Withdrawal by Subject|0|||
144497535|NCT01941316|521018350|FG001|Overall Study|Withdrawal by Subject|2|||
144497536|NCT01941316|521018351|FG002|Overall Study|Withdrawal by Subject|1|||
144497537|NCT01941316|521018352|FG003|Overall Study|Withdrawal by Subject|8|||
144497538|NCT01941316|521018349|FG000|Overall Study|Death|0|||
144497539|NCT01941316|521018350|FG001|Overall Study|Death|0|||
144497540|NCT01941316|521018351|FG002|Overall Study|Death|0|||
144497541|NCT01941316|521018352|FG003|Overall Study|Death|3|||
144497542|NCT01941316|521018349|FG000|Overall Study|Physician Decision|0|||
144497543|NCT01941316|521018350|FG001|Overall Study|Physician Decision|0|||
144497544|NCT01941316|521018351|FG002|Overall Study|Physician Decision|0|||
144497545|NCT01941316|521018352|FG003|Overall Study|Physician Decision|3|||
144497546|NCT01941316|521018349|FG000|Overall Study|Protocol Violation|0|||
144497547|NCT01941316|521018350|FG001|Overall Study|Protocol Violation|0|||
144497548|NCT01941316|521018351|FG002|Overall Study|Protocol Violation|0|||
144497549|NCT01941316|521018352|FG003|Overall Study|Protocol Violation|3|||
144370071|NCT02379091|520562804|FG003|Overall Study|Principal Investigator Discretion|0|||
144497550|NCT01941316|521018349|FG000|Overall Study|Intercurrent illness|0|||
144497551|NCT01941316|521018350|FG001|Overall Study|Intercurrent illness|0|||
144497552|NCT01941316|521018351|FG002|Overall Study|Intercurrent illness|0|||
144497553|NCT01941316|521018352|FG003|Overall Study|Intercurrent illness|1|||
144497554|NCT01941316|521018349|FG000|Overall Study|Other, not specified|0|||
144497555|NCT01941316|521018350|FG001|Overall Study|Other, not specified|0|||
144497556|NCT01941316|521018351|FG002|Overall Study|Other, not specified|0|||
144497557|NCT01941316|521018352|FG003|Overall Study|Other, not specified|1|||
144497558|NCT02775435|521018353|FG000|Overall Study|Adverse Event|32|||
144497559|NCT02775435|521018354|FG001|Overall Study|Adverse Event|27|||
144497560|NCT02775435|521018353|FG000|Overall Study|Lost to Follow-up|2|||
144497561|NCT02775435|521018354|FG001|Overall Study|Lost to Follow-up|2|||
144497562|NCT02775435|521018353|FG000|Overall Study|Sponsor decision|44|||
144497563|NCT02775435|521018354|FG001|Overall Study|Sponsor decision|19|||
144497564|NCT02775435|521018353|FG000|Overall Study|Withdrawal by Subject|4|||
144497565|NCT02775435|521018354|FG001|Overall Study|Withdrawal by Subject|9|||
144497566|NCT02775435|521018353|FG000|Overall Study|Death|196|||
144497567|NCT02775435|521018354|FG001|Overall Study|Death|224|||
144497568|NCT04555044|521018359|FG000|Overall Study|Adverse Event|0|||
144497569|NCT04555044|521018360|FG001|Overall Study|Adverse Event|1|||
144497570|NCT04088188|521018362|FG000|Overall Study|Withdrawal by Subject|2|||
144497571|NCT04088188|521018363|FG001|Overall Study|Withdrawal by Subject|0|||
144497572|NCT04088188|521018362|FG000|Overall Study|Adverse Event|2|||
144497573|NCT04088188|521018363|FG001|Overall Study|Adverse Event|0|||
144497574|NCT01670019|521018368|FG000|Overall Study|Adverse Event|3|||
144497575|NCT01670019|521018369|FG001|Overall Study|Adverse Event|0|||
144497576|NCT01670019|521018368|FG000|Overall Study|Withdrawal by Subject|6|||
144497577|NCT01670019|521018369|FG001|Overall Study|Withdrawal by Subject|0|||
144497578|NCT03601507|521018370|FG000|Overall Study|Adverse Event|1|||
144497579|NCT02107014|521018374|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
144497580|NCT03761784|521018375|FG000|Overall Study|Adverse Event|4|||
144497581|NCT03761784|521018376|FG001|Overall Study|Adverse Event|0|||
144497582|NCT03761784|521018375|FG000|Overall Study|Lost to Follow-up|10|||
144497583|NCT03761784|521018376|FG001|Overall Study|Lost to Follow-up|7|||
144370072|NCT02379091|520562801|FG000|Overall Study|Lost to Follow-up|0|||
144497584|NCT03761784|521018375|FG000|Overall Study|Pregnancy|1|||
144497585|NCT03761784|521018376|FG001|Overall Study|Pregnancy|0|||
144497586|NCT03761784|521018375|FG000|Overall Study|Protocol Violation|2|||
144497587|NCT03761784|521018376|FG001|Overall Study|Protocol Violation|0|||
144497588|NCT03761784|521018375|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
144719701|NCT00696709|521827479|FG000|Overall Study|Adverse Event|0|||
144719702|NCT00696709|521827480|FG001|Overall Study|Adverse Event|0|||
144719703|NCT00696709|521827481|FG002|Overall Study|Adverse Event|0|||
144719704|NCT00696709|521827482|FG003|Overall Study|Adverse Event|1|||
144719705|NCT00696709|521827483|FG004|Overall Study|Adverse Event|0|||
144719706|NCT00310856|521827484|FG000|Overall Study|Withdrawal by Subject|2|||
144719707|NCT00310856|521827485|FG001|Overall Study|Withdrawal by Subject|2|||
144719708|NCT00310856|521827486|FG002|Overall Study|Withdrawal by Subject|2|||
144719709|NCT00310856|521827484|FG000|Overall Study|Lost to Follow-up|1|||
144719710|NCT00310856|521827485|FG001|Overall Study|Lost to Follow-up|2|||
144719711|NCT00310856|521827486|FG002|Overall Study|Lost to Follow-up|6|||
144719712|NCT00310856|521827484|FG000|Overall Study|Inappropriate enrollment|1|||
144719713|NCT00310856|521827485|FG001|Overall Study|Inappropriate enrollment|1|||
144719714|NCT00310856|521827486|FG002|Overall Study|Inappropriate enrollment|0|||
144719715|NCT00310856|521827484|FG000|Overall Study|Unable to classify|1|||
144719716|NCT00310856|521827485|FG001|Overall Study|Unable to classify|0|||
144719717|NCT00310856|521827486|FG002|Overall Study|Unable to classify|0|||
144719718|NCT00321711|521827490|FG000|Part A|Adverse Event|3|||
144497589|NCT03761784|521018376|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
144497590|NCT03761784|521018375|FG000|Overall Study|Withdrawal by Subject|9|||
144497591|NCT03761784|521018376|FG001|Overall Study|Withdrawal by Subject|4|||
144497592|NCT03761784|521018375|FG000|Overall Study|Physician Decision|1|||
144497593|NCT03761784|521018376|FG001|Overall Study|Physician Decision|0|||
144497594|NCT03761784|521018375|FG000|Overall Study|Other Than Specified|1|||
144497595|NCT03761784|521018376|FG001|Overall Study|Other Than Specified|0|||
144497596|NCT03852433|521018380|FG000|Overall Study|Withdrawal of consent|5|||
144497597|NCT03852433|521018381|FG001|Overall Study|Withdrawal of consent|8|||
144497598|NCT03852433|521018382|FG002|Overall Study|Withdrawal of consent|1|||
144497599|NCT03852433|521018383|FG003|Overall Study|Withdrawal of consent|1|||
144497600|NCT03852433|521018380|FG000|Overall Study|Adverse Event|1|||
144497601|NCT03852433|521018381|FG001|Overall Study|Adverse Event|1|||
144497602|NCT03852433|521018382|FG002|Overall Study|Adverse Event|1|||
144497603|NCT03852433|521018383|FG003|Overall Study|Adverse Event|1|||
144497604|NCT03852433|521018380|FG000|Overall Study|Lost to Follow-up|0|||
144497605|NCT03852433|521018381|FG001|Overall Study|Lost to Follow-up|1|||
144497606|NCT03852433|521018382|FG002|Overall Study|Lost to Follow-up|0|||
144497607|NCT03852433|521018383|FG003|Overall Study|Lost to Follow-up|1|||
144497608|NCT03852433|521018380|FG000|Overall Study|Pregnancy|0|||
144497609|NCT03852433|521018381|FG001|Overall Study|Pregnancy|1|||
144497610|NCT03852433|521018382|FG002|Overall Study|Pregnancy|1|||
144497611|NCT03852433|521018383|FG003|Overall Study|Pregnancy|0|||
144497612|NCT03852433|521018380|FG000|Overall Study|Protocol Violation|0|||
144497613|NCT03852433|521018381|FG001|Overall Study|Protocol Violation|0|||
144497614|NCT03852433|521018382|FG002|Overall Study|Protocol Violation|1|||
144497615|NCT03852433|521018383|FG003|Overall Study|Protocol Violation|1|||
144497616|NCT03852433|521018380|FG000|Overall Study|Death|0|||
144497617|NCT03852433|521018381|FG001|Overall Study|Death|0|||
144497618|NCT03852433|521018382|FG002|Overall Study|Death|1|||
144497619|NCT03852433|521018383|FG003|Overall Study|Death|0|||
144497620|NCT03852433|521018380|FG000|Overall Study|Lack of Efficacy|0|||
144497621|NCT03852433|521018381|FG001|Overall Study|Lack of Efficacy|1|||
144497622|NCT03852433|521018382|FG002|Overall Study|Lack of Efficacy|0|||
144497623|NCT03852433|521018383|FG003|Overall Study|Lack of Efficacy|0|||
144497624|NCT03852433|521018380|FG000|Overall Study|Non-compliance with study drug|0|||
144497625|NCT03852433|521018381|FG001|Overall Study|Non-compliance with study drug|0|||
144497626|NCT03852433|521018382|FG002|Overall Study|Non-compliance with study drug|0|||
144497627|NCT03852433|521018383|FG003|Overall Study|Non-compliance with study drug|1|||
144497628|NCT03852433|521018380|FG000|Overall Study|Physician Decision|1|||
144497629|NCT03852433|521018381|FG001|Overall Study|Physician Decision|0|||
144497630|NCT03852433|521018382|FG002|Overall Study|Physician Decision|0|||
144497631|NCT03852433|521018383|FG003|Overall Study|Physician Decision|0|||
144497632|NCT03852433|521018380|FG000|Overall Study|Randomized but never treated|1|||
144497633|NCT03852433|521018381|FG001|Overall Study|Randomized but never treated|0|||
144497634|NCT03852433|521018382|FG002|Overall Study|Randomized but never treated|0|||
144497635|NCT03852433|521018383|FG003|Overall Study|Randomized but never treated|0|||
144497636|NCT01981850|521018384|FG000|Main Phase Stage 1|Death|2|||
144497637|NCT01981850|521018385|FG001|Main Phase Stage 1|Death|0|||
144497638|NCT01981850|521018386|FG002|Main Phase Stage 1|Death|0|||
144497639|NCT01981850|521018387|FG003|Main Phase Stage 1|Death|0|||
144497640|NCT01981850|521018388|FG004|Main Phase Stage 1|Death|0|||
144497641|NCT01981850|521018389|FG005|Main Phase Stage 1|Death|0|||
144497642|NCT01981850|521018390|FG006|Main Phase Stage 1|Death|0|||
144719719|NCT00321711|521827491|FG001|Part A|Adverse Event|3|||
144719720|NCT00321711|521827492|FG002|Part A|Adverse Event|2|||
144719721|NCT00321711|521827493|FG003|Part A|Adverse Event|0|||
144719722|NCT00321711|521827494|FG004|Part A|Adverse Event|0|||
144719723|NCT00321711|521827490|FG000|Part A|Withdrawal by Subject|1|||
144719724|NCT00321711|521827491|FG001|Part A|Withdrawal by Subject|1|||
144719725|NCT00321711|521827492|FG002|Part A|Withdrawal by Subject|1|||
144719726|NCT00321711|521827493|FG003|Part A|Withdrawal by Subject|0|||
144719727|NCT00321711|521827494|FG004|Part A|Withdrawal by Subject|0|||
144719728|NCT00321711|521827490|FG000|Part A|Disease progression|0|||
144719729|NCT00321711|521827491|FG001|Part A|Disease progression|1|||
144719730|NCT00321711|521827492|FG002|Part A|Disease progression|0|||
144719731|NCT00321711|521827493|FG003|Part A|Disease progression|0|||
144719732|NCT00321711|521827494|FG004|Part A|Disease progression|0|||
144719733|NCT00321711|521827490|FG000|Part A|Requirement for alternative therapy|0|||
144719734|NCT00321711|521827491|FG001|Part A|Requirement for alternative therapy|2|||
144719735|NCT00321711|521827492|FG002|Part A|Requirement for alternative therapy|1|||
144719736|NCT00321711|521827493|FG003|Part A|Requirement for alternative therapy|0|||
144719737|NCT00321711|521827494|FG004|Part A|Requirement for alternative therapy|0|||
144719738|NCT00321711|521827490|FG000|Part A|Physician Decision|0|||
144719739|NCT00321711|521827491|FG001|Part A|Physician Decision|1|||
144719740|NCT00321711|521827492|FG002|Part A|Physician Decision|3|||
144719741|NCT00321711|521827493|FG003|Part A|Physician Decision|0|||
144497643|NCT01981850|521018391|FG007|Main Phase Stage 1|Death|0|||
144497644|NCT01981850|521018392|FG008|Main Phase Stage 1|Death|0|||
144497645|NCT01981850|521018393|FG009|Main Phase Stage 1|Death|0|||
144497646|NCT01981850|521018384|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
144497647|NCT01981850|521018385|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497648|NCT01981850|521018386|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497649|NCT01981850|521018387|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497650|NCT01981850|521018388|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497651|NCT01981850|521018389|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497652|NCT01981850|521018390|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497653|NCT01981850|521018391|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497654|NCT01981850|521018392|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497655|NCT01981850|521018393|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
144497656|NCT01981850|521018384|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
144497657|NCT01981850|521018385|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
144497658|NCT01981850|521018386|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
144497659|NCT01981850|521018387|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
144497660|NCT01981850|521018388|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
144497661|NCT01981850|521018389|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
144497662|NCT01981850|521018390|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
144497663|NCT01981850|521018391|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
144497664|NCT01981850|521018392|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
144497665|NCT01981850|521018393|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
144497666|NCT01981850|521018384|FG000|Main Phase Stage 1|Various reasons|0|||
144497667|NCT01981850|521018385|FG001|Main Phase Stage 1|Various reasons|0|||
144497668|NCT01981850|521018386|FG002|Main Phase Stage 1|Various reasons|2|||
144497669|NCT01981850|521018387|FG003|Main Phase Stage 1|Various reasons|0|||
144497670|NCT01981850|521018388|FG004|Main Phase Stage 1|Various reasons|0|||
144497671|NCT01981850|521018389|FG005|Main Phase Stage 1|Various reasons|0|||
144497672|NCT01981850|521018390|FG006|Main Phase Stage 1|Various reasons|0|||
144497673|NCT01981850|521018391|FG007|Main Phase Stage 1|Various reasons|0|||
144497674|NCT01981850|521018392|FG008|Main Phase Stage 1|Various reasons|0|||
144497675|NCT01981850|521018393|FG009|Main Phase Stage 1|Various reasons|0|||
144497676|NCT01981850|521018384|FG000|Main Phase Stage 2|Adverse Event|0|||
144497677|NCT01981850|521018385|FG001|Main Phase Stage 2|Adverse Event|0|||
144497678|NCT01981850|521018386|FG002|Main Phase Stage 2|Adverse Event|0|||
144497679|NCT01981850|521018387|FG003|Main Phase Stage 2|Adverse Event|0|||
144497680|NCT01981850|521018388|FG004|Main Phase Stage 2|Adverse Event|6|||
144497681|NCT01981850|521018389|FG005|Main Phase Stage 2|Adverse Event|5|||
144497682|NCT01981850|521018390|FG006|Main Phase Stage 2|Adverse Event|7|||
144497683|NCT01981850|521018391|FG007|Main Phase Stage 2|Adverse Event|0|||
144497684|NCT01981850|521018392|FG008|Main Phase Stage 2|Adverse Event|0|||
144497685|NCT01981850|521018393|FG009|Main Phase Stage 2|Adverse Event|0|||
144497686|NCT01981850|521018384|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497687|NCT01981850|521018385|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497688|NCT01981850|521018386|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497689|NCT01981850|521018387|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497690|NCT01981850|521018388|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
144497691|NCT01981850|521018389|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
144497692|NCT01981850|521018390|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
144719742|NCT00321711|521827494|FG004|Part A|Physician Decision|0|||
144719743|NCT00321711|521827490|FG000|Part A|Other|1|||
144719744|NCT00321711|521827491|FG001|Part A|Other|2|||
144719745|NCT00321711|521827492|FG002|Part A|Other|3|||
144719746|NCT00321711|521827493|FG003|Part A|Other|0|||
144719747|NCT00321711|521827494|FG004|Part A|Other|0|||
144719748|NCT00321711|521827490|FG000|Part A|Protocol deviation|0|||
144719749|NCT00321711|521827491|FG001|Part A|Protocol deviation|0|||
144719750|NCT00321711|521827492|FG002|Part A|Protocol deviation|1|||
144719751|NCT00321711|521827493|FG003|Part A|Protocol deviation|0|||
144719752|NCT00321711|521827494|FG004|Part A|Protocol deviation|0|||
144719753|NCT00321711|521827490|FG000|Part B|Noncompliance|0|||
144719754|NCT00321711|521827491|FG001|Part B|Noncompliance|0|||
144719755|NCT00321711|521827492|FG002|Part B|Noncompliance|0|||
144719756|NCT00321711|521827493|FG003|Part B|Noncompliance|0|||
144719757|NCT00321711|521827494|FG004|Part B|Noncompliance|1|||
144719758|NCT00321711|521827490|FG000|Part B|Adverse Event|0|||
144719759|NCT00321711|521827491|FG001|Part B|Adverse Event|0|||
144497693|NCT01981850|521018391|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497694|NCT01981850|521018392|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497695|NCT01981850|521018393|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
144497696|NCT01981850|521018384|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
144719760|NCT00321711|521827492|FG002|Part B|Adverse Event|0|||
144719761|NCT00321711|521827493|FG003|Part B|Adverse Event|2|||
144719762|NCT00321711|521827494|FG004|Part B|Adverse Event|1|||
144719763|NCT00321711|521827490|FG000|Part B|Disease progression|0|||
144719764|NCT00321711|521827491|FG001|Part B|Disease progression|0|||
144497697|NCT01981850|521018385|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
144497698|NCT01981850|521018386|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
144497699|NCT01981850|521018387|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
144497700|NCT01981850|521018388|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
144497701|NCT01981850|521018389|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
144497702|NCT01981850|521018390|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
144497703|NCT01981850|521018391|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
144497704|NCT01981850|521018392|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
144497705|NCT01981850|521018393|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
144497706|NCT01981850|521018384|FG000|Main Phase Stage 2|Various reasons|0|||
144497707|NCT01981850|521018385|FG001|Main Phase Stage 2|Various reasons|0|||
144497708|NCT01981850|521018386|FG002|Main Phase Stage 2|Various reasons|0|||
144497709|NCT01981850|521018387|FG003|Main Phase Stage 2|Various reasons|0|||
144497710|NCT01981850|521018388|FG004|Main Phase Stage 2|Various reasons|2|||
144497711|NCT01981850|521018389|FG005|Main Phase Stage 2|Various reasons|0|||
144497712|NCT01981850|521018390|FG006|Main Phase Stage 2|Various reasons|1|||
144497713|NCT01981850|521018391|FG007|Main Phase Stage 2|Various reasons|0|||
144497714|NCT01981850|521018392|FG008|Main Phase Stage 2|Various reasons|0|||
144497715|NCT01981850|521018393|FG009|Main Phase Stage 2|Various reasons|0|||
144497716|NCT01981850|521018384|FG000|Main Phase Stage 2|Progressive Disease|0|||
144497717|NCT01981850|521018385|FG001|Main Phase Stage 2|Progressive Disease|0|||
144497718|NCT01981850|521018386|FG002|Main Phase Stage 2|Progressive Disease|0|||
144497719|NCT01981850|521018387|FG003|Main Phase Stage 2|Progressive Disease|0|||
144497720|NCT01981850|521018388|FG004|Main Phase Stage 2|Progressive Disease|0|||
144497721|NCT01981850|521018389|FG005|Main Phase Stage 2|Progressive Disease|6|||
144497722|NCT01981850|521018390|FG006|Main Phase Stage 2|Progressive Disease|6|||
144497723|NCT01981850|521018391|FG007|Main Phase Stage 2|Progressive Disease|0|||
144497724|NCT01981850|521018392|FG008|Main Phase Stage 2|Progressive Disease|0|||
144497725|NCT01981850|521018393|FG009|Main Phase Stage 2|Progressive Disease|0|||
144497726|NCT01981850|521018384|FG000|Open Label Extension (OLE)|Adverse Event|0|||
144497727|NCT01981850|521018385|FG001|Open Label Extension (OLE)|Adverse Event|0|||
144497728|NCT01981850|521018386|FG002|Open Label Extension (OLE)|Adverse Event|0|||
144497729|NCT01981850|521018387|FG003|Open Label Extension (OLE)|Adverse Event|0|||
144497730|NCT01981850|521018388|FG004|Open Label Extension (OLE)|Adverse Event|0|||
144497731|NCT01981850|521018389|FG005|Open Label Extension (OLE)|Adverse Event|0|||
144497732|NCT01981850|521018390|FG006|Open Label Extension (OLE)|Adverse Event|0|||
144497733|NCT01981850|521018391|FG007|Open Label Extension (OLE)|Adverse Event|2|||
144497734|NCT01981850|521018392|FG008|Open Label Extension (OLE)|Adverse Event|1|||
144497735|NCT01981850|521018393|FG009|Open Label Extension (OLE)|Adverse Event|8|||
144497736|NCT01981850|521018384|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497737|NCT01981850|521018385|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497738|NCT01981850|521018386|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497739|NCT01981850|521018387|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497740|NCT01981850|521018388|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497741|NCT01981850|521018389|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497742|NCT01981850|521018390|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
144497743|NCT01981850|521018391|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
144497744|NCT01981850|521018392|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
144497745|NCT01981850|521018393|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
144497746|NCT01981850|521018384|FG000|Open Label Extension (OLE)|Various reasons|0|||
144497747|NCT01981850|521018385|FG001|Open Label Extension (OLE)|Various reasons|0|||
144497748|NCT01981850|521018386|FG002|Open Label Extension (OLE)|Various reasons|0|||
144497749|NCT01981850|521018387|FG003|Open Label Extension (OLE)|Various reasons|0|||
144497750|NCT01981850|521018388|FG004|Open Label Extension (OLE)|Various reasons|0|||
144497751|NCT01981850|521018389|FG005|Open Label Extension (OLE)|Various reasons|0|||
144497752|NCT01981850|521018390|FG006|Open Label Extension (OLE)|Various reasons|0|||
144497753|NCT01981850|521018391|FG007|Open Label Extension (OLE)|Various reasons|3|||
144497754|NCT01981850|521018392|FG008|Open Label Extension (OLE)|Various reasons|1|||
144497755|NCT01981850|521018393|FG009|Open Label Extension (OLE)|Various reasons|3|||
144497756|NCT01981850|521018384|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
144497757|NCT01981850|521018385|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
144497758|NCT01981850|521018386|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
144497759|NCT01981850|521018387|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
144497760|NCT01981850|521018388|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
144497761|NCT01981850|521018389|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
144497762|NCT01981850|521018390|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
144497763|NCT01981850|521018391|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
144497764|NCT01981850|521018392|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
144497765|NCT01981850|521018393|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
144497766|NCT01981850|521018384|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497767|NCT01981850|521018385|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497768|NCT01981850|521018386|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497769|NCT01981850|521018387|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497770|NCT01981850|521018388|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497771|NCT01981850|521018389|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497772|NCT01981850|521018390|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497773|NCT01981850|521018391|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497774|NCT01981850|521018392|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
144497775|NCT01981850|521018393|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
144497776|NCT01981850|521018384|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497777|NCT01981850|521018385|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497778|NCT01981850|521018386|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497779|NCT01981850|521018387|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497780|NCT01981850|521018388|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497781|NCT01981850|521018389|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497782|NCT01981850|521018390|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497783|NCT01981850|521018391|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497784|NCT01981850|521018392|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
144497785|NCT01981850|521018393|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
144497786|NCT02524288|521018395|FG000|Overall Study|Adverse Event|115|||
144497787|NCT02524288|521018395|FG000|Overall Study|Lost to Follow-up|216|||
144497788|NCT02524288|521018395|FG000|Overall Study|Non-Compliance With Protocol|32|||
144497789|NCT02524288|521018395|FG000|Overall Study|Non-Compliance With Study Drug|14|||
144497790|NCT02524288|521018395|FG000|Overall Study|Pregnancy Wish|6|||
144497791|NCT02524288|521018395|FG000|Overall Study|Protocol Violation|6|||
144497792|NCT02524288|521018395|FG000|Overall Study|Screen Failure|2|||
144497793|NCT02524288|521018395|FG000|Overall Study|Site Discontinued Study Participation|1|||
144497794|NCT02524288|521018395|FG000|Overall Study|Study Terminated By Sponsor|1417|||
144497795|NCT02524288|521018395|FG000|Overall Study|Subject Moved|32|||
144497796|NCT02524288|521018395|FG000|Overall Study|Withdrawal by Subject|76|||
144497797|NCT02524288|521018395|FG000|Overall Study|Pregnancy|22|||
144497798|NCT02524288|521018395|FG000|Overall Study|Physician Decision|2|||
144497799|NCT00517933|521018396|FG000|Period 1|Death|2|||
144497800|NCT00517933|521018397|FG001|Period 1|Death|1|||
144497801|NCT00517933|521018396|FG000|Period 1|Adverse Event|4|||
144497802|NCT00517933|521018397|FG001|Period 1|Adverse Event|4|||
144497803|NCT00517933|521018396|FG000|Period 1|Lost to Follow-up|2|||
144497804|NCT00517933|521018397|FG001|Period 1|Lost to Follow-up|0|||
144497805|NCT00517933|521018396|FG000|Period 1|Underwent lung transplant|0|||
144497806|NCT00517933|521018397|FG001|Period 1|Underwent lung transplant|1|||
144497807|NCT00517933|521018396|FG000|Period 2|Death|2|||
144497808|NCT00517933|521018397|FG001|Period 2|Death|4|||
144497809|NCT00517933|521018396|FG000|Period 2|Adverse Event|2|||
144497810|NCT00517933|521018397|FG001|Period 2|Adverse Event|4|||
144497811|NCT00517933|521018396|FG000|Period 2|Physician Decision|1|||
144497812|NCT00517933|521018397|FG001|Period 2|Physician Decision|0|||
144497813|NCT00517933|521018396|FG000|Period 2|Withdrawal by Subject|1|||
144497814|NCT00517933|521018397|FG001|Period 2|Withdrawal by Subject|3|||
144497815|NCT00517933|521018396|FG000|Period 2|Underwent lung transplant|0|||
144497816|NCT00517933|521018397|FG001|Period 2|Underwent lung transplant|2|||
144497817|NCT00561574|521018400|FG000|Overall Study|Adverse Event|21|||
144497818|NCT00561574|521018401|FG001|Overall Study|Adverse Event|24|||
144497819|NCT00561574|521018400|FG000|Overall Study|Lack of Efficacy|11|||
144497820|NCT00561574|521018401|FG001|Overall Study|Lack of Efficacy|21|||
144497821|NCT00561574|521018400|FG000|Overall Study|Withdrawal by Subject|4|||
144497822|NCT00561574|521018401|FG001|Overall Study|Withdrawal by Subject|4|||
144497823|NCT00561574|521018400|FG000|Overall Study|Reason Unrelated to Trial|6|||
144497824|NCT00561574|521018401|FG001|Overall Study|Reason Unrelated to Trial|2|||
144497825|NCT00561574|521018400|FG000|Overall Study|Lost to Follow-up|1|||
144497826|NCT00561574|521018401|FG001|Overall Study|Lost to Follow-up|0|||
144497827|NCT00561574|521018400|FG000|Overall Study|Other|5|||
144497828|NCT00561574|521018401|FG001|Overall Study|Other|7|||
144497829|NCT00445692|521018402|FG000|Overall Study|Adverse Event|11|||
144497830|NCT00445692|521018402|FG000|Overall Study|Lack of Efficacy|5|||
144497831|NCT00430677|521018406|FG000|Short-term Period|Death|1|||
144497832|NCT00430677|521018407|FG001|Short-term Period|Death|1|||
144497833|NCT00430677|521018408|FG002|Short-term Period|Death|5|||
144497834|NCT00430677|521018406|FG000|Short-term Period|Adverse Event|15|||
144497835|NCT00430677|521018407|FG001|Short-term Period|Adverse Event|13|||
144497836|NCT00430677|521018408|FG002|Short-term Period|Adverse Event|9|||
144497837|NCT00430677|521018406|FG000|Short-term Period|Lack of Efficacy|5|||
144497838|NCT00430677|521018407|FG001|Short-term Period|Lack of Efficacy|6|||
144497839|NCT00430677|521018408|FG002|Short-term Period|Lack of Efficacy|4|||
144497840|NCT00430677|521018406|FG000|Short-term Period|Withdrawal by Subject|1|||
144497841|NCT00430677|521018407|FG001|Short-term Period|Withdrawal by Subject|1|||
144497842|NCT00430677|521018408|FG002|Short-term Period|Withdrawal by Subject|2|||
144497843|NCT00430677|521018406|FG000|Short-term Period|Participant no longer met study criteria|1|||
144497844|NCT00430677|521018407|FG001|Short-term Period|Participant no longer met study criteria|1|||
144497845|NCT00430677|521018408|FG002|Short-term Period|Participant no longer met study criteria|2|||
144497846|NCT00430677|521018406|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
144497847|NCT00430677|521018407|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
144497848|NCT00430677|521018408|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
144497849|NCT00430677|521018406|FG000|Short-term Period|Pregnancy|0|||
144497850|NCT00430677|521018407|FG001|Short-term Period|Pregnancy|2|||
144497851|NCT00430677|521018408|FG002|Short-term Period|Pregnancy|0|||
144497852|NCT00430677|521018406|FG000|Long-term Extension Period|Death|1|||
144497853|NCT00430677|521018407|FG001|Long-term Extension Period|Death|0|||
144497854|NCT00430677|521018408|FG002|Long-term Extension Period|Death|0|||
144497855|NCT00430677|521018406|FG000|Long-term Extension Period|Adverse Event|3|||
144497856|NCT00430677|521018407|FG001|Long-term Extension Period|Adverse Event|2|||
144497857|NCT00430677|521018408|FG002|Long-term Extension Period|Adverse Event|5|||
144497858|NCT00430677|521018406|FG000|Long-term Extension Period|Lack of Efficacy|5|||
144497859|NCT00430677|521018407|FG001|Long-term Extension Period|Lack of Efficacy|3|||
144497860|NCT00430677|521018408|FG002|Long-term Extension Period|Lack of Efficacy|8|||
144497861|NCT00430677|521018406|FG000|Long-term Extension Period|Lost to Follow-up|1|||
144497862|NCT00430677|521018407|FG001|Long-term Extension Period|Lost to Follow-up|1|||
144497863|NCT00430677|521018408|FG002|Long-term Extension Period|Lost to Follow-up|1|||
144497864|NCT00430677|521018406|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
144497865|NCT00430677|521018407|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
144497866|NCT00430677|521018408|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
144497867|NCT00430677|521018406|FG000|Long-term Extension Period|Pregnancy|1|||
144497868|NCT00430677|521018407|FG001|Long-term Extension Period|Pregnancy|1|||
144497869|NCT00430677|521018408|FG002|Long-term Extension Period|Pregnancy|0|||
144497870|NCT00430677|521018406|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
144497871|NCT00430677|521018407|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
144497872|NCT00430677|521018408|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
144497873|NCT00430677|521018406|FG000|Long-term Extension Period|Other|2|||
144497874|NCT00430677|521018407|FG001|Long-term Extension Period|Other|1|||
144497875|NCT00430677|521018408|FG002|Long-term Extension Period|Other|1|||
144497876|NCT00430677|521018406|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
144497877|NCT00430677|521018407|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
144497878|NCT00430677|521018408|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
144497879|NCT01137292|521018411|FG000|Overall Study|Death|30|||
144497880|NCT01137292|521018411|FG000|Overall Study|Adverse Event|3|||
144497881|NCT01137292|521018411|FG000|Overall Study|Lack of Efficacy|13|||
144497882|NCT01137292|521018411|FG000|Overall Study|Lost to Follow-up|1|||
144497883|NCT01137292|521018411|FG000|Overall Study|Other|7|||
144497884|NCT02040844|521018414|FG000|Overall Study|Adverse Event|0|||
144497885|NCT02040844|521018415|FG001|Overall Study|Adverse Event|0|||
144497886|NCT02040844|521018416|FG002|Overall Study|Adverse Event|1|||
144497887|NCT02040844|521018414|FG000|Overall Study|Withdrawal by Subject|16|||
144497888|NCT02040844|521018415|FG001|Overall Study|Withdrawal by Subject|22|||
144497889|NCT02040844|521018416|FG002|Overall Study|Withdrawal by Subject|25|||
144497890|NCT02040844|521018414|FG000|Overall Study|Lost to Follow-up|12|||
144497891|NCT02040844|521018415|FG001|Overall Study|Lost to Follow-up|9|||
144497892|NCT02040844|521018416|FG002|Overall Study|Lost to Follow-up|13|||
144497893|NCT02040844|521018414|FG000|Overall Study|Missing|13|||
144497894|NCT02040844|521018415|FG001|Overall Study|Missing|3|||
144497895|NCT02040844|521018416|FG002|Overall Study|Missing|2|||
144497896|NCT02040844|521018414|FG000|Overall Study|Non-specified|8|||
144497897|NCT02040844|521018415|FG001|Overall Study|Non-specified|2|||
144497898|NCT02040844|521018416|FG002|Overall Study|Non-specified|5|||
144497899|NCT02040844|521018414|FG000|Overall Study|Concomitant medication|1|||
144497900|NCT02040844|521018415|FG001|Overall Study|Concomitant medication|3|||
144497901|NCT02040844|521018416|FG002|Overall Study|Concomitant medication|1|||
144497902|NCT00828919|521018417|FG000|Overall Study|Death|0|||
144497903|NCT00828919|521018418|FG001|Overall Study|Death|1|||
144497904|NCT00828919|521018419|FG002|Overall Study|Death|2|||
144497905|NCT00828919|521018420|FG003|Overall Study|Death|0|||
144497906|NCT00828919|521018421|FG004|Overall Study|Death|0|||
144497907|NCT00828919|521018417|FG000|Overall Study|Adverse Event|2|||
144497908|NCT00828919|521018418|FG001|Overall Study|Adverse Event|2|||
144497909|NCT00828919|521018419|FG002|Overall Study|Adverse Event|2|||
144497910|NCT00828919|521018420|FG003|Overall Study|Adverse Event|1|||
144497911|NCT00828919|521018421|FG004|Overall Study|Adverse Event|3|||
144497912|NCT00828919|521018417|FG000|Overall Study|Objective progression or relapse|4|||
144497913|NCT00828919|521018418|FG001|Overall Study|Objective progression or relapse|4|||
144497914|NCT00828919|521018419|FG002|Overall Study|Objective progression or relapse|11|||
144497915|NCT00828919|521018420|FG003|Overall Study|Objective progression or relapse|0|||
144497916|NCT00828919|521018421|FG004|Overall Study|Objective progression or relapse|5|||
144497917|NCT00828919|521018417|FG000|Overall Study|No longer willing to participate in study|0|||
144497918|NCT00828919|521018418|FG001|Overall Study|No longer willing to participate in study|0|||
144497919|NCT00828919|521018419|FG002|Overall Study|No longer willing to participate in study|2|||
144497920|NCT00828919|521018420|FG003|Overall Study|No longer willing to participate in study|0|||
144497921|NCT00828919|521018421|FG004|Overall Study|No longer willing to participate in study|0|||
144497922|NCT00828919|521018417|FG000|Overall Study|Insufficient Clinical Response|0|||
144497923|NCT00828919|521018418|FG001|Overall Study|Insufficient Clinical Response|1|||
144497924|NCT00828919|521018419|FG002|Overall Study|Insufficient Clinical Response|2|||
144497925|NCT00828919|521018420|FG003|Overall Study|Insufficient Clinical Response|0|||
144497926|NCT00828919|521018421|FG004|Overall Study|Insufficient Clinical Response|0|||
144497927|NCT00828919|521018417|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
144497928|NCT00828919|521018418|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
144497929|NCT00828919|521018419|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
144497930|NCT00828919|521018420|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
144497931|NCT00828919|521018421|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
144497932|NCT00828919|521018417|FG000|Overall Study|Other|1|||
144497933|NCT00828919|521018418|FG001|Overall Study|Other|0|||
144497934|NCT00828919|521018419|FG002|Overall Study|Other|1|||
144497935|NCT00828919|521018420|FG003|Overall Study|Other|1|||
144497936|NCT00828919|521018421|FG004|Overall Study|Other|0|||
144497937|NCT00828919|521018417|FG000|Overall Study|Lost to Follow-up|0|||
144497938|NCT00828919|521018418|FG001|Overall Study|Lost to Follow-up|1|||
144497939|NCT00828919|521018419|FG002|Overall Study|Lost to Follow-up|0|||
144497940|NCT00828919|521018420|FG003|Overall Study|Lost to Follow-up|0|||
144497941|NCT00828919|521018421|FG004|Overall Study|Lost to Follow-up|0|||
144497942|NCT05567159|521018422|FG000|Overall Study|Adverse Event|4|||
144497943|NCT05567159|521018422|FG000|Overall Study|Physician Decision|3|||
144497944|NCT05567159|521018422|FG000|Overall Study|Protocol deviation|1|||
144497945|NCT02738840|521020663|FG000|Overall Study|MRI Scan not Performed|5|||
144497946|NCT02738840|521020663|FG000|Overall Study|Lost to Follow-up|1|||
144497947|NCT02738840|521020663|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
144497948|NCT02738840|521020663|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
144497949|NCT01268891|521020673|FG000|Overall Study|Adverse Event|3|||
144497950|NCT01268891|521020674|FG001|Overall Study|Adverse Event|7|||
144497951|NCT01268891|521020673|FG000|Overall Study|Lack of Efficacy|1|||
144497952|NCT01268891|521020674|FG001|Overall Study|Lack of Efficacy|0|||
144497953|NCT01268891|521020673|FG000|Overall Study|Withdrawal of Consent|3|||
144497954|NCT01268891|521020674|FG001|Overall Study|Withdrawal of Consent|1|||
144497955|NCT01268891|521020673|FG000|Overall Study|Administrative or other reason(s)|1|||
144497956|NCT01268891|521020674|FG001|Overall Study|Administrative or other reason(s)|0|||
144497957|NCT00991276|521020675|FG000|First Intervention Period|Adverse Event|0|||
144497958|NCT00991276|521020676|FG001|First Intervention Period|Adverse Event|1|||
144497959|NCT00991276|521020677|FG002|First Intervention Period|Adverse Event|0|||
144497960|NCT00991276|521020678|FG003|First Intervention Period|Adverse Event|1|||
144497961|NCT00991276|521020679|FG004|First Intervention Period|Adverse Event|0|||
144497962|NCT00991276|521020680|FG005|First Intervention Period|Adverse Event|0|||
144497963|NCT00991276|521020675|FG000|First Intervention Period|Protocol Violation|0|||
144497964|NCT00991276|521020676|FG001|First Intervention Period|Protocol Violation|0|||
144497965|NCT00991276|521020677|FG002|First Intervention Period|Protocol Violation|0|||
144497966|NCT00991276|521020678|FG003|First Intervention Period|Protocol Violation|0|||
144497967|NCT00991276|521020679|FG004|First Intervention Period|Protocol Violation|2|||
144497968|NCT00991276|521020680|FG005|First Intervention Period|Protocol Violation|0|||
144497969|NCT00991276|521020675|FG000|First Intervention Period|Insufficient clinical response|0|||
144497970|NCT00991276|521020676|FG001|First Intervention Period|Insufficient clinical response|0|||
144497971|NCT00991276|521020677|FG002|First Intervention Period|Insufficient clinical response|0|||
144497972|NCT00991276|521020678|FG003|First Intervention Period|Insufficient clinical response|0|||
144497973|NCT00991276|521020679|FG004|First Intervention Period|Insufficient clinical response|1|||
144497974|NCT00991276|521020680|FG005|First Intervention Period|Insufficient clinical response|0|||
144497975|NCT00991276|521020675|FG000|First Intervention Period|Other|0|||
144497976|NCT00991276|521020676|FG001|First Intervention Period|Other|0|||
144497977|NCT00991276|521020677|FG002|First Intervention Period|Other|0|||
144497978|NCT00991276|521020678|FG003|First Intervention Period|Other|1|||
144497979|NCT00991276|521020679|FG004|First Intervention Period|Other|1|||
144497980|NCT00991276|521020680|FG005|First Intervention Period|Other|0|||
144497981|NCT00991276|521020675|FG000|First Intervention Period|Withdrawal by Subject|0|||
144497982|NCT00991276|521020676|FG001|First Intervention Period|Withdrawal by Subject|1|||
144497983|NCT00991276|521020677|FG002|First Intervention Period|Withdrawal by Subject|0|||
144497984|NCT00991276|521020678|FG003|First Intervention Period|Withdrawal by Subject|1|||
144497985|NCT00991276|521020679|FG004|First Intervention Period|Withdrawal by Subject|0|||
144497986|NCT00991276|521020680|FG005|First Intervention Period|Withdrawal by Subject|1|||
144497987|NCT00991276|521020675|FG000|First Intervention Period|Lost to Follow-up|0|||
144497988|NCT00991276|521020676|FG001|First Intervention Period|Lost to Follow-up|1|||
144497989|NCT00991276|521020677|FG002|First Intervention Period|Lost to Follow-up|0|||
144497990|NCT00991276|521020678|FG003|First Intervention Period|Lost to Follow-up|1|||
144497991|NCT00991276|521020679|FG004|First Intervention Period|Lost to Follow-up|0|||
144497992|NCT00991276|521020680|FG005|First Intervention Period|Lost to Follow-up|0|||
144497993|NCT00991276|521020675|FG000|Second Intervention Period|Adverse Event|0|||
144497994|NCT00991276|521020676|FG001|Second Intervention Period|Adverse Event|2|||
144497995|NCT00991276|521020677|FG002|Second Intervention Period|Adverse Event|0|||
144497996|NCT00991276|521020678|FG003|Second Intervention Period|Adverse Event|1|||
144497997|NCT00991276|521020679|FG004|Second Intervention Period|Adverse Event|1|||
144497998|NCT00991276|521020680|FG005|Second Intervention Period|Adverse Event|0|||
144497999|NCT00991276|521020675|FG000|Second Intervention Period|Protocol Violation|1|||
144498000|NCT00991276|521020676|FG001|Second Intervention Period|Protocol Violation|0|||
144498001|NCT00991276|521020677|FG002|Second Intervention Period|Protocol Violation|0|||
144498002|NCT00991276|521020678|FG003|Second Intervention Period|Protocol Violation|0|||
144498003|NCT00991276|521020679|FG004|Second Intervention Period|Protocol Violation|0|||
144498004|NCT00991276|521020680|FG005|Second Intervention Period|Protocol Violation|0|||
144498005|NCT00991276|521020675|FG000|Second Intervention Period|Other|0|||
144498006|NCT00991276|521020676|FG001|Second Intervention Period|Other|0|||
144498007|NCT00991276|521020677|FG002|Second Intervention Period|Other|0|||
144498008|NCT00991276|521020678|FG003|Second Intervention Period|Other|1|||
144498009|NCT00991276|521020679|FG004|Second Intervention Period|Other|0|||
144498010|NCT00991276|521020680|FG005|Second Intervention Period|Other|1|||
144498011|NCT00991276|521020675|FG000|Third Intervention Period|Protocol Violation|1|||
144498012|NCT00991276|521020676|FG001|Third Intervention Period|Protocol Violation|0|||
144498013|NCT00991276|521020677|FG002|Third Intervention Period|Protocol Violation|0|||
144498014|NCT00991276|521020678|FG003|Third Intervention Period|Protocol Violation|0|||
144498015|NCT00991276|521020679|FG004|Third Intervention Period|Protocol Violation|0|||
144498016|NCT00991276|521020680|FG005|Third Intervention Period|Protocol Violation|0|||
144498017|NCT00991276|521020675|FG000|Third Intervention Period|Other|0|||
144498018|NCT00991276|521020676|FG001|Third Intervention Period|Other|0|||
144498019|NCT00991276|521020677|FG002|Third Intervention Period|Other|0|||
144498020|NCT00991276|521020678|FG003|Third Intervention Period|Other|0|||
144498021|NCT00991276|521020679|FG004|Third Intervention Period|Other|0|||
144498022|NCT00991276|521020680|FG005|Third Intervention Period|Other|1|||
144498023|NCT00991276|521020675|FG000|Third Intervention Period|Adverse Event|0|||
144498024|NCT00991276|521020676|FG001|Third Intervention Period|Adverse Event|0|||
144370073|NCT02379091|520562802|FG001|Overall Study|Lost to Follow-up|0|||
144370074|NCT02379091|520562803|FG002|Overall Study|Lost to Follow-up|0|||
144498025|NCT00991276|521020677|FG002|Third Intervention Period|Adverse Event|1|||
144498026|NCT00991276|521020678|FG003|Third Intervention Period|Adverse Event|0|||
144498027|NCT00991276|521020679|FG004|Third Intervention Period|Adverse Event|0|||
144498028|NCT00991276|521020680|FG005|Third Intervention Period|Adverse Event|0|||
144498029|NCT00991276|521020675|FG000|Third Intervention Period|Withdrawal by Subject|0|||
144498030|NCT00991276|521020676|FG001|Third Intervention Period|Withdrawal by Subject|0|||
144498031|NCT00991276|521020677|FG002|Third Intervention Period|Withdrawal by Subject|0|||
144498032|NCT00991276|521020678|FG003|Third Intervention Period|Withdrawal by Subject|1|||
144498033|NCT00991276|521020679|FG004|Third Intervention Period|Withdrawal by Subject|0|||
144498034|NCT00991276|521020680|FG005|Third Intervention Period|Withdrawal by Subject|0|||
144498035|NCT02232178|521020687|FG000|Overall Study|Lost to Follow-up|0|||
144498036|NCT02232178|521020688|FG001|Overall Study|Lost to Follow-up|1|||
144498037|NCT02232178|521020689|FG002|Overall Study|Lost to Follow-up|0|||
144498038|NCT02232178|521020687|FG000|Overall Study|ineligibility|0|||
144498039|NCT02232178|521020688|FG001|Overall Study|ineligibility|0|||
144498040|NCT02232178|521020689|FG002|Overall Study|ineligibility|1|||
144498041|NCT02232178|521020687|FG000|Overall Study|surgical complication|1|||
144498042|NCT02232178|521020688|FG001|Overall Study|surgical complication|0|||
144498043|NCT02232178|521020689|FG002|Overall Study|surgical complication|0|||
144498044|NCT04176458|521020691|FG000|Overall Study|Covid 19|4|||
144498045|NCT00920686|521020692|FG000|Overall Study|Lost to Follow-up|2|||
144498046|NCT00920686|521020693|FG001|Overall Study|Lost to Follow-up|3|||
144498047|NCT00920686|521020694|FG002|Overall Study|Lost to Follow-up|1|||
144498048|NCT00920686|521020692|FG000|Overall Study|Study drug dosing criteria not met|17|||
144498049|NCT00920686|521020693|FG001|Overall Study|Study drug dosing criteria not met|19|||
144719765|NCT00321711|521827492|FG002|Part B|Disease progression|0|||
144719766|NCT00321711|521827493|FG003|Part B|Disease progression|1|||
144719767|NCT00321711|521827494|FG004|Part B|Disease progression|0|||
144719768|NCT00321711|521827490|FG000|Part B|Physician Decision|0|||
144719769|NCT00321711|521827491|FG001|Part B|Physician Decision|0|||
144719770|NCT00321711|521827492|FG002|Part B|Physician Decision|0|||
144719771|NCT00321711|521827493|FG003|Part B|Physician Decision|1|||
144719772|NCT00321711|521827494|FG004|Part B|Physician Decision|2|||
144719773|NCT00321711|521827490|FG000|Part B|Death|0|||
144498050|NCT00920686|521020694|FG002|Overall Study|Study drug dosing criteria not met|12|||
144498051|NCT00003656|521020695|FG000|Overall Study|Adverse Event|0|||
144498052|NCT00003656|521020696|FG001|Overall Study|Adverse Event|1|||
144498053|NCT00763282|521020697|FG000|Overall Study|Withdrawal by Subject|6|||
144498054|NCT00763282|521020698|FG001|Overall Study|Withdrawal by Subject|5|||
144498055|NCT00763282|521020697|FG000|Overall Study|Death|4|||
144498056|NCT00763282|521020698|FG001|Overall Study|Death|3|||
144498057|NCT00763282|521020697|FG000|Overall Study|Lost to Follow-up|22|||
144498058|NCT00763282|521020698|FG001|Overall Study|Lost to Follow-up|26|||
144498059|NCT02595398|521020705|FG000|Overall Study|Non-compliance|1|||
144498060|NCT02595398|521020706|FG001|Overall Study|Non-compliance|0|||
144498061|NCT02595398|521020705|FG000|Overall Study|Withdrawal by Subject|2|||
144498062|NCT02595398|521020706|FG001|Overall Study|Withdrawal by Subject|1|||
144498063|NCT02595398|521020705|FG000|Overall Study|Lost to Follow-up|1|||
144498064|NCT02595398|521020706|FG001|Overall Study|Lost to Follow-up|0|||
144498065|NCT01664104|521020707|FG000|Overall Study|Adverse Event|6|||
144498066|NCT01664104|521020707|FG000|Overall Study|Lack of Efficacy|2|||
144498067|NCT01664104|521020707|FG000|Overall Study|Withdrawal by Subject|1|||
144498068|NCT01664104|521020707|FG000|Overall Study|Lost to Follow-up|4|||
144498069|NCT01664104|521020707|FG000|Overall Study|Other|1|||
144498070|NCT01664104|521020707|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
144498071|NCT00586339|521020708|FG000|Overall Study|Withdrawal by Subject|1|||
144498072|NCT00586339|521020709|FG001|Overall Study|Withdrawal by Subject|3|||
144498073|NCT00586339|521020710|FG002|Overall Study|Withdrawal by Subject|1|||
144498074|NCT00586339|521020708|FG000|Overall Study|Migrated/moved from study area|3|||
144498075|NCT00586339|521020709|FG001|Overall Study|Migrated/moved from study area|2|||
144498076|NCT00586339|521020710|FG002|Overall Study|Migrated/moved from study area|4|||
144498077|NCT00586339|521020708|FG000|Overall Study|Lost to Follow-up|3|||
144498078|NCT00586339|521020709|FG001|Overall Study|Lost to Follow-up|2|||
144498079|NCT00586339|521020710|FG002|Overall Study|Lost to Follow-up|1|||
144498080|NCT00746330|521020711|FG000|Period 1|Abnormal test procedure result|0|||
144498081|NCT00746330|521020712|FG001|Period 1|Abnormal test procedure result|0|||
144498082|NCT00746330|521020713|FG002|Period 1|Abnormal test procedure result|1|||
144498083|NCT00746330|521020714|FG003|Period 1|Abnormal test procedure result|0|||
144498084|NCT01467700|521020715|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
144498085|NCT01467700|521020716|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
144498086|NCT01467700|521020717|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
144719774|NCT00321711|521827491|FG001|Part B|Death|0|||
144498087|NCT01467700|521020718|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
144498088|NCT01467700|521020715|FG000|Overall Study|Major Protocol Deviation|3|||
144498089|NCT01467700|521020716|FG001|Overall Study|Major Protocol Deviation|3|||
144498090|NCT01467700|521020717|FG002|Overall Study|Major Protocol Deviation|2|||
144719775|NCT00321711|521827492|FG002|Part B|Death|0|||
144719776|NCT00321711|521827493|FG003|Part B|Death|2|||
144719777|NCT00321711|521827494|FG004|Part B|Death|1|||
144498091|NCT01467700|521020718|FG003|Overall Study|Major Protocol Deviation|3|||
144498092|NCT01467700|521020715|FG000|Overall Study|Lost to Follow-up|6|||
144498093|NCT01467700|521020716|FG001|Overall Study|Lost to Follow-up|5|||
144498094|NCT01467700|521020717|FG002|Overall Study|Lost to Follow-up|2|||
144498095|NCT01467700|521020718|FG003|Overall Study|Lost to Follow-up|3|||
144498096|NCT01467700|521020715|FG000|Overall Study|Voluntary Withdrawal|5|||
144498097|NCT01467700|521020716|FG001|Overall Study|Voluntary Withdrawal|7|||
144498098|NCT01467700|521020717|FG002|Overall Study|Voluntary Withdrawal|6|||
144498099|NCT01467700|521020718|FG003|Overall Study|Voluntary Withdrawal|2|||
144498100|NCT01467700|521020715|FG000|Overall Study|Study Termination|6|||
144498101|NCT01467700|521020716|FG001|Overall Study|Study Termination|5|||
144498102|NCT01467700|521020717|FG002|Overall Study|Study Termination|10|||
144498103|NCT01467700|521020718|FG003|Overall Study|Study Termination|7|||
144498104|NCT01467700|521020715|FG000|Overall Study|Pregnancy|0|||
144498105|NCT01467700|521020716|FG001|Overall Study|Pregnancy|1|||
144498106|NCT01467700|521020717|FG002|Overall Study|Pregnancy|1|||
144498107|NCT01467700|521020718|FG003|Overall Study|Pregnancy|0|||
144498108|NCT01467700|521020715|FG000|Overall Study|Lack of Efficacy|2|||
144498109|NCT01467700|521020716|FG001|Overall Study|Lack of Efficacy|0|||
144498110|NCT01467700|521020717|FG002|Overall Study|Lack of Efficacy|2|||
144498111|NCT01467700|521020718|FG003|Overall Study|Lack of Efficacy|1|||
144498112|NCT01467700|521020715|FG000|Overall Study|Reason not Specified|1|||
144498113|NCT01467700|521020716|FG001|Overall Study|Reason not Specified|3|||
144498114|NCT01467700|521020717|FG002|Overall Study|Reason not Specified|2|||
144498115|NCT01467700|521020718|FG003|Overall Study|Reason not Specified|8|||
144498116|NCT03523962|521020719|FG000|Closed Fractures|Death|86|||
144498117|NCT03523962|521020720|FG001|Closed Fractures|Death|71|||
144498118|NCT03523962|521020721|FG002|Closed Fractures|Death|0|||
144719778|NCT01186978|521827495|FG000|Overall Study|Withdrawal by Subject|1|||
144719779|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
144719780|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
144719781|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
144719782|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
144719783|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
144719784|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
144719785|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
144719786|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
144719787|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
144719788|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
144719789|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
144719790|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
144719791|NCT01227668|521827496|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
144719792|NCT01227668|521827497|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
144719793|NCT01227668|521827496|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
144719794|NCT01227668|521827497|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
144719795|NCT01227668|521827496|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
144719796|NCT01227668|521827497|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
144719797|NCT01227668|521827496|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
144719798|NCT01227668|521827497|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
144719799|NCT01227668|521827496|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
144719800|NCT01227668|521827497|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
144719801|NCT01227668|521827496|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
144719802|NCT01227668|521827497|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
144719803|NCT00947856|521827498|FG000|Treatment Period|Progressive Disease|33|||
144719804|NCT00947856|521827499|FG001|Treatment Period|Progressive Disease|12|||
144719805|NCT00947856|521827498|FG000|Treatment Period|Adverse Event|15|||
144719806|NCT00947856|521827499|FG001|Treatment Period|Adverse Event|9|||
144719807|NCT00947856|521827498|FG000|Treatment Period|Physician Decision|14|||
144719808|NCT00947856|521827499|FG001|Treatment Period|Physician Decision|6|||
144719809|NCT00947856|521827498|FG000|Treatment Period|Study Stopped by Sponsor|4|||
144719810|NCT00947856|521827499|FG001|Treatment Period|Study Stopped by Sponsor|4|||
144719811|NCT00947856|521827498|FG000|Treatment Period|Withdrawal by Subject|12|||
144719812|NCT00947856|521827499|FG001|Treatment Period|Withdrawal by Subject|1|||
144719813|NCT00947856|521827498|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
144719814|NCT00947856|521827499|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
144719815|NCT00947856|521827498|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
144719816|NCT00947856|521827499|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
144719817|NCT00947856|521827498|FG000|Follow-up Period|Lost to Follow-up|7|||
144498119|NCT03523962|521020722|FG003|Closed Fractures|Death|0|||
144498120|NCT03523962|521020719|FG000|Closed Fractures|Lost to Follow-up|62|||
144498121|NCT03523962|521020720|FG001|Closed Fractures|Lost to Follow-up|36|||
144498122|NCT03523962|521020721|FG002|Closed Fractures|Lost to Follow-up|0|||
144498123|NCT03523962|521020722|FG003|Closed Fractures|Lost to Follow-up|0|||
144498124|NCT03523962|521020719|FG000|Closed Fractures|Withdrawal by Subject|19|||
144498125|NCT03523962|521020720|FG001|Closed Fractures|Withdrawal by Subject|29|||
144498126|NCT03523962|521020721|FG002|Closed Fractures|Withdrawal by Subject|0|||
144498127|NCT03523962|521020722|FG003|Closed Fractures|Withdrawal by Subject|0|||
144498128|NCT03523962|521020719|FG000|Closed Fractures|Incarceration|1|||
144498129|NCT03523962|521020720|FG001|Closed Fractures|Incarceration|4|||
144498130|NCT03523962|521020721|FG002|Closed Fractures|Incarceration|0|||
144498131|NCT03523962|521020722|FG003|Closed Fractures|Incarceration|0|||
144498132|NCT03523962|521020719|FG000|Open Fractures|Death|0|||
144498133|NCT03523962|521020720|FG001|Open Fractures|Death|0|||
144498134|NCT03523962|521020721|FG002|Open Fractures|Death|11|||
144498135|NCT03523962|521020722|FG003|Open Fractures|Death|6|||
144498136|NCT03523962|521020719|FG000|Open Fractures|Lost to Follow-up|0|||
144498137|NCT03523962|521020720|FG001|Open Fractures|Lost to Follow-up|0|||
144498138|NCT03523962|521020721|FG002|Open Fractures|Lost to Follow-up|15|||
144498139|NCT03523962|521020722|FG003|Open Fractures|Lost to Follow-up|8|||
144498140|NCT03523962|521020719|FG000|Open Fractures|Withdrawal by Subject|0|||
144498141|NCT03523962|521020720|FG001|Open Fractures|Withdrawal by Subject|0|||
144498142|NCT03523962|521020721|FG002|Open Fractures|Withdrawal by Subject|6|||
144498143|NCT03523962|521020722|FG003|Open Fractures|Withdrawal by Subject|2|||
144498144|NCT03523962|521020719|FG000|Open Fractures|Incarceration|0|||
144498145|NCT03523962|521020720|FG001|Open Fractures|Incarceration|0|||
144498146|NCT03523962|521020721|FG002|Open Fractures|Incarceration|1|||
144498147|NCT03523962|521020722|FG003|Open Fractures|Incarceration|0|||
144498148|NCT01081145|521020732|FG000|Open-Label Phase|Lack of Efficacy|56|||
144498149|NCT01081145|521020733|FG001|Open-Label Phase|Lack of Efficacy|0|||
144498150|NCT01081145|521020732|FG000|Open-Label Phase|Response criteria not met|46|||
144498151|NCT01081145|521020733|FG001|Open-Label Phase|Response criteria not met|0|||
144498152|NCT01081145|521020732|FG000|Open-Label Phase|Adverse Event|42|||
144498153|NCT01081145|521020733|FG001|Open-Label Phase|Adverse Event|0|||
144498154|NCT01081145|521020732|FG000|Open-Label Phase|Withdrawal by Subject|41|||
144498155|NCT01081145|521020733|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144498156|NCT01081145|521020732|FG000|Open-Label Phase|Other|12|||
144498157|NCT01081145|521020733|FG001|Open-Label Phase|Other|0|||
144498158|NCT01081145|521020732|FG000|Open-Label Phase|Lost to Follow-up|11|||
144498159|NCT01081145|521020733|FG001|Open-Label Phase|Lost to Follow-up|0|||
144498160|NCT01081145|521020732|FG000|Open-Label Phase|Protocol Violation|4|||
144498161|NCT01081145|521020733|FG001|Open-Label Phase|Protocol Violation|0|||
144719818|NCT00947856|521827499|FG001|Follow-up Period|Lost to Follow-up|0|||
144719819|NCT00947856|521827498|FG000|Follow-up Period|Patient unavailable for site visits|1|||
144719820|NCT00947856|521827499|FG001|Follow-up Period|Patient unavailable for site visits|0|||
144719821|NCT00947856|521827498|FG000|Follow-up Period|Withdrawal by Subject|1|||
144719822|NCT00947856|521827499|FG001|Follow-up Period|Withdrawal by Subject|0|||
144719823|NCT01306253|521827503|FG000|Overall Study|Lost to Follow-up|1|||
144719824|NCT01306253|521827504|FG001|Overall Study|Lost to Follow-up|1|||
144719825|NCT00543439|521827505|FG000|Period 1|Adverse Event|0|||
144719826|NCT00543439|521827506|FG001|Period 1|Adverse Event|2|||
144719827|NCT00543439|521827507|FG002|Period 1|Adverse Event|1|||
144719828|NCT00543439|521827505|FG000|Period 1|Withdrawal by Subject|1|||
144719829|NCT00543439|521827506|FG001|Period 1|Withdrawal by Subject|1|||
144719830|NCT00543439|521827507|FG002|Period 1|Withdrawal by Subject|0|||
144719831|NCT00543439|521827505|FG000|Period 1|Physician Decision|0|||
144719832|NCT00543439|521827506|FG001|Period 1|Physician Decision|0|||
144719833|NCT00543439|521827507|FG002|Period 1|Physician Decision|1|||
144719834|NCT00543439|521827505|FG000|Period 2|Protocol Violation|1|||
144719835|NCT00543439|521827506|FG001|Period 2|Protocol Violation|0|||
144719836|NCT00543439|521827507|FG002|Period 2|Protocol Violation|1|||
144719837|NCT00543439|521827505|FG000|Period 2|Adverse Event|0|||
144719838|NCT00543439|521827506|FG001|Period 2|Adverse Event|1|||
144719839|NCT00543439|521827507|FG002|Period 2|Adverse Event|1|||
144719840|NCT01709383|521827512|FG000|Overall Study|Lost to Follow-up|1|||
144719841|NCT01709383|521827513|FG001|Overall Study|Lost to Follow-up|0|||
144719842|NCT03264066|521827514|FG000|Overall Study|Adverse Event|1|||
144719843|NCT03264066|521827515|FG001|Overall Study|Adverse Event|1|||
144719844|NCT03264066|521827516|FG002|Overall Study|Adverse Event|0|||
144719845|NCT03264066|521827517|FG003|Overall Study|Adverse Event|0|||
144719846|NCT03264066|521827518|FG004|Overall Study|Adverse Event|0|||
144719847|NCT03264066|521827519|FG005|Overall Study|Adverse Event|0|||
144719848|NCT03264066|521827514|FG000|Overall Study|Death|12|||
144719849|NCT03264066|521827515|FG001|Overall Study|Death|12|||
144719850|NCT03264066|521827516|FG002|Overall Study|Death|8|||
144719851|NCT03264066|521827517|FG003|Overall Study|Death|10|||
144498162|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
144498163|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
144498164|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
144498165|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
144719852|NCT03264066|521827518|FG004|Overall Study|Death|6|||
144498166|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
144719853|NCT03264066|521827519|FG005|Overall Study|Death|1|||
144719854|NCT03264066|521827514|FG000|Overall Study|Lost to Follow-up|1|||
144498167|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
144498168|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
144498169|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
144498170|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
144498171|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
144498172|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
144498173|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
144498174|NCT01081145|521020732|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
144498175|NCT01081145|521020733|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
144498176|NCT00121199|521020735|FG000|Overall Study|Adverse Event|11|||
144498177|NCT00121199|521020735|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
144498178|NCT00121199|521020735|FG000|Overall Study|Progression/Relapse|1|||
144498179|NCT00121199|521020735|FG000|Overall Study|Death|3|||
144498180|NCT00121199|521020735|FG000|Overall Study|Other - Not Protocol Specified|3|||
144498181|NCT00121199|521020735|FG000|Overall Study|Ineligible|9|||
144498182|NCT03168438|521020736|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
144498183|NCT03168438|521020737|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
144498184|NCT03235349|521020742|FG000|Overall Study|Adverse Event|1|||
144498185|NCT03235349|521020742|FG000|Overall Study|Other|1|||
144498186|NCT01018511|521020744|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
144498187|NCT01018511|521020745|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
144498188|NCT01018511|521020746|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
144498189|NCT01018511|521020747|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
144498190|NCT01018511|521020744|FG000|Overall Study|Adverse Event|5|||
144498191|NCT01018511|521020745|FG001|Overall Study|Adverse Event|9|||
144498192|NCT01018511|521020746|FG002|Overall Study|Adverse Event|13|||
144498193|NCT01018511|521020747|FG003|Overall Study|Adverse Event|10|||
144498194|NCT01018511|521020744|FG000|Overall Study|Lack of Efficacy|4|||
144498195|NCT01018511|521020745|FG001|Overall Study|Lack of Efficacy|1|||
144498196|NCT01018511|521020746|FG002|Overall Study|Lack of Efficacy|1|||
144498197|NCT01018511|521020747|FG003|Overall Study|Lack of Efficacy|2|||
144498198|NCT01018511|521020744|FG000|Overall Study|Withdrawal by Subject|6|||
144498199|NCT01018511|521020745|FG001|Overall Study|Withdrawal by Subject|5|||
144498200|NCT01018511|521020746|FG002|Overall Study|Withdrawal by Subject|11|||
144498201|NCT01018511|521020747|FG003|Overall Study|Withdrawal by Subject|9|||
144498202|NCT01018511|521020744|FG000|Overall Study|Lost to Follow-up|0|||
144498203|NCT01018511|521020745|FG001|Overall Study|Lost to Follow-up|0|||
144498204|NCT01018511|521020746|FG002|Overall Study|Lost to Follow-up|1|||
144498205|NCT01018511|521020747|FG003|Overall Study|Lost to Follow-up|0|||
144498206|NCT01018511|521020744|FG000|Overall Study|Protocol Violation|5|||
144498207|NCT01018511|521020745|FG001|Overall Study|Protocol Violation|8|||
144498208|NCT01018511|521020746|FG002|Overall Study|Protocol Violation|7|||
144498209|NCT01018511|521020747|FG003|Overall Study|Protocol Violation|9|||
144498210|NCT01018511|521020744|FG000|Overall Study|Miscellaneous|0|||
144498211|NCT01018511|521020745|FG001|Overall Study|Miscellaneous|2|||
144498212|NCT01018511|521020746|FG002|Overall Study|Miscellaneous|0|||
144498213|NCT01018511|521020747|FG003|Overall Study|Miscellaneous|0|||
144498214|NCT04523181|521020748|FG000|Overall Study|Withdrawal by Subject|4|||
144498215|NCT04523181|521020749|FG001|Overall Study|Withdrawal by Subject|5|||
144498216|NCT04523181|521020748|FG000|Overall Study|Lost to Follow-up|2|||
144498217|NCT04523181|521020749|FG001|Overall Study|Lost to Follow-up|3|||
144498218|NCT04523181|521020748|FG000|Overall Study|Physician Decision|1|||
144498219|NCT04523181|521020749|FG001|Overall Study|Physician Decision|0|||
144498220|NCT04523181|521020748|FG000|Overall Study|Transferred to external facility.|1|||
144498221|NCT04523181|521020749|FG001|Overall Study|Transferred to external facility.|1|||
144498222|NCT04305912|521020750|FG000|First Intervention|COVID-19 Suspension|2|||
144498223|NCT04305912|521020751|FG001|First Intervention|COVID-19 Suspension|0|||
144498224|NCT04305912|521020750|FG000|First Intervention|Withdrawal by Subject|0|||
144498225|NCT04305912|521020751|FG001|First Intervention|Withdrawal by Subject|1|||
144498226|NCT04305912|521020750|FG000|Second Intervention|Adverse Event|0|||
144498227|NCT04305912|521020751|FG001|Second Intervention|Adverse Event|1|||
144498228|NCT01348087|521020756|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
144498229|NCT01348087|521020756|FG000|Overall Study|Administrative problems|79|||
144498230|NCT01348087|521020756|FG000|Overall Study|protocol deviation|1|||
144498231|NCT01348087|521020756|FG000|Overall Study|Lost to Follow-up|1|||
144498232|NCT01348087|521020756|FG000|Overall Study|Subject withdrew consent|7|||
144498233|NCT01348087|521020756|FG000|Overall Study|Adverse Event|25|||
144498234|NCT00117988|521020761|FG000|Overall Study|Death|3|||
144498235|NCT00117988|521020761|FG000|Overall Study|Adverse Event|1|||
144498236|NCT02482233|521020768|FG000|Overall Study|Lost to Follow-up|1|||
144498237|NCT02482233|521020769|FG001|Overall Study|Lost to Follow-up|1|||
144498238|NCT04888585|521020770|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
144498239|NCT04888585|521020771|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
144498240|NCT04888585|521020772|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
144498241|NCT04888585|521020773|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
144498242|NCT04888585|521020774|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
144498243|NCT04888585|521020775|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
144498244|NCT04888585|521020776|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
144498245|NCT04888585|521020777|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
144498246|NCT04888585|521020778|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
144498247|NCT04888585|521020779|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
144498248|NCT04888585|521020780|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
144498249|NCT04888585|521020770|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498250|NCT04888585|521020771|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
144498251|NCT04888585|521020772|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
144498252|NCT04888585|521020773|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
144498253|NCT04888585|521020774|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
144498254|NCT04888585|521020775|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498255|NCT04888585|521020776|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498256|NCT04888585|521020777|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498257|NCT04888585|521020778|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498258|NCT04888585|521020779|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498259|NCT04888585|521020780|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
144498260|NCT04888585|521020770|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498261|NCT04888585|521020771|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498262|NCT04888585|521020772|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
144498263|NCT04888585|521020773|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498264|NCT04888585|521020774|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
144498265|NCT04888585|521020775|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498266|NCT04888585|521020776|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498267|NCT04888585|521020777|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498268|NCT04888585|521020778|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498269|NCT04888585|521020779|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498270|NCT04888585|521020780|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
144498271|NCT04888585|521020770|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498272|NCT04888585|521020771|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498273|NCT04888585|521020772|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498274|NCT04888585|521020773|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498275|NCT04888585|521020774|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498276|NCT04888585|521020775|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498277|NCT04888585|521020776|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498278|NCT04888585|521020777|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
144498279|NCT04888585|521020778|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498280|NCT04888585|521020779|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
144498281|NCT04888585|521020780|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
144498282|NCT04888585|521020770|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
144498283|NCT04888585|521020771|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
144498284|NCT04888585|521020772|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
144498285|NCT04888585|521020773|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
144498286|NCT04888585|521020774|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
144498287|NCT04888585|521020775|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
144498288|NCT04888585|521020776|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
144498289|NCT04888585|521020777|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
144498290|NCT04888585|521020778|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
144498291|NCT04888585|521020779|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
144498292|NCT04888585|521020780|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
144498293|NCT04888585|521020770|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
144498294|NCT04888585|521020771|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
144498295|NCT04888585|521020772|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
144498296|NCT04888585|521020773|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
144498297|NCT04888585|521020774|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
144498298|NCT04888585|521020775|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
144498299|NCT04888585|521020776|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
144498300|NCT04888585|521020777|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
144498301|NCT04888585|521020778|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
144719855|NCT03264066|521827515|FG001|Overall Study|Lost to Follow-up|0|||
144719856|NCT03264066|521827516|FG002|Overall Study|Lost to Follow-up|0|||
144719857|NCT03264066|521827517|FG003|Overall Study|Lost to Follow-up|0|||
144719858|NCT03264066|521827518|FG004|Overall Study|Lost to Follow-up|0|||
144719859|NCT03264066|521827519|FG005|Overall Study|Lost to Follow-up|0|||
144498302|NCT04888585|521020779|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
144498303|NCT04888585|521020780|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
144498304|NCT04888585|521020770|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
144498305|NCT04888585|521020771|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
144498306|NCT04888585|521020772|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
144498307|NCT04888585|521020773|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
144498308|NCT04888585|521020774|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
144498309|NCT04888585|521020775|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
144498310|NCT04888585|521020776|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
144498311|NCT04888585|521020777|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
144498312|NCT04888585|521020778|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
144498313|NCT04888585|521020779|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
144498314|NCT04888585|521020780|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
144498315|NCT04888585|521020770|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498316|NCT04888585|521020771|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498317|NCT04888585|521020772|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498318|NCT04888585|521020773|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498319|NCT04888585|521020774|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498320|NCT04888585|521020775|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498321|NCT04888585|521020776|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
144498322|NCT04888585|521020777|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
144498323|NCT04888585|521020778|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
144498324|NCT04888585|521020779|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
144498325|NCT04888585|521020780|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
144498326|NCT04927975|521020781|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
144498327|NCT04927975|521020782|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
144498328|NCT04927975|521020783|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
144498329|NCT04927975|521020784|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
144498330|NCT04927975|521020785|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
144498331|NCT04927975|521020786|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
144498332|NCT04927975|521020781|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
144498333|NCT04927975|521020782|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
144498334|NCT04927975|521020783|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
144498335|NCT04927975|521020784|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
144498336|NCT04927975|521020785|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
144498337|NCT04927975|521020786|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
144498338|NCT04927975|521020781|FG000|Period 1 (Baseline-Week 24)|Death|0|||
144498339|NCT04927975|521020782|FG001|Period 1 (Baseline-Week 24)|Death|0|||
144498340|NCT04927975|521020783|FG002|Period 1 (Baseline-Week 24)|Death|0|||
144498341|NCT04927975|521020784|FG003|Period 1 (Baseline-Week 24)|Death|0|||
144498342|NCT04927975|521020785|FG004|Period 1 (Baseline-Week 24)|Death|0|||
144498343|NCT04927975|521020786|FG005|Period 1 (Baseline-Week 24)|Death|1|||
144498344|NCT04927975|521020781|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
144498345|NCT04927975|521020782|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
144498346|NCT04927975|521020783|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
144498347|NCT04927975|521020784|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
144498348|NCT04927975|521020785|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
144498349|NCT04927975|521020786|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
144498350|NCT04927975|521020781|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
144498351|NCT04927975|521020782|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
144498352|NCT04927975|521020783|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
144498353|NCT04927975|521020784|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
144498354|NCT04927975|521020785|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
144498355|NCT04927975|521020786|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
144498356|NCT03822351|521020787|FG000|Overall Study|Death|27|||
144498357|NCT03822351|521020788|FG001|Overall Study|Death|23|||
144498358|NCT03822351|521020789|FG002|Overall Study|Death|24|||
144498359|NCT03822351|521020787|FG000|Overall Study|Lost to Follow-up|6|||
144498360|NCT03822351|521020788|FG001|Overall Study|Lost to Follow-up|2|||
144498361|NCT03822351|521020789|FG002|Overall Study|Lost to Follow-up|1|||
144498362|NCT03822351|521020787|FG000|Overall Study|Withdrawal by Subject|10|||
144719860|NCT03264066|521827514|FG000|Overall Study|Progressive Disease|0|||
144719861|NCT03264066|521827515|FG001|Overall Study|Progressive Disease|2|||
144719862|NCT03264066|521827516|FG002|Overall Study|Progressive Disease|1|||
144719863|NCT03264066|521827517|FG003|Overall Study|Progressive Disease|0|||
144719864|NCT03264066|521827518|FG004|Overall Study|Progressive Disease|0|||
144719865|NCT03264066|521827519|FG005|Overall Study|Progressive Disease|0|||
144719866|NCT03264066|521827514|FG000|Overall Study|Study Terminated by Sponsor|5|||
144498363|NCT03822351|521020788|FG001|Overall Study|Withdrawal by Subject|4|||
144719867|NCT03264066|521827515|FG001|Overall Study|Study Terminated by Sponsor|5|||
144719868|NCT03264066|521827516|FG002|Overall Study|Study Terminated by Sponsor|8|||
144719869|NCT03264066|521827517|FG003|Overall Study|Study Terminated by Sponsor|5|||
144719870|NCT03264066|521827518|FG004|Overall Study|Study Terminated by Sponsor|1|||
144719871|NCT03264066|521827519|FG005|Overall Study|Study Terminated by Sponsor|2|||
144719872|NCT03264066|521827514|FG000|Overall Study|Withdrawal by Subject|1|||
144719873|NCT03264066|521827515|FG001|Overall Study|Withdrawal by Subject|0|||
144719874|NCT03264066|521827516|FG002|Overall Study|Withdrawal by Subject|0|||
144498364|NCT03822351|521020789|FG002|Overall Study|Withdrawal by Subject|6|||
144498365|NCT03822351|521020787|FG000|Overall Study|Progressive Disease|2|||
144498366|NCT03822351|521020788|FG001|Overall Study|Progressive Disease|1|||
144498367|NCT03822351|521020789|FG002|Overall Study|Progressive Disease|0|||
144498368|NCT03822351|521020787|FG000|Overall Study|Not Treated|1|||
144498369|NCT03822351|521020788|FG001|Overall Study|Not Treated|1|||
144498370|NCT03822351|521020789|FG002|Overall Study|Not Treated|1|||
144498371|NCT03563053|521020798|FG000|Overall Study|Withdrawal by Subject|17|||
144498372|NCT03563053|521020798|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
144498373|NCT03563053|521020798|FG000|Overall Study|Adverse Event|3|||
144498374|NCT03563053|521020798|FG000|Overall Study|Physician Decision|1|||
144498375|NCT03563053|521020798|FG000|Overall Study|study terminated by sponsor|71|||
144498376|NCT02081391|521020799|FG000|12-hour Treatment|Withdrawal by Subject|3|||
144498377|NCT02081391|521020800|FG001|12-hour Treatment|Withdrawal by Subject|2|||
144498378|NCT02081391|521020801|FG002|12-hour Treatment|Withdrawal by Subject|0|||
144498379|NCT02081391|521020802|FG003|12-hour Treatment|Withdrawal by Subject|0|||
144498380|NCT02081391|521020799|FG000|12-hour Treatment|Physician Decision|4|||
144498381|NCT02081391|521020800|FG001|12-hour Treatment|Physician Decision|1|||
144498382|NCT02081391|521020801|FG002|12-hour Treatment|Physician Decision|0|||
144498383|NCT02081391|521020802|FG003|12-hour Treatment|Physician Decision|0|||
144498384|NCT02081391|521020799|FG000|12-hour Treatment|Lack of Efficacy|3|||
144498385|NCT02081391|521020800|FG001|12-hour Treatment|Lack of Efficacy|0|||
144498386|NCT02081391|521020801|FG002|12-hour Treatment|Lack of Efficacy|0|||
144498387|NCT02081391|521020802|FG003|12-hour Treatment|Lack of Efficacy|0|||
144498388|NCT02081391|521020799|FG000|12-hour Treatment|Adverse Event|4|||
144498389|NCT02081391|521020800|FG001|12-hour Treatment|Adverse Event|2|||
144498390|NCT02081391|521020801|FG002|12-hour Treatment|Adverse Event|0|||
144498391|NCT02081391|521020802|FG003|12-hour Treatment|Adverse Event|0|||
144498392|NCT02081391|521020799|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
144498393|NCT02081391|521020800|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
144498394|NCT02081391|521020801|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
144498395|NCT02081391|521020802|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
144498396|NCT02081391|521020799|FG000|12-hour Treatment|Further reasons|2|||
144498397|NCT02081391|521020800|FG001|12-hour Treatment|Further reasons|1|||
144498398|NCT02081391|521020801|FG002|12-hour Treatment|Further reasons|0|||
144498399|NCT02081391|521020802|FG003|12-hour Treatment|Further reasons|0|||
144498400|NCT02081391|521020799|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
144498401|NCT02081391|521020800|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
144498402|NCT02081391|521020801|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
144498403|NCT02081391|521020802|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
144498404|NCT02081391|521020799|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
144498405|NCT02081391|521020800|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
144498406|NCT02081391|521020801|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
144498407|NCT02081391|521020802|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
144498408|NCT02081391|521020799|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
144498409|NCT02081391|521020800|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
144498410|NCT02081391|521020801|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
144498411|NCT02081391|521020802|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
144498412|NCT02081391|521020799|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
144498413|NCT02081391|521020800|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
144498414|NCT02081391|521020801|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
144498415|NCT02081391|521020802|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
144498416|NCT02081391|521020799|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
144498417|NCT02081391|521020800|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
144498418|NCT02081391|521020801|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
144498419|NCT02081391|521020802|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
144719875|NCT03264066|521827517|FG003|Overall Study|Withdrawal by Subject|5|||
144498420|NCT02081391|521020799|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
144498421|NCT02081391|521020800|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
144498422|NCT02081391|521020801|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
144498423|NCT02081391|521020802|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
144498424|NCT01458275|521020803|FG000|Overall Study|Adverse Event|3|||
144498425|NCT01458275|521020804|FG001|Overall Study|Adverse Event|4|||
144498426|NCT01458275|521020805|FG002|Overall Study|Adverse Event|1|||
144719876|NCT03264066|521827518|FG004|Overall Study|Withdrawal by Subject|0|||
144719877|NCT03264066|521827519|FG005|Overall Study|Withdrawal by Subject|0|||
144498427|NCT01458275|521020803|FG000|Overall Study|Lost to Follow-up|3|||
144498428|NCT01458275|521020804|FG001|Overall Study|Lost to Follow-up|2|||
144498429|NCT01458275|521020805|FG002|Overall Study|Lost to Follow-up|5|||
144498430|NCT01458275|521020803|FG000|Overall Study|Protocol Violation|5|||
144498431|NCT01458275|521020804|FG001|Overall Study|Protocol Violation|5|||
144498432|NCT01458275|521020805|FG002|Overall Study|Protocol Violation|2|||
144498433|NCT01458275|521020803|FG000|Overall Study|Withdrawal by Subject|3|||
144498434|NCT01458275|521020804|FG001|Overall Study|Withdrawal by Subject|2|||
144498435|NCT01458275|521020805|FG002|Overall Study|Withdrawal by Subject|1|||
144498436|NCT00813488|521020806|FG000|Titration Period 1|Adverse Event|6|||
144498437|NCT00813488|521020807|FG001|Titration Period 1|Adverse Event|1|||
144498438|NCT00813488|521020806|FG000|Titration Period 1|Lack of Efficacy|9|||
144498439|NCT00813488|521020807|FG001|Titration Period 1|Lack of Efficacy|7|||
144498440|NCT00813488|521020806|FG000|Titration Period 1|Withdrawal by Subject|2|||
144498441|NCT00813488|521020807|FG001|Titration Period 1|Withdrawal by Subject|2|||
144498442|NCT00813488|521020806|FG000|Titration Period 1|Protocol Violation|4|||
144498443|NCT00813488|521020807|FG001|Titration Period 1|Protocol Violation|3|||
144498444|NCT00813488|521020806|FG000|Titration Period 1|Non-compliance to study medication|4|||
144498445|NCT00813488|521020807|FG001|Titration Period 1|Non-compliance to study medication|1|||
144498446|NCT00813488|521020806|FG000|Titration Period 1|Non-compliance to study procedures|2|||
144498447|NCT00813488|521020807|FG001|Titration Period 1|Non-compliance to study procedures|2|||
144498448|NCT00813488|521020806|FG000|Titration Period 1|Technical Difficulties|0|||
144498449|NCT00813488|521020807|FG001|Titration Period 1|Technical Difficulties|1|||
144498450|NCT00813488|521020806|FG000|Titration Period 2|Adverse Event|2|||
144498451|NCT00813488|521020807|FG001|Titration Period 2|Adverse Event|3|||
144498452|NCT00813488|521020806|FG000|Titration Period 2|Lack of Efficacy|8|||
144498453|NCT00813488|521020807|FG001|Titration Period 2|Lack of Efficacy|4|||
144498454|NCT00813488|521020806|FG000|Titration Period 2|Protocol Violation|3|||
144498455|NCT00813488|521020807|FG001|Titration Period 2|Protocol Violation|2|||
144498456|NCT00813488|521020806|FG000|Titration Period 2|Lost to Follow-up|1|||
144498457|NCT00813488|521020807|FG001|Titration Period 2|Lost to Follow-up|0|||
144498458|NCT00813488|521020806|FG000|Titration Period 2|Non-compliance with study procedures|2|||
144498459|NCT00813488|521020807|FG001|Titration Period 2|Non-compliance with study procedures|1|||
144498460|NCT00813488|521020806|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
144498461|NCT00813488|521020807|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
144498462|NCT00813488|521020806|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
144498463|NCT00813488|521020807|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
144498464|NCT00813488|521020806|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
144498465|NCT00813488|521020807|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
144498466|NCT00813488|521020806|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
144498467|NCT00813488|521020807|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
144498468|NCT00813488|521020806|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
144498469|NCT00813488|521020807|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
144498470|NCT00813488|521020806|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
144498471|NCT00813488|521020807|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
144498472|NCT00813488|521020806|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
144498473|NCT00813488|521020807|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
144498474|NCT00813488|521020806|FG000|Double-blind Treatment Period 2|Other|1|||
144498475|NCT00813488|521020807|FG001|Double-blind Treatment Period 2|Other|0|||
144498476|NCT00813488|521020806|FG000|Open-label Extension|Adverse Event|1|||
144498477|NCT00813488|521020807|FG001|Open-label Extension|Adverse Event|2|||
144498478|NCT00813488|521020806|FG000|Open-label Extension|Lack of Efficacy|3|||
144498479|NCT00813488|521020807|FG001|Open-label Extension|Lack of Efficacy|0|||
144498480|NCT00813488|521020806|FG000|Open-label Extension|Withdrawal by Subject|0|||
144498481|NCT00813488|521020807|FG001|Open-label Extension|Withdrawal by Subject|2|||
144498482|NCT00813488|521020806|FG000|Open-label Extension|Protocol Violation|1|||
144498483|NCT00813488|521020807|FG001|Open-label Extension|Protocol Violation|2|||
144498484|NCT00813488|521020806|FG000|Open-label Extension|Non-compliance study medication|4|||
144498485|NCT00813488|521020807|FG001|Open-label Extension|Non-compliance study medication|0|||
144498486|NCT00813488|521020806|FG000|Open-label Extension|Non-compliance study procedures|2|||
144498487|NCT00813488|521020807|FG001|Open-label Extension|Non-compliance study procedures|1|||
144498488|NCT00813488|521020806|FG000|Open-label Extension|Other|1|||
144498489|NCT00813488|521020807|FG001|Open-label Extension|Other|0|||
144498490|NCT02926937|521020808|FG000|Overall Study|Adverse Event|0|||
144498491|NCT02926937|521020809|FG001|Overall Study|Adverse Event|1|||
144498492|NCT02926937|521020810|FG002|Overall Study|Adverse Event|1|||
144498493|NCT02926937|521020808|FG000|Overall Study|Poor Compliance to Protocol|1|||
144498494|NCT02926937|521020809|FG001|Overall Study|Poor Compliance to Protocol|0|||
144498495|NCT02926937|521020810|FG002|Overall Study|Poor Compliance to Protocol|0|||
144498496|NCT02926937|521020808|FG000|Overall Study|Lost to Follow-up|4|||
144498497|NCT02926937|521020809|FG001|Overall Study|Lost to Follow-up|5|||
144498498|NCT02926937|521020810|FG002|Overall Study|Lost to Follow-up|0|||
144498499|NCT02926937|521020808|FG000|Overall Study|At the Participant's own Request|11|||
144498500|NCT02926937|521020809|FG001|Overall Study|At the Participant's own Request|5|||
144498501|NCT02926937|521020810|FG002|Overall Study|At the Participant's own Request|8|||
144498502|NCT02926937|521020808|FG000|Overall Study|Reason not Specified|3|||
144498503|NCT02926937|521020809|FG001|Overall Study|Reason not Specified|4|||
144498504|NCT02926937|521020810|FG002|Overall Study|Reason not Specified|2|||
144498505|NCT01559090|521020811|FG000|Stage I|Withdrawal by Subject|2|||
144498506|NCT01559090|521020812|FG001|Stage I|Withdrawal by Subject|2|||
144498507|NCT01559090|521020813|FG002|Stage I|Withdrawal by Subject|3|||
144498508|NCT01559090|521020811|FG000|Stage II|Withdrawal by Subject|1|||
144498509|NCT01559090|521020812|FG001|Stage II|Withdrawal by Subject|0|||
144498510|NCT01559090|521020813|FG002|Stage II|Withdrawal by Subject|0|||
144498511|NCT03677375|521020815|FG000|Overall Study|Incomplete procedure|8|||
144498512|NCT03677375|521020815|FG000|Overall Study|Adverse Event|3|||
144498513|NCT03677375|521020815|FG000|Overall Study|Physician Decision|1|||
144498514|NCT01729871|521020818|FG000|Overall Study|Adverse Event|7|||
144498515|NCT01729871|521020819|FG001|Overall Study|Adverse Event|7|||
144498516|NCT01729871|521020818|FG000|Overall Study|Death|0|||
144498517|NCT01729871|521020819|FG001|Overall Study|Death|1|||
144498518|NCT01729871|521020818|FG000|Overall Study|Lack of Efficacy|0|||
144498519|NCT01729871|521020819|FG001|Overall Study|Lack of Efficacy|1|||
144498520|NCT01729871|521020818|FG000|Overall Study|Physician Decision|0|||
144498521|NCT01729871|521020819|FG001|Overall Study|Physician Decision|2|||
144498522|NCT01729871|521020818|FG000|Overall Study|Protocol Violation|1|||
144498523|NCT01729871|521020819|FG001|Overall Study|Protocol Violation|0|||
144498524|NCT01729871|521020818|FG000|Overall Study|Withdrawal by Subject|0|||
144498525|NCT01729871|521020819|FG001|Overall Study|Withdrawal by Subject|3|||
144498526|NCT01729871|521020818|FG000|Overall Study|Other|4|||
144498527|NCT01729871|521020819|FG001|Overall Study|Other|9|||
144498528|NCT03971357|521020820|FG000|Overall Study|Lack of Efficacy|0|||
144498529|NCT03971357|521020821|FG001|Overall Study|Lack of Efficacy|1|||
144498530|NCT01143077|521020822|FG000|Overall Study|Lack of Efficacy|0|||
144498531|NCT01143077|521020823|FG001|Overall Study|Lack of Efficacy|2|||
144498532|NCT01143077|521020824|FG002|Overall Study|Lack of Efficacy|1|||
144498533|NCT01143077|521020822|FG000|Overall Study|Adverse Event|5|||
144498534|NCT01143077|521020823|FG001|Overall Study|Adverse Event|6|||
144498535|NCT01143077|521020824|FG002|Overall Study|Adverse Event|5|||
144498536|NCT01143077|521020822|FG000|Overall Study|Lost to Follow-up|2|||
144498537|NCT01143077|521020823|FG001|Overall Study|Lost to Follow-up|3|||
144498538|NCT01143077|521020824|FG002|Overall Study|Lost to Follow-up|4|||
144498539|NCT01143077|521020822|FG000|Overall Study|Protocol Violation|2|||
144498540|NCT01143077|521020823|FG001|Overall Study|Protocol Violation|0|||
144498541|NCT01143077|521020824|FG002|Overall Study|Protocol Violation|0|||
144498542|NCT01143077|521020822|FG000|Overall Study|Withdrawal by Subject|4|||
144498543|NCT01143077|521020823|FG001|Overall Study|Withdrawal by Subject|3|||
144498544|NCT01143077|521020824|FG002|Overall Study|Withdrawal by Subject|3|||
144498545|NCT01143077|521020822|FG000|Overall Study|Non-compliance with study drug|0|||
144498546|NCT01143077|521020823|FG001|Overall Study|Non-compliance with study drug|1|||
144498547|NCT01143077|521020824|FG002|Overall Study|Non-compliance with study drug|1|||
144498548|NCT01143077|521020822|FG000|Overall Study|Administrative|1|||
144498549|NCT01143077|521020823|FG001|Overall Study|Administrative|0|||
144498550|NCT01143077|521020824|FG002|Overall Study|Administrative|0|||
144498551|NCT01143077|521020822|FG000|Overall Study|Principal Investigator Decision|2|||
144498552|NCT01143077|521020823|FG001|Overall Study|Principal Investigator Decision|0|||
144498553|NCT01143077|521020824|FG002|Overall Study|Principal Investigator Decision|1|||
144498554|NCT00630864|521020825|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
144498555|NCT00630864|521020825|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
144498556|NCT00124982|521020826|FG000|Short-term Period|Death|1|||
144498557|NCT00124982|521020827|FG001|Short-term Period|Death|1|||
144498558|NCT00124982|521020828|FG002|Short-term Period|Death|0|||
144498559|NCT00124982|521020826|FG000|Short-term Period|Adverse Event|17|||
144498560|NCT00124982|521020827|FG001|Short-term Period|Adverse Event|22|||
144498561|NCT00124982|521020828|FG002|Short-term Period|Adverse Event|0|||
144498562|NCT00124982|521020826|FG000|Short-term Period|Lack of Efficacy|32|||
144498563|NCT00124982|521020827|FG001|Short-term Period|Lack of Efficacy|73|||
144498564|NCT00124982|521020828|FG002|Short-term Period|Lack of Efficacy|0|||
144498565|NCT00124982|521020826|FG000|Short-term Period|Lost to Follow-up|8|||
144498566|NCT00124982|521020827|FG001|Short-term Period|Lost to Follow-up|5|||
144498567|NCT00124982|521020828|FG002|Short-term Period|Lost to Follow-up|0|||
144498568|NCT00124982|521020826|FG000|Short-term Period|Withdrawal of Consent|7|||
144498569|NCT00124982|521020827|FG001|Short-term Period|Withdrawal of Consent|9|||
144498570|NCT00124982|521020828|FG002|Short-term Period|Withdrawal of Consent|0|||
144498571|NCT00124982|521020826|FG000|Short-term Period|Poor/Non-compliance|3|||
144498572|NCT00124982|521020827|FG001|Short-term Period|Poor/Non-compliance|1|||
144498573|NCT00124982|521020828|FG002|Short-term Period|Poor/Non-compliance|0|||
144498574|NCT00124982|521020826|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
144498575|NCT00124982|521020827|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
144498576|NCT00124982|521020828|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
144498577|NCT00124982|521020826|FG000|Short-term Period|Participant Decision|1|||
144498578|NCT00124982|521020827|FG001|Short-term Period|Participant Decision|0|||
144498579|NCT00124982|521020828|FG002|Short-term Period|Participant Decision|0|||
144498580|NCT00124982|521020826|FG000|Short-term Period|Participant Chose Own Doctor|0|||
144498581|NCT00124982|521020827|FG001|Short-term Period|Participant Chose Own Doctor|1|||
144498582|NCT00124982|521020828|FG002|Short-term Period|Participant Chose Own Doctor|0|||
144498583|NCT00124982|521020826|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
144498584|NCT00124982|521020827|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
144498585|NCT00124982|521020828|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
144498586|NCT00124982|521020826|FG000|Short-term Period|Participant Had Lymphopenia|1|||
144498587|NCT00124982|521020827|FG001|Short-term Period|Participant Had Lymphopenia|0|||
144498588|NCT00124982|521020828|FG002|Short-term Period|Participant Had Lymphopenia|0|||
144498589|NCT00124982|521020826|FG000|Long-term Period|Death|0|||
144498590|NCT00124982|521020827|FG001|Long-term Period|Death|0|||
144498591|NCT00124982|521020828|FG002|Long-term Period|Death|1|||
144498592|NCT00124982|521020826|FG000|Long-term Period|Adverse Event|0|||
144498593|NCT00124982|521020827|FG001|Long-term Period|Adverse Event|0|||
144498594|NCT00124982|521020828|FG002|Long-term Period|Adverse Event|17|||
144498595|NCT00124982|521020826|FG000|Long-term Period|Lack of Efficacy|0|||
144498596|NCT00124982|521020827|FG001|Long-term Period|Lack of Efficacy|0|||
144498597|NCT00124982|521020828|FG002|Long-term Period|Lack of Efficacy|46|||
144498598|NCT00124982|521020826|FG000|Long-term Period|Lost to Follow-up|0|||
144498599|NCT00124982|521020827|FG001|Long-term Period|Lost to Follow-up|0|||
144498600|NCT00124982|521020828|FG002|Long-term Period|Lost to Follow-up|4|||
144498601|NCT00124982|521020826|FG000|Long-term Period|Withdrawal by Subject|0|||
144498602|NCT00124982|521020827|FG001|Long-term Period|Withdrawal by Subject|0|||
144498603|NCT00124982|521020828|FG002|Long-term Period|Withdrawal by Subject|16|||
144498604|NCT00124982|521020826|FG000|Long-term Period|Pregnancy|0|||
144498605|NCT00124982|521020827|FG001|Long-term Period|Pregnancy|0|||
144498606|NCT00124982|521020828|FG002|Long-term Period|Pregnancy|1|||
144498607|NCT00124982|521020826|FG000|Long-term Period|Poor/Non-compliance|0|||
144498608|NCT00124982|521020827|FG001|Long-term Period|Poor/Non-compliance|0|||
144498609|NCT00124982|521020828|FG002|Long-term Period|Poor/Non-compliance|2|||
144498610|NCT00124982|521020826|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
144498611|NCT00124982|521020827|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
144498612|NCT00124982|521020828|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
144498613|NCT00124982|521020826|FG000|Long-term Period|Neurologist Recommendation|0|||
144498614|NCT00124982|521020827|FG001|Long-term Period|Neurologist Recommendation|0|||
144498615|NCT00124982|521020828|FG002|Long-term Period|Neurologist Recommendation|1|||
144498616|NCT01555762|521020829|FG000|Overall Study|No information on Bevacizumab intake|11|||
144498617|NCT01555762|521020829|FG000|Overall Study|Missing start date of infusion|8|||
144498618|NCT01555762|521020829|FG000|Overall Study|75 years old or more ticked No|1|||
144498619|NCT01555762|521020829|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
144498620|NCT01555762|521020829|FG000|Overall Study|Death linked to progression of disease|165|||
144498621|NCT01555762|521020829|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
144498622|NCT01555762|521020829|FG000|Overall Study|Investigator's decision|10|||
144498623|NCT01555762|521020829|FG000|Overall Study|Participant not wishing to continue|5|||
144498624|NCT01555762|521020829|FG000|Overall Study|Missing data|1|||
144498625|NCT01555762|521020829|FG000|Overall Study|Death linked to an adverse event|14|||
144498626|NCT02501811|521020830|FG000|Overall Study|Death|1|||
144498627|NCT02501811|521020831|FG001|Overall Study|Death|3|||
144498628|NCT02501811|521020832|FG002|Overall Study|Death|2|||
144498629|NCT02501811|521020833|FG003|Overall Study|Death|3|||
144498630|NCT02501811|521020830|FG000|Overall Study|Withdrawal by Subject|3|||
144498631|NCT02501811|521020831|FG001|Overall Study|Withdrawal by Subject|3|||
144498632|NCT02501811|521020832|FG002|Overall Study|Withdrawal by Subject|2|||
144498633|NCT02501811|521020833|FG003|Overall Study|Withdrawal by Subject|3|||
144498634|NCT02501811|521020830|FG000|Overall Study|Lost to Follow-up|0|||
144498635|NCT02501811|521020831|FG001|Overall Study|Lost to Follow-up|0|||
144498636|NCT02501811|521020832|FG002|Overall Study|Lost to Follow-up|2|||
144498637|NCT02501811|521020833|FG003|Overall Study|Lost to Follow-up|1|||
144498638|NCT01311648|521022766|FG000|Main Study|Protocol Violation|0|||
144498639|NCT01311648|521022767|FG001|Main Study|Protocol Violation|1|||
144498640|NCT01311648|521022766|FG000|Main Study|Adverse Event|0|||
144498641|NCT01311648|521022767|FG001|Main Study|Adverse Event|1|||
144498642|NCT01311648|521022766|FG000|Main Study|Inhibitor management|0|||
144498643|NCT01311648|521022767|FG001|Main Study|Inhibitor management|17|||
144498644|NCT01311648|521022766|FG000|Main Study|Withdrawal by Subject|0|||
144498645|NCT01311648|521022767|FG001|Main Study|Withdrawal by Subject|2|||
144498646|NCT01311648|521022766|FG000|Extension Study|Physician Decision|0|||
144498647|NCT01311648|521022767|FG001|Extension Study|Physician Decision|1|||
144498648|NCT01311648|521022766|FG000|Extension Study|ITI therapy with marketed product|0|||
144498649|NCT01311648|521022767|FG001|Extension Study|ITI therapy with marketed product|1|||
144498650|NCT01311648|521022766|FG000|Extension Study|Incorrect visit planning|0|||
144498651|NCT01311648|521022767|FG001|Extension Study|Incorrect visit planning|1|||
144498652|NCT01311648|521022766|FG000|Extension Study|Family's decision|0|||
144498653|NCT01311648|521022767|FG001|Extension Study|Family's decision|1|||
144498654|NCT01311648|521022766|FG000|Extension Study|Failure of ITI therapy|0|||
144498655|NCT01311648|521022767|FG001|Extension Study|Failure of ITI therapy|3|||
144498656|NCT01311648|521022766|FG000|Extension Study|Long travel|0|||
144498657|NCT01311648|521022767|FG001|Extension Study|Long travel|1|||
144498658|NCT01311648|521022766|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
144498659|NCT01311648|521022767|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
144498660|NCT01311648|521022766|FG000|Extension Study|Withdrawal by Subject|0|||
144498661|NCT01311648|521022767|FG001|Extension Study|Withdrawal by Subject|1|||
144498662|NCT01311648|521022766|FG000|Extension Study|Inhibitor management|0|||
144498663|NCT01311648|521022767|FG001|Extension Study|Inhibitor management|2|||
144498664|NCT04057196|521022768|FG000|Overall Study|Withdrawal by Subject|3|||
144498665|NCT04057196|521022768|FG000|Overall Study|Death|3|||
144498666|NCT02466516|521022770|FG000|Overall Study|Adverse Event|1|||
144498667|NCT02466516|521022771|FG001|Overall Study|Adverse Event|1|||
144498668|NCT02466516|521022772|FG002|Overall Study|Adverse Event|0|||
144498669|NCT02466516|521022773|FG003|Overall Study|Adverse Event|0|||
144498670|NCT02466516|521022774|FG004|Overall Study|Adverse Event|0|||
144498671|NCT02466516|521022770|FG000|Overall Study|Withdrew Consent|1|||
144498672|NCT02466516|521022771|FG001|Overall Study|Withdrew Consent|0|||
144498673|NCT02466516|521022772|FG002|Overall Study|Withdrew Consent|0|||
144498674|NCT02466516|521022773|FG003|Overall Study|Withdrew Consent|0|||
144498675|NCT02466516|521022774|FG004|Overall Study|Withdrew Consent|0|||
144498676|NCT02466516|521022770|FG000|Overall Study|Lost to Follow-up|2|||
144498677|NCT02466516|521022771|FG001|Overall Study|Lost to Follow-up|0|||
144498678|NCT02466516|521022772|FG002|Overall Study|Lost to Follow-up|1|||
144498679|NCT02466516|521022773|FG003|Overall Study|Lost to Follow-up|0|||
144498680|NCT02466516|521022774|FG004|Overall Study|Lost to Follow-up|0|||
144498681|NCT03895034|521022775|FG000|Overall Study|Lost to Follow-up|2|||
144498682|NCT03712930|521022776|FG000|Overall Study|Death|7|||
144498683|NCT03712930|521022776|FG000|Overall Study|Physician Decision|1|||
144498684|NCT03712930|521022776|FG000|Overall Study|Study Terminated by Sponsor|3|||
144498685|NCT03712930|521022776|FG000|Overall Study|Progressive Disease|2|||
144498686|NCT01118377|521022781|FG000|Overall Study|Did Not Receive Study Medication|1|||
144498687|NCT01118377|521022781|FG000|Overall Study|Death|38|||
144498688|NCT01118377|521022781|FG000|Overall Study|Failure to Return|3|||
144498689|NCT00646451|521022784|FG000|Overall Study|Adverse Event|3|||
144498690|NCT00646451|521022785|FG001|Overall Study|Adverse Event|0|||
144498691|NCT00646451|521022784|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
144498692|NCT00646451|521022785|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
144498693|NCT00109967|521022786|FG000|Overall Study|Cancel Prior to Treatment|2|||
144498694|NCT00109967|521022787|FG001|Overall Study|Cancel Prior to Treatment|0|||
144498695|NCT00109967|521022786|FG000|Overall Study|Adverse Event|12|||
144498696|NCT00109967|521022787|FG001|Overall Study|Adverse Event|1|||
144498697|NCT00109967|521022786|FG000|Overall Study|Withdrawal by Subject|5|||
144498698|NCT00109967|521022787|FG001|Overall Study|Withdrawal by Subject|0|||
144498699|NCT00109967|521022786|FG000|Overall Study|Physician Decision|1|||
144498700|NCT00109967|521022787|FG001|Overall Study|Physician Decision|3|||
144498701|NCT00109967|521022786|FG000|Overall Study|Death|0|||
144498702|NCT00109967|521022787|FG001|Overall Study|Death|2|||
144498703|NCT01977612|521022792|FG000|Overall Study|Lost to Follow-up|1|||
144498704|NCT01977612|521022793|FG001|Overall Study|Lost to Follow-up|1|||
144498705|NCT02715258|521022794|FG000|Overall Study|Withdrawal by Subject|6|||
144498706|NCT02715258|521022795|FG001|Overall Study|Withdrawal by Subject|1|||
144498707|NCT02715258|521022794|FG000|Overall Study|Lost to Follow-up|7|||
144498708|NCT02715258|521022795|FG001|Overall Study|Lost to Follow-up|1|||
144498709|NCT02715258|521022794|FG000|Overall Study|Terminated by Sponsor|0|||
144498710|NCT02715258|521022795|FG001|Overall Study|Terminated by Sponsor|1|||
144498711|NCT02715258|521022794|FG000|Overall Study|Death|0|||
144498712|NCT02715258|521022795|FG001|Overall Study|Death|1|||
144498713|NCT02715258|521022794|FG000|Overall Study|Subject non-compliant|1|||
144498714|NCT02715258|521022795|FG001|Overall Study|Subject non-compliant|1|||
144498715|NCT02715258|521022794|FG000|Overall Study|GCP violation|2|||
144498716|NCT02715258|521022795|FG001|Overall Study|GCP violation|1|||
144498717|NCT02955069|521022797|FG000|Overall Study|Adverse Event|7|||
144498718|NCT02955069|521022798|FG001|Overall Study|Adverse Event|2|||
144498719|NCT02955069|521022797|FG000|Overall Study|Death|7|||
144498720|NCT02955069|521022798|FG001|Overall Study|Death|3|||
144498721|NCT02955069|521022797|FG000|Overall Study|Physician Decision|10|||
144498722|NCT02955069|521022798|FG001|Overall Study|Physician Decision|2|||
144498723|NCT02955069|521022797|FG000|Overall Study|Progressive disease|64|||
144498724|NCT02955069|521022798|FG001|Overall Study|Progressive disease|13|||
144498725|NCT02955069|521022797|FG000|Overall Study|Study terminated by sponsor|4|||
144498726|NCT02955069|521022798|FG001|Overall Study|Study terminated by sponsor|0|||
144498727|NCT02955069|521022797|FG000|Overall Study|Subject/Guardian decision|3|||
144498728|NCT02955069|521022798|FG001|Overall Study|Subject/Guardian decision|1|||
144498729|NCT01149681|521022799|FG000|Overall Study|Withdrawal by Subject|7|||
144498730|NCT01149681|521022799|FG000|Overall Study|Progressive disease|1|||
144498731|NCT01149681|521022799|FG000|Overall Study|Physician Decision|2|||
144498732|NCT01149681|521022799|FG000|Overall Study|adverse events nonrelated study drug|2|||
144498733|NCT03107611|521022801|FG000|Overall Study|Adverse Event|1|||
144498734|NCT03107611|521022802|FG001|Overall Study|Adverse Event|0|||
144498735|NCT03107611|521022803|FG002|Overall Study|Adverse Event|2|||
144498736|NCT03107611|521022801|FG000|Overall Study|Lost to Follow-up|3|||
144498737|NCT03107611|521022802|FG001|Overall Study|Lost to Follow-up|3|||
144498738|NCT03107611|521022803|FG002|Overall Study|Lost to Follow-up|3|||
144498739|NCT03107611|521022801|FG000|Overall Study|Protocol Violation|0|||
144498740|NCT03107611|521022802|FG001|Overall Study|Protocol Violation|0|||
144498741|NCT03107611|521022803|FG002|Overall Study|Protocol Violation|1|||
144498742|NCT03107611|521022801|FG000|Overall Study|Withdrawal by Subject|1|||
144498743|NCT03107611|521022802|FG001|Overall Study|Withdrawal by Subject|0|||
144498744|NCT03107611|521022803|FG002|Overall Study|Withdrawal by Subject|1|||
144498745|NCT03107611|521022801|FG000|Overall Study|Worsening signs/symptoms|2|||
144498746|NCT03107611|521022802|FG001|Overall Study|Worsening signs/symptoms|1|||
144498747|NCT03107611|521022803|FG002|Overall Study|Worsening signs/symptoms|2|||
144498748|NCT01720446|521022806|FG000|Overall Study|Lost to Follow-up|12|||
144498749|NCT01720446|521022807|FG001|Overall Study|Lost to Follow-up|6|||
144498750|NCT01720446|521022808|FG002|Overall Study|Lost to Follow-up|16|||
144498751|NCT01720446|521022809|FG003|Overall Study|Lost to Follow-up|16|||
144498752|NCT01720446|521022806|FG000|Overall Study|Withdrawal by Subject|2|||
144498753|NCT01720446|521022807|FG001|Overall Study|Withdrawal by Subject|5|||
144498754|NCT01720446|521022808|FG002|Overall Study|Withdrawal by Subject|4|||
144498755|NCT01720446|521022809|FG003|Overall Study|Withdrawal by Subject|4|||
144498756|NCT01908634|521022812|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
144498757|NCT01908634|521022812|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
144498758|NCT01570751|521022813|FG000|Period A (16 Weeks)|Protocol Violation|1|||
144498759|NCT01570751|521022814|FG001|Period A (16 Weeks)|Protocol Violation|1|||
144498760|NCT01570751|521022813|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
144498761|NCT01570751|521022814|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
144498762|NCT01570751|521022813|FG000|Period A (16 Weeks)|Unclassified|2|||
144498763|NCT01570751|521022814|FG001|Period A (16 Weeks)|Unclassified|3|||
144498764|NCT01570751|521022813|FG000|Period B (16 Weeks)|Adverse Event|1|||
144498765|NCT01570751|521022814|FG001|Period B (16 Weeks)|Adverse Event|0|||
144498766|NCT01570751|521022813|FG000|Period B (16 Weeks)|Protocol Violation|0|||
144498767|NCT01570751|521022814|FG001|Period B (16 Weeks)|Protocol Violation|1|||
144498768|NCT00930813|521022815|FG000|Overall Study|Death|4|||
144498769|NCT00930813|521022816|FG001|Overall Study|Death|5|||
144498770|NCT00930813|521022815|FG000|Overall Study|Withdrawal by Subject|2|||
144498771|NCT00930813|521022816|FG001|Overall Study|Withdrawal by Subject|5|||
144498772|NCT00930813|521022815|FG000|Overall Study|Lost to Follow-up|2|||
144498773|NCT00930813|521022816|FG001|Overall Study|Lost to Follow-up|4|||
144498774|NCT01876511|521022817|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
144498775|NCT01876511|521022818|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
144498776|NCT01876511|521022819|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
144498777|NCT01876511|521022817|FG000|Overall Study|Death (unrelated)|3|||
144498778|NCT01876511|521022818|FG001|Overall Study|Death (unrelated)|0|||
144498779|NCT01876511|521022819|FG002|Overall Study|Death (unrelated)|2|||
144498780|NCT01876511|521022817|FG000|Overall Study|Drug-related Toxicity|5|||
144498781|NCT01876511|521022818|FG001|Overall Study|Drug-related Toxicity|1|||
144498782|NCT01876511|521022819|FG002|Overall Study|Drug-related Toxicity|6|||
144498783|NCT01876511|521022817|FG000|Overall Study|Patient Decision|3|||
144498784|NCT01876511|521022818|FG001|Overall Study|Patient Decision|0|||
144498785|NCT01876511|521022819|FG002|Overall Study|Patient Decision|6|||
144498786|NCT01876511|521022817|FG000|Overall Study|Physician Decision|1|||
144498787|NCT01876511|521022818|FG001|Overall Study|Physician Decision|0|||
144498788|NCT01876511|521022819|FG002|Overall Study|Physician Decision|1|||
144498789|NCT02131324|521022824|FG000|Overall Study|Withdrawal by Subject|1|||
144498790|NCT02131324|521022825|FG001|Overall Study|Withdrawal by Subject|2|||
144498791|NCT02131324|521022824|FG000|Overall Study|Lost to Follow-up|1|||
144498792|NCT02131324|521022825|FG001|Overall Study|Lost to Follow-up|1|||
144498793|NCT00891618|521022826|FG000|Overall Study|Withdrawal by Subject|1|||
144498794|NCT05419557|521022828|FG000|Overall Study|Lost to Follow-up|11|||
144498795|NCT05419557|521022829|FG001|Overall Study|Lost to Follow-up|4|||
144498796|NCT01196988|521022830|FG000|Overall Study|Adverse Event|1|||
144498797|NCT01196988|521022831|FG001|Overall Study|Adverse Event|2|||
144498798|NCT01196988|521022832|FG002|Overall Study|Adverse Event|0|||
144498799|NCT01196988|521022833|FG003|Overall Study|Adverse Event|0|||
144498800|NCT01196988|521022830|FG000|Overall Study|Withdrawal by Subject|5|||
144498801|NCT01196988|521022831|FG001|Overall Study|Withdrawal by Subject|1|||
144498802|NCT01196988|521022832|FG002|Overall Study|Withdrawal by Subject|4|||
144498803|NCT01196988|521022833|FG003|Overall Study|Withdrawal by Subject|0|||
144498804|NCT01196988|521022830|FG000|Overall Study|Lost to Follow-up|16|||
144498805|NCT01196988|521022831|FG001|Overall Study|Lost to Follow-up|29|||
144498806|NCT01196988|521022832|FG002|Overall Study|Lost to Follow-up|21|||
144498807|NCT01196988|521022833|FG003|Overall Study|Lost to Follow-up|1|||
144498808|NCT01196988|521022830|FG000|Overall Study|Other|2|||
144498809|NCT01196988|521022831|FG001|Overall Study|Other|0|||
144498810|NCT01196988|521022832|FG002|Overall Study|Other|0|||
144498811|NCT01196988|521022833|FG003|Overall Study|Other|0|||
144498812|NCT01233050|521022834|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
144498813|NCT01233050|521022835|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
144498814|NCT04582877|521022836|FG000|Overall Study|Did not use device measurement|5|||
144498815|NCT04582877|521022836|FG000|Overall Study|No fractional flow reserve test results|2|||
144498816|NCT04582877|521022836|FG000|Overall Study|Protocol Violation|1|||
144498817|NCT02299635|521022837|FG000|Overall Study|Adverse Event|2|||
144498818|NCT02299635|521022837|FG000|Overall Study|Death|1|||
144498819|NCT02299635|521022837|FG000|Overall Study|Global deterioration of health status|1|||
144498820|NCT02299635|521022837|FG000|Overall Study|Objective progression or relapse|10|||
144498821|NCT02299635|521022837|FG000|Overall Study|Withdrawal by Subject|2|||
144498822|NCT02299635|521022837|FG000|Overall Study|Other|3|||
144498823|NCT00601640|521022838|FG000|Overall Study|Withdrawal by Subject|3|||
144498824|NCT00601640|521022839|FG001|Overall Study|Withdrawal by Subject|0|||
144498825|NCT00601640|521022840|FG002|Overall Study|Withdrawal by Subject|7|||
144498826|NCT00601640|521022838|FG000|Overall Study|Death|1|||
144498827|NCT00601640|521022839|FG001|Overall Study|Death|0|||
144498828|NCT00601640|521022840|FG002|Overall Study|Death|0|||
144498829|NCT00601640|521022838|FG000|Overall Study|Adverse Event|0|||
144498830|NCT00601640|521022839|FG001|Overall Study|Adverse Event|4|||
144498831|NCT00601640|521022840|FG002|Overall Study|Adverse Event|2|||
144498832|NCT00601640|521022838|FG000|Overall Study|intercurrent illness|1|||
144498833|NCT00601640|521022839|FG001|Overall Study|intercurrent illness|0|||
144498834|NCT00601640|521022840|FG002|Overall Study|intercurrent illness|0|||
144498835|NCT00601640|521022838|FG000|Overall Study|change in eligibility status|0|||
144498836|NCT00601640|521022839|FG001|Overall Study|change in eligibility status|1|||
144498837|NCT00601640|521022840|FG002|Overall Study|change in eligibility status|1|||
144498838|NCT01674569|521022841|FG000|Overall Study|Adverse Event|0|||
144498839|NCT01674569|521022842|FG001|Overall Study|Adverse Event|2|||
144498840|NCT01674569|521022843|FG002|Overall Study|Adverse Event|0|||
144498841|NCT01674569|521022844|FG003|Overall Study|Adverse Event|1|||
144498842|NCT01674569|521022845|FG004|Overall Study|Adverse Event|2|||
144498843|NCT01674569|521022846|FG005|Overall Study|Adverse Event|2|||
144498844|NCT01674569|521022841|FG000|Overall Study|Protocol Violation|0|||
144498845|NCT01674569|521022842|FG001|Overall Study|Protocol Violation|1|||
144498846|NCT01674569|521022843|FG002|Overall Study|Protocol Violation|1|||
144498847|NCT01674569|521022844|FG003|Overall Study|Protocol Violation|0|||
144498848|NCT01674569|521022845|FG004|Overall Study|Protocol Violation|0|||
144498849|NCT01674569|521022846|FG005|Overall Study|Protocol Violation|0|||
144498850|NCT01674569|521022841|FG000|Overall Study|Withdrawal by Subject|0|||
144498851|NCT01674569|521022842|FG001|Overall Study|Withdrawal by Subject|0|||
144498852|NCT01674569|521022843|FG002|Overall Study|Withdrawal by Subject|1|||
144498853|NCT01674569|521022844|FG003|Overall Study|Withdrawal by Subject|0|||
144498854|NCT01674569|521022845|FG004|Overall Study|Withdrawal by Subject|0|||
144498855|NCT01674569|521022846|FG005|Overall Study|Withdrawal by Subject|0|||
144498856|NCT01599325|521022847|FG000|Primary Parent Phase|Adverse Event|5|||
144498857|NCT01599325|521022847|FG000|Primary Parent Phase|Disease Progression|7|||
144498858|NCT01599325|521022847|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
144498859|NCT01599325|521022847|FG000|Primary Parent Phase|Death|13|||
144498860|NCT01599325|521022847|FG000|Primary Parent Phase|Protocol Violation|1|||
144498861|NCT01599325|521022847|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
144498862|NCT01599325|521022847|FG000|Primary Parent Phase|Other|2|||
144498863|NCT01599325|521022847|FG000|Extension Phase|Study Closure|1|||
144498864|NCT01599325|521022847|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
144498865|NCT01599325|521022847|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
144498866|NCT01599325|521022847|FG000|Extension Phase|Disease Progression|1|||
144498867|NCT01599325|521022847|FG000|Extension Phase|Withdrawal by Subject|8|||
144498868|NCT00567164|521022850|FG000|Overall Study|Withdrawal by Subject|171|||
144498869|NCT00567164|521022851|FG001|Overall Study|Withdrawal by Subject|21|||
144498870|NCT00567164|521022852|FG002|Overall Study|Withdrawal by Subject|17|||
144498871|NCT00567164|521022850|FG000|Overall Study|Protocol Violation|23|||
144498872|NCT00567164|521022851|FG001|Overall Study|Protocol Violation|4|||
144498873|NCT00567164|521022852|FG002|Overall Study|Protocol Violation|2|||
144498874|NCT00567164|521022850|FG000|Overall Study|Adverse Event|92|||
144498875|NCT00567164|521022851|FG001|Overall Study|Adverse Event|13|||
144498876|NCT00567164|521022852|FG002|Overall Study|Adverse Event|9|||
144498877|NCT00567164|521022850|FG000|Overall Study|Death|0|||
144498878|NCT00567164|521022851|FG001|Overall Study|Death|0|||
144498879|NCT00567164|521022852|FG002|Overall Study|Death|1|||
144498880|NCT00567164|521022850|FG000|Overall Study|Lost to Follow-up|202|||
144498881|NCT00567164|521022851|FG001|Overall Study|Lost to Follow-up|23|||
144498882|NCT00567164|521022852|FG002|Overall Study|Lost to Follow-up|21|||
144498883|NCT00567164|521022850|FG000|Overall Study|Pregnancy|20|||
144498884|NCT00567164|521022851|FG001|Overall Study|Pregnancy|4|||
144498885|NCT00567164|521022852|FG002|Overall Study|Pregnancy|6|||
144498886|NCT00567164|521022850|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
144498887|NCT00567164|521022851|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
144498888|NCT00567164|521022852|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
144498889|NCT00567164|521022850|FG000|Overall Study|Missing|1|||
144498890|NCT00567164|521022851|FG001|Overall Study|Missing|0|||
144498891|NCT00567164|521022852|FG002|Overall Study|Missing|0|||
144498892|NCT03736785|521022856|FG000|Overall Study|Adverse Event|1|||
144498893|NCT03736785|521022857|FG001|Overall Study|Adverse Event|1|||
144498894|NCT03736785|521022858|FG002|Overall Study|Adverse Event|1|||
144498895|NCT03736785|521022856|FG000|Overall Study|Death|1|||
144498896|NCT03736785|521022857|FG001|Overall Study|Death|0|||
144498897|NCT03736785|521022858|FG002|Overall Study|Death|1|||
144498898|NCT03736785|521022856|FG000|Overall Study|Lost to Follow-up|0|||
144498899|NCT03736785|521022857|FG001|Overall Study|Lost to Follow-up|2|||
144498900|NCT03736785|521022858|FG002|Overall Study|Lost to Follow-up|3|||
144498901|NCT03736785|521022856|FG000|Overall Study|Non compliance with study drug|1|||
144498902|NCT03736785|521022857|FG001|Overall Study|Non compliance with study drug|1|||
144498903|NCT03736785|521022858|FG002|Overall Study|Non compliance with study drug|0|||
144498904|NCT03736785|521022856|FG000|Overall Study|Physician Decision|0|||
144498905|NCT03736785|521022857|FG001|Overall Study|Physician Decision|1|||
144498906|NCT03736785|521022858|FG002|Overall Study|Physician Decision|1|||
144498907|NCT03736785|521022856|FG000|Overall Study|Protocol Violation|1|||
144498908|NCT03736785|521022857|FG001|Overall Study|Protocol Violation|4|||
144498909|NCT03736785|521022858|FG002|Overall Study|Protocol Violation|3|||
144498910|NCT03736785|521022856|FG000|Overall Study|Sponsor Decision|1|||
144498911|NCT03736785|521022857|FG001|Overall Study|Sponsor Decision|0|||
144498912|NCT03736785|521022858|FG002|Overall Study|Sponsor Decision|0|||
144498913|NCT03736785|521022856|FG000|Overall Study|Unknown/Missing data|3|||
144498914|NCT03736785|521022857|FG001|Overall Study|Unknown/Missing data|2|||
144498915|NCT03736785|521022858|FG002|Overall Study|Unknown/Missing data|1|||
144498916|NCT03736785|521022856|FG000|Overall Study|Withdrawal by Subject|9|||
144498917|NCT03736785|521022857|FG001|Overall Study|Withdrawal by Subject|6|||
144498918|NCT03736785|521022858|FG002|Overall Study|Withdrawal by Subject|4|||
144498919|NCT00320489|521022861|FG000|Overall Study|Adverse Event|26|||
144498920|NCT00320489|521022862|FG001|Overall Study|Adverse Event|25|||
144498921|NCT00320489|521022861|FG000|Overall Study|Clinical Relapse|26|||
144498922|NCT00320489|521022862|FG001|Overall Study|Clinical Relapse|20|||
144498923|NCT00320489|521022861|FG000|Overall Study|Death|0|||
144498924|NCT00320489|521022862|FG001|Overall Study|Death|2|||
144498925|NCT00320489|521022861|FG000|Overall Study|Entry Criteria Exclusion|2|||
144498926|NCT00320489|521022862|FG001|Overall Study|Entry Criteria Exclusion|4|||
144498927|NCT00320489|521022861|FG000|Overall Study|Lack of Efficacy|16|||
144498928|NCT00320489|521022862|FG001|Overall Study|Lack of Efficacy|7|||
144498929|NCT00320489|521022861|FG000|Overall Study|Lost to Follow-up|21|||
144498930|NCT00320489|521022862|FG001|Overall Study|Lost to Follow-up|22|||
144498931|NCT00320489|521022861|FG000|Overall Study|Physician Decision|8|||
144498932|NCT00320489|521022862|FG001|Overall Study|Physician Decision|8|||
144498933|NCT00320489|521022861|FG000|Overall Study|Protocol Violation|4|||
144498934|NCT00320489|521022862|FG001|Overall Study|Protocol Violation|4|||
144498935|NCT00320489|521022861|FG000|Overall Study|Sponsor Decision|3|||
144498936|NCT00320489|521022862|FG001|Overall Study|Sponsor Decision|3|||
144498937|NCT00320489|521022861|FG000|Overall Study|Withdrawal by Subject|39|||
144498938|NCT00320489|521022862|FG001|Overall Study|Withdrawal by Subject|41|||
144498939|NCT03441984|521022864|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498940|NCT03441984|521022865|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498941|NCT03441984|521022866|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
144498942|NCT03441984|521022867|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498943|NCT03441984|521022868|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498944|NCT03441984|521022869|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498945|NCT03441984|521022870|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498946|NCT03441984|521022871|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498947|NCT03441984|521022872|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498948|NCT03441984|521022873|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498949|NCT03441984|521022874|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498950|NCT03441984|521022875|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
144498951|NCT01190150|521022881|FG000|First Treatment|Withdrawal by Subject|1|||
144498952|NCT01190150|521022882|FG001|First Treatment|Withdrawal by Subject|0|||
144498953|NCT01190150|521022881|FG000|Washout|Withdrawal by Subject|0|||
144498954|NCT01190150|521022882|FG001|Washout|Withdrawal by Subject|1|||
144498955|NCT01190150|521022881|FG000|Washout|Difficulty in adherence|0|||
144498956|NCT01190150|521022882|FG001|Washout|Difficulty in adherence|1|||
144498957|NCT02138916|521022883|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
144498958|NCT02138916|521022884|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
144498959|NCT02138916|521022885|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
144498960|NCT02138916|521022883|FG000|Overall Study|Death|14|||
144498961|NCT02138916|521022884|FG001|Overall Study|Death|11|||
144498962|NCT02138916|521022885|FG002|Overall Study|Death|12|||
144498963|NCT02138916|521022883|FG000|Overall Study|Withdrawal by Subject|27|||
144498964|NCT02138916|521022884|FG001|Overall Study|Withdrawal by Subject|31|||
144498965|NCT02138916|521022885|FG002|Overall Study|Withdrawal by Subject|32|||
144498966|NCT02138916|521022883|FG000|Overall Study|Study specific withdrawal criteria|0|||
144498967|NCT02138916|521022884|FG001|Overall Study|Study specific withdrawal criteria|0|||
144498968|NCT02138916|521022885|FG002|Overall Study|Study specific withdrawal criteria|1|||
144498969|NCT02138916|521022883|FG000|Overall Study|incorrect enrolment|1|||
144498970|NCT02138916|521022884|FG001|Overall Study|incorrect enrolment|1|||
144498971|NCT02138916|521022885|FG002|Overall Study|incorrect enrolment|0|||
144498972|NCT02138916|521022883|FG000|Overall Study|Severe non-compliance|1|||
144498973|NCT02138916|521022884|FG001|Overall Study|Severe non-compliance|2|||
144498974|NCT02138916|521022885|FG002|Overall Study|Severe non-compliance|1|||
144498975|NCT02138916|521022883|FG000|Overall Study|Lost to Follow-up|4|||
144498976|NCT02138916|521022884|FG001|Overall Study|Lost to Follow-up|2|||
144498977|NCT02138916|521022885|FG002|Overall Study|Lost to Follow-up|3|||
144498978|NCT02138916|521022883|FG000|Overall Study|Adverse Event|4|||
144498979|NCT02138916|521022884|FG001|Overall Study|Adverse Event|4|||
144498980|NCT02138916|521022885|FG002|Overall Study|Adverse Event|3|||
144498981|NCT01333514|521022886|FG000|Overall Study|Withdrawal by Subject|1|||
144498982|NCT01333514|521022887|FG001|Overall Study|Withdrawal by Subject|0|||
144498983|NCT00836810|521022888|FG000|Overall Study|New diagnosis|1|||
144498984|NCT00836810|521022889|FG001|Overall Study|New diagnosis|0|||
144498985|NCT00819910|521022892|FG000|Overall Study|Adverse Event|0|||
144498986|NCT00819910|521022893|FG001|Overall Study|Adverse Event|0|||
144498987|NCT00819910|521022894|FG002|Overall Study|Adverse Event|2|||
144498988|NCT00819910|521022895|FG003|Overall Study|Adverse Event|1|||
144498989|NCT00819910|521022892|FG000|Overall Study|Withdrawal by Subject|1|||
144498990|NCT00819910|521022893|FG001|Overall Study|Withdrawal by Subject|1|||
144498991|NCT00819910|521022894|FG002|Overall Study|Withdrawal by Subject|1|||
144498992|NCT00819910|521022895|FG003|Overall Study|Withdrawal by Subject|0|||
144498993|NCT00819910|521022892|FG000|Overall Study|Lost to Follow-up|1|||
144498994|NCT00819910|521022893|FG001|Overall Study|Lost to Follow-up|0|||
144498995|NCT00819910|521022894|FG002|Overall Study|Lost to Follow-up|0|||
144498996|NCT00819910|521022895|FG003|Overall Study|Lost to Follow-up|0|||
144498997|NCT00871429|521022896|FG000|Overall Study|Lost to Follow-up|6|||
144498998|NCT00871429|521022896|FG000|Overall Study|Withdrawal by Subject|17|||
144498999|NCT00871429|521022896|FG000|Overall Study|Questionnaire not completed|1|||
144499000|NCT03102242|521022898|FG000|Overall Study|Adverse Event|2|||
144499001|NCT01311713|521022899|FG000|Overall Study|Death|0|||
144499002|NCT01311713|521022900|FG001|Overall Study|Death|0|||
144499003|NCT01311713|521022901|FG002|Overall Study|Death|1|||
144499004|NCT01311713|521022902|FG003|Overall Study|Death|1|||
144499005|NCT01311713|521022903|FG004|Overall Study|Death|0|||
144499006|NCT01311713|521022904|FG005|Overall Study|Death|1|||
144499007|NCT01311713|521022905|FG006|Overall Study|Death|0|||
144499008|NCT01311713|521022899|FG000|Overall Study|Adverse Event|0|||
144499009|NCT01311713|521022900|FG001|Overall Study|Adverse Event|1|||
144499010|NCT01311713|521022901|FG002|Overall Study|Adverse Event|0|||
144499011|NCT01311713|521022902|FG003|Overall Study|Adverse Event|2|||
144719878|NCT01484028|521827520|FG000|Period 1|Lost to Follow-up|0|||
144719879|NCT01484028|521827521|FG001|Period 1|Lost to Follow-up|1|||
144719880|NCT01484028|521827522|FG002|Period 1|Lost to Follow-up|0|||
144719881|NCT01484028|521827523|FG003|Period 1|Lost to Follow-up|0|||
144719882|NCT01484028|521827520|FG000|Period 1|Non-Compliance to Protocol|0|||
144719883|NCT01484028|521827521|FG001|Period 1|Non-Compliance to Protocol|1|||
144719884|NCT01484028|521827522|FG002|Period 1|Non-Compliance to Protocol|0|||
144499012|NCT01311713|521022903|FG004|Overall Study|Adverse Event|0|||
144499013|NCT01311713|521022904|FG005|Overall Study|Adverse Event|0|||
144499014|NCT01311713|521022905|FG006|Overall Study|Adverse Event|2|||
144499015|NCT01311713|521022899|FG000|Overall Study|Withdrawal by Subject|0|||
144499016|NCT01311713|521022900|FG001|Overall Study|Withdrawal by Subject|1|||
144499017|NCT01311713|521022901|FG002|Overall Study|Withdrawal by Subject|1|||
144719885|NCT01484028|521827523|FG003|Period 1|Non-Compliance to Protocol|1|||
144499018|NCT01311713|521022902|FG003|Overall Study|Withdrawal by Subject|0|||
144499019|NCT01311713|521022903|FG004|Overall Study|Withdrawal by Subject|0|||
144499020|NCT01311713|521022904|FG005|Overall Study|Withdrawal by Subject|1|||
144499021|NCT01311713|521022905|FG006|Overall Study|Withdrawal by Subject|2|||
144499022|NCT01311713|521022899|FG000|Overall Study|Disease progression|3|||
144499023|NCT01311713|521022900|FG001|Overall Study|Disease progression|4|||
144499024|NCT01311713|521022901|FG002|Overall Study|Disease progression|3|||
144499025|NCT01311713|521022902|FG003|Overall Study|Disease progression|2|||
144499026|NCT01311713|521022903|FG004|Overall Study|Disease progression|4|||
144499027|NCT01311713|521022904|FG005|Overall Study|Disease progression|4|||
144499028|NCT01311713|521022905|FG006|Overall Study|Disease progression|5|||
144499029|NCT01311713|521022899|FG000|Overall Study|Lost to Follow-up|0|||
144499030|NCT01311713|521022900|FG001|Overall Study|Lost to Follow-up|0|||
144499031|NCT01311713|521022901|FG002|Overall Study|Lost to Follow-up|1|||
144499032|NCT01311713|521022902|FG003|Overall Study|Lost to Follow-up|0|||
144499033|NCT01311713|521022903|FG004|Overall Study|Lost to Follow-up|0|||
144499034|NCT01311713|521022904|FG005|Overall Study|Lost to Follow-up|0|||
144499035|NCT01311713|521022905|FG006|Overall Study|Lost to Follow-up|0|||
144499036|NCT01311713|521022899|FG000|Overall Study|Stopped taking study medication|0|||
144499037|NCT01311713|521022900|FG001|Overall Study|Stopped taking study medication|0|||
144499038|NCT01311713|521022901|FG002|Overall Study|Stopped taking study medication|0|||
144499039|NCT01311713|521022902|FG003|Overall Study|Stopped taking study medication|1|||
144499040|NCT01311713|521022903|FG004|Overall Study|Stopped taking study medication|1|||
144499041|NCT01311713|521022904|FG005|Overall Study|Stopped taking study medication|0|||
144499042|NCT01311713|521022905|FG006|Overall Study|Stopped taking study medication|0|||
144499043|NCT01311713|521022899|FG000|Overall Study|Enrolled but not treated|0|||
144499044|NCT01311713|521022900|FG001|Overall Study|Enrolled but not treated|0|||
144499045|NCT01311713|521022901|FG002|Overall Study|Enrolled but not treated|1|||
144499046|NCT01311713|521022902|FG003|Overall Study|Enrolled but not treated|0|||
144499047|NCT01311713|521022903|FG004|Overall Study|Enrolled but not treated|0|||
144499048|NCT01311713|521022904|FG005|Overall Study|Enrolled but not treated|0|||
144499049|NCT01311713|521022905|FG006|Overall Study|Enrolled but not treated|0|||
144499050|NCT01311713|521022899|FG000|Overall Study|Other than specified|0|||
144719886|NCT01484028|521827520|FG000|Period 1|Lens Discomfort|0|||
144719887|NCT01484028|521827521|FG001|Period 1|Lens Discomfort|1|||
144719888|NCT01484028|521827522|FG002|Period 1|Lens Discomfort|0|||
144719889|NCT01484028|521827523|FG003|Period 1|Lens Discomfort|0|||
144719890|NCT01193517|521827526|FG000|Overall Study|Early Progression|1|||
144719891|NCT01193517|521827527|FG001|Overall Study|Early Progression|0|||
144719892|NCT01193517|521827528|FG002|Overall Study|Early Progression|0|||
144719893|NCT02115256|521827531|FG000|Overall Study|Withdrawal by Subject|0|||
144719894|NCT02115256|521827532|FG001|Overall Study|Withdrawal by Subject|1|||
144719895|NCT00146770|521827533|FG000|Overall Study|Adverse Event|2|||
144719896|NCT00146770|521827534|FG001|Overall Study|Adverse Event|0|||
144719897|NCT00146770|521827533|FG000|Overall Study|Pregnancy|1|||
144719898|NCT00146770|521827534|FG001|Overall Study|Pregnancy|0|||
144719899|NCT00146770|521827533|FG000|Overall Study|Withdrawal by Subject|2|||
144719900|NCT00146770|521827534|FG001|Overall Study|Withdrawal by Subject|0|||
144719901|NCT01626859|521827537|FG000|Overall Study|Adverse Event|1|||
144719902|NCT01626859|521827538|FG001|Overall Study|Adverse Event|3|||
144719903|NCT01626859|521827539|FG002|Overall Study|Adverse Event|2|||
144719904|NCT01626859|521827537|FG000|Overall Study|Physician Decision|0|||
144719905|NCT01626859|521827538|FG001|Overall Study|Physician Decision|1|||
144719906|NCT01626859|521827539|FG002|Overall Study|Physician Decision|0|||
144719907|NCT01626859|521827537|FG000|Overall Study|Withdrawal by Subject|1|||
144719908|NCT01626859|521827538|FG001|Overall Study|Withdrawal by Subject|4|||
144719909|NCT01626859|521827539|FG002|Overall Study|Withdrawal by Subject|2|||
144719910|NCT02826603|521827540|FG000|Overall Study|Adverse Event|17|||
144719911|NCT02826603|521827541|FG001|Overall Study|Adverse Event|9|||
144719912|NCT02826603|521827540|FG000|Overall Study|Lack of Efficacy|4|||
144719913|NCT02826603|521827541|FG001|Overall Study|Lack of Efficacy|9|||
144719914|NCT02826603|521827540|FG000|Overall Study|Lost to Follow-up|13|||
144719915|NCT02826603|521827541|FG001|Overall Study|Lost to Follow-up|12|||
144719916|NCT02826603|521827540|FG000|Overall Study|Noncompliance with treatment|0|||
144719917|NCT02826603|521827541|FG001|Overall Study|Noncompliance with treatment|2|||
144719918|NCT02826603|521827540|FG000|Overall Study|Physician Decision|1|||
144719919|NCT02826603|521827541|FG001|Overall Study|Physician Decision|7|||
144719920|NCT02826603|521827540|FG000|Overall Study|Pregnancy|1|||
144719921|NCT02826603|521827541|FG001|Overall Study|Pregnancy|2|||
144719922|NCT02826603|521827540|FG000|Overall Study|Protocol Violation|3|||
144719923|NCT02826603|521827541|FG001|Overall Study|Protocol Violation|3|||
144719924|NCT02826603|521827540|FG000|Overall Study|Withdrawal by Subject|20|||
144719925|NCT02826603|521827541|FG001|Overall Study|Withdrawal by Subject|19|||
144719926|NCT02826603|521827540|FG000|Overall Study|Death|2|||
144499051|NCT01311713|521022900|FG001|Overall Study|Other than specified|1|||
144499052|NCT01311713|521022901|FG002|Overall Study|Other than specified|2|||
144499053|NCT01311713|521022902|FG003|Overall Study|Other than specified|0|||
144499054|NCT01311713|521022903|FG004|Overall Study|Other than specified|0|||
144719927|NCT02826603|521827541|FG001|Overall Study|Death|0|||
144719928|NCT02826603|521827540|FG000|Overall Study|New therapy for study indication|0|||
144719929|NCT02826603|521827541|FG001|Overall Study|New therapy for study indication|1|||
144499055|NCT01311713|521022904|FG005|Overall Study|Other than specified|0|||
144499056|NCT01311713|521022905|FG006|Overall Study|Other than specified|0|||
144499057|NCT01772719|521022910|FG000|Overall Study|Withdrawal by Subject|3|||
144499058|NCT01772719|521022910|FG000|Overall Study|Adverse Event|2|||
144499059|NCT01772719|521022910|FG000|Overall Study|Protocol Violation|1|||
144499060|NCT01772719|521022910|FG000|Overall Study|Lost to Follow-up|1|||
144499061|NCT00477412|521022911|FG000|Overall Study|Death|0|||
144499062|NCT00477412|521022912|FG001|Overall Study|Death|0|||
144499063|NCT00477412|521022913|FG002|Overall Study|Death|0|||
144499064|NCT00477412|521022914|FG003|Overall Study|Death|4|||
144499065|NCT00477412|521022911|FG000|Overall Study|Lost to Follow-up|0|||
144499066|NCT00477412|521022912|FG001|Overall Study|Lost to Follow-up|0|||
144499067|NCT00477412|521022913|FG002|Overall Study|Lost to Follow-up|0|||
144499068|NCT00477412|521022914|FG003|Overall Study|Lost to Follow-up|1|||
144499069|NCT00477412|521022911|FG000|Overall Study|Withdrawal by Subject|0|||
144499070|NCT00477412|521022912|FG001|Overall Study|Withdrawal by Subject|0|||
144499071|NCT00477412|521022913|FG002|Overall Study|Withdrawal by Subject|0|||
144499072|NCT00477412|521022914|FG003|Overall Study|Withdrawal by Subject|2|||
144499073|NCT00477412|521022911|FG000|Overall Study|Second Malignancy|0|||
144499074|NCT00477412|521022912|FG001|Overall Study|Second Malignancy|0|||
144499075|NCT00477412|521022913|FG002|Overall Study|Second Malignancy|0|||
144499076|NCT00477412|521022914|FG003|Overall Study|Second Malignancy|1|||
144499077|NCT00477412|521022911|FG000|Overall Study|Adverse Event|1|||
144499078|NCT00477412|521022912|FG001|Overall Study|Adverse Event|0|||
144499079|NCT00477412|521022913|FG002|Overall Study|Adverse Event|1|||
144499080|NCT00477412|521022914|FG003|Overall Study|Adverse Event|0|||
144499081|NCT02931396|521022916|FG000|Overall Study|Lost to Follow-up|3|||
144499082|NCT02931396|521022917|FG001|Overall Study|Lost to Follow-up|0|||
144499083|NCT02931396|521022916|FG000|Overall Study|Withdrawal by Subject|2|||
144499084|NCT02931396|521022917|FG001|Overall Study|Withdrawal by Subject|0|||
144499085|NCT05460663|521022918|FG000|Overall Study|Withdrawal by Subject|2|||
144499086|NCT05460663|521022919|FG001|Overall Study|Withdrawal by Subject|5|||
144499087|NCT05273801|521022920|FG000|Overall Study|Physician Decision|1|||
144499088|NCT03181958|521024440|FG000|Overall Study|Lost to Follow-up|17|||
144499089|NCT03181958|521024441|FG001|Overall Study|Lost to Follow-up|21|||
144499090|NCT03181958|521024442|FG002|Overall Study|Lost to Follow-up|15|||
144499091|NCT00943605|521024453|FG000|Overall Study|Study termination|30|||
144499092|NCT00943605|521024454|FG001|Overall Study|Study termination|30|||
144499093|NCT04148937|521024455|FG000|Overall Study|Withdrawal by Subject|0|||
144499094|NCT04148937|521024456|FG001|Overall Study|Withdrawal by Subject|0|||
144499095|NCT04148937|521024457|FG002|Overall Study|Withdrawal by Subject|0|||
144499096|NCT04148937|521024458|FG003|Overall Study|Withdrawal by Subject|1|||
144499097|NCT04148937|521024459|FG004|Overall Study|Withdrawal by Subject|0|||
144499098|NCT04148937|521024460|FG005|Overall Study|Withdrawal by Subject|1|||
144499099|NCT04148937|521024461|FG006|Overall Study|Withdrawal by Subject|1|||
144499100|NCT04148937|521024462|FG007|Overall Study|Withdrawal by Subject|0|||
144499101|NCT04148937|521024455|FG000|Overall Study|Lost to Follow-up|0|||
144499102|NCT04148937|521024456|FG001|Overall Study|Lost to Follow-up|0|||
144499103|NCT04148937|521024457|FG002|Overall Study|Lost to Follow-up|1|||
144499104|NCT04148937|521024458|FG003|Overall Study|Lost to Follow-up|0|||
144499105|NCT04148937|521024459|FG004|Overall Study|Lost to Follow-up|0|||
144499106|NCT04148937|521024460|FG005|Overall Study|Lost to Follow-up|2|||
144499107|NCT04148937|521024461|FG006|Overall Study|Lost to Follow-up|0|||
144499108|NCT04148937|521024462|FG007|Overall Study|Lost to Follow-up|0|||
144499109|NCT00918957|521024463|FG000|Overall Study|Adverse Event|2|||
144499110|NCT00918957|521024464|FG001|Overall Study|Adverse Event|0|||
144499111|NCT00918957|521024463|FG000|Overall Study|Withdrawal by Subject|1|||
144499112|NCT00918957|521024464|FG001|Overall Study|Withdrawal by Subject|0|||
144499113|NCT01020838|521024465|FG000|Overall Study|Death|90|||
144499114|NCT01020838|521024465|FG000|Overall Study|Adverse Event|1|||
144499115|NCT01020838|521024465|FG000|Overall Study|Withdrawal by Subject|9|||
144499116|NCT01020838|521024465|FG000|Overall Study|Lost to Follow-up|6|||
144499117|NCT01020838|521024465|FG000|Overall Study|Most common: Study ended by sponsor|77|||
144499118|NCT04464421|521024466|FG000|Overall Study|Lost to Follow-up|2|||
144499119|NCT04464421|521024467|FG001|Overall Study|Lost to Follow-up|2|||
144499120|NCT01956669|521024468|FG000|Overall Study|Disease Progression|12|||
144499121|NCT01956669|521024469|FG001|Overall Study|Disease Progression|7|||
144499122|NCT01956669|521024470|FG002|Overall Study|Disease Progression|7|||
144499123|NCT01956669|521024471|FG003|Overall Study|Disease Progression|8|||
144499124|NCT01956669|521024472|FG004|Overall Study|Disease Progression|4|||
144499125|NCT01956669|521024473|FG005|Overall Study|Disease Progression|3|||
144499126|NCT01956669|521024474|FG006|Overall Study|Disease Progression|5|||
144499127|NCT01956669|521024468|FG000|Overall Study|Adverse Event|0|||
144499128|NCT01956669|521024469|FG001|Overall Study|Adverse Event|2|||
144499129|NCT01956669|521024470|FG002|Overall Study|Adverse Event|2|||
144499130|NCT01956669|521024471|FG003|Overall Study|Adverse Event|1|||
144499131|NCT01956669|521024472|FG004|Overall Study|Adverse Event|0|||
144499132|NCT01956669|521024473|FG005|Overall Study|Adverse Event|0|||
144499133|NCT01956669|521024474|FG006|Overall Study|Adverse Event|0|||
144499134|NCT01956669|521024468|FG000|Overall Study|Physician Decision|0|||
144499135|NCT01956669|521024469|FG001|Overall Study|Physician Decision|2|||
144499136|NCT01956669|521024470|FG002|Overall Study|Physician Decision|0|||
144499137|NCT01956669|521024471|FG003|Overall Study|Physician Decision|0|||
144499138|NCT01956669|521024472|FG004|Overall Study|Physician Decision|0|||
144499139|NCT01956669|521024473|FG005|Overall Study|Physician Decision|1|||
144499140|NCT01956669|521024474|FG006|Overall Study|Physician Decision|0|||
144499141|NCT01956669|521024468|FG000|Overall Study|Withdrawal by Subject|0|||
144499142|NCT01956669|521024469|FG001|Overall Study|Withdrawal by Subject|0|||
144499143|NCT01956669|521024470|FG002|Overall Study|Withdrawal by Subject|1|||
144499144|NCT01956669|521024471|FG003|Overall Study|Withdrawal by Subject|1|||
144499145|NCT01956669|521024472|FG004|Overall Study|Withdrawal by Subject|0|||
144499146|NCT01956669|521024473|FG005|Overall Study|Withdrawal by Subject|0|||
144499147|NCT01956669|521024474|FG006|Overall Study|Withdrawal by Subject|1|||
144499148|NCT01072357|521024475|FG000|Overall Study|Lost to Follow-up|0|||
144499149|NCT01072357|521024476|FG001|Overall Study|Lost to Follow-up|1|||
144499150|NCT01048788|521024477|FG000|Overall Study|Adverse Event|5|||
144499151|NCT01048788|521024478|FG001|Overall Study|Adverse Event|1|||
144499152|NCT01048788|521024479|FG002|Overall Study|Adverse Event|1|||
144499153|NCT01048788|521024477|FG000|Overall Study|Lack of Efficacy|0|||
144499154|NCT01048788|521024478|FG001|Overall Study|Lack of Efficacy|0|||
144499155|NCT01048788|521024479|FG002|Overall Study|Lack of Efficacy|1|||
144499156|NCT01048788|521024477|FG000|Overall Study|Withdrawal by Subject|0|||
144499157|NCT01048788|521024478|FG001|Overall Study|Withdrawal by Subject|1|||
144499158|NCT01048788|521024479|FG002|Overall Study|Withdrawal by Subject|0|||
144499159|NCT01131494|521024480|FG000|Overall Study|Withdrawal by Subject|2|||
144499160|NCT02145182|521024482|FG000|Overall Study|Adverse Event|4|||
144499161|NCT02145182|521024483|FG001|Overall Study|Adverse Event|1|||
144499162|NCT02145182|521024482|FG000|Overall Study|Death|7|||
144499163|NCT02145182|521024483|FG001|Overall Study|Death|7|||
144499164|NCT02145182|521024482|FG000|Overall Study|Lost to Follow-up|2|||
144499165|NCT02145182|521024483|FG001|Overall Study|Lost to Follow-up|2|||
144499166|NCT02145182|521024482|FG000|Overall Study|Pre-transplant Withdrawal|0|||
144499167|NCT02145182|521024483|FG001|Overall Study|Pre-transplant Withdrawal|2|||
144499168|NCT02145182|521024482|FG000|Overall Study|Withdrawal by Subject|5|||
144499169|NCT02145182|521024483|FG001|Overall Study|Withdrawal by Subject|4|||
144499170|NCT00588666|521024484|FG000|Overall Study|Adverse Event|4|||
144499171|NCT03999554|521024487|FG000|Overall Study|Lost to Follow-up|4|||
144499172|NCT03999554|521024488|FG001|Overall Study|Lost to Follow-up|5|||
144499173|NCT03999554|521024489|FG002|Overall Study|Lost to Follow-up|4|||
144499174|NCT03999554|521024490|FG003|Overall Study|Lost to Follow-up|5|||
144499175|NCT03999554|521024491|FG004|Overall Study|Lost to Follow-up|8|||
144499176|NCT03999554|521024487|FG000|Overall Study|Protocol Violation|0|||
144499177|NCT03999554|521024488|FG001|Overall Study|Protocol Violation|0|||
144499178|NCT03999554|521024489|FG002|Overall Study|Protocol Violation|5|||
144499179|NCT03999554|521024490|FG003|Overall Study|Protocol Violation|0|||
144499180|NCT03999554|521024491|FG004|Overall Study|Protocol Violation|0|||
144499181|NCT03999554|521024487|FG000|Overall Study|Pregnancy|0|||
144499182|NCT03999554|521024488|FG001|Overall Study|Pregnancy|0|||
144499183|NCT03999554|521024489|FG002|Overall Study|Pregnancy|1|||
144499184|NCT03999554|521024490|FG003|Overall Study|Pregnancy|0|||
144499185|NCT03999554|521024491|FG004|Overall Study|Pregnancy|0|||
144499186|NCT03999554|521024487|FG000|Overall Study|Withdrawal by Subject|2|||
144499187|NCT03999554|521024488|FG001|Overall Study|Withdrawal by Subject|2|||
144499188|NCT03999554|521024489|FG002|Overall Study|Withdrawal by Subject|2|||
144499189|NCT03999554|521024490|FG003|Overall Study|Withdrawal by Subject|1|||
144499190|NCT03999554|521024491|FG004|Overall Study|Withdrawal by Subject|1|||
144499191|NCT03999554|521024487|FG000|Overall Study|failure to comply with protocol requirements|0|||
144499192|NCT03999554|521024488|FG001|Overall Study|failure to comply with protocol requirements|0|||
144499193|NCT03999554|521024489|FG002|Overall Study|failure to comply with protocol requirements|0|||
144499194|NCT03999554|521024490|FG003|Overall Study|failure to comply with protocol requirements|1|||
144499195|NCT03999554|521024491|FG004|Overall Study|failure to comply with protocol requirements|0|||
144499196|NCT04304534|521024492|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
144499197|NCT04304534|521024493|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
144499198|NCT04304534|521024494|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
144499199|NCT04304534|521024495|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
144499200|NCT04304534|521024492|FG000|Overall Study|Non-Compliance with study drug|0|||
144499201|NCT04304534|521024493|FG001|Overall Study|Non-Compliance with study drug|1|||
144499202|NCT04304534|521024494|FG002|Overall Study|Non-Compliance with study drug|1|||
144499203|NCT04304534|521024495|FG003|Overall Study|Non-Compliance with study drug|1|||
144499204|NCT04304534|521024492|FG000|Overall Study|Lost to Follow-up|0|||
144499205|NCT04304534|521024493|FG001|Overall Study|Lost to Follow-up|1|||
144499206|NCT04304534|521024494|FG002|Overall Study|Lost to Follow-up|2|||
144499207|NCT04304534|521024495|FG003|Overall Study|Lost to Follow-up|3|||
144499208|NCT04304534|521024492|FG000|Overall Study|Unspecific|4|||
144499209|NCT04304534|521024493|FG001|Overall Study|Unspecific|2|||
144499210|NCT04304534|521024494|FG002|Overall Study|Unspecific|2|||
144499211|NCT04304534|521024495|FG003|Overall Study|Unspecific|2|||
144499212|NCT04304534|521024492|FG000|Overall Study|Technical Problems|2|||
144499213|NCT04304534|521024493|FG001|Overall Study|Technical Problems|2|||
144499214|NCT04304534|521024494|FG002|Overall Study|Technical Problems|3|||
144499215|NCT04304534|521024495|FG003|Overall Study|Technical Problems|4|||
144499216|NCT04304534|521024492|FG000|Overall Study|Death|7|||
144499217|NCT04304534|521024493|FG001|Overall Study|Death|2|||
144499218|NCT04304534|521024494|FG002|Overall Study|Death|4|||
144499219|NCT04304534|521024495|FG003|Overall Study|Death|3|||
144499220|NCT04304534|521024492|FG000|Overall Study|Withdrawal by Subject|7|||
144499221|NCT04304534|521024493|FG001|Overall Study|Withdrawal by Subject|2|||
144499222|NCT04304534|521024494|FG002|Overall Study|Withdrawal by Subject|7|||
144499223|NCT04304534|521024495|FG003|Overall Study|Withdrawal by Subject|4|||
144499224|NCT04304534|521024492|FG000|Overall Study|Physician Decision|4|||
144499225|NCT04304534|521024493|FG001|Overall Study|Physician Decision|9|||
144499226|NCT04304534|521024494|FG002|Overall Study|Physician Decision|9|||
144499227|NCT04304534|521024495|FG003|Overall Study|Physician Decision|5|||
144499228|NCT04304534|521024492|FG000|Overall Study|Subject Decision|34|||
144499229|NCT04304534|521024493|FG001|Overall Study|Subject Decision|25|||
144499230|NCT04304534|521024494|FG002|Overall Study|Subject Decision|25|||
144499231|NCT04304534|521024495|FG003|Overall Study|Subject Decision|26|||
144499232|NCT04304534|521024492|FG000|Overall Study|Adverse Event|35|||
144499233|NCT04304534|521024493|FG001|Overall Study|Adverse Event|40|||
144499234|NCT04304534|521024494|FG002|Overall Study|Adverse Event|39|||
144499235|NCT04304534|521024495|FG003|Overall Study|Adverse Event|44|||
144499236|NCT00464672|521024496|FG000|Overall Study|withdrawal of consent|0|||
144499237|NCT00464672|521024497|FG001|Overall Study|withdrawal of consent|0|||
144499238|NCT00464672|521024498|FG002|Overall Study|withdrawal of consent|0|||
144499239|NCT00464672|521024499|FG003|Overall Study|withdrawal of consent|1|||
144499240|NCT00464672|521024500|FG004|Overall Study|withdrawal of consent|9|||
144499241|NCT00464672|521024501|FG005|Overall Study|withdrawal of consent|4|||
144499242|NCT00464672|521024496|FG000|Overall Study|Lost to Follow-up|25|||
144499243|NCT00464672|521024497|FG001|Overall Study|Lost to Follow-up|10|||
144499244|NCT00464672|521024498|FG002|Overall Study|Lost to Follow-up|0|||
144499245|NCT00464672|521024499|FG003|Overall Study|Lost to Follow-up|0|||
144499246|NCT00464672|521024500|FG004|Overall Study|Lost to Follow-up|1|||
144499247|NCT00464672|521024501|FG005|Overall Study|Lost to Follow-up|0|||
144499248|NCT00015457|521024505|FG000|First Intervention|Adverse Event|0|||
144499249|NCT00015457|521024506|FG001|First Intervention|Adverse Event|2|||
144499250|NCT00015457|521024505|FG000|First Intervention|Lack of Efficacy|0|||
144499251|NCT00015457|521024506|FG001|First Intervention|Lack of Efficacy|1|||
144499252|NCT00015457|521024505|FG000|Second Intervention|Withdrawal by Subject|1|||
144499253|NCT00015457|521024506|FG001|Second Intervention|Withdrawal by Subject|0|||
144499254|NCT01878890|521024511|FG000|Overall Study|Protocol Violation|0|||
144499255|NCT01878890|521024512|FG001|Overall Study|Protocol Violation|1|||
144499256|NCT01878890|521024513|FG002|Overall Study|Protocol Violation|0|||
144499257|NCT01878890|521024514|FG003|Overall Study|Protocol Violation|0|||
144499258|NCT01710514|521024520|FG000|Overall Study|Adverse Event|6|||
144499259|NCT01710514|521024521|FG001|Overall Study|Adverse Event|7|||
144499260|NCT01710514|521024520|FG000|Overall Study|Withdrawal by Subject|1|||
144499261|NCT01710514|521024521|FG001|Overall Study|Withdrawal by Subject|0|||
144499262|NCT03404843|521024522|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
144499263|NCT03404843|521024523|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
144499264|NCT04044664|521024524|FG000|Stage 1|Adverse Event|3|||
144499265|NCT04044664|521024525|FG001|Stage 1|Adverse Event|3|||
144499266|NCT04044664|521024526|FG002|Stage 1|Adverse Event|1|||
144499267|NCT04044664|521024524|FG000|Stage 1|Lost to Follow-up|3|||
144499268|NCT04044664|521024525|FG001|Stage 1|Lost to Follow-up|2|||
144499269|NCT04044664|521024526|FG002|Stage 1|Lost to Follow-up|2|||
144499270|NCT04044664|521024524|FG000|Stage 1|Withdrawal by Subject|9|||
144499271|NCT04044664|521024525|FG001|Stage 1|Withdrawal by Subject|1|||
144499272|NCT04044664|521024526|FG002|Stage 1|Withdrawal by Subject|0|||
144499273|NCT04044664|521024524|FG000|Stage 1|noncompliance, personal reason|2|||
144499274|NCT04044664|521024525|FG001|Stage 1|noncompliance, personal reason|0|||
144499275|NCT04044664|521024526|FG002|Stage 1|noncompliance, personal reason|0|||
144499276|NCT04044664|521024524|FG000|Stage 1|randomization error|0|||
144499277|NCT04044664|521024525|FG001|Stage 1|randomization error|1|||
144719930|NCT00905489|521827542|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
144499278|NCT04044664|521024526|FG002|Stage 1|randomization error|0|||
144499279|NCT04044664|521024524|FG000|Stage 2|Adverse Event|2|||
144499280|NCT04044664|521024525|FG001|Stage 2|Adverse Event|0|||
144499281|NCT04044664|521024526|FG002|Stage 2|Adverse Event|0|||
144499282|NCT04044664|521024524|FG000|Stage 2|Lost to Follow-up|3|||
144499283|NCT04044664|521024525|FG001|Stage 2|Lost to Follow-up|2|||
144499284|NCT04044664|521024526|FG002|Stage 2|Lost to Follow-up|1|||
144499285|NCT04044664|521024524|FG000|Stage 2|Withdrawal by Subject|3|||
144499286|NCT04044664|521024525|FG001|Stage 2|Withdrawal by Subject|0|||
144499287|NCT04044664|521024526|FG002|Stage 2|Withdrawal by Subject|0|||
144499288|NCT04044664|521024524|FG000|Stage 2|protocol deviation|1|||
144499289|NCT04044664|521024525|FG001|Stage 2|protocol deviation|0|||
144499290|NCT04044664|521024526|FG002|Stage 2|protocol deviation|0|||
144499291|NCT01744691|521024530|FG000|Overall Study|Progressive Disease|18|||
144499292|NCT01744691|521024530|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
144499293|NCT01744691|521024530|FG000|Overall Study|Withdrawal of consent for treatment|3|||
144499294|NCT01744691|521024530|FG000|Overall Study|Physician Decision|4|||
144499295|NCT02701361|521024532|FG000|Overall Study|Lost to Follow-up|5|||
144499296|NCT02701361|521024533|FG001|Overall Study|Lost to Follow-up|2|||
144499297|NCT02701361|521024534|FG002|Overall Study|Lost to Follow-up|1|||
144499298|NCT02701361|521024532|FG000|Overall Study|Withdrawal by Subject|4|||
144499299|NCT02701361|521024533|FG001|Overall Study|Withdrawal by Subject|0|||
144499300|NCT02701361|521024534|FG002|Overall Study|Withdrawal by Subject|0|||
144499301|NCT02701361|521024532|FG000|Overall Study|timed out in rehab center|0|||
144499302|NCT02701361|521024533|FG001|Overall Study|timed out in rehab center|1|||
144499303|NCT02701361|521024534|FG002|Overall Study|timed out in rehab center|0|||
144499304|NCT02701361|521024532|FG000|Overall Study|incarceration|0|||
144499305|NCT02701361|521024533|FG001|Overall Study|incarceration|0|||
144499306|NCT02701361|521024534|FG002|Overall Study|incarceration|1|||
144499307|NCT04588480|521024535|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
144499308|NCT04588480|521024536|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
144499309|NCT04588480|521024537|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
144499310|NCT04588480|521024535|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
144499311|NCT04588480|521024536|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
144499312|NCT04588480|521024537|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
144499313|NCT02750709|521024540|FG000|Treatment Period 1|Adverse Event|0|||
144499314|NCT02750709|521024541|FG001|Treatment Period 1|Adverse Event|0|||
144499315|NCT02750709|521024542|FG002|Treatment Period 1|Adverse Event|0|||
144499316|NCT02750709|521024543|FG003|Treatment Period 1|Adverse Event|0|||
144499317|NCT02750709|521024544|FG004|Treatment Period 1|Adverse Event|0|||
144499318|NCT02750709|521024545|FG005|Treatment Period 1|Adverse Event|1|||
144499319|NCT03256344|521024546|FG000|Overall Study|Death|6|||
144499320|NCT03256344|521024547|FG001|Overall Study|Death|22|||
144499321|NCT03256344|521024546|FG000|Overall Study|Withdrawal by Subject|3|||
144499322|NCT03256344|521024547|FG001|Overall Study|Withdrawal by Subject|3|||
144499323|NCT03256344|521024546|FG000|Overall Study|Sponsor Decision|1|||
144499324|NCT03256344|521024547|FG001|Overall Study|Sponsor Decision|0|||
144499325|NCT00580801|521024557|FG000|Overall Study|Physician Decision|1|||
144499326|NCT00580801|521024558|FG001|Overall Study|Physician Decision|0|||
144499327|NCT00580801|521024559|FG002|Overall Study|Physician Decision|0|||
144499328|NCT00580801|521024557|FG000|Overall Study|Adverse Event|2|||
144499329|NCT00580801|521024558|FG001|Overall Study|Adverse Event|0|||
144499330|NCT00580801|521024559|FG002|Overall Study|Adverse Event|0|||
144499331|NCT00580801|521024557|FG000|Overall Study|Lost to Follow-up|2|||
144499332|NCT00580801|521024558|FG001|Overall Study|Lost to Follow-up|0|||
144499333|NCT00580801|521024559|FG002|Overall Study|Lost to Follow-up|0|||
144499334|NCT00580801|521024557|FG000|Overall Study|Reached a virologic endpoint|0|||
144499335|NCT00580801|521024558|FG001|Overall Study|Reached a virologic endpoint|1|||
144499336|NCT00580801|521024559|FG002|Overall Study|Reached a virologic endpoint|2|||
144499337|NCT00580801|521024557|FG000|Overall Study|Participant non-compliant|0|||
144499338|NCT00580801|521024558|FG001|Overall Study|Participant non-compliant|0|||
144499339|NCT00580801|521024559|FG002|Overall Study|Participant non-compliant|1|||
144499340|NCT00580801|521024557|FG000|Overall Study|Travel|1|||
144499341|NCT00580801|521024558|FG001|Overall Study|Travel|0|||
144499342|NCT00580801|521024559|FG002|Overall Study|Travel|0|||
144499343|NCT00843193|521024560|FG000|Overall Study|Adverse Event|2|||
144499344|NCT00843193|521024561|FG001|Overall Study|Adverse Event|4|||
144499345|NCT00843193|521024560|FG000|Overall Study|Lack of Efficacy|1|||
144499346|NCT00843193|521024561|FG001|Overall Study|Lack of Efficacy|1|||
144499347|NCT00843193|521024560|FG000|Overall Study|Protocol Violation|1|||
144499348|NCT00843193|521024561|FG001|Overall Study|Protocol Violation|2|||
144499349|NCT00843193|521024560|FG000|Overall Study|Lost to Follow-up|1|||
144499350|NCT00843193|521024561|FG001|Overall Study|Lost to Follow-up|0|||
144499351|NCT00843193|521024560|FG000|Overall Study|Physician Decision|0|||
144499352|NCT00843193|521024561|FG001|Overall Study|Physician Decision|1|||
144499353|NCT00843193|521024560|FG000|Overall Study|Withdrawal by Subject|3|||
144499354|NCT00843193|521024561|FG001|Overall Study|Withdrawal by Subject|3|||
144499355|NCT00542386|521024562|FG000|Overall Study|Adverse Event|1|||
144499356|NCT00542386|521024563|FG001|Overall Study|Adverse Event|7|||
144499357|NCT00542386|521024564|FG002|Overall Study|Adverse Event|7|||
144499358|NCT00542386|521024565|FG003|Overall Study|Adverse Event|8|||
144499359|NCT00542386|521024566|FG004|Overall Study|Adverse Event|13|||
144499360|NCT00542386|521024567|FG005|Overall Study|Adverse Event|4|||
144499361|NCT00542386|521024562|FG000|Overall Study|Death|0|||
144499362|NCT00542386|521024563|FG001|Overall Study|Death|0|||
144499363|NCT00542386|521024564|FG002|Overall Study|Death|1|||
144499364|NCT00542386|521024565|FG003|Overall Study|Death|2|||
144499365|NCT00542386|521024566|FG004|Overall Study|Death|1|||
144499366|NCT00542386|521024567|FG005|Overall Study|Death|2|||
144499367|NCT00542386|521024562|FG000|Overall Study|Lack of Efficacy|32|||
144499368|NCT00542386|521024563|FG001|Overall Study|Lack of Efficacy|12|||
144499369|NCT00542386|521024564|FG002|Overall Study|Lack of Efficacy|10|||
144499370|NCT00542386|521024565|FG003|Overall Study|Lack of Efficacy|13|||
144499371|NCT00542386|521024566|FG004|Overall Study|Lack of Efficacy|7|||
144499372|NCT00542386|521024567|FG005|Overall Study|Lack of Efficacy|31|||
144499373|NCT00542386|521024562|FG000|Overall Study|Physician Decision|1|||
144499374|NCT00542386|521024563|FG001|Overall Study|Physician Decision|0|||
144499375|NCT00542386|521024564|FG002|Overall Study|Physician Decision|0|||
144499376|NCT00542386|521024565|FG003|Overall Study|Physician Decision|1|||
144499377|NCT00542386|521024566|FG004|Overall Study|Physician Decision|0|||
144499378|NCT00542386|521024567|FG005|Overall Study|Physician Decision|0|||
144499379|NCT00542386|521024562|FG000|Overall Study|Protocol Violation|0|||
144499380|NCT00542386|521024563|FG001|Overall Study|Protocol Violation|0|||
144499381|NCT00542386|521024564|FG002|Overall Study|Protocol Violation|1|||
144499382|NCT00542386|521024565|FG003|Overall Study|Protocol Violation|0|||
144499383|NCT00542386|521024566|FG004|Overall Study|Protocol Violation|0|||
144499384|NCT00542386|521024567|FG005|Overall Study|Protocol Violation|4|||
144499385|NCT00542386|521024562|FG000|Overall Study|Withdrawal by Subject|5|||
144499386|NCT00542386|521024563|FG001|Overall Study|Withdrawal by Subject|8|||
144499387|NCT00542386|521024564|FG002|Overall Study|Withdrawal by Subject|10|||
144499388|NCT00542386|521024565|FG003|Overall Study|Withdrawal by Subject|11|||
144499389|NCT00542386|521024566|FG004|Overall Study|Withdrawal by Subject|15|||
144499390|NCT00542386|521024567|FG005|Overall Study|Withdrawal by Subject|7|||
144499391|NCT00542386|521024562|FG000|Overall Study|Other Reasons|4|||
144499392|NCT00542386|521024563|FG001|Overall Study|Other Reasons|1|||
144499393|NCT00542386|521024564|FG002|Overall Study|Other Reasons|4|||
144499394|NCT00542386|521024565|FG003|Overall Study|Other Reasons|3|||
144499395|NCT00542386|521024566|FG004|Overall Study|Other Reasons|4|||
144499396|NCT00542386|521024567|FG005|Overall Study|Other Reasons|2|||
144499397|NCT00880906|521024569|FG000|Overall Study|Lost to Follow-up|0|||
144499398|NCT00880906|521024570|FG001|Overall Study|Lost to Follow-up|1|||
144499399|NCT00880906|521024569|FG000|Overall Study|Did not meet criteria following patholog|12|||
144499400|NCT00880906|521024570|FG001|Overall Study|Did not meet criteria following patholog|6|||
144499401|NCT00544440|521024571|FG000|Overall Study|Other|1|||
144499402|NCT00544440|521024571|FG000|Overall Study|Adverse Event|1|||
144499403|NCT00544440|521024571|FG000|Overall Study|Withdrawal by Subject|2|||
144499404|NCT00544440|521024571|FG000|Overall Study|Subject Non-compliance|1|||
144499405|NCT00544440|521024571|FG000|Overall Study|Progressive Disease|47|||
144499406|NCT00544440|521024571|FG000|Overall Study|Other|5|||
144499407|NCT03586167|521024572|FG000|Overall Study|Other|1|||
144499408|NCT03586167|521024573|FG001|Overall Study|Other|0|||
144499409|NCT04109118|521024574|FG000|Overall Study|Lost to Follow-up|3|||
144499410|NCT03394027|521024575|FG000|Overall Study|Ineligible|3|||
144499411|NCT03394027|521024576|FG001|Overall Study|Ineligible|1|||
144499412|NCT03394027|521024577|FG002|Overall Study|Ineligible|3|||
144499413|NCT03394027|521024575|FG000|Overall Study|Participant declined to participate before treatment started|0|||
144499414|NCT03394027|521024576|FG001|Overall Study|Participant declined to participate before treatment started|0|||
144499415|NCT03394027|521024577|FG002|Overall Study|Participant declined to participate before treatment started|1|||
144499416|NCT01268566|521024587|FG000|Overall Study|Lost to Follow-up|1|||
144499417|NCT01268566|521024587|FG000|Overall Study|Withdrawal by Subject|12|||
144499418|NCT01268566|521024587|FG000|Overall Study|Death|30|||
144499419|NCT05196737|521024589|FG000|Non-intervention Week|Lost to Follow-up|2|||
144499420|NCT05196737|521024589|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
144499421|NCT03722446|521024590|FG000|Overall Study|Protocol Violation|15|||
144499422|NCT03722446|521024591|FG001|Overall Study|Protocol Violation|2|||
144499423|NCT02908464|521024592|FG000|Overall Study|Withdrawal by Subject|2|||
144499424|NCT02908464|521024593|FG001|Overall Study|Withdrawal by Subject|1|||
144499425|NCT02908464|521024592|FG000|Overall Study|Found ineligible after randomization|0|||
144499426|NCT02908464|521024593|FG001|Overall Study|Found ineligible after randomization|2|||
144499427|NCT02163915|521024594|FG000|Overall Study|Withdrawal by Subject|2|||
144499428|NCT02163915|521024595|FG001|Overall Study|Withdrawal by Subject|0|||
144499429|NCT02163915|521024596|FG002|Overall Study|Withdrawal by Subject|2|||
144499430|NCT02163915|521024597|FG003|Overall Study|Withdrawal by Subject|2|||
144499431|NCT02163915|521024598|FG004|Overall Study|Withdrawal by Subject|2|||
144499432|NCT02163915|521024594|FG000|Overall Study|Study termination|1|||
144499433|NCT02163915|521024595|FG001|Overall Study|Study termination|0|||
144499434|NCT02163915|521024596|FG002|Overall Study|Study termination|0|||
144499435|NCT02163915|521024597|FG003|Overall Study|Study termination|0|||
144499436|NCT02163915|521024598|FG004|Overall Study|Study termination|2|||
144499437|NCT02163915|521024594|FG000|Overall Study|Physician Decision|0|||
144499438|NCT02163915|521024595|FG001|Overall Study|Physician Decision|0|||
144499439|NCT02163915|521024596|FG002|Overall Study|Physician Decision|0|||
144499440|NCT02163915|521024597|FG003|Overall Study|Physician Decision|1|||
144499441|NCT02163915|521024598|FG004|Overall Study|Physician Decision|0|||
144499442|NCT01645111|521026414|FG000|Overall Study|Did not require Clevidipine|15|||
144499443|NCT03068468|521026415|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
144499444|NCT03068468|521026416|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
144499445|NCT03068468|521026417|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
144499446|NCT03068468|521026418|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
144499447|NCT03068468|521026415|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
144499448|NCT03068468|521026416|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
144499449|NCT03068468|521026417|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
144499450|NCT03068468|521026418|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
144499451|NCT03068468|521026415|FG000|Placebo-Controlled Period|Adverse Event|16|||
144499452|NCT03068468|521026416|FG001|Placebo-Controlled Period|Adverse Event|21|||
144499453|NCT03068468|521026417|FG002|Placebo-Controlled Period|Adverse Event|0|||
144499454|NCT03068468|521026418|FG003|Placebo-Controlled Period|Adverse Event|0|||
144499455|NCT03068468|521026415|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
144499456|NCT03068468|521026416|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
144499457|NCT03068468|521026417|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
144499458|NCT03068468|521026418|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
144499459|NCT03068468|521026415|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
144499460|NCT03068468|521026416|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
144499461|NCT03068468|521026417|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144499462|NCT03068468|521026418|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144499463|NCT03068468|521026415|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
144499464|NCT03068468|521026416|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
144499465|NCT03068468|521026417|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
144499466|NCT03068468|521026418|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
144499467|NCT03068468|521026415|FG000|Placebo-Controlled Period|Death|0|||
144499468|NCT03068468|521026416|FG001|Placebo-Controlled Period|Death|1|||
144499469|NCT03068468|521026417|FG002|Placebo-Controlled Period|Death|0|||
144499470|NCT03068468|521026418|FG003|Placebo-Controlled Period|Death|0|||
144499471|NCT03068468|521026415|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
144499472|NCT03068468|521026416|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
144499473|NCT03068468|521026417|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
144499474|NCT03068468|521026418|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
144499475|NCT03068468|521026415|FG000|Open-Label Extension Period|Adverse Event|0|||
144499476|NCT03068468|521026416|FG001|Open-Label Extension Period|Adverse Event|0|||
144499477|NCT03068468|521026417|FG002|Open-Label Extension Period|Adverse Event|13|||
144499478|NCT03068468|521026418|FG003|Open-Label Extension Period|Adverse Event|17|||
144499479|NCT03068468|521026415|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
144499480|NCT03068468|521026416|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
144499481|NCT03068468|521026417|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
144499482|NCT03068468|521026418|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
144499483|NCT03068468|521026415|FG000|Open-Label Extension Period|Death|0|||
144499484|NCT03068468|521026416|FG001|Open-Label Extension Period|Death|0|||
144499485|NCT03068468|521026417|FG002|Open-Label Extension Period|Death|0|||
144499486|NCT03068468|521026418|FG003|Open-Label Extension Period|Death|1|||
144499487|NCT03068468|521026415|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
144499488|NCT03068468|521026416|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
144499489|NCT03068468|521026417|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
144499490|NCT03068468|521026418|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
144499491|NCT03068468|521026415|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
144499492|NCT03068468|521026416|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
144499493|NCT03068468|521026417|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
144499494|NCT03068468|521026418|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
144499495|NCT03068468|521026415|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
144499496|NCT03068468|521026416|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
144499497|NCT03068468|521026417|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
144499498|NCT03068468|521026418|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
144499499|NCT03068468|521026415|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
144499500|NCT03068468|521026416|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
144499501|NCT03068468|521026417|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
144499502|NCT03068468|521026418|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
144499503|NCT03068468|521026415|FG000|Open-Label Extension Period|Reason not Specified|0|||
144499504|NCT03068468|521026416|FG001|Open-Label Extension Period|Reason not Specified|0|||
144499505|NCT03068468|521026417|FG002|Open-Label Extension Period|Reason not Specified|1|||
144719931|NCT00905489|521827542|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
144499506|NCT03068468|521026418|FG003|Open-Label Extension Period|Reason not Specified|4|||
144499507|NCT00739102|521026419|FG000|Overall Study|Death|5|||
144499508|NCT00739102|521026419|FG000|Overall Study|Withdrawal by Subject|10|||
144499509|NCT01062126|521026421|FG000|Overall Study|Death|209|||
144499510|NCT01062126|521026421|FG000|Overall Study|All Withdrawals|324|||
144499511|NCT01510912|521026422|FG000|Overall Study|Adverse Event|99|||
144499512|NCT01510912|521026422|FG000|Overall Study|Lack of Efficacy|12|||
144499513|NCT01510912|521026422|FG000|Overall Study|Non-compliance with trial drug|23|||
144499514|NCT01510912|521026422|FG000|Overall Study|Withdrawal by Subject|49|||
144499515|NCT01510912|521026422|FG000|Overall Study|Physician Decision|1|||
144499516|NCT01510912|521026422|FG000|Overall Study|Protocol Violation|27|||
144499517|NCT01510912|521026422|FG000|Overall Study|Lost to Follow-up|26|||
144499518|NCT01510912|521026422|FG000|Overall Study|Other, including joint replacement|5|||
144499519|NCT03784963|521026423|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
144499520|NCT03784963|521026424|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
144499521|NCT03784963|521026425|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
144499522|NCT03784963|521026426|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
144499523|NCT00349908|521026427|FG000|Overall Study|Withdrawal by Subject|0|||
144499524|NCT00349908|521026428|FG001|Overall Study|Withdrawal by Subject|4|||
144499525|NCT01249092|521026431|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
144499526|NCT01249092|521026431|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
144499527|NCT00151996|521026434|FG000|Overall Study|Adverse Event|3|||
144499528|NCT00151996|521026435|FG001|Overall Study|Adverse Event|2|||
144499529|NCT00151996|521026434|FG000|Overall Study|Withdrawal by Subject|1|||
144499530|NCT00151996|521026435|FG001|Overall Study|Withdrawal by Subject|1|||
144499531|NCT00151996|521026434|FG000|Overall Study|Protocol Violation|1|||
144499532|NCT00151996|521026435|FG001|Overall Study|Protocol Violation|2|||
144499533|NCT00151996|521026434|FG000|Overall Study|Sponsor's decision|0|||
144499534|NCT00151996|521026435|FG001|Overall Study|Sponsor's decision|2|||
144499535|NCT01259102|521026436|FG000|Overall Study|Adverse Event|1|||
144719932|NCT00905489|521827542|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
144499536|NCT01259102|521026437|FG001|Overall Study|Adverse Event|0|||
144499537|NCT01259102|521026438|FG002|Overall Study|Adverse Event|1|||
144499538|NCT01259102|521026439|FG003|Overall Study|Adverse Event|1|||
144499539|NCT01259102|521026440|FG004|Overall Study|Adverse Event|0|||
144499540|NCT01259102|521026436|FG000|Overall Study|Other|0|||
144499541|NCT01259102|521026437|FG001|Overall Study|Other|0|||
144499542|NCT01259102|521026438|FG002|Overall Study|Other|1|||
144499543|NCT01259102|521026439|FG003|Overall Study|Other|1|||
144499544|NCT01259102|521026440|FG004|Overall Study|Other|1|||
144499545|NCT05790408|521026441|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
144499546|NCT02274493|521026442|FG000|Overall Study|Withdrawal by Subject|1|||
144499547|NCT00558363|521026443|FG000|Overall Study|Physician Decision|18|||
144499548|NCT00558363|521026444|FG001|Overall Study|Physician Decision|4|||
144499549|NCT00558363|521026443|FG000|Overall Study|Withdrawal by Subject|11|||
144499550|NCT00558363|521026444|FG001|Overall Study|Withdrawal by Subject|4|||
144499551|NCT00558363|521026443|FG000|Overall Study|Adverse Event|5|||
144499552|NCT00558363|521026444|FG001|Overall Study|Adverse Event|5|||
144499553|NCT00558363|521026443|FG000|Overall Study|Lack of Efficacy|2|||
144499554|NCT00558363|521026444|FG001|Overall Study|Lack of Efficacy|2|||
144499555|NCT00558363|521026443|FG000|Overall Study|Protocol Violation|2|||
144499556|NCT00558363|521026444|FG001|Overall Study|Protocol Violation|1|||
144499557|NCT00558363|521026443|FG000|Overall Study|Lost to Follow-up|0|||
144499558|NCT00558363|521026444|FG001|Overall Study|Lost to Follow-up|1|||
144499559|NCT00558363|521026443|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
144499560|NCT00558363|521026444|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
144499561|NCT00558363|521026443|FG000|Overall Study|Randomized in Error|1|||
144499562|NCT00558363|521026444|FG001|Overall Study|Randomized in Error|2|||
144499563|NCT00558363|521026443|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
144499564|NCT00558363|521026444|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
144499565|NCT03102710|521026445|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
144499566|NCT03102710|521026446|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
144499567|NCT03102710|521026447|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
144499568|NCT03102710|521026445|FG000|Overall Study|Technical issues during final MRI scan|0|||
144499569|NCT03102710|521026446|FG001|Overall Study|Technical issues during final MRI scan|1|||
144499570|NCT03102710|521026447|FG002|Overall Study|Technical issues during final MRI scan|0|||
144719933|NCT00583596|521827543|FG000|Overall Study|Lost to Follow-up|110|||
144719934|NCT00583596|521827543|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
144719935|NCT00583596|521827543|FG000|Overall Study|Death|2|||
144719936|NCT00583596|521827543|FG000|Overall Study|Withdrawal by Subject|6|||
144719937|NCT00583596|521827543|FG000|Overall Study|Lost to Follow-up|94|||
144719938|NCT00583596|521827543|FG000|Overall Study|Data not complete|1|||
144719939|NCT00583596|521827543|FG000|Overall Study|Not consented|15|||
144719940|NCT00583596|521827543|FG000|Overall Study|Outside f-up window|26|||
144499571|NCT03102710|521026445|FG000|Overall Study|Nausea during MRI scan|0|||
144499572|NCT03102710|521026446|FG001|Overall Study|Nausea during MRI scan|1|||
144499573|NCT03102710|521026447|FG002|Overall Study|Nausea during MRI scan|0|||
144499574|NCT03102710|521026445|FG000|Overall Study|Subject unable to attend final session|0|||
144499575|NCT03102710|521026446|FG001|Overall Study|Subject unable to attend final session|1|||
144719941|NCT01855126|521827544|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
144499576|NCT03102710|521026447|FG002|Overall Study|Subject unable to attend final session|0|||
144499577|NCT04012853|521026448|FG000|Overall Study|Withdrawal by Subject|1|||
144499578|NCT04012853|521026449|FG001|Overall Study|Withdrawal by Subject|1|||
144499579|NCT04012853|521026448|FG000|Overall Study|Protocol Violation|1|||
144499580|NCT04012853|521026449|FG001|Overall Study|Protocol Violation|0|||
144499581|NCT04012853|521026448|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
144499582|NCT04012853|521026449|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
144499583|NCT01313182|521026450|FG000|Overall Study|Protocol Violation|66|||
144499584|NCT01313182|521026451|FG001|Overall Study|Protocol Violation|92|||
144499585|NCT01695317|521026452|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
144499586|NCT01695317|521026453|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
144499587|NCT01695317|521026452|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
144499588|NCT01695317|521026453|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
144499589|NCT03055767|521026454|FG000|Open-Label Period|Lost to Follow-up|0|||
144499590|NCT03055767|521026455|FG001|Open-Label Period|Lost to Follow-up|0|||
144499591|NCT03055767|521026456|FG002|Open-Label Period|Lost to Follow-up|2|||
144499592|NCT03055767|521026457|FG003|Open-Label Period|Lost to Follow-up|0|||
144499593|NCT03055767|521026454|FG000|Open-Label Period|Withdrawal by Subject|0|||
144499594|NCT03055767|521026455|FG001|Open-Label Period|Withdrawal by Subject|0|||
144499595|NCT03055767|521026456|FG002|Open-Label Period|Withdrawal by Subject|0|||
144499596|NCT03055767|521026457|FG003|Open-Label Period|Withdrawal by Subject|1|||
144499597|NCT02759731|521026460|FG000|Overall Study|Did not complete treatment.|8|||
144499598|NCT01466881|521026462|FG000|Overall Study|Ineligible|5|||
144499599|NCT01466881|521026462|FG000|Overall Study|Adverse Event|6|||
144499600|NCT01466881|521026462|FG000|Overall Study|Progression/relapse|20|||
144499601|NCT01466881|521026462|FG000|Overall Study|Death|4|||
144499602|NCT01466881|521026462|FG000|Overall Study|Other reason not protocol specified|5|||
144499603|NCT00606580|521026463|FG000|Overall Study|Lost to Follow-up|1|||
144499604|NCT00606580|521026464|FG001|Overall Study|Lost to Follow-up|1|||
144499605|NCT00606580|521026465|FG002|Overall Study|Lost to Follow-up|4|||
144499606|NCT00606580|521026463|FG000|Overall Study|Clinical failures|1|||
144499607|NCT00606580|521026464|FG001|Overall Study|Clinical failures|0|||
144499608|NCT00606580|521026465|FG002|Overall Study|Clinical failures|12|||
144499609|NCT00606580|521026463|FG000|Overall Study|Withdrawal by investigator|0|||
144499610|NCT00606580|521026464|FG001|Overall Study|Withdrawal by investigator|1|||
144499611|NCT00606580|521026465|FG002|Overall Study|Withdrawal by investigator|6|||
144499612|NCT00606580|521026463|FG000|Overall Study|Withdrawal by Subject|0|||
144499613|NCT00606580|521026464|FG001|Overall Study|Withdrawal by Subject|1|||
144499614|NCT00606580|521026465|FG002|Overall Study|Withdrawal by Subject|0|||
144499615|NCT01101165|521026466|FG000|Period 1|Adverse Event|1|||
144499616|NCT01101165|521026467|FG001|Period 1|Adverse Event|2|||
144499617|NCT01101165|521026466|FG000|Period 1|Withdrawal by Subject|0|||
144499618|NCT01101165|521026467|FG001|Period 1|Withdrawal by Subject|2|||
144499619|NCT01101165|521026466|FG000|Period 1|Positive Drug Screen|0|||
144499620|NCT01101165|521026467|FG001|Period 1|Positive Drug Screen|1|||
144499621|NCT01101165|521026466|FG000|Period 1|Lost to Follow-up|1|||
144499622|NCT01101165|521026467|FG001|Period 1|Lost to Follow-up|0|||
144499623|NCT01101165|521026466|FG000|Period 2|Withdrawal by Subject|3|||
144499624|NCT01101165|521026467|FG001|Period 2|Withdrawal by Subject|1|||
144499625|NCT01101165|521026466|FG000|Period 2|Adverse Event|1|||
144499626|NCT01101165|521026467|FG001|Period 2|Adverse Event|0|||
144499627|NCT04580303|521026468|FG000|Overall Study|Adverse Event|0|||
144499628|NCT04580303|521026469|FG001|Overall Study|Adverse Event|1|||
144499629|NCT04580303|521026470|FG002|Overall Study|Adverse Event|0|||
144499630|NCT04580303|521026471|FG003|Overall Study|Adverse Event|0|||
144499631|NCT04580303|521026468|FG000|Overall Study|Withdrawal by Subject|0|||
144499632|NCT04580303|521026469|FG001|Overall Study|Withdrawal by Subject|0|||
144499633|NCT04580303|521026470|FG002|Overall Study|Withdrawal by Subject|1|||
144499634|NCT04580303|521026471|FG003|Overall Study|Withdrawal by Subject|0|||
144499635|NCT00927823|521026475|FG000|Continuous Dosing Period|Death|0|||
144499636|NCT00927823|521026476|FG001|Continuous Dosing Period|Death|0|||
144499637|NCT00927823|521026477|FG002|Continuous Dosing Period|Death|6|||
144499638|NCT00927823|521026478|FG003|Continuous Dosing Period|Death|0|||
144499639|NCT00927823|521026475|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
144499640|NCT00927823|521026476|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
144499641|NCT00927823|521026477|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
144499642|NCT00927823|521026478|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
144499643|NCT00927823|521026475|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
144499644|NCT00927823|521026476|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
144499645|NCT00927823|521026477|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
144499646|NCT00927823|521026478|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
144499647|NCT00927823|521026475|FG000|Continuous Dosing Period|Other|1|||
144499648|NCT00927823|521026476|FG001|Continuous Dosing Period|Other|2|||
144499649|NCT00927823|521026477|FG002|Continuous Dosing Period|Other|9|||
144499650|NCT00927823|521026478|FG003|Continuous Dosing Period|Other|3|||
144499651|NCT02317705|521026484|FG000|Overall Study|Withdrawal by Subject|3|||
144499652|NCT02317705|521026484|FG000|Overall Study|Physician Decision|1|||
144499653|NCT02317705|521026484|FG000|Overall Study|Drug not usable|1|||
144499654|NCT02430532|521026493|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
144499655|NCT02430532|521026494|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
144499656|NCT02430532|521026493|FG000|Overall Study|Consent Withdrawn|0|||
144499657|NCT02430532|521026494|FG001|Overall Study|Consent Withdrawn|2|||
144499658|NCT02430532|521026493|FG000|Overall Study|Adverse Event|0|||
144499659|NCT02430532|521026494|FG001|Overall Study|Adverse Event|1|||
144499660|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Other|4|||
144499661|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Other|0|||
144499662|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
144719942|NCT01855126|521827545|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
144719943|NCT01855126|521827544|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
144719944|NCT01855126|521827545|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
144719945|NCT01533428|521827548|FG000|Overall Study|Adverse Event|0|||
144719946|NCT01533428|521827549|FG001|Overall Study|Adverse Event|1|||
144719947|NCT01533428|521827548|FG000|Overall Study|Lost to Follow-up|2|||
144719948|NCT01533428|521827549|FG001|Overall Study|Lost to Follow-up|1|||
144719949|NCT01533428|521827548|FG000|Overall Study|Withdrawal by Subject|7|||
144719950|NCT01533428|521827549|FG001|Overall Study|Withdrawal by Subject|6|||
144719951|NCT01078090|521827559|FG000|Overall Study|Lost to Follow-up|2363|||
144719952|NCT01078090|521827559|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
144719953|NCT01078090|521827559|FG000|Overall Study|Lack of Efficacy|1193|||
144719954|NCT01078090|521827559|FG000|Overall Study|ADR and lack of efficacy|61|||
144719955|NCT01078090|521827559|FG000|Overall Study|Other|523|||
144719956|NCT04535583|521827560|FG000|Overall Study|Lost to Follow-up|1|||
144719957|NCT04535583|521827560|FG000|Overall Study|Physician Decision|1|||
144719958|NCT04535583|521827560|FG000|Overall Study|Withdrawal by Subject|1|||
144719959|NCT01748890|521827562|FG000|Overall Study|Insufficient recruitment for analysis|4|||
144719960|NCT01688037|521827563|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
144719961|NCT01688037|521827564|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
144719962|NCT01688037|521827565|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
144719963|NCT01688037|521827563|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
144719964|NCT01688037|521827564|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
144719965|NCT01688037|521827565|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
144719966|NCT01688037|521827563|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
144719967|NCT01688037|521827564|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
144719968|NCT01688037|521827565|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
144719969|NCT01688037|521827563|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
144719970|NCT01688037|521827564|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
144719971|NCT01688037|521827565|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
144719972|NCT01688037|521827563|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
144719973|NCT01688037|521827564|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
144719974|NCT01688037|521827565|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
144499663|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
144499664|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
144499665|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
144719975|NCT01688037|521827563|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
144499666|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
144499667|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
144499668|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
144499669|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
144499670|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
144499671|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
144499672|NCT00853827|521026495|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
144499673|NCT00853827|521026496|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
144499674|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
144499675|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
144499676|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
144499677|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
144499678|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
144499679|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
144499680|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
144499681|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
144499682|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
144499683|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
144499684|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
144499685|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
144499686|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
144499687|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
144499688|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
144499689|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
144499690|NCT00853827|521026495|FG000|Double Blind Period (103 Weeks)|Death|1|||
144499691|NCT00853827|521026496|FG001|Double Blind Period (103 Weeks)|Death|6|||
144499692|NCT00290732|521026498|FG000|Overall Study|Inability to instill drug intraductally.|0|||
144499693|NCT00290732|521026499|FG001|Overall Study|Inability to instill drug intraductally.|1|||
144499694|NCT00290732|521026500|FG002|Overall Study|Inability to instill drug intraductally.|1|||
144499695|NCT00290732|521026501|FG003|Overall Study|Inability to instill drug intraductally.|0|||
144499696|NCT00290732|521026502|FG004|Overall Study|Inability to instill drug intraductally.|0|||
144499697|NCT00502593|521026503|FG000|Overall Study|Withdrawn unspecified reason|1|||
144499698|NCT00502593|521026504|FG001|Overall Study|Withdrawn unspecified reason|1|||
144499699|NCT00502593|521026505|FG002|Overall Study|Withdrawn unspecified reason|3|||
144499700|NCT00502593|521026506|FG003|Overall Study|Withdrawn unspecified reason|1|||
144499701|NCT00502593|521026507|FG004|Overall Study|Withdrawn unspecified reason|2|||
144499702|NCT00502593|521026508|FG005|Overall Study|Withdrawn unspecified reason|0|||
144499703|NCT00502593|521026509|FG006|Overall Study|Withdrawn unspecified reason|2|||
144499704|NCT00502593|521026510|FG007|Overall Study|Withdrawn unspecified reason|0|||
144499705|NCT00502593|521026511|FG008|Overall Study|Withdrawn unspecified reason|0|||
144499706|NCT00502593|521026512|FG009|Overall Study|Withdrawn unspecified reason|0|||
144499707|NCT00502593|521026513|FG010|Overall Study|Withdrawn unspecified reason|0|||
144499708|NCT00502593|521026514|FG011|Overall Study|Withdrawn unspecified reason|0|||
144499709|NCT00502593|521026503|FG000|Overall Study|Withdrawal by Subject|0|||
144499710|NCT00502593|521026504|FG001|Overall Study|Withdrawal by Subject|0|||
144499711|NCT00502593|521026505|FG002|Overall Study|Withdrawal by Subject|6|||
144499712|NCT00502593|521026506|FG003|Overall Study|Withdrawal by Subject|2|||
144499713|NCT00502593|521026507|FG004|Overall Study|Withdrawal by Subject|2|||
144499714|NCT00502593|521026508|FG005|Overall Study|Withdrawal by Subject|0|||
144499715|NCT00502593|521026509|FG006|Overall Study|Withdrawal by Subject|3|||
144499716|NCT00502593|521026510|FG007|Overall Study|Withdrawal by Subject|0|||
144499717|NCT00502593|521026511|FG008|Overall Study|Withdrawal by Subject|3|||
144499718|NCT00502593|521026512|FG009|Overall Study|Withdrawal by Subject|0|||
144499719|NCT00502593|521026513|FG010|Overall Study|Withdrawal by Subject|1|||
144499720|NCT00502593|521026514|FG011|Overall Study|Withdrawal by Subject|0|||
144499721|NCT00502593|521026503|FG000|Overall Study|Lost to Follow-up|2|||
144499722|NCT00502593|521026504|FG001|Overall Study|Lost to Follow-up|1|||
144499723|NCT00502593|521026505|FG002|Overall Study|Lost to Follow-up|1|||
144499724|NCT00502593|521026506|FG003|Overall Study|Lost to Follow-up|1|||
144499725|NCT00502593|521026507|FG004|Overall Study|Lost to Follow-up|0|||
144499726|NCT00502593|521026508|FG005|Overall Study|Lost to Follow-up|0|||
144499727|NCT00502593|521026509|FG006|Overall Study|Lost to Follow-up|0|||
144499728|NCT00502593|521026510|FG007|Overall Study|Lost to Follow-up|0|||
144499729|NCT00502593|521026511|FG008|Overall Study|Lost to Follow-up|3|||
144499730|NCT00502593|521026512|FG009|Overall Study|Lost to Follow-up|0|||
144719976|NCT01688037|521827564|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
144719977|NCT01688037|521827565|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
144719978|NCT01688037|521827563|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
144719979|NCT01688037|521827564|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
144370075|NCT02379091|520562804|FG003|Overall Study|Lost to Follow-up|1|||
144499731|NCT00502593|521026513|FG010|Overall Study|Lost to Follow-up|1|||
144499732|NCT00502593|521026514|FG011|Overall Study|Lost to Follow-up|0|||
144499733|NCT01460342|521026517|FG000|Overall Study|Adverse Event|5|||
144499734|NCT01460342|521026518|FG001|Overall Study|Adverse Event|4|||
144499735|NCT01460342|521026517|FG000|Overall Study|Lost to Follow-up|1|||
144499736|NCT01460342|521026518|FG001|Overall Study|Lost to Follow-up|2|||
144499737|NCT01460342|521026517|FG000|Overall Study|Protocol Violation|0|||
144719980|NCT01688037|521827565|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
144719981|NCT01688037|521827563|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
144719982|NCT01688037|521827564|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
144719983|NCT01688037|521827565|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
144719984|NCT01688037|521827563|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
144719985|NCT01688037|521827564|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
144719986|NCT01688037|521827565|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
144719987|NCT01688037|521827563|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
144719988|NCT01688037|521827564|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
144719989|NCT01688037|521827565|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
144719990|NCT02100956|521827566|FG000|At Least One Week Between Injections|Adverse Event|0|||
144719991|NCT02100956|521827567|FG001|At Least One Week Between Injections|Adverse Event|1|||
144719992|NCT02220907|521827568|FG000|Overall Study|Adverse Event|7|||
144719993|NCT02220907|521827568|FG000|Overall Study|Physician Decision|1|||
144719994|NCT02220907|521827568|FG000|Overall Study|Withdrawal by Subject|2|||
144719995|NCT02220907|521827568|FG000|Overall Study|Conflict with the stopping criteria|1|||
144719996|NCT01098240|521827569|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
144719997|NCT01098240|521827570|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
144719998|NCT01098240|521827571|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
144719999|NCT01098240|521827569|FG000|Open-Label Phase|Protocol Violation|4|||
144720000|NCT01098240|521827570|FG001|Open-Label Phase|Protocol Violation|0|||
144720001|NCT01098240|521827571|FG002|Open-Label Phase|Protocol Violation|0|||
144720002|NCT01098240|521827569|FG000|Open-Label Phase|Lost to Follow-up|13|||
144720003|NCT01098240|521827570|FG001|Open-Label Phase|Lost to Follow-up|0|||
144720004|NCT01098240|521827571|FG002|Open-Label Phase|Lost to Follow-up|0|||
144720005|NCT01098240|521827569|FG000|Open-Label Phase|Other|19|||
144720006|NCT01098240|521827570|FG001|Open-Label Phase|Other|0|||
144720007|NCT01098240|521827571|FG002|Open-Label Phase|Other|0|||
144720008|NCT01098240|521827569|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
144720009|NCT01098240|521827570|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
144720010|NCT01098240|521827571|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
144720011|NCT01098240|521827569|FG000|Open-Label Phase|Pregnancy|1|||
144720012|NCT01098240|521827570|FG001|Open-Label Phase|Pregnancy|0|||
144720013|NCT01098240|521827571|FG002|Open-Label Phase|Pregnancy|0|||
144720014|NCT01098240|521827569|FG000|Open-Label Phase|Withdrawal by Subject|9|||
144720015|NCT01098240|521827570|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144720016|NCT01098240|521827571|FG002|Open-Label Phase|Withdrawal by Subject|0|||
144720017|NCT01098240|521827569|FG000|Open-Label Phase|Adverse Event|12|||
144720018|NCT01098240|521827570|FG001|Open-Label Phase|Adverse Event|0|||
144720019|NCT01098240|521827571|FG002|Open-Label Phase|Adverse Event|0|||
144720020|NCT01098240|521827569|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
144720021|NCT01098240|521827570|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
144720022|NCT01098240|521827571|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
144720023|NCT01098240|521827569|FG000|Double-Blind Phase|Protocol Violation|0|||
144720024|NCT01098240|521827570|FG001|Double-Blind Phase|Protocol Violation|2|||
144720025|NCT01098240|521827571|FG002|Double-Blind Phase|Protocol Violation|4|||
144720026|NCT01098240|521827569|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144720027|NCT01098240|521827570|FG001|Double-Blind Phase|Lost to Follow-up|2|||
144720028|NCT01098240|521827571|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144720029|NCT01098240|521827569|FG000|Double-Blind Phase|Other|0|||
144720030|NCT01098240|521827570|FG001|Double-Blind Phase|Other|2|||
144720031|NCT01098240|521827571|FG002|Double-Blind Phase|Other|2|||
144720032|NCT01098240|521827569|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
144720033|NCT01098240|521827570|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
144720034|NCT01098240|521827571|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
144720035|NCT01098240|521827569|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
144720036|NCT01098240|521827570|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
144720037|NCT01098240|521827571|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
144720038|NCT01098240|521827569|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
144720039|NCT01098240|521827570|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
144720040|NCT01098240|521827571|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
144720041|NCT01098240|521827569|FG000|Double-Blind Phase|Adverse Event|0|||
144499738|NCT01460342|521026518|FG001|Overall Study|Protocol Violation|1|||
144499739|NCT01460342|521026517|FG000|Overall Study|Withdrawal by Subject|3|||
144499740|NCT01460342|521026518|FG001|Overall Study|Withdrawal by Subject|4|||
144720042|NCT01098240|521827570|FG001|Double-Blind Phase|Adverse Event|3|||
144720043|NCT01098240|521827571|FG002|Double-Blind Phase|Adverse Event|3|||
144720044|NCT03280537|521827572|FG000|Overall Study|Withdrawal by Subject|2|||
144499741|NCT01460342|521026517|FG000|Overall Study|Physician Decision|1|||
144499742|NCT01460342|521026518|FG001|Overall Study|Physician Decision|3|||
144499743|NCT01460342|521026517|FG000|Overall Study|Lack of Efficacy|1|||
144499744|NCT01460342|521026518|FG001|Overall Study|Lack of Efficacy|0|||
144499745|NCT00591838|521026519|FG000|Overall Study|Withdrawal by Subject|0|||
144499746|NCT00591838|521026520|FG001|Overall Study|Withdrawal by Subject|0|||
144499747|NCT00591838|521026521|FG002|Overall Study|Withdrawal by Subject|0|||
144499748|NCT00591838|521026522|FG003|Overall Study|Withdrawal by Subject|1|||
144499749|NCT00591838|521026523|FG004|Overall Study|Withdrawal by Subject|0|||
144499750|NCT02982213|521026524|FG000|Overall Study|Did not complete follow up questionnaire|5|||
144499751|NCT02982213|521026525|FG001|Overall Study|Did not complete follow up questionnaire|1|||
144499752|NCT01549652|521026527|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
144499753|NCT01549652|521026528|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
144499754|NCT01549652|521026529|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
144499755|NCT01549652|521026530|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
144499756|NCT01549652|521026527|FG000|Overall Study|Study Drug Titration Failure|5|||
144499757|NCT01549652|521026528|FG001|Overall Study|Study Drug Titration Failure|6|||
144499758|NCT01549652|521026529|FG002|Overall Study|Study Drug Titration Failure|0|||
144499759|NCT01549652|521026530|FG003|Overall Study|Study Drug Titration Failure|0|||
144499760|NCT01549652|521026527|FG000|Overall Study|Withdrawal Effect|0|||
144499761|NCT01549652|521026528|FG001|Overall Study|Withdrawal Effect|2|||
144499762|NCT01549652|521026529|FG002|Overall Study|Withdrawal Effect|0|||
144499763|NCT01549652|521026530|FG003|Overall Study|Withdrawal Effect|0|||
144499764|NCT01549652|521026527|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
144499765|NCT01549652|521026528|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
144499766|NCT01549652|521026529|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
144499767|NCT01549652|521026530|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
144499768|NCT01549652|521026527|FG000|Overall Study|Problem with Infusion|1|||
144499769|NCT01549652|521026528|FG001|Overall Study|Problem with Infusion|0|||
144499770|NCT01549652|521026529|FG002|Overall Study|Problem with Infusion|0|||
144499771|NCT01549652|521026530|FG003|Overall Study|Problem with Infusion|0|||
144499772|NCT01549652|521026527|FG000|Overall Study|Titration Non-Compliance|1|||
144499773|NCT01549652|521026528|FG001|Overall Study|Titration Non-Compliance|3|||
144499774|NCT01549652|521026529|FG002|Overall Study|Titration Non-Compliance|4|||
144499775|NCT01549652|521026530|FG003|Overall Study|Titration Non-Compliance|5|||
144499776|NCT01549652|521026527|FG000|Overall Study|Titration Side Effects|0|||
144499777|NCT01549652|521026528|FG001|Overall Study|Titration Side Effects|0|||
144499778|NCT01549652|521026529|FG002|Overall Study|Titration Side Effects|6|||
144499779|NCT01549652|521026530|FG003|Overall Study|Titration Side Effects|3|||
144499780|NCT01549652|521026527|FG000|Overall Study|Withdrawal by Subject|0|||
144499781|NCT01549652|521026528|FG001|Overall Study|Withdrawal by Subject|0|||
144499782|NCT01549652|521026529|FG002|Overall Study|Withdrawal by Subject|5|||
144499783|NCT01549652|521026530|FG003|Overall Study|Withdrawal by Subject|3|||
144499784|NCT02512042|521026531|FG000|Overall Study|Adverse Event|0|||
144499785|NCT02512042|521026532|FG001|Overall Study|Adverse Event|4|||
144499786|NCT02512042|521026531|FG000|Overall Study|Withdrawal by Subject|6|||
144499787|NCT02512042|521026532|FG001|Overall Study|Withdrawal by Subject|6|||
144499788|NCT02512042|521026531|FG000|Overall Study|Non-compliance with study drug|1|||
144499789|NCT02512042|521026532|FG001|Overall Study|Non-compliance with study drug|2|||
144499790|NCT02512042|521026531|FG000|Overall Study|Lost to Follow-up|5|||
144499791|NCT02512042|521026532|FG001|Overall Study|Lost to Follow-up|2|||
144499792|NCT02512042|521026531|FG000|Overall Study|Other|11|||
144499793|NCT02512042|521026532|FG001|Overall Study|Other|11|||
144499794|NCT04163458|521026537|FG000|Overall Study|Protocol Deviation|7|||
144499795|NCT04163458|521026538|FG001|Overall Study|Protocol Deviation|13|||
144499796|NCT04163458|521026537|FG000|Overall Study|Adverse Event|5|||
144499797|NCT04163458|521026538|FG001|Overall Study|Adverse Event|8|||
144499798|NCT04163458|521026537|FG000|Overall Study|Due to COVID-19 pandemic|4|||
144499799|NCT04163458|521026538|FG001|Overall Study|Due to COVID-19 pandemic|2|||
144499800|NCT04163458|521026537|FG000|Overall Study|Participant withdrew consent|2|||
144499801|NCT04163458|521026538|FG001|Overall Study|Participant withdrew consent|3|||
144499802|NCT04163458|521026537|FG000|Overall Study|Randomization failure|2|||
144499803|NCT04163458|521026538|FG001|Overall Study|Randomization failure|2|||
144499804|NCT04163458|521026537|FG000|Overall Study|Other|4|||
144499805|NCT04163458|521026538|FG001|Overall Study|Other|2|||
144499806|NCT03247543|521026543|FG000|Overall Study|Adverse Event|3|||
144499807|NCT03247543|521026544|FG001|Overall Study|Adverse Event|6|||
144499808|NCT03247543|521026545|FG002|Overall Study|Adverse Event|4|||
144499809|NCT03247543|521026543|FG000|Overall Study|Lost to Follow-up|10|||
144499810|NCT03247543|521026544|FG001|Overall Study|Lost to Follow-up|7|||
144499811|NCT03247543|521026545|FG002|Overall Study|Lost to Follow-up|8|||
144499812|NCT03247543|521026543|FG000|Overall Study|Consent withdrawn by caregiver|2|||
144499813|NCT03247543|521026544|FG001|Overall Study|Consent withdrawn by caregiver|2|||
144499814|NCT03247543|521026545|FG002|Overall Study|Consent withdrawn by caregiver|9|||
144499815|NCT03247543|521026543|FG000|Overall Study|Withdrawal by Subject|0|||
144499816|NCT03247543|521026544|FG001|Overall Study|Withdrawal by Subject|0|||
144499817|NCT03247543|521026545|FG002|Overall Study|Withdrawal by Subject|1|||
144499818|NCT03247543|521026543|FG000|Overall Study|Failure to Follow study procedures|1|||
144499819|NCT03247543|521026544|FG001|Overall Study|Failure to Follow study procedures|3|||
144499820|NCT03247543|521026545|FG002|Overall Study|Failure to Follow study procedures|1|||
144499821|NCT03247543|521026543|FG000|Overall Study|Lack of Efficacy|1|||
144499822|NCT03247543|521026544|FG001|Overall Study|Lack of Efficacy|0|||
144499823|NCT03247543|521026545|FG002|Overall Study|Lack of Efficacy|0|||
144499824|NCT03247543|521026543|FG000|Overall Study|Non-compliance with study visits|0|||
144499825|NCT03247543|521026544|FG001|Overall Study|Non-compliance with study visits|1|||
144499826|NCT03247543|521026545|FG002|Overall Study|Non-compliance with study visits|0|||
144499827|NCT02059980|521026549|FG000|Overall Study|Lost to Follow-up|2|||
144499828|NCT02059980|521026550|FG001|Overall Study|Lost to Follow-up|1|||
144499829|NCT01104415|521026551|FG000|Core Phase|Consent withdrawn by subjects|1|||
144499830|NCT01104415|521026552|FG001|Core Phase|Consent withdrawn by subjects|0|||
144499831|NCT01104415|521026551|FG000|Extension Period|Progressive disease|0|||
144499832|NCT01104415|521026552|FG001|Extension Period|Progressive disease|4|||
144499833|NCT01104415|521026551|FG000|Extension Period|Death|0|||
144499834|NCT01104415|521026552|FG001|Extension Period|Death|1|||
144499835|NCT01104415|521026551|FG000|Extension Period|Physician Decision|0|||
144499836|NCT01104415|521026552|FG001|Extension Period|Physician Decision|1|||
144499837|NCT01104415|521026551|FG000|Extension Period|Transition to Study LX1606.302|0|||
144499838|NCT01104415|521026552|FG001|Extension Period|Transition to Study LX1606.302|4|||
144499839|NCT01104415|521026551|FG000|Extension Period|Heart surgery/feeling miserable|0|||
144499840|NCT01104415|521026552|FG001|Extension Period|Heart surgery/feeling miserable|1|||
144499841|NCT04257058|521028115|FG000|Overall Study|Lost to Follow-up|31|||
144499842|NCT03227757|521028116|FG000|Overall Study|Death|25|||
144499843|NCT03227757|521028116|FG000|Overall Study|Withdrawal|10|||
144499844|NCT03227757|521028116|FG000|Overall Study|Missed visits|1|||
144499845|NCT03227757|521028116|FG000|Overall Study|Lost to Follow-up|2|||
144499846|NCT01144468|521028118|FG000|Overall Study|Lost to Follow-up|4|||
144499847|NCT01144468|521028119|FG001|Overall Study|Lost to Follow-up|7|||
144499848|NCT01144468|521028118|FG000|Overall Study|Adverse Event|3|||
144499849|NCT01144468|521028119|FG001|Overall Study|Adverse Event|2|||
144499850|NCT01144468|521028118|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
144499851|NCT01144468|521028119|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
144499852|NCT02960659|521028120|FG000|Overall Study|Withdrawal by Subject|1|||
144499853|NCT02960659|521028121|FG001|Overall Study|Withdrawal by Subject|0|||
144499854|NCT02960659|521028120|FG000|Overall Study|Poor compliance|0|||
144499855|NCT02960659|521028121|FG001|Overall Study|Poor compliance|1|||
144499856|NCT04199728|521028125|FG000|Overall Study|Adverse Event|1|||
144499857|NCT04199728|521028126|FG001|Overall Study|Adverse Event|0|||
144499858|NCT04199728|521028125|FG000|Overall Study|Withdrawal by Subject|8|||
144499859|NCT04199728|521028126|FG001|Overall Study|Withdrawal by Subject|3|||
144499860|NCT04199728|521028125|FG000|Overall Study|Screen fail after consent|0|||
144499861|NCT04199728|521028126|FG001|Overall Study|Screen fail after consent|1|||
144499862|NCT04199728|521028125|FG000|Overall Study|Early withdraw criteria met|0|||
144499863|NCT04199728|521028126|FG001|Overall Study|Early withdraw criteria met|1|||
144499864|NCT04199728|521028125|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
144499865|NCT04199728|521028126|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
144499866|NCT01875250|521028130|FG000|Overall Study|Adverse Event|2|||
144499867|NCT01875250|521028131|FG001|Overall Study|Adverse Event|0|||
144499868|NCT00482729|521028134|FG000|Overall Study|Adverse Event|29|||
144499869|NCT00482729|521028135|FG001|Overall Study|Adverse Event|33|||
144499870|NCT00482729|521028134|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
144499871|NCT00482729|521028135|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
144499872|NCT00482729|521028134|FG000|Overall Study|Hyperglycemia Criteria|7|||
144499873|NCT00482729|521028135|FG001|Overall Study|Hyperglycemia Criteria|5|||
144499874|NCT00482729|521028134|FG000|Overall Study|Lack of Efficacy|4|||
144499875|NCT00482729|521028135|FG001|Overall Study|Lack of Efficacy|16|||
144499876|NCT00482729|521028134|FG000|Overall Study|Lost to Follow-up|86|||
144499877|NCT00482729|521028135|FG001|Overall Study|Lost to Follow-up|66|||
144499878|NCT00482729|521028134|FG000|Overall Study|Physician Decision|10|||
144499879|NCT00482729|521028135|FG001|Overall Study|Physician Decision|7|||
144499880|NCT00482729|521028134|FG000|Overall Study|Pregnancy|4|||
144499881|NCT00482729|521028135|FG001|Overall Study|Pregnancy|2|||
144499882|NCT00482729|521028134|FG000|Overall Study|Protocol Violation|10|||
144499883|NCT00482729|521028135|FG001|Overall Study|Protocol Violation|18|||
144499884|NCT00482729|521028134|FG000|Overall Study|Withdrawal by Subject|67|||
144499885|NCT00482729|521028135|FG001|Overall Study|Withdrawal by Subject|69|||
144499886|NCT03140176|521028136|FG000|Overall Study|Reason missing|23|||
144499887|NCT03140176|521028136|FG000|Overall Study|Death|33|||
144499888|NCT03140176|521028136|FG000|Overall Study|Disease progression|1|||
144499889|NCT03140176|521028136|FG000|Overall Study|Physician Decision|1|||
144499890|NCT03140176|521028136|FG000|Overall Study|Withdrawal by Subject|1|||
144499891|NCT03140176|521028136|FG000|Overall Study|Lost to Follow-up|15|||
144499892|NCT01331824|521028140|FG000|Overall Study|Adverse Event|2|||
144499893|NCT01331824|521028140|FG000|Overall Study|Death|1|||
144499894|NCT01331824|521028140|FG000|Overall Study|Disease Progression|9|||
144499895|NCT01331824|521028140|FG000|Overall Study|Withdrawal by Subject|1|||
144499896|NCT01091454|521028141|FG000|Overall Study|Ineligible|1|||
144499897|NCT03179787|521028147|FG000|Overall Study|Lost to Follow-up|15|||
144499898|NCT03179787|521028147|FG000|Overall Study|Case report failures|2|||
144499899|NCT03179787|521028147|FG000|Overall Study|Treatment not administered|1|||
144499900|NCT02030028|521028148|FG000|Overall Study|Withdrawal by Subject|4|||
144499901|NCT02030028|521028148|FG000|Overall Study|lack of transportation|1|||
144499902|NCT00661778|521028149|FG000|Overall Study|Disease Progression|23|||
144499903|NCT00661778|521028149|FG000|Overall Study|Adverse Event|18|||
144499904|NCT00661778|521028149|FG000|Overall Study|Reason not Specified|6|||
144499905|NCT00661778|521028149|FG000|Overall Study|Protocol Violation|2|||
144499906|NCT00661778|521028149|FG000|Overall Study|Withdrawal of Consent|1|||
144499907|NCT01090024|521028154|FG000|Period 1|Met exclusion criteria|0|||
144499908|NCT01090024|521028155|FG001|Period 1|Met exclusion criteria|0|||
144499909|NCT01090024|521028156|FG002|Period 1|Met exclusion criteria|0|||
144499910|NCT01090024|521028157|FG003|Period 1|Met exclusion criteria|0|||
144499911|NCT01090024|521028158|FG004|Period 1|Met exclusion criteria|0|||
144499912|NCT01090024|521028159|FG005|Period 1|Met exclusion criteria|0|||
144499913|NCT01090024|521028160|FG006|Period 1|Met exclusion criteria|0|||
144499914|NCT01090024|521028161|FG007|Period 1|Met exclusion criteria|0|||
144499915|NCT01090024|521028162|FG008|Period 1|Met exclusion criteria|0|||
144499916|NCT01090024|521028163|FG009|Period 1|Met exclusion criteria|0|||
144499917|NCT01090024|521028164|FG010|Period 1|Met exclusion criteria|0|||
144499918|NCT01090024|521028165|FG011|Period 1|Met exclusion criteria|0|||
144499919|NCT01090024|521028166|FG012|Period 1|Met exclusion criteria|0|||
144499920|NCT01090024|521028167|FG013|Period 1|Met exclusion criteria|0|||
144499921|NCT01090024|521028168|FG014|Period 1|Met exclusion criteria|1|||
144499922|NCT01090024|521028169|FG015|Period 1|Met exclusion criteria|0|||
144499923|NCT01090024|521028170|FG016|Period 1|Met exclusion criteria|0|||
144499924|NCT01090024|521028171|FG017|Period 1|Met exclusion criteria|0|||
144499925|NCT01090024|521028154|FG000|Period 1|Adverse Event|0|||
144499926|NCT01090024|521028155|FG001|Period 1|Adverse Event|0|||
144499927|NCT01090024|521028156|FG002|Period 1|Adverse Event|0|||
144499928|NCT01090024|521028157|FG003|Period 1|Adverse Event|0|||
144499929|NCT01090024|521028158|FG004|Period 1|Adverse Event|0|||
144499930|NCT01090024|521028159|FG005|Period 1|Adverse Event|0|||
144499931|NCT01090024|521028160|FG006|Period 1|Adverse Event|0|||
144499932|NCT01090024|521028161|FG007|Period 1|Adverse Event|0|||
144499933|NCT01090024|521028162|FG008|Period 1|Adverse Event|0|||
144499934|NCT01090024|521028163|FG009|Period 1|Adverse Event|1|||
144499935|NCT01090024|521028164|FG010|Period 1|Adverse Event|0|||
144499936|NCT01090024|521028165|FG011|Period 1|Adverse Event|1|||
144499937|NCT01090024|521028166|FG012|Period 1|Adverse Event|0|||
144499938|NCT01090024|521028167|FG013|Period 1|Adverse Event|0|||
144499939|NCT01090024|521028168|FG014|Period 1|Adverse Event|0|||
144499940|NCT01090024|521028169|FG015|Period 1|Adverse Event|0|||
144499941|NCT01090024|521028170|FG016|Period 1|Adverse Event|0|||
144499942|NCT01090024|521028171|FG017|Period 1|Adverse Event|1|||
144499943|NCT01090024|521028154|FG000|Period 1|Withdrawal by Subject|0|||
144499944|NCT01090024|521028155|FG001|Period 1|Withdrawal by Subject|0|||
144499945|NCT01090024|521028156|FG002|Period 1|Withdrawal by Subject|0|||
144499946|NCT01090024|521028157|FG003|Period 1|Withdrawal by Subject|1|||
144499947|NCT01090024|521028158|FG004|Period 1|Withdrawal by Subject|0|||
144499948|NCT01090024|521028159|FG005|Period 1|Withdrawal by Subject|0|||
144499949|NCT01090024|521028160|FG006|Period 1|Withdrawal by Subject|0|||
144499950|NCT01090024|521028161|FG007|Period 1|Withdrawal by Subject|0|||
144499951|NCT01090024|521028162|FG008|Period 1|Withdrawal by Subject|0|||
144499952|NCT01090024|521028163|FG009|Period 1|Withdrawal by Subject|0|||
144499953|NCT01090024|521028164|FG010|Period 1|Withdrawal by Subject|0|||
144499954|NCT01090024|521028165|FG011|Period 1|Withdrawal by Subject|0|||
144499955|NCT01090024|521028166|FG012|Period 1|Withdrawal by Subject|0|||
144499956|NCT01090024|521028167|FG013|Period 1|Withdrawal by Subject|0|||
144499957|NCT01090024|521028168|FG014|Period 1|Withdrawal by Subject|0|||
144499958|NCT01090024|521028169|FG015|Period 1|Withdrawal by Subject|0|||
144499959|NCT01090024|521028170|FG016|Period 1|Withdrawal by Subject|0|||
144499960|NCT01090024|521028171|FG017|Period 1|Withdrawal by Subject|0|||
144499961|NCT01090024|521028154|FG000|Period 1|Lost to Follow-up|0|||
144499962|NCT01090024|521028155|FG001|Period 1|Lost to Follow-up|1|||
144499963|NCT01090024|521028156|FG002|Period 1|Lost to Follow-up|0|||
144499964|NCT01090024|521028157|FG003|Period 1|Lost to Follow-up|0|||
144499965|NCT01090024|521028158|FG004|Period 1|Lost to Follow-up|0|||
144499966|NCT01090024|521028159|FG005|Period 1|Lost to Follow-up|0|||
144499967|NCT01090024|521028160|FG006|Period 1|Lost to Follow-up|0|||
144499968|NCT01090024|521028161|FG007|Period 1|Lost to Follow-up|0|||
144499969|NCT01090024|521028162|FG008|Period 1|Lost to Follow-up|0|||
144499970|NCT01090024|521028163|FG009|Period 1|Lost to Follow-up|0|||
144499971|NCT01090024|521028164|FG010|Period 1|Lost to Follow-up|0|||
144499972|NCT01090024|521028165|FG011|Period 1|Lost to Follow-up|0|||
144499973|NCT01090024|521028166|FG012|Period 1|Lost to Follow-up|0|||
144499974|NCT01090024|521028167|FG013|Period 1|Lost to Follow-up|0|||
144499975|NCT01090024|521028168|FG014|Period 1|Lost to Follow-up|0|||
144499976|NCT01090024|521028169|FG015|Period 1|Lost to Follow-up|0|||
144499977|NCT01090024|521028170|FG016|Period 1|Lost to Follow-up|0|||
144499978|NCT01090024|521028171|FG017|Period 1|Lost to Follow-up|0|||
144499979|NCT01090024|521028154|FG000|Period 2|Lost to Follow-up|0|||
144499980|NCT01090024|521028155|FG001|Period 2|Lost to Follow-up|0|||
144499981|NCT01090024|521028156|FG002|Period 2|Lost to Follow-up|0|||
144499982|NCT01090024|521028157|FG003|Period 2|Lost to Follow-up|1|||
144499983|NCT01090024|521028158|FG004|Period 2|Lost to Follow-up|0|||
144499984|NCT01090024|521028159|FG005|Period 2|Lost to Follow-up|0|||
144499985|NCT01090024|521028160|FG006|Period 2|Lost to Follow-up|0|||
144499986|NCT01090024|521028161|FG007|Period 2|Lost to Follow-up|0|||
144499987|NCT01090024|521028162|FG008|Period 2|Lost to Follow-up|0|||
144499988|NCT01090024|521028163|FG009|Period 2|Lost to Follow-up|0|||
144499989|NCT01090024|521028164|FG010|Period 2|Lost to Follow-up|0|||
144499990|NCT01090024|521028165|FG011|Period 2|Lost to Follow-up|0|||
144499991|NCT01090024|521028166|FG012|Period 2|Lost to Follow-up|0|||
144499992|NCT01090024|521028167|FG013|Period 2|Lost to Follow-up|0|||
144499993|NCT01090024|521028168|FG014|Period 2|Lost to Follow-up|0|||
144499994|NCT01090024|521028169|FG015|Period 2|Lost to Follow-up|0|||
144499995|NCT01090024|521028170|FG016|Period 2|Lost to Follow-up|0|||
144499996|NCT01090024|521028171|FG017|Period 2|Lost to Follow-up|0|||
144499997|NCT01090024|521028154|FG000|Period 2|Adverse Event|1|||
144499998|NCT01090024|521028155|FG001|Period 2|Adverse Event|0|||
144499999|NCT01090024|521028156|FG002|Period 2|Adverse Event|0|||
144500000|NCT01090024|521028157|FG003|Period 2|Adverse Event|0|||
144500001|NCT01090024|521028158|FG004|Period 2|Adverse Event|0|||
144500002|NCT01090024|521028159|FG005|Period 2|Adverse Event|0|||
144500003|NCT01090024|521028160|FG006|Period 2|Adverse Event|0|||
144500004|NCT01090024|521028161|FG007|Period 2|Adverse Event|0|||
144500005|NCT01090024|521028162|FG008|Period 2|Adverse Event|0|||
144500006|NCT01090024|521028163|FG009|Period 2|Adverse Event|0|||
144500007|NCT01090024|521028164|FG010|Period 2|Adverse Event|0|||
144500008|NCT01090024|521028165|FG011|Period 2|Adverse Event|0|||
144500009|NCT01090024|521028166|FG012|Period 2|Adverse Event|0|||
144500010|NCT01090024|521028167|FG013|Period 2|Adverse Event|0|||
144500011|NCT01090024|521028168|FG014|Period 2|Adverse Event|0|||
144500012|NCT01090024|521028169|FG015|Period 2|Adverse Event|0|||
144500013|NCT01090024|521028170|FG016|Period 2|Adverse Event|0|||
144500014|NCT01090024|521028171|FG017|Period 2|Adverse Event|0|||
144500015|NCT01090024|521028154|FG000|Period 3|Withdrawal by Subject|0|||
144500016|NCT01090024|521028155|FG001|Period 3|Withdrawal by Subject|0|||
144500017|NCT01090024|521028156|FG002|Period 3|Withdrawal by Subject|0|||
144500018|NCT01090024|521028157|FG003|Period 3|Withdrawal by Subject|0|||
144500019|NCT01090024|521028158|FG004|Period 3|Withdrawal by Subject|0|||
144500020|NCT01090024|521028159|FG005|Period 3|Withdrawal by Subject|0|||
144500021|NCT01090024|521028160|FG006|Period 3|Withdrawal by Subject|0|||
144500022|NCT01090024|521028161|FG007|Period 3|Withdrawal by Subject|0|||
144500023|NCT01090024|521028162|FG008|Period 3|Withdrawal by Subject|0|||
144500024|NCT01090024|521028163|FG009|Period 3|Withdrawal by Subject|0|||
144500025|NCT01090024|521028164|FG010|Period 3|Withdrawal by Subject|0|||
144500026|NCT01090024|521028165|FG011|Period 3|Withdrawal by Subject|0|||
144500027|NCT01090024|521028166|FG012|Period 3|Withdrawal by Subject|0|||
144500028|NCT01090024|521028167|FG013|Period 3|Withdrawal by Subject|0|||
144500029|NCT01090024|521028168|FG014|Period 3|Withdrawal by Subject|0|||
144500030|NCT01090024|521028169|FG015|Period 3|Withdrawal by Subject|1|||
144500031|NCT01090024|521028170|FG016|Period 3|Withdrawal by Subject|0|||
144500032|NCT01090024|521028171|FG017|Period 3|Withdrawal by Subject|0|||
144500033|NCT01090024|521028154|FG000|Period 3|Protocol Violation|0|||
144500034|NCT01090024|521028155|FG001|Period 3|Protocol Violation|0|||
144500035|NCT01090024|521028156|FG002|Period 3|Protocol Violation|0|||
144500036|NCT01090024|521028157|FG003|Period 3|Protocol Violation|0|||
144500037|NCT01090024|521028158|FG004|Period 3|Protocol Violation|0|||
144500038|NCT01090024|521028159|FG005|Period 3|Protocol Violation|0|||
144500039|NCT01090024|521028160|FG006|Period 3|Protocol Violation|0|||
144500040|NCT01090024|521028161|FG007|Period 3|Protocol Violation|0|||
144500041|NCT01090024|521028162|FG008|Period 3|Protocol Violation|1|||
144500042|NCT01090024|521028163|FG009|Period 3|Protocol Violation|0|||
144500043|NCT01090024|521028164|FG010|Period 3|Protocol Violation|0|||
144500044|NCT01090024|521028165|FG011|Period 3|Protocol Violation|0|||
144500045|NCT01090024|521028166|FG012|Period 3|Protocol Violation|0|||
144500046|NCT01090024|521028167|FG013|Period 3|Protocol Violation|0|||
144500047|NCT01090024|521028168|FG014|Period 3|Protocol Violation|0|||
144500048|NCT01090024|521028169|FG015|Period 3|Protocol Violation|0|||
144500049|NCT01090024|521028170|FG016|Period 3|Protocol Violation|0|||
144500050|NCT01090024|521028171|FG017|Period 3|Protocol Violation|0|||
144500051|NCT01090024|521028154|FG000|Period 3|Adverse Event|0|||
144500052|NCT01090024|521028155|FG001|Period 3|Adverse Event|0|||
144500053|NCT01090024|521028156|FG002|Period 3|Adverse Event|0|||
144500054|NCT01090024|521028157|FG003|Period 3|Adverse Event|0|||
144500055|NCT01090024|521028158|FG004|Period 3|Adverse Event|0|||
144500056|NCT01090024|521028159|FG005|Period 3|Adverse Event|1|||
144500057|NCT01090024|521028160|FG006|Period 3|Adverse Event|0|||
144500058|NCT01090024|521028161|FG007|Period 3|Adverse Event|0|||
144500059|NCT01090024|521028162|FG008|Period 3|Adverse Event|0|||
144500060|NCT01090024|521028163|FG009|Period 3|Adverse Event|0|||
144500061|NCT01090024|521028164|FG010|Period 3|Adverse Event|0|||
144500062|NCT01090024|521028165|FG011|Period 3|Adverse Event|0|||
144500063|NCT01090024|521028166|FG012|Period 3|Adverse Event|0|||
144500064|NCT01090024|521028167|FG013|Period 3|Adverse Event|0|||
144500065|NCT01090024|521028168|FG014|Period 3|Adverse Event|0|||
144500066|NCT01090024|521028169|FG015|Period 3|Adverse Event|0|||
144500067|NCT01090024|521028170|FG016|Period 3|Adverse Event|0|||
144500068|NCT01090024|521028171|FG017|Period 3|Adverse Event|0|||
144500069|NCT00149630|521028174|FG000|Overall Study|Incarceration|2|||
144500070|NCT00149630|521028175|FG001|Overall Study|Incarceration|0|||
144500071|NCT00149630|521028174|FG000|Overall Study|Treatment Programs|4|||
144500072|NCT00149630|521028175|FG001|Overall Study|Treatment Programs|5|||
144500073|NCT00149630|521028174|FG000|Overall Study|Adverse Event|2|||
144500074|NCT00149630|521028175|FG001|Overall Study|Adverse Event|0|||
144500075|NCT00567879|521028179|FG000|Overall Study|Adverse Event|2|||
144500076|NCT00567879|521028180|FG001|Overall Study|Adverse Event|0|||
144500077|NCT00567879|521028181|FG002|Overall Study|Adverse Event|1|||
144500078|NCT00567879|521028182|FG003|Overall Study|Adverse Event|0|||
144500079|NCT00567879|521028183|FG004|Overall Study|Adverse Event|1|||
144500080|NCT00567879|521028184|FG005|Overall Study|Adverse Event|0|||
144500081|NCT00567879|521028179|FG000|Overall Study|Abnormal test procedure(s)|0|||
144500082|NCT00567879|521028180|FG001|Overall Study|Abnormal test procedure(s)|0|||
144500083|NCT00567879|521028181|FG002|Overall Study|Abnormal test procedure(s)|1|||
144500084|NCT00567879|521028182|FG003|Overall Study|Abnormal test procedure(s)|0|||
144500085|NCT00567879|521028183|FG004|Overall Study|Abnormal test procedure(s)|0|||
144500086|NCT00567879|521028184|FG005|Overall Study|Abnormal test procedure(s)|0|||
144500087|NCT00567879|521028179|FG000|Overall Study|Withdrawal by Subject|0|||
144500088|NCT00567879|521028180|FG001|Overall Study|Withdrawal by Subject|0|||
144500089|NCT00567879|521028181|FG002|Overall Study|Withdrawal by Subject|3|||
144500090|NCT00567879|521028182|FG003|Overall Study|Withdrawal by Subject|1|||
144500091|NCT00567879|521028183|FG004|Overall Study|Withdrawal by Subject|0|||
144500092|NCT00567879|521028184|FG005|Overall Study|Withdrawal by Subject|0|||
144500093|NCT00567879|521028179|FG000|Overall Study|New cancer therapy|0|||
144500094|NCT00567879|521028180|FG001|Overall Study|New cancer therapy|0|||
144500095|NCT00567879|521028181|FG002|Overall Study|New cancer therapy|1|||
144500096|NCT00567879|521028182|FG003|Overall Study|New cancer therapy|0|||
144500097|NCT00567879|521028183|FG004|Overall Study|New cancer therapy|0|||
144500098|NCT00567879|521028184|FG005|Overall Study|New cancer therapy|0|||
144500099|NCT00567879|521028179|FG000|Overall Study|Disease progression|5|||
144500100|NCT00567879|521028180|FG001|Overall Study|Disease progression|7|||
144500101|NCT00567879|521028181|FG002|Overall Study|Disease progression|15|||
144500102|NCT00567879|521028182|FG003|Overall Study|Disease progression|5|||
144500103|NCT00567879|521028183|FG004|Overall Study|Disease progression|11|||
144500104|NCT00567879|521028184|FG005|Overall Study|Disease progression|3|||
144500105|NCT00777556|521028187|FG000|Overall Study|Inappropriate self-selection|34|||
144500106|NCT00777556|521028187|FG000|Overall Study|Dispensed but did not use product|12|||
144500107|NCT00777556|521028187|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
144500108|NCT05298111|521028189|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
144500109|NCT05298111|521028190|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
144500110|NCT02380742|521028193|FG000|Overall Study|Withdrawal by Subject|1|||
144500111|NCT02380742|521028194|FG001|Overall Study|Withdrawal by Subject|0|||
144500112|NCT01729819|521028196|FG000|Overall Study|Adverse Event|2|||
144500113|NCT01729819|521028197|FG001|Overall Study|Adverse Event|4|||
144500114|NCT01729819|521028196|FG000|Overall Study|Lack of Efficacy|1|||
144500115|NCT01729819|521028197|FG001|Overall Study|Lack of Efficacy|0|||
144500116|NCT01729819|521028196|FG000|Overall Study|Lost to Follow-up|2|||
144500117|NCT01729819|521028197|FG001|Overall Study|Lost to Follow-up|0|||
144500118|NCT01729819|521028196|FG000|Overall Study|Other reason|1|||
144500119|NCT01729819|521028197|FG001|Overall Study|Other reason|0|||
144500120|NCT01729819|521028196|FG000|Overall Study|Protocol Violation|0|||
144500121|NCT01729819|521028197|FG001|Overall Study|Protocol Violation|1|||
144500122|NCT01729819|521028196|FG000|Overall Study|Withdrawal by Subject|0|||
144500123|NCT01729819|521028197|FG001|Overall Study|Withdrawal by Subject|2|||
144500124|NCT02987543|521028200|FG000|Overall Study|Ongoing study at data cut off|49|||
144500125|NCT02987543|521028201|FG001|Overall Study|Ongoing study at data cut off|21|||
144500126|NCT02987543|521028202|FG002|Overall Study|Ongoing study at data cut off|19|||
144500127|NCT02987543|521028203|FG003|Overall Study|Ongoing study at data cut off|12|||
144500128|NCT02987543|521028200|FG000|Overall Study|Death|88|||
144500129|NCT02987543|521028201|FG001|Overall Study|Death|54|||
144500130|NCT02987543|521028202|FG002|Overall Study|Death|67|||
144500131|NCT02987543|521028203|FG003|Overall Study|Death|28|||
144500132|NCT02987543|521028200|FG000|Overall Study|Lost to Follow-up|3|||
144500133|NCT02987543|521028201|FG001|Overall Study|Lost to Follow-up|0|||
144500134|NCT02987543|521028202|FG002|Overall Study|Lost to Follow-up|1|||
144500135|NCT02987543|521028203|FG003|Overall Study|Lost to Follow-up|0|||
144500136|NCT02987543|521028200|FG000|Overall Study|Screen failure|0|||
144500137|NCT02987543|521028201|FG001|Overall Study|Screen failure|0|||
144500138|NCT02987543|521028202|FG002|Overall Study|Screen failure|0|||
144500139|NCT02987543|521028203|FG003|Overall Study|Screen failure|1|||
144500140|NCT02987543|521028200|FG000|Overall Study|Withdrawal by Subject|21|||
144500141|NCT02987543|521028201|FG001|Overall Study|Withdrawal by Subject|7|||
144500142|NCT02987543|521028202|FG002|Overall Study|Withdrawal by Subject|7|||
144500143|NCT02987543|521028203|FG003|Overall Study|Withdrawal by Subject|6|||
144720045|NCT03280537|521827573|FG001|Overall Study|Withdrawal by Subject|4|||
144500144|NCT02987543|521028200|FG000|Overall Study|Study terminated by sponsor|1|||
144500145|NCT02987543|521028201|FG001|Overall Study|Study terminated by sponsor|0|||
144500146|NCT02987543|521028202|FG002|Overall Study|Study terminated by sponsor|0|||
144500147|NCT02987543|521028203|FG003|Overall Study|Study terminated by sponsor|0|||
144500148|NCT02987543|521028200|FG000|Overall Study|Investigator decision|0|||
144500149|NCT02987543|521028201|FG001|Overall Study|Investigator decision|1|||
144500150|NCT02987543|521028202|FG002|Overall Study|Investigator decision|0|||
144500151|NCT02987543|521028203|FG003|Overall Study|Investigator decision|0|||
144500152|NCT02987543|521028200|FG000|Overall Study|Disease progression|0|||
144500153|NCT02987543|521028201|FG001|Overall Study|Disease progression|0|||
144500154|NCT02987543|521028202|FG002|Overall Study|Disease progression|0|||
144500155|NCT02987543|521028203|FG003|Overall Study|Disease progression|1|||
144500156|NCT02001623|521028204|FG000|Overall Study|Disease Progression|2|||
144500157|NCT02001623|521028205|FG001|Overall Study|Disease Progression|2|||
144500158|NCT02001623|521028206|FG002|Overall Study|Disease Progression|3|||
144500159|NCT02001623|521028207|FG003|Overall Study|Disease Progression|2|||
144500160|NCT02001623|521028208|FG004|Overall Study|Disease Progression|3|||
144720046|NCT01588106|521827574|FG000|Overall Study|Withdrawal by Subject|5|||
144720047|NCT01588106|521827575|FG001|Overall Study|Withdrawal by Subject|4|||
144720048|NCT02995837|521827576|FG000|Overall Study|Lost to Follow-up|9|||
144720049|NCT02995837|521827577|FG001|Overall Study|Lost to Follow-up|8|||
144720050|NCT04274192|521827578|FG000|Overall Study|Protocol Violation|1|||
144720051|NCT04274192|521827579|FG001|Overall Study|Protocol Violation|0|||
144720052|NCT00874757|521827580|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
144720053|NCT00832078|521829466|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
144720054|NCT00832078|521829467|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
144720055|NCT00832078|521829466|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
144720056|NCT00832078|521829467|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
144720057|NCT02058628|521829468|FG000|Overall Study|Adverse Event|1|||
144720058|NCT02058628|521829469|FG001|Overall Study|Adverse Event|0|||
144720059|NCT02058628|521829468|FG000|Overall Study|Withdrawal by Subject|2|||
144500161|NCT02001623|521028209|FG005|Overall Study|Disease Progression|2|||
144500162|NCT02001623|521028210|FG006|Overall Study|Disease Progression|3|||
144500163|NCT02001623|521028211|FG007|Overall Study|Disease Progression|3|||
144500164|NCT02001623|521028212|FG008|Overall Study|Disease Progression|7|||
144500165|NCT02001623|521028213|FG009|Overall Study|Disease Progression|40|||
144720060|NCT02058628|521829469|FG001|Overall Study|Withdrawal by Subject|2|||
144500166|NCT02001623|521028214|FG010|Overall Study|Disease Progression|5|||
144500167|NCT02001623|521028215|FG011|Overall Study|Disease Progression|9|||
144500168|NCT02001623|521028216|FG012|Overall Study|Disease Progression|9|||
144500169|NCT02001623|521028217|FG013|Overall Study|Disease Progression|20|||
144500170|NCT02001623|521028218|FG014|Overall Study|Disease Progression|9|||
144500171|NCT02001623|521028204|FG000|Overall Study|Physician Decision|0|||
144500172|NCT02001623|521028205|FG001|Overall Study|Physician Decision|0|||
144500173|NCT02001623|521028206|FG002|Overall Study|Physician Decision|0|||
144720061|NCT02058628|521829468|FG000|Overall Study|Lost to Follow-up|2|||
144500174|NCT02001623|521028207|FG003|Overall Study|Physician Decision|0|||
144500175|NCT02001623|521028208|FG004|Overall Study|Physician Decision|0|||
144500176|NCT02001623|521028209|FG005|Overall Study|Physician Decision|0|||
144500177|NCT02001623|521028210|FG006|Overall Study|Physician Decision|0|||
144500178|NCT02001623|521028211|FG007|Overall Study|Physician Decision|0|||
144500179|NCT02001623|521028212|FG008|Overall Study|Physician Decision|3|||
144500180|NCT02001623|521028213|FG009|Overall Study|Physician Decision|2|||
144500181|NCT02001623|521028214|FG010|Overall Study|Physician Decision|3|||
144500182|NCT02001623|521028215|FG011|Overall Study|Physician Decision|3|||
144500183|NCT02001623|521028216|FG012|Overall Study|Physician Decision|1|||
144500184|NCT02001623|521028217|FG013|Overall Study|Physician Decision|2|||
144500185|NCT02001623|521028218|FG014|Overall Study|Physician Decision|1|||
144500186|NCT02001623|521028204|FG000|Overall Study|Death|0|||
144500187|NCT02001623|521028205|FG001|Overall Study|Death|1|||
144500188|NCT02001623|521028206|FG002|Overall Study|Death|0|||
144500189|NCT02001623|521028207|FG003|Overall Study|Death|0|||
144500190|NCT02001623|521028208|FG004|Overall Study|Death|0|||
144500191|NCT02001623|521028209|FG005|Overall Study|Death|0|||
144500192|NCT02001623|521028210|FG006|Overall Study|Death|0|||
144500193|NCT02001623|521028211|FG007|Overall Study|Death|0|||
144500194|NCT02001623|521028212|FG008|Overall Study|Death|0|||
144500195|NCT02001623|521028213|FG009|Overall Study|Death|0|||
144500196|NCT02001623|521028214|FG010|Overall Study|Death|0|||
144500197|NCT02001623|521028215|FG011|Overall Study|Death|0|||
144500198|NCT02001623|521028216|FG012|Overall Study|Death|0|||
144500199|NCT02001623|521028217|FG013|Overall Study|Death|0|||
144500200|NCT02001623|521028218|FG014|Overall Study|Death|0|||
144500201|NCT02001623|521028204|FG000|Overall Study|Adverse Event|0|||
144500202|NCT02001623|521028205|FG001|Overall Study|Adverse Event|0|||
144500203|NCT02001623|521028206|FG002|Overall Study|Adverse Event|0|||
144500204|NCT02001623|521028207|FG003|Overall Study|Adverse Event|0|||
144500205|NCT02001623|521028208|FG004|Overall Study|Adverse Event|0|||
144500206|NCT02001623|521028209|FG005|Overall Study|Adverse Event|1|||
144500207|NCT02001623|521028210|FG006|Overall Study|Adverse Event|0|||
144500208|NCT02001623|521028211|FG007|Overall Study|Adverse Event|3|||
144500209|NCT02001623|521028212|FG008|Overall Study|Adverse Event|4|||
144500210|NCT02001623|521028213|FG009|Overall Study|Adverse Event|6|||
144500211|NCT02001623|521028214|FG010|Overall Study|Adverse Event|4|||
144500212|NCT02001623|521028215|FG011|Overall Study|Adverse Event|0|||
144500213|NCT02001623|521028216|FG012|Overall Study|Adverse Event|3|||
144500214|NCT02001623|521028217|FG013|Overall Study|Adverse Event|5|||
144500215|NCT02001623|521028218|FG014|Overall Study|Adverse Event|6|||
144500216|NCT02001623|521028204|FG000|Overall Study|Other - Miscellaneous|0|||
144500217|NCT02001623|521028205|FG001|Overall Study|Other - Miscellaneous|0|||
144500218|NCT02001623|521028206|FG002|Overall Study|Other - Miscellaneous|0|||
144500219|NCT02001623|521028207|FG003|Overall Study|Other - Miscellaneous|0|||
144500220|NCT02001623|521028208|FG004|Overall Study|Other - Miscellaneous|0|||
144500221|NCT02001623|521028209|FG005|Overall Study|Other - Miscellaneous|0|||
144500222|NCT02001623|521028210|FG006|Overall Study|Other - Miscellaneous|0|||
144500223|NCT02001623|521028211|FG007|Overall Study|Other - Miscellaneous|0|||
144500224|NCT02001623|521028212|FG008|Overall Study|Other - Miscellaneous|0|||
144500225|NCT02001623|521028213|FG009|Overall Study|Other - Miscellaneous|1|||
144500226|NCT02001623|521028214|FG010|Overall Study|Other - Miscellaneous|0|||
144500227|NCT02001623|521028215|FG011|Overall Study|Other - Miscellaneous|0|||
144500228|NCT02001623|521028216|FG012|Overall Study|Other - Miscellaneous|0|||
144500229|NCT02001623|521028217|FG013|Overall Study|Other - Miscellaneous|1|||
144500230|NCT02001623|521028218|FG014|Overall Study|Other - Miscellaneous|0|||
144500231|NCT02001623|521028204|FG000|Overall Study|Withdrawal by Subject|1|||
144500232|NCT02001623|521028205|FG001|Overall Study|Withdrawal by Subject|0|||
144500233|NCT02001623|521028206|FG002|Overall Study|Withdrawal by Subject|0|||
144500234|NCT02001623|521028207|FG003|Overall Study|Withdrawal by Subject|0|||
144500235|NCT02001623|521028208|FG004|Overall Study|Withdrawal by Subject|0|||
144500236|NCT02001623|521028209|FG005|Overall Study|Withdrawal by Subject|0|||
144500237|NCT02001623|521028210|FG006|Overall Study|Withdrawal by Subject|0|||
144500238|NCT02001623|521028211|FG007|Overall Study|Withdrawal by Subject|0|||
144500239|NCT02001623|521028212|FG008|Overall Study|Withdrawal by Subject|1|||
144500240|NCT02001623|521028213|FG009|Overall Study|Withdrawal by Subject|3|||
144500241|NCT02001623|521028214|FG010|Overall Study|Withdrawal by Subject|2|||
144500242|NCT02001623|521028215|FG011|Overall Study|Withdrawal by Subject|2|||
144500243|NCT02001623|521028216|FG012|Overall Study|Withdrawal by Subject|1|||
144500244|NCT02001623|521028217|FG013|Overall Study|Withdrawal by Subject|5|||
144720062|NCT02058628|521829469|FG001|Overall Study|Lost to Follow-up|4|||
144720063|NCT02058628|521829468|FG000|Overall Study|Not in time schedule|0|||
144720064|NCT02058628|521829469|FG001|Overall Study|Not in time schedule|1|||
144720065|NCT02058628|521829468|FG000|Overall Study|The visit date was not in timeline|0|||
144500245|NCT02001623|521028218|FG014|Overall Study|Withdrawal by Subject|2|||
144500246|NCT02001623|521028204|FG000|Overall Study|Lost to Follow-up|0|||
144500247|NCT02001623|521028205|FG001|Overall Study|Lost to Follow-up|0|||
144500248|NCT02001623|521028206|FG002|Overall Study|Lost to Follow-up|0|||
144500249|NCT02001623|521028207|FG003|Overall Study|Lost to Follow-up|0|||
144500250|NCT02001623|521028208|FG004|Overall Study|Lost to Follow-up|0|||
144500251|NCT02001623|521028209|FG005|Overall Study|Lost to Follow-up|0|||
144500252|NCT02001623|521028210|FG006|Overall Study|Lost to Follow-up|0|||
144500253|NCT02001623|521028211|FG007|Overall Study|Lost to Follow-up|0|||
144500254|NCT02001623|521028212|FG008|Overall Study|Lost to Follow-up|0|||
144500255|NCT02001623|521028213|FG009|Overall Study|Lost to Follow-up|1|||
144500256|NCT02001623|521028214|FG010|Overall Study|Lost to Follow-up|0|||
144500257|NCT02001623|521028215|FG011|Overall Study|Lost to Follow-up|0|||
144500258|NCT02001623|521028216|FG012|Overall Study|Lost to Follow-up|0|||
144500259|NCT02001623|521028217|FG013|Overall Study|Lost to Follow-up|0|||
144500260|NCT02001623|521028218|FG014|Overall Study|Lost to Follow-up|0|||
144720066|NCT02058628|521829469|FG001|Overall Study|The visit date was not in timeline|1|||
144720067|NCT02058628|521829468|FG000|Overall Study|A lot of time for study for participant|1|||
144720068|NCT02058628|521829469|FG001|Overall Study|A lot of time for study for participant|0|||
144720069|NCT02058628|521829468|FG000|Overall Study|Non compliance|1|||
144720070|NCT02058628|521829469|FG001|Overall Study|Non compliance|0|||
144720071|NCT04527471|521829472|FG000|Overall Study|Adverse Event|1|||
144720072|NCT04527471|521829473|FG001|Overall Study|Adverse Event|0|||
144720073|NCT04527471|521829472|FG000|Overall Study|Lost to Follow-up|1|||
144720074|NCT04527471|521829473|FG001|Overall Study|Lost to Follow-up|0|||
144720075|NCT01628120|521829481|FG000|Overall Study|Withdrawal by Subject|7|||
144720076|NCT01628120|521829481|FG000|Overall Study|Adverse Event|12|||
144720077|NCT01628120|521829481|FG000|Overall Study|Lost to Follow-up|1|||
144720078|NCT01628120|521829481|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
144720079|NCT01628120|521829481|FG000|Overall Study|Non-compliant with Study Procedures|1|||
144720080|NCT01628120|521829481|FG000|Overall Study|Not Treated|3|||
144720081|NCT01628120|521829481|FG000|Overall Study|Sponsor Decision|5|||
144720082|NCT01628120|521829481|FG000|Overall Study|Switched Dialysis Method|2|||
144720083|NCT01628120|521829481|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
144720084|NCT01628120|521829481|FG000|Overall Study|Moved or Relocated|5|||
144720085|NCT01628120|521829481|FG000|Overall Study|Kidney Transplant|2|||
144720086|NCT01628120|521829481|FG000|Overall Study|Use of Standard of Care|1|||
144720087|NCT01165996|521829483|FG000|Overall Study|Death|1|||
144720088|NCT01165996|521829483|FG000|Overall Study|Physician Decision|1|||
144720089|NCT00096265|521829484|FG000|Overall Study|Ineligible|1|||
144720090|NCT00096265|521829485|FG001|Overall Study|Ineligible|0|||
144720091|NCT00096265|521829486|FG002|Overall Study|Ineligible|0|||
144720092|NCT01506323|521829487|FG000|Overall Study|Lost to Follow-up|5|||
144720093|NCT01506323|521829488|FG001|Overall Study|Lost to Follow-up|4|||
144720094|NCT01506323|521829487|FG000|Overall Study|Withdrawal by Subject|4|||
144720095|NCT01506323|521829488|FG001|Overall Study|Withdrawal by Subject|4|||
144720096|NCT01506323|521829487|FG000|Overall Study|Lack of Efficacy|1|||
144720097|NCT01506323|521829488|FG001|Overall Study|Lack of Efficacy|3|||
144720098|NCT01506323|521829487|FG000|Overall Study|Moved out of area|5|||
144720099|NCT01506323|521829488|FG001|Overall Study|Moved out of area|2|||
144720100|NCT01506323|521829487|FG000|Overall Study|Schedule or Transportation conflict|8|||
144720101|NCT01506323|521829488|FG001|Overall Study|Schedule or Transportation conflict|0|||
144720102|NCT01506323|521829487|FG000|Overall Study|Started another treatment|1|||
144720103|NCT01506323|521829488|FG001|Overall Study|Started another treatment|0|||
144720104|NCT02232074|521829489|FG000|Overall Study|Withdrawal by Subject|5|||
144720105|NCT02232074|521829490|FG001|Overall Study|Withdrawal by Subject|3|||
144720106|NCT02232074|521829489|FG000|Overall Study|No legal concerns at baseline|36|||
144720107|NCT02232074|521829490|FG001|Overall Study|No legal concerns at baseline|41|||
144720108|NCT02232074|521829489|FG000|Overall Study|deemed ineligible|0|||
144720109|NCT02232074|521829490|FG001|Overall Study|deemed ineligible|1|||
144720110|NCT00704418|521829492|FG000|Overall Study|Withdrawal by Subject|2|||
144720111|NCT00704418|521829493|FG001|Overall Study|Withdrawal by Subject|0|||
144720112|NCT00704418|521829492|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
144720113|NCT00704418|521829493|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
144720114|NCT01579474|521829494|FG000|Overall Study|Adverse Event|1|||
144720115|NCT01579474|521829495|FG001|Overall Study|Adverse Event|13|||
144720116|NCT01579474|521829496|FG002|Overall Study|Adverse Event|2|||
144720117|NCT01579474|521829497|FG003|Overall Study|Adverse Event|0|||
144720118|NCT01579474|521829498|FG004|Overall Study|Adverse Event|0|||
144720119|NCT01579474|521829499|FG005|Overall Study|Adverse Event|1|||
144720120|NCT01579474|521829494|FG000|Overall Study|Lack of Efficacy|1|||
144720121|NCT01579474|521829495|FG001|Overall Study|Lack of Efficacy|0|||
144720122|NCT01579474|521829496|FG002|Overall Study|Lack of Efficacy|0|||
144720123|NCT01579474|521829497|FG003|Overall Study|Lack of Efficacy|0|||
144720124|NCT01579474|521829498|FG004|Overall Study|Lack of Efficacy|1|||
144720125|NCT01579474|521829499|FG005|Overall Study|Lack of Efficacy|0|||
144720126|NCT01579474|521829494|FG000|Overall Study|Withdrawal by Subject|1|||
144720127|NCT01579474|521829495|FG001|Overall Study|Withdrawal by Subject|0|||
144720128|NCT01579474|521829496|FG002|Overall Study|Withdrawal by Subject|0|||
144720129|NCT01579474|521829497|FG003|Overall Study|Withdrawal by Subject|0|||
144500261|NCT02001623|521028204|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
144500262|NCT02001623|521028205|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
144720130|NCT01579474|521829498|FG004|Overall Study|Withdrawal by Subject|0|||
144500263|NCT02001623|521028206|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
144500264|NCT02001623|521028207|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
144500265|NCT02001623|521028208|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
144500266|NCT02001623|521028209|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
144500267|NCT02001623|521028210|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
144500268|NCT02001623|521028211|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
144500269|NCT02001623|521028212|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
144500270|NCT02001623|521028213|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
144500271|NCT02001623|521028214|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
144500272|NCT02001623|521028215|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
144500273|NCT02001623|521028216|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
144500274|NCT02001623|521028217|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
144500275|NCT02001623|521028218|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
144500276|NCT02001623|521028204|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
144500277|NCT02001623|521028205|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
144500278|NCT02001623|521028206|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
144500279|NCT02001623|521028207|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
144500280|NCT02001623|521028208|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
144500281|NCT02001623|521028209|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
144500282|NCT02001623|521028210|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
144500283|NCT02001623|521028211|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
144500284|NCT02001623|521028212|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
144500285|NCT02001623|521028213|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
144500286|NCT02001623|521028214|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
144500287|NCT02001623|521028215|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
144500288|NCT02001623|521028216|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
144500289|NCT02001623|521028217|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
144500290|NCT02001623|521028218|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
144500291|NCT01063036|521028223|FG000|Participants Treated With Study Drug|Adverse Event|1|||
144500292|NCT01063036|521028223|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
144500293|NCT01063036|521028223|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
144500294|NCT01063036|521028223|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
144500295|NCT01063036|521028223|FG000|Participants Treated With Study Drug|Pregnancy|1|||
144500296|NCT01063036|521028223|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
144500297|NCT01063036|521028223|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
144500298|NCT01063036|521028223|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
144500299|NCT02814643|521028224|FG000|Overall Study|Lost to Follow-up|0|||
144500300|NCT02814643|521028225|FG001|Overall Study|Lost to Follow-up|1|||
144500301|NCT02814643|521028224|FG000|Overall Study|Withdrawal by Subject|1|||
144500302|NCT02814643|521028225|FG001|Overall Study|Withdrawal by Subject|2|||
144500303|NCT01064817|521028226|FG000|Study Completion|Physician Decision|1|||
144500304|NCT01064817|521028227|FG001|Study Completion|Physician Decision|0|||
144500305|NCT01064817|521028226|FG000|Study Completion|Withdrawal by Subject|1|||
144500306|NCT01064817|521028227|FG001|Study Completion|Withdrawal by Subject|0|||
144500307|NCT01456936|521028228|FG000|Overall Study|Other reason|41|||
144500308|NCT01456936|521028229|FG001|Overall Study|Other reason|30|||
144500309|NCT01456936|521028230|FG002|Overall Study|Other reason|36|||
144500310|NCT01456936|521028231|FG003|Overall Study|Other reason|33|||
144500311|NCT01456936|521028228|FG000|Overall Study|No longer meets eligibility criteria|4|||
144500312|NCT01456936|521028229|FG001|Overall Study|No longer meets eligibility criteria|8|||
144500313|NCT01456936|521028230|FG002|Overall Study|No longer meets eligibility criteria|6|||
144500314|NCT01456936|521028231|FG003|Overall Study|No longer meets eligibility criteria|5|||
144500315|NCT01456936|521028228|FG000|Overall Study|Protocol Violation|4|||
144500316|NCT01456936|521028229|FG001|Overall Study|Protocol Violation|2|||
144500317|NCT01456936|521028230|FG002|Overall Study|Protocol Violation|5|||
144500318|NCT01456936|521028231|FG003|Overall Study|Protocol Violation|5|||
144500319|NCT01456936|521028228|FG000|Overall Study|Pregnancy|1|||
144500320|NCT01456936|521028229|FG001|Overall Study|Pregnancy|0|||
144500321|NCT01456936|521028230|FG002|Overall Study|Pregnancy|0|||
144500322|NCT01456936|521028231|FG003|Overall Study|Pregnancy|1|||
144500323|NCT01456936|521028228|FG000|Overall Study|Insufficient clinical response|4|||
144500324|NCT01456936|521028229|FG001|Overall Study|Insufficient clinical response|4|||
144500325|NCT01456936|521028230|FG002|Overall Study|Insufficient clinical response|14|||
144500326|NCT01456936|521028231|FG003|Overall Study|Insufficient clinical response|13|||
144500327|NCT01456936|521028228|FG000|Overall Study|No longer willing to participate|195|||
144500328|NCT01456936|521028229|FG001|Overall Study|No longer willing to participate|218|||
144500329|NCT01456936|521028230|FG002|Overall Study|No longer willing to participate|224|||
144500330|NCT01456936|521028231|FG003|Overall Study|No longer willing to participate|248|||
144720131|NCT01579474|521829499|FG005|Overall Study|Withdrawal by Subject|0|||
144720132|NCT00586521|521829500|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
144720133|NCT02710071|521829504|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
144720134|NCT02710071|521829505|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
144720135|NCT02710071|521829504|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
144720136|NCT02710071|521829505|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
144720137|NCT02637557|521829506|FG000|Overall Study|Adverse Event|3|||
144720138|NCT02637557|521829507|FG001|Overall Study|Adverse Event|1|||
144720139|NCT02637557|521829508|FG002|Overall Study|Adverse Event|3|||
144720140|NCT02637557|521829509|FG003|Overall Study|Adverse Event|3|||
144720141|NCT02637557|521829506|FG000|Overall Study|Lost to Follow-up|1|||
144720142|NCT02637557|521829507|FG001|Overall Study|Lost to Follow-up|1|||
144720143|NCT02637557|521829508|FG002|Overall Study|Lost to Follow-up|0|||
144720144|NCT02637557|521829509|FG003|Overall Study|Lost to Follow-up|1|||
144720145|NCT02637557|521829506|FG000|Overall Study|Physician Decision|1|||
144720146|NCT02637557|521829507|FG001|Overall Study|Physician Decision|0|||
144720147|NCT02637557|521829508|FG002|Overall Study|Physician Decision|0|||
144720148|NCT02637557|521829509|FG003|Overall Study|Physician Decision|0|||
144720149|NCT02637557|521829506|FG000|Overall Study|Protocol Violation|2|||
144720150|NCT02637557|521829507|FG001|Overall Study|Protocol Violation|0|||
144720151|NCT02637557|521829508|FG002|Overall Study|Protocol Violation|2|||
144720152|NCT02637557|521829509|FG003|Overall Study|Protocol Violation|1|||
144720153|NCT02637557|521829506|FG000|Overall Study|Withdrawal by Subject|1|||
144720154|NCT02637557|521829507|FG001|Overall Study|Withdrawal by Subject|3|||
144720155|NCT02637557|521829508|FG002|Overall Study|Withdrawal by Subject|4|||
144720156|NCT02637557|521829509|FG003|Overall Study|Withdrawal by Subject|2|||
144720157|NCT01238848|521829517|FG000|Overall Study|Physician Decision|13|||
144720158|NCT01238848|521829518|FG001|Overall Study|Physician Decision|5|||
144720159|NCT00576901|521829519|FG000|Overall Study|Withdrawal by Subject|1|||
144720160|NCT00576901|521829519|FG000|Overall Study|Disease course|1|||
144720161|NCT00576901|521829519|FG000|Overall Study|Protocol Violation|1|||
144720162|NCT00755326|521829526|FG000|Overall Study|Lost to Follow-up|2|||
144720163|NCT00755326|521829527|FG001|Overall Study|Lost to Follow-up|3|||
144720164|NCT00368966|521829530|FG000|Infant Series|Withdrawal by Subject|11|||
144720165|NCT00368966|521829531|FG001|Infant Series|Withdrawal by Subject|6|||
144720166|NCT00368966|521829530|FG000|Infant Series|Protocol Violation|2|||
144720167|NCT00368966|521829531|FG001|Infant Series|Protocol Violation|1|||
144720168|NCT00368966|521829530|FG000|Infant Series|Lost to Follow-up|2|||
144720169|NCT00368966|521829531|FG001|Infant Series|Lost to Follow-up|0|||
144720170|NCT00368966|521829530|FG000|Infant Series|Randomization error|0|||
144720171|NCT00368966|521829531|FG001|Infant Series|Randomization error|1|||
144720172|NCT00368966|521829530|FG000|Infant Series|Failed to meet eligibility criteria|0|||
144720173|NCT00368966|521829531|FG001|Infant Series|Failed to meet eligibility criteria|1|||
144720174|NCT00368966|521829530|FG000|Infant Series|Adverse Event|0|||
144720175|NCT00368966|521829531|FG001|Infant Series|Adverse Event|1|||
144720176|NCT00368966|521829530|FG000|Infant Series|Failed to return|1|||
144720177|NCT00368966|521829531|FG001|Infant Series|Failed to return|0|||
144720178|NCT00368966|521829530|FG000|After Infant|Failed to return|3|||
144720179|NCT00368966|521829531|FG001|After Infant|Failed to return|1|||
144720180|NCT00368966|521829530|FG000|After Infant|Adverse Event|1|||
144720181|NCT00368966|521829531|FG001|After Infant|Adverse Event|2|||
144720182|NCT00368966|521829530|FG000|After Infant|Withdrawal by Subject|1|||
144720183|NCT00368966|521829531|FG001|After Infant|Withdrawal by Subject|1|||
144720184|NCT00368966|521829530|FG000|After Infant|Death|1|||
144720185|NCT00368966|521829531|FG001|After Infant|Death|0|||
144720186|NCT00368966|521829530|FG000|After Infant|Lost to Follow-up|0|||
144720187|NCT00368966|521829531|FG001|After Infant|Lost to Follow-up|1|||
144720188|NCT00368966|521829530|FG000|Toddler Dose|Withdrawal by Subject|1|||
144720189|NCT00368966|521829531|FG001|Toddler Dose|Withdrawal by Subject|1|||
144720190|NCT00368966|521829530|FG000|Toddler Dose|Lost to Follow-up|0|||
144720191|NCT00368966|521829531|FG001|Toddler Dose|Lost to Follow-up|2|||
144720192|NCT01689974|521829532|FG000|Overall Study|Termination of Study|5|||
144720193|NCT01689974|521829533|FG001|Overall Study|Termination of Study|5|||
144720194|NCT01333033|521829537|FG000|Overall Study|Ineligible|0|||
144720195|NCT01333033|521829538|FG001|Overall Study|Ineligible|0|||
144720196|NCT01333033|521829539|FG002|Overall Study|Ineligible|0|||
144720197|NCT01333033|521829540|FG003|Overall Study|Ineligible|0|||
144720198|NCT01333033|521829541|FG004|Overall Study|Ineligible|6|||
144720199|NCT01333033|521829542|FG005|Overall Study|Ineligible|8|||
144720200|NCT01333033|521829537|FG000|Overall Study|Withdrawal by Subject|0|||
144720201|NCT01333033|521829538|FG001|Overall Study|Withdrawal by Subject|0|||
144720202|NCT01333033|521829539|FG002|Overall Study|Withdrawal by Subject|0|||
144720203|NCT01333033|521829540|FG003|Overall Study|Withdrawal by Subject|0|||
144720204|NCT01333033|521829541|FG004|Overall Study|Withdrawal by Subject|4|||
144720205|NCT01333033|521829542|FG005|Overall Study|Withdrawal by Subject|2|||
144720206|NCT01333033|521829537|FG000|Overall Study|PET inevaluable|0|||
144720207|NCT01333033|521829538|FG001|Overall Study|PET inevaluable|0|||
144720208|NCT01333033|521829539|FG002|Overall Study|PET inevaluable|0|||
144720209|NCT01333033|521829540|FG003|Overall Study|PET inevaluable|0|||
144500331|NCT01456936|521028228|FG000|Overall Study|Lost to Follow-up|135|||
144500332|NCT01456936|521028229|FG001|Overall Study|Lost to Follow-up|126|||
144500333|NCT01456936|521028230|FG002|Overall Study|Lost to Follow-up|144|||
144500334|NCT01456936|521028231|FG003|Overall Study|Lost to Follow-up|127|||
144500335|NCT01456936|521028228|FG000|Overall Study|Medication error|0|||
144500336|NCT01456936|521028229|FG001|Overall Study|Medication error|1|||
144500337|NCT01456936|521028230|FG002|Overall Study|Medication error|0|||
144500338|NCT01456936|521028231|FG003|Overall Study|Medication error|1|||
144500339|NCT01456936|521028228|FG000|Overall Study|Adverse event (study drug)|25|||
144500340|NCT01456936|521028229|FG001|Overall Study|Adverse event (study drug)|21|||
144500341|NCT01456936|521028230|FG002|Overall Study|Adverse event (study drug)|26|||
144500342|NCT01456936|521028231|FG003|Overall Study|Adverse event (study drug)|17|||
144500343|NCT01456936|521028228|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
144500344|NCT01456936|521028229|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
144500345|NCT01456936|521028230|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
144500346|NCT01456936|521028231|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
144500347|NCT01456936|521028228|FG000|Overall Study|Death|0|||
144500348|NCT01456936|521028229|FG001|Overall Study|Death|3|||
144500349|NCT01456936|521028230|FG002|Overall Study|Death|1|||
144500350|NCT01456936|521028231|FG003|Overall Study|Death|3|||
144500351|NCT01456936|521028228|FG000|Overall Study|Randomized but not treated|21|||
144500352|NCT01456936|521028229|FG001|Overall Study|Randomized but not treated|28|||
144500353|NCT01456936|521028230|FG002|Overall Study|Randomized but not treated|16|||
144500354|NCT01456936|521028231|FG003|Overall Study|Randomized but not treated|21|||
144500355|NCT00906698|521028232|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
144500356|NCT00906698|521028233|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
144500357|NCT00906698|521028234|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
144500358|NCT00906698|521028235|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
144500359|NCT00906698|521028236|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
144500360|NCT00906698|521028237|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
144500361|NCT00906698|521028232|FG000|Overall Study|Adverse Event|0|||
144500362|NCT00906698|521028233|FG001|Overall Study|Adverse Event|0|||
144500363|NCT00906698|521028234|FG002|Overall Study|Adverse Event|2|||
144500364|NCT00906698|521028235|FG003|Overall Study|Adverse Event|0|||
144500365|NCT00906698|521028236|FG004|Overall Study|Adverse Event|4|||
144500366|NCT00906698|521028237|FG005|Overall Study|Adverse Event|1|||
144500367|NCT00906698|521028232|FG000|Overall Study|Disease progression|3|||
144500368|NCT00906698|521028233|FG001|Overall Study|Disease progression|12|||
144500369|NCT00906698|521028234|FG002|Overall Study|Disease progression|4|||
144500370|NCT00906698|521028235|FG003|Overall Study|Disease progression|4|||
144500371|NCT00906698|521028236|FG004|Overall Study|Disease progression|12|||
144500372|NCT00906698|521028237|FG005|Overall Study|Disease progression|4|||
144500373|NCT00906698|521028232|FG000|Overall Study|Withdrawal by Subject|0|||
144500374|NCT00906698|521028233|FG001|Overall Study|Withdrawal by Subject|0|||
144500375|NCT00906698|521028234|FG002|Overall Study|Withdrawal by Subject|0|||
144500376|NCT00906698|521028235|FG003|Overall Study|Withdrawal by Subject|0|||
144500377|NCT00906698|521028236|FG004|Overall Study|Withdrawal by Subject|1|||
144500378|NCT00906698|521028237|FG005|Overall Study|Withdrawal by Subject|0|||
144500379|NCT00906698|521028232|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
144500380|NCT00906698|521028233|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
144500381|NCT00906698|521028234|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
144500382|NCT00906698|521028235|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
144500383|NCT00906698|521028236|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
144500384|NCT00906698|521028237|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
144720210|NCT01333033|521829541|FG004|Overall Study|PET inevaluable|2|||
144720211|NCT01333033|521829542|FG005|Overall Study|PET inevaluable|4|||
144720212|NCT01333033|521829537|FG000|Overall Study|Adverse Event|0|||
144720213|NCT01333033|521829538|FG001|Overall Study|Adverse Event|0|||
144720214|NCT01333033|521829539|FG002|Overall Study|Adverse Event|0|||
144720215|NCT01333033|521829540|FG003|Overall Study|Adverse Event|0|||
144720216|NCT01333033|521829541|FG004|Overall Study|Adverse Event|2|||
144720217|NCT01333033|521829542|FG005|Overall Study|Adverse Event|1|||
144720218|NCT01333033|521829537|FG000|Overall Study|Progression|0|||
144720219|NCT01333033|521829538|FG001|Overall Study|Progression|0|||
144720220|NCT01333033|521829539|FG002|Overall Study|Progression|0|||
144720221|NCT01333033|521829540|FG003|Overall Study|Progression|0|||
144720222|NCT01333033|521829541|FG004|Overall Study|Progression|0|||
144720223|NCT01333033|521829542|FG005|Overall Study|Progression|1|||
144720224|NCT01333033|521829537|FG000|Overall Study|MD Decision|0|||
144500385|NCT01250002|521028238|FG000|Overall Study|Change to open surgical procedure|4|||
144500386|NCT01250002|521028239|FG001|Overall Study|Change to open surgical procedure|3|||
144500387|NCT03095508|521028240|FG000|Overall Study|Adverse Event|0|||
144500388|NCT03095508|521028241|FG001|Overall Study|Adverse Event|1|||
144500389|NCT00831792|521028249|FG000|Overall Study|Not Eligible|3|||
144500390|NCT00831792|521028249|FG000|Overall Study|Adverse Event|1|||
144500391|NCT00831792|521028249|FG000|Overall Study|Death|1|||
144500392|NCT00831792|521028249|FG000|Overall Study|Lack of Efficacy|1|||
144500393|NCT01242085|521028250|FG000|Overall Study|Withdrawal by Subject|4|||
144500394|NCT01242085|521028251|FG001|Overall Study|Withdrawal by Subject|2|||
144500395|NCT01242085|521028252|FG002|Overall Study|Withdrawal by Subject|0|||
144500396|NCT01242085|521028250|FG000|Overall Study|medically unable to have surgery|4|||
144500397|NCT01242085|521028251|FG001|Overall Study|medically unable to have surgery|5|||
144500398|NCT01242085|521028252|FG002|Overall Study|medically unable to have surgery|0|||
144500399|NCT01178762|521028253|FG000|Overall Study|Lost to Follow-up|15|||
144500400|NCT00608907|521028256|FG000|Overall Study|Adverse Event|6|||
144500401|NCT00608907|521028257|FG001|Overall Study|Adverse Event|0|||
144500402|NCT00608907|521028258|FG002|Overall Study|Adverse Event|1|||
144500403|NCT00608907|521028256|FG000|Overall Study|Death|1|||
144500404|NCT00608907|521028257|FG001|Overall Study|Death|0|||
144500405|NCT00608907|521028258|FG002|Overall Study|Death|0|||
144500406|NCT00608907|521028256|FG000|Overall Study|Withdrawal by Subject|4|||
144500407|NCT00608907|521028257|FG001|Overall Study|Withdrawal by Subject|0|||
144500408|NCT00608907|521028258|FG002|Overall Study|Withdrawal by Subject|0|||
144500409|NCT00608907|521028256|FG000|Overall Study|Progressive Disease|1|||
144500410|NCT00608907|521028257|FG001|Overall Study|Progressive Disease|0|||
144500411|NCT00608907|521028258|FG002|Overall Study|Progressive Disease|0|||
144500412|NCT00906035|521028260|FG000|Overall Study|Withdrawal by Subject|2|||
144500413|NCT00906035|521028261|FG001|Overall Study|Withdrawal by Subject|3|||
144500414|NCT00906035|521028262|FG002|Overall Study|Withdrawal by Subject|0|||
144500415|NCT00835380|521028264|FG000|Overall Study|Withdrawal by Subject|2|||
144500416|NCT01582945|521028265|FG000|Overall Study|Intolerable side-effects|1|||
144500417|NCT01582945|521028265|FG000|Overall Study|Scheduling conflicts|1|||
144500418|NCT02824432|521028275|FG000|Overall Study|Major Protocol Deviation|1|||
144500419|NCT02824432|521028276|FG001|Overall Study|Major Protocol Deviation|0|||
144500420|NCT05824351|521028277|FG000|Overall Study|Adverse Event|6|||
144500421|NCT00828945|521028278|FG000|Overall Study|Death|4|||
144500422|NCT00828945|521028278|FG000|Overall Study|Participant was missing|1|||
144500423|NCT00828945|521028278|FG000|Overall Study|Other|36|||
144500424|NCT01543685|521028281|FG000|Overall Study|Lack of Efficacy|1|||
144500425|NCT01543685|521028282|FG001|Overall Study|Lack of Efficacy|2|||
144500426|NCT01543685|521028283|FG002|Overall Study|Lack of Efficacy|2|||
144500427|NCT01543685|521028284|FG003|Overall Study|Lack of Efficacy|0|||
144500428|NCT01543685|521028285|FG004|Overall Study|Lack of Efficacy|2|||
144500429|NCT01543685|521028281|FG000|Overall Study|Adverse Event|2|||
144500430|NCT01543685|521028282|FG001|Overall Study|Adverse Event|1|||
144500431|NCT01543685|521028283|FG002|Overall Study|Adverse Event|0|||
144500432|NCT01543685|521028284|FG003|Overall Study|Adverse Event|0|||
144500433|NCT01543685|521028285|FG004|Overall Study|Adverse Event|2|||
144500434|NCT00708097|521028288|FG000|Period 1|Protocol Violation|0|||
144500435|NCT00708097|521028289|FG001|Period 1|Protocol Violation|1|||
144500436|NCT00708097|521028290|FG002|Period 1|Protocol Violation|0|||
144500437|NCT00708097|521028291|FG003|Period 1|Protocol Violation|2|||
144500438|NCT00708097|521028292|FG004|Period 1|Protocol Violation|0|||
144500439|NCT00708097|521028288|FG000|Period 1|Other Reason|0|||
144500440|NCT00708097|521028289|FG001|Period 1|Other Reason|0|||
144500441|NCT00708097|521028290|FG002|Period 1|Other Reason|0|||
144500442|NCT00708097|521028291|FG003|Period 1|Other Reason|0|||
144500443|NCT00708097|521028292|FG004|Period 1|Other Reason|1|||
144500444|NCT00708097|521028288|FG000|Period 2|Protocol Violation|0|||
144500445|NCT00708097|521028289|FG001|Period 2|Protocol Violation|1|||
144500446|NCT00708097|521028290|FG002|Period 2|Protocol Violation|1|||
144500447|NCT00708097|521028291|FG003|Period 2|Protocol Violation|1|||
144500448|NCT00708097|521028292|FG004|Period 2|Protocol Violation|0|||
144500449|NCT01838200|521028293|FG000|Overall Study|Adverse Event|0|||
144500450|NCT01838200|521028294|FG001|Overall Study|Adverse Event|2|||
144500451|NCT01838200|521028293|FG000|Overall Study|Progressive disease|3|||
144500452|NCT01838200|521028294|FG001|Overall Study|Progressive disease|0|||
144500453|NCT02689349|521029651|FG000|Overall Study|Not implanted|4|||
144500454|NCT02689349|521029652|FG001|Overall Study|Not implanted|0|||
144500455|NCT02689349|521029651|FG000|Overall Study|Withdrawal by Subject|9|||
144500456|NCT02689349|521029652|FG001|Overall Study|Withdrawal by Subject|0|||
144500457|NCT03518112|521029653|FG000|Overall Study|Withdrawal by Subject|1|||
144500458|NCT02930343|521029654|FG000|Overall Study|Lost to Follow-up|9|||
144500459|NCT02930343|521029655|FG001|Overall Study|Lost to Follow-up|7|||
144500460|NCT00377455|521029658|FG000|Overall Study|Withdrawal by Subject|1|||
144500461|NCT02263508|521029660|FG000|Overall Study|Withdrawal by Subject|1|||
144500462|NCT02263508|521029661|FG001|Overall Study|Withdrawal by Subject|23|||
144500463|NCT02263508|521029662|FG002|Overall Study|Withdrawal by Subject|17|||
144500464|NCT02263508|521029660|FG000|Overall Study|Sponsor Decision|12|||
144500465|NCT02263508|521029661|FG001|Overall Study|Sponsor Decision|165|||
144500466|NCT02263508|521029662|FG002|Overall Study|Sponsor Decision|182|||
144500467|NCT02263508|521029660|FG000|Overall Study|Lost to Follow-up|2|||
144500468|NCT02263508|521029661|FG001|Overall Study|Lost to Follow-up|7|||
144500469|NCT02263508|521029662|FG002|Overall Study|Lost to Follow-up|7|||
144500470|NCT02263508|521029660|FG000|Overall Study|Death|6|||
144500471|NCT02263508|521029661|FG001|Overall Study|Death|151|||
144500472|NCT02263508|521029662|FG002|Overall Study|Death|140|||
144500473|NCT01280591|521029663|FG000|Overall Study|Withdrawal by Subject|0|||
144500474|NCT01280591|521029664|FG001|Overall Study|Withdrawal by Subject|0|||
144500475|NCT01280591|521029665|FG002|Overall Study|Withdrawal by Subject|0|||
144500476|NCT01280591|521029666|FG003|Overall Study|Withdrawal by Subject|2|||
144500477|NCT01280591|521029663|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
144500478|NCT01280591|521029664|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
144720225|NCT01333033|521829538|FG001|Overall Study|MD Decision|0|||
144720226|NCT01333033|521829539|FG002|Overall Study|MD Decision|0|||
144720227|NCT01333033|521829540|FG003|Overall Study|MD Decision|0|||
144720228|NCT01333033|521829541|FG004|Overall Study|MD Decision|0|||
144720229|NCT01333033|521829542|FG005|Overall Study|MD Decision|2|||
144720230|NCT01388647|521829545|FG000|Overall Study|Adverse Event|1|||
144720231|NCT01388647|521829546|FG001|Overall Study|Adverse Event|2|||
144720232|NCT00818623|521829547|FG000|Overall Study|Adverse Event|1|||
144720233|NCT00818623|521829548|FG001|Overall Study|Adverse Event|0|||
144720234|NCT00818623|521829549|FG002|Overall Study|Adverse Event|1|||
144720235|NCT00818623|521829550|FG003|Overall Study|Adverse Event|0|||
144720236|NCT00818623|521829551|FG004|Overall Study|Adverse Event|0|||
144720237|NCT00818623|521829552|FG005|Overall Study|Adverse Event|1|||
144720238|NCT00818623|521829553|FG006|Overall Study|Adverse Event|0|||
144720239|NCT00818623|521829554|FG007|Overall Study|Adverse Event|0|||
144720240|NCT00818623|521829547|FG000|Overall Study|Bad prostate specific antigen response|0|||
144720241|NCT00818623|521829548|FG001|Overall Study|Bad prostate specific antigen response|3|||
144720242|NCT00818623|521829549|FG002|Overall Study|Bad prostate specific antigen response|2|||
144720243|NCT00818623|521829550|FG003|Overall Study|Bad prostate specific antigen response|5|||
144720244|NCT00818623|521829551|FG004|Overall Study|Bad prostate specific antigen response|0|||
144720245|NCT00818623|521829552|FG005|Overall Study|Bad prostate specific antigen response|1|||
144720246|NCT00818623|521829553|FG006|Overall Study|Bad prostate specific antigen response|0|||
144720247|NCT00818623|521829554|FG007|Overall Study|Bad prostate specific antigen response|0|||
144720248|NCT00818623|521829547|FG000|Overall Study|Withdrawal by Subject|0|||
144720249|NCT00818623|521829548|FG001|Overall Study|Withdrawal by Subject|1|||
144720250|NCT00818623|521829549|FG002|Overall Study|Withdrawal by Subject|1|||
144720251|NCT00818623|521829550|FG003|Overall Study|Withdrawal by Subject|0|||
144720252|NCT00818623|521829551|FG004|Overall Study|Withdrawal by Subject|0|||
144720253|NCT00818623|521829552|FG005|Overall Study|Withdrawal by Subject|1|||
144720254|NCT00818623|521829553|FG006|Overall Study|Withdrawal by Subject|1|||
144720255|NCT00818623|521829554|FG007|Overall Study|Withdrawal by Subject|1|||
144720256|NCT00818623|521829547|FG000|Overall Study|Protocol Violation|1|||
144720257|NCT00818623|521829548|FG001|Overall Study|Protocol Violation|0|||
144500479|NCT01280591|521029665|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
144500480|NCT01280591|521029666|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
144500481|NCT01883492|521029670|FG000|Overall Study|Lost to Follow-up|3|||
144500482|NCT01883492|521029671|FG001|Overall Study|Lost to Follow-up|4|||
144720258|NCT00818623|521829549|FG002|Overall Study|Protocol Violation|0|||
144720259|NCT00818623|521829550|FG003|Overall Study|Protocol Violation|0|||
144500483|NCT01883492|521029670|FG000|Overall Study|Surgery on contra-lateral hip|0|||
144500484|NCT01883492|521029671|FG001|Overall Study|Surgery on contra-lateral hip|1|||
144500485|NCT01883492|521029670|FG000|Overall Study|Poor X-ray quality|7|||
144500486|NCT01883492|521029671|FG001|Overall Study|Poor X-ray quality|4|||
144500487|NCT01883492|521029670|FG000|Overall Study|Withdrawal by Subject|1|||
144500488|NCT01883492|521029671|FG001|Overall Study|Withdrawal by Subject|0|||
144500489|NCT01883492|521029670|FG000|Overall Study|inappropriate implant used|1|||
144500490|NCT01883492|521029671|FG001|Overall Study|inappropriate implant used|1|||
144500491|NCT01883492|521029670|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
144500492|NCT01883492|521029671|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
144500493|NCT03265210|521029672|FG000|Overall Study|Withdrawal by Subject|7|||
144500494|NCT03265210|521029673|FG001|Overall Study|Withdrawal by Subject|9|||
144500495|NCT03265210|521029672|FG000|Overall Study|Lost to Follow-up|2|||
144500496|NCT03265210|521029673|FG001|Overall Study|Lost to Follow-up|0|||
144500497|NCT03265210|521029672|FG000|Overall Study|Physician Decision|2|||
144500498|NCT03265210|521029673|FG001|Overall Study|Physician Decision|0|||
144500499|NCT03265210|521029672|FG000|Overall Study|Adverse Event|1|||
144500500|NCT03265210|521029673|FG001|Overall Study|Adverse Event|0|||
144500501|NCT03357341|521029676|FG000|Overall Study|Withdrawal by Subject|3|||
144500502|NCT03357341|521029677|FG001|Overall Study|Withdrawal by Subject|6|||
144500503|NCT03357341|521029676|FG000|Overall Study|Lost to Follow-up|4|||
144500504|NCT03357341|521029677|FG001|Overall Study|Lost to Follow-up|5|||
144500505|NCT03357341|521029676|FG000|Overall Study|Death|0|||
144500506|NCT03357341|521029677|FG001|Overall Study|Death|1|||
144500507|NCT00686517|521029678|FG000|Treatment|Serious Adverse Event|1|||
144500508|NCT00686517|521029679|FG001|Treatment|Serious Adverse Event|2|||
144500509|NCT00686517|521029680|FG002|Treatment|Serious Adverse Event|1|||
144500510|NCT00686517|521029678|FG000|Treatment|Adverse Event|2|||
144500511|NCT00686517|521029679|FG001|Treatment|Adverse Event|0|||
144500512|NCT00686517|521029680|FG002|Treatment|Adverse Event|0|||
144500513|NCT00686517|521029678|FG000|Treatment|Poor Protocol Compliance|1|||
144500514|NCT00686517|521029679|FG001|Treatment|Poor Protocol Compliance|0|||
144500515|NCT00686517|521029680|FG002|Treatment|Poor Protocol Compliance|0|||
144500516|NCT00686517|521029678|FG000|Treatment|Protocol Violation|2|||
144500517|NCT00686517|521029679|FG001|Treatment|Protocol Violation|1|||
144500518|NCT00686517|521029680|FG002|Treatment|Protocol Violation|0|||
144500519|NCT01803646|521029683|FG000|Overall Study|Protocol Violation|1|||
144500520|NCT01803646|521029684|FG001|Overall Study|Protocol Violation|0|||
144500521|NCT01803646|521029683|FG000|Overall Study|Adverse Event|1|||
144500522|NCT01803646|521029684|FG001|Overall Study|Adverse Event|1|||
144500523|NCT01803646|521029683|FG000|Overall Study|Withdrawal by Subject|9|||
144500524|NCT01803646|521029684|FG001|Overall Study|Withdrawal by Subject|6|||
144500525|NCT01803646|521029683|FG000|Overall Study|Randomization error|1|||
144500526|NCT01803646|521029684|FG001|Overall Study|Randomization error|2|||
144500527|NCT01803646|521029683|FG000|Overall Study|Lost to Follow-up|5|||
144500528|NCT01803646|521029684|FG001|Overall Study|Lost to Follow-up|1|||
144500529|NCT01693614|521029686|FG000|Overall Study|Adverse Event|7|||
144500530|NCT01693614|521029687|FG001|Overall Study|Adverse Event|11|||
144500531|NCT01693614|521029688|FG002|Overall Study|Adverse Event|5|||
144500532|NCT01693614|521029686|FG000|Overall Study|Disease progression|11|||
144500533|NCT01693614|521029687|FG001|Overall Study|Disease progression|8|||
144500534|NCT01693614|521029688|FG002|Overall Study|Disease progression|7|||
144500535|NCT01693614|521029686|FG000|Overall Study|Protocol Violation|5|||
144500536|NCT01693614|521029687|FG001|Overall Study|Protocol Violation|2|||
144500537|NCT01693614|521029688|FG002|Overall Study|Protocol Violation|1|||
144500538|NCT01693614|521029686|FG000|Overall Study|Death|1|||
144500539|NCT01693614|521029687|FG001|Overall Study|Death|0|||
144500540|NCT01693614|521029688|FG002|Overall Study|Death|0|||
144500541|NCT01693614|521029686|FG000|Overall Study|Physician Decision|1|||
144500542|NCT01693614|521029687|FG001|Overall Study|Physician Decision|1|||
144500543|NCT01693614|521029688|FG002|Overall Study|Physician Decision|4|||
144500544|NCT01693614|521029686|FG000|Overall Study|Withdrawal by subject/guardian|0|||
144500545|NCT01693614|521029687|FG001|Overall Study|Withdrawal by subject/guardian|0|||
144500546|NCT01693614|521029688|FG002|Overall Study|Withdrawal by subject/guardian|2|||
144500547|NCT01693614|521029686|FG000|Overall Study|Withdrawal by Subject|1|||
144500548|NCT01693614|521029687|FG001|Overall Study|Withdrawal by Subject|0|||
144500549|NCT01693614|521029688|FG002|Overall Study|Withdrawal by Subject|5|||
144500550|NCT00420316|521029691|FG000|Overall Study|Withdrawal by Subject|0|||
144500551|NCT00420316|521029692|FG001|Overall Study|Withdrawal by Subject|1|||
144500552|NCT00420316|521029691|FG000|Overall Study|Lost to Follow-up|12|||
144720260|NCT00818623|521829551|FG004|Overall Study|Protocol Violation|1|||
144720261|NCT00818623|521829552|FG005|Overall Study|Protocol Violation|0|||
144720262|NCT00818623|521829553|FG006|Overall Study|Protocol Violation|1|||
144720263|NCT00818623|521829554|FG007|Overall Study|Protocol Violation|0|||
144720264|NCT00818623|521829547|FG000|Overall Study|Need of additional treatment|0|||
144720265|NCT00818623|521829548|FG001|Overall Study|Need of additional treatment|0|||
144720266|NCT00818623|521829549|FG002|Overall Study|Need of additional treatment|0|||
144720267|NCT00818623|521829550|FG003|Overall Study|Need of additional treatment|0|||
144720268|NCT00818623|521829551|FG004|Overall Study|Need of additional treatment|1|||
144720269|NCT00818623|521829552|FG005|Overall Study|Need of additional treatment|0|||
144720270|NCT00818623|521829553|FG006|Overall Study|Need of additional treatment|0|||
144720271|NCT00818623|521829554|FG007|Overall Study|Need of additional treatment|0|||
144720272|NCT00818623|521829547|FG000|Overall Study|Lack of trial drug at site|0|||
144720273|NCT00818623|521829548|FG001|Overall Study|Lack of trial drug at site|0|||
144720274|NCT00818623|521829549|FG002|Overall Study|Lack of trial drug at site|0|||
144720275|NCT00818623|521829550|FG003|Overall Study|Lack of trial drug at site|0|||
144720276|NCT00818623|521829551|FG004|Overall Study|Lack of trial drug at site|2|||
144720277|NCT00818623|521829552|FG005|Overall Study|Lack of trial drug at site|0|||
144720278|NCT00818623|521829553|FG006|Overall Study|Lack of trial drug at site|1|||
144720279|NCT00818623|521829554|FG007|Overall Study|Lack of trial drug at site|0|||
144720280|NCT00818623|521829547|FG000|Overall Study|Disease progression|0|||
144720281|NCT00818623|521829548|FG001|Overall Study|Disease progression|0|||
144720282|NCT00818623|521829549|FG002|Overall Study|Disease progression|0|||
144720283|NCT00818623|521829550|FG003|Overall Study|Disease progression|0|||
144720284|NCT00818623|521829551|FG004|Overall Study|Disease progression|0|||
144720285|NCT00818623|521829552|FG005|Overall Study|Disease progression|0|||
144720286|NCT00818623|521829553|FG006|Overall Study|Disease progression|1|||
144720287|NCT00818623|521829554|FG007|Overall Study|Disease progression|0|||
144720288|NCT00903383|521829558|FG000|Overall Study|Adverse Event|1|||
144720289|NCT00903383|521829559|FG001|Overall Study|Adverse Event|2|||
144720290|NCT00903383|521829560|FG002|Overall Study|Adverse Event|3|||
144720291|NCT00903383|521829561|FG003|Overall Study|Adverse Event|1|||
144720292|NCT00903383|521829558|FG000|Overall Study|Physician Decision|1|||
144720293|NCT00903383|521829559|FG001|Overall Study|Physician Decision|2|||
144720294|NCT00903383|521829560|FG002|Overall Study|Physician Decision|0|||
144720295|NCT00903383|521829561|FG003|Overall Study|Physician Decision|0|||
144720296|NCT00903383|521829558|FG000|Overall Study|Lost to Follow-up|0|||
144720297|NCT00903383|521829559|FG001|Overall Study|Lost to Follow-up|0|||
144720298|NCT00903383|521829560|FG002|Overall Study|Lost to Follow-up|0|||
144720299|NCT00903383|521829561|FG003|Overall Study|Lost to Follow-up|1|||
144720300|NCT00903383|521829558|FG000|Overall Study|Decision of Sponsor|1|||
144720301|NCT00903383|521829559|FG001|Overall Study|Decision of Sponsor|0|||
144720302|NCT00903383|521829560|FG002|Overall Study|Decision of Sponsor|0|||
144720303|NCT00903383|521829561|FG003|Overall Study|Decision of Sponsor|0|||
144720304|NCT00903383|521829558|FG000|Overall Study|Withdrawal by Subject|4|||
144720305|NCT00903383|521829559|FG001|Overall Study|Withdrawal by Subject|1|||
144720306|NCT00903383|521829560|FG002|Overall Study|Withdrawal by Subject|0|||
144720307|NCT00903383|521829561|FG003|Overall Study|Withdrawal by Subject|2|||
144720308|NCT00903383|521829558|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
144720309|NCT00903383|521829559|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
144720310|NCT00903383|521829560|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
144720311|NCT00903383|521829561|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
144720312|NCT00903383|521829558|FG000|Overall Study|Patient Decision|0|||
144720313|NCT00903383|521829559|FG001|Overall Study|Patient Decision|0|||
144720314|NCT00903383|521829560|FG002|Overall Study|Patient Decision|0|||
144720315|NCT00903383|521829561|FG003|Overall Study|Patient Decision|1|||
144720316|NCT02015793|521829566|FG000|Overall Study|Adverse Event|3|||
144720317|NCT02015793|521829567|FG001|Overall Study|Adverse Event|3|||
144720318|NCT02015793|521829566|FG000|Overall Study|Withdrawal by Subject|1|||
144720319|NCT02015793|521829567|FG001|Overall Study|Withdrawal by Subject|1|||
144720320|NCT00320593|521829568|FG000|Overall Study|Lost to Follow-up|3|||
144720321|NCT00320593|521829569|FG001|Overall Study|Lost to Follow-up|0|||
144720322|NCT00320593|521829568|FG000|Overall Study|Moved to another state|1|||
144500553|NCT00420316|521029692|FG001|Overall Study|Lost to Follow-up|8|||
144720323|NCT00320593|521829569|FG001|Overall Study|Moved to another state|0|||
144720324|NCT00320593|521829568|FG000|Overall Study|Withdrawal by Subject|2|||
144720325|NCT00320593|521829569|FG001|Overall Study|Withdrawal by Subject|1|||
144720326|NCT00320593|521829568|FG000|Overall Study|Withdrawal by clinical center|1|||
144500554|NCT02281318|521029693|FG000|Overall Study|Adverse Event|2|||
144370076|NCT02379091|520562801|FG000|Overall Study|Voluntary Withdrawal|2|||
144370077|NCT02379091|520562802|FG001|Overall Study|Voluntary Withdrawal|5|||
144370078|NCT02379091|520562803|FG002|Overall Study|Voluntary Withdrawal|2|||
144370079|NCT02379091|520562804|FG003|Overall Study|Voluntary Withdrawal|4|||
144500555|NCT02281318|521029694|FG001|Overall Study|Adverse Event|2|||
144500556|NCT02281318|521029693|FG000|Overall Study|Lack of Efficacy|2|||
144500557|NCT02281318|521029694|FG001|Overall Study|Lack of Efficacy|0|||
144500558|NCT02281318|521029693|FG000|Overall Study|Lost to Follow-up|2|||
144500559|NCT02281318|521029694|FG001|Overall Study|Lost to Follow-up|1|||
144500560|NCT02281318|521029693|FG000|Overall Study|Physician Decision|2|||
144500561|NCT02281318|521029694|FG001|Overall Study|Physician Decision|0|||
144500562|NCT02281318|521029693|FG000|Overall Study|Withdrawal by Subject|6|||
144500563|NCT02281318|521029694|FG001|Overall Study|Withdrawal by Subject|2|||
144500564|NCT02614560|521029695|FG000|Overall Study|Death|6|||
144720327|NCT00320593|521829569|FG001|Overall Study|Withdrawal by clinical center|0|||
144720328|NCT02110706|521829572|FG000|Overall Study|Adverse Event|2|||
144720329|NCT02110706|521829573|FG001|Overall Study|Adverse Event|3|||
144720330|NCT02110706|521829572|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
144720331|NCT02110706|521829573|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
144720332|NCT02970669|521829576|FG000|Double-blind Period|Adverse Event|4|||
144720333|NCT02970669|521829577|FG001|Double-blind Period|Adverse Event|0|||
144720334|NCT02970669|521829576|FG000|Double-blind Period|Death|1|||
144720335|NCT02970669|521829577|FG001|Double-blind Period|Death|0|||
144720336|NCT02970669|521829576|FG000|Double-blind Period|Study terminated by sponsor|1|||
144720337|NCT02970669|521829577|FG001|Double-blind Period|Study terminated by sponsor|2|||
144720338|NCT02970669|521829576|FG000|Double-blind Period|Physician Decision|0|||
144720339|NCT02970669|521829577|FG001|Double-blind Period|Physician Decision|2|||
144720340|NCT02970669|521829576|FG000|Double-blind Period|Withdrawal by Subject|2|||
144720341|NCT02970669|521829577|FG001|Double-blind Period|Withdrawal by Subject|2|||
144720342|NCT02970669|521829576|FG000|Open-label Period|Withdrawal by Subject|2|||
144720343|NCT02970669|521829577|FG001|Open-label Period|Withdrawal by Subject|2|||
144720344|NCT02970669|521829576|FG000|Open-label Period|Adverse Event|1|||
144720345|NCT02970669|521829577|FG001|Open-label Period|Adverse Event|0|||
144720346|NCT02970669|521829576|FG000|Open-label Period|Physician Decision|1|||
144720347|NCT02970669|521829577|FG001|Open-label Period|Physician Decision|0|||
144720348|NCT00876733|521829579|FG000|Overall Study|Adverse Event|34|||
144720349|NCT00876733|521829580|FG001|Overall Study|Adverse Event|20|||
144720350|NCT00876733|521829581|FG002|Overall Study|Adverse Event|10|||
144720351|NCT00876733|521829582|FG003|Overall Study|Adverse Event|3|||
144500565|NCT02614560|521029696|FG001|Overall Study|Death|2|||
144720352|NCT00876733|521829579|FG000|Overall Study|Lack of Efficacy|17|||
144500566|NCT01368406|521029697|FG000|Overall Study|Lost to Follow-up|8|||
144720353|NCT00876733|521829580|FG001|Overall Study|Lack of Efficacy|9|||
144720354|NCT00876733|521829581|FG002|Overall Study|Lack of Efficacy|10|||
144500567|NCT01368406|521029698|FG001|Overall Study|Lost to Follow-up|4|||
144500568|NCT01368406|521029697|FG000|Overall Study|Withdrawal by Subject|8|||
144500569|NCT01368406|521029698|FG001|Overall Study|Withdrawal by Subject|4|||
144500570|NCT01368406|521029697|FG000|Overall Study|relapse of the disease|3|||
144500571|NCT01368406|521029698|FG001|Overall Study|relapse of the disease|2|||
144500572|NCT01368406|521029697|FG000|Overall Study|started working|2|||
144500573|NCT01368406|521029698|FG001|Overall Study|started working|3|||
144500574|NCT00957229|521029699|FG000|Study Start|Adverse Event|0|||
144500575|NCT00957229|521029700|FG001|Study Start|Adverse Event|3|||
144500576|NCT00957229|521029699|FG000|Study Start|Disease Progression|1|||
144500577|NCT00957229|521029700|FG001|Study Start|Disease Progression|0|||
144500578|NCT00957229|521029699|FG000|Reallocated to or Continued Vismodegib|Death|1|||
144500579|NCT00957229|521029700|FG001|Reallocated to or Continued Vismodegib|Death|1|||
144500580|NCT00957229|521029699|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
144500581|NCT00957229|521029700|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
144500582|NCT00828672|521029701|FG000|Study Treatment|Lost to Follow-up|1|||
144500583|NCT00828672|521029702|FG001|Study Treatment|Lost to Follow-up|0|||
144500584|NCT00828672|521029701|FG000|Study Treatment|Adverse Event|0|||
144500585|NCT00828672|521029702|FG001|Study Treatment|Adverse Event|1|||
144500586|NCT00828672|521029701|FG000|Study Treatment|Complete response, no surgery|1|||
144500587|NCT00828672|521029702|FG001|Study Treatment|Complete response, no surgery|1|||
144500588|NCT00828672|521029701|FG000|Post-surgery (<30 Days)|No central review materials|0|||
144500589|NCT00828672|521029702|FG001|Post-surgery (<30 Days)|No central review materials|1|||
144500590|NCT00001575|521029705|FG000|Overall Study|Screening failures-Ph I portion|22|||
144720355|NCT00876733|521829582|FG003|Overall Study|Lack of Efficacy|1|||
144720356|NCT00876733|521829579|FG000|Overall Study|Lost to Follow-up|26|||
144720357|NCT00876733|521829580|FG001|Overall Study|Lost to Follow-up|10|||
144720358|NCT00876733|521829581|FG002|Overall Study|Lost to Follow-up|3|||
144720359|NCT00876733|521829582|FG003|Overall Study|Lost to Follow-up|2|||
144720360|NCT00876733|521829579|FG000|Overall Study|Data not available|14|||
144720361|NCT00876733|521829580|FG001|Overall Study|Data not available|3|||
144720362|NCT00876733|521829581|FG002|Overall Study|Data not available|7|||
144720363|NCT00876733|521829582|FG003|Overall Study|Data not available|1|||
144720364|NCT03521999|521829583|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
144720365|NCT03521999|521829584|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
144720366|NCT03521999|521829583|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
144720367|NCT03521999|521829584|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
144720368|NCT03521999|521829583|FG000|Completed 3 Month Follow up|Death|0|||
144720369|NCT03521999|521829584|FG001|Completed 3 Month Follow up|Death|1|||
144720370|NCT03521999|521829583|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
144720371|NCT03521999|521829584|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
144720372|NCT02843074|521829585|FG000|Overall Study|Withdrawal by Subject|5|||
144720373|NCT02843074|521829585|FG000|Overall Study|Progressive disease|1|||
144720374|NCT02843074|521829585|FG000|Overall Study|Physician Decision|1|||
144720375|NCT02843074|521829585|FG000|Overall Study|Lost to Follow-up|1|||
144720376|NCT02843074|521829585|FG000|Overall Study|Death|9|||
144720377|NCT01564758|521829586|FG000|Overall Study|Death|8|||
144720378|NCT01564758|521829586|FG000|Overall Study|Adverse Event|3|||
144720379|NCT01564758|521829586|FG000|Overall Study|Other|3|||
144720380|NCT01185288|521829589|FG000|Overall Study|Adverse Event|7|||
144720381|NCT01185288|521829590|FG001|Overall Study|Adverse Event|6|||
144720382|NCT01185288|521829589|FG000|Overall Study|Withdrawal by Subject|6|||
144720383|NCT01185288|521829590|FG001|Overall Study|Withdrawal by Subject|4|||
144720384|NCT01185288|521829589|FG000|Overall Study|Lost to Follow-up|2|||
144720385|NCT01185288|521829590|FG001|Overall Study|Lost to Follow-up|5|||
144720386|NCT01185288|521829589|FG000|Overall Study|Lack of Efficacy|2|||
144720387|NCT01185288|521829590|FG001|Overall Study|Lack of Efficacy|0|||
144720388|NCT01185288|521829589|FG000|Overall Study|Investigator discretion|1|||
144370080|NCT02379091|520562801|FG000|Overall Study|Study Termination|7|||
144500591|NCT00001575|521029705|FG000|Overall Study|Withdrawn/deaths|23|||
144500592|NCT03383887|521029706|FG000|Overall Study|Lost to Follow-up|0|||
144500593|NCT03383887|521029707|FG001|Overall Study|Lost to Follow-up|1|||
144500594|NCT02322216|521029715|FG000|Overall Study|Adverse Event|1|||
144500595|NCT02322216|521029716|FG001|Overall Study|Adverse Event|0|||
144500596|NCT02322216|521029715|FG000|Overall Study|Withdrawal by Subject|1|||
144500597|NCT02322216|521029716|FG001|Overall Study|Withdrawal by Subject|4|||
144500598|NCT01651949|521029718|FG000|Overall Study|Unknown status|4|||
144500599|NCT01651949|521029719|FG001|Overall Study|Unknown status|4|||
144500600|NCT01651949|521029720|FG002|Overall Study|Unknown status|0|||
144500601|NCT01651949|521029718|FG000|Overall Study|Lost to Follow-up|30|||
144500602|NCT01651949|521029719|FG001|Overall Study|Lost to Follow-up|56|||
144500603|NCT01651949|521029720|FG002|Overall Study|Lost to Follow-up|20|||
144500604|NCT01651949|521029718|FG000|Overall Study|Protocol Violation|0|||
144500605|NCT01651949|521029719|FG001|Overall Study|Protocol Violation|2|||
144500606|NCT01651949|521029720|FG002|Overall Study|Protocol Violation|1|||
144500607|NCT01651949|521029718|FG000|Overall Study|Physician Decision|0|||
144500608|NCT01651949|521029719|FG001|Overall Study|Physician Decision|2|||
144500609|NCT01651949|521029720|FG002|Overall Study|Physician Decision|0|||
144500610|NCT01651949|521029718|FG000|Overall Study|Adverse Event|0|||
144500611|NCT01651949|521029719|FG001|Overall Study|Adverse Event|2|||
144500612|NCT01651949|521029720|FG002|Overall Study|Adverse Event|1|||
144500613|NCT01651949|521029718|FG000|Overall Study|Screen failure|2|||
144500614|NCT01651949|521029719|FG001|Overall Study|Screen failure|2|||
144500615|NCT01651949|521029720|FG002|Overall Study|Screen failure|0|||
144500616|NCT01651949|521029718|FG000|Overall Study|Withdrawal by Subject|17|||
144500617|NCT01651949|521029719|FG001|Overall Study|Withdrawal by Subject|18|||
144500618|NCT01651949|521029720|FG002|Overall Study|Withdrawal by Subject|9|||
144500619|NCT01806714|521029721|FG000|Overall Study|No functioning phone number|200|||
144500620|NCT01806714|521029722|FG001|Overall Study|No functioning phone number|170|||
144500621|NCT00678795|521029723|FG000|Overall Study|Adverse Event|7|||
144500622|NCT00678795|521029724|FG001|Overall Study|Adverse Event|3|||
144370081|NCT02379091|520562802|FG001|Overall Study|Study Termination|2|||
144500623|NCT00678795|521029723|FG000|Overall Study|Withdrawal by Subject|3|||
144500624|NCT00678795|521029724|FG001|Overall Study|Withdrawal by Subject|0|||
144500625|NCT00678795|521029723|FG000|Overall Study|Protocol Violation|0|||
144500626|NCT00678795|521029724|FG001|Overall Study|Protocol Violation|1|||
144500627|NCT00678795|521029723|FG000|Overall Study|Lost to Follow-up|0|||
144370082|NCT02379091|520562803|FG002|Overall Study|Study Termination|5|||
144500628|NCT00678795|521029724|FG001|Overall Study|Lost to Follow-up|1|||
144500629|NCT00678795|521029723|FG000|Overall Study|Lack of Efficacy|1|||
144500630|NCT00678795|521029724|FG001|Overall Study|Lack of Efficacy|1|||
144500631|NCT04107805|521029725|FG000|Overall Study|Adverse Event|0|||
144500632|NCT04107805|521029726|FG001|Overall Study|Adverse Event|0|||
144500633|NCT04107805|521029727|FG002|Overall Study|Adverse Event|0|||
144500634|NCT04107805|521029728|FG003|Overall Study|Adverse Event|1|||
144500635|NCT04107805|521029729|FG004|Overall Study|Adverse Event|0|||
144500636|NCT04107805|521029730|FG005|Overall Study|Adverse Event|1|||
144500637|NCT04107805|521029731|FG006|Overall Study|Adverse Event|0|||
144500638|NCT04107805|521029732|FG007|Overall Study|Adverse Event|0|||
144500639|NCT04107805|521029733|FG008|Overall Study|Adverse Event|1|||
144500640|NCT01191086|521029736|FG000|Overall Study|Adverse Event|20|||
144500641|NCT01191086|521029736|FG000|Overall Study|Lack of Efficacy|10|||
144500642|NCT01191086|521029736|FG000|Overall Study|Lost to Follow-up|4|||
144500643|NCT01191086|521029736|FG000|Overall Study|Physician Decision|2|||
144500644|NCT01191086|521029736|FG000|Overall Study|Withdrawal by Subject|24|||
144370083|NCT02379091|520562804|FG003|Overall Study|Study Termination|8|||
144500645|NCT01191086|521029736|FG000|Overall Study|Discontinuation criterion met|1|||
144500646|NCT01191086|521029736|FG000|Overall Study|Other|1|||
144500647|NCT00771849|521029737|FG000|Overall Study|Lost to Follow-up|1|||
144500648|NCT00771849|521029738|FG001|Overall Study|Lost to Follow-up|2|||
144500649|NCT00771849|521029737|FG000|Overall Study|Withdrawal by Subject|1|||
144500650|NCT00771849|521029738|FG001|Overall Study|Withdrawal by Subject|1|||
144500651|NCT00771849|521029737|FG000|Overall Study|Not vaccinated|0|||
144370084|NCT02379091|520562801|FG000|Overall Study|Lack of Efficacy|3|||
144500652|NCT00771849|521029738|FG001|Overall Study|Not vaccinated|1|||
144500653|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
144500654|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
144500655|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
144500656|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
144500657|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
144500658|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
144720389|NCT01185288|521829590|FG001|Overall Study|Investigator discretion|0|||
144720390|NCT01185288|521829589|FG000|Overall Study|Did not meet inclusion criteria|1|||
144720391|NCT01185288|521829590|FG001|Overall Study|Did not meet inclusion criteria|0|||
144720392|NCT01185288|521829589|FG000|Overall Study|Noncompliance|0|||
144720393|NCT01185288|521829590|FG001|Overall Study|Noncompliance|1|||
144720394|NCT00656019|521829591|FG000|Overall Study|Not Eligible|10|||
144720395|NCT00656019|521829592|FG001|Overall Study|Not Eligible|0|||
144720396|NCT00656019|521829593|FG002|Overall Study|Not Eligible|0|||
144720397|NCT00656019|521829594|FG003|Overall Study|Not Eligible|0|||
144720398|NCT00656019|521829591|FG000|Overall Study|Withdrawal by Subject|2|||
144720399|NCT00656019|521829592|FG001|Overall Study|Withdrawal by Subject|0|||
144720400|NCT00656019|521829593|FG002|Overall Study|Withdrawal by Subject|0|||
144720401|NCT00656019|521829594|FG003|Overall Study|Withdrawal by Subject|0|||
144720402|NCT00656019|521829591|FG000|Overall Study|Lost to Follow-up|2|||
144720403|NCT00656019|521829592|FG001|Overall Study|Lost to Follow-up|1|||
144720404|NCT00656019|521829593|FG002|Overall Study|Lost to Follow-up|0|||
144720405|NCT00656019|521829594|FG003|Overall Study|Lost to Follow-up|0|||
144720406|NCT01626885|521829603|FG000|Overall Study|Adverse Event|8|||
144720407|NCT01626885|521829603|FG000|Overall Study|Withdrawal by Subject|4|||
144720408|NCT02669264|521829604|FG000|Overall Study|Death|5|||
144720409|NCT02669264|521829605|FG001|Overall Study|Death|5|||
144720410|NCT02669264|521829606|FG002|Overall Study|Death|3|||
144720411|NCT02669264|521829607|FG003|Overall Study|Death|3|||
144720412|NCT02669264|521829608|FG004|Overall Study|Death|3|||
144720413|NCT02669264|521829609|FG005|Overall Study|Death|6|||
144720414|NCT02669264|521829610|FG006|Overall Study|Death|3|||
144720415|NCT02669264|521829604|FG000|Overall Study|Withdrawal by Subject|0|||
144720416|NCT02669264|521829605|FG001|Overall Study|Withdrawal by Subject|1|||
144720417|NCT02669264|521829606|FG002|Overall Study|Withdrawal by Subject|0|||
144720418|NCT02669264|521829607|FG003|Overall Study|Withdrawal by Subject|0|||
144720419|NCT02669264|521829608|FG004|Overall Study|Withdrawal by Subject|1|||
144720420|NCT02669264|521829609|FG005|Overall Study|Withdrawal by Subject|0|||
144720421|NCT02669264|521829610|FG006|Overall Study|Withdrawal by Subject|0|||
144720422|NCT02669264|521829604|FG000|Overall Study|Lost to Follow-up|0|||
144720423|NCT02669264|521829605|FG001|Overall Study|Lost to Follow-up|0|||
144720424|NCT02669264|521829606|FG002|Overall Study|Lost to Follow-up|0|||
144720425|NCT02669264|521829607|FG003|Overall Study|Lost to Follow-up|0|||
144720426|NCT02669264|521829608|FG004|Overall Study|Lost to Follow-up|1|||
144720427|NCT02669264|521829609|FG005|Overall Study|Lost to Follow-up|0|||
144720428|NCT02669264|521829610|FG006|Overall Study|Lost to Follow-up|0|||
144720429|NCT02669264|521829604|FG000|Overall Study|Miscellaneous|0|||
144720430|NCT02669264|521829605|FG001|Overall Study|Miscellaneous|0|||
144720431|NCT02669264|521829606|FG002|Overall Study|Miscellaneous|0|||
144720432|NCT02669264|521829607|FG003|Overall Study|Miscellaneous|0|||
144720433|NCT02669264|521829608|FG004|Overall Study|Miscellaneous|0|||
144720434|NCT02669264|521829609|FG005|Overall Study|Miscellaneous|0|||
144720435|NCT02669264|521829610|FG006|Overall Study|Miscellaneous|2|||
144720436|NCT00526890|521829611|FG000|Overall Study|Adverse Event|2|||
144720437|NCT03035227|521829612|FG000|Overall Study|study stopped due to PI leaving institut|1|||
144720438|NCT03035227|521829613|FG001|Overall Study|study stopped due to PI leaving institut|1|||
144720439|NCT00859469|521829615|FG000|Overall Study|Adverse Event|2|||
144720440|NCT00859469|521829615|FG000|Overall Study|Lack of Efficacy|9|||
144720441|NCT00859469|521829615|FG000|Overall Study|Withdrawal by Subject|1|||
144720442|NCT00859469|521829615|FG000|Overall Study|Death|16|||
144720443|NCT04345471|521829620|FG000|Overall Study|Adverse Event|8|||
144720444|NCT04345471|521829621|FG001|Overall Study|Adverse Event|5|||
144720445|NCT04345471|521829622|FG002|Overall Study|Adverse Event|6|||
144500659|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
144500660|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
144500661|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
144500662|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
144500663|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
144500664|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
144500665|NCT02057718|521029741|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
144500666|NCT02057718|521029742|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
144500667|NCT02057718|521029741|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
144500668|NCT02057718|521029742|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
144500669|NCT02057718|521029741|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
144500670|NCT02057718|521029742|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
144500671|NCT02057718|521029741|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
144500672|NCT02057718|521029742|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
144500673|NCT02057718|521029741|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
144500674|NCT02057718|521029742|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
144500675|NCT03058991|521029747|FG000|Overall Study|Lost to Follow-up|17|||
144500676|NCT03058991|521029748|FG001|Overall Study|Lost to Follow-up|12|||
144500677|NCT03058991|521029749|FG002|Overall Study|Lost to Follow-up|12|||
144720446|NCT04345471|521829620|FG000|Overall Study|Lack of Efficacy|1|||
144720447|NCT04345471|521829621|FG001|Overall Study|Lack of Efficacy|1|||
144720448|NCT04345471|521829622|FG002|Overall Study|Lack of Efficacy|0|||
144720449|NCT04345471|521829620|FG000|Overall Study|Protocol Violation|0|||
144720450|NCT04345471|521829621|FG001|Overall Study|Protocol Violation|1|||
144720451|NCT04345471|521829622|FG002|Overall Study|Protocol Violation|2|||
144720452|NCT04345471|521829620|FG000|Overall Study|Withdrawal by Subject|10|||
144720453|NCT04345471|521829621|FG001|Overall Study|Withdrawal by Subject|5|||
144720454|NCT04345471|521829622|FG002|Overall Study|Withdrawal by Subject|10|||
144720455|NCT03083132|521829625|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
144720456|NCT03083132|521829626|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
144720457|NCT03083132|521829625|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
144720458|NCT03083132|521829626|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
144720459|NCT03083132|521829625|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
144720460|NCT03083132|521829626|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
144720461|NCT03118739|521829627|FG000|Overall Study|Physician Decision|0|||
144720462|NCT03118739|521829628|FG001|Overall Study|Physician Decision|1|||
144720463|NCT03118739|521829627|FG000|Overall Study|Withdrawal by Subject|5|||
144720464|NCT03118739|521829628|FG001|Overall Study|Withdrawal by Subject|3|||
144720465|NCT03118739|521829627|FG000|Overall Study|Lost to Follow-up|2|||
144720466|NCT03118739|521829628|FG001|Overall Study|Lost to Follow-up|0|||
144720467|NCT00669955|521829629|FG000|Overall Study|Adverse Event|3|||
144720468|NCT00669955|521829630|FG001|Overall Study|Adverse Event|5|||
144720469|NCT00669955|521829629|FG000|Overall Study|Death|0|||
144720470|NCT00669955|521829630|FG001|Overall Study|Death|1|||
144720471|NCT00669955|521829629|FG000|Overall Study|Withdrawal by Subject|2|||
144720472|NCT00669955|521829630|FG001|Overall Study|Withdrawal by Subject|3|||
144720473|NCT00669955|521829629|FG000|Overall Study|Lost to Follow-up|5|||
144720474|NCT00669955|521829630|FG001|Overall Study|Lost to Follow-up|7|||
144720475|NCT00669955|521829629|FG000|Overall Study|Protocol Violation|2|||
144720476|NCT00669955|521829630|FG001|Overall Study|Protocol Violation|7|||
144720477|NCT00669955|521829629|FG000|Overall Study|Investigator Sponsor Judgement|0|||
144720478|NCT00669955|521829630|FG001|Overall Study|Investigator Sponsor Judgement|1|||
144720479|NCT00669955|521829629|FG000|Overall Study|not compliant with study drug/visit|2|||
144720480|NCT00669955|521829630|FG001|Overall Study|not compliant with study drug/visit|3|||
144720481|NCT03507439|521829634|FG000|Overall Study|Other|2|||
144720482|NCT03507439|521829635|FG001|Overall Study|Other|1|||
144720483|NCT03507439|521829634|FG000|Overall Study|Withdrawal by Subject|1|||
144720484|NCT03507439|521829635|FG001|Overall Study|Withdrawal by Subject|0|||
144720485|NCT03507439|521829634|FG000|Overall Study|Death|1|||
144720486|NCT03507439|521829635|FG001|Overall Study|Death|1|||
144720487|NCT00289458|521829636|FG000|Overall Study|Death|1|||
144720488|NCT00289458|521829637|FG001|Overall Study|Death|0|||
144720489|NCT00289458|521829638|FG002|Overall Study|Death|0|||
144720490|NCT00289458|521829636|FG000|Overall Study|Physician Decision|3|||
144720491|NCT00289458|521829637|FG001|Overall Study|Physician Decision|4|||
144720492|NCT00289458|521829638|FG002|Overall Study|Physician Decision|2|||
144720493|NCT00289458|521829636|FG000|Overall Study|Withdrawal by Subject|2|||
144720494|NCT00289458|521829637|FG001|Overall Study|Withdrawal by Subject|2|||
144720495|NCT00289458|521829638|FG002|Overall Study|Withdrawal by Subject|4|||
144720496|NCT00982410|521831215|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
144720497|NCT00982410|521831216|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
144720498|NCT00982410|521831215|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
144720499|NCT00982410|521831216|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
144500678|NCT03058991|521029747|FG000|Overall Study|Withdrawal by Subject|1|||
144500679|NCT03058991|521029748|FG001|Overall Study|Withdrawal by Subject|0|||
144500680|NCT03058991|521029749|FG002|Overall Study|Withdrawal by Subject|0|||
144500681|NCT01689519|521029750|FG000|Intent to Treat|Death|157|||
144500682|NCT01689519|521029751|FG001|Intent to Treat|Death|167|||
144500683|NCT01689519|521029750|FG000|Intent to Treat|Lost to Follow-up|4|||
144500684|NCT01689519|521029751|FG001|Intent to Treat|Lost to Follow-up|8|||
144500685|NCT01689519|521029750|FG000|Intent to Treat|Other|2|||
144500686|NCT01689519|521029751|FG001|Intent to Treat|Other|4|||
144500687|NCT01689519|521029750|FG000|Intent to Treat|Physician Decision|4|||
144500688|NCT01689519|521029751|FG001|Intent to Treat|Physician Decision|1|||
144500689|NCT01689519|521029750|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
144500690|NCT01689519|521029751|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
144500691|NCT01689519|521029750|FG000|Intent to Treat|Withdrawal by Subject|21|||
144500692|NCT01689519|521029751|FG001|Intent to Treat|Withdrawal by Subject|20|||
144500693|NCT01689519|521029750|FG000|Safety Population|Death|158|||
144500694|NCT01689519|521029751|FG001|Safety Population|Death|165|||
144500695|NCT01689519|521029750|FG000|Safety Population|Lost to Follow-up|4|||
144500696|NCT01689519|521029751|FG001|Safety Population|Lost to Follow-up|8|||
144500697|NCT01689519|521029750|FG000|Safety Population|Other|2|||
144500698|NCT01689519|521029751|FG001|Safety Population|Other|4|||
144500699|NCT01689519|521029750|FG000|Safety Population|Physician Decision|4|||
144500700|NCT01689519|521029751|FG001|Safety Population|Physician Decision|1|||
144500701|NCT01689519|521029750|FG000|Safety Population|Study Terminated By Sponsor|60|||
144500702|NCT01689519|521029751|FG001|Safety Population|Study Terminated By Sponsor|47|||
144500703|NCT01689519|521029750|FG000|Safety Population|Withdrawal by Subject|20|||
144500704|NCT01689519|521029751|FG001|Safety Population|Withdrawal by Subject|20|||
144500705|NCT00559949|521029754|FG000|Overall Study|Progressive Disease during cycle 1|1|||
144500706|NCT00559949|521029754|FG000|Overall Study|Adverse Event|1|||
144500707|NCT00559949|521029754|FG000|Overall Study|Withdrawal by Subject|4|||
144500708|NCT00559949|521029754|FG000|Overall Study|No disease evaluation per protocol|1|||
144500709|NCT02596035|521029755|FG000|Overall Study|Disease Progression|64|||
144500710|NCT02596035|521029756|FG001|Overall Study|Disease Progression|32|||
144500711|NCT02596035|521029757|FG002|Overall Study|Disease Progression|1|||
144500712|NCT02596035|521029755|FG000|Overall Study|study drug toxicity|12|||
144500713|NCT02596035|521029756|FG001|Overall Study|study drug toxicity|3|||
144500714|NCT02596035|521029757|FG002|Overall Study|study drug toxicity|0|||
144500715|NCT02596035|521029755|FG000|Overall Study|AE unrelated to study drug|5|||
144500716|NCT02596035|521029756|FG001|Overall Study|AE unrelated to study drug|2|||
144500717|NCT02596035|521029757|FG002|Overall Study|AE unrelated to study drug|0|||
144500718|NCT02596035|521029755|FG000|Overall Study|participant request to discontinue study treatment|2|||
144500719|NCT02596035|521029756|FG001|Overall Study|participant request to discontinue study treatment|0|||
144500720|NCT02596035|521029757|FG002|Overall Study|participant request to discontinue study treatment|0|||
144500721|NCT02596035|521029755|FG000|Overall Study|participant withdrew consent|2|||
144500722|NCT02596035|521029756|FG001|Overall Study|participant withdrew consent|2|||
144500723|NCT02596035|521029757|FG002|Overall Study|participant withdrew consent|0|||
144500724|NCT02596035|521029755|FG000|Overall Study|Poor/Non Comlpiance|0|||
144500725|NCT02596035|521029756|FG001|Overall Study|Poor/Non Comlpiance|1|||
144500726|NCT02596035|521029757|FG002|Overall Study|Poor/Non Comlpiance|0|||
144500727|NCT02596035|521029755|FG000|Overall Study|participant no longer meets study criteria|1|||
144500728|NCT02596035|521029756|FG001|Overall Study|participant no longer meets study criteria|0|||
144500729|NCT02596035|521029757|FG002|Overall Study|participant no longer meets study criteria|0|||
144500730|NCT02596035|521029755|FG000|Overall Study|other reasons|11|||
144500731|NCT02596035|521029756|FG001|Overall Study|other reasons|4|||
144500732|NCT02596035|521029757|FG002|Overall Study|other reasons|0|||
144500733|NCT04173572|521029761|FG000|Overall Study|Withdrawal by Subject|1|||
144500734|NCT04173572|521029762|FG001|Overall Study|Withdrawal by Subject|5|||
144500735|NCT04173572|521029761|FG000|Overall Study|Lost to Follow-up|3|||
144500736|NCT04173572|521029762|FG001|Overall Study|Lost to Follow-up|1|||
144500737|NCT01253226|521029764|FG000|Overall Study|Adverse Event|0|||
144500738|NCT01253226|521029765|FG001|Overall Study|Adverse Event|0|||
144500739|NCT01253226|521029766|FG002|Overall Study|Adverse Event|1|||
144500740|NCT01253226|521029767|FG003|Overall Study|Adverse Event|0|||
144500741|NCT01253226|521029768|FG004|Overall Study|Adverse Event|0|||
144500742|NCT01253226|521029764|FG000|Overall Study|Death|0|||
144500743|NCT01253226|521029765|FG001|Overall Study|Death|1|||
144500744|NCT01253226|521029766|FG002|Overall Study|Death|0|||
144500745|NCT01253226|521029767|FG003|Overall Study|Death|0|||
144500746|NCT01253226|521029768|FG004|Overall Study|Death|0|||
144500747|NCT01253226|521029764|FG000|Overall Study|Physician Decision|0|||
144500748|NCT01253226|521029765|FG001|Overall Study|Physician Decision|0|||
144500749|NCT01253226|521029766|FG002|Overall Study|Physician Decision|0|||
144500750|NCT01253226|521029767|FG003|Overall Study|Physician Decision|0|||
144500751|NCT01253226|521029768|FG004|Overall Study|Physician Decision|2|||
144500752|NCT01253226|521029764|FG000|Overall Study|Withdrawal by Subject|0|||
144500753|NCT01253226|521029765|FG001|Overall Study|Withdrawal by Subject|0|||
144500754|NCT01253226|521029766|FG002|Overall Study|Withdrawal by Subject|0|||
144500755|NCT01253226|521029767|FG003|Overall Study|Withdrawal by Subject|1|||
144500756|NCT01253226|521029768|FG004|Overall Study|Withdrawal by Subject|0|||
144500757|NCT00988637|521029769|FG000|Overall Study|Lost to Follow-up|2|||
144500758|NCT00988637|521029770|FG001|Overall Study|Lost to Follow-up|1|||
144500759|NCT00988637|521029769|FG000|Overall Study|Withdrawal by Subject|1|||
144500760|NCT00988637|521029770|FG001|Overall Study|Withdrawal by Subject|1|||
144500761|NCT00988637|521029769|FG000|Overall Study|non-compliance with study drug|0|||
144500762|NCT00988637|521029770|FG001|Overall Study|non-compliance with study drug|1|||
144500763|NCT01726023|521029772|FG000|Overall Study|Death|1|||
144500764|NCT01726023|521029773|FG001|Overall Study|Death|1|||
144500765|NCT01726023|521029772|FG000|Overall Study|Lost to Follow-up|5|||
144500766|NCT01726023|521029773|FG001|Overall Study|Lost to Follow-up|10|||
144500767|NCT01726023|521029772|FG000|Overall Study|Other Eligibility criteria|7|||
144500768|NCT01726023|521029773|FG001|Overall Study|Other Eligibility criteria|7|||
144500769|NCT01726023|521029772|FG000|Overall Study|Withdrawal by Subject|16|||
144500770|NCT01726023|521029773|FG001|Overall Study|Withdrawal by Subject|8|||
144500771|NCT03643211|521029779|FG000|Overall Study|Contract violation/deficiency|12|||
144500772|NCT03643211|521029779|FG000|Overall Study|Invalid registration|3|||
144500773|NCT03643211|521029779|FG000|Overall Study|No treatment information|2|||
144500774|NCT03643211|521029779|FG000|Overall Study|No adverse event information - No revisit|4|||
144720500|NCT00982410|521831215|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
144720501|NCT00982410|521831216|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
144720502|NCT00982410|521831215|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
144720503|NCT00982410|521831216|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
144720504|NCT00982410|521831215|FG000|6-month Follow-up Assessment|participant no transportation|1|||
144720505|NCT00982410|521831216|FG001|6-month Follow-up Assessment|participant no transportation|0|||
144720506|NCT00982410|521831215|FG000|6-month Follow-up Assessment|incarceration|0|||
144720507|NCT00982410|521831216|FG001|6-month Follow-up Assessment|incarceration|2|||
144720508|NCT00982410|521831215|FG000|6-month Follow-up Assessment|patent surgery|0|||
144720509|NCT00982410|521831216|FG001|6-month Follow-up Assessment|patent surgery|1|||
144720510|NCT00982410|521831215|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
144720511|NCT00982410|521831216|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
144720512|NCT00982410|521831215|FG000|12-month Follow-up Assessment|Death|0|||
144720513|NCT00982410|521831216|FG001|12-month Follow-up Assessment|Death|2|||
144720514|NCT00982410|521831215|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
144720515|NCT00982410|521831216|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
144720516|NCT00982410|521831215|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
144720517|NCT00982410|521831216|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
144720518|NCT00982410|521831215|FG000|12-month Follow-up Assessment|incarceration|2|||
144720519|NCT00982410|521831216|FG001|12-month Follow-up Assessment|incarceration|1|||
144720520|NCT00982410|521831215|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
144720521|NCT00982410|521831216|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
144720522|NCT04014959|521831217|FG000|Baseline MRI and Assessments|Physician Decision|2|||
144720523|NCT04014959|521831217|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
144720524|NCT04014959|521831217|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
144720525|NCT02004847|521831219|FG000|Overall Study|Protocol Violation|1|||
144720526|NCT02004847|521831220|FG001|Overall Study|Protocol Violation|1|||
144720527|NCT00759148|521831225|FG000|Overall Study|Adverse Event|1|||
144720528|NCT00759148|521831226|FG001|Overall Study|Adverse Event|6|||
144720529|NCT00759148|521831225|FG000|Overall Study|Withdrawal by Subject|3|||
144720530|NCT00759148|521831226|FG001|Overall Study|Withdrawal by Subject|7|||
144720531|NCT00759148|521831225|FG000|Overall Study|Lost to Follow-up|3|||
144720532|NCT00759148|521831226|FG001|Overall Study|Lost to Follow-up|9|||
144720533|NCT00759148|521831225|FG000|Overall Study|Treatment Failure|6|||
144720534|NCT00759148|521831226|FG001|Overall Study|Treatment Failure|10|||
144720535|NCT00759148|521831225|FG000|Overall Study|Reason not given|1|||
144720536|NCT00759148|521831226|FG001|Overall Study|Reason not given|0|||
144720537|NCT03381248|521831227|FG000|0-6 Months|Withdrawal by Subject|4|||
144720538|NCT03381248|521831228|FG001|0-6 Months|Withdrawal by Subject|1|||
144720539|NCT03381248|521831227|FG000|0-6 Months|Lost to Follow-up|3|||
144720540|NCT03381248|521831228|FG001|0-6 Months|Lost to Follow-up|2|||
144720541|NCT03381248|521831227|FG000|0-6 Months|Lack of Efficacy|1|||
144720542|NCT03381248|521831228|FG001|0-6 Months|Lack of Efficacy|0|||
144720543|NCT03381248|521831227|FG000|0-6 Months|Adverse Event|1|||
144720544|NCT03381248|521831228|FG001|0-6 Months|Adverse Event|0|||
144720545|NCT03381248|521831227|FG000|0-6 Months|Protocol Violation|2|||
144720546|NCT03381248|521831228|FG001|0-6 Months|Protocol Violation|1|||
144720547|NCT03381248|521831227|FG000|0-6 Months|Physician Decision|1|||
144720548|NCT03381248|521831228|FG001|0-6 Months|Physician Decision|0|||
144720549|NCT03381248|521831227|FG000|0-6 Months|Planning another procedure|1|||
144720550|NCT03381248|521831228|FG001|0-6 Months|Planning another procedure|2|||
144720551|NCT03381248|521831227|FG000|6-12 Months|Withdrawal by Subject|1|||
144720552|NCT03381248|521831228|FG001|6-12 Months|Withdrawal by Subject|3|||
144720553|NCT03381248|521831227|FG000|6-12 Months|Lost to Follow-up|0|||
144720554|NCT03381248|521831228|FG001|6-12 Months|Lost to Follow-up|2|||
144720555|NCT03381248|521831227|FG000|6-12 Months|Protocol Violation|3|||
144720556|NCT03381248|521831228|FG001|6-12 Months|Protocol Violation|2|||
144720557|NCT03381248|521831227|FG000|6-12 Months|Planning another procedure|6|||
144720558|NCT03381248|521831228|FG001|6-12 Months|Planning another procedure|2|||
144720559|NCT03381248|521831227|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
144720560|NCT03381248|521831228|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
144720561|NCT03381248|521831227|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
144720562|NCT03381248|521831228|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
144720563|NCT03381248|521831227|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
144720564|NCT03381248|521831228|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
144500775|NCT04858425|521029780|FG000|Overall Study|Adverse Event|2|||
144500776|NCT04858425|521029781|FG001|Overall Study|Adverse Event|2|||
144500777|NCT04858425|521029780|FG000|Overall Study|Withdrawal by Subject|3|||
144500778|NCT04858425|521029781|FG001|Overall Study|Withdrawal by Subject|1|||
144500779|NCT04858425|521029780|FG000|Overall Study|Lost to Follow-up|4|||
144500780|NCT04858425|521029781|FG001|Overall Study|Lost to Follow-up|2|||
144500781|NCT04858425|521029780|FG000|Overall Study|Lost to Follow-up|1|||
144500782|NCT04858425|521029781|FG001|Overall Study|Lost to Follow-up|0|||
144500783|NCT04536077|521029783|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
144500784|NCT04536077|521029784|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
144500785|NCT04536077|521029783|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
144500786|NCT04536077|521029784|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
144500787|NCT04550039|521029787|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
144500788|NCT04550039|521029788|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
144500789|NCT04550039|521029787|FG000|Overall Study|patient self-withdrew from study|0|||
144720565|NCT05188521|521831229|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
144500790|NCT04550039|521029788|FG001|Overall Study|patient self-withdrew from study|1|||
144500791|NCT01155869|521029790|FG000|Overall Study|Lost to Follow-up|3|||
144500792|NCT01155869|521029791|FG001|Overall Study|Lost to Follow-up|1|||
144500793|NCT02698241|521029792|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
144500794|NCT02698241|521029792|FG000|Overall Study|Screening not met|7|||
144720566|NCT05188521|521831230|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
144720567|NCT00458302|521831231|FG000|Overall Study|Adverse Event|4|||
144720568|NCT00458302|521831232|FG001|Overall Study|Adverse Event|14|||
144720569|NCT00458302|521831231|FG000|Overall Study|Pregnancy|2|||
144720570|NCT00458302|521831232|FG001|Overall Study|Pregnancy|1|||
144720571|NCT00458302|521831231|FG000|Overall Study|Protocol Violation|0|||
144720572|NCT00458302|521831232|FG001|Overall Study|Protocol Violation|2|||
144720573|NCT00458302|521831231|FG000|Overall Study|Withdrawal by Subject|6|||
144720574|NCT00458302|521831232|FG001|Overall Study|Withdrawal by Subject|4|||
144720575|NCT00458302|521831231|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
144720576|NCT00458302|521831232|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
144720577|NCT00458302|521831231|FG000|Overall Study|Study Termination By Sponsor|1|||
144720578|NCT00458302|521831232|FG001|Overall Study|Study Termination By Sponsor|0|||
144720579|NCT00458302|521831231|FG000|Overall Study|Lost to Follow-up|2|||
144720580|NCT00458302|521831232|FG001|Overall Study|Lost to Follow-up|0|||
144720581|NCT00458302|521831231|FG000|Overall Study|Other|4|||
144720582|NCT00458302|521831232|FG001|Overall Study|Other|2|||
144720583|NCT04582266|521831233|FG000|Overall Study|Lost to Follow-up|7|||
144720584|NCT04582266|521831234|FG001|Overall Study|Lost to Follow-up|5|||
144720585|NCT04582266|521831233|FG000|Overall Study|Withdrawal by Subject|1|||
144720586|NCT04582266|521831234|FG001|Overall Study|Withdrawal by Subject|0|||
144720587|NCT04582266|521831233|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
144720588|NCT04582266|521831234|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
144720589|NCT01341639|521831235|FG000|Infant Series|Protocol Violation|1|||
144720590|NCT01341639|521831236|FG001|Infant Series|Protocol Violation|0|||
144720591|NCT01341639|521831235|FG000|Infant Series|Not Vaccinated|0|||
144720592|NCT01341639|521831236|FG001|Infant Series|Not Vaccinated|1|||
144720593|NCT01341639|521831235|FG000|Infant Series|Adverse Event|0|||
144720594|NCT01341639|521831236|FG001|Infant Series|Adverse Event|5|||
144720595|NCT01341639|521831235|FG000|Infant Series|Withdrawal by Subject|11|||
144720596|NCT01341639|521831236|FG001|Infant Series|Withdrawal by Subject|8|||
144720597|NCT01341639|521831235|FG000|Infant Series|Lost to Follow-up|0|||
144720598|NCT01341639|521831236|FG001|Infant Series|Lost to Follow-up|2|||
144720599|NCT01341639|521831235|FG000|Infant Series|Site 0048 Participants|17|||
144720600|NCT01341639|521831236|FG001|Infant Series|Site 0048 Participants|16|||
144720601|NCT01341639|521831235|FG000|Interim Period|Withdrawal by Subject|6|||
144720602|NCT01341639|521831236|FG001|Interim Period|Withdrawal by Subject|7|||
144720603|NCT01341639|521831235|FG000|Interim Period|Lost to Follow-up|2|||
144720604|NCT01341639|521831236|FG001|Interim Period|Lost to Follow-up|0|||
144720605|NCT01341639|521831235|FG000|Interim Period|Physician Decision|0|||
144720606|NCT01341639|521831236|FG001|Interim Period|Physician Decision|1|||
144720607|NCT01341639|521831235|FG000|Interim Period|Protocol Violation|0|||
144720608|NCT01341639|521831236|FG001|Interim Period|Protocol Violation|1|||
144720609|NCT01341639|521831235|FG000|Post-Treatment|Withdrawal by Subject|0|||
144720610|NCT01341639|521831236|FG001|Post-Treatment|Withdrawal by Subject|1|||
144720611|NCT01341639|521831235|FG000|Post-Treatment|Adverse Event|0|||
144720612|NCT01341639|521831236|FG001|Post-Treatment|Adverse Event|2|||
144720613|NCT02224456|521831237|FG000|Overall Study|Lack of Efficacy|1|||
144720614|NCT02224456|521831237|FG000|Overall Study|Lost to Follow-up|15|||
144720615|NCT02224456|521831237|FG000|Overall Study|Withdrawal by Subject|9|||
144720616|NCT02224456|521831237|FG000|Overall Study|Physician Decision|3|||
144720617|NCT02224456|521831237|FG000|Overall Study|Death|2|||
144720618|NCT02224456|521831237|FG000|Overall Study|Pregnancy|4|||
144720619|NCT02224456|521831237|FG000|Overall Study|Protocol Violation|1|||
144370085|NCT02379091|520562802|FG001|Overall Study|Lack of Efficacy|0|||
144720620|NCT02224456|521831237|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
144720621|NCT01241461|521831238|FG000|Overall Study|Progressive Disease|3|||
144720622|NCT01241461|521831239|FG001|Overall Study|Progressive Disease|6|||
144720623|NCT01379781|521831243|FG000|Overall Study|Lost to Follow-up|11|||
144720624|NCT01379781|521831244|FG001|Overall Study|Lost to Follow-up|8|||
144720625|NCT02247479|521831245|FG000|Overall Study|Adverse Event|8|||
144720626|NCT02247479|521831246|FG001|Overall Study|Adverse Event|9|||
144720627|NCT02247479|521831247|FG002|Overall Study|Adverse Event|8|||
144720628|NCT02247479|521831245|FG000|Overall Study|Death|5|||
144720629|NCT02247479|521831246|FG001|Overall Study|Death|4|||
144720630|NCT02247479|521831247|FG002|Overall Study|Death|6|||
144720631|NCT02247479|521831245|FG000|Overall Study|Lost to Follow-up|3|||
144720632|NCT02247479|521831246|FG001|Overall Study|Lost to Follow-up|3|||
144720633|NCT02247479|521831247|FG002|Overall Study|Lost to Follow-up|1|||
144720634|NCT02247479|521831245|FG000|Overall Study|Non-compliance|0|||
144720635|NCT02247479|521831246|FG001|Overall Study|Non-compliance|0|||
144720636|NCT02247479|521831247|FG002|Overall Study|Non-compliance|1|||
144720637|NCT02247479|521831245|FG000|Overall Study|Withdrawal by Subject|25|||
144720638|NCT02247479|521831246|FG001|Overall Study|Withdrawal by Subject|29|||
144720639|NCT02247479|521831247|FG002|Overall Study|Withdrawal by Subject|24|||
144720640|NCT02247479|521831245|FG000|Overall Study|Study Terminated by Sponsor|98|||
144720641|NCT02247479|521831246|FG001|Overall Study|Study Terminated by Sponsor|88|||
144720642|NCT02247479|521831247|FG002|Overall Study|Study Terminated by Sponsor|94|||
144720643|NCT02247479|521831245|FG000|Overall Study|Physician Decision|1|||
144720644|NCT02247479|521831246|FG001|Overall Study|Physician Decision|0|||
144720645|NCT02247479|521831247|FG002|Overall Study|Physician Decision|2|||
144720646|NCT02247479|521831245|FG000|Overall Study|Unspecified Reason|2|||
144720647|NCT02247479|521831246|FG001|Overall Study|Unspecified Reason|5|||
144720648|NCT02247479|521831247|FG002|Overall Study|Unspecified Reason|2|||
144720649|NCT01132118|521831248|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
144720650|NCT01132118|521831249|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
144720651|NCT01132118|521831248|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
144720652|NCT01132118|521831249|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
144720653|NCT01132118|521831248|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
144720654|NCT01132118|521831249|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
144720655|NCT03031899|521831257|FG000|Overall Study|Protocol Violation|1|||
144720656|NCT03031899|521831257|FG000|Overall Study|lesion disappeared after stopping habit|1|||
144720657|NCT00094302|521831258|FG000|Overall Study|Lost to Follow-up|43|||
144720658|NCT00094302|521831259|FG001|Overall Study|Lost to Follow-up|41|||
144720659|NCT00094302|521831258|FG000|Overall Study|Physician Decision|5|||
144720660|NCT00094302|521831259|FG001|Overall Study|Physician Decision|8|||
144720661|NCT00094302|521831258|FG000|Overall Study|Withdrawal by Subject|103|||
144720662|NCT00094302|521831259|FG001|Overall Study|Withdrawal by Subject|111|||
144720663|NCT00094302|521831258|FG000|Overall Study|Death|266|||
144720664|NCT00094302|521831259|FG001|Overall Study|Death|246|||
144720665|NCT03705351|521831265|FG000|Overall Study|Study termination|3|||
144720666|NCT03705351|521831265|FG000|Overall Study|Death|1|||
144720667|NCT03705351|521831265|FG000|Overall Study|Lack of Efficacy|2|||
144720668|NCT03705351|521831265|FG000|Overall Study|Withdrawal by Subject|1|||
144720669|NCT01907087|521831270|FG000|Overall Study|Withdrawal by Subject|1|||
144720670|NCT02180061|521831271|FG000|Overall Study|Adverse Event|4|||
144720671|NCT02180061|521831272|FG001|Overall Study|Adverse Event|2|||
144720672|NCT02180061|521831271|FG000|Overall Study|Clinical Progression|5|||
144720673|NCT02180061|521831272|FG001|Overall Study|Clinical Progression|1|||
144720674|NCT02180061|521831271|FG000|Overall Study|Progressive Disease|15|||
144720675|NCT02180061|521831272|FG001|Overall Study|Progressive Disease|5|||
144720676|NCT02180061|521831271|FG000|Overall Study|Physician Decision|1|||
144720677|NCT02180061|521831272|FG001|Overall Study|Physician Decision|0|||
144720678|NCT01469364|521831275|FG000|Overall Study|Adverse Event|1|||
144720679|NCT01469364|521831275|FG000|Overall Study|Withdrawal by Subject|1|||
144720680|NCT01299038|521831279|FG000|Overall Study|Withdrawal by Subject|1|||
144720681|NCT01299038|521831280|FG001|Overall Study|Withdrawal by Subject|0|||
144720682|NCT01162499|521831285|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
144720683|NCT01162499|521831286|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
144720684|NCT00322556|521831287|FG000|Overall Study|Adverse Event|1|||
144720685|NCT00322556|521831287|FG000|Overall Study|Withdrawal by Subject|1|||
144720686|NCT00322556|521831287|FG000|Overall Study|Lost to Follow-up|3|||
144720687|NCT00322556|521831287|FG000|Overall Study|Other Reason|7|||
144720688|NCT01590433|521831288|FG000|Overall Study|Lost to Follow-up|20|||
144720689|NCT01590433|521831289|FG001|Overall Study|Lost to Follow-up|8|||
144720690|NCT01590433|521831288|FG000|Overall Study|Withdrawal by Subject|21|||
144720691|NCT01590433|521831289|FG001|Overall Study|Withdrawal by Subject|11|||
144720692|NCT01590433|521831288|FG000|Overall Study|Adverse Event|11|||
144720693|NCT01590433|521831289|FG001|Overall Study|Adverse Event|3|||
144720694|NCT00555009|521831290|FG000|Overall Study|Withdrawal by Subject|0|||
144720695|NCT00555009|521831291|FG001|Overall Study|Withdrawal by Subject|1|||
144720696|NCT00555009|521831290|FG000|Overall Study|Terminated by Sponsor|2|||
144720697|NCT00555009|521831291|FG001|Overall Study|Terminated by Sponsor|5|||
144720698|NCT01673009|521831297|FG000|Overall Study|Physician Decision|5|||
144720699|NCT01673009|521831297|FG000|Overall Study|Withdrawal by Subject|8|||
144720700|NCT01844583|521831298|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
144720701|NCT01844583|521831299|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
144720702|NCT01787825|521831300|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
144720703|NCT01787825|521831301|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
144720704|NCT01787825|521831300|FG000|Overall Study|Data Not Analyzable|5|||
144720705|NCT01787825|521831301|FG001|Overall Study|Data Not Analyzable|1|||
144720706|NCT01259869|521831307|FG000|Overall Study|Duplicated registration|1|||
144720707|NCT00952484|521831311|FG000|Overall Study|Withdrawal by Subject|0|||
144720708|NCT00952484|521831312|FG001|Overall Study|Withdrawal by Subject|1|||
144720709|NCT00952484|521831313|FG002|Overall Study|Withdrawal by Subject|0|||
144720710|NCT02750306|521831314|FG000|Overall Study|Withdrawal by Subject|5|||
144720711|NCT02750306|521831315|FG001|Overall Study|Withdrawal by Subject|2|||
144720712|NCT02750306|521831314|FG000|Overall Study|Protocol Violation|1|||
144720713|NCT02750306|521831315|FG001|Overall Study|Protocol Violation|0|||
144720714|NCT00192296|521831317|FG000|Overall Study|Withdrawal by Subject|0|||
144720715|NCT00192296|521831318|FG001|Overall Study|Withdrawal by Subject|1|||
144720716|NCT00192296|521831319|FG002|Overall Study|Withdrawal by Subject|0|||
144720717|NCT00192296|521831320|FG003|Overall Study|Withdrawal by Subject|0|||
144720718|NCT01829477|521831322|FG000|Overall Study|Study Terminated by Sponsor|15|||
144720719|NCT01829477|521831323|FG001|Overall Study|Study Terminated by Sponsor|15|||
144720720|NCT01829477|521831322|FG000|Overall Study|Withdrawal by Subject|1|||
144720721|NCT01829477|521831323|FG001|Overall Study|Withdrawal by Subject|0|||
144500795|NCT02698241|521029792|FG000|Overall Study|Withdrawal by Subject|7|||
144500796|NCT02698241|521029792|FG000|Overall Study|Physician Decision|2|||
144500797|NCT02698241|521029792|FG000|Overall Study|Subject underwent system modification|2|||
144500798|NCT02698241|521029792|FG000|Overall Study|Lost to Follow-up|3|||
144500799|NCT02698241|521029792|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
144500800|NCT02698241|521029792|FG000|Overall Study|geographic and licensing issue|1|||
144720722|NCT03361423|521831324|FG000|Overall Study|Withdrawal by Subject|4|||
144720723|NCT03361423|521831325|FG001|Overall Study|Withdrawal by Subject|3|||
144720724|NCT03361423|521831324|FG000|Overall Study|Did not treat|19|||
144720725|NCT03361423|521831325|FG001|Overall Study|Did not treat|18|||
144720726|NCT03361423|521831324|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
144720727|NCT03361423|521831325|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
144720728|NCT03361423|521831324|FG000|Overall Study|Missing data|4|||
144720729|NCT03361423|521831325|FG001|Overall Study|Missing data|1|||
144720730|NCT01336894|521831326|FG000|Follow-up|Study terminated prematurely|2|||
144720731|NCT01336894|521831327|FG001|Follow-up|Study terminated prematurely|7|||
144720732|NCT05034731|521831328|FG000|Overall Study|Screen fail|1|||
144720733|NCT05034731|521831329|FG001|Overall Study|Screen fail|1|||
144720734|NCT00299156|521831332|FG000|Period 2 (Randomized)|Screen Failure|0|||
144720735|NCT00299156|521831333|FG001|Period 2 (Randomized)|Screen Failure|1|||
144720736|NCT00299156|521831334|FG002|Period 2 (Randomized)|Screen Failure|0|||
144720737|NCT01716754|521831335|FG000|Overall Study|Death|0|||
144500801|NCT02698241|521029792|FG000|Overall Study|Death|2|||
144720738|NCT01716754|521831336|FG001|Overall Study|Death|0|||
144720739|NCT01716754|521831337|FG002|Overall Study|Death|0|||
144720740|NCT01716754|521831338|FG003|Overall Study|Death|1|||
144720741|NCT01716754|521831335|FG000|Overall Study|Protocol deviation|0|||
144720742|NCT01716754|521831336|FG001|Overall Study|Protocol deviation|2|||
144720743|NCT01716754|521831337|FG002|Overall Study|Protocol deviation|7|||
144720744|NCT01716754|521831338|FG003|Overall Study|Protocol deviation|2|||
144500802|NCT00603447|521029793|FG000|Overall Study|Adverse Event|0|||
144500803|NCT00603447|521029794|FG001|Overall Study|Adverse Event|1|||
144720745|NCT01716754|521831335|FG000|Overall Study|Non-compliance with study treatment|0|||
144720746|NCT01716754|521831336|FG001|Overall Study|Non-compliance with study treatment|0|||
144720747|NCT01716754|521831337|FG002|Overall Study|Non-compliance with study treatment|1|||
144720748|NCT01716754|521831338|FG003|Overall Study|Non-compliance with study treatment|0|||
144720749|NCT01716754|521831335|FG000|Overall Study|Physician Decision|1|||
144720750|NCT01716754|521831336|FG001|Overall Study|Physician Decision|0|||
144720751|NCT01716754|521831337|FG002|Overall Study|Physician Decision|0|||
144720752|NCT01716754|521831338|FG003|Overall Study|Physician Decision|0|||
144720753|NCT01716754|521831335|FG000|Overall Study|Lost to Follow-up|1|||
144720754|NCT01716754|521831336|FG001|Overall Study|Lost to Follow-up|0|||
144720755|NCT01716754|521831337|FG002|Overall Study|Lost to Follow-up|0|||
144720756|NCT01716754|521831338|FG003|Overall Study|Lost to Follow-up|1|||
144720757|NCT01716754|521831335|FG000|Overall Study|Adverse Event|4|||
144720758|NCT01716754|521831336|FG001|Overall Study|Adverse Event|2|||
144720759|NCT01716754|521831337|FG002|Overall Study|Adverse Event|2|||
144720760|NCT01716754|521831338|FG003|Overall Study|Adverse Event|1|||
144720761|NCT01716754|521831335|FG000|Overall Study|Withdrawal by Subject|5|||
144720762|NCT01716754|521831336|FG001|Overall Study|Withdrawal by Subject|0|||
144720763|NCT01716754|521831337|FG002|Overall Study|Withdrawal by Subject|4|||
144720764|NCT01716754|521831338|FG003|Overall Study|Withdrawal by Subject|3|||
144720765|NCT04317781|521831339|FG000|Overall Study|Adverse Event|1|||
144720766|NCT04317781|521831339|FG000|Overall Study|Disease relapse|1|||
144720767|NCT04317781|521831339|FG000|Overall Study|Withdrawal by Subject|1|||
144720768|NCT02611752|521831362|FG000|Overall Study|Adverse Event|0|||
144720769|NCT02611752|521831363|FG001|Overall Study|Adverse Event|1|||
144720770|NCT02427607|521831366|FG000|Overall Study|Withdrawal by Subject|1|||
144720771|NCT02277769|521831367|FG000|Overall Study|Protocol Violation|3|||
144720772|NCT02277769|521831368|FG001|Overall Study|Protocol Violation|3|||
144720773|NCT02277769|521831369|FG002|Overall Study|Protocol Violation|5|||
144720774|NCT02277769|521831367|FG000|Overall Study|Lack of Efficacy|17|||
144720775|NCT02277769|521831368|FG001|Overall Study|Lack of Efficacy|0|||
144720776|NCT02277769|521831369|FG002|Overall Study|Lack of Efficacy|4|||
144720777|NCT02277769|521831367|FG000|Overall Study|Adverse Event|14|||
144720778|NCT02277769|521831368|FG001|Overall Study|Adverse Event|2|||
144720779|NCT02277769|521831369|FG002|Overall Study|Adverse Event|4|||
144720780|NCT02277769|521831367|FG000|Overall Study|Other than specified above|12|||
144720781|NCT02277769|521831368|FG001|Overall Study|Other than specified above|8|||
144720782|NCT02277769|521831369|FG002|Overall Study|Other than specified above|5|||
144720783|NCT01754259|521831372|FG000|Overall Study|Withdrawal by Subject|2|||
144720784|NCT01754259|521831373|FG001|Overall Study|Withdrawal by Subject|4|||
144720785|NCT01754259|521831372|FG000|Overall Study|Adverse Event|3|||
144720786|NCT01754259|521831373|FG001|Overall Study|Adverse Event|1|||
144720787|NCT01754259|521831372|FG000|Overall Study|Lost to Follow-up|0|||
144720788|NCT01754259|521831373|FG001|Overall Study|Lost to Follow-up|1|||
144720789|NCT01364870|521831378|FG000|Overall Study|Withdrawal by Subject|13|||
144720790|NCT01364870|521831379|FG001|Overall Study|Withdrawal by Subject|24|||
144720791|NCT01364870|521831380|FG002|Overall Study|Withdrawal by Subject|10|||
144720792|NCT01364870|521831378|FG000|Overall Study|Adverse Event|8|||
144720793|NCT01364870|521831379|FG001|Overall Study|Adverse Event|6|||
144720794|NCT01364870|521831380|FG002|Overall Study|Adverse Event|4|||
144720795|NCT01364870|521831378|FG000|Overall Study|Protocol Violation|1|||
144720796|NCT01364870|521831379|FG001|Overall Study|Protocol Violation|0|||
144720797|NCT01364870|521831380|FG002|Overall Study|Protocol Violation|0|||
144720798|NCT01326026|521831387|FG000|Overall Study|Adverse Event|4|||
144720799|NCT01326026|521831388|FG001|Overall Study|Adverse Event|3|||
144500804|NCT00603447|521029795|FG002|Overall Study|Adverse Event|1|||
144500805|NCT00603447|521029796|FG003|Overall Study|Adverse Event|2|||
144500806|NCT00603447|521029797|FG004|Overall Study|Adverse Event|1|||
144500807|NCT00603447|521029798|FG005|Overall Study|Adverse Event|2|||
144500808|NCT00603447|521029799|FG006|Overall Study|Adverse Event|10|||
144720800|NCT01326026|521831387|FG000|Overall Study|Withdrawal Criteria|5|||
144720801|NCT01326026|521831388|FG001|Overall Study|Withdrawal Criteria|7|||
144720802|NCT01326026|521831387|FG000|Overall Study|Other|3|||
144720803|NCT01326026|521831388|FG001|Overall Study|Other|3|||
144720804|NCT04317053|521831389|FG000|Overall Study|Withdrawn (screen failure)|4|||
144720805|NCT04317053|521831390|FG001|Overall Study|Withdrawn (screen failure)|2|||
144720806|NCT01073020|521833276|FG000|Overall Study|Withdrawal by Subject|6|||
144720807|NCT01073020|521833277|FG001|Overall Study|Withdrawal by Subject|4|||
144720808|NCT01073020|521833278|FG002|Overall Study|Withdrawal by Subject|1|||
144720809|NCT01073020|521833279|FG003|Overall Study|Withdrawal by Subject|2|||
144720810|NCT01073020|521833276|FG000|Overall Study|Physician Decision|1|||
144720811|NCT01073020|521833277|FG001|Overall Study|Physician Decision|0|||
144720812|NCT01073020|521833278|FG002|Overall Study|Physician Decision|2|||
144720813|NCT01073020|521833279|FG003|Overall Study|Physician Decision|0|||
144720814|NCT01073020|521833276|FG000|Overall Study|Death|0|||
144720815|NCT01073020|521833277|FG001|Overall Study|Death|1|||
144720816|NCT01073020|521833278|FG002|Overall Study|Death|0|||
144720817|NCT01073020|521833279|FG003|Overall Study|Death|0|||
144720818|NCT01644890|521833280|FG000|Overall Study|Adverse Event|7|||
144720819|NCT01644890|521833281|FG001|Overall Study|Adverse Event|20|||
144720820|NCT01644890|521833280|FG000|Overall Study|Death|1|||
144720821|NCT01644890|521833281|FG001|Overall Study|Death|3|||
144720822|NCT01644890|521833280|FG000|Overall Study|Physician Decision|3|||
144720823|NCT01644890|521833281|FG001|Overall Study|Physician Decision|9|||
144720824|NCT01644890|521833280|FG000|Overall Study|Protocol Violation|6|||
144720825|NCT01644890|521833281|FG001|Overall Study|Protocol Violation|7|||
144720826|NCT01644890|521833280|FG000|Overall Study|Withdrawal by Subject|19|||
144720827|NCT01644890|521833281|FG001|Overall Study|Withdrawal by Subject|27|||
144720828|NCT01644890|521833280|FG000|Overall Study|Progression Disease|160|||
144720829|NCT01644890|521833281|FG001|Overall Study|Progression Disease|131|||
144720830|NCT01644890|521833280|FG000|Overall Study|Clinical Progression|6|||
144720831|NCT01644890|521833281|FG001|Overall Study|Clinical Progression|6|||
144720832|NCT01644890|521833280|FG000|Overall Study|> 28 days since last dose of study drug|6|||
144720833|NCT01644890|521833281|FG001|Overall Study|> 28 days since last dose of study drug|3|||
144720834|NCT01644890|521833280|FG000|Overall Study|Other|8|||
144720835|NCT01644890|521833281|FG001|Overall Study|Other|9|||
144720836|NCT01060670|521833282|FG000|Run In|screen failure|0|||
144720837|NCT01060670|521833283|FG001|Run In|screen failure|238|||
144720838|NCT02761980|521833286|FG000|Overall Study|Adverse Event|4|||
144720839|NCT02761980|521833287|FG001|Overall Study|Adverse Event|6|||
144720840|NCT02761980|521833288|FG002|Overall Study|Adverse Event|5|||
144720841|NCT02761980|521833289|FG003|Overall Study|Adverse Event|6|||
144720842|NCT02761980|521833286|FG000|Overall Study|Withdrawal by Subject|0|||
144720843|NCT02761980|521833287|FG001|Overall Study|Withdrawal by Subject|1|||
144720844|NCT02761980|521833288|FG002|Overall Study|Withdrawal by Subject|0|||
144720845|NCT02761980|521833289|FG003|Overall Study|Withdrawal by Subject|0|||
144720846|NCT02761980|521833286|FG000|Overall Study|Other|0|||
144720847|NCT02761980|521833287|FG001|Overall Study|Other|0|||
144720848|NCT02761980|521833288|FG002|Overall Study|Other|1|||
144720849|NCT02761980|521833289|FG003|Overall Study|Other|0|||
144720850|NCT00056160|521833296|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
144720851|NCT00056160|521833297|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
144720852|NCT00056160|521833296|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
144720853|NCT00056160|521833297|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
144720854|NCT00056160|521833296|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
144720855|NCT00056160|521833297|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
144720856|NCT00056160|521833296|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
144720857|NCT00056160|521833297|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
144720858|NCT00056160|521833296|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
144720859|NCT00056160|521833297|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
144720860|NCT00056160|521833296|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
144720861|NCT00056160|521833297|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
144720862|NCT00056160|521833296|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
144500809|NCT00603447|521029793|FG000|Overall Study|Other|0|||
144500810|NCT00603447|521029794|FG001|Overall Study|Other|0|||
144500811|NCT00603447|521029795|FG002|Overall Study|Other|1|||
144500812|NCT00603447|521029796|FG003|Overall Study|Other|0|||
144500813|NCT00603447|521029797|FG004|Overall Study|Other|3|||
144500814|NCT00603447|521029798|FG005|Overall Study|Other|0|||
144500815|NCT00603447|521029799|FG006|Overall Study|Other|13|||
144500816|NCT00603447|521029793|FG000|Overall Study|Withdrew Consent|0|||
144500817|NCT00603447|521029794|FG001|Overall Study|Withdrew Consent|2|||
144500818|NCT00603447|521029795|FG002|Overall Study|Withdrew Consent|0|||
144500819|NCT00603447|521029796|FG003|Overall Study|Withdrew Consent|0|||
144500820|NCT00603447|521029797|FG004|Overall Study|Withdrew Consent|1|||
144500821|NCT00603447|521029798|FG005|Overall Study|Withdrew Consent|0|||
144500822|NCT00603447|521029799|FG006|Overall Study|Withdrew Consent|1|||
144500823|NCT00470626|521031169|FG000|Overall Study|Lost to Follow-up|10|||
144500824|NCT00470626|521031169|FG000|Overall Study|Withdrawal by Subject|7|||
144500825|NCT01833065|521031172|FG000|Overall Study|Adverse Event|6|||
144500826|NCT01833065|521031173|FG001|Overall Study|Adverse Event|1|||
144500827|NCT01833065|521031174|FG002|Overall Study|Adverse Event|0|||
144500828|NCT01833065|521031175|FG003|Overall Study|Adverse Event|2|||
144500829|NCT01833065|521031176|FG004|Overall Study|Adverse Event|3|||
144500830|NCT01833065|521031172|FG000|Overall Study|Protocol Violation|1|||
144500831|NCT01833065|521031173|FG001|Overall Study|Protocol Violation|0|||
144500832|NCT01833065|521031174|FG002|Overall Study|Protocol Violation|0|||
144500833|NCT01833065|521031175|FG003|Overall Study|Protocol Violation|0|||
144500834|NCT01833065|521031176|FG004|Overall Study|Protocol Violation|2|||
144500835|NCT01833065|521031172|FG000|Overall Study|Lost to Follow-up|1|||
144500836|NCT01833065|521031173|FG001|Overall Study|Lost to Follow-up|0|||
144500837|NCT01833065|521031174|FG002|Overall Study|Lost to Follow-up|0|||
144500838|NCT01833065|521031175|FG003|Overall Study|Lost to Follow-up|0|||
144500839|NCT01833065|521031176|FG004|Overall Study|Lost to Follow-up|3|||
144500840|NCT01833065|521031172|FG000|Overall Study|Withdrawal by Subject|6|||
144500841|NCT01833065|521031173|FG001|Overall Study|Withdrawal by Subject|2|||
144500842|NCT01833065|521031174|FG002|Overall Study|Withdrawal by Subject|4|||
144370086|NCT02379091|520562803|FG002|Overall Study|Lack of Efficacy|0|||
144500843|NCT01833065|521031175|FG003|Overall Study|Withdrawal by Subject|3|||
144500844|NCT01833065|521031176|FG004|Overall Study|Withdrawal by Subject|11|||
144500845|NCT01833065|521031172|FG000|Overall Study|Subject's substantial non-compliance|0|||
144500846|NCT01833065|521031173|FG001|Overall Study|Subject's substantial non-compliance|1|||
144500847|NCT01833065|521031174|FG002|Overall Study|Subject's substantial non-compliance|0|||
144500848|NCT01833065|521031175|FG003|Overall Study|Subject's substantial non-compliance|0|||
144500849|NCT01833065|521031176|FG004|Overall Study|Subject's substantial non-compliance|0|||
144500850|NCT01833065|521031172|FG000|Overall Study|Trial terminated by sponsor|8|||
144500851|NCT01833065|521031173|FG001|Overall Study|Trial terminated by sponsor|8|||
144500852|NCT01833065|521031174|FG002|Overall Study|Trial terminated by sponsor|7|||
144500853|NCT01833065|521031175|FG003|Overall Study|Trial terminated by sponsor|3|||
144500854|NCT01833065|521031176|FG004|Overall Study|Trial terminated by sponsor|13|||
144500855|NCT01833065|521031172|FG000|Overall Study|Others|2|||
144500856|NCT01833065|521031173|FG001|Overall Study|Others|1|||
144500857|NCT01833065|521031174|FG002|Overall Study|Others|1|||
144500858|NCT01833065|521031175|FG003|Overall Study|Others|1|||
144500859|NCT01833065|521031176|FG004|Overall Study|Others|4|||
144500860|NCT00543725|521031177|FG000|Overall Study|Adverse Event|18|||
144500861|NCT00543725|521031178|FG001|Overall Study|Adverse Event|27|||
144720863|NCT00056160|521833297|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
144720864|NCT00056160|521833296|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
144720865|NCT00056160|521833297|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
144720866|NCT00056160|521833296|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
144720867|NCT00056160|521833297|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
144720868|NCT00056160|521833296|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
144720869|NCT00056160|521833297|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
144720870|NCT00056160|521833296|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
144720871|NCT00056160|521833297|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
144720872|NCT00056160|521833296|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
144720873|NCT00056160|521833297|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
144720874|NCT00056160|521833296|FG000|Final Follow-up|Transferred into expanded access study.|3|||
144720875|NCT00056160|521833297|FG001|Final Follow-up|Transferred into expanded access study.|0|||
144720876|NCT00056160|521833296|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
144720877|NCT00056160|521833297|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
144720878|NCT00056160|521833296|FG000|Final Follow-up|Adverse Event|1|||
144720879|NCT00056160|521833297|FG001|Final Follow-up|Adverse Event|0|||
144720880|NCT02742090|521833299|FG000|Overall Study|Adverse Event|10|||
144720881|NCT02742090|521833299|FG000|Overall Study|Death|3|||
144720882|NCT02742090|521833299|FG000|Overall Study|Disease Progression|25|||
144720883|NCT02742090|521833299|FG000|Overall Study|Investigator's Decision|1|||
144720884|NCT02742090|521833299|FG000|Overall Study|Lost to Follow-up|1|||
144720885|NCT02742090|521833299|FG000|Overall Study|Non-compliance with Study|1|||
144720886|NCT02742090|521833299|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
144720887|NCT02742090|521833299|FG000|Overall Study|Withdrawal by Subject|4|||
144720888|NCT02742090|521833299|FG000|Overall Study|Reason Not Specified|1|||
144720889|NCT01767597|521833300|FG000|Overall Study|Incomplete intervention|3|||
144720890|NCT01767597|521833301|FG001|Overall Study|Incomplete intervention|1|||
144720891|NCT01767597|521833300|FG000|Overall Study|Withdrawal by Subject|1|||
144720892|NCT01767597|521833301|FG001|Overall Study|Withdrawal by Subject|0|||
144720893|NCT03355742|521833302|FG000|Overall Study|Lost to Follow-up|4|||
144720894|NCT03355742|521833302|FG000|Overall Study|Withdrawal by Subject|29|||
144720895|NCT03355742|521833302|FG000|Overall Study|Physician Decision|6|||
144720896|NCT03355742|521833302|FG000|Overall Study|Death|55|||
144720897|NCT03355742|521833302|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
144720898|NCT00836927|521833303|FG000|Overall Study|Progressive disease|2|||
144720899|NCT00836927|521833304|FG001|Overall Study|Progressive disease|0|||
144720900|NCT00836927|521833305|FG002|Overall Study|Progressive disease|0|||
144720901|NCT00836927|521833306|FG003|Overall Study|Progressive disease|1|||
144720902|NCT00836927|521833307|FG004|Overall Study|Progressive disease|1|||
144720903|NCT00836927|521833303|FG000|Overall Study|Withdrawal by Subject|1|||
144720904|NCT00836927|521833304|FG001|Overall Study|Withdrawal by Subject|0|||
144720905|NCT00836927|521833305|FG002|Overall Study|Withdrawal by Subject|0|||
144720906|NCT00836927|521833306|FG003|Overall Study|Withdrawal by Subject|0|||
144720907|NCT00836927|521833307|FG004|Overall Study|Withdrawal by Subject|0|||
144720908|NCT00614055|521833313|FG000|Overall Study|Adverse Event|1|||
144720909|NCT00614055|521833314|FG001|Overall Study|Adverse Event|0|||
144720910|NCT00614055|521833315|FG002|Overall Study|Adverse Event|0|||
144720911|NCT00614055|521833313|FG000|Overall Study|Protocol Violation|2|||
144720912|NCT00614055|521833314|FG001|Overall Study|Protocol Violation|2|||
144720913|NCT00614055|521833315|FG002|Overall Study|Protocol Violation|1|||
144720914|NCT00614055|521833313|FG000|Overall Study|Lack of Efficacy|0|||
144720915|NCT00614055|521833314|FG001|Overall Study|Lack of Efficacy|0|||
144720916|NCT00614055|521833315|FG002|Overall Study|Lack of Efficacy|2|||
144720917|NCT00614055|521833313|FG000|Overall Study|Unclassified|1|||
144720918|NCT00614055|521833314|FG001|Overall Study|Unclassified|4|||
144720919|NCT00614055|521833315|FG002|Overall Study|Unclassified|2|||
144720920|NCT00449072|521833316|FG000|Overall Study|Adverse Event|3|||
144720921|NCT00449072|521833317|FG001|Overall Study|Adverse Event|1|||
144720922|NCT00449072|521833316|FG000|Overall Study|Protocol Violation|14|||
144720923|NCT00449072|521833317|FG001|Overall Study|Protocol Violation|12|||
144720924|NCT00449072|521833316|FG000|Overall Study|Lost to Follow-up|5|||
144720925|NCT00449072|521833317|FG001|Overall Study|Lost to Follow-up|7|||
144720926|NCT00449072|521833316|FG000|Overall Study|Withdrawal by Subject|11|||
144720927|NCT00449072|521833317|FG001|Overall Study|Withdrawal by Subject|8|||
144720928|NCT00449072|521833316|FG000|Overall Study|Lack of Efficacy|1|||
144720929|NCT00449072|521833317|FG001|Overall Study|Lack of Efficacy|1|||
144720930|NCT00449072|521833316|FG000|Overall Study|Physician Decision|1|||
144720931|NCT00449072|521833317|FG001|Overall Study|Physician Decision|0|||
144720932|NCT00449072|521833316|FG000|Overall Study|Not treated|0|||
144720933|NCT00449072|521833317|FG001|Overall Study|Not treated|1|||
144720934|NCT00449072|521833316|FG000|Overall Study|Excluded medication|0|||
144720935|NCT00449072|521833317|FG001|Overall Study|Excluded medication|2|||
144720936|NCT00449072|521833316|FG000|Overall Study|Non-compliance|2|||
144720937|NCT00449072|521833317|FG001|Overall Study|Non-compliance|5|||
144720938|NCT00449072|521833316|FG000|Overall Study|Sponsor decision|1|||
144370087|NCT02379091|520562804|FG003|Overall Study|Lack of Efficacy|0|||
144500862|NCT00543725|521031177|FG000|Overall Study|Sponsor's Decision|0|||
144720939|NCT00449072|521833317|FG001|Overall Study|Sponsor decision|3|||
144720940|NCT00449072|521833316|FG000|Overall Study|Relocation|3|||
144720941|NCT00449072|521833317|FG001|Overall Study|Relocation|2|||
144720942|NCT00989261|521833318|FG000|Overall Study|Still in follow up|12|||
144720943|NCT00989261|521833319|FG001|Overall Study|Still in follow up|21|||
144720944|NCT00989261|521833318|FG000|Overall Study|Withdrawal by Subject|0|||
144720945|NCT00989261|521833319|FG001|Overall Study|Withdrawal by Subject|1|||
144720946|NCT00989261|521833318|FG000|Overall Study|Lost to Follow-up|3|||
144720947|NCT00989261|521833319|FG001|Overall Study|Lost to Follow-up|0|||
144720948|NCT02398188|521833320|FG000|Overall Study|Adverse Event|2|||
144720949|NCT02398188|521833321|FG001|Overall Study|Adverse Event|3|||
144720950|NCT02398188|521833320|FG000|Overall Study|Lost to Follow-up|5|||
144720951|NCT02398188|521833321|FG001|Overall Study|Lost to Follow-up|0|||
144720952|NCT02398188|521833320|FG000|Overall Study|Non-compliance|4|||
144720953|NCT02398188|521833321|FG001|Overall Study|Non-compliance|4|||
144720954|NCT02398188|521833320|FG000|Overall Study|Protocol Violation|6|||
144720955|NCT02398188|521833321|FG001|Overall Study|Protocol Violation|10|||
144720956|NCT02398188|521833320|FG000|Overall Study|Sponsor Decision|2|||
144720957|NCT02398188|521833321|FG001|Overall Study|Sponsor Decision|1|||
144720958|NCT02398188|521833320|FG000|Overall Study|Pregnancy|1|||
144720959|NCT02398188|521833321|FG001|Overall Study|Pregnancy|0|||
144720960|NCT02398188|521833320|FG000|Overall Study|Withdrawal by Subject|7|||
144720961|NCT02398188|521833321|FG001|Overall Study|Withdrawal by Subject|16|||
144720962|NCT03209570|521833322|FG000|Overall Study|Death|1|||
144720963|NCT03209570|521833323|FG001|Overall Study|Death|0|||
144720964|NCT03209570|521833322|FG000|Overall Study|Incomplete Data|8|||
144720965|NCT03209570|521833323|FG001|Overall Study|Incomplete Data|10|||
144720966|NCT03209570|521833322|FG000|Overall Study|Protocol Violation|1|||
144720967|NCT03209570|521833323|FG001|Overall Study|Protocol Violation|0|||
144720968|NCT03209570|521833322|FG000|Overall Study|Withdrawal by Subject|0|||
144720969|NCT03209570|521833323|FG001|Overall Study|Withdrawal by Subject|3|||
144720970|NCT00220701|521833324|FG000|Overall Study|Lost to Follow-up|5|||
144720971|NCT00220701|521833325|FG001|Overall Study|Lost to Follow-up|4|||
144720972|NCT01338636|521833330|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
144720973|NCT02385526|521833331|FG000|Overall Study|Withdrawal by Subject|0|||
144720974|NCT02385526|521833332|FG001|Overall Study|Withdrawal by Subject|2|||
144720975|NCT02385526|521833333|FG002|Overall Study|Withdrawal by Subject|0|||
144720976|NCT02385526|521833331|FG000|Overall Study|Lost to Follow-up|0|||
144720977|NCT02385526|521833332|FG001|Overall Study|Lost to Follow-up|1|||
144720978|NCT02385526|521833333|FG002|Overall Study|Lost to Follow-up|0|||
144720979|NCT02385526|521833331|FG000|Overall Study|Physician Decision|1|||
144720980|NCT02385526|521833332|FG001|Overall Study|Physician Decision|0|||
144720981|NCT02385526|521833333|FG002|Overall Study|Physician Decision|0|||
144720982|NCT02385526|521833331|FG000|Overall Study|Protocol Violation|1|||
144720983|NCT02385526|521833332|FG001|Overall Study|Protocol Violation|0|||
144720984|NCT02385526|521833333|FG002|Overall Study|Protocol Violation|0|||
144720985|NCT03532009|521833336|FG000|Overall Study|Other|1|||
144720986|NCT03532009|521833337|FG001|Overall Study|Other|1|||
144720987|NCT03532009|521833336|FG000|Overall Study|Death|1|||
144720988|NCT03532009|521833337|FG001|Overall Study|Death|1|||
144720989|NCT03532009|521833336|FG000|Overall Study|Withdrawal by Patient|0|||
144720990|NCT03532009|521833337|FG001|Overall Study|Withdrawal by Patient|2|||
144720991|NCT01694485|521833338|FG000|Overall Study|Withdrawal by Subject|20|||
144720992|NCT01694485|521833339|FG001|Overall Study|Withdrawal by Subject|6|||
144720993|NCT01694485|521833340|FG002|Overall Study|Withdrawal by Subject|7|||
144720994|NCT01694485|521833341|FG003|Overall Study|Withdrawal by Subject|25|||
144720995|NCT01694485|521833342|FG004|Overall Study|Withdrawal by Subject|18|||
144720996|NCT01694485|521833338|FG000|Overall Study|Sponsor Decision|3|||
144720997|NCT01694485|521833339|FG001|Overall Study|Sponsor Decision|0|||
144720998|NCT01694485|521833340|FG002|Overall Study|Sponsor Decision|0|||
144720999|NCT01694485|521833341|FG003|Overall Study|Sponsor Decision|2|||
144721000|NCT01694485|521833342|FG004|Overall Study|Sponsor Decision|0|||
144721001|NCT01694485|521833338|FG000|Overall Study|Lost to Follow-up|9|||
144721002|NCT01694485|521833339|FG001|Overall Study|Lost to Follow-up|1|||
144721003|NCT01694485|521833340|FG002|Overall Study|Lost to Follow-up|6|||
144721004|NCT01694485|521833341|FG003|Overall Study|Lost to Follow-up|10|||
144721005|NCT01694485|521833342|FG004|Overall Study|Lost to Follow-up|7|||
144721006|NCT01694485|521833338|FG000|Overall Study|Death|1|||
144721007|NCT01694485|521833339|FG001|Overall Study|Death|0|||
144721008|NCT01694485|521833340|FG002|Overall Study|Death|0|||
144721009|NCT01694485|521833341|FG003|Overall Study|Death|1|||
144721010|NCT01694485|521833342|FG004|Overall Study|Death|0|||
144721011|NCT02907203|521833343|FG000|Overall Study|Death|1|||
144370088|NCT02129699|520562806|FG000|Overall Study|Did not start treatment|3|||
144721012|NCT02907203|521833343|FG000|Overall Study|Lost to Follow-up|3|||
144721013|NCT02907203|521833343|FG000|Overall Study|Withdrawal by Subject|3|||
144721014|NCT02907203|521833343|FG000|Overall Study|Surgical bypass|1|||
144721015|NCT00681863|521833345|FG000|Overall Study|Adverse Event|1|||
144721016|NCT00681863|521833345|FG000|Overall Study|Lost to Follow-up|2|||
144721017|NCT00681863|521833345|FG000|Overall Study|Lack of Efficacy|2|||
144721018|NCT00681863|521833345|FG000|Overall Study|Other|18|||
144721019|NCT00384033|521833355|FG000|Overall Study|Adverse Event|10|||
144721020|NCT00384033|521833356|FG001|Overall Study|Adverse Event|8|||
144721021|NCT00384033|521833357|FG002|Overall Study|Adverse Event|11|||
144721022|NCT00384033|521833358|FG003|Overall Study|Adverse Event|20|||
144721023|NCT00384033|521833355|FG000|Overall Study|Failed to return|1|||
144721024|NCT00384033|521833356|FG001|Overall Study|Failed to return|3|||
144721025|NCT00384033|521833357|FG002|Overall Study|Failed to return|2|||
144721026|NCT00384033|521833358|FG003|Overall Study|Failed to return|2|||
144721027|NCT00384033|521833355|FG000|Overall Study|Physician Decision|1|||
144721028|NCT00384033|521833356|FG001|Overall Study|Physician Decision|0|||
144721029|NCT00384033|521833357|FG002|Overall Study|Physician Decision|0|||
144721030|NCT00384033|521833358|FG003|Overall Study|Physician Decision|0|||
144721031|NCT00384033|521833355|FG000|Overall Study|Lost to Follow-up|6|||
144721032|NCT00384033|521833356|FG001|Overall Study|Lost to Follow-up|12|||
144721033|NCT00384033|521833357|FG002|Overall Study|Lost to Follow-up|7|||
144721034|NCT00384033|521833358|FG003|Overall Study|Lost to Follow-up|7|||
144721035|NCT00384033|521833355|FG000|Overall Study|Other|2|||
144721036|NCT00384033|521833356|FG001|Overall Study|Other|0|||
144721037|NCT00384033|521833357|FG002|Overall Study|Other|0|||
144721038|NCT00384033|521833358|FG003|Overall Study|Other|0|||
144721039|NCT00384033|521833355|FG000|Overall Study|Protocol Violation|5|||
144721040|NCT00384033|521833356|FG001|Overall Study|Protocol Violation|0|||
144721041|NCT00384033|521833357|FG002|Overall Study|Protocol Violation|5|||
144721042|NCT00384033|521833358|FG003|Overall Study|Protocol Violation|6|||
144721043|NCT00384033|521833355|FG000|Overall Study|Withdrawal by Subject|6|||
144721044|NCT00384033|521833356|FG001|Overall Study|Withdrawal by Subject|2|||
144721045|NCT00384033|521833357|FG002|Overall Study|Withdrawal by Subject|5|||
144721046|NCT00384033|521833358|FG003|Overall Study|Withdrawal by Subject|2|||
144721047|NCT00384033|521833355|FG000|Overall Study|Lack of Efficacy|7|||
144721048|NCT00384033|521833356|FG001|Overall Study|Lack of Efficacy|3|||
144721049|NCT00384033|521833357|FG002|Overall Study|Lack of Efficacy|3|||
144721050|NCT00384033|521833358|FG003|Overall Study|Lack of Efficacy|1|||
144721051|NCT00384033|521833355|FG000|Overall Study|Randomized but not treated|3|||
144721052|NCT00384033|521833356|FG001|Overall Study|Randomized but not treated|7|||
144721053|NCT00384033|521833357|FG002|Overall Study|Randomized but not treated|10|||
144721054|NCT00384033|521833358|FG003|Overall Study|Randomized but not treated|2|||
144721055|NCT01006707|521833359|FG000|Study Session 1|Lost to Follow-up|2|||
144721056|NCT01006707|521833360|FG001|Study Session 1|Lost to Follow-up|0|||
144500863|NCT00543725|521031178|FG001|Overall Study|Sponsor's Decision|1|||
144500864|NCT00543725|521031177|FG000|Overall Study|Subject Non-Compliant|4|||
144500865|NCT00543725|521031178|FG001|Overall Study|Subject Non-Compliant|4|||
144500866|NCT00543725|521031177|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
144500867|NCT00543725|521031178|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
144721057|NCT01006707|521833361|FG002|Study Session 1|Lost to Follow-up|0|||
144721058|NCT01006707|521833359|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
144721059|NCT01006707|521833360|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
144721060|NCT01006707|521833361|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
144721061|NCT00760383|521833362|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
144721062|NCT00760383|521833363|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
144721063|NCT03465891|521833365|FG000|Overall Study|Withdrawal by Subject|0|||
144721064|NCT03465891|521833366|FG001|Overall Study|Withdrawal by Subject|1|||
144721065|NCT03465891|521833365|FG000|Overall Study|Disease progression|1|||
144721066|NCT03465891|521833366|FG001|Overall Study|Disease progression|0|||
144721067|NCT02737306|521833368|FG000|Overall Study|Adverse Event|3|||
144721068|NCT02737306|521833369|FG001|Overall Study|Adverse Event|0|||
144721069|NCT02737306|521833368|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
144721070|NCT02737306|521833369|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
144721071|NCT01725451|521833370|FG000|Period 1|Withdrawal by Subject|1|||
144721072|NCT01725451|521833371|FG001|Period 1|Withdrawal by Subject|0|||
144721073|NCT01725451|521833372|FG002|Period 1|Withdrawal by Subject|0|||
144721074|NCT01725451|521833373|FG003|Period 1|Withdrawal by Subject|0|||
144721075|NCT01725451|521833370|FG000|Washout From Period 3|Protocol Violation|0|||
144721076|NCT01725451|521833371|FG001|Washout From Period 3|Protocol Violation|0|||
144721077|NCT01725451|521833372|FG002|Washout From Period 3|Protocol Violation|1|||
144721078|NCT01725451|521833373|FG003|Washout From Period 3|Protocol Violation|0|||
144721079|NCT01725451|521833370|FG000|Washout From Period 3|Adverse Event|0|||
144721080|NCT01725451|521833371|FG001|Washout From Period 3|Adverse Event|1|||
144721081|NCT01725451|521833372|FG002|Washout From Period 3|Adverse Event|0|||
144721082|NCT01725451|521833373|FG003|Washout From Period 3|Adverse Event|0|||
144721083|NCT01725451|521833370|FG000|Period 4|Adverse Event|0|||
144721084|NCT01725451|521833371|FG001|Period 4|Adverse Event|0|||
144721085|NCT01725451|521833372|FG002|Period 4|Adverse Event|1|||
144721086|NCT01725451|521833373|FG003|Period 4|Adverse Event|0|||
144721087|NCT00283686|521833379|FG000|Overall Study|Death|1|||
144721088|NCT00283686|521833380|FG001|Overall Study|Death|1|||
144721089|NCT00283686|521833381|FG002|Overall Study|Death|1|||
144721090|NCT00283686|521833382|FG003|Overall Study|Death|0|||
144721091|NCT00283686|521833379|FG000|Overall Study|Lost to Follow-up|21|||
144721092|NCT00283686|521833380|FG001|Overall Study|Lost to Follow-up|31|||
144721093|NCT00283686|521833381|FG002|Overall Study|Lost to Follow-up|26|||
144721094|NCT00283686|521833382|FG003|Overall Study|Lost to Follow-up|20|||
144721095|NCT00283686|521833379|FG000|Overall Study|Less than full participation|7|||
144721096|NCT00283686|521833380|FG001|Overall Study|Less than full participation|9|||
144721097|NCT00283686|521833381|FG002|Overall Study|Less than full participation|6|||
144721098|NCT00283686|521833382|FG003|Overall Study|Less than full participation|12|||
144721099|NCT01076166|521833383|FG000|Overall Study|Adverse Event|3|||
144721100|NCT01076166|521833383|FG000|Overall Study|Symptoms improved/resolved|6|||
144721101|NCT00481247|521833384|FG000|Overall Study|Death|0|||
144721102|NCT00481247|521833385|FG001|Overall Study|Death|1|||
144721103|NCT00481247|521833384|FG000|Overall Study|Disease progression|18|||
144721104|NCT00481247|521833385|FG001|Overall Study|Disease progression|22|||
144721105|NCT00481247|521833384|FG000|Overall Study|Intolerance|42|||
144721106|NCT00481247|521833385|FG001|Overall Study|Intolerance|17|||
144721107|NCT00481247|521833384|FG000|Overall Study|Treatment failure|10|||
144721108|NCT00481247|521833385|FG001|Overall Study|Treatment failure|14|||
144721109|NCT00481247|521833384|FG000|Overall Study|AE unrelated to study drug|13|||
144721110|NCT00481247|521833385|FG001|Overall Study|AE unrelated to study drug|4|||
144721111|NCT00481247|521833384|FG000|Overall Study|Withdrawal by Subject|8|||
144721112|NCT00481247|521833385|FG001|Overall Study|Withdrawal by Subject|13|||
144721113|NCT00481247|521833384|FG000|Overall Study|Pregnancy|2|||
144721114|NCT00481247|521833385|FG001|Overall Study|Pregnancy|1|||
144721115|NCT00481247|521833384|FG000|Overall Study|Lost to Follow-up|1|||
144721116|NCT00481247|521833385|FG001|Overall Study|Lost to Follow-up|2|||
144721117|NCT00481247|521833384|FG000|Overall Study|Poor compliance/noncompliance|1|||
144721118|NCT00481247|521833385|FG001|Overall Study|Poor compliance/noncompliance|7|||
144721119|NCT00481247|521833384|FG000|Overall Study|Administrative reason by sponsor|157|||
144721120|NCT00481247|521833385|FG001|Overall Study|Administrative reason by sponsor|162|||
144721121|NCT00481247|521833384|FG000|Overall Study|Varied|6|||
144721122|NCT00481247|521833385|FG001|Overall Study|Varied|15|||
144721123|NCT00481247|521833384|FG000|Overall Study|Did not receive treatment|1|||
144721124|NCT00481247|521833385|FG001|Overall Study|Did not receive treatment|2|||
144721125|NCT02649231|521833388|FG000|Overall Study|Adverse Event|0|||
144721126|NCT02649231|521833389|FG001|Overall Study|Adverse Event|0|||
144721127|NCT02649231|521833390|FG002|Overall Study|Adverse Event|0|||
144721128|NCT02649231|521833391|FG003|Overall Study|Adverse Event|1|||
144721129|NCT02649231|521833388|FG000|Overall Study|Lost to Follow-up|2|||
144721130|NCT02649231|521833389|FG001|Overall Study|Lost to Follow-up|1|||
144721131|NCT02649231|521833390|FG002|Overall Study|Lost to Follow-up|1|||
144199251|NCT02935686|519928863|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
144500868|NCT00543725|521031177|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
144500869|NCT00543725|521031178|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
144500870|NCT00543725|521031177|FG000|Overall Study|Protocol Violation|0|||
144500871|NCT00543725|521031178|FG001|Overall Study|Protocol Violation|1|||
144500872|NCT00543725|521031177|FG000|Overall Study|Withdrawal by Subject|4|||
144500873|NCT00543725|521031178|FG001|Overall Study|Withdrawal by Subject|13|||
144500874|NCT00543725|521031177|FG000|Overall Study|Lost to Follow-up|15|||
144500875|NCT00543725|521031178|FG001|Overall Study|Lost to Follow-up|11|||
144500876|NCT00543725|521031177|FG000|Overall Study|Other|3|||
144500877|NCT00543725|521031178|FG001|Overall Study|Other|3|||
144500878|NCT00975806|521031180|FG000|Overall Study|Adverse Event|2|||
144500879|NCT00975806|521031181|FG001|Overall Study|Adverse Event|1|||
144500880|NCT00975806|521031182|FG002|Overall Study|Adverse Event|2|||
144500881|NCT00975806|521031180|FG000|Overall Study|Disease Progression|1|||
144500882|NCT00975806|521031181|FG001|Overall Study|Disease Progression|5|||
144500883|NCT00975806|521031182|FG002|Overall Study|Disease Progression|1|||
144500884|NCT00975806|521031180|FG000|Overall Study|Withdrawal by Subject|1|||
144500885|NCT00975806|521031181|FG001|Overall Study|Withdrawal by Subject|0|||
144500886|NCT00975806|521031182|FG002|Overall Study|Withdrawal by Subject|0|||
144500887|NCT00975806|521031180|FG000|Overall Study|Death|0|||
144500888|NCT00975806|521031181|FG001|Overall Study|Death|1|||
144500889|NCT00975806|521031182|FG002|Overall Study|Death|0|||
144500890|NCT00975806|521031180|FG000|Overall Study|Physician decision and disease related|1|||
144500891|NCT00975806|521031181|FG001|Overall Study|Physician decision and disease related|0|||
144500892|NCT00975806|521031182|FG002|Overall Study|Physician decision and disease related|1|||
144500893|NCT02377362|521031183|FG000|Part A Second Treatment|Protocol Violation|0|||
144500894|NCT02377362|521031184|FG001|Part A Second Treatment|Protocol Violation|0|||
144500895|NCT02377362|521031185|FG002|Part A Second Treatment|Protocol Violation|0|||
144500896|NCT02377362|521031186|FG003|Part A Second Treatment|Protocol Violation|0|||
144500897|NCT02377362|521031187|FG004|Part A Second Treatment|Protocol Violation|1|||
144500898|NCT02377362|521031188|FG005|Part A Second Treatment|Protocol Violation|0|||
144500899|NCT02377362|521031189|FG006|Part A Second Treatment|Protocol Violation|0|||
144500900|NCT02377362|521031190|FG007|Part A Second Treatment|Protocol Violation|0|||
144500901|NCT02377362|521031191|FG008|Part A Second Treatment|Protocol Violation|0|||
144500902|NCT02377362|521031192|FG009|Part A Second Treatment|Protocol Violation|0|||
144500903|NCT02377362|521031193|FG010|Part A Second Treatment|Protocol Violation|0|||
144500904|NCT02377362|521031194|FG011|Part A Second Treatment|Protocol Violation|0|||
144500905|NCT02377362|521031195|FG012|Part A Second Treatment|Protocol Violation|0|||
144500906|NCT02377362|521031183|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500907|NCT02377362|521031184|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500908|NCT02377362|521031185|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500909|NCT02377362|521031186|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
144500910|NCT02377362|521031187|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
144500911|NCT02377362|521031188|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
144500912|NCT02377362|521031189|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500913|NCT02377362|521031190|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500914|NCT02377362|521031191|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500915|NCT02377362|521031192|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500916|NCT02377362|521031193|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500917|NCT02377362|521031194|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500918|NCT02377362|521031195|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
144500919|NCT02377362|521031183|FG000|Part B Overall|Protocol Violation|0|||
144500920|NCT02377362|521031184|FG001|Part B Overall|Protocol Violation|0|||
144500921|NCT02377362|521031185|FG002|Part B Overall|Protocol Violation|0|||
144500922|NCT02377362|521031186|FG003|Part B Overall|Protocol Violation|0|||
144500923|NCT02377362|521031187|FG004|Part B Overall|Protocol Violation|0|||
144500924|NCT02377362|521031188|FG005|Part B Overall|Protocol Violation|0|||
144500925|NCT02377362|521031189|FG006|Part B Overall|Protocol Violation|0|||
144500926|NCT02377362|521031190|FG007|Part B Overall|Protocol Violation|0|||
144500927|NCT02377362|521031191|FG008|Part B Overall|Protocol Violation|0|||
144500928|NCT02377362|521031192|FG009|Part B Overall|Protocol Violation|1|||
144500929|NCT02377362|521031193|FG010|Part B Overall|Protocol Violation|0|||
144500930|NCT02377362|521031194|FG011|Part B Overall|Protocol Violation|0|||
144500931|NCT02377362|521031195|FG012|Part B Overall|Protocol Violation|0|||
144500932|NCT02377362|521031183|FG000|Part B Overall|Adverse Event|0|||
144500933|NCT02377362|521031184|FG001|Part B Overall|Adverse Event|0|||
144500934|NCT02377362|521031185|FG002|Part B Overall|Adverse Event|0|||
144500935|NCT02377362|521031186|FG003|Part B Overall|Adverse Event|0|||
144500936|NCT02377362|521031187|FG004|Part B Overall|Adverse Event|0|||
144500937|NCT02377362|521031188|FG005|Part B Overall|Adverse Event|0|||
144500938|NCT02377362|521031189|FG006|Part B Overall|Adverse Event|1|||
144500939|NCT02377362|521031190|FG007|Part B Overall|Adverse Event|1|||
144500940|NCT02377362|521031191|FG008|Part B Overall|Adverse Event|0|||
144500941|NCT02377362|521031192|FG009|Part B Overall|Adverse Event|0|||
144500942|NCT02377362|521031193|FG010|Part B Overall|Adverse Event|0|||
144500943|NCT02377362|521031194|FG011|Part B Overall|Adverse Event|0|||
144500944|NCT02377362|521031195|FG012|Part B Overall|Adverse Event|0|||
144500945|NCT02377362|521031183|FG000|Part B Overall|Withdrawal by Subject|0|||
144500946|NCT02377362|521031184|FG001|Part B Overall|Withdrawal by Subject|0|||
144500947|NCT02377362|521031185|FG002|Part B Overall|Withdrawal by Subject|0|||
144500948|NCT02377362|521031186|FG003|Part B Overall|Withdrawal by Subject|0|||
144500949|NCT02377362|521031187|FG004|Part B Overall|Withdrawal by Subject|0|||
144500950|NCT02377362|521031188|FG005|Part B Overall|Withdrawal by Subject|0|||
144500951|NCT02377362|521031189|FG006|Part B Overall|Withdrawal by Subject|1|||
144500952|NCT02377362|521031190|FG007|Part B Overall|Withdrawal by Subject|0|||
144500953|NCT02377362|521031191|FG008|Part B Overall|Withdrawal by Subject|0|||
144500954|NCT02377362|521031192|FG009|Part B Overall|Withdrawal by Subject|0|||
144500955|NCT02377362|521031193|FG010|Part B Overall|Withdrawal by Subject|0|||
144500956|NCT02377362|521031194|FG011|Part B Overall|Withdrawal by Subject|1|||
144500957|NCT02377362|521031195|FG012|Part B Overall|Withdrawal by Subject|0|||
144500958|NCT04889664|521031196|FG000|Screen|Lost to Follow-up|1|||
144500959|NCT04889664|521031196|FG000|Screen|Failed to meet screening criteria|1|||
144500960|NCT04889664|521031196|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
144500961|NCT00404079|521031206|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
144500962|NCT00404079|521031207|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
144500963|NCT01120275|521031208|FG000|Overall Study|Adverse Event|3|||
144500964|NCT01120275|521031208|FG000|Overall Study|Progression|27|||
144500965|NCT01120275|521031208|FG000|Overall Study|Ineligible|3|||
144500966|NCT01120275|521031208|FG000|Overall Study|Withdrawal by Subject|1|||
144500967|NCT01120275|521031208|FG000|Overall Study|Refusal|1|||
144500968|NCT01120275|521031208|FG000|Overall Study|Not specific|1|||
144500969|NCT02736799|521031214|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
144500970|NCT02736799|521031215|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
144500971|NCT02736799|521031216|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
144500972|NCT02736799|521031217|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
144500973|NCT00197015|521031218|FG000|Overall Study|Adverse Event|3|||
144500974|NCT00197015|521031219|FG001|Overall Study|Adverse Event|0|||
144500975|NCT00197015|521031220|FG002|Overall Study|Adverse Event|1|||
144500976|NCT00197015|521031218|FG000|Overall Study|Protocol Violation|0|||
144500977|NCT00197015|521031219|FG001|Overall Study|Protocol Violation|3|||
144500978|NCT00197015|521031220|FG002|Overall Study|Protocol Violation|3|||
144500979|NCT00197015|521031218|FG000|Overall Study|Withdrawal by Subject|17|||
144500980|NCT00197015|521031219|FG001|Overall Study|Withdrawal by Subject|37|||
144500981|NCT00197015|521031220|FG002|Overall Study|Withdrawal by Subject|34|||
144500982|NCT00197015|521031218|FG000|Overall Study|Lost to Follow-up|28|||
144500983|NCT00197015|521031219|FG001|Overall Study|Lost to Follow-up|46|||
144500984|NCT00197015|521031220|FG002|Overall Study|Lost to Follow-up|37|||
144500985|NCT00197015|521031218|FG000|Overall Study|Other|2|||
144500986|NCT00197015|521031219|FG001|Overall Study|Other|3|||
144500987|NCT00197015|521031220|FG002|Overall Study|Other|2|||
144500988|NCT04511650|521031223|FG000|Overall Study|Lost to Follow-up|1|||
144500989|NCT04511650|521031224|FG001|Overall Study|Lost to Follow-up|0|||
144500990|NCT04511650|521031225|FG002|Overall Study|Lost to Follow-up|0|||
144500991|NCT04511650|521031223|FG000|Overall Study|Withdrawal by Subject|1|||
144500992|NCT04511650|521031224|FG001|Overall Study|Withdrawal by Subject|0|||
144500993|NCT04511650|521031225|FG002|Overall Study|Withdrawal by Subject|0|||
144500994|NCT04511650|521031223|FG000|Overall Study|reason not provided|0|||
144500995|NCT04511650|521031224|FG001|Overall Study|reason not provided|0|||
144500996|NCT04511650|521031225|FG002|Overall Study|reason not provided|1|||
144500997|NCT04511650|521031223|FG000|Overall Study|Death|1|||
144500998|NCT04511650|521031224|FG001|Overall Study|Death|1|||
144500999|NCT04511650|521031225|FG002|Overall Study|Death|1|||
144501000|NCT01972152|521031228|FG000|First Treatment Visit|Lost to Follow-up|0|||
144501001|NCT01972152|521031229|FG001|First Treatment Visit|Lost to Follow-up|1|||
144501002|NCT01972152|521031230|FG002|First Treatment Visit|Lost to Follow-up|0|||
144501003|NCT01972152|521031231|FG003|First Treatment Visit|Lost to Follow-up|0|||
144501004|NCT01972152|521031232|FG004|First Treatment Visit|Lost to Follow-up|0|||
144501005|NCT01972152|521031233|FG005|First Treatment Visit|Lost to Follow-up|0|||
144501006|NCT01972152|521031228|FG000|Second Treatment Visit|Protocol Violation|0|||
144501007|NCT01972152|521031229|FG001|Second Treatment Visit|Protocol Violation|1|||
144501008|NCT01972152|521031230|FG002|Second Treatment Visit|Protocol Violation|0|||
144501009|NCT01972152|521031231|FG003|Second Treatment Visit|Protocol Violation|0|||
144501010|NCT01972152|521031232|FG004|Second Treatment Visit|Protocol Violation|0|||
144501011|NCT01972152|521031233|FG005|Second Treatment Visit|Protocol Violation|0|||
144501012|NCT00509769|521031234|FG000|Overall Study|Progressive disease|77|||
144501013|NCT00509769|521031234|FG000|Overall Study|Adverse Event|4|||
144501014|NCT00509769|521031234|FG000|Overall Study|Patient's decision|1|||
144501015|NCT00509769|521031234|FG000|Overall Study|Physician Decision|8|||
144501016|NCT00509769|521031234|FG000|Overall Study|Use of prohibited therapies during study|1|||
144501017|NCT03593070|521031235|FG000|Overall Study|administrative withdrawal|1|||
144501018|NCT03593070|521031236|FG001|Overall Study|administrative withdrawal|1|||
144501019|NCT03098030|521031239|FG000|Overall Study|Death|10|||
144501020|NCT03098030|521031240|FG001|Overall Study|Death|156|||
144501021|NCT03098030|521031241|FG002|Overall Study|Death|156|||
144501022|NCT03098030|521031242|FG003|Overall Study|Death|82|||
144501023|NCT03098030|521031239|FG000|Overall Study|Withdrawal by Subject|0|||
144501024|NCT03098030|521031240|FG001|Overall Study|Withdrawal by Subject|7|||
144501025|NCT03098030|521031241|FG002|Overall Study|Withdrawal by Subject|8|||
144501026|NCT03098030|521031242|FG003|Overall Study|Withdrawal by Subject|2|||
144501027|NCT03098030|521031239|FG000|Overall Study|Lost to Follow-up|0|||
144501028|NCT03098030|521031240|FG001|Overall Study|Lost to Follow-up|0|||
144501029|NCT03098030|521031241|FG002|Overall Study|Lost to Follow-up|2|||
144501030|NCT03098030|521031242|FG003|Overall Study|Lost to Follow-up|1|||
144501031|NCT03310983|521031243|FG000|Overall Study|Lost to Follow-up|15|||
144501032|NCT03310983|521031244|FG001|Overall Study|Lost to Follow-up|17|||
144501033|NCT03612804|521031245|FG000|Overall Study|Death|0|||
144501034|NCT03612804|521031246|FG001|Overall Study|Death|7|||
144501035|NCT03612804|521031247|FG002|Overall Study|Death|0|||
144501036|NCT03612804|521031248|FG003|Overall Study|Death|8|||
144501037|NCT03612804|521031245|FG000|Overall Study|Medication copay coverage issues|0|||
144501038|NCT03612804|521031246|FG001|Overall Study|Medication copay coverage issues|0|||
144501039|NCT03612804|521031247|FG002|Overall Study|Medication copay coverage issues|0|||
144501040|NCT03612804|521031248|FG003|Overall Study|Medication copay coverage issues|17|||
144501041|NCT03612804|521031245|FG000|Overall Study|Not current smoker at time of screening|0|||
144501042|NCT03612804|521031246|FG001|Overall Study|Not current smoker at time of screening|1|||
144501043|NCT03612804|521031247|FG002|Overall Study|Not current smoker at time of screening|0|||
144501044|NCT03612804|521031248|FG003|Overall Study|Not current smoker at time of screening|3|||
144501045|NCT03612804|521031245|FG000|Overall Study|Non-veteran status|0|||
144501046|NCT03612804|521031246|FG001|Overall Study|Non-veteran status|1|||
144501047|NCT03612804|521031247|FG002|Overall Study|Non-veteran status|0|||
144501048|NCT03612804|521031248|FG003|Overall Study|Non-veteran status|0|||
144501049|NCT03612804|521031245|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
144501050|NCT03612804|521031246|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
144501051|NCT03612804|521031247|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
144501052|NCT03612804|521031248|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
144501053|NCT03612804|521031245|FG000|Overall Study|Provider retired from VA|0|||
144501054|NCT03612804|521031246|FG001|Overall Study|Provider retired from VA|0|||
144501055|NCT03612804|521031247|FG002|Overall Study|Provider retired from VA|2|||
144501056|NCT03612804|521031248|FG003|Overall Study|Provider retired from VA|0|||
144501057|NCT03612804|521031245|FG000|Overall Study|Withdrawal by Subject|0|||
144501058|NCT03612804|521031246|FG001|Overall Study|Withdrawal by Subject|0|||
144501059|NCT03612804|521031247|FG002|Overall Study|Withdrawal by Subject|7|||
144501060|NCT03612804|521031248|FG003|Overall Study|Withdrawal by Subject|0|||
144501061|NCT03612804|521031245|FG000|Overall Study|Provider involved with study activities|1|||
144501062|NCT03612804|521031246|FG001|Overall Study|Provider involved with study activities|0|||
144501063|NCT03612804|521031247|FG002|Overall Study|Provider involved with study activities|0|||
144501064|NCT03612804|521031248|FG003|Overall Study|Provider involved with study activities|0|||
144501065|NCT01656304|521031249|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
144501066|NCT04391309|521031250|FG000|Overall Study|Death|1|||
144501067|NCT04391309|521031251|FG001|Overall Study|Death|1|||
144501068|NCT04391309|521031250|FG000|Overall Study|Lost to Follow-up|3|||
144501069|NCT04391309|521031251|FG001|Overall Study|Lost to Follow-up|2|||
144501070|NCT04391309|521031250|FG000|Overall Study|Withdrawal by Subject|2|||
144501071|NCT04391309|521031251|FG001|Overall Study|Withdrawal by Subject|2|||
144501072|NCT03396913|521031252|FG000|Overall Study|Lost to Follow-up|0|||
144501073|NCT03396913|521031253|FG001|Overall Study|Lost to Follow-up|6|||
144501074|NCT00881335|521031254|FG000|Overall Study|Lost to Follow-up|3|||
144501075|NCT00881335|521031255|FG001|Overall Study|Lost to Follow-up|2|||
144501076|NCT00554801|521031257|FG000|Overall Study|left area before completion|5|||
144501077|NCT00554801|521031258|FG001|Overall Study|left area before completion|0|||
144501078|NCT00554801|521031257|FG000|Overall Study|Withdrawal by Subject|14|||
144501079|NCT00554801|521031258|FG001|Overall Study|Withdrawal by Subject|0|||
144501080|NCT05826431|521031259|FG000|Overall Study|Withdrawal by Subject|1|||
144501081|NCT02104765|521031262|FG000|Overall Study|Lost to Follow-up|0|||
144501082|NCT02104765|521031263|FG001|Overall Study|Lost to Follow-up|0|||
144501083|NCT02104765|521031264|FG002|Overall Study|Lost to Follow-up|1|||
144501084|NCT02104765|521031265|FG003|Overall Study|Lost to Follow-up|0|||
144501085|NCT02104765|521031266|FG004|Overall Study|Lost to Follow-up|0|||
144501086|NCT02104765|521031267|FG005|Overall Study|Lost to Follow-up|0|||
144501087|NCT02104765|521031268|FG006|Overall Study|Lost to Follow-up|0|||
144501088|NCT02104765|521031262|FG000|Overall Study|Withdrawal by Subject|0|||
144501089|NCT02104765|521031263|FG001|Overall Study|Withdrawal by Subject|0|||
144721132|NCT02649231|521833391|FG003|Overall Study|Lost to Follow-up|0|||
144721133|NCT02649231|521833388|FG000|Overall Study|Withdrawal by Subject|0|||
144721134|NCT02649231|521833389|FG001|Overall Study|Withdrawal by Subject|1|||
144721135|NCT02649231|521833390|FG002|Overall Study|Withdrawal by Subject|0|||
144721136|NCT02649231|521833391|FG003|Overall Study|Withdrawal by Subject|1|||
144721137|NCT02649231|521833388|FG000|Overall Study|Protocol Violation|2|||
144721138|NCT02649231|521833389|FG001|Overall Study|Protocol Violation|1|||
144721139|NCT02649231|521833390|FG002|Overall Study|Protocol Violation|1|||
144721140|NCT02649231|521833391|FG003|Overall Study|Protocol Violation|0|||
144721141|NCT00638157|521833392|FG000|Overall Study|Adverse Event|0|||
144721142|NCT00638157|521833393|FG001|Overall Study|Adverse Event|1|||
144721143|NCT00638157|521833392|FG000|Overall Study|Clinical (symptomatic) failure|1|||
144721144|NCT00638157|521833393|FG001|Overall Study|Clinical (symptomatic) failure|1|||
144721145|NCT00638157|521833392|FG000|Overall Study|Microbiological failure|1|||
144721146|NCT00638157|521833393|FG001|Overall Study|Microbiological failure|0|||
144721147|NCT00638157|521833392|FG000|Overall Study|Lost to Follow-up|1|||
144721148|NCT00638157|521833393|FG001|Overall Study|Lost to Follow-up|0|||
144721149|NCT00638157|521833392|FG000|Overall Study|Physician Decision|1|||
144721150|NCT00638157|521833393|FG001|Overall Study|Physician Decision|0|||
144721151|NCT00638157|521833392|FG000|Overall Study|Other|1|||
144721152|NCT00638157|521833393|FG001|Overall Study|Other|2|||
144721153|NCT00638157|521833392|FG000|Overall Study|Randomized, not treated|2|||
144721154|NCT00638157|521833393|FG001|Overall Study|Randomized, not treated|0|||
144721155|NCT00437281|521833394|FG000|Overall Study|Adverse Event|0|||
144721156|NCT00437281|521833395|FG001|Overall Study|Adverse Event|0|||
144721157|NCT00437281|521833396|FG002|Overall Study|Adverse Event|0|||
144721158|NCT00437281|521833397|FG003|Overall Study|Adverse Event|1|||
144721159|NCT00437281|521833398|FG004|Overall Study|Adverse Event|0|||
144721160|NCT00437281|521833399|FG005|Overall Study|Adverse Event|1|||
144721161|NCT00437281|521833400|FG006|Overall Study|Adverse Event|0|||
144721162|NCT00437281|521833401|FG007|Overall Study|Adverse Event|0|||
144721163|NCT00437281|521833402|FG008|Overall Study|Adverse Event|0|||
144721164|NCT00437281|521833403|FG009|Overall Study|Adverse Event|1|||
144721165|NCT00437281|521833404|FG010|Overall Study|Adverse Event|0|||
144721166|NCT00437281|521833405|FG011|Overall Study|Adverse Event|0|||
144721167|NCT00437281|521833406|FG012|Overall Study|Adverse Event|0|||
144721168|NCT00437281|521833407|FG013|Overall Study|Adverse Event|1|||
144721169|NCT00437281|521833408|FG014|Overall Study|Adverse Event|1|||
144721170|NCT00437281|521833409|FG015|Overall Study|Adverse Event|0|||
144721171|NCT00437281|521833410|FG016|Overall Study|Adverse Event|0|||
144721172|NCT00437281|521833411|FG017|Overall Study|Adverse Event|0|||
144721173|NCT00437281|521833412|FG018|Overall Study|Adverse Event|1|||
144721174|NCT00437281|521833413|FG019|Overall Study|Adverse Event|0|||
144721175|NCT00437281|521833394|FG000|Overall Study|Lost to Follow-up|0|||
144721176|NCT00437281|521833395|FG001|Overall Study|Lost to Follow-up|0|||
144721177|NCT00437281|521833396|FG002|Overall Study|Lost to Follow-up|0|||
144721178|NCT00437281|521833397|FG003|Overall Study|Lost to Follow-up|0|||
144721179|NCT00437281|521833398|FG004|Overall Study|Lost to Follow-up|0|||
144721180|NCT00437281|521833399|FG005|Overall Study|Lost to Follow-up|0|||
144721181|NCT00437281|521833400|FG006|Overall Study|Lost to Follow-up|0|||
144721182|NCT00437281|521833401|FG007|Overall Study|Lost to Follow-up|0|||
144721183|NCT00437281|521833402|FG008|Overall Study|Lost to Follow-up|0|||
144721184|NCT00437281|521833403|FG009|Overall Study|Lost to Follow-up|0|||
144721185|NCT00437281|521833404|FG010|Overall Study|Lost to Follow-up|0|||
144721186|NCT00437281|521833405|FG011|Overall Study|Lost to Follow-up|0|||
144721187|NCT00437281|521833406|FG012|Overall Study|Lost to Follow-up|0|||
144721188|NCT00437281|521833407|FG013|Overall Study|Lost to Follow-up|0|||
144721189|NCT00437281|521833408|FG014|Overall Study|Lost to Follow-up|0|||
144721190|NCT00437281|521833409|FG015|Overall Study|Lost to Follow-up|0|||
144721191|NCT00437281|521833410|FG016|Overall Study|Lost to Follow-up|0|||
144721192|NCT00437281|521833411|FG017|Overall Study|Lost to Follow-up|0|||
144501090|NCT02104765|521031264|FG002|Overall Study|Withdrawal by Subject|0|||
144501091|NCT02104765|521031265|FG003|Overall Study|Withdrawal by Subject|1|||
144501092|NCT02104765|521031266|FG004|Overall Study|Withdrawal by Subject|1|||
144721193|NCT00437281|521833412|FG018|Overall Study|Lost to Follow-up|0|||
144721194|NCT00437281|521833413|FG019|Overall Study|Lost to Follow-up|1|||
144721195|NCT01211769|521833416|FG000|Overall Study|Lost to Follow-up|7|||
144721196|NCT01211769|521833417|FG001|Overall Study|Lost to Follow-up|9|||
144501093|NCT02104765|521031267|FG005|Overall Study|Withdrawal by Subject|0|||
144501094|NCT02104765|521031268|FG006|Overall Study|Withdrawal by Subject|1|||
144501095|NCT00462943|521031269|FG000|Overall Study|Failure to achieve a response|5|||
144501096|NCT00462943|521031270|FG001|Overall Study|Failure to achieve a response|5|||
144501097|NCT00462943|521031271|FG002|Overall Study|Failure to achieve a response|1|||
144501098|NCT00462943|521031269|FG000|Overall Study|Adverse Event|6|||
144501099|NCT00462943|521031270|FG001|Overall Study|Adverse Event|4|||
144501100|NCT00462943|521031271|FG002|Overall Study|Adverse Event|1|||
144501101|NCT00462943|521031269|FG000|Overall Study|Protocol Violation|1|||
144501102|NCT00462943|521031270|FG001|Overall Study|Protocol Violation|0|||
144501103|NCT00462943|521031271|FG002|Overall Study|Protocol Violation|0|||
144501104|NCT00462943|521031269|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
144501105|NCT00462943|521031270|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
144501106|NCT00462943|521031271|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
144501107|NCT00462943|521031269|FG000|Overall Study|Disease Progression|15|||
144501108|NCT00462943|521031270|FG001|Overall Study|Disease Progression|15|||
144501109|NCT00462943|521031271|FG002|Overall Study|Disease Progression|9|||
144501110|NCT00462943|521031269|FG000|Overall Study|Death|5|||
144501111|NCT00462943|521031270|FG001|Overall Study|Death|2|||
144501112|NCT00462943|521031271|FG002|Overall Study|Death|7|||
144501113|NCT00462943|521031269|FG000|Overall Study|Stem Cell Transplant|1|||
144501114|NCT00462943|521031270|FG001|Overall Study|Stem Cell Transplant|1|||
144501115|NCT00462943|521031271|FG002|Overall Study|Stem Cell Transplant|0|||
144501116|NCT00462943|521031269|FG000|Overall Study|Bone Marrow Transplant|1|||
144501117|NCT00462943|521031270|FG001|Overall Study|Bone Marrow Transplant|0|||
144501118|NCT00462943|521031271|FG002|Overall Study|Bone Marrow Transplant|0|||
144501119|NCT00462943|521031269|FG000|Overall Study|Required Lymphocyte Infusion|1|||
144501120|NCT00462943|521031270|FG001|Overall Study|Required Lymphocyte Infusion|0|||
144501121|NCT00462943|521031271|FG002|Overall Study|Required Lymphocyte Infusion|0|||
144501122|NCT00462943|521031269|FG000|Overall Study|Transplant - not specified|1|||
144501123|NCT00462943|521031270|FG001|Overall Study|Transplant - not specified|0|||
144501124|NCT00462943|521031271|FG002|Overall Study|Transplant - not specified|1|||
144501125|NCT00462943|521031269|FG000|Overall Study|Physician Decision|1|||
144501126|NCT00462943|521031270|FG001|Overall Study|Physician Decision|0|||
144501127|NCT00462943|521031271|FG002|Overall Study|Physician Decision|0|||
144721197|NCT01211769|521833418|FG002|Overall Study|Lost to Follow-up|5|||
144721198|NCT01211769|521833419|FG003|Overall Study|Lost to Follow-up|9|||
144721199|NCT01211769|521833416|FG000|Overall Study|Physician Decision|2|||
144721200|NCT01211769|521833417|FG001|Overall Study|Physician Decision|0|||
144721201|NCT01211769|521833418|FG002|Overall Study|Physician Decision|2|||
144721202|NCT01211769|521833419|FG003|Overall Study|Physician Decision|1|||
144721203|NCT01211769|521833416|FG000|Overall Study|Adverse Event|0|||
144721204|NCT01211769|521833417|FG001|Overall Study|Adverse Event|1|||
144721205|NCT01211769|521833418|FG002|Overall Study|Adverse Event|1|||
144721206|NCT01211769|521833419|FG003|Overall Study|Adverse Event|1|||
144721207|NCT01214330|521833420|FG000|Overall Study|Withdrawal by Subject|2|||
144721208|NCT01214330|521833420|FG000|Overall Study|Withdrawal by Subject|2|||
144721209|NCT01348542|521833421|FG000|Overall Study|Withdrawal by Subject|3|||
144721210|NCT01348542|521833422|FG001|Overall Study|Withdrawal by Subject|0|||
144721211|NCT03402893|521833423|FG000|Overall Study|Withdrawal by Subject|1|||
144721212|NCT00686036|521833428|FG000|Overall Study|Adverse Event|3|||
144721213|NCT00686036|521833429|FG001|Overall Study|Adverse Event|0|||
144721214|NCT00686036|521833428|FG000|Overall Study|Withdrawal by Subject|3|||
144721215|NCT00686036|521833429|FG001|Overall Study|Withdrawal by Subject|1|||
144721216|NCT00686036|521833428|FG000|Overall Study|Study terminated by AstraZeneca|2|||
144721217|NCT00686036|521833429|FG001|Overall Study|Study terminated by AstraZeneca|1|||
144721218|NCT00686036|521833428|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
144721219|NCT00686036|521833429|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
144721220|NCT00686036|521833428|FG000|Overall Study|Other reasons not identified|0|||
144721221|NCT00686036|521833429|FG001|Overall Study|Other reasons not identified|4|||
144721222|NCT00467584|521833430|FG000|Overall Study|Withdrawal by Subject|4|||
144721223|NCT00467584|521833431|FG001|Overall Study|Withdrawal by Subject|5|||
144721224|NCT00467584|521833432|FG002|Overall Study|Withdrawal by Subject|1|||
144721225|NCT00926289|521833436|FG000|Overall Study|Adverse Event|9|||
144721226|NCT00926289|521833437|FG001|Overall Study|Adverse Event|11|||
144721227|NCT00926289|521833436|FG000|Overall Study|Protocol Violation|8|||
144721228|NCT00926289|521833437|FG001|Overall Study|Protocol Violation|12|||
144721229|NCT00926289|521833436|FG000|Overall Study|Lost to Follow-up|3|||
144721230|NCT00926289|521833437|FG001|Overall Study|Lost to Follow-up|6|||
144721231|NCT00926289|521833436|FG000|Overall Study|Withdrawal by Subject|4|||
144721232|NCT00926289|521833437|FG001|Overall Study|Withdrawal by Subject|4|||
144721233|NCT00926289|521833436|FG000|Overall Study|Other|1|||
144721234|NCT00926289|521833437|FG001|Overall Study|Other|3|||
144721235|NCT00753714|521833438|FG000|Overall Study|Lack of Efficacy|21|||
144721236|NCT00753714|521833439|FG001|Overall Study|Lack of Efficacy|34|||
144721237|NCT00753714|521833438|FG000|Overall Study|Adverse Event|26|||
144721238|NCT00753714|521833439|FG001|Overall Study|Adverse Event|18|||
144721239|NCT00753714|521833438|FG000|Overall Study|Protocol Violation|1|||
144721240|NCT00753714|521833439|FG001|Overall Study|Protocol Violation|0|||
144721241|NCT00753714|521833438|FG000|Overall Study|Lost to Follow-up|0|||
144721242|NCT00753714|521833439|FG001|Overall Study|Lost to Follow-up|1|||
144501128|NCT00462943|521031269|FG000|Overall Study|Withdrawal by Subject|0|||
144501129|NCT00462943|521031270|FG001|Overall Study|Withdrawal by Subject|1|||
144721243|NCT00753714|521833438|FG000|Overall Study|Withdrawal by Subject|2|||
144501130|NCT00462943|521031271|FG002|Overall Study|Withdrawal by Subject|0|||
144501131|NCT01697319|521031272|FG000|Primary Phase|Withdrawal by Subject|1|||
144501132|NCT01697319|521031272|FG000|Extension Phase|Terminated by Sponsor|15|||
144721244|NCT00753714|521833439|FG001|Overall Study|Withdrawal by Subject|1|||
144501133|NCT00604721|521031277|FG000|Overall Study|Physician Decision|1|||
144501134|NCT00604721|521031277|FG000|Overall Study|Withdrawal by Subject|1|||
144501135|NCT01838551|521031281|FG000|Overall Study|Adverse Event|16|||
144501136|NCT01838551|521031281|FG000|Overall Study|Death|1|||
144501137|NCT01838551|521031281|FG000|Overall Study|Lack of Efficacy|10|||
144501138|NCT01838551|521031281|FG000|Overall Study|Physician Decision|4|||
144501139|NCT01838551|521031281|FG000|Overall Study|Withdrawal by Subject|10|||
144501140|NCT01838551|521031281|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
144501141|NCT00906282|521031282|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
144501142|NCT00906282|521031282|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
144501143|NCT00906282|521031282|FG000|Preoperative Chemotherapy|Progressive disease|6|||
144501144|NCT00906282|521031282|FG000|Preoperative Chemotherapy|Toxicity|1|||
144501145|NCT00038103|521031285|FG000|Overall Study|Adverse Event|5|||
144501146|NCT00038103|521031286|FG001|Overall Study|Adverse Event|6|||
144501147|NCT00038103|521031285|FG000|Overall Study|Lack of Efficacy|48|||
144501148|NCT00038103|521031286|FG001|Overall Study|Lack of Efficacy|41|||
144501149|NCT00038103|521031285|FG000|Overall Study|Withdrawal by Subject|0|||
144501150|NCT00038103|521031286|FG001|Overall Study|Withdrawal by Subject|3|||
144501151|NCT00038103|521031285|FG000|Overall Study|Lost to Follow-up|0|||
144501152|NCT00038103|521031286|FG001|Overall Study|Lost to Follow-up|3|||
144501153|NCT00038103|521031285|FG000|Overall Study|Protocol Violation|0|||
144501154|NCT00038103|521031286|FG001|Overall Study|Protocol Violation|2|||
144501155|NCT00038103|521031285|FG000|Overall Study|Sponsor Decision|0|||
144501156|NCT00038103|521031286|FG001|Overall Study|Sponsor Decision|1|||
144501157|NCT00038103|521031285|FG000|Overall Study|Randomized/never treated|2|||
144501158|NCT00038103|521031286|FG001|Overall Study|Randomized/never treated|0|||
144501159|NCT02685033|521031290|FG000|Overall Study|Withdrawal of Consent|0|||
144501160|NCT02685033|521031291|FG001|Overall Study|Withdrawal of Consent|1|||
144501161|NCT02685033|521031290|FG000|Overall Study|Lost to Follow-up|2|||
144501162|NCT02685033|521031291|FG001|Overall Study|Lost to Follow-up|1|||
144501163|NCT02685033|521031290|FG000|Overall Study|Adverse Event|1|||
144501164|NCT02685033|521031291|FG001|Overall Study|Adverse Event|0|||
144501165|NCT02465359|521031296|FG000|Overall Study|Lack of Efficacy|1|||
144501166|NCT02465359|521031296|FG000|Overall Study|Withdrawal by Subject|1|||
144501167|NCT02465359|521031296|FG000|Overall Study|Adverse Event|1|||
144501168|NCT01278862|521031297|FG000|Overall Study|Lost to Follow-up|1|||
144501169|NCT01278862|521031298|FG001|Overall Study|Lost to Follow-up|1|||
144501170|NCT02952261|521031299|FG000|Overall Study|Withdrawal by Subject|4|||
144501171|NCT02952261|521031300|FG001|Overall Study|Withdrawal by Subject|5|||
144501172|NCT02952261|521031299|FG000|Overall Study|Protocol Violation|1|||
144501173|NCT02952261|521031300|FG001|Overall Study|Protocol Violation|0|||
144501174|NCT00798265|521031301|FG000|Overall Study|Lost to Follow-up|1|||
144501175|NCT00798265|521031302|FG001|Overall Study|Lost to Follow-up|10|||
144501176|NCT00798265|521031301|FG000|Overall Study|Study closing|7|||
144501177|NCT00798265|521031302|FG001|Overall Study|Study closing|6|||
144501178|NCT00798265|521031301|FG000|Overall Study|Withdrawal by Subject|0|||
144501179|NCT00798265|521031302|FG001|Overall Study|Withdrawal by Subject|1|||
144501180|NCT00798265|521031301|FG000|Overall Study|Screen failure|0|||
144501181|NCT00798265|521031302|FG001|Overall Study|Screen failure|1|||
144501182|NCT03425643|521031305|FG000|Overall Study|Withdrawal by Subject|10|||
144501183|NCT03425643|521031306|FG001|Overall Study|Withdrawal by Subject|12|||
144501184|NCT03425643|521031305|FG000|Overall Study|Lost to Follow-up|2|||
144501185|NCT03425643|521031306|FG001|Overall Study|Lost to Follow-up|0|||
144501186|NCT03425643|521031305|FG000|Overall Study|Death|109|||
144501187|NCT03425643|521031306|FG001|Overall Study|Death|141|||
144501188|NCT03425643|521031305|FG000|Overall Study|Ongoing in study|276|||
144501189|NCT03425643|521031306|FG001|Overall Study|Ongoing in study|247|||
144501190|NCT03141788|521031307|FG000|Overall Study|Lost to Follow-up|1|||
144501191|NCT03141788|521031307|FG000|Overall Study|Protocol Violation|3|||
144501192|NCT03141788|521031307|FG000|Overall Study|Withdrawal by Subject|4|||
144501193|NCT04133363|521031308|FG000|Overall Study|Lost to Follow-up|2|||
144501194|NCT04133363|521031309|FG001|Overall Study|Lost to Follow-up|1|||
144501195|NCT04133363|521031310|FG002|Overall Study|Lost to Follow-up|4|||
144501196|NCT01185522|521032910|FG000|Overall Study|Lack of Efficacy|28|||
144501197|NCT01185522|521032910|FG000|Overall Study|Lost to Follow-up|19|||
144501198|NCT01185522|521032910|FG000|Overall Study|Withdrawal by Subject|10|||
144501199|NCT01185522|521032910|FG000|Overall Study|Poor tolerance|39|||
144501200|NCT01185522|521032910|FG000|Overall Study|Other reasons|12|||
144501201|NCT00486759|521032911|FG000|Treatment|Adverse event/intercurrent illness|86|||
144501202|NCT00486759|521032912|FG001|Treatment|Adverse event/intercurrent illness|39|||
144501203|NCT00486759|521032911|FG000|Treatment|Insufficient therapeutic response|37|||
144501204|NCT00486759|521032912|FG001|Treatment|Insufficient therapeutic response|39|||
144501205|NCT00486759|521032911|FG000|Treatment|Death|17|||
144721245|NCT00753714|521833438|FG000|Overall Study|Death|3|||
144721246|NCT00753714|521833439|FG001|Overall Study|Death|3|||
144501206|NCT00486759|521032912|FG001|Treatment|Death|10|||
144721247|NCT00753714|521833438|FG000|Overall Study|Other|7|||
144721248|NCT00753714|521833439|FG001|Overall Study|Other|5|||
144721249|NCT01202747|521833440|FG000|Overall Study|Withdrawal by Subject|1|||
144721250|NCT01446913|521833441|FG000|Overall Study|Significant illness|1|||
144721251|NCT01446913|521833442|FG001|Overall Study|Significant illness|1|||
144721252|NCT01446913|521833443|FG002|Overall Study|Significant illness|1|||
144721253|NCT01446913|521833441|FG000|Overall Study|Withdrawal by Subject|5|||
144721254|NCT01446913|521833442|FG001|Overall Study|Withdrawal by Subject|3|||
144721255|NCT01446913|521833443|FG002|Overall Study|Withdrawal by Subject|5|||
144721256|NCT01446913|521833441|FG000|Overall Study|Physician Decision|0|||
144721257|NCT01446913|521833442|FG001|Overall Study|Physician Decision|0|||
144721258|NCT01446913|521833443|FG002|Overall Study|Physician Decision|2|||
144721259|NCT01446913|521833441|FG000|Overall Study|Lost to Follow-up|3|||
144721260|NCT01446913|521833442|FG001|Overall Study|Lost to Follow-up|5|||
144721261|NCT01446913|521833443|FG002|Overall Study|Lost to Follow-up|3|||
144721262|NCT00095199|521833448|FG000|Overall Study|Adverse Event|40|||
144721263|NCT00095199|521833449|FG001|Overall Study|Adverse Event|22|||
144721264|NCT00095199|521833450|FG002|Overall Study|Adverse Event|26|||
144721265|NCT00095199|521833451|FG003|Overall Study|Adverse Event|11|||
144721266|NCT00095199|521833448|FG000|Overall Study|Progressive disease|213|||
144721267|NCT00095199|521833449|FG001|Overall Study|Progressive disease|179|||
144721268|NCT00095199|521833450|FG002|Overall Study|Progressive disease|105|||
144721269|NCT00095199|521833451|FG003|Overall Study|Progressive disease|98|||
144721270|NCT00095199|521833448|FG000|Overall Study|Death|10|||
144721271|NCT00095199|521833449|FG001|Overall Study|Death|6|||
144721272|NCT00095199|521833450|FG002|Overall Study|Death|11|||
144721273|NCT00095199|521833451|FG003|Overall Study|Death|9|||
144721274|NCT00095199|521833448|FG000|Overall Study|Withdrawal by Subject|21|||
144721275|NCT00095199|521833449|FG001|Overall Study|Withdrawal by Subject|16|||
144721276|NCT00095199|521833450|FG002|Overall Study|Withdrawal by Subject|13|||
144721277|NCT00095199|521833451|FG003|Overall Study|Withdrawal by Subject|22|||
144721278|NCT00095199|521833448|FG000|Overall Study|Protocol Violation|4|||
144721279|NCT00095199|521833449|FG001|Overall Study|Protocol Violation|4|||
144721280|NCT00095199|521833450|FG002|Overall Study|Protocol Violation|2|||
144721281|NCT00095199|521833451|FG003|Overall Study|Protocol Violation|0|||
144721282|NCT00095199|521833448|FG000|Overall Study|Liver function test results elevated|0|||
144721283|NCT00095199|521833449|FG001|Overall Study|Liver function test results elevated|0|||
144721284|NCT00095199|521833450|FG002|Overall Study|Liver function test results elevated|1|||
144721285|NCT00095199|521833451|FG003|Overall Study|Liver function test results elevated|1|||
144721286|NCT00095199|521833448|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
144721287|NCT00095199|521833449|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
144721288|NCT00095199|521833450|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
144721289|NCT00095199|521833451|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
144721290|NCT00095199|521833448|FG000|Overall Study|Physician Decision|5|||
144721291|NCT00095199|521833449|FG001|Overall Study|Physician Decision|6|||
144721292|NCT00095199|521833450|FG002|Overall Study|Physician Decision|1|||
144721293|NCT00095199|521833451|FG003|Overall Study|Physician Decision|1|||
144721294|NCT00095199|521833448|FG000|Overall Study|Not eligible|1|||
144721295|NCT00095199|521833449|FG001|Overall Study|Not eligible|7|||
144721296|NCT00095199|521833450|FG002|Overall Study|Not eligible|0|||
144721297|NCT00095199|521833451|FG003|Overall Study|Not eligible|1|||
144721298|NCT00095199|521833448|FG000|Overall Study|Started Palliative Radiotherapy|1|||
144721299|NCT00095199|521833449|FG001|Overall Study|Started Palliative Radiotherapy|0|||
144721300|NCT00095199|521833450|FG002|Overall Study|Started Palliative Radiotherapy|0|||
144721301|NCT00095199|521833451|FG003|Overall Study|Started Palliative Radiotherapy|0|||
144721302|NCT00095199|521833448|FG000|Overall Study|Started radiotherapy regimen|0|||
144721303|NCT00095199|521833449|FG001|Overall Study|Started radiotherapy regimen|1|||
144721304|NCT00095199|521833450|FG002|Overall Study|Started radiotherapy regimen|0|||
144721305|NCT00095199|521833451|FG003|Overall Study|Started radiotherapy regimen|0|||
144721306|NCT00095199|521833448|FG000|Overall Study|Primary tumor removed in other surgery|0|||
144721307|NCT00095199|521833449|FG001|Overall Study|Primary tumor removed in other surgery|1|||
144721308|NCT00095199|521833450|FG002|Overall Study|Primary tumor removed in other surgery|0|||
144721309|NCT00095199|521833451|FG003|Overall Study|Primary tumor removed in other surgery|0|||
144721310|NCT00095199|521833448|FG000|Overall Study|Data inadvertently lost by site|1|||
144721311|NCT00095199|521833449|FG001|Overall Study|Data inadvertently lost by site|0|||
144721312|NCT00095199|521833450|FG002|Overall Study|Data inadvertently lost by site|0|||
144721313|NCT00095199|521833451|FG003|Overall Study|Data inadvertently lost by site|0|||
144721314|NCT03896490|521833486|FG000|Overall Study|Withdrawal by Subject|1|||
144721315|NCT03896490|521833487|FG001|Overall Study|Withdrawal by Subject|1|||
144501207|NCT00486759|521032911|FG000|Treatment|Withdrew consent|15|||
144501208|NCT00486759|521032912|FG001|Treatment|Withdrew consent|12|||
144501209|NCT00486759|521032911|FG000|Treatment|Administrative/reason not specified|17|||
144501210|NCT00486759|521032912|FG001|Treatment|Administrative/reason not specified|21|||
144501211|NCT00486759|521032911|FG000|Treatment|Refused treatment|10|||
144501212|NCT00486759|521032912|FG001|Treatment|Refused treatment|7|||
144501213|NCT00486759|521032911|FG000|Treatment|Violation of selection criteria at entry|3|||
144501214|NCT00486759|521032912|FG001|Treatment|Violation of selection criteria at entry|3|||
144501215|NCT00486759|521032911|FG000|Treatment|Other protocol violation|1|||
144501216|NCT00486759|521032912|FG001|Treatment|Other protocol violation|5|||
144501217|NCT00486759|521032911|FG000|Treatment|Failure to return|1|||
144501218|NCT00486759|521032912|FG001|Treatment|Failure to return|1|||
144501219|NCT00486759|521032911|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
144501220|NCT00486759|521032912|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
144501221|NCT00486759|521032911|FG000|Safety Follow-up|Death|40|||
144501222|NCT00486759|521032912|FG001|Safety Follow-up|Death|29|||
144501223|NCT00486759|521032911|FG000|Safety Follow-up|Withdrew consent|32|||
144501224|NCT00486759|521032912|FG001|Safety Follow-up|Withdrew consent|23|||
144501225|NCT00486759|521032911|FG000|Safety Follow-up|Failure to return|9|||
144501226|NCT00486759|521032912|FG001|Safety Follow-up|Failure to return|6|||
144501227|NCT00486759|521032911|FG000|Safety Follow-up|Administrative/not specified|8|||
144501228|NCT00486759|521032912|FG001|Safety Follow-up|Administrative/not specified|6|||
144501229|NCT00486759|521032911|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
144501230|NCT00486759|521032912|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
144501231|NCT00486759|521032911|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
144501232|NCT00486759|521032912|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
144501233|NCT00954707|521032913|FG000|Overall Study|Death|34|||
144501234|NCT00954707|521032913|FG000|Overall Study|Withdrawal by Subject|100|||
144501235|NCT00954707|521032913|FG000|Overall Study|Lost to Follow-up|33|||
144501236|NCT01025843|521032914|FG000|Washout 4|Withdrawal by Subject|0|||
144501237|NCT01025843|521032915|FG001|Washout 4|Withdrawal by Subject|0|||
144501238|NCT01025843|521032916|FG002|Washout 4|Withdrawal by Subject|1|||
144501239|NCT01025843|521032917|FG003|Washout 4|Withdrawal by Subject|1|||
144501240|NCT01025843|521032918|FG004|Washout 4|Withdrawal by Subject|0|||
144501241|NCT01025843|521032919|FG005|Washout 4|Withdrawal by Subject|0|||
144501242|NCT01025843|521032920|FG006|Washout 4|Withdrawal by Subject|0|||
144501243|NCT01025843|521032921|FG007|Washout 4|Withdrawal by Subject|0|||
144501244|NCT01025843|521032922|FG008|Washout 4|Withdrawal by Subject|0|||
144501245|NCT01025843|521032923|FG009|Washout 4|Withdrawal by Subject|0|||
144501246|NCT01649791|521032926|FG000|Overall Study|Disease Progression|2|||
144501247|NCT01649791|521032926|FG000|Overall Study|Adverse Event|1|||
144501248|NCT03646669|521032929|FG000|Overall Study|Withdrawal by Subject|5|||
144501249|NCT03646669|521032930|FG001|Overall Study|Withdrawal by Subject|0|||
144501250|NCT00309452|521032931|FG000|Overall Study|Withdrawal by Subject|3|||
144501251|NCT00309452|521032932|FG001|Overall Study|Withdrawal by Subject|0|||
144501252|NCT00771667|521032933|FG000|Induction Phase|Adverse Event|5|||
144501253|NCT00771667|521032934|FG001|Induction Phase|Adverse Event|2|||
144501254|NCT00771667|521032935|FG002|Induction Phase|Adverse Event|4|||
144501255|NCT00771667|521032936|FG003|Induction Phase|Adverse Event|1|||
144721316|NCT01736553|521833492|FG000|Overall Study|Death|12|||
144721317|NCT01736553|521833493|FG001|Overall Study|Death|0|||
144721318|NCT01736553|521833492|FG000|Overall Study|Withdrawal by Subject|5|||
144721319|NCT01736553|521833493|FG001|Overall Study|Withdrawal by Subject|2|||
144721320|NCT01736553|521833492|FG000|Overall Study|Lost to Follow-up|2|||
144721321|NCT01736553|521833493|FG001|Overall Study|Lost to Follow-up|2|||
144721322|NCT01896297|521833494|FG000|Overall Study|Died in post treatment phase|1|||
144721323|NCT00003782|521833495|FG000|Overall Study|No follow up data|30|||
144721324|NCT00003782|521833496|FG001|Overall Study|No follow up data|31|||
144721325|NCT00003782|521833497|FG002|Overall Study|No follow up data|26|||
144721326|NCT01890707|521833498|FG000|Overall Study|Lost to Follow-up|1|||
144721327|NCT01890707|521833499|FG001|Overall Study|Lost to Follow-up|1|||
144721328|NCT00929708|521833502|FG000|Overall Study|Protocol Violation|2|||
144721329|NCT00929708|521833503|FG001|Overall Study|Protocol Violation|1|||
144721330|NCT00929708|521833504|FG002|Overall Study|Protocol Violation|1|||
144721331|NCT00929708|521833505|FG003|Overall Study|Protocol Violation|1|||
144721332|NCT00929708|521833506|FG004|Overall Study|Protocol Violation|1|||
144721333|NCT00929708|521833502|FG000|Overall Study|Withdrawal by Subject|2|||
144721334|NCT00929708|521833503|FG001|Overall Study|Withdrawal by Subject|0|||
144721335|NCT00929708|521833504|FG002|Overall Study|Withdrawal by Subject|0|||
144721336|NCT00929708|521833505|FG003|Overall Study|Withdrawal by Subject|2|||
144721337|NCT00929708|521833506|FG004|Overall Study|Withdrawal by Subject|1|||
144721338|NCT00929708|521833502|FG000|Overall Study|Adverse Event|0|||
144721339|NCT00929708|521833503|FG001|Overall Study|Adverse Event|0|||
144721340|NCT00929708|521833504|FG002|Overall Study|Adverse Event|0|||
144721341|NCT00929708|521833505|FG003|Overall Study|Adverse Event|0|||
144721342|NCT00929708|521833506|FG004|Overall Study|Adverse Event|3|||
144721343|NCT00929708|521833502|FG000|Overall Study|Physician Decision|0|||
144721344|NCT00929708|521833503|FG001|Overall Study|Physician Decision|2|||
144721345|NCT00929708|521833504|FG002|Overall Study|Physician Decision|2|||
144721346|NCT00929708|521833505|FG003|Overall Study|Physician Decision|2|||
144721347|NCT00929708|521833506|FG004|Overall Study|Physician Decision|1|||
144721348|NCT00929708|521833502|FG000|Overall Study|Lost to Follow-up|0|||
144721349|NCT00929708|521833503|FG001|Overall Study|Lost to Follow-up|0|||
144501256|NCT00771667|521032937|FG004|Induction Phase|Adverse Event|0|||
144501257|NCT00771667|521032938|FG005|Induction Phase|Adverse Event|0|||
144501258|NCT00771667|521032939|FG006|Induction Phase|Adverse Event|0|||
144501259|NCT00771667|521032940|FG007|Induction Phase|Adverse Event|0|||
144501260|NCT00771667|521032941|FG008|Induction Phase|Adverse Event|0|||
144501261|NCT00771667|521032942|FG009|Induction Phase|Adverse Event|0|||
144501262|NCT00771667|521032933|FG000|Induction Phase|Lack of Efficacy|9|||
144501263|NCT00771667|521032934|FG001|Induction Phase|Lack of Efficacy|2|||
144501264|NCT00771667|521032935|FG002|Induction Phase|Lack of Efficacy|4|||
144501265|NCT00771667|521032936|FG003|Induction Phase|Lack of Efficacy|3|||
144501266|NCT00771667|521032937|FG004|Induction Phase|Lack of Efficacy|0|||
144501267|NCT00771667|521032938|FG005|Induction Phase|Lack of Efficacy|0|||
144501268|NCT00771667|521032939|FG006|Induction Phase|Lack of Efficacy|0|||
144501269|NCT00771667|521032940|FG007|Induction Phase|Lack of Efficacy|0|||
144501270|NCT00771667|521032941|FG008|Induction Phase|Lack of Efficacy|0|||
144501271|NCT00771667|521032942|FG009|Induction Phase|Lack of Efficacy|0|||
144501272|NCT00771667|521032933|FG000|Induction Phase|Lost to Follow-up|1|||
144501273|NCT00771667|521032934|FG001|Induction Phase|Lost to Follow-up|0|||
144501274|NCT00771667|521032935|FG002|Induction Phase|Lost to Follow-up|1|||
144501275|NCT00771667|521032936|FG003|Induction Phase|Lost to Follow-up|0|||
144501276|NCT00771667|521032937|FG004|Induction Phase|Lost to Follow-up|0|||
144501277|NCT00771667|521032938|FG005|Induction Phase|Lost to Follow-up|0|||
144501278|NCT00771667|521032939|FG006|Induction Phase|Lost to Follow-up|0|||
144501279|NCT00771667|521032940|FG007|Induction Phase|Lost to Follow-up|0|||
144501280|NCT00771667|521032941|FG008|Induction Phase|Lost to Follow-up|0|||
144501281|NCT00771667|521032942|FG009|Induction Phase|Lost to Follow-up|0|||
144501282|NCT00771667|521032933|FG000|Induction Phase|Other|4|||
144501283|NCT00771667|521032934|FG001|Induction Phase|Other|6|||
144501284|NCT00771667|521032935|FG002|Induction Phase|Other|3|||
144501285|NCT00771667|521032936|FG003|Induction Phase|Other|4|||
144501286|NCT00771667|521032937|FG004|Induction Phase|Other|0|||
144501287|NCT00771667|521032938|FG005|Induction Phase|Other|0|||
144501288|NCT00771667|521032939|FG006|Induction Phase|Other|0|||
144501289|NCT00771667|521032940|FG007|Induction Phase|Other|0|||
144501290|NCT00771667|521032941|FG008|Induction Phase|Other|0|||
144501291|NCT00771667|521032942|FG009|Induction Phase|Other|0|||
144501292|NCT00771667|521032933|FG000|Maintenance Phase|Adverse Event|0|||
144501293|NCT00771667|521032934|FG001|Maintenance Phase|Adverse Event|0|||
144721350|NCT00929708|521833504|FG002|Overall Study|Lost to Follow-up|0|||
144721351|NCT00929708|521833505|FG003|Overall Study|Lost to Follow-up|1|||
144721352|NCT00929708|521833506|FG004|Overall Study|Lost to Follow-up|0|||
144721353|NCT01893138|521833507|FG000|Double-Blind Period|Withdrawal by Subject|1|||
144721354|NCT01893138|521833508|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144721355|NCT01893138|521833507|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
144721356|NCT01893138|521833508|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
144721357|NCT01893138|521833507|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
144721358|NCT01893138|521833508|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
144721359|NCT01893138|521833507|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
144721360|NCT01893138|521833508|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
144721361|NCT01893138|521833507|FG000|Open Label - Unblinded Period|Adverse Event|1|||
144721362|NCT01893138|521833508|FG001|Open Label - Unblinded Period|Adverse Event|0|||
144721363|NCT02192905|521835191|FG000|Overall Study|Lost to Follow-up|1|||
144721364|NCT04820842|521835192|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
144721365|NCT04820842|521835193|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
144721366|NCT04820842|521835194|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
144721367|NCT04820842|521835195|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
144721368|NCT04820842|521835196|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
144721369|NCT04820842|521835197|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
144721370|NCT04820842|521835198|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
144721371|NCT04820842|521835192|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
144721372|NCT04820842|521835193|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
144721373|NCT04820842|521835194|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
144721374|NCT04820842|521835195|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721375|NCT04820842|521835196|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721376|NCT04820842|521835197|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721377|NCT04820842|521835198|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721378|NCT04820842|521835192|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144721379|NCT04820842|521835193|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
144721380|NCT04820842|521835194|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144721381|NCT04820842|521835195|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144721382|NCT04820842|521835196|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144721383|NCT04820842|521835197|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144721384|NCT04820842|521835198|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
144721385|NCT04820842|521835192|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721386|NCT04820842|521835193|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721387|NCT04820842|521835194|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721388|NCT04820842|521835195|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
144721389|NCT04820842|521835196|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721390|NCT04820842|521835197|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
144721391|NCT04820842|521835198|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
144721392|NCT01296932|521835199|FG000|Overall Study|Dose limiting toxicity|0|||
144721393|NCT01296932|521835200|FG001|Overall Study|Dose limiting toxicity|0|||
144721394|NCT01296932|521835201|FG002|Overall Study|Dose limiting toxicity|0|||
144721395|NCT01296932|521835202|FG003|Overall Study|Dose limiting toxicity|0|||
144721396|NCT01296932|521835203|FG004|Overall Study|Dose limiting toxicity|0|||
144721397|NCT01296932|521835204|FG005|Overall Study|Dose limiting toxicity|0|||
144721398|NCT01296932|521835205|FG006|Overall Study|Dose limiting toxicity|1|||
144501294|NCT00771667|521032935|FG002|Maintenance Phase|Adverse Event|0|||
144501295|NCT00771667|521032936|FG003|Maintenance Phase|Adverse Event|0|||
144501296|NCT00771667|521032937|FG004|Maintenance Phase|Adverse Event|1|||
144501297|NCT00771667|521032938|FG005|Maintenance Phase|Adverse Event|3|||
144501298|NCT00771667|521032939|FG006|Maintenance Phase|Adverse Event|5|||
144501299|NCT00771667|521032940|FG007|Maintenance Phase|Adverse Event|1|||
144501300|NCT00771667|521032941|FG008|Maintenance Phase|Adverse Event|8|||
144501301|NCT00771667|521032942|FG009|Maintenance Phase|Adverse Event|7|||
144501302|NCT00771667|521032933|FG000|Maintenance Phase|Lack of Efficacy|0|||
144501303|NCT00771667|521032934|FG001|Maintenance Phase|Lack of Efficacy|0|||
144501304|NCT00771667|521032935|FG002|Maintenance Phase|Lack of Efficacy|0|||
144501305|NCT00771667|521032936|FG003|Maintenance Phase|Lack of Efficacy|0|||
144501306|NCT00771667|521032937|FG004|Maintenance Phase|Lack of Efficacy|1|||
144501307|NCT00771667|521032938|FG005|Maintenance Phase|Lack of Efficacy|3|||
144501308|NCT00771667|521032939|FG006|Maintenance Phase|Lack of Efficacy|3|||
144501309|NCT00771667|521032940|FG007|Maintenance Phase|Lack of Efficacy|2|||
144501310|NCT00771667|521032941|FG008|Maintenance Phase|Lack of Efficacy|11|||
144501311|NCT00771667|521032942|FG009|Maintenance Phase|Lack of Efficacy|7|||
144501312|NCT00771667|521032933|FG000|Maintenance Phase|Other|0|||
144501313|NCT00771667|521032934|FG001|Maintenance Phase|Other|0|||
144501314|NCT00771667|521032935|FG002|Maintenance Phase|Other|0|||
144501315|NCT00771667|521032936|FG003|Maintenance Phase|Other|0|||
144501316|NCT00771667|521032937|FG004|Maintenance Phase|Other|0|||
144501317|NCT00771667|521032938|FG005|Maintenance Phase|Other|1|||
144501318|NCT00771667|521032939|FG006|Maintenance Phase|Other|2|||
144501319|NCT00771667|521032940|FG007|Maintenance Phase|Other|2|||
144501320|NCT00771667|521032941|FG008|Maintenance Phase|Other|3|||
144501321|NCT00771667|521032942|FG009|Maintenance Phase|Other|3|||
144501322|NCT01897233|521032945|FG000|Part B (24 Weeks)|Adverse Event|1|||
144501323|NCT01897233|521032945|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
144501324|NCT01897233|521032945|FG000|Part B (24 Weeks)|Physician Decision|1|||
144501325|NCT00628862|521032946|FG000|Overall Study|Adverse Event|6|||
144501326|NCT00628862|521032947|FG001|Overall Study|Adverse Event|8|||
144501327|NCT00628862|521032948|FG002|Overall Study|Adverse Event|10|||
144501328|NCT00628862|521032946|FG000|Overall Study|Withdrawal by Subject|4|||
144501329|NCT00628862|521032947|FG001|Overall Study|Withdrawal by Subject|6|||
144501330|NCT00628862|521032948|FG002|Overall Study|Withdrawal by Subject|11|||
144501331|NCT00628862|521032946|FG000|Overall Study|Lost to Follow-up|0|||
144501332|NCT00628862|521032947|FG001|Overall Study|Lost to Follow-up|2|||
144501333|NCT00628862|521032948|FG002|Overall Study|Lost to Follow-up|1|||
144501334|NCT00628862|521032946|FG000|Overall Study|Protocol Violation|1|||
144501335|NCT00628862|521032947|FG001|Overall Study|Protocol Violation|0|||
144501336|NCT00628862|521032948|FG002|Overall Study|Protocol Violation|0|||
144501337|NCT00628862|521032946|FG000|Overall Study|COPD Exacerbation|0|||
144501338|NCT00628862|521032947|FG001|Overall Study|COPD Exacerbation|1|||
144501339|NCT00628862|521032948|FG002|Overall Study|COPD Exacerbation|0|||
144501340|NCT01281813|521032959|FG000|Overall Study|Adverse Event|0|||
144501341|NCT01281813|521032960|FG001|Overall Study|Adverse Event|0|||
144501342|NCT01281813|521032961|FG002|Overall Study|Adverse Event|10|||
144501343|NCT01281813|521032959|FG000|Overall Study|Lost to Follow-up|0|||
144501344|NCT01281813|521032960|FG001|Overall Study|Lost to Follow-up|0|||
144501345|NCT01281813|521032961|FG002|Overall Study|Lost to Follow-up|31|||
144501346|NCT01281813|521032959|FG000|Overall Study|Withdrawal by Subject|0|||
144501347|NCT01281813|521032960|FG001|Overall Study|Withdrawal by Subject|0|||
144501348|NCT01281813|521032961|FG002|Overall Study|Withdrawal by Subject|13|||
144501349|NCT01281813|521032959|FG000|Overall Study|Subject Non-Compliant|0|||
144501350|NCT01281813|521032960|FG001|Overall Study|Subject Non-Compliant|0|||
144501351|NCT01281813|521032961|FG002|Overall Study|Subject Non-Compliant|6|||
144501352|NCT01281813|521032959|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
144501353|NCT01281813|521032960|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
144501354|NCT01281813|521032961|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
144501355|NCT01281813|521032959|FG000|Overall Study|Sponsor's Decision|4|||
144501356|NCT01281813|521032960|FG001|Overall Study|Sponsor's Decision|3|||
144501357|NCT01281813|521032961|FG002|Overall Study|Sponsor's Decision|7|||
144501358|NCT01281813|521032959|FG000|Overall Study|Switched to Commercially Available Medication|0|||
144501359|NCT01281813|521032960|FG001|Overall Study|Switched to Commercially Available Medication|0|||
144501360|NCT01281813|521032961|FG002|Overall Study|Switched to Commercially Available Medication|26|||
144501361|NCT01281813|521032959|FG000|Overall Study|Other|0|||
144501362|NCT01281813|521032960|FG001|Overall Study|Other|1|||
144501363|NCT01281813|521032961|FG002|Overall Study|Other|39|||
144501364|NCT05257798|521032968|FG000|Follow-up Phase|Lost to Follow-up|1|||
144501365|NCT05257798|521032969|FG001|Follow-up Phase|Lost to Follow-up|0|||
144501366|NCT00703911|521032976|FG000|Overall Study|Death|1|||
144501367|NCT00703911|521032976|FG000|Overall Study|Physician Decision|6|||
144501368|NCT00703911|521032976|FG000|Overall Study|Lost to Follow-up|1|||
144501369|NCT00703911|521032976|FG000|Overall Study|Withdrawal by Subject|2|||
144501370|NCT04033432|521032977|FG000|Overall Study|Progressive Disease|8|||
144501371|NCT04033432|521032977|FG000|Overall Study|Adverse Event|4|||
144501372|NCT04033432|521032977|FG000|Overall Study|Death|1|||
144501373|NCT02082158|521032980|FG000|Overall Study|Withdrawal by Subject|0|||
144501374|NCT02082158|521032981|FG001|Overall Study|Withdrawal by Subject|0|||
144501375|NCT02082158|521032982|FG002|Overall Study|Withdrawal by Subject|0|||
144501376|NCT02082158|521032983|FG003|Overall Study|Withdrawal by Subject|0|||
144501377|NCT02082158|521032984|FG004|Overall Study|Withdrawal by Subject|1|||
144501378|NCT02082158|521032985|FG005|Overall Study|Withdrawal by Subject|0|||
144501379|NCT02082158|521032980|FG000|Overall Study|Failed Fit-testing|8|||
144501380|NCT02082158|521032981|FG001|Overall Study|Failed Fit-testing|8|||
144501381|NCT02082158|521032982|FG002|Overall Study|Failed Fit-testing|14|||
144501382|NCT02082158|521032983|FG003|Overall Study|Failed Fit-testing|4|||
144501383|NCT02082158|521032984|FG004|Overall Study|Failed Fit-testing|3|||
144501384|NCT02082158|521032985|FG005|Overall Study|Failed Fit-testing|7|||
144501385|NCT00738699|521032989|FG000|Overall Study|Withdrawal by Subject|5|||
144501386|NCT00738699|521032990|FG001|Overall Study|Withdrawal by Subject|0|||
144501387|NCT00738699|521032989|FG000|Overall Study|Lost to Follow-up|1|||
144501388|NCT00738699|521032990|FG001|Overall Study|Lost to Follow-up|0|||
144501389|NCT00738699|521032989|FG000|Overall Study|Death|144|||
144501390|NCT00738699|521032990|FG001|Overall Study|Death|68|||
144501391|NCT00738699|521032989|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
144501392|NCT00738699|521032990|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
144501393|NCT00738699|521032989|FG000|Overall Study|Other|2|||
144501394|NCT00738699|521032990|FG001|Overall Study|Other|0|||
144501395|NCT00549848|521032991|FG000|Overall Study|Death|1|||
144501396|NCT00549848|521032992|FG001|Overall Study|Death|4|||
144501397|NCT00549848|521032993|FG002|Overall Study|Death|13|||
144501398|NCT00549848|521032991|FG000|Overall Study|Physician Decision|0|||
144501399|NCT00549848|521032992|FG001|Overall Study|Physician Decision|0|||
144501400|NCT00549848|521032993|FG002|Overall Study|Physician Decision|4|||
144501401|NCT00549848|521032991|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
144501402|NCT00549848|521032992|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
144501403|NCT00549848|521032993|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
144501404|NCT00549848|521032991|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
144501405|NCT00549848|521032992|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
144501406|NCT00549848|521032993|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
144501407|NCT00549848|521032991|FG000|Overall Study|Participant/Family Withdraw|2|||
144501408|NCT00549848|521032992|FG001|Overall Study|Participant/Family Withdraw|3|||
144501409|NCT00549848|521032993|FG002|Overall Study|Participant/Family Withdraw|5|||
144501410|NCT00549848|521032991|FG000|Overall Study|Second Malignancy|1|||
144501411|NCT00549848|521032992|FG001|Overall Study|Second Malignancy|0|||
144501412|NCT00549848|521032993|FG002|Overall Study|Second Malignancy|0|||
144501413|NCT00549848|521032991|FG000|Overall Study|Transplant|3|||
144501414|NCT00549848|521032992|FG001|Overall Study|Transplant|3|||
144501415|NCT00549848|521032993|FG002|Overall Study|Transplant|18|||
144501416|NCT00549848|521032991|FG000|Overall Study|Unacceptable Toxicity|1|||
144501417|NCT00549848|521032992|FG001|Overall Study|Unacceptable Toxicity|6|||
144501418|NCT00549848|521032993|FG002|Overall Study|Unacceptable Toxicity|6|||
144501419|NCT00868192|521032995|FG000|Overall Study|Ineligible|4|||
144501420|NCT02174562|521033002|FG000|Overall Study|Withdrawal by Subject|7|||
144501421|NCT02174562|521033003|FG001|Overall Study|Withdrawal by Subject|2|||
144501422|NCT02174562|521033002|FG000|Overall Study|Death|2|||
144501423|NCT02174562|521033003|FG001|Overall Study|Death|0|||
144501424|NCT02174562|521033002|FG000|Overall Study|Lost to Follow-up|0|||
144501425|NCT02174562|521033003|FG001|Overall Study|Lost to Follow-up|3|||
144501426|NCT05193318|521033005|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
144501427|NCT05193318|521033005|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
144501428|NCT00798096|521033006|FG000|Overall Study|Ongoing|2|||
144501429|NCT03670602|521033007|FG000|Overall Study|Lost to Follow-up|1|||
144501430|NCT03670602|521033008|FG001|Overall Study|Lost to Follow-up|0|||
144501431|NCT03670602|521033007|FG000|Overall Study|Withdrawal by Subject|0|||
144501432|NCT03670602|521033008|FG001|Overall Study|Withdrawal by Subject|3|||
144501433|NCT03201809|521033009|FG000|Overall Study|Lost to Follow-up|2|||
144501434|NCT03201809|521033010|FG001|Overall Study|Lost to Follow-up|0|||
144501435|NCT02846415|521033011|FG000|Overall Study|Lost to Follow-up|2|||
144501436|NCT02846415|521033012|FG001|Overall Study|Lost to Follow-up|0|||
144501437|NCT02846415|521033011|FG000|Overall Study|Withdrawal by Subject|1|||
144501438|NCT02846415|521033012|FG001|Overall Study|Withdrawal by Subject|1|||
144501439|NCT00957658|521033013|FG000|Overall Study|Death|1|||
144501440|NCT00957658|521033013|FG000|Overall Study|Lost to Follow-up|4|||
144501441|NCT00957658|521033013|FG000|Overall Study|Withdrawal by Subject|12|||
144501442|NCT00957658|521033013|FG000|Overall Study|Revision|1|||
144501443|NCT00957658|521033013|FG000|Overall Study|Incomplete 2 yr data|28|||
144501444|NCT00957658|521033013|FG000|Overall Study|Site termination|10|||
144501445|NCT00957658|521033013|FG000|Overall Study|unwilling/unable to return|2|||
144501446|NCT00957658|521033013|FG000|Overall Study|surgery cancelled|2|||
144501447|NCT00957658|521033013|FG000|Overall Study|Protocol Violation|5|||
144501448|NCT00246012|521033016|FG000|Overall Study|Adverse Event|0|||
144721399|NCT01296932|521835206|FG007|Overall Study|Dose limiting toxicity|0|||
144501449|NCT00246012|521033017|FG001|Overall Study|Adverse Event|0|||
144501450|NCT00246012|521033018|FG002|Overall Study|Adverse Event|0|||
144501451|NCT00246012|521033019|FG003|Overall Study|Adverse Event|0|||
144501452|NCT00246012|521033020|FG004|Overall Study|Adverse Event|0|||
144501453|NCT00246012|521033021|FG005|Overall Study|Adverse Event|1|||
144501454|NCT00246012|521033022|FG006|Overall Study|Adverse Event|0|||
144501455|NCT00246012|521033023|FG007|Overall Study|Adverse Event|0|||
144501456|NCT00246012|521033024|FG008|Overall Study|Adverse Event|2|||
144501457|NCT00246012|521033016|FG000|Overall Study|Withdrawal by Subject|0|||
144501458|NCT00246012|521033017|FG001|Overall Study|Withdrawal by Subject|0|||
144501459|NCT00246012|521033018|FG002|Overall Study|Withdrawal by Subject|0|||
144501460|NCT00246012|521033019|FG003|Overall Study|Withdrawal by Subject|0|||
144501461|NCT00246012|521033020|FG004|Overall Study|Withdrawal by Subject|0|||
144501462|NCT00246012|521033021|FG005|Overall Study|Withdrawal by Subject|1|||
144501463|NCT00246012|521033022|FG006|Overall Study|Withdrawal by Subject|0|||
144501464|NCT00246012|521033023|FG007|Overall Study|Withdrawal by Subject|0|||
144501465|NCT00246012|521033024|FG008|Overall Study|Withdrawal by Subject|0|||
144501466|NCT00246012|521033016|FG000|Overall Study|Disease progression|3|||
144501467|NCT00246012|521033017|FG001|Overall Study|Disease progression|1|||
144501468|NCT00246012|521033018|FG002|Overall Study|Disease progression|2|||
144501469|NCT00246012|521033019|FG003|Overall Study|Disease progression|3|||
144501470|NCT00246012|521033020|FG004|Overall Study|Disease progression|3|||
144501471|NCT00246012|521033021|FG005|Overall Study|Disease progression|25|||
144501472|NCT00246012|521033022|FG006|Overall Study|Disease progression|30|||
144501473|NCT00246012|521033023|FG007|Overall Study|Disease progression|27|||
144501474|NCT00246012|521033024|FG008|Overall Study|Disease progression|26|||
144501475|NCT00246012|521033016|FG000|Overall Study|Other|0|||
144501476|NCT00246012|521033017|FG001|Overall Study|Other|0|||
144501477|NCT00246012|521033018|FG002|Overall Study|Other|0|||
144501478|NCT00246012|521033019|FG003|Overall Study|Other|0|||
144501479|NCT00246012|521033020|FG004|Overall Study|Other|0|||
144501480|NCT00246012|521033021|FG005|Overall Study|Other|0|||
144501481|NCT00246012|521033022|FG006|Overall Study|Other|0|||
144501482|NCT00246012|521033023|FG007|Overall Study|Other|1|||
144501483|NCT00246012|521033024|FG008|Overall Study|Other|0|||
144501484|NCT00246012|521033016|FG000|Overall Study|Randomly assigned but not treated|0|||
144501485|NCT00246012|521033017|FG001|Overall Study|Randomly assigned but not treated|0|||
144501486|NCT00246012|521033018|FG002|Overall Study|Randomly assigned but not treated|0|||
144501487|NCT00246012|521033019|FG003|Overall Study|Randomly assigned but not treated|0|||
144501488|NCT00246012|521033020|FG004|Overall Study|Randomly assigned but not treated|0|||
144501489|NCT00246012|521033021|FG005|Overall Study|Randomly assigned but not treated|1|||
144501490|NCT00246012|521033022|FG006|Overall Study|Randomly assigned but not treated|1|||
144501491|NCT00246012|521033023|FG007|Overall Study|Randomly assigned but not treated|0|||
144501492|NCT00246012|521033024|FG008|Overall Study|Randomly assigned but not treated|0|||
144501493|NCT02469064|521033027|FG000|Overall Study|Request not to receive intervention.|1|||
144501494|NCT02469064|521033028|FG001|Overall Study|Request not to receive intervention.|3|||
144501495|NCT02155829|521033029|FG000|Overall Study|Adverse Event|1|||
144501496|NCT02155829|521033030|FG001|Overall Study|Adverse Event|0|||
144501497|NCT02155829|521033029|FG000|Overall Study|Withdrawal by Subject|3|||
144501498|NCT02155829|521033030|FG001|Overall Study|Withdrawal by Subject|3|||
144501499|NCT02155829|521033029|FG000|Overall Study|Protocol Violation|2|||
144501500|NCT02155829|521033030|FG001|Overall Study|Protocol Violation|0|||
144501501|NCT02046616|521033033|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
144501502|NCT02046616|521033033|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
144501503|NCT02046616|521033033|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
144501504|NCT02046616|521033033|FG000|24-Week Treatment Period|Physician Decision|3|||
144501505|NCT02046616|521033033|FG000|24-Week Treatment Period|Other|1|||
144501506|NCT02046616|521033033|FG000|8-Week FU Period|Lost to Follow-up|1|||
144501507|NCT01156116|521033034|FG000|Overall Study|Withdrawal by Subject|3|||
144501508|NCT01156116|521033035|FG001|Overall Study|Withdrawal by Subject|1|||
144501509|NCT01156116|521033034|FG000|Overall Study|CPAP intolerance|2|||
144501510|NCT01156116|521033035|FG001|Overall Study|CPAP intolerance|0|||
144501511|NCT00344019|521033036|FG000|Overall Study|did not meet final inclusion criteria|0|||
144501512|NCT00344019|521033037|FG001|Overall Study|did not meet final inclusion criteria|0|||
144501513|NCT00344019|521033038|FG002|Overall Study|did not meet final inclusion criteria|74|||
144501514|NCT02503202|521033039|FG000|Base Study: Up to Month 6|Death|1|||
144501515|NCT02503202|521033040|FG001|Base Study: Up to Month 6|Death|1|||
144501516|NCT02503202|521033041|FG002|Base Study: Up to Month 6|Death|0|||
144501517|NCT02503202|521033042|FG003|Base Study: Up to Month 6|Death|0|||
144501518|NCT02503202|521033043|FG004|Base Study: Up to Month 6|Death|0|||
144501519|NCT02503202|521033039|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
144501520|NCT02503202|521033040|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
144501521|NCT02503202|521033041|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
144501522|NCT02503202|521033042|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
144501523|NCT02503202|521033043|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
144501524|NCT02503202|521033039|FG000|Base Study: Up to Month 6|Physician Decision|0|||
144501525|NCT02503202|521033040|FG001|Base Study: Up to Month 6|Physician Decision|0|||
144501526|NCT02503202|521033041|FG002|Base Study: Up to Month 6|Physician Decision|0|||
144501527|NCT02503202|521033042|FG003|Base Study: Up to Month 6|Physician Decision|0|||
144501528|NCT02503202|521033043|FG004|Base Study: Up to Month 6|Physician Decision|1|||
144501529|NCT02503202|521033039|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
144501530|NCT02503202|521033040|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
144501531|NCT02503202|521033041|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
144501532|NCT02503202|521033042|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
144501533|NCT02503202|521033043|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
144501534|NCT02503202|521033039|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
144501535|NCT02503202|521033040|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
144501536|NCT02503202|521033041|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
144501537|NCT02503202|521033042|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
144501538|NCT02503202|521033043|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
144501539|NCT02503202|521033039|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
144501540|NCT02503202|521033040|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
144501541|NCT02503202|521033041|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
144501542|NCT02503202|521033042|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
144501543|NCT02503202|521033043|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
144501544|NCT02503202|521033039|FG000|Extension: Month 6 to 24|Death|1|||
144501545|NCT02503202|521033040|FG001|Extension: Month 6 to 24|Death|0|||
144501546|NCT02503202|521033041|FG002|Extension: Month 6 to 24|Death|0|||
144501547|NCT02503202|521033042|FG003|Extension: Month 6 to 24|Death|0|||
144501548|NCT02503202|521033043|FG004|Extension: Month 6 to 24|Death|0|||
144501549|NCT02503202|521033039|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
144501550|NCT02503202|521033040|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
144501551|NCT02503202|521033041|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
144501552|NCT02503202|521033042|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
144501553|NCT02503202|521033043|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
144501554|NCT02503202|521033039|FG000|Extension: Month 6 to 24|Physician Decision|1|||
144501555|NCT02503202|521033040|FG001|Extension: Month 6 to 24|Physician Decision|0|||
144501556|NCT02503202|521033041|FG002|Extension: Month 6 to 24|Physician Decision|1|||
144501557|NCT02503202|521033042|FG003|Extension: Month 6 to 24|Physician Decision|3|||
144501558|NCT02503202|521033043|FG004|Extension: Month 6 to 24|Physician Decision|0|||
144501559|NCT02503202|521033039|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
144501560|NCT02503202|521033040|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
144501561|NCT02503202|521033041|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
144501562|NCT02503202|521033042|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
144501563|NCT02503202|521033043|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
144501564|NCT00130637|521033044|FG000|Overall Study|Adverse Event|2|||
144501565|NCT00130637|521033044|FG000|Overall Study|Withdrawal by Subject|1|||
144501566|NCT01591616|521033046|FG000|Overall Study|Withdrawal by Subject|1|||
144721400|NCT01296932|521835207|FG008|Overall Study|Dose limiting toxicity|1|||
144501567|NCT00414648|521033049|FG000|Overall Study|Adverse Event|5|||
144721401|NCT01296932|521835199|FG000|Overall Study|Progressive disease|2|||
144721402|NCT01296932|521835200|FG001|Overall Study|Progressive disease|0|||
144721403|NCT01296932|521835201|FG002|Overall Study|Progressive disease|1|||
144721404|NCT01296932|521835202|FG003|Overall Study|Progressive disease|1|||
144721405|NCT01296932|521835203|FG004|Overall Study|Progressive disease|2|||
144721406|NCT01296932|521835204|FG005|Overall Study|Progressive disease|3|||
144721407|NCT01296932|521835205|FG006|Overall Study|Progressive disease|1|||
144721408|NCT01296932|521835206|FG007|Overall Study|Progressive disease|0|||
144721409|NCT01296932|521835207|FG008|Overall Study|Progressive disease|0|||
144721410|NCT01296932|521835199|FG000|Overall Study|Withdrawal by Subject|0|||
144721411|NCT01296932|521835200|FG001|Overall Study|Withdrawal by Subject|0|||
144501568|NCT00414648|521033050|FG001|Overall Study|Adverse Event|5|||
144501569|NCT00414648|521033049|FG000|Overall Study|Death|0|||
144501570|NCT00414648|521033050|FG001|Overall Study|Death|1|||
144501571|NCT00414648|521033049|FG000|Overall Study|Lack of Efficacy|0|||
144501572|NCT00414648|521033050|FG001|Overall Study|Lack of Efficacy|2|||
144501573|NCT00414648|521033049|FG000|Overall Study|Withdrawal by Subject|0|||
144501574|NCT00414648|521033050|FG001|Overall Study|Withdrawal by Subject|1|||
144501575|NCT01194258|521033051|FG000|Titration Period|Withdrawal by Subject|6|||
144501576|NCT01194258|521033052|FG001|Titration Period|Withdrawal by Subject|0|||
144501577|NCT01194258|521033053|FG002|Titration Period|Withdrawal by Subject|0|||
144501578|NCT01194258|521033054|FG003|Titration Period|Withdrawal by Subject|0|||
144501579|NCT01194258|521033055|FG004|Titration Period|Withdrawal by Subject|0|||
144501580|NCT01194258|521033051|FG000|Titration Period|Lost to Follow-up|2|||
144501581|NCT01194258|521033052|FG001|Titration Period|Lost to Follow-up|0|||
144501582|NCT01194258|521033053|FG002|Titration Period|Lost to Follow-up|0|||
144501583|NCT01194258|521033054|FG003|Titration Period|Lost to Follow-up|0|||
144501584|NCT01194258|521033055|FG004|Titration Period|Lost to Follow-up|0|||
144501585|NCT01194258|521033051|FG000|Titration Period|Titration failure|3|||
144501586|NCT01194258|521033052|FG001|Titration Period|Titration failure|0|||
144501587|NCT01194258|521033053|FG002|Titration Period|Titration failure|0|||
144501588|NCT01194258|521033054|FG003|Titration Period|Titration failure|0|||
144501589|NCT01194258|521033055|FG004|Titration Period|Titration failure|0|||
144501590|NCT01194258|521033051|FG000|Period 1 (12 Weeks)|Death|0|||
144501591|NCT01194258|521033052|FG001|Period 1 (12 Weeks)|Death|0|||
144501592|NCT01194258|521033053|FG002|Period 1 (12 Weeks)|Death|0|||
144501593|NCT01194258|521033054|FG003|Period 1 (12 Weeks)|Death|0|||
144501594|NCT01194258|521033055|FG004|Period 1 (12 Weeks)|Death|1|||
144501595|NCT01194258|521033051|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144501596|NCT01194258|521033052|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144501597|NCT01194258|521033053|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144501598|NCT01194258|521033054|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144501599|NCT01194258|521033055|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
144501600|NCT01194258|521033051|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
144501601|NCT01194258|521033052|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
144501602|NCT01194258|521033053|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
144501603|NCT01194258|521033054|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
144501604|NCT01194258|521033055|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
144370089|NCT02129699|520562807|FG001|Overall Study|Did not start treatment|2|||
144370090|NCT00670748|520562813|FG000|Overall Study|Death during treatment|1|||
144501605|NCT01194258|521033051|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144501606|NCT01194258|521033052|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144501607|NCT01194258|521033053|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144501608|NCT01194258|521033054|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144501609|NCT01194258|521033055|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144501610|NCT02026258|521033058|FG000|Randomized|Did not start treatment|2|||
144501611|NCT02026258|521033059|FG001|Randomized|Did not start treatment|1|||
144501612|NCT02026258|521033058|FG000|Randomized|Change in treatment plan|1|||
144501613|NCT02026258|521033059|FG001|Randomized|Change in treatment plan|0|||
144501614|NCT02026258|521033058|FG000|Randomized|Presence of periodontal disease|1|||
144501615|NCT02026258|521033059|FG001|Randomized|Presence of periodontal disease|1|||
144501616|NCT02026258|521033058|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
144501617|NCT02026258|521033059|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
144501618|NCT02026258|521033058|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
144501619|NCT02026258|521033059|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
144501620|NCT04246762|521033060|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
144501621|NCT00597519|521033061|FG000|Overall Study|Death|1|||
144501622|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
144501623|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
144501624|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
144501625|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
144501626|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
144501627|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
144501628|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
144501629|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
144501630|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
144501631|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
144501632|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
144501633|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
144501634|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Death|7|||
144501635|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Death|4|||
144501636|NCT00410124|521033062|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
144501637|NCT00410124|521033063|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
144501638|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
144501639|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
144501640|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
144501641|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
144501642|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
144501643|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
144501644|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
144501645|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
144501646|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
144501647|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
144501648|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
144370091|NCT00670748|520562814|FG001|Overall Study|Death during treatment|1|||
144501649|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
144501650|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
144501651|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
144501652|NCT00410124|521033062|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
144501653|NCT00410124|521033063|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
144501654|NCT02357784|521033068|FG000|Overall Study|Withdrawal by Subject|1|||
144501655|NCT01751724|521033069|FG000|Overall Study|extubated bef.start assigned treatment|1|||
144501656|NCT01751724|521033070|FG001|Overall Study|extubated bef.start assigned treatment|0|||
144501657|NCT01751724|521033069|FG000|Overall Study|withdrawn by parent|0|||
144501658|NCT01751724|521033070|FG001|Overall Study|withdrawn by parent|2|||
144501659|NCT03354390|521033071|FG000|Level 1|Death|2|||
144501660|NCT03354390|521033072|FG001|Level 1|Death|0|||
144501661|NCT03354390|521033073|FG002|Level 1|Death|0|||
144501662|NCT03354390|521033074|FG003|Level 1|Death|0|||
144501663|NCT03354390|521033071|FG000|Level 1|Physician Decision|1|||
144501664|NCT03354390|521033072|FG001|Level 1|Physician Decision|0|||
144501665|NCT03354390|521033073|FG002|Level 1|Physician Decision|0|||
144501666|NCT03354390|521033074|FG003|Level 1|Physician Decision|0|||
144501667|NCT03354390|521033071|FG000|Level 2|Physician Decision|0|||
144501668|NCT03354390|521033072|FG001|Level 2|Physician Decision|2|||
144501669|NCT03354390|521033073|FG002|Level 2|Physician Decision|0|||
144501670|NCT03354390|521033074|FG003|Level 2|Physician Decision|0|||
144501671|NCT03354390|521033071|FG000|Level 2|Lack of Efficacy|0|||
144501672|NCT03354390|521033072|FG001|Level 2|Lack of Efficacy|1|||
144501673|NCT03354390|521033073|FG002|Level 2|Lack of Efficacy|0|||
144501674|NCT03354390|521033074|FG003|Level 2|Lack of Efficacy|0|||
144501675|NCT03354390|521033071|FG000|Level 2|Lost to Follow-up|0|||
144501676|NCT03354390|521033072|FG001|Level 2|Lost to Follow-up|1|||
144501677|NCT03354390|521033073|FG002|Level 2|Lost to Follow-up|0|||
144501678|NCT03354390|521033074|FG003|Level 2|Lost to Follow-up|0|||
144501679|NCT03354390|521033071|FG000|Level 3|Death|0|||
144501680|NCT03354390|521033072|FG001|Level 3|Death|0|||
144501681|NCT03354390|521033073|FG002|Level 3|Death|1|||
144501682|NCT03354390|521033074|FG003|Level 3|Death|0|||
144501683|NCT03354390|521033071|FG000|Level 3|Physician Decision|0|||
144501684|NCT03354390|521033072|FG001|Level 3|Physician Decision|0|||
144501685|NCT03354390|521033073|FG002|Level 3|Physician Decision|2|||
144501686|NCT03354390|521033074|FG003|Level 3|Physician Decision|0|||
144501687|NCT03354390|521033071|FG000|Level 4|Death|0|||
144501688|NCT03354390|521033072|FG001|Level 4|Death|0|||
144501689|NCT03354390|521033073|FG002|Level 4|Death|0|||
144501690|NCT03354390|521033074|FG003|Level 4|Death|3|||
144501691|NCT01546155|521034425|FG000|Overall Study|could not tolerate long scan duration|3|||
144501692|NCT00864682|521034430|FG000|Overall Study|Protocol Violation|2|||
144501693|NCT00864682|521034431|FG001|Overall Study|Protocol Violation|1|||
144501694|NCT00864682|521034432|FG002|Overall Study|Protocol Violation|2|||
144501695|NCT01585038|521034433|FG000|Overall Study|Adverse Event|2|||
144501696|NCT01585038|521034434|FG001|Overall Study|Adverse Event|2|||
144501697|NCT01833832|521034438|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
144501698|NCT04842604|521034439|FG000|Overall Study|Death|1|||
144501699|NCT04842604|521034440|FG001|Overall Study|Death|0|||
144501700|NCT04842604|521034439|FG000|Overall Study|Other|4|||
144501701|NCT04842604|521034440|FG001|Overall Study|Other|4|||
144501702|NCT04842604|521034439|FG000|Overall Study|Randomized but not treated|1|||
144501703|NCT04842604|521034440|FG001|Overall Study|Randomized but not treated|0|||
144501704|NCT01191788|521034444|FG000|Overall Study|Lost to Follow-up|21|||
144501705|NCT01191788|521034445|FG001|Overall Study|Lost to Follow-up|22|||
144501706|NCT00217672|521034449|FG000|Allocation|Ineligible|2|||
144501707|NCT00217672|521034450|FG001|Allocation|Ineligible|0|||
144501708|NCT00217672|521034449|FG000|Treatment|disease progression|33|||
144501709|NCT00217672|521034450|FG001|Treatment|disease progression|4|||
144501710|NCT00217672|521034449|FG000|Treatment|Adverse Event|18|||
144501711|NCT00217672|521034450|FG001|Treatment|Adverse Event|2|||
144501712|NCT00217672|521034449|FG000|Treatment|reqd treatment not permitted by protocol|6|||
144501713|NCT00217672|521034450|FG001|Treatment|reqd treatment not permitted by protocol|0|||
144501714|NCT00217672|521034449|FG000|Treatment|Physician Decision|6|||
144501715|NCT00217672|521034450|FG001|Treatment|Physician Decision|0|||
144501716|NCT00217672|521034449|FG000|Treatment|insurance issues|1|||
144501717|NCT00217672|521034450|FG001|Treatment|insurance issues|1|||
144501718|NCT00217672|521034449|FG000|Treatment|Death|2|||
144501719|NCT00217672|521034450|FG001|Treatment|Death|0|||
144501720|NCT00217672|521034449|FG000|Treatment|secondary malignancy|1|||
144501721|NCT00217672|521034450|FG001|Treatment|secondary malignancy|0|||
144501722|NCT00217672|521034449|FG000|Follow-up|Withdrawal by Subject|4|||
144501723|NCT00217672|521034450|FG001|Follow-up|Withdrawal by Subject|0|||
144501724|NCT00217672|521034449|FG000|Follow-up|Lost to Follow-up|1|||
144501725|NCT00217672|521034450|FG001|Follow-up|Lost to Follow-up|0|||
144501726|NCT01959412|521034452|FG000|Overall Study|Protocol deviation|1|||
144501727|NCT01959412|521034453|FG001|Overall Study|Protocol deviation|1|||
144501728|NCT01959412|521034454|FG002|Overall Study|Protocol deviation|0|||
144501729|NCT01959412|521034455|FG003|Overall Study|Protocol deviation|1|||
144501730|NCT01959412|521034456|FG004|Overall Study|Protocol deviation|3|||
144501731|NCT01959412|521034457|FG005|Overall Study|Protocol deviation|0|||
144501732|NCT01959412|521034452|FG000|Overall Study|Adverse Event|0|||
144501733|NCT01959412|521034453|FG001|Overall Study|Adverse Event|0|||
144501734|NCT01959412|521034454|FG002|Overall Study|Adverse Event|0|||
144501735|NCT01959412|521034455|FG003|Overall Study|Adverse Event|1|||
144501736|NCT01959412|521034456|FG004|Overall Study|Adverse Event|0|||
144501737|NCT01959412|521034457|FG005|Overall Study|Adverse Event|0|||
144501738|NCT01186848|521034463|FG000|Overall Study|Lost to Follow-up|4|||
144501739|NCT01186848|521034463|FG000|Overall Study|Withdrawal by Subject|2|||
144501740|NCT01186848|521034463|FG000|Overall Study|Adverse Event|2|||
144501741|NCT00158054|521034467|FG000|Overall Study|Refused to continue|3|||
144501742|NCT00158054|521034468|FG001|Overall Study|Refused to continue|0|||
144501743|NCT00158054|521034467|FG000|Overall Study|Unavailable for follow up|7|||
144501744|NCT00158054|521034468|FG001|Overall Study|Unavailable for follow up|3|||
144501745|NCT04567888|521034474|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
144501746|NCT04567888|521034475|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
144501747|NCT04567888|521034474|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
144501748|NCT04567888|521034475|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
144501749|NCT04567888|521034474|FG000|Overall Study|Reported Unusual Birth Year|2|||
144501750|NCT04567888|521034475|FG001|Overall Study|Reported Unusual Birth Year|3|||
144501751|NCT04567888|521034474|FG000|Overall Study|Duplicate Responses|0|||
144501752|NCT04567888|521034475|FG001|Overall Study|Duplicate Responses|1|||
144501753|NCT00619645|521034476|FG000|Overall Study|Adverse Event|1|||
144501754|NCT00436644|521034477|FG000|Overall Study|Adverse Event|2|||
144501755|NCT00436644|521034477|FG000|Overall Study|Death|1|||
144501756|NCT04364269|521034478|FG000|Overall Study|Adverse Event|1|||
144501757|NCT04364269|521034479|FG001|Overall Study|Adverse Event|0|||
144501758|NCT04364269|521034480|FG002|Overall Study|Adverse Event|0|||
144501759|NCT04364269|521034478|FG000|Overall Study|Withdrawal by Subject|0|||
144501760|NCT04364269|521034479|FG001|Overall Study|Withdrawal by Subject|1|||
144501761|NCT04364269|521034480|FG002|Overall Study|Withdrawal by Subject|0|||
144501762|NCT01490580|521034482|FG000|Overall Study|Parents withdrew consent|0|||
144501763|NCT01490580|521034483|FG001|Overall Study|Parents withdrew consent|2|||
144501764|NCT00878722|521034484|FG000|Overall Study|Progressive disease|3|||
144501765|NCT00878722|521034485|FG001|Overall Study|Progressive disease|3|||
144501766|NCT00878722|521034486|FG002|Overall Study|Progressive disease|3|||
144501767|NCT00878722|521034487|FG003|Overall Study|Progressive disease|7|||
144501768|NCT00878722|521034488|FG004|Overall Study|Progressive disease|7|||
144501769|NCT00878722|521034489|FG005|Overall Study|Progressive disease|1|||
144501770|NCT00878722|521034490|FG006|Overall Study|Progressive disease|4|||
144501771|NCT00878722|521034491|FG007|Overall Study|Progressive disease|3|||
144501772|NCT00878722|521034484|FG000|Overall Study|Death|0|||
144501773|NCT00878722|521034485|FG001|Overall Study|Death|0|||
144501774|NCT00878722|521034486|FG002|Overall Study|Death|0|||
144501775|NCT00878722|521034487|FG003|Overall Study|Death|1|||
144501776|NCT00878722|521034488|FG004|Overall Study|Death|0|||
144501777|NCT00878722|521034489|FG005|Overall Study|Death|1|||
144501778|NCT00878722|521034490|FG006|Overall Study|Death|0|||
144501779|NCT00878722|521034491|FG007|Overall Study|Death|2|||
144501780|NCT00878722|521034484|FG000|Overall Study|Adverse Event|0|||
144501781|NCT00878722|521034485|FG001|Overall Study|Adverse Event|0|||
144501782|NCT00878722|521034486|FG002|Overall Study|Adverse Event|0|||
144501783|NCT00878722|521034487|FG003|Overall Study|Adverse Event|0|||
144501784|NCT00878722|521034488|FG004|Overall Study|Adverse Event|0|||
144501785|NCT00878722|521034489|FG005|Overall Study|Adverse Event|0|||
144501786|NCT00878722|521034490|FG006|Overall Study|Adverse Event|2|||
144501787|NCT00878722|521034491|FG007|Overall Study|Adverse Event|0|||
144501788|NCT00878722|521034484|FG000|Overall Study|Withdrawal by Subject|0|||
144501789|NCT00878722|521034485|FG001|Overall Study|Withdrawal by Subject|0|||
144501790|NCT00878722|521034486|FG002|Overall Study|Withdrawal by Subject|0|||
144501791|NCT00878722|521034487|FG003|Overall Study|Withdrawal by Subject|0|||
144501792|NCT00878722|521034488|FG004|Overall Study|Withdrawal by Subject|0|||
144501793|NCT00878722|521034489|FG005|Overall Study|Withdrawal by Subject|0|||
144501794|NCT00878722|521034490|FG006|Overall Study|Withdrawal by Subject|0|||
144501795|NCT00878722|521034491|FG007|Overall Study|Withdrawal by Subject|2|||
144501796|NCT00878722|521034484|FG000|Overall Study|Relapse|0|||
144501797|NCT00878722|521034485|FG001|Overall Study|Relapse|0|||
144501798|NCT00878722|521034486|FG002|Overall Study|Relapse|0|||
144501799|NCT00878722|521034487|FG003|Overall Study|Relapse|1|||
144501800|NCT00878722|521034488|FG004|Overall Study|Relapse|0|||
144501801|NCT00878722|521034489|FG005|Overall Study|Relapse|0|||
144501802|NCT00878722|521034490|FG006|Overall Study|Relapse|0|||
144501803|NCT00878722|521034491|FG007|Overall Study|Relapse|0|||
144501804|NCT00383188|521034492|FG000|Overall Study|Adverse Event|4|||
144501805|NCT00383188|521034493|FG001|Overall Study|Adverse Event|7|||
144501806|NCT00383188|521034494|FG002|Overall Study|Adverse Event|9|||
144501807|NCT00383188|521034495|FG003|Overall Study|Adverse Event|8|||
144501808|NCT00383188|521034496|FG004|Overall Study|Adverse Event|8|||
144501809|NCT00383188|521034492|FG000|Overall Study|Lack of Efficacy|9|||
144501810|NCT00383188|521034493|FG001|Overall Study|Lack of Efficacy|3|||
144501811|NCT00383188|521034494|FG002|Overall Study|Lack of Efficacy|3|||
144501812|NCT00383188|521034495|FG003|Overall Study|Lack of Efficacy|2|||
144501813|NCT00383188|521034496|FG004|Overall Study|Lack of Efficacy|6|||
144501814|NCT00383188|521034492|FG000|Overall Study|Other|3|||
144501815|NCT00383188|521034493|FG001|Overall Study|Other|1|||
144501816|NCT00383188|521034494|FG002|Overall Study|Other|0|||
144501817|NCT00383188|521034495|FG003|Overall Study|Other|2|||
144501818|NCT00383188|521034496|FG004|Overall Study|Other|6|||
144501819|NCT00383188|521034492|FG000|Overall Study|No longer willing to participate|1|||
144501820|NCT00383188|521034493|FG001|Overall Study|No longer willing to participate|0|||
144501821|NCT00383188|521034494|FG002|Overall Study|No longer willing to participate|1|||
144501822|NCT00383188|521034495|FG003|Overall Study|No longer willing to participate|0|||
144501823|NCT00383188|521034496|FG004|Overall Study|No longer willing to participate|2|||
144501824|NCT00383188|521034492|FG000|Overall Study|Lost to Follow-up|0|||
144501825|NCT00383188|521034493|FG001|Overall Study|Lost to Follow-up|0|||
144501826|NCT00383188|521034494|FG002|Overall Study|Lost to Follow-up|0|||
144501827|NCT00383188|521034495|FG003|Overall Study|Lost to Follow-up|0|||
144501828|NCT00383188|521034496|FG004|Overall Study|Lost to Follow-up|1|||
144501829|NCT02873754|521034497|FG000|Overall Study|Lost to Follow-up|5|||
144501830|NCT02873754|521034497|FG000|Overall Study|Couldn't complete study procedures|1|||
144501831|NCT02341625|521034507|FG000|Overall Study|Disease Progression|2|||
144501832|NCT02341625|521034508|FG001|Overall Study|Disease Progression|2|||
144501833|NCT02341625|521034509|FG002|Overall Study|Disease Progression|3|||
144501834|NCT02341625|521034510|FG003|Overall Study|Disease Progression|6|||
144501835|NCT02341625|521034511|FG004|Overall Study|Disease Progression|7|||
144501836|NCT02341625|521034512|FG005|Overall Study|Disease Progression|7|||
144501837|NCT02341625|521034513|FG006|Overall Study|Disease Progression|28|||
144501838|NCT02341625|521034514|FG007|Overall Study|Disease Progression|5|||
144501839|NCT02341625|521034515|FG008|Overall Study|Disease Progression|4|||
144501840|NCT02341625|521034516|FG009|Overall Study|Disease Progression|19|||
144501841|NCT02341625|521034507|FG000|Overall Study|Study Drug Toxicity|0|||
144501842|NCT02341625|521034508|FG001|Overall Study|Study Drug Toxicity|0|||
144501843|NCT02341625|521034509|FG002|Overall Study|Study Drug Toxicity|0|||
144501844|NCT02341625|521034510|FG003|Overall Study|Study Drug Toxicity|1|||
144501845|NCT02341625|521034511|FG004|Overall Study|Study Drug Toxicity|0|||
144501846|NCT02341625|521034512|FG005|Overall Study|Study Drug Toxicity|3|||
144501847|NCT02341625|521034513|FG006|Overall Study|Study Drug Toxicity|10|||
144501848|NCT02341625|521034514|FG007|Overall Study|Study Drug Toxicity|0|||
144501849|NCT02341625|521034515|FG008|Overall Study|Study Drug Toxicity|0|||
144501850|NCT02341625|521034516|FG009|Overall Study|Study Drug Toxicity|3|||
144501851|NCT02341625|521034507|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501852|NCT02341625|521034508|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501853|NCT02341625|521034509|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501854|NCT02341625|521034510|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501855|NCT02341625|521034511|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501856|NCT02341625|521034512|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501857|NCT02341625|521034513|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
144501858|NCT02341625|521034514|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
144501859|NCT02341625|521034515|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144501860|NCT02341625|521034516|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
144501861|NCT02341625|521034507|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501862|NCT02341625|521034508|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501863|NCT02341625|521034509|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501864|NCT02341625|521034510|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501865|NCT02341625|521034511|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501866|NCT02341625|521034512|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501867|NCT02341625|521034513|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
144501868|NCT02341625|521034514|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
144501869|NCT02341625|521034515|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501870|NCT02341625|521034516|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
144501871|NCT02341625|521034507|FG000|Overall Study|Participant Withdrew Consent|0|||
144501872|NCT02341625|521034508|FG001|Overall Study|Participant Withdrew Consent|0|||
144501873|NCT02341625|521034509|FG002|Overall Study|Participant Withdrew Consent|0|||
144501874|NCT02341625|521034510|FG003|Overall Study|Participant Withdrew Consent|1|||
144501875|NCT02341625|521034511|FG004|Overall Study|Participant Withdrew Consent|0|||
144501876|NCT02341625|521034512|FG005|Overall Study|Participant Withdrew Consent|0|||
144501877|NCT02341625|521034513|FG006|Overall Study|Participant Withdrew Consent|0|||
144501878|NCT02341625|521034514|FG007|Overall Study|Participant Withdrew Consent|0|||
144501879|NCT02341625|521034515|FG008|Overall Study|Participant Withdrew Consent|0|||
144501880|NCT02341625|521034516|FG009|Overall Study|Participant Withdrew Consent|0|||
144501881|NCT02341625|521034507|FG000|Overall Study|Completed Treatment as per Protocol|0|||
144501882|NCT02341625|521034508|FG001|Overall Study|Completed Treatment as per Protocol|0|||
144501883|NCT02341625|521034509|FG002|Overall Study|Completed Treatment as per Protocol|0|||
144501884|NCT02341625|521034510|FG003|Overall Study|Completed Treatment as per Protocol|0|||
144501885|NCT02341625|521034511|FG004|Overall Study|Completed Treatment as per Protocol|0|||
144501886|NCT02341625|521034512|FG005|Overall Study|Completed Treatment as per Protocol|0|||
144501887|NCT02341625|521034513|FG006|Overall Study|Completed Treatment as per Protocol|0|||
144501888|NCT02341625|521034514|FG007|Overall Study|Completed Treatment as per Protocol|0|||
144501889|NCT02341625|521034515|FG008|Overall Study|Completed Treatment as per Protocol|0|||
144501890|NCT02341625|521034516|FG009|Overall Study|Completed Treatment as per Protocol|1|||
144501891|NCT02341625|521034507|FG000|Overall Study|Other Reasons|0|||
144501892|NCT02341625|521034508|FG001|Overall Study|Other Reasons|0|||
144501893|NCT02341625|521034509|FG002|Overall Study|Other Reasons|0|||
144501894|NCT02341625|521034510|FG003|Overall Study|Other Reasons|0|||
144501895|NCT02341625|521034511|FG004|Overall Study|Other Reasons|1|||
144501896|NCT02341625|521034512|FG005|Overall Study|Other Reasons|0|||
144501897|NCT02341625|521034513|FG006|Overall Study|Other Reasons|5|||
144501898|NCT02341625|521034514|FG007|Overall Study|Other Reasons|0|||
144501899|NCT02341625|521034515|FG008|Overall Study|Other Reasons|0|||
144501900|NCT02341625|521034516|FG009|Overall Study|Other Reasons|2|||
144501901|NCT02341625|521034507|FG000|Overall Study|Not Reported|0|||
144501902|NCT02341625|521034508|FG001|Overall Study|Not Reported|0|||
144501903|NCT02341625|521034509|FG002|Overall Study|Not Reported|0|||
144501904|NCT02341625|521034510|FG003|Overall Study|Not Reported|0|||
144501905|NCT02341625|521034511|FG004|Overall Study|Not Reported|0|||
144501906|NCT02341625|521034512|FG005|Overall Study|Not Reported|0|||
144501907|NCT02341625|521034513|FG006|Overall Study|Not Reported|0|||
144501908|NCT02341625|521034514|FG007|Overall Study|Not Reported|0|||
144501909|NCT02341625|521034515|FG008|Overall Study|Not Reported|0|||
144501910|NCT02341625|521034516|FG009|Overall Study|Not Reported|3|||
144501911|NCT01839877|521034519|FG000|Overall Study|Protocol Violation|1|||
144501912|NCT03368001|521034520|FG000|Allocation|Lost to Pretest|16|||
144501913|NCT03368001|521034521|FG001|Allocation|Lost to Pretest|25|||
144501914|NCT03368001|521034520|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
144501915|NCT03368001|521034521|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
144501916|NCT03368001|521034520|FG000|Posttest|Lost to Posttest|7|||
144501917|NCT03368001|521034521|FG001|Posttest|Lost to Posttest|11|||
144501918|NCT03368001|521034520|FG000|Posttest|Discontinued Intervention|6|||
144501919|NCT03368001|521034521|FG001|Posttest|Discontinued Intervention|19|||
144501920|NCT03368001|521034520|FG000|Follow-up|Lost to Follow-up|6|||
144501921|NCT03368001|521034521|FG001|Follow-up|Lost to Follow-up|3|||
144501922|NCT04771273|521034522|FG000|Dose Escalation Period|Not treated with trial medication|0|||
144501923|NCT04771273|521034523|FG001|Dose Escalation Period|Not treated with trial medication|1|||
144501924|NCT04771273|521034524|FG002|Dose Escalation Period|Not treated with trial medication|1|||
144501925|NCT04771273|521034525|FG003|Dose Escalation Period|Not treated with trial medication|0|||
144501926|NCT04771273|521034522|FG000|Dose Escalation Period|Other reasons than listed|2|||
144501927|NCT04771273|521034523|FG001|Dose Escalation Period|Other reasons than listed|0|||
144501928|NCT04771273|521034524|FG002|Dose Escalation Period|Other reasons than listed|2|||
144501929|NCT04771273|521034525|FG003|Dose Escalation Period|Other reasons than listed|1|||
144501930|NCT04771273|521034522|FG000|Dose Escalation Period|Protocol Violation|0|||
144501931|NCT04771273|521034523|FG001|Dose Escalation Period|Protocol Violation|0|||
144501932|NCT04771273|521034524|FG002|Dose Escalation Period|Protocol Violation|3|||
144501933|NCT04771273|521034525|FG003|Dose Escalation Period|Protocol Violation|1|||
144501934|NCT04771273|521034522|FG000|Dose Escalation Period|Burden of study procedures|1|||
144501935|NCT04771273|521034523|FG001|Dose Escalation Period|Burden of study procedures|0|||
144501936|NCT04771273|521034524|FG002|Dose Escalation Period|Burden of study procedures|0|||
144501937|NCT04771273|521034525|FG003|Dose Escalation Period|Burden of study procedures|0|||
144501938|NCT04771273|521034522|FG000|Dose Escalation Period|Change of residence|0|||
144501939|NCT04771273|521034523|FG001|Dose Escalation Period|Change of residence|0|||
144501940|NCT04771273|521034524|FG002|Dose Escalation Period|Change of residence|0|||
144501941|NCT04771273|521034525|FG003|Dose Escalation Period|Change of residence|1|||
144501942|NCT04771273|521034522|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
144501943|NCT04771273|521034523|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
144501944|NCT04771273|521034524|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
144501945|NCT04771273|521034525|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
144501946|NCT04771273|521034522|FG000|Dose Escalation Period|Adverse Event|8|||
144501947|NCT04771273|521034523|FG001|Dose Escalation Period|Adverse Event|9|||
144501948|NCT04771273|521034524|FG002|Dose Escalation Period|Adverse Event|12|||
144501949|NCT04771273|521034525|FG003|Dose Escalation Period|Adverse Event|2|||
144501950|NCT04771273|521034522|FG000|Maintenance Period|Other than listed|4|||
144501951|NCT04771273|521034523|FG001|Maintenance Period|Other than listed|2|||
144501952|NCT04771273|521034524|FG002|Maintenance Period|Other than listed|0|||
144501953|NCT04771273|521034525|FG003|Maintenance Period|Other than listed|3|||
144501954|NCT04771273|521034522|FG000|Maintenance Period|Burden of study procedures|1|||
144501955|NCT04771273|521034523|FG001|Maintenance Period|Burden of study procedures|0|||
144501956|NCT04771273|521034524|FG002|Maintenance Period|Burden of study procedures|0|||
144501957|NCT04771273|521034525|FG003|Maintenance Period|Burden of study procedures|0|||
144501958|NCT04771273|521034522|FG000|Maintenance Period|Change of residence|0|||
144501959|NCT04771273|521034523|FG001|Maintenance Period|Change of residence|1|||
144501960|NCT04771273|521034524|FG002|Maintenance Period|Change of residence|3|||
144501961|NCT04771273|521034525|FG003|Maintenance Period|Change of residence|0|||
144501962|NCT04771273|521034522|FG000|Maintenance Period|Perceived lack of efficacy|0|||
144501963|NCT04771273|521034523|FG001|Maintenance Period|Perceived lack of efficacy|0|||
144501964|NCT04771273|521034524|FG002|Maintenance Period|Perceived lack of efficacy|0|||
144501965|NCT04771273|521034525|FG003|Maintenance Period|Perceived lack of efficacy|1|||
144501966|NCT04771273|521034522|FG000|Maintenance Period|Adverse Event|4|||
144501967|NCT04771273|521034523|FG001|Maintenance Period|Adverse Event|5|||
144501968|NCT04771273|521034524|FG002|Maintenance Period|Adverse Event|5|||
144501969|NCT04771273|521034525|FG003|Maintenance Period|Adverse Event|0|||
144501970|NCT04436120|521034529|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
144501971|NCT04436120|521034530|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
144501972|NCT04436120|521034531|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
144501973|NCT04436120|521034532|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
144501974|NCT04436120|521034533|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
144501975|NCT04436120|521034534|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
144501976|NCT04436120|521034535|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
144501977|NCT04222959|521034539|FG000|Overall Study|Lost to Follow-up|76|||
144501978|NCT04222959|521034540|FG001|Overall Study|Lost to Follow-up|28|||
144501979|NCT04776213|521034543|FG000|Overall Study|Other|1|||
144501980|NCT04776213|521034543|FG000|Overall Study|Withdrawal by Subject|7|||
144501981|NCT04776213|521034543|FG000|Overall Study|Protocol Violation|1|||
144501982|NCT04776213|521034543|FG000|Overall Study|Lost to Follow-up|2|||
144501983|NCT02540213|521034544|FG000|Overall Study|Death/adverse event|18|||
144501984|NCT02540213|521034544|FG000|Overall Study|Administrative reasons|3|||
144501985|NCT02540213|521034544|FG000|Overall Study|Kidney transplant|3|||
144501986|NCT02540213|521034544|FG000|Overall Study|Lack of Efficacy|6|||
144501987|NCT02540213|521034544|FG000|Overall Study|Consent withdrawn|7|||
144501988|NCT02540213|521034544|FG000|Overall Study|Enrolled but not treated|2|||
144501989|NCT02289560|521034545|FG000|Overall Study|Lost to Follow-up|6|||
144501990|NCT02289560|521034545|FG000|Overall Study|Alternative Treatment|4|||
144501991|NCT02289560|521034545|FG000|Overall Study|Inadequate Treatment|2|||
144501992|NCT02289560|521034545|FG000|Overall Study|Withdrawal by Subject|23|||
144501993|NCT01981356|521034553|FG000|Overall Study|Lost to Follow-up|4|||
144501994|NCT01981356|521034554|FG001|Overall Study|Lost to Follow-up|1|||
144501995|NCT01981356|521034553|FG000|Overall Study|Withdrawal by Subject|1|||
144501996|NCT01981356|521034554|FG001|Overall Study|Withdrawal by Subject|1|||
144501997|NCT01981356|521034553|FG000|Overall Study|Protocol Violation|2|||
144501998|NCT01981356|521034554|FG001|Overall Study|Protocol Violation|0|||
144501999|NCT03395353|521034555|FG000|Overall Study|Adverse Event|20|||
144502000|NCT03395353|521034555|FG000|Overall Study|Protocol Violation|1|||
144502001|NCT03395353|521034555|FG000|Overall Study|Lack of Efficacy|3|||
144502002|NCT03395353|521034555|FG000|Overall Study|Withdrawal by Subject|24|||
144502003|NCT03395353|521034555|FG000|Overall Study|Discontinued visit|1|||
144502004|NCT03395353|521034555|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
144502005|NCT03395353|521034555|FG000|Overall Study|Physician Decision|4|||
144502006|NCT03395353|521034555|FG000|Overall Study|Early termination of overall study|33|||
144502007|NCT02013037|521034557|FG000|Overall Study|Death|6|||
144502008|NCT02013037|521034557|FG000|Overall Study|Withdrawal by Subject|1|||
144502009|NCT02013037|521034557|FG000|Overall Study|Awaiting Transplantation|7|||
144502010|NCT02013037|521034557|FG000|Overall Study|Transplanted without DSA|2|||
144502011|NCT05233085|521034559|FG000|Overall Study|Adverse Event|1|||
144502012|NCT05233085|521034560|FG001|Overall Study|Adverse Event|0|||
144502013|NCT05233085|521034561|FG002|Overall Study|Adverse Event|0|||
144502014|NCT05233085|521034562|FG003|Overall Study|Adverse Event|0|||
144502015|NCT00726596|521035912|FG000|Overall Study|Adverse Event|2|||
144502016|NCT00726596|521035913|FG001|Overall Study|Adverse Event|1|||
144502017|NCT00726596|521035912|FG000|Overall Study|Withdrawal by Subject|3|||
144502018|NCT00726596|521035913|FG001|Overall Study|Withdrawal by Subject|3|||
144502019|NCT02962674|521035918|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
144502020|NCT00364286|521035920|FG000|Overall Study|Withdrawal by Subject|1|||
144502021|NCT00364286|521035920|FG000|Overall Study|Adverse Event|2|||
144502022|NCT00357396|521035923|FG000|Overall Study|Adverse Event|1|||
144502023|NCT00357396|521035924|FG001|Overall Study|Adverse Event|0|||
144502024|NCT02488980|521035926|FG000|Overall Study|Protocol Violation|2|||
144502025|NCT02488980|521035927|FG001|Overall Study|Protocol Violation|2|||
144502026|NCT02488980|521035928|FG002|Overall Study|Protocol Violation|2|||
144502027|NCT01227278|521035929|FG000|Overall Study|Withdrawal by Subject|4|||
144502028|NCT01227278|521035930|FG001|Overall Study|Withdrawal by Subject|4|||
144502029|NCT01227278|521035929|FG000|Overall Study|Death|0|||
144502030|NCT01227278|521035930|FG001|Overall Study|Death|2|||
144502031|NCT01227278|521035929|FG000|Overall Study|Other|1|||
144502032|NCT01227278|521035930|FG001|Overall Study|Other|2|||
144502033|NCT03546907|521035931|FG000|Overall Study|Lack of Efficacy|1|||
144502034|NCT03546907|521035932|FG001|Overall Study|Lack of Efficacy|1|||
144502035|NCT03546907|521035931|FG000|Overall Study|Withdrawal by Subject|8|||
144502036|NCT03546907|521035932|FG001|Overall Study|Withdrawal by Subject|9|||
144502037|NCT03546907|521035931|FG000|Overall Study|Adverse events (AEs)|7|||
144502038|NCT03546907|521035932|FG001|Overall Study|Adverse events (AEs)|10|||
144502039|NCT03546907|521035931|FG000|Overall Study|Other-unspecified|1|||
144502040|NCT03546907|521035932|FG001|Overall Study|Other-unspecified|1|||
144502041|NCT03720210|521035933|FG000|Overall Study|Lost to Follow-up|1|||
144502042|NCT02224924|521035934|FG000|Overall Study|Withdrawal by Subject|7|||
144502043|NCT02224924|521035935|FG001|Overall Study|Withdrawal by Subject|6|||
144502044|NCT02224924|521035934|FG000|Overall Study|Biopsy cancelled|20|||
144502045|NCT02224924|521035935|FG001|Overall Study|Biopsy cancelled|14|||
144502046|NCT02224924|521035934|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
144502047|NCT02224924|521035935|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
144502048|NCT02224924|521035934|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
144502049|NCT02224924|521035935|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
144502050|NCT00753012|521035941|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
144502051|NCT00753012|521035942|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
144502052|NCT00753012|521035941|FG000|Overall Study|Adverse Event|2|||
144502053|NCT00753012|521035942|FG001|Overall Study|Adverse Event|0|||
144502054|NCT00753012|521035941|FG000|Overall Study|Withdrawal by Subject|0|||
144502055|NCT00753012|521035942|FG001|Overall Study|Withdrawal by Subject|1|||
144502056|NCT00753012|521035941|FG000|Overall Study|Lost to Follow-up|4|||
144502057|NCT00753012|521035942|FG001|Overall Study|Lost to Follow-up|0|||
144502058|NCT00753012|521035941|FG000|Overall Study|Confounded endpoint data|1|||
144502059|NCT00753012|521035942|FG001|Overall Study|Confounded endpoint data|0|||
144502060|NCT01027286|521035943|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
144502061|NCT01027286|521035944|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
144502062|NCT01027286|521035943|FG000|Overall Study|Lost to Follow-up|0|||
144502063|NCT01027286|521035944|FG001|Overall Study|Lost to Follow-up|1|||
144502064|NCT00545844|521035945|FG000|Overall Study|Lost to Follow-up|9|||
144502065|NCT00545844|521035945|FG000|Overall Study|Protocol Violation|1|||
144502066|NCT00545844|521035945|FG000|Overall Study|Withdrawal by Subject|2|||
144502067|NCT01565928|521035958|FG000|Overall Study|Adverse Event|3|||
144502068|NCT01565928|521035958|FG000|Overall Study|Other|3|||
144502069|NCT01565928|521035958|FG000|Overall Study|Progressive Disease|13|||
144502070|NCT01565928|521035958|FG000|Overall Study|Withdrawal by Subject|1|||
144502071|NCT01565928|521035958|FG000|Overall Study|Death|2|||
144502072|NCT01713530|521035966|FG000|Overall Study|Adverse Event|0|||
144502073|NCT01713530|521035967|FG001|Overall Study|Adverse Event|5|||
144502074|NCT01713530|521035966|FG000|Overall Study|Withdrawal criteria|21|||
144502075|NCT01713530|521035967|FG001|Overall Study|Withdrawal criteria|12|||
144502076|NCT01713530|521035966|FG000|Overall Study|Unclassified|4|||
144502077|NCT01713530|521035967|FG001|Overall Study|Unclassified|2|||
144502078|NCT03525119|521035968|FG000|Overall Study|Adverse Event|0|||
144502079|NCT03525119|521035969|FG001|Overall Study|Adverse Event|1|||
144502080|NCT03525119|521035970|FG002|Overall Study|Adverse Event|0|||
144502081|NCT03525119|521035968|FG000|Overall Study|Lost to Follow-up|32|||
144502082|NCT03525119|521035969|FG001|Overall Study|Lost to Follow-up|33|||
144502083|NCT03525119|521035970|FG002|Overall Study|Lost to Follow-up|37|||
144502084|NCT03525119|521035968|FG000|Overall Study|Withdrawal by Subject|5|||
144502085|NCT03525119|521035969|FG001|Overall Study|Withdrawal by Subject|4|||
144502086|NCT03525119|521035970|FG002|Overall Study|Withdrawal by Subject|2|||
144502087|NCT03525119|521035968|FG000|Overall Study|Reason not Specified|2|||
144502088|NCT03525119|521035969|FG001|Overall Study|Reason not Specified|1|||
144502089|NCT03525119|521035970|FG002|Overall Study|Reason not Specified|2|||
144502090|NCT03525119|521035968|FG000|Overall Study|Randomized but not Vaccinated|1|||
144502091|NCT03525119|521035969|FG001|Overall Study|Randomized but not Vaccinated|0|||
144502092|NCT03525119|521035970|FG002|Overall Study|Randomized but not Vaccinated|2|||
144502093|NCT03939819|521035971|FG000|Overall Study|Death|2|||
144502094|NCT03939819|521035972|FG001|Overall Study|Death|0|||
144502095|NCT05046132|521035973|FG000|Overall Study|Adverse Event|4|||
144502096|NCT05046132|521035974|FG001|Overall Study|Adverse Event|0|||
144502097|NCT05046132|521035975|FG002|Overall Study|Adverse Event|0|||
144502098|NCT05046132|521035973|FG000|Overall Study|Withdrawal by Subject|3|||
144502099|NCT05046132|521035974|FG001|Overall Study|Withdrawal by Subject|0|||
144502100|NCT05046132|521035975|FG002|Overall Study|Withdrawal by Subject|0|||
144502101|NCT05046132|521035973|FG000|Overall Study|Positive Covid19 Result.|0|||
144502102|NCT05046132|521035974|FG001|Overall Study|Positive Covid19 Result.|1|||
144502103|NCT05046132|521035975|FG002|Overall Study|Positive Covid19 Result.|0|||
144502104|NCT04379713|521035980|FG000|Overall Study|Adverse Event|2|||
144502105|NCT04379713|521035981|FG001|Overall Study|Adverse Event|0|||
144502106|NCT04379713|521035980|FG000|Overall Study|Physician Decision|2|||
144502107|NCT04379713|521035981|FG001|Overall Study|Physician Decision|1|||
144502108|NCT04379713|521035980|FG000|Overall Study|Protocol Violation|11|||
144502109|NCT04379713|521035981|FG001|Overall Study|Protocol Violation|6|||
144502110|NCT04379713|521035980|FG000|Overall Study|No longer met eligibility criteria|14|||
144502111|NCT04379713|521035981|FG001|Overall Study|No longer met eligibility criteria|11|||
144502112|NCT04379713|521035980|FG000|Overall Study|Withdrawal by parent/guardian|36|||
144502113|NCT04379713|521035981|FG001|Overall Study|Withdrawal by parent/guardian|15|||
144502114|NCT04379713|521035980|FG000|Overall Study|Lost to Follow-up|31|||
144502115|NCT04379713|521035981|FG001|Overall Study|Lost to Follow-up|21|||
144502116|NCT03808883|521035982|FG000|Overall Study|Withdrawal by Subject|2|||
144502117|NCT03808883|521035983|FG001|Overall Study|Withdrawal by Subject|0|||
144502118|NCT03808883|521035982|FG000|Overall Study|Did not complete pre test or post test survey|4|||
144502119|NCT03808883|521035983|FG001|Overall Study|Did not complete pre test or post test survey|3|||
144502120|NCT02371746|521035987|FG000|Overall Study|Consent withdrawn|0|||
144502121|NCT02371746|521035988|FG001|Overall Study|Consent withdrawn|0|||
144502122|NCT02371746|521035989|FG002|Overall Study|Consent withdrawn|0|||
144502123|NCT02371746|521035990|FG003|Overall Study|Consent withdrawn|0|||
144502124|NCT02371746|521035991|FG004|Overall Study|Consent withdrawn|0|||
144502125|NCT02371746|521035992|FG005|Overall Study|Consent withdrawn|0|||
144502126|NCT02371746|521035993|FG006|Overall Study|Consent withdrawn|1|||
144502127|NCT02613364|521035994|FG000|Overall Study|Other|19|||
144502128|NCT02613364|521035995|FG001|Overall Study|Other|29|||
144502129|NCT02613364|521035996|FG002|Overall Study|Other|17|||
144502130|NCT02613364|521035994|FG000|Overall Study|Too time consuming|21|||
144502131|NCT02613364|521035995|FG001|Overall Study|Too time consuming|26|||
144502132|NCT02613364|521035996|FG002|Overall Study|Too time consuming|26|||
144502133|NCT02613364|521035994|FG000|Overall Study|Withdrawal by Subject|13|||
144502134|NCT02613364|521035995|FG001|Overall Study|Withdrawal by Subject|18|||
144502135|NCT02613364|521035996|FG002|Overall Study|Withdrawal by Subject|17|||
144502136|NCT02613364|521035994|FG000|Overall Study|Medical|12|||
144502137|NCT02613364|521035995|FG001|Overall Study|Medical|13|||
144502138|NCT02613364|521035996|FG002|Overall Study|Medical|9|||
144502139|NCT02613364|521035994|FG000|Overall Study|Disliked Study Procedure|1|||
144502140|NCT02613364|521035995|FG001|Overall Study|Disliked Study Procedure|1|||
144502141|NCT02613364|521035996|FG002|Overall Study|Disliked Study Procedure|4|||
144502142|NCT02613364|521035994|FG000|Overall Study|Disliked Intervention|0|||
144502143|NCT02613364|521035995|FG001|Overall Study|Disliked Intervention|3|||
144502144|NCT02613364|521035996|FG002|Overall Study|Disliked Intervention|3|||
144502145|NCT01909336|521035997|FG000|Overall Study|Lost to Follow-up|4|||
144502146|NCT01909336|521035998|FG001|Overall Study|Lost to Follow-up|2|||
144502147|NCT01909336|521035999|FG002|Overall Study|Lost to Follow-up|2|||
144502148|NCT01909336|521035997|FG000|Overall Study|Physician Decision|0|||
144502149|NCT01909336|521035998|FG001|Overall Study|Physician Decision|1|||
144502150|NCT01909336|521035999|FG002|Overall Study|Physician Decision|1|||
144502151|NCT01235949|521036000|FG000|Primary Phase|Migrated/moved from study area|1|||
144502152|NCT01235949|521036001|FG001|Primary Phase|Migrated/moved from study area|1|||
144502153|NCT01235949|521036002|FG002|Primary Phase|Migrated/moved from study area|0|||
144502154|NCT01235949|521036003|FG003|Primary Phase|Migrated/moved from study area|0|||
144502155|NCT01235949|521036004|FG004|Primary Phase|Migrated/moved from study area|1|||
144502156|NCT01235949|521036005|FG005|Primary Phase|Migrated/moved from study area|2|||
144502157|NCT01235949|521036006|FG006|Primary Phase|Migrated/moved from study area|0|||
144502158|NCT01235949|521036007|FG007|Primary Phase|Migrated/moved from study area|0|||
144502159|NCT01235949|521036008|FG008|Primary Phase|Migrated/moved from study area|0|||
144502160|NCT01235949|521036009|FG009|Primary Phase|Migrated/moved from study area|0|||
144502161|NCT01235949|521036010|FG010|Primary Phase|Migrated/moved from study area|0|||
144502162|NCT01235949|521036011|FG011|Primary Phase|Migrated/moved from study area|0|||
144502163|NCT01235949|521036012|FG012|Primary Phase|Migrated/moved from study area|0|||
144502164|NCT01235949|521036013|FG013|Primary Phase|Migrated/moved from study area|0|||
144502165|NCT01235949|521036014|FG014|Primary Phase|Migrated/moved from study area|0|||
144502166|NCT01235949|521036015|FG015|Primary Phase|Migrated/moved from study area|0|||
144502167|NCT01235949|521036016|FG016|Primary Phase|Migrated/moved from study area|0|||
144502168|NCT01235949|521036017|FG017|Primary Phase|Migrated/moved from study area|0|||
144502169|NCT01235949|521036000|FG000|Primary Phase|Adverse Event|0|||
144502170|NCT01235949|521036001|FG001|Primary Phase|Adverse Event|0|||
144502171|NCT01235949|521036002|FG002|Primary Phase|Adverse Event|0|||
144502172|NCT01235949|521036003|FG003|Primary Phase|Adverse Event|1|||
144502173|NCT01235949|521036004|FG004|Primary Phase|Adverse Event|0|||
144502174|NCT01235949|521036005|FG005|Primary Phase|Adverse Event|0|||
144502175|NCT01235949|521036006|FG006|Primary Phase|Adverse Event|0|||
144502176|NCT01235949|521036007|FG007|Primary Phase|Adverse Event|0|||
144502177|NCT01235949|521036008|FG008|Primary Phase|Adverse Event|0|||
144502178|NCT01235949|521036009|FG009|Primary Phase|Adverse Event|0|||
144502179|NCT01235949|521036010|FG010|Primary Phase|Adverse Event|0|||
144502180|NCT01235949|521036011|FG011|Primary Phase|Adverse Event|0|||
144502181|NCT01235949|521036012|FG012|Primary Phase|Adverse Event|0|||
144502182|NCT01235949|521036013|FG013|Primary Phase|Adverse Event|0|||
144502183|NCT01235949|521036014|FG014|Primary Phase|Adverse Event|0|||
144502184|NCT01235949|521036015|FG015|Primary Phase|Adverse Event|0|||
144502185|NCT01235949|521036016|FG016|Primary Phase|Adverse Event|0|||
144502186|NCT01235949|521036017|FG017|Primary Phase|Adverse Event|0|||
144502187|NCT01235949|521036000|FG000|Primary Phase|Withdrawal by Subject|3|||
144502188|NCT01235949|521036001|FG001|Primary Phase|Withdrawal by Subject|2|||
144502189|NCT01235949|521036002|FG002|Primary Phase|Withdrawal by Subject|2|||
144502190|NCT01235949|521036003|FG003|Primary Phase|Withdrawal by Subject|0|||
144502191|NCT01235949|521036004|FG004|Primary Phase|Withdrawal by Subject|0|||
144502192|NCT01235949|521036005|FG005|Primary Phase|Withdrawal by Subject|3|||
144502193|NCT01235949|521036006|FG006|Primary Phase|Withdrawal by Subject|0|||
144502194|NCT01235949|521036007|FG007|Primary Phase|Withdrawal by Subject|0|||
144502195|NCT01235949|521036008|FG008|Primary Phase|Withdrawal by Subject|0|||
144502196|NCT01235949|521036009|FG009|Primary Phase|Withdrawal by Subject|0|||
144502197|NCT01235949|521036010|FG010|Primary Phase|Withdrawal by Subject|0|||
144502198|NCT01235949|521036011|FG011|Primary Phase|Withdrawal by Subject|0|||
144502199|NCT01235949|521036012|FG012|Primary Phase|Withdrawal by Subject|0|||
144502200|NCT01235949|521036013|FG013|Primary Phase|Withdrawal by Subject|0|||
144502201|NCT01235949|521036014|FG014|Primary Phase|Withdrawal by Subject|0|||
144502202|NCT01235949|521036015|FG015|Primary Phase|Withdrawal by Subject|0|||
144502203|NCT01235949|521036016|FG016|Primary Phase|Withdrawal by Subject|0|||
144502204|NCT01235949|521036017|FG017|Primary Phase|Withdrawal by Subject|0|||
144502205|NCT01235949|521036000|FG000|Primary Phase|Lost to Follow-up|0|||
144502206|NCT01235949|521036001|FG001|Primary Phase|Lost to Follow-up|0|||
144502207|NCT01235949|521036002|FG002|Primary Phase|Lost to Follow-up|1|||
144502208|NCT01235949|521036003|FG003|Primary Phase|Lost to Follow-up|1|||
144502209|NCT01235949|521036004|FG004|Primary Phase|Lost to Follow-up|0|||
144247751|NCT01764997|520104205|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
144247752|NCT01764997|520104206|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
144247753|NCT01764997|520104202|FG000|Study Drug Treatment Period|Other than specified above|0|||
144247754|NCT01764997|520104203|FG001|Study Drug Treatment Period|Other than specified above|0|||
144247755|NCT01764997|520104204|FG002|Study Drug Treatment Period|Other than specified above|0|||
144247756|NCT01764997|520104205|FG003|Study Drug Treatment Period|Other than specified above|0|||
144247757|NCT01764997|520104206|FG004|Study Drug Treatment Period|Other than specified above|10|||
144247758|NCT00787917|520104207|FG000|Blinded Treatment|Adverse Event|1|||
144247759|NCT00787917|520104208|FG001|Blinded Treatment|Adverse Event|0|||
144247760|NCT00787917|520104207|FG000|Blinded Treatment|Lack of Efficacy|1|||
144247761|NCT00787917|520104208|FG001|Blinded Treatment|Lack of Efficacy|0|||
144247762|NCT00787917|520104207|FG000|Blinded Treatment|Administrative problems|3|||
144247763|NCT00787917|520104208|FG001|Blinded Treatment|Administrative problems|2|||
144247764|NCT00787917|520104207|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
144247765|NCT00787917|520104208|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
144247766|NCT00787917|520104207|FG000|Open Label|Administrative problems|3|||
144247767|NCT00787917|520104208|FG001|Open Label|Administrative problems|0|||
144247768|NCT04438499|520104217|FG000|Overall Study|Lack of Efficacy|3|||
144247769|NCT01709864|520106275|FG000|Overall Study|Physician Decision|0|||
144247770|NCT01709864|520106276|FG001|Overall Study|Physician Decision|1|||
144247771|NCT01709864|520106275|FG000|Overall Study|subject/guardian decision|5|||
144247772|NCT01709864|520106276|FG001|Overall Study|subject/guardian decision|6|||
144247773|NCT01709864|520106275|FG000|Overall Study|Lost to Follow-up|1|||
144247774|NCT01709864|520106276|FG001|Overall Study|Lost to Follow-up|0|||
144247775|NCT01709864|520106275|FG000|Overall Study|non-compliance with study treatment|1|||
144247776|NCT01709864|520106276|FG001|Overall Study|non-compliance with study treatment|1|||
144247777|NCT01709864|520106275|FG000|Overall Study|Adverse Event|0|||
144247778|NCT01709864|520106276|FG001|Overall Study|Adverse Event|2|||
144247779|NCT01709864|520106275|FG000|Overall Study|Death|0|||
144247780|NCT01709864|520106276|FG001|Overall Study|Death|1|||
144247781|NCT01066793|520106283|FG000|Overall Study|Death|4|||
144247782|NCT01066793|520106284|FG001|Overall Study|Death|1|||
144247783|NCT01066793|520106285|FG002|Overall Study|Death|1|||
144247784|NCT01066793|520106286|FG003|Overall Study|Death|0|||
144247785|NCT01066793|520106287|FG004|Overall Study|Death|0|||
144247786|NCT01066793|520106288|FG005|Overall Study|Death|0|||
144247787|NCT01066793|520106283|FG000|Overall Study|Lack of Efficacy|2|||
144247788|NCT01066793|520106284|FG001|Overall Study|Lack of Efficacy|1|||
144247789|NCT01066793|520106285|FG002|Overall Study|Lack of Efficacy|0|||
144247790|NCT01066793|520106286|FG003|Overall Study|Lack of Efficacy|0|||
144247791|NCT01066793|520106287|FG004|Overall Study|Lack of Efficacy|0|||
144247792|NCT01066793|520106288|FG005|Overall Study|Lack of Efficacy|0|||
144247793|NCT01066793|520106283|FG000|Overall Study|Lost to Follow-up|180|||
144247794|NCT01066793|520106284|FG001|Overall Study|Lost to Follow-up|39|||
144247795|NCT01066793|520106285|FG002|Overall Study|Lost to Follow-up|82|||
144247796|NCT01066793|520106286|FG003|Overall Study|Lost to Follow-up|16|||
144247797|NCT01066793|520106287|FG004|Overall Study|Lost to Follow-up|0|||
144247798|NCT01066793|520106288|FG005|Overall Study|Lost to Follow-up|1|||
144247799|NCT01066793|520106283|FG000|Overall Study|Physician Decision|3|||
144247800|NCT01066793|520106284|FG001|Overall Study|Physician Decision|0|||
144247801|NCT01066793|520106285|FG002|Overall Study|Physician Decision|0|||
144247802|NCT01066793|520106286|FG003|Overall Study|Physician Decision|0|||
144247803|NCT01066793|520106287|FG004|Overall Study|Physician Decision|0|||
144247804|NCT01066793|520106288|FG005|Overall Study|Physician Decision|0|||
144247805|NCT01066793|520106283|FG000|Overall Study|Protocol Violation|3|||
144247806|NCT01066793|520106284|FG001|Overall Study|Protocol Violation|2|||
144247807|NCT01066793|520106285|FG002|Overall Study|Protocol Violation|2|||
144247808|NCT01066793|520106286|FG003|Overall Study|Protocol Violation|0|||
144247809|NCT01066793|520106287|FG004|Overall Study|Protocol Violation|0|||
144247810|NCT01066793|520106288|FG005|Overall Study|Protocol Violation|0|||
144247811|NCT01066793|520106283|FG000|Overall Study|Withdrawal by Subject|7|||
144247812|NCT01066793|520106284|FG001|Overall Study|Withdrawal by Subject|4|||
144247813|NCT01066793|520106285|FG002|Overall Study|Withdrawal by Subject|1|||
144247814|NCT01066793|520106286|FG003|Overall Study|Withdrawal by Subject|0|||
144247815|NCT01066793|520106287|FG004|Overall Study|Withdrawal by Subject|0|||
144247816|NCT01066793|520106288|FG005|Overall Study|Withdrawal by Subject|0|||
144247817|NCT01066793|520106283|FG000|Overall Study|Early Termination|3|||
144247818|NCT01066793|520106284|FG001|Overall Study|Early Termination|0|||
144247819|NCT01066793|520106285|FG002|Overall Study|Early Termination|0|||
144502210|NCT01235949|521036005|FG005|Primary Phase|Lost to Follow-up|2|||
144502211|NCT01235949|521036006|FG006|Primary Phase|Lost to Follow-up|0|||
144247820|NCT01066793|520106286|FG003|Overall Study|Early Termination|0|||
144721412|NCT01296932|521835201|FG002|Overall Study|Withdrawal by Subject|1|||
144247821|NCT01066793|520106287|FG004|Overall Study|Early Termination|0|||
144247822|NCT01066793|520106288|FG005|Overall Study|Early Termination|0|||
144247823|NCT01066793|520106283|FG000|Overall Study|Lab test not done|7|||
144247824|NCT01066793|520106284|FG001|Overall Study|Lab test not done|0|||
144502212|NCT01235949|521036007|FG007|Primary Phase|Lost to Follow-up|0|||
144721413|NCT01296932|521835202|FG003|Overall Study|Withdrawal by Subject|1|||
144247825|NCT01066793|520106285|FG002|Overall Study|Lab test not done|0|||
144247826|NCT01066793|520106286|FG003|Overall Study|Lab test not done|1|||
144247827|NCT01066793|520106287|FG004|Overall Study|Lab test not done|0|||
144721414|NCT01296932|521835203|FG004|Overall Study|Withdrawal by Subject|0|||
144721415|NCT01296932|521835204|FG005|Overall Study|Withdrawal by Subject|0|||
144721416|NCT01296932|521835205|FG006|Overall Study|Withdrawal by Subject|3|||
144721417|NCT01296932|521835206|FG007|Overall Study|Withdrawal by Subject|0|||
144721418|NCT01296932|521835207|FG008|Overall Study|Withdrawal by Subject|0|||
144721419|NCT01296932|521835199|FG000|Overall Study|Adverse Event|1|||
144247828|NCT01066793|520106288|FG005|Overall Study|Lab test not done|0|||
144247829|NCT01066793|520106283|FG000|Overall Study|Miscellaneous|4|||
144247830|NCT01066793|520106284|FG001|Overall Study|Miscellaneous|5|||
144247831|NCT01066793|520106285|FG002|Overall Study|Miscellaneous|6|||
144247832|NCT01066793|520106286|FG003|Overall Study|Miscellaneous|0|||
144247833|NCT01066793|520106287|FG004|Overall Study|Miscellaneous|0|||
144247834|NCT01066793|520106288|FG005|Overall Study|Miscellaneous|0|||
144247835|NCT01066793|520106283|FG000|Overall Study|Non-responders|104|||
144247836|NCT01066793|520106284|FG001|Overall Study|Non-responders|5|||
144247837|NCT01066793|520106285|FG002|Overall Study|Non-responders|11|||
144247838|NCT01066793|520106286|FG003|Overall Study|Non-responders|25|||
144247839|NCT01066793|520106287|FG004|Overall Study|Non-responders|0|||
144247840|NCT01066793|520106288|FG005|Overall Study|Non-responders|0|||
144247841|NCT01066793|520106283|FG000|Overall Study|Other|15|||
144247842|NCT01066793|520106284|FG001|Overall Study|Other|5|||
144247843|NCT01066793|520106285|FG002|Overall Study|Other|6|||
144247844|NCT01066793|520106286|FG003|Overall Study|Other|2|||
144247845|NCT01066793|520106287|FG004|Overall Study|Other|0|||
144247846|NCT01066793|520106288|FG005|Overall Study|Other|0|||
144247847|NCT01066793|520106283|FG000|Overall Study|Relapse|20|||
144247848|NCT01066793|520106284|FG001|Overall Study|Relapse|8|||
144247849|NCT01066793|520106285|FG002|Overall Study|Relapse|2|||
144247850|NCT01066793|520106286|FG003|Overall Study|Relapse|3|||
144247851|NCT01066793|520106287|FG004|Overall Study|Relapse|0|||
144247852|NCT01066793|520106288|FG005|Overall Study|Relapse|0|||
144247853|NCT01066793|520106283|FG000|Overall Study|Result Not Available|1|||
144247854|NCT01066793|520106284|FG001|Overall Study|Result Not Available|0|||
144247855|NCT01066793|520106285|FG002|Overall Study|Result Not Available|0|||
144247856|NCT01066793|520106286|FG003|Overall Study|Result Not Available|0|||
144247857|NCT01066793|520106287|FG004|Overall Study|Result Not Available|0|||
144247858|NCT01066793|520106288|FG005|Overall Study|Result Not Available|0|||
144247859|NCT01066793|520106283|FG000|Overall Study|Treatment Interrupted|1|||
144247860|NCT01066793|520106284|FG001|Overall Study|Treatment Interrupted|1|||
144247861|NCT01066793|520106285|FG002|Overall Study|Treatment Interrupted|0|||
144247862|NCT01066793|520106286|FG003|Overall Study|Treatment Interrupted|0|||
144247863|NCT01066793|520106287|FG004|Overall Study|Treatment Interrupted|0|||
144247864|NCT01066793|520106288|FG005|Overall Study|Treatment Interrupted|0|||
144247865|NCT01066793|520106283|FG000|Overall Study|Treatment Never Started|18|||
144247866|NCT01066793|520106284|FG001|Overall Study|Treatment Never Started|5|||
144247867|NCT01066793|520106285|FG002|Overall Study|Treatment Never Started|4|||
144247868|NCT01066793|520106286|FG003|Overall Study|Treatment Never Started|1|||
144247869|NCT01066793|520106287|FG004|Overall Study|Treatment Never Started|0|||
144247870|NCT01066793|520106288|FG005|Overall Study|Treatment Never Started|0|||
144247871|NCT01066793|520106283|FG000|Overall Study|Treatment Stopped|2|||
144247872|NCT01066793|520106284|FG001|Overall Study|Treatment Stopped|1|||
144247873|NCT01066793|520106285|FG002|Overall Study|Treatment Stopped|0|||
144247874|NCT01066793|520106286|FG003|Overall Study|Treatment Stopped|1|||
144247875|NCT01066793|520106287|FG004|Overall Study|Treatment Stopped|0|||
144247876|NCT01066793|520106288|FG005|Overall Study|Treatment Stopped|0|||
144247877|NCT03334422|520106289|FG000|Overall Study|Adverse Event|1|||
144247878|NCT03334422|520106290|FG001|Overall Study|Adverse Event|3|||
144247879|NCT03334422|520106291|FG002|Overall Study|Adverse Event|2|||
144247880|NCT03334422|520106292|FG003|Overall Study|Adverse Event|2|||
144502213|NCT01235949|521036008|FG008|Primary Phase|Lost to Follow-up|0|||
144247881|NCT03334422|520106289|FG000|Overall Study|Lack of Efficacy|10|||
144247882|NCT03334422|520106290|FG001|Overall Study|Lack of Efficacy|2|||
144247883|NCT03334422|520106291|FG002|Overall Study|Lack of Efficacy|7|||
144247884|NCT03334422|520106292|FG003|Overall Study|Lack of Efficacy|3|||
144247885|NCT03334422|520106289|FG000|Overall Study|Withdrawal by Subject|8|||
144247886|NCT03334422|520106290|FG001|Overall Study|Withdrawal by Subject|3|||
144247887|NCT03334422|520106291|FG002|Overall Study|Withdrawal by Subject|1|||
144247888|NCT03334422|520106292|FG003|Overall Study|Withdrawal by Subject|0|||
144247889|NCT03334422|520106289|FG000|Overall Study|Lost to Follow-up|0|||
144247890|NCT03334422|520106290|FG001|Overall Study|Lost to Follow-up|0|||
144247891|NCT03334422|520106291|FG002|Overall Study|Lost to Follow-up|0|||
144247892|NCT03334422|520106292|FG003|Overall Study|Lost to Follow-up|1|||
144247893|NCT03334422|520106289|FG000|Overall Study|Inability to obtain laboratory samples|0|||
144247894|NCT03334422|520106290|FG001|Overall Study|Inability to obtain laboratory samples|1|||
144247895|NCT03334422|520106291|FG002|Overall Study|Inability to obtain laboratory samples|0|||
144247896|NCT03334422|520106292|FG003|Overall Study|Inability to obtain laboratory samples|0|||
144247897|NCT03334422|520106289|FG000|Overall Study|Pregnancy|0|||
144247898|NCT03334422|520106290|FG001|Overall Study|Pregnancy|1|||
144247899|NCT03334422|520106291|FG002|Overall Study|Pregnancy|0|||
144247900|NCT03334422|520106292|FG003|Overall Study|Pregnancy|0|||
144247901|NCT00427999|520106293|FG000|Overall Study|Adverse Event|6|||
144247902|NCT00427999|520106293|FG000|Overall Study|Abnormal laboratory values|1|||
144247903|NCT00427999|520106293|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
144247904|NCT00427999|520106293|FG000|Overall Study|Protocol Violation|2|||
144247905|NCT00427999|520106293|FG000|Overall Study|Withdrawal by Subject|9|||
144247906|NCT00427999|520106293|FG000|Overall Study|Death|1|||
144247907|NCT00766467|520106295|FG000|Overall Study|Withdrawal by Subject|7|||
144247908|NCT00766467|520106296|FG001|Overall Study|Withdrawal by Subject|2|||
144247909|NCT00766467|520106295|FG000|Overall Study|Adverse Event|1|||
144247910|NCT00766467|520106296|FG001|Overall Study|Adverse Event|1|||
144247911|NCT00766467|520106295|FG000|Overall Study|Protocol Violation|2|||
144247912|NCT00766467|520106296|FG001|Overall Study|Protocol Violation|4|||
144247913|NCT00766467|520106295|FG000|Overall Study|Tumor Progression on Study|0|||
144247914|NCT00766467|520106296|FG001|Overall Study|Tumor Progression on Study|1|||
144247915|NCT00766467|520106295|FG000|Overall Study|Physician Decision|1|||
144247916|NCT00766467|520106296|FG001|Overall Study|Physician Decision|0|||
144247917|NCT01917344|520106301|FG000|Overall Study|Withdrawal by Subject|1|||
144247918|NCT01420679|520106306|FG000|Overall Study|Disease Progression|3|||
144247919|NCT01420679|520106307|FG001|Overall Study|Disease Progression|2|||
144247920|NCT01420679|520106306|FG000|Overall Study|Adverse Event|4|||
144247921|NCT01420679|520106307|FG001|Overall Study|Adverse Event|0|||
144247922|NCT01420679|520106306|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
144247923|NCT01420679|520106307|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
144247924|NCT01420679|520106306|FG000|Overall Study|Patient Decision|1|||
144247925|NCT01420679|520106307|FG001|Overall Study|Patient Decision|0|||
144247926|NCT01420679|520106306|FG000|Overall Study|Investigator Decision|1|||
144247927|NCT01420679|520106307|FG001|Overall Study|Investigator Decision|2|||
144247928|NCT01420679|520106306|FG000|Overall Study|Sponsor Decision|3|||
144247929|NCT01420679|520106307|FG001|Overall Study|Sponsor Decision|3|||
144247930|NCT01420679|520106306|FG000|Overall Study|Other|1|||
144247931|NCT01420679|520106307|FG001|Overall Study|Other|0|||
144247932|NCT00943670|520106308|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
144247933|NCT00943670|520106308|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
144247934|NCT00943670|520106308|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
144247935|NCT00943670|520106308|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
144247936|NCT00943670|520106308|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
144247937|NCT00943670|520106308|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
144247938|NCT00943670|520106308|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
144247939|NCT00943670|520106308|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
144247940|NCT00943670|520106308|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
144247941|NCT00943670|520106308|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
144247942|NCT01777295|520106309|FG000|Overall Study|Withdrawal by Subject|2|||
144247943|NCT01777295|520106310|FG001|Overall Study|Withdrawal by Subject|2|||
144247944|NCT01777295|520106309|FG000|Overall Study|Pregnancy|0|||
144247945|NCT01777295|520106310|FG001|Overall Study|Pregnancy|1|||
144247946|NCT01777295|520106309|FG000|Overall Study|Personal problem|1|||
144247947|NCT01777295|520106310|FG001|Overall Study|Personal problem|0|||
144721420|NCT01296932|521835200|FG001|Overall Study|Adverse Event|1|||
144721421|NCT01296932|521835201|FG002|Overall Study|Adverse Event|1|||
144247948|NCT01777295|520106309|FG000|Overall Study|Investigator call for AEs check|1|||
144502214|NCT01235949|521036009|FG009|Primary Phase|Lost to Follow-up|0|||
144721422|NCT01296932|521835202|FG003|Overall Study|Adverse Event|2|||
144721423|NCT01296932|521835203|FG004|Overall Study|Adverse Event|1|||
144721424|NCT01296932|521835204|FG005|Overall Study|Adverse Event|0|||
144247949|NCT01777295|520106310|FG001|Overall Study|Investigator call for AEs check|0|||
144247950|NCT03114657|520106312|FG000|Overall Study|Adverse Event|9|||
144247951|NCT03114657|520106313|FG001|Overall Study|Adverse Event|6|||
144247952|NCT03114657|520106312|FG000|Overall Study|Death|4|||
144247953|NCT03114657|520106313|FG001|Overall Study|Death|0|||
144247954|NCT03114657|520106312|FG000|Overall Study|Multiple Reasons|1|||
144247955|NCT03114657|520106313|FG001|Overall Study|Multiple Reasons|2|||
144247956|NCT03114657|520106312|FG000|Overall Study|Physician Decision|2|||
144247957|NCT03114657|520106313|FG001|Overall Study|Physician Decision|2|||
144247958|NCT03114657|520106312|FG000|Overall Study|Study Terminated By Sponsor|355|||
144247959|NCT03114657|520106313|FG001|Overall Study|Study Terminated By Sponsor|374|||
144247960|NCT03114657|520106312|FG000|Overall Study|Symptomatic Deterioration|0|||
144721425|NCT01296932|521835205|FG006|Overall Study|Adverse Event|0|||
144502215|NCT01235949|521036010|FG010|Primary Phase|Lost to Follow-up|0|||
144247961|NCT03114657|520106313|FG001|Overall Study|Symptomatic Deterioration|1|||
144247962|NCT03114657|520106312|FG000|Overall Study|Withdrawal by Subject|28|||
144247963|NCT03114657|520106313|FG001|Overall Study|Withdrawal by Subject|22|||
144247964|NCT01179737|520106314|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
144247965|NCT01179737|520106315|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
144247966|NCT01179737|520106316|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
144247967|NCT01179737|520106317|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
144247968|NCT01179737|520106314|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
144247969|NCT01179737|520106315|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
144247970|NCT01179737|520106316|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
144247971|NCT01179737|520106317|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
144247972|NCT01179737|520106314|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
144247973|NCT01179737|520106315|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
144247974|NCT01179737|520106316|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
144247975|NCT01179737|520106317|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
144247976|NCT01179737|520106314|FG000|Cohort 1 & Cohort 2|Death|0|||
144247977|NCT01179737|520106315|FG001|Cohort 1 & Cohort 2|Death|0|||
144502216|NCT01235949|521036011|FG011|Primary Phase|Lost to Follow-up|0|||
144502217|NCT01235949|521036012|FG012|Primary Phase|Lost to Follow-up|0|||
144502218|NCT01235949|521036013|FG013|Primary Phase|Lost to Follow-up|0|||
144502219|NCT01235949|521036014|FG014|Primary Phase|Lost to Follow-up|0|||
144502220|NCT01235949|521036015|FG015|Primary Phase|Lost to Follow-up|0|||
144502221|NCT01235949|521036016|FG016|Primary Phase|Lost to Follow-up|0|||
144502222|NCT01235949|521036017|FG017|Primary Phase|Lost to Follow-up|0|||
144502223|NCT01235949|521036000|FG000|Booster Phase|Migrated/moved from study area|0|||
144502224|NCT01235949|521036001|FG001|Booster Phase|Migrated/moved from study area|0|||
144502225|NCT01235949|521036002|FG002|Booster Phase|Migrated/moved from study area|0|||
144502226|NCT01235949|521036003|FG003|Booster Phase|Migrated/moved from study area|0|||
144502227|NCT01235949|521036004|FG004|Booster Phase|Migrated/moved from study area|0|||
144502228|NCT01235949|521036005|FG005|Booster Phase|Migrated/moved from study area|0|||
144502229|NCT01235949|521036006|FG006|Booster Phase|Migrated/moved from study area|0|||
144502230|NCT01235949|521036007|FG007|Booster Phase|Migrated/moved from study area|0|||
144502231|NCT01235949|521036008|FG008|Booster Phase|Migrated/moved from study area|0|||
144502232|NCT01235949|521036009|FG009|Booster Phase|Migrated/moved from study area|0|||
144502233|NCT01235949|521036010|FG010|Booster Phase|Migrated/moved from study area|0|||
144502234|NCT01235949|521036011|FG011|Booster Phase|Migrated/moved from study area|1|||
144502235|NCT01235949|521036012|FG012|Booster Phase|Migrated/moved from study area|1|||
144502236|NCT01235949|521036013|FG013|Booster Phase|Migrated/moved from study area|0|||
144502237|NCT01235949|521036014|FG014|Booster Phase|Migrated/moved from study area|0|||
144502238|NCT01235949|521036015|FG015|Booster Phase|Migrated/moved from study area|0|||
144502239|NCT01235949|521036016|FG016|Booster Phase|Migrated/moved from study area|0|||
144502240|NCT01235949|521036017|FG017|Booster Phase|Migrated/moved from study area|1|||
144502241|NCT01235949|521036000|FG000|Booster Phase|Adverse Event|0|||
144502242|NCT01235949|521036001|FG001|Booster Phase|Adverse Event|0|||
144502243|NCT01235949|521036002|FG002|Booster Phase|Adverse Event|0|||
144502244|NCT01235949|521036003|FG003|Booster Phase|Adverse Event|0|||
144502245|NCT01235949|521036004|FG004|Booster Phase|Adverse Event|0|||
144502246|NCT01235949|521036005|FG005|Booster Phase|Adverse Event|0|||
144502247|NCT01235949|521036006|FG006|Booster Phase|Adverse Event|0|||
144502248|NCT01235949|521036007|FG007|Booster Phase|Adverse Event|0|||
144502249|NCT01235949|521036008|FG008|Booster Phase|Adverse Event|0|||
144502250|NCT01235949|521036009|FG009|Booster Phase|Adverse Event|0|||
144502251|NCT01235949|521036010|FG010|Booster Phase|Adverse Event|0|||
144247978|NCT01179737|520106316|FG002|Cohort 1 & Cohort 2|Death|1|||
144247979|NCT01179737|520106317|FG003|Cohort 1 & Cohort 2|Death|0|||
144247980|NCT01179737|520106314|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
144247981|NCT01179737|520106315|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
144502252|NCT01235949|521036011|FG011|Booster Phase|Adverse Event|0|||
144502253|NCT01235949|521036012|FG012|Booster Phase|Adverse Event|0|||
144502254|NCT01235949|521036013|FG013|Booster Phase|Adverse Event|0|||
144502255|NCT01235949|521036014|FG014|Booster Phase|Adverse Event|0|||
144247982|NCT01179737|520106316|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
144502256|NCT01235949|521036015|FG015|Booster Phase|Adverse Event|1|||
144502257|NCT01235949|521036016|FG016|Booster Phase|Adverse Event|0|||
144502258|NCT01235949|521036017|FG017|Booster Phase|Adverse Event|0|||
144502259|NCT01235949|521036000|FG000|Booster Phase|Withdrawal by Subject|0|||
144502260|NCT01235949|521036001|FG001|Booster Phase|Withdrawal by Subject|0|||
144502261|NCT01235949|521036002|FG002|Booster Phase|Withdrawal by Subject|0|||
144502262|NCT01235949|521036003|FG003|Booster Phase|Withdrawal by Subject|0|||
144502263|NCT01235949|521036004|FG004|Booster Phase|Withdrawal by Subject|0|||
144502264|NCT01235949|521036005|FG005|Booster Phase|Withdrawal by Subject|0|||
144502265|NCT01235949|521036006|FG006|Booster Phase|Withdrawal by Subject|0|||
144502266|NCT01235949|521036007|FG007|Booster Phase|Withdrawal by Subject|1|||
144502267|NCT01235949|521036008|FG008|Booster Phase|Withdrawal by Subject|1|||
144502268|NCT01235949|521036009|FG009|Booster Phase|Withdrawal by Subject|0|||
144502269|NCT01235949|521036010|FG010|Booster Phase|Withdrawal by Subject|1|||
144502270|NCT01235949|521036011|FG011|Booster Phase|Withdrawal by Subject|1|||
144502271|NCT01235949|521036012|FG012|Booster Phase|Withdrawal by Subject|2|||
144502272|NCT01235949|521036013|FG013|Booster Phase|Withdrawal by Subject|0|||
144247983|NCT01179737|520106317|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
144247984|NCT01179737|520106314|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
144247985|NCT01179737|520106315|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
144247986|NCT01179737|520106316|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
144247987|NCT01179737|520106317|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
144247988|NCT01179737|520106314|FG000|Extension|The study was terminated|3|||
144247989|NCT01179737|520106315|FG001|Extension|The study was terminated|0|||
144247990|NCT01179737|520106316|FG002|Extension|The study was terminated|0|||
144247991|NCT01179737|520106317|FG003|Extension|The study was terminated|0|||
144247992|NCT00115037|520106318|FG000|Phase1|Lost to Follow-up|16|||
144247993|NCT00115037|520106319|FG001|Phase1|Lost to Follow-up|23|||
144247994|NCT00115037|520106320|FG002|Phase1|Lost to Follow-up|0|||
144247995|NCT00115037|520106321|FG003|Phase1|Lost to Follow-up|0|||
144247996|NCT00115037|520106322|FG004|Phase1|Lost to Follow-up|0|||
144247997|NCT00115037|520106323|FG005|Phase1|Lost to Follow-up|0|||
144247998|NCT00115037|520106318|FG000|Phase1|Withdrawal by Subject|9|||
144247999|NCT00115037|520106319|FG001|Phase1|Withdrawal by Subject|4|||
144248000|NCT00115037|520106320|FG002|Phase1|Withdrawal by Subject|0|||
144502273|NCT01235949|521036014|FG014|Booster Phase|Withdrawal by Subject|2|||
144502274|NCT01235949|521036015|FG015|Booster Phase|Withdrawal by Subject|0|||
144502275|NCT01235949|521036016|FG016|Booster Phase|Withdrawal by Subject|0|||
144502276|NCT01235949|521036017|FG017|Booster Phase|Withdrawal by Subject|0|||
144502277|NCT01235949|521036000|FG000|Booster Phase|Lost to Follow-up|0|||
144502278|NCT01235949|521036001|FG001|Booster Phase|Lost to Follow-up|0|||
144502279|NCT01235949|521036002|FG002|Booster Phase|Lost to Follow-up|0|||
144502280|NCT01235949|521036003|FG003|Booster Phase|Lost to Follow-up|0|||
144502281|NCT01235949|521036004|FG004|Booster Phase|Lost to Follow-up|0|||
144502282|NCT01235949|521036005|FG005|Booster Phase|Lost to Follow-up|0|||
144502283|NCT01235949|521036006|FG006|Booster Phase|Lost to Follow-up|0|||
144502284|NCT01235949|521036007|FG007|Booster Phase|Lost to Follow-up|0|||
144502285|NCT01235949|521036008|FG008|Booster Phase|Lost to Follow-up|1|||
144248001|NCT00115037|520106321|FG003|Phase1|Withdrawal by Subject|0|||
144248002|NCT00115037|520106322|FG004|Phase1|Withdrawal by Subject|0|||
144248003|NCT00115037|520106323|FG005|Phase1|Withdrawal by Subject|0|||
144248004|NCT00115037|520106318|FG000|Phase2|Death|0|||
144248005|NCT00115037|520106319|FG001|Phase2|Death|0|||
144248006|NCT00115037|520106320|FG002|Phase2|Death|1|||
144248007|NCT00115037|520106321|FG003|Phase2|Death|0|||
144248008|NCT00115037|520106322|FG004|Phase2|Death|0|||
144248009|NCT00115037|520106323|FG005|Phase2|Death|1|||
144248010|NCT00115037|520106318|FG000|Phase2|Withdrawal by Subject|0|||
144248011|NCT00115037|520106319|FG001|Phase2|Withdrawal by Subject|0|||
144248012|NCT00115037|520106320|FG002|Phase2|Withdrawal by Subject|2|||
144248013|NCT00115037|520106321|FG003|Phase2|Withdrawal by Subject|1|||
144248014|NCT00115037|520106322|FG004|Phase2|Withdrawal by Subject|2|||
144248015|NCT00115037|520106323|FG005|Phase2|Withdrawal by Subject|1|||
144248016|NCT00115037|520106318|FG000|Phase2|Lost to Follow-up|0|||
144248017|NCT00115037|520106319|FG001|Phase2|Lost to Follow-up|0|||
144248018|NCT00115037|520106320|FG002|Phase2|Lost to Follow-up|12|||
144248019|NCT00115037|520106321|FG003|Phase2|Lost to Follow-up|14|||
144502286|NCT01235949|521036009|FG009|Booster Phase|Lost to Follow-up|1|||
144248020|NCT00115037|520106322|FG004|Phase2|Lost to Follow-up|4|||
144248021|NCT00115037|520106323|FG005|Phase2|Lost to Follow-up|10|||
144502287|NCT01235949|521036010|FG010|Booster Phase|Lost to Follow-up|1|||
144502288|NCT01235949|521036011|FG011|Booster Phase|Lost to Follow-up|1|||
144502289|NCT01235949|521036012|FG012|Booster Phase|Lost to Follow-up|0|||
144502290|NCT01235949|521036013|FG013|Booster Phase|Lost to Follow-up|0|||
144502291|NCT01235949|521036014|FG014|Booster Phase|Lost to Follow-up|0|||
144502292|NCT01235949|521036015|FG015|Booster Phase|Lost to Follow-up|0|||
144502293|NCT01235949|521036016|FG016|Booster Phase|Lost to Follow-up|0|||
144502294|NCT01235949|521036017|FG017|Booster Phase|Lost to Follow-up|1|||
144502295|NCT00754936|521036018|FG000|Overall Study|Lost to Follow-up|3|||
144502296|NCT00754936|521036018|FG000|Overall Study|Physician Decision|1|||
144502297|NCT00754936|521036018|FG000|Overall Study|Withdrawal by Subject|2|||
144502298|NCT00754936|521036018|FG000|Overall Study|Side Effects|3|||
144502299|NCT00754936|521036018|FG000|Overall Study|Inter-current medical events|3|||
144502300|NCT01157182|521036023|FG000|Washout of 28 Days|Adverse Event|2|||
144502301|NCT01157182|521036024|FG001|Washout of 28 Days|Adverse Event|0|||
144502302|NCT00371566|521036025|FG000|Treatment Phase|Withdrawal by Subject|0|||
144502303|NCT00371566|521036026|FG001|Treatment Phase|Withdrawal by Subject|1|||
144502304|NCT00371566|521036025|FG000|Treatment Phase|Adverse Event|0|||
144502305|NCT00371566|521036026|FG001|Treatment Phase|Adverse Event|1|||
144502306|NCT00371566|521036025|FG000|Treatment Phase|Protocol Violation|0|||
144502307|NCT00371566|521036026|FG001|Treatment Phase|Protocol Violation|1|||
144502308|NCT00371566|521036025|FG000|Chemoradiation Phase|Physician Decision|2|||
144502309|NCT00371566|521036026|FG001|Chemoradiation Phase|Physician Decision|0|||
144502310|NCT00371566|521036025|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
144502311|NCT00371566|521036026|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
144502312|NCT00371566|521036025|FG000|Chemoradiation Phase|Non compliant|0|||
144502313|NCT00371566|521036026|FG001|Chemoradiation Phase|Non compliant|1|||
144502314|NCT00371566|521036025|FG000|Chemoradiation Phase|Progressive Disease|1|||
144502315|NCT00371566|521036026|FG001|Chemoradiation Phase|Progressive Disease|1|||
144502316|NCT00371566|521036025|FG000|Chemoradiation Phase|Death|2|||
144502317|NCT00371566|521036026|FG001|Chemoradiation Phase|Death|0|||
144502318|NCT00371566|521036025|FG000|Follow Up Phase|Death|0|||
144502319|NCT00371566|521036026|FG001|Follow Up Phase|Death|5|||
144502320|NCT00371566|521036025|FG000|Follow Up Phase|Disease progression|1|||
144502321|NCT00371566|521036026|FG001|Follow Up Phase|Disease progression|0|||
144502322|NCT00371566|521036025|FG000|Follow Up Phase|Withdrawal by Subject|0|||
144502323|NCT00371566|521036026|FG001|Follow Up Phase|Withdrawal by Subject|1|||
144502324|NCT00371566|521036025|FG000|Follow Up Phase|Physician Decision|1|||
144248022|NCT01546038|520106324|FG000|Overall Study|Death|15|||
144248023|NCT01546038|520106325|FG001|Overall Study|Death|6|||
144248024|NCT01546038|520106326|FG002|Overall Study|Death|4|||
144248025|NCT01546038|520106327|FG003|Overall Study|Death|2|||
144248026|NCT01546038|520106328|FG004|Overall Study|Death|9|||
144248027|NCT01546038|520106329|FG005|Overall Study|Death|3|||
144248028|NCT01546038|520106330|FG006|Overall Study|Death|46|||
144248029|NCT01546038|520106331|FG007|Overall Study|Death|76|||
144248030|NCT01546038|520106332|FG008|Overall Study|Death|39|||
144248031|NCT01546038|520106324|FG000|Overall Study|Lost to Follow-up|0|||
144248032|NCT01546038|520106325|FG001|Overall Study|Lost to Follow-up|0|||
144248033|NCT01546038|520106326|FG002|Overall Study|Lost to Follow-up|0|||
144248034|NCT01546038|520106327|FG003|Overall Study|Lost to Follow-up|0|||
144248035|NCT01546038|520106328|FG004|Overall Study|Lost to Follow-up|1|||
144248036|NCT01546038|520106329|FG005|Overall Study|Lost to Follow-up|0|||
144248037|NCT01546038|520106330|FG006|Overall Study|Lost to Follow-up|2|||
144248038|NCT01546038|520106331|FG007|Overall Study|Lost to Follow-up|1|||
144248039|NCT01546038|520106332|FG008|Overall Study|Lost to Follow-up|0|||
144248040|NCT01546038|520106324|FG000|Overall Study|Withdrawal by Subject|1|||
144248041|NCT01546038|520106325|FG001|Overall Study|Withdrawal by Subject|0|||
144248042|NCT01546038|520106326|FG002|Overall Study|Withdrawal by Subject|0|||
144248043|NCT01546038|520106327|FG003|Overall Study|Withdrawal by Subject|1|||
144248044|NCT01546038|520106328|FG004|Overall Study|Withdrawal by Subject|0|||
144248045|NCT01546038|520106329|FG005|Overall Study|Withdrawal by Subject|1|||
144248046|NCT01546038|520106330|FG006|Overall Study|Withdrawal by Subject|3|||
144248047|NCT01546038|520106331|FG007|Overall Study|Withdrawal by Subject|3|||
144248048|NCT01546038|520106332|FG008|Overall Study|Withdrawal by Subject|1|||
144248049|NCT01546038|520106324|FG000|Overall Study|: Randomized, not treated|0|||
144248050|NCT01546038|520106325|FG001|Overall Study|: Randomized, not treated|0|||
144248051|NCT01546038|520106326|FG002|Overall Study|: Randomized, not treated|0|||
144248052|NCT01546038|520106327|FG003|Overall Study|: Randomized, not treated|0|||
144248053|NCT01546038|520106328|FG004|Overall Study|: Randomized, not treated|0|||
144248054|NCT01546038|520106329|FG005|Overall Study|: Randomized, not treated|0|||
144248055|NCT01546038|520106330|FG006|Overall Study|: Randomized, not treated|2|||
144248056|NCT01546038|520106331|FG007|Overall Study|: Randomized, not treated|4|||
144502325|NCT00371566|521036026|FG001|Follow Up Phase|Physician Decision|1|||
144502326|NCT00371566|521036025|FG000|Follow Up Phase|Lost to Follow-up|1|||
144502327|NCT00371566|521036026|FG001|Follow Up Phase|Lost to Follow-up|0|||
144502328|NCT00972504|521036027|FG000|Overall Study|Adverse Event|2|||
144502329|NCT00972504|521036027|FG000|Overall Study|Investigator discretion|1|||
144502330|NCT02878330|521036028|FG000|Overall Study|Death|3|||
144502331|NCT02878330|521036029|FG001|Overall Study|Death|2|||
144502332|NCT02878330|521036028|FG000|Overall Study|Lost to Follow-up|11|||
144502333|NCT02878330|521036029|FG001|Overall Study|Lost to Follow-up|26|||
144502334|NCT02878330|521036028|FG000|Overall Study|Withdrawal by Subject|11|||
144502335|NCT02878330|521036029|FG001|Overall Study|Withdrawal by Subject|21|||
144502336|NCT02878330|521036028|FG000|Overall Study|Other|4|||
144502337|NCT02878330|521036029|FG001|Overall Study|Other|7|||
144502338|NCT00082810|521036030|FG000|Overall Study|Adverse Event|3|||
144502339|NCT00082810|521036030|FG000|Overall Study|Progressive disease|24|||
144502340|NCT00082810|521036030|FG000|Overall Study|Withdrawal by Subject|4|||
144502341|NCT01321606|521036031|FG000|Overall Study|Lost to Follow-up|0|||
144502342|NCT01321606|521036032|FG001|Overall Study|Lost to Follow-up|0|||
144502343|NCT01321606|521036033|FG002|Overall Study|Lost to Follow-up|0|||
144502344|NCT01321606|521036034|FG003|Overall Study|Lost to Follow-up|1|||
144248057|NCT01546038|520106332|FG008|Overall Study|: Randomized, not treated|3|||
144248058|NCT01133288|520106336|FG000|Eligibility Assessment|met exclusion criteria|5|||
144248059|NCT01133288|520106336|FG000|Intervention Allocation|study terminated|2|||
144248060|NCT03209518|520106337|FG000|Overall Study|Case Report Forms Uncollected|1|||
144248061|NCT03209518|520106337|FG000|Overall Study|Protocol Deviation|1|||
144248062|NCT00236899|520106338|FG000|Overall Study|Adverse Event (Study Related)|1|||
144248063|NCT00236899|520106339|FG001|Overall Study|Adverse Event (Study Related)|1|||
144248064|NCT00236899|520106340|FG002|Overall Study|Adverse Event (Study Related)|2|||
144248065|NCT00236899|520106341|FG003|Overall Study|Adverse Event (Study Related)|1|||
144248066|NCT00236899|520106338|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
144248067|NCT00236899|520106339|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
144248068|NCT00236899|520106340|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
144248069|NCT00236899|520106341|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
144248070|NCT00236899|520106338|FG000|Overall Study|Death (Study Disease)|1|||
144248071|NCT00236899|520106339|FG001|Overall Study|Death (Study Disease)|4|||
144248072|NCT00236899|520106340|FG002|Overall Study|Death (Study Disease)|0|||
144248073|NCT00236899|520106341|FG003|Overall Study|Death (Study Disease)|0|||
144248074|NCT00236899|520106338|FG000|Overall Study|Death (Not Study Related)|2|||
144248075|NCT00236899|520106339|FG001|Overall Study|Death (Not Study Related)|0|||
144248076|NCT00236899|520106340|FG002|Overall Study|Death (Not Study Related)|0|||
144248077|NCT00236899|520106341|FG003|Overall Study|Death (Not Study Related)|0|||
144248078|NCT00236899|520106338|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
144248079|NCT00236899|520106339|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
144248080|NCT00236899|520106340|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
144248081|NCT00236899|520106341|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
144248082|NCT00236899|520106338|FG000|Overall Study|Lost to Follow-up|0|||
144248083|NCT00236899|520106339|FG001|Overall Study|Lost to Follow-up|1|||
144248084|NCT00236899|520106340|FG002|Overall Study|Lost to Follow-up|0|||
144248085|NCT00236899|520106341|FG003|Overall Study|Lost to Follow-up|0|||
144248086|NCT00236899|520106338|FG000|Overall Study|Entry Criteria Exclusion|0|||
144248087|NCT00236899|520106339|FG001|Overall Study|Entry Criteria Exclusion|1|||
144248088|NCT00236899|520106340|FG002|Overall Study|Entry Criteria Exclusion|1|||
144248089|NCT00236899|520106341|FG003|Overall Study|Entry Criteria Exclusion|0|||
144248090|NCT00236899|520106338|FG000|Overall Study|Protocol Violation|1|||
144248091|NCT00236899|520106339|FG001|Overall Study|Protocol Violation|0|||
144248092|NCT00236899|520106340|FG002|Overall Study|Protocol Violation|0|||
144248093|NCT00236899|520106341|FG003|Overall Study|Protocol Violation|0|||
144248094|NCT00236899|520106338|FG000|Overall Study|Withdrawal by Subject|6|||
144248095|NCT00236899|520106339|FG001|Overall Study|Withdrawal by Subject|4|||
144248096|NCT00236899|520106340|FG002|Overall Study|Withdrawal by Subject|5|||
144248097|NCT00236899|520106341|FG003|Overall Study|Withdrawal by Subject|2|||
144248098|NCT00236899|520106338|FG000|Overall Study|Physician Decision|7|||
144248099|NCT00236899|520106339|FG001|Overall Study|Physician Decision|8|||
144248100|NCT00236899|520106340|FG002|Overall Study|Physician Decision|7|||
144248101|NCT00236899|520106341|FG003|Overall Study|Physician Decision|6|||
144248102|NCT00236899|520106338|FG000|Overall Study|Satisfactory Response|2|||
144248103|NCT00236899|520106339|FG001|Overall Study|Satisfactory Response|0|||
144248104|NCT00236899|520106340|FG002|Overall Study|Satisfactory Response|0|||
144248105|NCT00236899|520106341|FG003|Overall Study|Satisfactory Response|1|||
144248106|NCT00236899|520106338|FG000|Overall Study|Lack of Efficacy|18|||
144502345|NCT05484726|521036040|FG000|Overall Study|Protocol Violation|3|||
144502346|NCT05484726|521036041|FG001|Overall Study|Protocol Violation|3|||
144502347|NCT05484726|521036040|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
144502348|NCT05484726|521036041|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
144502349|NCT05484726|521036040|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
144502350|NCT05484726|521036041|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
144248107|NCT00236899|520106339|FG001|Overall Study|Lack of Efficacy|18|||
144248108|NCT00236899|520106340|FG002|Overall Study|Lack of Efficacy|25|||
144248109|NCT00236899|520106341|FG003|Overall Study|Lack of Efficacy|23|||
144248110|NCT01285492|520106347|FG000|Overall Study|Adverse Event|11|||
144248111|NCT01285492|520106348|FG001|Overall Study|Adverse Event|0|||
144248112|NCT01285492|520106347|FG000|Overall Study|Protocol Violation|3|||
144248113|NCT01285492|520106348|FG001|Overall Study|Protocol Violation|0|||
144248114|NCT01285492|520106347|FG000|Overall Study|Withdrawal by Subject|2|||
144248115|NCT01285492|520106348|FG001|Overall Study|Withdrawal by Subject|1|||
144248116|NCT01285492|520106347|FG000|Overall Study|Death|1|||
144248117|NCT01285492|520106348|FG001|Overall Study|Death|0|||
144248118|NCT03379792|520106349|FG000|Overall Study|Physician Decision|0|||
144248119|NCT03379792|520106350|FG001|Overall Study|Physician Decision|0|||
144248120|NCT03379792|520106351|FG002|Overall Study|Physician Decision|0|||
144248121|NCT03379792|520106352|FG003|Overall Study|Physician Decision|1|||
144248122|NCT03379792|520106353|FG004|Overall Study|Physician Decision|0|||
144248123|NCT03379792|520106354|FG005|Overall Study|Physician Decision|0|||
144248124|NCT03379792|520106349|FG000|Overall Study|Withdrawal by Subject|0|||
144248125|NCT03379792|520106350|FG001|Overall Study|Withdrawal by Subject|0|||
144248126|NCT03379792|520106351|FG002|Overall Study|Withdrawal by Subject|0|||
144248127|NCT03379792|520106352|FG003|Overall Study|Withdrawal by Subject|0|||
144248128|NCT03379792|520106353|FG004|Overall Study|Withdrawal by Subject|1|||
144248129|NCT03379792|520106354|FG005|Overall Study|Withdrawal by Subject|1|||
144248130|NCT01121536|520106355|FG000|Overall Study|Adverse Event|63|||
144248131|NCT01121536|520106355|FG000|Overall Study|Lack of Efficacy|35|||
144248132|NCT01121536|520106355|FG000|Overall Study|Withdrawal by Subject|65|||
144248133|NCT01121536|520106355|FG000|Overall Study|Protocol Violation|20|||
144248134|NCT01121536|520106355|FG000|Overall Study|Noncompliance with study medication|12|||
144248135|NCT01121536|520106355|FG000|Overall Study|Noncompliance with study procedures|9|||
144248136|NCT01121536|520106355|FG000|Overall Study|Lost to Follow-up|39|||
144248137|NCT01121536|520106355|FG000|Overall Study|Other|118|||
144248138|NCT00306787|520106357|FG000|Overall Study|Discontinued without taking study drug|208|||
144248139|NCT00306787|520106358|FG001|Overall Study|Discontinued without taking study drug|215|||
144248140|NCT00306787|520106357|FG000|Overall Study|Adverse Event|1|||
144248141|NCT00306787|520106358|FG001|Overall Study|Adverse Event|1|||
144248142|NCT00306787|520106357|FG000|Overall Study|Lack of Efficacy|1|||
144248143|NCT00306787|520106358|FG001|Overall Study|Lack of Efficacy|0|||
144248144|NCT00306787|520106357|FG000|Overall Study|Protocol Violation|8|||
144248145|NCT00306787|520106358|FG001|Overall Study|Protocol Violation|10|||
144248146|NCT00306787|520106357|FG000|Overall Study|Withdrawal by Subject|2|||
144248147|NCT00306787|520106358|FG001|Overall Study|Withdrawal by Subject|9|||
144248148|NCT00306787|520106357|FG000|Overall Study|Lost to Follow-up|9|||
144248149|NCT00306787|520106358|FG001|Overall Study|Lost to Follow-up|6|||
144248150|NCT00306787|520106357|FG000|Overall Study|Administrative problems|4|||
144248151|NCT00306787|520106358|FG001|Overall Study|Administrative problems|0|||
144248152|NCT00306787|520106357|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144370092|NCT00670748|520562815|FG002|Overall Study|Death during treatment|1|||
144248153|NCT00306787|520106358|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144248154|NCT01438814|520106359|FG000|Overall Study|Adverse Event|3|||
144248155|NCT01438814|520106360|FG001|Overall Study|Adverse Event|3|||
144248156|NCT01438814|520106359|FG000|Overall Study|Protocol Violation|1|||
144248157|NCT01438814|520106360|FG001|Overall Study|Protocol Violation|2|||
144248158|NCT01438814|520106359|FG000|Overall Study|Lost to Follow-up|4|||
144248159|NCT01438814|520106360|FG001|Overall Study|Lost to Follow-up|3|||
144248160|NCT01438814|520106359|FG000|Overall Study|Withdrawal by Subject|4|||
144248161|NCT01438814|520106360|FG001|Overall Study|Withdrawal by Subject|2|||
144248162|NCT01438814|520106359|FG000|Overall Study|Other|2|||
144248163|NCT01438814|520106360|FG001|Overall Study|Other|4|||
144248164|NCT02273908|520106361|FG000|Overall Study|Adverse Event|16|||
144248165|NCT02273908|520106362|FG001|Overall Study|Adverse Event|0|||
144248166|NCT02273908|520106361|FG000|Overall Study|Lost to Follow-up|10|||
144248167|NCT02273908|520106362|FG001|Overall Study|Lost to Follow-up|1|||
144248168|NCT02273908|520106361|FG000|Overall Study|Did not meet entrance criteria|3|||
144248169|NCT02273908|520106362|FG001|Overall Study|Did not meet entrance criteria|2|||
144248170|NCT02273908|520106361|FG000|Overall Study|Withdrawal by Subject|4|||
144248171|NCT02273908|520106362|FG001|Overall Study|Withdrawal by Subject|2|||
144248172|NCT00369161|520106363|FG000|Overall Study|Adverse Event|15|||
144248173|NCT00369161|520106364|FG001|Overall Study|Adverse Event|13|||
144248174|NCT00369161|520106363|FG000|Overall Study|Abnormal laboratory value|0|||
144248175|NCT00369161|520106364|FG001|Overall Study|Abnormal laboratory value|1|||
144248176|NCT00369161|520106363|FG000|Overall Study|Lack of Efficacy|3|||
144248177|NCT00369161|520106364|FG001|Overall Study|Lack of Efficacy|1|||
144248178|NCT00369161|520106363|FG000|Overall Study|Protocol Violation|0|||
144248179|NCT00369161|520106364|FG001|Overall Study|Protocol Violation|2|||
144248180|NCT00369161|520106363|FG000|Overall Study|Withdrawal by Subject|2|||
144248181|NCT00369161|520106364|FG001|Overall Study|Withdrawal by Subject|3|||
144248182|NCT00369161|520106363|FG000|Overall Study|Death|1|||
144248183|NCT00369161|520106364|FG001|Overall Study|Death|2|||
144248184|NCT00369161|520106363|FG000|Overall Study|Graft loss|4|||
144248185|NCT00369161|520106364|FG001|Overall Study|Graft loss|0|||
144248186|NCT00369161|520106363|FG000|Overall Study|Administrative Problem|2|||
144248187|NCT00369161|520106364|FG001|Overall Study|Administrative Problem|2|||
144248188|NCT04908475|520106365|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
144248189|NCT04908475|520106366|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144248190|NCT04908475|520106367|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144248191|NCT04908475|520106368|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144248192|NCT04908475|520106369|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144248193|NCT04908475|520106370|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144248194|NCT04908475|520106365|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
144248195|NCT04908475|520106366|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
144248196|NCT04908475|520106367|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
144248197|NCT04908475|520106368|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
144721426|NCT01296932|521835206|FG007|Overall Study|Adverse Event|0|||
144721427|NCT01296932|521835207|FG008|Overall Study|Adverse Event|1|||
144721428|NCT01296932|521835199|FG000|Overall Study|Investigator decision|0|||
144721429|NCT01296932|521835200|FG001|Overall Study|Investigator decision|1|||
144721430|NCT01296932|521835201|FG002|Overall Study|Investigator decision|0|||
144721431|NCT01296932|521835202|FG003|Overall Study|Investigator decision|1|||
144721432|NCT01296932|521835203|FG004|Overall Study|Investigator decision|0|||
144721433|NCT01296932|521835204|FG005|Overall Study|Investigator decision|0|||
144721434|NCT01296932|521835205|FG006|Overall Study|Investigator decision|1|||
144721435|NCT01296932|521835206|FG007|Overall Study|Investigator decision|0|||
144721436|NCT01296932|521835207|FG008|Overall Study|Investigator decision|1|||
144721437|NCT01296932|521835199|FG000|Overall Study|No clinical benefit anymore|0|||
144721438|NCT01296932|521835200|FG001|Overall Study|No clinical benefit anymore|1|||
144721439|NCT01296932|521835201|FG002|Overall Study|No clinical benefit anymore|0|||
144721440|NCT01296932|521835202|FG003|Overall Study|No clinical benefit anymore|0|||
144721441|NCT01296932|521835203|FG004|Overall Study|No clinical benefit anymore|0|||
144721442|NCT01296932|521835204|FG005|Overall Study|No clinical benefit anymore|0|||
144721443|NCT01296932|521835205|FG006|Overall Study|No clinical benefit anymore|0|||
144721444|NCT01296932|521835206|FG007|Overall Study|No clinical benefit anymore|0|||
144721445|NCT01296932|521835207|FG008|Overall Study|No clinical benefit anymore|0|||
144721446|NCT01296932|521835199|FG000|Overall Study|Physician Decision|0|||
144721447|NCT01296932|521835200|FG001|Overall Study|Physician Decision|0|||
144721448|NCT01296932|521835201|FG002|Overall Study|Physician Decision|1|||
144721449|NCT01296932|521835202|FG003|Overall Study|Physician Decision|0|||
144721450|NCT01296932|521835203|FG004|Overall Study|Physician Decision|0|||
144721451|NCT01296932|521835204|FG005|Overall Study|Physician Decision|0|||
144721452|NCT01296932|521835205|FG006|Overall Study|Physician Decision|0|||
144721453|NCT01296932|521835206|FG007|Overall Study|Physician Decision|0|||
144721454|NCT01296932|521835207|FG008|Overall Study|Physician Decision|0|||
144721455|NCT01296932|521835199|FG000|Overall Study|IV problems, administration not possible|0|||
144721456|NCT01296932|521835200|FG001|Overall Study|IV problems, administration not possible|0|||
144721457|NCT01296932|521835201|FG002|Overall Study|IV problems, administration not possible|1|||
144721458|NCT01296932|521835202|FG003|Overall Study|IV problems, administration not possible|0|||
144721459|NCT01296932|521835203|FG004|Overall Study|IV problems, administration not possible|0|||
144721460|NCT01296932|521835204|FG005|Overall Study|IV problems, administration not possible|0|||
144721461|NCT01296932|521835205|FG006|Overall Study|IV problems, administration not possible|0|||
144721462|NCT01296932|521835206|FG007|Overall Study|IV problems, administration not possible|0|||
144721463|NCT01296932|521835207|FG008|Overall Study|IV problems, administration not possible|0|||
144721464|NCT01296932|521835199|FG000|Overall Study|per protocol|0|||
144721465|NCT01296932|521835200|FG001|Overall Study|per protocol|0|||
144370093|NCT00670748|520562816|FG003|Overall Study|Death during treatment|0|||
144248198|NCT04908475|520106369|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
144248199|NCT04908475|520106370|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
144248200|NCT04908475|520106365|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
144248201|NCT04908475|520106366|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
144248202|NCT04908475|520106367|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
144248203|NCT04908475|520106368|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
144248204|NCT04908475|520106369|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
144248205|NCT04908475|520106370|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
144502351|NCT05484726|521036040|FG000|Overall Study|continued need of mechanical ventilation|2|||
144502352|NCT05484726|521036041|FG001|Overall Study|continued need of mechanical ventilation|3|||
144502353|NCT05484726|521036040|FG000|Overall Study|Withdrawal by Subject|2|||
144502354|NCT05484726|521036041|FG001|Overall Study|Withdrawal by Subject|3|||
144502355|NCT05484726|521036040|FG000|Overall Study|IVH (G III & IV)|2|||
144502356|NCT05484726|521036041|FG001|Overall Study|IVH (G III & IV)|1|||
144248206|NCT04908475|520106365|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144248207|NCT04908475|520106366|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
144248208|NCT04908475|520106367|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
144248209|NCT04908475|520106368|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
144248210|NCT04908475|520106369|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144248211|NCT04908475|520106370|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144248212|NCT04908475|520106365|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
144248213|NCT04908475|520106366|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
144248214|NCT04908475|520106367|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
144248215|NCT04908475|520106368|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
144248216|NCT04908475|520106369|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
144248217|NCT04908475|520106370|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
144248218|NCT04908475|520106365|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
144248219|NCT04908475|520106366|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
144248220|NCT04908475|520106367|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
144248221|NCT04908475|520106368|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
144248222|NCT04908475|520106369|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
144248223|NCT04908475|520106370|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
144370094|NCT00670748|520562813|FG000|Overall Study|Not off study|2|||
144502357|NCT05484726|521036040|FG000|Overall Study|NEC (stage II & III)|2|||
144502358|NCT05484726|521036041|FG001|Overall Study|NEC (stage II & III)|3|||
144502359|NCT02781584|521036042|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
144502360|NCT02781584|521036043|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
144502361|NCT02781584|521036044|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
144502362|NCT02781584|521036045|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
144502363|NCT02781584|521036046|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
144502364|NCT02781584|521036047|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
144502365|NCT02781584|521036048|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
144502366|NCT02781584|521036049|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
144502367|NCT02781584|521036050|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
144502368|NCT02781584|521036051|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
144502369|NCT02781584|521036052|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
144502370|NCT02781584|521036053|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
144502371|NCT02781584|521036054|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
144502372|NCT02781584|521036042|FG000|Pre-treatment Phase|Adverse Event|0|||
144502373|NCT02781584|521036043|FG001|Pre-treatment Phase|Adverse Event|0|||
144502374|NCT02781584|521036044|FG002|Pre-treatment Phase|Adverse Event|0|||
144502375|NCT02781584|521036045|FG003|Pre-treatment Phase|Adverse Event|0|||
144502376|NCT02781584|521036046|FG004|Pre-treatment Phase|Adverse Event|0|||
144502377|NCT02781584|521036047|FG005|Pre-treatment Phase|Adverse Event|0|||
144502378|NCT02781584|521036048|FG006|Pre-treatment Phase|Adverse Event|0|||
144502379|NCT02781584|521036049|FG007|Pre-treatment Phase|Adverse Event|0|||
144502380|NCT02781584|521036050|FG008|Pre-treatment Phase|Adverse Event|0|||
144502381|NCT02781584|521036051|FG009|Pre-treatment Phase|Adverse Event|0|||
144248224|NCT01870297|520106371|FG000|Overall Study|Adverse Event|0|||
144370095|NCT00670748|520562814|FG001|Overall Study|Not off study|1|||
144248225|NCT01870297|520106372|FG001|Overall Study|Adverse Event|0|||
144248226|NCT01870297|520106373|FG002|Overall Study|Adverse Event|0|||
144248227|NCT01870297|520106374|FG003|Overall Study|Adverse Event|0|||
144248228|NCT01870297|520106375|FG004|Overall Study|Adverse Event|2|||
144248229|NCT01870297|520106376|FG005|Overall Study|Adverse Event|0|||
144248230|NCT01870297|520106377|FG006|Overall Study|Adverse Event|0|||
144248231|NCT01870297|520106371|FG000|Overall Study|Lost to Follow-up|0|||
144248232|NCT01870297|520106372|FG001|Overall Study|Lost to Follow-up|1|||
144248233|NCT01870297|520106373|FG002|Overall Study|Lost to Follow-up|1|||
144248234|NCT01870297|520106374|FG003|Overall Study|Lost to Follow-up|0|||
144248235|NCT01870297|520106375|FG004|Overall Study|Lost to Follow-up|0|||
144248236|NCT01870297|520106376|FG005|Overall Study|Lost to Follow-up|0|||
144248237|NCT01870297|520106377|FG006|Overall Study|Lost to Follow-up|0|||
144248238|NCT01870297|520106371|FG000|Overall Study|Withdrawal by Subject|0|||
144248239|NCT01870297|520106372|FG001|Overall Study|Withdrawal by Subject|0|||
144248240|NCT01870297|520106373|FG002|Overall Study|Withdrawal by Subject|0|||
144248241|NCT01870297|520106374|FG003|Overall Study|Withdrawal by Subject|0|||
144248242|NCT01870297|520106375|FG004|Overall Study|Withdrawal by Subject|1|||
144248243|NCT01870297|520106376|FG005|Overall Study|Withdrawal by Subject|1|||
144248244|NCT01870297|520106377|FG006|Overall Study|Withdrawal by Subject|1|||
144248245|NCT01870297|520106371|FG000|Overall Study|Sponsor Decision|0|||
144248246|NCT01870297|520106372|FG001|Overall Study|Sponsor Decision|6|||
144248247|NCT01870297|520106373|FG002|Overall Study|Sponsor Decision|0|||
144502382|NCT02781584|521036052|FG010|Pre-treatment Phase|Adverse Event|0|||
144502383|NCT02781584|521036053|FG011|Pre-treatment Phase|Adverse Event|1|||
144502384|NCT02781584|521036054|FG012|Pre-treatment Phase|Adverse Event|0|||
144502385|NCT02781584|521036042|FG000|Treatment Phase|Withdrew Consent|0|||
144248248|NCT01870297|520106374|FG003|Overall Study|Sponsor Decision|0|||
144248249|NCT01870297|520106375|FG004|Overall Study|Sponsor Decision|0|||
144248250|NCT01870297|520106376|FG005|Overall Study|Sponsor Decision|0|||
144248251|NCT01870297|520106377|FG006|Overall Study|Sponsor Decision|1|||
144248252|NCT01739764|520106378|FG000|Overall Study|Adverse Event|0|||
144248253|NCT01739764|520106379|FG001|Overall Study|Adverse Event|3|||
144248254|NCT01739764|520106380|FG002|Overall Study|Adverse Event|4|||
144370096|NCT00670748|520562815|FG002|Overall Study|Not off study|1|||
144248255|NCT01739764|520106378|FG000|Overall Study|Death|4|||
144502386|NCT02781584|521036043|FG001|Treatment Phase|Withdrew Consent|0|||
144248256|NCT01739764|520106379|FG001|Overall Study|Death|6|||
144248257|NCT01739764|520106380|FG002|Overall Study|Death|38|||
144248258|NCT01739764|520106378|FG000|Overall Study|Lost to Follow-up|0|||
144248259|NCT01739764|520106379|FG001|Overall Study|Lost to Follow-up|0|||
144248260|NCT01739764|520106380|FG002|Overall Study|Lost to Follow-up|5|||
144248261|NCT01739764|520106378|FG000|Overall Study|Non-Compliance|0|||
144248262|NCT01739764|520106379|FG001|Overall Study|Non-Compliance|0|||
144248263|NCT01739764|520106380|FG002|Overall Study|Non-Compliance|1|||
144248264|NCT01739764|520106378|FG000|Overall Study|Multiple Reasons|3|||
144248265|NCT01739764|520106379|FG001|Overall Study|Multiple Reasons|2|||
144248266|NCT01739764|520106380|FG002|Overall Study|Multiple Reasons|3|||
144248267|NCT01739764|520106378|FG000|Overall Study|Physician Decision|2|||
144248268|NCT01739764|520106379|FG001|Overall Study|Physician Decision|2|||
144248269|NCT01739764|520106380|FG002|Overall Study|Physician Decision|4|||
144248270|NCT01739764|520106378|FG000|Overall Study|Progressive Disease|3|||
144248271|NCT01739764|520106379|FG001|Overall Study|Progressive Disease|5|||
144248272|NCT01739764|520106380|FG002|Overall Study|Progressive Disease|16|||
144248273|NCT01739764|520106378|FG000|Overall Study|Protocol Violation|0|||
144248274|NCT01739764|520106379|FG001|Overall Study|Protocol Violation|0|||
144248275|NCT01739764|520106380|FG002|Overall Study|Protocol Violation|2|||
144248276|NCT01739764|520106378|FG000|Overall Study|Study Terminated by Sponsor|8|||
144248277|NCT01739764|520106379|FG001|Overall Study|Study Terminated by Sponsor|13|||
144248278|NCT01739764|520106380|FG002|Overall Study|Study Terminated by Sponsor|26|||
144248279|NCT01739764|520106378|FG000|Overall Study|Withdrawal by Subject|6|||
144248280|NCT01739764|520106379|FG001|Overall Study|Withdrawal by Subject|5|||
144248281|NCT01739764|520106380|FG002|Overall Study|Withdrawal by Subject|27|||
144248282|NCT00337779|520106381|FG000|Overall Study|Withdrawal by Subject|10|||
144248283|NCT00337779|520106382|FG001|Overall Study|Withdrawal by Subject|12|||
144248284|NCT00337779|520106381|FG000|Overall Study|Sponsor decision|1|||
144248285|NCT00337779|520106382|FG001|Overall Study|Sponsor decision|1|||
144248286|NCT00337779|520106381|FG000|Overall Study|Physician Decision|3|||
144248287|NCT00337779|520106382|FG001|Overall Study|Physician Decision|6|||
144248288|NCT00337779|520106381|FG000|Overall Study|Protocol Violation|1|||
144248289|NCT00337779|520106382|FG001|Overall Study|Protocol Violation|1|||
144248290|NCT00337779|520106381|FG000|Overall Study|Lost to Follow-up|6|||
144248291|NCT00337779|520106382|FG001|Overall Study|Lost to Follow-up|5|||
144248292|NCT00337779|520106381|FG000|Overall Study|Adverse Event|28|||
144248293|NCT00337779|520106382|FG001|Overall Study|Adverse Event|51|||
144248294|NCT00337779|520106381|FG000|Overall Study|Pregnancy|3|||
144248295|NCT00337779|520106382|FG001|Overall Study|Pregnancy|2|||
144248296|NCT00337779|520106381|FG000|Overall Study|Death|0|||
144248297|NCT00337779|520106382|FG001|Overall Study|Death|1|||
144248298|NCT00404924|520106383|FG000|Overall Study|Adverse Event|75|||
144248299|NCT00404924|520106384|FG001|Overall Study|Adverse Event|16|||
144248300|NCT00404924|520106383|FG000|Overall Study|Condition under investigation worsened|475|||
144248301|NCT00404924|520106384|FG001|Overall Study|Condition under investigation worsened|264|||
144248302|NCT00404924|520106383|FG000|Overall Study|Lost to Follow-up|1|||
144248303|NCT00404924|520106384|FG001|Overall Study|Lost to Follow-up|1|||
144248304|NCT00404924|520106383|FG000|Overall Study|Withdrawal by Subject|26|||
144248305|NCT00404924|520106384|FG001|Overall Study|Withdrawal by Subject|13|||
144248306|NCT00404924|520106383|FG000|Overall Study|Other|25|||
144248307|NCT00404924|520106384|FG001|Overall Study|Other|11|||
144248308|NCT00404924|520106383|FG000|Overall Study|Randomised but not received treatment|1|||
144248309|NCT00404924|520106384|FG001|Overall Study|Randomised but not received treatment|1|||
144248310|NCT01074255|520106391|FG000|Overall Study|Did not receive EMEND|2|||
144248311|NCT00422422|520106392|FG000|Overall Study|Lack of Efficacy|1|||
144248312|NCT00422422|520106392|FG000|Overall Study|Protocol Violation|1|||
144248313|NCT00422422|520106392|FG000|Overall Study|Withdrawal by Subject|2|||
144248314|NCT00422422|520106392|FG000|Overall Study|SAE, non-fatal|1|||
144248315|NCT00422422|520106392|FG000|Overall Study|AE, non-serious non-fatal|5|||
144248316|NCT02943785|520106394|FG000|Overall Study|Adverse Event|112|||
144248317|NCT02943785|520106395|FG001|Overall Study|Adverse Event|97|||
144248318|NCT02943785|520106394|FG000|Overall Study|Withdrawal by Subject|63|||
144248319|NCT02943785|520106395|FG001|Overall Study|Withdrawal by Subject|126|||
144248320|NCT02943785|520106394|FG000|Overall Study|Physician Decision|23|||
144248321|NCT02943785|520106395|FG001|Overall Study|Physician Decision|47|||
144248322|NCT02943785|520106394|FG000|Overall Study|Death|46|||
144248323|NCT02943785|520106395|FG001|Overall Study|Death|46|||
144248324|NCT02943785|520106394|FG000|Overall Study|Lost to Follow-up|1|||
144248325|NCT02943785|520106395|FG001|Overall Study|Lost to Follow-up|0|||
144248326|NCT02943785|520106394|FG000|Overall Study|Other|16|||
144248327|NCT02943785|520106395|FG001|Overall Study|Other|19|||
144248328|NCT02943785|520106394|FG000|Overall Study|Did not receive any study medication|21|||
144248329|NCT02943785|520106395|FG001|Overall Study|Did not receive any study medication|28|||
144248330|NCT00090987|520106399|FG000|Overall Study|Adverse Event|5|||
144248331|NCT00090987|520106399|FG000|Overall Study|Lack of Efficacy|7|||
144248332|NCT00090987|520106399|FG000|Overall Study|Withdrawal by Subject|3|||
144248333|NCT00090987|520106399|FG000|Overall Study|alternative therapy|1|||
144248334|NCT00090987|520106399|FG000|Overall Study|Non-compliance|4|||
144248335|NCT00090987|520106399|FG000|Overall Study|Incarcerated|1|||
144248336|NCT01534208|520106405|FG000|Overall Study|Lost to Follow-up|19|||
144248337|NCT01534208|520106406|FG001|Overall Study|Lost to Follow-up|14|||
144248338|NCT01534208|520106405|FG000|Overall Study|Withdrawal by Subject|6|||
144248339|NCT01534208|520106406|FG001|Overall Study|Withdrawal by Subject|20|||
144248340|NCT01534208|520106405|FG000|Overall Study|Adverse Event|15|||
144248341|NCT01534208|520106406|FG001|Overall Study|Adverse Event|8|||
144248342|NCT01534208|520106405|FG000|Overall Study|Physician Decision|2|||
144248343|NCT01534208|520106406|FG001|Overall Study|Physician Decision|0|||
144248344|NCT01534208|520106405|FG000|Overall Study|Lack of Efficacy|0|||
144248345|NCT01534208|520106406|FG001|Overall Study|Lack of Efficacy|3|||
144248346|NCT01534208|520106405|FG000|Overall Study|Protocol Violation|2|||
144248347|NCT01534208|520106406|FG001|Overall Study|Protocol Violation|2|||
144248348|NCT01534208|520106405|FG000|Overall Study|Sponsor decision|4|||
144248349|NCT01534208|520106406|FG001|Overall Study|Sponsor decision|1|||
144248350|NCT01534208|520106405|FG000|Overall Study|Subject relocation|2|||
144248351|NCT01534208|520106406|FG001|Overall Study|Subject relocation|0|||
144248352|NCT01534208|520106405|FG000|Overall Study|Lab assessment|2|||
144248353|NCT01534208|520106406|FG001|Overall Study|Lab assessment|1|||
144248354|NCT01534208|520106405|FG000|Overall Study|Eligibility error|3|||
144248355|NCT01534208|520106406|FG001|Overall Study|Eligibility error|0|||
144248356|NCT01534208|520106405|FG000|Overall Study|PCP decision|1|||
144248357|NCT01534208|520106406|FG001|Overall Study|PCP decision|0|||
144248358|NCT01534208|520106405|FG000|Overall Study|Needed prohibited meds|1|||
144248359|NCT01534208|520106406|FG001|Overall Study|Needed prohibited meds|0|||
144248360|NCT01904903|520106407|FG000|Overall Study|Withdrawal by Subject|1|||
144248361|NCT03578146|520106412|FG000|Overall Study|Did Not Receive Treatment|1|||
144248362|NCT03578146|520106413|FG001|Overall Study|Did Not Receive Treatment|0|||
144248363|NCT03578146|520106414|FG002|Overall Study|Did Not Receive Treatment|0|||
144248364|NCT03578146|520106415|FG003|Overall Study|Did Not Receive Treatment|0|||
144248365|NCT03578146|520106416|FG004|Overall Study|Did Not Receive Treatment|0|||
144248366|NCT03578146|520106417|FG005|Overall Study|Did Not Receive Treatment|2|||
144248367|NCT03578146|520106412|FG000|Overall Study|Lost to Follow-up|0|||
144248368|NCT03578146|520106413|FG001|Overall Study|Lost to Follow-up|1|||
144248369|NCT03578146|520106414|FG002|Overall Study|Lost to Follow-up|1|||
144248370|NCT03578146|520106415|FG003|Overall Study|Lost to Follow-up|0|||
144248371|NCT03578146|520106416|FG004|Overall Study|Lost to Follow-up|0|||
144248372|NCT03578146|520106417|FG005|Overall Study|Lost to Follow-up|1|||
144248373|NCT00634049|520106418|FG000|Overall Study|Never received study drug|1|||
144248374|NCT00634049|520106418|FG000|Overall Study|Died prior to receiving study drug|1|||
144721466|NCT01296932|521835201|FG002|Overall Study|per protocol|1|||
144721467|NCT01296932|521835202|FG003|Overall Study|per protocol|1|||
144721468|NCT01296932|521835203|FG004|Overall Study|per protocol|0|||
144721469|NCT01296932|521835204|FG005|Overall Study|per protocol|0|||
144721470|NCT01296932|521835205|FG006|Overall Study|per protocol|0|||
144721471|NCT01296932|521835206|FG007|Overall Study|per protocol|0|||
144721472|NCT01296932|521835207|FG008|Overall Study|per protocol|0|||
144721473|NCT01296932|521835199|FG000|Overall Study|Low benefit and too many side effects|0|||
144721474|NCT01296932|521835200|FG001|Overall Study|Low benefit and too many side effects|0|||
144721475|NCT01296932|521835201|FG002|Overall Study|Low benefit and too many side effects|0|||
144721476|NCT01296932|521835202|FG003|Overall Study|Low benefit and too many side effects|0|||
144721477|NCT01296932|521835203|FG004|Overall Study|Low benefit and too many side effects|0|||
144721478|NCT01296932|521835204|FG005|Overall Study|Low benefit and too many side effects|0|||
144721479|NCT01296932|521835205|FG006|Overall Study|Low benefit and too many side effects|0|||
144721480|NCT01296932|521835206|FG007|Overall Study|Low benefit and too many side effects|1|||
144721481|NCT01296932|521835207|FG008|Overall Study|Low benefit and too many side effects|0|||
144721482|NCT01296932|521835199|FG000|Overall Study|No adequate treatment response|0|||
144721483|NCT01296932|521835200|FG001|Overall Study|No adequate treatment response|0|||
144721484|NCT01296932|521835201|FG002|Overall Study|No adequate treatment response|0|||
144721485|NCT01296932|521835202|FG003|Overall Study|No adequate treatment response|0|||
144721486|NCT01296932|521835203|FG004|Overall Study|No adequate treatment response|0|||
144721487|NCT01296932|521835204|FG005|Overall Study|No adequate treatment response|0|||
144721488|NCT01296932|521835205|FG006|Overall Study|No adequate treatment response|0|||
144721489|NCT01296932|521835206|FG007|Overall Study|No adequate treatment response|1|||
144721490|NCT01296932|521835207|FG008|Overall Study|No adequate treatment response|0|||
144721491|NCT01296932|521835199|FG000|Overall Study|Dosage already reduced, AE still present|0|||
144721492|NCT01296932|521835200|FG001|Overall Study|Dosage already reduced, AE still present|0|||
144721493|NCT01296932|521835201|FG002|Overall Study|Dosage already reduced, AE still present|0|||
144721494|NCT01296932|521835202|FG003|Overall Study|Dosage already reduced, AE still present|0|||
144721495|NCT01296932|521835203|FG004|Overall Study|Dosage already reduced, AE still present|0|||
144721496|NCT01296932|521835204|FG005|Overall Study|Dosage already reduced, AE still present|0|||
144721497|NCT01296932|521835205|FG006|Overall Study|Dosage already reduced, AE still present|0|||
144248375|NCT00634049|520106418|FG000|Overall Study|Screening failure|1|||
144248376|NCT01717391|520106419|FG000|Overall Study|Withdrawal by Subject|5|||
144248377|NCT01717391|520106419|FG000|Overall Study|Physician Decision|1|||
144248378|NCT01717391|520106419|FG000|Overall Study|FLT technical failure|3|||
144248379|NCT00314132|520106420|FG000|Overall Study|Lost to Follow-up|3|||
144248380|NCT00314132|520106421|FG001|Overall Study|Lost to Follow-up|13|||
144248381|NCT00314132|520106420|FG000|Overall Study|Withdrawal by Subject|3|||
144248382|NCT00314132|520106421|FG001|Overall Study|Withdrawal by Subject|5|||
144248383|NCT00314132|520106420|FG000|Overall Study|Adverse Event|1|||
144248384|NCT00314132|520106421|FG001|Overall Study|Adverse Event|0|||
144248385|NCT00314132|520106420|FG000|Overall Study|Physician Decision|1|||
144248386|NCT00314132|520106421|FG001|Overall Study|Physician Decision|0|||
144248387|NCT04769739|520106422|FG000|Overall Study|Colorectal cancer obstruction|2|||
144248388|NCT04769739|520106423|FG001|Overall Study|Colorectal cancer obstruction|0|||
144248389|NCT04769739|520106424|FG002|Overall Study|Colorectal cancer obstruction|0|||
144248390|NCT04769739|520106425|FG003|Overall Study|Colorectal cancer obstruction|0|||
144248391|NCT04769739|520106422|FG000|Overall Study|Failed cecal intubation|1|||
144248392|NCT04769739|520106423|FG001|Overall Study|Failed cecal intubation|0|||
144248393|NCT04769739|520106424|FG002|Overall Study|Failed cecal intubation|0|||
144248394|NCT04769739|520106425|FG003|Overall Study|Failed cecal intubation|1|||
144248395|NCT04769739|520106422|FG000|Overall Study|Poor bowel preparation|0|||
144248396|NCT04769739|520106423|FG001|Overall Study|Poor bowel preparation|0|||
144248397|NCT04769739|520106424|FG002|Overall Study|Poor bowel preparation|0|||
144248398|NCT04769739|520106425|FG003|Overall Study|Poor bowel preparation|1|||
144248399|NCT01260584|520106426|FG000|Period 1|Protocol Violation|0|||
144248400|NCT01260584|520106427|FG001|Period 1|Protocol Violation|0|||
144248401|NCT01260584|520106428|FG002|Period 1|Protocol Violation|1|||
144248402|NCT01260584|520106429|FG003|Period 1|Protocol Violation|1|||
144248403|NCT01260584|520106426|FG000|Period 1|Adverse Event|0|||
144502387|NCT02781584|521036044|FG002|Treatment Phase|Withdrew Consent|0|||
144502388|NCT02781584|521036045|FG003|Treatment Phase|Withdrew Consent|0|||
144502389|NCT02781584|521036046|FG004|Treatment Phase|Withdrew Consent|0|||
144502390|NCT02781584|521036047|FG005|Treatment Phase|Withdrew Consent|1|||
144502391|NCT02781584|521036048|FG006|Treatment Phase|Withdrew Consent|0|||
144502392|NCT02781584|521036049|FG007|Treatment Phase|Withdrew Consent|0|||
144502393|NCT02781584|521036050|FG008|Treatment Phase|Withdrew Consent|0|||
144502394|NCT02781584|521036051|FG009|Treatment Phase|Withdrew Consent|0|||
144502395|NCT02781584|521036052|FG010|Treatment Phase|Withdrew Consent|1|||
144502396|NCT02781584|521036053|FG011|Treatment Phase|Withdrew Consent|2|||
144502397|NCT02781584|521036054|FG012|Treatment Phase|Withdrew Consent|0|||
144502398|NCT02781584|521036042|FG000|Treatment Phase|Adverse Event|0|||
144502399|NCT02781584|521036043|FG001|Treatment Phase|Adverse Event|0|||
144502400|NCT02781584|521036044|FG002|Treatment Phase|Adverse Event|0|||
144502401|NCT02781584|521036045|FG003|Treatment Phase|Adverse Event|0|||
144502402|NCT02781584|521036046|FG004|Treatment Phase|Adverse Event|0|||
144502403|NCT02781584|521036047|FG005|Treatment Phase|Adverse Event|0|||
144502404|NCT02781584|521036048|FG006|Treatment Phase|Adverse Event|0|||
144502405|NCT02781584|521036049|FG007|Treatment Phase|Adverse Event|1|||
144502406|NCT02781584|521036050|FG008|Treatment Phase|Adverse Event|0|||
144502407|NCT02781584|521036051|FG009|Treatment Phase|Adverse Event|0|||
144502408|NCT02781584|521036052|FG010|Treatment Phase|Adverse Event|0|||
144502409|NCT02781584|521036053|FG011|Treatment Phase|Adverse Event|0|||
144502410|NCT02781584|521036054|FG012|Treatment Phase|Adverse Event|0|||
144248404|NCT01260584|520106427|FG001|Period 1|Adverse Event|0|||
144248405|NCT01260584|520106428|FG002|Period 1|Adverse Event|1|||
144248406|NCT01260584|520106429|FG003|Period 1|Adverse Event|0|||
144248407|NCT01260584|520106426|FG000|Period 2|Protocol Violation|0|||
144248408|NCT01260584|520106427|FG001|Period 2|Protocol Violation|2|||
144248409|NCT01260584|520106428|FG002|Period 2|Protocol Violation|3|||
144248410|NCT01260584|520106429|FG003|Period 2|Protocol Violation|1|||
144248411|NCT01260584|520106426|FG000|Period 2|Adverse Event|1|||
144248412|NCT01260584|520106427|FG001|Period 2|Adverse Event|0|||
144248413|NCT01260584|520106428|FG002|Period 2|Adverse Event|2|||
144248414|NCT01260584|520106429|FG003|Period 2|Adverse Event|0|||
144248415|NCT01260584|520106426|FG000|Period 2|Withdrawal by Subject|0|||
144248416|NCT01260584|520106427|FG001|Period 2|Withdrawal by Subject|1|||
144248417|NCT01260584|520106428|FG002|Period 2|Withdrawal by Subject|0|||
144248418|NCT01260584|520106429|FG003|Period 2|Withdrawal by Subject|0|||
144248419|NCT00335959|520106431|FG000|Overall Study|Adverse Event|2|||
144248420|NCT00335959|520106431|FG000|Overall Study|Ineligible|1|||
144248421|NCT02450552|520106434|FG000|Overall Study|Withdrawal by Subject|4|||
144248422|NCT02450552|520106435|FG001|Overall Study|Withdrawal by Subject|0|||
144248423|NCT02450552|520106436|FG002|Overall Study|Withdrawal by Subject|4|||
144248424|NCT02450552|520106434|FG000|Overall Study|Physician Decision|1|||
144248425|NCT02450552|520106435|FG001|Overall Study|Physician Decision|0|||
144248426|NCT02450552|520106436|FG002|Overall Study|Physician Decision|1|||
144248427|NCT04148287|520106445|FG000|Overall Study|Death|2|||
144248428|NCT03164265|520106446|FG000|Overall Study|Physician Decision|3|||
144248429|NCT00824382|520106448|FG000|Overall Study|Adverse Event|4|||
144502411|NCT00995709|521036061|FG000|Overall Study|Adverse Event|4|||
144502412|NCT00995709|521036062|FG001|Overall Study|Adverse Event|2|||
144248430|NCT00824382|520106449|FG001|Overall Study|Adverse Event|1|||
144248431|NCT00824382|520106450|FG002|Overall Study|Adverse Event|1|||
144248432|NCT00824382|520106451|FG003|Overall Study|Adverse Event|4|||
144248433|NCT00824382|520106448|FG000|Overall Study|Protocol Violation|1|||
144248434|NCT00824382|520106449|FG001|Overall Study|Protocol Violation|0|||
144248435|NCT00824382|520106450|FG002|Overall Study|Protocol Violation|0|||
144248436|NCT00824382|520106451|FG003|Overall Study|Protocol Violation|1|||
144248437|NCT00824382|520106448|FG000|Overall Study|Investigator's decision|0|||
144248438|NCT00824382|520106449|FG001|Overall Study|Investigator's decision|1|||
144248439|NCT00824382|520106450|FG002|Overall Study|Investigator's decision|2|||
144248440|NCT00824382|520106451|FG003|Overall Study|Investigator's decision|0|||
144248441|NCT03673345|520106452|FG000|Overall Study|Lost to Follow-up|1|||
144248442|NCT03673345|520106453|FG001|Overall Study|Lost to Follow-up|0|||
144248443|NCT03673345|520106454|FG002|Overall Study|Lost to Follow-up|3|||
144248444|NCT03673345|520106455|FG003|Overall Study|Lost to Follow-up|3|||
144248445|NCT03673345|520106456|FG004|Overall Study|Lost to Follow-up|2|||
144248446|NCT03673345|520106457|FG005|Overall Study|Lost to Follow-up|1|||
144248447|NCT03673345|520106458|FG006|Overall Study|Lost to Follow-up|0|||
144248448|NCT03673345|520106459|FG007|Overall Study|Lost to Follow-up|0|||
144248449|NCT03673345|520106452|FG000|Overall Study|Withdrawal by Subject|1|||
144248450|NCT03673345|520106453|FG001|Overall Study|Withdrawal by Subject|0|||
144248451|NCT03673345|520106454|FG002|Overall Study|Withdrawal by Subject|4|||
144248452|NCT03673345|520106455|FG003|Overall Study|Withdrawal by Subject|2|||
144248453|NCT03673345|520106456|FG004|Overall Study|Withdrawal by Subject|0|||
144248454|NCT03673345|520106457|FG005|Overall Study|Withdrawal by Subject|0|||
144248455|NCT03673345|520106458|FG006|Overall Study|Withdrawal by Subject|0|||
144248456|NCT03673345|520106459|FG007|Overall Study|Withdrawal by Subject|0|||
144248457|NCT03673345|520106452|FG000|Overall Study|Physician Decision|0|||
144248458|NCT03673345|520106453|FG001|Overall Study|Physician Decision|0|||
144248459|NCT03673345|520106454|FG002|Overall Study|Physician Decision|2|||
144248460|NCT03673345|520106455|FG003|Overall Study|Physician Decision|0|||
144248461|NCT03673345|520106456|FG004|Overall Study|Physician Decision|0|||
144248462|NCT03673345|520106457|FG005|Overall Study|Physician Decision|0|||
144248463|NCT03673345|520106458|FG006|Overall Study|Physician Decision|0|||
144248464|NCT03673345|520106459|FG007|Overall Study|Physician Decision|0|||
144248465|NCT02172040|520106463|FG000|Overall Study|Adverse Event|0|||
144248466|NCT02172040|520106464|FG001|Overall Study|Adverse Event|2|||
144248467|NCT02172040|520106465|FG002|Overall Study|Adverse Event|0|||
144248468|NCT02172040|520106466|FG003|Overall Study|Adverse Event|0|||
144248469|NCT02172040|520106463|FG000|Overall Study|Protocol Violation|0|||
144248470|NCT02172040|520106464|FG001|Overall Study|Protocol Violation|1|||
144248471|NCT02172040|520106465|FG002|Overall Study|Protocol Violation|0|||
144248472|NCT02172040|520106466|FG003|Overall Study|Protocol Violation|0|||
144248473|NCT02172040|520106463|FG000|Overall Study|Withdrawal by Subject|0|||
144248474|NCT02172040|520106464|FG001|Overall Study|Withdrawal by Subject|0|||
144248475|NCT02172040|520106465|FG002|Overall Study|Withdrawal by Subject|1|||
144248476|NCT02172040|520106466|FG003|Overall Study|Withdrawal by Subject|0|||
144248477|NCT02172040|520106463|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
144248478|NCT02172040|520106464|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
144248479|NCT02172040|520106465|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
144248480|NCT02172040|520106466|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
144502413|NCT00995709|521036063|FG002|Overall Study|Adverse Event|0|||
144502414|NCT00995709|521036061|FG000|Overall Study|Lack of Efficacy|0|||
144502415|NCT00995709|521036062|FG001|Overall Study|Lack of Efficacy|1|||
144502416|NCT00995709|521036063|FG002|Overall Study|Lack of Efficacy|4|||
144502417|NCT00995709|521036061|FG000|Overall Study|Withdrawal by Subject|0|||
144502418|NCT00995709|521036062|FG001|Overall Study|Withdrawal by Subject|4|||
144502419|NCT00995709|521036063|FG002|Overall Study|Withdrawal by Subject|1|||
144502420|NCT00995709|521036061|FG000|Overall Study|Lost to Follow-up|1|||
144502421|NCT00995709|521036062|FG001|Overall Study|Lost to Follow-up|0|||
144502422|NCT00995709|521036063|FG002|Overall Study|Lost to Follow-up|0|||
144502423|NCT00995709|521036061|FG000|Overall Study|Death|0|||
144502424|NCT00995709|521036062|FG001|Overall Study|Death|1|||
144502425|NCT00995709|521036063|FG002|Overall Study|Death|0|||
144502426|NCT00995709|521036061|FG000|Overall Study|Protocol Violation|2|||
144502427|NCT00995709|521036062|FG001|Overall Study|Protocol Violation|1|||
144248481|NCT02172040|520106463|FG000|Overall Study|Family emergency abroad|0|||
144248482|NCT02172040|520106464|FG001|Overall Study|Family emergency abroad|0|||
144248483|NCT02172040|520106465|FG002|Overall Study|Family emergency abroad|0|||
144248484|NCT02172040|520106466|FG003|Overall Study|Family emergency abroad|1|||
144248485|NCT02607306|520106467|FG000|Overall Study|Adverse Event|8|||
144248486|NCT02607306|520106468|FG001|Overall Study|Adverse Event|6|||
144248487|NCT02607306|520106469|FG002|Overall Study|Adverse Event|6|||
144248488|NCT02607306|520106467|FG000|Overall Study|Unclassified|1|||
144248489|NCT02607306|520106468|FG001|Overall Study|Unclassified|4|||
144248490|NCT02607306|520106469|FG002|Overall Study|Unclassified|0|||
144502428|NCT00995709|521036063|FG002|Overall Study|Protocol Violation|0|||
144502429|NCT03008915|521036068|FG000|Treatment 1|Withdrawal by Subject|0|||
144502430|NCT03008915|521036069|FG001|Treatment 1|Withdrawal by Subject|1|||
144538225|NCT00146172|521174122|FG000|Overall Study|Withdrawal by Subject|0|||
144538226|NCT00146172|521174123|FG001|Overall Study|Withdrawal by Subject|0|||
144538227|NCT00146172|521174124|FG002|Overall Study|Withdrawal by Subject|0|||
144538228|NCT00146172|521174125|FG003|Overall Study|Withdrawal by Subject|0|||
144538229|NCT00146172|521174126|FG004|Overall Study|Withdrawal by Subject|0|||
144538230|NCT00146172|521174127|FG005|Overall Study|Withdrawal by Subject|1|||
144538231|NCT00146172|521174128|FG006|Overall Study|Withdrawal by Subject|1|||
144538232|NCT00146172|521174129|FG007|Overall Study|Withdrawal by Subject|4|||
144538233|NCT00146172|521174122|FG000|Overall Study|Symptomatic Deterioration|1|||
144538234|NCT00146172|521174123|FG001|Overall Study|Symptomatic Deterioration|0|||
144538235|NCT00146172|521174124|FG002|Overall Study|Symptomatic Deterioration|1|||
144538236|NCT00146172|521174125|FG003|Overall Study|Symptomatic Deterioration|0|||
144538237|NCT00146172|521174126|FG004|Overall Study|Symptomatic Deterioration|1|||
144538238|NCT00146172|521174127|FG005|Overall Study|Symptomatic Deterioration|2|||
144538239|NCT00146172|521174128|FG006|Overall Study|Symptomatic Deterioration|0|||
144538240|NCT00146172|521174129|FG007|Overall Study|Symptomatic Deterioration|2|||
144538241|NCT02760654|521174130|FG000|Overall Study|Lost to Follow-up|3|||
144538242|NCT02760654|521174131|FG001|Overall Study|Lost to Follow-up|3|||
144538243|NCT02760654|521174130|FG000|Overall Study|Withdrawal by Subject|4|||
144538244|NCT02760654|521174131|FG001|Overall Study|Withdrawal by Subject|3|||
144538245|NCT00786864|521174132|FG000|Overall Study|Lost to Follow-up|0|||
144538246|NCT00786864|521174133|FG001|Overall Study|Lost to Follow-up|1|||
144538247|NCT00786864|521174132|FG000|Overall Study|Sustained serious back injury|1|||
144538248|NCT00786864|521174133|FG001|Overall Study|Sustained serious back injury|0|||
144538249|NCT01084694|521174135|FG000|Overall Study|Withdrawal by Subject|2|||
144538250|NCT01084694|521174136|FG001|Overall Study|Withdrawal by Subject|1|||
144538251|NCT01084694|521174135|FG000|Overall Study|Death|2|||
144538252|NCT01084694|521174136|FG001|Overall Study|Death|12|||
144538253|NCT01084694|521174135|FG000|Overall Study|eligibility not maintained|2|||
144538254|NCT01084694|521174136|FG001|Overall Study|eligibility not maintained|7|||
144538255|NCT04213807|521174140|FG000|Overall Study|Physician Decision|0|||
144538256|NCT04213807|521174141|FG001|Overall Study|Physician Decision|0|||
144538257|NCT04213807|521174142|FG002|Overall Study|Physician Decision|1|||
144538258|NCT03801148|521174143|FG000|Period 1 (2 Days)|Adverse Event|1|||
144538259|NCT03801148|521174144|FG001|Period 1 (2 Days)|Adverse Event|1|||
144538260|NCT03801148|521174145|FG002|Period 1 (2 Days)|Adverse Event|0|||
144538261|NCT03801148|521174146|FG003|Period 1 (2 Days)|Adverse Event|0|||
144538262|NCT03801148|521174143|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
144538263|NCT03801148|521174144|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
144538264|NCT03801148|521174145|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
144538265|NCT03801148|521174146|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
144248491|NCT02607306|520106467|FG000|Overall Study|Withdrawal by Subject|8|||
144248492|NCT02607306|520106468|FG001|Overall Study|Withdrawal by Subject|10|||
144248493|NCT02607306|520106469|FG002|Overall Study|Withdrawal by Subject|2|||
144248494|NCT02607306|520106467|FG000|Overall Study|Lack of Efficacy|0|||
144248495|NCT02607306|520106468|FG001|Overall Study|Lack of Efficacy|1|||
144248496|NCT02607306|520106469|FG002|Overall Study|Lack of Efficacy|1|||
144248497|NCT02607306|520106467|FG000|Overall Study|Protocol Violation|4|||
144248498|NCT02607306|520106468|FG001|Overall Study|Protocol Violation|2|||
144248499|NCT02607306|520106469|FG002|Overall Study|Protocol Violation|1|||
144538266|NCT03801148|521174143|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144538267|NCT03801148|521174144|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144538268|NCT03801148|521174145|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
144248500|NCT01911793|520107933|FG000|Overall Study|Physician Decision|1|||
144248501|NCT01911793|520107934|FG001|Overall Study|Physician Decision|5|||
144248502|NCT03774394|520107935|FG000|Overall Study|Withdrawal by Subject|2|||
144248503|NCT03774394|520107936|FG001|Overall Study|Withdrawal by Subject|0|||
144248504|NCT02697916|520107937|FG000|Overall Study|Death|357|||
144370097|NCT00670748|520562816|FG003|Overall Study|Not off study|1|||
144502431|NCT00028769|521037985|FG000|Overall Study|Adverse Event|2|||
144502432|NCT00028769|521037985|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
144502433|NCT00028769|521037985|FG000|Overall Study|Progression or Death|31|||
144502434|NCT00028769|521037985|FG000|Overall Study|Other - Not Protocol Specified|1|||
144502435|NCT00028769|521037985|FG000|Overall Study|Ineligible|5|||
144502436|NCT00028769|521037985|FG000|Overall Study|Not Analyzable|1|||
144502437|NCT00487578|521037986|FG000|Overall Study|Adverse Event|1|||
144502438|NCT00487578|521037987|FG001|Overall Study|Adverse Event|2|||
144502439|NCT00487578|521037986|FG000|Overall Study|Lack of Efficacy|0|||
144502440|NCT00487578|521037987|FG001|Overall Study|Lack of Efficacy|1|||
144502441|NCT00487578|521037986|FG000|Overall Study|Lost to Follow-up|0|||
144502442|NCT00487578|521037987|FG001|Overall Study|Lost to Follow-up|1|||
144502443|NCT02525796|521037988|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
144502444|NCT02525796|521037989|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
144502445|NCT02525796|521037990|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
144502446|NCT02525796|521037988|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
144502447|NCT02525796|521037989|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
144502448|NCT02525796|521037990|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
144502449|NCT02525796|521037988|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
144502450|NCT02525796|521037989|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
144502451|NCT02525796|521037990|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
144502452|NCT02525796|521037988|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
144502453|NCT02525796|521037989|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
144502454|NCT02525796|521037990|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
144502455|NCT02525796|521037988|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
144502456|NCT02525796|521037989|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
144502457|NCT02525796|521037990|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
144502458|NCT00726999|521037991|FG000|Overall Study|Physician Decision|0|||
144502459|NCT00726999|521037992|FG001|Overall Study|Physician Decision|1|||
144502460|NCT00726999|521037991|FG000|Overall Study|Withdrawal by Subject|2|||
144502461|NCT00726999|521037992|FG001|Overall Study|Withdrawal by Subject|0|||
144502462|NCT00726999|521037991|FG000|Overall Study|Protocol Violation|1|||
144502463|NCT00726999|521037992|FG001|Overall Study|Protocol Violation|0|||
144502464|NCT01198275|521037993|FG000|Overall Study|Adverse Event|2|||
144502465|NCT01198275|521037994|FG001|Overall Study|Adverse Event|3|||
144502466|NCT01198275|521037993|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
144502467|NCT01198275|521037994|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
144502468|NCT02385669|521037997|FG000|Overall Study|Adverse Event|2|||
144502469|NCT00970307|521037998|FG000|Overall Study|Serious Adverse Event|1|||
144502470|NCT00970307|521037999|FG001|Overall Study|Serious Adverse Event|0|||
144502471|NCT00970307|521038000|FG002|Overall Study|Serious Adverse Event|0|||
144502472|NCT00970307|521037998|FG000|Overall Study|Withdrawal by Subject|2|||
144502473|NCT00970307|521037999|FG001|Overall Study|Withdrawal by Subject|3|||
144502474|NCT00970307|521038000|FG002|Overall Study|Withdrawal by Subject|2|||
144502475|NCT02810080|521038001|FG000|Overall Study|Adverse Event|3|||
144502476|NCT02810080|521038002|FG001|Overall Study|Adverse Event|0|||
144502477|NCT02810080|521038001|FG000|Overall Study|Death|0|||
144502478|NCT02810080|521038002|FG001|Overall Study|Death|2|||
144502479|NCT02810080|521038001|FG000|Overall Study|Physician Decision|4|||
144502480|NCT02810080|521038002|FG001|Overall Study|Physician Decision|0|||
144502481|NCT02810080|521038001|FG000|Overall Study|Withdrawal by Subject|0|||
144502482|NCT02810080|521038002|FG001|Overall Study|Withdrawal by Subject|2|||
144502483|NCT01458210|521038008|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
144502484|NCT01458210|521038008|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
144502485|NCT01458210|521038008|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
144502486|NCT01458210|521038008|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
144502487|NCT05174013|521038009|FG000|Overall Study|Lost to Follow-up|0|||
144502488|NCT05174013|521038010|FG001|Overall Study|Lost to Follow-up|0|||
144502489|NCT05174013|521038011|FG002|Overall Study|Lost to Follow-up|0|||
144502490|NCT05174013|521038012|FG003|Overall Study|Lost to Follow-up|1|||
144502491|NCT05174013|521038013|FG004|Overall Study|Lost to Follow-up|0|||
144502492|NCT05174013|521038014|FG005|Overall Study|Lost to Follow-up|0|||
144502493|NCT05174013|521038009|FG000|Overall Study|Withdrawal by Subject|0|||
144502494|NCT05174013|521038010|FG001|Overall Study|Withdrawal by Subject|0|||
144721498|NCT01296932|521835206|FG007|Overall Study|Dosage already reduced, AE still present|0|||
144721499|NCT01296932|521835207|FG008|Overall Study|Dosage already reduced, AE still present|1|||
144721500|NCT04161144|521835213|FG000|Overall Study|Withdrawal by Subject|0|||
144721501|NCT04161144|521835214|FG001|Overall Study|Withdrawal by Subject|1|||
144721502|NCT04161144|521835213|FG000|Overall Study|Protocol Violation|1|||
144721503|NCT04161144|521835214|FG001|Overall Study|Protocol Violation|0|||
144721504|NCT02207621|521835216|FG000|Overall Study|Adverse Event|71|||
144721505|NCT02207621|521835217|FG001|Overall Study|Adverse Event|15|||
144721506|NCT02207621|521835218|FG002|Overall Study|Adverse Event|132|||
144721507|NCT02207621|521835216|FG000|Overall Study|Withdrawal by Subject|9|||
144502495|NCT05174013|521038011|FG002|Overall Study|Withdrawal by Subject|1|||
144502496|NCT05174013|521038012|FG003|Overall Study|Withdrawal by Subject|0|||
144502497|NCT05174013|521038013|FG004|Overall Study|Withdrawal by Subject|0|||
144502498|NCT05174013|521038014|FG005|Overall Study|Withdrawal by Subject|0|||
144502499|NCT02034916|521038015|FG000|Overall Study|Death|39|||
144502500|NCT02034916|521038016|FG001|Overall Study|Death|28|||
144502501|NCT02034916|521038015|FG000|Overall Study|Withdrawal by Subject|2|||
144502502|NCT02034916|521038016|FG001|Overall Study|Withdrawal by Subject|1|||
144502503|NCT02034916|521038015|FG000|Overall Study|Lost to Follow-up|4|||
144502504|NCT02034916|521038016|FG001|Overall Study|Lost to Follow-up|1|||
144502505|NCT02034916|521038015|FG000|Overall Study|Study terminated by sponsor|4|||
144502506|NCT02034916|521038016|FG001|Overall Study|Study terminated by sponsor|5|||
144502507|NCT01616654|521038017|FG000|Overall Study|Lack of Efficacy|1|||
144502508|NCT01616654|521038018|FG001|Overall Study|Lack of Efficacy|0|||
144502509|NCT01616654|521038019|FG002|Overall Study|Lack of Efficacy|0|||
144502510|NCT01616654|521038020|FG003|Overall Study|Lack of Efficacy|0|||
144502511|NCT01616654|521038021|FG004|Overall Study|Lack of Efficacy|1|||
144502512|NCT01616654|521038017|FG000|Overall Study|Adverse Event|0|||
144502513|NCT01616654|521038018|FG001|Overall Study|Adverse Event|1|||
144502514|NCT01616654|521038019|FG002|Overall Study|Adverse Event|2|||
144502515|NCT01616654|521038020|FG003|Overall Study|Adverse Event|1|||
144502516|NCT01616654|521038021|FG004|Overall Study|Adverse Event|0|||
144502517|NCT01616654|521038017|FG000|Overall Study|Withdrawal by Subject|2|||
144502518|NCT01616654|521038018|FG001|Overall Study|Withdrawal by Subject|2|||
144502519|NCT01616654|521038019|FG002|Overall Study|Withdrawal by Subject|3|||
144502520|NCT01616654|521038020|FG003|Overall Study|Withdrawal by Subject|1|||
144502521|NCT01616654|521038021|FG004|Overall Study|Withdrawal by Subject|5|||
144502522|NCT01616654|521038017|FG000|Overall Study|Protocol Violation|0|||
144502523|NCT01616654|521038018|FG001|Overall Study|Protocol Violation|5|||
144502524|NCT01616654|521038019|FG002|Overall Study|Protocol Violation|2|||
144502525|NCT01616654|521038020|FG003|Overall Study|Protocol Violation|4|||
144502526|NCT01616654|521038021|FG004|Overall Study|Protocol Violation|4|||
144502527|NCT01616654|521038017|FG000|Overall Study|Lost to Follow-up|1|||
144502528|NCT01616654|521038018|FG001|Overall Study|Lost to Follow-up|0|||
144502529|NCT01616654|521038019|FG002|Overall Study|Lost to Follow-up|3|||
144502530|NCT01616654|521038020|FG003|Overall Study|Lost to Follow-up|2|||
144502531|NCT01616654|521038021|FG004|Overall Study|Lost to Follow-up|1|||
144502532|NCT01616654|521038017|FG000|Overall Study|Pregnancy|1|||
144502533|NCT01616654|521038018|FG001|Overall Study|Pregnancy|0|||
144502534|NCT01616654|521038019|FG002|Overall Study|Pregnancy|0|||
144502535|NCT01616654|521038020|FG003|Overall Study|Pregnancy|0|||
144502536|NCT01616654|521038021|FG004|Overall Study|Pregnancy|1|||
144502537|NCT00094809|521038025|FG000|Overall Study|Protocol deviation|2|||
144502538|NCT00094809|521038026|FG001|Overall Study|Protocol deviation|2|||
144502539|NCT00094809|521038025|FG000|Overall Study|Noncompliance|1|||
144502540|NCT00094809|521038026|FG001|Overall Study|Noncompliance|0|||
144502541|NCT00094809|521038025|FG000|Overall Study|Adverse Event|3|||
144502542|NCT00094809|521038026|FG001|Overall Study|Adverse Event|1|||
144502543|NCT00094809|521038025|FG000|Overall Study|Withdrawal by Subject|8|||
144502544|NCT00094809|521038026|FG001|Overall Study|Withdrawal by Subject|9|||
144502545|NCT00094809|521038025|FG000|Overall Study|Disease progression|3|||
144502546|NCT00094809|521038026|FG001|Overall Study|Disease progression|3|||
144502547|NCT00094809|521038025|FG000|Overall Study|Physician Decision|3|||
144502548|NCT00094809|521038026|FG001|Overall Study|Physician Decision|5|||
144502549|NCT00094809|521038025|FG000|Overall Study|Lost to Follow-up|6|||
144502550|NCT00094809|521038026|FG001|Overall Study|Lost to Follow-up|6|||
144502551|NCT00094809|521038025|FG000|Overall Study|Death|19|||
144502552|NCT00094809|521038026|FG001|Overall Study|Death|25|||
144502553|NCT00094809|521038025|FG000|Overall Study|Protocol-specified criteria|1|||
144502554|NCT00094809|521038026|FG001|Overall Study|Protocol-specified criteria|1|||
144502555|NCT00094809|521038025|FG000|Overall Study|Other|2|||
144502556|NCT00094809|521038026|FG001|Overall Study|Other|4|||
144502557|NCT00094809|521038025|FG000|Overall Study|Informed consent signed after treatment|1|||
144502558|NCT00094809|521038026|FG001|Overall Study|Informed consent signed after treatment|0|||
144502559|NCT00094809|521038025|FG000|Overall Study|Study drug not received|2|||
144502560|NCT00094809|521038026|FG001|Overall Study|Study drug not received|8|||
144502561|NCT00094809|521038025|FG000|Overall Study|Other|1|||
144502562|NCT00094809|521038026|FG001|Overall Study|Other|1|||
144502563|NCT01329328|521038027|FG000|Overall Study|Withdrawal by Subject|2|||
144502564|NCT01329328|521038028|FG001|Overall Study|Withdrawal by Subject|4|||
144502565|NCT01329328|521038029|FG002|Overall Study|Withdrawal by Subject|3|||
144502566|NCT02393716|521038030|FG000|Overall Study|Death|29|||
144502567|NCT02393716|521038030|FG000|Overall Study|Withdrawal by Subject|8|||
144502568|NCT02393716|521038030|FG000|Overall Study|Device Explanted|8|||
144502569|NCT02393716|521038030|FG000|Overall Study|Missed visit|16|||
144502570|NCT01119950|521038031|FG000|Overall Study|Adverse Event|25|||
144502571|NCT01119950|521038031|FG000|Overall Study|Withdrawal by Subject|9|||
144502572|NCT01119950|521038031|FG000|Overall Study|Protocol Violation|5|||
144502573|NCT01119950|521038031|FG000|Overall Study|Lost to Follow-up|4|||
144502574|NCT01119950|521038031|FG000|Overall Study|Administrative|2|||
144502575|NCT01119950|521038031|FG000|Overall Study|Abnormal lab value|1|||
144502576|NCT01119950|521038031|FG000|Overall Study|Death|1|||
144502577|NCT00758602|521038036|FG000|Overall Study|Adverse Event|11|||
144502578|NCT00758602|521038037|FG001|Overall Study|Adverse Event|10|||
144502579|NCT00758602|521038036|FG000|Overall Study|Lost to Follow-up|4|||
144502580|NCT00758602|521038037|FG001|Overall Study|Lost to Follow-up|3|||
144502581|NCT00758602|521038036|FG000|Overall Study|Withdrawal by Subject|1|||
144502582|NCT00758602|521038037|FG001|Overall Study|Withdrawal by Subject|3|||
144502583|NCT00758602|521038036|FG000|Overall Study|Protocol Violation|0|||
144502584|NCT00758602|521038037|FG001|Overall Study|Protocol Violation|2|||
144502585|NCT00758602|521038036|FG000|Overall Study|Death|0|||
144502586|NCT00758602|521038037|FG001|Overall Study|Death|1|||
144502587|NCT00758602|521038036|FG000|Overall Study|Reason not specified|3|||
144502588|NCT00758602|521038037|FG001|Overall Study|Reason not specified|3|||
144502589|NCT02148133|521038042|FG000|Overall Study|Investigator discretion|1|||
144502590|NCT02148133|521038042|FG000|Overall Study|Lack of Efficacy|1|||
144502591|NCT02148133|521038042|FG000|Overall Study|Protocol deviation|1|||
144502592|NCT02148133|521038042|FG000|Overall Study|Protocol-defined stopping criteria|2|||
144502593|NCT00855465|521038046|FG000|Treatment Period|Adverse Event|4|||
144502594|NCT00855465|521038047|FG001|Treatment Period|Adverse Event|2|||
144502595|NCT00855465|521038046|FG000|Treatment Period|Death|2|||
144502596|NCT00855465|521038047|FG001|Treatment Period|Death|2|||
144502597|NCT00855465|521038046|FG000|Treatment Period|Lack of Efficacy|2|||
144502598|NCT00855465|521038047|FG001|Treatment Period|Lack of Efficacy|1|||
144502599|NCT00855465|521038046|FG000|Treatment Period|Non-compliance|1|||
144502600|NCT00855465|521038047|FG001|Treatment Period|Non-compliance|0|||
144502601|NCT00855465|521038046|FG000|Treatment Period|Protocol Violation|2|||
144502602|NCT00855465|521038047|FG001|Treatment Period|Protocol Violation|0|||
144502603|NCT00855465|521038046|FG000|Treatment Period|Withdrawal by Subject|2|||
144502604|NCT00855465|521038047|FG001|Treatment Period|Withdrawal by Subject|0|||
144502605|NCT00855465|521038046|FG000|Treatment Period|Not treated|1|||
144502606|NCT00855465|521038047|FG001|Treatment Period|Not treated|0|||
144502607|NCT00855465|521038046|FG000|Follow-up Period (FUP)|Adverse Event|0|||
144502608|NCT00855465|521038047|FG001|Follow-up Period (FUP)|Adverse Event|1|||
144502609|NCT00855465|521038046|FG000|Follow-up Period (FUP)|Death|0|||
144502610|NCT00855465|521038047|FG001|Follow-up Period (FUP)|Death|1|||
144502611|NCT00855465|521038046|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
144502612|NCT00855465|521038047|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
144502613|NCT00855465|521038046|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
144502614|NCT00855465|521038047|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
144502615|NCT00855465|521038046|FG000|Follow-up Period (FUP)|Missing|1|||
144502616|NCT00855465|521038047|FG001|Follow-up Period (FUP)|Missing|0|||
144502617|NCT00079183|521038053|FG000|Overall Study|Withdrawal by Subject|4|||
144502618|NCT00079183|521038053|FG000|Overall Study|Study medication non-compliance|2|||
144502619|NCT00079183|521038053|FG000|Overall Study|Specimen collection non-compliance|1|||
144502620|NCT00530842|521038054|FG000|Overall Study|Adverse Event|10|||
144502621|NCT00530842|521038055|FG001|Overall Study|Adverse Event|6|||
144502622|NCT00530842|521038054|FG000|Overall Study|Lack of Efficacy|2|||
144502623|NCT00530842|521038055|FG001|Overall Study|Lack of Efficacy|1|||
144502624|NCT00530842|521038054|FG000|Overall Study|Lost to Follow-up|0|||
144502625|NCT00530842|521038055|FG001|Overall Study|Lost to Follow-up|4|||
144502626|NCT00530842|521038054|FG000|Overall Study|Protocol Violation|3|||
144502627|NCT00530842|521038055|FG001|Overall Study|Protocol Violation|2|||
144502628|NCT00530842|521038054|FG000|Overall Study|Withdrawal by Subject|4|||
144502629|NCT00530842|521038055|FG001|Overall Study|Withdrawal by Subject|5|||
144502630|NCT00530842|521038054|FG000|Overall Study|Individual different reasons|4|||
144502631|NCT00530842|521038055|FG001|Overall Study|Individual different reasons|3|||
144502632|NCT00530842|521038054|FG000|Period 1|Adverse Event|7|||
144502633|NCT00530842|521038055|FG001|Period 1|Adverse Event|3|||
144502634|NCT00530842|521038054|FG000|Period 1|Lack of Efficacy|1|||
144502635|NCT00530842|521038055|FG001|Period 1|Lack of Efficacy|1|||
144502636|NCT00530842|521038054|FG000|Period 1|Protocol Violation|2|||
144502637|NCT00530842|521038055|FG001|Period 1|Protocol Violation|1|||
144502638|NCT00530842|521038054|FG000|Period 1|Withdrawal by Subject|2|||
144502639|NCT00530842|521038055|FG001|Period 1|Withdrawal by Subject|3|||
144502640|NCT00530842|521038054|FG000|Period 1|Individual different reasons|2|||
144502641|NCT00530842|521038055|FG001|Period 1|Individual different reasons|3|||
144502642|NCT00530842|521038054|FG000|Period 2|Adverse Event|3|||
144502643|NCT00530842|521038055|FG001|Period 2|Adverse Event|3|||
144502644|NCT00530842|521038054|FG000|Period 2|Lack of Efficacy|1|||
144502645|NCT00530842|521038055|FG001|Period 2|Lack of Efficacy|0|||
144502646|NCT00530842|521038054|FG000|Period 2|Lost to Follow-up|0|||
144502647|NCT00530842|521038055|FG001|Period 2|Lost to Follow-up|4|||
144502648|NCT00530842|521038054|FG000|Period 2|Protocol Violation|1|||
144502649|NCT00530842|521038055|FG001|Period 2|Protocol Violation|0|||
144502650|NCT00530842|521038054|FG000|Period 2|Withdrawal by Subject|1|||
144502651|NCT00530842|521038055|FG001|Period 2|Withdrawal by Subject|2|||
144502652|NCT00530842|521038054|FG000|Period 2|Individual different reasons|2|||
144502653|NCT00530842|521038055|FG001|Period 2|Individual different reasons|0|||
144502654|NCT00880048|521038056|FG000|Overall Study|Adverse Event|2|||
144502655|NCT00880048|521038057|FG001|Overall Study|Adverse Event|3|||
144502656|NCT00880048|521038058|FG002|Overall Study|Adverse Event|5|||
144502657|NCT00880048|521038056|FG000|Overall Study|Lack of Efficacy|1|||
144502658|NCT00880048|521038057|FG001|Overall Study|Lack of Efficacy|2|||
144502659|NCT00880048|521038058|FG002|Overall Study|Lack of Efficacy|2|||
144502660|NCT00880048|521038056|FG000|Overall Study|Protocol Violation|4|||
144502661|NCT00880048|521038057|FG001|Overall Study|Protocol Violation|6|||
144502662|NCT00880048|521038058|FG002|Overall Study|Protocol Violation|5|||
144502663|NCT00880048|521038056|FG000|Overall Study|Lost to Follow-up|6|||
144502664|NCT00880048|521038057|FG001|Overall Study|Lost to Follow-up|6|||
144502665|NCT00880048|521038058|FG002|Overall Study|Lost to Follow-up|5|||
144502666|NCT00880048|521038056|FG000|Overall Study|Physician Decision|1|||
144502667|NCT00880048|521038057|FG001|Overall Study|Physician Decision|1|||
144502668|NCT00880048|521038058|FG002|Overall Study|Physician Decision|7|||
144502669|NCT00880048|521038056|FG000|Overall Study|Withdrawal by Subject|5|||
144502670|NCT00880048|521038057|FG001|Overall Study|Withdrawal by Subject|8|||
144502671|NCT00880048|521038058|FG002|Overall Study|Withdrawal by Subject|5|||
144502672|NCT00880048|521038056|FG000|Overall Study|Study closed/terminated|9|||
144502673|NCT00880048|521038057|FG001|Overall Study|Study closed/terminated|7|||
144502674|NCT00880048|521038058|FG002|Overall Study|Study closed/terminated|6|||
144502675|NCT02950558|521038062|FG000|Overall Study|Lost to Follow-up|2|||
144502676|NCT02950558|521038063|FG001|Overall Study|Lost to Follow-up|0|||
144502677|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
144502678|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
144502679|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
144502680|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
144502681|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
144502682|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
144502683|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
144502684|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
144502685|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
144502686|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
144502687|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
144502688|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
144502689|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
144502690|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
144502691|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
144502692|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
144502693|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
144502694|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
144502695|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
144502696|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
144502697|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
144502698|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
144502699|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
144502700|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
144502701|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
144502702|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
144502703|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
144502704|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
144502705|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
144502706|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
144502707|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
144502708|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
144502709|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
144502710|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502711|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
144502712|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
144502713|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
144502714|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502715|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502716|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502717|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502718|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502719|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502720|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
144502721|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502722|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502723|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502724|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502725|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
144502726|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502727|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502728|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502729|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502730|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502731|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
144502732|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
144502733|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502734|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502735|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502736|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502737|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502738|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502739|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502740|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502741|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502742|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
144502743|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
144502744|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
144502745|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
144502746|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
144502747|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
144502748|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
144502749|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
144502750|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
144502751|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
144502752|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
144502753|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
144502754|NCT02914522|521038070|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502755|NCT02914522|521038071|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
144502756|NCT02914522|521038072|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144721508|NCT02207621|521835217|FG001|Overall Study|Withdrawal by Subject|9|||
144721509|NCT02207621|521835218|FG002|Overall Study|Withdrawal by Subject|13|||
144721510|NCT02207621|521835216|FG000|Overall Study|Non-Compliant|3|||
144721511|NCT02207621|521835217|FG001|Overall Study|Non-Compliant|3|||
144721512|NCT02207621|521835218|FG002|Overall Study|Non-Compliant|1|||
144721513|NCT02207621|521835216|FG000|Overall Study|Lost to Follow-up|1|||
144721514|NCT02207621|521835217|FG001|Overall Study|Lost to Follow-up|0|||
144721515|NCT02207621|521835218|FG002|Overall Study|Lost to Follow-up|3|||
144721516|NCT02207621|521835216|FG000|Overall Study|Lack of Efficacy|10|||
144721517|NCT02207621|521835217|FG001|Overall Study|Lack of Efficacy|2|||
144721518|NCT02207621|521835218|FG002|Overall Study|Lack of Efficacy|4|||
144721519|NCT02207621|521835216|FG000|Overall Study|Disallowed Concurrent Medication|2|||
144721520|NCT02207621|521835217|FG001|Overall Study|Disallowed Concurrent Medication|5|||
144721521|NCT02207621|521835218|FG002|Overall Study|Disallowed Concurrent Medication|2|||
144721522|NCT02207621|521835216|FG000|Overall Study|Physician Decision|1|||
144721523|NCT02207621|521835217|FG001|Overall Study|Physician Decision|2|||
144721524|NCT02207621|521835218|FG002|Overall Study|Physician Decision|2|||
144721525|NCT02207621|521835216|FG000|Overall Study|Protocol Violation|4|||
144721526|NCT02207621|521835217|FG001|Overall Study|Protocol Violation|10|||
144721527|NCT02207621|521835218|FG002|Overall Study|Protocol Violation|6|||
144502757|NCT02914522|521038073|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502758|NCT02914522|521038074|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
144502759|NCT02914522|521038075|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
144502760|NCT02914522|521038076|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502761|NCT02914522|521038077|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502762|NCT02914522|521038078|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502763|NCT02914522|521038079|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502764|NCT02914522|521038080|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
144502765|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
144502766|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
144502767|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
144502768|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
144502769|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
144502770|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
144502771|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
144502772|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
144502773|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
144502774|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
144502775|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
144502776|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
144502777|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
144502778|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
144502779|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
144502780|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
144502781|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
144502782|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
144502783|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
144502784|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
144502785|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
144502786|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
144502787|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502788|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502789|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502790|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502791|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502792|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502793|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
144502794|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
144502795|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
144502796|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
144502797|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
144502798|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
144502799|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
144502800|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
144502801|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
144502802|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
144502803|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
144502804|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
144502805|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
144502806|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
144502807|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
144502808|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
144502809|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
144502810|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
144502811|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
144502812|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
144502813|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
144502814|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
144502815|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
144502816|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
144502817|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
144502818|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
144502819|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
144502820|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502821|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502822|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502823|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502824|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502825|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502826|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502827|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
144502828|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
144502829|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502830|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
144502831|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502832|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502833|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502834|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502835|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502836|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502837|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502838|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502839|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
144502840|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
144502841|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
144502842|NCT02914522|521038070|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502843|NCT02914522|521038071|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502844|NCT02914522|521038072|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502845|NCT02914522|521038073|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502846|NCT02914522|521038074|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502847|NCT02914522|521038075|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502848|NCT02914522|521038076|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502849|NCT02914522|521038077|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502850|NCT02914522|521038078|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502851|NCT02914522|521038079|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
144502852|NCT02914522|521038080|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
144502853|NCT00177216|521038081|FG000|Overall Study|Withdrawal by Subject|6|||
144502854|NCT00177216|521038082|FG001|Overall Study|Withdrawal by Subject|3|||
144502855|NCT00177216|521038083|FG002|Overall Study|Withdrawal by Subject|1|||
144502856|NCT01161498|521038086|FG000|Overall Study|Disease Progression|0|||
144502857|NCT01161498|521038087|FG001|Overall Study|Disease Progression|1|||
144502858|NCT02807493|521038088|FG000|Overall Study|Adverse Event|5|||
144502859|NCT02807493|521038089|FG001|Overall Study|Adverse Event|2|||
144502860|NCT02807493|521038088|FG000|Overall Study|Lost to Follow-up|6|||
144502861|NCT02807493|521038089|FG001|Overall Study|Lost to Follow-up|0|||
144502862|NCT02807493|521038088|FG000|Overall Study|Physician Decision|4|||
144502863|NCT02807493|521038089|FG001|Overall Study|Physician Decision|1|||
144502864|NCT02807493|521038088|FG000|Overall Study|Protocol Violation|7|||
144502865|NCT02807493|521038089|FG001|Overall Study|Protocol Violation|0|||
144502866|NCT02807493|521038088|FG000|Overall Study|Withdrawal by Subject|17|||
144502867|NCT02807493|521038089|FG001|Overall Study|Withdrawal by Subject|10|||
144502868|NCT02807493|521038088|FG000|Overall Study|Other withdrawal|17|||
144502869|NCT02807493|521038089|FG001|Overall Study|Other withdrawal|0|||
144502870|NCT02807493|521038088|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
144502871|NCT02807493|521038089|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
144502872|NCT01227707|521038090|FG000|Overall Study|Adverse Event|10|||
144502873|NCT01227707|521038090|FG000|Overall Study|Progression of disease|3|||
144502874|NCT01227707|521038090|FG000|Overall Study|Withdrawal by Subject|1|||
144502875|NCT01227707|521038090|FG000|Overall Study|Patient non-compliance|3|||
144502876|NCT01227707|521038090|FG000|Overall Study|Medical decision|6|||
144502877|NCT01227707|521038090|FG000|Overall Study|Death|1|||
144502878|NCT01093534|521038093|FG000|Overall Study|Adverse Event|2|||
144502879|NCT01093534|521038094|FG001|Overall Study|Adverse Event|5|||
144502880|NCT01093534|521038095|FG002|Overall Study|Adverse Event|2|||
144502881|NCT01093534|521038093|FG000|Overall Study|Lack of Efficacy|2|||
144502882|NCT01093534|521038094|FG001|Overall Study|Lack of Efficacy|1|||
144502883|NCT01093534|521038095|FG002|Overall Study|Lack of Efficacy|1|||
144502884|NCT01093534|521038093|FG000|Overall Study|Withdrawal by Subject|5|||
144502885|NCT01093534|521038094|FG001|Overall Study|Withdrawal by Subject|7|||
144502886|NCT01093534|521038095|FG002|Overall Study|Withdrawal by Subject|2|||
144502887|NCT01093534|521038093|FG000|Overall Study|Other|1|||
144502888|NCT01093534|521038094|FG001|Overall Study|Other|3|||
144502889|NCT01093534|521038095|FG002|Overall Study|Other|4|||
144502890|NCT00811057|521038096|FG000|Overall Study|Protocol Violation|5|||
144502891|NCT00811057|521038097|FG001|Overall Study|Protocol Violation|10|||
144502892|NCT00811057|521038098|FG002|Overall Study|Protocol Violation|10|||
144502893|NCT00768651|521038099|FG000|Overall Study|Withdrawal by Subject|1|||
144502894|NCT00712166|521038104|FG000|Overall Study|Noncompliance|0|||
144502895|NCT00712166|521038105|FG001|Overall Study|Noncompliance|1|||
144502896|NCT01773122|521038106|FG000|Overall Study|Due to amended age eligibility criteria|3|||
144502897|NCT01773122|521038107|FG001|Overall Study|Due to amended age eligibility criteria|1|||
144502898|NCT01773122|521038108|FG002|Overall Study|Due to amended age eligibility criteria|0|||
144502899|NCT01773122|521038109|FG003|Overall Study|Due to amended age eligibility criteria|1|||
144502900|NCT01264718|521038110|FG000|Overall Study|Lost to Follow-up|3|||
144502901|NCT01264718|521038111|FG001|Overall Study|Lost to Follow-up|2|||
144502902|NCT01264718|521038110|FG000|Overall Study|Withdrawal by Subject|9|||
144502903|NCT01264718|521038111|FG001|Overall Study|Withdrawal by Subject|15|||
144502904|NCT01264718|521038110|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
144502905|NCT01264718|521038111|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
144502906|NCT01769391|521038112|FG000|Overall Study|Death|10|||
144502907|NCT01769391|521038113|FG001|Overall Study|Death|1|||
144502908|NCT01769391|521038112|FG000|Overall Study|Adverse Event|0|||
144502909|NCT01769391|521038113|FG001|Overall Study|Adverse Event|3|||
144502910|NCT01769391|521038112|FG000|Overall Study|Progressive Disease|1|||
144502911|NCT01769391|521038113|FG001|Overall Study|Progressive Disease|2|||
144502912|NCT01769391|521038112|FG000|Overall Study|Withdrawal by Subject|4|||
144502913|NCT01769391|521038113|FG001|Overall Study|Withdrawal by Subject|3|||
144502914|NCT01769391|521038112|FG000|Overall Study|Investigator Decision|2|||
144502915|NCT01769391|521038113|FG001|Overall Study|Investigator Decision|0|||
144502916|NCT03386929|521038114|FG000|Overall Study|Death|0|||
144502917|NCT03386929|521038115|FG001|Overall Study|Death|0|||
144502918|NCT03386929|521038116|FG002|Overall Study|Death|1|||
144502919|NCT03386929|521038114|FG000|Overall Study|Withdrawal by Subject|0|||
144502920|NCT03386929|521038115|FG001|Overall Study|Withdrawal by Subject|1|||
144502921|NCT03386929|521038116|FG002|Overall Study|Withdrawal by Subject|0|||
144502922|NCT03386929|521038114|FG000|Overall Study|Physician Decision|0|||
144502923|NCT03386929|521038115|FG001|Overall Study|Physician Decision|0|||
144502924|NCT03386929|521038116|FG002|Overall Study|Physician Decision|1|||
144502925|NCT03386929|521038114|FG000|Overall Study|Progression|4|||
144502926|NCT03386929|521038115|FG001|Overall Study|Progression|4|||
144502927|NCT03386929|521038116|FG002|Overall Study|Progression|0|||
144502928|NCT03386929|521038114|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
144502929|NCT03386929|521038115|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
144502930|NCT03386929|521038116|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
144502931|NCT03386929|521038114|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
144502932|NCT03386929|521038115|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
144502933|NCT03386929|521038116|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
144502934|NCT00290706|521038126|FG000|Overall Study|Withdrawal by Subject|2|||
144502935|NCT00290706|521038127|FG001|Overall Study|Withdrawal by Subject|0|||
144502936|NCT00290706|521038128|FG002|Overall Study|Withdrawal by Subject|0|||
144502937|NCT00290706|521038129|FG003|Overall Study|Withdrawal by Subject|0|||
144502938|NCT00290706|521038126|FG000|Overall Study|Progressive Disease|3|||
144502939|NCT00290706|521038127|FG001|Overall Study|Progressive Disease|5|||
144502940|NCT00290706|521038128|FG002|Overall Study|Progressive Disease|4|||
144502941|NCT00290706|521038129|FG003|Overall Study|Progressive Disease|10|||
144502942|NCT00290706|521038126|FG000|Overall Study|Adverse Event|0|||
144502943|NCT00290706|521038127|FG001|Overall Study|Adverse Event|1|||
144502944|NCT00290706|521038128|FG002|Overall Study|Adverse Event|2|||
144502945|NCT00290706|521038129|FG003|Overall Study|Adverse Event|0|||
144502946|NCT00290706|521038126|FG000|Overall Study|Receive auto transplant or radiation|0|||
144502947|NCT00290706|521038127|FG001|Overall Study|Receive auto transplant or radiation|0|||
144502948|NCT00290706|521038128|FG002|Overall Study|Receive auto transplant or radiation|0|||
144502949|NCT00290706|521038129|FG003|Overall Study|Receive auto transplant or radiation|1|||
144502950|NCT00290706|521038126|FG000|Overall Study|Physician Decision|0|||
144502951|NCT00290706|521038127|FG001|Overall Study|Physician Decision|0|||
144502952|NCT00290706|521038128|FG002|Overall Study|Physician Decision|0|||
144502953|NCT00290706|521038129|FG003|Overall Study|Physician Decision|1|||
144502954|NCT03121950|521038130|FG000|Overall Study|Withdrawal by Subject|11|||
144502955|NCT03121950|521038131|FG001|Overall Study|Withdrawal by Subject|2|||
144502956|NCT01867580|521038135|FG000|Overall Study|Withdrawal by Subject|2|||
144502957|NCT01867580|521038136|FG001|Overall Study|Withdrawal by Subject|3|||
144502958|NCT01867580|521038135|FG000|Overall Study|Physician Decision|17|||
144502959|NCT01867580|521038136|FG001|Overall Study|Physician Decision|12|||
144502960|NCT01867580|521038135|FG000|Overall Study|Lost to Follow-up|3|||
144502961|NCT01867580|521038136|FG001|Overall Study|Lost to Follow-up|5|||
144502962|NCT01867580|521038135|FG000|Overall Study|Sponsor terminated study|1|||
144502963|NCT01867580|521038136|FG001|Overall Study|Sponsor terminated study|0|||
144502964|NCT01867580|521038135|FG000|Overall Study|Missed follow-up assessment|2|||
144502965|NCT01867580|521038136|FG001|Overall Study|Missed follow-up assessment|1|||
144502966|NCT01867580|521038135|FG000|Overall Study|Interruption to therapy|3|||
144502967|NCT01867580|521038136|FG001|Overall Study|Interruption to therapy|0|||
144502968|NCT01867580|521038135|FG000|Overall Study|Osteomyelitis|0|||
144502969|NCT01867580|521038136|FG001|Overall Study|Osteomyelitis|1|||
144502970|NCT01867580|521038135|FG000|Overall Study|Continuation of therapy|0|||
144502971|NCT01867580|521038136|FG001|Overall Study|Continuation of therapy|1|||
144502972|NCT01867580|521038135|FG000|Overall Study|Wound recurrence|0|||
144502973|NCT01867580|521038136|FG001|Overall Study|Wound recurrence|1|||
144502974|NCT01304147|521038137|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
144502975|NCT01304147|521038138|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
144502976|NCT01244828|521038139|FG000|Overall Study|Adverse Event|37|||
144502977|NCT01244828|521038139|FG000|Overall Study|Withdrawal by Subject|31|||
144502978|NCT01244828|521038139|FG000|Overall Study|Lack of Efficacy|7|||
144502979|NCT01244828|521038139|FG000|Overall Study|Lost to Follow-up|2|||
144502980|NCT01244828|521038139|FG000|Overall Study|Other reason (not specified)|1|||
144502981|NCT05052983|521038140|FG000|Overall Study|Lack of Efficacy|3|||
144502982|NCT05052983|521038141|FG001|Overall Study|Lack of Efficacy|12|||
144502983|NCT05052983|521038140|FG000|Overall Study|Adverse Event|1|||
144502984|NCT05052983|521038141|FG001|Overall Study|Adverse Event|0|||
144502985|NCT02812966|521038142|FG000|Overall Study|Death|1|||
144502986|NCT02812966|521038143|FG001|Overall Study|Death|0|||
144502987|NCT01066923|521038144|FG000|Overall Study|Withdrawal by Subject|3|||
144502988|NCT01066923|521038145|FG001|Overall Study|Withdrawal by Subject|3|||
144502989|NCT01066923|521038146|FG002|Overall Study|Withdrawal by Subject|8|||
144502990|NCT01066923|521038147|FG003|Overall Study|Withdrawal by Subject|8|||
144502991|NCT05147233|521039956|FG000|Overall Study|Adverse Event|0|||
144502992|NCT05147233|521039957|FG001|Overall Study|Adverse Event|1|||
144502993|NCT05147233|521039956|FG000|Overall Study|Lost to Follow-up|1|||
144502994|NCT05147233|521039957|FG001|Overall Study|Lost to Follow-up|1|||
144502995|NCT05147233|521039956|FG000|Overall Study|Protocol Violation|0|||
144502996|NCT05147233|521039957|FG001|Overall Study|Protocol Violation|1|||
144502997|NCT05147233|521039956|FG000|Overall Study|Withdrawal by Subject|2|||
144502998|NCT05147233|521039957|FG001|Overall Study|Withdrawal by Subject|1|||
144502999|NCT01049503|521039960|FG000|Overall Study|Lost to Follow-up|11|||
144503000|NCT01049503|521039961|FG001|Overall Study|Lost to Follow-up|12|||
144503001|NCT01049503|521039962|FG002|Overall Study|Lost to Follow-up|24|||
144503002|NCT01049503|521039963|FG003|Overall Study|Lost to Follow-up|26|||
144503003|NCT01049503|521039964|FG004|Overall Study|Lost to Follow-up|27|||
144503004|NCT01049503|521039965|FG005|Overall Study|Lost to Follow-up|8|||
144503005|NCT02974634|521039966|FG000|Overall Study|Advanced disease|12|||
144503006|NCT02974634|521039967|FG001|Overall Study|Advanced disease|3|||
144503007|NCT02974634|521039966|FG000|Overall Study|Noncompliance|3|||
144503008|NCT02974634|521039967|FG001|Overall Study|Noncompliance|7|||
144503009|NCT02974634|521039966|FG000|Overall Study|intervention technology related issues|5|||
144503010|NCT02974634|521039967|FG001|Overall Study|intervention technology related issues|0|||
144503011|NCT02974634|521039966|FG000|Overall Study|Death|8|||
144503012|NCT02974634|521039967|FG001|Overall Study|Death|11|||
144503013|NCT01070888|521039973|FG000|First Intervention (14 Days)|Adverse Event|0|||
144503014|NCT01070888|521039974|FG001|First Intervention (14 Days)|Adverse Event|1|||
144503015|NCT01070888|521039973|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
144503016|NCT01070888|521039974|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
144503017|NCT01070888|521039973|FG000|Washout (14 Days)|Physician Decision|1|||
144503018|NCT01070888|521039974|FG001|Washout (14 Days)|Physician Decision|0|||
144503019|NCT02577523|521039975|FG000|Overall Study|Adverse Event|1|||
144503020|NCT02577523|521039976|FG001|Overall Study|Adverse Event|1|||
144503021|NCT02577523|521039975|FG000|Overall Study|Lack of Efficacy|1|||
144503022|NCT02577523|521039976|FG001|Overall Study|Lack of Efficacy|1|||
144503023|NCT02577523|521039975|FG000|Overall Study|Withdrawal by Subject|1|||
144503024|NCT02577523|521039976|FG001|Overall Study|Withdrawal by Subject|0|||
144503025|NCT02631148|521039977|FG000|Overall Study|8 were ineligible|8|||
144503026|NCT02631148|521039978|FG001|Overall Study|8 were ineligible|0|||
144503027|NCT02631148|521039977|FG000|Overall Study|Withdrawal by Subject|1|||
144503028|NCT02631148|521039978|FG001|Overall Study|Withdrawal by Subject|0|||
144503029|NCT02631148|521039977|FG000|Overall Study|PAH not available to study participant|1|||
144503030|NCT02631148|521039978|FG001|Overall Study|PAH not available to study participant|0|||
144503031|NCT00955825|521039986|FG000|Overall Study|Adverse Event|15|||
144503032|NCT00955825|521039987|FG001|Overall Study|Adverse Event|2|||
144503033|NCT00955825|521039986|FG000|Overall Study|Withdrawal by Subject|4|||
144503034|NCT00955825|521039987|FG001|Overall Study|Withdrawal by Subject|6|||
144503035|NCT00955825|521039986|FG000|Overall Study|Any other reason not above-mentioned|7|||
144503036|NCT00955825|521039987|FG001|Overall Study|Any other reason not above-mentioned|9|||
144503037|NCT00150176|521039988|FG000|Overall Study|Adverse Event|16|||
144503038|NCT00150176|521039989|FG001|Overall Study|Adverse Event|53|||
144503039|NCT00150176|521039988|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
144503040|NCT00150176|521039989|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
144503041|NCT00150176|521039988|FG000|Overall Study|Withdrawal by Subject|19|||
144503042|NCT00150176|521039989|FG001|Overall Study|Withdrawal by Subject|12|||
144503043|NCT00150176|521039988|FG000|Overall Study|Lost to Follow-up|3|||
144503044|NCT00150176|521039989|FG001|Overall Study|Lost to Follow-up|3|||
144503045|NCT00150176|521039988|FG000|Overall Study|OTHER|11|||
144503046|NCT00150176|521039989|FG001|Overall Study|OTHER|13|||
144503047|NCT00393848|521039991|FG000|Overall Study|Surgical schedule|0|||
144503048|NCT00393848|521039992|FG001|Overall Study|Surgical schedule|0|||
144503049|NCT00393848|521039993|FG002|Overall Study|Surgical schedule|0|||
144503050|NCT00393848|521039994|FG003|Overall Study|Surgical schedule|1|||
144503051|NCT00393848|521039991|FG000|Overall Study|Personal reasons|0|||
144503052|NCT00393848|521039992|FG001|Overall Study|Personal reasons|0|||
144503053|NCT00393848|521039993|FG002|Overall Study|Personal reasons|2|||
144503054|NCT00393848|521039994|FG003|Overall Study|Personal reasons|0|||
144503055|NCT02192606|521039995|FG000|Overall Study|surgery type was changed|1|||
144503056|NCT02192606|521039996|FG001|Overall Study|surgery type was changed|1|||
144503057|NCT02192606|521039995|FG000|Overall Study|Physician Decision|1|||
144503058|NCT02192606|521039996|FG001|Overall Study|Physician Decision|2|||
144503059|NCT02192606|521039995|FG000|Overall Study|3D equipment rep unable to join|0|||
144503060|NCT02192606|521039996|FG001|Overall Study|3D equipment rep unable to join|1|||
144503061|NCT00943735|521040001|FG000|Overall Study|Adverse Event|12|||
144503062|NCT00943735|521040001|FG000|Overall Study|Withdrawal by Subject|8|||
144503063|NCT00943735|521040001|FG000|Overall Study|Death|1|||
144503064|NCT00943735|521040001|FG000|Overall Study|Other|8|||
144503065|NCT00943735|521040001|FG000|Overall Study|Other|3|||
144503066|NCT00486330|521040002|FG000|Overall Study|Adverse Event|2|||
144503067|NCT00139737|521040003|FG000|Overall Study|Withdrawal by Subject|190|||
144503068|NCT00139737|521040003|FG000|Overall Study|Adverse Event|58|||
144503069|NCT00139737|521040003|FG000|Overall Study|Lack of Efficacy|40|||
144503070|NCT00139737|521040003|FG000|Overall Study|Lost to Follow-up|8|||
144503071|NCT00139737|521040003|FG000|Overall Study|Death|3|||
144503072|NCT00139737|521040003|FG000|Overall Study|Laboratory Abnormality|2|||
144503073|NCT00139737|521040003|FG000|Overall Study|Protocol Violation|18|||
144503074|NCT00139737|521040003|FG000|Overall Study|Withdrew During Screening Phase|8|||
144503075|NCT00139737|521040003|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
144503076|NCT00139737|521040003|FG000|Overall Study|Screened, Not Treated|13|||
144503077|NCT03743246|521040005|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
144503078|NCT03743246|521040006|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
144503079|NCT03743246|521040007|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
144503080|NCT03743246|521040008|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
144503081|NCT03743246|521040005|FG000|Pre-Treatment Period|Death|0|||
144503082|NCT03743246|521040006|FG001|Pre-Treatment Period|Death|1|||
144503083|NCT03743246|521040007|FG002|Pre-Treatment Period|Death|0|||
144503084|NCT03743246|521040008|FG003|Pre-Treatment Period|Death|1|||
144503085|NCT03743246|521040005|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
144503086|NCT03743246|521040006|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
144503087|NCT03743246|521040007|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
144503088|NCT03743246|521040008|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
144503089|NCT03743246|521040005|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
144503090|NCT03743246|521040006|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
144503091|NCT03743246|521040007|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
144503092|NCT03743246|521040008|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
144503093|NCT03743246|521040005|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
144503094|NCT03743246|521040006|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
144503095|NCT03743246|521040007|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
144503096|NCT03743246|521040008|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
144503097|NCT03743246|521040005|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
144503098|NCT03743246|521040006|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
144503099|NCT03743246|521040007|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
144503100|NCT03743246|521040008|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
144503101|NCT03743246|521040005|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
144503102|NCT03743246|521040006|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
144503103|NCT03743246|521040007|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
144503104|NCT03743246|521040008|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
144503105|NCT03743246|521040005|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
144503106|NCT03743246|521040006|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
144503107|NCT03743246|521040007|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
144503108|NCT03743246|521040008|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
144503109|NCT03743246|521040005|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
144503110|NCT03743246|521040006|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
144503111|NCT03743246|521040007|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
144503112|NCT03743246|521040008|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
144503113|NCT01069341|521040013|FG000|Overall Study|Lost to Follow-up|1|||
144503114|NCT01184508|521040014|FG000|Overall Study|Adverse Event|4|||
144503115|NCT01184508|521040015|FG001|Overall Study|Adverse Event|6|||
144503116|NCT01184508|521040014|FG000|Overall Study|Lack of Efficacy|1|||
144503117|NCT01184508|521040015|FG001|Overall Study|Lack of Efficacy|1|||
144503118|NCT01184508|521040014|FG000|Overall Study|Lost to Follow-up|1|||
144503119|NCT01184508|521040015|FG001|Overall Study|Lost to Follow-up|1|||
144503120|NCT01184508|521040014|FG000|Overall Study|Physician Decision|1|||
144503121|NCT01184508|521040015|FG001|Overall Study|Physician Decision|0|||
144503122|NCT01184508|521040014|FG000|Overall Study|Protocol Violation|3|||
144503123|NCT01184508|521040015|FG001|Overall Study|Protocol Violation|1|||
144503124|NCT01184508|521040014|FG000|Overall Study|Sponsor Decision|5|||
144503125|NCT01184508|521040015|FG001|Overall Study|Sponsor Decision|2|||
144503126|NCT01184508|521040014|FG000|Overall Study|Withdrawal by Subject|1|||
144503127|NCT01184508|521040015|FG001|Overall Study|Withdrawal by Subject|3|||
144503128|NCT01184508|521040014|FG000|Overall Study|Randomized, Not Treated|0|||
144503129|NCT01184508|521040015|FG001|Overall Study|Randomized, Not Treated|1|||
144503130|NCT00319436|521040016|FG000|Overall Study|Withdrawal by Subject|6|||
144503131|NCT00319436|521040017|FG001|Overall Study|Withdrawal by Subject|7|||
144503132|NCT01493778|521040022|FG000|Overall Study|Withdrawal by Subject|8|||
144503133|NCT04210180|521040023|FG000|Overall Study|Withdrawal by Subject|2|||
144503134|NCT02517307|521040027|FG000|Overall Study|Withdrawal by Subject|1|||
144503135|NCT02517307|521040028|FG001|Overall Study|Withdrawal by Subject|0|||
144503136|NCT02517307|521040029|FG002|Overall Study|Withdrawal by Subject|1|||
144503137|NCT02517307|521040030|FG003|Overall Study|Withdrawal by Subject|0|||
144503138|NCT02517307|521040027|FG000|Overall Study|Protocol Violation|0|||
144503139|NCT02517307|521040028|FG001|Overall Study|Protocol Violation|0|||
144503140|NCT02517307|521040029|FG002|Overall Study|Protocol Violation|1|||
144503141|NCT02517307|521040030|FG003|Overall Study|Protocol Violation|1|||
144503142|NCT00823979|521040040|FG000|Overall Study|Lack of Efficacy|13|||
144503143|NCT00823979|521040041|FG001|Overall Study|Lack of Efficacy|16|||
144503144|NCT00823979|521040042|FG002|Overall Study|Lack of Efficacy|9|||
144503145|NCT00823979|521040040|FG000|Overall Study|Lost to Follow-up|2|||
144503146|NCT00823979|521040041|FG001|Overall Study|Lost to Follow-up|1|||
144503147|NCT00823979|521040042|FG002|Overall Study|Lost to Follow-up|0|||
144503148|NCT00823979|521040040|FG000|Overall Study|Withdrawal by Subject|2|||
144503149|NCT00823979|521040041|FG001|Overall Study|Withdrawal by Subject|3|||
144503150|NCT00823979|521040042|FG002|Overall Study|Withdrawal by Subject|2|||
144503151|NCT00823979|521040040|FG000|Overall Study|Protocol Violation|1|||
144503152|NCT00823979|521040041|FG001|Overall Study|Protocol Violation|1|||
144503153|NCT00823979|521040042|FG002|Overall Study|Protocol Violation|0|||
144503154|NCT00823979|521040040|FG000|Overall Study|Pregnancy|0|||
144503155|NCT00823979|521040041|FG001|Overall Study|Pregnancy|1|||
144503156|NCT00823979|521040042|FG002|Overall Study|Pregnancy|0|||
144503157|NCT00823979|521040040|FG000|Overall Study|Adverse Event|0|||
144503158|NCT00823979|521040041|FG001|Overall Study|Adverse Event|2|||
144503159|NCT00823979|521040042|FG002|Overall Study|Adverse Event|4|||
144503160|NCT00823979|521040040|FG000|Overall Study|Other|2|||
144503161|NCT00823979|521040041|FG001|Overall Study|Other|0|||
144503162|NCT00823979|521040042|FG002|Overall Study|Other|1|||
144503163|NCT00823979|521040040|FG000|Overall Study|Randomized but not Treated|4|||
144503164|NCT00823979|521040041|FG001|Overall Study|Randomized but not Treated|3|||
144503165|NCT00823979|521040042|FG002|Overall Study|Randomized but not Treated|1|||
144503166|NCT00823979|521040040|FG000|Overall Study|Study Terminated by Sponsor|5|||
144503167|NCT00823979|521040041|FG001|Overall Study|Study Terminated by Sponsor|5|||
144503168|NCT00823979|521040042|FG002|Overall Study|Study Terminated by Sponsor|7|||
144503169|NCT03523091|521040043|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
144503170|NCT03523091|521040044|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
144503171|NCT03523091|521040043|FG000|Overall Study|Withdrawal by Subject|0|||
144503172|NCT03523091|521040044|FG001|Overall Study|Withdrawal by Subject|3|||
144503173|NCT03523091|521040043|FG000|Overall Study|Increase Botox dose|0|||
144503174|NCT03523091|521040044|FG001|Overall Study|Increase Botox dose|1|||
144503175|NCT00741988|521040045|FG000|Overall Study|Adverse Event|2|||
144503176|NCT00741988|521040046|FG001|Overall Study|Adverse Event|4|||
144503177|NCT00741988|521040045|FG000|Overall Study|Lack of Efficacy|2|||
144503178|NCT00741988|521040046|FG001|Overall Study|Lack of Efficacy|0|||
144503179|NCT01144182|521040053|FG000|Overall Study|Death|5|||
144721528|NCT02207621|521835216|FG000|Overall Study|Death|2|||
144503180|NCT01144182|521040054|FG001|Overall Study|Death|6|||
144503181|NCT01144182|521040053|FG000|Overall Study|Withdrawal by Subject|3|||
144503182|NCT01144182|521040054|FG001|Overall Study|Withdrawal by Subject|6|||
144503183|NCT01144182|521040053|FG000|Overall Study|Lost to Follow-up|9|||
144503184|NCT01144182|521040054|FG001|Overall Study|Lost to Follow-up|9|||
144503185|NCT03538054|521040055|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
144503186|NCT03538054|521040055|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
144503187|NCT03538054|521040055|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
144503188|NCT03254394|521040060|FG000|Overall Study|Withdrawal by Subject|0|||
144721529|NCT02207621|521835217|FG001|Overall Study|Death|0|||
144721530|NCT02207621|521835218|FG002|Overall Study|Death|0|||
144721531|NCT02207621|521835216|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
144721532|NCT02207621|521835217|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
144721533|NCT02207621|521835218|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
144721534|NCT00421174|521835228|FG000|Overall Study|Withdrawal by Subject|0|||
144721535|NCT00421174|521835229|FG001|Overall Study|Withdrawal by Subject|1|||
144721536|NCT00421174|521835228|FG000|Overall Study|Ineligible due to infection|2|||
144503189|NCT03254394|521040061|FG001|Overall Study|Withdrawal by Subject|2|||
144503190|NCT02351180|521040062|FG000|Overall Study|Withdrawal by Subject|1|||
144503191|NCT02351180|521040063|FG001|Overall Study|Withdrawal by Subject|0|||
144503192|NCT00208767|521040064|FG000|Overall Study|Adverse Event|9|||
144503193|NCT00208767|521040065|FG001|Overall Study|Adverse Event|1|||
144503194|NCT00208767|521040064|FG000|Overall Study|Withdrawal by Subject|14|||
144503195|NCT00208767|521040065|FG001|Overall Study|Withdrawal by Subject|3|||
144503196|NCT00208767|521040064|FG000|Overall Study|Death|1|||
144503197|NCT00208767|521040065|FG001|Overall Study|Death|0|||
144721537|NCT00421174|521835229|FG001|Overall Study|Ineligible due to infection|0|||
144503198|NCT00208767|521040064|FG000|Overall Study|Lost to Follow-up|3|||
144503199|NCT00208767|521040065|FG001|Overall Study|Lost to Follow-up|3|||
144721538|NCT00992407|521835232|FG000|Overall Study|Protocol Violation|2|||
144721539|NCT00992407|521835233|FG001|Overall Study|Protocol Violation|1|||
144721540|NCT00992407|521835232|FG000|Overall Study|Lost to Follow-up|3|||
144721541|NCT00992407|521835233|FG001|Overall Study|Lost to Follow-up|3|||
144721542|NCT00992407|521835232|FG000|Overall Study|Adverse Event|3|||
144721543|NCT00992407|521835233|FG001|Overall Study|Adverse Event|2|||
144721544|NCT00992407|521835232|FG000|Overall Study|protocol Violation & Adverse events|2|||
144721545|NCT00992407|521835233|FG001|Overall Study|protocol Violation & Adverse events|4|||
144721546|NCT00992407|521835232|FG000|Overall Study|Other|2|||
144721547|NCT00992407|521835233|FG001|Overall Study|Other|0|||
144721548|NCT00992407|521835232|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
144721549|NCT00992407|521835233|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
144721550|NCT00992407|521835232|FG000|Overall Study|Study medication not administered|17|||
144721551|NCT00992407|521835233|FG001|Overall Study|Study medication not administered|13|||
144721552|NCT04700449|521835236|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
144721553|NCT04700449|521835237|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
144721554|NCT04700449|521835238|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
144721555|NCT04700449|521835239|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
144721556|NCT04700449|521835236|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
144721557|NCT04700449|521835237|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
144721558|NCT04700449|521835238|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
144721559|NCT04700449|521835239|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
144721560|NCT04700449|521835236|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
144721561|NCT04700449|521835237|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
144721562|NCT04700449|521835238|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
144721563|NCT04700449|521835239|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
144721564|NCT04700449|521835236|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
144721565|NCT04700449|521835237|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
144721566|NCT04700449|521835238|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
144721567|NCT04700449|521835239|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
144721568|NCT04700449|521835236|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
144721569|NCT04700449|521835237|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
144721570|NCT04700449|521835238|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
144721571|NCT04700449|521835239|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
144721572|NCT04700449|521835236|FG000|Stage 1: Double-Blind Period|Other|0|||
144721573|NCT04700449|521835237|FG001|Stage 1: Double-Blind Period|Other|0|||
144721574|NCT04700449|521835238|FG002|Stage 1: Double-Blind Period|Other|1|||
144721575|NCT04700449|521835239|FG003|Stage 1: Double-Blind Period|Other|0|||
144721576|NCT04700449|521835236|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
144721577|NCT04700449|521835237|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
144721578|NCT04700449|521835238|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
144721579|NCT04700449|521835239|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
144721580|NCT04700449|521835236|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
144721581|NCT04700449|521835237|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
144721582|NCT04700449|521835238|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
144721583|NCT04700449|521835239|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
144721584|NCT04700449|521835236|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
144721585|NCT04700449|521835237|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
144721586|NCT04700449|521835238|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
144721587|NCT04700449|521835239|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
144721588|NCT04700449|521835236|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
144721589|NCT04700449|521835237|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
144721590|NCT04700449|521835238|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
144721591|NCT04700449|521835239|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
144721592|NCT04700449|521835236|FG000|Stage 2 Sub-study 1|Other|1|||
144721593|NCT04700449|521835237|FG001|Stage 2 Sub-study 1|Other|2|||
144721594|NCT04700449|521835238|FG002|Stage 2 Sub-study 1|Other|0|||
144721595|NCT04700449|521835239|FG003|Stage 2 Sub-study 1|Other|0|||
144721596|NCT04700449|521835236|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
144721597|NCT04700449|521835237|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
144721598|NCT04700449|521835238|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
144721599|NCT04700449|521835239|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
144721600|NCT04700449|521835236|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
144721601|NCT04700449|521835237|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
144721602|NCT04700449|521835238|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
144721603|NCT04700449|521835239|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
144721604|NCT04700449|521835236|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
144721605|NCT04700449|521835237|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
144721606|NCT04700449|521835238|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
144721607|NCT04700449|521835239|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
144721608|NCT04700449|521835236|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
144721609|NCT04700449|521835237|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
144721610|NCT04700449|521835238|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
144721611|NCT04700449|521835239|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
144721612|NCT04700449|521835236|FG000|Stage 2 Sub-study 2|Other|0|||
144503200|NCT02317016|521040072|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
144503201|NCT02317016|521040072|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
144503202|NCT02317016|521040072|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
144503203|NCT02317016|521040072|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
144503204|NCT02317016|521040072|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
144503205|NCT02317016|521040072|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
144503206|NCT02317016|521040072|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
144503207|NCT01123083|521040073|FG000|Overall Study|Investigator recommendation|1|||
144503208|NCT01123083|521040074|FG001|Overall Study|Investigator recommendation|1|||
144503209|NCT01123083|521040073|FG000|Overall Study|Administrative reasons|0|||
144503210|NCT01123083|521040074|FG001|Overall Study|Administrative reasons|4|||
144503211|NCT01123083|521040073|FG000|Overall Study|Lost to Follow-up|2|||
144503212|NCT01123083|521040074|FG001|Overall Study|Lost to Follow-up|6|||
144503213|NCT01123083|521040073|FG000|Overall Study|Adverse Event|1|||
144503214|NCT01123083|521040074|FG001|Overall Study|Adverse Event|0|||
144503215|NCT01123083|521040073|FG000|Overall Study|Withdrew for another reason not covered|0|||
144503216|NCT01123083|521040074|FG001|Overall Study|Withdrew for another reason not covered|1|||
144503217|NCT01123083|521040073|FG000|Overall Study|Participant/legal representative request|7|||
144503218|NCT01123083|521040074|FG001|Overall Study|Participant/legal representative request|3|||
144721613|NCT04700449|521835237|FG001|Stage 2 Sub-study 2|Other|0|||
144503219|NCT00536380|521040075|FG000|Overall Study|Adverse Event|0|||
144503220|NCT00536380|521040076|FG001|Overall Study|Adverse Event|2|||
144721614|NCT04700449|521835238|FG002|Stage 2 Sub-study 2|Other|0|||
144503221|NCT00536380|521040077|FG002|Overall Study|Adverse Event|2|||
144503222|NCT00536380|521040075|FG000|Overall Study|Lost to Follow-up|0|||
144503223|NCT00536380|521040076|FG001|Overall Study|Lost to Follow-up|0|||
144503224|NCT00536380|521040077|FG002|Overall Study|Lost to Follow-up|1|||
144503225|NCT00536380|521040075|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
144503226|NCT00536380|521040076|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
144503227|NCT00536380|521040077|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
144503228|NCT00536380|521040075|FG000|Overall Study|Withdrawal related to study drug|7|||
144503229|NCT00536380|521040076|FG001|Overall Study|Withdrawal related to study drug|5|||
144503230|NCT00536380|521040077|FG002|Overall Study|Withdrawal related to study drug|2|||
144503231|NCT00536380|521040075|FG000|Overall Study|Noncompliance with protocol|3|||
144503232|NCT00536380|521040076|FG001|Overall Study|Noncompliance with protocol|2|||
144503233|NCT00536380|521040077|FG002|Overall Study|Noncompliance with protocol|2|||
144503234|NCT00536380|521040075|FG000|Overall Study|Did not meet protocol eligibility|0|||
144721615|NCT04700449|521835239|FG003|Stage 2 Sub-study 2|Other|5|||
144721616|NCT02396381|521835240|FG000|Overall Study|Adverse Event|3|||
144503235|NCT00536380|521040076|FG001|Overall Study|Did not meet protocol eligibility|0|||
144503236|NCT00536380|521040077|FG002|Overall Study|Did not meet protocol eligibility|1|||
144503237|NCT00536380|521040075|FG000|Overall Study|Administrative|0|||
144503238|NCT00536380|521040076|FG001|Overall Study|Administrative|0|||
144503239|NCT00536380|521040077|FG002|Overall Study|Administrative|1|||
144503240|NCT00387465|521040078|FG000|Overall Study|Withdrawal by Subject|0|||
144503241|NCT00387465|521040079|FG001|Overall Study|Withdrawal by Subject|1|||
144503242|NCT00387465|521040080|FG002|Overall Study|Withdrawal by Subject|0|||
144503243|NCT03545984|521040081|FG000|Overall Study|CSF cases not present during rotation|11|||
144503244|NCT03545984|521040082|FG001|Overall Study|CSF cases not present during rotation|9|||
144503245|NCT03418324|521040084|FG000|Overall Study|Death|0|||
144503246|NCT03418324|521040085|FG001|Overall Study|Death|1|||
144503247|NCT03418324|521040084|FG000|Overall Study|Physician Decision|1|||
144503248|NCT03418324|521040085|FG001|Overall Study|Physician Decision|1|||
144503249|NCT01768676|521040088|FG000|Overall Study|Adverse Event|3|||
144503250|NCT01768676|521040089|FG001|Overall Study|Adverse Event|3|||
144503251|NCT01768676|521040088|FG000|Overall Study|Lost to Follow-up|13|||
144503252|NCT01768676|521040089|FG001|Overall Study|Lost to Follow-up|16|||
144503253|NCT01768676|521040088|FG000|Overall Study|Protocol Violation|1|||
144503254|NCT01768676|521040089|FG001|Overall Study|Protocol Violation|1|||
144503255|NCT01768676|521040088|FG000|Overall Study|Physician Decision|4|||
144503256|NCT01768676|521040089|FG001|Overall Study|Physician Decision|1|||
144503257|NCT01768676|521040088|FG000|Overall Study|Withdrawal by Subject|3|||
144503258|NCT01768676|521040089|FG001|Overall Study|Withdrawal by Subject|10|||
144503259|NCT00605033|521040091|FG000|Overall Study|Adverse Event|2|||
144503260|NCT00605033|521040092|FG001|Overall Study|Adverse Event|2|||
144503261|NCT00605033|521040091|FG000|Overall Study|Lost to Follow-up|1|||
144503262|NCT00605033|521040092|FG001|Overall Study|Lost to Follow-up|1|||
144503263|NCT00605033|521040091|FG000|Overall Study|Withdrawal by Subject|3|||
144503264|NCT00605033|521040092|FG001|Overall Study|Withdrawal by Subject|4|||
144503265|NCT00605033|521040091|FG000|Overall Study|Protocol Violation|1|||
144503266|NCT00605033|521040092|FG001|Overall Study|Protocol Violation|1|||
144503267|NCT01196429|521040093|FG000|Overall Study|Ineligible - inadequate pathology|1|||
144503268|NCT01196429|521040094|FG001|Overall Study|Ineligible - inadequate pathology|0|||
144503269|NCT01196429|521040093|FG000|Overall Study|Ineligible - wrong cell type|1|||
144721617|NCT02396381|521835241|FG001|Overall Study|Adverse Event|2|||
144503270|NCT01196429|521040094|FG001|Overall Study|Ineligible - wrong cell type|0|||
144503271|NCT01196429|521040093|FG000|Overall Study|Refused - Never Treated|1|||
144503272|NCT01196429|521040094|FG001|Overall Study|Refused - Never Treated|0|||
144503273|NCT03768206|521040095|FG000|Overall Study|Lost to Follow-up|2|||
144503274|NCT03768206|521040096|FG001|Overall Study|Lost to Follow-up|1|||
144503275|NCT03768206|521040095|FG000|Overall Study|Withdrawal by Subject|0|||
144503276|NCT03768206|521040096|FG001|Overall Study|Withdrawal by Subject|1|||
144503277|NCT02754479|521040102|FG000|Overall Study|Lost to Follow-up|1|||
144503278|NCT03183518|521040105|FG000|Overall Study|Other (Not specified)|2|||
144503279|NCT03183518|521040105|FG000|Overall Study|Other (Withdrawal of consent)|1|||
144503280|NCT04248829|521040106|FG000|Overall Study|Disease progression|44|||
144503281|NCT04248829|521040107|FG001|Overall Study|Disease progression|109|||
144503282|NCT04248829|521040106|FG000|Overall Study|Adverse Event|19|||
144503283|NCT04248829|521040107|FG001|Overall Study|Adverse Event|18|||
144503284|NCT04248829|521040106|FG000|Overall Study|Withdrawal by Subject|11|||
144503285|NCT04248829|521040107|FG001|Overall Study|Withdrawal by Subject|2|||
144503286|NCT04248829|521040106|FG000|Overall Study|Lost to Follow-up|0|||
144503287|NCT04248829|521040107|FG001|Overall Study|Lost to Follow-up|1|||
144503288|NCT04248829|521040106|FG000|Overall Study|Death|12|||
144503289|NCT04248829|521040107|FG001|Overall Study|Death|14|||
144503290|NCT04248829|521040106|FG000|Overall Study|Physician Decision|2|||
144503291|NCT04248829|521040107|FG001|Overall Study|Physician Decision|4|||
144503292|NCT04248829|521040106|FG000|Overall Study|Any reason not specifically recorded|0|||
144503293|NCT04248829|521040107|FG001|Overall Study|Any reason not specifically recorded|2|||
144721618|NCT02396381|521835240|FG000|Overall Study|Withdrawal by Subject|33|||
144503294|NCT02132702|521040108|FG000|Overall Study|Protocol Violation|2|||
144503295|NCT02132702|521040108|FG000|Overall Study|Adverse Event|3|||
144503296|NCT02132702|521040108|FG000|Overall Study|Withdrawal by Subject|3|||
144503297|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
144503298|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
144503299|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
144503300|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144503301|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144503302|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144503303|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144503304|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144503305|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144503306|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
144503307|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
144503308|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
144503309|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144503310|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144503311|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144503312|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144370098|NCT02991768|520562818|FG000|Overall Study|Physician Decision|4|||
144370099|NCT03467750|520562819|FG000|Overall Study|Surgery canceled|1|||
144370100|NCT03467750|520562820|FG001|Overall Study|Surgery canceled|0|||
144370101|NCT03467750|520562819|FG000|Overall Study|Protocol Violation|1|||
144370102|NCT03467750|520562820|FG001|Overall Study|Protocol Violation|1|||
144370103|NCT03467750|520562819|FG000|Overall Study|Withdrawal by Subject|0|||
144370104|NCT03467750|520562820|FG001|Overall Study|Withdrawal by Subject|1|||
144370105|NCT05673876|520562821|FG000|Overall Study|Death|3|||
144370106|NCT05673876|520562822|FG001|Overall Study|Death|1|||
144370107|NCT05673876|520562821|FG000|Overall Study|Study Terminated by Sponsor|0|||
144370108|NCT05673876|520562822|FG001|Overall Study|Study Terminated by Sponsor|1|||
144370109|NCT05673876|520562821|FG000|Overall Study|Physician Decision|0|||
144370110|NCT05673876|520562822|FG001|Overall Study|Physician Decision|1|||
144370111|NCT03529422|520562823|FG000|Overall Study|Withdrawal by Subject|1|||
144370112|NCT03529422|520562823|FG000|Overall Study|Protocol Violation|1|||
144370113|NCT03529422|520562823|FG000|Overall Study|Disease progression|2|||
144370114|NCT02000115|520562826|FG000|Overall Study|Death|56|||
144370115|NCT02000115|520562827|FG001|Overall Study|Death|45|||
144370116|NCT02000115|520562828|FG002|Overall Study|Death|0|||
144370117|NCT02000115|520562829|FG003|Overall Study|Death|0|||
144370118|NCT02000115|520562826|FG000|Overall Study|Missed Visit|6|||
144370119|NCT02000115|520562827|FG001|Overall Study|Missed Visit|8|||
144370120|NCT02000115|520562828|FG002|Overall Study|Missed Visit|1|||
144370121|NCT02000115|520562829|FG003|Overall Study|Missed Visit|0|||
144370122|NCT02000115|520562826|FG000|Overall Study|Protocol Violation|2|||
144370123|NCT02000115|520562827|FG001|Overall Study|Protocol Violation|1|||
144370124|NCT02000115|520562828|FG002|Overall Study|Protocol Violation|0|||
144370125|NCT02000115|520562829|FG003|Overall Study|Protocol Violation|0|||
144370126|NCT02000115|520562826|FG000|Overall Study|Physician Decision|2|||
144370127|NCT02000115|520562827|FG001|Overall Study|Physician Decision|0|||
144370128|NCT02000115|520562828|FG002|Overall Study|Physician Decision|0|||
144370129|NCT02000115|520562829|FG003|Overall Study|Physician Decision|0|||
144370130|NCT02000115|520562826|FG000|Overall Study|Withdrawal by Subject|11|||
144370131|NCT02000115|520562827|FG001|Overall Study|Withdrawal by Subject|11|||
144370132|NCT02000115|520562828|FG002|Overall Study|Withdrawal by Subject|0|||
144370133|NCT02000115|520562829|FG003|Overall Study|Withdrawal by Subject|0|||
144370134|NCT02000115|520562826|FG000|Overall Study|Lost to Follow-up|0|||
144370135|NCT02000115|520562827|FG001|Overall Study|Lost to Follow-up|1|||
144370136|NCT02000115|520562828|FG002|Overall Study|Lost to Follow-up|0|||
144370137|NCT02000115|520562829|FG003|Overall Study|Lost to Follow-up|0|||
144370138|NCT02000115|520562826|FG000|Overall Study|Non-compliance|2|||
144370139|NCT02000115|520562827|FG001|Overall Study|Non-compliance|1|||
144370140|NCT02000115|520562828|FG002|Overall Study|Non-compliance|0|||
144370141|NCT02000115|520562829|FG003|Overall Study|Non-compliance|0|||
144370142|NCT02000115|520562826|FG000|Overall Study|Withdrawn on day of randomization|0|||
144370143|NCT02000115|520562827|FG001|Overall Study|Withdrawn on day of randomization|1|||
144370144|NCT02000115|520562828|FG002|Overall Study|Withdrawn on day of randomization|0|||
144370145|NCT02000115|520562829|FG003|Overall Study|Withdrawn on day of randomization|0|||
144370146|NCT02000115|520562826|FG000|Overall Study|Still on Study|0|||
144370147|NCT02000115|520562827|FG001|Overall Study|Still on Study|0|||
144370148|NCT02000115|520562828|FG002|Overall Study|Still on Study|0|||
144370149|NCT02000115|520562829|FG003|Overall Study|Still on Study|53|||
144370150|NCT04988477|520562832|FG000|Overall Study|Death|1|||
144370151|NCT04988477|520562833|FG001|Overall Study|Death|0|||
144370152|NCT04988477|520562834|FG002|Overall Study|Death|0|||
144503313|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144503314|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144503315|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
144503316|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
144503317|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
144503318|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144503319|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144503320|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144503321|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144503322|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144503323|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144503324|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
144503325|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503326|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
144503327|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503328|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503329|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503330|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503331|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503332|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144503333|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
144503334|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
144503335|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
144503336|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144503337|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144503338|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144503339|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144503340|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144503341|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144503342|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503343|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
144503344|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
144503345|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503346|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503347|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503348|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503349|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503350|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144503351|NCT01212757|521040109|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
144503352|NCT01212757|521040110|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
144503353|NCT01212757|521040111|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503354|NCT01212757|521040112|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503355|NCT01212757|521040113|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503356|NCT01212757|521040114|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503357|NCT01212757|521040115|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503358|NCT01212757|521040116|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503359|NCT01212757|521040117|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144503360|NCT01212757|521040109|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
144503361|NCT01212757|521040110|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
144503362|NCT01212757|521040111|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
144503363|NCT01212757|521040112|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
144503364|NCT01212757|521040113|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
144503365|NCT01212757|521040114|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
144503366|NCT01212757|521040115|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
144503367|NCT01212757|521040116|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
144503368|NCT01212757|521040117|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
144503369|NCT01212757|521040109|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
144503370|NCT01212757|521040110|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
144503371|NCT01212757|521040111|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
144503372|NCT01212757|521040112|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
144503373|NCT01212757|521040113|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
144503374|NCT01212757|521040114|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
144503375|NCT01212757|521040115|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
144503376|NCT01212757|521040116|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
144503377|NCT01212757|521040117|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
144503378|NCT01212757|521040109|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503379|NCT01212757|521040110|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503380|NCT01212757|521040111|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
144503381|NCT01212757|521040112|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503382|NCT01212757|521040113|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503383|NCT01212757|521040114|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503384|NCT01212757|521040115|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503385|NCT01212757|521040116|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503386|NCT01212757|521040117|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
144503387|NCT01212757|521040109|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144503388|NCT01212757|521040110|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
144503389|NCT01212757|521040111|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
144503390|NCT01212757|521040112|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
144503391|NCT01212757|521040113|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
144503392|NCT01212757|521040114|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
144503393|NCT01212757|521040115|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144503394|NCT01212757|521040116|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144503395|NCT01212757|521040117|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144503396|NCT01212757|521040109|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503397|NCT01212757|521040110|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
144503398|NCT01212757|521040111|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503399|NCT01212757|521040112|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503400|NCT01212757|521040113|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
144503401|NCT01212757|521040114|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503402|NCT01212757|521040115|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503403|NCT01212757|521040116|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503404|NCT01212757|521040117|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144503405|NCT01212757|521040109|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503406|NCT01212757|521040110|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
144503407|NCT01212757|521040111|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
144503408|NCT01212757|521040112|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503409|NCT01212757|521040113|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503410|NCT01212757|521040114|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503411|NCT01212757|521040115|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503412|NCT01212757|521040116|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503413|NCT01212757|521040117|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
144503414|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503415|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503416|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503417|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503418|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503419|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503420|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503421|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
144503422|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
144503423|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
144503424|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
144503425|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
144503426|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
144248505|NCT02697916|520107938|FG001|Overall Study|Death|315|||
144503427|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
144503428|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
144503429|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
144503430|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
144503431|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
144503432|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
144503433|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
144503434|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
144503435|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
144503436|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
144370153|NCT04988477|520562832|FG000|Overall Study|Lost to Follow-up|5|||
144370154|NCT04988477|520562833|FG001|Overall Study|Lost to Follow-up|2|||
144503437|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
144503438|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
144503439|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
144503440|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
144503441|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144503442|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
144370155|NCT04988477|520562834|FG002|Overall Study|Lost to Follow-up|0|||
144503443|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
144503444|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144503445|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144503446|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144503447|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144503448|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
144503449|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
144503450|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503451|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503452|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
144503453|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503454|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503455|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503456|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503457|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503458|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
144503459|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
144503460|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
144503461|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
144503462|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
144503463|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
144503464|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
144503465|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
144503466|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
144503467|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
144503468|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
144503469|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
144503470|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
144503471|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
144503472|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
144503473|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
144503474|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
144503475|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
144503476|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
144503477|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503478|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503479|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
144503480|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503481|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503482|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503483|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503484|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503485|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
144503486|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144503487|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
144503488|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
144503489|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144503490|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144503491|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144503492|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144503493|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
144503494|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
144503495|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503496|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503497|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503498|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503499|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503500|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503501|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503502|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
144503503|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
144503504|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503505|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
144503506|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503507|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503508|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503509|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503510|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503511|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503512|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
144503513|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503514|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503515|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
144503516|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503517|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503518|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503519|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503520|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
144503521|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
144503522|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503523|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
144503524|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503525|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503526|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503527|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503528|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503529|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
144503530|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
144503531|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
144503532|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
144503533|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
144503534|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
144503535|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
144503536|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
144503537|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
144503538|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
144503539|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
144503540|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
144503541|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
144503542|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
144503543|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
144503544|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
144503545|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
144503546|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
144503547|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
144503548|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
144503549|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144503550|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
144721619|NCT02396381|521835241|FG001|Overall Study|Withdrawal by Subject|24|||
144721620|NCT02396381|521835240|FG000|Overall Study|Lost to Follow-up|49|||
144503551|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
144503552|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144503553|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144503554|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144503555|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144721621|NCT02396381|521835241|FG001|Overall Study|Lost to Follow-up|31|||
144721622|NCT02396381|521835240|FG000|Overall Study|Protocol Violation|1|||
144721623|NCT02396381|521835241|FG001|Overall Study|Protocol Violation|0|||
144721624|NCT02396381|521835240|FG000|Overall Study|Site terminated by sponsor|7|||
144721625|NCT02396381|521835241|FG001|Overall Study|Site terminated by sponsor|8|||
144503556|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
144503557|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
144503558|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
144503559|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
144503560|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
144503561|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
144503562|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
144503563|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
144503564|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
144503565|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
144503566|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
144503567|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503568|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503569|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503570|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503571|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503572|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503573|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503574|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
144503575|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
144503576|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144503577|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
144503578|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
144503579|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144503580|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144503581|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144503582|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144503583|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
144503584|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
144503585|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
144503586|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
144503587|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
144503588|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
144503589|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
144503590|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
144503591|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
144503592|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
144503593|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
144503594|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
144503595|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
144503596|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
144503597|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
144503598|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
144503599|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
144503600|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
144503601|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
144503602|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
144503603|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503604|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
144503605|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503606|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503607|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503608|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503609|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503610|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503611|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
144503612|NCT01212757|521040109|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503613|NCT01212757|521040110|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
144503614|NCT01212757|521040111|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
144721626|NCT02396381|521835240|FG000|Overall Study|Physician Decision|5|||
144503615|NCT01212757|521040112|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503616|NCT01212757|521040113|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503617|NCT01212757|521040114|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503618|NCT01212757|521040115|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503619|NCT01212757|521040116|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503620|NCT01212757|521040117|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
144503621|NCT00589667|521042979|FG000|Overall Study|Adverse Event|2|||
144503622|NCT00589667|521042979|FG000|Overall Study|Withdrawal by Subject|1|||
144503623|NCT03538041|521042982|FG000|12-Week Treatment Period|Adverse Event|1|||
144503624|NCT03538041|521042983|FG001|12-Week Treatment Period|Adverse Event|1|||
144503625|NCT03538041|521042982|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
144503626|NCT03538041|521042983|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
144503627|NCT03538041|521042982|FG000|Treatment Extension Period|Adverse Event|4|||
144503628|NCT03538041|521042983|FG001|Treatment Extension Period|Adverse Event|1|||
144503629|NCT03538041|521042982|FG000|Treatment Extension Period|Physician Decision|1|||
144503630|NCT03538041|521042983|FG001|Treatment Extension Period|Physician Decision|1|||
144503631|NCT03538041|521042982|FG000|Treatment Extension Period|Lack of Efficacy|1|||
144503632|NCT03538041|521042983|FG001|Treatment Extension Period|Lack of Efficacy|4|||
144503633|NCT03538041|521042982|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
144503634|NCT03538041|521042983|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
144503635|NCT03538041|521042982|FG000|Treatment Extension Period|Death|0|||
144370156|NCT04988477|520562832|FG000|Overall Study|Withdrawal by Subject|2|||
144503636|NCT03538041|521042983|FG001|Treatment Extension Period|Death|1|||
144503637|NCT04860258|521042986|FG000|Overall Study|Withdrawal by Subject|0|||
144503638|NCT04860258|521042987|FG001|Overall Study|Withdrawal by Subject|0|||
144503639|NCT04860258|521042988|FG002|Overall Study|Withdrawal by Subject|4|||
144503640|NCT04860258|521042989|FG003|Overall Study|Withdrawal by Subject|1|||
144503641|NCT04860258|521042990|FG004|Overall Study|Withdrawal by Subject|4|||
144503642|NCT04860258|521042991|FG005|Overall Study|Withdrawal by Subject|1|||
144503643|NCT04860258|521042992|FG006|Overall Study|Withdrawal by Subject|0|||
144503644|NCT02496702|521042993|FG000|Overall Study|Lost to Follow-up|8|||
144503645|NCT02496702|521042994|FG001|Overall Study|Lost to Follow-up|6|||
144503646|NCT02496702|521042993|FG000|Overall Study|Only partially tested|0|||
144503647|NCT02496702|521042994|FG001|Overall Study|Only partially tested|2|||
144503648|NCT01499134|521042995|FG000|Overall Study|Withdrawal by Subject|0|||
144503649|NCT01499134|521042996|FG001|Overall Study|Withdrawal by Subject|1|||
144503650|NCT01400776|521042997|FG000|Overall Study|Adverse Event|7|||
144503651|NCT01400776|521042998|FG001|Overall Study|Adverse Event|2|||
144503652|NCT01400776|521042999|FG002|Overall Study|Adverse Event|9|||
144503653|NCT01400776|521043000|FG003|Overall Study|Adverse Event|2|||
144503654|NCT01400776|521042997|FG000|Overall Study|Lost to Follow-up|1|||
144503655|NCT01400776|521042998|FG001|Overall Study|Lost to Follow-up|0|||
144503656|NCT01400776|521042999|FG002|Overall Study|Lost to Follow-up|4|||
144503657|NCT01400776|521043000|FG003|Overall Study|Lost to Follow-up|1|||
144503658|NCT01400776|521042997|FG000|Overall Study|Withdrew Consent|4|||
144503659|NCT01400776|521042998|FG001|Overall Study|Withdrew Consent|2|||
144503660|NCT01400776|521042999|FG002|Overall Study|Withdrew Consent|6|||
144503661|NCT01400776|521043000|FG003|Overall Study|Withdrew Consent|1|||
144503662|NCT01400776|521042997|FG000|Overall Study|Protocol Deviation|6|||
144503663|NCT01400776|521042998|FG001|Overall Study|Protocol Deviation|1|||
144503664|NCT01400776|521042999|FG002|Overall Study|Protocol Deviation|5|||
144503665|NCT01400776|521043000|FG003|Overall Study|Protocol Deviation|2|||
144503666|NCT01400776|521042997|FG000|Overall Study|Reason not Specified|3|||
144503667|NCT01400776|521042998|FG001|Overall Study|Reason not Specified|0|||
144503668|NCT01400776|521042999|FG002|Overall Study|Reason not Specified|4|||
144503669|NCT01400776|521043000|FG003|Overall Study|Reason not Specified|3|||
144503670|NCT00391846|521043001|FG000|Overall Study|Adverse Event|4|||
144503671|NCT00391846|521043002|FG001|Overall Study|Adverse Event|1|||
144503672|NCT00391846|521043001|FG000|Overall Study|Did not meet the required elig. crit|2|||
144503673|NCT00391846|521043002|FG001|Overall Study|Did not meet the required elig. crit|2|||
144503674|NCT00391846|521043001|FG000|Overall Study|Withdrawal by Subject|2|||
144503675|NCT00391846|521043002|FG001|Overall Study|Withdrawal by Subject|3|||
144503676|NCT00391846|521043001|FG000|Overall Study|Developed study specific DC criteria|0|||
144503677|NCT00391846|521043002|FG001|Overall Study|Developed study specific DC criteria|1|||
144503678|NCT04035668|521043004|FG000|Overall Study|Adverse Event|3|||
144503679|NCT04035668|521043005|FG001|Overall Study|Adverse Event|4|||
144503680|NCT04035668|521043006|FG002|Overall Study|Adverse Event|2|||
144503681|NCT04035668|521043004|FG000|Overall Study|Lost to Follow-up|0|||
144503682|NCT04035668|521043005|FG001|Overall Study|Lost to Follow-up|1|||
144503683|NCT04035668|521043006|FG002|Overall Study|Lost to Follow-up|0|||
144503684|NCT04035668|521043004|FG000|Overall Study|Physician Decision|2|||
144503685|NCT04035668|521043005|FG001|Overall Study|Physician Decision|1|||
144503686|NCT04035668|521043006|FG002|Overall Study|Physician Decision|1|||
144503687|NCT04035668|521043004|FG000|Overall Study|Subject Decision|2|||
144503688|NCT04035668|521043005|FG001|Overall Study|Subject Decision|2|||
144503689|NCT04035668|521043006|FG002|Overall Study|Subject Decision|0|||
144503690|NCT01376089|521043007|FG000|Overall Study|Patient received no contrast media|3|||
144503691|NCT01376089|521043008|FG001|Overall Study|Patient received no contrast media|4|||
144503692|NCT00419094|521043011|FG000|Overall Study|Adverse Event|3|||
144503693|NCT00419094|521043012|FG001|Overall Study|Adverse Event|7|||
144503694|NCT00419094|521043011|FG000|Overall Study|Lack of Efficacy|1|||
144370157|NCT04988477|520562833|FG001|Overall Study|Withdrawal by Subject|0|||
144503695|NCT00419094|521043012|FG001|Overall Study|Lack of Efficacy|0|||
144503696|NCT00419094|521043011|FG000|Overall Study|Lost to Follow-up|0|||
144503697|NCT00419094|521043012|FG001|Overall Study|Lost to Follow-up|2|||
144503698|NCT00419094|521043011|FG000|Overall Study|Protocol Violation|1|||
144503699|NCT00419094|521043012|FG001|Overall Study|Protocol Violation|14|||
144503700|NCT00419094|521043011|FG000|Overall Study|Withdrawal of consent|1|||
144503701|NCT00419094|521043012|FG001|Overall Study|Withdrawal of consent|5|||
144503702|NCT00419094|521043011|FG000|Overall Study|Other: Error determining exit criteria|1|||
144503703|NCT00419094|521043012|FG001|Overall Study|Other: Error determining exit criteria|0|||
144721627|NCT02396381|521835241|FG001|Overall Study|Physician Decision|5|||
144721628|NCT02396381|521835240|FG000|Overall Study|Pregnancy|2|||
144721629|NCT02396381|521835241|FG001|Overall Study|Pregnancy|0|||
144721630|NCT02396381|521835240|FG000|Overall Study|Non-compliance with study procedures|1|||
144721631|NCT02396381|521835241|FG001|Overall Study|Non-compliance with study procedures|0|||
144721632|NCT02396381|521835240|FG000|Overall Study|Moved out of town/state|1|||
144721633|NCT02396381|521835241|FG001|Overall Study|Moved out of town/state|3|||
144721634|NCT02396381|521835240|FG000|Overall Study|Could not complete visit|1|||
144503704|NCT00419094|521043011|FG000|Overall Study|Other: Patient non-compliant|0|||
144503705|NCT00419094|521043012|FG001|Overall Study|Other: Patient non-compliant|1|||
144503706|NCT00419094|521043011|FG000|Overall Study|Other: No contact for extended period|0|||
144503707|NCT00419094|521043012|FG001|Overall Study|Other: No contact for extended period|1|||
144503708|NCT01811706|521043013|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
144503709|NCT01811706|521043014|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
144503710|NCT03020745|521043015|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503711|NCT03020745|521043016|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503712|NCT03020745|521043017|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503713|NCT03020745|521043018|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503714|NCT03020745|521043019|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503715|NCT03020745|521043020|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503716|NCT03020745|521043021|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503717|NCT03020745|521043022|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503718|NCT03020745|521043023|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
144503719|NCT03020745|521043024|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
144503720|NCT03020745|521043015|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503721|NCT03020745|521043016|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503722|NCT03020745|521043017|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503723|NCT03020745|521043018|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503724|NCT03020745|521043019|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503725|NCT03020745|521043020|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503726|NCT03020745|521043021|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503727|NCT03020745|521043022|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
144503728|NCT03020745|521043023|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503729|NCT03020745|521043024|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
144503730|NCT03020745|521043015|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503731|NCT03020745|521043016|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503732|NCT03020745|521043017|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503733|NCT03020745|521043018|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503734|NCT03020745|521043019|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503735|NCT03020745|521043020|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
144503736|NCT03020745|521043021|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503737|NCT03020745|521043022|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503738|NCT03020745|521043023|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
144503739|NCT03020745|521043024|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
144503740|NCT03020745|521043015|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503741|NCT03020745|521043016|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503742|NCT03020745|521043017|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503743|NCT03020745|521043018|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503744|NCT03020745|521043019|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503745|NCT03020745|521043020|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503746|NCT03020745|521043021|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503747|NCT03020745|521043022|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503748|NCT03020745|521043023|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
144503749|NCT03020745|521043024|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
144503750|NCT02057692|521043029|FG000|Overall Study|Adverse Event|1|||
144503751|NCT02057692|521043030|FG001|Overall Study|Adverse Event|0|||
144503752|NCT02057692|521043031|FG002|Overall Study|Adverse Event|0|||
144503753|NCT02057692|521043032|FG003|Overall Study|Adverse Event|0|||
144503754|NCT02057692|521043029|FG000|Overall Study|Lost to Follow-up|0|||
144503755|NCT02057692|521043030|FG001|Overall Study|Lost to Follow-up|0|||
144503756|NCT02057692|521043031|FG002|Overall Study|Lost to Follow-up|0|||
144503757|NCT02057692|521043032|FG003|Overall Study|Lost to Follow-up|1|||
144503758|NCT03923491|521043033|FG000|Overall Study|Lost to Follow-up|5|||
144503759|NCT03923491|521043034|FG001|Overall Study|Lost to Follow-up|8|||
144503760|NCT03923491|521043033|FG000|Overall Study|Withdrawal by Subject|4|||
144503761|NCT03923491|521043034|FG001|Overall Study|Withdrawal by Subject|6|||
144503762|NCT03823300|521043041|FG000|Overall Study|Withdrawal by Subject|16|||
144503763|NCT03823300|521043042|FG001|Overall Study|Withdrawal by Subject|22|||
144503764|NCT03823300|521043041|FG000|Overall Study|Death|10|||
144503765|NCT03823300|521043042|FG001|Overall Study|Death|14|||
144503766|NCT03823300|521043041|FG000|Overall Study|Adverse Event|3|||
144503767|NCT03823300|521043042|FG001|Overall Study|Adverse Event|5|||
144503768|NCT03823300|521043041|FG000|Overall Study|Physician Decision|1|||
144503769|NCT03823300|521043042|FG001|Overall Study|Physician Decision|7|||
144503770|NCT03823300|521043041|FG000|Overall Study|Lost to Follow-up|1|||
144503771|NCT03823300|521043042|FG001|Overall Study|Lost to Follow-up|3|||
144503772|NCT03823300|521043041|FG000|Overall Study|Protocol Violation|1|||
144503773|NCT03823300|521043042|FG001|Overall Study|Protocol Violation|1|||
144503774|NCT03823300|521043041|FG000|Overall Study|Lack of Efficacy|1|||
144503775|NCT03823300|521043042|FG001|Overall Study|Lack of Efficacy|1|||
144503776|NCT03823300|521043041|FG000|Overall Study|Not Eligible|0|||
144503777|NCT03823300|521043042|FG001|Overall Study|Not Eligible|1|||
144503778|NCT03823300|521043041|FG000|Overall Study|Other|1|||
144503779|NCT03823300|521043042|FG001|Overall Study|Other|0|||
144503780|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
144503781|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
144503782|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
144503783|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
144503784|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
144503785|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
144503786|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
144503787|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
144503788|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
144503789|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
144503790|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
144503791|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
144503792|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
144503793|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
144503794|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
144503795|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
144503796|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
144503797|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
144503798|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
144503799|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
144503800|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
144503801|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
144503802|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
144503803|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
144503804|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
144503805|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
144503806|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
144503807|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
144503808|NCT00241644|521043043|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
144503809|NCT00241644|521043044|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
144503810|NCT00241644|521043045|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
144503811|NCT00241644|521043046|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
144503812|NCT00241644|521043043|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
144503813|NCT00241644|521043044|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
144503814|NCT00241644|521043045|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
144503815|NCT00241644|521043046|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
144503816|NCT00241644|521043043|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
144503817|NCT00241644|521043044|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
144503818|NCT00241644|521043045|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
144503819|NCT00241644|521043046|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
144503820|NCT00241644|521043043|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
144503821|NCT00241644|521043044|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
144503822|NCT00241644|521043045|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
144503823|NCT00241644|521043046|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
144503824|NCT00241644|521043043|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
144503825|NCT00241644|521043044|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
144503826|NCT00241644|521043045|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
144503827|NCT00241644|521043046|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
144503828|NCT00241644|521043043|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
144503829|NCT00241644|521043044|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
144503830|NCT00241644|521043045|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
144503831|NCT00241644|521043046|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
144721635|NCT02396381|521835241|FG001|Overall Study|Could not complete visit|0|||
144503832|NCT03804918|521043047|FG000|Overall Study|Participant did not use the app|1|||
144503833|NCT02506257|521043048|FG000|Overall Study|Adverse Event|0|||
144503834|NCT02506257|521043049|FG001|Overall Study|Adverse Event|2|||
144503835|NCT02506257|521043050|FG002|Overall Study|Adverse Event|3|||
144503836|NCT02506257|521043051|FG003|Overall Study|Adverse Event|0|||
144721636|NCT02396381|521835240|FG000|Overall Study|Possible conflict of interest|1|||
144503837|NCT02506257|521043048|FG000|Overall Study|Protocol Violation|0|||
144503838|NCT02506257|521043049|FG001|Overall Study|Protocol Violation|0|||
144503839|NCT02506257|521043050|FG002|Overall Study|Protocol Violation|1|||
144503840|NCT02506257|521043051|FG003|Overall Study|Protocol Violation|0|||
144503841|NCT00964366|521043052|FG000|Overall Study|Did not qualify at Day 1|1|||
144503842|NCT00964366|521043053|FG001|Overall Study|Did not qualify at Day 1|0|||
144503843|NCT00964366|521043052|FG000|Overall Study|Withdrawal by Subject|0|||
144503844|NCT00964366|521043053|FG001|Overall Study|Withdrawal by Subject|1|||
144503845|NCT01370694|521043054|FG000|Overall Study|Switched to rituximab|4|||
144503846|NCT01370694|521043054|FG000|Overall Study|Progressive disease|2|||
144503847|NCT02957539|521043057|FG000|Baseline to Week 16|Lost to Follow-up|8|||
144503848|NCT02957539|521043058|FG001|Baseline to Week 16|Lost to Follow-up|10|||
144503849|NCT02957539|521043059|FG002|Baseline to Week 16|Lost to Follow-up|16|||
144503850|NCT02957539|521043057|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
144503851|NCT02957539|521043058|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
144503852|NCT02957539|521043059|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
144503853|NCT02957539|521043057|FG000|Week 16 to 32|Withdrawal by Subject|3|||
144503854|NCT02957539|521043058|FG001|Week 16 to 32|Withdrawal by Subject|3|||
144503855|NCT02957539|521043059|FG002|Week 16 to 32|Withdrawal by Subject|1|||
144503856|NCT02957539|521043057|FG000|Week 16 to 32|Lost to Follow-up|8|||
144503857|NCT02957539|521043058|FG001|Week 16 to 32|Lost to Follow-up|7|||
144503858|NCT02957539|521043059|FG002|Week 16 to 32|Lost to Follow-up|5|||
144503859|NCT02957539|521043057|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
144503860|NCT02957539|521043058|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
144503861|NCT02957539|521043059|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
144503862|NCT02957539|521043057|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
144503863|NCT02957539|521043058|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
144503864|NCT02957539|521043059|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
144503865|NCT01924767|521043060|FG000|Overall Study|Adverse Event|1|||
144503866|NCT01924767|521043061|FG001|Overall Study|Adverse Event|0|||
144503867|NCT01924767|521043062|FG002|Overall Study|Adverse Event|1|||
144503868|NCT01924767|521043063|FG003|Overall Study|Adverse Event|0|||
144503869|NCT01924767|521043064|FG004|Overall Study|Adverse Event|0|||
144503870|NCT01193153|521043065|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
144503871|NCT01193153|521043066|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
144503872|NCT01193153|521043065|FG000|Open-label Lead in Period|Pregnancy|1|||
144503873|NCT01193153|521043066|FG001|Open-label Lead in Period|Pregnancy|0|||
144503874|NCT01193153|521043065|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
144503875|NCT01193153|521043066|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
144503876|NCT01193153|521043065|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
144503877|NCT01193153|521043066|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
144503878|NCT01193153|521043065|FG000|Open-label Lead in Period|Other|14|||
144503879|NCT01193153|521043066|FG001|Open-label Lead in Period|Other|0|||
144503880|NCT01193153|521043065|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
144503881|NCT01193153|521043066|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
144503882|NCT01193153|521043065|FG000|Open-label Lead in Period|Adverse Event|41|||
144503883|NCT01193153|521043066|FG001|Open-label Lead in Period|Adverse Event|0|||
144503884|NCT01193153|521043065|FG000|Open-label Lead in Period|Death|1|||
144503885|NCT01193153|521043066|FG001|Open-label Lead in Period|Death|0|||
144503886|NCT01193153|521043065|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
144503887|NCT01193153|521043066|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
144503888|NCT01193153|521043065|FG000|Open-label Stabilization Period|Adverse Event|9|||
144503889|NCT01193153|521043066|FG001|Open-label Stabilization Period|Adverse Event|0|||
144503890|NCT01193153|521043065|FG000|Open-label Stabilization Period|Death|2|||
144503891|NCT01193153|521043066|FG001|Open-label Stabilization Period|Death|0|||
144503892|NCT01193153|521043065|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
144503893|NCT01193153|521043066|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
144503894|NCT01193153|521043065|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
144503895|NCT01193153|521043066|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
144503896|NCT01193153|521043065|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
144503897|NCT01193153|521043066|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
144503898|NCT01193153|521043065|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
144503899|NCT01193153|521043066|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
144503900|NCT01193153|521043065|FG000|Open-label Stabilization Period|Other|8|||
144503901|NCT01193153|521043066|FG001|Open-label Stabilization Period|Other|0|||
144503902|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Other|2|||
144503903|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Other|3|||
144503904|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
144503905|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
144503906|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Death|2|||
144503907|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Death|0|||
144503908|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
144503909|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
144503910|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
144503911|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
144503912|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
144503913|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
144503914|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
144503915|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
144503916|NCT01193153|521043065|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
144503917|NCT01193153|521043066|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
144503918|NCT01648140|521043067|FG000|Overall Study|Physician Decision|1|||
144503919|NCT01648140|521043068|FG001|Overall Study|Physician Decision|0|||
144503920|NCT01648140|521043069|FG002|Overall Study|Physician Decision|0|||
144503921|NCT01648140|521043070|FG003|Overall Study|Physician Decision|0|||
144503922|NCT01648140|521043067|FG000|Overall Study|Lack of Efficacy|4|||
144503923|NCT01648140|521043068|FG001|Overall Study|Lack of Efficacy|7|||
144503924|NCT01648140|521043069|FG002|Overall Study|Lack of Efficacy|1|||
144503925|NCT01648140|521043070|FG003|Overall Study|Lack of Efficacy|0|||
144503926|NCT01648140|521043067|FG000|Overall Study|Adverse Event|3|||
144503927|NCT01648140|521043068|FG001|Overall Study|Adverse Event|1|||
144503928|NCT01648140|521043069|FG002|Overall Study|Adverse Event|2|||
144503929|NCT01648140|521043070|FG003|Overall Study|Adverse Event|0|||
144503930|NCT01648140|521043067|FG000|Overall Study|Withdrawal by Subject|2|||
144503931|NCT01648140|521043068|FG001|Overall Study|Withdrawal by Subject|3|||
144503932|NCT01648140|521043069|FG002|Overall Study|Withdrawal by Subject|3|||
144503933|NCT01648140|521043070|FG003|Overall Study|Withdrawal by Subject|2|||
144503934|NCT01648140|521043067|FG000|Overall Study|Lost to Follow-up|2|||
144503935|NCT01648140|521043068|FG001|Overall Study|Lost to Follow-up|1|||
144503936|NCT01648140|521043069|FG002|Overall Study|Lost to Follow-up|2|||
144503937|NCT01648140|521043070|FG003|Overall Study|Lost to Follow-up|0|||
144503938|NCT03781336|521043076|FG000|Overall Study|Withdrawal by Subject|2|||
144503939|NCT03781336|521043077|FG001|Overall Study|Withdrawal by Subject|2|||
144503940|NCT02534350|521043080|FG000|Overall Study|Randomized But Not Treated|1|||
144503941|NCT02534350|521043081|FG001|Overall Study|Randomized But Not Treated|0|||
144503942|NCT02534350|521043080|FG000|Overall Study|Protocol Violation|1|||
144503943|NCT02534350|521043081|FG001|Overall Study|Protocol Violation|0|||
144503944|NCT02534350|521043080|FG000|Overall Study|Withdrew Consent|2|||
144503945|NCT02534350|521043081|FG001|Overall Study|Withdrew Consent|0|||
144503946|NCT03615924|521043094|FG000|Overall Study|Withdrawal by Subject|2|||
144503947|NCT03615924|521043095|FG001|Overall Study|Withdrawal by Subject|5|||
144503948|NCT03615924|521043094|FG000|Overall Study|Death|3|||
144503949|NCT03615924|521043095|FG001|Overall Study|Death|1|||
144503950|NCT03615924|521043094|FG000|Overall Study|Lost to Follow-up|1|||
144503951|NCT03615924|521043095|FG001|Overall Study|Lost to Follow-up|0|||
144503952|NCT03615924|521043094|FG000|Overall Study|Randomized in error|1|||
144503953|NCT03615924|521043095|FG001|Overall Study|Randomized in error|0|||
144503954|NCT03615924|521043094|FG000|Overall Study|Study termination by Sponsor|94|||
144503955|NCT03615924|521043095|FG001|Overall Study|Study termination by Sponsor|86|||
144503956|NCT02808338|521043096|FG000|Screening|Screen Failure|10|||
144503957|NCT02808338|521043096|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
144503958|NCT02808338|521043096|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
144503959|NCT02194933|521043097|FG000|Overall Study|Lost to Follow-up|1|||
144503960|NCT02194933|521043098|FG001|Overall Study|Lost to Follow-up|2|||
144503961|NCT02194933|521043097|FG000|Overall Study|Participant met withdrawal criteria|1|||
144503962|NCT02194933|521043098|FG001|Overall Study|Participant met withdrawal criteria|3|||
144503963|NCT02194933|521043097|FG000|Overall Study|Withdrawal by Subject|0|||
144503964|NCT02194933|521043098|FG001|Overall Study|Withdrawal by Subject|2|||
144503965|NCT02194933|521043097|FG000|Overall Study|Lack of Efficacy|1|||
144503966|NCT02194933|521043098|FG001|Overall Study|Lack of Efficacy|2|||
144503967|NCT00367055|521043105|FG000|Overall Study|Adverse Event|6|||
144503968|NCT00367055|521043106|FG001|Overall Study|Adverse Event|3|||
144503969|NCT00367055|521043105|FG000|Overall Study|Patient's Willing|3|||
144503970|NCT00367055|521043106|FG001|Overall Study|Patient's Willing|2|||
144503971|NCT00367055|521043105|FG000|Overall Study|Lack of Efficacy|1|||
144503972|NCT00367055|521043106|FG001|Overall Study|Lack of Efficacy|2|||
144503973|NCT00367055|521043105|FG000|Overall Study|Lost to Follow-up|1|||
144503974|NCT00367055|521043106|FG001|Overall Study|Lost to Follow-up|1|||
144503975|NCT00367055|521043105|FG000|Overall Study|Protocol Violation|0|||
144503976|NCT00367055|521043106|FG001|Overall Study|Protocol Violation|1|||
144503977|NCT00367055|521043105|FG000|Overall Study|Stopping Criterion Met|0|||
144503978|NCT00367055|521043106|FG001|Overall Study|Stopping Criterion Met|1|||
144503979|NCT00367055|521043105|FG000|Overall Study|Participant Living too Far from Hospital|0|||
144503980|NCT00367055|521043106|FG001|Overall Study|Participant Living too Far from Hospital|1|||
144503981|NCT03210402|521043107|FG000|Overall Study|Withdrawal by Subject|0|||
144503982|NCT03210402|521043108|FG001|Overall Study|Withdrawal by Subject|1|||
144503983|NCT02685488|521043112|FG000|Overall Study|Withdrawal by Subject|0|||
144503984|NCT02685488|521043113|FG001|Overall Study|Withdrawal by Subject|1|||
144503985|NCT05019729|521043114|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
144503986|NCT05019729|521043115|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
144503987|NCT05019729|521043116|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
144503988|NCT05019729|521043117|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
144503989|NCT05019729|521043118|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
144503990|NCT05019729|521043119|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
144503991|NCT02770248|521043120|FG000|Overall Study|Adverse Event|0|||
144503992|NCT02770248|521043121|FG001|Overall Study|Adverse Event|1|||
144503993|NCT02770248|521043120|FG000|Overall Study|Randomized in error, prior to treatment|0|||
144503994|NCT02770248|521043121|FG001|Overall Study|Randomized in error, prior to treatment|1|||
144503995|NCT01837641|521043122|FG000|Overall Study|Sponsor decision|1|||
144503996|NCT01837641|521043123|FG001|Overall Study|Sponsor decision|0|||
144503997|NCT01837641|521043124|FG002|Overall Study|Sponsor decision|0|||
144503998|NCT01837641|521043125|FG003|Overall Study|Sponsor decision|0|||
144503999|NCT01837641|521043126|FG004|Overall Study|Sponsor decision|0|||
144504000|NCT01837641|521043127|FG005|Overall Study|Sponsor decision|1|||
144504001|NCT01837641|521043128|FG006|Overall Study|Sponsor decision|0|||
144504002|NCT01837641|521043129|FG007|Overall Study|Sponsor decision|0|||
144504003|NCT01837641|521043122|FG000|Overall Study|Adverse Event|0|||
144504004|NCT01837641|521043123|FG001|Overall Study|Adverse Event|0|||
144504005|NCT01837641|521043124|FG002|Overall Study|Adverse Event|0|||
144504006|NCT01837641|521043125|FG003|Overall Study|Adverse Event|0|||
144504007|NCT01837641|521043126|FG004|Overall Study|Adverse Event|0|||
144504008|NCT01837641|521043127|FG005|Overall Study|Adverse Event|1|||
144504009|NCT01837641|521043128|FG006|Overall Study|Adverse Event|0|||
144504010|NCT01837641|521043129|FG007|Overall Study|Adverse Event|0|||
144504011|NCT01837641|521043122|FG000|Overall Study|Withdrawal by Subject|0|||
144504012|NCT01837641|521043123|FG001|Overall Study|Withdrawal by Subject|0|||
144504013|NCT01837641|521043124|FG002|Overall Study|Withdrawal by Subject|0|||
144504014|NCT01837641|521043125|FG003|Overall Study|Withdrawal by Subject|0|||
144504015|NCT01837641|521043126|FG004|Overall Study|Withdrawal by Subject|1|||
144504016|NCT01837641|521043127|FG005|Overall Study|Withdrawal by Subject|0|||
144504017|NCT01837641|521043128|FG006|Overall Study|Withdrawal by Subject|1|||
144504018|NCT01837641|521043129|FG007|Overall Study|Withdrawal by Subject|0|||
144504019|NCT01579916|521043130|FG000|Overall Study|Lost to Follow-up|6|||
144504020|NCT01579916|521043131|FG001|Overall Study|Lost to Follow-up|1|||
144504021|NCT01579916|521043130|FG000|Overall Study|Withdrawal by Subject|1|||
144504022|NCT01579916|521043131|FG001|Overall Study|Withdrawal by Subject|1|||
144504023|NCT01579916|521043130|FG000|Overall Study|Death|1|||
144504024|NCT01579916|521043131|FG001|Overall Study|Death|0|||
144504025|NCT03264456|521043132|FG000|Overall Study|Withdrawal by Subject|3|||
144504026|NCT03264456|521043132|FG000|Overall Study|Lost to Follow-up|1|||
144504027|NCT02486588|521043137|FG000|Overall Study|Randomized in error- ineligible|738|||
144504028|NCT02486588|521043138|FG001|Overall Study|Randomized in error- ineligible|750|||
144504029|NCT02486588|521043139|FG002|Overall Study|Randomized in error- ineligible|755|||
144504030|NCT02486588|521043140|FG003|Overall Study|Randomized in error- ineligible|738|||
144504031|NCT02486588|521043141|FG004|Overall Study|Randomized in error- ineligible|746|||
144504032|NCT02486588|521043142|FG005|Overall Study|Randomized in error- ineligible|746|||
144504033|NCT02551055|521043143|FG000|Overall Study|Death|2|||
144504034|NCT02551055|521043144|FG001|Overall Study|Death|4|||
144504035|NCT02551055|521043145|FG002|Overall Study|Death|2|||
144504036|NCT02551055|521043146|FG003|Overall Study|Death|2|||
144504037|NCT02551055|521043147|FG004|Overall Study|Death|2|||
144504038|NCT02551055|521043148|FG005|Overall Study|Death|1|||
144504039|NCT02551055|521043149|FG006|Overall Study|Death|2|||
144504040|NCT02551055|521043150|FG007|Overall Study|Death|0|||
144504041|NCT02551055|521043143|FG000|Overall Study|Study Terminated by Sponsor|1|||
144504042|NCT02551055|521043144|FG001|Overall Study|Study Terminated by Sponsor|1|||
144504043|NCT02551055|521043145|FG002|Overall Study|Study Terminated by Sponsor|0|||
144504044|NCT02551055|521043146|FG003|Overall Study|Study Terminated by Sponsor|2|||
144504045|NCT02551055|521043147|FG004|Overall Study|Study Terminated by Sponsor|2|||
144504046|NCT02551055|521043148|FG005|Overall Study|Study Terminated by Sponsor|0|||
144504047|NCT02551055|521043149|FG006|Overall Study|Study Terminated by Sponsor|0|||
144504048|NCT02551055|521043150|FG007|Overall Study|Study Terminated by Sponsor|0|||
144504049|NCT02551055|521043143|FG000|Overall Study|Withdrawal by Subject|1|||
144504050|NCT02551055|521043144|FG001|Overall Study|Withdrawal by Subject|1|||
144504051|NCT02551055|521043145|FG002|Overall Study|Withdrawal by Subject|0|||
144504052|NCT02551055|521043146|FG003|Overall Study|Withdrawal by Subject|1|||
144504053|NCT02551055|521043147|FG004|Overall Study|Withdrawal by Subject|2|||
144504054|NCT02551055|521043148|FG005|Overall Study|Withdrawal by Subject|0|||
144504055|NCT02551055|521043149|FG006|Overall Study|Withdrawal by Subject|0|||
144504056|NCT02551055|521043150|FG007|Overall Study|Withdrawal by Subject|0|||
144504057|NCT02551055|521043143|FG000|Overall Study|Reason not specified|0|||
144504058|NCT02551055|521043144|FG001|Overall Study|Reason not specified|0|||
144504059|NCT02551055|521043145|FG002|Overall Study|Reason not specified|0|||
144504060|NCT02551055|521043146|FG003|Overall Study|Reason not specified|0|||
144504061|NCT02551055|521043147|FG004|Overall Study|Reason not specified|1|||
144504062|NCT02551055|521043148|FG005|Overall Study|Reason not specified|0|||
144504063|NCT02551055|521043149|FG006|Overall Study|Reason not specified|1|||
144504064|NCT02551055|521043150|FG007|Overall Study|Reason not specified|0|||
144504065|NCT00430300|521043151|FG000|Overall Study|Adverse Event|0|||
144504066|NCT00430300|521043152|FG001|Overall Study|Adverse Event|2|||
144504067|NCT00430300|521043153|FG002|Overall Study|Adverse Event|1|||
144504068|NCT00430300|521043154|FG003|Overall Study|Adverse Event|1|||
144504069|NCT00430300|521043151|FG000|Overall Study|Withdrawal by Subject|1|||
144504070|NCT00430300|521043152|FG001|Overall Study|Withdrawal by Subject|0|||
144504071|NCT00430300|521043153|FG002|Overall Study|Withdrawal by Subject|5|||
144504072|NCT00430300|521043154|FG003|Overall Study|Withdrawal by Subject|0|||
144504073|NCT00430300|521043151|FG000|Overall Study|Laboratory abnormality|1|||
144504074|NCT00430300|521043152|FG001|Overall Study|Laboratory abnormality|0|||
144504075|NCT00430300|521043153|FG002|Overall Study|Laboratory abnormality|0|||
144504076|NCT00430300|521043154|FG003|Overall Study|Laboratory abnormality|0|||
144504077|NCT00430300|521043151|FG000|Overall Study|Other|0|||
144504078|NCT00430300|521043152|FG001|Overall Study|Other|0|||
144504079|NCT00430300|521043153|FG002|Overall Study|Other|0|||
144504080|NCT00430300|521043154|FG003|Overall Study|Other|1|||
144504081|NCT02041104|521043157|FG000|Overall Study|Lost to Follow-up|1|||
144504082|NCT02041104|521043158|FG001|Overall Study|Lost to Follow-up|4|||
144504083|NCT02041104|521043157|FG000|Overall Study|discomfort during OGTT|0|||
144504084|NCT02041104|521043158|FG001|Overall Study|discomfort during OGTT|3|||
144504085|NCT00546871|521043161|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
144504086|NCT00546871|521043162|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
144504087|NCT00546871|521043161|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
144504088|NCT00546871|521043162|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
144504089|NCT00546871|521043161|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
144504090|NCT00546871|521043162|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
144504091|NCT00546871|521043161|FG000|Study Extension Period|Protocol Violation|1|||
144504092|NCT00546871|521043162|FG001|Study Extension Period|Protocol Violation|0|||
144504093|NCT00546871|521043161|FG000|Study Extension Period|Withdrawal by Subject|0|||
144504094|NCT00546871|521043162|FG001|Study Extension Period|Withdrawal by Subject|1|||
144504095|NCT01713946|521043163|FG000|Overall Study|Death|0|||
144504096|NCT01713946|521043164|FG001|Overall Study|Death|2|||
144504097|NCT01713946|521043165|FG002|Overall Study|Death|2|||
144504098|NCT01713946|521043163|FG000|Overall Study|Adverse Event|19|||
144504099|NCT01713946|521043164|FG001|Overall Study|Adverse Event|14|||
144504100|NCT01713946|521043165|FG002|Overall Study|Adverse Event|13|||
144504101|NCT01713946|521043163|FG000|Overall Study|Withdrawal by Subject|12|||
144504102|NCT01713946|521043164|FG001|Overall Study|Withdrawal by Subject|12|||
144504103|NCT01713946|521043165|FG002|Overall Study|Withdrawal by Subject|8|||
144504104|NCT01713946|521043163|FG000|Overall Study|Lack of Efficacy|8|||
144504105|NCT01713946|521043164|FG001|Overall Study|Lack of Efficacy|8|||
144504106|NCT01713946|521043165|FG002|Overall Study|Lack of Efficacy|14|||
144504107|NCT01713946|521043163|FG000|Overall Study|Protocol Violation|2|||
144504108|NCT01713946|521043164|FG001|Overall Study|Protocol Violation|4|||
144504109|NCT01713946|521043165|FG002|Overall Study|Protocol Violation|1|||
144504110|NCT01713946|521043163|FG000|Overall Study|Lost to Follow-up|0|||
144504111|NCT01713946|521043164|FG001|Overall Study|Lost to Follow-up|0|||
144504112|NCT01713946|521043165|FG002|Overall Study|Lost to Follow-up|1|||
144504113|NCT01713946|521043163|FG000|Overall Study|Administrative problems|1|||
144504114|NCT01713946|521043164|FG001|Overall Study|Administrative problems|0|||
144504115|NCT01713946|521043165|FG002|Overall Study|Administrative problems|0|||
144504116|NCT01713946|521043163|FG000|Overall Study|Did not continue in Ext|0|||
144504117|NCT01713946|521043164|FG001|Overall Study|Did not continue in Ext|3|||
144504118|NCT01713946|521043165|FG002|Overall Study|Did not continue in Ext|0|||
144504119|NCT01713946|521043163|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
144504120|NCT01713946|521043164|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
144504121|NCT01713946|521043165|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
144504122|NCT01713946|521043163|FG000|Overall Study|Patients never switched to everolimus|0|||
144504123|NCT01713946|521043164|FG001|Overall Study|Patients never switched to everolimus|0|||
144504124|NCT01713946|521043165|FG002|Overall Study|Patients never switched to everolimus|5|||
144504125|NCT02299336|521043166|FG000|Overall Study|Withdrawal by Subject|11|||
144504126|NCT02299336|521043166|FG000|Overall Study|Adverse Event|1|||
144504127|NCT02299336|521043166|FG000|Overall Study|Death|1|||
144504128|NCT02299336|521043166|FG000|Overall Study|Lost to Follow-up|1|||
144504129|NCT02106442|521043170|FG000|Overall Study|Case Report Forms Uncollected|7|||
144504130|NCT02106442|521043170|FG000|Overall Study|Protocol Deviation|30|||
144504131|NCT00573833|521043174|FG000|Overall Study|Not Treated|2|||
144504132|NCT04493242|521043175|FG000|Overall Study|Death|10|||
144504133|NCT04493242|521043176|FG001|Overall Study|Death|14|||
144504134|NCT04493242|521043177|FG002|Overall Study|Death|16|||
144504135|NCT04493242|521043175|FG000|Overall Study|Lost to Follow-up|1|||
144504136|NCT04493242|521043176|FG001|Overall Study|Lost to Follow-up|1|||
144504137|NCT04493242|521043177|FG002|Overall Study|Lost to Follow-up|0|||
144504138|NCT04493242|521043175|FG000|Overall Study|Withdrawal by Subject|1|||
144504139|NCT04493242|521043176|FG001|Overall Study|Withdrawal by Subject|0|||
144504140|NCT04493242|521043177|FG002|Overall Study|Withdrawal by Subject|0|||
144504141|NCT04493242|521043175|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
144504142|NCT04493242|521043176|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
144504143|NCT04493242|521043177|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
144504144|NCT04493242|521043175|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
144504145|NCT04493242|521043176|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
144504146|NCT04493242|521043177|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
144504147|NCT00849147|521043178|FG000|Overall Study|Withdrawal by Subject|1|||
144504148|NCT00849147|521043178|FG000|Overall Study|Protocol Violation|2|||
144504149|NCT00849147|521043178|FG000|Overall Study|Disease Relapse/Progression|2|||
144504150|NCT04517864|521045005|FG000|Placebo-Controlled Phase|Adverse Event|1|||
144504151|NCT04517864|521045006|FG001|Placebo-Controlled Phase|Adverse Event|0|||
144504152|NCT04517864|521045007|FG002|Placebo-Controlled Phase|Adverse Event|0|||
144504153|NCT04517864|521045005|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
144504154|NCT04517864|521045006|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
144504155|NCT04517864|521045007|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
144504156|NCT04517864|521045005|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
144504157|NCT04517864|521045006|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
144504158|NCT04517864|521045007|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
144504159|NCT04517864|521045005|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
144504160|NCT04517864|521045006|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
144504161|NCT04517864|521045007|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
144504162|NCT04517864|521045005|FG000|Active Therapy Extension Phase|Adverse Event|1|||
144504163|NCT04517864|521045006|FG001|Active Therapy Extension Phase|Adverse Event|0|||
144504164|NCT04517864|521045007|FG002|Active Therapy Extension Phase|Adverse Event|0|||
144504165|NCT04517864|521045005|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
144504166|NCT04517864|521045006|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
144504167|NCT04517864|521045007|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
144504168|NCT04517864|521045005|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
144504169|NCT04517864|521045006|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
144504170|NCT04517864|521045007|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
144504171|NCT04517864|521045005|FG000|Active Therapy Extension Phase|Physician Decision|1|||
144504172|NCT04517864|521045006|FG001|Active Therapy Extension Phase|Physician Decision|0|||
144504173|NCT04517864|521045007|FG002|Active Therapy Extension Phase|Physician Decision|0|||
144504174|NCT04517864|521045005|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
144504175|NCT04517864|521045006|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
144504176|NCT04517864|521045007|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
144504177|NCT04517864|521045005|FG000|Extension Phase|Adverse Event|0|||
144504178|NCT04517864|521045006|FG001|Extension Phase|Adverse Event|0|||
144504179|NCT04517864|521045007|FG002|Extension Phase|Adverse Event|1|||
144504180|NCT04517864|521045005|FG000|Extension Phase|Lack of Efficacy|0|||
144504181|NCT04517864|521045006|FG001|Extension Phase|Lack of Efficacy|0|||
144504182|NCT04517864|521045007|FG002|Extension Phase|Lack of Efficacy|2|||
144504183|NCT04517864|521045005|FG000|Extension Phase|Study Terminated By Sponsor|0|||
144504184|NCT04517864|521045006|FG001|Extension Phase|Study Terminated By Sponsor|0|||
144504185|NCT04517864|521045007|FG002|Extension Phase|Study Terminated By Sponsor|32|||
144504186|NCT04517864|521045005|FG000|Extension Phase|Withdrawal by Subject|0|||
144721637|NCT02396381|521835241|FG001|Overall Study|Possible conflict of interest|0|||
144504187|NCT04517864|521045006|FG001|Extension Phase|Withdrawal by Subject|0|||
144504188|NCT04517864|521045007|FG002|Extension Phase|Withdrawal by Subject|3|||
144504189|NCT04517864|521045005|FG000|Extension Phase|Approved Drug Available for Indication|0|||
144504190|NCT04517864|521045006|FG001|Extension Phase|Approved Drug Available for Indication|0|||
144504191|NCT04517864|521045007|FG002|Extension Phase|Approved Drug Available for Indication|7|||
144504192|NCT04722003|521045008|FG000|Overall Study|Lost to Follow-up|2|||
144504193|NCT04722003|521045009|FG001|Overall Study|Lost to Follow-up|0|||
144504194|NCT04722003|521045008|FG000|Overall Study|Physician Decision|1|||
144504195|NCT04722003|521045009|FG001|Overall Study|Physician Decision|0|||
144504196|NCT03351075|521045010|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
144504197|NCT03351075|521045011|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
144504198|NCT03351075|521045010|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
144504199|NCT03351075|521045011|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
144504200|NCT03351075|521045010|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
144504201|NCT03351075|521045011|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
144504202|NCT03351075|521045010|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
144504203|NCT03351075|521045011|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
144504204|NCT03175172|521045012|FG000|Overall Study|Death|3|||
144504205|NCT03175172|521045012|FG000|Overall Study|Withdrawal by Subject|3|||
144504206|NCT03175172|521045012|FG000|Overall Study|Lost to Follow-up|1|||
144504207|NCT03175172|521045012|FG000|Overall Study|Study Terminated by Sponsor|3|||
144504208|NCT03169244|521045013|FG000|Overall Study|Lost to Follow-up|1|||
144504209|NCT03169244|521045014|FG001|Overall Study|Lost to Follow-up|2|||
144504210|NCT03169244|521045013|FG000|Overall Study|Adverse Event|1|||
144504211|NCT03169244|521045014|FG001|Overall Study|Adverse Event|0|||
144504212|NCT03169244|521045013|FG000|Overall Study|Withdrawal by Subject|2|||
144504213|NCT03169244|521045014|FG001|Overall Study|Withdrawal by Subject|2|||
144504214|NCT03169244|521045013|FG000|Overall Study|Physician Decision|1|||
144504215|NCT03169244|521045014|FG001|Overall Study|Physician Decision|0|||
144504216|NCT00446550|521045015|FG000|Overall Study|Adverse Event|1|||
144504217|NCT00446550|521045016|FG001|Overall Study|Adverse Event|0|||
144504218|NCT02937831|521045017|FG000|Overall Study|Protocol Violation|4|||
144504219|NCT01087762|521045021|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
144504220|NCT01087762|521045022|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
144504221|NCT01087762|521045023|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
144504222|NCT01087762|521045024|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
144504223|NCT01087762|521045025|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
144504224|NCT01087762|521045021|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
144504225|NCT01087762|521045022|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
144504226|NCT01087762|521045023|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
144504227|NCT01087762|521045024|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
144504228|NCT01087762|521045025|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
144504229|NCT01087762|521045021|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
144504230|NCT01087762|521045022|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
144504231|NCT01087762|521045023|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
144504232|NCT01087762|521045024|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
144504233|NCT01087762|521045025|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
144504234|NCT01087762|521045021|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
144504235|NCT01087762|521045022|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
144504236|NCT01087762|521045023|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
144504237|NCT01087762|521045024|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
144504238|NCT01087762|521045025|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
144504239|NCT01087762|521045021|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
144504240|NCT01087762|521045022|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
144504241|NCT01087762|521045023|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
144504242|NCT01087762|521045024|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
144504243|NCT01087762|521045025|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
144504244|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
144504245|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
144504246|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
144504247|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
144504248|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
144504249|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
144504250|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
144504251|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
144504252|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
144504253|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
144504254|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
144504255|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
144504256|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
144504257|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
144504258|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
144504259|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
144504260|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
144504261|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
144504262|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
144504263|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
144504264|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
144504265|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
144504266|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
144504267|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
144504268|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
144504269|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
144504270|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
144504271|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
144504272|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
144504273|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
144504274|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
144504275|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
144504276|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
144504277|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
144504278|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
144504279|NCT01087762|521045021|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
144504280|NCT01087762|521045022|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
144504281|NCT01087762|521045023|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
144504282|NCT01087762|521045024|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
144504283|NCT01087762|521045025|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
144504284|NCT00813904|521045026|FG000|Overall Study|Death|1|||
144504285|NCT01405924|521045029|FG000|Overall Study|Protocol Violation|8|||
144504286|NCT01405924|521045029|FG000|Overall Study|Missing/Incomplete Data|2|||
144504287|NCT01563354|521045031|FG000|Core Phase|Adverse Event|5|||
144504288|NCT01563354|521045032|FG001|Core Phase|Adverse Event|15|||
144504289|NCT01563354|521045033|FG002|Core Phase|Adverse Event|13|||
144504290|NCT01563354|521045031|FG000|Core Phase|Withdrawal by Subject|1|||
144504291|NCT01563354|521045032|FG001|Core Phase|Withdrawal by Subject|0|||
144504292|NCT01563354|521045033|FG002|Core Phase|Withdrawal by Subject|3|||
144504293|NCT01563354|521045031|FG000|Core Phase|Lost to Follow-up|1|||
144504294|NCT01563354|521045032|FG001|Core Phase|Lost to Follow-up|0|||
144504295|NCT01563354|521045033|FG002|Core Phase|Lost to Follow-up|0|||
144504296|NCT01563354|521045031|FG000|Core Phase|Death|1|||
144504297|NCT01563354|521045032|FG001|Core Phase|Death|5|||
144504298|NCT01563354|521045033|FG002|Core Phase|Death|2|||
144504299|NCT01563354|521045031|FG000|Core Phase|Diseasse progression|18|||
144504300|NCT01563354|521045032|FG001|Core Phase|Diseasse progression|7|||
144504301|NCT01563354|521045033|FG002|Core Phase|Diseasse progression|8|||
144504302|NCT01563354|521045031|FG000|Core Phase|Protocol deviation|2|||
144504303|NCT01563354|521045032|FG001|Core Phase|Protocol deviation|0|||
144504304|NCT01563354|521045033|FG002|Core Phase|Protocol deviation|0|||
144504305|NCT01563354|521045031|FG000|Core Phase|PI decision - did not enter extension|0|||
144504306|NCT01563354|521045032|FG001|Core Phase|PI decision - did not enter extension|1|||
144504307|NCT01563354|521045033|FG002|Core Phase|PI decision - did not enter extension|0|||
144504308|NCT01563354|521045031|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
144504309|NCT01563354|521045032|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
144504310|NCT01563354|521045033|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
144504311|NCT01563354|521045031|FG000|Extension Phase|Adverse Event|0|||
144504312|NCT01563354|521045032|FG001|Extension Phase|Adverse Event|3|||
144504313|NCT01563354|521045033|FG002|Extension Phase|Adverse Event|2|||
144504314|NCT01563354|521045031|FG000|Extension Phase|Withdrawal by Subject|0|||
144504315|NCT01563354|521045032|FG001|Extension Phase|Withdrawal by Subject|1|||
144504316|NCT01563354|521045033|FG002|Extension Phase|Withdrawal by Subject|0|||
144504317|NCT01563354|521045031|FG000|Extension Phase|Administration problems|3|||
144504318|NCT01563354|521045032|FG001|Extension Phase|Administration problems|2|||
144504319|NCT01563354|521045033|FG002|Extension Phase|Administration problems|3|||
144504320|NCT01563354|521045031|FG000|Extension Phase|Disease progression|9|||
144504321|NCT01563354|521045032|FG001|Extension Phase|Disease progression|8|||
144504322|NCT01563354|521045033|FG002|Extension Phase|Disease progression|10|||
144504323|NCT01988233|521045036|FG000|Overall Study|Lost to Follow-up|64|||
144504324|NCT01988233|521045037|FG001|Overall Study|Lost to Follow-up|51|||
144504325|NCT03621761|521045042|FG000|Overall Study|Lost to Follow-up|1|||
144504326|NCT03621761|521045043|FG001|Overall Study|Lost to Follow-up|1|||
144504327|NCT03621761|521045044|FG002|Overall Study|Lost to Follow-up|2|||
144504328|NCT03621761|521045042|FG000|Overall Study|Withdrawal by Subject|2|||
144504329|NCT03621761|521045043|FG001|Overall Study|Withdrawal by Subject|1|||
144504330|NCT03621761|521045044|FG002|Overall Study|Withdrawal by Subject|1|||
144504331|NCT03621761|521045042|FG000|Overall Study|Became Ineligible|0|||
144504332|NCT03621761|521045043|FG001|Overall Study|Became Ineligible|2|||
144504333|NCT03621761|521045044|FG002|Overall Study|Became Ineligible|0|||
144504334|NCT01050569|521045045|FG000|Overall Study|Lost to Follow-up|20|||
144504335|NCT01050569|521045046|FG001|Overall Study|Lost to Follow-up|14|||
144504336|NCT01050569|521045047|FG002|Overall Study|Lost to Follow-up|16|||
144504337|NCT01050569|521045045|FG000|Overall Study|Withdrawal by Subject|9|||
144504338|NCT01050569|521045046|FG001|Overall Study|Withdrawal by Subject|3|||
144504339|NCT01050569|521045047|FG002|Overall Study|Withdrawal by Subject|11|||
144504340|NCT01050569|521045045|FG000|Overall Study|Lack of Efficacy|5|||
144504341|NCT01050569|521045046|FG001|Overall Study|Lack of Efficacy|4|||
144504342|NCT01050569|521045047|FG002|Overall Study|Lack of Efficacy|3|||
144504343|NCT01050569|521045045|FG000|Overall Study|Adverse Event|1|||
144504344|NCT01050569|521045046|FG001|Overall Study|Adverse Event|0|||
144504345|NCT01050569|521045047|FG002|Overall Study|Adverse Event|0|||
144504346|NCT01050569|521045045|FG000|Overall Study|Physician Decision|3|||
144504347|NCT01050569|521045046|FG001|Overall Study|Physician Decision|3|||
144504348|NCT01050569|521045047|FG002|Overall Study|Physician Decision|3|||
144504349|NCT03987451|521045050|FG000|Overall Study|Lost to Follow-up|1|||
144504350|NCT03987451|521045051|FG001|Overall Study|Lost to Follow-up|0|||
144504351|NCT03987451|521045050|FG000|Overall Study|Withdrawal by Subject|1|||
144504352|NCT03987451|521045051|FG001|Overall Study|Withdrawal by Subject|1|||
144504353|NCT02441036|521045052|FG000|Overall Study|No tissue resected|0|||
144504354|NCT02441036|521045053|FG001|Overall Study|No tissue resected|1|||
144504355|NCT02441036|521045054|FG002|Overall Study|No tissue resected|0|||
144504356|NCT02441036|521045055|FG003|Overall Study|No tissue resected|1|||
144504357|NCT02441036|521045056|FG004|Overall Study|No tissue resected|0|||
144504358|NCT01183780|521045057|FG000|Overall Study|Withdrawal by Subject|25|||
144504359|NCT01183780|521045058|FG001|Overall Study|Withdrawal by Subject|14|||
144504360|NCT01183780|521045057|FG000|Overall Study|Lost to Follow-up|6|||
144504361|NCT01183780|521045058|FG001|Overall Study|Lost to Follow-up|11|||
144504362|NCT00770965|521045061|FG000|Safety Set|Withdrawal by Subject|0|||
144504363|NCT00770965|521045062|FG001|Safety Set|Withdrawal by Subject|0|||
144504364|NCT00770965|521045063|FG002|Safety Set|Withdrawal by Subject|0|||
144504365|NCT00770965|521045064|FG003|Safety Set|Withdrawal by Subject|1|||
144504366|NCT00770965|521045061|FG000|Safety Set|Protocol deviation|0|||
144504367|NCT00770965|521045062|FG001|Safety Set|Protocol deviation|0|||
144504368|NCT00770965|521045063|FG002|Safety Set|Protocol deviation|1|||
144504369|NCT00770965|521045064|FG003|Safety Set|Protocol deviation|0|||
144504370|NCT00770965|521045061|FG000|Excluded Set|Administrative problems|14|||
144504371|NCT00770965|521045062|FG001|Excluded Set|Administrative problems|12|||
144504372|NCT00770965|521045063|FG002|Excluded Set|Administrative problems|12|||
144504373|NCT00770965|521045064|FG003|Excluded Set|Administrative problems|10|||
144504374|NCT00770965|521045061|FG000|Excluded Set|Withdrawal by Subject|1|||
144504375|NCT00770965|521045062|FG001|Excluded Set|Withdrawal by Subject|1|||
144504376|NCT00770965|521045063|FG002|Excluded Set|Withdrawal by Subject|2|||
144504377|NCT00770965|521045064|FG003|Excluded Set|Withdrawal by Subject|3|||
144504378|NCT00612586|521045065|FG000|Overall Study|Adverse Event|6|||
144504379|NCT00612586|521045066|FG001|Overall Study|Adverse Event|2|||
144504380|NCT00612586|521045065|FG000|Overall Study|Death|1|||
144504381|NCT00612586|521045066|FG001|Overall Study|Death|0|||
144504382|NCT00612586|521045065|FG000|Overall Study|Entry Criteria Not Met|0|||
144504383|NCT00612586|521045066|FG001|Overall Study|Entry Criteria Not Met|2|||
144504384|NCT00612586|521045065|FG000|Overall Study|Withdrawal by Subject|7|||
144504385|NCT00612586|521045066|FG001|Overall Study|Withdrawal by Subject|9|||
144504386|NCT00612586|521045065|FG000|Overall Study|Physician Decision|1|||
144504387|NCT00612586|521045066|FG001|Overall Study|Physician Decision|2|||
144504388|NCT00612586|521045065|FG000|Overall Study|Sponsor Decision|1|||
144504389|NCT00612586|521045066|FG001|Overall Study|Sponsor Decision|1|||
144504390|NCT00612586|521045065|FG000|Overall Study|Progressive Disease|26|||
144504391|NCT00612586|521045066|FG001|Overall Study|Progressive Disease|24|||
144504392|NCT00612586|521045065|FG000|Overall Study|Randomized and Not Treated|1|||
144504393|NCT00612586|521045066|FG001|Overall Study|Randomized and Not Treated|1|||
144504394|NCT01505881|521045067|FG000|Overall Study|Adverse Event|0|||
144504395|NCT01505881|521045068|FG001|Overall Study|Adverse Event|1|||
144504396|NCT01505881|521045067|FG000|Overall Study|Lost to Follow-up|2|||
144504397|NCT01505881|521045068|FG001|Overall Study|Lost to Follow-up|0|||
144504398|NCT01505881|521045067|FG000|Overall Study|Withdrawal by Subject|2|||
144504399|NCT01505881|521045068|FG001|Overall Study|Withdrawal by Subject|0|||
144504400|NCT01194154|521045069|FG000|Overall Study|Adverse Event|12|||
144504401|NCT01194154|521045070|FG001|Overall Study|Adverse Event|7|||
144504402|NCT01194154|521045069|FG000|Overall Study|Lost to Follow-up|2|||
144504403|NCT01194154|521045070|FG001|Overall Study|Lost to Follow-up|3|||
144504404|NCT01194154|521045069|FG000|Overall Study|Protocol Violation|0|||
144504405|NCT01194154|521045070|FG001|Overall Study|Protocol Violation|1|||
144504406|NCT01194154|521045069|FG000|Overall Study|Withdrawal by Subject|5|||
144504407|NCT01194154|521045070|FG001|Overall Study|Withdrawal by Subject|6|||
144504408|NCT01194154|521045069|FG000|Overall Study|Blood pressure increase|5|||
144504409|NCT01194154|521045070|FG001|Overall Study|Blood pressure increase|3|||
144504410|NCT01194154|521045069|FG000|Overall Study|Hemoglobin decrease|0|||
144504411|NCT01194154|521045070|FG001|Overall Study|Hemoglobin decrease|1|||
144504412|NCT01194154|521045069|FG000|Overall Study|Hemoglobin increase|12|||
144504413|NCT01194154|521045070|FG001|Overall Study|Hemoglobin increase|3|||
144504414|NCT01194154|521045069|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
144504415|NCT01194154|521045070|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
144504416|NCT01194154|521045069|FG000|Overall Study|Treatment with prohibited medication|4|||
144504417|NCT01194154|521045070|FG001|Overall Study|Treatment with prohibited medication|5|||
144504418|NCT01194154|521045069|FG000|Overall Study|Other|4|||
144504419|NCT01194154|521045070|FG001|Overall Study|Other|0|||
144504420|NCT01194154|521045069|FG000|Overall Study|Did not receive study medication|2|||
144504421|NCT01194154|521045070|FG001|Overall Study|Did not receive study medication|4|||
144504422|NCT01901276|521045071|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
144504423|NCT01901276|521045072|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
144504424|NCT01596504|521045073|FG000|Overall Study|Participant's Private Reason|0|||
144504425|NCT01596504|521045074|FG001|Overall Study|Participant's Private Reason|1|||
144504426|NCT01596504|521045075|FG002|Overall Study|Participant's Private Reason|0|||
144504427|NCT01596504|521045073|FG000|Overall Study|Adverse Event|1|||
144504428|NCT01596504|521045074|FG001|Overall Study|Adverse Event|2|||
144504429|NCT01596504|521045075|FG002|Overall Study|Adverse Event|1|||
144504430|NCT01596504|521045073|FG000|Overall Study|Withdrawal by Subject|1|||
144504431|NCT01596504|521045074|FG001|Overall Study|Withdrawal by Subject|0|||
144504432|NCT01596504|521045075|FG002|Overall Study|Withdrawal by Subject|0|||
144504433|NCT02314117|521045076|FG000|Overall Study|Lost to Follow-up|9|||
144504434|NCT02314117|521045077|FG001|Overall Study|Lost to Follow-up|14|||
144504435|NCT02314117|521045076|FG000|Overall Study|Withdrawal by Subject|3|||
144504436|NCT02314117|521045077|FG001|Overall Study|Withdrawal by Subject|2|||
144504437|NCT00949975|521045078|FG000|Overall Study|Voluntary discontinuation|6|||
144504438|NCT00949975|521045079|FG001|Overall Study|Voluntary discontinuation|5|||
144504439|NCT00949975|521045080|FG002|Overall Study|Voluntary discontinuation|3|||
144504440|NCT00949975|521045081|FG003|Overall Study|Voluntary discontinuation|6|||
144504441|NCT00949975|521045078|FG000|Overall Study|Adverse Event|11|||
144504442|NCT00949975|521045079|FG001|Overall Study|Adverse Event|11|||
144504443|NCT00949975|521045080|FG002|Overall Study|Adverse Event|10|||
144504444|NCT00949975|521045081|FG003|Overall Study|Adverse Event|10|||
144504445|NCT00949975|521045078|FG000|Overall Study|Safety reason|0|||
144504446|NCT00949975|521045079|FG001|Overall Study|Safety reason|1|||
144504447|NCT00949975|521045080|FG002|Overall Study|Safety reason|0|||
144504448|NCT00949975|521045081|FG003|Overall Study|Safety reason|0|||
144504449|NCT00949975|521045078|FG000|Overall Study|Study-specific criteria|0|||
144504450|NCT00949975|521045079|FG001|Overall Study|Study-specific criteria|1|||
144504451|NCT00949975|521045080|FG002|Overall Study|Study-specific criteria|1|||
144504452|NCT00949975|521045081|FG003|Overall Study|Study-specific criteria|0|||
144504453|NCT00949975|521045078|FG000|Overall Study|Incorrect enrolment|5|||
144504454|NCT00949975|521045079|FG001|Overall Study|Incorrect enrolment|10|||
144504455|NCT00949975|521045080|FG002|Overall Study|Incorrect enrolment|4|||
144504456|NCT00949975|521045081|FG003|Overall Study|Incorrect enrolment|7|||
144504457|NCT00949975|521045078|FG000|Overall Study|Severe non-compliance|3|||
144504458|NCT00949975|521045079|FG001|Overall Study|Severe non-compliance|1|||
144504459|NCT00949975|521045080|FG002|Overall Study|Severe non-compliance|0|||
144504460|NCT00949975|521045081|FG003|Overall Study|Severe non-compliance|2|||
144504461|NCT00949975|521045078|FG000|Overall Study|Lost to Follow-up|1|||
144504462|NCT00949975|521045079|FG001|Overall Study|Lost to Follow-up|0|||
144504463|NCT00949975|521045080|FG002|Overall Study|Lost to Follow-up|1|||
144504464|NCT00949975|521045081|FG003|Overall Study|Lost to Follow-up|3|||
144504465|NCT00949975|521045078|FG000|Overall Study|Other|1|||
144504466|NCT00949975|521045079|FG001|Overall Study|Other|0|||
144504467|NCT00949975|521045080|FG002|Overall Study|Other|0|||
144504468|NCT00949975|521045081|FG003|Overall Study|Other|0|||
144504469|NCT04347954|521045082|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
144504470|NCT04347954|521045083|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
144504471|NCT04347954|521045084|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
144504472|NCT04347954|521045082|FG000|Overall Study|Lost to Follow-up|0|||
144504473|NCT04347954|521045083|FG001|Overall Study|Lost to Follow-up|1|||
144504474|NCT04347954|521045084|FG002|Overall Study|Lost to Follow-up|0|||
144504475|NCT03257813|521045088|FG000|Overall Study|Protocol Violation|6|||
144504476|NCT03257813|521045089|FG001|Overall Study|Protocol Violation|3|||
144504477|NCT03478696|521045090|FG000|Overall Study|Adverse Event|1|||
144504478|NCT03478696|521045091|FG001|Overall Study|Adverse Event|5|||
144504479|NCT03478696|521045090|FG000|Overall Study|Lost to Follow-up|1|||
144504480|NCT03478696|521045091|FG001|Overall Study|Lost to Follow-up|0|||
144504481|NCT03478696|521045090|FG000|Overall Study|Physician Decision|6|||
144504482|NCT03478696|521045091|FG001|Overall Study|Physician Decision|3|||
144504483|NCT03478696|521045090|FG000|Overall Study|Withdrawal by Subject|9|||
144504484|NCT03478696|521045091|FG001|Overall Study|Withdrawal by Subject|4|||
144504485|NCT00716144|521045092|FG000|Overall Study|Withdrawal by Subject|4|||
144504486|NCT00716144|521045093|FG001|Overall Study|Withdrawal by Subject|2|||
144504487|NCT00716144|521045094|FG002|Overall Study|Withdrawal by Subject|6|||
144504488|NCT00716144|521045095|FG003|Overall Study|Withdrawal by Subject|6|||
144504489|NCT00716144|521045092|FG000|Overall Study|Lost to Follow-up|2|||
144504490|NCT00716144|521045093|FG001|Overall Study|Lost to Follow-up|2|||
144504491|NCT00716144|521045094|FG002|Overall Study|Lost to Follow-up|1|||
144504492|NCT00716144|521045095|FG003|Overall Study|Lost to Follow-up|2|||
144504493|NCT00716144|521045092|FG000|Overall Study|Adverse Event|0|||
144504494|NCT00716144|521045093|FG001|Overall Study|Adverse Event|0|||
144504495|NCT00716144|521045094|FG002|Overall Study|Adverse Event|0|||
144504496|NCT00716144|521045095|FG003|Overall Study|Adverse Event|2|||
144504497|NCT00716144|521045092|FG000|Overall Study|Non-compliance|1|||
144504498|NCT00716144|521045093|FG001|Overall Study|Non-compliance|0|||
144504499|NCT00716144|521045094|FG002|Overall Study|Non-compliance|0|||
144504500|NCT00716144|521045095|FG003|Overall Study|Non-compliance|0|||
144504501|NCT00716144|521045092|FG000|Overall Study|Protocol Violation|2|||
144504502|NCT00716144|521045093|FG001|Overall Study|Protocol Violation|0|||
144504503|NCT00716144|521045094|FG002|Overall Study|Protocol Violation|1|||
144504504|NCT00716144|521045095|FG003|Overall Study|Protocol Violation|0|||
144504505|NCT00716144|521045092|FG000|Overall Study|Physician Decision|0|||
144504506|NCT00716144|521045093|FG001|Overall Study|Physician Decision|1|||
144504507|NCT00716144|521045094|FG002|Overall Study|Physician Decision|2|||
144504508|NCT00716144|521045095|FG003|Overall Study|Physician Decision|2|||
144504509|NCT00716144|521045092|FG000|Overall Study|Intercurrent illness|0|||
144504510|NCT00716144|521045093|FG001|Overall Study|Intercurrent illness|0|||
144504511|NCT00716144|521045094|FG002|Overall Study|Intercurrent illness|1|||
144504512|NCT00716144|521045095|FG003|Overall Study|Intercurrent illness|0|||
144504513|NCT00716144|521045092|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
144504514|NCT00716144|521045093|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
144504515|NCT00716144|521045094|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
144504516|NCT00716144|521045095|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
144504517|NCT00716144|521045092|FG000|Overall Study|Adverse event: left foot pain|0|||
144504518|NCT00716144|521045093|FG001|Overall Study|Adverse event: left foot pain|1|||
144504519|NCT00716144|521045094|FG002|Overall Study|Adverse event: left foot pain|0|||
144504520|NCT00716144|521045095|FG003|Overall Study|Adverse event: left foot pain|0|||
144504521|NCT00716144|521045092|FG000|Overall Study|Clinical Depression|0|||
144504522|NCT00716144|521045093|FG001|Overall Study|Clinical Depression|1|||
144504523|NCT00716144|521045094|FG002|Overall Study|Clinical Depression|0|||
144504524|NCT00716144|521045095|FG003|Overall Study|Clinical Depression|0|||
144504525|NCT00909363|521045096|FG000|Overall Study|Withdrawal by Subject|1|||
144504526|NCT00909363|521045097|FG001|Overall Study|Withdrawal by Subject|0|||
144504527|NCT00909363|521045098|FG002|Overall Study|Withdrawal by Subject|0|||
144504528|NCT00909363|521045096|FG000|Overall Study|Lack of Efficacy|1|||
144504529|NCT00909363|521045097|FG001|Overall Study|Lack of Efficacy|0|||
144504530|NCT00909363|521045098|FG002|Overall Study|Lack of Efficacy|0|||
144504531|NCT02954848|521045108|FG000|Overall Study|Randomized but Not Treated|0|||
144504532|NCT02954848|521045109|FG001|Overall Study|Randomized but Not Treated|1|||
144504533|NCT02954848|521045108|FG000|Overall Study|Adverse Event|2|||
144504534|NCT02954848|521045109|FG001|Overall Study|Adverse Event|3|||
144504535|NCT02954848|521045108|FG000|Overall Study|Withdrawal by Participant|0|||
144504536|NCT02954848|521045109|FG001|Overall Study|Withdrawal by Participant|1|||
144504537|NCT00790790|521045110|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
144504538|NCT00790790|521045111|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
144504539|NCT00790790|521045112|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
144504540|NCT00790790|521045110|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
144504541|NCT00790790|521045111|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
144504542|NCT00790790|521045112|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
144504543|NCT00790790|521045110|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
144504544|NCT00790790|521045111|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
144504545|NCT00790790|521045112|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
144504546|NCT00790790|521045110|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
144504547|NCT00790790|521045111|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
144504548|NCT00790790|521045112|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
144504549|NCT00790790|521045110|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
144504550|NCT00790790|521045111|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
144504551|NCT00790790|521045112|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
144504552|NCT02000817|521045113|FG000|Overall Study|Withdrawal by Subject|2|||
144504553|NCT02000817|521045114|FG001|Overall Study|Withdrawal by Subject|0|||
144504554|NCT02000817|521045115|FG002|Overall Study|Withdrawal by Subject|0|||
144504555|NCT02000817|521045116|FG003|Overall Study|Withdrawal by Subject|0|||
144504556|NCT02000817|521045113|FG000|Overall Study|Adverse Event|0|||
144504557|NCT02000817|521045114|FG001|Overall Study|Adverse Event|1|||
144504558|NCT02000817|521045115|FG002|Overall Study|Adverse Event|0|||
144504559|NCT02000817|521045116|FG003|Overall Study|Adverse Event|0|||
144504560|NCT02000817|521045113|FG000|Overall Study|Lost to Follow-up|0|||
144504561|NCT02000817|521045114|FG001|Overall Study|Lost to Follow-up|0|||
144504562|NCT02000817|521045115|FG002|Overall Study|Lost to Follow-up|1|||
144504563|NCT02000817|521045116|FG003|Overall Study|Lost to Follow-up|0|||
144504564|NCT00756730|521045117|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
144504565|NCT00756730|521045118|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
144504566|NCT00756730|521045117|FG000|Overall Study|persistent low-level viremmia|0|||
144504567|NCT00756730|521045118|FG001|Overall Study|persistent low-level viremmia|1|||
144504568|NCT03383146|521045120|FG000|Overall Study|Screen Failure|1|||
144504569|NCT03383146|521045121|FG001|Overall Study|Screen Failure|0|||
144504570|NCT03383146|521045120|FG000|Overall Study|Adverse Event|6|||
144504571|NCT03383146|521045121|FG001|Overall Study|Adverse Event|18|||
144504572|NCT03383146|521045120|FG000|Overall Study|Lack of Efficacy|0|||
144504573|NCT03383146|521045121|FG001|Overall Study|Lack of Efficacy|3|||
144504574|NCT03383146|521045120|FG000|Overall Study|Withdrawal by Subject|20|||
144504575|NCT03383146|521045121|FG001|Overall Study|Withdrawal by Subject|36|||
144504576|NCT03383146|521045120|FG000|Overall Study|Lost to Follow-up|5|||
144504577|NCT03383146|521045121|FG001|Overall Study|Lost to Follow-up|15|||
144504578|NCT03383146|521045120|FG000|Overall Study|Death|0|||
144504579|NCT03383146|521045121|FG001|Overall Study|Death|2|||
144504580|NCT03383146|521045120|FG000|Overall Study|Physician Decision|0|||
144504581|NCT03383146|521045121|FG001|Overall Study|Physician Decision|1|||
144504582|NCT03383146|521045120|FG000|Overall Study|Protocol Deviation|1|||
144504583|NCT03383146|521045121|FG001|Overall Study|Protocol Deviation|8|||
144504584|NCT03383146|521045120|FG000|Overall Study|Study Terminated by the Sponsor|48|||
144504585|NCT03383146|521045121|FG001|Overall Study|Study Terminated by the Sponsor|95|||
144504586|NCT03383146|521045120|FG000|Overall Study|Reason not Specified|4|||
144504587|NCT03383146|521045121|FG001|Overall Study|Reason not Specified|6|||
144504588|NCT05382104|521045122|FG000|Period 2 (2 Days)|Adverse Event|0|||
144504589|NCT05382104|521045123|FG001|Period 2 (2 Days)|Adverse Event|1|||
144504590|NCT05382104|521045124|FG002|Period 2 (2 Days)|Adverse Event|0|||
144504591|NCT05382104|521045125|FG003|Period 2 (2 Days)|Adverse Event|0|||
144504592|NCT05382104|521045126|FG004|Period 2 (2 Days)|Adverse Event|0|||
144504593|NCT05382104|521045127|FG005|Period 2 (2 Days)|Adverse Event|0|||
144504594|NCT00639002|521045128|FG000|Overall Study|Death|1|||
144504595|NCT00639002|521045128|FG000|Overall Study|Adverse Event|1|||
144504596|NCT00639002|521045128|FG000|Overall Study|Protocol Violation|1|||
144504597|NCT00639002|521045128|FG000|Overall Study|Disease progression|3|||
144504598|NCT00639002|521045128|FG000|Overall Study|Physician Decision|6|||
144504599|NCT00639002|521045128|FG000|Overall Study|Lack of Efficacy|1|||
144504600|NCT01317420|521045134|FG000|Overall Study|Progressive disease according to RECIST|2|||
144504601|NCT01317420|521045135|FG001|Overall Study|Progressive disease according to RECIST|3|||
144504602|NCT01317420|521045136|FG002|Overall Study|Progressive disease according to RECIST|3|||
144504603|NCT01317420|521045137|FG003|Overall Study|Progressive disease according to RECIST|3|||
144504604|NCT01317420|521045138|FG004|Overall Study|Progressive disease according to RECIST|3|||
144504605|NCT01317420|521045139|FG005|Overall Study|Progressive disease according to RECIST|3|||
144504606|NCT01317420|521045140|FG006|Overall Study|Progressive disease according to RECIST|3|||
144504607|NCT01317420|521045141|FG007|Overall Study|Progressive disease according to RECIST|3|||
144504608|NCT01317420|521045142|FG008|Overall Study|Progressive disease according to RECIST|3|||
144504609|NCT01317420|521045143|FG009|Overall Study|Progressive disease according to RECIST|2|||
144504610|NCT01317420|521045144|FG010|Overall Study|Progressive disease according to RECIST|3|||
144504611|NCT01317420|521045145|FG011|Overall Study|Progressive disease according to RECIST|11|||
144504612|NCT01317420|521045146|FG012|Overall Study|Progressive disease according to RECIST|16|||
144504613|NCT01317420|521045134|FG000|Overall Study|Other adverse event|1|||
144504614|NCT01317420|521045135|FG001|Overall Study|Other adverse event|0|||
144504615|NCT01317420|521045136|FG002|Overall Study|Other adverse event|0|||
144504616|NCT01317420|521045137|FG003|Overall Study|Other adverse event|0|||
144504617|NCT01317420|521045138|FG004|Overall Study|Other adverse event|0|||
144504618|NCT01317420|521045139|FG005|Overall Study|Other adverse event|0|||
144504619|NCT01317420|521045140|FG006|Overall Study|Other adverse event|0|||
144504620|NCT01317420|521045141|FG007|Overall Study|Other adverse event|0|||
144504621|NCT01317420|521045142|FG008|Overall Study|Other adverse event|0|||
144504622|NCT01317420|521045143|FG009|Overall Study|Other adverse event|0|||
144504623|NCT01317420|521045144|FG010|Overall Study|Other adverse event|0|||
144504624|NCT01317420|521045145|FG011|Overall Study|Other adverse event|0|||
144504625|NCT01317420|521045146|FG012|Overall Study|Other adverse event|2|||
144504626|NCT01317420|521045134|FG000|Overall Study|Non-compliant with protocol|0|||
144504627|NCT01317420|521045135|FG001|Overall Study|Non-compliant with protocol|0|||
144504628|NCT01317420|521045136|FG002|Overall Study|Non-compliant with protocol|0|||
144504629|NCT01317420|521045137|FG003|Overall Study|Non-compliant with protocol|0|||
144504630|NCT01317420|521045138|FG004|Overall Study|Non-compliant with protocol|0|||
144504631|NCT01317420|521045139|FG005|Overall Study|Non-compliant with protocol|0|||
144504632|NCT01317420|521045140|FG006|Overall Study|Non-compliant with protocol|0|||
144504633|NCT01317420|521045141|FG007|Overall Study|Non-compliant with protocol|0|||
144504634|NCT01317420|521045142|FG008|Overall Study|Non-compliant with protocol|0|||
144504635|NCT01317420|521045143|FG009|Overall Study|Non-compliant with protocol|0|||
144504636|NCT01317420|521045144|FG010|Overall Study|Non-compliant with protocol|0|||
144504637|NCT01317420|521045145|FG011|Overall Study|Non-compliant with protocol|0|||
144504638|NCT01317420|521045146|FG012|Overall Study|Non-compliant with protocol|1|||
144504639|NCT01317420|521045134|FG000|Overall Study|Refused to cont. taking trial medication|0|||
144504640|NCT01317420|521045135|FG001|Overall Study|Refused to cont. taking trial medication|0|||
144504641|NCT01317420|521045136|FG002|Overall Study|Refused to cont. taking trial medication|0|||
144721638|NCT02396381|521835240|FG000|Overall Study|Randomization/Screening Error|3|||
144721639|NCT02396381|521835241|FG001|Overall Study|Randomization/Screening Error|1|||
144721640|NCT00356200|521835243|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
144504642|NCT01317420|521045137|FG003|Overall Study|Refused to cont. taking trial medication|0|||
144504643|NCT01317420|521045138|FG004|Overall Study|Refused to cont. taking trial medication|0|||
144504644|NCT01317420|521045139|FG005|Overall Study|Refused to cont. taking trial medication|0|||
144504645|NCT01317420|521045140|FG006|Overall Study|Refused to cont. taking trial medication|0|||
144504646|NCT01317420|521045141|FG007|Overall Study|Refused to cont. taking trial medication|0|||
144504647|NCT01317420|521045142|FG008|Overall Study|Refused to cont. taking trial medication|0|||
144504648|NCT01317420|521045143|FG009|Overall Study|Refused to cont. taking trial medication|0|||
144504649|NCT01317420|521045144|FG010|Overall Study|Refused to cont. taking trial medication|0|||
144504650|NCT01317420|521045145|FG011|Overall Study|Refused to cont. taking trial medication|0|||
144504651|NCT01317420|521045146|FG012|Overall Study|Refused to cont. taking trial medication|1|||
144504652|NCT01317420|521045134|FG000|Overall Study|Reason other than those specified|0|||
144504653|NCT01317420|521045135|FG001|Overall Study|Reason other than those specified|0|||
144504654|NCT01317420|521045136|FG002|Overall Study|Reason other than those specified|0|||
144504655|NCT01317420|521045137|FG003|Overall Study|Reason other than those specified|0|||
144504656|NCT01317420|521045138|FG004|Overall Study|Reason other than those specified|0|||
144504657|NCT01317420|521045139|FG005|Overall Study|Reason other than those specified|0|||
144504658|NCT01317420|521045140|FG006|Overall Study|Reason other than those specified|0|||
144504659|NCT01317420|521045141|FG007|Overall Study|Reason other than those specified|0|||
144504660|NCT01317420|521045142|FG008|Overall Study|Reason other than those specified|0|||
144504661|NCT01317420|521045143|FG009|Overall Study|Reason other than those specified|1|||
144504662|NCT01317420|521045144|FG010|Overall Study|Reason other than those specified|0|||
144504663|NCT01317420|521045145|FG011|Overall Study|Reason other than those specified|0|||
144504664|NCT01317420|521045146|FG012|Overall Study|Reason other than those specified|0|||
144504665|NCT05686421|521045147|FG000|Overall Study|Screen failure|22|||
144504666|NCT05686421|521045148|FG001|Overall Study|Screen failure|0|||
144504667|NCT05686421|521045149|FG002|Overall Study|Screen failure|0|||
144504668|NCT05686421|521045150|FG003|Overall Study|Screen failure|0|||
144504669|NCT05082025|521045151|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
144504670|NCT00857649|521045152|FG000|Overall Study|Adverse Event|15|||
144504671|NCT00857649|521045153|FG001|Overall Study|Adverse Event|10|||
144504672|NCT00857649|521045152|FG000|Overall Study|Non-compliance|1|||
144504673|NCT00857649|521045153|FG001|Overall Study|Non-compliance|1|||
144504674|NCT00857649|521045152|FG000|Overall Study|Protocol Violation|2|||
144504675|NCT00857649|521045153|FG001|Overall Study|Protocol Violation|2|||
144504676|NCT00857649|521045152|FG000|Overall Study|Withdrawal of Consent|10|||
144504677|NCT00857649|521045153|FG001|Overall Study|Withdrawal of Consent|7|||
144504678|NCT00857649|521045152|FG000|Overall Study|Nursing Home Placement|2|||
144504679|NCT00857649|521045153|FG001|Overall Study|Nursing Home Placement|9|||
144504680|NCT00857649|521045152|FG000|Overall Study|Other Reasons|1|||
144504681|NCT00857649|521045153|FG001|Overall Study|Other Reasons|3|||
144504682|NCT05190419|521045154|FG000|Overall Study|Lack of Efficacy|8|||
144504683|NCT05190419|521045155|FG001|Overall Study|Lack of Efficacy|0|||
144504684|NCT05190419|521045156|FG002|Overall Study|Lack of Efficacy|1|||
144504685|NCT05190419|521045157|FG003|Overall Study|Lack of Efficacy|0|||
144504686|NCT05190419|521045154|FG000|Overall Study|Withdrawal by Subject|7|||
144504687|NCT05190419|521045155|FG001|Overall Study|Withdrawal by Subject|1|||
144504688|NCT05190419|521045156|FG002|Overall Study|Withdrawal by Subject|2|||
144504689|NCT05190419|521045157|FG003|Overall Study|Withdrawal by Subject|2|||
144504690|NCT05190419|521045154|FG000|Overall Study|Adverse Event|2|||
144504691|NCT05190419|521045155|FG001|Overall Study|Adverse Event|10|||
144504692|NCT05190419|521045156|FG002|Overall Study|Adverse Event|11|||
144504693|NCT05190419|521045157|FG003|Overall Study|Adverse Event|21|||
144504694|NCT05190419|521045154|FG000|Overall Study|Lost to Follow-up|1|||
144504695|NCT05190419|521045155|FG001|Overall Study|Lost to Follow-up|2|||
144504696|NCT05190419|521045156|FG002|Overall Study|Lost to Follow-up|3|||
144504697|NCT05190419|521045157|FG003|Overall Study|Lost to Follow-up|1|||
144504698|NCT05190419|521045154|FG000|Overall Study|Other|1|||
144504699|NCT05190419|521045155|FG001|Overall Study|Other|1|||
144504700|NCT05190419|521045156|FG002|Overall Study|Other|0|||
144504701|NCT05190419|521045157|FG003|Overall Study|Other|3|||
144504702|NCT03586544|521045172|FG000|First Intervention|Adverse Event|0|||
144504703|NCT03586544|521045173|FG001|First Intervention|Adverse Event|1|||
144504704|NCT03586544|521045172|FG000|Second Intervention|Withdrawal by Subject|0|||
144504705|NCT03586544|521045173|FG001|Second Intervention|Withdrawal by Subject|1|||
144504706|NCT03863834|521045174|FG000|Overall Study|Lost to Follow-up|3|||
144504707|NCT05328297|521047354|FG000|Overall Study|Adverse Event|5|||
144504708|NCT05328297|521047355|FG001|Overall Study|Adverse Event|7|||
144721641|NCT00356200|521835244|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
144504709|NCT05328297|521047354|FG000|Overall Study|Withdrawal by Subject|4|||
144504710|NCT05328297|521047355|FG001|Overall Study|Withdrawal by Subject|3|||
144504711|NCT05328297|521047354|FG000|Overall Study|Lack of Efficacy|1|||
144504712|NCT05328297|521047355|FG001|Overall Study|Lack of Efficacy|0|||
144504713|NCT05328297|521047354|FG000|Overall Study|Lost to Follow-up|1|||
144504714|NCT05328297|521047355|FG001|Overall Study|Lost to Follow-up|0|||
144504715|NCT05328297|521047354|FG000|Overall Study|Protocol Violation|1|||
144504716|NCT05328297|521047355|FG001|Overall Study|Protocol Violation|0|||
144504717|NCT05328297|521047354|FG000|Overall Study|Randomized but not treated|1|||
144504718|NCT05328297|521047355|FG001|Overall Study|Randomized but not treated|1|||
144504719|NCT04513522|521047356|FG000|Overall Study|Other reasons|1|||
144504720|NCT04513522|521047356|FG000|Overall Study|Adverse event unrelated to study drug|9|||
144504721|NCT04513522|521047356|FG000|Overall Study|Study drug toxicity|14|||
144504722|NCT04513522|521047356|FG000|Overall Study|Disease progression|39|||
144504723|NCT04513522|521047356|FG000|Overall Study|Participants withdrew consent|2|||
144504724|NCT00178399|521047362|FG000|Overall Study|Physician Decision|4|||
144504725|NCT00178399|521047362|FG000|Overall Study|Withdrawal by Subject|8|||
144504726|NCT00178399|521047362|FG000|Overall Study|Lost to Follow-up|1|||
144504727|NCT01134562|521047365|FG000|Overall Study|Adverse Event|0|||
144504728|NCT01134562|521047366|FG001|Overall Study|Adverse Event|1|||
144504729|NCT01134562|521047367|FG002|Overall Study|Adverse Event|0|||
144504730|NCT01134562|521047368|FG003|Overall Study|Adverse Event|0|||
144504731|NCT01134562|521047369|FG004|Overall Study|Adverse Event|0|||
144504732|NCT00768664|521047370|FG000|Overall Study|Death|57|||
144504733|NCT00768664|521047370|FG000|Overall Study|Lost to Follow-up|2|||
144504734|NCT00768664|521047370|FG000|Overall Study|Other|9|||
144504735|NCT00768664|521047370|FG000|Overall Study|Participant refused|1|||
144504736|NCT00708032|521047373|FG000|Overall Study|Adverse Event|0|||
144504737|NCT00708032|521047374|FG001|Overall Study|Adverse Event|2|||
144504738|NCT00708032|521047373|FG000|Overall Study|Lost to Follow-up|1|||
144504739|NCT00708032|521047374|FG001|Overall Study|Lost to Follow-up|2|||
144504740|NCT00708032|521047373|FG000|Overall Study|Pregnancy|0|||
144504741|NCT00708032|521047374|FG001|Overall Study|Pregnancy|1|||
144504742|NCT00708032|521047373|FG000|Overall Study|Poor vision|0|||
144504743|NCT00708032|521047374|FG001|Overall Study|Poor vision|6|||
144504744|NCT00708032|521047373|FG000|Overall Study|Visit out of range at month 12|4|||
144504745|NCT00708032|521047374|FG001|Overall Study|Visit out of range at month 12|1|||
144504746|NCT00708032|521047373|FG000|Overall Study|Did not meet protocol criteria|1|||
144504747|NCT00708032|521047374|FG001|Overall Study|Did not meet protocol criteria|2|||
144504748|NCT00708032|521047373|FG000|Overall Study|Protocol Violation|4|||
144504749|NCT00708032|521047374|FG001|Overall Study|Protocol Violation|1|||
144504750|NCT00708032|521047373|FG000|Overall Study|Withdrawal by Subject|0|||
144504751|NCT00708032|521047374|FG001|Overall Study|Withdrawal by Subject|1|||
144504752|NCT00941655|521047383|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
144504753|NCT00941655|521047384|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
144504754|NCT00941655|521047383|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
144504755|NCT00941655|521047384|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
144504756|NCT00941655|521047383|FG000|Overall Study|progressed while on chemo|0|||
144504757|NCT00941655|521047384|FG001|Overall Study|progressed while on chemo|2|||
144504758|NCT00941655|521047383|FG000|Overall Study|refused further treatment|0|||
144504759|NCT00941655|521047384|FG001|Overall Study|refused further treatment|1|||
144504760|NCT00941655|521047383|FG000|Overall Study|withdrew consent|0|||
144504761|NCT00941655|521047384|FG001|Overall Study|withdrew consent|1|||
144504762|NCT00941655|521047383|FG000|Overall Study|non-compliant|0|||
144504763|NCT00941655|521047384|FG001|Overall Study|non-compliant|1|||
144504764|NCT02477670|521047385|FG000|Stage 1|Adverse Event|2|||
144504765|NCT02477670|521047386|FG001|Stage 1|Adverse Event|7|||
144504766|NCT02477670|521047387|FG002|Stage 1|Adverse Event|0|||
144504767|NCT02477670|521047388|FG003|Stage 1|Adverse Event|0|||
144504768|NCT02477670|521047389|FG004|Stage 1|Adverse Event|0|||
144504769|NCT02477670|521047390|FG005|Stage 1|Adverse Event|0|||
144504770|NCT02477670|521047391|FG006|Stage 1|Adverse Event|0|||
144504771|NCT02477670|521047385|FG000|Stage 1|Lost to Follow-up|0|||
144504772|NCT02477670|521047386|FG001|Stage 1|Lost to Follow-up|2|||
144504773|NCT02477670|521047387|FG002|Stage 1|Lost to Follow-up|0|||
144504774|NCT02477670|521047388|FG003|Stage 1|Lost to Follow-up|0|||
144504775|NCT02477670|521047389|FG004|Stage 1|Lost to Follow-up|0|||
144504776|NCT02477670|521047390|FG005|Stage 1|Lost to Follow-up|0|||
144504777|NCT02477670|521047391|FG006|Stage 1|Lost to Follow-up|0|||
144504778|NCT02477670|521047385|FG000|Stage 1|Withdrawal by Subject|1|||
144504779|NCT02477670|521047386|FG001|Stage 1|Withdrawal by Subject|2|||
144504780|NCT02477670|521047387|FG002|Stage 1|Withdrawal by Subject|0|||
144504781|NCT02477670|521047388|FG003|Stage 1|Withdrawal by Subject|0|||
144504782|NCT02477670|521047389|FG004|Stage 1|Withdrawal by Subject|0|||
144504783|NCT02477670|521047390|FG005|Stage 1|Withdrawal by Subject|0|||
144504784|NCT02477670|521047391|FG006|Stage 1|Withdrawal by Subject|0|||
144504785|NCT02477670|521047385|FG000|Stage 1|Non-compliance with Study Drug|1|||
144504786|NCT02477670|521047386|FG001|Stage 1|Non-compliance with Study Drug|2|||
144504787|NCT02477670|521047387|FG002|Stage 1|Non-compliance with Study Drug|0|||
144504788|NCT02477670|521047388|FG003|Stage 1|Non-compliance with Study Drug|0|||
144504789|NCT02477670|521047389|FG004|Stage 1|Non-compliance with Study Drug|0|||
144504790|NCT02477670|521047390|FG005|Stage 1|Non-compliance with Study Drug|0|||
144504791|NCT02477670|521047391|FG006|Stage 1|Non-compliance with Study Drug|0|||
144504792|NCT02477670|521047385|FG000|Stage 2|Adverse Event|0|||
144504793|NCT02477670|521047386|FG001|Stage 2|Adverse Event|0|||
144504794|NCT02477670|521047387|FG002|Stage 2|Adverse Event|1|||
144504795|NCT02477670|521047388|FG003|Stage 2|Adverse Event|0|||
144504796|NCT02477670|521047389|FG004|Stage 2|Adverse Event|0|||
144504797|NCT02477670|521047390|FG005|Stage 2|Adverse Event|0|||
144504798|NCT02477670|521047391|FG006|Stage 2|Adverse Event|0|||
144504799|NCT02477670|521047385|FG000|Stage 2|Antipsychotic Medication Changed|0|||
144504800|NCT02477670|521047386|FG001|Stage 2|Antipsychotic Medication Changed|0|||
144504801|NCT02477670|521047387|FG002|Stage 2|Antipsychotic Medication Changed|1|||
144504802|NCT02477670|521047388|FG003|Stage 2|Antipsychotic Medication Changed|0|||
144504803|NCT02477670|521047389|FG004|Stage 2|Antipsychotic Medication Changed|0|||
144504804|NCT02477670|521047390|FG005|Stage 2|Antipsychotic Medication Changed|0|||
144504805|NCT02477670|521047391|FG006|Stage 2|Antipsychotic Medication Changed|0|||
144504806|NCT02477670|521047385|FG000|Stage 2|Withdrawal by Subject|0|||
144504807|NCT02477670|521047386|FG001|Stage 2|Withdrawal by Subject|0|||
144504808|NCT02477670|521047387|FG002|Stage 2|Withdrawal by Subject|0|||
144504809|NCT02477670|521047388|FG003|Stage 2|Withdrawal by Subject|1|||
144504810|NCT02477670|521047389|FG004|Stage 2|Withdrawal by Subject|0|||
144504811|NCT02477670|521047390|FG005|Stage 2|Withdrawal by Subject|0|||
144504812|NCT02477670|521047391|FG006|Stage 2|Withdrawal by Subject|0|||
144504813|NCT00004124|521047396|FG000|Overall Study|Received no protocol therapy|12|||
144504814|NCT00004124|521047397|FG001|Overall Study|Received no protocol therapy|20|||
144370158|NCT04988477|520562834|FG002|Overall Study|Withdrawal by Subject|0|||
144370159|NCT01987453|520564031|FG000|Overall Study|Death|0|||
144370160|NCT01987453|520564032|FG001|Overall Study|Death|0|||
144370161|NCT01987453|520564033|FG002|Overall Study|Death|1|||
144370162|NCT01987453|520564031|FG000|Overall Study|Lack of Efficacy|1|||
144370163|NCT01987453|520564032|FG001|Overall Study|Lack of Efficacy|12|||
144370164|NCT01987453|520564033|FG002|Overall Study|Lack of Efficacy|0|||
144370165|NCT02105662|520564034|FG000|Overall Study|Lost to Follow-up|5|||
144370166|NCT02105662|520564034|FG000|Overall Study|Withdrawal by Subject|1|||
144370167|NCT01399372|520564035|FG000|Overall Study|Protocol Violation|3|||
144370168|NCT01399372|520564036|FG001|Overall Study|Protocol Violation|1|||
144370169|NCT01071798|520564037|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
144370170|NCT01071798|520564037|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
144370171|NCT01071798|520564037|FG000|Participants Who Received One Cycle|Patient requirement|20|||
144370172|NCT01071798|520564037|FG000|Participants Who Received One Cycle|Death|5|||
144370173|NCT01071798|520564037|FG000|Participants Who Received One Cycle|Change of therapy|6|||
144370174|NCT01071798|520564037|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
144370175|NCT01071798|520564037|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
144370176|NCT01071798|520564037|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
144370177|NCT01071798|520564037|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
144370178|NCT01071798|520564037|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
144370179|NCT01705509|520564040|FG000|Inclusion CPET|Screen Failure|5|||
144370180|NCT01705509|520564040|FG000|Inclusion CPET|Withdrawal by Subject|2|||
144370181|NCT01705509|520564040|FG000|CPET w/ Ranexa|Screen Failure|2|||
144370182|NCT02736890|520564041|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
144370183|NCT02736890|520564042|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
144370184|NCT02736890|520564041|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
144370185|NCT02736890|520564042|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
144370186|NCT02904954|520564043|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
144370187|NCT02904954|520564044|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
144370188|NCT02904954|520564043|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
144504815|NCT02698891|521047402|FG000|Overall Study|Withdrawal by Subject|2|||
144370189|NCT02904954|520564044|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
144504816|NCT02698891|521047402|FG000|Overall Study|deemed ineligible|1|||
144504817|NCT02698891|521047402|FG000|Overall Study|Adverse Event|9|||
144504818|NCT00516386|521047403|FG000|Overall Study|not interested in the study|4|||
144504819|NCT00516386|521047403|FG000|Overall Study|Lost to Follow-up|2|||
144504820|NCT00114244|521047404|FG000|Overall Study|Adverse Event|2|||
144504821|NCT00114244|521047405|FG001|Overall Study|Adverse Event|5|||
144504822|NCT00114244|521047404|FG000|Overall Study|Withdrawal by Subject|0|||
144504823|NCT00114244|521047405|FG001|Overall Study|Withdrawal by Subject|2|||
144504824|NCT01111526|521047406|FG000|Overall Study|GVHD Disease Progression|0|||
144504825|NCT01111526|521047407|FG001|Overall Study|GVHD Disease Progression|1|||
144504826|NCT01111526|521047408|FG002|Overall Study|GVHD Disease Progression|2|||
144504827|NCT04424641|521047413|FG000|Overall Study|Death|1|||
144504828|NCT04424641|521047414|FG001|Overall Study|Death|2|||
144504829|NCT04424641|521047415|FG002|Overall Study|Death|3|||
144504830|NCT04424641|521047416|FG003|Overall Study|Death|0|||
144504831|NCT04424641|521047417|FG004|Overall Study|Death|3|||
144504832|NCT04424641|521047418|FG005|Overall Study|Death|0|||
144504833|NCT04424641|521047419|FG006|Overall Study|Death|1|||
144504834|NCT04424641|521047420|FG007|Overall Study|Death|2|||
144504835|NCT04424641|521047413|FG000|Overall Study|Sponsor decision|0|||
144504836|NCT04424641|521047414|FG001|Overall Study|Sponsor decision|2|||
144504837|NCT04424641|521047415|FG002|Overall Study|Sponsor decision|3|||
144504838|NCT04424641|521047416|FG003|Overall Study|Sponsor decision|7|||
144504839|NCT04424641|521047417|FG004|Overall Study|Sponsor decision|2|||
144504840|NCT04424641|521047418|FG005|Overall Study|Sponsor decision|2|||
144504841|NCT04424641|521047419|FG006|Overall Study|Sponsor decision|3|||
144504842|NCT04424641|521047420|FG007|Overall Study|Sponsor decision|4|||
144504843|NCT04424641|521047413|FG000|Overall Study|Withdrawal by Subject|0|||
144504844|NCT04424641|521047414|FG001|Overall Study|Withdrawal by Subject|0|||
144504845|NCT04424641|521047415|FG002|Overall Study|Withdrawal by Subject|0|||
144504846|NCT04424641|521047416|FG003|Overall Study|Withdrawal by Subject|0|||
144504847|NCT04424641|521047417|FG004|Overall Study|Withdrawal by Subject|1|||
144504848|NCT04424641|521047418|FG005|Overall Study|Withdrawal by Subject|0|||
144504849|NCT04424641|521047419|FG006|Overall Study|Withdrawal by Subject|0|||
144504850|NCT04424641|521047420|FG007|Overall Study|Withdrawal by Subject|0|||
144504851|NCT04424641|521047413|FG000|Overall Study|Other|0|||
144504852|NCT04424641|521047414|FG001|Overall Study|Other|0|||
144504853|NCT04424641|521047415|FG002|Overall Study|Other|1|||
144504854|NCT04424641|521047416|FG003|Overall Study|Other|0|||
144504855|NCT04424641|521047417|FG004|Overall Study|Other|0|||
144504856|NCT04424641|521047418|FG005|Overall Study|Other|0|||
144504857|NCT04424641|521047419|FG006|Overall Study|Other|0|||
144504858|NCT04424641|521047420|FG007|Overall Study|Other|0|||
144504859|NCT02694978|521047427|FG000|Overall Study|Adverse Event|10|||
144504860|NCT02694978|521047428|FG001|Overall Study|Adverse Event|9|||
144504861|NCT02694978|521047427|FG000|Overall Study|Withdrawal by Subject|22|||
144504862|NCT02694978|521047428|FG001|Overall Study|Withdrawal by Subject|19|||
144504863|NCT02694978|521047427|FG000|Overall Study|Lost to Follow-up|14|||
144504864|NCT02694978|521047428|FG001|Overall Study|Lost to Follow-up|17|||
144504865|NCT02694978|521047427|FG000|Overall Study|Death|4|||
144504866|NCT02694978|521047428|FG001|Overall Study|Death|1|||
144504867|NCT02694978|521047427|FG000|Overall Study|Other-Decision of Participant|6|||
144504868|NCT02694978|521047428|FG001|Overall Study|Other-Decision of Participant|1|||
144504869|NCT02694978|521047427|FG000|Overall Study|Other-Investigator's decision|1|||
144504870|NCT02694978|521047428|FG001|Overall Study|Other-Investigator's decision|0|||
144504871|NCT02694978|521047427|FG000|Overall Study|Other-Unable to be reached|0|||
144504872|NCT02694978|521047428|FG001|Overall Study|Other-Unable to be reached|1|||
144504873|NCT02694978|521047427|FG000|Overall Study|Other-Protocol noncompliant|2|||
144504874|NCT02694978|521047428|FG001|Overall Study|Other-Protocol noncompliant|1|||
144504875|NCT02694978|521047427|FG000|Overall Study|Other-Personal reasons|3|||
144504876|NCT02694978|521047428|FG001|Overall Study|Other-Personal reasons|3|||
144504877|NCT02694978|521047427|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
144504878|NCT02694978|521047428|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
144504879|NCT01613716|521047429|FG000|Overall Study|screen failures|3|||
144504880|NCT01613716|521047429|FG000|Overall Study|Lost to Follow-up|4|||
144504881|NCT01171625|521047431|FG000|Overall Study|On-Protocol|67|||
144504882|NCT01171625|521047431|FG000|Overall Study|Death|38|||
144504883|NCT01171625|521047431|FG000|Overall Study|Withdrawal by Subject|31|||
144504884|NCT01171625|521047431|FG000|Overall Study|Explanted|10|||
144504885|NCT01171625|521047431|FG000|Overall Study|Lost to Follow-up|5|||
144504886|NCT01171625|521047431|FG000|Overall Study|Patient received valve-in-valve|3|||
144504887|NCT01171625|521047431|FG000|Overall Study|Other|1|||
144504888|NCT01171625|521047431|FG000|Overall Study|Consented but did not receive device|25|||
144504889|NCT03262935|521047432|FG000|Overall Study|Withdrawal by Subject|6|||
144504890|NCT03262935|521047433|FG001|Overall Study|Withdrawal by Subject|7|||
144504891|NCT03262935|521047432|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
144504892|NCT03262935|521047433|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
144504893|NCT03262935|521047432|FG000|Overall Study|Death|181|||
144504894|NCT03262935|521047433|FG001|Overall Study|Death|94|||
144504895|NCT03262935|521047432|FG000|Overall Study|Lost to Follow-up|9|||
144504896|NCT03262935|521047433|FG001|Overall Study|Lost to Follow-up|4|||
144504897|NCT03262935|521047432|FG000|Overall Study|Other reason|5|||
144504898|NCT03262935|521047433|FG001|Overall Study|Other reason|0|||
144504899|NCT00743444|521047434|FG000|First Intervention|Catheter placement problems|0|||
144504900|NCT00743444|521047435|FG001|First Intervention|Catheter placement problems|1|||
144504901|NCT00743444|521047434|FG000|Washout Period|Adverse Event|0|||
144504902|NCT00743444|521047435|FG001|Washout Period|Adverse Event|1|||
144504903|NCT02567656|521047438|FG000|Overall Study|Premature discontinuation due to PD|1|||
144504904|NCT02567656|521047439|FG001|Overall Study|Premature discontinuation due to PD|1|||
144504905|NCT02567656|521047440|FG002|Overall Study|Premature discontinuation due to PD|2|||
144504906|NCT02567656|521047441|FG003|Overall Study|Premature discontinuation due to PD|0|||
144504907|NCT02567656|521047442|FG004|Overall Study|Premature discontinuation due to PD|0|||
144504908|NCT02567656|521047443|FG005|Overall Study|Premature discontinuation due to PD|0|||
144504909|NCT03287622|521047444|FG000|Overall Study|Withdrawal by Subject|1|||
144504910|NCT03287622|521047445|FG001|Overall Study|Withdrawal by Subject|0|||
144504911|NCT03287622|521047444|FG000|Overall Study|Lost to Follow-up|27|||
144504912|NCT03287622|521047445|FG001|Overall Study|Lost to Follow-up|15|||
144504913|NCT03287622|521047444|FG000|Overall Study|No prescripion after surgery|28|||
144504914|NCT03287622|521047445|FG001|Overall Study|No prescripion after surgery|31|||
144504915|NCT03287622|521047444|FG000|Overall Study|prolonged Length of stay|2|||
144504916|NCT03287622|521047445|FG001|Overall Study|prolonged Length of stay|0|||
144504917|NCT03287622|521047444|FG000|Overall Study|surgery related|0|||
144504918|NCT03287622|521047445|FG001|Overall Study|surgery related|2|||
144504919|NCT03622580|521047446|FG000|Overall Study|Death|16|||
144504920|NCT03622580|521047447|FG001|Overall Study|Death|21|||
144504921|NCT03622580|521047448|FG002|Overall Study|Death|13|||
144504922|NCT03622580|521047446|FG000|Overall Study|Adverse Event|6|||
144504923|NCT03622580|521047447|FG001|Overall Study|Adverse Event|6|||
144504924|NCT03622580|521047448|FG002|Overall Study|Adverse Event|5|||
144504925|NCT03622580|521047446|FG000|Overall Study|Withdrawal by Subject|12|||
144504926|NCT03622580|521047447|FG001|Overall Study|Withdrawal by Subject|7|||
144504927|NCT03622580|521047448|FG002|Overall Study|Withdrawal by Subject|19|||
144504928|NCT03622580|521047446|FG000|Overall Study|Lost to Follow-up|12|||
144504929|NCT03622580|521047447|FG001|Overall Study|Lost to Follow-up|9|||
144504930|NCT03622580|521047448|FG002|Overall Study|Lost to Follow-up|9|||
144504931|NCT03622580|521047446|FG000|Overall Study|Protocol Violation|1|||
144504932|NCT03622580|521047447|FG001|Overall Study|Protocol Violation|0|||
144504933|NCT03622580|521047448|FG002|Overall Study|Protocol Violation|1|||
144504934|NCT03622580|521047446|FG000|Overall Study|Physician Decision|3|||
144504935|NCT03622580|521047447|FG001|Overall Study|Physician Decision|0|||
144504936|NCT03622580|521047448|FG002|Overall Study|Physician Decision|1|||
144504937|NCT03622580|521047446|FG000|Overall Study|Pregnancy|0|||
144504938|NCT03622580|521047447|FG001|Overall Study|Pregnancy|1|||
144504939|NCT03622580|521047448|FG002|Overall Study|Pregnancy|0|||
144504940|NCT03622580|521047446|FG000|Overall Study|Lack of Efficacy|0|||
144504941|NCT03622580|521047447|FG001|Overall Study|Lack of Efficacy|0|||
144504942|NCT03622580|521047448|FG002|Overall Study|Lack of Efficacy|1|||
144504943|NCT03622580|521047446|FG000|Overall Study|Other|2|||
144504944|NCT03622580|521047447|FG001|Overall Study|Other|0|||
144504945|NCT03622580|521047448|FG002|Overall Study|Other|3|||
144504946|NCT01930045|521047451|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
144504947|NCT01930045|521047452|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
144504948|NCT01930045|521047453|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
144504949|NCT01930045|521047454|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
144504950|NCT01930045|521047455|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
144504951|NCT01930045|521047456|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
144504952|NCT01930045|521047451|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
144504953|NCT01930045|521047452|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
144504954|NCT01930045|521047453|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
144504955|NCT01930045|521047454|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
144504956|NCT01930045|521047455|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
144504957|NCT01930045|521047456|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
144504958|NCT00395018|521047459|FG000|On-Treatment|Death|4|||
144504959|NCT00395018|521047459|FG000|On-Treatment|Other Reason|2|||
144504960|NCT00395018|521047459|FG000|On-Treatment|Poor/non-compliance|2|||
144504961|NCT00395018|521047459|FG000|On-Treatment|Subject no longer meets study criteria|2|||
144504962|NCT00395018|521047459|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
144504963|NCT00395018|521047459|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
144504964|NCT00395018|521047459|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
144504965|NCT04439799|521047460|FG000|Overall Study|Lost to Follow-up|6|||
144504966|NCT04439799|521047461|FG001|Overall Study|Lost to Follow-up|6|||
144504967|NCT04439799|521047460|FG000|Overall Study|Withdrawal by Subject|2|||
144504968|NCT04439799|521047461|FG001|Overall Study|Withdrawal by Subject|6|||
144504969|NCT04439799|521047460|FG000|Overall Study|Adverse Event|2|||
144504970|NCT04439799|521047461|FG001|Overall Study|Adverse Event|5|||
144504971|NCT01802632|521047462|FG000|Overall Study|Death|28|||
144504972|NCT01802632|521047463|FG001|Overall Study|Death|1|||
144504973|NCT01802632|521047464|FG002|Overall Study|Death|38|||
144504974|NCT01802632|521047465|FG003|Overall Study|Death|0|||
144504975|NCT01802632|521047466|FG004|Overall Study|Death|2|||
144504976|NCT01802632|521047467|FG005|Overall Study|Death|0|||
144504977|NCT01802632|521047462|FG000|Overall Study|Withdrawal by Subject|4|||
144504978|NCT01802632|521047463|FG001|Overall Study|Withdrawal by Subject|2|||
144504979|NCT01802632|521047464|FG002|Overall Study|Withdrawal by Subject|7|||
144504980|NCT01802632|521047465|FG003|Overall Study|Withdrawal by Subject|3|||
144504981|NCT01802632|521047466|FG004|Overall Study|Withdrawal by Subject|0|||
144504982|NCT01802632|521047467|FG005|Overall Study|Withdrawal by Subject|1|||
144504983|NCT01802632|521047462|FG000|Overall Study|Objective Disease Progression|1|||
144504984|NCT01802632|521047463|FG001|Overall Study|Objective Disease Progression|12|||
144504985|NCT01802632|521047464|FG002|Overall Study|Objective Disease Progression|104|||
144504986|NCT01802632|521047465|FG003|Overall Study|Objective Disease Progression|6|||
144504987|NCT01802632|521047466|FG004|Overall Study|Objective Disease Progression|4|||
144504988|NCT01802632|521047467|FG005|Overall Study|Objective Disease Progression|4|||
144504989|NCT01802632|521047462|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
144504990|NCT01802632|521047463|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
144504991|NCT01802632|521047464|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
144504992|NCT01802632|521047465|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
144504993|NCT01802632|521047466|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
144504994|NCT01802632|521047467|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
144504995|NCT01802632|521047462|FG000|Overall Study|Other (not specified)|0|||
144504996|NCT01802632|521047463|FG001|Overall Study|Other (not specified)|0|||
144504997|NCT01802632|521047464|FG002|Overall Study|Other (not specified)|7|||
144504998|NCT01802632|521047465|FG003|Overall Study|Other (not specified)|1|||
144504999|NCT01802632|521047466|FG004|Overall Study|Other (not specified)|0|||
144505000|NCT01802632|521047467|FG005|Overall Study|Other (not specified)|1|||
144505001|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
144505002|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
144505003|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
144505004|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
144505005|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
144505006|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
144505007|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
144505008|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
144505009|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
144505010|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
144505011|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
144505012|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
144505013|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
144505014|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
144505015|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
144505016|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505017|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505018|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
144505019|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505020|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505021|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505022|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505023|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505024|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505025|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505026|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
144505027|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
144505028|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
144505029|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
144505030|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
144505031|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
144505032|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
144505033|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
144505034|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
144505035|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
144505036|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
144505037|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
144505038|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
144505039|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
144505040|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505041|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
144505042|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
144505043|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505044|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
144505045|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505046|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505047|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505048|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505049|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505050|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505051|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505052|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
144505053|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
144505054|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
144505055|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
144505056|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
144505057|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
144505058|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505059|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505060|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505061|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
144505062|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505063|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505064|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505065|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
144505066|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
144505067|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505068|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505069|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505070|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505071|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
144505072|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
144505073|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
144505074|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505075|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505076|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505077|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505078|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
144505079|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
144505080|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
144505081|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
144505082|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
144505083|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
144505084|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
144505085|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
144505086|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
144505087|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
144505088|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
144505089|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
144505090|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
144505091|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
144505092|NCT04707313|521047469|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505093|NCT04707313|521047470|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505094|NCT04707313|521047471|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
144505095|NCT04707313|521047472|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505096|NCT04707313|521047473|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505097|NCT04707313|521047474|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505098|NCT04707313|521047475|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505099|NCT04707313|521047476|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
144505100|NCT04707313|521047477|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505101|NCT04707313|521047478|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505102|NCT04707313|521047479|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505103|NCT04707313|521047480|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505104|NCT04707313|521047481|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
144505105|NCT04707313|521047469|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505106|NCT04707313|521047470|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505107|NCT04707313|521047471|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505108|NCT04707313|521047472|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505109|NCT04707313|521047473|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505110|NCT04707313|521047474|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505111|NCT04707313|521047475|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505112|NCT04707313|521047476|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505113|NCT04707313|521047477|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505114|NCT04707313|521047478|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
144505115|NCT04707313|521047479|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
144505116|NCT04707313|521047480|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
144505117|NCT04707313|521047481|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
144505118|NCT04707313|521047469|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505119|NCT04707313|521047470|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505120|NCT04707313|521047471|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505121|NCT04707313|521047472|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505122|NCT04707313|521047473|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505123|NCT04707313|521047474|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505124|NCT04707313|521047475|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505125|NCT04707313|521047476|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505126|NCT04707313|521047477|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505127|NCT04707313|521047478|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
144505128|NCT04707313|521047479|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
144505129|NCT04707313|521047480|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
144505130|NCT04707313|521047481|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
144505131|NCT04707313|521047469|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505132|NCT04707313|521047470|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505133|NCT04707313|521047471|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505134|NCT04707313|521047472|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505135|NCT04707313|521047473|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505136|NCT04707313|521047474|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505137|NCT04707313|521047475|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505138|NCT04707313|521047476|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505139|NCT04707313|521047477|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
144505140|NCT04707313|521047478|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
144505141|NCT04707313|521047479|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
144505142|NCT04707313|521047480|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
144505143|NCT04707313|521047481|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
144505144|NCT04707313|521047469|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505145|NCT04707313|521047470|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505146|NCT04707313|521047471|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505147|NCT04707313|521047472|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505148|NCT04707313|521047473|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505149|NCT04707313|521047474|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505150|NCT04707313|521047475|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505151|NCT04707313|521047476|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505152|NCT04707313|521047477|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505153|NCT04707313|521047478|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505154|NCT04707313|521047479|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
144505155|NCT04707313|521047480|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
144505156|NCT04707313|521047481|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
144505157|NCT04707313|521047469|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505158|NCT04707313|521047470|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505159|NCT04707313|521047471|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505160|NCT04707313|521047472|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505161|NCT04707313|521047473|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505162|NCT04707313|521047474|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505163|NCT04707313|521047475|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505164|NCT04707313|521047476|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505165|NCT04707313|521047477|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505166|NCT04707313|521047478|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
144370190|NCT02904954|520564043|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
144370191|NCT02904954|520564044|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
144370192|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Recurrence|2|||
144370193|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Recurrence|0|||
144505167|NCT04707313|521047479|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
144505168|NCT04707313|521047480|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505169|NCT04707313|521047481|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
144505170|NCT04707313|521047469|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505171|NCT04707313|521047470|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505172|NCT04707313|521047471|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505173|NCT04707313|521047472|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505174|NCT04707313|521047473|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505175|NCT04707313|521047474|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505176|NCT04707313|521047475|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505177|NCT04707313|521047476|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505178|NCT04707313|521047477|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
144505179|NCT04707313|521047478|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
144505180|NCT04707313|521047479|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
144505181|NCT04707313|521047480|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
144505182|NCT04707313|521047481|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
144505183|NCT02459899|521047482|FG000|Overall Study|Adverse Event|1|||
144505184|NCT02459899|521047483|FG001|Overall Study|Adverse Event|1|||
144505185|NCT02459899|521047484|FG002|Overall Study|Adverse Event|0|||
144505186|NCT02459899|521047485|FG003|Overall Study|Adverse Event|0|||
144505187|NCT02459899|521047482|FG000|Overall Study|Lost to Follow-up|1|||
144505188|NCT02459899|521047483|FG001|Overall Study|Lost to Follow-up|2|||
144505189|NCT02459899|521047484|FG002|Overall Study|Lost to Follow-up|0|||
144505190|NCT02459899|521047485|FG003|Overall Study|Lost to Follow-up|1|||
144505191|NCT02459899|521047482|FG000|Overall Study|Non-compliance with the treatment|0|||
144505192|NCT02459899|521047483|FG001|Overall Study|Non-compliance with the treatment|0|||
144505193|NCT02459899|521047484|FG002|Overall Study|Non-compliance with the treatment|0|||
144505194|NCT02459899|521047485|FG003|Overall Study|Non-compliance with the treatment|1|||
144505195|NCT02459899|521047482|FG000|Overall Study|Withdrawal by Subject|1|||
144505196|NCT02459899|521047483|FG001|Overall Study|Withdrawal by Subject|3|||
144505197|NCT02459899|521047484|FG002|Overall Study|Withdrawal by Subject|0|||
144505198|NCT02459899|521047485|FG003|Overall Study|Withdrawal by Subject|0|||
144505199|NCT00940992|521047489|FG000|Overall Study|Adverse Event|2|||
144505200|NCT00940992|521047490|FG001|Overall Study|Adverse Event|0|||
144505201|NCT00940992|521047491|FG002|Overall Study|Adverse Event|1|||
144505202|NCT00940992|521047489|FG000|Overall Study|subject request|2|||
144505203|NCT00940992|521047490|FG001|Overall Study|subject request|1|||
144505204|NCT00940992|521047491|FG002|Overall Study|subject request|0|||
144505205|NCT00940992|521047489|FG000|Overall Study|Lost to Follow-up|0|||
144505206|NCT00940992|521047490|FG001|Overall Study|Lost to Follow-up|1|||
144505207|NCT00940992|521047491|FG002|Overall Study|Lost to Follow-up|1|||
144505208|NCT00539292|521047492|FG000|Overall Study|Physician Decision|1|||
144505209|NCT00539292|521047493|FG001|Overall Study|Physician Decision|0|||
144505210|NCT00630786|521047494|FG000|Overall Study|Physician Decision|0|||
144505211|NCT00630786|521047495|FG001|Overall Study|Physician Decision|0|||
144505212|NCT00630786|521047496|FG002|Overall Study|Physician Decision|1|||
144505213|NCT00630786|521047494|FG000|Overall Study|Withdrawal by Subject|0|||
144505214|NCT00630786|521047495|FG001|Overall Study|Withdrawal by Subject|1|||
144505215|NCT00630786|521047496|FG002|Overall Study|Withdrawal by Subject|1|||
144505216|NCT00630786|521047494|FG000|Overall Study|Lost to Follow-up|0|||
144370194|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Adverse Event|2|||
144370195|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Adverse Event|6|||
144370196|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Participant wishes|12|||
144370197|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Participant wishes|7|||
144505217|NCT00630786|521047495|FG001|Overall Study|Lost to Follow-up|1|||
144505218|NCT00630786|521047496|FG002|Overall Study|Lost to Follow-up|0|||
144505219|NCT00630786|521047494|FG000|Overall Study|Other|1|||
144505220|NCT00630786|521047495|FG001|Overall Study|Other|0|||
144505221|NCT00630786|521047496|FG002|Overall Study|Other|0|||
144505222|NCT02020616|521047500|FG000|Overall Study|Adverse Event|0|||
144505223|NCT02020616|521047501|FG001|Overall Study|Adverse Event|0|||
144505224|NCT02020616|521047502|FG002|Overall Study|Adverse Event|0|||
144505225|NCT02020616|521047503|FG003|Overall Study|Adverse Event|0|||
144505226|NCT02020616|521047504|FG004|Overall Study|Adverse Event|0|||
144505227|NCT02020616|521047505|FG005|Overall Study|Adverse Event|1|||
144505228|NCT02020616|521047506|FG006|Overall Study|Adverse Event|1|||
144505229|NCT02020616|521047500|FG000|Overall Study|Physician Decision|0|||
144505230|NCT02020616|521047501|FG001|Overall Study|Physician Decision|0|||
144505231|NCT02020616|521047502|FG002|Overall Study|Physician Decision|0|||
144505232|NCT02020616|521047503|FG003|Overall Study|Physician Decision|0|||
144505233|NCT02020616|521047504|FG004|Overall Study|Physician Decision|0|||
144505234|NCT02020616|521047505|FG005|Overall Study|Physician Decision|1|||
144505235|NCT02020616|521047506|FG006|Overall Study|Physician Decision|2|||
144505236|NCT02020616|521047500|FG000|Overall Study|Withdrawal by Subject|0|||
144505237|NCT02020616|521047501|FG001|Overall Study|Withdrawal by Subject|0|||
144505238|NCT02020616|521047502|FG002|Overall Study|Withdrawal by Subject|1|||
144505239|NCT02020616|521047503|FG003|Overall Study|Withdrawal by Subject|0|||
144505240|NCT02020616|521047504|FG004|Overall Study|Withdrawal by Subject|0|||
144505241|NCT02020616|521047505|FG005|Overall Study|Withdrawal by Subject|1|||
144505242|NCT02020616|521047506|FG006|Overall Study|Withdrawal by Subject|1|||
144505243|NCT02020616|521047500|FG000|Overall Study|Lost to Follow-up|0|||
144505244|NCT02020616|521047501|FG001|Overall Study|Lost to Follow-up|1|||
144505245|NCT02020616|521047502|FG002|Overall Study|Lost to Follow-up|0|||
144505246|NCT02020616|521047503|FG003|Overall Study|Lost to Follow-up|1|||
144505247|NCT02020616|521047504|FG004|Overall Study|Lost to Follow-up|1|||
144505248|NCT02020616|521047505|FG005|Overall Study|Lost to Follow-up|1|||
144505249|NCT02020616|521047506|FG006|Overall Study|Lost to Follow-up|0|||
144505250|NCT02020616|521047500|FG000|Overall Study|Early Termination Criteria Met|0|||
144505251|NCT02020616|521047501|FG001|Overall Study|Early Termination Criteria Met|0|||
144505252|NCT02020616|521047502|FG002|Overall Study|Early Termination Criteria Met|1|||
144505253|NCT02020616|521047503|FG003|Overall Study|Early Termination Criteria Met|0|||
144505254|NCT02020616|521047504|FG004|Overall Study|Early Termination Criteria Met|0|||
144505255|NCT02020616|521047505|FG005|Overall Study|Early Termination Criteria Met|1|||
144505256|NCT02020616|521047506|FG006|Overall Study|Early Termination Criteria Met|0|||
144505257|NCT02020616|521047500|FG000|Overall Study|Randomized in Error|0|||
144505258|NCT02020616|521047501|FG001|Overall Study|Randomized in Error|0|||
144505259|NCT02020616|521047502|FG002|Overall Study|Randomized in Error|0|||
144505260|NCT02020616|521047503|FG003|Overall Study|Randomized in Error|1|||
144505261|NCT02020616|521047504|FG004|Overall Study|Randomized in Error|0|||
144505262|NCT02020616|521047505|FG005|Overall Study|Randomized in Error|0|||
144505263|NCT02020616|521047506|FG006|Overall Study|Randomized in Error|0|||
144505264|NCT02020616|521047500|FG000|Overall Study|Lack of Efficacy|0|||
144505265|NCT02020616|521047501|FG001|Overall Study|Lack of Efficacy|0|||
144505266|NCT02020616|521047502|FG002|Overall Study|Lack of Efficacy|0|||
144505267|NCT02020616|521047503|FG003|Overall Study|Lack of Efficacy|0|||
144505268|NCT02020616|521047504|FG004|Overall Study|Lack of Efficacy|1|||
144505269|NCT02020616|521047505|FG005|Overall Study|Lack of Efficacy|0|||
144505270|NCT02020616|521047506|FG006|Overall Study|Lack of Efficacy|0|||
144505271|NCT00324038|521047517|FG000|Overall Study|Adverse Event|38|||
144505272|NCT00324038|521047518|FG001|Overall Study|Adverse Event|23|||
144505273|NCT00324038|521047517|FG000|Overall Study|Lack of Efficacy|5|||
144505274|NCT00324038|521047518|FG001|Overall Study|Lack of Efficacy|13|||
144505275|NCT00324038|521047517|FG000|Overall Study|Lost to Follow-up|0|||
144505276|NCT00324038|521047518|FG001|Overall Study|Lost to Follow-up|2|||
144505277|NCT00324038|521047517|FG000|Overall Study|Other|6|||
144505278|NCT00324038|521047518|FG001|Overall Study|Other|13|||
144505279|NCT02031471|521047519|FG000|24 Week Treatment Period|Adverse Event|6|||
144505280|NCT02031471|521047519|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
144505281|NCT02031471|521047519|FG000|24 Week Treatment Period|Protocol Violation|1|||
144505282|NCT02031471|521047519|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
144505283|NCT02031471|521047519|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
144505284|NCT02031471|521047519|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
144505285|NCT02031471|521047519|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
144505286|NCT03070483|521047520|FG000|Overall Study|Lost to Follow-up|2|||
144505287|NCT01585558|521047522|FG000|Overall Study|Withdrawal by Subject|4|||
144505288|NCT01585558|521047523|FG001|Overall Study|Withdrawal by Subject|5|||
144505289|NCT01585558|521047524|FG002|Overall Study|Withdrawal by Subject|8|||
144505290|NCT01585558|521047522|FG000|Overall Study|Lost to Follow-up|2|||
144505291|NCT01585558|521047523|FG001|Overall Study|Lost to Follow-up|0|||
144505292|NCT01585558|521047524|FG002|Overall Study|Lost to Follow-up|3|||
144505293|NCT01585558|521047522|FG000|Overall Study|Adverse Event|3|||
144505294|NCT01585558|521047523|FG001|Overall Study|Adverse Event|4|||
144505295|NCT01585558|521047524|FG002|Overall Study|Adverse Event|1|||
144505296|NCT01585558|521047522|FG000|Overall Study|Protocol Violation|4|||
144505297|NCT01585558|521047523|FG001|Overall Study|Protocol Violation|3|||
144505298|NCT01585558|521047524|FG002|Overall Study|Protocol Violation|2|||
144505299|NCT01585558|521047522|FG000|Overall Study|Lack of Efficacy|0|||
144505300|NCT01585558|521047523|FG001|Overall Study|Lack of Efficacy|0|||
144505301|NCT01585558|521047524|FG002|Overall Study|Lack of Efficacy|1|||
144505302|NCT00361283|521047525|FG000|Overall Study|Lost to Follow-up|27|||
144505303|NCT00997386|521047526|FG000|Overall Study|Death|7|||
144505304|NCT00961636|521047529|FG000|Overall Study|Adverse Event|35|||
144505305|NCT00961636|521047530|FG001|Overall Study|Adverse Event|54|||
144505306|NCT00961636|521047531|FG002|Overall Study|Adverse Event|13|||
144505307|NCT00961636|521047529|FG000|Overall Study|Flushing Symptoms|29|||
144505308|NCT00961636|521047530|FG001|Overall Study|Flushing Symptoms|46|||
144505309|NCT00961636|521047531|FG002|Overall Study|Flushing Symptoms|3|||
144505310|NCT00961636|521047529|FG000|Overall Study|Lost to Follow-up|2|||
144505311|NCT00961636|521047530|FG001|Overall Study|Lost to Follow-up|3|||
144505312|NCT00961636|521047531|FG002|Overall Study|Lost to Follow-up|1|||
144505313|NCT00961636|521047529|FG000|Overall Study|Physician Decision|3|||
144505314|NCT00961636|521047530|FG001|Overall Study|Physician Decision|1|||
144505315|NCT00961636|521047531|FG002|Overall Study|Physician Decision|1|||
144505316|NCT00961636|521047529|FG000|Overall Study|Protocol Violation|9|||
144505317|NCT00961636|521047530|FG001|Overall Study|Protocol Violation|5|||
144505318|NCT00961636|521047531|FG002|Overall Study|Protocol Violation|1|||
144505319|NCT00961636|521047529|FG000|Overall Study|Withdrawal by Subject|29|||
144505320|NCT00961636|521047530|FG001|Overall Study|Withdrawal by Subject|22|||
144505321|NCT00961636|521047531|FG002|Overall Study|Withdrawal by Subject|13|||
144505322|NCT00688519|521047532|FG000|Overall Study|Adverse Event|2|||
144505323|NCT00688519|521047533|FG001|Overall Study|Adverse Event|3|||
144505324|NCT00688519|521047532|FG000|Overall Study|Lost to Follow-up|3|||
144505325|NCT00688519|521047533|FG001|Overall Study|Lost to Follow-up|3|||
144505326|NCT00688519|521047532|FG000|Overall Study|Lack of Efficacy|3|||
144505327|NCT00688519|521047533|FG001|Overall Study|Lack of Efficacy|1|||
144505328|NCT00688519|521047532|FG000|Overall Study|Withdrawal by Subject|7|||
144505329|NCT00688519|521047533|FG001|Overall Study|Withdrawal by Subject|6|||
144370198|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Physician Decision|2|||
144370199|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Physician Decision|1|||
144370200|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
144370201|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
144370202|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Death|0|||
144370203|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Death|1|||
144370204|NCT02904954|520564043|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
144370205|NCT02904954|520564044|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
144370206|NCT05097963|520564045|FG000|Overall Study|Protocol Violation|13|||
144370207|NCT05097963|520564045|FG000|Overall Study|Withdrawal by Subject|21|||
144370208|NCT03349034|520564048|FG000|Overall Study|catheters dislodged during transport|2|||
144370209|NCT03349034|520564049|FG001|Overall Study|catheters dislodged during transport|0|||
144370210|NCT03349034|520564048|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
144370211|NCT03349034|520564049|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
144505330|NCT00688519|521047532|FG000|Overall Study|Prohibited medication|1|||
144505331|NCT00688519|521047533|FG001|Overall Study|Prohibited medication|0|||
144505332|NCT00688519|521047532|FG000|Overall Study|Non-compliance|0|||
144505333|NCT00688519|521047533|FG001|Overall Study|Non-compliance|1|||
144505334|NCT00688519|521047532|FG000|Overall Study|Subject moved out of state|1|||
144505335|NCT00688519|521047533|FG001|Overall Study|Subject moved out of state|0|||
144505336|NCT00688519|521047532|FG000|Overall Study|Investigator decision|1|||
144505337|NCT00688519|521047533|FG001|Overall Study|Investigator decision|0|||
144505338|NCT00688519|521047532|FG000|Overall Study|Subject moved out of area|1|||
144505339|NCT00688519|521047533|FG001|Overall Study|Subject moved out of area|0|||
144505340|NCT00688519|521047532|FG000|Overall Study|Pregnancy|0|||
144505341|NCT00688519|521047533|FG001|Overall Study|Pregnancy|1|||
144505342|NCT01063517|521047534|FG000|Overall Study|Consent withdrawal|1|||
144505343|NCT01063517|521047535|FG001|Overall Study|Consent withdrawal|0|||
144505344|NCT01063517|521047534|FG000|Overall Study|Study reached data cut-off|19|||
144505345|NCT01063517|521047535|FG001|Overall Study|Study reached data cut-off|7|||
144505346|NCT01063517|521047534|FG000|Overall Study|Lost to Follow-up|4|||
144505347|NCT01063517|521047535|FG001|Overall Study|Lost to Follow-up|3|||
144505348|NCT01063517|521047534|FG000|Overall Study|Withdrawal by Subject|1|||
144505349|NCT01063517|521047535|FG001|Overall Study|Withdrawal by Subject|2|||
144505350|NCT01063517|521047534|FG000|Overall Study|Death|33|||
144505351|NCT01063517|521047535|FG001|Overall Study|Death|48|||
144505352|NCT00617201|521047536|FG000|Overall Study|Lost to Follow-up|9|||
144505353|NCT00617201|521047537|FG001|Overall Study|Lost to Follow-up|13|||
144505354|NCT05219253|521048914|FG000|Overall Study|Withdrawal by Subject|1|||
144505355|NCT05219253|521048915|FG001|Overall Study|Withdrawal by Subject|2|||
144505356|NCT03086369|521048916|FG000|Overall Study|Lost to Follow-up|1|||
144505357|NCT03086369|521048917|FG001|Overall Study|Lost to Follow-up|0|||
144505358|NCT03086369|521048918|FG002|Overall Study|Lost to Follow-up|0|||
144505359|NCT03086369|521048919|FG003|Overall Study|Lost to Follow-up|2|||
144505360|NCT03086369|521048920|FG004|Overall Study|Lost to Follow-up|1|||
144505361|NCT03086369|521048916|FG000|Overall Study|Physician Decision|0|||
144721642|NCT00356200|521835243|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
144721643|NCT00356200|521835244|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
144505362|NCT03086369|521048917|FG001|Overall Study|Physician Decision|0|||
144505363|NCT03086369|521048918|FG002|Overall Study|Physician Decision|0|||
144505364|NCT03086369|521048919|FG003|Overall Study|Physician Decision|1|||
144505365|NCT03086369|521048920|FG004|Overall Study|Physician Decision|2|||
144721644|NCT00635778|521835245|FG000|Overall Study|Adverse Event|1|||
144505366|NCT03086369|521048916|FG000|Overall Study|Withdrawal by Subject|0|||
144505367|NCT03086369|521048917|FG001|Overall Study|Withdrawal by Subject|0|||
144505368|NCT03086369|521048918|FG002|Overall Study|Withdrawal by Subject|0|||
144505369|NCT03086369|521048919|FG003|Overall Study|Withdrawal by Subject|5|||
144505370|NCT03086369|521048920|FG004|Overall Study|Withdrawal by Subject|3|||
144505371|NCT03086369|521048916|FG000|Overall Study|Progressive Disease|0|||
144505372|NCT03086369|521048917|FG001|Overall Study|Progressive Disease|0|||
144505373|NCT03086369|521048918|FG002|Overall Study|Progressive Disease|0|||
144505374|NCT03086369|521048919|FG003|Overall Study|Progressive Disease|1|||
144505375|NCT03086369|521048920|FG004|Overall Study|Progressive Disease|1|||
144505376|NCT04668339|521048921|FG000|Overall Study|Physician Decision|1|||
144505377|NCT04668339|521048922|FG001|Overall Study|Physician Decision|0|||
144505378|NCT04668339|521048923|FG002|Overall Study|Physician Decision|1|||
144505379|NCT04668339|521048924|FG003|Overall Study|Physician Decision|1|||
144505380|NCT04668339|521048921|FG000|Overall Study|Lost to Follow-up|14|||
144505381|NCT04668339|521048922|FG001|Overall Study|Lost to Follow-up|12|||
144505382|NCT04668339|521048923|FG002|Overall Study|Lost to Follow-up|8|||
144505383|NCT04668339|521048924|FG003|Overall Study|Lost to Follow-up|5|||
144505384|NCT04668339|521048921|FG000|Overall Study|Adverse Event|0|||
144505385|NCT04668339|521048922|FG001|Overall Study|Adverse Event|0|||
144505386|NCT04668339|521048923|FG002|Overall Study|Adverse Event|1|||
144505387|NCT04668339|521048924|FG003|Overall Study|Adverse Event|0|||
144505388|NCT04668339|521048921|FG000|Overall Study|Other than specified|3|||
144505389|NCT04668339|521048922|FG001|Overall Study|Other than specified|0|||
144505390|NCT04668339|521048923|FG002|Overall Study|Other than specified|1|||
144505391|NCT04668339|521048924|FG003|Overall Study|Other than specified|0|||
144505392|NCT04668339|521048921|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
144505393|NCT04668339|521048922|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
144505394|NCT04668339|521048923|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
144505395|NCT04668339|521048924|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
144505396|NCT04668339|521048921|FG000|Overall Study|Vaccine not Administered|0|||
144505397|NCT04668339|521048922|FG001|Overall Study|Vaccine not Administered|0|||
144505398|NCT04668339|521048923|FG002|Overall Study|Vaccine not Administered|1|||
144505399|NCT04668339|521048924|FG003|Overall Study|Vaccine not Administered|0|||
144505400|NCT04668339|521048921|FG000|Overall Study|Protocol Violation|18|||
144505401|NCT04668339|521048922|FG001|Overall Study|Protocol Violation|23|||
144505402|NCT04668339|521048923|FG002|Overall Study|Protocol Violation|12|||
144505403|NCT04668339|521048924|FG003|Overall Study|Protocol Violation|20|||
144505404|NCT04668339|521048921|FG000|Overall Study|Withdrawal by Subject|45|||
144505405|NCT04668339|521048922|FG001|Overall Study|Withdrawal by Subject|46|||
144505406|NCT04668339|521048923|FG002|Overall Study|Withdrawal by Subject|46|||
144505407|NCT04668339|521048924|FG003|Overall Study|Withdrawal by Subject|27|||
144505408|NCT04668339|521048921|FG000|Overall Study|Study Terminated by Sponsor|59|||
144505409|NCT04668339|521048922|FG001|Overall Study|Study Terminated by Sponsor|59|||
144505410|NCT04668339|521048923|FG002|Overall Study|Study Terminated by Sponsor|71|||
144505411|NCT04668339|521048924|FG003|Overall Study|Study Terminated by Sponsor|1|||
144370212|NCT03349034|520564048|FG000|Overall Study|soft tissue flap used|1|||
144370213|NCT03349034|520564049|FG001|Overall Study|soft tissue flap used|0|||
144370214|NCT03349034|520564048|FG000|Overall Study|Other|0|||
144370215|NCT03349034|520564049|FG001|Overall Study|Other|1|||
144370216|NCT01177397|520564050|FG000|Overall Study|Protocol Violation|0|||
144370217|NCT01177397|520564051|FG001|Overall Study|Protocol Violation|0|||
144370218|NCT01177397|520564052|FG002|Overall Study|Protocol Violation|0|||
144370219|NCT01177397|520564053|FG003|Overall Study|Protocol Violation|0|||
144370220|NCT01177397|520564054|FG004|Overall Study|Protocol Violation|0|||
144370221|NCT01177397|520564055|FG005|Overall Study|Protocol Violation|1|||
144370222|NCT01177397|520564056|FG006|Overall Study|Protocol Violation|0|||
144370223|NCT01177397|520564057|FG007|Overall Study|Protocol Violation|0|||
144370224|NCT01177397|520564058|FG008|Overall Study|Protocol Violation|0|||
144370225|NCT01177397|520564059|FG009|Overall Study|Protocol Violation|0|||
144370226|NCT01177397|520564060|FG010|Overall Study|Protocol Violation|0|||
144370227|NCT01177397|520564061|FG011|Overall Study|Protocol Violation|0|||
144370228|NCT01177397|520564050|FG000|Overall Study|Lost to Follow-up|0|||
144370229|NCT01177397|520564051|FG001|Overall Study|Lost to Follow-up|0|||
144370230|NCT01177397|520564052|FG002|Overall Study|Lost to Follow-up|0|||
144370231|NCT01177397|520564053|FG003|Overall Study|Lost to Follow-up|0|||
144370232|NCT01177397|520564054|FG004|Overall Study|Lost to Follow-up|1|||
144370233|NCT01177397|520564055|FG005|Overall Study|Lost to Follow-up|0|||
144370234|NCT01177397|520564056|FG006|Overall Study|Lost to Follow-up|0|||
144370235|NCT01177397|520564057|FG007|Overall Study|Lost to Follow-up|2|||
144370236|NCT01177397|520564058|FG008|Overall Study|Lost to Follow-up|0|||
144370237|NCT01177397|520564059|FG009|Overall Study|Lost to Follow-up|0|||
144370238|NCT01177397|520564060|FG010|Overall Study|Lost to Follow-up|0|||
144370239|NCT01177397|520564061|FG011|Overall Study|Lost to Follow-up|0|||
144370240|NCT01177397|520564050|FG000|Overall Study|Death|0|||
144370241|NCT01177397|520564051|FG001|Overall Study|Death|0|||
144370242|NCT01177397|520564052|FG002|Overall Study|Death|1|||
144370243|NCT01177397|520564053|FG003|Overall Study|Death|1|||
144370244|NCT01177397|520564054|FG004|Overall Study|Death|0|||
144370245|NCT01177397|520564055|FG005|Overall Study|Death|0|||
144370246|NCT01177397|520564056|FG006|Overall Study|Death|0|||
144370247|NCT01177397|520564057|FG007|Overall Study|Death|5|||
144370248|NCT01177397|520564058|FG008|Overall Study|Death|2|||
144370249|NCT01177397|520564059|FG009|Overall Study|Death|1|||
144370250|NCT01177397|520564060|FG010|Overall Study|Death|0|||
144505412|NCT02320123|521048930|FG000|Overall Study|Lost to Follow-up|4|||
144505413|NCT02320123|521048931|FG001|Overall Study|Lost to Follow-up|6|||
144505414|NCT02320123|521048930|FG000|Overall Study|Death|6|||
144505415|NCT02320123|521048931|FG001|Overall Study|Death|5|||
144370251|NCT01177397|520564061|FG011|Overall Study|Death|0|||
144505416|NCT01759264|521048932|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
144505417|NCT01759264|521048932|FG000|Overall Study|Adverse Event|1|||
144370252|NCT01177397|520564050|FG000|Overall Study|Withdrawal by Subject|0|||
144370253|NCT01177397|520564051|FG001|Overall Study|Withdrawal by Subject|0|||
144370254|NCT01177397|520564052|FG002|Overall Study|Withdrawal by Subject|1|||
144370255|NCT01177397|520564053|FG003|Overall Study|Withdrawal by Subject|1|||
144370256|NCT01177397|520564054|FG004|Overall Study|Withdrawal by Subject|1|||
144370257|NCT01177397|520564055|FG005|Overall Study|Withdrawal by Subject|2|||
144505418|NCT01759264|521048932|FG000|Overall Study|Other|2|||
144370258|NCT01177397|520564056|FG006|Overall Study|Withdrawal by Subject|0|||
144370259|NCT01177397|520564057|FG007|Overall Study|Withdrawal by Subject|5|||
144505419|NCT01759264|521048932|FG000|Overall Study|Lost to Follow-up|2|||
144370260|NCT01177397|520564058|FG008|Overall Study|Withdrawal by Subject|9|||
144370261|NCT01177397|520564059|FG009|Overall Study|Withdrawal by Subject|1|||
144370262|NCT01177397|520564060|FG010|Overall Study|Withdrawal by Subject|1|||
144370263|NCT01177397|520564061|FG011|Overall Study|Withdrawal by Subject|0|||
144370264|NCT01177397|520564050|FG000|Overall Study|Adverse Event|0|||
144370265|NCT01177397|520564051|FG001|Overall Study|Adverse Event|0|||
144370266|NCT01177397|520564052|FG002|Overall Study|Adverse Event|1|||
144370267|NCT01177397|520564053|FG003|Overall Study|Adverse Event|2|||
144370268|NCT01177397|520564054|FG004|Overall Study|Adverse Event|0|||
144370269|NCT01177397|520564055|FG005|Overall Study|Adverse Event|12|||
144370270|NCT01177397|520564056|FG006|Overall Study|Adverse Event|1|||
144370271|NCT01177397|520564057|FG007|Overall Study|Adverse Event|14|||
144370272|NCT01177397|520564058|FG008|Overall Study|Adverse Event|8|||
144370273|NCT01177397|520564059|FG009|Overall Study|Adverse Event|6|||
144370274|NCT01177397|520564060|FG010|Overall Study|Adverse Event|3|||
144370275|NCT01177397|520564061|FG011|Overall Study|Adverse Event|7|||
144370276|NCT01177397|520564050|FG000|Overall Study|Disease progression|1|||
144370277|NCT01177397|520564051|FG001|Overall Study|Disease progression|2|||
144370278|NCT01177397|520564052|FG002|Overall Study|Disease progression|5|||
144370279|NCT01177397|520564053|FG003|Overall Study|Disease progression|5|||
144370280|NCT01177397|520564054|FG004|Overall Study|Disease progression|4|||
144370281|NCT01177397|520564055|FG005|Overall Study|Disease progression|10|||
144370282|NCT01177397|520564056|FG006|Overall Study|Disease progression|10|||
144370283|NCT01177397|520564057|FG007|Overall Study|Disease progression|21|||
144370284|NCT01177397|520564058|FG008|Overall Study|Disease progression|18|||
144370285|NCT01177397|520564059|FG009|Overall Study|Disease progression|12|||
144370286|NCT01177397|520564060|FG010|Overall Study|Disease progression|10|||
144370287|NCT01177397|520564061|FG011|Overall Study|Disease progression|8|||
144370288|NCT01177397|520564050|FG000|Overall Study|Other reasons|0|||
144370289|NCT01177397|520564051|FG001|Overall Study|Other reasons|0|||
144370290|NCT01177397|520564052|FG002|Overall Study|Other reasons|1|||
144370291|NCT01177397|520564053|FG003|Overall Study|Other reasons|0|||
144370292|NCT01177397|520564054|FG004|Overall Study|Other reasons|1|||
144370293|NCT01177397|520564055|FG005|Overall Study|Other reasons|1|||
144370294|NCT01177397|520564056|FG006|Overall Study|Other reasons|2|||
144370295|NCT01177397|520564057|FG007|Overall Study|Other reasons|6|||
144370296|NCT01177397|520564058|FG008|Overall Study|Other reasons|10|||
144370297|NCT01177397|520564059|FG009|Overall Study|Other reasons|8|||
144370298|NCT01177397|520564060|FG010|Overall Study|Other reasons|0|||
144370299|NCT01177397|520564061|FG011|Overall Study|Other reasons|2|||
144370300|NCT01039376|520564062|FG000|Overall Study|Lost to Follow-up|5|||
144370301|NCT01039376|520564063|FG001|Overall Study|Lost to Follow-up|12|||
144370302|NCT01039376|520564062|FG000|Overall Study|Physician Decision|15|||
144370303|NCT01039376|520564063|FG001|Overall Study|Physician Decision|10|||
144370304|NCT01039376|520564062|FG000|Overall Study|Withdrawal by Subject|20|||
144370305|NCT01039376|520564063|FG001|Overall Study|Withdrawal by Subject|32|||
144370306|NCT01039376|520564062|FG000|Overall Study|Study terminated by Sponsor|90|||
144370307|NCT01039376|520564063|FG001|Overall Study|Study terminated by Sponsor|72|||
144370308|NCT00123422|520564064|FG000|Overall Study|Physician Decision|2|||
144370309|NCT00123422|520564065|FG001|Overall Study|Physician Decision|2|||
144370310|NCT00123422|520564066|FG002|Overall Study|Physician Decision|6|||
144370311|NCT00123422|520564064|FG000|Overall Study|Withdrawal by Subject|1|||
144370312|NCT00123422|520564065|FG001|Overall Study|Withdrawal by Subject|2|||
144370313|NCT00123422|520564066|FG002|Overall Study|Withdrawal by Subject|2|||
144370314|NCT00123422|520564064|FG000|Overall Study|Lost to Follow-up|1|||
144370315|NCT00123422|520564065|FG001|Overall Study|Lost to Follow-up|2|||
144370316|NCT00123422|520564066|FG002|Overall Study|Lost to Follow-up|2|||
144370317|NCT04555616|520564067|FG000|Overall Study|Death|1|||
144370318|NCT04555616|520564068|FG001|Overall Study|Death|0|||
144370319|NCT04555616|520564069|FG002|Overall Study|Death|1|||
144370320|NCT04555616|520564067|FG000|Overall Study|Withdrawal by Subject|2|||
144370321|NCT04555616|520564068|FG001|Overall Study|Withdrawal by Subject|1|||
144370322|NCT04555616|520564069|FG002|Overall Study|Withdrawal by Subject|0|||
144370323|NCT01554241|520564070|FG000|Overall Study|Death|3|||
144370324|NCT01554241|520564071|FG001|Overall Study|Death|1|||
144370325|NCT01554241|520564072|FG002|Overall Study|Death|1|||
144370326|NCT01554241|520564073|FG003|Overall Study|Death|0|||
144370327|NCT01554241|520564070|FG000|Overall Study|protocol specified renal stone|0|||
144370328|NCT01554241|520564071|FG001|Overall Study|protocol specified renal stone|0|||
144370329|NCT01554241|520564072|FG002|Overall Study|protocol specified renal stone|0|||
144370330|NCT01554241|520564073|FG003|Overall Study|protocol specified renal stone|1|||
144370331|NCT01554241|520564070|FG000|Overall Study|protocol specified change in eGFR|0|||
144370332|NCT01554241|520564071|FG001|Overall Study|protocol specified change in eGFR|0|||
144370333|NCT01554241|520564072|FG002|Overall Study|protocol specified change in eGFR|1|||
144370334|NCT01554241|520564073|FG003|Overall Study|protocol specified change in eGFR|0|||
144370335|NCT01554241|520564070|FG000|Overall Study|Withdrawal by Subject|0|||
144505420|NCT01759264|521048932|FG000|Overall Study|Withdrawal by Subject|3|||
144505421|NCT01759264|521048932|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
144505422|NCT02983617|521048933|FG000|Overall Study|Adverse Event|0|||
144505423|NCT02983617|521048934|FG001|Overall Study|Adverse Event|7|||
144505424|NCT02983617|521048933|FG000|Overall Study|Death|0|||
144505425|NCT02983617|521048934|FG001|Overall Study|Death|1|||
144721645|NCT00635778|521835246|FG001|Overall Study|Adverse Event|0|||
144370336|NCT01554241|520564071|FG001|Overall Study|Withdrawal by Subject|0|||
144370337|NCT01554241|520564072|FG002|Overall Study|Withdrawal by Subject|2|||
144370338|NCT01554241|520564073|FG003|Overall Study|Withdrawal by Subject|0|||
144370339|NCT02118961|520564074|FG000|Overall Study|Withdrawal by Subject|1|||
144370340|NCT02118961|520564075|FG001|Overall Study|Withdrawal by Subject|0|||
144370341|NCT03809104|520564079|FG000|Overall Study|Withdrawal by Subject|3|||
144370342|NCT05021978|520564080|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
144721646|NCT00635778|521835247|FG002|Overall Study|Adverse Event|0|||
144370343|NCT05021978|520564081|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
144370344|NCT05021978|520564082|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
144370345|NCT05021978|520564083|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
144370346|NCT05021978|520564080|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
144370347|NCT05021978|520564081|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
144370348|NCT05021978|520564082|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
144370349|NCT05021978|520564083|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
144370350|NCT00196313|520564084|FG000|Overall Study|Protocol Violation|2|||
144505426|NCT02983617|521048933|FG000|Overall Study|Investigator's Discretion|0|||
144505427|NCT02983617|521048934|FG001|Overall Study|Investigator's Discretion|1|||
144505428|NCT02027558|521048935|FG000|Overall Study|Death|0|||
144370351|NCT00196313|520564085|FG001|Overall Study|Protocol Violation|3|||
144370352|NCT00196313|520564084|FG000|Overall Study|Withdrawal by Subject|3|||
144370353|NCT00196313|520564085|FG001|Overall Study|Withdrawal by Subject|1|||
144370354|NCT00196313|520564084|FG000|Overall Study|Adverse Event|3|||
144370355|NCT00196313|520564085|FG001|Overall Study|Adverse Event|1|||
144370356|NCT00196313|520564084|FG000|Overall Study|Subject Pregnant|1|||
144370357|NCT00196313|520564085|FG001|Overall Study|Subject Pregnant|1|||
144370358|NCT00196313|520564084|FG000|Overall Study|Lost to Follow-up|2|||
144370359|NCT00196313|520564085|FG001|Overall Study|Lost to Follow-up|2|||
144370360|NCT00043979|520564086|FG000|Period 1|recipient with progressive disease|7|||
144370361|NCT00043979|520564087|FG001|Period 1|recipient with progressive disease|4|||
144370362|NCT00043979|520564088|FG002|Period 1|recipient with progressive disease|3|||
144370363|NCT03096288|520564090|FG000|Overall Study|Withdrawal by Subject|0|||
144370364|NCT03096288|520564091|FG001|Overall Study|Withdrawal by Subject|1|||
144370365|NCT03096288|520564092|FG002|Overall Study|Withdrawal by Subject|0|||
144370366|NCT03096288|520564093|FG003|Overall Study|Withdrawal by Subject|1|||
144370367|NCT01411891|520564099|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
144370368|NCT01411891|520564100|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
144370369|NCT02004093|520564101|FG000|Overall Study|Death|2|||
144370370|NCT02004093|520564102|FG001|Overall Study|Death|1|||
144370371|NCT02004093|520564101|FG000|Overall Study|Lack of Efficacy|66|||
144370372|NCT02004093|520564102|FG001|Overall Study|Lack of Efficacy|62|||
144370373|NCT02004093|520564101|FG000|Overall Study|Protocol Violation|0|||
144370374|NCT02004093|520564102|FG001|Overall Study|Protocol Violation|1|||
144370375|NCT02004093|520564101|FG000|Overall Study|Lost to Follow-up|0|||
144370376|NCT02004093|520564102|FG001|Overall Study|Lost to Follow-up|1|||
144370377|NCT02004093|520564101|FG000|Overall Study|Withdrawal by Subject|3|||
144370378|NCT02004093|520564102|FG001|Overall Study|Withdrawal by Subject|7|||
144370379|NCT02004093|520564101|FG000|Overall Study|Other|3|||
144370380|NCT02004093|520564102|FG001|Overall Study|Other|1|||
144370381|NCT04085289|520564103|FG000|Overall Study|Withdrawal by Subject|0|||
144370382|NCT04085289|520564104|FG001|Overall Study|Withdrawal by Subject|0|||
144370383|NCT04085289|520564105|FG002|Overall Study|Withdrawal by Subject|1|||
144370384|NCT00414596|520564106|FG000|Overall Study|Protocol Violation|2|||
144370385|NCT04614974|520564108|FG000|Overall Study|Lost to Follow-up|14|||
144370386|NCT04614974|520564109|FG001|Overall Study|Lost to Follow-up|11|||
144370387|NCT02754440|520564111|FG000|Overall Study|Protocol Violation|3|||
144370388|NCT02754440|520564112|FG001|Overall Study|Protocol Violation|2|||
144370389|NCT02754440|520564113|FG002|Overall Study|Protocol Violation|2|||
144370390|NCT02754440|520564114|FG003|Overall Study|Protocol Violation|6|||
144370391|NCT02754440|520564111|FG000|Overall Study|Adverse Event|3|||
144370392|NCT02754440|520564112|FG001|Overall Study|Adverse Event|1|||
144370393|NCT02754440|520564113|FG002|Overall Study|Adverse Event|0|||
144370394|NCT02754440|520564114|FG003|Overall Study|Adverse Event|9|||
144370395|NCT02754440|520564111|FG000|Overall Study|Withdrawal by Subject|0|||
144370396|NCT02754440|520564112|FG001|Overall Study|Withdrawal by Subject|0|||
144370397|NCT02754440|520564113|FG002|Overall Study|Withdrawal by Subject|0|||
144505429|NCT02027558|521048936|FG001|Overall Study|Death|1|||
144721647|NCT00635778|521835248|FG003|Overall Study|Adverse Event|3|||
144721648|NCT00635778|521835249|FG004|Overall Study|Adverse Event|3|||
144370398|NCT02754440|520564114|FG003|Overall Study|Withdrawal by Subject|1|||
144370399|NCT02754440|520564111|FG000|Overall Study|Equipment failure|0|||
144370400|NCT02754440|520564112|FG001|Overall Study|Equipment failure|5|||
144370401|NCT02754440|520564113|FG002|Overall Study|Equipment failure|5|||
144370402|NCT02754440|520564114|FG003|Overall Study|Equipment failure|7|||
144370403|NCT02754440|520564111|FG000|Overall Study|Subject issues not resulting in AE|0|||
144370404|NCT02754440|520564112|FG001|Overall Study|Subject issues not resulting in AE|0|||
144370405|NCT02754440|520564113|FG002|Overall Study|Subject issues not resulting in AE|0|||
144370406|NCT02754440|520564114|FG003|Overall Study|Subject issues not resulting in AE|12|||
144370407|NCT02557139|520564115|FG000|Overall Study|Significant liver elevation|1|||
144505430|NCT02027558|521048935|FG000|Overall Study|Withdrawal by Subject|2|||
144505431|NCT02027558|521048936|FG001|Overall Study|Withdrawal by Subject|0|||
144505432|NCT02027558|521048935|FG000|Overall Study|Lost to Follow-up|4|||
144505433|NCT02027558|521048936|FG001|Overall Study|Lost to Follow-up|1|||
144505434|NCT02027558|521048935|FG000|Overall Study|Refused assessment|3|||
144505435|NCT02027558|521048936|FG001|Overall Study|Refused assessment|0|||
144505436|NCT00711958|521048941|FG000|Overall Study|Withdrawal by Subject|6|||
144505437|NCT00711958|521048942|FG001|Overall Study|Withdrawal by Subject|8|||
144505438|NCT00711958|521048941|FG000|Overall Study|Lack of Efficacy|3|||
144505439|NCT00711958|521048942|FG001|Overall Study|Lack of Efficacy|1|||
144505440|NCT00711958|521048941|FG000|Overall Study|Clinical deterioration|1|||
144505441|NCT00711958|521048942|FG001|Overall Study|Clinical deterioration|0|||
144505442|NCT00711958|521048941|FG000|Overall Study|Adverse Event|9|||
144505443|NCT00711958|521048942|FG001|Overall Study|Adverse Event|7|||
144505444|NCT00711958|521048941|FG000|Overall Study|Protocol Violation|1|||
144370408|NCT02557139|520564116|FG001|Overall Study|Significant liver elevation|0|||
144370409|NCT02557139|520564117|FG002|Overall Study|Significant liver elevation|1|||
144370410|NCT02557139|520564115|FG000|Overall Study|Withdrawal by Subject|1|||
144370411|NCT02557139|520564116|FG001|Overall Study|Withdrawal by Subject|0|||
144370412|NCT02557139|520564117|FG002|Overall Study|Withdrawal by Subject|0|||
144370413|NCT02557139|520564115|FG000|Overall Study|Illness of prohibited medication|0|||
144370414|NCT02557139|520564116|FG001|Overall Study|Illness of prohibited medication|0|||
144370415|NCT02557139|520564117|FG002|Overall Study|Illness of prohibited medication|1|||
144370416|NCT01146795|520564119|FG000|Overall Study|Withdrawal by Subject|4|||
144370417|NCT01146795|520564119|FG000|Overall Study|Adverse Event|6|||
144370418|NCT01146795|520564119|FG000|Overall Study|Still in treatment at study closure|10|||
144370419|NCT05375760|520564120|FG000|Overall Study|Adverse Event|1|||
144370420|NCT05375760|520564121|FG001|Overall Study|Adverse Event|0|||
144370421|NCT05375760|520564120|FG000|Overall Study|Death|0|||
144370422|NCT05375760|520564121|FG001|Overall Study|Death|1|||
144370423|NCT05375760|520564120|FG000|Overall Study|Lost to Follow-up|6|||
144370424|NCT05375760|520564121|FG001|Overall Study|Lost to Follow-up|6|||
144370425|NCT05375760|520564120|FG000|Overall Study|Withdrawal by Subject|17|||
144370426|NCT05375760|520564121|FG001|Overall Study|Withdrawal by Subject|19|||
144370427|NCT05375760|520564120|FG000|Overall Study|Dosing halted by FDA|96|||
144370428|NCT05375760|520564121|FG001|Overall Study|Dosing halted by FDA|100|||
144370429|NCT05375760|520564120|FG000|Overall Study|Not compliant with study visit|2|||
144370430|NCT05375760|520564121|FG001|Overall Study|Not compliant with study visit|0|||
144370431|NCT05375760|520564120|FG000|Overall Study|Physician Decision|1|||
144370432|NCT05375760|520564121|FG001|Overall Study|Physician Decision|0|||
144505445|NCT00711958|521048942|FG001|Overall Study|Protocol Violation|0|||
144505446|NCT00711958|521048941|FG000|Overall Study|Lost to Follow-up|2|||
144370433|NCT05375760|520564120|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
144370434|NCT05375760|520564121|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
144370435|NCT05375760|520564120|FG000|Overall Study|Participant moved|1|||
144370436|NCT05375760|520564121|FG001|Overall Study|Participant moved|0|||
144370437|NCT03853109|520564122|FG000|Overall Study|Withdrawal by Subject|0|||
144505447|NCT00711958|521048942|FG001|Overall Study|Lost to Follow-up|2|||
144370438|NCT03853109|520564123|FG001|Overall Study|Withdrawal by Subject|0|||
144370439|NCT03853109|520564124|FG002|Overall Study|Withdrawal by Subject|1|||
144370440|NCT03853109|520564125|FG003|Overall Study|Withdrawal by Subject|2|||
144370441|NCT03853109|520564126|FG004|Overall Study|Withdrawal by Subject|1|||
144370442|NCT03853109|520564127|FG005|Overall Study|Withdrawal by Subject|4|||
144370443|NCT03853109|520564128|FG006|Overall Study|Withdrawal by Subject|5|||
144370444|NCT03853109|520564129|FG007|Overall Study|Withdrawal by Subject|3|||
144370445|NCT03853109|520564122|FG000|Overall Study|Decision by Sponsor|0|||
144370446|NCT03853109|520564123|FG001|Overall Study|Decision by Sponsor|0|||
144370447|NCT03853109|520564124|FG002|Overall Study|Decision by Sponsor|1|||
144370448|NCT03853109|520564125|FG003|Overall Study|Decision by Sponsor|0|||
144370449|NCT03853109|520564126|FG004|Overall Study|Decision by Sponsor|1|||
144370450|NCT03853109|520564127|FG005|Overall Study|Decision by Sponsor|1|||
144370451|NCT03853109|520564128|FG006|Overall Study|Decision by Sponsor|10|||
144370452|NCT03853109|520564129|FG007|Overall Study|Decision by Sponsor|2|||
144370453|NCT03853109|520564122|FG000|Overall Study|Lost to Follow-up|0|||
144370454|NCT03853109|520564123|FG001|Overall Study|Lost to Follow-up|0|||
144370455|NCT03853109|520564124|FG002|Overall Study|Lost to Follow-up|0|||
144370456|NCT03853109|520564125|FG003|Overall Study|Lost to Follow-up|0|||
144370457|NCT03853109|520564126|FG004|Overall Study|Lost to Follow-up|1|||
144370458|NCT03853109|520564127|FG005|Overall Study|Lost to Follow-up|3|||
144370459|NCT03853109|520564128|FG006|Overall Study|Lost to Follow-up|0|||
144370460|NCT03853109|520564129|FG007|Overall Study|Lost to Follow-up|0|||
144370461|NCT03853109|520564122|FG000|Overall Study|Death|2|||
144370462|NCT03853109|520564123|FG001|Overall Study|Death|5|||
144370463|NCT03853109|520564124|FG002|Overall Study|Death|8|||
144370464|NCT03853109|520564125|FG003|Overall Study|Death|10|||
144370465|NCT03853109|520564126|FG004|Overall Study|Death|3|||
144370466|NCT03853109|520564127|FG005|Overall Study|Death|20|||
144370467|NCT03853109|520564128|FG006|Overall Study|Death|10|||
144370468|NCT03853109|520564129|FG007|Overall Study|Death|5|||
144370469|NCT04269889|520564130|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
144370470|NCT01721044|520564131|FG000|Treatment Period|Adverse Event|7|||
144370471|NCT01721044|520564132|FG001|Treatment Period|Adverse Event|7|||
144370472|NCT01721044|520564133|FG002|Treatment Period|Adverse Event|10|||
144370473|NCT01721044|520564131|FG000|Treatment Period|Death|0|||
144370474|NCT01721044|520564132|FG001|Treatment Period|Death|0|||
144370475|NCT01721044|520564133|FG002|Treatment Period|Death|1|||
144370476|NCT01721044|520564131|FG000|Treatment Period|Lack of Efficacy|16|||
144370477|NCT01721044|520564132|FG001|Treatment Period|Lack of Efficacy|4|||
144370478|NCT01721044|520564133|FG002|Treatment Period|Lack of Efficacy|4|||
144370479|NCT01721044|520564131|FG000|Treatment Period|Lost to Follow-up|0|||
144370480|NCT01721044|520564132|FG001|Treatment Period|Lost to Follow-up|0|||
144370481|NCT01721044|520564133|FG002|Treatment Period|Lost to Follow-up|1|||
144370482|NCT01721044|520564131|FG000|Treatment Period|Physician Decision|1|||
144370483|NCT01721044|520564132|FG001|Treatment Period|Physician Decision|0|||
144370484|NCT01721044|520564133|FG002|Treatment Period|Physician Decision|2|||
144370485|NCT01721044|520564131|FG000|Treatment Period|Protocol Violation|1|||
144370486|NCT01721044|520564132|FG001|Treatment Period|Protocol Violation|0|||
144370487|NCT01721044|520564133|FG002|Treatment Period|Protocol Violation|0|||
144370488|NCT01721044|520564131|FG000|Treatment Period|Withdrawal by Subject|7|||
144370489|NCT01721044|520564132|FG001|Treatment Period|Withdrawal by Subject|6|||
144370490|NCT01721044|520564133|FG002|Treatment Period|Withdrawal by Subject|1|||
144370491|NCT04634253|520564134|FG000|Overall Study|Adverse Event|1|||
144370492|NCT04634253|520564135|FG001|Overall Study|Adverse Event|1|||
144370493|NCT04634253|520564136|FG002|Overall Study|Adverse Event|0|||
144370494|NCT04634253|520564134|FG000|Overall Study|Physician Decision|0|||
144370495|NCT04634253|520564135|FG001|Overall Study|Physician Decision|1|||
144370496|NCT04634253|520564136|FG002|Overall Study|Physician Decision|0|||
144370497|NCT04634253|520564134|FG000|Overall Study|Withdrawal by Subject|1|||
144370498|NCT04634253|520564135|FG001|Overall Study|Withdrawal by Subject|0|||
144370499|NCT04634253|520564136|FG002|Overall Study|Withdrawal by Subject|3|||
144370500|NCT03155841|520564139|FG000|Overall Study|Protocol Violation|3|||
144370501|NCT03155841|520564140|FG001|Overall Study|Protocol Violation|4|||
144370502|NCT01499355|520564141|FG000|Run-In Period|Study Termination|15|||
144370503|NCT01499355|520564142|FG001|Run-In Period|Study Termination|0|||
144370504|NCT01499355|520564143|FG002|Run-In Period|Study Termination|0|||
144370505|NCT01499355|520564144|FG003|Run-In Period|Study Termination|0|||
144370506|NCT01499355|520564141|FG000|Run-In Period|Other|3|||
144370507|NCT01499355|520564142|FG001|Run-In Period|Other|0|||
144370508|NCT01499355|520564143|FG002|Run-In Period|Other|0|||
144370509|NCT01499355|520564144|FG003|Run-In Period|Other|0|||
144370510|NCT01499355|520564141|FG000|Run-In Period|Death|2|||
144370511|NCT01499355|520564142|FG001|Run-In Period|Death|0|||
144370512|NCT01499355|520564143|FG002|Run-In Period|Death|0|||
144370513|NCT01499355|520564144|FG003|Run-In Period|Death|0|||
144370514|NCT01499355|520564141|FG000|Run-In Period|Investigator Decision|2|||
144370515|NCT01499355|520564142|FG001|Run-In Period|Investigator Decision|0|||
144370516|NCT01499355|520564143|FG002|Run-In Period|Investigator Decision|0|||
144370517|NCT01499355|520564144|FG003|Run-In Period|Investigator Decision|0|||
144370518|NCT01499355|520564141|FG000|Run-In Period|Consent Withdrawn|1|||
144370519|NCT01499355|520564142|FG001|Run-In Period|Consent Withdrawn|0|||
144370520|NCT01499355|520564143|FG002|Run-In Period|Consent Withdrawn|0|||
144370521|NCT01499355|520564144|FG003|Run-In Period|Consent Withdrawn|0|||
144370522|NCT01499355|520564141|FG000|Run-In Period|Adverse Event|8|||
144370523|NCT01499355|520564142|FG001|Run-In Period|Adverse Event|0|||
144370524|NCT01499355|520564143|FG002|Run-In Period|Adverse Event|0|||
144370525|NCT01499355|520564144|FG003|Run-In Period|Adverse Event|0|||
144370526|NCT01499355|520564141|FG000|Double-Blind Period|Adverse Event|0|||
144370527|NCT01499355|520564142|FG001|Double-Blind Period|Adverse Event|2|||
144370528|NCT01499355|520564143|FG002|Double-Blind Period|Adverse Event|3|||
144370529|NCT01499355|520564144|FG003|Double-Blind Period|Adverse Event|2|||
144370530|NCT01499355|520564141|FG000|Double-Blind Period|Study Termination|0|||
144370531|NCT01499355|520564142|FG001|Double-Blind Period|Study Termination|18|||
144370532|NCT01499355|520564143|FG002|Double-Blind Period|Study Termination|16|||
144370533|NCT01499355|520564144|FG003|Double-Blind Period|Study Termination|14|||
144370534|NCT01499355|520564141|FG000|Double-Blind Period|Other|0|||
144370535|NCT01499355|520564142|FG001|Double-Blind Period|Other|1|||
144370536|NCT01499355|520564143|FG002|Double-Blind Period|Other|2|||
144370537|NCT01499355|520564144|FG003|Double-Blind Period|Other|2|||
144370538|NCT01499355|520564141|FG000|Double-Blind Period|Death|0|||
144370539|NCT01499355|520564142|FG001|Double-Blind Period|Death|1|||
144370540|NCT01499355|520564143|FG002|Double-Blind Period|Death|0|||
144370541|NCT01499355|520564144|FG003|Double-Blind Period|Death|0|||
144370542|NCT01499355|520564141|FG000|Double-Blind Period|Investigator Decision|0|||
144370543|NCT01499355|520564142|FG001|Double-Blind Period|Investigator Decision|0|||
144370544|NCT01499355|520564143|FG002|Double-Blind Period|Investigator Decision|3|||
144370545|NCT01499355|520564144|FG003|Double-Blind Period|Investigator Decision|3|||
144370546|NCT01499355|520564141|FG000|Double-Blind Period|Consent Withdrawn|0|||
144370547|NCT01499355|520564142|FG001|Double-Blind Period|Consent Withdrawn|0|||
144721649|NCT00635778|521835250|FG005|Overall Study|Adverse Event|6|||
144505448|NCT00711958|521048941|FG000|Overall Study|Death|10|||
144505449|NCT00711958|521048942|FG001|Overall Study|Death|5|||
144505450|NCT00711958|521048941|FG000|Overall Study|Progression of disease|1|||
144505451|NCT00711958|521048942|FG001|Overall Study|Progression of disease|0|||
144505452|NCT02383472|521048943|FG000|Overall Study|Withdrawal by Subject|1|||
144505453|NCT02383472|521048944|FG001|Overall Study|Withdrawal by Subject|1|||
144505454|NCT02013830|521048945|FG000|Overall Study|Adverse Event|3|||
144721650|NCT00635778|521835251|FG006|Overall Study|Adverse Event|1|||
144370548|NCT01499355|520564143|FG002|Double-Blind Period|Consent Withdrawn|1|||
144370549|NCT01499355|520564144|FG003|Double-Blind Period|Consent Withdrawn|2|||
144370550|NCT01499355|520564141|FG000|Double-Blind Period|Lost to Follow-up|0|||
144370551|NCT01499355|520564142|FG001|Double-Blind Period|Lost to Follow-up|1|||
144370552|NCT01499355|520564143|FG002|Double-Blind Period|Lost to Follow-up|0|||
144505455|NCT02013830|521048945|FG000|Overall Study|Death|1|||
144721651|NCT00635778|521835245|FG000|Overall Study|Withdrawal by Subject|0|||
144370553|NCT01499355|520564144|FG003|Double-Blind Period|Lost to Follow-up|0|||
144370554|NCT01526733|520564145|FG000|Phase 1|Protocol Violation|1|||
144370555|NCT01526733|520564146|FG001|Phase 1|Protocol Violation|0|||
144370556|NCT01526733|520564145|FG000|Phase 1|Withdrawal by Subject|1|||
144370557|NCT01526733|520564146|FG001|Phase 1|Withdrawal by Subject|1|||
144370558|NCT01457703|520564147|FG000|Overall Study|Screen Failure|5|||
144370559|NCT01457703|520564148|FG001|Overall Study|Screen Failure|7|||
144370560|NCT01457703|520564147|FG000|Overall Study|Withdrawal by Subject|1|||
144370561|NCT01457703|520564148|FG001|Overall Study|Withdrawal by Subject|4|||
144370562|NCT00949702|520564149|FG000|Overall Study|Death|40|||
144370563|NCT00949702|520564149|FG000|Overall Study|Disease progression|7|||
144370564|NCT00949702|520564149|FG000|Overall Study|Withdrawal of consent|1|||
144370565|NCT03133793|520564152|FG000|Overall Study|Withdrawal by Subject|0|||
144370566|NCT03133793|520564153|FG001|Overall Study|Withdrawal by Subject|4|||
144370567|NCT03133793|520564154|FG002|Overall Study|Withdrawal by Subject|2|||
144370568|NCT03133793|520564155|FG003|Overall Study|Withdrawal by Subject|4|||
144370569|NCT03133793|520564152|FG000|Overall Study|Lost to Follow-up|1|||
144370570|NCT03133793|520564153|FG001|Overall Study|Lost to Follow-up|0|||
144370571|NCT03133793|520564154|FG002|Overall Study|Lost to Follow-up|2|||
144370572|NCT03133793|520564155|FG003|Overall Study|Lost to Follow-up|0|||
144370573|NCT03133793|520564152|FG000|Overall Study|Death|0|||
144370574|NCT03133793|520564153|FG001|Overall Study|Death|0|||
144370575|NCT03133793|520564154|FG002|Overall Study|Death|0|||
144370576|NCT03133793|520564155|FG003|Overall Study|Death|1|||
144370577|NCT05006573|520564158|FG000|Double-blind Treatment Period|Physician Decision|2|||
144370578|NCT05006573|520564159|FG001|Double-blind Treatment Period|Physician Decision|0|||
144370579|NCT05006573|520564158|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
144370580|NCT05006573|520564159|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
144370581|NCT05006573|520564158|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
144370582|NCT05006573|520564159|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
144370583|NCT05006573|520564158|FG000|Double-blind Treatment Period|Protocol Violation|2|||
144370584|NCT05006573|520564159|FG001|Double-blind Treatment Period|Protocol Violation|0|||
144370585|NCT05006573|520564158|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
144370586|NCT05006573|520564159|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
144370587|NCT05006573|520564158|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
144370588|NCT05006573|520564159|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
144370589|NCT04949490|520564160|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
144370590|NCT04949490|520564161|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
144370591|NCT04949490|520564162|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
144370592|NCT04949490|520564163|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
144370593|NCT04949490|520564164|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
144370594|NCT04949490|520564165|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
144370595|NCT04949490|520564160|FG000|Group A and Group B|Withdrawal by Subject|0|||
144370596|NCT04949490|520564161|FG001|Group A and Group B|Withdrawal by Subject|0|||
144370597|NCT04949490|520564162|FG002|Group A and Group B|Withdrawal by Subject|1|||
144370598|NCT04949490|520564163|FG003|Group A and Group B|Withdrawal by Subject|0|||
144370599|NCT04949490|520564164|FG004|Group A and Group B|Withdrawal by Subject|0|||
144370600|NCT04949490|520564165|FG005|Group A and Group B|Withdrawal by Subject|0|||
144370601|NCT04949490|520564160|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
144370602|NCT04949490|520564161|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
144370603|NCT04949490|520564162|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
144370604|NCT04949490|520564163|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
144370605|NCT04949490|520564164|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
144370606|NCT04949490|520564165|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
144370607|NCT04949490|520564160|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
144370608|NCT04949490|520564161|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
144721652|NCT00635778|521835246|FG001|Overall Study|Withdrawal by Subject|0|||
144370609|NCT04949490|520564162|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
144370610|NCT04949490|520564163|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
144370611|NCT04949490|520564164|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
144370612|NCT04949490|520564165|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
144370613|NCT02446899|520565840|FG000|Overall Study|Adverse Event|4|||
144370614|NCT02446899|520565841|FG001|Overall Study|Adverse Event|7|||
144370615|NCT02446899|520565840|FG000|Overall Study|Condition Under Investigation Worsened|1|||
144505456|NCT02013830|521048945|FG000|Overall Study|Insufficient therapeutic response|25|||
144721653|NCT00635778|521835247|FG002|Overall Study|Withdrawal by Subject|0|||
144721654|NCT00635778|521835248|FG003|Overall Study|Withdrawal by Subject|1|||
144370616|NCT02446899|520565841|FG001|Overall Study|Condition Under Investigation Worsened|4|||
144370617|NCT02446899|520565840|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
144370618|NCT02446899|520565841|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
144505457|NCT02013830|521048945|FG000|Overall Study|Refused treatment|1|||
144505458|NCT03557008|521048947|FG000|Overall Study|Withdrawal by Subject|2|||
144505459|NCT03557008|521048948|FG001|Overall Study|Withdrawal by Subject|2|||
144505460|NCT03557008|521048947|FG000|Overall Study|Early termination from study|3|||
144370619|NCT02446899|520565840|FG000|Overall Study|Lack of Efficacy|2|||
144505461|NCT03557008|521048948|FG001|Overall Study|Early termination from study|1|||
144505462|NCT02296424|521048951|FG000|Part 1|New therapy for study indication|0|||
144505463|NCT02296424|521048952|FG001|Part 1|New therapy for study indication|1|||
144505464|NCT02296424|521048953|FG002|Part 1|New therapy for study indication|0|||
144505465|NCT02296424|521048954|FG003|Part 1|New therapy for study indication|0|||
144505466|NCT02296424|521048951|FG000|Part 1|Protocol Violation|0|||
144505467|NCT02296424|521048952|FG001|Part 1|Protocol Violation|1|||
144505468|NCT02296424|521048953|FG002|Part 1|Protocol Violation|0|||
144505469|NCT02296424|521048954|FG003|Part 1|Protocol Violation|0|||
144505470|NCT02296424|521048951|FG000|Part 1|Withdrawal by Subject|0|||
144505471|NCT02296424|521048952|FG001|Part 1|Withdrawal by Subject|2|||
144505472|NCT02296424|521048953|FG002|Part 1|Withdrawal by Subject|0|||
144505473|NCT02296424|521048954|FG003|Part 1|Withdrawal by Subject|0|||
144505474|NCT02296424|521048951|FG000|Part 1|Study terminated by sponsor|0|||
144721655|NCT00635778|521835249|FG004|Overall Study|Withdrawal by Subject|0|||
144505475|NCT02296424|521048952|FG001|Part 1|Study terminated by sponsor|1|||
144505476|NCT02296424|521048953|FG002|Part 1|Study terminated by sponsor|0|||
144370620|NCT02446899|520565841|FG001|Overall Study|Lack of Efficacy|8|||
144370621|NCT02446899|520565840|FG000|Overall Study|Lost to Follow-up|1|||
144370622|NCT02446899|520565841|FG001|Overall Study|Lost to Follow-up|3|||
144370623|NCT02446899|520565840|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
144370624|NCT02446899|520565841|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
144370625|NCT02446899|520565840|FG000|Overall Study|Withdrawal by Subject|11|||
144370626|NCT02446899|520565841|FG001|Overall Study|Withdrawal by Subject|19|||
144370627|NCT02446899|520565840|FG000|Overall Study|Miscellaneous|5|||
144370628|NCT02446899|520565841|FG001|Overall Study|Miscellaneous|4|||
144370629|NCT02446899|520565840|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
144370630|NCT02446899|520565841|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
144370631|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
144370632|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
144370633|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
144370634|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
144370635|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
144370636|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
144370637|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
144370638|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
144370639|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
144370640|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
144370641|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
144370642|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
144370643|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
144370644|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
144370645|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
144370646|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144370647|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
144370648|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144370649|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
144370650|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144370651|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144370652|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
144370653|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
144370654|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
144370655|NCT01106690|520565846|FG000|Core Period: Baseline to Week 26|Other|10|||
144370656|NCT01106690|520565847|FG001|Core Period: Baseline to Week 26|Other|2|||
144370657|NCT01106690|520565848|FG002|Core Period: Baseline to Week 26|Other|6|||
144370658|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
144721656|NCT00635778|521835250|FG005|Overall Study|Withdrawal by Subject|1|||
144721657|NCT00635778|521835251|FG006|Overall Study|Withdrawal by Subject|1|||
144721658|NCT00635778|521835245|FG000|Overall Study|Progressive disease|0|||
144370659|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
144370660|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
144370661|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144370662|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
144370663|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
144505477|NCT02296424|521048954|FG003|Part 1|Study terminated by sponsor|0|||
144721659|NCT00635778|521835246|FG001|Overall Study|Progressive disease|3|||
144721660|NCT00635778|521835247|FG002|Overall Study|Progressive disease|3|||
144370664|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144370665|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
144370666|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
144370667|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
144370668|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
144370669|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
144370670|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
144370671|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
144370672|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144370673|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Other|8|||
144370674|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Other|3|||
144370675|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Other|4|||
144370676|NCT01106690|520565846|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
144505478|NCT02296424|521048951|FG000|Part 1|Adverse Event|2|||
144505479|NCT02296424|521048952|FG001|Part 1|Adverse Event|11|||
144505480|NCT02296424|521048953|FG002|Part 1|Adverse Event|0|||
144370677|NCT01106690|520565847|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144370678|NCT01106690|520565848|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144370679|NCT00998296|520565849|FG000|Overall Study|Progressive disease|0|||
144370680|NCT00998296|520565850|FG001|Overall Study|Progressive disease|1|||
144370681|NCT00998296|520565851|FG002|Overall Study|Progressive disease|0|||
144370682|NCT00998296|520565852|FG003|Overall Study|Progressive disease|0|||
144370683|NCT00998296|520565853|FG004|Overall Study|Progressive disease|0|||
144370684|NCT00998296|520565854|FG005|Overall Study|Progressive disease|0|||
144370685|NCT00998296|520565855|FG006|Overall Study|Progressive disease|1|||
144370686|NCT00998296|520565856|FG007|Overall Study|Progressive disease|0|||
144370687|NCT00998296|520565857|FG008|Overall Study|Progressive disease|0|||
144370688|NCT00998296|520565858|FG009|Overall Study|Progressive disease|14|||
144370689|NCT00998296|520565859|FG010|Overall Study|Progressive disease|5|||
144370690|NCT00998296|520565849|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370691|NCT00998296|520565850|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370692|NCT00998296|520565851|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370693|NCT00998296|520565852|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370694|NCT00998296|520565853|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
144370695|NCT00998296|520565854|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370696|NCT00998296|520565855|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370697|NCT00998296|520565856|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
144370698|NCT00998296|520565857|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
144370699|NCT00998296|520565858|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370700|NCT00998296|520565859|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
144370701|NCT00998296|520565849|FG000|Overall Study|Other adverse event|0|||
144370702|NCT00998296|520565850|FG001|Overall Study|Other adverse event|0|||
144370703|NCT00998296|520565851|FG002|Overall Study|Other adverse event|0|||
144370704|NCT00998296|520565852|FG003|Overall Study|Other adverse event|0|||
144370705|NCT00998296|520565853|FG004|Overall Study|Other adverse event|1|||
144370706|NCT00998296|520565854|FG005|Overall Study|Other adverse event|0|||
144370707|NCT00998296|520565855|FG006|Overall Study|Other adverse event|0|||
144370708|NCT00998296|520565856|FG007|Overall Study|Other adverse event|0|||
144370709|NCT00998296|520565857|FG008|Overall Study|Other adverse event|0|||
144370710|NCT00998296|520565858|FG009|Overall Study|Other adverse event|1|||
144370711|NCT00998296|520565859|FG010|Overall Study|Other adverse event|2|||
144370712|NCT00998296|520565849|FG000|Overall Study|Refused to continue taking trial med.|0|||
144370713|NCT00998296|520565850|FG001|Overall Study|Refused to continue taking trial med.|0|||
144370714|NCT00998296|520565851|FG002|Overall Study|Refused to continue taking trial med.|0|||
144370715|NCT00998296|520565852|FG003|Overall Study|Refused to continue taking trial med.|0|||
144370716|NCT00998296|520565853|FG004|Overall Study|Refused to continue taking trial med.|0|||
144370717|NCT00998296|520565854|FG005|Overall Study|Refused to continue taking trial med.|0|||
144370718|NCT00998296|520565855|FG006|Overall Study|Refused to continue taking trial med.|0|||
144370719|NCT00998296|520565856|FG007|Overall Study|Refused to continue taking trial med.|0|||
144370720|NCT00998296|520565857|FG008|Overall Study|Refused to continue taking trial med.|0|||
144370721|NCT00998296|520565858|FG009|Overall Study|Refused to continue taking trial med.|2|||
144370722|NCT00998296|520565859|FG010|Overall Study|Refused to continue taking trial med.|0|||
144370723|NCT00998296|520565849|FG000|Overall Study|Reason other than those specified above|0|||
144370724|NCT00998296|520565850|FG001|Overall Study|Reason other than those specified above|0|||
144370725|NCT00998296|520565851|FG002|Overall Study|Reason other than those specified above|0|||
144505481|NCT02296424|521048954|FG003|Part 1|Adverse Event|0|||
144370726|NCT00998296|520565852|FG003|Overall Study|Reason other than those specified above|0|||
144370727|NCT00998296|520565853|FG004|Overall Study|Reason other than those specified above|0|||
144370728|NCT00998296|520565854|FG005|Overall Study|Reason other than those specified above|0|||
144370729|NCT00998296|520565855|FG006|Overall Study|Reason other than those specified above|0|||
144370730|NCT00998296|520565856|FG007|Overall Study|Reason other than those specified above|0|||
144370731|NCT00998296|520565857|FG008|Overall Study|Reason other than those specified above|0|||
144370732|NCT00998296|520565858|FG009|Overall Study|Reason other than those specified above|1|||
144370733|NCT00998296|520565859|FG010|Overall Study|Reason other than those specified above|0|||
144370734|NCT04396639|520565860|FG000|Overall Study|Withdrawal by Subject|1|||
144370735|NCT04396639|520565860|FG000|Overall Study|Other|1|||
144370736|NCT01544335|520565861|FG000|Overall Study|Lost to Follow-up|27|||
144370737|NCT01544335|520565861|FG000|Overall Study|Death|4|||
144370738|NCT01544335|520565861|FG000|Overall Study|Disease progression|3|||
144370739|NCT01544335|520565861|FG000|Overall Study|Baseline Measurements not Available|19|||
144370740|NCT03219528|520565868|FG000|Overall Study|Lost to Follow-up|5|||
144370741|NCT03219528|520565869|FG001|Overall Study|Lost to Follow-up|4|||
144370742|NCT03219528|520565868|FG000|Overall Study|Withdrawal by Subject|4|||
144370743|NCT03219528|520565869|FG001|Overall Study|Withdrawal by Subject|4|||
144370744|NCT00241839|520565870|FG000|Overall Study|Withdrawal by Subject|18|||
144370745|NCT00241839|520565871|FG001|Overall Study|Withdrawal by Subject|17|||
144370746|NCT00241839|520565870|FG000|Overall Study|Adverse Event|1|||
144370747|NCT00241839|520565871|FG001|Overall Study|Adverse Event|1|||
144370748|NCT04639258|520565876|FG000|Overall Study|Screen failure|5|||
144370749|NCT04639258|520565876|FG000|Overall Study|Physician Decision|2|||
144370750|NCT04639258|520565876|FG000|Overall Study|Early study termination|3|||
144370751|NCT04639258|520565876|FG000|Overall Study|Withdrawal by Subject|1|||
144370752|NCT01635153|520565877|FG000|Overall Study|Lost to Follow-up|40|||
144370753|NCT01635153|520565878|FG001|Overall Study|Lost to Follow-up|43|||
144370754|NCT02560558|520565879|FG000|Overall Study|Adverse Event|1|||
144370755|NCT02560558|520565880|FG001|Overall Study|Adverse Event|0|||
144370756|NCT02560558|520565879|FG000|Overall Study|Death|0|||
144370757|NCT02560558|520565880|FG001|Overall Study|Death|2|||
144370758|NCT02560558|520565879|FG000|Overall Study|Lost to Follow-up|0|||
144370759|NCT02560558|520565880|FG001|Overall Study|Lost to Follow-up|4|||
144370760|NCT02560558|520565879|FG000|Overall Study|Protocol Violation|3|||
144370761|NCT02560558|520565880|FG001|Overall Study|Protocol Violation|0|||
144370762|NCT02560558|520565879|FG000|Overall Study|Withdrawal by Subject|3|||
144370763|NCT02560558|520565880|FG001|Overall Study|Withdrawal by Subject|0|||
144370764|NCT00297258|520565891|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
144370765|NCT00297258|520565891|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
144370766|NCT00297258|520565891|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
144370767|NCT00297258|520565891|FG000|Overall Study|Intercurrent Illness|3|||
144370768|NCT00297258|520565891|FG000|Overall Study|Intercurrent Death|2|||
144370769|NCT00297258|520565891|FG000|Overall Study|Deteriorization of General Condition|1|||
144370770|NCT00297258|520565891|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
144505482|NCT02296424|521048951|FG000|Part 1|Lack of Efficacy|5|||
144505483|NCT02296424|521048952|FG001|Part 1|Lack of Efficacy|17|||
144505484|NCT02296424|521048953|FG002|Part 1|Lack of Efficacy|0|||
144505485|NCT02296424|521048954|FG003|Part 1|Lack of Efficacy|0|||
144370771|NCT00297258|520565891|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
144370772|NCT00297258|520565891|FG000|Overall Study|Switch to Commercial Treatment|1|||
144370773|NCT00297258|520565891|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
144370774|NCT01263197|520565893|FG000|First Intervention (Period 1)|Adverse Event|0|||
144370775|NCT01263197|520565894|FG001|First Intervention (Period 1)|Adverse Event|0|||
144370776|NCT01263197|520565895|FG002|First Intervention (Period 1)|Adverse Event|0|||
144370777|NCT01263197|520565896|FG003|First Intervention (Period 1)|Adverse Event|0|||
144370778|NCT01263197|520565897|FG004|First Intervention (Period 1)|Adverse Event|0|||
144505486|NCT02296424|521048951|FG000|Part 1|16 directly started part II|16|||
144370779|NCT01263197|520565898|FG005|First Intervention (Period 1)|Adverse Event|1|||
144370780|NCT01263197|520565893|FG000|Washout Period 1|Protocol Violation|0|||
144505487|NCT02296424|521048952|FG001|Part 1|16 directly started part II|0|||
144370781|NCT01263197|520565894|FG001|Washout Period 1|Protocol Violation|0|||
144370782|NCT01263197|520565895|FG002|Washout Period 1|Protocol Violation|0|||
144370783|NCT01263197|520565896|FG003|Washout Period 1|Protocol Violation|0|||
144370784|NCT01263197|520565897|FG004|Washout Period 1|Protocol Violation|1|||
144370785|NCT01263197|520565898|FG005|Washout Period 1|Protocol Violation|0|||
144370786|NCT01263197|520565893|FG000|Washout Period 2|Physician Decision|0|||
144370787|NCT01263197|520565894|FG001|Washout Period 2|Physician Decision|0|||
144370788|NCT01263197|520565895|FG002|Washout Period 2|Physician Decision|0|||
144370789|NCT01263197|520565896|FG003|Washout Period 2|Physician Decision|0|||
144370790|NCT01263197|520565897|FG004|Washout Period 2|Physician Decision|0|||
144370791|NCT01263197|520565898|FG005|Washout Period 2|Physician Decision|1|||
144370792|NCT01263197|520565893|FG000|Washout Period 2|Protocol Violation|0|||
144370793|NCT01263197|520565894|FG001|Washout Period 2|Protocol Violation|0|||
144370794|NCT01263197|520565895|FG002|Washout Period 2|Protocol Violation|0|||
144370795|NCT01263197|520565896|FG003|Washout Period 2|Protocol Violation|1|||
144370796|NCT01263197|520565897|FG004|Washout Period 2|Protocol Violation|0|||
144370797|NCT01263197|520565898|FG005|Washout Period 2|Protocol Violation|0|||
144370798|NCT01263197|520565893|FG000|Third Intervention (Period 3)|Adverse Event|0|||
144370799|NCT01263197|520565894|FG001|Third Intervention (Period 3)|Adverse Event|1|||
144370800|NCT01263197|520565895|FG002|Third Intervention (Period 3)|Adverse Event|0|||
144505488|NCT02296424|521048953|FG002|Part 1|16 directly started part II|0|||
144505489|NCT02296424|521048954|FG003|Part 1|16 directly started part II|0|||
144505490|NCT02296424|521048951|FG000|Part 2|Lack of Efficacy|0|||
144505491|NCT02296424|521048952|FG001|Part 2|Lack of Efficacy|0|||
144370801|NCT01263197|520565896|FG003|Third Intervention (Period 3)|Adverse Event|0|||
144370802|NCT01263197|520565897|FG004|Third Intervention (Period 3)|Adverse Event|0|||
144505492|NCT02296424|521048953|FG002|Part 2|Lack of Efficacy|1|||
144505493|NCT02296424|521048954|FG003|Part 2|Lack of Efficacy|0|||
144505494|NCT02296424|521048951|FG000|Part 2|Adverse Event|0|||
144505495|NCT02296424|521048952|FG001|Part 2|Adverse Event|0|||
144505496|NCT02296424|521048953|FG002|Part 2|Adverse Event|1|||
144505497|NCT02296424|521048954|FG003|Part 2|Adverse Event|0|||
144505498|NCT02296424|521048951|FG000|Part 2|Lost to Follow-up|0|||
144505499|NCT02296424|521048952|FG001|Part 2|Lost to Follow-up|0|||
144505500|NCT02296424|521048953|FG002|Part 2|Lost to Follow-up|1|||
144505501|NCT02296424|521048954|FG003|Part 2|Lost to Follow-up|0|||
144505502|NCT00186186|521048955|FG000|Overall Study|Lack of Efficacy|3|||
144505503|NCT00186186|521048955|FG000|Overall Study|Withdrawal by Subject|3|||
144505504|NCT00186186|521048955|FG000|Overall Study|Not reported as to reason|2|||
144505505|NCT00807144|521048956|FG000|Overall Study|Lost to Follow-up|0|||
144370803|NCT01263197|520565898|FG005|Third Intervention (Period 3)|Adverse Event|0|||
144370804|NCT01470326|520565899|FG000|Overall Study|Protocol Violation|32|||
144505506|NCT00807144|521048957|FG001|Overall Study|Lost to Follow-up|1|||
144505507|NCT00814346|521048958|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
144505508|NCT00814346|521048959|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
144505509|NCT00814346|521048958|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
144370805|NCT01470326|520565899|FG000|Overall Study|No Drug Administration Information|2|||
144370806|NCT01470326|520565899|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
144370807|NCT01967576|520565900|FG000|Overall Study|Withdrawal by Subject|3|||
144370808|NCT01967576|520565900|FG000|Overall Study|Progressed/Removed from treatment|1|||
144370809|NCT01967576|520565900|FG000|Overall Study|Study closing at site|1|||
144370810|NCT01967576|520565900|FG000|Overall Study|Adverse Event|1|||
144370811|NCT01967576|520565900|FG000|Overall Study|Refused further treatment|1|||
144370812|NCT03967444|520565903|FG000|Overall Study|Lost to Follow-up|1|||
144370813|NCT03967444|520565904|FG001|Overall Study|Lost to Follow-up|2|||
144370814|NCT00345358|520565910|FG000|Primary Vaccination Phase|Other|0|||
144370815|NCT00345358|520565911|FG001|Primary Vaccination Phase|Other|1|||
144370816|NCT00345358|520565912|FG002|Primary Vaccination Phase|Other|1|||
144370817|NCT00345358|520565913|FG003|Primary Vaccination Phase|Other|0|||
144370818|NCT00345358|520565910|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
144370819|NCT00345358|520565911|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
144370820|NCT00345358|520565912|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
144370821|NCT00345358|520565913|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
144370822|NCT00345358|520565910|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
144370823|NCT00345358|520565911|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
144370824|NCT00345358|520565912|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
144370825|NCT00345358|520565913|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
144370826|NCT00345358|520565910|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
144370827|NCT00345358|520565911|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
144370828|NCT00345358|520565912|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
144370829|NCT00345358|520565913|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
144370830|NCT00345358|520565910|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
144370831|NCT00345358|520565911|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
144370832|NCT00345358|520565912|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
144370833|NCT00345358|520565913|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
144370834|NCT00345358|520565910|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
144370835|NCT00345358|520565911|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
144370836|NCT00345358|520565912|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
144370837|NCT00345358|520565913|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
144370838|NCT00346697|520565915|FG000|Overall Study|Lost to Follow-up|0|||
144370839|NCT00346697|520565916|FG001|Overall Study|Lost to Follow-up|1|||
144370840|NCT02892448|520565917|FG000|Overall Study|Screening failure|2|||
144370841|NCT02892448|520565918|FG001|Overall Study|Screening failure|2|||
144370842|NCT02892448|520565919|FG002|Overall Study|Screening failure|1|||
144370843|NCT00499083|520565920|FG000|Overall Study|Not evaluable|3|||
144505510|NCT00814346|521048959|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
144505511|NCT00814346|521048958|FG000|Open Phase (17 Months)|Adverse Event|5|||
144505512|NCT00814346|521048959|FG001|Open Phase (17 Months)|Adverse Event|0|||
144505513|NCT00814346|521048958|FG000|Open Phase (17 Months)|Consent|2|||
144370844|NCT00318643|520565923|FG000|Overall Study|Adverse Event|0|||
144370845|NCT00318643|520565924|FG001|Overall Study|Adverse Event|0|||
144370846|NCT00318643|520565925|FG002|Overall Study|Adverse Event|0|||
144370847|NCT00318643|520565926|FG003|Overall Study|Adverse Event|0|||
144370848|NCT00318643|520565927|FG004|Overall Study|Adverse Event|1|||
144370849|NCT00318643|520565923|FG000|Overall Study|Participant's Decision|0|||
144370850|NCT00318643|520565924|FG001|Overall Study|Participant's Decision|0|||
144505514|NCT00814346|521048959|FG001|Open Phase (17 Months)|Consent|0|||
144505515|NCT00814346|521048958|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
144505516|NCT00814346|521048959|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
144370851|NCT00318643|520565925|FG002|Overall Study|Participant's Decision|0|||
144370852|NCT00318643|520565926|FG003|Overall Study|Participant's Decision|0|||
144248506|NCT02697916|520107937|FG000|Overall Study|Withdrawal by Subject|221|||
144721661|NCT00635778|521835248|FG003|Overall Study|Progressive disease|4|||
144370853|NCT00318643|520565927|FG004|Overall Study|Participant's Decision|1|||
144370854|NCT00318643|520565923|FG000|Overall Study|Investigator's Decision|0|||
144248507|NCT02697916|520107938|FG001|Overall Study|Withdrawal by Subject|393|||
144721662|NCT00635778|521835249|FG004|Overall Study|Progressive disease|5|||
144370855|NCT00318643|520565924|FG001|Overall Study|Investigator's Decision|0|||
144370856|NCT00318643|520565925|FG002|Overall Study|Investigator's Decision|0|||
144370857|NCT00318643|520565926|FG003|Overall Study|Investigator's Decision|0|||
144370858|NCT00318643|520565927|FG004|Overall Study|Investigator's Decision|1|||
144370859|NCT01812252|520565928|FG000|Overall Study|Persistent Disease|1|||
144370860|NCT01812252|520565929|FG001|Overall Study|Persistent Disease|0|||
144370861|NCT01812252|520565928|FG000|Overall Study|Not transplanted|11|||
144370862|NCT01812252|520565929|FG001|Overall Study|Not transplanted|11|||
144370863|NCT01812252|520565928|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
144505517|NCT00814346|521048958|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
144505518|NCT00814346|521048959|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
144505519|NCT05136443|521048961|FG000|Overall Study|Lost to Follow-up|2|||
144505520|NCT05136443|521048961|FG000|Overall Study|Adverse Event|2|||
144505521|NCT03192046|521048972|FG000|Overall Study|Withdrawal by Subject|1|||
144505522|NCT03192046|521048973|FG001|Overall Study|Withdrawal by Subject|1|||
144505523|NCT00762606|521048974|FG000|Overall Study|Lost to Follow-up|18|||
144505524|NCT00762606|521048975|FG001|Overall Study|Lost to Follow-up|13|||
144370864|NCT01812252|520565929|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
144370865|NCT01812252|520565928|FG000|Overall Study|Withdrawal by Subject|1|||
144370866|NCT01812252|520565929|FG001|Overall Study|Withdrawal by Subject|1|||
144370867|NCT01812252|520565928|FG000|Overall Study|Screen Failure|1|||
144370868|NCT01812252|520565929|FG001|Overall Study|Screen Failure|0|||
144370869|NCT01519921|520565933|FG000|Overall Study|Adverse Event|10|||
144370870|NCT01519921|520565934|FG001|Overall Study|Adverse Event|9|||
144370871|NCT01519921|520565933|FG000|Overall Study|Lack of Efficacy|4|||
144370872|NCT01519921|520565934|FG001|Overall Study|Lack of Efficacy|3|||
144370873|NCT01519921|520565933|FG000|Overall Study|Withdrawal by Subject|3|||
144370874|NCT01519921|520565934|FG001|Overall Study|Withdrawal by Subject|0|||
144370875|NCT01519921|520565933|FG000|Overall Study|Lost to Follow-up|2|||
144370876|NCT01519921|520565934|FG001|Overall Study|Lost to Follow-up|1|||
144370877|NCT01519921|520565933|FG000|Overall Study|Treatment refusal|2|||
144370878|NCT01519921|520565934|FG001|Overall Study|Treatment refusal|1|||
144370879|NCT01519921|520565933|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
144370880|NCT01519921|520565934|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
144370881|NCT04032093|520565935|FG000|Overall Study|Lost to Follow-up|7|||
144370882|NCT04032093|520565936|FG001|Overall Study|Lost to Follow-up|7|||
144370883|NCT04032093|520565937|FG002|Overall Study|Lost to Follow-up|6|||
144370884|NCT04032093|520565938|FG003|Overall Study|Lost to Follow-up|10|||
144370885|NCT04032093|520565939|FG004|Overall Study|Lost to Follow-up|13|||
144370886|NCT04032093|520565940|FG005|Overall Study|Lost to Follow-up|7|||
144370887|NCT04032093|520565941|FG006|Overall Study|Lost to Follow-up|7|||
144370888|NCT04032093|520565942|FG007|Overall Study|Lost to Follow-up|5|||
144370889|NCT04032093|520565943|FG008|Overall Study|Lost to Follow-up|9|||
144370890|NCT04032093|520565944|FG009|Overall Study|Lost to Follow-up|12|||
144370891|NCT04032093|520565935|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144370892|NCT04032093|520565936|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144370893|NCT04032093|520565937|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
144370894|NCT04032093|520565938|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
144370895|NCT04032093|520565939|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
144370896|NCT04032093|520565940|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
144370897|NCT04032093|520565941|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
144370898|NCT04032093|520565942|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
144505525|NCT00842257|521048978|FG000|Overall Study|Adverse Event|1|||
144505526|NCT01147341|521048979|FG000|Double Blind Period|Lack of Efficacy|1|||
144505527|NCT01147341|521048980|FG001|Double Blind Period|Lack of Efficacy|1|||
144505528|NCT01147341|521048979|FG000|Double Blind Period|Withdrawal by Subject|0|||
144505529|NCT01147341|521048980|FG001|Double Blind Period|Withdrawal by Subject|1|||
144505530|NCT01147341|521048979|FG000|Open Label Period|Lack of Efficacy|3|||
144505531|NCT01147341|521048980|FG001|Open Label Period|Lack of Efficacy|0|||
144505532|NCT01147341|521048979|FG000|Open Label Period|Subject moved|1|||
144505533|NCT01147341|521048980|FG001|Open Label Period|Subject moved|0|||
144505534|NCT05641311|521048988|FG000|Dosing Period 1|Adverse Event|1|||
144505535|NCT05641311|521048989|FG001|Dosing Period 1|Adverse Event|0|||
144505536|NCT02705586|521049001|FG000|Overall Study|Health Issues|2|||
144505537|NCT02705586|521049001|FG000|Overall Study|Transportation Difficulties|5|||
144505538|NCT02705586|521049001|FG000|Overall Study|Vacation/Planned Absence|1|||
144505539|NCT02045836|521049005|FG000|Overall Study|Adverse Event|4|||
144505540|NCT02045836|521049006|FG001|Overall Study|Adverse Event|4|||
144505541|NCT02045836|521049005|FG000|Overall Study|Withdrawal by Subject|1|||
144505542|NCT02045836|521049006|FG001|Overall Study|Withdrawal by Subject|1|||
144505543|NCT02045836|521049005|FG000|Overall Study|Lost to Follow-up|4|||
144505544|NCT02045836|521049006|FG001|Overall Study|Lost to Follow-up|7|||
144505545|NCT02045836|521049005|FG000|Overall Study|Migrated from study area|0|||
144505546|NCT02045836|521049006|FG001|Overall Study|Migrated from study area|2|||
144505547|NCT03920215|521049008|FG000|Overall Study|Lost to Follow-up|1|||
144505548|NCT03920215|521049009|FG001|Overall Study|Lost to Follow-up|2|||
144505549|NCT03920215|521049010|FG002|Overall Study|Lost to Follow-up|0|||
144505550|NCT03920215|521049011|FG003|Overall Study|Lost to Follow-up|0|||
144505551|NCT03920215|521049008|FG000|Overall Study|Death|0|||
144505552|NCT03920215|521049009|FG001|Overall Study|Death|0|||
144505553|NCT03920215|521049010|FG002|Overall Study|Death|0|||
144505554|NCT03920215|521049011|FG003|Overall Study|Death|1|||
144505555|NCT02798835|521049012|FG000|Overall Study|Protocol Violation|0|||
144505556|NCT02798835|521049013|FG001|Overall Study|Protocol Violation|0|||
144505557|NCT02798835|521049014|FG002|Overall Study|Protocol Violation|3|||
144370899|NCT04032093|520565943|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
144370900|NCT04032093|520565944|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
144370901|NCT04032093|520565935|FG000|Overall Study|Other|1|||
144370902|NCT04032093|520565936|FG001|Overall Study|Other|0|||
144370903|NCT04032093|520565937|FG002|Overall Study|Other|0|||
144370904|NCT04032093|520565938|FG003|Overall Study|Other|1|||
144370905|NCT04032093|520565939|FG004|Overall Study|Other|1|||
144370906|NCT04032093|520565940|FG005|Overall Study|Other|0|||
144370907|NCT04032093|520565941|FG006|Overall Study|Other|0|||
144370908|NCT04032093|520565942|FG007|Overall Study|Other|0|||
144370909|NCT04032093|520565943|FG008|Overall Study|Other|0|||
144370910|NCT04032093|520565944|FG009|Overall Study|Other|1|||
144370911|NCT04032093|520565935|FG000|Overall Study|Withdrawal by Subject|1|||
144505558|NCT03024606|521049019|FG000|Overall Study|Withdrawal by Subject|9|||
144505559|NCT03024606|521049020|FG001|Overall Study|Withdrawal by Subject|10|||
144505560|NCT02547922|521049027|FG000|Overall Study|Withdrawal by Subject|9|||
144505561|NCT02547922|521049028|FG001|Overall Study|Withdrawal by Subject|6|||
144505562|NCT02547922|521049029|FG002|Overall Study|Withdrawal by Subject|10|||
144505563|NCT02547922|521049027|FG000|Overall Study|Adverse Event|3|||
144505564|NCT02547922|521049028|FG001|Overall Study|Adverse Event|1|||
144505565|NCT02547922|521049029|FG002|Overall Study|Adverse Event|2|||
144505566|NCT02547922|521049027|FG000|Overall Study|Lost to Follow-up|1|||
144505567|NCT02547922|521049028|FG001|Overall Study|Lost to Follow-up|0|||
144505568|NCT02547922|521049029|FG002|Overall Study|Lost to Follow-up|0|||
144505569|NCT02547922|521049027|FG000|Overall Study|Lack of Efficacy|5|||
144505570|NCT02547922|521049028|FG001|Overall Study|Lack of Efficacy|7|||
144505571|NCT02547922|521049029|FG002|Overall Study|Lack of Efficacy|4|||
144505572|NCT02547922|521049027|FG000|Overall Study|Death|1|||
144505573|NCT02547922|521049028|FG001|Overall Study|Death|0|||
144505574|NCT02547922|521049029|FG002|Overall Study|Death|0|||
144505575|NCT02547922|521049027|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
144505576|NCT02547922|521049028|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
144505577|NCT02547922|521049029|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
144505578|NCT02547922|521049027|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
144505579|NCT02547922|521049028|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
144370912|NCT04032093|520565936|FG001|Overall Study|Withdrawal by Subject|3|||
144370913|NCT04032093|520565937|FG002|Overall Study|Withdrawal by Subject|2|||
144370914|NCT04032093|520565938|FG003|Overall Study|Withdrawal by Subject|2|||
144370915|NCT04032093|520565939|FG004|Overall Study|Withdrawal by Subject|3|||
144370916|NCT04032093|520565940|FG005|Overall Study|Withdrawal by Subject|0|||
144370917|NCT04032093|520565941|FG006|Overall Study|Withdrawal by Subject|0|||
144370918|NCT04032093|520565942|FG007|Overall Study|Withdrawal by Subject|0|||
144370919|NCT04032093|520565943|FG008|Overall Study|Withdrawal by Subject|0|||
144370920|NCT04032093|520565944|FG009|Overall Study|Withdrawal by Subject|0|||
144370921|NCT04032093|520565935|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144370922|NCT04032093|520565936|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144370923|NCT04032093|520565937|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144370924|NCT04032093|520565938|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144370925|NCT04032093|520565939|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144370926|NCT04032093|520565940|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144370927|NCT04032093|520565941|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
144370928|NCT04032093|520565942|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
144370929|NCT04032093|520565943|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
144370930|NCT04032093|520565944|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
144370931|NCT04032093|520565935|FG000|Overall Study|Adverse Event|0|||
144370932|NCT04032093|520565936|FG001|Overall Study|Adverse Event|0|||
144370933|NCT04032093|520565937|FG002|Overall Study|Adverse Event|0|||
144370934|NCT04032093|520565938|FG003|Overall Study|Adverse Event|0|||
144370935|NCT04032093|520565939|FG004|Overall Study|Adverse Event|0|||
144370936|NCT04032093|520565940|FG005|Overall Study|Adverse Event|0|||
144370937|NCT04032093|520565941|FG006|Overall Study|Adverse Event|0|||
144370938|NCT04032093|520565942|FG007|Overall Study|Adverse Event|0|||
144505580|NCT02547922|521049029|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
144505581|NCT02547922|521049027|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
144505582|NCT02547922|521049028|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
144370939|NCT04032093|520565943|FG008|Overall Study|Adverse Event|0|||
144370940|NCT04032093|520565944|FG009|Overall Study|Adverse Event|1|||
144370941|NCT04032093|520565935|FG000|Overall Study|Physician Decision|0|||
144370942|NCT04032093|520565936|FG001|Overall Study|Physician Decision|0|||
144370943|NCT04032093|520565937|FG002|Overall Study|Physician Decision|0|||
144370944|NCT04032093|520565938|FG003|Overall Study|Physician Decision|0|||
144370945|NCT04032093|520565939|FG004|Overall Study|Physician Decision|0|||
144370946|NCT04032093|520565940|FG005|Overall Study|Physician Decision|1|||
144505583|NCT02547922|521049029|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
144505584|NCT02547922|521049027|FG000|Overall Study|Physician Decision|2|||
144505585|NCT02547922|521049028|FG001|Overall Study|Physician Decision|1|||
144505586|NCT02547922|521049029|FG002|Overall Study|Physician Decision|2|||
144505587|NCT02547922|521049027|FG000|Overall Study|Patients did not receive IP|1|||
144505588|NCT02547922|521049028|FG001|Overall Study|Patients did not receive IP|1|||
144505589|NCT02547922|521049029|FG002|Overall Study|Patients did not receive IP|0|||
144505590|NCT00102063|521049034|FG000|Overall Study|Lack of Efficacy|5|||
144505591|NCT00102063|521049035|FG001|Overall Study|Lack of Efficacy|1|||
144505592|NCT00102063|521049036|FG002|Overall Study|Lack of Efficacy|1|||
144505593|NCT00102063|521049034|FG000|Overall Study|Adverse Event|7|||
144505594|NCT00102063|521049035|FG001|Overall Study|Adverse Event|4|||
144505595|NCT00102063|521049036|FG002|Overall Study|Adverse Event|2|||
144505596|NCT00102063|521049034|FG000|Overall Study|Withdrawal by Subject|4|||
144505597|NCT00102063|521049035|FG001|Overall Study|Withdrawal by Subject|12|||
144505598|NCT00102063|521049036|FG002|Overall Study|Withdrawal by Subject|5|||
144505599|NCT00102063|521049034|FG000|Overall Study|Lost to Follow-up|0|||
144721663|NCT00635778|521835250|FG005|Overall Study|Progressive disease|14|||
144370947|NCT04032093|520565941|FG006|Overall Study|Physician Decision|0|||
144505600|NCT00102063|521049035|FG001|Overall Study|Lost to Follow-up|0|||
144505601|NCT00102063|521049036|FG002|Overall Study|Lost to Follow-up|1|||
144505602|NCT00102063|521049034|FG000|Overall Study|Protocol Violation|0|||
144505603|NCT00102063|521049035|FG001|Overall Study|Protocol Violation|1|||
144505604|NCT00102063|521049036|FG002|Overall Study|Protocol Violation|1|||
144505605|NCT02739035|521049040|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
144505606|NCT02739035|521049041|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
144505607|NCT02739035|521049040|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
144505608|NCT02739035|521049041|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
144505609|NCT02739035|521049040|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
144505610|NCT02739035|521049041|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
144505611|NCT02739035|521049040|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
144505612|NCT02739035|521049041|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
144505613|NCT01350804|521049047|FG000|Core Study|Withdrawal by Subject|11|||
144505614|NCT01350804|521049048|FG001|Core Study|Withdrawal by Subject|17|||
144505615|NCT01350804|521049049|FG002|Core Study|Withdrawal by Subject|16|||
144505616|NCT01350804|521049050|FG003|Core Study|Withdrawal by Subject|7|||
144505617|NCT01350804|521049047|FG000|Core Study|Study terminated by Sponsor|0|||
144505618|NCT01350804|521049048|FG001|Core Study|Study terminated by Sponsor|0|||
144505619|NCT01350804|521049049|FG002|Core Study|Study terminated by Sponsor|0|||
144505620|NCT01350804|521049050|FG003|Core Study|Study terminated by Sponsor|2|||
144505621|NCT01350804|521049047|FG000|Core Study|Protocol deviation|1|||
144505622|NCT01350804|521049048|FG001|Core Study|Protocol deviation|0|||
144505623|NCT01350804|521049049|FG002|Core Study|Protocol deviation|1|||
144505624|NCT01350804|521049050|FG003|Core Study|Protocol deviation|0|||
144505625|NCT01350804|521049047|FG000|Core Study|Physician Decision|1|||
144505626|NCT01350804|521049048|FG001|Core Study|Physician Decision|0|||
144505627|NCT01350804|521049049|FG002|Core Study|Physician Decision|1|||
144505628|NCT01350804|521049050|FG003|Core Study|Physician Decision|3|||
144505629|NCT01350804|521049047|FG000|Core Study|Lost to Follow-up|3|||
144505630|NCT01350804|521049048|FG001|Core Study|Lost to Follow-up|0|||
144505631|NCT01350804|521049049|FG002|Core Study|Lost to Follow-up|2|||
144505632|NCT01350804|521049050|FG003|Core Study|Lost to Follow-up|1|||
144505633|NCT01350804|521049047|FG000|Core Study|Lack of Efficacy|16|||
144505634|NCT01350804|521049048|FG001|Core Study|Lack of Efficacy|19|||
144370948|NCT04032093|520565942|FG007|Overall Study|Physician Decision|0|||
144370949|NCT04032093|520565943|FG008|Overall Study|Physician Decision|0|||
144370950|NCT04032093|520565944|FG009|Overall Study|Physician Decision|0|||
144370951|NCT01654302|520565950|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
144370952|NCT01654302|520565951|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
144370953|NCT02377817|520565959|FG000|Overall Study|Transportation/childcare barriers.|2|||
144370954|NCT02377817|520565960|FG001|Overall Study|Transportation/childcare barriers.|0|||
144370955|NCT02377817|520565959|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
144370956|NCT02377817|520565960|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
144370957|NCT02839200|520565961|FG000|Overall Study|Withdrawal by Subject|2|||
144370958|NCT02839200|520565962|FG001|Overall Study|Withdrawal by Subject|0|||
144370959|NCT02839200|520565963|FG002|Overall Study|Withdrawal by Subject|1|||
144370960|NCT02839200|520565964|FG003|Overall Study|Withdrawal by Subject|0|||
144370961|NCT02839200|520565965|FG004|Overall Study|Withdrawal by Subject|0|||
144370962|NCT02839200|520565966|FG005|Overall Study|Withdrawal by Subject|1|||
144370963|NCT02839200|520565961|FG000|Overall Study|Lost to Follow-up|2|||
144370964|NCT02839200|520565962|FG001|Overall Study|Lost to Follow-up|0|||
144370965|NCT02839200|520565963|FG002|Overall Study|Lost to Follow-up|0|||
144370966|NCT02839200|520565964|FG003|Overall Study|Lost to Follow-up|0|||
144370967|NCT02839200|520565965|FG004|Overall Study|Lost to Follow-up|1|||
144370968|NCT02839200|520565966|FG005|Overall Study|Lost to Follow-up|0|||
144370969|NCT02839200|520565961|FG000|Overall Study|Adverse Event|0|||
144370970|NCT02839200|520565962|FG001|Overall Study|Adverse Event|0|||
144370971|NCT02839200|520565963|FG002|Overall Study|Adverse Event|0|||
144370972|NCT02839200|520565964|FG003|Overall Study|Adverse Event|0|||
144370973|NCT02839200|520565965|FG004|Overall Study|Adverse Event|1|||
144370974|NCT02839200|520565966|FG005|Overall Study|Adverse Event|0|||
144370975|NCT02839200|520565961|FG000|Overall Study|Randomized in error|0|||
144370976|NCT02839200|520565962|FG001|Overall Study|Randomized in error|1|||
144370977|NCT02839200|520565963|FG002|Overall Study|Randomized in error|0|||
144370978|NCT02839200|520565964|FG003|Overall Study|Randomized in error|0|||
144370979|NCT02839200|520565965|FG004|Overall Study|Randomized in error|0|||
144370980|NCT02839200|520565966|FG005|Overall Study|Randomized in error|0|||
144370981|NCT04139018|520565967|FG000|Overall Study|Screen fail|1|||
144370982|NCT04139018|520565968|FG001|Overall Study|Screen fail|0|||
144370983|NCT04139018|520565967|FG000|Overall Study|Withdrawal by Subject|2|||
144370984|NCT04139018|520565968|FG001|Overall Study|Withdrawal by Subject|0|||
144370985|NCT04139018|520565967|FG000|Overall Study|Lost to Follow-up|0|||
144370986|NCT04139018|520565968|FG001|Overall Study|Lost to Follow-up|1|||
144370987|NCT03614156|520565985|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
144370988|NCT03614156|520565986|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
144370989|NCT03614156|520565987|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
144370990|NCT03614156|520565988|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
144370991|NCT03614156|520565985|FG000|Open-Label Treatment Period|Adverse Event|7|||
144370992|NCT03614156|520565986|FG001|Open-Label Treatment Period|Adverse Event|0|||
144370993|NCT03614156|520565987|FG002|Open-Label Treatment Period|Adverse Event|0|||
144370994|NCT03614156|520565988|FG003|Open-Label Treatment Period|Adverse Event|0|||
144370995|NCT03614156|520565985|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
144370996|NCT03614156|520565986|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
144370997|NCT03614156|520565987|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
144370998|NCT03614156|520565988|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
144370999|NCT03614156|520565985|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
144371000|NCT03614156|520565986|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
144505635|NCT01350804|521049049|FG002|Core Study|Lack of Efficacy|18|||
144505636|NCT01350804|521049050|FG003|Core Study|Lack of Efficacy|5|||
144505637|NCT01350804|521049047|FG000|Core Study|Death|1|||
144505638|NCT01350804|521049048|FG001|Core Study|Death|1|||
144505639|NCT01350804|521049049|FG002|Core Study|Death|1|||
144505640|NCT01350804|521049050|FG003|Core Study|Death|0|||
144371001|NCT03614156|520565987|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
144505641|NCT01350804|521049047|FG000|Core Study|Adverse Event|8|||
144505642|NCT01350804|521049048|FG001|Core Study|Adverse Event|10|||
144371002|NCT03614156|520565988|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
144371003|NCT03614156|520565985|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
144371004|NCT03614156|520565986|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
144371005|NCT03614156|520565987|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
144505643|NCT01350804|521049049|FG002|Core Study|Adverse Event|8|||
144505644|NCT01350804|521049050|FG003|Core Study|Adverse Event|8|||
144505645|NCT01350804|521049047|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
144505646|NCT01350804|521049048|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
144505647|NCT01350804|521049049|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
144505648|NCT01350804|521049050|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
144505649|NCT01350804|521049047|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
144505650|NCT01350804|521049048|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
144505651|NCT01350804|521049049|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
144505652|NCT01350804|521049050|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
144505653|NCT01350804|521049047|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
144505654|NCT01350804|521049048|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
144505655|NCT01350804|521049049|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
144505656|NCT01350804|521049050|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
144505657|NCT01350804|521049047|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
144505658|NCT01350804|521049048|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
144505659|NCT01350804|521049049|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
144505660|NCT01350804|521049050|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
144505661|NCT01350804|521049047|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
144505662|NCT01350804|521049048|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
144505663|NCT01350804|521049049|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
144505664|NCT01350804|521049050|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
144505665|NCT01350804|521049047|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
144505666|NCT01350804|521049048|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
144505667|NCT01350804|521049049|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
144505668|NCT01350804|521049050|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
144505669|NCT03544515|521051343|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
144505670|NCT03544515|521051344|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
144505671|NCT03544515|521051343|FG000|Overall Study|Lost to Follow-up|2|||
144505672|NCT03544515|521051344|FG001|Overall Study|Lost to Follow-up|0|||
144505673|NCT03622593|521051345|FG000|Overall Study|Withdrawal by Subject|11|||
144505674|NCT03622593|521051346|FG001|Overall Study|Withdrawal by Subject|9|||
144505675|NCT03622593|521051347|FG002|Overall Study|Withdrawal by Subject|13|||
144505676|NCT03622593|521051345|FG000|Overall Study|Death|12|||
144505677|NCT03622593|521051346|FG001|Overall Study|Death|9|||
144505678|NCT03622593|521051347|FG002|Overall Study|Death|10|||
144505679|NCT03622593|521051345|FG000|Overall Study|Lost to Follow-up|11|||
144505680|NCT03622593|521051346|FG001|Overall Study|Lost to Follow-up|5|||
144505681|NCT03622593|521051347|FG002|Overall Study|Lost to Follow-up|8|||
144505682|NCT03622593|521051345|FG000|Overall Study|Adverse Event|4|||
144505683|NCT03622593|521051346|FG001|Overall Study|Adverse Event|5|||
144505684|NCT03622593|521051347|FG002|Overall Study|Adverse Event|6|||
144505685|NCT03622593|521051345|FG000|Overall Study|Physician Decision|2|||
144505686|NCT03622593|521051346|FG001|Overall Study|Physician Decision|1|||
144505687|NCT03622593|521051347|FG002|Overall Study|Physician Decision|6|||
144505688|NCT03622593|521051345|FG000|Overall Study|Other|2|||
144505689|NCT03622593|521051346|FG001|Overall Study|Other|2|||
144505690|NCT03622593|521051347|FG002|Overall Study|Other|3|||
144505691|NCT03622593|521051345|FG000|Overall Study|Protocol Violation|0|||
144505692|NCT03622593|521051346|FG001|Overall Study|Protocol Violation|0|||
144505693|NCT03622593|521051347|FG002|Overall Study|Protocol Violation|1|||
144505694|NCT03622593|521051345|FG000|Overall Study|Pregnancy|0|||
144505695|NCT03622593|521051346|FG001|Overall Study|Pregnancy|0|||
144505696|NCT03622593|521051347|FG002|Overall Study|Pregnancy|1|||
144505697|NCT01393119|521051348|FG000|Overall Study|Adverse Event|1|||
144505698|NCT01393119|521051349|FG001|Overall Study|Adverse Event|1|||
144505699|NCT01393119|521051350|FG002|Overall Study|Adverse Event|0|||
144505700|NCT01393119|521051351|FG003|Overall Study|Adverse Event|1|||
144505701|NCT01393119|521051348|FG000|Overall Study|Withdrawal by Subject|0|||
144505702|NCT01393119|521051349|FG001|Overall Study|Withdrawal by Subject|1|||
144505703|NCT01393119|521051350|FG002|Overall Study|Withdrawal by Subject|1|||
144505704|NCT01393119|521051351|FG003|Overall Study|Withdrawal by Subject|0|||
144505705|NCT01393119|521051348|FG000|Overall Study|Lack of Efficacy|1|||
144505706|NCT01393119|521051349|FG001|Overall Study|Lack of Efficacy|0|||
144505707|NCT01393119|521051350|FG002|Overall Study|Lack of Efficacy|2|||
144505708|NCT01393119|521051351|FG003|Overall Study|Lack of Efficacy|1|||
144505709|NCT01393119|521051348|FG000|Overall Study|Protocol Violation|0|||
144505710|NCT01393119|521051349|FG001|Overall Study|Protocol Violation|0|||
144505711|NCT01393119|521051350|FG002|Overall Study|Protocol Violation|1|||
144505712|NCT01393119|521051351|FG003|Overall Study|Protocol Violation|0|||
144505713|NCT01393119|521051348|FG000|Overall Study|Death|0|||
144505714|NCT01393119|521051349|FG001|Overall Study|Death|0|||
144505715|NCT01393119|521051350|FG002|Overall Study|Death|0|||
144505716|NCT01393119|521051351|FG003|Overall Study|Death|1|||
144721664|NCT00635778|521835251|FG006|Overall Study|Progressive disease|4|||
144721665|NCT01000337|521835255|FG000|Overall Study|Lost to Follow-up|4|||
144505717|NCT01393119|521051348|FG000|Overall Study|Randomized but Not treated|1|||
144505718|NCT01393119|521051349|FG001|Overall Study|Randomized but Not treated|0|||
144505719|NCT01393119|521051350|FG002|Overall Study|Randomized but Not treated|1|||
144505720|NCT01393119|521051351|FG003|Overall Study|Randomized but Not treated|1|||
144505721|NCT01393119|521051348|FG000|Overall Study|Sponsor Termination of Study|11|||
144505722|NCT01393119|521051349|FG001|Overall Study|Sponsor Termination of Study|12|||
144505723|NCT01393119|521051350|FG002|Overall Study|Sponsor Termination of Study|9|||
144505724|NCT01393119|521051351|FG003|Overall Study|Sponsor Termination of Study|12|||
144505725|NCT01266265|521051352|FG000|Overall Study|Death|95|||
144505726|NCT01266265|521051353|FG001|Overall Study|Death|73|||
144505727|NCT01266265|521051352|FG000|Overall Study|Lost to Follow-up|23|||
144505728|NCT01266265|521051353|FG001|Overall Study|Lost to Follow-up|28|||
144505729|NCT01266265|521051352|FG000|Overall Study|Withdrawal by Subject|13|||
144505730|NCT01266265|521051353|FG001|Overall Study|Withdrawal by Subject|11|||
144505731|NCT01266265|521051352|FG000|Overall Study|Respiratory-related adverse event|2|||
144505732|NCT01266265|521051353|FG001|Overall Study|Respiratory-related adverse event|1|||
144505733|NCT01266265|521051352|FG000|Overall Study|Transferred care to another provider|22|||
144505734|NCT01266265|521051353|FG001|Overall Study|Transferred care to another provider|28|||
144505735|NCT01266265|521051352|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
144505736|NCT01266265|521051353|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
144505737|NCT01266265|521051352|FG000|Overall Study|Enrolled in another clinical study|15|||
144505738|NCT01266265|521051353|FG001|Overall Study|Enrolled in another clinical study|26|||
144505739|NCT01266265|521051352|FG000|Overall Study|Non-compliance|8|||
144505740|NCT01266265|521051353|FG001|Overall Study|Non-compliance|5|||
144505741|NCT01266265|521051352|FG000|Overall Study|Lung transplant|6|||
144505742|NCT01266265|521051353|FG001|Overall Study|Lung transplant|5|||
144505743|NCT01266265|521051352|FG000|Overall Study|Site closed early|4|||
144505744|NCT01266265|521051353|FG001|Overall Study|Site closed early|3|||
144505745|NCT01266265|521051352|FG000|Overall Study|Clinical worsening|1|||
144505746|NCT01266265|521051353|FG001|Overall Study|Clinical worsening|1|||
144505747|NCT01580293|521051354|FG000|Part A_Main Trial|Adverse Event|0|||
144505748|NCT01580293|521051355|FG001|Part A_Main Trial|Adverse Event|2|||
144505749|NCT01580293|521051356|FG002|Part A_Main Trial|Adverse Event|0|||
144505750|NCT01580293|521051354|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
144505751|NCT01580293|521051355|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
144505752|NCT01580293|521051356|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
144505753|NCT01580293|521051354|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
144505754|NCT01580293|521051355|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
144505755|NCT01580293|521051356|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
144505756|NCT01580293|521051354|FG000|Part A_Extension|Adverse Event|0|||
144505757|NCT01580293|521051355|FG001|Part A_Extension|Adverse Event|2|||
144505758|NCT01580293|521051356|FG002|Part A_Extension|Adverse Event|0|||
144505759|NCT01580293|521051354|FG000|Part A_Extension|Withdrawal by Subject|0|||
144505760|NCT01580293|521051355|FG001|Part A_Extension|Withdrawal by Subject|3|||
144505761|NCT01580293|521051356|FG002|Part A_Extension|Withdrawal by Subject|0|||
144505762|NCT01580293|521051354|FG000|Part A_Extension|Lost to Follow-up|0|||
144505763|NCT01580293|521051355|FG001|Part A_Extension|Lost to Follow-up|1|||
144505764|NCT01580293|521051356|FG002|Part A_Extension|Lost to Follow-up|0|||
144505765|NCT01580293|521051354|FG000|Part A_Extension|Other Reason|0|||
144505766|NCT01580293|521051355|FG001|Part A_Extension|Other Reason|1|||
144505767|NCT01580293|521051356|FG002|Part A_Extension|Other Reason|0|||
144721666|NCT01000337|521835256|FG001|Overall Study|Lost to Follow-up|3|||
144721667|NCT01612000|521835257|FG000|Overall Study|Lost to Follow-up|6|||
144505768|NCT01580293|521051354|FG000|Part A_Extension|Completed Japan only|0|||
144505769|NCT01580293|521051355|FG001|Part A_Extension|Completed Japan only|5|||
144505770|NCT01580293|521051356|FG002|Part A_Extension|Completed Japan only|0|||
144505771|NCT01580293|521051354|FG000|Part B|Withdrawal by Subject|0|||
144505772|NCT01580293|521051355|FG001|Part B|Withdrawal by Subject|0|||
144721668|NCT01612000|521835258|FG001|Overall Study|Lost to Follow-up|4|||
144505773|NCT01580293|521051356|FG002|Part B|Withdrawal by Subject|1|||
144505774|NCT01580293|521051354|FG000|Part B|Other reason|0|||
144505775|NCT01580293|521051355|FG001|Part B|Other reason|0|||
144505776|NCT01580293|521051356|FG002|Part B|Other reason|1|||
144505777|NCT02544152|521051357|FG000|Overall Study|Adverse Event|0|||
144505778|NCT02544152|521051358|FG001|Overall Study|Adverse Event|4|||
144505779|NCT02544152|521051357|FG000|Overall Study|Withdrawal by Subject|0|||
144505780|NCT02544152|521051358|FG001|Overall Study|Withdrawal by Subject|3|||
144505781|NCT02544152|521051357|FG000|Overall Study|Other|1|||
144505782|NCT02544152|521051358|FG001|Overall Study|Other|0|||
144505783|NCT00423098|521051359|FG000|Overall Study|Adverse Event|1|||
144505784|NCT00423098|521051360|FG001|Overall Study|Adverse Event|2|||
144505785|NCT00423098|521051359|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144505786|NCT00423098|521051360|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144505787|NCT00423098|521051359|FG000|Overall Study|Administrative problems|0|||
144505788|NCT00423098|521051360|FG001|Overall Study|Administrative problems|1|||
144505789|NCT00423098|521051359|FG000|Overall Study|Death|2|||
144505790|NCT00423098|521051360|FG001|Overall Study|Death|0|||
144505791|NCT04480827|521051362|FG000|Overall Study|Adverse Event|0|||
144505792|NCT04480827|521051363|FG001|Overall Study|Adverse Event|0|||
144505793|NCT04480827|521051364|FG002|Overall Study|Adverse Event|0|||
144505794|NCT04480827|521051365|FG003|Overall Study|Adverse Event|0|||
144505795|NCT04480827|521051366|FG004|Overall Study|Adverse Event|0|||
144505796|NCT04480827|521051367|FG005|Overall Study|Adverse Event|1|||
144505797|NCT04480827|521051368|FG006|Overall Study|Adverse Event|0|||
144505798|NCT04218110|521051372|FG000|Overall Study|Withdrawal by Subject|0|||
144505799|NCT04218110|521051373|FG001|Overall Study|Withdrawal by Subject|0|||
144505800|NCT04218110|521051374|FG002|Overall Study|Withdrawal by Subject|0|||
144505801|NCT04218110|521051375|FG003|Overall Study|Withdrawal by Subject|1|||
144505802|NCT00002842|521051376|FG000|Overall Study|ineligible for surgical resection|27|||
144505803|NCT02015546|521051377|FG000|Overall Study|Withdrawal by Subject|1|||
144505804|NCT02015546|521051378|FG001|Overall Study|Withdrawal by Subject|1|||
144505805|NCT02015546|521051379|FG002|Overall Study|Withdrawal by Subject|1|||
144505806|NCT02015546|521051377|FG000|Overall Study|Screem Failure|2|||
144505807|NCT02015546|521051378|FG001|Overall Study|Screem Failure|1|||
144505808|NCT02015546|521051379|FG002|Overall Study|Screem Failure|3|||
144505809|NCT01337635|521051380|FG000|Overall Study|Lost to Follow-up|0|||
144505810|NCT01337635|521051381|FG001|Overall Study|Lost to Follow-up|1|||
144505811|NCT01113931|521051382|FG000|Overall Study|Adverse Event|2|||
144505812|NCT01113931|521051383|FG001|Overall Study|Adverse Event|2|||
144505813|NCT01113931|521051382|FG000|Overall Study|Physician Decision|0|||
144505814|NCT01113931|521051383|FG001|Overall Study|Physician Decision|2|||
144505815|NCT01113931|521051382|FG000|Overall Study|Lost to Follow-up|12|||
144505816|NCT01113931|521051383|FG001|Overall Study|Lost to Follow-up|9|||
144505817|NCT01113931|521051382|FG000|Overall Study|Various|2|||
144505818|NCT01113931|521051383|FG001|Overall Study|Various|4|||
144505819|NCT01113931|521051382|FG000|Overall Study|Withdrawal by Subject|3|||
144505820|NCT01113931|521051383|FG001|Overall Study|Withdrawal by Subject|0|||
144505821|NCT01307267|521051386|FG000|Overall Study|Death|4|||
144505822|NCT01307267|521051387|FG001|Overall Study|Death|3|||
144505823|NCT01307267|521051388|FG002|Overall Study|Death|5|||
144505824|NCT01307267|521051389|FG003|Overall Study|Death|3|||
144505825|NCT01307267|521051390|FG004|Overall Study|Death|1|||
144505826|NCT01307267|521051391|FG005|Overall Study|Death|26|||
144505827|NCT01307267|521051392|FG006|Overall Study|Death|2|||
144505828|NCT01307267|521051393|FG007|Overall Study|Death|2|||
144505829|NCT01307267|521051394|FG008|Overall Study|Death|21|||
144505830|NCT01307267|521051395|FG009|Overall Study|Death|2|||
144505831|NCT01307267|521051396|FG010|Overall Study|Death|3|||
144505832|NCT01307267|521051397|FG011|Overall Study|Death|9|||
144505833|NCT01307267|521051398|FG012|Overall Study|Death|0|||
144505834|NCT01307267|521051399|FG013|Overall Study|Death|0|||
144505835|NCT01307267|521051400|FG014|Overall Study|Death|0|||
144505836|NCT01307267|521051401|FG015|Overall Study|Death|0|||
144505837|NCT01307267|521051402|FG016|Overall Study|Death|1|||
144505838|NCT01307267|521051403|FG017|Overall Study|Death|1|||
144505839|NCT01307267|521051404|FG018|Overall Study|Death|2|||
144505840|NCT01307267|521051405|FG019|Overall Study|Death|8|||
144505841|NCT01307267|521051406|FG020|Overall Study|Death|1|||
144505842|NCT01307267|521051407|FG021|Overall Study|Death|2|||
144505843|NCT01307267|521051408|FG022|Overall Study|Death|2|||
144505844|NCT01307267|521051386|FG000|Overall Study|Lost to Follow-up|0|||
144505845|NCT01307267|521051387|FG001|Overall Study|Lost to Follow-up|0|||
144505846|NCT01307267|521051388|FG002|Overall Study|Lost to Follow-up|0|||
144505847|NCT01307267|521051389|FG003|Overall Study|Lost to Follow-up|0|||
144505848|NCT01307267|521051390|FG004|Overall Study|Lost to Follow-up|0|||
144505849|NCT01307267|521051391|FG005|Overall Study|Lost to Follow-up|7|||
144505850|NCT01307267|521051392|FG006|Overall Study|Lost to Follow-up|0|||
144505851|NCT01307267|521051393|FG007|Overall Study|Lost to Follow-up|0|||
144505852|NCT01307267|521051394|FG008|Overall Study|Lost to Follow-up|1|||
144721669|NCT01612000|521835259|FG002|Overall Study|Lost to Follow-up|4|||
144505853|NCT01307267|521051395|FG009|Overall Study|Lost to Follow-up|2|||
144505854|NCT01307267|521051396|FG010|Overall Study|Lost to Follow-up|1|||
144505855|NCT01307267|521051397|FG011|Overall Study|Lost to Follow-up|0|||
144505856|NCT01307267|521051398|FG012|Overall Study|Lost to Follow-up|0|||
144505857|NCT01307267|521051399|FG013|Overall Study|Lost to Follow-up|0|||
144505858|NCT01307267|521051400|FG014|Overall Study|Lost to Follow-up|0|||
144505859|NCT01307267|521051401|FG015|Overall Study|Lost to Follow-up|0|||
144505860|NCT01307267|521051402|FG016|Overall Study|Lost to Follow-up|0|||
144721670|NCT01612000|521835260|FG003|Overall Study|Lost to Follow-up|8|||
144505861|NCT01307267|521051403|FG017|Overall Study|Lost to Follow-up|0|||
144505862|NCT01307267|521051404|FG018|Overall Study|Lost to Follow-up|0|||
144505863|NCT01307267|521051405|FG019|Overall Study|Lost to Follow-up|2|||
144505864|NCT01307267|521051406|FG020|Overall Study|Lost to Follow-up|0|||
144505865|NCT01307267|521051407|FG021|Overall Study|Lost to Follow-up|0|||
144505866|NCT01307267|521051408|FG022|Overall Study|Lost to Follow-up|0|||
144505867|NCT01307267|521051386|FG000|Overall Study|Withdrawal by Subject|0|||
144505868|NCT01307267|521051387|FG001|Overall Study|Withdrawal by Subject|0|||
144505869|NCT01307267|521051388|FG002|Overall Study|Withdrawal by Subject|0|||
144505870|NCT01307267|521051389|FG003|Overall Study|Withdrawal by Subject|0|||
144505871|NCT01307267|521051390|FG004|Overall Study|Withdrawal by Subject|0|||
144505872|NCT01307267|521051391|FG005|Overall Study|Withdrawal by Subject|1|||
144505873|NCT01307267|521051392|FG006|Overall Study|Withdrawal by Subject|0|||
144505874|NCT01307267|521051393|FG007|Overall Study|Withdrawal by Subject|1|||
144505875|NCT01307267|521051394|FG008|Overall Study|Withdrawal by Subject|5|||
144505876|NCT01307267|521051395|FG009|Overall Study|Withdrawal by Subject|1|||
144505877|NCT01307267|521051396|FG010|Overall Study|Withdrawal by Subject|1|||
144505878|NCT01307267|521051397|FG011|Overall Study|Withdrawal by Subject|1|||
144505879|NCT01307267|521051398|FG012|Overall Study|Withdrawal by Subject|0|||
144505880|NCT01307267|521051399|FG013|Overall Study|Withdrawal by Subject|0|||
144505881|NCT01307267|521051400|FG014|Overall Study|Withdrawal by Subject|0|||
144505882|NCT01307267|521051401|FG015|Overall Study|Withdrawal by Subject|0|||
144505883|NCT01307267|521051402|FG016|Overall Study|Withdrawal by Subject|0|||
144505884|NCT01307267|521051403|FG017|Overall Study|Withdrawal by Subject|0|||
144505885|NCT01307267|521051404|FG018|Overall Study|Withdrawal by Subject|0|||
144505886|NCT01307267|521051405|FG019|Overall Study|Withdrawal by Subject|3|||
144505887|NCT01307267|521051406|FG020|Overall Study|Withdrawal by Subject|0|||
144505888|NCT01307267|521051407|FG021|Overall Study|Withdrawal by Subject|0|||
144505889|NCT01307267|521051408|FG022|Overall Study|Withdrawal by Subject|0|||
144505890|NCT01307267|521051386|FG000|Overall Study|Other|0|||
144505891|NCT01307267|521051387|FG001|Overall Study|Other|0|||
144505892|NCT01307267|521051388|FG002|Overall Study|Other|0|||
144505893|NCT01307267|521051389|FG003|Overall Study|Other|0|||
144505894|NCT01307267|521051390|FG004|Overall Study|Other|0|||
144505895|NCT01307267|521051391|FG005|Overall Study|Other|7|||
144505896|NCT01307267|521051392|FG006|Overall Study|Other|0|||
144505897|NCT01307267|521051393|FG007|Overall Study|Other|1|||
144505898|NCT01307267|521051394|FG008|Overall Study|Other|3|||
144505899|NCT01307267|521051395|FG009|Overall Study|Other|0|||
144505900|NCT01307267|521051396|FG010|Overall Study|Other|1|||
144505901|NCT01307267|521051397|FG011|Overall Study|Other|1|||
144505902|NCT01307267|521051398|FG012|Overall Study|Other|1|||
144505903|NCT01307267|521051399|FG013|Overall Study|Other|0|||
144505904|NCT01307267|521051400|FG014|Overall Study|Other|2|||
144505905|NCT01307267|521051401|FG015|Overall Study|Other|1|||
144505906|NCT01307267|521051402|FG016|Overall Study|Other|0|||
144505907|NCT01307267|521051403|FG017|Overall Study|Other|0|||
144505908|NCT01307267|521051404|FG018|Overall Study|Other|0|||
144505909|NCT01307267|521051405|FG019|Overall Study|Other|19|||
144505910|NCT01307267|521051406|FG020|Overall Study|Other|2|||
144505911|NCT01307267|521051407|FG021|Overall Study|Other|3|||
144505912|NCT01307267|521051408|FG022|Overall Study|Other|2|||
144505913|NCT04956575|521051412|FG000|Overall Study|Death|1|||
144505914|NCT04956575|521051413|FG001|Overall Study|Death|0|||
144505915|NCT04956575|521051414|FG002|Overall Study|Death|0|||
144505916|NCT04956575|521051415|FG003|Overall Study|Death|0|||
144505917|NCT04956575|521051416|FG004|Overall Study|Death|0|||
144505918|NCT04956575|521051417|FG005|Overall Study|Death|0|||
144505919|NCT04956575|521051418|FG006|Overall Study|Death|0|||
144505920|NCT04956575|521051419|FG007|Overall Study|Death|1|||
144505921|NCT04956575|521051420|FG008|Overall Study|Death|0|||
144505922|NCT04956575|521051421|FG009|Overall Study|Death|1|||
144505923|NCT04956575|521051422|FG010|Overall Study|Death|0|||
144505924|NCT04956575|521051423|FG011|Overall Study|Death|0|||
144505925|NCT04956575|521051412|FG000|Overall Study|Lost to Follow-up|3|||
144505926|NCT04956575|521051413|FG001|Overall Study|Lost to Follow-up|4|||
144505927|NCT04956575|521051414|FG002|Overall Study|Lost to Follow-up|2|||
144505928|NCT04956575|521051415|FG003|Overall Study|Lost to Follow-up|3|||
144505929|NCT04956575|521051416|FG004|Overall Study|Lost to Follow-up|1|||
144505930|NCT04956575|521051417|FG005|Overall Study|Lost to Follow-up|10|||
144505931|NCT04956575|521051418|FG006|Overall Study|Lost to Follow-up|11|||
144505932|NCT04956575|521051419|FG007|Overall Study|Lost to Follow-up|7|||
144505933|NCT04956575|521051420|FG008|Overall Study|Lost to Follow-up|4|||
144505934|NCT04956575|521051421|FG009|Overall Study|Lost to Follow-up|2|||
144505935|NCT04956575|521051422|FG010|Overall Study|Lost to Follow-up|3|||
144505936|NCT04956575|521051423|FG011|Overall Study|Lost to Follow-up|8|||
144505937|NCT04956575|521051412|FG000|Overall Study|Withdrawal by Subject|1|||
144505938|NCT04956575|521051413|FG001|Overall Study|Withdrawal by Subject|2|||
144505939|NCT04956575|521051414|FG002|Overall Study|Withdrawal by Subject|1|||
144505940|NCT04956575|521051415|FG003|Overall Study|Withdrawal by Subject|4|||
144505941|NCT04956575|521051416|FG004|Overall Study|Withdrawal by Subject|2|||
144505942|NCT04956575|521051417|FG005|Overall Study|Withdrawal by Subject|8|||
144505943|NCT04956575|521051418|FG006|Overall Study|Withdrawal by Subject|5|||
144505944|NCT04956575|521051419|FG007|Overall Study|Withdrawal by Subject|1|||
144505945|NCT04956575|521051420|FG008|Overall Study|Withdrawal by Subject|1|||
144505946|NCT04956575|521051421|FG009|Overall Study|Withdrawal by Subject|0|||
144505947|NCT04956575|521051422|FG010|Overall Study|Withdrawal by Subject|3|||
144505948|NCT04956575|521051423|FG011|Overall Study|Withdrawal by Subject|1|||
144505949|NCT03593876|521051424|FG000|Overall Study|Withdrawal by Subject|1|||
144505950|NCT03593876|521051424|FG000|Overall Study|Discharged home before intervention completion|2|||
144505951|NCT00854906|521051430|FG000|Overall Study|One person had no ocular history|1|||
144505952|NCT00071799|521051431|FG000|Overall Study|Adverse Event|19|||
144505953|NCT00071799|521051432|FG001|Overall Study|Adverse Event|10|||
144505954|NCT00071799|521051431|FG000|Overall Study|Protocol Violation|1|||
144505955|NCT00071799|521051432|FG001|Overall Study|Protocol Violation|7|||
144505956|NCT00071799|521051431|FG000|Overall Study|Lost to Follow-up|1|||
144505957|NCT00071799|521051432|FG001|Overall Study|Lost to Follow-up|1|||
144505958|NCT00071799|521051431|FG000|Overall Study|Withdrawal by Subject|15|||
144505959|NCT00071799|521051432|FG001|Overall Study|Withdrawal by Subject|37|||
144505960|NCT00071799|521051431|FG000|Overall Study|Physician Decision|0|||
144505961|NCT00071799|521051432|FG001|Overall Study|Physician Decision|2|||
144505962|NCT00071799|521051431|FG000|Overall Study|Lack of Efficacy|11|||
144505963|NCT00071799|521051432|FG001|Overall Study|Lack of Efficacy|18|||
144505964|NCT00071799|521051431|FG000|Overall Study|Disease Progression|23|||
144505965|NCT00071799|521051432|FG001|Overall Study|Disease Progression|20|||
144505966|NCT00071799|521051431|FG000|Overall Study|Different Central+Local Pathology Review|0|||
144505967|NCT00071799|521051432|FG001|Overall Study|Different Central+Local Pathology Review|1|||
144505968|NCT00071799|521051431|FG000|Overall Study|Not Documented|0|||
144505969|NCT00071799|521051432|FG001|Overall Study|Not Documented|2|||
144505970|NCT03959241|521051433|FG000|Overall Study|Withdrawal by Subject|7|||
144505971|NCT03959241|521051434|FG001|Overall Study|Withdrawal by Subject|8|||
144505972|NCT03959241|521051433|FG000|Overall Study|Lost to Follow-up|1|||
144505973|NCT03959241|521051434|FG001|Overall Study|Lost to Follow-up|0|||
144505974|NCT03959241|521051433|FG000|Overall Study|Move to Hospice Care|1|||
144505975|NCT03959241|521051434|FG001|Overall Study|Move to Hospice Care|0|||
144505976|NCT03959241|521051433|FG000|Overall Study|Screen Failure|1|||
144505977|NCT03959241|521051434|FG001|Overall Study|Screen Failure|0|||
144505978|NCT03959241|521051433|FG000|Overall Study|Disease Relapse|0|||
144505979|NCT03959241|521051434|FG001|Overall Study|Disease Relapse|1|||
144505980|NCT03959241|521051433|FG000|Overall Study|Off Study|1|||
144505981|NCT03959241|521051434|FG001|Overall Study|Off Study|0|||
144505982|NCT00831415|521051435|FG000|Overall Study|Adverse Event|14|||
144505983|NCT00831415|521051435|FG000|Overall Study|Failed to return|3|||
144505984|NCT00831415|521051435|FG000|Overall Study|Physician Decision|6|||
144505985|NCT00831415|521051435|FG000|Overall Study|Lost to Follow-up|9|||
144505986|NCT00831415|521051435|FG000|Overall Study|Protocol Violation|3|||
144505987|NCT00831415|521051435|FG000|Overall Study|Withdrawal by Subject|35|||
144505988|NCT00831415|521051435|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
144505989|NCT00831415|521051435|FG000|Overall Study|Death|1|||
144505990|NCT01290224|521051436|FG000|Overall Study|Adverse Event|1|||
144505991|NCT01290224|521051436|FG000|Overall Study|Refused Further Treatment|4|||
144505992|NCT03861767|521051437|FG000|Overall Study|Withdrawal by Subject|2|||
144505993|NCT03861767|521051438|FG001|Overall Study|Withdrawal by Subject|1|||
144505994|NCT03861767|521051439|FG002|Overall Study|Withdrawal by Subject|0|||
144505995|NCT03861767|521051440|FG003|Overall Study|Withdrawal by Subject|5|||
144505996|NCT03861767|521051441|FG004|Overall Study|Withdrawal by Subject|2|||
144505997|NCT03861767|521051442|FG005|Overall Study|Withdrawal by Subject|1|||
144505998|NCT03861767|521051443|FG006|Overall Study|Withdrawal by Subject|3|||
144505999|NCT03861767|521051444|FG007|Overall Study|Withdrawal by Subject|1|||
144506000|NCT03861767|521051445|FG008|Overall Study|Withdrawal by Subject|0|||
144506001|NCT03861767|521051446|FG009|Overall Study|Withdrawal by Subject|5|||
144506002|NCT00346333|521051447|FG000|Overall Study|Death|1|||
144506003|NCT00346333|521051448|FG001|Overall Study|Death|0|||
144506004|NCT00346333|521051447|FG000|Overall Study|unwilling or unable to continue|4|||
144506005|NCT00346333|521051448|FG001|Overall Study|unwilling or unable to continue|8|||
144506006|NCT03184558|521051449|FG000|Overall Study|Withdrawal by Subject|2|||
144506007|NCT03184558|521051449|FG000|Overall Study|Death|16|||
144506008|NCT03184558|521051449|FG000|Overall Study|Lost to Follow-up|2|||
144506009|NCT03184558|521051449|FG000|Overall Study|Other|9|||
144506010|NCT03460756|521051450|FG000|Overall Study|Adverse Event|0|||
144506011|NCT03460756|521051451|FG001|Overall Study|Adverse Event|0|||
144506012|NCT03460756|521051452|FG002|Overall Study|Adverse Event|0|||
144506013|NCT03460756|521051453|FG003|Overall Study|Adverse Event|1|||
144506014|NCT03460756|521051450|FG000|Overall Study|Lack of Efficacy|0|||
144506015|NCT03460756|521051451|FG001|Overall Study|Lack of Efficacy|0|||
144506016|NCT03460756|521051452|FG002|Overall Study|Lack of Efficacy|0|||
144506017|NCT03460756|521051453|FG003|Overall Study|Lack of Efficacy|2|||
144506018|NCT03460756|521051450|FG000|Overall Study|Lost to Follow-up|0|||
144506019|NCT03460756|521051451|FG001|Overall Study|Lost to Follow-up|1|||
144506020|NCT03460756|521051452|FG002|Overall Study|Lost to Follow-up|2|||
144506021|NCT03460756|521051453|FG003|Overall Study|Lost to Follow-up|1|||
144506022|NCT03460756|521051450|FG000|Overall Study|Pregnancy|0|||
144506023|NCT03460756|521051451|FG001|Overall Study|Pregnancy|0|||
144506024|NCT03460756|521051452|FG002|Overall Study|Pregnancy|0|||
144506025|NCT03460756|521051453|FG003|Overall Study|Pregnancy|1|||
144506026|NCT03460756|521051450|FG000|Overall Study|Protocol Violation|0|||
144506027|NCT03460756|521051451|FG001|Overall Study|Protocol Violation|0|||
144506028|NCT03460756|521051452|FG002|Overall Study|Protocol Violation|0|||
144506029|NCT03460756|521051453|FG003|Overall Study|Protocol Violation|1|||
144506030|NCT03460756|521051450|FG000|Overall Study|Withdrawal by Subject|0|||
144506031|NCT03460756|521051451|FG001|Overall Study|Withdrawal by Subject|4|||
144506032|NCT03460756|521051452|FG002|Overall Study|Withdrawal by Subject|7|||
144506033|NCT03460756|521051453|FG003|Overall Study|Withdrawal by Subject|3|||
144506034|NCT00922207|521051458|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
144506035|NCT00922207|521051459|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
144506036|NCT00922207|521051460|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
144506037|NCT00922207|521051458|FG000|Overall Study|Insufficient Therapeutic Response|0|||
144506038|NCT00922207|521051459|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144506039|NCT00922207|521051460|FG002|Overall Study|Insufficient Therapeutic Response|1|||
144506040|NCT00922207|521051458|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
144506041|NCT00922207|521051459|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
144506042|NCT00922207|521051460|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
144506043|NCT00922207|521051458|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
144506044|NCT00922207|521051459|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
144506045|NCT00922207|521051460|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
144506046|NCT00922207|521051458|FG000|Overall Study|Withdrew Consent|2|||
144506047|NCT00922207|521051459|FG001|Overall Study|Withdrew Consent|5|||
144506048|NCT00922207|521051460|FG002|Overall Study|Withdrew Consent|2|||
144506049|NCT00922207|521051458|FG000|Overall Study|Abnormality of Laboratory Test|0|||
144506050|NCT00922207|521051459|FG001|Overall Study|Abnormality of Laboratory Test|1|||
144506051|NCT00922207|521051460|FG002|Overall Study|Abnormality of Laboratory Test|1|||
144506052|NCT03299816|521051461|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
144506053|NCT03299816|521051462|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
144506054|NCT03299816|521051461|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
144506055|NCT03299816|521051462|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
144506056|NCT03299816|521051461|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
144506057|NCT03299816|521051462|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
144506058|NCT00367991|521051466|FG000|Overall Study|Withdrawal by Subject|1|||
144506059|NCT00367991|521051467|FG001|Overall Study|Withdrawal by Subject|1|||
144506060|NCT00367991|521051466|FG000|Overall Study|Adverse Event|1|||
144506061|NCT00367991|521051467|FG001|Overall Study|Adverse Event|1|||
144506062|NCT02969863|521051475|FG000|Overall Study|Physician Decision|1|||
144506063|NCT02969863|521051476|FG001|Overall Study|Physician Decision|0|||
144506064|NCT02969863|521051477|FG002|Overall Study|Physician Decision|0|||
144506065|NCT02969863|521051478|FG003|Overall Study|Physician Decision|0|||
144506066|NCT02969863|521051479|FG004|Overall Study|Physician Decision|0|||
144506067|NCT02969863|521051480|FG005|Overall Study|Physician Decision|0|||
144506068|NCT01135511|521051481|FG000|Overall Study|Adverse Event|0|||
144506069|NCT01135511|521051482|FG001|Overall Study|Adverse Event|1|||
144506070|NCT01135511|521051483|FG002|Overall Study|Adverse Event|2|||
144506071|NCT01135511|521051484|FG003|Overall Study|Adverse Event|0|||
144506072|NCT01135511|521051485|FG004|Overall Study|Adverse Event|0|||
144506073|NCT01135511|521051486|FG005|Overall Study|Adverse Event|1|||
144506074|NCT01135511|521051487|FG006|Overall Study|Adverse Event|0|||
144506075|NCT01135511|521051488|FG007|Overall Study|Adverse Event|1|||
144506076|NCT01135511|521051489|FG008|Overall Study|Adverse Event|0|||
144506077|NCT01135511|521051481|FG000|Overall Study|Lack of Efficacy|0|||
144506078|NCT01135511|521051482|FG001|Overall Study|Lack of Efficacy|1|||
144506079|NCT01135511|521051483|FG002|Overall Study|Lack of Efficacy|1|||
144506080|NCT01135511|521051484|FG003|Overall Study|Lack of Efficacy|2|||
144506081|NCT01135511|521051485|FG004|Overall Study|Lack of Efficacy|0|||
144506082|NCT01135511|521051486|FG005|Overall Study|Lack of Efficacy|0|||
144506083|NCT01135511|521051487|FG006|Overall Study|Lack of Efficacy|0|||
144506084|NCT01135511|521051488|FG007|Overall Study|Lack of Efficacy|0|||
144506085|NCT01135511|521051489|FG008|Overall Study|Lack of Efficacy|0|||
144506086|NCT01135511|521051481|FG000|Overall Study|Protocol Violation|0|||
144506087|NCT01135511|521051482|FG001|Overall Study|Protocol Violation|0|||
144506088|NCT01135511|521051483|FG002|Overall Study|Protocol Violation|3|||
144506089|NCT01135511|521051484|FG003|Overall Study|Protocol Violation|0|||
144506090|NCT01135511|521051485|FG004|Overall Study|Protocol Violation|0|||
144506091|NCT01135511|521051486|FG005|Overall Study|Protocol Violation|0|||
144506092|NCT01135511|521051487|FG006|Overall Study|Protocol Violation|0|||
144506093|NCT01135511|521051488|FG007|Overall Study|Protocol Violation|0|||
144506094|NCT01135511|521051489|FG008|Overall Study|Protocol Violation|0|||
144506095|NCT01135511|521051481|FG000|Overall Study|Pregnancy|0|||
144506096|NCT01135511|521051482|FG001|Overall Study|Pregnancy|0|||
144506097|NCT01135511|521051483|FG002|Overall Study|Pregnancy|0|||
144506098|NCT01135511|521051484|FG003|Overall Study|Pregnancy|1|||
144506099|NCT01135511|521051485|FG004|Overall Study|Pregnancy|0|||
144506100|NCT01135511|521051486|FG005|Overall Study|Pregnancy|0|||
144506101|NCT01135511|521051487|FG006|Overall Study|Pregnancy|0|||
144506102|NCT01135511|521051488|FG007|Overall Study|Pregnancy|0|||
144506103|NCT01135511|521051489|FG008|Overall Study|Pregnancy|0|||
144506104|NCT01135511|521051481|FG000|Overall Study|could not visit the clinic|0|||
144506105|NCT01135511|521051482|FG001|Overall Study|could not visit the clinic|1|||
144506106|NCT01135511|521051483|FG002|Overall Study|could not visit the clinic|2|||
144506107|NCT01135511|521051484|FG003|Overall Study|could not visit the clinic|0|||
144506108|NCT01135511|521051485|FG004|Overall Study|could not visit the clinic|0|||
144506109|NCT01135511|521051486|FG005|Overall Study|could not visit the clinic|0|||
144506110|NCT01135511|521051487|FG006|Overall Study|could not visit the clinic|0|||
144506111|NCT01135511|521051488|FG007|Overall Study|could not visit the clinic|0|||
144506112|NCT01135511|521051489|FG008|Overall Study|could not visit the clinic|0|||
144506113|NCT01135511|521051481|FG000|Overall Study|noncompliance with study drug taken|0|||
144506114|NCT01135511|521051482|FG001|Overall Study|noncompliance with study drug taken|0|||
144506115|NCT01135511|521051483|FG002|Overall Study|noncompliance with study drug taken|0|||
144506116|NCT01135511|521051484|FG003|Overall Study|noncompliance with study drug taken|0|||
144506117|NCT01135511|521051485|FG004|Overall Study|noncompliance with study drug taken|1|||
144506118|NCT01135511|521051486|FG005|Overall Study|noncompliance with study drug taken|0|||
144506119|NCT01135511|521051487|FG006|Overall Study|noncompliance with study drug taken|0|||
144506120|NCT01135511|521051488|FG007|Overall Study|noncompliance with study drug taken|0|||
144506121|NCT01135511|521051489|FG008|Overall Study|noncompliance with study drug taken|0|||
144506122|NCT01135511|521051481|FG000|Overall Study|Withdrawal by Subject|0|||
144506123|NCT01135511|521051482|FG001|Overall Study|Withdrawal by Subject|0|||
144506124|NCT01135511|521051483|FG002|Overall Study|Withdrawal by Subject|0|||
144506125|NCT01135511|521051484|FG003|Overall Study|Withdrawal by Subject|0|||
144506126|NCT01135511|521051485|FG004|Overall Study|Withdrawal by Subject|0|||
144506127|NCT01135511|521051486|FG005|Overall Study|Withdrawal by Subject|0|||
144506128|NCT01135511|521051487|FG006|Overall Study|Withdrawal by Subject|1|||
144506129|NCT01135511|521051488|FG007|Overall Study|Withdrawal by Subject|0|||
144506130|NCT01135511|521051489|FG008|Overall Study|Withdrawal by Subject|1|||
144506131|NCT02880241|521051490|FG000|Overall Study|Lack of Efficacy|1|||
144506132|NCT02880241|521051491|FG001|Overall Study|Lack of Efficacy|0|||
144506133|NCT02880241|521051492|FG002|Overall Study|Lack of Efficacy|0|||
144506134|NCT02880241|521051493|FG003|Overall Study|Lack of Efficacy|0|||
144506135|NCT02880241|521051494|FG004|Overall Study|Lack of Efficacy|0|||
144506136|NCT02880241|521051495|FG005|Overall Study|Lack of Efficacy|0|||
144506137|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
144506138|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
144506139|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
144506140|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
144506141|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
144506142|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
144506143|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
144506144|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
144506145|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
144506146|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
144506147|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
144506148|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
144506149|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
144506150|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
144506151|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
144506152|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
144721671|NCT01612000|521835257|FG000|Overall Study|Physician Decision|0|||
144506153|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
144506154|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
144506155|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
144506156|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
144506157|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
144506158|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
144506159|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
144506160|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
144506161|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
144506162|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
144506163|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
144506164|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
144506165|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
144506166|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
144506167|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
144506168|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
144506169|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
144506170|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
144371006|NCT03614156|520565988|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
144371007|NCT03614156|520565985|FG000|Open-Label Treatment Period|Protocol Violation|2|||
144506171|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
144506172|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
144506173|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
144506174|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
144506175|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
144506176|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
144506177|NCT02709655|521051496|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
144506178|NCT02709655|521051497|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
144506179|NCT02709655|521051498|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
144506180|NCT02709655|521051499|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
144506181|NCT02709655|521051500|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
144506182|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
144506183|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
144506184|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
144506185|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
144506186|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
144506187|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
144506188|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
144506189|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
144506190|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
144506191|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
144506192|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
144506193|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
144506194|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
144506195|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
144506196|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
144506197|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
144506198|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
144506199|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
144506200|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
144506201|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
144506202|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
144506203|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
144506204|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
144506205|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
144506206|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
144506207|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
144506208|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
144506209|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
144506210|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
144506211|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
144506212|NCT02709655|521051496|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
144506213|NCT02709655|521051497|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
144506214|NCT02709655|521051498|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
144506215|NCT02709655|521051499|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
144506216|NCT02709655|521051500|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
144506217|NCT01179334|521051501|FG000|Treatment Period|Adverse Event|1|||
144506218|NCT01179334|521051502|FG001|Treatment Period|Adverse Event|0|||
144506219|NCT01179334|521051501|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
144506220|NCT01179334|521051502|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
144506221|NCT01179334|521051501|FG000|Long-term Extension (LTE) Period|Death|3|||
144506222|NCT01179334|521051502|FG001|Long-term Extension (LTE) Period|Death|0|||
144506223|NCT01179334|521051501|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
144506224|NCT01179334|521051502|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
144506225|NCT00256243|521051503|FG000|Overall Study|Lost to Follow-up|2|||
144506226|NCT00256243|521051503|FG000|Overall Study|Death|7|||
144506227|NCT00256243|521051503|FG000|Overall Study|Not treated|1|||
144506228|NCT03215927|521052752|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
144506229|NCT03215927|521052753|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
144506230|NCT03215927|521052752|FG000|Open Label Extension|Adverse Event|1|||
144506231|NCT03215927|521052753|FG001|Open Label Extension|Adverse Event|0|||
144506232|NCT03215927|521052752|FG000|Open Label Extension|Lack of Efficacy|1|||
144506233|NCT03215927|521052753|FG001|Open Label Extension|Lack of Efficacy|0|||
144506234|NCT03215927|521052752|FG000|Open Label Extension|Death|0|||
144506235|NCT03215927|521052753|FG001|Open Label Extension|Death|1|||
144506236|NCT00465816|521052754|FG000|Overall Study|Lost to Follow-up|0|||
144506237|NCT00465816|521052755|FG001|Overall Study|Lost to Follow-up|0|||
144506238|NCT00465816|521052756|FG002|Overall Study|Lost to Follow-up|2|||
144506239|NCT01426269|521052759|FG000|Period 1: 12 Weeks|Adverse Event|5|||
144506240|NCT01426269|521052760|FG001|Period 1: 12 Weeks|Adverse Event|0|||
144506241|NCT01426269|521052761|FG002|Period 1: 12 Weeks|Adverse Event|0|||
144506242|NCT01426269|521052759|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
144506243|NCT01426269|521052760|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
144506244|NCT01426269|521052761|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
144506245|NCT01426269|521052759|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
144506246|NCT01426269|521052760|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
144506247|NCT01426269|521052761|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
144506248|NCT01426269|521052759|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
144506249|NCT01426269|521052760|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
144506250|NCT01426269|521052761|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
144506251|NCT01426269|521052759|FG000|Period 1: 12 Weeks|Pregnancy|1|||
144506252|NCT01426269|521052760|FG001|Period 1: 12 Weeks|Pregnancy|0|||
144506253|NCT01426269|521052761|FG002|Period 1: 12 Weeks|Pregnancy|0|||
144506254|NCT01426269|521052759|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
144506255|NCT01426269|521052760|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
144506256|NCT01426269|521052761|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
144506257|NCT01426269|521052759|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
144506258|NCT01426269|521052760|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
144506259|NCT01426269|521052761|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
144506260|NCT01426269|521052759|FG000|Period 2: 40 Weeks|Adverse Event|0|||
144506261|NCT01426269|521052760|FG001|Period 2: 40 Weeks|Adverse Event|1|||
144506262|NCT01426269|521052761|FG002|Period 2: 40 Weeks|Adverse Event|2|||
144506263|NCT01426269|521052759|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
144506264|NCT01426269|521052760|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
144506265|NCT01426269|521052761|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
144506266|NCT01426269|521052759|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
144506267|NCT01426269|521052760|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
144506268|NCT01426269|521052761|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
144506269|NCT01426269|521052759|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
144506270|NCT01426269|521052760|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
144506271|NCT01426269|521052761|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
144506272|NCT01426269|521052759|FG000|Period 2: 40 Weeks|Site closed|0|||
144506273|NCT01426269|521052760|FG001|Period 2: 40 Weeks|Site closed|6|||
144506274|NCT01426269|521052761|FG002|Period 2: 40 Weeks|Site closed|5|||
144506275|NCT01426269|521052759|FG000|Period 2: 40 Weeks|Relapsed|0|||
144506276|NCT01426269|521052760|FG001|Period 2: 40 Weeks|Relapsed|9|||
144506277|NCT01426269|521052761|FG002|Period 2: 40 Weeks|Relapsed|18|||
144506278|NCT00818454|521052762|FG000|Treatment Period 1|Adverse Event|0|||
144506279|NCT00818454|521052763|FG001|Treatment Period 1|Adverse Event|1|||
144506280|NCT00818454|521052764|FG002|Treatment Period 1|Adverse Event|0|||
144506281|NCT00818454|521052765|FG003|Treatment Period 1|Adverse Event|0|||
144506282|NCT00818454|521052762|FG000|Treatment Period 1|Other|3|||
144506283|NCT00818454|521052763|FG001|Treatment Period 1|Other|0|||
144506284|NCT00818454|521052764|FG002|Treatment Period 1|Other|0|||
144506285|NCT00818454|521052765|FG003|Treatment Period 1|Other|0|||
144506286|NCT00818454|521052762|FG000|Washout Period of 1 Week|Adverse Event|1|||
144506287|NCT00818454|521052763|FG001|Washout Period of 1 Week|Adverse Event|1|||
144506288|NCT00818454|521052764|FG002|Washout Period of 1 Week|Adverse Event|0|||
144506289|NCT00818454|521052765|FG003|Washout Period of 1 Week|Adverse Event|0|||
144506290|NCT00818454|521052762|FG000|Washout Period of 1 Week|Protocol Violation|2|||
144506291|NCT00818454|521052763|FG001|Washout Period of 1 Week|Protocol Violation|0|||
144506292|NCT00818454|521052764|FG002|Washout Period of 1 Week|Protocol Violation|0|||
144506293|NCT00818454|521052765|FG003|Washout Period of 1 Week|Protocol Violation|0|||
144506294|NCT00818454|521052762|FG000|Washout Period of 1 Week|Other|1|||
144506295|NCT00818454|521052763|FG001|Washout Period of 1 Week|Other|2|||
144506296|NCT00818454|521052764|FG002|Washout Period of 1 Week|Other|0|||
144506297|NCT00818454|521052765|FG003|Washout Period of 1 Week|Other|0|||
144506298|NCT00818454|521052762|FG000|Treatment Period 2|Other|2|||
144506299|NCT00818454|521052763|FG001|Treatment Period 2|Other|1|||
144506300|NCT00818454|521052764|FG002|Treatment Period 2|Other|0|||
144506301|NCT00818454|521052765|FG003|Treatment Period 2|Other|0|||
144506302|NCT00818454|521052762|FG000|Treatment Period 3|Adverse Event|0|||
144506303|NCT00818454|521052763|FG001|Treatment Period 3|Adverse Event|0|||
144506304|NCT00818454|521052764|FG002|Treatment Period 3|Adverse Event|0|||
144506305|NCT00818454|521052765|FG003|Treatment Period 3|Adverse Event|1|||
144506306|NCT00799396|521052767|FG000|Clopidogrel Treatment|Adverse Event|6|||
144506307|NCT00799396|521052767|FG000|Clopidogrel Treatment|Physician Decision|5|||
144506308|NCT00799396|521052767|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
144506309|NCT00799396|521052767|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
144506310|NCT00799396|521052767|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
144506311|NCT01867216|521052768|FG000|Overall Study|Withdrawal by Subject|2|||
144506312|NCT01867216|521052769|FG001|Overall Study|Withdrawal by Subject|0|||
144506313|NCT01867216|521052770|FG002|Overall Study|Withdrawal by Subject|0|||
144506314|NCT01867216|521052771|FG003|Overall Study|Withdrawal by Subject|0|||
144506315|NCT01867216|521052772|FG004|Overall Study|Withdrawal by Subject|1|||
144506316|NCT01867216|521052773|FG005|Overall Study|Withdrawal by Subject|0|||
144506317|NCT01867216|521052774|FG006|Overall Study|Withdrawal by Subject|1|||
144506318|NCT01867216|521052768|FG000|Overall Study|Physician Decision|1|||
144506319|NCT01867216|521052769|FG001|Overall Study|Physician Decision|0|||
144506320|NCT01867216|521052770|FG002|Overall Study|Physician Decision|0|||
144506321|NCT01867216|521052771|FG003|Overall Study|Physician Decision|0|||
144506322|NCT01867216|521052772|FG004|Overall Study|Physician Decision|0|||
144506323|NCT01867216|521052773|FG005|Overall Study|Physician Decision|0|||
144506324|NCT01867216|521052774|FG006|Overall Study|Physician Decision|0|||
144506325|NCT01867216|521052768|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
144506326|NCT01867216|521052769|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
144506327|NCT01867216|521052770|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
144506328|NCT01867216|521052771|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
144506329|NCT01867216|521052772|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
144506330|NCT01867216|521052773|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
144506331|NCT01867216|521052774|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
144506332|NCT01765543|521052785|FG000|Overall Study|Death|1|||
144506333|NCT01765543|521052785|FG000|Overall Study|Withdrawal by Subject|2|||
144506334|NCT03454529|521052786|FG000|Overall Study|Did not receive treatment|6|||
144506335|NCT03454529|521052786|FG000|Overall Study|Received < 80% doses|1|||
144506336|NCT00507689|521052787|FG000|Pre-Randomization Period|Adverse Event|1|||
144506337|NCT00507689|521052788|FG001|Pre-Randomization Period|Adverse Event|0|||
144506338|NCT00507689|521052787|FG000|Pre-Randomization Period|Physician Decision|1|||
144506339|NCT00507689|521052788|FG001|Pre-Randomization Period|Physician Decision|0|||
144506340|NCT00507689|521052787|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
144506341|NCT00507689|521052788|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
144506342|NCT00507689|521052787|FG000|Randomized Period|Adverse Event|1|||
144506343|NCT00507689|521052788|FG001|Randomized Period|Adverse Event|1|||
144506344|NCT00507689|521052787|FG000|Randomized Period|Withdrawal by Subject|0|||
144506345|NCT00507689|521052788|FG001|Randomized Period|Withdrawal by Subject|1|||
144506346|NCT00424762|521052796|FG000|Overall Study|Withdrawal by Subject|18|||
144506347|NCT00424762|521052797|FG001|Overall Study|Withdrawal by Subject|19|||
144506348|NCT00424762|521052796|FG000|Overall Study|Lost to Follow-up|2|||
144506349|NCT00424762|521052797|FG001|Overall Study|Lost to Follow-up|3|||
144506350|NCT01145885|521052798|FG000|Overall Study|Progressive Disease|7|||
144506351|NCT00723450|521052799|FG000|Open-Label Phase|Adverse Event|26|||
144506352|NCT00723450|521052800|FG001|Open-Label Phase|Adverse Event|0|||
144506353|NCT00723450|521052801|FG002|Open-Label Phase|Adverse Event|0|||
144506354|NCT00723450|521052799|FG000|Open-Label Phase|Lack of Efficacy|18|||
144506355|NCT00723450|521052800|FG001|Open-Label Phase|Lack of Efficacy|0|||
144506356|NCT00723450|521052801|FG002|Open-Label Phase|Lack of Efficacy|0|||
144506357|NCT00723450|521052799|FG000|Open-Label Phase|Protocol Violation|35|||
144506358|NCT00723450|521052800|FG001|Open-Label Phase|Protocol Violation|0|||
144506359|NCT00723450|521052801|FG002|Open-Label Phase|Protocol Violation|0|||
144506360|NCT00723450|521052799|FG000|Open-Label Phase|Lost to Follow-up|7|||
144506361|NCT00723450|521052800|FG001|Open-Label Phase|Lost to Follow-up|0|||
144506362|NCT00723450|521052801|FG002|Open-Label Phase|Lost to Follow-up|0|||
144506363|NCT00723450|521052799|FG000|Open-Label Phase|Physician Decision|2|||
144506364|NCT00723450|521052800|FG001|Open-Label Phase|Physician Decision|0|||
144506365|NCT00723450|521052801|FG002|Open-Label Phase|Physician Decision|0|||
144506366|NCT00723450|521052799|FG000|Open-Label Phase|Withdrawal by Subject|37|||
144506367|NCT00723450|521052800|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144506368|NCT00723450|521052801|FG002|Open-Label Phase|Withdrawal by Subject|0|||
144506369|NCT00723450|521052799|FG000|Randomized Phase|Adverse Event|0|||
144506370|NCT00723450|521052800|FG001|Randomized Phase|Adverse Event|26|||
144506371|NCT00723450|521052801|FG002|Randomized Phase|Adverse Event|17|||
144506372|NCT00723450|521052799|FG000|Randomized Phase|Lack of Efficacy|0|||
144506373|NCT00723450|521052800|FG001|Randomized Phase|Lack of Efficacy|11|||
144506374|NCT00723450|521052801|FG002|Randomized Phase|Lack of Efficacy|11|||
144506375|NCT00723450|521052799|FG000|Randomized Phase|Protocol Violation|0|||
144506376|NCT00723450|521052800|FG001|Randomized Phase|Protocol Violation|9|||
144506377|NCT00723450|521052801|FG002|Randomized Phase|Protocol Violation|13|||
144506378|NCT00723450|521052799|FG000|Randomized Phase|Lost to Follow-up|0|||
144506379|NCT00723450|521052800|FG001|Randomized Phase|Lost to Follow-up|2|||
144506380|NCT00723450|521052801|FG002|Randomized Phase|Lost to Follow-up|3|||
144506381|NCT00723450|521052799|FG000|Randomized Phase|Physician Decision|0|||
144506382|NCT00723450|521052800|FG001|Randomized Phase|Physician Decision|3|||
144506383|NCT00723450|521052801|FG002|Randomized Phase|Physician Decision|1|||
144506384|NCT00723450|521052799|FG000|Randomized Phase|Withdrawal by Subject|0|||
144506385|NCT00723450|521052800|FG001|Randomized Phase|Withdrawal by Subject|14|||
144506386|NCT00723450|521052801|FG002|Randomized Phase|Withdrawal by Subject|22|||
144506387|NCT00057837|521052802|FG000|Overall Study|Progression/relapse|12|||
144506388|NCT00057837|521052803|FG001|Overall Study|Progression/relapse|14|||
144506389|NCT00057837|521052802|FG000|Overall Study|Adverse Event|2|||
144506390|NCT00057837|521052803|FG001|Overall Study|Adverse Event|12|||
144506391|NCT00057837|521052802|FG000|Overall Study|Death|5|||
144506392|NCT00057837|521052803|FG001|Overall Study|Death|4|||
144506393|NCT00057837|521052802|FG000|Overall Study|Withdrawal by Subject|5|||
144506394|NCT00057837|521052803|FG001|Overall Study|Withdrawal by Subject|3|||
144506395|NCT00057837|521052802|FG000|Overall Study|Alternative therapy|0|||
144506396|NCT00057837|521052803|FG001|Overall Study|Alternative therapy|1|||
144506397|NCT00057837|521052802|FG000|Overall Study|Other complicating disease|2|||
144506398|NCT00057837|521052803|FG001|Overall Study|Other complicating disease|1|||
144506399|NCT00057837|521052802|FG000|Overall Study|Physician Decision|1|||
144506400|NCT00057837|521052803|FG001|Overall Study|Physician Decision|0|||
144506401|NCT00057837|521052802|FG000|Overall Study|Ineligible|3|||
144506402|NCT00057837|521052803|FG001|Overall Study|Ineligible|3|||
144506403|NCT00057837|521052802|FG000|Overall Study|Never started treatment|1|||
144506404|NCT00057837|521052803|FG001|Overall Study|Never started treatment|1|||
144506405|NCT05001945|521052805|FG000|Overall Study|Adverse Event|0|||
144506406|NCT05001945|521052806|FG001|Overall Study|Adverse Event|0|||
144506407|NCT05001945|521052807|FG002|Overall Study|Adverse Event|0|||
144506408|NCT05001945|521052808|FG003|Overall Study|Adverse Event|1|||
144506409|NCT05001945|521052809|FG004|Overall Study|Adverse Event|0|||
144506410|NCT05001945|521052810|FG005|Overall Study|Adverse Event|0|||
144506411|NCT05001945|521052811|FG006|Overall Study|Adverse Event|0|||
144506412|NCT05001945|521052812|FG007|Overall Study|Adverse Event|0|||
144506413|NCT05001945|521052805|FG000|Overall Study|Lost to Follow-up|0|||
144506414|NCT05001945|521052806|FG001|Overall Study|Lost to Follow-up|1|||
144506415|NCT05001945|521052807|FG002|Overall Study|Lost to Follow-up|1|||
144506416|NCT05001945|521052808|FG003|Overall Study|Lost to Follow-up|2|||
144506417|NCT05001945|521052809|FG004|Overall Study|Lost to Follow-up|0|||
144506418|NCT05001945|521052810|FG005|Overall Study|Lost to Follow-up|1|||
144506419|NCT05001945|521052811|FG006|Overall Study|Lost to Follow-up|0|||
144506420|NCT05001945|521052812|FG007|Overall Study|Lost to Follow-up|0|||
144506421|NCT05001945|521052805|FG000|Overall Study|Protocol Violation|1|||
144506422|NCT05001945|521052806|FG001|Overall Study|Protocol Violation|0|||
144506423|NCT05001945|521052807|FG002|Overall Study|Protocol Violation|1|||
144506424|NCT05001945|521052808|FG003|Overall Study|Protocol Violation|1|||
144506425|NCT05001945|521052809|FG004|Overall Study|Protocol Violation|0|||
144506426|NCT05001945|521052810|FG005|Overall Study|Protocol Violation|1|||
144506427|NCT05001945|521052811|FG006|Overall Study|Protocol Violation|0|||
144506428|NCT05001945|521052812|FG007|Overall Study|Protocol Violation|0|||
144506429|NCT05001945|521052805|FG000|Overall Study|Withdrawal by Subject|0|||
144506430|NCT05001945|521052806|FG001|Overall Study|Withdrawal by Subject|0|||
144506431|NCT05001945|521052807|FG002|Overall Study|Withdrawal by Subject|0|||
144506432|NCT05001945|521052808|FG003|Overall Study|Withdrawal by Subject|1|||
144506433|NCT05001945|521052809|FG004|Overall Study|Withdrawal by Subject|1|||
144506434|NCT05001945|521052810|FG005|Overall Study|Withdrawal by Subject|1|||
144506435|NCT05001945|521052811|FG006|Overall Study|Withdrawal by Subject|0|||
144506436|NCT05001945|521052812|FG007|Overall Study|Withdrawal by Subject|1|||
144506437|NCT05001945|521052805|FG000|Overall Study|Not specified by Investigator|0|||
144506438|NCT05001945|521052806|FG001|Overall Study|Not specified by Investigator|3|||
144506439|NCT05001945|521052807|FG002|Overall Study|Not specified by Investigator|0|||
144506440|NCT05001945|521052808|FG003|Overall Study|Not specified by Investigator|0|||
144506441|NCT05001945|521052809|FG004|Overall Study|Not specified by Investigator|1|||
144506442|NCT05001945|521052810|FG005|Overall Study|Not specified by Investigator|0|||
144506443|NCT05001945|521052811|FG006|Overall Study|Not specified by Investigator|0|||
144506444|NCT05001945|521052812|FG007|Overall Study|Not specified by Investigator|0|||
144506445|NCT02570711|521052813|FG000|Overall Study|Death|1|||
144506446|NCT02570711|521052814|FG001|Overall Study|Death|0|||
144506447|NCT02570711|521052813|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
144506448|NCT02570711|521052814|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
144506449|NCT02425111|521052815|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
144506450|NCT02425111|521052815|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
144506451|NCT02425111|521052815|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
144506452|NCT02425111|521052815|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
144721672|NCT01612000|521835258|FG001|Overall Study|Physician Decision|0|||
144721673|NCT01612000|521835259|FG002|Overall Study|Physician Decision|1|||
144506453|NCT02425111|521052815|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
144506454|NCT02425111|521052815|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
144506455|NCT00585533|521052816|FG000|Overall Study|objective or symptomatic progression|9|||
144506456|NCT00545077|521052817|FG000|Overall Study|Treatment not received|5|||
144506457|NCT00545077|521052818|FG001|Overall Study|Treatment not received|1|||
144506458|NCT00545077|521052817|FG000|Overall Study|Disease Progression|131|||
144506459|NCT00545077|521052818|FG001|Overall Study|Disease Progression|98|||
144506460|NCT00545077|521052817|FG000|Overall Study|Withdrawal by Subject|3|||
144506461|NCT00545077|521052818|FG001|Overall Study|Withdrawal by Subject|14|||
144506462|NCT00545077|521052817|FG000|Overall Study|Physician Decision|6|||
144506463|NCT00545077|521052818|FG001|Overall Study|Physician Decision|3|||
144506464|NCT00545077|521052817|FG000|Overall Study|Lost to Follow-up|2|||
144506465|NCT00545077|521052818|FG001|Overall Study|Lost to Follow-up|0|||
144506466|NCT00545077|521052817|FG000|Overall Study|Protocol Violation|1|||
144506467|NCT00545077|521052818|FG001|Overall Study|Protocol Violation|0|||
144506468|NCT00545077|521052817|FG000|Overall Study|Adverse Event|0|||
144506469|NCT00545077|521052818|FG001|Overall Study|Adverse Event|31|||
144506470|NCT00545077|521052817|FG000|Overall Study|Death|0|||
144506471|NCT00545077|521052818|FG001|Overall Study|Death|8|||
144506472|NCT03260140|521052819|FG000|Overall Study|Death|4|||
144506473|NCT03260140|521052820|FG001|Overall Study|Death|1|||
144506474|NCT03260140|521052819|FG000|Overall Study|Withdrawal by Subject|1|||
144506475|NCT03260140|521052820|FG001|Overall Study|Withdrawal by Subject|4|||
144506476|NCT00463788|521052821|FG000|Overall Study|Progressive Disease|86|||
144506477|NCT00463788|521052822|FG001|Overall Study|Progressive Disease|42|||
144506478|NCT00463788|521052821|FG000|Overall Study|Adverse Event|6|||
144506479|NCT00463788|521052822|FG001|Overall Study|Adverse Event|2|||
144506480|NCT00463788|521052821|FG000|Overall Study|Withdrawal by Subject|6|||
144506481|NCT00463788|521052822|FG001|Overall Study|Withdrawal by Subject|2|||
144506482|NCT00463788|521052821|FG000|Overall Study|Death|4|||
144506483|NCT00463788|521052822|FG001|Overall Study|Death|3|||
144506484|NCT00463788|521052821|FG000|Overall Study|Symptomatic Deterioration|2|||
144506485|NCT00463788|521052822|FG001|Overall Study|Symptomatic Deterioration|3|||
144506486|NCT00463788|521052821|FG000|Overall Study|Lost to Follow-up|1|||
144506487|NCT00463788|521052822|FG001|Overall Study|Lost to Follow-up|0|||
144506488|NCT00463788|521052821|FG000|Overall Study|Protocol Violation|0|||
144506489|NCT00463788|521052822|FG001|Overall Study|Protocol Violation|1|||
144506490|NCT00463788|521052821|FG000|Overall Study|Other|3|||
144506491|NCT00463788|521052822|FG001|Overall Study|Other|0|||
144506492|NCT00463788|521052821|FG000|Overall Study|Randomized but not treated|1|||
144506493|NCT00463788|521052822|FG001|Overall Study|Randomized but not treated|1|||
144506494|NCT00360698|521052823|FG000|Run-In|Physician Decision|0|||
144506495|NCT00360698|521052824|FG001|Run-In|Physician Decision|1|||
144506496|NCT00360698|521052823|FG000|Run-In|Withdrawal by Subject|0|||
144506497|NCT00360698|521052824|FG001|Run-In|Withdrawal by Subject|2|||
144506498|NCT00360698|521052823|FG000|Run-In|Non compliance with treatment procedure|0|||
144506499|NCT00360698|521052824|FG001|Run-In|Non compliance with treatment procedure|1|||
144506500|NCT00360698|521052823|FG000|Run-In|Sponsor request|0|||
144506501|NCT00360698|521052824|FG001|Run-In|Sponsor request|2|||
144506502|NCT00360698|521052823|FG000|Run-In|Patient did not meet inclusion criteria|0|||
144506503|NCT00360698|521052824|FG001|Run-In|Patient did not meet inclusion criteria|1|||
144506504|NCT00360698|521052823|FG000|Run-In|Patient personal reasons|0|||
144506505|NCT00360698|521052824|FG001|Run-In|Patient personal reasons|2|||
144506506|NCT00360698|521052823|FG000|Run-In|Need of insulin with meals|0|||
144506507|NCT00360698|521052824|FG001|Run-In|Need of insulin with meals|1|||
144506508|NCT00360698|521052823|FG000|Treatment Period|Non compliance with treatment procedure|1|||
144506509|NCT00360698|521052824|FG001|Treatment Period|Non compliance with treatment procedure|0|||
144506510|NCT00360698|521052823|FG000|Treatment Period|Early termination by error|0|||
144506511|NCT00360698|521052824|FG001|Treatment Period|Early termination by error|1|||
144506512|NCT01692938|521052827|FG000|Overall Study|Protocol Deviation|1|||
144506513|NCT01692938|521052828|FG001|Overall Study|Protocol Deviation|1|||
144506514|NCT01692938|521052827|FG000|Overall Study|Study completed prior to site completion|3|||
144506515|NCT01692938|521052828|FG001|Overall Study|Study completed prior to site completion|3|||
144506516|NCT05283395|521052831|FG000|Overall Study|Adverse Event|4|||
144506517|NCT05283395|521052832|FG001|Overall Study|Adverse Event|4|||
144506518|NCT05283395|521052833|FG002|Overall Study|Adverse Event|0|||
144506519|NCT05283395|521052831|FG000|Overall Study|Patient Lost to Follow-Up|0|||
144506520|NCT05283395|521052832|FG001|Overall Study|Patient Lost to Follow-Up|0|||
144506521|NCT05283395|521052833|FG002|Overall Study|Patient Lost to Follow-Up|1|||
144506522|NCT05283395|521052831|FG000|Overall Study|Patient Withdrawal|2|||
144506523|NCT05283395|521052832|FG001|Overall Study|Patient Withdrawal|4|||
144506524|NCT05283395|521052833|FG002|Overall Study|Patient Withdrawal|2|||
144506525|NCT05283395|521052831|FG000|Overall Study|Investigator Decision|1|||
144506526|NCT05283395|521052832|FG001|Overall Study|Investigator Decision|0|||
144506527|NCT05283395|521052833|FG002|Overall Study|Investigator Decision|1|||
144506528|NCT05283395|521052831|FG000|Overall Study|Enrolled in error|0|||
144506529|NCT05283395|521052832|FG001|Overall Study|Enrolled in error|0|||
144506530|NCT05283395|521052833|FG002|Overall Study|Enrolled in error|1|||
144506531|NCT01063972|521052834|FG000|Overall Study|Death|12|||
144506532|NCT01063972|521052835|FG001|Overall Study|Death|11|||
144506533|NCT01063972|521052834|FG000|Overall Study|Incarcerated|2|||
144506534|NCT01063972|521052835|FG001|Overall Study|Incarcerated|1|||
144506535|NCT00712335|521052836|FG000|Overall Study|Withdrawal by Subject|0|||
144506536|NCT00712335|521052837|FG001|Overall Study|Withdrawal by Subject|7|||
144506537|NCT00712335|521052838|FG002|Overall Study|Withdrawal by Subject|2|||
144506538|NCT00712335|521052839|FG003|Overall Study|Withdrawal by Subject|3|||
144506539|NCT00712335|521052840|FG004|Overall Study|Withdrawal by Subject|0|||
144506540|NCT00712335|521052836|FG000|Overall Study|Lost to Follow-up|2|||
144506541|NCT00712335|521052837|FG001|Overall Study|Lost to Follow-up|5|||
144506542|NCT00712335|521052838|FG002|Overall Study|Lost to Follow-up|0|||
144506543|NCT00712335|521052839|FG003|Overall Study|Lost to Follow-up|1|||
144506544|NCT00712335|521052840|FG004|Overall Study|Lost to Follow-up|0|||
144506545|NCT00712335|521052836|FG000|Overall Study|Protocol Violation|1|||
144506546|NCT00712335|521052837|FG001|Overall Study|Protocol Violation|2|||
144506547|NCT00712335|521052838|FG002|Overall Study|Protocol Violation|1|||
144506548|NCT00712335|521052839|FG003|Overall Study|Protocol Violation|0|||
144506549|NCT00712335|521052840|FG004|Overall Study|Protocol Violation|0|||
144506550|NCT00712335|521052836|FG000|Overall Study|Lack of Efficacy|0|||
144506551|NCT00712335|521052837|FG001|Overall Study|Lack of Efficacy|0|||
144506552|NCT00712335|521052838|FG002|Overall Study|Lack of Efficacy|1|||
144506553|NCT00712335|521052839|FG003|Overall Study|Lack of Efficacy|1|||
144506554|NCT00712335|521052840|FG004|Overall Study|Lack of Efficacy|0|||
144506555|NCT00712335|521052836|FG000|Overall Study|Other Reason|0|||
144506556|NCT00712335|521052837|FG001|Overall Study|Other Reason|3|||
144506557|NCT00712335|521052838|FG002|Overall Study|Other Reason|1|||
144506558|NCT00712335|521052839|FG003|Overall Study|Other Reason|0|||
144506559|NCT00712335|521052840|FG004|Overall Study|Other Reason|0|||
144506560|NCT03401112|521052841|FG000|Overall Study|Adverse Event|1|||
144506561|NCT03401112|521052842|FG001|Overall Study|Adverse Event|2|||
144506562|NCT03401112|521052843|FG002|Overall Study|Adverse Event|3|||
144506563|NCT03401112|521052844|FG003|Overall Study|Adverse Event|2|||
144506564|NCT03401112|521052845|FG004|Overall Study|Adverse Event|0|||
144506565|NCT03401112|521052841|FG000|Overall Study|Lost to Follow-up|1|||
144506566|NCT03401112|521052842|FG001|Overall Study|Lost to Follow-up|0|||
144506567|NCT03401112|521052843|FG002|Overall Study|Lost to Follow-up|0|||
144506568|NCT03401112|521052844|FG003|Overall Study|Lost to Follow-up|0|||
144506569|NCT03401112|521052845|FG004|Overall Study|Lost to Follow-up|0|||
144506570|NCT03401112|521052841|FG000|Overall Study|Noncompliance|1|||
144506571|NCT03401112|521052842|FG001|Overall Study|Noncompliance|2|||
144506572|NCT03401112|521052843|FG002|Overall Study|Noncompliance|3|||
144506573|NCT03401112|521052844|FG003|Overall Study|Noncompliance|0|||
144506574|NCT03401112|521052845|FG004|Overall Study|Noncompliance|0|||
144506575|NCT03401112|521052841|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
144506576|NCT03401112|521052842|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
144506577|NCT03401112|521052843|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
144506578|NCT03401112|521052844|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
144506579|NCT03401112|521052845|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
144506580|NCT03401112|521052841|FG000|Overall Study|Withdrawal by Subject|0|||
144506581|NCT03401112|521052842|FG001|Overall Study|Withdrawal by Subject|3|||
144506582|NCT03401112|521052843|FG002|Overall Study|Withdrawal by Subject|2|||
144506583|NCT03401112|521052844|FG003|Overall Study|Withdrawal by Subject|1|||
144506584|NCT03401112|521052845|FG004|Overall Study|Withdrawal by Subject|0|||
144506585|NCT03401112|521052841|FG000|Overall Study|Physician Decision|0|||
144506586|NCT03401112|521052842|FG001|Overall Study|Physician Decision|0|||
144506587|NCT03401112|521052843|FG002|Overall Study|Physician Decision|0|||
144506588|NCT03401112|521052844|FG003|Overall Study|Physician Decision|2|||
144506589|NCT03401112|521052845|FG004|Overall Study|Physician Decision|0|||
144506590|NCT03401112|521052841|FG000|Overall Study|Study was Terminated by Sponsor|0|||
144506591|NCT03401112|521052842|FG001|Overall Study|Study was Terminated by Sponsor|0|||
144506592|NCT03401112|521052843|FG002|Overall Study|Study was Terminated by Sponsor|0|||
144506593|NCT03401112|521052844|FG003|Overall Study|Study was Terminated by Sponsor|1|||
144506594|NCT03401112|521052845|FG004|Overall Study|Study was Terminated by Sponsor|0|||
144506595|NCT03401112|521052841|FG000|Overall Study|Day 1 Assessment not Done|1|||
144506596|NCT03401112|521052842|FG001|Overall Study|Day 1 Assessment not Done|0|||
144506597|NCT03401112|521052843|FG002|Overall Study|Day 1 Assessment not Done|0|||
144506598|NCT03401112|521052844|FG003|Overall Study|Day 1 Assessment not Done|0|||
144371008|NCT03614156|520565986|FG001|Open-Label Treatment Period|Protocol Violation|0|||
144371009|NCT03614156|520565987|FG002|Open-Label Treatment Period|Protocol Violation|0|||
144371010|NCT03614156|520565988|FG003|Open-Label Treatment Period|Protocol Violation|0|||
144506599|NCT03401112|521052845|FG004|Overall Study|Day 1 Assessment not Done|0|||
144506600|NCT03401112|521052841|FG000|Overall Study|Not Dosed|0|||
144506601|NCT03401112|521052842|FG001|Overall Study|Not Dosed|0|||
144506602|NCT03401112|521052843|FG002|Overall Study|Not Dosed|1|||
144506603|NCT03401112|521052844|FG003|Overall Study|Not Dosed|0|||
144506604|NCT03401112|521052845|FG004|Overall Study|Not Dosed|0|||
144506605|NCT03401112|521052841|FG000|Overall Study|Missed Clinical Visit|0|||
144506606|NCT03401112|521052842|FG001|Overall Study|Missed Clinical Visit|0|||
144506607|NCT03401112|521052843|FG002|Overall Study|Missed Clinical Visit|1|||
144506608|NCT03401112|521052844|FG003|Overall Study|Missed Clinical Visit|0|||
144506609|NCT03401112|521052845|FG004|Overall Study|Missed Clinical Visit|0|||
144506610|NCT03401112|521052841|FG000|Overall Study|Missed Doses|0|||
144506611|NCT03401112|521052842|FG001|Overall Study|Missed Doses|0|||
144506612|NCT03401112|521052843|FG002|Overall Study|Missed Doses|1|||
144506613|NCT03401112|521052844|FG003|Overall Study|Missed Doses|0|||
144506614|NCT03401112|521052845|FG004|Overall Study|Missed Doses|0|||
144506615|NCT01264679|521052846|FG000|Overall Study|Participation in Another Clinical Trial|1|||
144506616|NCT01264679|521052846|FG000|Overall Study|Physician Decision|1|||
144506617|NCT01264679|521052846|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
144506618|NCT01264679|521052846|FG000|Overall Study|Withdrawal by Subject|1|||
144506619|NCT03482011|521052847|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
144506620|NCT03482011|521052848|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
144506621|NCT03482011|521052849|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
144506622|NCT03482011|521052850|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
144506623|NCT03482011|521052851|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
144506624|NCT03482011|521052852|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
144506625|NCT03482011|521052853|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
144506626|NCT03482011|521052854|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
144506627|NCT03482011|521052847|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
144506628|NCT03482011|521052848|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
144506629|NCT03482011|521052849|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144506630|NCT03482011|521052850|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144506631|NCT03482011|521052851|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144506632|NCT03482011|521052852|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144506633|NCT03482011|521052853|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144506634|NCT03482011|521052854|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144506635|NCT03482011|521052847|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144506636|NCT03482011|521052848|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
144506637|NCT03482011|521052849|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144506638|NCT03482011|521052850|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144506639|NCT03482011|521052851|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144371011|NCT03614156|520565985|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
144506640|NCT03482011|521052852|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144506641|NCT03482011|521052853|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144506642|NCT03482011|521052854|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
144506643|NCT03482011|521052847|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
144506644|NCT03482011|521052848|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
144506645|NCT03482011|521052849|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
144506646|NCT03482011|521052850|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
144721674|NCT01612000|521835260|FG003|Overall Study|Physician Decision|0|||
144506647|NCT03482011|521052851|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
144506648|NCT03482011|521052852|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
144506649|NCT03482011|521052853|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
144506650|NCT03482011|521052854|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
144506651|NCT03482011|521052847|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
144506652|NCT03482011|521052848|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
144506653|NCT03482011|521052849|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144506654|NCT03482011|521052850|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144506655|NCT03482011|521052851|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144506656|NCT03482011|521052852|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144506657|NCT03482011|521052853|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144506658|NCT03482011|521052854|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144506659|NCT03482011|521052847|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
144506660|NCT03482011|521052848|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
144506661|NCT03482011|521052849|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
144506662|NCT03482011|521052850|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
144506663|NCT03482011|521052851|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
144506664|NCT03482011|521052852|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
144506665|NCT03482011|521052853|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
144506666|NCT03482011|521052854|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
144506667|NCT03482011|521052847|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
144506668|NCT03482011|521052848|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
144506669|NCT03482011|521052849|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
144506670|NCT03482011|521052850|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
144506671|NCT03482011|521052851|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
144506672|NCT03482011|521052852|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
144506673|NCT03482011|521052853|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
144506674|NCT03482011|521052854|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
144506675|NCT03482011|521052847|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144506676|NCT03482011|521052848|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144506677|NCT03482011|521052849|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144506678|NCT03482011|521052850|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144506679|NCT03482011|521052851|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
144506680|NCT03482011|521052852|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144506681|NCT03482011|521052853|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144506682|NCT03482011|521052854|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
144506683|NCT03482011|521052847|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
144506684|NCT03482011|521052848|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
144506685|NCT03482011|521052849|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
144506686|NCT03482011|521052850|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
144506687|NCT03482011|521052851|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
144506688|NCT03482011|521052852|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
144506689|NCT03482011|521052853|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
144506690|NCT03482011|521052854|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
144506691|NCT03482011|521052847|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144506692|NCT03482011|521052848|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144506693|NCT03482011|521052849|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144506694|NCT03482011|521052850|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
144506695|NCT03482011|521052851|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
144506696|NCT03482011|521052852|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
144506697|NCT03482011|521052853|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
144506698|NCT03482011|521052854|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
144506699|NCT03482011|521052847|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144506700|NCT03482011|521052848|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144506701|NCT03482011|521052849|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144506702|NCT03482011|521052850|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
144506703|NCT03482011|521052851|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144506704|NCT03482011|521052852|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
144506705|NCT03482011|521052853|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
144506706|NCT03482011|521052854|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
144506707|NCT03482011|521052847|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
144506708|NCT03482011|521052848|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
144506709|NCT03482011|521052849|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
144506710|NCT03482011|521052850|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
144506711|NCT03482011|521052851|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
144506712|NCT03482011|521052852|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
144506713|NCT03482011|521052853|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
144506714|NCT03482011|521052854|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
144506715|NCT03482011|521052847|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
144506716|NCT03482011|521052848|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
144506717|NCT03482011|521052849|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
144506718|NCT03482011|521052850|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
144506719|NCT03482011|521052851|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
144506720|NCT03482011|521052852|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
144506721|NCT03482011|521052853|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
144506722|NCT03482011|521052854|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
144506723|NCT03482011|521052847|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506724|NCT03482011|521052848|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506725|NCT03482011|521052849|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506726|NCT03482011|521052850|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506727|NCT03482011|521052851|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506728|NCT03482011|521052852|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506729|NCT03482011|521052853|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
144506730|NCT03482011|521052854|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
144506731|NCT03482011|521052847|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506732|NCT03482011|521052848|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506733|NCT03482011|521052849|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506734|NCT03482011|521052850|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506735|NCT03482011|521052851|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506736|NCT03482011|521052852|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506737|NCT03482011|521052853|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144506738|NCT03482011|521052854|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
144506739|NCT03475316|521052855|FG000|6 Month Intervention|Adverse Event|2|||
144506740|NCT03475316|521052856|FG001|6 Month Intervention|Adverse Event|1|||
144506741|NCT03475316|521052855|FG000|6 Month Intervention|Withdrawal by Subject|2|||
144506742|NCT03475316|521052856|FG001|6 Month Intervention|Withdrawal by Subject|0|||
144506743|NCT03475316|521052855|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
144506744|NCT03475316|521052856|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
144506745|NCT03475316|521052855|FG000|9 Months|Study stopped due to COVID pandemic|3|||
144506746|NCT03475316|521052856|FG001|9 Months|Study stopped due to COVID pandemic|4|||
144506747|NCT00424645|521052857|FG000|Overall Study|Death|1|||
144506748|NCT00424645|521052858|FG001|Overall Study|Death|0|||
144506749|NCT00468052|521052859|FG000|Overall Study|Protocol Violation|7|||
144506750|NCT00468052|521052860|FG001|Overall Study|Protocol Violation|8|||
144506751|NCT04975308|521052861|FG000|Overall Study|Withdrawal by Subject|6|||
144506752|NCT04975308|521052862|FG001|Overall Study|Withdrawal by Subject|16|||
144506753|NCT04975308|521052863|FG002|Overall Study|Withdrawal by Subject|6|||
144506754|NCT04975308|521052861|FG000|Overall Study|Physician Decision|0|||
144506755|NCT04975308|521052862|FG001|Overall Study|Physician Decision|3|||
144506756|NCT04975308|521052863|FG002|Overall Study|Physician Decision|1|||
144506757|NCT04975308|521052861|FG000|Overall Study|Adverse Event|10|||
144506758|NCT04975308|521052862|FG001|Overall Study|Adverse Event|1|||
144506759|NCT04975308|521052863|FG002|Overall Study|Adverse Event|12|||
144506760|NCT04975308|521052861|FG000|Overall Study|On study treatment (Ongoing)|65|||
144506761|NCT04975308|521052862|FG001|Overall Study|On study treatment (Ongoing)|43|||
144506762|NCT04975308|521052863|FG002|Overall Study|On study treatment (Ongoing)|75|||
144506763|NCT04975308|521052861|FG000|Overall Study|Protocol Deviation|4|||
144506764|NCT04975308|521052862|FG001|Overall Study|Protocol Deviation|3|||
144506765|NCT04975308|521052863|FG002|Overall Study|Protocol Deviation|2|||
144506766|NCT04177394|521052864|FG000|Overall Study|Death|16|||
144506767|NCT04177394|521052864|FG000|Overall Study|Withdrawal by Subject|19|||
144506768|NCT04177394|521052864|FG000|Overall Study|Missed visits|61|||
144506769|NCT04177394|521052864|FG000|Overall Study|Expected Visits|15|||
144506770|NCT00258895|521052865|FG000|Overall Study|Lost to Follow-up|3|||
144506771|NCT00258895|521052866|FG001|Overall Study|Lost to Follow-up|1|||
144506772|NCT00258895|521052865|FG000|Overall Study|Protocol Violation|6|||
144506773|NCT00258895|521052866|FG001|Overall Study|Protocol Violation|2|||
144506774|NCT00258895|521052865|FG000|Overall Study|Withdrawal by Subject|1|||
144506775|NCT00258895|521052866|FG001|Overall Study|Withdrawal by Subject|0|||
144506776|NCT00547118|521052867|FG000|Overall Study|Did not qualify prior to starting drug|1|||
144506777|NCT00547118|521052868|FG001|Overall Study|Did not qualify prior to starting drug|1|||
144506778|NCT00547118|521052867|FG000|Overall Study|Study suspended|7|||
144506779|NCT00547118|521052868|FG001|Overall Study|Study suspended|8|||
144506780|NCT02248480|521052871|FG000|Overall Study|Lack of Efficacy|4|||
144506781|NCT02248480|521052872|FG001|Overall Study|Lack of Efficacy|6|||
144506782|NCT02248480|521052871|FG000|Overall Study|Adverse Event|11|||
144506783|NCT02248480|521052872|FG001|Overall Study|Adverse Event|2|||
144506784|NCT02248480|521052871|FG000|Overall Study|Withdrawal by Subject|2|||
144506785|NCT02248480|521052872|FG001|Overall Study|Withdrawal by Subject|4|||
144506786|NCT02248480|521052871|FG000|Overall Study|Entry Criteria Not Met|0|||
144506787|NCT02248480|521052872|FG001|Overall Study|Entry Criteria Not Met|1|||
144506788|NCT02248480|521052871|FG000|Overall Study|Other:Physician Decision|0|||
144506789|NCT02248480|521052872|FG001|Overall Study|Other:Physician Decision|1|||
144506790|NCT01595321|521052873|FG000|Overall Study|Adverse Event|1|||
144506791|NCT01595321|521052874|FG001|Overall Study|Adverse Event|1|||
144506792|NCT01595321|521052875|FG002|Overall Study|Adverse Event|1|||
144506793|NCT01595321|521052873|FG000|Overall Study|Lack of Efficacy|0|||
144506794|NCT01595321|521052874|FG001|Overall Study|Lack of Efficacy|0|||
144506795|NCT01595321|521052875|FG002|Overall Study|Lack of Efficacy|4|||
144506796|NCT00834834|521052876|FG000|Overall Study|Withdrawal by Subject|4|||
144506797|NCT00834834|521052877|FG001|Overall Study|Withdrawal by Subject|3|||
144506798|NCT00373529|521052878|FG000|Overall Study|Physician Decision|19|||
144506799|NCT00373529|521052878|FG000|Overall Study|Withdrawal by Subject|7|||
144506800|NCT00373529|521052878|FG000|Overall Study|Adverse Event|7|||
144506801|NCT00373529|521052878|FG000|Overall Study|Treatment failure|36|||
144506802|NCT00373529|521052878|FG000|Overall Study|Disease recurrence|10|||
144506803|NCT00373529|521052878|FG000|Overall Study|Death|16|||
144506804|NCT00373529|521052878|FG000|Overall Study|Need for treatment prohibited by study|1|||
144506805|NCT00373529|521052878|FG000|Overall Study|Other|8|||
144506806|NCT00373529|521052878|FG000|Overall Study|Failed independent confirmation of AML|3|||
144506807|NCT00373529|521052878|FG000|Overall Study|Consent violation|1|||
144506808|NCT00442117|521052879|FG000|Overall Study|Adverse Event|3|||
144506809|NCT00442117|521052880|FG001|Overall Study|Adverse Event|2|||
144506810|NCT00442117|521052879|FG000|Overall Study|Lack of Efficacy|2|||
144506811|NCT00442117|521052880|FG001|Overall Study|Lack of Efficacy|6|||
144506812|NCT00442117|521052879|FG000|Overall Study|Lost to Follow-up|1|||
144506813|NCT00442117|521052880|FG001|Overall Study|Lost to Follow-up|2|||
144506814|NCT00442117|521052879|FG000|Overall Study|Withdrawal by Subject|2|||
144506815|NCT00442117|521052880|FG001|Overall Study|Withdrawal by Subject|2|||
144506816|NCT00442117|521052879|FG000|Overall Study|Major Deviation|25|||
144506817|NCT00442117|521052880|FG001|Overall Study|Major Deviation|20|||
144506818|NCT00442117|521052879|FG000|Overall Study|Non compliance with protocol|3|||
144506819|NCT00442117|521052880|FG001|Overall Study|Non compliance with protocol|5|||
144506820|NCT00442117|521052879|FG000|Overall Study|Met Withdrawal Criteria|2|||
144506821|NCT00442117|521052880|FG001|Overall Study|Met Withdrawal Criteria|1|||
144506822|NCT04009577|521052881|FG000|Core Study|Adverse Event|1|||
144506823|NCT04009577|521052882|FG001|Core Study|Adverse Event|0|||
144506824|NCT04009577|521052883|FG002|Core Study|Adverse Event|2|||
144506825|NCT04009577|521052884|FG003|Core Study|Adverse Event|4|||
144506826|NCT04009577|521052881|FG000|Core Study|Withdrawal by Subject|0|||
144506827|NCT04009577|521052882|FG001|Core Study|Withdrawal by Subject|0|||
144506828|NCT04009577|521052883|FG002|Core Study|Withdrawal by Subject|2|||
144506829|NCT04009577|521052884|FG003|Core Study|Withdrawal by Subject|0|||
144506830|NCT04009577|521052881|FG000|Core Study|Other|0|||
144506831|NCT04009577|521052882|FG001|Core Study|Other|0|||
144506832|NCT04009577|521052883|FG002|Core Study|Other|0|||
144506833|NCT04009577|521052884|FG003|Core Study|Other|1|||
144506834|NCT04009577|521052881|FG000|Extension Phase|Adverse Event|0|||
144506835|NCT04009577|521052882|FG001|Extension Phase|Adverse Event|0|||
144506836|NCT04009577|521052883|FG002|Extension Phase|Adverse Event|0|||
144506837|NCT04009577|521052884|FG003|Extension Phase|Adverse Event|1|||
144506838|NCT04009577|521052881|FG000|Extension Phase|Inadequate therapeutic effect|0|||
144506839|NCT04009577|521052882|FG001|Extension Phase|Inadequate therapeutic effect|0|||
144506840|NCT04009577|521052883|FG002|Extension Phase|Inadequate therapeutic effect|1|||
144506841|NCT04009577|521052884|FG003|Extension Phase|Inadequate therapeutic effect|0|||
144506842|NCT04009577|521052881|FG000|Extension Phase|Withdrawal by Subject|0|||
144506843|NCT04009577|521052882|FG001|Extension Phase|Withdrawal by Subject|0|||
144506844|NCT04009577|521052883|FG002|Extension Phase|Withdrawal by Subject|1|||
144506845|NCT04009577|521052884|FG003|Extension Phase|Withdrawal by Subject|0|||
144506846|NCT04009577|521052881|FG000|Extension Phase|Not Treated|0|||
144506847|NCT04009577|521052882|FG001|Extension Phase|Not Treated|0|||
144506848|NCT04009577|521052883|FG002|Extension Phase|Not Treated|2|||
144506849|NCT04009577|521052884|FG003|Extension Phase|Not Treated|0|||
144506850|NCT00305695|521052890|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
144506851|NCT00305695|521052891|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
144506852|NCT00305695|521052890|FG000|Overall Study|Did not have baseline scan|1|||
144506853|NCT00305695|521052891|FG001|Overall Study|Did not have baseline scan|1|||
144506854|NCT00841035|521052893|FG000|Phase 1 Overall Study|Physician Decision|13|||
144506855|NCT02994654|521052902|FG000|Overall Study|Lost to Follow-up|1|||
144506856|NCT03779048|521054044|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
144506857|NCT03779048|521054045|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
144506858|NCT03779048|521054046|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
144506859|NCT03779048|521054044|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
144506860|NCT03779048|521054045|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
144506861|NCT03779048|521054046|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
144506862|NCT03779048|521054044|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
144506863|NCT03779048|521054045|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
144506864|NCT03779048|521054046|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
144506865|NCT00686855|521054048|FG000|Overall Study|Lost to Follow-up|1|||
144506866|NCT00686855|521054049|FG001|Overall Study|Lost to Follow-up|0|||
144506867|NCT00686855|521054048|FG000|Overall Study|Progressive GVHD|0|||
144506868|NCT00686855|521054049|FG001|Overall Study|Progressive GVHD|1|||
144506869|NCT00516321|521054050|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
144506870|NCT00516321|521054051|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
144506871|NCT00516321|521054052|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
144506872|NCT00516321|521054050|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
144506873|NCT00516321|521054051|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
144506874|NCT00516321|521054052|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
144506875|NCT00516321|521054050|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
144506876|NCT00516321|521054051|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
144506877|NCT00516321|521054052|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
144506878|NCT00516321|521054050|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
144506879|NCT00516321|521054051|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
144506880|NCT00516321|521054052|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
144506881|NCT00516321|521054050|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
144506882|NCT00516321|521054051|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
144506883|NCT00516321|521054052|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
144506884|NCT00516321|521054050|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
144506885|NCT00516321|521054051|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
144506886|NCT00516321|521054052|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
144506887|NCT00516321|521054050|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
144506888|NCT00516321|521054051|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
144506889|NCT00516321|521054052|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
144506890|NCT00516321|521054050|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
144506891|NCT00516321|521054051|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
144506892|NCT00516321|521054052|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
144506893|NCT00516321|521054050|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
144506894|NCT00516321|521054051|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
144506895|NCT00516321|521054052|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
144506896|NCT00516321|521054050|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
144506897|NCT00516321|521054051|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
144506898|NCT00516321|521054052|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
144506899|NCT00516321|521054050|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
144506900|NCT00516321|521054051|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
144506901|NCT00516321|521054052|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
144506902|NCT05876949|521054058|FG000|Overall Study|Withdrawal by Subject|1|||
144506903|NCT05876949|521054059|FG001|Overall Study|Withdrawal by Subject|3|||
144506904|NCT05876949|521054058|FG000|Overall Study|Physician Decision|0|||
144506905|NCT05876949|521054059|FG001|Overall Study|Physician Decision|2|||
144506906|NCT05876949|521054058|FG000|Overall Study|Death|0|||
144506907|NCT05876949|521054059|FG001|Overall Study|Death|1|||
144506908|NCT02613871|521054066|FG000|Overall Study|Death|2|||
144506909|NCT02613871|521054066|FG000|Overall Study|Withdrew Consent|1|||
144506910|NCT01786564|521054067|FG000|Overall Study|Lost to Follow-up|47|||
144506911|NCT01786564|521054067|FG000|Overall Study|Ineligible|17|||
144506912|NCT00494442|521054068|FG000|Overall Study|Death|1|||
144506913|NCT00494442|521054069|FG001|Overall Study|Death|1|||
144506914|NCT00494442|521054068|FG000|Overall Study|Lack of Efficacy|16|||
144506915|NCT00494442|521054069|FG001|Overall Study|Lack of Efficacy|10|||
144371012|NCT03614156|520565986|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
144506916|NCT00494442|521054068|FG000|Overall Study|Adverse Event|0|||
144506917|NCT00494442|521054069|FG001|Overall Study|Adverse Event|2|||
144506918|NCT00494442|521054068|FG000|Overall Study|Physician Decision|0|||
144506919|NCT00494442|521054069|FG001|Overall Study|Physician Decision|1|||
144506920|NCT00494442|521054068|FG000|Overall Study|Non-compliance|0|||
144506921|NCT00494442|521054069|FG001|Overall Study|Non-compliance|1|||
144506922|NCT00494442|521054068|FG000|Overall Study|Intercurrent illness|0|||
144506923|NCT00494442|521054069|FG001|Overall Study|Intercurrent illness|1|||
144506924|NCT01241292|521054072|FG000|Overall Study|Administrative Reason by Sponsor|1|||
144506925|NCT01241292|521054073|FG001|Overall Study|Administrative Reason by Sponsor|0|||
144506926|NCT01241292|521054072|FG000|Overall Study|Disease Progression|2|||
144506927|NCT01241292|521054073|FG001|Overall Study|Disease Progression|0|||
144506928|NCT01241292|521054072|FG000|Overall Study|Study Drug Toxicity|0|||
144506929|NCT01241292|521054073|FG001|Overall Study|Study Drug Toxicity|1|||
144506930|NCT01241292|521054072|FG000|Overall Study|Participant Discontinued Treatment|0|||
144506931|NCT01241292|521054073|FG001|Overall Study|Participant Discontinued Treatment|2|||
144506932|NCT03034915|521054076|FG000|Overall Study|Adverse Event|29|||
144506933|NCT03034915|521054077|FG001|Overall Study|Adverse Event|32|||
144506934|NCT03034915|521054078|FG002|Overall Study|Adverse Event|22|||
144506935|NCT03034915|521054076|FG000|Overall Study|Lost to Follow-up|5|||
144506936|NCT03034915|521054077|FG001|Overall Study|Lost to Follow-up|13|||
144506937|NCT03034915|521054078|FG002|Overall Study|Lost to Follow-up|3|||
144506938|NCT03034915|521054076|FG000|Overall Study|Withdrawal by Subject|29|||
144506939|NCT03034915|521054077|FG001|Overall Study|Withdrawal by Subject|46|||
144506940|NCT03034915|521054078|FG002|Overall Study|Withdrawal by Subject|41|||
144506941|NCT03034915|521054076|FG000|Overall Study|Protocol Deviation|2|||
144506942|NCT03034915|521054077|FG001|Overall Study|Protocol Deviation|14|||
144506943|NCT03034915|521054078|FG002|Overall Study|Protocol Deviation|7|||
144506944|NCT03034915|521054076|FG000|Overall Study|Lack of Efficacy|8|||
144506945|NCT03034915|521054077|FG001|Overall Study|Lack of Efficacy|16|||
144506946|NCT03034915|521054078|FG002|Overall Study|Lack of Efficacy|18|||
144506947|NCT03034915|521054076|FG000|Overall Study|Site closed|2|||
144506948|NCT03034915|521054077|FG001|Overall Study|Site closed|2|||
144506949|NCT03034915|521054078|FG002|Overall Study|Site closed|4|||
144506950|NCT03034915|521054076|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
144506951|NCT03034915|521054077|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
144506952|NCT03034915|521054078|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
144506953|NCT03034915|521054076|FG000|Overall Study|Physician Decision|1|||
144506954|NCT03034915|521054077|FG001|Overall Study|Physician Decision|5|||
144506955|NCT03034915|521054078|FG002|Overall Study|Physician Decision|2|||
144506956|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
144506957|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
144506958|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
144506959|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
144506960|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
144506961|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
144506962|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
144506963|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
144506964|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
144506965|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
144506966|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
144506967|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
144506968|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
144506969|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
144506970|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
144506971|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
144506972|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
144506973|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
144506974|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
144506975|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
144506976|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
144506977|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
144506978|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
144506979|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
144506980|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
144506981|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
144506982|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
144506983|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
144506984|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
144506985|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
144506986|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
144506987|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
144506988|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
144506989|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
144506990|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
144506991|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
144506992|NCT03593213|521054079|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
144506993|NCT03593213|521054080|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
144506994|NCT03593213|521054081|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
144506995|NCT03593213|521054082|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
144506996|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
144506997|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
144506998|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
144506999|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
144507000|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
144507001|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
144507002|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
144507003|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
144507004|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
144507005|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
144507006|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
144507007|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
144507008|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
144507009|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
144507010|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
144507011|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
144507012|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
144507013|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
144507014|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
144507015|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
144507016|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
144507017|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
144507018|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
144507019|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
144507020|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
144507021|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
144507022|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
144507023|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
144507024|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
144507025|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
144507026|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
144507027|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
144507028|NCT03593213|521054079|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
144507029|NCT03593213|521054080|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
144507030|NCT03593213|521054081|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
144507031|NCT03593213|521054082|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
144507032|NCT01831791|521054083|FG000|Overall Study|Withdrawal by Subject|10|||
144507033|NCT00494780|521054084|FG000|Overall Study|Adverse Event|1|||
144507034|NCT00494780|521054085|FG001|Overall Study|Adverse Event|0|||
144507035|NCT00494780|521054084|FG000|Overall Study|Withdrew before Dosed|0|||
144507036|NCT00494780|521054085|FG001|Overall Study|Withdrew before Dosed|1|||
144507037|NCT00494780|521054084|FG000|Overall Study|Progression of Study Disease|7|||
144507038|NCT00494780|521054085|FG001|Overall Study|Progression of Study Disease|8|||
144507039|NCT00494780|521054084|FG000|Overall Study|New Treatment|2|||
144507040|NCT00494780|521054085|FG001|Overall Study|New Treatment|2|||
144507041|NCT00494780|521054084|FG000|Overall Study|Non-compliance|1|||
144507042|NCT00494780|521054085|FG001|Overall Study|Non-compliance|0|||
144507043|NCT00494780|521054084|FG000|Overall Study|Residual Tumour Mass|0|||
144507044|NCT00494780|521054085|FG001|Overall Study|Residual Tumour Mass|1|||
144507045|NCT00494780|521054084|FG000|Overall Study|Insurance Issues|0|||
144507046|NCT00494780|521054085|FG001|Overall Study|Insurance Issues|1|||
144507047|NCT01190007|521054086|FG000|Overall Study|Withdrawal by Subject|4|||
144507048|NCT01190007|521054086|FG000|Overall Study|Adverse Event|8|||
144507049|NCT01190007|521054086|FG000|Overall Study|Difficulty of visit for complications|1|||
144507050|NCT01190007|521054086|FG000|Overall Study|Participant was arrested|1|||
144507051|NCT01254019|521054087|FG000|Overall Study|Adverse Event|0|||
144507052|NCT01254019|521054088|FG001|Overall Study|Adverse Event|2|||
144507053|NCT01254019|521054087|FG000|Overall Study|Protocol Violation|1|||
144507054|NCT01254019|521054088|FG001|Overall Study|Protocol Violation|0|||
144507055|NCT01254019|521054087|FG000|Overall Study|Withdrawal by Subject|0|||
144507056|NCT01254019|521054088|FG001|Overall Study|Withdrawal by Subject|2|||
144507057|NCT03061474|521054089|FG000|Overall Study|Adverse Event|2|||
144507058|NCT03061474|521054090|FG001|Overall Study|Adverse Event|0|||
144507059|NCT03061474|521054089|FG000|Overall Study|Safety Risk|0|||
144507060|NCT03061474|521054090|FG001|Overall Study|Safety Risk|1|||
144507061|NCT03061474|521054089|FG000|Overall Study|Participant unwilling or unable to participate|0|||
144507062|NCT03061474|521054090|FG001|Overall Study|Participant unwilling or unable to participate|2|||
144507063|NCT03061474|521054089|FG000|Overall Study|Lost to Follow-up|0|||
144507064|NCT03061474|521054090|FG001|Overall Study|Lost to Follow-up|1|||
144507065|NCT00845832|521054093|FG000|Treatment Period|Adverse Event|0|||
144507066|NCT00845832|521054094|FG001|Treatment Period|Adverse Event|2|||
144507067|NCT00845832|521054095|FG002|Treatment Period|Adverse Event|0|||
144507068|NCT00845832|521054093|FG000|Treatment Period|Protocol Violation|1|||
144507069|NCT00845832|521054094|FG001|Treatment Period|Protocol Violation|1|||
144507070|NCT00845832|521054095|FG002|Treatment Period|Protocol Violation|0|||
144507071|NCT00845832|521054093|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
144507072|NCT00845832|521054094|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
144507073|NCT00845832|521054095|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
144507074|NCT00845832|521054093|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
144507075|NCT00845832|521054094|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
144507076|NCT00845832|521054095|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
144507077|NCT01391130|521054096|FG000|Overall Study|Withdrawal by Subject|3|||
144507078|NCT01391130|521054097|FG001|Overall Study|Withdrawal by Subject|2|||
144507079|NCT01391130|521054096|FG000|Overall Study|Physician Decision|2|||
144507080|NCT01391130|521054097|FG001|Overall Study|Physician Decision|3|||
144507081|NCT01391130|521054096|FG000|Overall Study|Did not Receive Drug|1|||
144507082|NCT01391130|521054097|FG001|Overall Study|Did not Receive Drug|1|||
144507083|NCT00668863|521054098|FG000|Overall Study|Objective Progression or Relapse|42|||
144507084|NCT00668863|521054098|FG000|Overall Study|Adverse Event|13|||
144507085|NCT00668863|521054098|FG000|Overall Study|Study Terminated by Sponsor|8|||
144507086|NCT00668863|521054098|FG000|Overall Study|Global Deterioration of Health Status|4|||
144507087|NCT00668863|521054098|FG000|Overall Study|Withdrawal by Subject|1|||
144507088|NCT00668863|521054098|FG000|Overall Study|Surgery|1|||
144507089|NCT00668863|521054098|FG000|Overall Study|Subject's work scheduling problem|1|||
144507090|NCT00668863|521054098|FG000|Overall Study|Physician Decision|1|||
144507091|NCT00869323|521054101|FG000|Maintenance Therapy|concurrent illness|1|||
144507092|NCT01068743|521054106|FG000|Period 3|Adverse Event|0|||
144507093|NCT01068743|521054107|FG001|Period 3|Adverse Event|1|||
144507094|NCT01068743|521054108|FG002|Period 3|Adverse Event|0|||
144507095|NCT01068743|521054109|FG003|Period 3|Adverse Event|0|||
144507096|NCT00638963|521054110|FG000|Overall Study|Withdrawal by Subject|1|||
144507097|NCT00638963|521054111|FG001|Overall Study|Withdrawal by Subject|0|||
144507098|NCT02537522|521054114|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
144507099|NCT02537522|521054115|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
144507100|NCT02537522|521054116|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
144507101|NCT02537522|521054117|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
144507102|NCT02537522|521054114|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
144507103|NCT02537522|521054115|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
144507104|NCT02537522|521054116|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
144507105|NCT02537522|521054117|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
144507106|NCT02537522|521054114|FG000|Phase I - Contralateral|incorrect randomization|0|||
144507107|NCT02537522|521054115|FG001|Phase I - Contralateral|incorrect randomization|1|||
144507108|NCT02537522|521054116|FG002|Phase I - Contralateral|incorrect randomization|0|||
144507109|NCT02537522|521054117|FG003|Phase I - Contralateral|incorrect randomization|0|||
144507110|NCT02537522|521054114|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
144507111|NCT02537522|521054115|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
144507112|NCT02537522|521054116|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
144507113|NCT02537522|521054117|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
144507114|NCT02537522|521054114|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
144507115|NCT02537522|521054115|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
144507116|NCT02537522|521054116|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
144507117|NCT02537522|521054117|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
144507118|NCT02202499|521054121|FG000|Overall Study|Cancer diagnosis|0|||
144507119|NCT02202499|521054122|FG001|Overall Study|Cancer diagnosis|0|||
144507120|NCT02202499|521054123|FG002|Overall Study|Cancer diagnosis|1|||
144507121|NCT02202499|521054121|FG000|Overall Study|Moved from area|0|||
144507122|NCT02202499|521054122|FG001|Overall Study|Moved from area|0|||
144507123|NCT02202499|521054123|FG002|Overall Study|Moved from area|1|||
144507124|NCT02202499|521054121|FG000|Overall Study|Declined before randomization|1|||
144507125|NCT02202499|521054122|FG001|Overall Study|Declined before randomization|0|||
144507126|NCT02202499|521054123|FG002|Overall Study|Declined before randomization|0|||
144507127|NCT02202499|521054121|FG000|Overall Study|Auto accident|1|||
144507128|NCT02202499|521054122|FG001|Overall Study|Auto accident|0|||
144507129|NCT02202499|521054123|FG002|Overall Study|Auto accident|0|||
144507130|NCT05323734|521054133|FG000|Overall Study|Adverse Event|5|||
144507131|NCT05323734|521054134|FG001|Overall Study|Adverse Event|2|||
144507132|NCT05323734|521054133|FG000|Overall Study|Physician Decision|1|||
144507133|NCT05323734|521054134|FG001|Overall Study|Physician Decision|0|||
144507134|NCT05323734|521054133|FG000|Overall Study|Lack of Efficacy|1|||
144507135|NCT05323734|521054134|FG001|Overall Study|Lack of Efficacy|2|||
144507136|NCT05323734|521054133|FG000|Overall Study|Withdrawal by Subject|2|||
144507137|NCT05323734|521054134|FG001|Overall Study|Withdrawal by Subject|0|||
144507138|NCT05323734|521054133|FG000|Overall Study|Participant Withdrawn Due|0|||
144507139|NCT05323734|521054134|FG001|Overall Study|Participant Withdrawn Due|1|||
144507140|NCT00658996|521054135|FG000|First Intervention|Positive slit lamp finding|1|||
144507141|NCT00658996|521054136|FG001|First Intervention|Positive slit lamp finding|0|||
144507142|NCT00658996|521054135|FG000|First Intervention|Lack of lenses|0|||
144507143|NCT00658996|521054136|FG001|First Intervention|Lack of lenses|1|||
144507144|NCT00658996|521054135|FG000|Crossover Period|Physician Decision|1|||
144507145|NCT00658996|521054136|FG001|Crossover Period|Physician Decision|0|||
144507146|NCT00658996|521054135|FG000|Crossover Period|Ineligible|1|||
144507147|NCT00658996|521054136|FG001|Crossover Period|Ineligible|1|||
144507148|NCT00658996|521054135|FG000|Second Intervention|Developed a stye on upper lid|1|||
144507149|NCT00658996|521054136|FG001|Second Intervention|Developed a stye on upper lid|0|||
144507150|NCT00658996|521054135|FG000|Second Intervention|Positive slit lamp finding|0|||
144507151|NCT00658996|521054136|FG001|Second Intervention|Positive slit lamp finding|1|||
144507152|NCT01810263|521054147|FG000|Overall Study|Lost to Follow-up|8|||
144507153|NCT01810263|521054148|FG001|Overall Study|Lost to Follow-up|7|||
144507154|NCT01390402|521054149|FG000|Overall Study|Death|1|||
144507155|NCT01390402|521054149|FG000|Overall Study|Disease Progression|4|||
144507156|NCT01353963|521054150|FG000|Overall Study|Adverse Event|2|||
144507157|NCT01121549|521054151|FG000|Overall Study|Adverse Event|10|||
144507158|NCT01121549|521054151|FG000|Overall Study|Lack of Efficacy|11|||
144507159|NCT01121549|521054151|FG000|Overall Study|Lost to Follow-up|12|||
144507160|NCT01121549|521054151|FG000|Overall Study|Did not meet entrance criteria|9|||
144507161|NCT01121549|521054151|FG000|Overall Study|Study terminated by sponsor|197|||
144507162|NCT01121549|521054151|FG000|Overall Study|Pregnancy|1|||
144507163|NCT01121549|521054151|FG000|Overall Study|Protocol Violation|33|||
144507164|NCT01121549|521054151|FG000|Overall Study|Withdrawal by Subject|16|||
144507165|NCT01121549|521054151|FG000|Overall Study|Other|58|||
144507166|NCT04789408|521054152|FG000|Overall Study|Death|4|||
144507167|NCT04789408|521054153|FG001|Overall Study|Death|3|||
144507168|NCT04789408|521054154|FG002|Overall Study|Death|6|||
144507169|NCT04789408|521054152|FG000|Overall Study|Did not meet eligibility criteria|1|||
144507170|NCT04789408|521054153|FG001|Overall Study|Did not meet eligibility criteria|0|||
144507171|NCT04789408|521054154|FG002|Overall Study|Did not meet eligibility criteria|0|||
144507172|NCT04789408|521054152|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
144507173|NCT04789408|521054153|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
144507174|NCT04789408|521054154|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
144507175|NCT01170026|521055277|FG000|Overall Study|Lost to Follow-up|4|||
144507176|NCT01170026|521055278|FG001|Overall Study|Lost to Follow-up|2|||
144507177|NCT03785782|521055290|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
144507178|NCT03785782|521055291|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
144507179|NCT03785782|521055290|FG000|Overall Study|Withdrawal by Subject|1|||
144507180|NCT03785782|521055291|FG001|Overall Study|Withdrawal by Subject|1|||
144507181|NCT03785782|521055290|FG000|Overall Study|insufficient image quality.|3|||
144507182|NCT03785782|521055291|FG001|Overall Study|insufficient image quality.|0|||
144507183|NCT03889925|521055292|FG000|Overall Study|Lost to Follow-up|11|||
144507184|NCT03889925|521055293|FG001|Overall Study|Lost to Follow-up|10|||
144507185|NCT00493649|521055294|FG000|Overall Study|Adverse Event|44|||
144507186|NCT00493649|521055294|FG000|Overall Study|Patient Request|21|||
144507187|NCT00493649|521055294|FG000|Overall Study|Investigator Request|2|||
144507188|NCT00493649|521055294|FG000|Overall Study|Disease Progression|1|||
144507189|NCT00493649|521055294|FG000|Overall Study|Lost to Follow-up|1|||
144507190|NCT00493649|521055294|FG000|Overall Study|Other|13|||
144507191|NCT01662336|521055307|FG000|Overall Study|Adverse Event|1|||
144507192|NCT01662336|521055307|FG000|Overall Study|No longer on LPV/r|30|||
144507193|NCT01662336|521055307|FG000|Overall Study|Other|29|||
144507194|NCT01662336|521055307|FG000|Overall Study|Withdrawal by Subject|6|||
144507195|NCT02189252|521055308|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
144507196|NCT02189252|521055309|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
144507197|NCT02189252|521055310|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
144507198|NCT02189252|521055311|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
144507199|NCT02189252|521055308|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
144507200|NCT02189252|521055309|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
144507201|NCT02189252|521055310|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
144507202|NCT02189252|521055311|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
144507203|NCT04603924|521055312|FG000|Overall Study|Not Dosed|2|||
144507204|NCT04603924|521055313|FG001|Overall Study|Not Dosed|1|||
144507205|NCT04603924|521055312|FG000|Overall Study|Withdrawal by Subject|6|||
144507206|NCT04603924|521055313|FG001|Overall Study|Withdrawal by Subject|6|||
144507207|NCT04603924|521055312|FG000|Overall Study|Adverse Event|2|||
144507208|NCT04603924|521055313|FG001|Overall Study|Adverse Event|2|||
144507209|NCT03762668|521055314|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
144507210|NCT03762668|521055315|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
144507211|NCT02731755|521055321|FG000|First Intervention|Withdrawal by Subject|0|||
144507212|NCT02731755|521055322|FG001|First Intervention|Withdrawal by Subject|2|||
144507213|NCT01460446|521055323|FG000|Overall Study|Non-compliance|2|||
144507214|NCT01460446|521055324|FG001|Overall Study|Non-compliance|9|||
144507215|NCT01460446|521055323|FG000|Overall Study|Consent Withdrawn|0|||
144507216|NCT01460446|521055324|FG001|Overall Study|Consent Withdrawn|4|||
144507217|NCT01460446|521055323|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
144507218|NCT01460446|521055324|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
144507219|NCT01460446|521055323|FG000|Overall Study|Surgery/Illness|1|||
144507220|NCT01460446|521055324|FG001|Overall Study|Surgery/Illness|1|||
144507221|NCT01460446|521055323|FG000|Overall Study|Pregnancy|1|||
144507222|NCT01460446|521055324|FG001|Overall Study|Pregnancy|0|||
144507223|NCT01460446|521055323|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
144507224|NCT01460446|521055324|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
144507225|NCT02139046|521055325|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
144507226|NCT02139046|521055326|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
144507227|NCT02139046|521055327|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
144507228|NCT02139046|521055328|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
144507229|NCT02139046|521055329|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
144507230|NCT02139046|521055325|FG000|Overall Study|Major Protocol Deviation|9|||
144507231|NCT02139046|521055326|FG001|Overall Study|Major Protocol Deviation|10|||
144507232|NCT02139046|521055327|FG002|Overall Study|Major Protocol Deviation|16|||
144507233|NCT02139046|521055328|FG003|Overall Study|Major Protocol Deviation|12|||
144507234|NCT02139046|521055329|FG004|Overall Study|Major Protocol Deviation|6|||
144507235|NCT02139046|521055325|FG000|Overall Study|Lost to Follow-up|13|||
144507236|NCT02139046|521055326|FG001|Overall Study|Lost to Follow-up|16|||
144507237|NCT02139046|521055327|FG002|Overall Study|Lost to Follow-up|16|||
144507238|NCT02139046|521055328|FG003|Overall Study|Lost to Follow-up|18|||
144507239|NCT02139046|521055329|FG004|Overall Study|Lost to Follow-up|13|||
144507240|NCT02139046|521055325|FG000|Overall Study|Voluntary Withdrawal|20|||
144507241|NCT02139046|521055326|FG001|Overall Study|Voluntary Withdrawal|8|||
144507242|NCT02139046|521055327|FG002|Overall Study|Voluntary Withdrawal|10|||
144507243|NCT02139046|521055328|FG003|Overall Study|Voluntary Withdrawal|15|||
144507244|NCT02139046|521055329|FG004|Overall Study|Voluntary Withdrawal|16|||
144507245|NCT02139046|521055325|FG000|Overall Study|Lack of Efficacy|0|||
144507246|NCT02139046|521055326|FG001|Overall Study|Lack of Efficacy|1|||
144507247|NCT02139046|521055327|FG002|Overall Study|Lack of Efficacy|2|||
144507248|NCT02139046|521055328|FG003|Overall Study|Lack of Efficacy|1|||
144507249|NCT02139046|521055329|FG004|Overall Study|Lack of Efficacy|2|||
144507250|NCT02139046|521055325|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
144507251|NCT02139046|521055326|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
144507252|NCT02139046|521055327|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
144507253|NCT02139046|521055328|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
144507254|NCT02139046|521055329|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
144507255|NCT02139046|521055325|FG000|Overall Study|Other Miscellaneous Reasons|10|||
144507256|NCT02139046|521055326|FG001|Overall Study|Other Miscellaneous Reasons|9|||
144507257|NCT02139046|521055327|FG002|Overall Study|Other Miscellaneous Reasons|4|||
144507258|NCT02139046|521055328|FG003|Overall Study|Other Miscellaneous Reasons|9|||
144507259|NCT02139046|521055329|FG004|Overall Study|Other Miscellaneous Reasons|12|||
144507260|NCT01582100|521055333|FG000|Overall Study|Adverse Event|1|||
144507261|NCT01582100|521055333|FG000|Overall Study|Withdrawal by Subject|1|||
144507262|NCT01040689|521055334|FG000|Overall Study|Adverse Event|0|||
144507263|NCT01040689|521055335|FG001|Overall Study|Adverse Event|0|||
144507264|NCT01040689|521055336|FG002|Overall Study|Adverse Event|2|||
144507265|NCT01040689|521055337|FG003|Overall Study|Adverse Event|4|||
144507266|NCT01040689|521055334|FG000|Overall Study|Lack of Efficacy|0|||
144507267|NCT01040689|521055335|FG001|Overall Study|Lack of Efficacy|0|||
144507268|NCT01040689|521055336|FG002|Overall Study|Lack of Efficacy|1|||
144507269|NCT01040689|521055337|FG003|Overall Study|Lack of Efficacy|0|||
144507270|NCT01040689|521055334|FG000|Overall Study|Lost to Follow-up|1|||
144507271|NCT01040689|521055335|FG001|Overall Study|Lost to Follow-up|0|||
144507272|NCT01040689|521055336|FG002|Overall Study|Lost to Follow-up|0|||
144507273|NCT01040689|521055337|FG003|Overall Study|Lost to Follow-up|0|||
144507274|NCT01040689|521055334|FG000|Overall Study|Withdrawal by Subject|2|||
144507275|NCT01040689|521055335|FG001|Overall Study|Withdrawal by Subject|1|||
144507276|NCT01040689|521055336|FG002|Overall Study|Withdrawal by Subject|1|||
144507277|NCT01040689|521055337|FG003|Overall Study|Withdrawal by Subject|0|||
144507278|NCT01040689|521055334|FG000|Overall Study|Other reasons not listed above|0|||
144507279|NCT01040689|521055335|FG001|Overall Study|Other reasons not listed above|1|||
144507280|NCT01040689|521055336|FG002|Overall Study|Other reasons not listed above|0|||
144507281|NCT01040689|521055337|FG003|Overall Study|Other reasons not listed above|0|||
144507282|NCT02755805|521055338|FG000|Overall Study|Lost to Follow-up|1|||
144507283|NCT02755805|521055339|FG001|Overall Study|Lost to Follow-up|2|||
144507284|NCT02755805|521055338|FG000|Overall Study|Refused assessments|1|||
144507285|NCT02755805|521055339|FG001|Overall Study|Refused assessments|0|||
144507286|NCT02755805|521055338|FG000|Overall Study|Withdrawal by Subject|0|||
144507287|NCT02755805|521055339|FG001|Overall Study|Withdrawal by Subject|2|||
144507288|NCT02252042|521055342|FG000|Overall Study|Adverse Event|9|||
144507289|NCT02252042|521055343|FG001|Overall Study|Adverse Event|6|||
144507290|NCT02252042|521055342|FG000|Overall Study|Death|209|||
144507291|NCT02252042|521055343|FG001|Overall Study|Death|217|||
144507292|NCT02252042|521055342|FG000|Overall Study|Physician Decision|0|||
144507293|NCT02252042|521055343|FG001|Overall Study|Physician Decision|2|||
144507294|NCT02252042|521055342|FG000|Overall Study|Transferred to Extension Study|7|||
144507295|NCT02252042|521055343|FG001|Overall Study|Transferred to Extension Study|1|||
144507296|NCT02252042|521055342|FG000|Overall Study|Did Not Continue on Extension Study|7|||
144507297|NCT02252042|521055343|FG001|Overall Study|Did Not Continue on Extension Study|2|||
144507298|NCT02252042|521055342|FG000|Overall Study|Withdrawal by Subject|15|||
144507299|NCT02252042|521055343|FG001|Overall Study|Withdrawal by Subject|20|||
144507300|NCT02593149|521055344|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
144507301|NCT02593149|521055345|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
144507302|NCT02593149|521055344|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
144507303|NCT02593149|521055345|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
144507304|NCT00979992|521055346|FG000|Overall Study|Ineligible - inadequate pathology|1|||
144507305|NCT00979992|521055346|FG000|Overall Study|Ineligible - wrong cell type|2|||
144507306|NCT00979992|521055346|FG000|Overall Study|Refused - Never Treated|2|||
144507307|NCT03691428|521055349|FG000|Overall Study|Withdrawal by Subject|6|||
144507308|NCT03691428|521055350|FG001|Overall Study|Withdrawal by Subject|8|||
144507309|NCT01460290|521055351|FG000|Overall Study|Adverse Event|3|||
144507310|NCT01460290|521055351|FG000|Overall Study|Elevated liver function|1|||
144507311|NCT02527148|521055352|FG000|Overall Study|Did not receive study intervention|1|||
144507312|NCT02527148|521055353|FG001|Overall Study|Did not receive study intervention|0|||
144507313|NCT00189202|521055362|FG000|Overall Study|Physician Decision|5|||
144507314|NCT02448446|521055363|FG000|Overall Study|Withdrawal by Subject|1|||
144507315|NCT02448446|521055364|FG001|Overall Study|Withdrawal by Subject|0|||
144507316|NCT01254188|521055365|FG000|Overall Study|Disease Progression|6|||
144507317|NCT01254188|521055365|FG000|Overall Study|Protocol Violation|6|||
144507318|NCT01254188|521055365|FG000|Overall Study|Pregnancy|2|||
144507319|NCT01254188|521055365|FG000|Overall Study|Death|4|||
144507320|NCT01254188|521055365|FG000|Overall Study|Lost to Follow-up|5|||
144507321|NCT01254188|521055365|FG000|Overall Study|Withdrawal by Subject|7|||
144507322|NCT01254188|521055365|FG000|Overall Study|Adverse Event|43|||
144507323|NCT01254188|521055365|FG000|Overall Study|per investigator discretion|20|||
144507324|NCT02957136|521055372|FG000|Overall Study|Withdrawal by Subject|2|||
144507325|NCT02957136|521055373|FG001|Overall Study|Withdrawal by Subject|1|||
144507326|NCT02755116|521055375|FG000|Overall Study|surgery converted to open, pt admitted|3|||
144507327|NCT02755116|521055376|FG001|Overall Study|surgery converted to open, pt admitted|1|||
144507328|NCT02200770|521055377|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
144507329|NCT02200770|521055378|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
144507330|NCT02200770|521055377|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
144507331|NCT02200770|521055378|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
144507332|NCT02200770|521055377|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
144507333|NCT02200770|521055378|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
144507334|NCT02200770|521055377|FG000|Randomized-controlled Period (RCP)|Other|1|||
144507335|NCT02200770|521055378|FG001|Randomized-controlled Period (RCP)|Other|2|||
144507336|NCT02200770|521055377|FG000|Open-label Period (OLP)|Adverse Event|1|||
144507337|NCT02200770|521055378|FG001|Open-label Period (OLP)|Adverse Event|2|||
144507338|NCT02200770|521055377|FG000|Open-label Period (OLP)|Death|1|||
144507339|NCT02200770|521055378|FG001|Open-label Period (OLP)|Death|2|||
144507340|NCT02200770|521055377|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
144507341|NCT02200770|521055378|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
144507342|NCT02200770|521055377|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
144507343|NCT02200770|521055378|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
144507344|NCT02200770|521055377|FG000|Open-label Period (OLP)|Other|6|||
144507345|NCT02200770|521055378|FG001|Open-label Period (OLP)|Other|15|||
144507346|NCT02423291|521055379|FG000|Overall Study|Lack of Efficacy|14|||
144507347|NCT02423291|521055379|FG000|Overall Study|Adverse Event|1|||
144507348|NCT02555215|521055387|FG000|Overall Study|Other|1|||
144507349|NCT02555215|521055387|FG000|Overall Study|Investigator Decision|2|||
144507350|NCT02538107|521055392|FG000|Overall Study|Did not receive any Mircera dose|11|||
144507351|NCT02538107|521055392|FG000|Overall Study|Missing|5|||
144507352|NCT02538107|521055392|FG000|Overall Study|Necessity of dialysis|20|||
144507353|NCT02538107|521055392|FG000|Overall Study|Administration of other ESA|11|||
144507354|NCT02538107|521055392|FG000|Overall Study|No further treatment necessary|18|||
144507355|NCT02538107|521055392|FG000|Overall Study|Withdrawal by Subject|17|||
144507356|NCT02538107|521055392|FG000|Overall Study|Death|4|||
144507357|NCT02538107|521055392|FG000|Overall Study|Administrative reason|5|||
144507358|NCT02538107|521055392|FG000|Overall Study|Adverse Event|4|||
144507359|NCT02538107|521055392|FG000|Overall Study|Surgery|1|||
144507360|NCT02538107|521055392|FG000|Overall Study|Other|7|||
144507361|NCT02538107|521055392|FG000|Overall Study|Not recorded|7|||
144507362|NCT00468910|521055393|FG000|Overall Study|Lost to Follow-up|2|||
144507363|NCT00468910|521055394|FG001|Overall Study|Lost to Follow-up|1|||
144507364|NCT00468910|521055393|FG000|Overall Study|Withdrawal by Subject|2|||
144507365|NCT00468910|521055394|FG001|Overall Study|Withdrawal by Subject|1|||
144507366|NCT00468910|521055393|FG000|Overall Study|Medical Contraindication|0|||
144507367|NCT00468910|521055394|FG001|Overall Study|Medical Contraindication|1|||
144507368|NCT01909778|521055395|FG000|Overall Study|failed screening|1|||
144507369|NCT00919763|521055396|FG000|Overall Study|Adverse Event|7|||
144507370|NCT00919763|521055397|FG001|Overall Study|Adverse Event|1|||
144507371|NCT00919763|521055396|FG000|Overall Study|Lost to Follow-up|1|||
144507372|NCT00919763|521055397|FG001|Overall Study|Lost to Follow-up|0|||
144588160|NCT02594163|521352301|FG000|Follow-up Period|Physician Decision|0|||
144588161|NCT02594163|521352302|FG001|Follow-up Period|Physician Decision|1|||
144588162|NCT00117845|521352303|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
144588163|NCT00932113|521352306|FG000|Overall Study|Lost to Follow-up|1|||
144588164|NCT00932113|521352307|FG001|Overall Study|Lost to Follow-up|0|||
144588165|NCT01403610|521352308|FG000|Overall Study|Withdrawal by Subject|2|||
144588166|NCT01403610|521352309|FG001|Overall Study|Withdrawal by Subject|0|||
144507373|NCT00919763|521055396|FG000|Overall Study|Protocol Violation|1|||
144507374|NCT00919763|521055397|FG001|Overall Study|Protocol Violation|1|||
144507375|NCT00919763|521055396|FG000|Overall Study|Withdrawal by Subject|3|||
144507376|NCT00919763|521055397|FG001|Overall Study|Withdrawal by Subject|1|||
144507377|NCT00919763|521055396|FG000|Overall Study|Non-compliance|0|||
144588167|NCT01403610|521352310|FG002|Overall Study|Withdrawal by Subject|0|||
144588168|NCT01403610|521352311|FG003|Overall Study|Withdrawal by Subject|0|||
144588169|NCT01403610|521352308|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
144588170|NCT01403610|521352309|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
144588171|NCT01403610|521352310|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
144507378|NCT00919763|521055397|FG001|Overall Study|Non-compliance|1|||
144507379|NCT02471755|521055398|FG000|Overall Study|Withdrawal by Subject|1|||
144507380|NCT02471755|521055399|FG001|Overall Study|Withdrawal by Subject|0|||
144507381|NCT02471755|521055398|FG000|Overall Study|Lost to Follow-up|0|||
144507382|NCT02471755|521055399|FG001|Overall Study|Lost to Follow-up|1|||
144507383|NCT04740164|521055401|FG000|Overall Study|Lack of Efficacy|4|||
144507384|NCT04740164|521055402|FG001|Overall Study|Lack of Efficacy|0|||
144507385|NCT04740164|521055401|FG000|Overall Study|Physician Decision|3|||
144507386|NCT04740164|521055402|FG001|Overall Study|Physician Decision|3|||
144507387|NCT05061693|521055403|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
144507388|NCT05061693|521055404|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
144507389|NCT05061693|521055405|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
144507390|NCT05061693|521055406|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507391|NCT05061693|521055407|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507392|NCT05061693|521055408|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507393|NCT05061693|521055409|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507394|NCT05061693|521055410|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507395|NCT05061693|521055411|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507396|NCT05061693|521055412|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507397|NCT05061693|521055413|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144371013|NCT03614156|520565987|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
144507398|NCT05061693|521055414|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
144507399|NCT05061693|521055403|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
144507400|NCT05061693|521055404|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
144507401|NCT05061693|521055405|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
144507402|NCT05061693|521055406|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
144507403|NCT05061693|521055407|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
144507404|NCT05061693|521055408|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
144507405|NCT05061693|521055409|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
144507406|NCT05061693|521055410|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
144507407|NCT05061693|521055411|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
144507408|NCT05061693|521055412|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
144507409|NCT05061693|521055413|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
144507410|NCT05061693|521055414|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
144507411|NCT05061693|521055403|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
144507412|NCT05061693|521055404|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507413|NCT05061693|521055405|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507414|NCT05061693|521055406|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507415|NCT05061693|521055407|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507416|NCT05061693|521055408|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507417|NCT05061693|521055409|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507418|NCT05061693|521055410|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507419|NCT05061693|521055411|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507420|NCT05061693|521055412|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507421|NCT05061693|521055413|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507422|NCT05061693|521055414|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
144507423|NCT05061693|521055403|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507424|NCT05061693|521055404|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144588172|NCT01403610|521352311|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
144371014|NCT03614156|520565988|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
144507425|NCT05061693|521055405|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
144507426|NCT05061693|521055406|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507427|NCT05061693|521055407|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507428|NCT05061693|521055408|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507429|NCT05061693|521055409|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507430|NCT05061693|521055410|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507431|NCT05061693|521055411|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507432|NCT05061693|521055412|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507433|NCT05061693|521055413|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507434|NCT05061693|521055414|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
144507435|NCT05061693|521055403|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
144507436|NCT05061693|521055404|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
144507437|NCT05061693|521055405|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
144507438|NCT05061693|521055406|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
144507439|NCT05061693|521055407|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507440|NCT05061693|521055408|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507441|NCT05061693|521055409|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507442|NCT05061693|521055410|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507443|NCT05061693|521055411|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507444|NCT05061693|521055412|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507445|NCT05061693|521055413|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507446|NCT05061693|521055414|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
144507447|NCT05061693|521055403|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
144507448|NCT05061693|521055404|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
144507449|NCT05061693|521055405|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
144507450|NCT05061693|521055406|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
144507451|NCT05061693|521055407|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507452|NCT05061693|521055408|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507453|NCT05061693|521055409|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507454|NCT05061693|521055410|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507455|NCT05061693|521055411|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507456|NCT05061693|521055412|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507457|NCT05061693|521055413|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507458|NCT05061693|521055414|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
144507459|NCT05061693|521055403|FG000|24-week Extension Period|Adverse Event|0|||
144507460|NCT05061693|521055404|FG001|24-week Extension Period|Adverse Event|0|||
144507461|NCT05061693|521055405|FG002|24-week Extension Period|Adverse Event|0|||
144507462|NCT05061693|521055406|FG003|24-week Extension Period|Adverse Event|0|||
144507463|NCT05061693|521055407|FG004|24-week Extension Period|Adverse Event|0|||
144507464|NCT05061693|521055408|FG005|24-week Extension Period|Adverse Event|0|||
144507465|NCT05061693|521055409|FG006|24-week Extension Period|Adverse Event|0|||
144507466|NCT05061693|521055410|FG007|24-week Extension Period|Adverse Event|2|||
144507467|NCT05061693|521055411|FG008|24-week Extension Period|Adverse Event|2|||
144507468|NCT05061693|521055412|FG009|24-week Extension Period|Adverse Event|0|||
144507469|NCT05061693|521055413|FG010|24-week Extension Period|Adverse Event|1|||
144507470|NCT05061693|521055414|FG011|24-week Extension Period|Adverse Event|3|||
144507471|NCT05061693|521055403|FG000|24-week Extension Period|Lack of Efficacy|0|||
144507472|NCT05061693|521055404|FG001|24-week Extension Period|Lack of Efficacy|0|||
144507473|NCT05061693|521055405|FG002|24-week Extension Period|Lack of Efficacy|0|||
144507474|NCT05061693|521055406|FG003|24-week Extension Period|Lack of Efficacy|0|||
144507475|NCT05061693|521055407|FG004|24-week Extension Period|Lack of Efficacy|0|||
144507476|NCT05061693|521055408|FG005|24-week Extension Period|Lack of Efficacy|0|||
144507477|NCT05061693|521055409|FG006|24-week Extension Period|Lack of Efficacy|0|||
144507478|NCT05061693|521055410|FG007|24-week Extension Period|Lack of Efficacy|0|||
144507479|NCT05061693|521055411|FG008|24-week Extension Period|Lack of Efficacy|0|||
144507480|NCT05061693|521055412|FG009|24-week Extension Period|Lack of Efficacy|0|||
144507481|NCT05061693|521055413|FG010|24-week Extension Period|Lack of Efficacy|2|||
144507482|NCT05061693|521055414|FG011|24-week Extension Period|Lack of Efficacy|0|||
144507483|NCT05061693|521055403|FG000|24-week Extension Period|Lost to Follow-up|0|||
144507484|NCT05061693|521055404|FG001|24-week Extension Period|Lost to Follow-up|0|||
144507485|NCT05061693|521055405|FG002|24-week Extension Period|Lost to Follow-up|0|||
144507486|NCT05061693|521055406|FG003|24-week Extension Period|Lost to Follow-up|0|||
144507487|NCT05061693|521055407|FG004|24-week Extension Period|Lost to Follow-up|0|||
144507488|NCT05061693|521055408|FG005|24-week Extension Period|Lost to Follow-up|0|||
144507489|NCT05061693|521055409|FG006|24-week Extension Period|Lost to Follow-up|1|||
144371015|NCT03614156|520565985|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
144371016|NCT03614156|520565986|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
144507490|NCT05061693|521055410|FG007|24-week Extension Period|Lost to Follow-up|0|||
144507491|NCT05061693|521055411|FG008|24-week Extension Period|Lost to Follow-up|1|||
144507492|NCT05061693|521055412|FG009|24-week Extension Period|Lost to Follow-up|1|||
144507493|NCT05061693|521055413|FG010|24-week Extension Period|Lost to Follow-up|0|||
144507494|NCT05061693|521055414|FG011|24-week Extension Period|Lost to Follow-up|0|||
144507495|NCT05061693|521055403|FG000|24-week Extension Period|Withdrawal by Subject|0|||
144507496|NCT05061693|521055404|FG001|24-week Extension Period|Withdrawal by Subject|0|||
144507497|NCT05061693|521055405|FG002|24-week Extension Period|Withdrawal by Subject|0|||
144507498|NCT05061693|521055406|FG003|24-week Extension Period|Withdrawal by Subject|0|||
144507499|NCT05061693|521055407|FG004|24-week Extension Period|Withdrawal by Subject|0|||
144507500|NCT05061693|521055408|FG005|24-week Extension Period|Withdrawal by Subject|0|||
144507501|NCT05061693|521055409|FG006|24-week Extension Period|Withdrawal by Subject|0|||
144507502|NCT05061693|521055410|FG007|24-week Extension Period|Withdrawal by Subject|0|||
144507503|NCT05061693|521055411|FG008|24-week Extension Period|Withdrawal by Subject|1|||
144507504|NCT05061693|521055412|FG009|24-week Extension Period|Withdrawal by Subject|2|||
144507505|NCT05061693|521055413|FG010|24-week Extension Period|Withdrawal by Subject|2|||
144507506|NCT05061693|521055414|FG011|24-week Extension Period|Withdrawal by Subject|1|||
144507507|NCT05061693|521055403|FG000|24-week Extension Period|Sponsor Decision|0|||
144507508|NCT05061693|521055404|FG001|24-week Extension Period|Sponsor Decision|0|||
144507509|NCT05061693|521055405|FG002|24-week Extension Period|Sponsor Decision|0|||
144507510|NCT05061693|521055406|FG003|24-week Extension Period|Sponsor Decision|0|||
144507511|NCT05061693|521055407|FG004|24-week Extension Period|Sponsor Decision|0|||
144507512|NCT05061693|521055408|FG005|24-week Extension Period|Sponsor Decision|0|||
144507513|NCT05061693|521055409|FG006|24-week Extension Period|Sponsor Decision|0|||
144507514|NCT05061693|521055410|FG007|24-week Extension Period|Sponsor Decision|1|||
144507515|NCT05061693|521055411|FG008|24-week Extension Period|Sponsor Decision|0|||
144507516|NCT05061693|521055412|FG009|24-week Extension Period|Sponsor Decision|0|||
144507517|NCT05061693|521055413|FG010|24-week Extension Period|Sponsor Decision|0|||
144507518|NCT05061693|521055414|FG011|24-week Extension Period|Sponsor Decision|0|||
144507519|NCT05061693|521055403|FG000|24-week Extension Period|Site Closure|0|||
144507520|NCT05061693|521055404|FG001|24-week Extension Period|Site Closure|0|||
144507521|NCT05061693|521055405|FG002|24-week Extension Period|Site Closure|0|||
144507522|NCT05061693|521055406|FG003|24-week Extension Period|Site Closure|0|||
144507523|NCT05061693|521055407|FG004|24-week Extension Period|Site Closure|0|||
144507524|NCT05061693|521055408|FG005|24-week Extension Period|Site Closure|0|||
144507525|NCT05061693|521055409|FG006|24-week Extension Period|Site Closure|0|||
144507526|NCT05061693|521055410|FG007|24-week Extension Period|Site Closure|0|||
144507527|NCT05061693|521055411|FG008|24-week Extension Period|Site Closure|1|||
144507528|NCT05061693|521055412|FG009|24-week Extension Period|Site Closure|0|||
144507529|NCT05061693|521055413|FG010|24-week Extension Period|Site Closure|0|||
144507530|NCT05061693|521055414|FG011|24-week Extension Period|Site Closure|1|||
144507531|NCT01152190|521055415|FG000|Overall Study|Adverse Event|2|||
144507532|NCT01152190|521055416|FG001|Overall Study|Adverse Event|4|||
144507533|NCT01152190|521055415|FG000|Overall Study|Death|1|||
144507534|NCT01152190|521055416|FG001|Overall Study|Death|0|||
144507535|NCT01152190|521055415|FG000|Overall Study|Protocol Violation|1|||
144507536|NCT01152190|521055416|FG001|Overall Study|Protocol Violation|1|||
144507537|NCT01152190|521055415|FG000|Overall Study|Withdrawal by Subject|1|||
144507538|NCT01152190|521055416|FG001|Overall Study|Withdrawal by Subject|3|||
144507539|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
144507540|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
144507541|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
144507542|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
144507543|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
144507544|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
144507545|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
144507546|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
144507547|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
144507548|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
144507549|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
144507550|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
144507551|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
144507552|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
144507553|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
144507554|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
144507555|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
144507556|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
144507557|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
144507558|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
144507559|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
144507560|NCT00304031|521056646|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
144507561|NCT00304031|521056647|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
144507562|NCT00304031|521056648|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
144507563|NCT00304031|521056646|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
144507564|NCT00304031|521056647|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
144507565|NCT00304031|521056648|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
144507566|NCT02396316|521056651|FG000|Overall Study|Physician Decision|1|||
144507567|NCT02396316|521056652|FG001|Overall Study|Physician Decision|0|||
144507568|NCT02396316|521056651|FG000|Overall Study|Progressive disease|6|||
144507569|NCT02396316|521056652|FG001|Overall Study|Progressive disease|3|||
144507570|NCT02396316|521056651|FG000|Overall Study|Protocol Violation|0|||
144507571|NCT02396316|521056652|FG001|Overall Study|Protocol Violation|1|||
144507572|NCT02396316|521056651|FG000|Overall Study|Treatment unblinded|0|||
144507573|NCT02396316|521056652|FG001|Overall Study|Treatment unblinded|1|||
144507574|NCT00566735|521056653|FG000|Overall Study|Withdrawal by Subject|0|||
144507575|NCT00566735|521056654|FG001|Overall Study|Withdrawal by Subject|1|||
144507576|NCT00566735|521056653|FG000|Overall Study|Refused neuropsychological testing|2|||
144507577|NCT00566735|521056654|FG001|Overall Study|Refused neuropsychological testing|5|||
144507578|NCT00566735|521056653|FG000|Overall Study|Switched into a manic episode|0|||
144507579|NCT00566735|521056654|FG001|Overall Study|Switched into a manic episode|1|||
144507580|NCT00714714|521056663|FG000|Overall Study|Adverse Event|1|||
144507581|NCT01185561|521056666|FG000|Overall Study|Lost to Follow-up|0|||
144507582|NCT01185561|521056667|FG001|Overall Study|Lost to Follow-up|4|||
144507583|NCT01185561|521056666|FG000|Overall Study|Withdrawal by Subject|2|||
144507584|NCT01185561|521056667|FG001|Overall Study|Withdrawal by Subject|8|||
144507585|NCT01078116|521056668|FG000|Overall Study|Lost to Follow-up|17|||
144507586|NCT01078116|521056668|FG000|Overall Study|Adverse Event|5|||
144507587|NCT01078116|521056668|FG000|Overall Study|Withdrawal by Subject|8|||
144507588|NCT01078116|521056668|FG000|Overall Study|Lack of effectiveness|15|||
144507589|NCT01078116|521056668|FG000|Overall Study|Case report form not completed|3|||
144507590|NCT02616900|521056669|FG000|Overall Study|Lack of Efficacy|7|||
144507591|NCT02616900|521056669|FG000|Overall Study|Lost to Follow-up|2|||
144507592|NCT02616900|521056669|FG000|Overall Study|Protocol Violation|5|||
144507593|NCT02616900|521056669|FG000|Overall Study|Withdrawal by Subject|3|||
144507594|NCT02616900|521056669|FG000|Overall Study|Incomplete data|6|||
144507595|NCT02242487|521056670|FG000|Overall Study|Adverse Event|13|||
144507596|NCT02242487|521056671|FG001|Overall Study|Adverse Event|15|||
144507597|NCT02242487|521056670|FG000|Overall Study|Lack of Efficacy|4|||
144507598|NCT02242487|521056671|FG001|Overall Study|Lack of Efficacy|6|||
144507599|NCT02242487|521056670|FG000|Overall Study|Protocol Violation|2|||
144507600|NCT02242487|521056671|FG001|Overall Study|Protocol Violation|0|||
144507601|NCT02242487|521056670|FG000|Overall Study|Lost to Follow-up|2|||
144507602|NCT02242487|521056671|FG001|Overall Study|Lost to Follow-up|1|||
144507603|NCT02242487|521056670|FG000|Overall Study|Other - Miscellaneous|4|||
144507604|NCT02242487|521056671|FG001|Overall Study|Other - Miscellaneous|6|||
144507605|NCT02242487|521056670|FG000|Overall Study|Withdrawal by Subject|37|||
144507606|NCT02242487|521056671|FG001|Overall Study|Withdrawal by Subject|19|||
144507607|NCT00439569|521056674|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
144507608|NCT00439569|521056674|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
144507609|NCT00439569|521056674|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
144507610|NCT01510717|521056675|FG000|Overall Study|Adverse Event|1|||
144507611|NCT01510717|521056676|FG001|Overall Study|Adverse Event|2|||
144507612|NCT01510717|521056675|FG000|Overall Study|Death|1|||
144507613|NCT01510717|521056676|FG001|Overall Study|Death|0|||
144507614|NCT01510717|521056675|FG000|Overall Study|Lost to Follow-up|0|||
144507615|NCT01510717|521056676|FG001|Overall Study|Lost to Follow-up|1|||
144507616|NCT01510717|521056675|FG000|Overall Study|Withdrawal by Subject|0|||
144507617|NCT01510717|521056676|FG001|Overall Study|Withdrawal by Subject|2|||
144507618|NCT00529789|521056677|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
144507619|NCT00529789|521056677|FG000|Study Period II/III|Adverse Event|3|||
144507620|NCT00529789|521056677|FG000|Study Period II/III|Lack of Efficacy|2|||
144507621|NCT00529789|521056677|FG000|Study Period II/III|Withdrawal by Subject|1|||
144507622|NCT00529789|521056677|FG000|Study Period II/III|Protocol Violation|3|||
144507623|NCT00529789|521056677|FG000|Study Period II/III|Physician Decision|3|||
144507624|NCT00529789|521056677|FG000|Study Period II/III|Lost to Follow-up|3|||
144507625|NCT00529789|521056677|FG000|Study Period IV|Parent/Caregiver Decision|1|||
144507626|NCT00529789|521056677|FG000|Study Period IV|Adverse Event|1|||
144507627|NCT00529789|521056677|FG000|Study Period IV|Lack of Efficacy|1|||
144507628|NCT00529789|521056677|FG000|Study Period IV|Lost to Follow-up|3|||
144507629|NCT01595061|521056678|FG000|Overall Study|Never Treated|3|||
144507630|NCT01595061|521056678|FG000|Overall Study|Inadequate Pathology|1|||
144507631|NCT03194958|521056679|FG000|Overall Study|Death|0|||
144721675|NCT01612000|521835257|FG000|Overall Study|Withdrawal by Subject|3|||
144507632|NCT03194958|521056680|FG001|Overall Study|Death|1|||
144507633|NCT03194958|521056681|FG002|Overall Study|Death|1|||
144507634|NCT03194958|521056682|FG003|Overall Study|Death|1|||
144507635|NCT03194958|521056679|FG000|Overall Study|Withdrawal by Subject|24|||
144507636|NCT03194958|521056680|FG001|Overall Study|Withdrawal by Subject|27|||
144507637|NCT03194958|521056681|FG002|Overall Study|Withdrawal by Subject|7|||
144507638|NCT03194958|521056682|FG003|Overall Study|Withdrawal by Subject|22|||
144507639|NCT03194958|521056679|FG000|Overall Study|Lost to Follow-up|168|||
144507640|NCT03194958|521056680|FG001|Overall Study|Lost to Follow-up|196|||
144507641|NCT03194958|521056681|FG002|Overall Study|Lost to Follow-up|174|||
144507642|NCT03194958|521056682|FG003|Overall Study|Lost to Follow-up|186|||
144507643|NCT01968226|521056684|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
144507644|NCT00566527|521056688|FG000|Overall Study|Reason not provided|3|||
144507645|NCT00566527|521056689|FG001|Overall Study|Reason not provided|11|||
144507646|NCT00566527|521056690|FG002|Overall Study|Reason not provided|10|||
144588173|NCT01190514|521352312|FG000|First Intervention (Period 1)|Adverse Event|1|||
144371017|NCT03614156|520565987|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
144588174|NCT01190514|521352313|FG001|First Intervention (Period 1)|Adverse Event|0|||
144588175|NCT01190514|521352314|FG002|First Intervention (Period 1)|Adverse Event|0|||
144588176|NCT01190514|521352315|FG003|First Intervention (Period 1)|Adverse Event|0|||
144588177|NCT01190514|521352312|FG000|Third Intervention (Period 3)|Adverse Event|1|||
144588178|NCT01190514|521352313|FG001|Third Intervention (Period 3)|Adverse Event|0|||
144371018|NCT03614156|520565988|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
144371019|NCT03614156|520565985|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
144371020|NCT03614156|520565986|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
144371021|NCT03614156|520565987|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
144371022|NCT03614156|520565988|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
144371023|NCT03614156|520565985|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144371024|NCT03614156|520565986|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
144371025|NCT03614156|520565987|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
144371026|NCT03614156|520565988|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
144371027|NCT03614156|520565985|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144371028|NCT03614156|520565986|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144371029|NCT03614156|520565987|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
144371030|NCT03614156|520565988|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
144371031|NCT03614156|520565985|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
144371032|NCT03614156|520565986|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
144371033|NCT03614156|520565987|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
144371034|NCT03614156|520565988|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
144371035|NCT03614156|520565985|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
144371036|NCT03614156|520565986|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
144371037|NCT03614156|520565987|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
144371038|NCT03614156|520565988|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
144371039|NCT03614156|520565985|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
144371040|NCT03614156|520565986|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
144371041|NCT03614156|520565987|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
144371042|NCT03614156|520565988|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
144371043|NCT03614156|520565985|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
144371044|NCT03614156|520565986|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
144371045|NCT03614156|520565987|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
144371046|NCT03614156|520565988|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
144371047|NCT03614156|520565985|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
144371048|NCT03614156|520565986|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
144371049|NCT03614156|520565987|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
144371050|NCT03614156|520565988|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
144371051|NCT03614156|520565985|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
144371052|NCT03614156|520565986|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
144371053|NCT03614156|520565987|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
144371054|NCT03614156|520565988|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
144371055|NCT01094119|520565990|FG000|Overall Study|Lack of Efficacy|2|||
144371056|NCT01094119|520565991|FG001|Overall Study|Lack of Efficacy|4|||
144371057|NCT02668393|520565992|FG000|Overall Study|Progressive disease|6|||
144371058|NCT02668393|520565993|FG001|Overall Study|Progressive disease|3|||
144371059|NCT02668393|520565992|FG000|Overall Study|Adverse Event|0|||
144507647|NCT00566527|521056688|FG000|Overall Study|Adverse Event|2|||
144507648|NCT00566527|521056689|FG001|Overall Study|Adverse Event|0|||
144507649|NCT00566527|521056690|FG002|Overall Study|Adverse Event|1|||
144371060|NCT02668393|520565993|FG001|Overall Study|Adverse Event|2|||
144371061|NCT02668393|520565992|FG000|Overall Study|Withdrawal from the trial|0|||
144371062|NCT02668393|520565993|FG001|Overall Study|Withdrawal from the trial|1|||
144371063|NCT02668393|520565992|FG000|Overall Study|Lack of benefit and side effects|1|||
144371064|NCT02668393|520565993|FG001|Overall Study|Lack of benefit and side effects|0|||
144588179|NCT01190514|521352314|FG002|Third Intervention (Period 3)|Adverse Event|0|||
144588180|NCT01190514|521352315|FG003|Third Intervention (Period 3)|Adverse Event|0|||
144588181|NCT00700258|521352317|FG000|Overall Study|Premature discontinuation of documentation|136|||
144588182|NCT00700258|521352317|FG000|Overall Study|Type of study end not documented|1|||
144588183|NCT00700258|521352317|FG000|Overall Study|Lost to Follow-up|81|||
144588184|NCT00700258|521352317|FG000|Overall Study|Premature discontinuation of therapy|1013|||
144588185|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
144588186|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
144588187|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
144588188|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
144588189|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
144588190|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
144588191|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
144588192|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
144588193|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
144588194|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
144588195|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
144588196|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
144588197|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
144588198|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
144507650|NCT00566527|521056688|FG000|Overall Study|Physician Decision|3|||
144507651|NCT00566527|521056689|FG001|Overall Study|Physician Decision|8|||
144507652|NCT00566527|521056690|FG002|Overall Study|Physician Decision|20|||
144507653|NCT00566527|521056688|FG000|Overall Study|Lost to Follow-up|3|||
144507654|NCT00566527|521056689|FG001|Overall Study|Lost to Follow-up|4|||
144507655|NCT00566527|521056690|FG002|Overall Study|Lost to Follow-up|4|||
144507656|NCT00566527|521056688|FG000|Overall Study|Withdrawal by Subject|6|||
144507657|NCT00566527|521056689|FG001|Overall Study|Withdrawal by Subject|43|||
144507658|NCT00566527|521056690|FG002|Overall Study|Withdrawal by Subject|43|||
144507659|NCT00959946|521056691|FG000|Overall Study|Adverse Event|0|||
144507660|NCT00959946|521056692|FG001|Overall Study|Adverse Event|0|||
144507661|NCT00959946|521056693|FG002|Overall Study|Adverse Event|2|||
144507662|NCT00959946|521056694|FG003|Overall Study|Adverse Event|1|||
144507663|NCT00959946|521056695|FG004|Overall Study|Adverse Event|0|||
144507664|NCT00959946|521056696|FG005|Overall Study|Adverse Event|1|||
144507665|NCT00959946|521056697|FG006|Overall Study|Adverse Event|0|||
144507666|NCT00959946|521056698|FG007|Overall Study|Adverse Event|0|||
144507667|NCT00959946|521056691|FG000|Overall Study|Death|0|||
144507668|NCT00959946|521056692|FG001|Overall Study|Death|0|||
144507669|NCT00959946|521056693|FG002|Overall Study|Death|0|||
144507670|NCT00959946|521056694|FG003|Overall Study|Death|0|||
144507671|NCT00959946|521056695|FG004|Overall Study|Death|0|||
144507672|NCT00959946|521056696|FG005|Overall Study|Death|1|||
144507673|NCT00959946|521056697|FG006|Overall Study|Death|0|||
144507674|NCT00959946|521056698|FG007|Overall Study|Death|0|||
144507675|NCT00959946|521056691|FG000|Overall Study|Disease Progression|2|||
144507676|NCT00959946|521056692|FG001|Overall Study|Disease Progression|4|||
144507677|NCT00959946|521056693|FG002|Overall Study|Disease Progression|2|||
144507678|NCT00959946|521056694|FG003|Overall Study|Disease Progression|4|||
144507679|NCT00959946|521056695|FG004|Overall Study|Disease Progression|4|||
144507680|NCT00959946|521056696|FG005|Overall Study|Disease Progression|6|||
144507681|NCT00959946|521056697|FG006|Overall Study|Disease Progression|2|||
144507682|NCT00959946|521056698|FG007|Overall Study|Disease Progression|2|||
144507683|NCT00959946|521056691|FG000|Overall Study|Withdrawal by Subject|0|||
144507684|NCT00959946|521056692|FG001|Overall Study|Withdrawal by Subject|0|||
144507685|NCT00959946|521056693|FG002|Overall Study|Withdrawal by Subject|0|||
144507686|NCT00959946|521056694|FG003|Overall Study|Withdrawal by Subject|0|||
144507687|NCT00959946|521056695|FG004|Overall Study|Withdrawal by Subject|0|||
144507688|NCT00959946|521056696|FG005|Overall Study|Withdrawal by Subject|1|||
144507689|NCT00959946|521056697|FG006|Overall Study|Withdrawal by Subject|0|||
144507690|NCT00959946|521056698|FG007|Overall Study|Withdrawal by Subject|0|||
144507691|NCT00457743|521056699|FG000|Overall Study|Adverse Event|0|||
144507692|NCT00457743|521056700|FG001|Overall Study|Adverse Event|4|||
144507693|NCT00457743|521056701|FG002|Overall Study|Adverse Event|0|||
144507694|NCT00457743|521056699|FG000|Overall Study|Lack of Efficacy|3|||
144507695|NCT00457743|521056700|FG001|Overall Study|Lack of Efficacy|23|||
144507696|NCT00457743|521056701|FG002|Overall Study|Lack of Efficacy|3|||
144507697|NCT00356265|521056702|FG000|Overall Study|Withdrawal by Subject|0|||
144507698|NCT00356265|521056703|FG001|Overall Study|Withdrawal by Subject|0|||
144588199|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
144588200|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
144588201|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
144507699|NCT00356265|521056704|FG002|Overall Study|Withdrawal by Subject|1|||
144507700|NCT01837966|521056708|FG000|Overall Study|Withdrawal by Subject|2|||
144507701|NCT01837966|521056709|FG001|Overall Study|Withdrawal by Subject|1|||
144588202|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
144588203|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
144588204|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
144588205|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
144588206|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
144588207|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
144588208|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
144588209|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
144588210|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
144588211|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
144588212|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
144588213|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
144588214|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
144588215|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
144588216|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
144588217|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
144588218|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
144507702|NCT01202955|521056710|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
144507703|NCT01202955|521056711|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
144507704|NCT00159783|521056717|FG000|Overall Study|Adverse Event|5|||
144507705|NCT00159783|521056718|FG001|Overall Study|Adverse Event|7|||
144507706|NCT00159783|521056719|FG002|Overall Study|Adverse Event|9|||
144507707|NCT00159783|521056717|FG000|Overall Study|Lack of Efficacy|1|||
144507708|NCT00159783|521056718|FG001|Overall Study|Lack of Efficacy|2|||
144507709|NCT00159783|521056719|FG002|Overall Study|Lack of Efficacy|3|||
144507710|NCT00159783|521056717|FG000|Overall Study|Withdrawal by Subject|7|||
144507711|NCT00159783|521056718|FG001|Overall Study|Withdrawal by Subject|11|||
144507712|NCT00159783|521056719|FG002|Overall Study|Withdrawal by Subject|12|||
144507713|NCT00159783|521056717|FG000|Overall Study|Lost to Follow-up|6|||
144507714|NCT00159783|521056718|FG001|Overall Study|Lost to Follow-up|5|||
144507715|NCT00159783|521056719|FG002|Overall Study|Lost to Follow-up|11|||
144507716|NCT00159783|521056717|FG000|Overall Study|Other|0|||
144507717|NCT00159783|521056718|FG001|Overall Study|Other|2|||
144507718|NCT00159783|521056719|FG002|Overall Study|Other|4|||
144507719|NCT02928224|521056720|FG000|Overall Study|Lost to Follow-up|1|||
144507720|NCT02928224|521056721|FG001|Overall Study|Lost to Follow-up|1|||
144507721|NCT02928224|521056722|FG002|Overall Study|Lost to Follow-up|3|||
144507722|NCT02928224|521056723|FG003|Overall Study|Lost to Follow-up|0|||
144507723|NCT02928224|521056720|FG000|Overall Study|Death|30|||
144507724|NCT02928224|521056721|FG001|Overall Study|Death|209|||
144507725|NCT02928224|521056722|FG002|Overall Study|Death|193|||
144507726|NCT02928224|521056723|FG003|Overall Study|Death|198|||
144507727|NCT02928224|521056720|FG000|Overall Study|Withdrawal by Subject|0|||
144507728|NCT02928224|521056721|FG001|Overall Study|Withdrawal by Subject|3|||
144507729|NCT02928224|521056722|FG002|Overall Study|Withdrawal by Subject|7|||
144507730|NCT02928224|521056723|FG003|Overall Study|Withdrawal by Subject|20|||
144507731|NCT02928224|521056720|FG000|Overall Study|Study participation terminated by sponsor|3|||
144507732|NCT02928224|521056721|FG001|Overall Study|Study participation terminated by sponsor|8|||
144507733|NCT02928224|521056722|FG002|Overall Study|Study participation terminated by sponsor|12|||
144507734|NCT02928224|521056723|FG003|Overall Study|Study participation terminated by sponsor|3|||
144507735|NCT02928224|521056720|FG000|Overall Study|Other|3|||
144507736|NCT02928224|521056721|FG001|Overall Study|Other|3|||
144507737|NCT02928224|521056722|FG002|Overall Study|Other|5|||
144507738|NCT02928224|521056723|FG003|Overall Study|Other|0|||
144507739|NCT01278394|521056726|FG000|Overall Study|Lost to Follow-up|1|||
144507740|NCT01236560|521056727|FG000|Overall Study|Adverse Event|0|||
144507741|NCT01236560|521056728|FG001|Overall Study|Adverse Event|2|||
144507742|NCT01236560|521056729|FG002|Overall Study|Adverse Event|1|||
144507743|NCT01236560|521056730|FG003|Overall Study|Adverse Event|3|||
144507744|NCT01236560|521056731|FG004|Overall Study|Adverse Event|0|||
144507745|NCT01236560|521056732|FG005|Overall Study|Adverse Event|0|||
144507746|NCT01236560|521056727|FG000|Overall Study|Death|0|||
144507747|NCT01236560|521056728|FG001|Overall Study|Death|1|||
144507748|NCT01236560|521056729|FG002|Overall Study|Death|0|||
144507749|NCT01236560|521056730|FG003|Overall Study|Death|1|||
144507750|NCT01236560|521056731|FG004|Overall Study|Death|0|||
144507751|NCT01236560|521056732|FG005|Overall Study|Death|0|||
144507752|NCT01236560|521056727|FG000|Overall Study|Lost to Follow-up|0|||
144507753|NCT01236560|521056728|FG001|Overall Study|Lost to Follow-up|1|||
144507754|NCT01236560|521056729|FG002|Overall Study|Lost to Follow-up|1|||
144507755|NCT01236560|521056730|FG003|Overall Study|Lost to Follow-up|0|||
144507756|NCT01236560|521056731|FG004|Overall Study|Lost to Follow-up|0|||
144507757|NCT01236560|521056732|FG005|Overall Study|Lost to Follow-up|0|||
144507758|NCT01236560|521056727|FG000|Overall Study|Physician Decision|0|||
144507759|NCT01236560|521056728|FG001|Overall Study|Physician Decision|1|||
144507760|NCT01236560|521056729|FG002|Overall Study|Physician Decision|8|||
144507761|NCT01236560|521056730|FG003|Overall Study|Physician Decision|0|||
144507762|NCT01236560|521056731|FG004|Overall Study|Physician Decision|0|||
144507763|NCT01236560|521056732|FG005|Overall Study|Physician Decision|0|||
144507764|NCT01236560|521056727|FG000|Overall Study|Withdrawal by Subject|0|||
144507765|NCT01236560|521056728|FG001|Overall Study|Withdrawal by Subject|0|||
144507766|NCT01236560|521056729|FG002|Overall Study|Withdrawal by Subject|1|||
144507767|NCT01236560|521056730|FG003|Overall Study|Withdrawal by Subject|2|||
144507768|NCT01236560|521056731|FG004|Overall Study|Withdrawal by Subject|0|||
144507769|NCT01236560|521056732|FG005|Overall Study|Withdrawal by Subject|0|||
144507770|NCT01236560|521056727|FG000|Overall Study|Progressive disease|5|||
144507771|NCT01236560|521056728|FG001|Overall Study|Progressive disease|19|||
144507772|NCT01236560|521056729|FG002|Overall Study|Progressive disease|9|||
144507773|NCT01236560|521056730|FG003|Overall Study|Progressive disease|16|||
144507774|NCT01236560|521056731|FG004|Overall Study|Progressive disease|0|||
144507775|NCT01236560|521056732|FG005|Overall Study|Progressive disease|0|||
144507776|NCT02115139|521056733|FG000|Overall Study|Protocol Violation|1|||
144507777|NCT02115139|521056733|FG000|Overall Study|treatment discontinuation|6|||
144507778|NCT01576484|521056734|FG000|Overall Study|Adverse Event|1|||
144507779|NCT01576484|521056735|FG001|Overall Study|Adverse Event|1|||
144507780|NCT01576484|521056734|FG000|Overall Study|Protocol Violation|0|||
144507781|NCT01576484|521056735|FG001|Overall Study|Protocol Violation|2|||
144507782|NCT01576484|521056734|FG000|Overall Study|Sponsor Decision|2|||
144507783|NCT01576484|521056735|FG001|Overall Study|Sponsor Decision|8|||
144507784|NCT01576484|521056734|FG000|Overall Study|Withdrawal by Subject|0|||
144507785|NCT01576484|521056735|FG001|Overall Study|Withdrawal by Subject|3|||
144507786|NCT01576484|521056734|FG000|Overall Study|Other|2|||
144507787|NCT01576484|521056735|FG001|Overall Study|Other|5|||
144507788|NCT03823911|521056739|FG000|Overall Study|Lost to Follow-up|1|||
144507789|NCT03823911|521056740|FG001|Overall Study|Lost to Follow-up|5|||
144507790|NCT03823911|521056741|FG002|Overall Study|Lost to Follow-up|2|||
144507791|NCT03823911|521056739|FG000|Overall Study|Did not meet eligibility criteria|13|||
144507792|NCT03823911|521056740|FG001|Overall Study|Did not meet eligibility criteria|7|||
144507793|NCT03823911|521056741|FG002|Overall Study|Did not meet eligibility criteria|4|||
144507794|NCT03823911|521056739|FG000|Overall Study|Death|0|||
144507795|NCT03823911|521056740|FG001|Overall Study|Death|1|||
144507796|NCT03823911|521056741|FG002|Overall Study|Death|0|||
144507797|NCT00433199|521056750|FG000|Double-Blind Period|Adverse Event|0|||
144507798|NCT00433199|521056751|FG001|Double-Blind Period|Adverse Event|25|||
144507799|NCT00433199|521056750|FG000|Double-Blind Period|Lack of Efficacy|0|||
144507800|NCT00433199|521056751|FG001|Double-Blind Period|Lack of Efficacy|2|||
144507801|NCT00433199|521056750|FG000|Double-Blind Period|Lost to Follow-up|2|||
144507802|NCT00433199|521056751|FG001|Double-Blind Period|Lost to Follow-up|5|||
144507803|NCT00433199|521056750|FG000|Double-Blind Period|Withdrawal by Subject|8|||
144507804|NCT00433199|521056751|FG001|Double-Blind Period|Withdrawal by Subject|19|||
144507805|NCT00433199|521056750|FG000|Double-Blind Period|Protocol Violation|1|||
144507806|NCT00433199|521056751|FG001|Double-Blind Period|Protocol Violation|10|||
144507807|NCT00433199|521056750|FG000|Double-Blind Period|Administrative|1|||
144507808|NCT00433199|521056751|FG001|Double-Blind Period|Administrative|5|||
144507809|NCT00433199|521056750|FG000|Open-Label Period|Adverse Event|0|||
144507810|NCT00433199|521056751|FG001|Open-Label Period|Adverse Event|19|||
144507811|NCT00433199|521056750|FG000|Open-Label Period|Lack of Efficacy|0|||
144507812|NCT00433199|521056751|FG001|Open-Label Period|Lack of Efficacy|2|||
144507813|NCT00433199|521056750|FG000|Open-Label Period|Lost to Follow-up|0|||
144507814|NCT00433199|521056751|FG001|Open-Label Period|Lost to Follow-up|3|||
144507815|NCT00433199|521056750|FG000|Open-Label Period|Withdrawal by Subject|0|||
144507816|NCT00433199|521056751|FG001|Open-Label Period|Withdrawal by Subject|7|||
144507817|NCT00433199|521056750|FG000|Open-Label Period|Protocol Violation|0|||
144507818|NCT00433199|521056751|FG001|Open-Label Period|Protocol Violation|2|||
144507819|NCT00433199|521056750|FG000|Open-Label Period|Administrative|0|||
144507820|NCT00433199|521056751|FG001|Open-Label Period|Administrative|1|||
144507821|NCT00094575|521056752|FG000|Overall Study|Death|146|||
144507822|NCT00094575|521056753|FG001|Overall Study|Death|146|||
144507823|NCT04305405|521056754|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144507824|NCT04305405|521056755|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144507825|NCT00206375|521056757|FG000|Overall Study|Lost to Follow-up|1|||
144507826|NCT00206375|521056758|FG001|Overall Study|Lost to Follow-up|0|||
144507827|NCT00206375|521056759|FG002|Overall Study|Lost to Follow-up|0|||
144507828|NCT00206375|521056757|FG000|Overall Study|Withdrawal by Subject|2|||
144507829|NCT00206375|521056758|FG001|Overall Study|Withdrawal by Subject|1|||
144507830|NCT00206375|521056759|FG002|Overall Study|Withdrawal by Subject|3|||
144507831|NCT00206375|521056757|FG000|Overall Study|Study terminated due to lack of funds|0|||
144507832|NCT00206375|521056758|FG001|Overall Study|Study terminated due to lack of funds|1|||
144507833|NCT00206375|521056759|FG002|Overall Study|Study terminated due to lack of funds|1|||
144507834|NCT03603717|521056762|FG000|Overall Study|Lost to Follow-up|20|||
144507835|NCT03603717|521056763|FG001|Overall Study|Lost to Follow-up|20|||
144507836|NCT03603717|521056762|FG000|Overall Study|Withdrawal by Subject|16|||
144507837|NCT03603717|521056763|FG001|Overall Study|Withdrawal by Subject|10|||
144507838|NCT00732381|521056764|FG000|Overall Study|Adverse Event|1|||
144507839|NCT00732381|521056765|FG001|Overall Study|Adverse Event|0|||
144507840|NCT00732381|521056764|FG000|Overall Study|Treatment Failure|1|||
144507841|NCT00732381|521056765|FG001|Overall Study|Treatment Failure|1|||
144507842|NCT01420549|521056766|FG000|Overall Study|Adverse Event|1|||
144507843|NCT01420549|521056767|FG001|Overall Study|Adverse Event|1|||
144507844|NCT01420549|521056766|FG000|Overall Study|Lost to Follow-up|2|||
144507845|NCT01420549|521056767|FG001|Overall Study|Lost to Follow-up|2|||
144507846|NCT01420549|521056766|FG000|Overall Study|Protocol Violation|0|||
144507847|NCT01420549|521056767|FG001|Overall Study|Protocol Violation|1|||
144507848|NCT01420549|521056766|FG000|Overall Study|Non-adherence to medication|4|||
144507849|NCT01420549|521056767|FG001|Overall Study|Non-adherence to medication|1|||
144507850|NCT05777785|521058285|FG000|Overall Study|Withdrawal by Subject|5|||
144507851|NCT05777785|521058285|FG000|Overall Study|Lost to Follow-up|1|||
144507852|NCT05644444|521058290|FG000|Tolerance Phase|Adverse Event|0|||
144507853|NCT05644444|521058291|FG001|Tolerance Phase|Adverse Event|2|||
144507854|NCT05644444|521058290|FG000|Treatment Phase|Adverse Event|0|||
144507855|NCT05644444|521058291|FG001|Treatment Phase|Adverse Event|2|||
144507856|NCT04817670|521058292|FG000|Overall Study|Withdrawal by Subject|1|||
144507857|NCT04817670|521058293|FG001|Overall Study|Withdrawal by Subject|0|||
144507858|NCT04817670|521058294|FG002|Overall Study|Withdrawal by Subject|0|||
144507859|NCT04817670|521058295|FG003|Overall Study|Withdrawal by Subject|0|||
144507860|NCT04817670|521058296|FG004|Overall Study|Withdrawal by Subject|0|||
144507861|NCT04817670|521058292|FG000|Overall Study|Lost to Follow-up|0|||
144507862|NCT04817670|521058293|FG001|Overall Study|Lost to Follow-up|0|||
144507863|NCT04817670|521058294|FG002|Overall Study|Lost to Follow-up|1|||
144507864|NCT04817670|521058295|FG003|Overall Study|Lost to Follow-up|0|||
144507865|NCT04817670|521058296|FG004|Overall Study|Lost to Follow-up|0|||
144507866|NCT03073941|521058297|FG000|Overall Study|Received non-study device intraoperatively|0|||
144507867|NCT03073941|521058298|FG001|Overall Study|Received non-study device intraoperatively|2|||
144507868|NCT03073941|521058297|FG000|Overall Study|Death|1|||
144507869|NCT03073941|521058298|FG001|Overall Study|Death|0|||
144507870|NCT03073941|521058297|FG000|Overall Study|Withdrawal by Subject|1|||
144507871|NCT03073941|521058298|FG001|Overall Study|Withdrawal by Subject|3|||
144507872|NCT03073941|521058297|FG000|Overall Study|Lost to Follow-up|5|||
144507873|NCT03073941|521058298|FG001|Overall Study|Lost to Follow-up|4|||
144507874|NCT03073941|521058297|FG000|Overall Study|Adverse Event|4|||
144507875|NCT03073941|521058298|FG001|Overall Study|Adverse Event|2|||
144507876|NCT03073941|521058297|FG000|Overall Study|Met an exclusion criterion|0|||
144507877|NCT03073941|521058298|FG001|Overall Study|Met an exclusion criterion|1|||
144507878|NCT01188655|521058299|FG000|Overall Study|Lack of Efficacy|1|||
144507879|NCT01188655|521058299|FG000|Overall Study|Lost to Follow-up|1|||
144507880|NCT01188655|521058299|FG000|Overall Study|Other|11|||
144507881|NCT00925899|521058300|FG000|Part 1|Death|1|||
144507882|NCT00925899|521058301|FG001|Part 1|Death|2|||
144507883|NCT00925899|521058300|FG000|Part 1|Withdrawal by Subject|10|||
144507884|NCT00925899|521058301|FG001|Part 1|Withdrawal by Subject|9|||
144507885|NCT00683696|521058302|FG000|Overall Study|Withdrawn due to study closure|337|||
144507886|NCT00683696|521058303|FG001|Overall Study|Withdrawn due to study closure|338|||
144507887|NCT00683696|521058302|FG000|Overall Study|Withdrawn prior to study closure|13|||
144507888|NCT00683696|521058303|FG001|Overall Study|Withdrawn prior to study closure|28|||
144507889|NCT00683696|521058302|FG000|Overall Study|Lost to Follow-up|5|||
144507890|NCT00683696|521058303|FG001|Overall Study|Lost to Follow-up|6|||
144507891|NCT00683696|521058302|FG000|Overall Study|Vital status follow-up only|3|||
144507892|NCT00683696|521058303|FG001|Overall Study|Vital status follow-up only|3|||
144507893|NCT00683696|521058302|FG000|Overall Study|Death|46|||
144507894|NCT00683696|521058303|FG001|Overall Study|Death|30|||
144507895|NCT00089544|521058304|FG000|Overall Study|Ineligible|1|||
144507896|NCT00089544|521058305|FG001|Overall Study|Ineligible|0|||
144507897|NCT01823536|521058306|FG000|Overall Study|Lost to Follow-up|1|||
144507898|NCT01823536|521058307|FG001|Overall Study|Lost to Follow-up|0|||
144507899|NCT01823536|521058308|FG002|Overall Study|Lost to Follow-up|0|||
144507900|NCT01823536|521058309|FG003|Overall Study|Lost to Follow-up|1|||
144507901|NCT01823536|521058310|FG004|Overall Study|Lost to Follow-up|1|||
144507902|NCT01823536|521058311|FG005|Overall Study|Lost to Follow-up|0|||
144507903|NCT01823536|521058306|FG000|Overall Study|Protocol Violation|0|||
144507904|NCT01823536|521058307|FG001|Overall Study|Protocol Violation|1|||
144507905|NCT01823536|521058308|FG002|Overall Study|Protocol Violation|0|||
144507906|NCT01823536|521058309|FG003|Overall Study|Protocol Violation|0|||
144507907|NCT01823536|521058310|FG004|Overall Study|Protocol Violation|0|||
144507908|NCT01823536|521058311|FG005|Overall Study|Protocol Violation|0|||
144507909|NCT01823536|521058306|FG000|Overall Study|Withdrawal by Subject|1|||
144507910|NCT01823536|521058307|FG001|Overall Study|Withdrawal by Subject|1|||
144507911|NCT01823536|521058308|FG002|Overall Study|Withdrawal by Subject|0|||
144507912|NCT01823536|521058309|FG003|Overall Study|Withdrawal by Subject|0|||
144507913|NCT01823536|521058310|FG004|Overall Study|Withdrawal by Subject|0|||
144507914|NCT01823536|521058311|FG005|Overall Study|Withdrawal by Subject|0|||
144507915|NCT01823536|521058306|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
144507916|NCT01823536|521058307|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
144507917|NCT01823536|521058308|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
144507918|NCT01823536|521058309|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
144507919|NCT01823536|521058310|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
144507920|NCT01823536|521058311|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
144507921|NCT01823536|521058306|FG000|Overall Study|Met exclusion criterion No 6|0|||
144507922|NCT01823536|521058307|FG001|Overall Study|Met exclusion criterion No 6|0|||
144588219|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
144588220|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
144588221|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
144588222|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
144588223|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
144588224|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
144588225|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
144588226|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
144588227|NCT01160289|521352318|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
144588228|NCT01160289|521352319|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
144588229|NCT01160289|521352320|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
144588230|NCT01160289|521352321|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
144588231|NCT01160289|521352322|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
144588232|NCT01160289|521352323|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
144588233|NCT01160289|521352318|FG000|Post-Randomization Period|Adverse Event|0|||
144588234|NCT01160289|521352319|FG001|Post-Randomization Period|Adverse Event|4|||
144588235|NCT01160289|521352320|FG002|Post-Randomization Period|Adverse Event|4|||
144588236|NCT01160289|521352321|FG003|Post-Randomization Period|Adverse Event|2|||
144588237|NCT01160289|521352322|FG004|Post-Randomization Period|Adverse Event|0|||
144588238|NCT01160289|521352323|FG005|Post-Randomization Period|Adverse Event|0|||
144588239|NCT01160289|521352318|FG000|Post-Randomization Period|Death|0|||
144588240|NCT01160289|521352319|FG001|Post-Randomization Period|Death|0|||
144588241|NCT01160289|521352320|FG002|Post-Randomization Period|Death|0|||
144588242|NCT01160289|521352321|FG003|Post-Randomization Period|Death|1|||
144588243|NCT01160289|521352322|FG004|Post-Randomization Period|Death|0|||
144588244|NCT01160289|521352323|FG005|Post-Randomization Period|Death|0|||
144588245|NCT01160289|521352318|FG000|Post-Randomization Period|Lack of Efficacy|0|||
144588246|NCT01160289|521352319|FG001|Post-Randomization Period|Lack of Efficacy|1|||
144588247|NCT01160289|521352320|FG002|Post-Randomization Period|Lack of Efficacy|0|||
144588248|NCT01160289|521352321|FG003|Post-Randomization Period|Lack of Efficacy|3|||
144588249|NCT01160289|521352322|FG004|Post-Randomization Period|Lack of Efficacy|0|||
144588250|NCT01160289|521352323|FG005|Post-Randomization Period|Lack of Efficacy|0|||
144588251|NCT01160289|521352318|FG000|Post-Randomization Period|Lost to Follow-up|0|||
144588252|NCT01160289|521352319|FG001|Post-Randomization Period|Lost to Follow-up|3|||
144588253|NCT01160289|521352320|FG002|Post-Randomization Period|Lost to Follow-up|2|||
144588254|NCT01160289|521352321|FG003|Post-Randomization Period|Lost to Follow-up|5|||
144588255|NCT01160289|521352322|FG004|Post-Randomization Period|Lost to Follow-up|3|||
144588256|NCT01160289|521352323|FG005|Post-Randomization Period|Lost to Follow-up|4|||
144588257|NCT01160289|521352318|FG000|Post-Randomization Period|Physician Decision|0|||
144588258|NCT01160289|521352319|FG001|Post-Randomization Period|Physician Decision|0|||
144588259|NCT01160289|521352320|FG002|Post-Randomization Period|Physician Decision|1|||
144588260|NCT01160289|521352321|FG003|Post-Randomization Period|Physician Decision|0|||
144507923|NCT01823536|521058308|FG002|Overall Study|Met exclusion criterion No 6|0|||
144507924|NCT01823536|521058309|FG003|Overall Study|Met exclusion criterion No 6|1|||
144507925|NCT01823536|521058310|FG004|Overall Study|Met exclusion criterion No 6|0|||
144507926|NCT01823536|521058311|FG005|Overall Study|Met exclusion criterion No 6|0|||
144507927|NCT01823536|521058306|FG000|Overall Study|Subject moved out of the state|0|||
144507928|NCT01823536|521058307|FG001|Overall Study|Subject moved out of the state|0|||
144507929|NCT01823536|521058308|FG002|Overall Study|Subject moved out of the state|0|||
144507930|NCT01823536|521058309|FG003|Overall Study|Subject moved out of the state|0|||
144507931|NCT01823536|521058310|FG004|Overall Study|Subject moved out of the state|1|||
144507932|NCT01823536|521058311|FG005|Overall Study|Subject moved out of the state|0|||
144507933|NCT03648762|521058312|FG000|Overall Study|Lost to Follow-up|1|||
144507934|NCT03648762|521058313|FG001|Overall Study|Lost to Follow-up|2|||
144507935|NCT03648762|521058314|FG002|Overall Study|Lost to Follow-up|0|||
144507936|NCT03648762|521058312|FG000|Overall Study|Withdrawal by Subject|5|||
144507937|NCT03648762|521058313|FG001|Overall Study|Withdrawal by Subject|2|||
144507938|NCT03648762|521058314|FG002|Overall Study|Withdrawal by Subject|1|||
144507939|NCT03644849|521058319|FG000|Overall Study|Lost to Follow-up|1|||
144721676|NCT01612000|521835258|FG001|Overall Study|Withdrawal by Subject|1|||
144588261|NCT01160289|521352322|FG004|Post-Randomization Period|Physician Decision|0|||
144588262|NCT01160289|521352323|FG005|Post-Randomization Period|Physician Decision|0|||
144507940|NCT03644849|521058320|FG001|Overall Study|Lost to Follow-up|3|||
144507941|NCT00508924|521058321|FG000|Overall Study|Protocol Violation|0|||
144507942|NCT00508924|521058322|FG001|Overall Study|Protocol Violation|0|||
144588263|NCT01160289|521352318|FG000|Post-Randomization Period|Protocol Violation|0|||
144588264|NCT01160289|521352319|FG001|Post-Randomization Period|Protocol Violation|4|||
144588265|NCT01160289|521352320|FG002|Post-Randomization Period|Protocol Violation|2|||
144588266|NCT01160289|521352321|FG003|Post-Randomization Period|Protocol Violation|0|||
144588267|NCT01160289|521352322|FG004|Post-Randomization Period|Protocol Violation|1|||
144588268|NCT01160289|521352323|FG005|Post-Randomization Period|Protocol Violation|3|||
144588269|NCT01160289|521352318|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
144588270|NCT01160289|521352319|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
144588271|NCT01160289|521352320|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
144588272|NCT01160289|521352321|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
144588273|NCT01160289|521352322|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
144588274|NCT01160289|521352323|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
144588275|NCT01160289|521352318|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
144588276|NCT01160289|521352319|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
144588277|NCT01160289|521352320|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
144588278|NCT01160289|521352321|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
144588279|NCT01160289|521352322|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
144588280|NCT01160289|521352323|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
144588281|NCT01160289|521352318|FG000|Post-Randomization Period|Sponsor Decision|0|||
144588282|NCT01160289|521352319|FG001|Post-Randomization Period|Sponsor Decision|1|||
144588283|NCT01160289|521352320|FG002|Post-Randomization Period|Sponsor Decision|0|||
144588284|NCT01160289|521352321|FG003|Post-Randomization Period|Sponsor Decision|0|||
144588285|NCT01160289|521352322|FG004|Post-Randomization Period|Sponsor Decision|0|||
144588286|NCT01160289|521352323|FG005|Post-Randomization Period|Sponsor Decision|0|||
144588287|NCT00993668|521352324|FG000|Single-Blind Period|Adverse Event|1|||
144588288|NCT00993668|521352325|FG001|Single-Blind Period|Adverse Event|1|||
144588289|NCT00993668|521352324|FG000|Single-Blind Period|Lack of Efficacy|0|||
144588290|NCT00993668|521352325|FG001|Single-Blind Period|Lack of Efficacy|1|||
144588291|NCT00993668|521352324|FG000|Single-Blind Period|Lost to Follow-up|3|||
144588292|NCT00993668|521352325|FG001|Single-Blind Period|Lost to Follow-up|1|||
144588293|NCT00993668|521352324|FG000|Open-Label Period|Adverse Event|9|||
144588294|NCT00993668|521352325|FG001|Open-Label Period|Adverse Event|8|||
144588295|NCT00993668|521352324|FG000|Open-Label Period|Lack of Efficacy|4|||
144588296|NCT00993668|521352325|FG001|Open-Label Period|Lack of Efficacy|3|||
144588297|NCT00993668|521352324|FG000|Open-Label Period|Withdrawal by Subject|4|||
144588298|NCT00993668|521352325|FG001|Open-Label Period|Withdrawal by Subject|3|||
144588299|NCT00993668|521352324|FG000|Open-Label Period|Lost to Follow-up|6|||
144588300|NCT00993668|521352325|FG001|Open-Label Period|Lost to Follow-up|1|||
144588301|NCT03606668|521352329|FG000|Overall Study|Screen Failure|1|||
144588302|NCT03606668|521352329|FG000|Overall Study|Lost to Follow-up|1|||
144588303|NCT01029652|521352330|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
144588304|NCT01029652|521352331|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
144588305|NCT01029652|521352330|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
144588306|NCT01029652|521352331|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
144588307|NCT01029652|521352330|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
144588308|NCT01029652|521352331|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
144588309|NCT01029652|521352330|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
144588310|NCT01029652|521352331|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
144588311|NCT01029652|521352330|FG000|Core Study (0-12 Weeks)|Death|0|||
144588312|NCT01029652|521352331|FG001|Core Study (0-12 Weeks)|Death|1|||
144588313|NCT01029652|521352330|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
144588314|NCT01029652|521352331|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
144588315|NCT01029652|521352330|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
144588316|NCT01029652|521352331|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
144588317|NCT01029652|521352330|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
144588318|NCT01029652|521352331|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
144588319|NCT01029652|521352330|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
144371065|NCT00606593|520565994|FG000|Overall Study|Adverse Event|0|||
144371066|NCT00606593|520565995|FG001|Overall Study|Adverse Event|0|||
144588320|NCT01029652|521352331|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
144588321|NCT01029652|521352330|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
144588322|NCT01029652|521352331|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
144588323|NCT01029652|521352330|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
144588324|NCT01029652|521352331|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
144588325|NCT01029652|521352330|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
144588326|NCT01029652|521352331|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
144588327|NCT02313233|521352332|FG000|Overall Study|Withdrawal by Subject|1|||
144588328|NCT02313233|521352333|FG001|Overall Study|Withdrawal by Subject|2|||
144588329|NCT02313233|521352332|FG000|Overall Study|Administrative reason|1|||
144371067|NCT00606593|520565996|FG002|Overall Study|Adverse Event|0|||
144371068|NCT00606593|520565997|FG003|Overall Study|Adverse Event|1|||
144588330|NCT02313233|521352333|FG001|Overall Study|Administrative reason|1|||
144588331|NCT02095951|521352334|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
144588332|NCT02095951|521352335|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
144588333|NCT04638920|521352336|FG000|Overall Study|Withdrawal by Subject|5|||
144588334|NCT05383508|521352337|FG000|Overall Study|Withdrawal by Subject|1|||
144588335|NCT05383508|521352338|FG001|Overall Study|Withdrawal by Subject|0|||
144588336|NCT05383508|521352339|FG002|Overall Study|Withdrawal by Subject|1|||
144588337|NCT05383508|521352340|FG003|Overall Study|Withdrawal by Subject|1|||
144588338|NCT05383508|521352341|FG004|Overall Study|Withdrawal by Subject|2|||
144588339|NCT05383508|521352342|FG005|Overall Study|Withdrawal by Subject|0|||
144588340|NCT03775434|521352344|FG000|Overall Study|Adverse Event|2|||
144588341|NCT03775434|521352344|FG000|Overall Study|Withdrawal by Subject|1|||
144588342|NCT01621568|521352345|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
144588343|NCT01621568|521352346|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
144588344|NCT01621568|521352345|FG000|Week 5-6 No Treatment|Death|1|||
144588345|NCT01621568|521352346|FG001|Week 5-6 No Treatment|Death|0|||
144588346|NCT01859988|521352347|FG000|Overall Study|Withdrawal by Subject|6|||
144588347|NCT01859988|521352348|FG001|Overall Study|Withdrawal by Subject|3|||
144588348|NCT01859988|521352349|FG002|Overall Study|Withdrawal by Subject|4|||
144588349|NCT01859988|521352350|FG003|Overall Study|Withdrawal by Subject|3|||
144588350|NCT01859988|521352351|FG004|Overall Study|Withdrawal by Subject|2|||
144588351|NCT01859988|521352352|FG005|Overall Study|Withdrawal by Subject|2|||
144588352|NCT01859988|521352347|FG000|Overall Study|Lack of Efficacy|1|||
144588353|NCT01859988|521352348|FG001|Overall Study|Lack of Efficacy|1|||
144588354|NCT01859988|521352349|FG002|Overall Study|Lack of Efficacy|5|||
144588355|NCT01859988|521352350|FG003|Overall Study|Lack of Efficacy|0|||
144588356|NCT01859988|521352351|FG004|Overall Study|Lack of Efficacy|7|||
144588357|NCT01859988|521352352|FG005|Overall Study|Lack of Efficacy|9|||
144588358|NCT01859988|521352347|FG000|Overall Study|Physician Decision|1|||
144588359|NCT01859988|521352348|FG001|Overall Study|Physician Decision|3|||
144588360|NCT01859988|521352349|FG002|Overall Study|Physician Decision|1|||
144588361|NCT01859988|521352350|FG003|Overall Study|Physician Decision|3|||
144588362|NCT01859988|521352351|FG004|Overall Study|Physician Decision|4|||
144588363|NCT01859988|521352352|FG005|Overall Study|Physician Decision|1|||
144588364|NCT01859988|521352347|FG000|Overall Study|Adverse Event|2|||
144588365|NCT01859988|521352348|FG001|Overall Study|Adverse Event|1|||
144588366|NCT01859988|521352349|FG002|Overall Study|Adverse Event|3|||
144588367|NCT01859988|521352350|FG003|Overall Study|Adverse Event|1|||
144588368|NCT01859988|521352351|FG004|Overall Study|Adverse Event|2|||
144588369|NCT01859988|521352352|FG005|Overall Study|Adverse Event|2|||
144588370|NCT01859988|521352347|FG000|Overall Study|Lost to Follow-up|1|||
144588371|NCT01859988|521352348|FG001|Overall Study|Lost to Follow-up|2|||
144588372|NCT01859988|521352349|FG002|Overall Study|Lost to Follow-up|3|||
144588373|NCT01859988|521352350|FG003|Overall Study|Lost to Follow-up|0|||
144588374|NCT01859988|521352351|FG004|Overall Study|Lost to Follow-up|3|||
144588375|NCT01859988|521352352|FG005|Overall Study|Lost to Follow-up|2|||
144588376|NCT01859988|521352347|FG000|Overall Study|Protocol Violation|0|||
144588377|NCT01859988|521352348|FG001|Overall Study|Protocol Violation|0|||
144588378|NCT01859988|521352349|FG002|Overall Study|Protocol Violation|1|||
144588379|NCT01859988|521352350|FG003|Overall Study|Protocol Violation|0|||
144588380|NCT01859988|521352351|FG004|Overall Study|Protocol Violation|0|||
144588381|NCT01859988|521352352|FG005|Overall Study|Protocol Violation|0|||
144588382|NCT01859988|521352347|FG000|Overall Study|Other than specified above|0|||
144588383|NCT01859988|521352348|FG001|Overall Study|Other than specified above|2|||
144588384|NCT01859988|521352349|FG002|Overall Study|Other than specified above|11|||
144588385|NCT01859988|521352350|FG003|Overall Study|Other than specified above|3|||
144588386|NCT01859988|521352351|FG004|Overall Study|Other than specified above|5|||
144588387|NCT01859988|521352352|FG005|Overall Study|Other than specified above|3|||
144588388|NCT02081417|521352353|FG000|Overall Study|Lost to Follow-up|26|||
144588389|NCT02081417|521352354|FG001|Overall Study|Lost to Follow-up|23|||
144588390|NCT02081417|521352353|FG000|Overall Study|Moved Away|1|||
144588391|NCT02081417|521352354|FG001|Overall Study|Moved Away|2|||
144588392|NCT02081417|521352353|FG000|Overall Study|Incarcerated|2|||
144588393|NCT02081417|521352354|FG001|Overall Study|Incarcerated|2|||
144588394|NCT02081417|521352353|FG000|Overall Study|Death|4|||
144588395|NCT02081417|521352354|FG001|Overall Study|Death|3|||
144371069|NCT00606593|520565998|FG004|Overall Study|Adverse Event|1|||
144588396|NCT02081417|521352353|FG000|Overall Study|Withdrawal by Subject|4|||
144588397|NCT02081417|521352354|FG001|Overall Study|Withdrawal by Subject|0|||
144588398|NCT02081417|521352353|FG000|Overall Study|Admitted to Residential Treatment|2|||
144588399|NCT02081417|521352354|FG001|Overall Study|Admitted to Residential Treatment|0|||
144588400|NCT02081417|521352353|FG000|Overall Study|Did not start treatment|17|||
144588401|NCT02081417|521352354|FG001|Overall Study|Did not start treatment|21|||
144588402|NCT01157676|521352358|FG000|Randomization|Death|1|||
144588403|NCT01157676|521352359|FG001|Randomization|Death|1|||
144588404|NCT01157676|521352358|FG000|Randomization|unresectable|2|||
144588405|NCT01157676|521352359|FG001|Randomization|unresectable|3|||
144588406|NCT01157676|521352358|FG000|Randomization|Withdrawal by Subject|17|||
144588407|NCT01157676|521352359|FG001|Randomization|Withdrawal by Subject|13|||
144588408|NCT01157676|521352358|FG000|Randomization|Physician Decision|1|||
144588409|NCT01157676|521352359|FG001|Randomization|Physician Decision|0|||
144588410|NCT01157676|521352358|FG000|Surgery|underwent open cystectomy|0|||
144588411|NCT01157676|521352359|FG001|Surgery|underwent open cystectomy|4|||
144588412|NCT01157676|521352358|FG000|Surgery|converted to open procedure|0|||
144588413|NCT01157676|521352359|FG001|Surgery|converted to open procedure|5|||
144588414|NCT01157676|521352358|FG000|Surgery|underwent robotic cystectomy|1|||
144588415|NCT01157676|521352359|FG001|Surgery|underwent robotic cystectomy|0|||
144588416|NCT00682890|521352360|FG000|Overall Study|Lost to Follow-up|1|||
144588417|NCT00682890|521352361|FG001|Overall Study|Lost to Follow-up|1|||
144588418|NCT00682890|521352360|FG000|Overall Study|subject moved away|0|||
144588419|NCT00682890|521352361|FG001|Overall Study|subject moved away|1|||
144588420|NCT00682890|521352360|FG000|Overall Study|heavy menstrual bleeding|1|||
144588421|NCT00682890|521352361|FG001|Overall Study|heavy menstrual bleeding|0|||
144588422|NCT00324116|521352369|FG000|Overall Study|Adverse Event|5|||
144588423|NCT00324116|521352369|FG000|Overall Study|Lack of Efficacy|17|||
144588424|NCT00324116|521352369|FG000|Overall Study|Withdrawal by Subject|5|||
144588425|NCT00324116|521352369|FG000|Overall Study|Other|5|||
144588426|NCT01642251|521352370|FG000|Overall Study|Progressive disease|0|||
144588427|NCT01642251|521352371|FG001|Overall Study|Progressive disease|0|||
144588428|NCT01642251|521352372|FG002|Overall Study|Progressive disease|3|||
144588429|NCT01642251|521352373|FG003|Overall Study|Progressive disease|3|||
144588430|NCT01642251|521352370|FG000|Overall Study|Adverse Event|0|||
144588431|NCT01642251|521352371|FG001|Overall Study|Adverse Event|0|||
144588432|NCT01642251|521352372|FG002|Overall Study|Adverse Event|5|||
144588433|NCT01642251|521352373|FG003|Overall Study|Adverse Event|4|||
144588434|NCT01642251|521352370|FG000|Overall Study|Death|0|||
144588435|NCT01642251|521352371|FG001|Overall Study|Death|0|||
144588436|NCT01642251|521352372|FG002|Overall Study|Death|1|||
144588437|NCT01642251|521352373|FG003|Overall Study|Death|3|||
144588438|NCT01642251|521352370|FG000|Overall Study|Withdrawal by Subject|0|||
144588439|NCT01642251|521352371|FG001|Overall Study|Withdrawal by Subject|0|||
144588440|NCT01642251|521352372|FG002|Overall Study|Withdrawal by Subject|1|||
144588441|NCT01642251|521352373|FG003|Overall Study|Withdrawal by Subject|3|||
144588442|NCT01642251|521352370|FG000|Overall Study|Alternative therapy|0|||
144588443|NCT01642251|521352371|FG001|Overall Study|Alternative therapy|0|||
144588444|NCT01642251|521352372|FG002|Overall Study|Alternative therapy|0|||
144588445|NCT01642251|521352373|FG003|Overall Study|Alternative therapy|2|||
144588446|NCT01642251|521352370|FG000|Overall Study|Other complicating disease|0|||
144588447|NCT01642251|521352371|FG001|Overall Study|Other complicating disease|0|||
144588448|NCT01642251|521352372|FG002|Overall Study|Other complicating disease|1|||
144588449|NCT01642251|521352373|FG003|Overall Study|Other complicating disease|0|||
144588450|NCT01642251|521352370|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
144588451|NCT01642251|521352371|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
144588452|NCT01642251|521352372|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
144588453|NCT01642251|521352373|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
144588454|NCT00190749|521352374|FG000|Overall Study|Lost to Follow-up|8|||
144588455|NCT00190749|521352375|FG001|Overall Study|Lost to Follow-up|11|||
144588456|NCT00190749|521352374|FG000|Overall Study|Withdrawal by Subject|10|||
144588457|NCT00190749|521352375|FG001|Overall Study|Withdrawal by Subject|6|||
144588458|NCT00190749|521352374|FG000|Overall Study|Protocol Violation|5|||
144507943|NCT00508924|521058323|FG002|Overall Study|Protocol Violation|1|||
144507944|NCT00508924|521058324|FG003|Overall Study|Protocol Violation|1|||
144507945|NCT04532528|521058325|FG000|Overall Study|Adverse Event|12|||
144507946|NCT04532528|521058326|FG001|Overall Study|Adverse Event|17|||
144507947|NCT04532528|521058325|FG000|Overall Study|Withdrawal of consent|16|||
144507948|NCT04532528|521058326|FG001|Overall Study|Withdrawal of consent|17|||
144507949|NCT04532528|521058325|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
144507950|NCT04532528|521058326|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
144588459|NCT00190749|521352375|FG001|Overall Study|Protocol Violation|4|||
144588460|NCT00190749|521352374|FG000|Overall Study|Adverse Event|0|||
144588461|NCT00190749|521352375|FG001|Overall Study|Adverse Event|5|||
144588462|NCT00190749|521352374|FG000|Overall Study|Lack of Efficacy|2|||
144588463|NCT00190749|521352375|FG001|Overall Study|Lack of Efficacy|3|||
144588464|NCT00190749|521352374|FG000|Overall Study|Reason Not Specified|0|||
144588465|NCT00190749|521352375|FG001|Overall Study|Reason Not Specified|2|||
144588466|NCT00190749|521352374|FG000|Overall Study|Sponsor Decision|1|||
144507951|NCT04532528|521058325|FG000|Overall Study|Lost to Follow-up|69|||
144721677|NCT01612000|521835259|FG002|Overall Study|Withdrawal by Subject|2|||
144721678|NCT01612000|521835260|FG003|Overall Study|Withdrawal by Subject|2|||
144507952|NCT04532528|521058326|FG001|Overall Study|Lost to Follow-up|68|||
144588467|NCT00190749|521352375|FG001|Overall Study|Sponsor Decision|0|||
144588468|NCT01605916|521352378|FG000|Overall Study|Adverse Event|1|||
144588469|NCT01605916|521352379|FG001|Overall Study|Adverse Event|0|||
144588470|NCT01605916|521352380|FG002|Overall Study|Adverse Event|0|||
144588471|NCT01605916|521352381|FG003|Overall Study|Adverse Event|1|||
144588472|NCT01605916|521352382|FG004|Overall Study|Adverse Event|0|||
144588473|NCT01605916|521352378|FG000|Overall Study|Lack of Efficacy|2|||
144588474|NCT01605916|521352379|FG001|Overall Study|Lack of Efficacy|3|||
144588475|NCT01605916|521352380|FG002|Overall Study|Lack of Efficacy|3|||
144588476|NCT01605916|521352381|FG003|Overall Study|Lack of Efficacy|5|||
144588477|NCT01605916|521352382|FG004|Overall Study|Lack of Efficacy|4|||
144588478|NCT01605916|521352378|FG000|Overall Study|Withdrawal by Subject|1|||
144588479|NCT01605916|521352379|FG001|Overall Study|Withdrawal by Subject|1|||
144588480|NCT01605916|521352380|FG002|Overall Study|Withdrawal by Subject|0|||
144588481|NCT01605916|521352381|FG003|Overall Study|Withdrawal by Subject|0|||
144588482|NCT01605916|521352382|FG004|Overall Study|Withdrawal by Subject|2|||
144588483|NCT01465347|521352383|FG000|Overall Study|Withdrawal by Subject|1|||
144588484|NCT01465347|521352384|FG001|Overall Study|Withdrawal by Subject|1|||
144588485|NCT01465347|521352383|FG000|Overall Study|Physician Decision|0|||
144588486|NCT01465347|521352384|FG001|Overall Study|Physician Decision|1|||
144588487|NCT01465347|521352383|FG000|Overall Study|Admitted to hospice|0|||
144588488|NCT01465347|521352384|FG001|Overall Study|Admitted to hospice|1|||
144588489|NCT02414932|521352385|FG000|Overall Study|Withdrawal by Subject|2|||
144588490|NCT02414932|521352386|FG001|Overall Study|Withdrawal by Subject|3|||
144588491|NCT02414932|521352385|FG000|Overall Study|Adverse Event|1|||
144588492|NCT02414932|521352386|FG001|Overall Study|Adverse Event|0|||
144588493|NCT02996474|521352387|FG000|Overall Study|Physician Decision|5|||
144588494|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
144588495|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
144588496|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
144588497|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
144588498|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
144588499|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
144588500|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
144588501|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
144588502|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
144588503|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
144588504|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
144588505|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
144588506|NCT04493502|521352388|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
144588507|NCT04493502|521352389|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
144588508|NCT04493502|521352388|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
144588509|NCT04493502|521352389|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
144588510|NCT04493502|521352388|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
144588511|NCT04493502|521352389|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
144588512|NCT04493502|521352388|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
144588513|NCT04493502|521352389|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
144588514|NCT04493502|521352388|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
144588515|NCT04493502|521352389|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
144588516|NCT04493502|521352388|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
144588517|NCT04493502|521352389|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
144507953|NCT04532528|521058325|FG000|Overall Study|Administrative problems|12|||
144507954|NCT04532528|521058326|FG001|Overall Study|Administrative problems|14|||
144507955|NCT04532528|521058325|FG000|Overall Study|Death|3|||
144507956|NCT04532528|521058326|FG001|Overall Study|Death|3|||
144507957|NCT04532528|521058325|FG000|Overall Study|Other|38|||
144507958|NCT04532528|521058326|FG001|Overall Study|Other|46|||
144507959|NCT01140048|521058332|FG000|Overall Study|Physician Decision|1|||
144507960|NCT01140048|521058332|FG000|Overall Study|Withdrawal by Subject|13|||
144507961|NCT01140048|521058332|FG000|Overall Study|Lost to Follow-up|31|||
144507962|NCT02888080|521058333|FG000|Overall Study|Subject / Guardian decision|1|||
144507963|NCT02888080|521058334|FG001|Overall Study|Subject / Guardian decision|3|||
144507964|NCT02888080|521058333|FG000|Overall Study|New Therapy for study indication|1|||
144507965|NCT02888080|521058334|FG001|Overall Study|New Therapy for study indication|0|||
144507966|NCT02888080|521058333|FG000|Overall Study|Lack of Efficacy|0|||
144507967|NCT02888080|521058334|FG001|Overall Study|Lack of Efficacy|1|||
144507968|NCT02888080|521058333|FG000|Overall Study|Adverse Event|0|||
144507969|NCT02888080|521058334|FG001|Overall Study|Adverse Event|1|||
144588518|NCT04493502|521352388|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
144507970|NCT00980330|521058335|FG000|Overall Study|Adverse Event|0|||
144588519|NCT04493502|521352389|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
144588520|NCT00540046|521352390|FG000|Overall Study|Lost to Follow-up|33|||
144588521|NCT00540046|521352391|FG001|Overall Study|Lost to Follow-up|23|||
144507971|NCT00980330|521058336|FG001|Overall Study|Adverse Event|0|||
144507972|NCT00980330|521058337|FG002|Overall Study|Adverse Event|0|||
144507973|NCT00980330|521058338|FG003|Overall Study|Adverse Event|1|||
144507974|NCT00980330|521058339|FG004|Overall Study|Adverse Event|0|||
144507975|NCT00980330|521058340|FG005|Overall Study|Adverse Event|0|||
144507976|NCT00980330|521058341|FG006|Overall Study|Adverse Event|0|||
144507977|NCT00980330|521058335|FG000|Overall Study|Lost to Follow-up|1|||
144507978|NCT00980330|521058336|FG001|Overall Study|Lost to Follow-up|1|||
144507979|NCT00980330|521058337|FG002|Overall Study|Lost to Follow-up|4|||
144507980|NCT00980330|521058338|FG003|Overall Study|Lost to Follow-up|2|||
144507981|NCT00980330|521058339|FG004|Overall Study|Lost to Follow-up|1|||
144507982|NCT00980330|521058340|FG005|Overall Study|Lost to Follow-up|1|||
144507983|NCT00980330|521058341|FG006|Overall Study|Lost to Follow-up|2|||
144507984|NCT00980330|521058335|FG000|Overall Study|Withdrawal by Subject|2|||
144507985|NCT00980330|521058336|FG001|Overall Study|Withdrawal by Subject|4|||
144507986|NCT00980330|521058337|FG002|Overall Study|Withdrawal by Subject|4|||
144507987|NCT00980330|521058338|FG003|Overall Study|Withdrawal by Subject|1|||
144507988|NCT00980330|521058339|FG004|Overall Study|Withdrawal by Subject|3|||
144507989|NCT00980330|521058340|FG005|Overall Study|Withdrawal by Subject|2|||
144507990|NCT00980330|521058341|FG006|Overall Study|Withdrawal by Subject|5|||
144507991|NCT00980330|521058335|FG000|Overall Study|(not specified)|2|||
144507992|NCT00980330|521058336|FG001|Overall Study|(not specified)|0|||
144507993|NCT00980330|521058337|FG002|Overall Study|(not specified)|0|||
144507994|NCT00980330|521058338|FG003|Overall Study|(not specified)|1|||
144507995|NCT00980330|521058339|FG004|Overall Study|(not specified)|1|||
144507996|NCT00980330|521058340|FG005|Overall Study|(not specified)|1|||
144507997|NCT00980330|521058341|FG006|Overall Study|(not specified)|0|||
144507998|NCT00666276|521058344|FG000|Overall Study|Protocol Violation|34|||
144507999|NCT01039688|521058345|FG000|Overall Study|Adverse Event|38|||
144508000|NCT01039688|521058346|FG001|Overall Study|Adverse Event|39|||
144508001|NCT01039688|521058347|FG002|Overall Study|Adverse Event|24|||
144508002|NCT01039688|521058345|FG000|Overall Study|Lack of Efficacy|20|||
144508003|NCT01039688|521058346|FG001|Overall Study|Lack of Efficacy|11|||
144508004|NCT01039688|521058347|FG002|Overall Study|Lack of Efficacy|26|||
144508005|NCT01039688|521058345|FG000|Overall Study|Lost to Follow-up|11|||
144508006|NCT01039688|521058346|FG001|Overall Study|Lost to Follow-up|9|||
144508007|NCT01039688|521058347|FG002|Overall Study|Lost to Follow-up|5|||
144508008|NCT01039688|521058345|FG000|Overall Study|Other|13|||
144508009|NCT01039688|521058346|FG001|Overall Study|Other|25|||
144508010|NCT01039688|521058347|FG002|Overall Study|Other|12|||
144508011|NCT01039688|521058345|FG000|Overall Study|Withdrawal by Subject|23|||
144508012|NCT01039688|521058346|FG001|Overall Study|Withdrawal by Subject|27|||
144508013|NCT01039688|521058347|FG002|Overall Study|Withdrawal by Subject|13|||
144508014|NCT01039688|521058345|FG000|Overall Study|Death|2|||
144508015|NCT01039688|521058346|FG001|Overall Study|Death|0|||
144508016|NCT01039688|521058347|FG002|Overall Study|Death|0|||
144508017|NCT02594735|521058348|FG000|Overall Study|Adverse Event|1|||
144508018|NCT03844269|521058352|FG000|Overall Study|Withdrawal pre-intervention|1|||
144508019|NCT03844269|521058352|FG000|Overall Study|Did not complete the intervention|2|||
144508020|NCT00665444|521058353|FG000|Overall Study|Physician Decision|1|||
144508021|NCT00665444|521058353|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
144508022|NCT00101010|521058357|FG000|Overall Study|Physician Decision|1|||
144508023|NCT03520413|521058358|FG000|Overall Study|Lost to Follow-up|1|||
144508024|NCT03520413|521058359|FG001|Overall Study|Lost to Follow-up|1|||
144508025|NCT03520413|521058358|FG000|Overall Study|Withdrawal by Subject|1|||
144508026|NCT03520413|521058359|FG001|Overall Study|Withdrawal by Subject|2|||
144508027|NCT03520413|521058358|FG000|Overall Study|Death|0|||
144508028|NCT03520413|521058359|FG001|Overall Study|Death|1|||
144508029|NCT03520413|521058358|FG000|Overall Study|Physician Decision|3|||
144508030|NCT03520413|521058359|FG001|Overall Study|Physician Decision|3|||
144508031|NCT03520413|521058358|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
144508032|NCT03520413|521058359|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
144508033|NCT00346151|521058360|FG000|Overall Study|Withdrawal by Subject|3|||
144508034|NCT04054635|521058365|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
144508035|NCT04054635|521058366|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
144508036|NCT04054635|521058367|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
144508037|NCT04054635|521058365|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
144508038|NCT04054635|521058366|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
144508039|NCT04054635|521058367|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
144508040|NCT03737240|521058368|FG000|Overall Study|Lost to Follow-up|16|||
144508041|NCT03737240|521058369|FG001|Overall Study|Lost to Follow-up|15|||
144508042|NCT00891930|521058370|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
144508043|NCT00891930|521058370|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
144508044|NCT00891930|521058370|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
144508045|NCT00891930|521058370|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
144508046|NCT00891930|521058370|FG000|Part 2 Panitumumab + AMG479|Death|30|||
144508047|NCT02507752|521058375|FG000|Overall Study|Adverse Event|1|||
144508048|NCT02507752|521058375|FG000|Overall Study|Protocol Violation|6|||
144508049|NCT02507752|521058375|FG000|Overall Study|Lost to Follow-up|7|||
144508050|NCT02507752|521058375|FG000|Overall Study|Infusion reaction at first infusion|1|||
144588522|NCT02891837|521352392|FG000|Overall Study|Lost to Follow-up|2|||
144588523|NCT02891837|521352393|FG001|Overall Study|Lost to Follow-up|0|||
144588524|NCT02891837|521352392|FG000|Overall Study|Withdrawal by Subject|1|||
144588525|NCT02891837|521352393|FG001|Overall Study|Withdrawal by Subject|0|||
144588526|NCT01237587|521352395|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
144588527|NCT01237587|521352396|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
144588528|NCT01237587|521352395|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
144588529|NCT01237587|521352396|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
144588530|NCT01237587|521352395|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
144588531|NCT01237587|521352396|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
144588532|NCT01237587|521352395|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
144588533|NCT01237587|521352396|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
144588534|NCT01237587|521352395|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
144588535|NCT01237587|521352396|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
144588536|NCT01237587|521352395|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
144588537|NCT01237587|521352396|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
144588538|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
144588539|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
144588540|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
144588541|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
144588542|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
144588543|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
144588544|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
144588545|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
144588546|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
144588547|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
144588548|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
144588549|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
144588550|NCT01237587|521352395|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
144588551|NCT01237587|521352396|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
144588552|NCT01237587|521352395|FG000|Taper Phase|Adverse Event|0|||
144588553|NCT01237587|521352396|FG001|Taper Phase|Adverse Event|2|||
144588554|NCT01237587|521352395|FG000|Taper Phase|Protocol Violation|2|||
144588555|NCT01237587|521352396|FG001|Taper Phase|Protocol Violation|0|||
144588556|NCT01237587|521352395|FG000|Taper Phase|Lack of Efficacy|2|||
144588557|NCT01237587|521352396|FG001|Taper Phase|Lack of Efficacy|5|||
144588558|NCT01237587|521352395|FG000|Taper Phase|Parent/Guardian Decision|0|||
144588559|NCT01237587|521352396|FG001|Taper Phase|Parent/Guardian Decision|2|||
144588560|NCT01237587|521352395|FG000|Taper Phase|Sponsor Decision|1|||
144588561|NCT01237587|521352396|FG001|Taper Phase|Sponsor Decision|0|||
144588562|NCT01237587|521352395|FG000|Taper Phase|Withdrawal by Subject|0|||
144588563|NCT01237587|521352396|FG001|Taper Phase|Withdrawal by Subject|1|||
144588564|NCT01103362|521352399|FG000|Overall Study|study terminated|596|||
144588565|NCT02047903|521352400|FG000|Overall Study|Adverse Event|14|||
144588566|NCT02047903|521352400|FG000|Overall Study|Serious adverse event|10|||
144588567|NCT02047903|521352400|FG000|Overall Study|Withdrawal by Subject|16|||
144588568|NCT02047903|521352400|FG000|Overall Study|Lost to Follow-up|4|||
144588569|NCT02047903|521352400|FG000|Overall Study|Reason not listed|6|||
144588570|NCT02047903|521352400|FG000|Overall Study|Not Treated|9|||
144588571|NCT03538301|521352403|FG000|Overall Study|Adverse Event|1|||
144588572|NCT03538301|521352404|FG001|Overall Study|Adverse Event|4|||
144588573|NCT03538301|521352405|FG002|Overall Study|Adverse Event|4|||
144588574|NCT03538301|521352403|FG000|Overall Study|Death|1|||
144588575|NCT03538301|521352404|FG001|Overall Study|Death|1|||
144588576|NCT03538301|521352405|FG002|Overall Study|Death|0|||
144588577|NCT03538301|521352403|FG000|Overall Study|Physician Decision|0|||
144588578|NCT03538301|521352404|FG001|Overall Study|Physician Decision|1|||
144588579|NCT03538301|521352405|FG002|Overall Study|Physician Decision|0|||
144588580|NCT03538301|521352403|FG000|Overall Study|Protocol Violation|0|||
144588581|NCT03538301|521352404|FG001|Overall Study|Protocol Violation|0|||
144588582|NCT03538301|521352405|FG002|Overall Study|Protocol Violation|1|||
144588583|NCT03538301|521352403|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
144588584|NCT03538301|521352404|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
144588585|NCT03538301|521352405|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
144588586|NCT03616977|521352406|FG000|Period 1|Physician Decision|0|||
144588587|NCT03616977|521352407|FG001|Period 1|Physician Decision|1|||
144588588|NCT03616977|521352406|FG000|Period 3|Adverse Event|1|||
144588589|NCT03616977|521352407|FG001|Period 3|Adverse Event|1|||
144588590|NCT02665338|521352408|FG000|Overall Study|Withdrawal by Subject|0|||
144588591|NCT02665338|521352409|FG001|Overall Study|Withdrawal by Subject|1|||
144588592|NCT04617275|521352411|FG000|Treatment Period|Adverse Event|1|||
144588593|NCT04617275|521352412|FG001|Treatment Period|Adverse Event|6|||
144588594|NCT04617275|521352413|FG002|Treatment Period|Adverse Event|4|||
144588595|NCT04617275|521352414|FG003|Treatment Period|Adverse Event|6|||
144588596|NCT04617275|521352415|FG004|Treatment Period|Adverse Event|7|||
144588597|NCT04617275|521352416|FG005|Treatment Period|Adverse Event|8|||
144588598|NCT04617275|521352417|FG006|Treatment Period|Adverse Event|0|||
144588599|NCT04617275|521352418|FG007|Treatment Period|Adverse Event|12|||
144588600|NCT04617275|521352411|FG000|Treatment Period|Lost to Follow-up|0|||
144588601|NCT04617275|521352412|FG001|Treatment Period|Lost to Follow-up|0|||
144588602|NCT04617275|521352413|FG002|Treatment Period|Lost to Follow-up|2|||
144588603|NCT04617275|521352414|FG003|Treatment Period|Lost to Follow-up|0|||
144588604|NCT04617275|521352415|FG004|Treatment Period|Lost to Follow-up|0|||
144588605|NCT04617275|521352416|FG005|Treatment Period|Lost to Follow-up|3|||
144588606|NCT04617275|521352417|FG006|Treatment Period|Lost to Follow-up|0|||
144508051|NCT02507752|521058375|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
144508052|NCT02507752|521058375|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
144508053|NCT00535145|521058380|FG000|Phase I|Adverse Event|3|||
144508054|NCT00535145|521058380|FG000|Phase I|Lost to Follow-up|7|||
144508055|NCT00535145|521058380|FG000|Phase I|Withdrawal by Subject|6|||
144508056|NCT00535145|521058380|FG000|Phase I|(eligibility)|8|||
144508057|NCT00535145|521058380|FG000|Phase I|(protocol violation)|1|||
144508058|NCT00535145|521058380|FG000|Phase I|(PI decision)|1|||
144508059|NCT00535145|521058380|FG000|Phase I|(diagnosis)|3|||
144508060|NCT00535145|521058380|FG000|Phase II|Adverse Event|2|||
144508061|NCT00535145|521058380|FG000|Phase II|Lack of Efficacy|1|||
144508062|NCT00535145|521058380|FG000|Phase II|Lost to Follow-up|5|||
144508063|NCT00535145|521058380|FG000|Phase II|Withdrawal by Subject|5|||
144508064|NCT00535145|521058380|FG000|Phase II|Subject non-compliance|2|||
144508065|NCT01124734|521058384|FG000|Overall Study|Disease progression|13|||
144508066|NCT01124734|521058384|FG000|Overall Study|Adverse Event|1|||
144508067|NCT01124734|521058384|FG000|Overall Study|Withdrawal by Subject|1|||
144508068|NCT01124734|521058384|FG000|Overall Study|Elected for alternative treatment|2|||
144508069|NCT02214160|521058385|FG000|Overall Study|Withdrawal by Subject|1|||
144508070|NCT02214160|521058386|FG001|Overall Study|Withdrawal by Subject|0|||
144508071|NCT02214160|521058387|FG002|Overall Study|Withdrawal by Subject|6|||
144508072|NCT02214160|521058385|FG000|Overall Study|Death|2|||
144508073|NCT02214160|521058386|FG001|Overall Study|Death|2|||
144508074|NCT02214160|521058387|FG002|Overall Study|Death|1|||
144508075|NCT02214160|521058385|FG000|Overall Study|Subject Non-Compliance|0|||
144508076|NCT02214160|521058386|FG001|Overall Study|Subject Non-Compliance|3|||
144508077|NCT02214160|521058387|FG002|Overall Study|Subject Non-Compliance|1|||
144508078|NCT02214160|521058385|FG000|Overall Study|Adverse Event|0|||
144508079|NCT02214160|521058386|FG001|Overall Study|Adverse Event|1|||
144508080|NCT02214160|521058387|FG002|Overall Study|Adverse Event|1|||
144508081|NCT02214160|521058385|FG000|Overall Study|Sponsor Decision|0|||
144508082|NCT02214160|521058386|FG001|Overall Study|Sponsor Decision|2|||
144508083|NCT02214160|521058387|FG002|Overall Study|Sponsor Decision|0|||
144508084|NCT02214160|521058385|FG000|Overall Study|Protocol Violation|1|||
144508085|NCT02214160|521058386|FG001|Overall Study|Protocol Violation|0|||
144508086|NCT02214160|521058387|FG002|Overall Study|Protocol Violation|0|||
144508087|NCT02214160|521058385|FG000|Overall Study|Physician Decision|0|||
144508088|NCT02214160|521058386|FG001|Overall Study|Physician Decision|0|||
144508089|NCT02214160|521058387|FG002|Overall Study|Physician Decision|1|||
144508090|NCT01430611|521058393|FG000|Overall Study|Adverse Event|0|||
144508091|NCT01430611|521058394|FG001|Overall Study|Adverse Event|1|||
144508092|NCT01430611|521058393|FG000|Overall Study|Protocol Violation|1|||
144508093|NCT01430611|521058394|FG001|Overall Study|Protocol Violation|0|||
144508094|NCT01430611|521058393|FG000|Overall Study|Lost to Follow-up|1|||
144508095|NCT01430611|521058394|FG001|Overall Study|Lost to Follow-up|0|||
144508096|NCT01430611|521058393|FG000|Overall Study|Withdrawal by Subject|15|||
144508097|NCT01430611|521058394|FG001|Overall Study|Withdrawal by Subject|14|||
144508098|NCT02204982|521058395|FG000|Overall Study|Patient ineligible-medical monitor|1|||
144508099|NCT02204982|521058396|FG001|Overall Study|Patient ineligible-medical monitor|0|||
144508100|NCT02204982|521058395|FG000|Overall Study|Withdrawal by Subject|1|||
144508101|NCT02204982|521058396|FG001|Overall Study|Withdrawal by Subject|0|||
144508102|NCT02204982|521058395|FG000|Overall Study|Adverse Event|1|||
144508103|NCT02204982|521058396|FG001|Overall Study|Adverse Event|0|||
144508104|NCT02204982|521058395|FG000|Overall Study|Adverse Event and Investigator decision|1|||
144588607|NCT04617275|521352418|FG007|Treatment Period|Lost to Follow-up|2|||
144588608|NCT04617275|521352411|FG000|Treatment Period|No longer meets eligibility criteria|0|||
144588609|NCT04617275|521352412|FG001|Treatment Period|No longer meets eligibility criteria|0|||
144588610|NCT04617275|521352413|FG002|Treatment Period|No longer meets eligibility criteria|0|||
144508105|NCT02204982|521058396|FG001|Overall Study|Adverse Event and Investigator decision|0|||
144508106|NCT02204982|521058395|FG000|Overall Study|Physician Decision|0|||
144508107|NCT02204982|521058396|FG001|Overall Study|Physician Decision|2|||
144508108|NCT02204982|521058395|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
144508109|NCT02204982|521058396|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
144508110|NCT02204982|521058395|FG000|Overall Study|Termination of Study bySponsor|0|||
144508111|NCT02204982|521058396|FG001|Overall Study|Termination of Study bySponsor|1|||
144588611|NCT04617275|521352414|FG003|Treatment Period|No longer meets eligibility criteria|1|||
144588612|NCT04617275|521352415|FG004|Treatment Period|No longer meets eligibility criteria|0|||
144588613|NCT04617275|521352416|FG005|Treatment Period|No longer meets eligibility criteria|0|||
144588614|NCT04617275|521352417|FG006|Treatment Period|No longer meets eligibility criteria|0|||
144588615|NCT04617275|521352418|FG007|Treatment Period|No longer meets eligibility criteria|0|||
144588616|NCT04617275|521352411|FG000|Treatment Period|Other|0|||
144588617|NCT04617275|521352412|FG001|Treatment Period|Other|1|||
144588618|NCT04617275|521352413|FG002|Treatment Period|Other|0|||
144588619|NCT04617275|521352414|FG003|Treatment Period|Other|0|||
144588620|NCT04617275|521352415|FG004|Treatment Period|Other|0|||
144588621|NCT04617275|521352416|FG005|Treatment Period|Other|0|||
144588622|NCT04617275|521352417|FG006|Treatment Period|Other|0|||
144588623|NCT04617275|521352418|FG007|Treatment Period|Other|0|||
144588624|NCT04617275|521352411|FG000|Treatment Period|Withdrawal by Subject|2|||
144588625|NCT04617275|521352412|FG001|Treatment Period|Withdrawal by Subject|0|||
144588626|NCT04617275|521352413|FG002|Treatment Period|Withdrawal by Subject|0|||
144588627|NCT04617275|521352414|FG003|Treatment Period|Withdrawal by Subject|2|||
144588628|NCT04617275|521352415|FG004|Treatment Period|Withdrawal by Subject|2|||
144588629|NCT04617275|521352416|FG005|Treatment Period|Withdrawal by Subject|0|||
144588630|NCT04617275|521352417|FG006|Treatment Period|Withdrawal by Subject|1|||
144588631|NCT04617275|521352418|FG007|Treatment Period|Withdrawal by Subject|2|||
144588632|NCT04617275|521352411|FG000|Follow-up Period|Adverse Event|1|||
144588633|NCT04617275|521352412|FG001|Follow-up Period|Adverse Event|1|||
144588634|NCT04617275|521352413|FG002|Follow-up Period|Adverse Event|2|||
144588635|NCT04617275|521352414|FG003|Follow-up Period|Adverse Event|3|||
144588636|NCT04617275|521352415|FG004|Follow-up Period|Adverse Event|4|||
144588637|NCT04617275|521352416|FG005|Follow-up Period|Adverse Event|3|||
144588638|NCT04617275|521352417|FG006|Follow-up Period|Adverse Event|0|||
144588639|NCT04617275|521352418|FG007|Follow-up Period|Adverse Event|3|||
144588640|NCT04617275|521352411|FG000|Follow-up Period|Lost to Follow-up|0|||
144588641|NCT04617275|521352412|FG001|Follow-up Period|Lost to Follow-up|1|||
144588642|NCT04617275|521352413|FG002|Follow-up Period|Lost to Follow-up|2|||
144588643|NCT04617275|521352414|FG003|Follow-up Period|Lost to Follow-up|0|||
144588644|NCT04617275|521352415|FG004|Follow-up Period|Lost to Follow-up|0|||
144588645|NCT04617275|521352416|FG005|Follow-up Period|Lost to Follow-up|4|||
144588646|NCT04617275|521352417|FG006|Follow-up Period|Lost to Follow-up|0|||
144588647|NCT04617275|521352418|FG007|Follow-up Period|Lost to Follow-up|3|||
144588648|NCT04617275|521352411|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
144588649|NCT04617275|521352412|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
144588650|NCT04617275|521352413|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
144588651|NCT04617275|521352414|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
144588652|NCT04617275|521352415|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
144588653|NCT04617275|521352416|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
144588654|NCT04617275|521352417|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
144588655|NCT04617275|521352418|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
144588656|NCT04617275|521352411|FG000|Follow-up Period|Other|0|||
144588657|NCT04617275|521352412|FG001|Follow-up Period|Other|1|||
144588658|NCT04617275|521352413|FG002|Follow-up Period|Other|0|||
144588659|NCT04617275|521352414|FG003|Follow-up Period|Other|0|||
144588660|NCT04617275|521352415|FG004|Follow-up Period|Other|0|||
144588661|NCT04617275|521352416|FG005|Follow-up Period|Other|0|||
144588662|NCT04617275|521352417|FG006|Follow-up Period|Other|0|||
144588663|NCT04617275|521352418|FG007|Follow-up Period|Other|0|||
144588664|NCT04617275|521352411|FG000|Follow-up Period|Withdrawal by Subject|2|||
144588665|NCT04617275|521352412|FG001|Follow-up Period|Withdrawal by Subject|0|||
144588666|NCT04617275|521352413|FG002|Follow-up Period|Withdrawal by Subject|0|||
144588667|NCT04617275|521352414|FG003|Follow-up Period|Withdrawal by Subject|2|||
144588668|NCT04617275|521352415|FG004|Follow-up Period|Withdrawal by Subject|2|||
144588669|NCT04617275|521352416|FG005|Follow-up Period|Withdrawal by Subject|0|||
144588670|NCT04617275|521352417|FG006|Follow-up Period|Withdrawal by Subject|1|||
144588671|NCT04617275|521352418|FG007|Follow-up Period|Withdrawal by Subject|2|||
144588672|NCT04927884|521352419|FG000|Overall Study|Progressive Disease|2|||
144588673|NCT05917470|521352420|FG000|Overall Study|Progressive Disease|1|||
144588674|NCT05917470|521352421|FG001|Overall Study|Progressive Disease|1|||
144588675|NCT05917470|521352422|FG002|Overall Study|Progressive Disease|2|||
144588676|NCT05917470|521352423|FG003|Overall Study|Progressive Disease|3|||
144588677|NCT05917470|521352424|FG004|Overall Study|Progressive Disease|1|||
144588678|NCT05917470|521352425|FG005|Overall Study|Progressive Disease|1|||
144588679|NCT05917470|521352426|FG006|Overall Study|Progressive Disease|0|||
144588680|NCT05917470|521352427|FG007|Overall Study|Progressive Disease|0|||
144588681|NCT05917470|521352420|FG000|Overall Study|Withdrawal by Subject|0|||
144588682|NCT05917470|521352421|FG001|Overall Study|Withdrawal by Subject|0|||
144588683|NCT05917470|521352422|FG002|Overall Study|Withdrawal by Subject|1|||
144588684|NCT05917470|521352423|FG003|Overall Study|Withdrawal by Subject|0|||
144588685|NCT05917470|521352424|FG004|Overall Study|Withdrawal by Subject|0|||
144588686|NCT05917470|521352425|FG005|Overall Study|Withdrawal by Subject|0|||
144588687|NCT05917470|521352426|FG006|Overall Study|Withdrawal by Subject|0|||
144371070|NCT00606593|520565999|FG005|Overall Study|Adverse Event|0|||
144371071|NCT00606593|520566000|FG006|Overall Study|Adverse Event|1|||
144371072|NCT00606593|520566001|FG007|Overall Study|Adverse Event|2|||
144371073|NCT00606593|520566002|FG008|Overall Study|Adverse Event|1|||
144371074|NCT00606593|520566003|FG009|Overall Study|Adverse Event|0|||
144371075|NCT00606593|520565994|FG000|Overall Study|Withdrawal of consent|1|||
144371076|NCT00606593|520565995|FG001|Overall Study|Withdrawal of consent|0|||
144371077|NCT00606593|520565996|FG002|Overall Study|Withdrawal of consent|1|||
144371078|NCT00606593|520565997|FG003|Overall Study|Withdrawal of consent|0|||
144371079|NCT00606593|520565998|FG004|Overall Study|Withdrawal of consent|0|||
144371080|NCT00606593|520565999|FG005|Overall Study|Withdrawal of consent|0|||
144371081|NCT00606593|520566000|FG006|Overall Study|Withdrawal of consent|0|||
144371082|NCT00606593|520566001|FG007|Overall Study|Withdrawal of consent|0|||
144371083|NCT00606593|520566002|FG008|Overall Study|Withdrawal of consent|0|||
144371084|NCT00606593|520566003|FG009|Overall Study|Withdrawal of consent|0|||
144508112|NCT01943916|521058397|FG000|Overall Study|Technically invalid images|10|||
144508113|NCT01943916|521058397|FG000|Overall Study|Enrollment Failure|23|||
144508114|NCT01943916|521058397|FG000|Overall Study|Pilot Phase exclusion|100|||
144508115|NCT01943916|521058397|FG000|Overall Study|Quality Assurance Reader Fail|130|||
144508116|NCT01943916|521058397|FG000|Overall Study|Technical Failure|39|||
144508117|NCT01943916|521058397|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
144508118|NCT01943916|521058397|FG000|Overall Study|No Truth Panel Review|38|||
144508119|NCT01943916|521058397|FG000|Overall Study|Protocol Deviation|1|||
144508120|NCT00958633|521058400|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
144508121|NCT00958633|521058401|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
144508122|NCT00958633|521058402|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
144508123|NCT00958633|521058400|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
144508124|NCT00958633|521058401|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
144508125|NCT00958633|521058402|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
144508126|NCT00958633|521058400|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
144508127|NCT00958633|521058401|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
144508128|NCT00958633|521058402|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
144508129|NCT00958633|521058400|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
144508130|NCT00958633|521058401|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
144508131|NCT00958633|521058402|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
144508132|NCT00958633|521058400|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
144508133|NCT00958633|521058401|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
144508134|NCT00958633|521058402|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
144508135|NCT00958633|521058400|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
144508136|NCT00958633|521058401|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
144508137|NCT00958633|521058402|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
144508138|NCT00958633|521058400|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
144508139|NCT00958633|521058401|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
144508140|NCT00958633|521058402|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
144508141|NCT00457691|521058404|FG000|Overall Study|Adverse Event|4|||
144508142|NCT00457691|521058405|FG001|Overall Study|Adverse Event|1|||
144508143|NCT00457691|521058404|FG000|Overall Study|Death|163|||
144508144|NCT00457691|521058405|FG001|Overall Study|Death|148|||
144508145|NCT00457691|521058404|FG000|Overall Study|Protocol Violation|1|||
144508146|NCT00457691|521058405|FG001|Overall Study|Protocol Violation|3|||
144508147|NCT00457691|521058404|FG000|Overall Study|Lost to Follow-up|23|||
144508148|NCT00457691|521058405|FG001|Overall Study|Lost to Follow-up|14|||
144508149|NCT00457691|521058404|FG000|Overall Study|Study terminated by Sponsor|1|||
144508150|NCT00457691|521058405|FG001|Overall Study|Study terminated by Sponsor|1|||
144508151|NCT00457691|521058404|FG000|Overall Study|Subject refused (reason other than AE)|14|||
144508152|NCT00457691|521058405|FG001|Overall Study|Subject refused (reason other than AE)|19|||
144508153|NCT00457691|521058404|FG000|Overall Study|Disease progression, study terminated|180|||
144508154|NCT00457691|521058405|FG001|Overall Study|Disease progression, study terminated|196|||
144508155|NCT02674750|521058406|FG000|Overall Study|Death|4|||
144508156|NCT02674750|521058407|FG001|Overall Study|Death|5|||
144508157|NCT02674750|521058408|FG002|Overall Study|Death|8|||
144508158|NCT02674750|521058406|FG000|Overall Study|Lost to Follow-up|0|||
144508159|NCT02674750|521058407|FG001|Overall Study|Lost to Follow-up|8|||
144508160|NCT02674750|521058408|FG002|Overall Study|Lost to Follow-up|0|||
144508161|NCT02674750|521058406|FG000|Overall Study|Lack of Efficacy|1|||
144508162|NCT02674750|521058407|FG001|Overall Study|Lack of Efficacy|17|||
144508163|NCT02674750|521058408|FG002|Overall Study|Lack of Efficacy|3|||
144508164|NCT02674750|521058406|FG000|Overall Study|Withdrawal by Subject|0|||
144508165|NCT02674750|521058407|FG001|Overall Study|Withdrawal by Subject|7|||
144508166|NCT02674750|521058408|FG002|Overall Study|Withdrawal by Subject|1|||
144371085|NCT00606593|520565994|FG000|Overall Study|Administrative/Other|0|||
144371086|NCT00606593|520565995|FG001|Overall Study|Administrative/Other|0|||
144371087|NCT00606593|520565996|FG002|Overall Study|Administrative/Other|1|||
144371088|NCT00606593|520565997|FG003|Overall Study|Administrative/Other|0|||
144588688|NCT05917470|521352427|FG007|Overall Study|Withdrawal by Subject|0|||
144588689|NCT05917470|521352420|FG000|Overall Study|Sponsor Decision|0|||
144588690|NCT05917470|521352421|FG001|Overall Study|Sponsor Decision|0|||
144588691|NCT05917470|521352422|FG002|Overall Study|Sponsor Decision|1|||
144588692|NCT05917470|521352423|FG003|Overall Study|Sponsor Decision|0|||
144588693|NCT05917470|521352424|FG004|Overall Study|Sponsor Decision|2|||
144508167|NCT02674750|521058406|FG000|Overall Study|Other|0|||
144588694|NCT05917470|521352425|FG005|Overall Study|Sponsor Decision|1|||
144588695|NCT05917470|521352426|FG006|Overall Study|Sponsor Decision|3|||
144508168|NCT02674750|521058407|FG001|Overall Study|Other|8|||
144508169|NCT02674750|521058408|FG002|Overall Study|Other|0|||
144508170|NCT01787760|521058411|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
144508171|NCT01787760|521058412|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
144508172|NCT01787760|521058413|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
144508173|NCT01787760|521058411|FG000|Overall Study|Decompensated on left exotropia|0|||
144508174|NCT01787760|521058412|FG001|Overall Study|Decompensated on left exotropia|0|||
144508175|NCT01787760|521058413|FG002|Overall Study|Decompensated on left exotropia|1|||
144508176|NCT01787760|521058411|FG000|Overall Study|Dryness|0|||
144508177|NCT01787760|521058412|FG001|Overall Study|Dryness|1|||
144508178|NCT01787760|521058413|FG002|Overall Study|Dryness|0|||
144508179|NCT01787760|521058411|FG000|Overall Study|Relocation|1|||
144508180|NCT01787760|521058412|FG001|Overall Study|Relocation|1|||
144508181|NCT01787760|521058413|FG002|Overall Study|Relocation|0|||
144508182|NCT01787760|521058411|FG000|Overall Study|Lens discomfort|3|||
144508183|NCT01787760|521058412|FG001|Overall Study|Lens discomfort|0|||
144508184|NCT01787760|521058413|FG002|Overall Study|Lens discomfort|0|||
144508185|NCT01787760|521058411|FG000|Overall Study|Lens handling difficulty|1|||
144508186|NCT01787760|521058412|FG001|Overall Study|Lens handling difficulty|2|||
144508187|NCT01787760|521058413|FG002|Overall Study|Lens handling difficulty|0|||
144508188|NCT01787760|521058411|FG000|Overall Study|Protocol Violation|6|||
144508189|NCT01787760|521058412|FG001|Overall Study|Protocol Violation|0|||
144508190|NCT01787760|521058413|FG002|Overall Study|Protocol Violation|1|||
144508191|NCT01787760|521058411|FG000|Overall Study|Withdrawal by Subject|5|||
144508192|NCT01787760|521058412|FG001|Overall Study|Withdrawal by Subject|1|||
144508193|NCT01787760|521058413|FG002|Overall Study|Withdrawal by Subject|2|||
144508194|NCT01787760|521058411|FG000|Overall Study|Lost to Follow-up|1|||
144508195|NCT01787760|521058412|FG001|Overall Study|Lost to Follow-up|0|||
144508196|NCT01787760|521058413|FG002|Overall Study|Lost to Follow-up|1|||
144508197|NCT01787760|521058411|FG000|Overall Study|Stroke|1|||
144508198|NCT01787760|521058412|FG001|Overall Study|Stroke|0|||
144508199|NCT01787760|521058413|FG002|Overall Study|Stroke|0|||
144508200|NCT01787760|521058411|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
144508201|NCT01787760|521058412|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
144508202|NCT01787760|521058413|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
144508203|NCT01787760|521058411|FG000|Overall Study|Unsatisfactory physiological response|2|||
144508204|NCT01787760|521058412|FG001|Overall Study|Unsatisfactory physiological response|4|||
144508205|NCT01787760|521058413|FG002|Overall Study|Unsatisfactory physiological response|0|||
144508206|NCT01787760|521058411|FG000|Overall Study|Unsatisfactory visual response|1|||
144508207|NCT01787760|521058412|FG001|Overall Study|Unsatisfactory visual response|1|||
144508208|NCT01787760|521058413|FG002|Overall Study|Unsatisfactory visual response|0|||
144508209|NCT01787760|521058411|FG000|Overall Study|Near vision blur|1|||
144508210|NCT01787760|521058412|FG001|Overall Study|Near vision blur|0|||
144508211|NCT01787760|521058413|FG002|Overall Study|Near vision blur|0|||
144508212|NCT03512756|521058414|FG000|Part 1|Death|23|||
144508213|NCT03512756|521058415|FG001|Part 1|Death|18|||
144508214|NCT03512756|521058416|FG002|Part 1|Death|0|||
144508215|NCT03512756|521058417|FG003|Part 1|Death|0|||
144508216|NCT03512756|521058414|FG000|Part 1|Lost to Follow-up|0|||
144508217|NCT03512756|521058415|FG001|Part 1|Lost to Follow-up|3|||
144508218|NCT03512756|521058416|FG002|Part 1|Lost to Follow-up|0|||
144588696|NCT05917470|521352427|FG007|Overall Study|Sponsor Decision|3|||
144508219|NCT03512756|521058417|FG003|Part 1|Lost to Follow-up|0|||
144588697|NCT05917470|521352420|FG000|Overall Study|Adverse Event|0|||
144588698|NCT05917470|521352421|FG001|Overall Study|Adverse Event|0|||
144508220|NCT03512756|521058414|FG000|Part 1|Physician Decision|0|||
144508221|NCT03512756|521058415|FG001|Part 1|Physician Decision|1|||
144508222|NCT03512756|521058416|FG002|Part 1|Physician Decision|0|||
144508223|NCT03512756|521058417|FG003|Part 1|Physician Decision|0|||
144508224|NCT03512756|521058414|FG000|Part 1|Withdrawal by Subject|2|||
144508225|NCT03512756|521058415|FG001|Part 1|Withdrawal by Subject|2|||
144508226|NCT03512756|521058416|FG002|Part 1|Withdrawal by Subject|0|||
144508227|NCT03512756|521058417|FG003|Part 1|Withdrawal by Subject|0|||
144508228|NCT03512756|521058414|FG000|Part 2|Death|0|||
144588699|NCT05917470|521352422|FG002|Overall Study|Adverse Event|0|||
144508229|NCT03512756|521058415|FG001|Part 2|Death|0|||
144508230|NCT03512756|521058416|FG002|Part 2|Death|32|||
144588700|NCT05917470|521352423|FG003|Overall Study|Adverse Event|0|||
144588701|NCT05917470|521352424|FG004|Overall Study|Adverse Event|0|||
144508231|NCT03512756|521058417|FG003|Part 2|Death|21|||
144508232|NCT03512756|521058414|FG000|Part 2|Lost to Follow-up|0|||
144508233|NCT03512756|521058415|FG001|Part 2|Lost to Follow-up|0|||
144508234|NCT03512756|521058416|FG002|Part 2|Lost to Follow-up|1|||
144508235|NCT03512756|521058417|FG003|Part 2|Lost to Follow-up|0|||
144508236|NCT03512756|521058414|FG000|Part 2|Physician Decision|0|||
144508237|NCT03512756|521058415|FG001|Part 2|Physician Decision|0|||
144508238|NCT03512756|521058416|FG002|Part 2|Physician Decision|2|||
144508239|NCT03512756|521058417|FG003|Part 2|Physician Decision|4|||
144508240|NCT03512756|521058414|FG000|Part 2|Study Terminated by Sponsor|0|||
144508241|NCT03512756|521058415|FG001|Part 2|Study Terminated by Sponsor|0|||
144508242|NCT03512756|521058416|FG002|Part 2|Study Terminated by Sponsor|2|||
144508243|NCT03512756|521058417|FG003|Part 2|Study Terminated by Sponsor|6|||
144508244|NCT03512756|521058414|FG000|Part 2|Protocol Violation|0|||
144508245|NCT03512756|521058415|FG001|Part 2|Protocol Violation|0|||
144508246|NCT03512756|521058416|FG002|Part 2|Protocol Violation|1|||
144508247|NCT03512756|521058417|FG003|Part 2|Protocol Violation|0|||
144508248|NCT03512756|521058414|FG000|Part 2|Withdrawal by Subject|0|||
144508249|NCT03512756|521058415|FG001|Part 2|Withdrawal by Subject|0|||
144508250|NCT03512756|521058416|FG002|Part 2|Withdrawal by Subject|3|||
144508251|NCT03512756|521058417|FG003|Part 2|Withdrawal by Subject|9|||
144508252|NCT00632424|521058424|FG000|Overall Study|Disease Progression|17|||
144508253|NCT00632424|521058424|FG000|Overall Study|Study Drug Toxicity|1|||
144508254|NCT04250883|521060493|FG000|Overall Study|Lost to Follow-up|1|||
144508255|NCT04250883|521060494|FG001|Overall Study|Lost to Follow-up|0|||
144508256|NCT04588259|521060495|FG000|Run-in Period|Run-in failure|0|||
144508257|NCT04588259|521060496|FG001|Run-in Period|Run-in failure|23|||
144508258|NCT04588259|521060495|FG000|Run-in Period|Withdrawn before randomisation|0|||
144508259|NCT04588259|521060496|FG001|Run-in Period|Withdrawn before randomisation|8|||
144508260|NCT04588259|521060495|FG000|Treatment Period|Withdrawal by Subject|6|||
144508261|NCT04588259|521060496|FG001|Treatment Period|Withdrawal by Subject|6|||
144508262|NCT01391832|521060497|FG000|Overall Study|Withdrawal by Subject|21|||
144508263|NCT01391832|521060498|FG001|Overall Study|Withdrawal by Subject|22|||
144508264|NCT01391832|521060497|FG000|Overall Study|Lost to Follow-up|0|||
144508265|NCT01391832|521060498|FG001|Overall Study|Lost to Follow-up|1|||
144508266|NCT03345901|521060504|FG000|Overall Study|The study was terminated|18|||
144508267|NCT00722046|521060505|FG000|Overall Study|Adverse Event|0|||
144508268|NCT00722046|521060506|FG001|Overall Study|Adverse Event|1|||
144508269|NCT00722046|521060507|FG002|Overall Study|Adverse Event|2|||
144508270|NCT00722046|521060508|FG003|Overall Study|Adverse Event|1|||
144508271|NCT00722046|521060509|FG004|Overall Study|Adverse Event|2|||
144508272|NCT00722046|521060510|FG005|Overall Study|Adverse Event|1|||
144508273|NCT00722046|521060511|FG006|Overall Study|Adverse Event|0|||
144508274|NCT00722046|521060505|FG000|Overall Study|Death|0|||
144508275|NCT00722046|521060506|FG001|Overall Study|Death|1|||
144508276|NCT00722046|521060507|FG002|Overall Study|Death|0|||
144508277|NCT00722046|521060508|FG003|Overall Study|Death|0|||
144508278|NCT00722046|521060509|FG004|Overall Study|Death|0|||
144508279|NCT00722046|521060510|FG005|Overall Study|Death|0|||
144508280|NCT00722046|521060511|FG006|Overall Study|Death|2|||
144508281|NCT00722046|521060505|FG000|Overall Study|Protocol Violation|1|||
144508282|NCT00722046|521060506|FG001|Overall Study|Protocol Violation|0|||
144508283|NCT00722046|521060507|FG002|Overall Study|Protocol Violation|0|||
144508284|NCT00722046|521060508|FG003|Overall Study|Protocol Violation|0|||
144508285|NCT00722046|521060509|FG004|Overall Study|Protocol Violation|0|||
144508286|NCT00722046|521060510|FG005|Overall Study|Protocol Violation|1|||
144508287|NCT00722046|521060511|FG006|Overall Study|Protocol Violation|0|||
144508288|NCT00722046|521060505|FG000|Overall Study|Withdrawal by Subject|3|||
144508289|NCT00722046|521060506|FG001|Overall Study|Withdrawal by Subject|3|||
144508290|NCT00722046|521060507|FG002|Overall Study|Withdrawal by Subject|4|||
144508291|NCT00722046|521060508|FG003|Overall Study|Withdrawal by Subject|4|||
144508292|NCT00722046|521060509|FG004|Overall Study|Withdrawal by Subject|4|||
144508293|NCT00722046|521060510|FG005|Overall Study|Withdrawal by Subject|7|||
144508294|NCT00722046|521060511|FG006|Overall Study|Withdrawal by Subject|3|||
144508295|NCT00722046|521060505|FG000|Overall Study|Randomized, but not treated|1|||
144508296|NCT00722046|521060506|FG001|Overall Study|Randomized, but not treated|1|||
144508297|NCT00722046|521060507|FG002|Overall Study|Randomized, but not treated|0|||
144508298|NCT00722046|521060508|FG003|Overall Study|Randomized, but not treated|2|||
144508299|NCT00722046|521060509|FG004|Overall Study|Randomized, but not treated|0|||
144508300|NCT00722046|521060510|FG005|Overall Study|Randomized, but not treated|0|||
144508301|NCT00722046|521060511|FG006|Overall Study|Randomized, but not treated|0|||
144508302|NCT00722046|521060505|FG000|Overall Study|Other|0|||
144508303|NCT00722046|521060506|FG001|Overall Study|Other|0|||
144508304|NCT00722046|521060507|FG002|Overall Study|Other|1|||
144508305|NCT00722046|521060508|FG003|Overall Study|Other|1|||
144508306|NCT00722046|521060509|FG004|Overall Study|Other|3|||
144508307|NCT00722046|521060510|FG005|Overall Study|Other|2|||
144508308|NCT00722046|521060511|FG006|Overall Study|Other|1|||
144508309|NCT00925587|521060512|FG000|Overall Study|Protocol Specified Criteria|6|||
144508310|NCT00925587|521060513|FG001|Overall Study|Protocol Specified Criteria|6|||
144508311|NCT00925587|521060512|FG000|Overall Study|Physician Decision|4|||
144588702|NCT05917470|521352425|FG005|Overall Study|Adverse Event|1|||
144588703|NCT05917470|521352426|FG006|Overall Study|Adverse Event|0|||
144588704|NCT05917470|521352427|FG007|Overall Study|Adverse Event|0|||
144588705|NCT01022268|521355678|FG000|Overall Study|Withdrawal by Subject|1|||
144588706|NCT01022268|521355679|FG001|Overall Study|Withdrawal by Subject|0|||
144588707|NCT01022268|521355678|FG000|Overall Study|Withdrawal by Subject|1|||
144588708|NCT01022268|521355679|FG001|Overall Study|Withdrawal by Subject|0|||
144588709|NCT00734097|521355680|FG000|Screening|Protocol Violation|12|||
144588710|NCT00734097|521355680|FG000|Screening|Withdrawal by Subject|5|||
144588711|NCT00734097|521355680|FG000|Screening|Lost to Follow-up|2|||
144588712|NCT00734097|521355680|FG000|Screening|Unconfirmed pregnancy|1|||
144588713|NCT00734097|521355680|FG000|Open Label|Lost to Follow-up|7|||
144588714|NCT00734097|521355680|FG000|Open Label|Withdrawal by Subject|5|||
144588715|NCT00734097|521355680|FG000|Open Label|Protocol Violation|4|||
144588716|NCT02924428|521355683|FG000|Overall Study|Adverse Event|1|||
144588717|NCT02924428|521355684|FG001|Overall Study|Adverse Event|0|||
144588718|NCT02924428|521355683|FG000|Overall Study|Physician Decision|1|||
144588719|NCT02924428|521355684|FG001|Overall Study|Physician Decision|0|||
144588720|NCT02924428|521355683|FG000|Overall Study|Lost to Follow-up|2|||
144588721|NCT02924428|521355684|FG001|Overall Study|Lost to Follow-up|4|||
144588722|NCT02924428|521355683|FG000|Overall Study|Pregnancy|0|||
144588723|NCT02924428|521355684|FG001|Overall Study|Pregnancy|1|||
144588724|NCT01877837|521355685|FG000|Overall Study|Lost to Follow-up|1|||
144588725|NCT01877837|521355685|FG000|Overall Study|Ineligible|4|||
144588726|NCT01775475|521355691|FG000|Overall Study|Death|3|||
144588727|NCT01775475|521355692|FG001|Overall Study|Death|3|||
144588728|NCT00896051|521355693|FG000|Overall Study|Adverse Event|2|||
144588729|NCT00896051|521355694|FG001|Overall Study|Adverse Event|1|||
144588730|NCT00896051|521355693|FG000|Overall Study|Lost to Follow-up|3|||
144588731|NCT00896051|521355694|FG001|Overall Study|Lost to Follow-up|2|||
144588732|NCT00896051|521355693|FG000|Overall Study|Withdrawal by Subject|3|||
144588733|NCT00896051|521355694|FG001|Overall Study|Withdrawal by Subject|2|||
144508312|NCT00925587|521060513|FG001|Overall Study|Physician Decision|1|||
144508313|NCT00925587|521060512|FG000|Overall Study|Protocol Violation|6|||
144508314|NCT00925587|521060513|FG001|Overall Study|Protocol Violation|4|||
144508315|NCT00925587|521060512|FG000|Overall Study|Withdrawal by Subject|9|||
144508316|NCT00925587|521060513|FG001|Overall Study|Withdrawal by Subject|6|||
144508317|NCT00925587|521060512|FG000|Overall Study|Death|5|||
144508318|NCT00925587|521060513|FG001|Overall Study|Death|5|||
144508319|NCT00925587|521060512|FG000|Overall Study|Adverse Event|6|||
144508320|NCT00925587|521060513|FG001|Overall Study|Adverse Event|2|||
144508321|NCT00925587|521060512|FG000|Overall Study|Lost to Follow-up|0|||
144508322|NCT00925587|521060513|FG001|Overall Study|Lost to Follow-up|1|||
144508323|NCT01318382|521060517|FG000|Overall Study|Physician Decision|2|||
144508324|NCT01318382|521060517|FG000|Overall Study|Device Malfunction|10|||
144508325|NCT01318382|521060517|FG000|Overall Study|Protocol Violation|1|||
144508326|NCT01599104|521060518|FG000|Overall Study|Withdrawal by Subject|1|||
144508327|NCT01599104|521060519|FG001|Overall Study|Withdrawal by Subject|1|||
144508328|NCT01599104|521060520|FG002|Overall Study|Withdrawal by Subject|2|||
144508329|NCT01599104|521060518|FG000|Overall Study|Technical Problems|1|||
144508330|NCT01599104|521060519|FG001|Overall Study|Technical Problems|0|||
144508331|NCT01599104|521060520|FG002|Overall Study|Technical Problems|0|||
144508332|NCT01599104|521060518|FG000|Overall Study|Physician Decision|3|||
144508333|NCT01599104|521060519|FG001|Overall Study|Physician Decision|2|||
144508334|NCT01599104|521060520|FG002|Overall Study|Physician Decision|2|||
144508335|NCT01599104|521060518|FG000|Overall Study|Non-compliance with study treatment|0|||
144508336|NCT01599104|521060519|FG001|Overall Study|Non-compliance with study treatment|1|||
144508337|NCT01599104|521060520|FG002|Overall Study|Non-compliance with study treatment|0|||
144508338|NCT01599104|521060518|FG000|Overall Study|Lack of Efficacy|4|||
144508339|NCT01599104|521060519|FG001|Overall Study|Lack of Efficacy|4|||
144508340|NCT01599104|521060520|FG002|Overall Study|Lack of Efficacy|10|||
144508341|NCT01599104|521060518|FG000|Overall Study|Adverse Event|7|||
144508342|NCT01599104|521060519|FG001|Overall Study|Adverse Event|6|||
144508343|NCT01599104|521060520|FG002|Overall Study|Adverse Event|12|||
144508344|NCT02271854|521060523|FG000|Overall Study|Withdrawal by Subject|2|||
144588734|NCT00896051|521355693|FG000|Overall Study|Subject noncompliant|1|||
144588735|NCT00896051|521355694|FG001|Overall Study|Subject noncompliant|3|||
144588736|NCT00896051|521355693|FG000|Overall Study|Other|1|||
144588737|NCT00896051|521355694|FG001|Overall Study|Other|1|||
144721679|NCT02173704|521835261|FG000|Overall Study|Adverse Event|1|||
144588738|NCT02935452|521355695|FG000|Overall Study|work and life commintment|3|||
144588739|NCT02935452|521355696|FG001|Overall Study|work and life commintment|1|||
144588740|NCT03103763|521355697|FG000|Overall Study|Death|15|||
144721680|NCT02173704|521835262|FG001|Overall Study|Adverse Event|0|||
144508345|NCT02271854|521060523|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
144508346|NCT02271854|521060523|FG000|Overall Study|Lost to Follow-up|1|||
144508347|NCT01308567|521060524|FG000|Overall Study|Lost to Follow-up|2|||
144508348|NCT01308567|521060525|FG001|Overall Study|Lost to Follow-up|4|||
144588741|NCT03103763|521355698|FG001|Overall Study|Death|5|||
144588742|NCT03103763|521355699|FG002|Overall Study|Death|5|||
144588743|NCT03103763|521355697|FG000|Overall Study|Withdrawal by Subject|0|||
144588744|NCT03103763|521355698|FG001|Overall Study|Withdrawal by Subject|3|||
144588745|NCT03103763|521355699|FG002|Overall Study|Withdrawal by Subject|2|||
144588746|NCT00618982|521355700|FG000|Overall Study|Adverse Event|23|||
144588747|NCT00618982|521355700|FG000|Overall Study|Withdrawal by Subject|1|||
144588748|NCT00618982|521355700|FG000|Overall Study|Protocol Violation|1|||
144588749|NCT00618982|521355700|FG000|Overall Study|ongoing, still treated with study med.|25|||
144588750|NCT03310268|521355701|FG000|Overall Study|(Not specified)|1|||
144588751|NCT03310268|521355702|FG001|Overall Study|(Not specified)|5|||
144588752|NCT03310268|521355703|FG002|Overall Study|(Not specified)|0|||
144588753|NCT00717067|521355706|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
144588754|NCT00717067|521355707|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
144588755|NCT00717067|521355708|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
144588756|NCT00717067|521355709|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
144588757|NCT00717067|521355710|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
144588758|NCT00822172|521355713|FG000|Overall Study|Adverse Event|10|||
144588759|NCT00822172|521355714|FG001|Overall Study|Adverse Event|12|||
144588760|NCT00822172|521355713|FG000|Overall Study|Death|1|||
144588761|NCT00822172|521355714|FG001|Overall Study|Death|0|||
144588762|NCT00822172|521355713|FG000|Overall Study|Lost to Follow-up|3|||
144588763|NCT00822172|521355714|FG001|Overall Study|Lost to Follow-up|1|||
144371089|NCT00606593|520565998|FG004|Overall Study|Administrative/Other|0|||
144588764|NCT00822172|521355713|FG000|Overall Study|Withdrawal by Subject|1|||
144588765|NCT00822172|521355714|FG001|Overall Study|Withdrawal by Subject|4|||
144588766|NCT00822172|521355713|FG000|Overall Study|site closed|0|||
144371090|NCT00606593|520565999|FG005|Overall Study|Administrative/Other|0|||
144371091|NCT00606593|520566000|FG006|Overall Study|Administrative/Other|0|||
144371092|NCT00606593|520566001|FG007|Overall Study|Administrative/Other|0|||
144371093|NCT00606593|520566002|FG008|Overall Study|Administrative/Other|0|||
144371094|NCT00606593|520566003|FG009|Overall Study|Administrative/Other|0|||
144371095|NCT03181529|520566004|FG000|Overall Study|Withdrawal by Subject|1|||
144371096|NCT03181529|520566005|FG001|Overall Study|Withdrawal by Subject|1|||
144371097|NCT03181529|520566004|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
144371098|NCT03181529|520566005|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
144371099|NCT00787644|520566006|FG000|Overall Study|Lost to Follow-up|1|||
144371100|NCT00787644|520566007|FG001|Overall Study|Lost to Follow-up|1|||
144371101|NCT00787644|520566006|FG000|Overall Study|Withdrawal by Subject|1|||
144371102|NCT00787644|520566007|FG001|Overall Study|Withdrawal by Subject|1|||
144371103|NCT00759941|520566008|FG000|Overall Study|Use of medication|1|||
144371104|NCT00759941|520566009|FG001|Overall Study|Use of medication|0|||
144371105|NCT00759941|520566008|FG000|Overall Study|Adverse Event|1|||
144371106|NCT00759941|520566009|FG001|Overall Study|Adverse Event|0|||
144371107|NCT00759941|520566008|FG000|Overall Study|Exited in error by site|1|||
144371108|NCT00759941|520566009|FG001|Overall Study|Exited in error by site|1|||
144371109|NCT05615922|520566011|FG000|Overall Study|Lost to Follow-up|1|||
144371110|NCT06083506|520566012|FG000|Overall Study|Physician Decision|2|||
144371111|NCT06083506|520566012|FG000|Overall Study|Lack of Efficacy|1|||
144371112|NCT05307692|520566014|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
144371113|NCT05307692|520566015|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
144371114|NCT05307692|520566016|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
144371115|NCT05307692|520566017|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
144371116|NCT05307692|520566014|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
144371117|NCT05307692|520566015|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
144371118|NCT05307692|520566016|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
144371119|NCT05307692|520566017|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
144371120|NCT05307692|520566014|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
144371121|NCT05307692|520566015|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
144371122|NCT05307692|520566016|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
144371123|NCT05307692|520566017|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
144371124|NCT05307692|520566014|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
144371125|NCT05307692|520566015|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
144371126|NCT05307692|520566016|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
144371127|NCT05307692|520566017|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
144371128|NCT05307692|520566014|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
144371129|NCT05307692|520566015|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
144371130|NCT05307692|520566016|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
144588767|NCT00822172|521355714|FG001|Overall Study|site closed|1|||
144588768|NCT00822172|521355713|FG000|Overall Study|Other|0|||
144588769|NCT00822172|521355714|FG001|Overall Study|Other|1|||
144588770|NCT00370331|521355715|FG000|Overall Study|Adverse Event|4|||
144588771|NCT00370331|521355716|FG001|Overall Study|Adverse Event|13|||
144588772|NCT00370331|521355715|FG000|Overall Study|Withdrawal by Subject|2|||
144508349|NCT01308567|521060526|FG002|Overall Study|Lost to Follow-up|4|||
144508350|NCT01149369|521060531|FG000|Overall Study|Adverse Event|6|||
144508351|NCT01149369|521060532|FG001|Overall Study|Adverse Event|3|||
144508352|NCT01424397|521060533|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508353|NCT01424397|521060534|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508354|NCT01424397|521060535|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
144508355|NCT01424397|521060536|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508356|NCT01424397|521060537|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508357|NCT01424397|521060538|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508358|NCT01424397|521060539|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508359|NCT01424397|521060540|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508360|NCT01424397|521060541|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508361|NCT01424397|521060542|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508362|NCT01424397|521060543|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508363|NCT01424397|521060544|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
144508364|NCT02564744|521060545|FG000|Overall Study|Investigator decision|0|||
144508365|NCT02564744|521060546|FG001|Overall Study|Investigator decision|0|||
144508366|NCT02564744|521060547|FG002|Overall Study|Investigator decision|0|||
144508367|NCT02564744|521060548|FG003|Overall Study|Investigator decision|0|||
144508368|NCT02564744|521060549|FG004|Overall Study|Investigator decision|1|||
144508369|NCT02564744|521060545|FG000|Overall Study|Death|10|||
144508370|NCT02564744|521060546|FG001|Overall Study|Death|5|||
144508371|NCT02564744|521060547|FG002|Overall Study|Death|4|||
144508372|NCT02564744|521060548|FG003|Overall Study|Death|16|||
144508373|NCT02564744|521060549|FG004|Overall Study|Death|16|||
144508374|NCT02564744|521060545|FG000|Overall Study|End of study Page Missing|0|||
144508375|NCT02564744|521060546|FG001|Overall Study|End of study Page Missing|0|||
144508376|NCT02564744|521060547|FG002|Overall Study|End of study Page Missing|3|||
144508377|NCT02564744|521060548|FG003|Overall Study|End of study Page Missing|3|||
144508378|NCT02564744|521060549|FG004|Overall Study|End of study Page Missing|0|||
144508379|NCT02564744|521060545|FG000|Overall Study|Subject Withdrew Consent|1|||
144508380|NCT02564744|521060546|FG001|Overall Study|Subject Withdrew Consent|1|||
144508381|NCT02564744|521060547|FG002|Overall Study|Subject Withdrew Consent|1|||
144508382|NCT02564744|521060548|FG003|Overall Study|Subject Withdrew Consent|0|||
144508383|NCT02564744|521060549|FG004|Overall Study|Subject Withdrew Consent|2|||
144508384|NCT02564744|521060545|FG000|Overall Study|Lost to Follow-up|0|||
144508385|NCT02564744|521060546|FG001|Overall Study|Lost to Follow-up|1|||
144508386|NCT02564744|521060547|FG002|Overall Study|Lost to Follow-up|0|||
144508387|NCT02564744|521060548|FG003|Overall Study|Lost to Follow-up|0|||
144508388|NCT02564744|521060549|FG004|Overall Study|Lost to Follow-up|1|||
144508389|NCT02564744|521060545|FG000|Overall Study|Reason not specified|1|||
144508390|NCT02564744|521060546|FG001|Overall Study|Reason not specified|0|||
144508391|NCT02564744|521060547|FG002|Overall Study|Reason not specified|0|||
144508392|NCT02564744|521060548|FG003|Overall Study|Reason not specified|0|||
144508393|NCT02564744|521060549|FG004|Overall Study|Reason not specified|0|||
144508394|NCT01177670|521060558|FG000|Overall Study|Study Terminated|115|||
144508395|NCT01177670|521060558|FG000|Overall Study|Physician Decision|50|||
144508396|NCT01177670|521060558|FG000|Overall Study|Withdrawal by Subject|4|||
144508397|NCT01636687|521060562|FG000|Induction Period|Withdrawal by Subject|1|||
144508398|NCT01636687|521060563|FG001|Induction Period|Withdrawal by Subject|0|||
144508399|NCT01636687|521060564|FG002|Induction Period|Withdrawal by Subject|0|||
144508400|NCT01636687|521060565|FG003|Induction Period|Withdrawal by Subject|0|||
144508401|NCT01636687|521060566|FG004|Induction Period|Withdrawal by Subject|0|||
144508402|NCT01636687|521060562|FG000|Induction Period|Adverse Event|1|||
144508403|NCT01636687|521060563|FG001|Induction Period|Adverse Event|0|||
144508404|NCT01636687|521060564|FG002|Induction Period|Adverse Event|0|||
144508405|NCT01636687|521060565|FG003|Induction Period|Adverse Event|0|||
144588773|NCT00370331|521355716|FG001|Overall Study|Withdrawal by Subject|4|||
144588774|NCT00370331|521355715|FG000|Overall Study|Lost to Follow-up|0|||
144508406|NCT01636687|521060566|FG004|Induction Period|Adverse Event|1|||
144508407|NCT01636687|521060562|FG000|Induction Period|Lack of Efficacy|0|||
144508408|NCT01636687|521060563|FG001|Induction Period|Lack of Efficacy|0|||
144508409|NCT01636687|521060564|FG002|Induction Period|Lack of Efficacy|0|||
144508410|NCT01636687|521060565|FG003|Induction Period|Lack of Efficacy|0|||
144588775|NCT00370331|521355716|FG001|Overall Study|Lost to Follow-up|3|||
144508411|NCT01636687|521060566|FG004|Induction Period|Lack of Efficacy|1|||
144508412|NCT01636687|521060562|FG000|Induction Period|Physician Decision|1|||
144508413|NCT01636687|521060563|FG001|Induction Period|Physician Decision|0|||
144508414|NCT01636687|521060564|FG002|Induction Period|Physician Decision|0|||
144508415|NCT01636687|521060565|FG003|Induction Period|Physician Decision|0|||
144508416|NCT01636687|521060566|FG004|Induction Period|Physician Decision|0|||
144508417|NCT01636687|521060562|FG000|Maintenance Period|Withdrawal by Subject|2|||
144508418|NCT01636687|521060563|FG001|Maintenance Period|Withdrawal by Subject|0|||
144508419|NCT01636687|521060564|FG002|Maintenance Period|Withdrawal by Subject|2|||
144508420|NCT01636687|521060565|FG003|Maintenance Period|Withdrawal by Subject|0|||
144588776|NCT00370331|521355715|FG000|Overall Study|Lack of Efficacy|0|||
144508421|NCT01636687|521060566|FG004|Maintenance Period|Withdrawal by Subject|0|||
144508422|NCT01636687|521060562|FG000|Maintenance Period|Adverse Event|1|||
144508423|NCT01636687|521060563|FG001|Maintenance Period|Adverse Event|0|||
144508424|NCT01636687|521060564|FG002|Maintenance Period|Adverse Event|0|||
144508425|NCT01636687|521060565|FG003|Maintenance Period|Adverse Event|0|||
144508426|NCT01636687|521060566|FG004|Maintenance Period|Adverse Event|0|||
144508427|NCT01636687|521060562|FG000|Maintenance Period|Lack of Efficacy|4|||
144508428|NCT01636687|521060563|FG001|Maintenance Period|Lack of Efficacy|1|||
144508429|NCT01636687|521060564|FG002|Maintenance Period|Lack of Efficacy|0|||
144508430|NCT01636687|521060565|FG003|Maintenance Period|Lack of Efficacy|0|||
144508431|NCT01636687|521060566|FG004|Maintenance Period|Lack of Efficacy|0|||
144508432|NCT01636687|521060562|FG000|Maintenance Period|Lost to Follow-up|1|||
144508433|NCT01636687|521060563|FG001|Maintenance Period|Lost to Follow-up|1|||
144508434|NCT01636687|521060564|FG002|Maintenance Period|Lost to Follow-up|0|||
144508435|NCT01636687|521060565|FG003|Maintenance Period|Lost to Follow-up|0|||
144508436|NCT01636687|521060566|FG004|Maintenance Period|Lost to Follow-up|1|||
144508437|NCT01636687|521060562|FG000|Maintenance Period|Physician Decision|0|||
144508438|NCT01636687|521060563|FG001|Maintenance Period|Physician Decision|0|||
144508439|NCT01636687|521060564|FG002|Maintenance Period|Physician Decision|0|||
144508440|NCT01636687|521060565|FG003|Maintenance Period|Physician Decision|0|||
144508441|NCT01636687|521060566|FG004|Maintenance Period|Physician Decision|1|||
144508442|NCT01636687|521060562|FG000|Extension Period|technical problems|0|||
144508443|NCT01636687|521060563|FG001|Extension Period|technical problems|1|||
144508444|NCT01636687|521060564|FG002|Extension Period|technical problems|2|||
144508445|NCT01636687|521060565|FG003|Extension Period|technical problems|1|||
144508446|NCT01636687|521060566|FG004|Extension Period|technical problems|0|||
144508447|NCT01636687|521060562|FG000|Extension Period|Adverse Event|4|||
144508448|NCT01636687|521060563|FG001|Extension Period|Adverse Event|3|||
144508449|NCT01636687|521060564|FG002|Extension Period|Adverse Event|2|||
144508450|NCT01636687|521060565|FG003|Extension Period|Adverse Event|1|||
144508451|NCT01636687|521060566|FG004|Extension Period|Adverse Event|0|||
144508452|NCT01636687|521060562|FG000|Extension Period|Lack of Efficacy|7|||
144508453|NCT01636687|521060563|FG001|Extension Period|Lack of Efficacy|0|||
144508454|NCT01636687|521060564|FG002|Extension Period|Lack of Efficacy|2|||
144508455|NCT01636687|521060565|FG003|Extension Period|Lack of Efficacy|1|||
144508456|NCT01636687|521060566|FG004|Extension Period|Lack of Efficacy|0|||
144508457|NCT01636687|521060562|FG000|Extension Period|Lost to Follow-up|1|||
144508458|NCT01636687|521060563|FG001|Extension Period|Lost to Follow-up|0|||
144508459|NCT01636687|521060564|FG002|Extension Period|Lost to Follow-up|1|||
144508460|NCT01636687|521060565|FG003|Extension Period|Lost to Follow-up|0|||
144508461|NCT01636687|521060566|FG004|Extension Period|Lost to Follow-up|0|||
144508462|NCT01636687|521060562|FG000|Extension Period|Physician Decision|1|||
144508463|NCT01636687|521060563|FG001|Extension Period|Physician Decision|0|||
144508464|NCT01636687|521060564|FG002|Extension Period|Physician Decision|0|||
144508465|NCT01636687|521060565|FG003|Extension Period|Physician Decision|1|||
144508466|NCT01636687|521060566|FG004|Extension Period|Physician Decision|0|||
144508467|NCT01636687|521060562|FG000|Extension Period|study terminated by sponsor|33|||
144508468|NCT01636687|521060563|FG001|Extension Period|study terminated by sponsor|50|||
144508469|NCT01636687|521060564|FG002|Extension Period|study terminated by sponsor|17|||
144508470|NCT01636687|521060565|FG003|Extension Period|study terminated by sponsor|23|||
144508471|NCT01636687|521060566|FG004|Extension Period|study terminated by sponsor|0|||
144508472|NCT01636687|521060562|FG000|Extension Period|Withdrawal by Subject|1|||
144508473|NCT01636687|521060563|FG001|Extension Period|Withdrawal by Subject|0|||
144508474|NCT01636687|521060564|FG002|Extension Period|Withdrawal by Subject|1|||
144508475|NCT01636687|521060565|FG003|Extension Period|Withdrawal by Subject|1|||
144508476|NCT01636687|521060566|FG004|Extension Period|Withdrawal by Subject|0|||
144508477|NCT01636687|521060562|FG000|Follow-up Period|Withdrawal by Subject|1|||
144508478|NCT01636687|521060563|FG001|Follow-up Period|Withdrawal by Subject|0|||
144508479|NCT01636687|521060564|FG002|Follow-up Period|Withdrawal by Subject|0|||
144508480|NCT01636687|521060565|FG003|Follow-up Period|Withdrawal by Subject|0|||
144508481|NCT01636687|521060566|FG004|Follow-up Period|Withdrawal by Subject|1|||
144508482|NCT02918279|521060569|FG000|Overall Study|Lost to Follow-up|3|||
144508483|NCT02918279|521060570|FG001|Overall Study|Lost to Follow-up|6|||
144508484|NCT02918279|521060569|FG000|Overall Study|Withdrawal by Subject|5|||
144508485|NCT02918279|521060570|FG001|Overall Study|Withdrawal by Subject|15|||
144508486|NCT02918279|521060569|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144508487|NCT02918279|521060570|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144588777|NCT00370331|521355716|FG001|Overall Study|Lack of Efficacy|1|||
144508488|NCT02918279|521060569|FG000|Overall Study|Other|3|||
144508489|NCT02918279|521060570|FG001|Overall Study|Other|1|||
144508490|NCT00636207|521060575|FG000|Overall Study|Adverse Event|1|||
144508491|NCT00636207|521060576|FG001|Overall Study|Adverse Event|0|||
144508492|NCT00636207|521060577|FG002|Overall Study|Adverse Event|0|||
144508493|NCT00636207|521060578|FG003|Overall Study|Adverse Event|0|||
144508494|NCT00636207|521060579|FG004|Overall Study|Adverse Event|0|||
144508495|NCT00636207|521060580|FG005|Overall Study|Adverse Event|0|||
144508496|NCT00636207|521060581|FG006|Overall Study|Adverse Event|0|||
144508497|NCT00636207|521060575|FG000|Overall Study|Withdrawal by Subject|0|||
144721681|NCT02173704|521835261|FG000|Overall Study|Lost to Follow-up|1|||
144508498|NCT00636207|521060576|FG001|Overall Study|Withdrawal by Subject|1|||
144508499|NCT00636207|521060577|FG002|Overall Study|Withdrawal by Subject|0|||
144508500|NCT00636207|521060578|FG003|Overall Study|Withdrawal by Subject|0|||
144508501|NCT00636207|521060579|FG004|Overall Study|Withdrawal by Subject|1|||
144508502|NCT00636207|521060580|FG005|Overall Study|Withdrawal by Subject|0|||
144508503|NCT00636207|521060581|FG006|Overall Study|Withdrawal by Subject|0|||
144508504|NCT01641198|521060582|FG000|After 12 Months of Function|Lost to Follow-up|3|||
144508505|NCT01641198|521060583|FG001|After 12 Months of Function|Lost to Follow-up|2|||
144508506|NCT01641198|521060584|FG002|After 12 Months of Function|Lost to Follow-up|2|||
144508507|NCT01641198|521060582|FG000|After 12 Months of Function|Protocol Violation|1|||
144508508|NCT01641198|521060583|FG001|After 12 Months of Function|Protocol Violation|0|||
144508509|NCT01641198|521060584|FG002|After 12 Months of Function|Protocol Violation|0|||
144508510|NCT01641198|521060582|FG000|After 12 Months of Function|Adverse Event|0|||
144508511|NCT01641198|521060583|FG001|After 12 Months of Function|Adverse Event|1|||
144508512|NCT01641198|521060584|FG002|After 12 Months of Function|Adverse Event|0|||
144508513|NCT01641198|521060582|FG000|After 24 Months of Function|Lost to Follow-up|4|||
144508514|NCT01641198|521060583|FG001|After 24 Months of Function|Lost to Follow-up|9|||
144508515|NCT01641198|521060584|FG002|After 24 Months of Function|Lost to Follow-up|6|||
144508516|NCT01641198|521060582|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
144508517|NCT01641198|521060583|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
144508518|NCT01641198|521060584|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
144508519|NCT01641198|521060582|FG000|At 15-20 Years of Function|Death|1|||
144508520|NCT01641198|521060583|FG001|At 15-20 Years of Function|Death|0|||
144508521|NCT01641198|521060584|FG002|At 15-20 Years of Function|Death|1|||
144508522|NCT02529995|521060586|FG000|Part A|Ongoing Study at Data Cut-off|14|||
144508523|NCT02529995|521060587|FG001|Part A|Ongoing Study at Data Cut-off|16|||
144508524|NCT02529995|521060586|FG000|Part A|Discontinued Study|1|||
144508525|NCT02529995|521060587|FG001|Part A|Discontinued Study|0|||
144508526|NCT02529995|521060586|FG000|Part B|Ongoing Study at Data Cut-off|0|||
144508527|NCT02529995|521060587|FG001|Part B|Ongoing Study at Data Cut-off|7|||
144508528|NCT02529995|521060586|FG000|Part B|Discontinued Study|6|||
144508529|NCT02529995|521060587|FG001|Part B|Discontinued Study|5|||
144508530|NCT00364013|521060592|FG000|Overall Study|Ineligibility determined|4|||
144508531|NCT00364013|521060593|FG001|Overall Study|Ineligibility determined|2|||
144508532|NCT00364013|521060592|FG000|Overall Study|Adverse Event|4|||
144508533|NCT00364013|521060593|FG001|Overall Study|Adverse Event|3|||
144508534|NCT00364013|521060592|FG000|Overall Study|Withdrawal by Subject|13|||
144508535|NCT00364013|521060593|FG001|Overall Study|Withdrawal by Subject|18|||
144508536|NCT00364013|521060592|FG000|Overall Study|Physician Decision|3|||
144508537|NCT00364013|521060593|FG001|Overall Study|Physician Decision|3|||
144508538|NCT00364013|521060592|FG000|Overall Study|Lost to Follow-up|10|||
144508539|NCT00364013|521060593|FG001|Overall Study|Lost to Follow-up|3|||
144508540|NCT00364013|521060592|FG000|Overall Study|Protocol-specified criteria|6|||
144508541|NCT00364013|521060593|FG001|Overall Study|Protocol-specified criteria|6|||
144508542|NCT00364013|521060592|FG000|Overall Study|Other|41|||
144508543|NCT00364013|521060593|FG001|Overall Study|Other|47|||
144508544|NCT00364013|521060592|FG000|Overall Study|Ongoing|20|||
144508545|NCT00364013|521060593|FG001|Overall Study|Ongoing|13|||
144508546|NCT01369498|521060598|FG000|Overall Study|Lack of Efficacy|9|||
144508547|NCT01369498|521060599|FG001|Overall Study|Lack of Efficacy|9|||
144508548|NCT01369498|521060600|FG002|Overall Study|Lack of Efficacy|1|||
144508549|NCT01369498|521060601|FG003|Overall Study|Lack of Efficacy|3|||
144508550|NCT01369498|521060598|FG000|Overall Study|Adverse Event|1|||
144508551|NCT01369498|521060599|FG001|Overall Study|Adverse Event|2|||
144508552|NCT01369498|521060600|FG002|Overall Study|Adverse Event|0|||
144508553|NCT01369498|521060601|FG003|Overall Study|Adverse Event|1|||
144508554|NCT01369498|521060598|FG000|Overall Study|Withdrawal of Consent|0|||
144508555|NCT01369498|521060599|FG001|Overall Study|Withdrawal of Consent|1|||
144508556|NCT01369498|521060600|FG002|Overall Study|Withdrawal of Consent|1|||
144508557|NCT01369498|521060601|FG003|Overall Study|Withdrawal of Consent|1|||
144508558|NCT01369498|521060598|FG000|Overall Study|Death|0|||
144508559|NCT01369498|521060599|FG001|Overall Study|Death|0|||
144508560|NCT01369498|521060600|FG002|Overall Study|Death|1|||
144508561|NCT01369498|521060601|FG003|Overall Study|Death|0|||
144508562|NCT01369498|521060598|FG000|Overall Study|Investigator's Discretion|1|||
144508563|NCT01369498|521060599|FG001|Overall Study|Investigator's Discretion|0|||
144508564|NCT01369498|521060600|FG002|Overall Study|Investigator's Discretion|1|||
144508565|NCT01369498|521060601|FG003|Overall Study|Investigator's Discretion|3|||
144508566|NCT01369498|521060598|FG000|Overall Study|Unknown Reason|1|||
144508567|NCT01369498|521060599|FG001|Overall Study|Unknown Reason|0|||
144508568|NCT01369498|521060600|FG002|Overall Study|Unknown Reason|11|||
144508569|NCT01369498|521060601|FG003|Overall Study|Unknown Reason|6|||
144508570|NCT01369498|521060598|FG000|Overall Study|Disease Progression|0|||
144508571|NCT01369498|521060599|FG001|Overall Study|Disease Progression|0|||
144508572|NCT01369498|521060600|FG002|Overall Study|Disease Progression|0|||
144508573|NCT01369498|521060601|FG003|Overall Study|Disease Progression|1|||
144508574|NCT01444417|521060604|FG000|Overall Study|Ineligibility Determined|0|||
144588778|NCT00370331|521355715|FG000|Overall Study|Non-compliance|0|||
144588779|NCT00370331|521355716|FG001|Overall Study|Non-compliance|1|||
144588780|NCT00370331|521355715|FG000|Overall Study|Protocol Violation|1|||
144588781|NCT00370331|521355716|FG001|Overall Study|Protocol Violation|1|||
144588782|NCT00545051|521355717|FG000|Overall Study|Adverse Event|7|||
144588783|NCT00545051|521355718|FG001|Overall Study|Adverse Event|3|||
144588784|NCT00545051|521355717|FG000|Overall Study|Death|1|||
144588785|NCT00545051|521355718|FG001|Overall Study|Death|0|||
144588786|NCT00545051|521355717|FG000|Overall Study|Violation of inclusion/exclusion|0|||
144588787|NCT00545051|521355718|FG001|Overall Study|Violation of inclusion/exclusion|2|||
144588788|NCT00545051|521355717|FG000|Overall Study|Protocol Violation|1|||
144588789|NCT00545051|521355718|FG001|Overall Study|Protocol Violation|0|||
144588790|NCT00545051|521355717|FG000|Overall Study|Withdrawal by Subject|0|||
144588791|NCT00545051|521355718|FG001|Overall Study|Withdrawal by Subject|1|||
144588792|NCT00545051|521355717|FG000|Overall Study|Administrative reasons|0|||
144588793|NCT00545051|521355718|FG001|Overall Study|Administrative reasons|1|||
144588794|NCT03271021|521355720|FG000|Overall Study|Adverse Event|3|||
144588795|NCT03271021|521355721|FG001|Overall Study|Adverse Event|2|||
144588796|NCT03271021|521355720|FG000|Overall Study|Withdrawal by Subject|36|||
144588797|NCT03271021|521355721|FG001|Overall Study|Withdrawal by Subject|53|||
144588798|NCT03271021|521355720|FG000|Overall Study|Lost to Follow-up|34|||
144588799|NCT03271021|521355721|FG001|Overall Study|Lost to Follow-up|39|||
144588800|NCT03271021|521355720|FG000|Overall Study|Protocol Violation|6|||
144588801|NCT03271021|521355721|FG001|Overall Study|Protocol Violation|4|||
144588802|NCT03271021|521355720|FG000|Overall Study|Abnormal Lab Results|1|||
144588803|NCT03271021|521355721|FG001|Overall Study|Abnormal Lab Results|0|||
144588804|NCT03271021|521355720|FG000|Overall Study|Miscellaneous|9|||
144588805|NCT03271021|521355721|FG001|Overall Study|Miscellaneous|8|||
144588806|NCT01474434|521355722|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
144588807|NCT01474434|521355723|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
144588808|NCT01474434|521355724|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
144588809|NCT01474434|521355725|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
144588810|NCT01474434|521355722|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
144588811|NCT01474434|521355723|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
144588812|NCT01474434|521355724|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
144588813|NCT01474434|521355725|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
144588814|NCT01474434|521355722|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
144588815|NCT01474434|521355723|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
144588816|NCT01474434|521355724|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
144588817|NCT01474434|521355725|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
144371131|NCT05307692|520566017|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
144588818|NCT02207569|521355729|FG000|1-Month|Death|6|||
144588819|NCT02207569|521355729|FG000|1-Month|Withdrawal by Subject|2|||
144588820|NCT02207569|521355729|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
144371132|NCT05307692|520566014|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
144371133|NCT05307692|520566015|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
144371134|NCT05307692|520566016|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
144371135|NCT05307692|520566017|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
144371136|NCT05307692|520566014|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
144371137|NCT05307692|520566015|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
144371138|NCT05307692|520566016|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
144371139|NCT05307692|520566017|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
144371140|NCT05307692|520566014|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
144371141|NCT05307692|520566015|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
144371142|NCT05307692|520566016|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
144371143|NCT05307692|520566017|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
144371144|NCT04500158|520566018|FG000|Overall Study|Physician Decision|17|||
144371145|NCT04500158|520566019|FG001|Overall Study|Physician Decision|11|||
144371146|NCT03493464|520566024|FG000|Overall Study|Surgery not performed|1|||
144371147|NCT04774094|520566030|FG000|Overall Study|Other|2|||
144371148|NCT04774094|520566030|FG000|Overall Study|Withdrawal by Subject|9|||
144371149|NCT04774094|520566030|FG000|Overall Study|Lost to Follow-up|7|||
144371150|NCT04774094|520566030|FG000|Overall Study|Lack of Efficacy|5|||
144371151|NCT04774094|520566030|FG000|Overall Study|Death|17|||
144588821|NCT02207569|521355729|FG000|6-Month|Death|8|||
144588822|NCT02207569|521355729|FG000|6-Month|Withdrawal by Subject|2|||
144371152|NCT04774094|520566030|FG000|Overall Study|Adverse Event|4|||
144371153|NCT05232682|520566033|FG000|Overall Study|Lost to Follow-up|2|||
144588823|NCT02207569|521355729|FG000|12-Month|Death|14|||
144588824|NCT02207569|521355729|FG000|12-Month|Withdrawal by Subject|2|||
144588825|NCT02207569|521355729|FG000|24-Month|Death|23|||
144588826|NCT02207569|521355729|FG000|24-Month|Withdrawal by Subject|3|||
144588827|NCT02207569|521355729|FG000|36-Month|Death|23|||
144588828|NCT02207569|521355729|FG000|36-Month|Withdrawal by Subject|4|||
144588829|NCT02207569|521355729|FG000|48-Month|Death|25|||
144588830|NCT02207569|521355729|FG000|48-Month|Withdrawal by Subject|2|||
144588831|NCT02207569|521355729|FG000|48-Month|Lost to Follow-up|4|||
144588832|NCT02207569|521355729|FG000|60-Month|Death|1|||
144588833|NCT02207569|521355729|FG000|60-Month|Lost to Follow-up|1|||
144588834|NCT02207569|521355729|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
144588835|NCT02207569|521355729|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
144588836|NCT00495586|521355730|FG000|Overall Study|Withdrawal by Subject|4|||
144588837|NCT00495586|521355731|FG001|Overall Study|Withdrawal by Subject|4|||
144588838|NCT02038543|521355732|FG000|Overall Study|Screen Failure|0|||
144588839|NCT02038543|521355733|FG001|Overall Study|Screen Failure|0|||
144588840|NCT02038543|521355734|FG002|Overall Study|Screen Failure|0|||
144588841|NCT02038543|521355735|FG003|Overall Study|Screen Failure|1|||
144588842|NCT02038543|521355732|FG000|Overall Study|Withdrawal by Subject|0|||
144588843|NCT02038543|521355733|FG001|Overall Study|Withdrawal by Subject|0|||
144588844|NCT02038543|521355734|FG002|Overall Study|Withdrawal by Subject|0|||
144588845|NCT02038543|521355735|FG003|Overall Study|Withdrawal by Subject|1|||
144588846|NCT03618823|521355736|FG000|Overall Study|Lost to Follow-up|63|||
144588847|NCT03618823|521355737|FG001|Overall Study|Lost to Follow-up|61|||
144588848|NCT02292927|521355740|FG000|Overall Study|Protocol Violation|13|||
144588849|NCT02292927|521355741|FG001|Overall Study|Protocol Violation|7|||
144588850|NCT01656733|521355745|FG000|Overall Study|No permission to collect birth outcomes|0|||
144588851|NCT01656733|521355746|FG001|Overall Study|No permission to collect birth outcomes|1|||
144588852|NCT01656733|521355745|FG000|Overall Study|Delivery at another hospital|0|||
144588853|NCT01656733|521355746|FG001|Overall Study|Delivery at another hospital|2|||
144588854|NCT01656733|521355745|FG000|Overall Study|Spontaneous abortion|0|||
144588855|NCT01656733|521355746|FG001|Overall Study|Spontaneous abortion|1|||
144588856|NCT01506609|521355748|FG000|Overall Study|Adverse Event Related to Progression|0|||
144588857|NCT01506609|521355749|FG001|Overall Study|Adverse Event Related to Progression|0|||
144588858|NCT01506609|521355750|FG002|Overall Study|Adverse Event Related to Progression|0|||
144588859|NCT01506609|521355751|FG003|Overall Study|Adverse Event Related to Progression|3|||
144508575|NCT01444417|521060605|FG001|Overall Study|Ineligibility Determined|1|||
144508576|NCT01444417|521060604|FG000|Overall Study|Withdrawal by Subject|2|||
144508577|NCT01444417|521060605|FG001|Overall Study|Withdrawal by Subject|0|||
144508578|NCT02423798|521060607|FG000|Overall Study|Withdrawal by Subject|3|||
144508579|NCT02261467|521060608|FG000|Overall Study|Enrolled in Error|1|||
144508580|NCT02261467|521060609|FG001|Overall Study|Enrolled in Error|0|||
144508581|NCT02261467|521060608|FG000|Overall Study|Protocol Violation|0|||
144508582|NCT02261467|521060609|FG001|Overall Study|Protocol Violation|1|||
144508583|NCT02261467|521060608|FG000|Overall Study|Personal Reasons|17|||
144508584|NCT02261467|521060609|FG001|Overall Study|Personal Reasons|22|||
144508585|NCT02261467|521060608|FG000|Overall Study|Lost to Follow-up|2|||
144508586|NCT02261467|521060609|FG001|Overall Study|Lost to Follow-up|13|||
144508587|NCT02261467|521060608|FG000|Overall Study|Adverse Event|1|||
144508588|NCT02261467|521060609|FG001|Overall Study|Adverse Event|1|||
144508589|NCT00357097|521060612|FG000|Overall Study|Did not meet inclusion criteria|5|||
144508590|NCT00357097|521060613|FG001|Overall Study|Did not meet inclusion criteria|3|||
144508591|NCT00357097|521060612|FG000|Overall Study|Adverse Event|34|||
144508592|NCT00357097|521060613|FG001|Overall Study|Adverse Event|6|||
144508593|NCT00357097|521060612|FG000|Overall Study|Withdrawal by Subject|8|||
144508594|NCT00357097|521060613|FG001|Overall Study|Withdrawal by Subject|7|||
144508595|NCT00357097|521060612|FG000|Overall Study|Non-compliance|1|||
144508596|NCT00357097|521060613|FG001|Overall Study|Non-compliance|2|||
144508597|NCT00357097|521060612|FG000|Overall Study|Lack of Efficacy|2|||
144508598|NCT00357097|521060613|FG001|Overall Study|Lack of Efficacy|8|||
144508599|NCT00357097|521060612|FG000|Overall Study|Met Exclusion Criteria|3|||
144508600|NCT00357097|521060613|FG001|Overall Study|Met Exclusion Criteria|1|||
144508601|NCT00357097|521060612|FG000|Overall Study|Other|1|||
144508602|NCT00357097|521060613|FG001|Overall Study|Other|1|||
144508603|NCT00357097|521060612|FG000|Overall Study|Increase of RLS Symptoms|0|||
144508604|NCT00357097|521060613|FG001|Overall Study|Increase of RLS Symptoms|1|||
144508605|NCT00794118|521060614|FG000|Overall Study|Lost to Follow-up|16|||
144588860|NCT01506609|521355752|FG004|Overall Study|Adverse Event Related to Progression|7|||
144508606|NCT00794118|521060614|FG000|Overall Study|Withdrawal by Subject|9|||
144508607|NCT00794118|521060614|FG000|Overall Study|Changed hospital center|2|||
144508608|NCT00837616|521060617|FG000|Overall Study|Withdrawal by Subject|0|||
144508609|NCT00837616|521060618|FG001|Overall Study|Withdrawal by Subject|1|||
144508610|NCT01685606|521060625|FG000|Overall Study|Withdrawal by Subject|1|||
144508611|NCT01597258|521060626|FG000|Overall Study|No Drug Administration|1|||
144508612|NCT01199705|521060627|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
144508613|NCT01415349|521060628|FG000|Treatment Period 1|Adverse Event|0|||
144588861|NCT01506609|521355753|FG005|Overall Study|Adverse Event Related to Progression|3|||
144588862|NCT01506609|521355748|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
144588863|NCT01506609|521355749|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
144588864|NCT01506609|521355750|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
144588865|NCT01506609|521355751|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
144588866|NCT01506609|521355752|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
144508614|NCT01415349|521060629|FG001|Treatment Period 1|Adverse Event|1|||
144508615|NCT01415349|521060628|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144508616|NCT01415349|521060629|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144588867|NCT01506609|521355753|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
144588868|NCT01506609|521355748|FG000|Overall Study|Withdrawal by Subject|0|||
144588869|NCT01506609|521355749|FG001|Overall Study|Withdrawal by Subject|0|||
144588870|NCT01506609|521355750|FG002|Overall Study|Withdrawal by Subject|0|||
144588871|NCT01506609|521355751|FG003|Overall Study|Withdrawal by Subject|9|||
144588872|NCT01506609|521355752|FG004|Overall Study|Withdrawal by Subject|7|||
144588873|NCT01506609|521355753|FG005|Overall Study|Withdrawal by Subject|7|||
144588874|NCT01506609|521355748|FG000|Overall Study|Lost to Follow-up|0|||
144588875|NCT01506609|521355749|FG001|Overall Study|Lost to Follow-up|0|||
144588876|NCT01506609|521355750|FG002|Overall Study|Lost to Follow-up|0|||
144588877|NCT01506609|521355751|FG003|Overall Study|Lost to Follow-up|1|||
144588878|NCT01506609|521355752|FG004|Overall Study|Lost to Follow-up|2|||
144588879|NCT01506609|521355753|FG005|Overall Study|Lost to Follow-up|0|||
144588880|NCT01506609|521355748|FG000|Overall Study|Sponsor Discontinued Study|0|||
144588881|NCT01506609|521355749|FG001|Overall Study|Sponsor Discontinued Study|0|||
144588882|NCT01506609|521355750|FG002|Overall Study|Sponsor Discontinued Study|0|||
144588883|NCT01506609|521355751|FG003|Overall Study|Sponsor Discontinued Study|2|||
144588884|NCT01506609|521355752|FG004|Overall Study|Sponsor Discontinued Study|2|||
144508617|NCT00933400|521060630|FG000|Overall Study|Withdrawal by Subject|21|||
144508618|NCT00933400|521060631|FG001|Overall Study|Withdrawal by Subject|1|||
144508619|NCT01041417|521060632|FG000|Overall Study|Adverse Event|5|||
144508620|NCT01041417|521060633|FG001|Overall Study|Adverse Event|2|||
144508621|NCT01041417|521060632|FG000|Overall Study|Lost to Follow-up|1|||
144508622|NCT01041417|521060633|FG001|Overall Study|Lost to Follow-up|1|||
144508623|NCT01041417|521060632|FG000|Overall Study|Death|1|||
144508624|NCT01041417|521060633|FG001|Overall Study|Death|0|||
144508625|NCT01764464|521060634|FG000|First Intervention|Withdrawal by Subject|1|||
144508626|NCT01764464|521060635|FG001|First Intervention|Withdrawal by Subject|0|||
144508627|NCT01764464|521060634|FG000|First Intervention|Lost to Follow-up|1|||
144508628|NCT01764464|521060635|FG001|First Intervention|Lost to Follow-up|0|||
144508629|NCT01764464|521060634|FG000|First Intervention|Adverse Event|0|||
144508630|NCT01764464|521060635|FG001|First Intervention|Adverse Event|2|||
144508631|NCT01764464|521060634|FG000|First Intervention|did not receive study drug|0|||
144508632|NCT01764464|521060635|FG001|First Intervention|did not receive study drug|1|||
144508633|NCT01764464|521060634|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
144508634|NCT01764464|521060635|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
144508635|NCT03473340|521060636|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
144508636|NCT03473340|521060637|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
144508637|NCT03473340|521060636|FG000|Overall Study|Withdrawal by Subject|1|||
144508638|NCT03473340|521060637|FG001|Overall Study|Withdrawal by Subject|0|||
144508639|NCT03473340|521060636|FG000|Overall Study|Lost to Follow-up|1|||
144508640|NCT03473340|521060637|FG001|Overall Study|Lost to Follow-up|2|||
144508641|NCT02079844|521060638|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
144508642|NCT02079844|521060639|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
144508643|NCT02079844|521060640|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
144508644|NCT02079844|521060638|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
144508645|NCT02079844|521060639|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
144508646|NCT02079844|521060640|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
144508647|NCT00203411|521060641|FG000|Follow-up|Progressive Disease|4|||
144508648|NCT04980755|521060642|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
144508649|NCT04980755|521060642|FG000|Body Reprogramming Courses|Work commitment|2|||
144508650|NCT04980755|521060642|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
144508651|NCT04980755|521060642|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
144508652|NCT01212991|521060643|FG000|Double-blind|Lost to Follow-up|8|||
144508653|NCT01212991|521060644|FG001|Double-blind|Lost to Follow-up|4|||
144508654|NCT01212991|521060645|FG002|Double-blind|Lost to Follow-up|0|||
144508655|NCT01212991|521060643|FG000|Double-blind|Death|699|||
144508656|NCT01212991|521060644|FG001|Double-blind|Death|550|||
144508657|NCT01212991|521060645|FG002|Double-blind|Death|0|||
144721682|NCT02173704|521835262|FG001|Overall Study|Lost to Follow-up|0|||
144508658|NCT01212991|521060643|FG000|Double-blind|Withdrawal by Subject|16|||
144508659|NCT01212991|521060644|FG001|Double-blind|Withdrawal by Subject|19|||
144508660|NCT01212991|521060645|FG002|Double-blind|Withdrawal by Subject|0|||
144508661|NCT01212991|521060643|FG000|Double-blind|Other|7|||
144508662|NCT01212991|521060644|FG001|Double-blind|Other|0|||
144508663|NCT01212991|521060645|FG002|Double-blind|Other|0|||
144508664|NCT01212991|521060643|FG000|Double-blind|Sponsor decision|142|||
144508665|NCT01212991|521060644|FG001|Double-blind|Sponsor decision|38|||
144588885|NCT01506609|521355753|FG005|Overall Study|Sponsor Discontinued Study|0|||
144588886|NCT01506609|521355748|FG000|Overall Study|Progressive Disease per Protocol|1|||
144588887|NCT01506609|521355749|FG001|Overall Study|Progressive Disease per Protocol|0|||
144588888|NCT01506609|521355750|FG002|Overall Study|Progressive Disease per Protocol|0|||
144508666|NCT01212991|521060645|FG002|Double-blind|Sponsor decision|0|||
144508667|NCT01212991|521060643|FG000|Open-label|Death|0|||
144508668|NCT01212991|521060644|FG001|Open-label|Death|0|||
144508669|NCT01212991|521060645|FG002|Open-label|Death|166|||
144508670|NCT01212991|521060643|FG000|Open-label|Lost to Follow-up|0|||
144508671|NCT01212991|521060644|FG001|Open-label|Lost to Follow-up|0|||
144508672|NCT01212991|521060645|FG002|Open-label|Lost to Follow-up|5|||
144508673|NCT01212991|521060643|FG000|Open-label|Withdrawal by Subject|0|||
144508674|NCT01212991|521060644|FG001|Open-label|Withdrawal by Subject|0|||
144508675|NCT01212991|521060645|FG002|Open-label|Withdrawal by Subject|7|||
144508676|NCT01212991|521060643|FG000|Open-label|Sponsor decision|0|||
144508677|NCT01212991|521060644|FG001|Open-label|Sponsor decision|0|||
144508678|NCT01212991|521060645|FG002|Open-label|Sponsor decision|53|||
144508679|NCT01212991|521060643|FG000|Open-label|Other|0|||
144508680|NCT01212991|521060644|FG001|Open-label|Other|0|||
144508681|NCT01212991|521060645|FG002|Open-label|Other|3|||
144508682|NCT02531113|521060648|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
144508683|NCT02531113|521060648|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
144508684|NCT02531113|521060648|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
144508685|NCT02531113|521060648|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
144508686|NCT02531113|521060648|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
144508687|NCT02531113|521060648|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
144508688|NCT02531113|521060648|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
144508689|NCT02531113|521060648|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
144508690|NCT02763319|521062126|FG000|Overall Study|Adverse Event|12|||
144508691|NCT02763319|521062127|FG001|Overall Study|Adverse Event|3|||
144508692|NCT02763319|521062126|FG000|Overall Study|Death|123|||
144508693|NCT02763319|521062127|FG001|Overall Study|Death|123|||
144508694|NCT02763319|521062126|FG000|Overall Study|Lost to Follow-up|6|||
144508695|NCT02763319|521062127|FG001|Overall Study|Lost to Follow-up|7|||
144508696|NCT02763319|521062126|FG000|Overall Study|Noncompliance with Study Drug|2|||
144588889|NCT01506609|521355751|FG003|Overall Study|Progressive Disease per Protocol|64|||
144588890|NCT01506609|521355752|FG004|Overall Study|Progressive Disease per Protocol|57|||
144588891|NCT01506609|521355753|FG005|Overall Study|Progressive Disease per Protocol|74|||
144508697|NCT02763319|521062127|FG001|Overall Study|Noncompliance with Study Drug|0|||
144508698|NCT02763319|521062126|FG000|Overall Study|"Captured as Other in Database"|29|||
144508699|NCT02763319|521062127|FG001|Overall Study|"Captured as Other in Database"|34|||
144508700|NCT02763319|521062126|FG000|Overall Study|Physician Decision|1|||
144508701|NCT02763319|521062127|FG001|Overall Study|Physician Decision|7|||
144508702|NCT02763319|521062126|FG000|Overall Study|Progressive Disease|24|||
144508703|NCT02763319|521062127|FG001|Overall Study|Progressive Disease|27|||
144508704|NCT02763319|521062126|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
144508705|NCT02763319|521062127|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
144508706|NCT02763319|521062126|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
144508707|NCT02763319|521062127|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
144508708|NCT02763319|521062126|FG000|Overall Study|Withdrawal by Subject|26|||
144508709|NCT02763319|521062127|FG001|Overall Study|Withdrawal by Subject|25|||
144508710|NCT03936660|521062129|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
144508711|NCT03936660|521062130|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
144508712|NCT01875848|521062134|FG000|Overall Study|Withdrawal by Subject|2|||
144508713|NCT01875848|521062135|FG001|Overall Study|Withdrawal by Subject|0|||
144508714|NCT02407249|521062136|FG000|Overall Study|Did not complete 12-month follow-up|13|||
144508715|NCT02407249|521062136|FG000|Overall Study|Not treated|13|||
144508716|NCT00840177|521062137|FG000|Overall Study|Adverse Event|5|||
144508717|NCT00840177|521062138|FG001|Overall Study|Adverse Event|1|||
144508718|NCT00840177|521062139|FG002|Overall Study|Adverse Event|1|||
144508719|NCT00840177|521062137|FG000|Overall Study|Refusal unrelated to adverse events|1|||
144508720|NCT00840177|521062138|FG001|Overall Study|Refusal unrelated to adverse events|0|||
144508721|NCT00840177|521062139|FG002|Overall Study|Refusal unrelated to adverse events|1|||
144508722|NCT00840177|521062137|FG000|Overall Study|Progression/relapse|2|||
144508723|NCT00840177|521062138|FG001|Overall Study|Progression/relapse|0|||
144508724|NCT00840177|521062139|FG002|Overall Study|Progression/relapse|0|||
144588892|NCT01506609|521355748|FG000|Overall Study|Other, Not Specified|0|||
144588893|NCT01506609|521355749|FG001|Overall Study|Other, Not Specified|0|||
144588894|NCT01506609|521355750|FG002|Overall Study|Other, Not Specified|0|||
144508725|NCT00840177|521062137|FG000|Overall Study|Death|4|||
144508726|NCT00840177|521062138|FG001|Overall Study|Death|5|||
144508727|NCT00840177|521062139|FG002|Overall Study|Death|5|||
144508728|NCT00840177|521062137|FG000|Overall Study|not protocol specified|6|||
144508729|NCT00840177|521062138|FG001|Overall Study|not protocol specified|3|||
144588895|NCT01506609|521355751|FG003|Overall Study|Other, Not Specified|10|||
144721683|NCT02173704|521835261|FG000|Overall Study|Other|1|||
144508730|NCT00840177|521062139|FG002|Overall Study|not protocol specified|0|||
144508731|NCT00840177|521062137|FG000|Overall Study|Ineligible|0|||
144508732|NCT00840177|521062138|FG001|Overall Study|Ineligible|0|||
144508733|NCT00840177|521062139|FG002|Overall Study|Ineligible|3|||
144508734|NCT00840177|521062137|FG000|Overall Study|Did not start treatment|0|||
144508735|NCT00840177|521062138|FG001|Overall Study|Did not start treatment|0|||
144508736|NCT00840177|521062139|FG002|Overall Study|Did not start treatment|1|||
144508737|NCT01571596|521062143|FG000|Overall Study|Adverse Event|2|||
144508738|NCT01571596|521062144|FG001|Overall Study|Adverse Event|0|||
144508739|NCT01571596|521062145|FG002|Overall Study|Adverse Event|0|||
144508740|NCT01571596|521062143|FG000|Overall Study|Study Terminated by the Sponsor|0|||
144508741|NCT01571596|521062144|FG001|Overall Study|Study Terminated by the Sponsor|1|||
144508742|NCT01571596|521062145|FG002|Overall Study|Study Terminated by the Sponsor|1|||
144508743|NCT00434304|521062146|FG000|Overall Study|Adverse Event|14|||
144508744|NCT00434304|521062146|FG000|Overall Study|Lack of Efficacy|2|||
144508745|NCT00434304|521062146|FG000|Overall Study|Withdrawal by Subject|4|||
144508746|NCT05262738|521062147|FG000|Overall Study|Withdrawal by Subject|1|||
144508747|NCT05262738|521062148|FG001|Overall Study|Withdrawal by Subject|0|||
144508748|NCT02374463|521062151|FG000|Overall Study|Withdrawal by Subject|3|||
144508749|NCT02374463|521062152|FG001|Overall Study|Withdrawal by Subject|3|||
144508750|NCT00077675|521062162|FG000|Overall Study|Adverse Event|1|||
144508751|NCT00077675|521062163|FG001|Overall Study|Adverse Event|2|||
144508752|NCT00077675|521062162|FG000|Overall Study|Lost to Follow-up|6|||
144508753|NCT00077675|521062163|FG001|Overall Study|Lost to Follow-up|3|||
144508754|NCT00077675|521062162|FG000|Overall Study|Withdrawal by Subject|1|||
144508755|NCT00077675|521062163|FG001|Overall Study|Withdrawal by Subject|0|||
144508756|NCT00077675|521062162|FG000|Overall Study|Other|0|||
144508757|NCT00077675|521062163|FG001|Overall Study|Other|1|||
144508758|NCT00077675|521062162|FG000|Overall Study|Never received study treatment|3|||
144508759|NCT00077675|521062163|FG001|Overall Study|Never received study treatment|3|||
144508760|NCT02601820|521062164|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
144508761|NCT02601820|521062164|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
144508762|NCT02601820|521062164|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
144508763|NCT02601820|521062164|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
144508764|NCT01599793|521062165|FG000|Overall Study|Adverse Event|2|||
144508765|NCT00391898|521062172|FG000|Overall Study|Adverse Event|3|||
144508766|NCT00391898|521062173|FG001|Overall Study|Adverse Event|0|||
144508767|NCT00391898|521062172|FG000|Overall Study|Other|8|||
144508768|NCT00391898|521062173|FG001|Overall Study|Other|10|||
144508769|NCT00244855|521062176|FG000|Overall Study|Withdrawal by Subject|0|||
144508770|NCT00244855|521062177|FG001|Overall Study|Withdrawal by Subject|1|||
144508771|NCT00869258|521062178|FG000|Overall Study|Physician Decision|1|||
144508772|NCT01236001|521062179|FG000|Overall Study|Adverse Event|5|||
144508773|NCT01236001|521062180|FG001|Overall Study|Adverse Event|14|||
144508774|NCT01236001|521062179|FG000|Overall Study|Lack of Efficacy|6|||
144508775|NCT01236001|521062180|FG001|Overall Study|Lack of Efficacy|6|||
144508776|NCT01236001|521062179|FG000|Overall Study|Lost to Follow-up|6|||
144508777|NCT01236001|521062180|FG001|Overall Study|Lost to Follow-up|1|||
144508778|NCT01236001|521062179|FG000|Overall Study|Incompliance|1|||
144508779|NCT01236001|521062180|FG001|Overall Study|Incompliance|0|||
144508780|NCT01236001|521062179|FG000|Overall Study|Planned Visit After End of Study|0|||
144508781|NCT01236001|521062180|FG001|Overall Study|Planned Visit After End of Study|1|||
144508782|NCT03451721|521062183|FG000|Overall Study|Death|1|||
144508783|NCT00960141|521062184|FG000|Overall Study|Adverse Event|4|||
144508784|NCT00960141|521062185|FG001|Overall Study|Adverse Event|8|||
144508785|NCT00960141|521062186|FG002|Overall Study|Adverse Event|2|||
144508786|NCT00960141|521062184|FG000|Overall Study|Lack of Efficacy|3|||
144508787|NCT00960141|521062185|FG001|Overall Study|Lack of Efficacy|4|||
144508788|NCT00960141|521062186|FG002|Overall Study|Lack of Efficacy|2|||
144508789|NCT00960141|521062184|FG000|Overall Study|Lost to Follow-up|1|||
144508790|NCT00960141|521062185|FG001|Overall Study|Lost to Follow-up|0|||
144508791|NCT00960141|521062186|FG002|Overall Study|Lost to Follow-up|0|||
144508792|NCT00960141|521062184|FG000|Overall Study|Protocol Violation|1|||
144508793|NCT00960141|521062185|FG001|Overall Study|Protocol Violation|3|||
144508794|NCT00960141|521062186|FG002|Overall Study|Protocol Violation|2|||
144508795|NCT00960141|521062184|FG000|Overall Study|Withdrawal by Subject|1|||
144508796|NCT00960141|521062185|FG001|Overall Study|Withdrawal by Subject|2|||
144721684|NCT02173704|521835262|FG001|Overall Study|Other|0|||
144508797|NCT00960141|521062186|FG002|Overall Study|Withdrawal by Subject|1|||
144508798|NCT00939510|521062187|FG000|Overall Study|Withdrawal by Subject|1|||
144508799|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
144508800|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
144508801|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
144508802|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
144508803|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
144508804|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
144508805|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
144508806|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
144508807|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
144508808|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
144508809|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
144508810|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
144508811|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
144508812|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
144508813|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
144508814|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
144508815|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
144508816|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
144508817|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
144508818|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
144508819|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
144508820|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
144508821|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
144508822|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
144508823|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508824|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
144508825|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508826|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508827|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508828|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508829|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508830|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
144508831|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
144508832|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
144508833|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
144508834|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
144508835|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
144508836|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
144508837|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
144508838|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
144508839|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508840|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508841|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508842|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
144508843|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508844|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508845|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508846|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
144508847|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
144508848|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
144508849|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
144508850|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
144508851|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
144508852|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
144508853|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
144508854|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
144508855|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
144508856|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
144508857|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
144508858|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
144508859|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
144508860|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
144508861|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
144508862|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
144508863|NCT03903822|521062190|FG000|Treatment Phase (6 Weeks)|Other|2|||
144508864|NCT03903822|521062191|FG001|Treatment Phase (6 Weeks)|Other|1|||
144508865|NCT03903822|521062192|FG002|Treatment Phase (6 Weeks)|Other|0|||
144508866|NCT03903822|521062193|FG003|Treatment Phase (6 Weeks)|Other|0|||
144508867|NCT03903822|521062194|FG004|Treatment Phase (6 Weeks)|Other|1|||
144508868|NCT03903822|521062195|FG005|Treatment Phase (6 Weeks)|Other|1|||
144508869|NCT03903822|521062196|FG006|Treatment Phase (6 Weeks)|Other|0|||
144508870|NCT03903822|521062197|FG007|Treatment Phase (6 Weeks)|Other|0|||
144508871|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
144508872|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
144508873|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
144508874|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
144508875|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
144508876|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
144508877|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
144508878|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
144508879|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144508880|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144588896|NCT01506609|521355752|FG004|Overall Study|Other, Not Specified|7|||
144588897|NCT01506609|521355753|FG005|Overall Study|Other, Not Specified|3|||
144588898|NCT01506609|521355748|FG000|Overall Study|Missing / Unknown Reason|1|||
144588899|NCT01506609|521355749|FG001|Overall Study|Missing / Unknown Reason|0|||
144588900|NCT01506609|521355750|FG002|Overall Study|Missing / Unknown Reason|1|||
144588901|NCT01506609|521355751|FG003|Overall Study|Missing / Unknown Reason|4|||
144588902|NCT01506609|521355752|FG004|Overall Study|Missing / Unknown Reason|4|||
144588903|NCT01506609|521355753|FG005|Overall Study|Missing / Unknown Reason|2|||
144588904|NCT02595073|521355756|FG000|Overall Study|Progressive Disease|0|||
144588905|NCT02595073|521355757|FG001|Overall Study|Progressive Disease|1|||
144588906|NCT02595073|521355756|FG000|Overall Study|Protocol Violation|2|||
144588907|NCT02595073|521355757|FG001|Overall Study|Protocol Violation|0|||
144588908|NCT01990560|521355758|FG000|Overall Study|Withdrawal by Subject|1|||
144588909|NCT01324440|521355764|FG000|Overall Study|Subject moved|0|||
144588910|NCT01324440|521355765|FG001|Overall Study|Subject moved|1|||
144588911|NCT02054741|521355766|FG000|Overall Study|Protocol Violation|13|||
144588912|NCT02054741|521355767|FG001|Overall Study|Protocol Violation|2|||
144588913|NCT02054741|521355766|FG000|Overall Study|Withdrawal by Subject|10|||
144508881|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144508882|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144508883|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
144508884|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144508885|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144508886|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
144508887|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
144508888|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
144508889|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
144508890|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
144508891|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
144508892|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
144508893|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
144508894|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
144508895|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
144508896|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
144508897|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
144508898|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
144508899|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
144508900|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
144508901|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
144508902|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
144508903|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
144508904|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
144508905|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
144508906|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
144508907|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
144508908|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
144508909|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
144508910|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
144508911|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508912|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508913|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508914|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508915|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508916|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
144508917|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508918|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
144508919|NCT03903822|521062190|FG000|Follow up Phase (4 Weeks)|Other|1|||
144508920|NCT03903822|521062191|FG001|Follow up Phase (4 Weeks)|Other|1|||
144508921|NCT03903822|521062192|FG002|Follow up Phase (4 Weeks)|Other|0|||
144508922|NCT03903822|521062193|FG003|Follow up Phase (4 Weeks)|Other|0|||
144508923|NCT03903822|521062194|FG004|Follow up Phase (4 Weeks)|Other|0|||
144508924|NCT03903822|521062195|FG005|Follow up Phase (4 Weeks)|Other|0|||
144508925|NCT03903822|521062196|FG006|Follow up Phase (4 Weeks)|Other|0|||
144508926|NCT03903822|521062197|FG007|Follow up Phase (4 Weeks)|Other|0|||
144508927|NCT05274217|521062219|FG000|Overall Study|Study terminated.|11|||
144508928|NCT05274217|521062220|FG001|Overall Study|Study terminated.|0|||
144588914|NCT02054741|521355767|FG001|Overall Study|Withdrawal by Subject|5|||
144588915|NCT02054741|521355766|FG000|Overall Study|Death|94|||
144588916|NCT02054741|521355767|FG001|Overall Study|Death|90|||
144588917|NCT02054741|521355766|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
144721685|NCT02173704|521835261|FG000|Overall Study|Protocol Violation|1|||
144508929|NCT04594759|521062221|FG000|Overall Study|Lost to Follow-up|3|||
144508930|NCT03144674|521062230|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
144508931|NCT03144674|521062231|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
144508932|NCT03144674|521062232|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
144508933|NCT03144674|521062233|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
144508934|NCT03144674|521062230|FG000|Overall Study|Death|3|||
144508935|NCT03144674|521062231|FG001|Overall Study|Death|2|||
144508936|NCT03144674|521062232|FG002|Overall Study|Death|6|||
144508937|NCT03144674|521062233|FG003|Overall Study|Death|24|||
144508938|NCT03144674|521062230|FG000|Overall Study|Lost to Follow-up|0|||
144508939|NCT03144674|521062231|FG001|Overall Study|Lost to Follow-up|1|||
144508940|NCT03144674|521062232|FG002|Overall Study|Lost to Follow-up|0|||
144508941|NCT03144674|521062233|FG003|Overall Study|Lost to Follow-up|4|||
144508942|NCT03144674|521062230|FG000|Overall Study|Withdrawal by Participant|0|||
144508943|NCT03144674|521062231|FG001|Overall Study|Withdrawal by Participant|0|||
144508944|NCT03144674|521062232|FG002|Overall Study|Withdrawal by Participant|2|||
144508945|NCT03144674|521062233|FG003|Overall Study|Withdrawal by Participant|6|||
144508946|NCT03144674|521062230|FG000|Overall Study|Discharged from the Trust|0|||
144508947|NCT03144674|521062231|FG001|Overall Study|Discharged from the Trust|0|||
144508948|NCT03144674|521062232|FG002|Overall Study|Discharged from the Trust|1|||
144508949|NCT03144674|521062233|FG003|Overall Study|Discharged from the Trust|0|||
144508950|NCT03144674|521062230|FG000|Overall Study|Exclusion Criteria Met|0|||
144508951|NCT03144674|521062231|FG001|Overall Study|Exclusion Criteria Met|0|||
144508952|NCT03144674|521062232|FG002|Overall Study|Exclusion Criteria Met|1|||
144508953|NCT03144674|521062233|FG003|Overall Study|Exclusion Criteria Met|0|||
144508954|NCT03144674|521062230|FG000|Overall Study|Changed Physicians|0|||
144508955|NCT03144674|521062231|FG001|Overall Study|Changed Physicians|0|||
144508956|NCT03144674|521062232|FG002|Overall Study|Changed Physicians|0|||
144508957|NCT03144674|521062233|FG003|Overall Study|Changed Physicians|1|||
144508958|NCT03144674|521062230|FG000|Overall Study|Removed for Safety|0|||
144508959|NCT03144674|521062231|FG001|Overall Study|Removed for Safety|0|||
144508960|NCT03144674|521062232|FG002|Overall Study|Removed for Safety|0|||
144508961|NCT03144674|521062233|FG003|Overall Study|Removed for Safety|1|||
144508962|NCT03144674|521062230|FG000|Overall Study|Site Closed|0|||
144508963|NCT03144674|521062231|FG001|Overall Study|Site Closed|0|||
144508964|NCT03144674|521062232|FG002|Overall Study|Site Closed|0|||
144508965|NCT03144674|521062233|FG003|Overall Study|Site Closed|1|||
144508966|NCT03144674|521062230|FG000|Overall Study|Histological Criteria Not Met|0|||
144508967|NCT03144674|521062231|FG001|Overall Study|Histological Criteria Not Met|0|||
144508968|NCT03144674|521062232|FG002|Overall Study|Histological Criteria Not Met|0|||
144508969|NCT03144674|521062233|FG003|Overall Study|Histological Criteria Not Met|1|||
144508970|NCT03144674|521062230|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
144508971|NCT03144674|521062231|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
144508972|NCT03144674|521062232|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
144508973|NCT03144674|521062233|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
144508974|NCT03144674|521062230|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
144508975|NCT03144674|521062231|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
144508976|NCT03144674|521062232|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
144508977|NCT03144674|521062233|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
144508978|NCT01395758|521062234|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
144508979|NCT01395758|521062235|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
144508980|NCT01395758|521062236|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
144508981|NCT03942042|521062240|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
144508982|NCT03942042|521062241|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
144508983|NCT03942042|521062240|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
144508984|NCT03942042|521062241|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
144508985|NCT00736853|521062242|FG000|Open-Label Period|Physician Decision|2|||
144508986|NCT00736853|521062243|FG001|Open-Label Period|Physician Decision|0|||
144508987|NCT00736853|521062244|FG002|Open-Label Period|Physician Decision|0|||
144508988|NCT00736853|521062242|FG000|Open-Label Period|Adverse Event|31|||
144508989|NCT00736853|521062243|FG001|Open-Label Period|Adverse Event|0|||
144508990|NCT00736853|521062244|FG002|Open-Label Period|Adverse Event|0|||
144508991|NCT00736853|521062242|FG000|Open-Label Period|Withdrawal by Subject|16|||
144508992|NCT00736853|521062243|FG001|Open-Label Period|Withdrawal by Subject|0|||
144508993|NCT00736853|521062244|FG002|Open-Label Period|Withdrawal by Subject|0|||
144508994|NCT00736853|521062242|FG000|Open-Label Period|Started but not treated|42|||
144508995|NCT00736853|521062243|FG001|Open-Label Period|Started but not treated|0|||
144508996|NCT00736853|521062244|FG002|Open-Label Period|Started but not treated|0|||
144508997|NCT00736853|521062242|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
144508998|NCT00736853|521062243|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
144508999|NCT00736853|521062244|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
144509000|NCT00736853|521062242|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
144509001|NCT00736853|521062243|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
144509002|NCT00736853|521062244|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
144509003|NCT00736853|521062242|FG000|Double-Blind Period|Lack of Efficacy|0|||
144509004|NCT00736853|521062243|FG001|Double-Blind Period|Lack of Efficacy|19|||
144509005|NCT00736853|521062244|FG002|Double-Blind Period|Lack of Efficacy|42|||
144588918|NCT02054741|521355767|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
144588919|NCT02325557|521355769|FG000|Overall Study|Progressive disease|1|||
144588920|NCT02325557|521355770|FG001|Overall Study|Progressive disease|0|||
144588921|NCT02325557|521355771|FG002|Overall Study|Progressive disease|0|||
144588922|NCT02325557|521355772|FG003|Overall Study|Progressive disease|0|||
144588923|NCT02325557|521355769|FG000|Overall Study|Withdrawal by Subject|4|||
144588924|NCT02325557|521355770|FG001|Overall Study|Withdrawal by Subject|0|||
144588925|NCT02325557|521355771|FG002|Overall Study|Withdrawal by Subject|0|||
144588926|NCT02325557|521355772|FG003|Overall Study|Withdrawal by Subject|15|||
144588927|NCT02325557|521355769|FG000|Overall Study|Death|5|||
144588928|NCT02325557|521355770|FG001|Overall Study|Death|1|||
144509006|NCT00736853|521062242|FG000|Double-Blind Period|Adverse Event|0|||
144509007|NCT00736853|521062243|FG001|Double-Blind Period|Adverse Event|3|||
144509008|NCT00736853|521062244|FG002|Double-Blind Period|Adverse Event|2|||
144509009|NCT00736853|521062242|FG000|Double-Blind Period|Withdrawal by Subject|0|||
144509010|NCT00736853|521062243|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144509011|NCT00736853|521062244|FG002|Double-Blind Period|Withdrawal by Subject|4|||
144509012|NCT00736853|521062242|FG000|Double-Blind Period|Ineligible to participate the study|0|||
144509013|NCT00736853|521062243|FG001|Double-Blind Period|Ineligible to participate the study|1|||
144509014|NCT00736853|521062244|FG002|Double-Blind Period|Ineligible to participate the study|0|||
144509015|NCT05135000|521062247|FG000|Overall Study|Adverse Event|2|||
144509016|NCT05135000|521062248|FG001|Overall Study|Adverse Event|0|||
144509017|NCT05135000|521062247|FG000|Overall Study|Lost to Follow-up|1|||
144588929|NCT02325557|521355771|FG002|Overall Study|Death|1|||
144588930|NCT02325557|521355772|FG003|Overall Study|Death|16|||
144588931|NCT02325557|521355769|FG000|Overall Study|Lost to Follow-up|0|||
144588932|NCT02325557|521355770|FG001|Overall Study|Lost to Follow-up|0|||
144588933|NCT02325557|521355771|FG002|Overall Study|Lost to Follow-up|1|||
144588934|NCT02325557|521355772|FG003|Overall Study|Lost to Follow-up|1|||
144588935|NCT02325557|521355769|FG000|Overall Study|Other|0|||
144588936|NCT02325557|521355770|FG001|Overall Study|Other|0|||
144588937|NCT02325557|521355771|FG002|Overall Study|Other|0|||
144588938|NCT02325557|521355772|FG003|Overall Study|Other|5|||
144588939|NCT01488487|521355773|FG000|Overall Study|Adverse Event|6|||
144588940|NCT01488487|521355773|FG000|Overall Study|Death|1|||
144509018|NCT05135000|521062248|FG001|Overall Study|Lost to Follow-up|0|||
144509019|NCT05135000|521062247|FG000|Overall Study|Study Terminated by Sponsor|6|||
144509020|NCT05135000|521062248|FG001|Overall Study|Study Terminated by Sponsor|3|||
144509021|NCT00446459|521064124|FG000|8 Months|Protocol Violation|12|||
144509022|NCT00446459|521064124|FG000|12 Months|Protocol Violation|4|||
144509023|NCT00446459|521064124|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
144509024|NCT00774397|521064125|FG000|Overall Study|Adverse Event|1|||
144509025|NCT00774397|521064126|FG001|Overall Study|Adverse Event|3|||
144509026|NCT00774397|521064127|FG002|Overall Study|Adverse Event|16|||
144509027|NCT00774397|521064128|FG003|Overall Study|Adverse Event|8|||
144509028|NCT00774397|521064129|FG004|Overall Study|Adverse Event|8|||
144509029|NCT00774397|521064130|FG005|Overall Study|Adverse Event|3|||
144509030|NCT00774397|521064131|FG006|Overall Study|Adverse Event|16|||
144509031|NCT00774397|521064125|FG000|Overall Study|Lack of Efficacy|11|||
144509032|NCT00774397|521064126|FG001|Overall Study|Lack of Efficacy|4|||
144509033|NCT00774397|521064127|FG002|Overall Study|Lack of Efficacy|5|||
144509034|NCT00774397|521064128|FG003|Overall Study|Lack of Efficacy|3|||
144509035|NCT00774397|521064129|FG004|Overall Study|Lack of Efficacy|27|||
144509036|NCT00774397|521064130|FG005|Overall Study|Lack of Efficacy|15|||
144509037|NCT00774397|521064131|FG006|Overall Study|Lack of Efficacy|9|||
144509038|NCT00774397|521064125|FG000|Overall Study|Protocol Violation|0|||
144509039|NCT00774397|521064126|FG001|Overall Study|Protocol Violation|1|||
144509040|NCT00774397|521064127|FG002|Overall Study|Protocol Violation|3|||
144509041|NCT00774397|521064128|FG003|Overall Study|Protocol Violation|1|||
144509042|NCT00774397|521064129|FG004|Overall Study|Protocol Violation|2|||
144509043|NCT00774397|521064130|FG005|Overall Study|Protocol Violation|1|||
144509044|NCT00774397|521064131|FG006|Overall Study|Protocol Violation|0|||
144509045|NCT00774397|521064125|FG000|Overall Study|Lost to Follow-up|0|||
144509046|NCT00774397|521064126|FG001|Overall Study|Lost to Follow-up|1|||
144509047|NCT00774397|521064127|FG002|Overall Study|Lost to Follow-up|1|||
144509048|NCT00774397|521064128|FG003|Overall Study|Lost to Follow-up|1|||
144509049|NCT00774397|521064129|FG004|Overall Study|Lost to Follow-up|0|||
144509050|NCT00774397|521064130|FG005|Overall Study|Lost to Follow-up|1|||
144509051|NCT00774397|521064131|FG006|Overall Study|Lost to Follow-up|0|||
144509052|NCT00774397|521064125|FG000|Overall Study|Refused to continue trial medication|1|||
144509053|NCT00774397|521064126|FG001|Overall Study|Refused to continue trial medication|3|||
144509054|NCT00774397|521064127|FG002|Overall Study|Refused to continue trial medication|2|||
144509055|NCT00774397|521064128|FG003|Overall Study|Refused to continue trial medication|2|||
144509056|NCT00774397|521064129|FG004|Overall Study|Refused to continue trial medication|6|||
144509057|NCT00774397|521064130|FG005|Overall Study|Refused to continue trial medication|2|||
144509058|NCT00774397|521064131|FG006|Overall Study|Refused to continue trial medication|3|||
144509059|NCT00774397|521064125|FG000|Overall Study|Not treated|0|||
144509060|NCT00774397|521064126|FG001|Overall Study|Not treated|0|||
144509061|NCT00774397|521064127|FG002|Overall Study|Not treated|0|||
144509062|NCT00774397|521064128|FG003|Overall Study|Not treated|0|||
144509063|NCT00774397|521064129|FG004|Overall Study|Not treated|1|||
144509064|NCT00774397|521064130|FG005|Overall Study|Not treated|0|||
144509065|NCT00774397|521064131|FG006|Overall Study|Not treated|1|||
144509066|NCT00774397|521064125|FG000|Overall Study|Other than those stated above|1|||
144509067|NCT00774397|521064126|FG001|Overall Study|Other than those stated above|1|||
144509068|NCT00774397|521064127|FG002|Overall Study|Other than those stated above|3|||
144509069|NCT00774397|521064128|FG003|Overall Study|Other than those stated above|2|||
144509070|NCT00774397|521064129|FG004|Overall Study|Other than those stated above|2|||
144509071|NCT00774397|521064130|FG005|Overall Study|Other than those stated above|0|||
144509072|NCT00774397|521064131|FG006|Overall Study|Other than those stated above|1|||
144509073|NCT00858117|521064133|FG000|Treatment on Study|Adverse Event|2|||
144509074|NCT00858117|521064133|FG000|Follow up for 5 Years|Death|4|||
144509075|NCT00858117|521064133|FG000|Follow up for 5 Years|No further data collected for study|9|||
144509076|NCT02499159|521064136|FG000|Randomization|Protocol Violation|1|||
144509077|NCT02499159|521064137|FG001|Randomization|Protocol Violation|1|||
144509078|NCT02499159|521064136|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
144509079|NCT02499159|521064137|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
144509080|NCT02499159|521064136|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
144509081|NCT02499159|521064137|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
144509082|NCT02499159|521064136|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
144509083|NCT02499159|521064137|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
144588941|NCT01488487|521355773|FG000|Overall Study|Withdrawal by Subject|2|||
144588942|NCT02084056|521355774|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
144588943|NCT02084056|521355775|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144588944|NCT02084056|521355776|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144588945|NCT02084056|521355777|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144588946|NCT02084056|521355774|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
144588947|NCT02084056|521355775|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
144588948|NCT02084056|521355776|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
144588949|NCT02084056|521355777|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
144588950|NCT01293487|521355779|FG000|Overall Study|Lost to Follow-up|0|||
144588951|NCT01293487|521355780|FG001|Overall Study|Lost to Follow-up|0|||
144588952|NCT01293487|521355781|FG002|Overall Study|Lost to Follow-up|0|||
144588953|NCT01293487|521355782|FG003|Overall Study|Lost to Follow-up|1|||
144588954|NCT01293487|521355783|FG004|Overall Study|Lost to Follow-up|0|||
144588955|NCT01293487|521355784|FG005|Overall Study|Lost to Follow-up|0|||
144588956|NCT01293487|521355785|FG006|Overall Study|Lost to Follow-up|0|||
144588957|NCT01293487|521355786|FG007|Overall Study|Lost to Follow-up|0|||
144509084|NCT02499159|521064136|FG000|30-Day Follow-Up Phone Call|Other|1|||
144509085|NCT02499159|521064137|FG001|30-Day Follow-Up Phone Call|Other|0|||
144509086|NCT04425863|521064138|FG000|Overall Study|Death|0|||
144509087|NCT04425863|521064139|FG001|Overall Study|Death|0|||
144509088|NCT04425863|521064140|FG002|Overall Study|Death|1|||
144509089|NCT00277355|521064147|FG000|Overall Study|Withdrawal by Subject|3|||
144509090|NCT00277355|521064148|FG001|Overall Study|Withdrawal by Subject|3|||
144509091|NCT00277355|521064147|FG000|Overall Study|Lost to Follow-up|2|||
144509092|NCT00277355|521064148|FG001|Overall Study|Lost to Follow-up|2|||
144509093|NCT00277355|521064147|FG000|Overall Study|Adverse Event|5|||
144509094|NCT00277355|521064148|FG001|Overall Study|Adverse Event|0|||
144509095|NCT00277355|521064147|FG000|Overall Study|Death|3|||
144509096|NCT00277355|521064148|FG001|Overall Study|Death|0|||
144509097|NCT00277355|521064147|FG000|Overall Study|Physician Decision|1|||
144509098|NCT00277355|521064148|FG001|Overall Study|Physician Decision|0|||
144509099|NCT02765100|521064149|FG000|Overall Study|subject found ineligible after baseline|1|||
144509100|NCT02765100|521064150|FG001|Overall Study|subject found ineligible after baseline|1|||
144509101|NCT02765100|521064149|FG000|Overall Study|Lost to Follow-up|0|||
144509102|NCT02765100|521064150|FG001|Overall Study|Lost to Follow-up|1|||
144509103|NCT02675244|521064153|FG000|Overall Study|Death|9|||
144509104|NCT02675244|521064154|FG001|Overall Study|Death|6|||
144509105|NCT02675244|521064153|FG000|Overall Study|Withdrawal by Subject|3|||
144509106|NCT02675244|521064154|FG001|Overall Study|Withdrawal by Subject|6|||
144509107|NCT02675244|521064153|FG000|Overall Study|Lost to Follow-up|1|||
144509108|NCT02675244|521064154|FG001|Overall Study|Lost to Follow-up|1|||
144509109|NCT02675244|521064153|FG000|Overall Study|Ongoing at 2 Years|190|||
144509110|NCT02675244|521064154|FG001|Overall Study|Ongoing at 2 Years|185|||
144509111|NCT02652442|521064156|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
144509112|NCT00309907|521064157|FG000|Overall Study|Death|4|||
144509113|NCT00309907|521064157|FG000|Overall Study|Physician Decision|1|||
144509114|NCT00309907|521064157|FG000|Overall Study|Ineligible|11|||
144509115|NCT00309907|521064157|FG000|Overall Study|Major infectious event|4|||
144509116|NCT01075217|521064158|FG000|Overall Study|Adverse Event|1|||
144509117|NCT01075217|521064159|FG001|Overall Study|Adverse Event|1|||
144509118|NCT01075217|521064158|FG000|Overall Study|Physician Decision|1|||
144509119|NCT01075217|521064159|FG001|Overall Study|Physician Decision|0|||
144509120|NCT00293293|521064162|FG000|Overall Study|Withdrawal by Subject|1|||
144509121|NCT00293293|521064163|FG001|Overall Study|Withdrawal by Subject|1|||
144509122|NCT00293293|521064162|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
144509123|NCT00293293|521064163|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
144509124|NCT00293293|521064162|FG000|Overall Study|Patient discontinued chemotherapy|0|||
144509125|NCT00293293|521064163|FG001|Overall Study|Patient discontinued chemotherapy|1|||
144509126|NCT02512965|521064166|FG000|Overall Study|Withdrawal by Subject|0|||
144509127|NCT02512965|521064167|FG001|Overall Study|Withdrawal by Subject|4|||
144509128|NCT00835770|521064168|FG000|Overall Study|MS Relapse|17|||
144509129|NCT00835770|521064169|FG001|Overall Study|MS Relapse|23|||
144509130|NCT00835770|521064168|FG000|Overall Study|MS Progression|14|||
144509131|NCT00835770|521064169|FG001|Overall Study|MS Progression|9|||
144588958|NCT01293487|521355779|FG000|Overall Study|Withdrawal by Subject|0|||
144588959|NCT01293487|521355780|FG001|Overall Study|Withdrawal by Subject|0|||
144588960|NCT01293487|521355781|FG002|Overall Study|Withdrawal by Subject|0|||
144588961|NCT01293487|521355782|FG003|Overall Study|Withdrawal by Subject|0|||
144588962|NCT01293487|521355783|FG004|Overall Study|Withdrawal by Subject|0|||
144721686|NCT02173704|521835262|FG001|Overall Study|Protocol Violation|0|||
144509132|NCT00835770|521064168|FG000|Overall Study|Adverse Event|113|||
144509133|NCT00835770|521064169|FG001|Overall Study|Adverse Event|124|||
144509134|NCT00835770|521064168|FG000|Overall Study|Lost to Follow-up|22|||
144509135|NCT00835770|521064169|FG001|Overall Study|Lost to Follow-up|19|||
144509136|NCT00835770|521064168|FG000|Overall Study|Consent Withdrawn|144|||
144509137|NCT00835770|521064169|FG001|Overall Study|Consent Withdrawn|156|||
144509138|NCT00835770|521064168|FG000|Overall Study|Investigator Decision|42|||
144509139|NCT00835770|521064169|FG001|Overall Study|Investigator Decision|42|||
144509140|NCT00835770|521064168|FG000|Overall Study|Participant Non-Compliance|11|||
144509141|NCT00835770|521064169|FG001|Overall Study|Participant Non-Compliance|9|||
144509142|NCT00835770|521064168|FG000|Overall Study|Death|4|||
144509143|NCT00835770|521064169|FG001|Overall Study|Death|6|||
144509144|NCT00835770|521064168|FG000|Overall Study|Other|115|||
144509145|NCT00835770|521064169|FG001|Overall Study|Other|104|||
144509146|NCT00835770|521064168|FG000|Overall Study|Other|2|||
144509147|NCT00835770|521064169|FG001|Overall Study|Other|1|||
144509148|NCT01185782|521064170|FG000|Overall Study|Adverse Event|0|||
144509149|NCT01185782|521064171|FG001|Overall Study|Adverse Event|1|||
144509150|NCT01185782|521064170|FG000|Overall Study|Protocol Violation|1|||
144509151|NCT01185782|521064171|FG001|Overall Study|Protocol Violation|0|||
144509152|NCT01185782|521064170|FG000|Overall Study|Poor Response to Treatment|3|||
144509153|NCT01185782|521064171|FG001|Overall Study|Poor Response to Treatment|1|||
144509154|NCT01185782|521064170|FG000|Overall Study|Other|2|||
144509155|NCT01185782|521064171|FG001|Overall Study|Other|5|||
144588963|NCT01293487|521355784|FG005|Overall Study|Withdrawal by Subject|0|||
144588964|NCT01293487|521355785|FG006|Overall Study|Withdrawal by Subject|0|||
144588965|NCT01293487|521355786|FG007|Overall Study|Withdrawal by Subject|2|||
144588966|NCT01737827|521355788|FG000|Overall Study|Adverse Event|3|||
144588967|NCT01737827|521355789|FG001|Overall Study|Adverse Event|6|||
144588968|NCT01737827|521355790|FG002|Overall Study|Adverse Event|0|||
144588969|NCT01737827|521355788|FG000|Overall Study|Lost to Follow-up|0|||
144588970|NCT01737827|521355789|FG001|Overall Study|Lost to Follow-up|1|||
144588971|NCT01737827|521355790|FG002|Overall Study|Lost to Follow-up|0|||
144588972|NCT01737827|521355788|FG000|Overall Study|Physician Decision|0|||
144588973|NCT01737827|521355789|FG001|Overall Study|Physician Decision|2|||
144588974|NCT01737827|521355790|FG002|Overall Study|Physician Decision|0|||
144588975|NCT01737827|521355788|FG000|Overall Study|Progressive Disease|5|||
144588976|NCT01737827|521355789|FG001|Overall Study|Progressive Disease|16|||
144588977|NCT01737827|521355790|FG002|Overall Study|Progressive Disease|2|||
144588978|NCT01737827|521355788|FG000|Overall Study|Study Terminated by Sponsor|0|||
144588979|NCT01737827|521355789|FG001|Overall Study|Study Terminated by Sponsor|1|||
144588980|NCT01737827|521355790|FG002|Overall Study|Study Terminated by Sponsor|0|||
144588981|NCT01737827|521355788|FG000|Overall Study|Subject/Guardian Decision|0|||
144588982|NCT01737827|521355789|FG001|Overall Study|Subject/Guardian Decision|2|||
144588983|NCT01737827|521355790|FG002|Overall Study|Subject/Guardian Decision|0|||
144588984|NCT01451827|521355791|FG000|Overall Study|Adverse Event|2|||
144588985|NCT01451827|521355792|FG001|Overall Study|Adverse Event|0|||
144588986|NCT01451827|521355793|FG002|Overall Study|Adverse Event|1|||
144588987|NCT01451827|521355794|FG003|Overall Study|Adverse Event|1|||
144588988|NCT01451827|521355791|FG000|Overall Study|Protocol deviation|1|||
144588989|NCT01451827|521355792|FG001|Overall Study|Protocol deviation|0|||
144588990|NCT01451827|521355793|FG002|Overall Study|Protocol deviation|0|||
144588991|NCT01451827|521355794|FG003|Overall Study|Protocol deviation|0|||
144588992|NCT01451827|521355791|FG000|Overall Study|Lost to Follow-up|0|||
144588993|NCT01451827|521355792|FG001|Overall Study|Lost to Follow-up|3|||
144588994|NCT01451827|521355793|FG002|Overall Study|Lost to Follow-up|0|||
144588995|NCT01451827|521355794|FG003|Overall Study|Lost to Follow-up|2|||
144588996|NCT01451827|521355791|FG000|Overall Study|Participant met withdrawal criteria|0|||
144588997|NCT01451827|521355792|FG001|Overall Study|Participant met withdrawal criteria|2|||
144588998|NCT01451827|521355793|FG002|Overall Study|Participant met withdrawal criteria|0|||
144588999|NCT01451827|521355794|FG003|Overall Study|Participant met withdrawal criteria|0|||
144589000|NCT01451827|521355791|FG000|Overall Study|Withdrawal by Subject|0|||
144589001|NCT01451827|521355792|FG001|Overall Study|Withdrawal by Subject|0|||
144589002|NCT01451827|521355793|FG002|Overall Study|Withdrawal by Subject|1|||
144589003|NCT01451827|521355794|FG003|Overall Study|Withdrawal by Subject|1|||
144589004|NCT01964924|521355795|FG000|Trametinib Monotherapy|Progression|19|||
144589005|NCT01964924|521355796|FG001|Trametinib Monotherapy|Progression|0|||
144589006|NCT01528345|521355797|FG000|Overall Study|Adverse Event|10|||
144509156|NCT01185782|521064170|FG000|Overall Study|Randomized but not treated|0|||
144509157|NCT01185782|521064171|FG001|Overall Study|Randomized but not treated|4|||
144509158|NCT03740009|521064173|FG000|Overall Study|Physician Decision|9|||
144509159|NCT03740009|521064173|FG000|Overall Study|Lost to Follow-up|1|||
144589007|NCT01528345|521355798|FG001|Overall Study|Adverse Event|1|||
144589008|NCT01528345|521355797|FG000|Overall Study|Death|1|||
144589009|NCT01528345|521355798|FG001|Overall Study|Death|1|||
144589010|NCT01528345|521355797|FG000|Overall Study|Non-compliance with study treatment|1|||
144589011|NCT01528345|521355798|FG001|Overall Study|Non-compliance with study treatment|0|||
144589012|NCT01528345|521355797|FG000|Overall Study|Progressive Disease|26|||
144589013|NCT01528345|521355798|FG001|Overall Study|Progressive Disease|40|||
144589014|NCT01528345|521355797|FG000|Overall Study|Study Terminated by Sponsor|4|||
144589015|NCT01528345|521355798|FG001|Overall Study|Study Terminated by Sponsor|8|||
144589016|NCT01528345|521355797|FG000|Overall Study|Subject/Guardian Decision|5|||
144589017|NCT01528345|521355798|FG001|Overall Study|Subject/Guardian Decision|0|||
144509160|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
144589018|NCT00528645|521355799|FG000|Overall Study|Adverse Event|3|||
144589019|NCT01445301|521355800|FG000|Overall Study|Adverse Event|15|||
144589020|NCT01445301|521355801|FG001|Overall Study|Adverse Event|25|||
144509161|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
144509162|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
144509163|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
144509164|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
144509165|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
144509166|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
144509167|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
144509168|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
144509169|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
144509170|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
144509171|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
144509172|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
144589021|NCT01445301|521355802|FG002|Overall Study|Adverse Event|4|||
144509173|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
144509174|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
144509175|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
144509176|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
144509177|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
144509178|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
144509179|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
144509180|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
144509181|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
144509182|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
144509183|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
144509184|NCT01061151|521064174|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
144509185|NCT01061151|521064175|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
144509186|NCT01061151|521064176|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
144509187|NCT01061151|521064177|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
144509188|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
144509189|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
144509190|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
144509191|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
144509192|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
144509193|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
144509194|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
144509195|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
144509196|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
144509197|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
144509198|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
144509199|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
144509200|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
144509201|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
144509202|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
144509203|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
144509204|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
144509205|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
144509206|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
144509207|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
144509208|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
144509209|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
144509210|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
144509211|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
144509212|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
144509213|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
144509214|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
144509215|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
144509216|NCT01061151|521064174|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
144509217|NCT01061151|521064175|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
144509218|NCT01061151|521064176|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
144509219|NCT01061151|521064177|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
144509220|NCT02988817|521064178|FG000|Overall Study|Withdrawal by Subject|1|||
144509221|NCT02988817|521064179|FG001|Overall Study|Withdrawal by Subject|0|||
144509222|NCT02988817|521064180|FG002|Overall Study|Withdrawal by Subject|0|||
144589022|NCT01445301|521355800|FG000|Overall Study|Lack of Efficacy|0|||
144589023|NCT01445301|521355801|FG001|Overall Study|Lack of Efficacy|1|||
144589024|NCT01445301|521355802|FG002|Overall Study|Lack of Efficacy|0|||
144589025|NCT01445301|521355800|FG000|Overall Study|Protocol Violation|1|||
144589026|NCT01445301|521355801|FG001|Overall Study|Protocol Violation|0|||
144589027|NCT01445301|521355802|FG002|Overall Study|Protocol Violation|0|||
144589028|NCT01445301|521355800|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
144589029|NCT01445301|521355801|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
144589030|NCT01445301|521355802|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
144589031|NCT01445301|521355800|FG000|Overall Study|Physician Decision|0|||
144589032|NCT01445301|521355801|FG001|Overall Study|Physician Decision|2|||
144589033|NCT01445301|521355802|FG002|Overall Study|Physician Decision|0|||
144589034|NCT01445301|521355800|FG000|Overall Study|Withdrawal by Subject|5|||
144589035|NCT01445301|521355801|FG001|Overall Study|Withdrawal by Subject|6|||
144589036|NCT01445301|521355802|FG002|Overall Study|Withdrawal by Subject|4|||
144589037|NCT00752557|521355803|FG000|Overall Study|Withdrawal by Subject|4|||
144589038|NCT00752557|521355804|FG001|Overall Study|Withdrawal by Subject|3|||
144589039|NCT00752557|521355805|FG002|Overall Study|Withdrawal by Subject|3|||
144589040|NCT00752557|521355803|FG000|Overall Study|Unspecified resaons|0|||
144589041|NCT00752557|521355804|FG001|Overall Study|Unspecified resaons|2|||
144589042|NCT00752557|521355805|FG002|Overall Study|Unspecified resaons|2|||
144589043|NCT00752557|521355803|FG000|Overall Study|Lost to Follow-up|1|||
144589044|NCT00752557|521355804|FG001|Overall Study|Lost to Follow-up|0|||
144589045|NCT00752557|521355805|FG002|Overall Study|Lost to Follow-up|1|||
144589046|NCT02150343|521355810|FG000|Overall Study|Adverse Event|2|||
144589047|NCT02150343|521355811|FG001|Overall Study|Adverse Event|0|||
144589048|NCT02150343|521355812|FG002|Overall Study|Adverse Event|1|||
144589049|NCT02150343|521355813|FG003|Overall Study|Adverse Event|1|||
144589050|NCT02150343|521355810|FG000|Overall Study|Withdrawal by Subject|13|||
144589051|NCT02150343|521355811|FG001|Overall Study|Withdrawal by Subject|10|||
144589052|NCT02150343|521355812|FG002|Overall Study|Withdrawal by Subject|9|||
144589053|NCT02150343|521355813|FG003|Overall Study|Withdrawal by Subject|4|||
144589054|NCT02150343|521355810|FG000|Overall Study|Lost to Follow-up|4|||
144589055|NCT02150343|521355811|FG001|Overall Study|Lost to Follow-up|4|||
144589056|NCT02150343|521355812|FG002|Overall Study|Lost to Follow-up|2|||
144589057|NCT02150343|521355813|FG003|Overall Study|Lost to Follow-up|3|||
144589058|NCT02150343|521355810|FG000|Overall Study|Other|2|||
144589059|NCT02150343|521355811|FG001|Overall Study|Other|6|||
144589060|NCT02150343|521355812|FG002|Overall Study|Other|0|||
144589061|NCT02150343|521355813|FG003|Overall Study|Other|2|||
144589062|NCT02729753|521355814|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
144589063|NCT02729753|521355815|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
144589064|NCT01090427|521355816|FG000|After Controlled Period|Death|0|||
144589065|NCT01090427|521355817|FG001|After Controlled Period|Death|0|||
144589066|NCT01090427|521355818|FG002|After Controlled Period|Death|0|||
144589067|NCT01090427|521355819|FG003|After Controlled Period|Death|0|||
144589068|NCT01090427|521355820|FG004|After Controlled Period|Death|0|||
144589069|NCT01090427|521355821|FG005|After Controlled Period|Death|1|||
144589070|NCT01090427|521355822|FG006|After Controlled Period|Death|0|||
144589071|NCT01090427|521355816|FG000|After Controlled Period|Lack of Efficacy|0|||
144589072|NCT01090427|521355817|FG001|After Controlled Period|Lack of Efficacy|0|||
144589073|NCT01090427|521355818|FG002|After Controlled Period|Lack of Efficacy|0|||
144589074|NCT01090427|521355819|FG003|After Controlled Period|Lack of Efficacy|0|||
144589075|NCT01090427|521355820|FG004|After Controlled Period|Lack of Efficacy|0|||
144589076|NCT01090427|521355821|FG005|After Controlled Period|Lack of Efficacy|3|||
144589077|NCT01090427|521355822|FG006|After Controlled Period|Lack of Efficacy|2|||
144589078|NCT01090427|521355816|FG000|After Controlled Period|Adverse Event|0|||
144589079|NCT01090427|521355817|FG001|After Controlled Period|Adverse Event|0|||
144589080|NCT01090427|521355818|FG002|After Controlled Period|Adverse Event|0|||
144589081|NCT01090427|521355819|FG003|After Controlled Period|Adverse Event|2|||
144589082|NCT01090427|521355820|FG004|After Controlled Period|Adverse Event|0|||
144589083|NCT01090427|521355821|FG005|After Controlled Period|Adverse Event|1|||
144589084|NCT01090427|521355822|FG006|After Controlled Period|Adverse Event|0|||
144589085|NCT01154010|521355823|FG000|Overall Study|Lost to Follow-up|0|||
144589086|NCT01154010|521355824|FG001|Overall Study|Lost to Follow-up|1|||
144589087|NCT00439231|521355825|FG000|Overall Study|Lack of Efficacy|28|||
144589088|NCT01048671|521355832|FG000|Overall Study|Protocol Violation|0|||
144589089|NCT01048671|521355833|FG001|Overall Study|Protocol Violation|1|||
144589090|NCT01048671|521355834|FG002|Overall Study|Protocol Violation|1|||
144589091|NCT01014533|521355835|FG000|Overall Study|Protocol Violation|3|||
144589092|NCT01014533|521355836|FG001|Overall Study|Protocol Violation|2|||
144589093|NCT01014533|521355835|FG000|Overall Study|Withdrawal by Subject|2|||
144589094|NCT01014533|521355836|FG001|Overall Study|Withdrawal by Subject|0|||
144589095|NCT01014533|521355835|FG000|Overall Study|unable to come to appointment|0|||
144589096|NCT01014533|521355836|FG001|Overall Study|unable to come to appointment|3|||
144589097|NCT00296400|521355837|FG000|Overall Study|Adverse Event|7|||
144589098|NCT00296400|521355838|FG001|Overall Study|Adverse Event|7|||
144589099|NCT00296400|521355839|FG002|Overall Study|Adverse Event|7|||
144589100|NCT00296400|521355837|FG000|Overall Study|Withdrawal by Subject|5|||
144589101|NCT00296400|521355838|FG001|Overall Study|Withdrawal by Subject|6|||
144589102|NCT00296400|521355839|FG002|Overall Study|Withdrawal by Subject|2|||
144509223|NCT02988817|521064181|FG003|Overall Study|Withdrawal by Subject|1|||
144509224|NCT02988817|521064182|FG004|Overall Study|Withdrawal by Subject|3|||
144509225|NCT02988817|521064183|FG005|Overall Study|Withdrawal by Subject|1|||
144509226|NCT02988817|521064184|FG006|Overall Study|Withdrawal by Subject|2|||
144509227|NCT02988817|521064185|FG007|Overall Study|Withdrawal by Subject|1|||
144509228|NCT02988817|521064186|FG008|Overall Study|Withdrawal by Subject|1|||
144509229|NCT02988817|521064187|FG009|Overall Study|Withdrawal by Subject|1|||
144509230|NCT02988817|521064188|FG010|Overall Study|Withdrawal by Subject|1|||
144509231|NCT02988817|521064189|FG011|Overall Study|Withdrawal by Subject|12|||
144509232|NCT02988817|521064190|FG012|Overall Study|Withdrawal by Subject|6|||
144509233|NCT02988817|521064191|FG013|Overall Study|Withdrawal by Subject|6|||
144509234|NCT02988817|521064192|FG014|Overall Study|Withdrawal by Subject|4|||
144509235|NCT02988817|521064193|FG015|Overall Study|Withdrawal by Subject|5|||
144509236|NCT02988817|521064194|FG016|Overall Study|Withdrawal by Subject|4|||
144509237|NCT02988817|521064195|FG017|Overall Study|Withdrawal by Subject|11|||
144509238|NCT02988817|521064196|FG018|Overall Study|Withdrawal by Subject|4|||
144509239|NCT02988817|521064197|FG019|Overall Study|Withdrawal by Subject|2|||
144509240|NCT02988817|521064178|FG000|Overall Study|Death|0|||
144509241|NCT02988817|521064179|FG001|Overall Study|Death|1|||
144509242|NCT02988817|521064180|FG002|Overall Study|Death|3|||
144509243|NCT02988817|521064181|FG003|Overall Study|Death|1|||
144509244|NCT02988817|521064182|FG004|Overall Study|Death|6|||
144509245|NCT02988817|521064183|FG005|Overall Study|Death|10|||
144509246|NCT02988817|521064184|FG006|Overall Study|Death|1|||
144509247|NCT02988817|521064185|FG007|Overall Study|Death|2|||
144509248|NCT02988817|521064186|FG008|Overall Study|Death|1|||
144509249|NCT02988817|521064187|FG009|Overall Study|Death|5|||
144509250|NCT02988817|521064188|FG010|Overall Study|Death|1|||
144509251|NCT02988817|521064189|FG011|Overall Study|Death|8|||
144509252|NCT02988817|521064190|FG012|Overall Study|Death|9|||
144509253|NCT02988817|521064191|FG013|Overall Study|Death|17|||
144509254|NCT02988817|521064192|FG014|Overall Study|Death|18|||
144509255|NCT02988817|521064193|FG015|Overall Study|Death|30|||
144509256|NCT02988817|521064194|FG016|Overall Study|Death|17|||
144509257|NCT02988817|521064195|FG017|Overall Study|Death|38|||
144509258|NCT02988817|521064196|FG018|Overall Study|Death|14|||
144509259|NCT02988817|521064197|FG019|Overall Study|Death|16|||
144509260|NCT02988817|521064178|FG000|Overall Study|Other|0|||
144509261|NCT02988817|521064179|FG001|Overall Study|Other|0|||
144509262|NCT02988817|521064180|FG002|Overall Study|Other|0|||
144509263|NCT02988817|521064181|FG003|Overall Study|Other|1|||
144509264|NCT02988817|521064182|FG004|Overall Study|Other|1|||
144509265|NCT02988817|521064183|FG005|Overall Study|Other|0|||
144509266|NCT02988817|521064184|FG006|Overall Study|Other|0|||
144509267|NCT02988817|521064185|FG007|Overall Study|Other|0|||
144509268|NCT02988817|521064186|FG008|Overall Study|Other|0|||
144509269|NCT02988817|521064187|FG009|Overall Study|Other|0|||
144509270|NCT02988817|521064188|FG010|Overall Study|Other|0|||
144509271|NCT02988817|521064189|FG011|Overall Study|Other|0|||
144509272|NCT02988817|521064190|FG012|Overall Study|Other|0|||
144509273|NCT02988817|521064191|FG013|Overall Study|Other|0|||
144509274|NCT02988817|521064192|FG014|Overall Study|Other|0|||
144509275|NCT02988817|521064193|FG015|Overall Study|Other|1|||
144509276|NCT02988817|521064194|FG016|Overall Study|Other|0|||
144509277|NCT02988817|521064195|FG017|Overall Study|Other|0|||
144509278|NCT02988817|521064196|FG018|Overall Study|Other|0|||
144509279|NCT02988817|521064197|FG019|Overall Study|Other|0|||
144509280|NCT02988817|521064178|FG000|Overall Study|Lost to Follow-up|0|||
144509281|NCT02988817|521064179|FG001|Overall Study|Lost to Follow-up|0|||
144509282|NCT02988817|521064180|FG002|Overall Study|Lost to Follow-up|0|||
144509283|NCT02988817|521064181|FG003|Overall Study|Lost to Follow-up|0|||
144509284|NCT02988817|521064182|FG004|Overall Study|Lost to Follow-up|0|||
144509285|NCT02988817|521064183|FG005|Overall Study|Lost to Follow-up|0|||
144509286|NCT02988817|521064184|FG006|Overall Study|Lost to Follow-up|0|||
144509287|NCT02988817|521064185|FG007|Overall Study|Lost to Follow-up|0|||
144509288|NCT02988817|521064186|FG008|Overall Study|Lost to Follow-up|1|||
144509289|NCT02988817|521064187|FG009|Overall Study|Lost to Follow-up|0|||
144509290|NCT02988817|521064188|FG010|Overall Study|Lost to Follow-up|1|||
144509291|NCT02988817|521064189|FG011|Overall Study|Lost to Follow-up|1|||
144509292|NCT02988817|521064190|FG012|Overall Study|Lost to Follow-up|0|||
144509293|NCT02988817|521064191|FG013|Overall Study|Lost to Follow-up|0|||
144509294|NCT02988817|521064192|FG014|Overall Study|Lost to Follow-up|1|||
144509295|NCT02988817|521064193|FG015|Overall Study|Lost to Follow-up|1|||
144509296|NCT02988817|521064194|FG016|Overall Study|Lost to Follow-up|2|||
144509297|NCT02988817|521064195|FG017|Overall Study|Lost to Follow-up|3|||
144509298|NCT02988817|521064196|FG018|Overall Study|Lost to Follow-up|0|||
144509299|NCT02988817|521064197|FG019|Overall Study|Lost to Follow-up|0|||
144589103|NCT00296400|521355837|FG000|Overall Study|Incorrect enrollment|2|||
144589104|NCT00296400|521355838|FG001|Overall Study|Incorrect enrollment|0|||
144589105|NCT00296400|521355839|FG002|Overall Study|Incorrect enrollment|0|||
144589106|NCT00296400|521355837|FG000|Overall Study|Protocol Violation|1|||
144589107|NCT00296400|521355838|FG001|Overall Study|Protocol Violation|1|||
144589108|NCT00296400|521355839|FG002|Overall Study|Protocol Violation|1|||
144589109|NCT00296400|521355837|FG000|Overall Study|Lost to Follow-up|1|||
144589110|NCT00296400|521355838|FG001|Overall Study|Lost to Follow-up|1|||
144589111|NCT00296400|521355839|FG002|Overall Study|Lost to Follow-up|2|||
144589112|NCT00296400|521355837|FG000|Overall Study|Study specific discontinuation criteria|0|||
144589113|NCT00296400|521355838|FG001|Overall Study|Study specific discontinuation criteria|0|||
144589114|NCT00296400|521355839|FG002|Overall Study|Study specific discontinuation criteria|1|||
144589115|NCT00296400|521355837|FG000|Overall Study|Visit 10 was performed earlier|0|||
144589116|NCT00296400|521355838|FG001|Overall Study|Visit 10 was performed earlier|1|||
144589117|NCT00296400|521355839|FG002|Overall Study|Visit 10 was performed earlier|0|||
144589118|NCT00296400|521355837|FG000|Overall Study|Pregnancy|1|||
144589119|NCT00296400|521355838|FG001|Overall Study|Pregnancy|2|||
144589120|NCT00296400|521355839|FG002|Overall Study|Pregnancy|0|||
144589121|NCT00412061|521355844|FG000|Double Blind Phase|Disease Progression|101|||
144589122|NCT00412061|521355845|FG001|Double Blind Phase|Disease Progression|154|||
144589123|NCT00412061|521355844|FG000|Double Blind Phase|Adverse Event|61|||
144589124|NCT00412061|521355845|FG001|Double Blind Phase|Adverse Event|16|||
144589125|NCT00412061|521355844|FG000|Double Blind Phase|Final Primary Analysis|26|||
144589126|NCT00412061|521355845|FG001|Double Blind Phase|Final Primary Analysis|14|||
144589127|NCT00412061|521355844|FG000|Double Blind Phase|Withdrawal by Subject|18|||
144589128|NCT00412061|521355845|FG001|Double Blind Phase|Withdrawal by Subject|20|||
144589129|NCT00412061|521355844|FG000|Double Blind Phase|Death|6|||
144589130|NCT00412061|521355845|FG001|Double Blind Phase|Death|3|||
144589131|NCT00412061|521355844|FG000|Double Blind Phase|Protocol Violation|3|||
144589132|NCT00412061|521355845|FG001|Double Blind Phase|Protocol Violation|4|||
144589133|NCT00412061|521355844|FG000|Double Blind Phase|New Cander Therapy|1|||
144589134|NCT00412061|521355845|FG001|Double Blind Phase|New Cander Therapy|1|||
144589135|NCT00412061|521355844|FG000|Double Blind Phase|Lost to Follow-up|0|||
144589136|NCT00412061|521355845|FG001|Double Blind Phase|Lost to Follow-up|1|||
144589137|NCT00412061|521355844|FG000|Open Label Phase|Disease Progression|0|||
144589138|NCT00412061|521355845|FG001|Open Label Phase|Disease Progression|86|||
144589139|NCT00412061|521355844|FG000|Open Label Phase|Adverse Event|0|||
144589140|NCT00412061|521355845|FG001|Open Label Phase|Adverse Event|46|||
144589141|NCT00412061|521355844|FG000|Open Label Phase|Withdrawal by Subject|0|||
144589142|NCT00412061|521355845|FG001|Open Label Phase|Withdrawal by Subject|15|||
144589143|NCT00412061|521355844|FG000|Open Label Phase|Administrative Problems|0|||
144589144|NCT00412061|521355845|FG001|Open Label Phase|Administrative Problems|13|||
144589145|NCT00412061|521355844|FG000|Open Label Phase|Death|0|||
144589146|NCT00412061|521355845|FG001|Open Label Phase|Death|7|||
144589147|NCT00412061|521355844|FG000|Open Label Phase|Lost to Follow-up|0|||
144589148|NCT00412061|521355845|FG001|Open Label Phase|Lost to Follow-up|2|||
144589149|NCT00412061|521355844|FG000|Open Label Phase|New Cancer Therapy|0|||
144589150|NCT00412061|521355845|FG001|Open Label Phase|New Cancer Therapy|1|||
144589151|NCT02689518|521355847|FG000|Overall Study|Withdrawal by Subject|3|||
144589152|NCT02433340|521355851|FG000|Overall Study|Adverse Event|0|||
144589153|NCT02433340|521355852|FG001|Overall Study|Adverse Event|0|||
144589154|NCT02433340|521355853|FG002|Overall Study|Adverse Event|1|||
144589155|NCT02433340|521355854|FG003|Overall Study|Adverse Event|0|||
144589156|NCT02433340|521355851|FG000|Overall Study|Withdrawal by Subject|1|||
144589157|NCT02433340|521355852|FG001|Overall Study|Withdrawal by Subject|0|||
144589158|NCT02433340|521355853|FG002|Overall Study|Withdrawal by Subject|1|||
144589159|NCT02433340|521355854|FG003|Overall Study|Withdrawal by Subject|2|||
144589160|NCT02433340|521355851|FG000|Overall Study|Lost to Follow-up|0|||
144589161|NCT02433340|521355852|FG001|Overall Study|Lost to Follow-up|1|||
144589162|NCT02433340|521355853|FG002|Overall Study|Lost to Follow-up|0|||
144589163|NCT02433340|521355854|FG003|Overall Study|Lost to Follow-up|0|||
144589164|NCT02433340|521355851|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
144589165|NCT02433340|521355852|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
144589166|NCT02433340|521355853|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
144589167|NCT02433340|521355854|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
144589168|NCT02433340|521355851|FG000|Overall Study|Other|0|||
144589169|NCT02433340|521355852|FG001|Overall Study|Other|1|||
144589170|NCT02433340|521355853|FG002|Overall Study|Other|0|||
144589171|NCT02433340|521355854|FG003|Overall Study|Other|0|||
144589172|NCT01178385|521355855|FG000|Overall Study|Withdrawal by Subject|2|||
144589173|NCT01178385|521355856|FG001|Overall Study|Withdrawal by Subject|0|||
144589174|NCT01688830|521355859|FG000|Overall Study|Lost to Follow-up|0|||
144589175|NCT01688830|521355860|FG001|Overall Study|Lost to Follow-up|0|||
144589176|NCT01688830|521355861|FG002|Overall Study|Lost to Follow-up|0|||
144589177|NCT01688830|521355862|FG003|Overall Study|Lost to Follow-up|0|||
144589178|NCT01688830|521355863|FG004|Overall Study|Lost to Follow-up|0|||
144589179|NCT01688830|521355864|FG005|Overall Study|Lost to Follow-up|0|||
144509300|NCT02988817|521064178|FG000|Overall Study|Sponsor decision|0|||
144509301|NCT02988817|521064179|FG001|Overall Study|Sponsor decision|0|||
144509302|NCT02988817|521064180|FG002|Overall Study|Sponsor decision|0|||
144509303|NCT02988817|521064181|FG003|Overall Study|Sponsor decision|0|||
144509304|NCT02988817|521064182|FG004|Overall Study|Sponsor decision|0|||
144509305|NCT02988817|521064183|FG005|Overall Study|Sponsor decision|0|||
144509306|NCT02988817|521064184|FG006|Overall Study|Sponsor decision|0|||
144509307|NCT02988817|521064185|FG007|Overall Study|Sponsor decision|0|||
144509308|NCT02988817|521064186|FG008|Overall Study|Sponsor decision|0|||
144509309|NCT02988817|521064187|FG009|Overall Study|Sponsor decision|0|||
144509310|NCT02988817|521064188|FG010|Overall Study|Sponsor decision|0|||
144509311|NCT02988817|521064189|FG011|Overall Study|Sponsor decision|1|||
144509312|NCT02988817|521064190|FG012|Overall Study|Sponsor decision|1|||
144509313|NCT02988817|521064191|FG013|Overall Study|Sponsor decision|2|||
144509314|NCT02988817|521064192|FG014|Overall Study|Sponsor decision|2|||
144509315|NCT02988817|521064193|FG015|Overall Study|Sponsor decision|6|||
144509316|NCT02988817|521064194|FG016|Overall Study|Sponsor decision|2|||
144509317|NCT02988817|521064195|FG017|Overall Study|Sponsor decision|3|||
144509318|NCT02988817|521064196|FG018|Overall Study|Sponsor decision|2|||
144509319|NCT02988817|521064197|FG019|Overall Study|Sponsor decision|7|||
144509320|NCT02988817|521064178|FG000|Overall Study|Physician Decision|0|||
144509321|NCT02988817|521064179|FG001|Overall Study|Physician Decision|0|||
144509322|NCT02988817|521064180|FG002|Overall Study|Physician Decision|0|||
144509323|NCT02988817|521064181|FG003|Overall Study|Physician Decision|0|||
144509324|NCT02988817|521064182|FG004|Overall Study|Physician Decision|0|||
144509325|NCT02988817|521064183|FG005|Overall Study|Physician Decision|0|||
144509326|NCT02988817|521064184|FG006|Overall Study|Physician Decision|0|||
144509327|NCT02988817|521064185|FG007|Overall Study|Physician Decision|0|||
144509328|NCT02988817|521064186|FG008|Overall Study|Physician Decision|0|||
144509329|NCT02988817|521064187|FG009|Overall Study|Physician Decision|0|||
144509330|NCT02988817|521064188|FG010|Overall Study|Physician Decision|0|||
144509331|NCT02988817|521064189|FG011|Overall Study|Physician Decision|0|||
144509332|NCT02988817|521064190|FG012|Overall Study|Physician Decision|0|||
144509333|NCT02988817|521064191|FG013|Overall Study|Physician Decision|0|||
144509334|NCT02988817|521064192|FG014|Overall Study|Physician Decision|0|||
144509335|NCT02988817|521064193|FG015|Overall Study|Physician Decision|1|||
144509336|NCT02988817|521064194|FG016|Overall Study|Physician Decision|0|||
144509337|NCT02988817|521064195|FG017|Overall Study|Physician Decision|0|||
144509338|NCT02988817|521064196|FG018|Overall Study|Physician Decision|1|||
144509339|NCT02988817|521064197|FG019|Overall Study|Physician Decision|1|||
144509340|NCT05082935|521064204|FG000|Overall Study|Lost to Follow-up|549|||
144509341|NCT05082935|521064205|FG001|Overall Study|Lost to Follow-up|631|||
144509342|NCT05082935|521064204|FG000|Overall Study|Withdrawal by Subject|27|||
144509343|NCT05082935|521064205|FG001|Overall Study|Withdrawal by Subject|58|||
144509344|NCT04530747|521064210|FG000|Overall Study|Withdrawal by Subject|1|||
144509345|NCT04530747|521064211|FG001|Overall Study|Withdrawal by Subject|0|||
144509346|NCT03292913|521064212|FG000|Overall Study|Death|9|||
144509347|NCT03292913|521064213|FG001|Overall Study|Death|3|||
144509348|NCT03292913|521064212|FG000|Overall Study|Lost to Follow-up|49|||
144509349|NCT03292913|521064213|FG001|Overall Study|Lost to Follow-up|49|||
144509350|NCT03292913|521064212|FG000|Overall Study|Withdrawal by Subject|2|||
144509351|NCT03292913|521064213|FG001|Overall Study|Withdrawal by Subject|0|||
144509352|NCT03292913|521064212|FG000|Overall Study|Clinic closed due to COVID|22|||
144509353|NCT03292913|521064213|FG001|Overall Study|Clinic closed due to COVID|36|||
144509354|NCT03950622|521064214|FG000|Overall Study|Withdrawal by Subject|1|||
144509355|NCT03950622|521064215|FG001|Overall Study|Withdrawal by Subject|0|||
144509356|NCT03950622|521064214|FG000|Overall Study|Protocol Deviation|0|||
144509357|NCT03950622|521064215|FG001|Overall Study|Protocol Deviation|1|||
144509358|NCT03950622|521064214|FG000|Overall Study|Physician Decision|1|||
144509359|NCT03950622|521064215|FG001|Overall Study|Physician Decision|0|||
144509360|NCT03950622|521064214|FG000|Overall Study|Lost to Follow-up|5|||
144509361|NCT03950622|521064215|FG001|Overall Study|Lost to Follow-up|5|||
144509362|NCT03950622|521064214|FG000|Overall Study|Death|1|||
144509363|NCT03950622|521064215|FG001|Overall Study|Death|1|||
144509364|NCT02379819|521064216|FG000|Overall Study|Withdrawal by Subject|10|||
144509365|NCT02379819|521064216|FG000|Overall Study|Death|2|||
144509366|NCT02379819|521064216|FG000|Overall Study|Lack of Efficacy|1|||
144509367|NCT02379819|521064216|FG000|Overall Study|Lost to Follow-up|1|||
144509368|NCT01839331|521064217|FG000|Overall Study|Early Termination|3|||
144509369|NCT01839331|521064218|FG001|Overall Study|Early Termination|0|||
144509370|NCT01839331|521064219|FG002|Overall Study|Early Termination|1|||
144509371|NCT01839331|521064220|FG003|Overall Study|Early Termination|2|||
144509372|NCT01839331|521064217|FG000|Overall Study|Protocol Violation|1|||
144509373|NCT01839331|521064218|FG001|Overall Study|Protocol Violation|6|||
144509374|NCT01839331|521064219|FG002|Overall Study|Protocol Violation|4|||
144509375|NCT01839331|521064220|FG003|Overall Study|Protocol Violation|3|||
144509376|NCT03752151|521064221|FG000|Overall Study|Withdrawal by Subject|1|||
144509377|NCT03752151|521064221|FG000|Overall Study|Protocol Violation|1|||
144509378|NCT04056624|521064222|FG000|Overall Study|Withdrawal by Subject|0|||
144509379|NCT04056624|521064223|FG001|Overall Study|Withdrawal by Subject|0|||
144509380|NCT04056624|521064224|FG002|Overall Study|Withdrawal by Subject|1|||
144509381|NCT04056624|521064222|FG000|Overall Study|Protocol Violation|1|||
144509382|NCT04056624|521064223|FG001|Overall Study|Protocol Violation|2|||
144509383|NCT04056624|521064224|FG002|Overall Study|Protocol Violation|0|||
144509384|NCT03531840|521064230|FG000|Overall Study|Death on study|3|||
144509385|NCT03531840|521064231|FG001|Overall Study|Death on study|2|||
144509386|NCT03531840|521064232|FG002|Overall Study|Death on study|1|||
144509387|NCT03531840|521064233|FG003|Overall Study|Death on study|2|||
144509388|NCT03531840|521064230|FG000|Overall Study|Death during follow up|2|||
144509389|NCT03531840|521064231|FG001|Overall Study|Death during follow up|3|||
144509390|NCT03531840|521064232|FG002|Overall Study|Death during follow up|4|||
144509391|NCT03531840|521064233|FG003|Overall Study|Death during follow up|1|||
144509392|NCT02092116|521064234|FG000|Overall Study|Withdrawal by Subject|0|||
144509393|NCT02092116|521064235|FG001|Overall Study|Withdrawal by Subject|3|||
144509394|NCT02092116|521064234|FG000|Overall Study|Adverse Event|0|||
144509395|NCT02092116|521064235|FG001|Overall Study|Adverse Event|1|||
144509396|NCT02267824|521064236|FG000|Overall Study|Pregnancy|1|||
144509397|NCT02267824|521064237|FG001|Overall Study|Pregnancy|1|||
144509398|NCT02267824|521064236|FG000|Overall Study|Lost to Follow-up|4|||
144509399|NCT02267824|521064237|FG001|Overall Study|Lost to Follow-up|0|||
144509400|NCT02267824|521064236|FG000|Overall Study|Protocol Violation|3|||
144509401|NCT02267824|521064237|FG001|Overall Study|Protocol Violation|0|||
144509402|NCT02267824|521064236|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
144509403|NCT02267824|521064237|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
144509404|NCT03074331|521064238|FG000|Overall Study|Enrolled but Not Treated|1|||
144509405|NCT03074331|521064238|FG000|Overall Study|Lost to Follow-up|5|||
144509406|NCT03074331|521064238|FG000|Overall Study|Withdrew Consent|1|||
144509407|NCT01792830|521064242|FG000|Overall Study|Withdrawal by Subject|22|||
144509408|NCT01792830|521064243|FG001|Overall Study|Withdrawal by Subject|0|||
144509409|NCT01792830|521064244|FG002|Overall Study|Withdrawal by Subject|0|||
144509410|NCT01792830|521064245|FG003|Overall Study|Withdrawal by Subject|2|||
144509411|NCT01792830|521064246|FG004|Overall Study|Withdrawal by Subject|1|||
144509412|NCT01792830|521064247|FG005|Overall Study|Withdrawal by Subject|1|||
144509413|NCT01792830|521064248|FG006|Overall Study|Withdrawal by Subject|1|||
144509414|NCT01792830|521064249|FG007|Overall Study|Withdrawal by Subject|1|||
144509415|NCT01792830|521064250|FG008|Overall Study|Withdrawal by Subject|7|||
144509416|NCT01792830|521064251|FG009|Overall Study|Withdrawal by Subject|0|||
144509417|NCT01792830|521064252|FG010|Overall Study|Withdrawal by Subject|2|||
144509418|NCT01792830|521064242|FG000|Overall Study|Death|3|||
144509419|NCT01792830|521064243|FG001|Overall Study|Death|0|||
144509420|NCT01792830|521064244|FG002|Overall Study|Death|0|||
144509421|NCT01792830|521064245|FG003|Overall Study|Death|1|||
144509422|NCT01792830|521064246|FG004|Overall Study|Death|0|||
144509423|NCT01792830|521064247|FG005|Overall Study|Death|0|||
144509424|NCT01792830|521064248|FG006|Overall Study|Death|1|||
144509425|NCT01792830|521064249|FG007|Overall Study|Death|0|||
144509426|NCT01792830|521064250|FG008|Overall Study|Death|1|||
144509427|NCT01792830|521064251|FG009|Overall Study|Death|0|||
144509428|NCT01792830|521064252|FG010|Overall Study|Death|1|||
144509429|NCT01792830|521064242|FG000|Overall Study|Adverse Event|0|||
144509430|NCT01792830|521064243|FG001|Overall Study|Adverse Event|0|||
144509431|NCT01792830|521064244|FG002|Overall Study|Adverse Event|0|||
144509432|NCT01792830|521064245|FG003|Overall Study|Adverse Event|0|||
144509433|NCT01792830|521064246|FG004|Overall Study|Adverse Event|0|||
144509434|NCT01792830|521064247|FG005|Overall Study|Adverse Event|0|||
144509435|NCT01792830|521064248|FG006|Overall Study|Adverse Event|0|||
144509436|NCT01792830|521064249|FG007|Overall Study|Adverse Event|0|||
144509437|NCT01792830|521064250|FG008|Overall Study|Adverse Event|1|||
144589180|NCT01688830|521355865|FG006|Overall Study|Lost to Follow-up|0|||
144589181|NCT01688830|521355866|FG007|Overall Study|Lost to Follow-up|0|||
144589182|NCT01688830|521355867|FG008|Overall Study|Lost to Follow-up|0|||
144509438|NCT01792830|521064251|FG009|Overall Study|Adverse Event|0|||
144509439|NCT01792830|521064252|FG010|Overall Study|Adverse Event|0|||
144509440|NCT01943799|521064253|FG000|Overall Study|Lost to Follow-up|0|||
144509441|NCT01943799|521064254|FG001|Overall Study|Lost to Follow-up|1|||
144509442|NCT01943799|521064255|FG002|Overall Study|Lost to Follow-up|1|||
144509443|NCT01943799|521064256|FG003|Overall Study|Lost to Follow-up|0|||
144509444|NCT01943799|521064253|FG000|Overall Study|Protocol Violation|1|||
144509445|NCT01943799|521064254|FG001|Overall Study|Protocol Violation|0|||
144509446|NCT01943799|521064255|FG002|Overall Study|Protocol Violation|0|||
144509447|NCT01943799|521064256|FG003|Overall Study|Protocol Violation|0|||
144509448|NCT01943799|521064253|FG000|Overall Study|Withdrawal by Subject|4|||
144509449|NCT01943799|521064254|FG001|Overall Study|Withdrawal by Subject|2|||
144589183|NCT01688830|521355868|FG009|Overall Study|Lost to Follow-up|0|||
144509450|NCT01943799|521064255|FG002|Overall Study|Withdrawal by Subject|1|||
144509451|NCT01943799|521064256|FG003|Overall Study|Withdrawal by Subject|0|||
144509452|NCT03811574|521064259|FG000|Overall Study|Withdrawal by Subject|2|||
144509453|NCT03811574|521064260|FG001|Overall Study|Withdrawal by Subject|4|||
144509454|NCT03811574|521064261|FG002|Overall Study|Withdrawal by Subject|0|||
144509455|NCT01170962|521064263|FG000|Treatment Period|Lack of Efficacy|96|||
144589184|NCT01688830|521355869|FG010|Overall Study|Lost to Follow-up|1|||
144589185|NCT01688830|521355870|FG011|Overall Study|Lost to Follow-up|0|||
144589186|NCT01688830|521355871|FG012|Overall Study|Lost to Follow-up|0|||
144589187|NCT01688830|521355872|FG013|Overall Study|Lost to Follow-up|0|||
144589188|NCT01688830|521355873|FG014|Overall Study|Lost to Follow-up|0|||
144589189|NCT01688830|521355874|FG015|Overall Study|Lost to Follow-up|0|||
144589190|NCT01688830|521355875|FG016|Overall Study|Lost to Follow-up|0|||
144589191|NCT01688830|521355876|FG017|Overall Study|Lost to Follow-up|0|||
144589192|NCT01688830|521355877|FG018|Overall Study|Lost to Follow-up|0|||
144589193|NCT01688830|521355878|FG019|Overall Study|Lost to Follow-up|0|||
144589194|NCT01688830|521355879|FG020|Overall Study|Lost to Follow-up|0|||
144589195|NCT02679508|521355881|FG000|Healing Phase|Protocol Violation|1|||
144589196|NCT02679508|521355882|FG001|Healing Phase|Protocol Violation|1|||
144589197|NCT02679508|521355881|FG000|Healing Phase|Lost to Follow-up|1|||
144589198|NCT02679508|521355882|FG001|Healing Phase|Lost to Follow-up|0|||
144589199|NCT02679508|521355881|FG000|Maintenance Phase|Adverse Event|12|||
144589200|NCT02679508|521355882|FG001|Maintenance Phase|Adverse Event|2|||
144589201|NCT02679508|521355881|FG000|Maintenance Phase|Lost to Follow-up|0|||
144589202|NCT02679508|521355882|FG001|Maintenance Phase|Lost to Follow-up|1|||
144589203|NCT02679508|521355881|FG000|Maintenance Phase|Withdrawal by Subject|15|||
144589204|NCT02679508|521355882|FG001|Maintenance Phase|Withdrawal by Subject|8|||
144589205|NCT02679508|521355881|FG000|Maintenance Phase|Other|5|||
144589206|NCT02679508|521355882|FG001|Maintenance Phase|Other|4|||
144589207|NCT03143166|521355883|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
144589208|NCT00589121|521355888|FG000|Overall Study|Protocol Violation|2|||
144589209|NCT00589121|521355889|FG001|Overall Study|Protocol Violation|6|||
144589210|NCT00589121|521355888|FG000|Overall Study|No protocol treatment received|0|||
144589211|NCT00589121|521355889|FG001|Overall Study|No protocol treatment received|1|||
144589212|NCT00847808|521355890|FG000|Overall Study|Adverse Event|7|||
144589213|NCT00847808|521355890|FG000|Overall Study|Protocol Violation|1|||
144589214|NCT00847808|521355890|FG000|Overall Study|Lost to Follow-up|1|||
144589215|NCT00847808|521355890|FG000|Overall Study|Withdrawal by Subject|4|||
144589216|NCT00847808|521355890|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
144589217|NCT00847808|521355890|FG000|Overall Study|Participant Took Excluded Medication|1|||
144589218|NCT05326815|521355891|FG000|Overall Study|Withdrawal by Subject|3|||
144589219|NCT05326815|521355891|FG000|Overall Study|Did not complete required labs|6|||
144589220|NCT05326815|521355891|FG000|Overall Study|Screen fail- abnormal labs|5|||
144589221|NCT00925132|521355892|FG000|Overall Study|Withdrawal by Subject|2|||
144589222|NCT00925132|521355893|FG001|Overall Study|Withdrawal by Subject|0|||
144589223|NCT00925132|521355894|FG002|Overall Study|Withdrawal by Subject|0|||
144589224|NCT00925132|521355895|FG003|Overall Study|Withdrawal by Subject|0|||
144589225|NCT00925132|521355896|FG004|Overall Study|Withdrawal by Subject|1|||
144589226|NCT00925132|521355892|FG000|Overall Study|Removed due to disease progression|0|||
144589227|NCT00925132|521355893|FG001|Overall Study|Removed due to disease progression|0|||
144589228|NCT00925132|521355894|FG002|Overall Study|Removed due to disease progression|0|||
144589229|NCT00925132|521355895|FG003|Overall Study|Removed due to disease progression|0|||
144589230|NCT00925132|521355896|FG004|Overall Study|Removed due to disease progression|4|||
144589231|NCT02545933|521355897|FG000|Overall Study|Adverse Event|3|||
144589232|NCT02545933|521355898|FG001|Overall Study|Adverse Event|0|||
144589233|NCT02545933|521355899|FG002|Overall Study|Adverse Event|0|||
144589234|NCT02545933|521355897|FG000|Overall Study|Withdrawal by Subject|2|||
144589235|NCT02545933|521355898|FG001|Overall Study|Withdrawal by Subject|3|||
144589236|NCT02545933|521355899|FG002|Overall Study|Withdrawal by Subject|3|||
144589237|NCT02545933|521355897|FG000|Overall Study|Protocol Violation|1|||
144589238|NCT02545933|521355898|FG001|Overall Study|Protocol Violation|0|||
144589239|NCT02545933|521355899|FG002|Overall Study|Protocol Violation|1|||
144589240|NCT01370590|521355900|FG000|Period 1|Adverse Event|8|||
144589241|NCT01370590|521355901|FG001|Period 1|Adverse Event|4|||
144589242|NCT01370590|521355900|FG000|Period 1|Lost to Follow-up|2|||
144589243|NCT01370590|521355901|FG001|Period 1|Lost to Follow-up|2|||
144589244|NCT01370590|521355900|FG000|Period 1|Protocol Violation|2|||
144589245|NCT01370590|521355901|FG001|Period 1|Protocol Violation|2|||
144589246|NCT01370590|521355900|FG000|Period 1|Withdrawal by Subject|4|||
144589247|NCT01370590|521355901|FG001|Period 1|Withdrawal by Subject|2|||
144589248|NCT01370590|521355900|FG000|Period 1|Could not access randomization system|0|||
144589249|NCT01370590|521355901|FG001|Period 1|Could not access randomization system|1|||
144589250|NCT01370590|521355900|FG000|Crossover Washout Period|Adverse Event|1|||
144589251|NCT01370590|521355901|FG001|Crossover Washout Period|Adverse Event|4|||
144589252|NCT01370590|521355900|FG000|Crossover Washout Period|Lost to Follow-up|2|||
144589253|NCT01370590|521355901|FG001|Crossover Washout Period|Lost to Follow-up|0|||
144589254|NCT01370590|521355900|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
144589255|NCT01370590|521355901|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
144589256|NCT01370590|521355900|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
144589257|NCT01370590|521355901|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
144589258|NCT01370590|521355900|FG000|Period 2|Adverse Event|0|||
144589259|NCT01370590|521355901|FG001|Period 2|Adverse Event|1|||
144509456|NCT01170962|521064264|FG001|Treatment Period|Lack of Efficacy|91|||
144509457|NCT01170962|521064265|FG002|Treatment Period|Lack of Efficacy|7|||
144509458|NCT01170962|521064263|FG000|Treatment Period|Adverse Event|11|||
144509459|NCT01170962|521064264|FG001|Treatment Period|Adverse Event|12|||
144509460|NCT01170962|521064265|FG002|Treatment Period|Adverse Event|3|||
144509461|NCT01170962|521064263|FG000|Treatment Period|Withdrawal by Subject|2|||
144509462|NCT01170962|521064264|FG001|Treatment Period|Withdrawal by Subject|1|||
144509463|NCT01170962|521064265|FG002|Treatment Period|Withdrawal by Subject|0|||
144509464|NCT01170962|521064263|FG000|Treatment Period|Lost to Follow-up|1|||
144509465|NCT01170962|521064264|FG001|Treatment Period|Lost to Follow-up|1|||
144509466|NCT01170962|521064265|FG002|Treatment Period|Lost to Follow-up|1|||
144509467|NCT01170962|521064263|FG000|Treatment Period|Participant no longer meets criteria|0|||
144509468|NCT01170962|521064264|FG001|Treatment Period|Participant no longer meets criteria|1|||
144509469|NCT01170962|521064265|FG002|Treatment Period|Participant no longer meets criteria|0|||
144509470|NCT01170962|521064263|FG000|Treatment Period|Request to discontinue treatment|7|||
144509471|NCT01170962|521064264|FG001|Treatment Period|Request to discontinue treatment|3|||
144509472|NCT01170962|521064265|FG002|Treatment Period|Request to discontinue treatment|1|||
144509473|NCT01170962|521064263|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
144509474|NCT01170962|521064264|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
144509475|NCT01170962|521064265|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
144509476|NCT01170962|521064263|FG000|Follow up Period|Withdrawal by Subject|14|||
144509477|NCT01170962|521064264|FG001|Follow up Period|Withdrawal by Subject|10|||
144509478|NCT01170962|521064265|FG002|Follow up Period|Withdrawal by Subject|2|||
144509479|NCT01170962|521064263|FG000|Follow up Period|Lost to Follow-up|13|||
144509480|NCT01170962|521064264|FG001|Follow up Period|Lost to Follow-up|8|||
144509481|NCT01170962|521064265|FG002|Follow up Period|Lost to Follow-up|1|||
144509482|NCT01170962|521064263|FG000|Follow up Period|Death|2|||
144509483|NCT01170962|521064264|FG001|Follow up Period|Death|2|||
144509484|NCT01170962|521064265|FG002|Follow up Period|Death|0|||
144509485|NCT01170962|521064263|FG000|Follow up Period|Others|10|||
144509486|NCT01170962|521064264|FG001|Follow up Period|Others|7|||
144509487|NCT01170962|521064265|FG002|Follow up Period|Others|3|||
144509488|NCT02918071|521064266|FG000|Overall Study|Withdrawal by Subject|2|||
144509489|NCT02918071|521064266|FG000|Overall Study|Lost to Follow-up|1|||
144509490|NCT01616459|521064267|FG000|Overall Study|Adverse Event|1|||
144509491|NCT01616459|521064268|FG001|Overall Study|Adverse Event|1|||
144509492|NCT01616459|521064269|FG002|Overall Study|Adverse Event|2|||
144509493|NCT01616459|521064270|FG003|Overall Study|Adverse Event|0|||
144509494|NCT01616459|521064267|FG000|Overall Study|Lost to Follow-up|1|||
144509495|NCT01616459|521064268|FG001|Overall Study|Lost to Follow-up|11|||
144509496|NCT01616459|521064269|FG002|Overall Study|Lost to Follow-up|3|||
144509497|NCT01616459|521064270|FG003|Overall Study|Lost to Follow-up|2|||
144509498|NCT01616459|521064267|FG000|Overall Study|Protocol Violation|0|||
144509499|NCT01616459|521064268|FG001|Overall Study|Protocol Violation|0|||
144509500|NCT01616459|521064269|FG002|Overall Study|Protocol Violation|0|||
144509501|NCT01616459|521064270|FG003|Overall Study|Protocol Violation|2|||
144509502|NCT01616459|521064267|FG000|Overall Study|Withdrawal by Subject|2|||
144509503|NCT01616459|521064268|FG001|Overall Study|Withdrawal by Subject|4|||
144509504|NCT01616459|521064269|FG002|Overall Study|Withdrawal by Subject|4|||
144509505|NCT01616459|521064270|FG003|Overall Study|Withdrawal by Subject|4|||
144509506|NCT01616459|521064267|FG000|Overall Study|Other reason|0|||
144509507|NCT01616459|521064268|FG001|Overall Study|Other reason|1|||
144509508|NCT01616459|521064269|FG002|Overall Study|Other reason|1|||
144509509|NCT01616459|521064270|FG003|Overall Study|Other reason|0|||
144509510|NCT03394885|521064271|FG000|Overall Study|Adverse Event|4|||
144509511|NCT03394885|521064271|FG000|Overall Study|Lack of Efficacy|1|||
144509512|NCT03394885|521064271|FG000|Overall Study|Physician Decision|1|||
144509513|NCT03394885|521064271|FG000|Overall Study|Withdrawal by Subject|8|||
144509514|NCT03394885|521064271|FG000|Overall Study|Alternative Therapy|1|||
144509515|NCT00801983|521064272|FG000|Period 1|Lost to Follow-up|2|||
144509516|NCT00801983|521064273|FG001|Period 1|Lost to Follow-up|0|||
144509517|NCT00801983|521064272|FG000|Period 1|Withdrawal by Subject|2|||
144509518|NCT00801983|521064273|FG001|Period 1|Withdrawal by Subject|8|||
144509519|NCT00801983|521064272|FG000|Period 2|Withdrawal by Subject|2|||
144509520|NCT00801983|521064273|FG001|Period 2|Withdrawal by Subject|1|||
144509521|NCT04411056|521066144|FG000|Overall Study|surgery cancelled|1|||
144509522|NCT04411056|521066145|FG001|Overall Study|surgery cancelled|0|||
144509523|NCT04411056|521066144|FG000|Overall Study|Equipment problem during intubation|0|||
144509524|NCT04411056|521066145|FG001|Overall Study|Equipment problem during intubation|1|||
144509525|NCT04623008|521066146|FG000|Baseline to T2|Withdrawal by Subject|4|||
144509526|NCT04623008|521066147|FG001|Baseline to T2|Withdrawal by Subject|2|||
144509527|NCT04623008|521066146|FG000|Baseline to T3|Withdrawal by Subject|4|||
144509528|NCT04623008|521066147|FG001|Baseline to T3|Withdrawal by Subject|2|||
144509529|NCT01622868|521066154|FG000|Overall Study|Protocol Violation|7|||
144509530|NCT01622868|521066155|FG001|Overall Study|Protocol Violation|0|||
144509531|NCT04425629|521066158|FG000|Overall Study|Adverse Event|0|||
144509532|NCT04425629|521066159|FG001|Overall Study|Adverse Event|0|||
144509533|NCT04425629|521066160|FG002|Overall Study|Adverse Event|0|||
144509534|NCT04425629|521066161|FG003|Overall Study|Adverse Event|0|||
144509535|NCT04425629|521066162|FG004|Overall Study|Adverse Event|1|||
144509536|NCT04425629|521066163|FG005|Overall Study|Adverse Event|0|||
144509537|NCT04425629|521066164|FG006|Overall Study|Adverse Event|0|||
144509538|NCT04425629|521066165|FG007|Overall Study|Adverse Event|0|||
144509539|NCT04425629|521066166|FG008|Overall Study|Adverse Event|0|||
144509540|NCT04425629|521066167|FG009|Overall Study|Adverse Event|3|||
144509541|NCT04425629|521066168|FG010|Overall Study|Adverse Event|2|||
144509542|NCT04425629|521066169|FG011|Overall Study|Adverse Event|1|||
144509543|NCT04425629|521066170|FG012|Overall Study|Adverse Event|1|||
144509544|NCT04425629|521066171|FG013|Overall Study|Adverse Event|0|||
144509545|NCT04425629|521066172|FG014|Overall Study|Adverse Event|0|||
144509546|NCT04425629|521066173|FG015|Overall Study|Adverse Event|0|||
144509547|NCT04425629|521066174|FG016|Overall Study|Adverse Event|0|||
144509548|NCT04425629|521066175|FG017|Overall Study|Adverse Event|0|||
144509549|NCT04425629|521066176|FG018|Overall Study|Adverse Event|0|||
144509550|NCT04425629|521066158|FG000|Overall Study|Lost to Follow-up|1|||
144509551|NCT04425629|521066159|FG001|Overall Study|Lost to Follow-up|3|||
144509552|NCT04425629|521066160|FG002|Overall Study|Lost to Follow-up|1|||
144509553|NCT04425629|521066161|FG003|Overall Study|Lost to Follow-up|7|||
144509554|NCT04425629|521066162|FG004|Overall Study|Lost to Follow-up|1|||
144509555|NCT04425629|521066163|FG005|Overall Study|Lost to Follow-up|2|||
144509556|NCT04425629|521066164|FG006|Overall Study|Lost to Follow-up|1|||
144509557|NCT04425629|521066165|FG007|Overall Study|Lost to Follow-up|0|||
144509558|NCT04425629|521066166|FG008|Overall Study|Lost to Follow-up|1|||
144509559|NCT04425629|521066167|FG009|Overall Study|Lost to Follow-up|64|||
144509560|NCT04425629|521066168|FG010|Overall Study|Lost to Follow-up|70|||
144509561|NCT04425629|521066169|FG011|Overall Study|Lost to Follow-up|98|||
144509562|NCT04425629|521066170|FG012|Overall Study|Lost to Follow-up|30|||
144509563|NCT04425629|521066171|FG013|Overall Study|Lost to Follow-up|0|||
144509564|NCT04425629|521066172|FG014|Overall Study|Lost to Follow-up|5|||
144509565|NCT04425629|521066173|FG015|Overall Study|Lost to Follow-up|4|||
144509566|NCT04425629|521066174|FG016|Overall Study|Lost to Follow-up|0|||
144509567|NCT04425629|521066175|FG017|Overall Study|Lost to Follow-up|3|||
144509568|NCT04425629|521066176|FG018|Overall Study|Lost to Follow-up|1|||
144509569|NCT04425629|521066158|FG000|Overall Study|Subject Decision|0|||
144509570|NCT04425629|521066159|FG001|Overall Study|Subject Decision|2|||
144509571|NCT04425629|521066160|FG002|Overall Study|Subject Decision|1|||
144509572|NCT04425629|521066161|FG003|Overall Study|Subject Decision|3|||
144509573|NCT04425629|521066162|FG004|Overall Study|Subject Decision|6|||
144509574|NCT04425629|521066163|FG005|Overall Study|Subject Decision|6|||
144509575|NCT04425629|521066164|FG006|Overall Study|Subject Decision|3|||
144509576|NCT04425629|521066165|FG007|Overall Study|Subject Decision|3|||
144509577|NCT04425629|521066166|FG008|Overall Study|Subject Decision|1|||
144509578|NCT04425629|521066167|FG009|Overall Study|Subject Decision|70|||
144509579|NCT04425629|521066168|FG010|Overall Study|Subject Decision|95|||
144509580|NCT04425629|521066169|FG011|Overall Study|Subject Decision|124|||
144509581|NCT04425629|521066170|FG012|Overall Study|Subject Decision|25|||
144509582|NCT04425629|521066171|FG013|Overall Study|Subject Decision|0|||
144509583|NCT04425629|521066172|FG014|Overall Study|Subject Decision|1|||
144509584|NCT04425629|521066173|FG015|Overall Study|Subject Decision|4|||
144509585|NCT04425629|521066174|FG016|Overall Study|Subject Decision|1|||
144509586|NCT04425629|521066175|FG017|Overall Study|Subject Decision|0|||
144509587|NCT04425629|521066176|FG018|Overall Study|Subject Decision|2|||
144509588|NCT04425629|521066158|FG000|Overall Study|Death|0|||
144509589|NCT04425629|521066159|FG001|Overall Study|Death|0|||
144509590|NCT04425629|521066160|FG002|Overall Study|Death|0|||
144509591|NCT04425629|521066161|FG003|Overall Study|Death|0|||
144509592|NCT04425629|521066162|FG004|Overall Study|Death|0|||
144509593|NCT04425629|521066163|FG005|Overall Study|Death|0|||
144509594|NCT04425629|521066164|FG006|Overall Study|Death|0|||
144509595|NCT04425629|521066165|FG007|Overall Study|Death|0|||
144509596|NCT04425629|521066166|FG008|Overall Study|Death|0|||
144509597|NCT04425629|521066167|FG009|Overall Study|Death|11|||
144509598|NCT04425629|521066168|FG010|Overall Study|Death|2|||
144509599|NCT04425629|521066169|FG011|Overall Study|Death|4|||
144509600|NCT04425629|521066170|FG012|Overall Study|Death|0|||
144509601|NCT04425629|521066171|FG013|Overall Study|Death|0|||
144509602|NCT04425629|521066172|FG014|Overall Study|Death|0|||
144509603|NCT04425629|521066173|FG015|Overall Study|Death|0|||
144509604|NCT04425629|521066174|FG016|Overall Study|Death|0|||
144509605|NCT04425629|521066175|FG017|Overall Study|Death|0|||
144509606|NCT04425629|521066176|FG018|Overall Study|Death|0|||
144509607|NCT04425629|521066158|FG000|Overall Study|Sponsor Request|0|||
144509608|NCT04425629|521066159|FG001|Overall Study|Sponsor Request|0|||
144509609|NCT04425629|521066160|FG002|Overall Study|Sponsor Request|0|||
144509610|NCT04425629|521066161|FG003|Overall Study|Sponsor Request|2|||
144509611|NCT04425629|521066162|FG004|Overall Study|Sponsor Request|2|||
144509612|NCT04425629|521066163|FG005|Overall Study|Sponsor Request|2|||
144509613|NCT04425629|521066164|FG006|Overall Study|Sponsor Request|1|||
144509614|NCT04425629|521066165|FG007|Overall Study|Sponsor Request|0|||
144509615|NCT04425629|521066166|FG008|Overall Study|Sponsor Request|0|||
144509616|NCT04425629|521066167|FG009|Overall Study|Sponsor Request|9|||
144589260|NCT01370590|521355900|FG000|Period 2|Withdrawal by Subject|1|||
144589261|NCT01370590|521355901|FG001|Period 2|Withdrawal by Subject|1|||
144589262|NCT05172050|521355902|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
144509617|NCT04425629|521066168|FG010|Overall Study|Sponsor Request|9|||
144509618|NCT04425629|521066169|FG011|Overall Study|Sponsor Request|10|||
144509619|NCT04425629|521066170|FG012|Overall Study|Sponsor Request|8|||
144589263|NCT05172050|521355903|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
144589264|NCT05172050|521355904|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
144589265|NCT05172050|521355902|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
144589266|NCT05172050|521355903|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
144589267|NCT05172050|521355904|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
144589268|NCT05172050|521355902|FG000|Overall Study|Other|2|||
144509620|NCT04425629|521066171|FG013|Overall Study|Sponsor Request|0|||
144509621|NCT04425629|521066172|FG014|Overall Study|Sponsor Request|0|||
144509622|NCT04425629|521066173|FG015|Overall Study|Sponsor Request|1|||
144509623|NCT04425629|521066174|FG016|Overall Study|Sponsor Request|0|||
144509624|NCT04425629|521066175|FG017|Overall Study|Sponsor Request|0|||
144509625|NCT04425629|521066176|FG018|Overall Study|Sponsor Request|0|||
144509626|NCT04425629|521066158|FG000|Overall Study|Physician Decision|0|||
144509627|NCT04425629|521066159|FG001|Overall Study|Physician Decision|0|||
144509628|NCT04425629|521066160|FG002|Overall Study|Physician Decision|0|||
144509629|NCT04425629|521066161|FG003|Overall Study|Physician Decision|0|||
144509630|NCT04425629|521066162|FG004|Overall Study|Physician Decision|0|||
144509631|NCT04425629|521066163|FG005|Overall Study|Physician Decision|0|||
144509632|NCT04425629|521066164|FG006|Overall Study|Physician Decision|0|||
144509633|NCT04425629|521066165|FG007|Overall Study|Physician Decision|0|||
144509634|NCT04425629|521066166|FG008|Overall Study|Physician Decision|0|||
144509635|NCT04425629|521066167|FG009|Overall Study|Physician Decision|4|||
144509636|NCT04425629|521066168|FG010|Overall Study|Physician Decision|3|||
144509637|NCT04425629|521066169|FG011|Overall Study|Physician Decision|5|||
144509638|NCT04425629|521066170|FG012|Overall Study|Physician Decision|1|||
144509639|NCT04425629|521066171|FG013|Overall Study|Physician Decision|0|||
144509640|NCT04425629|521066172|FG014|Overall Study|Physician Decision|0|||
144509641|NCT04425629|521066173|FG015|Overall Study|Physician Decision|1|||
144509642|NCT04425629|521066174|FG016|Overall Study|Physician Decision|0|||
144509643|NCT04425629|521066175|FG017|Overall Study|Physician Decision|0|||
144509644|NCT04425629|521066176|FG018|Overall Study|Physician Decision|0|||
144509645|NCT04425629|521066158|FG000|Overall Study|Lack of Efficacy|0|||
144509646|NCT04425629|521066159|FG001|Overall Study|Lack of Efficacy|0|||
144509647|NCT04425629|521066160|FG002|Overall Study|Lack of Efficacy|0|||
144509648|NCT04425629|521066161|FG003|Overall Study|Lack of Efficacy|0|||
144509649|NCT04425629|521066162|FG004|Overall Study|Lack of Efficacy|0|||
144509650|NCT04425629|521066163|FG005|Overall Study|Lack of Efficacy|0|||
144509651|NCT04425629|521066164|FG006|Overall Study|Lack of Efficacy|0|||
144509652|NCT04425629|521066165|FG007|Overall Study|Lack of Efficacy|0|||
144509653|NCT04425629|521066166|FG008|Overall Study|Lack of Efficacy|0|||
144509654|NCT04425629|521066167|FG009|Overall Study|Lack of Efficacy|0|||
144509655|NCT04425629|521066168|FG010|Overall Study|Lack of Efficacy|1|||
144509656|NCT04425629|521066169|FG011|Overall Study|Lack of Efficacy|0|||
144509657|NCT04425629|521066170|FG012|Overall Study|Lack of Efficacy|0|||
144509658|NCT04425629|521066171|FG013|Overall Study|Lack of Efficacy|0|||
144509659|NCT04425629|521066172|FG014|Overall Study|Lack of Efficacy|0|||
144509660|NCT04425629|521066173|FG015|Overall Study|Lack of Efficacy|0|||
144509661|NCT04425629|521066174|FG016|Overall Study|Lack of Efficacy|0|||
144509662|NCT04425629|521066175|FG017|Overall Study|Lack of Efficacy|0|||
144509663|NCT04425629|521066176|FG018|Overall Study|Lack of Efficacy|0|||
144509664|NCT00610649|521066178|FG000|Overall Study|Adverse Event|1|||
144509665|NCT00610649|521066179|FG001|Overall Study|Adverse Event|0|||
144509666|NCT00610649|521066180|FG002|Overall Study|Adverse Event|0|||
144509667|NCT00610649|521066181|FG003|Overall Study|Adverse Event|0|||
144509668|NCT00610649|521066182|FG004|Overall Study|Adverse Event|0|||
144509669|NCT00610649|521066183|FG005|Overall Study|Adverse Event|0|||
144509670|NCT00610649|521066184|FG006|Overall Study|Adverse Event|0|||
144509671|NCT00610649|521066185|FG007|Overall Study|Adverse Event|0|||
144509672|NCT00610649|521066186|FG008|Overall Study|Adverse Event|0|||
144509673|NCT00610649|521066187|FG009|Overall Study|Adverse Event|0|||
144509674|NCT00610649|521066188|FG010|Overall Study|Adverse Event|1|||
144509675|NCT00610649|521066178|FG000|Overall Study|Family Emergency|0|||
144509676|NCT00610649|521066179|FG001|Overall Study|Family Emergency|1|||
144509677|NCT00610649|521066180|FG002|Overall Study|Family Emergency|0|||
144509678|NCT00610649|521066181|FG003|Overall Study|Family Emergency|0|||
144589269|NCT05172050|521355903|FG001|Overall Study|Other|2|||
144589270|NCT05172050|521355904|FG002|Overall Study|Other|1|||
144589271|NCT05180500|521355905|FG000|Overall Study|Adverse Event|1|||
144509679|NCT00610649|521066182|FG004|Overall Study|Family Emergency|0|||
144509680|NCT00610649|521066183|FG005|Overall Study|Family Emergency|0|||
144509681|NCT00610649|521066184|FG006|Overall Study|Family Emergency|0|||
144509682|NCT00610649|521066185|FG007|Overall Study|Family Emergency|0|||
144509683|NCT00610649|521066186|FG008|Overall Study|Family Emergency|0|||
144509684|NCT00610649|521066187|FG009|Overall Study|Family Emergency|0|||
144589272|NCT05180500|521355906|FG001|Overall Study|Adverse Event|0|||
144589273|NCT05180500|521355905|FG000|Overall Study|Withdrawal by Subject|2|||
144589274|NCT05180500|521355906|FG001|Overall Study|Withdrawal by Subject|0|||
144509685|NCT00610649|521066188|FG010|Overall Study|Family Emergency|0|||
144509686|NCT00610649|521066178|FG000|Overall Study|Withdrawal by Subject|0|||
144509687|NCT00610649|521066179|FG001|Overall Study|Withdrawal by Subject|0|||
144509688|NCT00610649|521066180|FG002|Overall Study|Withdrawal by Subject|0|||
144509689|NCT00610649|521066181|FG003|Overall Study|Withdrawal by Subject|0|||
144509690|NCT00610649|521066182|FG004|Overall Study|Withdrawal by Subject|0|||
144509691|NCT00610649|521066183|FG005|Overall Study|Withdrawal by Subject|0|||
144509692|NCT00610649|521066184|FG006|Overall Study|Withdrawal by Subject|0|||
144509693|NCT00610649|521066185|FG007|Overall Study|Withdrawal by Subject|0|||
144509694|NCT00610649|521066186|FG008|Overall Study|Withdrawal by Subject|0|||
144509695|NCT00610649|521066187|FG009|Overall Study|Withdrawal by Subject|1|||
144509696|NCT00610649|521066188|FG010|Overall Study|Withdrawal by Subject|0|||
144509697|NCT04252586|521066189|FG000|Overall Study|Withdrawal by parent/guardian|3|||
144509698|NCT04252586|521066189|FG000|Overall Study|Adverse Event|1|||
144509699|NCT04252586|521066189|FG000|Overall Study|Death|2|||
144509700|NCT04252586|521066189|FG000|Overall Study|Study terminated by sponsor|4|||
144509701|NCT04252586|521066189|FG000|Overall Study|Sponsor request|10|||
144509702|NCT04252586|521066189|FG000|Overall Study|Did not complete treatment period|1|||
144509703|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Death|186|||
144509704|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Death|222|||
144509705|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Death|0|||
144509706|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
144509707|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
144509708|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
144509709|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
144509710|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
144509711|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
144509712|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
144509713|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
144509714|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
144509715|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Adverse Event|83|||
144509716|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Adverse Event|100|||
144509717|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Adverse Event|0|||
144509718|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Other|70|||
144509719|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Other|75|||
144509720|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Other|0|||
144509721|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
144509722|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
144509723|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
144509724|NCT00232180|521066190|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
144509725|NCT00232180|521066191|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
144509726|NCT00232180|521066192|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
144509727|NCT00232180|521066190|FG000|Open Label Phase|Death|0|||
144509728|NCT00232180|521066191|FG001|Open Label Phase|Death|0|||
144509729|NCT00232180|521066192|FG002|Open Label Phase|Death|48|||
144509730|NCT00232180|521066190|FG000|Open Label Phase|Lost to Follow-up|0|||
144509731|NCT00232180|521066191|FG001|Open Label Phase|Lost to Follow-up|0|||
144509732|NCT00232180|521066192|FG002|Open Label Phase|Lost to Follow-up|5|||
144509733|NCT00232180|521066190|FG000|Open Label Phase|Protocol Violation|0|||
144509734|NCT00232180|521066191|FG001|Open Label Phase|Protocol Violation|0|||
144509735|NCT00232180|521066192|FG002|Open Label Phase|Protocol Violation|3|||
144509736|NCT00232180|521066190|FG000|Open Label Phase|Study terminated by sponsor|0|||
144509737|NCT00232180|521066191|FG001|Open Label Phase|Study terminated by sponsor|0|||
144509738|NCT00232180|521066192|FG002|Open Label Phase|Study terminated by sponsor|3|||
144509739|NCT00232180|521066190|FG000|Open Label Phase|Withdrawal by Subject|0|||
144509740|NCT00232180|521066191|FG001|Open Label Phase|Withdrawal by Subject|0|||
144509741|NCT00232180|521066192|FG002|Open Label Phase|Withdrawal by Subject|37|||
144509742|NCT00232180|521066190|FG000|Open Label Phase|Other|0|||
144509743|NCT00232180|521066191|FG001|Open Label Phase|Other|0|||
144589275|NCT03992846|521355907|FG000|Overall Study|Adverse Event|8|||
144589276|NCT03992846|521355908|FG001|Overall Study|Adverse Event|6|||
144589277|NCT03992846|521355909|FG002|Overall Study|Adverse Event|3|||
144589278|NCT03992846|521355907|FG000|Overall Study|Lost to Follow-up|0|||
144589279|NCT03992846|521355908|FG001|Overall Study|Lost to Follow-up|1|||
144509744|NCT00232180|521066192|FG002|Open Label Phase|Other|16|||
144509745|NCT00232180|521066190|FG000|Open Label Phase|Adverse Event|0|||
144509746|NCT00232180|521066191|FG001|Open Label Phase|Adverse Event|0|||
144589280|NCT03992846|521355909|FG002|Overall Study|Lost to Follow-up|1|||
144509747|NCT00232180|521066192|FG002|Open Label Phase|Adverse Event|25|||
144509748|NCT00232180|521066190|FG000|Open Label Phase|Laboratory abnormality|0|||
144509749|NCT00232180|521066191|FG001|Open Label Phase|Laboratory abnormality|0|||
144509750|NCT00232180|521066192|FG002|Open Label Phase|Laboratory abnormality|10|||
144589281|NCT03992846|521355907|FG000|Overall Study|Pregnancy|2|||
144589282|NCT03992846|521355908|FG001|Overall Study|Pregnancy|0|||
144589283|NCT03992846|521355909|FG002|Overall Study|Pregnancy|1|||
144589284|NCT03992846|521355907|FG000|Overall Study|Protocol Violation|1|||
144589285|NCT03992846|521355908|FG001|Overall Study|Protocol Violation|2|||
144589286|NCT03992846|521355909|FG002|Overall Study|Protocol Violation|0|||
144589287|NCT03992846|521355907|FG000|Overall Study|Withdrawal by Subject|8|||
144589288|NCT03992846|521355908|FG001|Overall Study|Withdrawal by Subject|10|||
144589289|NCT03992846|521355909|FG002|Overall Study|Withdrawal by Subject|20|||
144589290|NCT03992846|521355907|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
144589291|NCT03992846|521355908|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
144589292|NCT03992846|521355909|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
144589293|NCT01773291|521357945|FG000|Overall Study|Protocol Violation|1|||
144589294|NCT01773291|521357946|FG001|Overall Study|Protocol Violation|0|||
144589295|NCT01773291|521357947|FG002|Overall Study|Protocol Violation|0|||
144589296|NCT01773291|521357945|FG000|Overall Study|Withdrawal by Subject|0|||
144589297|NCT01773291|521357946|FG001|Overall Study|Withdrawal by Subject|0|||
144589298|NCT01773291|521357947|FG002|Overall Study|Withdrawal by Subject|1|||
144589299|NCT01491672|521357948|FG000|Overall Study|Lost to Follow-up|0|||
144589300|NCT01491672|521357949|FG001|Overall Study|Lost to Follow-up|4|||
144589301|NCT01491672|521357950|FG002|Overall Study|Lost to Follow-up|1|||
144589302|NCT01491672|521357948|FG000|Overall Study|Withdrawal by Subject|6|||
144589303|NCT01491672|521357949|FG001|Overall Study|Withdrawal by Subject|7|||
144589304|NCT01491672|521357950|FG002|Overall Study|Withdrawal by Subject|0|||
144589305|NCT01491672|521357948|FG000|Overall Study|Adverse Event|8|||
144589306|NCT01491672|521357949|FG001|Overall Study|Adverse Event|10|||
144589307|NCT01491672|521357950|FG002|Overall Study|Adverse Event|4|||
144589308|NCT01491672|521357948|FG000|Overall Study|Disease progression|42|||
144589309|NCT01491672|521357949|FG001|Overall Study|Disease progression|34|||
144589310|NCT01491672|521357950|FG002|Overall Study|Disease progression|6|||
144589311|NCT01491672|521357948|FG000|Overall Study|Protocol deviation|0|||
144589312|NCT01491672|521357949|FG001|Overall Study|Protocol deviation|1|||
144589313|NCT01491672|521357950|FG002|Overall Study|Protocol deviation|0|||
144589314|NCT01491672|521357948|FG000|Overall Study|Death|0|||
144589315|NCT01491672|521357949|FG001|Overall Study|Death|4|||
144589316|NCT01491672|521357950|FG002|Overall Study|Death|0|||
144589317|NCT03064035|521357951|FG000|Overall Study|Did not receive allocated intervention|4|||
144589318|NCT03064035|521357952|FG001|Overall Study|Did not receive allocated intervention|2|||
144589319|NCT03064035|521357951|FG000|Overall Study|Lost to Follow-up|1|||
144589320|NCT03064035|521357952|FG001|Overall Study|Lost to Follow-up|1|||
144589321|NCT01143038|521357953|FG000|Overall Study|Withdrawal by Subject|4|||
144589322|NCT01143038|521357953|FG000|Overall Study|Requirement for alternative therapy|5|||
144589323|NCT01143038|521357953|FG000|Overall Study|Adverse Event|3|||
144589324|NCT01143038|521357953|FG000|Overall Study|Lost to Follow-up|2|||
144589325|NCT01143038|521357953|FG000|Overall Study|Protocol Deviation|1|||
144589326|NCT01143038|521357953|FG000|Overall Study|Death|1|||
144589327|NCT02336178|521357954|FG000|Overall Study|Lost to Follow-up|1|||
144589328|NCT02336178|521357954|FG000|Overall Study|Protocol Violation|1|||
144589329|NCT02336178|521357954|FG000|Overall Study|Withdrawal by Subject|1|||
144589330|NCT02336178|521357954|FG000|Overall Study|Other|1|||
144589331|NCT00706433|521357958|FG000|Overall Study|Lost to Follow-up|3|||
144589332|NCT00706433|521357959|FG001|Overall Study|Lost to Follow-up|1|||
144509751|NCT00232180|521066190|FG000|Open Label Phase|Randomized but not treated|0|||
144509752|NCT00232180|521066191|FG001|Open Label Phase|Randomized but not treated|0|||
144509753|NCT00232180|521066192|FG002|Open Label Phase|Randomized but not treated|1|||
144509754|NCT00414544|521066193|FG000|Overall Study|Lost to Follow-up|14|||
144509755|NCT00542789|521066194|FG000|Overall Study|Adverse Event|18|||
144509756|NCT00542789|521066195|FG001|Overall Study|Adverse Event|17|||
144509757|NCT00542789|521066194|FG000|Overall Study|Withdrawal by Subject|7|||
144509758|NCT00542789|521066195|FG001|Overall Study|Withdrawal by Subject|3|||
144509759|NCT00542789|521066194|FG000|Overall Study|Protocol Violation|8|||
144509760|NCT00542789|521066195|FG001|Overall Study|Protocol Violation|1|||
144509761|NCT00542789|521066194|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
144509762|NCT00542789|521066195|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
144509763|NCT02584829|521066197|FG000|Overall Study|Physician Decision|1|||
144509764|NCT02584829|521066198|FG001|Overall Study|Physician Decision|0|||
144589333|NCT00706433|521357960|FG002|Overall Study|Lost to Follow-up|6|||
144721687|NCT02173704|521835261|FG000|Overall Study|Withdrawal by Subject|9|||
144509765|NCT02584829|521066197|FG000|Overall Study|Withdrawal by Subject|0|||
144589334|NCT00706433|521357961|FG003|Overall Study|Lost to Follow-up|0|||
144589335|NCT00706433|521357958|FG000|Overall Study|Withdrawal by Subject|1|||
144589336|NCT00706433|521357959|FG001|Overall Study|Withdrawal by Subject|2|||
144589337|NCT00706433|521357960|FG002|Overall Study|Withdrawal by Subject|3|||
144589338|NCT00706433|521357961|FG003|Overall Study|Withdrawal by Subject|1|||
144589339|NCT00706433|521357958|FG000|Overall Study|Adverse Event|0|||
144589340|NCT00706433|521357959|FG001|Overall Study|Adverse Event|0|||
144589341|NCT00706433|521357960|FG002|Overall Study|Adverse Event|1|||
144589342|NCT00706433|521357961|FG003|Overall Study|Adverse Event|0|||
144589343|NCT00706433|521357958|FG000|Overall Study|Protocol Violation|1|||
144509766|NCT02584829|521066198|FG001|Overall Study|Withdrawal by Subject|1|||
144509767|NCT02584829|521066197|FG000|Overall Study|Progressive Disease|0|||
144509768|NCT02584829|521066198|FG001|Overall Study|Progressive Disease|3|||
144509769|NCT02767765|521066202|FG000|Overall Study|Adverse Event|4|||
144509770|NCT02767765|521066202|FG000|Overall Study|Death|1|||
144509771|NCT02767765|521066202|FG000|Overall Study|Insufficient response|1|||
144509772|NCT02767765|521066202|FG000|Overall Study|Lost to Follow-up|2|||
144509773|NCT02767765|521066202|FG000|Overall Study|Investigator decision|1|||
144509774|NCT02767765|521066202|FG000|Overall Study|Non-Compliance|1|||
144509775|NCT02767765|521066202|FG000|Overall Study|Withdrawal by Subject|1|||
144509776|NCT01951170|521066203|FG000|Overall Study|Investigator decision|1|||
144509777|NCT04512482|521066210|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
144509778|NCT04512482|521066211|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
144509779|NCT00585052|521066214|FG000|Overall Study|Withdrawal by Subject|1|||
144509780|NCT00350792|521066219|FG000|Overall Study|Adverse Event|11|||
144509781|NCT00350792|521066219|FG000|Overall Study|Death from Study Disease|1|||
144509782|NCT00350792|521066219|FG000|Overall Study|Death from Study Drug Toxicity|1|||
144509783|NCT00350792|521066219|FG000|Overall Study|Death Not Study Drug Related|2|||
144509784|NCT00350792|521066219|FG000|Overall Study|Protocol Violation|1|||
144509785|NCT00350792|521066219|FG000|Overall Study|Withdrawal by Subject|4|||
144509786|NCT00350792|521066219|FG000|Overall Study|Physician Decision|2|||
144509787|NCT00350792|521066219|FG000|Overall Study|Lack of Efficacy|11|||
144509788|NCT01832480|521066220|FG000|Overall Study|Lost to Follow-up|33|||
144509789|NCT01832480|521066221|FG001|Overall Study|Lost to Follow-up|30|||
144509790|NCT01832480|521066220|FG000|Overall Study|Withdrawal by Subject|0|||
144509791|NCT01832480|521066221|FG001|Overall Study|Withdrawal by Subject|2|||
144509792|NCT01832480|521066220|FG000|Overall Study|post randomization ineligible|8|||
144509793|NCT01832480|521066221|FG001|Overall Study|post randomization ineligible|10|||
144509794|NCT05609032|521066227|FG000|Overall Study|Lost to Follow-up|3|||
144509795|NCT05609032|521066228|FG001|Overall Study|Lost to Follow-up|1|||
144509796|NCT05609032|521066227|FG000|Overall Study|Withdrawal by Subject|1|||
144509797|NCT05609032|521066228|FG001|Overall Study|Withdrawal by Subject|0|||
144509798|NCT03764475|521066229|FG000|Overall Study|Adverse Event|11|||
144509799|NCT03764475|521066230|FG001|Overall Study|Adverse Event|2|||
144509800|NCT03764475|521066229|FG000|Overall Study|Lost to Follow-up|24|||
144509801|NCT03764475|521066230|FG001|Overall Study|Lost to Follow-up|10|||
144509802|NCT03764475|521066229|FG000|Overall Study|Withdrawal by Subject|26|||
144509803|NCT03764475|521066230|FG001|Overall Study|Withdrawal by Subject|10|||
144509804|NCT03764475|521066229|FG000|Overall Study|Lack of Efficacy|3|||
144509805|NCT03764475|521066230|FG001|Overall Study|Lack of Efficacy|0|||
144509806|NCT03764475|521066229|FG000|Overall Study|COVID-19 Disruption|2|||
144509807|NCT03764475|521066230|FG001|Overall Study|COVID-19 Disruption|0|||
144509808|NCT05510245|521066234|FG000|Overall Study|Withdrawal by Subject|1|||
144509809|NCT05510245|521066235|FG001|Overall Study|Withdrawal by Subject|0|||
144509810|NCT05510245|521066236|FG002|Overall Study|Withdrawal by Subject|0|||
144509811|NCT01373346|521066242|FG000|Overall Study|Death|1|||
144509812|NCT01198028|521066243|FG000|Overall Study|Adverse Event|5|||
144509813|NCT01198028|521066243|FG000|Overall Study|Death|3|||
144509814|NCT01198028|521066243|FG000|Overall Study|Physician Decision|2|||
144509815|NCT00970359|521066247|FG000|Overall Study|Not Treated|4|||
144509816|NCT01565148|521066248|FG000|Overall Study|Withdrawal by Subject|1|||
144509817|NCT01565148|521066249|FG001|Overall Study|Withdrawal by Subject|1|||
144509818|NCT01565148|521066250|FG002|Overall Study|Withdrawal by Subject|1|||
144509819|NCT01565148|521066251|FG003|Overall Study|Withdrawal by Subject|2|||
144509820|NCT01565148|521066248|FG000|Overall Study|Lost to Follow-up|4|||
144509821|NCT01565148|521066249|FG001|Overall Study|Lost to Follow-up|4|||
144509822|NCT01565148|521066250|FG002|Overall Study|Lost to Follow-up|0|||
144509823|NCT01565148|521066251|FG003|Overall Study|Lost to Follow-up|3|||
144509824|NCT01565148|521066248|FG000|Overall Study|Rescue Therapy|8|||
144509825|NCT01565148|521066249|FG001|Overall Study|Rescue Therapy|5|||
144509826|NCT01565148|521066250|FG002|Overall Study|Rescue Therapy|5|||
144509827|NCT01565148|521066251|FG003|Overall Study|Rescue Therapy|8|||
144509828|NCT01565148|521066248|FG000|Overall Study|Death|0|||
144509829|NCT01565148|521066249|FG001|Overall Study|Death|0|||
144509830|NCT01565148|521066250|FG002|Overall Study|Death|1|||
144721688|NCT02173704|521835262|FG001|Overall Study|Withdrawal by Subject|4|||
144509831|NCT01565148|521066251|FG003|Overall Study|Death|0|||
144509832|NCT01565148|521066248|FG000|Overall Study|Physician Decision|2|||
144509833|NCT01565148|521066249|FG001|Overall Study|Physician Decision|5|||
144509834|NCT01565148|521066250|FG002|Overall Study|Physician Decision|0|||
144509835|NCT01565148|521066251|FG003|Overall Study|Physician Decision|0|||
144509836|NCT01759771|521066252|FG000|Overall Study|Withdrawal by Subject|1|||
144509837|NCT01759771|521066253|FG001|Overall Study|Withdrawal by Subject|1|||
144509838|NCT02528188|521066254|FG000|Overall Study|Adverse Event|23|||
144509839|NCT02528188|521066255|FG001|Overall Study|Adverse Event|22|||
144509840|NCT02528188|521066256|FG002|Overall Study|Adverse Event|8|||
144509841|NCT02528188|521066254|FG000|Overall Study|Protocol Violation|4|||
144509842|NCT02528188|521066255|FG001|Overall Study|Protocol Violation|6|||
144509843|NCT02528188|521066256|FG002|Overall Study|Protocol Violation|4|||
144589344|NCT00706433|521357959|FG001|Overall Study|Protocol Violation|0|||
144589345|NCT00706433|521357960|FG002|Overall Study|Protocol Violation|0|||
144589346|NCT00706433|521357961|FG003|Overall Study|Protocol Violation|0|||
144589347|NCT00706433|521357958|FG000|Overall Study|new job|0|||
144589348|NCT00706433|521357959|FG001|Overall Study|new job|0|||
144589349|NCT00706433|521357960|FG002|Overall Study|new job|0|||
144589350|NCT00706433|521357961|FG003|Overall Study|new job|1|||
144589351|NCT01236365|521357963|FG000|Overall Study|Lost to Follow-up|0|||
144589352|NCT01236365|521357964|FG001|Overall Study|Lost to Follow-up|2|||
144589353|NCT01236365|521357963|FG000|Overall Study|Moved Out of State|1|||
144589354|NCT01236365|521357964|FG001|Overall Study|Moved Out of State|0|||
144589355|NCT01236365|521357963|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
144589356|NCT01236365|521357964|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
144589357|NCT02090959|521357965|FG000|Overall Study|Withdrawal by Subject|10|||
144589358|NCT02090959|521357965|FG000|Overall Study|Adverse Event|1|||
144589359|NCT02090959|521357965|FG000|Overall Study|Investigator decision|2|||
144589360|NCT02090959|521357965|FG000|Overall Study|Study termination|6|||
144589361|NCT02090959|521357965|FG000|Overall Study|Enrolled but not treated|1|||
144589362|NCT02090959|521357965|FG000|Overall Study|Transfer for compassionate use medicine|4|||
144589363|NCT02090959|521357965|FG000|Overall Study|Move to medical need program|3|||
144589364|NCT02090959|521357965|FG000|Overall Study|Entered in to other study|34|||
144589365|NCT02090959|521357965|FG000|Overall Study|Switched to commercial supply|88|||
144589366|NCT02090959|521357965|FG000|Overall Study|Other than specified|2|||
144589367|NCT02808143|521357968|FG000|Maintenance Phase|Disease recurrence|1|||
144589368|NCT02808143|521357969|FG001|Maintenance Phase|Disease recurrence|3|||
144589369|NCT02808143|521357968|FG000|Maintenance Phase|Disease progression|1|||
144589370|NCT02808143|521357969|FG001|Maintenance Phase|Disease progression|2|||
144589371|NCT02808143|521357968|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
144589372|NCT02808143|521357969|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
144589373|NCT02808143|521357968|FG000|Survival Follow-Up|Disease recurrence|0|||
144589374|NCT02808143|521357969|FG001|Survival Follow-Up|Disease recurrence|2|||
144589375|NCT02808143|521357968|FG000|Survival Follow-Up|Adverse Event|0|||
144589376|NCT02808143|521357969|FG001|Survival Follow-Up|Adverse Event|1|||
144589377|NCT02808143|521357968|FG000|Survival Follow-Up|Death|1|||
144589378|NCT02808143|521357969|FG001|Survival Follow-Up|Death|0|||
144589379|NCT00522873|521357970|FG000|Overall Study|Adverse Event|41|||
144589380|NCT00522873|521357971|FG001|Overall Study|Adverse Event|26|||
144589381|NCT00522873|521357970|FG000|Overall Study|Withdrawal by Subject|20|||
144589382|NCT00522873|521357971|FG001|Overall Study|Withdrawal by Subject|9|||
144589383|NCT00522873|521357970|FG000|Overall Study|Protocol Violation|14|||
144589384|NCT00522873|521357971|FG001|Overall Study|Protocol Violation|4|||
144589385|NCT00522873|521357970|FG000|Overall Study|Lost to Follow-up|11|||
144589386|NCT00522873|521357971|FG001|Overall Study|Lost to Follow-up|3|||
144589387|NCT00522873|521357970|FG000|Overall Study|Personal Reasons|8|||
144589388|NCT00522873|521357971|FG001|Overall Study|Personal Reasons|1|||
144589389|NCT00522873|521357970|FG000|Overall Study|Medication Errors|1|||
144589390|NCT00522873|521357971|FG001|Overall Study|Medication Errors|1|||
144589391|NCT00522873|521357970|FG000|Overall Study|Never Received Medication|1|||
144589392|NCT00522873|521357971|FG001|Overall Study|Never Received Medication|0|||
144589393|NCT01874431|521357973|FG000|Overall Study|Physician Decision|0|||
144589394|NCT01874431|521357974|FG001|Overall Study|Physician Decision|0|||
144589395|NCT01874431|521357975|FG002|Overall Study|Physician Decision|1|||
144589396|NCT01874431|521357976|FG003|Overall Study|Physician Decision|0|||
144589397|NCT01874431|521357977|FG004|Overall Study|Physician Decision|0|||
144589398|NCT01874431|521357978|FG005|Overall Study|Physician Decision|0|||
144589399|NCT01874431|521357979|FG006|Overall Study|Physician Decision|0|||
144589400|NCT01874431|521357980|FG007|Overall Study|Physician Decision|0|||
144589401|NCT01874431|521357973|FG000|Overall Study|Adverse Event|5|||
144589402|NCT01874431|521357974|FG001|Overall Study|Adverse Event|4|||
144589403|NCT01874431|521357975|FG002|Overall Study|Adverse Event|6|||
144589404|NCT01874431|521357976|FG003|Overall Study|Adverse Event|5|||
144589405|NCT01874431|521357977|FG004|Overall Study|Adverse Event|2|||
144589406|NCT01874431|521357978|FG005|Overall Study|Adverse Event|8|||
144589407|NCT01874431|521357979|FG006|Overall Study|Adverse Event|2|||
144589408|NCT01874431|521357980|FG007|Overall Study|Adverse Event|3|||
144589409|NCT01874431|521357973|FG000|Overall Study|Protocol Violation|1|||
144589410|NCT01874431|521357974|FG001|Overall Study|Protocol Violation|1|||
144589411|NCT01874431|521357975|FG002|Overall Study|Protocol Violation|1|||
144589412|NCT01874431|521357976|FG003|Overall Study|Protocol Violation|0|||
144589413|NCT01874431|521357977|FG004|Overall Study|Protocol Violation|3|||
144589414|NCT01874431|521357978|FG005|Overall Study|Protocol Violation|2|||
144589415|NCT01874431|521357979|FG006|Overall Study|Protocol Violation|1|||
144589416|NCT01874431|521357980|FG007|Overall Study|Protocol Violation|1|||
144589417|NCT01874431|521357973|FG000|Overall Study|Non-compliance|0|||
144589418|NCT01874431|521357974|FG001|Overall Study|Non-compliance|0|||
144589419|NCT01874431|521357975|FG002|Overall Study|Non-compliance|0|||
144589420|NCT01874431|521357976|FG003|Overall Study|Non-compliance|0|||
144589421|NCT01874431|521357977|FG004|Overall Study|Non-compliance|1|||
144589422|NCT01874431|521357978|FG005|Overall Study|Non-compliance|0|||
144589423|NCT01874431|521357979|FG006|Overall Study|Non-compliance|1|||
144589424|NCT01874431|521357980|FG007|Overall Study|Non-compliance|0|||
144589425|NCT01874431|521357973|FG000|Overall Study|Logistical difficulties|0|||
144589426|NCT01874431|521357974|FG001|Overall Study|Logistical difficulties|0|||
144589427|NCT01874431|521357975|FG002|Overall Study|Logistical difficulties|0|||
144589428|NCT01874431|521357976|FG003|Overall Study|Logistical difficulties|0|||
144589429|NCT01874431|521357977|FG004|Overall Study|Logistical difficulties|0|||
144589430|NCT01874431|521357978|FG005|Overall Study|Logistical difficulties|0|||
144589431|NCT01874431|521357979|FG006|Overall Study|Logistical difficulties|1|||
144589432|NCT01874431|521357980|FG007|Overall Study|Logistical difficulties|0|||
144589433|NCT01874431|521357973|FG000|Overall Study|Withdrawal by Subject|0|||
144589434|NCT01874431|521357974|FG001|Overall Study|Withdrawal by Subject|0|||
144589435|NCT01874431|521357975|FG002|Overall Study|Withdrawal by Subject|1|||
144589436|NCT01874431|521357976|FG003|Overall Study|Withdrawal by Subject|2|||
144589437|NCT01874431|521357977|FG004|Overall Study|Withdrawal by Subject|1|||
144589438|NCT01874431|521357978|FG005|Overall Study|Withdrawal by Subject|1|||
144589439|NCT01874431|521357979|FG006|Overall Study|Withdrawal by Subject|3|||
144589440|NCT01874431|521357980|FG007|Overall Study|Withdrawal by Subject|0|||
144589441|NCT01874431|521357973|FG000|Overall Study|Sponsor decision|0|||
144589442|NCT01874431|521357974|FG001|Overall Study|Sponsor decision|0|||
144509844|NCT02528188|521066254|FG000|Overall Study|Lack of Efficacy|19|||
144509845|NCT02528188|521066255|FG001|Overall Study|Lack of Efficacy|21|||
144509846|NCT02528188|521066256|FG002|Overall Study|Lack of Efficacy|22|||
144509847|NCT02528188|521066254|FG000|Overall Study|Withdrawal by Subject|97|||
144509848|NCT02528188|521066255|FG001|Overall Study|Withdrawal by Subject|104|||
144509849|NCT02528188|521066256|FG002|Overall Study|Withdrawal by Subject|100|||
144509850|NCT02528188|521066254|FG000|Overall Study|Lost to Follow-up|25|||
144509851|NCT02528188|521066255|FG001|Overall Study|Lost to Follow-up|21|||
144509852|NCT02528188|521066256|FG002|Overall Study|Lost to Follow-up|31|||
144509853|NCT02528188|521066254|FG000|Overall Study|Death|4|||
144509854|NCT02528188|521066255|FG001|Overall Study|Death|4|||
144509855|NCT02528188|521066256|FG002|Overall Study|Death|0|||
144509856|NCT02528188|521066254|FG000|Overall Study|Other|89|||
144509857|NCT02528188|521066255|FG001|Overall Study|Other|91|||
144509858|NCT02528188|521066256|FG002|Overall Study|Other|74|||
144509859|NCT02528188|521066254|FG000|Overall Study|Randomized but not treated|6|||
144509860|NCT02528188|521066255|FG001|Overall Study|Randomized but not treated|7|||
144509861|NCT02528188|521066256|FG002|Overall Study|Randomized but not treated|12|||
144509862|NCT05368831|521066257|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
144509863|NCT00529659|521066258|FG000|Overall Study|Adverse Event|8|||
144509864|NCT00529659|521066259|FG001|Overall Study|Adverse Event|7|||
144509865|NCT00529659|521066258|FG000|Overall Study|Lost to Follow-up|0|||
144589443|NCT01874431|521357975|FG002|Overall Study|Sponsor decision|0|||
144509866|NCT00529659|521066259|FG001|Overall Study|Lost to Follow-up|2|||
144509867|NCT00529659|521066258|FG000|Overall Study|Physician Decision|0|||
144589444|NCT01874431|521357976|FG003|Overall Study|Sponsor decision|0|||
144589445|NCT01874431|521357977|FG004|Overall Study|Sponsor decision|1|||
144589446|NCT01874431|521357978|FG005|Overall Study|Sponsor decision|0|||
144589447|NCT01874431|521357979|FG006|Overall Study|Sponsor decision|0|||
144589448|NCT01874431|521357980|FG007|Overall Study|Sponsor decision|0|||
144509868|NCT00529659|521066259|FG001|Overall Study|Physician Decision|2|||
144509869|NCT00529659|521066258|FG000|Overall Study|Protocol Violation|2|||
144509870|NCT00529659|521066259|FG001|Overall Study|Protocol Violation|6|||
144509871|NCT00529659|521066258|FG000|Overall Study|Withdrawal by Subject|1|||
144509872|NCT00529659|521066259|FG001|Overall Study|Withdrawal by Subject|6|||
144509873|NCT03887650|521066260|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
144509874|NCT03887650|521066261|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
144509875|NCT03887650|521066260|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
144509876|NCT03887650|521066261|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
144589449|NCT01874431|521357973|FG000|Overall Study|Lost to Follow-up|0|||
144589450|NCT01874431|521357974|FG001|Overall Study|Lost to Follow-up|0|||
144589451|NCT01874431|521357975|FG002|Overall Study|Lost to Follow-up|1|||
144589452|NCT01874431|521357976|FG003|Overall Study|Lost to Follow-up|0|||
144589453|NCT01874431|521357977|FG004|Overall Study|Lost to Follow-up|0|||
144589454|NCT01874431|521357978|FG005|Overall Study|Lost to Follow-up|0|||
144589455|NCT01874431|521357979|FG006|Overall Study|Lost to Follow-up|0|||
144589456|NCT01874431|521357980|FG007|Overall Study|Lost to Follow-up|0|||
144589457|NCT03038438|521357986|FG000|Overall Study|Death|3|||
144589458|NCT03038438|521357986|FG000|Overall Study|Lost to Follow-up|8|||
144589459|NCT03038438|521357986|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
144589460|NCT03038438|521357986|FG000|Overall Study|Withdrawal by Subject|5|||
144589461|NCT03038438|521357986|FG000|Overall Study|No 36-Month Follow-Up|18|||
144589462|NCT03215810|521357987|FG000|Overall Study|Still responding to nivolumab|1|||
144589463|NCT03215810|521357987|FG000|Overall Study|Insufficient TIL growth|1|||
144589464|NCT03215810|521357987|FG000|Overall Study|Decline in performance status|1|||
144589465|NCT03215810|521357987|FG000|Overall Study|Withdrawal by Subject|1|||
144589466|NCT02647866|521357988|FG000|Overall Study|Adverse Event|0|||
144589467|NCT02647866|521357989|FG001|Overall Study|Adverse Event|0|||
144589468|NCT02647866|521357990|FG002|Overall Study|Adverse Event|2|||
144589469|NCT02647866|521357991|FG003|Overall Study|Adverse Event|2|||
144589470|NCT02647866|521357992|FG004|Overall Study|Adverse Event|1|||
144589471|NCT02647866|521357988|FG000|Overall Study|Disease Worsening|3|||
144589472|NCT02647866|521357989|FG001|Overall Study|Disease Worsening|1|||
144589473|NCT02647866|521357990|FG002|Overall Study|Disease Worsening|0|||
144589474|NCT02647866|521357991|FG003|Overall Study|Disease Worsening|0|||
144589475|NCT02647866|521357992|FG004|Overall Study|Disease Worsening|1|||
144589476|NCT02647866|521357988|FG000|Overall Study|Withdrawal by Subject|1|||
144589477|NCT02647866|521357989|FG001|Overall Study|Withdrawal by Subject|1|||
144589478|NCT02647866|521357990|FG002|Overall Study|Withdrawal by Subject|2|||
144589479|NCT02647866|521357991|FG003|Overall Study|Withdrawal by Subject|4|||
144589480|NCT02647866|521357992|FG004|Overall Study|Withdrawal by Subject|4|||
144589481|NCT02647866|521357988|FG000|Overall Study|Physician Decision|0|||
144589482|NCT02647866|521357989|FG001|Overall Study|Physician Decision|1|||
144589483|NCT02647866|521357990|FG002|Overall Study|Physician Decision|1|||
144589484|NCT02647866|521357991|FG003|Overall Study|Physician Decision|0|||
144589485|NCT02647866|521357992|FG004|Overall Study|Physician Decision|2|||
144509877|NCT03887650|521066260|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
144509878|NCT03887650|521066261|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
144589486|NCT02647866|521357988|FG000|Overall Study|Death|0|||
144589487|NCT02647866|521357989|FG001|Overall Study|Death|1|||
144509879|NCT01692730|521066265|FG000|Overall Study|Lost to Follow-up|225|||
144509880|NCT01692730|521066266|FG001|Overall Study|Lost to Follow-up|227|||
144509881|NCT01849055|521066267|FG000|Overall Study|Withdrawal by Subject|0|||
144509882|NCT01849055|521066268|FG001|Overall Study|Withdrawal by Subject|0|||
144509883|NCT01849055|521066269|FG002|Overall Study|Withdrawal by Subject|1|||
144509884|NCT01849055|521066270|FG003|Overall Study|Withdrawal by Subject|0|||
144509885|NCT01849055|521066271|FG004|Overall Study|Withdrawal by Subject|0|||
144509886|NCT01849055|521066272|FG005|Overall Study|Withdrawal by Subject|0|||
144509887|NCT00223795|521066273|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
144509888|NCT00223795|521066274|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
144509889|NCT00223795|521066273|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
144509890|NCT00223795|521066274|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
144509891|NCT02299375|521066279|FG000|Overall Study|Adverse Event, serious fatal|1|||
144509892|NCT02299375|521066280|FG001|Overall Study|Adverse Event, serious fatal|3|||
144509893|NCT02299375|521066279|FG000|Overall Study|Adverse Event, non-fatal|8|||
144509894|NCT02299375|521066280|FG001|Overall Study|Adverse Event, non-fatal|9|||
144509895|NCT02299375|521066279|FG000|Overall Study|Lack of Efficacy|1|||
144509896|NCT02299375|521066280|FG001|Overall Study|Lack of Efficacy|3|||
144589488|NCT02647866|521357990|FG002|Overall Study|Death|0|||
144589489|NCT02647866|521357991|FG003|Overall Study|Death|0|||
144589490|NCT02647866|521357992|FG004|Overall Study|Death|0|||
144589491|NCT02647866|521357988|FG000|Overall Study|Subject moved to different country|1|||
144589492|NCT02647866|521357989|FG001|Overall Study|Subject moved to different country|0|||
144589493|NCT02647866|521357990|FG002|Overall Study|Subject moved to different country|0|||
144589494|NCT02647866|521357991|FG003|Overall Study|Subject moved to different country|0|||
144509897|NCT02299375|521066279|FG000|Overall Study|Protocol Violation|1|||
144589495|NCT02647866|521357992|FG004|Overall Study|Subject moved to different country|0|||
144589496|NCT03406260|521357993|FG000|Period 1|Adverse Event|0|||
144589497|NCT03406260|521357994|FG001|Period 1|Adverse Event|0|||
144589498|NCT03406260|521357995|FG002|Period 1|Adverse Event|0|||
144589499|NCT03406260|521357996|FG003|Period 1|Adverse Event|0|||
144589500|NCT03406260|521357997|FG004|Period 1|Adverse Event|1|||
144509898|NCT02299375|521066280|FG001|Overall Study|Protocol Violation|3|||
144509899|NCT02299375|521066279|FG000|Overall Study|Other: Met stopping criteria|1|||
144509900|NCT02299375|521066280|FG001|Overall Study|Other: Met stopping criteria|0|||
144509901|NCT02299375|521066279|FG000|Overall Study|Other: Study closed/terminated|66|||
144509902|NCT02299375|521066280|FG001|Overall Study|Other: Study closed/terminated|55|||
144509903|NCT02299375|521066279|FG000|Overall Study|Lost to Follow-up|0|||
144509904|NCT02299375|521066280|FG001|Overall Study|Lost to Follow-up|2|||
144509905|NCT02299375|521066279|FG000|Overall Study|Physician Decision|1|||
144509906|NCT02299375|521066280|FG001|Overall Study|Physician Decision|1|||
144509907|NCT02299375|521066279|FG000|Overall Study|Withdrawal by Subject|1|||
144509908|NCT02299375|521066280|FG001|Overall Study|Withdrawal by Subject|4|||
144509909|NCT00704184|521066285|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
144509910|NCT00704184|521066286|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
144509911|NCT00704184|521066287|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
144509912|NCT00704184|521066288|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
144509913|NCT00704184|521066289|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
144509914|NCT00704184|521066285|FG000|Open-Label Treatment|Adverse Event|0|||
144509915|NCT00704184|521066286|FG001|Open-Label Treatment|Adverse Event|0|||
144509916|NCT00704184|521066287|FG002|Open-Label Treatment|Adverse Event|2|||
144509917|NCT00704184|521066288|FG003|Open-Label Treatment|Adverse Event|0|||
144509918|NCT00704184|521066289|FG004|Open-Label Treatment|Adverse Event|1|||
144509919|NCT00704184|521066285|FG000|Open-Label Treatment|Lack of Efficacy|0|||
144509920|NCT00704184|521066286|FG001|Open-Label Treatment|Lack of Efficacy|2|||
144509921|NCT00704184|521066287|FG002|Open-Label Treatment|Lack of Efficacy|2|||
144509922|NCT00704184|521066288|FG003|Open-Label Treatment|Lack of Efficacy|2|||
144509923|NCT00704184|521066289|FG004|Open-Label Treatment|Lack of Efficacy|1|||
144509924|NCT00704184|521066285|FG000|Open-Label Treatment|Physician Decision|0|||
144509925|NCT00704184|521066286|FG001|Open-Label Treatment|Physician Decision|0|||
144509926|NCT00704184|521066287|FG002|Open-Label Treatment|Physician Decision|0|||
144509927|NCT00704184|521066288|FG003|Open-Label Treatment|Physician Decision|0|||
144509928|NCT00704184|521066289|FG004|Open-Label Treatment|Physician Decision|1|||
144509929|NCT00704184|521066285|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
144509930|NCT00704184|521066286|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
144509931|NCT00704184|521066287|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
144509932|NCT00704184|521066288|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
144509933|NCT00704184|521066289|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
144509934|NCT00716859|521066290|FG000|Overall Study|Adverse Event|4|||
144509935|NCT00716859|521066291|FG001|Overall Study|Adverse Event|1|||
144509936|NCT00716859|521066290|FG000|Overall Study|Lack of Efficacy|3|||
144509937|NCT00716859|521066291|FG001|Overall Study|Lack of Efficacy|0|||
144509938|NCT00716859|521066290|FG000|Overall Study|Withdrawal by Subject|1|||
144509939|NCT00716859|521066291|FG001|Overall Study|Withdrawal by Subject|3|||
144509940|NCT00716859|521066290|FG000|Overall Study|Not treated|1|||
144509941|NCT00716859|521066291|FG001|Overall Study|Not treated|1|||
144509942|NCT03122886|521067703|FG000|Overall Study|Withdrawal by Subject|1|||
144509943|NCT03122886|521067704|FG001|Overall Study|Withdrawal by Subject|2|||
144509944|NCT05985044|521067705|FG000|Overall Study|Death|6|||
144509945|NCT05985044|521067705|FG000|Overall Study|Lost to Follow-up|4|||
144509946|NCT05985044|521067705|FG000|Overall Study|Incapacitation|3|||
144509947|NCT05985044|521067705|FG000|Overall Study|Withdrawal by Subject|2|||
144509948|NCT03312907|521067708|FG000|Overall Study|Adverse Event|1|||
144509949|NCT03312907|521067709|FG001|Overall Study|Adverse Event|6|||
144509950|NCT03312907|521067710|FG002|Overall Study|Adverse Event|1|||
144509951|NCT03312907|521067708|FG000|Overall Study|Protocol Violation|2|||
144509952|NCT03312907|521067709|FG001|Overall Study|Protocol Violation|3|||
144589501|NCT03406260|521357998|FG005|Period 1|Adverse Event|0|||
144589502|NCT00523640|521358007|FG000|Overall Study|Death|1|||
144589503|NCT02399254|521358008|FG000|Overall Study|Physician Decision|2|||
144589504|NCT02334423|521358009|FG000|Overall Study|Protocol Violation|10|||
144721689|NCT00419926|521835263|FG000|Overall Study|Withdrawal by Subject|7|||
144509953|NCT03312907|521067710|FG002|Overall Study|Protocol Violation|4|||
144509954|NCT03312907|521067708|FG000|Overall Study|Lost to Follow-up|2|||
144509955|NCT03312907|521067709|FG001|Overall Study|Lost to Follow-up|3|||
144509956|NCT03312907|521067710|FG002|Overall Study|Lost to Follow-up|2|||
144509957|NCT03312907|521067708|FG000|Overall Study|Physician Decision|3|||
144509958|NCT03312907|521067709|FG001|Overall Study|Physician Decision|4|||
144509959|NCT03312907|521067710|FG002|Overall Study|Physician Decision|2|||
144509960|NCT03312907|521067708|FG000|Overall Study|Withdrawal by Subject|9|||
144509961|NCT03312907|521067709|FG001|Overall Study|Withdrawal by Subject|14|||
144589505|NCT02334423|521358010|FG001|Overall Study|Protocol Violation|3|||
144721690|NCT00419926|521835264|FG001|Overall Study|Withdrawal by Subject|3|||
144589506|NCT02930226|521358011|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
144589507|NCT02930226|521358012|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
144589508|NCT02930226|521358013|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
144589509|NCT02930226|521358014|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
144589510|NCT02930226|521358015|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
144589511|NCT02930226|521358016|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
144589512|NCT00652327|521358017|FG000|Overall Study|Adverse Event|0|||
144589513|NCT00652327|521358018|FG001|Overall Study|Adverse Event|2|||
144589514|NCT00652327|521358017|FG000|Overall Study|Lost to Follow-up|0|||
144589515|NCT00652327|521358018|FG001|Overall Study|Lost to Follow-up|3|||
144589516|NCT01076647|521358019|FG000|Overall Study|Adverse Event|4|||
144589517|NCT01076647|521358020|FG001|Overall Study|Adverse Event|1|||
144589518|NCT01076647|521358019|FG000|Overall Study|Lack of Efficacy|0|||
144589519|NCT01076647|521358020|FG001|Overall Study|Lack of Efficacy|1|||
144589520|NCT01076647|521358019|FG000|Overall Study|Protocol Violation|7|||
144589521|NCT01076647|521358020|FG001|Overall Study|Protocol Violation|9|||
144589522|NCT01076647|521358019|FG000|Overall Study|Withdrawal criteria|2|||
144589523|NCT01076647|521358020|FG001|Overall Study|Withdrawal criteria|2|||
144589524|NCT01076647|521358019|FG000|Overall Study|Unclassified|12|||
144589525|NCT01076647|521358020|FG001|Overall Study|Unclassified|12|||
144589526|NCT02224690|521358028|FG000|Overall Study|Adverse Event|8|||
144589527|NCT02224690|521358029|FG001|Overall Study|Adverse Event|1|||
144589528|NCT02224690|521358028|FG000|Overall Study|Met Withdrawal Criteria|4|||
144589529|NCT02224690|521358029|FG001|Overall Study|Met Withdrawal Criteria|0|||
144589530|NCT02224690|521358028|FG000|Overall Study|Use of G-tube|1|||
144589531|NCT02224690|521358029|FG001|Overall Study|Use of G-tube|0|||
144589532|NCT02224690|521358028|FG000|Overall Study|Did not meet eligibility criteria|1|||
144589533|NCT02224690|521358029|FG001|Overall Study|Did not meet eligibility criteria|0|||
144589534|NCT00141219|521358030|FG000|Overall Study|Protocol violations|5|||
144589535|NCT00141219|521358031|FG001|Overall Study|Protocol violations|4|||
144589536|NCT00141219|521358030|FG000|Overall Study|Adverse Event|8|||
144589537|NCT00141219|521358031|FG001|Overall Study|Adverse Event|6|||
144589538|NCT00141219|521358030|FG000|Overall Study|Lack of Efficacy|5|||
144589539|NCT00141219|521358031|FG001|Overall Study|Lack of Efficacy|4|||
144589540|NCT00141219|521358030|FG000|Overall Study|Withdrawal by Subject|6|||
144589541|NCT00141219|521358031|FG001|Overall Study|Withdrawal by Subject|2|||
144589542|NCT01577745|521358032|FG000|Overall Study|Withdrawal by Subject|0|||
144589543|NCT01577745|521358033|FG001|Overall Study|Withdrawal by Subject|1|||
144589544|NCT01577745|521358034|FG002|Overall Study|Withdrawal by Subject|0|||
144589545|NCT01577745|521358035|FG003|Overall Study|Withdrawal by Subject|3|||
144589546|NCT01577745|521358036|FG004|Overall Study|Withdrawal by Subject|2|||
144589547|NCT01577745|521358037|FG005|Overall Study|Withdrawal by Subject|0|||
144589548|NCT01577745|521358032|FG000|Overall Study|Death|3|||
144589549|NCT01577745|521358033|FG001|Overall Study|Death|2|||
144589550|NCT01577745|521358034|FG002|Overall Study|Death|2|||
144589551|NCT01577745|521358035|FG003|Overall Study|Death|1|||
144589552|NCT01577745|521358036|FG004|Overall Study|Death|1|||
144589553|NCT01577745|521358037|FG005|Overall Study|Death|3|||
144589554|NCT01577745|521358032|FG000|Overall Study|Physician Decision|0|||
144589555|NCT01577745|521358033|FG001|Overall Study|Physician Decision|0|||
144589556|NCT01577745|521358034|FG002|Overall Study|Physician Decision|0|||
144589557|NCT01577745|521358035|FG003|Overall Study|Physician Decision|1|||
144589558|NCT01577745|521358036|FG004|Overall Study|Physician Decision|1|||
144589559|NCT01577745|521358037|FG005|Overall Study|Physician Decision|0|||
144589560|NCT01577745|521358032|FG000|Overall Study|Lost to Follow-up|0|||
144589561|NCT01577745|521358033|FG001|Overall Study|Lost to Follow-up|0|||
144589562|NCT01577745|521358034|FG002|Overall Study|Lost to Follow-up|0|||
144589563|NCT01577745|521358035|FG003|Overall Study|Lost to Follow-up|0|||
144589564|NCT01577745|521358036|FG004|Overall Study|Lost to Follow-up|0|||
144589565|NCT01577745|521358037|FG005|Overall Study|Lost to Follow-up|1|||
144589566|NCT01577745|521358032|FG000|Overall Study|Alternative Therapy|0|||
144589567|NCT01577745|521358033|FG001|Overall Study|Alternative Therapy|0|||
144589568|NCT01577745|521358034|FG002|Overall Study|Alternative Therapy|0|||
144589569|NCT01577745|521358035|FG003|Overall Study|Alternative Therapy|1|||
144589570|NCT01577745|521358036|FG004|Overall Study|Alternative Therapy|1|||
144589571|NCT01577745|521358037|FG005|Overall Study|Alternative Therapy|0|||
144589572|NCT00122460|521358038|FG000|Overall Study|investigational study phase ongoing|7|||
144589573|NCT00122460|521358039|FG001|Overall Study|investigational study phase ongoing|1|||
144589574|NCT00577473|521358042|FG000|Overall Study|Protocol Violation|1|||
144589575|NCT00577473|521358043|FG001|Overall Study|Protocol Violation|4|||
144589576|NCT00577473|521358042|FG000|Overall Study|Adverse Event|8|||
144589577|NCT00577473|521358043|FG001|Overall Study|Adverse Event|5|||
144589578|NCT00577473|521358042|FG000|Overall Study|Withdrawal by Subject|2|||
144589579|NCT00577473|521358043|FG001|Overall Study|Withdrawal by Subject|6|||
144589580|NCT00577473|521358042|FG000|Overall Study|Physician Decision|2|||
144589581|NCT00577473|521358043|FG001|Overall Study|Physician Decision|2|||
144589582|NCT00577473|521358042|FG000|Overall Study|Lack of Efficacy|8|||
144589583|NCT00577473|521358043|FG001|Overall Study|Lack of Efficacy|7|||
144589584|NCT00825916|521358044|FG000|Overall Study|Lost to Follow-up|4|||
144589585|NCT00825916|521358045|FG001|Overall Study|Lost to Follow-up|2|||
144589586|NCT00825916|521358046|FG002|Overall Study|Lost to Follow-up|1|||
144589587|NCT02962960|521358047|FG000|Overall Study|Withdrawal by Subject|1|||
144589588|NCT02962960|521358048|FG001|Overall Study|Withdrawal by Subject|1|||
144589589|NCT02962960|521358049|FG002|Overall Study|Withdrawal by Subject|0|||
144589590|NCT02962960|521358047|FG000|Overall Study|Adverse Event|1|||
144589591|NCT02962960|521358048|FG001|Overall Study|Adverse Event|1|||
144589592|NCT02962960|521358049|FG002|Overall Study|Adverse Event|0|||
144589593|NCT02962960|521358047|FG000|Overall Study|Protocol Violation|1|||
144589594|NCT02962960|521358048|FG001|Overall Study|Protocol Violation|0|||
144589595|NCT02962960|521358049|FG002|Overall Study|Protocol Violation|0|||
144589596|NCT02884908|521358050|FG000|Overall Study|Lost to Follow-up|13|||
144589597|NCT02884908|521358051|FG001|Overall Study|Lost to Follow-up|18|||
144589598|NCT02344004|521358059|FG000|Overall Study|Adverse Event|11|||
144589599|NCT02344004|521358060|FG001|Overall Study|Adverse Event|1|||
144589600|NCT02344004|521358059|FG000|Overall Study|Death|9|||
144589601|NCT02344004|521358060|FG001|Overall Study|Death|7|||
144589602|NCT02344004|521358059|FG000|Overall Study|Physician Decision|4|||
144589603|NCT02344004|521358060|FG001|Overall Study|Physician Decision|1|||
144589604|NCT02344004|521358059|FG000|Overall Study|Withdrawal by Subject|22|||
144589605|NCT02344004|521358060|FG001|Overall Study|Withdrawal by Subject|5|||
144589606|NCT02344004|521358059|FG000|Overall Study|Rescue Medication|2|||
144589607|NCT02344004|521358060|FG001|Overall Study|Rescue Medication|0|||
144589608|NCT02344004|521358059|FG000|Overall Study|Other Not Specified|12|||
144589609|NCT02344004|521358060|FG001|Overall Study|Other Not Specified|0|||
144589610|NCT02344004|521358059|FG000|Overall Study|Protocol Violation|1|||
144589611|NCT02344004|521358060|FG001|Overall Study|Protocol Violation|0|||
144589612|NCT01502631|521358061|FG000|Overall Study|Adverse Event|5|||
144589613|NCT01502631|521358062|FG001|Overall Study|Adverse Event|8|||
144589614|NCT01502631|521358061|FG000|Overall Study|Lost to Follow-up|2|||
144589615|NCT01502631|521358062|FG001|Overall Study|Lost to Follow-up|2|||
144589616|NCT01502631|521358061|FG000|Overall Study|Participant withdrew consent|2|||
144589617|NCT01502631|521358062|FG001|Overall Study|Participant withdrew consent|4|||
144589618|NCT01502631|521358061|FG000|Overall Study|Participant non-compliant|1|||
144589619|NCT01502631|521358062|FG001|Overall Study|Participant non-compliant|0|||
144589620|NCT01502631|521358061|FG000|Overall Study|Investigator's decision|0|||
144589621|NCT01502631|521358062|FG001|Overall Study|Investigator's decision|1|||
144589622|NCT01502631|521358061|FG000|Overall Study|Other|10|||
144589623|NCT01502631|521358062|FG001|Overall Study|Other|5|||
144589624|NCT00395460|521358063|FG000|Overall Study|Withdrawal by Subject|1|||
144589625|NCT00395460|521358064|FG001|Overall Study|Withdrawal by Subject|0|||
144589626|NCT04223830|521358068|FG000|Overall Study|Lost to Follow-up|9|||
144589627|NCT04223830|521358068|FG000|Overall Study|Adverse Event|1|||
144589628|NCT00862719|521358069|FG000|Overall Study|Disease Progression|5|||
144589629|NCT00862719|521358070|FG001|Overall Study|Disease Progression|0|||
144589630|NCT00862719|521358071|FG002|Overall Study|Disease Progression|1|||
144589631|NCT00862719|521358072|FG003|Overall Study|Disease Progression|0|||
144589632|NCT00862719|521358069|FG000|Overall Study|Death|5|||
144589633|NCT00862719|521358070|FG001|Overall Study|Death|6|||
144589634|NCT00862719|521358071|FG002|Overall Study|Death|1|||
144589635|NCT00862719|521358072|FG003|Overall Study|Death|1|||
144589636|NCT00862719|521358069|FG000|Overall Study|Engraftment failure|0|||
144589637|NCT00862719|521358070|FG001|Overall Study|Engraftment failure|0|||
144589638|NCT00862719|521358071|FG002|Overall Study|Engraftment failure|1|||
144589639|NCT00862719|521358072|FG003|Overall Study|Engraftment failure|0|||
144589640|NCT00862719|521358069|FG000|Overall Study|Veno-Occlusive Disease|0|||
144589641|NCT00862719|521358070|FG001|Overall Study|Veno-Occlusive Disease|0|||
144589642|NCT00862719|521358071|FG002|Overall Study|Veno-Occlusive Disease|1|||
144589643|NCT00862719|521358072|FG003|Overall Study|Veno-Occlusive Disease|0|||
144589644|NCT01806623|521358073|FG000|Overall Study|Withdrawal by Subject|1|||
144589645|NCT01806623|521358073|FG000|Overall Study|Adverse Event|1|||
144589646|NCT01806623|521358073|FG000|Overall Study|Did not meet the inclusion criteria|56|||
144589647|NCT02424734|521358074|FG000|Overall Study|Treatment stopped to be discharged home|2|||
144589648|NCT02424734|521358075|FG001|Overall Study|Treatment stopped to be discharged home|2|||
144589649|NCT02424734|521358076|FG002|Overall Study|Treatment stopped to be discharged home|0|||
144589650|NCT02413333|521358082|FG000|Period 1|Adverse Event|1|||
144589651|NCT02413333|521358083|FG001|Period 1|Adverse Event|0|||
144589652|NCT02413333|521358082|FG000|Period 1|Reason Not Specified|0|||
144589653|NCT02413333|521358083|FG001|Period 1|Reason Not Specified|1|||
144589654|NCT02413333|521358082|FG000|Period 2|Protocol Deviation|1|||
144589655|NCT02413333|521358083|FG001|Period 2|Protocol Deviation|0|||
144589656|NCT00709852|521358084|FG000|Period 1|Adverse Event|2|||
144589657|NCT00709852|521358085|FG001|Period 1|Adverse Event|0|||
144589658|NCT00709852|521358084|FG000|Period 1|Withdrawal by Subject|4|||
144589659|NCT00709852|521358085|FG001|Period 1|Withdrawal by Subject|2|||
144589660|NCT00709852|521358084|FG000|Period 1|Protocol Violation|1|||
144589661|NCT00709852|521358085|FG001|Period 1|Protocol Violation|0|||
144589662|NCT00709852|521358084|FG000|Period 1|Defective scanner|0|||
144589663|NCT00709852|521358085|FG001|Period 1|Defective scanner|1|||
144589664|NCT00709852|521358084|FG000|Period 1|Lost to Follow-up|1|||
144589665|NCT00709852|521358085|FG001|Period 1|Lost to Follow-up|0|||
144589666|NCT00709852|521358084|FG000|Period 2|Protocol Violation|4|||
144589667|NCT00709852|521358085|FG001|Period 2|Protocol Violation|1|||
144589668|NCT00709852|521358084|FG000|Period 2|Adverse Event|1|||
144589669|NCT00709852|521358085|FG001|Period 2|Adverse Event|1|||
144589670|NCT00709852|521358084|FG000|Period 2|Lost to Follow-up|1|||
144589671|NCT00709852|521358085|FG001|Period 2|Lost to Follow-up|0|||
144589672|NCT00709852|521358084|FG000|Period 2|No 72-hour follow-up|3|||
144589673|NCT00709852|521358085|FG001|Period 2|No 72-hour follow-up|0|||
144589674|NCT00185965|521358086|FG000|Overall Study|Adverse Event|0|||
144589675|NCT00185965|521358087|FG001|Overall Study|Adverse Event|1|||
144589676|NCT03814187|521358088|FG000|Overall Study|Sponsor's Administrative Decision|0|||
144589677|NCT03814187|521358089|FG001|Overall Study|Sponsor's Administrative Decision|0|||
144589678|NCT03814187|521358090|FG002|Overall Study|Sponsor's Administrative Decision|272|||
144589679|NCT03814187|521358088|FG000|Overall Study|Death|80|||
144589680|NCT03814187|521358089|FG001|Overall Study|Death|81|||
144589681|NCT03814187|521358090|FG002|Overall Study|Death|4|||
144589682|NCT03814187|521358088|FG000|Overall Study|Withdrew Consent|77|||
144589683|NCT03814187|521358089|FG001|Overall Study|Withdrew Consent|78|||
144589684|NCT03814187|521358090|FG002|Overall Study|Withdrew Consent|2|||
144589685|NCT03814187|521358088|FG000|Overall Study|Lost to Follow-up|47|||
144589686|NCT03814187|521358089|FG001|Overall Study|Lost to Follow-up|52|||
144589687|NCT03814187|521358090|FG002|Overall Study|Lost to Follow-up|1|||
144589688|NCT03814187|521358088|FG000|Overall Study|Adverse Event|22|||
144589689|NCT03814187|521358089|FG001|Overall Study|Adverse Event|23|||
144589690|NCT03814187|521358090|FG002|Overall Study|Adverse Event|0|||
144509962|NCT03312907|521067710|FG002|Overall Study|Withdrawal by Subject|10|||
144509963|NCT03189524|521067712|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
144509964|NCT03189524|521067713|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
144509965|NCT03189524|521067714|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
144509966|NCT03189524|521067712|FG000|Overall Study|Death|2|||
144509967|NCT03189524|521067713|FG001|Overall Study|Death|2|||
144509968|NCT03189524|521067714|FG002|Overall Study|Death|1|||
144509969|NCT03189524|521067712|FG000|Overall Study|Lost to Follow-up|1|||
144509970|NCT03189524|521067713|FG001|Overall Study|Lost to Follow-up|0|||
144509971|NCT03189524|521067714|FG002|Overall Study|Lost to Follow-up|8|||
144509972|NCT03189524|521067712|FG000|Overall Study|Withdrawal by Subject|1|||
144509973|NCT03189524|521067713|FG001|Overall Study|Withdrawal by Subject|1|||
144509974|NCT03189524|521067714|FG002|Overall Study|Withdrawal by Subject|3|||
144509975|NCT03189524|521067712|FG000|Overall Study|Progressive Disease|0|||
144509976|NCT03189524|521067713|FG001|Overall Study|Progressive Disease|2|||
144509977|NCT03189524|521067714|FG002|Overall Study|Progressive Disease|0|||
144509978|NCT01780298|521067716|FG000|Overall Study|Physician Decision|1|||
144509979|NCT01780298|521067717|FG001|Overall Study|Physician Decision|5|||
144509980|NCT01780298|521067718|FG002|Overall Study|Physician Decision|1|||
144509981|NCT01780298|521067719|FG003|Overall Study|Physician Decision|1|||
144509982|NCT01780298|521067716|FG000|Overall Study|Subject not matched|1|||
144509983|NCT01780298|521067717|FG001|Overall Study|Subject not matched|0|||
144509984|NCT01780298|521067718|FG002|Overall Study|Subject not matched|1|||
144509985|NCT01780298|521067719|FG003|Overall Study|Subject not matched|0|||
144509986|NCT01780298|521067716|FG000|Overall Study|Adverse Event|0|||
144509987|NCT01780298|521067717|FG001|Overall Study|Adverse Event|0|||
144509988|NCT01780298|521067718|FG002|Overall Study|Adverse Event|2|||
144509989|NCT01780298|521067719|FG003|Overall Study|Adverse Event|0|||
144509990|NCT04907474|521067724|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
144509991|NCT04907474|521067725|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
144509992|NCT03873779|521067726|FG000|Overall Study|Withdrawal by Subject|1|||
144509993|NCT02581215|521067727|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
144509994|NCT02581215|521067728|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
144509995|NCT02581215|521067727|FG000|Overall Study|Eligibility Criteria Not Met|0|||
144509996|NCT02581215|521067728|FG001|Overall Study|Eligibility Criteria Not Met|1|||
144589691|NCT03814187|521358088|FG000|Overall Study|Physician Decision|7|||
144589692|NCT03814187|521358089|FG001|Overall Study|Physician Decision|4|||
144589693|NCT03814187|521358090|FG002|Overall Study|Physician Decision|2|||
144589694|NCT03814187|521358088|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
144509997|NCT04279574|521067729|FG000|Overall Study|Death|1|||
144509998|NCT04279574|521067730|FG001|Overall Study|Death|0|||
144509999|NCT04279574|521067729|FG000|Overall Study|lost restoration, tooth fracture|1|||
144510000|NCT04279574|521067730|FG001|Overall Study|lost restoration, tooth fracture|0|||
144589695|NCT03814187|521358089|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
144589696|NCT03814187|521358090|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
144589697|NCT03814187|521358088|FG000|Overall Study|Other reasons|34|||
144589698|NCT03814187|521358089|FG001|Overall Study|Other reasons|40|||
144589699|NCT03814187|521358090|FG002|Overall Study|Other reasons|2|||
144589700|NCT02009761|521358092|FG000|Overall Study|Adverse Event|4|||
144589701|NCT00825825|521358093|FG000|First Medication Period (14 Days)|Adverse Event|1|||
144589702|NCT00825825|521358094|FG001|First Medication Period (14 Days)|Adverse Event|0|||
144589703|NCT00825825|521358095|FG002|First Medication Period (14 Days)|Adverse Event|0|||
144589704|NCT00825825|521358096|FG003|First Medication Period (14 Days)|Adverse Event|0|||
144510001|NCT04279574|521067729|FG000|Overall Study|Lost to Follow-up|0|||
144510002|NCT04279574|521067730|FG001|Overall Study|Lost to Follow-up|1|||
144510003|NCT02566902|521067732|FG000|Overall Study|Protocol Violation|2|||
144510004|NCT02566902|521067733|FG001|Overall Study|Protocol Violation|1|||
144510005|NCT04259450|521067735|FG000|Overall Study|Adverse event/ Toxicity|0|||
144510006|NCT04259450|521067736|FG001|Overall Study|Adverse event/ Toxicity|3|||
144510007|NCT04259450|521067737|FG002|Overall Study|Adverse event/ Toxicity|0|||
144510008|NCT04259450|521067738|FG003|Overall Study|Adverse event/ Toxicity|1|||
144510009|NCT04259450|521067739|FG004|Overall Study|Adverse event/ Toxicity|0|||
144510010|NCT04259450|521067740|FG005|Overall Study|Adverse event/ Toxicity|0|||
144510011|NCT04259450|521067741|FG006|Overall Study|Adverse event/ Toxicity|0|||
144510012|NCT04259450|521067742|FG007|Overall Study|Adverse event/ Toxicity|1|||
144510013|NCT04259450|521067743|FG008|Overall Study|Adverse event/ Toxicity|0|||
144510014|NCT04259450|521067744|FG009|Overall Study|Adverse event/ Toxicity|3|||
144510015|NCT04259450|521067735|FG000|Overall Study|Disease progression|2|||
144510016|NCT04259450|521067736|FG001|Overall Study|Disease progression|3|||
144510017|NCT04259450|521067737|FG002|Overall Study|Disease progression|4|||
144510018|NCT04259450|521067738|FG003|Overall Study|Disease progression|4|||
144510019|NCT04259450|521067739|FG004|Overall Study|Disease progression|6|||
144510020|NCT04259450|521067740|FG005|Overall Study|Disease progression|6|||
144510021|NCT04259450|521067741|FG006|Overall Study|Disease progression|6|||
144510022|NCT04259450|521067742|FG007|Overall Study|Disease progression|15|||
144510023|NCT04259450|521067743|FG008|Overall Study|Disease progression|6|||
144510024|NCT04259450|521067744|FG009|Overall Study|Disease progression|18|||
144510025|NCT04259450|521067735|FG000|Overall Study|Death|0|||
144510026|NCT04259450|521067736|FG001|Overall Study|Death|0|||
144510027|NCT04259450|521067737|FG002|Overall Study|Death|0|||
144510028|NCT04259450|521067738|FG003|Overall Study|Death|0|||
144510029|NCT04259450|521067739|FG004|Overall Study|Death|0|||
144510030|NCT04259450|521067740|FG005|Overall Study|Death|0|||
144510031|NCT04259450|521067741|FG006|Overall Study|Death|0|||
144510032|NCT04259450|521067742|FG007|Overall Study|Death|1|||
144589705|NCT00825825|521358097|FG004|First Medication Period (14 Days)|Adverse Event|0|||
144589706|NCT00825825|521358098|FG005|First Medication Period (14 Days)|Adverse Event|1|||
144510033|NCT04259450|521067743|FG008|Overall Study|Death|1|||
144589707|NCT00825825|521358093|FG000|First Medication Period (14 Days)|Physician Decision|2|||
144510034|NCT04259450|521067744|FG009|Overall Study|Death|0|||
144510035|NCT04259450|521067735|FG000|Overall Study|Withdrawal by Subject|0|||
144510036|NCT04259450|521067736|FG001|Overall Study|Withdrawal by Subject|0|||
144589708|NCT00825825|521358094|FG001|First Medication Period (14 Days)|Physician Decision|0|||
144510037|NCT04259450|521067737|FG002|Overall Study|Withdrawal by Subject|0|||
144510038|NCT04259450|521067738|FG003|Overall Study|Withdrawal by Subject|0|||
144510039|NCT04259450|521067739|FG004|Overall Study|Withdrawal by Subject|0|||
144510040|NCT04259450|521067740|FG005|Overall Study|Withdrawal by Subject|0|||
144589709|NCT00825825|521358095|FG002|First Medication Period (14 Days)|Physician Decision|1|||
144589710|NCT00825825|521358096|FG003|First Medication Period (14 Days)|Physician Decision|0|||
144589711|NCT00825825|521358097|FG004|First Medication Period (14 Days)|Physician Decision|0|||
144589712|NCT00825825|521358098|FG005|First Medication Period (14 Days)|Physician Decision|1|||
144589713|NCT00825825|521358093|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
144589714|NCT00825825|521358094|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
144589715|NCT00825825|521358095|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
144589716|NCT00825825|521358096|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
144589717|NCT00825825|521358097|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
144589718|NCT00825825|521358098|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
144589719|NCT00825825|521358093|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
144589720|NCT00825825|521358094|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
144589721|NCT00825825|521358095|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
144589722|NCT00825825|521358096|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
144589723|NCT00825825|521358097|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
144589724|NCT00825825|521358098|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
144589725|NCT00825825|521358093|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
144589726|NCT00825825|521358094|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
144589727|NCT00825825|521358095|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
144589728|NCT00825825|521358096|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
144589729|NCT00825825|521358097|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
144589730|NCT00825825|521358098|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
144589731|NCT00825825|521358093|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
144589732|NCT00825825|521358094|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
144589733|NCT00825825|521358095|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
144589734|NCT00825825|521358096|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
144589735|NCT00825825|521358097|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
144589736|NCT00825825|521358098|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
144589737|NCT00825825|521358093|FG000|Third Medication Period (14 Days)|poor data quality|0|||
144589738|NCT00825825|521358094|FG001|Third Medication Period (14 Days)|poor data quality|1|||
144589739|NCT00825825|521358095|FG002|Third Medication Period (14 Days)|poor data quality|0|||
144589740|NCT00825825|521358096|FG003|Third Medication Period (14 Days)|poor data quality|0|||
144589741|NCT00825825|521358097|FG004|Third Medication Period (14 Days)|poor data quality|0|||
144589742|NCT00825825|521358098|FG005|Third Medication Period (14 Days)|poor data quality|0|||
144589743|NCT03265938|521358100|FG000|Overall Study|Withdrawal by Subject|1|||
144589744|NCT03265938|521358100|FG000|Overall Study|Physician Decision|1|||
144589745|NCT03265938|521358100|FG000|Overall Study|friable mass|6|||
144589746|NCT01892540|521358101|FG000|Overall Study|Did not complete PET/MRI|0|||
144589747|NCT01892540|521358102|FG001|Overall Study|Did not complete PET/MRI|0|||
144589748|NCT01892540|521358103|FG002|Overall Study|Did not complete PET/MRI|2|||
144589749|NCT01892540|521358101|FG000|Overall Study|Did not fit in scanner|0|||
144510041|NCT04259450|521067741|FG006|Overall Study|Withdrawal by Subject|0|||
144510042|NCT04259450|521067742|FG007|Overall Study|Withdrawal by Subject|1|||
144510043|NCT04259450|521067743|FG008|Overall Study|Withdrawal by Subject|0|||
144510044|NCT04259450|521067744|FG009|Overall Study|Withdrawal by Subject|0|||
144589750|NCT01892540|521358102|FG001|Overall Study|Did not fit in scanner|0|||
144589751|NCT01892540|521358103|FG002|Overall Study|Did not fit in scanner|1|||
144589752|NCT02317432|521358107|FG000|Overall Study|Death|4|||
144589753|NCT02317432|521358108|FG001|Overall Study|Death|1|||
144589754|NCT02317432|521358107|FG000|Overall Study|Lost to Follow-up|0|||
144589755|NCT02317432|521358108|FG001|Overall Study|Lost to Follow-up|5|||
144589756|NCT02317432|521358107|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
144589757|NCT02317432|521358108|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
144589758|NCT00727311|521358113|FG000|Overall Study|Did not receive drug|316|||
144510045|NCT04259450|521067735|FG000|Overall Study|Other than listed|0|||
144510046|NCT04259450|521067736|FG001|Overall Study|Other than listed|0|||
144510047|NCT04259450|521067737|FG002|Overall Study|Other than listed|0|||
144510048|NCT04259450|521067738|FG003|Overall Study|Other than listed|0|||
144510049|NCT04259450|521067739|FG004|Overall Study|Other than listed|0|||
144510050|NCT04259450|521067740|FG005|Overall Study|Other than listed|0|||
144510051|NCT04259450|521067741|FG006|Overall Study|Other than listed|0|||
144510052|NCT04259450|521067742|FG007|Overall Study|Other than listed|1|||
144589759|NCT00727311|521358113|FG000|Overall Study|Missing end of therapy data|205|||
144589760|NCT00727311|521358113|FG000|Overall Study|Adverse Event|58|||
144589761|NCT00727311|521358113|FG000|Overall Study|Lack of Efficacy|242|||
144589762|NCT00727311|521358113|FG000|Overall Study|Lost to Follow-up|73|||
144510053|NCT04259450|521067743|FG008|Overall Study|Other than listed|1|||
144510054|NCT04259450|521067744|FG009|Overall Study|Other than listed|2|||
144510055|NCT03452189|521067745|FG000|First Intervention (3 Months)|Adverse Event|1|||
144510056|NCT03452189|521067746|FG001|First Intervention (3 Months)|Adverse Event|0|||
144589763|NCT00727311|521358113|FG000|Overall Study|Withdrawal by Subject|77|||
144589764|NCT00727311|521358113|FG000|Overall Study|Other|97|||
144589765|NCT00727311|521358113|FG000|Overall Study|Multiple reasons|39|||
144510057|NCT03452189|521067745|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
144510058|NCT03452189|521067746|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
144510059|NCT02724592|521067753|FG000|Overall Study|Lost to Follow-up|4|||
144510060|NCT02724592|521067754|FG001|Overall Study|Lost to Follow-up|1|||
144510061|NCT04723394|521067758|FG000|Overall Study|Adverse Event|0|||
144510062|NCT04723394|521067759|FG001|Overall Study|Adverse Event|3|||
144510063|NCT04723394|521067758|FG000|Overall Study|Death|8|||
144510064|NCT04723394|521067759|FG001|Overall Study|Death|8|||
144510065|NCT04723394|521067758|FG000|Overall Study|Lost to Follow-up|20|||
144510066|NCT04723394|521067759|FG001|Overall Study|Lost to Follow-up|17|||
144510067|NCT04723394|521067758|FG000|Overall Study|Physician Decision|1|||
144510068|NCT04723394|521067759|FG001|Overall Study|Physician Decision|0|||
144510069|NCT04723394|521067758|FG000|Overall Study|Withdrawal by Subject|20|||
144510070|NCT04723394|521067759|FG001|Overall Study|Withdrawal by Subject|34|||
144510071|NCT04723394|521067758|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
144510072|NCT04723394|521067759|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
144510073|NCT00371787|521067760|FG000|Overall Study|Withdrawal by Subject|3|||
144510074|NCT00371787|521067761|FG001|Overall Study|Withdrawal by Subject|1|||
144510075|NCT02706717|521067767|FG000|Overall Study|Withdrawal by Subject|1|||
144510076|NCT02706717|521067768|FG001|Overall Study|Withdrawal by Subject|8|||
144510077|NCT02706717|521067767|FG000|Overall Study|Lost to Follow-up|0|||
144510078|NCT02706717|521067768|FG001|Overall Study|Lost to Follow-up|1|||
144510079|NCT02706717|521067767|FG000|Overall Study|Physician Decision|0|||
144510080|NCT02706717|521067768|FG001|Overall Study|Physician Decision|1|||
144510081|NCT02706717|521067767|FG000|Overall Study|Death|0|||
144510082|NCT02706717|521067768|FG001|Overall Study|Death|1|||
144510083|NCT00106080|521067769|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
144510084|NCT00106080|521067770|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
144510085|NCT01546753|521067774|FG000|Overall Study|anxiety|1|||
144510086|NCT01546753|521067775|FG001|Overall Study|anxiety|1|||
144510087|NCT01546753|521067774|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
144510088|NCT01546753|521067775|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
144510089|NCT00546754|521067776|FG000|Overall Study|Serious Adverse Event|1|||
144510090|NCT00546754|521067777|FG001|Overall Study|Serious Adverse Event|1|||
144510091|NCT00546754|521067776|FG000|Overall Study|Adverse Event|11|||
144510092|NCT00546754|521067777|FG001|Overall Study|Adverse Event|16|||
144510093|NCT00546754|521067776|FG000|Overall Study|Lack of Efficacy|1|||
144510094|NCT00546754|521067777|FG001|Overall Study|Lack of Efficacy|1|||
144510095|NCT00546754|521067776|FG000|Overall Study|Lost to Follow-up|9|||
144510096|NCT00546754|521067777|FG001|Overall Study|Lost to Follow-up|15|||
144510097|NCT00546754|521067776|FG000|Overall Study|Protocol Violation|3|||
144510098|NCT00546754|521067777|FG001|Overall Study|Protocol Violation|0|||
144510099|NCT00546754|521067776|FG000|Overall Study|Withdrawal by Subject|6|||
144510100|NCT00546754|521067777|FG001|Overall Study|Withdrawal by Subject|7|||
144510101|NCT00546754|521067776|FG000|Overall Study|Dyspnea|1|||
144510102|NCT00546754|521067777|FG001|Overall Study|Dyspnea|0|||
144510103|NCT00546754|521067776|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
144510104|NCT00546754|521067777|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
144510105|NCT00546754|521067776|FG000|Overall Study|Hip Replacement|1|||
144510106|NCT00546754|521067777|FG001|Overall Study|Hip Replacement|0|||
144510107|NCT00546754|521067776|FG000|Overall Study|Suicide|1|||
144510108|NCT00546754|521067777|FG001|Overall Study|Suicide|0|||
144510109|NCT00546754|521067776|FG000|Overall Study|Missing Cooperation|1|||
144510110|NCT00546754|521067777|FG001|Overall Study|Missing Cooperation|0|||
144589766|NCT02359877|521359824|FG000|Overall Study|Withdrawal by Subject|1|||
144589767|NCT02359877|521359825|FG001|Overall Study|Withdrawal by Subject|0|||
144589768|NCT02359877|521359826|FG002|Overall Study|Withdrawal by Subject|0|||
144589769|NCT02359877|521359827|FG003|Overall Study|Withdrawal by Subject|2|||
144589770|NCT02359877|521359824|FG000|Overall Study|Adverse Event|0|||
144510111|NCT00546754|521067776|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
144510112|NCT00546754|521067777|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
144510113|NCT00546754|521067776|FG000|Overall Study|Patient's Decision|0|||
144510114|NCT00546754|521067777|FG001|Overall Study|Patient's Decision|1|||
144510115|NCT00546754|521067776|FG000|Overall Study|Missing|14|||
144510116|NCT00546754|521067777|FG001|Overall Study|Missing|7|||
144510117|NCT00396084|521067780|FG000|Overall Study|Adverse Event|0|||
144510118|NCT00396084|521067781|FG001|Overall Study|Adverse Event|0|||
144510119|NCT00396084|521067782|FG002|Overall Study|Adverse Event|0|||
144510120|NCT00396084|521067783|FG003|Overall Study|Adverse Event|0|||
144510121|NCT00396084|521067784|FG004|Overall Study|Adverse Event|1|||
144510122|NCT00396084|521067785|FG005|Overall Study|Adverse Event|2|||
144510123|NCT00396084|521067780|FG000|Overall Study|Withdrawal by Subject|0|||
144589771|NCT02359877|521359825|FG001|Overall Study|Adverse Event|0|||
144589772|NCT02359877|521359826|FG002|Overall Study|Adverse Event|0|||
144589773|NCT02359877|521359827|FG003|Overall Study|Adverse Event|1|||
144589774|NCT01290029|521359831|FG000|Overall Study|Other|2|||
144589775|NCT00189488|521359832|FG000|Overall Study|Ineligibility determined|1|||
144589776|NCT00189488|521359833|FG001|Overall Study|Ineligibility determined|0|||
144589777|NCT00189488|521359832|FG000|Overall Study|Protocol deviation|2|||
144589778|NCT00189488|521359833|FG001|Overall Study|Protocol deviation|1|||
144589779|NCT00189488|521359832|FG000|Overall Study|Adverse Event|2|||
144589780|NCT00189488|521359833|FG001|Overall Study|Adverse Event|1|||
144589781|NCT00189488|521359832|FG000|Overall Study|Withdrawal by Subject|2|||
144589782|NCT00189488|521359833|FG001|Overall Study|Withdrawal by Subject|6|||
144589783|NCT00189488|521359832|FG000|Overall Study|Disease progression|2|||
144589784|NCT00189488|521359833|FG001|Overall Study|Disease progression|4|||
144510124|NCT00396084|521067781|FG001|Overall Study|Withdrawal by Subject|0|||
144510125|NCT00396084|521067782|FG002|Overall Study|Withdrawal by Subject|0|||
144510126|NCT00396084|521067783|FG003|Overall Study|Withdrawal by Subject|1|||
144510127|NCT00396084|521067784|FG004|Overall Study|Withdrawal by Subject|0|||
144510128|NCT00396084|521067785|FG005|Overall Study|Withdrawal by Subject|0|||
144510129|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
144510130|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
144510131|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
144510132|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
144510133|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
144510134|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
144510135|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
144510136|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
144510137|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
144510138|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
144510139|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
144510140|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
144510141|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
144510142|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
144510143|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
144510144|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
144510145|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
144510146|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
144510147|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
144510148|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
144510149|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
144510150|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
144510151|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
144510152|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
144510153|NCT00311363|521067786|FG000|24-Week Single-Blind Treatment Period|Death|1|||
144510154|NCT00311363|521067787|FG001|24-Week Single-Blind Treatment Period|Death|0|||
144510155|NCT00311363|521067788|FG002|24-Week Single-Blind Treatment Period|Death|0|||
144510156|NCT00311363|521067786|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
144510157|NCT00311363|521067787|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
144510158|NCT00311363|521067788|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
144510159|NCT00311363|521067786|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
144510160|NCT00311363|521067787|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
144510161|NCT00311363|521067788|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
144510162|NCT00311363|521067786|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
144510163|NCT00311363|521067787|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
144510164|NCT00311363|521067788|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
144510165|NCT00311363|521067786|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
144510166|NCT00311363|521067787|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
144510167|NCT00311363|521067788|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
144510168|NCT00311363|521067786|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
144510169|NCT00311363|521067787|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
144510170|NCT00311363|521067788|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
144510171|NCT00311363|521067786|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
144510172|NCT00311363|521067787|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
144510173|NCT00311363|521067788|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
144510174|NCT01697969|521067789|FG000|Overall Study|Did not meet inc/exc criteria|3|||
144510175|NCT04200365|521067790|FG000|Overall Study|Adverse Event|2|||
144510176|NCT04200365|521067790|FG000|Overall Study|Progressive Disease|4|||
144510177|NCT04200365|521067790|FG000|Overall Study|Lack of Efficacy|1|||
144589785|NCT00189488|521359832|FG000|Overall Study|Administrative Decision|0|||
144589786|NCT00189488|521359833|FG001|Overall Study|Administrative Decision|2|||
144510178|NCT04200365|521067790|FG000|Overall Study|Study Closure|4|||
144510179|NCT01499199|521067793|FG000|Overall Study|Adverse Event|1|||
144510180|NCT01499199|521067793|FG000|Overall Study|Lack of Efficacy|1|||
144510181|NCT01199575|521067794|FG000|Overall Study|Withdrawal by Subject|5|||
144510182|NCT01239316|521067795|FG000|Overall Study|Progression/Relapse|11|||
144510183|NCT01239316|521067795|FG000|Overall Study|Adverse Event|1|||
144510184|NCT02139943|521067796|FG000|Overall Study|Adverse Event|0|||
144510185|NCT02139943|521067797|FG001|Overall Study|Adverse Event|1|||
144510186|NCT02139943|521067798|FG002|Overall Study|Adverse Event|2|||
144510187|NCT02139943|521067796|FG000|Overall Study|Lost to Follow-up|3|||
144510188|NCT02139943|521067797|FG001|Overall Study|Lost to Follow-up|2|||
144510189|NCT02139943|521067798|FG002|Overall Study|Lost to Follow-up|2|||
144510190|NCT02139943|521067796|FG000|Overall Study|Withdrawal by Subject|4|||
144510191|NCT02139943|521067797|FG001|Overall Study|Withdrawal by Subject|3|||
144510192|NCT02139943|521067798|FG002|Overall Study|Withdrawal by Subject|0|||
144510193|NCT02139943|521067796|FG000|Overall Study|Other|0|||
144510194|NCT02139943|521067797|FG001|Overall Study|Other|0|||
144510195|NCT02139943|521067798|FG002|Overall Study|Other|1|||
144510196|NCT02139943|521067796|FG000|Overall Study|Participant wishes to discontinue|2|||
144510197|NCT02139943|521067797|FG001|Overall Study|Participant wishes to discontinue|0|||
144510198|NCT02139943|521067798|FG002|Overall Study|Participant wishes to discontinue|0|||
144510199|NCT02139943|521067796|FG000|Overall Study|Participant in Poor Compliance|1|||
144510200|NCT02139943|521067797|FG001|Overall Study|Participant in Poor Compliance|0|||
144510201|NCT02139943|521067798|FG002|Overall Study|Participant in Poor Compliance|1|||
144510202|NCT02139943|521067796|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
144510203|NCT02139943|521067797|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
144510204|NCT02139943|521067798|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
144510205|NCT00411216|521067815|FG000|Overall Study|Ten participants were entered into the c|0|||
144510206|NCT00411216|521067816|FG001|Overall Study|Ten participants were entered into the c|2|||
144510207|NCT01251354|521067821|FG000|Overall Study|Adverse Event|1|||
144510208|NCT01251354|521067821|FG000|Overall Study|Investigator's Decision|1|||
144510209|NCT01251354|521067821|FG000|Overall Study|Disease Progression|4|||
144510210|NCT04688450|521069121|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
144510211|NCT04688450|521069121|FG000|Overall Study|Withdrawal by Subject|1|||
144510212|NCT02544074|521069122|FG000|Overall Study|Withdrawal by Subject|0|||
144510213|NCT02544074|521069123|FG001|Overall Study|Withdrawal by Subject|1|||
144510214|NCT02544074|521069124|FG002|Overall Study|Withdrawal by Subject|0|||
144510215|NCT02544074|521069125|FG003|Overall Study|Withdrawal by Subject|0|||
144510216|NCT02544074|521069126|FG004|Overall Study|Withdrawal by Subject|0|||
144510217|NCT02544074|521069127|FG005|Overall Study|Withdrawal by Subject|0|||
144510218|NCT02544074|521069128|FG006|Overall Study|Withdrawal by Subject|0|||
144510219|NCT02544074|521069129|FG007|Overall Study|Withdrawal by Subject|0|||
144510220|NCT02544074|521069130|FG008|Overall Study|Withdrawal by Subject|0|||
144510221|NCT02544074|521069131|FG009|Overall Study|Withdrawal by Subject|0|||
144510222|NCT02544074|521069132|FG010|Overall Study|Withdrawal by Subject|0|||
144510223|NCT02544074|521069133|FG011|Overall Study|Withdrawal by Subject|0|||
144510224|NCT02544074|521069134|FG012|Overall Study|Withdrawal by Subject|0|||
144510225|NCT02544074|521069135|FG013|Overall Study|Withdrawal by Subject|0|||
144510226|NCT02544074|521069136|FG014|Overall Study|Withdrawal by Subject|0|||
144510227|NCT02544074|521069137|FG015|Overall Study|Withdrawal by Subject|0|||
144510228|NCT02544074|521069138|FG016|Overall Study|Withdrawal by Subject|0|||
144510229|NCT02544074|521069139|FG017|Overall Study|Withdrawal by Subject|0|||
144510230|NCT02544074|521069140|FG018|Overall Study|Withdrawal by Subject|0|||
144510231|NCT02544074|521069141|FG019|Overall Study|Withdrawal by Subject|0|||
144510232|NCT02544074|521069142|FG020|Overall Study|Withdrawal by Subject|0|||
144510233|NCT02544074|521069122|FG000|Overall Study|Tablet error|0|||
144510234|NCT02544074|521069123|FG001|Overall Study|Tablet error|0|||
144510235|NCT02544074|521069124|FG002|Overall Study|Tablet error|0|||
144510236|NCT02544074|521069125|FG003|Overall Study|Tablet error|0|||
144510237|NCT02544074|521069126|FG004|Overall Study|Tablet error|0|||
144510238|NCT02544074|521069127|FG005|Overall Study|Tablet error|1|||
144510239|NCT02544074|521069128|FG006|Overall Study|Tablet error|0|||
144510240|NCT02544074|521069129|FG007|Overall Study|Tablet error|0|||
144510241|NCT02544074|521069130|FG008|Overall Study|Tablet error|0|||
144510242|NCT02544074|521069131|FG009|Overall Study|Tablet error|1|||
144510243|NCT02544074|521069132|FG010|Overall Study|Tablet error|0|||
144510244|NCT02544074|521069133|FG011|Overall Study|Tablet error|0|||
144510245|NCT02544074|521069134|FG012|Overall Study|Tablet error|0|||
144510246|NCT02544074|521069135|FG013|Overall Study|Tablet error|0|||
144510247|NCT02544074|521069136|FG014|Overall Study|Tablet error|0|||
144510248|NCT02544074|521069137|FG015|Overall Study|Tablet error|0|||
144510249|NCT02544074|521069138|FG016|Overall Study|Tablet error|0|||
144510250|NCT02544074|521069139|FG017|Overall Study|Tablet error|0|||
144510251|NCT02544074|521069140|FG018|Overall Study|Tablet error|0|||
144510252|NCT02544074|521069141|FG019|Overall Study|Tablet error|0|||
144510253|NCT02544074|521069142|FG020|Overall Study|Tablet error|0|||
144510254|NCT02748317|521069150|FG000|Overall Study|Withdrawal by Subject|14|||
144510255|NCT02748317|521069150|FG000|Overall Study|Lost to Follow-up|8|||
144510256|NCT02748317|521069150|FG000|Overall Study|Death|1|||
144510257|NCT00332241|521069151|FG000|Overall Study|Lack of Efficacy|6|||
144510258|NCT00332241|521069152|FG001|Overall Study|Lack of Efficacy|1|||
144510259|NCT00332241|521069151|FG000|Overall Study|Adverse Event|3|||
144510260|NCT00332241|521069152|FG001|Overall Study|Adverse Event|5|||
144510261|NCT00332241|521069151|FG000|Overall Study|Withdrawal by Subject|2|||
144510262|NCT00332241|521069152|FG001|Overall Study|Withdrawal by Subject|1|||
144510263|NCT00332241|521069151|FG000|Overall Study|Lost to Follow-up|4|||
144510264|NCT00332241|521069152|FG001|Overall Study|Lost to Follow-up|1|||
144510265|NCT01534494|521069153|FG000|Overall Study|Withdrawal by Subject|1|||
144510266|NCT00802464|521069154|FG000|Month 0 - Month 8|Adverse Event|0|||
144510267|NCT00802464|521069155|FG001|Month 0 - Month 8|Adverse Event|1|||
144510268|NCT00802464|521069156|FG002|Month 0 - Month 8|Adverse Event|1|||
144510269|NCT00802464|521069157|FG003|Month 0 - Month 8|Adverse Event|2|||
144510270|NCT00802464|521069154|FG000|Month 0 - Month 8|Protocol Violation|0|||
144510271|NCT00802464|521069155|FG001|Month 0 - Month 8|Protocol Violation|0|||
144510272|NCT00802464|521069156|FG002|Month 0 - Month 8|Protocol Violation|1|||
144510273|NCT00802464|521069157|FG003|Month 0 - Month 8|Protocol Violation|0|||
144510274|NCT00802464|521069154|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
144510275|NCT00802464|521069155|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
144510276|NCT00802464|521069156|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
144510277|NCT00802464|521069157|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
144510278|NCT00802464|521069154|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
144510279|NCT00802464|521069155|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
144510280|NCT00802464|521069156|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
144510281|NCT00802464|521069157|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
144510282|NCT00802464|521069154|FG000|Month 0 - Month 8|Other|0|||
144510283|NCT00802464|521069155|FG001|Month 0 - Month 8|Other|0|||
144510284|NCT00802464|521069156|FG002|Month 0 - Month 8|Other|1|||
144510285|NCT00802464|521069157|FG003|Month 0 - Month 8|Other|0|||
144510286|NCT00802464|521069154|FG000|Month 8 - Month 14|Adverse Event|0|||
144510287|NCT00802464|521069155|FG001|Month 8 - Month 14|Adverse Event|1|||
144510288|NCT00802464|521069156|FG002|Month 8 - Month 14|Adverse Event|0|||
144510289|NCT00802464|521069157|FG003|Month 8 - Month 14|Adverse Event|0|||
144510290|NCT00802464|521069154|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
144510291|NCT00802464|521069155|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
144510292|NCT00802464|521069156|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
144510293|NCT00802464|521069157|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
144510294|NCT00802464|521069154|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
144510295|NCT00802464|521069155|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
144510296|NCT00802464|521069156|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
144510297|NCT00802464|521069157|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
144510298|NCT01939899|521069158|FG000|Lead-in Dose Finding Phase|Death|0|||
144510299|NCT01939899|521069159|FG001|Lead-in Dose Finding Phase|Death|3|||
144510300|NCT01939899|521069160|FG002|Lead-in Dose Finding Phase|Death|1|||
144510301|NCT01939899|521069161|FG003|Lead-in Dose Finding Phase|Death|0|||
144510302|NCT01939899|521069162|FG004|Lead-in Dose Finding Phase|Death|0|||
144510303|NCT01939899|521069158|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
144510304|NCT01939899|521069159|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
144510305|NCT01939899|521069160|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
144510306|NCT01939899|521069161|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
144510307|NCT01939899|521069162|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
144510308|NCT01939899|521069158|FG000|Lead-in Dose Finding Phase|Other|0|||
144510309|NCT01939899|521069159|FG001|Lead-in Dose Finding Phase|Other|0|||
144510310|NCT01939899|521069160|FG002|Lead-in Dose Finding Phase|Other|1|||
144510311|NCT01939899|521069161|FG003|Lead-in Dose Finding Phase|Other|0|||
144510312|NCT01939899|521069162|FG004|Lead-in Dose Finding Phase|Other|0|||
144510313|NCT01939899|521069158|FG000|Phase 2|Withdrawal by Subject|0|||
144510314|NCT01939899|521069159|FG001|Phase 2|Withdrawal by Subject|0|||
144510315|NCT01939899|521069160|FG002|Phase 2|Withdrawal by Subject|0|||
144510316|NCT01939899|521069161|FG003|Phase 2|Withdrawal by Subject|2|||
144510317|NCT01939899|521069162|FG004|Phase 2|Withdrawal by Subject|0|||
144510318|NCT01939899|521069158|FG000|Phase 2|Disease Progression|0|||
144510319|NCT01939899|521069159|FG001|Phase 2|Disease Progression|0|||
144510320|NCT01939899|521069160|FG002|Phase 2|Disease Progression|0|||
144510321|NCT01939899|521069161|FG003|Phase 2|Disease Progression|9|||
144510322|NCT01939899|521069162|FG004|Phase 2|Disease Progression|1|||
144510323|NCT01972724|521069163|FG000|Double-Blind|Rescue Criteria Met|1|||
144510324|NCT01972724|521069164|FG001|Double-Blind|Rescue Criteria Met|0|||
144510325|NCT01972724|521069165|FG002|Double-Blind|Rescue Criteria Met|0|||
144510326|NCT01972724|521069163|FG000|Double-Blind|Adverse Event|1|||
144510327|NCT01972724|521069164|FG001|Double-Blind|Adverse Event|0|||
144510328|NCT01972724|521069165|FG002|Double-Blind|Adverse Event|0|||
144510329|NCT01972724|521069163|FG000|Double-Blind|Withdrawal of Consent|2|||
144510330|NCT01972724|521069164|FG001|Double-Blind|Withdrawal of Consent|1|||
144510331|NCT01972724|521069165|FG002|Double-Blind|Withdrawal of Consent|0|||
144589787|NCT00189488|521359832|FG000|Overall Study|Death|5|||
144589788|NCT00189488|521359833|FG001|Overall Study|Death|8|||
144589789|NCT00189488|521359832|FG000|Overall Study|Other|1|||
144589790|NCT00189488|521359833|FG001|Overall Study|Other|0|||
144589791|NCT02349425|521359834|FG000|Period 1|Adverse Event|1|||
144589792|NCT02349425|521359835|FG001|Period 1|Adverse Event|1|||
144589793|NCT02349425|521359836|FG002|Period 1|Adverse Event|0|||
144589794|NCT02349425|521359837|FG003|Period 1|Adverse Event|0|||
144589795|NCT02349425|521359834|FG000|Period 2|Adverse Event|0|||
144589796|NCT02349425|521359835|FG001|Period 2|Adverse Event|1|||
144589797|NCT02349425|521359836|FG002|Period 2|Adverse Event|1|||
144589798|NCT02349425|521359837|FG003|Period 2|Adverse Event|0|||
144589799|NCT00876928|521359838|FG000|Overall Study|Lost to Follow-up|2|||
144589800|NCT00876928|521359839|FG001|Overall Study|Lost to Follow-up|5|||
144589801|NCT00876928|521359838|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
144589802|NCT00876928|521359839|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
144589803|NCT01111474|521359840|FG000|Overall Study|Lost to Follow-up|12|||
144589804|NCT04101318|521359843|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
144589805|NCT04101318|521359844|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
144589806|NCT04101318|521359843|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
144589807|NCT04101318|521359844|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
144589808|NCT04101318|521359843|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
144589809|NCT04101318|521359844|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
144589810|NCT00558259|521359845|FG000|Overall Study|Adverse Event|50|||
144589811|NCT00558259|521359846|FG001|Overall Study|Adverse Event|81|||
144371154|NCT03207763|520567754|FG000|Overall Study|Lost to Follow-up|1|||
144371155|NCT03207763|520567755|FG001|Overall Study|Lost to Follow-up|0|||
144371156|NCT03751657|520567756|FG000|Overall Study|Physician Decision|0|||
144371157|NCT03751657|520567757|FG001|Overall Study|Physician Decision|1|||
144589812|NCT00558259|521359845|FG000|Overall Study|Protocol Violation|9|||
144589813|NCT00558259|521359846|FG001|Overall Study|Protocol Violation|5|||
144589814|NCT00558259|521359845|FG000|Overall Study|Withdrawal by Subject|12|||
144589815|NCT00558259|521359846|FG001|Overall Study|Withdrawal by Subject|13|||
144589816|NCT02874924|521359847|FG000|Overall Study|Adverse Event|2|||
144589817|NCT02874924|521359848|FG001|Overall Study|Adverse Event|0|||
144589818|NCT02874924|521359849|FG002|Overall Study|Adverse Event|0|||
144589819|NCT02874924|521359847|FG000|Overall Study|Withdrawal by Subject|1|||
144589820|NCT02874924|521359848|FG001|Overall Study|Withdrawal by Subject|0|||
144589821|NCT02874924|521359849|FG002|Overall Study|Withdrawal by Subject|0|||
144589822|NCT02029846|521359852|FG000|Overall Study|n=1 each arm|1|||
144589823|NCT02029846|521359853|FG001|Overall Study|n=1 each arm|1|||
144589824|NCT02966301|521359857|FG000|Overall Study|Death|2|||
144589825|NCT02966301|521359857|FG000|Overall Study|Withdrawal by Subject|1|||
144589826|NCT03718533|521359862|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
144589827|NCT03718533|521359862|FG000|Overall Study|Protocol deviation|1|||
144589828|NCT03718533|521359862|FG000|Overall Study|Disease progression|1|||
144589829|NCT03718533|521359862|FG000|Overall Study|Relapse|1|||
144589830|NCT03718533|521359862|FG000|Overall Study|Physician Decision|2|||
144589831|NCT03718533|521359862|FG000|Overall Study|Physician Decision and Adverse Event|1|||
144589832|NCT02518490|521359863|FG000|Overall Study|Withdrawal by Subject|1|||
144589833|NCT02518490|521359864|FG001|Overall Study|Withdrawal by Subject|1|||
144589834|NCT04256629|521359865|FG000|Overall Study|Adverse Event|0|||
144589835|NCT04256629|521359866|FG001|Overall Study|Adverse Event|0|||
144589836|NCT04256629|521359867|FG002|Overall Study|Adverse Event|0|||
144589837|NCT04256629|521359868|FG003|Overall Study|Adverse Event|0|||
144589838|NCT04256629|521359869|FG004|Overall Study|Adverse Event|0|||
144589839|NCT04256629|521359870|FG005|Overall Study|Adverse Event|1|||
144589840|NCT04256629|521359865|FG000|Overall Study|Protocol Violation|0|||
144589841|NCT04256629|521359866|FG001|Overall Study|Protocol Violation|1|||
144589842|NCT04256629|521359867|FG002|Overall Study|Protocol Violation|0|||
144589843|NCT04256629|521359868|FG003|Overall Study|Protocol Violation|0|||
144589844|NCT04256629|521359869|FG004|Overall Study|Protocol Violation|0|||
144589845|NCT04256629|521359870|FG005|Overall Study|Protocol Violation|0|||
144589846|NCT00346632|521359871|FG000|Overall Study|Progressive Disease|2|||
144589847|NCT00346632|521359872|FG001|Overall Study|Progressive Disease|2|||
144589848|NCT00346632|521359873|FG002|Overall Study|Progressive Disease|4|||
144589849|NCT00346632|521359874|FG003|Overall Study|Progressive Disease|3|||
144589850|NCT00346632|521359875|FG004|Overall Study|Progressive Disease|3|||
144589851|NCT00346632|521359876|FG005|Overall Study|Progressive Disease|1|||
144589852|NCT00346632|521359877|FG006|Overall Study|Progressive Disease|2|||
144371158|NCT03751657|520567756|FG000|Overall Study|Withdrawal by Subject|1|||
144589853|NCT00346632|521359878|FG007|Overall Study|Progressive Disease|2|||
144721691|NCT00419926|521835263|FG000|Overall Study|Administrative Problem|4|||
144589854|NCT00346632|521359879|FG008|Overall Study|Progressive Disease|2|||
144589855|NCT00346632|521359880|FG009|Overall Study|Progressive Disease|2|||
144589856|NCT00346632|521359871|FG000|Overall Study|Adverse Event|0|||
144589857|NCT00346632|521359872|FG001|Overall Study|Adverse Event|0|||
144589858|NCT00346632|521359873|FG002|Overall Study|Adverse Event|0|||
144589859|NCT00346632|521359874|FG003|Overall Study|Adverse Event|0|||
144589860|NCT00346632|521359875|FG004|Overall Study|Adverse Event|1|||
144589861|NCT00346632|521359876|FG005|Overall Study|Adverse Event|1|||
144589862|NCT00346632|521359877|FG006|Overall Study|Adverse Event|1|||
144589863|NCT00346632|521359878|FG007|Overall Study|Adverse Event|0|||
144589864|NCT00346632|521359879|FG008|Overall Study|Adverse Event|0|||
144589865|NCT00346632|521359880|FG009|Overall Study|Adverse Event|0|||
144589866|NCT00346632|521359871|FG000|Overall Study|Death|0|||
144589867|NCT00346632|521359872|FG001|Overall Study|Death|0|||
144589868|NCT00346632|521359873|FG002|Overall Study|Death|1|||
144589869|NCT00346632|521359874|FG003|Overall Study|Death|0|||
144589870|NCT00346632|521359875|FG004|Overall Study|Death|0|||
144589871|NCT00346632|521359876|FG005|Overall Study|Death|0|||
144589872|NCT00346632|521359877|FG006|Overall Study|Death|0|||
144589873|NCT00346632|521359878|FG007|Overall Study|Death|0|||
144589874|NCT00346632|521359879|FG008|Overall Study|Death|0|||
144589875|NCT00346632|521359880|FG009|Overall Study|Death|0|||
144589876|NCT00346632|521359871|FG000|Overall Study|Protocol Violation|0|||
144589877|NCT00346632|521359872|FG001|Overall Study|Protocol Violation|0|||
144589878|NCT00346632|521359873|FG002|Overall Study|Protocol Violation|0|||
144589879|NCT00346632|521359874|FG003|Overall Study|Protocol Violation|0|||
144589880|NCT00346632|521359875|FG004|Overall Study|Protocol Violation|0|||
144589881|NCT00346632|521359876|FG005|Overall Study|Protocol Violation|0|||
144589882|NCT00346632|521359877|FG006|Overall Study|Protocol Violation|1|||
144589883|NCT00346632|521359878|FG007|Overall Study|Protocol Violation|0|||
144589884|NCT00346632|521359879|FG008|Overall Study|Protocol Violation|0|||
144589885|NCT00346632|521359880|FG009|Overall Study|Protocol Violation|0|||
144589886|NCT00346632|521359871|FG000|Overall Study|Withdrawal by Subject|0|||
144589887|NCT00346632|521359872|FG001|Overall Study|Withdrawal by Subject|0|||
144589888|NCT00346632|521359873|FG002|Overall Study|Withdrawal by Subject|0|||
144589889|NCT00346632|521359874|FG003|Overall Study|Withdrawal by Subject|0|||
144589890|NCT00346632|521359875|FG004|Overall Study|Withdrawal by Subject|0|||
144589891|NCT00346632|521359876|FG005|Overall Study|Withdrawal by Subject|0|||
144589892|NCT00346632|521359877|FG006|Overall Study|Withdrawal by Subject|1|||
144589893|NCT00346632|521359878|FG007|Overall Study|Withdrawal by Subject|0|||
144589894|NCT00346632|521359879|FG008|Overall Study|Withdrawal by Subject|0|||
144589895|NCT00346632|521359880|FG009|Overall Study|Withdrawal by Subject|0|||
144589896|NCT00346632|521359871|FG000|Overall Study|Switched to alternative treatment|0|||
144589897|NCT00346632|521359872|FG001|Overall Study|Switched to alternative treatment|0|||
144589898|NCT00346632|521359873|FG002|Overall Study|Switched to alternative treatment|1|||
144589899|NCT00346632|521359874|FG003|Overall Study|Switched to alternative treatment|0|||
144589900|NCT00346632|521359875|FG004|Overall Study|Switched to alternative treatment|0|||
144589901|NCT00346632|521359876|FG005|Overall Study|Switched to alternative treatment|0|||
144589902|NCT00346632|521359877|FG006|Overall Study|Switched to alternative treatment|0|||
144589903|NCT00346632|521359878|FG007|Overall Study|Switched to alternative treatment|0|||
144589904|NCT00346632|521359879|FG008|Overall Study|Switched to alternative treatment|0|||
144589905|NCT00346632|521359880|FG009|Overall Study|Switched to alternative treatment|0|||
144589906|NCT00346632|521359871|FG000|Overall Study|Not Stated|1|||
144589907|NCT00346632|521359872|FG001|Overall Study|Not Stated|1|||
144589908|NCT00346632|521359873|FG002|Overall Study|Not Stated|0|||
144589909|NCT00346632|521359874|FG003|Overall Study|Not Stated|0|||
144589910|NCT00346632|521359875|FG004|Overall Study|Not Stated|0|||
144589911|NCT00346632|521359876|FG005|Overall Study|Not Stated|0|||
144589912|NCT00346632|521359877|FG006|Overall Study|Not Stated|0|||
144589913|NCT00346632|521359878|FG007|Overall Study|Not Stated|2|||
144589914|NCT00346632|521359879|FG008|Overall Study|Not Stated|2|||
144589915|NCT00346632|521359880|FG009|Overall Study|Not Stated|1|||
144589916|NCT00477334|521359881|FG000|Overall Study|Discontinued prior to taking study drug|106|||
144589917|NCT00477334|521359882|FG001|Overall Study|Discontinued prior to taking study drug|53|||
144589918|NCT00477334|521359881|FG000|Overall Study|Adverse Event|1|||
144589919|NCT00477334|521359882|FG001|Overall Study|Adverse Event|2|||
144589920|NCT00477334|521359881|FG000|Overall Study|Withdrawal by Subject|2|||
144589921|NCT00477334|521359882|FG001|Overall Study|Withdrawal by Subject|1|||
144589922|NCT00477334|521359881|FG000|Overall Study|Lost to Follow-up|15|||
144589923|NCT00477334|521359882|FG001|Overall Study|Lost to Follow-up|4|||
144589924|NCT00477334|521359881|FG000|Overall Study|Administrative Problems|39|||
144589925|NCT00477334|521359882|FG001|Overall Study|Administrative Problems|15|||
144589926|NCT00477334|521359881|FG000|Overall Study|Protocol Violation|7|||
144589927|NCT00477334|521359882|FG001|Overall Study|Protocol Violation|1|||
144589928|NCT00297232|521359883|FG000|Overall Study|Lack of Efficacy|7|||
144721692|NCT00419926|521835264|FG001|Overall Study|Administrative Problem|4|||
144589929|NCT00297232|521359883|FG000|Overall Study|Lost to Follow-up|10|||
144589930|NCT00297232|521359883|FG000|Overall Study|Adverse Event|63|||
144589931|NCT00297232|521359883|FG000|Overall Study|Voluntary Withdrawal|120|||
144589932|NCT00297232|521359883|FG000|Overall Study|Subject was Noncompliant|9|||
144589933|NCT00297232|521359883|FG000|Overall Study|Death|9|||
144589934|NCT00297232|521359883|FG000|Overall Study|Anti-natalizumab Positive|8|||
144589935|NCT00297232|521359883|FG000|Overall Study|Switched to Commercial Tysabri|22|||
144589936|NCT00297232|521359883|FG000|Overall Study|Disease Progression|8|||
144589937|NCT00297232|521359883|FG000|Overall Study|Fear of PML|10|||
144589938|NCT00297232|521359883|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
144589939|NCT00297232|521359883|FG000|Overall Study|Miscellaneous|5|||
144589940|NCT00297232|521359883|FG000|Overall Study|Sponsor Decision|34|||
144589941|NCT00297232|521359883|FG000|Overall Study|Subject Relocated|7|||
144589942|NCT00297232|521359883|FG000|Overall Study|Subject Withdrew Consent|37|||
144589943|NCT00297232|521359883|FG000|Overall Study|Persistently Positive Antibodies|11|||
144589944|NCT00297232|521359883|FG000|Overall Study|Investigator Withdrew From Program|19|||
144589945|NCT00297232|521359883|FG000|Overall Study|Did Not Enroll to Week 264|34|||
144589946|NCT00297232|521359883|FG000|Overall Study|Did Not Enroll to Week 480|17|||
144589947|NCT00297232|521359883|FG000|Overall Study|No data available after Week 264|161|||
144589948|NCT00297232|521359883|FG000|Overall Study|Other|1|||
144589949|NCT00552240|521359888|FG000|Overall Study|Adverse Event|9|||
144589950|NCT00552240|521359889|FG001|Overall Study|Adverse Event|9|||
144589951|NCT00552240|521359888|FG000|Overall Study|Protocol Violation|1|||
144589952|NCT00552240|521359889|FG001|Overall Study|Protocol Violation|1|||
144589953|NCT00552240|521359888|FG000|Overall Study|Lost to Follow-up|5|||
144589954|NCT00552240|521359889|FG001|Overall Study|Lost to Follow-up|6|||
144589955|NCT00552240|521359888|FG000|Overall Study|Withdrawal by Subject|2|||
144589956|NCT00552240|521359889|FG001|Overall Study|Withdrawal by Subject|2|||
144589957|NCT00552240|521359888|FG000|Overall Study|Lack of Efficacy|6|||
144589958|NCT00552240|521359889|FG001|Overall Study|Lack of Efficacy|0|||
144589959|NCT00552240|521359888|FG000|Overall Study|Other|1|||
144589960|NCT00552240|521359889|FG001|Overall Study|Other|0|||
144589961|NCT02319525|521359890|FG000|Overall Study|Withdrawal by Subject|2|||
144589962|NCT02319525|521359891|FG001|Overall Study|Withdrawal by Subject|1|||
144589963|NCT00577577|521359892|FG000|Overall Study|Adverse Event|3|||
144589964|NCT00577577|521359893|FG001|Overall Study|Adverse Event|2|||
144589965|NCT00577577|521359892|FG000|Overall Study|Lost to Follow-up|1|||
144589966|NCT00577577|521359893|FG001|Overall Study|Lost to Follow-up|0|||
144589967|NCT00577577|521359892|FG000|Overall Study|Protocol Violation|0|||
144589968|NCT00577577|521359893|FG001|Overall Study|Protocol Violation|3|||
144589969|NCT00577577|521359892|FG000|Overall Study|Transportation|1|||
144589970|NCT00577577|521359893|FG001|Overall Study|Transportation|0|||
144589971|NCT01200589|521359894|FG000|Overall Study|Withdrawal by Subject|13|||
144589972|NCT01200589|521359895|FG001|Overall Study|Withdrawal by Subject|11|||
144589973|NCT01200589|521359894|FG000|Overall Study|Physician Decision|2|||
144589974|NCT01200589|521359895|FG001|Overall Study|Physician Decision|2|||
144589975|NCT01200589|521359894|FG000|Overall Study|Lost to Follow-up|5|||
144589976|NCT01200589|521359895|FG001|Overall Study|Lost to Follow-up|4|||
144589977|NCT01200589|521359894|FG000|Overall Study|Study terminated|170|||
144589978|NCT01200589|521359895|FG001|Overall Study|Study terminated|172|||
144589979|NCT02549196|521359896|FG000|Overall Study|Protocol Violation|0|||
144589980|NCT02549196|521359897|FG001|Overall Study|Protocol Violation|0|||
144589981|NCT02549196|521359898|FG002|Overall Study|Protocol Violation|0|||
144589982|NCT02549196|521359899|FG003|Overall Study|Protocol Violation|1|||
144589983|NCT02549196|521359896|FG000|Overall Study|Withdrawal by Subject|1|||
144589984|NCT02549196|521359897|FG001|Overall Study|Withdrawal by Subject|0|||
144589985|NCT02549196|521359898|FG002|Overall Study|Withdrawal by Subject|1|||
144589986|NCT02549196|521359899|FG003|Overall Study|Withdrawal by Subject|0|||
144589987|NCT01442779|521359900|FG000|Overall Study|Withdrawal by Subject|3|||
144589988|NCT01442779|521359900|FG000|Overall Study|Death|3|||
144589989|NCT01442779|521359900|FG000|Overall Study|Non-compliance|1|||
144589990|NCT00757783|521359904|FG000|Overall Study|Adverse Event|0|||
144589991|NCT00757783|521359905|FG001|Overall Study|Adverse Event|2|||
144589992|NCT00757783|521359904|FG000|Overall Study|Lost to Follow-up|1|||
144589993|NCT00757783|521359905|FG001|Overall Study|Lost to Follow-up|1|||
144589994|NCT00757783|521359904|FG000|Overall Study|Protocol Violation|1|||
144589995|NCT00757783|521359905|FG001|Overall Study|Protocol Violation|0|||
144589996|NCT00757783|521359904|FG000|Overall Study|Withdrawal by Subject|2|||
144589997|NCT00757783|521359905|FG001|Overall Study|Withdrawal by Subject|1|||
144589998|NCT00757783|521359904|FG000|Overall Study|Other|1|||
144589999|NCT00757783|521359905|FG001|Overall Study|Other|2|||
144590000|NCT03683823|521359911|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
144590001|NCT03683823|521359912|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
144590002|NCT03683823|521359911|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
144590003|NCT03683823|521359912|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
144590004|NCT03683823|521359911|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
144590005|NCT03683823|521359912|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
144590006|NCT03965351|521359914|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
144590007|NCT03965351|521359915|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
144590008|NCT03965351|521359914|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
144590009|NCT03965351|521359915|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
144590010|NCT01323972|521359917|FG000|Overall Study|Withdrawal by Subject|1|||
144590011|NCT01323972|521359918|FG001|Overall Study|Withdrawal by Subject|0|||
144590012|NCT01323972|521359919|FG002|Overall Study|Withdrawal by Subject|1|||
144590013|NCT01323972|521359920|FG003|Overall Study|Withdrawal by Subject|0|||
144590014|NCT01323972|521359917|FG000|Overall Study|Migrated/moved from study area|1|||
144590015|NCT01323972|521359918|FG001|Overall Study|Migrated/moved from study area|2|||
144590016|NCT01323972|521359919|FG002|Overall Study|Migrated/moved from study area|0|||
144590017|NCT01323972|521359920|FG003|Overall Study|Migrated/moved from study area|0|||
144590018|NCT01323972|521359917|FG000|Overall Study|Lost to Follow-up|0|||
144590019|NCT01323972|521359918|FG001|Overall Study|Lost to Follow-up|1|||
144590020|NCT01323972|521359919|FG002|Overall Study|Lost to Follow-up|1|||
144590021|NCT01323972|521359920|FG003|Overall Study|Lost to Follow-up|1|||
144590022|NCT00994682|521359921|FG000|Double Bilnd|Withdrawal by Subject|5|||
144590023|NCT00994682|521359922|FG001|Double Bilnd|Withdrawal by Subject|6|||
144590024|NCT00994682|521359921|FG000|Double Bilnd|Lost to Follow-up|3|||
144590025|NCT00994682|521359922|FG001|Double Bilnd|Lost to Follow-up|3|||
144590026|NCT00994682|521359921|FG000|Double Bilnd|Adverse Event|1|||
144590027|NCT00994682|521359922|FG001|Double Bilnd|Adverse Event|0|||
144590028|NCT00994682|521359921|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
144590029|NCT00994682|521359922|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
144510332|NCT01972724|521069163|FG000|Double-Blind|Significant Protocol Deviation|5|||
144510333|NCT01972724|521069164|FG001|Double-Blind|Significant Protocol Deviation|8|||
144510334|NCT01972724|521069165|FG002|Double-Blind|Significant Protocol Deviation|0|||
144510335|NCT01972724|521069163|FG000|Open-Label|Withdrew Consent|0|||
144510336|NCT01972724|521069164|FG001|Open-Label|Withdrew Consent|0|||
144510337|NCT01972724|521069165|FG002|Open-Label|Withdrew Consent|3|||
144510338|NCT01972724|521069163|FG000|Open-Label|Significant Protocol Deviation|0|||
144510339|NCT01972724|521069164|FG001|Open-Label|Significant Protocol Deviation|0|||
144510340|NCT01972724|521069165|FG002|Open-Label|Significant Protocol Deviation|2|||
144510341|NCT01414738|521069172|FG000|Overall Study|Death|26|||
144510342|NCT01414738|521069172|FG000|Overall Study|Refused testing|5|||
144510343|NCT01414738|521069172|FG000|Overall Study|Lost to Follow-up|2|||
144510344|NCT01414738|521069172|FG000|Overall Study|Refused, disease progression|8|||
144510345|NCT01414738|521069172|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
144510346|NCT01266122|521069173|FG000|Overall Study|Lost to Follow-up|6|||
144510347|NCT01266122|521069174|FG001|Overall Study|Lost to Follow-up|6|||
144510348|NCT00421889|521069175|FG000|Overall Study|Adverse Event|1|||
144510349|NCT00421889|521069176|FG001|Overall Study|Adverse Event|0|||
144510350|NCT00421889|521069177|FG002|Overall Study|Adverse Event|1|||
144510351|NCT00421889|521069178|FG003|Overall Study|Adverse Event|1|||
144510352|NCT00421889|521069179|FG004|Overall Study|Adverse Event|1|||
144510353|NCT00421889|521069180|FG005|Overall Study|Adverse Event|4|||
144510354|NCT00421889|521069181|FG006|Overall Study|Adverse Event|1|||
144510355|NCT00421889|521069182|FG007|Overall Study|Adverse Event|0|||
144510356|NCT00421889|521069183|FG008|Overall Study|Adverse Event|2|||
144510357|NCT00421889|521069175|FG000|Overall Study|Withdrawal by Subject|1|||
144510358|NCT00421889|521069176|FG001|Overall Study|Withdrawal by Subject|3|||
144510359|NCT00421889|521069177|FG002|Overall Study|Withdrawal by Subject|0|||
144510360|NCT00421889|521069178|FG003|Overall Study|Withdrawal by Subject|0|||
144510361|NCT00421889|521069179|FG004|Overall Study|Withdrawal by Subject|2|||
144510362|NCT00421889|521069180|FG005|Overall Study|Withdrawal by Subject|0|||
144510363|NCT00421889|521069181|FG006|Overall Study|Withdrawal by Subject|0|||
144510364|NCT00421889|521069182|FG007|Overall Study|Withdrawal by Subject|0|||
144510365|NCT00421889|521069183|FG008|Overall Study|Withdrawal by Subject|0|||
144510366|NCT00421889|521069175|FG000|Overall Study|Death|0|||
144510367|NCT00421889|521069176|FG001|Overall Study|Death|0|||
144510368|NCT00421889|521069177|FG002|Overall Study|Death|0|||
144510369|NCT00421889|521069178|FG003|Overall Study|Death|0|||
144510370|NCT00421889|521069179|FG004|Overall Study|Death|1|||
144510371|NCT00421889|521069180|FG005|Overall Study|Death|1|||
144510372|NCT00421889|521069181|FG006|Overall Study|Death|0|||
144510373|NCT00421889|521069182|FG007|Overall Study|Death|0|||
144510374|NCT00421889|521069183|FG008|Overall Study|Death|0|||
144510375|NCT00421889|521069175|FG000|Overall Study|Progressive disease|3|||
144510376|NCT00421889|521069176|FG001|Overall Study|Progressive disease|2|||
144510377|NCT00421889|521069177|FG002|Overall Study|Progressive disease|2|||
144510378|NCT00421889|521069178|FG003|Overall Study|Progressive disease|3|||
144510379|NCT00421889|521069179|FG004|Overall Study|Progressive disease|2|||
144510380|NCT00421889|521069180|FG005|Overall Study|Progressive disease|21|||
144590030|NCT00994682|521359921|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
144590031|NCT00994682|521359922|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
144590032|NCT00994682|521359921|FG000|Pioglitazone Open Label|Physician Decision|6|||
144721693|NCT00419926|521835263|FG000|Overall Study|Lost to Follow-up|1|||
144510381|NCT00421889|521069181|FG006|Overall Study|Progressive disease|3|||
144510382|NCT00421889|521069182|FG007|Overall Study|Progressive disease|1|||
144510383|NCT00421889|521069183|FG008|Overall Study|Progressive disease|5|||
144510384|NCT00421889|521069175|FG000|Overall Study|Patient/Investigator request|0|||
144510385|NCT00421889|521069176|FG001|Overall Study|Patient/Investigator request|0|||
144510386|NCT00421889|521069177|FG002|Overall Study|Patient/Investigator request|0|||
144510387|NCT00421889|521069178|FG003|Overall Study|Patient/Investigator request|0|||
144590033|NCT00994682|521359922|FG001|Pioglitazone Open Label|Physician Decision|1|||
144590034|NCT00943111|521359925|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
144590035|NCT00943111|521359926|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
144590036|NCT00943111|521359927|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
144590037|NCT00943111|521359925|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
144590038|NCT00943111|521359926|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
144590039|NCT00943111|521359927|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
144590040|NCT00943111|521359925|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
144590041|NCT00943111|521359926|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
144590042|NCT00943111|521359927|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
144590043|NCT00943111|521359925|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
144590044|NCT00943111|521359926|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
144590045|NCT00943111|521359927|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
144590046|NCT00943111|521359925|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
144590047|NCT00943111|521359926|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
144590048|NCT00943111|521359927|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
144590049|NCT00943111|521359925|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
144590050|NCT00943111|521359926|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
144590051|NCT00943111|521359927|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
144590052|NCT00943111|521359925|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
144510388|NCT00421889|521069179|FG004|Overall Study|Patient/Investigator request|0|||
144510389|NCT00421889|521069180|FG005|Overall Study|Patient/Investigator request|9|||
144590053|NCT00943111|521359926|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
144590054|NCT00943111|521359927|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
144590055|NCT00943111|521359925|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
144510390|NCT00421889|521069181|FG006|Overall Study|Patient/Investigator request|0|||
144510391|NCT00421889|521069182|FG007|Overall Study|Patient/Investigator request|1|||
144510392|NCT00421889|521069183|FG008|Overall Study|Patient/Investigator request|3|||
144510393|NCT00421889|521069175|FG000|Overall Study|Lost to Follow-up|0|||
144510394|NCT00421889|521069176|FG001|Overall Study|Lost to Follow-up|0|||
144510395|NCT00421889|521069177|FG002|Overall Study|Lost to Follow-up|0|||
144510396|NCT00421889|521069178|FG003|Overall Study|Lost to Follow-up|0|||
144510397|NCT00421889|521069179|FG004|Overall Study|Lost to Follow-up|0|||
144510398|NCT00421889|521069180|FG005|Overall Study|Lost to Follow-up|0|||
144510399|NCT00421889|521069181|FG006|Overall Study|Lost to Follow-up|0|||
144510400|NCT00421889|521069182|FG007|Overall Study|Lost to Follow-up|0|||
144510401|NCT00421889|521069183|FG008|Overall Study|Lost to Follow-up|1|||
144510402|NCT03756571|521069184|FG000|Overall Study|Lost to Follow-up|1|||
144510403|NCT03756571|521069185|FG001|Overall Study|Lost to Follow-up|1|||
144510404|NCT00978042|521069186|FG000|Initial Treatment Period|Treated in Error|0|||
144510405|NCT00978042|521069187|FG001|Initial Treatment Period|Treated in Error|3|||
144510406|NCT00978042|521069186|FG000|Initial Treatment Period|Ineligibility|1|||
144510407|NCT00978042|521069187|FG001|Initial Treatment Period|Ineligibility|0|||
144510408|NCT00978042|521069186|FG000|Initial Treatment Period|Lost to Follow-up|21|||
144510409|NCT00978042|521069187|FG001|Initial Treatment Period|Lost to Follow-up|3|||
144510410|NCT00978042|521069186|FG000|Initial Treatment Period|Adverse Event|2|||
144590056|NCT00943111|521359926|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
144590057|NCT00943111|521359927|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
144590058|NCT02859324|521359928|FG000|Overall Study|Death|4|||
144590059|NCT02859324|521359929|FG001|Overall Study|Death|6|||
144590060|NCT02859324|521359930|FG002|Overall Study|Death|5|||
144590061|NCT02859324|521359928|FG000|Overall Study|Other reasons|3|||
144590062|NCT02859324|521359929|FG001|Overall Study|Other reasons|3|||
144590063|NCT02859324|521359930|FG002|Overall Study|Other reasons|0|||
144590064|NCT02008877|521359931|FG000|Overall Study|Inevaluable|0|||
144371159|NCT03751657|520567757|FG001|Overall Study|Withdrawal by Subject|1|||
144510411|NCT00978042|521069187|FG001|Initial Treatment Period|Adverse Event|0|||
144510412|NCT00978042|521069186|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
144510413|NCT00978042|521069187|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
144510414|NCT00978042|521069186|FG000|Initial Treatment Period|Consent withdrawn|22|||
144510415|NCT00978042|521069187|FG001|Initial Treatment Period|Consent withdrawn|9|||
144510416|NCT00978042|521069186|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
144590065|NCT02008877|521359932|FG001|Overall Study|Inevaluable|1|||
144590066|NCT02008877|521359933|FG002|Overall Study|Inevaluable|0|||
144590067|NCT01049217|521359934|FG000|Overall Study|Adverse Event|2|||
144590068|NCT01049217|521359935|FG001|Overall Study|Adverse Event|1|||
144590069|NCT01049217|521359934|FG000|Overall Study|Lack of Efficacy|1|||
144590070|NCT01049217|521359935|FG001|Overall Study|Lack of Efficacy|1|||
144510417|NCT00978042|521069187|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
144510418|NCT00529516|521069188|FG000|Overall Study|Adverse Event|2|||
144510419|NCT00529516|521069189|FG001|Overall Study|Adverse Event|1|||
144510420|NCT00529516|521069190|FG002|Overall Study|Adverse Event|0|||
144371160|NCT03751657|520567756|FG000|Overall Study|Lost to Follow-up|2|||
144371161|NCT03751657|520567757|FG001|Overall Study|Lost to Follow-up|1|||
144371162|NCT01938716|520567762|FG000|Overall Study|Physician Decision|2|||
144371163|NCT01938716|520567762|FG000|Overall Study|Withdrawal by Subject|2|||
144371164|NCT01358721|520567763|FG000|Overall Study|Withdrawal by Subject|0|||
144371165|NCT01358721|520567764|FG001|Overall Study|Withdrawal by Subject|0|||
144371166|NCT01358721|520567765|FG002|Overall Study|Withdrawal by Subject|0|||
144371167|NCT01358721|520567766|FG003|Overall Study|Withdrawal by Subject|1|||
144371168|NCT01358721|520567763|FG000|Overall Study|Death|0|||
144371169|NCT01358721|520567764|FG001|Overall Study|Death|2|||
144371170|NCT01358721|520567765|FG002|Overall Study|Death|0|||
144371171|NCT01358721|520567766|FG003|Overall Study|Death|0|||
144371172|NCT01358721|520567763|FG000|Overall Study|Study Drug Toxicity|1|||
144371173|NCT01358721|520567764|FG001|Overall Study|Study Drug Toxicity|3|||
144371174|NCT01358721|520567765|FG002|Overall Study|Study Drug Toxicity|4|||
144371175|NCT01358721|520567766|FG003|Overall Study|Study Drug Toxicity|5|||
144371176|NCT01358721|520567763|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
144371177|NCT01358721|520567764|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
144371178|NCT01358721|520567765|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
144371179|NCT01358721|520567766|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
144371180|NCT01358721|520567763|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
144371181|NCT01358721|520567764|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
144371182|NCT01358721|520567765|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
144371183|NCT01358721|520567766|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
144371184|NCT01358721|520567763|FG000|Overall Study|Adverse Event related to study drug|1|||
144371185|NCT01358721|520567764|FG001|Overall Study|Adverse Event related to study drug|0|||
144371186|NCT01358721|520567765|FG002|Overall Study|Adverse Event related to study drug|0|||
144371187|NCT01358721|520567766|FG003|Overall Study|Adverse Event related to study drug|1|||
144371188|NCT01358721|520567763|FG000|Overall Study|Disease Progression|19|||
144371189|NCT01358721|520567764|FG001|Overall Study|Disease Progression|15|||
144371190|NCT01358721|520567765|FG002|Overall Study|Disease Progression|17|||
144371191|NCT01358721|520567766|FG003|Overall Study|Disease Progression|15|||
144371192|NCT01358721|520567763|FG000|Overall Study|Out of State/Unmet Criteria|0|||
144371193|NCT01358721|520567764|FG001|Overall Study|Out of State/Unmet Criteria|0|||
144371194|NCT01358721|520567765|FG002|Overall Study|Out of State/Unmet Criteria|1|||
144371195|NCT01358721|520567766|FG003|Overall Study|Out of State/Unmet Criteria|0|||
144371196|NCT04730271|520567772|FG000|Overall Study|Adverse Event|0|||
144371197|NCT04730271|520567773|FG001|Overall Study|Adverse Event|2|||
144371198|NCT04730271|520567772|FG000|Overall Study|Withdrawal by Subject|1|||
144371199|NCT04730271|520567773|FG001|Overall Study|Withdrawal by Subject|1|||
144371200|NCT04730271|520567772|FG000|Overall Study|Protocol Violation|7|||
144371201|NCT04730271|520567773|FG001|Overall Study|Protocol Violation|13|||
144371202|NCT04730271|520567772|FG000|Overall Study|Lost to Follow-up|3|||
144371203|NCT04730271|520567773|FG001|Overall Study|Lost to Follow-up|3|||
144371204|NCT04730271|520567772|FG000|Overall Study|Death|1|||
144371205|NCT04730271|520567773|FG001|Overall Study|Death|0|||
144371206|NCT02223858|520567778|FG000|Overall Study|Death|1|||
144371207|NCT02223858|520567779|FG001|Overall Study|Death|1|||
144371208|NCT02223858|520567778|FG000|Overall Study|Lost to Follow-up|6|||
144371209|NCT02223858|520567779|FG001|Overall Study|Lost to Follow-up|11|||
144371210|NCT02223858|520567778|FG000|Overall Study|Withdrawal by Subject|8|||
144371211|NCT02223858|520567779|FG001|Overall Study|Withdrawal by Subject|5|||
144371212|NCT02223858|520567778|FG000|Overall Study|Refused|9|||
144371213|NCT02223858|520567779|FG001|Overall Study|Refused|9|||
144371214|NCT04455815|520567780|FG000|Randomisation Phase|Adverse Event|1|||
144371215|NCT04455815|520567781|FG001|Randomisation Phase|Adverse Event|0|||
144371216|NCT04455815|520567780|FG000|Treatment Phase|Adverse Event|0|||
144371217|NCT04455815|520567781|FG001|Treatment Phase|Adverse Event|1|||
144371218|NCT04455815|520567780|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
144371219|NCT04455815|520567781|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
144371220|NCT04455815|520567780|FG000|Treatment Phase|Withdrawal by Subject|1|||
144371221|NCT04455815|520567781|FG001|Treatment Phase|Withdrawal by Subject|1|||
144371222|NCT02106390|520567782|FG000|Overall Study|Withdrawal by Subject|15|||
144371223|NCT02106390|520567783|FG001|Overall Study|Withdrawal by Subject|16|||
144371224|NCT02106390|520567784|FG002|Overall Study|Withdrawal by Subject|15|||
144371225|NCT02106390|520567782|FG000|Overall Study|Lost to Follow-up|25|||
144371226|NCT02106390|520567783|FG001|Overall Study|Lost to Follow-up|20|||
144371227|NCT02106390|520567784|FG002|Overall Study|Lost to Follow-up|13|||
144371228|NCT02106390|520567782|FG000|Overall Study|Other: Administrative Reason|8|||
144371229|NCT02106390|520567783|FG001|Overall Study|Other: Administrative Reason|5|||
144371230|NCT02106390|520567784|FG002|Overall Study|Other: Administrative Reason|12|||
144371231|NCT02106390|520567782|FG000|Overall Study|Other: Unspecified|1|||
144371232|NCT02106390|520567783|FG001|Overall Study|Other: Unspecified|4|||
144371233|NCT02106390|520567784|FG002|Overall Study|Other: Unspecified|2|||
144371234|NCT02106390|520567782|FG000|Overall Study|Adverse Event|0|||
144371235|NCT02106390|520567783|FG001|Overall Study|Adverse Event|2|||
144371236|NCT02106390|520567784|FG002|Overall Study|Adverse Event|1|||
144590071|NCT01049217|521359934|FG000|Overall Study|Lost to Follow-up|3|||
144590072|NCT01049217|521359935|FG001|Overall Study|Lost to Follow-up|8|||
144590073|NCT01049217|521359934|FG000|Overall Study|Withdrawal by Subject|4|||
144590074|NCT01049217|521359935|FG001|Overall Study|Withdrawal by Subject|3|||
144590075|NCT01049217|521359934|FG000|Overall Study|Protocol Violation|1|||
144590076|NCT01049217|521359935|FG001|Overall Study|Protocol Violation|3|||
144590077|NCT01049217|521359934|FG000|Overall Study|Pregnancy|1|||
144590078|NCT01049217|521359935|FG001|Overall Study|Pregnancy|0|||
144590079|NCT01049217|521359934|FG000|Overall Study|Study Terminated by Sponsor|43|||
144590080|NCT01049217|521359935|FG001|Overall Study|Study Terminated by Sponsor|43|||
144590081|NCT01049217|521359934|FG000|Overall Study|Other|1|||
144590082|NCT01049217|521359935|FG001|Overall Study|Other|2|||
144590083|NCT01049217|521359934|FG000|Overall Study|Randomized but not Treated|0|||
144590084|NCT01049217|521359935|FG001|Overall Study|Randomized but not Treated|2|||
144590085|NCT01946438|521359936|FG000|Overall Study|Adverse Event|0|||
144590086|NCT01946438|521359937|FG001|Overall Study|Adverse Event|0|||
144590087|NCT01946438|521359938|FG002|Overall Study|Adverse Event|0|||
144590088|NCT01946438|521359939|FG003|Overall Study|Adverse Event|1|||
144590089|NCT01946438|521359936|FG000|Overall Study|Serious Adverse event|1|||
144590090|NCT01946438|521359937|FG001|Overall Study|Serious Adverse event|0|||
144590091|NCT01946438|521359938|FG002|Overall Study|Serious Adverse event|0|||
144590092|NCT01946438|521359939|FG003|Overall Study|Serious Adverse event|0|||
144590093|NCT01946438|521359936|FG000|Overall Study|Protocol Violation|0|||
144590094|NCT01946438|521359937|FG001|Overall Study|Protocol Violation|0|||
144590095|NCT01946438|521359938|FG002|Overall Study|Protocol Violation|1|||
144590096|NCT01946438|521359939|FG003|Overall Study|Protocol Violation|0|||
144590097|NCT01946438|521359936|FG000|Overall Study|Withdrawal by Subject|1|||
144590098|NCT01946438|521359937|FG001|Overall Study|Withdrawal by Subject|0|||
144590099|NCT01946438|521359938|FG002|Overall Study|Withdrawal by Subject|0|||
144590100|NCT01946438|521359939|FG003|Overall Study|Withdrawal by Subject|0|||
144590101|NCT02412371|521359940|FG000|Overall Study|Withdrawal by Subject|0|||
144590102|NCT02412371|521359941|FG001|Overall Study|Withdrawal by Subject|2|||
144590103|NCT02412371|521359942|FG002|Overall Study|Withdrawal by Subject|0|||
144590104|NCT02412371|521359943|FG003|Overall Study|Withdrawal by Subject|1|||
144590105|NCT02412371|521359944|FG004|Overall Study|Withdrawal by Subject|1|||
144590106|NCT02412371|521359945|FG005|Overall Study|Withdrawal by Subject|0|||
144590107|NCT02412371|521359940|FG000|Overall Study|Sponsor Discontinued Study|1|||
144590108|NCT02412371|521359941|FG001|Overall Study|Sponsor Discontinued Study|4|||
144590109|NCT02412371|521359942|FG002|Overall Study|Sponsor Discontinued Study|6|||
144590110|NCT02412371|521359943|FG003|Overall Study|Sponsor Discontinued Study|4|||
144590111|NCT02412371|521359944|FG004|Overall Study|Sponsor Discontinued Study|5|||
144590112|NCT02412371|521359945|FG005|Overall Study|Sponsor Discontinued Study|0|||
144590113|NCT02412371|521359940|FG000|Overall Study|Death|4|||
144590114|NCT02412371|521359941|FG001|Overall Study|Death|2|||
144590115|NCT02412371|521359942|FG002|Overall Study|Death|1|||
144590116|NCT02412371|521359943|FG003|Overall Study|Death|3|||
144590117|NCT02412371|521359944|FG004|Overall Study|Death|5|||
144590118|NCT02412371|521359945|FG005|Overall Study|Death|2|||
144590119|NCT02412371|521359940|FG000|Overall Study|Other|2|||
144590120|NCT02412371|521359941|FG001|Overall Study|Other|1|||
144590121|NCT02412371|521359942|FG002|Overall Study|Other|0|||
144590122|NCT02412371|521359943|FG003|Overall Study|Other|0|||
144590123|NCT02412371|521359944|FG004|Overall Study|Other|1|||
144590124|NCT02412371|521359945|FG005|Overall Study|Other|3|||
144590125|NCT05000931|521359946|FG000|Overall Study|Lost to Follow-up|1|||
144590126|NCT03149549|521359947|FG000|Study Discontinuation--Treatment Period|Death|0|||
144590127|NCT03149549|521359948|FG001|Study Discontinuation--Treatment Period|Death|0|||
144590128|NCT03149549|521359949|FG002|Study Discontinuation--Treatment Period|Death|0|||
144590129|NCT03149549|521359950|FG003|Study Discontinuation--Treatment Period|Death|1|||
144590130|NCT03149549|521359951|FG004|Study Discontinuation--Treatment Period|Death|2|||
144590131|NCT03149549|521359952|FG005|Study Discontinuation--Treatment Period|Death|1|||
144590132|NCT03149549|521359953|FG006|Study Discontinuation--Treatment Period|Death|1|||
144590133|NCT03149549|521359954|FG007|Study Discontinuation--Treatment Period|Death|2|||
144590134|NCT03149549|521359955|FG008|Study Discontinuation--Treatment Period|Death|4|||
144590135|NCT03149549|521359956|FG009|Study Discontinuation--Treatment Period|Death|1|||
144590136|NCT03149549|521359957|FG010|Study Discontinuation--Treatment Period|Death|0|||
144590137|NCT03149549|521359958|FG011|Study Discontinuation--Treatment Period|Death|0|||
144590138|NCT03149549|521359959|FG012|Study Discontinuation--Treatment Period|Death|1|||
144590139|NCT03149549|521359947|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590140|NCT03149549|521359948|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590141|NCT03149549|521359949|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590142|NCT03149549|521359950|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590143|NCT03149549|521359951|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590144|NCT03149549|521359952|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590145|NCT03149549|521359953|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590146|NCT03149549|521359954|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
144590147|NCT03149549|521359955|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590148|NCT03149549|521359956|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590149|NCT03149549|521359957|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590150|NCT03149549|521359958|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
144590151|NCT03149549|521359959|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
144590152|NCT03149549|521359947|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590153|NCT03149549|521359948|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590154|NCT03149549|521359949|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590155|NCT03149549|521359950|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
144590156|NCT03149549|521359951|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
144590157|NCT03149549|521359952|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
144590158|NCT03149549|521359953|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
144590159|NCT03149549|521359954|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590160|NCT03149549|521359955|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
144590161|NCT03149549|521359956|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590162|NCT03149549|521359957|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590163|NCT03149549|521359958|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590164|NCT03149549|521359959|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
144590165|NCT03149549|521359947|FG000|Study Discontinuation--Treatment Period|Other|0|||
144590166|NCT03149549|521359948|FG001|Study Discontinuation--Treatment Period|Other|0|||
144590167|NCT03149549|521359949|FG002|Study Discontinuation--Treatment Period|Other|0|||
144590168|NCT03149549|521359950|FG003|Study Discontinuation--Treatment Period|Other|0|||
144590169|NCT03149549|521359951|FG004|Study Discontinuation--Treatment Period|Other|0|||
144590170|NCT03149549|521359952|FG005|Study Discontinuation--Treatment Period|Other|0|||
144590171|NCT03149549|521359953|FG006|Study Discontinuation--Treatment Period|Other|0|||
144590172|NCT03149549|521359954|FG007|Study Discontinuation--Treatment Period|Other|1|||
144590173|NCT03149549|521359955|FG008|Study Discontinuation--Treatment Period|Other|0|||
144590174|NCT03149549|521359956|FG009|Study Discontinuation--Treatment Period|Other|1|||
144590175|NCT03149549|521359957|FG010|Study Discontinuation--Treatment Period|Other|0|||
144590176|NCT03149549|521359958|FG011|Study Discontinuation--Treatment Period|Other|0|||
144590177|NCT03149549|521359959|FG012|Study Discontinuation--Treatment Period|Other|0|||
144590178|NCT03149549|521359947|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590179|NCT03149549|521359948|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590180|NCT03149549|521359949|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590181|NCT03149549|521359950|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590182|NCT03149549|521359951|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590183|NCT03149549|521359952|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
144590184|NCT03149549|521359953|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
144590185|NCT03149549|521359954|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590186|NCT03149549|521359955|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
144590187|NCT03149549|521359956|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590188|NCT03149549|521359957|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590189|NCT03149549|521359958|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590190|NCT03149549|521359959|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
144590191|NCT03149549|521359947|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590192|NCT03149549|521359948|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590193|NCT03149549|521359949|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590194|NCT03149549|521359950|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590195|NCT03149549|521359951|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
144590196|NCT03149549|521359952|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590197|NCT03149549|521359953|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590198|NCT03149549|521359954|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
144590199|NCT03149549|521359955|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
144590200|NCT03149549|521359956|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590201|NCT03149549|521359957|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
144590202|NCT03149549|521359958|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
144590203|NCT03149549|521359959|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
144590204|NCT03149549|521359947|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144590205|NCT03149549|521359948|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144590206|NCT03149549|521359949|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144590207|NCT03149549|521359950|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144721694|NCT00419926|521835264|FG001|Overall Study|Lost to Follow-up|2|||
144590208|NCT03149549|521359951|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
144590209|NCT03149549|521359952|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144590210|NCT03149549|521359953|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144590211|NCT03149549|521359954|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
144590212|NCT03149549|521359955|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
144590213|NCT03149549|521359956|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
144590214|NCT03149549|521359957|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
144590215|NCT03149549|521359958|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
144590216|NCT03149549|521359959|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
144590217|NCT03149549|521359947|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
144590218|NCT03149549|521359948|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
144590219|NCT03149549|521359949|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
144590220|NCT03149549|521359950|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
144590221|NCT03149549|521359951|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
144510421|NCT00529516|521069188|FG000|Overall Study|Withdrawal by Subject|1|||
144510422|NCT00529516|521069189|FG001|Overall Study|Withdrawal by Subject|1|||
144510423|NCT00529516|521069190|FG002|Overall Study|Withdrawal by Subject|0|||
144510424|NCT00529516|521069188|FG000|Overall Study|Lost to Follow-up|0|||
144510425|NCT00529516|521069189|FG001|Overall Study|Lost to Follow-up|0|||
144510426|NCT00529516|521069190|FG002|Overall Study|Lost to Follow-up|1|||
144510427|NCT00703820|521069193|FG000|Overall Study|Adverse Event|12|||
144510428|NCT00703820|521069194|FG001|Overall Study|Adverse Event|17|||
144510429|NCT00703820|521069193|FG000|Overall Study|Death|5|||
144510430|NCT00703820|521069194|FG001|Overall Study|Death|0|||
144510431|NCT00703820|521069193|FG000|Overall Study|Lack of Efficacy|11|||
144510432|NCT00703820|521069194|FG001|Overall Study|Lack of Efficacy|11|||
144510433|NCT00703820|521069193|FG000|Overall Study|Received non-protocol therapy|1|||
144510434|NCT00703820|521069194|FG001|Overall Study|Received non-protocol therapy|0|||
144510435|NCT00703820|521069193|FG000|Overall Study|Physician Decision|4|||
144510436|NCT00703820|521069194|FG001|Overall Study|Physician Decision|5|||
144510437|NCT00703820|521069193|FG000|Overall Study|Withdrawal by Subject|2|||
144510438|NCT00703820|521069194|FG001|Overall Study|Withdrawal by Subject|1|||
144510439|NCT00761605|521069197|FG000|Overall Study|Adverse Event|26|||
144510440|NCT00761605|521069197|FG000|Overall Study|Death|2|||
144510441|NCT00761605|521069197|FG000|Overall Study|Lack of Efficacy|26|||
144510442|NCT00761605|521069197|FG000|Overall Study|Lost to Follow-up|29|||
144510443|NCT00761605|521069197|FG000|Overall Study|Withdrawal by Subject|37|||
144510444|NCT00761605|521069197|FG000|Overall Study|Other|21|||
144510445|NCT03036813|521069199|FG000|Overall Study|Adverse Event|6|||
144510446|NCT03036813|521069200|FG001|Overall Study|Adverse Event|11|||
144510447|NCT03036813|521069201|FG002|Overall Study|Adverse Event|6|||
144510448|NCT03036813|521069199|FG000|Overall Study|Withdrawal by Subject|12|||
144510449|NCT03036813|521069200|FG001|Overall Study|Withdrawal by Subject|6|||
144510450|NCT03036813|521069201|FG002|Overall Study|Withdrawal by Subject|10|||
144510451|NCT03036813|521069199|FG000|Overall Study|Lost to Follow-up|1|||
144510452|NCT03036813|521069200|FG001|Overall Study|Lost to Follow-up|1|||
144510453|NCT03036813|521069201|FG002|Overall Study|Lost to Follow-up|0|||
144510454|NCT03036813|521069199|FG000|Overall Study|Physician Decision|2|||
144510455|NCT03036813|521069200|FG001|Overall Study|Physician Decision|1|||
144510456|NCT03036813|521069201|FG002|Overall Study|Physician Decision|1|||
144510457|NCT03036813|521069199|FG000|Overall Study|Non-Compliance|1|||
144510458|NCT03036813|521069200|FG001|Overall Study|Non-Compliance|5|||
144510459|NCT03036813|521069201|FG002|Overall Study|Non-Compliance|3|||
144510460|NCT03036813|521069199|FG000|Overall Study|Pregnancy|0|||
144510461|NCT03036813|521069200|FG001|Overall Study|Pregnancy|0|||
144510462|NCT03036813|521069201|FG002|Overall Study|Pregnancy|1|||
144510463|NCT03036813|521069199|FG000|Overall Study|Other|0|||
144510464|NCT03036813|521069200|FG001|Overall Study|Other|3|||
144590222|NCT03149549|521359952|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
144590223|NCT03149549|521359953|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
144590224|NCT03149549|521359954|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
144590225|NCT03149549|521359955|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
144590226|NCT03149549|521359956|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
144590227|NCT03149549|521359957|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
144590228|NCT03149549|521359958|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
144590229|NCT03149549|521359959|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
144590230|NCT03149549|521359947|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
144590231|NCT03149549|521359948|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
144590232|NCT03149549|521359949|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
144510465|NCT03036813|521069201|FG002|Overall Study|Other|5|||
144510466|NCT01102231|521069206|FG000|Overall Study|Protocol Violation|3|||
144510467|NCT01102231|521069206|FG000|Overall Study|Lack of Efficacy|2|||
144510468|NCT01102231|521069206|FG000|Overall Study|Death|2|||
144510469|NCT01102231|521069206|FG000|Overall Study|Adverse Event|3|||
144510470|NCT01102231|521069206|FG000|Overall Study|Withdrawal by Subject|1|||
144510471|NCT01102231|521069206|FG000|Overall Study|Did not received the treatment|4|||
144510472|NCT00785512|521069209|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
144510473|NCT00785512|521069210|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
144590233|NCT03149549|521359950|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
144590234|NCT03149549|521359951|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
144590235|NCT03149549|521359952|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
144590236|NCT03149549|521359953|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
144590237|NCT03149549|521359954|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
144590238|NCT03149549|521359955|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
144590239|NCT03149549|521359956|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
144590240|NCT03149549|521359957|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
144590241|NCT03149549|521359958|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
144590242|NCT03149549|521359959|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
144590243|NCT03141905|521359964|FG000|Overall Study|Death|3|||
144590244|NCT03141905|521359965|FG001|Overall Study|Death|2|||
144590245|NCT03141905|521359964|FG000|Overall Study|Withdrawal by Subject|1|||
144590246|NCT03141905|521359965|FG001|Overall Study|Withdrawal by Subject|0|||
144590247|NCT03141905|521359964|FG000|Overall Study|Lost to Follow-up|3|||
144590248|NCT03141905|521359965|FG001|Overall Study|Lost to Follow-up|7|||
144590249|NCT03141905|521359964|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
144590250|NCT03141905|521359965|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
144590251|NCT01775124|521359967|FG000|Core Period|Disease Progression|0|||
144590252|NCT01775124|521359968|FG001|Core Period|Disease Progression|1|||
144590253|NCT01775124|521359967|FG000|Core Period|Physician Decision|1|||
144590254|NCT01775124|521359968|FG001|Core Period|Physician Decision|1|||
144590255|NCT01775124|521359967|FG000|Core Period|Death|0|||
144590256|NCT01775124|521359968|FG001|Core Period|Death|1|||
144590257|NCT01775124|521359967|FG000|Core Period|Administrative problems|1|||
144590258|NCT01775124|521359968|FG001|Core Period|Administrative problems|0|||
144590259|NCT01775124|521359967|FG000|Core Period|Withdrawal by Subject|4|||
144590260|NCT01775124|521359968|FG001|Core Period|Withdrawal by Subject|2|||
144590261|NCT01775124|521359967|FG000|Core Period|Adverse Event|5|||
144590262|NCT01775124|521359968|FG001|Core Period|Adverse Event|5|||
144590263|NCT01775124|521359967|FG000|Extension Period|Adverse Event|3|||
144590264|NCT01775124|521359968|FG001|Extension Period|Adverse Event|2|||
144590265|NCT01775124|521359967|FG000|Extension Period|Physician Decision|0|||
144590266|NCT01775124|521359968|FG001|Extension Period|Physician Decision|2|||
144590267|NCT01775124|521359967|FG000|Extension Period|Administrative problems|0|||
144590268|NCT01775124|521359968|FG001|Extension Period|Administrative problems|1|||
144590269|NCT01775124|521359967|FG000|Extension Period|Lost to Follow-up|0|||
144590270|NCT01775124|521359968|FG001|Extension Period|Lost to Follow-up|1|||
144590271|NCT01775124|521359967|FG000|Extension Period|Withdrawal by Subject|9|||
144590272|NCT01775124|521359968|FG001|Extension Period|Withdrawal by Subject|12|||
144590273|NCT00346268|521361764|FG000|Overall Study|Adverse Event|1|||
144590274|NCT00346268|521361765|FG001|Overall Study|Adverse Event|0|||
144590275|NCT00346268|521361764|FG000|Overall Study|Protocol Violation|1|||
144590276|NCT00346268|521361765|FG001|Overall Study|Protocol Violation|0|||
144590277|NCT00346268|521361764|FG000|Overall Study|Participant refused|0|||
144590278|NCT00346268|521361765|FG001|Overall Study|Participant refused|3|||
144590279|NCT02164383|521361766|FG000|Overall Study|Lost to Follow-up|1|||
144590280|NCT02164383|521361767|FG001|Overall Study|Lost to Follow-up|0|||
144590281|NCT01672723|521361768|FG000|First Intervention|Adverse Event|3|||
144590282|NCT01672723|521361769|FG001|First Intervention|Adverse Event|0|||
144510474|NCT00785512|521069209|FG000|Overall Study|Adverse Event|0|||
144510475|NCT00785512|521069210|FG001|Overall Study|Adverse Event|0|||
144510476|NCT00785512|521069209|FG000|Overall Study|Lack of Efficacy|0|||
144510477|NCT00785512|521069210|FG001|Overall Study|Lack of Efficacy|2|||
144510478|NCT00785512|521069209|FG000|Overall Study|Withdrawal by Subject|0|||
144510479|NCT00785512|521069210|FG001|Overall Study|Withdrawal by Subject|1|||
144510480|NCT00785512|521069209|FG000|Overall Study|Lost to Follow-up|3|||
144510481|NCT00785512|521069210|FG001|Overall Study|Lost to Follow-up|0|||
144590283|NCT00743275|521361770|FG000|Overall Study|Protocol Violation|0|||
144590284|NCT00743275|521361771|FG001|Overall Study|Protocol Violation|1|||
144590285|NCT00484289|521361780|FG000|Long Term Phase|Adverse Event|1|||
144590286|NCT00484289|521361781|FG001|Long Term Phase|Adverse Event|17|||
144590287|NCT00484289|521361782|FG002|Long Term Phase|Adverse Event|5|||
144510482|NCT00785512|521069209|FG000|Overall Study|Precedure Refused|0|||
144510483|NCT00785512|521069210|FG001|Overall Study|Precedure Refused|0|||
144510484|NCT00785512|521069209|FG000|Overall Study|IVRS Programing Error|0|||
144510485|NCT00785512|521069210|FG001|Overall Study|IVRS Programing Error|0|||
144590288|NCT00484289|521361780|FG000|Long Term Phase|Withdrawal by Subject|0|||
144590289|NCT00484289|521361781|FG001|Long Term Phase|Withdrawal by Subject|7|||
144590290|NCT00484289|521361782|FG002|Long Term Phase|Withdrawal by Subject|6|||
144590291|NCT00484289|521361780|FG000|Long Term Phase|Inadequate response|2|||
144590292|NCT00484289|521361781|FG001|Long Term Phase|Inadequate response|7|||
144590293|NCT00484289|521361782|FG002|Long Term Phase|Inadequate response|4|||
144590294|NCT00484289|521361780|FG000|Long Term Phase|Other Reason|0|||
144590295|NCT00484289|521361781|FG001|Long Term Phase|Other Reason|5|||
144590296|NCT00484289|521361782|FG002|Long Term Phase|Other Reason|1|||
144590297|NCT00484289|521361780|FG000|Post Marketing Phase|Adverse Event|0|||
144590298|NCT00484289|521361781|FG001|Post Marketing Phase|Adverse Event|1|||
144590299|NCT00484289|521361782|FG002|Post Marketing Phase|Adverse Event|0|||
144590300|NCT02831387|521361783|FG000|Overall Study|Withdrawal by Subject|1|||
144590301|NCT02831387|521361784|FG001|Overall Study|Withdrawal by Subject|1|||
144590302|NCT02831387|521361783|FG000|Overall Study|Discontinued due to stock recovery|0|||
144590303|NCT02831387|521361784|FG001|Overall Study|Discontinued due to stock recovery|1|||
144590304|NCT02186223|521361785|FG000|Overall Study|Not eligible for device placement|6|||
144590305|NCT02186223|521361785|FG000|Overall Study|Unable to obtain femoral access|3|||
144590306|NCT02186223|521361785|FG000|Overall Study|Death|3|||
144590307|NCT02186223|521361785|FG000|Overall Study|Device in place less than 48 hours|9|||
144590308|NCT00252733|521361786|FG000|Overall Study|Withdrawal by Subject|73|||
144590309|NCT00252733|521361787|FG001|Overall Study|Withdrawal by Subject|67|||
144590310|NCT00252733|521361786|FG000|Overall Study|Death|7|||
144590311|NCT00252733|521361787|FG001|Overall Study|Death|5|||
144590312|NCT00252733|521361786|FG000|Overall Study|Lost to Follow-up|12|||
144590313|NCT00252733|521361787|FG001|Overall Study|Lost to Follow-up|6|||
144590314|NCT00252733|521361786|FG000|Overall Study|Multiple Reasons|14|||
144590315|NCT00252733|521361787|FG001|Overall Study|Multiple Reasons|14|||
144590316|NCT01375114|521361790|FG000|Overall Study|Lost to Follow-up|1|||
144590317|NCT01375114|521361791|FG001|Overall Study|Lost to Follow-up|0|||
144590318|NCT01375114|521361792|FG002|Overall Study|Lost to Follow-up|1|||
144590319|NCT01375114|521361790|FG000|Overall Study|Disease Progression|3|||
144590320|NCT01375114|521361791|FG001|Overall Study|Disease Progression|2|||
144590321|NCT01375114|521361792|FG002|Overall Study|Disease Progression|2|||
144590322|NCT01375114|521361790|FG000|Overall Study|Patient Changed Mind|0|||
144590323|NCT01375114|521361791|FG001|Overall Study|Patient Changed Mind|0|||
144590324|NCT01375114|521361792|FG002|Overall Study|Patient Changed Mind|2|||
144590325|NCT01375114|521361790|FG000|Overall Study|Pruritus|0|||
144590326|NCT01375114|521361791|FG001|Overall Study|Pruritus|0|||
144590327|NCT01375114|521361792|FG002|Overall Study|Pruritus|1|||
144590328|NCT01375114|521361790|FG000|Overall Study|Restlessness|0|||
144590329|NCT01375114|521361791|FG001|Overall Study|Restlessness|0|||
144590330|NCT01375114|521361792|FG002|Overall Study|Restlessness|1|||
144590331|NCT01375114|521361790|FG000|Overall Study|Diarrhea|0|||
144590332|NCT01375114|521361791|FG001|Overall Study|Diarrhea|0|||
144590333|NCT01375114|521361792|FG002|Overall Study|Diarrhea|1|||
144590334|NCT01375114|521361790|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
144590335|NCT01375114|521361791|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
144590336|NCT01375114|521361792|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
144590337|NCT01375114|521361790|FG000|Overall Study|Nausea|0|||
144590338|NCT01375114|521361791|FG001|Overall Study|Nausea|1|||
144590339|NCT01375114|521361792|FG002|Overall Study|Nausea|0|||
144590340|NCT01375114|521361790|FG000|Overall Study|Increased AST/ALT|0|||
144590341|NCT01375114|521361791|FG001|Overall Study|Increased AST/ALT|1|||
144590342|NCT01375114|521361792|FG002|Overall Study|Increased AST/ALT|0|||
144590343|NCT01375114|521361790|FG000|Overall Study|Vaginal Hemorrhage|0|||
144590344|NCT01375114|521361791|FG001|Overall Study|Vaginal Hemorrhage|1|||
144590345|NCT01375114|521361792|FG002|Overall Study|Vaginal Hemorrhage|0|||
144590346|NCT01375114|521361790|FG000|Overall Study|Family problem|0|||
144590347|NCT01375114|521361791|FG001|Overall Study|Family problem|1|||
144590348|NCT01375114|521361792|FG002|Overall Study|Family problem|0|||
144590349|NCT01375114|521361790|FG000|Overall Study|Protocol Violation|2|||
144590350|NCT01375114|521361791|FG001|Overall Study|Protocol Violation|0|||
144590351|NCT01375114|521361792|FG002|Overall Study|Protocol Violation|0|||
144590352|NCT01888900|521361798|FG000|Overall Study|failed treatment|0|||
144590353|NCT01888900|521361799|FG001|Overall Study|failed treatment|2|||
144590354|NCT01248065|521361804|FG000|Overall Study|Lost to Follow-up|3|||
144590355|NCT01248065|521361805|FG001|Overall Study|Lost to Follow-up|5|||
144590356|NCT01248065|521361804|FG000|Overall Study|Withdrawal by Subject|14|||
144590357|NCT01248065|521361805|FG001|Overall Study|Withdrawal by Subject|11|||
144590358|NCT01248065|521361804|FG000|Overall Study|Adverse Event|3|||
144590359|NCT01248065|521361805|FG001|Overall Study|Adverse Event|0|||
144590360|NCT01248065|521361804|FG000|Overall Study|Third treatment failure event|3|||
144590361|NCT01248065|521361805|FG001|Overall Study|Third treatment failure event|1|||
144721695|NCT00419926|521835263|FG000|Overall Study|Death|2|||
144590362|NCT01248065|521361804|FG000|Overall Study|Other|3|||
144590363|NCT01248065|521361805|FG001|Overall Study|Other|5|||
144590364|NCT02781844|521361812|FG000|Treatment Period 1|Adverse Event|0|||
144590365|NCT02781844|521361813|FG001|Treatment Period 1|Adverse Event|0|||
144590366|NCT02781844|521361814|FG002|Treatment Period 1|Adverse Event|0|||
144590367|NCT02781844|521361815|FG003|Treatment Period 1|Adverse Event|0|||
144590368|NCT02781844|521361816|FG004|Treatment Period 1|Adverse Event|0|||
144590369|NCT02781844|521361817|FG005|Treatment Period 1|Adverse Event|1|||
144590370|NCT02781844|521361818|FG006|Treatment Period 1|Adverse Event|0|||
144590371|NCT02781844|521361819|FG007|Treatment Period 1|Adverse Event|0|||
144590372|NCT00321373|521361824|FG000|Overall Study|Adverse Event|0|||
144590373|NCT00321373|521361825|FG001|Overall Study|Adverse Event|0|||
144590374|NCT00321373|521361826|FG002|Overall Study|Adverse Event|1|||
144590375|NCT00321373|521361824|FG000|Overall Study|Lost to Follow-up|1|||
144590376|NCT00321373|521361825|FG001|Overall Study|Lost to Follow-up|0|||
144590377|NCT00321373|521361826|FG002|Overall Study|Lost to Follow-up|1|||
144590378|NCT00321373|521361824|FG000|Overall Study|Withdrawal by Subject|1|||
144590379|NCT00321373|521361825|FG001|Overall Study|Withdrawal by Subject|0|||
144590380|NCT00321373|521361826|FG002|Overall Study|Withdrawal by Subject|0|||
144590381|NCT00321373|521361824|FG000|Overall Study|Other|0|||
144590382|NCT00321373|521361825|FG001|Overall Study|Other|0|||
144590383|NCT00321373|521361826|FG002|Overall Study|Other|1|||
144590384|NCT01774487|521361827|FG000|Overall Study|Did not tolerate taste|4|||
144590385|NCT01774487|521361828|FG001|Overall Study|Did not tolerate taste|4|||
144590386|NCT04275089|521361829|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
144590387|NCT02354508|521361833|FG000|Period 1: Core Phase|Adverse Event|1|||
144590388|NCT02354508|521361834|FG001|Period 1: Core Phase|Adverse Event|1|||
144590389|NCT02354508|521361835|FG002|Period 1: Core Phase|Adverse Event|2|||
144590390|NCT02354508|521361833|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
144590391|NCT02354508|521361834|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
144590392|NCT02354508|521361835|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
144590393|NCT02354508|521361833|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
144721696|NCT00419926|521835264|FG001|Overall Study|Death|1|||
144510486|NCT00785512|521069209|FG000|Overall Study|Physician Decision|0|||
144510487|NCT00785512|521069210|FG001|Overall Study|Physician Decision|0|||
144510488|NCT00785512|521069209|FG000|Overall Study|Lack of compliance|0|||
144510489|NCT00785512|521069210|FG001|Overall Study|Lack of compliance|1|||
144510490|NCT00529100|521069215|FG000|Overall Study|Adverse Event|0|||
144510491|NCT00529100|521069216|FG001|Overall Study|Adverse Event|5|||
144510492|NCT00529100|521069215|FG000|Overall Study|Protocol Violation|0|||
144510493|NCT00529100|521069216|FG001|Overall Study|Protocol Violation|1|||
144510494|NCT00529100|521069215|FG000|Overall Study|Progressive Disease|0|||
144510495|NCT00529100|521069216|FG001|Overall Study|Progressive Disease|1|||
144510496|NCT00529100|521069215|FG000|Overall Study|Withdrawal by Subject|0|||
144510497|NCT00529100|521069216|FG001|Overall Study|Withdrawal by Subject|1|||
144510498|NCT00529100|521069215|FG000|Overall Study|Participant Ineligibility|0|||
144510499|NCT00529100|521069216|FG001|Overall Study|Participant Ineligibility|1|||
144510500|NCT00603954|521069226|FG000|Overall Study|Protocol Violation|1|||
144510501|NCT00603954|521069227|FG001|Overall Study|Protocol Violation|2|||
144510502|NCT02568683|521069228|FG000|Overall Study|Death|0|||
144510503|NCT02568683|521069229|FG001|Overall Study|Death|2|||
144510504|NCT02568683|521069228|FG000|Overall Study|Withdrew Consent|1|||
144510505|NCT02568683|521069229|FG001|Overall Study|Withdrew Consent|0|||
144510506|NCT02568683|521069228|FG000|Overall Study|Study Terminated By Sponsor|5|||
144510507|NCT02568683|521069229|FG001|Overall Study|Study Terminated By Sponsor|2|||
144510508|NCT04556981|521069241|FG000|Overall Study|Death|0|||
144510509|NCT04556981|521069242|FG001|Overall Study|Death|1|||
144510510|NCT04556981|521069241|FG000|Overall Study|Lost to Follow-up|2|||
144510511|NCT04556981|521069242|FG001|Overall Study|Lost to Follow-up|11|||
144510512|NCT04556981|521069241|FG000|Overall Study|Moved from the study area|1|||
144510513|NCT04556981|521069242|FG001|Overall Study|Moved from the study area|4|||
144510514|NCT04556981|521069241|FG000|Overall Study|Withdrawal by Subject|2|||
144510515|NCT04556981|521069242|FG001|Overall Study|Withdrawal by Subject|2|||
144510516|NCT04556981|521069241|FG000|Overall Study|Other|2|||
144510517|NCT04556981|521069242|FG001|Overall Study|Other|1|||
144510518|NCT02477605|521069246|FG000|Overall Study|Discontinued prior to treatment|1|||
144510519|NCT02477605|521069247|FG001|Overall Study|Discontinued prior to treatment|0|||
144510520|NCT02477605|521069246|FG000|Overall Study|Lost to Follow-up|0|||
144510521|NCT02477605|521069247|FG001|Overall Study|Lost to Follow-up|2|||
144510522|NCT02477605|521069246|FG000|Overall Study|Withdrawal by Subject|0|||
144510523|NCT02477605|521069247|FG001|Overall Study|Withdrawal by Subject|1|||
144510524|NCT02477605|521069246|FG000|Overall Study|Administered gas during surgery|0|||
144510525|NCT02477605|521069247|FG001|Overall Study|Administered gas during surgery|1|||
144510526|NCT02574455|521069249|FG000|Overall Study|Death|197|||
144721697|NCT04041570|521835267|FG000|Overall Study|Moved from Area|0|||
144510527|NCT02574455|521069250|FG001|Overall Study|Death|210|||
144510528|NCT02574455|521069249|FG000|Overall Study|Withdrawal of Consent|11|||
144510529|NCT02574455|521069250|FG001|Overall Study|Withdrawal of Consent|28|||
144510530|NCT02574455|521069249|FG000|Overall Study|Lost to Follow-up|4|||
144510531|NCT02574455|521069250|FG001|Overall Study|Lost to Follow-up|4|||
144510532|NCT02574455|521069249|FG000|Overall Study|Sponsor's Decision|55|||
144510533|NCT02574455|521069250|FG001|Overall Study|Sponsor's Decision|20|||
144510534|NCT01388361|521069251|FG000|Overall Study|Adverse Event|0|||
144510535|NCT01388361|521069252|FG001|Overall Study|Adverse Event|5|||
144510536|NCT01388361|521069253|FG002|Overall Study|Adverse Event|1|||
144590394|NCT02354508|521361834|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
144590395|NCT02354508|521361835|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
144590396|NCT02354508|521361833|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
144510537|NCT01388361|521069251|FG000|Overall Study|Protocol Violation|0|||
144590397|NCT02354508|521361834|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
144590398|NCT02354508|521361835|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
144590399|NCT02354508|521361833|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
144590400|NCT02354508|521361834|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
144590401|NCT02354508|521361835|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
144590402|NCT02354508|521361833|FG000|Period 2: Extension Phase|Physician Decision|5|||
144590403|NCT02354508|521361834|FG001|Period 2: Extension Phase|Physician Decision|0|||
144590404|NCT02354508|521361835|FG002|Period 2: Extension Phase|Physician Decision|1|||
144590405|NCT02354508|521361833|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
144590406|NCT02354508|521361834|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
144590407|NCT02354508|521361835|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
144590408|NCT02354508|521361833|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
144590409|NCT02354508|521361834|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
144590410|NCT02354508|521361835|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
144590411|NCT02354508|521361833|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
144590412|NCT02354508|521361834|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
144590413|NCT02354508|521361835|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
144590414|NCT02585232|521361838|FG000|Overall Study|Lost to Follow-up|8|||
144590415|NCT02585232|521361839|FG001|Overall Study|Lost to Follow-up|8|||
144590416|NCT02585232|521361838|FG000|Overall Study|Withdrawal by Subject|4|||
144590417|NCT02585232|521361839|FG001|Overall Study|Withdrawal by Subject|8|||
144590418|NCT04447846|521361840|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
144590419|NCT02257567|521361842|FG000|Overall Study|Adverse Event|0|||
144590420|NCT02257567|521361843|FG001|Overall Study|Adverse Event|0|||
144590421|NCT02257567|521361844|FG002|Overall Study|Adverse Event|0|||
144590422|NCT02257567|521361845|FG003|Overall Study|Adverse Event|1|||
144590423|NCT02257567|521361846|FG004|Overall Study|Adverse Event|1|||
144590424|NCT02257567|521361847|FG005|Overall Study|Adverse Event|0|||
144590425|NCT02257567|521361848|FG006|Overall Study|Adverse Event|0|||
144590426|NCT02257567|521361849|FG007|Overall Study|Adverse Event|0|||
144590427|NCT02257567|521361850|FG008|Overall Study|Adverse Event|1|||
144590428|NCT02257567|521361851|FG009|Overall Study|Adverse Event|0|||
144590429|NCT02257567|521361852|FG010|Overall Study|Adverse Event|0|||
144590430|NCT02257567|521361842|FG000|Overall Study|Death|2|||
144590431|NCT02257567|521361843|FG001|Overall Study|Death|2|||
144510538|NCT01388361|521069252|FG001|Overall Study|Protocol Violation|0|||
144510539|NCT01388361|521069253|FG002|Overall Study|Protocol Violation|2|||
144510540|NCT01388361|521069251|FG000|Overall Study|Withdrawal criteria|12|||
144510541|NCT01388361|521069252|FG001|Overall Study|Withdrawal criteria|7|||
144590432|NCT02257567|521361844|FG002|Overall Study|Death|2|||
144590433|NCT02257567|521361845|FG003|Overall Study|Death|4|||
144590434|NCT02257567|521361846|FG004|Overall Study|Death|15|||
144510542|NCT01388361|521069253|FG002|Overall Study|Withdrawal criteria|10|||
144510543|NCT01388361|521069251|FG000|Overall Study|Unclassified|0|||
144510544|NCT01388361|521069252|FG001|Overall Study|Unclassified|0|||
144510545|NCT01388361|521069253|FG002|Overall Study|Unclassified|1|||
144510546|NCT01061671|521069256|FG000|Overall Study|Withdrawal by Subject|16|||
144510547|NCT01061671|521069257|FG001|Overall Study|Withdrawal by Subject|20|||
144510548|NCT01061671|521069256|FG000|Overall Study|Lost to Follow-up|3|||
144510549|NCT01061671|521069257|FG001|Overall Study|Lost to Follow-up|5|||
144510550|NCT01061671|521069256|FG000|Overall Study|Death|28|||
144510551|NCT01061671|521069257|FG001|Overall Study|Death|30|||
144510552|NCT03565315|521069261|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
144510553|NCT03565315|521069262|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
144510554|NCT03565315|521069263|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
144510555|NCT03565315|521069264|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
144590435|NCT02257567|521361847|FG005|Overall Study|Death|11|||
144590436|NCT02257567|521361848|FG006|Overall Study|Death|26|||
144590437|NCT02257567|521361849|FG007|Overall Study|Death|30|||
144590438|NCT02257567|521361850|FG008|Overall Study|Death|2|||
144590439|NCT02257567|521361851|FG009|Overall Study|Death|18|||
144590440|NCT02257567|521361852|FG010|Overall Study|Death|65|||
144590441|NCT02257567|521361842|FG000|Overall Study|Lost to Follow-up|0|||
144590442|NCT02257567|521361843|FG001|Overall Study|Lost to Follow-up|0|||
144590443|NCT02257567|521361844|FG002|Overall Study|Lost to Follow-up|0|||
144590444|NCT02257567|521361845|FG003|Overall Study|Lost to Follow-up|0|||
144590445|NCT02257567|521361846|FG004|Overall Study|Lost to Follow-up|2|||
144590446|NCT02257567|521361847|FG005|Overall Study|Lost to Follow-up|2|||
144590447|NCT02257567|521361848|FG006|Overall Study|Lost to Follow-up|0|||
144590448|NCT02257567|521361849|FG007|Overall Study|Lost to Follow-up|0|||
144590449|NCT02257567|521361850|FG008|Overall Study|Lost to Follow-up|0|||
144590450|NCT02257567|521361851|FG009|Overall Study|Lost to Follow-up|1|||
144590451|NCT02257567|521361852|FG010|Overall Study|Lost to Follow-up|1|||
144510556|NCT00440011|521069265|FG000|Overall Study|Adverse Event|2|||
144510557|NCT00440011|521069266|FG001|Overall Study|Adverse Event|0|||
144510558|NCT00440011|521069265|FG000|Overall Study|Lost to Follow-up|0|||
144510559|NCT00440011|521069266|FG001|Overall Study|Lost to Follow-up|2|||
144510560|NCT00440011|521069265|FG000|Overall Study|Protocol Violation|1|||
144510561|NCT00440011|521069266|FG001|Overall Study|Protocol Violation|1|||
144510562|NCT00440011|521069265|FG000|Overall Study|Withdrawal by Subject|1|||
144510563|NCT00440011|521069266|FG001|Overall Study|Withdrawal by Subject|0|||
144510564|NCT01083316|521069270|FG000|Overall Study|Adverse Event|2|||
144510565|NCT01083316|521069270|FG000|Overall Study|Withdrawal by Subject|1|||
144510566|NCT00419341|521069271|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
144510567|NCT00419341|521069271|FG000|Wash in/Wash Out Period|Adverse Event|2|||
144510568|NCT00419341|521069271|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
144510569|NCT00419341|521069271|FG000|Efficacy Period|Withdrawal by Subject|6|||
144510570|NCT00419341|521069271|FG000|Efficacy Period|Protocol Violation|1|||
144510571|NCT00419341|521069271|FG000|Efficacy Period|Lost to Follow-up|1|||
144510572|NCT00419341|521069271|FG000|Efficacy Period|Non-compliance|1|||
144510573|NCT00419341|521069271|FG000|Efficacy Period|Termination of study site|1|||
144510574|NCT03960463|521070686|FG000|Overall Study|Withdrawal by Subject|2|||
144510575|NCT03960463|521070687|FG001|Overall Study|Withdrawal by Subject|0|||
144510576|NCT05568615|521070688|FG000|Overall Study|Death|1|||
144510577|NCT05568615|521070688|FG000|Overall Study|Physician Decision|1|||
144510578|NCT03422276|521070693|FG000|Overall Study|Withdrawal by Subject|21|||
144510579|NCT03422276|521070694|FG001|Overall Study|Withdrawal by Subject|25|||
144510580|NCT03422276|521070695|FG002|Overall Study|Withdrawal by Subject|14|||
144510581|NCT03422276|521070696|FG003|Overall Study|Withdrawal by Subject|16|||
144510582|NCT03422276|521070693|FG000|Overall Study|Death|14|||
144510583|NCT03422276|521070694|FG001|Overall Study|Death|21|||
144510584|NCT03422276|521070695|FG002|Overall Study|Death|3|||
144510585|NCT03422276|521070696|FG003|Overall Study|Death|1|||
144510586|NCT03422276|521070693|FG000|Overall Study|Discontinued, ineligible|4|||
144510587|NCT03422276|521070694|FG001|Overall Study|Discontinued, ineligible|3|||
144510588|NCT03422276|521070695|FG002|Overall Study|Discontinued, ineligible|0|||
144510589|NCT03422276|521070696|FG003|Overall Study|Discontinued, ineligible|0|||
144510590|NCT03422276|521070693|FG000|Overall Study|Lost to Follow-up|15|||
144510591|NCT03422276|521070694|FG001|Overall Study|Lost to Follow-up|8|||
144510592|NCT03422276|521070695|FG002|Overall Study|Lost to Follow-up|13|||
144510593|NCT03422276|521070696|FG003|Overall Study|Lost to Follow-up|4|||
144510594|NCT03422276|521070693|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
144510595|NCT03422276|521070694|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
144510596|NCT03422276|521070695|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
144510597|NCT03422276|521070696|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
144510598|NCT03422276|521070693|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
144510599|NCT03422276|521070694|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
144510600|NCT03422276|521070695|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
144510601|NCT03422276|521070696|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
144510602|NCT03422276|521070693|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
144510603|NCT03422276|521070694|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
144510604|NCT03422276|521070695|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
144510605|NCT03422276|521070696|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
144510606|NCT03422276|521070693|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
144510607|NCT03422276|521070694|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
144510608|NCT03422276|521070695|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
144510609|NCT03422276|521070696|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
144510610|NCT03422276|521070693|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
144510611|NCT03422276|521070694|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
144510612|NCT03422276|521070695|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
144510613|NCT03422276|521070696|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
144510614|NCT05194917|521070697|FG000|Overall Study|Lost to Follow-up|7|||
144510615|NCT05194917|521070698|FG001|Overall Study|Lost to Follow-up|5|||
144510616|NCT05194917|521070699|FG002|Overall Study|Lost to Follow-up|6|||
144510617|NCT05194917|521070700|FG003|Overall Study|Lost to Follow-up|5|||
144510618|NCT02279095|521070706|FG000|Overall Study|Non-Compliance|1|||
144510619|NCT02279095|521070706|FG000|Overall Study|Withdrawal by Subject|8|||
144510620|NCT02279095|521070706|FG000|Overall Study|Adverse Event|2|||
144510621|NCT02279095|521070706|FG000|Overall Study|Other|7|||
144510622|NCT02279095|521070706|FG000|Overall Study|Lost to Follow-up|1|||
144510623|NCT05938413|521070707|FG000|Overall Study|Lost to Follow-up|1|||
144510624|NCT05938413|521070708|FG001|Overall Study|Lost to Follow-up|7|||
144510625|NCT05938413|521070707|FG000|Overall Study|Withdrawal by Subject|1|||
144510626|NCT05938413|521070708|FG001|Overall Study|Withdrawal by Subject|1|||
144510627|NCT04922021|521070709|FG000|Overall Study|Withdrawal by Subject|4|||
144721698|NCT04041570|521835268|FG001|Overall Study|Moved from Area|2|||
144721699|NCT01180244|521835269|FG000|Overall Study|Lack of Efficacy|0|||
144510628|NCT04922021|521070710|FG001|Overall Study|Withdrawal by Subject|10|||
144510629|NCT04922021|521070709|FG000|Overall Study|Adverse Event|2|||
144510630|NCT04922021|521070710|FG001|Overall Study|Adverse Event|2|||
144510631|NCT04922021|521070709|FG000|Overall Study|Lack of Efficacy|0|||
144510632|NCT04922021|521070710|FG001|Overall Study|Lack of Efficacy|1|||
144510633|NCT04922021|521070709|FG000|Overall Study|Multiple reasons|1|||
144371237|NCT02106390|520567782|FG000|Overall Study|Protocol Violation|0|||
144590452|NCT02257567|521361842|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144614801|NCT00205855|521450210|FG000|Overall Study|Withdrawal by Subject|5|||
144510634|NCT04922021|521070710|FG001|Overall Study|Multiple reasons|0|||
144510635|NCT03237481|521070726|FG000|Overall Study|Lost to Follow-up|1|||
144510636|NCT03237481|521070727|FG001|Overall Study|Lost to Follow-up|0|||
144510637|NCT03237481|521070728|FG002|Overall Study|Lost to Follow-up|0|||
144510638|NCT03237481|521070726|FG000|Overall Study|Protocol Violation|1|||
144510639|NCT03237481|521070727|FG001|Overall Study|Protocol Violation|0|||
144510640|NCT03237481|521070728|FG002|Overall Study|Protocol Violation|0|||
144510641|NCT03237481|521070726|FG000|Overall Study|Withdrawal by Subject|3|||
144510642|NCT03237481|521070727|FG001|Overall Study|Withdrawal by Subject|2|||
144510643|NCT03237481|521070728|FG002|Overall Study|Withdrawal by Subject|1|||
144510644|NCT03481777|521070732|FG000|Overall Study|Withdrawal by Subject|36|||
144510645|NCT03481777|521070733|FG001|Overall Study|Withdrawal by Subject|31|||
144510646|NCT03481777|521070732|FG000|Overall Study|Non stroke = non target population|277|||
144371238|NCT02106390|520567783|FG001|Overall Study|Protocol Violation|1|||
144510647|NCT03481777|521070733|FG001|Overall Study|Non stroke = non target population|254|||
144371239|NCT02106390|520567784|FG002|Overall Study|Protocol Violation|0|||
144371240|NCT00473382|520567785|FG000|Core Study|Adverse Event|3|||
144371241|NCT00473382|520567786|FG001|Core Study|Adverse Event|1|||
144371242|NCT00473382|520567787|FG002|Core Study|Adverse Event|1|||
144371243|NCT00473382|520567785|FG000|Core Study|Death|3|||
144371244|NCT00473382|520567786|FG001|Core Study|Death|5|||
144371245|NCT00473382|520567787|FG002|Core Study|Death|10|||
144371246|NCT00473382|520567785|FG000|Core Study|Lost to Follow-up|3|||
144371247|NCT00473382|520567786|FG001|Core Study|Lost to Follow-up|3|||
144371248|NCT00473382|520567787|FG002|Core Study|Lost to Follow-up|3|||
144371249|NCT00473382|520567785|FG000|Core Study|Physician Decision|1|||
144371250|NCT00473382|520567786|FG001|Core Study|Physician Decision|2|||
144371251|NCT00473382|520567787|FG002|Core Study|Physician Decision|2|||
144371252|NCT00473382|520567785|FG000|Core Study|Subject non-compliance|5|||
144371253|NCT00473382|520567786|FG001|Core Study|Subject non-compliance|2|||
144371254|NCT00473382|520567787|FG002|Core Study|Subject non-compliance|1|||
144371255|NCT00473382|520567785|FG000|Core Study|Subject needed other treatment|1|||
144590453|NCT02257567|521361843|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590454|NCT02257567|521361844|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590455|NCT02257567|521361845|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590456|NCT02257567|521361846|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
144590457|NCT02257567|521361847|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590458|NCT02257567|521361848|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
144590459|NCT02257567|521361849|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590460|NCT02257567|521361850|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590461|NCT02257567|521361851|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590462|NCT02257567|521361852|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
144590463|NCT02257567|521361842|FG000|Overall Study|Physician Decision|0|||
144590464|NCT02257567|521361843|FG001|Overall Study|Physician Decision|0|||
144590465|NCT02257567|521361844|FG002|Overall Study|Physician Decision|0|||
144590466|NCT02257567|521361845|FG003|Overall Study|Physician Decision|0|||
144590467|NCT02257567|521361846|FG004|Overall Study|Physician Decision|0|||
144590468|NCT02257567|521361847|FG005|Overall Study|Physician Decision|0|||
144590469|NCT02257567|521361848|FG006|Overall Study|Physician Decision|0|||
144590470|NCT02257567|521361849|FG007|Overall Study|Physician Decision|2|||
144590471|NCT02257567|521361850|FG008|Overall Study|Physician Decision|0|||
144590472|NCT02257567|521361851|FG009|Overall Study|Physician Decision|1|||
144590473|NCT02257567|521361852|FG010|Overall Study|Physician Decision|0|||
144590474|NCT02257567|521361842|FG000|Overall Study|Withdrawal by Subject|0|||
144590475|NCT02257567|521361843|FG001|Overall Study|Withdrawal by Subject|0|||
144590476|NCT02257567|521361844|FG002|Overall Study|Withdrawal by Subject|2|||
144590477|NCT02257567|521361845|FG003|Overall Study|Withdrawal by Subject|0|||
144590478|NCT02257567|521361846|FG004|Overall Study|Withdrawal by Subject|0|||
144590479|NCT02257567|521361847|FG005|Overall Study|Withdrawal by Subject|6|||
144590480|NCT02257567|521361848|FG006|Overall Study|Withdrawal by Subject|6|||
144590481|NCT02257567|521361849|FG007|Overall Study|Withdrawal by Subject|6|||
144590482|NCT02257567|521361850|FG008|Overall Study|Withdrawal by Subject|1|||
144590483|NCT02257567|521361851|FG009|Overall Study|Withdrawal by Subject|1|||
144590484|NCT02257567|521361852|FG010|Overall Study|Withdrawal by Subject|10|||
144590485|NCT00871780|521361855|FG000|Overall Study|Enrolled But Not Treated|6|||
144590486|NCT00871780|521361855|FG000|Overall Study|Withdrawal by Subject|9|||
144590487|NCT00871780|521361855|FG000|Overall Study|Adverse Event|6|||
144590488|NCT00871780|521361855|FG000|Overall Study|Voluntary Discontinuation|4|||
144590489|NCT00871780|521361855|FG000|Overall Study|Death|1|||
144590490|NCT00871780|521361855|FG000|Overall Study|Physician Decision|1|||
144590491|NCT05767021|521361856|FG000|Overall Study|Adverse Event|2|||
144590492|NCT05767021|521361856|FG000|Overall Study|Protocol Deviation|1|||
144590493|NCT05767021|521361856|FG000|Overall Study|Withdrawal by Subject|1|||
144590494|NCT05767021|521361856|FG000|Overall Study|Physician Decision|1|||
144590495|NCT05767021|521361856|FG000|Overall Study|Lack of Efficacy|11|||
144590496|NCT05767021|521361856|FG000|Overall Study|Assigned Treatment by Mistake|1|||
144590497|NCT06377488|521361857|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
144590498|NCT06377488|521361857|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
144371256|NCT00473382|520567786|FG001|Core Study|Subject needed other treatment|3|||
144371257|NCT00473382|520567787|FG002|Core Study|Subject needed other treatment|2|||
144371258|NCT00473382|520567785|FG000|Core Study|Subject's decision|12|||
144371259|NCT00473382|520567786|FG001|Core Study|Subject's decision|11|||
144371260|NCT00473382|520567787|FG002|Core Study|Subject's decision|10|||
144371261|NCT00473382|520567785|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
144371262|NCT00473382|520567786|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
144371263|NCT00473382|520567787|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
144510648|NCT04139668|521070738|FG000|Overall Study|Withdrawal by Subject|1|||
144510649|NCT04300647|521070740|FG000|Pre-Crossover|Death|19|||
144510650|NCT04300647|521070741|FG001|Pre-Crossover|Death|58|||
144510651|NCT04300647|521070742|FG002|Pre-Crossover|Death|0|||
144510652|NCT04300647|521070740|FG000|Pre-Crossover|Lost to Follow-up|0|||
144510653|NCT04300647|521070741|FG001|Pre-Crossover|Lost to Follow-up|3|||
144510654|NCT04300647|521070742|FG002|Pre-Crossover|Lost to Follow-up|0|||
144510655|NCT04300647|521070740|FG000|Pre-Crossover|Withdrawal by Subject|2|||
144510656|NCT04300647|521070741|FG001|Pre-Crossover|Withdrawal by Subject|4|||
144510657|NCT04300647|521070742|FG002|Pre-Crossover|Withdrawal by Subject|0|||
144510658|NCT04300647|521070740|FG000|Pre-Crossover|On-going in Study|24|||
144510659|NCT04300647|521070741|FG001|Pre-Crossover|On-going in Study|61|||
144510660|NCT04300647|521070742|FG002|Pre-Crossover|On-going in Study|0|||
144510661|NCT04300647|521070740|FG000|Post-Crossover|Death|0|||
144510662|NCT04300647|521070741|FG001|Post-Crossover|Death|0|||
144510663|NCT04300647|521070742|FG002|Post-Crossover|Death|3|||
144510664|NCT04300647|521070740|FG000|Post-Crossover|Lost to Follow-up|0|||
144510665|NCT04300647|521070741|FG001|Post-Crossover|Lost to Follow-up|0|||
144510666|NCT04300647|521070742|FG002|Post-Crossover|Lost to Follow-up|1|||
144510667|NCT04300647|521070740|FG000|Post-Crossover|Withdrawal by Subject|0|||
144510668|NCT04300647|521070741|FG001|Post-Crossover|Withdrawal by Subject|0|||
144510669|NCT04300647|521070742|FG002|Post-Crossover|Withdrawal by Subject|1|||
144510670|NCT04300647|521070740|FG000|Post-Crossover|On-going in Study|0|||
144510671|NCT04300647|521070741|FG001|Post-Crossover|On-going in Study|0|||
144510672|NCT04300647|521070742|FG002|Post-Crossover|On-going in Study|8|||
144510673|NCT05386238|521070748|FG000|Overall Study|Lost to Follow-up|3|||
144510674|NCT05386238|521070749|FG001|Overall Study|Lost to Follow-up|2|||
144510675|NCT05386238|521070748|FG000|Overall Study|Withdrawal by Subject|0|||
144510676|NCT05386238|521070749|FG001|Overall Study|Withdrawal by Subject|1|||
144510677|NCT04714320|521070752|FG000|Overall Study|Voluntary Withdrawal|4|||
144510678|NCT04714320|521070753|FG001|Overall Study|Voluntary Withdrawal|1|||
144510679|NCT04714320|521070754|FG002|Overall Study|Voluntary Withdrawal|2|||
144510680|NCT04714320|521070752|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
144510681|NCT04714320|521070753|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
144510682|NCT04714320|521070754|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
144510683|NCT04714320|521070752|FG000|Overall Study|Reason Not Specified|1|||
144510684|NCT04714320|521070753|FG001|Overall Study|Reason Not Specified|3|||
144510685|NCT04714320|521070754|FG002|Overall Study|Reason Not Specified|3|||
144510686|NCT05057897|521070755|FG000|Overall Study|Site closure|2|||
144510687|NCT05057897|521070756|FG001|Overall Study|Site closure|2|||
144510688|NCT05057897|521070755|FG000|Overall Study|Death|1|||
144510689|NCT05057897|521070756|FG001|Overall Study|Death|0|||
144510690|NCT01353313|521070761|FG000|Overall Study|Lost to Follow-up|22|||
144510691|NCT01353313|521070762|FG001|Overall Study|Lost to Follow-up|23|||
144510692|NCT01353313|521070761|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
144510693|NCT01353313|521070762|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
144510694|NCT04755660|521070763|FG000|Overall Study|Lost to Follow-up|1|||
144510695|NCT04755660|521070764|FG001|Overall Study|Lost to Follow-up|1|||
144510696|NCT04755660|521070765|FG002|Overall Study|Lost to Follow-up|0|||
144510697|NCT04755660|521070763|FG000|Overall Study|Withdrawal by Subject|0|||
144510698|NCT04755660|521070764|FG001|Overall Study|Withdrawal by Subject|1|||
144510699|NCT04755660|521070765|FG002|Overall Study|Withdrawal by Subject|1|||
144510700|NCT04755660|521070763|FG000|Overall Study|Physician Decision|0|||
144510701|NCT04755660|521070764|FG001|Overall Study|Physician Decision|0|||
144510702|NCT04755660|521070765|FG002|Overall Study|Physician Decision|1|||
144510703|NCT02824029|521070767|FG000|Overall Study|Didn't receive treatment|2|||
144510704|NCT02824029|521070767|FG000|Overall Study|Patient decision to discontinue treatment|3|||
144510705|NCT02824029|521070767|FG000|Overall Study|Non-compliant|5|||
144510706|NCT02824029|521070767|FG000|Overall Study|Progression of disease|15|||
144248508|NCT00994214|520107939|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
144371264|NCT00473382|520567785|FG000|Open-label Extension Through Month 48|Death|1|||
144510707|NCT02824029|521070767|FG000|Overall Study|Inadequate response to therapy|2|||
144510708|NCT02824029|521070767|FG000|Overall Study|Possible progression per treating physician|1|||
144510709|NCT04524390|521070768|FG000|Double Blind|Consent Withdrawal by subject|2|||
144248509|NCT00994214|520107940|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
144248510|NCT00994214|520107941|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
144248511|NCT00994214|520107942|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
144248512|NCT00994214|520107939|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
144248513|NCT00994214|520107940|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
144371265|NCT00473382|520567786|FG001|Open-label Extension Through Month 48|Death|3|||
144510710|NCT04524390|521070769|FG001|Double Blind|Consent Withdrawal by subject|1|||
144510711|NCT04524390|521070770|FG002|Double Blind|Consent Withdrawal by subject|0|||
144510712|NCT04524390|521070768|FG000|Double Blind|Adverse Event|5|||
144510713|NCT04524390|521070769|FG001|Double Blind|Adverse Event|3|||
144510714|NCT04524390|521070770|FG002|Double Blind|Adverse Event|0|||
144510715|NCT04524390|521070768|FG000|Double Blind|Liver Transplant|5|||
144510716|NCT04524390|521070769|FG001|Double Blind|Liver Transplant|6|||
144510717|NCT04524390|521070770|FG002|Double Blind|Liver Transplant|0|||
144510718|NCT04524390|521070768|FG000|Double Blind|Disease Progression|0|||
144248514|NCT00994214|520107941|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
144248515|NCT00994214|520107942|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
144248516|NCT00994214|520107939|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
144248517|NCT00994214|520107940|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
144248518|NCT00994214|520107941|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
144248519|NCT00994214|520107942|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
144510719|NCT04524390|521070769|FG001|Double Blind|Disease Progression|1|||
144510720|NCT04524390|521070770|FG002|Double Blind|Disease Progression|0|||
144510721|NCT04524390|521070768|FG000|Open-Label|Drug interruption criteria|0|||
144510722|NCT04524390|521070769|FG001|Open-Label|Drug interruption criteria|0|||
144510723|NCT04524390|521070770|FG002|Open-Label|Drug interruption criteria|1|||
144510724|NCT04524390|521070768|FG000|Open-Label|Liver Transplant|0|||
144510725|NCT04524390|521070769|FG001|Open-Label|Liver Transplant|0|||
144510726|NCT04524390|521070770|FG002|Open-Label|Liver Transplant|1|||
144248520|NCT00994214|520107939|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
144248521|NCT00994214|520107940|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
144248522|NCT00994214|520107941|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
144248523|NCT00994214|520107942|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
144590499|NCT06377488|521361857|FG000|Overall Study|Protocol Violation|1|||
144721700|NCT01180244|521835270|FG001|Overall Study|Lack of Efficacy|7|||
144721701|NCT01180244|521835269|FG000|Overall Study|Physician Decision|3|||
144590500|NCT06377488|521361857|FG000|Overall Study|Lost to Follow-up|1|||
144590501|NCT06377488|521361857|FG000|Overall Study|Incorrect Lens Dispensed|2|||
144590502|NCT03625895|521361858|FG000|Overall Study|Protocol Violation|585|||
144590503|NCT01065844|521361859|FG000|Overall Study|Adverse Event|5|||
144590504|NCT02679573|521361860|FG000|Overall Study|Adverse Event|13|||
144590505|NCT02679573|521361861|FG001|Overall Study|Adverse Event|6|||
144590506|NCT02679573|521361860|FG000|Overall Study|Lack of Efficacy|12|||
144590507|NCT02679573|521361861|FG001|Overall Study|Lack of Efficacy|15|||
144590508|NCT02679573|521361860|FG000|Overall Study|Could not complete required study visits|6|||
144590509|NCT02679573|521361861|FG001|Overall Study|Could not complete required study visits|2|||
144590510|NCT02679573|521361860|FG000|Overall Study|Withdrawal by Subject|2|||
144590511|NCT02679573|521361861|FG001|Overall Study|Withdrawal by Subject|9|||
144590512|NCT02679573|521361860|FG000|Overall Study|Death|2|||
144590513|NCT02679573|521361861|FG001|Overall Study|Death|0|||
144590514|NCT02679573|521361860|FG000|Overall Study|Physician Decision|2|||
144590515|NCT02679573|521361861|FG001|Overall Study|Physician Decision|4|||
144590516|NCT02679573|521361860|FG000|Overall Study|Lost to Follow-up|0|||
144590517|NCT02679573|521361861|FG001|Overall Study|Lost to Follow-up|3|||
144590518|NCT03545503|521361862|FG000|Overall Study|Protocol Violation|14|||
144590519|NCT03545503|521361863|FG001|Overall Study|Protocol Violation|16|||
144590520|NCT01415531|521361864|FG000|Overall Study|Adverse Event|7|||
144590521|NCT01415531|521361865|FG001|Overall Study|Adverse Event|10|||
144590522|NCT01415531|521361864|FG000|Overall Study|Lack of Efficacy|3|||
144590523|NCT01415531|521361865|FG001|Overall Study|Lack of Efficacy|2|||
144590524|NCT01415531|521361864|FG000|Overall Study|Protocol Violation|0|||
144590525|NCT01415531|521361865|FG001|Overall Study|Protocol Violation|1|||
144590526|NCT01415531|521361864|FG000|Overall Study|Withdrawal by Subject|5|||
144590527|NCT01415531|521361865|FG001|Overall Study|Withdrawal by Subject|4|||
144590528|NCT01415531|521361864|FG000|Overall Study|Lost to Follow-up|6|||
144590529|NCT01415531|521361865|FG001|Overall Study|Lost to Follow-up|14|||
144590530|NCT01415531|521361864|FG000|Overall Study|Lack of Compliance|1|||
144590531|NCT01415531|521361865|FG001|Overall Study|Lack of Compliance|4|||
144590532|NCT01415531|521361864|FG000|Overall Study|Other Reasons|3|||
144590533|NCT01415531|521361865|FG001|Overall Study|Other Reasons|2|||
144590534|NCT05753670|521361866|FG000|Overall Study|Withdrawal by Subject|6|||
144590535|NCT05753670|521361867|FG001|Overall Study|Withdrawal by Subject|8|||
144590536|NCT05753670|521361866|FG000|Overall Study|Protocol Violation|3|||
144590537|NCT05753670|521361867|FG001|Overall Study|Protocol Violation|1|||
144590538|NCT02483585|521361868|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
144590539|NCT02483585|521361869|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
144590540|NCT02483585|521361868|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
144590541|NCT02483585|521361869|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
144590542|NCT02483585|521361868|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
144590543|NCT02483585|521361869|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
144590544|NCT02483585|521361868|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
144590545|NCT02483585|521361869|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
144590546|NCT02483585|521361868|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
144590547|NCT02483585|521361869|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
144590548|NCT02483585|521361868|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
144590549|NCT02483585|521361869|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
144590550|NCT02483585|521361868|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
144371266|NCT00473382|520567787|FG002|Open-label Extension Through Month 48|Death|3|||
144371267|NCT00473382|520567785|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
144371268|NCT00473382|520567786|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
144371269|NCT00473382|520567787|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
144371270|NCT00473382|520567785|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
144371271|NCT00473382|520567786|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
144371272|NCT00473382|520567787|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
144371273|NCT00473382|520567785|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
144371274|NCT00473382|520567786|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
144371275|NCT00473382|520567787|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
144371276|NCT00473382|520567785|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
144371277|NCT00473382|520567786|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
144371278|NCT00473382|520567787|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
144371279|NCT00473382|520567785|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
144371280|NCT00473382|520567786|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
144371281|NCT00473382|520567787|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
144371282|NCT00473382|520567785|FG000|Open-label Extension Through Month 60|Death|1|||
144371283|NCT00473382|520567786|FG001|Open-label Extension Through Month 60|Death|7|||
144371284|NCT00473382|520567787|FG002|Open-label Extension Through Month 60|Death|4|||
144371285|NCT00473382|520567785|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
144371286|NCT00473382|520567786|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
144371287|NCT00473382|520567787|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
144371288|NCT00473382|520567785|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
144371289|NCT00473382|520567786|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
144371290|NCT00473382|520567787|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
144371291|NCT00473382|520567785|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
144371292|NCT00473382|520567786|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
144371293|NCT00473382|520567787|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
144371294|NCT00473382|520567785|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
144371295|NCT00473382|520567786|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
144371296|NCT00473382|520567787|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
144371297|NCT01189032|520567788|FG000|Overall Study|Adverse Event|1|||
144371298|NCT01189032|520567789|FG001|Overall Study|Adverse Event|3|||
144371299|NCT01189032|520567790|FG002|Overall Study|Adverse Event|4|||
144371300|NCT01189032|520567788|FG000|Overall Study|Lack of Efficacy|2|||
144371301|NCT01189032|520567789|FG001|Overall Study|Lack of Efficacy|3|||
144371302|NCT01189032|520567790|FG002|Overall Study|Lack of Efficacy|0|||
144371303|NCT01189032|520567788|FG000|Overall Study|Withdrawal by Subject|1|||
144371304|NCT01189032|520567789|FG001|Overall Study|Withdrawal by Subject|0|||
144371305|NCT01189032|520567790|FG002|Overall Study|Withdrawal by Subject|1|||
144371306|NCT01189032|520567788|FG000|Overall Study|Protocol Violation|1|||
144371307|NCT01189032|520567789|FG001|Overall Study|Protocol Violation|1|||
144371308|NCT01189032|520567790|FG002|Overall Study|Protocol Violation|1|||
144248524|NCT00994214|520107939|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
144248525|NCT00994214|520107940|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
144721702|NCT01180244|521835270|FG001|Overall Study|Physician Decision|0|||
144371309|NCT01166282|520567791|FG000|Open-label Period|Adverse Event|0|||
144721703|NCT01180244|521835269|FG000|Overall Study|Adverse Event|1|||
144248526|NCT00994214|520107941|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
144371310|NCT01166282|520567792|FG001|Open-label Period|Adverse Event|0|||
144371311|NCT01166282|520567793|FG002|Open-label Period|Adverse Event|6|||
144510727|NCT04524390|521070768|FG000|Open-Label|Disease Progression|0|||
144371312|NCT01166282|520567791|FG000|Open-label Period|Withdrawal by Subject|0|||
144371313|NCT01166282|520567792|FG001|Open-label Period|Withdrawal by Subject|0|||
144371314|NCT01166282|520567793|FG002|Open-label Period|Withdrawal by Subject|4|||
144371315|NCT01166282|520567791|FG000|Open-label Period|Lack of Efficacy|0|||
144371316|NCT01166282|520567792|FG001|Open-label Period|Lack of Efficacy|0|||
144371317|NCT01166282|520567793|FG002|Open-label Period|Lack of Efficacy|2|||
144371318|NCT01166282|520567791|FG000|Open-label Period|Remission|0|||
144371319|NCT01166282|520567792|FG001|Open-label Period|Remission|0|||
144371320|NCT01166282|520567793|FG002|Open-label Period|Remission|4|||
144371321|NCT01166282|520567791|FG000|Open-label Period|Irregular Compliance|0|||
144371322|NCT01166282|520567792|FG001|Open-label Period|Irregular Compliance|0|||
144371323|NCT01166282|520567793|FG002|Open-label Period|Irregular Compliance|1|||
144371324|NCT02577718|520567794|FG000|Overall Study|Death|6|||
144371325|NCT02577718|520567794|FG000|Overall Study|Withdrawal by Subject|2|||
144371326|NCT01995838|520567795|FG000|Overall Study|Lost to Follow-up|0|||
144371327|NCT01995838|520567796|FG001|Overall Study|Lost to Follow-up|1|||
144371328|NCT01995838|520567797|FG002|Overall Study|Lost to Follow-up|0|||
144371329|NCT01995838|520567798|FG003|Overall Study|Lost to Follow-up|0|||
144371330|NCT01995838|520567799|FG004|Overall Study|Lost to Follow-up|0|||
144371331|NCT01995838|520567800|FG005|Overall Study|Lost to Follow-up|0|||
144371332|NCT01995838|520567801|FG006|Overall Study|Lost to Follow-up|1|||
144371333|NCT01995838|520567795|FG000|Overall Study|Participant choice|2|||
144371334|NCT01995838|520567796|FG001|Overall Study|Participant choice|0|||
144371335|NCT01995838|520567797|FG002|Overall Study|Participant choice|0|||
144371336|NCT01995838|520567798|FG003|Overall Study|Participant choice|0|||
144371337|NCT01995838|520567799|FG004|Overall Study|Participant choice|0|||
144371338|NCT01995838|520567800|FG005|Overall Study|Participant choice|1|||
144371339|NCT01995838|520567801|FG006|Overall Study|Participant choice|1|||
144371340|NCT01995838|520567795|FG000|Overall Study|Adverse Event|0|||
144371341|NCT01995838|520567796|FG001|Overall Study|Adverse Event|0|||
144371342|NCT01995838|520567797|FG002|Overall Study|Adverse Event|0|||
144371343|NCT01995838|520567798|FG003|Overall Study|Adverse Event|0|||
144371344|NCT01995838|520567799|FG004|Overall Study|Adverse Event|0|||
144371345|NCT01995838|520567800|FG005|Overall Study|Adverse Event|0|||
144371346|NCT01995838|520567801|FG006|Overall Study|Adverse Event|1|||
144371347|NCT01995838|520567795|FG000|Overall Study|Withdrawal by Subject|0|||
144371348|NCT01995838|520567796|FG001|Overall Study|Withdrawal by Subject|0|||
144371349|NCT01995838|520567797|FG002|Overall Study|Withdrawal by Subject|0|||
144371350|NCT01995838|520567798|FG003|Overall Study|Withdrawal by Subject|0|||
144371351|NCT01995838|520567799|FG004|Overall Study|Withdrawal by Subject|1|||
144371352|NCT01995838|520567800|FG005|Overall Study|Withdrawal by Subject|0|||
144371353|NCT01995838|520567801|FG006|Overall Study|Withdrawal by Subject|0|||
144371354|NCT01995838|520567795|FG000|Overall Study|Other|3|||
144371355|NCT01995838|520567796|FG001|Overall Study|Other|1|||
144371356|NCT01995838|520567797|FG002|Overall Study|Other|0|||
144371357|NCT01995838|520567798|FG003|Overall Study|Other|2|||
144371358|NCT01995838|520567799|FG004|Overall Study|Other|1|||
144371359|NCT01995838|520567800|FG005|Overall Study|Other|1|||
144371360|NCT01995838|520567801|FG006|Overall Study|Other|2|||
144371361|NCT00275509|520567806|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
144248527|NCT00994214|520107942|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
144248528|NCT00994214|520107939|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
144248529|NCT00994214|520107940|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
144248530|NCT00994214|520107941|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
144248531|NCT00994214|520107942|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
144248532|NCT03246061|520107943|FG000|Overall Study|Still in follow-up|15|||
144248533|NCT03246061|520107944|FG001|Overall Study|Still in follow-up|21|||
144248534|NCT04710368|520107945|FG000|Overall Study|Withdrawal by Subject|9|||
144248535|NCT04710368|520107945|FG000|Overall Study|Lost to Follow-up|4|||
144248536|NCT04710368|520107945|FG000|Overall Study|Death|2|||
144248537|NCT04710368|520107945|FG000|Overall Study|Patient preference|11|||
144248538|NCT04710368|520107945|FG000|Overall Study|Treatment discontinuation|1|||
144248539|NCT02667587|520107957|FG000|Pre-Treatment|Not reported|1|||
144248540|NCT02667587|520107958|FG001|Pre-Treatment|Not reported|0|||
144248541|NCT02667587|520107957|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
144248542|NCT02667587|520107958|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
144248543|NCT02667587|520107957|FG000|Pre-Treatment|Participant withdrew consent|0|||
144248544|NCT02667587|520107958|FG001|Pre-Treatment|Participant withdrew consent|1|||
144510728|NCT04524390|521070769|FG001|Open-Label|Disease Progression|0|||
144510729|NCT04524390|521070770|FG002|Open-Label|Disease Progression|1|||
144248545|NCT02667587|520107957|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
144248546|NCT02667587|520107958|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
144248547|NCT02667587|520107957|FG000|End of Treatment|Disease Progression|193|||
144248548|NCT02667587|520107958|FG001|End of Treatment|Disease Progression|226|||
144510730|NCT04524390|521070768|FG000|Open-Label|Adverse Event|0|||
144510731|NCT04524390|521070769|FG001|Open-Label|Adverse Event|0|||
144371362|NCT00275509|520567807|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
144371363|NCT02819804|520567808|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
144371364|NCT03196349|520567809|FG000|Overall Study|Did not receive study drug|0|||
144371365|NCT03196349|520567810|FG001|Overall Study|Did not receive study drug|1|||
144371366|NCT03196349|520567811|FG002|Overall Study|Did not receive study drug|2|||
144371367|NCT03196349|520567809|FG000|Overall Study|No data entered|2|||
144371368|NCT03196349|520567810|FG001|Overall Study|No data entered|4|||
144371369|NCT03196349|520567811|FG002|Overall Study|No data entered|0|||
144371370|NCT03196349|520567809|FG000|Overall Study|Study Terminated early|15|||
144371371|NCT03196349|520567810|FG001|Overall Study|Study Terminated early|9|||
144371372|NCT03196349|520567811|FG002|Overall Study|Study Terminated early|11|||
144371373|NCT03388164|520567816|FG000|Overall Study|Withdrawal by Subject|3|||
144371374|NCT03388164|520567817|FG001|Overall Study|Withdrawal by Subject|1|||
144371375|NCT00686686|520567819|FG000|Overall Study|Non-compliance|1|||
144371376|NCT00686686|520567819|FG000|Overall Study|Adverse Event|2|||
144371377|NCT00686686|520567819|FG000|Overall Study|Lost to Follow-up|3|||
144371378|NCT01012440|520567820|FG000|Overall Study|Withdrawal by Subject|2|||
144371379|NCT00131248|520567822|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
144371380|NCT00131248|520567823|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
144371381|NCT00477386|520567831|FG000|Overall Study|Adverse Event|4|||
144371382|NCT00477386|520567832|FG001|Overall Study|Adverse Event|8|||
144371383|NCT00477386|520567831|FG000|Overall Study|Disease progression, relapse|3|||
144371384|NCT00477386|520567832|FG001|Overall Study|Disease progression, relapse|4|||
144371385|NCT00477386|520567831|FG000|Overall Study|Disease progression, refractory|1|||
144371386|NCT00477386|520567832|FG001|Overall Study|Disease progression, refractory|3|||
144371387|NCT00477386|520567831|FG000|Overall Study|Other|1|||
144371388|NCT00477386|520567832|FG001|Overall Study|Other|2|||
144371389|NCT00477386|520567831|FG000|Overall Study|Physician Decision|1|||
144371390|NCT00477386|520567832|FG001|Overall Study|Physician Decision|0|||
144371391|NCT00477386|520567831|FG000|Overall Study|Withdrawal by Subject|1|||
144371392|NCT00477386|520567832|FG001|Overall Study|Withdrawal by Subject|0|||
144371393|NCT01254422|520567833|FG000|Overall Study|Protocol Violation|1|||
144371394|NCT01254422|520567834|FG001|Overall Study|Protocol Violation|0|||
144371395|NCT01254422|520567833|FG000|Overall Study|Adverse Event|1|||
144371396|NCT01254422|520567834|FG001|Overall Study|Adverse Event|0|||
144371397|NCT01254422|520567833|FG000|Overall Study|Serious adverse event|0|||
144371398|NCT01254422|520567834|FG001|Overall Study|Serious adverse event|1|||
144371399|NCT01254422|520567833|FG000|Overall Study|Lost to Follow-up|1|||
144371400|NCT01254422|520567834|FG001|Overall Study|Lost to Follow-up|0|||
144371401|NCT02207088|520567835|FG000|Overall Study|Adverse Event|2|||
144371402|NCT00643162|520567836|FG000|Overall Study|Withdrawal by Subject|1|||
144371403|NCT00643162|520567837|FG001|Overall Study|Withdrawal by Subject|1|||
144371404|NCT02691507|520567838|FG000|Overall Study|Missed Visit 3|0|||
144371405|NCT02691507|520567839|FG001|Overall Study|Missed Visit 3|1|||
144371406|NCT03023397|520567840|FG000|Run-In|Failed screening allergen challenge|1|||
144371407|NCT03023397|520567841|FG001|Run-In|Failed screening allergen challenge|0|||
144371408|NCT03023397|520567842|FG002|Run-In|Failed screening allergen challenge|0|||
144371409|NCT03023397|520567840|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
144371410|NCT03023397|520567841|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
144371411|NCT03023397|520567842|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
144371412|NCT01216189|520567844|FG000|Overall Study|Lost to Follow-up|21|||
144371413|NCT01216189|520567845|FG001|Overall Study|Lost to Follow-up|3|||
144371414|NCT01216189|520567844|FG000|Overall Study|Death|4|||
144371415|NCT01216189|520567845|FG001|Overall Study|Death|2|||
144371416|NCT00541385|520567846|FG000|Overall Study|Adverse Event|6|||
144371417|NCT00541385|520567847|FG001|Overall Study|Adverse Event|3|||
144371418|NCT00541385|520567846|FG000|Overall Study|Withdrawal by Subject|2|||
144371419|NCT00541385|520567847|FG001|Overall Study|Withdrawal by Subject|2|||
144371420|NCT00541385|520567846|FG000|Overall Study|Lost to Follow-up|6|||
144371421|NCT00541385|520567847|FG001|Overall Study|Lost to Follow-up|1|||
144371422|NCT00541385|520567846|FG000|Overall Study|Parasite reappearance/malaria|67|||
144371423|NCT00541385|520567847|FG001|Overall Study|Parasite reappearance/malaria|32|||
144721704|NCT01180244|521835270|FG001|Overall Study|Adverse Event|0|||
144371424|NCT01733680|520567848|FG000|Overall Study|Withdrawal by Subject|0|||
144371425|NCT01733680|520567849|FG001|Overall Study|Withdrawal by Subject|1|||
144371426|NCT02699749|520567851|FG000|Overall Study|Other|0|||
144371427|NCT02699749|520567852|FG001|Overall Study|Other|0|||
144371428|NCT02699749|520567853|FG002|Overall Study|Other|2|||
144371429|NCT02699749|520567854|FG003|Overall Study|Other|0|||
144371430|NCT02699749|520567855|FG004|Overall Study|Other|0|||
144510732|NCT04524390|521070770|FG002|Open-Label|Adverse Event|3|||
144510733|NCT04524390|521070768|FG000|Open-Label|Study Termination by sponsor|0|||
144510734|NCT04524390|521070769|FG001|Open-Label|Study Termination by sponsor|0|||
144510735|NCT04524390|521070770|FG002|Open-Label|Study Termination by sponsor|45|||
144510736|NCT03088813|521070773|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
144510737|NCT03088813|521070774|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
144510738|NCT03088813|521070775|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
144721705|NCT01180244|521835269|FG000|Overall Study|Withdrawal by Subject|0|||
144371431|NCT02699749|520567856|FG005|Overall Study|Other|1|||
144371432|NCT02699749|520567857|FG006|Overall Study|Other|1|||
144371433|NCT02699749|520567858|FG007|Overall Study|Other|0|||
144371434|NCT02699749|520567859|FG008|Overall Study|Other|0|||
144371435|NCT02699749|520567860|FG009|Overall Study|Other|0|||
144371436|NCT02699749|520567861|FG010|Overall Study|Other|1|||
144371437|NCT02699749|520567862|FG011|Overall Study|Other|0|||
144371438|NCT02699749|520567863|FG012|Overall Study|Other|0|||
144371439|NCT02699749|520567864|FG013|Overall Study|Other|0|||
144371440|NCT02699749|520567851|FG000|Overall Study|Progressive Disease|3|||
144371441|NCT02699749|520567852|FG001|Overall Study|Progressive Disease|3|||
144371442|NCT02699749|520567853|FG002|Overall Study|Progressive Disease|14|||
144371443|NCT02699749|520567854|FG003|Overall Study|Progressive Disease|3|||
144371444|NCT02699749|520567855|FG004|Overall Study|Progressive Disease|3|||
144371445|NCT02699749|520567856|FG005|Overall Study|Progressive Disease|7|||
144371446|NCT02699749|520567857|FG006|Overall Study|Progressive Disease|5|||
144371447|NCT02699749|520567858|FG007|Overall Study|Progressive Disease|5|||
144371448|NCT02699749|520567859|FG008|Overall Study|Progressive Disease|6|||
144371449|NCT02699749|520567860|FG009|Overall Study|Progressive Disease|6|||
144371450|NCT02699749|520567861|FG010|Overall Study|Progressive Disease|5|||
144371451|NCT02699749|520567862|FG011|Overall Study|Progressive Disease|4|||
144371452|NCT02699749|520567863|FG012|Overall Study|Progressive Disease|3|||
144371453|NCT02699749|520567864|FG013|Overall Study|Progressive Disease|5|||
144371454|NCT02699749|520567851|FG000|Overall Study|Death|0|||
144371455|NCT02699749|520567852|FG001|Overall Study|Death|0|||
144371456|NCT02699749|520567853|FG002|Overall Study|Death|0|||
144371457|NCT02699749|520567854|FG003|Overall Study|Death|0|||
144371458|NCT02699749|520567855|FG004|Overall Study|Death|0|||
144371459|NCT02699749|520567856|FG005|Overall Study|Death|0|||
144371460|NCT02699749|520567857|FG006|Overall Study|Death|0|||
144371461|NCT02699749|520567858|FG007|Overall Study|Death|0|||
144371462|NCT02699749|520567859|FG008|Overall Study|Death|0|||
144371463|NCT02699749|520567860|FG009|Overall Study|Death|0|||
144371464|NCT02699749|520567861|FG010|Overall Study|Death|0|||
144371465|NCT02699749|520567862|FG011|Overall Study|Death|0|||
144248549|NCT02667587|520107957|FG000|End of Treatment|Study Drug Toxicity|75|||
144248550|NCT02667587|520107958|FG001|End of Treatment|Study Drug Toxicity|19|||
144248551|NCT02667587|520107957|FG000|End of Treatment|Death|2|||
144248552|NCT02667587|520107958|FG001|End of Treatment|Death|1|||
144248553|NCT02667587|520107957|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
144248554|NCT02667587|520107958|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
144371466|NCT02699749|520567863|FG012|Overall Study|Death|0|||
144371467|NCT02699749|520567864|FG013|Overall Study|Death|1|||
144371468|NCT02699749|520567851|FG000|Overall Study|Lost to Follow-up|0|||
144371469|NCT02699749|520567852|FG001|Overall Study|Lost to Follow-up|0|||
144371470|NCT02699749|520567853|FG002|Overall Study|Lost to Follow-up|0|||
144371471|NCT02699749|520567854|FG003|Overall Study|Lost to Follow-up|0|||
144248555|NCT02667587|520107957|FG000|End of Treatment|participant request to discontinue treatment|33|||
144371472|NCT02699749|520567855|FG004|Overall Study|Lost to Follow-up|0|||
144371473|NCT02699749|520567856|FG005|Overall Study|Lost to Follow-up|1|||
144371474|NCT02699749|520567857|FG006|Overall Study|Lost to Follow-up|0|||
144371475|NCT02699749|520567858|FG007|Overall Study|Lost to Follow-up|1|||
144590551|NCT02483585|521361869|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
144590552|NCT01236339|521361870|FG000|Overall Study|Termination of study by sponsor|11|||
144590553|NCT01236339|521361871|FG001|Overall Study|Termination of study by sponsor|13|||
144590554|NCT00394082|521361872|FG000|Overall Study|Unacceptable toxicity|15|||
144371476|NCT02699749|520567859|FG008|Overall Study|Lost to Follow-up|0|||
144371477|NCT02699749|520567860|FG009|Overall Study|Lost to Follow-up|0|||
144590555|NCT00394082|521361872|FG000|Overall Study|Adverse Event|4|||
144590556|NCT00394082|521361872|FG000|Overall Study|Physician Decision|4|||
144590557|NCT00394082|521361872|FG000|Overall Study|Withdrawal by Subject|2|||
144590558|NCT00394082|521361872|FG000|Overall Study|Other|1|||
144590559|NCT01945060|521361873|FG000|Overall Study|Lost to follow up|1|||
144590560|NCT01945060|521361874|FG001|Overall Study|Lost to follow up|0|||
144590561|NCT01945060|521361873|FG000|Overall Study|Distress related to IV access|0|||
144590562|NCT01945060|521361874|FG001|Overall Study|Distress related to IV access|1|||
144590563|NCT01210664|521361877|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
144590564|NCT01210664|521361878|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
144590565|NCT01210664|521361879|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
144590566|NCT01210664|521361880|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
144590567|NCT01210664|521361877|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
144590568|NCT01210664|521361878|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
144590569|NCT01210664|521361879|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
144590570|NCT01210664|521361880|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
144590571|NCT01210664|521361877|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
144721706|NCT01180244|521835270|FG001|Overall Study|Withdrawal by Subject|1|||
144371478|NCT02699749|520567861|FG010|Overall Study|Lost to Follow-up|0|||
144371479|NCT02699749|520567862|FG011|Overall Study|Lost to Follow-up|0|||
144371480|NCT02699749|520567863|FG012|Overall Study|Lost to Follow-up|0|||
144371481|NCT02699749|520567864|FG013|Overall Study|Lost to Follow-up|0|||
144371482|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
144371483|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
144371484|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
144371485|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
144371486|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
144371487|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
144371488|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
144371489|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
144371490|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
144371491|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
144371492|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
144371493|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
144371494|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
144371495|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
144371496|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
144371497|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
144371498|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
144371499|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
144371500|NCT02952820|520567865|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
144371501|NCT02952820|520567866|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
144371502|NCT02952820|520567867|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
144371503|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
144371504|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
144371505|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
144371506|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
144371507|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
144371508|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
144371509|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
144371510|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
144371511|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
144371512|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
144371513|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
144371514|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
144371515|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
144371516|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
144371517|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
144371518|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
144371519|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
144371520|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
144371521|NCT02952820|520567865|FG000|Active Treatment Period (6 Months)|Not treated|0|||
144371522|NCT02952820|520567866|FG001|Active Treatment Period (6 Months)|Not treated|0|||
144371523|NCT02952820|520567867|FG002|Active Treatment Period (6 Months)|Not treated|1|||
144371524|NCT02565108|520567868|FG000|Overall Study|Adverse Event|1|||
144371525|NCT02565108|520567869|FG001|Overall Study|Adverse Event|0|||
144371526|NCT02565108|520567868|FG000|Overall Study|Withdrew Consent|1|||
144371527|NCT02565108|520567869|FG001|Overall Study|Withdrew Consent|0|||
144371528|NCT01310075|520567870|FG000|Overall Study|Lost to Follow-up|1|||
144371529|NCT01310075|520567871|FG001|Overall Study|Lost to Follow-up|0|||
144371530|NCT01310075|520567870|FG000|Overall Study|Physician Decision|10|||
144371531|NCT01310075|520567871|FG001|Overall Study|Physician Decision|7|||
144371532|NCT01310075|520567870|FG000|Overall Study|Protocol Violation|2|||
144371533|NCT01310075|520567871|FG001|Overall Study|Protocol Violation|2|||
144371534|NCT01310075|520567870|FG000|Overall Study|Withdrawal by Subject|1|||
144371535|NCT01310075|520567871|FG001|Overall Study|Withdrawal by Subject|1|||
144371536|NCT01587924|520567872|FG000|Overall Study|Adverse Event|0|||
144371537|NCT01587924|520567873|FG001|Overall Study|Adverse Event|2|||
144590572|NCT01210664|521361878|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
144590573|NCT01210664|521361879|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
144371538|NCT01587924|520567874|FG002|Overall Study|Adverse Event|0|||
144590574|NCT01210664|521361880|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
144371539|NCT01587924|520567875|FG003|Overall Study|Adverse Event|0|||
144371540|NCT01587924|520567872|FG000|Overall Study|Protocol Violation|2|||
144371541|NCT01587924|520567873|FG001|Overall Study|Protocol Violation|1|||
144371542|NCT01587924|520567874|FG002|Overall Study|Protocol Violation|2|||
144371543|NCT01587924|520567875|FG003|Overall Study|Protocol Violation|1|||
144371544|NCT01587924|520567872|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
144371545|NCT01587924|520567873|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
144371546|NCT01587924|520567874|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
144371547|NCT01587924|520567875|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
144371548|NCT01587924|520567872|FG000|Overall Study|Withdrawal by Subject|0|||
144371549|NCT01587924|520567873|FG001|Overall Study|Withdrawal by Subject|1|||
144371550|NCT01587924|520567874|FG002|Overall Study|Withdrawal by Subject|1|||
144371551|NCT01587924|520567875|FG003|Overall Study|Withdrawal by Subject|0|||
144371552|NCT01696188|520567876|FG000|Overall Study|Protocol Violation|1|||
144371553|NCT01696188|520567877|FG001|Overall Study|Protocol Violation|1|||
144371554|NCT00960999|520567878|FG000|Overall Study|Withdrawal by Subject|1|||
144371555|NCT00960999|520567879|FG001|Overall Study|Withdrawal by Subject|0|||
144371556|NCT00960999|520567878|FG000|Overall Study|Protocol Violation|5|||
144371557|NCT00960999|520567879|FG001|Overall Study|Protocol Violation|2|||
144371558|NCT00960999|520567878|FG000|Overall Study|RT dose constraints not met|2|||
144371559|NCT00960999|520567879|FG001|Overall Study|RT dose constraints not met|0|||
144371560|NCT02425943|520567880|FG000|Overall Study|Adverse Event|3|||
144371561|NCT02425943|520567881|FG001|Overall Study|Adverse Event|1|||
144371562|NCT02425943|520567880|FG000|Overall Study|Lost to Follow-up|59|||
144371563|NCT02425943|520567881|FG001|Overall Study|Lost to Follow-up|37|||
144371564|NCT02425943|520567880|FG000|Overall Study|Protocol Violation|4|||
144371565|NCT02425943|520567881|FG001|Overall Study|Protocol Violation|1|||
144371566|NCT02425943|520567880|FG000|Overall Study|Withdrawal by Subject|64|||
144371567|NCT02425943|520567881|FG001|Overall Study|Withdrawal by Subject|31|||
144371568|NCT02425943|520567880|FG000|Overall Study|Other|6|||
144371569|NCT02425943|520567881|FG001|Overall Study|Other|0|||
144371570|NCT01106248|520567884|FG000|Overall Study|Adverse Event|1|||
144371571|NCT01106248|520567884|FG000|Overall Study|Administrative|2|||
144371572|NCT00357903|520567885|FG000|Overall Study|Adverse Event|87|||
144371573|NCT00357903|520567886|FG001|Overall Study|Adverse Event|4|||
144371574|NCT00357903|520567885|FG000|Overall Study|Death|33|||
144371575|NCT00357903|520567886|FG001|Overall Study|Death|0|||
144371576|NCT00357903|520567885|FG000|Overall Study|Lost to Follow-up|23|||
144371577|NCT00357903|520567886|FG001|Overall Study|Lost to Follow-up|4|||
144371578|NCT00357903|520567885|FG000|Overall Study|Physician Decision|39|||
144371579|NCT00357903|520567886|FG001|Overall Study|Physician Decision|5|||
144371580|NCT00357903|520567885|FG000|Overall Study|Withdrawal by Subject|57|||
144371581|NCT00357903|520567886|FG001|Overall Study|Withdrawal by Subject|7|||
144371582|NCT00357903|520567885|FG000|Overall Study|Completed month 12 only|0|||
144371583|NCT00357903|520567886|FG001|Overall Study|Completed month 12 only|1|||
144371584|NCT00357903|520567885|FG000|Overall Study|Protocol issues|14|||
144371585|NCT00357903|520567886|FG001|Overall Study|Protocol issues|3|||
144371586|NCT00357903|520567885|FG000|Overall Study|Response status|61|||
144371587|NCT00357903|520567886|FG001|Overall Study|Response status|9|||
144371588|NCT00357903|520567885|FG000|Overall Study|Other|49|||
144371589|NCT00357903|520567886|FG001|Overall Study|Other|10|||
144371590|NCT01967238|520567887|FG000|Overall Study|Adverse Event|1|||
144371591|NCT01967238|520567888|FG001|Overall Study|Adverse Event|1|||
144371592|NCT01967238|520567889|FG002|Overall Study|Adverse Event|0|||
144371593|NCT01967238|520567887|FG000|Overall Study|Lost to Follow-up|1|||
144371594|NCT01967238|520567888|FG001|Overall Study|Lost to Follow-up|0|||
144371595|NCT01967238|520567889|FG002|Overall Study|Lost to Follow-up|1|||
144371596|NCT01967238|520567887|FG000|Overall Study|Withdrawal by Subject|0|||
144371597|NCT01967238|520567888|FG001|Overall Study|Withdrawal by Subject|0|||
144371598|NCT01967238|520567889|FG002|Overall Study|Withdrawal by Subject|1|||
144371599|NCT02807402|520567894|FG000|Overall Study|Failure to Return|1|||
144590575|NCT01853644|521361881|FG000|Registration and Treatment Start|Did not start treatment|1|||
144590576|NCT01853644|521361881|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
144590577|NCT01853644|521361881|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
144590578|NCT01853644|521361881|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
144371600|NCT02807402|520567894|FG000|Overall Study|Death|3|||
144371601|NCT02807402|520567894|FG000|Overall Study|Other|2|||
144371602|NCT01104311|520567895|FG000|Overall Study|Withdrawal by Subject|6|||
144371603|NCT01104311|520567896|FG001|Overall Study|Withdrawal by Subject|6|||
144371604|NCT01104311|520567895|FG000|Overall Study|Protocol Violation|0|||
144371605|NCT01104311|520567896|FG001|Overall Study|Protocol Violation|1|||
144371606|NCT01104311|520567895|FG000|Overall Study|Physician Decision|2|||
144371607|NCT01104311|520567896|FG001|Overall Study|Physician Decision|2|||
144371608|NCT01104311|520567895|FG000|Overall Study|low compliance|1|||
144371609|NCT01104311|520567896|FG001|Overall Study|low compliance|1|||
144371610|NCT01104311|520567895|FG000|Overall Study|Adverse Event|1|||
144371611|NCT01104311|520567896|FG001|Overall Study|Adverse Event|2|||
144371612|NCT01442103|520569210|FG000|Overall Study|Lost to Follow-up|2|||
144721707|NCT01180244|521835269|FG000|Overall Study|Protocol Violation|1|||
144371613|NCT03894813|520569219|FG000|Overall Study|Adverse Event|1|||
144371614|NCT03894813|520569220|FG001|Overall Study|Adverse Event|1|||
144371615|NCT03894813|520569219|FG000|Overall Study|Lack of Efficacy|3|||
144371616|NCT03894813|520569220|FG001|Overall Study|Lack of Efficacy|3|||
144371617|NCT03894813|520569219|FG000|Overall Study|Lost to Follow-up|1|||
144371618|NCT03894813|520569220|FG001|Overall Study|Lost to Follow-up|0|||
144371619|NCT03894813|520569219|FG000|Overall Study|Pregnancy|2|||
144371620|NCT03894813|520569220|FG001|Overall Study|Pregnancy|1|||
144371621|NCT03894813|520569219|FG000|Overall Study|Protocol Violation|3|||
144371622|NCT03894813|520569220|FG001|Overall Study|Protocol Violation|7|||
144371623|NCT03894813|520569219|FG000|Overall Study|Withdrawal by Subject|1|||
144371624|NCT03894813|520569220|FG001|Overall Study|Withdrawal by Subject|3|||
144371625|NCT03894813|520569219|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
144371626|NCT03894813|520569220|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
144371627|NCT02139592|520569234|FG000|Overall Study|Case Report Forms Uncollected|8|||
144371628|NCT05661409|520569239|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
144371629|NCT05661409|520569240|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
144371630|NCT05661409|520569241|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
144371631|NCT05661409|520569242|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
144371632|NCT05661409|520569243|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
144371633|NCT05661409|520569244|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
144371634|NCT05661409|520569239|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
144371635|NCT05661409|520569240|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
144371636|NCT05661409|520569241|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
144371637|NCT05661409|520569242|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
144371638|NCT05661409|520569243|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
144371639|NCT05661409|520569244|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
144371640|NCT05661409|520569239|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
144371641|NCT05661409|520569240|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
144371642|NCT05661409|520569241|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
144371643|NCT05661409|520569242|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
144371644|NCT05661409|520569243|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
144371645|NCT05661409|520569244|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
144371646|NCT05661409|520569239|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
144371647|NCT05661409|520569240|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
144371648|NCT05661409|520569241|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
144371649|NCT05661409|520569242|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
144371650|NCT05661409|520569243|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
144371651|NCT05661409|520569244|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
144371652|NCT05661409|520569239|FG000|Overall Study|Miscommu-nication about administration|0|||
144371653|NCT05661409|520569240|FG001|Overall Study|Miscommu-nication about administration|0|||
144371654|NCT05661409|520569241|FG002|Overall Study|Miscommu-nication about administration|0|||
144371655|NCT05661409|520569242|FG003|Overall Study|Miscommu-nication about administration|0|||
144371656|NCT05661409|520569243|FG004|Overall Study|Miscommu-nication about administration|0|||
144371657|NCT05661409|520569244|FG005|Overall Study|Miscommu-nication about administration|1|||
144371658|NCT00831181|520569252|FG000|Overall Study|Adverse Event|12|||
144371659|NCT02863419|520569253|FG000|Overall Study|Lost to Follow-up|0|||
144371660|NCT02863419|520569254|FG001|Overall Study|Lost to Follow-up|1|||
144371661|NCT02863419|520569255|FG002|Overall Study|Lost to Follow-up|4|||
144371662|NCT02863419|520569253|FG000|Overall Study|Withdrawal by Subject|5|||
144371663|NCT02863419|520569254|FG001|Overall Study|Withdrawal by Subject|5|||
144371664|NCT02863419|520569255|FG002|Overall Study|Withdrawal by Subject|3|||
144371665|NCT02863419|520569253|FG000|Overall Study|Died|3|||
144371666|NCT02863419|520569254|FG001|Overall Study|Died|4|||
144371667|NCT02863419|520569255|FG002|Overall Study|Died|1|||
144371668|NCT02362282|520569256|FG000|Overall Study|Withdrawal by Subject|1|||
144371669|NCT02362282|520569257|FG001|Overall Study|Withdrawal by Subject|0|||
144371670|NCT02454517|520569264|FG000|Overall Study|Withdrawal by Subject|3|||
144371671|NCT02454517|520569265|FG001|Overall Study|Withdrawal by Subject|0|||
144371672|NCT02454517|520569264|FG000|Overall Study|Lost to Follow-up|4|||
144371673|NCT02454517|520569265|FG001|Overall Study|Lost to Follow-up|7|||
144371674|NCT02454517|520569264|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
144371675|NCT02454517|520569265|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
144371676|NCT02284243|520569266|FG000|Overall Study|Lack of Efficacy|3|||
144371677|NCT02284243|520569267|FG001|Overall Study|Lack of Efficacy|3|||
144371678|NCT02284243|520569266|FG000|Overall Study|Adverse Event|1|||
144371679|NCT02284243|520569267|FG001|Overall Study|Adverse Event|0|||
144371680|NCT01932437|520569268|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
144371681|NCT01932437|520569269|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
144371682|NCT01932437|520569270|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
144371683|NCT01932437|520569271|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
144371684|NCT01932437|520569272|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
144371685|NCT01932437|520569273|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
144371686|NCT00074490|520569274|FG000|Overall Study|Progressive malignancy|0|||
144371687|NCT00074490|520569275|FG001|Overall Study|Progressive malignancy|7|||
144371688|NCT00074490|520569276|FG002|Overall Study|Progressive malignancy|0|||
144371689|NCT00074490|520569277|FG003|Overall Study|Progressive malignancy|0|||
144371690|NCT00074490|520569278|FG004|Overall Study|Progressive malignancy|3|||
144371691|NCT00074490|520569279|FG005|Overall Study|Progressive malignancy|0|||
144371692|NCT04139798|520569282|FG000|Overall Study|Withdrawal by Subject|6|||
144371693|NCT04139798|520569283|FG001|Overall Study|Withdrawal by Subject|5|||
144371694|NCT04139798|520569282|FG000|Overall Study|Lost to Follow-up|2|||
144371695|NCT04139798|520569283|FG001|Overall Study|Lost to Follow-up|5|||
144371696|NCT04139798|520569282|FG000|Overall Study|Discontinued|4|||
144371697|NCT04139798|520569283|FG001|Overall Study|Discontinued|2|||
144371698|NCT04139798|520569282|FG000|Overall Study|Adverse Event|1|||
144371699|NCT04139798|520569283|FG001|Overall Study|Adverse Event|3|||
144371700|NCT04139798|520569282|FG000|Overall Study|Protocol Violation|1|||
144371701|NCT04139798|520569283|FG001|Overall Study|Protocol Violation|0|||
144371702|NCT04411667|520569284|FG000|Overall Study|Physician Decision|1|||
144371703|NCT04411667|520569285|FG001|Overall Study|Physician Decision|0|||
144371704|NCT04287517|520569288|FG000|Overall Study|Withdrawal by Subject|1|||
144371705|NCT04287517|520569289|FG001|Overall Study|Withdrawal by Subject|1|||
144371706|NCT02721966|520569290|FG000|Overall Study|Protocol Violation|1|||
144371707|NCT02721966|520569291|FG001|Overall Study|Protocol Violation|0|||
144371708|NCT02721966|520569292|FG002|Overall Study|Protocol Violation|0|||
144371709|NCT02721966|520569293|FG003|Overall Study|Protocol Violation|0|||
144371710|NCT02721966|520569294|FG004|Overall Study|Protocol Violation|0|||
144371711|NCT02721966|520569290|FG000|Overall Study|Withdrawal by Subject|9|||
144371712|NCT02721966|520569291|FG001|Overall Study|Withdrawal by Subject|2|||
144371713|NCT02721966|520569292|FG002|Overall Study|Withdrawal by Subject|3|||
144371714|NCT02721966|520569293|FG003|Overall Study|Withdrawal by Subject|7|||
144371715|NCT02721966|520569294|FG004|Overall Study|Withdrawal by Subject|0|||
144371716|NCT02721966|520569290|FG000|Overall Study|Adverse Event|4|||
144371717|NCT02721966|520569291|FG001|Overall Study|Adverse Event|4|||
144371718|NCT02721966|520569292|FG002|Overall Study|Adverse Event|3|||
144371719|NCT02721966|520569293|FG003|Overall Study|Adverse Event|0|||
144371720|NCT02721966|520569294|FG004|Overall Study|Adverse Event|0|||
144371721|NCT02721966|520569290|FG000|Overall Study|Death|1|||
144371722|NCT02721966|520569291|FG001|Overall Study|Death|0|||
144371723|NCT02721966|520569292|FG002|Overall Study|Death|0|||
144371724|NCT02721966|520569293|FG003|Overall Study|Death|0|||
144371725|NCT02721966|520569294|FG004|Overall Study|Death|0|||
144371726|NCT02721966|520569290|FG000|Overall Study|Lack of Efficacy|7|||
144371727|NCT02721966|520569291|FG001|Overall Study|Lack of Efficacy|4|||
144371728|NCT02721966|520569292|FG002|Overall Study|Lack of Efficacy|0|||
144371729|NCT02721966|520569293|FG003|Overall Study|Lack of Efficacy|0|||
144371730|NCT02721966|520569294|FG004|Overall Study|Lack of Efficacy|0|||
144371731|NCT02721966|520569290|FG000|Overall Study|Lost to Follow-up|0|||
144371732|NCT02721966|520569291|FG001|Overall Study|Lost to Follow-up|0|||
144371733|NCT02721966|520569292|FG002|Overall Study|Lost to Follow-up|3|||
144371734|NCT02721966|520569293|FG003|Overall Study|Lost to Follow-up|0|||
144371735|NCT02721966|520569294|FG004|Overall Study|Lost to Follow-up|0|||
144371736|NCT02721966|520569290|FG000|Overall Study|Physician Decision|1|||
144371737|NCT02721966|520569291|FG001|Overall Study|Physician Decision|1|||
144371738|NCT02721966|520569292|FG002|Overall Study|Physician Decision|0|||
144371739|NCT02721966|520569293|FG003|Overall Study|Physician Decision|0|||
144371740|NCT02721966|520569294|FG004|Overall Study|Physician Decision|0|||
144371741|NCT02721966|520569290|FG000|Overall Study|Pregnancy|1|||
144721708|NCT01180244|521835270|FG001|Overall Study|Protocol Violation|0|||
144371742|NCT02721966|520569291|FG001|Overall Study|Pregnancy|0|||
144371743|NCT02721966|520569292|FG002|Overall Study|Pregnancy|0|||
144371744|NCT02721966|520569293|FG003|Overall Study|Pregnancy|0|||
144371745|NCT02721966|520569294|FG004|Overall Study|Pregnancy|0|||
144371746|NCT02721966|520569290|FG000|Overall Study|Did not continue to period 2|5|||
144371747|NCT02721966|520569291|FG001|Overall Study|Did not continue to period 2|12|||
144371748|NCT02721966|520569292|FG002|Overall Study|Did not continue to period 2|0|||
144371749|NCT02721966|520569293|FG003|Overall Study|Did not continue to period 2|0|||
144371750|NCT02721966|520569294|FG004|Overall Study|Did not continue to period 2|5|||
144371751|NCT03857867|520569295|FG000|Overall Study|Physician Decision|1|||
144371752|NCT01869764|520569296|FG000|Overall Study|Withdrawal by Subject|0|||
144371753|NCT01869764|520569297|FG001|Overall Study|Withdrawal by Subject|2|||
144371754|NCT01286480|520569298|FG000|Overall Study|Withdrawal by Subject|5|||
144371755|NCT01286480|520569299|FG001|Overall Study|Withdrawal by Subject|3|||
144371756|NCT00834093|520569300|FG000|Overall Study|Progressive Disease|3|||
144371757|NCT00834093|520569300|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
144371758|NCT01578486|520569301|FG000|Overall Study|Physician Decision|3|||
144371759|NCT01578486|520569301|FG000|Overall Study|Withdrawal by Subject|2|||
144371760|NCT00607373|520569302|FG000|Treatment Period|Adverse Event|0|||
144371761|NCT00607373|520569303|FG001|Treatment Period|Adverse Event|4|||
144371762|NCT00607373|520569302|FG000|Treatment Period|Physician Decision|0|||
144371763|NCT00607373|520569303|FG001|Treatment Period|Physician Decision|1|||
144371764|NCT00607373|520569302|FG000|Treatment Period|Withdrawal by Subject|0|||
144371765|NCT00607373|520569303|FG001|Treatment Period|Withdrawal by Subject|1|||
144371766|NCT00607373|520569302|FG000|Follow-up Period|Other|0|||
144371767|NCT00607373|520569303|FG001|Follow-up Period|Other|1|||
144371768|NCT00607373|520569302|FG000|Follow-up Period|Protocol Violation|0|||
144371769|NCT00607373|520569303|FG001|Follow-up Period|Protocol Violation|1|||
144371770|NCT00607373|520569302|FG000|Follow-up Period|Withdrawal by Subject|1|||
144371771|NCT00607373|520569303|FG001|Follow-up Period|Withdrawal by Subject|3|||
144371772|NCT02170077|520569304|FG000|Overall Study|Withdrawal by Subject|3|||
144371773|NCT02170077|520569305|FG001|Overall Study|Withdrawal by Subject|4|||
144371774|NCT02170077|520569306|FG002|Overall Study|Withdrawal by Subject|2|||
144371775|NCT02170077|520569304|FG000|Overall Study|Adverse Event|4|||
144371776|NCT02170077|520569305|FG001|Overall Study|Adverse Event|4|||
144371777|NCT02170077|520569306|FG002|Overall Study|Adverse Event|4|||
144371778|NCT02170077|520569304|FG000|Overall Study|Lost to Follow-up|0|||
144371779|NCT02170077|520569305|FG001|Overall Study|Lost to Follow-up|1|||
144371780|NCT02170077|520569306|FG002|Overall Study|Lost to Follow-up|0|||
144371781|NCT02170077|520569304|FG000|Overall Study|Exclusion criteria|2|||
144371782|NCT02170077|520569305|FG001|Overall Study|Exclusion criteria|2|||
144371783|NCT02170077|520569306|FG002|Overall Study|Exclusion criteria|5|||
144371784|NCT02170077|520569304|FG000|Overall Study|Exacerbation of seizures|0|||
144371785|NCT02170077|520569305|FG001|Overall Study|Exacerbation of seizures|2|||
144371786|NCT02170077|520569306|FG002|Overall Study|Exacerbation of seizures|1|||
144371787|NCT01958164|520569307|FG000|Overall Study|Adverse Event|0|||
144371788|NCT01958164|520569308|FG001|Overall Study|Adverse Event|2|||
144371789|NCT01958164|520569307|FG000|Overall Study|Lost to Follow-up|2|||
144371790|NCT01958164|520569308|FG001|Overall Study|Lost to Follow-up|3|||
144371791|NCT01780974|520569311|FG000|Overall Study|Death|1|||
144371792|NCT01780974|520569312|FG001|Overall Study|Death|0|||
144371793|NCT01780974|520569311|FG000|Overall Study|Adverse Event|1|||
144371794|NCT01780974|520569312|FG001|Overall Study|Adverse Event|3|||
144371795|NCT01724346|520569313|FG000|Overall Study|Death|42|||
144371796|NCT01724346|520569314|FG001|Overall Study|Death|42|||
144371797|NCT01724346|520569313|FG000|Overall Study|Lost to Follow-up|5|||
144371798|NCT01724346|520569314|FG001|Overall Study|Lost to Follow-up|1|||
144371799|NCT01724346|520569313|FG000|Overall Study|Withdrawal by Subject|27|||
144371800|NCT01724346|520569314|FG001|Overall Study|Withdrawal by Subject|19|||
144371801|NCT01724346|520569313|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
144371802|NCT01724346|520569314|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
144371803|NCT00525161|520569317|FG000|Overall Study|Adverse Event|1|||
144371804|NCT01076361|520569318|FG000|Overall Study|22 leads were excluded from analysis|21|||
144371805|NCT00750438|520569321|FG000|Overall Study|Protocol Violation|4|||
144371806|NCT00750438|520569322|FG001|Overall Study|Protocol Violation|1|||
144371807|NCT00750438|520569321|FG000|Overall Study|Physician Decision|2|||
144371808|NCT00750438|520569322|FG001|Overall Study|Physician Decision|2|||
144721709|NCT01180244|521835269|FG000|Overall Study|Lost to Follow-up|1|||
144371809|NCT00750438|520569321|FG000|Overall Study|Withdrawal by Subject|1|||
144371810|NCT00750438|520569322|FG001|Overall Study|Withdrawal by Subject|1|||
144371811|NCT03848728|520569323|FG000|Overall Study|Death|16|||
144371812|NCT03848728|520569324|FG001|Overall Study|Death|13|||
144371813|NCT03848728|520569323|FG000|Overall Study|Outmigrated to non-study community|98|||
144371814|NCT03848728|520569324|FG001|Overall Study|Outmigrated to non-study community|106|||
144371815|NCT03848728|520569323|FG000|Overall Study|Transfered to non-study clinic|32|||
144371816|NCT03848728|520569324|FG001|Overall Study|Transfered to non-study clinic|48|||
144371817|NCT03848728|520569323|FG000|Overall Study|Withdrawal by Subject|1|||
144371818|NCT03848728|520569324|FG001|Overall Study|Withdrawal by Subject|0|||
144371819|NCT00536744|520569327|FG000|Overall Study|Adverse Event|13|||
144371820|NCT00536744|520569328|FG001|Overall Study|Adverse Event|10|||
144371821|NCT00536744|520569327|FG000|Overall Study|Death|2|||
144371822|NCT00536744|520569328|FG001|Overall Study|Death|1|||
144371823|NCT00536744|520569327|FG000|Overall Study|Physician Decision|3|||
144371824|NCT00536744|520569328|FG001|Overall Study|Physician Decision|1|||
144371825|NCT00536744|520569327|FG000|Overall Study|Lost to Follow-up|3|||
144371826|NCT00536744|520569328|FG001|Overall Study|Lost to Follow-up|5|||
144371827|NCT00536744|520569327|FG000|Overall Study|Withdrawal by Subject|7|||
144371828|NCT00536744|520569328|FG001|Overall Study|Withdrawal by Subject|8|||
144371829|NCT00536744|520569327|FG000|Overall Study|PI tried alternative treatment|1|||
144371830|NCT00536744|520569328|FG001|Overall Study|PI tried alternative treatment|3|||
144371831|NCT01642589|520569332|FG000|Overall Study|Withdrawal by Subject|1|||
144371832|NCT01642589|520569333|FG001|Overall Study|Withdrawal by Subject|1|||
144371833|NCT01108185|520569338|FG000|Overall Study|Non-compliance|15|||
144371834|NCT01108185|520569338|FG000|Overall Study|Lost to Follow-up|12|||
144371835|NCT02581410|520569339|FG000|Vaccination Phase|Adverse Event|2|||
144371836|NCT02581410|520569340|FG001|Vaccination Phase|Adverse Event|1|||
144371837|NCT02581410|520569339|FG000|Vaccination Phase|Withdrawal by Subject|0|||
144371838|NCT02581410|520569340|FG001|Vaccination Phase|Withdrawal by Subject|1|||
144371839|NCT02581410|520569339|FG000|Vaccination Phase|Migrated/moved from study area|0|||
144371840|NCT02581410|520569340|FG001|Vaccination Phase|Migrated/moved from study area|1|||
144371841|NCT02581410|520569339|FG000|End of Study Phase|Adverse Event|4|||
144371842|NCT02581410|520569340|FG001|End of Study Phase|Adverse Event|3|||
144371843|NCT02581410|520569339|FG000|End of Study Phase|Withdrawal by Subject|1|||
144371844|NCT02581410|520569340|FG001|End of Study Phase|Withdrawal by Subject|2|||
144371845|NCT02581410|520569339|FG000|End of Study Phase|Migrated/moved from study area|0|||
144371846|NCT02581410|520569340|FG001|End of Study Phase|Migrated/moved from study area|3|||
144371847|NCT02581410|520569339|FG000|End of Study Phase|Lost to Follow-up|0|||
144371848|NCT02581410|520569340|FG001|End of Study Phase|Lost to Follow-up|2|||
144371849|NCT02581410|520569339|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
144371850|NCT02581410|520569340|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
144371851|NCT02908672|520569343|FG000|Run-in Period|Death|12|||
144371852|NCT02908672|520569344|FG001|Run-in Period|Death|10|||
144371853|NCT02908672|520569345|FG002|Run-in Period|Death|0|||
144371854|NCT02908672|520569346|FG003|Run-in Period|Death|0|||
144371855|NCT02908672|520569343|FG000|Run-in Period|Lost to Follow-up|1|||
144371856|NCT02908672|520569344|FG001|Run-in Period|Lost to Follow-up|1|||
144371857|NCT02908672|520569345|FG002|Run-in Period|Lost to Follow-up|0|||
144371858|NCT02908672|520569346|FG003|Run-in Period|Lost to Follow-up|0|||
144371859|NCT02908672|520569343|FG000|Run-in Period|Reason Not Specified|2|||
144371860|NCT02908672|520569344|FG001|Run-in Period|Reason Not Specified|0|||
144371861|NCT02908672|520569345|FG002|Run-in Period|Reason Not Specified|0|||
144371862|NCT02908672|520569346|FG003|Run-in Period|Reason Not Specified|0|||
144371863|NCT02908672|520569343|FG000|Run-in Period|Protocol Violation|1|||
144371864|NCT02908672|520569344|FG001|Run-in Period|Protocol Violation|1|||
144371865|NCT02908672|520569345|FG002|Run-in Period|Protocol Violation|0|||
144371866|NCT02908672|520569346|FG003|Run-in Period|Protocol Violation|0|||
144371867|NCT02908672|520569343|FG000|Run-in Period|Study Ended by Sponsor|5|||
144371868|NCT02908672|520569344|FG001|Run-in Period|Study Ended by Sponsor|1|||
144371869|NCT02908672|520569345|FG002|Run-in Period|Study Ended by Sponsor|0|||
144371870|NCT02908672|520569346|FG003|Run-in Period|Study Ended by Sponsor|0|||
144371871|NCT02908672|520569343|FG000|Run-in Period|Withdrawal by Subject|3|||
144371872|NCT02908672|520569344|FG001|Run-in Period|Withdrawal by Subject|9|||
144371873|NCT02908672|520569345|FG002|Run-in Period|Withdrawal by Subject|0|||
144371874|NCT02908672|520569346|FG003|Run-in Period|Withdrawal by Subject|0|||
144371875|NCT02908672|520569343|FG000|Triple Combination Period|Death|0|||
144371876|NCT02908672|520569344|FG001|Triple Combination Period|Death|0|||
144371877|NCT02908672|520569345|FG002|Triple Combination Period|Death|150|||
144371878|NCT02908672|520569346|FG003|Triple Combination Period|Death|127|||
144371879|NCT02908672|520569343|FG000|Triple Combination Period|Lost to Follow-up|0|||
144371880|NCT02908672|520569344|FG001|Triple Combination Period|Lost to Follow-up|0|||
144371881|NCT02908672|520569345|FG002|Triple Combination Period|Lost to Follow-up|6|||
144371882|NCT02908672|520569346|FG003|Triple Combination Period|Lost to Follow-up|8|||
144248556|NCT02667587|520107958|FG001|End of Treatment|participant request to discontinue treatment|35|||
144248557|NCT02667587|520107957|FG000|End of Treatment|participant withdrew consent|5|||
144248558|NCT02667587|520107958|FG001|End of Treatment|participant withdrew consent|6|||
144248559|NCT02667587|520107957|FG000|End of Treatment|Lost to Follow-up|1|||
144371883|NCT02908672|520569343|FG000|Triple Combination Period|Reason Not Specified|0|||
144371884|NCT02908672|520569344|FG001|Triple Combination Period|Reason Not Specified|0|||
144371885|NCT02908672|520569345|FG002|Triple Combination Period|Reason Not Specified|0|||
144371886|NCT02908672|520569346|FG003|Triple Combination Period|Reason Not Specified|1|||
144371887|NCT02908672|520569343|FG000|Triple Combination Period|Physician Decision|0|||
144371888|NCT02908672|520569344|FG001|Triple Combination Period|Physician Decision|0|||
144371889|NCT02908672|520569345|FG002|Triple Combination Period|Physician Decision|1|||
144510739|NCT03088813|521070776|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
144371890|NCT02908672|520569346|FG003|Triple Combination Period|Physician Decision|1|||
144371891|NCT02908672|520569343|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
144371892|NCT02908672|520569344|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
144371893|NCT02908672|520569345|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
144371894|NCT02908672|520569346|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
144371895|NCT02908672|520569343|FG000|Triple Combination Period|Withdrawal by Subject|0|||
144371896|NCT02908672|520569344|FG001|Triple Combination Period|Withdrawal by Subject|0|||
144371897|NCT02908672|520569345|FG002|Triple Combination Period|Withdrawal by Subject|13|||
144371898|NCT02908672|520569346|FG003|Triple Combination Period|Withdrawal by Subject|16|||
144371899|NCT01185080|520569350|FG000|Overall Study|Adverse Event|1|||
144371900|NCT01185080|520569351|FG001|Overall Study|Adverse Event|1|||
144371901|NCT01185080|520569352|FG002|Overall Study|Adverse Event|0|||
144371902|NCT01185080|520569350|FG000|Overall Study|Personal reasons|0|||
144371903|NCT01185080|520569351|FG001|Overall Study|Personal reasons|0|||
144371904|NCT01185080|520569352|FG002|Overall Study|Personal reasons|1|||
144371905|NCT02876601|520569353|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
144371906|NCT02876601|520569354|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
144371907|NCT02876601|520569355|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
144371908|NCT02876601|520569356|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
144371909|NCT02605122|520570943|FG000|Overall Study|Withdrawal by Subject|4|||
144371910|NCT02605122|520570944|FG001|Overall Study|Withdrawal by Subject|1|||
144371911|NCT02605122|520570943|FG000|Overall Study|Lost to Follow-up|1|||
144371912|NCT02605122|520570944|FG001|Overall Study|Lost to Follow-up|1|||
144371913|NCT00807001|520570945|FG000|Overall Study|Non-compliance|0|||
144371914|NCT00807001|520570946|FG001|Overall Study|Non-compliance|1|||
144371915|NCT00807001|520570947|FG002|Overall Study|Non-compliance|0|||
144371916|NCT00807001|520570948|FG003|Overall Study|Non-compliance|0|||
144371917|NCT00807001|520570949|FG004|Overall Study|Non-compliance|0|||
144371918|NCT02873702|520570954|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
144371919|NCT02873702|520570955|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
144371920|NCT02873702|520570956|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
144371921|NCT02873702|520570957|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
144371922|NCT02873702|520570954|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
144371923|NCT02873702|520570955|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
144371924|NCT02873702|520570956|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
144371925|NCT02873702|520570957|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
144371926|NCT02873702|520570954|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
144371927|NCT02873702|520570955|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
144371928|NCT02873702|520570956|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
144371929|NCT02873702|520570957|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
144371930|NCT02873702|520570954|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
144371931|NCT02873702|520570955|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
144371932|NCT02873702|520570956|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
144371933|NCT02873702|520570957|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
144371934|NCT02873702|520570954|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
144371935|NCT02873702|520570955|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
144371936|NCT02873702|520570956|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
144371937|NCT02873702|520570957|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
144371938|NCT01255436|520570967|FG000|Overall Study|Lost to Follow-up|178|||
144371939|NCT01255436|520570968|FG001|Overall Study|Lost to Follow-up|191|||
144371940|NCT01255436|520570967|FG000|Overall Study|Death, stroke, or MI|4|||
144371941|NCT01255436|520570968|FG001|Overall Study|Death, stroke, or MI|3|||
144371942|NCT04816669|520570969|FG000|Part 1|Adverse Event|1|||
144371943|NCT04816669|520570970|FG001|Part 1|Adverse Event|1|||
144371944|NCT04816669|520570971|FG002|Part 1|Adverse Event|0|||
144371945|NCT04816669|520570972|FG003|Part 1|Adverse Event|0|||
144371946|NCT04816669|520570969|FG000|Part 1|Lost to Follow-up|2|||
144614802|NCT01073267|521450211|FG000|Overall Study|Disease Progression|3|||
144371947|NCT04816669|520570970|FG001|Part 1|Lost to Follow-up|2|||
144371948|NCT04816669|520570971|FG002|Part 1|Lost to Follow-up|0|||
144371949|NCT04816669|520570972|FG003|Part 1|Lost to Follow-up|0|||
144371950|NCT04816669|520570969|FG000|Part 1|Protocol Violation|0|||
144371951|NCT04816669|520570970|FG001|Part 1|Protocol Violation|1|||
144371952|NCT04816669|520570971|FG002|Part 1|Protocol Violation|0|||
144371953|NCT04816669|520570972|FG003|Part 1|Protocol Violation|0|||
144371954|NCT04816669|520570969|FG000|Part 1|Withdrawal by Subject|1|||
144371955|NCT04816669|520570970|FG001|Part 1|Withdrawal by Subject|2|||
144371956|NCT04816669|520570971|FG002|Part 1|Withdrawal by Subject|0|||
144371957|NCT04816669|520570972|FG003|Part 1|Withdrawal by Subject|0|||
144371958|NCT04816669|520570969|FG000|Part 2|Other|0|||
144371959|NCT04816669|520570970|FG001|Part 2|Other|0|||
144371960|NCT04816669|520570971|FG002|Part 2|Other|1|||
144371961|NCT04816669|520570972|FG003|Part 2|Other|0|||
144371962|NCT04816669|520570969|FG000|Part 2|Withdrawal by Subject|0|||
144371963|NCT04816669|520570970|FG001|Part 2|Withdrawal by Subject|0|||
144371964|NCT04816669|520570971|FG002|Part 2|Withdrawal by Subject|0|||
144371965|NCT04816669|520570972|FG003|Part 2|Withdrawal by Subject|1|||
144371966|NCT04816669|520570969|FG000|Part 2|Lost to Follow-up|0|||
144371967|NCT04816669|520570970|FG001|Part 2|Lost to Follow-up|0|||
144371968|NCT04816669|520570971|FG002|Part 2|Lost to Follow-up|1|||
144371969|NCT04816669|520570972|FG003|Part 2|Lost to Follow-up|0|||
144371970|NCT01229267|520570973|FG000|Overall Study|Adverse Event|4|||
144371971|NCT01229267|520570974|FG001|Overall Study|Adverse Event|6|||
144371972|NCT01229267|520570975|FG002|Overall Study|Adverse Event|3|||
144371973|NCT01229267|520570976|FG003|Overall Study|Adverse Event|2|||
144371974|NCT01229267|520570977|FG004|Overall Study|Adverse Event|10|||
144371975|NCT01229267|520570973|FG000|Overall Study|Death|40|||
144371976|NCT01229267|520570974|FG001|Overall Study|Death|37|||
144371977|NCT01229267|520570975|FG002|Overall Study|Death|35|||
144371978|NCT01229267|520570976|FG003|Overall Study|Death|13|||
144371979|NCT01229267|520570977|FG004|Overall Study|Death|103|||
144371980|NCT01229267|520570973|FG000|Overall Study|Withdrawal by Subject|23|||
144371981|NCT01229267|520570974|FG001|Overall Study|Withdrawal by Subject|22|||
144371982|NCT01229267|520570975|FG002|Overall Study|Withdrawal by Subject|32|||
144371983|NCT01229267|520570976|FG003|Overall Study|Withdrawal by Subject|14|||
144371984|NCT01229267|520570977|FG004|Overall Study|Withdrawal by Subject|59|||
144371985|NCT01229267|520570973|FG000|Overall Study|Protocol Violation|0|||
144371986|NCT01229267|520570974|FG001|Overall Study|Protocol Violation|1|||
144371987|NCT01229267|520570975|FG002|Overall Study|Protocol Violation|0|||
144371988|NCT01229267|520570976|FG003|Overall Study|Protocol Violation|0|||
144371989|NCT01229267|520570977|FG004|Overall Study|Protocol Violation|0|||
144371990|NCT01229267|520570973|FG000|Overall Study|Progressive disease|0|||
144371991|NCT01229267|520570974|FG001|Overall Study|Progressive disease|0|||
144371992|NCT01229267|520570975|FG002|Overall Study|Progressive disease|0|||
144371993|NCT01229267|520570976|FG003|Overall Study|Progressive disease|0|||
144371994|NCT01229267|520570977|FG004|Overall Study|Progressive disease|1|||
144371995|NCT01229267|520570973|FG000|Overall Study|Physician Decision|8|||
144371996|NCT01229267|520570974|FG001|Overall Study|Physician Decision|11|||
144371997|NCT01229267|520570975|FG002|Overall Study|Physician Decision|8|||
144371998|NCT01229267|520570976|FG003|Overall Study|Physician Decision|3|||
144371999|NCT01229267|520570977|FG004|Overall Study|Physician Decision|25|||
144372000|NCT01229267|520570973|FG000|Overall Study|Lost to Follow-up|6|||
144248560|NCT02667587|520107958|FG001|End of Treatment|Lost to Follow-up|2|||
144248561|NCT02667587|520107957|FG000|End of Treatment|maximum clinical benefit|4|||
144248562|NCT02667587|520107958|FG001|End of Treatment|maximum clinical benefit|4|||
144248563|NCT02667587|520107957|FG000|End of Treatment|poor or non compliant|0|||
144248564|NCT02667587|520107958|FG001|End of Treatment|poor or non compliant|1|||
144248565|NCT02667587|520107957|FG000|End of Treatment|participant no longer meets study criteria|1|||
144248566|NCT02667587|520107958|FG001|End of Treatment|participant no longer meets study criteria|1|||
144248567|NCT02667587|520107957|FG000|End of Treatment|administrative reason by sponsor|1|||
144248568|NCT02667587|520107958|FG001|End of Treatment|administrative reason by sponsor|29|||
144248569|NCT02667587|520107957|FG000|End of Treatment|other reasonse|21|||
144248570|NCT02667587|520107958|FG001|End of Treatment|other reasonse|10|||
144248571|NCT00388297|520107959|FG000|Overall Study|Lost to Follow-up|16|||
144248572|NCT00388297|520107960|FG001|Overall Study|Lost to Follow-up|12|||
144248573|NCT00388297|520107961|FG002|Overall Study|Lost to Follow-up|11|||
144248574|NCT00388297|520107962|FG003|Overall Study|Lost to Follow-up|8|||
144248575|NCT04105010|520107966|FG000|Overall Study|Death|3|||
144372001|NCT01229267|520570974|FG001|Overall Study|Lost to Follow-up|5|||
144248576|NCT04105010|520107967|FG001|Overall Study|Death|1|||
144248577|NCT04105010|520107968|FG002|Overall Study|Death|1|||
144248578|NCT04105010|520107969|FG003|Overall Study|Death|54|||
144248579|NCT04105010|520107966|FG000|Overall Study|Lost to Follow-up|0|||
144248580|NCT04105010|520107967|FG001|Overall Study|Lost to Follow-up|0|||
144372002|NCT01229267|520570975|FG002|Overall Study|Lost to Follow-up|8|||
144372003|NCT01229267|520570976|FG003|Overall Study|Lost to Follow-up|3|||
144372004|NCT01229267|520570977|FG004|Overall Study|Lost to Follow-up|22|||
144372005|NCT00867815|520570980|FG000|Overall Study|Lost to Follow-up|1|||
144372006|NCT04050202|520570981|FG000|Overall Study|Lost to Follow-up|2|||
144372007|NCT00001213|520570982|FG000|Overall Study|Death|18|||
144372008|NCT01499277|520570985|FG000|Overall Study|Adverse Event|3|||
144372009|NCT01499277|520570986|FG001|Overall Study|Adverse Event|6|||
144372010|NCT01499277|520570985|FG000|Overall Study|Death|3|||
144372011|NCT01499277|520570986|FG001|Overall Study|Death|2|||
144372012|NCT01499277|520570985|FG000|Overall Study|Lost to Follow-up|15|||
144372013|NCT01499277|520570986|FG001|Overall Study|Lost to Follow-up|8|||
144372014|NCT01499277|520570985|FG000|Overall Study|Protocol Violation|2|||
144372015|NCT01499277|520570986|FG001|Overall Study|Protocol Violation|3|||
144372016|NCT01499277|520570985|FG000|Overall Study|Withdrawal by Subject|16|||
144372017|NCT01499277|520570986|FG001|Overall Study|Withdrawal by Subject|6|||
144372018|NCT01499277|520570985|FG000|Overall Study|Lack of therapeutic response and other|8|||
144372019|NCT01499277|520570986|FG001|Overall Study|Lack of therapeutic response and other|7|||
144372020|NCT00372593|520570989|FG000|Overall Study|Adverse Event|43|||
144372021|NCT00372593|520570990|FG001|Overall Study|Adverse Event|45|||
144372022|NCT00372593|520570991|FG002|Overall Study|Adverse Event|0|||
144372023|NCT00372593|520570989|FG000|Overall Study|Death|16|||
144372024|NCT00372593|520570990|FG001|Overall Study|Death|20|||
144372025|NCT00372593|520570991|FG002|Overall Study|Death|1|||
144372026|NCT00372593|520570989|FG000|Overall Study|Lack of Efficacy|82|||
144372027|NCT00372593|520570990|FG001|Overall Study|Lack of Efficacy|71|||
144372028|NCT00372593|520570991|FG002|Overall Study|Lack of Efficacy|2|||
144372029|NCT00372593|520570989|FG000|Overall Study|Lost to Follow-up|1|||
144372030|NCT00372593|520570990|FG001|Overall Study|Lost to Follow-up|0|||
144372031|NCT00372593|520570991|FG002|Overall Study|Lost to Follow-up|0|||
144372032|NCT00372593|520570989|FG000|Overall Study|Physician Decision|42|||
144372033|NCT00372593|520570990|FG001|Overall Study|Physician Decision|41|||
144372034|NCT00372593|520570991|FG002|Overall Study|Physician Decision|0|||
144372035|NCT00372593|520570989|FG000|Overall Study|Ineligible|20|||
144372036|NCT00372593|520570990|FG001|Overall Study|Ineligible|21|||
144372037|NCT00372593|520570991|FG002|Overall Study|Ineligible|1|||
144372038|NCT02974543|520570992|FG000|Overall Study|Withdrawal by Subject|1|||
144372039|NCT02974543|520570993|FG001|Overall Study|Withdrawal by Subject|0|||
144372040|NCT00433004|520570994|FG000|Overall Study|Lost to Follow-up|5|||
144372041|NCT00433004|520570995|FG001|Overall Study|Lost to Follow-up|7|||
144372042|NCT00742235|520570996|FG000|Overall Study|Lost to Follow-up|0|||
144372043|NCT00742235|520570997|FG001|Overall Study|Lost to Follow-up|31|||
144372044|NCT03534180|520570998|FG000|Overall Study|Withdrawal by Subject|1|||
144372045|NCT00220636|520570999|FG000|Overall Study|Withdrawal by Subject|4|||
144372046|NCT01237899|520571002|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
144372047|NCT01237899|520571003|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
144372048|NCT01237899|520571004|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
144372049|NCT01237899|520571005|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
144372050|NCT01237899|520571006|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
144372051|NCT01237899|520571007|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
144372052|NCT01237899|520571008|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
144372053|NCT01237899|520571009|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
144372054|NCT01237899|520571010|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
144372055|NCT01237899|520571011|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
144372056|NCT01237899|520571012|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
144372057|NCT00790088|520571013|FG000|Overall Study|Protocol Violation|11|||
144372058|NCT00790088|520571013|FG000|Overall Study|Withdrawal by Subject|17|||
144372059|NCT00790088|520571013|FG000|Overall Study|Lost to Follow-up|7|||
144372060|NCT00790088|520571013|FG000|Overall Study|Physician Decision|4|||
144372061|NCT02636595|520571014|FG000|Overall Study|Lost to Follow-up|1|||
144372062|NCT02636595|520571014|FG000|Overall Study|Other|1|||
144372063|NCT02015637|520571015|FG000|Overall Study|Lost to Follow-up|3|||
144372064|NCT02015637|520571016|FG001|Overall Study|Lost to Follow-up|5|||
144372065|NCT02015637|520571015|FG000|Overall Study|Adverse Event|3|||
144372066|NCT02015637|520571016|FG001|Overall Study|Adverse Event|0|||
144372067|NCT02015637|520571015|FG000|Overall Study|Did not take study drug|2|||
144372068|NCT02015637|520571016|FG001|Overall Study|Did not take study drug|0|||
144372069|NCT03198507|520571017|FG000|Overall Study|Withdrawal by Subject|1|||
144372070|NCT03198507|520571018|FG001|Overall Study|Withdrawal by Subject|0|||
144372071|NCT04896073|520571019|FG000|Overall Study|Screen failure|0|||
144372072|NCT04896073|520571020|FG001|Overall Study|Screen failure|2|||
144372073|NCT04896073|520571019|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
144372074|NCT04896073|520571020|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
144372075|NCT02194985|520571023|FG000|Overall Study|Adverse Event|1|||
144372076|NCT02194985|520571023|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
144372077|NCT02194985|520571023|FG000|Overall Study|Physician Decision|4|||
144372078|NCT02194985|520571023|FG000|Overall Study|Lost to Follow-up|1|||
144372079|NCT02194985|520571023|FG000|Overall Study|Withdrawal by Subject|2|||
144372080|NCT00439517|520571032|FG000|Overall Study|Subject on treatment|1|||
144372081|NCT00439517|520571033|FG001|Overall Study|Subject on treatment|0|||
144372082|NCT00439517|520571032|FG000|Overall Study|Subject in survival follow-up|1|||
144372083|NCT00439517|520571033|FG001|Overall Study|Subject in survival follow-up|0|||
144372084|NCT00594815|520571034|FG000|Overall Study|Never Treated|3|||
144372085|NCT00594815|520571034|FG000|Overall Study|Withdrawal by Subject|2|||
144372086|NCT00594815|520571034|FG000|Overall Study|Toxicity|4|||
144372087|NCT02304367|520571035|FG000|Overall Study|Lack of Response to Bruosumab|1|||
144372088|NCT02304367|520571035|FG000|Overall Study|Sponsor Decision|3|||
144372089|NCT02304367|520571035|FG000|Overall Study|Death|2|||
144372090|NCT02304367|520571035|FG000|Overall Study|Physician Decision|1|||
144372091|NCT02304367|520571035|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
144248581|NCT04105010|520107968|FG002|Overall Study|Lost to Follow-up|0|||
144248582|NCT04105010|520107969|FG003|Overall Study|Lost to Follow-up|4|||
144248583|NCT04105010|520107966|FG000|Overall Study|Withdrawal by Subject|8|||
144248584|NCT04105010|520107967|FG001|Overall Study|Withdrawal by Subject|1|||
144248585|NCT04105010|520107968|FG002|Overall Study|Withdrawal by Subject|1|||
144248586|NCT04105010|520107969|FG003|Overall Study|Withdrawal by Subject|4|||
144248587|NCT04105010|520107966|FG000|Overall Study|Other reason|4|||
144248588|NCT04105010|520107967|FG001|Overall Study|Other reason|7|||
144248589|NCT04105010|520107968|FG002|Overall Study|Other reason|0|||
144248590|NCT04105010|520107969|FG003|Overall Study|Other reason|19|||
144248591|NCT05323994|520107970|FG000|Overall Study|Protocol Violation|1|||
144248592|NCT03570554|520107971|FG000|Overall Study|Non-compliance with study drug|0|||
144248593|NCT03570554|520107972|FG001|Overall Study|Non-compliance with study drug|0|||
144248594|NCT03570554|520107973|FG002|Overall Study|Non-compliance with study drug|1|||
144248595|NCT03570554|520107974|FG003|Overall Study|Non-compliance with study drug|0|||
144248596|NCT03570554|520107971|FG000|Overall Study|Adverse Event|0|||
144248597|NCT03570554|520107972|FG001|Overall Study|Adverse Event|0|||
144248598|NCT03570554|520107973|FG002|Overall Study|Adverse Event|0|||
144248599|NCT03570554|520107974|FG003|Overall Study|Adverse Event|1|||
144248600|NCT04472026|520107986|FG000|Overall Study|Lost to Follow-up|5|||
144248601|NCT01398410|520107987|FG000|Overall Study|Adverse Event|12|||
144248602|NCT01398410|520107988|FG001|Overall Study|Adverse Event|16|||
144248603|NCT01398410|520107987|FG000|Overall Study|Participants Choice|8|||
144248604|NCT01398410|520107988|FG001|Overall Study|Participants Choice|11|||
144248605|NCT01398410|520107987|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
144248606|NCT01398410|520107988|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
144248607|NCT01398410|520107987|FG000|Overall Study|Other|36|||
144248608|NCT01398410|520107988|FG001|Overall Study|Other|29|||
144248609|NCT00717275|520107989|FG000|Overall Study|Premature study termination.|3|||
144248610|NCT01254721|520107990|FG000|Overall Study|Lost to Follow-up|0|||
144248611|NCT01254721|520107991|FG001|Overall Study|Lost to Follow-up|4|||
144248612|NCT01254721|520107990|FG000|Overall Study|Lack of Efficacy|4|||
144248613|NCT01254721|520107991|FG001|Overall Study|Lack of Efficacy|2|||
144248614|NCT01254721|520107990|FG000|Overall Study|Death|0|||
144248615|NCT01254721|520107991|FG001|Overall Study|Death|1|||
144248616|NCT01254721|520107990|FG000|Overall Study|technical problum|1|||
144248617|NCT01254721|520107991|FG001|Overall Study|technical problum|0|||
144248618|NCT01254721|520107990|FG000|Overall Study|Adverse Event|2|||
144248619|NCT01254721|520107991|FG001|Overall Study|Adverse Event|3|||
144248620|NCT01254721|520107990|FG000|Overall Study|Withdrawal by Subject|8|||
144248621|NCT01254721|520107991|FG001|Overall Study|Withdrawal by Subject|11|||
144248622|NCT01254721|520107990|FG000|Overall Study|Wrongly randomization|0|||
144248623|NCT01254721|520107991|FG001|Overall Study|Wrongly randomization|1|||
144248624|NCT03313310|520107992|FG000|Phase 2|Lost to Follow-up|4|||
144248625|NCT03313310|520107993|FG001|Phase 2|Lost to Follow-up|0|||
144248626|NCT03313310|520107992|FG000|Phase 3|Lost to Follow-up|0|||
144248627|NCT03313310|520107993|FG001|Phase 3|Lost to Follow-up|1|||
144510740|NCT03088813|521070773|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
144510741|NCT03088813|521070774|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
144510742|NCT03088813|521070775|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
144248628|NCT03170609|520107994|FG000|Overall Study|Death|0|||
144248629|NCT03170609|520107995|FG001|Overall Study|Death|0|||
144248630|NCT03170609|520107996|FG002|Overall Study|Death|1|||
144372092|NCT03214666|520571036|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
144372093|NCT03214666|520571037|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
144248631|NCT03170609|520107997|FG003|Overall Study|Death|0|||
144248632|NCT03170609|520107998|FG004|Overall Study|Death|0|||
144248633|NCT03170609|520107999|FG005|Overall Study|Death|0|||
144248634|NCT03170609|520108000|FG006|Overall Study|Death|0|||
144248635|NCT03170609|520107994|FG000|Overall Study|Withdrawal by Subject|1|||
144248636|NCT03170609|520107995|FG001|Overall Study|Withdrawal by Subject|2|||
144248637|NCT03170609|520107996|FG002|Overall Study|Withdrawal by Subject|0|||
144248638|NCT03170609|520107997|FG003|Overall Study|Withdrawal by Subject|0|||
144248639|NCT03170609|520107998|FG004|Overall Study|Withdrawal by Subject|0|||
144248640|NCT03170609|520107999|FG005|Overall Study|Withdrawal by Subject|0|||
144248641|NCT03170609|520108000|FG006|Overall Study|Withdrawal by Subject|1|||
144248642|NCT03170609|520107994|FG000|Overall Study|Lost to Follow-up|1|||
144248643|NCT03170609|520107995|FG001|Overall Study|Lost to Follow-up|0|||
144248644|NCT03170609|520107996|FG002|Overall Study|Lost to Follow-up|5|||
144248645|NCT03170609|520107997|FG003|Overall Study|Lost to Follow-up|2|||
144590579|NCT01853644|521361881|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
144590580|NCT01853644|521361881|FG000|Continued Treatment After First Response|Adverse Event|2|||
144590581|NCT01853644|521361881|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
144590582|NCT02891408|521361882|FG000|Overall Study|Lost to Follow-up|0|||
144590583|NCT02891408|521361883|FG001|Overall Study|Lost to Follow-up|0|||
144590584|NCT02891408|521361884|FG002|Overall Study|Lost to Follow-up|1|||
144590585|NCT02891408|521361885|FG003|Overall Study|Lost to Follow-up|0|||
144590586|NCT02891408|521361886|FG004|Overall Study|Lost to Follow-up|0|||
144590587|NCT02891408|521361887|FG005|Overall Study|Lost to Follow-up|0|||
144590588|NCT02891408|521361888|FG006|Overall Study|Lost to Follow-up|0|||
144590589|NCT01054170|521361889|FG000|Overall Study|Protocol Violation|1|||
144590590|NCT01054170|521361890|FG001|Overall Study|Protocol Violation|0|||
144590591|NCT01054170|521361889|FG000|Overall Study|Withdrawal by Subject|3|||
144590592|NCT01054170|521361890|FG001|Overall Study|Withdrawal by Subject|2|||
144590593|NCT01054170|521361889|FG000|Overall Study|Adverse Event|0|||
144590594|NCT01054170|521361890|FG001|Overall Study|Adverse Event|4|||
144590595|NCT02951767|521361891|FG000|Overall Study|Study Terminated By Sponsor|9|||
144590596|NCT02951767|521361891|FG000|Overall Study|Withdrawal by Subject|11|||
144590597|NCT02951767|521361891|FG000|Overall Study|Death|96|||
144590598|NCT02951767|521361891|FG000|Overall Study|Lost to Follow-up|2|||
144590599|NCT02951767|521361891|FG000|Overall Study|Physician Decision|1|||
144590600|NCT00609765|521361894|FG000|Overall Study|Study ended prior to 12 months|1|||
144590601|NCT00950950|521361895|FG000|Overall Study|Adverse Event|1|||
144590602|NCT00950950|521361896|FG001|Overall Study|Adverse Event|0|||
144590603|NCT00950950|521361895|FG000|Overall Study|Withdrawal by Subject|0|||
144590604|NCT00950950|521361896|FG001|Overall Study|Withdrawal by Subject|1|||
144590605|NCT01047293|521361897|FG000|Overall Study|DLT criteria not fulfilled|1|||
144590606|NCT01047293|521361898|FG001|Overall Study|DLT criteria not fulfilled|1|||
144590607|NCT01047293|521361899|FG002|Overall Study|DLT criteria not fulfilled|0|||
144590608|NCT01047293|521361900|FG003|Overall Study|DLT criteria not fulfilled|0|||
144590609|NCT01920854|521361903|FG000|Overall Study|Withdrawal by Subject|1|||
144590610|NCT01920854|521361904|FG001|Overall Study|Withdrawal by Subject|0|||
144590611|NCT01920854|521361905|FG002|Overall Study|Withdrawal by Subject|0|||
144590612|NCT01920854|521361906|FG003|Overall Study|Withdrawal by Subject|0|||
144590613|NCT01920854|521361907|FG004|Overall Study|Withdrawal by Subject|1|||
144590614|NCT01920854|521361908|FG005|Overall Study|Withdrawal by Subject|0|||
144590615|NCT01920854|521361909|FG006|Overall Study|Withdrawal by Subject|1|||
144510743|NCT03088813|521070776|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
144510744|NCT03088813|521070773|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
144510745|NCT03088813|521070774|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
144510746|NCT03088813|521070775|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
144510747|NCT03088813|521070776|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
144510748|NCT03088813|521070773|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
144510749|NCT03088813|521070774|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
144510750|NCT03088813|521070775|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
144510751|NCT03088813|521070776|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
144510752|NCT03088813|521070773|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
144510753|NCT03088813|521070774|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
144510754|NCT03088813|521070775|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
144510755|NCT03088813|521070776|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
144510756|NCT03088813|521070773|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
144510757|NCT03088813|521070774|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
144510758|NCT03088813|521070775|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
144590616|NCT02372136|521361912|FG000|Overall Study|Death|3|||
144590617|NCT02372136|521361913|FG001|Overall Study|Death|1|||
144590618|NCT00985946|521361914|FG000|Overall Study|Lost to Follow-up|6|||
144590619|NCT00985946|521361914|FG000|Overall Study|Withdrawal by Subject|1|||
144590620|NCT02673515|521361915|FG000|Overall Study|Lack of motivation|2|||
144590621|NCT02673515|521361916|FG001|Overall Study|Lack of motivation|1|||
144590622|NCT04227704|521361921|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
144590623|NCT04227704|521361922|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
144590624|NCT04227704|521361923|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
144510759|NCT03088813|521070776|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
144510760|NCT03088813|521070773|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
144510761|NCT03088813|521070774|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
144510762|NCT03088813|521070775|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
144510763|NCT03088813|521070776|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
144510764|NCT02411084|521070778|FG000|Overall Study|Lack of Efficacy|6|||
144510765|NCT02411084|521070779|FG001|Overall Study|Lack of Efficacy|3|||
144510766|NCT02411084|521070778|FG000|Overall Study|Death|5|||
144510767|NCT02411084|521070779|FG001|Overall Study|Death|4|||
144510768|NCT02411084|521070778|FG000|Overall Study|Adverse Event|2|||
144510769|NCT02411084|521070779|FG001|Overall Study|Adverse Event|1|||
144510770|NCT02411084|521070778|FG000|Overall Study|Other reasons|0|||
144510771|NCT02411084|521070779|FG001|Overall Study|Other reasons|5|||
144510772|NCT03112174|521070780|FG000|Overall Study|Withdrawal by Subject|3|||
144510773|NCT03112174|521070781|FG001|Overall Study|Withdrawal by Subject|0|||
144510774|NCT03112174|521070782|FG002|Overall Study|Withdrawal by Subject|11|||
144510775|NCT03112174|521070783|FG003|Overall Study|Withdrawal by Subject|9|||
144510776|NCT03112174|521070784|FG004|Overall Study|Withdrawal by Subject|7|||
144510777|NCT03112174|521070780|FG000|Overall Study|Lost to Follow-up|1|||
144510778|NCT03112174|521070781|FG001|Overall Study|Lost to Follow-up|1|||
144248646|NCT03170609|520107998|FG004|Overall Study|Lost to Follow-up|1|||
144510779|NCT03112174|521070782|FG002|Overall Study|Lost to Follow-up|2|||
144510780|NCT03112174|521070783|FG003|Overall Study|Lost to Follow-up|3|||
144510781|NCT03112174|521070784|FG004|Overall Study|Lost to Follow-up|2|||
144510782|NCT03112174|521070780|FG000|Overall Study|Death|8|||
144510783|NCT03112174|521070781|FG001|Overall Study|Death|3|||
144248647|NCT03170609|520107999|FG005|Overall Study|Lost to Follow-up|1|||
144248648|NCT03170609|520108000|FG006|Overall Study|Lost to Follow-up|0|||
144248649|NCT03170609|520107994|FG000|Overall Study|Other|1|||
144248650|NCT03170609|520107995|FG001|Overall Study|Other|0|||
144248651|NCT03170609|520107996|FG002|Overall Study|Other|0|||
144248652|NCT03170609|520107997|FG003|Overall Study|Other|0|||
144248653|NCT03170609|520107998|FG004|Overall Study|Other|0|||
144248654|NCT03170609|520107999|FG005|Overall Study|Other|1|||
144248655|NCT03170609|520108000|FG006|Overall Study|Other|0|||
144248656|NCT01281956|520108001|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
144248657|NCT01281956|520108002|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
144248658|NCT01593254|520108007|FG000|Overall Study|Disease progression|2|||
144510784|NCT03112174|521070782|FG002|Overall Study|Death|67|||
144372094|NCT03214666|520571038|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
144372095|NCT03214666|520571039|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
144372096|NCT03214666|520571040|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
144372097|NCT03214666|520571041|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
144372098|NCT02500797|520571044|FG000|Overall Study|Cancel (rapid disease progression)|0|||
144372099|NCT02500797|520571045|FG001|Overall Study|Cancel (rapid disease progression)|0|||
144372100|NCT02500797|520571046|FG002|Overall Study|Cancel (rapid disease progression)|0|||
144372101|NCT02500797|520571047|FG003|Overall Study|Cancel (rapid disease progression)|0|||
144372102|NCT02500797|520571048|FG004|Overall Study|Cancel (rapid disease progression)|1|||
144372103|NCT02500797|520571049|FG005|Overall Study|Cancel (rapid disease progression)|1|||
144372104|NCT02500797|520571050|FG006|Overall Study|Cancel (rapid disease progression)|0|||
144590625|NCT04227704|521361921|FG000|Overall Study|due to C/S being cancelled|1|||
144372105|NCT02500797|520571051|FG007|Overall Study|Cancel (rapid disease progression)|0|||
144372106|NCT02500797|520571044|FG000|Overall Study|Withdrawal by Subject|1|||
144372107|NCT02500797|520571045|FG001|Overall Study|Withdrawal by Subject|0|||
144372108|NCT02500797|520571046|FG002|Overall Study|Withdrawal by Subject|0|||
144372109|NCT02500797|520571047|FG003|Overall Study|Withdrawal by Subject|0|||
144372110|NCT02500797|520571048|FG004|Overall Study|Withdrawal by Subject|0|||
144372111|NCT02500797|520571049|FG005|Overall Study|Withdrawal by Subject|0|||
144372112|NCT02500797|520571050|FG006|Overall Study|Withdrawal by Subject|0|||
144372113|NCT02500797|520571051|FG007|Overall Study|Withdrawal by Subject|0|||
144372114|NCT00976560|520571054|FG000|Overall Study|Adverse Event|5|||
144372115|NCT00976560|520571055|FG001|Overall Study|Adverse Event|5|||
144372116|NCT00976560|520571054|FG000|Overall Study|Lack of Efficacy|3|||
144372117|NCT00976560|520571055|FG001|Overall Study|Lack of Efficacy|5|||
144372118|NCT00976560|520571054|FG000|Overall Study|Protocol Violation|1|||
144372119|NCT00976560|520571055|FG001|Overall Study|Protocol Violation|0|||
144372120|NCT00976560|520571054|FG000|Overall Study|Lost to Follow-up|1|||
144372121|NCT00976560|520571055|FG001|Overall Study|Lost to Follow-up|0|||
144372122|NCT00976560|520571054|FG000|Overall Study|Physician Decision|2|||
144372123|NCT00976560|520571055|FG001|Overall Study|Physician Decision|0|||
144372124|NCT00976560|520571054|FG000|Overall Study|Withdrawal by Subject|2|||
144372125|NCT00976560|520571055|FG001|Overall Study|Withdrawal by Subject|3|||
144372126|NCT03895840|520571060|FG000|Overall Study|Withdrawal by Subject|21|||
144372127|NCT01931566|520571061|FG000|Overall Study|Randomized But Not Treated|6|||
144372128|NCT01931566|520571062|FG001|Overall Study|Randomized But Not Treated|9|||
144372129|NCT01931566|520571063|FG002|Overall Study|Randomized But Not Treated|14|||
144372130|NCT01931566|520571061|FG000|Overall Study|Adverse Event|37|||
144372131|NCT01931566|520571062|FG001|Overall Study|Adverse Event|167|||
144372132|NCT01931566|520571063|FG002|Overall Study|Adverse Event|132|||
144372133|NCT01931566|520571061|FG000|Overall Study|Major Protocol Deviation|5|||
144372134|NCT01931566|520571062|FG001|Overall Study|Major Protocol Deviation|14|||
144372135|NCT01931566|520571063|FG002|Overall Study|Major Protocol Deviation|21|||
144372136|NCT01931566|520571061|FG000|Overall Study|Lost to Follow-up|3|||
144372137|NCT01931566|520571062|FG001|Overall Study|Lost to Follow-up|26|||
144372138|NCT01931566|520571063|FG002|Overall Study|Lost to Follow-up|23|||
144372139|NCT01931566|520571061|FG000|Overall Study|Voluntary Withdrawal|78|||
144372140|NCT01931566|520571062|FG001|Overall Study|Voluntary Withdrawal|245|||
144372141|NCT01931566|520571063|FG002|Overall Study|Voluntary Withdrawal|225|||
144372142|NCT01931566|520571061|FG000|Overall Study|Study Termination|289|||
144372143|NCT01931566|520571062|FG001|Overall Study|Study Termination|968|||
144372144|NCT01931566|520571063|FG002|Overall Study|Study Termination|1037|||
144372145|NCT01931566|520571061|FG000|Overall Study|Reason Not Specified|11|||
144372146|NCT01931566|520571062|FG001|Overall Study|Reason Not Specified|47|||
144372147|NCT01931566|520571063|FG002|Overall Study|Reason Not Specified|53|||
144372148|NCT01931566|520571061|FG000|Overall Study|Missing|0|||
144372149|NCT01931566|520571062|FG001|Overall Study|Missing|0|||
144372150|NCT01931566|520571063|FG002|Overall Study|Missing|1|||
144372151|NCT01599637|520571064|FG000|Overall Study|administrative problems|0|||
144372152|NCT01599637|520571065|FG001|Overall Study|administrative problems|2|||
144372153|NCT01599637|520571066|FG002|Overall Study|administrative problems|0|||
144372154|NCT01599637|520571064|FG000|Overall Study|Adverse Event|1|||
144372155|NCT01599637|520571065|FG001|Overall Study|Adverse Event|0|||
144372156|NCT01599637|520571066|FG002|Overall Study|Adverse Event|0|||
144372157|NCT00760617|520571068|FG000|Overall Study|Adverse Event|5|||
144372158|NCT00760617|520571069|FG001|Overall Study|Adverse Event|2|||
144372159|NCT00760617|520571070|FG002|Overall Study|Adverse Event|0|||
144372160|NCT00760617|520571068|FG000|Overall Study|Lost to Follow-up|0|||
144372161|NCT00760617|520571069|FG001|Overall Study|Lost to Follow-up|0|||
144372162|NCT00760617|520571070|FG002|Overall Study|Lost to Follow-up|5|||
144372163|NCT04476797|520571071|FG000|Overall Study|Withdrawal by Subject|1|||
144590626|NCT04227704|521361922|FG001|Overall Study|due to C/S being cancelled|0|||
144372164|NCT04476797|520571072|FG001|Overall Study|Withdrawal by Subject|0|||
144372165|NCT04476797|520571073|FG002|Overall Study|Withdrawal by Subject|0|||
144590627|NCT04227704|521361923|FG002|Overall Study|due to C/S being cancelled|0|||
144372166|NCT04476797|520571071|FG000|Overall Study|Death|0|||
144372167|NCT04476797|520571072|FG001|Overall Study|Death|1|||
144372168|NCT04476797|520571073|FG002|Overall Study|Death|2|||
144372169|NCT04476797|520571071|FG000|Overall Study|Sponsor Terminated Study|0|||
144372170|NCT04476797|520571072|FG001|Overall Study|Sponsor Terminated Study|18|||
144372171|NCT04476797|520571073|FG002|Overall Study|Sponsor Terminated Study|17|||
144372172|NCT02395081|520571074|FG000|Overall Study|Withdrawal by Subject|1|||
144372173|NCT02395081|520571075|FG001|Overall Study|Withdrawal by Subject|1|||
144372174|NCT02395081|520571076|FG002|Overall Study|Withdrawal by Subject|0|||
144372175|NCT02395081|520571074|FG000|Overall Study|Moved where blood couldn't be collected|4|||
144372176|NCT02395081|520571075|FG001|Overall Study|Moved where blood couldn't be collected|1|||
144372177|NCT02395081|520571076|FG002|Overall Study|Moved where blood couldn't be collected|3|||
144372178|NCT02395081|520571074|FG000|Overall Study|Fetal Loss|2|||
144372179|NCT02395081|520571075|FG001|Overall Study|Fetal Loss|3|||
144372180|NCT02395081|520571076|FG002|Overall Study|Fetal Loss|1|||
144372181|NCT04625101|520571079|FG000|Overall Study|Withdrawal by Subject|0|||
144372182|NCT04625101|520571080|FG001|Overall Study|Withdrawal by Subject|1|||
144372183|NCT04625101|520571079|FG000|Overall Study|Protocol Deviation|1|||
144372184|NCT04625101|520571080|FG001|Overall Study|Protocol Deviation|0|||
144372185|NCT02991040|520571081|FG000|Overall Study|Withdrawal by Subject|2|||
144372186|NCT02991040|520571081|FG000|Overall Study|Lost to Follow-up|2|||
144372187|NCT03070964|520571083|FG000|Overall Study|Progressive disease|8|||
144372188|NCT03070964|520571083|FG000|Overall Study|Treatment-unrelated adverse event|2|||
144372189|NCT03070964|520571083|FG000|Overall Study|Never treated|1|||
144372190|NCT03070964|520571083|FG000|Overall Study|Physician Decision|1|||
144372191|NCT03070964|520571083|FG000|Overall Study|Withdrawal by Subject|1|||
144372192|NCT03070964|520571083|FG000|Overall Study|Adverse Event|1|||
144372193|NCT01626872|520571084|FG000|Overall Study|Physician Decision|13|||
144372194|NCT01626872|520571085|FG001|Overall Study|Physician Decision|9|||
144372195|NCT01626872|520571086|FG002|Overall Study|Physician Decision|6|||
144510785|NCT03112174|521070783|FG003|Overall Study|Death|73|||
144510786|NCT03112174|521070784|FG004|Overall Study|Death|18|||
144510787|NCT03112174|521070780|FG000|Overall Study|Other, Not Specified|1|||
144510788|NCT03112174|521070781|FG001|Overall Study|Other, Not Specified|0|||
144510789|NCT03112174|521070782|FG002|Overall Study|Other, Not Specified|1|||
144510790|NCT03112174|521070783|FG003|Overall Study|Other, Not Specified|2|||
144510791|NCT03112174|521070784|FG004|Overall Study|Other, Not Specified|0|||
144510792|NCT03051165|521070797|FG000|Overall Study|Withdrawal by Subject|1|||
144510793|NCT03051165|521070797|FG000|Overall Study|Early termination of study|12|||
144510794|NCT01985334|521070800|FG000|Overall Study|Administrative problems|1|||
144510795|NCT01985334|521070801|FG001|Overall Study|Administrative problems|1|||
144510796|NCT01985334|521070802|FG002|Overall Study|Administrative problems|0|||
144510797|NCT01985334|521070803|FG003|Overall Study|Administrative problems|2|||
144510798|NCT01985334|521070804|FG004|Overall Study|Administrative problems|0|||
144510799|NCT01985334|521070805|FG005|Overall Study|Administrative problems|1|||
144510800|NCT01985334|521070806|FG006|Overall Study|Administrative problems|1|||
144510801|NCT01985334|521070807|FG007|Overall Study|Administrative problems|3|||
144510802|NCT01985334|521070800|FG000|Overall Study|Death|1|||
144510803|NCT01985334|521070801|FG001|Overall Study|Death|0|||
144510804|NCT01985334|521070802|FG002|Overall Study|Death|0|||
144510805|NCT01985334|521070803|FG003|Overall Study|Death|3|||
144510806|NCT01985334|521070804|FG004|Overall Study|Death|0|||
144510807|NCT01985334|521070805|FG005|Overall Study|Death|0|||
144510808|NCT01985334|521070806|FG006|Overall Study|Death|1|||
144510809|NCT01985334|521070807|FG007|Overall Study|Death|2|||
144510810|NCT01985334|521070800|FG000|Overall Study|Worsening of disease|0|||
144510811|NCT01985334|521070801|FG001|Overall Study|Worsening of disease|0|||
144510812|NCT01985334|521070802|FG002|Overall Study|Worsening of disease|0|||
144510813|NCT01985334|521070803|FG003|Overall Study|Worsening of disease|1|||
144510814|NCT01985334|521070804|FG004|Overall Study|Worsening of disease|0|||
144510815|NCT01985334|521070805|FG005|Overall Study|Worsening of disease|3|||
144590628|NCT01586910|521364054|FG000|Overall Study|Death|4|||
144590629|NCT01586910|521364055|FG001|Overall Study|Death|4|||
144510816|NCT01985334|521070806|FG006|Overall Study|Worsening of disease|0|||
144510817|NCT01985334|521070807|FG007|Overall Study|Worsening of disease|1|||
144590630|NCT01586910|521364054|FG000|Overall Study|Withdrawal by Subject|6|||
144590631|NCT01586910|521364055|FG001|Overall Study|Withdrawal by Subject|43|||
144510818|NCT01985334|521070800|FG000|Overall Study|Other|2|||
144510819|NCT01985334|521070801|FG001|Overall Study|Other|9|||
144372196|NCT01626872|520571084|FG000|Overall Study|Withdrawal by Subject|19|||
144372197|NCT01626872|520571085|FG001|Overall Study|Withdrawal by Subject|27|||
144372198|NCT01626872|520571086|FG002|Overall Study|Withdrawal by Subject|8|||
144372199|NCT01626872|520571084|FG000|Overall Study|Adverse Event (including Death)|20|||
144372200|NCT01626872|520571085|FG001|Overall Study|Adverse Event (including Death)|28|||
144372201|NCT01626872|520571086|FG002|Overall Study|Adverse Event (including Death)|8|||
144372202|NCT01626872|520571084|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
144510820|NCT01985334|521070802|FG002|Overall Study|Other|7|||
144590632|NCT01586910|521364054|FG000|Overall Study|Physician withdrew Subject|5|||
144372203|NCT01626872|520571085|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
144372204|NCT01626872|520571086|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
144372205|NCT01209325|520571089|FG000|Overall Study|Lost to Follow-up|24|||
144372206|NCT01209325|520571089|FG000|Overall Study|Adverse Event|1|||
144372207|NCT01209325|520571089|FG000|Overall Study|Relocated|3|||
144372208|NCT01209325|520571089|FG000|Overall Study|Refusal after starting therapy|8|||
144372209|NCT01209325|520571089|FG000|Overall Study|Protocol Violation|4|||
144372210|NCT01209325|520571089|FG000|Overall Study|Refusal prior to therapy|1|||
144372211|NCT01209325|520571089|FG000|Overall Study|Incarceration|2|||
144372212|NCT01918306|520571090|FG000|Overall Study|progresive disease|4|||
144372213|NCT01918306|520571091|FG001|Overall Study|progresive disease|0|||
144372214|NCT01918306|520571092|FG002|Overall Study|progresive disease|1|||
144372215|NCT01918306|520571093|FG003|Overall Study|progresive disease|1|||
144372216|NCT01918306|520571090|FG000|Overall Study|Withdrawal by Subject|0|||
144372217|NCT01918306|520571091|FG001|Overall Study|Withdrawal by Subject|0|||
144372218|NCT01918306|520571092|FG002|Overall Study|Withdrawal by Subject|0|||
144372219|NCT01918306|520571093|FG003|Overall Study|Withdrawal by Subject|2|||
144372220|NCT01918306|520571090|FG000|Overall Study|neutropenia|1|||
144372221|NCT01918306|520571091|FG001|Overall Study|neutropenia|0|||
144372222|NCT01918306|520571092|FG002|Overall Study|neutropenia|0|||
144372223|NCT01918306|520571093|FG003|Overall Study|neutropenia|0|||
144372224|NCT01918306|520571090|FG000|Overall Study|Lack of Efficacy|1|||
144372225|NCT01918306|520571091|FG001|Overall Study|Lack of Efficacy|0|||
144372226|NCT01918306|520571092|FG002|Overall Study|Lack of Efficacy|0|||
144372227|NCT01918306|520571093|FG003|Overall Study|Lack of Efficacy|0|||
144372228|NCT01918306|520571090|FG000|Overall Study|progress disease, crossover|0|||
144372229|NCT01918306|520571091|FG001|Overall Study|progress disease, crossover|0|||
144372230|NCT01918306|520571092|FG002|Overall Study|progress disease, crossover|1|||
144372231|NCT01918306|520571093|FG003|Overall Study|progress disease, crossover|0|||
144372232|NCT01160822|520571098|FG000|Overall Study|Adverse Event|0|||
144372233|NCT01160822|520571099|FG001|Overall Study|Adverse Event|0|||
144372234|NCT01160822|520571100|FG002|Overall Study|Adverse Event|0|||
144372235|NCT01160822|520571101|FG003|Overall Study|Adverse Event|0|||
144372236|NCT01160822|520571102|FG004|Overall Study|Adverse Event|1|||
144372237|NCT01160822|520571103|FG005|Overall Study|Adverse Event|2|||
144372238|NCT01160822|520571104|FG006|Overall Study|Adverse Event|5|||
144372239|NCT01160822|520571098|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144372240|NCT01160822|520571099|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144510821|NCT01985334|521070803|FG003|Overall Study|Other|17|||
144510822|NCT01985334|521070804|FG004|Overall Study|Other|4|||
144372241|NCT01160822|520571100|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144372242|NCT01160822|520571101|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
144372243|NCT01160822|520571102|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
144372244|NCT01160822|520571103|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
144372245|NCT01160822|520571104|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
144372246|NCT01160822|520571098|FG000|Overall Study|Withdrawal by Subject|0|||
144372247|NCT01160822|520571099|FG001|Overall Study|Withdrawal by Subject|0|||
144372248|NCT01160822|520571100|FG002|Overall Study|Withdrawal by Subject|0|||
144372249|NCT01160822|520571101|FG003|Overall Study|Withdrawal by Subject|0|||
144510823|NCT01985334|521070805|FG005|Overall Study|Other|8|||
144372250|NCT01160822|520571102|FG004|Overall Study|Withdrawal by Subject|0|||
144372251|NCT01160822|520571103|FG005|Overall Study|Withdrawal by Subject|0|||
144372252|NCT01160822|520571104|FG006|Overall Study|Withdrawal by Subject|1|||
144372253|NCT01160822|520571098|FG000|Overall Study|Lost to Follow-up|0|||
144372254|NCT01160822|520571099|FG001|Overall Study|Lost to Follow-up|0|||
144372255|NCT01160822|520571100|FG002|Overall Study|Lost to Follow-up|0|||
144372256|NCT01160822|520571101|FG003|Overall Study|Lost to Follow-up|0|||
144372257|NCT01160822|520571102|FG004|Overall Study|Lost to Follow-up|1|||
144372258|NCT01160822|520571103|FG005|Overall Study|Lost to Follow-up|0|||
144372259|NCT01160822|520571104|FG006|Overall Study|Lost to Follow-up|0|||
144372260|NCT01160822|520571098|FG000|Overall Study|Administrative problems|0|||
144372261|NCT01160822|520571099|FG001|Overall Study|Administrative problems|0|||
144372262|NCT01160822|520571100|FG002|Overall Study|Administrative problems|0|||
144372263|NCT01160822|520571101|FG003|Overall Study|Administrative problems|0|||
144372264|NCT01160822|520571102|FG004|Overall Study|Administrative problems|1|||
144372265|NCT01160822|520571103|FG005|Overall Study|Administrative problems|0|||
144372266|NCT01160822|520571104|FG006|Overall Study|Administrative problems|0|||
144372267|NCT01160822|520571098|FG000|Overall Study|Protocol deviation|0|||
144372268|NCT01160822|520571099|FG001|Overall Study|Protocol deviation|0|||
144372269|NCT01160822|520571100|FG002|Overall Study|Protocol deviation|0|||
144372270|NCT01160822|520571101|FG003|Overall Study|Protocol deviation|0|||
144372271|NCT01160822|520571102|FG004|Overall Study|Protocol deviation|2|||
144372272|NCT01160822|520571103|FG005|Overall Study|Protocol deviation|0|||
144372273|NCT01160822|520571104|FG006|Overall Study|Protocol deviation|0|||
144372274|NCT02506244|520571105|FG000|Overall Study|Did not undergo active monitoring|458|||
144372275|NCT02506244|520571106|FG001|Overall Study|Did not undergo active monitoring|459|||
144372276|NCT02506244|520571107|FG002|Overall Study|Did not undergo active monitoring|0|||
144372277|NCT00314795|520571111|FG000|Overall Study|Adverse Event|8|||
144372278|NCT00314795|520571111|FG000|Overall Study|Death|4|||
144372279|NCT00314795|520571111|FG000|Overall Study|Reason not Specified|3|||
144372280|NCT00314795|520571111|FG000|Overall Study|Renal Transplant|3|||
144372281|NCT00314795|520571111|FG000|Overall Study|Participants Withdrew Consent|2|||
144372282|NCT04717336|520571112|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
144372283|NCT04717336|520571113|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
144372284|NCT04717336|520571112|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
144372285|NCT04717336|520571113|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
144372286|NCT02039843|520571114|FG000|Randomization and Observation Period|Adverse Event|2|||
144372287|NCT02039843|520571115|FG001|Randomization and Observation Period|Adverse Event|0|||
144372288|NCT02039843|520571114|FG000|Randomization and Observation Period|Death|1|||
144372289|NCT02039843|520571115|FG001|Randomization and Observation Period|Death|0|||
144372290|NCT02039843|520571114|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
144372291|NCT02039843|520571115|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
144372292|NCT02039843|520571114|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
144372293|NCT02039843|520571115|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
144372294|NCT02039843|520571114|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
144372295|NCT02039843|520571115|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
144372296|NCT02039843|520571114|FG000|Pairing With a Study Dog|Death|1|||
144372297|NCT02039843|520571115|FG001|Pairing With a Study Dog|Death|0|||
144372298|NCT02039843|520571114|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
144372299|NCT02039843|520571115|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
144372300|NCT02039843|520571114|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
144372301|NCT02039843|520571115|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
144372302|NCT02039843|520571114|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
144372303|NCT02039843|520571115|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
144372304|NCT00256997|520571126|FG000|Overall Study|Protocol Violation|1|||
144372305|NCT00256997|520571127|FG001|Overall Study|Protocol Violation|4|||
144372306|NCT00256997|520571126|FG000|Overall Study|Lack of Efficacy|1|||
144372307|NCT00256997|520571127|FG001|Overall Study|Lack of Efficacy|4|||
144372308|NCT00256997|520571126|FG000|Overall Study|Death|2|||
144372309|NCT00256997|520571127|FG001|Overall Study|Death|0|||
144372310|NCT00256997|520571126|FG000|Overall Study|Adverse Event|4|||
144372311|NCT00256997|520571127|FG001|Overall Study|Adverse Event|0|||
144372312|NCT00256997|520571126|FG000|Overall Study|Lost to Follow-up|3|||
144372313|NCT00256997|520571127|FG001|Overall Study|Lost to Follow-up|5|||
144372314|NCT00256997|520571126|FG000|Overall Study|Withdrawal by Subject|13|||
144372315|NCT00256997|520571127|FG001|Overall Study|Withdrawal by Subject|3|||
144372316|NCT00256997|520571126|FG000|Overall Study|Started but not treated|2|||
144372317|NCT00256997|520571127|FG001|Overall Study|Started but not treated|0|||
144372318|NCT00256997|520571126|FG000|Overall Study|Other|5|||
144372319|NCT00256997|520571127|FG001|Overall Study|Other|8|||
144372320|NCT00256997|520571126|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
144372321|NCT00256997|520571127|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
144372322|NCT00256997|520571126|FG000|Overall Study|Participant Non-compliant|3|||
144372323|NCT00256997|520571127|FG001|Overall Study|Participant Non-compliant|6|||
144372324|NCT00256997|520571126|FG000|Overall Study|Investigator Withdrew Participant|2|||
144372325|NCT00256997|520571127|FG001|Overall Study|Investigator Withdrew Participant|1|||
144372326|NCT00354432|520571128|FG000|Overall Study|Adverse Event|3|||
144372327|NCT00354432|520571129|FG001|Overall Study|Adverse Event|1|||
144372328|NCT00354432|520571130|FG002|Overall Study|Adverse Event|5|||
144372329|NCT00354432|520571131|FG003|Overall Study|Adverse Event|5|||
144372330|NCT00354432|520571128|FG000|Overall Study|Off/Toxicity|3|||
144372331|NCT00354432|520571129|FG001|Overall Study|Off/Toxicity|7|||
144372332|NCT00354432|520571130|FG002|Overall Study|Off/Toxicity|5|||
144372333|NCT00354432|520571131|FG003|Overall Study|Off/Toxicity|5|||
144372334|NCT02736578|520571132|FG000|Overall Study|Adverse Event|1|||
144372335|NCT02736578|520571133|FG001|Overall Study|Adverse Event|0|||
144372336|NCT00802945|520571134|FG000|Overall Study|Death|27|||
144372337|NCT00802945|520571135|FG001|Overall Study|Death|23|||
144372338|NCT00802945|520571134|FG000|Overall Study|Terminated by sponsor|8|||
144372339|NCT00802945|520571135|FG001|Overall Study|Terminated by sponsor|12|||
144372340|NCT03843541|520571136|FG000|Overall Study|Adverse Event|4|||
144372341|NCT03843541|520571137|FG001|Overall Study|Adverse Event|2|||
144372342|NCT03843541|520571138|FG002|Overall Study|Adverse Event|3|||
144372343|NCT03843541|520571136|FG000|Overall Study|Death|1|||
144372344|NCT03843541|520571137|FG001|Overall Study|Death|0|||
144372345|NCT03843541|520571138|FG002|Overall Study|Death|0|||
144372346|NCT03843541|520571136|FG000|Overall Study|Lack of adherence to study medication|0|||
144372347|NCT03843541|520571137|FG001|Overall Study|Lack of adherence to study medication|0|||
144372348|NCT03843541|520571138|FG002|Overall Study|Lack of adherence to study medication|1|||
144372349|NCT03843541|520571136|FG000|Overall Study|Physician Decision|1|||
144372350|NCT03843541|520571137|FG001|Overall Study|Physician Decision|2|||
144248659|NCT01593254|520108008|FG001|Overall Study|Disease progression|7|||
144248660|NCT01593254|520108007|FG000|Overall Study|Study drug toxicity|6|||
144248661|NCT01593254|520108008|FG001|Overall Study|Study drug toxicity|20|||
144248662|NCT01593254|520108007|FG000|Overall Study|Death|3|||
144248663|NCT01593254|520108008|FG001|Overall Study|Death|3|||
144248664|NCT01593254|520108007|FG000|Overall Study|AE unrelated to study drug|0|||
144248665|NCT01593254|520108008|FG001|Overall Study|AE unrelated to study drug|1|||
144248666|NCT01593254|520108007|FG000|Overall Study|participant request to discontinue study treatment|1|||
144248667|NCT01593254|520108008|FG001|Overall Study|participant request to discontinue study treatment|3|||
144248668|NCT01593254|520108007|FG000|Overall Study|participant withdrew consent|0|||
144248669|NCT01593254|520108008|FG001|Overall Study|participant withdrew consent|9|||
144248670|NCT01593254|520108007|FG000|Overall Study|lost to follow up|1|||
144248671|NCT01593254|520108008|FG001|Overall Study|lost to follow up|6|||
144248672|NCT01593254|520108007|FG000|Overall Study|maximum clinical benefit|1|||
144248673|NCT01593254|520108008|FG001|Overall Study|maximum clinical benefit|2|||
144248674|NCT01593254|520108007|FG000|Overall Study|Poor/non compliance|1|||
144248675|NCT01593254|520108008|FG001|Overall Study|Poor/non compliance|1|||
144248676|NCT01593254|520108007|FG000|Overall Study|Pregnancy|0|||
144248677|NCT01593254|520108008|FG001|Overall Study|Pregnancy|3|||
144248678|NCT01593254|520108007|FG000|Overall Study|participant no longer meets study criteria|1|||
144248679|NCT01593254|520108008|FG001|Overall Study|participant no longer meets study criteria|1|||
144248680|NCT01593254|520108007|FG000|Overall Study|Admin reason by sponsor|7|||
144248681|NCT01593254|520108008|FG001|Overall Study|Admin reason by sponsor|3|||
144248682|NCT01593254|520108007|FG000|Overall Study|Imatinib treatment failure|2|||
144248683|NCT01593254|520108008|FG001|Overall Study|Imatinib treatment failure|0|||
144248684|NCT01593254|520108007|FG000|Overall Study|Other Reasons|61|||
144248685|NCT01593254|520108008|FG001|Overall Study|Other Reasons|115|||
144248686|NCT03013985|520108011|FG000|Overall Study|Protocol Violation|2|||
144372351|NCT03843541|520571138|FG002|Overall Study|Physician Decision|2|||
144372352|NCT03843541|520571136|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
144248687|NCT03013985|520108012|FG001|Overall Study|Protocol Violation|2|||
144248688|NCT03013985|520108011|FG000|Overall Study|Withdrawal by Subject|14|||
144248689|NCT03013985|520108012|FG001|Overall Study|Withdrawal by Subject|17|||
144248690|NCT03411902|520108013|FG000|Overall Study|Lost to Follow-up|3|||
144372353|NCT03843541|520571137|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
144372354|NCT03843541|520571138|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
144372355|NCT03843541|520571136|FG000|Overall Study|Withdrawal by Subject|6|||
144590633|NCT01586910|521364055|FG001|Overall Study|Physician withdrew Subject|24|||
144590634|NCT00192647|521364056|FG000|Overall Study|Death|1|||
144590635|NCT00192647|521364057|FG001|Overall Study|Death|1|||
144248691|NCT03411902|520108014|FG001|Overall Study|Lost to Follow-up|0|||
144248692|NCT00791492|520108015|FG000|Overall Study|Withdrawal by Subject|1|||
144248693|NCT00791492|520108016|FG001|Overall Study|Withdrawal by Subject|2|||
144248694|NCT00791492|520108015|FG000|Overall Study|Liver transplantation|5|||
144248695|NCT00791492|520108016|FG001|Overall Study|Liver transplantation|1|||
144248696|NCT00076999|520108019|FG000|Overall Study|Adverse Event|2|||
144248697|NCT00076999|520108020|FG001|Overall Study|Adverse Event|8|||
144372356|NCT03843541|520571137|FG001|Overall Study|Withdrawal by Subject|9|||
144372357|NCT03843541|520571138|FG002|Overall Study|Withdrawal by Subject|7|||
144372358|NCT03843541|520571136|FG000|Overall Study|Administration of rescue mucolytic|0|||
144372359|NCT03843541|520571137|FG001|Overall Study|Administration of rescue mucolytic|0|||
144372360|NCT03843541|520571138|FG002|Overall Study|Administration of rescue mucolytic|1|||
144372361|NCT03843541|520571136|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
144372362|NCT03843541|520571137|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
144372363|NCT03843541|520571138|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
144372364|NCT03773796|520572922|FG000|Overall Study|Adverse Event|1|||
144372365|NCT03773796|520572922|FG000|Overall Study|Withdrawal by Subject|1|||
144372366|NCT03773796|520572922|FG000|Overall Study|Lack of Efficacy|1|||
144372367|NCT03805659|520572924|FG000|Overall Study|Withdrawal by Subject|0|||
144372368|NCT03805659|520572925|FG001|Overall Study|Withdrawal by Subject|1|||
144372369|NCT02273596|520572928|FG000|24-Week Treatment Period|Adverse Event|3|||
144372370|NCT02273596|520572928|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
144372371|NCT02273596|520572928|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
144372372|NCT02273596|520572928|FG000|24-Week Treatment Period|Physician Decision|1|||
144372373|NCT02273596|520572928|FG000|24-Week Treatment Period|Protocol Deviation|1|||
144372374|NCT02273596|520572928|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
144372375|NCT02273596|520572928|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
144372376|NCT02273596|520572928|FG000|Extension Period|Lost to Follow-up|1|||
144372377|NCT02273596|520572928|FG000|Extension Period|Protocol Deviation|1|||
144372378|NCT02604160|520572929|FG000|Overall Study|Protocol Violation|0|||
144372379|NCT02604160|520572930|FG001|Overall Study|Protocol Violation|1|||
144372380|NCT02604160|520572929|FG000|Overall Study|Physician Decision|0|||
144372381|NCT02604160|520572930|FG001|Overall Study|Physician Decision|1|||
144372382|NCT01596062|520572931|FG000|Overall Study|Adverse Event|1|||
144372383|NCT01596062|520572932|FG001|Overall Study|Adverse Event|0|||
144372384|NCT01596062|520572933|FG002|Overall Study|Adverse Event|2|||
144372385|NCT01596062|520572931|FG000|Overall Study|Lack of Efficacy|0|||
144372386|NCT01596062|520572932|FG001|Overall Study|Lack of Efficacy|0|||
144372387|NCT01596062|520572933|FG002|Overall Study|Lack of Efficacy|1|||
144372388|NCT02255435|520572934|FG000|Overall Study|Patient's Limited Time Availability|0|||
144372389|NCT02255435|520572935|FG001|Overall Study|Patient's Limited Time Availability|0|||
144372390|NCT02255435|520572936|FG002|Overall Study|Patient's Limited Time Availability|0|||
144372391|NCT02255435|520572937|FG003|Overall Study|Patient's Limited Time Availability|0|||
144372392|NCT02255435|520572938|FG004|Overall Study|Patient's Limited Time Availability|0|||
144372393|NCT02255435|520572939|FG005|Overall Study|Patient's Limited Time Availability|0|||
144372394|NCT02255435|520572940|FG006|Overall Study|Patient's Limited Time Availability|0|||
144372395|NCT02255435|520572941|FG007|Overall Study|Patient's Limited Time Availability|1|||
144372396|NCT02255435|520572942|FG008|Overall Study|Patient's Limited Time Availability|0|||
144372397|NCT02255435|520572943|FG009|Overall Study|Patient's Limited Time Availability|0|||
144372398|NCT02255435|520572934|FG000|Overall Study|Withdrawal by Subject|0|||
144372399|NCT02255435|520572935|FG001|Overall Study|Withdrawal by Subject|0|||
144372400|NCT02255435|520572936|FG002|Overall Study|Withdrawal by Subject|0|||
144372401|NCT02255435|520572937|FG003|Overall Study|Withdrawal by Subject|0|||
144372402|NCT02255435|520572938|FG004|Overall Study|Withdrawal by Subject|0|||
144372403|NCT02255435|520572939|FG005|Overall Study|Withdrawal by Subject|0|||
144372404|NCT02255435|520572940|FG006|Overall Study|Withdrawal by Subject|0|||
144372405|NCT02255435|520572941|FG007|Overall Study|Withdrawal by Subject|0|||
144372406|NCT02255435|520572942|FG008|Overall Study|Withdrawal by Subject|1|||
144372407|NCT02255435|520572943|FG009|Overall Study|Withdrawal by Subject|4|||
144372408|NCT02255435|520572934|FG000|Overall Study|Administrative reasons|0|||
144372409|NCT02255435|520572935|FG001|Overall Study|Administrative reasons|0|||
144372410|NCT02255435|520572936|FG002|Overall Study|Administrative reasons|0|||
144372411|NCT02255435|520572937|FG003|Overall Study|Administrative reasons|0|||
144372412|NCT02255435|520572938|FG004|Overall Study|Administrative reasons|0|||
144372413|NCT02255435|520572939|FG005|Overall Study|Administrative reasons|0|||
144721710|NCT01180244|521835270|FG001|Overall Study|Lost to Follow-up|0|||
144372414|NCT02255435|520572940|FG006|Overall Study|Administrative reasons|0|||
144372415|NCT02255435|520572941|FG007|Overall Study|Administrative reasons|0|||
144372416|NCT02255435|520572942|FG008|Overall Study|Administrative reasons|0|||
144372417|NCT02255435|520572943|FG009|Overall Study|Administrative reasons|2|||
144510824|NCT01985334|521070806|FG006|Overall Study|Other|4|||
144248698|NCT00076999|520108021|FG002|Overall Study|Adverse Event|6|||
144248699|NCT00076999|520108022|FG003|Overall Study|Adverse Event|0|||
144248700|NCT00076999|520108023|FG004|Overall Study|Adverse Event|2|||
144248701|NCT00076999|520108019|FG000|Overall Study|Protocol Violation|0|||
144248702|NCT00076999|520108020|FG001|Overall Study|Protocol Violation|3|||
144248703|NCT00076999|520108021|FG002|Overall Study|Protocol Violation|4|||
144248704|NCT00076999|520108022|FG003|Overall Study|Protocol Violation|0|||
144248705|NCT00076999|520108023|FG004|Overall Study|Protocol Violation|9|||
144248706|NCT00076999|520108019|FG000|Overall Study|Lost to Follow-up|2|||
144248707|NCT00076999|520108020|FG001|Overall Study|Lost to Follow-up|1|||
144248708|NCT00076999|520108021|FG002|Overall Study|Lost to Follow-up|0|||
144248709|NCT00076999|520108022|FG003|Overall Study|Lost to Follow-up|0|||
144248710|NCT00076999|520108023|FG004|Overall Study|Lost to Follow-up|0|||
144248711|NCT00076999|520108019|FG000|Overall Study|Withdrawal by Subject|0|||
144248712|NCT00076999|520108020|FG001|Overall Study|Withdrawal by Subject|4|||
144248713|NCT00076999|520108021|FG002|Overall Study|Withdrawal by Subject|3|||
144248714|NCT00076999|520108022|FG003|Overall Study|Withdrawal by Subject|0|||
144248715|NCT00076999|520108023|FG004|Overall Study|Withdrawal by Subject|1|||
144248716|NCT00076999|520108019|FG000|Overall Study|Other reason (not specified)|8|||
144248717|NCT00076999|520108020|FG001|Overall Study|Other reason (not specified)|8|||
144248718|NCT00076999|520108021|FG002|Overall Study|Other reason (not specified)|4|||
144248719|NCT00076999|520108022|FG003|Overall Study|Other reason (not specified)|1|||
144248720|NCT00076999|520108023|FG004|Overall Study|Other reason (not specified)|13|||
144248721|NCT00990665|520108026|FG000|Overall Study|Unsuccessful Implant|8|||
144248722|NCT00990665|520108026|FG000|Overall Study|Death|29|||
144248723|NCT00990665|520108026|FG000|Overall Study|Heart Transplant|1|||
144248724|NCT00990665|520108026|FG000|Overall Study|Withdrawal by Subject|6|||
144248725|NCT00990665|520108026|FG000|Overall Study|Lost to Follow-up|1|||
144248726|NCT00990665|520108026|FG000|Overall Study|System Explant|3|||
144248727|NCT02603562|520108027|FG000|Overall Study|Lost to Follow-up|1|||
144248728|NCT02079636|520108033|FG000|Overall Study|Death|2|||
144248729|NCT02079636|520108034|FG001|Overall Study|Death|1|||
144248730|NCT02079636|520108035|FG002|Overall Study|Death|0|||
144248731|NCT02079636|520108036|FG003|Overall Study|Death|5|||
144248732|NCT02079636|520108037|FG004|Overall Study|Death|1|||
144248733|NCT02079636|520108038|FG005|Overall Study|Death|2|||
144248734|NCT02079636|520108039|FG006|Overall Study|Death|1|||
144248735|NCT02079636|520108040|FG007|Overall Study|Death|0|||
144248736|NCT02079636|520108041|FG008|Overall Study|Death|0|||
144248737|NCT02079636|520108042|FG009|Overall Study|Death|0|||
144248738|NCT02079636|520108043|FG010|Overall Study|Death|0|||
144248739|NCT02079636|520108044|FG011|Overall Study|Death|1|||
144248740|NCT02079636|520108045|FG012|Overall Study|Death|1|||
144590636|NCT00192647|521364056|FG000|Overall Study|Adverse Event|35|||
144590637|NCT00192647|521364057|FG001|Overall Study|Adverse Event|29|||
144590638|NCT00192647|521364056|FG000|Overall Study|Laboratory Test Abnormality|4|||
144590639|NCT00192647|521364057|FG001|Overall Study|Laboratory Test Abnormality|2|||
144590640|NCT00192647|521364056|FG000|Overall Study|Insufficient Therapeutic Response|53|||
144590641|NCT00192647|521364057|FG001|Overall Study|Insufficient Therapeutic Response|83|||
144590642|NCT00192647|521364056|FG000|Overall Study|Entry Criteria Violation|6|||
144590643|NCT00192647|521364057|FG001|Overall Study|Entry Criteria Violation|6|||
144372418|NCT00145158|520572944|FG000|Overall Study|premature withdrawal|2|||
144372419|NCT00145158|520572945|FG001|Overall Study|premature withdrawal|3|||
144372420|NCT02687191|520572946|FG000|Overall Study|Death|0|||
144372421|NCT02687191|520572947|FG001|Overall Study|Death|1|||
144372422|NCT02687191|520572948|FG002|Overall Study|Death|1|||
144372423|NCT02687191|520572949|FG003|Overall Study|Death|0|||
144372424|NCT02687191|520572950|FG004|Overall Study|Death|1|||
144372425|NCT02687191|520572951|FG005|Overall Study|Death|1|||
144372426|NCT02687191|520572946|FG000|Overall Study|Withdrawal by Subject|0|||
144372427|NCT02687191|520572947|FG001|Overall Study|Withdrawal by Subject|0|||
144372428|NCT02687191|520572948|FG002|Overall Study|Withdrawal by Subject|0|||
144372429|NCT02687191|520572949|FG003|Overall Study|Withdrawal by Subject|1|||
144372430|NCT02687191|520572950|FG004|Overall Study|Withdrawal by Subject|0|||
144372431|NCT02687191|520572951|FG005|Overall Study|Withdrawal by Subject|0|||
144372432|NCT03180840|520572952|FG000|Overall Study|Withdrawal by Subject|1|||
144372433|NCT01788358|520572956|FG000|Overall Study|Other|11|||
144372434|NCT01788358|520572956|FG000|Overall Study|Logistical difficulties|1|||
144372435|NCT01788358|520572956|FG000|Overall Study|Lost to Follow-up|5|||
144372436|NCT01788358|520572956|FG000|Overall Study|Protocol Violation|3|||
144372437|NCT01788358|520572956|FG000|Overall Study|Withdrawal by Subject|26|||
144372438|NCT01788358|520572956|FG000|Overall Study|Lack of Efficacy|1|||
144372439|NCT01788358|520572956|FG000|Overall Study|Adverse Event|51|||
144372440|NCT01227018|520572957|FG000|Overall Study|Disease progression|9|||
144372441|NCT01227018|520572957|FG000|Overall Study|Toxicity|2|||
144372442|NCT01227018|520572957|FG000|Overall Study|Withdrew after beginning treatment|4|||
144372443|NCT02948634|520572958|FG000|Overall Study|Lack of efficacy and study suspended|10|||
144372444|NCT02948634|520572959|FG001|Overall Study|Lack of efficacy and study suspended|2|||
144372445|NCT01413204|520572962|FG000|Overall Study|Adverse Event|1|||
144372446|NCT01413204|520572963|FG001|Overall Study|Adverse Event|2|||
144372447|NCT01413204|520572964|FG002|Overall Study|Adverse Event|2|||
144372448|NCT01413204|520572962|FG000|Overall Study|Physician Decision|3|||
144372449|NCT01413204|520572963|FG001|Overall Study|Physician Decision|0|||
144372450|NCT01413204|520572964|FG002|Overall Study|Physician Decision|2|||
144372451|NCT01413204|520572962|FG000|Overall Study|Withdrawal by Subject|1|||
144372452|NCT01413204|520572963|FG001|Overall Study|Withdrawal by Subject|4|||
144372453|NCT01413204|520572964|FG002|Overall Study|Withdrawal by Subject|4|||
144372454|NCT01413204|520572962|FG000|Overall Study|Clearly not eligible for the study|0|||
144372455|NCT01413204|520572963|FG001|Overall Study|Clearly not eligible for the study|0|||
144372456|NCT01413204|520572964|FG002|Overall Study|Clearly not eligible for the study|1|||
144372457|NCT01413204|520572962|FG000|Overall Study|Fasting plasma glucose level increased|1|||
144372458|NCT01413204|520572963|FG001|Overall Study|Fasting plasma glucose level increased|0|||
144372459|NCT01413204|520572964|FG002|Overall Study|Fasting plasma glucose level increased|10|||
144372460|NCT00753649|520572965|FG000|Overall Study|Migrated/moved from study area|1|||
144372461|NCT00753649|520572966|FG001|Overall Study|Migrated/moved from study area|0|||
144372462|NCT00753649|520572965|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
144372463|NCT00753649|520572966|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
144372464|NCT00753649|520572965|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
144372465|NCT00753649|520572966|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
144372466|NCT00753649|520572965|FG000|Overall Study|Protocol Violation|2|||
144372467|NCT00753649|520572966|FG001|Overall Study|Protocol Violation|0|||
144372468|NCT00499616|520572967|FG000|Overall Study|Death|1|||
144372469|NCT00499616|520572968|FG001|Overall Study|Death|5|||
144372470|NCT00499616|520572969|FG002|Overall Study|Death|3|||
144590644|NCT00192647|521364056|FG000|Overall Study|Protocol Violation|3|||
144372471|NCT00499616|520572970|FG003|Overall Study|Death|1|||
144372472|NCT00499616|520572967|FG000|Overall Study|Lack of Efficacy|5|||
144372473|NCT00499616|520572968|FG001|Overall Study|Lack of Efficacy|0|||
144372474|NCT00499616|520572969|FG002|Overall Study|Lack of Efficacy|19|||
144590645|NCT00192647|521364057|FG001|Overall Study|Protocol Violation|1|||
144372475|NCT00499616|520572970|FG003|Overall Study|Lack of Efficacy|0|||
144372476|NCT00499616|520572967|FG000|Overall Study|Lost to Follow-up|0|||
144372477|NCT00499616|520572968|FG001|Overall Study|Lost to Follow-up|0|||
144372478|NCT00499616|520572969|FG002|Overall Study|Lost to Follow-up|1|||
144372479|NCT00499616|520572970|FG003|Overall Study|Lost to Follow-up|0|||
144372480|NCT00499616|520572967|FG000|Overall Study|Physician Decision|6|||
144372481|NCT00499616|520572968|FG001|Overall Study|Physician Decision|16|||
144372482|NCT00499616|520572969|FG002|Overall Study|Physician Decision|9|||
144372483|NCT00499616|520572970|FG003|Overall Study|Physician Decision|0|||
144372484|NCT00499616|520572967|FG000|Overall Study|Withdrawal by Subject|1|||
144372485|NCT00499616|520572968|FG001|Overall Study|Withdrawal by Subject|0|||
144372486|NCT00499616|520572969|FG002|Overall Study|Withdrawal by Subject|1|||
144372487|NCT00499616|520572970|FG003|Overall Study|Withdrawal by Subject|0|||
144372488|NCT00499616|520572967|FG000|Overall Study|Ineligible|1|||
144372489|NCT00499616|520572968|FG001|Overall Study|Ineligible|2|||
144372490|NCT00499616|520572969|FG002|Overall Study|Ineligible|0|||
144372491|NCT00499616|520572970|FG003|Overall Study|Ineligible|15|||
144372492|NCT00499616|520572967|FG000|Overall Study|Not evaluable|0|||
144372493|NCT00499616|520572968|FG001|Overall Study|Not evaluable|0|||
144372494|NCT00499616|520572969|FG002|Overall Study|Not evaluable|0|||
144372495|NCT00499616|520572970|FG003|Overall Study|Not evaluable|41|||
144372496|NCT00499616|520572967|FG000|Overall Study|Patient/Parent Refusal|1|||
144372497|NCT00499616|520572968|FG001|Overall Study|Patient/Parent Refusal|5|||
144372498|NCT00499616|520572969|FG002|Overall Study|Patient/Parent Refusal|3|||
144372499|NCT00499616|520572970|FG003|Overall Study|Patient/Parent Refusal|0|||
144372500|NCT01864603|520572971|FG000|Stage 2|DSMB design modification|86056|||
144372501|NCT01864603|520572972|FG001|Stage 2|DSMB design modification|92558|||
144372502|NCT00330967|520572973|FG000|Overall Study|Withdrawal by Subject|0|||
144372503|NCT00330967|520572974|FG001|Overall Study|Withdrawal by Subject|5|||
144372504|NCT00330967|520572973|FG000|Overall Study|Physician Decision|0|||
144372505|NCT00330967|520572974|FG001|Overall Study|Physician Decision|9|||
144372506|NCT00859456|520572975|FG000|Overall Study|Adverse Event|3|||
144372507|NCT00859456|520572975|FG000|Overall Study|Progressive disease|2|||
144372508|NCT00859456|520572975|FG000|Overall Study|Non-compliance|3|||
144372509|NCT02578706|520572978|FG000|Overall Study|Withdrawal by Subject|1|||
144372510|NCT02578706|520572979|FG001|Overall Study|Withdrawal by Subject|0|||
144372511|NCT02578706|520572980|FG002|Overall Study|Withdrawal by Subject|0|||
144372512|NCT02578706|520572978|FG000|Overall Study|Lost to Follow-up|0|||
144372513|NCT02578706|520572979|FG001|Overall Study|Lost to Follow-up|4|||
144248741|NCT02079636|520108046|FG013|Overall Study|Death|0|||
144248742|NCT02079636|520108047|FG014|Overall Study|Death|2|||
144248743|NCT02079636|520108033|FG000|Overall Study|Adverse Event|1|||
144248744|NCT02079636|520108034|FG001|Overall Study|Adverse Event|1|||
144248745|NCT02079636|520108035|FG002|Overall Study|Adverse Event|0|||
144248746|NCT02079636|520108036|FG003|Overall Study|Adverse Event|1|||
144248747|NCT02079636|520108037|FG004|Overall Study|Adverse Event|1|||
144248748|NCT02079636|520108038|FG005|Overall Study|Adverse Event|2|||
144248749|NCT02079636|520108039|FG006|Overall Study|Adverse Event|0|||
144248750|NCT02079636|520108040|FG007|Overall Study|Adverse Event|0|||
144248751|NCT02079636|520108041|FG008|Overall Study|Adverse Event|0|||
144248752|NCT02079636|520108042|FG009|Overall Study|Adverse Event|0|||
144248753|NCT02079636|520108043|FG010|Overall Study|Adverse Event|0|||
144248754|NCT02079636|520108044|FG011|Overall Study|Adverse Event|0|||
144248755|NCT02079636|520108045|FG012|Overall Study|Adverse Event|0|||
144248756|NCT02079636|520108046|FG013|Overall Study|Adverse Event|0|||
144248757|NCT02079636|520108047|FG014|Overall Study|Adverse Event|0|||
144248758|NCT02079636|520108033|FG000|Overall Study|Progressive disease|0|||
144248759|NCT02079636|520108034|FG001|Overall Study|Progressive disease|0|||
144248760|NCT02079636|520108035|FG002|Overall Study|Progressive disease|0|||
144248761|NCT02079636|520108036|FG003|Overall Study|Progressive disease|2|||
144248762|NCT02079636|520108037|FG004|Overall Study|Progressive disease|0|||
144248763|NCT02079636|520108038|FG005|Overall Study|Progressive disease|0|||
144248764|NCT02079636|520108039|FG006|Overall Study|Progressive disease|0|||
144248765|NCT02079636|520108040|FG007|Overall Study|Progressive disease|0|||
144248766|NCT02079636|520108041|FG008|Overall Study|Progressive disease|0|||
144248767|NCT02079636|520108042|FG009|Overall Study|Progressive disease|0|||
144248768|NCT02079636|520108043|FG010|Overall Study|Progressive disease|0|||
144248769|NCT02079636|520108044|FG011|Overall Study|Progressive disease|0|||
144248770|NCT02079636|520108045|FG012|Overall Study|Progressive disease|1|||
144248771|NCT02079636|520108046|FG013|Overall Study|Progressive disease|0|||
144248772|NCT02079636|520108047|FG014|Overall Study|Progressive disease|0|||
144248773|NCT02079636|520108033|FG000|Overall Study|Withdrawal by Subject|0|||
144248774|NCT02079636|520108034|FG001|Overall Study|Withdrawal by Subject|0|||
144248775|NCT02079636|520108035|FG002|Overall Study|Withdrawal by Subject|0|||
144248776|NCT02079636|520108036|FG003|Overall Study|Withdrawal by Subject|4|||
144248777|NCT02079636|520108037|FG004|Overall Study|Withdrawal by Subject|0|||
144248778|NCT02079636|520108038|FG005|Overall Study|Withdrawal by Subject|1|||
144248779|NCT02079636|520108039|FG006|Overall Study|Withdrawal by Subject|0|||
144372514|NCT02578706|520572980|FG002|Overall Study|Lost to Follow-up|0|||
144372515|NCT02578706|520572978|FG000|Overall Study|Physician Decision|0|||
144372516|NCT02578706|520572979|FG001|Overall Study|Physician Decision|1|||
144372517|NCT02578706|520572980|FG002|Overall Study|Physician Decision|0|||
144372518|NCT05782179|520572987|FG000|Overall Study|Adverse Event|0|||
144372519|NCT05782179|520572988|FG001|Overall Study|Adverse Event|0|||
144372520|NCT05782179|520572989|FG002|Overall Study|Adverse Event|2|||
144372521|NCT05782179|520572990|FG003|Overall Study|Adverse Event|0|||
144372522|NCT05782179|520572991|FG004|Overall Study|Adverse Event|0|||
144372523|NCT05782179|520572992|FG005|Overall Study|Adverse Event|0|||
144372524|NCT06170242|520572993|FG000|Overall Study|Lost to Follow-up|0|||
144372525|NCT06170242|520572994|FG001|Overall Study|Lost to Follow-up|0|||
144372526|NCT06170242|520572995|FG002|Overall Study|Lost to Follow-up|1|||
144372527|NCT06170242|520572996|FG003|Overall Study|Lost to Follow-up|1|||
144372528|NCT03682770|520573006|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
144372529|NCT03682770|520573007|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
144372530|NCT03682770|520573008|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
144372531|NCT03682770|520573009|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
144372532|NCT03682770|520573010|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
144372533|NCT03682770|520573011|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
144372534|NCT03682770|520573012|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
144372535|NCT03682770|520573006|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
144372536|NCT03682770|520573007|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
144372537|NCT03682770|520573008|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
144372538|NCT03682770|520573009|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
144372539|NCT03682770|520573010|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
144372540|NCT03682770|520573011|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
144372541|NCT03682770|520573012|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
144372542|NCT03682770|520573006|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
144372543|NCT03682770|520573007|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
144372544|NCT03682770|520573008|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
144372545|NCT03682770|520573009|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
144372546|NCT03682770|520573010|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
144372547|NCT03682770|520573011|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
144372548|NCT03682770|520573012|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
144372549|NCT03682770|520573006|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
144372550|NCT03682770|520573007|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
144372551|NCT03682770|520573008|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
144372552|NCT03682770|520573009|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
144372553|NCT03682770|520573010|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
144372554|NCT03682770|520573011|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
144372555|NCT03682770|520573012|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
144372556|NCT03682770|520573006|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
144372557|NCT03682770|520573007|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
144372558|NCT03682770|520573008|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
144372559|NCT03682770|520573009|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
144372560|NCT03682770|520573010|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
144248780|NCT02079636|520108040|FG007|Overall Study|Withdrawal by Subject|0|||
144248781|NCT02079636|520108041|FG008|Overall Study|Withdrawal by Subject|0|||
144248782|NCT02079636|520108042|FG009|Overall Study|Withdrawal by Subject|2|||
144248783|NCT02079636|520108043|FG010|Overall Study|Withdrawal by Subject|1|||
144248784|NCT02079636|520108044|FG011|Overall Study|Withdrawal by Subject|1|||
144248785|NCT02079636|520108045|FG012|Overall Study|Withdrawal by Subject|1|||
144248786|NCT02079636|520108046|FG013|Overall Study|Withdrawal by Subject|0|||
144248787|NCT02079636|520108047|FG014|Overall Study|Withdrawal by Subject|2|||
144248788|NCT02079636|520108033|FG000|Overall Study|Physician Decision|0|||
144248789|NCT02079636|520108034|FG001|Overall Study|Physician Decision|0|||
144248790|NCT02079636|520108035|FG002|Overall Study|Physician Decision|0|||
144248791|NCT02079636|520108036|FG003|Overall Study|Physician Decision|0|||
144248792|NCT02079636|520108037|FG004|Overall Study|Physician Decision|0|||
144248793|NCT02079636|520108038|FG005|Overall Study|Physician Decision|1|||
144248794|NCT02079636|520108039|FG006|Overall Study|Physician Decision|0|||
144248795|NCT02079636|520108040|FG007|Overall Study|Physician Decision|0|||
144372561|NCT03682770|520573011|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
144721711|NCT01595009|521835275|FG000|Core|Patients completed per protocol|85|||
144721712|NCT01595009|521835276|FG001|Core|Patients completed per protocol|44|||
144248796|NCT02079636|520108041|FG008|Overall Study|Physician Decision|0|||
144248797|NCT02079636|520108042|FG009|Overall Study|Physician Decision|1|||
144248798|NCT02079636|520108043|FG010|Overall Study|Physician Decision|1|||
144248799|NCT02079636|520108044|FG011|Overall Study|Physician Decision|0|||
144248800|NCT02079636|520108045|FG012|Overall Study|Physician Decision|0|||
144248801|NCT02079636|520108046|FG013|Overall Study|Physician Decision|0|||
144248802|NCT02079636|520108047|FG014|Overall Study|Physician Decision|1|||
144248803|NCT02079636|520108033|FG000|Overall Study|Lost to Follow-up|0|||
144248804|NCT02079636|520108034|FG001|Overall Study|Lost to Follow-up|0|||
144248805|NCT02079636|520108035|FG002|Overall Study|Lost to Follow-up|0|||
144510825|NCT01985334|521070807|FG007|Overall Study|Other|7|||
144510826|NCT01985334|521070800|FG000|Overall Study|Protocol deviation|6|||
144510827|NCT01985334|521070801|FG001|Overall Study|Protocol deviation|31|||
144510828|NCT01985334|521070802|FG002|Overall Study|Protocol deviation|25|||
144510829|NCT01985334|521070803|FG003|Overall Study|Protocol deviation|84|||
144510830|NCT01985334|521070804|FG004|Overall Study|Protocol deviation|17|||
144248806|NCT02079636|520108036|FG003|Overall Study|Lost to Follow-up|0|||
144248807|NCT02079636|520108037|FG004|Overall Study|Lost to Follow-up|0|||
144248808|NCT02079636|520108038|FG005|Overall Study|Lost to Follow-up|0|||
144248809|NCT02079636|520108039|FG006|Overall Study|Lost to Follow-up|0|||
144248810|NCT02079636|520108040|FG007|Overall Study|Lost to Follow-up|1|||
144248811|NCT02079636|520108041|FG008|Overall Study|Lost to Follow-up|0|||
144248812|NCT02079636|520108042|FG009|Overall Study|Lost to Follow-up|0|||
144248813|NCT02079636|520108043|FG010|Overall Study|Lost to Follow-up|0|||
144248814|NCT02079636|520108044|FG011|Overall Study|Lost to Follow-up|0|||
144248815|NCT02079636|520108045|FG012|Overall Study|Lost to Follow-up|0|||
144248816|NCT02079636|520108046|FG013|Overall Study|Lost to Follow-up|0|||
144248817|NCT02079636|520108047|FG014|Overall Study|Lost to Follow-up|0|||
144248818|NCT00561470|520108048|FG000|Overall Study|Adverse Event|74|||
144248819|NCT00561470|520108049|FG001|Overall Study|Adverse Event|163|||
144248820|NCT00561470|520108048|FG000|Overall Study|Disease progression|437|||
144248821|NCT00561470|520108049|FG001|Overall Study|Disease progression|305|||
144248822|NCT00561470|520108048|FG000|Overall Study|poor compliance to protocol|4|||
144248823|NCT00561470|520108049|FG001|Overall Study|poor compliance to protocol|4|||
144248824|NCT00561470|520108048|FG000|Overall Study|Lost to Follow-up|2|||
144248825|NCT00561470|520108049|FG001|Overall Study|Lost to Follow-up|0|||
144248826|NCT00561470|520108048|FG000|Overall Study|Physician Decision|21|||
144248827|NCT00561470|520108049|FG001|Overall Study|Physician Decision|20|||
144248828|NCT00561470|520108048|FG000|Overall Study|Consent Withdrawn|2|||
144248829|NCT00561470|520108049|FG001|Overall Study|Consent Withdrawn|6|||
144248830|NCT00561470|520108048|FG000|Overall Study|Subject request|43|||
144248831|NCT00561470|520108049|FG001|Overall Study|Subject request|77|||
144248832|NCT00561470|520108048|FG000|Overall Study|Metastatic surgery|10|||
144248833|NCT00561470|520108049|FG001|Overall Study|Metastatic surgery|12|||
144510831|NCT01985334|521070805|FG005|Overall Study|Protocol deviation|47|||
144590646|NCT00192647|521364056|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
144248834|NCT00561470|520108048|FG000|Overall Study|Unauthorized procedure|3|||
144248835|NCT00561470|520108049|FG001|Overall Study|Unauthorized procedure|1|||
144248836|NCT00561470|520108048|FG000|Overall Study|Randomized but not treated|5|||
144248837|NCT00561470|520108049|FG001|Overall Study|Randomized but not treated|5|||
144248838|NCT00561470|520108048|FG000|Overall Study|Missed visit window|1|||
144248839|NCT00561470|520108049|FG001|Overall Study|Missed visit window|4|||
144248840|NCT00561470|520108048|FG000|Overall Study|Planning surgery|1|||
144248841|NCT00561470|520108049|FG001|Overall Study|Planning surgery|1|||
144248842|NCT00561470|520108048|FG000|Overall Study|Ongoing Treatment|11|||
144248843|NCT00561470|520108049|FG001|Overall Study|Ongoing Treatment|14|||
144248844|NCT01001598|520108052|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
144248845|NCT01001598|520108052|FG000|Overall Study|Adverse Event|1|||
144248846|NCT05079230|520108061|FG000|Overall Study|Study Terminated by Sponsor|101|||
144248847|NCT05079230|520108062|FG001|Overall Study|Study Terminated by Sponsor|102|||
144248848|NCT05079230|520108061|FG000|Overall Study|Death|72|||
144248849|NCT05079230|520108062|FG001|Overall Study|Death|66|||
144248850|NCT05079230|520108061|FG000|Overall Study|Withdrew Consent|16|||
144248851|NCT05079230|520108062|FG001|Overall Study|Withdrew Consent|18|||
144590647|NCT00192647|521364057|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
144590648|NCT00192647|521364056|FG000|Overall Study|Failure to Return|11|||
144248852|NCT05079230|520108061|FG000|Overall Study|Lost to Follow-up|0|||
144248853|NCT05079230|520108062|FG001|Overall Study|Lost to Follow-up|3|||
144248854|NCT02824562|520109945|FG000|Overall Study|Lost to Follow-up|3|||
144248855|NCT02824562|520109946|FG001|Overall Study|Lost to Follow-up|4|||
144248856|NCT02824562|520109945|FG000|Overall Study|Death|0|||
144248857|NCT02824562|520109946|FG001|Overall Study|Death|1|||
144248858|NCT02168777|520109947|FG000|Overall Study|Withdrawal by Subject|1|||
144248859|NCT02168777|520109948|FG001|Overall Study|Withdrawal by Subject|0|||
144248860|NCT02168777|520109949|FG002|Overall Study|Withdrawal by Subject|2|||
144248861|NCT02168777|520109947|FG000|Overall Study|Adverse Event|1|||
144248862|NCT02168777|520109948|FG001|Overall Study|Adverse Event|0|||
144248863|NCT02168777|520109949|FG002|Overall Study|Adverse Event|1|||
144248864|NCT02168777|520109947|FG000|Overall Study|Disease recurrence|0|||
144248865|NCT02168777|520109948|FG001|Overall Study|Disease recurrence|0|||
144248866|NCT02168777|520109949|FG002|Overall Study|Disease recurrence|1|||
144248867|NCT02168777|520109947|FG000|Overall Study|Radiological disease progression|0|||
144248868|NCT02168777|520109948|FG001|Overall Study|Radiological disease progression|5|||
144248869|NCT02168777|520109949|FG002|Overall Study|Radiological disease progression|5|||
144248870|NCT02168777|520109947|FG000|Overall Study|Clinical disease progression|0|||
144510832|NCT01985334|521070806|FG006|Overall Study|Protocol deviation|15|||
144590649|NCT00192647|521364057|FG001|Overall Study|Failure to Return|13|||
144372562|NCT03682770|520573012|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
144372563|NCT03682770|520573006|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
144372564|NCT03682770|520573007|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
144372565|NCT03682770|520573008|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
144372566|NCT03682770|520573009|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
144372567|NCT03682770|520573010|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
144372568|NCT03682770|520573011|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
144372569|NCT03682770|520573012|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
144372570|NCT03682770|520573006|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
144372571|NCT03682770|520573007|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
144372572|NCT03682770|520573008|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
144372573|NCT03682770|520573009|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
144510833|NCT01985334|521070807|FG007|Overall Study|Protocol deviation|42|||
144372574|NCT03682770|520573010|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
144372575|NCT03682770|520573011|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
144372576|NCT03682770|520573012|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
144372577|NCT03682770|520573006|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
144372578|NCT03682770|520573007|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
144372579|NCT03682770|520573008|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
144372580|NCT03682770|520573009|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
144372581|NCT03682770|520573010|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
144372582|NCT03682770|520573011|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
144372583|NCT03682770|520573012|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
144372584|NCT03682770|520573006|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
144372585|NCT03682770|520573007|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
144372586|NCT03682770|520573008|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
144372587|NCT03682770|520573009|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
144372588|NCT03682770|520573010|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
144372589|NCT03682770|520573011|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
144372590|NCT03682770|520573012|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
144372591|NCT03682770|520573006|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
144372592|NCT03682770|520573007|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
144372593|NCT03682770|520573008|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
144372594|NCT03682770|520573009|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
144372595|NCT03682770|520573010|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
144372596|NCT03682770|520573011|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
144372597|NCT03682770|520573012|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
144372598|NCT03682770|520573006|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
144372599|NCT03682770|520573007|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
144372600|NCT03682770|520573008|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
144372601|NCT03682770|520573009|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
144372602|NCT03682770|520573010|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
144372603|NCT03682770|520573011|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
144372604|NCT03682770|520573012|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
144372605|NCT03682770|520573006|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
144372606|NCT03682770|520573007|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
144372607|NCT03682770|520573008|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
144372608|NCT03682770|520573009|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
144372609|NCT03682770|520573010|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
144372610|NCT03682770|520573011|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
144372611|NCT03682770|520573012|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
144372612|NCT01491607|520573013|FG000|Overall Study|Lost to Follow-up|7|||
144372613|NCT01491607|520573013|FG000|Overall Study|Withdrawal by Subject|3|||
144372614|NCT01317277|520573014|FG000|Overall Study|Lost to Follow-up|3|||
144372615|NCT01317277|520573015|FG001|Overall Study|Lost to Follow-up|1|||
144372616|NCT01317277|520573014|FG000|Overall Study|Lost MEMS|1|||
144372617|NCT01317277|520573015|FG001|Overall Study|Lost MEMS|1|||
144372618|NCT01317277|520573014|FG000|Overall Study|Unable to comply with intervention|1|||
144372619|NCT01317277|520573015|FG001|Overall Study|Unable to comply with intervention|0|||
144372620|NCT01317277|520573014|FG000|Overall Study|Withdrawal by Subject|1|||
144372621|NCT01317277|520573015|FG001|Overall Study|Withdrawal by Subject|0|||
144372622|NCT01317277|520573014|FG000|Overall Study|Adverse Event|1|||
144372623|NCT01317277|520573015|FG001|Overall Study|Adverse Event|0|||
144372624|NCT00774566|520573016|FG000|Overall Study|Protocol Violation|18|||
144372625|NCT00774566|520573017|FG001|Overall Study|Protocol Violation|15|||
144372626|NCT03565497|520573024|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
144372627|NCT03565497|520573025|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
144372628|NCT03565497|520573026|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
144372629|NCT03565497|520573024|FG000|Overall Study|Lost to Follow-up|1|||
144372630|NCT03565497|520573025|FG001|Overall Study|Lost to Follow-up|1|||
144372631|NCT03565497|520573026|FG002|Overall Study|Lost to Follow-up|2|||
144590650|NCT00192647|521364056|FG000|Overall Study|Other/Administrative|5|||
144372632|NCT03565497|520573024|FG000|Overall Study|Withdrawal by Subject|1|||
144372633|NCT03565497|520573025|FG001|Overall Study|Withdrawal by Subject|1|||
144372634|NCT03565497|520573026|FG002|Overall Study|Withdrawal by Subject|1|||
144372635|NCT02999672|520573027|FG000|Overall Study|Death|0|||
144372636|NCT02999672|520573028|FG001|Overall Study|Death|1|||
144372637|NCT02999672|520573027|FG000|Overall Study|Study Terminated by Sponsor|0|||
144372638|NCT02999672|520573028|FG001|Overall Study|Study Terminated by Sponsor|1|||
144372639|NCT02999672|520573027|FG000|Overall Study|Progressive Disease|9|||
144372640|NCT02999672|520573028|FG001|Overall Study|Progressive Disease|5|||
144372641|NCT02999672|520573027|FG000|Overall Study|Adverse Event|4|||
144372642|NCT02999672|520573028|FG001|Overall Study|Adverse Event|0|||
144372643|NCT01385176|520573029|FG000|Randomization Phase|Death|1|||
144372644|NCT01385176|520573030|FG001|Randomization Phase|Death|2|||
144372645|NCT01385176|520573029|FG000|6-18 Month All VNS Active|Death|1|||
144372646|NCT01385176|520573030|FG001|6-18 Month All VNS Active|Death|2|||
144372647|NCT01385176|520573029|FG000|6-18 Month All VNS Active|Physician Decision|0|||
144372648|NCT01385176|520573030|FG001|6-18 Month All VNS Active|Physician Decision|1|||
144372649|NCT01385176|520573029|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
144372650|NCT01385176|520573030|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
144372651|NCT01385176|520573029|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
144372652|NCT01385176|520573030|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
144372653|NCT01075685|520573031|FG000|Overall Study|Protocol Violation|9|||
144372654|NCT01075685|520573032|FG001|Overall Study|Protocol Violation|1|||
144372655|NCT01075685|520573031|FG000|Overall Study|Withdrawal by Subject|20|||
144372656|NCT01075685|520573032|FG001|Overall Study|Withdrawal by Subject|5|||
144372657|NCT01075685|520573031|FG000|Overall Study|Lost to Follow-up|563|||
144372658|NCT01075685|520573032|FG001|Overall Study|Lost to Follow-up|220|||
144372659|NCT02858362|520573035|FG000|Overall Study|Protocol Violation|0|||
144372660|NCT02858362|520573036|FG001|Overall Study|Protocol Violation|1|||
144372661|NCT02858362|520573037|FG002|Overall Study|Protocol Violation|0|||
144372662|NCT02858362|520573035|FG000|Overall Study|Withdrawal by Subject|1|||
144372663|NCT02858362|520573036|FG001|Overall Study|Withdrawal by Subject|0|||
144248871|NCT02168777|520109948|FG001|Overall Study|Clinical disease progression|1|||
144248872|NCT02168777|520109949|FG002|Overall Study|Clinical disease progression|2|||
144248873|NCT02168777|520109947|FG000|Overall Study|Other reason|0|||
144372664|NCT02858362|520573037|FG002|Overall Study|Withdrawal by Subject|0|||
144248874|NCT02168777|520109948|FG001|Overall Study|Other reason|1|||
144248875|NCT02168777|520109949|FG002|Overall Study|Other reason|0|||
144248876|NCT01663857|520109950|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
144248877|NCT01663857|520109951|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
144248878|NCT01663857|520109952|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
144248879|NCT01663857|520109953|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
144248880|NCT01663857|520109950|FG000|Overall Study|Lost to Follow-up|0|||
144248881|NCT01663857|520109951|FG001|Overall Study|Lost to Follow-up|0|||
144248882|NCT01663857|520109952|FG002|Overall Study|Lost to Follow-up|3|||
144248883|NCT01663857|520109953|FG003|Overall Study|Lost to Follow-up|1|||
144248884|NCT01172808|520109954|FG000|Overall Study|Adverse Event|8|||
144248885|NCT01172808|520109955|FG001|Overall Study|Adverse Event|4|||
144248886|NCT01172808|520109956|FG002|Overall Study|Adverse Event|8|||
144248887|NCT01172808|520109957|FG003|Overall Study|Adverse Event|3|||
144248888|NCT01172808|520109954|FG000|Overall Study|Lack of Efficacy|1|||
144248889|NCT01172808|520109955|FG001|Overall Study|Lack of Efficacy|0|||
144248890|NCT01172808|520109956|FG002|Overall Study|Lack of Efficacy|0|||
144248891|NCT01172808|520109957|FG003|Overall Study|Lack of Efficacy|0|||
144248892|NCT01172808|520109954|FG000|Overall Study|Protocol Violation|2|||
144248893|NCT01172808|520109955|FG001|Overall Study|Protocol Violation|2|||
144248894|NCT01172808|520109956|FG002|Overall Study|Protocol Violation|2|||
144248895|NCT01172808|520109957|FG003|Overall Study|Protocol Violation|0|||
144248896|NCT01172808|520109954|FG000|Overall Study|Lost to Follow-up|0|||
144248897|NCT01172808|520109955|FG001|Overall Study|Lost to Follow-up|1|||
144248898|NCT01172808|520109956|FG002|Overall Study|Lost to Follow-up|1|||
144372665|NCT02858362|520573035|FG000|Overall Study|Early Study Termination|0|||
144248899|NCT01172808|520109957|FG003|Overall Study|Lost to Follow-up|3|||
144248900|NCT01172808|520109954|FG000|Overall Study|Withdrawal by Subject|4|||
144248901|NCT01172808|520109955|FG001|Overall Study|Withdrawal by Subject|1|||
144248902|NCT01172808|520109956|FG002|Overall Study|Withdrawal by Subject|3|||
144248903|NCT01172808|520109957|FG003|Overall Study|Withdrawal by Subject|2|||
144248904|NCT01172808|520109954|FG000|Overall Study|Other|6|||
144248905|NCT01172808|520109955|FG001|Overall Study|Other|5|||
144248906|NCT01172808|520109956|FG002|Overall Study|Other|9|||
144248907|NCT01172808|520109957|FG003|Overall Study|Other|7|||
144248908|NCT00290693|520109958|FG000|Overall Study|Withdrawal by Subject|2|||
144248909|NCT05625477|520109959|FG000|Overall Study|Lost to Follow-up|2|||
144248910|NCT05625477|520109960|FG001|Overall Study|Lost to Follow-up|2|||
144248911|NCT05625477|520109961|FG002|Overall Study|Lost to Follow-up|1|||
144248912|NCT05625477|520109962|FG003|Overall Study|Lost to Follow-up|1|||
144248913|NCT05625477|520109963|FG004|Overall Study|Lost to Follow-up|0|||
144248914|NCT05625477|520109959|FG000|Overall Study|Covid quarantine|1|||
144248915|NCT05625477|520109960|FG001|Overall Study|Covid quarantine|0|||
144248916|NCT05625477|520109961|FG002|Overall Study|Covid quarantine|0|||
144248917|NCT05625477|520109962|FG003|Overall Study|Covid quarantine|0|||
144372666|NCT02858362|520573036|FG001|Overall Study|Early Study Termination|0|||
144372667|NCT02858362|520573037|FG002|Overall Study|Early Study Termination|3|||
144372668|NCT02858362|520573035|FG000|Overall Study|Lost to Follow-up|1|||
144372669|NCT02858362|520573036|FG001|Overall Study|Lost to Follow-up|0|||
144372670|NCT02858362|520573037|FG002|Overall Study|Lost to Follow-up|0|||
144372671|NCT00392769|520573038|FG000|Overall Study|Clinical Deterioration|9|||
144372672|NCT00392769|520573038|FG000|Overall Study|Adverse Event|1|||
144372673|NCT02561832|520573039|FG000|Overall Study|Withdrawal by Subject|1|||
144372674|NCT02561832|520573040|FG001|Overall Study|Withdrawal by Subject|1|||
144372675|NCT02561832|520573039|FG000|Overall Study|Adverse Event|3|||
144372676|NCT02561832|520573040|FG001|Overall Study|Adverse Event|0|||
144372677|NCT02561832|520573039|FG000|Overall Study|Disease progression|3|||
144372678|NCT02561832|520573040|FG001|Overall Study|Disease progression|3|||
144372679|NCT03599089|520573044|FG000|Overall Study|Lost to Follow-up|1|||
144372680|NCT03599089|520573045|FG001|Overall Study|Lost to Follow-up|0|||
144372681|NCT03599089|520573046|FG002|Overall Study|Lost to Follow-up|0|||
144372682|NCT03599089|520573047|FG003|Overall Study|Lost to Follow-up|0|||
144372683|NCT03599089|520573044|FG000|Overall Study|Withdrawal by Subject|2|||
144372684|NCT03599089|520573045|FG001|Overall Study|Withdrawal by Subject|1|||
144372685|NCT03599089|520573046|FG002|Overall Study|Withdrawal by Subject|0|||
144372686|NCT03599089|520573047|FG003|Overall Study|Withdrawal by Subject|0|||
144372687|NCT03599089|520573044|FG000|Overall Study|Lack of Efficacy|0|||
144372688|NCT03599089|520573045|FG001|Overall Study|Lack of Efficacy|0|||
144372689|NCT03599089|520573046|FG002|Overall Study|Lack of Efficacy|1|||
144372690|NCT03599089|520573047|FG003|Overall Study|Lack of Efficacy|2|||
144372691|NCT00060840|520573048|FG000|Overall Study|Change in surgical plan|2|||
144372692|NCT00060840|520573049|FG001|Overall Study|Change in surgical plan|6|||
144372693|NCT00060840|520573048|FG000|Overall Study|Death|0|||
144372694|NCT00060840|520573049|FG001|Overall Study|Death|1|||
144372695|NCT00060840|520573048|FG000|Overall Study|Withdrawal by Subject|0|||
144372696|NCT00060840|520573049|FG001|Overall Study|Withdrawal by Subject|1|||
144372697|NCT00060840|520573048|FG000|Overall Study|Subinvestigator unavailable|0|||
144372698|NCT00060840|520573049|FG001|Overall Study|Subinvestigator unavailable|1|||
144372699|NCT00060840|520573048|FG000|Overall Study|Physician Decision|1|||
144372700|NCT00060840|520573049|FG001|Overall Study|Physician Decision|0|||
144372701|NCT00060840|520573048|FG000|Overall Study|Other|1|||
144372702|NCT00060840|520573049|FG001|Overall Study|Other|0|||
144372703|NCT00357006|520573054|FG000|Overall Study|Lost to Follow-up|1|||
144372704|NCT00357006|520573055|FG001|Overall Study|Lost to Follow-up|2|||
144372705|NCT00357006|520573056|FG002|Overall Study|Lost to Follow-up|1|||
144372706|NCT00357006|520573054|FG000|Overall Study|Withdrawal by Subject|1|||
144372707|NCT00357006|520573055|FG001|Overall Study|Withdrawal by Subject|3|||
144372708|NCT00357006|520573056|FG002|Overall Study|Withdrawal by Subject|2|||
144372709|NCT03710161|520573057|FG000|Overall Study|Study halted due to COVID pandemic|3|||
144372710|NCT03710161|520573058|FG001|Overall Study|Study halted due to COVID pandemic|2|||
144372711|NCT05340478|520573063|FG000|Overall Study|Scheduling Issues|10|||
144372712|NCT05340478|520573064|FG001|Overall Study|Scheduling Issues|4|||
144372713|NCT05340478|520573063|FG000|Overall Study|Neither member of dyad started treatment|2|||
144372714|NCT05340478|520573064|FG001|Overall Study|Neither member of dyad started treatment|2|||
144372715|NCT05340478|520573063|FG000|Overall Study|Withdrawn from study|2|||
144372716|NCT05340478|520573064|FG001|Overall Study|Withdrawn from study|2|||
144372717|NCT05340478|520573063|FG000|Overall Study|Lost to Follow-up|1|||
144372718|NCT05340478|520573064|FG001|Overall Study|Lost to Follow-up|4|||
144372719|NCT00092443|520573065|FG000|Overall Study|Adverse Event|9|||
144372720|NCT00092443|520573066|FG001|Overall Study|Adverse Event|13|||
144372721|NCT00092443|520573065|FG000|Overall Study|Lost to Follow-up|7|||
144372722|NCT00092443|520573066|FG001|Overall Study|Lost to Follow-up|3|||
144372723|NCT00092443|520573065|FG000|Overall Study|Protocol Violation|11|||
144372724|NCT00092443|520573066|FG001|Overall Study|Protocol Violation|9|||
144510834|NCT01985334|521070800|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
144510835|NCT01985334|521070801|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
144721713|NCT01595009|521835277|FG002|Core|Patients completed per protocol|0|||
144372725|NCT00092443|520573065|FG000|Overall Study|Withdrawal by Subject|9|||
144372726|NCT00092443|520573066|FG001|Overall Study|Withdrawal by Subject|11|||
144372727|NCT00092443|520573065|FG000|Overall Study|Moved|5|||
144372728|NCT00092443|520573066|FG001|Overall Study|Moved|5|||
144372729|NCT00092443|520573065|FG000|Overall Study|Other|17|||
144372730|NCT00092443|520573066|FG001|Overall Study|Other|13|||
144372731|NCT02963506|520573068|FG000|Double-Blind Period|Adverse Event|0|||
144372732|NCT02963506|520573069|FG001|Double-Blind Period|Adverse Event|0|||
144372733|NCT02963506|520573070|FG002|Double-Blind Period|Adverse Event|1|||
144721714|NCT01595009|521835278|FG003|Core|Patients completed per protocol|0|||
144372734|NCT02963506|520573071|FG003|Double-Blind Period|Adverse Event|0|||
144372735|NCT02963506|520573072|FG004|Double-Blind Period|Adverse Event|0|||
144372736|NCT02963506|520573073|FG005|Double-Blind Period|Adverse Event|0|||
144372737|NCT02963506|520573074|FG006|Double-Blind Period|Adverse Event|0|||
144372738|NCT02963506|520573075|FG007|Double-Blind Period|Adverse Event|0|||
144372739|NCT02963506|520573076|FG008|Double-Blind Period|Adverse Event|0|||
144372740|NCT02963506|520573077|FG009|Double-Blind Period|Adverse Event|0|||
144372741|NCT02963506|520573078|FG010|Double-Blind Period|Adverse Event|0|||
144372742|NCT02963506|520573079|FG011|Double-Blind Period|Adverse Event|0|||
144372743|NCT02963506|520573080|FG012|Double-Blind Period|Adverse Event|0|||
144372744|NCT02963506|520573068|FG000|Double-Blind Period|Death|0|||
144372745|NCT02963506|520573069|FG001|Double-Blind Period|Death|0|||
144372746|NCT02963506|520573070|FG002|Double-Blind Period|Death|0|||
144372747|NCT02963506|520573071|FG003|Double-Blind Period|Death|1|||
144372748|NCT02963506|520573072|FG004|Double-Blind Period|Death|0|||
144372749|NCT02963506|520573073|FG005|Double-Blind Period|Death|0|||
144372750|NCT02963506|520573074|FG006|Double-Blind Period|Death|0|||
144372751|NCT02963506|520573075|FG007|Double-Blind Period|Death|0|||
144372752|NCT02963506|520573076|FG008|Double-Blind Period|Death|0|||
144372753|NCT02963506|520573077|FG009|Double-Blind Period|Death|0|||
144372754|NCT02963506|520573078|FG010|Double-Blind Period|Death|0|||
144372755|NCT02963506|520573079|FG011|Double-Blind Period|Death|0|||
144372756|NCT02963506|520573080|FG012|Double-Blind Period|Death|0|||
144372757|NCT02963506|520573068|FG000|Double-Blind Period|Lost to Follow-up|0|||
144372758|NCT02963506|520573069|FG001|Double-Blind Period|Lost to Follow-up|1|||
144372759|NCT02963506|520573070|FG002|Double-Blind Period|Lost to Follow-up|0|||
144372760|NCT02963506|520573071|FG003|Double-Blind Period|Lost to Follow-up|0|||
144372761|NCT02963506|520573072|FG004|Double-Blind Period|Lost to Follow-up|0|||
144372762|NCT02963506|520573073|FG005|Double-Blind Period|Lost to Follow-up|0|||
144372763|NCT02963506|520573074|FG006|Double-Blind Period|Lost to Follow-up|0|||
144372764|NCT02963506|520573075|FG007|Double-Blind Period|Lost to Follow-up|0|||
144372765|NCT02963506|520573076|FG008|Double-Blind Period|Lost to Follow-up|0|||
144372766|NCT02963506|520573077|FG009|Double-Blind Period|Lost to Follow-up|0|||
144372767|NCT02963506|520573078|FG010|Double-Blind Period|Lost to Follow-up|0|||
144372768|NCT02963506|520573079|FG011|Double-Blind Period|Lost to Follow-up|0|||
144372769|NCT02963506|520573080|FG012|Double-Blind Period|Lost to Follow-up|0|||
144372770|NCT02963506|520573068|FG000|Double-Blind Period|Withdrawal by Subject|0|||
144372771|NCT02963506|520573069|FG001|Double-Blind Period|Withdrawal by Subject|0|||
144372772|NCT02963506|520573070|FG002|Double-Blind Period|Withdrawal by Subject|1|||
144372773|NCT02963506|520573071|FG003|Double-Blind Period|Withdrawal by Subject|1|||
144372774|NCT02963506|520573072|FG004|Double-Blind Period|Withdrawal by Subject|0|||
144372775|NCT02963506|520573073|FG005|Double-Blind Period|Withdrawal by Subject|0|||
144372776|NCT02963506|520573074|FG006|Double-Blind Period|Withdrawal by Subject|0|||
144372777|NCT02963506|520573075|FG007|Double-Blind Period|Withdrawal by Subject|0|||
144372778|NCT02963506|520573076|FG008|Double-Blind Period|Withdrawal by Subject|0|||
144372779|NCT02963506|520573077|FG009|Double-Blind Period|Withdrawal by Subject|0|||
144372780|NCT02963506|520573078|FG010|Double-Blind Period|Withdrawal by Subject|0|||
144372781|NCT02963506|520573079|FG011|Double-Blind Period|Withdrawal by Subject|0|||
144372782|NCT02963506|520573080|FG012|Double-Blind Period|Withdrawal by Subject|0|||
144372783|NCT02963506|520573068|FG000|Double-Blind Period|No compliance|0|||
144372784|NCT02963506|520573069|FG001|Double-Blind Period|No compliance|1|||
144372785|NCT02963506|520573070|FG002|Double-Blind Period|No compliance|0|||
144372786|NCT02963506|520573071|FG003|Double-Blind Period|No compliance|0|||
144372787|NCT02963506|520573072|FG004|Double-Blind Period|No compliance|0|||
144372788|NCT02963506|520573073|FG005|Double-Blind Period|No compliance|0|||
144372789|NCT02963506|520573074|FG006|Double-Blind Period|No compliance|0|||
144372790|NCT02963506|520573075|FG007|Double-Blind Period|No compliance|0|||
144372791|NCT02963506|520573076|FG008|Double-Blind Period|No compliance|0|||
144372792|NCT02963506|520573077|FG009|Double-Blind Period|No compliance|0|||
144372793|NCT02963506|520573078|FG010|Double-Blind Period|No compliance|0|||
144372794|NCT02963506|520573079|FG011|Double-Blind Period|No compliance|0|||
144372795|NCT02963506|520573080|FG012|Double-Blind Period|No compliance|0|||
144510836|NCT01985334|521070802|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
144510837|NCT01985334|521070803|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
144248918|NCT05625477|520109963|FG004|Overall Study|Covid quarantine|0|||
144248919|NCT04849416|520109964|FG000|Overall Study|Ongoing Treatment|12|||
144372796|NCT02963506|520573068|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372797|NCT02963506|520573069|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
144372798|NCT02963506|520573070|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372799|NCT02963506|520573071|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372800|NCT02963506|520573072|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372801|NCT02963506|520573073|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372802|NCT02963506|520573074|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372803|NCT02963506|520573075|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372804|NCT02963506|520573076|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372805|NCT02963506|520573077|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372806|NCT02963506|520573078|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372807|NCT02963506|520573079|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144248920|NCT04849416|520109965|FG001|Overall Study|Ongoing Treatment|5|||
144372808|NCT02963506|520573080|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
144372809|NCT02963506|520573068|FG000|Dose-Blind Period|Adverse Event|0|||
144372810|NCT02963506|520573069|FG001|Dose-Blind Period|Adverse Event|0|||
144372811|NCT02963506|520573070|FG002|Dose-Blind Period|Adverse Event|0|||
144372812|NCT02963506|520573071|FG003|Dose-Blind Period|Adverse Event|0|||
144372813|NCT02963506|520573072|FG004|Dose-Blind Period|Adverse Event|0|||
144372814|NCT02963506|520573073|FG005|Dose-Blind Period|Adverse Event|1|||
144372815|NCT02963506|520573074|FG006|Dose-Blind Period|Adverse Event|3|||
144372816|NCT02963506|520573075|FG007|Dose-Blind Period|Adverse Event|2|||
144372817|NCT02963506|520573076|FG008|Dose-Blind Period|Adverse Event|2|||
144372818|NCT02963506|520573077|FG009|Dose-Blind Period|Adverse Event|2|||
144372819|NCT02963506|520573078|FG010|Dose-Blind Period|Adverse Event|1|||
144372820|NCT02963506|520573079|FG011|Dose-Blind Period|Adverse Event|1|||
144372821|NCT02963506|520573080|FG012|Dose-Blind Period|Adverse Event|6|||
144372822|NCT02963506|520573068|FG000|Dose-Blind Period|Lack of Efficacy|0|||
144372823|NCT02963506|520573069|FG001|Dose-Blind Period|Lack of Efficacy|0|||
144372824|NCT02963506|520573070|FG002|Dose-Blind Period|Lack of Efficacy|0|||
144372825|NCT02963506|520573071|FG003|Dose-Blind Period|Lack of Efficacy|0|||
144372826|NCT02963506|520573072|FG004|Dose-Blind Period|Lack of Efficacy|0|||
144372827|NCT02963506|520573073|FG005|Dose-Blind Period|Lack of Efficacy|0|||
144372828|NCT02963506|520573074|FG006|Dose-Blind Period|Lack of Efficacy|0|||
144372829|NCT02963506|520573075|FG007|Dose-Blind Period|Lack of Efficacy|1|||
144372830|NCT02963506|520573076|FG008|Dose-Blind Period|Lack of Efficacy|0|||
144372831|NCT02963506|520573077|FG009|Dose-Blind Period|Lack of Efficacy|1|||
144372832|NCT02963506|520573078|FG010|Dose-Blind Period|Lack of Efficacy|0|||
144372833|NCT02963506|520573079|FG011|Dose-Blind Period|Lack of Efficacy|0|||
144372834|NCT02963506|520573080|FG012|Dose-Blind Period|Lack of Efficacy|0|||
144372835|NCT02963506|520573068|FG000|Dose-Blind Period|Lost to Follow-up|0|||
144372836|NCT02963506|520573069|FG001|Dose-Blind Period|Lost to Follow-up|0|||
144372837|NCT02963506|520573070|FG002|Dose-Blind Period|Lost to Follow-up|0|||
144372838|NCT02963506|520573071|FG003|Dose-Blind Period|Lost to Follow-up|0|||
144372839|NCT02963506|520573072|FG004|Dose-Blind Period|Lost to Follow-up|0|||
144372840|NCT02963506|520573073|FG005|Dose-Blind Period|Lost to Follow-up|1|||
144372841|NCT02963506|520573074|FG006|Dose-Blind Period|Lost to Follow-up|0|||
144372842|NCT02963506|520573075|FG007|Dose-Blind Period|Lost to Follow-up|0|||
144372843|NCT02963506|520573076|FG008|Dose-Blind Period|Lost to Follow-up|1|||
144372844|NCT02963506|520573077|FG009|Dose-Blind Period|Lost to Follow-up|0|||
144372845|NCT02963506|520573078|FG010|Dose-Blind Period|Lost to Follow-up|0|||
144372846|NCT02963506|520573079|FG011|Dose-Blind Period|Lost to Follow-up|1|||
144372847|NCT02963506|520573080|FG012|Dose-Blind Period|Lost to Follow-up|0|||
144372848|NCT02963506|520573068|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
144372849|NCT02963506|520573069|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
144372850|NCT02963506|520573070|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
144372851|NCT02963506|520573071|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
144372852|NCT02963506|520573072|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
144372853|NCT02963506|520573073|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
144372854|NCT02963506|520573074|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
144372855|NCT02963506|520573075|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
144372856|NCT02963506|520573076|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
144372857|NCT02963506|520573077|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
144372858|NCT02963506|520573078|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
144372859|NCT02963506|520573079|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
144372860|NCT02963506|520573080|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
144372861|NCT02963506|520573068|FG000|Dose-Blind Period|Sponsor decision|0|||
144372862|NCT02963506|520573069|FG001|Dose-Blind Period|Sponsor decision|0|||
144372863|NCT02963506|520573070|FG002|Dose-Blind Period|Sponsor decision|0|||
144372864|NCT02963506|520573071|FG003|Dose-Blind Period|Sponsor decision|0|||
144372865|NCT02963506|520573072|FG004|Dose-Blind Period|Sponsor decision|0|||
144372866|NCT02963506|520573073|FG005|Dose-Blind Period|Sponsor decision|1|||
144372867|NCT02963506|520573074|FG006|Dose-Blind Period|Sponsor decision|0|||
144372868|NCT02963506|520573075|FG007|Dose-Blind Period|Sponsor decision|0|||
144372869|NCT02963506|520573076|FG008|Dose-Blind Period|Sponsor decision|0|||
144372870|NCT02963506|520573077|FG009|Dose-Blind Period|Sponsor decision|0|||
144372871|NCT02963506|520573078|FG010|Dose-Blind Period|Sponsor decision|0|||
144372872|NCT02963506|520573079|FG011|Dose-Blind Period|Sponsor decision|0|||
144372873|NCT02963506|520573080|FG012|Dose-Blind Period|Sponsor decision|0|||
144372874|NCT02963506|520573068|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372875|NCT02963506|520573069|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372876|NCT02963506|520573070|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372877|NCT02963506|520573071|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144510838|NCT01985334|521070804|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
144372878|NCT02963506|520573072|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372879|NCT02963506|520573073|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372880|NCT02963506|520573074|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372881|NCT02963506|520573075|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372882|NCT02963506|520573076|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372883|NCT02963506|520573077|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372884|NCT02963506|520573078|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372885|NCT02963506|520573079|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
144372886|NCT02963506|520573080|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
144372887|NCT00630838|520573085|FG000|Overall Study|Death|0|||
144372888|NCT00630838|520573086|FG001|Overall Study|Death|1|||
144372889|NCT00630838|520573085|FG000|Overall Study|Lost to Follow-up|0|||
144372890|NCT00630838|520573086|FG001|Overall Study|Lost to Follow-up|1|||
144372891|NCT00928408|520573087|FG000|Overall Study|Other|2|||
144372892|NCT00928408|520573087|FG000|Overall Study|Withdrawal by Subject|4|||
144372893|NCT00928408|520573087|FG000|Overall Study|Death|5|||
144372894|NCT00928408|520573087|FG000|Overall Study|Lost to Follow-up|12|||
144372895|NCT04163016|520573088|FG000|Enrollment|Adverse Event|1|||
144372896|NCT04163016|520573089|FG001|Enrollment|Adverse Event|0|||
144372897|NCT04163016|520573090|FG002|Enrollment|Adverse Event|0|||
144372898|NCT04163016|520573091|FG003|Enrollment|Adverse Event|0|||
144372899|NCT04163016|520573088|FG000|Treatment|Adverse Event|0|||
144372900|NCT04163016|520573089|FG001|Treatment|Adverse Event|1|||
144372901|NCT04163016|520573090|FG002|Treatment|Adverse Event|0|||
144372902|NCT04163016|520573091|FG003|Treatment|Adverse Event|0|||
144372903|NCT04163016|520573088|FG000|Treatment|Withdrawal by Subject|0|||
144372904|NCT04163016|520573089|FG001|Treatment|Withdrawal by Subject|2|||
144372905|NCT04163016|520573090|FG002|Treatment|Withdrawal by Subject|0|||
144372906|NCT04163016|520573091|FG003|Treatment|Withdrawal by Subject|0|||
144372907|NCT04163016|520573088|FG000|Treatment|Indeterminate TB-test|0|||
144372908|NCT04163016|520573089|FG001|Treatment|Indeterminate TB-test|0|||
144372909|NCT04163016|520573090|FG002|Treatment|Indeterminate TB-test|0|||
144372910|NCT04163016|520573091|FG003|Treatment|Indeterminate TB-test|1|||
144372911|NCT04163016|520573088|FG000|Treatment|Participant did not want to continue in study|0|||
144372912|NCT04163016|520573089|FG001|Treatment|Participant did not want to continue in study|0|||
144372913|NCT04163016|520573090|FG002|Treatment|Participant did not want to continue in study|0|||
144372914|NCT04163016|520573091|FG003|Treatment|Participant did not want to continue in study|1|||
144372915|NCT02930018|520573095|FG000|Overall Study|Lost to Follow-up|1|||
144372916|NCT02930018|520573096|FG001|Overall Study|Lost to Follow-up|1|||
144372917|NCT02930018|520573095|FG000|Overall Study|Withdrawal by Subject|5|||
144372918|NCT02930018|520573096|FG001|Overall Study|Withdrawal by Subject|2|||
144372919|NCT02102204|520574571|FG000|Overall Study|Withdrawal by Subject|137|||
144372920|NCT02102204|520574571|FG000|Overall Study|Death|92|||
144372921|NCT02102204|520574571|FG000|Overall Study|Lost to Follow-up|65|||
144372922|NCT02102204|520574571|FG000|Overall Study|Sponsor Decision|5|||
144372923|NCT02102204|520574571|FG000|Overall Study|Ongoing|5|||
144372924|NCT02656693|520574573|FG000|Overall Study|Pregnancy|1|||
144372925|NCT02656693|520574574|FG001|Overall Study|Pregnancy|1|||
144372926|NCT02656693|520574575|FG002|Overall Study|Pregnancy|1|||
144372927|NCT02656693|520574573|FG000|Overall Study|Bariatric surgery|0|||
144372928|NCT02656693|520574574|FG001|Overall Study|Bariatric surgery|1|||
144372929|NCT02656693|520574575|FG002|Overall Study|Bariatric surgery|2|||
144372930|NCT02269267|520574577|FG000|Overall Study|Death|5|||
144372931|NCT01069900|520574581|FG000|Overall Study|Technical problems|0|||
144372932|NCT01069900|520574582|FG001|Overall Study|Technical problems|1|||
144372933|NCT01069900|520574581|FG000|Overall Study|Lost to Follow-up|7|||
144372934|NCT01069900|520574582|FG001|Overall Study|Lost to Follow-up|1|||
144372935|NCT01069900|520574581|FG000|Overall Study|Withdrawal by Subject|6|||
144372936|NCT01069900|520574582|FG001|Overall Study|Withdrawal by Subject|1|||
144510839|NCT01985334|521070805|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
144510840|NCT01985334|521070806|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
144510841|NCT01985334|521070807|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
144510842|NCT01985334|521070800|FG000|Overall Study|Subject withdrawal of consent|3|||
144372937|NCT01069900|520574581|FG000|Overall Study|Protocol Violation|4|||
144372938|NCT01069900|520574582|FG001|Overall Study|Protocol Violation|1|||
144372939|NCT01069900|520574581|FG000|Overall Study|Insufficient Therapeutic effect|1|||
144372940|NCT01069900|520574582|FG001|Overall Study|Insufficient Therapeutic effect|0|||
144372941|NCT03085797|520574584|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
144372942|NCT03085797|520574585|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
144372943|NCT03085797|520574584|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
144372944|NCT03085797|520574585|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
144372945|NCT03085797|520574584|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
144372946|NCT03085797|520574585|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
144372947|NCT00337675|520574587|FG000|Overall Study|Adverse Event|10|||
144372948|NCT00337675|520574588|FG001|Overall Study|Adverse Event|9|||
144372949|NCT00337675|520574589|FG002|Overall Study|Adverse Event|19|||
144372950|NCT00337675|520574587|FG000|Overall Study|Lack of Efficacy|10|||
144372951|NCT00337675|520574588|FG001|Overall Study|Lack of Efficacy|7|||
144372952|NCT00337675|520574589|FG002|Overall Study|Lack of Efficacy|9|||
144372953|NCT00337675|520574587|FG000|Overall Study|Lost to Follow-up|22|||
144372954|NCT00337675|520574588|FG001|Overall Study|Lost to Follow-up|19|||
144372955|NCT00337675|520574589|FG002|Overall Study|Lost to Follow-up|17|||
144372956|NCT00337675|520574587|FG000|Overall Study|Physician Decision|9|||
144372957|NCT00337675|520574588|FG001|Overall Study|Physician Decision|17|||
144372958|NCT00337675|520574589|FG002|Overall Study|Physician Decision|14|||
144372959|NCT00337675|520574587|FG000|Overall Study|Protocol Violation|21|||
144372960|NCT00337675|520574588|FG001|Overall Study|Protocol Violation|24|||
144372961|NCT00337675|520574589|FG002|Overall Study|Protocol Violation|19|||
144372962|NCT00337675|520574587|FG000|Overall Study|Withdrawal by Subject|25|||
144372963|NCT00337675|520574588|FG001|Overall Study|Withdrawal by Subject|25|||
144372964|NCT00337675|520574589|FG002|Overall Study|Withdrawal by Subject|19|||
144372965|NCT00337675|520574587|FG000|Overall Study|Progressive Disease|0|||
144372966|NCT00337675|520574588|FG001|Overall Study|Progressive Disease|2|||
144372967|NCT00337675|520574589|FG002|Overall Study|Progressive Disease|0|||
144372968|NCT00337675|520574587|FG000|Overall Study|Trial Terminated|0|||
144372969|NCT00337675|520574588|FG001|Overall Study|Trial Terminated|0|||
144372970|NCT00337675|520574589|FG002|Overall Study|Trial Terminated|2|||
144372971|NCT02910986|520574595|FG000|Overall Study|non-Latina|14|||
144372972|NCT02910986|520574596|FG001|Overall Study|non-Latina|13|||
144372973|NCT02910986|520574597|FG002|Overall Study|non-Latina|12|||
144372974|NCT02910986|520574595|FG000|Overall Study|Failure to return T! survey|72|||
144372975|NCT02910986|520574596|FG001|Overall Study|Failure to return T! survey|84|||
144372976|NCT02910986|520574597|FG002|Overall Study|Failure to return T! survey|72|||
144372977|NCT02910986|520574595|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
144372978|NCT02910986|520574596|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
144372979|NCT02910986|520574597|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
144372980|NCT02910986|520574595|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
144372981|NCT02910986|520574596|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
144372982|NCT02910986|520574597|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
144372983|NCT03306173|520574603|FG000|Overall Study|Lost to Follow-up|16|||
144372984|NCT03306173|520574604|FG001|Overall Study|Lost to Follow-up|23|||
144372985|NCT03306173|520574603|FG000|Overall Study|Withdrawal by Subject|4|||
144372986|NCT03306173|520574604|FG001|Overall Study|Withdrawal by Subject|3|||
144372987|NCT03306173|520574603|FG000|Overall Study|Discontinued|4|||
144372988|NCT03306173|520574604|FG001|Overall Study|Discontinued|4|||
144372989|NCT01339052|520574610|FG000|Overall Study|Disease progression|13|||
144372990|NCT01339052|520574611|FG001|Overall Study|Disease progression|46|||
144372991|NCT01339052|520574610|FG000|Overall Study|Adverse Event|1|||
144372992|NCT01339052|520574611|FG001|Overall Study|Adverse Event|1|||
144372993|NCT01339052|520574610|FG000|Overall Study|Withdrawal by Subject|0|||
144372994|NCT01339052|520574611|FG001|Overall Study|Withdrawal by Subject|3|||
144372995|NCT01339052|520574610|FG000|Overall Study|Physician Decision|1|||
144372996|NCT01339052|520574611|FG001|Overall Study|Physician Decision|0|||
144372997|NCT02637037|520574612|FG000|Overall Study|Positive drug screen at admission|1|||
144372998|NCT02637037|520574613|FG001|Overall Study|Positive drug screen at admission|0|||
144372999|NCT02637037|520574612|FG000|Overall Study|Withdrawal by Subject|2|||
144373000|NCT02637037|520574613|FG001|Overall Study|Withdrawal by Subject|1|||
144373001|NCT02637037|520574612|FG000|Overall Study|Adverse Event|1|||
144373002|NCT02637037|520574613|FG001|Overall Study|Adverse Event|0|||
144373003|NCT02023697|520574616|FG000|Treatment Period|Radiological progression|13|||
144373004|NCT02023697|520574617|FG001|Treatment Period|Radiological progression|17|||
144373005|NCT02023697|520574618|FG002|Treatment Period|Radiological progression|26|||
144373006|NCT02023697|520574616|FG000|Treatment Period|Never Treated|5|||
144373007|NCT02023697|520574617|FG001|Treatment Period|Never Treated|6|||
144373008|NCT02023697|520574618|FG002|Treatment Period|Never Treated|10|||
144373009|NCT02023697|520574616|FG000|Treatment Period|Adverse Event|13|||
144721715|NCT01595009|521835275|FG000|Core|Adverse Event|19|||
144373010|NCT02023697|520574617|FG001|Treatment Period|Adverse Event|25|||
144373011|NCT02023697|520574618|FG002|Treatment Period|Adverse Event|23|||
144373012|NCT02023697|520574616|FG000|Treatment Period|Logistical difficulties|1|||
144373013|NCT02023697|520574617|FG001|Treatment Period|Logistical difficulties|1|||
144373014|NCT02023697|520574618|FG002|Treatment Period|Logistical difficulties|1|||
144373015|NCT02023697|520574616|FG000|Treatment Period|Clinical progression|10|||
144510843|NCT01985334|521070801|FG001|Overall Study|Subject withdrawal of consent|6|||
144510844|NCT01985334|521070802|FG002|Overall Study|Subject withdrawal of consent|2|||
144248921|NCT04849416|520109966|FG002|Overall Study|Ongoing Treatment|3|||
144248922|NCT04849416|520109964|FG000|Overall Study|On Post-Treatment Follow-up|8|||
144510845|NCT01985334|521070803|FG003|Overall Study|Subject withdrawal of consent|28|||
144510846|NCT01985334|521070804|FG004|Overall Study|Subject withdrawal of consent|4|||
144510847|NCT01985334|521070805|FG005|Overall Study|Subject withdrawal of consent|19|||
144510848|NCT01985334|521070806|FG006|Overall Study|Subject withdrawal of consent|0|||
144510849|NCT01985334|521070807|FG007|Overall Study|Subject withdrawal of consent|20|||
144510850|NCT01985334|521070800|FG000|Overall Study|Adverse Event|0|||
144510851|NCT01985334|521070801|FG001|Overall Study|Adverse Event|8|||
144510852|NCT01985334|521070802|FG002|Overall Study|Adverse Event|2|||
144510853|NCT01985334|521070803|FG003|Overall Study|Adverse Event|26|||
144510854|NCT01985334|521070804|FG004|Overall Study|Adverse Event|3|||
144510855|NCT01985334|521070805|FG005|Overall Study|Adverse Event|18|||
144510856|NCT01985334|521070806|FG006|Overall Study|Adverse Event|3|||
144510857|NCT01985334|521070807|FG007|Overall Study|Adverse Event|15|||
144510858|NCT01985334|521070800|FG000|Overall Study|Other|4|||
144510859|NCT01985334|521070801|FG001|Overall Study|Other|2|||
144510860|NCT01985334|521070802|FG002|Overall Study|Other|3|||
144510861|NCT01985334|521070803|FG003|Overall Study|Other|10|||
144248923|NCT04849416|520109965|FG001|Overall Study|On Post-Treatment Follow-up|9|||
144248924|NCT04849416|520109966|FG002|Overall Study|On Post-Treatment Follow-up|10|||
144248925|NCT04849416|520109964|FG000|Overall Study|Withdrawal by Subject|0|||
144248926|NCT04849416|520109965|FG001|Overall Study|Withdrawal by Subject|0|||
144248927|NCT04849416|520109966|FG002|Overall Study|Withdrawal by Subject|1|||
144248928|NCT04849416|520109964|FG000|Overall Study|Lost to Follow-up|1|||
144248929|NCT04849416|520109965|FG001|Overall Study|Lost to Follow-up|0|||
144248930|NCT04849416|520109966|FG002|Overall Study|Lost to Follow-up|0|||
144248931|NCT01636947|520109967|FG000|Overall Study|Not Treated|2|||
144248932|NCT01636947|520109968|FG001|Overall Study|Not Treated|2|||
144248933|NCT01636947|520109967|FG000|Overall Study|Lost to Follow-up|4|||
144248934|NCT01636947|520109968|FG001|Overall Study|Lost to Follow-up|0|||
144248935|NCT01636947|520109967|FG000|Overall Study|Protocol Violation|1|||
144248936|NCT01636947|520109968|FG001|Overall Study|Protocol Violation|1|||
144248937|NCT01636947|520109967|FG000|Overall Study|Withdrawal by Subject|3|||
144248938|NCT01636947|520109968|FG001|Overall Study|Withdrawal by Subject|3|||
144248939|NCT01636947|520109967|FG000|Overall Study|Adverse Event|1|||
144248940|NCT01636947|520109968|FG001|Overall Study|Adverse Event|1|||
144248941|NCT01636947|520109967|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
144248942|NCT01636947|520109968|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
144510862|NCT01985334|521070804|FG004|Overall Study|Other|1|||
144248943|NCT00460265|520109971|FG000|Overall Study|Lost to Follow-up|14|||
144248944|NCT00460265|520109972|FG001|Overall Study|Lost to Follow-up|15|||
144248945|NCT00460265|520109971|FG000|Overall Study|Physician Decision|1|||
144248946|NCT00460265|520109972|FG001|Overall Study|Physician Decision|2|||
144248947|NCT00460265|520109971|FG000|Overall Study|Withdrawal by Subject|10|||
144248948|NCT00460265|520109972|FG001|Overall Study|Withdrawal by Subject|25|||
144248949|NCT00460265|520109971|FG000|Overall Study|Ongoing|60|||
144248950|NCT00460265|520109972|FG001|Overall Study|Ongoing|47|||
144248951|NCT03956615|520109974|FG000|Overall Study|No multiple myeloma confirmed|2|||
144248952|NCT03956615|520109974|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
144248953|NCT03956615|520109974|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
144248954|NCT03956615|520109974|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
144248955|NCT00412217|520109975|FG000|Overall Study|Insufficient Data Available|8|||
144248956|NCT00412217|520109976|FG001|Overall Study|Insufficient Data Available|3|||
144248957|NCT00412217|520109975|FG000|Overall Study|Death|5|||
144248958|NCT00412217|520109976|FG001|Overall Study|Death|4|||
144248959|NCT00412217|520109975|FG000|Overall Study|Disease Progression|2|||
144248960|NCT00412217|520109976|FG001|Overall Study|Disease Progression|3|||
144248961|NCT00412217|520109975|FG000|Overall Study|Investigator Decision|1|||
144510863|NCT01985334|521070805|FG005|Overall Study|Other|6|||
144510864|NCT01985334|521070806|FG006|Overall Study|Other|2|||
144510865|NCT01985334|521070807|FG007|Overall Study|Other|2|||
144248962|NCT00412217|520109976|FG001|Overall Study|Investigator Decision|0|||
144248963|NCT00412217|520109975|FG000|Overall Study|Withdrawal by Subject|2|||
144248964|NCT00412217|520109976|FG001|Overall Study|Withdrawal by Subject|0|||
144248965|NCT00412217|520109975|FG000|Overall Study|Lost to Follow-up|1|||
144248966|NCT00412217|520109976|FG001|Overall Study|Lost to Follow-up|4|||
144248967|NCT00412217|520109975|FG000|Overall Study|Study Terminated by Sponsor|26|||
144248968|NCT00412217|520109976|FG001|Overall Study|Study Terminated by Sponsor|33|||
144248969|NCT00412217|520109975|FG000|Overall Study|Other|1|||
144248970|NCT00412217|520109976|FG001|Overall Study|Other|1|||
144248971|NCT01069419|520109977|FG000|Overall Study|Adverse Event|233|||
144248972|NCT01069419|520109977|FG000|Overall Study|Lack of Efficacy|332|||
144248973|NCT01069419|520109977|FG000|Overall Study|Lost to Follow-up|49|||
144248974|NCT01069419|520109977|FG000|Overall Study|Remission of disease|11|||
144248975|NCT01069419|520109977|FG000|Overall Study|Withdrawal by Subject|34|||
144248976|NCT01069419|520109977|FG000|Overall Study|Other Reason|43|||
144248977|NCT01069419|520109977|FG000|Overall Study|Missing termination information|13|||
144248978|NCT01797094|520109978|FG000|Overall Study|Adverse Event|1|||
144248979|NCT01797094|520109979|FG001|Overall Study|Adverse Event|1|||
144248980|NCT01797094|520109978|FG000|Overall Study|Personal Reasons|4|||
144248981|NCT01797094|520109979|FG001|Overall Study|Personal Reasons|0|||
144248982|NCT01797094|520109978|FG000|Overall Study|Protocol Violation|0|||
144248983|NCT01797094|520109979|FG001|Overall Study|Protocol Violation|1|||
144248984|NCT01797094|520109978|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144248985|NCT01797094|520109979|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144248986|NCT00821015|520109984|FG000|Overall Study|Lost to Follow-up|12|||
144248987|NCT01887678|520109985|FG000|Overall Study|Adverse Event|4|||
144248988|NCT01887678|520109986|FG001|Overall Study|Adverse Event|6|||
144248989|NCT01887678|520109985|FG000|Overall Study|Exceeded rescue medication dosage|4|||
144248990|NCT01887678|520109986|FG001|Overall Study|Exceeded rescue medication dosage|5|||
144248991|NCT01887678|520109985|FG000|Overall Study|Withdrawal of consent|3|||
144248992|NCT01887678|520109986|FG001|Overall Study|Withdrawal of consent|4|||
144248993|NCT01887678|520109985|FG000|Overall Study|Lost to Follow-up|4|||
144248994|NCT01887678|520109986|FG001|Overall Study|Lost to Follow-up|2|||
144248995|NCT01887678|520109985|FG000|Overall Study|Deterioration of clinical condition|0|||
144248996|NCT01887678|520109986|FG001|Overall Study|Deterioration of clinical condition|4|||
144248997|NCT01887678|520109985|FG000|Overall Study|Lack of Efficacy|1|||
144248998|NCT01887678|520109986|FG001|Overall Study|Lack of Efficacy|2|||
144248999|NCT01887678|520109985|FG000|Overall Study|Non-compliance|0|||
144249000|NCT01887678|520109986|FG001|Overall Study|Non-compliance|3|||
144249001|NCT01887678|520109985|FG000|Overall Study|Specified|1|||
144249002|NCT01887678|520109986|FG001|Overall Study|Specified|2|||
144249003|NCT00187278|520109989|FG000|Overall Study|Protocol Violation|10|||
144249004|NCT00187278|520109990|FG001|Overall Study|Protocol Violation|13|||
144249005|NCT00270231|520109998|FG000|First Intervention|Lost to Follow-up|1|||
144249006|NCT00270231|520109999|FG001|First Intervention|Lost to Follow-up|1|||
144249007|NCT00270231|520109998|FG000|Washout Period|Lost to Follow-up|1|||
144249008|NCT00270231|520109999|FG001|Washout Period|Lost to Follow-up|0|||
144249009|NCT00270231|520109998|FG000|Second Intervention|Lost to Follow-up|0|||
144249010|NCT00270231|520109999|FG001|Second Intervention|Lost to Follow-up|1|||
144249011|NCT00574795|520110014|FG000|Infant Series|Withdrawal by Subject|2|||
144249012|NCT00574795|520110014|FG000|Infant Series|Protocol Violation|2|||
144249013|NCT00574795|520110014|FG000|Infant Series|Adverse Event|1|||
144249014|NCT00574795|520110014|FG000|After Infant Series|Withdrawal by Subject|1|||
144249015|NCT00574795|520110014|FG000|After Infant Series|Adverse Event|2|||
144249016|NCT00574795|520110014|FG000|Toddler Dose|Withdrawal by Subject|1|||
144249017|NCT00672841|520110015|FG000|Overall Study|Comfort care|1|||
144249018|NCT00672841|520110016|FG001|Overall Study|Comfort care|4|||
144249019|NCT00672841|520110015|FG000|Overall Study|icteric specimens|0|||
144249020|NCT00672841|520110016|FG001|Overall Study|icteric specimens|3|||
144249021|NCT00672841|520110015|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
144249022|NCT00672841|520110016|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
144510866|NCT01985334|521070800|FG000|Overall Study|Medication non-compliance|0|||
144510867|NCT01985334|521070801|FG001|Overall Study|Medication non-compliance|4|||
144510868|NCT01985334|521070802|FG002|Overall Study|Medication non-compliance|1|||
144510869|NCT01985334|521070803|FG003|Overall Study|Medication non-compliance|6|||
144249023|NCT00672841|520110015|FG000|Overall Study|Adverse Event|0|||
144249024|NCT00672841|520110016|FG001|Overall Study|Adverse Event|3|||
144249025|NCT00672841|520110015|FG000|Overall Study|Pregnancy|0|||
144249026|NCT00672841|520110016|FG001|Overall Study|Pregnancy|1|||
144249027|NCT02638259|520110017|FG000|Treatment Period 1|Adverse Event|1|||
144249028|NCT02638259|520110018|FG001|Treatment Period 1|Adverse Event|5|||
144249029|NCT02638259|520110017|FG000|Treatment Period 1|Death|0|||
144249030|NCT02638259|520110018|FG001|Treatment Period 1|Death|1|||
144249031|NCT02638259|520110017|FG000|Treatment Period 1|Lack of Efficacy|0|||
144249032|NCT02638259|520110018|FG001|Treatment Period 1|Lack of Efficacy|1|||
144249033|NCT02638259|520110017|FG000|Treatment Period 1|Protocol Violation|0|||
144249034|NCT02638259|520110018|FG001|Treatment Period 1|Protocol Violation|3|||
144249035|NCT02638259|520110017|FG000|Treatment Period 1|Withdrawal by Subject|4|||
144721716|NCT01595009|521835276|FG001|Core|Adverse Event|23|||
144373016|NCT02023697|520574617|FG001|Treatment Period|Clinical progression|8|||
144373017|NCT02023697|520574618|FG002|Treatment Period|Clinical progression|28|||
144373018|NCT02023697|520574616|FG000|Treatment Period|Withdrawal by Subject|4|||
144373019|NCT02023697|520574617|FG001|Treatment Period|Withdrawal by Subject|5|||
144373020|NCT02023697|520574618|FG002|Treatment Period|Withdrawal by Subject|13|||
144373021|NCT02023697|520574616|FG000|Treatment Period|Safety outcome reached|0|||
144373022|NCT02023697|520574617|FG001|Treatment Period|Safety outcome reached|1|||
144373023|NCT02023697|520574618|FG002|Treatment Period|Safety outcome reached|0|||
144373024|NCT02023697|520574616|FG000|Treatment Period|Physician Decision|0|||
144373025|NCT02023697|520574617|FG001|Treatment Period|Physician Decision|0|||
144373026|NCT02023697|520574618|FG002|Treatment Period|Physician Decision|1|||
144373027|NCT02023697|520574616|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
144373028|NCT02023697|520574617|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
144373029|NCT02023697|520574618|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
144373030|NCT02023697|520574616|FG000|Active Follow-up Period|Lost to Follow-up|1|||
144373031|NCT02023697|520574617|FG001|Active Follow-up Period|Lost to Follow-up|1|||
144373032|NCT02023697|520574618|FG002|Active Follow-up Period|Lost to Follow-up|1|||
144373033|NCT02023697|520574616|FG000|Active Follow-up Period|Deterioration of general condition|1|||
144373034|NCT02023697|520574617|FG001|Active Follow-up Period|Deterioration of general condition|1|||
144373035|NCT02023697|520574618|FG002|Active Follow-up Period|Deterioration of general condition|1|||
144373036|NCT02023697|520574616|FG000|Active Follow-up Period|Other unspecified|2|||
144373037|NCT02023697|520574617|FG001|Active Follow-up Period|Other unspecified|0|||
144373038|NCT02023697|520574618|FG002|Active Follow-up Period|Other unspecified|1|||
144373039|NCT02023697|520574616|FG000|Active Follow-up Period|Clinical progression|0|||
144373040|NCT02023697|520574617|FG001|Active Follow-up Period|Clinical progression|2|||
144373041|NCT02023697|520574618|FG002|Active Follow-up Period|Clinical progression|1|||
144373042|NCT02023697|520574616|FG000|Active Follow-up Period|Radiological progression|0|||
144373043|NCT02023697|520574617|FG001|Active Follow-up Period|Radiological progression|0|||
144373044|NCT02023697|520574618|FG002|Active Follow-up Period|Radiological progression|1|||
144373045|NCT02023697|520574616|FG000|Active Follow-up Period|Death|83|||
144373046|NCT02023697|520574617|FG001|Active Follow-up Period|Death|82|||
144373047|NCT02023697|520574618|FG002|Active Follow-up Period|Death|87|||
144373048|NCT02023697|520574616|FG000|Long-term Follow-up Period|Death|9|||
144373049|NCT02023697|520574617|FG001|Long-term Follow-up Period|Death|6|||
144373050|NCT02023697|520574618|FG002|Long-term Follow-up Period|Death|4|||
144373051|NCT02023697|520574616|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
144373052|NCT02023697|520574617|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
144373053|NCT02023697|520574618|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
144373054|NCT02023697|520574616|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
144373055|NCT02023697|520574617|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
144373056|NCT02023697|520574618|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
144373057|NCT02023697|520574616|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
144373058|NCT02023697|520574617|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
144373059|NCT02023697|520574618|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
144373060|NCT02023697|520574616|FG000|Long-term Follow-up Period|Technical problems|0|||
144373061|NCT02023697|520574617|FG001|Long-term Follow-up Period|Technical problems|0|||
144373062|NCT02023697|520574618|FG002|Long-term Follow-up Period|Technical problems|1|||
144373063|NCT02023697|520574616|FG000|Long-term Follow-up Period|Other unspecified|6|||
144373064|NCT02023697|520574617|FG001|Long-term Follow-up Period|Other unspecified|3|||
144373065|NCT02023697|520574618|FG002|Long-term Follow-up Period|Other unspecified|5|||
144373066|NCT01469377|520574624|FG000|Overall Study|Protocol Deviation|7|||
144373067|NCT01469377|520574625|FG001|Overall Study|Protocol Deviation|10|||
144373068|NCT01469377|520574626|FG002|Overall Study|Protocol Deviation|10|||
144373069|NCT01469377|520574624|FG000|Overall Study|Lost to Follow-up|3|||
144373070|NCT01469377|520574625|FG001|Overall Study|Lost to Follow-up|2|||
144373071|NCT01469377|520574626|FG002|Overall Study|Lost to Follow-up|5|||
144373072|NCT01469377|520574624|FG000|Overall Study|Withdrawal of Consent|12|||
144721717|NCT01595009|521835277|FG002|Core|Adverse Event|0|||
144249036|NCT02638259|520110018|FG001|Treatment Period 1|Withdrawal by Subject|6|||
144249037|NCT02638259|520110017|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
144249038|NCT02638259|520110018|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
144249039|NCT02638259|520110017|FG000|Treatment Period 2|Adverse Event|5|||
144249040|NCT02638259|520110018|FG001|Treatment Period 2|Adverse Event|4|||
144373073|NCT01469377|520574625|FG001|Overall Study|Withdrawal of Consent|14|||
144373074|NCT01469377|520574626|FG002|Overall Study|Withdrawal of Consent|15|||
144373075|NCT01469377|520574624|FG000|Overall Study|Adverse Event|8|||
144373076|NCT01469377|520574625|FG001|Overall Study|Adverse Event|18|||
144373077|NCT01469377|520574626|FG002|Overall Study|Adverse Event|36|||
144373078|NCT01469377|520574624|FG000|Overall Study|Insufficient Therapeutic Response|3|||
144373079|NCT01469377|520574625|FG001|Overall Study|Insufficient Therapeutic Response|4|||
144373080|NCT01469377|520574626|FG002|Overall Study|Insufficient Therapeutic Response|0|||
144373081|NCT01469377|520574624|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144373082|NCT01469377|520574625|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144373083|NCT01469377|520574626|FG002|Overall Study|Other Miscellaneous Reasons|0|||
144373084|NCT04939415|520574628|FG000|Overall Study|Withdrawal by Subject|1|||
144373085|NCT04939415|520574629|FG001|Overall Study|Withdrawal by Subject|3|||
144373086|NCT04939415|520574628|FG000|Overall Study|Lost to Follow-up|0|||
144373087|NCT04939415|520574629|FG001|Overall Study|Lost to Follow-up|2|||
144373088|NCT04308291|520574630|FG000|Run-In Phase|Withdrawal by Subject|4|||
144373089|NCT04308291|520574630|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
144373090|NCT04308291|520574630|FG000|Study Phase 6-M|Physician Decision|2|||
144373091|NCT04308291|520574630|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
144373092|NCT04308291|520574630|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
144373093|NCT04308291|520574630|FG000|Study Phase 12-M|Physician Decision|2|||
144373094|NCT04308291|520574630|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
144373095|NCT03610269|520574632|FG000|Overall Study|Physician Decision|10|||
144373096|NCT03610269|520574632|FG000|Overall Study|Protocol Violation|1|||
144373097|NCT03610269|520574632|FG000|Overall Study|Unable to draw blood|1|||
144373098|NCT03610269|520574632|FG000|Overall Study|Screen fail|4|||
144373099|NCT00067002|520574635|FG000|Overall Study|Early Death|1|||
144373100|NCT00067002|520574636|FG001|Overall Study|Early Death|2|||
144373101|NCT00067002|520574635|FG000|Overall Study|Delayed|1|||
144373102|NCT00067002|520574636|FG001|Overall Study|Delayed|1|||
144373103|NCT00067002|520574635|FG000|Overall Study|Graft Failure|5|||
144373104|NCT00067002|520574636|FG001|Overall Study|Graft Failure|6|||
144373105|NCT01354314|520574637|FG000|Overall Study|Lost to Follow-up|1|||
144373106|NCT01354314|520574638|FG001|Overall Study|Lost to Follow-up|0|||
144373107|NCT01354314|520574639|FG002|Overall Study|Lost to Follow-up|1|||
144373108|NCT01354314|520574640|FG003|Overall Study|Lost to Follow-up|1|||
144373109|NCT01354314|520574637|FG000|Overall Study|Withdrawal by Subject|0|||
144373110|NCT01354314|520574638|FG001|Overall Study|Withdrawal by Subject|0|||
144373111|NCT01354314|520574639|FG002|Overall Study|Withdrawal by Subject|1|||
144373112|NCT01354314|520574640|FG003|Overall Study|Withdrawal by Subject|0|||
144373113|NCT01354314|520574637|FG000|Overall Study|Adverse Event|0|||
144373114|NCT01354314|520574638|FG001|Overall Study|Adverse Event|0|||
144373115|NCT01354314|520574639|FG002|Overall Study|Adverse Event|0|||
144373116|NCT01354314|520574640|FG003|Overall Study|Adverse Event|1|||
144373117|NCT01354314|520574637|FG000|Overall Study|Protocol Violation|1|||
144373118|NCT01354314|520574638|FG001|Overall Study|Protocol Violation|1|||
144373119|NCT01354314|520574639|FG002|Overall Study|Protocol Violation|0|||
144373120|NCT01354314|520574640|FG003|Overall Study|Protocol Violation|0|||
144373121|NCT01354314|520574637|FG000|Overall Study|Less than 90% Adherence|4|||
144373122|NCT01354314|520574638|FG001|Overall Study|Less than 90% Adherence|2|||
144373123|NCT01354314|520574639|FG002|Overall Study|Less than 90% Adherence|6|||
144373124|NCT01354314|520574640|FG003|Overall Study|Less than 90% Adherence|4|||
144373125|NCT00714870|520574642|FG000|Overall Study|Lost to Follow-up|22|||
144373126|NCT00714870|520574643|FG001|Overall Study|Lost to Follow-up|5|||
144373127|NCT00714870|520574642|FG000|Overall Study|patient unable to come b/c back pain|1|||
144373128|NCT00714870|520574643|FG001|Overall Study|patient unable to come b/c back pain|0|||
144373129|NCT00714870|520574642|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
144373130|NCT00714870|520574643|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
144373131|NCT03399552|520574644|FG000|Overall Study|No evidence of disease|1|||
144373132|NCT03399552|520574644|FG000|Overall Study|Unevaluable|1|||
144373133|NCT02357368|520574645|FG000|Overall Study|Lost to Follow-up|0|||
144373134|NCT02357368|520574646|FG001|Overall Study|Lost to Follow-up|0|||
144373135|NCT02357368|520574647|FG002|Overall Study|Lost to Follow-up|0|||
144373136|NCT02357368|520574648|FG003|Overall Study|Lost to Follow-up|1|||
144373137|NCT02357368|520574645|FG000|Overall Study|Pregnancy|3|||
144373138|NCT02357368|520574646|FG001|Overall Study|Pregnancy|2|||
144373139|NCT02357368|520574647|FG002|Overall Study|Pregnancy|0|||
144373140|NCT02357368|520574648|FG003|Overall Study|Pregnancy|0|||
144373141|NCT02357368|520574645|FG000|Overall Study|Withdrawal by Subject|3|||
144373142|NCT02357368|520574646|FG001|Overall Study|Withdrawal by Subject|1|||
144373143|NCT02357368|520574647|FG002|Overall Study|Withdrawal by Subject|1|||
144373144|NCT02357368|520574648|FG003|Overall Study|Withdrawal by Subject|2|||
144373145|NCT00611026|520574651|FG000|Randomized to Double-blind Treatment|Not treated|2|||
144373146|NCT00611026|520574652|FG001|Randomized to Double-blind Treatment|Not treated|1|||
144373147|NCT00611026|520574653|FG002|Randomized to Double-blind Treatment|Not treated|3|||
144373148|NCT00611026|520574651|FG000|Double-blind Treatment Period|Death|1|||
144721718|NCT01595009|521835278|FG003|Core|Adverse Event|0|||
144373149|NCT00611026|520574652|FG001|Double-blind Treatment Period|Death|0|||
144373150|NCT00611026|520574653|FG002|Double-blind Treatment Period|Death|0|||
144373151|NCT00611026|520574651|FG000|Double-blind Treatment Period|Adverse Event|9|||
144373152|NCT00611026|520574652|FG001|Double-blind Treatment Period|Adverse Event|28|||
144373153|NCT00611026|520574653|FG002|Double-blind Treatment Period|Adverse Event|46|||
144373154|NCT00611026|520574651|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
144373155|NCT00611026|520574652|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
144373156|NCT00611026|520574653|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
144373157|NCT00611026|520574651|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
144721719|NCT01595009|521835275|FG000|Core|Disease progression|14|||
144373158|NCT00611026|520574652|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
144373159|NCT00611026|520574653|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
144373160|NCT00611026|520574651|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
144373161|NCT00611026|520574652|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
144373162|NCT00611026|520574653|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
144373163|NCT00611026|520574651|FG000|Double-blind Treatment Period|Other|13|||
144373164|NCT00611026|520574652|FG001|Double-blind Treatment Period|Other|20|||
144373165|NCT00611026|520574653|FG002|Double-blind Treatment Period|Other|18|||
144373166|NCT01147874|520574654|FG000|Overall Study|Adverse Event|5|||
144373167|NCT01147874|520574654|FG000|Overall Study|Investigator's Request|1|||
144373168|NCT01147874|520574654|FG000|Overall Study|Lost to Follow-up|25|||
144373169|NCT01147874|520574654|FG000|Overall Study|Other|5|||
144373170|NCT01147874|520574654|FG000|Overall Study|Protocol Violation|5|||
144373171|NCT01147874|520574654|FG000|Overall Study|Sponsor's Decision|2|||
144373172|NCT01147874|520574654|FG000|Overall Study|Withdrawal by Subject|24|||
144373173|NCT02175030|520574663|FG000|Overall Study|Failed screen after consent|7|||
144373174|NCT02175030|520574664|FG001|Overall Study|Failed screen after consent|6|||
144373175|NCT02175030|520574663|FG000|Overall Study|Failed IUD Insertion|20|||
144373176|NCT02175030|520574664|FG001|Overall Study|Failed IUD Insertion|21|||
144373177|NCT02175030|520574663|FG000|Overall Study|Physician Decision|1|||
144373178|NCT02175030|520574664|FG001|Overall Study|Physician Decision|1|||
144373179|NCT02175030|520574663|FG000|Overall Study|Lost to Follow-up|6|||
144373180|NCT02175030|520574664|FG001|Overall Study|Lost to Follow-up|6|||
144373181|NCT02175030|520574663|FG000|Overall Study|Withdrawal by Subject|1|||
144373182|NCT02175030|520574664|FG001|Overall Study|Withdrawal by Subject|4|||
144373183|NCT02533453|520574665|FG000|Overall Study|Adverse Event|6|||
144373184|NCT02533453|520574665|FG000|Overall Study|Protocol Violation|1|||
144373185|NCT02533453|520574665|FG000|Overall Study|Withdrawal by Subject|2|||
144373186|NCT00068419|520574669|FG000|Overall Study|Adverse Event|3|||
144373187|NCT00068419|520574669|FG000|Overall Study|Lack of Efficacy|24|||
144373188|NCT00068419|520574669|FG000|Overall Study|Lost to Follow-up|1|||
144373189|NCT00068419|520574669|FG000|Overall Study|Physician Decision|7|||
144373190|NCT00068419|520574669|FG000|Overall Study|Withdrawal by Subject|14|||
144373191|NCT00068419|520574669|FG000|Overall Study|Ineligible|11|||
144373192|NCT00396253|520574678|FG000|Overall Study|Protocol Violation|1|||
144373193|NCT00396253|520574678|FG000|Overall Study|Withdrawal by Subject|7|||
144373194|NCT00396253|520574678|FG000|Overall Study|Death|3|||
144373195|NCT00396253|520574678|FG000|Overall Study|Physician Decision|1|||
144373196|NCT00396253|520574678|FG000|Overall Study|Change in eligibility status|1|||
144373197|NCT04672655|520574684|FG000|Overall Study|Lost to Follow-up|12|||
144373198|NCT04672655|520574685|FG001|Overall Study|Lost to Follow-up|17|||
144373199|NCT04672655|520574684|FG000|Overall Study|Withdrawal by Subject|1|||
144373200|NCT04672655|520574685|FG001|Overall Study|Withdrawal by Subject|0|||
144373201|NCT04672655|520574684|FG000|Overall Study|Withdrawal by Study|1|||
144373202|NCT04672655|520574685|FG001|Overall Study|Withdrawal by Study|0|||
144373203|NCT03892967|520574688|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
144373204|NCT03892967|520574689|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
144373205|NCT03892967|520574690|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
144373206|NCT03892967|520574691|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
144373207|NCT03892967|520574692|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
144373208|NCT03892967|520574688|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
144373209|NCT03892967|520574689|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
144373210|NCT03892967|520574690|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
144373211|NCT03892967|520574691|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
144373212|NCT03892967|520574692|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
144721720|NCT01595009|521835276|FG001|Core|Disease progression|26|||
144249041|NCT02638259|520110017|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144249042|NCT02638259|520110018|FG001|Treatment Period 2|Withdrawal by Subject|7|||
144249043|NCT04299048|520110020|FG000|Overall Study|Death|1|||
144249044|NCT04299048|520110020|FG000|Overall Study|Global deterioration of health status|2|||
144249045|NCT04299048|520110020|FG000|Overall Study|Enrolled and not treated|1|||
144373213|NCT03892967|520574688|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
144471682|NCT00246337|520925260|FG008|Overall Study|Reported as completing trial in error|0|||
144471683|NCT01226511|520925263|FG000|Acute Treatment Period|Adverse Event|7|||
144471684|NCT01226511|520925264|FG001|Acute Treatment Period|Adverse Event|6|||
144471685|NCT01226511|520925263|FG000|Acute Treatment Period|Lack of Efficacy|2|||
144471686|NCT01226511|520925264|FG001|Acute Treatment Period|Lack of Efficacy|1|||
144471687|NCT01226511|520925263|FG000|Acute Treatment Period|Lost to Follow-up|3|||
144373214|NCT03892967|520574689|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
144373215|NCT03892967|520574690|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
144373216|NCT03892967|520574691|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
144373217|NCT03892967|520574692|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
144373218|NCT03892967|520574688|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
144373219|NCT03892967|520574689|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
144373220|NCT03892967|520574690|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
144373221|NCT03892967|520574691|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
144373222|NCT03892967|520574692|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
144373223|NCT03892967|520574688|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
144373224|NCT03892967|520574689|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
144373225|NCT03892967|520574690|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
144373226|NCT03892967|520574691|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
144373227|NCT03892967|520574692|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
144373228|NCT03892967|520574688|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
144373229|NCT03892967|520574689|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
144373230|NCT03892967|520574690|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
144373231|NCT03892967|520574691|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
144373232|NCT03892967|520574692|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
144373233|NCT04434937|520574693|FG000|Overall Study|Death|4|||
144373234|NCT04434937|520574693|FG000|Overall Study|Withdrawal by Subject|1|||
144373235|NCT04434937|520574693|FG000|Overall Study|Transitioned to Rollover Study|19|||
144373236|NCT04434937|520574693|FG000|Overall Study|Progressive Disease|18|||
144373237|NCT03387085|520574698|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
144373238|NCT04193189|520574699|FG000|Overall Study|Lost to Follow-up|9|||
144373239|NCT04193189|520574700|FG001|Overall Study|Lost to Follow-up|7|||
144373240|NCT04193189|520574701|FG002|Overall Study|Lost to Follow-up|9|||
144373241|NCT04193189|520574702|FG003|Overall Study|Lost to Follow-up|0|||
144373242|NCT04193189|520574699|FG000|Overall Study|Withdrawal by Subject|1|||
144373243|NCT04193189|520574700|FG001|Overall Study|Withdrawal by Subject|2|||
144373244|NCT04193189|520574701|FG002|Overall Study|Withdrawal by Subject|2|||
144373245|NCT04193189|520574702|FG003|Overall Study|Withdrawal by Subject|0|||
144373246|NCT04193189|520574699|FG000|Overall Study|Death|1|||
144373247|NCT04193189|520574700|FG001|Overall Study|Death|1|||
144373248|NCT04193189|520574701|FG002|Overall Study|Death|0|||
144373249|NCT04193189|520574702|FG003|Overall Study|Death|0|||
144373250|NCT04193189|520574699|FG000|Overall Study|Protocol Violation|0|||
144373251|NCT04193189|520574700|FG001|Overall Study|Protocol Violation|0|||
144373252|NCT04193189|520574701|FG002|Overall Study|Protocol Violation|0|||
144373253|NCT04193189|520574702|FG003|Overall Study|Protocol Violation|1|||
144373254|NCT00476008|520576053|FG000|Overall Study|Adverse Event|4|||
144373255|NCT00476008|520576054|FG001|Overall Study|Adverse Event|4|||
144373256|NCT00476008|520576053|FG000|Overall Study|Placebo concerns|2|||
144373257|NCT00476008|520576054|FG001|Overall Study|Placebo concerns|2|||
144373258|NCT00476008|520576053|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
144373259|NCT00476008|520576054|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
144373260|NCT00476008|520576053|FG000|Overall Study|Withdrawal by Subject|0|||
144373261|NCT00476008|520576054|FG001|Overall Study|Withdrawal by Subject|1|||
144373262|NCT00476008|520576053|FG000|Overall Study|Death|1|||
144373263|NCT00476008|520576054|FG001|Overall Study|Death|0|||
144373264|NCT01168219|520576055|FG000|Overall Study|off study before starting treatment|2|||
144373265|NCT01168219|520576055|FG000|Overall Study|withdrew before transplant|1|||
144373266|NCT01168219|520576055|FG000|Overall Study|ineligible due to CML|2|||
144510870|NCT01985334|521070804|FG004|Overall Study|Medication non-compliance|2|||
144249046|NCT03677934|520110021|FG000|Overall Study|Adverse Event|1|||
144249047|NCT03677934|520110022|FG001|Overall Study|Adverse Event|1|||
144249048|NCT03677934|520110021|FG000|Overall Study|Death|8|||
144249049|NCT03677934|520110022|FG001|Overall Study|Death|4|||
144249050|NCT03677934|520110021|FG000|Overall Study|Lost to Follow-up|3|||
144249051|NCT03677934|520110022|FG001|Overall Study|Lost to Follow-up|0|||
144249052|NCT03677934|520110021|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144249053|NCT03677934|520110022|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144249054|NCT03677934|520110021|FG000|Overall Study|Physician Decision|0|||
144373267|NCT02563067|520576058|FG000|Overall Study|Subject/guardian decision|14|||
144373268|NCT02563067|520576059|FG001|Overall Study|Subject/guardian decision|20|||
144373269|NCT02563067|520576060|FG002|Overall Study|Subject/guardian decision|16|||
144373270|NCT02563067|520576058|FG000|Overall Study|Physician Decision|0|||
144373271|NCT02563067|520576059|FG001|Overall Study|Physician Decision|1|||
144373272|NCT02563067|520576060|FG002|Overall Study|Physician Decision|3|||
144373273|NCT02563067|520576058|FG000|Overall Study|Lost to Follow-up|1|||
144373274|NCT02563067|520576059|FG001|Overall Study|Lost to Follow-up|2|||
144373275|NCT02563067|520576060|FG002|Overall Study|Lost to Follow-up|0|||
144373276|NCT02563067|520576058|FG000|Overall Study|Technical problems|0|||
144373277|NCT02563067|520576059|FG001|Overall Study|Technical problems|1|||
144373278|NCT02563067|520576060|FG002|Overall Study|Technical problems|0|||
144373279|NCT02563067|520576058|FG000|Overall Study|Lack of Efficacy|1|||
144373280|NCT02563067|520576059|FG001|Overall Study|Lack of Efficacy|0|||
144373281|NCT02563067|520576060|FG002|Overall Study|Lack of Efficacy|0|||
144373282|NCT02563067|520576058|FG000|Overall Study|Death|0|||
144373283|NCT02563067|520576059|FG001|Overall Study|Death|1|||
144373284|NCT02563067|520576060|FG002|Overall Study|Death|1|||
144373285|NCT02563067|520576058|FG000|Overall Study|Adverse Event|2|||
144373286|NCT02563067|520576059|FG001|Overall Study|Adverse Event|1|||
144373287|NCT02563067|520576060|FG002|Overall Study|Adverse Event|0|||
144373288|NCT02563067|520576058|FG000|Overall Study|Death post Treatment/safety period|1|||
144373289|NCT02563067|520576059|FG001|Overall Study|Death post Treatment/safety period|0|||
144373290|NCT02563067|520576060|FG002|Overall Study|Death post Treatment/safety period|0|||
144373291|NCT01039519|520576068|FG000|Treatment|Progressive disease|20|||
144373292|NCT01039519|520576068|FG000|Treatment|Treatment failure|2|||
144373293|NCT01039519|520576068|FG000|Treatment|Adverse Event|3|||
144373294|NCT01039519|520576068|FG000|Treatment|Physician Decision|2|||
144373295|NCT01039519|520576068|FG000|Survival Follow-up|Death|23|||
144373296|NCT01039519|520576068|FG000|Survival Follow-up|Sponsor decision|4|||
144373297|NCT00808080|520576069|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
144373298|NCT00423917|520576072|FG000|Overall Study|Cancel|2|||
144373299|NCT00423917|520576072|FG000|Overall Study|Ineligible|1|||
144373300|NCT00243269|520576073|FG000|Overall Study|Protocol Violation|2|||
144373301|NCT00243269|520576074|FG001|Overall Study|Protocol Violation|1|||
144373302|NCT00243269|520576075|FG002|Overall Study|Protocol Violation|0|||
144373303|NCT00243269|520576076|FG003|Overall Study|Protocol Violation|1|||
144373304|NCT00243269|520576073|FG000|Overall Study|Lost to Follow-up|1|||
144373305|NCT00243269|520576074|FG001|Overall Study|Lost to Follow-up|0|||
144373306|NCT00243269|520576075|FG002|Overall Study|Lost to Follow-up|1|||
144373307|NCT00243269|520576076|FG003|Overall Study|Lost to Follow-up|3|||
144373308|NCT01837823|520576077|FG000|Overall Study|Lost to Follow-up|6|||
144373309|NCT03052400|520576078|FG000|Overall Study|Lost to Follow-up|1|||
144373310|NCT03052400|520576079|FG001|Overall Study|Lost to Follow-up|0|||
144373311|NCT03052400|520576078|FG000|Overall Study|Withdrawal by Subject|0|||
144373312|NCT03052400|520576079|FG001|Overall Study|Withdrawal by Subject|1|||
144373313|NCT00555061|520576080|FG000|Overall Study|Adverse Event|3|||
144373314|NCT00555061|520576080|FG000|Overall Study|Protocol Violation|1|||
144373315|NCT00555061|520576080|FG000|Overall Study|Lost to Follow-up|2|||
144373316|NCT00555061|520576080|FG000|Overall Study|Withdrawal by Subject|2|||
144510871|NCT01985334|521070805|FG005|Overall Study|Medication non-compliance|3|||
144510872|NCT01985334|521070806|FG006|Overall Study|Medication non-compliance|1|||
144510873|NCT01985334|521070807|FG007|Overall Study|Medication non-compliance|3|||
144510874|NCT01985334|521070800|FG000|Overall Study|Use of prohibited treatment|1|||
144510875|NCT01985334|521070801|FG001|Overall Study|Use of prohibited treatment|4|||
144510876|NCT01985334|521070802|FG002|Overall Study|Use of prohibited treatment|1|||
144510877|NCT01985334|521070803|FG003|Overall Study|Use of prohibited treatment|2|||
144510878|NCT01985334|521070804|FG004|Overall Study|Use of prohibited treatment|1|||
144510879|NCT01985334|521070805|FG005|Overall Study|Use of prohibited treatment|6|||
144510880|NCT01985334|521070806|FG006|Overall Study|Use of prohibited treatment|2|||
144510881|NCT01985334|521070807|FG007|Overall Study|Use of prohibited treatment|0|||
144373317|NCT00555061|520576080|FG000|Overall Study|Participant enrolled, but never treated|1|||
144373318|NCT03830892|520576083|FG000|Overall Study|Physician Decision|2|||
144373319|NCT03830892|520576084|FG001|Overall Study|Physician Decision|3|||
144373320|NCT03830892|520576083|FG000|Overall Study|Study terminated due to COVID|4|||
144373321|NCT03830892|520576084|FG001|Overall Study|Study terminated due to COVID|0|||
144510882|NCT01985334|521070800|FG000|Overall Study|Investigator decision|0|||
144510883|NCT01985334|521070801|FG001|Overall Study|Investigator decision|3|||
144249055|NCT03677934|520110022|FG001|Overall Study|Physician Decision|1|||
144373322|NCT03830892|520576083|FG000|Overall Study|Protocol Violation|0|||
144373323|NCT03830892|520576084|FG001|Overall Study|Protocol Violation|1|||
144373324|NCT03830892|520576083|FG000|Overall Study|Withdrawal by Subject|0|||
144373325|NCT03830892|520576084|FG001|Overall Study|Withdrawal by Subject|2|||
144373326|NCT04269265|520576085|FG000|Overall Study|Physician Decision|1|||
144373327|NCT04269265|520576085|FG000|Overall Study|Withdrawal by Subject|1|||
144373328|NCT04269265|520576085|FG000|Overall Study|Overenrolled (sample size reached)|4|||
144510884|NCT01985334|521070802|FG002|Overall Study|Investigator decision|0|||
144510885|NCT01985334|521070803|FG003|Overall Study|Investigator decision|7|||
144373329|NCT04439136|520576086|FG000|Overall Study|Ineligible|1|||
144373330|NCT04439136|520576086|FG000|Overall Study|Never Started Treatment|2|||
144373331|NCT04439136|520576086|FG000|Overall Study|Adverse Event|4|||
144373332|NCT04439136|520576086|FG000|Overall Study|Death|3|||
144373333|NCT04439136|520576086|FG000|Overall Study|Disease Progression|27|||
144373334|NCT04439136|520576086|FG000|Overall Study|Alternative Therapy|1|||
144373335|NCT04439136|520576086|FG000|Overall Study|Increased Tumor Burden|1|||
144373336|NCT04439136|520576086|FG000|Overall Study|Symptomatic Detrioration|1|||
144373337|NCT04849559|520576087|FG000|Overall Study|Withdrawal by Subject|2|||
144373338|NCT04849559|520576088|FG001|Overall Study|Withdrawal by Subject|1|||
144373339|NCT01662102|520576092|FG000|Overall Study|Sponsor's decision|1|||
144373340|NCT01662102|520576093|FG001|Overall Study|Sponsor's decision|0|||
144373341|NCT02586207|520576094|FG000|Overall Study|Physician Decision|1|||
144373342|NCT02586207|520576094|FG000|Overall Study|Withdrawal by Subject|1|||
144373343|NCT03527732|520576095|FG000|Overall Study|Lost to Follow-up|21|||
144373344|NCT03527732|520576096|FG001|Overall Study|Lost to Follow-up|23|||
144373345|NCT03527732|520576097|FG002|Overall Study|Lost to Follow-up|80|||
144373346|NCT03527732|520576098|FG003|Overall Study|Lost to Follow-up|62|||
144373347|NCT03527732|520576099|FG004|Overall Study|Lost to Follow-up|12|||
144373348|NCT03527732|520576100|FG005|Overall Study|Lost to Follow-up|20|||
144373349|NCT01262989|520576101|FG000|Period 1|Lost to Follow-up|1|||
144373350|NCT01262989|520576102|FG001|Period 1|Lost to Follow-up|1|||
144373351|NCT01262989|520576101|FG000|Period 1|Intercurrent disease|0|||
144373352|NCT01262989|520576102|FG001|Period 1|Intercurrent disease|1|||
144373353|NCT01262989|520576101|FG000|Period 1|Positive answer for exclusion criteria|0|||
144373354|NCT01262989|520576102|FG001|Period 1|Positive answer for exclusion criteria|1|||
144373355|NCT01262989|520576101|FG000|Period 2|Intercurrent disease|0|||
144373356|NCT01262989|520576102|FG001|Period 2|Intercurrent disease|1|||
144373357|NCT02306161|520576103|FG000|Overall Study|Death|1|||
144373358|NCT02306161|520576104|FG001|Overall Study|Death|3|||
144373359|NCT02306161|520576103|FG000|Overall Study|Lack of Efficacy|20|||
144373360|NCT02306161|520576104|FG001|Overall Study|Lack of Efficacy|43|||
144373361|NCT02306161|520576103|FG000|Overall Study|Physician Decision|30|||
144373362|NCT02306161|520576104|FG001|Overall Study|Physician Decision|18|||
144373363|NCT02306161|520576103|FG000|Overall Study|Withdrawal by Subject|4|||
144373364|NCT02306161|520576104|FG001|Overall Study|Withdrawal by Subject|0|||
144373365|NCT02306161|520576103|FG000|Overall Study|Ineligible|9|||
144373366|NCT02306161|520576104|FG001|Overall Study|Ineligible|5|||
144373367|NCT00470275|520576105|FG000|Overall Study|Death|1|||
144373368|NCT00470275|520576105|FG000|Overall Study|Lack of Efficacy|7|||
144373369|NCT00470275|520576105|FG000|Overall Study|Withdrawal by Subject|2|||
144373370|NCT03048578|520576106|FG000|Overall Study|Withdrawal by Subject|5|||
144373371|NCT03048578|520576107|FG001|Overall Study|Withdrawal by Subject|6|||
144373372|NCT03048578|520576106|FG000|Overall Study|Lost to Follow-up|22|||
144373373|NCT03048578|520576107|FG001|Overall Study|Lost to Follow-up|10|||
144373374|NCT03048578|520576106|FG000|Overall Study|Adverse Event|1|||
144373375|NCT03048578|520576107|FG001|Overall Study|Adverse Event|2|||
144373376|NCT03048578|520576106|FG000|Overall Study|Terminated|3|||
144373377|NCT03048578|520576107|FG001|Overall Study|Terminated|2|||
144373378|NCT00526071|520576108|FG000|Overall Study|Adverse Event|1|||
144373379|NCT00526071|520576108|FG000|Overall Study|Withdrawal by Subject|1|||
144373380|NCT00526071|520576108|FG000|Overall Study|Lack of Response to Study Drug|4|||
144373381|NCT04995419|520576109|FG000|Overall Study|Withdrawal by Subject|3|||
144373382|NCT04995419|520576109|FG000|Overall Study|Progressive Disease|19|||
144373383|NCT04995419|520576109|FG000|Overall Study|Adverse Event|2|||
144373384|NCT04995419|520576109|FG000|Overall Study|Ongoing|16|||
144373385|NCT00573144|520576112|FG000|Overall Study|Withdrawal by Subject|2|||
144373386|NCT00573144|520576113|FG001|Overall Study|Withdrawal by Subject|3|||
144373387|NCT00125164|520576114|FG000|Overall Study|Adverse Event|0|||
144373388|NCT00125164|520576115|FG001|Overall Study|Adverse Event|0|||
144373389|NCT00125164|520576116|FG002|Overall Study|Adverse Event|2|||
144373390|NCT00125164|520576117|FG003|Overall Study|Adverse Event|4|||
144373391|NCT00125164|520576114|FG000|Overall Study|Lost to Follow-up|0|||
144373392|NCT00125164|520576115|FG001|Overall Study|Lost to Follow-up|0|||
144373393|NCT00125164|520576116|FG002|Overall Study|Lost to Follow-up|1|||
144373394|NCT00125164|520576117|FG003|Overall Study|Lost to Follow-up|1|||
144373395|NCT00125164|520576114|FG000|Overall Study|Withdrawal by Subject|2|||
144373396|NCT00125164|520576115|FG001|Overall Study|Withdrawal by Subject|0|||
144373397|NCT00125164|520576116|FG002|Overall Study|Withdrawal by Subject|1|||
144373398|NCT00125164|520576117|FG003|Overall Study|Withdrawal by Subject|1|||
144373399|NCT00478023|520576120|FG000|Overall Study|Adverse Event|11|||
144373400|NCT00478023|520576121|FG001|Overall Study|Adverse Event|7|||
144373401|NCT00478023|520576122|FG002|Overall Study|Adverse Event|8|||
144373402|NCT00478023|520576123|FG003|Overall Study|Adverse Event|14|||
144373403|NCT00478023|520576124|FG004|Overall Study|Adverse Event|6|||
144373404|NCT00478023|520576120|FG000|Overall Study|Death|1|||
144373405|NCT00478023|520576121|FG001|Overall Study|Death|0|||
144373406|NCT00478023|520576122|FG002|Overall Study|Death|0|||
144373407|NCT00478023|520576123|FG003|Overall Study|Death|0|||
144373408|NCT00478023|520576124|FG004|Overall Study|Death|0|||
144373409|NCT00478023|520576120|FG000|Overall Study|Lack of Efficacy|11|||
144373410|NCT00478023|520576121|FG001|Overall Study|Lack of Efficacy|10|||
144373411|NCT00478023|520576122|FG002|Overall Study|Lack of Efficacy|4|||
144373412|NCT00478023|520576123|FG003|Overall Study|Lack of Efficacy|5|||
144373413|NCT00478023|520576124|FG004|Overall Study|Lack of Efficacy|41|||
144373414|NCT00478023|520576120|FG000|Overall Study|Lost to Follow-up|3|||
144373415|NCT00478023|520576121|FG001|Overall Study|Lost to Follow-up|1|||
144373416|NCT00478023|520576122|FG002|Overall Study|Lost to Follow-up|1|||
144373417|NCT00478023|520576123|FG003|Overall Study|Lost to Follow-up|1|||
144373418|NCT00478023|520576124|FG004|Overall Study|Lost to Follow-up|0|||
144373419|NCT00478023|520576120|FG000|Overall Study|Withdrawal by Subject|2|||
144373420|NCT00478023|520576121|FG001|Overall Study|Withdrawal by Subject|3|||
144373421|NCT00478023|520576122|FG002|Overall Study|Withdrawal by Subject|2|||
144373422|NCT00478023|520576123|FG003|Overall Study|Withdrawal by Subject|4|||
144373423|NCT00478023|520576124|FG004|Overall Study|Withdrawal by Subject|5|||
144373424|NCT00478023|520576120|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
144373425|NCT00478023|520576121|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
144373426|NCT00478023|520576122|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
144373427|NCT00478023|520576123|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
144373428|NCT00478023|520576124|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
144373429|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
144373430|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
144373431|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
144373432|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
144373433|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
144373434|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
144373435|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
144373436|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
144373437|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
144373438|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373439|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
144373440|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373441|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373442|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373443|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
144373444|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
144510886|NCT01985334|521070804|FG004|Overall Study|Investigator decision|1|||
144510887|NCT01985334|521070805|FG005|Overall Study|Investigator decision|1|||
144510888|NCT01985334|521070806|FG006|Overall Study|Investigator decision|0|||
144510889|NCT01985334|521070807|FG007|Overall Study|Investigator decision|4|||
144510890|NCT01985334|521070800|FG000|Overall Study|Lost to Follow-up|0|||
144510891|NCT01985334|521070801|FG001|Overall Study|Lost to Follow-up|2|||
144510892|NCT01985334|521070802|FG002|Overall Study|Lost to Follow-up|0|||
144510893|NCT01985334|521070803|FG003|Overall Study|Lost to Follow-up|3|||
144510894|NCT01985334|521070804|FG004|Overall Study|Lost to Follow-up|1|||
144510895|NCT01985334|521070805|FG005|Overall Study|Lost to Follow-up|4|||
144510896|NCT01985334|521070806|FG006|Overall Study|Lost to Follow-up|0|||
144510897|NCT01985334|521070807|FG007|Overall Study|Lost to Follow-up|3|||
144510898|NCT01290341|521070808|FG000|Overall Study|Protocol Violation|7|||
144510899|NCT01290341|521070809|FG001|Overall Study|Protocol Violation|3|||
144510900|NCT01290341|521070808|FG000|Overall Study|Adverse Event|1|||
144510901|NCT01290341|521070809|FG001|Overall Study|Adverse Event|0|||
144510902|NCT01290341|521070808|FG000|Overall Study|Lost to Follow-up|21|||
144510903|NCT01290341|521070809|FG001|Overall Study|Lost to Follow-up|10|||
144510904|NCT01290341|521070808|FG000|Overall Study|Withdrawal by Subject|19|||
144510905|NCT01290341|521070809|FG001|Overall Study|Withdrawal by Subject|5|||
144510906|NCT01290341|521070808|FG000|Overall Study|Negative baseline culture and others|44|||
144510907|NCT01290341|521070809|FG001|Overall Study|Negative baseline culture and others|11|||
144510908|NCT03684044|521070810|FG000|Overall Study|Adverse Event|3|||
144510909|NCT03684044|521070811|FG001|Overall Study|Adverse Event|0|||
144510910|NCT03684044|521070810|FG000|Overall Study|Death|4|||
144510911|NCT03684044|521070811|FG001|Overall Study|Death|7|||
144373445|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
144373446|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
144373447|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
144373448|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
144373449|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
144373450|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
144373451|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
144373452|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
144373453|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
144373454|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
144373455|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
144373456|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
144373457|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
144373458|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
144373459|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
144373460|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
144373461|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
144373462|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
144373463|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
144373464|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
144373465|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373466|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373467|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373468|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373469|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373470|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373471|NCT05019521|520576128|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
144373472|NCT05019521|520576129|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144373473|NCT05019521|520576130|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
144373474|NCT05019521|520576131|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
144373475|NCT05019521|520576132|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144373476|NCT05019521|520576133|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144373477|NCT05019521|520576134|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144373478|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
144373479|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
144373480|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
144373481|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
144373482|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
144373483|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
144373484|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
144373485|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
144373486|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
144373487|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
144373488|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373489|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373490|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
144373491|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
144373492|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
144373493|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
144373494|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
144373495|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
144373496|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
144373497|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
144373498|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
144373499|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
144373500|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
144373501|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
144373502|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
144373503|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
144373504|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
144510912|NCT03684044|521070810|FG000|Overall Study|Lost to Follow-up|3|||
144510913|NCT03684044|521070811|FG001|Overall Study|Lost to Follow-up|2|||
144721721|NCT01595009|521835277|FG002|Core|Disease progression|0|||
144721722|NCT01595009|521835278|FG003|Core|Disease progression|0|||
144373505|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
144373506|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
144373507|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
144373508|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
144373509|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
144373510|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
144373511|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
144373512|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
144373513|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373514|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373515|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373516|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373517|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373518|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
144373519|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
144373520|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
144373521|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
144510914|NCT03684044|521070810|FG000|Overall Study|Patient Not Available|0|||
144510915|NCT03684044|521070811|FG001|Overall Study|Patient Not Available|2|||
144510916|NCT03684044|521070810|FG000|Overall Study|Physician Decision|1|||
144510917|NCT03684044|521070811|FG001|Overall Study|Physician Decision|0|||
144510918|NCT03684044|521070810|FG000|Overall Study|Withdrawal by Subject|11|||
144510919|NCT03684044|521070811|FG001|Overall Study|Withdrawal by Subject|9|||
144510920|NCT03703336|521070812|FG000|Overall Study|Parent withdrew consent|29|||
144510921|NCT03703336|521070813|FG001|Overall Study|Parent withdrew consent|8|||
144510922|NCT03703336|521070812|FG000|Overall Study|Migration|3|||
144510923|NCT03703336|521070813|FG001|Overall Study|Migration|3|||
144510924|NCT03703336|521070812|FG000|Overall Study|Protocol Violation|3|||
144510925|NCT03703336|521070813|FG001|Overall Study|Protocol Violation|1|||
144510926|NCT03703336|521070812|FG000|Overall Study|Physician Decision|2|||
144510927|NCT03703336|521070813|FG001|Overall Study|Physician Decision|0|||
144510928|NCT03703336|521070812|FG000|Overall Study|Adverse Event|0|||
144510929|NCT03703336|521070813|FG001|Overall Study|Adverse Event|2|||
144510930|NCT03703336|521070812|FG000|Overall Study|Lost to Follow-up|1|||
144510931|NCT03703336|521070813|FG001|Overall Study|Lost to Follow-up|0|||
144510932|NCT02708108|521070814|FG000|Overall Study|Death|1|||
144510933|NCT02708108|521070815|FG001|Overall Study|Death|2|||
144510934|NCT02708108|521070814|FG000|Overall Study|Regimen change|1|||
144510935|NCT02708108|521070815|FG001|Overall Study|Regimen change|0|||
144510936|NCT02708108|521070814|FG000|Overall Study|No MRD and no imaging available|0|||
144510937|NCT02708108|521070815|FG001|Overall Study|No MRD and no imaging available|1|||
144510938|NCT03807778|521070820|FG000|Overall Study|Adverse Event|0|||
144510939|NCT03807778|521070821|FG001|Overall Study|Adverse Event|0|||
144510940|NCT03807778|521070822|FG002|Overall Study|Adverse Event|3|||
144510941|NCT03807778|521070823|FG003|Overall Study|Adverse Event|5|||
144510942|NCT03807778|521070820|FG000|Overall Study|Progressive Disease|4|||
144510943|NCT03807778|521070821|FG001|Overall Study|Progressive Disease|2|||
144510944|NCT03807778|521070822|FG002|Overall Study|Progressive Disease|8|||
144510945|NCT03807778|521070823|FG003|Overall Study|Progressive Disease|15|||
144510946|NCT03807778|521070820|FG000|Overall Study|Symptomatic Deterioration|0|||
144510947|NCT03807778|521070821|FG001|Overall Study|Symptomatic Deterioration|1|||
144510948|NCT03807778|521070822|FG002|Overall Study|Symptomatic Deterioration|0|||
144721723|NCT01595009|521835275|FG000|Core|Withdrawal by Subject|4|||
144373522|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
144373523|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144373524|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144510949|NCT03807778|521070823|FG003|Overall Study|Symptomatic Deterioration|1|||
144510950|NCT03807778|521070820|FG000|Overall Study|Withdrawal by Subject|0|||
144510951|NCT03807778|521070821|FG001|Overall Study|Withdrawal by Subject|1|||
144510952|NCT03807778|521070822|FG002|Overall Study|Withdrawal by Subject|0|||
144510953|NCT03807778|521070823|FG003|Overall Study|Withdrawal by Subject|1|||
144510954|NCT03807778|521070820|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
144510955|NCT03807778|521070821|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
144510956|NCT03807778|521070822|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
144510957|NCT03807778|521070823|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
144510958|NCT05505045|521072524|FG000|Overall Study|Withdrawal by Subject|2|||
144510959|NCT05505045|521072525|FG001|Overall Study|Withdrawal by Subject|1|||
144510960|NCT03346538|521072526|FG000|Overall Study|Physician Decision|0|||
144373525|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
144373526|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
144373527|NCT05019521|520576128|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
144373528|NCT05019521|520576129|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
144373529|NCT05019521|520576130|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
144373530|NCT05019521|520576131|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
144373531|NCT05019521|520576132|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
144373532|NCT05019521|520576133|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
144373533|NCT05019521|520576134|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
144373534|NCT00885534|520576135|FG000|Overall Study|Patient deemed ineligible|1|||
144373535|NCT02453711|520576136|FG000|Overall Study|Withdrawal by Subject|5|||
144373536|NCT02453711|520576137|FG001|Overall Study|Withdrawal by Subject|4|||
144373537|NCT02453711|520576138|FG002|Overall Study|Withdrawal by Subject|6|||
144373538|NCT02453711|520576139|FG003|Overall Study|Withdrawal by Subject|4|||
144373539|NCT02453711|520576140|FG004|Overall Study|Withdrawal by Subject|1|||
144373540|NCT02453711|520576141|FG005|Overall Study|Withdrawal by Subject|1|||
144373541|NCT02453711|520576142|FG006|Overall Study|Withdrawal by Subject|0|||
144373542|NCT02453711|520576143|FG007|Overall Study|Withdrawal by Subject|1|||
144373543|NCT02453711|520576144|FG008|Overall Study|Withdrawal by Subject|7|||
144373544|NCT02453711|520576136|FG000|Overall Study|Lost to Follow-up|5|||
144373545|NCT02453711|520576137|FG001|Overall Study|Lost to Follow-up|3|||
144373546|NCT02453711|520576138|FG002|Overall Study|Lost to Follow-up|2|||
144373547|NCT02453711|520576139|FG003|Overall Study|Lost to Follow-up|3|||
144373548|NCT02453711|520576140|FG004|Overall Study|Lost to Follow-up|1|||
144373549|NCT02453711|520576141|FG005|Overall Study|Lost to Follow-up|5|||
144373550|NCT02453711|520576142|FG006|Overall Study|Lost to Follow-up|2|||
144373551|NCT02453711|520576143|FG007|Overall Study|Lost to Follow-up|6|||
144373552|NCT02453711|520576144|FG008|Overall Study|Lost to Follow-up|6|||
144373553|NCT02453711|520576136|FG000|Overall Study|Death|0|||
144373554|NCT02453711|520576137|FG001|Overall Study|Death|0|||
144373555|NCT02453711|520576138|FG002|Overall Study|Death|0|||
144373556|NCT02453711|520576139|FG003|Overall Study|Death|0|||
144373557|NCT02453711|520576140|FG004|Overall Study|Death|0|||
144373558|NCT02453711|520576141|FG005|Overall Study|Death|0|||
144373559|NCT02453711|520576142|FG006|Overall Study|Death|1|||
144373560|NCT02453711|520576143|FG007|Overall Study|Death|0|||
144373561|NCT02453711|520576144|FG008|Overall Study|Death|0|||
144373562|NCT02453711|520576136|FG000|Overall Study|Unclassified|1|||
144373563|NCT02453711|520576137|FG001|Overall Study|Unclassified|0|||
144373564|NCT02453711|520576138|FG002|Overall Study|Unclassified|1|||
144373565|NCT02453711|520576139|FG003|Overall Study|Unclassified|0|||
144510961|NCT03346538|521072527|FG001|Overall Study|Physician Decision|1|||
144510962|NCT03346538|521072528|FG002|Overall Study|Physician Decision|0|||
144510963|NCT03346538|521072526|FG000|Overall Study|Withdrawal by Subject|3|||
144510964|NCT03346538|521072527|FG001|Overall Study|Withdrawal by Subject|2|||
144510965|NCT03346538|521072528|FG002|Overall Study|Withdrawal by Subject|0|||
144510966|NCT03346538|521072526|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
144510967|NCT03346538|521072527|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
144510968|NCT03346538|521072528|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
144510969|NCT05672667|521072529|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
144510970|NCT01903811|521072537|FG000|Overall Study|No measurable disease|1|||
144510971|NCT01903811|521072538|FG001|Overall Study|No measurable disease|1|||
144510972|NCT01903811|521072537|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
144510973|NCT01903811|521072538|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
144510974|NCT01903811|521072537|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
144510975|NCT01903811|521072538|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
144510976|NCT01903811|521072537|FG000|Overall Study|Withdrawal by Subject|0|||
144510977|NCT01903811|521072538|FG001|Overall Study|Withdrawal by Subject|1|||
144510978|NCT04540913|521072539|FG000|Overall Study|Withdrawal by Subject|14|||
144510979|NCT04540913|521072540|FG001|Overall Study|Withdrawal by Subject|3|||
144510980|NCT03613740|521072544|FG000|Overall Study|Lost to Follow-up|1|||
144510981|NCT03613740|521072545|FG001|Overall Study|Lost to Follow-up|1|||
144721724|NCT01595009|521835276|FG001|Core|Withdrawal by Subject|17|||
144510982|NCT03575052|521072546|FG000|Overall Study|Adverse Event|6|||
144721725|NCT01595009|521835277|FG002|Core|Withdrawal by Subject|0|||
144721726|NCT01595009|521835278|FG003|Core|Withdrawal by Subject|0|||
144373566|NCT02453711|520576140|FG004|Overall Study|Unclassified|0|||
144373567|NCT02453711|520576141|FG005|Overall Study|Unclassified|0|||
144373568|NCT02453711|520576142|FG006|Overall Study|Unclassified|0|||
144373569|NCT02453711|520576143|FG007|Overall Study|Unclassified|0|||
144373570|NCT02453711|520576144|FG008|Overall Study|Unclassified|0|||
144373571|NCT03695367|520576145|FG000|Overall Study|Missed the Day 28 visit.|1|||
144373572|NCT03695367|520576146|FG001|Overall Study|Missed the Day 28 visit.|0|||
144373573|NCT03695367|520576145|FG000|Overall Study|Lost to Follow-up|0|||
144373574|NCT03695367|520576146|FG001|Overall Study|Lost to Follow-up|1|||
144373575|NCT03695367|520576145|FG000|Overall Study|Withdrawal by Subject|0|||
144373576|NCT03695367|520576146|FG001|Overall Study|Withdrawal by Subject|1|||
144373577|NCT03695367|520576145|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
144373578|NCT03695367|520576146|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
144373579|NCT01500720|520576152|FG000|Overall Study|Randomized But Not Treated|1|||
144373580|NCT01500720|520576153|FG001|Overall Study|Randomized But Not Treated|1|||
144373581|NCT01500720|520576152|FG000|Overall Study|Other|4|||
144373582|NCT01500720|520576153|FG001|Overall Study|Other|8|||
144373583|NCT00740857|520576154|FG000|Overall Study|Withdrawal by Subject|1|||
144373584|NCT00740857|520576155|FG001|Overall Study|Withdrawal by Subject|0|||
144373585|NCT00740857|520576156|FG002|Overall Study|Withdrawal by Subject|0|||
144373586|NCT03532451|520576160|FG000|Overall Study|Withdrawal by Subject|0|||
144373587|NCT03532451|520576161|FG001|Overall Study|Withdrawal by Subject|1|||
144373588|NCT03532451|520576160|FG000|Overall Study|Did not undergo surgery|1|||
144373589|NCT03532451|520576161|FG001|Overall Study|Did not undergo surgery|1|||
144373590|NCT02527421|520576162|FG000|Overall Study|Withdrawal by Subject|1|||
144373591|NCT02527421|520576163|FG001|Overall Study|Withdrawal by Subject|0|||
144373592|NCT01615029|520576164|FG000|Overall Study|Adverse Event|0|||
144373593|NCT01615029|520576165|FG001|Overall Study|Adverse Event|0|||
144373594|NCT01615029|520576166|FG002|Overall Study|Adverse Event|0|||
144373595|NCT01615029|520576167|FG003|Overall Study|Adverse Event|0|||
144373596|NCT01615029|520576168|FG004|Overall Study|Adverse Event|1|||
144373597|NCT01615029|520576164|FG000|Overall Study|Death|0|||
144373598|NCT01615029|520576165|FG001|Overall Study|Death|0|||
144373599|NCT01615029|520576166|FG002|Overall Study|Death|0|||
144373600|NCT01615029|520576167|FG003|Overall Study|Death|0|||
144373601|NCT01615029|520576168|FG004|Overall Study|Death|1|||
144373602|NCT01615029|520576164|FG000|Overall Study|Lost to Follow-up|0|||
144373603|NCT01615029|520576165|FG001|Overall Study|Lost to Follow-up|0|||
144373604|NCT01615029|520576166|FG002|Overall Study|Lost to Follow-up|0|||
144373605|NCT01615029|520576167|FG003|Overall Study|Lost to Follow-up|0|||
144373606|NCT01615029|520576168|FG004|Overall Study|Lost to Follow-up|1|||
144373607|NCT01615029|520576164|FG000|Overall Study|Progressive disease|2|||
144373608|NCT01615029|520576165|FG001|Overall Study|Progressive disease|1|||
144373609|NCT01615029|520576166|FG002|Overall Study|Progressive disease|1|||
144373610|NCT01615029|520576167|FG003|Overall Study|Progressive disease|1|||
144373611|NCT01615029|520576168|FG004|Overall Study|Progressive disease|5|||
144373612|NCT01615029|520576164|FG000|Overall Study|Physician Decision|0|||
144373613|NCT01615029|520576165|FG001|Overall Study|Physician Decision|0|||
144510983|NCT03575052|521072547|FG001|Overall Study|Adverse Event|10|||
144510984|NCT03575052|521072546|FG000|Overall Study|Not further specified|5|||
144510985|NCT03575052|521072547|FG001|Overall Study|Not further specified|7|||
144510986|NCT03575052|521072546|FG000|Overall Study|Withdrawal by Subject|5|||
144510987|NCT03575052|521072547|FG001|Overall Study|Withdrawal by Subject|6|||
144510988|NCT03575052|521072546|FG000|Overall Study|Lost to Follow-up|3|||
144510989|NCT03575052|521072547|FG001|Overall Study|Lost to Follow-up|0|||
144373614|NCT01615029|520576166|FG002|Overall Study|Physician Decision|0|||
144373615|NCT01615029|520576167|FG003|Overall Study|Physician Decision|0|||
144373616|NCT01615029|520576168|FG004|Overall Study|Physician Decision|1|||
144373617|NCT01615029|520576164|FG000|Overall Study|Ongoing|1|||
144373618|NCT01615029|520576165|FG001|Overall Study|Ongoing|2|||
144373619|NCT01615029|520576166|FG002|Overall Study|Ongoing|3|||
144373620|NCT01615029|520576167|FG003|Overall Study|Ongoing|2|||
144373621|NCT01615029|520576168|FG004|Overall Study|Ongoing|23|||
144510990|NCT03575052|521072546|FG000|Overall Study|Death|2|||
144373622|NCT05767749|520576169|FG000|Overall Study|Withdrawal by Subject|0|||
144373623|NCT05767749|520576170|FG001|Overall Study|Withdrawal by Subject|0|||
144510991|NCT03575052|521072547|FG001|Overall Study|Death|1|||
144510992|NCT03575052|521072546|FG000|Overall Study|Lack of Efficacy|2|||
144510993|NCT03575052|521072547|FG001|Overall Study|Lack of Efficacy|1|||
144510994|NCT03575052|521072546|FG000|Overall Study|Study drug noncompliance|1|||
144510995|NCT03575052|521072547|FG001|Overall Study|Study drug noncompliance|2|||
144510996|NCT03575052|521072546|FG000|Overall Study|Protocol Violation|0|||
144510997|NCT03575052|521072547|FG001|Overall Study|Protocol Violation|2|||
144510998|NCT03575052|521072546|FG000|Overall Study|Physician Decision|1|||
144510999|NCT03575052|521072547|FG001|Overall Study|Physician Decision|0|||
144511000|NCT04188379|521072548|FG000|Overall Study|Withdrawal by Subject|10|||
144511001|NCT04188379|521072549|FG001|Overall Study|Withdrawal by Subject|3|||
144511002|NCT04188379|521072548|FG000|Overall Study|Physician Decision|0|||
144511003|NCT04188379|521072549|FG001|Overall Study|Physician Decision|1|||
144511004|NCT04188379|521072548|FG000|Overall Study|Adverse Event|3|||
144511005|NCT04188379|521072549|FG001|Overall Study|Adverse Event|1|||
144511006|NCT04188379|521072548|FG000|Overall Study|Pregnancy|1|||
144511007|NCT04188379|521072549|FG001|Overall Study|Pregnancy|0|||
144511008|NCT04188379|521072548|FG000|Overall Study|Lack of Efficacy|8|||
144511009|NCT04188379|521072549|FG001|Overall Study|Lack of Efficacy|5|||
144511010|NCT04188379|521072548|FG000|Overall Study|Other|0|||
144511011|NCT04188379|521072549|FG001|Overall Study|Other|3|||
144511012|NCT01693120|521072551|FG000|Enrollment|Lost to Follow-up|1|||
144511013|NCT01693120|521072551|FG000|Enrollment|Withdrawal by Subject|10|||
144511014|NCT01693120|521072551|FG000|Enrollment|Protocol Violation|46|||
144511015|NCT01693120|521072551|FG000|Enrollment|Physician Decision|3|||
144511016|NCT01693120|521072551|FG000|Enrollment|Adverse Event|1|||
144511017|NCT01693120|521072551|FG000|Enrollment|Study closed|8|||
144511018|NCT01693120|521072551|FG000|Enrollment|Other|1|||
144511019|NCT01693120|521072551|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
144511020|NCT01693120|521072551|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
144511021|NCT01693120|521072551|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
144511022|NCT01693120|521072551|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
144511023|NCT01693120|521072551|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
144511024|NCT03624972|521072560|FG000|Overall Study|Lost to Follow-up|2|||
144511025|NCT03624972|521072561|FG001|Overall Study|Lost to Follow-up|0|||
144511026|NCT03624972|521072562|FG002|Overall Study|Lost to Follow-up|0|||
144511027|NCT03624972|521072560|FG000|Overall Study|Withdrawal by Subject|0|||
144511028|NCT03624972|521072561|FG001|Overall Study|Withdrawal by Subject|2|||
144511029|NCT03624972|521072562|FG002|Overall Study|Withdrawal by Subject|0|||
144511030|NCT05137236|521072563|FG000|Part A|Other than Specified|1|||
144511031|NCT05137236|521072564|FG001|Part A|Other than Specified|0|||
144511032|NCT05137236|521072565|FG002|Part A|Other than Specified|0|||
144511033|NCT05137236|521072566|FG003|Part A|Other than Specified|0|||
144511034|NCT05137236|521072567|FG004|Part A|Other than Specified|0|||
144511035|NCT05137236|521072568|FG005|Part A|Other than Specified|0|||
144511036|NCT05137236|521072569|FG006|Part A|Other than Specified|0|||
144511037|NCT05137236|521072570|FG007|Part A|Other than Specified|0|||
144511038|NCT05137236|521072563|FG000|Part A|Withdrawal by Subject|0|||
144511039|NCT05137236|521072564|FG001|Part A|Withdrawal by Subject|4|||
144511040|NCT05137236|521072565|FG002|Part A|Withdrawal by Subject|1|||
144511041|NCT05137236|521072566|FG003|Part A|Withdrawal by Subject|1|||
144511042|NCT05137236|521072567|FG004|Part A|Withdrawal by Subject|3|||
144511043|NCT05137236|521072568|FG005|Part A|Withdrawal by Subject|2|||
144511044|NCT05137236|521072569|FG006|Part A|Withdrawal by Subject|0|||
144511045|NCT05137236|521072570|FG007|Part A|Withdrawal by Subject|0|||
144511046|NCT05137236|521072563|FG000|Part A|Lost to Follow-up|5|||
144511047|NCT05137236|521072564|FG001|Part A|Lost to Follow-up|7|||
144511048|NCT05137236|521072565|FG002|Part A|Lost to Follow-up|1|||
144511049|NCT05137236|521072566|FG003|Part A|Lost to Follow-up|3|||
144511050|NCT05137236|521072567|FG004|Part A|Lost to Follow-up|3|||
144511051|NCT05137236|521072568|FG005|Part A|Lost to Follow-up|8|||
144511052|NCT05137236|521072569|FG006|Part A|Lost to Follow-up|0|||
144511053|NCT05137236|521072570|FG007|Part A|Lost to Follow-up|0|||
144511054|NCT05137236|521072563|FG000|Part B|Withdrawal by Subject|0|||
144511055|NCT05137236|521072564|FG001|Part B|Withdrawal by Subject|0|||
144511056|NCT05137236|521072565|FG002|Part B|Withdrawal by Subject|0|||
144511057|NCT05137236|521072566|FG003|Part B|Withdrawal by Subject|0|||
144511058|NCT05137236|521072567|FG004|Part B|Withdrawal by Subject|0|||
144511059|NCT05137236|521072568|FG005|Part B|Withdrawal by Subject|0|||
144511060|NCT05137236|521072569|FG006|Part B|Withdrawal by Subject|0|||
144511061|NCT05137236|521072570|FG007|Part B|Withdrawal by Subject|2|||
144511062|NCT05137236|521072563|FG000|Part B|Lost to Follow-up|0|||
144511063|NCT05137236|521072564|FG001|Part B|Lost to Follow-up|0|||
144511064|NCT05137236|521072565|FG002|Part B|Lost to Follow-up|0|||
144511065|NCT05137236|521072566|FG003|Part B|Lost to Follow-up|0|||
144511066|NCT05137236|521072567|FG004|Part B|Lost to Follow-up|0|||
144590651|NCT00192647|521364057|FG001|Overall Study|Other/Administrative|3|||
144590652|NCT01828073|521364058|FG000|Overall Study|Lost to Follow-up|1|||
144590653|NCT01828073|521364059|FG001|Overall Study|Lost to Follow-up|2|||
144590654|NCT00690443|521364060|FG000|Overall Study|Adverse Event|1|||
144590655|NCT00690443|521364061|FG001|Overall Study|Adverse Event|2|||
144590656|NCT02502097|521364062|FG000|Period 1|Adverse Event|0|||
144590657|NCT02502097|521364063|FG001|Period 1|Adverse Event|0|||
144590658|NCT02502097|521364064|FG002|Period 1|Adverse Event|1|||
144590659|NCT02502097|521364065|FG003|Period 1|Adverse Event|0|||
144590660|NCT02502097|521364062|FG000|Wash Out Period|Adverse Event|0|||
144590661|NCT02502097|521364063|FG001|Wash Out Period|Adverse Event|1|||
144590662|NCT02502097|521364064|FG002|Wash Out Period|Adverse Event|1|||
144590663|NCT02502097|521364065|FG003|Wash Out Period|Adverse Event|1|||
144590664|NCT02502097|521364062|FG000|Period 2|Adverse Event|0|||
144590665|NCT02502097|521364063|FG001|Period 2|Adverse Event|0|||
144590666|NCT02502097|521364064|FG002|Period 2|Adverse Event|1|||
144590667|NCT02502097|521364065|FG003|Period 2|Adverse Event|0|||
144590668|NCT01350336|521364066|FG000|Overall Study|Lost to Follow-up|31|||
144590669|NCT01350336|521364066|FG000|Overall Study|Withdrawal by Subject|14|||
144590670|NCT01350336|521364066|FG000|Overall Study|Physician Decision|8|||
144590671|NCT01350336|521364066|FG000|Overall Study|Death|4|||
144590672|NCT01776541|521364067|FG000|Overall Study|Administrative Reason|6|||
144590673|NCT01776541|521364068|FG001|Overall Study|Administrative Reason|2|||
144590674|NCT01776541|521364067|FG000|Overall Study|Death|4|||
144590675|NCT01776541|521364068|FG001|Overall Study|Death|0|||
144590676|NCT01776541|521364067|FG000|Overall Study|Lost to Follow-up|27|||
144590677|NCT01776541|521364068|FG001|Overall Study|Lost to Follow-up|48|||
144590678|NCT01776541|521364067|FG000|Overall Study|Unclassified|5|||
144590679|NCT01776541|521364068|FG001|Overall Study|Unclassified|4|||
144590680|NCT01776541|521364067|FG000|Overall Study|Protocol Violation|2|||
144590681|NCT01776541|521364068|FG001|Overall Study|Protocol Violation|1|||
144590682|NCT01776541|521364067|FG000|Overall Study|Withdrawal by Subject|12|||
144590683|NCT01776541|521364068|FG001|Overall Study|Withdrawal by Subject|20|||
144590684|NCT01981473|521364069|FG000|Overall Study|Incorrect diagnosis of RA|0|||
144590685|NCT01981473|521364070|FG001|Overall Study|Incorrect diagnosis of RA|0|||
144590686|NCT01981473|521364071|FG002|Overall Study|Incorrect diagnosis of RA|1|||
144590687|NCT01981473|521364069|FG000|Overall Study|Received treatment for < 6 months|0|||
144590688|NCT01981473|521364070|FG001|Overall Study|Received treatment for < 6 months|0|||
144590689|NCT01981473|521364071|FG002|Overall Study|Received treatment for < 6 months|1|||
144590690|NCT01981473|521364069|FG000|Overall Study|Received treatment for >24 months|2|||
144590691|NCT01981473|521364070|FG001|Overall Study|Received treatment for >24 months|0|||
144590692|NCT01981473|521364071|FG002|Overall Study|Received treatment for >24 months|6|||
144590693|NCT00799513|521364074|FG000|Overall Study|Physician Decision|1|||
144590694|NCT00799513|521364074|FG000|Overall Study|Adverse Event|1|||
144590695|NCT05398237|521364075|FG000|Overall Study|Withdrawal by Subject|1|||
144590696|NCT01312857|521364077|FG000|Overall Study|Adverse Event|1|||
144590697|NCT01312857|521364078|FG001|Overall Study|Adverse Event|1|||
144590698|NCT01312857|521364077|FG000|Overall Study|Lost to Follow-up|2|||
144590699|NCT01312857|521364078|FG001|Overall Study|Lost to Follow-up|0|||
144590700|NCT01312857|521364077|FG000|Overall Study|Physician Decision|3|||
144590701|NCT01312857|521364078|FG001|Overall Study|Physician Decision|0|||
144590702|NCT01312857|521364077|FG000|Overall Study|Withdrawal by Subject|2|||
144590703|NCT01312857|521364078|FG001|Overall Study|Withdrawal by Subject|0|||
144590704|NCT00461032|521364079|FG000|Overall Study|Adverse Event|5|||
144590705|NCT00461032|521364080|FG001|Overall Study|Adverse Event|6|||
144590706|NCT00461032|521364079|FG000|Overall Study|Lack of Efficacy|5|||
144590707|NCT00461032|521364080|FG001|Overall Study|Lack of Efficacy|1|||
144590708|NCT00461032|521364079|FG000|Overall Study|Lost to Follow-up|7|||
144590709|NCT00461032|521364080|FG001|Overall Study|Lost to Follow-up|12|||
144590710|NCT00461032|521364079|FG000|Overall Study|Protocol Violation|4|||
144590711|NCT00461032|521364080|FG001|Overall Study|Protocol Violation|4|||
144590712|NCT00461032|521364079|FG000|Overall Study|Withdrawal by Subject|7|||
144590713|NCT00461032|521364080|FG001|Overall Study|Withdrawal by Subject|15|||
144590714|NCT00461032|521364079|FG000|Overall Study|Patient Moved or Relocated|2|||
144590715|NCT00461032|521364080|FG001|Overall Study|Patient Moved or Relocated|1|||
144590716|NCT00461032|521364079|FG000|Overall Study|Other|7|||
144590717|NCT00461032|521364080|FG001|Overall Study|Other|5|||
144590718|NCT01098097|521364086|FG000|Overall Study|Adverse Event|17|||
144590719|NCT01098097|521364086|FG000|Overall Study|Lost to Follow-up|18|||
144590720|NCT01098097|521364086|FG000|Overall Study|Status unknown|16|||
144590721|NCT01098097|521364086|FG000|Overall Study|No reason reported|31|||
144590722|NCT00232544|521364090|FG000|Overall Study|Lost to Follow-up|20|||
144590723|NCT00232544|521364091|FG001|Overall Study|Lost to Follow-up|15|||
144590724|NCT00116753|521364092|FG000|Overall Study|Adverse Event|16|||
144590725|NCT00116753|521364093|FG001|Overall Study|Adverse Event|10|||
144590726|NCT00116753|521364094|FG002|Overall Study|Adverse Event|7|||
144590727|NCT00116753|521364092|FG000|Overall Study|Withdrawal by Subject|11|||
144590728|NCT00116753|521364093|FG001|Overall Study|Withdrawal by Subject|12|||
144590729|NCT00116753|521364094|FG002|Overall Study|Withdrawal by Subject|8|||
144590730|NCT00116753|521364092|FG000|Overall Study|Lost to Follow-up|0|||
144511067|NCT05137236|521072568|FG005|Part B|Lost to Follow-up|0|||
144511068|NCT05137236|521072569|FG006|Part B|Lost to Follow-up|5|||
144511069|NCT05137236|521072570|FG007|Part B|Lost to Follow-up|5|||
144511070|NCT05137236|521072563|FG000|Part B|Death|0|||
144511071|NCT05137236|521072564|FG001|Part B|Death|0|||
144511072|NCT05137236|521072565|FG002|Part B|Death|0|||
144511073|NCT05137236|521072566|FG003|Part B|Death|0|||
144511074|NCT05137236|521072567|FG004|Part B|Death|0|||
144511075|NCT05137236|521072568|FG005|Part B|Death|0|||
144511076|NCT05137236|521072569|FG006|Part B|Death|0|||
144511077|NCT05137236|521072570|FG007|Part B|Death|2|||
144511078|NCT00431834|521072572|FG000|Overall Study|Withdrawal by Subject|7|||
144511079|NCT00431834|521072572|FG000|Overall Study|Death|3|||
144511080|NCT00431834|521072572|FG000|Overall Study|Missed Endpoint Visit|2|||
144511081|NCT00431834|521072572|FG000|Overall Study|Lost to Follow-up|1|||
144511082|NCT02622568|521072573|FG000|Overall Study|Lost to Follow-up|5|||
144511083|NCT02622568|521072574|FG001|Overall Study|Lost to Follow-up|5|||
144511084|NCT02647905|521072579|FG000|Overall Study|Lost to Follow-up|1|||
144511085|NCT02647905|521072579|FG000|Overall Study|Withdrawal by Subject|2|||
144511086|NCT05119855|521072582|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
144511087|NCT05119855|521072583|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
144511088|NCT05119855|521072582|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
144511089|NCT05119855|521072583|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
144511090|NCT05119855|521072582|FG000|Overall Study|Lost to Follow-up|6|||
144511091|NCT05119855|521072583|FG001|Overall Study|Lost to Follow-up|8|||
144511092|NCT02597920|521072587|FG000|Overall Study|Worsening of other pre-existing disease|0|||
144511093|NCT02597920|521072588|FG001|Overall Study|Worsening of other pre-existing disease|1|||
144511094|NCT02597920|521072589|FG002|Overall Study|Worsening of other pre-existing disease|0|||
144511095|NCT02597920|521072587|FG000|Overall Study|Other adverse event|20|||
144511096|NCT02597920|521072588|FG001|Overall Study|Other adverse event|30|||
144511097|NCT02597920|521072589|FG002|Overall Study|Other adverse event|0|||
144511098|NCT02597920|521072587|FG000|Overall Study|Lost to Follow-up|7|||
144511099|NCT02597920|521072588|FG001|Overall Study|Lost to Follow-up|9|||
144511100|NCT02597920|521072589|FG002|Overall Study|Lost to Follow-up|0|||
144511101|NCT02597920|521072587|FG000|Overall Study|Refuse to continue in the study|3|||
144511102|NCT02597920|521072588|FG001|Overall Study|Refuse to continue in the study|13|||
144511103|NCT02597920|521072589|FG002|Overall Study|Refuse to continue in the study|1|||
144511104|NCT02597920|521072587|FG000|Overall Study|Other than specified|10|||
144511105|NCT02597920|521072588|FG001|Overall Study|Other than specified|31|||
144511106|NCT02597920|521072589|FG002|Overall Study|Other than specified|5|||
144511107|NCT02597920|521072587|FG000|Overall Study|Other|1|||
144511108|NCT02597920|521072588|FG001|Overall Study|Other|0|||
144511109|NCT02597920|521072589|FG002|Overall Study|Other|0|||
144511110|NCT00642850|521072590|FG000|Overall Study|Death|7|||
144511111|NCT00642850|521072590|FG000|Overall Study|Adverse Event|2|||
144511112|NCT00642850|521072590|FG000|Overall Study|Lack of Efficacy|1|||
144511113|NCT00642850|521072590|FG000|Overall Study|Protocol Violation|2|||
144511114|NCT00642850|521072590|FG000|Overall Study|Kidney transplantation|8|||
144511115|NCT00642850|521072590|FG000|Overall Study|Blood transfusion|6|||
144249056|NCT03677934|520110021|FG000|Overall Study|Withdrawal by Subject|1|||
144249057|NCT03677934|520110022|FG001|Overall Study|Withdrawal by Subject|7|||
144249058|NCT00045734|520110023|FG000|Overall Study|Protocol Violation|1|||
144249059|NCT02069093|520110024|FG000|Overall Study|Disease progression|14|||
144249060|NCT02069093|520110024|FG000|Overall Study|New cancer therapy|1|||
144249061|NCT02069093|520110024|FG000|Overall Study|Death|1|||
144249062|NCT02069093|520110024|FG000|Overall Study|Administrative problems|1|||
144249063|NCT02069093|520110024|FG000|Overall Study|Withdrawal by Subject|2|||
144249064|NCT02069093|520110024|FG000|Overall Study|Abnormal laboratory values|1|||
144249065|NCT02069093|520110024|FG000|Overall Study|Adverse Event|10|||
144249066|NCT03434249|520110025|FG000|Overall Study|Adverse Event|1|||
144249067|NCT03434249|520110026|FG001|Overall Study|Adverse Event|0|||
144249068|NCT03434249|520110025|FG000|Overall Study|Lost to Follow-up|0|||
144249069|NCT03434249|520110026|FG001|Overall Study|Lost to Follow-up|1|||
144249070|NCT03434249|520110025|FG000|Overall Study|Non-compliance of family|2|||
144249071|NCT03434249|520110026|FG001|Overall Study|Non-compliance of family|1|||
144249072|NCT03434249|520110025|FG000|Overall Study|Difficulties in completing daily diary|2|||
144249073|NCT03434249|520110026|FG001|Overall Study|Difficulties in completing daily diary|1|||
144249074|NCT00721279|520110029|FG000|Overall Study|Lack of Efficacy|6|||
144249075|NCT00721279|520110030|FG001|Overall Study|Lack of Efficacy|3|||
144249076|NCT00721279|520110029|FG000|Overall Study|Tolerability insufficient|5|||
144249077|NCT00721279|520110030|FG001|Overall Study|Tolerability insufficient|2|||
144249078|NCT00721279|520110029|FG000|Overall Study|Withdrawal by Subject|13|||
144249079|NCT00721279|520110030|FG001|Overall Study|Withdrawal by Subject|3|||
144249080|NCT00721279|520110029|FG000|Overall Study|Other|12|||
144249081|NCT00721279|520110030|FG001|Overall Study|Other|16|||
144249082|NCT05153148|520110031|FG000|Overall Study|Adverse Event|1|||
144511116|NCT00642850|521072590|FG000|Overall Study|Other reasons|7|||
144511117|NCT05489484|521072597|FG000|Overall Study|withdrawn|1|||
144511118|NCT00444600|521072598|FG000|Overall Study|Death|7|||
144511119|NCT00444600|521072599|FG001|Overall Study|Death|5|||
144590731|NCT00116753|521364093|FG001|Overall Study|Lost to Follow-up|2|||
144590732|NCT00116753|521364094|FG002|Overall Study|Lost to Follow-up|1|||
144590733|NCT00116753|521364092|FG000|Overall Study|Protocol Violation|0|||
144590734|NCT00116753|521364093|FG001|Overall Study|Protocol Violation|0|||
144590735|NCT00116753|521364094|FG002|Overall Study|Protocol Violation|1|||
144590736|NCT00116753|521364092|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
144590737|NCT00116753|521364093|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
144590738|NCT00116753|521364094|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
144590739|NCT00116753|521364092|FG000|Overall Study|Disease Progression|3|||
144590740|NCT00116753|521364093|FG001|Overall Study|Disease Progression|4|||
144590741|NCT00116753|521364094|FG002|Overall Study|Disease Progression|3|||
144590742|NCT00116753|521364092|FG000|Overall Study|Abnormal Echocardiogram|0|||
144590743|NCT00116753|521364093|FG001|Overall Study|Abnormal Echocardiogram|0|||
144590744|NCT00116753|521364094|FG002|Overall Study|Abnormal Echocardiogram|1|||
144590745|NCT00116753|521364092|FG000|Overall Study|Progressive Parkinson's Disease|1|||
144590746|NCT00116753|521364093|FG001|Overall Study|Progressive Parkinson's Disease|0|||
144590747|NCT00116753|521364094|FG002|Overall Study|Progressive Parkinson's Disease|0|||
144590748|NCT00116753|521364092|FG000|Overall Study|Dosing Error|0|||
144590749|NCT00116753|521364093|FG001|Overall Study|Dosing Error|1|||
144590750|NCT00116753|521364094|FG002|Overall Study|Dosing Error|0|||
144590751|NCT01590082|521364095|FG000|Overall Study|Withdrawal by Subject|1|||
144590752|NCT01590082|521364096|FG001|Overall Study|Withdrawal by Subject|0|||
144590753|NCT01590082|521364095|FG000|Overall Study|Ineligible|1|||
144590754|NCT01590082|521364096|FG001|Overall Study|Ineligible|0|||
144590755|NCT00906945|521364097|FG000|Overall Study|Found to be not eligible|0|||
144590756|NCT00906945|521364098|FG001|Overall Study|Found to be not eligible|0|||
144590757|NCT00906945|521364099|FG002|Overall Study|Found to be not eligible|0|||
144590758|NCT00906945|521364100|FG003|Overall Study|Found to be not eligible|1|||
144590759|NCT00906945|521364101|FG004|Overall Study|Found to be not eligible|1|||
144590760|NCT00906945|521364102|FG005|Overall Study|Found to be not eligible|1|||
144590761|NCT00906945|521364097|FG000|Overall Study|Physician Decision|0|||
144590762|NCT00906945|521364098|FG001|Overall Study|Physician Decision|0|||
144590763|NCT00906945|521364099|FG002|Overall Study|Physician Decision|0|||
144590764|NCT00906945|521364100|FG003|Overall Study|Physician Decision|0|||
144590765|NCT00906945|521364101|FG004|Overall Study|Physician Decision|0|||
144590766|NCT00906945|521364102|FG005|Overall Study|Physician Decision|1|||
144590767|NCT02751320|521364104|FG000|Overall Study|Adverse Event|2|||
144590768|NCT02751320|521364104|FG000|Overall Study|Withdrawal by Subject|1|||
144590769|NCT05249829|521364105|FG000|Overall Study|Participant Relocation|0|||
144590770|NCT05249829|521364106|FG001|Overall Study|Participant Relocation|1|||
144590771|NCT05249829|521364107|FG002|Overall Study|Participant Relocation|2|||
144590772|NCT05249829|521364108|FG003|Overall Study|Participant Relocation|2|||
144590773|NCT05249829|521364105|FG000|Overall Study|Withdrawal by Subject|9|||
144590774|NCT05249829|521364106|FG001|Overall Study|Withdrawal by Subject|17|||
144590775|NCT05249829|521364107|FG002|Overall Study|Withdrawal by Subject|40|||
144590776|NCT05249829|521364108|FG003|Overall Study|Withdrawal by Subject|35|||
144590777|NCT05249829|521364105|FG000|Overall Study|Physician Decision|1|||
144590778|NCT05249829|521364106|FG001|Overall Study|Physician Decision|0|||
144590779|NCT05249829|521364107|FG002|Overall Study|Physician Decision|0|||
144590780|NCT05249829|521364108|FG003|Overall Study|Physician Decision|0|||
144590781|NCT05249829|521364105|FG000|Overall Study|Lost to Follow-up|16|||
144590782|NCT05249829|521364106|FG001|Overall Study|Lost to Follow-up|16|||
144590783|NCT05249829|521364107|FG002|Overall Study|Lost to Follow-up|57|||
144590784|NCT05249829|521364108|FG003|Overall Study|Lost to Follow-up|60|||
144590785|NCT05249829|521364105|FG000|Overall Study|Adverse Event|2|||
144590786|NCT05249829|521364106|FG001|Overall Study|Adverse Event|2|||
144590787|NCT05249829|521364107|FG002|Overall Study|Adverse Event|2|||
144590788|NCT05249829|521364108|FG003|Overall Study|Adverse Event|2|||
144590789|NCT05249829|521364105|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
144590790|NCT05249829|521364106|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
144590791|NCT05249829|521364107|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
144590792|NCT05249829|521364108|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
144590793|NCT05249829|521364105|FG000|Overall Study|Protocol Violation|2|||
144590794|NCT05249829|521364106|FG001|Overall Study|Protocol Violation|0|||
144590795|NCT05249829|521364107|FG002|Overall Study|Protocol Violation|5|||
144590796|NCT05249829|521364108|FG003|Overall Study|Protocol Violation|3|||
144590797|NCT05249829|521364105|FG000|Overall Study|Death|0|||
144590798|NCT05249829|521364106|FG001|Overall Study|Death|1|||
144590799|NCT05249829|521364107|FG002|Overall Study|Death|2|||
144590800|NCT05249829|521364108|FG003|Overall Study|Death|4|||
144590801|NCT00513604|521364109|FG000|Overall Study|Not treated|2|||
144590802|NCT00513604|521364110|FG001|Overall Study|Not treated|0|||
144590803|NCT00513604|521364111|FG002|Overall Study|Not treated|1|||
144590804|NCT00513604|521364112|FG003|Overall Study|Not treated|0|||
144590805|NCT00513604|521364113|FG004|Overall Study|Not treated|0|||
144590806|NCT00513604|521364109|FG000|Overall Study|Death during treatment|0|||
144590807|NCT00513604|521364110|FG001|Overall Study|Death during treatment|3|||
144590808|NCT00513604|521364111|FG002|Overall Study|Death during treatment|2|||
144590809|NCT00513604|521364112|FG003|Overall Study|Death during treatment|0|||
144590810|NCT00513604|521364113|FG004|Overall Study|Death during treatment|0|||
144590811|NCT00196976|521364114|FG000|Primary Study|Migrated from study area|0|||
144590812|NCT00196976|521364115|FG001|Primary Study|Migrated from study area|0|||
144590813|NCT00196976|521364116|FG002|Primary Study|Migrated from study area|0|||
144590814|NCT00196976|521364117|FG003|Primary Study|Migrated from study area|0|||
144590815|NCT00196976|521364118|FG004|Primary Study|Migrated from study area|0|||
144590816|NCT00196976|521364119|FG005|Primary Study|Migrated from study area|0|||
144590817|NCT00196976|521364120|FG006|Primary Study|Migrated from study area|0|||
144590818|NCT00196976|521364121|FG007|Primary Study|Migrated from study area|1|||
144590819|NCT00196976|521364122|FG008|Primary Study|Migrated from study area|0|||
144249083|NCT05153148|520110032|FG001|Overall Study|Adverse Event|0|||
144249084|NCT05153148|520110033|FG002|Overall Study|Adverse Event|3|||
144249085|NCT05153148|520110034|FG003|Overall Study|Adverse Event|5|||
144249086|NCT05153148|520110031|FG000|Overall Study|Lost to Follow-up|1|||
144249087|NCT05153148|520110032|FG001|Overall Study|Lost to Follow-up|1|||
144249088|NCT05153148|520110033|FG002|Overall Study|Lost to Follow-up|2|||
144249089|NCT05153148|520110034|FG003|Overall Study|Lost to Follow-up|0|||
144249090|NCT05153148|520110031|FG000|Overall Study|Withdrawal by Subject|6|||
144249091|NCT05153148|520110032|FG001|Overall Study|Withdrawal by Subject|8|||
144249092|NCT05153148|520110033|FG002|Overall Study|Withdrawal by Subject|6|||
144249093|NCT05153148|520110034|FG003|Overall Study|Withdrawal by Subject|8|||
144249094|NCT05153148|520110031|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
144249095|NCT05153148|520110032|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
144249096|NCT05153148|520110033|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
144590820|NCT00196976|521364123|FG009|Primary Study|Migrated from study area|0|||
144590821|NCT00196976|521364124|FG010|Primary Study|Migrated from study area|0|||
144590822|NCT00196976|521364125|FG011|Primary Study|Migrated from study area|0|||
144590823|NCT00196976|521364126|FG012|Primary Study|Migrated from study area|0|||
144590824|NCT00196976|521364127|FG013|Primary Study|Migrated from study area|0|||
144590825|NCT00196976|521364114|FG000|Primary Study|Protocol Violation|0|||
144590826|NCT00196976|521364115|FG001|Primary Study|Protocol Violation|1|||
144590827|NCT00196976|521364116|FG002|Primary Study|Protocol Violation|1|||
144590828|NCT00196976|521364117|FG003|Primary Study|Protocol Violation|0|||
144590829|NCT00196976|521364118|FG004|Primary Study|Protocol Violation|0|||
144590830|NCT00196976|521364119|FG005|Primary Study|Protocol Violation|0|||
144590831|NCT00196976|521364120|FG006|Primary Study|Protocol Violation|0|||
144590832|NCT00196976|521364121|FG007|Primary Study|Protocol Violation|0|||
144590833|NCT00196976|521364122|FG008|Primary Study|Protocol Violation|0|||
144590834|NCT00196976|521364123|FG009|Primary Study|Protocol Violation|0|||
144590835|NCT00196976|521364124|FG010|Primary Study|Protocol Violation|0|||
144249097|NCT05153148|520110034|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
144249098|NCT05153148|520110031|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
144249099|NCT05153148|520110032|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
144249100|NCT05153148|520110033|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
144249101|NCT05153148|520110034|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
144249102|NCT05153148|520110031|FG000|Overall Study|Reason not Specified|1|||
144249103|NCT05153148|520110032|FG001|Overall Study|Reason not Specified|1|||
144249104|NCT05153148|520110033|FG002|Overall Study|Reason not Specified|1|||
144249105|NCT05153148|520110034|FG003|Overall Study|Reason not Specified|1|||
144249106|NCT00232596|520110035|FG000|6-Week Titration Phase|Adverse Event|6|||
144249107|NCT00232596|520110036|FG001|6-Week Titration Phase|Adverse Event|19|||
144249108|NCT00232596|520110035|FG000|6-Week Titration Phase|Failed to Return|2|||
144249109|NCT00232596|520110036|FG001|6-Week Titration Phase|Failed to Return|1|||
144249110|NCT00232596|520110035|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
144249111|NCT00232596|520110036|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
144249112|NCT00232596|520110035|FG000|6-Week Titration Phase|Protocol Violation|1|||
144249113|NCT00232596|520110036|FG001|6-Week Titration Phase|Protocol Violation|3|||
144249114|NCT00232596|520110035|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
144249115|NCT00232596|520110036|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
144249116|NCT00232596|520110035|FG000|6-Week Titration Phase|Other|3|||
144249117|NCT00232596|520110036|FG001|6-Week Titration Phase|Other|3|||
144511120|NCT00444600|521072600|FG002|Overall Study|Death|3|||
144511121|NCT00444600|521072601|FG003|Overall Study|Death|2|||
144511122|NCT00444600|521072598|FG000|Overall Study|Dropped|11|||
144511123|NCT00444600|521072599|FG001|Overall Study|Dropped|11|||
144511124|NCT00444600|521072600|FG002|Overall Study|Dropped|7|||
144511125|NCT00444600|521072601|FG003|Overall Study|Dropped|7|||
144511126|NCT00444600|521072598|FG000|Overall Study|Missed visit|1|||
144511127|NCT00444600|521072599|FG001|Overall Study|Missed visit|0|||
144511128|NCT00444600|521072600|FG002|Overall Study|Missed visit|0|||
144511129|NCT00444600|521072601|FG003|Overall Study|Missed visit|1|||
144511130|NCT05132478|521072602|FG000|Overall Study|did not complete survey after consent|1|||
144511131|NCT05132478|521072603|FG001|Overall Study|did not complete survey after consent|1|||
144511132|NCT05132478|521072602|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
144511133|NCT05132478|521072603|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
144249118|NCT00232596|520110035|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
144249119|NCT00232596|520110036|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
144249120|NCT00232596|520110035|FG000|12-Week Maintenance Phase|Adverse Event|7|||
144249121|NCT00232596|520110036|FG001|12-Week Maintenance Phase|Adverse Event|22|||
144249122|NCT00232596|520110035|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
144511134|NCT02549170|521072606|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
144511135|NCT02549170|521072607|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
144511136|NCT02549170|521072608|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
144511137|NCT02549170|521072609|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
144249123|NCT00232596|520110036|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
144249124|NCT00232596|520110035|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
144249125|NCT00232596|520110036|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
144249126|NCT00232596|520110035|FG000|12-Week Maintenance Phase|Other|1|||
144249127|NCT00232596|520110036|FG001|12-Week Maintenance Phase|Other|3|||
144249128|NCT01712334|520110037|FG000|Treatment Period 1|Randomized in Error|0|||
144249129|NCT01712334|520110038|FG001|Treatment Period 1|Randomized in Error|2|||
144249130|NCT01253174|520110039|FG000|Period 1|Randomized but not treated|0|||
144249131|NCT01253174|520110040|FG001|Period 1|Randomized but not treated|1|||
144249132|NCT01253174|520110041|FG002|Period 1|Randomized but not treated|1|||
144249133|NCT01253174|520110042|FG003|Period 1|Randomized but not treated|0|||
144249134|NCT01253174|520110043|FG004|Period 1|Randomized but not treated|1|||
144249135|NCT01253174|520110044|FG005|Period 1|Randomized but not treated|0|||
144249136|NCT01253174|520110039|FG000|Period 2|Adverse Event|0|||
144249137|NCT01253174|520110040|FG001|Period 2|Adverse Event|0|||
144249138|NCT01253174|520110041|FG002|Period 2|Adverse Event|1|||
144511138|NCT02549170|521072610|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
144511139|NCT02549170|521072606|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
144511140|NCT02549170|521072607|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
144511141|NCT02549170|521072608|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
144511142|NCT02549170|521072609|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
144511143|NCT02549170|521072610|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
144511144|NCT02549170|521072606|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
144511145|NCT02549170|521072607|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
144511146|NCT02549170|521072608|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
144511147|NCT02549170|521072609|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
144511148|NCT02549170|521072610|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
144511149|NCT00111813|521072611|FG000|Overall Study|Adverse Event|1|||
144511150|NCT00111813|521072612|FG001|Overall Study|Adverse Event|2|||
144511151|NCT00111813|521072613|FG002|Overall Study|Adverse Event|4|||
144511152|NCT00111813|521072614|FG003|Overall Study|Adverse Event|2|||
144511153|NCT00111813|521072615|FG004|Overall Study|Adverse Event|2|||
144511154|NCT00111813|521072616|FG005|Overall Study|Adverse Event|2|||
144511155|NCT00111813|521072611|FG000|Overall Study|Progressive disease|2|||
144511156|NCT00111813|521072612|FG001|Overall Study|Progressive disease|1|||
144511157|NCT00111813|521072613|FG002|Overall Study|Progressive disease|5|||
144511158|NCT00111813|521072614|FG003|Overall Study|Progressive disease|3|||
144511159|NCT00111813|521072615|FG004|Overall Study|Progressive disease|4|||
144511160|NCT00111813|521072616|FG005|Overall Study|Progressive disease|3|||
144511161|NCT00111813|521072611|FG000|Overall Study|Lack of Efficacy|0|||
144511162|NCT00111813|521072612|FG001|Overall Study|Lack of Efficacy|0|||
144511163|NCT00111813|521072613|FG002|Overall Study|Lack of Efficacy|0|||
144511164|NCT00111813|521072614|FG003|Overall Study|Lack of Efficacy|0|||
144511165|NCT00111813|521072615|FG004|Overall Study|Lack of Efficacy|0|||
144511166|NCT00111813|521072616|FG005|Overall Study|Lack of Efficacy|1|||
144511167|NCT00111813|521072611|FG000|Overall Study|Other|0|||
144511168|NCT00111813|521072612|FG001|Overall Study|Other|0|||
144511169|NCT00111813|521072613|FG002|Overall Study|Other|1|||
144511170|NCT00111813|521072614|FG003|Overall Study|Other|0|||
144511171|NCT00111813|521072615|FG004|Overall Study|Other|0|||
144511172|NCT00111813|521072616|FG005|Overall Study|Other|0|||
144590836|NCT00196976|521364125|FG011|Primary Study|Protocol Violation|0|||
144249139|NCT01253174|520110042|FG003|Period 2|Adverse Event|0|||
144249140|NCT01253174|520110043|FG004|Period 2|Adverse Event|0|||
144249141|NCT01253174|520110044|FG005|Period 2|Adverse Event|0|||
144249142|NCT01253174|520110039|FG000|Period 3|Withdrawal by Subject|0|||
144249143|NCT01253174|520110040|FG001|Period 3|Withdrawal by Subject|1|||
144249144|NCT01253174|520110041|FG002|Period 3|Withdrawal by Subject|0|||
144249145|NCT01253174|520110042|FG003|Period 3|Withdrawal by Subject|0|||
144249146|NCT01253174|520110043|FG004|Period 3|Withdrawal by Subject|1|||
144590837|NCT00196976|521364126|FG012|Primary Study|Protocol Violation|0|||
144249147|NCT01253174|520110044|FG005|Period 3|Withdrawal by Subject|0|||
144249148|NCT01253174|520110039|FG000|Period 3|Pregnancy|0|||
144590838|NCT00196976|521364127|FG013|Primary Study|Protocol Violation|0|||
144249149|NCT01253174|520110040|FG001|Period 3|Pregnancy|0|||
144249150|NCT01253174|520110041|FG002|Period 3|Pregnancy|1|||
144249151|NCT01253174|520110042|FG003|Period 3|Pregnancy|0|||
144249152|NCT01253174|520110043|FG004|Period 3|Pregnancy|0|||
144249153|NCT01253174|520110044|FG005|Period 3|Pregnancy|0|||
144249154|NCT02267135|520110045|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
144249155|NCT02267135|520110046|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
144249156|NCT02267135|520110045|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
144249157|NCT02267135|520110046|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
144249158|NCT02267135|520110045|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
144249159|NCT02267135|520110046|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
144249160|NCT02267135|520110045|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
144249161|NCT02267135|520110046|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
144249162|NCT02267135|520110045|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
144249163|NCT02267135|520110046|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
144249164|NCT00900731|520110047|FG000|Overall Study|Adverse Event|31|||
144249165|NCT00900731|520110048|FG001|Overall Study|Adverse Event|27|||
144249166|NCT00900731|520110047|FG000|Overall Study|Withdrawal by Subject|8|||
144249167|NCT00900731|520110048|FG001|Overall Study|Withdrawal by Subject|7|||
144249168|NCT00900731|520110047|FG000|Overall Study|Protocol Deviation|8|||
144249169|NCT00900731|520110048|FG001|Overall Study|Protocol Deviation|11|||
144249170|NCT00900731|520110047|FG000|Overall Study|Administrative Problems|5|||
144249171|NCT00900731|520110048|FG001|Overall Study|Administrative Problems|4|||
144249172|NCT00900731|520110047|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
144249173|NCT00900731|520110048|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
144249174|NCT00900731|520110047|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
144249175|NCT00900731|520110048|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
144249176|NCT00900731|520110047|FG000|Overall Study|Lost to Follow-up|2|||
144249177|NCT00900731|520110048|FG001|Overall Study|Lost to Follow-up|3|||
144249178|NCT00900731|520110047|FG000|Overall Study|Lack of Efficacy|1|||
144249179|NCT00900731|520110048|FG001|Overall Study|Lack of Efficacy|3|||
144249180|NCT00900731|520110047|FG000|Overall Study|Death|0|||
144249181|NCT00900731|520110048|FG001|Overall Study|Death|2|||
144249182|NCT03806231|520110049|FG000|Overall Study|Physician Decision|1|||
144249183|NCT03806231|520110050|FG001|Overall Study|Physician Decision|0|||
144249184|NCT03806231|520110049|FG000|Overall Study|Withdrawal by Subject|1|||
144249185|NCT03806231|520110050|FG001|Overall Study|Withdrawal by Subject|0|||
144249186|NCT02919267|520110051|FG000|Overall Study|Protocol Violation|0|||
144249187|NCT02919267|520110052|FG001|Overall Study|Protocol Violation|3|||
144249188|NCT02919267|520110053|FG002|Overall Study|Protocol Violation|3|||
144249189|NCT02919267|520110054|FG003|Overall Study|Protocol Violation|4|||
144249190|NCT03467763|520110055|FG000|Overall Study|Lost to Follow-up|1|||
144249191|NCT03467763|520110055|FG000|Overall Study|Protocol Violation|2|||
144249192|NCT00932698|520110056|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
144249193|NCT00932698|520110057|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
144249194|NCT00932698|520110058|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
144249195|NCT00932698|520110059|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
144249196|NCT00932698|520110060|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
144249197|NCT00932698|520110061|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
144249198|NCT00932698|520110062|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
144249199|NCT00932698|520110063|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
144249200|NCT00932698|520110064|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
144511173|NCT00409838|521072620|FG000|Short-term Period|Adverse Event|0|||
144511174|NCT00409838|521072621|FG001|Short-term Period|Adverse Event|1|||
144511175|NCT00409838|521072620|FG000|Short-term Period|Lost to Follow-up|0|||
144511176|NCT00409838|521072621|FG001|Short-term Period|Lost to Follow-up|1|||
144511177|NCT00409838|521072620|FG000|Short-term Period|Withdrawal by Subject|2|||
144249201|NCT00932698|520110065|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
144249202|NCT00932698|520110066|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
144249203|NCT00932698|520110056|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249204|NCT00932698|520110057|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
144249205|NCT00932698|520110058|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249206|NCT00932698|520110059|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
144249207|NCT00932698|520110060|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249208|NCT00932698|520110061|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
144249209|NCT00932698|520110062|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
144249210|NCT00932698|520110063|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249211|NCT00932698|520110064|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249212|NCT00932698|520110065|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249213|NCT00932698|520110066|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
144249214|NCT00932698|520110056|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
144249215|NCT00932698|520110057|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
144249216|NCT00932698|520110058|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
144249217|NCT00932698|520110059|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
144249218|NCT00932698|520110060|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
144249219|NCT00932698|520110061|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
144249220|NCT00932698|520110062|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
144249221|NCT00932698|520110063|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
144249222|NCT00932698|520110064|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
144249223|NCT00932698|520110065|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
144249224|NCT00932698|520110066|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
144249225|NCT00932698|520110056|FG000|Part 1 (Dose Escalation)|Other|0|||
144249226|NCT00932698|520110057|FG001|Part 1 (Dose Escalation)|Other|0|||
144249227|NCT00932698|520110058|FG002|Part 1 (Dose Escalation)|Other|1|||
144249228|NCT00932698|520110059|FG003|Part 1 (Dose Escalation)|Other|0|||
144249229|NCT00932698|520110060|FG004|Part 1 (Dose Escalation)|Other|0|||
144249230|NCT00932698|520110061|FG005|Part 1 (Dose Escalation)|Other|0|||
144249231|NCT00932698|520110062|FG006|Part 1 (Dose Escalation)|Other|1|||
144249232|NCT00932698|520110063|FG007|Part 1 (Dose Escalation)|Other|0|||
144249233|NCT00932698|520110064|FG008|Part 1 (Dose Escalation)|Other|0|||
144249234|NCT00932698|520110065|FG009|Part 1 (Dose Escalation)|Other|0|||
144249235|NCT00932698|520110066|FG010|Part 1 (Dose Escalation)|Other|0|||
144249236|NCT00932698|520110056|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249237|NCT00932698|520110057|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249238|NCT00932698|520110058|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249239|NCT00932698|520110059|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249240|NCT00932698|520110060|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249241|NCT00932698|520110061|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249242|NCT00932698|520110062|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
144249243|NCT00932698|520110063|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
144249244|NCT00932698|520110064|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
144249245|NCT00932698|520110065|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
144249246|NCT00932698|520110066|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
144249247|NCT00932698|520110056|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249248|NCT00932698|520110057|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249249|NCT00932698|520110058|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249250|NCT00932698|520110059|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249251|NCT00932698|520110060|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249252|NCT00932698|520110061|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249253|NCT00932698|520110062|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249254|NCT00932698|520110063|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
144249255|NCT00932698|520110064|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
144249256|NCT00932698|520110065|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
144249257|NCT00932698|520110066|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
144249258|NCT00932698|520110056|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
144249259|NCT00932698|520110057|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
144249260|NCT00932698|520110058|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
144249261|NCT00932698|520110059|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
144249262|NCT00932698|520110060|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
144249263|NCT00932698|520110061|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
144249264|NCT00932698|520110062|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
144249265|NCT00932698|520110063|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
144249266|NCT00932698|520110064|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
144249267|NCT00932698|520110065|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
144249268|NCT00932698|520110066|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
144249269|NCT04608344|520110069|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
144249270|NCT04608344|520110070|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
144590839|NCT00196976|521364114|FG000|Primary Study|Withdrawal by Subject|1|||
144590840|NCT00196976|521364115|FG001|Primary Study|Withdrawal by Subject|0|||
144590841|NCT00196976|521364116|FG002|Primary Study|Withdrawal by Subject|1|||
144590842|NCT00196976|521364117|FG003|Primary Study|Withdrawal by Subject|1|||
144590843|NCT00196976|521364118|FG004|Primary Study|Withdrawal by Subject|2|||
144590844|NCT00196976|521364119|FG005|Primary Study|Withdrawal by Subject|1|||
144590845|NCT00196976|521364120|FG006|Primary Study|Withdrawal by Subject|0|||
144590846|NCT00196976|521364121|FG007|Primary Study|Withdrawal by Subject|0|||
144590847|NCT00196976|521364122|FG008|Primary Study|Withdrawal by Subject|0|||
144590848|NCT00196976|521364123|FG009|Primary Study|Withdrawal by Subject|1|||
144590849|NCT00196976|521364124|FG010|Primary Study|Withdrawal by Subject|0|||
144590850|NCT00196976|521364125|FG011|Primary Study|Withdrawal by Subject|0|||
144590851|NCT00196976|521364126|FG012|Primary Study|Withdrawal by Subject|0|||
144590852|NCT00196976|521364127|FG013|Primary Study|Withdrawal by Subject|0|||
144590853|NCT00196976|521364114|FG000|Primary Study|Lost to Follow-up|0|||
144590854|NCT00196976|521364115|FG001|Primary Study|Lost to Follow-up|0|||
144590855|NCT00196976|521364116|FG002|Primary Study|Lost to Follow-up|0|||
144590856|NCT00196976|521364117|FG003|Primary Study|Lost to Follow-up|0|||
144590857|NCT00196976|521364118|FG004|Primary Study|Lost to Follow-up|1|||
144590858|NCT00196976|521364119|FG005|Primary Study|Lost to Follow-up|1|||
144590859|NCT00196976|521364120|FG006|Primary Study|Lost to Follow-up|0|||
144590860|NCT00196976|521364121|FG007|Primary Study|Lost to Follow-up|2|||
144590861|NCT00196976|521364122|FG008|Primary Study|Lost to Follow-up|0|||
144590862|NCT00196976|521364123|FG009|Primary Study|Lost to Follow-up|0|||
144590863|NCT00196976|521364124|FG010|Primary Study|Lost to Follow-up|0|||
144590864|NCT00196976|521364125|FG011|Primary Study|Lost to Follow-up|0|||
144590865|NCT00196976|521364126|FG012|Primary Study|Lost to Follow-up|0|||
144590866|NCT00196976|521364127|FG013|Primary Study|Lost to Follow-up|0|||
144590867|NCT00196976|521364114|FG000|Primary Study|Other|0|||
144590868|NCT00196976|521364115|FG001|Primary Study|Other|0|||
144590869|NCT00196976|521364116|FG002|Primary Study|Other|2|||
144590870|NCT00196976|521364117|FG003|Primary Study|Other|0|||
144590871|NCT00196976|521364118|FG004|Primary Study|Other|0|||
144590872|NCT00196976|521364119|FG005|Primary Study|Other|0|||
144590873|NCT00196976|521364120|FG006|Primary Study|Other|0|||
144590874|NCT00196976|521364121|FG007|Primary Study|Other|0|||
144590875|NCT00196976|521364122|FG008|Primary Study|Other|0|||
144590876|NCT00196976|521364123|FG009|Primary Study|Other|0|||
144590877|NCT00196976|521364124|FG010|Primary Study|Other|0|||
144590878|NCT00196976|521364125|FG011|Primary Study|Other|0|||
144590879|NCT00196976|521364126|FG012|Primary Study|Other|0|||
144590880|NCT00196976|521364127|FG013|Primary Study|Other|0|||
144590881|NCT00196976|521364114|FG000|Booster Study|Withdrawal by Subject|0|||
144590882|NCT00196976|521364115|FG001|Booster Study|Withdrawal by Subject|0|||
144590883|NCT00196976|521364116|FG002|Booster Study|Withdrawal by Subject|0|||
144590884|NCT00196976|521364117|FG003|Booster Study|Withdrawal by Subject|0|||
144590885|NCT00196976|521364118|FG004|Booster Study|Withdrawal by Subject|0|||
144590886|NCT00196976|521364119|FG005|Booster Study|Withdrawal by Subject|0|||
144590887|NCT00196976|521364120|FG006|Booster Study|Withdrawal by Subject|0|||
144590888|NCT00196976|521364121|FG007|Booster Study|Withdrawal by Subject|0|||
144590889|NCT00196976|521364122|FG008|Booster Study|Withdrawal by Subject|0|||
144590890|NCT00196976|521364123|FG009|Booster Study|Withdrawal by Subject|0|||
144590891|NCT00196976|521364124|FG010|Booster Study|Withdrawal by Subject|1|||
144590892|NCT00196976|521364125|FG011|Booster Study|Withdrawal by Subject|0|||
144590893|NCT00196976|521364126|FG012|Booster Study|Withdrawal by Subject|0|||
144590894|NCT00196976|521364127|FG013|Booster Study|Withdrawal by Subject|0|||
144590895|NCT00196976|521364114|FG000|Booster Study|Lost to Follow-up|0|||
144590896|NCT00196976|521364115|FG001|Booster Study|Lost to Follow-up|0|||
144590897|NCT00196976|521364116|FG002|Booster Study|Lost to Follow-up|0|||
144590898|NCT00196976|521364117|FG003|Booster Study|Lost to Follow-up|0|||
144590899|NCT00196976|521364118|FG004|Booster Study|Lost to Follow-up|0|||
144721727|NCT01595009|521835275|FG000|Core|Death|3|||
144590900|NCT00196976|521364119|FG005|Booster Study|Lost to Follow-up|0|||
144590901|NCT00196976|521364120|FG006|Booster Study|Lost to Follow-up|0|||
144590902|NCT00196976|521364121|FG007|Booster Study|Lost to Follow-up|0|||
144590903|NCT00196976|521364122|FG008|Booster Study|Lost to Follow-up|0|||
144590904|NCT00196976|521364123|FG009|Booster Study|Lost to Follow-up|0|||
144590905|NCT00196976|521364124|FG010|Booster Study|Lost to Follow-up|1|||
144590906|NCT00196976|521364125|FG011|Booster Study|Lost to Follow-up|2|||
144721728|NCT01595009|521835276|FG001|Core|Death|6|||
144590907|NCT00196976|521364126|FG012|Booster Study|Lost to Follow-up|0|||
144590908|NCT00196976|521364127|FG013|Booster Study|Lost to Follow-up|0|||
144590909|NCT01535560|521364128|FG000|Overall Study|Adverse Event|12|||
144590910|NCT01535560|521364129|FG001|Overall Study|Adverse Event|7|||
144590911|NCT01535560|521364128|FG000|Overall Study|Lost to Follow-up|1|||
144590912|NCT01535560|521364129|FG001|Overall Study|Lost to Follow-up|3|||
144590913|NCT01535560|521364128|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
144590914|NCT01535560|521364129|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
144721729|NCT01595009|521835277|FG002|Core|Death|0|||
144373624|NCT05767749|520576171|FG002|Overall Study|Withdrawal by Subject|2|||
144373625|NCT05767749|520576172|FG003|Overall Study|Withdrawal by Subject|2|||
144373626|NCT05767749|520576173|FG004|Overall Study|Withdrawal by Subject|2|||
144249271|NCT04608344|520110069|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
144249272|NCT04608344|520110070|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
144249273|NCT00131365|520110071|FG000|Overall Study|Withdrawal by Subject|1|||
144249274|NCT00131365|520110071|FG000|Overall Study|Alternative treatment|3|||
144249275|NCT05249127|520110072|FG000|Overall Study|Protocol Violation|13|||
144249276|NCT05249127|520110072|FG000|Overall Study|Physician Decision|4|||
144249277|NCT05249127|520110072|FG000|Overall Study|Withdrawal by Subject|2|||
144249278|NCT05249127|520110072|FG000|Overall Study|Participant Non-compliance|1|||
144249279|NCT02908074|520110073|FG000|Overall Study|sponsor/ICON decision|0|||
144249280|NCT02908074|520110074|FG001|Overall Study|sponsor/ICON decision|0|||
144249281|NCT02908074|520110075|FG002|Overall Study|sponsor/ICON decision|1|||
144249282|NCT02908074|520110076|FG003|Overall Study|sponsor/ICON decision|0|||
144249283|NCT02908074|520110077|FG004|Overall Study|sponsor/ICON decision|0|||
144249284|NCT02908074|520110078|FG005|Overall Study|sponsor/ICON decision|0|||
144249285|NCT02908074|520110073|FG000|Overall Study|Protocol Violation|0|||
144249286|NCT02908074|520110074|FG001|Overall Study|Protocol Violation|1|||
144249287|NCT02908074|520110075|FG002|Overall Study|Protocol Violation|0|||
144249288|NCT02908074|520110076|FG003|Overall Study|Protocol Violation|0|||
144249289|NCT02908074|520110077|FG004|Overall Study|Protocol Violation|0|||
144249290|NCT02908074|520110078|FG005|Overall Study|Protocol Violation|0|||
144249291|NCT02908074|520110073|FG000|Overall Study|Adverse Event|5|||
144249292|NCT02908074|520110074|FG001|Overall Study|Adverse Event|2|||
144249293|NCT02908074|520110075|FG002|Overall Study|Adverse Event|0|||
144249294|NCT02908074|520110076|FG003|Overall Study|Adverse Event|0|||
144249295|NCT02908074|520110077|FG004|Overall Study|Adverse Event|1|||
144249296|NCT02908074|520110078|FG005|Overall Study|Adverse Event|0|||
144249297|NCT02908074|520110073|FG000|Overall Study|AESI|1|||
144249298|NCT02908074|520110074|FG001|Overall Study|AESI|0|||
144249299|NCT02908074|520110075|FG002|Overall Study|AESI|1|||
144249300|NCT02908074|520110076|FG003|Overall Study|AESI|0|||
144249301|NCT02908074|520110077|FG004|Overall Study|AESI|1|||
144249302|NCT02908074|520110078|FG005|Overall Study|AESI|0|||
144249303|NCT02908074|520110073|FG000|Overall Study|Discontinuation criteria per protocol|0|||
144249304|NCT02908074|520110074|FG001|Overall Study|Discontinuation criteria per protocol|0|||
144249305|NCT02908074|520110075|FG002|Overall Study|Discontinuation criteria per protocol|1|||
144249306|NCT02908074|520110076|FG003|Overall Study|Discontinuation criteria per protocol|0|||
144249307|NCT02908074|520110077|FG004|Overall Study|Discontinuation criteria per protocol|0|||
144249308|NCT02908074|520110078|FG005|Overall Study|Discontinuation criteria per protocol|1|||
144249309|NCT02908074|520110073|FG000|Overall Study|Withdrawal by Subject|3|||
144249310|NCT02908074|520110074|FG001|Overall Study|Withdrawal by Subject|2|||
144249311|NCT02908074|520110075|FG002|Overall Study|Withdrawal by Subject|2|||
144249312|NCT02908074|520110076|FG003|Overall Study|Withdrawal by Subject|2|||
144249313|NCT02908074|520110077|FG004|Overall Study|Withdrawal by Subject|2|||
144249314|NCT02908074|520110078|FG005|Overall Study|Withdrawal by Subject|2|||
144249315|NCT02908074|520110073|FG000|Overall Study|Lost to Follow-up|0|||
144249316|NCT02908074|520110074|FG001|Overall Study|Lost to Follow-up|1|||
144249317|NCT02908074|520110075|FG002|Overall Study|Lost to Follow-up|1|||
144249318|NCT02908074|520110076|FG003|Overall Study|Lost to Follow-up|1|||
144249319|NCT02908074|520110077|FG004|Overall Study|Lost to Follow-up|0|||
144249320|NCT02908074|520110078|FG005|Overall Study|Lost to Follow-up|1|||
144249321|NCT02073565|520110079|FG000|Cohort A|Withdrawal by Subject|1|||
144249322|NCT02073565|520110080|FG001|Cohort A|Withdrawal by Subject|0|||
144249323|NCT02073565|520110079|FG000|Cohort B|Withdrawal by Subject|1|||
144249324|NCT02073565|520110080|FG001|Cohort B|Withdrawal by Subject|2|||
144249325|NCT02073565|520110079|FG000|Cohort C|Withdrawal by Subject|0|||
144249326|NCT02073565|520110080|FG001|Cohort C|Withdrawal by Subject|2|||
144249327|NCT02073565|520110079|FG000|Cohort C|Lost to Follow-up|0|||
144249328|NCT02073565|520110080|FG001|Cohort C|Lost to Follow-up|2|||
144249329|NCT03646305|520110081|FG000|Overall Study|Lost to Follow-up|4|||
144249330|NCT03646305|520110082|FG001|Overall Study|Lost to Follow-up|2|||
144249331|NCT03646305|520110083|FG002|Overall Study|Lost to Follow-up|2|||
144249332|NCT03646305|520110084|FG003|Overall Study|Lost to Follow-up|1|||
144249333|NCT03646305|520110081|FG000|Overall Study|Withdrawal by Subject|1|||
144249334|NCT03646305|520110082|FG001|Overall Study|Withdrawal by Subject|0|||
144249335|NCT03646305|520110083|FG002|Overall Study|Withdrawal by Subject|0|||
144249336|NCT03646305|520110084|FG003|Overall Study|Withdrawal by Subject|1|||
144249337|NCT01554176|520110085|FG000|Treatment Phase|Protocol Violation|1|||
144249338|NCT01554176|520110086|FG001|Treatment Phase|Protocol Violation|2|||
144249339|NCT01554176|520110087|FG002|Treatment Phase|Protocol Violation|0|||
144249340|NCT01554176|520110088|FG003|Treatment Phase|Protocol Violation|0|||
144249341|NCT01554176|520110089|FG004|Treatment Phase|Protocol Violation|0|||
144249342|NCT01554176|520110085|FG000|Treatment Phase|Physician Decision|1|||
144249343|NCT01554176|520110086|FG001|Treatment Phase|Physician Decision|1|||
144249344|NCT01554176|520110087|FG002|Treatment Phase|Physician Decision|0|||
144590915|NCT01535560|521364128|FG000|Overall Study|Treatment Failure|21|||
144590916|NCT01535560|521364129|FG001|Overall Study|Treatment Failure|83|||
144590917|NCT01535560|521364128|FG000|Overall Study|Other|0|||
144590918|NCT01535560|521364129|FG001|Overall Study|Other|1|||
144590919|NCT01535560|521364128|FG000|Overall Study|Randomized in Error|0|||
144590920|NCT01535560|521364129|FG001|Overall Study|Randomized in Error|1|||
144590921|NCT02842827|521364132|FG000|Overall Study|Adverse Event|0|||
144590922|NCT02842827|521364133|FG001|Overall Study|Adverse Event|1|||
144590923|NCT02842827|521364134|FG002|Overall Study|Adverse Event|0|||
144590924|NCT02842827|521364135|FG003|Overall Study|Adverse Event|1|||
144590925|NCT02842827|521364136|FG004|Overall Study|Adverse Event|0|||
144590926|NCT02842827|521364137|FG005|Overall Study|Adverse Event|1|||
144590927|NCT02842827|521364138|FG006|Overall Study|Adverse Event|0|||
144590928|NCT02842827|521364139|FG007|Overall Study|Adverse Event|0|||
144590929|NCT02842827|521364132|FG000|Overall Study|Death|1|||
144590930|NCT02842827|521364133|FG001|Overall Study|Death|0|||
144590931|NCT02842827|521364134|FG002|Overall Study|Death|2|||
144590932|NCT02842827|521364135|FG003|Overall Study|Death|3|||
144590933|NCT02842827|521364136|FG004|Overall Study|Death|2|||
144590934|NCT02842827|521364137|FG005|Overall Study|Death|1|||
144590935|NCT02842827|521364138|FG006|Overall Study|Death|0|||
144590936|NCT02842827|521364139|FG007|Overall Study|Death|4|||
144590937|NCT02842827|521364132|FG000|Overall Study|Physician Decision|1|||
144590938|NCT02842827|521364133|FG001|Overall Study|Physician Decision|3|||
144590939|NCT02842827|521364134|FG002|Overall Study|Physician Decision|0|||
144590940|NCT02842827|521364135|FG003|Overall Study|Physician Decision|0|||
144590941|NCT02842827|521364136|FG004|Overall Study|Physician Decision|1|||
144590942|NCT02842827|521364137|FG005|Overall Study|Physician Decision|4|||
144590943|NCT02842827|521364138|FG006|Overall Study|Physician Decision|2|||
144590944|NCT02842827|521364139|FG007|Overall Study|Physician Decision|1|||
144590945|NCT02842827|521364132|FG000|Overall Study|Protocol Defined Disease Progression|0|||
144590946|NCT02842827|521364133|FG001|Overall Study|Protocol Defined Disease Progression|0|||
144590947|NCT02842827|521364134|FG002|Overall Study|Protocol Defined Disease Progression|0|||
144590948|NCT02842827|521364135|FG003|Overall Study|Protocol Defined Disease Progression|0|||
144590949|NCT02842827|521364136|FG004|Overall Study|Protocol Defined Disease Progression|0|||
144590950|NCT02842827|521364137|FG005|Overall Study|Protocol Defined Disease Progression|1|||
144590951|NCT02842827|521364138|FG006|Overall Study|Protocol Defined Disease Progression|0|||
144590952|NCT02842827|521364139|FG007|Overall Study|Protocol Defined Disease Progression|0|||
144590953|NCT02842827|521364132|FG000|Overall Study|Participant Withdrawal of Consent|1|||
144590954|NCT02842827|521364133|FG001|Overall Study|Participant Withdrawal of Consent|2|||
144590955|NCT02842827|521364134|FG002|Overall Study|Participant Withdrawal of Consent|2|||
144590956|NCT02842827|521364135|FG003|Overall Study|Participant Withdrawal of Consent|2|||
144590957|NCT02842827|521364136|FG004|Overall Study|Participant Withdrawal of Consent|2|||
144590958|NCT02842827|521364137|FG005|Overall Study|Participant Withdrawal of Consent|1|||
144590959|NCT02842827|521364138|FG006|Overall Study|Participant Withdrawal of Consent|2|||
144590960|NCT02842827|521364139|FG007|Overall Study|Participant Withdrawal of Consent|1|||
144590961|NCT02649946|521364145|FG000|Overall Study|Withdrawal by Subject|1|||
144590962|NCT02649946|521364146|FG001|Overall Study|Withdrawal by Subject|1|||
144590963|NCT02649946|521364145|FG000|Overall Study|Death|7|||
144590964|NCT02649946|521364146|FG001|Overall Study|Death|9|||
144590965|NCT02649946|521364145|FG000|Overall Study|Physician Decision|1|||
144590966|NCT02649946|521364146|FG001|Overall Study|Physician Decision|0|||
144590967|NCT02649946|521364145|FG000|Overall Study|Lost to Follow-up|2|||
144590968|NCT02649946|521364146|FG001|Overall Study|Lost to Follow-up|1|||
144590969|NCT02649946|521364145|FG000|Overall Study|Erroneously enrolled|1|||
144590970|NCT02649946|521364146|FG001|Overall Study|Erroneously enrolled|0|||
144590971|NCT02649946|521364145|FG000|Overall Study|Missed 6-month follow-up visit|0|||
144590972|NCT02649946|521364146|FG001|Overall Study|Missed 6-month follow-up visit|4|||
144590973|NCT02054520|521364147|FG000|Overall Study|Adverse Event|1|||
144590974|NCT02054520|521364148|FG001|Overall Study|Adverse Event|4|||
144590975|NCT02054520|521364149|FG002|Overall Study|Adverse Event|2|||
144590976|NCT02054520|521364150|FG003|Overall Study|Adverse Event|1|||
144590977|NCT02054520|521364151|FG004|Overall Study|Adverse Event|1|||
144590978|NCT02054520|521364152|FG005|Overall Study|Adverse Event|0|||
144590979|NCT02054520|521364147|FG000|Overall Study|Lack of Efficacy|7|||
144590980|NCT02054520|521364148|FG001|Overall Study|Lack of Efficacy|0|||
144590981|NCT02054520|521364149|FG002|Overall Study|Lack of Efficacy|2|||
144590982|NCT02054520|521364150|FG003|Overall Study|Lack of Efficacy|1|||
144590983|NCT02054520|521364151|FG004|Overall Study|Lack of Efficacy|3|||
144590984|NCT02054520|521364152|FG005|Overall Study|Lack of Efficacy|2|||
144590985|NCT02054520|521364147|FG000|Overall Study|Withdrawal by Subject|1|||
144590986|NCT02054520|521364148|FG001|Overall Study|Withdrawal by Subject|0|||
144590987|NCT02054520|521364149|FG002|Overall Study|Withdrawal by Subject|0|||
144590988|NCT02054520|521364150|FG003|Overall Study|Withdrawal by Subject|2|||
144590989|NCT02054520|521364151|FG004|Overall Study|Withdrawal by Subject|1|||
144590990|NCT02054520|521364152|FG005|Overall Study|Withdrawal by Subject|0|||
144590991|NCT02054520|521364147|FG000|Overall Study|Physician Decision|0|||
144590992|NCT02054520|521364148|FG001|Overall Study|Physician Decision|1|||
144590993|NCT02054520|521364149|FG002|Overall Study|Physician Decision|0|||
144590994|NCT02054520|521364150|FG003|Overall Study|Physician Decision|1|||
144590995|NCT02054520|521364151|FG004|Overall Study|Physician Decision|0|||
144590996|NCT02054520|521364152|FG005|Overall Study|Physician Decision|1|||
144590997|NCT02054520|521364147|FG000|Overall Study|Study terminated by Sponsor|0|||
144590998|NCT02054520|521364148|FG001|Overall Study|Study terminated by Sponsor|0|||
144590999|NCT02054520|521364149|FG002|Overall Study|Study terminated by Sponsor|2|||
144591000|NCT02054520|521364150|FG003|Overall Study|Study terminated by Sponsor|1|||
144591001|NCT02054520|521364151|FG004|Overall Study|Study terminated by Sponsor|0|||
144591002|NCT02054520|521364152|FG005|Overall Study|Study terminated by Sponsor|0|||
144591003|NCT01272804|521364153|FG000|Overall Study|Adverse Event|1|||
144591004|NCT01272804|521364154|FG001|Overall Study|Adverse Event|0|||
144591005|NCT01272804|521364155|FG002|Overall Study|Adverse Event|0|||
144591006|NCT01272804|521364156|FG003|Overall Study|Adverse Event|0|||
144591007|NCT01272804|521364157|FG004|Overall Study|Adverse Event|2|||
144591008|NCT01272804|521364158|FG005|Overall Study|Adverse Event|1|||
144591009|NCT03801915|521364159|FG000|Overall Study|Screen failure|0|||
144591010|NCT03801915|521364160|FG001|Overall Study|Screen failure|0|||
144591011|NCT03801915|521364161|FG002|Overall Study|Screen failure|1|||
144591012|NCT03801915|521364159|FG000|Overall Study|Ineligible|1|||
144591013|NCT03801915|521364160|FG001|Overall Study|Ineligible|0|||
144591014|NCT03801915|521364161|FG002|Overall Study|Ineligible|0|||
144591015|NCT03801915|521364159|FG000|Overall Study|Physician Decision|2|||
144591016|NCT03801915|521364160|FG001|Overall Study|Physician Decision|1|||
144591017|NCT03801915|521364161|FG002|Overall Study|Physician Decision|0|||
144591018|NCT01211288|521364162|FG000|Overall Study|Lost to Follow-up|1|||
144591019|NCT01211288|521364163|FG001|Overall Study|Lost to Follow-up|1|||
144591020|NCT01588496|521364164|FG000|Overall Study|Withdrawal by Subject|0|||
144591021|NCT01588496|521364165|FG001|Overall Study|Withdrawal by Subject|1|||
144591022|NCT01588496|521364166|FG002|Overall Study|Withdrawal by Subject|0|||
144591023|NCT01551212|521364167|FG000|Overall Study|Graft loss/Retransplantation|0|||
144591024|NCT01551212|521364168|FG001|Overall Study|Graft loss/Retransplantation|1|||
144591025|NCT01551212|521364167|FG000|Overall Study|Administrative problems|1|||
144591026|NCT01551212|521364168|FG001|Overall Study|Administrative problems|2|||
144591027|NCT01551212|521364167|FG000|Overall Study|Lost to Follow-up|0|||
144591028|NCT01551212|521364168|FG001|Overall Study|Lost to Follow-up|1|||
144591029|NCT01551212|521364167|FG000|Overall Study|Protocol Violation|0|||
144591030|NCT01551212|521364168|FG001|Overall Study|Protocol Violation|1|||
144591031|NCT01551212|521364167|FG000|Overall Study|Withdrawal by Subject|0|||
144591032|NCT01551212|521364168|FG001|Overall Study|Withdrawal by Subject|7|||
144591033|NCT01551212|521364167|FG000|Overall Study|Death|2|||
144591034|NCT01551212|521364168|FG001|Overall Study|Death|4|||
144591035|NCT01551212|521364167|FG000|Overall Study|Never Received Study Treatment|2|||
144591036|NCT01551212|521364168|FG001|Overall Study|Never Received Study Treatment|4|||
144591037|NCT05924945|521364169|FG000|Overall Study|Withdrawal by Subject|3|||
144591038|NCT05924945|521364170|FG001|Overall Study|Withdrawal by Subject|4|||
144591039|NCT02471833|521364171|FG000|Overall Study|Lost to Follow-up|1|||
144591040|NCT02471833|521364172|FG001|Overall Study|Lost to Follow-up|0|||
144591041|NCT02471833|521364173|FG002|Overall Study|Lost to Follow-up|0|||
144591042|NCT02471833|521364171|FG000|Overall Study|Withdrawal by Subject|2|||
144591043|NCT02471833|521364172|FG001|Overall Study|Withdrawal by Subject|1|||
144591044|NCT02471833|521364173|FG002|Overall Study|Withdrawal by Subject|5|||
144591045|NCT04217590|521364174|FG000|Overall Study|Other|1|||
144591046|NCT04217590|521364175|FG001|Overall Study|Other|1|||
144591047|NCT04217590|521364174|FG000|Overall Study|Withdrawal by Subject|3|||
144591048|NCT04217590|521364175|FG001|Overall Study|Withdrawal by Subject|1|||
144591049|NCT04217590|521364174|FG000|Overall Study|Death|0|||
144591050|NCT04217590|521364175|FG001|Overall Study|Death|1|||
144591051|NCT02232243|521364178|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
144591052|NCT02232243|521364179|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
144591053|NCT02232243|521364180|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
144591054|NCT05026710|521364181|FG000|Overall Study|No longer met eligibility criteria|3|||
144591055|NCT05026710|521364182|FG001|Overall Study|No longer met eligibility criteria|1|||
144249345|NCT01554176|520110088|FG003|Treatment Phase|Physician Decision|0|||
144249346|NCT01554176|520110089|FG004|Treatment Phase|Physician Decision|0|||
144249347|NCT01554176|520110085|FG000|Treatment Phase|Lack of Efficacy|0|||
144249348|NCT01554176|520110086|FG001|Treatment Phase|Lack of Efficacy|1|||
144249349|NCT01554176|520110087|FG002|Treatment Phase|Lack of Efficacy|0|||
144249350|NCT01554176|520110088|FG003|Treatment Phase|Lack of Efficacy|0|||
144249351|NCT01554176|520110089|FG004|Treatment Phase|Lack of Efficacy|0|||
144249352|NCT01554176|520110085|FG000|Treatment Phase|Adverse event, non-fatal|1|||
144249353|NCT01554176|520110086|FG001|Treatment Phase|Adverse event, non-fatal|1|||
144249354|NCT01554176|520110087|FG002|Treatment Phase|Adverse event, non-fatal|0|||
144249355|NCT01554176|520110088|FG003|Treatment Phase|Adverse event, non-fatal|0|||
144249356|NCT01554176|520110089|FG004|Treatment Phase|Adverse event, non-fatal|0|||
144249357|NCT01554176|520110085|FG000|Treatment Phase|Non-compliance with study drug|1|||
144249358|NCT01554176|520110086|FG001|Treatment Phase|Non-compliance with study drug|0|||
144249359|NCT01554176|520110087|FG002|Treatment Phase|Non-compliance with study drug|0|||
144249360|NCT01554176|520110088|FG003|Treatment Phase|Non-compliance with study drug|0|||
144249361|NCT01554176|520110089|FG004|Treatment Phase|Non-compliance with study drug|0|||
144249362|NCT01554176|520110085|FG000|Treatment Phase|Withdrawal by Subject|1|||
144249363|NCT01554176|520110086|FG001|Treatment Phase|Withdrawal by Subject|0|||
144249364|NCT01554176|520110087|FG002|Treatment Phase|Withdrawal by Subject|0|||
144249365|NCT01554176|520110088|FG003|Treatment Phase|Withdrawal by Subject|0|||
144249366|NCT01554176|520110089|FG004|Treatment Phase|Withdrawal by Subject|0|||
144249367|NCT01554176|520110085|FG000|Treatment Phase|Lost to Follow-up|3|||
144249368|NCT01554176|520110086|FG001|Treatment Phase|Lost to Follow-up|0|||
144249369|NCT01554176|520110087|FG002|Treatment Phase|Lost to Follow-up|0|||
144249370|NCT01554176|520110088|FG003|Treatment Phase|Lost to Follow-up|0|||
144249371|NCT01554176|520110089|FG004|Treatment Phase|Lost to Follow-up|0|||
144249372|NCT01554176|520110085|FG000|Run-out Phase|Protocol Violation|0|||
144249373|NCT01554176|520110086|FG001|Run-out Phase|Protocol Violation|0|||
144249374|NCT01554176|520110087|FG002|Run-out Phase|Protocol Violation|0|||
144249375|NCT01554176|520110088|FG003|Run-out Phase|Protocol Violation|1|||
144249376|NCT01554176|520110089|FG004|Run-out Phase|Protocol Violation|0|||
144249377|NCT01324570|520110099|FG000|Overall Study|Adverse Event|4|||
144249378|NCT01324570|520110100|FG001|Overall Study|Adverse Event|7|||
144249379|NCT01324570|520110099|FG000|Overall Study|Withdrawal by Subject|0|||
144249380|NCT01324570|520110100|FG001|Overall Study|Withdrawal by Subject|3|||
144249381|NCT01324570|520110099|FG000|Overall Study|Lack of Efficacy|0|||
144249382|NCT01324570|520110100|FG001|Overall Study|Lack of Efficacy|1|||
144249383|NCT01324570|520110099|FG000|Overall Study|Confirmed or suspected diversion|0|||
144249384|NCT01324570|520110100|FG001|Overall Study|Confirmed or suspected diversion|1|||
144249385|NCT01324570|520110099|FG000|Overall Study|Administrative|0|||
144249386|NCT01324570|520110100|FG001|Overall Study|Administrative|2|||
144249387|NCT04683939|520110101|FG000|Overall Study|Study termination by the sponsor|0|||
144249388|NCT04683939|520110102|FG001|Overall Study|Study termination by the sponsor|1|||
144249389|NCT04683939|520110103|FG002|Overall Study|Study termination by the sponsor|2|||
144249390|NCT04683939|520110104|FG003|Overall Study|Study termination by the sponsor|2|||
144249391|NCT04683939|520110101|FG000|Overall Study|Death|1|||
144249392|NCT04683939|520110102|FG001|Overall Study|Death|1|||
144249393|NCT04683939|520110103|FG002|Overall Study|Death|2|||
144249394|NCT04683939|520110104|FG003|Overall Study|Death|1|||
144249395|NCT04683939|520110101|FG000|Overall Study|Withdrawal by Subject|1|||
144249396|NCT04683939|520110102|FG001|Overall Study|Withdrawal by Subject|0|||
144249397|NCT04683939|520110103|FG002|Overall Study|Withdrawal by Subject|0|||
144249398|NCT04683939|520110104|FG003|Overall Study|Withdrawal by Subject|0|||
144249399|NCT04683939|520110101|FG000|Overall Study|Physician Decision|1|||
144249400|NCT04683939|520110102|FG001|Overall Study|Physician Decision|0|||
144249401|NCT04683939|520110103|FG002|Overall Study|Physician Decision|0|||
144249402|NCT04683939|520110104|FG003|Overall Study|Physician Decision|0|||
144249403|NCT04683939|520110101|FG000|Overall Study|Lost to Follow-up|0|||
144249404|NCT04683939|520110102|FG001|Overall Study|Lost to Follow-up|1|||
144249405|NCT04683939|520110103|FG002|Overall Study|Lost to Follow-up|0|||
144249406|NCT04683939|520110104|FG003|Overall Study|Lost to Follow-up|0|||
144511178|NCT00409838|521072621|FG001|Short-term Period|Withdrawal by Subject|3|||
144511179|NCT00409838|521072620|FG000|Short-term Period|Never Treated|1|||
144511180|NCT00409838|521072621|FG001|Short-term Period|Never Treated|0|||
144511181|NCT00409838|521072620|FG000|Long-term Extension Period|Adverse Event|10|||
144511182|NCT00409838|521072621|FG001|Long-term Extension Period|Adverse Event|0|||
144511183|NCT00409838|521072620|FG000|Long-term Extension Period|Death|1|||
144511184|NCT00409838|521072621|FG001|Long-term Extension Period|Death|0|||
144259284|NCT01089127|520150357|FG003|Overall Study|Subject withdrew consent|1|||
144259285|NCT01089127|520150358|FG004|Overall Study|Subject withdrew consent|0|||
144259286|NCT01089127|520150359|FG005|Overall Study|Subject withdrew consent|2|||
144259287|NCT01089127|520150354|FG000|Overall Study|Abnormal test procedure result(s)|2|||
144259288|NCT01089127|520150355|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144259289|NCT01089127|520150356|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144259290|NCT01089127|520150357|FG003|Overall Study|Abnormal test procedure result(s)|0|||
144259291|NCT01089127|520150358|FG004|Overall Study|Abnormal test procedure result(s)|0|||
144373627|NCT05767749|520576174|FG005|Overall Study|Withdrawal by Subject|2|||
144373628|NCT01077050|520578120|FG000|Overall Study|Subjects signed ICF could not be located|1|||
144373629|NCT01077050|520578120|FG000|Overall Study|Screen failure|8|||
144373630|NCT01006291|520578126|FG000|Overall Study|Adverse Event|2|||
144373631|NCT01006291|520578127|FG001|Overall Study|Adverse Event|1|||
144373632|NCT01006291|520578128|FG002|Overall Study|Adverse Event|2|||
144373633|NCT01006291|520578126|FG000|Overall Study|Lack of Efficacy|2|||
144373634|NCT01006291|520578127|FG001|Overall Study|Lack of Efficacy|2|||
144373635|NCT01006291|520578128|FG002|Overall Study|Lack of Efficacy|1|||
144373636|NCT01006291|520578126|FG000|Overall Study|Protocol Violation|3|||
144373637|NCT01006291|520578127|FG001|Overall Study|Protocol Violation|3|||
144373638|NCT01006291|520578128|FG002|Overall Study|Protocol Violation|3|||
144373639|NCT01006291|520578126|FG000|Overall Study|Withdrawal criteria|5|||
144373640|NCT01006291|520578127|FG001|Overall Study|Withdrawal criteria|4|||
144373641|NCT01006291|520578128|FG002|Overall Study|Withdrawal criteria|4|||
144373642|NCT01006291|520578126|FG000|Overall Study|Other|14|||
144373643|NCT01006291|520578127|FG001|Overall Study|Other|14|||
144373644|NCT01006291|520578128|FG002|Overall Study|Other|17|||
144373645|NCT00684060|520578129|FG000|Overall Study|Lost to Follow-up|1|||
144373646|NCT00684060|520578130|FG001|Overall Study|Lost to Follow-up|0|||
144373647|NCT00684060|520578129|FG000|Overall Study|New stenosis identified|1|||
144373648|NCT00684060|520578130|FG001|Overall Study|New stenosis identified|0|||
144373649|NCT00684060|520578129|FG000|Overall Study|Unable to collect MRI|1|||
144373650|NCT00684060|520578130|FG001|Overall Study|Unable to collect MRI|2|||
144373651|NCT00684060|520578129|FG000|Overall Study|Death|0|||
144373652|NCT00684060|520578130|FG001|Overall Study|Death|1|||
144373653|NCT00702715|520578131|FG000|Overall Study|Lost to Follow-up|1|||
144373654|NCT00702715|520578132|FG001|Overall Study|Lost to Follow-up|0|||
144373655|NCT01865552|520578137|FG000|Period 1|Adverse Event|1|||
144373656|NCT01865552|520578138|FG001|Period 1|Adverse Event|0|||
144373657|NCT01865552|520578139|FG002|Period 1|Adverse Event|0|||
144373658|NCT01865552|520578140|FG003|Period 1|Adverse Event|1|||
144373659|NCT01865552|520578141|FG004|Period 1|Adverse Event|1|||
144373660|NCT01865552|520578142|FG005|Period 1|Adverse Event|1|||
144373661|NCT01865552|520578137|FG000|Period 1|Pathological lab|0|||
144373662|NCT01865552|520578138|FG001|Period 1|Pathological lab|0|||
144373663|NCT01865552|520578139|FG002|Period 1|Pathological lab|0|||
144373664|NCT01865552|520578140|FG003|Period 1|Pathological lab|0|||
144373665|NCT01865552|520578141|FG004|Period 1|Pathological lab|1|||
144373666|NCT01865552|520578142|FG005|Period 1|Pathological lab|0|||
144249407|NCT03089853|520111636|FG000|Overall Study|Lost to Follow-up|2|||
144249408|NCT03089853|520111637|FG001|Overall Study|Lost to Follow-up|1|||
144373667|NCT01865552|520578137|FG000|Period 1|Other|0|||
144373668|NCT01865552|520578138|FG001|Period 1|Other|0|||
144373669|NCT01865552|520578139|FG002|Period 1|Other|0|||
144373670|NCT01865552|520578140|FG003|Period 1|Other|0|||
144373671|NCT01865552|520578141|FG004|Period 1|Other|1|||
144373672|NCT01865552|520578142|FG005|Period 1|Other|0|||
144373673|NCT03079102|520578145|FG000|Overall Study|Physician Decision|0|||
144373674|NCT03079102|520578146|FG001|Overall Study|Physician Decision|1|||
144373675|NCT02923921|520578147|FG000|Overall Study|Sponsor Decision|39|||
144373676|NCT02923921|520578148|FG001|Overall Study|Sponsor Decision|38|||
144373677|NCT02923921|520578147|FG000|Overall Study|Lost to Follow-up|1|||
144373678|NCT02923921|520578148|FG001|Overall Study|Lost to Follow-up|0|||
144373679|NCT02923921|520578147|FG000|Overall Study|Withdrawal by Subject|6|||
144373680|NCT02923921|520578148|FG001|Overall Study|Withdrawal by Subject|13|||
144373681|NCT02923921|520578147|FG000|Overall Study|Unknown, Not Collected|7|||
144373682|NCT02923921|520578148|FG001|Overall Study|Unknown, Not Collected|6|||
144373683|NCT00854113|520578149|FG000|Overall Study|Adverse Event|0|||
144373684|NCT00854113|520578150|FG001|Overall Study|Adverse Event|0|||
144373685|NCT00854113|520578151|FG002|Overall Study|Adverse Event|0|||
144373686|NCT00854113|520578152|FG003|Overall Study|Adverse Event|0|||
144373687|NCT00854113|520578153|FG004|Overall Study|Adverse Event|0|||
144373688|NCT00854113|520578154|FG005|Overall Study|Adverse Event|0|||
144373689|NCT00854113|520578155|FG006|Overall Study|Adverse Event|0|||
144511185|NCT00409838|521072620|FG000|Long-term Extension Period|Lack of Efficacy|2|||
144511186|NCT00409838|521072621|FG001|Long-term Extension Period|Lack of Efficacy|0|||
144511187|NCT00409838|521072620|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
144511188|NCT00409838|521072621|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
144511189|NCT00409838|521072620|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
144511190|NCT00409838|521072621|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
144511191|NCT00409838|521072620|FG000|Long-term Extension Period|Pregnancy|1|||
144511192|NCT00409838|521072621|FG001|Long-term Extension Period|Pregnancy|0|||
144511193|NCT04788641|521072622|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
144511194|NCT04788641|521072623|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
144511195|NCT04788641|521072624|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
144511196|NCT04788641|521072625|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
144511197|NCT04788641|521072622|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
144538269|NCT03801148|521174146|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144249409|NCT00642954|520111638|FG000|Overall Study|Progressive Disease|3|||
144249410|NCT00642954|520111639|FG001|Overall Study|Progressive Disease|3|||
144249411|NCT00642954|520111640|FG002|Overall Study|Progressive Disease|3|||
144249412|NCT00642954|520111641|FG003|Overall Study|Progressive Disease|3|||
144249413|NCT00642954|520111642|FG004|Overall Study|Progressive Disease|9|||
144249414|NCT00642954|520111638|FG000|Overall Study|Withdrawal by Subject|0|||
144249415|NCT00642954|520111639|FG001|Overall Study|Withdrawal by Subject|0|||
144249416|NCT00642954|520111640|FG002|Overall Study|Withdrawal by Subject|0|||
144249417|NCT00642954|520111641|FG003|Overall Study|Withdrawal by Subject|0|||
144249418|NCT00642954|520111642|FG004|Overall Study|Withdrawal by Subject|1|||
144249419|NCT00642954|520111638|FG000|Overall Study|Adverse Event|1|||
144249420|NCT00642954|520111639|FG001|Overall Study|Adverse Event|1|||
144373690|NCT00854113|520578156|FG007|Overall Study|Adverse Event|2|||
144511198|NCT04788641|521072623|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
144511199|NCT04788641|521072624|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
144511200|NCT04788641|521072625|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
144511201|NCT04788641|521072622|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
144511202|NCT04788641|521072623|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
144511203|NCT04788641|521072624|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
144511204|NCT04788641|521072625|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
144511205|NCT01250769|521072626|FG000|Overall Study|Withdrawal by Subject|0|||
144511206|NCT01250769|521072627|FG001|Overall Study|Withdrawal by Subject|1|||
144511207|NCT01250769|521072628|FG002|Overall Study|Withdrawal by Subject|1|||
144511208|NCT01250769|521072629|FG003|Overall Study|Withdrawal by Subject|0|||
144511209|NCT01250769|521072626|FG000|Overall Study|Adverse Event|0|||
144511210|NCT01250769|521072627|FG001|Overall Study|Adverse Event|0|||
144511211|NCT01250769|521072628|FG002|Overall Study|Adverse Event|1|||
144511212|NCT01250769|521072629|FG003|Overall Study|Adverse Event|0|||
144511213|NCT03283371|521072630|FG000|Placebo-controlled|Adverse Event|1|||
144511214|NCT03283371|521072631|FG001|Placebo-controlled|Adverse Event|1|||
144511215|NCT03283371|521072632|FG002|Placebo-controlled|Adverse Event|0|||
144511216|NCT03283371|521072633|FG003|Placebo-controlled|Adverse Event|0|||
144511217|NCT03283371|521072630|FG000|Placebo-controlled|Lack of Efficacy|1|||
144511218|NCT03283371|521072631|FG001|Placebo-controlled|Lack of Efficacy|0|||
144511219|NCT03283371|521072632|FG002|Placebo-controlled|Lack of Efficacy|0|||
144511220|NCT03283371|521072633|FG003|Placebo-controlled|Lack of Efficacy|0|||
144511221|NCT03283371|521072630|FG000|Placebo-controlled|Withdrawal by Subject|1|||
144511222|NCT03283371|521072631|FG001|Placebo-controlled|Withdrawal by Subject|1|||
144511223|NCT03283371|521072632|FG002|Placebo-controlled|Withdrawal by Subject|0|||
144511224|NCT03283371|521072633|FG003|Placebo-controlled|Withdrawal by Subject|0|||
144511225|NCT03283371|521072630|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
144511226|NCT03283371|521072631|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
144511227|NCT03283371|521072632|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
144511228|NCT03283371|521072633|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
144511229|NCT03283371|521072630|FG000|Open-label Phase|Adverse Event|0|||
144511230|NCT03283371|521072631|FG001|Open-label Phase|Adverse Event|0|||
144511231|NCT03283371|521072632|FG002|Open-label Phase|Adverse Event|2|||
144511232|NCT03283371|521072633|FG003|Open-label Phase|Adverse Event|0|||
144511233|NCT03283371|521072630|FG000|Open-label Phase|Withdrawal by Subject|0|||
144511234|NCT03283371|521072631|FG001|Open-label Phase|Withdrawal by Subject|0|||
144511235|NCT03283371|521072632|FG002|Open-label Phase|Withdrawal by Subject|1|||
144511236|NCT03283371|521072633|FG003|Open-label Phase|Withdrawal by Subject|0|||
144511237|NCT03283371|521072630|FG000|Open-label Phase|Other|0|||
144511238|NCT03283371|521072631|FG001|Open-label Phase|Other|0|||
144511239|NCT03283371|521072632|FG002|Open-label Phase|Other|1|||
144511240|NCT03283371|521072633|FG003|Open-label Phase|Other|1|||
144511241|NCT00243503|521072634|FG000|Overall Study|Adverse Event|11|||
144511242|NCT00243503|521072634|FG000|Overall Study|Withdrawal by Subject|1|||
144511243|NCT00243503|521072634|FG000|Overall Study|Lack of Efficacy|44|||
144511244|NCT00243503|521072634|FG000|Overall Study|Death|1|||
144511245|NCT00243503|521072634|FG000|Overall Study|Other|1|||
144511246|NCT00914589|521072635|FG000|Overall Study|Adverse Event|1|||
144511247|NCT00914589|521072636|FG001|Overall Study|Adverse Event|0|||
144511248|NCT00914589|521072637|FG002|Overall Study|Adverse Event|1|||
144511249|NCT00914589|521072635|FG000|Overall Study|Protocol Violation|8|||
144511250|NCT00914589|521072636|FG001|Overall Study|Protocol Violation|6|||
144511251|NCT00914589|521072637|FG002|Overall Study|Protocol Violation|3|||
144511252|NCT00914589|521072635|FG000|Overall Study|unclassified|16|||
144511253|NCT00914589|521072636|FG001|Overall Study|unclassified|9|||
144511254|NCT00914589|521072637|FG002|Overall Study|unclassified|7|||
144511255|NCT00914589|521072635|FG000|Overall Study|Death|0|||
144511256|NCT00914589|521072636|FG001|Overall Study|Death|1|||
144511257|NCT00914589|521072637|FG002|Overall Study|Death|1|||
144511258|NCT00093015|521072642|FG000|Overall Study|Withdrawal by Subject|194|||
144511259|NCT00093015|521072643|FG001|Overall Study|Withdrawal by Subject|171|||
144249421|NCT00642954|520111640|FG002|Overall Study|Adverse Event|0|||
144249422|NCT00642954|520111641|FG003|Overall Study|Adverse Event|0|||
144511260|NCT00093015|521072642|FG000|Overall Study|Lost to Follow-up|96|||
144511261|NCT00093015|521072643|FG001|Overall Study|Lost to Follow-up|108|||
144511262|NCT00093015|521072642|FG000|Overall Study|Death|375|||
144249423|NCT00642954|520111642|FG004|Overall Study|Adverse Event|6|||
144249424|NCT03052920|520111643|FG000|Overall Study|Withdrawal by Subject|1|||
144249425|NCT02578940|520111644|FG000|Overall Study|Screening failure|5|||
144249426|NCT02578940|520111644|FG000|Overall Study|Lost to Follow-up|1|||
144249427|NCT01533688|520111645|FG000|Overall Study|Withdrawal by Subject|5|||
144249428|NCT01533688|520111646|FG001|Overall Study|Withdrawal by Subject|4|||
144249429|NCT01533688|520111647|FG002|Overall Study|Withdrawal by Subject|3|||
144249430|NCT01533688|520111645|FG000|Overall Study|Medically unstable|1|||
144249431|NCT01533688|520111646|FG001|Overall Study|Medically unstable|3|||
144249432|NCT01533688|520111647|FG002|Overall Study|Medically unstable|3|||
144511263|NCT00093015|521072643|FG001|Overall Study|Death|385|||
144511264|NCT00520546|521072646|FG000|Overall Study|Withdrawal by Subject|1|||
144511265|NCT00520546|521072646|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
144511266|NCT03076515|521072647|FG000|Overall Study|DMC decision based on interim analysis|25|||
144511267|NCT03076515|521072648|FG001|Overall Study|DMC decision based on interim analysis|29|||
144511268|NCT03988023|521072652|FG000|Overall Study|Non-compliance|3|||
144511269|NCT03988023|521072653|FG001|Overall Study|Non-compliance|0|||
144511270|NCT03988023|521072652|FG000|Overall Study|Withdrawal by Subject|39|||
144511271|NCT03988023|521072653|FG001|Overall Study|Withdrawal by Subject|37|||
144511272|NCT03988023|521072652|FG000|Overall Study|Adverse Event|0|||
144511273|NCT03988023|521072653|FG001|Overall Study|Adverse Event|2|||
144511274|NCT03988023|521072652|FG000|Overall Study|Physician Decision|0|||
144511275|NCT03988023|521072653|FG001|Overall Study|Physician Decision|1|||
144511276|NCT03988023|521072652|FG000|Overall Study|Lost to Follow-up|5|||
144511277|NCT03988023|521072653|FG001|Overall Study|Lost to Follow-up|8|||
144511278|NCT03988023|521072652|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
144511279|NCT03988023|521072653|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
144511280|NCT03988023|521072652|FG000|Overall Study|Lack of Efficacy|3|||
144511281|NCT03988023|521072653|FG001|Overall Study|Lack of Efficacy|1|||
144249433|NCT01533688|520111645|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
144511282|NCT03988023|521072652|FG000|Overall Study|COVID-19 pandemic|225|||
144511283|NCT03988023|521072653|FG001|Overall Study|COVID-19 pandemic|227|||
144511284|NCT02101281|521072654|FG000|Overall Study|Adverse Event|0|||
144249434|NCT01533688|520111646|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
144249435|NCT01533688|520111647|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
144249436|NCT02509078|520111648|FG000|Overall Study|Protocol Violation|1|||
144249437|NCT02509078|520111649|FG001|Overall Study|Protocol Violation|1|||
144249438|NCT01716520|520111653|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
144249439|NCT01716520|520111654|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
144249440|NCT01716520|520111655|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
144249441|NCT01716520|520111656|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
144511285|NCT02101281|521072655|FG001|Overall Study|Adverse Event|1|||
144511286|NCT00174382|521072656|FG000|Overall Study|Death|2|||
144249442|NCT01716520|520111657|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
144249443|NCT01716520|520111658|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
144249444|NCT01716520|520111653|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
144249445|NCT01716520|520111654|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249446|NCT01716520|520111655|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
144249447|NCT01716520|520111656|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
144249448|NCT01716520|520111657|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249449|NCT01716520|520111658|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
144249450|NCT01716520|520111653|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144249451|NCT01716520|520111654|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144249452|NCT01716520|520111655|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144249453|NCT01716520|520111656|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144249454|NCT01716520|520111657|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144249455|NCT01716520|520111658|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144249456|NCT01716520|520111653|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
144249457|NCT01716520|520111654|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
144249458|NCT01716520|520111655|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
144249459|NCT01716520|520111656|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
144249460|NCT01716520|520111657|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
144249461|NCT01716520|520111658|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
144249462|NCT01716520|520111653|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144249463|NCT01716520|520111654|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144249464|NCT01716520|520111655|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144249465|NCT01716520|520111656|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144249466|NCT01716520|520111657|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144249467|NCT01716520|520111658|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
144249468|NCT01716520|520111653|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
144249469|NCT01716520|520111654|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
144249470|NCT01716520|520111655|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
144249471|NCT01716520|520111656|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
144249472|NCT01716520|520111657|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
144249473|NCT01716520|520111658|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
144249474|NCT01716520|520111653|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
144249475|NCT01716520|520111654|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
144249476|NCT01716520|520111655|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
144249477|NCT01716520|520111656|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
144249478|NCT01716520|520111657|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
144249479|NCT01716520|520111658|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
144249480|NCT01716520|520111653|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144249481|NCT01716520|520111654|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144249482|NCT01716520|520111655|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144249483|NCT01716520|520111656|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144249484|NCT01716520|520111657|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
144249485|NCT01716520|520111658|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144249486|NCT01716520|520111653|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249487|NCT01716520|520111654|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249488|NCT01716520|520111655|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249489|NCT01716520|520111656|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
144249490|NCT01716520|520111657|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249491|NCT01716520|520111658|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
144249492|NCT01716520|520111653|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
144249493|NCT01716520|520111654|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
144249494|NCT01716520|520111655|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
144249495|NCT01716520|520111656|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
144249496|NCT01716520|520111657|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
144249497|NCT01716520|520111658|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
144249498|NCT01716520|520111653|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
144249499|NCT01716520|520111654|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
144591056|NCT00490724|521364183|FG000|Period I|Physician Decision|0|||
144721730|NCT01595009|521835278|FG003|Core|Death|0|||
144721731|NCT01595009|521835275|FG000|Core|Lost to Follow-up|1|||
144249500|NCT01716520|520111655|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
144249501|NCT01716520|520111656|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
144249502|NCT01716520|520111657|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
144249503|NCT01716520|520111658|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
144249504|NCT01716520|520111653|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
144249505|NCT01716520|520111654|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
144721732|NCT01595009|521835276|FG001|Core|Lost to Follow-up|2|||
144511287|NCT00174382|521072656|FG000|Overall Study|Adverse Event|19|||
144511288|NCT00174382|521072656|FG000|Overall Study|Withdrawal by Subject|6|||
144511289|NCT00174382|521072656|FG000|Overall Study|Protocol Violation|3|||
144511290|NCT00174382|521072656|FG000|Overall Study|Arrived early for last visit in error|1|||
144511291|NCT00174382|521072656|FG000|Overall Study|Subject felt pill not effective enough|1|||
144511292|NCT00174382|521072656|FG000|Overall Study|Lost to Follow-up|1|||
144511293|NCT03733119|521072658|FG000|Overall Study|Physician Decision|2|||
144511294|NCT03733119|521072659|FG001|Overall Study|Physician Decision|1|||
144511295|NCT03733119|521072658|FG000|Overall Study|ineligible to treat per protocol|0|||
144511296|NCT03733119|521072659|FG001|Overall Study|ineligible to treat per protocol|1|||
144511297|NCT00595413|521072660|FG000|Overall Study|Adverse Event|0|||
144511298|NCT00595413|521072661|FG001|Overall Study|Adverse Event|2|||
144511299|NCT00595413|521072662|FG002|Overall Study|Adverse Event|1|||
144511300|NCT00595413|521072663|FG003|Overall Study|Adverse Event|1|||
144511301|NCT00595413|521072660|FG000|Overall Study|Lost to Follow-up|2|||
144511302|NCT00595413|521072661|FG001|Overall Study|Lost to Follow-up|2|||
144511303|NCT00595413|521072662|FG002|Overall Study|Lost to Follow-up|1|||
144511304|NCT00595413|521072663|FG003|Overall Study|Lost to Follow-up|3|||
144511305|NCT00595413|521072660|FG000|Overall Study|Death|0|||
144511306|NCT00595413|521072661|FG001|Overall Study|Death|0|||
144511307|NCT00595413|521072662|FG002|Overall Study|Death|1|||
144511308|NCT00595413|521072663|FG003|Overall Study|Death|0|||
144511309|NCT00595413|521072660|FG000|Overall Study|Other|5|||
144511310|NCT00595413|521072661|FG001|Overall Study|Other|1|||
144511311|NCT00595413|521072662|FG002|Overall Study|Other|5|||
144511312|NCT00595413|521072663|FG003|Overall Study|Other|0|||
144511313|NCT00807937|521072664|FG000|Overall Study|Adverse Event|12|||
144511314|NCT00807937|521072665|FG001|Overall Study|Adverse Event|12|||
144511315|NCT00807937|521072666|FG002|Overall Study|Adverse Event|5|||
144511316|NCT00807937|521072667|FG003|Overall Study|Adverse Event|4|||
144511317|NCT00807937|521072664|FG000|Overall Study|Protocol Violation|4|||
144511318|NCT00807937|521072665|FG001|Overall Study|Protocol Violation|5|||
144511319|NCT00807937|521072666|FG002|Overall Study|Protocol Violation|3|||
144511320|NCT00807937|521072667|FG003|Overall Study|Protocol Violation|3|||
144511321|NCT00807937|521072664|FG000|Overall Study|Withdrawal by Subject|5|||
144511322|NCT00807937|521072665|FG001|Overall Study|Withdrawal by Subject|4|||
144511323|NCT00807937|521072666|FG002|Overall Study|Withdrawal by Subject|1|||
144511324|NCT00807937|521072667|FG003|Overall Study|Withdrawal by Subject|4|||
144511325|NCT00807937|521072664|FG000|Overall Study|Lost to Follow-up|4|||
144511326|NCT00807937|521072665|FG001|Overall Study|Lost to Follow-up|0|||
144511327|NCT00807937|521072666|FG002|Overall Study|Lost to Follow-up|2|||
144511328|NCT00807937|521072667|FG003|Overall Study|Lost to Follow-up|1|||
144511329|NCT00807937|521072664|FG000|Overall Study|Lack of Efficacy|0|||
144511330|NCT00807937|521072665|FG001|Overall Study|Lack of Efficacy|0|||
144511331|NCT00807937|521072666|FG002|Overall Study|Lack of Efficacy|1|||
144511332|NCT00807937|521072667|FG003|Overall Study|Lack of Efficacy|2|||
144511333|NCT00807937|521072664|FG000|Overall Study|Intake of prohibited medicine|0|||
144511334|NCT00807937|521072665|FG001|Overall Study|Intake of prohibited medicine|0|||
144511335|NCT00807937|521072666|FG002|Overall Study|Intake of prohibited medicine|2|||
144511336|NCT00807937|521072667|FG003|Overall Study|Intake of prohibited medicine|0|||
144511337|NCT00807937|521072664|FG000|Overall Study|All other reasons (not provided)|2|||
144511338|NCT00807937|521072665|FG001|Overall Study|All other reasons (not provided)|4|||
144511339|NCT00807937|521072666|FG002|Overall Study|All other reasons (not provided)|0|||
144511340|NCT00807937|521072667|FG003|Overall Study|All other reasons (not provided)|1|||
144511341|NCT04629950|521072670|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
144511342|NCT04629950|521072671|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
144511343|NCT04629950|521072672|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
144511344|NCT04629950|521072673|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
144511345|NCT04629950|521072670|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
144511346|NCT04629950|521072671|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
144511347|NCT04629950|521072672|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
144511348|NCT04629950|521072673|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
144511349|NCT04629950|521072670|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
144511350|NCT04629950|521072671|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
144511351|NCT04629950|521072672|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
144511352|NCT04629950|521072673|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
144511353|NCT04629950|521072670|FG000|Extension Study|Withdrawal by Subject|0|||
144511354|NCT04629950|521072671|FG001|Extension Study|Withdrawal by Subject|0|||
144511355|NCT04629950|521072672|FG002|Extension Study|Withdrawal by Subject|1|||
144511356|NCT04629950|521072673|FG003|Extension Study|Withdrawal by Subject|0|||
144511357|NCT04629950|521072670|FG000|Extension Study|Adverse Event|0|||
144511358|NCT04629950|521072671|FG001|Extension Study|Adverse Event|0|||
144511359|NCT04629950|521072672|FG002|Extension Study|Adverse Event|0|||
144511360|NCT04629950|521072673|FG003|Extension Study|Adverse Event|1|||
144511361|NCT03233633|521072674|FG000|Overall Study|Adverse Event|2|||
144511362|NCT03233633|521072674|FG000|Overall Study|Less Than 3 Days of Data|6|||
144511363|NCT02088853|521072675|FG000|Overall Study|Pregnancy|1|||
144511364|NCT02088853|521072676|FG001|Overall Study|Pregnancy|0|||
144511365|NCT05782231|521072677|FG000|Overall Study|Withdrawal by Subject|1|||
144511366|NCT01198145|521072678|FG000|Overall Study|Withdrawal by Subject|1|||
144511367|NCT01198145|521072679|FG001|Overall Study|Withdrawal by Subject|1|||
144511368|NCT03830866|521072680|FG000|Overall Study|Death|90|||
144511369|NCT03830866|521072681|FG001|Overall Study|Death|111|||
144511370|NCT03830866|521072680|FG000|Overall Study|Lost to Follow-up|7|||
144511371|NCT03830866|521072681|FG001|Overall Study|Lost to Follow-up|7|||
144511372|NCT03830866|521072680|FG000|Overall Study|Withdrawal by Subject|19|||
144511373|NCT03830866|521072681|FG001|Overall Study|Withdrawal by Subject|16|||
144511374|NCT03830866|521072680|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
144511375|NCT03830866|521072681|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
144511376|NCT03830866|521072680|FG000|Overall Study|Other|1|||
144511377|NCT03830866|521072681|FG001|Overall Study|Other|1|||
144511378|NCT01207492|521072684|FG000|Overall Study|Still on study|1|||
144511379|NCT01207492|521072684|FG000|Overall Study|Withdrawal by Subject|9|||
144511380|NCT01207492|521072684|FG000|Overall Study|Physician Decision|1|||
144511381|NCT01207492|521072684|FG000|Overall Study|Progressive disease|3|||
144511382|NCT01207492|521072684|FG000|Overall Study|Toxicity|1|||
144511383|NCT02769858|521072685|FG000|Overall Study|Withdrawal by Subject|2|||
144511384|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
144511385|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
144511386|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
144511387|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
144511388|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
144511389|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
144511390|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
144511391|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
144511392|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
144511393|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
144591057|NCT00490724|521364184|FG001|Period I|Physician Decision|0|||
144511394|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
144511395|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
144511396|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
144511397|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
144591058|NCT00490724|521364185|FG002|Period I|Physician Decision|1|||
144373691|NCT00854113|520578157|FG008|Overall Study|Adverse Event|0|||
144373692|NCT00854113|520578158|FG009|Overall Study|Adverse Event|0|||
144373693|NCT00854113|520578159|FG010|Overall Study|Adverse Event|0|||
144373694|NCT00854113|520578149|FG000|Overall Study|Withdrawal by Subject|0|||
144373695|NCT00854113|520578150|FG001|Overall Study|Withdrawal by Subject|0|||
144373696|NCT00854113|520578151|FG002|Overall Study|Withdrawal by Subject|0|||
144373697|NCT00854113|520578152|FG003|Overall Study|Withdrawal by Subject|0|||
144373698|NCT00854113|520578153|FG004|Overall Study|Withdrawal by Subject|0|||
144373699|NCT00854113|520578154|FG005|Overall Study|Withdrawal by Subject|0|||
144373700|NCT00854113|520578155|FG006|Overall Study|Withdrawal by Subject|0|||
144373701|NCT00854113|520578156|FG007|Overall Study|Withdrawal by Subject|1|||
144373702|NCT00854113|520578157|FG008|Overall Study|Withdrawal by Subject|1|||
144373703|NCT00854113|520578158|FG009|Overall Study|Withdrawal by Subject|0|||
144373704|NCT00854113|520578159|FG010|Overall Study|Withdrawal by Subject|0|||
144373705|NCT00796419|520578161|FG000|Overall Study|Death|0|||
144373706|NCT00796419|520578162|FG001|Overall Study|Death|1|||
144373707|NCT01250145|520578165|FG000|Overall Study|Adverse Event|2|||
144373708|NCT01250145|520578166|FG001|Overall Study|Adverse Event|1|||
144373709|NCT01250145|520578165|FG000|Overall Study|Withdrawal by Subject|0|||
144373710|NCT01250145|520578166|FG001|Overall Study|Withdrawal by Subject|4|||
144373711|NCT02840799|520578167|FG000|Phase 1|Physician Decision|1|||
144373712|NCT02840799|520578168|FG001|Phase 1|Physician Decision|3|||
144373713|NCT02840799|520578167|FG000|Phase 1|Withdrawal by Subject|4|||
144373714|NCT02840799|520578168|FG001|Phase 1|Withdrawal by Subject|0|||
144373715|NCT02840799|520578167|FG000|Phase 2 (Crossover)|Adverse Event|0|||
144373716|NCT02840799|520578168|FG001|Phase 2 (Crossover)|Adverse Event|1|||
144373717|NCT02840799|520578167|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
144373718|NCT02840799|520578168|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
144373719|NCT02565784|520578169|FG000|First Treatment|Adverse Event|1|||
144373720|NCT02565784|520578169|FG000|First Treatment|Withdrawal by Subject|1|||
144373721|NCT02565784|520578169|FG000|Second Treatment|Withdrawal by Subject|2|||
144373722|NCT02741518|520578173|FG000|Overall Study|Withdrawal by Subject|1|||
144373723|NCT02741518|520578174|FG001|Overall Study|Withdrawal by Subject|1|||
144373724|NCT01349049|520578175|FG000|Overall Study|Disease progression|3|||
144373725|NCT01349049|520578176|FG001|Overall Study|Disease progression|5|||
144373726|NCT01349049|520578177|FG002|Overall Study|Disease progression|3|||
144373727|NCT01349049|520578178|FG003|Overall Study|Disease progression|2|||
144373728|NCT01349049|520578179|FG004|Overall Study|Disease progression|2|||
144373729|NCT01349049|520578180|FG005|Overall Study|Disease progression|2|||
144373730|NCT01349049|520578181|FG006|Overall Study|Disease progression|3|||
144373731|NCT01349049|520578182|FG007|Overall Study|Disease progression|2|||
144373732|NCT01349049|520578183|FG008|Overall Study|Disease progression|33|||
144373733|NCT01349049|520578175|FG000|Overall Study|Adverse Event|0|||
144373734|NCT01349049|520578176|FG001|Overall Study|Adverse Event|1|||
144373735|NCT01349049|520578177|FG002|Overall Study|Adverse Event|0|||
144373736|NCT01349049|520578178|FG003|Overall Study|Adverse Event|0|||
144373737|NCT01349049|520578179|FG004|Overall Study|Adverse Event|0|||
144373738|NCT01349049|520578180|FG005|Overall Study|Adverse Event|3|||
144373739|NCT01349049|520578181|FG006|Overall Study|Adverse Event|1|||
144373740|NCT01349049|520578182|FG007|Overall Study|Adverse Event|0|||
144373741|NCT01349049|520578183|FG008|Overall Study|Adverse Event|4|||
144373742|NCT01349049|520578175|FG000|Overall Study|Physician Decision|0|||
144373743|NCT01349049|520578176|FG001|Overall Study|Physician Decision|1|||
144373744|NCT01349049|520578177|FG002|Overall Study|Physician Decision|0|||
144373745|NCT01349049|520578178|FG003|Overall Study|Physician Decision|0|||
144373746|NCT01349049|520578179|FG004|Overall Study|Physician Decision|0|||
144373747|NCT01349049|520578180|FG005|Overall Study|Physician Decision|0|||
144373748|NCT01349049|520578181|FG006|Overall Study|Physician Decision|0|||
144373749|NCT01349049|520578182|FG007|Overall Study|Physician Decision|0|||
144373750|NCT01349049|520578183|FG008|Overall Study|Physician Decision|2|||
144373751|NCT01349049|520578175|FG000|Overall Study|Protocol Violation|0|||
144373752|NCT01349049|520578176|FG001|Overall Study|Protocol Violation|0|||
144373753|NCT01349049|520578177|FG002|Overall Study|Protocol Violation|0|||
144373754|NCT01349049|520578178|FG003|Overall Study|Protocol Violation|0|||
144511398|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
144373755|NCT01349049|520578179|FG004|Overall Study|Protocol Violation|0|||
144373756|NCT01349049|520578180|FG005|Overall Study|Protocol Violation|0|||
144373757|NCT01349049|520578181|FG006|Overall Study|Protocol Violation|0|||
144373758|NCT01349049|520578182|FG007|Overall Study|Protocol Violation|0|||
144373759|NCT01349049|520578183|FG008|Overall Study|Protocol Violation|1|||
144373760|NCT01349049|520578175|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
144373761|NCT01349049|520578176|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
144511399|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
144511400|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
144373762|NCT01349049|520578177|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
144373763|NCT01349049|520578178|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
144373764|NCT01349049|520578179|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
144373765|NCT01349049|520578180|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
144373766|NCT01349049|520578181|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
144373767|NCT01349049|520578182|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
144373768|NCT01349049|520578183|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
144373769|NCT01349049|520578175|FG000|Overall Study|Other|0|||
144373770|NCT01349049|520578176|FG001|Overall Study|Other|0|||
144373771|NCT01349049|520578177|FG002|Overall Study|Other|0|||
144373772|NCT01349049|520578178|FG003|Overall Study|Other|0|||
144373773|NCT01349049|520578179|FG004|Overall Study|Other|0|||
144373774|NCT01349049|520578180|FG005|Overall Study|Other|1|||
144373775|NCT01349049|520578181|FG006|Overall Study|Other|0|||
144373776|NCT01349049|520578182|FG007|Overall Study|Other|0|||
144373777|NCT01349049|520578183|FG008|Overall Study|Other|4|||
144373778|NCT01349049|520578175|FG000|Overall Study|Death|0|||
144373779|NCT01349049|520578176|FG001|Overall Study|Death|0|||
144373780|NCT01349049|520578177|FG002|Overall Study|Death|0|||
144373781|NCT01349049|520578178|FG003|Overall Study|Death|0|||
144373782|NCT01349049|520578179|FG004|Overall Study|Death|0|||
144373783|NCT01349049|520578180|FG005|Overall Study|Death|0|||
144373784|NCT01349049|520578181|FG006|Overall Study|Death|0|||
144373785|NCT01349049|520578182|FG007|Overall Study|Death|1|||
144373786|NCT01349049|520578183|FG008|Overall Study|Death|5|||
144373787|NCT01349049|520578175|FG000|Overall Study|Non-compliance|0|||
144373788|NCT01349049|520578176|FG001|Overall Study|Non-compliance|0|||
144373789|NCT01349049|520578177|FG002|Overall Study|Non-compliance|0|||
144373790|NCT01349049|520578178|FG003|Overall Study|Non-compliance|1|||
144373791|NCT01349049|520578179|FG004|Overall Study|Non-compliance|0|||
144373792|NCT01349049|520578180|FG005|Overall Study|Non-compliance|0|||
144373793|NCT01349049|520578181|FG006|Overall Study|Non-compliance|0|||
144373794|NCT01349049|520578182|FG007|Overall Study|Non-compliance|0|||
144373795|NCT01349049|520578183|FG008|Overall Study|Non-compliance|0|||
144373796|NCT01349049|520578175|FG000|Overall Study|Withdrawal by Subject|0|||
144373797|NCT01349049|520578176|FG001|Overall Study|Withdrawal by Subject|0|||
144373798|NCT01349049|520578177|FG002|Overall Study|Withdrawal by Subject|0|||
144373799|NCT01349049|520578178|FG003|Overall Study|Withdrawal by Subject|0|||
144373800|NCT01349049|520578179|FG004|Overall Study|Withdrawal by Subject|0|||
144373801|NCT01349049|520578180|FG005|Overall Study|Withdrawal by Subject|0|||
144373802|NCT01349049|520578181|FG006|Overall Study|Withdrawal by Subject|0|||
144373803|NCT01349049|520578182|FG007|Overall Study|Withdrawal by Subject|0|||
144373804|NCT01349049|520578183|FG008|Overall Study|Withdrawal by Subject|6|||
144373805|NCT00552188|520578186|FG000|Overall Study|Adverse Event|0|||
144373806|NCT00552188|520578187|FG001|Overall Study|Adverse Event|2|||
144373807|NCT00552188|520578186|FG000|Overall Study|Lost to Follow-up|2|||
144373808|NCT00552188|520578187|FG001|Overall Study|Lost to Follow-up|1|||
144373809|NCT00552188|520578186|FG000|Overall Study|Withdrawal of consent|0|||
144373810|NCT00552188|520578187|FG001|Overall Study|Withdrawal of consent|1|||
144373811|NCT00552188|520578186|FG000|Overall Study|Subject returned to home country|0|||
144373812|NCT00552188|520578187|FG001|Overall Study|Subject returned to home country|1|||
144373813|NCT03887702|520578188|FG000|Overall Study|Study terminated|0|||
144373814|NCT03887702|520578189|FG001|Overall Study|Study terminated|0|||
144373815|NCT03887702|520578190|FG002|Overall Study|Study terminated|2|||
144373816|NCT03887702|520578191|FG003|Overall Study|Study terminated|2|||
144373817|NCT01193257|520578194|FG000|Overall Study|Death|202|||
144373818|NCT01193257|520578195|FG001|Overall Study|Death|391|||
144373819|NCT01193257|520578194|FG000|Overall Study|Study termination by sponsor|0|||
144373820|NCT01193257|520578195|FG001|Overall Study|Study termination by sponsor|3|||
144373821|NCT01193257|520578194|FG000|Overall Study|Withdrawal by Subject|26|||
144373822|NCT01193257|520578195|FG001|Overall Study|Withdrawal by Subject|86|||
144373823|NCT01193257|520578194|FG000|Overall Study|Lost to Follow-up|2|||
144373824|NCT01193257|520578195|FG001|Overall Study|Lost to Follow-up|3|||
144373825|NCT01193257|520578194|FG000|Overall Study|Unblinded due to futility|135|||
144373826|NCT01193257|520578195|FG001|Overall Study|Unblinded due to futility|251|||
144373827|NCT01675544|520578206|FG000|Overall Study|Withdrawal by Subject|2|||
144373828|NCT03544333|520578213|FG000|Overall Study|Withdrawal by Subject|1|||
144373829|NCT03544333|520578214|FG001|Overall Study|Withdrawal by Subject|0|||
144373830|NCT03656562|520578215|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
144373831|NCT03656562|520578216|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
144373832|NCT03656562|520578217|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
144373833|NCT03656562|520578218|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
144373834|NCT03656562|520578215|FG000|Overall Study|Physician Decision|1|||
144373835|NCT03656562|520578216|FG001|Overall Study|Physician Decision|2|||
144373836|NCT03656562|520578217|FG002|Overall Study|Physician Decision|0|||
144373837|NCT03656562|520578218|FG003|Overall Study|Physician Decision|0|||
144373838|NCT03656562|520578215|FG000|Overall Study|Subject Decision|3|||
144373839|NCT03656562|520578216|FG001|Overall Study|Subject Decision|5|||
144373840|NCT03656562|520578217|FG002|Overall Study|Subject Decision|0|||
144373841|NCT03656562|520578218|FG003|Overall Study|Subject Decision|2|||
144373842|NCT02920242|520578219|FG000|Overall Study|Withdrawal by Subject|1|||
144373843|NCT02920242|520578220|FG001|Overall Study|Withdrawal by Subject|0|||
144373844|NCT02920242|520578221|FG002|Overall Study|Withdrawal by Subject|1|||
144373845|NCT02920242|520578219|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
144373846|NCT02920242|520578220|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
144373847|NCT02920242|520578221|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
144373848|NCT00441064|520578222|FG000|Overall Study|Adverse Event|1|||
144373849|NCT00441064|520578223|FG001|Overall Study|Adverse Event|0|||
144373850|NCT00441064|520578222|FG000|Overall Study|Abnormal laboratory values|0|||
144373851|NCT00441064|520578223|FG001|Overall Study|Abnormal laboratory values|2|||
144373852|NCT00441064|520578222|FG000|Overall Study|Abnormal test procedure results|0|||
144373853|NCT00441064|520578223|FG001|Overall Study|Abnormal test procedure results|1|||
144373854|NCT00441064|520578222|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144373855|NCT00441064|520578223|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144373856|NCT00441064|520578222|FG000|Overall Study|Protocol Deviation|3|||
144373857|NCT00441064|520578223|FG001|Overall Study|Protocol Deviation|2|||
144373858|NCT00441064|520578222|FG000|Overall Study|Patient withdrew consent|5|||
144373859|NCT00441064|520578223|FG001|Overall Study|Patient withdrew consent|2|||
144373860|NCT03051178|520578224|FG000|Overall Study|Withdrawal by Subject|5|||
144373861|NCT00953056|520578225|FG000|Overall Study|Withdrew Consent|0|||
144373862|NCT00953056|520578226|FG001|Overall Study|Withdrew Consent|0|||
144373863|NCT00953056|520578227|FG002|Overall Study|Withdrew Consent|0|||
144373864|NCT00953056|520578228|FG003|Overall Study|Withdrew Consent|0|||
144373865|NCT00953056|520578229|FG004|Overall Study|Withdrew Consent|2|||
144373866|NCT00953056|520578230|FG005|Overall Study|Withdrew Consent|3|||
144373867|NCT00953056|520578225|FG000|Overall Study|Serious Adverse Event|0|||
144373868|NCT00953056|520578226|FG001|Overall Study|Serious Adverse Event|0|||
144373869|NCT00953056|520578227|FG002|Overall Study|Serious Adverse Event|0|||
144511401|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
144511402|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
144511403|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
144511404|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
144511405|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
144511406|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
144511407|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
144511408|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
144511409|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
144511410|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
144511411|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
144511412|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
144511413|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
144511414|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
144511415|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
144511416|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
144511417|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
144511418|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
144511419|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
144511420|NCT04043455|521073798|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
144511421|NCT04043455|521073799|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
144511422|NCT04043455|521073800|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
144511423|NCT04043455|521073801|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
144511424|NCT04043455|521073802|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
144511425|NCT04043455|521073803|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
144373870|NCT00953056|520578228|FG003|Overall Study|Serious Adverse Event|0|||
144511426|NCT04043455|521073798|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
144511427|NCT04043455|521073799|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
144373871|NCT00953056|520578229|FG004|Overall Study|Serious Adverse Event|0|||
144373872|NCT00953056|520578230|FG005|Overall Study|Serious Adverse Event|1|||
144373873|NCT03962504|520578231|FG000|Overall Study|Other|11|||
144373874|NCT03962504|520578232|FG001|Overall Study|Other|32|||
144511428|NCT04043455|521073800|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
144511429|NCT04043455|521073801|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
144373875|NCT02813577|520578233|FG000|Overall Study|Study terminated|4|||
144373876|NCT01388335|520578234|FG000|Period 1|Progressive Disease|1|||
144373877|NCT01388335|520578234|FG000|Period 2|Progressive Disease|2|||
144373878|NCT01388335|520578234|FG000|Period 2|Sponsor Decision|1|||
144373879|NCT01388335|520578234|FG000|Safety Extension|Progressive Disease|7|||
144373880|NCT01273519|520578237|FG000|Overall Study|Adverse Event|3|||
144373881|NCT01273519|520578238|FG001|Overall Study|Adverse Event|0|||
144373882|NCT01273519|520578239|FG002|Overall Study|Adverse Event|0|||
144373883|NCT01273519|520578237|FG000|Overall Study|Lost to Follow-up|2|||
144373884|NCT01273519|520578238|FG001|Overall Study|Lost to Follow-up|1|||
144373885|NCT01273519|520578239|FG002|Overall Study|Lost to Follow-up|3|||
144373886|NCT01273519|520578237|FG000|Overall Study|Lack of Efficacy|8|||
144373887|NCT01273519|520578238|FG001|Overall Study|Lack of Efficacy|3|||
144373888|NCT01273519|520578239|FG002|Overall Study|Lack of Efficacy|4|||
144373889|NCT01273519|520578237|FG000|Overall Study|Other|6|||
144373890|NCT01273519|520578238|FG001|Overall Study|Other|1|||
144373891|NCT01273519|520578239|FG002|Overall Study|Other|1|||
144373892|NCT04292899|520578240|FG000|Overall Study|Death|21|||
144373893|NCT04292899|520578241|FG001|Overall Study|Death|28|||
144373894|NCT04292899|520578242|FG002|Overall Study|Death|188|||
144373895|NCT04292899|520578243|FG003|Overall Study|Death|371|||
144373896|NCT04292899|520578240|FG000|Overall Study|Lost to Follow-up|8|||
144373897|NCT04292899|520578241|FG001|Overall Study|Lost to Follow-up|4|||
144373898|NCT04292899|520578242|FG002|Overall Study|Lost to Follow-up|22|||
144373899|NCT04292899|520578243|FG003|Overall Study|Lost to Follow-up|235|||
144373900|NCT04292899|520578240|FG000|Overall Study|Withdrew consent|1|||
144373901|NCT04292899|520578241|FG001|Overall Study|Withdrew consent|0|||
144373902|NCT04292899|520578242|FG002|Overall Study|Withdrew consent|11|||
144373903|NCT04292899|520578243|FG003|Overall Study|Withdrew consent|32|||
144373904|NCT04292899|520578240|FG000|Overall Study|Adverse Event|2|||
144373905|NCT04292899|520578241|FG001|Overall Study|Adverse Event|1|||
144373906|NCT04292899|520578242|FG002|Overall Study|Adverse Event|2|||
144373907|NCT04292899|520578243|FG003|Overall Study|Adverse Event|2|||
144373908|NCT04292899|520578240|FG000|Overall Study|Investigator's Discretion|0|||
144373909|NCT04292899|520578241|FG001|Overall Study|Investigator's Discretion|0|||
144373910|NCT04292899|520578242|FG002|Overall Study|Investigator's Discretion|0|||
144373911|NCT04292899|520578243|FG003|Overall Study|Investigator's Discretion|3|||
144373912|NCT04292899|520578240|FG000|Overall Study|Non-compliance With Study Drug|0|||
144373913|NCT04292899|520578241|FG001|Overall Study|Non-compliance With Study Drug|0|||
144373914|NCT04292899|520578242|FG002|Overall Study|Non-compliance With Study Drug|0|||
144373915|NCT04292899|520578243|FG003|Overall Study|Non-compliance With Study Drug|1|||
144373916|NCT04292899|520578240|FG000|Overall Study|Protocol Violation|0|||
144373917|NCT04292899|520578241|FG001|Overall Study|Protocol Violation|0|||
144373918|NCT04292899|520578242|FG002|Overall Study|Protocol Violation|0|||
144373919|NCT04292899|520578243|FG003|Overall Study|Protocol Violation|1|||
144373920|NCT01032889|520578244|FG000|Overall Study|Adverse Event|2|||
144373921|NCT01032889|520578245|FG001|Overall Study|Adverse Event|2|||
144373922|NCT01032889|520578246|FG002|Overall Study|Adverse Event|0|||
144373923|NCT01032889|520578244|FG000|Overall Study|Withdrawal of Consent|1|||
144373924|NCT01032889|520578245|FG001|Overall Study|Withdrawal of Consent|2|||
144373925|NCT01032889|520578246|FG002|Overall Study|Withdrawal of Consent|1|||
144373926|NCT01032889|520578244|FG000|Overall Study|Patient Request|0|||
144373927|NCT01032889|520578245|FG001|Overall Study|Patient Request|1|||
144373928|NCT01032889|520578246|FG002|Overall Study|Patient Request|0|||
144373929|NCT01032889|520578244|FG000|Overall Study|Lost to Follow-up|1|||
144373930|NCT01032889|520578245|FG001|Overall Study|Lost to Follow-up|1|||
144373931|NCT01032889|520578246|FG002|Overall Study|Lost to Follow-up|0|||
144373932|NCT01032889|520578244|FG000|Overall Study|Lack of Submental Fat|2|||
144373933|NCT01032889|520578245|FG001|Overall Study|Lack of Submental Fat|8|||
144373934|NCT01032889|520578246|FG002|Overall Study|Lack of Submental Fat|1|||
144373935|NCT01032889|520578244|FG000|Overall Study|Miscellaneous Reasons|2|||
144373936|NCT01032889|520578245|FG001|Overall Study|Miscellaneous Reasons|1|||
144373937|NCT01032889|520578246|FG002|Overall Study|Miscellaneous Reasons|1|||
144373938|NCT02541604|520578249|FG000|Overall Study|Death|6|||
144373939|NCT02541604|520578250|FG001|Overall Study|Death|5|||
144373940|NCT02541604|520578251|FG002|Overall Study|Death|7|||
144373941|NCT02541604|520578252|FG003|Overall Study|Death|2|||
144373942|NCT02541604|520578253|FG004|Overall Study|Death|9|||
144373943|NCT02541604|520578254|FG005|Overall Study|Death|8|||
144373944|NCT02541604|520578255|FG006|Overall Study|Death|9|||
144373945|NCT02541604|520578256|FG007|Overall Study|Death|9|||
144373946|NCT02541604|520578257|FG008|Overall Study|Death|3|||
144373947|NCT02541604|520578258|FG009|Overall Study|Death|4|||
144373948|NCT02541604|520578259|FG010|Overall Study|Death|2|||
144373949|NCT02541604|520578260|FG011|Overall Study|Death|3|||
144373950|NCT02541604|520578249|FG000|Overall Study|Lost to Follow-up|2|||
144373951|NCT02541604|520578250|FG001|Overall Study|Lost to Follow-up|0|||
144373952|NCT02541604|520578251|FG002|Overall Study|Lost to Follow-up|1|||
144373953|NCT02541604|520578252|FG003|Overall Study|Lost to Follow-up|0|||
144373954|NCT02541604|520578253|FG004|Overall Study|Lost to Follow-up|0|||
144373955|NCT02541604|520578254|FG005|Overall Study|Lost to Follow-up|1|||
144373956|NCT02541604|520578255|FG006|Overall Study|Lost to Follow-up|1|||
144373957|NCT02541604|520578256|FG007|Overall Study|Lost to Follow-up|0|||
144511430|NCT04043455|521073802|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
144511431|NCT04043455|521073803|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
144511432|NCT04043455|521073798|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
144511433|NCT04043455|521073799|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
144511434|NCT04043455|521073800|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
144511435|NCT04043455|521073801|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
144511436|NCT04043455|521073802|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
144511437|NCT04043455|521073803|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
144511438|NCT04043455|521073798|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
144511439|NCT04043455|521073799|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
144511440|NCT04043455|521073800|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
144511441|NCT04043455|521073801|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
144511442|NCT04043455|521073802|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
144511443|NCT04043455|521073803|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
144511444|NCT04043455|521073798|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
144511445|NCT04043455|521073799|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
144511446|NCT04043455|521073800|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
144511447|NCT04043455|521073801|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
144511448|NCT04043455|521073802|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
144511449|NCT04043455|521073803|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
144511450|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
144511451|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
144511452|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
144511453|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
144511454|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
144511455|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
144511456|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
144511457|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
144511458|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
144511459|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
144511460|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
144511461|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
144511462|NCT01600014|521073806|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
144511463|NCT01600014|521073807|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
144511464|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
144511465|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
144511466|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
144511467|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
144511468|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
144511469|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
144511470|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
144511471|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
144511472|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
144511473|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
144511474|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
144511475|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
144511476|NCT01600014|521073806|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
144511477|NCT01600014|521073807|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
144511478|NCT01600014|521073806|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
144511479|NCT01600014|521073807|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
144511480|NCT01600014|521073806|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
144511481|NCT01600014|521073807|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
144511482|NCT01600014|521073806|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
144511483|NCT01600014|521073807|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
144511484|NCT00296036|521073808|FG000|Overall Study|Withdrawal by Subject|1|||
144511485|NCT00296036|521073809|FG001|Overall Study|Withdrawal by Subject|0|||
144511486|NCT00296036|521073810|FG002|Overall Study|Withdrawal by Subject|2|||
144511487|NCT00296036|521073811|FG003|Overall Study|Withdrawal by Subject|1|||
144511488|NCT00296036|521073812|FG004|Overall Study|Withdrawal by Subject|2|||
144511489|NCT00296036|521073813|FG005|Overall Study|Withdrawal by Subject|1|||
144373958|NCT02541604|520578257|FG008|Overall Study|Lost to Follow-up|0|||
144373959|NCT02541604|520578258|FG009|Overall Study|Lost to Follow-up|0|||
144373960|NCT02541604|520578259|FG010|Overall Study|Lost to Follow-up|0|||
144373961|NCT02541604|520578260|FG011|Overall Study|Lost to Follow-up|0|||
144373962|NCT02541604|520578249|FG000|Overall Study|Withdrawal by Subject|2|||
144511490|NCT00296036|521073808|FG000|Overall Study|Protocol Violation|0|||
144373963|NCT02541604|520578250|FG001|Overall Study|Withdrawal by Subject|0|||
144373964|NCT02541604|520578251|FG002|Overall Study|Withdrawal by Subject|1|||
144373965|NCT02541604|520578252|FG003|Overall Study|Withdrawal by Subject|0|||
144373966|NCT02541604|520578253|FG004|Overall Study|Withdrawal by Subject|1|||
144373967|NCT02541604|520578254|FG005|Overall Study|Withdrawal by Subject|1|||
144373968|NCT02541604|520578255|FG006|Overall Study|Withdrawal by Subject|0|||
144373969|NCT02541604|520578256|FG007|Overall Study|Withdrawal by Subject|0|||
144373970|NCT02541604|520578257|FG008|Overall Study|Withdrawal by Subject|1|||
144373971|NCT02541604|520578258|FG009|Overall Study|Withdrawal by Subject|0|||
144373972|NCT02541604|520578259|FG010|Overall Study|Withdrawal by Subject|0|||
144373973|NCT02541604|520578260|FG011|Overall Study|Withdrawal by Subject|0|||
144373974|NCT02541604|520578249|FG000|Overall Study|Study Terminated by Sponsor|1|||
144373975|NCT02541604|520578250|FG001|Overall Study|Study Terminated by Sponsor|4|||
144373976|NCT02541604|520578251|FG002|Overall Study|Study Terminated by Sponsor|2|||
144373977|NCT02541604|520578252|FG003|Overall Study|Study Terminated by Sponsor|1|||
144373978|NCT02541604|520578253|FG004|Overall Study|Study Terminated by Sponsor|0|||
144373979|NCT02541604|520578254|FG005|Overall Study|Study Terminated by Sponsor|0|||
144373980|NCT02541604|520578255|FG006|Overall Study|Study Terminated by Sponsor|0|||
144373981|NCT02541604|520578256|FG007|Overall Study|Study Terminated by Sponsor|0|||
144373982|NCT02541604|520578257|FG008|Overall Study|Study Terminated by Sponsor|0|||
144373983|NCT02541604|520578258|FG009|Overall Study|Study Terminated by Sponsor|0|||
144373984|NCT02541604|520578259|FG010|Overall Study|Study Terminated by Sponsor|0|||
144373985|NCT02541604|520578260|FG011|Overall Study|Study Terminated by Sponsor|0|||
144373986|NCT02541604|520578249|FG000|Overall Study|Medical condition may jeopardize safety|0|||
144373987|NCT02541604|520578250|FG001|Overall Study|Medical condition may jeopardize safety|0|||
144373988|NCT02541604|520578251|FG002|Overall Study|Medical condition may jeopardize safety|0|||
144373989|NCT02541604|520578252|FG003|Overall Study|Medical condition may jeopardize safety|0|||
144373990|NCT02541604|520578253|FG004|Overall Study|Medical condition may jeopardize safety|0|||
144373991|NCT02541604|520578254|FG005|Overall Study|Medical condition may jeopardize safety|0|||
144373992|NCT02541604|520578255|FG006|Overall Study|Medical condition may jeopardize safety|0|||
144373993|NCT02541604|520578256|FG007|Overall Study|Medical condition may jeopardize safety|1|||
144373994|NCT02541604|520578257|FG008|Overall Study|Medical condition may jeopardize safety|0|||
144373995|NCT02541604|520578258|FG009|Overall Study|Medical condition may jeopardize safety|0|||
144373996|NCT02541604|520578259|FG010|Overall Study|Medical condition may jeopardize safety|0|||
144373997|NCT02541604|520578260|FG011|Overall Study|Medical condition may jeopardize safety|0|||
144373998|NCT00828204|520578261|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
144373999|NCT00828204|520578262|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
144374000|NCT00828204|520578261|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
144374001|NCT00828204|520578262|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
144374002|NCT00828204|520578261|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
144374003|NCT00828204|520578262|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
144374004|NCT00828204|520578261|FG000|Main Study: After Study Restart|Adverse Event|0|||
144374005|NCT00828204|520578262|FG001|Main Study: After Study Restart|Adverse Event|2|||
144374006|NCT00828204|520578261|FG000|Main Study: After Study Restart|Noncompliance|0|||
144374007|NCT00828204|520578262|FG001|Main Study: After Study Restart|Noncompliance|1|||
144374008|NCT00828204|520578261|FG000|Extension Study|Lost to Follow-up|0|||
144374009|NCT00828204|520578262|FG001|Extension Study|Lost to Follow-up|1|||
144374010|NCT00828204|520578261|FG000|Extension Study|Physician Decision|0|||
144374011|NCT00828204|520578262|FG001|Extension Study|Physician Decision|2|||
144374012|NCT01737502|520578265|FG000|Phase I|Disease progression|2|||
144374013|NCT01737502|520578266|FG001|Phase I|Disease progression|3|||
144374014|NCT01737502|520578265|FG000|Phase I|Complicating disease|1|||
144374015|NCT01737502|520578266|FG001|Phase I|Complicating disease|0|||
144374016|NCT01737502|520578265|FG000|Phase II|Adverse Event|0|||
144374017|NCT01737502|520578266|FG001|Phase II|Adverse Event|3|||
144374018|NCT01737502|520578265|FG000|Phase II|Disease progression|0|||
144374019|NCT01737502|520578266|FG001|Phase II|Disease progression|18|||
144374020|NCT01737502|520578265|FG000|Phase II|Death|0|||
144374021|NCT01737502|520578266|FG001|Phase II|Death|1|||
144374022|NCT01737502|520578265|FG000|Phase II|Transition to hospice care|0|||
144374023|NCT01737502|520578266|FG001|Phase II|Transition to hospice care|1|||
144374024|NCT05064358|520578268|FG000|Overall Study|Death|23|||
144374025|NCT05064358|520578269|FG001|Overall Study|Death|23|||
144374026|NCT05064358|520578270|FG002|Overall Study|Death|25|||
144374027|NCT05064358|520578271|FG003|Overall Study|Death|21|||
144374028|NCT05064358|520578272|FG004|Overall Study|Death|5|||
144374029|NCT05064358|520578268|FG000|Overall Study|Lost to Follow-up|1|||
144374030|NCT05064358|520578269|FG001|Overall Study|Lost to Follow-up|2|||
144374031|NCT05064358|520578270|FG002|Overall Study|Lost to Follow-up|0|||
144374032|NCT05064358|520578271|FG003|Overall Study|Lost to Follow-up|2|||
144374033|NCT05064358|520578272|FG004|Overall Study|Lost to Follow-up|0|||
144374034|NCT05064358|520578268|FG000|Overall Study|Physician Decision|1|||
144374035|NCT05064358|520578269|FG001|Overall Study|Physician Decision|1|||
144374036|NCT05064358|520578270|FG002|Overall Study|Physician Decision|2|||
144374037|NCT05064358|520578271|FG003|Overall Study|Physician Decision|0|||
144374038|NCT05064358|520578272|FG004|Overall Study|Physician Decision|0|||
144374039|NCT05064358|520578268|FG000|Overall Study|Withdrawal by Subject|4|||
144374040|NCT05064358|520578269|FG001|Overall Study|Withdrawal by Subject|5|||
144374041|NCT05064358|520578270|FG002|Overall Study|Withdrawal by Subject|3|||
144374042|NCT05064358|520578271|FG003|Overall Study|Withdrawal by Subject|6|||
144374043|NCT05064358|520578272|FG004|Overall Study|Withdrawal by Subject|3|||
144374044|NCT05064358|520578268|FG000|Overall Study|Ongoing at the time of analysis|1|||
144374045|NCT05064358|520578269|FG001|Overall Study|Ongoing at the time of analysis|2|||
144374046|NCT05064358|520578270|FG002|Overall Study|Ongoing at the time of analysis|2|||
144374047|NCT05064358|520578271|FG003|Overall Study|Ongoing at the time of analysis|2|||
144374048|NCT05064358|520578272|FG004|Overall Study|Ongoing at the time of analysis|2|||
144374049|NCT01287741|520578273|FG000|Overall Study|Withdrawal by Subject|35|||
144374050|NCT01287741|520578274|FG001|Overall Study|Withdrawal by Subject|38|||
144374051|NCT01287741|520578273|FG000|Overall Study|Protocol Violation|2|||
144374052|NCT01287741|520578274|FG001|Overall Study|Protocol Violation|0|||
144374053|NCT01287741|520578273|FG000|Overall Study|Physician Decision|15|||
144374054|NCT01287741|520578274|FG001|Overall Study|Physician Decision|23|||
144374055|NCT01287741|520578273|FG000|Overall Study|Non-compliance|8|||
144374056|NCT01287741|520578274|FG001|Overall Study|Non-compliance|6|||
144374057|NCT01287741|520578273|FG000|Overall Study|Lost to Follow-up|10|||
144374058|NCT01287741|520578274|FG001|Overall Study|Lost to Follow-up|8|||
144374059|NCT01287741|520578273|FG000|Overall Study|Death|32|||
144374060|NCT01287741|520578274|FG001|Overall Study|Death|44|||
144374061|NCT01287741|520578273|FG000|Overall Study|Adverse Event|4|||
144374062|NCT01287741|520578274|FG001|Overall Study|Adverse Event|6|||
144374063|NCT01287741|520578273|FG000|Overall Study|Study terminated by Sponsor|307|||
144374064|NCT01287741|520578274|FG001|Overall Study|Study terminated by Sponsor|315|||
144374065|NCT01287741|520578273|FG000|Overall Study|Progressive disease|190|||
144374066|NCT01287741|520578274|FG001|Overall Study|Progressive disease|166|||
144374067|NCT01287741|520578273|FG000|Overall Study|Reason not specified|23|||
144374068|NCT01287741|520578274|FG001|Overall Study|Reason not specified|9|||
144374069|NCT04421027|520578275|FG000|Treatment Period|Adverse Event|5|||
144374070|NCT04421027|520578276|FG001|Treatment Period|Adverse Event|3|||
144374071|NCT04421027|520578277|FG002|Treatment Period|Adverse Event|0|||
144374072|NCT04421027|520578278|FG003|Treatment Period|Adverse Event|0|||
144374073|NCT04421027|520578275|FG000|Treatment Period|Death|98|||
144374074|NCT04421027|520578276|FG001|Treatment Period|Death|61|||
144374075|NCT04421027|520578277|FG002|Treatment Period|Death|0|||
144374076|NCT04421027|520578278|FG003|Treatment Period|Death|0|||
144374077|NCT04421027|520578275|FG000|Treatment Period|Lost to Follow-up|22|||
144374078|NCT04421027|520578276|FG001|Treatment Period|Lost to Follow-up|20|||
144374079|NCT04421027|520578277|FG002|Treatment Period|Lost to Follow-up|0|||
144374080|NCT04421027|520578278|FG003|Treatment Period|Lost to Follow-up|0|||
144374081|NCT04421027|520578275|FG000|Treatment Period|Other-Unknown|15|||
144374082|NCT04421027|520578276|FG001|Treatment Period|Other-Unknown|9|||
144374083|NCT04421027|520578277|FG002|Treatment Period|Other-Unknown|0|||
144374084|NCT04421027|520578278|FG003|Treatment Period|Other-Unknown|0|||
144374085|NCT04421027|520578275|FG000|Treatment Period|Physician Decision|1|||
144374086|NCT04421027|520578276|FG001|Treatment Period|Physician Decision|1|||
144374087|NCT04421027|520578277|FG002|Treatment Period|Physician Decision|0|||
144374088|NCT04421027|520578278|FG003|Treatment Period|Physician Decision|0|||
144374089|NCT04421027|520578275|FG000|Treatment Period|Withdrawal by Subject|7|||
144374090|NCT04421027|520578276|FG001|Treatment Period|Withdrawal by Subject|12|||
144374091|NCT04421027|520578277|FG002|Treatment Period|Withdrawal by Subject|0|||
144374092|NCT04421027|520578278|FG003|Treatment Period|Withdrawal by Subject|0|||
144374093|NCT04421027|520578275|FG000|Treatment Period|Randomized Not Dosed|9|||
144374094|NCT04421027|520578276|FG001|Treatment Period|Randomized Not Dosed|14|||
144374095|NCT04421027|520578277|FG002|Treatment Period|Randomized Not Dosed|0|||
144374096|NCT04421027|520578278|FG003|Treatment Period|Randomized Not Dosed|0|||
144374097|NCT04421027|520578275|FG000|Follow-Up Period|Adverse Event|0|||
144374098|NCT04421027|520578276|FG001|Follow-Up Period|Adverse Event|0|||
144374099|NCT04421027|520578277|FG002|Follow-Up Period|Adverse Event|0|||
144374100|NCT04421027|520578278|FG003|Follow-Up Period|Adverse Event|3|||
144374101|NCT04421027|520578275|FG000|Follow-Up Period|Death|0|||
144374102|NCT04421027|520578276|FG001|Follow-Up Period|Death|0|||
144374103|NCT04421027|520578277|FG002|Follow-Up Period|Death|16|||
144374104|NCT04421027|520578278|FG003|Follow-Up Period|Death|17|||
144374105|NCT04421027|520578275|FG000|Follow-Up Period|Lost to Follow-up|0|||
144374106|NCT04421027|520578276|FG001|Follow-Up Period|Lost to Follow-up|0|||
144374107|NCT04421027|520578277|FG002|Follow-Up Period|Lost to Follow-up|7|||
144374108|NCT04421027|520578278|FG003|Follow-Up Period|Lost to Follow-up|7|||
144374109|NCT04421027|520578275|FG000|Follow-Up Period|Protocol Deviation|0|||
144374110|NCT04421027|520578276|FG001|Follow-Up Period|Protocol Deviation|0|||
144374111|NCT04421027|520578277|FG002|Follow-Up Period|Protocol Deviation|1|||
144374112|NCT04421027|520578278|FG003|Follow-Up Period|Protocol Deviation|0|||
144374113|NCT04421027|520578275|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
144374114|NCT04421027|520578276|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
144511491|NCT00296036|521073809|FG001|Overall Study|Protocol Violation|0|||
144374115|NCT04421027|520578277|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
144374116|NCT04421027|520578278|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
144374117|NCT04421027|520578275|FG000|Follow-Up Period|Left message, participant did not call back|0|||
144374118|NCT04421027|520578276|FG001|Follow-Up Period|Left message, participant did not call back|0|||
144374119|NCT04421027|520578277|FG002|Follow-Up Period|Left message, participant did not call back|0|||
144374120|NCT04421027|520578278|FG003|Follow-Up Period|Left message, participant did not call back|1|||
144374121|NCT04421027|520578275|FG000|Follow-Up Period|Participant died|0|||
144374122|NCT04421027|520578276|FG001|Follow-Up Period|Participant died|0|||
144374123|NCT04421027|520578277|FG002|Follow-Up Period|Participant died|0|||
144374124|NCT04421027|520578278|FG003|Follow-Up Period|Participant died|1|||
144374125|NCT04421027|520578275|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
144374126|NCT04421027|520578276|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
144374127|NCT04421027|520578277|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
144374128|NCT04421027|520578278|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
144374129|NCT02003924|520578293|FG000|Double-blind Phase|Lost to Follow-up|2|||
144374130|NCT02003924|520578294|FG001|Double-blind Phase|Lost to Follow-up|1|||
144374131|NCT02003924|520578295|FG002|Double-blind Phase|Lost to Follow-up|0|||
144374132|NCT02003924|520578293|FG000|Double-blind Phase|Protocol Violation|1|||
144374133|NCT02003924|520578294|FG001|Double-blind Phase|Protocol Violation|2|||
144374134|NCT02003924|520578295|FG002|Double-blind Phase|Protocol Violation|0|||
144374135|NCT02003924|520578293|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
144374136|NCT02003924|520578294|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
144374137|NCT02003924|520578295|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
144374138|NCT02003924|520578293|FG000|Double-blind Phase|Disease Progression|229|||
144374139|NCT02003924|520578294|FG001|Double-blind Phase|Disease Progression|247|||
144374140|NCT02003924|520578295|FG002|Double-blind Phase|Disease Progression|0|||
144374141|NCT02003924|520578293|FG000|Double-blind Phase|Adverse Event|120|||
144374142|NCT02003924|520578294|FG001|Double-blind Phase|Adverse Event|31|||
144374143|NCT02003924|520578295|FG002|Double-blind Phase|Adverse Event|0|||
144374144|NCT02003924|520578293|FG000|Double-blind Phase|Randomized But not Treated|3|||
144374145|NCT02003924|520578294|FG001|Double-blind Phase|Randomized But not Treated|3|||
144374146|NCT02003924|520578295|FG002|Double-blind Phase|Randomized But not Treated|0|||
144374147|NCT02003924|520578293|FG000|Double-blind Phase|Other|29|||
144374148|NCT02003924|520578294|FG001|Double-blind Phase|Other|50|||
144374149|NCT02003924|520578295|FG002|Double-blind Phase|Other|0|||
144374150|NCT02003924|520578293|FG000|Open-label Phase|Lost to Follow-up|0|||
144374151|NCT02003924|520578294|FG001|Open-label Phase|Lost to Follow-up|0|||
144374152|NCT02003924|520578295|FG002|Open-label Phase|Lost to Follow-up|1|||
144374153|NCT02003924|520578293|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
144374154|NCT02003924|520578294|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
144374155|NCT02003924|520578295|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
144374156|NCT02003924|520578293|FG000|Open-label Phase|Disease Progression|59|||
144374157|NCT02003924|520578294|FG001|Open-label Phase|Disease Progression|0|||
144374158|NCT02003924|520578295|FG002|Open-label Phase|Disease Progression|5|||
144374159|NCT02003924|520578293|FG000|Open-label Phase|Adverse Event|25|||
144374160|NCT02003924|520578294|FG001|Open-label Phase|Adverse Event|0|||
144374161|NCT02003924|520578295|FG002|Open-label Phase|Adverse Event|10|||
144374162|NCT02003924|520578293|FG000|Open-label Phase|Other|7|||
144374163|NCT02003924|520578294|FG001|Open-label Phase|Other|0|||
144374164|NCT02003924|520578295|FG002|Open-label Phase|Other|0|||
144374165|NCT02003924|520578293|FG000|Long-term Follow-up Phase|Death|288|||
144374166|NCT02003924|520578294|FG001|Long-term Follow-up Phase|Death|174|||
144374167|NCT02003924|520578295|FG002|Long-term Follow-up Phase|Death|4|||
144374168|NCT02003924|520578293|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
144374169|NCT02003924|520578294|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
144374170|NCT02003924|520578295|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
144374171|NCT02003924|520578293|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
144374172|NCT02003924|520578294|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
144374173|NCT02003924|520578295|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
144374174|NCT02003924|520578293|FG000|Long-term Follow-up Phase|Other|5|||
144374175|NCT02003924|520578294|FG001|Long-term Follow-up Phase|Other|2|||
144374176|NCT02003924|520578295|FG002|Long-term Follow-up Phase|Other|1|||
144374177|NCT00560352|520578298|FG000|Overall Study|Adverse event unrelated to study drug|2|||
144374178|NCT00560352|520578299|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144374179|NCT00560352|520578300|FG002|Overall Study|Adverse event unrelated to study drug|1|||
144374180|NCT00560352|520578298|FG000|Overall Study|Study drug toxicity|3|||
144374181|NCT00560352|520578299|FG001|Overall Study|Study drug toxicity|0|||
144374182|NCT00560352|520578300|FG002|Overall Study|Study drug toxicity|1|||
144374183|NCT00560352|520578298|FG000|Overall Study|Disease progression|0|||
144374184|NCT00560352|520578299|FG001|Overall Study|Disease progression|1|||
144511492|NCT00296036|521073810|FG002|Overall Study|Protocol Violation|0|||
144511493|NCT00296036|521073811|FG003|Overall Study|Protocol Violation|0|||
144511494|NCT00296036|521073812|FG004|Overall Study|Protocol Violation|0|||
144374185|NCT00560352|520578300|FG002|Overall Study|Disease progression|1|||
144374186|NCT00560352|520578298|FG000|Overall Study|Withdrawal by Subject|1|||
144374187|NCT00560352|520578299|FG001|Overall Study|Withdrawal by Subject|1|||
144374188|NCT00560352|520578300|FG002|Overall Study|Withdrawal by Subject|1|||
144374189|NCT00560352|520578298|FG000|Overall Study|Maximum clinical benefit|1|||
144374190|NCT00560352|520578299|FG001|Overall Study|Maximum clinical benefit|0|||
144374191|NCT00560352|520578300|FG002|Overall Study|Maximum clinical benefit|0|||
144374192|NCT00114517|520578304|FG000|Overall Study|Adverse Event|6|||
144374193|NCT00114517|520578305|FG001|Overall Study|Adverse Event|1|||
144374194|NCT00114517|520578306|FG002|Overall Study|Adverse Event|6|||
144374195|NCT00114517|520578307|FG003|Overall Study|Adverse Event|3|||
144374196|NCT00114517|520578304|FG000|Overall Study|Lost to Follow-up|2|||
144374197|NCT00114517|520578305|FG001|Overall Study|Lost to Follow-up|2|||
144374198|NCT00114517|520578306|FG002|Overall Study|Lost to Follow-up|2|||
144374199|NCT00114517|520578307|FG003|Overall Study|Lost to Follow-up|1|||
144374200|NCT00114517|520578304|FG000|Overall Study|Too busy|3|||
144374201|NCT00114517|520578305|FG001|Overall Study|Too busy|1|||
144374202|NCT00114517|520578306|FG002|Overall Study|Too busy|1|||
144374203|NCT00114517|520578307|FG003|Overall Study|Too busy|2|||
144374204|NCT00114517|520578304|FG000|Overall Study|Moved from area|0|||
144374205|NCT00114517|520578305|FG001|Overall Study|Moved from area|3|||
144374206|NCT00114517|520578306|FG002|Overall Study|Moved from area|2|||
144374207|NCT00114517|520578307|FG003|Overall Study|Moved from area|1|||
144374208|NCT00114517|520578304|FG000|Overall Study|Did not want estradiol|1|||
144374209|NCT00114517|520578305|FG001|Overall Study|Did not want estradiol|1|||
144374210|NCT00114517|520578306|FG002|Overall Study|Did not want estradiol|0|||
144374211|NCT00114517|520578307|FG003|Overall Study|Did not want estradiol|0|||
144374212|NCT00114517|520578304|FG000|Overall Study|Armed-services duty|0|||
144374213|NCT00114517|520578305|FG001|Overall Study|Armed-services duty|1|||
144374214|NCT00114517|520578306|FG002|Overall Study|Armed-services duty|0|||
144374215|NCT00114517|520578307|FG003|Overall Study|Armed-services duty|1|||
144374216|NCT00114517|520578304|FG000|Overall Study|Competing family issue|0|||
144374217|NCT00114517|520578305|FG001|Overall Study|Competing family issue|1|||
144374218|NCT00114517|520578306|FG002|Overall Study|Competing family issue|0|||
144374219|NCT00114517|520578307|FG003|Overall Study|Competing family issue|1|||
144374220|NCT00114517|520578304|FG000|Overall Study|Physician Decision|0|||
144374221|NCT00114517|520578305|FG001|Overall Study|Physician Decision|1|||
144374222|NCT00114517|520578306|FG002|Overall Study|Physician Decision|0|||
144374223|NCT00114517|520578307|FG003|Overall Study|Physician Decision|0|||
144374224|NCT00114517|520578304|FG000|Overall Study|Lost interest|0|||
144374225|NCT00114517|520578305|FG001|Overall Study|Lost interest|0|||
144374226|NCT00114517|520578306|FG002|Overall Study|Lost interest|1|||
144374227|NCT00114517|520578307|FG003|Overall Study|Lost interest|0|||
144374228|NCT00114517|520578304|FG000|Overall Study|Weight increase|0|||
144374229|NCT00114517|520578305|FG001|Overall Study|Weight increase|0|||
144374230|NCT00114517|520578306|FG002|Overall Study|Weight increase|1|||
144374231|NCT00114517|520578307|FG003|Overall Study|Weight increase|0|||
144374232|NCT00114517|520578304|FG000|Overall Study|Concern about blood clots|0|||
144374233|NCT00114517|520578305|FG001|Overall Study|Concern about blood clots|0|||
144374234|NCT00114517|520578306|FG002|Overall Study|Concern about blood clots|1|||
144374235|NCT00114517|520578307|FG003|Overall Study|Concern about blood clots|0|||
144374236|NCT00114517|520578304|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
144374237|NCT00114517|520578305|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
144374238|NCT00114517|520578306|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
144374239|NCT00114517|520578307|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
144374240|NCT03083873|520579784|FG000|Overall Study|Death|6|||
144374241|NCT03083873|520579785|FG001|Overall Study|Death|15|||
144374242|NCT03083873|520579786|FG002|Overall Study|Death|13|||
144374243|NCT03083873|520579787|FG003|Overall Study|Death|9|||
144374244|NCT03083873|520579788|FG004|Overall Study|Death|0|||
144374245|NCT03083873|520579784|FG000|Overall Study|Sponsor Terminated Study|0|||
144374246|NCT03083873|520579785|FG001|Overall Study|Sponsor Terminated Study|1|||
144374247|NCT03083873|520579786|FG002|Overall Study|Sponsor Terminated Study|2|||
144374248|NCT03083873|520579787|FG003|Overall Study|Sponsor Terminated Study|3|||
144374249|NCT03083873|520579788|FG004|Overall Study|Sponsor Terminated Study|0|||
144374250|NCT03083873|520579784|FG000|Overall Study|Lost to Follow-up|0|||
144511495|NCT00296036|521073813|FG005|Overall Study|Protocol Violation|3|||
144374251|NCT03083873|520579785|FG001|Overall Study|Lost to Follow-up|1|||
144374252|NCT03083873|520579786|FG002|Overall Study|Lost to Follow-up|1|||
144374253|NCT03083873|520579787|FG003|Overall Study|Lost to Follow-up|0|||
144374254|NCT03083873|520579788|FG004|Overall Study|Lost to Follow-up|0|||
144374255|NCT03083873|520579784|FG000|Overall Study|Withdrawal by Subject|2|||
144374256|NCT03083873|520579785|FG001|Overall Study|Withdrawal by Subject|0|||
144374257|NCT03083873|520579786|FG002|Overall Study|Withdrawal by Subject|0|||
144374258|NCT03083873|520579787|FG003|Overall Study|Withdrawal by Subject|0|||
144374259|NCT03083873|520579788|FG004|Overall Study|Withdrawal by Subject|0|||
144374260|NCT03083873|520579784|FG000|Overall Study|Did Not Receive TIL|2|||
144374261|NCT03083873|520579785|FG001|Overall Study|Did Not Receive TIL|5|||
144374262|NCT03083873|520579786|FG002|Overall Study|Did Not Receive TIL|3|||
144374263|NCT03083873|520579787|FG003|Overall Study|Did Not Receive TIL|1|||
144374264|NCT03083873|520579788|FG004|Overall Study|Did Not Receive TIL|0|||
144374265|NCT01677377|520579789|FG000|Overall Study|Protocol Violation|1|||
144374266|NCT01677377|520579790|FG001|Overall Study|Protocol Violation|0|||
144374267|NCT01677377|520579791|FG002|Overall Study|Protocol Violation|0|||
144374268|NCT01677377|520579789|FG000|Overall Study|Lost to Follow-up|0|||
144374269|NCT01677377|520579790|FG001|Overall Study|Lost to Follow-up|1|||
144374270|NCT01677377|520579791|FG002|Overall Study|Lost to Follow-up|1|||
144374271|NCT01677377|520579789|FG000|Overall Study|Withdrawal by Subject|0|||
144374272|NCT01677377|520579790|FG001|Overall Study|Withdrawal by Subject|0|||
144374273|NCT01677377|520579791|FG002|Overall Study|Withdrawal by Subject|3|||
144374274|NCT01677377|520579789|FG000|Overall Study|Lack of Efficacy|0|||
144374275|NCT01677377|520579790|FG001|Overall Study|Lack of Efficacy|0|||
144374276|NCT01677377|520579791|FG002|Overall Study|Lack of Efficacy|1|||
144374277|NCT01677377|520579789|FG000|Overall Study|Pregnancy|0|||
144374278|NCT01677377|520579790|FG001|Overall Study|Pregnancy|0|||
144374279|NCT01677377|520579791|FG002|Overall Study|Pregnancy|1|||
144374280|NCT00479687|520579792|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
144374281|NCT00479687|520579793|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
144374282|NCT00479687|520579794|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
144374283|NCT00479687|520579792|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
144374284|NCT00479687|520579793|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
144374285|NCT00479687|520579794|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
144374286|NCT00479687|520579792|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
144374287|NCT00479687|520579793|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
144374288|NCT00479687|520579794|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
144374289|NCT00479687|520579792|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
144374290|NCT00479687|520579793|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
144374291|NCT00479687|520579794|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
144374292|NCT00479687|520579792|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
144374293|NCT00479687|520579793|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
144374294|NCT00479687|520579794|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
144374295|NCT00479687|520579792|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
144374296|NCT00479687|520579793|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
144374297|NCT00479687|520579794|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
144374298|NCT00479687|520579792|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
144374299|NCT00479687|520579793|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
144374300|NCT00479687|520579794|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
144374301|NCT00479687|520579792|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
144374302|NCT00479687|520579793|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
144374303|NCT00479687|520579794|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
144374304|NCT00479687|520579792|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
144374305|NCT00479687|520579793|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
144374306|NCT00479687|520579794|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
144374307|NCT00295880|520579795|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
144374308|NCT00295880|520579795|FG000|Overall Study|Unit randomization did not occur|1|||
144374309|NCT01474239|520579796|FG000|Overall Study|Disease Progression|37|||
144374310|NCT01474239|520579797|FG001|Overall Study|Disease Progression|25|||
144374311|NCT01474239|520579796|FG000|Overall Study|Adverse Event|12|||
144374312|NCT01474239|520579797|FG001|Overall Study|Adverse Event|3|||
144374313|NCT01474239|520579796|FG000|Overall Study|Withdrawal by Subject|1|||
144374314|NCT01474239|520579797|FG001|Overall Study|Withdrawal by Subject|2|||
144374315|NCT01474239|520579796|FG000|Overall Study|Death|1|||
144374316|NCT01474239|520579797|FG001|Overall Study|Death|1|||
144374317|NCT01474239|520579796|FG000|Overall Study|Clinical Disease Progression|7|||
144374318|NCT01474239|520579797|FG001|Overall Study|Clinical Disease Progression|1|||
144374319|NCT01474239|520579796|FG000|Overall Study|Withdrawal for Economic Reason|1|||
144374320|NCT01474239|520579797|FG001|Overall Study|Withdrawal for Economic Reason|0|||
144374321|NCT02260180|520579801|FG000|Overall Study|Adverse Event|2|||
144374322|NCT02260180|520579802|FG001|Overall Study|Adverse Event|0|||
144374323|NCT02260180|520579803|FG002|Overall Study|Adverse Event|1|||
144374324|NCT03126344|520579810|FG000|Overall Study|Lost to Follow-up|0|||
144374325|NCT03126344|520579811|FG001|Overall Study|Lost to Follow-up|0|||
144374326|NCT03126344|520579812|FG002|Overall Study|Lost to Follow-up|5|||
144374327|NCT01027273|520579813|FG000|Overall Study|Lost to Follow-up|57|||
144374328|NCT01027273|520579814|FG001|Overall Study|Lost to Follow-up|31|||
144374329|NCT01027273|520579813|FG000|Overall Study|Death|2|||
144374330|NCT01027273|520579814|FG001|Overall Study|Death|2|||
144374331|NCT03790696|520579816|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
144374332|NCT03790696|520579817|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
144374333|NCT01330108|520579820|FG000|Overall Study|Withdrawal by Subject|4|||
144374334|NCT00485134|520579825|FG000|Overall Study|Lost to Follow-up|1|||
144374335|NCT00485134|520579826|FG001|Overall Study|Lost to Follow-up|0|||
144374336|NCT00485134|520579827|FG002|Overall Study|Lost to Follow-up|0|||
144374337|NCT00485134|520579828|FG003|Overall Study|Lost to Follow-up|0|||
144374338|NCT00485134|520579829|FG004|Overall Study|Lost to Follow-up|0|||
144374339|NCT00485134|520579830|FG005|Overall Study|Lost to Follow-up|0|||
144374340|NCT00485134|520579831|FG006|Overall Study|Lost to Follow-up|0|||
144374341|NCT00485134|520579832|FG007|Overall Study|Lost to Follow-up|0|||
144374342|NCT00485134|520579825|FG000|Overall Study|Withdrawal by Subject|0|||
144374343|NCT00485134|520579826|FG001|Overall Study|Withdrawal by Subject|1|||
144374344|NCT00485134|520579827|FG002|Overall Study|Withdrawal by Subject|0|||
144374345|NCT00485134|520579828|FG003|Overall Study|Withdrawal by Subject|0|||
144374346|NCT00485134|520579829|FG004|Overall Study|Withdrawal by Subject|0|||
144374347|NCT00485134|520579830|FG005|Overall Study|Withdrawal by Subject|0|||
144374348|NCT00485134|520579831|FG006|Overall Study|Withdrawal by Subject|0|||
144374349|NCT00485134|520579832|FG007|Overall Study|Withdrawal by Subject|0|||
144374350|NCT00485134|520579825|FG000|Overall Study|Change in health status|0|||
144374351|NCT00485134|520579826|FG001|Overall Study|Change in health status|1|||
144374352|NCT00485134|520579827|FG002|Overall Study|Change in health status|2|||
144374353|NCT00485134|520579828|FG003|Overall Study|Change in health status|1|||
144374354|NCT00485134|520579829|FG004|Overall Study|Change in health status|0|||
144374355|NCT00485134|520579830|FG005|Overall Study|Change in health status|1|||
144374356|NCT00485134|520579831|FG006|Overall Study|Change in health status|0|||
144374357|NCT00485134|520579832|FG007|Overall Study|Change in health status|0|||
144374358|NCT00485134|520579825|FG000|Overall Study|Withdrew for adverse event|0|||
144374359|NCT00485134|520579826|FG001|Overall Study|Withdrew for adverse event|0|||
144374360|NCT00485134|520579827|FG002|Overall Study|Withdrew for adverse event|1|||
144374361|NCT00485134|520579828|FG003|Overall Study|Withdrew for adverse event|0|||
144374362|NCT00485134|520579829|FG004|Overall Study|Withdrew for adverse event|0|||
144374363|NCT00485134|520579830|FG005|Overall Study|Withdrew for adverse event|0|||
144374364|NCT00485134|520579831|FG006|Overall Study|Withdrew for adverse event|0|||
144374365|NCT00485134|520579832|FG007|Overall Study|Withdrew for adverse event|0|||
144374366|NCT00485134|520579825|FG000|Overall Study|Positive drug test|0|||
144374367|NCT00485134|520579826|FG001|Overall Study|Positive drug test|0|||
144374368|NCT00485134|520579827|FG002|Overall Study|Positive drug test|0|||
144374369|NCT00485134|520579828|FG003|Overall Study|Positive drug test|0|||
144374370|NCT00485134|520579829|FG004|Overall Study|Positive drug test|2|||
144374371|NCT00485134|520579830|FG005|Overall Study|Positive drug test|1|||
144374372|NCT00485134|520579831|FG006|Overall Study|Positive drug test|0|||
144374373|NCT00485134|520579832|FG007|Overall Study|Positive drug test|0|||
144374374|NCT00485134|520579825|FG000|Overall Study|Non-compliance|0|||
144374375|NCT00485134|520579826|FG001|Overall Study|Non-compliance|0|||
144374376|NCT00485134|520579827|FG002|Overall Study|Non-compliance|0|||
144374377|NCT00485134|520579828|FG003|Overall Study|Non-compliance|0|||
144374378|NCT00485134|520579829|FG004|Overall Study|Non-compliance|1|||
144374379|NCT00485134|520579830|FG005|Overall Study|Non-compliance|2|||
144374380|NCT00485134|520579831|FG006|Overall Study|Non-compliance|2|||
144374381|NCT00485134|520579832|FG007|Overall Study|Non-compliance|0|||
144374382|NCT00485134|520579825|FG000|Overall Study|Unable to comply with study schedule|0|||
144374383|NCT00485134|520579826|FG001|Overall Study|Unable to comply with study schedule|0|||
144374384|NCT00485134|520579827|FG002|Overall Study|Unable to comply with study schedule|0|||
144374385|NCT00485134|520579828|FG003|Overall Study|Unable to comply with study schedule|0|||
144374386|NCT00485134|520579829|FG004|Overall Study|Unable to comply with study schedule|0|||
144374387|NCT00485134|520579830|FG005|Overall Study|Unable to comply with study schedule|0|||
144374388|NCT00485134|520579831|FG006|Overall Study|Unable to comply with study schedule|0|||
144374389|NCT00485134|520579832|FG007|Overall Study|Unable to comply with study schedule|1|||
144374390|NCT00485134|520579825|FG000|Overall Study|Pregnancy|0|||
144374391|NCT00485134|520579826|FG001|Overall Study|Pregnancy|0|||
144374392|NCT00485134|520579827|FG002|Overall Study|Pregnancy|0|||
144374393|NCT00485134|520579828|FG003|Overall Study|Pregnancy|0|||
144374394|NCT00485134|520579829|FG004|Overall Study|Pregnancy|0|||
144511496|NCT03403413|521073814|FG000|Overall Study|Lack of Efficacy|2|||
144511497|NCT03655262|521073815|FG000|Overall Study|Withdrawal by Subject|0|||
144374395|NCT00485134|520579830|FG005|Overall Study|Pregnancy|0|||
144374396|NCT00485134|520579831|FG006|Overall Study|Pregnancy|1|||
144374397|NCT00485134|520579832|FG007|Overall Study|Pregnancy|0|||
144374398|NCT00970684|520579833|FG000|Overall Study|Lack of Efficacy|5|||
144374399|NCT00970684|520579833|FG000|Overall Study|Adverse Event|4|||
144374400|NCT00970684|520579833|FG000|Overall Study|Withdrawal by Subject|1|||
144374401|NCT04294680|520579834|FG000|Overall Study|Withdrawal by Subject|2|||
144374402|NCT04294680|520579835|FG001|Overall Study|Withdrawal by Subject|1|||
144374403|NCT04294680|520579834|FG000|Overall Study|Follow-up visits completed outside of window|1|||
144374404|NCT04294680|520579835|FG001|Overall Study|Follow-up visits completed outside of window|0|||
144374405|NCT00475306|520579836|FG000|Overall Study|Protocol Violation|1|||
144374406|NCT00475306|520579837|FG001|Overall Study|Protocol Violation|1|||
144374407|NCT00475306|520579838|FG002|Overall Study|Protocol Violation|0|||
144511498|NCT03655262|521073816|FG001|Overall Study|Withdrawal by Subject|0|||
144511499|NCT03655262|521073817|FG002|Overall Study|Withdrawal by Subject|1|||
144511500|NCT05052996|521073821|FG000|Overall Study|Still on study|0|||
144511501|NCT05052996|521073822|FG001|Overall Study|Still on study|0|||
144511502|NCT05052996|521073823|FG002|Overall Study|Still on study|47|||
144511503|NCT05052996|521073824|FG003|Overall Study|Still on study|44|||
144511504|NCT05052996|521073821|FG000|Overall Study|Cohort terminated by sponsor|21|||
144511505|NCT05052996|521073822|FG001|Overall Study|Cohort terminated by sponsor|12|||
144511506|NCT05052996|521073823|FG002|Overall Study|Cohort terminated by sponsor|0|||
144511507|NCT05052996|521073824|FG003|Overall Study|Cohort terminated by sponsor|0|||
144511508|NCT05052996|521073821|FG000|Overall Study|Withdrew consent|1|||
144511509|NCT05052996|521073822|FG001|Overall Study|Withdrew consent|0|||
144511510|NCT05052996|521073823|FG002|Overall Study|Withdrew consent|1|||
144511511|NCT05052996|521073824|FG003|Overall Study|Withdrew consent|2|||
144511512|NCT05052996|521073821|FG000|Overall Study|Lost to Follow-up|1|||
144511513|NCT05052996|521073822|FG001|Overall Study|Lost to Follow-up|0|||
144511514|NCT05052996|521073823|FG002|Overall Study|Lost to Follow-up|0|||
144511515|NCT05052996|521073824|FG003|Overall Study|Lost to Follow-up|2|||
144511516|NCT05052996|521073821|FG000|Overall Study|Adverse Event|0|||
144511517|NCT05052996|521073822|FG001|Overall Study|Adverse Event|0|||
144511518|NCT05052996|521073823|FG002|Overall Study|Adverse Event|2|||
144511519|NCT05052996|521073824|FG003|Overall Study|Adverse Event|0|||
144511520|NCT05052996|521073821|FG000|Overall Study|Randomized but never treated|0|||
144511521|NCT05052996|521073822|FG001|Overall Study|Randomized but never treated|0|||
144511522|NCT05052996|521073823|FG002|Overall Study|Randomized but never treated|1|||
144511523|NCT05052996|521073824|FG003|Overall Study|Randomized but never treated|1|||
144511524|NCT05052996|521073821|FG000|Overall Study|Protocol Violation|1|||
144511525|NCT05052996|521073822|FG001|Overall Study|Protocol Violation|0|||
144511526|NCT05052996|521073823|FG002|Overall Study|Protocol Violation|0|||
144511527|NCT05052996|521073824|FG003|Overall Study|Protocol Violation|0|||
144511528|NCT03951805|521073825|FG000|Overall Study|Adverse Event|1|||
144511529|NCT03951805|521073826|FG001|Overall Study|Adverse Event|0|||
144511530|NCT03951805|521073827|FG002|Overall Study|Adverse Event|0|||
144511531|NCT03951805|521073828|FG003|Overall Study|Adverse Event|0|||
144511532|NCT00510887|521073831|FG000|Overall Study|Lost to Follow-up|1|||
144511533|NCT01561989|521073832|FG000|Overall Study|accural target not met.|5|||
144511534|NCT01561989|521073833|FG001|Overall Study|accural target not met.|6|||
144511535|NCT01736215|521073834|FG000|Overall Study|Early termination of erythropoietin use|1|||
144511536|NCT01736215|521073834|FG000|Overall Study|Adverse Event|4|||
144511537|NCT01736215|521073834|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
144511538|NCT01736215|521073834|FG000|Overall Study|Insufficient data to perform analysis|8|||
144511539|NCT03447249|521073835|FG000|Overall Study|Adverse Event|1|||
144511540|NCT03447249|521073836|FG001|Overall Study|Adverse Event|0|||
144511541|NCT03447249|521073835|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
144511542|NCT03447249|521073836|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
144511543|NCT03447249|521073835|FG000|Overall Study|Other|3|||
144511544|NCT03447249|521073836|FG001|Overall Study|Other|0|||
144511545|NCT01248936|521073837|FG000|Overall Study|Sponsor Decision|259|||
144511546|NCT01248936|521073837|FG000|Overall Study|Progression of Disease|50|||
144511547|NCT01248936|521073837|FG000|Overall Study|Death|26|||
144511548|NCT01248936|521073837|FG000|Overall Study|Withdrawal of Consent|20|||
144511549|NCT01248936|521073837|FG000|Overall Study|Adverse Event|8|||
144511550|NCT01248936|521073837|FG000|Overall Study|Lost to Follow-up|7|||
144511551|NCT01248936|521073837|FG000|Overall Study|Refused Treatment|1|||
144511552|NCT01248936|521073837|FG000|Overall Study|Other reason|3|||
144511553|NCT03485950|521073838|FG000|Overall Study|Adverse Event|1|||
144511554|NCT03485950|521073839|FG001|Overall Study|Adverse Event|0|||
144511555|NCT03485950|521073838|FG000|Overall Study|Death|3|||
144511556|NCT03485950|521073839|FG001|Overall Study|Death|2|||
144511557|NCT03485950|521073838|FG000|Overall Study|Withdrawal by Subject|3|||
144511558|NCT03485950|521073839|FG001|Overall Study|Withdrawal by Subject|0|||
144511559|NCT00988858|521073840|FG000|Overall Study|Adverse Event|7|||
144511560|NCT00988858|521073840|FG000|Overall Study|Death|1|||
144511561|NCT00988858|521073840|FG000|Overall Study|Physician Decision|1|||
144511562|NCT00988858|521073840|FG000|Overall Study|Sponsor Decision|1|||
144511563|NCT00580866|521073841|FG000|Overall Study|Lost to Follow-up|2|||
144511564|NCT00580866|521073842|FG001|Overall Study|Lost to Follow-up|2|||
144511565|NCT00609336|521073843|FG000|Overall Study|Protocol Violation|3|||
144511566|NCT00609336|521073843|FG000|Overall Study|Death|1|||
144511567|NCT00609336|521073843|FG000|Overall Study|LA or Met at Surgery|9|||
144511568|NCT02238483|521073844|FG000|Overall Study|Withdrawal by Subject|2|||
144511569|NCT02238483|521073845|FG001|Overall Study|Withdrawal by Subject|7|||
144511570|NCT02238483|521073844|FG000|Overall Study|Lost to Follow-up|1|||
144511571|NCT02238483|521073845|FG001|Overall Study|Lost to Follow-up|1|||
144511572|NCT02238483|521073844|FG000|Overall Study|Protocol Violation|1|||
144511573|NCT02238483|521073845|FG001|Overall Study|Protocol Violation|2|||
144511574|NCT02238483|521073844|FG000|Overall Study|Death|1|||
144511575|NCT02238483|521073845|FG001|Overall Study|Death|0|||
144511576|NCT02238483|521073844|FG000|Overall Study|Adverse Event|7|||
144374408|NCT00475306|520579839|FG003|Overall Study|Protocol Violation|1|||
144374409|NCT02078960|520579841|FG000|Treatment Period|Other|0|||
144374410|NCT02078960|520579842|FG001|Treatment Period|Other|0|||
144374411|NCT02078960|520579843|FG002|Treatment Period|Other|1|||
144374412|NCT02078960|520579841|FG000|Treatment Period|Lack of Efficacy|0|||
144374413|NCT02078960|520579842|FG001|Treatment Period|Lack of Efficacy|1|||
144374414|NCT02078960|520579843|FG002|Treatment Period|Lack of Efficacy|0|||
144374415|NCT02078960|520579841|FG000|Treatment Period|Disease progression - accelerated phase|0|||
144374416|NCT02078960|520579842|FG001|Treatment Period|Disease progression - accelerated phase|1|||
144374417|NCT02078960|520579843|FG002|Treatment Period|Disease progression - accelerated phase|0|||
144374418|NCT02078960|520579841|FG000|Treatment Period|Disease progression - blast phase|1|||
144374419|NCT02078960|520579842|FG001|Treatment Period|Disease progression - blast phase|0|||
144374420|NCT02078960|520579843|FG002|Treatment Period|Disease progression - blast phase|0|||
144374421|NCT02078960|520579841|FG000|Treatment Period|Withdrawal by Subject|0|||
144374422|NCT02078960|520579842|FG001|Treatment Period|Withdrawal by Subject|1|||
144374423|NCT02078960|520579843|FG002|Treatment Period|Withdrawal by Subject|1|||
144374424|NCT02078960|520579841|FG000|Treatment Period|Adverse Event|1|||
144374425|NCT02078960|520579842|FG001|Treatment Period|Adverse Event|0|||
144374426|NCT02078960|520579843|FG002|Treatment Period|Adverse Event|0|||
144374427|NCT02078960|520579841|FG000|Treatment Period|Death|0|||
144374428|NCT02078960|520579842|FG001|Treatment Period|Death|0|||
144374429|NCT02078960|520579843|FG002|Treatment Period|Death|1|||
144374430|NCT02078960|520579841|FG000|Follow-up Period|Death|2|||
144374431|NCT02078960|520579842|FG001|Follow-up Period|Death|0|||
144374432|NCT02078960|520579843|FG002|Follow-up Period|Death|0|||
144374433|NCT02078960|520579841|FG000|Follow-up Period|Lost to Follow-up|0|||
144374434|NCT02078960|520579842|FG001|Follow-up Period|Lost to Follow-up|1|||
144374435|NCT02078960|520579843|FG002|Follow-up Period|Lost to Follow-up|0|||
144374436|NCT04661579|520579845|FG000|Overall Study|Lost to Follow-up|19|||
144374437|NCT04661579|520579846|FG001|Overall Study|Lost to Follow-up|10|||
144374438|NCT04661579|520579847|FG002|Overall Study|Lost to Follow-up|2|||
144374439|NCT04661579|520579848|FG003|Overall Study|Lost to Follow-up|7|||
144374440|NCT04661579|520579849|FG004|Overall Study|Lost to Follow-up|11|||
144374441|NCT04661579|520579845|FG000|Overall Study|Physician Decision|2|||
144374442|NCT04661579|520579846|FG001|Overall Study|Physician Decision|0|||
144374443|NCT04661579|520579847|FG002|Overall Study|Physician Decision|0|||
144374444|NCT04661579|520579848|FG003|Overall Study|Physician Decision|1|||
144374445|NCT04661579|520579849|FG004|Overall Study|Physician Decision|0|||
144374446|NCT04661579|520579845|FG000|Overall Study|Withdrawal by Subject|1|||
144374447|NCT04661579|520579846|FG001|Overall Study|Withdrawal by Subject|4|||
144374448|NCT04661579|520579847|FG002|Overall Study|Withdrawal by Subject|0|||
144374449|NCT04661579|520579848|FG003|Overall Study|Withdrawal by Subject|2|||
144374450|NCT04661579|520579849|FG004|Overall Study|Withdrawal by Subject|0|||
144374451|NCT04661579|520579845|FG000|Overall Study|Death|1|||
144374452|NCT04661579|520579846|FG001|Overall Study|Death|0|||
144374453|NCT04661579|520579847|FG002|Overall Study|Death|0|||
144374454|NCT04661579|520579848|FG003|Overall Study|Death|0|||
144374455|NCT04661579|520579849|FG004|Overall Study|Death|0|||
144374456|NCT04661579|520579845|FG000|Overall Study|Other|1|||
144374457|NCT04661579|520579846|FG001|Overall Study|Other|2|||
144374458|NCT04661579|520579847|FG002|Overall Study|Other|1|||
144374459|NCT04661579|520579848|FG003|Overall Study|Other|1|||
144374460|NCT04661579|520579849|FG004|Overall Study|Other|1|||
144374461|NCT04661579|520579845|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
144374462|NCT04661579|520579846|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
144374463|NCT04661579|520579847|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
144374464|NCT04661579|520579848|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
144374465|NCT04661579|520579849|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
144374466|NCT00905645|520579851|FG000|Overall Study|Death (not device related)|10|||
144374467|NCT00905645|520579852|FG001|Overall Study|Death (not device related)|4|||
144374468|NCT00905645|520579853|FG002|Overall Study|Death (not device related)|15|||
144591059|NCT00490724|521364183|FG000|Period II|Treatment Discontinuation|3|||
144591060|NCT00490724|521364184|FG001|Period II|Treatment Discontinuation|1|||
144374469|NCT00905645|520579854|FG003|Overall Study|Death (not device related)|8|||
144374470|NCT00905645|520579851|FG000|Overall Study|Explantation of study device(s)|78|||
144374471|NCT00905645|520579852|FG001|Overall Study|Explantation of study device(s)|47|||
144374472|NCT00905645|520579853|FG002|Overall Study|Explantation of study device(s)|28|||
144374473|NCT00905645|520579854|FG003|Overall Study|Explantation of study device(s)|21|||
144374474|NCT00905645|520579851|FG000|Overall Study|Subject Request|41|||
144374475|NCT00905645|520579852|FG001|Overall Study|Subject Request|17|||
144374476|NCT00905645|520579853|FG002|Overall Study|Subject Request|13|||
144374477|NCT00905645|520579854|FG003|Overall Study|Subject Request|11|||
144374478|NCT00905645|520579851|FG000|Overall Study|Lost to Follow-up|299|||
144374479|NCT00905645|520579852|FG001|Overall Study|Lost to Follow-up|103|||
144374480|NCT00905645|520579853|FG002|Overall Study|Lost to Follow-up|51|||
144374481|NCT00905645|520579854|FG003|Overall Study|Lost to Follow-up|12|||
144374482|NCT04881942|520579856|FG000|Overall Study|Adverse Event|0|||
144374483|NCT04881942|520579857|FG001|Overall Study|Adverse Event|0|||
144511577|NCT02238483|521073845|FG001|Overall Study|Adverse Event|3|||
144511578|NCT02238483|521073844|FG000|Overall Study|Withdrawn due to physician decision|1|||
144511579|NCT02238483|521073845|FG001|Overall Study|Withdrawn due to physician decision|0|||
144511580|NCT02238483|521073844|FG000|Overall Study|Completion status not recorded|1|||
144511581|NCT02238483|521073845|FG001|Overall Study|Completion status not recorded|1|||
144511582|NCT02238483|521073844|FG000|Overall Study|Illness in family member|1|||
144511583|NCT02238483|521073845|FG001|Overall Study|Illness in family member|0|||
144511584|NCT00567489|521073846|FG000|Overall Study|Adverse Event|6|||
144511585|NCT00567489|521073847|FG001|Overall Study|Adverse Event|14|||
144511586|NCT00567489|521073846|FG000|Overall Study|Physician Decision|0|||
144511587|NCT00567489|521073847|FG001|Overall Study|Physician Decision|4|||
144511588|NCT00567489|521073846|FG000|Overall Study|Withdrawal by Subject|0|||
144511589|NCT00567489|521073847|FG001|Overall Study|Withdrawal by Subject|2|||
144511590|NCT00567489|521073846|FG000|Overall Study|Renal Transplantation|0|||
144511591|NCT00567489|521073847|FG001|Overall Study|Renal Transplantation|3|||
144511592|NCT00567489|521073846|FG000|Overall Study|Other|1|||
144511593|NCT00567489|521073847|FG001|Overall Study|Other|0|||
144511594|NCT00390299|521073848|FG000|Overall Study|Cancellation|1|||
144511595|NCT00390299|521073849|FG001|Overall Study|Cancellation|0|||
144511596|NCT00390299|521073850|FG002|Overall Study|Cancellation|0|||
144511597|NCT00390299|521073851|FG003|Overall Study|Cancellation|0|||
144511598|NCT00390299|521073852|FG004|Overall Study|Cancellation|0|||
144511599|NCT00068601|521073855|FG000|Overall Study|Ineligible|11|||
144511600|NCT00068601|521073856|FG001|Overall Study|Ineligible|13|||
144511601|NCT00068601|521073855|FG000|Overall Study|Not evaluable: withdrew consent|5|||
144511602|NCT00068601|521073856|FG001|Overall Study|Not evaluable: withdrew consent|4|||
144511603|NCT00068601|521073855|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
144511604|NCT00068601|521073856|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
144511605|NCT00068601|521073855|FG000|Overall Study|Death|11|||
144511606|NCT00068601|521073856|FG001|Overall Study|Death|3|||
144511607|NCT00068601|521073855|FG000|Overall Study|Lost to Follow-up|3|||
144511608|NCT00068601|521073856|FG001|Overall Study|Lost to Follow-up|2|||
144511609|NCT00068601|521073855|FG000|Overall Study|Missing primary outcome data|30|||
144511610|NCT00068601|521073856|FG001|Overall Study|Missing primary outcome data|34|||
144511611|NCT02692417|521073867|FG000|Overall Study|Withdrawal by Subject|5|||
144511612|NCT02692417|521073868|FG001|Overall Study|Withdrawal by Subject|1|||
144511613|NCT02692417|521073867|FG000|Overall Study|Adverse Event|1|||
144511614|NCT02692417|521073868|FG001|Overall Study|Adverse Event|0|||
144511615|NCT01803555|521073877|FG000|Overall Study|Adverse Event|3|||
144511616|NCT01803555|521073878|FG001|Overall Study|Adverse Event|2|||
144511617|NCT01803555|521073877|FG000|Overall Study|Withdrawal by Subject|3|||
144511618|NCT01803555|521073878|FG001|Overall Study|Withdrawal by Subject|3|||
144511619|NCT01803555|521073877|FG000|Overall Study|Non-compliance|1|||
144511620|NCT01803555|521073878|FG001|Overall Study|Non-compliance|1|||
144511621|NCT01803555|521073877|FG000|Overall Study|Protocol Violation|3|||
144511622|NCT01803555|521073878|FG001|Overall Study|Protocol Violation|5|||
144511623|NCT01803555|521073877|FG000|Overall Study|Lost to Follow-up|0|||
144511624|NCT01803555|521073878|FG001|Overall Study|Lost to Follow-up|2|||
144511625|NCT01803555|521073877|FG000|Overall Study|Other than specified|3|||
144511626|NCT01803555|521073878|FG001|Overall Study|Other than specified|5|||
144511627|NCT01551355|521073879|FG000|Overall Study|Lost to Follow-up|51|||
144511628|NCT01551355|521073880|FG001|Overall Study|Lost to Follow-up|49|||
144511629|NCT01551355|521073881|FG002|Overall Study|Lost to Follow-up|34|||
144511630|NCT01551355|521073882|FG003|Overall Study|Lost to Follow-up|24|||
144511631|NCT01551355|521073883|FG004|Overall Study|Lost to Follow-up|9|||
144511632|NCT01551355|521073884|FG005|Overall Study|Lost to Follow-up|6|||
144511633|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
144511634|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
144511635|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
144511636|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
144511637|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
144511638|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
144511639|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
144511640|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
144511641|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
144511642|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
144511643|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
144511644|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
144511645|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
144511646|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
144511647|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
144721733|NCT01595009|521835277|FG002|Core|Lost to Follow-up|0|||
144374484|NCT04881942|520579858|FG002|Overall Study|Adverse Event|0|||
144374485|NCT04881942|520579859|FG003|Overall Study|Adverse Event|0|||
144374486|NCT04881942|520579860|FG004|Overall Study|Adverse Event|1|||
144374487|NCT04881942|520579856|FG000|Overall Study|Alternates|0|||
144374488|NCT04881942|520579857|FG001|Overall Study|Alternates|0|||
144374489|NCT04881942|520579858|FG002|Overall Study|Alternates|0|||
144374490|NCT04881942|520579859|FG003|Overall Study|Alternates|0|||
144374491|NCT04881942|520579860|FG004|Overall Study|Alternates|2|||
144374492|NCT02423902|520579861|FG000|Overall Study|Disease progression|1|||
144511648|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
144511649|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
144511650|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
144511651|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
144511652|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
144511653|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
144511654|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
144511655|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
144511656|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
144511657|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
144511658|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
144511659|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
144511660|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
144511661|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
144511662|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
144511663|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
144511664|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
144511665|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
144511666|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
144511667|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
144511668|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
144511669|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
144511670|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
144511671|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
144511672|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
144511673|NCT02409667|521073885|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
144511674|NCT02409667|521073886|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
144511675|NCT02409667|521073887|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
144511676|NCT02409667|521073888|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
144511677|NCT02409667|521073889|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
144511678|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
144511679|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
144511680|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
144511681|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
144511682|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
144511683|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
144511684|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
144511685|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
144511686|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
144511687|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
144511688|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
144511689|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
144511690|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
144511691|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
144511692|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
144511693|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
144511694|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
144511695|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
144511696|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
144511697|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
144511698|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
144511699|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
144721734|NCT01595009|521835278|FG003|Core|Lost to Follow-up|0|||
144374493|NCT02423902|520579862|FG001|Overall Study|Disease progression|4|||
144374494|NCT02136069|520579863|FG000|Overall Study|UC flare-up|1|||
144374495|NCT02136069|520579864|FG001|Overall Study|UC flare-up|0|||
144374496|NCT02136069|520579863|FG000|Overall Study|Adverse Event|6|||
144374497|NCT02136069|520579864|FG001|Overall Study|Adverse Event|8|||
144374498|NCT02136069|520579863|FG000|Overall Study|Death|0|||
144374499|NCT02136069|520579864|FG001|Overall Study|Death|1|||
144374500|NCT02136069|520579863|FG000|Overall Study|Lack of Efficacy|10|||
144374501|NCT02136069|520579864|FG001|Overall Study|Lack of Efficacy|4|||
144374502|NCT02136069|520579863|FG000|Overall Study|Lost to Follow-up|1|||
144374503|NCT02136069|520579864|FG001|Overall Study|Lost to Follow-up|0|||
144374504|NCT02136069|520579863|FG000|Overall Study|Non-Compliance|1|||
144374505|NCT02136069|520579864|FG001|Overall Study|Non-Compliance|0|||
144374506|NCT02136069|520579863|FG000|Overall Study|Physician Decision|5|||
144374507|NCT02136069|520579864|FG001|Overall Study|Physician Decision|4|||
144374508|NCT02136069|520579863|FG000|Overall Study|Withdrawal by Subject|10|||
144374509|NCT02136069|520579864|FG001|Overall Study|Withdrawal by Subject|11|||
144374510|NCT04693234|520579865|FG000|Overall Study|Death|79|||
144374511|NCT04693234|520579866|FG001|Overall Study|Death|19|||
144374512|NCT04693234|520579865|FG000|Overall Study|Sponsor Ended Study|47|||
144374513|NCT04693234|520579866|FG001|Overall Study|Sponsor Ended Study|18|||
144511700|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
144511701|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
144511702|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
144511703|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
144511704|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
144511705|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
144511706|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
144511707|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
144511708|NCT02409667|521073885|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
144511709|NCT02409667|521073886|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
144511710|NCT02409667|521073887|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
144511711|NCT02409667|521073888|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
144511712|NCT02409667|521073889|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
144511713|NCT01925339|521073890|FG000|Overall Study|Adverse Event|2|||
144511714|NCT01925339|521073891|FG001|Overall Study|Adverse Event|0|||
144511715|NCT01205048|521073894|FG000|Overall Study|Withdrawal by Subject|14|||
144511716|NCT01205048|521073894|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
144511717|NCT01205048|521073894|FG000|Overall Study|Lost to Follow-up|4|||
144511718|NCT01205048|521073894|FG000|Overall Study|Other|2|||
144511719|NCT01255670|521073895|FG000|Overall Study|Adverse Event|10|||
144511720|NCT01255670|521073896|FG001|Overall Study|Adverse Event|10|||
144511721|NCT01255670|521073895|FG000|Overall Study|Lost to Follow-up|16|||
144511722|NCT01255670|521073896|FG001|Overall Study|Lost to Follow-up|10|||
144511723|NCT03664960|521073897|FG000|Overall Study|Adverse Event|0|||
144511724|NCT03664960|521073898|FG001|Overall Study|Adverse Event|3|||
144511725|NCT03664960|521073897|FG000|Overall Study|Lost to Follow-up|3|||
144511726|NCT03664960|521073898|FG001|Overall Study|Lost to Follow-up|2|||
144511727|NCT03664960|521073897|FG000|Overall Study|Physician Decision|1|||
144511728|NCT03664960|521073898|FG001|Overall Study|Physician Decision|0|||
144511729|NCT03664960|521073897|FG000|Overall Study|Withdrawal by Subject|3|||
144511730|NCT03664960|521073898|FG001|Overall Study|Withdrawal by Subject|14|||
144511731|NCT03664960|521073897|FG000|Overall Study|Sponsor Decision|1|||
144511732|NCT03664960|521073898|FG001|Overall Study|Sponsor Decision|1|||
144511733|NCT03664960|521073897|FG000|Overall Study|Other|1|||
144511734|NCT03664960|521073898|FG001|Overall Study|Other|2|||
144511735|NCT00823472|521073899|FG000|Overall Study|Physician Decision|24|||
144511736|NCT00823472|521073900|FG001|Overall Study|Physician Decision|28|||
144511737|NCT04019444|521073901|FG000|Overall Study|Withdrawal by Subject|0|||
144511738|NCT04019444|521073902|FG001|Overall Study|Withdrawal by Subject|1|||
144511739|NCT04019444|521073903|FG002|Overall Study|Withdrawal by Subject|0|||
144511740|NCT04019444|521073904|FG003|Overall Study|Withdrawal by Subject|1|||
144511741|NCT04019444|521073901|FG000|Overall Study|Solicited Event|0|||
144511742|NCT04019444|521073902|FG001|Overall Study|Solicited Event|0|||
144374514|NCT04693234|520579865|FG000|Overall Study|Withdrawal by Subject|10|||
144511743|NCT04019444|521073903|FG002|Overall Study|Solicited Event|2|||
144511744|NCT04019444|521073904|FG003|Overall Study|Solicited Event|0|||
144511745|NCT05094141|521073918|FG000|Overall Study|Death|0|||
144511746|NCT05094141|521073919|FG001|Overall Study|Death|0|||
144511747|NCT05094141|521073920|FG002|Overall Study|Death|1|||
144511748|NCT05094141|521073918|FG000|Overall Study|Withdrawal by Subject|0|||
144511749|NCT05094141|521073919|FG001|Overall Study|Withdrawal by Subject|0|||
144511750|NCT05094141|521073920|FG002|Overall Study|Withdrawal by Subject|1|||
144511751|NCT05094141|521073918|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
144721735|NCT01595009|521835275|FG000|Core|Protocol deviation|0|||
144374515|NCT04693234|520579866|FG001|Overall Study|Withdrawal by Subject|2|||
144374516|NCT04693234|520579865|FG000|Overall Study|Lost to Follow-up|2|||
144374517|NCT04693234|520579866|FG001|Overall Study|Lost to Follow-up|1|||
144374518|NCT04329806|520579867|FG000|Overall Study|Physician Decision|3|||
144374519|NCT04329806|520579868|FG001|Overall Study|Physician Decision|4|||
144374520|NCT04838626|520579869|FG000|Overall Study|Adverse Event|2|||
144511752|NCT05094141|521073919|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
144511753|NCT05094141|521073920|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
144511754|NCT05094141|521073918|FG000|Overall Study|Did not participate in randomization|0|||
144511755|NCT05094141|521073919|FG001|Overall Study|Did not participate in randomization|0|||
144511756|NCT05094141|521073920|FG002|Overall Study|Did not participate in randomization|33|||
144511757|NCT03783026|521075971|FG000|Treatment Phase|Adverse Event|15|||
144511758|NCT03783026|521075971|FG000|Treatment Phase|Lack of Efficacy|11|||
144511759|NCT03783026|521075971|FG000|Treatment Phase|Withdrawal by Subject|6|||
144511760|NCT03783026|521075971|FG000|Treatment Phase|Lost to Follow-up|2|||
144511761|NCT03783026|521075971|FG000|Treatment Phase|Protocol Deviation|8|||
144374521|NCT04838626|520579869|FG000|Overall Study|Physician Decision|6|||
144374522|NCT04838626|520579869|FG000|Overall Study|Protocol Violation|3|||
144374523|NCT04838626|520579869|FG000|Overall Study|Withdrawal by Subject|9|||
144374524|NCT04838626|520579869|FG000|Overall Study|Technical Problems|2|||
144374525|NCT00578292|520579870|FG000|Overall Study|Death|1|||
144374526|NCT00578292|520579870|FG000|Overall Study|Graft failure|2|||
144374527|NCT03901469|520579871|FG000|Overall Study|Radiographic Progression|4|||
144374528|NCT03901469|520579872|FG001|Overall Study|Radiographic Progression|6|||
144374529|NCT03901469|520579873|FG002|Overall Study|Radiographic Progression|3|||
144374530|NCT03901469|520579874|FG003|Overall Study|Radiographic Progression|30|||
144374531|NCT03901469|520579875|FG004|Overall Study|Radiographic Progression|7|||
144374532|NCT03901469|520579876|FG005|Overall Study|Radiographic Progression|2|||
144374533|NCT03901469|520579877|FG006|Overall Study|Radiographic Progression|11|||
144374534|NCT03901469|520579871|FG000|Overall Study|Clinical Progression|0|||
144374535|NCT03901469|520579872|FG001|Overall Study|Clinical Progression|2|||
144374536|NCT03901469|520579873|FG002|Overall Study|Clinical Progression|0|||
144374537|NCT03901469|520579874|FG003|Overall Study|Clinical Progression|7|||
144374538|NCT03901469|520579875|FG004|Overall Study|Clinical Progression|6|||
144374539|NCT03901469|520579876|FG005|Overall Study|Clinical Progression|0|||
144374540|NCT03901469|520579877|FG006|Overall Study|Clinical Progression|2|||
144374541|NCT03901469|520579871|FG000|Overall Study|Adverse Event|1|||
144374542|NCT03901469|520579872|FG001|Overall Study|Adverse Event|0|||
144374543|NCT03901469|520579873|FG002|Overall Study|Adverse Event|0|||
144374544|NCT03901469|520579874|FG003|Overall Study|Adverse Event|0|||
144374545|NCT03901469|520579875|FG004|Overall Study|Adverse Event|0|||
144374546|NCT03901469|520579876|FG005|Overall Study|Adverse Event|0|||
144374547|NCT03901469|520579877|FG006|Overall Study|Adverse Event|9|||
144374548|NCT03901469|520579871|FG000|Overall Study|Physician Decision|0|||
144374549|NCT03901469|520579872|FG001|Overall Study|Physician Decision|0|||
144374550|NCT03901469|520579873|FG002|Overall Study|Physician Decision|0|||
144374551|NCT03901469|520579874|FG003|Overall Study|Physician Decision|1|||
144374552|NCT03901469|520579875|FG004|Overall Study|Physician Decision|0|||
144374553|NCT03901469|520579876|FG005|Overall Study|Physician Decision|0|||
144374554|NCT03901469|520579877|FG006|Overall Study|Physician Decision|0|||
144374555|NCT03901469|520579871|FG000|Overall Study|Withdrawal by Subject|0|||
144374556|NCT03901469|520579872|FG001|Overall Study|Withdrawal by Subject|0|||
144374557|NCT03901469|520579873|FG002|Overall Study|Withdrawal by Subject|0|||
144374558|NCT03901469|520579874|FG003|Overall Study|Withdrawal by Subject|0|||
144374559|NCT03901469|520579875|FG004|Overall Study|Withdrawal by Subject|2|||
144374560|NCT03901469|520579876|FG005|Overall Study|Withdrawal by Subject|0|||
144374561|NCT03901469|520579877|FG006|Overall Study|Withdrawal by Subject|8|||
144374562|NCT03901469|520579871|FG000|Overall Study|Death|0|||
144374563|NCT03901469|520579872|FG001|Overall Study|Death|0|||
144374564|NCT03901469|520579873|FG002|Overall Study|Death|0|||
144374565|NCT03901469|520579874|FG003|Overall Study|Death|3|||
144374566|NCT03901469|520579875|FG004|Overall Study|Death|5|||
144374567|NCT03901469|520579876|FG005|Overall Study|Death|0|||
144374568|NCT03901469|520579877|FG006|Overall Study|Death|1|||
144374569|NCT03901469|520579871|FG000|Overall Study|Termination of study by sponsor|0|||
144374570|NCT03901469|520579872|FG001|Overall Study|Termination of study by sponsor|0|||
144511762|NCT03783026|521075971|FG000|Treatment Phase|Did Not Receive Treatment|1|||
144511763|NCT03783026|521075971|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
144374571|NCT03901469|520579873|FG002|Overall Study|Termination of study by sponsor|0|||
144374572|NCT03901469|520579874|FG003|Overall Study|Termination of study by sponsor|0|||
144374573|NCT03901469|520579875|FG004|Overall Study|Termination of study by sponsor|1|||
144374574|NCT03901469|520579876|FG005|Overall Study|Termination of study by sponsor|1|||
144374575|NCT03901469|520579877|FG006|Overall Study|Termination of study by sponsor|0|||
144374576|NCT03901469|520579871|FG000|Overall Study|Not Reported|1|||
144374577|NCT03901469|520579872|FG001|Overall Study|Not Reported|0|||
144374578|NCT03901469|520579873|FG002|Overall Study|Not Reported|0|||
144374579|NCT03901469|520579874|FG003|Overall Study|Not Reported|1|||
144374580|NCT03901469|520579875|FG004|Overall Study|Not Reported|0|||
144374581|NCT03901469|520579876|FG005|Overall Study|Not Reported|0|||
144511764|NCT04814186|521075972|FG000|Treatment Phase|Adverse Event|1|||
144511765|NCT04814186|521075972|FG000|Treatment Phase|Death|6|||
144511766|NCT04814186|521075972|FG000|Treatment Phase|Withdrawal by Subject|2|||
144511767|NCT04814186|521075972|FG000|Treatment Phase|Other|1|||
144511768|NCT04814186|521075972|FG000|Follow-Up Phase|Adverse Event|1|||
144511769|NCT04814186|521075972|FG000|Follow-Up Phase|Death|6|||
144511770|NCT04814186|521075972|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
144511771|NCT04814186|521075972|FG000|Follow-Up Phase|Other|1|||
144511772|NCT01853748|521075976|FG000|Allocation|Withdrawal by Subject|1|||
144511773|NCT01853748|521075977|FG001|Allocation|Withdrawal by Subject|13|||
144511774|NCT01853748|521075976|FG000|Allocation|not sufficient to receive intervention|0|||
144511775|NCT01853748|521075977|FG001|Allocation|not sufficient to receive intervention|1|||
144511776|NCT01853748|521075976|FG000|Follow-Up|Withdrawal by Subject|7|||
144511777|NCT01853748|521075977|FG001|Follow-Up|Withdrawal by Subject|6|||
144511778|NCT01853748|521075976|FG000|Follow-Up|Adverse Event|67|||
144511779|NCT01853748|521075977|FG001|Follow-Up|Adverse Event|7|||
144511780|NCT01853748|521075976|FG000|Follow-Up|not available for data collection|16|||
144511781|NCT01853748|521075977|FG001|Follow-Up|not available for data collection|4|||
144511782|NCT01643070|521075982|FG000|Overall Study|Withdrawal by Subject|3|||
144511783|NCT01643070|521075983|FG001|Overall Study|Withdrawal by Subject|1|||
144511784|NCT01643070|521075982|FG000|Overall Study|Death|1|||
144511785|NCT01643070|521075983|FG001|Overall Study|Death|0|||
144511786|NCT01643070|521075982|FG000|Overall Study|Pregressive disease|0|||
144511787|NCT01643070|521075983|FG001|Overall Study|Pregressive disease|2|||
144511788|NCT04278586|521075986|FG000|Overall Study|Withdrawal by Subject|13|||
144511789|NCT04278586|521075987|FG001|Overall Study|Withdrawal by Subject|6|||
144511790|NCT04278586|521075986|FG000|Overall Study|Lost to Follow-up|37|||
144511791|NCT04278586|521075987|FG001|Overall Study|Lost to Follow-up|24|||
144511792|NCT02791230|521075988|FG000|Overall Study|Adverse Event|10|||
144511793|NCT02791230|521075989|FG001|Overall Study|Adverse Event|9|||
144511794|NCT02791230|521075990|FG002|Overall Study|Adverse Event|66|||
144511795|NCT02791230|521075988|FG000|Overall Study|Death|38|||
144511796|NCT02791230|521075989|FG001|Overall Study|Death|25|||
144511797|NCT02791230|521075990|FG002|Overall Study|Death|184|||
144511798|NCT02791230|521075988|FG000|Overall Study|Lack of Efficacy|1|||
144511799|NCT02791230|521075989|FG001|Overall Study|Lack of Efficacy|0|||
144511800|NCT02791230|521075990|FG002|Overall Study|Lack of Efficacy|3|||
144511801|NCT02791230|521075988|FG000|Overall Study|Lost to Follow-up|0|||
144511802|NCT02791230|521075989|FG001|Overall Study|Lost to Follow-up|0|||
144511803|NCT02791230|521075990|FG002|Overall Study|Lost to Follow-up|10|||
144511804|NCT02791230|521075988|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
144511805|NCT02791230|521075989|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
144511806|NCT02791230|521075990|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
144511807|NCT02791230|521075988|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
144511808|NCT02791230|521075989|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
144511809|NCT02791230|521075990|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
144511810|NCT02791230|521075988|FG000|Overall Study|Study sites terminated by sponsor|1|||
144511811|NCT02791230|521075989|FG001|Overall Study|Study sites terminated by sponsor|0|||
144511812|NCT02791230|521075990|FG002|Overall Study|Study sites terminated by sponsor|5|||
144511813|NCT02791230|521075988|FG000|Overall Study|Other|9|||
144511814|NCT02791230|521075989|FG001|Overall Study|Other|1|||
144511815|NCT02791230|521075990|FG002|Overall Study|Other|28|||
144511816|NCT02791230|521075988|FG000|Overall Study|Protocol Violation|0|||
144511817|NCT02791230|521075989|FG001|Overall Study|Protocol Violation|0|||
144511818|NCT02791230|521075990|FG002|Overall Study|Protocol Violation|4|||
144511819|NCT02791230|521075988|FG000|Overall Study|Withdrawal by Subject|24|||
144511820|NCT02791230|521075989|FG001|Overall Study|Withdrawal by Subject|13|||
144511821|NCT02791230|521075990|FG002|Overall Study|Withdrawal by Subject|172|||
144511822|NCT02791230|521075988|FG000|Overall Study|Enrolled but not treated|0|||
144511823|NCT02791230|521075989|FG001|Overall Study|Enrolled but not treated|0|||
144374582|NCT03901469|520579877|FG006|Overall Study|Not Reported|1|||
144374583|NCT00459186|520579878|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
144374584|NCT00459186|520579878|FG000|PET Imaging and Assessment|Adverse Event|3|||
144511824|NCT02791230|521075990|FG002|Overall Study|Enrolled but not treated|5|||
144511825|NCT04941287|521076000|FG000|Overall Study|Rapid decline before starting treatment|3|||
144511826|NCT04941287|521076001|FG001|Overall Study|Rapid decline before starting treatment|1|||
144511827|NCT02980276|521076002|FG000|Overall Study|Withdrawal by Subject|4|||
144511828|NCT02980276|521076003|FG001|Overall Study|Withdrawal by Subject|4|||
144374585|NCT03710083|520579879|FG000|Overall Study|Withdrawal by Subject|2|||
144511829|NCT02980276|521076002|FG000|Overall Study|Physician Decision|0|||
144511830|NCT02980276|521076003|FG001|Overall Study|Physician Decision|1|||
144511831|NCT02980276|521076002|FG000|Overall Study|Lost to Follow-up|18|||
144511832|NCT02980276|521076003|FG001|Overall Study|Lost to Follow-up|18|||
144511833|NCT02980276|521076002|FG000|Overall Study|Death|1|||
144511834|NCT02980276|521076003|FG001|Overall Study|Death|0|||
144511835|NCT02980276|521076002|FG000|Overall Study|Miscellaneous other|10|||
144374586|NCT03710083|520579879|FG000|Overall Study|Unsuccessful Procedure|1|||
144374587|NCT01415882|520579880|FG000|Overall Study|Ineligible|1|||
144374588|NCT01415882|520579881|FG001|Overall Study|Ineligible|0|||
144374589|NCT01415882|520579882|FG002|Overall Study|Ineligible|0|||
144374590|NCT01415882|520579883|FG003|Overall Study|Ineligible|3|||
144374591|NCT01415882|520579884|FG004|Overall Study|Ineligible|0|||
144374592|NCT01415882|520579880|FG000|Overall Study|Withdrawal by Subject|0|||
144374593|NCT01415882|520579881|FG001|Overall Study|Withdrawal by Subject|1|||
144374594|NCT01415882|520579882|FG002|Overall Study|Withdrawal by Subject|0|||
144374595|NCT01415882|520579883|FG003|Overall Study|Withdrawal by Subject|1|||
144374596|NCT01415882|520579884|FG004|Overall Study|Withdrawal by Subject|0|||
144374597|NCT03339219|520579885|FG000|Overall Study|Death|12|||
144374598|NCT03339219|520579885|FG000|Overall Study|Site Terminated by Sponsor|22|||
144374599|NCT03339219|520579885|FG000|Overall Study|Withdrawal by Subject|1|||
144374600|NCT00845897|520579888|FG000|Overall Study|Lost to Follow-up|1|||
144374601|NCT00845897|520579889|FG001|Overall Study|Lost to Follow-up|1|||
144374602|NCT00845897|520579890|FG002|Overall Study|Lost to Follow-up|0|||
144374603|NCT00845897|520579888|FG000|Overall Study|Withdrawal by Subject|0|||
144374604|NCT00845897|520579889|FG001|Overall Study|Withdrawal by Subject|3|||
144374605|NCT00845897|520579890|FG002|Overall Study|Withdrawal by Subject|2|||
144374606|NCT00845897|520579888|FG000|Overall Study|Ulcer did not heal|1|||
144374607|NCT00845897|520579889|FG001|Overall Study|Ulcer did not heal|0|||
144374608|NCT00845897|520579890|FG002|Overall Study|Ulcer did not heal|1|||
144374609|NCT00845897|520579888|FG000|Overall Study|Too ill to participate|0|||
144374610|NCT00845897|520579889|FG001|Overall Study|Too ill to participate|1|||
144374611|NCT00845897|520579890|FG002|Overall Study|Too ill to participate|0|||
144374612|NCT02722499|520579891|FG000|Overall Study|Lost to Follow-up|2|||
144374613|NCT02722499|520579892|FG001|Overall Study|Lost to Follow-up|0|||
144374614|NCT02722499|520579893|FG002|Overall Study|Lost to Follow-up|1|||
144374615|NCT00369265|520579903|FG000|Overall Study|Study terminated|4|||
144374616|NCT00369265|520579904|FG001|Overall Study|Study terminated|7|||
144374617|NCT00467753|520579905|FG000|Overall Study|Lost to Follow-up|1|||
144374618|NCT00467753|520579906|FG001|Overall Study|Lost to Follow-up|2|||
144374619|NCT00467753|520579905|FG000|Overall Study|Adverse Event|2|||
144374620|NCT00467753|520579906|FG001|Overall Study|Adverse Event|0|||
144374621|NCT02817464|520579908|FG000|Overall Study|Lost to Follow-up|1|||
144374622|NCT02817464|520579909|FG001|Overall Study|Lost to Follow-up|0|||
144374623|NCT02817464|520579908|FG000|Overall Study|Discontinued early due to personal decision|1|||
144374624|NCT02817464|520579909|FG001|Overall Study|Discontinued early due to personal decision|1|||
144374625|NCT01704599|520579917|FG000|Overall Study|Adverse Event|1|||
144374626|NCT02840461|520579918|FG000|Overall Study|Adverse Event|1|||
144374627|NCT02840461|520579919|FG001|Overall Study|Adverse Event|5|||
144374628|NCT02840461|520579920|FG002|Overall Study|Adverse Event|3|||
144374629|NCT02840461|520579918|FG000|Overall Study|Lost to Follow-up|10|||
144374630|NCT02840461|520579919|FG001|Overall Study|Lost to Follow-up|7|||
144374631|NCT02840461|520579920|FG002|Overall Study|Lost to Follow-up|6|||
144374632|NCT02840461|520579918|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
144374633|NCT02840461|520579919|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
144374634|NCT02840461|520579920|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
144374635|NCT02840461|520579918|FG000|Overall Study|Protocol Violation|2|||
144374636|NCT02840461|520579919|FG001|Overall Study|Protocol Violation|3|||
144374637|NCT02840461|520579920|FG002|Overall Study|Protocol Violation|1|||
144374638|NCT02840461|520579918|FG000|Overall Study|Withdrawal by Subject|10|||
144374639|NCT02840461|520579919|FG001|Overall Study|Withdrawal by Subject|6|||
144374640|NCT02840461|520579920|FG002|Overall Study|Withdrawal by Subject|2|||
144374641|NCT02840461|520579918|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
144374642|NCT02840461|520579919|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
144721736|NCT01595009|521835276|FG001|Core|Protocol deviation|1|||
144374643|NCT02840461|520579920|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
144374644|NCT00124306|520579924|FG000|Overall Study|Adverse Event|7|||
144374645|NCT00124306|520579925|FG001|Overall Study|Adverse Event|2|||
144374646|NCT00124306|520579924|FG000|Overall Study|Lost to Follow-up|10|||
144374647|NCT00124306|520579925|FG001|Overall Study|Lost to Follow-up|6|||
144374648|NCT00124306|520579924|FG000|Overall Study|Lack of Efficacy|3|||
144374649|NCT00124306|520579925|FG001|Overall Study|Lack of Efficacy|6|||
144374650|NCT00124306|520579924|FG000|Overall Study|Personal constraints|0|||
144374651|NCT00124306|520579925|FG001|Overall Study|Personal constraints|2|||
144374652|NCT00124306|520579924|FG000|Overall Study|Use of unacceptable medication|1|||
144374653|NCT00124306|520579925|FG001|Overall Study|Use of unacceptable medication|0|||
144374654|NCT00124306|520579924|FG000|Overall Study|Abnormal lab result|0|||
144374655|NCT00124306|520579925|FG001|Overall Study|Abnormal lab result|1|||
144374656|NCT00124306|520579924|FG000|Overall Study|Other|2|||
144374657|NCT00124306|520579925|FG001|Overall Study|Other|0|||
144374658|NCT00539864|520581698|FG000|Overall Study|Lost to Follow-up|0|||
144374659|NCT00539864|520581699|FG001|Overall Study|Lost to Follow-up|1|||
144374660|NCT00539864|520581698|FG000|Overall Study|Withdrawal by Subject|1|||
144374661|NCT00539864|520581699|FG001|Overall Study|Withdrawal by Subject|1|||
144374662|NCT00943072|520581705|FG000|Overall Study|Adverse Event|0|||
144374663|NCT00943072|520581706|FG001|Overall Study|Adverse Event|3|||
144374664|NCT00943072|520581705|FG000|Overall Study|Death|0|||
144374665|NCT00943072|520581706|FG001|Overall Study|Death|2|||
144374666|NCT00943072|520581705|FG000|Overall Study|Withdrawal by Subject|3|||
144374667|NCT00943072|520581706|FG001|Overall Study|Withdrawal by Subject|1|||
144374668|NCT00943072|520581705|FG000|Overall Study|Protocol Violation|0|||
144374669|NCT00943072|520581706|FG001|Overall Study|Protocol Violation|1|||
144374670|NCT00943072|520581705|FG000|Overall Study|Lost to Follow-up|1|||
144374671|NCT00943072|520581706|FG001|Overall Study|Lost to Follow-up|2|||
144374672|NCT00943072|520581705|FG000|Overall Study|Lack of Efficacy|0|||
144374673|NCT00943072|520581706|FG001|Overall Study|Lack of Efficacy|4|||
144374674|NCT00943072|520581705|FG000|Overall Study|Other|1|||
144374675|NCT00943072|520581706|FG001|Overall Study|Other|1|||
144374676|NCT03860818|520581712|FG000|Overall Study|Death|144|||
144374677|NCT03860818|520581713|FG001|Overall Study|Death|195|||
144374678|NCT03860818|520581712|FG000|Overall Study|Graft Loss|32|||
144374679|NCT03860818|520581713|FG001|Overall Study|Graft Loss|45|||
144374680|NCT00792571|520581714|FG000|Overall Study|Death|1|||
144374681|NCT00792571|520581714|FG000|Overall Study|Adverse Event|4|||
144374682|NCT00792571|520581714|FG000|Overall Study|Withdrawal by Subject|1|||
144374683|NCT00792571|520581714|FG000|Overall Study|Other|4|||
144374684|NCT02600819|520581715|FG000|GEN Phase|Adverse Event|2|||
144374685|NCT02600819|520581716|FG001|GEN Phase|Adverse Event|0|||
144374686|NCT02600819|520581715|FG000|GEN Phase|Death|2|||
144374687|NCT02600819|520581716|FG001|GEN Phase|Death|0|||
144374688|NCT02600819|520581715|FG000|GEN Phase|Investigator's Discretion|4|||
144374689|NCT02600819|520581716|FG001|GEN Phase|Investigator's Discretion|0|||
144374690|NCT02600819|520581715|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
144374691|NCT02600819|520581716|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
144374692|NCT02600819|520581715|FG000|GEN Phase|Withdrew Consent|5|||
144374693|NCT02600819|520581716|FG001|GEN Phase|Withdrew Consent|0|||
144374694|NCT02600819|520581715|FG000|GEN Phase|Lost to Follow-up|2|||
144374695|NCT02600819|520581716|FG001|GEN Phase|Lost to Follow-up|0|||
144374696|NCT01715857|520581717|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
144374697|NCT00505778|520581718|FG000|Overall Study|Adverse Event|2|||
144374698|NCT00505778|520581719|FG001|Overall Study|Adverse Event|7|||
144374699|NCT00505778|520581718|FG000|Overall Study|Physician Decision|8|||
144374700|NCT00505778|520581719|FG001|Overall Study|Physician Decision|14|||
144374701|NCT00505778|520581718|FG000|Overall Study|Lost to Follow-up|17|||
144374702|NCT00505778|520581719|FG001|Overall Study|Lost to Follow-up|23|||
144374703|NCT00505778|520581718|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
144374704|NCT00505778|520581719|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
144374705|NCT00505778|520581718|FG000|Overall Study|Protocol Violation|7|||
144374706|NCT00505778|520581719|FG001|Overall Study|Protocol Violation|9|||
144374707|NCT00505778|520581718|FG000|Overall Study|Withdrawal by Subject|29|||
144374708|NCT00505778|520581719|FG001|Overall Study|Withdrawal by Subject|14|||
144374709|NCT00505778|520581718|FG000|Overall Study|Relapse|65|||
144374710|NCT00505778|520581719|FG001|Overall Study|Relapse|65|||
144374711|NCT00505778|520581718|FG000|Overall Study|Took No Study Drug|2|||
144374712|NCT00505778|520581719|FG001|Overall Study|Took No Study Drug|2|||
144374713|NCT00481091|520581721|FG000|Overall Study|Withdrawal by Subject|0|||
144374714|NCT00481091|520581722|FG001|Overall Study|Withdrawal by Subject|1|||
144374715|NCT00481091|520581723|FG002|Overall Study|Withdrawal by Subject|1|||
144374716|NCT00481091|520581724|FG003|Overall Study|Withdrawal by Subject|0|||
144374717|NCT00481091|520581725|FG004|Overall Study|Withdrawal by Subject|0|||
144374718|NCT00481091|520581726|FG005|Overall Study|Withdrawal by Subject|0|||
144511836|NCT02980276|521076003|FG001|Overall Study|Miscellaneous other|4|||
144374719|NCT00481091|520581727|FG006|Overall Study|Withdrawal by Subject|0|||
144374720|NCT00481091|520581728|FG007|Overall Study|Withdrawal by Subject|0|||
144374721|NCT00481091|520581729|FG008|Overall Study|Withdrawal by Subject|1|||
144374722|NCT00481091|520581730|FG009|Overall Study|Withdrawal by Subject|6|||
144511837|NCT01998984|521076004|FG000|Overall Study|Adverse Event|0|||
144374723|NCT00481091|520581721|FG000|Overall Study|Other, Not Specified|0|||
144374724|NCT00481091|520581722|FG001|Overall Study|Other, Not Specified|1|||
144374725|NCT00481091|520581723|FG002|Overall Study|Other, Not Specified|1|||
144374726|NCT00481091|520581724|FG003|Overall Study|Other, Not Specified|0|||
144374727|NCT00481091|520581725|FG004|Overall Study|Other, Not Specified|0|||
144374728|NCT00481091|520581726|FG005|Overall Study|Other, Not Specified|1|||
144374729|NCT00481091|520581727|FG006|Overall Study|Other, Not Specified|0|||
144374730|NCT00481091|520581728|FG007|Overall Study|Other, Not Specified|0|||
144374731|NCT00481091|520581729|FG008|Overall Study|Other, Not Specified|0|||
144374732|NCT00481091|520581730|FG009|Overall Study|Other, Not Specified|4|||
144374733|NCT00481091|520581721|FG000|Overall Study|Adverse Event|1|||
144374734|NCT00481091|520581722|FG001|Overall Study|Adverse Event|2|||
144374735|NCT00481091|520581723|FG002|Overall Study|Adverse Event|0|||
144511838|NCT01998984|521076005|FG001|Overall Study|Adverse Event|0|||
144511839|NCT01998984|521076006|FG002|Overall Study|Adverse Event|0|||
144511840|NCT01998984|521076007|FG003|Overall Study|Adverse Event|1|||
144511841|NCT01998984|521076004|FG000|Overall Study|Lost to Follow-up|0|||
144511842|NCT01998984|521076005|FG001|Overall Study|Lost to Follow-up|1|||
144511843|NCT01998984|521076006|FG002|Overall Study|Lost to Follow-up|0|||
144511844|NCT01998984|521076007|FG003|Overall Study|Lost to Follow-up|1|||
144511845|NCT01998984|521076004|FG000|Overall Study|Withdrawal by Subject|0|||
144511846|NCT01998984|521076005|FG001|Overall Study|Withdrawal by Subject|0|||
144511847|NCT01998984|521076006|FG002|Overall Study|Withdrawal by Subject|1|||
144511848|NCT01998984|521076007|FG003|Overall Study|Withdrawal by Subject|0|||
144511849|NCT01998984|521076004|FG000|Overall Study|Other|0|||
144511850|NCT01998984|521076005|FG001|Overall Study|Other|0|||
144511851|NCT01998984|521076006|FG002|Overall Study|Other|0|||
144511852|NCT01998984|521076007|FG003|Overall Study|Other|1|||
144511853|NCT03025789|521076009|FG000|Overall Study|Lack of Efficacy|6|||
144511854|NCT03025789|521076010|FG001|Overall Study|Lack of Efficacy|1|||
144511855|NCT03025789|521076009|FG000|Overall Study|Death|1|||
144511856|NCT03025789|521076010|FG001|Overall Study|Death|0|||
144511857|NCT03025789|521076009|FG000|Overall Study|Withdrawal by Subject|0|||
144511858|NCT03025789|521076010|FG001|Overall Study|Withdrawal by Subject|2|||
144511859|NCT02723955|521076011|FG000|Escalation Phase|Death|1|||
144511860|NCT02723955|521076012|FG001|Escalation Phase|Death|1|||
144511861|NCT02723955|521076013|FG002|Escalation Phase|Death|2|||
144511862|NCT02723955|521076014|FG003|Escalation Phase|Death|7|||
144511863|NCT02723955|521076015|FG004|Escalation Phase|Death|18|||
144511864|NCT02723955|521076016|FG005|Escalation Phase|Death|17|||
144511865|NCT02723955|521076017|FG006|Escalation Phase|Death|11|||
144721737|NCT01595009|521835277|FG002|Core|Protocol deviation|0|||
144721738|NCT01595009|521835278|FG003|Core|Protocol deviation|0|||
144374736|NCT00481091|520581724|FG003|Overall Study|Adverse Event|1|||
144374737|NCT00481091|520581725|FG004|Overall Study|Adverse Event|1|||
144374738|NCT00481091|520581726|FG005|Overall Study|Adverse Event|1|||
144374739|NCT00481091|520581727|FG006|Overall Study|Adverse Event|2|||
144374740|NCT00481091|520581728|FG007|Overall Study|Adverse Event|1|||
144374741|NCT00481091|520581729|FG008|Overall Study|Adverse Event|1|||
144374742|NCT00481091|520581730|FG009|Overall Study|Adverse Event|6|||
144374743|NCT00481091|520581721|FG000|Overall Study|Progressive disease clinical|0|||
144374744|NCT00481091|520581722|FG001|Overall Study|Progressive disease clinical|0|||
144374745|NCT00481091|520581723|FG002|Overall Study|Progressive disease clinical|0|||
144374746|NCT00481091|520581724|FG003|Overall Study|Progressive disease clinical|0|||
144374747|NCT00481091|520581725|FG004|Overall Study|Progressive disease clinical|0|||
144374748|NCT00481091|520581726|FG005|Overall Study|Progressive disease clinical|0|||
144374749|NCT00481091|520581727|FG006|Overall Study|Progressive disease clinical|0|||
144374750|NCT00481091|520581728|FG007|Overall Study|Progressive disease clinical|0|||
144374751|NCT00481091|520581729|FG008|Overall Study|Progressive disease clinical|1|||
144374752|NCT00481091|520581730|FG009|Overall Study|Progressive disease clinical|7|||
144374753|NCT00481091|520581721|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
144374754|NCT00481091|520581722|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
144374755|NCT00481091|520581723|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374756|NCT00481091|520581724|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374757|NCT00481091|520581725|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374758|NCT00481091|520581726|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
144374759|NCT00481091|520581727|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374760|NCT00481091|520581728|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374761|NCT00481091|520581729|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374762|NCT00481091|520581730|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
144374763|NCT00481091|520581721|FG000|Overall Study|Progressive disease other|1|||
144374764|NCT00481091|520581722|FG001|Overall Study|Progressive disease other|1|||
144374765|NCT00481091|520581723|FG002|Overall Study|Progressive disease other|0|||
144374766|NCT00481091|520581724|FG003|Overall Study|Progressive disease other|1|||
144374767|NCT00481091|520581725|FG004|Overall Study|Progressive disease other|1|||
144511866|NCT02723955|521076018|FG007|Escalation Phase|Death|21|||
144511867|NCT02723955|521076019|FG008|Escalation Phase|Death|3|||
144511868|NCT02723955|521076020|FG009|Escalation Phase|Death|0|||
144511869|NCT02723955|521076021|FG010|Escalation Phase|Death|0|||
144511870|NCT02723955|521076022|FG011|Escalation Phase|Death|0|||
144511871|NCT02723955|521076023|FG012|Escalation Phase|Death|2|||
144511872|NCT02723955|521076024|FG013|Escalation Phase|Death|4|||
144511873|NCT02723955|521076025|FG014|Escalation Phase|Death|5|||
144511874|NCT02723955|521076026|FG015|Escalation Phase|Death|6|||
144511875|NCT02723955|521076027|FG016|Escalation Phase|Death|6|||
144721739|NCT01595009|521835275|FG000|Core|Administrative problems|0|||
144374768|NCT00481091|520581726|FG005|Overall Study|Progressive disease other|1|||
144374769|NCT00481091|520581727|FG006|Overall Study|Progressive disease other|0|||
144374770|NCT00481091|520581728|FG007|Overall Study|Progressive disease other|2|||
144374771|NCT00481091|520581729|FG008|Overall Study|Progressive disease other|0|||
144374772|NCT00481091|520581730|FG009|Overall Study|Progressive disease other|0|||
144374773|NCT00481091|520581721|FG000|Overall Study|No reason given|0|||
144374774|NCT00481091|520581722|FG001|Overall Study|No reason given|0|||
144374775|NCT00481091|520581723|FG002|Overall Study|No reason given|1|||
144374776|NCT00481091|520581724|FG003|Overall Study|No reason given|1|||
144374777|NCT00481091|520581725|FG004|Overall Study|No reason given|1|||
144374778|NCT00481091|520581726|FG005|Overall Study|No reason given|0|||
144374779|NCT00481091|520581727|FG006|Overall Study|No reason given|1|||
144374780|NCT00481091|520581728|FG007|Overall Study|No reason given|1|||
144374781|NCT00481091|520581729|FG008|Overall Study|No reason given|1|||
144374782|NCT00481091|520581730|FG009|Overall Study|No reason given|4|||
144374783|NCT02881567|520581731|FG000|Overall Study|Adverse Event|1|||
144374784|NCT02881567|520581731|FG000|Overall Study|Lost to Follow-up|3|||
144374785|NCT02881567|520581731|FG000|Overall Study|Consent withdrawn|1|||
144374786|NCT02881567|520581731|FG000|Overall Study|Investigator decision|1|||
144374787|NCT02881567|520581731|FG000|Overall Study|Study terminated by sponsor|9|||
144374788|NCT02881567|520581731|FG000|Overall Study|Reason not Specified|3|||
144374789|NCT02405442|520581732|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
144374790|NCT02405442|520581733|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
144374791|NCT02405442|520581734|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
144374792|NCT02405442|520581735|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
144374793|NCT02405442|520581732|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
144374794|NCT02405442|520581733|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
144374795|NCT02405442|520581734|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
144374796|NCT02405442|520581735|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
144374797|NCT02405442|520581732|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
144374798|NCT02405442|520581733|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
144374799|NCT02405442|520581734|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
144374800|NCT02405442|520581735|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
144374801|NCT02405442|520581732|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
144374802|NCT02405442|520581733|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
144374803|NCT02405442|520581734|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
144374804|NCT02405442|520581735|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
144374805|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
144374806|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
144374807|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
144374808|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
144374809|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
144374810|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
144374811|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
144374812|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
144374813|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
144374814|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
144374815|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
144374816|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
144374817|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
144374818|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
144721740|NCT01595009|521835276|FG001|Core|Administrative problems|1|||
144721741|NCT01595009|521835277|FG002|Core|Administrative problems|0|||
144374819|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
144374820|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
144374821|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
144374822|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
144374823|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
144374824|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
144374825|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
144374826|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
144374827|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
144374828|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
144374829|NCT02405442|520581732|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
144374830|NCT02405442|520581733|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
144374831|NCT02405442|520581734|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
144374832|NCT02405442|520581735|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
144374833|NCT02405442|520581732|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
144721742|NCT01595009|521835278|FG003|Core|Administrative problems|0|||
144374834|NCT02405442|520581733|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
144374835|NCT02405442|520581734|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
144374836|NCT02405442|520581735|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
144374837|NCT02405442|520581732|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
144374838|NCT02405442|520581733|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
144374839|NCT02405442|520581734|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
144374840|NCT02405442|520581735|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
144374841|NCT02405442|520581732|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
144374842|NCT02405442|520581733|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
144374843|NCT02405442|520581734|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
144374844|NCT02405442|520581735|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
144374845|NCT00373113|520581736|FG000|Overall Study|Death|1|||
144374846|NCT00373113|520581737|FG001|Overall Study|Death|7|||
144374847|NCT00373113|520581736|FG000|Overall Study|Adverse Event|38|||
144374848|NCT00373113|520581737|FG001|Overall Study|Adverse Event|24|||
144374849|NCT00373113|520581736|FG000|Overall Study|Study terminated by sponsor|9|||
144374850|NCT00373113|520581737|FG001|Overall Study|Study terminated by sponsor|1|||
144374851|NCT00373113|520581736|FG000|Overall Study|Global deterioration of health status|10|||
144374852|NCT00373113|520581737|FG001|Overall Study|Global deterioration of health status|7|||
144374853|NCT00373113|520581736|FG000|Overall Study|Lost to Follow-up|1|||
144374854|NCT00373113|520581737|FG001|Overall Study|Lost to Follow-up|3|||
144374855|NCT00373113|520581736|FG000|Overall Study|Objective progression or relapse|150|||
144374856|NCT00373113|520581737|FG001|Overall Study|Objective progression or relapse|169|||
144374857|NCT00373113|520581736|FG000|Overall Study|Other|14|||
144374858|NCT00373113|520581737|FG001|Overall Study|Other|17|||
144374859|NCT00373113|520581736|FG000|Overall Study|Protocol Violation|5|||
144374860|NCT00373113|520581737|FG001|Overall Study|Protocol Violation|1|||
144374861|NCT00373113|520581736|FG000|Overall Study|Withdrawal by Subject|10|||
144374862|NCT00373113|520581737|FG001|Overall Study|Withdrawal by Subject|15|||
144374863|NCT03275350|520581738|FG000|Overall Study|Lost to Follow-up|4|||
144374864|NCT03275350|520581739|FG001|Overall Study|Lost to Follow-up|6|||
144374865|NCT03275350|520581738|FG000|Overall Study|Death|2|||
144374866|NCT03275350|520581739|FG001|Overall Study|Death|1|||
144374867|NCT03275350|520581738|FG000|Overall Study|Physician Decision|1|||
144374868|NCT03275350|520581739|FG001|Overall Study|Physician Decision|0|||
144374869|NCT03275350|520581738|FG000|Overall Study|Incarcerated|1|||
144374870|NCT03275350|520581739|FG001|Overall Study|Incarcerated|1|||
144374871|NCT01396447|520581742|FG000|Overall Study|Did Not Receive Treatment|3|||
144374872|NCT01396447|520581743|FG001|Overall Study|Did Not Receive Treatment|2|||
144374873|NCT01396447|520581744|FG002|Overall Study|Did Not Receive Treatment|1|||
144374874|NCT01396447|520581745|FG003|Overall Study|Did Not Receive Treatment|0|||
144374875|NCT01396447|520581742|FG000|Overall Study|Adverse Event|15|||
144374876|NCT01396447|520581743|FG001|Overall Study|Adverse Event|12|||
144374877|NCT01396447|520581744|FG002|Overall Study|Adverse Event|12|||
144374878|NCT01396447|520581745|FG003|Overall Study|Adverse Event|17|||
144374879|NCT01396447|520581742|FG000|Overall Study|Insufficient Therapeutic Response|5|||
144374880|NCT01396447|520581743|FG001|Overall Study|Insufficient Therapeutic Response|5|||
144374881|NCT01396447|520581744|FG002|Overall Study|Insufficient Therapeutic Response|2|||
144374882|NCT01396447|520581745|FG003|Overall Study|Insufficient Therapeutic Response|4|||
144374883|NCT01396447|520581742|FG000|Overall Study|Protocol Violation|5|||
144374884|NCT01396447|520581743|FG001|Overall Study|Protocol Violation|2|||
144374885|NCT01396447|520581744|FG002|Overall Study|Protocol Violation|3|||
144374886|NCT01396447|520581745|FG003|Overall Study|Protocol Violation|7|||
144374887|NCT01396447|520581742|FG000|Overall Study|Withdrawal of Consent|11|||
144374888|NCT01396447|520581743|FG001|Overall Study|Withdrawal of Consent|9|||
144374889|NCT01396447|520581744|FG002|Overall Study|Withdrawal of Consent|4|||
144374890|NCT01396447|520581745|FG003|Overall Study|Withdrawal of Consent|15|||
144374891|NCT01396447|520581742|FG000|Overall Study|Lost to Follow-up|4|||
144374892|NCT01396447|520581743|FG001|Overall Study|Lost to Follow-up|8|||
144721743|NCT01595009|521835275|FG000|Extension|Administrative problems|0|||
144374893|NCT01396447|520581744|FG002|Overall Study|Lost to Follow-up|7|||
144374894|NCT01396447|520581745|FG003|Overall Study|Lost to Follow-up|9|||
144374895|NCT01396447|520581742|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144374896|NCT01396447|520581743|FG001|Overall Study|Other Miscellaneous Reasons|2|||
144374897|NCT01396447|520581744|FG002|Overall Study|Other Miscellaneous Reasons|1|||
144374898|NCT01396447|520581745|FG003|Overall Study|Other Miscellaneous Reasons|0|||
144374899|NCT01402102|520581746|FG000|Overall Study|Protocol Violation|1|||
144374900|NCT01402102|520581747|FG001|Overall Study|Protocol Violation|0|||
144374901|NCT01402102|520581746|FG000|Overall Study|Insufficiency of compliance|1|||
144374902|NCT01402102|520581747|FG001|Overall Study|Insufficiency of compliance|1|||
144374903|NCT01402102|520581746|FG000|Overall Study|Withdrawal by Subject|0|||
144374904|NCT01402102|520581747|FG001|Overall Study|Withdrawal by Subject|2|||
144374905|NCT01386970|520581748|FG000|Overall Study|Withdrawal by Subject|0|||
144374906|NCT01386970|520581749|FG001|Overall Study|Withdrawal by Subject|1|||
144374907|NCT01386970|520581748|FG000|Overall Study|Adverse Event|4|||
144374908|NCT01386970|520581749|FG001|Overall Study|Adverse Event|1|||
144374909|NCT02867384|520581750|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
144374910|NCT02867384|520581751|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
144374911|NCT02867384|520581752|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
144374912|NCT02867384|520581750|FG000|Overall Study|Progression/ Relapse|15|||
144374913|NCT02867384|520581751|FG001|Overall Study|Progression/ Relapse|19|||
144374914|NCT02867384|520581752|FG002|Overall Study|Progression/ Relapse|0|||
144374915|NCT02867384|520581750|FG000|Overall Study|Adverse Event|13|||
144374916|NCT02867384|520581751|FG001|Overall Study|Adverse Event|1|||
144374917|NCT02867384|520581752|FG002|Overall Study|Adverse Event|0|||
144374918|NCT02867384|520581750|FG000|Overall Study|Withdrawal by Subject|6|||
144374919|NCT02867384|520581751|FG001|Overall Study|Withdrawal by Subject|5|||
144374920|NCT02867384|520581752|FG002|Overall Study|Withdrawal by Subject|0|||
144374921|NCT02867384|520581750|FG000|Overall Study|Physician Decision|1|||
144374922|NCT02867384|520581751|FG001|Overall Study|Physician Decision|2|||
144374923|NCT02867384|520581752|FG002|Overall Study|Physician Decision|0|||
144374924|NCT02867384|520581750|FG000|Overall Study|Patient compliance|1|||
144374925|NCT02867384|520581751|FG001|Overall Study|Patient compliance|0|||
144374926|NCT02867384|520581752|FG002|Overall Study|Patient compliance|0|||
144374927|NCT02867384|520581750|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
144374928|NCT02867384|520581751|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
144374929|NCT02867384|520581752|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
144374930|NCT02867384|520581750|FG000|Overall Study|Never start treatment|3|||
144374931|NCT02867384|520581751|FG001|Overall Study|Never start treatment|0|||
144374932|NCT02867384|520581752|FG002|Overall Study|Never start treatment|0|||
144374933|NCT01727024|520581753|FG000|Period 1|Lost to Follow-up|1|||
144374934|NCT01727024|520581754|FG001|Period 1|Lost to Follow-up|1|||
144374935|NCT01727024|520581753|FG000|Period 1|Withdrawal by Subject|2|||
144374936|NCT01727024|520581754|FG001|Period 1|Withdrawal by Subject|3|||
144374937|NCT01485172|520581755|FG000|Overall Study|Adverse Event|2|||
144374938|NCT01485172|520581756|FG001|Overall Study|Adverse Event|1|||
144374939|NCT01485172|520581757|FG002|Overall Study|Adverse Event|2|||
144374940|NCT01485172|520581758|FG003|Overall Study|Adverse Event|2|||
144374941|NCT01485172|520581759|FG004|Overall Study|Adverse Event|1|||
144374942|NCT01485172|520581760|FG005|Overall Study|Adverse Event|2|||
144374943|NCT01485172|520581755|FG000|Overall Study|Lack of Efficacy|2|||
144374944|NCT01485172|520581756|FG001|Overall Study|Lack of Efficacy|0|||
144374945|NCT01485172|520581757|FG002|Overall Study|Lack of Efficacy|0|||
144374946|NCT01485172|520581758|FG003|Overall Study|Lack of Efficacy|0|||
144374947|NCT01485172|520581759|FG004|Overall Study|Lack of Efficacy|0|||
144374948|NCT01485172|520581760|FG005|Overall Study|Lack of Efficacy|0|||
144374949|NCT01485172|520581755|FG000|Overall Study|Protocol Violation|0|||
144374950|NCT01485172|520581756|FG001|Overall Study|Protocol Violation|0|||
144374951|NCT01485172|520581757|FG002|Overall Study|Protocol Violation|4|||
144374952|NCT01485172|520581758|FG003|Overall Study|Protocol Violation|5|||
144374953|NCT01485172|520581759|FG004|Overall Study|Protocol Violation|1|||
144374954|NCT01485172|520581760|FG005|Overall Study|Protocol Violation|0|||
144374955|NCT01485172|520581755|FG000|Overall Study|Protocol defined stopping criteria|1|||
144374956|NCT01485172|520581756|FG001|Overall Study|Protocol defined stopping criteria|0|||
144374957|NCT01485172|520581757|FG002|Overall Study|Protocol defined stopping criteria|0|||
144374958|NCT01485172|520581758|FG003|Overall Study|Protocol defined stopping criteria|0|||
144374959|NCT01485172|520581759|FG004|Overall Study|Protocol defined stopping criteria|1|||
144374960|NCT01485172|520581760|FG005|Overall Study|Protocol defined stopping criteria|0|||
144374961|NCT01485172|520581755|FG000|Overall Study|Lost to Follow-up|0|||
144374962|NCT01485172|520581756|FG001|Overall Study|Lost to Follow-up|0|||
144374963|NCT01485172|520581757|FG002|Overall Study|Lost to Follow-up|1|||
144374964|NCT01485172|520581758|FG003|Overall Study|Lost to Follow-up|0|||
144374965|NCT01485172|520581759|FG004|Overall Study|Lost to Follow-up|0|||
144721744|NCT01595009|521835276|FG001|Extension|Administrative problems|0|||
144721745|NCT01595009|521835277|FG002|Extension|Administrative problems|0|||
144721746|NCT01595009|521835278|FG003|Extension|Administrative problems|1|||
144374966|NCT01485172|520581760|FG005|Overall Study|Lost to Follow-up|1|||
144374967|NCT01485172|520581755|FG000|Overall Study|Physician Decision|0|||
144374968|NCT01485172|520581756|FG001|Overall Study|Physician Decision|0|||
144374969|NCT01485172|520581757|FG002|Overall Study|Physician Decision|0|||
144374970|NCT01485172|520581758|FG003|Overall Study|Physician Decision|0|||
144374971|NCT01485172|520581759|FG004|Overall Study|Physician Decision|1|||
144374972|NCT01485172|520581760|FG005|Overall Study|Physician Decision|0|||
144374973|NCT01485172|520581755|FG000|Overall Study|Withdrawal by Subject|2|||
144374974|NCT01485172|520581756|FG001|Overall Study|Withdrawal by Subject|0|||
144374975|NCT01485172|520581757|FG002|Overall Study|Withdrawal by Subject|0|||
144374976|NCT01485172|520581758|FG003|Overall Study|Withdrawal by Subject|1|||
144374977|NCT01485172|520581759|FG004|Overall Study|Withdrawal by Subject|1|||
144374978|NCT01485172|520581760|FG005|Overall Study|Withdrawal by Subject|1|||
144511876|NCT02723955|521076028|FG017|Escalation Phase|Death|7|||
144511877|NCT02723955|521076029|FG018|Escalation Phase|Death|1|||
144511878|NCT02723955|521076030|FG019|Escalation Phase|Death|3|||
144511879|NCT02723955|521076031|FG020|Escalation Phase|Death|13|||
144511880|NCT02723955|521076032|FG021|Escalation Phase|Death|3|||
144511881|NCT02723955|521076033|FG022|Escalation Phase|Death|2|||
144511882|NCT02723955|521076034|FG023|Escalation Phase|Death|4|||
144511883|NCT02723955|521076035|FG024|Escalation Phase|Death|31|||
144511884|NCT02723955|521076036|FG025|Escalation Phase|Death|7|||
144511885|NCT02723955|521076037|FG026|Escalation Phase|Death|13|||
144511886|NCT02723955|521076038|FG027|Escalation Phase|Death|0|||
144511887|NCT02723955|521076039|FG028|Escalation Phase|Death|1|||
144511888|NCT02723955|521076040|FG029|Escalation Phase|Death|0|||
144511889|NCT02723955|521076041|FG030|Escalation Phase|Death|0|||
144511890|NCT02723955|521076042|FG031|Escalation Phase|Death|0|||
144511891|NCT02723955|521076043|FG032|Escalation Phase|Death|0|||
144511892|NCT02723955|521076044|FG033|Escalation Phase|Death|0|||
144511893|NCT02723955|521076045|FG034|Escalation Phase|Death|0|||
144511894|NCT02723955|521076046|FG035|Escalation Phase|Death|0|||
144511895|NCT02723955|521076047|FG036|Escalation Phase|Death|0|||
144511896|NCT02723955|521076048|FG037|Escalation Phase|Death|0|||
144511897|NCT02723955|521076049|FG038|Escalation Phase|Death|0|||
144511898|NCT02723955|521076050|FG039|Escalation Phase|Death|0|||
144511899|NCT02723955|521076051|FG040|Escalation Phase|Death|0|||
144511900|NCT02723955|521076052|FG041|Escalation Phase|Death|0|||
144511901|NCT02723955|521076053|FG042|Escalation Phase|Death|0|||
144511902|NCT02723955|521076011|FG000|Escalation Phase|Lost to Follow-up|0|||
144511903|NCT02723955|521076012|FG001|Escalation Phase|Lost to Follow-up|0|||
144511904|NCT02723955|521076013|FG002|Escalation Phase|Lost to Follow-up|0|||
144511905|NCT02723955|521076014|FG003|Escalation Phase|Lost to Follow-up|0|||
144511906|NCT02723955|521076015|FG004|Escalation Phase|Lost to Follow-up|0|||
144511907|NCT02723955|521076016|FG005|Escalation Phase|Lost to Follow-up|2|||
144511908|NCT02723955|521076017|FG006|Escalation Phase|Lost to Follow-up|1|||
144511909|NCT02723955|521076018|FG007|Escalation Phase|Lost to Follow-up|1|||
144511910|NCT02723955|521076019|FG008|Escalation Phase|Lost to Follow-up|1|||
144511911|NCT02723955|521076020|FG009|Escalation Phase|Lost to Follow-up|0|||
144511912|NCT02723955|521076021|FG010|Escalation Phase|Lost to Follow-up|0|||
144511913|NCT02723955|521076022|FG011|Escalation Phase|Lost to Follow-up|0|||
144511914|NCT02723955|521076023|FG012|Escalation Phase|Lost to Follow-up|1|||
144511915|NCT02723955|521076024|FG013|Escalation Phase|Lost to Follow-up|0|||
144511916|NCT02723955|521076025|FG014|Escalation Phase|Lost to Follow-up|0|||
144511917|NCT02723955|521076026|FG015|Escalation Phase|Lost to Follow-up|0|||
144511918|NCT02723955|521076027|FG016|Escalation Phase|Lost to Follow-up|1|||
144511919|NCT02723955|521076028|FG017|Escalation Phase|Lost to Follow-up|2|||
144511920|NCT02723955|521076029|FG018|Escalation Phase|Lost to Follow-up|0|||
144511921|NCT02723955|521076030|FG019|Escalation Phase|Lost to Follow-up|1|||
144511922|NCT02723955|521076031|FG020|Escalation Phase|Lost to Follow-up|2|||
144511923|NCT02723955|521076032|FG021|Escalation Phase|Lost to Follow-up|1|||
144511924|NCT02723955|521076033|FG022|Escalation Phase|Lost to Follow-up|0|||
144511925|NCT02723955|521076034|FG023|Escalation Phase|Lost to Follow-up|0|||
144511926|NCT02723955|521076035|FG024|Escalation Phase|Lost to Follow-up|1|||
144511927|NCT02723955|521076036|FG025|Escalation Phase|Lost to Follow-up|1|||
144511928|NCT02723955|521076037|FG026|Escalation Phase|Lost to Follow-up|3|||
144511929|NCT02723955|521076038|FG027|Escalation Phase|Lost to Follow-up|0|||
144511930|NCT02723955|521076039|FG028|Escalation Phase|Lost to Follow-up|1|||
144511931|NCT02723955|521076040|FG029|Escalation Phase|Lost to Follow-up|0|||
144511932|NCT02723955|521076041|FG030|Escalation Phase|Lost to Follow-up|0|||
144511933|NCT02723955|521076042|FG031|Escalation Phase|Lost to Follow-up|0|||
144511934|NCT02723955|521076043|FG032|Escalation Phase|Lost to Follow-up|0|||
144511935|NCT02723955|521076044|FG033|Escalation Phase|Lost to Follow-up|0|||
144511936|NCT02723955|521076045|FG034|Escalation Phase|Lost to Follow-up|0|||
144511937|NCT02723955|521076046|FG035|Escalation Phase|Lost to Follow-up|0|||
144511938|NCT02723955|521076047|FG036|Escalation Phase|Lost to Follow-up|0|||
144511939|NCT02723955|521076048|FG037|Escalation Phase|Lost to Follow-up|0|||
144511940|NCT02723955|521076049|FG038|Escalation Phase|Lost to Follow-up|0|||
144511941|NCT02723955|521076050|FG039|Escalation Phase|Lost to Follow-up|0|||
144511942|NCT02723955|521076051|FG040|Escalation Phase|Lost to Follow-up|0|||
144511943|NCT02723955|521076052|FG041|Escalation Phase|Lost to Follow-up|0|||
144511944|NCT02723955|521076053|FG042|Escalation Phase|Lost to Follow-up|0|||
144511945|NCT02723955|521076011|FG000|Escalation Phase|Physician Decision|0|||
144511946|NCT02723955|521076012|FG001|Escalation Phase|Physician Decision|0|||
144511947|NCT02723955|521076013|FG002|Escalation Phase|Physician Decision|0|||
144511948|NCT02723955|521076014|FG003|Escalation Phase|Physician Decision|0|||
144511949|NCT02723955|521076015|FG004|Escalation Phase|Physician Decision|0|||
144511950|NCT02723955|521076016|FG005|Escalation Phase|Physician Decision|2|||
144511951|NCT02723955|521076017|FG006|Escalation Phase|Physician Decision|0|||
144511952|NCT02723955|521076018|FG007|Escalation Phase|Physician Decision|0|||
144511953|NCT02723955|521076019|FG008|Escalation Phase|Physician Decision|0|||
144374979|NCT01587014|520581761|FG000|Overall Study|Death|2|||
144374980|NCT02948088|520581765|FG000|Overall Study|Lost to Follow-up|8|||
144374981|NCT02948088|520581765|FG000|Overall Study|Death|1|||
144374982|NCT02948088|520581765|FG000|Overall Study|Withdrawal by Subject|4|||
144374983|NCT02948088|520581765|FG000|Overall Study|Other|2|||
144374984|NCT01409811|520581766|FG000|Overall Study|Insurance denial|1|||
144374985|NCT00634101|520581767|FG000|Overall Study|Study Terminated|3|||
144374986|NCT00634101|520581768|FG001|Overall Study|Study Terminated|3|||
144374987|NCT00634101|520581767|FG000|Overall Study|Lost to Follow-up|2|||
144374988|NCT00634101|520581768|FG001|Overall Study|Lost to Follow-up|0|||
144374989|NCT00838513|520581770|FG000|Screening Period|Screen Failure|3|||
144374990|NCT00838513|520581770|FG000|Extension Treatment Period|Death|1|||
144374991|NCT00838513|520581770|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
144374992|NCT00139477|520581774|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
144374993|NCT00139477|520581775|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
144374994|NCT00139477|520581774|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
144374995|NCT00139477|520581775|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
144374996|NCT00139477|520581774|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
144374997|NCT00139477|520581775|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
144374998|NCT00139477|520581774|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
144374999|NCT00139477|520581775|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
144375000|NCT00139477|520581774|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
144375001|NCT00139477|520581775|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
144375002|NCT00139477|520581774|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
144375003|NCT00139477|520581775|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
144375004|NCT00139477|520581774|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
144375005|NCT00139477|520581775|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
144375006|NCT00975780|520581776|FG000|Follow Up|Death|88|||
144375007|NCT00975780|520581777|FG001|Follow Up|Death|122|||
144375008|NCT00975780|520581776|FG000|Follow Up|Facility Withdrawal|7|||
144375009|NCT00975780|520581777|FG001|Follow Up|Facility Withdrawal|23|||
144375010|NCT00975780|520581776|FG000|Follow Up|Discharged from Facility|7|||
144375011|NCT00975780|520581777|FG001|Follow Up|Discharged from Facility|12|||
144375012|NCT01077076|520581780|FG000|First Intervention|Withdrawal by Subject|1|||
144375013|NCT01077076|520581781|FG001|First Intervention|Withdrawal by Subject|0|||
144375014|NCT01077076|520581782|FG002|First Intervention|Withdrawal by Subject|0|||
144375015|NCT01077076|520581783|FG003|First Intervention|Withdrawal by Subject|0|||
144375016|NCT01077076|520581784|FG004|First Intervention|Withdrawal by Subject|0|||
144375017|NCT01077076|520581785|FG005|First Intervention|Withdrawal by Subject|0|||
144375018|NCT01077076|520581780|FG000|Third Intervention|Death in the participant's family|0|||
144375019|NCT01077076|520581781|FG001|Third Intervention|Death in the participant's family|0|||
144375020|NCT01077076|520581782|FG002|Third Intervention|Death in the participant's family|0|||
144375021|NCT01077076|520581783|FG003|Third Intervention|Death in the participant's family|0|||
144375022|NCT01077076|520581784|FG004|Third Intervention|Death in the participant's family|0|||
144375023|NCT01077076|520581785|FG005|Third Intervention|Death in the participant's family|1|||
144375024|NCT01976741|520581788|FG000|Overall Study|Withdrawal by Subject|1|||
144375025|NCT01976741|520581789|FG001|Overall Study|Withdrawal by Subject|0|||
144375026|NCT01976741|520581790|FG002|Overall Study|Withdrawal by Subject|1|||
144375027|NCT01976741|520581791|FG003|Overall Study|Withdrawal by Subject|1|||
144375028|NCT01976741|520581792|FG004|Overall Study|Withdrawal by Subject|0|||
144375029|NCT01976741|520581793|FG005|Overall Study|Withdrawal by Subject|0|||
144375030|NCT01976741|520581794|FG006|Overall Study|Withdrawal by Subject|1|||
144375031|NCT01976741|520581795|FG007|Overall Study|Withdrawal by Subject|4|||
144375032|NCT01976741|520581796|FG008|Overall Study|Withdrawal by Subject|0|||
144375033|NCT01976741|520581797|FG009|Overall Study|Withdrawal by Subject|0|||
144375034|NCT01976741|520581788|FG000|Overall Study|Adverse Event|0|||
144375035|NCT01976741|520581789|FG001|Overall Study|Adverse Event|0|||
144375036|NCT01976741|520581790|FG002|Overall Study|Adverse Event|2|||
144375037|NCT01976741|520581791|FG003|Overall Study|Adverse Event|0|||
144375038|NCT01976741|520581792|FG004|Overall Study|Adverse Event|0|||
144375039|NCT01976741|520581793|FG005|Overall Study|Adverse Event|0|||
144375040|NCT01976741|520581794|FG006|Overall Study|Adverse Event|3|||
144375041|NCT01976741|520581795|FG007|Overall Study|Adverse Event|8|||
144375042|NCT01976741|520581796|FG008|Overall Study|Adverse Event|1|||
144375043|NCT01976741|520581797|FG009|Overall Study|Adverse Event|4|||
144375044|NCT00670306|520581798|FG000|Overall Study|Adverse Event|8|||
144375045|NCT00670306|520581798|FG000|Overall Study|Lack of Efficacy|10|||
144375046|NCT00670306|520581798|FG000|Overall Study|Withdrawal by Subject|9|||
144375047|NCT00670306|520581798|FG000|Overall Study|Physician Decision|1|||
144375048|NCT00670306|520581798|FG000|Overall Study|Lost to Follow-up|8|||
144375049|NCT00670306|520581798|FG000|Overall Study|incl/excl criterias did not meet|19|||
144375050|NCT01301027|520581799|FG000|Overall Study|Physician Decision|2|||
144375051|NCT01301027|520581800|FG001|Overall Study|Physician Decision|0|||
144375052|NCT01301027|520581799|FG000|Overall Study|Withdrawal by Subject|2|||
144375053|NCT01301027|520581800|FG001|Overall Study|Withdrawal by Subject|3|||
144375054|NCT01301027|520581799|FG000|Overall Study|Adverse Event|0|||
144375055|NCT01301027|520581800|FG001|Overall Study|Adverse Event|2|||
144375056|NCT01301027|520581799|FG000|Overall Study|Fracture|1|||
144375057|NCT01301027|520581800|FG001|Overall Study|Fracture|3|||
144375058|NCT01301027|520581799|FG000|Overall Study|Transplant|0|||
144375059|NCT01301027|520581800|FG001|Overall Study|Transplant|2|||
144375060|NCT01301027|520581799|FG000|Overall Study|Volume Overload|3|||
144375061|NCT01301027|520581800|FG001|Overall Study|Volume Overload|0|||
144375062|NCT03566485|520581801|FG000|Overall Study|Disease progression|5|||
144375063|NCT03566485|520581802|FG001|Overall Study|Disease progression|4|||
144375064|NCT03566485|520581801|FG000|Overall Study|Clinical progression|0|||
144375065|NCT03566485|520581802|FG001|Overall Study|Clinical progression|1|||
144375066|NCT03566485|520581801|FG000|Overall Study|Toxicity|0|||
144375067|NCT03566485|520581802|FG001|Overall Study|Toxicity|2|||
144375068|NCT01192191|520581803|FG000|Overall Study|Adverse Event|7|||
144375069|NCT01192191|520581804|FG001|Overall Study|Adverse Event|12|||
144375070|NCT01192191|520581803|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
144375071|NCT01192191|520581804|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
144375072|NCT01192191|520581803|FG000|Overall Study|Lost to Follow-up|0|||
144375073|NCT01192191|520581804|FG001|Overall Study|Lost to Follow-up|1|||
144375074|NCT01192191|520581803|FG000|Overall Study|Withdrawal by Subject|1|||
144375075|NCT01192191|520581804|FG001|Overall Study|Withdrawal by Subject|6|||
144375076|NCT02624986|520581810|FG000|Overall Study|Death|0|||
144375077|NCT02624986|520581811|FG001|Overall Study|Death|1|||
144375078|NCT02624986|520581812|FG002|Overall Study|Death|2|||
144375079|NCT02624986|520581813|FG003|Overall Study|Death|2|||
144375080|NCT02624986|520581814|FG004|Overall Study|Death|2|||
144375081|NCT02624986|520581815|FG005|Overall Study|Death|0|||
144375082|NCT02624986|520581816|FG006|Overall Study|Death|0|||
144375083|NCT02624986|520581817|FG007|Overall Study|Death|1|||
144375084|NCT02624986|520581810|FG000|Overall Study|Study Terminated by Sponsor|1|||
144375085|NCT02624986|520581811|FG001|Overall Study|Study Terminated by Sponsor|1|||
144375086|NCT02624986|520581812|FG002|Overall Study|Study Terminated by Sponsor|0|||
144375087|NCT02624986|520581813|FG003|Overall Study|Study Terminated by Sponsor|1|||
144375088|NCT02624986|520581814|FG004|Overall Study|Study Terminated by Sponsor|2|||
144375089|NCT02624986|520581815|FG005|Overall Study|Study Terminated by Sponsor|2|||
144375090|NCT02624986|520581816|FG006|Overall Study|Study Terminated by Sponsor|4|||
144375091|NCT02624986|520581817|FG007|Overall Study|Study Terminated by Sponsor|3|||
144375092|NCT02624986|520581810|FG000|Overall Study|Progressive Disease|0|||
144375093|NCT02624986|520581811|FG001|Overall Study|Progressive Disease|1|||
144375094|NCT02624986|520581812|FG002|Overall Study|Progressive Disease|0|||
144375095|NCT02624986|520581813|FG003|Overall Study|Progressive Disease|0|||
144375096|NCT02624986|520581814|FG004|Overall Study|Progressive Disease|0|||
144375097|NCT02624986|520581815|FG005|Overall Study|Progressive Disease|0|||
144375098|NCT02624986|520581816|FG006|Overall Study|Progressive Disease|0|||
144375099|NCT02624986|520581817|FG007|Overall Study|Progressive Disease|0|||
144375100|NCT02624986|520581810|FG000|Overall Study|Protocol Violation|1|||
144375101|NCT02624986|520581811|FG001|Overall Study|Protocol Violation|0|||
144375102|NCT02624986|520581812|FG002|Overall Study|Protocol Violation|0|||
144375103|NCT02624986|520581813|FG003|Overall Study|Protocol Violation|0|||
144375104|NCT02624986|520581814|FG004|Overall Study|Protocol Violation|0|||
144375105|NCT02624986|520581815|FG005|Overall Study|Protocol Violation|0|||
144375106|NCT02624986|520581816|FG006|Overall Study|Protocol Violation|0|||
144375107|NCT02624986|520581817|FG007|Overall Study|Protocol Violation|0|||
144375108|NCT02624986|520581810|FG000|Overall Study|Withdrawal by Subject|0|||
144375109|NCT02624986|520581811|FG001|Overall Study|Withdrawal by Subject|0|||
144375110|NCT02624986|520581812|FG002|Overall Study|Withdrawal by Subject|0|||
144375111|NCT02624986|520581813|FG003|Overall Study|Withdrawal by Subject|0|||
144375112|NCT02624986|520581814|FG004|Overall Study|Withdrawal by Subject|0|||
144375113|NCT02624986|520581815|FG005|Overall Study|Withdrawal by Subject|0|||
144375114|NCT02624986|520581816|FG006|Overall Study|Withdrawal by Subject|0|||
144375115|NCT02624986|520581817|FG007|Overall Study|Withdrawal by Subject|1|||
144375116|NCT01668589|520581818|FG000|Overall Study|Lost to Follow-up|29|||
144375117|NCT01668589|520581819|FG001|Overall Study|Lost to Follow-up|37|||
144375118|NCT01668589|520581820|FG002|Overall Study|Lost to Follow-up|15|||
144375119|NCT01668589|520581821|FG003|Overall Study|Lost to Follow-up|5|||
144375120|NCT01668589|520581818|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
144375121|NCT01668589|520581819|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
144375122|NCT01668589|520581820|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
144375123|NCT01668589|520581821|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
144375124|NCT01668589|520581818|FG000|Overall Study|Death|12|||
144375125|NCT01668589|520581819|FG001|Overall Study|Death|3|||
144375126|NCT01668589|520581820|FG002|Overall Study|Death|2|||
144375127|NCT01668589|520581821|FG003|Overall Study|Death|11|||
144375128|NCT01668589|520581818|FG000|Overall Study|Other|44|||
144375129|NCT01668589|520581819|FG001|Overall Study|Other|10|||
144375130|NCT01668589|520581820|FG002|Overall Study|Other|7|||
144375131|NCT01668589|520581821|FG003|Overall Study|Other|15|||
144375132|NCT02116205|520581822|FG000|Overall Study|Withdrawal by Subject|2|||
144375133|NCT02116205|520581823|FG001|Overall Study|Withdrawal by Subject|4|||
144375134|NCT02116205|520581824|FG002|Overall Study|Withdrawal by Subject|1|||
144375135|NCT02116205|520581825|FG003|Overall Study|Withdrawal by Subject|3|||
144375136|NCT02116205|520581822|FG000|Overall Study|Lost to Follow-up|0|||
144375137|NCT02116205|520581823|FG001|Overall Study|Lost to Follow-up|2|||
144375138|NCT02116205|520581824|FG002|Overall Study|Lost to Follow-up|1|||
144375139|NCT02116205|520581825|FG003|Overall Study|Lost to Follow-up|2|||
144375140|NCT02116205|520581822|FG000|Overall Study|Physician Decision|0|||
144375141|NCT02116205|520581823|FG001|Overall Study|Physician Decision|1|||
144375142|NCT02116205|520581824|FG002|Overall Study|Physician Decision|1|||
144375143|NCT02116205|520581825|FG003|Overall Study|Physician Decision|1|||
144375144|NCT02116205|520581822|FG000|Overall Study|Exclusion criteria|0|||
144375145|NCT02116205|520581823|FG001|Overall Study|Exclusion criteria|0|||
144375146|NCT02116205|520581824|FG002|Overall Study|Exclusion criteria|1|||
144375147|NCT02116205|520581825|FG003|Overall Study|Exclusion criteria|0|||
144375148|NCT04200352|520581831|FG000|Overall Study|Death|1|||
144375149|NCT04200352|520581831|FG000|Overall Study|Adverse Event|6|||
144375150|NCT04200352|520581831|FG000|Overall Study|Withdrawal by parent/guardian|6|||
144375151|NCT04200352|520581831|FG000|Overall Study|Lack of Efficacy|1|||
144375152|NCT04200352|520581831|FG000|Overall Study|Other than specified|6|||
144375153|NCT00806819|520581832|FG000|Overall Study|progressive disease (modified RECIST )|217|||
144375154|NCT00806819|520581833|FG001|Overall Study|progressive disease (modified RECIST )|216|||
144375155|NCT00806819|520581832|FG000|Overall Study|Worsening or AE of underlying disease|18|||
144375156|NCT00806819|520581833|FG001|Overall Study|Worsening or AE of underlying disease|25|||
144375157|NCT00806819|520581832|FG000|Overall Study|Other AE|38|||
144375158|NCT00806819|520581833|FG001|Overall Study|Other AE|40|||
144375159|NCT00806819|520581832|FG000|Overall Study|Protocol Violation|9|||
144375160|NCT00806819|520581833|FG001|Overall Study|Protocol Violation|4|||
144375161|NCT00806819|520581832|FG000|Overall Study|Lost to Follow-up|1|||
144375162|NCT00806819|520581833|FG001|Overall Study|Lost to Follow-up|0|||
144375163|NCT00806819|520581832|FG000|Overall Study|Withdrawal by Subject|32|||
144375164|NCT00806819|520581833|FG001|Overall Study|Withdrawal by Subject|29|||
144375165|NCT00806819|520581832|FG000|Overall Study|Not treated|6|||
144375166|NCT00806819|520581833|FG001|Overall Study|Not treated|3|||
144375167|NCT00806819|520581832|FG000|Overall Study|Reasons other than stated above|25|||
144375168|NCT00806819|520581833|FG001|Overall Study|Reasons other than stated above|41|||
144375169|NCT02302339|520581836|FG000|Overall Study|Lost to Follow-up|1|||
144375170|NCT02302339|520581837|FG001|Overall Study|Lost to Follow-up|0|||
144375171|NCT02302339|520581838|FG002|Overall Study|Lost to Follow-up|0|||
144375172|NCT02302339|520581839|FG003|Overall Study|Lost to Follow-up|0|||
144375173|NCT02302339|520581836|FG000|Overall Study|Withdrawal by Subject|0|||
144375174|NCT02302339|520581837|FG001|Overall Study|Withdrawal by Subject|2|||
144375175|NCT02302339|520581838|FG002|Overall Study|Withdrawal by Subject|1|||
144375176|NCT02302339|520581839|FG003|Overall Study|Withdrawal by Subject|0|||
144375177|NCT02752165|520581842|FG000|Overall Study|Withdrawal by Subject|6|||
144375178|NCT02752165|520581843|FG001|Overall Study|Withdrawal by Subject|6|||
144375179|NCT02752165|520581842|FG000|Overall Study|Protocol Violation|6|||
144375180|NCT02752165|520581843|FG001|Overall Study|Protocol Violation|5|||
144375181|NCT02752165|520581842|FG000|Overall Study|Lost to Follow-up|33|||
144375182|NCT02752165|520581843|FG001|Overall Study|Lost to Follow-up|38|||
144375183|NCT00912197|520581844|FG000|Overall Study|Withdrawal by Subject|3|||
144375184|NCT00912197|520581845|FG001|Overall Study|Withdrawal by Subject|3|||
144375185|NCT01326104|520581853|FG000|Overall Study|progressed prior to vaccine|0|||
144375186|NCT01326104|520581854|FG001|Overall Study|progressed prior to vaccine|2|||
144375187|NCT01326104|520581853|FG000|Overall Study|unable to make vaccine|0|||
144375188|NCT01326104|520581854|FG001|Overall Study|unable to make vaccine|2|||
144375189|NCT00494676|520581857|FG000|Allocation|Withdrawal by Subject|2|||
144375190|NCT00494676|520581858|FG001|Allocation|Withdrawal by Subject|4|||
144375191|NCT00494676|520581857|FG000|First Intervention|Withdrawal by Subject|1|||
144375192|NCT00494676|520581858|FG001|First Intervention|Withdrawal by Subject|3|||
144375193|NCT00494676|520581857|FG000|Second Intervention|Withdrawal by Subject|1|||
144375194|NCT00494676|520581858|FG001|Second Intervention|Withdrawal by Subject|1|||
144375195|NCT04073225|520581860|FG000|Overall Study|Lost to Follow-up|4|||
144375196|NCT04073225|520581861|FG001|Overall Study|Lost to Follow-up|3|||
144375197|NCT04695977|520581863|FG000|Overall Study|Sponsor Decision|9|||
144375198|NCT04695977|520581864|FG001|Overall Study|Sponsor Decision|4|||
144375199|NCT04695977|520581863|FG000|Overall Study|Death|2|||
144375200|NCT04695977|520581864|FG001|Overall Study|Death|5|||
144375201|NCT00775593|520582887|FG000|Overall Study|Unmet eligibility criteria|6|||
144375202|NCT00775593|520582887|FG000|Overall Study|Death|1|||
144375203|NCT02067676|520582888|FG000|Overall Study|Withdrawal by Subject|1|||
144375204|NCT02067676|520582889|FG001|Overall Study|Withdrawal by Subject|0|||
144375205|NCT02067676|520582890|FG002|Overall Study|Withdrawal by Subject|0|||
144375206|NCT02067676|520582891|FG003|Overall Study|Withdrawal by Subject|0|||
144375207|NCT02067676|520582892|FG004|Overall Study|Withdrawal by Subject|0|||
144375208|NCT02067676|520582893|FG005|Overall Study|Withdrawal by Subject|0|||
144375209|NCT00996333|520582894|FG000|Overall Study|Screen failure|1|||
144375210|NCT00996333|520582894|FG000|Overall Study|Withdrawal by Subject|1|||
144375211|NCT00996333|520582894|FG000|Overall Study|Death|4|||
144375212|NCT00996333|520582894|FG000|Overall Study|Adverse Event|1|||
144375213|NCT00996333|520582894|FG000|Overall Study|Physician Decision|1|||
144375214|NCT00996333|520582894|FG000|Overall Study|Other|5|||
144375215|NCT01327482|520582895|FG000|Overall Study|Adverse Event|1|||
144375216|NCT03865381|520582898|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
144591061|NCT00490724|521364185|FG002|Period II|Treatment Discontinuation|3|||
144375217|NCT03865381|520582898|FG000|Overall Study|Withdrawal by Subject|2|||
144375218|NCT04999852|520582899|FG000|Overall Study|Withdrawal by Subject|11|||
144375219|NCT04999852|520582900|FG001|Overall Study|Withdrawal by Subject|1|||
144471688|NCT01226511|520925264|FG001|Acute Treatment Period|Lost to Follow-up|6|||
144471689|NCT01226511|520925263|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
144471690|NCT01226511|520925264|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
144471691|NCT01226511|520925263|FG000|Acute Treatment Period|Protocol Violation|5|||
144471692|NCT01226511|520925264|FG001|Acute Treatment Period|Protocol Violation|5|||
144471693|NCT01226511|520925263|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
144471694|NCT01226511|520925264|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
144471695|NCT01226511|520925263|FG000|Extension Treatment Period|Adverse Event|8|||
144471696|NCT01226511|520925264|FG001|Extension Treatment Period|Adverse Event|8|||
144471697|NCT01226511|520925263|FG000|Extension Treatment Period|Lack of Efficacy|3|||
144471698|NCT01226511|520925264|FG001|Extension Treatment Period|Lack of Efficacy|2|||
144471699|NCT01226511|520925263|FG000|Extension Treatment Period|Lost to Follow-up|4|||
144471700|NCT01226511|520925264|FG001|Extension Treatment Period|Lost to Follow-up|3|||
144471701|NCT01226511|520925263|FG000|Extension Treatment Period|Protocol Violation|2|||
144471702|NCT01226511|520925264|FG001|Extension Treatment Period|Protocol Violation|2|||
144471703|NCT01226511|520925263|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
144471704|NCT01226511|520925264|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
144471705|NCT01226511|520925263|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
144471706|NCT01226511|520925264|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
144471707|NCT01226511|520925263|FG000|Extension Treatment Period|Sponsor Decision|1|||
144471708|NCT01226511|520925264|FG001|Extension Treatment Period|Sponsor Decision|1|||
144471709|NCT01226511|520925263|FG000|Taper Period|Adverse Event|1|||
144471710|NCT01226511|520925264|FG001|Taper Period|Adverse Event|0|||
144471711|NCT01226511|520925263|FG000|Taper Period|Lost to Follow-up|2|||
144471712|NCT01226511|520925264|FG001|Taper Period|Lost to Follow-up|2|||
144471713|NCT01226511|520925263|FG000|Taper Period|Protocol Violation|1|||
144471714|NCT01226511|520925264|FG001|Taper Period|Protocol Violation|0|||
144471715|NCT01226511|520925263|FG000|Taper Period|Parent/Caregiver Decision|1|||
144471716|NCT01226511|520925264|FG001|Taper Period|Parent/Caregiver Decision|1|||
144471717|NCT05267600|520925265|FG000|Overall Study|Adverse Event|1|||
144471718|NCT05267600|520925266|FG001|Overall Study|Adverse Event|4|||
144471719|NCT05267600|520925265|FG000|Overall Study|Death|1|||
144471720|NCT05267600|520925266|FG001|Overall Study|Death|2|||
144471721|NCT05267600|520925265|FG000|Overall Study|Lack of Efficacy|1|||
144471722|NCT05267600|520925266|FG001|Overall Study|Lack of Efficacy|2|||
144471723|NCT05267600|520925265|FG000|Overall Study|Lost to Follow-up|3|||
144471724|NCT05267600|520925266|FG001|Overall Study|Lost to Follow-up|0|||
144471725|NCT05267600|520925265|FG000|Overall Study|Physician Decision|4|||
144471726|NCT05267600|520925266|FG001|Overall Study|Physician Decision|0|||
144471727|NCT05267600|520925265|FG000|Overall Study|Treatment Unblinded|0|||
144471728|NCT05267600|520925266|FG001|Overall Study|Treatment Unblinded|1|||
144471729|NCT05267600|520925265|FG000|Overall Study|Withdrawal by Subject|5|||
144471730|NCT05267600|520925266|FG001|Overall Study|Withdrawal by Subject|4|||
144471731|NCT04067401|520925267|FG000|Overall Study|Withdrawal by Subject|7|||
144471732|NCT04067401|520925268|FG001|Overall Study|Withdrawal by Subject|0|||
144471733|NCT04067401|520925267|FG000|Overall Study|no data provided|1|||
144471734|NCT04067401|520925268|FG001|Overall Study|no data provided|0|||
144471735|NCT05292534|520925271|FG000|Overall Study|Protocol Violation|3|||
144471736|NCT05292534|520925272|FG001|Overall Study|Protocol Violation|4|||
144471737|NCT05292534|520925271|FG000|Overall Study|Withdrawal by Subject|0|||
144471738|NCT05292534|520925272|FG001|Overall Study|Withdrawal by Subject|1|||
144471739|NCT01538472|520925273|FG000|Overall Study|Disease Progression|3|||
144471740|NCT01538472|520925273|FG000|Overall Study|Death|1|||
144471741|NCT00948974|520925274|FG000|Overall Study|Lost to Follow-up|23|||
144471742|NCT00948974|520925275|FG001|Overall Study|Lost to Follow-up|20|||
144471743|NCT00238433|520925277|FG000|Overall Study|Screen failure|1|||
144471744|NCT00238433|520925277|FG000|Overall Study|Lost to Follow-up|1|||
144471745|NCT00238433|520925277|FG000|Overall Study|Death|1|||
144511954|NCT02723955|521076020|FG009|Escalation Phase|Physician Decision|0|||
144511955|NCT02723955|521076021|FG010|Escalation Phase|Physician Decision|0|||
144511956|NCT02723955|521076022|FG011|Escalation Phase|Physician Decision|0|||
144511957|NCT02723955|521076023|FG012|Escalation Phase|Physician Decision|0|||
144511958|NCT02723955|521076024|FG013|Escalation Phase|Physician Decision|0|||
144511959|NCT02723955|521076025|FG014|Escalation Phase|Physician Decision|0|||
144511960|NCT02723955|521076026|FG015|Escalation Phase|Physician Decision|0|||
144511961|NCT02723955|521076027|FG016|Escalation Phase|Physician Decision|0|||
144511962|NCT02723955|521076028|FG017|Escalation Phase|Physician Decision|0|||
144511963|NCT02723955|521076029|FG018|Escalation Phase|Physician Decision|0|||
144511964|NCT02723955|521076030|FG019|Escalation Phase|Physician Decision|0|||
144511965|NCT02723955|521076031|FG020|Escalation Phase|Physician Decision|0|||
144511966|NCT02723955|521076032|FG021|Escalation Phase|Physician Decision|0|||
144511967|NCT02723955|521076033|FG022|Escalation Phase|Physician Decision|0|||
144511968|NCT02723955|521076034|FG023|Escalation Phase|Physician Decision|0|||
144511969|NCT02723955|521076035|FG024|Escalation Phase|Physician Decision|0|||
144511970|NCT02723955|521076036|FG025|Escalation Phase|Physician Decision|0|||
144511971|NCT02723955|521076037|FG026|Escalation Phase|Physician Decision|2|||
144511972|NCT02723955|521076038|FG027|Escalation Phase|Physician Decision|0|||
144511973|NCT02723955|521076039|FG028|Escalation Phase|Physician Decision|0|||
144511974|NCT02723955|521076040|FG029|Escalation Phase|Physician Decision|0|||
144511975|NCT02723955|521076041|FG030|Escalation Phase|Physician Decision|0|||
144511976|NCT02723955|521076042|FG031|Escalation Phase|Physician Decision|0|||
144511977|NCT02723955|521076043|FG032|Escalation Phase|Physician Decision|0|||
144511978|NCT02723955|521076044|FG033|Escalation Phase|Physician Decision|0|||
144511979|NCT02723955|521076045|FG034|Escalation Phase|Physician Decision|0|||
144511980|NCT02723955|521076046|FG035|Escalation Phase|Physician Decision|0|||
144511981|NCT02723955|521076047|FG036|Escalation Phase|Physician Decision|0|||
144511982|NCT02723955|521076048|FG037|Escalation Phase|Physician Decision|0|||
144511983|NCT02723955|521076049|FG038|Escalation Phase|Physician Decision|0|||
144511984|NCT02723955|521076050|FG039|Escalation Phase|Physician Decision|0|||
144511985|NCT02723955|521076051|FG040|Escalation Phase|Physician Decision|0|||
144511986|NCT02723955|521076052|FG041|Escalation Phase|Physician Decision|0|||
144511987|NCT02723955|521076053|FG042|Escalation Phase|Physician Decision|0|||
144511988|NCT02723955|521076011|FG000|Escalation Phase|Withdrawal by Subject|0|||
144511989|NCT02723955|521076012|FG001|Escalation Phase|Withdrawal by Subject|0|||
144511990|NCT02723955|521076013|FG002|Escalation Phase|Withdrawal by Subject|0|||
144511991|NCT02723955|521076014|FG003|Escalation Phase|Withdrawal by Subject|0|||
144511992|NCT02723955|521076015|FG004|Escalation Phase|Withdrawal by Subject|1|||
144511993|NCT02723955|521076016|FG005|Escalation Phase|Withdrawal by Subject|1|||
144511994|NCT02723955|521076017|FG006|Escalation Phase|Withdrawal by Subject|1|||
144511995|NCT02723955|521076018|FG007|Escalation Phase|Withdrawal by Subject|1|||
144511996|NCT02723955|521076019|FG008|Escalation Phase|Withdrawal by Subject|0|||
144511997|NCT02723955|521076020|FG009|Escalation Phase|Withdrawal by Subject|0|||
144511998|NCT02723955|521076021|FG010|Escalation Phase|Withdrawal by Subject|0|||
144511999|NCT02723955|521076022|FG011|Escalation Phase|Withdrawal by Subject|0|||
144512000|NCT02723955|521076023|FG012|Escalation Phase|Withdrawal by Subject|1|||
144512001|NCT02723955|521076024|FG013|Escalation Phase|Withdrawal by Subject|0|||
144512002|NCT02723955|521076025|FG014|Escalation Phase|Withdrawal by Subject|0|||
144512003|NCT02723955|521076026|FG015|Escalation Phase|Withdrawal by Subject|0|||
144512004|NCT02723955|521076027|FG016|Escalation Phase|Withdrawal by Subject|1|||
144512005|NCT02723955|521076028|FG017|Escalation Phase|Withdrawal by Subject|0|||
144512006|NCT02723955|521076029|FG018|Escalation Phase|Withdrawal by Subject|0|||
144512007|NCT02723955|521076030|FG019|Escalation Phase|Withdrawal by Subject|0|||
144512008|NCT02723955|521076031|FG020|Escalation Phase|Withdrawal by Subject|0|||
144512009|NCT02723955|521076032|FG021|Escalation Phase|Withdrawal by Subject|0|||
144512010|NCT02723955|521076033|FG022|Escalation Phase|Withdrawal by Subject|0|||
144512011|NCT02723955|521076034|FG023|Escalation Phase|Withdrawal by Subject|2|||
144512012|NCT02723955|521076035|FG024|Escalation Phase|Withdrawal by Subject|0|||
144512013|NCT02723955|521076036|FG025|Escalation Phase|Withdrawal by Subject|1|||
144512014|NCT02723955|521076037|FG026|Escalation Phase|Withdrawal by Subject|0|||
144512015|NCT02723955|521076038|FG027|Escalation Phase|Withdrawal by Subject|0|||
144512016|NCT02723955|521076039|FG028|Escalation Phase|Withdrawal by Subject|1|||
144512017|NCT02723955|521076040|FG029|Escalation Phase|Withdrawal by Subject|0|||
144512018|NCT02723955|521076041|FG030|Escalation Phase|Withdrawal by Subject|0|||
144512019|NCT02723955|521076042|FG031|Escalation Phase|Withdrawal by Subject|0|||
144512020|NCT02723955|521076043|FG032|Escalation Phase|Withdrawal by Subject|0|||
144512021|NCT02723955|521076044|FG033|Escalation Phase|Withdrawal by Subject|0|||
144512022|NCT02723955|521076045|FG034|Escalation Phase|Withdrawal by Subject|0|||
144512023|NCT02723955|521076046|FG035|Escalation Phase|Withdrawal by Subject|0|||
144512024|NCT02723955|521076047|FG036|Escalation Phase|Withdrawal by Subject|0|||
144512025|NCT02723955|521076048|FG037|Escalation Phase|Withdrawal by Subject|0|||
144512026|NCT02723955|521076049|FG038|Escalation Phase|Withdrawal by Subject|0|||
144512027|NCT02723955|521076050|FG039|Escalation Phase|Withdrawal by Subject|0|||
144512028|NCT02723955|521076051|FG040|Escalation Phase|Withdrawal by Subject|0|||
144375220|NCT04999852|520582899|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
144375221|NCT04999852|520582900|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
144375222|NCT05626322|520582901|FG000|Overall Study|Death|2|||
144375223|NCT05626322|520582902|FG001|Overall Study|Death|0|||
144375224|NCT05626322|520582903|FG002|Overall Study|Death|0|||
144375225|NCT05626322|520582901|FG000|Overall Study|Physician Decision|1|||
144375226|NCT05626322|520582902|FG001|Overall Study|Physician Decision|0|||
144375227|NCT05626322|520582903|FG002|Overall Study|Physician Decision|0|||
144375228|NCT05626322|520582901|FG000|Overall Study|Progressive Disease|0|||
144375229|NCT05626322|520582902|FG001|Overall Study|Progressive Disease|1|||
144375230|NCT05626322|520582903|FG002|Overall Study|Progressive Disease|1|||
144375231|NCT05626322|520582901|FG000|Overall Study|Study terminated by sponsor|0|||
144375232|NCT05626322|520582902|FG001|Overall Study|Study terminated by sponsor|1|||
144375233|NCT05626322|520582903|FG002|Overall Study|Study terminated by sponsor|0|||
144375234|NCT03776812|520582904|FG000|Overall Study|Death|53|||
144375235|NCT03776812|520582905|FG001|Overall Study|Death|49|||
144375236|NCT03776812|520582906|FG002|Overall Study|Death|56|||
144375237|NCT03776812|520582904|FG000|Overall Study|Withdrawal by Subject|1|||
144375238|NCT03776812|520582905|FG001|Overall Study|Withdrawal by Subject|7|||
144375239|NCT03776812|520582906|FG002|Overall Study|Withdrawal by Subject|2|||
144375240|NCT03776812|520582904|FG000|Overall Study|Lost to Follow-up|1|||
144375241|NCT03776812|520582905|FG001|Overall Study|Lost to Follow-up|1|||
144375242|NCT03776812|520582906|FG002|Overall Study|Lost to Follow-up|0|||
144375243|NCT03776812|520582904|FG000|Overall Study|Did not enter long-term follow-up|3|||
144375244|NCT03776812|520582905|FG001|Overall Study|Did not enter long-term follow-up|3|||
144375245|NCT03776812|520582906|FG002|Overall Study|Did not enter long-term follow-up|2|||
144375246|NCT04758637|520582909|FG000|Overall Study|Lost to Follow-up|0|||
144375247|NCT04758637|520582910|FG001|Overall Study|Lost to Follow-up|1|||
144375248|NCT04758637|520582911|FG002|Overall Study|Lost to Follow-up|0|||
144375249|NCT04758637|520582912|FG003|Overall Study|Lost to Follow-up|0|||
144375250|NCT03350672|520582918|FG000|Overall Study|Withdrawal by Subject|7|||
144375251|NCT03350672|520582919|FG001|Overall Study|Withdrawal by Subject|0|||
144375252|NCT03350672|520582920|FG002|Overall Study|Withdrawal by Subject|0|||
144375253|NCT00048074|520582923|FG000|Overall Study|Adverse Event|46|||
144375254|NCT00048074|520582924|FG001|Overall Study|Adverse Event|41|||
144375255|NCT00048074|520582925|FG002|Overall Study|Adverse Event|53|||
144375256|NCT00048074|520582923|FG000|Overall Study|Death|3|||
144375257|NCT00048074|520582924|FG001|Overall Study|Death|3|||
144375258|NCT00048074|520582925|FG002|Overall Study|Death|2|||
144375259|NCT00048074|520582923|FG000|Overall Study|Lost to Follow-up|2|||
144375260|NCT00048074|520582924|FG001|Overall Study|Lost to Follow-up|6|||
144375261|NCT00048074|520582925|FG002|Overall Study|Lost to Follow-up|6|||
144375262|NCT00048074|520582923|FG000|Overall Study|Withdrawal by Subject|28|||
144375263|NCT00048074|520582924|FG001|Overall Study|Withdrawal by Subject|30|||
144375264|NCT00048074|520582925|FG002|Overall Study|Withdrawal by Subject|35|||
144375265|NCT00048074|520582923|FG000|Overall Study|Protocol Violation|1|||
144375266|NCT00048074|520582924|FG001|Overall Study|Protocol Violation|3|||
144375267|NCT00048074|520582925|FG002|Overall Study|Protocol Violation|0|||
144375268|NCT00048074|520582923|FG000|Overall Study|Study participation was terminated|0|||
144375269|NCT00048074|520582924|FG001|Overall Study|Study participation was terminated|1|||
144375270|NCT00048074|520582925|FG002|Overall Study|Study participation was terminated|0|||
144375271|NCT00048074|520582923|FG000|Overall Study|Husband ill|0|||
144375272|NCT00048074|520582924|FG001|Overall Study|Husband ill|1|||
144375273|NCT00048074|520582925|FG002|Overall Study|Husband ill|0|||
144375274|NCT00048074|520582923|FG000|Overall Study|Poor compliance|0|||
144375275|NCT00048074|520582924|FG001|Overall Study|Poor compliance|1|||
144375276|NCT00048074|520582925|FG002|Overall Study|Poor compliance|0|||
144375277|NCT00048074|520582923|FG000|Overall Study|Out of station|0|||
144721747|NCT01595009|521835275|FG000|Extension|Patients completed per protocol|0|||
144721748|NCT01595009|521835276|FG001|Extension|Patients completed per protocol|0|||
144721749|NCT01595009|521835277|FG002|Extension|Patients completed per protocol|0|||
144721750|NCT01595009|521835278|FG003|Extension|Patients completed per protocol|2|||
144375278|NCT00048074|520582924|FG001|Overall Study|Out of station|1|||
144375279|NCT00048074|520582925|FG002|Overall Study|Out of station|1|||
144375280|NCT00048074|520582923|FG000|Overall Study|Social reasons|1|||
144375281|NCT00048074|520582924|FG001|Overall Study|Social reasons|0|||
144375282|NCT00048074|520582925|FG002|Overall Study|Social reasons|0|||
144375283|NCT02873377|520582926|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
144375284|NCT02873377|520582927|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
144375285|NCT02873377|520582926|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
144375286|NCT02873377|520582927|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
144375287|NCT01583296|520582930|FG000|Overall Study|Withdrawal by Subject|11|||
144375288|NCT01583296|520582931|FG001|Overall Study|Withdrawal by Subject|10|||
144375289|NCT01047553|520582932|FG000|Overall Study|Adverse Event|10|||
144375290|NCT01047553|520582933|FG001|Overall Study|Adverse Event|5|||
144375291|NCT01047553|520582932|FG000|Overall Study|Withdrawal by Subject|4|||
144375292|NCT01047553|520582933|FG001|Overall Study|Withdrawal by Subject|2|||
144721751|NCT01595009|521835275|FG000|Extension|Disease progression|0|||
144512029|NCT02723955|521076052|FG041|Escalation Phase|Withdrawal by Subject|0|||
144512030|NCT02723955|521076053|FG042|Escalation Phase|Withdrawal by Subject|0|||
144512031|NCT02723955|521076011|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512032|NCT02723955|521076012|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512033|NCT02723955|521076013|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512034|NCT02723955|521076014|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512035|NCT02723955|521076015|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
144512036|NCT02723955|521076016|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
144512037|NCT02723955|521076017|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
144512038|NCT02723955|521076018|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
144512039|NCT02723955|521076019|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
144512040|NCT02723955|521076020|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512041|NCT02723955|521076021|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512042|NCT02723955|521076022|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512043|NCT02723955|521076023|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512044|NCT02723955|521076024|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512045|NCT02723955|521076025|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512046|NCT02723955|521076026|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512047|NCT02723955|521076027|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512048|NCT02723955|521076028|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512049|NCT02723955|521076029|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512050|NCT02723955|521076030|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512051|NCT02723955|521076031|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512052|NCT02723955|521076032|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512053|NCT02723955|521076033|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512054|NCT02723955|521076034|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512055|NCT02723955|521076035|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512056|NCT02723955|521076036|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512057|NCT02723955|521076037|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512058|NCT02723955|521076038|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512059|NCT02723955|521076039|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512060|NCT02723955|521076040|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512061|NCT02723955|521076041|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512062|NCT02723955|521076042|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512063|NCT02723955|521076043|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512064|NCT02723955|521076044|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512065|NCT02723955|521076045|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512066|NCT02723955|521076046|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512067|NCT02723955|521076047|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512068|NCT02723955|521076048|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512069|NCT02723955|521076049|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512070|NCT02723955|521076050|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144721752|NCT01595009|521835276|FG001|Extension|Disease progression|0|||
144375293|NCT01047553|520582932|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
144375294|NCT01047553|520582933|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
144375295|NCT01047553|520582932|FG000|Overall Study|Lost to Follow-up|1|||
144375296|NCT01047553|520582933|FG001|Overall Study|Lost to Follow-up|0|||
144375297|NCT01047553|520582932|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
144375298|NCT01047553|520582933|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
144375299|NCT01047553|520582932|FG000|Overall Study|PI's decision|0|||
144375300|NCT01047553|520582933|FG001|Overall Study|PI's decision|1|||
144375301|NCT01063283|520582934|FG000|Cycle 1|Adverse Event|2|||
144375302|NCT01063283|520582935|FG001|Cycle 1|Adverse Event|0|||
144375303|NCT01063283|520582936|FG002|Cycle 1|Adverse Event|0|||
144375304|NCT01063283|520582934|FG000|Cycle 1|Technical failure in data collection|1|||
144375305|NCT01063283|520582935|FG001|Cycle 1|Technical failure in data collection|0|||
144375306|NCT01063283|520582936|FG002|Cycle 1|Technical failure in data collection|0|||
144375307|NCT03237286|520582939|FG000|Overall Study|Withdrawal by Subject|1|||
144375308|NCT03237286|520582940|FG001|Overall Study|Withdrawal by Subject|0|||
144375309|NCT03237286|520582941|FG002|Overall Study|Withdrawal by Subject|2|||
144375310|NCT03237286|520582939|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
144375311|NCT03237286|520582940|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
144375312|NCT03237286|520582941|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
144375313|NCT00948441|520582942|FG000|Overall Study|no longer meet inclusion criteria|1|||
144375314|NCT00948441|520582943|FG001|Overall Study|no longer meet inclusion criteria|4|||
144375315|NCT02792829|520582944|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144375316|NCT02792829|520582945|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
144375317|NCT02792829|520582946|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144375318|NCT02792829|520582947|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144375319|NCT02792829|520582948|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144375320|NCT02792829|520582949|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144375321|NCT02792829|520582950|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144512071|NCT02723955|521076051|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512072|NCT02723955|521076052|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512073|NCT02723955|521076053|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
144512074|NCT02723955|521076011|FG000|Escalation Phase|Site Closed|0|||
144512075|NCT02723955|521076012|FG001|Escalation Phase|Site Closed|0|||
144512076|NCT02723955|521076013|FG002|Escalation Phase|Site Closed|0|||
144512077|NCT02723955|521076014|FG003|Escalation Phase|Site Closed|0|||
144512078|NCT02723955|521076015|FG004|Escalation Phase|Site Closed|0|||
144512079|NCT02723955|521076016|FG005|Escalation Phase|Site Closed|0|||
144512080|NCT02723955|521076017|FG006|Escalation Phase|Site Closed|0|||
144512081|NCT02723955|521076018|FG007|Escalation Phase|Site Closed|0|||
144512082|NCT02723955|521076019|FG008|Escalation Phase|Site Closed|0|||
144512083|NCT02723955|521076020|FG009|Escalation Phase|Site Closed|0|||
144375322|NCT02792829|520582951|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
144375323|NCT02792829|520582944|FG000|Treatment Period 2|Adverse Event|0|||
144375324|NCT02792829|520582945|FG001|Treatment Period 2|Adverse Event|0|||
144375325|NCT02792829|520582946|FG002|Treatment Period 2|Adverse Event|0|||
144375326|NCT02792829|520582947|FG003|Treatment Period 2|Adverse Event|0|||
144375327|NCT02792829|520582948|FG004|Treatment Period 2|Adverse Event|1|||
144375328|NCT02792829|520582949|FG005|Treatment Period 2|Adverse Event|0|||
144375329|NCT02792829|520582950|FG006|Treatment Period 2|Adverse Event|1|||
144375330|NCT02792829|520582951|FG007|Treatment Period 2|Adverse Event|1|||
144375331|NCT02792829|520582944|FG000|Treatment Period 2|Use of proscribed medications|0|||
144375332|NCT02792829|520582945|FG001|Treatment Period 2|Use of proscribed medications|0|||
144375333|NCT02792829|520582946|FG002|Treatment Period 2|Use of proscribed medications|0|||
144375334|NCT02792829|520582947|FG003|Treatment Period 2|Use of proscribed medications|0|||
144375335|NCT02792829|520582948|FG004|Treatment Period 2|Use of proscribed medications|0|||
144375336|NCT02792829|520582949|FG005|Treatment Period 2|Use of proscribed medications|0|||
144375337|NCT02792829|520582950|FG006|Treatment Period 2|Use of proscribed medications|0|||
144375338|NCT02792829|520582951|FG007|Treatment Period 2|Use of proscribed medications|1|||
144375339|NCT00104520|520582954|FG000|Overall Study|Unrelated adverse event|34|||
144512084|NCT02723955|521076021|FG010|Escalation Phase|Site Closed|0|||
144512085|NCT02723955|521076022|FG011|Escalation Phase|Site Closed|0|||
144512086|NCT02723955|521076023|FG012|Escalation Phase|Site Closed|0|||
144375340|NCT00104520|520582955|FG001|Overall Study|Unrelated adverse event|47|||
144375341|NCT00104520|520582954|FG000|Overall Study|Study drug intolerance|0|||
144375342|NCT00104520|520582955|FG001|Overall Study|Study drug intolerance|1|||
144375343|NCT00104520|520582954|FG000|Overall Study|Related adverse event|13|||
144375344|NCT00104520|520582955|FG001|Overall Study|Related adverse event|15|||
144375345|NCT00104520|520582954|FG000|Overall Study|Lost to Follow-up|1|||
144375346|NCT00104520|520582955|FG001|Overall Study|Lost to Follow-up|0|||
144512087|NCT02723955|521076024|FG013|Escalation Phase|Site Closed|0|||
144512088|NCT02723955|521076025|FG014|Escalation Phase|Site Closed|0|||
144375347|NCT00104520|520582954|FG000|Overall Study|Noncompliance|0|||
144375348|NCT00104520|520582955|FG001|Overall Study|Noncompliance|2|||
144375349|NCT00104520|520582954|FG000|Overall Study|Personal/administrative|1|||
144375350|NCT00104520|520582955|FG001|Overall Study|Personal/administrative|1|||
144375351|NCT00104520|520582954|FG000|Overall Study|Other|1|||
144375352|NCT00104520|520582955|FG001|Overall Study|Other|5|||
144375353|NCT01026324|520582957|FG000|Follow up/Survival|Withdrawal by Subject|1|||
144375354|NCT01026324|520582958|FG001|Follow up/Survival|Withdrawal by Subject|0|||
144375355|NCT01026324|520582959|FG002|Follow up/Survival|Withdrawal by Subject|0|||
144375356|NCT02442804|520582961|FG000|Overall Study|Withdrawal by Subject|0|||
144375357|NCT02442804|520582962|FG001|Overall Study|Withdrawal by Subject|1|||
144375358|NCT02442804|520582961|FG000|Overall Study|Adverse Event|1|||
144375359|NCT02442804|520582962|FG001|Overall Study|Adverse Event|0|||
144375360|NCT03568461|520582969|FG000|Overall Study|Death|7|||
144375361|NCT03568461|520582969|FG000|Overall Study|Physician Decision|5|||
144375362|NCT03568461|520582969|FG000|Overall Study|Subject decision|5|||
144375363|NCT03568461|520582969|FG000|Overall Study|Lost to Follow-up|1|||
144375364|NCT02355184|520582970|FG000|Overall Study|Lost to Follow-up|2|||
144375365|NCT02355184|520582970|FG000|Overall Study|Study Terminated|10|||
144375366|NCT02175199|520584395|FG000|Overall Study|Withdrawal by Subject|1|||
144375367|NCT02175199|520584396|FG001|Overall Study|Withdrawal by Subject|5|||
144375368|NCT02175199|520584395|FG000|Overall Study|Randomized in Error|1|||
144375369|NCT02175199|520584396|FG001|Overall Study|Randomized in Error|0|||
144375370|NCT02175199|520584395|FG000|Overall Study|Sponsor Decision|1|||
144375371|NCT02175199|520584396|FG001|Overall Study|Sponsor Decision|0|||
144512089|NCT02723955|521076026|FG015|Escalation Phase|Site Closed|1|||
144512090|NCT02723955|521076027|FG016|Escalation Phase|Site Closed|0|||
144512091|NCT02723955|521076028|FG017|Escalation Phase|Site Closed|2|||
144512092|NCT02723955|521076029|FG018|Escalation Phase|Site Closed|0|||
144512093|NCT02723955|521076030|FG019|Escalation Phase|Site Closed|0|||
144512094|NCT02723955|521076031|FG020|Escalation Phase|Site Closed|1|||
144512095|NCT02723955|521076032|FG021|Escalation Phase|Site Closed|0|||
144512096|NCT02723955|521076033|FG022|Escalation Phase|Site Closed|0|||
144512097|NCT02723955|521076034|FG023|Escalation Phase|Site Closed|0|||
144512098|NCT02723955|521076035|FG024|Escalation Phase|Site Closed|3|||
144512099|NCT02723955|521076036|FG025|Escalation Phase|Site Closed|1|||
144512100|NCT02723955|521076037|FG026|Escalation Phase|Site Closed|3|||
144512101|NCT02723955|521076038|FG027|Escalation Phase|Site Closed|1|||
144512102|NCT02723955|521076039|FG028|Escalation Phase|Site Closed|1|||
144512103|NCT02723955|521076040|FG029|Escalation Phase|Site Closed|0|||
144512104|NCT02723955|521076041|FG030|Escalation Phase|Site Closed|0|||
144512105|NCT02723955|521076042|FG031|Escalation Phase|Site Closed|0|||
144512106|NCT02723955|521076043|FG032|Escalation Phase|Site Closed|0|||
144512107|NCT02723955|521076044|FG033|Escalation Phase|Site Closed|0|||
144512108|NCT02723955|521076045|FG034|Escalation Phase|Site Closed|0|||
144512109|NCT02723955|521076046|FG035|Escalation Phase|Site Closed|0|||
144512110|NCT02723955|521076047|FG036|Escalation Phase|Site Closed|0|||
144512111|NCT02723955|521076048|FG037|Escalation Phase|Site Closed|0|||
144512112|NCT02723955|521076049|FG038|Escalation Phase|Site Closed|0|||
144512113|NCT02723955|521076050|FG039|Escalation Phase|Site Closed|0|||
144512114|NCT02723955|521076051|FG040|Escalation Phase|Site Closed|0|||
144512115|NCT02723955|521076052|FG041|Escalation Phase|Site Closed|0|||
144512116|NCT02723955|521076053|FG042|Escalation Phase|Site Closed|0|||
144512117|NCT02723955|521076011|FG000|Expansion Phase|Death|0|||
144512118|NCT02723955|521076012|FG001|Expansion Phase|Death|0|||
144512119|NCT02723955|521076013|FG002|Expansion Phase|Death|0|||
144512120|NCT02723955|521076014|FG003|Expansion Phase|Death|0|||
144375372|NCT03983317|520584403|FG000|Overall Study|Physician Decision|5|||
144375373|NCT01761162|520584404|FG000|Overall Study|Withdrawal by Subject|3|||
144512121|NCT02723955|521076015|FG004|Expansion Phase|Death|0|||
144375374|NCT04681352|520584405|FG000|Overall Study|Lost to Follow-up|2|||
144375375|NCT04681352|520584405|FG000|Overall Study|Withdrawal by Subject|22|||
144512122|NCT02723955|521076016|FG005|Expansion Phase|Death|0|||
144512123|NCT02723955|521076017|FG006|Expansion Phase|Death|0|||
144512124|NCT02723955|521076018|FG007|Expansion Phase|Death|0|||
144512125|NCT02723955|521076019|FG008|Expansion Phase|Death|0|||
144512126|NCT02723955|521076020|FG009|Expansion Phase|Death|25|||
144512127|NCT02723955|521076021|FG010|Expansion Phase|Death|69|||
144512128|NCT02723955|521076022|FG011|Expansion Phase|Death|48|||
144512129|NCT02723955|521076023|FG012|Expansion Phase|Death|0|||
144512130|NCT02723955|521076024|FG013|Expansion Phase|Death|0|||
144512131|NCT02723955|521076025|FG014|Expansion Phase|Death|0|||
144512132|NCT02723955|521076026|FG015|Expansion Phase|Death|0|||
144512133|NCT02723955|521076027|FG016|Expansion Phase|Death|0|||
144512134|NCT02723955|521076028|FG017|Expansion Phase|Death|0|||
144512135|NCT02723955|521076029|FG018|Expansion Phase|Death|0|||
144512136|NCT02723955|521076030|FG019|Expansion Phase|Death|0|||
144512137|NCT02723955|521076031|FG020|Expansion Phase|Death|0|||
144512138|NCT02723955|521076032|FG021|Expansion Phase|Death|0|||
144512139|NCT02723955|521076033|FG022|Expansion Phase|Death|0|||
144512140|NCT02723955|521076034|FG023|Expansion Phase|Death|0|||
144512141|NCT02723955|521076035|FG024|Expansion Phase|Death|0|||
144512142|NCT02723955|521076036|FG025|Expansion Phase|Death|0|||
144512143|NCT02723955|521076037|FG026|Expansion Phase|Death|0|||
144512144|NCT02723955|521076038|FG027|Expansion Phase|Death|0|||
144512145|NCT02723955|521076039|FG028|Expansion Phase|Death|0|||
144512146|NCT02723955|521076040|FG029|Expansion Phase|Death|12|||
144512147|NCT02723955|521076041|FG030|Expansion Phase|Death|202|||
144512148|NCT02723955|521076042|FG031|Expansion Phase|Death|31|||
144512149|NCT02723955|521076043|FG032|Expansion Phase|Death|17|||
144512150|NCT02723955|521076044|FG033|Expansion Phase|Death|2|||
144512151|NCT02723955|521076045|FG034|Expansion Phase|Death|3|||
144512152|NCT02723955|521076046|FG035|Expansion Phase|Death|3|||
144512153|NCT02723955|521076047|FG036|Expansion Phase|Death|1|||
144512154|NCT02723955|521076048|FG037|Expansion Phase|Death|0|||
144512155|NCT02723955|521076049|FG038|Expansion Phase|Death|0|||
144512156|NCT02723955|521076050|FG039|Expansion Phase|Death|0|||
144512157|NCT02723955|521076051|FG040|Expansion Phase|Death|0|||
144512158|NCT02723955|521076052|FG041|Expansion Phase|Death|0|||
144512159|NCT02723955|521076053|FG042|Expansion Phase|Death|0|||
144512160|NCT02723955|521076011|FG000|Expansion Phase|Lost to Follow-up|0|||
144512161|NCT02723955|521076012|FG001|Expansion Phase|Lost to Follow-up|0|||
144512162|NCT02723955|521076013|FG002|Expansion Phase|Lost to Follow-up|0|||
144512163|NCT02723955|521076014|FG003|Expansion Phase|Lost to Follow-up|0|||
144512164|NCT02723955|521076015|FG004|Expansion Phase|Lost to Follow-up|0|||
144512165|NCT02723955|521076016|FG005|Expansion Phase|Lost to Follow-up|0|||
144512166|NCT02723955|521076017|FG006|Expansion Phase|Lost to Follow-up|0|||
144512167|NCT02723955|521076018|FG007|Expansion Phase|Lost to Follow-up|0|||
144512168|NCT02723955|521076019|FG008|Expansion Phase|Lost to Follow-up|0|||
144512169|NCT02723955|521076020|FG009|Expansion Phase|Lost to Follow-up|0|||
144512170|NCT02723955|521076021|FG010|Expansion Phase|Lost to Follow-up|4|||
144512171|NCT02723955|521076022|FG011|Expansion Phase|Lost to Follow-up|1|||
144512172|NCT02723955|521076023|FG012|Expansion Phase|Lost to Follow-up|0|||
144512173|NCT02723955|521076024|FG013|Expansion Phase|Lost to Follow-up|0|||
144512174|NCT02723955|521076025|FG014|Expansion Phase|Lost to Follow-up|0|||
144512175|NCT02723955|521076026|FG015|Expansion Phase|Lost to Follow-up|0|||
144512176|NCT02723955|521076027|FG016|Expansion Phase|Lost to Follow-up|0|||
144512177|NCT02723955|521076028|FG017|Expansion Phase|Lost to Follow-up|0|||
144512178|NCT02723955|521076029|FG018|Expansion Phase|Lost to Follow-up|0|||
144512179|NCT02723955|521076030|FG019|Expansion Phase|Lost to Follow-up|0|||
144512180|NCT02723955|521076031|FG020|Expansion Phase|Lost to Follow-up|0|||
144512181|NCT02723955|521076032|FG021|Expansion Phase|Lost to Follow-up|0|||
144512182|NCT02723955|521076033|FG022|Expansion Phase|Lost to Follow-up|0|||
144512183|NCT02723955|521076034|FG023|Expansion Phase|Lost to Follow-up|0|||
144512184|NCT02723955|521076035|FG024|Expansion Phase|Lost to Follow-up|0|||
144512185|NCT02723955|521076036|FG025|Expansion Phase|Lost to Follow-up|0|||
144512186|NCT02723955|521076037|FG026|Expansion Phase|Lost to Follow-up|0|||
144512187|NCT02723955|521076038|FG027|Expansion Phase|Lost to Follow-up|0|||
144512188|NCT02723955|521076039|FG028|Expansion Phase|Lost to Follow-up|0|||
144512189|NCT02723955|521076040|FG029|Expansion Phase|Lost to Follow-up|1|||
144512190|NCT02723955|521076041|FG030|Expansion Phase|Lost to Follow-up|19|||
144375376|NCT01643772|520584406|FG000|Overall Study|Protocol Violation|0|||
144375377|NCT01643772|520584407|FG001|Overall Study|Protocol Violation|0|||
144375378|NCT01643772|520584408|FG002|Overall Study|Protocol Violation|0|||
144512191|NCT02723955|521076042|FG031|Expansion Phase|Lost to Follow-up|2|||
144512192|NCT02723955|521076043|FG032|Expansion Phase|Lost to Follow-up|1|||
144512193|NCT02723955|521076044|FG033|Expansion Phase|Lost to Follow-up|0|||
144375379|NCT01643772|520584409|FG003|Overall Study|Protocol Violation|1|||
144375380|NCT01643772|520584406|FG000|Overall Study|Adverse Event|0|||
144512194|NCT02723955|521076045|FG034|Expansion Phase|Lost to Follow-up|0|||
144512195|NCT02723955|521076046|FG035|Expansion Phase|Lost to Follow-up|0|||
144512196|NCT02723955|521076047|FG036|Expansion Phase|Lost to Follow-up|0|||
144512197|NCT02723955|521076048|FG037|Expansion Phase|Lost to Follow-up|0|||
144512198|NCT02723955|521076049|FG038|Expansion Phase|Lost to Follow-up|0|||
144512199|NCT02723955|521076050|FG039|Expansion Phase|Lost to Follow-up|0|||
144512200|NCT02723955|521076051|FG040|Expansion Phase|Lost to Follow-up|0|||
144512201|NCT02723955|521076052|FG041|Expansion Phase|Lost to Follow-up|0|||
144512202|NCT02723955|521076053|FG042|Expansion Phase|Lost to Follow-up|0|||
144512203|NCT02723955|521076011|FG000|Expansion Phase|Physician Decision|0|||
144512204|NCT02723955|521076012|FG001|Expansion Phase|Physician Decision|0|||
144512205|NCT02723955|521076013|FG002|Expansion Phase|Physician Decision|0|||
144512206|NCT02723955|521076014|FG003|Expansion Phase|Physician Decision|0|||
144375381|NCT01643772|520584407|FG001|Overall Study|Adverse Event|0|||
144375382|NCT01643772|520584408|FG002|Overall Study|Adverse Event|0|||
144375383|NCT01643772|520584409|FG003|Overall Study|Adverse Event|1|||
144375384|NCT03436082|520584411|FG000|Overall Study|Did not undergo procedure|1|||
144375385|NCT03436082|520584412|FG001|Overall Study|Did not undergo procedure|0|||
144375386|NCT00724867|520584417|FG000|Overall Study|Adverse Event|25|||
144375387|NCT00724867|520584417|FG000|Overall Study|Lack of Efficacy|14|||
144375388|NCT00724867|520584417|FG000|Overall Study|Lost to Follow-up|12|||
144375389|NCT00724867|520584417|FG000|Overall Study|Non-compliance with study drug|6|||
144375390|NCT00724867|520584417|FG000|Overall Study|Physician Decision|17|||
144375391|NCT00724867|520584417|FG000|Overall Study|Protocol Violation|1|||
144375392|NCT00724867|520584417|FG000|Overall Study|Withdrawal by Subject|31|||
144375393|NCT00724867|520584417|FG000|Overall Study|Sponsor decision to end study|14|||
144375394|NCT00724867|520584417|FG000|Overall Study|Subject incarcerated|1|||
144375395|NCT00724867|520584417|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
144375396|NCT00724867|520584417|FG000|Overall Study|Subject moved out of state|1|||
144375397|NCT00724867|520584417|FG000|Overall Study|Elected to exit due to site closure|2|||
144375398|NCT00436345|520584418|FG000|Overall Study|ICU resident beyond follow-up period|3|||
144375399|NCT00436345|520584419|FG001|Overall Study|ICU resident beyond follow-up period|0|||
144375400|NCT01175083|520584420|FG000|Primary Epoch|Withdrawal by Subject|0|||
144375401|NCT01175083|520584421|FG001|Primary Epoch|Withdrawal by Subject|0|||
144375402|NCT01175083|520584422|FG002|Primary Epoch|Withdrawal by Subject|0|||
144375403|NCT01175083|520584423|FG003|Primary Epoch|Withdrawal by Subject|0|||
144375404|NCT01175083|520584424|FG004|Primary Epoch|Withdrawal by Subject|0|||
144375405|NCT01175083|520584425|FG005|Primary Epoch|Withdrawal by Subject|2|||
144375406|NCT01175083|520584420|FG000|Primary Epoch|Lost to Follow-up|0|||
144375407|NCT01175083|520584421|FG001|Primary Epoch|Lost to Follow-up|0|||
144375408|NCT01175083|520584422|FG002|Primary Epoch|Lost to Follow-up|0|||
144375409|NCT01175083|520584423|FG003|Primary Epoch|Lost to Follow-up|0|||
144375410|NCT01175083|520584424|FG004|Primary Epoch|Lost to Follow-up|0|||
144375411|NCT01175083|520584425|FG005|Primary Epoch|Lost to Follow-up|1|||
144375412|NCT01175083|520584420|FG000|Booster Epoch|Death|0|||
144375413|NCT01175083|520584421|FG001|Booster Epoch|Death|0|||
144375414|NCT01175083|520584422|FG002|Booster Epoch|Death|1|||
144375415|NCT01175083|520584423|FG003|Booster Epoch|Death|0|||
144375416|NCT01175083|520584424|FG004|Booster Epoch|Death|0|||
144375417|NCT01175083|520584425|FG005|Booster Epoch|Death|0|||
144375418|NCT01175083|520584420|FG000|Booster Epoch|Withdrawal by Subject|0|||
144375419|NCT01175083|520584421|FG001|Booster Epoch|Withdrawal by Subject|0|||
144375420|NCT01175083|520584422|FG002|Booster Epoch|Withdrawal by Subject|0|||
144375421|NCT01175083|520584423|FG003|Booster Epoch|Withdrawal by Subject|1|||
144375422|NCT01175083|520584424|FG004|Booster Epoch|Withdrawal by Subject|0|||
144375423|NCT01175083|520584425|FG005|Booster Epoch|Withdrawal by Subject|0|||
144375424|NCT01296672|520584426|FG000|Overall Study|Lost to Follow-up|73|||
144375425|NCT01296672|520584427|FG001|Overall Study|Lost to Follow-up|18|||
144375426|NCT01716052|520584428|FG000|Overall Study|Withdrawal of funding|1|||
144375427|NCT01716052|520584429|FG001|Overall Study|Withdrawal of funding|1|||
144375428|NCT04027608|520584432|FG000|Overall Study|Withdrawal by Subject|13|||
144375429|NCT04027608|520584433|FG001|Overall Study|Withdrawal by Subject|2|||
144375430|NCT04027608|520584432|FG000|Overall Study|Protocol Violation|2|||
144375431|NCT04027608|520584433|FG001|Overall Study|Protocol Violation|1|||
144375432|NCT04027608|520584432|FG000|Overall Study|Physician Decision|1|||
144375433|NCT04027608|520584433|FG001|Overall Study|Physician Decision|0|||
144375434|NCT04027608|520584432|FG000|Overall Study|Lost to Follow-up|20|||
144375435|NCT04027608|520584433|FG001|Overall Study|Lost to Follow-up|4|||
144375436|NCT00975689|520584438|FG000|Overall Study|Adverse Event|0|||
144375437|NCT00975689|520584439|FG001|Overall Study|Adverse Event|3|||
144375438|NCT00975689|520584438|FG000|Overall Study|Withdrawal by Subject|1|||
144375439|NCT00975689|520584439|FG001|Overall Study|Withdrawal by Subject|0|||
144375440|NCT00975689|520584438|FG000|Overall Study|Physician Decision|1|||
144375441|NCT00975689|520584439|FG001|Overall Study|Physician Decision|0|||
144375442|NCT04335136|520584440|FG000|Overall Study|Death|8|||
144375443|NCT04335136|520584441|FG001|Overall Study|Death|4|||
144375444|NCT04335136|520584440|FG000|Overall Study|Lost to Follow-up|2|||
144375445|NCT04335136|520584441|FG001|Overall Study|Lost to Follow-up|0|||
144375446|NCT04335136|520584440|FG000|Overall Study|Protocol Violation|1|||
144375447|NCT04335136|520584441|FG001|Overall Study|Protocol Violation|0|||
144375448|NCT04335136|520584440|FG000|Overall Study|Withdrawal by Subject|1|||
144375449|NCT04335136|520584441|FG001|Overall Study|Withdrawal by Subject|1|||
144375450|NCT04335136|520584440|FG000|Overall Study|Health-threatening condition|0|||
144375451|NCT04335136|520584441|FG001|Overall Study|Health-threatening condition|1|||
144375452|NCT04335136|520584440|FG000|Overall Study|Adverse Event|0|||
144375453|NCT04335136|520584441|FG001|Overall Study|Adverse Event|1|||
144375454|NCT04335136|520584440|FG000|Overall Study|Erroneously randomized|2|||
144375455|NCT04335136|520584441|FG001|Overall Study|Erroneously randomized|0|||
144375456|NCT01305577|520584445|FG000|Overall Study|Adverse Event|2|||
144375457|NCT01305577|520584446|FG001|Overall Study|Adverse Event|2|||
144375458|NCT01305577|520584447|FG002|Overall Study|Adverse Event|1|||
144512207|NCT02723955|521076015|FG004|Expansion Phase|Physician Decision|0|||
144512208|NCT02723955|521076016|FG005|Expansion Phase|Physician Decision|0|||
144512209|NCT02723955|521076017|FG006|Expansion Phase|Physician Decision|0|||
144512210|NCT02723955|521076018|FG007|Expansion Phase|Physician Decision|0|||
144512211|NCT02723955|521076019|FG008|Expansion Phase|Physician Decision|0|||
144512212|NCT02723955|521076020|FG009|Expansion Phase|Physician Decision|0|||
144512213|NCT02723955|521076021|FG010|Expansion Phase|Physician Decision|0|||
144512214|NCT02723955|521076022|FG011|Expansion Phase|Physician Decision|0|||
144512215|NCT02723955|521076023|FG012|Expansion Phase|Physician Decision|0|||
144512216|NCT02723955|521076024|FG013|Expansion Phase|Physician Decision|0|||
144512217|NCT02723955|521076025|FG014|Expansion Phase|Physician Decision|0|||
144512218|NCT02723955|521076026|FG015|Expansion Phase|Physician Decision|0|||
144512219|NCT02723955|521076027|FG016|Expansion Phase|Physician Decision|0|||
144512220|NCT02723955|521076028|FG017|Expansion Phase|Physician Decision|0|||
144512221|NCT02723955|521076029|FG018|Expansion Phase|Physician Decision|0|||
144512222|NCT02723955|521076030|FG019|Expansion Phase|Physician Decision|0|||
144512223|NCT02723955|521076031|FG020|Expansion Phase|Physician Decision|0|||
144512224|NCT02723955|521076032|FG021|Expansion Phase|Physician Decision|0|||
144512225|NCT02723955|521076033|FG022|Expansion Phase|Physician Decision|0|||
144512226|NCT02723955|521076034|FG023|Expansion Phase|Physician Decision|0|||
144512227|NCT02723955|521076035|FG024|Expansion Phase|Physician Decision|0|||
144512228|NCT02723955|521076036|FG025|Expansion Phase|Physician Decision|0|||
144512229|NCT02723955|521076037|FG026|Expansion Phase|Physician Decision|0|||
144512230|NCT02723955|521076038|FG027|Expansion Phase|Physician Decision|0|||
144512231|NCT02723955|521076039|FG028|Expansion Phase|Physician Decision|0|||
144512232|NCT02723955|521076040|FG029|Expansion Phase|Physician Decision|0|||
144512233|NCT02723955|521076041|FG030|Expansion Phase|Physician Decision|1|||
144512234|NCT02723955|521076042|FG031|Expansion Phase|Physician Decision|1|||
144512235|NCT02723955|521076043|FG032|Expansion Phase|Physician Decision|0|||
144512236|NCT02723955|521076044|FG033|Expansion Phase|Physician Decision|0|||
144512237|NCT02723955|521076045|FG034|Expansion Phase|Physician Decision|0|||
144512238|NCT02723955|521076046|FG035|Expansion Phase|Physician Decision|0|||
144512239|NCT02723955|521076047|FG036|Expansion Phase|Physician Decision|0|||
144512240|NCT02723955|521076048|FG037|Expansion Phase|Physician Decision|0|||
144512241|NCT02723955|521076049|FG038|Expansion Phase|Physician Decision|0|||
144512242|NCT02723955|521076050|FG039|Expansion Phase|Physician Decision|0|||
144512243|NCT02723955|521076051|FG040|Expansion Phase|Physician Decision|0|||
144512244|NCT02723955|521076052|FG041|Expansion Phase|Physician Decision|0|||
144512245|NCT02723955|521076053|FG042|Expansion Phase|Physician Decision|0|||
144512246|NCT02723955|521076011|FG000|Expansion Phase|Withdrawal by Subject|0|||
144512247|NCT02723955|521076012|FG001|Expansion Phase|Withdrawal by Subject|0|||
144512248|NCT02723955|521076013|FG002|Expansion Phase|Withdrawal by Subject|0|||
144512249|NCT02723955|521076014|FG003|Expansion Phase|Withdrawal by Subject|0|||
144512250|NCT02723955|521076015|FG004|Expansion Phase|Withdrawal by Subject|0|||
144512251|NCT02723955|521076016|FG005|Expansion Phase|Withdrawal by Subject|0|||
144512252|NCT02723955|521076017|FG006|Expansion Phase|Withdrawal by Subject|0|||
144512253|NCT02723955|521076018|FG007|Expansion Phase|Withdrawal by Subject|0|||
144512254|NCT02723955|521076019|FG008|Expansion Phase|Withdrawal by Subject|0|||
144512255|NCT02723955|521076020|FG009|Expansion Phase|Withdrawal by Subject|2|||
144512256|NCT02723955|521076021|FG010|Expansion Phase|Withdrawal by Subject|1|||
144512257|NCT02723955|521076022|FG011|Expansion Phase|Withdrawal by Subject|0|||
144512258|NCT02723955|521076023|FG012|Expansion Phase|Withdrawal by Subject|0|||
144512259|NCT02723955|521076024|FG013|Expansion Phase|Withdrawal by Subject|0|||
144512260|NCT02723955|521076025|FG014|Expansion Phase|Withdrawal by Subject|0|||
144512261|NCT02723955|521076026|FG015|Expansion Phase|Withdrawal by Subject|0|||
144512262|NCT02723955|521076027|FG016|Expansion Phase|Withdrawal by Subject|0|||
144512263|NCT02723955|521076028|FG017|Expansion Phase|Withdrawal by Subject|0|||
144512264|NCT02723955|521076029|FG018|Expansion Phase|Withdrawal by Subject|0|||
144512265|NCT02723955|521076030|FG019|Expansion Phase|Withdrawal by Subject|0|||
144512266|NCT02723955|521076031|FG020|Expansion Phase|Withdrawal by Subject|0|||
144512267|NCT02723955|521076032|FG021|Expansion Phase|Withdrawal by Subject|0|||
144512268|NCT02723955|521076033|FG022|Expansion Phase|Withdrawal by Subject|0|||
144512269|NCT02723955|521076034|FG023|Expansion Phase|Withdrawal by Subject|0|||
144512270|NCT02723955|521076035|FG024|Expansion Phase|Withdrawal by Subject|0|||
144512271|NCT02723955|521076036|FG025|Expansion Phase|Withdrawal by Subject|0|||
144512272|NCT02723955|521076037|FG026|Expansion Phase|Withdrawal by Subject|0|||
144512273|NCT02723955|521076038|FG027|Expansion Phase|Withdrawal by Subject|0|||
144512274|NCT02723955|521076039|FG028|Expansion Phase|Withdrawal by Subject|0|||
144512275|NCT02723955|521076040|FG029|Expansion Phase|Withdrawal by Subject|0|||
144512276|NCT02723955|521076041|FG030|Expansion Phase|Withdrawal by Subject|8|||
144512277|NCT02723955|521076042|FG031|Expansion Phase|Withdrawal by Subject|4|||
144512278|NCT02723955|521076043|FG032|Expansion Phase|Withdrawal by Subject|0|||
144512279|NCT02723955|521076044|FG033|Expansion Phase|Withdrawal by Subject|0|||
144512280|NCT02723955|521076045|FG034|Expansion Phase|Withdrawal by Subject|0|||
144512281|NCT02723955|521076046|FG035|Expansion Phase|Withdrawal by Subject|1|||
144375459|NCT01305577|520584445|FG000|Overall Study|Withdrawal by Subject|7|||
144375460|NCT01305577|520584446|FG001|Overall Study|Withdrawal by Subject|5|||
144375461|NCT01305577|520584447|FG002|Overall Study|Withdrawal by Subject|6|||
144375462|NCT01305577|520584445|FG000|Overall Study|Lost to Follow-up|4|||
144375463|NCT01305577|520584446|FG001|Overall Study|Lost to Follow-up|3|||
144375464|NCT01305577|520584447|FG002|Overall Study|Lost to Follow-up|2|||
144375465|NCT01305577|520584445|FG000|Overall Study|Protocol Deviation|0|||
144375466|NCT01305577|520584446|FG001|Overall Study|Protocol Deviation|1|||
144375467|NCT01305577|520584447|FG002|Overall Study|Protocol Deviation|1|||
144375468|NCT00796978|520584448|FG000|Overall Study|Cardiac adverse event|5|||
144375469|NCT00796978|520584448|FG000|Overall Study|Adverse Event|4|||
144375470|NCT00796978|520584448|FG000|Overall Study|Withdrawal by Subject|3|||
144375471|NCT00622440|520584461|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
144375472|NCT00622440|520584462|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
144375473|NCT00622440|520584461|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
144375474|NCT00622440|520584462|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
144375475|NCT00622440|520584461|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
144375476|NCT00622440|520584462|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
144375477|NCT00622440|520584461|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
144375478|NCT00622440|520584462|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
144375479|NCT02675634|520584463|FG000|Test Period 1|Adverse Event|0|||
144375480|NCT02675634|520584464|FG001|Test Period 1|Adverse Event|1|||
144375481|NCT02675634|520584465|FG002|Test Period 1|Adverse Event|0|||
144375482|NCT02675634|520584466|FG003|Test Period 1|Adverse Event|1|||
144375483|NCT02675634|520584467|FG004|Test Period 1|Adverse Event|0|||
144375484|NCT02675634|520584468|FG005|Test Period 1|Adverse Event|0|||
144375485|NCT02675634|520584463|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
144375486|NCT02675634|520584464|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
144375487|NCT02675634|520584465|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
144375488|NCT02675634|520584466|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
144375489|NCT02675634|520584467|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
144375490|NCT02675634|520584468|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
144375491|NCT02675634|520584463|FG000|Test Period 2|Lack of Efficacy|1|||
144375492|NCT02675634|520584464|FG001|Test Period 2|Lack of Efficacy|0|||
144375493|NCT02675634|520584465|FG002|Test Period 2|Lack of Efficacy|0|||
144375494|NCT02675634|520584466|FG003|Test Period 2|Lack of Efficacy|0|||
144375495|NCT02675634|520584467|FG004|Test Period 2|Lack of Efficacy|0|||
144375496|NCT02675634|520584468|FG005|Test Period 2|Lack of Efficacy|0|||
144375497|NCT02675634|520584463|FG000|Test Period 2|Adverse Event|0|||
144375498|NCT02675634|520584464|FG001|Test Period 2|Adverse Event|0|||
144375499|NCT02675634|520584465|FG002|Test Period 2|Adverse Event|0|||
144375500|NCT02675634|520584466|FG003|Test Period 2|Adverse Event|0|||
144375501|NCT02675634|520584467|FG004|Test Period 2|Adverse Event|0|||
144375502|NCT02675634|520584468|FG005|Test Period 2|Adverse Event|1|||
144375503|NCT01652534|520584469|FG000|Overall Study|Lack of Efficacy|1|||
144375504|NCT01652534|520584470|FG001|Overall Study|Lack of Efficacy|0|||
144375505|NCT02105961|520584471|FG000|Overall Study|Adverse Event|18|||
144375506|NCT02105961|520584472|FG001|Overall Study|Adverse Event|7|||
144375507|NCT02105961|520584473|FG002|Overall Study|Adverse Event|13|||
144375508|NCT02105961|520584471|FG000|Overall Study|Lack of Efficacy|3|||
144375509|NCT02105961|520584472|FG001|Overall Study|Lack of Efficacy|0|||
144375510|NCT02105961|520584473|FG002|Overall Study|Lack of Efficacy|3|||
144375511|NCT02105961|520584471|FG000|Overall Study|Lost to Follow-up|2|||
144375512|NCT02105961|520584472|FG001|Overall Study|Lost to Follow-up|0|||
144375513|NCT02105961|520584473|FG002|Overall Study|Lost to Follow-up|1|||
144375514|NCT02105961|520584471|FG000|Overall Study|Physician Decision|3|||
144375515|NCT02105961|520584472|FG001|Overall Study|Physician Decision|3|||
144375516|NCT02105961|520584473|FG002|Overall Study|Physician Decision|2|||
144375517|NCT02105961|520584471|FG000|Overall Study|Withdrawal by Subject|15|||
144375518|NCT02105961|520584472|FG001|Overall Study|Withdrawal by Subject|7|||
144375519|NCT02105961|520584473|FG002|Overall Study|Withdrawal by Subject|11|||
144375520|NCT03860259|520584474|FG000|Overall Study|Lost to Follow-up|5|||
144375521|NCT03860259|520584475|FG001|Overall Study|Lost to Follow-up|5|||
144375522|NCT03860259|520584474|FG000|Overall Study|Protocol Violation|1|||
144375523|NCT03860259|520584475|FG001|Overall Study|Protocol Violation|0|||
144375524|NCT00811018|520584476|FG000|Overall Study|Additional Chronic Treatment|31|||
144375525|NCT00811018|520584476|FG000|Overall Study|Adverse Event|79|||
144375526|NCT00811018|520584476|FG000|Overall Study|Death|147|||
144375527|NCT00811018|520584476|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
144375528|NCT00811018|520584476|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
144375529|NCT00811018|520584476|FG000|Overall Study|Investigator Decision|57|||
144375530|NCT00811018|520584476|FG000|Overall Study|Lost to Follow-up|19|||
144375531|NCT00811018|520584476|FG000|Overall Study|Pregnancy|6|||
144375532|NCT00811018|520584476|FG000|Overall Study|Sponsor Decision|450|||
144375533|NCT00811018|520584476|FG000|Overall Study|Withdrawal by Subject|70|||
144375534|NCT00811018|520584476|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
144375535|NCT00811018|520584476|FG000|Overall Study|Other|26|||
144375536|NCT02722304|520584480|FG000|Overall Study|Study Terminated by Sponsor|1|||
144375537|NCT02722304|520584481|FG001|Overall Study|Study Terminated by Sponsor|0|||
144375538|NCT02722304|520584482|FG002|Overall Study|Study Terminated by Sponsor|2|||
144375539|NCT02722304|520584483|FG003|Overall Study|Study Terminated by Sponsor|1|||
144375540|NCT02722304|520584484|FG004|Overall Study|Study Terminated by Sponsor|1|||
144375541|NCT02722304|520584480|FG000|Overall Study|Other|0|||
144375542|NCT02722304|520584481|FG001|Overall Study|Other|0|||
144375543|NCT02722304|520584482|FG002|Overall Study|Other|0|||
144375544|NCT02722304|520584483|FG003|Overall Study|Other|1|||
144375545|NCT02722304|520584484|FG004|Overall Study|Other|1|||
144375546|NCT04380519|520584487|FG000|Overall Study|Withdrawal by Subject|4|||
144375547|NCT04380519|520584488|FG001|Overall Study|Withdrawal by Subject|0|||
144375548|NCT04380519|520584489|FG002|Overall Study|Withdrawal by Subject|1|||
144375549|NCT04380519|520584487|FG000|Overall Study|Death|14|||
144375550|NCT04380519|520584488|FG001|Overall Study|Death|9|||
144375551|NCT04380519|520584489|FG002|Overall Study|Death|6|||
144375552|NCT04380519|520584487|FG000|Overall Study|Adverse Event|0|||
144375553|NCT04380519|520584488|FG001|Overall Study|Adverse Event|1|||
144375554|NCT04380519|520584489|FG002|Overall Study|Adverse Event|0|||
144375555|NCT04380519|520584487|FG000|Overall Study|relatives' decision|0|||
144375556|NCT04380519|520584488|FG001|Overall Study|relatives' decision|1|||
144375557|NCT04380519|520584489|FG002|Overall Study|relatives' decision|0|||
144375558|NCT02147561|520584494|FG000|Overall Study|Lost to Follow-up|3|||
144375559|NCT02147561|520584494|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
144375560|NCT00393861|520584495|FG000|Overall Study|Adverse Event|2|||
144375561|NCT00393861|520584495|FG000|Overall Study|Disease Progression|24|||
144375562|NCT05300763|520584496|FG000|Overall Study|Adverse Event|0|||
144375563|NCT05300763|520584497|FG001|Overall Study|Adverse Event|1|||
144375564|NCT05300763|520584496|FG000|Overall Study|Major Protocol Deviation|1|||
144375565|NCT05300763|520584497|FG001|Overall Study|Major Protocol Deviation|0|||
144375566|NCT05300763|520584496|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
144375567|NCT05300763|520584497|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
144375568|NCT02283762|520584501|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
144375569|NCT02283762|520584502|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
144375570|NCT02283762|520584501|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
144375571|NCT02283762|520584502|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
144375572|NCT02283762|520584501|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
144375573|NCT02283762|520584502|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
144375574|NCT02283762|520584501|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
144512282|NCT02723955|521076047|FG036|Expansion Phase|Withdrawal by Subject|0|||
144512283|NCT02723955|521076048|FG037|Expansion Phase|Withdrawal by Subject|0|||
144512284|NCT02723955|521076049|FG038|Expansion Phase|Withdrawal by Subject|0|||
144512285|NCT02723955|521076050|FG039|Expansion Phase|Withdrawal by Subject|0|||
144512286|NCT02723955|521076051|FG040|Expansion Phase|Withdrawal by Subject|0|||
144512287|NCT02723955|521076052|FG041|Expansion Phase|Withdrawal by Subject|0|||
144512288|NCT02723955|521076053|FG042|Expansion Phase|Withdrawal by Subject|0|||
144512289|NCT02723955|521076011|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512290|NCT02723955|521076012|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512291|NCT02723955|521076013|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512292|NCT02723955|521076014|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512293|NCT02723955|521076015|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512294|NCT02723955|521076016|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512295|NCT02723955|521076017|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512296|NCT02723955|521076018|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512297|NCT02723955|521076019|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512298|NCT02723955|521076020|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
144512299|NCT02723955|521076021|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
144512300|NCT02723955|521076022|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
144512301|NCT02723955|521076023|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512302|NCT02723955|521076024|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512303|NCT02723955|521076025|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144375575|NCT02283762|520584502|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
144375576|NCT02283762|520584501|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
144375577|NCT02283762|520584502|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
144375578|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
144375579|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
144375580|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
144375581|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
144375582|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
144375583|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
144375584|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
144375585|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
144375586|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
144375587|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
144375588|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
144375589|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
144375590|NCT02283762|520584501|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
144375591|NCT02283762|520584502|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
144375592|NCT02367833|520584503|FG000|Overall Study|Withdrawal by Subject|1|||
144375593|NCT02367833|520584504|FG001|Overall Study|Withdrawal by Subject|1|||
144375594|NCT02367833|520584505|FG002|Overall Study|Withdrawal by Subject|0|||
144375595|NCT00889720|520584508|FG000|Overall Study|Withdrawal by Subject|4|||
144375596|NCT00889720|520584508|FG000|Overall Study|Other|4|||
144375597|NCT00476229|520584509|FG000|Overall Study|Progressive shortness of breath|1|||
144375598|NCT02164461|520584510|FG000|Overall Study|Adverse Event|0|||
144375599|NCT02164461|520584511|FG001|Overall Study|Adverse Event|0|||
144375600|NCT02164461|520584512|FG002|Overall Study|Adverse Event|1|||
144375601|NCT02164461|520584510|FG000|Overall Study|Disease Progression|1|||
144375602|NCT02164461|520584511|FG001|Overall Study|Disease Progression|3|||
144375603|NCT02164461|520584512|FG002|Overall Study|Disease Progression|4|||
144375604|NCT02164461|520584510|FG000|Overall Study|Withdrawal by Subject|0|||
144375605|NCT02164461|520584511|FG001|Overall Study|Withdrawal by Subject|3|||
144375606|NCT02164461|520584512|FG002|Overall Study|Withdrawal by Subject|0|||
144375607|NCT02100696|520584514|FG000|Induction Phase|Adverse Event|0|||
144375608|NCT02100696|520584515|FG001|Induction Phase|Adverse Event|0|||
144375609|NCT02100696|520584516|FG002|Induction Phase|Adverse Event|1|||
144375610|NCT02100696|520584517|FG003|Induction Phase|Adverse Event|0|||
144375611|NCT02100696|520584518|FG004|Induction Phase|Adverse Event|0|||
144375612|NCT02100696|520584519|FG005|Induction Phase|Adverse Event|0|||
144375613|NCT02100696|520584514|FG000|Induction Phase|Lost to Follow-up|1|||
144375614|NCT02100696|520584515|FG001|Induction Phase|Lost to Follow-up|0|||
144375615|NCT02100696|520584516|FG002|Induction Phase|Lost to Follow-up|1|||
144375616|NCT02100696|520584517|FG003|Induction Phase|Lost to Follow-up|0|||
144375617|NCT02100696|520584518|FG004|Induction Phase|Lost to Follow-up|0|||
144375618|NCT02100696|520584519|FG005|Induction Phase|Lost to Follow-up|0|||
144375619|NCT02100696|520584514|FG000|Induction Phase|Protocol Violation|0|||
144375620|NCT02100696|520584515|FG001|Induction Phase|Protocol Violation|1|||
144375621|NCT02100696|520584516|FG002|Induction Phase|Protocol Violation|1|||
144375622|NCT02100696|520584517|FG003|Induction Phase|Protocol Violation|0|||
144375623|NCT02100696|520584518|FG004|Induction Phase|Protocol Violation|0|||
144375624|NCT02100696|520584519|FG005|Induction Phase|Protocol Violation|0|||
144375625|NCT02100696|520584514|FG000|Induction Phase|Withdrawal by Subject|8|||
144375626|NCT02100696|520584515|FG001|Induction Phase|Withdrawal by Subject|2|||
144375627|NCT02100696|520584516|FG002|Induction Phase|Withdrawal by Subject|13|||
144375628|NCT02100696|520584517|FG003|Induction Phase|Withdrawal by Subject|0|||
144375629|NCT02100696|520584518|FG004|Induction Phase|Withdrawal by Subject|0|||
144375630|NCT02100696|520584519|FG005|Induction Phase|Withdrawal by Subject|0|||
144375631|NCT02100696|520584514|FG000|Induction Phase|Physician Decision|1|||
144375632|NCT02100696|520584515|FG001|Induction Phase|Physician Decision|0|||
144375633|NCT02100696|520584516|FG002|Induction Phase|Physician Decision|2|||
144375634|NCT02100696|520584517|FG003|Induction Phase|Physician Decision|0|||
144375635|NCT02100696|520584518|FG004|Induction Phase|Physician Decision|0|||
144375636|NCT02100696|520584519|FG005|Induction Phase|Physician Decision|0|||
144375637|NCT02100696|520584514|FG000|Induction Phase|Multiple Reasons|5|||
144375638|NCT02100696|520584515|FG001|Induction Phase|Multiple Reasons|2|||
144375639|NCT02100696|520584516|FG002|Induction Phase|Multiple Reasons|8|||
144375640|NCT02100696|520584517|FG003|Induction Phase|Multiple Reasons|0|||
144375641|NCT02100696|520584518|FG004|Induction Phase|Multiple Reasons|0|||
144375642|NCT02100696|520584519|FG005|Induction Phase|Multiple Reasons|0|||
144375643|NCT02100696|520584514|FG000|Maintenance Phase|Adverse Event|0|||
144375644|NCT02100696|520584515|FG001|Maintenance Phase|Adverse Event|0|||
144512304|NCT02723955|521076026|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144375645|NCT02100696|520584516|FG002|Maintenance Phase|Adverse Event|0|||
144375646|NCT02100696|520584517|FG003|Maintenance Phase|Adverse Event|0|||
144375647|NCT02100696|520584518|FG004|Maintenance Phase|Adverse Event|0|||
144721753|NCT01595009|521835277|FG002|Extension|Disease progression|4|||
144375648|NCT02100696|520584519|FG005|Maintenance Phase|Adverse Event|2|||
144375649|NCT02100696|520584514|FG000|Maintenance Phase|Lost to Follow-up|0|||
144375650|NCT02100696|520584515|FG001|Maintenance Phase|Lost to Follow-up|0|||
144375651|NCT02100696|520584516|FG002|Maintenance Phase|Lost to Follow-up|0|||
144375652|NCT02100696|520584517|FG003|Maintenance Phase|Lost to Follow-up|0|||
144375653|NCT02100696|520584518|FG004|Maintenance Phase|Lost to Follow-up|1|||
144375654|NCT02100696|520584519|FG005|Maintenance Phase|Lost to Follow-up|0|||
144375655|NCT02100696|520584514|FG000|Maintenance Phase|Protocol Violation|0|||
144375656|NCT02100696|520584515|FG001|Maintenance Phase|Protocol Violation|0|||
144375657|NCT02100696|520584516|FG002|Maintenance Phase|Protocol Violation|0|||
144375658|NCT02100696|520584517|FG003|Maintenance Phase|Protocol Violation|0|||
144375659|NCT02100696|520584518|FG004|Maintenance Phase|Protocol Violation|1|||
144375660|NCT02100696|520584519|FG005|Maintenance Phase|Protocol Violation|0|||
144375661|NCT02100696|520584514|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144375662|NCT02100696|520584515|FG001|Maintenance Phase|Withdrawal by Subject|0|||
144375663|NCT02100696|520584516|FG002|Maintenance Phase|Withdrawal by Subject|0|||
144375664|NCT02100696|520584517|FG003|Maintenance Phase|Withdrawal by Subject|1|||
144375665|NCT02100696|520584518|FG004|Maintenance Phase|Withdrawal by Subject|4|||
144375666|NCT02100696|520584519|FG005|Maintenance Phase|Withdrawal by Subject|2|||
144375667|NCT02100696|520584514|FG000|Maintenance Phase|Physician Decision|0|||
144375668|NCT02100696|520584515|FG001|Maintenance Phase|Physician Decision|0|||
144375669|NCT02100696|520584516|FG002|Maintenance Phase|Physician Decision|0|||
144375670|NCT02100696|520584517|FG003|Maintenance Phase|Physician Decision|0|||
144375671|NCT02100696|520584518|FG004|Maintenance Phase|Physician Decision|1|||
144375672|NCT02100696|520584519|FG005|Maintenance Phase|Physician Decision|0|||
144375673|NCT02100696|520584514|FG000|Maintenance Phase|Multiple Reasons|0|||
144375674|NCT02100696|520584515|FG001|Maintenance Phase|Multiple Reasons|0|||
144375675|NCT02100696|520584516|FG002|Maintenance Phase|Multiple Reasons|0|||
144375676|NCT02100696|520584517|FG003|Maintenance Phase|Multiple Reasons|0|||
144375677|NCT02100696|520584518|FG004|Maintenance Phase|Multiple Reasons|2|||
144375678|NCT02100696|520584519|FG005|Maintenance Phase|Multiple Reasons|1|||
144375679|NCT01262820|520584521|FG000|Overall Study|Adverse Event|5|||
144375680|NCT01262820|520584521|FG000|Overall Study|Lack of Efficacy|9|||
144375681|NCT01262820|520584521|FG000|Overall Study|Drug held for 21+ days|1|||
144375682|NCT00993148|520584522|FG000|Overall Study|Lost to Follow-up|2|||
144375683|NCT00993148|520584522|FG000|Overall Study|never initiated treatment|1|||
144375684|NCT01120964|520584523|FG000|Overall Study|Did not receive full treatment|1|||
144375685|NCT01120964|520584524|FG001|Overall Study|Did not receive full treatment|0|||
144375686|NCT02621151|520584527|FG000|Overall Study|Not eligible for trial|6|||
144375687|NCT04198714|520584528|FG000|Overall Study|Physician Decision|0|||
144375688|NCT04198714|520584529|FG001|Overall Study|Physician Decision|1|||
144375689|NCT04238819|520584530|FG000|Overall Study|Ongoing Treatment|0|||
144375690|NCT04238819|520584531|FG001|Overall Study|Ongoing Treatment|0|||
144375691|NCT04238819|520584532|FG002|Overall Study|Ongoing Treatment|0|||
144375692|NCT04238819|520584533|FG003|Overall Study|Ongoing Treatment|0|||
144375693|NCT04238819|520584534|FG004|Overall Study|Ongoing Treatment|1|||
144375694|NCT04238819|520584535|FG005|Overall Study|Ongoing Treatment|4|||
144375695|NCT04238819|520584536|FG006|Overall Study|Ongoing Treatment|0|||
144375696|NCT04238819|520584530|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
144375697|NCT04238819|520584531|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
144375698|NCT04238819|520584532|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
144375699|NCT04238819|520584533|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
144375700|NCT04238819|520584534|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
144375701|NCT04238819|520584535|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
144375702|NCT04238819|520584536|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
144375703|NCT02529553|520584537|FG000|Overall Study|Progressive Disease|1|||
144375704|NCT02529553|520584538|FG001|Overall Study|Progressive Disease|0|||
144375705|NCT02529553|520584539|FG002|Overall Study|Progressive Disease|1|||
144375706|NCT02529553|520584540|FG003|Overall Study|Progressive Disease|3|||
144375707|NCT02529553|520584541|FG004|Overall Study|Progressive Disease|2|||
144375708|NCT02529553|520584542|FG005|Overall Study|Progressive Disease|3|||
144375709|NCT02529553|520584543|FG006|Overall Study|Progressive Disease|3|||
144375710|NCT02529553|520584544|FG007|Overall Study|Progressive Disease|5|||
144375711|NCT02529553|520584545|FG008|Overall Study|Progressive Disease|3|||
144375712|NCT02529553|520584537|FG000|Overall Study|Physician Decision|0|||
144375713|NCT02529553|520584538|FG001|Overall Study|Physician Decision|1|||
144375714|NCT02529553|520584539|FG002|Overall Study|Physician Decision|0|||
144375715|NCT02529553|520584540|FG003|Overall Study|Physician Decision|0|||
144375716|NCT02529553|520584541|FG004|Overall Study|Physician Decision|1|||
144375717|NCT02529553|520584542|FG005|Overall Study|Physician Decision|0|||
144375718|NCT02529553|520584543|FG006|Overall Study|Physician Decision|0|||
144375719|NCT02529553|520584544|FG007|Overall Study|Physician Decision|0|||
144375720|NCT02529553|520584545|FG008|Overall Study|Physician Decision|0|||
144375721|NCT02529553|520584537|FG000|Overall Study|Withdrawal by Subject|0|||
144375722|NCT02529553|520584538|FG001|Overall Study|Withdrawal by Subject|0|||
144375723|NCT02529553|520584539|FG002|Overall Study|Withdrawal by Subject|0|||
144375724|NCT02529553|520584540|FG003|Overall Study|Withdrawal by Subject|0|||
144375725|NCT02529553|520584541|FG004|Overall Study|Withdrawal by Subject|0|||
144375726|NCT02529553|520584542|FG005|Overall Study|Withdrawal by Subject|1|||
144538270|NCT03801148|521174143|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
144375727|NCT02529553|520584543|FG006|Overall Study|Withdrawal by Subject|0|||
144375728|NCT02529553|520584544|FG007|Overall Study|Withdrawal by Subject|1|||
144375729|NCT02529553|520584545|FG008|Overall Study|Withdrawal by Subject|0|||
144375730|NCT00724711|520586214|FG000|Overall Study|Adverse Event|7|||
144375731|NCT00724711|520586215|FG001|Overall Study|Adverse Event|3|||
144375732|NCT00724711|520586214|FG000|Overall Study|Pregnancy|0|||
144375733|NCT00724711|520586215|FG001|Overall Study|Pregnancy|1|||
144375734|NCT00724711|520586214|FG000|Overall Study|Lack of Efficacy|0|||
144375735|NCT00724711|520586215|FG001|Overall Study|Lack of Efficacy|1|||
144375736|NCT00724711|520586214|FG000|Overall Study|Physician Decision|0|||
144375737|NCT00724711|520586215|FG001|Overall Study|Physician Decision|3|||
144375738|NCT00724711|520586214|FG000|Overall Study|Withdrawal by Subject|5|||
144375739|NCT00724711|520586215|FG001|Overall Study|Withdrawal by Subject|4|||
144375740|NCT00724711|520586214|FG000|Overall Study|Lost to Follow-up|4|||
144375741|NCT00724711|520586215|FG001|Overall Study|Lost to Follow-up|5|||
144375742|NCT00724711|520586214|FG000|Overall Study|Protocol Violation|1|||
144375743|NCT00724711|520586215|FG001|Overall Study|Protocol Violation|0|||
144375744|NCT01088048|520586216|FG000|Overall Study|Adverse Event|7|||
144375745|NCT01088048|520586217|FG001|Overall Study|Adverse Event|9|||
144375746|NCT01088048|520586218|FG002|Overall Study|Adverse Event|7|||
144375747|NCT01088048|520586219|FG003|Overall Study|Adverse Event|5|||
144375748|NCT01088048|520586220|FG004|Overall Study|Adverse Event|6|||
144375749|NCT01088048|520586221|FG005|Overall Study|Adverse Event|3|||
144375750|NCT01088048|520586222|FG006|Overall Study|Adverse Event|3|||
144375751|NCT01088048|520586223|FG007|Overall Study|Adverse Event|0|||
144375752|NCT01088048|520586224|FG008|Overall Study|Adverse Event|2|||
144375753|NCT01088048|520586225|FG009|Overall Study|Adverse Event|2|||
144375754|NCT01088048|520586216|FG000|Overall Study|Withdrew Consent|1|||
144375755|NCT01088048|520586217|FG001|Overall Study|Withdrew Consent|1|||
144375756|NCT01088048|520586218|FG002|Overall Study|Withdrew Consent|1|||
144375757|NCT01088048|520586219|FG003|Overall Study|Withdrew Consent|1|||
144375758|NCT01088048|520586220|FG004|Overall Study|Withdrew Consent|2|||
144375759|NCT01088048|520586221|FG005|Overall Study|Withdrew Consent|1|||
144375760|NCT01088048|520586222|FG006|Overall Study|Withdrew Consent|0|||
144375761|NCT01088048|520586223|FG007|Overall Study|Withdrew Consent|2|||
144375762|NCT01088048|520586224|FG008|Overall Study|Withdrew Consent|2|||
144375763|NCT01088048|520586225|FG009|Overall Study|Withdrew Consent|1|||
144375764|NCT01088048|520586216|FG000|Overall Study|Concomitant Medication Prohibited|1|||
144375765|NCT01088048|520586217|FG001|Overall Study|Concomitant Medication Prohibited|0|||
144375766|NCT01088048|520586218|FG002|Overall Study|Concomitant Medication Prohibited|0|||
144375767|NCT01088048|520586219|FG003|Overall Study|Concomitant Medication Prohibited|0|||
144512305|NCT02723955|521076027|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144375768|NCT01088048|520586220|FG004|Overall Study|Concomitant Medication Prohibited|0|||
144375769|NCT01088048|520586221|FG005|Overall Study|Concomitant Medication Prohibited|0|||
144375770|NCT01088048|520586222|FG006|Overall Study|Concomitant Medication Prohibited|0|||
144375771|NCT01088048|520586223|FG007|Overall Study|Concomitant Medication Prohibited|0|||
144375772|NCT01088048|520586224|FG008|Overall Study|Concomitant Medication Prohibited|0|||
144375773|NCT01088048|520586225|FG009|Overall Study|Concomitant Medication Prohibited|0|||
144375774|NCT01088048|520586216|FG000|Overall Study|Investigator Request|2|||
144375775|NCT01088048|520586217|FG001|Overall Study|Investigator Request|2|||
144375776|NCT01088048|520586218|FG002|Overall Study|Investigator Request|0|||
144375777|NCT01088048|520586219|FG003|Overall Study|Investigator Request|0|||
144375778|NCT01088048|520586220|FG004|Overall Study|Investigator Request|3|||
144375779|NCT01088048|520586221|FG005|Overall Study|Investigator Request|1|||
144375780|NCT01088048|520586222|FG006|Overall Study|Investigator Request|1|||
144375781|NCT01088048|520586223|FG007|Overall Study|Investigator Request|0|||
144375782|NCT01088048|520586224|FG008|Overall Study|Investigator Request|0|||
144375783|NCT01088048|520586225|FG009|Overall Study|Investigator Request|0|||
144375784|NCT01088048|520586216|FG000|Overall Study|Patient Non-compliance|0|||
144375785|NCT01088048|520586217|FG001|Overall Study|Patient Non-compliance|1|||
144375786|NCT01088048|520586218|FG002|Overall Study|Patient Non-compliance|0|||
144375787|NCT01088048|520586219|FG003|Overall Study|Patient Non-compliance|0|||
144375788|NCT01088048|520586220|FG004|Overall Study|Patient Non-compliance|0|||
144375789|NCT01088048|520586221|FG005|Overall Study|Patient Non-compliance|0|||
144375790|NCT01088048|520586222|FG006|Overall Study|Patient Non-compliance|0|||
144375791|NCT01088048|520586223|FG007|Overall Study|Patient Non-compliance|0|||
144375792|NCT01088048|520586224|FG008|Overall Study|Patient Non-compliance|0|||
144375793|NCT01088048|520586225|FG009|Overall Study|Patient Non-compliance|0|||
144375794|NCT01088048|520586216|FG000|Overall Study|Disease Progression|7|||
144375795|NCT01088048|520586217|FG001|Overall Study|Disease Progression|4|||
144375796|NCT01088048|520586218|FG002|Overall Study|Disease Progression|3|||
144375797|NCT01088048|520586219|FG003|Overall Study|Disease Progression|5|||
144375798|NCT01088048|520586220|FG004|Overall Study|Disease Progression|3|||
144375799|NCT01088048|520586221|FG005|Overall Study|Disease Progression|3|||
144375800|NCT01088048|520586222|FG006|Overall Study|Disease Progression|2|||
144375801|NCT01088048|520586223|FG007|Overall Study|Disease Progression|1|||
144375802|NCT01088048|520586224|FG008|Overall Study|Disease Progression|0|||
144375803|NCT01088048|520586225|FG009|Overall Study|Disease Progression|0|||
144375804|NCT01088048|520586216|FG000|Overall Study|Death|1|||
144375805|NCT01088048|520586217|FG001|Overall Study|Death|5|||
144375806|NCT01088048|520586218|FG002|Overall Study|Death|3|||
144375807|NCT01088048|520586219|FG003|Overall Study|Death|3|||
144375808|NCT01088048|520586220|FG004|Overall Study|Death|1|||
144375809|NCT01088048|520586221|FG005|Overall Study|Death|3|||
144375810|NCT01088048|520586222|FG006|Overall Study|Death|0|||
144375811|NCT01088048|520586223|FG007|Overall Study|Death|0|||
144375812|NCT01088048|520586224|FG008|Overall Study|Death|3|||
144375813|NCT01088048|520586225|FG009|Overall Study|Death|1|||
144375814|NCT01088048|520586216|FG000|Overall Study|Other|3|||
144375815|NCT01088048|520586217|FG001|Overall Study|Other|5|||
144375816|NCT01088048|520586218|FG002|Overall Study|Other|0|||
144375817|NCT01088048|520586219|FG003|Overall Study|Other|0|||
144375818|NCT01088048|520586220|FG004|Overall Study|Other|2|||
144375819|NCT01088048|520586221|FG005|Overall Study|Other|0|||
144375820|NCT01088048|520586222|FG006|Overall Study|Other|0|||
144375821|NCT01088048|520586223|FG007|Overall Study|Other|2|||
144375822|NCT01088048|520586224|FG008|Overall Study|Other|0|||
144375823|NCT01088048|520586225|FG009|Overall Study|Other|0|||
144375824|NCT01621802|520586226|FG000|Overall Study|Protocol Violation|0|||
144375825|NCT01621802|520586227|FG001|Overall Study|Protocol Violation|0|||
144375826|NCT01621802|520586228|FG002|Overall Study|Protocol Violation|0|||
144375827|NCT01621802|520586229|FG003|Overall Study|Protocol Violation|0|||
144375828|NCT01621802|520586230|FG004|Overall Study|Protocol Violation|0|||
144375829|NCT01621802|520586231|FG005|Overall Study|Protocol Violation|1|||
144375830|NCT01621802|520586226|FG000|Overall Study|Withdrawal by Subject|8|||
144375831|NCT01621802|520586227|FG001|Overall Study|Withdrawal by Subject|4|||
144375832|NCT01621802|520586228|FG002|Overall Study|Withdrawal by Subject|4|||
144375833|NCT01621802|520586229|FG003|Overall Study|Withdrawal by Subject|2|||
144375834|NCT01621802|520586230|FG004|Overall Study|Withdrawal by Subject|2|||
144375835|NCT01621802|520586231|FG005|Overall Study|Withdrawal by Subject|0|||
144375836|NCT01621802|520586226|FG000|Overall Study|Migrated/moved from study area|0|||
144375837|NCT01621802|520586227|FG001|Overall Study|Migrated/moved from study area|0|||
144375838|NCT01621802|520586228|FG002|Overall Study|Migrated/moved from study area|2|||
144375839|NCT01621802|520586229|FG003|Overall Study|Migrated/moved from study area|0|||
144538271|NCT03801148|521174144|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
144375840|NCT01621802|520586230|FG004|Overall Study|Migrated/moved from study area|1|||
144375841|NCT01621802|520586231|FG005|Overall Study|Migrated/moved from study area|0|||
144375842|NCT01621802|520586226|FG000|Overall Study|Others|3|||
144375843|NCT01621802|520586227|FG001|Overall Study|Others|3|||
144375844|NCT01621802|520586228|FG002|Overall Study|Others|3|||
144375845|NCT01621802|520586229|FG003|Overall Study|Others|2|||
144375846|NCT01621802|520586230|FG004|Overall Study|Others|1|||
144375847|NCT01621802|520586231|FG005|Overall Study|Others|0|||
144375848|NCT01621802|520586226|FG000|Overall Study|Lost to Follow-up|36|||
144375849|NCT01621802|520586227|FG001|Overall Study|Lost to Follow-up|16|||
144375850|NCT01621802|520586228|FG002|Overall Study|Lost to Follow-up|24|||
144375851|NCT01621802|520586229|FG003|Overall Study|Lost to Follow-up|7|||
144375852|NCT01621802|520586230|FG004|Overall Study|Lost to Follow-up|31|||
144375853|NCT01621802|520586231|FG005|Overall Study|Lost to Follow-up|11|||
144375854|NCT01149148|520586232|FG000|Overall Study|Lost to Follow-up|1|||
144375855|NCT01149148|520586233|FG001|Overall Study|Lost to Follow-up|2|||
144375856|NCT01149148|520586232|FG000|Overall Study|Death|1|||
144375857|NCT01149148|520586233|FG001|Overall Study|Death|0|||
144375858|NCT00950859|520586234|FG000|Overall Study|Adverse Event|3|||
144375859|NCT00950859|520586235|FG001|Overall Study|Adverse Event|3|||
144375860|NCT00950859|520586234|FG000|Overall Study|Insufficient Viral Load Response|12|||
144375861|NCT00950859|520586235|FG001|Overall Study|Insufficient Viral Load Response|3|||
144375862|NCT00950859|520586234|FG000|Overall Study|Protocol Violation|1|||
144375863|NCT00950859|520586235|FG001|Overall Study|Protocol Violation|1|||
144375864|NCT00950859|520586234|FG000|Overall Study|Lost to Follow-up|0|||
144375865|NCT00950859|520586235|FG001|Overall Study|Lost to Follow-up|3|||
144375866|NCT04896086|520586236|FG000|Overall Study|Lost to Follow-up|0|||
144375867|NCT04896086|520586237|FG001|Overall Study|Lost to Follow-up|2|||
144375868|NCT04896086|520586238|FG002|Overall Study|Lost to Follow-up|1|||
144375869|NCT04896086|520586239|FG003|Overall Study|Lost to Follow-up|0|||
144375870|NCT04896086|520586240|FG004|Overall Study|Lost to Follow-up|0|||
144375871|NCT04896086|520586236|FG000|Overall Study|Physician Decision|0|||
144375872|NCT04896086|520586237|FG001|Overall Study|Physician Decision|1|||
144375873|NCT04896086|520586238|FG002|Overall Study|Physician Decision|0|||
144375874|NCT04896086|520586239|FG003|Overall Study|Physician Decision|0|||
144375875|NCT04896086|520586240|FG004|Overall Study|Physician Decision|0|||
144375876|NCT04896086|520586236|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
144375877|NCT04896086|520586237|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
144375878|NCT04896086|520586238|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
144375879|NCT04896086|520586239|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
144375880|NCT04896086|520586240|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
144375881|NCT04896086|520586236|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
144375882|NCT04896086|520586237|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
144375883|NCT04896086|520586238|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
144375884|NCT04896086|520586239|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
144375885|NCT04896086|520586240|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
144375886|NCT02249832|520586243|FG000|Overall Study|Withdrawal by Subject|3|||
144375887|NCT02249832|520586243|FG000|Overall Study|Lost to Follow-up|10|||
144375888|NCT00545272|520586249|FG000|Overall Study|Protocol deviation|0|||
144375889|NCT00545272|520586250|FG001|Overall Study|Protocol deviation|1|||
144375890|NCT00545272|520586251|FG002|Overall Study|Protocol deviation|0|||
144375891|NCT00545272|520586252|FG003|Overall Study|Protocol deviation|1|||
144375892|NCT00545272|520586253|FG004|Overall Study|Protocol deviation|0|||
144375893|NCT00545272|520586254|FG005|Overall Study|Protocol deviation|1|||
144375894|NCT00545272|520586249|FG000|Overall Study|Adverse Event|0|||
144375895|NCT00545272|520586250|FG001|Overall Study|Adverse Event|0|||
144375896|NCT00545272|520586251|FG002|Overall Study|Adverse Event|1|||
144375897|NCT00545272|520586252|FG003|Overall Study|Adverse Event|0|||
144375898|NCT00545272|520586253|FG004|Overall Study|Adverse Event|0|||
144375899|NCT00545272|520586254|FG005|Overall Study|Adverse Event|1|||
144375900|NCT00545272|520586249|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144375901|NCT00545272|520586250|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144375902|NCT00545272|520586251|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144375903|NCT00545272|520586252|FG003|Overall Study|Abnormal laboratory value(s)|0|||
144375904|NCT00545272|520586253|FG004|Overall Study|Abnormal laboratory value(s)|0|||
144375905|NCT00545272|520586254|FG005|Overall Study|Abnormal laboratory value(s)|1|||
144375906|NCT00545272|520586249|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144375907|NCT00545272|520586250|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144375908|NCT00545272|520586251|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144375909|NCT00545272|520586252|FG003|Overall Study|Abnormal test procedure result(s)|0|||
144375910|NCT00545272|520586253|FG004|Overall Study|Abnormal test procedure result(s)|1|||
144375911|NCT00545272|520586254|FG005|Overall Study|Abnormal test procedure result(s)|0|||
144375912|NCT00545272|520586249|FG000|Overall Study|Lost to Follow-up|0|||
144375913|NCT00545272|520586250|FG001|Overall Study|Lost to Follow-up|0|||
144375914|NCT00545272|520586251|FG002|Overall Study|Lost to Follow-up|0|||
144375915|NCT00545272|520586252|FG003|Overall Study|Lost to Follow-up|0|||
144375916|NCT00545272|520586253|FG004|Overall Study|Lost to Follow-up|1|||
144375917|NCT00545272|520586254|FG005|Overall Study|Lost to Follow-up|0|||
144375918|NCT02934503|520586255|FG000|Overall Study|progression of disease|3|||
144375919|NCT02934503|520586255|FG000|Overall Study|Withdrawal by Subject|1|||
144375920|NCT04248491|520586256|FG000|Overall Study|Lost to Follow-up|1|||
144375921|NCT04248491|520586257|FG001|Overall Study|Lost to Follow-up|0|||
144375922|NCT01652469|520586258|FG000|Overall Study|Withdrawal by Subject|1|||
144375923|NCT01652469|520586259|FG001|Overall Study|Withdrawal by Subject|4|||
144375924|NCT01652469|520586258|FG000|Overall Study|Lost to Follow-up|0|||
144375925|NCT01652469|520586259|FG001|Overall Study|Lost to Follow-up|2|||
144375926|NCT02834793|520586260|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
144375927|NCT02834793|520586261|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
144375928|NCT02834793|520586262|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
144375929|NCT02834793|520586263|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
144375930|NCT02834793|520586260|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
144375931|NCT02834793|520586261|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
144375932|NCT02834793|520586262|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
144375933|NCT02834793|520586263|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
144375934|NCT02834793|520586260|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
144375935|NCT02834793|520586261|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
144375936|NCT02834793|520586262|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
144375937|NCT02834793|520586263|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
144375938|NCT02834793|520586260|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
144375939|NCT02834793|520586261|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
144375940|NCT02834793|520586262|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
144375941|NCT02834793|520586263|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
144375942|NCT02834793|520586260|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
144375943|NCT02834793|520586261|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
144375944|NCT02834793|520586262|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
144375945|NCT02834793|520586263|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
144375946|NCT02834793|520586260|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
144375947|NCT02834793|520586261|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
144375948|NCT02834793|520586262|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
144375949|NCT02834793|520586263|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
144375950|NCT02834793|520586260|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
144375951|NCT02834793|520586261|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
144375952|NCT02834793|520586262|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
144375953|NCT02834793|520586263|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
144375954|NCT02834793|520586260|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
144375955|NCT02834793|520586261|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
144375956|NCT02834793|520586262|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
144375957|NCT02834793|520586263|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
144375958|NCT02834793|520586260|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
144375959|NCT02834793|520586261|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
144375960|NCT02834793|520586262|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
144375961|NCT02834793|520586263|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
144375962|NCT02834793|520586260|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
144375963|NCT02834793|520586261|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
144375964|NCT02834793|520586262|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
144375965|NCT02834793|520586263|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
144375966|NCT02834793|520586260|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
144512306|NCT02723955|521076028|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512307|NCT02723955|521076029|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512308|NCT02723955|521076030|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512309|NCT02723955|521076031|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512310|NCT02723955|521076032|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512311|NCT02723955|521076033|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512312|NCT02723955|521076034|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512313|NCT02723955|521076035|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512314|NCT02723955|521076036|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512315|NCT02723955|521076037|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144375967|NCT02834793|520586261|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
144375968|NCT02834793|520586262|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
144375969|NCT02834793|520586263|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
144512316|NCT02723955|521076038|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512317|NCT02723955|521076039|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144375970|NCT02834793|520586260|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
144375971|NCT02834793|520586261|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
144375972|NCT02834793|520586262|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
144375973|NCT02834793|520586263|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
144375974|NCT02834793|520586260|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
144375975|NCT02834793|520586261|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
144375976|NCT02834793|520586262|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
144375977|NCT02834793|520586263|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
144375978|NCT02834793|520586260|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
144375979|NCT02834793|520586261|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
144375980|NCT02834793|520586262|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
144375981|NCT02834793|520586263|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
144375982|NCT02834793|520586260|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
144375983|NCT02834793|520586261|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
144375984|NCT02834793|520586262|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
144375985|NCT02834793|520586263|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
144375986|NCT01731938|520586264|FG000|Preliminary Part I|Withdrawal by Subject|2|||
144375987|NCT01731938|520586265|FG001|Preliminary Part I|Withdrawal by Subject|2|||
144375988|NCT01731938|520586264|FG000|Preliminary Part I|Physician Decision|1|||
144375989|NCT01731938|520586265|FG001|Preliminary Part I|Physician Decision|0|||
144375990|NCT01731938|520586264|FG000|Preliminary Part I|Lost to Follow-up|0|||
144375991|NCT01731938|520586265|FG001|Preliminary Part I|Lost to Follow-up|3|||
144375992|NCT01731938|520586264|FG000|Preliminary Part I|Missed Week 6 visit|0|||
144375993|NCT01731938|520586265|FG001|Preliminary Part I|Missed Week 6 visit|3|||
144375994|NCT01731938|520586264|FG000|Primary Part II|Withdrawal by Subject|5|||
144375995|NCT01731938|520586265|FG001|Primary Part II|Withdrawal by Subject|4|||
144375996|NCT01731938|520586264|FG000|Primary Part II|Lost to Follow-up|4|||
144375997|NCT01731938|520586265|FG001|Primary Part II|Lost to Follow-up|5|||
144375998|NCT01731938|520586264|FG000|Primary Part II|Death|2|||
144375999|NCT01731938|520586265|FG001|Primary Part II|Death|1|||
144376000|NCT01731938|520586264|FG000|Primary Part II|Missed Week 6 visit|2|||
144376001|NCT01731938|520586265|FG001|Primary Part II|Missed Week 6 visit|3|||
144376002|NCT04931888|520586266|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
144376003|NCT04931888|520586267|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
144376004|NCT04931888|520586268|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
144376005|NCT04931888|520586269|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
144376006|NCT01049009|520586270|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
144376007|NCT01049009|520586271|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
144376008|NCT01049009|520586270|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144376009|NCT01049009|520586271|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144376010|NCT01049009|520586270|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
144376011|NCT01049009|520586271|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
144376012|NCT01049009|520586270|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
144376013|NCT01049009|520586271|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
144376014|NCT03179202|520586272|FG000|Overall Study|Screen Failure|67|||
144376015|NCT03179202|520586272|FG000|Overall Study|Subject Lost to Follow Up|12|||
144512318|NCT02723955|521076040|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512319|NCT02723955|521076041|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
144376016|NCT03179202|520586272|FG000|Overall Study|Withdrawal by Subject|7|||
144376017|NCT03179202|520586272|FG000|Overall Study|Adverse Event|3|||
144376018|NCT03179202|520586272|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
144376019|NCT03179202|520586272|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
144376020|NCT00859638|520586273|FG000|Overall Study|Lost to Follow-up|6|||
144376021|NCT00859638|520586274|FG001|Overall Study|Lost to Follow-up|1|||
144376022|NCT00859638|520586273|FG000|Overall Study|Withdrawal by Subject|3|||
144376023|NCT00859638|520586274|FG001|Overall Study|Withdrawal by Subject|2|||
144376024|NCT00859638|520586273|FG000|Overall Study|Ill health|1|||
144376025|NCT00859638|520586274|FG001|Overall Study|Ill health|1|||
144376026|NCT02969408|520586276|FG000|Overall Study|Adverse Event|2|||
144376027|NCT02969408|520586276|FG000|Overall Study|Withdrawal by Subject|8|||
144376028|NCT02969408|520586276|FG000|Overall Study|Lost to Follow-up|4|||
144376029|NCT02969408|520586276|FG000|Overall Study|Protocol Violation|1|||
144376030|NCT02969408|520586276|FG000|Overall Study|Other than specified|1|||
144376031|NCT01092546|520586280|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
144376032|NCT00771953|520586283|FG000|Overall Study|Adverse Event|5|||
144376033|NCT00771953|520586284|FG001|Overall Study|Adverse Event|3|||
144376034|NCT00771953|520586283|FG000|Overall Study|Death|2|||
144376035|NCT00771953|520586284|FG001|Overall Study|Death|2|||
144376036|NCT00771953|520586283|FG000|Overall Study|Progression before active Tx|1|||
144376037|NCT00771953|520586284|FG001|Overall Study|Progression before active Tx|2|||
144376038|NCT00771953|520586283|FG000|Overall Study|Sponsor decision|1|||
144376039|NCT00771953|520586284|FG001|Overall Study|Sponsor decision|0|||
144376040|NCT00771953|520586283|FG000|Overall Study|Other complicating disease|1|||
144376041|NCT00771953|520586284|FG001|Overall Study|Other complicating disease|0|||
144376042|NCT00771953|520586283|FG000|Overall Study|Withdrawal by Subject|0|||
144376043|NCT00771953|520586284|FG001|Overall Study|Withdrawal by Subject|3|||
144376044|NCT00947193|520586287|FG000|Overall Study|Lost to Follow-up|1|||
144376045|NCT00947193|520586288|FG001|Overall Study|Lost to Follow-up|0|||
144376046|NCT00947193|520586287|FG000|Overall Study|Withdrawal by Subject|1|||
144376047|NCT00947193|520586288|FG001|Overall Study|Withdrawal by Subject|0|||
144512320|NCT02723955|521076042|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512321|NCT02723955|521076043|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512322|NCT02723955|521076044|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512323|NCT02723955|521076045|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512324|NCT02723955|521076046|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144376048|NCT00947193|520586287|FG000|Overall Study|Factor VIII >1%|1|||
144376049|NCT00947193|520586288|FG001|Overall Study|Factor VIII >1%|0|||
144376050|NCT04364984|520586289|FG000|Overall Study|Death|2|||
144376051|NCT04364984|520586290|FG001|Overall Study|Death|2|||
144376052|NCT04364984|520586291|FG002|Overall Study|Death|0|||
144376053|NCT01349959|520586292|FG000|Overall Study|Adverse Event|7|||
144376054|NCT01941186|520586293|FG000|Follow-up|Lost to Follow-up|1|||
144376055|NCT01941186|520586294|FG001|Follow-up|Lost to Follow-up|0|||
144376056|NCT00934362|520586295|FG000|Overall Study|Adverse Event|1|||
144376057|NCT00934362|520586296|FG001|Overall Study|Adverse Event|0|||
144376058|NCT04154189|520586297|FG000|Overall Study|Withdrawal by Subject|4|||
144376059|NCT04154189|520586298|FG001|Overall Study|Withdrawal by Subject|6|||
144376060|NCT04154189|520586297|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
144376061|NCT04154189|520586298|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
144376062|NCT04154189|520586297|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
144376063|NCT04154189|520586298|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
144376064|NCT04154189|520586297|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
144376065|NCT04154189|520586298|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
144376066|NCT04154189|520586297|FG000|Overall Study|Death|25|||
144376067|NCT04154189|520586298|FG001|Overall Study|Death|25|||
144376068|NCT02280408|520586299|FG000|Overall Study|Lost to Follow-up|0|||
144376069|NCT02280408|520586300|FG001|Overall Study|Lost to Follow-up|2|||
144376070|NCT02280408|520586301|FG002|Overall Study|Lost to Follow-up|0|||
144376071|NCT02280408|520586302|FG003|Overall Study|Lost to Follow-up|0|||
144376072|NCT01092117|520586303|FG000|Index Procedure to 1 Month|Death|1|||
144376073|NCT01092117|520586303|FG000|1 Month|Death|1|||
144376074|NCT01092117|520586303|FG000|1 Month|Withdrawal by Subject|1|||
144376075|NCT01092117|520586303|FG000|1 Month|Lost to Follow-up|1|||
144376076|NCT01092117|520586303|FG000|6 Months|Death|2|||
144376077|NCT01092117|520586303|FG000|6 Months|Withdrawal by Subject|3|||
144376078|NCT01092117|520586303|FG000|12 Month|Death|11|||
144376079|NCT01092117|520586303|FG000|12 Month|Withdrawal by Subject|2|||
144376080|NCT01092117|520586303|FG000|12 Month|Lost to Follow-up|1|||
144376081|NCT01092117|520586303|FG000|Year 2|Death|5|||
144376082|NCT01092117|520586303|FG000|Year 2|Withdrawal by Subject|4|||
144376083|NCT01092117|520586303|FG000|Year 2|Lost to Follow-up|1|||
144376084|NCT01092117|520586303|FG000|Year 3|Death|7|||
144376085|NCT01092117|520586303|FG000|Year 3|Withdrawal by Subject|9|||
144376086|NCT01092117|520586303|FG000|Year 3|Lost to Follow-up|3|||
144376087|NCT01092117|520586303|FG000|Year 4|Death|8|||
144376088|NCT01092117|520586303|FG000|Year 4|Withdrawal by Subject|4|||
144376089|NCT01092117|520586303|FG000|Year 4|Lost to Follow-up|4|||
144376090|NCT02474069|520586304|FG000|Selection Phase (SP)|Adverse Event|8|||
144376091|NCT02474069|520586305|FG001|Selection Phase (SP)|Adverse Event|0|||
144376092|NCT02474069|520586306|FG002|Selection Phase (SP)|Adverse Event|0|||
144376093|NCT02474069|520586304|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
144376094|NCT02474069|520586305|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
144376095|NCT02474069|520586306|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
144376096|NCT02474069|520586304|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
144376097|NCT02474069|520586305|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
144376098|NCT02474069|520586306|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
144376099|NCT02474069|520586304|FG000|Selection Phase (SP)|Physician Decision|1|||
144376100|NCT02474069|520586305|FG001|Selection Phase (SP)|Physician Decision|0|||
144376101|NCT02474069|520586306|FG002|Selection Phase (SP)|Physician Decision|0|||
144376102|NCT02474069|520586304|FG000|Selection Phase (SP)|Protocol Violation|1|||
144376103|NCT02474069|520586305|FG001|Selection Phase (SP)|Protocol Violation|0|||
144376104|NCT02474069|520586306|FG002|Selection Phase (SP)|Protocol Violation|0|||
144376105|NCT02474069|520586304|FG000|Selection Phase (SP)|No longer requires treatment|1|||
144376106|NCT02474069|520586305|FG001|Selection Phase (SP)|No longer requires treatment|0|||
144376107|NCT02474069|520586306|FG002|Selection Phase (SP)|No longer requires treatment|0|||
144376108|NCT02474069|520586304|FG000|Selection Phase (SP)|Technical Problem|1|||
144376109|NCT02474069|520586305|FG001|Selection Phase (SP)|Technical Problem|0|||
144376110|NCT02474069|520586306|FG002|Selection Phase (SP)|Technical Problem|0|||
144376111|NCT02474069|520586304|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
144376112|NCT02474069|520586305|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
144376113|NCT02474069|520586306|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
144376114|NCT02474069|520586304|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
144376115|NCT02474069|520586305|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
144376116|NCT02474069|520586306|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
144376117|NCT02474069|520586304|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
144376118|NCT02474069|520586305|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
144376119|NCT02474069|520586306|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
144376120|NCT02474069|520586304|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
144376121|NCT02474069|520586305|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
144512325|NCT02723955|521076047|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512326|NCT02723955|521076048|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512327|NCT02723955|521076049|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512328|NCT02723955|521076050|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512329|NCT02723955|521076051|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144721754|NCT01595009|521835278|FG003|Extension|Disease progression|7|||
144376122|NCT02474069|520586306|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
144376123|NCT02474069|520586304|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
144721755|NCT01595009|521835275|FG000|Extension|Adverse Event|0|||
144376124|NCT02474069|520586305|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
144376125|NCT02474069|520586306|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
144376126|NCT02474069|520586304|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
144376127|NCT02474069|520586305|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
144376128|NCT02474069|520586306|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
144376129|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
144376130|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
144376131|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
144376132|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
144376133|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
144376134|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
144376135|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
144376136|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
144376137|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
144376138|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
144376139|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
144376140|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
144376141|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
144376142|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
144376143|NCT04173494|520586307|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
144376144|NCT04173494|520586308|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
144376145|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
144376146|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
144376147|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
144376148|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
144376149|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
144376150|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
144376151|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
144376152|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
144376153|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
144376154|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
144376155|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
144376156|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
144512330|NCT02723955|521076052|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512331|NCT02723955|521076053|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
144512332|NCT02723955|521076011|FG000|Expansion Phase|Site Closed|0|||
144512333|NCT02723955|521076012|FG001|Expansion Phase|Site Closed|0|||
144512334|NCT02723955|521076013|FG002|Expansion Phase|Site Closed|0|||
144512335|NCT02723955|521076014|FG003|Expansion Phase|Site Closed|0|||
144512336|NCT02723955|521076015|FG004|Expansion Phase|Site Closed|0|||
144512337|NCT02723955|521076016|FG005|Expansion Phase|Site Closed|0|||
144512338|NCT02723955|521076017|FG006|Expansion Phase|Site Closed|0|||
144512339|NCT02723955|521076018|FG007|Expansion Phase|Site Closed|0|||
144512340|NCT02723955|521076019|FG008|Expansion Phase|Site Closed|0|||
144512341|NCT02723955|521076020|FG009|Expansion Phase|Site Closed|1|||
144512342|NCT02723955|521076021|FG010|Expansion Phase|Site Closed|2|||
144512343|NCT02723955|521076022|FG011|Expansion Phase|Site Closed|6|||
144512344|NCT02723955|521076023|FG012|Expansion Phase|Site Closed|0|||
144512345|NCT02723955|521076024|FG013|Expansion Phase|Site Closed|0|||
144512346|NCT02723955|521076025|FG014|Expansion Phase|Site Closed|0|||
144512347|NCT02723955|521076026|FG015|Expansion Phase|Site Closed|0|||
144512348|NCT02723955|521076027|FG016|Expansion Phase|Site Closed|0|||
144512349|NCT02723955|521076028|FG017|Expansion Phase|Site Closed|0|||
144512350|NCT02723955|521076029|FG018|Expansion Phase|Site Closed|0|||
144512351|NCT02723955|521076030|FG019|Expansion Phase|Site Closed|0|||
144512352|NCT02723955|521076031|FG020|Expansion Phase|Site Closed|0|||
144512353|NCT02723955|521076032|FG021|Expansion Phase|Site Closed|0|||
144512354|NCT02723955|521076033|FG022|Expansion Phase|Site Closed|0|||
144512355|NCT02723955|521076034|FG023|Expansion Phase|Site Closed|0|||
144512356|NCT02723955|521076035|FG024|Expansion Phase|Site Closed|0|||
144512357|NCT02723955|521076036|FG025|Expansion Phase|Site Closed|0|||
144512358|NCT02723955|521076037|FG026|Expansion Phase|Site Closed|0|||
144512359|NCT02723955|521076038|FG027|Expansion Phase|Site Closed|0|||
144512360|NCT02723955|521076039|FG028|Expansion Phase|Site Closed|0|||
144512361|NCT02723955|521076040|FG029|Expansion Phase|Site Closed|0|||
144512362|NCT02723955|521076041|FG030|Expansion Phase|Site Closed|8|||
144512363|NCT02723955|521076042|FG031|Expansion Phase|Site Closed|4|||
144512364|NCT02723955|521076043|FG032|Expansion Phase|Site Closed|2|||
144512365|NCT02723955|521076044|FG033|Expansion Phase|Site Closed|2|||
144512366|NCT02723955|521076045|FG034|Expansion Phase|Site Closed|0|||
144512367|NCT02723955|521076046|FG035|Expansion Phase|Site Closed|0|||
144512368|NCT02723955|521076047|FG036|Expansion Phase|Site Closed|0|||
144512369|NCT02723955|521076048|FG037|Expansion Phase|Site Closed|0|||
144512370|NCT02723955|521076049|FG038|Expansion Phase|Site Closed|0|||
144512371|NCT02723955|521076050|FG039|Expansion Phase|Site Closed|0|||
144376157|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
144512372|NCT02723955|521076051|FG040|Expansion Phase|Site Closed|0|||
144512373|NCT02723955|521076052|FG041|Expansion Phase|Site Closed|0|||
144376158|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
144376159|NCT04173494|520586307|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
144376160|NCT04173494|520586308|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
144376161|NCT01623050|520586309|FG000|Overall Study|Lost to Follow-up|9|||
144376162|NCT00202878|520586311|FG000|Overall Study|Death|964|||
144376163|NCT00202878|520586312|FG001|Overall Study|Death|968|||
144376164|NCT00202878|520586311|FG000|Overall Study|Only Vital Status Known|357|||
144376165|NCT00202878|520586312|FG001|Overall Study|Only Vital Status Known|356|||
144376166|NCT00202878|520586311|FG000|Overall Study|Lost to Follow-up|44|||
144376167|NCT00202878|520586312|FG001|Overall Study|Lost to Follow-up|49|||
144376168|NCT00202878|520586311|FG000|Overall Study|Site Closure|39|||
144376169|NCT00202878|520586312|FG001|Overall Study|Site Closure|36|||
144376170|NCT00202878|520586311|FG000|Overall Study|Withdrawal by Subject|795|||
144376171|NCT00202878|520586312|FG001|Overall Study|Withdrawal by Subject|808|||
144376172|NCT02123472|520586313|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
144376173|NCT02123472|520586314|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
144376174|NCT02433080|520586316|FG000|Overall Study|Lost to Follow-up|1|||
144376175|NCT02433080|520586317|FG001|Overall Study|Lost to Follow-up|2|||
144376176|NCT02433080|520586316|FG000|Overall Study|Withdrawal by Subject|0|||
144376177|NCT02433080|520586317|FG001|Overall Study|Withdrawal by Subject|2|||
144376178|NCT03801031|520586318|FG000|Overall Study|Lost to Follow-up|1|||
144376179|NCT03801031|520586319|FG001|Overall Study|Lost to Follow-up|0|||
144376180|NCT03801031|520586318|FG000|Overall Study|Unable to comply|1|||
144376181|NCT03801031|520586319|FG001|Overall Study|Unable to comply|0|||
144376182|NCT03801031|520586318|FG000|Overall Study|Withdrawal by Subject|0|||
144376183|NCT03801031|520586319|FG001|Overall Study|Withdrawal by Subject|1|||
144376184|NCT01598506|520586322|FG000|Overall Study|Withdrawal by Subject|2|||
144376185|NCT02504216|520586323|FG000|Overall Study|Lost to Follow-up|3|||
144376186|NCT02504216|520586324|FG001|Overall Study|Lost to Follow-up|3|||
144376187|NCT02504216|520586323|FG000|Overall Study|Withdrawal by Subject|8|||
144376188|NCT02504216|520586324|FG001|Overall Study|Withdrawal by Subject|12|||
144376189|NCT00223080|520586325|FG000|Overall Study|Withdrawal by Subject|253|||
144376190|NCT00223080|520586326|FG001|Overall Study|Withdrawal by Subject|232|||
144376191|NCT00223080|520586325|FG000|Overall Study|Required contraindicated med|0|||
144376192|NCT00223080|520586326|FG001|Overall Study|Required contraindicated med|1|||
144376193|NCT00223080|520586325|FG000|Overall Study|Non-compliant|7|||
144376194|NCT00223080|520586326|FG001|Overall Study|Non-compliant|7|||
144376195|NCT00223080|520586325|FG000|Overall Study|Moved from study area|37|||
144376196|NCT00223080|520586326|FG001|Overall Study|Moved from study area|47|||
144376197|NCT00223080|520586325|FG000|Overall Study|Lost to Follow-up|259|||
144376198|NCT00223080|520586326|FG001|Overall Study|Lost to Follow-up|284|||
144376199|NCT00223080|520586325|FG000|Overall Study|Death|85|||
144376200|NCT00223080|520586326|FG001|Overall Study|Death|74|||
144376201|NCT00223080|520586325|FG000|Overall Study|Other|14|||
144376202|NCT00223080|520586326|FG001|Overall Study|Other|11|||
144376203|NCT00223080|520586325|FG000|Overall Study|Reason not provided|141|||
144376204|NCT00223080|520586326|FG001|Overall Study|Reason not provided|140|||
144376205|NCT00223080|520586325|FG000|Overall Study|Adverse Event|0|||
144376206|NCT00223080|520586326|FG001|Overall Study|Adverse Event|1|||
144512374|NCT02723955|521076053|FG042|Expansion Phase|Site Closed|0|||
144512375|NCT02723955|521076011|FG000|Crossover/ Re-treatment Phase|Death|0|||
144512376|NCT02723955|521076012|FG001|Crossover/ Re-treatment Phase|Death|0|||
144512377|NCT02723955|521076013|FG002|Crossover/ Re-treatment Phase|Death|0|||
144512378|NCT02723955|521076014|FG003|Crossover/ Re-treatment Phase|Death|0|||
144512379|NCT02723955|521076015|FG004|Crossover/ Re-treatment Phase|Death|0|||
144512380|NCT02723955|521076016|FG005|Crossover/ Re-treatment Phase|Death|0|||
144512381|NCT02723955|521076017|FG006|Crossover/ Re-treatment Phase|Death|0|||
144512382|NCT02723955|521076018|FG007|Crossover/ Re-treatment Phase|Death|0|||
144512383|NCT02723955|521076019|FG008|Crossover/ Re-treatment Phase|Death|0|||
144376207|NCT02598583|520586327|FG000|Extension Period|Withdrawal by Subject|1|||
144376208|NCT02598583|520586328|FG001|Extension Period|Withdrawal by Subject|0|||
144376209|NCT00947882|520586336|FG000|Overall Study|Adverse Event|0|||
144376210|NCT00947882|520586337|FG001|Overall Study|Adverse Event|1|||
144512384|NCT02723955|521076020|FG009|Crossover/ Re-treatment Phase|Death|0|||
144512385|NCT02723955|521076021|FG010|Crossover/ Re-treatment Phase|Death|0|||
144512386|NCT02723955|521076022|FG011|Crossover/ Re-treatment Phase|Death|0|||
144512387|NCT02723955|521076023|FG012|Crossover/ Re-treatment Phase|Death|0|||
144512388|NCT02723955|521076024|FG013|Crossover/ Re-treatment Phase|Death|0|||
144512389|NCT02723955|521076025|FG014|Crossover/ Re-treatment Phase|Death|0|||
144376211|NCT00947882|520586338|FG002|Overall Study|Adverse Event|4|||
144376212|NCT00947882|520586339|FG003|Overall Study|Adverse Event|4|||
144376213|NCT00947882|520586336|FG000|Overall Study|Withdrawal by Subject|2|||
144376214|NCT00947882|520586337|FG001|Overall Study|Withdrawal by Subject|0|||
144376215|NCT00947882|520586338|FG002|Overall Study|Withdrawal by Subject|8|||
144376216|NCT00947882|520586339|FG003|Overall Study|Withdrawal by Subject|2|||
144376217|NCT00947882|520586336|FG000|Overall Study|Protocol Violation|0|||
144376218|NCT00947882|520586337|FG001|Overall Study|Protocol Violation|0|||
144376219|NCT00947882|520586338|FG002|Overall Study|Protocol Violation|1|||
144376220|NCT00947882|520586339|FG003|Overall Study|Protocol Violation|0|||
144376221|NCT00947882|520586336|FG000|Overall Study|Lost to Follow-up|0|||
144376222|NCT00947882|520586337|FG001|Overall Study|Lost to Follow-up|2|||
144376223|NCT00947882|520586338|FG002|Overall Study|Lost to Follow-up|1|||
144376224|NCT00947882|520586339|FG003|Overall Study|Lost to Follow-up|0|||
144376225|NCT00947882|520586336|FG000|Overall Study|Other/Unknown|10|||
144376226|NCT00947882|520586337|FG001|Overall Study|Other/Unknown|13|||
144376227|NCT00947882|520586338|FG002|Overall Study|Other/Unknown|3|||
144376228|NCT00947882|520586339|FG003|Overall Study|Other/Unknown|6|||
144376229|NCT00947882|520586336|FG000|Overall Study|Trial Terminated by Sponsor|62|||
144376230|NCT00947882|520586337|FG001|Overall Study|Trial Terminated by Sponsor|61|||
144376231|NCT00947882|520586338|FG002|Overall Study|Trial Terminated by Sponsor|62|||
144376232|NCT00947882|520586339|FG003|Overall Study|Trial Terminated by Sponsor|70|||
144376233|NCT00452361|520586340|FG000|Overall Study|Adverse Event|8|||
144376234|NCT00452361|520586341|FG001|Overall Study|Adverse Event|0|||
144376235|NCT00452361|520586340|FG000|Overall Study|Withdrawal by Subject|0|||
144376236|NCT00452361|520586341|FG001|Overall Study|Withdrawal by Subject|1|||
144376237|NCT00452361|520586340|FG000|Overall Study|Premature termination|13|||
144376238|NCT00452361|520586341|FG001|Overall Study|Premature termination|9|||
144376239|NCT05188053|520586342|FG000|Overall Study|Lost to Follow-up|23|||
144376240|NCT05188053|520586343|FG001|Overall Study|Lost to Follow-up|30|||
144376241|NCT05188053|520586342|FG000|Overall Study|Protocol Violation|16|||
144376242|NCT05188053|520586343|FG001|Overall Study|Protocol Violation|16|||
144376243|NCT05188053|520586342|FG000|Overall Study|Physician Decision|3|||
144376244|NCT05188053|520586343|FG001|Overall Study|Physician Decision|0|||
144376245|NCT05188053|520586342|FG000|Overall Study|Withdrawal by Subject|0|||
144376246|NCT05188053|520586343|FG001|Overall Study|Withdrawal by Subject|1|||
144376247|NCT01309282|520586347|FG000|Overall Study|Lost to Follow-up|1|||
144512390|NCT02723955|521076026|FG015|Crossover/ Re-treatment Phase|Death|0|||
144512391|NCT02723955|521076027|FG016|Crossover/ Re-treatment Phase|Death|0|||
144512392|NCT02723955|521076028|FG017|Crossover/ Re-treatment Phase|Death|0|||
144512393|NCT02723955|521076029|FG018|Crossover/ Re-treatment Phase|Death|0|||
144376248|NCT02087423|520586348|FG000|Overall Study|Withdrawal by Subject|20|||
144376249|NCT02087423|520586349|FG001|Overall Study|Withdrawal by Subject|20|||
144376250|NCT02087423|520586350|FG002|Overall Study|Withdrawal by Subject|3|||
144512394|NCT02723955|521076030|FG019|Crossover/ Re-treatment Phase|Death|0|||
144512395|NCT02723955|521076031|FG020|Crossover/ Re-treatment Phase|Death|0|||
144512396|NCT02723955|521076032|FG021|Crossover/ Re-treatment Phase|Death|0|||
144512397|NCT02723955|521076033|FG022|Crossover/ Re-treatment Phase|Death|0|||
144512398|NCT02723955|521076034|FG023|Crossover/ Re-treatment Phase|Death|0|||
144512399|NCT02723955|521076035|FG024|Crossover/ Re-treatment Phase|Death|0|||
144512400|NCT02723955|521076036|FG025|Crossover/ Re-treatment Phase|Death|0|||
144512401|NCT02723955|521076037|FG026|Crossover/ Re-treatment Phase|Death|0|||
144512402|NCT02723955|521076038|FG027|Crossover/ Re-treatment Phase|Death|0|||
144512403|NCT02723955|521076039|FG028|Crossover/ Re-treatment Phase|Death|0|||
144512404|NCT02723955|521076040|FG029|Crossover/ Re-treatment Phase|Death|0|||
144512405|NCT02723955|521076041|FG030|Crossover/ Re-treatment Phase|Death|0|||
144512406|NCT02723955|521076042|FG031|Crossover/ Re-treatment Phase|Death|0|||
144512407|NCT02723955|521076043|FG032|Crossover/ Re-treatment Phase|Death|0|||
144512408|NCT02723955|521076044|FG033|Crossover/ Re-treatment Phase|Death|0|||
144512409|NCT02723955|521076045|FG034|Crossover/ Re-treatment Phase|Death|0|||
144512410|NCT02723955|521076046|FG035|Crossover/ Re-treatment Phase|Death|0|||
144512411|NCT02723955|521076047|FG036|Crossover/ Re-treatment Phase|Death|0|||
144512412|NCT02723955|521076048|FG037|Crossover/ Re-treatment Phase|Death|1|||
144512413|NCT02723955|521076049|FG038|Crossover/ Re-treatment Phase|Death|14|||
144512414|NCT02723955|521076050|FG039|Crossover/ Re-treatment Phase|Death|32|||
144512415|NCT02723955|521076051|FG040|Crossover/ Re-treatment Phase|Death|2|||
144512416|NCT02723955|521076052|FG041|Crossover/ Re-treatment Phase|Death|1|||
144512417|NCT02723955|521076053|FG042|Crossover/ Re-treatment Phase|Death|0|||
144512418|NCT02723955|521076011|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144376251|NCT02087423|520586348|FG000|Overall Study|Death|68|||
144376252|NCT02087423|520586349|FG001|Overall Study|Death|207|||
144512419|NCT02723955|521076012|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512420|NCT02723955|521076013|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512421|NCT02723955|521076014|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512422|NCT02723955|521076015|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512423|NCT02723955|521076016|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144376253|NCT02087423|520586350|FG002|Overall Study|Death|40|||
144721756|NCT01595009|521835276|FG001|Extension|Adverse Event|0|||
144376254|NCT02087423|520586348|FG000|Overall Study|Lost to Follow-up|0|||
144376255|NCT02087423|520586349|FG001|Overall Study|Lost to Follow-up|2|||
144376256|NCT02087423|520586350|FG002|Overall Study|Lost to Follow-up|0|||
144376257|NCT02087423|520586348|FG000|Overall Study|Terminated from study at final DCO|23|||
144376258|NCT02087423|520586349|FG001|Overall Study|Terminated from study at final DCO|36|||
144376259|NCT02087423|520586350|FG002|Overall Study|Terminated from study at final DCO|25|||
144376260|NCT01010867|520586353|FG000|Overall Study|< 50% adherence to probiotic|1|||
144512424|NCT02723955|521076017|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512425|NCT02723955|521076018|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512426|NCT02723955|521076019|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512427|NCT02723955|521076020|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512428|NCT02723955|521076021|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512429|NCT02723955|521076022|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512430|NCT02723955|521076023|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512431|NCT02723955|521076024|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512432|NCT02723955|521076025|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512433|NCT02723955|521076026|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512434|NCT02723955|521076027|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512435|NCT02723955|521076028|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512436|NCT02723955|521076029|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512437|NCT02723955|521076030|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512438|NCT02723955|521076031|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512439|NCT02723955|521076032|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512440|NCT02723955|521076033|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512441|NCT02723955|521076034|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512442|NCT02723955|521076035|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512443|NCT02723955|521076036|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512444|NCT02723955|521076037|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512445|NCT02723955|521076038|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512446|NCT02723955|521076039|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512447|NCT02723955|521076040|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512448|NCT02723955|521076041|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512449|NCT02723955|521076042|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512450|NCT02723955|521076043|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512451|NCT02723955|521076044|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512452|NCT02723955|521076045|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512453|NCT02723955|521076046|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512454|NCT02723955|521076047|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512455|NCT02723955|521076048|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512456|NCT02723955|521076049|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512457|NCT02723955|521076050|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
144512458|NCT02723955|521076051|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512459|NCT02723955|521076052|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512460|NCT02723955|521076053|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
144512461|NCT02723955|521076011|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512462|NCT02723955|521076012|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512463|NCT02723955|521076013|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512464|NCT02723955|521076014|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512465|NCT02723955|521076015|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512466|NCT02723955|521076016|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512467|NCT02723955|521076017|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512468|NCT02723955|521076018|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512469|NCT02723955|521076019|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512470|NCT02723955|521076020|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512471|NCT02723955|521076021|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512472|NCT02723955|521076022|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512473|NCT02723955|521076023|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512474|NCT02723955|521076024|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512475|NCT02723955|521076025|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512476|NCT02723955|521076026|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512477|NCT02723955|521076027|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512478|NCT02723955|521076028|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512479|NCT02723955|521076029|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512480|NCT02723955|521076030|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512481|NCT02723955|521076031|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512482|NCT02723955|521076032|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512483|NCT02723955|521076033|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512484|NCT02723955|521076034|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512485|NCT02723955|521076035|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512486|NCT02723955|521076036|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512487|NCT02723955|521076037|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512488|NCT02723955|521076038|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512489|NCT02723955|521076039|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512490|NCT02723955|521076040|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512491|NCT02723955|521076041|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512492|NCT02723955|521076042|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512493|NCT02723955|521076043|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
144376261|NCT02762370|520586354|FG000|Overall Study|Protocol Violation|1|||
144376262|NCT02762370|520586355|FG001|Overall Study|Protocol Violation|0|||
144376263|NCT02445794|520586357|FG000|Overall Study|Adverse Event|0|||
144376264|NCT02445794|520586358|FG001|Overall Study|Adverse Event|0|||
144376265|NCT02445794|520586359|FG002|Overall Study|Adverse Event|2|||
144376266|NCT02445794|520586360|FG003|Overall Study|Adverse Event|0|||
144376267|NCT01136785|520586361|FG000|Overall Study|Protocol Violation|2|||
144376268|NCT01136785|520586362|FG001|Overall Study|Protocol Violation|1|||
144376269|NCT00233064|520586368|FG000|Overall Study|Lost to Follow-up|7|||
144376270|NCT00233064|520586369|FG001|Overall Study|Lost to Follow-up|7|||
144376271|NCT00233064|520586368|FG000|Overall Study|Withdrawal by Subject|5|||
144376272|NCT00233064|520586369|FG001|Overall Study|Withdrawal by Subject|3|||
144376273|NCT00233064|520586368|FG000|Overall Study|Death|0|||
144376274|NCT00233064|520586369|FG001|Overall Study|Death|1|||
144376275|NCT00233064|520586368|FG000|Overall Study|Relocation|0|||
144376276|NCT00233064|520586369|FG001|Overall Study|Relocation|1|||
144376277|NCT00233064|520586368|FG000|Overall Study|Protocol Violation|1|||
144376278|NCT00233064|520586369|FG001|Overall Study|Protocol Violation|0|||
144376279|NCT00233064|520586368|FG000|Overall Study|Moved to Dom. Republic|1|||
144376280|NCT00233064|520586369|FG001|Overall Study|Moved to Dom. Republic|0|||
144376281|NCT04393454|520586372|FG000|Overall Study|Death|1|||
144376282|NCT04393454|520586372|FG000|Overall Study|Lost to Follow-up|1|||
144376283|NCT03304249|520586374|FG000|Overall Study|Lost to Follow-up|8|||
144376284|NCT03304249|520586375|FG001|Overall Study|Lost to Follow-up|10|||
144376285|NCT03304249|520586374|FG000|Overall Study|Withdrawal by Subject|12|||
144376286|NCT03304249|520586375|FG001|Overall Study|Withdrawal by Subject|2|||
144376287|NCT03304249|520586374|FG000|Overall Study|Moved Out of District|4|||
144376288|NCT03304249|520586375|FG001|Overall Study|Moved Out of District|2|||
144376289|NCT04976192|520586376|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376290|NCT04976192|520586377|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
144376291|NCT04976192|520586378|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376292|NCT04976192|520586379|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376293|NCT04976192|520586380|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144512494|NCT02723955|521076044|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512495|NCT02723955|521076045|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512496|NCT02723955|521076046|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512497|NCT02723955|521076047|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512498|NCT02723955|521076048|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
144376294|NCT04976192|520586381|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376295|NCT04976192|520586382|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376296|NCT04976192|520586383|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376297|NCT04976192|520586384|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376298|NCT04976192|520586385|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
144376299|NCT04976192|520586376|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
144376300|NCT04976192|520586377|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
144376301|NCT04976192|520586378|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
144376302|NCT04976192|520586379|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
144376303|NCT04976192|520586380|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376304|NCT04976192|520586381|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376305|NCT04976192|520586382|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376306|NCT04976192|520586383|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376307|NCT04976192|520586384|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376308|NCT04976192|520586385|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376309|NCT04976192|520586376|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
144376310|NCT04976192|520586377|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376311|NCT04976192|520586378|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
144376312|NCT04976192|520586379|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376313|NCT04976192|520586380|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376314|NCT04976192|520586381|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376315|NCT04976192|520586382|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376316|NCT04976192|520586383|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376317|NCT04976192|520586384|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376318|NCT04976192|520586385|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
144376319|NCT04976192|520586376|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376320|NCT04976192|520586377|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376321|NCT04976192|520586378|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376322|NCT04976192|520586379|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144376323|NCT04976192|520586380|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
144376324|NCT04976192|520586381|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
144376325|NCT04976192|520586382|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
144376326|NCT04976192|520586383|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
144376327|NCT04976192|520586384|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
144376328|NCT04976192|520586385|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
144376329|NCT04976192|520586376|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376330|NCT04976192|520586377|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376331|NCT04976192|520586378|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376332|NCT04976192|520586379|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376333|NCT04976192|520586380|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
144376334|NCT04976192|520586381|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376335|NCT04976192|520586382|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376336|NCT04976192|520586383|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376337|NCT04976192|520586384|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376338|NCT04976192|520586385|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
144376339|NCT04976192|520586376|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376340|NCT04976192|520586377|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376341|NCT04976192|520586378|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376342|NCT04976192|520586379|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376343|NCT04976192|520586380|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376344|NCT04976192|520586381|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
144376345|NCT04976192|520586382|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376346|NCT04976192|520586383|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376347|NCT04976192|520586384|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376348|NCT04976192|520586385|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144376349|NCT00924027|520586386|FG000|Overall Study|Lost to Further Follow-Up|4|||
144376350|NCT00924027|520586387|FG001|Overall Study|Lost to Further Follow-Up|0|||
144376351|NCT00924027|520586388|FG002|Overall Study|Lost to Further Follow-Up|0|||
144376352|NCT00924027|520586389|FG003|Overall Study|Lost to Further Follow-Up|0|||
144376353|NCT00924027|520586386|FG000|Overall Study|Physician Decision|1|||
144376354|NCT00924027|520586387|FG001|Overall Study|Physician Decision|0|||
144376355|NCT00924027|520586388|FG002|Overall Study|Physician Decision|0|||
144376356|NCT00924027|520586389|FG003|Overall Study|Physician Decision|1|||
144376357|NCT00924027|520586386|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
144376358|NCT00924027|520586387|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
144376359|NCT00924027|520586388|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
144376360|NCT00924027|520586389|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
144376361|NCT00924027|520586386|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
144376362|NCT00924027|520586387|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
144721757|NCT01595009|521835277|FG002|Extension|Adverse Event|0|||
144376363|NCT00924027|520586388|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
144376364|NCT00924027|520586389|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
144376365|NCT00924027|520586386|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
144376366|NCT00924027|520586387|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
144376367|NCT00924027|520586388|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
144376368|NCT00924027|520586389|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
144376369|NCT04549545|520588348|FG000|Initial Period|Withdrawal by Subject|4|||
144376370|NCT04549545|520588349|FG001|Initial Period|Withdrawal by Subject|0|||
144376371|NCT04549545|520588348|FG000|Initial Period|Additional ENT Procedure|3|||
144376372|NCT04549545|520588349|FG001|Initial Period|Additional ENT Procedure|0|||
144376373|NCT04549545|520588348|FG000|Initial Period|Lost to Follow-up|3|||
144376374|NCT04549545|520588349|FG001|Initial Period|Lost to Follow-up|1|||
144376375|NCT04549545|520588348|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
144376376|NCT04549545|520588349|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
144376377|NCT04549545|520588348|FG000|Crossover Period|Additional ENT Procedure|0|||
144376378|NCT04549545|520588349|FG001|Crossover Period|Additional ENT Procedure|6|||
144376379|NCT04549545|520588348|FG000|Crossover Period|Lost to Follow-up|0|||
144376380|NCT04549545|520588349|FG001|Crossover Period|Lost to Follow-up|1|||
144376381|NCT04549545|520588348|FG000|Crossover Period|Withdrawal by Subject|0|||
144376382|NCT04549545|520588349|FG001|Crossover Period|Withdrawal by Subject|4|||
144376383|NCT01395524|520588352|FG000|Overall Study|Non-compliance with study schedule|1|||
144376384|NCT01395524|520588353|FG001|Overall Study|Non-compliance with study schedule|0|||
144376385|NCT01395524|520588354|FG002|Overall Study|Non-compliance with study schedule|1|||
144376386|NCT01395524|520588352|FG000|Overall Study|Lost to Follow-up|3|||
144376387|NCT01395524|520588353|FG001|Overall Study|Lost to Follow-up|1|||
144376388|NCT01395524|520588354|FG002|Overall Study|Lost to Follow-up|1|||
144376389|NCT01395524|520588352|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
144376390|NCT01395524|520588353|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
144376391|NCT01395524|520588354|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
144376392|NCT01395524|520588352|FG000|Overall Study|Severe noncompliance with protocol|1|||
144376393|NCT01395524|520588353|FG001|Overall Study|Severe noncompliance with protocol|0|||
144376394|NCT01395524|520588354|FG002|Overall Study|Severe noncompliance with protocol|0|||
144376395|NCT01395524|520588352|FG000|Overall Study|Adverse Event|4|||
144376396|NCT01395524|520588353|FG001|Overall Study|Adverse Event|4|||
144376397|NCT01395524|520588354|FG002|Overall Study|Adverse Event|3|||
144376398|NCT01395524|520588352|FG000|Overall Study|Death|1|||
144376399|NCT01395524|520588353|FG001|Overall Study|Death|0|||
144376400|NCT01395524|520588354|FG002|Overall Study|Death|0|||
144376401|NCT01395524|520588352|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
144376402|NCT01395524|520588353|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144376403|NCT01395524|520588354|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144376404|NCT01395524|520588352|FG000|Overall Study|Withdrawal by Subject|4|||
144376405|NCT01395524|520588353|FG001|Overall Study|Withdrawal by Subject|8|||
144376406|NCT01395524|520588354|FG002|Overall Study|Withdrawal by Subject|8|||
144376407|NCT01395524|520588352|FG000|Overall Study|Did not receive treatment|1|||
144376408|NCT01395524|520588353|FG001|Overall Study|Did not receive treatment|1|||
144376409|NCT01395524|520588354|FG002|Overall Study|Did not receive treatment|3|||
144376410|NCT01395524|520588352|FG000|Overall Study|Subject had spinal surgery|0|||
144376411|NCT01395524|520588353|FG001|Overall Study|Subject had spinal surgery|0|||
144376412|NCT01395524|520588354|FG002|Overall Study|Subject had spinal surgery|1|||
144376413|NCT01657461|520588355|FG000|Overall Study|Death|9|||
144376414|NCT01657461|520588356|FG001|Overall Study|Death|12|||
144376415|NCT01657461|520588355|FG000|Overall Study|Lost to Follow-up|0|||
144376416|NCT01657461|520588356|FG001|Overall Study|Lost to Follow-up|3|||
144376417|NCT01657461|520588355|FG000|Overall Study|Physician Decision|0|||
144376418|NCT01657461|520588356|FG001|Overall Study|Physician Decision|2|||
144376419|NCT01657461|520588355|FG000|Overall Study|Withdrawal by Subject|1|||
144376420|NCT01657461|520588356|FG001|Overall Study|Withdrawal by Subject|3|||
144376421|NCT01868542|520588357|FG000|Overall Study|Protocol Violation|0|||
144376422|NCT01868542|520588358|FG001|Overall Study|Protocol Violation|1|||
144376423|NCT01868542|520588357|FG000|Overall Study|Unclassified|0|||
144376424|NCT01868542|520588358|FG001|Overall Study|Unclassified|1|||
144376425|NCT00130247|520588359|FG000|Overall Study|Pregnancy|1|||
144376426|NCT00130247|520588360|FG001|Overall Study|Pregnancy|0|||
144376427|NCT00130247|520588359|FG000|Overall Study|Post-randomization exclusion|1|||
144376428|NCT00130247|520588360|FG001|Overall Study|Post-randomization exclusion|2|||
144376429|NCT00130247|520588359|FG000|Overall Study|Not compliant with DOT|0|||
144376430|NCT00130247|520588360|FG001|Overall Study|Not compliant with DOT|2|||
144376431|NCT00843284|520588365|FG000|Overall Study|Adverse Event|39|||
144512499|NCT02723955|521076049|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
144512500|NCT02723955|521076050|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
144376432|NCT00843284|520588365|FG000|Overall Study|Lack of Efficacy|5|||
144376433|NCT00843284|520588365|FG000|Overall Study|Lost to Follow-up|11|||
144376434|NCT00843284|520588365|FG000|Overall Study|Other|10|||
144512501|NCT02723955|521076051|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
144376435|NCT00843284|520588365|FG000|Overall Study|Withdrawal by Subject|4|||
144376436|NCT00843284|520588365|FG000|Overall Study|Death|3|||
144376437|NCT00122980|520588366|FG000|Overall Study|Death|0|||
144376438|NCT00122980|520588367|FG001|Overall Study|Death|1|||
144376439|NCT00122980|520588366|FG000|Overall Study|Physician Decision|2|||
144376440|NCT00122980|520588367|FG001|Overall Study|Physician Decision|0|||
144376441|NCT00122980|520588366|FG000|Overall Study|Protocol Violation|5|||
144512502|NCT02723955|521076052|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
144512503|NCT02723955|521076053|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
144512504|NCT02723955|521076011|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
144512505|NCT02723955|521076012|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
144512506|NCT02723955|521076013|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
144512507|NCT02723955|521076014|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
144512508|NCT02723955|521076015|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
144512509|NCT02723955|521076016|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
144512510|NCT02723955|521076017|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
144512511|NCT02723955|521076018|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
144512512|NCT02723955|521076019|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
144512513|NCT02723955|521076020|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
144512514|NCT02723955|521076021|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
144512515|NCT02723955|521076022|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
144512516|NCT02723955|521076023|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
144512517|NCT02723955|521076024|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
144512518|NCT02723955|521076025|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
144512519|NCT02723955|521076026|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
144512520|NCT02723955|521076027|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
144512521|NCT02723955|521076028|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
144512522|NCT02723955|521076029|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
144512523|NCT02723955|521076030|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
144512524|NCT02723955|521076031|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
144512525|NCT02723955|521076032|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
144512526|NCT02723955|521076033|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
144512527|NCT02723955|521076034|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
144512528|NCT02723955|521076035|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
144512529|NCT02723955|521076036|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
144512530|NCT02723955|521076037|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
144512531|NCT02723955|521076038|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
144512532|NCT02723955|521076039|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
144512533|NCT02723955|521076040|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
144512534|NCT02723955|521076041|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
144512535|NCT02723955|521076042|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
144512536|NCT02723955|521076043|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
144512537|NCT02723955|521076044|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
144512538|NCT02723955|521076045|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
144512539|NCT02723955|521076046|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
144512540|NCT02723955|521076047|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
144512541|NCT02723955|521076048|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
144512542|NCT02723955|521076049|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
144512543|NCT02723955|521076050|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
144512544|NCT02723955|521076051|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
144512545|NCT02723955|521076052|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
144512546|NCT02723955|521076053|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
144512547|NCT04999085|521076056|FG000|Overall Study|Death|1|||
144512548|NCT05056246|521076057|FG000|Overall Study|Adverse Event|0|||
144512549|NCT05056246|521076058|FG001|Overall Study|Adverse Event|0|||
144512550|NCT05056246|521076059|FG002|Overall Study|Adverse Event|0|||
144512551|NCT05056246|521076060|FG003|Overall Study|Adverse Event|0|||
144512552|NCT05056246|521076061|FG004|Overall Study|Adverse Event|1|||
144512553|NCT05056246|521076057|FG000|Overall Study|Lost to Follow-up|0|||
144512554|NCT05056246|521076058|FG001|Overall Study|Lost to Follow-up|0|||
144512555|NCT05056246|521076059|FG002|Overall Study|Lost to Follow-up|0|||
144512556|NCT05056246|521076060|FG003|Overall Study|Lost to Follow-up|2|||
144512557|NCT05056246|521076061|FG004|Overall Study|Lost to Follow-up|0|||
144512558|NCT05056246|521076057|FG000|Overall Study|Withdrawal by Subject|0|||
144376442|NCT00122980|520588367|FG001|Overall Study|Protocol Violation|1|||
144512559|NCT05056246|521076058|FG001|Overall Study|Withdrawal by Subject|1|||
144512560|NCT05056246|521076059|FG002|Overall Study|Withdrawal by Subject|0|||
144512561|NCT05056246|521076060|FG003|Overall Study|Withdrawal by Subject|0|||
144512562|NCT05056246|521076061|FG004|Overall Study|Withdrawal by Subject|0|||
144512563|NCT04440176|521076062|FG000|Overall Study|Withdrawal by Subject|5|||
144512564|NCT04440176|521076063|FG001|Overall Study|Withdrawal by Subject|3|||
144376443|NCT00122980|520588366|FG000|Overall Study|Withdrawal by Subject|2|||
144512565|NCT04440176|521076062|FG000|Overall Study|Withdrawal by parent/guardian|4|||
144376444|NCT00122980|520588367|FG001|Overall Study|Withdrawal by Subject|3|||
144512566|NCT04440176|521076063|FG001|Overall Study|Withdrawal by parent/guardian|5|||
144512567|NCT04440176|521076062|FG000|Overall Study|Adverse Event|2|||
144512568|NCT04440176|521076063|FG001|Overall Study|Adverse Event|6|||
144376445|NCT00122980|520588366|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
144376446|NCT00122980|520588367|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
144376447|NCT00122980|520588366|FG000|Overall Study|Study termination|27|||
144376448|NCT00122980|520588367|FG001|Overall Study|Study termination|35|||
144376449|NCT01124864|520588368|FG000|Overall Study|Follow up phase competed as per protocol|18|||
144376450|NCT01124864|520588369|FG001|Overall Study|Follow up phase competed as per protocol|22|||
144376451|NCT01124864|520588370|FG002|Overall Study|Follow up phase competed as per protocol|24|||
144376452|NCT01124864|520588371|FG003|Overall Study|Follow up phase competed as per protocol|18|||
144376453|NCT01124864|520588372|FG004|Overall Study|Follow up phase competed as per protocol|26|||
144376454|NCT01124864|520588373|FG005|Overall Study|Follow up phase competed as per protocol|2|||
144376455|NCT01124864|520588368|FG000|Overall Study|Death|6|||
144376456|NCT01124864|520588369|FG001|Overall Study|Death|9|||
144376457|NCT01124864|520588370|FG002|Overall Study|Death|6|||
144376458|NCT01124864|520588371|FG003|Overall Study|Death|2|||
144376459|NCT01124864|520588372|FG004|Overall Study|Death|1|||
144376460|NCT01124864|520588373|FG005|Overall Study|Death|0|||
144376461|NCT01124864|520588368|FG000|Overall Study|Withdrawal by Subject|2|||
144376462|NCT01124864|520588369|FG001|Overall Study|Withdrawal by Subject|3|||
144376463|NCT01124864|520588370|FG002|Overall Study|Withdrawal by Subject|4|||
144376464|NCT01124864|520588371|FG003|Overall Study|Withdrawal by Subject|0|||
144376465|NCT01124864|520588372|FG004|Overall Study|Withdrawal by Subject|2|||
144376466|NCT01124864|520588373|FG005|Overall Study|Withdrawal by Subject|1|||
144376467|NCT01124864|520588368|FG000|Overall Study|Lost to Follow-up|1|||
144376468|NCT01124864|520588369|FG001|Overall Study|Lost to Follow-up|1|||
144376469|NCT01124864|520588370|FG002|Overall Study|Lost to Follow-up|0|||
144376470|NCT01124864|520588371|FG003|Overall Study|Lost to Follow-up|1|||
144376471|NCT01124864|520588372|FG004|Overall Study|Lost to Follow-up|0|||
144376472|NCT01124864|520588373|FG005|Overall Study|Lost to Follow-up|0|||
144376473|NCT01124864|520588368|FG000|Overall Study|Protocol Violation|1|||
144376474|NCT01124864|520588369|FG001|Overall Study|Protocol Violation|0|||
144376475|NCT01124864|520588370|FG002|Overall Study|Protocol Violation|0|||
144376476|NCT01124864|520588371|FG003|Overall Study|Protocol Violation|0|||
144376477|NCT01124864|520588372|FG004|Overall Study|Protocol Violation|1|||
144376478|NCT01124864|520588373|FG005|Overall Study|Protocol Violation|0|||
144376479|NCT01243242|520588374|FG000|Overall Study|Adverse Event|1|||
144376480|NCT01243242|520588375|FG001|Overall Study|Adverse Event|1|||
144376481|NCT01243242|520588374|FG000|Overall Study|Withdrawal by Subject|1|||
144376482|NCT01243242|520588375|FG001|Overall Study|Withdrawal by Subject|1|||
144376483|NCT01243242|520588374|FG000|Overall Study|Physician Decision|0|||
144376484|NCT01243242|520588375|FG001|Overall Study|Physician Decision|1|||
144376485|NCT01243242|520588374|FG000|Overall Study|sponsor decision|0|||
144376486|NCT01243242|520588375|FG001|Overall Study|sponsor decision|1|||
144376487|NCT01243242|520588374|FG000|Overall Study|non compliance|1|||
144376488|NCT01243242|520588375|FG001|Overall Study|non compliance|0|||
144376489|NCT03844945|520588378|FG000|Overall Study|Adverse Event|1|||
144376490|NCT03844945|520588379|FG001|Overall Study|Adverse Event|1|||
144376491|NCT03844945|520588380|FG002|Overall Study|Adverse Event|4|||
144376492|NCT03844945|520588381|FG003|Overall Study|Adverse Event|0|||
144376493|NCT03844945|520588378|FG000|Overall Study|Withdrawal by Subject|0|||
144376494|NCT03844945|520588379|FG001|Overall Study|Withdrawal by Subject|0|||
144376495|NCT03844945|520588380|FG002|Overall Study|Withdrawal by Subject|1|||
144376496|NCT03844945|520588381|FG003|Overall Study|Withdrawal by Subject|0|||
144376497|NCT03844945|520588378|FG000|Overall Study|Lack of Efficacy|0|||
144376498|NCT03844945|520588379|FG001|Overall Study|Lack of Efficacy|0|||
144376499|NCT03844945|520588380|FG002|Overall Study|Lack of Efficacy|0|||
144376500|NCT03844945|520588381|FG003|Overall Study|Lack of Efficacy|1|||
144376501|NCT02160899|520588395|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
144376502|NCT02160899|520588396|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
144376503|NCT02160899|520588397|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
144376504|NCT02160899|520588398|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
144376505|NCT02160899|520588399|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
144376506|NCT02160899|520588400|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
144376507|NCT01256294|520588401|FG000|Overall Study|Adverse Event|1|||
144376508|NCT01256294|520588402|FG001|Overall Study|Adverse Event|0|||
144376509|NCT01256294|520588401|FG000|Overall Study|Withdrawal by Subject|1|||
144376510|NCT01256294|520588402|FG001|Overall Study|Withdrawal by Subject|1|||
144512569|NCT04440176|521076062|FG000|Overall Study|Lost to Follow-up|22|||
144376511|NCT01256294|520588401|FG000|Overall Study|Protocol deviation|2|||
144376512|NCT01256294|520588402|FG001|Overall Study|Protocol deviation|1|||
144376513|NCT04129151|520588403|FG000|Overall Study|Adverse Event|1|||
144376514|NCT04129151|520588403|FG000|Overall Study|Disease Progression|7|||
144376515|NCT04129151|520588403|FG000|Overall Study|Study closure|1|||
144376516|NCT01068600|520588405|FG000|Overall Study|Withdrawal by Subject|5|||
144376517|NCT01068600|520588406|FG001|Overall Study|Withdrawal by Subject|6|||
144376518|NCT01068600|520588405|FG000|Overall Study|Adverse Event|3|||
144376519|NCT01068600|520588406|FG001|Overall Study|Adverse Event|3|||
144512570|NCT04440176|521076063|FG001|Overall Study|Lost to Follow-up|23|||
144376520|NCT01068600|520588405|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144376521|NCT01068600|520588406|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144376522|NCT01068600|520588405|FG000|Overall Study|Lost to Follow-up|1|||
144376523|NCT01068600|520588406|FG001|Overall Study|Lost to Follow-up|2|||
144376524|NCT01068600|520588405|FG000|Overall Study|Protocol deviation|1|||
144376525|NCT01068600|520588406|FG001|Overall Study|Protocol deviation|1|||
144376526|NCT01068600|520588405|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144376527|NCT01068600|520588406|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
144376528|NCT01068600|520588405|FG000|Overall Study|Administrative problems|0|||
144376529|NCT01068600|520588406|FG001|Overall Study|Administrative problems|1|||
144376530|NCT01191762|520588407|FG000|Overall Study|Adverse Event|1|||
144376531|NCT01191762|520588408|FG001|Overall Study|Adverse Event|0|||
144376532|NCT01519869|520588411|FG000|Overall Study|Lost to Follow-up|1|||
144376533|NCT03023813|520588412|FG000|Overall Study|Lost to Follow-up|1|||
144376534|NCT03023813|520588413|FG001|Overall Study|Lost to Follow-up|2|||
144376535|NCT03023813|520588414|FG002|Overall Study|Lost to Follow-up|0|||
144376536|NCT00126490|520588419|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
144376537|NCT02625909|520588420|FG000|Overall Study|Death|2|||
144376538|NCT02625909|520588421|FG001|Overall Study|Death|0|||
144376539|NCT02625909|520588420|FG000|Overall Study|Lost to Follow-up|3|||
144376540|NCT02625909|520588421|FG001|Overall Study|Lost to Follow-up|5|||
144376541|NCT02625909|520588420|FG000|Overall Study|Lack of Efficacy|9|||
144376542|NCT02625909|520588421|FG001|Overall Study|Lack of Efficacy|2|||
144376543|NCT02625909|520588420|FG000|Overall Study|Reinfection|3|||
144376544|NCT02625909|520588421|FG001|Overall Study|Reinfection|2|||
144376545|NCT00035932|520588428|FG000|Overall Study|Adverse Event|10|||
144376546|NCT00035932|520588429|FG001|Overall Study|Adverse Event|9|||
144376547|NCT00035932|520588430|FG002|Overall Study|Adverse Event|9|||
144376548|NCT00035932|520588428|FG000|Overall Study|Death|0|||
144376549|NCT00035932|520588429|FG001|Overall Study|Death|0|||
144376550|NCT00035932|520588430|FG002|Overall Study|Death|1|||
144376551|NCT00035932|520588428|FG000|Overall Study|Disease Progression / Relapse|1|||
144376552|NCT00035932|520588429|FG001|Overall Study|Disease Progression / Relapse|1|||
144376553|NCT00035932|520588430|FG002|Overall Study|Disease Progression / Relapse|0|||
144376554|NCT00035932|520588428|FG000|Overall Study|Lost to Follow-up|4|||
144376555|NCT00035932|520588429|FG001|Overall Study|Lost to Follow-up|4|||
144376556|NCT00035932|520588430|FG002|Overall Study|Lost to Follow-up|3|||
144376557|NCT00035932|520588428|FG000|Overall Study|Noncompliance|6|||
144376558|NCT00035932|520588429|FG001|Overall Study|Noncompliance|7|||
144376559|NCT00035932|520588430|FG002|Overall Study|Noncompliance|6|||
144376560|NCT00035932|520588428|FG000|Overall Study|Protocol Violation While on Study|0|||
144376561|NCT00035932|520588429|FG001|Overall Study|Protocol Violation While on Study|1|||
144376562|NCT00035932|520588430|FG002|Overall Study|Protocol Violation While on Study|2|||
144376563|NCT00035932|520588428|FG000|Overall Study|Withdrawal by Subject|1|||
144376564|NCT00035932|520588429|FG001|Overall Study|Withdrawal by Subject|5|||
144376565|NCT00035932|520588430|FG002|Overall Study|Withdrawal by Subject|0|||
144376566|NCT00035932|520588428|FG000|Overall Study|Study Termination by Sponsor|1|||
144376567|NCT00035932|520588429|FG001|Overall Study|Study Termination by Sponsor|0|||
144376568|NCT00035932|520588430|FG002|Overall Study|Study Termination by Sponsor|0|||
144376569|NCT00035932|520588428|FG000|Overall Study|Lack of Efficacy|33|||
144376570|NCT00035932|520588429|FG001|Overall Study|Lack of Efficacy|33|||
144376571|NCT00035932|520588430|FG002|Overall Study|Lack of Efficacy|28|||
144376572|NCT04413617|520588431|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
144376573|NCT04413617|520588432|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
144376574|NCT04413617|520588433|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
144376575|NCT04413617|520588434|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
144376576|NCT04413617|520588435|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
144376577|NCT04413617|520588431|FG000|Overall Study|Protocol Violation|0|||
144376578|NCT04413617|520588432|FG001|Overall Study|Protocol Violation|1|||
144376579|NCT04413617|520588433|FG002|Overall Study|Protocol Violation|0|||
144376580|NCT04413617|520588434|FG003|Overall Study|Protocol Violation|0|||
144376581|NCT04413617|520588435|FG004|Overall Study|Protocol Violation|1|||
144376582|NCT04413617|520588431|FG000|Overall Study|Lack of Efficacy|2|||
144376583|NCT04413617|520588432|FG001|Overall Study|Lack of Efficacy|0|||
144376584|NCT04413617|520588433|FG002|Overall Study|Lack of Efficacy|2|||
144376585|NCT04413617|520588434|FG003|Overall Study|Lack of Efficacy|1|||
144376586|NCT04413617|520588435|FG004|Overall Study|Lack of Efficacy|0|||
144376587|NCT04413617|520588431|FG000|Overall Study|Withdrawal by Subject|3|||
144376588|NCT04413617|520588432|FG001|Overall Study|Withdrawal by Subject|4|||
144376589|NCT04413617|520588433|FG002|Overall Study|Withdrawal by Subject|2|||
144376590|NCT04413617|520588434|FG003|Overall Study|Withdrawal by Subject|5|||
144376591|NCT04413617|520588435|FG004|Overall Study|Withdrawal by Subject|3|||
144376592|NCT04413617|520588431|FG000|Overall Study|Death|1|||
144376593|NCT04413617|520588432|FG001|Overall Study|Death|0|||
144376594|NCT04413617|520588433|FG002|Overall Study|Death|0|||
144376595|NCT04413617|520588434|FG003|Overall Study|Death|0|||
144376596|NCT04413617|520588435|FG004|Overall Study|Death|0|||
144376597|NCT04413617|520588431|FG000|Overall Study|Adverse Event|1|||
144376598|NCT04413617|520588432|FG001|Overall Study|Adverse Event|0|||
144376599|NCT04413617|520588433|FG002|Overall Study|Adverse Event|0|||
144376600|NCT04413617|520588434|FG003|Overall Study|Adverse Event|1|||
144376601|NCT04413617|520588435|FG004|Overall Study|Adverse Event|1|||
144376602|NCT04413617|520588431|FG000|Overall Study|COVID-19|0|||
144376603|NCT04413617|520588432|FG001|Overall Study|COVID-19|1|||
144376604|NCT04413617|520588433|FG002|Overall Study|COVID-19|0|||
144376605|NCT04413617|520588434|FG003|Overall Study|COVID-19|0|||
144376606|NCT04413617|520588435|FG004|Overall Study|COVID-19|0|||
144376607|NCT00312195|520588436|FG000|Overall Study|Adverse Event|4|||
144376608|NCT00312195|520588437|FG001|Overall Study|Adverse Event|6|||
144376609|NCT00312195|520588436|FG000|Overall Study|Lost to Follow-up|1|||
144376610|NCT00312195|520588437|FG001|Overall Study|Lost to Follow-up|0|||
144376611|NCT00312195|520588436|FG000|Overall Study|Protocol Violation|1|||
144376612|NCT00312195|520588437|FG001|Overall Study|Protocol Violation|0|||
144376613|NCT02511106|520588440|FG000|Overall Study|Lost to Follow-up|6|||
144376614|NCT02511106|520588441|FG001|Overall Study|Lost to Follow-up|4|||
144376615|NCT02511106|520588440|FG000|Overall Study|Withdrawal by Subject|24|||
144376616|NCT02511106|520588441|FG001|Overall Study|Withdrawal by Subject|21|||
144376617|NCT02511106|520588440|FG000|Overall Study|Death|42|||
144376618|NCT02511106|520588441|FG001|Overall Study|Death|82|||
144376619|NCT02511106|520588440|FG000|Overall Study|Ongoing study at data cut-off|3|||
144376620|NCT02511106|520588441|FG001|Overall Study|Ongoing study at data cut-off|2|||
144376621|NCT02511106|520588440|FG000|Overall Study|Without specified reason|3|||
144376622|NCT02511106|520588441|FG001|Overall Study|Without specified reason|0|||
144376623|NCT01703754|520588444|FG000|Overall Study|Clinically significant disease progression|2|||
144376624|NCT01703754|520588445|FG001|Overall Study|Clinically significant disease progression|2|||
144376625|NCT01703754|520588446|FG002|Overall Study|Clinically significant disease progression|1|||
144376626|NCT01703754|520588444|FG000|Overall Study|Adverse Event|1|||
144376627|NCT01703754|520588445|FG001|Overall Study|Adverse Event|1|||
144376628|NCT01703754|520588446|FG002|Overall Study|Adverse Event|0|||
144376629|NCT01703754|520588444|FG000|Overall Study|Withdrawal by Subject|2|||
144376630|NCT01703754|520588445|FG001|Overall Study|Withdrawal by Subject|0|||
144376631|NCT01703754|520588446|FG002|Overall Study|Withdrawal by Subject|0|||
144376632|NCT01459497|520588450|FG000|Overall Study|Inability to meet trial constraints.|1|||
144376633|NCT01459497|520588451|FG001|Overall Study|Inability to meet trial constraints.|0|||
144376634|NCT01459497|520588450|FG000|Overall Study|Physician Decision|1|||
144376635|NCT01459497|520588451|FG001|Overall Study|Physician Decision|1|||
144376636|NCT01459497|520588450|FG000|Overall Study|Hospitalization.|0|||
144512571|NCT04440176|521076062|FG000|Overall Study|Medication error without associated adverse event|0|||
144512572|NCT04440176|521076063|FG001|Overall Study|Medication error without associated adverse event|1|||
144512573|NCT04440176|521076062|FG000|Overall Study|No longer met eligibility criteria|7|||
144376637|NCT01459497|520588451|FG001|Overall Study|Hospitalization.|3|||
144376638|NCT01459497|520588450|FG000|Overall Study|Disease progression.|0|||
144376639|NCT01459497|520588451|FG001|Overall Study|Disease progression.|1|||
144376640|NCT03530124|520588452|FG000|Overall Study|Withdrawal by Subject|0|||
144512574|NCT04440176|521076063|FG001|Overall Study|No longer met eligibility criteria|1|||
144512575|NCT04440176|521076062|FG000|Overall Study|Other|1|||
144512576|NCT04440176|521076063|FG001|Overall Study|Other|2|||
144512577|NCT04440176|521076062|FG000|Overall Study|Protocol deviation|6|||
144512578|NCT04440176|521076063|FG001|Overall Study|Protocol deviation|8|||
144512579|NCT04440176|521076062|FG000|Overall Study|Randomized but not vaccinated|6|||
144512580|NCT04440176|521076063|FG001|Overall Study|Randomized but not vaccinated|3|||
144512581|NCT01631214|521076064|FG000|Overall Study|Withdrawal by Subject|276|||
144512582|NCT01631214|521076065|FG001|Overall Study|Withdrawal by Subject|290|||
144512583|NCT01631214|521076064|FG000|Overall Study|Death|113|||
144512584|NCT01631214|521076065|FG001|Overall Study|Death|106|||
144512585|NCT01631214|521076064|FG000|Overall Study|Lost to Follow-up|54|||
144512586|NCT01631214|521076065|FG001|Overall Study|Lost to Follow-up|40|||
144512587|NCT01631214|521076064|FG000|Overall Study|Adverse Event|45|||
144376641|NCT03530124|520588453|FG001|Overall Study|Withdrawal by Subject|1|||
144376642|NCT03530124|520588452|FG000|Overall Study|Protocol Violation|1|||
144512588|NCT01631214|521076065|FG001|Overall Study|Adverse Event|45|||
144512589|NCT01631214|521076064|FG000|Overall Study|Other|22|||
144512590|NCT01631214|521076065|FG001|Overall Study|Other|19|||
144512591|NCT01631214|521076064|FG000|Overall Study|Noncompliance|16|||
144376643|NCT03530124|520588453|FG001|Overall Study|Protocol Violation|0|||
144376644|NCT03530124|520588452|FG000|Overall Study|Discharged prior to study completion|1|||
144376645|NCT03530124|520588453|FG001|Overall Study|Discharged prior to study completion|0|||
144376646|NCT03179319|520588454|FG000|Overall Study|Lost to Follow-up|6|||
144376647|NCT03179319|520588455|FG001|Overall Study|Lost to Follow-up|0|||
144512592|NCT01631214|521076065|FG001|Overall Study|Noncompliance|15|||
144512593|NCT01631214|521076064|FG000|Overall Study|Requirement for Alternative Therapy|8|||
144376648|NCT01120717|520588456|FG000|Overall Study|Withdrawal by Subject|11|||
144376649|NCT01120717|520588457|FG001|Overall Study|Withdrawal by Subject|6|||
144376650|NCT01120717|520588456|FG000|Overall Study|Adverse Event|10|||
144376651|NCT01120717|520588457|FG001|Overall Study|Adverse Event|6|||
144376652|NCT01120717|520588456|FG000|Overall Study|Protocol Deviation|2|||
144376653|NCT01120717|520588457|FG001|Overall Study|Protocol Deviation|5|||
144376654|NCT01120717|520588456|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144376655|NCT01120717|520588457|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144376656|NCT01120717|520588456|FG000|Overall Study|Lost to Follow-up|2|||
144512594|NCT01631214|521076065|FG001|Overall Study|Requirement for Alternative Therapy|3|||
144512595|NCT01631214|521076064|FG000|Overall Study|Protocol Deviation|4|||
144512596|NCT01631214|521076065|FG001|Overall Study|Protocol Deviation|3|||
144512597|NCT01631214|521076064|FG000|Overall Study|Ineligibility determined|5|||
144376657|NCT01120717|520588457|FG001|Overall Study|Lost to Follow-up|3|||
144512598|NCT01631214|521076065|FG001|Overall Study|Ineligibility determined|2|||
144512599|NCT01631214|521076064|FG000|Overall Study|Administrative Decision|1|||
144512600|NCT01631214|521076065|FG001|Overall Study|Administrative Decision|0|||
144512601|NCT04847999|521076066|FG000|Overall Study|Lost to Follow-up|0|||
144512602|NCT04847999|521076067|FG001|Overall Study|Lost to Follow-up|1|||
144512603|NCT02879448|521076068|FG000|Overall Study|Death|251|||
144512604|NCT02879448|521076069|FG001|Overall Study|Death|263|||
144512605|NCT02879448|521076068|FG000|Overall Study|Lost to Follow-up|23|||
144512606|NCT02879448|521076069|FG001|Overall Study|Lost to Follow-up|28|||
144512607|NCT02879448|521076068|FG000|Overall Study|Withdrawal by Subject|42|||
144512608|NCT02879448|521076069|FG001|Overall Study|Withdrawal by Subject|79|||
144512609|NCT02879448|521076068|FG000|Overall Study|Other Reasons|8|||
144512610|NCT02879448|521076069|FG001|Overall Study|Other Reasons|12|||
144512611|NCT05288283|521076079|FG000|Overall Study|Study Terminated Early|1|||
144512612|NCT05288283|521076080|FG001|Overall Study|Study Terminated Early|1|||
144512613|NCT04153565|521076081|FG000|Overall Study|Death|13|||
144512614|NCT04300231|521076082|FG000|Overall Study|Protocol Violation|4|||
144512615|NCT04300231|521076083|FG001|Overall Study|Protocol Violation|3|||
144512616|NCT04300231|521076084|FG002|Overall Study|Protocol Violation|0|||
144512617|NCT04300231|521076085|FG003|Overall Study|Protocol Violation|2|||
144512618|NCT02991807|521076086|FG000|Overall Study|Withdrawal by Subject|2|||
144512619|NCT02991807|521076087|FG001|Overall Study|Withdrawal by Subject|1|||
144512620|NCT02991807|521076086|FG000|Overall Study|Physician Decision|0|||
144512621|NCT02991807|521076087|FG001|Overall Study|Physician Decision|1|||
144512622|NCT02991807|521076086|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
144512623|NCT02991807|521076087|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
144512624|NCT02300298|521076090|FG000|Disposition for Nintedanib|Progressive disease|10|||
144376658|NCT01120717|520588456|FG000|Overall Study|Death|3|||
144376659|NCT01120717|520588457|FG001|Overall Study|Death|1|||
144376660|NCT01120717|520588456|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
144376661|NCT01120717|520588457|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
144376662|NCT02379637|520588462|FG000|Overall Study|Protocol Violation|0|||
144376663|NCT02379637|520588463|FG001|Overall Study|Protocol Violation|1|||
144376664|NCT02379637|520588462|FG000|Overall Study|Adverse Event|1|||
144376665|NCT02379637|520588463|FG001|Overall Study|Adverse Event|0|||
144376666|NCT02379637|520588462|FG000|Overall Study|Withdrawal by Subject|1|||
144376667|NCT02379637|520588463|FG001|Overall Study|Withdrawal by Subject|0|||
144376668|NCT02791763|520588464|FG000|Overall Study|Protocol Violation|0|||
144376669|NCT02791763|520588465|FG001|Overall Study|Protocol Violation|0|||
144376670|NCT02791763|520588466|FG002|Overall Study|Protocol Violation|1|||
144376671|NCT02791763|520588464|FG000|Overall Study|Withdrawal by Subject|5|||
144376672|NCT02791763|520588465|FG001|Overall Study|Withdrawal by Subject|1|||
144376673|NCT02791763|520588466|FG002|Overall Study|Withdrawal by Subject|0|||
144376674|NCT02791763|520588464|FG000|Overall Study|Physician Decision|0|||
144376675|NCT02791763|520588465|FG001|Overall Study|Physician Decision|1|||
144376676|NCT02791763|520588466|FG002|Overall Study|Physician Decision|0|||
144376677|NCT02791763|520588464|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
144376678|NCT02791763|520588465|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
144376679|NCT02791763|520588466|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
144376680|NCT02791763|520588464|FG000|Overall Study|Cancer event|1|||
144376681|NCT02791763|520588465|FG001|Overall Study|Cancer event|3|||
144376682|NCT02791763|520588466|FG002|Overall Study|Cancer event|0|||
144376683|NCT02791763|520588464|FG000|Overall Study|Participant had renal transplant|3|||
144376684|NCT02791763|520588465|FG001|Overall Study|Participant had renal transplant|0|||
144376685|NCT02791763|520588466|FG002|Overall Study|Participant had renal transplant|0|||
144376686|NCT02791763|520588464|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
144376687|NCT02791763|520588465|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
144376688|NCT02791763|520588466|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
144376689|NCT02791763|520588464|FG000|Overall Study|Adverse Event|12|||
144376690|NCT02791763|520588465|FG001|Overall Study|Adverse Event|13|||
144376691|NCT02791763|520588466|FG002|Overall Study|Adverse Event|7|||
144376692|NCT01561313|520588473|FG000|Overall Study|Withdrawal by Subject|1|||
144376693|NCT01561313|520588474|FG001|Overall Study|Withdrawal by Subject|0|||
144376694|NCT01561313|520588473|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
144376695|NCT01561313|520588474|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
144376696|NCT04535453|520588475|FG000|Overall Study|Death|0|||
144376697|NCT04535453|520588476|FG001|Overall Study|Death|1|||
144376698|NCT04535453|520588477|FG002|Overall Study|Death|0|||
144376699|NCT04535453|520588478|FG003|Overall Study|Death|0|||
144376700|NCT04535453|520588479|FG004|Overall Study|Death|0|||
144376701|NCT04535453|520588480|FG005|Overall Study|Death|0|||
144376702|NCT04535453|520588481|FG006|Overall Study|Death|0|||
144376703|NCT04535453|520588482|FG007|Overall Study|Death|0|||
144376704|NCT04535453|520588483|FG008|Overall Study|Death|0|||
144376705|NCT04535453|520588484|FG009|Overall Study|Death|0|||
144376706|NCT04535453|520588485|FG010|Overall Study|Death|0|||
144376707|NCT04535453|520588486|FG011|Overall Study|Death|0|||
144376708|NCT04535453|520588475|FG000|Overall Study|Lost to Follow-up|1|||
144512625|NCT02300298|521076091|FG001|Disposition for Nintedanib|Progressive disease|0|||
144376709|NCT04535453|520588476|FG001|Overall Study|Lost to Follow-up|1|||
144512626|NCT02300298|521076090|FG000|Disposition for Docetaxel|Progressive disease|0|||
144512627|NCT02300298|521076091|FG001|Disposition for Docetaxel|Progressive disease|6|||
144512628|NCT02300298|521076090|FG000|Disposition for Docetaxel|other adverse event|0|||
144512629|NCT02300298|521076091|FG001|Disposition for Docetaxel|other adverse event|4|||
144512630|NCT03285763|521076092|FG000|Overall Study|Death|470|||
144512631|NCT03285763|521076092|FG000|Overall Study|Lost to Follow-up|18|||
144512632|NCT03285763|521076092|FG000|Overall Study|Physician Decision|2|||
144512633|NCT03285763|521076092|FG000|Overall Study|Study Terminated By Sponsor|79|||
144512634|NCT03285763|521076092|FG000|Overall Study|Withdrawal by Subject|33|||
144512635|NCT03990649|521076093|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
144512636|NCT03990649|521076094|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
144512637|NCT03990649|521076095|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
144512638|NCT03990649|521076093|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
144512639|NCT03990649|521076094|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
144512640|NCT03990649|521076095|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
144512641|NCT03990649|521076093|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
144512642|NCT03990649|521076094|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
144512643|NCT03990649|521076095|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
144512644|NCT03990649|521076093|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
144512645|NCT03990649|521076094|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
144512646|NCT03990649|521076095|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
144512647|NCT03990649|521076093|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
144376710|NCT04535453|520588477|FG002|Overall Study|Lost to Follow-up|1|||
144376711|NCT04535453|520588478|FG003|Overall Study|Lost to Follow-up|0|||
144721758|NCT01595009|521835278|FG003|Extension|Adverse Event|1|||
144376712|NCT04535453|520588479|FG004|Overall Study|Lost to Follow-up|3|||
144376713|NCT04535453|520588480|FG005|Overall Study|Lost to Follow-up|1|||
144376714|NCT04535453|520588481|FG006|Overall Study|Lost to Follow-up|0|||
144376715|NCT04535453|520588482|FG007|Overall Study|Lost to Follow-up|0|||
144376716|NCT04535453|520588483|FG008|Overall Study|Lost to Follow-up|1|||
144376717|NCT04535453|520588484|FG009|Overall Study|Lost to Follow-up|1|||
144376718|NCT04535453|520588485|FG010|Overall Study|Lost to Follow-up|0|||
144376719|NCT04535453|520588486|FG011|Overall Study|Lost to Follow-up|0|||
144376720|NCT04535453|520588475|FG000|Overall Study|Physician Decision|0|||
144376721|NCT04535453|520588476|FG001|Overall Study|Physician Decision|0|||
144376722|NCT04535453|520588477|FG002|Overall Study|Physician Decision|0|||
144376723|NCT04535453|520588478|FG003|Overall Study|Physician Decision|1|||
144376724|NCT04535453|520588479|FG004|Overall Study|Physician Decision|0|||
144376725|NCT04535453|520588480|FG005|Overall Study|Physician Decision|0|||
144376726|NCT04535453|520588481|FG006|Overall Study|Physician Decision|0|||
144376727|NCT04535453|520588482|FG007|Overall Study|Physician Decision|0|||
144376728|NCT04535453|520588483|FG008|Overall Study|Physician Decision|0|||
144376729|NCT04535453|520588484|FG009|Overall Study|Physician Decision|0|||
144376730|NCT04535453|520588485|FG010|Overall Study|Physician Decision|0|||
144376731|NCT04535453|520588486|FG011|Overall Study|Physician Decision|0|||
144376732|NCT04535453|520588475|FG000|Overall Study|Withdrawal by Subject|3|||
144376733|NCT04535453|520588476|FG001|Overall Study|Withdrawal by Subject|6|||
144376734|NCT04535453|520588477|FG002|Overall Study|Withdrawal by Subject|3|||
144376735|NCT04535453|520588478|FG003|Overall Study|Withdrawal by Subject|3|||
144376736|NCT04535453|520588479|FG004|Overall Study|Withdrawal by Subject|2|||
144376737|NCT04535453|520588480|FG005|Overall Study|Withdrawal by Subject|1|||
144376738|NCT04535453|520588481|FG006|Overall Study|Withdrawal by Subject|1|||
144376739|NCT04535453|520588482|FG007|Overall Study|Withdrawal by Subject|1|||
144376740|NCT04535453|520588483|FG008|Overall Study|Withdrawal by Subject|1|||
144376741|NCT04535453|520588484|FG009|Overall Study|Withdrawal by Subject|1|||
144376742|NCT04535453|520588485|FG010|Overall Study|Withdrawal by Subject|0|||
144376743|NCT04535453|520588486|FG011|Overall Study|Withdrawal by Subject|1|||
144376744|NCT04535453|520588475|FG000|Overall Study|Other|0|||
144376745|NCT04535453|520588476|FG001|Overall Study|Other|0|||
144376746|NCT04535453|520588477|FG002|Overall Study|Other|1|||
144376747|NCT04535453|520588478|FG003|Overall Study|Other|0|||
144376748|NCT04535453|520588479|FG004|Overall Study|Other|1|||
144376749|NCT04535453|520588480|FG005|Overall Study|Other|0|||
144376750|NCT04535453|520588481|FG006|Overall Study|Other|1|||
144376751|NCT04535453|520588482|FG007|Overall Study|Other|1|||
144376752|NCT04535453|520588483|FG008|Overall Study|Other|1|||
144376753|NCT04535453|520588484|FG009|Overall Study|Other|0|||
144376754|NCT04535453|520588485|FG010|Overall Study|Other|0|||
144376755|NCT04535453|520588486|FG011|Overall Study|Other|0|||
144376756|NCT01742286|520588487|FG000|Escalation Phase|Administrative problems|1|||
144376757|NCT01742286|520588488|FG001|Escalation Phase|Administrative problems|1|||
144376758|NCT01742286|520588489|FG002|Escalation Phase|Administrative problems|0|||
144376759|NCT01742286|520588490|FG003|Escalation Phase|Administrative problems|0|||
144376760|NCT01742286|520588491|FG004|Escalation Phase|Administrative problems|0|||
144376761|NCT01742286|520588492|FG005|Escalation Phase|Administrative problems|0|||
144376762|NCT01742286|520588493|FG006|Escalation Phase|Administrative problems|2|||
144376763|NCT01742286|520588487|FG000|Escalation Phase|Adverse Event|0|||
144376764|NCT01742286|520588488|FG001|Escalation Phase|Adverse Event|1|||
144376765|NCT01742286|520588489|FG002|Escalation Phase|Adverse Event|2|||
144376766|NCT01742286|520588490|FG003|Escalation Phase|Adverse Event|0|||
144376767|NCT01742286|520588491|FG004|Escalation Phase|Adverse Event|0|||
144376768|NCT01742286|520588492|FG005|Escalation Phase|Adverse Event|1|||
144376769|NCT01742286|520588493|FG006|Escalation Phase|Adverse Event|0|||
144376770|NCT01742286|520588487|FG000|Escalation Phase|Disease progression|3|||
144376771|NCT01742286|520588488|FG001|Escalation Phase|Disease progression|7|||
144376772|NCT01742286|520588489|FG002|Escalation Phase|Disease progression|4|||
144376773|NCT01742286|520588490|FG003|Escalation Phase|Disease progression|1|||
144376774|NCT01742286|520588491|FG004|Escalation Phase|Disease progression|4|||
144512648|NCT03990649|521076094|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
144512649|NCT03990649|521076095|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
144512650|NCT03990649|521076093|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
144512651|NCT03990649|521076094|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
144376775|NCT01742286|520588492|FG005|Escalation Phase|Disease progression|3|||
144376776|NCT01742286|520588493|FG006|Escalation Phase|Disease progression|2|||
144512652|NCT03990649|521076095|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
144376777|NCT01742286|520588487|FG000|Escalation Phase|Death|0|||
144376778|NCT01742286|520588488|FG001|Escalation Phase|Death|0|||
144512653|NCT03990649|521076093|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
144721759|NCT01842958|521835279|FG000|Overall Study|Lost to Follow-up|1|||
144376779|NCT01742286|520588489|FG002|Escalation Phase|Death|0|||
144376780|NCT01742286|520588490|FG003|Escalation Phase|Death|0|||
144376781|NCT01742286|520588491|FG004|Escalation Phase|Death|0|||
144376782|NCT01742286|520588492|FG005|Escalation Phase|Death|1|||
144376783|NCT01742286|520588493|FG006|Escalation Phase|Death|0|||
144376784|NCT01742286|520588487|FG000|Escalation Phase|Physician Decision|0|||
144376785|NCT01742286|520588488|FG001|Escalation Phase|Physician Decision|3|||
144376786|NCT01742286|520588489|FG002|Escalation Phase|Physician Decision|0|||
144376787|NCT01742286|520588490|FG003|Escalation Phase|Physician Decision|1|||
144376788|NCT01742286|520588491|FG004|Escalation Phase|Physician Decision|0|||
144376789|NCT01742286|520588492|FG005|Escalation Phase|Physician Decision|0|||
144376790|NCT01742286|520588493|FG006|Escalation Phase|Physician Decision|2|||
144376791|NCT01742286|520588487|FG000|Escalation Phase|Subject/guardian decision|1|||
144376792|NCT01742286|520588488|FG001|Escalation Phase|Subject/guardian decision|0|||
144376793|NCT01742286|520588489|FG002|Escalation Phase|Subject/guardian decision|0|||
144376794|NCT01742286|520588490|FG003|Escalation Phase|Subject/guardian decision|0|||
144376795|NCT01742286|520588491|FG004|Escalation Phase|Subject/guardian decision|0|||
144376796|NCT01742286|520588492|FG005|Escalation Phase|Subject/guardian decision|0|||
144376797|NCT01742286|520588493|FG006|Escalation Phase|Subject/guardian decision|0|||
144376798|NCT01742286|520588487|FG000|Expansion Phase|Administrative problems|0|||
144376799|NCT01742286|520588488|FG001|Expansion Phase|Administrative problems|0|||
144376800|NCT01742286|520588489|FG002|Expansion Phase|Administrative problems|0|||
144376801|NCT01742286|520588490|FG003|Expansion Phase|Administrative problems|0|||
144376802|NCT01742286|520588491|FG004|Expansion Phase|Administrative problems|0|||
144376803|NCT01742286|520588492|FG005|Expansion Phase|Administrative problems|0|||
144376804|NCT01742286|520588493|FG006|Expansion Phase|Administrative problems|5|||
144376805|NCT01742286|520588487|FG000|Expansion Phase|Physician Decision|0|||
144376806|NCT01742286|520588488|FG001|Expansion Phase|Physician Decision|0|||
144376807|NCT01742286|520588489|FG002|Expansion Phase|Physician Decision|4|||
144376808|NCT01742286|520588490|FG003|Expansion Phase|Physician Decision|0|||
144376809|NCT01742286|520588491|FG004|Expansion Phase|Physician Decision|0|||
144376810|NCT01742286|520588492|FG005|Expansion Phase|Physician Decision|0|||
144376811|NCT01742286|520588493|FG006|Expansion Phase|Physician Decision|9|||
144376812|NCT01742286|520588487|FG000|Expansion Phase|Adverse Event|0|||
144376813|NCT01742286|520588488|FG001|Expansion Phase|Adverse Event|0|||
144376814|NCT01742286|520588489|FG002|Expansion Phase|Adverse Event|0|||
144376815|NCT01742286|520588490|FG003|Expansion Phase|Adverse Event|0|||
144376816|NCT01742286|520588491|FG004|Expansion Phase|Adverse Event|0|||
144376817|NCT01742286|520588492|FG005|Expansion Phase|Adverse Event|0|||
144376818|NCT01742286|520588493|FG006|Expansion Phase|Adverse Event|6|||
144376819|NCT01742286|520588487|FG000|Expansion Phase|Disease progression|0|||
144376820|NCT01742286|520588488|FG001|Expansion Phase|Disease progression|0|||
144376821|NCT01742286|520588489|FG002|Expansion Phase|Disease progression|3|||
144376822|NCT01742286|520588490|FG003|Expansion Phase|Disease progression|0|||
144376823|NCT01742286|520588491|FG004|Expansion Phase|Disease progression|0|||
144376824|NCT01742286|520588492|FG005|Expansion Phase|Disease progression|0|||
144376825|NCT01742286|520588493|FG006|Expansion Phase|Disease progression|15|||
144376826|NCT01742286|520588487|FG000|Expansion Phase|Withdrawal by Subject|0|||
144512654|NCT03990649|521076094|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
144512655|NCT03990649|521076095|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
144512656|NCT05773313|521076096|FG000|Overall Study|Lost to Follow-up|3|||
144512657|NCT03050814|521076097|FG000|Overall Study|Screen failures|0|||
144376827|NCT01742286|520588488|FG001|Expansion Phase|Withdrawal by Subject|0|||
144376828|NCT01742286|520588489|FG002|Expansion Phase|Withdrawal by Subject|0|||
144376829|NCT01742286|520588490|FG003|Expansion Phase|Withdrawal by Subject|0|||
144376830|NCT01742286|520588491|FG004|Expansion Phase|Withdrawal by Subject|0|||
144376831|NCT01742286|520588492|FG005|Expansion Phase|Withdrawal by Subject|0|||
144376832|NCT01742286|520588493|FG006|Expansion Phase|Withdrawal by Subject|1|||
144376833|NCT04530136|520588494|FG000|Overall Study|Lost to Follow-up|2|||
144376834|NCT04530136|520588495|FG001|Overall Study|Lost to Follow-up|3|||
144376835|NCT04530136|520588494|FG000|Overall Study|Withdrawal by Subject|1|||
144512658|NCT03050814|521076098|FG001|Overall Study|Screen failures|0|||
144512659|NCT03050814|521076099|FG002|Overall Study|Screen failures|4|||
144512660|NCT01443845|521076103|FG000|Overall Study|Protocol Violation|43|||
144512661|NCT01443845|521076104|FG001|Overall Study|Protocol Violation|45|||
144512662|NCT01443845|521076103|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
144512663|NCT01443845|521076104|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
144376836|NCT04530136|520588495|FG001|Overall Study|Withdrawal by Subject|0|||
144376837|NCT04530136|520588494|FG000|Overall Study|Death|0|||
144376838|NCT04530136|520588495|FG001|Overall Study|Death|1|||
144376839|NCT01387542|520588496|FG000|Overall Study|Adverse Event|3|||
144376840|NCT01387542|520588496|FG000|Overall Study|Withdrawal by Subject|1|||
144376841|NCT01387542|520588496|FG000|Overall Study|Changed diagnosis|1|||
144376842|NCT01387542|520588496|FG000|Overall Study|Insufficient response|1|||
144376843|NCT01387542|520588496|FG000|Overall Study|Non-compliant|1|||
144376844|NCT01387542|520588496|FG000|Overall Study|Lost to Follow-up|1|||
144512664|NCT01443845|521076103|FG000|Overall Study|Deterioration in pulmonary function|1|||
144512665|NCT01443845|521076104|FG001|Overall Study|Deterioration in pulmonary function|4|||
144376845|NCT01233232|520588497|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
144376846|NCT01233232|520588498|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
144376847|NCT01233232|520588499|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
144376848|NCT01519167|520588505|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
144376849|NCT01519167|520588506|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
144376850|NCT01519167|520588505|FG000|Overall Study|Adverse Event|0|||
144376851|NCT01519167|520588506|FG001|Overall Study|Adverse Event|1|||
144376852|NCT01519167|520588505|FG000|Overall Study|Lack of Efficacy|0|||
144376853|NCT01519167|520588506|FG001|Overall Study|Lack of Efficacy|1|||
144376854|NCT01519167|520588505|FG000|Overall Study|Medical condition changes&deep sedation|0|||
144376855|NCT01519167|520588506|FG001|Overall Study|Medical condition changes&deep sedation|2|||
144376856|NCT01519167|520588505|FG000|Overall Study|Physician Decision|0|||
144376857|NCT01519167|520588506|FG001|Overall Study|Physician Decision|1|||
144376858|NCT04189224|520588507|FG000|Period 2|Adverse Event|0|||
144376859|NCT04189224|520588508|FG001|Period 2|Adverse Event|1|||
144376860|NCT01925131|520590219|FG000|Overall Study|Death|0|||
144376861|NCT01925131|520590220|FG001|Overall Study|Death|0|||
144376862|NCT01925131|520590221|FG002|Overall Study|Death|1|||
144376863|NCT01925131|520590222|FG003|Overall Study|Death|0|||
144376864|NCT01925131|520590223|FG004|Overall Study|Death|0|||
144376865|NCT01925131|520590224|FG005|Overall Study|Death|0|||
144376866|NCT01925131|520590219|FG000|Overall Study|Progression/Relapse|1|||
144376867|NCT01925131|520590220|FG001|Overall Study|Progression/Relapse|1|||
144376868|NCT01925131|520590221|FG002|Overall Study|Progression/Relapse|4|||
144376869|NCT01925131|520590222|FG003|Overall Study|Progression/Relapse|0|||
144376870|NCT01925131|520590223|FG004|Overall Study|Progression/Relapse|0|||
144376871|NCT01925131|520590224|FG005|Overall Study|Progression/Relapse|1|||
144376872|NCT01925131|520590219|FG000|Overall Study|Patient Refusal|1|||
144376873|NCT01925131|520590220|FG001|Overall Study|Patient Refusal|0|||
144376874|NCT01925131|520590221|FG002|Overall Study|Patient Refusal|0|||
144376875|NCT01925131|520590222|FG003|Overall Study|Patient Refusal|0|||
144376876|NCT01925131|520590223|FG004|Overall Study|Patient Refusal|0|||
144376877|NCT01925131|520590224|FG005|Overall Study|Patient Refusal|0|||
144376878|NCT01925131|520590219|FG000|Overall Study|Adverse Event|0|||
144376879|NCT01925131|520590220|FG001|Overall Study|Adverse Event|0|||
144376880|NCT01925131|520590221|FG002|Overall Study|Adverse Event|2|||
144376881|NCT01925131|520590222|FG003|Overall Study|Adverse Event|0|||
144376882|NCT01925131|520590223|FG004|Overall Study|Adverse Event|1|||
144376883|NCT01925131|520590224|FG005|Overall Study|Adverse Event|3|||
144376884|NCT01925131|520590219|FG000|Overall Study|Other - Not Protocol Specified|3|||
144376885|NCT01925131|520590220|FG001|Overall Study|Other - Not Protocol Specified|1|||
144376886|NCT01925131|520590221|FG002|Overall Study|Other - Not Protocol Specified|2|||
144376887|NCT01925131|520590222|FG003|Overall Study|Other - Not Protocol Specified|5|||
144376888|NCT01925131|520590223|FG004|Overall Study|Other - Not Protocol Specified|10|||
144376889|NCT01925131|520590224|FG005|Overall Study|Other - Not Protocol Specified|6|||
144376890|NCT01139008|520590225|FG000|Overall Study|Withdrawal by Subject|5|||
144376891|NCT01139008|520590225|FG000|Overall Study|Non-compliant, lost product|1|||
144376892|NCT04838977|520590226|FG000|Overall Study|Lost to Follow-up|2|||
144376893|NCT04838977|520590227|FG001|Overall Study|Lost to Follow-up|3|||
144376894|NCT04838977|520590226|FG000|Overall Study|Withdrawal by Subject|1|||
144376895|NCT04838977|520590227|FG001|Overall Study|Withdrawal by Subject|1|||
144376896|NCT00265148|520590228|FG000|Overall Study|Adverse Event|2|||
144376897|NCT00265148|520590229|FG001|Overall Study|Adverse Event|2|||
144376898|NCT00265148|520590228|FG000|Overall Study|Lack of Efficacy|0|||
144376899|NCT00265148|520590229|FG001|Overall Study|Lack of Efficacy|2|||
144376900|NCT00265148|520590228|FG000|Overall Study|Protocol Violation|3|||
144376901|NCT00265148|520590229|FG001|Overall Study|Protocol Violation|2|||
144376902|NCT00265148|520590228|FG000|Overall Study|Lost to Follow-up|0|||
144376903|NCT00265148|520590229|FG001|Overall Study|Lost to Follow-up|1|||
144376904|NCT00265148|520590228|FG000|Overall Study|Withdrawal by Subject|2|||
144376905|NCT00265148|520590229|FG001|Overall Study|Withdrawal by Subject|1|||
144376906|NCT00265148|520590228|FG000|Overall Study|Physician Decision|1|||
144376907|NCT00265148|520590229|FG001|Overall Study|Physician Decision|0|||
144376908|NCT00265148|520590228|FG000|Overall Study|Increasing frailty|0|||
144376909|NCT00265148|520590229|FG001|Overall Study|Increasing frailty|1|||
144512666|NCT01443845|521076103|FG000|Overall Study|Lack of Efficacy|10|||
144376910|NCT00265148|520590228|FG000|Overall Study|Subject chose to change of the dose|1|||
144512667|NCT01443845|521076104|FG001|Overall Study|Lack of Efficacy|5|||
144512668|NCT01443845|521076103|FG000|Overall Study|Adverse Event|64|||
144512669|NCT01443845|521076104|FG001|Overall Study|Adverse Event|138|||
144376911|NCT00265148|520590229|FG001|Overall Study|Subject chose to change of the dose|0|||
144376912|NCT01463007|520590230|FG000|Overall Study|Physician Decision|1|||
144376913|NCT00942994|520590231|FG000|Overall Study|Adverse Event|7|||
144376914|NCT00942994|520590232|FG001|Overall Study|Adverse Event|4|||
144376915|NCT00942994|520590231|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144376916|NCT00942994|520590232|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144512670|NCT01443845|521076103|FG000|Overall Study|Withdrawal by Subject|63|||
144512671|NCT01443845|521076104|FG001|Overall Study|Withdrawal by Subject|67|||
144512672|NCT01443845|521076103|FG000|Overall Study|Military Conflict - Site Terminated|20|||
144721760|NCT01842958|521835280|FG001|Overall Study|Lost to Follow-up|1|||
144721761|NCT00622908|521835281|FG000|Overall Study|Protocol Violation|1|||
144721762|NCT00622908|521835282|FG001|Overall Study|Protocol Violation|0|||
144721763|NCT00622908|521835281|FG000|Overall Study|Adverse Event|0|||
144721764|NCT00622908|521835282|FG001|Overall Study|Adverse Event|1|||
144721765|NCT00622908|521835281|FG000|Overall Study|Lack of Efficacy|1|||
144721766|NCT00622908|521835282|FG001|Overall Study|Lack of Efficacy|7|||
144721767|NCT00622908|521835281|FG000|Overall Study|Lost to Follow-up|1|||
144721768|NCT00622908|521835282|FG001|Overall Study|Lost to Follow-up|0|||
144721769|NCT00622908|521835281|FG000|Overall Study|Refusal|0|||
144721770|NCT00622908|521835282|FG001|Overall Study|Refusal|1|||
144721771|NCT00622908|521835281|FG000|Overall Study|Termination by study sponser|0|||
144721772|NCT00622908|521835282|FG001|Overall Study|Termination by study sponser|1|||
144376917|NCT00942994|520590231|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144376918|NCT00942994|520590232|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144376919|NCT00942994|520590231|FG000|Overall Study|Patient withdrew consent|5|||
144376920|NCT00942994|520590232|FG001|Overall Study|Patient withdrew consent|8|||
144376921|NCT00942994|520590231|FG000|Overall Study|Lost to Follow-up|1|||
144376922|NCT00942994|520590232|FG001|Overall Study|Lost to Follow-up|4|||
144376923|NCT00942994|520590231|FG000|Overall Study|Protocol deviation|1|||
144376924|NCT00942994|520590232|FG001|Overall Study|Protocol deviation|2|||
144376925|NCT03583385|520590233|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144376926|NCT03583385|520590234|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144376927|NCT03583385|520590233|FG000|Treatment Period 2|Adverse Event|1|||
144376928|NCT03583385|520590234|FG001|Treatment Period 2|Adverse Event|0|||
144376929|NCT00095940|520590237|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
144376930|NCT00095940|520590238|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
144376931|NCT00095940|520590239|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
144376932|NCT00095940|520590240|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
144376933|NCT00095940|520590241|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
144376934|NCT00095940|520590242|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
144376935|NCT00095940|520590243|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
144376936|NCT00095940|520590244|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
144376937|NCT00095940|520590245|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
144376938|NCT00095940|520590237|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
144376939|NCT00095940|520590238|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
144376940|NCT00095940|520590239|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
144376941|NCT00095940|520590240|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
144376942|NCT00095940|520590241|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
144376943|NCT00095940|520590242|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
144376944|NCT00095940|520590243|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
144376945|NCT00095940|520590244|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
144376946|NCT00095940|520590245|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
144376947|NCT00095940|520590237|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376948|NCT00095940|520590238|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376949|NCT00095940|520590239|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376950|NCT00095940|520590240|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376951|NCT00095940|520590241|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376952|NCT00095940|520590242|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376953|NCT00095940|520590243|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376954|NCT00095940|520590244|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
144376955|NCT00095940|520590245|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
144376956|NCT02314637|520590248|FG000|Overall Study|Adverse Event|4|||
144376957|NCT02314637|520590249|FG001|Overall Study|Adverse Event|8|||
144376958|NCT02314637|520590248|FG000|Overall Study|Lack of Efficacy|1|||
144376959|NCT02314637|520590249|FG001|Overall Study|Lack of Efficacy|0|||
144376960|NCT02314637|520590248|FG000|Overall Study|Physician Decision|5|||
144376961|NCT02314637|520590249|FG001|Overall Study|Physician Decision|2|||
144376962|NCT02314637|520590248|FG000|Overall Study|Withdrawal by Subject|5|||
144376963|NCT02314637|520590249|FG001|Overall Study|Withdrawal by Subject|4|||
144376964|NCT02314637|520590248|FG000|Overall Study|Other Reason|1|||
144376965|NCT02314637|520590249|FG001|Overall Study|Other Reason|0|||
144376966|NCT01311024|520590264|FG000|Overall Study|Protocol Violation|35|||
144376967|NCT01311024|520590265|FG001|Overall Study|Protocol Violation|22|||
144376968|NCT02597478|520590270|FG000|Overall Study|Withdrawal by Subject|2|||
144376969|NCT02597478|520590271|FG001|Overall Study|Withdrawal by Subject|0|||
144512673|NCT01443845|521076104|FG001|Overall Study|Military Conflict - Site Terminated|21|||
144512674|NCT01443845|521076103|FG000|Overall Study|Lost to Follow-up|9|||
144721773|NCT03937466|521835283|FG000|Overall Study|not eligbile after the 2-week diary|9|||
144721774|NCT03937466|521835283|FG000|Overall Study|never returned their diary|6|||
144721775|NCT03937466|521835283|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
144721776|NCT03937466|521835283|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
144721777|NCT03305055|521835284|FG000|Overall Study|Withdrawal by Subject|0|||
144721778|NCT03305055|521835285|FG001|Overall Study|Withdrawal by Subject|1|||
144721779|NCT03305055|521835284|FG000|Overall Study|Adverse Event|1|||
144721780|NCT03305055|521835285|FG001|Overall Study|Adverse Event|1|||
144376970|NCT02597478|520590270|FG000|Overall Study|Change of opioid dose|1|||
144376971|NCT02597478|520590271|FG001|Overall Study|Change of opioid dose|0|||
144376972|NCT02597478|520590270|FG000|Overall Study|Insufficient exertional dyspnea|0|||
144376973|NCT02597478|520590271|FG001|Overall Study|Insufficient exertional dyspnea|1|||
144376974|NCT01256190|520590273|FG000|Overall Study|Lost to Follow-up|2|||
144376975|NCT01256190|520590274|FG001|Overall Study|Lost to Follow-up|0|||
144376976|NCT02364336|520590275|FG000|Overall Study|Adverse Event|0|||
144376977|NCT02364336|520590276|FG001|Overall Study|Adverse Event|1|||
144376978|NCT04643158|520590277|FG000|Overall Study|Study terminated by sponsor|0|||
144376979|NCT04643158|520590278|FG001|Overall Study|Study terminated by sponsor|0|||
144376980|NCT04643158|520590279|FG002|Overall Study|Study terminated by sponsor|1|||
144376981|NCT04643158|520590280|FG003|Overall Study|Study terminated by sponsor|0|||
144512675|NCT01443845|521076104|FG001|Overall Study|Lost to Follow-up|13|||
144512676|NCT00402246|521076105|FG000|Overall Study|Death|62|||
144512677|NCT00402246|521076106|FG001|Overall Study|Death|58|||
144512678|NCT00402246|521076105|FG000|Overall Study|Lost to Follow-up|20|||
144512679|NCT00402246|521076106|FG001|Overall Study|Lost to Follow-up|28|||
144512680|NCT00402246|521076105|FG000|Overall Study|Withdrawal by Subject|72|||
144512681|NCT00402246|521076106|FG001|Overall Study|Withdrawal by Subject|87|||
144512682|NCT00402246|521076105|FG000|Overall Study|Physician Decision|24|||
144512683|NCT00402246|521076106|FG001|Overall Study|Physician Decision|26|||
144512684|NCT00402246|521076105|FG000|Overall Study|Protocol Violation|25|||
144512685|NCT00402246|521076106|FG001|Overall Study|Protocol Violation|24|||
144512686|NCT00402246|521076105|FG000|Overall Study|Missed Final Visit|1|||
144512687|NCT00402246|521076106|FG001|Overall Study|Missed Final Visit|2|||
144512688|NCT00402246|521076105|FG000|Overall Study|Insurance Issues|2|||
144512689|NCT00402246|521076106|FG001|Overall Study|Insurance Issues|1|||
144512690|NCT00402246|521076105|FG000|Overall Study|Heart Transplant|0|||
144512691|NCT00402246|521076106|FG001|Overall Study|Heart Transplant|1|||
144512692|NCT00402246|521076105|FG000|Overall Study|Patient's device explanted|6|||
144512693|NCT00402246|521076106|FG001|Overall Study|Patient's device explanted|2|||
144512694|NCT00402246|521076105|FG000|Overall Study|Center Closure|5|||
144512695|NCT00402246|521076106|FG001|Overall Study|Center Closure|3|||
144376982|NCT04643158|520590281|FG004|Overall Study|Study terminated by sponsor|0|||
144512696|NCT00402246|521076105|FG000|Overall Study|Deterioriating Condition|3|||
144376983|NCT04643158|520590282|FG005|Overall Study|Study terminated by sponsor|1|||
144376984|NCT04643158|520590283|FG006|Overall Study|Study terminated by sponsor|0|||
144512697|NCT00402246|521076106|FG001|Overall Study|Deterioriating Condition|2|||
144512698|NCT01471691|521076107|FG000|Overall Study|Lack of Efficacy|0|||
144721781|NCT03213210|521835286|FG000|Overall Study|Lost to Follow-up|2|||
144721782|NCT03213210|521835286|FG000|Overall Study|Study termination|3|||
144376985|NCT04643158|520590277|FG000|Overall Study|Global/country situation|0|||
144376986|NCT04643158|520590278|FG001|Overall Study|Global/country situation|0|||
144376987|NCT04643158|520590279|FG002|Overall Study|Global/country situation|1|||
144376988|NCT04643158|520590280|FG003|Overall Study|Global/country situation|0|||
144376989|NCT04643158|520590281|FG004|Overall Study|Global/country situation|0|||
144376990|NCT04643158|520590282|FG005|Overall Study|Global/country situation|0|||
144376991|NCT04643158|520590283|FG006|Overall Study|Global/country situation|0|||
144376992|NCT04643158|520590277|FG000|Overall Study|Withdrawal by Subject|0|||
144376993|NCT04643158|520590278|FG001|Overall Study|Withdrawal by Subject|0|||
144376994|NCT04643158|520590279|FG002|Overall Study|Withdrawal by Subject|0|||
144376995|NCT04643158|520590280|FG003|Overall Study|Withdrawal by Subject|0|||
144376996|NCT04643158|520590281|FG004|Overall Study|Withdrawal by Subject|0|||
144376997|NCT04643158|520590282|FG005|Overall Study|Withdrawal by Subject|1|||
144376998|NCT04643158|520590283|FG006|Overall Study|Withdrawal by Subject|0|||
144376999|NCT02350478|520590284|FG000|Overall Study|Lost to Follow-up|5|||
144377000|NCT02350478|520590285|FG001|Overall Study|Lost to Follow-up|1|||
144377001|NCT02779556|520590286|FG000|Baseline|Partial baseline interview completed|1|||
144377002|NCT02779556|520590287|FG001|Baseline|Partial baseline interview completed|0|||
144377003|NCT02779556|520590286|FG000|3 Months|Lost to Follow-up|40|||
144377004|NCT02779556|520590287|FG001|3 Months|Lost to Follow-up|29|||
144377005|NCT02779556|520590286|FG000|3 Months|Missed 3 month clinic visit|27|||
144377006|NCT02779556|520590287|FG001|3 Months|Missed 3 month clinic visit|19|||
144377007|NCT02779556|520590286|FG000|6 Month|Lost to Follow-up|33|||
144377008|NCT02779556|520590287|FG001|6 Month|Lost to Follow-up|39|||
144377009|NCT02779556|520590286|FG000|6 Month HbA1c|No value collected during window|69|||
144377010|NCT02779556|520590287|FG001|6 Month HbA1c|No value collected during window|50|||
144377011|NCT02779556|520590286|FG000|12 Month HbA1c|No value collected during window|138|||
144377012|NCT02779556|520590287|FG001|12 Month HbA1c|No value collected during window|102|||
144377013|NCT03110770|520590289|FG000|Overall Study|Death|1|||
144377014|NCT03110770|520590290|FG001|Overall Study|Death|0|||
144377015|NCT03110770|520590291|FG002|Overall Study|Death|0|||
144377016|NCT03110770|520590292|FG003|Overall Study|Death|1|||
144377017|NCT03110770|520590293|FG004|Overall Study|Death|0|||
144377018|NCT03110770|520590289|FG000|Overall Study|Enrolled but did not receive product|0|||
144377019|NCT03110770|520590290|FG001|Overall Study|Enrolled but did not receive product|0|||
144377020|NCT03110770|520590291|FG002|Overall Study|Enrolled but did not receive product|0|||
144377021|NCT03110770|520590292|FG003|Overall Study|Enrolled but did not receive product|8|||
144377022|NCT03110770|520590293|FG004|Overall Study|Enrolled but did not receive product|7|||
144377023|NCT03110770|520590289|FG000|Overall Study|Lost to Follow-up|0|||
144377024|NCT03110770|520590290|FG001|Overall Study|Lost to Follow-up|0|||
144377025|NCT03110770|520590291|FG002|Overall Study|Lost to Follow-up|0|||
144377026|NCT03110770|520590292|FG003|Overall Study|Lost to Follow-up|53|||
144377027|NCT03110770|520590293|FG004|Overall Study|Lost to Follow-up|45|||
144377028|NCT03110770|520590289|FG000|Overall Study|Investigator Decision|0|||
144377029|NCT03110770|520590290|FG001|Overall Study|Investigator Decision|0|||
144512699|NCT01471691|521076108|FG001|Overall Study|Lack of Efficacy|1|||
144512700|NCT01808339|521076114|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144512701|NCT01808339|521076115|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144512702|NCT01808339|521076116|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144512703|NCT01808339|521076117|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
144512704|NCT01808339|521076118|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
144512705|NCT01808339|521076119|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
144512706|NCT01808339|521076114|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144512707|NCT01808339|521076115|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144512708|NCT01808339|521076116|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144512709|NCT01808339|521076117|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144512710|NCT01808339|521076118|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144512711|NCT01808339|521076119|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144512712|NCT01808339|521076114|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144512713|NCT01808339|521076115|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144377030|NCT03110770|520590291|FG002|Overall Study|Investigator Decision|0|||
144377031|NCT03110770|520590292|FG003|Overall Study|Investigator Decision|5|||
144377032|NCT03110770|520590293|FG004|Overall Study|Investigator Decision|3|||
144377033|NCT03110770|520590289|FG000|Overall Study|Withdrawal by Subject|0|||
144377034|NCT03110770|520590290|FG001|Overall Study|Withdrawal by Subject|0|||
144377035|NCT03110770|520590291|FG002|Overall Study|Withdrawal by Subject|0|||
144377036|NCT03110770|520590292|FG003|Overall Study|Withdrawal by Subject|24|||
144377037|NCT03110770|520590293|FG004|Overall Study|Withdrawal by Subject|24|||
144377038|NCT03110770|520590289|FG000|Overall Study|Moved from area|5|||
144377039|NCT03110770|520590290|FG001|Overall Study|Moved from area|0|||
144377040|NCT03110770|520590291|FG002|Overall Study|Moved from area|2|||
144377041|NCT03110770|520590292|FG003|Overall Study|Moved from area|42|||
144377042|NCT03110770|520590293|FG004|Overall Study|Moved from area|43|||
144377043|NCT03110770|520590289|FG000|Overall Study|Illness/Injury unrelated to product|0|||
144377044|NCT03110770|520590290|FG001|Overall Study|Illness/Injury unrelated to product|0|||
144377045|NCT03110770|520590291|FG002|Overall Study|Illness/Injury unrelated to product|0|||
144377046|NCT03110770|520590292|FG003|Overall Study|Illness/Injury unrelated to product|0|||
144377047|NCT03110770|520590293|FG004|Overall Study|Illness/Injury unrelated to product|1|||
144377048|NCT01667419|520590294|FG000|Overall Study|Reason Not Specified|1|||
144377049|NCT01667419|520590295|FG001|Overall Study|Reason Not Specified|0|||
144377050|NCT01667419|520590296|FG002|Overall Study|Reason Not Specified|0|||
144377051|NCT01667419|520590297|FG003|Overall Study|Reason Not Specified|0|||
144377052|NCT01667419|520590294|FG000|Overall Study|Withdrawal by Subject|16|||
144377053|NCT01667419|520590295|FG001|Overall Study|Withdrawal by Subject|8|||
144377054|NCT01667419|520590296|FG002|Overall Study|Withdrawal by Subject|9|||
144377055|NCT01667419|520590297|FG003|Overall Study|Withdrawal by Subject|8|||
144377056|NCT01667419|520590294|FG000|Overall Study|Non-compliance|0|||
144377057|NCT01667419|520590295|FG001|Overall Study|Non-compliance|0|||
144377058|NCT01667419|520590296|FG002|Overall Study|Non-compliance|0|||
144377059|NCT01667419|520590297|FG003|Overall Study|Non-compliance|1|||
144377060|NCT01667419|520590294|FG000|Overall Study|Protocol Violation|1|||
144377061|NCT01667419|520590295|FG001|Overall Study|Protocol Violation|0|||
144377062|NCT01667419|520590296|FG002|Overall Study|Protocol Violation|0|||
144377063|NCT01667419|520590297|FG003|Overall Study|Protocol Violation|0|||
144377064|NCT01667419|520590294|FG000|Overall Study|Lost to Follow-up|7|||
144377065|NCT01667419|520590295|FG001|Overall Study|Lost to Follow-up|6|||
144377066|NCT01667419|520590296|FG002|Overall Study|Lost to Follow-up|2|||
144377067|NCT01667419|520590297|FG003|Overall Study|Lost to Follow-up|4|||
144377068|NCT01667419|520590294|FG000|Overall Study|Death|18|||
144377069|NCT01667419|520590295|FG001|Overall Study|Death|33|||
144377070|NCT01667419|520590296|FG002|Overall Study|Death|25|||
144377071|NCT01667419|520590297|FG003|Overall Study|Death|26|||
144377072|NCT00856518|520590298|FG000|Overall Study|Lost to Follow-up|4|||
144377073|NCT00856518|520590299|FG001|Overall Study|Lost to Follow-up|2|||
144377074|NCT02082340|520590301|FG000|Overall Study|Lost to Follow-up|1|||
144377075|NCT02082340|520590302|FG001|Overall Study|Lost to Follow-up|1|||
144377076|NCT02644109|520590309|FG000|Overall Study|Adverse Event|0|||
144377077|NCT02644109|520590310|FG001|Overall Study|Adverse Event|4|||
144377078|NCT04195893|520590313|FG000|Second Intervention|Withdrawal by Subject|1|||
144377079|NCT04195893|520590314|FG001|Second Intervention|Withdrawal by Subject|0|||
144377080|NCT00918736|520590317|FG000|Overall Study|Withdrawal by Subject|4|||
144377081|NCT01474018|520590318|FG000|Overall Study|Lost to Follow-up|0|||
144377082|NCT01474018|520590319|FG001|Overall Study|Lost to Follow-up|1|||
144377083|NCT01474018|520590318|FG000|Overall Study|Withdrawal by Subject|0|||
144377084|NCT01474018|520590319|FG001|Overall Study|Withdrawal by Subject|2|||
144377085|NCT01942733|520590321|FG000|Overall Study|Lost to Follow-up|1|||
144377086|NCT01942733|520590321|FG000|Overall Study|Non-compliance with IMP|1|||
144377087|NCT01942733|520590321|FG000|Overall Study|Administrative|1|||
144377088|NCT00486291|520590325|FG000|Overall Study|Adverse Event|3|||
144377089|NCT00486291|520590326|FG001|Overall Study|Adverse Event|4|||
144377090|NCT00486291|520590325|FG000|Overall Study|Lost to Follow-up|3|||
144377091|NCT00486291|520590326|FG001|Overall Study|Lost to Follow-up|7|||
144377092|NCT00486291|520590325|FG000|Overall Study|protocol non-compliance|10|||
144377093|NCT00486291|520590326|FG001|Overall Study|protocol non-compliance|15|||
144377094|NCT00486291|520590325|FG000|Overall Study|requirement for restricted medication|0|||
144377095|NCT00486291|520590326|FG001|Overall Study|requirement for restricted medication|3|||
144377096|NCT03462511|520590330|FG000|Overall Study|Withdrawal by Subject|2|||
144377097|NCT03462511|520590331|FG001|Overall Study|Withdrawal by Subject|3|||
144377098|NCT02925416|520590332|FG000|Overall Study|Adverse Event|2|||
144377099|NCT02925416|520590333|FG001|Overall Study|Adverse Event|0|||
144377100|NCT00200356|520590334|FG000|Overall Study|Lack of Efficacy|3|||
144377101|NCT00200356|520590335|FG001|Overall Study|Lack of Efficacy|3|||
144377102|NCT00200356|520590334|FG000|Overall Study|Protocol Violation|4|||
144377103|NCT00200356|520590335|FG001|Overall Study|Protocol Violation|4|||
144377104|NCT00200356|520590334|FG000|Overall Study|Nontreatment|1|||
144377105|NCT00200356|520590335|FG001|Overall Study|Nontreatment|0|||
144377106|NCT04080167|520590339|FG000|Overall Study|Lost to Follow-up-Patients|7|||
144377107|NCT04080167|520590340|FG001|Overall Study|Lost to Follow-up-Patients|14|||
144377108|NCT04080167|520590341|FG002|Overall Study|Lost to Follow-up-Patients|0|||
144377109|NCT04080167|520590339|FG000|Overall Study|Lost to Follow-up-Providers|2|||
144512714|NCT01808339|521076116|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
144512715|NCT01808339|521076117|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144512716|NCT01808339|521076118|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144377110|NCT04080167|520590340|FG001|Overall Study|Lost to Follow-up-Providers|2|||
144512717|NCT01808339|521076119|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
144512718|NCT01854385|521076121|FG000|Pre-Treatment|Withdrawal by Subject|4|||
144377111|NCT04080167|520590341|FG002|Overall Study|Lost to Follow-up-Providers|0|||
144377112|NCT04080167|520590339|FG000|Overall Study|Withdrawal by Subject|1|||
144377113|NCT04080167|520590340|FG001|Overall Study|Withdrawal by Subject|2|||
144377114|NCT04080167|520590341|FG002|Overall Study|Withdrawal by Subject|0|||
144377115|NCT04080167|520590339|FG000|Overall Study|Withdrawal by Provider|0|||
144377116|NCT04080167|520590340|FG001|Overall Study|Withdrawal by Provider|0|||
144377117|NCT04080167|520590341|FG002|Overall Study|Withdrawal by Provider|4|||
144377118|NCT04080167|520590339|FG000|Overall Study|Death-Patient|2|||
144377119|NCT04080167|520590340|FG001|Overall Study|Death-Patient|1|||
144377120|NCT04080167|520590341|FG002|Overall Study|Death-Patient|0|||
144377121|NCT04080167|520590339|FG000|Overall Study|Hydroxyurea New Starts|0|||
144377122|NCT04080167|520590340|FG001|Overall Study|Hydroxyurea New Starts|0|||
144377123|NCT04080167|520590341|FG002|Overall Study|Hydroxyurea New Starts|1|||
144377124|NCT04080167|520590339|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
144377125|NCT04080167|520590340|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
144377126|NCT04080167|520590341|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
144377127|NCT02167139|520590342|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
144377128|NCT02167139|520590343|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
144377129|NCT02167139|520590344|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
144377130|NCT02167139|520590345|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
144377131|NCT02167139|520590342|FG000|Randomised, Double-blind|Adverse Event|2|||
144377132|NCT02167139|520590343|FG001|Randomised, Double-blind|Adverse Event|9|||
144377133|NCT02167139|520590344|FG002|Randomised, Double-blind|Adverse Event|0|||
144377134|NCT02167139|520590345|FG003|Randomised, Double-blind|Adverse Event|0|||
144377135|NCT02167139|520590342|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
144377136|NCT02167139|520590343|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
144377137|NCT02167139|520590344|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
144377138|NCT02167139|520590345|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
144377139|NCT02167139|520590342|FG000|Randomised, Double-blind|Other|3|||
144377140|NCT02167139|520590343|FG001|Randomised, Double-blind|Other|0|||
144377141|NCT02167139|520590344|FG002|Randomised, Double-blind|Other|0|||
144377142|NCT02167139|520590345|FG003|Randomised, Double-blind|Other|0|||
144377143|NCT02167139|520590342|FG000|Transition-extension|Adverse Event|2|||
144377144|NCT02167139|520590343|FG001|Transition-extension|Adverse Event|0|||
144377145|NCT02167139|520590344|FG002|Transition-extension|Adverse Event|2|||
144377146|NCT02167139|520590345|FG003|Transition-extension|Adverse Event|3|||
144377147|NCT02167139|520590342|FG000|Transition-extension|Withdrawal by Subject|2|||
144377148|NCT02167139|520590343|FG001|Transition-extension|Withdrawal by Subject|0|||
144377149|NCT02167139|520590344|FG002|Transition-extension|Withdrawal by Subject|4|||
144377150|NCT02167139|520590345|FG003|Transition-extension|Withdrawal by Subject|1|||
144377151|NCT02167139|520590342|FG000|Transition-extension|Lack of Efficacy|0|||
144377152|NCT02167139|520590343|FG001|Transition-extension|Lack of Efficacy|0|||
144377153|NCT02167139|520590344|FG002|Transition-extension|Lack of Efficacy|1|||
144377154|NCT02167139|520590345|FG003|Transition-extension|Lack of Efficacy|1|||
144377155|NCT02167139|520590342|FG000|Transition-extension|Other|1|||
144377156|NCT02167139|520590343|FG001|Transition-extension|Other|0|||
144377157|NCT02167139|520590344|FG002|Transition-extension|Other|1|||
144377158|NCT02167139|520590345|FG003|Transition-extension|Other|0|||
144377159|NCT02167139|520590342|FG000|Transition-extension|Lost to Follow-up|1|||
144377160|NCT02167139|520590343|FG001|Transition-extension|Lost to Follow-up|0|||
144377161|NCT02167139|520590344|FG002|Transition-extension|Lost to Follow-up|0|||
144377162|NCT02167139|520590345|FG003|Transition-extension|Lost to Follow-up|0|||
144377163|NCT01297491|520590346|FG000|Overall Study|Adverse Event|11|||
144377164|NCT01297491|520590347|FG001|Overall Study|Adverse Event|6|||
144377165|NCT01297491|520590346|FG000|Overall Study|Physician Decision|3|||
144377166|NCT01297491|520590347|FG001|Overall Study|Physician Decision|2|||
144377167|NCT01297491|520590346|FG000|Overall Study|Progressive disease|11|||
144377168|NCT01297491|520590347|FG001|Overall Study|Progressive disease|20|||
144377169|NCT01297491|520590346|FG000|Overall Study|Patient/Guardian decision|3|||
144377170|NCT01297491|520590347|FG001|Overall Study|Patient/Guardian decision|4|||
144377171|NCT01297491|520590346|FG000|Overall Study|Death|2|||
144377172|NCT01297491|520590347|FG001|Overall Study|Death|1|||
144377173|NCT01015638|520590353|FG000|Overall Study|Withdrawal by Subject|1|||
144377174|NCT01015638|520590354|FG001|Overall Study|Withdrawal by Subject|0|||
144377175|NCT00984620|520590355|FG000|Overall Study|Adverse Event|5|||
144377176|NCT00984620|520590356|FG001|Overall Study|Adverse Event|5|||
144377177|NCT00984620|520590355|FG000|Overall Study|Lost to Follow-up|1|||
144377178|NCT00984620|520590356|FG001|Overall Study|Lost to Follow-up|1|||
144377179|NCT00984620|520590355|FG000|Overall Study|Withdrawal by Subject|0|||
144377180|NCT00984620|520590356|FG001|Overall Study|Withdrawal by Subject|2|||
144377181|NCT00984620|520590355|FG000|Overall Study|reason other than listed above|0|||
144377182|NCT00984620|520590356|FG001|Overall Study|reason other than listed above|4|||
144377183|NCT02657408|520590359|FG000|Overall Study|Adverse Event|3|||
144377184|NCT02657408|520590360|FG001|Overall Study|Adverse Event|7|||
144377185|NCT00324961|520590362|FG000|Overall Study|Adverse Event|5|||
144377186|NCT00324961|520590362|FG000|Overall Study|Consent Withdrawn|11|||
144377187|NCT00324961|520590362|FG000|Overall Study|Lost to Follow-up|22|||
144377188|NCT00324961|520590362|FG000|Overall Study|Protocol Violation|3|||
144377189|NCT00324961|520590362|FG000|Overall Study|Other|2|||
144377190|NCT00344487|520590363|FG000|Overall Study|immunologic failure|1|||
144377191|NCT02447302|520590367|FG000|Overall Study|Physician Decision|1|||
144377192|NCT02447302|520590368|FG001|Overall Study|Physician Decision|0|||
144377193|NCT02447302|520590369|FG002|Overall Study|Physician Decision|0|||
144377194|NCT02447302|520590367|FG000|Overall Study|Adverse Event|4|||
144377195|NCT02447302|520590368|FG001|Overall Study|Adverse Event|3|||
144377196|NCT02447302|520590369|FG002|Overall Study|Adverse Event|0|||
144377197|NCT02447302|520590367|FG000|Overall Study|Withdrawal by Subject|0|||
144377198|NCT02447302|520590368|FG001|Overall Study|Withdrawal by Subject|1|||
144377199|NCT02447302|520590369|FG002|Overall Study|Withdrawal by Subject|5|||
144377200|NCT02447302|520590367|FG000|Overall Study|Sponsor Decision|0|||
144377201|NCT02447302|520590368|FG001|Overall Study|Sponsor Decision|0|||
144377202|NCT02447302|520590369|FG002|Overall Study|Sponsor Decision|1|||
144377203|NCT05334212|520590374|FG000|Overall Study|Study terminated prematurely|7|||
144377204|NCT00910299|520590375|FG000|Overall Study|Withdrawal by Subject|16|||
144377205|NCT00910299|520590376|FG001|Overall Study|Withdrawal by Subject|13|||
144377206|NCT00910299|520590375|FG000|Overall Study|Sponsor Decision|58|||
144377207|NCT00910299|520590376|FG001|Overall Study|Sponsor Decision|60|||
144377208|NCT00910299|520590375|FG000|Overall Study|Didn't receive any study drug|2|||
144377209|NCT00910299|520590376|FG001|Overall Study|Didn't receive any study drug|1|||
144377210|NCT01456897|520590377|FG000|Overall Study|Adverse Event|19|||
144377211|NCT01456897|520590378|FG001|Overall Study|Adverse Event|22|||
144377212|NCT01456897|520590377|FG000|Overall Study|Protocol Violation|3|||
144377213|NCT01456897|520590378|FG001|Overall Study|Protocol Violation|4|||
144377214|NCT01456897|520590377|FG000|Overall Study|Physician Decision|5|||
144377215|NCT01456897|520590378|FG001|Overall Study|Physician Decision|3|||
144377216|NCT01456897|520590377|FG000|Overall Study|Withdrawal by Subject|44|||
144377217|NCT01456897|520590378|FG001|Overall Study|Withdrawal by Subject|17|||
144377218|NCT01456897|520590377|FG000|Overall Study|Lack of Efficacy|4|||
144377219|NCT01456897|520590378|FG001|Overall Study|Lack of Efficacy|11|||
144377220|NCT01396070|520590380|FG000|Overall Study|Withdrawal by Subject|2|||
144377221|NCT01396070|520590380|FG000|Overall Study|Death|2|||
144377222|NCT01396070|520590380|FG000|Overall Study|Adverse Event|8|||
144377223|NCT01396070|520590380|FG000|Overall Study|Physician Decision|3|||
144377224|NCT01396070|520590380|FG000|Overall Study|Lack of Efficacy|4|||
144377225|NCT04254913|520590381|FG000|Overall Study|Adverse Event|1|||
144377226|NCT01396057|520590382|FG000|Overall Study|Adverse Event|2|||
144377227|NCT01396057|520590383|FG001|Overall Study|Adverse Event|6|||
144377228|NCT01396057|520590382|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144377229|NCT01396057|520590383|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
144377230|NCT01396057|520590382|FG000|Overall Study|Protocol deviation|4|||
144377231|NCT01396057|520590383|FG001|Overall Study|Protocol deviation|4|||
144377232|NCT01396057|520590382|FG000|Overall Study|Consent withdrawn|3|||
144377233|NCT01396057|520590383|FG001|Overall Study|Consent withdrawn|2|||
144377234|NCT03500224|520590384|FG000|Overall Study|Withdrawal by Subject|2|||
144377235|NCT00530816|520590385|FG000|Overall Study|Progressive Disease|16|||
144377236|NCT00530816|520590386|FG001|Overall Study|Progressive Disease|24|||
144377237|NCT00530816|520590387|FG002|Overall Study|Progressive Disease|24|||
144377238|NCT00530816|520590385|FG000|Overall Study|Adverse Event|6|||
144377239|NCT00530816|520590386|FG001|Overall Study|Adverse Event|13|||
144377240|NCT00530816|520590387|FG002|Overall Study|Adverse Event|7|||
144377241|NCT00530816|520590385|FG000|Overall Study|Other|3|||
144377242|NCT00530816|520590386|FG001|Overall Study|Other|3|||
144377243|NCT00530816|520590387|FG002|Overall Study|Other|4|||
144377244|NCT00530816|520590385|FG000|Overall Study|Withdrawal by Subject|1|||
144377245|NCT00530816|520590386|FG001|Overall Study|Withdrawal by Subject|2|||
144377246|NCT00530816|520590387|FG002|Overall Study|Withdrawal by Subject|6|||
144377247|NCT05661851|520590388|FG000|Overall Study|Protocol Violation|1|||
144377248|NCT05661851|520590389|FG001|Overall Study|Protocol Violation|1|||
144377249|NCT05661851|520590388|FG000|Overall Study|Covid-19 Related|3|||
144377250|NCT05661851|520590389|FG001|Overall Study|Covid-19 Related|4|||
144377251|NCT05661851|520590388|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
144377252|NCT05661851|520590389|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
144377253|NCT05661851|520590388|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
144377254|NCT05661851|520590389|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
144377255|NCT01388985|520590390|FG000|Overall Study|Death|0|||
144377256|NCT01388985|520590391|FG001|Overall Study|Death|1|||
144377257|NCT01388985|520590390|FG000|Overall Study|Lost to Follow-up|30|||
144377258|NCT01388985|520590391|FG001|Overall Study|Lost to Follow-up|30|||
144377259|NCT01388985|520590390|FG000|Overall Study|Withdrawal by Subject|13|||
144377260|NCT01388985|520590391|FG001|Overall Study|Withdrawal by Subject|4|||
144377261|NCT01388985|520590390|FG000|Overall Study|Subject unavailable|1|||
144377262|NCT01388985|520590391|FG001|Overall Study|Subject unavailable|1|||
144377263|NCT01388985|520590390|FG000|Overall Study|Other (no reason)|0|||
144377264|NCT01388985|520590391|FG001|Overall Study|Other (no reason)|1|||
144377265|NCT01388985|520590390|FG000|Overall Study|Error of nurse|5|||
144377266|NCT01388985|520590391|FG001|Overall Study|Error of nurse|1|||
144377267|NCT01057589|520590392|FG000|Overall Study|Disease Progression|35|||
144377268|NCT01057589|520590392|FG000|Overall Study|Adverse Event|10|||
144377269|NCT01057589|520590392|FG000|Overall Study|Physician Decision|8|||
144377270|NCT01057589|520590392|FG000|Overall Study|Withdrawal by Subject|3|||
144377271|NCT01057589|520590392|FG000|Overall Study|Sponsor Decision|1|||
144377272|NCT01057589|520590392|FG000|Overall Study|Death|8|||
144377273|NCT01057589|520590392|FG000|Overall Study|Lost to Follow-up|1|||
144377274|NCT02954172|520590395|FG000|Overall Study|Protocol Violation|3|||
144377275|NCT02954172|520590396|FG001|Overall Study|Protocol Violation|0|||
144377276|NCT02954172|520590395|FG000|Overall Study|allergic reaction|2|||
144377277|NCT02954172|520590396|FG001|Overall Study|allergic reaction|1|||
144377278|NCT02954172|520590395|FG000|Overall Study|non-measurable lesions at baseline|1|||
144377279|NCT02954172|520590396|FG001|Overall Study|non-measurable lesions at baseline|2|||
144377280|NCT00870584|520590397|FG000|Overall Study|Adverse Event|3|||
144377281|NCT00870584|520590398|FG001|Overall Study|Adverse Event|3|||
144377282|NCT00870584|520590397|FG000|Overall Study|Withdrawal by Subject|6|||
144377283|NCT00870584|520590398|FG001|Overall Study|Withdrawal by Subject|7|||
144377284|NCT00870584|520590397|FG000|Overall Study|Lost to Follow-up|5|||
144377285|NCT00870584|520590398|FG001|Overall Study|Lost to Follow-up|1|||
144377286|NCT00870584|520590397|FG000|Overall Study|Protocol Deviation|2|||
144377287|NCT00870584|520590398|FG001|Overall Study|Protocol Deviation|2|||
144377288|NCT01497366|520590399|FG000|Overall Study|Virologic failure|2|||
144377289|NCT01497366|520590400|FG001|Overall Study|Virologic failure|50|||
144377290|NCT01497366|520590399|FG000|Overall Study|Lost to Follow-up|11|||
144377291|NCT01497366|520590400|FG001|Overall Study|Lost to Follow-up|10|||
144377292|NCT01497366|520590399|FG000|Overall Study|Withdrawal by Subject|6|||
144377293|NCT01497366|520590400|FG001|Overall Study|Withdrawal by Subject|6|||
144377294|NCT01497366|520590399|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
144377295|NCT01497366|520590400|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
144377296|NCT01497366|520590399|FG000|Overall Study|Other|5|||
144377297|NCT01497366|520590400|FG001|Overall Study|Other|0|||
144377298|NCT01497366|520590399|FG000|Overall Study|Death|1|||
144377299|NCT01497366|520590400|FG001|Overall Study|Death|1|||
144377300|NCT01497366|520590399|FG000|Overall Study|Randomized but not treated|7|||
144377301|NCT01497366|520590400|FG001|Overall Study|Randomized but not treated|21|||
144377302|NCT00472030|520590412|FG000|Overall Study|Physician Decision|1|||
144377303|NCT00472030|520590413|FG001|Overall Study|Physician Decision|0|||
144377304|NCT00829504|520590414|FG000|First Intervention|Adverse Event|1|||
144377305|NCT00829504|520590415|FG001|First Intervention|Adverse Event|0|||
144377306|NCT00829504|520590414|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144377307|NCT00829504|520590415|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144377308|NCT00829504|520590414|FG000|Second Intervention|Physician Decision|1|||
144377309|NCT00829504|520590415|FG001|Second Intervention|Physician Decision|0|||
144377310|NCT00488683|520590416|FG000|Overall Study|Withdrawal by Subject|1|||
144377311|NCT00488683|520590417|FG001|Overall Study|Withdrawal by Subject|2|||
144377312|NCT00488683|520590418|FG002|Overall Study|Withdrawal by Subject|2|||
144377313|NCT00488683|520590416|FG000|Overall Study|Lost to Follow-up|5|||
144377314|NCT00488683|520590417|FG001|Overall Study|Lost to Follow-up|3|||
144377315|NCT00488683|520590418|FG002|Overall Study|Lost to Follow-up|0|||
144377316|NCT00488683|520590416|FG000|Overall Study|Protocol Violation|5|||
144377317|NCT00488683|520590417|FG001|Overall Study|Protocol Violation|1|||
144512719|NCT01854385|521076121|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
144512720|NCT01854385|521076121|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
144512721|NCT01854385|521076121|FG000|Pre-Treatment|Unable to come for study visits|1|||
144512722|NCT01854385|521076121|FG000|Treatment|Lost to Follow-up|1|||
144512723|NCT02932579|521076122|FG000|Overall Study|Withdrawal by Subject|4|||
144512724|NCT02932579|521076123|FG001|Overall Study|Withdrawal by Subject|1|||
144512725|NCT00818246|521076125|FG000|Overall Study|Impossible to match pictures|5|||
144512726|NCT01121991|521076127|FG000|Overall Study|Lack of Ovarian Response|2|||
144512727|NCT01121991|521076127|FG000|Overall Study|No Oocytes Retrieved|3|||
144512728|NCT01121991|521076127|FG000|Overall Study|No Fertilization|1|||
144512729|NCT02121002|521076128|FG000|Overall Study|Physician Decision|2|||
144377318|NCT00488683|520590418|FG002|Overall Study|Protocol Violation|0|||
144512730|NCT02121002|521076129|FG001|Overall Study|Physician Decision|0|||
144512731|NCT02121002|521076130|FG002|Overall Study|Physician Decision|0|||
144377319|NCT00488683|520590416|FG000|Overall Study|Unable to Classify|1|||
144377320|NCT00488683|520590417|FG001|Overall Study|Unable to Classify|0|||
144377321|NCT00488683|520590418|FG002|Overall Study|Unable to Classify|0|||
144377322|NCT04236141|520592789|FG000|Overall Study|Death|18|||
144377323|NCT04236141|520592790|FG001|Overall Study|Death|10|||
144377324|NCT04236141|520592789|FG000|Overall Study|Withdrawal by Participant|1|||
144377325|NCT04236141|520592790|FG001|Overall Study|Withdrawal by Participant|0|||
144377326|NCT04236141|520592789|FG000|Overall Study|Reason not Specified|1|||
144377327|NCT04236141|520592790|FG001|Overall Study|Reason not Specified|0|||
144377328|NCT04236141|520592789|FG000|Overall Study|Study terminated by Sponsor|8|||
144377329|NCT04236141|520592790|FG001|Overall Study|Study terminated by Sponsor|4|||
144377330|NCT01217307|520592794|FG000|Overall Study|Withdrawal by Subject|0|||
144377331|NCT01217307|520592795|FG001|Overall Study|Withdrawal by Subject|1|||
144377332|NCT01888432|520592800|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
144377333|NCT01888432|520592801|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
144377334|NCT01888432|520592800|FG000|12-month Analysis (FAS)|Physician Decision|1|||
144377335|NCT01888432|520592801|FG001|12-month Analysis (FAS)|Physician Decision|1|||
144377336|NCT01888432|520592800|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
144377337|NCT01888432|520592801|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
144377338|NCT01888432|520592800|FG000|12-month Analysis (FAS)|Death|4|||
144377339|NCT01888432|520592801|FG001|12-month Analysis (FAS)|Death|3|||
144377340|NCT01888432|520592800|FG000|24-month Analysis (FAS)|Graft loss|0|||
144377341|NCT01888432|520592801|FG001|24-month Analysis (FAS)|Graft loss|1|||
144377342|NCT01888432|520592800|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
144377343|NCT01888432|520592801|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
144377344|NCT01888432|520592800|FG000|24-month Analysis (FAS)|Physician Decision|2|||
144377345|NCT01888432|520592801|FG001|24-month Analysis (FAS)|Physician Decision|4|||
144377346|NCT01888432|520592800|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
144377347|NCT01888432|520592801|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
144377348|NCT01888432|520592800|FG000|24-month Analysis (FAS)|Death|8|||
144377349|NCT01888432|520592801|FG001|24-month Analysis (FAS)|Death|4|||
144377350|NCT01888432|520592800|FG000|36-month Analysis (Extension)|Death|1|||
144377351|NCT01888432|520592801|FG001|36-month Analysis (Extension)|Death|0|||
144377352|NCT01696929|520592804|FG000|Overall Study|Physician Decision|1|||
144377353|NCT04473235|520592807|FG000|Overall Study|Lost to Follow-up|6|||
144377354|NCT04473235|520592808|FG001|Overall Study|Lost to Follow-up|5|||
144377355|NCT04473235|520592807|FG000|Overall Study|Declined continuation|2|||
144377356|NCT04473235|520592808|FG001|Overall Study|Declined continuation|0|||
144377357|NCT04473235|520592807|FG000|Overall Study|Physician Decision|1|||
144377358|NCT04473235|520592808|FG001|Overall Study|Physician Decision|1|||
144377359|NCT04473235|520592807|FG000|Overall Study|Protocol Violation|10|||
144377360|NCT04473235|520592808|FG001|Overall Study|Protocol Violation|6|||
144377361|NCT00798759|520592811|FG000|Overall Study|Adverse Event|3|||
144377362|NCT00798759|520592812|FG001|Overall Study|Adverse Event|3|||
144377363|NCT00798759|520592811|FG000|Overall Study|Lost to Follow-up|1|||
144377364|NCT00798759|520592812|FG001|Overall Study|Lost to Follow-up|1|||
144377365|NCT00798759|520592811|FG000|Overall Study|Protocol Violation|4|||
144377366|NCT00798759|520592812|FG001|Overall Study|Protocol Violation|8|||
144377367|NCT00798759|520592811|FG000|Overall Study|Other|0|||
144377368|NCT00798759|520592812|FG001|Overall Study|Other|1|||
144377369|NCT02156271|520592813|FG000|Overall Study|Physician Decision|4|||
144377370|NCT02156271|520592814|FG001|Overall Study|Physician Decision|3|||
144377371|NCT00955305|520592815|FG000|Overall Study|Disease progression|39|||
144377372|NCT00955305|520592816|FG001|Overall Study|Disease progression|41|||
144377373|NCT00955305|520592815|FG000|Overall Study|Adverse Event|22|||
144377374|NCT00955305|520592816|FG001|Overall Study|Adverse Event|22|||
144377375|NCT00955305|520592815|FG000|Overall Study|Death|2|||
144377376|NCT00955305|520592816|FG001|Overall Study|Death|1|||
144377377|NCT00955305|520592815|FG000|Overall Study|Withdrawal by Subject|5|||
144377378|NCT00955305|520592816|FG001|Overall Study|Withdrawal by Subject|4|||
144377379|NCT00955305|520592815|FG000|Overall Study|Alternative therapy|4|||
144377380|NCT00955305|520592816|FG001|Overall Study|Alternative therapy|0|||
144377381|NCT00955305|520592815|FG000|Overall Study|Other complicating disease|2|||
144377382|NCT00955305|520592816|FG001|Overall Study|Other complicating disease|4|||
144377383|NCT00955305|520592815|FG000|Overall Study|Physician Decision|1|||
144377384|NCT00955305|520592816|FG001|Overall Study|Physician Decision|0|||
144377385|NCT00955305|520592815|FG000|Overall Study|Continued presence of residual disease|0|||
144377386|NCT00955305|520592816|FG001|Overall Study|Continued presence of residual disease|1|||
144377387|NCT00955305|520592815|FG000|Overall Study|Functional decline|2|||
144377388|NCT00955305|520592816|FG001|Overall Study|Functional decline|0|||
144377389|NCT00955305|520592815|FG000|Overall Study|Maximum response achieved|0|||
144377390|NCT00955305|520592816|FG001|Overall Study|Maximum response achieved|1|||
144377391|NCT00955305|520592815|FG000|Overall Study|Lost to Follow-up|0|||
144377392|NCT00955305|520592816|FG001|Overall Study|Lost to Follow-up|1|||
144377393|NCT00955305|520592815|FG000|Overall Study|No off-treatment reason submitted|1|||
144377394|NCT00955305|520592816|FG001|Overall Study|No off-treatment reason submitted|0|||
144377395|NCT00955305|520592815|FG000|Overall Study|Never started protocol treatment|5|||
144377396|NCT00955305|520592816|FG001|Overall Study|Never started protocol treatment|5|||
144377397|NCT00955305|520592815|FG000|Overall Study|Ineligible|5|||
144377398|NCT00955305|520592816|FG001|Overall Study|Ineligible|7|||
144377399|NCT03387111|520592817|FG000|Overall Study|Progressive Disease|3|||
144377400|NCT03387111|520592817|FG000|Overall Study|Other|1|||
144377401|NCT01945710|520592821|FG000|Overall Study|Progressive Disease|5|||
144377402|NCT01945710|520592822|FG001|Overall Study|Progressive Disease|4|||
144377403|NCT01945710|520592823|FG002|Overall Study|Progressive Disease|3|||
144377404|NCT01945710|520592824|FG003|Overall Study|Progressive Disease|2|||
144377405|NCT01945710|520592825|FG004|Overall Study|Progressive Disease|7|||
144377406|NCT01945710|520592826|FG005|Overall Study|Progressive Disease|3|||
144377407|NCT01945710|520592827|FG006|Overall Study|Progressive Disease|19|||
144377408|NCT01945710|520592821|FG000|Overall Study|Adverse Event|0|||
144377409|NCT01945710|520592822|FG001|Overall Study|Adverse Event|1|||
144377410|NCT01945710|520592823|FG002|Overall Study|Adverse Event|0|||
144377411|NCT01945710|520592824|FG003|Overall Study|Adverse Event|0|||
144377412|NCT01945710|520592825|FG004|Overall Study|Adverse Event|0|||
144377413|NCT01945710|520592826|FG005|Overall Study|Adverse Event|0|||
144377414|NCT01945710|520592827|FG006|Overall Study|Adverse Event|0|||
144377415|NCT01945710|520592821|FG000|Overall Study|Other|2|||
144377416|NCT01945710|520592822|FG001|Overall Study|Other|0|||
144377417|NCT01945710|520592823|FG002|Overall Study|Other|3|||
144377418|NCT01945710|520592824|FG003|Overall Study|Other|1|||
144377419|NCT01945710|520592825|FG004|Overall Study|Other|1|||
144377420|NCT01945710|520592826|FG005|Overall Study|Other|0|||
144377421|NCT01945710|520592827|FG006|Overall Study|Other|4|||
144377422|NCT01945710|520592821|FG000|Overall Study|Withdrawal by Subject|0|||
144377423|NCT01945710|520592822|FG001|Overall Study|Withdrawal by Subject|1|||
144377424|NCT01945710|520592823|FG002|Overall Study|Withdrawal by Subject|1|||
144377425|NCT01945710|520592824|FG003|Overall Study|Withdrawal by Subject|0|||
144377426|NCT01945710|520592825|FG004|Overall Study|Withdrawal by Subject|1|||
144377427|NCT01945710|520592826|FG005|Overall Study|Withdrawal by Subject|0|||
144377428|NCT01945710|520592827|FG006|Overall Study|Withdrawal by Subject|0|||
144377429|NCT02730195|520592828|FG000|Overall Study|Withdrawal by Subject|1|||
144377430|NCT00375609|520592829|FG000|Overall Study|Did not receive treatment|1|||
144377431|NCT00375609|520592830|FG001|Overall Study|Did not receive treatment|0|||
144377432|NCT00375609|520592831|FG002|Overall Study|Did not receive treatment|0|||
144377433|NCT00375609|520592829|FG000|Overall Study|Adverse Event|0|||
144377434|NCT00375609|520592830|FG001|Overall Study|Adverse Event|3|||
144377435|NCT00375609|520592831|FG002|Overall Study|Adverse Event|0|||
144377436|NCT00375609|520592829|FG000|Overall Study|Lost to Follow-up|1|||
144377437|NCT00375609|520592830|FG001|Overall Study|Lost to Follow-up|0|||
144377438|NCT00375609|520592831|FG002|Overall Study|Lost to Follow-up|0|||
144377439|NCT00375609|520592829|FG000|Overall Study|Physician Decision|0|||
144377440|NCT00375609|520592830|FG001|Overall Study|Physician Decision|0|||
144377441|NCT00375609|520592831|FG002|Overall Study|Physician Decision|1|||
144377442|NCT00375609|520592829|FG000|Overall Study|Withdrawal by Subject|1|||
144377443|NCT00375609|520592830|FG001|Overall Study|Withdrawal by Subject|4|||
144377444|NCT00375609|520592831|FG002|Overall Study|Withdrawal by Subject|0|||
144377445|NCT00375609|520592829|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
144377446|NCT00375609|520592830|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
144377447|NCT00375609|520592831|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
144377448|NCT01368562|520592832|FG000|Overall Study|Adverse Event|1|||
144377449|NCT01368562|520592832|FG000|Overall Study|Disease progression|1|||
144377450|NCT01368562|520592832|FG000|Overall Study|Lost to Follow-up|1|||
144377451|NCT01368562|520592832|FG000|Overall Study|Death|6|||
144377452|NCT01368562|520592832|FG000|Overall Study|Unresponsive to treatment|5|||
144377453|NCT01368562|520592832|FG000|Overall Study|Other|3|||
144377454|NCT01368562|520592832|FG000|Overall Study|Other than specified|2|||
144377455|NCT02810444|520592834|FG000|Overall Study|Screen Failures|14|||
144377456|NCT02810444|520592834|FG000|Overall Study|Withdrawal by Subject|4|||
144377457|NCT02810444|520592834|FG000|Overall Study|Adverse Event|3|||
144377458|NCT01754727|520592835|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
144377459|NCT02785770|520592838|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
144377460|NCT02785770|520592839|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
144377461|NCT02785770|520592840|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
144377462|NCT02785770|520592841|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
144377463|NCT02785770|520592838|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
144377464|NCT02785770|520592839|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
144377465|NCT02785770|520592840|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
144377466|NCT02785770|520592841|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
144377467|NCT02785770|520592838|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
144377468|NCT02785770|520592839|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
144377469|NCT02785770|520592840|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
144377470|NCT02785770|520592841|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
144377471|NCT02891070|520592854|FG000|Overall Study|Adverse Event|1|||
144377472|NCT02891070|520592855|FG001|Overall Study|Adverse Event|0|||
144377473|NCT02891070|520592854|FG000|Overall Study|Physician Decision|0|||
144377474|NCT02891070|520592855|FG001|Overall Study|Physician Decision|1|||
144377475|NCT02891070|520592854|FG000|Overall Study|Lost to Follow-up|4|||
144377476|NCT02891070|520592855|FG001|Overall Study|Lost to Follow-up|4|||
144377477|NCT02891070|520592854|FG000|Overall Study|Other|1|||
144377478|NCT02891070|520592855|FG001|Overall Study|Other|0|||
144377479|NCT02891070|520592854|FG000|Overall Study|Protocol Violation|0|||
144377480|NCT02891070|520592855|FG001|Overall Study|Protocol Violation|1|||
144377481|NCT02891070|520592854|FG000|Overall Study|Withdrawal by Subject|1|||
144377482|NCT02891070|520592855|FG001|Overall Study|Withdrawal by Subject|2|||
144377483|NCT02891070|520592854|FG000|Overall Study|Death|3|||
144377484|NCT02891070|520592855|FG001|Overall Study|Death|0|||
144377485|NCT04491604|520592858|FG000|Overall Study|Withdrawal by Subject|3|||
144377486|NCT02888119|520592863|FG000|Overall Study|Lost to Follow-up|5|||
144377487|NCT02888119|520592864|FG001|Overall Study|Lost to Follow-up|4|||
144377488|NCT02888119|520592865|FG002|Overall Study|Lost to Follow-up|0|||
144377489|NCT01767142|520592866|FG000|Overall Study|Lost to Follow-up|3|||
144377490|NCT00926029|520592867|FG000|Overall Study|Lost to Follow-up|2|||
144377491|NCT00926029|520592868|FG001|Overall Study|Lost to Follow-up|1|||
144377492|NCT00926029|520592869|FG002|Overall Study|Lost to Follow-up|1|||
144377493|NCT03206788|520592870|FG000|Overall Study|Withdrawal by Subject|0|||
144377494|NCT03206788|520592871|FG001|Overall Study|Withdrawal by Subject|1|||
144377495|NCT03206788|520592870|FG000|Overall Study|Adverse Event|0|||
144377496|NCT03206788|520592871|FG001|Overall Study|Adverse Event|1|||
144377497|NCT03206788|520592870|FG000|Overall Study|Physician Decision|0|||
144377498|NCT03206788|520592871|FG001|Overall Study|Physician Decision|1|||
144377499|NCT05246514|520592872|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
144377500|NCT05246514|520592872|FG000|Overall Study|Withdrawal by Subject|1|||
144377501|NCT05246514|520592872|FG000|Overall Study|Death|13|||
144377502|NCT01802073|520592875|FG000|Overall Study|Lost to Follow-up|0|||
144377503|NCT01802073|520592876|FG001|Overall Study|Lost to Follow-up|1|||
144377504|NCT01802073|520592875|FG000|Overall Study|Non-compliant|4|||
144377505|NCT01802073|520592876|FG001|Overall Study|Non-compliant|2|||
144377506|NCT01802073|520592875|FG000|Overall Study|Withdrawal by Subject|1|||
144377507|NCT01802073|520592876|FG001|Overall Study|Withdrawal by Subject|1|||
144377508|NCT01802073|520592875|FG000|Overall Study|Physician Decision|0|||
144377509|NCT01802073|520592876|FG001|Overall Study|Physician Decision|7|||
144377510|NCT02695420|520592879|FG000|Overall Study|Death|0|||
144377511|NCT02695420|520592880|FG001|Overall Study|Death|1|||
144377512|NCT02695420|520592881|FG002|Overall Study|Death|0|||
144377513|NCT02695420|520592882|FG003|Overall Study|Death|0|||
144377514|NCT00916929|520592885|FG000|Overall Study|Lost to Follow-up|1|||
144377515|NCT00916929|520592886|FG001|Overall Study|Lost to Follow-up|3|||
144377516|NCT00916929|520592885|FG000|Overall Study|Death|5|||
144377517|NCT00916929|520592886|FG001|Overall Study|Death|10|||
144377518|NCT00916929|520592885|FG000|Overall Study|Withdrawal by Subject|1|||
144377519|NCT00916929|520592886|FG001|Overall Study|Withdrawal by Subject|5|||
144377520|NCT00916929|520592885|FG000|Overall Study|Left ventricular epicardial lead|1|||
144377521|NCT00916929|520592886|FG001|Overall Study|Left ventricular epicardial lead|2|||
144377522|NCT00916929|520592885|FG000|Overall Study|Transferred to hospice care|1|||
144377523|NCT00916929|520592886|FG001|Overall Study|Transferred to hospice care|1|||
144377524|NCT00916929|520592885|FG000|Overall Study|System explant|1|||
144377525|NCT00916929|520592886|FG001|Overall Study|System explant|0|||
144377526|NCT00916929|520592885|FG000|Overall Study|Moved to another state|0|||
144377527|NCT00916929|520592886|FG001|Overall Study|Moved to another state|1|||
144377528|NCT00916929|520592885|FG000|Overall Study|Device unable to process impedance data|0|||
144377529|NCT00916929|520592886|FG001|Overall Study|Device unable to process impedance data|7|||
144377530|NCT02929407|520592887|FG000|Overall Study|Adverse Event|1|||
144377531|NCT02878798|520592890|FG000|Overall Study|Withdrawal by Subject|5|||
144377532|NCT02878798|520592891|FG001|Overall Study|Withdrawal by Subject|4|||
144377533|NCT02878798|520592890|FG000|Overall Study|Lost to Follow-up|2|||
144377534|NCT02878798|520592891|FG001|Overall Study|Lost to Follow-up|2|||
144377535|NCT02878798|520592890|FG000|Overall Study|Protocol Violation|0|||
144377536|NCT02878798|520592891|FG001|Overall Study|Protocol Violation|1|||
144377537|NCT01324401|520592892|FG000|Overall Study|Withdrawn before any treatment|0|||
144377538|NCT01324401|520592893|FG001|Overall Study|Withdrawn before any treatment|3|||
144377539|NCT01324401|520592892|FG000|Overall Study|Adverse Event|1|||
144377540|NCT01324401|520592893|FG001|Overall Study|Adverse Event|3|||
144377541|NCT01708902|520592895|FG000|Overall Study|Adverse Event|3|||
144377542|NCT01708902|520592896|FG001|Overall Study|Adverse Event|4|||
144377543|NCT01708902|520592897|FG002|Overall Study|Adverse Event|9|||
144377544|NCT01708902|520592898|FG003|Overall Study|Adverse Event|2|||
144377545|NCT01708902|520592899|FG004|Overall Study|Adverse Event|7|||
144377546|NCT01708902|520592900|FG005|Overall Study|Adverse Event|3|||
144377547|NCT01708902|520592901|FG006|Overall Study|Adverse Event|5|||
144377548|NCT01708902|520592895|FG000|Overall Study|Lack of Efficacy|3|||
144377549|NCT01708902|520592896|FG001|Overall Study|Lack of Efficacy|1|||
144377550|NCT01708902|520592897|FG002|Overall Study|Lack of Efficacy|0|||
144512732|NCT02121002|521076128|FG000|Overall Study|Withdrawal by Subject|3|||
144512733|NCT02121002|521076129|FG001|Overall Study|Withdrawal by Subject|1|||
144512734|NCT02121002|521076130|FG002|Overall Study|Withdrawal by Subject|4|||
144512735|NCT02121002|521076128|FG000|Overall Study|Protocol Violation|1|||
144512736|NCT02121002|521076129|FG001|Overall Study|Protocol Violation|2|||
144512737|NCT02121002|521076130|FG002|Overall Study|Protocol Violation|4|||
144512738|NCT02121002|521076128|FG000|Overall Study|Concomitant therapy|0|||
144512739|NCT02121002|521076129|FG001|Overall Study|Concomitant therapy|1|||
144512740|NCT02121002|521076130|FG002|Overall Study|Concomitant therapy|1|||
144512741|NCT02121002|521076128|FG000|Overall Study|Others|1|||
144512742|NCT02121002|521076129|FG001|Overall Study|Others|0|||
144512743|NCT02121002|521076130|FG002|Overall Study|Others|1|||
144512744|NCT01007396|521076131|FG000|Overall Study|Lost to Follow-up|47|||
144512745|NCT03892564|521076133|FG000|Overall Study|Withdrawal by Subject|2|||
144512746|NCT00774852|521076134|FG000|Overall Study|Adverse Event|9|||
144512747|NCT00774852|521076135|FG001|Overall Study|Adverse Event|6|||
144512748|NCT00774852|521076134|FG000|Overall Study|Death|2|||
144512749|NCT00774852|521076135|FG001|Overall Study|Death|1|||
144512750|NCT00774852|521076134|FG000|Overall Study|Lack of Efficacy|3|||
144512751|NCT00774852|521076135|FG001|Overall Study|Lack of Efficacy|7|||
144512752|NCT00774852|521076134|FG000|Overall Study|Lost to Follow-up|9|||
144512753|NCT00774852|521076135|FG001|Overall Study|Lost to Follow-up|5|||
144512754|NCT00774852|521076134|FG000|Overall Study|Physician Decision|2|||
144512755|NCT00774852|521076135|FG001|Overall Study|Physician Decision|6|||
144512756|NCT00774852|521076134|FG000|Overall Study|Pregnancy|1|||
144512757|NCT00774852|521076135|FG001|Overall Study|Pregnancy|2|||
144512758|NCT00774852|521076134|FG000|Overall Study|Withdrawal by Subject|2|||
144512759|NCT00774852|521076135|FG001|Overall Study|Withdrawal by Subject|2|||
144512760|NCT00774852|521076134|FG000|Overall Study|Non-responder|15|||
144512761|NCT00774852|521076135|FG001|Overall Study|Non-responder|11|||
144512762|NCT00774852|521076134|FG000|Overall Study|Subject non-compliance|0|||
144512763|NCT00774852|521076135|FG001|Overall Study|Subject non-compliance|1|||
144512764|NCT00774852|521076134|FG000|Overall Study|Protocol Violation|1|||
144512765|NCT00774852|521076135|FG001|Overall Study|Protocol Violation|0|||
144512766|NCT00774852|521076134|FG000|Overall Study|Subject received prohibited medication|1|||
144512767|NCT00774852|521076135|FG001|Overall Study|Subject received prohibited medication|0|||
144512768|NCT03997916|521076139|FG000|Overall Study|Protocol Violation|35|||
144512769|NCT02807779|521076142|FG000|Overall Study|Lost to Follow-up|1|||
144512770|NCT02807779|521076143|FG001|Overall Study|Lost to Follow-up|0|||
144512771|NCT02807779|521076144|FG002|Overall Study|Lost to Follow-up|0|||
144512772|NCT02807779|521076142|FG000|Overall Study|Physician Decision|2|||
144512773|NCT02807779|521076143|FG001|Overall Study|Physician Decision|0|||
144512774|NCT02807779|521076144|FG002|Overall Study|Physician Decision|1|||
144512775|NCT02807779|521076142|FG000|Overall Study|Death|1|||
144512776|NCT02807779|521076143|FG001|Overall Study|Death|1|||
144512777|NCT02807779|521076144|FG002|Overall Study|Death|0|||
144512778|NCT02576509|521078187|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
144512779|NCT02576509|521078188|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
144512780|NCT02576509|521078187|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
144512781|NCT02576509|521078188|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
144512782|NCT02576509|521078187|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
144512783|NCT02576509|521078188|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
144512784|NCT02576509|521078187|FG000|Treatment Period|Disease progression|263|||
144512785|NCT02576509|521078188|FG001|Treatment Period|Disease progression|244|||
144512786|NCT02576509|521078187|FG000|Treatment Period|Study drug toxicity|37|||
144512787|NCT02576509|521078188|FG001|Treatment Period|Study drug toxicity|41|||
144512788|NCT02576509|521078187|FG000|Treatment Period|Death|1|||
144512789|NCT02576509|521078188|FG001|Treatment Period|Death|1|||
144512790|NCT02576509|521078187|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
144512791|NCT02576509|521078188|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
144377551|NCT01708902|520592898|FG003|Overall Study|Lack of Efficacy|0|||
144377552|NCT01708902|520592899|FG004|Overall Study|Lack of Efficacy|0|||
144377553|NCT01708902|520592900|FG005|Overall Study|Lack of Efficacy|1|||
144377554|NCT01708902|520592901|FG006|Overall Study|Lack of Efficacy|0|||
144377555|NCT01708902|520592895|FG000|Overall Study|Non compliance with protocol|0|||
144377556|NCT01708902|520592896|FG001|Overall Study|Non compliance with protocol|2|||
144377557|NCT01708902|520592897|FG002|Overall Study|Non compliance with protocol|1|||
144377558|NCT01708902|520592898|FG003|Overall Study|Non compliance with protocol|3|||
144377559|NCT01708902|520592899|FG004|Overall Study|Non compliance with protocol|0|||
144377560|NCT01708902|520592900|FG005|Overall Study|Non compliance with protocol|0|||
144377561|NCT01708902|520592901|FG006|Overall Study|Non compliance with protocol|0|||
144377562|NCT01708902|520592895|FG000|Overall Study|Lost to Follow-up|2|||
144377563|NCT01708902|520592896|FG001|Overall Study|Lost to Follow-up|1|||
144377564|NCT01708902|520592897|FG002|Overall Study|Lost to Follow-up|2|||
144377565|NCT01708902|520592898|FG003|Overall Study|Lost to Follow-up|2|||
144377566|NCT01708902|520592899|FG004|Overall Study|Lost to Follow-up|0|||
144377567|NCT01708902|520592900|FG005|Overall Study|Lost to Follow-up|0|||
144377568|NCT01708902|520592901|FG006|Overall Study|Lost to Follow-up|1|||
144377569|NCT01708902|520592895|FG000|Overall Study|Refused to continue trial medication|8|||
144377570|NCT01708902|520592896|FG001|Overall Study|Refused to continue trial medication|0|||
144377571|NCT01708902|520592897|FG002|Overall Study|Refused to continue trial medication|4|||
144377572|NCT01708902|520592898|FG003|Overall Study|Refused to continue trial medication|2|||
144377573|NCT01708902|520592899|FG004|Overall Study|Refused to continue trial medication|8|||
144377574|NCT01708902|520592900|FG005|Overall Study|Refused to continue trial medication|1|||
144377575|NCT01708902|520592901|FG006|Overall Study|Refused to continue trial medication|1|||
144377576|NCT01708902|520592895|FG000|Overall Study|Other Reason|1|||
144377577|NCT01708902|520592896|FG001|Overall Study|Other Reason|0|||
144377578|NCT01708902|520592897|FG002|Overall Study|Other Reason|1|||
144377579|NCT01708902|520592898|FG003|Overall Study|Other Reason|1|||
144377580|NCT01708902|520592899|FG004|Overall Study|Other Reason|1|||
144377581|NCT01708902|520592900|FG005|Overall Study|Other Reason|2|||
144377582|NCT01708902|520592901|FG006|Overall Study|Other Reason|0|||
144377583|NCT00499590|520592904|FG000|Overall Study|Study Terminated|112|||
144377584|NCT00499590|520592905|FG001|Overall Study|Study Terminated|112|||
144377585|NCT00499590|520592906|FG002|Overall Study|Study Terminated|112|||
144377586|NCT00499590|520592904|FG000|Overall Study|Not treated|1|||
144377587|NCT00499590|520592905|FG001|Overall Study|Not treated|0|||
144377588|NCT00499590|520592906|FG002|Overall Study|Not treated|1|||
144377589|NCT02633020|520592910|FG000|Overall Study|Adverse Event|1|||
144377590|NCT02633020|520592911|FG001|Overall Study|Adverse Event|0|||
144377591|NCT00934440|520592912|FG000|Overall Study|Lost to Follow-up|1|||
144377592|NCT02152956|520592913|FG000|Overall Study|Adverse Event|0|||
144377593|NCT02152956|520592914|FG001|Overall Study|Adverse Event|0|||
144377594|NCT02152956|520592915|FG002|Overall Study|Adverse Event|0|||
144377595|NCT02152956|520592916|FG003|Overall Study|Adverse Event|0|||
144377596|NCT02152956|520592917|FG004|Overall Study|Adverse Event|0|||
144377597|NCT02152956|520592918|FG005|Overall Study|Adverse Event|0|||
144377598|NCT02152956|520592919|FG006|Overall Study|Adverse Event|0|||
144377599|NCT02152956|520592920|FG007|Overall Study|Adverse Event|0|||
144377600|NCT02152956|520592921|FG008|Overall Study|Adverse Event|0|||
144377601|NCT02152956|520592922|FG009|Overall Study|Adverse Event|0|||
144377602|NCT02152956|520592923|FG010|Overall Study|Adverse Event|0|||
144377603|NCT02152956|520592924|FG011|Overall Study|Adverse Event|4|||
144377604|NCT02152956|520592925|FG012|Overall Study|Adverse Event|0|||
144377605|NCT02152956|520592913|FG000|Overall Study|Death|0|||
144377606|NCT02152956|520592914|FG001|Overall Study|Death|3|||
144377607|NCT02152956|520592915|FG002|Overall Study|Death|3|||
144377608|NCT02152956|520592916|FG003|Overall Study|Death|4|||
144377609|NCT02152956|520592917|FG004|Overall Study|Death|1|||
144377610|NCT02152956|520592918|FG005|Overall Study|Death|2|||
144377611|NCT02152956|520592919|FG006|Overall Study|Death|6|||
144377612|NCT02152956|520592920|FG007|Overall Study|Death|6|||
144377613|NCT02152956|520592921|FG008|Overall Study|Death|4|||
144377614|NCT02152956|520592922|FG009|Overall Study|Death|5|||
144377615|NCT02152956|520592923|FG010|Overall Study|Death|3|||
144377616|NCT02152956|520592924|FG011|Overall Study|Death|143|||
144377617|NCT02152956|520592925|FG012|Overall Study|Death|12|||
144377618|NCT02152956|520592913|FG000|Overall Study|Lost to Follow-up|0|||
144377619|NCT02152956|520592914|FG001|Overall Study|Lost to Follow-up|1|||
144377620|NCT02152956|520592915|FG002|Overall Study|Lost to Follow-up|0|||
144377621|NCT02152956|520592916|FG003|Overall Study|Lost to Follow-up|0|||
144377622|NCT02152956|520592917|FG004|Overall Study|Lost to Follow-up|0|||
144377623|NCT02152956|520592918|FG005|Overall Study|Lost to Follow-up|0|||
144377624|NCT02152956|520592919|FG006|Overall Study|Lost to Follow-up|0|||
144377625|NCT02152956|520592920|FG007|Overall Study|Lost to Follow-up|0|||
144377626|NCT02152956|520592921|FG008|Overall Study|Lost to Follow-up|0|||
144377627|NCT02152956|520592922|FG009|Overall Study|Lost to Follow-up|0|||
144377628|NCT02152956|520592923|FG010|Overall Study|Lost to Follow-up|0|||
144377629|NCT02152956|520592924|FG011|Overall Study|Lost to Follow-up|3|||
144377630|NCT02152956|520592925|FG012|Overall Study|Lost to Follow-up|0|||
144377631|NCT02152956|520592913|FG000|Overall Study|Withdrawal by Subject|1|||
144377632|NCT02152956|520592914|FG001|Overall Study|Withdrawal by Subject|0|||
144377633|NCT02152956|520592915|FG002|Overall Study|Withdrawal by Subject|1|||
144377634|NCT02152956|520592916|FG003|Overall Study|Withdrawal by Subject|0|||
144377635|NCT02152956|520592917|FG004|Overall Study|Withdrawal by Subject|2|||
144377636|NCT02152956|520592918|FG005|Overall Study|Withdrawal by Subject|2|||
144377637|NCT02152956|520592919|FG006|Overall Study|Withdrawal by Subject|0|||
144377638|NCT02152956|520592920|FG007|Overall Study|Withdrawal by Subject|0|||
144377639|NCT02152956|520592921|FG008|Overall Study|Withdrawal by Subject|1|||
144377640|NCT02152956|520592922|FG009|Overall Study|Withdrawal by Subject|0|||
144377641|NCT02152956|520592923|FG010|Overall Study|Withdrawal by Subject|0|||
144377642|NCT02152956|520592924|FG011|Overall Study|Withdrawal by Subject|4|||
144377643|NCT02152956|520592925|FG012|Overall Study|Withdrawal by Subject|0|||
144377644|NCT02152956|520592913|FG000|Overall Study|Physician Decision|0|||
144377645|NCT02152956|520592914|FG001|Overall Study|Physician Decision|0|||
144377646|NCT02152956|520592915|FG002|Overall Study|Physician Decision|0|||
144377647|NCT02152956|520592916|FG003|Overall Study|Physician Decision|0|||
144377648|NCT02152956|520592917|FG004|Overall Study|Physician Decision|0|||
144377649|NCT02152956|520592918|FG005|Overall Study|Physician Decision|0|||
144377650|NCT02152956|520592919|FG006|Overall Study|Physician Decision|0|||
144377651|NCT02152956|520592920|FG007|Overall Study|Physician Decision|0|||
144377652|NCT02152956|520592921|FG008|Overall Study|Physician Decision|0|||
144377653|NCT02152956|520592922|FG009|Overall Study|Physician Decision|0|||
144377654|NCT02152956|520592923|FG010|Overall Study|Physician Decision|0|||
144377655|NCT02152956|520592924|FG011|Overall Study|Physician Decision|1|||
144377656|NCT02152956|520592925|FG012|Overall Study|Physician Decision|0|||
144377657|NCT02152956|520592913|FG000|Overall Study|Study terminated by sponsor|0|||
144377658|NCT02152956|520592914|FG001|Overall Study|Study terminated by sponsor|0|||
144377659|NCT02152956|520592915|FG002|Overall Study|Study terminated by sponsor|0|||
144377660|NCT02152956|520592916|FG003|Overall Study|Study terminated by sponsor|0|||
144377661|NCT02152956|520592917|FG004|Overall Study|Study terminated by sponsor|0|||
144377662|NCT02152956|520592918|FG005|Overall Study|Study terminated by sponsor|0|||
144377663|NCT02152956|520592919|FG006|Overall Study|Study terminated by sponsor|0|||
144377664|NCT02152956|520592920|FG007|Overall Study|Study terminated by sponsor|0|||
144377665|NCT02152956|520592921|FG008|Overall Study|Study terminated by sponsor|0|||
144377666|NCT02152956|520592922|FG009|Overall Study|Study terminated by sponsor|0|||
144377667|NCT02152956|520592923|FG010|Overall Study|Study terminated by sponsor|0|||
144377668|NCT02152956|520592924|FG011|Overall Study|Study terminated by sponsor|29|||
144377669|NCT02152956|520592925|FG012|Overall Study|Study terminated by sponsor|0|||
144377670|NCT02152956|520592913|FG000|Overall Study|progressive disease|0|||
144377671|NCT02152956|520592914|FG001|Overall Study|progressive disease|0|||
144377672|NCT02152956|520592915|FG002|Overall Study|progressive disease|0|||
144377673|NCT02152956|520592916|FG003|Overall Study|progressive disease|0|||
144377674|NCT02152956|520592917|FG004|Overall Study|progressive disease|0|||
144377675|NCT02152956|520592918|FG005|Overall Study|progressive disease|0|||
144377676|NCT02152956|520592919|FG006|Overall Study|progressive disease|0|||
144377677|NCT02152956|520592920|FG007|Overall Study|progressive disease|0|||
144377678|NCT02152956|520592921|FG008|Overall Study|progressive disease|1|||
144377679|NCT02152956|520592922|FG009|Overall Study|progressive disease|0|||
144377680|NCT02152956|520592923|FG010|Overall Study|progressive disease|0|||
144377681|NCT02152956|520592924|FG011|Overall Study|progressive disease|1|||
144377682|NCT02152956|520592925|FG012|Overall Study|progressive disease|0|||
144377683|NCT01014910|520592926|FG000|Overall Study|Withdrawal by Subject|0|||
144377684|NCT01014910|520592927|FG001|Overall Study|Withdrawal by Subject|2|||
144377685|NCT02560025|520592933|FG000|Overall Study|Ineligible after consent/ registration|3|||
144377686|NCT02703337|520592934|FG000|Period One (Part A)|Withdrawal by Subject|0|||
144377687|NCT02703337|520592935|FG001|Period One (Part A)|Withdrawal by Subject|0|||
144377688|NCT02703337|520592936|FG002|Period One (Part A)|Withdrawal by Subject|0|||
144377689|NCT02703337|520592937|FG003|Period One (Part A)|Withdrawal by Subject|0|||
144377690|NCT02703337|520592938|FG004|Period One (Part A)|Withdrawal by Subject|1|||
144377691|NCT02703337|520592939|FG005|Period One (Part A)|Withdrawal by Subject|0|||
144377692|NCT02703337|520592940|FG006|Period One (Part A)|Withdrawal by Subject|0|||
144377693|NCT02703337|520592941|FG007|Period One (Part A)|Withdrawal by Subject|0|||
144377694|NCT00282308|520592948|FG000|Treatment Period|Lost to Follow-up|1|||
144377695|NCT00282308|520592949|FG001|Treatment Period|Lost to Follow-up|0|||
144377696|NCT00282308|520592950|FG002|Treatment Period|Lost to Follow-up|0|||
144377697|NCT00282308|520592948|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
144377698|NCT00282308|520592949|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
144377699|NCT00282308|520592950|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
144377700|NCT00282308|520592948|FG000|Treatment Period|Adverse Event|0|||
144377701|NCT00282308|520592949|FG001|Treatment Period|Adverse Event|2|||
144377702|NCT00282308|520592950|FG002|Treatment Period|Adverse Event|0|||
144377703|NCT00282308|520592948|FG000|Treatment Period|Not Treated with Study Drug|1|||
144512792|NCT02576509|521078187|FG000|Treatment Period|Participant request to stop treatment|8|||
144512793|NCT02576509|521078188|FG001|Treatment Period|Participant request to stop treatment|18|||
144377704|NCT00282308|520592949|FG001|Treatment Period|Not Treated with Study Drug|0|||
144512794|NCT02576509|521078187|FG000|Treatment Period|Participant withdrew consent|3|||
144512795|NCT02576509|521078188|FG001|Treatment Period|Participant withdrew consent|7|||
144512796|NCT02576509|521078187|FG000|Treatment Period|Lost to Follow-up|0|||
144512797|NCT02576509|521078188|FG001|Treatment Period|Lost to Follow-up|1|||
144512798|NCT02576509|521078187|FG000|Treatment Period|Maximum clinical benefit|1|||
144512799|NCT02576509|521078188|FG001|Treatment Period|Maximum clinical benefit|0|||
144512800|NCT02576509|521078187|FG000|Treatment Period|Poor/non-compliance|1|||
144512801|NCT02576509|521078188|FG001|Treatment Period|Poor/non-compliance|1|||
144512802|NCT02576509|521078187|FG000|Treatment Period|Participant no longer meets criteria|1|||
144512803|NCT02576509|521078188|FG001|Treatment Period|Participant no longer meets criteria|0|||
144512804|NCT02576509|521078187|FG000|Treatment Period|Other reason|12|||
144512805|NCT02576509|521078188|FG001|Treatment Period|Other reason|8|||
144512806|NCT02576509|521078187|FG000|Treatment Period|NOT REPORTED|1|||
144512807|NCT02576509|521078188|FG001|Treatment Period|NOT REPORTED|0|||
144512808|NCT02576509|521078187|FG000|Treatment Period|Administrative reason by sponsor|0|||
144512809|NCT02576509|521078188|FG001|Treatment Period|Administrative reason by sponsor|1|||
144512810|NCT01216176|521078192|FG000|Overall Study|Adverse Event|0|||
144512811|NCT01216176|521078193|FG001|Overall Study|Adverse Event|8|||
144512812|NCT01216176|521078194|FG002|Overall Study|Adverse Event|0|||
144512813|NCT01216176|521078192|FG000|Overall Study|Physician Decision|0|||
144512814|NCT01216176|521078193|FG001|Overall Study|Physician Decision|0|||
144512815|NCT01216176|521078194|FG002|Overall Study|Physician Decision|1|||
144512816|NCT03398148|521078197|FG000|Substudy 1 Period 1|Adverse Event|5|||
144512817|NCT03398148|521078198|FG001|Substudy 1 Period 1|Adverse Event|2|||
144512818|NCT03398148|521078199|FG002|Substudy 1 Period 1|Adverse Event|2|||
144512819|NCT03398148|521078200|FG003|Substudy 1 Period 1|Adverse Event|0|||
144512820|NCT03398148|521078201|FG004|Substudy 1 Period 1|Adverse Event|8|||
144512821|NCT03398148|521078202|FG005|Substudy 1 Period 1|Adverse Event|0|||
144512822|NCT03398148|521078203|FG006|Substudy 1 Period 1|Adverse Event|0|||
144512823|NCT03398148|521078204|FG007|Substudy 1 Period 1|Adverse Event|0|||
144512824|NCT03398148|521078205|FG008|Substudy 1 Period 1|Adverse Event|0|||
144512825|NCT03398148|521078206|FG009|Substudy 1 Period 1|Adverse Event|0|||
144512826|NCT03398148|521078207|FG010|Substudy 1 Period 1|Adverse Event|0|||
144512827|NCT03398148|521078208|FG011|Substudy 1 Period 1|Adverse Event|0|||
144512828|NCT03398148|521078209|FG012|Substudy 1 Period 1|Adverse Event|0|||
144512829|NCT03398148|521078210|FG013|Substudy 1 Period 1|Adverse Event|0|||
144512830|NCT03398148|521078211|FG014|Substudy 1 Period 1|Adverse Event|0|||
144512831|NCT03398148|521078197|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
144512832|NCT03398148|521078198|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
144512833|NCT03398148|521078199|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512834|NCT03398148|521078200|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
144512835|NCT03398148|521078201|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
144512836|NCT03398148|521078202|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512837|NCT03398148|521078203|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512838|NCT03398148|521078204|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512839|NCT03398148|521078205|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512840|NCT03398148|521078206|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512841|NCT03398148|521078207|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512842|NCT03398148|521078208|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512843|NCT03398148|521078209|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512844|NCT03398148|521078210|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144377705|NCT00282308|520592950|FG002|Treatment Period|Not Treated with Study Drug|0|||
144512845|NCT03398148|521078211|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
144512846|NCT03398148|521078197|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
144512847|NCT03398148|521078198|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
144512848|NCT03398148|521078199|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
144512849|NCT03398148|521078200|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
144512850|NCT03398148|521078201|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
144512851|NCT03398148|521078202|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
144512852|NCT03398148|521078203|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
144512853|NCT03398148|521078204|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
144512854|NCT03398148|521078205|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
144512855|NCT03398148|521078206|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
144512856|NCT03398148|521078207|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
144377706|NCT00282308|520592948|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
144512857|NCT03398148|521078208|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
144512858|NCT03398148|521078209|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
144512859|NCT03398148|521078210|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
144512860|NCT03398148|521078211|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
144512861|NCT03398148|521078197|FG000|Substudy 1 Period 1|Other|0|||
144512862|NCT03398148|521078198|FG001|Substudy 1 Period 1|Other|1|||
144512863|NCT03398148|521078199|FG002|Substudy 1 Period 1|Other|0|||
144512864|NCT03398148|521078200|FG003|Substudy 1 Period 1|Other|0|||
144512865|NCT03398148|521078201|FG004|Substudy 1 Period 1|Other|3|||
144512866|NCT03398148|521078202|FG005|Substudy 1 Period 1|Other|0|||
144512867|NCT03398148|521078203|FG006|Substudy 1 Period 1|Other|0|||
144512868|NCT03398148|521078204|FG007|Substudy 1 Period 1|Other|0|||
144512869|NCT03398148|521078205|FG008|Substudy 1 Period 1|Other|0|||
144512870|NCT03398148|521078206|FG009|Substudy 1 Period 1|Other|0|||
144512871|NCT03398148|521078207|FG010|Substudy 1 Period 1|Other|0|||
144512872|NCT03398148|521078208|FG011|Substudy 1 Period 1|Other|0|||
144512873|NCT03398148|521078209|FG012|Substudy 1 Period 1|Other|0|||
144512874|NCT03398148|521078210|FG013|Substudy 1 Period 1|Other|0|||
144512875|NCT03398148|521078211|FG014|Substudy 1 Period 1|Other|0|||
144512876|NCT03398148|521078197|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512877|NCT03398148|521078198|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512878|NCT03398148|521078199|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512879|NCT03398148|521078200|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512880|NCT03398148|521078201|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
144512881|NCT03398148|521078202|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512882|NCT03398148|521078203|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512883|NCT03398148|521078204|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512884|NCT03398148|521078205|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512885|NCT03398148|521078206|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512886|NCT03398148|521078207|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512887|NCT03398148|521078208|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512888|NCT03398148|521078209|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512889|NCT03398148|521078210|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512890|NCT03398148|521078211|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
144512891|NCT03398148|521078197|FG000|Substudy 1 Period 2|Adverse Event|0|||
144512892|NCT03398148|521078198|FG001|Substudy 1 Period 2|Adverse Event|0|||
144512893|NCT03398148|521078199|FG002|Substudy 1 Period 2|Adverse Event|0|||
144512894|NCT03398148|521078200|FG003|Substudy 1 Period 2|Adverse Event|0|||
144512895|NCT03398148|521078201|FG004|Substudy 1 Period 2|Adverse Event|0|||
144512896|NCT03398148|521078202|FG005|Substudy 1 Period 2|Adverse Event|2|||
144512897|NCT03398148|521078203|FG006|Substudy 1 Period 2|Adverse Event|4|||
144512898|NCT03398148|521078204|FG007|Substudy 1 Period 2|Adverse Event|0|||
144512899|NCT03398148|521078205|FG008|Substudy 1 Period 2|Adverse Event|0|||
144512900|NCT03398148|521078206|FG009|Substudy 1 Period 2|Adverse Event|0|||
144512901|NCT03398148|521078207|FG010|Substudy 1 Period 2|Adverse Event|0|||
144512902|NCT03398148|521078208|FG011|Substudy 1 Period 2|Adverse Event|0|||
144512903|NCT03398148|521078209|FG012|Substudy 1 Period 2|Adverse Event|0|||
144512904|NCT03398148|521078210|FG013|Substudy 1 Period 2|Adverse Event|0|||
144512905|NCT03398148|521078211|FG014|Substudy 1 Period 2|Adverse Event|0|||
144512906|NCT03398148|521078197|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512907|NCT03398148|521078198|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512908|NCT03398148|521078199|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512909|NCT03398148|521078200|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512910|NCT03398148|521078201|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512911|NCT03398148|521078202|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512912|NCT03398148|521078203|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
144512913|NCT03398148|521078204|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
144512914|NCT03398148|521078205|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512915|NCT03398148|521078206|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512916|NCT03398148|521078207|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512917|NCT03398148|521078208|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512918|NCT03398148|521078209|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512919|NCT03398148|521078210|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512920|NCT03398148|521078211|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
144512921|NCT03398148|521078197|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
144512922|NCT03398148|521078198|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
144512923|NCT03398148|521078199|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
144512924|NCT03398148|521078200|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
144512925|NCT03398148|521078201|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
144512926|NCT03398148|521078202|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
144512927|NCT03398148|521078203|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
144512928|NCT03398148|521078204|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
144512929|NCT03398148|521078205|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
144512930|NCT03398148|521078206|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
144512931|NCT03398148|521078207|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
144512932|NCT03398148|521078208|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
144512933|NCT03398148|521078209|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
144512934|NCT03398148|521078210|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
144512935|NCT03398148|521078211|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
144512936|NCT03398148|521078197|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144377707|NCT00282308|520592949|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
144377708|NCT00282308|520592950|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
144377709|NCT00282308|520592948|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
144377710|NCT00282308|520592949|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
144377711|NCT00282308|520592950|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
144377712|NCT00282308|520592948|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
144377713|NCT00282308|520592949|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
144377714|NCT00282308|520592950|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
144377715|NCT00282308|520592948|FG000|Safety Follow-up Period|Adverse Event|0|||
144377716|NCT00282308|520592949|FG001|Safety Follow-up Period|Adverse Event|0|||
144377717|NCT00282308|520592950|FG002|Safety Follow-up Period|Adverse Event|1|||
144377718|NCT00282308|520592948|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
144377719|NCT00282308|520592949|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
144377720|NCT00282308|520592950|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
144377721|NCT00282308|520592948|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
144377722|NCT00282308|520592949|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
144377723|NCT00282308|520592950|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
144377724|NCT00282308|520592948|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
144377725|NCT00282308|520592949|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
144377726|NCT00282308|520592950|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
144377727|NCT01584440|520592952|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
144377728|NCT01584440|520592953|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
144377729|NCT01584440|520592954|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
144377730|NCT01584440|520592955|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
144377731|NCT01584440|520592956|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
144377732|NCT01584440|520592952|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
144377733|NCT01584440|520592953|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
144377734|NCT01584440|520592954|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
144377735|NCT01584440|520592955|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
144377736|NCT01584440|520592956|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
144377737|NCT01584440|520592952|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
144377738|NCT01584440|520592953|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
144377739|NCT01584440|520592954|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
144377740|NCT01584440|520592955|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
144377741|NCT01584440|520592956|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
144377742|NCT01584440|520592952|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
144377743|NCT01584440|520592953|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
144377744|NCT01584440|520592954|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
144377745|NCT01584440|520592955|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
144377746|NCT01584440|520592956|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
144377747|NCT01584440|520592952|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
144377748|NCT01584440|520592953|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
144377749|NCT01584440|520592954|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
144377750|NCT01584440|520592955|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
144377751|NCT01584440|520592956|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
144377752|NCT01584440|520592952|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
144377753|NCT01584440|520592953|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
144377754|NCT01584440|520592954|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
144377755|NCT01584440|520592955|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
144377756|NCT01584440|520592956|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
144377757|NCT01584440|520592952|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
144377758|NCT01584440|520592953|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
144377759|NCT01584440|520592954|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
144377760|NCT01584440|520592955|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
144377761|NCT01584440|520592956|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
144377762|NCT01584440|520592952|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
144377763|NCT01584440|520592953|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
144377764|NCT01584440|520592954|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
144377765|NCT01584440|520592955|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
144377766|NCT01584440|520592956|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
144377767|NCT01584440|520592952|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
144377768|NCT01584440|520592953|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
144377769|NCT01584440|520592954|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
144377770|NCT01584440|520592955|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
144377771|NCT01584440|520592956|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
144377772|NCT04237116|520592957|FG000|Overall Study|Adverse Event|0|||
144377773|NCT04237116|520592958|FG001|Overall Study|Adverse Event|1|||
144377774|NCT04237116|520592957|FG000|Overall Study|Study terminated by Sponsor|4|||
144377775|NCT04237116|520592958|FG001|Overall Study|Study terminated by Sponsor|1|||
144377776|NCT03212144|520592959|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
144377777|NCT03212144|520592960|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
144377778|NCT03212144|520592959|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
144377779|NCT03212144|520592960|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
144377780|NCT00599339|520592961|FG000|Overall Study|Adverse Event|79|||
144377781|NCT00599339|520592961|FG000|Overall Study|Withdrawal by Subject|137|||
144377782|NCT00599339|520592961|FG000|Overall Study|Other Reason|179|||
144377783|NCT00599339|520592961|FG000|Overall Study|Lost to Follow-up|221|||
144377784|NCT00599339|520592961|FG000|Overall Study|No valid data consent|36|||
144377785|NCT00599339|520592961|FG000|Overall Study|Study Termination Status Unknown|12|||
144377786|NCT05564052|520592962|FG000|Overall Study|Withdrawal by Subject|0|||
144377787|NCT05564052|520592963|FG001|Overall Study|Withdrawal by Subject|0|||
144377788|NCT05564052|520592964|FG002|Overall Study|Withdrawal by Subject|0|||
144377789|NCT05564052|520592965|FG003|Overall Study|Withdrawal by Subject|1|||
144377790|NCT01253577|520592967|FG000|Overall Study|Lost to Follow-up|3|||
144377791|NCT01064947|520592968|FG000|Overall Study|negative culture|41|||
144377792|NCT06457204|520592969|FG000|Washout|Adverse Event|0|||
144377793|NCT06457204|520592970|FG001|Washout|Adverse Event|2|||
144377794|NCT01601652|520592972|FG000|Overall Study|Death|1|||
144377795|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
144377796|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
144377797|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
144377798|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
144377799|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
144377800|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
144377801|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
144377802|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
144377803|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
144377804|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
144377805|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
144377806|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
144377807|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
144512937|NCT03398148|521078198|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512938|NCT03398148|521078199|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512939|NCT03398148|521078200|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512940|NCT03398148|521078201|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512941|NCT03398148|521078202|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512942|NCT03398148|521078203|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
144512943|NCT03398148|521078204|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512944|NCT03398148|521078205|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512945|NCT03398148|521078206|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512946|NCT03398148|521078207|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512947|NCT03398148|521078208|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512948|NCT03398148|521078209|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512949|NCT03398148|521078210|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512950|NCT03398148|521078211|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144512951|NCT03398148|521078197|FG000|Substudy 1 Period 2|Other|0|||
144512952|NCT03398148|521078198|FG001|Substudy 1 Period 2|Other|0|||
144512953|NCT03398148|521078199|FG002|Substudy 1 Period 2|Other|0|||
144512954|NCT03398148|521078200|FG003|Substudy 1 Period 2|Other|0|||
144512955|NCT03398148|521078201|FG004|Substudy 1 Period 2|Other|0|||
144512956|NCT03398148|521078202|FG005|Substudy 1 Period 2|Other|0|||
144512957|NCT03398148|521078203|FG006|Substudy 1 Period 2|Other|1|||
144512958|NCT03398148|521078204|FG007|Substudy 1 Period 2|Other|0|||
144512959|NCT03398148|521078205|FG008|Substudy 1 Period 2|Other|0|||
144512960|NCT03398148|521078206|FG009|Substudy 1 Period 2|Other|0|||
144512961|NCT03398148|521078207|FG010|Substudy 1 Period 2|Other|0|||
144512962|NCT03398148|521078208|FG011|Substudy 1 Period 2|Other|0|||
144512963|NCT03398148|521078209|FG012|Substudy 1 Period 2|Other|0|||
144512964|NCT03398148|521078210|FG013|Substudy 1 Period 2|Other|0|||
144377808|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
144377809|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
144377810|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
144377811|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
144512965|NCT03398148|521078211|FG014|Substudy 1 Period 2|Other|0|||
144512966|NCT03398148|521078197|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512967|NCT03398148|521078198|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512968|NCT03398148|521078199|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512969|NCT03398148|521078200|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512970|NCT03398148|521078201|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
144377812|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
144377813|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
144377814|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
144377815|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
144377816|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
144377817|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
144377818|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
144377819|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
144377820|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
144377821|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
144377822|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
144377823|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
144377824|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
144377825|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
144377826|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
144377827|NCT03818035|520592973|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
144377828|NCT03818035|520592974|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
144377829|NCT03818035|520592975|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
144377830|NCT03818035|520592976|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
144377831|NCT03818035|520592973|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
144377832|NCT03818035|520592974|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
144377833|NCT03818035|520592975|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
144377834|NCT03818035|520592976|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
144377835|NCT03818035|520592973|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
144377836|NCT03818035|520592974|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
144377837|NCT03818035|520592975|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
144377838|NCT03818035|520592976|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
144377839|NCT03818035|520592973|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
144377840|NCT03818035|520592974|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
144377841|NCT03818035|520592975|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
144377842|NCT03818035|520592976|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
144377843|NCT03818035|520592973|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
144377844|NCT03818035|520592974|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
144377845|NCT03818035|520592975|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
144721783|NCT02540356|521835287|FG000|Overall Study|Terminated due to disease progression|1|||
144377846|NCT03818035|520592976|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
144377847|NCT03818035|520592973|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
144377848|NCT03818035|520592974|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
144377849|NCT03818035|520592975|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
144377850|NCT03818035|520592976|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
144377851|NCT03818035|520592973|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
144377852|NCT03818035|520592974|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
144377853|NCT03818035|520592975|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
144377854|NCT03818035|520592976|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
144377855|NCT03374202|520592979|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
144377856|NCT03374202|520592980|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
144377857|NCT03374202|520592981|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
144377858|NCT03374202|520592979|FG000|Five Year Long Term Follow Up|Death|0|||
144377859|NCT03374202|520592980|FG001|Five Year Long Term Follow Up|Death|1|||
144377860|NCT03374202|520592981|FG002|Five Year Long Term Follow Up|Death|0|||
144377861|NCT02338882|520594541|FG000|Overall Study|Death|1|||
144377862|NCT02338882|520594542|FG001|Overall Study|Death|0|||
144377863|NCT02338882|520594541|FG000|Overall Study|Lost to Follow-up|6|||
144377864|NCT02338882|520594542|FG001|Overall Study|Lost to Follow-up|3|||
144377865|NCT01904773|520594543|FG000|Screen|Screen failure|3|||
144377866|NCT01904773|520594544|FG001|Screen|Screen failure|0|||
144377867|NCT01904773|520594545|FG002|Screen|Screen failure|0|||
144377868|NCT01904773|520594546|FG003|Screen|Screen failure|0|||
144377869|NCT01904773|520594547|FG004|Screen|Screen failure|0|||
144377870|NCT01904773|520594548|FG005|Screen|Screen failure|0|||
144377871|NCT01904773|520594549|FG006|Screen|Screen failure|0|||
144377872|NCT01904773|520594550|FG007|Screen|Screen failure|0|||
144377873|NCT01904773|520594551|FG008|Screen|Screen failure|0|||
144377874|NCT01904773|520594543|FG000|Screen|Withdrawal by Subject|1|||
144377875|NCT01904773|520594544|FG001|Screen|Withdrawal by Subject|0|||
144377876|NCT01904773|520594545|FG002|Screen|Withdrawal by Subject|0|||
144377877|NCT01904773|520594546|FG003|Screen|Withdrawal by Subject|0|||
144377878|NCT01904773|520594547|FG004|Screen|Withdrawal by Subject|0|||
144512971|NCT03398148|521078202|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512972|NCT03398148|521078203|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
144512973|NCT03398148|521078204|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512974|NCT03398148|521078205|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512975|NCT03398148|521078206|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512976|NCT03398148|521078207|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512977|NCT03398148|521078208|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512978|NCT03398148|521078209|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512979|NCT03398148|521078210|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512980|NCT03398148|521078211|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
144512981|NCT03398148|521078197|FG000|Substudy 2 Period 1|Adverse Event|0|||
144512982|NCT03398148|521078198|FG001|Substudy 2 Period 1|Adverse Event|0|||
144512983|NCT03398148|521078199|FG002|Substudy 2 Period 1|Adverse Event|0|||
144512984|NCT03398148|521078200|FG003|Substudy 2 Period 1|Adverse Event|0|||
144512985|NCT03398148|521078201|FG004|Substudy 2 Period 1|Adverse Event|0|||
144512986|NCT03398148|521078202|FG005|Substudy 2 Period 1|Adverse Event|0|||
144512987|NCT03398148|521078203|FG006|Substudy 2 Period 1|Adverse Event|0|||
144512988|NCT03398148|521078204|FG007|Substudy 2 Period 1|Adverse Event|0|||
144512989|NCT03398148|521078205|FG008|Substudy 2 Period 1|Adverse Event|0|||
144512990|NCT03398148|521078206|FG009|Substudy 2 Period 1|Adverse Event|12|||
144512991|NCT03398148|521078207|FG010|Substudy 2 Period 1|Adverse Event|2|||
144512992|NCT03398148|521078208|FG011|Substudy 2 Period 1|Adverse Event|0|||
144512993|NCT03398148|521078209|FG012|Substudy 2 Period 1|Adverse Event|0|||
144512994|NCT03398148|521078210|FG013|Substudy 2 Period 1|Adverse Event|0|||
144512995|NCT03398148|521078211|FG014|Substudy 2 Period 1|Adverse Event|0|||
144512996|NCT03398148|521078197|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144512997|NCT03398148|521078198|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144512998|NCT03398148|521078199|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144512999|NCT03398148|521078200|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513000|NCT03398148|521078201|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144377879|NCT01904773|520594548|FG005|Screen|Withdrawal by Subject|0|||
144377880|NCT01904773|520594549|FG006|Screen|Withdrawal by Subject|0|||
144377881|NCT01904773|520594550|FG007|Screen|Withdrawal by Subject|0|||
144377882|NCT01904773|520594551|FG008|Screen|Withdrawal by Subject|0|||
144377883|NCT01904773|520594543|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
144377884|NCT01904773|520594544|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377885|NCT01904773|520594545|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144513001|NCT03398148|521078202|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513002|NCT03398148|521078203|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513003|NCT03398148|521078204|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513004|NCT03398148|521078205|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144377886|NCT01904773|520594546|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377887|NCT01904773|520594547|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377888|NCT01904773|520594548|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377889|NCT01904773|520594549|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377890|NCT01904773|520594550|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377891|NCT01904773|520594551|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
144377892|NCT01904773|520594543|FG000|First Intervention|Adverse Event|0|||
144377893|NCT01904773|520594544|FG001|First Intervention|Adverse Event|0|||
144377894|NCT01904773|520594545|FG002|First Intervention|Adverse Event|0|||
144377895|NCT01904773|520594546|FG003|First Intervention|Adverse Event|0|||
144377896|NCT01904773|520594547|FG004|First Intervention|Adverse Event|0|||
144377897|NCT01904773|520594548|FG005|First Intervention|Adverse Event|0|||
144377898|NCT01904773|520594549|FG006|First Intervention|Adverse Event|1|||
144377899|NCT01904773|520594550|FG007|First Intervention|Adverse Event|0|||
144377900|NCT01904773|520594551|FG008|First Intervention|Adverse Event|0|||
144377901|NCT01904773|520594543|FG000|Placebo Washout First Intervention|Condition worsened|0|||
144377902|NCT01904773|520594544|FG001|Placebo Washout First Intervention|Condition worsened|1|||
144377903|NCT01904773|520594545|FG002|Placebo Washout First Intervention|Condition worsened|0|||
144377904|NCT01904773|520594546|FG003|Placebo Washout First Intervention|Condition worsened|0|||
144377905|NCT01904773|520594547|FG004|Placebo Washout First Intervention|Condition worsened|0|||
144377906|NCT01904773|520594548|FG005|Placebo Washout First Intervention|Condition worsened|0|||
144377907|NCT01904773|520594549|FG006|Placebo Washout First Intervention|Condition worsened|0|||
144377908|NCT01904773|520594550|FG007|Placebo Washout First Intervention|Condition worsened|0|||
144377909|NCT01904773|520594551|FG008|Placebo Washout First Intervention|Condition worsened|0|||
144377910|NCT01904773|520594543|FG000|Fifth Intervention|Adverse Event|0|||
144377911|NCT01904773|520594544|FG001|Fifth Intervention|Adverse Event|0|||
144377912|NCT01904773|520594545|FG002|Fifth Intervention|Adverse Event|0|||
144377913|NCT01904773|520594546|FG003|Fifth Intervention|Adverse Event|0|||
144377914|NCT01904773|520594547|FG004|Fifth Intervention|Adverse Event|0|||
144377915|NCT01904773|520594548|FG005|Fifth Intervention|Adverse Event|0|||
144377916|NCT01904773|520594549|FG006|Fifth Intervention|Adverse Event|0|||
144377917|NCT01904773|520594550|FG007|Fifth Intervention|Adverse Event|1|||
144377918|NCT01904773|520594551|FG008|Fifth Intervention|Adverse Event|0|||
144377919|NCT01904773|520594543|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377920|NCT01904773|520594544|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
144377921|NCT01904773|520594545|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377922|NCT01904773|520594546|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377923|NCT01904773|520594547|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377924|NCT01904773|520594548|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377925|NCT01904773|520594549|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377926|NCT01904773|520594550|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377927|NCT01904773|520594551|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
144377928|NCT04518995|520594552|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
144377929|NCT04518995|520594553|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
144377930|NCT04518995|520594554|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
144377931|NCT04518995|520594552|FG000|Overall Study|Lack of Efficacy|2|||
144377932|NCT04518995|520594553|FG001|Overall Study|Lack of Efficacy|1|||
144377933|NCT04518995|520594554|FG002|Overall Study|Lack of Efficacy|0|||
144377934|NCT04518995|520594552|FG000|Overall Study|Non-compliance With Study Drug|0|||
144377935|NCT04518995|520594553|FG001|Overall Study|Non-compliance With Study Drug|3|||
144377936|NCT04518995|520594554|FG002|Overall Study|Non-compliance With Study Drug|2|||
144377937|NCT04518995|520594552|FG000|Overall Study|Pregnancy|0|||
144377938|NCT04518995|520594553|FG001|Overall Study|Pregnancy|0|||
144377939|NCT04518995|520594554|FG002|Overall Study|Pregnancy|1|||
144377940|NCT04518995|520594552|FG000|Overall Study|Protocol Violation|2|||
144377941|NCT04518995|520594553|FG001|Overall Study|Protocol Violation|0|||
144377942|NCT04518995|520594554|FG002|Overall Study|Protocol Violation|1|||
144377943|NCT04518995|520594552|FG000|Overall Study|Reason not Specified|4|||
144377944|NCT04518995|520594553|FG001|Overall Study|Reason not Specified|11|||
144377945|NCT04518995|520594554|FG002|Overall Study|Reason not Specified|2|||
144377946|NCT04518995|520594552|FG000|Overall Study|Lost to Follow-up|1|||
144377947|NCT04518995|520594553|FG001|Overall Study|Lost to Follow-up|10|||
144377948|NCT04518995|520594554|FG002|Overall Study|Lost to Follow-up|6|||
144377949|NCT00669409|520594557|FG000|Part 2|Withdrawal by Subject|0|||
144377950|NCT00669409|520594558|FG001|Part 2|Withdrawal by Subject|0|||
144377951|NCT00669409|520594559|FG002|Part 2|Withdrawal by Subject|0|||
144377952|NCT00669409|520594560|FG003|Part 2|Withdrawal by Subject|0|||
144377953|NCT00669409|520594561|FG004|Part 2|Withdrawal by Subject|0|||
144377954|NCT00669409|520594562|FG005|Part 2|Withdrawal by Subject|0|||
144377955|NCT00669409|520594563|FG006|Part 2|Withdrawal by Subject|0|||
144377956|NCT00669409|520594564|FG007|Part 2|Withdrawal by Subject|0|||
144377957|NCT00669409|520594565|FG008|Part 2|Withdrawal by Subject|0|||
144377958|NCT00669409|520594566|FG009|Part 2|Withdrawal by Subject|1|||
144377959|NCT00669409|520594567|FG010|Part 2|Withdrawal by Subject|0|||
144377960|NCT00813943|520594568|FG000|Overall Study|Ongoing at cut-off date|5|||
144377961|NCT00813943|520594569|FG001|Overall Study|Ongoing at cut-off date|5|||
144377962|NCT00813943|520594570|FG002|Overall Study|Ongoing at cut-off date|3|||
144377963|NCT05367492|520594571|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
144377964|NCT05367492|520594572|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
144377965|NCT05367492|520594573|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
144377966|NCT05367492|520594571|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
144377967|NCT05367492|520594572|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
144377968|NCT05367492|520594573|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
144377969|NCT05367492|520594571|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
144377970|NCT05367492|520594572|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
144377971|NCT05367492|520594573|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
144377972|NCT05367492|520594571|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
144377973|NCT05367492|520594572|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
144377974|NCT05367492|520594573|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
144377975|NCT01523275|520594576|FG000|Overall Study|Lost to Follow-up|1|||
144377976|NCT01523275|520594577|FG001|Overall Study|Lost to Follow-up|2|||
144377977|NCT01523275|520594576|FG000|Overall Study|Withdrawal by Subject|1|||
144377978|NCT01523275|520594577|FG001|Overall Study|Withdrawal by Subject|0|||
144377979|NCT02471612|520594587|FG000|Overall Study|Lost to Follow-up|2|||
144377980|NCT05573386|520594588|FG000|Overall Study|Withdrawal by Subject|3|||
144377981|NCT05573386|520594589|FG001|Overall Study|Withdrawal by Subject|2|||
144377982|NCT03646123|520594590|FG000|Overall Study|Withdrawal by Subject|2|||
144377983|NCT03646123|520594591|FG001|Overall Study|Withdrawal by Subject|2|||
144377984|NCT03646123|520594592|FG002|Overall Study|Withdrawal by Subject|3|||
144377985|NCT03646123|520594590|FG000|Overall Study|Study termination by sponsor|0|||
144377986|NCT03646123|520594591|FG001|Overall Study|Study termination by sponsor|45|||
144377987|NCT03646123|520594592|FG002|Overall Study|Study termination by sponsor|139|||
144377988|NCT03646123|520594590|FG000|Overall Study|Lost to Follow-up|4|||
144377989|NCT03646123|520594591|FG001|Overall Study|Lost to Follow-up|10|||
144377990|NCT03646123|520594592|FG002|Overall Study|Lost to Follow-up|10|||
144377991|NCT03646123|520594590|FG000|Overall Study|Death|2|||
144377992|NCT03646123|520594591|FG001|Overall Study|Death|1|||
144377993|NCT03646123|520594592|FG002|Overall Study|Death|1|||
144377994|NCT03646123|520594590|FG000|Overall Study|Other|2|||
144377995|NCT03646123|520594591|FG001|Overall Study|Other|0|||
144377996|NCT03646123|520594592|FG002|Overall Study|Other|2|||
144377997|NCT03679754|520594593|FG000|Overall Study|Investigator request|1|||
144377998|NCT00964171|520594594|FG000|Overall Study|Death|5|||
144377999|NCT02872935|520594595|FG000|Overall Study|Other|0|||
144378000|NCT02872935|520594596|FG001|Overall Study|Other|1|||
144378001|NCT05343624|520594597|FG000|Overall Study|Chart review not completed|1|||
144378002|NCT00329797|520594598|FG000|Overall Study|Protocol Violation|1|||
144378003|NCT00329797|520594599|FG001|Overall Study|Protocol Violation|0|||
144378004|NCT00329797|520594598|FG000|Overall Study|Withdrawal by Subject|6|||
144378005|NCT00329797|520594599|FG001|Overall Study|Withdrawal by Subject|6|||
144378006|NCT03037580|520594611|FG000|Overall Study|Withdrawal by Subject|3|||
144378007|NCT03037580|520594612|FG001|Overall Study|Withdrawal by Subject|0|||
144378008|NCT03037580|520594611|FG000|Overall Study|Adverse Event|1|||
144378009|NCT03037580|520594612|FG001|Overall Study|Adverse Event|0|||
144378010|NCT03037580|520594611|FG000|Overall Study|Study Terminated by Sponsor|12|||
144378011|NCT03037580|520594612|FG001|Overall Study|Study Terminated by Sponsor|15|||
144378012|NCT03037580|520594611|FG000|Overall Study|Death|0|||
144378013|NCT03037580|520594612|FG001|Overall Study|Death|1|||
144378014|NCT01761240|520594613|FG000|Overall Study|Progressive disease:radiology assessment|3|||
144378015|NCT01761240|520594614|FG001|Overall Study|Progressive disease:radiology assessment|3|||
144378016|NCT01761240|520594615|FG002|Overall Study|Progressive disease:radiology assessment|0|||
144378017|NCT01761240|520594616|FG003|Overall Study|Progressive disease:radiology assessment|0|||
144513005|NCT03398148|521078206|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
144513006|NCT03398148|521078207|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
144513007|NCT03398148|521078208|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513008|NCT03398148|521078209|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513009|NCT03398148|521078210|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513010|NCT03398148|521078211|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
144513011|NCT03398148|521078197|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
144513012|NCT03398148|521078198|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
144513013|NCT03398148|521078199|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
144378018|NCT01761240|520594617|FG004|Overall Study|Progressive disease:radiology assessment|0|||
144378019|NCT01761240|520594613|FG000|Overall Study|Progressive disease:clinical assessment|0|||
144378020|NCT01761240|520594614|FG001|Overall Study|Progressive disease:clinical assessment|0|||
144378021|NCT01761240|520594615|FG002|Overall Study|Progressive disease:clinical assessment|3|||
144513014|NCT03398148|521078200|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
144378022|NCT01761240|520594616|FG003|Overall Study|Progressive disease:clinical assessment|1|||
144378023|NCT01761240|520594617|FG004|Overall Study|Progressive disease:clinical assessment|0|||
144378024|NCT01761240|520594613|FG000|Overall Study|Withdrawal by Subject|0|||
144378025|NCT01761240|520594614|FG001|Overall Study|Withdrawal by Subject|0|||
144378026|NCT01761240|520594615|FG002|Overall Study|Withdrawal by Subject|0|||
144378027|NCT01761240|520594616|FG003|Overall Study|Withdrawal by Subject|3|||
144378028|NCT01761240|520594617|FG004|Overall Study|Withdrawal by Subject|1|||
144378029|NCT01761240|520594613|FG000|Overall Study|Adverse Event|0|||
144378030|NCT01761240|520594614|FG001|Overall Study|Adverse Event|0|||
144378031|NCT01761240|520594615|FG002|Overall Study|Adverse Event|0|||
144378032|NCT01761240|520594616|FG003|Overall Study|Adverse Event|1|||
144378033|NCT01761240|520594617|FG004|Overall Study|Adverse Event|6|||
144378034|NCT01761240|520594613|FG000|Overall Study|Death|0|||
144378035|NCT01761240|520594614|FG001|Overall Study|Death|1|||
144378036|NCT01761240|520594615|FG002|Overall Study|Death|1|||
144378037|NCT01761240|520594616|FG003|Overall Study|Death|2|||
144378038|NCT01761240|520594617|FG004|Overall Study|Death|1|||
144378039|NCT01761240|520594613|FG000|Overall Study|Non-compliance|0|||
144378040|NCT01761240|520594614|FG001|Overall Study|Non-compliance|0|||
144378041|NCT01761240|520594615|FG002|Overall Study|Non-compliance|1|||
144378042|NCT01761240|520594616|FG003|Overall Study|Non-compliance|0|||
144378043|NCT01761240|520594617|FG004|Overall Study|Non-compliance|0|||
144378044|NCT02873429|520594618|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
144378045|NCT02873429|520594619|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
144378046|NCT02873429|520594618|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
144378047|NCT02873429|520594619|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
144378048|NCT02873429|520594618|FG000|16 Weeks|Lost to Follow-up|3|||
144378049|NCT02873429|520594619|FG001|16 Weeks|Lost to Follow-up|0|||
144378050|NCT00853567|520594621|FG000|Overall Study|Study prematurely terminated|71|||
144378051|NCT00782834|520594627|FG000|Treatment Phase|fibrous tumor not GIST|1|||
144378052|NCT02055118|520594628|FG000|Overall Study|Withdrawal by Subject|0|||
144378053|NCT02055118|520594629|FG001|Overall Study|Withdrawal by Subject|2|||
144378054|NCT02055118|520594630|FG002|Overall Study|Withdrawal by Subject|0|||
144378055|NCT02281383|520594632|FG000|Overall Study|Progressive Disease|1|||
144378056|NCT02281383|520594632|FG000|Overall Study|Withdrawal by Subject|6|||
144378057|NCT02281383|520594632|FG000|Overall Study|Protocol Violation|2|||
144378058|NCT02281383|520594632|FG000|Overall Study|Death|1|||
144378059|NCT02281383|520594632|FG000|Overall Study|Adverse Event|2|||
144378060|NCT01215097|520594634|FG000|Overall Study|Adverse Event|1|||
144513015|NCT03398148|521078201|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
144513016|NCT03398148|521078202|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
144513017|NCT03398148|521078203|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
144513018|NCT03398148|521078204|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
144513019|NCT03398148|521078205|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
144513020|NCT03398148|521078206|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
144513021|NCT03398148|521078207|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
144513022|NCT03398148|521078208|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
144513023|NCT03398148|521078209|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
144513024|NCT03398148|521078210|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
144513025|NCT03398148|521078211|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
144513026|NCT03398148|521078197|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513027|NCT03398148|521078198|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513028|NCT03398148|521078199|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513029|NCT03398148|521078200|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513030|NCT03398148|521078201|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513031|NCT03398148|521078202|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513032|NCT03398148|521078203|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513033|NCT03398148|521078204|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513034|NCT03398148|521078205|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513035|NCT03398148|521078206|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144378061|NCT01215097|520594635|FG001|Overall Study|Adverse Event|3|||
144378062|NCT01215097|520594634|FG000|Overall Study|Protocol Violation|0|||
144513036|NCT03398148|521078207|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
144513037|NCT03398148|521078208|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513038|NCT03398148|521078209|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513039|NCT03398148|521078210|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513040|NCT03398148|521078211|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
144513041|NCT03398148|521078197|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513042|NCT03398148|521078198|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144378063|NCT01215097|520594635|FG001|Overall Study|Protocol Violation|2|||
144378064|NCT01215097|520594634|FG000|Overall Study|Lost to Follow-up|2|||
144378065|NCT01215097|520594635|FG001|Overall Study|Lost to Follow-up|0|||
144378066|NCT01215097|520594634|FG000|Overall Study|Withdrawal by Subject|6|||
144378067|NCT01215097|520594635|FG001|Overall Study|Withdrawal by Subject|3|||
144378068|NCT01215097|520594634|FG000|Overall Study|Lack of Efficacy|0|||
144378069|NCT01215097|520594635|FG001|Overall Study|Lack of Efficacy|3|||
144378070|NCT01215097|520594634|FG000|Overall Study|patient's refusal to come|2|||
144378071|NCT01215097|520594635|FG001|Overall Study|patient's refusal to come|2|||
144378072|NCT01215097|520594634|FG000|Overall Study|patient's private reason|1|||
144378073|NCT01215097|520594635|FG001|Overall Study|patient's private reason|1|||
144378074|NCT02259088|520594636|FG000|Overall Study|Adverse Event|6|||
144378075|NCT02259088|520594637|FG001|Overall Study|Adverse Event|4|||
144378076|NCT02259088|520594636|FG000|Overall Study|Lost to Follow-up|2|||
144378077|NCT02259088|520594637|FG001|Overall Study|Lost to Follow-up|0|||
144378078|NCT02259088|520594636|FG000|Overall Study|Death|2|||
144378079|NCT02259088|520594637|FG001|Overall Study|Death|0|||
144378080|NCT02259088|520594636|FG000|Overall Study|Physician Decision|5|||
144378081|NCT02259088|520594637|FG001|Overall Study|Physician Decision|2|||
144378082|NCT02259088|520594636|FG000|Overall Study|Protocol deviation|5|||
144378083|NCT02259088|520594637|FG001|Overall Study|Protocol deviation|0|||
144378084|NCT02259088|520594636|FG000|Overall Study|Subject/guardian decision|8|||
144378085|NCT02259088|520594637|FG001|Overall Study|Subject/guardian decision|8|||
144378086|NCT02252939|520594638|FG000|Overall Study|Lost to Follow-up|3|||
144378087|NCT01516034|520594640|FG000|Overall Study|Physician Decision|1|||
144378088|NCT01516034|520594640|FG000|Overall Study|Lack of Efficacy|7|||
144378089|NCT01818752|520594641|FG000|Overall Study|Adverse Event|64|||
144378090|NCT01818752|520594642|FG001|Overall Study|Adverse Event|74|||
144378091|NCT01818752|520594641|FG000|Overall Study|Death|14|||
144378092|NCT01818752|520594642|FG001|Overall Study|Death|18|||
144378093|NCT01818752|520594641|FG000|Overall Study|Non-compliance|16|||
144378094|NCT01818752|520594642|FG001|Overall Study|Non-compliance|20|||
144378095|NCT01818752|520594641|FG000|Overall Study|Withdrawal by Subject|15|||
144378096|NCT01818752|520594642|FG001|Overall Study|Withdrawal by Subject|14|||
144378097|NCT01818752|520594641|FG000|Overall Study|Physician Decision|9|||
144378098|NCT01818752|520594642|FG001|Overall Study|Physician Decision|8|||
144378099|NCT01818752|520594641|FG000|Overall Study|Disease Progression|54|||
144378100|NCT01818752|520594642|FG001|Overall Study|Disease Progression|48|||
144378101|NCT01818752|520594641|FG000|Overall Study|Other|7|||
144378102|NCT01818752|520594642|FG001|Overall Study|Other|8|||
144378103|NCT01818752|520594641|FG000|Overall Study|Continuing Treatment|1|||
144378104|NCT01818752|520594642|FG001|Overall Study|Continuing Treatment|4|||
144378105|NCT01818752|520594641|FG000|Overall Study|Randomized but not Dosed|7|||
144378106|NCT01818752|520594642|FG001|Overall Study|Randomized but not Dosed|4|||
144378107|NCT01033448|520594643|FG000|Overall Study|Withdrawal by Subject|4|||
144378108|NCT01033448|520594643|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
144378109|NCT01033448|520594643|FG000|Overall Study|Lost to Follow-up|3|||
144378110|NCT01033448|520594643|FG000|Overall Study|Withdrew due to other reasons|3|||
144378111|NCT01033448|520594643|FG000|Overall Study|Unknown disposition|1|||
144378112|NCT04270370|520594644|FG000|Overall Study|Lost to Follow-up|1|||
144378113|NCT04270370|520594645|FG001|Overall Study|Lost to Follow-up|0|||
144378114|NCT04270370|520594646|FG002|Overall Study|Lost to Follow-up|0|||
144378115|NCT04270370|520594647|FG003|Overall Study|Lost to Follow-up|0|||
144378116|NCT04270370|520594648|FG004|Overall Study|Lost to Follow-up|0|||
144378117|NCT04270370|520594649|FG005|Overall Study|Lost to Follow-up|0|||
144378118|NCT04270370|520594650|FG006|Overall Study|Lost to Follow-up|0|||
144378119|NCT04270370|520594651|FG007|Overall Study|Lost to Follow-up|0|||
144378120|NCT04270370|520594652|FG008|Overall Study|Lost to Follow-up|1|||
144378121|NCT04270370|520594653|FG009|Overall Study|Lost to Follow-up|0|||
144378122|NCT04270370|520594654|FG010|Overall Study|Lost to Follow-up|0|||
144378123|NCT04270370|520594655|FG011|Overall Study|Lost to Follow-up|0|||
144378124|NCT01324141|520594656|FG000|Overall Study|Declined to participate before treatment started|1|||
144378125|NCT01324141|520594656|FG000|Overall Study|Disease progression on study|1|||
144513043|NCT03398148|521078199|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513044|NCT03398148|521078200|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513045|NCT03398148|521078201|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144378126|NCT02745080|520594657|FG000|Overall Study|Adverse Event|13|||
144378127|NCT02745080|520594658|FG001|Overall Study|Adverse Event|21|||
144378128|NCT02745080|520594657|FG000|Overall Study|Lack of Efficacy|11|||
144378129|NCT02745080|520594658|FG001|Overall Study|Lack of Efficacy|23|||
144378130|NCT02745080|520594657|FG000|Overall Study|Lost to Follow-up|3|||
144378131|NCT02745080|520594658|FG001|Overall Study|Lost to Follow-up|3|||
144378132|NCT02745080|520594657|FG000|Overall Study|Physician Decision|3|||
144378133|NCT02745080|520594658|FG001|Overall Study|Physician Decision|0|||
144378134|NCT02745080|520594657|FG000|Overall Study|Protocol Violation|3|||
144378135|NCT02745080|520594658|FG001|Overall Study|Protocol Violation|1|||
144378136|NCT02745080|520594657|FG000|Overall Study|Withdrawal by Subject|22|||
144378137|NCT02745080|520594658|FG001|Overall Study|Withdrawal by Subject|41|||
144378138|NCT01001325|520594660|FG000|Overall Study|Lost to Follow-up|16|||
144378139|NCT01001325|520594661|FG001|Overall Study|Lost to Follow-up|10|||
144378140|NCT01001325|520594660|FG000|Overall Study|Protocol Violation|2|||
144378141|NCT01001325|520594661|FG001|Overall Study|Protocol Violation|0|||
144378142|NCT00899431|520594664|FG000|Overall Study|Physician Decision|1|||
144378143|NCT00899431|520594665|FG001|Overall Study|Physician Decision|0|||
144378144|NCT00899431|520594666|FG002|Overall Study|Physician Decision|0|||
144378145|NCT00661427|520594667|FG000|Overall Study|Adverse Event|5|||
144378146|NCT00661427|520594668|FG001|Overall Study|Adverse Event|5|||
144378147|NCT00661427|520594667|FG000|Overall Study|Patient not treated|0|||
144378148|NCT00661427|520594668|FG001|Overall Study|Patient not treated|2|||
144378149|NCT01821560|520594669|FG000|Overall Study|Lost to Follow-up|5|||
144378150|NCT01821560|520594670|FG001|Overall Study|Lost to Follow-up|5|||
144378151|NCT01821560|520594669|FG000|Overall Study|Withdrawal by Subject|1|||
144378152|NCT01821560|520594670|FG001|Overall Study|Withdrawal by Subject|1|||
144378153|NCT01821560|520594669|FG000|Overall Study|Protocol Violation|0|||
144378154|NCT01821560|520594670|FG001|Overall Study|Protocol Violation|1|||
144378155|NCT00531427|520594671|FG000|Overall Study|Withdrawal by Subject|7|||
144378156|NCT00531427|520594672|FG001|Overall Study|Withdrawal by Subject|13|||
144378157|NCT00531427|520594671|FG000|Overall Study|Adverse Event|44|||
144378158|NCT00531427|520594672|FG001|Overall Study|Adverse Event|30|||
144378159|NCT00531427|520594671|FG000|Overall Study|Lost to Follow-up|4|||
144378160|NCT00531427|520594672|FG001|Overall Study|Lost to Follow-up|3|||
144378161|NCT00531427|520594671|FG000|Overall Study|Lack of Efficacy|14|||
144378162|NCT00531427|520594672|FG001|Overall Study|Lack of Efficacy|39|||
144378163|NCT00531427|520594671|FG000|Overall Study|Administrative|4|||
144378164|NCT00531427|520594672|FG001|Overall Study|Administrative|9|||
144378165|NCT01338298|520594673|FG000|Overall Study|Withdrawal by Subject|1|||
144378166|NCT01338298|520594674|FG001|Overall Study|Withdrawal by Subject|1|||
144378167|NCT01338298|520594673|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
144378168|NCT01338298|520594674|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
144378169|NCT01338298|520594673|FG000|Overall Study|Administrative error|0|||
144378170|NCT01338298|520594674|FG001|Overall Study|Administrative error|1|||
144378171|NCT01338298|520594673|FG000|Overall Study|Positive symptom worsening|1|||
144378172|NCT01338298|520594674|FG001|Overall Study|Positive symptom worsening|0|||
144378173|NCT01338298|520594673|FG000|Overall Study|Depressive symptoms and nausea|1|||
144378174|NCT01338298|520594674|FG001|Overall Study|Depressive symptoms and nausea|0|||
144378175|NCT01338298|520594673|FG000|Overall Study|Non-adherence|1|||
144378176|NCT01338298|520594674|FG001|Overall Study|Non-adherence|0|||
144378177|NCT02872285|520594675|FG000|Overall Study|Withdrawal by Subject|2|||
144378178|NCT02872285|520594676|FG001|Overall Study|Withdrawal by Subject|0|||
144378179|NCT02872285|520594675|FG000|Overall Study|Lost to Follow-up|2|||
144378180|NCT02872285|520594676|FG001|Overall Study|Lost to Follow-up|2|||
144378181|NCT02872285|520594675|FG000|Overall Study|Discontinued due to back surgery|1|||
144378182|NCT02872285|520594676|FG001|Overall Study|Discontinued due to back surgery|0|||
144378183|NCT02660983|520594678|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
144378184|NCT02660983|520594679|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
144378185|NCT02660983|520594678|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
144378186|NCT02660983|520594679|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
144378187|NCT02660983|520594678|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
144378188|NCT02660983|520594679|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
144378189|NCT02660983|520594678|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
144378190|NCT02660983|520594679|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
144378191|NCT02660983|520594678|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
144378192|NCT02660983|520594679|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
144378193|NCT02660983|520594678|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
144378194|NCT02660983|520594679|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
144378195|NCT02660983|520594678|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
144378196|NCT02660983|520594679|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
144378197|NCT00721968|520594682|FG000|Overall Study|Lost to Follow-up|2|||
144378198|NCT00721968|520594683|FG001|Overall Study|Lost to Follow-up|0|||
144378199|NCT05601544|520594684|FG000|Phase 2 Period 1|Adverse Event|0|||
144378200|NCT05601544|520594685|FG001|Phase 2 Period 1|Adverse Event|1|||
144378201|NCT05601544|520594686|FG002|Phase 2 Period 1|Adverse Event|0|||
144378202|NCT05601544|520594687|FG003|Phase 2 Period 1|Adverse Event|0|||
144378203|NCT05601544|520594688|FG004|Phase 2 Period 1|Adverse Event|0|||
144378204|NCT05601544|520594689|FG005|Phase 2 Period 1|Adverse Event|0|||
144378205|NCT01794338|520596863|FG000|Overall Study|Death|2|||
144378206|NCT01794338|520596864|FG001|Overall Study|Death|0|||
144378207|NCT01794338|520596863|FG000|Overall Study|Lost to Follow-up|6|||
144378208|NCT01794338|520596864|FG001|Overall Study|Lost to Follow-up|9|||
144378209|NCT01754402|520596865|FG000|Overall Study|Death|0|||
144378210|NCT01754402|520596866|FG001|Overall Study|Death|0|||
144378211|NCT01754402|520596867|FG002|Overall Study|Death|1|||
144378212|NCT01754402|520596865|FG000|Overall Study|Adverse Event|2|||
144378213|NCT01754402|520596866|FG001|Overall Study|Adverse Event|2|||
144378214|NCT01754402|520596867|FG002|Overall Study|Adverse Event|1|||
144378215|NCT01754402|520596865|FG000|Overall Study|Withdrawal by Subject|0|||
144378216|NCT01754402|520596866|FG001|Overall Study|Withdrawal by Subject|0|||
144378217|NCT01754402|520596867|FG002|Overall Study|Withdrawal by Subject|1|||
144378218|NCT01754402|520596865|FG000|Overall Study|Lack of Efficacy|0|||
144378219|NCT01754402|520596866|FG001|Overall Study|Lack of Efficacy|0|||
144378220|NCT01754402|520596867|FG002|Overall Study|Lack of Efficacy|1|||
144378221|NCT01282463|520596868|FG000|Overall Study|Lost to Follow-up|1|||
144378222|NCT01282463|520596869|FG001|Overall Study|Lost to Follow-up|0|||
144378223|NCT01282463|520596870|FG002|Overall Study|Lost to Follow-up|0|||
144378224|NCT01282463|520596868|FG000|Overall Study|Withdrawal by Subject|6|||
144378225|NCT01282463|520596869|FG001|Overall Study|Withdrawal by Subject|2|||
144378226|NCT01282463|520596870|FG002|Overall Study|Withdrawal by Subject|3|||
144378227|NCT01282463|520596868|FG000|Overall Study|"Never Treated Death"|0|||
144378228|NCT01282463|520596869|FG001|Overall Study|"Never Treated Death"|1|||
144378229|NCT01282463|520596870|FG002|Overall Study|"Never Treated Death"|0|||
144378230|NCT01282463|520596868|FG000|Overall Study|"Never Treated PD"|0|||
144378231|NCT01282463|520596869|FG001|Overall Study|"Never Treated PD"|1|||
144378232|NCT01282463|520596870|FG002|Overall Study|"Never Treated PD"|0|||
144378233|NCT01282463|520596868|FG000|Overall Study|Protocol Violation|0|||
144378234|NCT01282463|520596869|FG001|Overall Study|Protocol Violation|0|||
144378235|NCT01282463|520596870|FG002|Overall Study|Protocol Violation|1|||
144378236|NCT01282463|520596868|FG000|Overall Study|Physician Decision|1|||
144378237|NCT01282463|520596869|FG001|Overall Study|Physician Decision|0|||
144378238|NCT01282463|520596870|FG002|Overall Study|Physician Decision|0|||
144378239|NCT01954927|520596871|FG000|Overall Study|Withdrawal by Subject|3|||
144378240|NCT01954927|520596872|FG001|Overall Study|Withdrawal by Subject|1|||
144378241|NCT03320824|520596873|FG000|Overall Study|Withdrawal by Subject|8|||
144378242|NCT03320824|520596874|FG001|Overall Study|Withdrawal by Subject|1|||
144378243|NCT03320824|520596873|FG000|Overall Study|Lost to Follow-up|10|||
144378244|NCT03320824|520596874|FG001|Overall Study|Lost to Follow-up|1|||
144378245|NCT03320824|520596873|FG000|Overall Study|moved out of state|0|||
144378246|NCT03320824|520596874|FG001|Overall Study|moved out of state|1|||
144378247|NCT03320824|520596873|FG000|Overall Study|could not complete final visit|0|||
144378248|NCT03320824|520596874|FG001|Overall Study|could not complete final visit|1|||
144378249|NCT00109590|520596875|FG000|Overall Study|Lost to Follow-up|1|||
144378250|NCT00109590|520596876|FG001|Overall Study|Lost to Follow-up|0|||
144378251|NCT00109590|520596877|FG002|Overall Study|Lost to Follow-up|1|||
144378252|NCT00109590|520596875|FG000|Overall Study|Never Started Treatment|1|||
144378253|NCT00109590|520596876|FG001|Overall Study|Never Started Treatment|2|||
144378254|NCT00109590|520596877|FG002|Overall Study|Never Started Treatment|3|||
144378255|NCT01221285|520596878|FG000|Overall Study|Withdrawal by Subject|1|||
144378256|NCT02123251|520596879|FG000|Overall Study|Death|1|||
144378257|NCT02123251|520596880|FG001|Overall Study|Death|1|||
144378258|NCT02123251|520596879|FG000|Overall Study|Withdrawal by Subject|0|||
144378259|NCT02123251|520596880|FG001|Overall Study|Withdrawal by Subject|3|||
144378260|NCT02123251|520596879|FG000|Overall Study|Lost Medicaid eligibility|29|||
144378261|NCT02123251|520596880|FG001|Overall Study|Lost Medicaid eligibility|22|||
144378262|NCT02123251|520596879|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
144378263|NCT02123251|520596880|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
144378264|NCT00727441|520596883|FG000|Overall Study|Disease Progression|11|||
144378265|NCT00727441|520596884|FG001|Overall Study|Disease Progression|14|||
144378266|NCT00727441|520596885|FG002|Overall Study|Disease Progression|17|||
144378267|NCT00727441|520596883|FG000|Overall Study|Eligibility|7|||
144378268|NCT00727441|520596884|FG001|Overall Study|Eligibility|5|||
144378269|NCT00727441|520596885|FG002|Overall Study|Eligibility|7|||
144378270|NCT00727441|520596883|FG000|Overall Study|Death|0|||
144378271|NCT00727441|520596884|FG001|Overall Study|Death|1|||
144378272|NCT00727441|520596885|FG002|Overall Study|Death|1|||
144378273|NCT00727441|520596883|FG000|Overall Study|Physician Decision|0|||
144378274|NCT00727441|520596884|FG001|Overall Study|Physician Decision|1|||
144378275|NCT00727441|520596885|FG002|Overall Study|Physician Decision|0|||
144378276|NCT00727441|520596883|FG000|Overall Study|Withdrawal by Subject|0|||
144378277|NCT00727441|520596884|FG001|Overall Study|Withdrawal by Subject|1|||
144378278|NCT00727441|520596885|FG002|Overall Study|Withdrawal by Subject|0|||
144378279|NCT01239992|520596886|FG000|Overall Study|Withdrawal by Subject|2|||
144378280|NCT00535288|520596887|FG000|Overall Study|Adverse Event|20|||
144378281|NCT00535288|520596888|FG001|Overall Study|Adverse Event|19|||
144378282|NCT00535288|520596889|FG002|Overall Study|Adverse Event|25|||
144378283|NCT00535288|520596890|FG003|Overall Study|Adverse Event|20|||
144378284|NCT00535288|520596891|FG004|Overall Study|Adverse Event|30|||
144378285|NCT00535288|520596887|FG000|Overall Study|Lost to Follow-up|0|||
144378286|NCT00535288|520596888|FG001|Overall Study|Lost to Follow-up|3|||
144378287|NCT00535288|520596889|FG002|Overall Study|Lost to Follow-up|0|||
144378288|NCT00535288|520596890|FG003|Overall Study|Lost to Follow-up|0|||
144378289|NCT00535288|520596891|FG004|Overall Study|Lost to Follow-up|0|||
144378290|NCT00535288|520596887|FG000|Overall Study|Lack of Efficacy|26|||
144378291|NCT00535288|520596888|FG001|Overall Study|Lack of Efficacy|3|||
144378292|NCT00535288|520596889|FG002|Overall Study|Lack of Efficacy|4|||
144378293|NCT00535288|520596890|FG003|Overall Study|Lack of Efficacy|4|||
144378294|NCT00535288|520596891|FG004|Overall Study|Lack of Efficacy|7|||
144378295|NCT00535288|520596887|FG000|Overall Study|Unwilling to cooperate|6|||
144378296|NCT00535288|520596888|FG001|Overall Study|Unwilling to cooperate|6|||
144378297|NCT00535288|520596889|FG002|Overall Study|Unwilling to cooperate|3|||
144378298|NCT00535288|520596890|FG003|Overall Study|Unwilling to cooperate|3|||
144378299|NCT00535288|520596891|FG004|Overall Study|Unwilling to cooperate|4|||
144378300|NCT00535288|520596887|FG000|Overall Study|Other|2|||
144378301|NCT00535288|520596888|FG001|Overall Study|Other|1|||
144378302|NCT00535288|520596889|FG002|Overall Study|Other|1|||
144378303|NCT00535288|520596890|FG003|Overall Study|Other|2|||
144378304|NCT00535288|520596891|FG004|Overall Study|Other|1|||
144378305|NCT00745849|520596892|FG000|First Intervention|Withdrawal by Subject|0|||
144378306|NCT00745849|520596893|FG001|First Intervention|Withdrawal by Subject|1|||
144378307|NCT00745849|520596892|FG000|First Intervention|Lost to Follow-up|1|||
144378308|NCT00745849|520596893|FG001|First Intervention|Lost to Follow-up|1|||
144378309|NCT00745849|520596892|FG000|Second Intervention|Lost to Follow-up|2|||
144378310|NCT00745849|520596893|FG001|Second Intervention|Lost to Follow-up|1|||
144378311|NCT01129583|520596894|FG000|Overall Study|Death|1|||
144378312|NCT01129583|520596895|FG001|Overall Study|Death|0|||
144378313|NCT01129583|520596894|FG000|Overall Study|Lost to Follow-up|1|||
144378314|NCT01129583|520596895|FG001|Overall Study|Lost to Follow-up|1|||
144378315|NCT01129583|520596894|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
144378316|NCT01129583|520596895|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
144378317|NCT02848729|520596903|FG000|Overall Study|Withdrawal by Subject|1|||
144378318|NCT02848729|520596904|FG001|Overall Study|Withdrawal by Subject|0|||
144378319|NCT02848729|520596903|FG000|Overall Study|Emesis|15|||
144378320|NCT02848729|520596904|FG001|Overall Study|Emesis|11|||
144378321|NCT02617485|520596911|FG000|Treatment and Observation Period|Adverse Event|9|||
144378322|NCT02617485|520596912|FG001|Treatment and Observation Period|Adverse Event|1|||
144378323|NCT02617485|520596911|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
144378324|NCT02617485|520596912|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
144378325|NCT02617485|520596911|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
144378326|NCT02617485|520596912|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
144378327|NCT02617485|520596911|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
144378328|NCT02617485|520596912|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
144378329|NCT02617485|520596911|FG000|Treatment and Observation Period|Physician Decision|0|||
144378330|NCT02617485|520596912|FG001|Treatment and Observation Period|Physician Decision|1|||
144378331|NCT02617485|520596911|FG000|Follow-up Period|Adverse Event|1|||
144378332|NCT02617485|520596912|FG001|Follow-up Period|Adverse Event|0|||
144378333|NCT02617485|520596911|FG000|Follow-up Period|Withdrawal by Subject|1|||
144378334|NCT02617485|520596912|FG001|Follow-up Period|Withdrawal by Subject|0|||
144378335|NCT02617485|520596911|FG000|Follow-up Period|Disease progression|2|||
144378336|NCT02617485|520596912|FG001|Follow-up Period|Disease progression|1|||
144378337|NCT02617485|520596911|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
144378338|NCT02617485|520596912|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
144378339|NCT02617485|520596911|FG000|Follow-up Period|Patient needed radiotherapy|9|||
144378340|NCT02617485|520596912|FG001|Follow-up Period|Patient needed radiotherapy|5|||
144378341|NCT02617485|520596911|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
144378342|NCT02617485|520596912|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
144513046|NCT03398148|521078202|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513047|NCT03398148|521078203|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513048|NCT03398148|521078204|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513049|NCT03398148|521078205|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513050|NCT03398148|521078206|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513051|NCT03398148|521078207|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
144513052|NCT03398148|521078208|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513053|NCT03398148|521078209|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513054|NCT03398148|521078210|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144378343|NCT00220779|520596913|FG000|Overall Study|Adverse Event|1|||
144378344|NCT00220779|520596914|FG001|Overall Study|Adverse Event|0|||
144513055|NCT03398148|521078211|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
144513056|NCT03398148|521078197|FG000|Substudy 2 Period 1|Other|0|||
144513057|NCT03398148|521078198|FG001|Substudy 2 Period 1|Other|0|||
144513058|NCT03398148|521078199|FG002|Substudy 2 Period 1|Other|0|||
144513059|NCT03398148|521078200|FG003|Substudy 2 Period 1|Other|0|||
144513060|NCT03398148|521078201|FG004|Substudy 2 Period 1|Other|0|||
144378345|NCT00220779|520596915|FG002|Overall Study|Adverse Event|0|||
144513061|NCT03398148|521078202|FG005|Substudy 2 Period 1|Other|0|||
144513062|NCT03398148|521078203|FG006|Substudy 2 Period 1|Other|0|||
144378346|NCT00220779|520596913|FG000|Overall Study|Withdrawal by Subject|1|||
144378347|NCT00220779|520596914|FG001|Overall Study|Withdrawal by Subject|4|||
144378348|NCT00220779|520596915|FG002|Overall Study|Withdrawal by Subject|1|||
144378349|NCT00220779|520596913|FG000|Overall Study|Non-compliance|1|||
144378350|NCT00220779|520596914|FG001|Overall Study|Non-compliance|0|||
144378351|NCT00220779|520596915|FG002|Overall Study|Non-compliance|0|||
144378352|NCT00220779|520596913|FG000|Overall Study|Too time consuming|1|||
144378353|NCT00220779|520596914|FG001|Overall Study|Too time consuming|0|||
144378354|NCT00220779|520596915|FG002|Overall Study|Too time consuming|0|||
144378355|NCT00220779|520596913|FG000|Overall Study|Pregnancy|0|||
144378356|NCT00220779|520596914|FG001|Overall Study|Pregnancy|0|||
144378357|NCT00220779|520596915|FG002|Overall Study|Pregnancy|2|||
144378358|NCT00220779|520596913|FG000|Overall Study|Lack of Efficacy|3|||
144378359|NCT00220779|520596914|FG001|Overall Study|Lack of Efficacy|0|||
144378360|NCT00220779|520596915|FG002|Overall Study|Lack of Efficacy|1|||
144378361|NCT00791076|520596916|FG000|Overall Study|Study was terminated,PI left institution|8|||
144378362|NCT02248675|520596923|FG000|Overall Study|Lost to Follow-up|3|||
144378363|NCT02248675|520596924|FG001|Overall Study|Lost to Follow-up|1|||
144378364|NCT03390101|520596927|FG000|Weeks 0-12|Withdrawal by Subject|0|||
144378365|NCT03390101|520596928|FG001|Weeks 0-12|Withdrawal by Subject|1|||
144378366|NCT03390101|520596929|FG002|Weeks 0-12|Withdrawal by Subject|1|||
144378367|NCT03390101|520596927|FG000|Weeks 0-12|Lost to Follow-up|0|||
144378368|NCT03390101|520596928|FG001|Weeks 0-12|Lost to Follow-up|1|||
144378369|NCT03390101|520596929|FG002|Weeks 0-12|Lost to Follow-up|0|||
144378370|NCT03390101|520596927|FG000|Weeks 12-54|Withdrawal by Subject|0|||
144378371|NCT03390101|520596928|FG001|Weeks 12-54|Withdrawal by Subject|3|||
144378372|NCT03390101|520596929|FG002|Weeks 12-54|Withdrawal by Subject|1|||
144378373|NCT03390101|520596927|FG000|Weeks 12-54|Pregnancy|1|||
144378374|NCT03390101|520596928|FG001|Weeks 12-54|Pregnancy|0|||
144378375|NCT03390101|520596929|FG002|Weeks 12-54|Pregnancy|0|||
144378376|NCT03390101|520596927|FG000|Weeks 12-54|Adverse Event|2|||
144378377|NCT03390101|520596928|FG001|Weeks 12-54|Adverse Event|1|||
144378378|NCT03390101|520596929|FG002|Weeks 12-54|Adverse Event|1|||
144378379|NCT01511055|520596930|FG000|Overall Study|Withdrawal by Subject|6|||
144378380|NCT00830869|520596931|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
144378381|NCT00830869|520596932|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
144513063|NCT03398148|521078204|FG007|Substudy 2 Period 1|Other|0|||
144378382|NCT00830869|520596933|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
144513064|NCT03398148|521078205|FG008|Substudy 2 Period 1|Other|0|||
144513065|NCT03398148|521078206|FG009|Substudy 2 Period 1|Other|4|||
144513066|NCT03398148|521078207|FG010|Substudy 2 Period 1|Other|4|||
144378383|NCT00830869|520596934|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
144378384|NCT00830869|520596935|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
144378385|NCT00830869|520596936|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
144513067|NCT03398148|521078208|FG011|Substudy 2 Period 1|Other|0|||
144513068|NCT03398148|521078209|FG012|Substudy 2 Period 1|Other|0|||
144513069|NCT03398148|521078210|FG013|Substudy 2 Period 1|Other|0|||
144378386|NCT00830869|520596937|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
144378387|NCT00830869|520596938|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
144378388|NCT00830869|520596939|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
144378389|NCT00830869|520596940|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
144513070|NCT03398148|521078211|FG014|Substudy 2 Period 1|Other|0|||
144378390|NCT00830869|520596941|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
144378391|NCT00830869|520596942|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
144378392|NCT00830869|520596931|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
144378393|NCT00830869|520596932|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
144378394|NCT00830869|520596933|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
144378395|NCT00830869|520596934|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
144378396|NCT00830869|520596935|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
144378397|NCT00830869|520596936|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
144378398|NCT00830869|520596937|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
144378399|NCT00830869|520596938|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
144378400|NCT00830869|520596939|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
144378401|NCT00830869|520596940|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
144378402|NCT00830869|520596941|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
144378403|NCT00830869|520596942|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
144378404|NCT00830869|520596931|FG000|Period 1: Part 1|Adverse Event|0|||
144378405|NCT00830869|520596932|FG001|Period 1: Part 1|Adverse Event|0|||
144378406|NCT00830869|520596933|FG002|Period 1: Part 1|Adverse Event|0|||
144378407|NCT00830869|520596934|FG003|Period 1: Part 1|Adverse Event|0|||
144378408|NCT00830869|520596935|FG004|Period 1: Part 1|Adverse Event|0|||
144378409|NCT00830869|520596936|FG005|Period 1: Part 1|Adverse Event|1|||
144378410|NCT00830869|520596937|FG006|Period 1: Part 1|Adverse Event|1|||
144378411|NCT00830869|520596938|FG007|Period 1: Part 1|Adverse Event|0|||
144378412|NCT00830869|520596939|FG008|Period 1: Part 1|Adverse Event|0|||
144378413|NCT00830869|520596940|FG009|Period 1: Part 1|Adverse Event|0|||
144378414|NCT00830869|520596941|FG010|Period 1: Part 1|Adverse Event|0|||
144378415|NCT00830869|520596942|FG011|Period 1: Part 1|Adverse Event|0|||
144378416|NCT00830869|520596931|FG000|Period 1: Part 1|Progressive disease|1|||
144378417|NCT00830869|520596932|FG001|Period 1: Part 1|Progressive disease|0|||
144378418|NCT00830869|520596933|FG002|Period 1: Part 1|Progressive disease|1|||
144378419|NCT00830869|520596934|FG003|Period 1: Part 1|Progressive disease|6|||
144378420|NCT00830869|520596935|FG004|Period 1: Part 1|Progressive disease|4|||
144378421|NCT00830869|520596936|FG005|Period 1: Part 1|Progressive disease|4|||
144378422|NCT00830869|520596937|FG006|Period 1: Part 1|Progressive disease|1|||
144378423|NCT00830869|520596938|FG007|Period 1: Part 1|Progressive disease|0|||
144378424|NCT00830869|520596939|FG008|Period 1: Part 1|Progressive disease|0|||
144378425|NCT00830869|520596940|FG009|Period 1: Part 1|Progressive disease|0|||
144378426|NCT00830869|520596941|FG010|Period 1: Part 1|Progressive disease|0|||
144378427|NCT00830869|520596942|FG011|Period 1: Part 1|Progressive disease|0|||
144378428|NCT00830869|520596931|FG000|Period 2: Part 2|Protocol Violation|0|||
144378429|NCT00830869|520596932|FG001|Period 2: Part 2|Protocol Violation|0|||
144378430|NCT00830869|520596933|FG002|Period 2: Part 2|Protocol Violation|0|||
144378431|NCT00830869|520596934|FG003|Period 2: Part 2|Protocol Violation|0|||
144378432|NCT00830869|520596935|FG004|Period 2: Part 2|Protocol Violation|0|||
144378433|NCT00830869|520596936|FG005|Period 2: Part 2|Protocol Violation|0|||
144378434|NCT00830869|520596937|FG006|Period 2: Part 2|Protocol Violation|0|||
144378435|NCT00830869|520596938|FG007|Period 2: Part 2|Protocol Violation|1|||
144378436|NCT00830869|520596939|FG008|Period 2: Part 2|Protocol Violation|0|||
144378437|NCT00830869|520596940|FG009|Period 2: Part 2|Protocol Violation|1|||
144378438|NCT00830869|520596941|FG010|Period 2: Part 2|Protocol Violation|0|||
144378439|NCT00830869|520596942|FG011|Period 2: Part 2|Protocol Violation|0|||
144378440|NCT00830869|520596931|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
144378441|NCT00830869|520596932|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
144378442|NCT00830869|520596933|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
144378443|NCT00830869|520596934|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
144378444|NCT00830869|520596935|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
144378445|NCT00830869|520596936|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
144378446|NCT00830869|520596937|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
144378447|NCT00830869|520596938|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
144513071|NCT03398148|521078197|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513072|NCT03398148|521078198|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513073|NCT03398148|521078199|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513074|NCT03398148|521078200|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513075|NCT03398148|521078201|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513076|NCT03398148|521078202|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
144378448|NCT00830869|520596939|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
144513077|NCT03398148|521078203|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513078|NCT03398148|521078204|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513079|NCT03398148|521078205|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
144378449|NCT00830869|520596940|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
144378450|NCT00830869|520596941|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
144378451|NCT00830869|520596942|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
144513080|NCT03398148|521078206|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
144721784|NCT02540356|521835288|FG001|Overall Study|Terminated due to disease progression|0|||
144378452|NCT00830869|520596931|FG000|Period 2: Part 2|Adverse Event|0|||
144378453|NCT00830869|520596932|FG001|Period 2: Part 2|Adverse Event|0|||
144378454|NCT00830869|520596933|FG002|Period 2: Part 2|Adverse Event|0|||
144378455|NCT00830869|520596934|FG003|Period 2: Part 2|Adverse Event|0|||
144378456|NCT00830869|520596935|FG004|Period 2: Part 2|Adverse Event|0|||
144378457|NCT00830869|520596936|FG005|Period 2: Part 2|Adverse Event|0|||
144378458|NCT00830869|520596937|FG006|Period 2: Part 2|Adverse Event|0|||
144378459|NCT00830869|520596938|FG007|Period 2: Part 2|Adverse Event|4|||
144378460|NCT00830869|520596939|FG008|Period 2: Part 2|Adverse Event|3|||
144378461|NCT00830869|520596940|FG009|Period 2: Part 2|Adverse Event|2|||
144378462|NCT00830869|520596941|FG010|Period 2: Part 2|Adverse Event|2|||
144378463|NCT00830869|520596942|FG011|Period 2: Part 2|Adverse Event|0|||
144378464|NCT00830869|520596931|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
144378465|NCT00830869|520596932|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
144378466|NCT00830869|520596933|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
144378467|NCT00830869|520596934|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
144378468|NCT00830869|520596935|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
144378469|NCT00830869|520596936|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
144378470|NCT00830869|520596937|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
144378471|NCT00830869|520596938|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
144378472|NCT00830869|520596939|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
144378473|NCT00830869|520596940|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
144378474|NCT00830869|520596941|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
144378475|NCT00830869|520596942|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
144378476|NCT00830869|520596931|FG000|Period 2: Part 2|Progressive disease|0|||
144378477|NCT00830869|520596932|FG001|Period 2: Part 2|Progressive disease|0|||
144378478|NCT00830869|520596933|FG002|Period 2: Part 2|Progressive disease|0|||
144378479|NCT00830869|520596934|FG003|Period 2: Part 2|Progressive disease|0|||
144378480|NCT00830869|520596935|FG004|Period 2: Part 2|Progressive disease|0|||
144378481|NCT00830869|520596936|FG005|Period 2: Part 2|Progressive disease|0|||
144378482|NCT00830869|520596937|FG006|Period 2: Part 2|Progressive disease|0|||
144378483|NCT00830869|520596938|FG007|Period 2: Part 2|Progressive disease|14|||
144378484|NCT00830869|520596939|FG008|Period 2: Part 2|Progressive disease|11|||
144378485|NCT00830869|520596940|FG009|Period 2: Part 2|Progressive disease|12|||
144378486|NCT00830869|520596941|FG010|Period 2: Part 2|Progressive disease|8|||
144378487|NCT00830869|520596942|FG011|Period 2: Part 2|Progressive disease|15|||
144378488|NCT00830869|520596931|FG000|Period 2: Part 2|Other|0|||
144378489|NCT00830869|520596932|FG001|Period 2: Part 2|Other|0|||
144378490|NCT00830869|520596933|FG002|Period 2: Part 2|Other|0|||
144378491|NCT00830869|520596934|FG003|Period 2: Part 2|Other|0|||
144378492|NCT00830869|520596935|FG004|Period 2: Part 2|Other|0|||
144378493|NCT00830869|520596936|FG005|Period 2: Part 2|Other|0|||
144378494|NCT00830869|520596937|FG006|Period 2: Part 2|Other|0|||
144378495|NCT00830869|520596938|FG007|Period 2: Part 2|Other|0|||
144378496|NCT00830869|520596939|FG008|Period 2: Part 2|Other|0|||
144378497|NCT00830869|520596940|FG009|Period 2: Part 2|Other|1|||
144721785|NCT01166568|521835294|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
144721786|NCT01166568|521835295|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
144378498|NCT00830869|520596941|FG010|Period 2: Part 2|Other|0|||
144378499|NCT00830869|520596942|FG011|Period 2: Part 2|Other|0|||
144378500|NCT00281658|520596948|FG000|Randomized Phase|Adverse Event|0|||
144378501|NCT00281658|520596949|FG001|Randomized Phase|Adverse Event|2|||
144378502|NCT00281658|520596950|FG002|Randomized Phase|Adverse Event|0|||
144378503|NCT00281658|520596951|FG003|Randomized Phase|Adverse Event|0|||
144378504|NCT00281658|520596948|FG000|Randomized Phase|Lost to Follow-up|34|||
144378505|NCT00281658|520596949|FG001|Randomized Phase|Lost to Follow-up|27|||
144378506|NCT00281658|520596950|FG002|Randomized Phase|Lost to Follow-up|0|||
144378507|NCT00281658|520596951|FG003|Randomized Phase|Lost to Follow-up|0|||
144378508|NCT00281658|520596948|FG000|Randomized Phase|Withdrawal by Subject|8|||
144378509|NCT00281658|520596949|FG001|Randomized Phase|Withdrawal by Subject|7|||
144378510|NCT00281658|520596950|FG002|Randomized Phase|Withdrawal by Subject|0|||
144378511|NCT00281658|520596951|FG003|Randomized Phase|Withdrawal by Subject|0|||
144378512|NCT00281658|520596948|FG000|Randomized Phase|Study closed/terminated|1|||
144378513|NCT00281658|520596949|FG001|Randomized Phase|Study closed/terminated|1|||
144378514|NCT00281658|520596950|FG002|Randomized Phase|Study closed/terminated|0|||
144378515|NCT00281658|520596951|FG003|Randomized Phase|Study closed/terminated|0|||
144378516|NCT00281658|520596948|FG000|Randomized Phase|Disease progression|36|||
144378517|NCT00281658|520596949|FG001|Randomized Phase|Disease progression|27|||
144378518|NCT00281658|520596950|FG002|Randomized Phase|Disease progression|0|||
144378519|NCT00281658|520596951|FG003|Randomized Phase|Disease progression|0|||
144199252|NCT02935686|519928864|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
144199253|NCT02935686|519928865|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
144199254|NCT02935686|519928861|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
144199255|NCT02935686|519928862|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
144199256|NCT02935686|519928863|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
144199257|NCT02935686|519928864|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
144199258|NCT02935686|519928865|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
144199259|NCT02935686|519928861|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
144199260|NCT02935686|519928862|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
144199261|NCT02935686|519928863|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
144199262|NCT02935686|519928864|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
144199263|NCT02935686|519928865|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
144199264|NCT02935686|519928861|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
144199265|NCT02935686|519928862|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
144199266|NCT02935686|519928863|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
144199267|NCT02935686|519928864|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
144199268|NCT02935686|519928865|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
144199269|NCT02935686|519928861|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
144199270|NCT02935686|519928862|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
144199271|NCT02935686|519928863|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
144199272|NCT02935686|519928864|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
144199273|NCT02935686|519928865|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
144199274|NCT00541970|519928866|FG000|Month 7|Protocol Violation|9|||
144199275|NCT00541970|519928867|FG001|Month 7|Protocol Violation|13|||
144199276|NCT00541970|519928868|FG002|Month 7|Protocol Violation|11|||
144199277|NCT00541970|519928869|FG003|Month 7|Protocol Violation|5|||
144199278|NCT00541970|519928866|FG000|Month 12|Adverse Event|0|||
144199279|NCT00541970|519928867|FG001|Month 12|Adverse Event|1|||
144199280|NCT00541970|519928868|FG002|Month 12|Adverse Event|1|||
144199281|NCT00541970|519928869|FG003|Month 12|Adverse Event|1|||
144199282|NCT00541970|519928866|FG000|Month 12|Protocol Violation|12|||
144199283|NCT00541970|519928867|FG001|Month 12|Protocol Violation|21|||
144199284|NCT00541970|519928868|FG002|Month 12|Protocol Violation|20|||
144199285|NCT00541970|519928869|FG003|Month 12|Protocol Violation|15|||
144199286|NCT00541970|519928866|FG000|Month 18|Adverse Event|0|||
144199287|NCT00541970|519928867|FG001|Month 18|Adverse Event|1|||
144199288|NCT00541970|519928868|FG002|Month 18|Adverse Event|1|||
144199289|NCT00541970|519928869|FG003|Month 18|Adverse Event|1|||
144199290|NCT00541970|519928866|FG000|Month 18|Protocol Violation|14|||
144199291|NCT00541970|519928867|FG001|Month 18|Protocol Violation|23|||
144199292|NCT00541970|519928868|FG002|Month 18|Protocol Violation|24|||
144199293|NCT00541970|519928869|FG003|Month 18|Protocol Violation|16|||
144199294|NCT00541970|519928866|FG000|Month 24|Adverse Event|0|||
144199295|NCT00541970|519928867|FG001|Month 24|Adverse Event|1|||
144199296|NCT00541970|519928868|FG002|Month 24|Adverse Event|1|||
144199297|NCT00541970|519928869|FG003|Month 24|Adverse Event|1|||
144199298|NCT00541970|519928866|FG000|Month 24|Protocol Violation|29|||
144199299|NCT00541970|519928867|FG001|Month 24|Protocol Violation|31|||
144378520|NCT00281658|520596948|FG000|Randomized Phase|Physician Decision|1|||
144378521|NCT00281658|520596949|FG001|Randomized Phase|Physician Decision|1|||
144378522|NCT00281658|520596950|FG002|Randomized Phase|Physician Decision|0|||
144378523|NCT00281658|520596951|FG003|Randomized Phase|Physician Decision|0|||
144378524|NCT00281658|520596948|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
144378525|NCT00281658|520596949|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
144378526|NCT00281658|520596950|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
144378527|NCT00281658|520596951|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
144378528|NCT00281658|520596948|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
144378529|NCT00281658|520596949|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
144378530|NCT00281658|520596950|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
144378531|NCT00281658|520596951|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
144199300|NCT00541970|519928868|FG002|Month 24|Protocol Violation|31|||
144199301|NCT00541970|519928869|FG003|Month 24|Protocol Violation|21|||
144199302|NCT00541970|519928866|FG000|Month 36|Protocol Violation|61|||
144591062|NCT00928018|521364186|FG000|Overall Study|Withdrawal by Subject|1|||
144591063|NCT00928018|521364187|FG001|Overall Study|Withdrawal by Subject|0|||
144721787|NCT01166568|521835296|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
144199303|NCT00541970|519928867|FG001|Month 36|Protocol Violation|66|||
144199304|NCT00541970|519928868|FG002|Month 36|Protocol Violation|66|||
144199305|NCT00541970|519928869|FG003|Month 36|Protocol Violation|60|||
144199306|NCT00541970|519928866|FG000|Month 48|Withdrawal by Subject|2|||
144378532|NCT00281658|520596948|FG000|Randomized Phase|Treatment ongoing|1|||
144378533|NCT00281658|520596949|FG001|Randomized Phase|Treatment ongoing|0|||
144378534|NCT00281658|520596950|FG002|Randomized Phase|Treatment ongoing|0|||
144378535|NCT00281658|520596951|FG003|Randomized Phase|Treatment ongoing|0|||
144378536|NCT00281658|520596948|FG000|Open Label Phase|Adverse Event|0|||
144378537|NCT00281658|520596949|FG001|Open Label Phase|Adverse Event|0|||
144378538|NCT00281658|520596950|FG002|Open Label Phase|Adverse Event|1|||
144378539|NCT00281658|520596951|FG003|Open Label Phase|Adverse Event|0|||
144378540|NCT00281658|520596948|FG000|Open Label Phase|Lost to Follow-up|0|||
144378541|NCT00281658|520596949|FG001|Open Label Phase|Lost to Follow-up|0|||
144378542|NCT00281658|520596950|FG002|Open Label Phase|Lost to Follow-up|16|||
144378543|NCT00281658|520596951|FG003|Open Label Phase|Lost to Follow-up|2|||
144378544|NCT00281658|520596948|FG000|Open Label Phase|Withdrawal by Subject|0|||
144378545|NCT00281658|520596949|FG001|Open Label Phase|Withdrawal by Subject|0|||
144378546|NCT00281658|520596950|FG002|Open Label Phase|Withdrawal by Subject|3|||
144378547|NCT00281658|520596951|FG003|Open Label Phase|Withdrawal by Subject|2|||
144378548|NCT00281658|520596948|FG000|Open Label Phase|Disease progression|0|||
144378549|NCT00281658|520596949|FG001|Open Label Phase|Disease progression|0|||
144378550|NCT00281658|520596950|FG002|Open Label Phase|Disease progression|18|||
144378551|NCT00281658|520596951|FG003|Open Label Phase|Disease progression|0|||
144378552|NCT00281658|520596948|FG000|Open Label Phase|Physician Decision|0|||
144378553|NCT00281658|520596949|FG001|Open Label Phase|Physician Decision|0|||
144378554|NCT00281658|520596950|FG002|Open Label Phase|Physician Decision|1|||
144378555|NCT00281658|520596951|FG003|Open Label Phase|Physician Decision|0|||
144378556|NCT00281658|520596948|FG000|Open Label Phase|Relocation of patient|0|||
144378557|NCT00281658|520596949|FG001|Open Label Phase|Relocation of patient|0|||
144378558|NCT00281658|520596950|FG002|Open Label Phase|Relocation of patient|1|||
144378559|NCT00281658|520596951|FG003|Open Label Phase|Relocation of patient|0|||
144378560|NCT00281658|520596948|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
144378561|NCT00281658|520596949|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
144378562|NCT00281658|520596950|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
144378563|NCT00281658|520596951|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
144378564|NCT04590248|520596952|FG000|Overall Study|Lost to Follow-up|1|||
144378565|NCT04590248|520596952|FG000|Overall Study|Withdrawal by Subject|16|||
144378566|NCT04590248|520596952|FG000|Overall Study|Other|2|||
144378567|NCT02052414|520596955|FG000|Overall Study|Adverse Event|12|||
144378568|NCT02052414|520596955|FG000|Overall Study|Lack of Efficacy|2|||
144378569|NCT02052414|520596955|FG000|Overall Study|Withdrawal by Subject|3|||
144378570|NCT01343693|520596961|FG000|Overall Study|Lost to Follow-up|9|||
144378571|NCT02704143|520596962|FG000|Overall Study|disease progression|10|||
144378572|NCT01235598|520596963|FG000|Overall Study|Adverse Event|0|||
144378573|NCT01235598|520596964|FG001|Overall Study|Adverse Event|3|||
144378574|NCT01235598|520596963|FG000|Overall Study|Lack of Efficacy|0|||
144378575|NCT01235598|520596964|FG001|Overall Study|Lack of Efficacy|1|||
144378576|NCT01235598|520596963|FG000|Overall Study|Withdrawal by Subject|1|||
144378577|NCT01235598|520596964|FG001|Overall Study|Withdrawal by Subject|0|||
144378578|NCT02551991|520596965|FG000|Overall Study|Death|5|||
144378579|NCT02551991|520596966|FG001|Overall Study|Death|7|||
144378580|NCT02551991|520596967|FG002|Overall Study|Death|8|||
144378581|NCT02551991|520596968|FG003|Overall Study|Death|7|||
144378582|NCT02551991|520596969|FG004|Overall Study|Death|17|||
144378583|NCT02551991|520596965|FG000|Overall Study|Withdrawal by Subject|1|||
144378584|NCT02551991|520596966|FG001|Overall Study|Withdrawal by Subject|0|||
144513081|NCT03398148|521078207|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
144513082|NCT03398148|521078208|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513083|NCT03398148|521078209|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513084|NCT03398148|521078210|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513085|NCT03398148|521078211|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
144513086|NCT03398148|521078197|FG000|Substudy 2 Period 2|Adverse Event|0|||
144513087|NCT03398148|521078198|FG001|Substudy 2 Period 2|Adverse Event|0|||
144513088|NCT03398148|521078199|FG002|Substudy 2 Period 2|Adverse Event|0|||
144513089|NCT03398148|521078200|FG003|Substudy 2 Period 2|Adverse Event|0|||
144378585|NCT02551991|520596967|FG002|Overall Study|Withdrawal by Subject|0|||
144378586|NCT02551991|520596968|FG003|Overall Study|Withdrawal by Subject|0|||
144378587|NCT02551991|520596969|FG004|Overall Study|Withdrawal by Subject|2|||
144378588|NCT02551991|520596965|FG000|Overall Study|Lost to Follow-up|0|||
144513090|NCT03398148|521078201|FG004|Substudy 2 Period 2|Adverse Event|0|||
144513091|NCT03398148|521078202|FG005|Substudy 2 Period 2|Adverse Event|0|||
144513092|NCT03398148|521078203|FG006|Substudy 2 Period 2|Adverse Event|0|||
144378589|NCT02551991|520596966|FG001|Overall Study|Lost to Follow-up|0|||
144513093|NCT03398148|521078204|FG007|Substudy 2 Period 2|Adverse Event|0|||
144378590|NCT02551991|520596967|FG002|Overall Study|Lost to Follow-up|1|||
144378591|NCT02551991|520596968|FG003|Overall Study|Lost to Follow-up|0|||
144378592|NCT02551991|520596969|FG004|Overall Study|Lost to Follow-up|0|||
144378593|NCT02551991|520596965|FG000|Overall Study|Sponsor Decision|1|||
144513094|NCT03398148|521078205|FG008|Substudy 2 Period 2|Adverse Event|0|||
144513095|NCT03398148|521078206|FG009|Substudy 2 Period 2|Adverse Event|0|||
144513096|NCT03398148|521078207|FG010|Substudy 2 Period 2|Adverse Event|0|||
144513097|NCT03398148|521078208|FG011|Substudy 2 Period 2|Adverse Event|0|||
144513098|NCT03398148|521078209|FG012|Substudy 2 Period 2|Adverse Event|0|||
144513099|NCT03398148|521078210|FG013|Substudy 2 Period 2|Adverse Event|1|||
144513100|NCT03398148|521078211|FG014|Substudy 2 Period 2|Adverse Event|3|||
144513101|NCT03398148|521078197|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
144513102|NCT03398148|521078198|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
144513103|NCT03398148|521078199|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
144513104|NCT03398148|521078200|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
144513105|NCT03398148|521078201|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
144378594|NCT02551991|520596966|FG001|Overall Study|Sponsor Decision|0|||
144378595|NCT02551991|520596967|FG002|Overall Study|Sponsor Decision|1|||
144378596|NCT02551991|520596968|FG003|Overall Study|Sponsor Decision|0|||
144378597|NCT02551991|520596969|FG004|Overall Study|Sponsor Decision|5|||
144378598|NCT02551991|520596965|FG000|Overall Study|Other|0|||
144378599|NCT02551991|520596966|FG001|Overall Study|Other|0|||
144378600|NCT02551991|520596967|FG002|Overall Study|Other|0|||
144378601|NCT02551991|520596968|FG003|Overall Study|Other|0|||
144378602|NCT02551991|520596969|FG004|Overall Study|Other|1|||
144378603|NCT00395343|520596970|FG000|Overall Study|Adverse Event|13|||
144378604|NCT00395343|520596971|FG001|Overall Study|Adverse Event|5|||
144378605|NCT00395343|520596970|FG000|Overall Study|Lack of Efficacy|0|||
144378606|NCT00395343|520596971|FG001|Overall Study|Lack of Efficacy|1|||
144378607|NCT00395343|520596970|FG000|Overall Study|Lost to Follow-up|4|||
144378608|NCT00395343|520596971|FG001|Overall Study|Lost to Follow-up|4|||
144378609|NCT00395343|520596970|FG000|Overall Study|Physician Decision|2|||
144378610|NCT00395343|520596971|FG001|Overall Study|Physician Decision|4|||
144378611|NCT00395343|520596970|FG000|Overall Study|Protocol Violation|6|||
144378612|NCT00395343|520596971|FG001|Overall Study|Protocol Violation|8|||
144378613|NCT00395343|520596970|FG000|Overall Study|Withdrawal by Subject|11|||
144378614|NCT00395343|520596971|FG001|Overall Study|Withdrawal by Subject|12|||
144513106|NCT03398148|521078202|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
144513107|NCT03398148|521078203|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
144513108|NCT03398148|521078204|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
144513109|NCT03398148|521078205|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
144513110|NCT03398148|521078206|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
144513111|NCT03398148|521078207|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
144513112|NCT03398148|521078208|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
144513113|NCT03398148|521078209|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
144513114|NCT03398148|521078210|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
144513115|NCT03398148|521078211|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
144513116|NCT03398148|521078197|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513117|NCT03398148|521078198|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513118|NCT03398148|521078199|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513119|NCT03398148|521078200|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513120|NCT03398148|521078201|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513121|NCT03398148|521078202|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513122|NCT03398148|521078203|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513123|NCT03398148|521078204|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513124|NCT03398148|521078205|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513125|NCT03398148|521078206|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513126|NCT03398148|521078207|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513127|NCT03398148|521078208|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
144513128|NCT03398148|521078209|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
144513129|NCT03398148|521078210|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
144513130|NCT03398148|521078211|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
144513131|NCT03398148|521078197|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
144513132|NCT03398148|521078198|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
144513133|NCT03398148|521078199|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
144513134|NCT03398148|521078200|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
144513135|NCT03398148|521078201|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
144513136|NCT03398148|521078202|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
144513137|NCT03398148|521078203|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
144513138|NCT03398148|521078204|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
144513139|NCT03398148|521078205|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
144513140|NCT03398148|521078206|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
144513141|NCT03398148|521078207|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
144513142|NCT03398148|521078208|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
144513143|NCT03398148|521078209|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
144378615|NCT00395343|520596970|FG000|Overall Study|Other|5|||
144378616|NCT00395343|520596971|FG001|Overall Study|Other|2|||
144513144|NCT03398148|521078210|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
144513145|NCT03398148|521078211|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
144513146|NCT03398148|521078197|FG000|Substudy 2 Period 2|Other|0|||
144513147|NCT03398148|521078198|FG001|Substudy 2 Period 2|Other|0|||
144513148|NCT03398148|521078199|FG002|Substudy 2 Period 2|Other|0|||
144378617|NCT00387790|520596974|FG000|Overall Study|Adverse Event|5|||
144378618|NCT00387790|520596974|FG000|Overall Study|Lack of Efficacy|2|||
144378619|NCT00387790|520596974|FG000|Overall Study|Physician Decision|2|||
144513149|NCT03398148|521078200|FG003|Substudy 2 Period 2|Other|0|||
144378620|NCT00387790|520596974|FG000|Overall Study|Withdrawal by Subject|3|||
144378621|NCT00387790|520596974|FG000|Overall Study|Ineligible for study|2|||
144513150|NCT03398148|521078201|FG004|Substudy 2 Period 2|Other|0|||
144513151|NCT03398148|521078202|FG005|Substudy 2 Period 2|Other|0|||
144513152|NCT03398148|521078203|FG006|Substudy 2 Period 2|Other|0|||
144513153|NCT03398148|521078204|FG007|Substudy 2 Period 2|Other|0|||
144513154|NCT03398148|521078205|FG008|Substudy 2 Period 2|Other|0|||
144513155|NCT03398148|521078206|FG009|Substudy 2 Period 2|Other|0|||
144513156|NCT03398148|521078207|FG010|Substudy 2 Period 2|Other|0|||
144378622|NCT01874340|520596975|FG000|Overall Study|Study terminated by Sponsor|6|||
144378623|NCT01874340|520596976|FG001|Overall Study|Study terminated by Sponsor|8|||
144378624|NCT01874340|520596977|FG002|Overall Study|Study terminated by Sponsor|8|||
144378625|NCT01874340|520596978|FG003|Overall Study|Study terminated by Sponsor|4|||
144378626|NCT01874340|520596975|FG000|Overall Study|Withdrawal by Subject|0|||
144378627|NCT01874340|520596976|FG001|Overall Study|Withdrawal by Subject|0|||
144378628|NCT01874340|520596977|FG002|Overall Study|Withdrawal by Subject|0|||
144378629|NCT01874340|520596978|FG003|Overall Study|Withdrawal by Subject|1|||
144378630|NCT03539549|520596979|FG000|Overall Study|Adverse Event|12|||
144378631|NCT03539549|520596979|FG000|Overall Study|Lost to Follow-up|1|||
144378632|NCT03539549|520596979|FG000|Overall Study|Death|2|||
144378633|NCT03539549|520596979|FG000|Overall Study|Progressive Disease|1|||
144378634|NCT03539549|520596979|FG000|Overall Study|Reason not Specified|1|||
144378635|NCT02864862|520596981|FG000|Overall Study|Lost to Follow-up|1|||
144378636|NCT02864862|520596982|FG001|Overall Study|Lost to Follow-up|0|||
144378637|NCT02864862|520596983|FG002|Overall Study|Lost to Follow-up|1|||
144378638|NCT02864862|520596981|FG000|Overall Study|Protocol Violation|0|||
144378639|NCT02864862|520596982|FG001|Overall Study|Protocol Violation|0|||
144378640|NCT02864862|520596983|FG002|Overall Study|Protocol Violation|1|||
144378641|NCT03263702|520596984|FG000|Overall Study|Lost to Follow-up|2|||
144378642|NCT03263702|520596985|FG001|Overall Study|Lost to Follow-up|2|||
144378643|NCT03263702|520596984|FG000|Overall Study|Withdrawal by Subject|1|||
144378644|NCT03263702|520596985|FG001|Overall Study|Withdrawal by Subject|2|||
144378645|NCT03598114|520596986|FG000|Overall Study|Staff turnover/left the program|3|||
144378646|NCT03598114|520596987|FG001|Overall Study|Staff turnover/left the program|39|||
144378647|NCT01206322|520596988|FG000|Overall Study|Adverse Event|0|||
144378648|NCT01206322|520596989|FG001|Overall Study|Adverse Event|0|||
144378649|NCT01206322|520596990|FG002|Overall Study|Adverse Event|0|||
144378650|NCT01206322|520596991|FG003|Overall Study|Adverse Event|1|||
144378651|NCT00689117|520596992|FG000|Overall Study|Adverse Event|6|||
144378652|NCT00689117|520596993|FG001|Overall Study|Adverse Event|0|||
144378653|NCT00689117|520596994|FG002|Overall Study|Adverse Event|5|||
144378654|NCT00689117|520596995|FG003|Overall Study|Adverse Event|0|||
144378655|NCT00689117|520596992|FG000|Overall Study|Lost to Follow-up|26|||
144378656|NCT00689117|520596993|FG001|Overall Study|Lost to Follow-up|19|||
144378657|NCT00689117|520596994|FG002|Overall Study|Lost to Follow-up|17|||
144378658|NCT00689117|520596995|FG003|Overall Study|Lost to Follow-up|11|||
144378659|NCT00689117|520596992|FG000|Overall Study|Lack of Efficacy|1|||
144378660|NCT00689117|520596993|FG001|Overall Study|Lack of Efficacy|2|||
144378661|NCT00689117|520596994|FG002|Overall Study|Lack of Efficacy|2|||
144378662|NCT00689117|520596995|FG003|Overall Study|Lack of Efficacy|2|||
144378663|NCT00689117|520596992|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
144378664|NCT00689117|520596993|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
144378665|NCT00689117|520596994|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
144378666|NCT00689117|520596995|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
144378667|NCT00689117|520596992|FG000|Overall Study|Withdrawal by Subject|19|||
144378668|NCT00689117|520596993|FG001|Overall Study|Withdrawal by Subject|18|||
144378669|NCT00689117|520596994|FG002|Overall Study|Withdrawal by Subject|26|||
144378670|NCT00689117|520596995|FG003|Overall Study|Withdrawal by Subject|13|||
144378671|NCT00689117|520596992|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
144378672|NCT00689117|520596993|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
144378673|NCT00689117|520596994|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
144378674|NCT00689117|520596995|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
144378675|NCT00689117|520596992|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
144378676|NCT00689117|520596993|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
144378677|NCT00689117|520596994|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144378678|NCT00689117|520596995|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144378679|NCT00689117|520596992|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
144378680|NCT00689117|520596993|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
144378681|NCT00689117|520596994|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
144378682|NCT00689117|520596995|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
144378683|NCT00689117|520596992|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
144378684|NCT00689117|520596993|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
144378685|NCT00689117|520596994|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
144378686|NCT00689117|520596995|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
144378687|NCT00689117|520596992|FG000|Overall Study|Use of Prohibitive Medication|2|||
144378688|NCT00689117|520596993|FG001|Overall Study|Use of Prohibitive Medication|1|||
144378689|NCT00689117|520596994|FG002|Overall Study|Use of Prohibitive Medication|3|||
144378690|NCT00689117|520596995|FG003|Overall Study|Use of Prohibitive Medication|0|||
144378691|NCT00689117|520596992|FG000|Overall Study|Pregnancy|0|||
144591064|NCT03218397|521364188|FG000|Overall Study|Prior positive blood culture|8|||
144378692|NCT00689117|520596993|FG001|Overall Study|Pregnancy|2|||
144378693|NCT00689117|520596994|FG002|Overall Study|Pregnancy|0|||
144378694|NCT00689117|520596995|FG003|Overall Study|Pregnancy|2|||
144378695|NCT00689117|520596992|FG000|Overall Study|Incarceration|2|||
144378696|NCT00689117|520596993|FG001|Overall Study|Incarceration|0|||
144378697|NCT00689117|520596994|FG002|Overall Study|Incarceration|0|||
144378698|NCT00689117|520596995|FG003|Overall Study|Incarceration|0|||
144378699|NCT00689117|520596992|FG000|Overall Study|Fear of Birth Defects|0|||
144378700|NCT00689117|520596993|FG001|Overall Study|Fear of Birth Defects|0|||
144378701|NCT00689117|520596994|FG002|Overall Study|Fear of Birth Defects|1|||
144378702|NCT00689117|520596995|FG003|Overall Study|Fear of Birth Defects|0|||
144378703|NCT00689117|520596992|FG000|Overall Study|Transportation|1|||
144378704|NCT00689117|520596993|FG001|Overall Study|Transportation|0|||
144378705|NCT00689117|520596994|FG002|Overall Study|Transportation|0|||
144378706|NCT00689117|520596995|FG003|Overall Study|Transportation|0|||
144378707|NCT00689117|520596992|FG000|Overall Study|Patient Withdrew from Study|0|||
144378708|NCT00689117|520596993|FG001|Overall Study|Patient Withdrew from Study|0|||
144378709|NCT00689117|520596994|FG002|Overall Study|Patient Withdrew from Study|0|||
144378710|NCT00689117|520596995|FG003|Overall Study|Patient Withdrew from Study|1|||
144378711|NCT00689117|520596992|FG000|Overall Study|Personal Reason|0|||
144378712|NCT00689117|520596993|FG001|Overall Study|Personal Reason|1|||
144378713|NCT00689117|520596994|FG002|Overall Study|Personal Reason|0|||
144378714|NCT00689117|520596995|FG003|Overall Study|Personal Reason|0|||
144378715|NCT00689117|520596992|FG000|Overall Study|Dispensing Error|0|||
144378716|NCT00689117|520596993|FG001|Overall Study|Dispensing Error|1|||
144378717|NCT00689117|520596994|FG002|Overall Study|Dispensing Error|0|||
144378718|NCT00689117|520596995|FG003|Overall Study|Dispensing Error|0|||
144378719|NCT00444678|520596996|FG000|Overall Study|Toxicity|11|||
144378720|NCT00444678|520596996|FG000|Overall Study|Disease Progression|12|||
144378721|NCT00444678|520596996|FG000|Overall Study|Death|3|||
144378722|NCT00444678|520596996|FG000|Overall Study|Physician Decision|3|||
144378723|NCT00444678|520596996|FG000|Overall Study|Withdrawal by Subject|2|||
144378724|NCT02386189|520597002|FG000|Overall Study|Lost to Follow-up|2|||
144378725|NCT02386189|520597003|FG001|Overall Study|Lost to Follow-up|3|||
144378726|NCT02386189|520597002|FG000|Overall Study|Withdrawal by Subject|1|||
144378727|NCT02386189|520597003|FG001|Overall Study|Withdrawal by Subject|0|||
144378728|NCT02386189|520597002|FG000|Overall Study|Death|1|||
144378729|NCT02386189|520597003|FG001|Overall Study|Death|0|||
144591065|NCT03218397|521364189|FG001|Overall Study|Prior positive blood culture|13|||
144591066|NCT03218397|521364188|FG000|Overall Study|Comfort care|8|||
144591067|NCT03218397|521364189|FG001|Overall Study|Comfort care|5|||
144591068|NCT03218397|521364188|FG000|Overall Study|Comfort care and positive blood culture|1|||
144591069|NCT03218397|521364189|FG001|Overall Study|Comfort care and positive blood culture|0|||
144591070|NCT03218397|521364188|FG000|Overall Study|Comfort care and mixed culture|0|||
144591071|NCT03218397|521364189|FG001|Overall Study|Comfort care and mixed culture|1|||
144591072|NCT03218397|521364188|FG000|Overall Study|Mixed culture|2|||
144591073|NCT03218397|521364189|FG001|Overall Study|Mixed culture|2|||
144591074|NCT03218397|521364188|FG000|Overall Study|Inaccessible hospital records|2|||
144591075|NCT03218397|521364189|FG001|Overall Study|Inaccessible hospital records|5|||
144591076|NCT03218397|521364188|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
144591077|NCT03218397|521364189|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
144591078|NCT03218397|521364188|FG000|Overall Study|Randomized during laboratory off hours|2|||
144591079|NCT03218397|521364189|FG001|Overall Study|Randomized during laboratory off hours|1|||
144591080|NCT01796548|521364190|FG000|Overall Study|Lost to Follow-up|1|||
144591081|NCT01796548|521364190|FG000|Overall Study|Other|2|||
144591082|NCT00126503|521364191|FG000|Overall Study|disease progression|23|||
144591083|NCT00126503|521364192|FG001|Overall Study|disease progression|14|||
144591084|NCT00126503|521364191|FG000|Overall Study|Withdrawal by Subject|0|||
144591085|NCT00126503|521364192|FG001|Overall Study|Withdrawal by Subject|1|||
144591086|NCT00126503|521364191|FG000|Overall Study|alternative therapy|1|||
144591087|NCT00126503|521364192|FG001|Overall Study|alternative therapy|1|||
144591088|NCT00126503|521364191|FG000|Overall Study|other complicating disease|4|||
144591089|NCT00126503|521364192|FG001|Overall Study|other complicating disease|1|||
144591090|NCT00126503|521364191|FG000|Overall Study|Death|3|||
144378730|NCT04657666|520597004|FG000|Period 1|Withdrawal of participant consent|2|||
144378731|NCT04657666|520597005|FG001|Period 1|Withdrawal of participant consent|1|||
144378732|NCT04657666|520597004|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
144378733|NCT04657666|520597005|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
144378734|NCT04657666|520597004|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
144378735|NCT04657666|520597005|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
144378736|NCT04657666|520597004|FG000|Period 2|Other|2|||
144378737|NCT04657666|520597005|FG001|Period 2|Other|0|||
144378738|NCT04657666|520597004|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
144591091|NCT00126503|521364192|FG001|Overall Study|Death|0|||
144378739|NCT04657666|520597005|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
144378740|NCT00606905|520597006|FG000|Overall Study|No Pregnancy|9|||
144378741|NCT00606905|520597007|FG001|Overall Study|No Pregnancy|6|||
144378742|NCT00606905|520597006|FG000|Overall Study|Non-Index Pregnancy|1|||
144378743|NCT00606905|520597007|FG001|Overall Study|Non-Index Pregnancy|4|||
144378744|NCT00606905|520597006|FG000|Overall Study|Withdrew|5|||
144378745|NCT00606905|520597007|FG001|Overall Study|Withdrew|5|||
144378746|NCT03120351|520597008|FG000|Overall Study|Physician Decision|1|||
144378747|NCT03120351|520597009|FG001|Overall Study|Physician Decision|1|||
144378748|NCT01022398|520597018|FG000|Overall Study|Study terminated|2|||
144378749|NCT01022398|520597019|FG001|Overall Study|Study terminated|2|||
144378750|NCT03319745|520597021|FG000|Overall Study|Death|1|||
144378751|NCT03319745|520597021|FG000|Overall Study|Toxicity Precluding Surgery|1|||
144378752|NCT01317550|520597022|FG000|Overall Study|Withdrawal by Subject|1|||
144378753|NCT01317550|520597023|FG001|Overall Study|Withdrawal by Subject|0|||
144378754|NCT01317550|520597024|FG002|Overall Study|Withdrawal by Subject|0|||
144378755|NCT01317550|520597025|FG003|Overall Study|Withdrawal by Subject|0|||
144378756|NCT01317550|520597022|FG000|Overall Study|Lack of compliance study med|1|||
144378757|NCT01317550|520597023|FG001|Overall Study|Lack of compliance study med|0|||
144378758|NCT01317550|520597024|FG002|Overall Study|Lack of compliance study med|0|||
144378759|NCT01317550|520597025|FG003|Overall Study|Lack of compliance study med|0|||
144378760|NCT00870103|520597026|FG000|Overall Study|Physician Decision|2|||
144378761|NCT00870103|520597026|FG000|Overall Study|Lost to Follow-up|2|||
144378762|NCT03255629|520597027|FG000|Overall Study|Adverse Event|1|||
144378763|NCT03255629|520597028|FG001|Overall Study|Adverse Event|0|||
144378764|NCT03255629|520597027|FG000|Overall Study|did not experience hypoglycemia|2|||
144378765|NCT03255629|520597028|FG001|Overall Study|did not experience hypoglycemia|1|||
144378766|NCT00833417|520597032|FG000|Overall Study|Adverse Event|5|||
144378767|NCT00833417|520597033|FG001|Overall Study|Adverse Event|16|||
144378768|NCT00833417|520597032|FG000|Overall Study|Death|1|||
144378769|NCT00833417|520597033|FG001|Overall Study|Death|3|||
144378770|NCT00833417|520597032|FG000|Overall Study|Lost to Follow-up|1|||
144378771|NCT00833417|520597033|FG001|Overall Study|Lost to Follow-up|2|||
144378772|NCT00833417|520597032|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
144378773|NCT00833417|520597033|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
144378774|NCT00833417|520597032|FG000|Overall Study|Patient Decision to Withdraw|4|||
144378775|NCT00833417|520597033|FG001|Overall Study|Patient Decision to Withdraw|23|||
144378776|NCT00833417|520597032|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
144378777|NCT00833417|520597033|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
144378778|NCT00833417|520597032|FG000|Overall Study|Disease Progression|18|||
144513157|NCT03398148|521078208|FG011|Substudy 2 Period 2|Other|0|||
144513158|NCT03398148|521078209|FG012|Substudy 2 Period 2|Other|0|||
144513159|NCT03398148|521078210|FG013|Substudy 2 Period 2|Other|1|||
144513160|NCT03398148|521078211|FG014|Substudy 2 Period 2|Other|1|||
144513161|NCT03398148|521078197|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513162|NCT03398148|521078198|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513163|NCT03398148|521078199|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513164|NCT03398148|521078200|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513165|NCT03398148|521078201|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513166|NCT03398148|521078202|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513167|NCT03398148|521078203|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513168|NCT03398148|521078204|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513169|NCT03398148|521078205|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513170|NCT03398148|521078206|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513171|NCT03398148|521078207|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513172|NCT03398148|521078208|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513173|NCT03398148|521078209|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
144513174|NCT03398148|521078210|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
144513175|NCT03398148|521078211|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
144513176|NCT04201834|521078212|FG000|Overall Study|Screen fail|1|||
144513177|NCT00212355|521078213|FG000|Overall Study|Adverse Event|1|||
144513178|NCT00212355|521078213|FG000|Overall Study|Withdrawal by Subject|1|||
144513179|NCT00212355|521078213|FG000|Overall Study|A change of address|1|||
144513180|NCT04104321|521078219|FG000|Overall Study|didn't take the study drug|3|||
144378779|NCT00833417|520597033|FG001|Overall Study|Disease Progression|17|||
144513181|NCT03012841|521078220|FG000|Overall Study|Protocol Violation|0|||
144513182|NCT03012841|521078221|FG001|Overall Study|Protocol Violation|10|||
144378780|NCT00833417|520597032|FG000|Overall Study|Reason Not Specified|0|||
144378781|NCT00833417|520597033|FG001|Overall Study|Reason Not Specified|1|||
144378782|NCT03330002|520597034|FG000|Overall Study|Lost to Follow-up|15|||
144378783|NCT03330002|520597034|FG000|Overall Study|Death|7|||
144378784|NCT01625260|520597035|FG000|Overall Study|Adverse Event|3|||
144378785|NCT01625260|520597036|FG001|Overall Study|Adverse Event|0|||
144378786|NCT01625260|520597035|FG000|Overall Study|Study Terminated by Investigator|2|||
144378787|NCT01625260|520597036|FG001|Overall Study|Study Terminated by Investigator|0|||
144378788|NCT01625260|520597035|FG000|Overall Study|Disease Progression|2|||
144378789|NCT01625260|520597036|FG001|Overall Study|Disease Progression|0|||
144513183|NCT03012841|521078220|FG000|Overall Study|Lost to Follow-up|6|||
144513184|NCT03012841|521078221|FG001|Overall Study|Lost to Follow-up|1|||
144513185|NCT03012841|521078220|FG000|Overall Study|Withdrawal by Subject|6|||
144378790|NCT01625260|520597035|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
144378791|NCT01625260|520597036|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
144378792|NCT01776307|520597039|FG000|Overall Study|Not dosed|0|||
144378793|NCT01776307|520597040|FG001|Overall Study|Not dosed|0|||
144378794|NCT01776307|520597041|FG002|Overall Study|Not dosed|1|||
144513186|NCT03012841|521078221|FG001|Overall Study|Withdrawal by Subject|0|||
144513187|NCT03012841|521078220|FG000|Overall Study|Unable to complete 12 month visit|6|||
144513188|NCT03012841|521078221|FG001|Overall Study|Unable to complete 12 month visit|0|||
144513189|NCT03012841|521078220|FG000|Overall Study|Subject relocation|1|||
144378795|NCT03083990|520597042|FG000|Overall Study|Adverse Event|1|||
144378796|NCT03083990|520597043|FG001|Overall Study|Adverse Event|0|||
144378797|NCT02424578|520597044|FG000|Overall Study|Withdrawal by Subject|0|||
144378798|NCT02424578|520597045|FG001|Overall Study|Withdrawal by Subject|1|||
144378799|NCT00862082|520597047|FG000|Overall Study|Sponsor decision to terminate the study|5|||
144378800|NCT00862082|520597048|FG001|Overall Study|Sponsor decision to terminate the study|0|||
144378801|NCT00862082|520597047|FG000|Overall Study|Withdrawal by Subject|0|||
144378802|NCT00862082|520597048|FG001|Overall Study|Withdrawal by Subject|1|||
144378803|NCT00776919|520597049|FG000|Overall Study|Withdrawal by Subject|16|||
144378804|NCT00776919|520597050|FG001|Overall Study|Withdrawal by Subject|14|||
144378805|NCT00776919|520597051|FG002|Overall Study|Withdrawal by Subject|15|||
144378806|NCT00776919|520597052|FG003|Overall Study|Withdrawal by Subject|26|||
144378807|NCT00776919|520597049|FG000|Overall Study|Lost to Follow-up|8|||
144378808|NCT00776919|520597050|FG001|Overall Study|Lost to Follow-up|12|||
144378809|NCT00776919|520597051|FG002|Overall Study|Lost to Follow-up|11|||
144378810|NCT00776919|520597052|FG003|Overall Study|Lost to Follow-up|8|||
144378811|NCT00776919|520597049|FG000|Overall Study|Adverse Event|1|||
144378812|NCT00776919|520597050|FG001|Overall Study|Adverse Event|0|||
144378813|NCT00776919|520597051|FG002|Overall Study|Adverse Event|2|||
144378814|NCT00776919|520597052|FG003|Overall Study|Adverse Event|2|||
144378815|NCT00776919|520597049|FG000|Overall Study|Protocol Violation|1|||
144378816|NCT00776919|520597050|FG001|Overall Study|Protocol Violation|2|||
144378817|NCT00776919|520597051|FG002|Overall Study|Protocol Violation|0|||
144378818|NCT00776919|520597052|FG003|Overall Study|Protocol Violation|1|||
144378819|NCT00776919|520597049|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
144378820|NCT00776919|520597050|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
144378821|NCT00776919|520597051|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
144378822|NCT00776919|520597052|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
144378823|NCT00612807|520597054|FG000|Overall Study|Withdrawal by Subject|2|||
144378824|NCT00612807|520597055|FG001|Overall Study|Withdrawal by Subject|0|||
144378825|NCT00744042|520597058|FG000|Overall Study|Withdrawal by Subject|1|||
144378826|NCT02970942|520597061|FG000|Overall Study|Death|0|||
144378827|NCT02970942|520597062|FG001|Overall Study|Death|1|||
144378828|NCT02970942|520597063|FG002|Overall Study|Death|0|||
144513190|NCT03012841|521078221|FG001|Overall Study|Subject relocation|0|||
144513191|NCT03012841|521078220|FG000|Overall Study|Seasonal winter travel|1|||
144378829|NCT02970942|520597064|FG003|Overall Study|Death|0|||
144378830|NCT02970942|520597061|FG000|Overall Study|Lost to Follow-up|1|||
144378831|NCT02970942|520597062|FG001|Overall Study|Lost to Follow-up|0|||
144378832|NCT02970942|520597063|FG002|Overall Study|Lost to Follow-up|2|||
144378833|NCT02970942|520597064|FG003|Overall Study|Lost to Follow-up|1|||
144378834|NCT02970942|520597061|FG000|Overall Study|Withdrawal by Subject|3|||
144378835|NCT02970942|520597062|FG001|Overall Study|Withdrawal by Subject|5|||
144378836|NCT02970942|520597063|FG002|Overall Study|Withdrawal by Subject|3|||
144378837|NCT02970942|520597064|FG003|Overall Study|Withdrawal by Subject|2|||
144513192|NCT03012841|521078221|FG001|Overall Study|Seasonal winter travel|0|||
144378838|NCT02051933|520599426|FG000|Overall Study|Physician Decision|0|||
144378839|NCT02051933|520599427|FG001|Overall Study|Physician Decision|1|||
144378840|NCT03745820|520599429|FG000|Overall Study|Adverse Event|0|||
144378841|NCT03745820|520599430|FG001|Overall Study|Adverse Event|3|||
144378842|NCT03745820|520599431|FG002|Overall Study|Adverse Event|2|||
144378843|NCT03745820|520599429|FG000|Overall Study|Non-Compliance with Study Drug|4|||
144378844|NCT03745820|520599430|FG001|Overall Study|Non-Compliance with Study Drug|3|||
144378845|NCT03745820|520599431|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144378846|NCT03745820|520599429|FG000|Overall Study|Withdrawal by Subject|4|||
144378847|NCT03745820|520599430|FG001|Overall Study|Withdrawal by Subject|4|||
144378848|NCT03745820|520599431|FG002|Overall Study|Withdrawal by Subject|4|||
144513193|NCT03012841|521078220|FG000|Overall Study|Physician Decision|0|||
144513194|NCT03012841|521078221|FG001|Overall Study|Physician Decision|2|||
144513195|NCT03012841|521078220|FG000|Overall Study|No ablation performed|0|||
144513196|NCT03012841|521078221|FG001|Overall Study|No ablation performed|2|||
144513197|NCT03012841|521078220|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
144513198|NCT03012841|521078221|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
144513199|NCT03012841|521078220|FG000|Overall Study|Insurance change|0|||
144513200|NCT03012841|521078221|FG001|Overall Study|Insurance change|1|||
144513201|NCT04038957|521078222|FG000|Overall Study|Withdrawal by Subject|1|||
144513202|NCT04038957|521078222|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
144513203|NCT04065048|521078223|FG000|Overall Study|Withdrawal by Subject|1|||
144513204|NCT04065048|521078224|FG001|Overall Study|Withdrawal by Subject|2|||
144513205|NCT04065048|521078225|FG002|Overall Study|Withdrawal by Subject|1|||
144513206|NCT04065048|521078226|FG003|Overall Study|Withdrawal by Subject|1|||
144513207|NCT04065048|521078223|FG000|Overall Study|Adverse Event|1|||
144513208|NCT04065048|521078224|FG001|Overall Study|Adverse Event|0|||
144513209|NCT04065048|521078225|FG002|Overall Study|Adverse Event|1|||
144513210|NCT04065048|521078226|FG003|Overall Study|Adverse Event|0|||
144513211|NCT03397108|521078227|FG000|Overall Study|Lost to Follow-up|15|||
144513212|NCT03397108|521078228|FG001|Overall Study|Lost to Follow-up|0|||
144513213|NCT03397108|521078227|FG000|Overall Study|Insufficient milk production|3|||
144513214|NCT03397108|521078228|FG001|Overall Study|Insufficient milk production|2|||
144513215|NCT03397108|521078227|FG000|Overall Study|Withdrawal by Subject|2|||
144513216|NCT03397108|521078228|FG001|Overall Study|Withdrawal by Subject|0|||
144513217|NCT03554265|521078229|FG000|Overall Study|Withdrawal by Subject|2|||
144513218|NCT03554265|521078230|FG001|Overall Study|Withdrawal by Subject|2|||
144513219|NCT03554265|521078231|FG002|Overall Study|Withdrawal by Subject|3|||
144513220|NCT03554265|521078229|FG000|Overall Study|Physician Decision|0|||
144513221|NCT03554265|521078230|FG001|Overall Study|Physician Decision|0|||
144513222|NCT03554265|521078231|FG002|Overall Study|Physician Decision|1|||
144513223|NCT02652260|521078232|FG000|Base Study|Pregnancy|0|||
144513224|NCT02652260|521078233|FG001|Base Study|Pregnancy|1|||
144513225|NCT02652260|521078232|FG000|Base Study|Withdrawal by Subject|0|||
144513226|NCT02652260|521078233|FG001|Base Study|Withdrawal by Subject|1|||
144513227|NCT02652260|521078232|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
144513228|NCT02652260|521078233|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
144513229|NCT02652260|521078232|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
144513230|NCT02652260|521078233|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
144513231|NCT02652260|521078232|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
144513232|NCT02652260|521078233|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
144378849|NCT03745820|520599429|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
144378850|NCT03745820|520599430|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
144513233|NCT02652260|521078232|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
144513234|NCT02652260|521078233|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
144513235|NCT02652260|521078232|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
144513236|NCT02652260|521078233|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
144513237|NCT02652260|521078232|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
144591092|NCT00126503|521364191|FG000|Overall Study|Adverse Event|13|||
144591093|NCT00126503|521364192|FG001|Overall Study|Adverse Event|3|||
144378851|NCT03745820|520599431|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
144378852|NCT03745820|520599429|FG000|Overall Study|Lost to Follow-up|2|||
144378853|NCT03745820|520599430|FG001|Overall Study|Lost to Follow-up|0|||
144378854|NCT03745820|520599431|FG002|Overall Study|Lost to Follow-up|3|||
144378855|NCT03745820|520599429|FG000|Overall Study|Reason not Specified|2|||
144378856|NCT03745820|520599430|FG001|Overall Study|Reason not Specified|4|||
144378857|NCT03745820|520599431|FG002|Overall Study|Reason not Specified|1|||
144378858|NCT00507728|520599432|FG000|Randomization to Month 3|Lost to Follow-up|15|||
144378859|NCT00507728|520599433|FG001|Randomization to Month 3|Lost to Follow-up|14|||
144378860|NCT00507728|520599434|FG002|Randomization to Month 3|Lost to Follow-up|20|||
144378861|NCT00507728|520599432|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
144378862|NCT00507728|520599433|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
144378863|NCT00507728|520599434|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
144378864|NCT02151773|520599435|FG000|Overall Study|Protocol Deviation|64|||
144378865|NCT04605991|520599438|FG000|Overall Study|Adverse Event|5|||
144378866|NCT04605991|520599438|FG000|Overall Study|Lack of Efficacy|1|||
144378867|NCT04605991|520599438|FG000|Overall Study|Lost to Follow-up|8|||
144378868|NCT04605991|520599438|FG000|Overall Study|Physician Decision|4|||
144378869|NCT04605991|520599438|FG000|Overall Study|Withdrawal by Subject|14|||
144378870|NCT04605991|520599438|FG000|Overall Study|Non-compliance with study|1|||
144378871|NCT02527200|520599439|FG000|Overall Study|Withdrawal by Subject|3|||
144378872|NCT02527200|520599440|FG001|Overall Study|Withdrawal by Subject|2|||
144378873|NCT02527200|520599441|FG002|Overall Study|Withdrawal by Subject|1|||
144378874|NCT02527200|520599442|FG003|Overall Study|Withdrawal by Subject|0|||
144378875|NCT02527200|520599439|FG000|Overall Study|Unclassified|0|||
144378876|NCT02527200|520599440|FG001|Overall Study|Unclassified|1|||
144378877|NCT02527200|520599441|FG002|Overall Study|Unclassified|0|||
144378878|NCT02527200|520599442|FG003|Overall Study|Unclassified|0|||
144378879|NCT02527200|520599439|FG000|Overall Study|Lost to Follow-up|0|||
144378880|NCT02527200|520599440|FG001|Overall Study|Lost to Follow-up|0|||
144378881|NCT02527200|520599441|FG002|Overall Study|Lost to Follow-up|1|||
144378882|NCT02527200|520599442|FG003|Overall Study|Lost to Follow-up|0|||
144378883|NCT00966875|520599444|FG000|Part A|Adverse Event|2|||
144378884|NCT00966875|520599445|FG001|Part A|Adverse Event|1|||
144378885|NCT00966875|520599446|FG002|Part A|Adverse Event|0|||
144378886|NCT00966875|520599447|FG003|Part A|Adverse Event|1|||
144378887|NCT00966875|520599448|FG004|Part A|Adverse Event|0|||
144378888|NCT00966875|520599449|FG005|Part A|Adverse Event|1|||
144378889|NCT00966875|520599450|FG006|Part A|Adverse Event|0|||
144378890|NCT00966875|520599451|FG007|Part A|Adverse Event|3|||
144378891|NCT00966875|520599452|FG008|Part A|Adverse Event|3|||
144378892|NCT00966875|520599444|FG000|Part A|Entry Criteria|0|||
144378893|NCT00966875|520599445|FG001|Part A|Entry Criteria|0|||
144378894|NCT00966875|520599446|FG002|Part A|Entry Criteria|0|||
144378895|NCT00966875|520599447|FG003|Part A|Entry Criteria|0|||
144378896|NCT00966875|520599448|FG004|Part A|Entry Criteria|0|||
144378897|NCT00966875|520599449|FG005|Part A|Entry Criteria|2|||
144378898|NCT00966875|520599450|FG006|Part A|Entry Criteria|0|||
144378899|NCT00966875|520599451|FG007|Part A|Entry Criteria|0|||
144378900|NCT00966875|520599452|FG008|Part A|Entry Criteria|0|||
144378901|NCT00966875|520599444|FG000|Part A|Lack of Efficacy|0|||
144378902|NCT00966875|520599445|FG001|Part A|Lack of Efficacy|1|||
144378903|NCT00966875|520599446|FG002|Part A|Lack of Efficacy|0|||
144513238|NCT02652260|521078233|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
144513239|NCT02652260|521078232|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
144513240|NCT02652260|521078233|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
144513241|NCT02652260|521078232|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
144513242|NCT02652260|521078233|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
144513243|NCT02652260|521078232|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
144513244|NCT02652260|521078233|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
144378904|NCT00966875|520599447|FG003|Part A|Lack of Efficacy|0|||
144513245|NCT02652260|521078232|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
144513246|NCT02652260|521078233|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
144513247|NCT02652260|521078232|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
144378905|NCT00966875|520599448|FG004|Part A|Lack of Efficacy|0|||
144378906|NCT00966875|520599449|FG005|Part A|Lack of Efficacy|0|||
144378907|NCT00966875|520599450|FG006|Part A|Lack of Efficacy|4|||
144378908|NCT00966875|520599451|FG007|Part A|Lack of Efficacy|0|||
144378909|NCT00966875|520599452|FG008|Part A|Lack of Efficacy|0|||
144378910|NCT00966875|520599444|FG000|Part A|Lost to Follow-up|2|||
144378911|NCT00966875|520599445|FG001|Part A|Lost to Follow-up|0|||
144378912|NCT00966875|520599446|FG002|Part A|Lost to Follow-up|0|||
144378913|NCT00966875|520599447|FG003|Part A|Lost to Follow-up|0|||
144378914|NCT00966875|520599448|FG004|Part A|Lost to Follow-up|0|||
144378915|NCT00966875|520599449|FG005|Part A|Lost to Follow-up|1|||
144378916|NCT00966875|520599450|FG006|Part A|Lost to Follow-up|0|||
144378917|NCT00966875|520599451|FG007|Part A|Lost to Follow-up|0|||
144378918|NCT00966875|520599452|FG008|Part A|Lost to Follow-up|0|||
144378919|NCT00966875|520599444|FG000|Part A|Parent/Caregiver Decision|0|||
144378920|NCT00966875|520599445|FG001|Part A|Parent/Caregiver Decision|0|||
144378921|NCT00966875|520599446|FG002|Part A|Parent/Caregiver Decision|0|||
144378922|NCT00966875|520599447|FG003|Part A|Parent/Caregiver Decision|1|||
144378923|NCT00966875|520599448|FG004|Part A|Parent/Caregiver Decision|0|||
144378924|NCT00966875|520599449|FG005|Part A|Parent/Caregiver Decision|0|||
144378925|NCT00966875|520599450|FG006|Part A|Parent/Caregiver Decision|0|||
144378926|NCT00966875|520599451|FG007|Part A|Parent/Caregiver Decision|0|||
144378927|NCT00966875|520599452|FG008|Part A|Parent/Caregiver Decision|0|||
144378928|NCT00966875|520599444|FG000|Part A|Physician Decision|0|||
144378929|NCT00966875|520599445|FG001|Part A|Physician Decision|0|||
144378930|NCT00966875|520599446|FG002|Part A|Physician Decision|0|||
144378931|NCT00966875|520599447|FG003|Part A|Physician Decision|0|||
144378932|NCT00966875|520599448|FG004|Part A|Physician Decision|1|||
144378933|NCT00966875|520599449|FG005|Part A|Physician Decision|0|||
144378934|NCT00966875|520599450|FG006|Part A|Physician Decision|1|||
144378935|NCT00966875|520599451|FG007|Part A|Physician Decision|0|||
144378936|NCT00966875|520599452|FG008|Part A|Physician Decision|2|||
144378937|NCT00966875|520599444|FG000|Part A|Sponsor Decision|0|||
144378938|NCT00966875|520599445|FG001|Part A|Sponsor Decision|0|||
144378939|NCT00966875|520599446|FG002|Part A|Sponsor Decision|1|||
144378940|NCT00966875|520599447|FG003|Part A|Sponsor Decision|0|||
144378941|NCT00966875|520599448|FG004|Part A|Sponsor Decision|1|||
144378942|NCT00966875|520599449|FG005|Part A|Sponsor Decision|0|||
144378943|NCT00966875|520599450|FG006|Part A|Sponsor Decision|0|||
144378944|NCT00966875|520599451|FG007|Part A|Sponsor Decision|2|||
144378945|NCT00966875|520599452|FG008|Part A|Sponsor Decision|1|||
144378946|NCT00966875|520599444|FG000|Part A|Withdrawal by Subject|2|||
144378947|NCT00966875|520599445|FG001|Part A|Withdrawal by Subject|2|||
144378948|NCT00966875|520599446|FG002|Part A|Withdrawal by Subject|1|||
144378949|NCT00966875|520599447|FG003|Part A|Withdrawal by Subject|1|||
144378950|NCT00966875|520599448|FG004|Part A|Withdrawal by Subject|3|||
144378951|NCT00966875|520599449|FG005|Part A|Withdrawal by Subject|0|||
144378952|NCT00966875|520599450|FG006|Part A|Withdrawal by Subject|5|||
144378953|NCT00966875|520599451|FG007|Part A|Withdrawal by Subject|1|||
144378954|NCT00966875|520599452|FG008|Part A|Withdrawal by Subject|1|||
144378955|NCT00966875|520599444|FG000|Part A|Protocol Violation|0|||
144378956|NCT00966875|520599445|FG001|Part A|Protocol Violation|0|||
144378957|NCT00966875|520599446|FG002|Part A|Protocol Violation|0|||
144378958|NCT00966875|520599447|FG003|Part A|Protocol Violation|0|||
144378959|NCT00966875|520599448|FG004|Part A|Protocol Violation|0|||
144378960|NCT00966875|520599449|FG005|Part A|Protocol Violation|0|||
144378961|NCT00966875|520599450|FG006|Part A|Protocol Violation|2|||
144378962|NCT00966875|520599451|FG007|Part A|Protocol Violation|1|||
144378963|NCT00966875|520599452|FG008|Part A|Protocol Violation|1|||
144378964|NCT00966875|520599444|FG000|Part B|Adverse Event|0|||
144378965|NCT00966875|520599445|FG001|Part B|Adverse Event|1|||
144378966|NCT00966875|520599446|FG002|Part B|Adverse Event|1|||
144378967|NCT00966875|520599447|FG003|Part B|Adverse Event|0|||
144378968|NCT00966875|520599448|FG004|Part B|Adverse Event|1|||
144378969|NCT00966875|520599449|FG005|Part B|Adverse Event|0|||
144378970|NCT00966875|520599450|FG006|Part B|Adverse Event|5|||
144378971|NCT00966875|520599451|FG007|Part B|Adverse Event|2|||
144378972|NCT00966875|520599452|FG008|Part B|Adverse Event|2|||
144378973|NCT00966875|520599444|FG000|Part B|Death|0|||
144378974|NCT00966875|520599445|FG001|Part B|Death|0|||
144378975|NCT00966875|520599446|FG002|Part B|Death|1|||
144378976|NCT00966875|520599447|FG003|Part B|Death|0|||
144378977|NCT00966875|520599448|FG004|Part B|Death|0|||
144378978|NCT00966875|520599449|FG005|Part B|Death|0|||
144513248|NCT02652260|521078233|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
144378979|NCT00966875|520599450|FG006|Part B|Death|0|||
144513249|NCT02652260|521078232|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
144513250|NCT02652260|521078233|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
144378980|NCT00966875|520599451|FG007|Part B|Death|1|||
144513251|NCT05096819|521078238|FG000|Overall Study|Withdrawal by Subject|3|||
144513252|NCT05096819|521078239|FG001|Overall Study|Withdrawal by Subject|0|||
144513253|NCT03324984|521078240|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
144378981|NCT00966875|520599452|FG008|Part B|Death|0|||
144378982|NCT00966875|520599444|FG000|Part B|Lack of Efficacy|2|||
144378983|NCT00966875|520599445|FG001|Part B|Lack of Efficacy|1|||
144378984|NCT00966875|520599446|FG002|Part B|Lack of Efficacy|1|||
144378985|NCT00966875|520599447|FG003|Part B|Lack of Efficacy|1|||
144378986|NCT00966875|520599448|FG004|Part B|Lack of Efficacy|2|||
144378987|NCT00966875|520599449|FG005|Part B|Lack of Efficacy|3|||
144378988|NCT00966875|520599450|FG006|Part B|Lack of Efficacy|12|||
144378989|NCT00966875|520599451|FG007|Part B|Lack of Efficacy|9|||
144378990|NCT00966875|520599452|FG008|Part B|Lack of Efficacy|6|||
144378991|NCT00966875|520599444|FG000|Part B|Lost to Follow-up|0|||
144378992|NCT00966875|520599445|FG001|Part B|Lost to Follow-up|0|||
144378993|NCT00966875|520599446|FG002|Part B|Lost to Follow-up|0|||
144378994|NCT00966875|520599447|FG003|Part B|Lost to Follow-up|1|||
144378995|NCT00966875|520599448|FG004|Part B|Lost to Follow-up|0|||
144591094|NCT00126503|521364191|FG000|Overall Study|non-compliant|1|||
144513254|NCT03324984|521078241|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
144513255|NCT02152137|521078243|FG000|Overall Study|Withdrawal by Subject|1|||
144513256|NCT02152137|521078243|FG000|Overall Study|Originally assigned to Arm B|3|||
144513257|NCT04878354|521078244|FG000|Overall Study|Adverse Event|4|||
144513258|NCT04878354|521078245|FG001|Overall Study|Adverse Event|13|||
144513259|NCT04878354|521078244|FG000|Overall Study|Withdrawal by Subject|14|||
144513260|NCT04878354|521078245|FG001|Overall Study|Withdrawal by Subject|12|||
144513261|NCT04878354|521078244|FG000|Overall Study|Lost to Follow-up|4|||
144513262|NCT04878354|521078245|FG001|Overall Study|Lost to Follow-up|1|||
144513263|NCT04878354|521078244|FG000|Overall Study|Lack of Efficacy|1|||
144513264|NCT04878354|521078245|FG001|Overall Study|Lack of Efficacy|0|||
144513265|NCT04878354|521078244|FG000|Overall Study|Protocol Violation|0|||
144513266|NCT04878354|521078245|FG001|Overall Study|Protocol Violation|1|||
144513267|NCT04878354|521078244|FG000|Overall Study|"Reason stated as other in CRF"|2|||
144513268|NCT04878354|521078245|FG001|Overall Study|"Reason stated as other in CRF"|3|||
144513269|NCT03358875|521078246|FG000|Overall Study|Death|409|||
144513270|NCT03358875|521078247|FG001|Overall Study|Death|223|||
144513271|NCT03358875|521078246|FG000|Overall Study|Study Closed by Sponsor|66|||
144513272|NCT03358875|521078247|FG001|Overall Study|Study Closed by Sponsor|29|||
144513273|NCT03358875|521078246|FG000|Overall Study|Withdrawal by Subject|13|||
144513274|NCT03358875|521078247|FG001|Overall Study|Withdrawal by Subject|16|||
144513275|NCT03358875|521078246|FG000|Overall Study|Lost to Follow-up|13|||
144513276|NCT03358875|521078247|FG001|Overall Study|Lost to Follow-up|2|||
144513277|NCT03358875|521078246|FG000|Overall Study|Miscellaneous|33|||
144513278|NCT03358875|521078247|FG001|Overall Study|Miscellaneous|0|||
144513279|NCT03358875|521078246|FG000|Overall Study|Remained on Study|1|||
144513280|NCT03358875|521078247|FG001|Overall Study|Remained on Study|0|||
144513281|NCT06194214|521078263|FG000|Overall Study|Adverse Event|1|||
144513282|NCT04468776|521078264|FG000|Overall Study|Lost to Follow-up|4|||
144513283|NCT04468776|521078265|FG001|Overall Study|Lost to Follow-up|3|||
144513284|NCT04468776|521078266|FG002|Overall Study|Lost to Follow-up|4|||
144513285|NCT04468776|521078264|FG000|Overall Study|Withdrawal by Subject|1|||
144513286|NCT04468776|521078265|FG001|Overall Study|Withdrawal by Subject|10|||
144513287|NCT04468776|521078266|FG002|Overall Study|Withdrawal by Subject|4|||
144513288|NCT04468776|521078264|FG000|Overall Study|Physician Decision|0|||
144513289|NCT04468776|521078265|FG001|Overall Study|Physician Decision|1|||
144513290|NCT04468776|521078266|FG002|Overall Study|Physician Decision|1|||
144513291|NCT05687903|521078267|FG000|Overall Study|Protocol Deviation|1|||
144513292|NCT05687903|521078268|FG001|Overall Study|Protocol Deviation|1|||
144513293|NCT05687903|521078269|FG002|Overall Study|Protocol Deviation|0|||
144513294|NCT05687903|521078270|FG003|Overall Study|Protocol Deviation|1|||
144513295|NCT05687903|521078271|FG004|Overall Study|Protocol Deviation|0|||
144513296|NCT05613205|521078272|FG000|Overall Study|Lost to Follow-up|0|||
144513297|NCT05613205|521078273|FG001|Overall Study|Lost to Follow-up|0|||
144513298|NCT05613205|521078274|FG002|Overall Study|Lost to Follow-up|1|||
144513299|NCT05613205|521078275|FG003|Overall Study|Lost to Follow-up|1|||
144513300|NCT05613205|521078276|FG004|Overall Study|Lost to Follow-up|0|||
144513301|NCT05613205|521078272|FG000|Overall Study|Withdrawal by Subject|0|||
144513302|NCT05613205|521078273|FG001|Overall Study|Withdrawal by Subject|0|||
144513303|NCT05613205|521078274|FG002|Overall Study|Withdrawal by Subject|1|||
144513304|NCT05613205|521078275|FG003|Overall Study|Withdrawal by Subject|1|||
144513305|NCT05613205|521078276|FG004|Overall Study|Withdrawal by Subject|0|||
144513306|NCT04328727|521078282|FG000|Overall Study|Guardian Decision|1|||
144513307|NCT04328727|521078282|FG000|Overall Study|Participant decision|4|||
144513308|NCT04328727|521078282|FG000|Overall Study|Death|3|||
144513309|NCT04149002|521078283|FG000|Overall Study|Lost to Follow-up|1|||
144513310|NCT04149002|521078284|FG001|Overall Study|Lost to Follow-up|0|||
144513311|NCT04149002|521078283|FG000|Overall Study|Withdrawal by Subject|1|||
144513312|NCT04149002|521078284|FG001|Overall Study|Withdrawal by Subject|0|||
144513313|NCT04583423|521078285|FG000|Overall Study|Lost to Follow-up|0|||
144513314|NCT04583423|521078286|FG001|Overall Study|Lost to Follow-up|1|||
144513315|NCT04583423|521078287|FG002|Overall Study|Lost to Follow-up|0|||
144513316|NCT04583423|521078288|FG003|Overall Study|Lost to Follow-up|2|||
144513317|NCT04583423|521078285|FG000|Overall Study|Study Terminated by Sponsor|32|||
144513318|NCT04583423|521078286|FG001|Overall Study|Study Terminated by Sponsor|35|||
144513319|NCT04583423|521078287|FG002|Overall Study|Study Terminated by Sponsor|36|||
144513320|NCT04583423|521078288|FG003|Overall Study|Study Terminated by Sponsor|33|||
144513321|NCT04583423|521078285|FG000|Overall Study|Withdrawal by Subject|3|||
144513322|NCT04583423|521078286|FG001|Overall Study|Withdrawal by Subject|1|||
144513323|NCT04583423|521078287|FG002|Overall Study|Withdrawal by Subject|2|||
144513324|NCT04583423|521078288|FG003|Overall Study|Withdrawal by Subject|1|||
144513325|NCT04704284|521078289|FG000|Overall Study|Withdrawal by Subject|1|||
144513326|NCT03930420|521078294|FG000|Overall Study|Withdrawal by Subject|7|||
144513327|NCT03930420|521078295|FG001|Overall Study|Withdrawal by Subject|9|||
144513328|NCT01070069|521078296|FG000|Overall Study|Death|1|||
144513329|NCT01070069|521078297|FG001|Overall Study|Death|0|||
144513330|NCT01070069|521078298|FG002|Overall Study|Death|2|||
144513331|NCT01070069|521078299|FG003|Overall Study|Death|0|||
144513332|NCT01070069|521078300|FG004|Overall Study|Death|1|||
144378996|NCT00966875|520599449|FG005|Part B|Lost to Follow-up|0|||
144513333|NCT01070069|521078296|FG000|Overall Study|Withdrawal by Subject|1|||
144513334|NCT01070069|521078297|FG001|Overall Study|Withdrawal by Subject|1|||
144513335|NCT01070069|521078298|FG002|Overall Study|Withdrawal by Subject|4|||
144513336|NCT01070069|521078299|FG003|Overall Study|Withdrawal by Subject|0|||
144513337|NCT01070069|521078300|FG004|Overall Study|Withdrawal by Subject|0|||
144513338|NCT01070069|521078296|FG000|Overall Study|Lost to Follow-up|4|||
144513339|NCT01070069|521078297|FG001|Overall Study|Lost to Follow-up|1|||
144513340|NCT01070069|521078298|FG002|Overall Study|Lost to Follow-up|0|||
144513341|NCT01070069|521078299|FG003|Overall Study|Lost to Follow-up|0|||
144513342|NCT01070069|521078300|FG004|Overall Study|Lost to Follow-up|3|||
144513343|NCT04732338|521078308|FG000|Overall Study|Lost to Follow-up|3|||
144513344|NCT04732338|521078309|FG001|Overall Study|Lost to Follow-up|3|||
144513345|NCT02372253|521078310|FG000|Overall Study|Non Compliance|2|||
144513346|NCT02372253|521078311|FG001|Overall Study|Non Compliance|0|||
144513347|NCT00393484|521078312|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
144513348|NCT00393484|521078313|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
144513349|NCT00393484|521078312|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
144513350|NCT00393484|521078313|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
144513351|NCT00393484|521078312|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
144513352|NCT00393484|521078313|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
144513353|NCT00393484|521078312|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
144513354|NCT00393484|521078313|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
144513355|NCT00393484|521078312|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
144513356|NCT00393484|521078313|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
144513357|NCT00393484|521078312|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
144513358|NCT00393484|521078313|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
144513359|NCT00393484|521078312|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
144513360|NCT00393484|521078313|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
144513361|NCT00393484|521078312|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
144513362|NCT00393484|521078313|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
144513363|NCT00393484|521078312|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
144513364|NCT00393484|521078313|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
144513365|NCT00393484|521078312|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
144513366|NCT00393484|521078313|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
144513367|NCT03750968|521078314|FG000|Overall Study|Adverse Event|2|||
144513368|NCT03750968|521078315|FG001|Overall Study|Adverse Event|0|||
144513369|NCT03750968|521078314|FG000|Overall Study|Lost to Follow-up|1|||
144513370|NCT03750968|521078315|FG001|Overall Study|Lost to Follow-up|3|||
144513371|NCT03101371|521078323|FG000|Overall Study|Physician Decision|0|||
144513372|NCT03101371|521078324|FG001|Overall Study|Physician Decision|1|||
144513373|NCT03101371|521078323|FG000|Overall Study|Lost to Follow-up|1|||
144513374|NCT03101371|521078324|FG001|Overall Study|Lost to Follow-up|4|||
144513375|NCT03101371|521078323|FG000|Overall Study|Did not meet eligibility criteria|2|||
144513376|NCT03101371|521078324|FG001|Overall Study|Did not meet eligibility criteria|1|||
144513377|NCT01094184|521078327|FG000|Overall Study|Death|35|||
144513378|NCT01094184|521078328|FG001|Overall Study|Death|11|||
144513379|NCT02318134|521078329|FG000|Overall Study|Withdrawal by Subject|2|||
144513380|NCT02318134|521078330|FG001|Overall Study|Withdrawal by Subject|1|||
144513381|NCT00031694|521078335|FG000|Overall Study|Adverse Event|12|||
144513382|NCT00031694|521078335|FG000|Overall Study|Death|2|||
144513383|NCT00031694|521078335|FG000|Overall Study|Withdrawal by Subject|5|||
144513384|NCT04766034|521078336|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
144513385|NCT04766034|521078337|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
144513386|NCT04766034|521078338|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
144513387|NCT04766034|521078339|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
144513388|NCT04766034|521078340|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
144513389|NCT04766034|521078336|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
144513390|NCT04766034|521078337|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
144513391|NCT04766034|521078338|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
144513392|NCT04766034|521078339|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
144513393|NCT04766034|521078340|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
144378997|NCT00966875|520599450|FG006|Part B|Lost to Follow-up|0|||
144513394|NCT04766034|521078336|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
144513395|NCT04766034|521078337|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
144513396|NCT04766034|521078338|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
144378998|NCT00966875|520599451|FG007|Part B|Lost to Follow-up|0|||
144591095|NCT00126503|521364192|FG001|Overall Study|non-compliant|0|||
144378999|NCT00966875|520599452|FG008|Part B|Lost to Follow-up|1|||
144379000|NCT00966875|520599444|FG000|Part B|Physician Decision|0|||
144379001|NCT00966875|520599445|FG001|Part B|Physician Decision|0|||
144379002|NCT00966875|520599446|FG002|Part B|Physician Decision|1|||
144379003|NCT00966875|520599447|FG003|Part B|Physician Decision|0|||
144379004|NCT00966875|520599448|FG004|Part B|Physician Decision|2|||
144379005|NCT00966875|520599449|FG005|Part B|Physician Decision|1|||
144379006|NCT00966875|520599450|FG006|Part B|Physician Decision|0|||
144379007|NCT00966875|520599451|FG007|Part B|Physician Decision|0|||
144379008|NCT00966875|520599452|FG008|Part B|Physician Decision|2|||
144379009|NCT00966875|520599444|FG000|Part B|Sponsor Decision|1|||
144379010|NCT00966875|520599445|FG001|Part B|Sponsor Decision|0|||
144379011|NCT00966875|520599446|FG002|Part B|Sponsor Decision|0|||
144379012|NCT00966875|520599447|FG003|Part B|Sponsor Decision|0|||
144379013|NCT00966875|520599448|FG004|Part B|Sponsor Decision|0|||
144379014|NCT00966875|520599449|FG005|Part B|Sponsor Decision|1|||
144379015|NCT00966875|520599450|FG006|Part B|Sponsor Decision|0|||
144379016|NCT00966875|520599451|FG007|Part B|Sponsor Decision|2|||
144379017|NCT00966875|520599452|FG008|Part B|Sponsor Decision|1|||
144379018|NCT00966875|520599444|FG000|Part B|Withdrawal by Subject|2|||
144379019|NCT00966875|520599445|FG001|Part B|Withdrawal by Subject|1|||
144379020|NCT00966875|520599446|FG002|Part B|Withdrawal by Subject|2|||
144379021|NCT00966875|520599447|FG003|Part B|Withdrawal by Subject|1|||
144379022|NCT00966875|520599448|FG004|Part B|Withdrawal by Subject|2|||
144379023|NCT00966875|520599449|FG005|Part B|Withdrawal by Subject|1|||
144379024|NCT00966875|520599450|FG006|Part B|Withdrawal by Subject|4|||
144379025|NCT00966875|520599451|FG007|Part B|Withdrawal by Subject|5|||
144379026|NCT00966875|520599452|FG008|Part B|Withdrawal by Subject|5|||
144379027|NCT00966875|520599444|FG000|Part B|Entry Criteria|0|||
144379028|NCT00966875|520599445|FG001|Part B|Entry Criteria|0|||
144379029|NCT00966875|520599446|FG002|Part B|Entry Criteria|0|||
144379030|NCT00966875|520599447|FG003|Part B|Entry Criteria|0|||
144379031|NCT00966875|520599448|FG004|Part B|Entry Criteria|0|||
144513397|NCT04766034|521078339|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
144513398|NCT04766034|521078340|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
144513399|NCT04766034|521078336|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
144513400|NCT04766034|521078337|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
144513401|NCT04766034|521078338|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
144513402|NCT04766034|521078339|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
144513403|NCT04766034|521078340|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
144513404|NCT01976312|521078341|FG000|Overall Study|Pregnancy|0|||
144513405|NCT01976312|521078342|FG001|Overall Study|Pregnancy|1|||
144513406|NCT01976312|521078341|FG000|Overall Study|Lost to Follow-up|2|||
144513407|NCT01976312|521078342|FG001|Overall Study|Lost to Follow-up|0|||
144513408|NCT01976312|521078341|FG000|Overall Study|Withdrawal by Subject|7|||
144513409|NCT01976312|521078342|FG001|Overall Study|Withdrawal by Subject|2|||
144513410|NCT01976312|521078341|FG000|Overall Study|Adverse Event|6|||
144513411|NCT01976312|521078342|FG001|Overall Study|Adverse Event|6|||
144513412|NCT01976312|521078341|FG000|Overall Study|Protocol Violation|2|||
144513413|NCT01976312|521078342|FG001|Overall Study|Protocol Violation|0|||
144513414|NCT01538719|521078347|FG000|Overall Study|Lost to Follow-up|2|||
144513415|NCT01538719|521078348|FG001|Overall Study|Lost to Follow-up|0|||
144513416|NCT01609218|521078351|FG000|Period 1|Adverse Event|3|||
144513417|NCT01609218|521078352|FG001|Period 1|Adverse Event|5|||
144513418|NCT01609218|521078351|FG000|Period 1|Sponsor Decision|0|||
144513419|NCT01609218|521078352|FG001|Period 1|Sponsor Decision|1|||
144513420|NCT01609218|521078351|FG000|Period 2|Adverse Event|1|||
144513421|NCT01609218|521078352|FG001|Period 2|Adverse Event|0|||
144513422|NCT04992390|521078355|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
144513423|NCT04992390|521078356|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
144513424|NCT04992390|521078357|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
144513425|NCT04992390|521078355|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
144513426|NCT04992390|521078356|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
144513427|NCT04992390|521078357|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
144513428|NCT04992390|521078355|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
144513429|NCT04992390|521078356|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
144513430|NCT04992390|521078357|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
144379032|NCT00966875|520599449|FG005|Part B|Entry Criteria|0|||
144379033|NCT00966875|520599450|FG006|Part B|Entry Criteria|1|||
144379034|NCT00966875|520599451|FG007|Part B|Entry Criteria|0|||
144379035|NCT00966875|520599452|FG008|Part B|Entry Criteria|1|||
144379036|NCT01589653|520599455|FG000|Overall Study|Protocol Violation|3|||
144379037|NCT01589653|520599456|FG001|Overall Study|Protocol Violation|1|||
144379038|NCT01589653|520599455|FG000|Overall Study|Withdrawal criteria|4|||
144379039|NCT01589653|520599456|FG001|Overall Study|Withdrawal criteria|7|||
144379040|NCT01589653|520599455|FG000|Overall Study|Unclassified|0|||
144379041|NCT01589653|520599456|FG001|Overall Study|Unclassified|3|||
144721788|NCT01166568|521835294|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
144721789|NCT01166568|521835295|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
144721790|NCT01166568|521835296|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
144721791|NCT01166568|521835294|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
144721792|NCT01166568|521835295|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
144721793|NCT01166568|521835296|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
144721794|NCT03335371|521835297|FG000|Overall Study|Lost to Follow-up|0|||
144721795|NCT03335371|521835298|FG001|Overall Study|Lost to Follow-up|0|||
144721796|NCT03335371|521835299|FG002|Overall Study|Lost to Follow-up|0|||
144721797|NCT03335371|521835300|FG003|Overall Study|Lost to Follow-up|0|||
144721798|NCT03335371|521835301|FG004|Overall Study|Lost to Follow-up|1|||
144721799|NCT03335371|521835297|FG000|Overall Study|Withdrawal by Subject|0|||
144721800|NCT03335371|521835298|FG001|Overall Study|Withdrawal by Subject|0|||
144721801|NCT03335371|521835299|FG002|Overall Study|Withdrawal by Subject|0|||
144379042|NCT01536067|520599457|FG000|Overall Study|Disease Progression|1|||
144379043|NCT04250077|520599458|FG000|Overall Study|Withdrawal by Subject|0|||
144379044|NCT04250077|520599459|FG001|Overall Study|Withdrawal by Subject|1|||
144379045|NCT04250077|520599460|FG002|Overall Study|Withdrawal by Subject|0|||
144379046|NCT04250077|520599458|FG000|Overall Study|Lost to Follow-up|2|||
144379047|NCT04250077|520599459|FG001|Overall Study|Lost to Follow-up|3|||
144379048|NCT04250077|520599460|FG002|Overall Study|Lost to Follow-up|0|||
144379049|NCT04540198|520599461|FG000|Overall Study|Lost to Follow-up|25|||
144379050|NCT04540198|520599462|FG001|Overall Study|Lost to Follow-up|23|||
144379051|NCT04540198|520599461|FG000|Overall Study|Withdrawal by Subject|15|||
144379052|NCT04540198|520599462|FG001|Overall Study|Withdrawal by Subject|9|||
144379053|NCT04540198|520599461|FG000|Overall Study|Discontinued|1|||
144379054|NCT04540198|520599462|FG001|Overall Study|Discontinued|0|||
144379055|NCT01086358|520599463|FG000|First Intervention|Lost to Follow-up|9|||
144379056|NCT01086358|520599464|FG001|First Intervention|Lost to Follow-up|4|||
144379057|NCT01086358|520599463|FG000|First Intervention|Withdrawal by Subject|0|||
144379058|NCT01086358|520599464|FG001|First Intervention|Withdrawal by Subject|1|||
144379059|NCT01086358|520599463|FG000|Second Intervention|Lost to Follow-up|4|||
144379060|NCT01086358|520599464|FG001|Second Intervention|Lost to Follow-up|4|||
144379061|NCT03899805|520599465|FG000|Overall Study|Physician Decision|3|||
144379062|NCT03899805|520599466|FG001|Overall Study|Physician Decision|0|||
144379063|NCT03899805|520599467|FG002|Overall Study|Physician Decision|2|||
144379064|NCT03899805|520599465|FG000|Overall Study|Withdrawal by Subject|1|||
144379065|NCT03899805|520599466|FG001|Overall Study|Withdrawal by Subject|0|||
144379066|NCT03899805|520599467|FG002|Overall Study|Withdrawal by Subject|2|||
144379067|NCT03899805|520599465|FG000|Overall Study|Progressive Disease|10|||
144379068|NCT03899805|520599466|FG001|Overall Study|Progressive Disease|18|||
144379069|NCT03899805|520599467|FG002|Overall Study|Progressive Disease|12|||
144379070|NCT03899805|520599465|FG000|Overall Study|Adverse Event|3|||
144379071|NCT03899805|520599466|FG001|Overall Study|Adverse Event|1|||
144379072|NCT03899805|520599467|FG002|Overall Study|Adverse Event|0|||
144379073|NCT03899805|520599465|FG000|Overall Study|Death|2|||
144379074|NCT03899805|520599466|FG001|Overall Study|Death|0|||
144379075|NCT03899805|520599467|FG002|Overall Study|Death|0|||
144379076|NCT03899805|520599465|FG000|Overall Study|Came off for surgery|0|||
144379077|NCT03899805|520599466|FG001|Overall Study|Came off for surgery|0|||
144379078|NCT03899805|520599467|FG002|Overall Study|Came off for surgery|1|||
144379079|NCT03317405|520599468|FG000|Overall Study|Withdrawal by Subject|1|||
144379080|NCT03317405|520599469|FG001|Overall Study|Withdrawal by Subject|0|||
144379081|NCT03317405|520599470|FG002|Overall Study|Withdrawal by Subject|0|||
144379082|NCT03317405|520599468|FG000|Overall Study|Physician Decision|0|||
144379083|NCT03317405|520599469|FG001|Overall Study|Physician Decision|0|||
144379084|NCT03317405|520599470|FG002|Overall Study|Physician Decision|1|||
144379085|NCT03317405|520599468|FG000|Overall Study|Surgery Rescheduled|0|||
144379086|NCT03317405|520599469|FG001|Overall Study|Surgery Rescheduled|1|||
144379087|NCT03317405|520599470|FG002|Overall Study|Surgery Rescheduled|0|||
144379088|NCT04075734|520599473|FG000|Overall Study|Lost to Follow-up|1|||
144379089|NCT04075734|520599474|FG001|Overall Study|Lost to Follow-up|1|||
144379090|NCT04075734|520599475|FG002|Overall Study|Lost to Follow-up|0|||
144379091|NCT04075734|520599473|FG000|Overall Study|Withdrawal by Subject|3|||
144379092|NCT04075734|520599474|FG001|Overall Study|Withdrawal by Subject|0|||
144379093|NCT04075734|520599475|FG002|Overall Study|Withdrawal by Subject|0|||
144379094|NCT01137604|520599476|FG000|Overall Study|Adverse Event|3|||
144379095|NCT01137604|520599477|FG001|Overall Study|Adverse Event|6|||
144379096|NCT01137604|520599478|FG002|Overall Study|Adverse Event|9|||
144379097|NCT01137604|520599479|FG003|Overall Study|Adverse Event|9|||
144379098|NCT01137604|520599476|FG000|Overall Study|Participant Choice|0|||
144379099|NCT01137604|520599477|FG001|Overall Study|Participant Choice|2|||
144379100|NCT01137604|520599478|FG002|Overall Study|Participant Choice|2|||
144379101|NCT01137604|520599479|FG003|Overall Study|Participant Choice|0|||
144379102|NCT01137604|520599476|FG000|Overall Study|Withdrawal of consent|0|||
144379103|NCT01137604|520599477|FG001|Overall Study|Withdrawal of consent|0|||
144379104|NCT01137604|520599478|FG002|Overall Study|Withdrawal of consent|0|||
144379105|NCT01137604|520599479|FG003|Overall Study|Withdrawal of consent|2|||
144379106|NCT01137604|520599476|FG000|Overall Study|Clinical progression/deterioration|1|||
144379107|NCT01137604|520599477|FG001|Overall Study|Clinical progression/deterioration|2|||
144379108|NCT01137604|520599478|FG002|Overall Study|Clinical progression/deterioration|2|||
144379109|NCT01137604|520599479|FG003|Overall Study|Clinical progression/deterioration|0|||
144379110|NCT00591318|520599480|FG000|Overall Study|Lack of Efficacy|2|||
144379111|NCT00591318|520599481|FG001|Overall Study|Lack of Efficacy|0|||
144379112|NCT00591318|520599480|FG000|Overall Study|Adverse Event|2|||
144379113|NCT00591318|520599481|FG001|Overall Study|Adverse Event|0|||
144379114|NCT01024309|520599487|FG000|Overall Study|Physician Decision|4|||
144379115|NCT01024309|520599488|FG001|Overall Study|Physician Decision|0|||
144379116|NCT01024309|520599487|FG000|Overall Study|Withdrawal by Subject|4|||
144379117|NCT01024309|520599488|FG001|Overall Study|Withdrawal by Subject|4|||
144379118|NCT02745145|520599491|FG000|Overall Study|Adverse Event|1|||
144379119|NCT02745145|520599492|FG001|Overall Study|Adverse Event|0|||
144379120|NCT02745145|520599493|FG002|Overall Study|Adverse Event|0|||
144379121|NCT02745145|520599491|FG000|Overall Study|Death|0|||
144379122|NCT02745145|520599492|FG001|Overall Study|Death|1|||
144379123|NCT02745145|520599493|FG002|Overall Study|Death|0|||
144379124|NCT02745145|520599491|FG000|Overall Study|Progressive disease|0|||
144379125|NCT02745145|520599492|FG001|Overall Study|Progressive disease|0|||
144379126|NCT02745145|520599493|FG002|Overall Study|Progressive disease|1|||
144379127|NCT02745145|520599491|FG000|Overall Study|Withdrew consent|1|||
144379128|NCT02745145|520599492|FG001|Overall Study|Withdrew consent|1|||
144379129|NCT02745145|520599493|FG002|Overall Study|Withdrew consent|1|||
144379130|NCT02745145|520599491|FG000|Overall Study|Study Termination|8|||
144379131|NCT02745145|520599492|FG001|Overall Study|Study Termination|3|||
144379132|NCT02745145|520599493|FG002|Overall Study|Study Termination|7|||
144379133|NCT02640508|520599498|FG000|Overall Study|Death|19|||
144379134|NCT02640508|520599498|FG000|Overall Study|Withdrawal by Subject|8|||
144379135|NCT02640508|520599498|FG000|Overall Study|Physician Decision|1|||
144379136|NCT02640508|520599498|FG000|Overall Study|Lost to Follow-up|1|||
144379137|NCT05405257|520599499|FG000|Overall Study|Withdrawal by Subject|1|||
144379138|NCT03116152|520599500|FG000|Overall Study|Disease Progression|49|||
144379139|NCT03116152|520599501|FG001|Overall Study|Disease Progression|47|||
144379140|NCT03116152|520599500|FG000|Overall Study|Death|5|||
144379141|NCT03116152|520599501|FG001|Overall Study|Death|2|||
144379142|NCT03116152|520599500|FG000|Overall Study|Adverse Event|21|||
144379143|NCT03116152|520599501|FG001|Overall Study|Adverse Event|7|||
144513431|NCT04992390|521078355|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
144513432|NCT04992390|521078356|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
144513433|NCT04992390|521078357|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
144513434|NCT04992390|521078355|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
144513435|NCT04992390|521078356|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
144513436|NCT04992390|521078357|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
144513437|NCT04992390|521078355|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
144513438|NCT04992390|521078356|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
144513439|NCT04992390|521078357|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
144513440|NCT04992390|521078355|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
144513441|NCT04992390|521078356|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
144513442|NCT04992390|521078357|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
144513443|NCT04992390|521078355|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
144513444|NCT04992390|521078356|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
144513445|NCT04992390|521078357|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
144513446|NCT04992390|521078355|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
144513447|NCT04992390|521078356|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
144513448|NCT04992390|521078357|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
144513449|NCT04992390|521078355|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
144513450|NCT04992390|521078356|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
144513451|NCT04992390|521078357|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
144513452|NCT04992390|521078355|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
144513453|NCT04992390|521078356|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
144513454|NCT04992390|521078357|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
144513455|NCT04992390|521078355|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
144513456|NCT04992390|521078356|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
144513457|NCT04992390|521078357|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
144513458|NCT04992390|521078355|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
144513459|NCT04992390|521078356|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
144513460|NCT04992390|521078357|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
144513461|NCT04992390|521078355|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
144513462|NCT04992390|521078356|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
144513463|NCT04992390|521078357|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
144513464|NCT04992390|521078355|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
144379144|NCT03116152|520599500|FG000|Overall Study|Protocol Violation|2|||
144513465|NCT04992390|521078356|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
144513466|NCT04992390|521078357|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
144513467|NCT04992390|521078355|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
144379145|NCT03116152|520599501|FG001|Overall Study|Protocol Violation|2|||
144379146|NCT03116152|520599500|FG000|Overall Study|Withdrawal by Subject|0|||
144379147|NCT03116152|520599501|FG001|Overall Study|Withdrawal by Subject|1|||
144379148|NCT03116152|520599500|FG000|Overall Study|Physician Decision|3|||
144591096|NCT00126503|521364191|FG000|Overall Study|Physician Decision|2|||
144591097|NCT00126503|521364192|FG001|Overall Study|Physician Decision|1|||
144591098|NCT02457559|521364193|FG000|Overall Study|Progressive Disease|1|||
144591099|NCT02457559|521364194|FG001|Overall Study|Progressive Disease|2|||
144591100|NCT02457559|521364195|FG002|Overall Study|Progressive Disease|3|||
144591101|NCT02457559|521364196|FG003|Overall Study|Progressive Disease|0|||
144591102|NCT02457559|521364197|FG004|Overall Study|Progressive Disease|0|||
144591103|NCT02457559|521364198|FG005|Overall Study|Progressive Disease|2|||
144591104|NCT02457559|521364199|FG006|Overall Study|Progressive Disease|1|||
144591105|NCT02457559|521364200|FG007|Overall Study|Progressive Disease|0|||
144591106|NCT02457559|521364201|FG008|Overall Study|Progressive Disease|1|||
144591107|NCT02457559|521364202|FG009|Overall Study|Progressive Disease|1|||
144591108|NCT02457559|521364203|FG010|Overall Study|Progressive Disease|1|||
144591109|NCT02457559|521364193|FG000|Overall Study|Investigator's Discretion|0|||
144591110|NCT02457559|521364194|FG001|Overall Study|Investigator's Discretion|0|||
144591111|NCT02457559|521364195|FG002|Overall Study|Investigator's Discretion|2|||
144591112|NCT02457559|521364196|FG003|Overall Study|Investigator's Discretion|0|||
144591113|NCT02457559|521364197|FG004|Overall Study|Investigator's Discretion|1|||
144591114|NCT02457559|521364198|FG005|Overall Study|Investigator's Discretion|0|||
144591115|NCT02457559|521364199|FG006|Overall Study|Investigator's Discretion|1|||
144591116|NCT02457559|521364200|FG007|Overall Study|Investigator's Discretion|0|||
144591117|NCT02457559|521364201|FG008|Overall Study|Investigator's Discretion|1|||
144591118|NCT02457559|521364202|FG009|Overall Study|Investigator's Discretion|0|||
144591119|NCT02457559|521364203|FG010|Overall Study|Investigator's Discretion|1|||
144591120|NCT02457559|521364193|FG000|Overall Study|Adverse Event|0|||
144591121|NCT02457559|521364194|FG001|Overall Study|Adverse Event|1|||
144591122|NCT02457559|521364195|FG002|Overall Study|Adverse Event|2|||
144591123|NCT02457559|521364196|FG003|Overall Study|Adverse Event|0|||
144591124|NCT02457559|521364197|FG004|Overall Study|Adverse Event|0|||
144591125|NCT02457559|521364198|FG005|Overall Study|Adverse Event|0|||
144591126|NCT02457559|521364199|FG006|Overall Study|Adverse Event|0|||
144591127|NCT02457559|521364200|FG007|Overall Study|Adverse Event|0|||
144591128|NCT02457559|521364201|FG008|Overall Study|Adverse Event|0|||
144591129|NCT02457559|521364202|FG009|Overall Study|Adverse Event|0|||
144591130|NCT02457559|521364203|FG010|Overall Study|Adverse Event|0|||
144591131|NCT02457559|521364193|FG000|Overall Study|Reason not Specified|1|||
144591132|NCT02457559|521364194|FG001|Overall Study|Reason not Specified|0|||
144591133|NCT02457559|521364195|FG002|Overall Study|Reason not Specified|0|||
144591134|NCT02457559|521364196|FG003|Overall Study|Reason not Specified|0|||
144591135|NCT02457559|521364197|FG004|Overall Study|Reason not Specified|0|||
144591136|NCT02457559|521364198|FG005|Overall Study|Reason not Specified|0|||
144591137|NCT02457559|521364199|FG006|Overall Study|Reason not Specified|0|||
144591138|NCT02457559|521364200|FG007|Overall Study|Reason not Specified|0|||
144591139|NCT02457559|521364201|FG008|Overall Study|Reason not Specified|0|||
144591140|NCT02457559|521364202|FG009|Overall Study|Reason not Specified|2|||
144591141|NCT02457559|521364203|FG010|Overall Study|Reason not Specified|0|||
144591142|NCT02457559|521364193|FG000|Overall Study|Death|0|||
144591143|NCT02457559|521364194|FG001|Overall Study|Death|0|||
144591144|NCT02457559|521364195|FG002|Overall Study|Death|0|||
144591145|NCT02457559|521364196|FG003|Overall Study|Death|0|||
144591146|NCT02457559|521364197|FG004|Overall Study|Death|0|||
144591147|NCT02457559|521364198|FG005|Overall Study|Death|0|||
144591148|NCT02457559|521364199|FG006|Overall Study|Death|0|||
144591149|NCT02457559|521364200|FG007|Overall Study|Death|0|||
144591150|NCT02457559|521364201|FG008|Overall Study|Death|1|||
144591151|NCT02457559|521364202|FG009|Overall Study|Death|1|||
144591152|NCT02457559|521364203|FG010|Overall Study|Death|0|||
144591153|NCT00998335|521364206|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
144591154|NCT00998335|521364207|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
144591155|NCT02374671|521364208|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
144591156|NCT02374671|521364209|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
144591157|NCT02374671|521364210|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
144591158|NCT02374671|521364208|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
144591159|NCT02374671|521364209|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
144591160|NCT02374671|521364210|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
144591161|NCT02374671|521364208|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
144591162|NCT02374671|521364209|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
144591163|NCT02374671|521364210|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
144591164|NCT02374671|521364208|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
144591165|NCT02374671|521364209|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
144591166|NCT02374671|521364210|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
144379149|NCT03116152|520599501|FG001|Overall Study|Physician Decision|2|||
144591167|NCT02374671|521364208|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
144591168|NCT02374671|521364209|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
144591169|NCT02374671|521364210|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
144591170|NCT02495792|521364213|FG000|Overall Study|Lost to Follow-up|5|||
144591171|NCT02495792|521364214|FG001|Overall Study|Lost to Follow-up|9|||
144379150|NCT03116152|520599500|FG000|Overall Study|other|11|||
144379151|NCT03116152|520599501|FG001|Overall Study|other|34|||
144379152|NCT00862641|520599502|FG000|Overall Study|Randomized, but drug not received|1|||
144591172|NCT02495792|521364213|FG000|Overall Study|Protocol Violation|32|||
144591173|NCT02495792|521364214|FG001|Overall Study|Protocol Violation|31|||
144591174|NCT02523599|521364215|FG000|Overall Study|Adverse Event|1|||
144591175|NCT02523599|521364216|FG001|Overall Study|Adverse Event|0|||
144591176|NCT02523599|521364215|FG000|Overall Study|Physician Decision|1|||
144591177|NCT02523599|521364216|FG001|Overall Study|Physician Decision|0|||
144591178|NCT02523599|521364215|FG000|Overall Study|Lost to Follow-up|4|||
144591179|NCT02523599|521364216|FG001|Overall Study|Lost to Follow-up|1|||
144591180|NCT02523599|521364215|FG000|Overall Study|Did not return for Day 30 visit|2|||
144591181|NCT02523599|521364216|FG001|Overall Study|Did not return for Day 30 visit|0|||
144591182|NCT06729606|521364229|FG000|Overall Study|Adverse Event|0|||
144591183|NCT06729606|521364230|FG001|Overall Study|Adverse Event|2|||
144591184|NCT06729606|521364229|FG000|Overall Study|Death|1|||
144591185|NCT06729606|521364230|FG001|Overall Study|Death|0|||
144591186|NCT06729606|521364229|FG000|Overall Study|Physician Decision|0|||
144591187|NCT06729606|521364230|FG001|Overall Study|Physician Decision|1|||
144591188|NCT06729606|521364229|FG000|Overall Study|Withdrawal by Subject|2|||
144591189|NCT06729606|521364230|FG001|Overall Study|Withdrawal by Subject|4|||
144591190|NCT03570892|521364231|FG000|Overall Study|Death|51|||
144591191|NCT03570892|521364232|FG001|Overall Study|Death|45|||
144591192|NCT03570892|521364231|FG000|Overall Study|Subject decision|5|||
144591193|NCT03570892|521364232|FG001|Overall Study|Subject decision|3|||
144591194|NCT03570892|521364231|FG000|Overall Study|Protocol Violation|1|||
144591195|NCT03570892|521364232|FG001|Overall Study|Protocol Violation|4|||
144591196|NCT03570892|521364231|FG000|Overall Study|Physician Decision|0|||
144591197|NCT03570892|521364232|FG001|Overall Study|Physician Decision|2|||
144591198|NCT00729378|521366237|FG000|Baseline|Did not complete study measurements|72|||
144591199|NCT00729378|521366238|FG001|Baseline|Did not complete study measurements|33|||
144591200|NCT00729378|521366237|FG000|Baseline|Withdrawal by Subject|66|||
144591201|NCT00729378|521366238|FG001|Baseline|Withdrawal by Subject|59|||
144591202|NCT00729378|521366237|FG000|12-months|Lost to Follow-up|100|||
144591203|NCT00729378|521366238|FG001|12-months|Lost to Follow-up|65|||
144591204|NCT00729378|521366237|FG000|24-months|Lost to Follow-up|72|||
144591205|NCT00729378|521366238|FG001|24-months|Lost to Follow-up|51|||
144591206|NCT00729378|521366237|FG000|36-months|Lost to Follow-up|15|||
144591207|NCT00729378|521366238|FG001|36-months|Lost to Follow-up|6|||
144591208|NCT03057977|521366243|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
144591209|NCT03057977|521366244|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
144591210|NCT03057977|521366243|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
144591211|NCT03057977|521366244|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
144591212|NCT03057977|521366243|FG000|Discontinuation From Treatment|Protocol Violation|6|||
144591213|NCT03057977|521366244|FG001|Discontinuation From Treatment|Protocol Violation|5|||
144591214|NCT03057977|521366243|FG000|Discontinuation From Treatment|Not treated|4|||
144591215|NCT03057977|521366244|FG001|Discontinuation From Treatment|Not treated|0|||
144591216|NCT03057977|521366243|FG000|Discontinuation From Treatment|Adverse Event|343|||
144591217|NCT03057977|521366244|FG001|Discontinuation From Treatment|Adverse Event|337|||
144591218|NCT03057977|521366243|FG000|Discontinuation From Treatment|Reason Unknown|0|||
144591219|NCT03057977|521366244|FG001|Discontinuation From Treatment|Reason Unknown|1|||
144591220|NCT03057977|521366243|FG000|Discontinuation From Treatment|Personal Reasons|1|||
144591221|NCT03057977|521366244|FG001|Discontinuation From Treatment|Personal Reasons|1|||
144591222|NCT03057977|521366243|FG000|Discontinuation From Treatment|Unblinded medication|1|||
144591223|NCT03057977|521366244|FG001|Discontinuation From Treatment|Unblinded medication|0|||
144591224|NCT03057977|521366243|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
144591225|NCT03057977|521366244|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
144591226|NCT03057977|521366243|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
144591227|NCT03057977|521366244|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
144591228|NCT03057977|521366243|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
144591229|NCT03057977|521366244|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
144591230|NCT03057977|521366243|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
144379153|NCT00862641|520599503|FG001|Overall Study|Randomized, but drug not received|4|||
144513468|NCT04992390|521078356|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
144513469|NCT04992390|521078357|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
144513470|NCT04939246|521078358|FG000|After Treatment|Death|4|||
144513471|NCT04939246|521078358|FG000|After Treatment|Lost to Follow-up|1|||
144513472|NCT04939246|521078358|FG000|After Treatment|Discharged to hospice|2|||
144513473|NCT04310735|521080137|FG000|Overall Study|Withdrawal by Subject|1|||
144513474|NCT04310735|521080138|FG001|Overall Study|Withdrawal by Subject|3|||
144513475|NCT04310735|521080139|FG002|Overall Study|Withdrawal by Subject|8|||
144513476|NCT04310735|521080137|FG000|Overall Study|Equipment malfunction|0|||
144513477|NCT04310735|521080138|FG001|Overall Study|Equipment malfunction|1|||
144513478|NCT04310735|521080139|FG002|Overall Study|Equipment malfunction|0|||
144513479|NCT03954184|521080140|FG000|Overall Study|Lost to Follow-up|500|||
144513480|NCT03954184|521080141|FG001|Overall Study|Lost to Follow-up|0|||
144513481|NCT03398200|521080142|FG000|Overall Study|Withdrawal by Subject|0|||
144513482|NCT03398200|521080143|FG001|Overall Study|Withdrawal by Subject|1|||
144513483|NCT04842500|521080146|FG000|Overall Study|Withdrawal by Subject|4|||
144513484|NCT04842500|521080147|FG001|Overall Study|Withdrawal by Subject|1|||
144513485|NCT04842500|521080148|FG002|Overall Study|Withdrawal by Subject|2|||
144513486|NCT04842500|521080149|FG003|Overall Study|Withdrawal by Subject|3|||
144513487|NCT04842500|521080146|FG000|Overall Study|Protocol Violation|1|||
144513488|NCT04842500|521080147|FG001|Overall Study|Protocol Violation|0|||
144513489|NCT04842500|521080148|FG002|Overall Study|Protocol Violation|0|||
144513490|NCT04842500|521080149|FG003|Overall Study|Protocol Violation|1|||
144513491|NCT05104697|521080152|FG000|Overall Study|Withdrawal by Subject|0|||
144513492|NCT05104697|521080153|FG001|Overall Study|Withdrawal by Subject|1|||
144513493|NCT03845465|521080154|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
144513494|NCT03845465|521080155|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
144513495|NCT03845465|521080154|FG000|6-month Data Collection|Withdrawal by Subject|0|||
144513496|NCT03845465|521080155|FG001|6-month Data Collection|Withdrawal by Subject|2|||
144513497|NCT03845465|521080154|FG000|12-month Data Collection|Withdrawal by Subject|0|||
144513498|NCT03845465|521080155|FG001|12-month Data Collection|Withdrawal by Subject|2|||
144513499|NCT05952076|521080158|FG000|Overall Study|Death|1|||
144513500|NCT05952076|521080159|FG001|Overall Study|Death|1|||
144513501|NCT05952076|521080158|FG000|Overall Study|Lost to Follow-up|0|||
144513502|NCT05952076|521080159|FG001|Overall Study|Lost to Follow-up|1|||
144513503|NCT01704079|521080160|FG000|Overall Study|Withdrawal by Subject|5|||
144513504|NCT01704079|521080161|FG001|Overall Study|Withdrawal by Subject|7|||
144513505|NCT01704079|521080160|FG000|Overall Study|Lost to Follow-up|2|||
144513506|NCT01704079|521080161|FG001|Overall Study|Lost to Follow-up|5|||
144513507|NCT01704079|521080160|FG000|Overall Study|Adverse Event|4|||
144513508|NCT01704079|521080161|FG001|Overall Study|Adverse Event|7|||
144513509|NCT01704079|521080160|FG000|Overall Study|Protocol Violation|1|||
144513510|NCT01704079|521080161|FG001|Overall Study|Protocol Violation|0|||
144513511|NCT01704079|521080160|FG000|Overall Study|Subject noncompliance|2|||
144513512|NCT01704079|521080161|FG001|Overall Study|Subject noncompliance|3|||
144513513|NCT01704079|521080160|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
144513514|NCT01704079|521080161|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
144513515|NCT02015520|521080170|FG000|Overall Study|Lack of Efficacy|1|||
144513516|NCT02015520|521080171|FG001|Overall Study|Lack of Efficacy|0|||
144513517|NCT02015520|521080172|FG002|Overall Study|Lack of Efficacy|3|||
144513518|NCT02015520|521080173|FG003|Overall Study|Lack of Efficacy|2|||
144513519|NCT02015520|521080170|FG000|Overall Study|Adverse Event|0|||
144513520|NCT02015520|521080171|FG001|Overall Study|Adverse Event|0|||
144513521|NCT02015520|521080172|FG002|Overall Study|Adverse Event|0|||
144513522|NCT02015520|521080173|FG003|Overall Study|Adverse Event|1|||
144513523|NCT02015520|521080170|FG000|Overall Study|Withdrawal by Subject|2|||
144513524|NCT02015520|521080171|FG001|Overall Study|Withdrawal by Subject|2|||
144513525|NCT02015520|521080172|FG002|Overall Study|Withdrawal by Subject|1|||
144513526|NCT02015520|521080173|FG003|Overall Study|Withdrawal by Subject|0|||
144513527|NCT02015520|521080170|FG000|Overall Study|Death|1|||
144513528|NCT02015520|521080171|FG001|Overall Study|Death|0|||
144513529|NCT02015520|521080172|FG002|Overall Study|Death|0|||
144513530|NCT02015520|521080173|FG003|Overall Study|Death|0|||
144513531|NCT02015520|521080170|FG000|Overall Study|Lost to Follow-up|0|||
144513532|NCT02015520|521080171|FG001|Overall Study|Lost to Follow-up|0|||
144513533|NCT02015520|521080172|FG002|Overall Study|Lost to Follow-up|1|||
144513534|NCT02015520|521080173|FG003|Overall Study|Lost to Follow-up|0|||
144513535|NCT02015520|521080170|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
144513536|NCT02015520|521080171|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
144513537|NCT02015520|521080172|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
144513538|NCT02015520|521080173|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
144513539|NCT02015520|521080170|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
144379154|NCT00862641|520599504|FG002|Overall Study|Randomized, but drug not received|1|||
144513540|NCT02015520|521080171|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
144513541|NCT02015520|521080172|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
144379155|NCT00862641|520599505|FG003|Overall Study|Randomized, but drug not received|4|||
144379156|NCT03179605|520599506|FG000|Overall Study|Withdrawal by Subject|1|||
144379157|NCT00635999|520599507|FG000|Overall Study|Withdrawal by Subject|4|||
144379158|NCT00635999|520599508|FG001|Overall Study|Withdrawal by Subject|2|||
144379159|NCT00635999|520599509|FG002|Overall Study|Withdrawal by Subject|1|||
144379160|NCT00711477|520599510|FG000|Overall Study|Adverse Event|3|||
144379161|NCT00711477|520599511|FG001|Overall Study|Adverse Event|1|||
144379162|NCT00711477|520599510|FG000|Overall Study|Lost to Follow-up|0|||
144379163|NCT00711477|520599511|FG001|Overall Study|Lost to Follow-up|1|||
144379164|NCT00711477|520599510|FG000|Overall Study|Noncompliance|0|||
144379165|NCT00711477|520599511|FG001|Overall Study|Noncompliance|1|||
144379166|NCT01798849|520599512|FG000|Overall Study|Physician Decision|0|||
144379167|NCT01798849|520599513|FG001|Overall Study|Physician Decision|0|||
144379168|NCT01798849|520599514|FG002|Overall Study|Physician Decision|1|||
144379169|NCT02636361|520599515|FG000|Period 4|Physician Decision|0|||
144379170|NCT02636361|520599516|FG001|Period 4|Physician Decision|0|||
144379171|NCT02636361|520599517|FG002|Period 4|Physician Decision|0|||
144379172|NCT02636361|520599518|FG003|Period 4|Physician Decision|1|||
144379173|NCT02636361|520599519|FG004|Period 4|Physician Decision|0|||
144379174|NCT02410343|520599525|FG000|Core Period (24 Weeks)|Adverse Event|1|||
144379175|NCT02410343|520599526|FG001|Core Period (24 Weeks)|Adverse Event|0|||
144379176|NCT02410343|520599525|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
144379177|NCT02410343|520599526|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
144379178|NCT02410343|520599525|FG000|Extension Period (12 Months)|Adverse Event|1|||
144379179|NCT02410343|520599526|FG001|Extension Period (12 Months)|Adverse Event|0|||
144379180|NCT02410343|520599525|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
144379181|NCT02410343|520599526|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
144379182|NCT02036853|520599527|FG000|Overall Study|Adverse Event|0|||
144379183|NCT02036853|520599528|FG001|Overall Study|Adverse Event|2|||
144379184|NCT02036853|520599527|FG000|Overall Study|Lack of Efficacy|0|||
144379185|NCT02036853|520599528|FG001|Overall Study|Lack of Efficacy|2|||
144379186|NCT02036853|520599527|FG000|Overall Study|Physician Decision|0|||
144379187|NCT02036853|520599528|FG001|Overall Study|Physician Decision|1|||
144379188|NCT02036853|520599527|FG000|Overall Study|Withdrawal by Subject|0|||
144379189|NCT02036853|520599528|FG001|Overall Study|Withdrawal by Subject|1|||
144379190|NCT00228553|520599529|FG000|Overall Study|Adverse Event|112|||
144379191|NCT00228553|520599529|FG000|Overall Study|Lack of Efficacy|34|||
144379192|NCT00228553|520599529|FG000|Overall Study|Lost to Follow-up|67|||
144379193|NCT00228553|520599529|FG000|Overall Study|Physician Decision|48|||
144379194|NCT00228553|520599529|FG000|Overall Study|Protocol Violation|6|||
144379195|NCT00228553|520599529|FG000|Overall Study|Withdrawal by Subject|115|||
144379196|NCT00228553|520599529|FG000|Overall Study|Pregnancy|2|||
144379197|NCT00228553|520599529|FG000|Overall Study|Miscellaneous|46|||
144379198|NCT04556383|520599532|FG000|PCP|Lack of Efficacy|28|||
144379199|NCT04556383|520599533|FG001|PCP|Lack of Efficacy|23|||
144379200|NCT04556383|520599534|FG002|PCP|Lack of Efficacy|23|||
144379201|NCT04556383|520599535|FG003|PCP|Lack of Efficacy|0|||
144379202|NCT04556383|520599532|FG000|PCP|Study terminated by sponsor|15|||
144379203|NCT04556383|520599533|FG001|PCP|Study terminated by sponsor|13|||
144379204|NCT04556383|520599534|FG002|PCP|Study terminated by sponsor|16|||
144379205|NCT04556383|520599535|FG003|PCP|Study terminated by sponsor|0|||
144379206|NCT04556383|520599532|FG000|PCP|Withdrawal by Subject|8|||
144513542|NCT02015520|521080173|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
144513543|NCT01610297|521080174|FG000|Overall Study|Lost to Follow-up|1|||
144513544|NCT02590432|521080178|FG000|Open-label Treatment Period|Adverse Event|97|||
144513545|NCT02590432|521080179|FG001|Open-label Treatment Period|Adverse Event|79|||
144513546|NCT02590432|521080180|FG002|Open-label Treatment Period|Adverse Event|0|||
144513547|NCT02590432|521080181|FG003|Open-label Treatment Period|Adverse Event|0|||
144513548|NCT02590432|521080182|FG004|Open-label Treatment Period|Adverse Event|0|||
144513549|NCT02590432|521080183|FG005|Open-label Treatment Period|Adverse Event|0|||
144513550|NCT02590432|521080184|FG006|Open-label Treatment Period|Adverse Event|0|||
144513551|NCT02590432|521080185|FG007|Open-label Treatment Period|Adverse Event|0|||
144513552|NCT02590432|521080186|FG008|Open-label Treatment Period|Adverse Event|0|||
144513553|NCT02590432|521080178|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
144513554|NCT02590432|521080179|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
144513555|NCT02590432|521080180|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
144379207|NCT04556383|520599533|FG001|PCP|Withdrawal by Subject|6|||
144199307|NCT00541970|519928867|FG001|Month 48|Withdrawal by Subject|4|||
144513556|NCT02590432|521080181|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
144379208|NCT04556383|520599534|FG002|PCP|Withdrawal by Subject|6|||
144513557|NCT02590432|521080182|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
144513558|NCT02590432|521080183|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
144513559|NCT02590432|521080184|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
144379209|NCT04556383|520599535|FG003|PCP|Withdrawal by Subject|0|||
144379210|NCT04556383|520599532|FG000|PCP|Adverse Event|1|||
144379211|NCT04556383|520599533|FG001|PCP|Adverse Event|7|||
144379212|NCT04556383|520599534|FG002|PCP|Adverse Event|7|||
144513560|NCT02590432|521080185|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
144513561|NCT02590432|521080186|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
144513562|NCT02590432|521080178|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
144513563|NCT02590432|521080179|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
144513564|NCT02590432|521080180|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
144513565|NCT02590432|521080181|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
144513566|NCT02590432|521080182|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
144513567|NCT02590432|521080183|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
144513568|NCT02590432|521080184|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
144513569|NCT02590432|521080185|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
144513570|NCT02590432|521080186|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
144513571|NCT02590432|521080178|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
144513572|NCT02590432|521080179|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
144513573|NCT02590432|521080180|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
144513574|NCT02590432|521080181|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
144513575|NCT02590432|521080182|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
144513576|NCT02590432|521080183|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
144513577|NCT02590432|521080184|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
144513578|NCT02590432|521080185|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
144513579|NCT02590432|521080186|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
144513580|NCT02590432|521080178|FG000|Open-label Treatment Period|Protocol Violation|10|||
144513581|NCT02590432|521080179|FG001|Open-label Treatment Period|Protocol Violation|4|||
144513582|NCT02590432|521080180|FG002|Open-label Treatment Period|Protocol Violation|0|||
144513583|NCT02590432|521080181|FG003|Open-label Treatment Period|Protocol Violation|0|||
144513584|NCT02590432|521080182|FG004|Open-label Treatment Period|Protocol Violation|0|||
144513585|NCT02590432|521080183|FG005|Open-label Treatment Period|Protocol Violation|0|||
144513586|NCT02590432|521080184|FG006|Open-label Treatment Period|Protocol Violation|0|||
144513587|NCT02590432|521080185|FG007|Open-label Treatment Period|Protocol Violation|0|||
144513588|NCT02590432|521080186|FG008|Open-label Treatment Period|Protocol Violation|0|||
144513589|NCT02590432|521080178|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
144513590|NCT02590432|521080179|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
144513591|NCT02590432|521080180|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513592|NCT02590432|521080181|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513593|NCT02590432|521080182|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513594|NCT02590432|521080183|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513595|NCT02590432|521080184|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513596|NCT02590432|521080185|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513597|NCT02590432|521080186|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
144513598|NCT02590432|521080178|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
144513599|NCT02590432|521080179|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
144513600|NCT02590432|521080180|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144379213|NCT04556383|520599535|FG003|PCP|Adverse Event|0|||
144379214|NCT04556383|520599532|FG000|PCP|Other, Not Specified|1|||
144513601|NCT02590432|521080181|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144513602|NCT02590432|521080182|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144513603|NCT02590432|521080183|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144513604|NCT02590432|521080184|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144513605|NCT02590432|521080185|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144513606|NCT02590432|521080186|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
144513607|NCT02590432|521080178|FG000|Double-blind Treatment Period|Adverse Event|0|||
144513608|NCT02590432|521080179|FG001|Double-blind Treatment Period|Adverse Event|0|||
144513609|NCT02590432|521080180|FG002|Double-blind Treatment Period|Adverse Event|14|||
144513610|NCT02590432|521080181|FG003|Double-blind Treatment Period|Adverse Event|12|||
144513611|NCT02590432|521080182|FG004|Double-blind Treatment Period|Adverse Event|6|||
144379215|NCT04556383|520599533|FG001|PCP|Other, Not Specified|2|||
144379216|NCT04556383|520599534|FG002|PCP|Other, Not Specified|1|||
144379217|NCT04556383|520599535|FG003|PCP|Other, Not Specified|0|||
144379218|NCT04556383|520599532|FG000|PCP|Protocol Violation|1|||
144379219|NCT04556383|520599533|FG001|PCP|Protocol Violation|0|||
144379220|NCT04556383|520599534|FG002|PCP|Protocol Violation|1|||
144379221|NCT04556383|520599535|FG003|PCP|Protocol Violation|0|||
144379222|NCT04556383|520599532|FG000|PCP|Lost to Follow-up|1|||
144379223|NCT04556383|520599533|FG001|PCP|Lost to Follow-up|0|||
144379224|NCT04556383|520599534|FG002|PCP|Lost to Follow-up|0|||
144379225|NCT04556383|520599535|FG003|PCP|Lost to Follow-up|0|||
144379226|NCT04556383|520599532|FG000|PCP|Physician Decision|0|||
144379227|NCT04556383|520599533|FG001|PCP|Physician Decision|1|||
144379228|NCT04556383|520599534|FG002|PCP|Physician Decision|0|||
144379229|NCT04556383|520599535|FG003|PCP|Physician Decision|0|||
144379230|NCT04556383|520599532|FG000|PCP|Site terminated by sponsor|0|||
144379231|NCT04556383|520599533|FG001|PCP|Site terminated by sponsor|1|||
144379232|NCT04556383|520599534|FG002|PCP|Site terminated by sponsor|0|||
144379233|NCT04556383|520599535|FG003|PCP|Site terminated by sponsor|0|||
144379234|NCT04556383|520599532|FG000|OLE|Study terminated by sponsor|0|||
144379235|NCT04556383|520599533|FG001|OLE|Study terminated by sponsor|0|||
144379236|NCT04556383|520599534|FG002|OLE|Study terminated by sponsor|0|||
144379237|NCT04556383|520599535|FG003|OLE|Study terminated by sponsor|68|||
144379238|NCT04556383|520599532|FG000|OLE|Withdrawal by Subject|0|||
144379239|NCT04556383|520599533|FG001|OLE|Withdrawal by Subject|0|||
144379240|NCT04556383|520599534|FG002|OLE|Withdrawal by Subject|0|||
144379241|NCT04556383|520599535|FG003|OLE|Withdrawal by Subject|10|||
144379242|NCT04556383|520599532|FG000|OLE|Lack of Efficacy|0|||
144379243|NCT04556383|520599533|FG001|OLE|Lack of Efficacy|0|||
144379244|NCT04556383|520599534|FG002|OLE|Lack of Efficacy|0|||
144379245|NCT04556383|520599535|FG003|OLE|Lack of Efficacy|7|||
144379246|NCT04556383|520599532|FG000|OLE|Adverse Event|0|||
144379247|NCT04556383|520599533|FG001|OLE|Adverse Event|0|||
144379248|NCT04556383|520599534|FG002|OLE|Adverse Event|0|||
144379249|NCT04556383|520599535|FG003|OLE|Adverse Event|2|||
144379250|NCT04556383|520599532|FG000|OLE|Other, Not Specified|0|||
144379251|NCT04556383|520599533|FG001|OLE|Other, Not Specified|0|||
144379252|NCT04556383|520599534|FG002|OLE|Other, Not Specified|0|||
144379253|NCT04556383|520599535|FG003|OLE|Other, Not Specified|2|||
144379254|NCT04556383|520599532|FG000|OLE|Death|0|||
144379255|NCT04556383|520599533|FG001|OLE|Death|0|||
144379256|NCT04556383|520599534|FG002|OLE|Death|0|||
144379257|NCT04556383|520599535|FG003|OLE|Death|1|||
144379258|NCT04556383|520599532|FG000|OLE|Lost to Follow-up|0|||
144379259|NCT04556383|520599533|FG001|OLE|Lost to Follow-up|0|||
144379260|NCT04556383|520599534|FG002|OLE|Lost to Follow-up|0|||
144379261|NCT04556383|520599535|FG003|OLE|Lost to Follow-up|1|||
144379262|NCT00884741|520599543|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
144379263|NCT00884741|520599544|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
144379264|NCT00884741|520599545|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
144379265|NCT00884741|520599546|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
144379266|NCT00884741|520599543|FG000|Step 1 Registration: Tissue Screening|Death|3|||
144379267|NCT00884741|520599544|FG001|Step 1 Registration: Tissue Screening|Death|0|||
144379268|NCT00884741|520599545|FG002|Step 1 Registration: Tissue Screening|Death|0|||
144379269|NCT00884741|520599546|FG003|Step 1 Registration: Tissue Screening|Death|0|||
144379270|NCT00884741|520599543|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
144379271|NCT00884741|520599544|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
144379272|NCT00884741|520599545|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
144379273|NCT00884741|520599546|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
144379274|NCT00884741|520599543|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
144379275|NCT00884741|520599544|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
144379276|NCT00884741|520599545|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
144379277|NCT00884741|520599546|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
144513612|NCT02590432|521080183|FG005|Double-blind Treatment Period|Adverse Event|22|||
144379278|NCT00884741|520599543|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
144379279|NCT00884741|520599544|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
144379280|NCT00884741|520599545|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
144379281|NCT00884741|520599546|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
144379282|NCT00884741|520599543|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
144379283|NCT00884741|520599544|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
144379284|NCT00884741|520599545|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
144379285|NCT00884741|520599546|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
144379286|NCT00884741|520599543|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
144379287|NCT00884741|520599544|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
144379288|NCT00884741|520599545|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
144379289|NCT00884741|520599546|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
144379290|NCT00884741|520599543|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
144513613|NCT02590432|521080184|FG006|Double-blind Treatment Period|Adverse Event|20|||
144513614|NCT02590432|521080185|FG007|Double-blind Treatment Period|Adverse Event|0|||
144513615|NCT02590432|521080186|FG008|Double-blind Treatment Period|Adverse Event|0|||
144513616|NCT02590432|521080178|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
144513617|NCT02590432|521080179|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
144513618|NCT02590432|521080180|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
144513619|NCT02590432|521080181|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
144513620|NCT02590432|521080182|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
144513621|NCT02590432|521080183|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
144513622|NCT02590432|521080184|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
144513623|NCT02590432|521080185|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
144513624|NCT02590432|521080186|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
144513625|NCT02590432|521080178|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
144513626|NCT02590432|521080179|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
144379291|NCT00884741|520599544|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
144513627|NCT02590432|521080180|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
144513628|NCT02590432|521080181|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
144513629|NCT02590432|521080182|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
144513630|NCT02590432|521080183|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
144513631|NCT02590432|521080184|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
144513632|NCT02590432|521080185|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
144513633|NCT02590432|521080186|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
144379292|NCT00884741|520599545|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
144379293|NCT00884741|520599546|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
144379294|NCT00884741|520599543|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
144379295|NCT00884741|520599544|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
144379296|NCT00884741|520599545|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
144379297|NCT00884741|520599546|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
144379298|NCT00884741|520599543|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
144379299|NCT00884741|520599544|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
144379300|NCT00884741|520599545|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
144379301|NCT00884741|520599546|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
144379302|NCT00884741|520599543|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
144379303|NCT00884741|520599544|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
144379304|NCT00884741|520599545|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
144379305|NCT00884741|520599546|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
144379306|NCT00884741|520599543|FG000|Randomization|Protocol Violation|0|||
144379307|NCT00884741|520599544|FG001|Randomization|Protocol Violation|0|||
144379308|NCT00884741|520599545|FG002|Randomization|Protocol Violation|8|||
144379309|NCT00884741|520599546|FG003|Randomization|Protocol Violation|8|||
144379310|NCT00335764|520599547|FG000|Overall Study|wrong histology|1|||
144379311|NCT00335764|520599548|FG001|Overall Study|wrong histology|0|||
144379312|NCT00335764|520599549|FG002|Overall Study|wrong histology|0|||
144379313|NCT00335764|520599550|FG003|Overall Study|wrong histology|0|||
144379314|NCT00335764|520599551|FG004|Overall Study|wrong histology|1|||
144379315|NCT04303195|520599552|FG000|Overall Study|Adverse Event|1|||
144379316|NCT04303195|520599553|FG001|Overall Study|Adverse Event|3|||
144379317|NCT04303195|520599554|FG002|Overall Study|Adverse Event|7|||
144379318|NCT04303195|520599555|FG003|Overall Study|Adverse Event|0|||
144379319|NCT04303195|520599552|FG000|Overall Study|Lost to Follow-up|1|||
144379320|NCT04303195|520599553|FG001|Overall Study|Lost to Follow-up|0|||
144379321|NCT04303195|520599554|FG002|Overall Study|Lost to Follow-up|1|||
144379322|NCT04303195|520599555|FG003|Overall Study|Lost to Follow-up|4|||
144379323|NCT04303195|520599552|FG000|Overall Study|Withdrawal by Subject|3|||
144379324|NCT04303195|520599553|FG001|Overall Study|Withdrawal by Subject|1|||
144379325|NCT04303195|520599554|FG002|Overall Study|Withdrawal by Subject|1|||
144379326|NCT04303195|520599555|FG003|Overall Study|Withdrawal by Subject|1|||
144379327|NCT04303195|520599552|FG000|Overall Study|No study drug administered or protocol deviation|0|||
144379328|NCT04303195|520599553|FG001|Overall Study|No study drug administered or protocol deviation|2|||
144379329|NCT04303195|520599554|FG002|Overall Study|No study drug administered or protocol deviation|0|||
144379330|NCT04303195|520599555|FG003|Overall Study|No study drug administered or protocol deviation|2|||
144379331|NCT01065454|520599556|FG000|Treatment|Adverse Event|7|||
144379332|NCT01065454|520599557|FG001|Treatment|Adverse Event|4|||
144379333|NCT01065454|520599558|FG002|Treatment|Adverse Event|3|||
144379334|NCT01065454|520599559|FG003|Treatment|Adverse Event|6|||
144379335|NCT01065454|520599556|FG000|Treatment|Death|1|||
144379336|NCT01065454|520599557|FG001|Treatment|Death|0|||
144379337|NCT01065454|520599558|FG002|Treatment|Death|0|||
144379338|NCT01065454|520599559|FG003|Treatment|Death|0|||
144379339|NCT01065454|520599556|FG000|Treatment|Non-compliance|1|||
144379340|NCT01065454|520599557|FG001|Treatment|Non-compliance|0|||
144379341|NCT01065454|520599558|FG002|Treatment|Non-compliance|0|||
144513634|NCT02590432|521080178|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144513635|NCT02590432|521080179|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
144513636|NCT02590432|521080180|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
144513637|NCT02590432|521080181|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
144513638|NCT02590432|521080182|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
144513639|NCT02590432|521080183|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
144513640|NCT02590432|521080184|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
144513641|NCT02590432|521080185|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
144513642|NCT02590432|521080186|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
144379342|NCT01065454|520599559|FG003|Treatment|Non-compliance|1|||
144379343|NCT01065454|520599556|FG000|Treatment|Protocol Decision|0|||
144379344|NCT01065454|520599557|FG001|Treatment|Protocol Decision|0|||
144379345|NCT01065454|520599558|FG002|Treatment|Protocol Decision|3|||
144379346|NCT01065454|520599559|FG003|Treatment|Protocol Decision|2|||
144379347|NCT01065454|520599556|FG000|Treatment|Protocol Violation|1|||
144379348|NCT01065454|520599557|FG001|Treatment|Protocol Violation|0|||
144379349|NCT01065454|520599558|FG002|Treatment|Protocol Violation|1|||
144379350|NCT01065454|520599559|FG003|Treatment|Protocol Violation|0|||
144379351|NCT01065454|520599556|FG000|Treatment|Withdrawal by Subject|3|||
144379352|NCT01065454|520599557|FG001|Treatment|Withdrawal by Subject|1|||
144513643|NCT02590432|521080178|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513644|NCT02590432|521080179|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513645|NCT02590432|521080180|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513646|NCT02590432|521080181|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513647|NCT02590432|521080182|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144379353|NCT01065454|520599558|FG002|Treatment|Withdrawal by Subject|2|||
144379354|NCT01065454|520599559|FG003|Treatment|Withdrawal by Subject|3|||
144379355|NCT01065454|520599556|FG000|Follow up|Adverse Event|1|||
144379356|NCT01065454|520599557|FG001|Follow up|Adverse Event|0|||
144379357|NCT01065454|520599558|FG002|Follow up|Adverse Event|0|||
144379358|NCT01065454|520599559|FG003|Follow up|Adverse Event|1|||
144379359|NCT01065454|520599556|FG000|Follow up|Death|0|||
144379360|NCT01065454|520599557|FG001|Follow up|Death|1|||
144379361|NCT01065454|520599558|FG002|Follow up|Death|1|||
144379362|NCT01065454|520599559|FG003|Follow up|Death|0|||
144379363|NCT01065454|520599556|FG000|Follow up|Lost to Follow-up|0|||
144379364|NCT01065454|520599557|FG001|Follow up|Lost to Follow-up|0|||
144379365|NCT01065454|520599558|FG002|Follow up|Lost to Follow-up|0|||
144379366|NCT01065454|520599559|FG003|Follow up|Lost to Follow-up|1|||
144379367|NCT01065454|520599556|FG000|Follow up|Progressive disease|0|||
144379368|NCT01065454|520599557|FG001|Follow up|Progressive disease|0|||
144379369|NCT01065454|520599558|FG002|Follow up|Progressive disease|0|||
144379370|NCT01065454|520599559|FG003|Follow up|Progressive disease|1|||
144379371|NCT01065454|520599556|FG000|Follow up|Withdrawal by Subject|1|||
144379372|NCT01065454|520599557|FG001|Follow up|Withdrawal by Subject|1|||
144379373|NCT01065454|520599558|FG002|Follow up|Withdrawal by Subject|1|||
144379374|NCT01065454|520599559|FG003|Follow up|Withdrawal by Subject|0|||
144379375|NCT01065454|520599556|FG000|Follow up|study ongoing|37|||
144379376|NCT01065454|520599557|FG001|Follow up|study ongoing|22|||
144379377|NCT01065454|520599558|FG002|Follow up|study ongoing|15|||
144379378|NCT01065454|520599559|FG003|Follow up|study ongoing|41|||
144379379|NCT05688670|520599560|FG000|Overall Study|Change in surgery plan|1|||
144379380|NCT05688670|520599561|FG001|Overall Study|Change in surgery plan|4|||
144379381|NCT05688670|520599560|FG000|Overall Study|Inability to extubate|1|||
144379382|NCT05688670|520599561|FG001|Overall Study|Inability to extubate|2|||
144379383|NCT05688670|520599560|FG000|Overall Study|Day of surgery cancellation|0|||
144379384|NCT05688670|520599561|FG001|Overall Study|Day of surgery cancellation|1|||
144379385|NCT05688670|520599560|FG000|Overall Study|Reintubated on PCICU arrival|0|||
144379386|NCT05688670|520599561|FG001|Overall Study|Reintubated on PCICU arrival|1|||
144379387|NCT02537015|520599568|FG000|Overall Study|Adverse Event|3|||
144379388|NCT02537015|520599568|FG000|Overall Study|Withdrawal by Subject|2|||
144379389|NCT02537015|520599568|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144379390|NCT01097005|520599572|FG000|Overall Study|Case Report Form not collected|18|||
144379391|NCT01097005|520599572|FG000|Overall Study|Subjects cannot visit the hospital|1|||
144379392|NCT01097005|520599572|FG000|Overall Study|Poor medication compliance|1|||
144379393|NCT01097005|520599572|FG000|Overall Study|No examination data available|244|||
144379394|NCT01097005|520599572|FG000|Overall Study|Deviation from exclusion criteria|37|||
144379395|NCT01097005|520599572|FG000|Overall Study|Adverse Event|14|||
144379396|NCT01097005|520599572|FG000|Overall Study|Discontinuance by complication|50|||
144379397|NCT04627285|520599573|FG000|Overall Study|Adverse Event|0|||
144379398|NCT04627285|520599574|FG001|Overall Study|Adverse Event|2|||
144379399|NCT04627285|520599573|FG000|Overall Study|Lost to Follow-up|1|||
144379400|NCT04627285|520599574|FG001|Overall Study|Lost to Follow-up|0|||
144379401|NCT04627285|520599573|FG000|Overall Study|Withdrawal by Subject|1|||
144379402|NCT04627285|520599574|FG001|Overall Study|Withdrawal by Subject|1|||
144379403|NCT04627285|520599573|FG000|Overall Study|Sponsor decision|5|||
144379404|NCT04627285|520599574|FG001|Overall Study|Sponsor decision|0|||
144513648|NCT02590432|521080183|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
144513649|NCT02590432|521080184|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513650|NCT02590432|521080185|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513651|NCT02590432|521080186|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
144513652|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144513653|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144513654|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144513655|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144513656|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144513657|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144199308|NCT00541970|519928868|FG002|Month 48|Withdrawal by Subject|4|||
144379405|NCT04627285|520599573|FG000|Overall Study|Participant left country; aunt informed the site|0|||
144379406|NCT04627285|520599574|FG001|Overall Study|Participant left country; aunt informed the site|1|||
144379407|NCT00588861|520600867|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
144379408|NCT00588861|520600868|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
144379409|NCT00588861|520600867|FG000|6 Months|Patients did not return for follow-up|98|||
144379410|NCT00588861|520600868|FG001|6 Months|Patients did not return for follow-up|73|||
144379411|NCT00588861|520600867|FG000|1 Year|Patients did not return for follow-up|89|||
144513658|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
144513659|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
144513660|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
144513661|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513662|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513663|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513664|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144379412|NCT00588861|520600868|FG001|1 Year|Patients did not return for follow-up|82|||
144379413|NCT00588861|520600867|FG000|2 Years|Patients did not return for follow-up|92|||
144379414|NCT00588861|520600868|FG001|2 Years|Patients did not return for follow-up|87|||
144379415|NCT00588861|520600867|FG000|4 Years|Patients did not return for follow-up|91|||
144379416|NCT00588861|520600868|FG001|4 Years|Patients did not return for follow-up|103|||
144379417|NCT00588861|520600867|FG000|6 Years|Patients did not return for follow-up|104|||
144379418|NCT00588861|520600868|FG001|6 Years|Patients did not return for follow-up|109|||
144379419|NCT00588861|520600867|FG000|8 Years|Patients did not return for follow-up|105|||
144379420|NCT00588861|520600868|FG001|8 Years|Patients did not return for follow-up|114|||
144379421|NCT00588861|520600867|FG000|10 Years|Incomplete due to study termination|107|||
144379422|NCT00588861|520600868|FG001|10 Years|Incomplete due to study termination|114|||
144379423|NCT03254459|520600874|FG000|Overall Study|Adverse Event|7|||
144379424|NCT03254459|520600875|FG001|Overall Study|Adverse Event|20|||
144379425|NCT03254459|520600874|FG000|Overall Study|Withdrawal by Subject Consent|3|||
144379426|NCT03254459|520600875|FG001|Overall Study|Withdrawal by Subject Consent|1|||
144379427|NCT03254459|520600874|FG000|Overall Study|Lost to Follow-up|0|||
144379428|NCT03254459|520600875|FG001|Overall Study|Lost to Follow-up|1|||
144379429|NCT03254459|520600874|FG000|Overall Study|Miscellaneous|0|||
144379430|NCT03254459|520600875|FG001|Overall Study|Miscellaneous|1|||
144379431|NCT00617669|520600882|FG000|Overall Study|Withdrawal by Subject|71|||
144379432|NCT00617669|520600883|FG001|Overall Study|Withdrawal by Subject|77|||
144379433|NCT00617669|520600882|FG000|Overall Study|Lost to Follow-up|3|||
144379434|NCT00617669|520600883|FG001|Overall Study|Lost to Follow-up|2|||
144379435|NCT00617669|520600882|FG000|Overall Study|Adverse Event|87|||
144379436|NCT00617669|520600883|FG001|Overall Study|Adverse Event|76|||
144379437|NCT00617669|520600882|FG000|Overall Study|Protocol Violation|2|||
144379438|NCT00617669|520600883|FG001|Overall Study|Protocol Violation|3|||
144379439|NCT00617669|520600882|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
144379440|NCT00617669|520600883|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
144379441|NCT00617669|520600882|FG000|Overall Study|Patients randomized but not treated|2|||
144379442|NCT00617669|520600883|FG001|Overall Study|Patients randomized but not treated|3|||
144379443|NCT03680742|520600884|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
144379444|NCT02894502|520600885|FG000|Baseline|Withdrawal by Subject|24|||
144379445|NCT02894502|520600886|FG001|Baseline|Withdrawal by Subject|31|||
144379446|NCT02894502|520600887|FG002|Baseline|Withdrawal by Subject|36|||
144379447|NCT02894502|520600885|FG000|Baseline|Death|3|||
144379448|NCT02894502|520600886|FG001|Baseline|Death|1|||
144379449|NCT02894502|520600887|FG002|Baseline|Death|9|||
144379450|NCT02894502|520600885|FG000|First Follow up|Withdrawal by Subject|32|||
144379451|NCT02894502|520600886|FG001|First Follow up|Withdrawal by Subject|29|||
144379452|NCT02894502|520600887|FG002|First Follow up|Withdrawal by Subject|37|||
144379453|NCT02894502|520600885|FG000|First Follow up|Death|2|||
144379454|NCT02894502|520600886|FG001|First Follow up|Death|2|||
144379455|NCT02894502|520600887|FG002|First Follow up|Death|3|||
144513665|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513666|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513667|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513668|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
144379456|NCT02894502|520600885|FG000|Second Follow up|Withdrawal by Subject|13|||
144513669|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
144513670|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144513671|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144513672|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144513673|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144513674|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144513675|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144591231|NCT03057977|521366244|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
144379457|NCT02894502|520600886|FG001|Second Follow up|Withdrawal by Subject|15|||
144379458|NCT02894502|520600887|FG002|Second Follow up|Withdrawal by Subject|13|||
144379459|NCT02894502|520600885|FG000|Second Follow up|Death|2|||
144379460|NCT02894502|520600886|FG001|Second Follow up|Death|3|||
144379461|NCT02894502|520600887|FG002|Second Follow up|Death|1|||
144379462|NCT02894502|520600885|FG000|Third Follow up|Withdrawal by Subject|5|||
144379463|NCT02894502|520600886|FG001|Third Follow up|Withdrawal by Subject|6|||
144379464|NCT02894502|520600887|FG002|Third Follow up|Withdrawal by Subject|3|||
144379465|NCT02894502|520600885|FG000|Third Follow up|Death|1|||
144379466|NCT02894502|520600886|FG001|Third Follow up|Death|1|||
144379467|NCT02894502|520600887|FG002|Third Follow up|Death|0|||
144379468|NCT00615901|520600888|FG000|Overall Study|Withdrawal by Subject|2|||
144513676|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
144513677|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
144379469|NCT00615901|520600888|FG000|Overall Study|Adverse Event|7|||
144379470|NCT00796445|520600893|FG000|Overall Study|Protocol Violation|5|||
144379471|NCT00796445|520600894|FG001|Overall Study|Protocol Violation|3|||
144379472|NCT00796445|520600893|FG000|Overall Study|Adverse event, serious fatal|10|||
144379473|NCT00796445|520600894|FG001|Overall Study|Adverse event, serious fatal|5|||
144379474|NCT00796445|520600893|FG000|Overall Study|Adverse event, non-fatal|4|||
144379475|NCT00796445|520600894|FG001|Overall Study|Adverse event, non-fatal|0|||
144379476|NCT00796445|520600893|FG000|Overall Study|Disease progression/recurrence|537|||
144379477|NCT00796445|520600894|FG001|Overall Study|Disease progression/recurrence|268|||
144379478|NCT00796445|520600893|FG000|Overall Study|Other|10|||
144379479|NCT00796445|520600894|FG001|Overall Study|Other|7|||
144379480|NCT00796445|520600893|FG000|Overall Study|Withdrawal by Subject|18|||
144379481|NCT00796445|520600894|FG001|Overall Study|Withdrawal by Subject|9|||
144379482|NCT00796445|520600893|FG000|Overall Study|Invalid Informed Consent Form|1|||
144379483|NCT00796445|520600894|FG001|Overall Study|Invalid Informed Consent Form|0|||
144379484|NCT00388583|520600897|FG000|Overall Study|Protocol Violation|1|||
144379485|NCT00388583|520600898|FG001|Overall Study|Protocol Violation|0|||
144379486|NCT00388583|520600897|FG000|Overall Study|Withdrawal by Subject|3|||
144379487|NCT00388583|520600898|FG001|Overall Study|Withdrawal by Subject|3|||
144379488|NCT00388583|520600897|FG000|Overall Study|Serious Adverse Event|2|||
144379489|NCT00388583|520600898|FG001|Overall Study|Serious Adverse Event|0|||
144379490|NCT00388583|520600897|FG000|Overall Study|Did not receive vaccine|0|||
144379491|NCT00388583|520600898|FG001|Overall Study|Did not receive vaccine|1|||
144379492|NCT05194579|520600899|FG000|Overall Study|Lost to Follow-up|2|||
144379493|NCT05194579|520600900|FG001|Overall Study|Lost to Follow-up|3|||
144379494|NCT05194579|520600899|FG000|Overall Study|Withdrawal by Subject|3|||
144379495|NCT05194579|520600900|FG001|Overall Study|Withdrawal by Subject|4|||
144379496|NCT05194579|520600899|FG000|Overall Study|Refused further study procedures|0|||
144379497|NCT05194579|520600900|FG001|Overall Study|Refused further study procedures|1|||
144379498|NCT05194579|520600899|FG000|Overall Study|Protocol deviation|1|||
144379499|NCT05194579|520600900|FG001|Overall Study|Protocol deviation|0|||
144379500|NCT03595228|520600905|FG000|Overall Study|Death|2|||
144379501|NCT03595228|520600905|FG000|Overall Study|Lack of Efficacy|13|||
144379502|NCT03595228|520600905|FG000|Overall Study|Withdrawal by Subject|3|||
144379503|NCT03595228|520600905|FG000|Overall Study|Withdrawal by Sponsor|1|||
144379504|NCT03232333|520600906|FG000|Overall Study|Infection or Osteomyelitis|9|||
144379505|NCT03232333|520600906|FG000|Overall Study|Lost to Follow-up|4|||
144379506|NCT03232333|520600906|FG000|Overall Study|Withdrawal by Subject|2|||
144379507|NCT01253811|520600907|FG000|Overall Study|Withdrawal criteria|1|||
144379508|NCT01087736|520600908|FG000|Overall Study|Lost to Follow-up|1|||
144379509|NCT01087736|520600909|FG001|Overall Study|Lost to Follow-up|0|||
144379510|NCT01087736|520600908|FG000|Overall Study|Death|0|||
144379511|NCT01087736|520600909|FG001|Overall Study|Death|1|||
144379512|NCT01087736|520600908|FG000|Overall Study|Withdrawal by Subject|0|||
144379513|NCT01087736|520600909|FG001|Overall Study|Withdrawal by Subject|1|||
144379514|NCT00435045|520600911|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
144379515|NCT00435045|520600912|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
144513678|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
144513679|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513680|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513681|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513682|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513683|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513684|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513685|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513686|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
144513687|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
144513688|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513689|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513690|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513691|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513692|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513693|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513694|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513695|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
144513696|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
144513697|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513698|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513699|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513700|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144538272|NCT03801148|521174145|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
144379516|NCT00435045|520600911|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
144379517|NCT00435045|520600912|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
144379518|NCT00435045|520600911|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
144379519|NCT00435045|520600912|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
144379520|NCT00435045|520600911|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
144379521|NCT00435045|520600912|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
144379522|NCT00435045|520600911|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
144379523|NCT00435045|520600912|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
144379524|NCT00435045|520600911|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
144379525|NCT00435045|520600912|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
144379526|NCT00435045|520600911|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
144379527|NCT00435045|520600912|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
144379528|NCT00435045|520600911|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
144379529|NCT00435045|520600912|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
144379530|NCT00435045|520600911|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
144379531|NCT00435045|520600912|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
144379532|NCT00435045|520600911|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
144379533|NCT00435045|520600912|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
144379534|NCT00435045|520600911|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
144379535|NCT00435045|520600912|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
144379536|NCT00567255|520600913|FG000|Overall Study|Adverse Event|241|||
144379537|NCT00567255|520600914|FG001|Overall Study|Adverse Event|68|||
144379538|NCT00567255|520600913|FG000|Overall Study|Lost to Follow-up|77|||
144379539|NCT00567255|520600914|FG001|Overall Study|Lost to Follow-up|48|||
144379540|NCT00567255|520600913|FG000|Overall Study|Withdrawal by Subject|75|||
144379541|NCT00567255|520600914|FG001|Overall Study|Withdrawal by Subject|56|||
144379542|NCT00567255|520600913|FG000|Overall Study|Lack of Efficacy|19|||
144379543|NCT00567255|520600914|FG001|Overall Study|Lack of Efficacy|33|||
144379544|NCT00567255|520600913|FG000|Overall Study|Protocol Violation|20|||
144379545|NCT00567255|520600914|FG001|Overall Study|Protocol Violation|8|||
144379546|NCT00567255|520600913|FG000|Overall Study|Pregnancy|6|||
144379547|NCT00567255|520600914|FG001|Overall Study|Pregnancy|0|||
144379548|NCT00567255|520600913|FG000|Overall Study|Drug noncompliance,moved,other|25|||
144379549|NCT00567255|520600914|FG001|Overall Study|Drug noncompliance,moved,other|15|||
144379550|NCT01743001|520600917|FG000|Overall Study|Physician Decision|1|||
144379551|NCT01743001|520600918|FG001|Overall Study|Physician Decision|0|||
144379552|NCT01743001|520600917|FG000|Overall Study|Pregnancy|1|||
144379553|NCT01743001|520600918|FG001|Overall Study|Pregnancy|0|||
144379554|NCT01743001|520600917|FG000|Overall Study|Death|1|||
144379555|NCT01743001|520600918|FG001|Overall Study|Death|0|||
144379556|NCT03052426|520600921|FG000|Overall Study|Withdrawal by Subject|0|||
144379557|NCT03052426|520600922|FG001|Overall Study|Withdrawal by Subject|1|||
144379558|NCT03052426|520600923|FG002|Overall Study|Withdrawal by Subject|0|||
144379559|NCT03052426|520600921|FG000|Overall Study|Lost to Follow-up|2|||
144379560|NCT03052426|520600922|FG001|Overall Study|Lost to Follow-up|0|||
144379561|NCT03052426|520600923|FG002|Overall Study|Lost to Follow-up|1|||
144379562|NCT01565343|520600926|FG000|Overall Study|Administrative decision/technical issues|1|||
144379563|NCT01565343|520600927|FG001|Overall Study|Administrative decision/technical issues|0|||
144379564|NCT01565343|520600928|FG002|Overall Study|Administrative decision/technical issues|0|||
144379565|NCT01853839|520600934|FG000|Overall Study|Violated inclusion criteria|2|||
144513701|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513702|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513703|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513704|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
144513705|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
144513706|NCT02590432|521080178|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144379566|NCT01853839|520600934|FG000|Overall Study|Not meet ITT population definition|58|||
144379567|NCT01853839|520600934|FG000|Overall Study|End of treatment visit too early|33|||
144379568|NCT01853839|520600934|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
144379569|NCT01018810|520600935|FG000|Overall Study|Withdrawal by Subject|0|||
144379570|NCT01018810|520600936|FG001|Overall Study|Withdrawal by Subject|1|||
144379571|NCT01018810|520600937|FG002|Overall Study|Withdrawal by Subject|0|||
144379572|NCT01018810|520600938|FG003|Overall Study|Withdrawal by Subject|0|||
144379573|NCT01018810|520600939|FG004|Overall Study|Withdrawal by Subject|0|||
144379574|NCT01018810|520600935|FG000|Overall Study|Sponsor Decision|2|||
144379575|NCT01018810|520600936|FG001|Overall Study|Sponsor Decision|0|||
144379576|NCT01018810|520600937|FG002|Overall Study|Sponsor Decision|1|||
144379577|NCT01018810|520600938|FG003|Overall Study|Sponsor Decision|1|||
144379578|NCT01018810|520600939|FG004|Overall Study|Sponsor Decision|1|||
144379579|NCT03672097|520600940|FG000|Period 1|Withdrawal by Subject|2|||
144379580|NCT03672097|520600940|FG000|Period 1|Adverse Event|1|||
144379581|NCT03672097|520600940|FG000|Period 1|Did not receive treatment|1|||
144379582|NCT03672097|520600940|FG000|Period 2|Withdrawal by Subject|3|||
144379583|NCT03672097|520600940|FG000|Period 2|Other|1|||
144379584|NCT03087617|520600942|FG000|Overall Study|Lost to Follow-up|32|||
144379585|NCT03087617|520600943|FG001|Overall Study|Lost to Follow-up|30|||
144379586|NCT03087617|520600944|FG002|Overall Study|Lost to Follow-up|30|||
144379587|NCT03087617|520600945|FG003|Overall Study|Lost to Follow-up|39|||
144379588|NCT01433289|520600949|FG000|Overall Study|Pregnancy|0|||
144379589|NCT01433289|520600950|FG001|Overall Study|Pregnancy|1|||
144379590|NCT01433289|520600951|FG002|Overall Study|Pregnancy|0|||
144379591|NCT01433289|520600952|FG003|Overall Study|Pregnancy|0|||
144379592|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
144379593|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
144379594|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Adverse Event|7|||
144379595|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Adverse Event|6|||
144379596|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
144379597|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
144379598|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Physician Decision|4|||
144379599|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Physician Decision|4|||
144379600|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
144379601|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
144379602|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
144379603|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
144379604|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
144379605|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
144379606|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Non-compliance|1|||
144379607|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Non-compliance|0|||
144379608|NCT00470834|520600953|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
144379609|NCT00470834|520600954|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
144379610|NCT00470834|520600953|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
144379611|NCT00470834|520600954|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
144379612|NCT00470834|520600953|FG000|Extension Period (24 Months)|Adverse Event|3|||
144379613|NCT00470834|520600954|FG001|Extension Period (24 Months)|Adverse Event|4|||
144379614|NCT00470834|520600953|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
144379615|NCT00470834|520600954|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
144379616|NCT00470834|520600953|FG000|Extension Period (24 Months)|Physician Decision|4|||
144379617|NCT00470834|520600954|FG001|Extension Period (24 Months)|Physician Decision|3|||
144379618|NCT00470834|520600953|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
144379619|NCT00470834|520600954|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
144379620|NCT00470834|520600953|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
144379621|NCT00470834|520600954|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
144513707|NCT02590432|521080179|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513708|NCT02590432|521080180|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513709|NCT02590432|521080181|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513710|NCT02590432|521080182|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513711|NCT02590432|521080183|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513712|NCT02590432|521080184|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513713|NCT02590432|521080185|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
144513714|NCT02590432|521080186|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
144513715|NCT02006758|521080187|FG000|Overall Study|Protocol Violation|1|||
144513716|NCT02006758|521080187|FG000|Overall Study|Death|1|||
144513717|NCT02006758|521080187|FG000|Overall Study|Lost to Follow-up|4|||
144513718|NCT02006758|521080187|FG000|Overall Study|Withdrawal by Subject|4|||
144513719|NCT02006758|521080187|FG000|Overall Study|Procedurally excluded|1|||
144513720|NCT02006758|521080187|FG000|Overall Study|Other|2|||
144513721|NCT01619410|521080188|FG000|Overall Study|Lost to Follow-up|7|||
144513722|NCT01619410|521080189|FG001|Overall Study|Lost to Follow-up|4|||
144513723|NCT04110054|521080194|FG000|Overall Study|COVID-19 reason other than AE|0|||
144513724|NCT04110054|521080195|FG001|Overall Study|COVID-19 reason other than AE|0|||
144379622|NCT00470834|520600953|FG000|Extension Period (24 Months)|Non-compliance|0|||
144379623|NCT00470834|520600954|FG001|Extension Period (24 Months)|Non-compliance|1|||
144513725|NCT04110054|521080196|FG002|Overall Study|COVID-19 reason other than AE|2|||
144513726|NCT04110054|521080197|FG003|Overall Study|COVID-19 reason other than AE|0|||
144591232|NCT03057977|521366243|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
144379624|NCT00470834|520600953|FG000|Extension Period (24 Months)|Disease Progression|0|||
144379625|NCT00470834|520600954|FG001|Extension Period (24 Months)|Disease Progression|1|||
144379626|NCT02720042|520600961|FG000|Overall Study|Death|3|||
144379627|NCT02720042|520600961|FG000|Overall Study|Lost to Follow-up|4|||
144379628|NCT02720042|520600961|FG000|Overall Study|Withdrawal by Subject|1|||
144379629|NCT02720042|520600961|FG000|Overall Study|Physician Decision|3|||
144379630|NCT02720042|520600961|FG000|Overall Study|Phasix Mesh explanted|1|||
144379631|NCT02720042|520600961|FG000|Overall Study|unable due to non-study-related illness|3|||
144379632|NCT03060551|520600966|FG000|Overall Study|Withdrawal by Subject|1|||
144379633|NCT03060551|520600966|FG000|Overall Study|Adverse Event|1|||
144379634|NCT04629066|520600967|FG000|Overall Study|Lost to Follow-up|3|||
144379635|NCT04629066|520600968|FG001|Overall Study|Lost to Follow-up|2|||
144379636|NCT04359901|520600973|FG000|Overall Study|Withdrawal by Subject|0|||
144379637|NCT04359901|520600974|FG001|Overall Study|Withdrawal by Subject|1|||
144379638|NCT04359901|520600973|FG000|Overall Study|Death|6|||
144379639|NCT04359901|520600974|FG001|Overall Study|Death|2|||
144379640|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
144379641|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
144379642|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
144379643|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
144379644|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Other|2|||
144379645|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
144379646|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
144379647|NCT02509026|520600978|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
144379648|NCT02509026|520600978|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
144379649|NCT02509026|520600978|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
144379650|NCT02509026|520600978|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
144379651|NCT02509026|520600978|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
144379652|NCT02509026|520600978|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
144379653|NCT00243841|520600982|FG000|Overall Study|Physician Decision|0|||
144379654|NCT00243841|520600983|FG001|Overall Study|Physician Decision|0|||
144379655|NCT00243841|520600984|FG002|Overall Study|Physician Decision|1|||
144379656|NCT00243841|520600985|FG003|Overall Study|Physician Decision|0|||
144379657|NCT00243841|520600986|FG004|Overall Study|Physician Decision|0|||
144379658|NCT00243841|520600987|FG005|Overall Study|Physician Decision|2|||
144379659|NCT03425253|520600990|FG000|Overall Study|Adverse Event|2|||
144379660|NCT03425253|520600990|FG000|Overall Study|Lost to Follow-up|3|||
144379661|NCT03425253|520600990|FG000|Overall Study|Withdrew Consent|6|||
144379662|NCT03425253|520600990|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
144379663|NCT00635219|520602679|FG000|Overall Study|Adverse Event|12|||
144379664|NCT00635219|520602680|FG001|Overall Study|Adverse Event|10|||
144379665|NCT00635219|520602681|FG002|Overall Study|Adverse Event|18|||
144379666|NCT00635219|520602682|FG003|Overall Study|Adverse Event|15|||
144379667|NCT00635219|520602683|FG004|Overall Study|Adverse Event|19|||
144379668|NCT00635219|520602679|FG000|Overall Study|Lack of Efficacy|5|||
144379669|NCT00635219|520602680|FG001|Overall Study|Lack of Efficacy|6|||
144379670|NCT00635219|520602681|FG002|Overall Study|Lack of Efficacy|3|||
144379671|NCT00635219|520602682|FG003|Overall Study|Lack of Efficacy|4|||
144379672|NCT00635219|520602683|FG004|Overall Study|Lack of Efficacy|6|||
144379673|NCT00635219|520602679|FG000|Overall Study|Non-compliance With Study Product|0|||
144379674|NCT00635219|520602680|FG001|Overall Study|Non-compliance With Study Product|0|||
144379675|NCT00635219|520602681|FG002|Overall Study|Non-compliance With Study Product|0|||
144379676|NCT00635219|520602682|FG003|Overall Study|Non-compliance With Study Product|2|||
144379677|NCT00635219|520602683|FG004|Overall Study|Non-compliance With Study Product|1|||
144379678|NCT00635219|520602679|FG000|Overall Study|Protocol Violation|0|||
144379679|NCT00635219|520602680|FG001|Overall Study|Protocol Violation|2|||
144379680|NCT00635219|520602681|FG002|Overall Study|Protocol Violation|3|||
144379681|NCT00635219|520602682|FG003|Overall Study|Protocol Violation|2|||
144379682|NCT00635219|520602683|FG004|Overall Study|Protocol Violation|4|||
144379683|NCT00635219|520602679|FG000|Overall Study|Withdrawal of Consent|8|||
144379684|NCT00635219|520602680|FG001|Overall Study|Withdrawal of Consent|6|||
144379685|NCT00635219|520602681|FG002|Overall Study|Withdrawal of Consent|8|||
144379686|NCT00635219|520602682|FG003|Overall Study|Withdrawal of Consent|11|||
144379687|NCT00635219|520602683|FG004|Overall Study|Withdrawal of Consent|8|||
144379688|NCT00635219|520602679|FG000|Overall Study|Lost to Follow-up|0|||
144379689|NCT00635219|520602680|FG001|Overall Study|Lost to Follow-up|0|||
144379690|NCT00635219|520602681|FG002|Overall Study|Lost to Follow-up|2|||
144379691|NCT00635219|520602682|FG003|Overall Study|Lost to Follow-up|0|||
144379692|NCT00635219|520602683|FG004|Overall Study|Lost to Follow-up|3|||
144379693|NCT00635219|520602679|FG000|Overall Study|Administrative or Other Reasons|0|||
144379694|NCT00635219|520602680|FG001|Overall Study|Administrative or Other Reasons|1|||
144379695|NCT00635219|520602681|FG002|Overall Study|Administrative or Other Reasons|1|||
144379696|NCT00635219|520602682|FG003|Overall Study|Administrative or Other Reasons|0|||
144379697|NCT00635219|520602683|FG004|Overall Study|Administrative or Other Reasons|1|||
144379698|NCT01639729|520602684|FG000|Overall Study|Withdrawal by Subject|1|||
144379699|NCT01639729|520602685|FG001|Overall Study|Withdrawal by Subject|0|||
144379700|NCT01639729|520602686|FG002|Overall Study|Withdrawal by Subject|1|||
144379701|NCT01639729|520602687|FG003|Overall Study|Withdrawal by Subject|1|||
144379702|NCT01639729|520602688|FG004|Overall Study|Withdrawal by Subject|0|||
144379703|NCT01639729|520602689|FG005|Overall Study|Withdrawal by Subject|0|||
144379704|NCT00759564|520602690|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
144379705|NCT00759564|520602691|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
144379706|NCT00759564|520602692|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
144379707|NCT00759564|520602693|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
144379708|NCT00759564|520602694|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
144379709|NCT04145219|520602695|FG000|Overall Study|Adverse Event|18|||
144379710|NCT04145219|520602696|FG001|Overall Study|Adverse Event|6|||
144379711|NCT04145219|520602695|FG000|Overall Study|Lost to Follow-up|2|||
144379712|NCT04145219|520602696|FG001|Overall Study|Lost to Follow-up|3|||
144379713|NCT04145219|520602695|FG000|Overall Study|Physician Decision|0|||
144379714|NCT04145219|520602696|FG001|Overall Study|Physician Decision|2|||
144379715|NCT04145219|520602695|FG000|Overall Study|Withdrawal by Subject|12|||
144379716|NCT04145219|520602696|FG001|Overall Study|Withdrawal by Subject|8|||
144379717|NCT04145219|520602695|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
144379718|NCT04145219|520602696|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
144379719|NCT01640314|520602697|FG000|Overall Study|Protocol Violation|0|||
144379720|NCT01640314|520602698|FG001|Overall Study|Protocol Violation|1|||
144379721|NCT01290796|520602699|FG000|Overall Study|Lost to Follow-up|21|||
144379722|NCT01290796|520602699|FG000|Overall Study|Withdrawal by Subject|4|||
144379723|NCT01290796|520602699|FG000|Overall Study|Physician Decision|2|||
144379724|NCT01290796|520602699|FG000|Overall Study|Secondary Surgical Intervention|2|||
144379725|NCT01290796|520602699|FG000|Overall Study|Withdrawal by Sponsor|1|||
144379726|NCT02709538|520602701|FG000|Overall Study|Adverse Event|13|||
144379727|NCT02709538|520602702|FG001|Overall Study|Adverse Event|2|||
144379728|NCT02709538|520602703|FG002|Overall Study|Adverse Event|3|||
144379729|NCT02709538|520602701|FG000|Overall Study|Lack of Efficacy|1|||
144513727|NCT04110054|521080194|FG000|Overall Study|Withdrawal by Subject|0|||
144513728|NCT04110054|521080195|FG001|Overall Study|Withdrawal by Subject|3|||
144513729|NCT04110054|521080196|FG002|Overall Study|Withdrawal by Subject|2|||
144513730|NCT04110054|521080197|FG003|Overall Study|Withdrawal by Subject|0|||
144513731|NCT04110054|521080194|FG000|Overall Study|Adverse Event|1|||
144513732|NCT04110054|521080195|FG001|Overall Study|Adverse Event|1|||
144513733|NCT04110054|521080196|FG002|Overall Study|Adverse Event|4|||
144379730|NCT02709538|520602702|FG001|Overall Study|Lack of Efficacy|0|||
144379731|NCT02709538|520602703|FG002|Overall Study|Lack of Efficacy|0|||
144379732|NCT02709538|520602701|FG000|Overall Study|Lost to Follow-up|24|||
144379733|NCT02709538|520602702|FG001|Overall Study|Lost to Follow-up|8|||
144379734|NCT02709538|520602703|FG002|Overall Study|Lost to Follow-up|4|||
144379735|NCT02709538|520602701|FG000|Overall Study|Physician Decision|1|||
144379736|NCT02709538|520602702|FG001|Overall Study|Physician Decision|0|||
144379737|NCT02709538|520602703|FG002|Overall Study|Physician Decision|0|||
144379738|NCT02709538|520602701|FG000|Overall Study|Withdrawal by Subject|40|||
144379739|NCT02709538|520602702|FG001|Overall Study|Withdrawal by Subject|7|||
144379740|NCT02709538|520602703|FG002|Overall Study|Withdrawal by Subject|4|||
144379741|NCT02709538|520602701|FG000|Overall Study|Non-compliance with study procedures|5|||
144379742|NCT02709538|520602702|FG001|Overall Study|Non-compliance with study procedures|0|||
144379743|NCT02709538|520602703|FG002|Overall Study|Non-compliance with study procedures|0|||
144379744|NCT02709538|520602701|FG000|Overall Study|Non-compliance with study drug|2|||
144379745|NCT02709538|520602702|FG001|Overall Study|Non-compliance with study drug|0|||
144379746|NCT02709538|520602703|FG002|Overall Study|Non-compliance with study drug|0|||
144379747|NCT02709538|520602701|FG000|Overall Study|Protocol deviation|10|||
144379748|NCT02709538|520602702|FG001|Overall Study|Protocol deviation|4|||
144379749|NCT02709538|520602703|FG002|Overall Study|Protocol deviation|4|||
144379750|NCT02709538|520602701|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
144379751|NCT02709538|520602702|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
144379752|NCT02709538|520602703|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
144379753|NCT02709538|520602701|FG000|Overall Study|Other|16|||
144379754|NCT02709538|520602702|FG001|Overall Study|Other|7|||
144379755|NCT02709538|520602703|FG002|Overall Study|Other|5|||
144379756|NCT00835211|520602704|FG000|First Intervention|Withdrawal by Subject|0|||
144379757|NCT00835211|520602705|FG001|First Intervention|Withdrawal by Subject|1|||
144379758|NCT00835211|520602704|FG000|Washout: 7 Days|Adverse Event|2|||
144379759|NCT00835211|520602705|FG001|Washout: 7 Days|Adverse Event|1|||
144379760|NCT00835211|520602704|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
144379761|NCT00835211|520602705|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
144379762|NCT02343549|520602706|FG000|Overall Study|Death|11|||
144379763|NCT02343549|520602706|FG000|Overall Study|Withdrawal by Subject|2|||
144379764|NCT02160041|520602708|FG000|Overall Study|Adverse Event|11|||
144379765|NCT02160041|520602708|FG000|Overall Study|Death|2|||
144379766|NCT02160041|520602708|FG000|Overall Study|disease progression|57|||
144379767|NCT02160041|520602708|FG000|Overall Study|Protocol Violation|1|||
144379768|NCT02160041|520602708|FG000|Overall Study|non-compliance with study|1|||
144379769|NCT02160041|520602708|FG000|Overall Study|Physician Decision|3|||
144379770|NCT02160041|520602708|FG000|Overall Study|Withdrawal by Subject|8|||
144379771|NCT02160041|520602708|FG000|Overall Study|study terminated by by sponsor|1|||
144379772|NCT01403948|520602709|FG000|Overall Study|Progressive disease|0|||
144379773|NCT01403948|520602710|FG001|Overall Study|Progressive disease|2|||
144379774|NCT01403948|520602711|FG002|Overall Study|Progressive disease|2|||
144379775|NCT01403948|520602712|FG003|Overall Study|Progressive disease|4|||
144379776|NCT01403948|520602713|FG004|Overall Study|Progressive disease|2|||
144379777|NCT01403948|520602714|FG005|Overall Study|Progressive disease|6|||
144379778|NCT01403948|520602715|FG006|Overall Study|Progressive disease|2|||
144379779|NCT01403948|520602716|FG007|Overall Study|Progressive disease|4|||
144379780|NCT01403948|520602717|FG008|Overall Study|Progressive disease|5|||
144379781|NCT01403948|520602718|FG009|Overall Study|Progressive disease|5|||
144379782|NCT01403948|520602709|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379783|NCT01403948|520602710|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379784|NCT01403948|520602711|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379785|NCT01403948|520602712|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379786|NCT01403948|520602713|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
144379787|NCT01403948|520602714|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379788|NCT01403948|520602715|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
144379789|NCT01403948|520602716|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379790|NCT01403948|520602717|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
144379791|NCT01403948|520602718|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
144379792|NCT01403948|520602709|FG000|Overall Study|Lost to Follow-up|0|||
144379793|NCT01403948|520602710|FG001|Overall Study|Lost to Follow-up|0|||
144379794|NCT01403948|520602711|FG002|Overall Study|Lost to Follow-up|0|||
144379795|NCT01403948|520602712|FG003|Overall Study|Lost to Follow-up|0|||
144379796|NCT01403948|520602713|FG004|Overall Study|Lost to Follow-up|0|||
144379797|NCT01403948|520602714|FG005|Overall Study|Lost to Follow-up|0|||
144379798|NCT01403948|520602715|FG006|Overall Study|Lost to Follow-up|0|||
144379799|NCT01403948|520602716|FG007|Overall Study|Lost to Follow-up|0|||
144379800|NCT01403948|520602717|FG008|Overall Study|Lost to Follow-up|0|||
144379801|NCT01403948|520602718|FG009|Overall Study|Lost to Follow-up|1|||
144379802|NCT01403948|520602709|FG000|Overall Study|Refused cont. medication|0|||
144379803|NCT01403948|520602710|FG001|Overall Study|Refused cont. medication|0|||
144379804|NCT01403948|520602711|FG002|Overall Study|Refused cont. medication|0|||
144379805|NCT01403948|520602712|FG003|Overall Study|Refused cont. medication|0|||
144379806|NCT01403948|520602713|FG004|Overall Study|Refused cont. medication|1|||
144379807|NCT01403948|520602714|FG005|Overall Study|Refused cont. medication|0|||
144379808|NCT01403948|520602715|FG006|Overall Study|Refused cont. medication|0|||
144379809|NCT01403948|520602716|FG007|Overall Study|Refused cont. medication|0|||
144379810|NCT01403948|520602717|FG008|Overall Study|Refused cont. medication|0|||
144379811|NCT01403948|520602718|FG009|Overall Study|Refused cont. medication|1|||
144379812|NCT01403948|520602709|FG000|Overall Study|other than above|1|||
144379813|NCT01403948|520602710|FG001|Overall Study|other than above|2|||
144379814|NCT01403948|520602711|FG002|Overall Study|other than above|1|||
144379815|NCT01403948|520602712|FG003|Overall Study|other than above|0|||
144379816|NCT01403948|520602713|FG004|Overall Study|other than above|1|||
144379817|NCT01403948|520602714|FG005|Overall Study|other than above|1|||
144379818|NCT01403948|520602715|FG006|Overall Study|other than above|2|||
144379819|NCT01403948|520602716|FG007|Overall Study|other than above|0|||
144379820|NCT01403948|520602717|FG008|Overall Study|other than above|0|||
144379821|NCT01403948|520602718|FG009|Overall Study|other than above|0|||
144379822|NCT04450381|520602719|FG000|Overall Study|Protocol Violation|4|||
144379823|NCT04450381|520602719|FG000|Overall Study|Wrong device setting|2|||
144379824|NCT01090323|520602720|FG000|Overall Study|Adverse Event|12|||
144379825|NCT01090323|520602721|FG001|Overall Study|Adverse Event|2|||
144379826|NCT01090323|520602720|FG000|Overall Study|Abnormal Lab Values|3|||
144379827|NCT01090323|520602721|FG001|Overall Study|Abnormal Lab Values|1|||
144379828|NCT01090323|520602720|FG000|Overall Study|Abnormal Test Procedure Results|2|||
144513734|NCT04110054|521080197|FG003|Overall Study|Adverse Event|3|||
144513735|NCT01000480|521080199|FG000|Induction Phase|Adverse Event|2|||
144513736|NCT01000480|521080199|FG000|Induction Phase|Lost to Follow-up|1|||
144513737|NCT01000480|521080199|FG000|Induction Phase|Physician Decision|1|||
144513738|NCT01000480|521080199|FG000|Induction Phase|Entry Criteria Not Met|3|||
144513739|NCT01000480|521080199|FG000|Concurrent Therapy Phase|Adverse Event|4|||
144513740|NCT01000480|521080199|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
144513741|NCT01000480|521080199|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
144513742|NCT01000480|521080199|FG000|Concurrent Therapy Phase|Physician Decision|1|||
144513743|NCT02374307|521080204|FG000|3-months Follow-up|Lost to Follow-up|1|||
144513744|NCT02374307|521080205|FG001|3-months Follow-up|Lost to Follow-up|2|||
144513745|NCT02374307|521080204|FG000|3-months Follow-up|Withdrawal by Subject|1|||
144513746|NCT02374307|521080205|FG001|3-months Follow-up|Withdrawal by Subject|4|||
144513747|NCT02374307|521080204|FG000|3-months Follow-up|Death|1|||
144513748|NCT02374307|521080205|FG001|3-months Follow-up|Death|2|||
144513749|NCT02374307|521080204|FG000|3-months Follow-up|Missed first follow-up|5|||
144513750|NCT02374307|521080205|FG001|3-months Follow-up|Missed first follow-up|1|||
144513751|NCT02374307|521080204|FG000|6-months Follow-up|Lost to Follow-up|1|||
144513752|NCT02374307|521080205|FG001|6-months Follow-up|Lost to Follow-up|2|||
144513753|NCT02374307|521080204|FG000|6-months Follow-up|Death|2|||
144513754|NCT02374307|521080205|FG001|6-months Follow-up|Death|1|||
144513755|NCT02374307|521080204|FG000|6-months Follow-up|Withdrawal by Subject|0|||
144513756|NCT02374307|521080205|FG001|6-months Follow-up|Withdrawal by Subject|3|||
144513757|NCT04452318|521080208|FG000|Overall Study|Physician Decision|1|||
144513758|NCT04452318|521080209|FG001|Overall Study|Physician Decision|2|||
144513759|NCT04452318|521080210|FG002|Overall Study|Physician Decision|0|||
144513760|NCT04452318|521080211|FG003|Overall Study|Physician Decision|2|||
144513761|NCT04452318|521080212|FG004|Overall Study|Physician Decision|0|||
144513762|NCT04452318|521080213|FG005|Overall Study|Physician Decision|2|||
144513763|NCT04452318|521080214|FG006|Overall Study|Physician Decision|5|||
144513764|NCT04452318|521080208|FG000|Overall Study|Death|2|||
144513765|NCT04452318|521080209|FG001|Overall Study|Death|3|||
144513766|NCT04452318|521080210|FG002|Overall Study|Death|0|||
144513767|NCT04452318|521080211|FG003|Overall Study|Death|0|||
144513768|NCT04452318|521080212|FG004|Overall Study|Death|0|||
144513769|NCT04452318|521080213|FG005|Overall Study|Death|0|||
144513770|NCT04452318|521080214|FG006|Overall Study|Death|0|||
144513771|NCT04452318|521080208|FG000|Overall Study|Lost to Follow-up|38|||
144513772|NCT04452318|521080209|FG001|Overall Study|Lost to Follow-up|28|||
144513773|NCT04452318|521080210|FG002|Overall Study|Lost to Follow-up|0|||
144513774|NCT04452318|521080211|FG003|Overall Study|Lost to Follow-up|3|||
144513775|NCT04452318|521080212|FG004|Overall Study|Lost to Follow-up|3|||
144513776|NCT04452318|521080213|FG005|Overall Study|Lost to Follow-up|2|||
144513777|NCT04452318|521080214|FG006|Overall Study|Lost to Follow-up|1|||
144513778|NCT04452318|521080208|FG000|Overall Study|Withdrawal by Subject|46|||
144379829|NCT01090323|520602721|FG001|Overall Study|Abnormal Test Procedure Results|0|||
144379830|NCT01090323|520602720|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144379831|NCT01090323|520602721|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144379832|NCT01090323|520602720|FG000|Overall Study|Condition no longer requires drug|5|||
144513779|NCT04452318|521080209|FG001|Overall Study|Withdrawal by Subject|40|||
144513780|NCT04452318|521080210|FG002|Overall Study|Withdrawal by Subject|0|||
144513781|NCT04452318|521080211|FG003|Overall Study|Withdrawal by Subject|18|||
144513782|NCT04452318|521080212|FG004|Overall Study|Withdrawal by Subject|6|||
144513783|NCT04452318|521080213|FG005|Overall Study|Withdrawal by Subject|8|||
144513784|NCT04452318|521080214|FG006|Overall Study|Withdrawal by Subject|6|||
144513785|NCT02554786|521080215|FG000|Overall Study|Subject/guardian decision|29|||
144379833|NCT01090323|520602721|FG001|Overall Study|Condition no longer requires drug|4|||
144379834|NCT01090323|520602720|FG000|Overall Study|Protocol Violation|2|||
144513786|NCT02554786|521080216|FG001|Overall Study|Subject/guardian decision|17|||
144591233|NCT03057977|521366244|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
144591234|NCT03057977|521366243|FG000|Discontinuation From Treatment|Not attending study visit|3|||
144591235|NCT03057977|521366244|FG001|Discontinuation From Treatment|Not attending study visit|10|||
144591236|NCT03057977|521366243|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
144591237|NCT03057977|521366244|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
144591238|NCT03057977|521366243|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
144591239|NCT03057977|521366244|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
144591240|NCT03057977|521366243|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
144591241|NCT03057977|521366244|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
144591242|NCT03057977|521366243|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
144591243|NCT03057977|521366244|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
144591244|NCT03057977|521366243|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
144591245|NCT03057977|521366244|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
144591246|NCT02079610|521366245|FG000|Overall Study|Withdrawal by Subject|1|||
144591247|NCT02079610|521366246|FG001|Overall Study|Withdrawal by Subject|1|||
144591248|NCT01016977|521366254|FG000|Overall Study|Lost to Follow-up|1|||
144591249|NCT01016977|521366255|FG001|Overall Study|Lost to Follow-up|0|||
144591250|NCT01016977|521366254|FG000|Overall Study|Withdrawal by Subject|2|||
144591251|NCT01016977|521366255|FG001|Overall Study|Withdrawal by Subject|2|||
144591252|NCT05081388|521366258|FG000|Overall Study|Adverse Event|1|||
144591253|NCT05081388|521366259|FG001|Overall Study|Adverse Event|0|||
144591254|NCT05081388|521366260|FG002|Overall Study|Adverse Event|0|||
144591255|NCT05081388|521366261|FG003|Overall Study|Adverse Event|0|||
144591256|NCT05081388|521366262|FG004|Overall Study|Adverse Event|0|||
144591257|NCT05081388|521366258|FG000|Overall Study|Lost to Follow-up|0|||
144591258|NCT05081388|521366259|FG001|Overall Study|Lost to Follow-up|1|||
144591259|NCT05081388|521366260|FG002|Overall Study|Lost to Follow-up|0|||
144591260|NCT05081388|521366261|FG003|Overall Study|Lost to Follow-up|0|||
144591261|NCT05081388|521366262|FG004|Overall Study|Lost to Follow-up|0|||
144591262|NCT05081388|521366258|FG000|Overall Study|Subject decision|0|||
144591263|NCT05081388|521366259|FG001|Overall Study|Subject decision|0|||
144591264|NCT05081388|521366260|FG002|Overall Study|Subject decision|0|||
144591265|NCT05081388|521366261|FG003|Overall Study|Subject decision|1|||
144591266|NCT05081388|521366262|FG004|Overall Study|Subject decision|0|||
144591267|NCT04279392|521366263|FG000|Overall Study|Physician Decision|1|||
144591268|NCT04279392|521366264|FG001|Overall Study|Physician Decision|0|||
144591269|NCT01171807|521366265|FG000|Overall Study|Treatment failure|2|||
144591270|NCT01171807|521366266|FG001|Overall Study|Treatment failure|4|||
144591271|NCT01171807|521366265|FG000|Overall Study|Non compliance|1|||
144591272|NCT01171807|521366266|FG001|Overall Study|Non compliance|0|||
144591273|NCT01171807|521366265|FG000|Overall Study|Lost to Follow-up|3|||
144591274|NCT01171807|521366266|FG001|Overall Study|Lost to Follow-up|0|||
144591275|NCT01901341|521366267|FG000|Overall Study|Adverse Event|4|||
144591276|NCT01901341|521366268|FG001|Overall Study|Adverse Event|2|||
144591277|NCT01901341|521366267|FG000|Overall Study|Lack of Efficacy|0|||
144591278|NCT01901341|521366268|FG001|Overall Study|Lack of Efficacy|2|||
144591279|NCT01901341|521366267|FG000|Overall Study|Lost to Follow-up|0|||
144591280|NCT01901341|521366268|FG001|Overall Study|Lost to Follow-up|1|||
144591281|NCT01901341|521366267|FG000|Overall Study|Protocol Violation|2|||
144591282|NCT01901341|521366268|FG001|Overall Study|Protocol Violation|0|||
144591283|NCT01901341|521366267|FG000|Overall Study|Study Terminated by Sponsor|13|||
144591284|NCT01901341|521366268|FG001|Overall Study|Study Terminated by Sponsor|15|||
144591285|NCT01901341|521366267|FG000|Overall Study|Withdrawal by Subject|1|||
144591286|NCT01901341|521366268|FG001|Overall Study|Withdrawal by Subject|1|||
144591287|NCT00156819|521366269|FG000|Overall Study|Lost to Follow-up|1|||
144591288|NCT00156819|521366270|FG001|Overall Study|Lost to Follow-up|1|||
144591289|NCT00156819|521366271|FG002|Overall Study|Lost to Follow-up|3|||
144591290|NCT04964388|521366272|FG000|Overall Study|Lost to Follow-up|3|||
144591291|NCT04964388|521366273|FG001|Overall Study|Lost to Follow-up|2|||
144591292|NCT01689337|521366274|FG000|Overall Study|Study Discontinuation|1|||
144591293|NCT00738582|521366275|FG000|Combination Therapy|Completed Combination Therapy|1|||
144591294|NCT00738582|521366276|FG001|Combination Therapy|Completed Combination Therapy|0|||
144591295|NCT00738582|521366275|FG000|Combination Therapy|Physician Decision|1|||
144591296|NCT00738582|521366276|FG001|Combination Therapy|Physician Decision|0|||
144591297|NCT00738582|521366275|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
144591298|NCT00738582|521366276|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
144591299|NCT00738582|521366275|FG000|Combination Therapy|Other|5|||
144591300|NCT00738582|521366276|FG001|Combination Therapy|Other|0|||
144591301|NCT00738582|521366275|FG000|Combination Therapy|Adverse Event|16|||
144591302|NCT00738582|521366276|FG001|Combination Therapy|Adverse Event|0|||
144591303|NCT00738582|521366275|FG000|Combination Therapy|Progressive Disease|9|||
144591304|NCT00738582|521366276|FG001|Combination Therapy|Progressive Disease|0|||
144379835|NCT01090323|520602721|FG001|Overall Study|Protocol Violation|1|||
144379836|NCT01090323|520602720|FG000|Overall Study|Withdrew consent|33|||
144379837|NCT01090323|520602721|FG001|Overall Study|Withdrew consent|11|||
144379838|NCT01090323|520602720|FG000|Overall Study|Lost to Follow-up|11|||
144379839|NCT01090323|520602721|FG001|Overall Study|Lost to Follow-up|6|||
144379840|NCT01090323|520602720|FG000|Overall Study|Administrative problems|6|||
144379841|NCT01090323|520602721|FG001|Overall Study|Administrative problems|4|||
144379842|NCT01090323|520602720|FG000|Overall Study|Death|1|||
144379843|NCT01090323|520602721|FG001|Overall Study|Death|2|||
144379844|NCT01090323|520602720|FG000|Overall Study|Stopped end of core|7|||
144379845|NCT01090323|520602721|FG001|Overall Study|Stopped end of core|0|||
144379846|NCT01090323|520602720|FG000|Overall Study|Stopped end of extension 1#|3|||
144379847|NCT01090323|520602721|FG001|Overall Study|Stopped end of extension 1#|1|||
144379848|NCT05498701|520602722|FG000|Period 3|Adverse Event|1|||
144379849|NCT05498701|520602723|FG001|Period 3|Adverse Event|0|||
144379850|NCT01864005|520602724|FG000|Overall Study|Protocol Violation|0|||
144379851|NCT01864005|520602725|FG001|Overall Study|Protocol Violation|1|||
144379852|NCT01864005|520602724|FG000|Overall Study|Withdrawal by Subject|0|||
144379853|NCT01864005|520602725|FG001|Overall Study|Withdrawal by Subject|1|||
144379854|NCT01864005|520602724|FG000|Overall Study|Incorrect enrolment|1|||
144379855|NCT01864005|520602725|FG001|Overall Study|Incorrect enrolment|0|||
144379856|NCT01864005|520602724|FG000|Overall Study|Disease need|1|||
144379857|NCT01864005|520602725|FG001|Overall Study|Disease need|1|||
144379858|NCT01864005|520602724|FG000|Overall Study|Need GP IIb/IIIa|1|||
144379859|NCT01864005|520602725|FG001|Overall Study|Need GP IIb/IIIa|3|||
144379860|NCT00763698|520602731|FG000|Overall Study|Unsuccessful Implant|5|||
144379861|NCT00763698|520602731|FG000|Overall Study|Death|4|||
144379862|NCT00763698|520602731|FG000|Overall Study|Withdrawal by Subject|1|||
144379863|NCT02184572|520602732|FG000|Overall Study|Lost to Follow-up|29|||
144379864|NCT02184572|520602733|FG001|Overall Study|Lost to Follow-up|21|||
144379865|NCT02184572|520602732|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
144379866|NCT02184572|520602733|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
144379867|NCT02184572|520602732|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
144379868|NCT02184572|520602733|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
144379869|NCT02184572|520602732|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
144379870|NCT02184572|520602733|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
144379871|NCT02184572|520602732|FG000|Overall Study|Traveling Outside The Country|1|||
144379872|NCT02184572|520602733|FG001|Overall Study|Traveling Outside The Country|0|||
144379873|NCT02184572|520602732|FG000|Overall Study|Withdrawal by Subject|14|||
144379874|NCT02184572|520602733|FG001|Overall Study|Withdrawal by Subject|9|||
144379875|NCT00006409|520602737|FG000|Baseline|Protocol Violation|48|||
144379876|NCT00006409|520602738|FG001|Baseline|Protocol Violation|70|||
144379877|NCT00006409|520602739|FG002|Baseline|Protocol Violation|0|||
144379878|NCT00006409|520602740|FG003|Baseline|Protocol Violation|0|||
144379879|NCT00006409|520602741|FG004|Baseline|Protocol Violation|0|||
144379880|NCT00006409|520602742|FG005|Baseline|Protocol Violation|0|||
144379881|NCT00006409|520602737|FG000|Post-2 Year Intervention|Protocol Violation|0|||
144379882|NCT00006409|520602738|FG001|Post-2 Year Intervention|Protocol Violation|0|||
144379883|NCT00006409|520602739|FG002|Post-2 Year Intervention|Protocol Violation|251|||
144379884|NCT00006409|520602740|FG003|Post-2 Year Intervention|Protocol Violation|168|||
144379885|NCT00006409|520602741|FG004|Post-2 Year Intervention|Protocol Violation|0|||
144379886|NCT00006409|520602742|FG005|Post-2 Year Intervention|Protocol Violation|0|||
144379887|NCT00006409|520602737|FG000|Post-3 Year Intervention|Protocol Violation|0|||
144379888|NCT00006409|520602738|FG001|Post-3 Year Intervention|Protocol Violation|0|||
144379889|NCT00006409|520602739|FG002|Post-3 Year Intervention|Protocol Violation|0|||
144379890|NCT00006409|520602740|FG003|Post-3 Year Intervention|Protocol Violation|0|||
144379891|NCT00006409|520602741|FG004|Post-3 Year Intervention|Protocol Violation|62|||
144379892|NCT00006409|520602742|FG005|Post-3 Year Intervention|Protocol Violation|62|||
144379893|NCT00638183|520602743|FG000|Overall Study|Adverse Event|23|||
144379894|NCT00638183|520602743|FG000|Overall Study|Lack of Efficacy|14|||
144379895|NCT00638183|520602743|FG000|Overall Study|Physician Decision|9|||
144379896|NCT00638183|520602743|FG000|Overall Study|Lost to Follow-up|46|||
144379897|NCT00638183|520602743|FG000|Overall Study|Other reason not defined above|27|||
144379898|NCT02059291|520602744|FG000|Epoch 2|Lack of Efficacy|0|||
144379899|NCT02059291|520602745|FG001|Epoch 2|Lack of Efficacy|0|||
144379900|NCT02059291|520602746|FG002|Epoch 2|Lack of Efficacy|0|||
144379901|NCT02059291|520602747|FG003|Epoch 2|Lack of Efficacy|1|||
144379902|NCT02059291|520602748|FG004|Epoch 2|Lack of Efficacy|0|||
144379903|NCT02059291|520602749|FG005|Epoch 2|Lack of Efficacy|1|||
144379904|NCT02059291|520602750|FG006|Epoch 2|Lack of Efficacy|0|||
144379905|NCT02059291|520602751|FG007|Epoch 2|Lack of Efficacy|0|||
144379906|NCT02059291|520602752|FG008|Epoch 2|Lack of Efficacy|0|||
144379907|NCT02059291|520602753|FG009|Epoch 2|Lack of Efficacy|0|||
144379908|NCT02059291|520602754|FG010|Epoch 2|Lack of Efficacy|0|||
144379909|NCT02059291|520602755|FG011|Epoch 2|Lack of Efficacy|0|||
144379910|NCT02059291|520602756|FG012|Epoch 2|Lack of Efficacy|0|||
144379911|NCT02059291|520602757|FG013|Epoch 2|Lack of Efficacy|0|||
144379912|NCT02059291|520602758|FG014|Epoch 2|Lack of Efficacy|0|||
144379913|NCT02059291|520602759|FG015|Epoch 2|Lack of Efficacy|0|||
144379914|NCT02059291|520602760|FG016|Epoch 2|Lack of Efficacy|0|||
144379915|NCT02059291|520602761|FG017|Epoch 2|Lack of Efficacy|0|||
144379916|NCT02059291|520602762|FG018|Epoch 2|Lack of Efficacy|0|||
144379917|NCT02059291|520602763|FG019|Epoch 2|Lack of Efficacy|0|||
144379918|NCT02059291|520602764|FG020|Epoch 2|Lack of Efficacy|0|||
144379919|NCT02059291|520602765|FG021|Epoch 2|Lack of Efficacy|0|||
144379920|NCT02059291|520602766|FG022|Epoch 2|Lack of Efficacy|0|||
144379921|NCT02059291|520602767|FG023|Epoch 2|Lack of Efficacy|0|||
144379922|NCT02059291|520602768|FG024|Epoch 2|Lack of Efficacy|0|||
144379923|NCT02059291|520602744|FG000|Epoch 2|Adverse Event|0|||
144379924|NCT02059291|520602745|FG001|Epoch 2|Adverse Event|0|||
144379925|NCT02059291|520602746|FG002|Epoch 2|Adverse Event|1|||
144379926|NCT02059291|520602747|FG003|Epoch 2|Adverse Event|1|||
144379927|NCT02059291|520602748|FG004|Epoch 2|Adverse Event|0|||
144379928|NCT02059291|520602749|FG005|Epoch 2|Adverse Event|0|||
144379929|NCT02059291|520602750|FG006|Epoch 2|Adverse Event|0|||
144379930|NCT02059291|520602751|FG007|Epoch 2|Adverse Event|1|||
144379931|NCT02059291|520602752|FG008|Epoch 2|Adverse Event|1|||
144379932|NCT02059291|520602753|FG009|Epoch 2|Adverse Event|0|||
144379933|NCT02059291|520602754|FG010|Epoch 2|Adverse Event|0|||
144379934|NCT02059291|520602755|FG011|Epoch 2|Adverse Event|0|||
144379935|NCT02059291|520602756|FG012|Epoch 2|Adverse Event|0|||
144379936|NCT02059291|520602757|FG013|Epoch 2|Adverse Event|0|||
144379937|NCT02059291|520602758|FG014|Epoch 2|Adverse Event|0|||
144379938|NCT02059291|520602759|FG015|Epoch 2|Adverse Event|0|||
144379939|NCT02059291|520602760|FG016|Epoch 2|Adverse Event|0|||
144379940|NCT02059291|520602761|FG017|Epoch 2|Adverse Event|0|||
144379941|NCT02059291|520602762|FG018|Epoch 2|Adverse Event|0|||
144379942|NCT02059291|520602763|FG019|Epoch 2|Adverse Event|0|||
144379943|NCT02059291|520602764|FG020|Epoch 2|Adverse Event|0|||
144379944|NCT02059291|520602765|FG021|Epoch 2|Adverse Event|0|||
144379945|NCT02059291|520602766|FG022|Epoch 2|Adverse Event|0|||
144379946|NCT02059291|520602767|FG023|Epoch 2|Adverse Event|0|||
144379947|NCT02059291|520602768|FG024|Epoch 2|Adverse Event|0|||
144379948|NCT02059291|520602744|FG000|Epoch 2|Withdrawal by Subject|0|||
144379949|NCT02059291|520602745|FG001|Epoch 2|Withdrawal by Subject|1|||
144379950|NCT02059291|520602746|FG002|Epoch 2|Withdrawal by Subject|0|||
144379951|NCT02059291|520602747|FG003|Epoch 2|Withdrawal by Subject|0|||
144379952|NCT02059291|520602748|FG004|Epoch 2|Withdrawal by Subject|0|||
144379953|NCT02059291|520602749|FG005|Epoch 2|Withdrawal by Subject|1|||
144379954|NCT02059291|520602750|FG006|Epoch 2|Withdrawal by Subject|0|||
144513787|NCT02554786|521080217|FG002|Overall Study|Subject/guardian decision|18|||
144513788|NCT02554786|521080218|FG003|Overall Study|Subject/guardian decision|30|||
144513789|NCT02554786|521080219|FG004|Overall Study|Subject/guardian decision|20|||
144513790|NCT02554786|521080215|FG000|Overall Study|Lost to Follow-up|4|||
144513791|NCT02554786|521080216|FG001|Overall Study|Lost to Follow-up|3|||
144513792|NCT02554786|521080217|FG002|Overall Study|Lost to Follow-up|4|||
144513793|NCT02554786|521080218|FG003|Overall Study|Lost to Follow-up|2|||
144513794|NCT02554786|521080219|FG004|Overall Study|Lost to Follow-up|2|||
144513795|NCT02554786|521080215|FG000|Overall Study|Protocol deviation|1|||
144513796|NCT02554786|521080216|FG001|Overall Study|Protocol deviation|3|||
144513797|NCT02554786|521080217|FG002|Overall Study|Protocol deviation|3|||
144513798|NCT02554786|521080218|FG003|Overall Study|Protocol deviation|4|||
144513799|NCT02554786|521080219|FG004|Overall Study|Protocol deviation|2|||
144513800|NCT02554786|521080215|FG000|Overall Study|Technical problems|1|||
144513801|NCT02554786|521080216|FG001|Overall Study|Technical problems|1|||
144513802|NCT02554786|521080217|FG002|Overall Study|Technical problems|0|||
144513803|NCT02554786|521080218|FG003|Overall Study|Technical problems|2|||
144513804|NCT02554786|521080219|FG004|Overall Study|Technical problems|1|||
144513805|NCT02554786|521080215|FG000|Overall Study|Adverse Event|0|||
144513806|NCT02554786|521080216|FG001|Overall Study|Adverse Event|0|||
144513807|NCT02554786|521080217|FG002|Overall Study|Adverse Event|0|||
144513808|NCT02554786|521080218|FG003|Overall Study|Adverse Event|0|||
144513809|NCT02554786|521080219|FG004|Overall Study|Adverse Event|2|||
144513810|NCT02554786|521080215|FG000|Overall Study|Death|0|||
144513811|NCT02554786|521080216|FG001|Overall Study|Death|0|||
144513812|NCT02554786|521080217|FG002|Overall Study|Death|0|||
144379955|NCT02059291|520602751|FG007|Epoch 2|Withdrawal by Subject|0|||
144379956|NCT02059291|520602752|FG008|Epoch 2|Withdrawal by Subject|1|||
144379957|NCT02059291|520602753|FG009|Epoch 2|Withdrawal by Subject|0|||
144379958|NCT02059291|520602754|FG010|Epoch 2|Withdrawal by Subject|0|||
144513813|NCT02554786|521080218|FG003|Overall Study|Death|1|||
144513814|NCT02554786|521080219|FG004|Overall Study|Death|0|||
144513815|NCT02554786|521080215|FG000|Overall Study|Non-compliance with study treatment|0|||
144513816|NCT02554786|521080216|FG001|Overall Study|Non-compliance with study treatment|1|||
144513817|NCT02554786|521080217|FG002|Overall Study|Non-compliance with study treatment|1|||
144513818|NCT02554786|521080218|FG003|Overall Study|Non-compliance with study treatment|0|||
144379959|NCT02059291|520602755|FG011|Epoch 2|Withdrawal by Subject|0|||
144379960|NCT02059291|520602756|FG012|Epoch 2|Withdrawal by Subject|0|||
144379961|NCT02059291|520602757|FG013|Epoch 2|Withdrawal by Subject|0|||
144379962|NCT02059291|520602758|FG014|Epoch 2|Withdrawal by Subject|0|||
144379963|NCT02059291|520602759|FG015|Epoch 2|Withdrawal by Subject|0|||
144379964|NCT02059291|520602760|FG016|Epoch 2|Withdrawal by Subject|0|||
144379965|NCT02059291|520602761|FG017|Epoch 2|Withdrawal by Subject|0|||
144379966|NCT02059291|520602762|FG018|Epoch 2|Withdrawal by Subject|0|||
144379967|NCT02059291|520602763|FG019|Epoch 2|Withdrawal by Subject|0|||
144379968|NCT02059291|520602764|FG020|Epoch 2|Withdrawal by Subject|0|||
144379969|NCT02059291|520602765|FG021|Epoch 2|Withdrawal by Subject|0|||
144379970|NCT02059291|520602766|FG022|Epoch 2|Withdrawal by Subject|0|||
144379971|NCT02059291|520602767|FG023|Epoch 2|Withdrawal by Subject|0|||
144379972|NCT02059291|520602768|FG024|Epoch 2|Withdrawal by Subject|0|||
144379973|NCT02059291|520602744|FG000|Epoch 3|Physician Decision|0|||
144379974|NCT02059291|520602745|FG001|Epoch 3|Physician Decision|0|||
144379975|NCT02059291|520602746|FG002|Epoch 3|Physician Decision|0|||
144379976|NCT02059291|520602747|FG003|Epoch 3|Physician Decision|0|||
144379977|NCT02059291|520602748|FG004|Epoch 3|Physician Decision|0|||
144379978|NCT02059291|520602749|FG005|Epoch 3|Physician Decision|0|||
144379979|NCT02059291|520602750|FG006|Epoch 3|Physician Decision|0|||
144379980|NCT02059291|520602751|FG007|Epoch 3|Physician Decision|0|||
144721802|NCT03335371|521835300|FG003|Overall Study|Withdrawal by Subject|0|||
144721803|NCT03335371|521835301|FG004|Overall Study|Withdrawal by Subject|1|||
144379981|NCT02059291|520602752|FG008|Epoch 3|Physician Decision|0|||
144379982|NCT02059291|520602753|FG009|Epoch 3|Physician Decision|0|||
144379983|NCT02059291|520602754|FG010|Epoch 3|Physician Decision|0|||
144379984|NCT02059291|520602755|FG011|Epoch 3|Physician Decision|0|||
144379985|NCT02059291|520602756|FG012|Epoch 3|Physician Decision|0|||
144379986|NCT02059291|520602757|FG013|Epoch 3|Physician Decision|1|||
144379987|NCT02059291|520602758|FG014|Epoch 3|Physician Decision|0|||
144379988|NCT02059291|520602759|FG015|Epoch 3|Physician Decision|1|||
144379989|NCT02059291|520602760|FG016|Epoch 3|Physician Decision|0|||
144379990|NCT02059291|520602761|FG017|Epoch 3|Physician Decision|0|||
144379991|NCT02059291|520602762|FG018|Epoch 3|Physician Decision|0|||
144379992|NCT02059291|520602763|FG019|Epoch 3|Physician Decision|0|||
144379993|NCT02059291|520602764|FG020|Epoch 3|Physician Decision|0|||
144379994|NCT02059291|520602765|FG021|Epoch 3|Physician Decision|0|||
144379995|NCT02059291|520602766|FG022|Epoch 3|Physician Decision|0|||
144379996|NCT02059291|520602767|FG023|Epoch 3|Physician Decision|0|||
144379997|NCT02059291|520602768|FG024|Epoch 3|Physician Decision|0|||
144379998|NCT02059291|520602744|FG000|Epoch 3|Adverse Event|0|||
144379999|NCT02059291|520602745|FG001|Epoch 3|Adverse Event|0|||
144380000|NCT02059291|520602746|FG002|Epoch 3|Adverse Event|0|||
144380001|NCT02059291|520602747|FG003|Epoch 3|Adverse Event|0|||
144380002|NCT02059291|520602748|FG004|Epoch 3|Adverse Event|0|||
144380003|NCT02059291|520602749|FG005|Epoch 3|Adverse Event|0|||
144513819|NCT02554786|521080219|FG004|Overall Study|Non-compliance with study treatment|1|||
144513820|NCT02554786|521080215|FG000|Overall Study|Physician Decision|0|||
144513821|NCT02554786|521080216|FG001|Overall Study|Physician Decision|1|||
144513822|NCT02554786|521080217|FG002|Overall Study|Physician Decision|4|||
144513823|NCT02554786|521080218|FG003|Overall Study|Physician Decision|1|||
144513824|NCT02554786|521080219|FG004|Overall Study|Physician Decision|1|||
144513825|NCT02554786|521080215|FG000|Overall Study|Pregnancy|0|||
144513826|NCT02554786|521080216|FG001|Overall Study|Pregnancy|0|||
144513827|NCT02554786|521080217|FG002|Overall Study|Pregnancy|0|||
144513828|NCT02554786|521080218|FG003|Overall Study|Pregnancy|1|||
144513829|NCT02554786|521080219|FG004|Overall Study|Pregnancy|1|||
144513830|NCT00604669|521080220|FG000|Overall Study|lack of information in chart|7|||
144513831|NCT01695954|521080221|FG000|Overall Study|Withdrawal by Subject|4|||
144513832|NCT01695954|521080222|FG001|Overall Study|Withdrawal by Subject|0|||
144513833|NCT01695954|521080221|FG000|Overall Study|Adverse Event|0|||
144513834|NCT01695954|521080222|FG001|Overall Study|Adverse Event|2|||
144513835|NCT03330795|521080237|FG000|Overall Study|Death|3|||
144513836|NCT03330795|521080237|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
144380004|NCT02059291|520602750|FG006|Epoch 3|Adverse Event|0|||
144380005|NCT02059291|520602751|FG007|Epoch 3|Adverse Event|0|||
144380006|NCT02059291|520602752|FG008|Epoch 3|Adverse Event|0|||
144380007|NCT02059291|520602753|FG009|Epoch 3|Adverse Event|0|||
144380008|NCT02059291|520602754|FG010|Epoch 3|Adverse Event|0|||
144380009|NCT02059291|520602755|FG011|Epoch 3|Adverse Event|0|||
144380010|NCT02059291|520602756|FG012|Epoch 3|Adverse Event|0|||
144380011|NCT02059291|520602757|FG013|Epoch 3|Adverse Event|0|||
144513837|NCT00539734|521080239|FG000|Overall Study|Protocol Violation|1|||
144513838|NCT01771731|521080240|FG000|Overall Study|Physician Decision|1|||
144513839|NCT01771731|521080241|FG001|Overall Study|Physician Decision|0|||
144513840|NCT01771731|521080240|FG000|Overall Study|Protocol Violation|0|||
144380012|NCT02059291|520602758|FG014|Epoch 3|Adverse Event|0|||
144380013|NCT02059291|520602759|FG015|Epoch 3|Adverse Event|1|||
144380014|NCT02059291|520602760|FG016|Epoch 3|Adverse Event|0|||
144380015|NCT02059291|520602761|FG017|Epoch 3|Adverse Event|0|||
144591305|NCT00738582|521366275|FG000|Maintenance Therapy|Other|0|||
144591306|NCT00738582|521366276|FG001|Maintenance Therapy|Other|2|||
144591307|NCT00738582|521366275|FG000|Maintenance Therapy|Adverse Event|0|||
144591308|NCT00738582|521366276|FG001|Maintenance Therapy|Adverse Event|6|||
144591309|NCT00738582|521366275|FG000|Maintenance Therapy|Progressive Disease|0|||
144591310|NCT00738582|521366276|FG001|Maintenance Therapy|Progressive Disease|47|||
144591311|NCT00738582|521366275|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
144591312|NCT00738582|521366276|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
144591313|NCT00642772|521366277|FG000|Overall Study|Lost to Follow-up|3|||
144591314|NCT00642772|521366277|FG000|Overall Study|Withdrawal by Subject|7|||
144591315|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
144591316|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
144591317|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
144591318|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
144591319|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
144591320|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
144591321|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
144591322|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
144591323|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
144591324|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
144380016|NCT02059291|520602762|FG018|Epoch 3|Adverse Event|0|||
144380017|NCT02059291|520602763|FG019|Epoch 3|Adverse Event|0|||
144380018|NCT02059291|520602764|FG020|Epoch 3|Adverse Event|0|||
144380019|NCT02059291|520602765|FG021|Epoch 3|Adverse Event|0|||
144380020|NCT02059291|520602766|FG022|Epoch 3|Adverse Event|0|||
144380021|NCT02059291|520602767|FG023|Epoch 3|Adverse Event|0|||
144380022|NCT02059291|520602768|FG024|Epoch 3|Adverse Event|0|||
144380023|NCT02059291|520602744|FG000|Epoch 3|Lack of Efficacy|0|||
144380024|NCT02059291|520602745|FG001|Epoch 3|Lack of Efficacy|0|||
144380025|NCT02059291|520602746|FG002|Epoch 3|Lack of Efficacy|0|||
144380026|NCT02059291|520602747|FG003|Epoch 3|Lack of Efficacy|0|||
144591325|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
144591326|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
144591327|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
144591328|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
144591329|NCT00757588|521366278|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
144591330|NCT00757588|521366279|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
144591331|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
144591332|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
144591333|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
144591334|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
144591335|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
144591336|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
144591337|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
144591338|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
144591339|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
144591340|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
144591341|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
144591342|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
144591343|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
144591344|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
144380027|NCT02059291|520602748|FG004|Epoch 3|Lack of Efficacy|0|||
144380028|NCT02059291|520602749|FG005|Epoch 3|Lack of Efficacy|0|||
144513841|NCT01771731|521080241|FG001|Overall Study|Protocol Violation|1|||
144513842|NCT01771731|521080240|FG000|Overall Study|Adverse event: Pain Crisis|1|||
144513843|NCT01771731|521080241|FG001|Overall Study|Adverse event: Pain Crisis|1|||
144513844|NCT02538341|521080244|FG000|Overall Study|Lost to Follow-up|51|||
144513845|NCT02538341|521080245|FG001|Overall Study|Lost to Follow-up|46|||
144513846|NCT02538341|521080244|FG000|Overall Study|Withdrawal by Subject|3|||
144513847|NCT02538341|521080245|FG001|Overall Study|Withdrawal by Subject|1|||
144513848|NCT02538341|521080244|FG000|Overall Study|Death|2|||
144513849|NCT02538341|521080245|FG001|Overall Study|Death|0|||
144513850|NCT00331136|521080246|FG000|Overall Study|Adverse Event|3|||
144513851|NCT00331136|521080247|FG001|Overall Study|Adverse Event|5|||
144591345|NCT00757588|521366278|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
144591346|NCT00757588|521366279|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
144591347|NCT01052103|521366282|FG000|Overall Study|Adverse Event|10|||
144721804|NCT03335371|521835297|FG000|Overall Study|Randomization Error|0|||
144380029|NCT02059291|520602750|FG006|Epoch 3|Lack of Efficacy|0|||
144380030|NCT02059291|520602751|FG007|Epoch 3|Lack of Efficacy|0|||
144513852|NCT00331136|521080248|FG002|Overall Study|Adverse Event|0|||
144513853|NCT00331136|521080249|FG003|Overall Study|Adverse Event|1|||
144513854|NCT00331136|521080246|FG000|Overall Study|Withdrawal by Subject|0|||
144380031|NCT02059291|520602752|FG008|Epoch 3|Lack of Efficacy|0|||
144591348|NCT01052103|521366283|FG001|Overall Study|Adverse Event|6|||
144591349|NCT01052103|521366282|FG000|Overall Study|Entry Criteria Not Met|3|||
144591350|NCT01052103|521366283|FG001|Overall Study|Entry Criteria Not Met|1|||
144591351|NCT01052103|521366282|FG000|Overall Study|Lost to Follow-up|3|||
144591352|NCT01052103|521366283|FG001|Overall Study|Lost to Follow-up|5|||
144591353|NCT01052103|521366282|FG000|Overall Study|Protocol Violation|10|||
144591354|NCT01052103|521366283|FG001|Overall Study|Protocol Violation|4|||
144591355|NCT01052103|521366282|FG000|Overall Study|Scheduling conflict|2|||
144591356|NCT01052103|521366283|FG001|Overall Study|Scheduling conflict|1|||
144591357|NCT01052103|521366282|FG000|Overall Study|Sponsor Decision|2|||
144591358|NCT01052103|521366283|FG001|Overall Study|Sponsor Decision|0|||
144591359|NCT01052103|521366282|FG000|Overall Study|Withdrawal by Subject|3|||
144380032|NCT02059291|520602753|FG009|Epoch 3|Lack of Efficacy|0|||
144380033|NCT02059291|520602754|FG010|Epoch 3|Lack of Efficacy|0|||
144380034|NCT02059291|520602755|FG011|Epoch 3|Lack of Efficacy|0|||
144380035|NCT02059291|520602756|FG012|Epoch 3|Lack of Efficacy|0|||
144380036|NCT02059291|520602757|FG013|Epoch 3|Lack of Efficacy|0|||
144380037|NCT02059291|520602758|FG014|Epoch 3|Lack of Efficacy|0|||
144380038|NCT02059291|520602759|FG015|Epoch 3|Lack of Efficacy|3|||
144380039|NCT02059291|520602760|FG016|Epoch 3|Lack of Efficacy|0|||
144380040|NCT02059291|520602761|FG017|Epoch 3|Lack of Efficacy|0|||
144513855|NCT00331136|521080247|FG001|Overall Study|Withdrawal by Subject|1|||
144591360|NCT01052103|521366283|FG001|Overall Study|Withdrawal by Subject|6|||
144591361|NCT01052103|521366282|FG000|Overall Study|Perceived Lack of Efficacy|1|||
144591362|NCT01052103|521366283|FG001|Overall Study|Perceived Lack of Efficacy|0|||
144591363|NCT04874415|521366289|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591364|NCT04874415|521366290|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591365|NCT04874415|521366291|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591366|NCT04874415|521366292|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591367|NCT04874415|521366293|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591368|NCT04874415|521366294|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591369|NCT04874415|521366295|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
144591370|NCT04874415|521366296|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591371|NCT04874415|521366297|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
144591372|NCT04874415|521366298|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
144591373|NCT04874415|521366299|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591374|NCT04874415|521366300|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
144591375|NCT04874415|521366301|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
144591376|NCT04874415|521366302|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
144591377|NCT04874415|521366303|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
144591378|NCT04874415|521366304|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
144591379|NCT04874415|521366289|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
144591380|NCT04874415|521366290|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591381|NCT04874415|521366291|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591382|NCT04874415|521366292|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
144591383|NCT04874415|521366293|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591384|NCT04874415|521366294|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591385|NCT04874415|521366295|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
144591386|NCT04874415|521366296|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
144591387|NCT04874415|521366297|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591388|NCT04874415|521366298|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
144591389|NCT04874415|521366299|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
144513856|NCT00331136|521080248|FG002|Overall Study|Withdrawal by Subject|0|||
144513857|NCT00331136|521080249|FG003|Overall Study|Withdrawal by Subject|0|||
144513858|NCT00331136|521080246|FG000|Overall Study|Lost to Follow-up|0|||
144513859|NCT00331136|521080247|FG001|Overall Study|Lost to Follow-up|1|||
144513860|NCT00331136|521080248|FG002|Overall Study|Lost to Follow-up|0|||
144513861|NCT00331136|521080249|FG003|Overall Study|Lost to Follow-up|0|||
144513862|NCT00331136|521080246|FG000|Overall Study|Protocol Violation|1|||
144513863|NCT00331136|521080247|FG001|Overall Study|Protocol Violation|0|||
144513864|NCT00331136|521080248|FG002|Overall Study|Protocol Violation|0|||
144513865|NCT00331136|521080249|FG003|Overall Study|Protocol Violation|0|||
144591390|NCT04874415|521366300|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
144591391|NCT04874415|521366301|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
144721805|NCT03335371|521835298|FG001|Overall Study|Randomization Error|0|||
144513866|NCT00331136|521080246|FG000|Overall Study|Not treated|1|||
144513867|NCT00331136|521080247|FG001|Overall Study|Not treated|0|||
144380041|NCT02059291|520602762|FG018|Epoch 3|Lack of Efficacy|0|||
144380042|NCT02059291|520602763|FG019|Epoch 3|Lack of Efficacy|0|||
144380043|NCT02059291|520602764|FG020|Epoch 3|Lack of Efficacy|0|||
144380044|NCT02059291|520602765|FG021|Epoch 3|Lack of Efficacy|0|||
144513868|NCT00331136|521080248|FG002|Overall Study|Not treated|0|||
144513869|NCT00331136|521080249|FG003|Overall Study|Not treated|0|||
144513870|NCT02321514|521080250|FG000|Overall Study|Death|15|||
144591392|NCT04874415|521366302|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591393|NCT04874415|521366303|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
144591394|NCT04874415|521366304|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
144591395|NCT04874415|521366289|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591396|NCT04874415|521366290|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591397|NCT04874415|521366291|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591398|NCT04874415|521366292|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591399|NCT04874415|521366293|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
144591400|NCT04874415|521366294|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591401|NCT04874415|521366295|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591402|NCT04874415|521366296|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591403|NCT04874415|521366297|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591404|NCT04874415|521366298|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591405|NCT04874415|521366299|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591406|NCT04874415|521366300|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591407|NCT04874415|521366301|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591408|NCT04874415|521366302|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591409|NCT04874415|521366303|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591410|NCT04874415|521366304|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
144591411|NCT05062759|521366305|FG000|Overall Study|Death|0|||
144591412|NCT05062759|521366306|FG001|Overall Study|Death|1|||
144591413|NCT05062759|521366305|FG000|Overall Study|Lost to Follow-up|1|||
144591414|NCT05062759|521366306|FG001|Overall Study|Lost to Follow-up|0|||
144591415|NCT00903006|521366307|FG000|Overall Study|Withdrawal by Subject|2|||
144591416|NCT00903006|521366308|FG001|Overall Study|Withdrawal by Subject|0|||
144591417|NCT00903006|521366309|FG002|Overall Study|Withdrawal by Subject|0|||
144591418|NCT00903006|521366310|FG003|Overall Study|Withdrawal by Subject|0|||
144591419|NCT00903006|521366307|FG000|Overall Study|Progressive Disease|0|||
144591420|NCT00903006|521366308|FG001|Overall Study|Progressive Disease|3|||
144591421|NCT00903006|521366309|FG002|Overall Study|Progressive Disease|1|||
144591422|NCT00903006|521366310|FG003|Overall Study|Progressive Disease|0|||
144591423|NCT03405792|521366311|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
144591424|NCT03405792|521366312|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
144591425|NCT03405792|521366311|FG000|Overall Study|o Did not receive pembrolizumab|1|||
144591426|NCT03405792|521366312|FG001|Overall Study|o Did not receive pembrolizumab|0|||
144591427|NCT01383499|521366313|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
144591428|NCT01383499|521366314|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144591429|NCT01383499|521366315|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144591430|NCT01383499|521366316|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
144591431|NCT02572882|521366317|FG000|Overall Study|Withdrawal by Subject|1|||
144591432|NCT02572882|521366317|FG000|Overall Study|Participant received kidney transplant|1|||
144591433|NCT01079663|521366318|FG000|Overall Study|Adverse Event|0|||
144591434|NCT01079663|521366319|FG001|Overall Study|Adverse Event|2|||
144591435|NCT01079663|521366318|FG000|Overall Study|Protocol Violation|0|||
144591436|NCT01079663|521366319|FG001|Overall Study|Protocol Violation|2|||
144591437|NCT03587974|521366323|FG000|Overall Study|caregiver demented, care recipient died|3|||
144591438|NCT03587974|521366324|FG001|Overall Study|caregiver demented, care recipient died|3|||
144591439|NCT03587974|521366323|FG000|Overall Study|Withdrawal by Subject|2|||
144380045|NCT02059291|520602766|FG022|Epoch 3|Lack of Efficacy|0|||
144380046|NCT02059291|520602767|FG023|Epoch 3|Lack of Efficacy|0|||
144380047|NCT02059291|520602768|FG024|Epoch 3|Lack of Efficacy|0|||
144591440|NCT03587974|521366324|FG001|Overall Study|Withdrawal by Subject|1|||
144591441|NCT00372229|521366327|FG000|Study Phase|Graft loss|0|||
144591442|NCT00372229|521366328|FG001|Study Phase|Graft loss|3|||
144591443|NCT00372229|521366327|FG000|Study Phase|Protocol Violation|3|||
144591444|NCT00372229|521366328|FG001|Study Phase|Protocol Violation|4|||
144591445|NCT00372229|521366327|FG000|Study Phase|Consent withdrawn|16|||
144591446|NCT00372229|521366328|FG001|Study Phase|Consent withdrawn|14|||
144591447|NCT00372229|521366327|FG000|Study Phase|Refused treatment/did not cooperate|3|||
144380048|NCT02059291|520602744|FG000|Epoch 3|Withdrawal by Subject|0|||
144591448|NCT00372229|521366328|FG001|Study Phase|Refused treatment/did not cooperate|1|||
144591449|NCT00372229|521366327|FG000|Study Phase|Death|3|||
144591450|NCT00372229|521366328|FG001|Study Phase|Death|2|||
144591451|NCT00372229|521366327|FG000|Study Phase|Reason not specified|3|||
144721806|NCT03335371|521835299|FG002|Overall Study|Randomization Error|1|||
144380049|NCT02059291|520602745|FG001|Epoch 3|Withdrawal by Subject|0|||
144721807|NCT03335371|521835300|FG003|Overall Study|Randomization Error|0|||
144591452|NCT00372229|521366328|FG001|Study Phase|Reason not specified|2|||
144591453|NCT00372229|521366327|FG000|Study Phase|Lost to Follow-up|3|||
144591454|NCT00372229|521366328|FG001|Study Phase|Lost to Follow-up|3|||
144591455|NCT00372229|521366327|FG000|Follow-Up Phase|Graft loss|8|||
144513871|NCT02321514|521080250|FG000|Overall Study|Missed Visit|7|||
144513872|NCT02321514|521080250|FG000|Overall Study|Study Exit|3|||
144513873|NCT03201562|521080255|FG000|Overall Study|Physician Decision|0|||
144513874|NCT03201562|521080256|FG001|Overall Study|Physician Decision|0|||
144513875|NCT03201562|521080257|FG002|Overall Study|Physician Decision|1|||
144513876|NCT03201562|521080255|FG000|Overall Study|Adverse Event|0|||
144513877|NCT03201562|521080256|FG001|Overall Study|Adverse Event|0|||
144513878|NCT03201562|521080257|FG002|Overall Study|Adverse Event|1|||
144513879|NCT03201562|521080255|FG000|Overall Study|Lost to Follow-up|0|||
144513880|NCT03201562|521080256|FG001|Overall Study|Lost to Follow-up|1|||
144513881|NCT03201562|521080257|FG002|Overall Study|Lost to Follow-up|2|||
144513882|NCT00001277|521080260|FG000|Overall Study|Adverse Event|0|||
144513883|NCT00001277|521080261|FG001|Overall Study|Adverse Event|0|||
144513884|NCT00001277|521080262|FG002|Overall Study|Adverse Event|1|||
144513885|NCT00001277|521080260|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
144513886|NCT00001277|521080261|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
144513887|NCT00001277|521080262|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
144513888|NCT00065260|521080263|FG000|Overall Study|Death|0|||
144513889|NCT00065260|521080264|FG001|Overall Study|Death|1|||
144513890|NCT04484935|521080265|FG000|Overall Study|Other|0|||
144513891|NCT04484935|521080266|FG001|Overall Study|Other|1|||
144513892|NCT04484935|521080265|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144513893|NCT04484935|521080266|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144513894|NCT04484935|521080265|FG000|Overall Study|Lost to Follow-up|1|||
144513895|NCT04484935|521080266|FG001|Overall Study|Lost to Follow-up|0|||
144513896|NCT04484935|521080265|FG000|Overall Study|Death|2|||
144513897|NCT04484935|521080266|FG001|Overall Study|Death|1|||
144513898|NCT02178098|521080277|FG000|Overall Study|Withdrawal by Subject|0|||
144513899|NCT02178098|521080278|FG001|Overall Study|Withdrawal by Subject|6|||
144513900|NCT02178098|521080277|FG000|Overall Study|Adverse Event|1|||
144513901|NCT02178098|521080278|FG001|Overall Study|Adverse Event|2|||
144513902|NCT02178098|521080277|FG000|Overall Study|Protocol Violation|1|||
144513903|NCT02178098|521080278|FG001|Overall Study|Protocol Violation|1|||
144513904|NCT02178098|521080277|FG000|Overall Study|Lost to Follow-up|0|||
144513905|NCT02178098|521080278|FG001|Overall Study|Lost to Follow-up|1|||
144380050|NCT02059291|520602746|FG002|Epoch 3|Withdrawal by Subject|0|||
144380051|NCT02059291|520602747|FG003|Epoch 3|Withdrawal by Subject|0|||
144380052|NCT02059291|520602748|FG004|Epoch 3|Withdrawal by Subject|0|||
144380053|NCT02059291|520602749|FG005|Epoch 3|Withdrawal by Subject|0|||
144380054|NCT02059291|520602750|FG006|Epoch 3|Withdrawal by Subject|0|||
144380055|NCT02059291|520602751|FG007|Epoch 3|Withdrawal by Subject|0|||
144380056|NCT02059291|520602752|FG008|Epoch 3|Withdrawal by Subject|0|||
144380057|NCT02059291|520602753|FG009|Epoch 3|Withdrawal by Subject|0|||
144380058|NCT02059291|520602754|FG010|Epoch 3|Withdrawal by Subject|0|||
144380059|NCT02059291|520602755|FG011|Epoch 3|Withdrawal by Subject|0|||
144380060|NCT02059291|520602756|FG012|Epoch 3|Withdrawal by Subject|0|||
144380061|NCT02059291|520602757|FG013|Epoch 3|Withdrawal by Subject|0|||
144380062|NCT02059291|520602758|FG014|Epoch 3|Withdrawal by Subject|0|||
144513906|NCT02178098|521080277|FG000|Overall Study|Sponsor Request|1|||
144513907|NCT02178098|521080278|FG001|Overall Study|Sponsor Request|0|||
144513908|NCT02178098|521080277|FG000|Overall Study|Other|2|||
144513909|NCT02178098|521080278|FG001|Overall Study|Other|2|||
144513910|NCT00088413|521080280|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
144513911|NCT00088413|521080281|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
144513912|NCT00088413|521080282|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
144513913|NCT00088413|521080283|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
144513914|NCT00088413|521080280|FG000|Overall Study|Adverse Events/Side Effects|0|||
144513915|NCT00088413|521080281|FG001|Overall Study|Adverse Events/Side Effects|1|||
144513916|NCT00088413|521080282|FG002|Overall Study|Adverse Events/Side Effects|1|||
144513917|NCT00088413|521080283|FG003|Overall Study|Adverse Events/Side Effects|0|||
144513918|NCT00088413|521080280|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
144513919|NCT00088413|521080281|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
144513920|NCT00088413|521080282|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
144513921|NCT00088413|521080283|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
144513922|NCT00088413|521080280|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
144513923|NCT00088413|521080281|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
144513924|NCT00088413|521080282|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
144513925|NCT00088413|521080283|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
144513926|NCT00088413|521080280|FG000|Overall Study|Death|0|||
144513927|NCT00088413|521080281|FG001|Overall Study|Death|1|||
144513928|NCT00088413|521080282|FG002|Overall Study|Death|0|||
144513929|NCT00088413|521080283|FG003|Overall Study|Death|0|||
144513930|NCT00088413|521080280|FG000|Overall Study|Progressive disease|9|||
144513931|NCT00088413|521080281|FG001|Overall Study|Progressive disease|11|||
144513932|NCT00088413|521080282|FG002|Overall Study|Progressive disease|8|||
144513933|NCT00088413|521080283|FG003|Overall Study|Progressive disease|14|||
144513934|NCT00088413|521080280|FG000|Overall Study|Other|0|||
144513935|NCT00088413|521080281|FG001|Overall Study|Other|1|||
144513936|NCT00088413|521080282|FG002|Overall Study|Other|0|||
144513937|NCT00088413|521080283|FG003|Overall Study|Other|0|||
144513938|NCT00088413|521080280|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
144513939|NCT00088413|521080281|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
144513940|NCT00088413|521080282|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
144513941|NCT00088413|521080283|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
144513942|NCT02539225|521080290|FG000|Part A|Adverse Event|13|||
144513943|NCT02539225|521080291|FG001|Part A|Adverse Event|4|||
144513944|NCT02539225|521080290|FG000|Part A|Withdrawal by Subject|2|||
144513945|NCT02539225|521080291|FG001|Part A|Withdrawal by Subject|4|||
144513946|NCT02539225|521080290|FG000|Part A|Physician Decision|4|||
144513947|NCT02539225|521080291|FG001|Part A|Physician Decision|7|||
144513948|NCT02539225|521080290|FG000|Part A|Did Not Receive study Drug|1|||
144513949|NCT02539225|521080291|FG001|Part A|Did Not Receive study Drug|1|||
144513950|NCT02539225|521080290|FG000|Pre Treatment for Part B|Progressive disease|1|||
144513951|NCT02539225|521080291|FG001|Pre Treatment for Part B|Progressive disease|1|||
144513952|NCT02539225|521080290|FG000|Pre Treatment for Part B|Adverse Event|1|||
144513953|NCT02539225|521080291|FG001|Pre Treatment for Part B|Adverse Event|1|||
144721808|NCT03335371|521835301|FG004|Overall Study|Randomization Error|0|||
144721809|NCT00684671|521835302|FG000|Overall Study|Adverse Event|1|||
144513954|NCT02539225|521080290|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
144513955|NCT02539225|521080291|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
144513956|NCT02539225|521080290|FG000|Pre Treatment for Part B|Physician Decision|2|||
144513957|NCT02539225|521080291|FG001|Pre Treatment for Part B|Physician Decision|0|||
144513958|NCT02539225|521080290|FG000|Part B|Adverse Event|4|||
144513959|NCT02539225|521080291|FG001|Part B|Adverse Event|4|||
144513960|NCT02539225|521080290|FG000|Part B|Withdrawal by Subject|0|||
144513961|NCT02539225|521080291|FG001|Part B|Withdrawal by Subject|3|||
144380063|NCT02059291|520602759|FG015|Epoch 3|Withdrawal by Subject|1|||
144380064|NCT02059291|520602760|FG016|Epoch 3|Withdrawal by Subject|0|||
144380065|NCT02059291|520602761|FG017|Epoch 3|Withdrawal by Subject|0|||
144513962|NCT02539225|521080290|FG000|Part B|Physician Decision|0|||
144721810|NCT00684671|521835303|FG001|Overall Study|Adverse Event|0|||
144380066|NCT02059291|520602762|FG018|Epoch 3|Withdrawal by Subject|0|||
144591456|NCT00372229|521366328|FG001|Follow-Up Phase|Graft loss|7|||
144591457|NCT00372229|521366327|FG000|Follow-Up Phase|Consent withdrawn|13|||
144591458|NCT00372229|521366328|FG001|Follow-Up Phase|Consent withdrawn|19|||
144591459|NCT00372229|521366327|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
144591460|NCT00372229|521366328|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
144591461|NCT00372229|521366327|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
144591462|NCT00372229|521366328|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
144591463|NCT00372229|521366327|FG000|Follow-Up Phase|Death|9|||
144591464|NCT00372229|521366328|FG001|Follow-Up Phase|Death|12|||
144591465|NCT00372229|521366327|FG000|Follow-Up Phase|Administrative|1|||
144591466|NCT00372229|521366328|FG001|Follow-Up Phase|Administrative|0|||
144591467|NCT00372229|521366327|FG000|Follow-Up Phase|Reason not specified|2|||
144591468|NCT00372229|521366328|FG001|Follow-Up Phase|Reason not specified|3|||
144591469|NCT00372229|521366327|FG000|Follow-Up Phase|Lost to Follow-up|12|||
144591470|NCT00372229|521366328|FG001|Follow-Up Phase|Lost to Follow-up|10|||
144591471|NCT03536143|521366329|FG000|Overall Study|Early termination, Sponsor decision|1|||
144591472|NCT01878214|521366330|FG000|Overall Study|Withdrawal by Subject|18|||
144591473|NCT01878214|521366331|FG001|Overall Study|Withdrawal by Subject|7|||
144591474|NCT01878214|521366330|FG000|Overall Study|Death|0|||
144591475|NCT01878214|521366331|FG001|Overall Study|Death|1|||
144591476|NCT01878214|521366330|FG000|Overall Study|Lost to Follow-up|35|||
144591477|NCT01878214|521366331|FG001|Overall Study|Lost to Follow-up|36|||
144591478|NCT01174160|521366332|FG000|Overall Study|Adverse Event|1|||
144591479|NCT01174160|521366333|FG001|Overall Study|Adverse Event|0|||
144591480|NCT01174160|521366332|FG000|Overall Study|Lost to Follow-up|1|||
144591481|NCT01174160|521366333|FG001|Overall Study|Lost to Follow-up|0|||
144591482|NCT01174160|521366332|FG000|Overall Study|Physician Decision|1|||
144591483|NCT01174160|521366333|FG001|Overall Study|Physician Decision|0|||
144591484|NCT01174160|521366332|FG000|Overall Study|Protocol Violation|4|||
144591485|NCT01174160|521366333|FG001|Overall Study|Protocol Violation|6|||
144591486|NCT01174160|521366332|FG000|Overall Study|Withdrawal by Subject|1|||
144591487|NCT01174160|521366333|FG001|Overall Study|Withdrawal by Subject|0|||
144591488|NCT01590017|521366334|FG000|Overall Study|Adverse Event|1|||
144591489|NCT01590017|521366334|FG000|Overall Study|Withdrawal by Subject|1|||
144591490|NCT01590017|521366334|FG000|Overall Study|Lack of Efficacy|1|||
144591491|NCT01590017|521366334|FG000|Overall Study|Physician Decision|1|||
144591492|NCT02527343|521366335|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
144591493|NCT02527343|521366336|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
144591494|NCT02527343|521366337|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
144591495|NCT02527343|521366338|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
144591496|NCT02527343|521366339|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
144591497|NCT02527343|521366340|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
144591498|NCT02527343|521366335|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
144591499|NCT02527343|521366336|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
144591500|NCT02527343|521366337|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
144380067|NCT02059291|520602763|FG019|Epoch 3|Withdrawal by Subject|0|||
144380068|NCT02059291|520602764|FG020|Epoch 3|Withdrawal by Subject|0|||
144380069|NCT02059291|520602765|FG021|Epoch 3|Withdrawal by Subject|0|||
144591501|NCT02527343|521366338|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
144591502|NCT02527343|521366339|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
144591503|NCT02527343|521366340|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
144591504|NCT02527343|521366335|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144591505|NCT02527343|521366336|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
144591506|NCT02527343|521366337|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144591507|NCT02527343|521366338|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144591508|NCT02527343|521366339|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144380070|NCT02059291|520602766|FG022|Epoch 3|Withdrawal by Subject|0|||
144380071|NCT02059291|520602767|FG023|Epoch 3|Withdrawal by Subject|0|||
144513963|NCT02539225|521080291|FG001|Part B|Physician Decision|9|||
144513964|NCT01044303|521080292|FG000|Overall Study|Lost to Follow-up|2|||
144513965|NCT01109524|521080295|FG000|Overall Study|Disease Progression|29|||
144513966|NCT01109524|521080295|FG000|Overall Study|Study Drug toxicity|6|||
144513967|NCT01109524|521080295|FG000|Overall Study|Adverse Event|4|||
144513968|NCT01109524|521080295|FG000|Overall Study|Withdrawal by Subject|2|||
144513969|NCT01109524|521080295|FG000|Overall Study|Maximum clinical benefit|3|||
144513970|NCT01109524|521080295|FG000|Overall Study|Death|2|||
144513971|NCT01109524|521080295|FG000|Overall Study|No longer meets criteria|2|||
144513972|NCT01109524|521080295|FG000|Overall Study|Participant requested to end treatment|4|||
144513973|NCT01109524|521080295|FG000|Overall Study|Other|5|||
144513974|NCT02556138|521080296|FG000|Overall Study|Withdrawal by Subject|1|||
144513975|NCT01037985|521080298|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
144513976|NCT01037985|521080299|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
144513977|NCT01037985|521080298|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
144513978|NCT01037985|521080299|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
144513979|NCT01037985|521080298|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
144513980|NCT01037985|521080299|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
144513981|NCT01037985|521080298|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
144513982|NCT01037985|521080299|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
144513983|NCT04428112|521080300|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
144513984|NCT04428112|521080301|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
144513985|NCT04428112|521080300|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
144513986|NCT04428112|521080301|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
144513987|NCT04428112|521080300|FG000|Overall Study|Withdrawal by Subject|9|||
144513988|NCT04428112|521080301|FG001|Overall Study|Withdrawal by Subject|4|||
144380072|NCT02059291|520602768|FG024|Epoch 3|Withdrawal by Subject|0|||
144380073|NCT02059291|520602744|FG000|Epoch 4|Adverse Event|0|||
144380074|NCT02059291|520602745|FG001|Epoch 4|Adverse Event|0|||
144380075|NCT02059291|520602746|FG002|Epoch 4|Adverse Event|0|||
144380076|NCT02059291|520602747|FG003|Epoch 4|Adverse Event|0|||
144513989|NCT04428112|521080300|FG000|Overall Study|Lost to Follow-up|27|||
144513990|NCT04428112|521080301|FG001|Overall Study|Lost to Follow-up|7|||
144513991|NCT06024174|521080303|FG000|Overall Study|Other Reasons|1|||
144513992|NCT06024174|521080303|FG000|Overall Study|Study terminated by Sponsor|4|||
144513993|NCT05028582|521080304|FG000|Overall Study|Lost to Follow-up|11|||
144513994|NCT05028582|521080305|FG001|Overall Study|Lost to Follow-up|9|||
144513995|NCT05028582|521080304|FG000|Overall Study|Withdrawal by Subject|9|||
144513996|NCT05028582|521080305|FG001|Overall Study|Withdrawal by Subject|10|||
144513997|NCT05028582|521080304|FG000|Overall Study|Adverse Event|5|||
144513998|NCT05028582|521080305|FG001|Overall Study|Adverse Event|2|||
144513999|NCT05028582|521080304|FG000|Overall Study|Miscellaneous|3|||
144514000|NCT05028582|521080305|FG001|Overall Study|Miscellaneous|2|||
144514001|NCT05028582|521080304|FG000|Overall Study|Lack of Efficacy|3|||
144514002|NCT05028582|521080305|FG001|Overall Study|Lack of Efficacy|1|||
144514003|NCT05028582|521080304|FG000|Overall Study|Physician Decision|0|||
144514004|NCT05028582|521080305|FG001|Overall Study|Physician Decision|1|||
144514005|NCT05696080|521082069|FG000|Overall Study|Lost to Follow-up|2|||
144514006|NCT05696080|521082070|FG001|Overall Study|Lost to Follow-up|1|||
144514007|NCT05696080|521082069|FG000|Overall Study|Physician Decision|1|||
144514008|NCT05696080|521082070|FG001|Overall Study|Physician Decision|0|||
144514009|NCT05696080|521082069|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144514010|NCT05696080|521082070|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144514011|NCT05696080|521082069|FG000|Overall Study|Withdrawal by Subject|12|||
144514012|NCT05696080|521082070|FG001|Overall Study|Withdrawal by Subject|0|||
144514013|NCT05644002|521082073|FG000|Overall Study|Lost to Follow-up|1|||
144514014|NCT05644002|521082074|FG001|Overall Study|Lost to Follow-up|2|||
144591509|NCT02527343|521366340|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144591510|NCT02527343|521366335|FG000|RT Period: Weeks 1 to 52|Other|4|||
144514015|NCT05644002|521082073|FG000|Overall Study|Withdrawal by Subject|0|||
144514016|NCT05644002|521082074|FG001|Overall Study|Withdrawal by Subject|1|||
144514017|NCT05656911|521082078|FG000|Treatment Phase|Physician Decision|2|||
144514018|NCT05656911|521082079|FG001|Treatment Phase|Physician Decision|0|||
144380077|NCT02059291|520602748|FG004|Epoch 4|Adverse Event|0|||
144380078|NCT02059291|520602749|FG005|Epoch 4|Adverse Event|0|||
144514019|NCT05656911|521082078|FG000|Treatment Phase|Lack of Efficacy|6|||
144514020|NCT05656911|521082079|FG001|Treatment Phase|Lack of Efficacy|3|||
144514021|NCT05656911|521082078|FG000|Treatment Phase|Subject Decision|4|||
144514022|NCT05656911|521082079|FG001|Treatment Phase|Subject Decision|2|||
144380079|NCT02059291|520602750|FG006|Epoch 4|Adverse Event|0|||
144380080|NCT02059291|520602751|FG007|Epoch 4|Adverse Event|0|||
144380081|NCT02059291|520602752|FG008|Epoch 4|Adverse Event|0|||
144380082|NCT02059291|520602753|FG009|Epoch 4|Adverse Event|0|||
144380083|NCT02059291|520602754|FG010|Epoch 4|Adverse Event|0|||
144380084|NCT02059291|520602755|FG011|Epoch 4|Adverse Event|0|||
144380085|NCT02059291|520602756|FG012|Epoch 4|Adverse Event|0|||
144380086|NCT02059291|520602757|FG013|Epoch 4|Adverse Event|0|||
144380087|NCT02059291|520602758|FG014|Epoch 4|Adverse Event|0|||
144380088|NCT02059291|520602759|FG015|Epoch 4|Adverse Event|0|||
144380089|NCT02059291|520602760|FG016|Epoch 4|Adverse Event|1|||
144380090|NCT02059291|520602761|FG017|Epoch 4|Adverse Event|0|||
144380091|NCT02059291|520602762|FG018|Epoch 4|Adverse Event|0|||
144380092|NCT02059291|520602763|FG019|Epoch 4|Adverse Event|0|||
144380093|NCT02059291|520602764|FG020|Epoch 4|Adverse Event|0|||
144380094|NCT02059291|520602765|FG021|Epoch 4|Adverse Event|0|||
144380095|NCT02059291|520602766|FG022|Epoch 4|Adverse Event|1|||
144380096|NCT02059291|520602767|FG023|Epoch 4|Adverse Event|0|||
144380097|NCT02059291|520602768|FG024|Epoch 4|Adverse Event|0|||
144380098|NCT02059291|520602744|FG000|Epoch 4|Pregnancy|0|||
144380099|NCT02059291|520602745|FG001|Epoch 4|Pregnancy|0|||
144380100|NCT02059291|520602746|FG002|Epoch 4|Pregnancy|0|||
144380101|NCT02059291|520602747|FG003|Epoch 4|Pregnancy|0|||
144380102|NCT02059291|520602748|FG004|Epoch 4|Pregnancy|0|||
144380103|NCT02059291|520602749|FG005|Epoch 4|Pregnancy|0|||
144380104|NCT02059291|520602750|FG006|Epoch 4|Pregnancy|0|||
144591511|NCT02527343|521366336|FG001|RT Period: Weeks 1 to 52|Other|3|||
144380105|NCT02059291|520602751|FG007|Epoch 4|Pregnancy|0|||
144514023|NCT05656911|521082078|FG000|Treatment Phase|Other Reasons|1|||
144514024|NCT05656911|521082079|FG001|Treatment Phase|Other Reasons|0|||
144514025|NCT05656911|521082078|FG000|Treatment Phase|Adverse Event|3|||
144514026|NCT05656911|521082079|FG001|Treatment Phase|Adverse Event|1|||
144514027|NCT05656911|521082078|FG000|Follow-up Phase|Subject Decision|0|||
144514028|NCT05656911|521082079|FG001|Follow-up Phase|Subject Decision|1|||
144514029|NCT05656911|521082078|FG000|Follow-up Phase|Missing|1|||
144514030|NCT05656911|521082079|FG001|Follow-up Phase|Missing|0|||
144514031|NCT03547908|521082080|FG000|Blinded Phase|Lost to Follow-up|3|||
144514032|NCT03547908|521082081|FG001|Blinded Phase|Lost to Follow-up|3|||
144514033|NCT03547908|521082082|FG002|Blinded Phase|Lost to Follow-up|0|||
144514034|NCT03547908|521082083|FG003|Blinded Phase|Lost to Follow-up|0|||
144514035|NCT03547908|521082080|FG000|Blinded Phase|Withdrew Consent|2|||
144514036|NCT03547908|521082081|FG001|Blinded Phase|Withdrew Consent|3|||
144514037|NCT03547908|521082082|FG002|Blinded Phase|Withdrew Consent|0|||
144514038|NCT03547908|521082083|FG003|Blinded Phase|Withdrew Consent|0|||
144514039|NCT03547908|521082080|FG000|Blinded Phase|Investigator's Discretion|2|||
144514040|NCT03547908|521082081|FG001|Blinded Phase|Investigator's Discretion|1|||
144514041|NCT03547908|521082082|FG002|Blinded Phase|Investigator's Discretion|0|||
144514042|NCT03547908|521082083|FG003|Blinded Phase|Investigator's Discretion|0|||
144514043|NCT03547908|521082080|FG000|Blinded Phase|Death|2|||
144514044|NCT03547908|521082081|FG001|Blinded Phase|Death|0|||
144514045|NCT03547908|521082082|FG002|Blinded Phase|Death|0|||
144514046|NCT03547908|521082083|FG003|Blinded Phase|Death|0|||
144514047|NCT03547908|521082080|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
144514048|NCT03547908|521082081|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
144514049|NCT03547908|521082082|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
144514050|NCT03547908|521082083|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
144514051|NCT03547908|521082080|FG000|Blinded Phase|Adverse Event|1|||
144514052|NCT03547908|521082081|FG001|Blinded Phase|Adverse Event|0|||
144514053|NCT03547908|521082082|FG002|Blinded Phase|Adverse Event|0|||
144514054|NCT03547908|521082083|FG003|Blinded Phase|Adverse Event|0|||
144514055|NCT03547908|521082080|FG000|Blinded Phase|Randomized But Never Treated|1|||
144514056|NCT03547908|521082081|FG001|Blinded Phase|Randomized But Never Treated|0|||
144514057|NCT03547908|521082082|FG002|Blinded Phase|Randomized But Never Treated|0|||
144514058|NCT03547908|521082083|FG003|Blinded Phase|Randomized But Never Treated|0|||
144514059|NCT03547908|521082080|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
144514060|NCT03547908|521082081|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
144514061|NCT03547908|521082082|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
144514062|NCT03547908|521082083|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
144514063|NCT03547908|521082080|FG000|Open-label Extension Phase|Death|0|||
144514064|NCT03547908|521082081|FG001|Open-label Extension Phase|Death|0|||
144514065|NCT03547908|521082082|FG002|Open-label Extension Phase|Death|1|||
144591512|NCT02527343|521366337|FG002|RT Period: Weeks 1 to 52|Other|0|||
144380106|NCT02059291|520602752|FG008|Epoch 4|Pregnancy|0|||
144380107|NCT02059291|520602753|FG009|Epoch 4|Pregnancy|0|||
144380108|NCT02059291|520602754|FG010|Epoch 4|Pregnancy|0|||
144380109|NCT02059291|520602755|FG011|Epoch 4|Pregnancy|0|||
144380110|NCT02059291|520602756|FG012|Epoch 4|Pregnancy|0|||
144380111|NCT02059291|520602757|FG013|Epoch 4|Pregnancy|0|||
144380112|NCT02059291|520602758|FG014|Epoch 4|Pregnancy|0|||
144380113|NCT02059291|520602759|FG015|Epoch 4|Pregnancy|0|||
144380114|NCT02059291|520602760|FG016|Epoch 4|Pregnancy|1|||
144380115|NCT02059291|520602761|FG017|Epoch 4|Pregnancy|0|||
144380116|NCT02059291|520602762|FG018|Epoch 4|Pregnancy|0|||
144380117|NCT02059291|520602763|FG019|Epoch 4|Pregnancy|0|||
144380118|NCT02059291|520602764|FG020|Epoch 4|Pregnancy|0|||
144380119|NCT02059291|520602765|FG021|Epoch 4|Pregnancy|0|||
144380120|NCT02059291|520602766|FG022|Epoch 4|Pregnancy|0|||
144380121|NCT02059291|520602767|FG023|Epoch 4|Pregnancy|0|||
144380122|NCT02059291|520602768|FG024|Epoch 4|Pregnancy|0|||
144380123|NCT02059291|520602744|FG000|Epoch 4|Withdrawal by Subject|0|||
144380124|NCT02059291|520602745|FG001|Epoch 4|Withdrawal by Subject|0|||
144380125|NCT02059291|520602746|FG002|Epoch 4|Withdrawal by Subject|0|||
144380126|NCT02059291|520602747|FG003|Epoch 4|Withdrawal by Subject|0|||
144380127|NCT02059291|520602748|FG004|Epoch 4|Withdrawal by Subject|0|||
144380128|NCT02059291|520602749|FG005|Epoch 4|Withdrawal by Subject|0|||
144380129|NCT02059291|520602750|FG006|Epoch 4|Withdrawal by Subject|0|||
144380130|NCT02059291|520602751|FG007|Epoch 4|Withdrawal by Subject|0|||
144380131|NCT02059291|520602752|FG008|Epoch 4|Withdrawal by Subject|0|||
144380132|NCT02059291|520602753|FG009|Epoch 4|Withdrawal by Subject|0|||
144380133|NCT02059291|520602754|FG010|Epoch 4|Withdrawal by Subject|0|||
144380134|NCT02059291|520602755|FG011|Epoch 4|Withdrawal by Subject|0|||
144380135|NCT02059291|520602756|FG012|Epoch 4|Withdrawal by Subject|0|||
144380136|NCT02059291|520602757|FG013|Epoch 4|Withdrawal by Subject|0|||
144380137|NCT02059291|520602758|FG014|Epoch 4|Withdrawal by Subject|0|||
144380138|NCT02059291|520602759|FG015|Epoch 4|Withdrawal by Subject|0|||
144380139|NCT02059291|520602760|FG016|Epoch 4|Withdrawal by Subject|0|||
144380140|NCT02059291|520602761|FG017|Epoch 4|Withdrawal by Subject|0|||
144380141|NCT02059291|520602762|FG018|Epoch 4|Withdrawal by Subject|0|||
144380142|NCT02059291|520602763|FG019|Epoch 4|Withdrawal by Subject|0|||
144380143|NCT02059291|520602764|FG020|Epoch 4|Withdrawal by Subject|1|||
144380144|NCT02059291|520602765|FG021|Epoch 4|Withdrawal by Subject|0|||
144380145|NCT02059291|520602766|FG022|Epoch 4|Withdrawal by Subject|0|||
144380146|NCT02059291|520602767|FG023|Epoch 4|Withdrawal by Subject|0|||
144380147|NCT02059291|520602768|FG024|Epoch 4|Withdrawal by Subject|0|||
144380148|NCT02059291|520602744|FG000|Epoch 4|Lack of Efficacy|0|||
144380149|NCT02059291|520602745|FG001|Epoch 4|Lack of Efficacy|0|||
144380150|NCT02059291|520602746|FG002|Epoch 4|Lack of Efficacy|0|||
144380151|NCT02059291|520602747|FG003|Epoch 4|Lack of Efficacy|0|||
144380152|NCT02059291|520602748|FG004|Epoch 4|Lack of Efficacy|0|||
144380153|NCT02059291|520602749|FG005|Epoch 4|Lack of Efficacy|0|||
144380154|NCT02059291|520602750|FG006|Epoch 4|Lack of Efficacy|0|||
144380155|NCT02059291|520602751|FG007|Epoch 4|Lack of Efficacy|0|||
144380156|NCT02059291|520602752|FG008|Epoch 4|Lack of Efficacy|0|||
144380157|NCT02059291|520602753|FG009|Epoch 4|Lack of Efficacy|0|||
144380158|NCT02059291|520602754|FG010|Epoch 4|Lack of Efficacy|0|||
144380159|NCT02059291|520602755|FG011|Epoch 4|Lack of Efficacy|0|||
144380160|NCT02059291|520602756|FG012|Epoch 4|Lack of Efficacy|0|||
144380161|NCT02059291|520602757|FG013|Epoch 4|Lack of Efficacy|0|||
144380162|NCT02059291|520602758|FG014|Epoch 4|Lack of Efficacy|0|||
144380163|NCT02059291|520602759|FG015|Epoch 4|Lack of Efficacy|0|||
144380164|NCT02059291|520602760|FG016|Epoch 4|Lack of Efficacy|0|||
144380165|NCT02059291|520602761|FG017|Epoch 4|Lack of Efficacy|0|||
144380166|NCT02059291|520602762|FG018|Epoch 4|Lack of Efficacy|0|||
144380167|NCT02059291|520602763|FG019|Epoch 4|Lack of Efficacy|0|||
144380168|NCT02059291|520602764|FG020|Epoch 4|Lack of Efficacy|0|||
144380169|NCT02059291|520602765|FG021|Epoch 4|Lack of Efficacy|0|||
144380170|NCT02059291|520602766|FG022|Epoch 4|Lack of Efficacy|0|||
144380171|NCT02059291|520602767|FG023|Epoch 4|Lack of Efficacy|1|||
144380172|NCT02059291|520602768|FG024|Epoch 4|Lack of Efficacy|0|||
144380173|NCT01989208|520602769|FG000|200 mg (7 Days)|Protocol Violation|0|||
144380174|NCT01989208|520602770|FG001|200 mg (7 Days)|Protocol Violation|1|||
144380175|NCT04975438|520602771|FG000|Overall Study|Lost to Follow-up|1|||
144380176|NCT04975438|520602772|FG001|Overall Study|Lost to Follow-up|0|||
144380177|NCT04975438|520602773|FG002|Overall Study|Lost to Follow-up|1|||
144380178|NCT04975438|520602774|FG003|Overall Study|Lost to Follow-up|0|||
144380179|NCT04975438|520602771|FG000|Overall Study|Withdrawal by Subject|1|||
144380180|NCT04975438|520602772|FG001|Overall Study|Withdrawal by Subject|0|||
144380181|NCT04975438|520602773|FG002|Overall Study|Withdrawal by Subject|0|||
144380182|NCT04975438|520602774|FG003|Overall Study|Withdrawal by Subject|0|||
144380183|NCT04973436|520602775|FG000|Overall Study|Lost to Follow-up|3|||
144380184|NCT04973436|520602775|FG000|Overall Study|Withdrawal by Subject|1|||
144380185|NCT04973436|520602775|FG000|Overall Study|Death|2|||
144380186|NCT00566696|520602776|FG000|Overall Study|Met Exclusion Criteria|2|||
144380187|NCT00566696|520602776|FG000|Overall Study|Muromonab not available|1|||
144380188|NCT00566696|520602776|FG000|Overall Study|Health Status Change|1|||
144380189|NCT00566696|520602776|FG000|Overall Study|Physician Decision|1|||
144380190|NCT00566696|520602776|FG000|Overall Study|Non-Patient Donors|37|||
144380191|NCT00080899|520602780|FG000|Overall Study|Adverse Event|1|||
144380192|NCT01276054|520602785|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
144591513|NCT02527343|521366338|FG003|RT Period: Weeks 1 to 52|Other|0|||
144591514|NCT02527343|521366339|FG004|RT Period: Weeks 1 to 52|Other|0|||
144591515|NCT02527343|521366340|FG005|RT Period: Weeks 1 to 52|Other|0|||
144591516|NCT02527343|521366335|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
144591517|NCT02527343|521366336|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
144591518|NCT02527343|521366337|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
144591519|NCT02527343|521366338|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
144591520|NCT02527343|521366339|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
144591521|NCT02527343|521366340|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
144591522|NCT02527343|521366335|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
144591523|NCT02527343|521366336|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
144591524|NCT02527343|521366337|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
144591525|NCT02527343|521366338|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
144591526|NCT02527343|521366339|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
144591527|NCT02527343|521366340|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
144591528|NCT02527343|521366335|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
144591529|NCT02527343|521366336|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
144591530|NCT02527343|521366337|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
144591531|NCT02527343|521366338|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
144591532|NCT02527343|521366339|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
144591533|NCT02527343|521366340|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
144591534|NCT02527343|521366335|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
144591535|NCT02527343|521366336|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
144591536|NCT02527343|521366337|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
144591537|NCT02527343|521366338|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
144591538|NCT02527343|521366339|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
144591539|NCT02527343|521366340|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
144591540|NCT02527343|521366335|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
144591541|NCT02527343|521366336|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
144591542|NCT02527343|521366337|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
144591543|NCT02527343|521366338|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
144591544|NCT02527343|521366339|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
144591545|NCT02527343|521366340|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
144591546|NCT02527343|521366335|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
144591547|NCT02527343|521366336|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
144591548|NCT02527343|521366337|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
144591549|NCT02527343|521366338|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
144591550|NCT02527343|521366339|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
144591551|NCT02527343|521366340|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
144591552|NCT02527343|521366335|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
144591553|NCT02527343|521366336|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
144591554|NCT02527343|521366337|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
144591555|NCT02527343|521366338|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
144591556|NCT02527343|521366339|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
144591557|NCT02527343|521366340|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
144380193|NCT01276054|520602786|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
144380194|NCT04343235|520602787|FG000|Overall Study|Lost to Follow-up|3|||
144380195|NCT04343235|520602788|FG001|Overall Study|Lost to Follow-up|2|||
144380196|NCT00787267|520602789|FG000|Overall Study|Screen failure/Ineligible|10|||
144380197|NCT00787267|520602789|FG000|Overall Study|No Reason Provided|1|||
144380198|NCT00787267|520602789|FG000|Overall Study|Withdrawal by Subject|1|||
144380199|NCT01763996|520602790|FG000|Treatment Period 2|Adverse Event|0|||
144591558|NCT02527343|521366335|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
144591559|NCT02527343|521366336|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
144591560|NCT02527343|521366337|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
144591561|NCT02527343|521366338|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
144591562|NCT02527343|521366339|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
144591563|NCT02527343|521366340|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
144591564|NCT02527343|521366335|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
144591565|NCT02527343|521366336|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
144591566|NCT02527343|521366337|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
144591567|NCT02527343|521366338|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
144591568|NCT02527343|521366339|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
144380200|NCT01763996|520602791|FG001|Treatment Period 2|Adverse Event|1|||
144380201|NCT00865280|520602792|FG000|Overall Study|Withdrawal by Subject|4|||
144591569|NCT02527343|521366340|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
144721811|NCT00684671|521835304|FG002|Overall Study|Adverse Event|0|||
144380202|NCT00865280|520602793|FG001|Overall Study|Withdrawal by Subject|1|||
144380203|NCT00865280|520602792|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
144380204|NCT00865280|520602793|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
144380205|NCT00865280|520602792|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
144380206|NCT00865280|520602793|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
144380207|NCT00865280|520602792|FG000|Overall Study|Exclusion Condition|1|||
144380208|NCT00865280|520602793|FG001|Overall Study|Exclusion Condition|0|||
144380209|NCT00865280|520602792|FG000|Overall Study|Adverse Event|0|||
144380210|NCT00865280|520602793|FG001|Overall Study|Adverse Event|1|||
144380211|NCT01788215|520602798|FG000|Overall Study|Withdrawal by Subject|0|||
144380212|NCT01788215|520602799|FG001|Overall Study|Withdrawal by Subject|1|||
144380213|NCT01788215|520602798|FG000|Overall Study|Lost to Follow-up|2|||
144380214|NCT01788215|520602799|FG001|Overall Study|Lost to Follow-up|0|||
144380215|NCT02365480|520602804|FG000|Overall Study|Withdrawal by Subject|2|||
144380216|NCT02365480|520602805|FG001|Overall Study|Withdrawal by Subject|0|||
144380217|NCT03091348|520602806|FG000|Overall Study|Lost to Follow-up|2|||
144380218|NCT03091348|520602807|FG001|Overall Study|Lost to Follow-up|1|||
144380219|NCT04534686|520602808|FG000|Baseline Measurement|Lost to Follow-up|4|||
144380220|NCT04534686|520602809|FG001|Baseline Measurement|Lost to Follow-up|6|||
144380221|NCT04534686|520602808|FG000|Baseline Measurement|Withdrawal by Subject|3|||
144514066|NCT03547908|521082083|FG003|Open-label Extension Phase|Death|0|||
144514067|NCT04607044|521082090|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
144514068|NCT04607044|521082090|FG000|Overall Study|Adverse Event|1|||
144514069|NCT04607044|521082090|FG000|Overall Study|Did not receive study device|3|||
144591570|NCT04745026|521366345|FG000|Overall Study|Physician Decision|1|||
144591571|NCT04745026|521366346|FG001|Overall Study|Physician Decision|0|||
144591572|NCT04745026|521366345|FG000|Overall Study|Adverse Event|2|||
144591573|NCT04745026|521366346|FG001|Overall Study|Adverse Event|2|||
144514070|NCT04607044|521082090|FG000|Overall Study|Death|1|||
144514071|NCT05403801|521082091|FG000|Overall Study|Withdrawal by Subject|2|||
144514072|NCT05075408|521082092|FG000|Overall Study|Withdrawal by Subject|5|||
144514073|NCT05075408|521082093|FG001|Overall Study|Withdrawal by Subject|3|||
144514074|NCT05075408|521082094|FG002|Overall Study|Withdrawal by Subject|4|||
144514075|NCT05075408|521082092|FG000|Overall Study|Adverse Event|5|||
144514076|NCT05075408|521082093|FG001|Overall Study|Adverse Event|7|||
144514077|NCT05075408|521082094|FG002|Overall Study|Adverse Event|8|||
144514078|NCT05075408|521082092|FG000|Overall Study|Protocol Violation|0|||
144514079|NCT05075408|521082093|FG001|Overall Study|Protocol Violation|1|||
144514080|NCT05075408|521082094|FG002|Overall Study|Protocol Violation|0|||
144514081|NCT05075408|521082092|FG000|Overall Study|Lost to Follow-up|2|||
144514082|NCT05075408|521082093|FG001|Overall Study|Lost to Follow-up|1|||
144514083|NCT05075408|521082094|FG002|Overall Study|Lost to Follow-up|1|||
144514084|NCT05075408|521082092|FG000|Overall Study|Physician Decision|1|||
144514085|NCT05075408|521082093|FG001|Overall Study|Physician Decision|0|||
144514086|NCT05075408|521082094|FG002|Overall Study|Physician Decision|0|||
144514087|NCT05075408|521082092|FG000|Overall Study|Other-unspecified|3|||
144514088|NCT05075408|521082093|FG001|Overall Study|Other-unspecified|2|||
144514089|NCT05075408|521082094|FG002|Overall Study|Other-unspecified|0|||
144514090|NCT03651895|521082095|FG000|First Drug Assignment|Adverse Event|4|||
144514091|NCT03651895|521082096|FG001|First Drug Assignment|Adverse Event|5|||
144514092|NCT03651895|521082095|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
144514093|NCT03651895|521082096|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
144514094|NCT05419505|521082098|FG000|Overall Study|Adverse Event|0|||
144514095|NCT05419505|521082099|FG001|Overall Study|Adverse Event|0|||
144514096|NCT05419505|521082100|FG002|Overall Study|Adverse Event|0|||
144514097|NCT05419505|521082101|FG003|Overall Study|Adverse Event|1|||
144514098|NCT05419505|521082102|FG004|Overall Study|Adverse Event|0|||
144514099|NCT05419505|521082103|FG005|Overall Study|Adverse Event|0|||
144514100|NCT05419505|521082104|FG006|Overall Study|Adverse Event|0|||
144514101|NCT05419505|521082105|FG007|Overall Study|Adverse Event|0|||
144514102|NCT05419505|521082098|FG000|Overall Study|Withdrawal by Subject|1|||
144514103|NCT05419505|521082099|FG001|Overall Study|Withdrawal by Subject|2|||
144514104|NCT05419505|521082100|FG002|Overall Study|Withdrawal by Subject|0|||
144514105|NCT05419505|521082101|FG003|Overall Study|Withdrawal by Subject|0|||
144514106|NCT05419505|521082102|FG004|Overall Study|Withdrawal by Subject|0|||
144514107|NCT05419505|521082103|FG005|Overall Study|Withdrawal by Subject|0|||
144514108|NCT05419505|521082104|FG006|Overall Study|Withdrawal by Subject|1|||
144591574|NCT04745026|521366345|FG000|Overall Study|Protocol Violation|1|||
144591575|NCT04745026|521366346|FG001|Overall Study|Protocol Violation|3|||
144514109|NCT05419505|521082105|FG007|Overall Study|Withdrawal by Subject|0|||
144514110|NCT05419505|521082098|FG000|Overall Study|Lost to Follow-up|2|||
144514111|NCT05419505|521082099|FG001|Overall Study|Lost to Follow-up|1|||
144514112|NCT05419505|521082100|FG002|Overall Study|Lost to Follow-up|0|||
144514113|NCT05419505|521082101|FG003|Overall Study|Lost to Follow-up|0|||
144514114|NCT05419505|521082102|FG004|Overall Study|Lost to Follow-up|1|||
144514115|NCT05419505|521082103|FG005|Overall Study|Lost to Follow-up|2|||
144591576|NCT04745026|521366345|FG000|Overall Study|Lost to Follow-up|4|||
144380222|NCT04534686|520602809|FG001|Baseline Measurement|Withdrawal by Subject|1|||
144380223|NCT04534686|520602808|FG000|Intervention|Withdrawal by Subject|2|||
144380224|NCT04534686|520602809|FG001|Intervention|Withdrawal by Subject|2|||
144514116|NCT05419505|521082104|FG006|Overall Study|Lost to Follow-up|0|||
144514117|NCT05419505|521082105|FG007|Overall Study|Lost to Follow-up|1|||
144591577|NCT04745026|521366346|FG001|Overall Study|Lost to Follow-up|3|||
144591578|NCT04745026|521366345|FG000|Overall Study|Withdrawal by Subject|5|||
144591579|NCT04745026|521366346|FG001|Overall Study|Withdrawal by Subject|5|||
144591580|NCT05478499|521366347|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
144591581|NCT05478499|521366348|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
144591582|NCT05478499|521366347|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
144591583|NCT05478499|521366348|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
144591584|NCT05478499|521366347|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
144591585|NCT05478499|521366348|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
144591586|NCT05478499|521366347|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
144591587|NCT05478499|521366348|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
144591588|NCT05478499|521366347|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
144591589|NCT05478499|521366348|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
144591590|NCT05478499|521366347|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
144591591|NCT05478499|521366348|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
144591592|NCT05478499|521366347|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
144591593|NCT05478499|521366348|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
144591594|NCT05478499|521366347|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
144591595|NCT05478499|521366348|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
144591596|NCT05478499|521366347|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
144591597|NCT05478499|521366348|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
144591598|NCT05478499|521366347|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
144591599|NCT05478499|521366348|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
144591600|NCT05478499|521366347|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
144591601|NCT05478499|521366348|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
144591602|NCT02581631|521366354|FG000|Overall Study|Disease progression|29|||
144591603|NCT02581631|521366355|FG001|Overall Study|Disease progression|19|||
144591604|NCT02581631|521366356|FG002|Overall Study|Disease progression|13|||
144591605|NCT02581631|521366357|FG003|Overall Study|Disease progression|5|||
144591606|NCT02581631|521366358|FG004|Overall Study|Disease progression|8|||
144591607|NCT02581631|521366354|FG000|Overall Study|Study drug toxicity|4|||
144591608|NCT02581631|521366355|FG001|Overall Study|Study drug toxicity|6|||
144591609|NCT02581631|521366356|FG002|Overall Study|Study drug toxicity|7|||
144591610|NCT02581631|521366357|FG003|Overall Study|Study drug toxicity|0|||
144591611|NCT02581631|521366358|FG004|Overall Study|Study drug toxicity|3|||
144591612|NCT02581631|521366354|FG000|Overall Study|AE unrelated to study drug|3|||
144591613|NCT02581631|521366355|FG001|Overall Study|AE unrelated to study drug|1|||
144591614|NCT02581631|521366356|FG002|Overall Study|AE unrelated to study drug|1|||
144591615|NCT02581631|521366357|FG003|Overall Study|AE unrelated to study drug|0|||
144591616|NCT02581631|521366358|FG004|Overall Study|AE unrelated to study drug|2|||
144591617|NCT02581631|521366354|FG000|Overall Study|Request to discontinue|1|||
144591618|NCT02581631|521366355|FG001|Overall Study|Request to discontinue|0|||
144591619|NCT02581631|521366356|FG002|Overall Study|Request to discontinue|3|||
144591620|NCT02581631|521366357|FG003|Overall Study|Request to discontinue|0|||
144591621|NCT02581631|521366358|FG004|Overall Study|Request to discontinue|1|||
144591622|NCT02581631|521366354|FG000|Overall Study|participant withdrew consent|3|||
144591623|NCT02581631|521366355|FG001|Overall Study|participant withdrew consent|0|||
144591624|NCT02581631|521366356|FG002|Overall Study|participant withdrew consent|1|||
144591625|NCT02581631|521366357|FG003|Overall Study|participant withdrew consent|0|||
144591626|NCT02581631|521366358|FG004|Overall Study|participant withdrew consent|0|||
144591627|NCT02581631|521366354|FG000|Overall Study|Maximum clinical benefit|1|||
144591628|NCT02581631|521366355|FG001|Overall Study|Maximum clinical benefit|7|||
144591629|NCT02581631|521366356|FG002|Overall Study|Maximum clinical benefit|1|||
144591630|NCT02581631|521366357|FG003|Overall Study|Maximum clinical benefit|3|||
144591631|NCT02581631|521366358|FG004|Overall Study|Maximum clinical benefit|13|||
144591632|NCT02581631|521366354|FG000|Overall Study|Other Reasons|1|||
144591633|NCT02581631|521366355|FG001|Overall Study|Other Reasons|0|||
144591634|NCT02581631|521366356|FG002|Overall Study|Other Reasons|2|||
144591635|NCT02581631|521366357|FG003|Overall Study|Other Reasons|2|||
144591636|NCT02581631|521366358|FG004|Overall Study|Other Reasons|3|||
144591637|NCT02581631|521366354|FG000|Overall Study|Poor/Non-Compliance|0|||
144591638|NCT02581631|521366355|FG001|Overall Study|Poor/Non-Compliance|0|||
144591639|NCT02581631|521366356|FG002|Overall Study|Poor/Non-Compliance|1|||
144591640|NCT02581631|521366357|FG003|Overall Study|Poor/Non-Compliance|0|||
144591641|NCT02581631|521366358|FG004|Overall Study|Poor/Non-Compliance|0|||
144591642|NCT00986973|521366359|FG000|Overall Study|Withdrawn by study team|1|||
144591643|NCT00598273|521366360|FG000|Overall Study|Adverse Event|4|||
144591644|NCT00598273|521366361|FG001|Overall Study|Adverse Event|5|||
144591645|NCT00598273|521366362|FG002|Overall Study|Adverse Event|2|||
144591646|NCT00598273|521366360|FG000|Overall Study|Death|6|||
144591647|NCT00598273|521366361|FG001|Overall Study|Death|12|||
144591648|NCT00598273|521366362|FG002|Overall Study|Death|8|||
144591649|NCT00598273|521366360|FG000|Overall Study|Lost to Follow-up|8|||
144591650|NCT00598273|521366361|FG001|Overall Study|Lost to Follow-up|3|||
144591651|NCT00598273|521366362|FG002|Overall Study|Lost to Follow-up|5|||
144591652|NCT00598273|521366360|FG000|Overall Study|Physician Decision|0|||
144591653|NCT00598273|521366361|FG001|Overall Study|Physician Decision|0|||
144591654|NCT00598273|521366362|FG002|Overall Study|Physician Decision|1|||
144591655|NCT00598273|521366360|FG000|Overall Study|Withdrawal by Subject|12|||
144591656|NCT00598273|521366361|FG001|Overall Study|Withdrawal by Subject|10|||
144591657|NCT00598273|521366362|FG002|Overall Study|Withdrawal by Subject|10|||
144591658|NCT00598273|521366360|FG000|Overall Study|Noncompliance|3|||
144591659|NCT00598273|521366361|FG001|Overall Study|Noncompliance|2|||
144591660|NCT00598273|521366362|FG002|Overall Study|Noncompliance|3|||
144591661|NCT00598273|521366360|FG000|Overall Study|Relocation|0|||
144591662|NCT00598273|521366361|FG001|Overall Study|Relocation|2|||
144591663|NCT00598273|521366362|FG002|Overall Study|Relocation|4|||
144591664|NCT00598273|521366360|FG000|Overall Study|Renal transplant|1|||
144591665|NCT00598273|521366361|FG001|Overall Study|Renal transplant|0|||
144591666|NCT00598273|521366362|FG002|Overall Study|Renal transplant|1|||
144591667|NCT00598273|521366360|FG000|Overall Study|Site elected to close|1|||
144591668|NCT00598273|521366361|FG001|Overall Study|Site elected to close|0|||
144591669|NCT00598273|521366362|FG002|Overall Study|Site elected to close|0|||
144591670|NCT00598273|521366360|FG000|Overall Study|Started dialysis|6|||
144591671|NCT00598273|521366361|FG001|Overall Study|Started dialysis|4|||
144591672|NCT00598273|521366362|FG002|Overall Study|Started dialysis|5|||
144591673|NCT03426605|521366363|FG000|Overall Study|AML relapse or progression|2|||
144591674|NCT03426605|521366364|FG001|Overall Study|AML relapse or progression|1|||
144591675|NCT03426605|521366365|FG002|Overall Study|AML relapse or progression|2|||
144591676|NCT03426605|521366366|FG003|Overall Study|AML relapse or progression|2|||
144591677|NCT03426605|521366363|FG000|Overall Study|Treatment failure|3|||
144591678|NCT03426605|521366364|FG001|Overall Study|Treatment failure|2|||
144591679|NCT03426605|521366365|FG002|Overall Study|Treatment failure|0|||
144591680|NCT03426605|521366366|FG003|Overall Study|Treatment failure|0|||
144380225|NCT00706342|520602810|FG000|Overall Study|Adverse Event|3|||
144380226|NCT00706342|520602810|FG000|Overall Study|Not responding to treatment|2|||
144380227|NCT00706342|520602810|FG000|Overall Study|Withdrawn due to failure to respond|1|||
144380228|NCT00706342|520602810|FG000|Overall Study|Death|1|||
144591681|NCT03426605|521366363|FG000|Overall Study|Adverse Event|1|||
144591682|NCT03426605|521366364|FG001|Overall Study|Adverse Event|0|||
144591683|NCT03426605|521366365|FG002|Overall Study|Adverse Event|1|||
144591684|NCT03426605|521366366|FG003|Overall Study|Adverse Event|1|||
144591685|NCT03426605|521366363|FG000|Overall Study|Withdrawal by Subject|0|||
144380229|NCT00706342|520602810|FG000|Overall Study|Withdrew from the study on his own.|1|||
144380230|NCT00706342|520602810|FG000|Overall Study|Investigator discretion|2|||
144380231|NCT00706342|520602810|FG000|Overall Study|Non-responder Week 12|1|||
144380232|NCT00706342|520602810|FG000|Overall Study|Ongoing|6|||
144380233|NCT00706342|520602810|FG000|Overall Study|WIthdrawal of consent|1|||
144380234|NCT01419197|520602815|FG000|Overall Study|Death|247|||
144380235|NCT01419197|520602816|FG001|Overall Study|Death|122|||
144591686|NCT03426605|521366364|FG001|Overall Study|Withdrawal by Subject|0|||
144591687|NCT03426605|521366365|FG002|Overall Study|Withdrawal by Subject|1|||
144591688|NCT03426605|521366366|FG003|Overall Study|Withdrawal by Subject|1|||
144591689|NCT01815138|521366369|FG000|Overall Study|Withdrawal by Subject|0|||
144591690|NCT01815138|521366370|FG001|Overall Study|Withdrawal by Subject|1|||
144591691|NCT01815138|521366369|FG000|Overall Study|Physician Decision|8|||
144591692|NCT01815138|521366370|FG001|Overall Study|Physician Decision|5|||
144591693|NCT02308020|521366373|FG000|Overall Study|Lost to Follow-up|1|||
144591694|NCT02308020|521366374|FG001|Overall Study|Lost to Follow-up|7|||
144380236|NCT01419197|520602815|FG000|Overall Study|Physician Decision|4|||
144380237|NCT01419197|520602816|FG001|Overall Study|Physician Decision|4|||
144380238|NCT01419197|520602815|FG000|Overall Study|Non-compliance|3|||
144591695|NCT02308020|521366375|FG002|Overall Study|Lost to Follow-up|0|||
144591696|NCT02308020|521366376|FG003|Overall Study|Lost to Follow-up|0|||
144591697|NCT02308020|521366377|FG004|Overall Study|Lost to Follow-up|1|||
144591698|NCT02308020|521366378|FG005|Overall Study|Lost to Follow-up|2|||
144591699|NCT02308020|521366373|FG000|Overall Study|Sponsor Decision|0|||
144591700|NCT02308020|521366374|FG001|Overall Study|Sponsor Decision|8|||
144591701|NCT02308020|521366375|FG002|Overall Study|Sponsor Decision|0|||
144591702|NCT02308020|521366376|FG003|Overall Study|Sponsor Decision|2|||
144591703|NCT02308020|521366377|FG004|Overall Study|Sponsor Decision|2|||
144591704|NCT02308020|521366378|FG005|Overall Study|Sponsor Decision|1|||
144591705|NCT02308020|521366373|FG000|Overall Study|Withdrawal by Subject|3|||
144591706|NCT02308020|521366374|FG001|Overall Study|Withdrawal by Subject|5|||
144591707|NCT02308020|521366375|FG002|Overall Study|Withdrawal by Subject|3|||
144591708|NCT02308020|521366376|FG003|Overall Study|Withdrawal by Subject|2|||
144591709|NCT02308020|521366377|FG004|Overall Study|Withdrawal by Subject|1|||
144591710|NCT02308020|521366378|FG005|Overall Study|Withdrawal by Subject|2|||
144591711|NCT01270971|521366379|FG000|Overall Study|Withdrawal by Subject|24|||
144591712|NCT01270971|521366380|FG001|Overall Study|Withdrawal by Subject|11|||
144591713|NCT01270971|521366379|FG000|Overall Study|Lost to Follow-up|18|||
144591714|NCT01270971|521366380|FG001|Overall Study|Lost to Follow-up|5|||
144591715|NCT01270971|521366379|FG000|Overall Study|Adverse Event|1|||
144591716|NCT01270971|521366380|FG001|Overall Study|Adverse Event|2|||
144591717|NCT01270971|521366379|FG000|Overall Study|Non compliance|2|||
144591718|NCT01270971|521366380|FG001|Overall Study|Non compliance|2|||
144591719|NCT01270971|521366379|FG000|Overall Study|Non-specific|7|||
144591720|NCT01270971|521366380|FG001|Overall Study|Non-specific|3|||
144591721|NCT02003573|521366384|FG000|Overall Study|Progressive disease|2|||
144591722|NCT02003573|521366385|FG001|Overall Study|Progressive disease|0|||
144591723|NCT02003573|521366386|FG002|Overall Study|Progressive disease|1|||
144591724|NCT02003573|521366384|FG000|Overall Study|Other Adverse event|0|||
144591725|NCT02003573|521366385|FG001|Overall Study|Other Adverse event|1|||
144591726|NCT02003573|521366386|FG002|Overall Study|Other Adverse event|1|||
144591727|NCT02003573|521366384|FG000|Overall Study|Refuse to take trial medication|0|||
144591728|NCT02003573|521366385|FG001|Overall Study|Refuse to take trial medication|1|||
144591729|NCT02003573|521366386|FG002|Overall Study|Refuse to take trial medication|1|||
144591730|NCT02003573|521366384|FG000|Overall Study|Other than specified|1|||
144591731|NCT02003573|521366385|FG001|Overall Study|Other than specified|2|||
144591732|NCT02003573|521366386|FG002|Overall Study|Other than specified|3|||
144591733|NCT00704405|521366389|FG000|Overall Study (NC Population)|Adverse Event|1|||
144591734|NCT00704405|521366390|FG001|Overall Study (NC Population)|Adverse Event|0|||
144591735|NCT00704405|521366391|FG002|Overall Study (NC Population)|Adverse Event|0|||
144591736|NCT00704405|521366392|FG003|Overall Study (NC Population)|Adverse Event|0|||
144591737|NCT00704405|521366393|FG004|Overall Study (NC Population)|Adverse Event|0|||
144591738|NCT00704405|521366389|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
144591739|NCT00704405|521366390|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
144591740|NCT00704405|521366391|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
144591741|NCT00704405|521366392|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
144591742|NCT00704405|521366393|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
144591743|NCT00704405|521366389|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
144591744|NCT00704405|521366390|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
144591745|NCT00704405|521366391|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
144591746|NCT00704405|521366392|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
144591747|NCT00704405|521366393|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
144591748|NCT00704405|521366389|FG000|Overall Study (NC Population)|Other|0|||
144591749|NCT00704405|521366390|FG001|Overall Study (NC Population)|Other|0|||
144591750|NCT00704405|521366391|FG002|Overall Study (NC Population)|Other|0|||
144591751|NCT00704405|521366392|FG003|Overall Study (NC Population)|Other|0|||
144591752|NCT00704405|521366393|FG004|Overall Study (NC Population)|Other|1|||
144591753|NCT00704405|521366389|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
144591754|NCT00704405|521366390|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
144591755|NCT00704405|521366391|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
144591756|NCT00704405|521366392|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
144591757|NCT00704405|521366393|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
144591758|NCT00704405|521366389|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
144591759|NCT00704405|521366390|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
144591760|NCT00704405|521366391|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
144591761|NCT00704405|521366392|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
144591762|NCT00704405|521366393|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
144591763|NCT01395888|521366394|FG000|2-week Run-in Period|Adverse Event|2|||
144514118|NCT02780388|521082108|FG000|Overall Study|Lost to Follow-up|0|||
144514119|NCT02780388|521082109|FG001|Overall Study|Lost to Follow-up|1|||
144514120|NCT02780388|521082110|FG002|Overall Study|Lost to Follow-up|0|||
144514121|NCT02780388|521082111|FG003|Overall Study|Lost to Follow-up|0|||
144514122|NCT02780388|521082112|FG004|Overall Study|Lost to Follow-up|0|||
144514123|NCT02780388|521082108|FG000|Overall Study|Withdrawal by Subject|1|||
144514124|NCT02780388|521082109|FG001|Overall Study|Withdrawal by Subject|1|||
144514125|NCT02780388|521082110|FG002|Overall Study|Withdrawal by Subject|0|||
144514126|NCT02780388|521082111|FG003|Overall Study|Withdrawal by Subject|0|||
144514127|NCT02780388|521082112|FG004|Overall Study|Withdrawal by Subject|0|||
144514128|NCT05107401|521082113|FG000|Overall Study|Lost to Follow-up|13|||
144514129|NCT05107401|521082114|FG001|Overall Study|Lost to Follow-up|12|||
144514130|NCT04869982|521082122|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
144514131|NCT04869982|521082123|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
144514132|NCT04869982|521082122|FG000|Overall Study|Migrated / moved from the study area|1|||
144514133|NCT04869982|521082123|FG001|Overall Study|Migrated / moved from the study area|1|||
144514134|NCT04869982|521082122|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
144514135|NCT04869982|521082123|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
144514136|NCT04869982|521082122|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
144514137|NCT04869982|521082123|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
144514138|NCT04869982|521082122|FG000|Overall Study|Solicited adverse event|2|||
144514139|NCT04869982|521082123|FG001|Overall Study|Solicited adverse event|1|||
144514140|NCT04608045|521082124|FG000|Overall Study|Physician Decision|1|||
144514141|NCT03857620|521082125|FG000|Overall Study|Death|4|||
144514142|NCT03857620|521082126|FG001|Overall Study|Death|5|||
144514143|NCT03857620|521082127|FG002|Overall Study|Death|7|||
144514144|NCT03857620|521082125|FG000|Overall Study|Lost to Follow-up|2|||
144514145|NCT03857620|521082126|FG001|Overall Study|Lost to Follow-up|5|||
144514146|NCT03857620|521082127|FG002|Overall Study|Lost to Follow-up|3|||
144380239|NCT01419197|520602816|FG001|Overall Study|Non-compliance|1|||
144380240|NCT01419197|520602815|FG000|Overall Study|Withdrawal by Subject|33|||
144380241|NCT01419197|520602816|FG001|Overall Study|Withdrawal by Subject|32|||
144380242|NCT01419197|520602815|FG000|Overall Study|Study Completed by Sponsor|103|||
144380243|NCT01419197|520602816|FG001|Overall Study|Study Completed by Sponsor|34|||
144380244|NCT01419197|520602815|FG000|Overall Study|Reason Not Specified|0|||
144380245|NCT01419197|520602816|FG001|Overall Study|Reason Not Specified|1|||
144380246|NCT01419197|520602815|FG000|Overall Study|Lost to Follow-up|14|||
144380247|NCT01419197|520602816|FG001|Overall Study|Lost to Follow-up|4|||
144380248|NCT01781299|520602817|FG000|Overall Study|Withdrawal by Subject|0|||
144380249|NCT01781299|520602818|FG001|Overall Study|Withdrawal by Subject|1|||
144380250|NCT00146848|520602822|FG000|Pre-randomization|Death|19|||
144380251|NCT00146848|520602823|FG001|Pre-randomization|Death|0|||
144380252|NCT00146848|520602824|FG002|Pre-randomization|Death|0|||
144380253|NCT00146848|520602822|FG000|Pre-randomization|Lost to Follow-up|70|||
144380254|NCT00146848|520602823|FG001|Pre-randomization|Lost to Follow-up|0|||
144380255|NCT00146848|520602824|FG002|Pre-randomization|Lost to Follow-up|0|||
144380256|NCT00146848|520602822|FG000|Pre-randomization|Physician Decision|8|||
144380257|NCT00146848|520602823|FG001|Pre-randomization|Physician Decision|0|||
144380258|NCT00146848|520602824|FG002|Pre-randomization|Physician Decision|0|||
144380259|NCT00146848|520602822|FG000|Pre-randomization|Protocol Violation|172|||
144380260|NCT00146848|520602823|FG001|Pre-randomization|Protocol Violation|0|||
144380261|NCT00146848|520602824|FG002|Pre-randomization|Protocol Violation|0|||
144380262|NCT00146848|520602822|FG000|Pre-randomization|Withdrawal by Subject|40|||
144380263|NCT00146848|520602823|FG001|Pre-randomization|Withdrawal by Subject|0|||
144514147|NCT03857620|521082125|FG000|Overall Study|Disease progression or relapse after study registration|1|||
144514148|NCT03857620|521082126|FG001|Overall Study|Disease progression or relapse after study registration|5|||
144514149|NCT03857620|521082127|FG002|Overall Study|Disease progression or relapse after study registration|1|||
144514150|NCT03857620|521082125|FG000|Overall Study|Ineligible|5|||
144514151|NCT03857620|521082126|FG001|Overall Study|Ineligible|0|||
144514152|NCT03857620|521082127|FG002|Overall Study|Ineligible|2|||
144514153|NCT03857620|521082125|FG000|Overall Study|No malignancy|1|||
144514154|NCT03857620|521082126|FG001|Overall Study|No malignancy|0|||
144514155|NCT03857620|521082127|FG002|Overall Study|No malignancy|1|||
144514156|NCT03857620|521082125|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
144514157|NCT03857620|521082126|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
144514158|NCT03857620|521082127|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
144514159|NCT03857620|521082125|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
144514160|NCT03857620|521082126|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
144514161|NCT03857620|521082127|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
144514162|NCT03857620|521082125|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
144514163|NCT03857620|521082126|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
144514164|NCT03857620|521082127|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
144514165|NCT03857620|521082125|FG000|Overall Study|Surgery not performed, patient decision|0|||
144514166|NCT03857620|521082126|FG001|Overall Study|Surgery not performed, patient decision|3|||
144514167|NCT03857620|521082127|FG002|Overall Study|Surgery not performed, patient decision|1|||
144514168|NCT03857620|521082125|FG000|Overall Study|Surgery not performed, other reason|3|||
144514169|NCT03857620|521082126|FG001|Overall Study|Surgery not performed, other reason|1|||
144514170|NCT03857620|521082127|FG002|Overall Study|Surgery not performed, other reason|4|||
144514171|NCT03857620|521082125|FG000|Overall Study|Worsening performance status after surgery performed|0|||
144514172|NCT03857620|521082126|FG001|Overall Study|Worsening performance status after surgery performed|1|||
144514173|NCT03857620|521082127|FG002|Overall Study|Worsening performance status after surgery performed|1|||
144514174|NCT02473250|521082128|FG000|Overall Study|Lost to Follow-up|10|||
144514175|NCT02473250|521082128|FG000|Overall Study|Physician Decision|5|||
144514176|NCT02473250|521082128|FG000|Overall Study|Did not tolerate medication washout|3|||
144514177|NCT02473250|521082128|FG000|Overall Study|Antidepressant effect of divalproex|2|||
144514178|NCT03271151|521082129|FG000|Overall Study|Lost to Follow-up|1|||
144514179|NCT03271151|521082130|FG001|Overall Study|Lost to Follow-up|3|||
144514180|NCT03271151|521082129|FG000|Overall Study|Withdrawal by Subject|1|||
144514181|NCT03271151|521082130|FG001|Overall Study|Withdrawal by Subject|0|||
144514182|NCT03103321|521082131|FG000|Overall Study|Protocol Violation|1|||
144514183|NCT03103321|521082132|FG001|Overall Study|Protocol Violation|1|||
144514184|NCT03103321|521082133|FG002|Overall Study|Protocol Violation|1|||
144380264|NCT00146848|520602824|FG002|Pre-randomization|Withdrawal by Subject|0|||
144514185|NCT03103321|521082134|FG003|Overall Study|Protocol Violation|0|||
144514186|NCT04118452|521082135|FG000|Overall Study|Lost to Follow-up|5|||
144380265|NCT00146848|520602822|FG000|Post-randomization|Lost to Follow-up|12|||
144380266|NCT00146848|520602823|FG001|Post-randomization|Lost to Follow-up|15|||
144380267|NCT00146848|520602824|FG002|Post-randomization|Lost to Follow-up|12|||
144380268|NCT00146848|520602822|FG000|Post-randomization|Withdrawn|26|||
144380269|NCT00146848|520602823|FG001|Post-randomization|Withdrawn|32|||
144380270|NCT00146848|520602824|FG002|Post-randomization|Withdrawn|27|||
144380271|NCT00743106|520602825|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
144380272|NCT00743106|520602826|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
144380273|NCT00246740|520602827|FG000|Initial Enrollment|Death|1|||
144380274|NCT00246740|520602828|FG001|Initial Enrollment|Death|0|||
144380275|NCT00246740|520602827|FG000|Initial Enrollment|Additional surgery scheduled|0|||
144380276|NCT00246740|520602828|FG001|Initial Enrollment|Additional surgery scheduled|2|||
144380277|NCT00246740|520602827|FG000|Initial Enrollment|Surgery schedule change|4|||
144380278|NCT00246740|520602828|FG001|Initial Enrollment|Surgery schedule change|4|||
144380279|NCT00246740|520602827|FG000|Initial Enrollment|Other|1|||
144380280|NCT00246740|520602828|FG001|Initial Enrollment|Other|2|||
144380281|NCT00101452|520602829|FG000|Overall Study|Adverse Event|2|||
144380282|NCT00101452|520602830|FG001|Overall Study|Adverse Event|0|||
144380283|NCT00101452|520602831|FG002|Overall Study|Adverse Event|1|||
144380284|NCT00101452|520602829|FG000|Overall Study|Lost to Follow-up|13|||
144380285|NCT00101452|520602830|FG001|Overall Study|Lost to Follow-up|8|||
144380286|NCT00101452|520602831|FG002|Overall Study|Lost to Follow-up|14|||
144380287|NCT00101452|520602829|FG000|Overall Study|Withdrawal by Subject|10|||
144380288|NCT00101452|520602830|FG001|Overall Study|Withdrawal by Subject|14|||
144380289|NCT00101452|520602831|FG002|Overall Study|Withdrawal by Subject|9|||
144380290|NCT00101452|520602829|FG000|Overall Study|Baseline Fail|2|||
144380291|NCT00101452|520602830|FG001|Overall Study|Baseline Fail|1|||
144380292|NCT00101452|520602831|FG002|Overall Study|Baseline Fail|2|||
144380293|NCT00101452|520602829|FG000|Overall Study|Physician Decision|0|||
144380294|NCT00101452|520602830|FG001|Overall Study|Physician Decision|3|||
144380295|NCT00101452|520602831|FG002|Overall Study|Physician Decision|2|||
144380296|NCT00101452|520602829|FG000|Overall Study|Protocol Violation|2|||
144380297|NCT00101452|520602830|FG001|Overall Study|Protocol Violation|1|||
144380298|NCT00101452|520602831|FG002|Overall Study|Protocol Violation|3|||
144380299|NCT00101452|520602829|FG000|Overall Study|Other|15|||
144380300|NCT00101452|520602830|FG001|Overall Study|Other|16|||
144380301|NCT00101452|520602831|FG002|Overall Study|Other|12|||
144380302|NCT02969655|520602832|FG000|Overall Study|Withdrawal by Subject|3|||
144380303|NCT02969655|520602833|FG001|Overall Study|Withdrawal by Subject|2|||
144380304|NCT02969655|520602832|FG000|Overall Study|Physician Decision|4|||
144380305|NCT02969655|520602833|FG001|Overall Study|Physician Decision|3|||
144380306|NCT02969655|520602832|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
144380307|NCT02969655|520602833|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
144380308|NCT02969655|520602832|FG000|Overall Study|Adverse Event|10|||
144380309|NCT02969655|520602833|FG001|Overall Study|Adverse Event|8|||
144380310|NCT02466659|520602834|FG000|Overall Study|Lost to Follow-up|5|||
144514187|NCT04118452|521082136|FG001|Overall Study|Lost to Follow-up|5|||
144514188|NCT04118452|521082135|FG000|Overall Study|Withdrawal by Subject|17|||
144514189|NCT04118452|521082136|FG001|Overall Study|Withdrawal by Subject|17|||
144514190|NCT03215030|521082137|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
144514191|NCT03215030|521082138|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
144514192|NCT03215030|521082139|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514193|NCT03215030|521082140|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
144514194|NCT03215030|521082141|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514195|NCT03215030|521082142|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514196|NCT03215030|521082143|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514197|NCT03215030|521082144|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514198|NCT03215030|521082145|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514199|NCT03215030|521082146|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514200|NCT03215030|521082147|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514201|NCT03215030|521082148|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
144514202|NCT03215030|521082137|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
144514203|NCT03215030|521082138|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514204|NCT03215030|521082139|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514205|NCT03215030|521082140|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
144514206|NCT03215030|521082141|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514207|NCT03215030|521082142|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514208|NCT03215030|521082143|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514209|NCT03215030|521082144|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514210|NCT03215030|521082145|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514211|NCT03215030|521082146|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514212|NCT03215030|521082147|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514213|NCT03215030|521082148|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144514214|NCT03215030|521082137|FG000|Part 1: Dose Escalation|Death|15|||
144514215|NCT03215030|521082138|FG001|Part 1: Dose Escalation|Death|6|||
144514216|NCT03215030|521082139|FG002|Part 1: Dose Escalation|Death|6|||
144514217|NCT03215030|521082140|FG003|Part 1: Dose Escalation|Death|8|||
144514218|NCT03215030|521082141|FG004|Part 1: Dose Escalation|Death|0|||
144514219|NCT03215030|521082142|FG005|Part 1: Dose Escalation|Death|0|||
144514220|NCT03215030|521082143|FG006|Part 1: Dose Escalation|Death|0|||
144514221|NCT03215030|521082144|FG007|Part 1: Dose Escalation|Death|0|||
144514222|NCT03215030|521082145|FG008|Part 1: Dose Escalation|Death|0|||
144514223|NCT03215030|521082146|FG009|Part 1: Dose Escalation|Death|0|||
144514224|NCT03215030|521082147|FG010|Part 1: Dose Escalation|Death|0|||
144514225|NCT03215030|521082148|FG011|Part 1: Dose Escalation|Death|0|||
144514226|NCT03215030|521082137|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
144514227|NCT03215030|521082138|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
144514228|NCT03215030|521082139|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
144514229|NCT03215030|521082140|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
144514230|NCT03215030|521082141|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
144514231|NCT03215030|521082142|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
144514232|NCT03215030|521082143|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
144514233|NCT03215030|521082144|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
144514234|NCT03215030|521082145|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
144514235|NCT03215030|521082146|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
144514236|NCT03215030|521082147|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
144514237|NCT03215030|521082148|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
144380311|NCT02466659|520602835|FG001|Overall Study|Lost to Follow-up|2|||
144380312|NCT01536392|520602838|FG000|Overall Study|Adverse Event|2|||
144380313|NCT01536392|520602839|FG001|Overall Study|Adverse Event|2|||
144380314|NCT01536392|520602838|FG000|Overall Study|Physician Decision|2|||
144380315|NCT01536392|520602839|FG001|Overall Study|Physician Decision|3|||
144380316|NCT01536392|520602838|FG000|Overall Study|Withdrawal by Subject|3|||
144380317|NCT01536392|520602839|FG001|Overall Study|Withdrawal by Subject|6|||
144380318|NCT01536392|520602838|FG000|Overall Study|Non Compliance|3|||
144380319|NCT01536392|520602839|FG001|Overall Study|Non Compliance|4|||
144380320|NCT01536392|520602838|FG000|Overall Study|Completed therapy early|3|||
144380321|NCT01536392|520602839|FG001|Overall Study|Completed therapy early|0|||
144380322|NCT03753789|520602840|FG000|Overall Study|Withdrawal by Subject|2|||
144380323|NCT00145977|520602842|FG000|Overall Study|Lack of Efficacy|0|||
144380324|NCT00145977|520602843|FG001|Overall Study|Lack of Efficacy|4|||
144380325|NCT00145977|520602842|FG000|Overall Study|Lost to Follow-up|1|||
144380326|NCT00145977|520602843|FG001|Overall Study|Lost to Follow-up|0|||
144380327|NCT00145977|520602842|FG000|Overall Study|Withdrawal by Subject|1|||
144380328|NCT00145977|520602843|FG001|Overall Study|Withdrawal by Subject|0|||
144380329|NCT02929498|520602848|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
144380330|NCT02929498|520602849|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
144380331|NCT02929498|520602850|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
144380332|NCT02929498|520602848|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
144380333|NCT02929498|520602849|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
144380334|NCT02929498|520602850|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
144380335|NCT05477108|520602853|FG000|Overall Study|Participants randomized, not treated|1|||
144380336|NCT05477108|520602854|FG001|Overall Study|Participants randomized, not treated|1|||
144380337|NCT05477108|520602855|FG002|Overall Study|Participants randomized, not treated|1|||
144380338|NCT05477108|520602853|FG000|Overall Study|Physician Decision|0|||
144380339|NCT05477108|520602854|FG001|Overall Study|Physician Decision|0|||
144380340|NCT05477108|520602855|FG002|Overall Study|Physician Decision|1|||
144380341|NCT05477108|520602853|FG000|Overall Study|withdrawn from study|0|||
144380342|NCT05477108|520602854|FG001|Overall Study|withdrawn from study|0|||
144380343|NCT05477108|520602855|FG002|Overall Study|withdrawn from study|1|||
144380344|NCT00334113|520602857|FG000|Overall Study|Lost to Follow-up|2|||
144380345|NCT00334113|520602858|FG001|Overall Study|Lost to Follow-up|2|||
144380346|NCT00334113|520602857|FG000|Overall Study|Withdrawal by Subject|0|||
144380347|NCT00334113|520602858|FG001|Overall Study|Withdrawal by Subject|1|||
144380348|NCT01165216|520602863|FG000|Overall Study|Adverse Event|6|||
144380349|NCT01165216|520602864|FG001|Overall Study|Adverse Event|3|||
144380350|NCT01165216|520602863|FG000|Overall Study|Withdrawal by Subject|1|||
144380351|NCT01165216|520602864|FG001|Overall Study|Withdrawal by Subject|1|||
144380352|NCT01165216|520602863|FG000|Overall Study|Disease progression|1|||
144380353|NCT01165216|520602864|FG001|Overall Study|Disease progression|3|||
144380354|NCT01379508|520602867|FG000|Treatment to Week 104|Adverse Event|2|||
144380355|NCT01379508|520602868|FG001|Treatment to Week 104|Adverse Event|0|||
144380356|NCT01379508|520602869|FG002|Treatment to Week 104|Adverse Event|5|||
144380357|NCT01379508|520602870|FG003|Treatment to Week 104|Adverse Event|0|||
144380358|NCT01379508|520602867|FG000|Treatment to Week 104|Abnormal lab value|1|||
144380359|NCT01379508|520602868|FG001|Treatment to Week 104|Abnormal lab value|0|||
144591764|NCT01395888|521366395|FG001|2-week Run-in Period|Adverse Event|0|||
144591765|NCT01395888|521366396|FG002|2-week Run-in Period|Adverse Event|0|||
144591766|NCT01395888|521366394|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
144591767|NCT01395888|521366395|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
144380360|NCT01379508|520602869|FG002|Treatment to Week 104|Abnormal lab value|0|||
144380361|NCT01379508|520602870|FG003|Treatment to Week 104|Abnormal lab value|0|||
144380362|NCT01379508|520602867|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
144380363|NCT01379508|520602868|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
144380364|NCT01379508|520602869|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
144380365|NCT01379508|520602870|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
144380366|NCT01379508|520602867|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
144380367|NCT01379508|520602868|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
144380368|NCT01379508|520602869|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
144380369|NCT01379508|520602870|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
144380370|NCT01379508|520602867|FG000|Treatment to Week 104|Lost to Follow-up|5|||
144380371|NCT01379508|520602868|FG001|Treatment to Week 104|Lost to Follow-up|0|||
144380372|NCT01379508|520602869|FG002|Treatment to Week 104|Lost to Follow-up|3|||
144380373|NCT01379508|520602870|FG003|Treatment to Week 104|Lost to Follow-up|0|||
144380374|NCT01379508|520602867|FG000|Treatment to Week 104|Administrative problems|3|||
144380375|NCT01379508|520602868|FG001|Treatment to Week 104|Administrative problems|1|||
144380376|NCT01379508|520602869|FG002|Treatment to Week 104|Administrative problems|0|||
144380377|NCT01379508|520602870|FG003|Treatment to Week 104|Administrative problems|0|||
144380378|NCT01379508|520602867|FG000|Treatment to Week 104|Protocol Violation|1|||
144380379|NCT01379508|520602868|FG001|Treatment to Week 104|Protocol Violation|1|||
144380380|NCT01379508|520602869|FG002|Treatment to Week 104|Protocol Violation|1|||
144380381|NCT01379508|520602870|FG003|Treatment to Week 104|Protocol Violation|0|||
144380382|NCT01379508|520602867|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
144380383|NCT01379508|520602868|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
144380384|NCT01379508|520602869|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
144380385|NCT01379508|520602870|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
144380386|NCT01379508|520602867|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
144380387|NCT01379508|520602868|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
144380388|NCT01379508|520602869|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
144380389|NCT01379508|520602870|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
144380390|NCT01379508|520602867|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
144380391|NCT01379508|520602868|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
144380392|NCT01379508|520602869|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
144380393|NCT01379508|520602870|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
144380394|NCT01379508|520602867|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
144380395|NCT01379508|520602868|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
144380396|NCT01379508|520602869|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
144380397|NCT01379508|520602870|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
144380398|NCT01808092|520602873|FG000|Overall Study|Death|39|||
144380399|NCT01808092|520602874|FG001|Overall Study|Death|29|||
144380400|NCT01808092|520602873|FG000|Overall Study|Lost to Follow-up|3|||
144380401|NCT01808092|520602874|FG001|Overall Study|Lost to Follow-up|7|||
144380402|NCT01808092|520602873|FG000|Overall Study|Withdrawal by Subject|9|||
144380403|NCT01808092|520602874|FG001|Overall Study|Withdrawal by Subject|4|||
144380404|NCT01808092|520602873|FG000|Overall Study|Other Eligibility criteria|3|||
144380405|NCT01808092|520602874|FG001|Overall Study|Other Eligibility criteria|5|||
144380406|NCT01031836|520604433|FG000|Stage I|Adverse Event|1|||
144380407|NCT01031836|520604434|FG001|Stage I|Adverse Event|1|||
144380408|NCT01031836|520604435|FG002|Stage I|Adverse Event|0|||
144380409|NCT01031836|520604436|FG003|Stage I|Adverse Event|0|||
144380410|NCT01031836|520604437|FG004|Stage I|Adverse Event|0|||
144380411|NCT01031836|520604438|FG005|Stage I|Adverse Event|0|||
144380412|NCT01031836|520604433|FG000|Stage I|Other|0|||
144380413|NCT01031836|520604434|FG001|Stage I|Other|1|||
144380414|NCT01031836|520604435|FG002|Stage I|Other|0|||
144380415|NCT01031836|520604436|FG003|Stage I|Other|0|||
144380416|NCT01031836|520604437|FG004|Stage I|Other|0|||
144380417|NCT01031836|520604438|FG005|Stage I|Other|1|||
144380418|NCT01031836|520604433|FG000|Stage II|Adverse Event|0|||
144380419|NCT01031836|520604434|FG001|Stage II|Adverse Event|0|||
144380420|NCT01031836|520604435|FG002|Stage II|Adverse Event|2|||
144380421|NCT01031836|520604436|FG003|Stage II|Adverse Event|2|||
144380422|NCT01031836|520604437|FG004|Stage II|Adverse Event|1|||
144380423|NCT01031836|520604438|FG005|Stage II|Adverse Event|1|||
144380424|NCT01031836|520604433|FG000|Stage II|Other|2|||
144380425|NCT01031836|520604434|FG001|Stage II|Other|0|||
144380426|NCT01031836|520604435|FG002|Stage II|Other|0|||
144380427|NCT01031836|520604436|FG003|Stage II|Other|1|||
144380428|NCT01031836|520604437|FG004|Stage II|Other|1|||
144380429|NCT01031836|520604438|FG005|Stage II|Other|0|||
144380430|NCT00945906|520604440|FG000|Overall Study|Withdrawal by Subject|1|||
144380431|NCT00945906|520604440|FG000|Overall Study|Did not want to return for last visit|2|||
144380432|NCT00945906|520604440|FG000|Overall Study|Unable to return for last visit|2|||
144380433|NCT00945906|520604440|FG000|Overall Study|Moved to another country|2|||
144380434|NCT00361634|520604451|FG000|Overall Study|Lost to Follow-up|1|||
144380435|NCT00361634|520604451|FG000|Overall Study|Withdrawal by Subject|1|||
144380436|NCT05315908|520604452|FG000|Overall Study|Lost to Follow-up|4477|||
144380437|NCT05315908|520604453|FG001|Overall Study|Lost to Follow-up|4606|||
144380438|NCT00294762|520604454|FG000|Overall Study|Did not receive study treatment|3|||
144380439|NCT00294762|520604455|FG001|Overall Study|Did not receive study treatment|3|||
144380440|NCT02937584|520604456|FG000|Period 1|Adverse Event|1|||
144380441|NCT02937584|520604457|FG001|Period 1|Adverse Event|2|||
144380442|NCT02937584|520604456|FG000|Washout|Adverse Event|0|||
144380443|NCT02937584|520604457|FG001|Washout|Adverse Event|1|||
144380444|NCT03180619|520604459|FG000|Overall Study|Withdrew Consent|5|||
144380445|NCT03180619|520604460|FG001|Overall Study|Withdrew Consent|0|||
144380446|NCT03180619|520604461|FG002|Overall Study|Withdrew Consent|2|||
144380447|NCT03180619|520604459|FG000|Overall Study|Death|2|||
144380448|NCT03180619|520604460|FG001|Overall Study|Death|1|||
144380449|NCT03180619|520604461|FG002|Overall Study|Death|2|||
144380450|NCT03180619|520604459|FG000|Overall Study|Adverse Event|2|||
144380451|NCT03180619|520604460|FG001|Overall Study|Adverse Event|0|||
144380452|NCT03180619|520604461|FG002|Overall Study|Adverse Event|1|||
144380453|NCT03180619|520604459|FG000|Overall Study|Investigator's discretion|2|||
144380454|NCT03180619|520604460|FG001|Overall Study|Investigator's discretion|0|||
144380455|NCT03180619|520604461|FG002|Overall Study|Investigator's discretion|1|||
144380456|NCT03531632|520604462|FG000|Overall Study|Adverse Event|0|||
144380457|NCT03531632|520604463|FG001|Overall Study|Adverse Event|0|||
144380458|NCT03531632|520604464|FG002|Overall Study|Adverse Event|1|||
144380459|NCT03531632|520604462|FG000|Overall Study|Death|4|||
144380460|NCT03531632|520604463|FG001|Overall Study|Death|0|||
144380461|NCT03531632|520604464|FG002|Overall Study|Death|14|||
144380462|NCT03531632|520604462|FG000|Overall Study|Study Terminated|1|||
144380463|NCT03531632|520604463|FG001|Overall Study|Study Terminated|3|||
144380464|NCT03531632|520604464|FG002|Overall Study|Study Terminated|11|||
144380465|NCT02743611|520604465|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
144380466|NCT02743611|520604466|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
144380467|NCT02743611|520604467|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
144380468|NCT02743611|520604468|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
144380469|NCT00600119|520604469|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
144380470|NCT00600119|520604470|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
144380471|NCT00600119|520604471|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
144380472|NCT00600119|520604472|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
144380473|NCT00600119|520604473|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
144380474|NCT00600119|520604474|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
144380475|NCT00600119|520604469|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144380476|NCT00600119|520604470|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
144380477|NCT00600119|520604471|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
144380478|NCT00600119|520604472|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144380479|NCT00600119|520604473|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144380480|NCT00600119|520604474|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144380481|NCT00600119|520604469|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
144380482|NCT00600119|520604470|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
144380483|NCT00600119|520604471|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
144380484|NCT00600119|520604472|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
144380485|NCT00600119|520604473|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
144380486|NCT00600119|520604474|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
144380487|NCT00600119|520604469|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
144380488|NCT00600119|520604470|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
144380489|NCT00600119|520604471|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
144380490|NCT00600119|520604472|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
144380491|NCT00600119|520604473|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
144380492|NCT00600119|520604474|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
144380493|NCT00600119|520604469|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
144380494|NCT00600119|520604470|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
144380495|NCT00600119|520604471|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
144380496|NCT00600119|520604472|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
144380497|NCT00600119|520604473|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
144514238|NCT03215030|521082137|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144380498|NCT00600119|520604474|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
144380499|NCT00600119|520604469|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
144380500|NCT00600119|520604470|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
144380501|NCT00600119|520604471|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
144380502|NCT00600119|520604472|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
144721812|NCT00684671|521835302|FG000|Overall Study|Lost to Follow-up|1|||
144380503|NCT00600119|520604473|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
144380504|NCT00600119|520604474|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
144380505|NCT00600119|520604469|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
144380506|NCT00600119|520604470|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
144380507|NCT00600119|520604471|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144380508|NCT00600119|520604472|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
144380509|NCT00600119|520604473|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
144380510|NCT00600119|520604474|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
144380511|NCT00600119|520604469|FG000|Double-blind Treatment Period|Other|0|||
144380512|NCT00600119|520604470|FG001|Double-blind Treatment Period|Other|0|||
144380513|NCT00600119|520604471|FG002|Double-blind Treatment Period|Other|0|||
144380514|NCT00600119|520604472|FG003|Double-blind Treatment Period|Other|0|||
144380515|NCT00600119|520604473|FG004|Double-blind Treatment Period|Other|2|||
144380516|NCT00600119|520604474|FG005|Double-blind Treatment Period|Other|1|||
144380517|NCT00600119|520604469|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
144380518|NCT00600119|520604470|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
144380519|NCT00600119|520604471|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
144380520|NCT00600119|520604472|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
144380521|NCT00600119|520604473|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
144380522|NCT00600119|520604474|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
144380523|NCT00600119|520604469|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
144380524|NCT00600119|520604470|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
144380525|NCT00600119|520604471|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
144380526|NCT00600119|520604472|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
144380527|NCT00600119|520604473|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
144380528|NCT00600119|520604474|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
144380529|NCT00600119|520604469|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
144380530|NCT00600119|520604470|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
144380531|NCT00600119|520604471|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
144380532|NCT00600119|520604472|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
144380533|NCT00600119|520604473|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
144380534|NCT00600119|520604474|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
144380535|NCT00600119|520604469|FG000|Double-blind Treatment Period|Physician Decision|2|||
144380536|NCT00600119|520604470|FG001|Double-blind Treatment Period|Physician Decision|0|||
144380537|NCT00600119|520604471|FG002|Double-blind Treatment Period|Physician Decision|0|||
144380538|NCT00600119|520604472|FG003|Double-blind Treatment Period|Physician Decision|0|||
144380539|NCT00600119|520604473|FG004|Double-blind Treatment Period|Physician Decision|0|||
144380540|NCT00600119|520604474|FG005|Double-blind Treatment Period|Physician Decision|0|||
144380541|NCT00600119|520604469|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144380542|NCT00600119|520604470|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
144380543|NCT00600119|520604471|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
144380544|NCT00600119|520604472|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
144380545|NCT00600119|520604473|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
144380546|NCT00600119|520604474|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
144380547|NCT00600119|520604469|FG000|Double-blind Treatment Period|Adverse Event|1|||
144380548|NCT00600119|520604470|FG001|Double-blind Treatment Period|Adverse Event|1|||
144380549|NCT00600119|520604471|FG002|Double-blind Treatment Period|Adverse Event|0|||
144380550|NCT00600119|520604472|FG003|Double-blind Treatment Period|Adverse Event|1|||
144380551|NCT00600119|520604473|FG004|Double-blind Treatment Period|Adverse Event|2|||
144380552|NCT00600119|520604474|FG005|Double-blind Treatment Period|Adverse Event|10|||
144380553|NCT00600119|520604469|FG000|Follow-up Period|Adverse Event|0|||
144380554|NCT00600119|520604470|FG001|Follow-up Period|Adverse Event|0|||
144380555|NCT00600119|520604471|FG002|Follow-up Period|Adverse Event|0|||
144380556|NCT00600119|520604472|FG003|Follow-up Period|Adverse Event|0|||
144380557|NCT00600119|520604473|FG004|Follow-up Period|Adverse Event|0|||
144380558|NCT00600119|520604474|FG005|Follow-up Period|Adverse Event|1|||
144380559|NCT00600119|520604469|FG000|Follow-up Period|Other|1|||
144380560|NCT00600119|520604470|FG001|Follow-up Period|Other|0|||
144380561|NCT00600119|520604471|FG002|Follow-up Period|Other|0|||
144380562|NCT00600119|520604472|FG003|Follow-up Period|Other|0|||
144380563|NCT00600119|520604473|FG004|Follow-up Period|Other|0|||
144380564|NCT00600119|520604474|FG005|Follow-up Period|Other|0|||
144380565|NCT00729469|520604475|FG000|Overall Study|Adverse Event|14|||
144380566|NCT00729469|520604476|FG001|Overall Study|Adverse Event|25|||
144380567|NCT00729469|520604475|FG000|Overall Study|Lost to Follow-up|9|||
144380568|NCT00729469|520604476|FG001|Overall Study|Lost to Follow-up|9|||
144380569|NCT00729469|520604475|FG000|Overall Study|Protocol Violation|2|||
144380570|NCT00729469|520604476|FG001|Overall Study|Protocol Violation|1|||
144380571|NCT00729469|520604475|FG000|Overall Study|Withdrawal by Subject|19|||
144380572|NCT00729469|520604476|FG001|Overall Study|Withdrawal by Subject|8|||
144380573|NCT00729469|520604475|FG000|Overall Study|Other-Not mentioned|9|||
144380574|NCT00729469|520604476|FG001|Overall Study|Other-Not mentioned|4|||
144380575|NCT00561977|520604479|FG000|Overall Study|Withdrawal by Subject|0|||
144380576|NCT00561977|520604480|FG001|Overall Study|Withdrawal by Subject|2|||
144380577|NCT00561977|520604481|FG002|Overall Study|Withdrawal by Subject|1|||
144380578|NCT00561977|520604479|FG000|Overall Study|Pregnancy|0|||
144380579|NCT00561977|520604480|FG001|Overall Study|Pregnancy|1|||
144380580|NCT00561977|520604481|FG002|Overall Study|Pregnancy|1|||
144380581|NCT00977080|520604482|FG000|Overall Study|Adverse Event|2|||
144380582|NCT00977080|520604483|FG001|Overall Study|Adverse Event|7|||
144380583|NCT00977080|520604484|FG002|Overall Study|Adverse Event|7|||
144380584|NCT00977080|520604485|FG003|Overall Study|Adverse Event|7|||
144380585|NCT00977080|520604482|FG000|Overall Study|Withdrawal by Subject|1|||
144380586|NCT00977080|520604483|FG001|Overall Study|Withdrawal by Subject|5|||
144380587|NCT00977080|520604484|FG002|Overall Study|Withdrawal by Subject|1|||
144380588|NCT00977080|520604485|FG003|Overall Study|Withdrawal by Subject|5|||
144380589|NCT00977080|520604482|FG000|Overall Study|Protocol Violation|7|||
144380590|NCT00977080|520604483|FG001|Overall Study|Protocol Violation|3|||
144380591|NCT00977080|520604484|FG002|Overall Study|Protocol Violation|4|||
144380592|NCT00977080|520604485|FG003|Overall Study|Protocol Violation|3|||
144380593|NCT00977080|520604482|FG000|Overall Study|Noncompliance|0|||
144380594|NCT00977080|520604483|FG001|Overall Study|Noncompliance|2|||
144380595|NCT00977080|520604484|FG002|Overall Study|Noncompliance|1|||
144380596|NCT00977080|520604485|FG003|Overall Study|Noncompliance|0|||
144380597|NCT00977080|520604482|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
144380598|NCT00977080|520604483|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
144380599|NCT00977080|520604484|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
144380600|NCT00977080|520604485|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
144380601|NCT00977080|520604482|FG000|Overall Study|Required kidney transplantation|1|||
144380602|NCT00977080|520604483|FG001|Overall Study|Required kidney transplantation|3|||
144380603|NCT00977080|520604484|FG002|Overall Study|Required kidney transplantation|3|||
144380604|NCT00977080|520604485|FG003|Overall Study|Required kidney transplantation|1|||
144380605|NCT00977080|520604482|FG000|Overall Study|Travel for family reasons|1|||
144380606|NCT00977080|520604483|FG001|Overall Study|Travel for family reasons|0|||
144380607|NCT00977080|520604484|FG002|Overall Study|Travel for family reasons|0|||
144380608|NCT00977080|520604485|FG003|Overall Study|Travel for family reasons|0|||
144380609|NCT00275340|520604490|FG000|Overall Study|Lost to Follow-up|2|||
144380610|NCT00275340|520604491|FG001|Overall Study|Lost to Follow-up|4|||
144380611|NCT01950013|520604492|FG000|Overall Study|Withdrawal by Subject|0|||
144380612|NCT01950013|520604493|FG001|Overall Study|Withdrawal by Subject|2|||
144380613|NCT01950013|520604494|FG002|Overall Study|Withdrawal by Subject|0|||
144380614|NCT00653939|520604496|FG000|Overall Study|Adverse Event|1|||
144380615|NCT00653939|520604497|FG001|Overall Study|Adverse Event|3|||
144380616|NCT00653939|520604496|FG000|Overall Study|Withdrawal by Subject|3|||
144380617|NCT00653939|520604497|FG001|Overall Study|Withdrawal by Subject|3|||
144380618|NCT00653939|520604496|FG000|Overall Study|Physician Decision|4|||
144591768|NCT01395888|521366396|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
144591769|NCT01395888|521366394|FG000|2-week Run-in Period|Lost to Follow-up|1|||
144591770|NCT01395888|521366395|FG001|2-week Run-in Period|Lost to Follow-up|0|||
144591771|NCT01395888|521366396|FG002|2-week Run-in Period|Lost to Follow-up|0|||
144380619|NCT00653939|520604497|FG001|Overall Study|Physician Decision|0|||
144380620|NCT00653939|520604496|FG000|Overall Study|Disease Progression|2|||
144380621|NCT00653939|520604497|FG001|Overall Study|Disease Progression|3|||
144380622|NCT00653939|520604496|FG000|Overall Study|Other|2|||
144380623|NCT00653939|520604497|FG001|Overall Study|Other|6|||
144380624|NCT02032238|520604498|FG000|Overall Study|Lost to Follow-up|2|||
144380625|NCT02032238|520604499|FG001|Overall Study|Lost to Follow-up|0|||
144380626|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
144380627|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
144380628|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
144380629|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
144380630|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
144380631|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
144380632|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
144591772|NCT01395888|521366394|FG000|2-week Run-in Period|Protocol Violation|2|||
144591773|NCT01395888|521366395|FG001|2-week Run-in Period|Protocol Violation|0|||
144591774|NCT01395888|521366396|FG002|2-week Run-in Period|Protocol Violation|0|||
144380633|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
144591775|NCT01395888|521366394|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
144591776|NCT01395888|521366395|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144591777|NCT01395888|521366396|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144591778|NCT01395888|521366394|FG000|Treatment Period (TP)|Adverse Event|0|||
144380634|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
144380635|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
144380636|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
144380637|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
144380638|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
144380639|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
144380640|NCT00612105|520604500|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
144380641|NCT00612105|520604501|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
144380642|NCT00612105|520604500|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
144380643|NCT00612105|520604501|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
144380644|NCT00612105|520604500|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
144380645|NCT00612105|520604501|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
144380646|NCT00612105|520604500|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
144380647|NCT00612105|520604501|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
144380648|NCT00612105|520604500|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
144380649|NCT00612105|520604501|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
144380650|NCT00717236|520604502|FG000|Double-Blind Period|Adverse Event|33|||
144380651|NCT00717236|520604503|FG001|Double-Blind Period|Adverse Event|6|||
144380652|NCT00717236|520604502|FG000|Double-Blind Period|Lack of Efficacy|6|||
144380653|NCT00717236|520604503|FG001|Double-Blind Period|Lack of Efficacy|6|||
144380654|NCT00717236|520604502|FG000|Double-Blind Period|Lost to Follow-up|3|||
144380655|NCT00717236|520604503|FG001|Double-Blind Period|Lost to Follow-up|5|||
144380656|NCT00717236|520604502|FG000|Double-Blind Period|Withdrawal by Subject|10|||
144380657|NCT00717236|520604503|FG001|Double-Blind Period|Withdrawal by Subject|2|||
144380658|NCT00717236|520604502|FG000|Double-Blind Period|Loss of efficacy|3|||
144380659|NCT00717236|520604503|FG001|Double-Blind Period|Loss of efficacy|0|||
144380660|NCT00717236|520604502|FG000|Double-Blind Period|Other: Death|1|||
144380661|NCT00717236|520604503|FG001|Double-Blind Period|Other: Death|0|||
144380662|NCT00717236|520604502|FG000|Double-Blind Period|Other: Pregnancy|1|||
144380663|NCT00717236|520604503|FG001|Double-Blind Period|Other: Pregnancy|0|||
144380664|NCT00717236|520604502|FG000|Double-Blind Period|Other: Protocol Violation|2|||
144380665|NCT00717236|520604503|FG001|Double-Blind Period|Other: Protocol Violation|0|||
144380666|NCT00717236|520604502|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
144380667|NCT00717236|520604503|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
144380668|NCT00717236|520604502|FG000|Double-Blind Period|Other: Site withdrew|2|||
144380669|NCT00717236|520604503|FG001|Double-Blind Period|Other: Site withdrew|0|||
144380670|NCT00717236|520604502|FG000|Double-Blind Period|Other: Screening failure|1|||
144380671|NCT00717236|520604503|FG001|Double-Blind Period|Other: Screening failure|0|||
144380672|NCT00717236|520604502|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
144380673|NCT00717236|520604503|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
144380674|NCT00717236|520604502|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
144380675|NCT00717236|520604503|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
144380676|NCT00717236|520604502|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
144380677|NCT00717236|520604503|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
144380678|NCT00717236|520604502|FG000|Double-Blind Period|Other: History of cancer|1|||
144380679|NCT00717236|520604503|FG001|Double-Blind Period|Other: History of cancer|0|||
144380680|NCT00717236|520604502|FG000|Double-Blind Period|Other: Sponsor request|1|||
144380681|NCT00717236|520604503|FG001|Double-Blind Period|Other: Sponsor request|0|||
144380682|NCT00717236|520604502|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
144380683|NCT00717236|520604503|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
144380684|NCT00717236|520604502|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
144380685|NCT00717236|520604503|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
144591779|NCT01395888|521366395|FG001|Treatment Period (TP)|Adverse Event|7|||
144591780|NCT01395888|521366396|FG002|Treatment Period (TP)|Adverse Event|6|||
144591781|NCT01395888|521366394|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
144591782|NCT01395888|521366395|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
144591783|NCT01395888|521366396|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
144591784|NCT01395888|521366394|FG000|Treatment Period (TP)|Protocol Violation|0|||
144591785|NCT01395888|521366395|FG001|Treatment Period (TP)|Protocol Violation|1|||
144591786|NCT01395888|521366396|FG002|Treatment Period (TP)|Protocol Violation|5|||
144591787|NCT01395888|521366394|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
144591788|NCT01395888|521366395|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
144591789|NCT01395888|521366396|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
144380686|NCT00717236|520604502|FG000|Double-Blind Period|Other: Subject moved|1|||
144380687|NCT00717236|520604503|FG001|Double-Blind Period|Other: Subject moved|1|||
144380688|NCT00717236|520604502|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
144380689|NCT00717236|520604503|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
144380690|NCT00717236|520604502|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
144380691|NCT00717236|520604503|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
144380692|NCT00717236|520604502|FG000|Double-Blind Period|Other: Transportation problems|0|||
144380693|NCT00717236|520604503|FG001|Double-Blind Period|Other: Transportation problems|1|||
144380694|NCT00717236|520604502|FG000|Double-Blind Period|Other: Investigator Decision|0|||
144380695|NCT00717236|520604503|FG001|Double-Blind Period|Other: Investigator Decision|1|||
144380696|NCT00717236|520604502|FG000|Open-Label Period|Adverse Event|29|||
144380697|NCT00717236|520604503|FG001|Open-Label Period|Adverse Event|4|||
144380698|NCT00717236|520604502|FG000|Open-Label Period|Lack of Efficacy|30|||
144380699|NCT00717236|520604503|FG001|Open-Label Period|Lack of Efficacy|8|||
144380700|NCT00717236|520604502|FG000|Open-Label Period|Lost to Follow-up|28|||
144380701|NCT00717236|520604503|FG001|Open-Label Period|Lost to Follow-up|4|||
144380702|NCT00717236|520604502|FG000|Open-Label Period|Withdrawal by Subject|20|||
144380703|NCT00717236|520604503|FG001|Open-Label Period|Withdrawal by Subject|2|||
144380704|NCT00717236|520604502|FG000|Open-Label Period|Loss of Efficacy|6|||
144380705|NCT00717236|520604503|FG001|Open-Label Period|Loss of Efficacy|1|||
144380706|NCT00717236|520604502|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
144380707|NCT00717236|520604503|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
144380708|NCT00717236|520604502|FG000|Open-Label Period|Other: Lack of Compliance|1|||
144380709|NCT00717236|520604503|FG001|Open-Label Period|Other: Lack of Compliance|1|||
144380710|NCT00717236|520604502|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
144380711|NCT00717236|520604503|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
144380712|NCT00717236|520604502|FG000|Open-Label Period|Other: Moved|1|||
144380713|NCT00717236|520604503|FG001|Open-Label Period|Other: Moved|0|||
144380714|NCT00717236|520604502|FG000|Open-Label Period|Other: Investigator Decision|1|||
144380715|NCT00717236|520604503|FG001|Open-Label Period|Other: Investigator Decision|0|||
144380716|NCT00717236|520604502|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
144380717|NCT00717236|520604503|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
144380718|NCT00717236|520604502|FG000|Open-Label Period|Other: Sponsor Request|3|||
144380719|NCT00717236|520604503|FG001|Open-Label Period|Other: Sponsor Request|0|||
144380720|NCT00717236|520604502|FG000|Open-Label Period|Other: Cataract Surgery|1|||
144380721|NCT00717236|520604503|FG001|Open-Label Period|Other: Cataract Surgery|0|||
144380722|NCT00717236|520604502|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
144380723|NCT00717236|520604503|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
144380724|NCT00717236|520604502|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
144380725|NCT00717236|520604503|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
144380726|NCT00717236|520604502|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
144380727|NCT00717236|520604503|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
144380728|NCT00475982|520604504|FG000|Overall Study|surgery rescheduled|7|||
144380729|NCT00475982|520604505|FG001|Overall Study|surgery rescheduled|3|||
144380730|NCT01105767|520604506|FG000|Overall Study|Lost to Follow-up|1160|||
144380731|NCT01105767|520604507|FG001|Overall Study|Lost to Follow-up|1614|||
144380732|NCT01105767|520604508|FG002|Overall Study|Lost to Follow-up|1184|||
144380733|NCT00783198|520604517|FG000|Overall Study|Adverse Event|15|||
144380734|NCT00783198|520604518|FG001|Overall Study|Adverse Event|19|||
144380735|NCT00783198|520604519|FG002|Overall Study|Adverse Event|3|||
144380736|NCT00783198|520604517|FG000|Overall Study|Lost to Follow-up|11|||
144380737|NCT00783198|520604518|FG001|Overall Study|Lost to Follow-up|1|||
144380738|NCT00783198|520604519|FG002|Overall Study|Lost to Follow-up|7|||
144380739|NCT00783198|520604517|FG000|Overall Study|Withdrawal by Subject|22|||
144380740|NCT00783198|520604518|FG001|Overall Study|Withdrawal by Subject|14|||
144380741|NCT00783198|520604519|FG002|Overall Study|Withdrawal by Subject|20|||
144380742|NCT00783198|520604517|FG000|Overall Study|Noncompliance with protocol|7|||
144380743|NCT00783198|520604518|FG001|Overall Study|Noncompliance with protocol|7|||
144380744|NCT00783198|520604519|FG002|Overall Study|Noncompliance with protocol|10|||
144380745|NCT00783198|520604517|FG000|Overall Study|Did not meet protocol eligibility|0|||
144514239|NCT03215030|521082138|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514240|NCT03215030|521082139|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514241|NCT03215030|521082140|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514242|NCT03215030|521082141|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514243|NCT03215030|521082142|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514244|NCT03215030|521082143|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514245|NCT03215030|521082144|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
144514246|NCT03215030|521082145|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514247|NCT03215030|521082146|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144380746|NCT00783198|520604518|FG001|Overall Study|Did not meet protocol eligibility|1|||
144380747|NCT00783198|520604519|FG002|Overall Study|Did not meet protocol eligibility|0|||
144380748|NCT00783198|520604517|FG000|Overall Study|Administrative|2|||
144380749|NCT00783198|520604518|FG001|Overall Study|Administrative|1|||
144380750|NCT00783198|520604519|FG002|Overall Study|Administrative|2|||
144380751|NCT00271505|520604521|FG000|Overall Study|Screen Failure|3|||
144380752|NCT00271505|520604521|FG000|Overall Study|Adverse Event|1|||
144380753|NCT00271505|520604521|FG000|Overall Study|Death|1|||
144380754|NCT00119678|520604522|FG000|Double-blind Treatment Period|Death|1|||
144380755|NCT00119678|520604523|FG001|Double-blind Treatment Period|Death|0|||
144380756|NCT00119678|520604522|FG000|Double-blind Treatment Period|Adverse Event|7|||
144380757|NCT00119678|520604523|FG001|Double-blind Treatment Period|Adverse Event|1|||
144380758|NCT00119678|520604522|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
144380759|NCT00119678|520604523|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
144380760|NCT00119678|520604522|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
144380761|NCT00119678|520604523|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
144380762|NCT00119678|520604522|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
144380763|NCT00119678|520604523|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
144380764|NCT00119678|520604522|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
144380765|NCT00119678|520604523|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
144380766|NCT00119678|520604522|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
144380767|NCT00119678|520604523|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
144380768|NCT00119678|520604522|FG000|Double-blind Treatment Period|Pregnancy|0|||
144380769|NCT00119678|520604523|FG001|Double-blind Treatment Period|Pregnancy|2|||
144380770|NCT00119678|520604522|FG000|Double-blind Treatment Period|Not treated|1|||
144380771|NCT00119678|520604523|FG001|Double-blind Treatment Period|Not treated|2|||
144380772|NCT00119678|520604522|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
144380773|NCT00119678|520604523|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
144380774|NCT00119678|520604522|FG000|Open-label Treatment Period|Death|1|||
144380775|NCT00119678|520604523|FG001|Open-label Treatment Period|Death|0|||
144380776|NCT00119678|520604522|FG000|Open-label Treatment Period|Adverse Event|3|||
144380777|NCT00119678|520604523|FG001|Open-label Treatment Period|Adverse Event|0|||
144380778|NCT00119678|520604522|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
144380779|NCT00119678|520604523|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
144380780|NCT00119678|520604522|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
144380781|NCT00119678|520604523|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
144380782|NCT00119678|520604522|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
144380783|NCT00119678|520604523|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
144380784|NCT00119678|520604522|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
144380785|NCT00119678|520604523|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
144380786|NCT00119678|520604522|FG000|Open-label Treatment Period|Pregnancy|1|||
144380787|NCT00119678|520604523|FG001|Open-label Treatment Period|Pregnancy|0|||
144380788|NCT00119678|520604522|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
144380789|NCT00119678|520604523|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
144380790|NCT03704636|520604524|FG000|Overall Study|Inadequate Venous Flow|3|||
144380791|NCT01134705|520604527|FG000|Overall Study|Adverse Event|1|||
144380792|NCT01134705|520604528|FG001|Overall Study|Adverse Event|7|||
144380793|NCT01134705|520604527|FG000|Overall Study|Withdrawal by Subject|6|||
144380794|NCT01134705|520604528|FG001|Overall Study|Withdrawal by Subject|6|||
144380795|NCT01134705|520604527|FG000|Overall Study|Pregnancy|1|||
144380796|NCT01134705|520604528|FG001|Overall Study|Pregnancy|0|||
144380797|NCT01134705|520604527|FG000|Overall Study|Lost to Follow-up|5|||
144380798|NCT01134705|520604528|FG001|Overall Study|Lost to Follow-up|2|||
144380799|NCT01134705|520604527|FG000|Overall Study|Protocol Violation|1|||
144380800|NCT01134705|520604528|FG001|Overall Study|Protocol Violation|1|||
144380801|NCT01134705|520604527|FG000|Overall Study|Other|1|||
144380802|NCT01134705|520604528|FG001|Overall Study|Other|6|||
144380803|NCT00509145|520604529|FG000|Overall Study|Death|0|||
144380804|NCT00509145|520604530|FG001|Overall Study|Death|2|||
144380805|NCT00509145|520604529|FG000|Overall Study|Adverse Event|42|||
144380806|NCT00509145|520604530|FG001|Overall Study|Adverse Event|28|||
144380807|NCT00509145|520604529|FG000|Overall Study|Withdrawal by Subject|32|||
144380808|NCT00509145|520604530|FG001|Overall Study|Withdrawal by Subject|38|||
144380809|NCT00509145|520604529|FG000|Overall Study|Physician Decision|11|||
144380810|NCT00509145|520604530|FG001|Overall Study|Physician Decision|14|||
144380811|NCT00509145|520604529|FG000|Overall Study|Protocol Violation|1|||
144380812|NCT00509145|520604530|FG001|Overall Study|Protocol Violation|6|||
144380813|NCT00509145|520604529|FG000|Overall Study|Pregnancy|3|||
144380814|NCT00509145|520604530|FG001|Overall Study|Pregnancy|8|||
144380815|NCT00509145|520604529|FG000|Overall Study|Lost to Follow-up|6|||
144514248|NCT03215030|521082147|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144721813|NCT00684671|521835303|FG001|Overall Study|Lost to Follow-up|0|||
144380816|NCT00509145|520604530|FG001|Overall Study|Lost to Follow-up|5|||
144380817|NCT00509145|520604529|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
144380818|NCT00509145|520604530|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
144380819|NCT00509145|520604529|FG000|Overall Study|Other|6|||
144380820|NCT00509145|520604530|FG001|Overall Study|Other|6|||
144380821|NCT01994889|520604531|FG000|Overall Study|Adverse Event|5|||
144380822|NCT01994889|520604532|FG001|Overall Study|Adverse Event|12|||
144380823|NCT01994889|520604533|FG002|Overall Study|Adverse Event|11|||
144380824|NCT01994889|520604531|FG000|Overall Study|Cardiac Device Implantation|0|||
144721814|NCT00684671|521835304|FG002|Overall Study|Lost to Follow-up|0|||
144380825|NCT01994889|520604532|FG001|Overall Study|Cardiac Device Implantation|2|||
144380826|NCT01994889|520604533|FG002|Overall Study|Cardiac Device Implantation|0|||
144380827|NCT01994889|520604531|FG000|Overall Study|Organ Transplantation|1|||
144380828|NCT01994889|520604532|FG001|Overall Study|Organ Transplantation|5|||
144380829|NCT01994889|520604533|FG002|Overall Study|Organ Transplantation|5|||
144380830|NCT01994889|520604531|FG000|Overall Study|No longer willing to participate|8|||
144380831|NCT01994889|520604532|FG001|Overall Study|No longer willing to participate|17|||
144380832|NCT01994889|520604533|FG002|Overall Study|No longer willing to participate|37|||
144380833|NCT01994889|520604531|FG000|Overall Study|Lost to Follow-up|0|||
144380834|NCT01994889|520604532|FG001|Overall Study|Lost to Follow-up|1|||
144380835|NCT01994889|520604533|FG002|Overall Study|Lost to Follow-up|0|||
144380836|NCT01994889|520604531|FG000|Overall Study|Protocol Violation|0|||
144380837|NCT01994889|520604532|FG001|Overall Study|Protocol Violation|1|||
144380838|NCT01994889|520604533|FG002|Overall Study|Protocol Violation|1|||
144380839|NCT01994889|520604531|FG000|Overall Study|Death|14|||
144380840|NCT01994889|520604532|FG001|Overall Study|Death|25|||
144380841|NCT01994889|520604533|FG002|Overall Study|Death|38|||
144380842|NCT01510769|520604534|FG000|Overall Study|Adverse Event|7|||
144380843|NCT01510769|520604535|FG001|Overall Study|Adverse Event|6|||
144380844|NCT01510769|520604536|FG002|Overall Study|Adverse Event|4|||
144380845|NCT01510769|520604534|FG000|Overall Study|Gout Flare|0|||
144380846|NCT01510769|520604535|FG001|Overall Study|Gout Flare|3|||
144380847|NCT01510769|520604536|FG002|Overall Study|Gout Flare|1|||
144380848|NCT01510769|520604534|FG000|Overall Study|Protocol Violation|11|||
144380849|NCT01510769|520604535|FG001|Overall Study|Protocol Violation|10|||
144380850|NCT01510769|520604536|FG002|Overall Study|Protocol Violation|9|||
144380851|NCT01510769|520604534|FG000|Overall Study|Lost to Follow-up|5|||
144380852|NCT01510769|520604535|FG001|Overall Study|Lost to Follow-up|1|||
144380853|NCT01510769|520604536|FG002|Overall Study|Lost to Follow-up|5|||
144380854|NCT01510769|520604534|FG000|Overall Study|Withdrawal by Subject|3|||
144380855|NCT01510769|520604535|FG001|Overall Study|Withdrawal by Subject|4|||
144380856|NCT01510769|520604536|FG002|Overall Study|Withdrawal by Subject|3|||
144380857|NCT01510769|520604534|FG000|Overall Study|Death|1|||
144380858|NCT01510769|520604535|FG001|Overall Study|Death|1|||
144380859|NCT01510769|520604536|FG002|Overall Study|Death|0|||
144380860|NCT02674204|520604537|FG000|Overall Study|Adverse Event|1|||
144380861|NCT02674204|520604538|FG001|Overall Study|Adverse Event|0|||
144380862|NCT00929643|520604539|FG000|Overall Study|Protocol Violation|2|||
144380863|NCT02874144|520604540|FG000|Overall Study|Lost to Follow-up|3|||
144380864|NCT02874144|520604541|FG001|Overall Study|Lost to Follow-up|5|||
144380865|NCT01578850|520604545|FG000|Period 1|Insufficient Clinical Response|1|||
144380866|NCT01578850|520604546|FG001|Period 1|Insufficient Clinical Response|0|||
144380867|NCT01578850|520604547|FG002|Period 1|Insufficient Clinical Response|0|||
144380868|NCT01578850|520604545|FG000|Period 1|Adverse Event|11|||
144380869|NCT01578850|520604546|FG001|Period 1|Adverse Event|0|||
144380870|NCT01578850|520604547|FG002|Period 1|Adverse Event|0|||
144380871|NCT01578850|520604545|FG000|Period 1|Death|1|||
144380872|NCT01578850|520604546|FG001|Period 1|Death|0|||
144380873|NCT01578850|520604547|FG002|Period 1|Death|0|||
144380874|NCT01578850|520604545|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
144380875|NCT01578850|520604546|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
144380876|NCT01578850|520604547|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
144380877|NCT01578850|520604545|FG000|Period 1|Withdrawal by Subject|9|||
144380878|NCT01578850|520604546|FG001|Period 1|Withdrawal by Subject|0|||
144380879|NCT01578850|520604547|FG002|Period 1|Withdrawal by Subject|0|||
144380880|NCT01578850|520604545|FG000|Period 1|Study Terminated by Sponsor|3|||
144514249|NCT03215030|521082148|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
144514250|NCT03215030|521082137|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514251|NCT03215030|521082138|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514252|NCT03215030|521082139|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514253|NCT03215030|521082140|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514254|NCT03215030|521082141|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
144380881|NCT01578850|520604546|FG001|Period 1|Study Terminated by Sponsor|0|||
144380882|NCT01578850|520604547|FG002|Period 1|Study Terminated by Sponsor|0|||
144380883|NCT01578850|520604545|FG000|Period 2|Insufficient Clinical Response|0|||
144380884|NCT01578850|520604546|FG001|Period 2|Insufficient Clinical Response|1|||
144380885|NCT01578850|520604547|FG002|Period 2|Insufficient Clinical Response|0|||
144380886|NCT01578850|520604545|FG000|Period 2|Adverse Event|0|||
144380887|NCT01578850|520604546|FG001|Period 2|Adverse Event|3|||
144380888|NCT01578850|520604547|FG002|Period 2|Adverse Event|6|||
144380889|NCT01578850|520604545|FG000|Period 2|Lost to Follow-up|0|||
144380890|NCT01578850|520604546|FG001|Period 2|Lost to Follow-up|1|||
144380891|NCT01578850|520604547|FG002|Period 2|Lost to Follow-up|2|||
144380892|NCT01578850|520604545|FG000|Period 2|Withdrawal by Subject|0|||
144380893|NCT01578850|520604546|FG001|Period 2|Withdrawal by Subject|2|||
144380894|NCT01578850|520604547|FG002|Period 2|Withdrawal by Subject|2|||
144380895|NCT01578850|520604545|FG000|Period 2|Study Terminated by Sponsor|0|||
144380896|NCT01578850|520604546|FG001|Period 2|Study Terminated by Sponsor|5|||
144514255|NCT03215030|521082142|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
144514256|NCT03215030|521082143|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
144514257|NCT03215030|521082144|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
144514258|NCT03215030|521082145|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514259|NCT03215030|521082146|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514260|NCT03215030|521082147|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514261|NCT03215030|521082148|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144514262|NCT03215030|521082137|FG000|Part 2: Dose Expansion|Death|0|||
144380897|NCT01578850|520604547|FG002|Period 2|Study Terminated by Sponsor|4|||
144514263|NCT03215030|521082138|FG001|Part 2: Dose Expansion|Death|0|||
144514264|NCT03215030|521082139|FG002|Part 2: Dose Expansion|Death|0|||
144514265|NCT03215030|521082140|FG003|Part 2: Dose Expansion|Death|0|||
144514266|NCT03215030|521082141|FG004|Part 2: Dose Expansion|Death|3|||
144380898|NCT01578850|520604545|FG000|Period 2|Unspecified Reasons|0|||
144514267|NCT03215030|521082142|FG005|Part 2: Dose Expansion|Death|1|||
144380899|NCT01578850|520604546|FG001|Period 2|Unspecified Reasons|1|||
144514268|NCT03215030|521082143|FG006|Part 2: Dose Expansion|Death|5|||
144514269|NCT03215030|521082144|FG007|Part 2: Dose Expansion|Death|4|||
144514270|NCT03215030|521082145|FG008|Part 2: Dose Expansion|Death|0|||
144514271|NCT03215030|521082146|FG009|Part 2: Dose Expansion|Death|0|||
144514272|NCT03215030|521082147|FG010|Part 2: Dose Expansion|Death|0|||
144514273|NCT03215030|521082148|FG011|Part 2: Dose Expansion|Death|0|||
144514274|NCT03215030|521082137|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
144514275|NCT03215030|521082138|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
144514276|NCT03215030|521082139|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
144514277|NCT03215030|521082140|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
144514278|NCT03215030|521082141|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
144514279|NCT03215030|521082142|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
144514280|NCT03215030|521082143|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
144380900|NCT01578850|520604547|FG002|Period 2|Unspecified Reasons|0|||
144380901|NCT01711216|520604548|FG000|Overall Study|Adverse Event|4|||
144380902|NCT01711216|520604548|FG000|Overall Study|Pregnancy|56|||
144721815|NCT00684671|521835302|FG000|Overall Study|Alcoholic dependance|1|||
144721816|NCT00684671|521835303|FG001|Overall Study|Alcoholic dependance|0|||
144721817|NCT00684671|521835304|FG002|Overall Study|Alcoholic dependance|0|||
144721818|NCT00947427|521835305|FG000|Overall Study|Withdrawal by Subject|1|||
144721819|NCT00947427|521835306|FG001|Overall Study|Withdrawal by Subject|3|||
144380903|NCT01711216|520604548|FG000|Overall Study|Withdrawal by Subject|6|||
144380904|NCT01711216|520604548|FG000|Overall Study|Lost to Follow-up|46|||
144721820|NCT00947427|521835305|FG000|Overall Study|Protocol Violation|0|||
144721821|NCT00947427|521835306|FG001|Overall Study|Protocol Violation|1|||
144591790|NCT01395888|521366394|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
144721822|NCT00249821|521835307|FG000|Overall Study|Technical problem|0|||
144721823|NCT00249821|521835308|FG001|Overall Study|Technical problem|1|||
144721824|NCT01411995|521835312|FG000|Overall Study|Failed IUD insertion|0|||
144721825|NCT01411995|521835313|FG001|Overall Study|Failed IUD insertion|1|||
144721826|NCT00319956|521835316|FG000|Overall Study|Death|20|||
144721827|NCT00319956|521835317|FG001|Overall Study|Death|24|||
144721828|NCT02292238|521835318|FG000|Overall Study|Protocol Violation|1|||
144721829|NCT02292238|521835319|FG001|Overall Study|Protocol Violation|2|||
144721830|NCT02292238|521835318|FG000|Overall Study|Withdrawal by Subject|2|||
144721831|NCT02292238|521835319|FG001|Overall Study|Withdrawal by Subject|1|||
144721832|NCT02292238|521835318|FG000|Overall Study|Lost to Follow-up|1|||
144721833|NCT02292238|521835319|FG001|Overall Study|Lost to Follow-up|0|||
144721834|NCT02292238|521835318|FG000|Overall Study|Physician Decision|0|||
144721835|NCT02292238|521835319|FG001|Overall Study|Physician Decision|1|||
144721836|NCT04000009|521835320|FG000|Overall Study|Adverse Event|13|||
144721837|NCT04000009|521835320|FG000|Overall Study|Lack of Efficacy|7|||
144721838|NCT04000009|521835320|FG000|Overall Study|Lost to Follow-up|8|||
144721839|NCT04000009|521835320|FG000|Overall Study|Noncompliance with study drug|4|||
144721840|NCT04000009|521835320|FG000|Overall Study|Physician Decision|1|||
144721841|NCT04000009|521835320|FG000|Overall Study|Use of prohibited medication|3|||
144721842|NCT04000009|521835320|FG000|Overall Study|Pregnancy|1|||
144721843|NCT04000009|521835320|FG000|Overall Study|Withdrawal by Subject|22|||
144721844|NCT04000009|521835320|FG000|Overall Study|Study terminated by sponsor|98|||
144721845|NCT04000009|521835320|FG000|Overall Study|Not further specified|8|||
144721846|NCT01618305|521835321|FG000|Overall Study|Death|0|||
144721847|NCT01618305|521835322|FG001|Overall Study|Death|1|||
144721848|NCT01618305|521835321|FG000|Overall Study|Lost to Follow-up|11|||
144721849|NCT01618305|521835322|FG001|Overall Study|Lost to Follow-up|7|||
144721850|NCT01618305|521835321|FG000|Overall Study|Protocol Violation|1|||
144721851|NCT01618305|521835322|FG001|Overall Study|Protocol Violation|0|||
144721852|NCT01618305|521835321|FG000|Overall Study|Withdrawal by Subject|3|||
144721853|NCT01618305|521835322|FG001|Overall Study|Withdrawal by Subject|2|||
144721854|NCT01960816|521835323|FG000|Overall Study|Lost to Follow-up|1|||
144721855|NCT01309919|521835339|FG000|Overall Study|Did not receive a postpartum IUD|17|||
144721856|NCT01309919|521835340|FG001|Overall Study|Did not receive a postpartum IUD|48|||
144721857|NCT02102490|521835341|FG000|Overall Study|Death|6|||
144721858|NCT02102490|521835341|FG000|Overall Study|Lost to Follow-up|1|||
144721859|NCT00385541|521835342|FG000|Overall Study|severe pain, clinician requested unblind|0|||
144721860|NCT00385541|521835343|FG001|Overall Study|severe pain, clinician requested unblind|1|||
144721861|NCT02154529|521835344|FG000|Overall Study|Death|1|||
144721862|NCT02154529|521835345|FG001|Overall Study|Death|1|||
144721863|NCT02154529|521835346|FG002|Overall Study|Death|5|||
144721864|NCT02154529|521835347|FG003|Overall Study|Death|1|||
144721865|NCT02154529|521835344|FG000|Overall Study|Termination of study by sponsor|2|||
144721866|NCT02154529|521835345|FG001|Overall Study|Termination of study by sponsor|2|||
144721867|NCT02154529|521835346|FG002|Overall Study|Termination of study by sponsor|3|||
144721868|NCT02154529|521835347|FG003|Overall Study|Termination of study by sponsor|1|||
144721869|NCT02154529|521835344|FG000|Overall Study|Lost to Follow-up|1|||
144721870|NCT02154529|521835345|FG001|Overall Study|Lost to Follow-up|0|||
144721871|NCT02154529|521835346|FG002|Overall Study|Lost to Follow-up|0|||
144721872|NCT02154529|521835347|FG003|Overall Study|Lost to Follow-up|0|||
144721873|NCT01691859|521836846|FG000|Overall Study|Adverse Event|19|||
144721874|NCT01691859|521836846|FG000|Overall Study|Lack of Efficacy|11|||
144721875|NCT01691859|521836846|FG000|Overall Study|Protocol Violation|4|||
144721876|NCT01691859|521836846|FG000|Overall Study|Product commercially available|221|||
144721877|NCT01691859|521836846|FG000|Overall Study|Study closed/terminated|50|||
144721878|NCT01691859|521836846|FG000|Overall Study|Lost to Follow-up|5|||
144721879|NCT01691859|521836846|FG000|Overall Study|Physician Decision|6|||
144721880|NCT01691859|521836846|FG000|Overall Study|Withdrawal by Subject|31|||
144721881|NCT04583579|521836847|FG000|Overall Study|Lost to Follow-up|4|||
144721882|NCT01691508|521836848|FG000|Overall Study|Adverse Event|3|||
144721883|NCT01691508|521836849|FG001|Overall Study|Adverse Event|3|||
144721884|NCT01691508|521836848|FG000|Overall Study|Withdrawal by Subject|1|||
144721885|NCT01691508|521836849|FG001|Overall Study|Withdrawal by Subject|0|||
144721886|NCT03036579|521836853|FG000|2 Years|Lost to Follow-up|1|||
144721887|NCT03036579|521836854|FG001|2 Years|Lost to Follow-up|0|||
144721888|NCT03036579|521836853|FG000|3 Years|Lost to Follow-up|0|||
144721889|NCT03036579|521836854|FG001|3 Years|Lost to Follow-up|1|||
144721890|NCT02848599|521836855|FG000|Overall Study|Protocol Violation|7|||
144721891|NCT02848599|521836856|FG001|Overall Study|Protocol Violation|9|||
144721892|NCT05431153|521836857|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144721893|NCT05431153|521836858|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144721894|NCT05431153|521836859|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144514281|NCT03215030|521082144|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
144514282|NCT03215030|521082145|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
144514283|NCT03215030|521082146|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
144514284|NCT03215030|521082147|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
144514285|NCT03215030|521082148|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
144514286|NCT03215030|521082137|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
144514287|NCT03215030|521082138|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
144514288|NCT03215030|521082139|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
144514289|NCT03215030|521082140|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
144514290|NCT03215030|521082141|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
144514291|NCT03215030|521082142|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
144514292|NCT03215030|521082143|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
144380905|NCT01711216|520604548|FG000|Overall Study|variety of other minor reasons|83|||
144380906|NCT01711216|520604548|FG000|Overall Study|no reason specified|22|||
144514293|NCT03215030|521082144|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
144514294|NCT03215030|521082145|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
144514295|NCT03215030|521082146|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
144380907|NCT02228980|520604549|FG000|Overall Study|Adverse Event|14|||
144380908|NCT02228980|520604550|FG001|Overall Study|Adverse Event|0|||
144380909|NCT02228980|520604551|FG002|Overall Study|Adverse Event|0|||
144591791|NCT01395888|521366395|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
144380910|NCT02228980|520604552|FG003|Overall Study|Adverse Event|0|||
144380911|NCT02228980|520604549|FG000|Overall Study|Protocol Violation|7|||
144380912|NCT02228980|520604550|FG001|Overall Study|Protocol Violation|0|||
144380913|NCT02228980|520604551|FG002|Overall Study|Protocol Violation|0|||
144380914|NCT02228980|520604552|FG003|Overall Study|Protocol Violation|0|||
144380915|NCT02228980|520604549|FG000|Overall Study|Withdrawal by Subject|3|||
144380916|NCT02228980|520604550|FG001|Overall Study|Withdrawal by Subject|3|||
144380917|NCT02228980|520604551|FG002|Overall Study|Withdrawal by Subject|2|||
144721895|NCT05431153|521836860|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144721896|NCT05431153|521836861|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
144721897|NCT05431153|521836862|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144721898|NCT04828161|521836863|FG000|Overall Study|Withdrawal by Subject|0|||
144721899|NCT04828161|521836864|FG001|Overall Study|Withdrawal by Subject|3|||
144380918|NCT02228980|520604552|FG003|Overall Study|Withdrawal by Subject|3|||
144380919|NCT00750152|520604553|FG000|Overall Study|Adverse Event|2|||
144591792|NCT01395888|521366396|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
144591793|NCT00903682|521366397|FG000|Overall Study|Adverse Event|6|||
144591794|NCT00903682|521366398|FG001|Overall Study|Adverse Event|13|||
144591795|NCT00903682|521366397|FG000|Overall Study|Lost to Follow-up|1|||
144591796|NCT00903682|521366398|FG001|Overall Study|Lost to Follow-up|0|||
144591797|NCT00903682|521366397|FG000|Overall Study|Withdrawal by Subject|5|||
144591798|NCT00903682|521366398|FG001|Overall Study|Withdrawal by Subject|0|||
144591799|NCT00903682|521366397|FG000|Overall Study|Pregnancy|0|||
144591800|NCT00903682|521366398|FG001|Overall Study|Pregnancy|1|||
144591801|NCT00903682|521366397|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
144591802|NCT00903682|521366398|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
144591803|NCT00903682|521366397|FG000|Overall Study|Subject Non-Compliant|1|||
144591804|NCT00903682|521366398|FG001|Overall Study|Subject Non-Compliant|0|||
144591805|NCT00903682|521366397|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
144591806|NCT00903682|521366398|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
144591807|NCT00903682|521366397|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
144591808|NCT00903682|521366398|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
144591809|NCT03169101|521366399|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
144591810|NCT03169101|521366400|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
144591811|NCT03169101|521366401|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
144591812|NCT03169101|521366402|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
144591813|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
144591814|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
144591815|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
144591816|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
144591817|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
144591818|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
144591819|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
144591820|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
144591821|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
144591822|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
144591823|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
144591824|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
144591825|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
144591826|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
144591827|NCT00600886|521366403|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
144591828|NCT00600886|521366404|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
144591829|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
144380920|NCT00750152|520604554|FG001|Overall Study|Adverse Event|1|||
144380921|NCT00750152|520604553|FG000|Overall Study|Lost to Follow-up|8|||
144380922|NCT00750152|520604554|FG001|Overall Study|Lost to Follow-up|13|||
144591830|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
144591831|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
144591832|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
144591833|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
144591834|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
144380923|NCT00750152|520604553|FG000|Overall Study|Withdrawal by Subject|3|||
144591835|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
144591836|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
144591837|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
144591838|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
144591839|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
144591840|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
144591841|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Death|1|||
144591842|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Death|1|||
144721900|NCT04828161|521836865|FG002|Overall Study|Withdrawal by Subject|3|||
144721901|NCT04828161|521836866|FG003|Overall Study|Withdrawal by Subject|4|||
144721902|NCT04828161|521836863|FG000|Overall Study|Lost to Follow-up|1|||
144380924|NCT00750152|520604554|FG001|Overall Study|Withdrawal by Subject|3|||
144380925|NCT00750152|520604553|FG000|Overall Study|Physician Decision|1|||
144380926|NCT00750152|520604554|FG001|Overall Study|Physician Decision|1|||
144380927|NCT00750152|520604553|FG000|Overall Study|Non-compliance|0|||
144514296|NCT03215030|521082147|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
144514297|NCT03215030|521082148|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
144514298|NCT03215030|521082137|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514299|NCT03215030|521082138|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514300|NCT03215030|521082139|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514301|NCT03215030|521082140|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514302|NCT03215030|521082141|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514303|NCT03215030|521082142|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514304|NCT03215030|521082143|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514305|NCT03215030|521082144|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514306|NCT03215030|521082145|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
144514307|NCT03215030|521082146|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
144514308|NCT03215030|521082147|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514309|NCT03215030|521082148|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
144514310|NCT03215030|521082137|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514311|NCT03215030|521082138|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514312|NCT03215030|521082139|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514313|NCT03215030|521082140|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514314|NCT03215030|521082141|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514315|NCT03215030|521082142|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514316|NCT03215030|521082143|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514317|NCT03215030|521082144|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514318|NCT03215030|521082145|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
144514319|NCT03215030|521082146|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
144514320|NCT03215030|521082147|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
144721903|NCT04828161|521836864|FG001|Overall Study|Lost to Follow-up|4|||
144721904|NCT04828161|521836865|FG002|Overall Study|Lost to Follow-up|2|||
144721905|NCT04828161|521836866|FG003|Overall Study|Lost to Follow-up|2|||
144721906|NCT04828161|521836863|FG000|Overall Study|Other|2|||
144721907|NCT04828161|521836864|FG001|Overall Study|Other|0|||
144721908|NCT04828161|521836865|FG002|Overall Study|Other|2|||
144380928|NCT00750152|520604554|FG001|Overall Study|Non-compliance|1|||
144380929|NCT00750152|520604553|FG000|Overall Study|Termination by sponsor|1|||
144514321|NCT03215030|521082148|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
144514322|NCT03215030|521082137|FG000|Part 3: Dose Extension|Death|0|||
144514323|NCT03215030|521082138|FG001|Part 3: Dose Extension|Death|0|||
144721909|NCT04828161|521836866|FG003|Overall Study|Other|0|||
144514324|NCT03215030|521082139|FG002|Part 3: Dose Extension|Death|0|||
144721910|NCT04828161|521836863|FG000|Overall Study|Death|0|||
144721911|NCT04828161|521836864|FG001|Overall Study|Death|0|||
144721912|NCT04828161|521836865|FG002|Overall Study|Death|0|||
144591843|NCT00600886|521366403|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
144591844|NCT00600886|521366404|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
144591845|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
144591846|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
144591847|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
144591848|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
144591849|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
144591850|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
144591851|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
144591852|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
144591853|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
144591854|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
144591855|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
144591856|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
144591857|NCT00600886|521366403|FG000|Extension - After Crossover (CAS)|Death|1|||
144591858|NCT00600886|521366404|FG001|Extension - After Crossover (CAS)|Death|0|||
144591859|NCT02053792|521366405|FG000|Overall Study|Physician Decision|0|||
144591860|NCT02053792|521366406|FG001|Overall Study|Physician Decision|1|||
144591861|NCT02053792|521366405|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
144591862|NCT02053792|521366406|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
144514325|NCT03215030|521082140|FG003|Part 3: Dose Extension|Death|0|||
144514326|NCT03215030|521082141|FG004|Part 3: Dose Extension|Death|0|||
144514327|NCT03215030|521082142|FG005|Part 3: Dose Extension|Death|0|||
144514328|NCT03215030|521082143|FG006|Part 3: Dose Extension|Death|0|||
144514329|NCT03215030|521082144|FG007|Part 3: Dose Extension|Death|0|||
144514330|NCT03215030|521082145|FG008|Part 3: Dose Extension|Death|19|||
144514331|NCT03215030|521082146|FG009|Part 3: Dose Extension|Death|20|||
144514332|NCT03215030|521082147|FG010|Part 3: Dose Extension|Death|0|||
144514333|NCT03215030|521082148|FG011|Part 3: Dose Extension|Death|0|||
144514334|NCT03215030|521082137|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
144514335|NCT03215030|521082138|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
144514336|NCT03215030|521082139|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
144514337|NCT03215030|521082140|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
144591863|NCT02053792|521366405|FG000|Overall Study|Lack of Efficacy|1|||
144591864|NCT02053792|521366406|FG001|Overall Study|Lack of Efficacy|0|||
144591865|NCT02053792|521366405|FG000|Overall Study|Adverse Event|1|||
144591866|NCT02053792|521366406|FG001|Overall Study|Adverse Event|0|||
144591867|NCT02053792|521366405|FG000|Overall Study|Withdrawal by Subject|2|||
144591868|NCT02053792|521366406|FG001|Overall Study|Withdrawal by Subject|2|||
144591869|NCT02053792|521366405|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
144591870|NCT02053792|521366406|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
144591871|NCT02053792|521366405|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
144591872|NCT02053792|521366406|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
144591873|NCT04428151|521366407|FG000|Overall Study|Death|100|||
144591874|NCT04428151|521366408|FG001|Overall Study|Death|86|||
144591875|NCT04428151|521366409|FG002|Overall Study|Death|57|||
144591876|NCT04428151|521366407|FG000|Overall Study|Lost to Follow-up|1|||
144591877|NCT04428151|521366408|FG001|Overall Study|Lost to Follow-up|1|||
144591878|NCT04428151|521366409|FG002|Overall Study|Lost to Follow-up|0|||
144591879|NCT04428151|521366407|FG000|Overall Study|Withdrawal by Subject|2|||
144591880|NCT04428151|521366408|FG001|Overall Study|Withdrawal by Subject|2|||
144591881|NCT04428151|521366409|FG002|Overall Study|Withdrawal by Subject|3|||
144591882|NCT04428151|521366407|FG000|Overall Study|Participant Ongoing in Study|41|||
144591883|NCT04428151|521366408|FG001|Overall Study|Participant Ongoing in Study|53|||
144591884|NCT04428151|521366409|FG002|Overall Study|Participant Ongoing in Study|28|||
144591885|NCT04134845|521366413|FG000|Overall Study|withdrawl by PI|12|||
144591886|NCT04134845|521366414|FG001|Overall Study|withdrawl by PI|5|||
144591887|NCT03110224|521366415|FG000|Overall Study|Death|3|||
144591888|NCT03110224|521366415|FG000|Overall Study|Lost to Follow-up|132|||
144591889|NCT03110224|521366415|FG000|Overall Study|Physician Decision|2|||
144591890|NCT03110224|521366415|FG000|Overall Study|Site Closed by Physician|35|||
144591891|NCT03110224|521366415|FG000|Overall Study|Site Closed by Sponsor|202|||
144591892|NCT03110224|521366415|FG000|Overall Study|Withdrawal by Subject|9|||
144591893|NCT05328167|521366416|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
144591894|NCT05328167|521366416|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
144591895|NCT00112047|521366417|FG000|Randomized Phase|Lost to Follow-up|26|||
144591896|NCT00112047|521366418|FG001|Randomized Phase|Lost to Follow-up|33|||
144591897|NCT00112047|521366417|FG000|Randomized Phase|Adverse Event|10|||
144591898|NCT00112047|521366418|FG001|Randomized Phase|Adverse Event|10|||
144591899|NCT00112047|521366417|FG000|Randomized Phase|Withrawal of consent|10|||
144591900|NCT00112047|521366418|FG001|Randomized Phase|Withrawal of consent|18|||
144591901|NCT00112047|521366417|FG000|Randomized Phase|Sub-optimal virological response|3|||
144591902|NCT00112047|521366418|FG001|Randomized Phase|Sub-optimal virological response|13|||
144591903|NCT00112047|521366417|FG000|Randomized Phase|Noncompliance|8|||
144591904|NCT00112047|521366418|FG001|Randomized Phase|Noncompliance|4|||
144591905|NCT00112047|521366417|FG000|Randomized Phase|Protocol Violation|2|||
144591906|NCT00112047|521366418|FG001|Randomized Phase|Protocol Violation|0|||
144591907|NCT00112047|521366417|FG000|Randomized Phase|Pregnancy|3|||
144591908|NCT00112047|521366418|FG001|Randomized Phase|Pregnancy|1|||
144591909|NCT00112047|521366417|FG000|Randomized Phase|Death|1|||
144591910|NCT00112047|521366418|FG001|Randomized Phase|Death|3|||
144591911|NCT00112047|521366417|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
144591912|NCT00112047|521366418|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
144591913|NCT00112047|521366417|FG000|Randomized Phase|Inability to swallow pills|0|||
144591914|NCT00112047|521366418|FG001|Randomized Phase|Inability to swallow pills|1|||
144591915|NCT00112047|521366417|FG000|Randomized Phase|Incarceration|3|||
144591916|NCT00112047|521366418|FG001|Randomized Phase|Incarceration|2|||
144591917|NCT00112047|521366417|FG000|Randomized Phase|Moved out of State|0|||
144514338|NCT03215030|521082141|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
144514339|NCT03215030|521082142|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
144514340|NCT03215030|521082143|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
144514341|NCT03215030|521082144|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
144514342|NCT03215030|521082145|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
144514343|NCT03215030|521082146|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
144514344|NCT03215030|521082147|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
144514345|NCT03215030|521082148|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
144514346|NCT03215030|521082137|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514347|NCT03215030|521082138|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514348|NCT03215030|521082139|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514349|NCT03215030|521082140|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514350|NCT03215030|521082141|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514351|NCT03215030|521082142|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514352|NCT03215030|521082143|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514353|NCT03215030|521082144|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514354|NCT03215030|521082145|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514355|NCT03215030|521082146|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
144514356|NCT03215030|521082147|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
144514357|NCT03215030|521082148|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
144514358|NCT03433339|521082149|FG000|Overall Study|Lost to Follow-up|2|||
144514359|NCT03433339|521082150|FG001|Overall Study|Lost to Follow-up|0|||
144514360|NCT03433339|521082149|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
144514361|NCT03433339|521082150|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
144514362|NCT03433339|521082149|FG000|Overall Study|Withdrawal by Subject|0|||
144514363|NCT03433339|521082150|FG001|Overall Study|Withdrawal by Subject|2|||
144514364|NCT06629454|521082159|FG000|Overall Study|Withdraw by Clinician Decision|1|||
144514365|NCT05136404|521082160|FG000|Period 1|Adverse Event|0|||
144514366|NCT05136404|521082161|FG001|Period 1|Adverse Event|1|||
144514367|NCT05136404|521082162|FG002|Period 1|Adverse Event|1|||
144514368|NCT05136404|521082160|FG000|Period 2|Inappropriate Behavior|0|||
144514369|NCT05136404|521082161|FG001|Period 2|Inappropriate Behavior|0|||
144514370|NCT05136404|521082162|FG002|Period 2|Inappropriate Behavior|1|||
144514371|NCT05136404|521082160|FG000|Period 3|Adverse Event|0|||
144514372|NCT05136404|521082161|FG001|Period 3|Adverse Event|0|||
144514373|NCT05136404|521082162|FG002|Period 3|Adverse Event|1|||
144514374|NCT03584516|521082163|FG000|Part 1|Death|2|||
144514375|NCT03584516|521082164|FG001|Part 1|Death|3|||
144514376|NCT03584516|521082165|FG002|Part 1|Death|0|||
144514377|NCT03584516|521082166|FG003|Part 1|Death|0|||
144514378|NCT03584516|521082167|FG004|Part 1|Death|0|||
144514379|NCT03584516|521082168|FG005|Part 1|Death|0|||
144514380|NCT03584516|521082163|FG000|Part 1|Withdrawal by Subject|2|||
144514381|NCT03584516|521082164|FG001|Part 1|Withdrawal by Subject|0|||
144514382|NCT03584516|521082165|FG002|Part 1|Withdrawal by Subject|0|||
144514383|NCT03584516|521082166|FG003|Part 1|Withdrawal by Subject|0|||
144514384|NCT03584516|521082167|FG004|Part 1|Withdrawal by Subject|0|||
144514385|NCT03584516|521082168|FG005|Part 1|Withdrawal by Subject|0|||
144514386|NCT03584516|521082163|FG000|Part 1|Lost to Follow-up|1|||
144514387|NCT03584516|521082164|FG001|Part 1|Lost to Follow-up|0|||
144514388|NCT03584516|521082165|FG002|Part 1|Lost to Follow-up|0|||
144514389|NCT03584516|521082166|FG003|Part 1|Lost to Follow-up|0|||
144514390|NCT03584516|521082167|FG004|Part 1|Lost to Follow-up|0|||
144514391|NCT03584516|521082168|FG005|Part 1|Lost to Follow-up|0|||
144514392|NCT03584516|521082163|FG000|Part 1|Study Terminated by Sponsor|0|||
144514393|NCT03584516|521082164|FG001|Part 1|Study Terminated by Sponsor|2|||
144514394|NCT03584516|521082165|FG002|Part 1|Study Terminated by Sponsor|0|||
144514395|NCT03584516|521082166|FG003|Part 1|Study Terminated by Sponsor|0|||
144514396|NCT03584516|521082167|FG004|Part 1|Study Terminated by Sponsor|0|||
144514397|NCT03584516|521082168|FG005|Part 1|Study Terminated by Sponsor|0|||
144514398|NCT03584516|521082163|FG000|Part 1 Expansion|Death|0|||
144514399|NCT03584516|521082164|FG001|Part 1 Expansion|Death|0|||
144514400|NCT03584516|521082165|FG002|Part 1 Expansion|Death|9|||
144514401|NCT03584516|521082166|FG003|Part 1 Expansion|Death|8|||
144514402|NCT03584516|521082167|FG004|Part 1 Expansion|Death|4|||
144514403|NCT03584516|521082168|FG005|Part 1 Expansion|Death|5|||
144514404|NCT03584516|521082163|FG000|Part 1 Expansion|Lost to Follow-up|0|||
144514405|NCT03584516|521082164|FG001|Part 1 Expansion|Lost to Follow-up|0|||
144514406|NCT03584516|521082165|FG002|Part 1 Expansion|Lost to Follow-up|0|||
144514407|NCT03584516|521082166|FG003|Part 1 Expansion|Lost to Follow-up|1|||
144514408|NCT03584516|521082167|FG004|Part 1 Expansion|Lost to Follow-up|0|||
144514409|NCT03584516|521082168|FG005|Part 1 Expansion|Lost to Follow-up|0|||
144514410|NCT03584516|521082163|FG000|Part 1 Expansion|Physician Decision|0|||
144514411|NCT03584516|521082164|FG001|Part 1 Expansion|Physician Decision|0|||
144514412|NCT03584516|521082165|FG002|Part 1 Expansion|Physician Decision|4|||
144591918|NCT00112047|521366418|FG001|Randomized Phase|Moved out of State|1|||
144591919|NCT00112047|521366417|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
144591920|NCT00112047|521366418|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
144591921|NCT00112047|521366417|FG000|Randomized Phase|High Hepatitis B DNA|0|||
144591922|NCT00112047|521366418|FG001|Randomized Phase|High Hepatitis B DNA|1|||
144591923|NCT00112047|521366417|FG000|Atripla Phase|Adverse Event|2|||
144591924|NCT00112047|521366418|FG001|Atripla Phase|Adverse Event|1|||
144591925|NCT00112047|521366417|FG000|Atripla Phase|Lost to Follow-up|5|||
144591926|NCT00112047|521366418|FG001|Atripla Phase|Lost to Follow-up|7|||
144591927|NCT00112047|521366417|FG000|Atripla Phase|Pregnancy|0|||
144591928|NCT00112047|521366418|FG001|Atripla Phase|Pregnancy|1|||
144591929|NCT00112047|521366417|FG000|Atripla Phase|Death|0|||
144591930|NCT00112047|521366418|FG001|Atripla Phase|Death|2|||
144591931|NCT00112047|521366417|FG000|Atripla Phase|Withdrew consent|7|||
144591932|NCT00112047|521366418|FG001|Atripla Phase|Withdrew consent|7|||
144591933|NCT00112047|521366417|FG000|Atripla Phase|Sub-optimal virological response|0|||
144591934|NCT00112047|521366418|FG001|Atripla Phase|Sub-optimal virological response|1|||
144591935|NCT00112047|521366417|FG000|Atripla Phase|Non-compliance|1|||
144591936|NCT00112047|521366418|FG001|Atripla Phase|Non-compliance|0|||
144591937|NCT00112047|521366417|FG000|Atripla Phase|Other|3|||
144591938|NCT00112047|521366418|FG001|Atripla Phase|Other|1|||
144591939|NCT01307579|521366419|FG000|Overall Study|Death|3|||
144591940|NCT01307579|521366420|FG001|Overall Study|Death|6|||
144591941|NCT01307579|521366419|FG000|Overall Study|Physician Decision|26|||
144591942|NCT01307579|521366420|FG001|Overall Study|Physician Decision|29|||
144591943|NCT01307579|521366419|FG000|Overall Study|Withdrawal by Subject|7|||
144591944|NCT01307579|521366420|FG001|Overall Study|Withdrawal by Subject|3|||
144591945|NCT01307579|521366419|FG000|Overall Study|Institutional diagnosis of IFD|21|||
144591946|NCT01307579|521366420|FG001|Overall Study|Institutional diagnosis of IFD|36|||
144591947|NCT01307579|521366419|FG000|Overall Study|Begin conditioning for HSCT|42|||
144591948|NCT01307579|521366420|FG001|Overall Study|Begin conditioning for HSCT|44|||
144591949|NCT01307579|521366419|FG000|Overall Study|Refractory or relapsed AML|38|||
144591950|NCT01307579|521366420|FG001|Overall Study|Refractory or relapsed AML|23|||
144591951|NCT01307579|521366419|FG000|Overall Study|Ineligible|3|||
144591952|NCT01307579|521366420|FG001|Overall Study|Ineligible|4|||
144591953|NCT03727438|521366421|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
144591954|NCT03727438|521366422|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
144591955|NCT03727438|521366421|FG000|Intervention Period|Excluded (health)|1|||
144591956|NCT03727438|521366422|FG001|Intervention Period|Excluded (health)|0|||
144591957|NCT03727438|521366421|FG000|Intervention Period|Withdrawal by Subject|3|||
144591958|NCT03727438|521366422|FG001|Intervention Period|Withdrawal by Subject|1|||
144591959|NCT03727438|521366421|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
144591960|NCT03727438|521366422|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
144591961|NCT03727438|521366421|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
144591962|NCT03727438|521366422|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
144591963|NCT03727438|521366421|FG000|8 Week Assessment|Withdrawal by Subject|6|||
144591964|NCT03727438|521366422|FG001|8 Week Assessment|Withdrawal by Subject|1|||
144591965|NCT03727438|521366421|FG000|6 mo Assessment|did not complete assessment|10|||
144591966|NCT03727438|521366422|FG001|6 mo Assessment|did not complete assessment|11|||
144591967|NCT01328717|521368442|FG000|Overall Study|Adverse Event|1|||
144591968|NCT00031551|521368443|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
144591969|NCT00031551|521368444|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
144591970|NCT01177722|521368447|FG000|Overall Study|Serious Adverse Event|0|||
144591971|NCT01177722|521368448|FG001|Overall Study|Serious Adverse Event|0|||
144591972|NCT01177722|521368449|FG002|Overall Study|Serious Adverse Event|1|||
144591973|NCT01177722|521368450|FG003|Overall Study|Serious Adverse Event|0|||
144591974|NCT01177722|521368447|FG000|Overall Study|Protocol Violation|0|||
144591975|NCT01177722|521368448|FG001|Overall Study|Protocol Violation|0|||
144591976|NCT01177722|521368449|FG002|Overall Study|Protocol Violation|1|||
144591977|NCT01177722|521368450|FG003|Overall Study|Protocol Violation|0|||
144591978|NCT01177722|521368447|FG000|Overall Study|Lost to Follow-up|3|||
144591979|NCT01177722|521368448|FG001|Overall Study|Lost to Follow-up|4|||
144591980|NCT01177722|521368449|FG002|Overall Study|Lost to Follow-up|3|||
144591981|NCT01177722|521368450|FG003|Overall Study|Lost to Follow-up|1|||
144591982|NCT01177722|521368447|FG000|Overall Study|Withdrawal by Subject|10|||
144591983|NCT01177722|521368448|FG001|Overall Study|Withdrawal by Subject|6|||
144591984|NCT01177722|521368449|FG002|Overall Study|Withdrawal by Subject|4|||
144591985|NCT01177722|521368450|FG003|Overall Study|Withdrawal by Subject|6|||
144591986|NCT00953407|521368453|FG000|Overall Study|Failed inclusion criteria|1|||
144591987|NCT00953407|521368454|FG001|Overall Study|Failed inclusion criteria|1|||
144591988|NCT00953407|521368455|FG002|Overall Study|Failed inclusion criteria|1|||
144591989|NCT00953407|521368456|FG003|Overall Study|Failed inclusion criteria|1|||
144591990|NCT00953407|521368457|FG004|Overall Study|Failed inclusion criteria|1|||
144591991|NCT00953407|521368453|FG000|Overall Study|Lost to Follow-up|0|||
144591992|NCT00953407|521368454|FG001|Overall Study|Lost to Follow-up|0|||
144591993|NCT00953407|521368455|FG002|Overall Study|Lost to Follow-up|0|||
144591994|NCT00953407|521368456|FG003|Overall Study|Lost to Follow-up|1|||
144591995|NCT00953407|521368457|FG004|Overall Study|Lost to Follow-up|0|||
144591996|NCT01201317|521368458|FG000|Overall Study|Withdrawal by Subject|5|||
144591997|NCT01201317|521368459|FG001|Overall Study|Withdrawal by Subject|0|||
144591998|NCT01201317|521368460|FG002|Overall Study|Withdrawal by Subject|3|||
144591999|NCT01201317|521368458|FG000|Overall Study|Adverse Event|2|||
144592000|NCT01201317|521368459|FG001|Overall Study|Adverse Event|2|||
144592001|NCT01201317|521368460|FG002|Overall Study|Adverse Event|2|||
144592002|NCT01201317|521368458|FG000|Overall Study|Screen failure|1|||
144592003|NCT01201317|521368459|FG001|Overall Study|Screen failure|1|||
144592004|NCT01201317|521368460|FG002|Overall Study|Screen failure|0|||
144592005|NCT01201317|521368458|FG000|Overall Study|Protocol Violation|0|||
144592006|NCT01201317|521368459|FG001|Overall Study|Protocol Violation|1|||
144592007|NCT01201317|521368460|FG002|Overall Study|Protocol Violation|1|||
144592008|NCT01201317|521368458|FG000|Overall Study|Death|0|||
144592009|NCT01201317|521368459|FG001|Overall Study|Death|1|||
144592010|NCT01201317|521368460|FG002|Overall Study|Death|0|||
144592011|NCT01201317|521368458|FG000|Overall Study|Study-specific withdrawal criteria|0|||
144592012|NCT01201317|521368459|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144592013|NCT01201317|521368460|FG002|Overall Study|Study-specific withdrawal criteria|1|||
144592014|NCT01201317|521368458|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
144592015|NCT01201317|521368459|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
144721913|NCT04828161|521836866|FG003|Overall Study|Death|2|||
144721914|NCT02352337|521836867|FG000|Overall Study|Patients never treated|4|||
144380930|NCT00750152|520604554|FG001|Overall Study|Termination by sponsor|0|||
144592016|NCT01201317|521368460|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
144592017|NCT01201317|521368458|FG000|Overall Study|Decrease in renal function|0|||
144380931|NCT00750152|520604553|FG000|Overall Study|Other|7|||
144380932|NCT00750152|520604554|FG001|Overall Study|Other|8|||
144380933|NCT00715910|520604555|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
144380934|NCT00715910|520604556|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
144514413|NCT03584516|521082166|FG003|Part 1 Expansion|Physician Decision|3|||
144514414|NCT03584516|521082167|FG004|Part 1 Expansion|Physician Decision|2|||
144592018|NCT01201317|521368459|FG001|Overall Study|Decrease in renal function|1|||
144592019|NCT01201317|521368460|FG002|Overall Study|Decrease in renal function|0|||
144592020|NCT01201317|521368458|FG000|Overall Study|Lack of Efficacy|1|||
144592021|NCT01201317|521368459|FG001|Overall Study|Lack of Efficacy|0|||
144592022|NCT01201317|521368460|FG002|Overall Study|Lack of Efficacy|0|||
144592023|NCT01201317|521368458|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
144592024|NCT01201317|521368459|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
144592025|NCT01201317|521368460|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
144592026|NCT02563522|521368462|FG000|Overall Study|Adverse Event|2|||
144592027|NCT02563522|521368463|FG001|Overall Study|Adverse Event|3|||
144592028|NCT02563522|521368462|FG000|Overall Study|Lost to Follow-up|1|||
144592029|NCT02563522|521368463|FG001|Overall Study|Lost to Follow-up|0|||
144592030|NCT02563522|521368462|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
144592031|NCT02563522|521368463|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
144592032|NCT00918580|521368464|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
144592033|NCT00918580|521368464|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
144592034|NCT00918580|521368464|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
144592035|NCT00918580|521368464|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
144592036|NCT00918580|521368464|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
144592037|NCT00918580|521368464|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
144592038|NCT00918580|521368464|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
144592039|NCT03486457|521368465|FG000|Up to Month 3|Adverse Event|2|||
144592040|NCT03486457|521368466|FG001|Up to Month 3|Adverse Event|5|||
144592041|NCT03486457|521368465|FG000|Up to Month 3|Lack of Efficacy|1|||
144592042|NCT03486457|521368466|FG001|Up to Month 3|Lack of Efficacy|0|||
144592043|NCT03486457|521368465|FG000|Up to Month 3|Withdrawal by Subject|1|||
144592044|NCT03486457|521368466|FG001|Up to Month 3|Withdrawal by Subject|0|||
144592045|NCT03486457|521368465|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
144592046|NCT03486457|521368466|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
144592047|NCT03486457|521368465|FG000|Up to Month 3|Other|1|||
144592048|NCT03486457|521368466|FG001|Up to Month 3|Other|0|||
144592049|NCT03486457|521368465|FG000|Month 3 to Month 6|Adverse Event|2|||
144592050|NCT03486457|521368466|FG001|Month 3 to Month 6|Adverse Event|0|||
144592051|NCT03486457|521368465|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
144592052|NCT03486457|521368466|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
144592053|NCT03486457|521368465|FG000|Month 3 to Month 6|Pregnancy|0|||
144592054|NCT03486457|521368466|FG001|Month 3 to Month 6|Pregnancy|1|||
144592055|NCT03486457|521368465|FG000|Month 3 to Month 6|Other|1|||
144380935|NCT00715910|520604557|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
144592056|NCT03486457|521368466|FG001|Month 3 to Month 6|Other|0|||
144592057|NCT00946101|521368467|FG000|Overall Study|Lost to Follow-up|2|||
144592058|NCT00946101|521368468|FG001|Overall Study|Lost to Follow-up|1|||
144592059|NCT00946101|521368467|FG000|Overall Study|Withdrawal of consent|2|||
144592060|NCT00946101|521368468|FG001|Overall Study|Withdrawal of consent|0|||
144592061|NCT00946101|521368467|FG000|Overall Study|Physician Decision|0|||
144592062|NCT00946101|521368468|FG001|Overall Study|Physician Decision|1|||
144592063|NCT01347762|521368469|FG000|Overall Study|Lost to Follow-up|0|||
144592064|NCT01347762|521368470|FG001|Overall Study|Lost to Follow-up|1|||
144592065|NCT01347762|521368471|FG002|Overall Study|Lost to Follow-up|6|||
144592066|NCT01347762|521368472|FG003|Overall Study|Lost to Follow-up|5|||
144592067|NCT01347762|521368469|FG000|Overall Study|Withdrawal by Subject|4|||
144592068|NCT01347762|521368470|FG001|Overall Study|Withdrawal by Subject|1|||
144592069|NCT01347762|521368471|FG002|Overall Study|Withdrawal by Subject|3|||
144592070|NCT01347762|521368472|FG003|Overall Study|Withdrawal by Subject|3|||
144592071|NCT00093808|521368473|FG000|Overall Study|Cancel participation before receiving tx|1|||
144592072|NCT00093808|521368473|FG000|Overall Study|Protocol Violation|1|||
144592073|NCT00701220|521368474|FG000|Overall Study|Withdrawal by Subject|0|||
144592074|NCT00701220|521368475|FG001|Overall Study|Withdrawal by Subject|2|||
144592075|NCT00701220|521368474|FG000|Overall Study|Protocol Violation|2|||
144592076|NCT00701220|521368475|FG001|Overall Study|Protocol Violation|0|||
144592077|NCT03235284|521368476|FG000|Overall Study|Adverse Event|1|||
144592078|NCT03235284|521368477|FG001|Overall Study|Adverse Event|2|||
144592079|NCT03235284|521368478|FG002|Overall Study|Adverse Event|1|||
144592080|NCT00310037|521368479|FG000|Overall Study|Adverse Event|7|||
144592081|NCT00310037|521368480|FG001|Overall Study|Adverse Event|14|||
144592082|NCT00310037|521368479|FG000|Overall Study|Withdrawal by Subject|4|||
144592083|NCT00310037|521368480|FG001|Overall Study|Withdrawal by Subject|3|||
144592084|NCT00310037|521368479|FG000|Overall Study|Progression|6|||
144592085|NCT00310037|521368480|FG001|Overall Study|Progression|0|||
144592086|NCT00310037|521368479|FG000|Overall Study|Non-protocol treatment|1|||
144592087|NCT00310037|521368480|FG001|Overall Study|Non-protocol treatment|0|||
144592088|NCT01382706|521368493|FG000|Overall Study|Adverse Event|1|||
144592089|NCT01382706|521368493|FG000|Overall Study|Withdrawal by Subject|1|||
144592090|NCT05559099|521368494|FG000|Overall Study|Death|5|||
144592091|NCT05559099|521368495|FG001|Overall Study|Death|4|||
144592092|NCT05559099|521368494|FG000|Overall Study|Lost to Follow-up|0|||
144592093|NCT05559099|521368495|FG001|Overall Study|Lost to Follow-up|2|||
144380936|NCT00715910|520604558|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
144380937|NCT00715910|520604559|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
144592094|NCT05559099|521368494|FG000|Overall Study|Adverse Event|1|||
144592095|NCT05559099|521368495|FG001|Overall Study|Adverse Event|1|||
144592096|NCT04018092|521368496|FG000|Overall Study|Withdrawal by Subject|1|||
144592097|NCT04018092|521368497|FG001|Overall Study|Withdrawal by Subject|1|||
144592098|NCT04018092|521368496|FG000|Overall Study|Withdrawal by Subject|1|||
144592099|NCT04018092|521368497|FG001|Overall Study|Withdrawal by Subject|1|||
144592100|NCT04055090|521368498|FG000|Overall Study|screen failure|1|||
144592101|NCT04055090|521368499|FG001|Overall Study|screen failure|0|||
144592102|NCT04055090|521368498|FG000|Overall Study|Withdrawal by Subject|1|||
144592103|NCT04055090|521368499|FG001|Overall Study|Withdrawal by Subject|0|||
144380938|NCT00715910|520604560|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
144592104|NCT04426851|521368502|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
144592105|NCT04426851|521368503|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
144592106|NCT04426851|521368502|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
144592107|NCT04426851|521368503|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
144592108|NCT03256851|521368504|FG000|Overall Study|Withdrawal by Subject|1|||
144592109|NCT03256851|521368505|FG001|Overall Study|Withdrawal by Subject|0|||
144592110|NCT02476279|521368510|FG000|Overall Study|Lost to Follow-up|1|||
144380939|NCT00715910|520604555|FG000|Booster and ESFU Phase|Other|0|||
144592111|NCT02476279|521368511|FG001|Overall Study|Lost to Follow-up|1|||
144592112|NCT02208999|521368513|FG000|Overall Study|Lost to Follow-up|1|||
144592113|NCT00319839|521368514|FG000|Overall Study|Adverse Event|5|||
144592114|NCT00319839|521368514|FG000|Overall Study|Withdrawal by Subject|1|||
144592115|NCT04494256|521368515|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
144592116|NCT04494256|521368516|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
144380940|NCT00715910|520604556|FG001|Booster and ESFU Phase|Other|0|||
144380941|NCT00715910|520604557|FG002|Booster and ESFU Phase|Other|0|||
144380942|NCT00715910|520604558|FG003|Booster and ESFU Phase|Other|5|||
144380943|NCT00715910|520604559|FG004|Booster and ESFU Phase|Other|1|||
144380944|NCT00715910|520604560|FG005|Booster and ESFU Phase|Other|0|||
144380945|NCT01030666|520604561|FG000|Overall Study|Lost to Follow-up|3|||
144514415|NCT03584516|521082168|FG005|Part 1 Expansion|Physician Decision|3|||
144514416|NCT03584516|521082163|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
144514417|NCT03584516|521082164|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
144514418|NCT03584516|521082165|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
144514419|NCT03584516|521082166|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
144514420|NCT03584516|521082167|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
144514421|NCT03584516|521082168|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
144514422|NCT03584516|521082163|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
144514423|NCT03584516|521082164|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
144514424|NCT03584516|521082165|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
144514425|NCT03584516|521082166|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
144514426|NCT03584516|521082167|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
144514427|NCT03584516|521082168|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
144514428|NCT03584516|521082163|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
144514429|NCT03584516|521082164|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
144514430|NCT03584516|521082165|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
144514431|NCT03584516|521082166|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
144514432|NCT03584516|521082167|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
144514433|NCT03584516|521082168|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
144514434|NCT03584516|521082163|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
144514435|NCT03584516|521082164|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
144514436|NCT03584516|521082165|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
144514437|NCT03584516|521082166|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
144514438|NCT03584516|521082167|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
144514439|NCT03584516|521082168|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
144514440|NCT05986565|521082169|FG000|Overall Study|Lost to Follow-up|8|||
144514441|NCT05986565|521082170|FG001|Overall Study|Lost to Follow-up|3|||
144514442|NCT05986565|521082169|FG000|Overall Study|Withdrawal by Subject|0|||
144514443|NCT05986565|521082170|FG001|Overall Study|Withdrawal by Subject|1|||
144514444|NCT00670046|521082173|FG000|Overall Study|Lost to Follow-up|1|||
144514445|NCT00670046|521082174|FG001|Overall Study|Lost to Follow-up|1|||
144721915|NCT02352337|521836868|FG001|Overall Study|Patients never treated|1|||
144380946|NCT01030666|520604562|FG001|Overall Study|Lost to Follow-up|2|||
144380947|NCT04002908|520604565|FG000|Overall Study|Death|41|||
144380948|NCT04002908|520604566|FG001|Overall Study|Death|0|||
144380949|NCT04002908|520604567|FG002|Overall Study|Death|0|||
144514446|NCT00670046|521082173|FG000|Overall Study|Withdrawal by Subject|0|||
144514447|NCT00670046|521082174|FG001|Overall Study|Withdrawal by Subject|1|||
144514448|NCT00505934|521082183|FG000|Overall Study|Adverse Event|1|||
144514449|NCT00505934|521082183|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
144514450|NCT00505934|521082183|FG000|Overall Study|Other: IV dose needed to be changed|1|||
144514451|NCT02461628|521082186|FG000|Overall Study|Refused to complete survey|4|||
144514452|NCT02461628|521082187|FG001|Overall Study|Refused to complete survey|7|||
144514453|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
144514454|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
144514455|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
144514456|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
144514457|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
144514458|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
144514459|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
144514460|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
144514461|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
144514462|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
144514463|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
144514464|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
144514465|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
144514466|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
144514467|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
144514468|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
144514469|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
144514470|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
144514471|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
144514472|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
144514473|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
144514474|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
144514475|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
144514476|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
144514477|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
144514478|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
144514479|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
144514480|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
144514481|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
144514482|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
144514483|NCT04759833|521082188|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
144514484|NCT04759833|521082189|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
144514485|NCT04759833|521082190|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
144514486|NCT04759833|521082191|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
144514487|NCT04759833|521082192|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
144514488|NCT04759833|521082188|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
144514489|NCT04759833|521082189|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
144514490|NCT04759833|521082190|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
144514491|NCT04759833|521082191|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
144514492|NCT04759833|521082192|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
144514493|NCT04759833|521082188|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
144514494|NCT04759833|521082189|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
144514495|NCT04759833|521082190|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
144514496|NCT04759833|521082191|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
144514497|NCT04759833|521082192|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
144514498|NCT04759833|521082188|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
144514499|NCT04759833|521082189|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
144514500|NCT04759833|521082190|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
144514501|NCT04759833|521082191|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
144514502|NCT04759833|521082192|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
144514503|NCT04759833|521082188|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
144514504|NCT04759833|521082189|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
144514505|NCT04759833|521082190|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
144514506|NCT04759833|521082191|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
144514507|NCT04759833|521082192|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
144514508|NCT04759833|521082188|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
144514509|NCT04759833|521082189|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
144514510|NCT04759833|521082190|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
144514511|NCT04759833|521082191|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
144514512|NCT04759833|521082192|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
144592117|NCT04494256|521368517|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
144592118|NCT04494256|521368518|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
144592119|NCT04494256|521368519|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
144592120|NCT04494256|521368520|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
144592121|NCT04494256|521368521|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
144592122|NCT04494256|521368515|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
144592123|NCT04494256|521368516|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
144592124|NCT04494256|521368517|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
144592125|NCT04494256|521368518|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
144592126|NCT04494256|521368519|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
144592127|NCT04494256|521368520|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
144592128|NCT04494256|521368521|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
144380950|NCT04002908|520604568|FG003|Overall Study|Death|0|||
144380951|NCT04002908|520604565|FG000|Overall Study|Withdrawal by Subject|112|||
144380952|NCT04002908|520604566|FG001|Overall Study|Withdrawal by Subject|0|||
144592129|NCT04494256|521368515|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
144721916|NCT02352337|521836869|FG002|Overall Study|Patients never treated|2|||
144721917|NCT02458638|521836870|FG000|Overall Study|Death|309|||
144380953|NCT04002908|520604567|FG002|Overall Study|Withdrawal by Subject|0|||
144380954|NCT04002908|520604568|FG003|Overall Study|Withdrawal by Subject|0|||
144380955|NCT04002908|520604565|FG000|Overall Study|Lost to Follow-up|72|||
144380956|NCT04002908|520604566|FG001|Overall Study|Lost to Follow-up|0|||
144380957|NCT04002908|520604567|FG002|Overall Study|Lost to Follow-up|0|||
144380958|NCT04002908|520604568|FG003|Overall Study|Lost to Follow-up|0|||
144380959|NCT04002908|520604565|FG000|Overall Study|Infant died, so mother withdrawn|34|||
144380960|NCT04002908|520604566|FG001|Overall Study|Infant died, so mother withdrawn|0|||
144380961|NCT04002908|520604567|FG002|Overall Study|Infant died, so mother withdrawn|0|||
144380962|NCT04002908|520604568|FG003|Overall Study|Infant died, so mother withdrawn|0|||
144380963|NCT03698591|520604569|FG000|Overall Study|Withdrawal by Subject|2|||
144380964|NCT03698591|520604570|FG001|Overall Study|Withdrawal by Subject|2|||
144514513|NCT04759833|521082188|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
144380965|NCT03698591|520604569|FG000|Overall Study|Failed drug screen|1|||
144380966|NCT03698591|520604570|FG001|Overall Study|Failed drug screen|1|||
144380967|NCT03698591|520604569|FG000|Overall Study|Failed health screen|0|||
144592130|NCT04494256|521368516|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
144592131|NCT04494256|521368517|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
144592132|NCT04494256|521368518|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
144592133|NCT04494256|521368519|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
144592134|NCT04494256|521368520|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
144592135|NCT04494256|521368521|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
144592136|NCT04494256|521368515|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592137|NCT04494256|521368516|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592138|NCT04494256|521368517|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592139|NCT04494256|521368518|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
144592140|NCT04494256|521368519|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
144592141|NCT04494256|521368520|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592142|NCT04494256|521368521|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592143|NCT04494256|521368515|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
144592144|NCT04494256|521368516|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
144592145|NCT04494256|521368517|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
144592146|NCT04494256|521368518|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
144592147|NCT04494256|521368519|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
144592148|NCT04494256|521368520|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
144592149|NCT04494256|521368521|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
144592150|NCT04494256|521368515|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
144592151|NCT04494256|521368516|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
144592152|NCT04494256|521368517|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
144592153|NCT04494256|521368518|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
144592154|NCT04494256|521368519|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
144592155|NCT04494256|521368520|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
144592156|NCT04494256|521368521|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
144592157|NCT04494256|521368515|FG000|Part 2: Open Label Period|Death|0|||
144592158|NCT04494256|521368516|FG001|Part 2: Open Label Period|Death|0|||
144592159|NCT04494256|521368517|FG002|Part 2: Open Label Period|Death|0|||
144592160|NCT04494256|521368518|FG003|Part 2: Open Label Period|Death|0|||
144592161|NCT04494256|521368519|FG004|Part 2: Open Label Period|Death|0|||
144592162|NCT04494256|521368520|FG005|Part 2: Open Label Period|Death|4|||
144592163|NCT04494256|521368521|FG006|Part 2: Open Label Period|Death|2|||
144592164|NCT04494256|521368515|FG000|Part 2: Open Label Period|Adverse Event|0|||
144592165|NCT04494256|521368516|FG001|Part 2: Open Label Period|Adverse Event|0|||
144592166|NCT04494256|521368517|FG002|Part 2: Open Label Period|Adverse Event|0|||
144592167|NCT04494256|521368518|FG003|Part 2: Open Label Period|Adverse Event|0|||
144592168|NCT04494256|521368519|FG004|Part 2: Open Label Period|Adverse Event|0|||
144592169|NCT04494256|521368520|FG005|Part 2: Open Label Period|Adverse Event|0|||
144592170|NCT04494256|521368521|FG006|Part 2: Open Label Period|Adverse Event|2|||
144592171|NCT04494256|521368515|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
144592172|NCT04494256|521368516|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
144592173|NCT04494256|521368517|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
144592174|NCT04494256|521368518|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
144592175|NCT04494256|521368519|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
144592176|NCT04494256|521368520|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
144592177|NCT04494256|521368521|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
144592178|NCT04494256|521368515|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
144592179|NCT04494256|521368516|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
144592180|NCT04494256|521368517|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
144592181|NCT04494256|521368518|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
144592182|NCT04494256|521368519|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
144592183|NCT04494256|521368520|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
144721918|NCT02458638|521836870|FG000|Overall Study|End of Cohort/End of Study|67|||
144514514|NCT04759833|521082189|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
144514515|NCT04759833|521082190|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
144514516|NCT04759833|521082191|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
144514517|NCT04759833|521082192|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
144514518|NCT03446157|521082193|FG000|Overall Study|Death|11|||
144514519|NCT03446157|521082194|FG001|Overall Study|Death|9|||
144514520|NCT03446157|521082193|FG000|Overall Study|Lost to Follow-up|0|||
144514521|NCT03446157|521082194|FG001|Overall Study|Lost to Follow-up|1|||
144514522|NCT03446157|521082193|FG000|Overall Study|Withdrawal by Subject|2|||
144514523|NCT03446157|521082194|FG001|Overall Study|Withdrawal by Subject|1|||
144514524|NCT02386553|521082195|FG000|Overall Study|Reason Not Specified|1|||
144514525|NCT02386553|521082196|FG001|Overall Study|Reason Not Specified|1|||
144514526|NCT02386553|521082195|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
144514527|NCT02386553|521082196|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
144514528|NCT00998881|521082200|FG000|Overall Study|Adverse Event|2|||
144514529|NCT00998881|521082201|FG001|Overall Study|Adverse Event|2|||
144514530|NCT00998881|521082200|FG000|Overall Study|Lack of Efficacy|1|||
144514531|NCT00998881|521082201|FG001|Overall Study|Lack of Efficacy|0|||
144514532|NCT00998881|521082200|FG000|Overall Study|Physician Decision|3|||
144514533|NCT00998881|521082201|FG001|Overall Study|Physician Decision|0|||
144514534|NCT00998881|521082200|FG000|Overall Study|Withdrawal by Subject|1|||
144514535|NCT00998881|521082201|FG001|Overall Study|Withdrawal by Subject|0|||
144514536|NCT00998881|521082200|FG000|Overall Study|Personal matter|1|||
144514537|NCT00998881|521082201|FG001|Overall Study|Personal matter|0|||
144514538|NCT02740231|521082202|FG000|Overall Study|Withdrawal by Subject|1|||
144514539|NCT02740231|521082203|FG001|Overall Study|Withdrawal by Subject|1|||
144514540|NCT02740231|521082204|FG002|Overall Study|Withdrawal by Subject|1|||
144514541|NCT02740231|521082205|FG003|Overall Study|Withdrawal by Subject|0|||
144514542|NCT02740231|521082202|FG000|Overall Study|Lack of Efficacy|0|||
144514543|NCT02740231|521082203|FG001|Overall Study|Lack of Efficacy|1|||
144514544|NCT02740231|521082204|FG002|Overall Study|Lack of Efficacy|0|||
144514545|NCT02740231|521082205|FG003|Overall Study|Lack of Efficacy|4|||
144514546|NCT02740231|521082202|FG000|Overall Study|Lost to Follow-up|1|||
144514547|NCT02740231|521082203|FG001|Overall Study|Lost to Follow-up|3|||
144514548|NCT02740231|521082204|FG002|Overall Study|Lost to Follow-up|0|||
144514549|NCT02740231|521082205|FG003|Overall Study|Lost to Follow-up|3|||
144514550|NCT02740231|521082202|FG000|Overall Study|Adverse Event|0|||
144514551|NCT02740231|521082203|FG001|Overall Study|Adverse Event|1|||
144514552|NCT02740231|521082204|FG002|Overall Study|Adverse Event|0|||
144514553|NCT02740231|521082205|FG003|Overall Study|Adverse Event|1|||
144514554|NCT02462759|521082206|FG000|Part 1: Double Blind|Death|1|||
144514555|NCT02462759|521082207|FG001|Part 1: Double Blind|Death|0|||
144514556|NCT02462759|521082208|FG002|Part 1: Double Blind|Death|0|||
144514557|NCT00632203|521082209|FG000|Overall Study|Did not start study treatment|1|||
144514558|NCT00632203|521082210|FG001|Overall Study|Did not start study treatment|0|||
144514559|NCT04994509|521082214|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
144514560|NCT04994509|521082215|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
144514561|NCT04994509|521082216|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
144514562|NCT04994509|521082214|FG000|Overall Study|Withdrew Consent|73|||
144514563|NCT04994509|521082215|FG001|Overall Study|Withdrew Consent|72|||
144514564|NCT04994509|521082216|FG002|Overall Study|Withdrew Consent|46|||
144514565|NCT04994509|521082214|FG000|Overall Study|Lost to Follow-up|39|||
144514566|NCT04994509|521082215|FG001|Overall Study|Lost to Follow-up|36|||
144514567|NCT04994509|521082216|FG002|Overall Study|Lost to Follow-up|26|||
144514568|NCT04994509|521082214|FG000|Overall Study|HIV-1 Infection|4|||
144514569|NCT04994509|521082215|FG001|Overall Study|HIV-1 Infection|20|||
144514570|NCT04994509|521082216|FG002|Overall Study|HIV-1 Infection|12|||
144514571|NCT04994509|521082214|FG000|Overall Study|Investigator's Discretion|9|||
144592184|NCT04494256|521368521|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
144514572|NCT04994509|521082215|FG001|Overall Study|Investigator's Discretion|8|||
144514573|NCT04994509|521082216|FG002|Overall Study|Investigator's Discretion|11|||
144514574|NCT04994509|521082214|FG000|Overall Study|Randomized but Never Treated|10|||
144514575|NCT04994509|521082215|FG001|Overall Study|Randomized but Never Treated|10|||
144514576|NCT04994509|521082216|FG002|Overall Study|Randomized but Never Treated|3|||
144514577|NCT04994509|521082214|FG000|Overall Study|Pregnancy|5|||
144514578|NCT04994509|521082215|FG001|Overall Study|Pregnancy|5|||
144514579|NCT04994509|521082216|FG002|Overall Study|Pregnancy|0|||
144514580|NCT04994509|521082214|FG000|Overall Study|Death|0|||
144514581|NCT04994509|521082215|FG001|Overall Study|Death|5|||
144514582|NCT04994509|521082216|FG002|Overall Study|Death|0|||
144514583|NCT04994509|521082214|FG000|Overall Study|Adverse Event|2|||
144514584|NCT04994509|521082215|FG001|Overall Study|Adverse Event|1|||
144514585|NCT04994509|521082216|FG002|Overall Study|Adverse Event|0|||
144514586|NCT04994509|521082214|FG000|Overall Study|Non-compliance With Study Drug|1|||
144514587|NCT04994509|521082215|FG001|Overall Study|Non-compliance With Study Drug|1|||
144514588|NCT04994509|521082216|FG002|Overall Study|Non-compliance With Study Drug|1|||
144514589|NCT04994509|521082214|FG000|Overall Study|Withdrew Assent|3|||
144514590|NCT04994509|521082215|FG001|Overall Study|Withdrew Assent|0|||
144514591|NCT04994509|521082216|FG002|Overall Study|Withdrew Assent|0|||
144514592|NCT04994509|521082214|FG000|Overall Study|Protocol Violation|1|||
144514593|NCT04994509|521082215|FG001|Overall Study|Protocol Violation|0|||
144514594|NCT04994509|521082216|FG002|Overall Study|Protocol Violation|0|||
144514595|NCT04402294|521082218|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
144514596|NCT04402294|521082219|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
144514597|NCT04402294|521082218|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
144514598|NCT04402294|521082219|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
144514599|NCT04459416|521083887|FG000|Overall Study|Lost to Follow-up|2|||
144514600|NCT04459416|521083888|FG001|Overall Study|Lost to Follow-up|0|||
144514601|NCT04459416|521083887|FG000|Overall Study|Withdrawal by Subject|8|||
144721919|NCT02458638|521836870|FG000|Overall Study|Lost to Follow-up|31|||
144514602|NCT04459416|521083888|FG001|Overall Study|Withdrawal by Subject|10|||
144514603|NCT04459416|521083887|FG000|Overall Study|Disease progression|0|||
144514604|NCT04459416|521083888|FG001|Overall Study|Disease progression|3|||
144592185|NCT04494256|521368515|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
144592186|NCT04494256|521368516|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
144592187|NCT04494256|521368517|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
144592188|NCT04494256|521368518|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
144592189|NCT04494256|521368519|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
144721920|NCT02458638|521836870|FG000|Overall Study|Other Reasons|4|||
144721921|NCT02458638|521836870|FG000|Overall Study|Physician Decision|1|||
144721922|NCT02458638|521836870|FG000|Overall Study|Withdrawal by Subject|47|||
144721923|NCT00135707|521836879|FG000|Overall Study|Lost to Follow-up|94|||
144721924|NCT00135707|521836880|FG001|Overall Study|Lost to Follow-up|89|||
144380968|NCT03698591|520604570|FG001|Overall Study|Failed health screen|1|||
144380969|NCT03698591|520604569|FG000|Overall Study|Ineligible for financial compensation|1|||
144380970|NCT03698591|520604570|FG001|Overall Study|Ineligible for financial compensation|0|||
144380971|NCT03698591|520604569|FG000|Overall Study|Equipment Error|1|||
144514605|NCT05134337|521083889|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
144592190|NCT04494256|521368520|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
144592191|NCT04494256|521368521|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
144592192|NCT04494256|521368515|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592193|NCT04494256|521368516|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592194|NCT04494256|521368517|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592195|NCT04494256|521368518|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592196|NCT04494256|521368519|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
144592197|NCT04494256|521368520|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
144592198|NCT04494256|521368521|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
144514606|NCT05134337|521083890|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
144514607|NCT03725722|521083891|FG000|Overall Study|Lack of Efficacy|2|||
144514608|NCT03725722|521083892|FG001|Overall Study|Lack of Efficacy|1|||
144514609|NCT03725722|521083893|FG002|Overall Study|Lack of Efficacy|2|||
144514610|NCT03725722|521083894|FG003|Overall Study|Lack of Efficacy|0|||
144514611|NCT03725722|521083895|FG004|Overall Study|Lack of Efficacy|2|||
144514612|NCT03725722|521083891|FG000|Overall Study|Adverse Event|2|||
144514613|NCT03725722|521083892|FG001|Overall Study|Adverse Event|2|||
144514614|NCT03725722|521083893|FG002|Overall Study|Adverse Event|1|||
144514615|NCT03725722|521083894|FG003|Overall Study|Adverse Event|0|||
144514616|NCT03725722|521083895|FG004|Overall Study|Adverse Event|6|||
144514617|NCT03725722|521083891|FG000|Overall Study|Withdrawal by Subject|4|||
144514618|NCT03725722|521083892|FG001|Overall Study|Withdrawal by Subject|1|||
144514619|NCT03725722|521083893|FG002|Overall Study|Withdrawal by Subject|0|||
144514620|NCT03725722|521083894|FG003|Overall Study|Withdrawal by Subject|4|||
144514621|NCT03725722|521083895|FG004|Overall Study|Withdrawal by Subject|4|||
144514622|NCT03725722|521083891|FG000|Overall Study|Lost to Follow-up|3|||
144514623|NCT03725722|521083892|FG001|Overall Study|Lost to Follow-up|1|||
144514624|NCT03725722|521083893|FG002|Overall Study|Lost to Follow-up|2|||
144514625|NCT03725722|521083894|FG003|Overall Study|Lost to Follow-up|2|||
144514626|NCT03725722|521083895|FG004|Overall Study|Lost to Follow-up|1|||
144514627|NCT03725722|521083891|FG000|Overall Study|Personal reasons|0|||
144514628|NCT03725722|521083892|FG001|Overall Study|Personal reasons|0|||
144514629|NCT03725722|521083893|FG002|Overall Study|Personal reasons|1|||
144514630|NCT03725722|521083894|FG003|Overall Study|Personal reasons|0|||
144514631|NCT03725722|521083895|FG004|Overall Study|Personal reasons|1|||
144514632|NCT03725722|521083891|FG000|Overall Study|COVID-19 situation|0|||
144514633|NCT03725722|521083892|FG001|Overall Study|COVID-19 situation|1|||
144514634|NCT03725722|521083893|FG002|Overall Study|COVID-19 situation|0|||
144514635|NCT03725722|521083894|FG003|Overall Study|COVID-19 situation|0|||
144514636|NCT03725722|521083895|FG004|Overall Study|COVID-19 situation|0|||
144514637|NCT03481660|521083899|FG000|Overall Study|Adverse Event|5|||
144514638|NCT03481660|521083900|FG001|Overall Study|Adverse Event|4|||
144514639|NCT03481660|521083899|FG000|Overall Study|Death|13|||
144514640|NCT03481660|521083900|FG001|Overall Study|Death|9|||
144514641|NCT03481660|521083899|FG000|Overall Study|Lost to Follow-up|2|||
144514642|NCT03481660|521083900|FG001|Overall Study|Lost to Follow-up|2|||
144514643|NCT03481660|521083899|FG000|Overall Study|Physician Decision|2|||
144514644|NCT03481660|521083900|FG001|Overall Study|Physician Decision|3|||
144514645|NCT03481660|521083899|FG000|Overall Study|Withdrawal by Subject|14|||
144514646|NCT03481660|521083900|FG001|Overall Study|Withdrawal by Subject|7|||
144514647|NCT01259401|521083901|FG000|4-month Follow-up|Death|0|||
144380972|NCT03698591|520604570|FG001|Overall Study|Equipment Error|0|||
144380973|NCT03698591|520604569|FG000|Overall Study|Could not establish TMS dosage|0|||
144514648|NCT01259401|521083902|FG001|4-month Follow-up|Death|1|||
144514649|NCT01259401|521083901|FG000|4-month Follow-up|Lost to Follow-up|0|||
144514650|NCT01259401|521083902|FG001|4-month Follow-up|Lost to Follow-up|1|||
144514651|NCT00186992|521083903|FG000|Overall Study|Withdrawal by Subject|5|||
144514652|NCT00186992|521083903|FG000|Overall Study|Physician's discretion|13|||
144514653|NCT00186992|521083903|FG000|Overall Study|PI Discretion|4|||
144514654|NCT00186992|521083903|FG000|Overall Study|Ineligible|2|||
144514655|NCT00186992|521083903|FG000|Overall Study|Lost to Follow-up|2|||
144514656|NCT00186992|521083903|FG000|Overall Study|Still on Study|9|||
144514657|NCT03683069|521083904|FG000|Overall Study|see limitations|12|||
144514658|NCT03683069|521083905|FG001|Overall Study|see limitations|13|||
144514659|NCT05478525|521083906|FG000|Overall Study|Withdrawal by Subject|0|||
144721925|NCT00135707|521836879|FG000|Overall Study|Withdrawal by Subject|0|||
144380974|NCT03698591|520604570|FG001|Overall Study|Could not establish TMS dosage|1|||
144721926|NCT00135707|521836880|FG001|Overall Study|Withdrawal by Subject|1|||
144514660|NCT05478525|521083907|FG001|Overall Study|Withdrawal by Subject|1|||
144514661|NCT05478525|521083908|FG002|Overall Study|Withdrawal by Subject|2|||
144514662|NCT05478525|521083909|FG003|Overall Study|Withdrawal by Subject|0|||
144514663|NCT05478525|521083906|FG000|Overall Study|COVID-19 Infection|2|||
144514664|NCT05478525|521083907|FG001|Overall Study|COVID-19 Infection|0|||
144514665|NCT05478525|521083908|FG002|Overall Study|COVID-19 Infection|1|||
144514666|NCT05478525|521083909|FG003|Overall Study|COVID-19 Infection|1|||
144514667|NCT01649271|521083910|FG000|Overall Study|Progressive disease|4|||
144514668|NCT01649271|521083911|FG001|Overall Study|Progressive disease|5|||
144514669|NCT01649271|521083910|FG000|Overall Study|Other Adverse Event|0|||
144514670|NCT01649271|521083911|FG001|Overall Study|Other Adverse Event|2|||
144514671|NCT01649271|521083910|FG000|Overall Study|Withdrawal by Subject|1|||
144514672|NCT01649271|521083911|FG001|Overall Study|Withdrawal by Subject|0|||
144514673|NCT01649271|521083910|FG000|Overall Study|Other than stated above|1|||
144514674|NCT01649271|521083911|FG001|Overall Study|Other than stated above|0|||
144592199|NCT04494256|521368515|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
144514675|NCT05756075|521083912|FG000|Overall Study|Withdrawal by Subject|16|||
144514676|NCT05756075|521083913|FG001|Overall Study|Withdrawal by Subject|9|||
144514677|NCT01991977|521083914|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
144514678|NCT01991977|521083914|FG000|Overall Study|Withdrew after start of treatment|5|||
144380975|NCT02626624|520604574|FG000|Overall Study|Adverse Event|1|||
144592200|NCT04494256|521368516|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
144592201|NCT04494256|521368517|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
144592202|NCT04494256|521368518|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
144592203|NCT04494256|521368519|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
144592204|NCT04494256|521368520|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
144592205|NCT04494256|521368521|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
144592206|NCT02128542|521368522|FG000|Overall Study|Lost to Follow-up|3|||
144592207|NCT02128542|521368523|FG001|Overall Study|Lost to Follow-up|0|||
144592208|NCT02128542|521368522|FG000|Overall Study|Withdrew Consent|1|||
144592209|NCT02128542|521368523|FG001|Overall Study|Withdrew Consent|0|||
144592210|NCT01778023|521368525|FG000|Overall Study|Withdrawal by Subject|0|||
144592211|NCT01778023|521368526|FG001|Overall Study|Withdrawal by Subject|3|||
144592212|NCT01411215|521368527|FG000|Overall Study|Adverse Event|1|||
144592213|NCT01411215|521368528|FG001|Overall Study|Adverse Event|2|||
144592214|NCT01411215|521368527|FG000|Overall Study|Lack of Efficacy|2|||
144592215|NCT01411215|521368528|FG001|Overall Study|Lack of Efficacy|4|||
144592216|NCT01411215|521368527|FG000|Overall Study|Lost to Follow-up|12|||
144592217|NCT01411215|521368528|FG001|Overall Study|Lost to Follow-up|18|||
144592218|NCT01411215|521368527|FG000|Overall Study|Did not meet entrance criteria|0|||
144592219|NCT01411215|521368528|FG001|Overall Study|Did not meet entrance criteria|1|||
144592220|NCT01411215|521368527|FG000|Overall Study|Study terminated by sponsor|2|||
144592221|NCT01411215|521368528|FG001|Overall Study|Study terminated by sponsor|15|||
144592222|NCT01411215|521368527|FG000|Overall Study|Protocol Violation|3|||
144592223|NCT01411215|521368528|FG001|Overall Study|Protocol Violation|5|||
144592224|NCT01411215|521368527|FG000|Overall Study|Withdrawal by Subject|34|||
144592225|NCT01411215|521368528|FG001|Overall Study|Withdrawal by Subject|21|||
144592226|NCT01411215|521368527|FG000|Overall Study|Other|12|||
144592227|NCT01411215|521368528|FG001|Overall Study|Other|17|||
144592228|NCT01411215|521368527|FG000|Overall Study|Screen failure|0|||
144592229|NCT01411215|521368528|FG001|Overall Study|Screen failure|1|||
144592230|NCT00848926|521368529|FG000|Treatment Period|Progressive disease|45|||
144592231|NCT00848926|521368529|FG000|Treatment Period|Adverse Event|20|||
144592232|NCT00848926|521368529|FG000|Treatment Period|Physician Decision|12|||
144592233|NCT00848926|521368529|FG000|Treatment Period|Withdrawal by Subject|7|||
144592234|NCT00848926|521368529|FG000|Follow-up Period|Lost to Follow-up|7|||
144592235|NCT00848926|521368529|FG000|Follow-up Period|Withdrawal by Subject|3|||
144592236|NCT00848926|521368529|FG000|Follow-up Period|Other|2|||
144592237|NCT02203695|521368530|FG000|Overall Study|Patient withdrew consent|1|||
144592238|NCT02203695|521368531|FG001|Overall Study|Patient withdrew consent|1|||
144592239|NCT02203695|521368530|FG000|Overall Study|Started non-study treatment|1|||
144592240|NCT02203695|521368531|FG001|Overall Study|Started non-study treatment|0|||
144592241|NCT00903630|521368532|FG000|Phase 2|Adverse Event|0|||
144592242|NCT00903630|521368533|FG001|Phase 2|Adverse Event|0|||
144592243|NCT00903630|521368534|FG002|Phase 2|Adverse Event|1|||
144592244|NCT04025580|521368535|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
144592245|NCT04025580|521368536|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
144592246|NCT04025580|521368537|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
144592247|NCT01249274|521368543|FG000|Overall Study|Lost to Follow-up|3|||
144592248|NCT01249274|521368544|FG001|Overall Study|Lost to Follow-up|4|||
144592249|NCT01249274|521368543|FG000|Overall Study|Received inpatient substance treatment|1|||
144592250|NCT01249274|521368544|FG001|Overall Study|Received inpatient substance treatment|2|||
144592251|NCT01000636|521368545|FG000|Overall Study|Withdrawal by Subject|1|||
144592252|NCT01000636|521368545|FG000|Overall Study|Adverse Event|1|||
144592253|NCT00138671|521368546|FG000|Overall Study|Death|0|||
144592254|NCT00138671|521368547|FG001|Overall Study|Death|3|||
144592255|NCT00138671|521368546|FG000|Overall Study|Adverse Event|6|||
144592256|NCT00138671|521368547|FG001|Overall Study|Adverse Event|3|||
144592257|NCT00138671|521368546|FG000|Overall Study|Lost to Follow-up|1|||
144592258|NCT00138671|521368547|FG001|Overall Study|Lost to Follow-up|2|||
144592259|NCT00138671|521368546|FG000|Overall Study|Withdrawal by Subject|3|||
144592260|NCT00138671|521368547|FG001|Overall Study|Withdrawal by Subject|5|||
144592261|NCT00138671|521368546|FG000|Overall Study|Other|3|||
144592262|NCT00138671|521368547|FG001|Overall Study|Other|3|||
144592263|NCT03451162|521368548|FG000|Overall Study|Lost to Follow-up|1|||
144592264|NCT03451162|521368549|FG001|Overall Study|Lost to Follow-up|0|||
144592265|NCT03451162|521368550|FG002|Overall Study|Lost to Follow-up|0|||
144592266|NCT03451162|521368551|FG003|Overall Study|Lost to Follow-up|0|||
144592267|NCT03451162|521368552|FG004|Overall Study|Lost to Follow-up|0|||
144592268|NCT03451162|521368548|FG000|Overall Study|Physician Decision|0|||
144592269|NCT03451162|521368549|FG001|Overall Study|Physician Decision|1|||
144592270|NCT03451162|521368550|FG002|Overall Study|Physician Decision|0|||
144592271|NCT03451162|521368551|FG003|Overall Study|Physician Decision|0|||
144592272|NCT03451162|521368552|FG004|Overall Study|Physician Decision|0|||
144592273|NCT03451162|521368548|FG000|Overall Study|Withdrawal by Subject|1|||
144592274|NCT03451162|521368549|FG001|Overall Study|Withdrawal by Subject|1|||
144592275|NCT03451162|521368550|FG002|Overall Study|Withdrawal by Subject|0|||
144592276|NCT03451162|521368551|FG003|Overall Study|Withdrawal by Subject|0|||
144592277|NCT03451162|521368552|FG004|Overall Study|Withdrawal by Subject|0|||
144592278|NCT04634825|521368553|FG000|Overall Study|Death|10|||
144592279|NCT04634825|521368554|FG001|Overall Study|Death|3|||
144592280|NCT04634825|521368553|FG000|Overall Study|Lost to Follow-up|1|||
144592281|NCT04634825|521368554|FG001|Overall Study|Lost to Follow-up|0|||
144592282|NCT04634825|521368553|FG000|Overall Study|Study terminated by sponsor|35|||
144592283|NCT04634825|521368554|FG001|Overall Study|Study terminated by sponsor|11|||
144592284|NCT04634825|521368553|FG000|Overall Study|Withdrawal by Subject|2|||
144592285|NCT04634825|521368554|FG001|Overall Study|Withdrawal by Subject|0|||
144592286|NCT01100034|521368557|FG000|Overall Study|Lost to Follow-up|11|||
144592287|NCT01100034|521368557|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
144592288|NCT01100034|521368557|FG000|Overall Study|Withdrawal by Subject|4|||
144592289|NCT01100034|521368557|FG000|Overall Study|Sponsor decision|21|||
144592290|NCT01100034|521368557|FG000|Overall Study|Participated in another clinical trial|1|||
144592291|NCT01100034|521368557|FG000|Overall Study|Participants moved to another hospital|4|||
144592292|NCT01100034|521368557|FG000|Overall Study|Site closed due to non-responsiveness|1|||
144592293|NCT00402597|521368558|FG000|Overall Study|Death|15|||
144592294|NCT00402597|521368559|FG001|Overall Study|Death|7|||
144592295|NCT00402597|521368560|FG002|Overall Study|Death|6|||
144592296|NCT00402597|521368561|FG003|Overall Study|Death|4|||
144380976|NCT02626624|520604574|FG000|Overall Study|Lost to Follow-up|3|||
144380977|NCT02626624|520604574|FG000|Overall Study|Protocol Violation|4|||
144514679|NCT02605837|521083916|FG000|Overall Study|Adverse Event|3|||
144380978|NCT02626624|520604574|FG000|Overall Study|Death|2|||
144514680|NCT02605837|521083917|FG001|Overall Study|Adverse Event|1|||
144380979|NCT04614324|520604577|FG000|Overall Study|Lost to Follow-up|3|||
144380980|NCT04614324|520604577|FG000|Overall Study|Physician Decision|1|||
144380981|NCT04614324|520604577|FG000|Overall Study|Withdrawal by Subject|2|||
144380982|NCT04614324|520604577|FG000|Overall Study|Remaining in Follow up|123|||
144380983|NCT05141448|520604578|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
144380984|NCT05141448|520604579|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
144380985|NCT05141448|520604580|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
144380986|NCT05141448|520604581|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
144380987|NCT05141448|520604582|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
144380988|NCT05141448|520604583|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
144380989|NCT05141448|520604578|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144380990|NCT05141448|520604579|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144380991|NCT05141448|520604580|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144380992|NCT05141448|520604581|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144380993|NCT05141448|520604582|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
144380994|NCT05141448|520604583|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144380995|NCT05141448|520604578|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144380996|NCT05141448|520604579|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
144380997|NCT05141448|520604580|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144380998|NCT05141448|520604581|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144380999|NCT05141448|520604582|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144381000|NCT05141448|520604583|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144381001|NCT05141448|520604578|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144381002|NCT05141448|520604579|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144381003|NCT05141448|520604580|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144381004|NCT05141448|520604581|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144381005|NCT05141448|520604582|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144381006|NCT05141448|520604583|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
144381007|NCT05141448|520604578|FG000|Period 2|COVID-19 Related|0|||
144381008|NCT05141448|520604579|FG001|Period 2|COVID-19 Related|0|||
144381009|NCT05141448|520604580|FG002|Period 2|COVID-19 Related|0|||
144381010|NCT05141448|520604581|FG003|Period 2|COVID-19 Related|1|||
144381011|NCT05141448|520604582|FG004|Period 2|COVID-19 Related|0|||
144381012|NCT05141448|520604583|FG005|Period 2|COVID-19 Related|1|||
144381013|NCT05141448|520604578|FG000|3|Covid-19 related|2|||
144381014|NCT05141448|520604579|FG001|3|Covid-19 related|0|||
144381015|NCT05141448|520604580|FG002|3|Covid-19 related|0|||
144381016|NCT05141448|520604581|FG003|3|Covid-19 related|0|||
144381017|NCT05141448|520604582|FG004|3|Covid-19 related|0|||
144381018|NCT05141448|520604583|FG005|3|Covid-19 related|1|||
144381019|NCT05141448|520604578|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
144381020|NCT05141448|520604579|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
144721927|NCT00135707|521836879|FG000|Overall Study|Institutional review board request|1|||
144381021|NCT05141448|520604580|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
144381022|NCT05141448|520604581|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
144381023|NCT05141448|520604582|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
144381024|NCT05141448|520604583|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
144381025|NCT01948193|520606575|FG000|Overall Study|Serious event|2|||
144381026|NCT01948193|520606575|FG000|Overall Study|Lost to Follow-up|7|||
144381027|NCT00490529|520606576|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
144381028|NCT00490529|520606576|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
144381029|NCT00490529|520606576|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
144381030|NCT00490529|520606576|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
144381031|NCT00490529|520606576|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
144381032|NCT00490529|520606576|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
144381033|NCT01964755|520606580|FG000|Overall Study|Death|2|||
144381034|NCT01410357|520606581|FG000|Overall Study|Death|2|||
144381035|NCT01410357|520606582|FG001|Overall Study|Death|1|||
144381036|NCT01410357|520606581|FG000|Overall Study|Withdrawal by Subject|1|||
144381037|NCT01410357|520606582|FG001|Overall Study|Withdrawal by Subject|2|||
144381038|NCT01410357|520606581|FG000|Overall Study|Lost to Follow-up|23|||
144381039|NCT01410357|520606582|FG001|Overall Study|Lost to Follow-up|21|||
144381040|NCT03467152|520606587|FG000|Overall Study|Adverse Event|4|||
144381041|NCT03467152|520606588|FG001|Overall Study|Adverse Event|5|||
144381042|NCT03467152|520606589|FG002|Overall Study|Adverse Event|0|||
144381043|NCT03467152|520606587|FG000|Overall Study|Subject Choice|1|||
144381044|NCT03467152|520606588|FG001|Overall Study|Subject Choice|3|||
144381045|NCT03467152|520606589|FG002|Overall Study|Subject Choice|0|||
144381046|NCT03467152|520606587|FG000|Overall Study|Lost to Follow-up|1|||
144381047|NCT03467152|520606588|FG001|Overall Study|Lost to Follow-up|0|||
144381048|NCT03467152|520606589|FG002|Overall Study|Lost to Follow-up|0|||
144381049|NCT03467152|520606587|FG000|Overall Study|Withdrawal by Subject|4|||
144381050|NCT03467152|520606588|FG001|Overall Study|Withdrawal by Subject|2|||
144381051|NCT03467152|520606589|FG002|Overall Study|Withdrawal by Subject|0|||
144381052|NCT03467152|520606587|FG000|Overall Study|Others|3|||
144381053|NCT03467152|520606588|FG001|Overall Study|Others|0|||
144381054|NCT03467152|520606589|FG002|Overall Study|Others|0|||
144381055|NCT03467152|520606587|FG000|Overall Study|Not treated|3|||
144514681|NCT02605837|521083916|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144514682|NCT02605837|521083917|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144381056|NCT03467152|520606588|FG001|Overall Study|Not treated|1|||
144381057|NCT03467152|520606589|FG002|Overall Study|Not treated|6|||
144381058|NCT03700684|520606590|FG000|Overall Study|COVID-19|0|||
144514683|NCT02605837|521083916|FG000|Overall Study|Withdrawal by Subject|8|||
144514684|NCT02605837|521083917|FG001|Overall Study|Withdrawal by Subject|8|||
144381059|NCT03700684|520606591|FG001|Overall Study|COVID-19|0|||
144381060|NCT03700684|520606592|FG002|Overall Study|COVID-19|2|||
144514685|NCT02605837|521083916|FG000|Overall Study|Physician Decision|0|||
144514686|NCT02605837|521083917|FG001|Overall Study|Physician Decision|1|||
144381061|NCT01120782|520606593|FG000|Overall Study|Test article shipping error|11|||
144381062|NCT04140227|520606594|FG000|Overall Study|Withdrawal by Subject|26|||
144381063|NCT04140227|520606594|FG000|Overall Study|Lost to Follow-up|8|||
144381064|NCT04140227|520606594|FG000|Overall Study|Adverse Event|8|||
144381065|NCT04140227|520606594|FG000|Overall Study|Death|1|||
144381066|NCT04140227|520606594|FG000|Overall Study|Other|3|||
144381067|NCT04140227|520606594|FG000|Overall Study|Protocol Violation|2|||
144381068|NCT02238080|520606603|FG000|Overall Study|Death|13|||
144381069|NCT02238080|520606603|FG000|Overall Study|Treatment interrupted|6|||
144381070|NCT02238080|520606603|FG000|Overall Study|Withdrawal by Subject|2|||
144381071|NCT02238080|520606603|FG000|Overall Study|Other|4|||
144381072|NCT01738646|520606604|FG000|Overall Study|Still Receiving Treatment|2|||
144381073|NCT01598129|520606605|FG000|Overall Study|Disease progression|6|||
144381074|NCT01598129|520606605|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
144381075|NCT01598129|520606605|FG000|Overall Study|Withdrawal by Subject|1|||
144381076|NCT00505076|520606606|FG000|Overall Study|Adverse Event|1|||
144381077|NCT00505076|520606607|FG001|Overall Study|Adverse Event|0|||
144381078|NCT00505076|520606608|FG002|Overall Study|Adverse Event|1|||
144381079|NCT00505076|520606606|FG000|Overall Study|Protocol Violation|2|||
144381080|NCT00505076|520606607|FG001|Overall Study|Protocol Violation|1|||
144381081|NCT00505076|520606608|FG002|Overall Study|Protocol Violation|2|||
144381082|NCT00505076|520606606|FG000|Overall Study|Withdrawal by Subject|0|||
144381083|NCT00505076|520606607|FG001|Overall Study|Withdrawal by Subject|1|||
144381084|NCT00505076|520606608|FG002|Overall Study|Withdrawal by Subject|2|||
144381085|NCT04093024|520606611|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
144381086|NCT04093024|520606612|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
144381087|NCT04093024|520606611|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
144381088|NCT04093024|520606612|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
144381089|NCT04093024|520606611|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
144381090|NCT04093024|520606612|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
144381091|NCT04093024|520606611|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
144381092|NCT04093024|520606612|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
144381093|NCT00647270|520606617|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
144381094|NCT00647270|520606618|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
144381095|NCT00647270|520606619|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
144381096|NCT00647270|520606617|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
144381097|NCT00647270|520606618|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
144381098|NCT00647270|520606619|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
144514687|NCT05307978|521083918|FG000|Overall Study|Lost to Follow-up|0|||
144514688|NCT05307978|521083919|FG001|Overall Study|Lost to Follow-up|1|||
144514689|NCT05307978|521083920|FG002|Overall Study|Lost to Follow-up|0|||
144514690|NCT05307978|521083921|FG003|Overall Study|Lost to Follow-up|4|||
144514691|NCT05307978|521083922|FG004|Overall Study|Lost to Follow-up|0|||
144514692|NCT05307978|521083923|FG005|Overall Study|Lost to Follow-up|0|||
144514693|NCT05307978|521083924|FG006|Overall Study|Lost to Follow-up|1|||
144514694|NCT03416023|521083925|FG000|Overall Study|Exclusion criteria failure|1|||
144514695|NCT03416023|521083925|FG000|Overall Study|Withdrawal by Subject|6|||
144514696|NCT03416023|521083925|FG000|Overall Study|Explanted|7|||
144514697|NCT03416023|521083925|FG000|Overall Study|Physician Decision|1|||
144514698|NCT03416023|521083925|FG000|Overall Study|Lost to Follow-up|1|||
144514699|NCT03416023|521083925|FG000|Overall Study|Death|1|||
144514700|NCT02837510|521083926|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
144514701|NCT02837510|521083927|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
144514702|NCT02837510|521083926|FG000|Washout (2 Weeks)|Adverse Event|0|||
144514703|NCT02837510|521083927|FG001|Washout (2 Weeks)|Adverse Event|1|||
144514704|NCT02837510|521083926|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
144514705|NCT02837510|521083927|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
144514706|NCT02837510|521083926|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
144514707|NCT02837510|521083927|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
144514708|NCT02837510|521083926|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
144514709|NCT02837510|521083927|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
144381099|NCT00647270|520606617|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
144381100|NCT00647270|520606618|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
144381101|NCT00647270|520606619|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
144381102|NCT00647270|520606617|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
144381103|NCT00647270|520606618|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
144381104|NCT00647270|520606619|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
144381105|NCT00647270|520606617|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
144381106|NCT00647270|520606618|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
144381107|NCT00647270|520606619|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
144381108|NCT00647270|520606617|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
144381109|NCT00647270|520606618|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
144381110|NCT00647270|520606619|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
144381111|NCT00647270|520606617|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
144381112|NCT00647270|520606618|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
144381113|NCT00647270|520606619|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
144381114|NCT03615040|520606620|FG000|Overall Study|Withdrawal by Subject|2|||
144381115|NCT03615040|520606621|FG001|Overall Study|Withdrawal by Subject|1|||
144381116|NCT03615040|520606620|FG000|Overall Study|Physician Decision|2|||
144381117|NCT03615040|520606621|FG001|Overall Study|Physician Decision|2|||
144381118|NCT03615040|520606620|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
144381119|NCT03615040|520606621|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
144381120|NCT03615040|520606620|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
144381121|NCT03615040|520606621|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
144381122|NCT03615040|520606620|FG000|Overall Study|Death|0|||
144381123|NCT03615040|520606621|FG001|Overall Study|Death|2|||
144381124|NCT01541397|520606622|FG000|Overall Study|Study ended prior to data collection|4|||
144381125|NCT01541397|520606623|FG001|Overall Study|Study ended prior to data collection|2|||
144381126|NCT01128621|520606626|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
144381127|NCT01128621|520606627|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
144381128|NCT02267317|520606628|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
144381129|NCT02267317|520606629|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
144381130|NCT02267317|520606630|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
144381131|NCT02267317|520606631|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
144381132|NCT02267317|520606632|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
144381133|NCT02267317|520606633|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
144381134|NCT02267317|520606628|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
144381135|NCT02267317|520606629|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
144381136|NCT02267317|520606630|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
144381137|NCT02267317|520606631|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
144514710|NCT02837510|521083926|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
144514711|NCT02837510|521083927|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
144514712|NCT04527146|521083928|FG000|Overall Study|Withdrawal by Subject|12|||
144514713|NCT04527146|521083929|FG001|Overall Study|Withdrawal by Subject|15|||
144514714|NCT04527146|521083930|FG002|Overall Study|Withdrawal by Subject|7|||
144514715|NCT04527146|521083931|FG003|Overall Study|Withdrawal by Subject|16|||
144381138|NCT02267317|520606632|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
144381139|NCT02267317|520606633|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
144381140|NCT00233454|520606637|FG000|Overall Study|Death|6|||
144381141|NCT04224688|520606638|FG000|Overall Study|Withdrawal by Subject|1|||
144381142|NCT04224688|520606639|FG001|Overall Study|Withdrawal by Subject|3|||
144381143|NCT04224688|520606638|FG000|Overall Study|Lack of Efficacy|1|||
144381144|NCT04224688|520606639|FG001|Overall Study|Lack of Efficacy|1|||
144381145|NCT04224688|520606638|FG000|Overall Study|Adverse event, not fatal|0|||
144381146|NCT04224688|520606639|FG001|Overall Study|Adverse event, not fatal|2|||
144381147|NCT04224688|520606638|FG000|Overall Study|COVID-19|0|||
144381148|NCT04224688|520606639|FG001|Overall Study|COVID-19|1|||
144381149|NCT03726996|520606644|FG000|Overall Study|Parent's decision|2|||
144381150|NCT03726996|520606644|FG000|Overall Study|Study early termination|2|||
144381151|NCT01616693|520606645|FG000|Evaluated for Safety|Physician Decision|1|||
144381152|NCT01616693|520606646|FG001|Evaluated for Safety|Physician Decision|0|||
144381153|NCT01616693|520606647|FG002|Evaluated for Safety|Physician Decision|1|||
144381154|NCT01616693|520606648|FG003|Evaluated for Safety|Physician Decision|0|||
144381155|NCT01616693|520606645|FG000|Received Both Vaccines|Adverse Event|2|||
144381156|NCT01616693|520606646|FG001|Received Both Vaccines|Adverse Event|0|||
144381157|NCT01616693|520606647|FG002|Received Both Vaccines|Adverse Event|0|||
144381158|NCT01616693|520606648|FG003|Received Both Vaccines|Adverse Event|0|||
144381159|NCT01616693|520606645|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
144381160|NCT01616693|520606646|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
144381161|NCT01616693|520606647|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
144381162|NCT01616693|520606648|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
144381163|NCT01616693|520606645|FG000|Received Both Vaccines|Lost to Follow-up|4|||
144381164|NCT01616693|520606646|FG001|Received Both Vaccines|Lost to Follow-up|3|||
144381165|NCT01616693|520606647|FG002|Received Both Vaccines|Lost to Follow-up|4|||
144381166|NCT01616693|520606648|FG003|Received Both Vaccines|Lost to Follow-up|4|||
144381167|NCT01616693|520606645|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
144381168|NCT01616693|520606646|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
144381169|NCT01616693|520606647|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
144381170|NCT01616693|520606648|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
144381171|NCT00539188|520606649|FG000|Overall Study|Withdrawal by Subject|1|||
144381172|NCT00539188|520606650|FG001|Overall Study|Withdrawal by Subject|0|||
144381173|NCT00539188|520606649|FG000|Overall Study|Lost to Follow-up|2|||
144381174|NCT00539188|520606650|FG001|Overall Study|Lost to Follow-up|1|||
144381175|NCT04784442|520606651|FG000|Overall Study|Adverse Event|1|||
144381176|NCT04784442|520606652|FG001|Overall Study|Adverse Event|0|||
144381177|NCT04784442|520606653|FG002|Overall Study|Adverse Event|2|||
144381178|NCT04784442|520606654|FG003|Overall Study|Adverse Event|1|||
144381179|NCT04784442|520606651|FG000|Overall Study|Protocol Violation|1|||
144381180|NCT04784442|520606652|FG001|Overall Study|Protocol Violation|0|||
144381181|NCT04784442|520606653|FG002|Overall Study|Protocol Violation|0|||
144381182|NCT04784442|520606654|FG003|Overall Study|Protocol Violation|0|||
144381183|NCT04784442|520606651|FG000|Overall Study|Non-compliance with study drug|1|||
144381184|NCT04784442|520606652|FG001|Overall Study|Non-compliance with study drug|0|||
144381185|NCT04784442|520606653|FG002|Overall Study|Non-compliance with study drug|0|||
144381186|NCT04784442|520606654|FG003|Overall Study|Non-compliance with study drug|0|||
144381187|NCT00486811|520606657|FG000|Overall Study|Adverse Event|28|||
144381188|NCT00486811|520606658|FG001|Overall Study|Adverse Event|60|||
144381189|NCT00486811|520606659|FG002|Overall Study|Adverse Event|135|||
144381190|NCT00486811|520606657|FG000|Overall Study|Lack of Efficacy|34|||
144381191|NCT00486811|520606658|FG001|Overall Study|Lack of Efficacy|14|||
144592297|NCT00402597|521368562|FG004|Overall Study|Death|6|||
144592298|NCT00402597|521368558|FG000|Overall Study|Adverse Event|81|||
144592299|NCT00402597|521368559|FG001|Overall Study|Adverse Event|18|||
144592300|NCT00402597|521368560|FG002|Overall Study|Adverse Event|106|||
144592301|NCT00402597|521368561|FG003|Overall Study|Adverse Event|39|||
144592302|NCT00402597|521368562|FG004|Overall Study|Adverse Event|71|||
144592303|NCT00402597|521368558|FG000|Overall Study|Lost to Follow-up|8|||
144592304|NCT00402597|521368559|FG001|Overall Study|Lost to Follow-up|1|||
144592305|NCT00402597|521368560|FG002|Overall Study|Lost to Follow-up|8|||
144592306|NCT00402597|521368561|FG003|Overall Study|Lost to Follow-up|2|||
144592307|NCT00402597|521368562|FG004|Overall Study|Lost to Follow-up|3|||
144592308|NCT00402597|521368558|FG000|Overall Study|Withdrawal by Subject|57|||
144592309|NCT00402597|521368559|FG001|Overall Study|Withdrawal by Subject|16|||
144592310|NCT00402597|521368560|FG002|Overall Study|Withdrawal by Subject|65|||
144592311|NCT00402597|521368561|FG003|Overall Study|Withdrawal by Subject|15|||
144592312|NCT00402597|521368562|FG004|Overall Study|Withdrawal by Subject|24|||
144592313|NCT00402597|521368558|FG000|Overall Study|reason not specified|30|||
144592314|NCT00402597|521368559|FG001|Overall Study|reason not specified|4|||
144592315|NCT00402597|521368560|FG002|Overall Study|reason not specified|27|||
144592316|NCT00402597|521368561|FG003|Overall Study|reason not specified|14|||
144592317|NCT00402597|521368562|FG004|Overall Study|reason not specified|20|||
144592318|NCT01136772|521368563|FG000|Overall Study|Adverse Event|15|||
144592319|NCT01136772|521368564|FG001|Overall Study|Adverse Event|14|||
144592320|NCT01136772|521368563|FG000|Overall Study|Lack of Efficacy|42|||
144592321|NCT01136772|521368564|FG001|Overall Study|Lack of Efficacy|39|||
144592322|NCT01136772|521368563|FG000|Overall Study|Administrative|14|||
144592323|NCT01136772|521368564|FG001|Overall Study|Administrative|12|||
144592324|NCT01136772|521368563|FG000|Overall Study|Withdrawal by Subject|33|||
144381192|NCT00486811|520606659|FG002|Overall Study|Lack of Efficacy|7|||
144381193|NCT00486811|520606657|FG000|Overall Study|Lost to Follow-up|4|||
144381194|NCT00486811|520606658|FG001|Overall Study|Lost to Follow-up|6|||
144381195|NCT00486811|520606659|FG002|Overall Study|Lost to Follow-up|4|||
144592325|NCT01136772|521368564|FG001|Overall Study|Withdrawal by Subject|36|||
144592326|NCT01136772|521368563|FG000|Overall Study|Did not receive injection|10|||
144592327|NCT01136772|521368564|FG001|Overall Study|Did not receive injection|7|||
144592328|NCT01136772|521368563|FG000|Overall Study|Did not follow up after first injection|2|||
144592329|NCT01136772|521368564|FG001|Overall Study|Did not follow up after first injection|2|||
144592330|NCT01831856|521368565|FG000|Overall Study|Adverse Event|5|||
144592331|NCT01831856|521368566|FG001|Overall Study|Adverse Event|8|||
144381196|NCT00486811|520606657|FG000|Overall Study|Withdrawal by Subject|33|||
144381197|NCT00486811|520606658|FG001|Overall Study|Withdrawal by Subject|44|||
144381198|NCT00486811|520606659|FG002|Overall Study|Withdrawal by Subject|58|||
144381199|NCT00486811|520606657|FG000|Overall Study|Study drug non-compliant|5|||
144592332|NCT01831856|521368565|FG000|Overall Study|Lack of Efficacy|13|||
144381200|NCT00486811|520606658|FG001|Overall Study|Study drug non-compliant|6|||
144381201|NCT00486811|520606659|FG002|Overall Study|Study drug non-compliant|3|||
144381202|NCT00486811|520606657|FG000|Overall Study|All other|18|||
144381203|NCT00486811|520606658|FG001|Overall Study|All other|11|||
144381204|NCT00486811|520606659|FG002|Overall Study|All other|7|||
144381205|NCT00852371|520606663|FG000|Overall Study|Lost to Follow-up|2|||
144381206|NCT00852371|520606664|FG001|Overall Study|Lost to Follow-up|3|||
144381207|NCT00852371|520606665|FG002|Overall Study|Lost to Follow-up|4|||
144381208|NCT00852371|520606666|FG003|Overall Study|Lost to Follow-up|2|||
144381209|NCT02756806|520606667|FG000|Overall Study|Study terminated early|5|||
144381210|NCT03158285|520606668|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
144381211|NCT03158285|520606669|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
144381212|NCT03158285|520606670|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
144381213|NCT03158285|520606668|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
144381214|NCT03158285|520606669|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
144381215|NCT03158285|520606670|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
144381216|NCT03158285|520606668|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
144381217|NCT03158285|520606669|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
144381218|NCT03158285|520606670|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
144381219|NCT03158285|520606668|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
144381220|NCT03158285|520606669|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
144381221|NCT03158285|520606670|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
144381222|NCT03158285|520606668|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
144381223|NCT03158285|520606669|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
144381224|NCT03158285|520606670|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
144381225|NCT03158285|520606668|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
144381226|NCT03158285|520606669|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
144381227|NCT03158285|520606670|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
144381228|NCT03158285|520606668|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
144381229|NCT03158285|520606669|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
144381230|NCT03158285|520606670|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
144381231|NCT03158285|520606668|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
144381232|NCT03158285|520606669|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
144514716|NCT04527146|521083928|FG000|Overall Study|Lost to Follow-up|13|||
144721928|NCT00135707|521836880|FG001|Overall Study|Institutional review board request|0|||
144514717|NCT04527146|521083929|FG001|Overall Study|Lost to Follow-up|9|||
144592333|NCT01831856|521368566|FG001|Overall Study|Lack of Efficacy|11|||
144592334|NCT01831856|521368565|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
144592335|NCT01831856|521368566|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
144592336|NCT01498653|521368568|FG000|Overall Study|Adverse Event|2|||
144592337|NCT01498653|521368569|FG001|Overall Study|Adverse Event|2|||
144592338|NCT01498653|521368568|FG000|Overall Study|Lack of Efficacy|12|||
144592339|NCT01498653|521368569|FG001|Overall Study|Lack of Efficacy|26|||
144592340|NCT01498653|521368568|FG000|Overall Study|Protocol Violation|0|||
144592341|NCT01498653|521368569|FG001|Overall Study|Protocol Violation|4|||
144592342|NCT01498653|521368568|FG000|Overall Study|Lost to Follow-up|1|||
144592343|NCT01498653|521368569|FG001|Overall Study|Lost to Follow-up|0|||
144592344|NCT01498653|521368568|FG000|Overall Study|Physician Decision|2|||
144592345|NCT01498653|521368569|FG001|Overall Study|Physician Decision|0|||
144592346|NCT01498653|521368568|FG000|Overall Study|Withdrawal by Subject|2|||
144592347|NCT01498653|521368569|FG001|Overall Study|Withdrawal by Subject|3|||
144592348|NCT05208866|521368570|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
144592349|NCT00836095|521368575|FG000|Overall Study|Physician Decision|0|||
144592350|NCT00836095|521368576|FG001|Overall Study|Physician Decision|3|||
144592351|NCT01602562|521368577|FG000|Overall Study|Adverse Event|3|||
144381233|NCT03158285|520606670|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
144381234|NCT03158285|520606668|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
144381235|NCT03158285|520606669|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
144381236|NCT03158285|520606670|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
144381237|NCT03158285|520606668|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
144381238|NCT03158285|520606669|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
144381239|NCT03158285|520606670|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
144381240|NCT03158285|520606668|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
144381241|NCT03158285|520606669|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
144381242|NCT03158285|520606670|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
144381243|NCT03158285|520606668|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
144381244|NCT03158285|520606669|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
144381245|NCT03158285|520606670|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
144381246|NCT03158285|520606668|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
144381247|NCT03158285|520606669|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
144381248|NCT03158285|520606670|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
144381249|NCT03158285|520606668|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
144381250|NCT03158285|520606669|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
144381251|NCT03158285|520606670|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
144381252|NCT03158285|520606668|FG000|Active Treatment Period: Week 52-100|Death|1|||
144381253|NCT03158285|520606669|FG001|Active Treatment Period: Week 52-100|Death|0|||
144381254|NCT03158285|520606670|FG002|Active Treatment Period: Week 52-100|Death|0|||
144381255|NCT03158285|520606668|FG000|Active Treatment Period: Week 52-100|Other|4|||
144514718|NCT04527146|521083930|FG002|Overall Study|Lost to Follow-up|16|||
144514719|NCT04527146|521083931|FG003|Overall Study|Lost to Follow-up|13|||
144514720|NCT04527146|521083928|FG000|Overall Study|Death|0|||
144514721|NCT04527146|521083929|FG001|Overall Study|Death|1|||
144514722|NCT04527146|521083930|FG002|Overall Study|Death|1|||
144514723|NCT04527146|521083931|FG003|Overall Study|Death|0|||
144514724|NCT04527146|521083928|FG000|Overall Study|Adverse Event|0|||
144514725|NCT04527146|521083929|FG001|Overall Study|Adverse Event|0|||
144514726|NCT04527146|521083930|FG002|Overall Study|Adverse Event|1|||
144514727|NCT04527146|521083931|FG003|Overall Study|Adverse Event|0|||
144514728|NCT04527146|521083928|FG000|Overall Study|Ineligible after randomization|2|||
144514729|NCT04527146|521083929|FG001|Overall Study|Ineligible after randomization|0|||
144514730|NCT04527146|521083930|FG002|Overall Study|Ineligible after randomization|2|||
144514731|NCT04527146|521083931|FG003|Overall Study|Ineligible after randomization|2|||
144514732|NCT04527146|521083928|FG000|Overall Study|Moved to a different group|6|||
144514733|NCT04527146|521083929|FG001|Overall Study|Moved to a different group|3|||
144514734|NCT04527146|521083930|FG002|Overall Study|Moved to a different group|0|||
144514735|NCT04527146|521083931|FG003|Overall Study|Moved to a different group|2|||
144514736|NCT04337372|521083933|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
144514737|NCT04337372|521083934|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
144514738|NCT04337372|521083935|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
144514739|NCT04337372|521083936|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
144514740|NCT04337372|521083933|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
144514741|NCT04337372|521083934|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
144514742|NCT04337372|521083935|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
144514743|NCT04337372|521083936|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
144514744|NCT04337372|521083933|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
144381256|NCT03158285|520606669|FG001|Active Treatment Period: Week 52-100|Other|1|||
144381257|NCT03158285|520606670|FG002|Active Treatment Period: Week 52-100|Other|0|||
144381258|NCT02744040|520606673|FG000|Overall Study|Withdrawal by Subject|3|||
144381259|NCT02744040|520606674|FG001|Overall Study|Withdrawal by Subject|2|||
144381260|NCT02744040|520606675|FG002|Overall Study|Withdrawal by Subject|2|||
144381261|NCT02744040|520606673|FG000|Overall Study|Physician Decision|0|||
144381262|NCT02744040|520606674|FG001|Overall Study|Physician Decision|8|||
144381263|NCT02744040|520606675|FG002|Overall Study|Physician Decision|13|||
144381264|NCT02744040|520606673|FG000|Overall Study|Lost to Follow-up|3|||
144381265|NCT02744040|520606674|FG001|Overall Study|Lost to Follow-up|1|||
144381266|NCT02744040|520606675|FG002|Overall Study|Lost to Follow-up|7|||
144381267|NCT01642615|520606676|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
144381268|NCT01642615|520606677|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
144381269|NCT01642615|520606678|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
144381270|NCT01642615|520606676|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
144381271|NCT01642615|520606677|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
144381272|NCT01642615|520606678|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
144381273|NCT01642615|520606676|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
144381274|NCT01642615|520606677|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
144381275|NCT01642615|520606678|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
144381276|NCT01642615|520606676|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
144381277|NCT01642615|520606677|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
144381278|NCT01642615|520606678|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
144381279|NCT01642615|520606676|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
144381280|NCT01642615|520606677|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
144381281|NCT01642615|520606678|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
144381282|NCT01642615|520606676|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
144381283|NCT01642615|520606677|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
144381284|NCT01642615|520606678|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
144381285|NCT01642615|520606676|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
144381286|NCT01642615|520606677|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
144381287|NCT01642615|520606678|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
144381288|NCT01642615|520606676|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
144381289|NCT01642615|520606677|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
144381290|NCT01642615|520606678|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
144381291|NCT01642615|520606676|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
144381292|NCT01642615|520606677|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
144381293|NCT01642615|520606678|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
144381294|NCT00096356|520606679|FG000|Overall Study|Adverse Event|11|||
144381295|NCT00096356|520606680|FG001|Overall Study|Adverse Event|9|||
144381296|NCT00096356|520606679|FG000|Overall Study|Physician Decision|5|||
144381297|NCT00096356|520606680|FG001|Overall Study|Physician Decision|3|||
144381298|NCT00096356|520606679|FG000|Overall Study|Withdrawal by Subject|17|||
144592352|NCT01602562|521368578|FG001|Overall Study|Adverse Event|1|||
144592353|NCT01602562|521368577|FG000|Overall Study|Physician Decision|1|||
144592354|NCT01602562|521368578|FG001|Overall Study|Physician Decision|1|||
144592355|NCT01602562|521368577|FG000|Overall Study|Withdrawal by Subject|1|||
144592356|NCT01602562|521368578|FG001|Overall Study|Withdrawal by Subject|1|||
144721929|NCT03093454|521836881|FG000|Overall Study|Withdrawal by Subject|1|||
144381299|NCT00096356|520606680|FG001|Overall Study|Withdrawal by Subject|23|||
144381300|NCT00096356|520606679|FG000|Overall Study|Lack of Efficacy|1|||
144381301|NCT00096356|520606680|FG001|Overall Study|Lack of Efficacy|0|||
144381302|NCT00096356|520606679|FG000|Overall Study|multiple reasons|10|||
144381303|NCT00096356|520606680|FG001|Overall Study|multiple reasons|18|||
144381304|NCT01008423|520606681|FG000|Overall Study|Adverse Event|13|||
144381305|NCT01008423|520606682|FG001|Overall Study|Adverse Event|6|||
144381306|NCT01008423|520606681|FG000|Overall Study|Withdrawal by Subject|4|||
144381307|NCT01008423|520606682|FG001|Overall Study|Withdrawal by Subject|7|||
144381308|NCT01008423|520606681|FG000|Overall Study|Lost to Follow-up|0|||
144381309|NCT01008423|520606682|FG001|Overall Study|Lost to Follow-up|2|||
144381310|NCT01008423|520606681|FG000|Overall Study|Low Cortisol|0|||
144592357|NCT04964414|521368579|FG000|Overall Study|Lost to Follow-up|10|||
144721930|NCT03093454|521836882|FG001|Overall Study|Withdrawal by Subject|1|||
144721931|NCT03093454|521836881|FG000|Overall Study|Scheduling conflict|3|||
144514745|NCT04337372|521083934|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
144514746|NCT04337372|521083935|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
144514747|NCT04337372|521083936|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
144514748|NCT04337372|521083933|FG000|Day 2: EEG Measures|Protocol Violation|6|||
144514749|NCT04337372|521083934|FG001|Day 2: EEG Measures|Protocol Violation|6|||
144514750|NCT04337372|521083935|FG002|Day 2: EEG Measures|Protocol Violation|5|||
144514751|NCT04337372|521083936|FG003|Day 2: EEG Measures|Protocol Violation|17|||
144514752|NCT05307783|521083937|FG000|Overall Study|Death|7|||
144514753|NCT05307783|521083937|FG000|Overall Study|Lost to Follow-up|4|||
144514754|NCT04883645|521083938|FG000|Overall Study|Death|1|||
144514755|NCT03460236|521083942|FG000|Overall Study|failed radiographic screening|16|||
144514756|NCT03460236|521083942|FG000|Overall Study|Withdrawal by Subject|11|||
144514757|NCT04247542|521083948|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
144592358|NCT04964414|521368580|FG001|Overall Study|Lost to Follow-up|8|||
144381311|NCT01008423|520606682|FG001|Overall Study|Low Cortisol|1|||
144381312|NCT01008423|520606681|FG000|Overall Study|Lack of Efficacy|0|||
144381313|NCT01008423|520606682|FG001|Overall Study|Lack of Efficacy|5|||
144381314|NCT01008423|520606681|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
144381315|NCT01008423|520606682|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
144381316|NCT01008423|520606681|FG000|Overall Study|Personal Conflict|1|||
144381317|NCT01008423|520606682|FG001|Overall Study|Personal Conflict|0|||
144381318|NCT01008423|520606681|FG000|Overall Study|Other|0|||
144381319|NCT01008423|520606682|FG001|Overall Study|Other|1|||
144381320|NCT01699867|520606686|FG000|Overall Study|Screening Failure|3|||
144381321|NCT00530504|520606691|FG000|Overall Study|Death|54|||
144381322|NCT00530504|520606691|FG000|Overall Study|Lost to Follow-up|26|||
144381323|NCT00530504|520606691|FG000|Overall Study|Withdrawal by Subject|39|||
144381324|NCT00530504|520606691|FG000|Overall Study|Exited study due to other reasons|33|||
144381325|NCT00006289|520606692|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
144381326|NCT00006289|520606693|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
144381327|NCT00006289|520606692|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
144381328|NCT00006289|520606693|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
144381329|NCT03952039|520606703|FG000|Overall Study|Adverse Event|22|||
144381330|NCT03952039|520606704|FG001|Overall Study|Adverse Event|8|||
144381331|NCT03952039|520606703|FG000|Overall Study|Withdrawal by Participant|17|||
144381332|NCT03952039|520606704|FG001|Overall Study|Withdrawal by Participant|12|||
144381333|NCT03952039|520606703|FG000|Overall Study|Death|13|||
144381334|NCT03952039|520606704|FG001|Overall Study|Death|6|||
144381335|NCT03952039|520606703|FG000|Overall Study|Lack of Efficacy|12|||
144381336|NCT03952039|520606704|FG001|Overall Study|Lack of Efficacy|2|||
144381337|NCT03952039|520606703|FG000|Overall Study|Physician Decision|9|||
144381338|NCT03952039|520606704|FG001|Overall Study|Physician Decision|3|||
144381339|NCT03952039|520606703|FG000|Overall Study|Progressive Disease|6|||
144381340|NCT03952039|520606704|FG001|Overall Study|Progressive Disease|4|||
144381341|NCT03952039|520606703|FG000|Overall Study|Other Reasons|12|||
144381342|NCT03952039|520606704|FG001|Overall Study|Other Reasons|4|||
144381343|NCT05009979|520606705|FG000|Overall Study|Withdrawal by Subject|1|||
144381344|NCT04174365|520606706|FG000|Overall Study|Lost to Follow-up|1|||
144381345|NCT04174365|520606707|FG001|Overall Study|Lost to Follow-up|2|||
144381346|NCT04174365|520606706|FG000|Overall Study|Adverse Event|2|||
144381347|NCT04174365|520606707|FG001|Overall Study|Adverse Event|1|||
144381348|NCT04174365|520606706|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
144381349|NCT04174365|520606707|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
144381350|NCT04174365|520606706|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
144381351|NCT04174365|520606707|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
144381352|NCT04174365|520606706|FG000|Overall Study|Protocol Deviation|1|||
144381353|NCT04174365|520606707|FG001|Overall Study|Protocol Deviation|0|||
144381354|NCT04174365|520606706|FG000|Overall Study|Lack of Efficacy|0|||
144381355|NCT04174365|520606707|FG001|Overall Study|Lack of Efficacy|2|||
144381356|NCT04174365|520606706|FG000|Overall Study|Disease Relapse|1|||
144381357|NCT04174365|520606707|FG001|Overall Study|Disease Relapse|0|||
144381358|NCT04174365|520606706|FG000|Overall Study|Reason Not Specified|0|||
144381359|NCT04174365|520606707|FG001|Overall Study|Reason Not Specified|1|||
144381360|NCT03472547|520606708|FG000|Overall Study|Withdrawal by Subject|30|||
144381361|NCT03865316|520608131|FG000|Overall Study|Procedure Cancelled|4|||
144381362|NCT03865316|520608131|FG000|Overall Study|Equipment failure|4|||
144381363|NCT03137069|520608137|FG000|Overall Study|Withdrawal by Subject|1|||
144381364|NCT03137069|520608138|FG001|Overall Study|Withdrawal by Subject|2|||
144381365|NCT03137069|520608139|FG002|Overall Study|Withdrawal by Subject|2|||
144381366|NCT03137069|520608140|FG003|Overall Study|Withdrawal by Subject|2|||
144381367|NCT03137069|520608141|FG004|Overall Study|Withdrawal by Subject|0|||
144381368|NCT03137069|520608142|FG005|Overall Study|Withdrawal by Subject|0|||
144381369|NCT03137069|520608137|FG000|Overall Study|Adverse Event|0|||
144381370|NCT03137069|520608138|FG001|Overall Study|Adverse Event|3|||
144381371|NCT03137069|520608139|FG002|Overall Study|Adverse Event|1|||
144381372|NCT03137069|520608140|FG003|Overall Study|Adverse Event|1|||
144381373|NCT03137069|520608141|FG004|Overall Study|Adverse Event|0|||
144592359|NCT04964414|521368579|FG000|Overall Study|Withdrawal by Subject|1|||
144381374|NCT03137069|520608142|FG005|Overall Study|Adverse Event|1|||
144381375|NCT03137069|520608137|FG000|Overall Study|Protocol Violation|0|||
144381376|NCT03137069|520608138|FG001|Overall Study|Protocol Violation|1|||
144381377|NCT03137069|520608139|FG002|Overall Study|Protocol Violation|0|||
144381378|NCT03137069|520608140|FG003|Overall Study|Protocol Violation|1|||
144381379|NCT03137069|520608141|FG004|Overall Study|Protocol Violation|1|||
144381380|NCT03137069|520608142|FG005|Overall Study|Protocol Violation|1|||
144381381|NCT03137069|520608137|FG000|Overall Study|Physician Decision|0|||
144381382|NCT03137069|520608138|FG001|Overall Study|Physician Decision|0|||
144381383|NCT03137069|520608139|FG002|Overall Study|Physician Decision|0|||
144381384|NCT03137069|520608140|FG003|Overall Study|Physician Decision|1|||
144381385|NCT03137069|520608141|FG004|Overall Study|Physician Decision|0|||
144381386|NCT03137069|520608142|FG005|Overall Study|Physician Decision|0|||
144381387|NCT03137069|520608137|FG000|Overall Study|Study Terminated by Sponsor|0|||
144381388|NCT03137069|520608138|FG001|Overall Study|Study Terminated by Sponsor|0|||
144381389|NCT03137069|520608139|FG002|Overall Study|Study Terminated by Sponsor|0|||
144381390|NCT03137069|520608140|FG003|Overall Study|Study Terminated by Sponsor|0|||
144381391|NCT03137069|520608141|FG004|Overall Study|Study Terminated by Sponsor|1|||
144381392|NCT03137069|520608142|FG005|Overall Study|Study Terminated by Sponsor|0|||
144381393|NCT03137069|520608137|FG000|Overall Study|Data Entry Error|0|||
144381394|NCT03137069|520608138|FG001|Overall Study|Data Entry Error|0|||
144381395|NCT03137069|520608139|FG002|Overall Study|Data Entry Error|0|||
144381396|NCT03137069|520608140|FG003|Overall Study|Data Entry Error|1|||
144381397|NCT03137069|520608141|FG004|Overall Study|Data Entry Error|0|||
144381398|NCT03137069|520608142|FG005|Overall Study|Data Entry Error|0|||
144381399|NCT00336856|520608143|FG000|Overall Study|Withdrawal by Subject|3|||
144381400|NCT00336856|520608143|FG000|Overall Study|Found ineligible at time of analysis|1|||
144381401|NCT02522624|520608145|FG000|Overall Study|Technical failure|1|||
144381402|NCT02522624|520608146|FG001|Overall Study|Technical failure|0|||
144381403|NCT01325337|520608147|FG000|Overall Study|Adverse Event|0|||
144381404|NCT01325337|520608148|FG001|Overall Study|Adverse Event|2|||
144381405|NCT01325337|520608149|FG002|Overall Study|Adverse Event|2|||
144381406|NCT01325337|520608150|FG003|Overall Study|Adverse Event|1|||
144381407|NCT01325337|520608151|FG004|Overall Study|Adverse Event|2|||
144381408|NCT01325337|520608147|FG000|Overall Study|Lost to Follow-up|2|||
144381409|NCT01325337|520608148|FG001|Overall Study|Lost to Follow-up|2|||
144381410|NCT01325337|520608149|FG002|Overall Study|Lost to Follow-up|2|||
144381411|NCT01325337|520608150|FG003|Overall Study|Lost to Follow-up|1|||
144381412|NCT01325337|520608151|FG004|Overall Study|Lost to Follow-up|2|||
144381413|NCT01325337|520608147|FG000|Overall Study|Personal Reasons|2|||
144381414|NCT01325337|520608148|FG001|Overall Study|Personal Reasons|5|||
144381415|NCT01325337|520608149|FG002|Overall Study|Personal Reasons|4|||
144381416|NCT01325337|520608150|FG003|Overall Study|Personal Reasons|8|||
144381417|NCT01325337|520608151|FG004|Overall Study|Personal Reasons|3|||
144381418|NCT01325337|520608147|FG000|Overall Study|Withdrawal by Subject|1|||
144381419|NCT01325337|520608148|FG001|Overall Study|Withdrawal by Subject|0|||
144381420|NCT01325337|520608149|FG002|Overall Study|Withdrawal by Subject|1|||
144381421|NCT01325337|520608150|FG003|Overall Study|Withdrawal by Subject|0|||
144381422|NCT01325337|520608151|FG004|Overall Study|Withdrawal by Subject|1|||
144381423|NCT01347580|520608159|FG000|Overall Study|Withdrawal by Subject|13|||
144381424|NCT01347580|520608160|FG001|Overall Study|Withdrawal by Subject|23|||
144381425|NCT01347580|520608159|FG000|Overall Study|Death|30|||
144381426|NCT01347580|520608160|FG001|Overall Study|Death|19|||
144381427|NCT01347580|520608159|FG000|Overall Study|Protocol Violation|10|||
144381428|NCT01347580|520608160|FG001|Overall Study|Protocol Violation|7|||
144381429|NCT01347580|520608159|FG000|Overall Study|Lost to Follow-up|3|||
144381430|NCT01347580|520608160|FG001|Overall Study|Lost to Follow-up|1|||
144381431|NCT01347580|520608159|FG000|Overall Study|Had other reason|9|||
144381432|NCT01347580|520608160|FG001|Overall Study|Had other reason|6|||
144381433|NCT00538785|520608162|FG000|Overall Study|Death|9|||
144381434|NCT00538785|520608163|FG001|Overall Study|Death|10|||
144381435|NCT00538785|520608162|FG000|Overall Study|Withdrawal of consent|9|||
144381436|NCT00538785|520608163|FG001|Overall Study|Withdrawal of consent|7|||
144381437|NCT00538785|520608162|FG000|Overall Study|Lost to Follow-up|1|||
144381438|NCT00538785|520608163|FG001|Overall Study|Lost to Follow-up|0|||
144381439|NCT04022733|520608164|FG000|Overall Study|conversion to open surgery|3|||
144381440|NCT04022733|520608165|FG001|Overall Study|conversion to open surgery|2|||
144381441|NCT04022733|520608164|FG000|Overall Study|bradycardia|0|||
144381442|NCT04022733|520608165|FG001|Overall Study|bradycardia|1|||
144381443|NCT04074161|520608173|FG000|Overall Study|Withdrawal by Subject|2|||
144381444|NCT04074161|520608174|FG001|Overall Study|Withdrawal by Subject|4|||
144381445|NCT04074161|520608175|FG002|Overall Study|Withdrawal by Subject|1|||
144381446|NCT04074161|520608173|FG000|Overall Study|Lost to Follow-up|4|||
144381447|NCT04074161|520608174|FG001|Overall Study|Lost to Follow-up|5|||
144592360|NCT04964414|521368580|FG001|Overall Study|Withdrawal by Subject|1|||
144592361|NCT00819390|521368582|FG000|Overall Study|Lost to Follow-up|1|||
144381448|NCT04074161|520608175|FG002|Overall Study|Lost to Follow-up|3|||
144381449|NCT02208063|520608178|FG000|Overall Study|Death|3|||
144381450|NCT02208063|520608179|FG001|Overall Study|Death|5|||
144381451|NCT02208063|520608178|FG000|Overall Study|Not Specified in report|3|||
144381452|NCT02208063|520608179|FG001|Overall Study|Not Specified in report|4|||
144381453|NCT02208063|520608178|FG000|Overall Study|Withdrawal by Subject|5|||
144381454|NCT02208063|520608179|FG001|Overall Study|Withdrawal by Subject|2|||
144381455|NCT02208063|520608178|FG000|Overall Study|Lost to Follow-up|1|||
144381456|NCT02208063|520608179|FG001|Overall Study|Lost to Follow-up|0|||
144381457|NCT02122783|520608185|FG000|Overall Study|Adverse Event|0|||
144381458|NCT02122783|520608186|FG001|Overall Study|Adverse Event|1|||
144381459|NCT00329849|520608187|FG000|Overall Study|Withdrawal by Subject|6|||
144381460|NCT00329849|520608188|FG001|Overall Study|Withdrawal by Subject|4|||
144381461|NCT00322621|520608195|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
144381462|NCT00322621|520608196|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
144381463|NCT00322621|520608197|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
144381464|NCT00322621|520608195|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
144381465|NCT00322621|520608196|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
144381466|NCT00322621|520608197|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
144381467|NCT00322621|520608195|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
144381468|NCT00322621|520608196|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
144381469|NCT00322621|520608197|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
144381470|NCT00322621|520608195|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
144381471|NCT00322621|520608196|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
144381472|NCT00322621|520608197|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
144381473|NCT00322621|520608195|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
144381474|NCT00322621|520608196|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
144381475|NCT00322621|520608197|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
144381476|NCT00322621|520608195|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
144381477|NCT00322621|520608196|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
144381478|NCT00322621|520608197|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
144381479|NCT00322621|520608195|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
144381480|NCT00322621|520608196|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
144381481|NCT00322621|520608197|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
144381482|NCT00322621|520608195|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
144381483|NCT00322621|520608196|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
144721932|NCT03093454|521836882|FG001|Overall Study|Scheduling conflict|1|||
144381484|NCT00322621|520608197|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
144381485|NCT00322621|520608195|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
144381486|NCT00322621|520608196|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
144381487|NCT00322621|520608197|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
144381488|NCT00322621|520608195|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
144514758|NCT04247542|521083949|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
144514759|NCT04247542|521083950|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
144514760|NCT04247542|521083948|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
144381489|NCT00322621|520608196|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
144381490|NCT00322621|520608197|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
144381491|NCT00322621|520608195|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
144381492|NCT00322621|520608196|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
144381493|NCT00322621|520608197|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
144381494|NCT01038869|520608200|FG000|Overall Study|Withdrawal by Subject|1|||
144381495|NCT01038869|520608200|FG000|Overall Study|Lost to Follow-up|6|||
144381496|NCT02238067|520608201|FG000|Overall Study|Not completed survey at Month 6|45|||
144381497|NCT02213133|520608202|FG000|Overall Study|Participant discontinued study therapy|2|||
144381498|NCT02213133|520608203|FG001|Overall Study|Participant discontinued study therapy|0|||
144381499|NCT02213133|520608204|FG002|Overall Study|Participant discontinued study therapy|0|||
144381500|NCT02213133|520608202|FG000|Overall Study|Participant withdrew informed consent|2|||
144381501|NCT02213133|520608203|FG001|Overall Study|Participant withdrew informed consent|1|||
144592362|NCT00819390|521368583|FG001|Overall Study|Lost to Follow-up|1|||
144381502|NCT02213133|520608204|FG002|Overall Study|Participant withdrew informed consent|2|||
144381503|NCT02213133|520608202|FG000|Overall Study|Disease progression|11|||
144381504|NCT02213133|520608203|FG001|Overall Study|Disease progression|2|||
144381505|NCT02213133|520608204|FG002|Overall Study|Disease progression|0|||
144381506|NCT02213133|520608202|FG000|Overall Study|Adverse Event (AE)|1|||
144381507|NCT02213133|520608203|FG001|Overall Study|Adverse Event (AE)|0|||
144381508|NCT02213133|520608204|FG002|Overall Study|Adverse Event (AE)|0|||
144381509|NCT02213133|520608202|FG000|Overall Study|Death|16|||
144381510|NCT02213133|520608203|FG001|Overall Study|Death|2|||
144381511|NCT02213133|520608204|FG002|Overall Study|Death|1|||
144381512|NCT02213133|520608202|FG000|Overall Study|Other|5|||
144381513|NCT02213133|520608203|FG001|Overall Study|Other|0|||
144381514|NCT02213133|520608204|FG002|Overall Study|Other|0|||
144381515|NCT01328444|520608205|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
144381516|NCT01328444|520608206|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
144381517|NCT01328444|520608207|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
144381518|NCT01328444|520608208|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
144381519|NCT01328444|520608209|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
144381520|NCT01328444|520608210|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
144381521|NCT01328444|520608205|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
144381522|NCT01328444|520608206|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
144381523|NCT01328444|520608207|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
144381524|NCT01328444|520608208|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
144381525|NCT01328444|520608209|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
144381526|NCT01328444|520608210|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
144381527|NCT01328444|520608205|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
144381528|NCT01328444|520608206|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
144381529|NCT01328444|520608207|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
144381530|NCT01328444|520608208|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
144381531|NCT01328444|520608209|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
144381532|NCT01328444|520608210|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
144381533|NCT01328444|520608205|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
144381534|NCT01328444|520608206|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
144381535|NCT01328444|520608207|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
144381536|NCT01328444|520608208|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
144381537|NCT01328444|520608209|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
144381538|NCT01328444|520608210|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
144381539|NCT01328444|520608205|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
144381540|NCT01328444|520608206|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144381541|NCT01328444|520608207|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144381542|NCT01328444|520608208|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144381543|NCT01328444|520608209|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144381544|NCT01328444|520608210|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144381545|NCT01328444|520608205|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144381546|NCT01328444|520608206|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
144381547|NCT01328444|520608207|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
144381548|NCT01328444|520608208|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
144592363|NCT00819390|521368584|FG002|Overall Study|Lost to Follow-up|0|||
144592364|NCT00819390|521368585|FG003|Overall Study|Lost to Follow-up|0|||
144592365|NCT00819390|521368582|FG000|Overall Study|Withdrawal by Subject|2|||
144592366|NCT00819390|521368583|FG001|Overall Study|Withdrawal by Subject|0|||
144592367|NCT00819390|521368584|FG002|Overall Study|Withdrawal by Subject|0|||
144592368|NCT00819390|521368585|FG003|Overall Study|Withdrawal by Subject|0|||
144592369|NCT00819390|521368582|FG000|Overall Study|Adverse Event|0|||
144592370|NCT00819390|521368583|FG001|Overall Study|Adverse Event|0|||
144592371|NCT00819390|521368584|FG002|Overall Study|Adverse Event|1|||
144592372|NCT00819390|521368585|FG003|Overall Study|Adverse Event|0|||
144592373|NCT00705523|521368586|FG000|Overall Study|Lost to Follow-up|2|||
144721933|NCT03093454|521836881|FG000|Overall Study|Physician Decision|2|||
144592374|NCT00705523|521368587|FG001|Overall Study|Lost to Follow-up|3|||
144592375|NCT00790751|521368599|FG000|Overall Study|Protocol non-compliance|16|||
144381549|NCT01328444|520608209|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
144381550|NCT01328444|520608210|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144381551|NCT01328444|520608205|FG000|Washout Period (14 Days)|Adverse Event|1|||
144381552|NCT01328444|520608206|FG001|Washout Period (14 Days)|Adverse Event|1|||
144592376|NCT00790751|521368600|FG001|Overall Study|Protocol non-compliance|16|||
144592377|NCT00790751|521368601|FG002|Overall Study|Protocol non-compliance|10|||
144592378|NCT00790751|521368602|FG003|Overall Study|Protocol non-compliance|11|||
144381553|NCT01328444|520608207|FG002|Washout Period (14 Days)|Adverse Event|0|||
144381554|NCT01328444|520608208|FG003|Washout Period (14 Days)|Adverse Event|1|||
144381555|NCT01328444|520608209|FG004|Washout Period (14 Days)|Adverse Event|1|||
144381556|NCT01328444|520608210|FG005|Washout Period (14 Days)|Adverse Event|2|||
144381557|NCT01328444|520608205|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
144381558|NCT01328444|520608206|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
144381559|NCT01328444|520608207|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
144381560|NCT01328444|520608208|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
144381561|NCT01328444|520608209|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
144381562|NCT01328444|520608210|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
144381563|NCT01328444|520608205|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
144381564|NCT01328444|520608206|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
144381565|NCT01328444|520608207|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
144381566|NCT01328444|520608208|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
144381567|NCT01328444|520608209|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
144381568|NCT01328444|520608210|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
144381569|NCT01328444|520608205|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
144381570|NCT01328444|520608206|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
144381571|NCT01328444|520608207|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
144381572|NCT01328444|520608208|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
144381573|NCT01328444|520608209|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
144381574|NCT01328444|520608210|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
144381575|NCT01328444|520608205|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
144381576|NCT01328444|520608206|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
144381577|NCT01328444|520608207|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
144381578|NCT01328444|520608208|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
144381579|NCT01328444|520608209|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
144381580|NCT01328444|520608210|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
144381581|NCT01328444|520608205|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
144381582|NCT01328444|520608206|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
144381583|NCT01328444|520608207|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
144381584|NCT01328444|520608208|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
144381585|NCT01328444|520608209|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
144381586|NCT01328444|520608210|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
144381587|NCT01328444|520608205|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
144381588|NCT01328444|520608206|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
144381589|NCT01328444|520608207|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
144381590|NCT01328444|520608208|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
144381591|NCT01328444|520608209|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
144381592|NCT01328444|520608210|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
144381593|NCT01328444|520608205|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
144381594|NCT01328444|520608206|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
144381595|NCT01328444|520608207|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
144381596|NCT01328444|520608208|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
144381597|NCT01328444|520608209|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
144381598|NCT01328444|520608210|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
144381599|NCT01328444|520608205|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144381600|NCT01328444|520608206|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144381601|NCT01328444|520608207|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144381602|NCT01328444|520608208|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144514761|NCT04247542|521083949|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
144514762|NCT04247542|521083950|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
144514763|NCT02201108|521083951|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
144514764|NCT02201108|521083952|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
144514765|NCT02201108|521083953|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
144381603|NCT01328444|520608209|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144381604|NCT01328444|520608210|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144381605|NCT04620798|520608213|FG000|Overall Study|Lost to Follow-up|126|||
144381606|NCT04620798|520608214|FG001|Overall Study|Lost to Follow-up|138|||
144381607|NCT01960907|520608217|FG000|Overall Study|Death|4|||
144381608|NCT01960907|520608218|FG001|Overall Study|Death|3|||
144381609|NCT01960907|520608217|FG000|Overall Study|Withdrawal by Subject|32|||
144381610|NCT01960907|520608218|FG001|Overall Study|Withdrawal by Subject|42|||
144514766|NCT02201108|521083951|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
144381611|NCT03288142|520608231|FG000|Overall Study|Lost to Follow-up|22|||
144381612|NCT03288142|520608232|FG001|Overall Study|Lost to Follow-up|15|||
144381613|NCT00402740|520608235|FG000|Overall Study|Withdrawal by Subject|18|||
144381614|NCT00402740|520608235|FG000|Overall Study|Death|50|||
144381615|NCT00402740|520608235|FG000|Overall Study|Lost to Follow-up|6|||
144381616|NCT00402740|520608235|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
144381617|NCT00402740|520608235|FG000|Overall Study|Subject disposition unknown.|1|||
144381618|NCT01028300|520608236|FG000|Overall Study|Study Terminated|4|||
144381619|NCT01214395|520608239|FG000|Overall Study|All patients had infection|5|||
144381620|NCT02034409|520608240|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
144381621|NCT02034409|520608241|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
144381622|NCT02034409|520608240|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
144381623|NCT02034409|520608241|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
144381624|NCT02034409|520608240|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
144381625|NCT02034409|520608241|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
144381626|NCT02034409|520608240|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
144381627|NCT02034409|520608241|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
144381628|NCT02034409|520608240|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
144381629|NCT02034409|520608241|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
144381630|NCT02034409|520608240|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
144381631|NCT02034409|520608241|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
144381632|NCT00946153|520608242|FG000|Phase 2|Adverse Event|0|||
144381633|NCT00946153|520608243|FG001|Phase 2|Adverse Event|0|||
144381634|NCT00946153|520608244|FG002|Phase 2|Adverse Event|0|||
144381635|NCT00946153|520608245|FG003|Phase 2|Adverse Event|0|||
144381636|NCT00946153|520608246|FG004|Phase 2|Adverse Event|6|||
144381637|NCT00946153|520608242|FG000|Phase 2|Need more reduction of dose|0|||
144381638|NCT00946153|520608243|FG001|Phase 2|Need more reduction of dose|0|||
144381639|NCT00946153|520608244|FG002|Phase 2|Need more reduction of dose|0|||
144381640|NCT00946153|520608245|FG003|Phase 2|Need more reduction of dose|0|||
144381641|NCT00946153|520608246|FG004|Phase 2|Need more reduction of dose|2|||
144381642|NCT00946153|520608242|FG000|Phase 2|Physician Decision|0|||
144381643|NCT00946153|520608243|FG001|Phase 2|Physician Decision|0|||
144381644|NCT00946153|520608244|FG002|Phase 2|Physician Decision|0|||
144381645|NCT00946153|520608245|FG003|Phase 2|Physician Decision|0|||
144381646|NCT00946153|520608246|FG004|Phase 2|Physician Decision|1|||
144381647|NCT00946153|520608242|FG000|Phase 2|14 days washout for recovery due to AE|0|||
144381648|NCT00946153|520608243|FG001|Phase 2|14 days washout for recovery due to AE|0|||
144381649|NCT00946153|520608244|FG002|Phase 2|14 days washout for recovery due to AE|0|||
144381650|NCT00946153|520608245|FG003|Phase 2|14 days washout for recovery due to AE|0|||
144381651|NCT00946153|520608246|FG004|Phase 2|14 days washout for recovery due to AE|4|||
144381652|NCT00934843|520608247|FG000|Overall Study|Protocol Violation|0|||
144381653|NCT00934843|520608248|FG001|Overall Study|Protocol Violation|1|||
144381654|NCT00831493|520608261|FG000|Overall Study|Intractable nausea and vomiting|1|||
144381655|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
144381656|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
144381657|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
144381658|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
144381659|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
144381660|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
144381661|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
144381662|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
144381663|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
144381664|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
144592379|NCT00790751|521368599|FG000|Overall Study|Lost to Follow-up|4|||
144381665|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144381666|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
144381667|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144381668|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144592380|NCT00790751|521368600|FG001|Overall Study|Lost to Follow-up|9|||
144381669|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144592381|NCT00790751|521368601|FG002|Overall Study|Lost to Follow-up|4|||
144592382|NCT00790751|521368602|FG003|Overall Study|Lost to Follow-up|5|||
144381670|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144381671|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144381672|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
144381673|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
144381674|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
144381675|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
144381676|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
144381677|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
144381678|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
144381679|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
144381680|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
144381681|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
144381682|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|Other|0|||
144381683|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|Other|0|||
144381684|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|Other|1|||
144381685|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|Other|1|||
144381686|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|Other|0|||
144381687|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|Other|0|||
144381688|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|Other|0|||
144381689|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|Other|1|||
144381690|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|Other|0|||
144381691|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|Death|0|||
144381692|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|Death|0|||
144381693|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|Death|0|||
144381694|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|Death|0|||
144381695|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|Death|0|||
144381696|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|Death|1|||
144381697|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|Death|0|||
144381698|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|Death|0|||
144381699|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|Death|0|||
144381700|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381701|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381702|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381703|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381704|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381705|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
144381706|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
144381707|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381708|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
144381709|NCT00557856|520608264|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
144381710|NCT00557856|520608265|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381711|NCT00557856|520608266|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381712|NCT00557856|520608267|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381713|NCT00557856|520608268|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381714|NCT00557856|520608269|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381715|NCT00557856|520608270|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381716|NCT00557856|520608271|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381717|NCT00557856|520608272|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
144381718|NCT00557856|520608264|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381719|NCT00557856|520608265|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381720|NCT00557856|520608266|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381721|NCT00557856|520608267|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381722|NCT00557856|520608268|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381723|NCT00557856|520608269|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381724|NCT00557856|520608270|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381725|NCT00557856|520608271|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
144381726|NCT00557856|520608272|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
144381727|NCT00557856|520608264|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381728|NCT00557856|520608265|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381729|NCT00557856|520608266|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381730|NCT00557856|520608267|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381731|NCT00557856|520608268|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381732|NCT00557856|520608269|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381733|NCT00557856|520608270|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381734|NCT00557856|520608271|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
144381735|NCT00557856|520608272|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
144381736|NCT00557856|520608264|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
144381737|NCT00557856|520608265|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
144381738|NCT00557856|520608266|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
144381739|NCT00557856|520608267|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
144381740|NCT00557856|520608268|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
144381741|NCT00557856|520608269|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
144381742|NCT00557856|520608270|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
144381743|NCT00557856|520608271|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
144381744|NCT00557856|520608272|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
144381745|NCT00557856|520608264|FG000|Part 2: Exploratory Phase|Other|0|||
144381746|NCT00557856|520608265|FG001|Part 2: Exploratory Phase|Other|0|||
144381747|NCT00557856|520608266|FG002|Part 2: Exploratory Phase|Other|0|||
144381748|NCT00557856|520608267|FG003|Part 2: Exploratory Phase|Other|0|||
144381749|NCT00557856|520608268|FG004|Part 2: Exploratory Phase|Other|0|||
144381750|NCT00557856|520608269|FG005|Part 2: Exploratory Phase|Other|0|||
144381751|NCT00557856|520608270|FG006|Part 2: Exploratory Phase|Other|0|||
144381752|NCT00557856|520608271|FG007|Part 2: Exploratory Phase|Other|0|||
144381753|NCT00557856|520608272|FG008|Part 2: Exploratory Phase|Other|1|||
144381754|NCT00557856|520608264|FG000|Part 2: Exploratory Phase|Death|0|||
144381755|NCT00557856|520608265|FG001|Part 2: Exploratory Phase|Death|0|||
144381756|NCT00557856|520608266|FG002|Part 2: Exploratory Phase|Death|0|||
144514767|NCT02201108|521083952|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
144514768|NCT02201108|521083953|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
144514769|NCT02201108|521083951|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
144514770|NCT02201108|521083952|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
144514771|NCT02201108|521083953|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
144381757|NCT00557856|520608267|FG003|Part 2: Exploratory Phase|Death|0|||
144381758|NCT00557856|520608268|FG004|Part 2: Exploratory Phase|Death|0|||
144381759|NCT00557856|520608269|FG005|Part 2: Exploratory Phase|Death|0|||
144381760|NCT00557856|520608270|FG006|Part 2: Exploratory Phase|Death|0|||
144381761|NCT00557856|520608271|FG007|Part 2: Exploratory Phase|Death|0|||
144381762|NCT00557856|520608272|FG008|Part 2: Exploratory Phase|Death|2|||
144381763|NCT00557856|520608264|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381764|NCT00557856|520608265|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
144514772|NCT02201108|521083951|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
144381765|NCT00557856|520608266|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381766|NCT00557856|520608267|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381767|NCT00557856|520608268|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381768|NCT00557856|520608269|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381769|NCT00557856|520608270|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381770|NCT00557856|520608271|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
144381771|NCT00557856|520608272|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
144381772|NCT05092360|520608273|FG000|Overall Study|Withdrawal by Subject|21|||
144381773|NCT05092360|520608274|FG001|Overall Study|Withdrawal by Subject|4|||
144381774|NCT05092360|520608275|FG002|Overall Study|Withdrawal by Subject|9|||
144381775|NCT05092360|520608276|FG003|Overall Study|Withdrawal by Subject|26|||
144381776|NCT05092360|520608273|FG000|Overall Study|Death|97|||
144381777|NCT05092360|520608274|FG001|Overall Study|Death|14|||
144381778|NCT05092360|520608275|FG002|Overall Study|Death|31|||
144381779|NCT05092360|520608276|FG003|Overall Study|Death|101|||
144381780|NCT05092360|520608273|FG000|Overall Study|Lost to Follow-up|1|||
144381781|NCT05092360|520608274|FG001|Overall Study|Lost to Follow-up|2|||
144381782|NCT05092360|520608275|FG002|Overall Study|Lost to Follow-up|2|||
144381783|NCT05092360|520608276|FG003|Overall Study|Lost to Follow-up|2|||
144381784|NCT05092360|520608273|FG000|Overall Study|Study terminated by sponsor|65|||
144381785|NCT05092360|520608274|FG001|Overall Study|Study terminated by sponsor|7|||
144381786|NCT05092360|520608275|FG002|Overall Study|Study terminated by sponsor|13|||
144381787|NCT05092360|520608276|FG003|Overall Study|Study terminated by sponsor|61|||
144381788|NCT01675167|520608277|FG000|Open-label Titration Phase|Adverse Event|81|||
144381789|NCT01675167|520608278|FG001|Open-label Titration Phase|Adverse Event|0|||
144381790|NCT01675167|520608279|FG002|Open-label Titration Phase|Adverse Event|0|||
144381791|NCT01675167|520608277|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
144381792|NCT01675167|520608278|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
144381793|NCT01675167|520608279|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
144381794|NCT01675167|520608277|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
144381795|NCT01675167|520608278|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
144381796|NCT01675167|520608279|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
144381797|NCT01675167|520608277|FG000|Open-label Titration Phase|Protocol Violation|43|||
144381798|NCT01675167|520608278|FG001|Open-label Titration Phase|Protocol Violation|0|||
144381799|NCT01675167|520608279|FG002|Open-label Titration Phase|Protocol Violation|0|||
144381800|NCT01675167|520608277|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
144381801|NCT01675167|520608278|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
144381802|NCT01675167|520608279|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
144381803|NCT01675167|520608277|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
144381804|NCT01675167|520608278|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
144381805|NCT01675167|520608279|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
144381806|NCT01675167|520608277|FG000|Open-label Titration Phase|Other|55|||
144381807|NCT01675167|520608278|FG001|Open-label Titration Phase|Other|0|||
144381808|NCT01675167|520608279|FG002|Open-label Titration Phase|Other|0|||
144381809|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
144381810|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
144381811|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
144381812|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144381813|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
144381814|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
144381815|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Adverse Event|0|||
144381816|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Adverse Event|5|||
144381817|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Adverse Event|13|||
144381818|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
144381819|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
144381820|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
144381821|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
144381822|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
144381823|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
144381824|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
144381825|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
144381826|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
144381827|NCT01675167|520608277|FG000|Double-blind Treatment Phase|Other|0|||
144381828|NCT01675167|520608278|FG001|Double-blind Treatment Phase|Other|7|||
144381829|NCT01675167|520608279|FG002|Double-blind Treatment Phase|Other|5|||
144381830|NCT01525225|520608280|FG000|Enrollment|No longer met study criteria|1|||
144381831|NCT01525225|520608280|FG000|Enrollment|Other|1|||
144381832|NCT03255083|520608281|FG000|Overall Study|Clinical progression|1|||
144381833|NCT03255083|520608282|FG001|Overall Study|Clinical progression|0|||
144381834|NCT03255083|520608283|FG002|Overall Study|Clinical progression|0|||
144381835|NCT03255083|520608284|FG003|Overall Study|Clinical progression|0|||
144381836|NCT03255083|520608281|FG000|Overall Study|Adverse Event|0|||
144381837|NCT03255083|520608282|FG001|Overall Study|Adverse Event|1|||
144381838|NCT03255083|520608283|FG002|Overall Study|Adverse Event|0|||
144381839|NCT03255083|520608284|FG003|Overall Study|Adverse Event|0|||
144381840|NCT03255083|520608281|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
144381841|NCT03255083|520608282|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
144381842|NCT03255083|520608283|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
144381843|NCT03255083|520608284|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
144381844|NCT03255083|520608281|FG000|Overall Study|Withdrawal by Subject|1|||
144381845|NCT03255083|520608282|FG001|Overall Study|Withdrawal by Subject|1|||
144381846|NCT03255083|520608283|FG002|Overall Study|Withdrawal by Subject|1|||
144381847|NCT03255083|520608284|FG003|Overall Study|Withdrawal by Subject|0|||
144381848|NCT00363545|520608285|FG000|Overall Study|Serious Adverse Event|0|||
144381849|NCT00363545|520608286|FG001|Overall Study|Serious Adverse Event|1|||
144381850|NCT00363545|520608285|FG000|Overall Study|Withdrawal by Subject|12|||
144381851|NCT00363545|520608286|FG001|Overall Study|Withdrawal by Subject|15|||
144381852|NCT00363545|520608285|FG000|Overall Study|Migrated/moved from study area|3|||
144381853|NCT00363545|520608286|FG001|Overall Study|Migrated/moved from study area|6|||
144381854|NCT00363545|520608285|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
144381855|NCT00363545|520608286|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
144381856|NCT00363545|520608285|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
144381857|NCT00363545|520608286|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
144381858|NCT00363545|520608285|FG000|Overall Study|Others|1|||
144381859|NCT00363545|520608286|FG001|Overall Study|Others|0|||
144381860|NCT01457352|520608287|FG000|Period 1|Adverse Event|2|||
144381861|NCT01457352|520608288|FG001|Period 1|Adverse Event|0|||
144381862|NCT01457352|520608287|FG000|Period 1|Withdrawal by Subject|2|||
144381863|NCT01457352|520608288|FG001|Period 1|Withdrawal by Subject|0|||
144381864|NCT01457352|520608287|FG000|Period 1|Physician Decision|2|||
144381865|NCT01457352|520608288|FG001|Period 1|Physician Decision|0|||
144381866|NCT01457352|520608287|FG000|Period 1|MS related disease progression|1|||
144381867|NCT01457352|520608288|FG001|Period 1|MS related disease progression|0|||
144381868|NCT01457352|520608287|FG000|Period 1|Withdrawn|1|||
144381869|NCT01457352|520608288|FG001|Period 1|Withdrawn|0|||
144381870|NCT01457352|520608287|FG000|Period 1|withdrew per sponsor|1|||
144381871|NCT01457352|520608288|FG001|Period 1|withdrew per sponsor|0|||
144381872|NCT01457352|520608287|FG000|Period 1|Protocol Violation|4|||
144381873|NCT01457352|520608288|FG001|Period 1|Protocol Violation|0|||
144381874|NCT01457352|520608287|FG000|Period 1|Did not meet eligibility criteria|3|||
144381875|NCT01457352|520608288|FG001|Period 1|Did not meet eligibility criteria|0|||
144381876|NCT01457352|520608287|FG000|Period 2|Withdrawal by Subject|23|||
144381877|NCT01457352|520608288|FG001|Period 2|Withdrawal by Subject|0|||
144381878|NCT01457352|520608287|FG000|Period 2|Adverse Event|22|||
144381879|NCT01457352|520608288|FG001|Period 2|Adverse Event|0|||
144381880|NCT01457352|520608287|FG000|Period 2|no analysis|10|||
144381881|NCT01457352|520608288|FG001|Period 2|no analysis|0|||
144381882|NCT01457352|520608287|FG000|Period 2|Lack of Efficacy|8|||
144381883|NCT01457352|520608288|FG001|Period 2|Lack of Efficacy|0|||
144381884|NCT01457352|520608287|FG000|Period 2|Protocol Violation|4|||
144592383|NCT00790751|521368599|FG000|Overall Study|Adverse Event|5|||
144592384|NCT00790751|521368600|FG001|Overall Study|Adverse Event|3|||
144592385|NCT00790751|521368601|FG002|Overall Study|Adverse Event|5|||
144592386|NCT00790751|521368602|FG003|Overall Study|Adverse Event|4|||
144592387|NCT00790751|521368599|FG000|Overall Study|Requirement for restricted medication|0|||
144592388|NCT00790751|521368600|FG001|Overall Study|Requirement for restricted medication|2|||
144592389|NCT00790751|521368601|FG002|Overall Study|Requirement for restricted medication|0|||
144592390|NCT00790751|521368602|FG003|Overall Study|Requirement for restricted medication|0|||
144592391|NCT00790751|521368599|FG000|Overall Study|Death|0|||
144592392|NCT00790751|521368600|FG001|Overall Study|Death|0|||
144592393|NCT00790751|521368601|FG002|Overall Study|Death|1|||
144721934|NCT03093454|521836882|FG001|Overall Study|Physician Decision|1|||
144381885|NCT01457352|520608288|FG001|Period 2|Protocol Violation|0|||
144381886|NCT01457352|520608287|FG000|Period 2|Sponsor's withdrawal|7|||
144381887|NCT01457352|520608288|FG001|Period 2|Sponsor's withdrawal|0|||
144592394|NCT00790751|521368602|FG003|Overall Study|Death|0|||
144592395|NCT00790751|521368599|FG000|Overall Study|Physician Decision|0|||
144721935|NCT04540497|521836883|FG000|Overall Study|Adverse Event|0|||
144381888|NCT01457352|520608287|FG000|Period 2|Lost to Follow-up|1|||
144381889|NCT01457352|520608288|FG001|Period 2|Lost to Follow-up|0|||
144381890|NCT01457352|520608287|FG000|Period 2|dose change|1|||
144381891|NCT01457352|520608288|FG001|Period 2|dose change|0|||
144381892|NCT01457352|520608287|FG000|Period 2|Physician Decision|1|||
144381893|NCT01457352|520608288|FG001|Period 2|Physician Decision|0|||
144381894|NCT01457352|520608287|FG000|Period 2|Did not meet eligibility criteria|3|||
144381895|NCT01457352|520608288|FG001|Period 2|Did not meet eligibility criteria|0|||
144381896|NCT01457352|520608287|FG000|Period 3|Adverse Event|1|||
144381897|NCT01457352|520608288|FG001|Period 3|Adverse Event|1|||
144381898|NCT01457352|520608287|FG000|Period 3|Withdrawal by Subject|0|||
144381899|NCT01457352|520608288|FG001|Period 3|Withdrawal by Subject|2|||
144381900|NCT01457352|520608287|FG000|Period 3|incorrect treatment|0|||
144381901|NCT01457352|520608288|FG001|Period 3|incorrect treatment|1|||
144381902|NCT01457352|520608287|FG000|Period 3|Sponsor's withdrawal|0|||
144381903|NCT01457352|520608288|FG001|Period 3|Sponsor's withdrawal|1|||
144381904|NCT00843778|520609939|FG000|Overall Study|Adverse Event|15|||
144381905|NCT00843778|520609939|FG000|Overall Study|Lack of Efficacy|14|||
144381906|NCT00843778|520609939|FG000|Overall Study|Loss of efficacy|2|||
144381907|NCT00843778|520609939|FG000|Overall Study|Withdrawal by Subject|4|||
144381908|NCT00369629|520609940|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
144381909|NCT00369629|520609941|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
144381910|NCT00369629|520609942|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
144381911|NCT00369629|520609943|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
144381912|NCT00369629|520609940|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
144381913|NCT00369629|520609941|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
144381914|NCT00369629|520609942|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
144381915|NCT00369629|520609943|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
144381916|NCT00369629|520609940|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
144381917|NCT00369629|520609941|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
144381918|NCT00369629|520609942|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
144381919|NCT00369629|520609943|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
144381920|NCT00369629|520609940|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
144381921|NCT00369629|520609941|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
144381922|NCT00369629|520609942|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
144381923|NCT00369629|520609943|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
144381924|NCT00369629|520609940|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
144381925|NCT00369629|520609941|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
144381926|NCT00369629|520609942|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
144381927|NCT00369629|520609943|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
144381928|NCT00369629|520609940|FG000|Completed 4 More Cycles|Progressive disease|2|||
144381929|NCT00369629|520609941|FG001|Completed 4 More Cycles|Progressive disease|1|||
144381930|NCT00369629|520609942|FG002|Completed 4 More Cycles|Progressive disease|2|||
144381931|NCT00369629|520609943|FG003|Completed 4 More Cycles|Progressive disease|0|||
144381932|NCT00369629|520609940|FG000|Follow up for 1 Year|Death|2|||
144381933|NCT00369629|520609941|FG001|Follow up for 1 Year|Death|1|||
144381934|NCT00369629|520609942|FG002|Follow up for 1 Year|Death|1|||
144381935|NCT00369629|520609943|FG003|Follow up for 1 Year|Death|0|||
144381936|NCT00369629|520609940|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
144381937|NCT00369629|520609941|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
144381938|NCT00369629|520609942|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
144381939|NCT00369629|520609943|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
144381940|NCT00369629|520609940|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
144381941|NCT00369629|520609941|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
144381942|NCT00369629|520609942|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
144381943|NCT00369629|520609943|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
144381944|NCT02600871|520609944|FG000|Overall Study|Lost to Follow-up|13|||
144381945|NCT02600871|520609945|FG001|Overall Study|Lost to Follow-up|10|||
144381946|NCT03338959|520609946|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
144381947|NCT03338959|520609946|FG000|Overall Study|Physician Decision|1|||
144381948|NCT01604278|520609951|FG000|Overall Study|Lack of Efficacy|0|||
144381949|NCT01604278|520609952|FG001|Overall Study|Lack of Efficacy|1|||
144381950|NCT01604278|520609951|FG000|Overall Study|Lost to Follow-up|1|||
144381951|NCT01604278|520609952|FG001|Overall Study|Lost to Follow-up|0|||
144381952|NCT01604278|520609951|FG000|Overall Study|Administrative problems|2|||
144381953|NCT01604278|520609952|FG001|Overall Study|Administrative problems|1|||
144381954|NCT01604278|520609951|FG000|Overall Study|Withdrawal by Subject|3|||
144381955|NCT01604278|520609952|FG001|Overall Study|Withdrawal by Subject|3|||
144381956|NCT01604278|520609951|FG000|Overall Study|Adverse Event|3|||
144381957|NCT01604278|520609952|FG001|Overall Study|Adverse Event|5|||
144381958|NCT01604278|520609951|FG000|Overall Study|Protocol Deviation|5|||
144381959|NCT01604278|520609952|FG001|Overall Study|Protocol Deviation|3|||
144381960|NCT00409331|520609953|FG000|Overall Study|Physician Decision|1|||
144381961|NCT02184455|520609954|FG000|Overall Study|Lost to Follow-up|1|||
144381962|NCT00730028|520609959|FG000|Overall Study|Adverse Event|23|||
144381963|NCT00730028|520609960|FG001|Overall Study|Adverse Event|26|||
144381964|NCT00730028|520609961|FG002|Overall Study|Adverse Event|16|||
144381965|NCT00730028|520609962|FG003|Overall Study|Adverse Event|20|||
144381966|NCT00730028|520609963|FG004|Overall Study|Adverse Event|43|||
144381967|NCT00730028|520609959|FG000|Overall Study|Lost to Follow-up|13|||
144381968|NCT00730028|520609960|FG001|Overall Study|Lost to Follow-up|26|||
144381969|NCT00730028|520609961|FG002|Overall Study|Lost to Follow-up|22|||
144381970|NCT00730028|520609962|FG003|Overall Study|Lost to Follow-up|26|||
144381971|NCT00730028|520609963|FG004|Overall Study|Lost to Follow-up|25|||
144381972|NCT00730028|520609959|FG000|Overall Study|Protocol Violation|6|||
144381973|NCT00730028|520609960|FG001|Overall Study|Protocol Violation|1|||
144381974|NCT00730028|520609961|FG002|Overall Study|Protocol Violation|1|||
144381975|NCT00730028|520609962|FG003|Overall Study|Protocol Violation|2|||
144381976|NCT00730028|520609963|FG004|Overall Study|Protocol Violation|0|||
144381977|NCT00730028|520609959|FG000|Overall Study|Withdrawal by Subject|9|||
144381978|NCT00730028|520609960|FG001|Overall Study|Withdrawal by Subject|5|||
144381979|NCT00730028|520609961|FG002|Overall Study|Withdrawal by Subject|4|||
144381980|NCT00730028|520609962|FG003|Overall Study|Withdrawal by Subject|5|||
144381981|NCT00730028|520609963|FG004|Overall Study|Withdrawal by Subject|9|||
144381982|NCT00730028|520609959|FG000|Overall Study|Physician Decision|3|||
144381983|NCT00730028|520609960|FG001|Overall Study|Physician Decision|3|||
144381984|NCT00730028|520609961|FG002|Overall Study|Physician Decision|2|||
144381985|NCT00730028|520609962|FG003|Overall Study|Physician Decision|3|||
144381986|NCT00730028|520609963|FG004|Overall Study|Physician Decision|2|||
144381987|NCT00730028|520609959|FG000|Overall Study|Treatment Failure|5|||
144381988|NCT00730028|520609960|FG001|Overall Study|Treatment Failure|5|||
144381989|NCT00730028|520609961|FG002|Overall Study|Treatment Failure|0|||
144381990|NCT00730028|520609962|FG003|Overall Study|Treatment Failure|0|||
144381991|NCT00730028|520609963|FG004|Overall Study|Treatment Failure|1|||
144381992|NCT00730028|520609959|FG000|Overall Study|Randomization Error|1|||
144381993|NCT00730028|520609960|FG001|Overall Study|Randomization Error|0|||
144381994|NCT00730028|520609961|FG002|Overall Study|Randomization Error|0|||
144381995|NCT00730028|520609962|FG003|Overall Study|Randomization Error|0|||
144381996|NCT00730028|520609963|FG004|Overall Study|Randomization Error|2|||
144381997|NCT00874939|520609964|FG000|Overall Study|Study terminated|4|||
144381998|NCT02870933|520609965|FG000|Overall Study|Death|2|||
144381999|NCT02870933|520609966|FG001|Overall Study|Death|1|||
144382000|NCT02870933|520609965|FG000|Overall Study|Withdrawal by Subject|0|||
144382001|NCT02870933|520609966|FG001|Overall Study|Withdrawal by Subject|1|||
144382002|NCT01250496|520609969|FG000|Overall Study|Study terminated|124|||
144382003|NCT01250496|520609970|FG001|Overall Study|Study terminated|124|||
144382004|NCT00003590|520609971|FG000|Overall Study|Ineligible Patient|1|||
144382005|NCT00003590|520609971|FG000|Overall Study|Adverse Event|7|||
144382006|NCT00003590|520609971|FG000|Overall Study|Withdrawal by Subject|1|||
144382007|NCT00003590|520609971|FG000|Overall Study|Lack of Efficacy|11|||
144382008|NCT00003590|520609971|FG000|Overall Study|Death|1|||
144382009|NCT00003590|520609971|FG000|Overall Study|Physician Decision|1|||
144382010|NCT01425463|520609977|FG000|Overall Study|Adverse Event|5|||
144382011|NCT01425463|520609978|FG001|Overall Study|Adverse Event|7|||
144382012|NCT01425463|520609977|FG000|Overall Study|Lack of Efficacy|1|||
144382013|NCT01425463|520609978|FG001|Overall Study|Lack of Efficacy|1|||
144382014|NCT01425463|520609977|FG000|Overall Study|Protocol Violation|2|||
144382015|NCT01425463|520609978|FG001|Overall Study|Protocol Violation|2|||
144382016|NCT01425463|520609977|FG000|Overall Study|Lost to Follow-up|5|||
144382017|NCT01425463|520609978|FG001|Overall Study|Lost to Follow-up|2|||
144382018|NCT01425463|520609977|FG000|Overall Study|Withdrawal by Subject|7|||
144382019|NCT01425463|520609978|FG001|Overall Study|Withdrawal by Subject|5|||
144382020|NCT01425463|520609977|FG000|Overall Study|Unknown Reason|4|||
144382021|NCT01425463|520609978|FG001|Overall Study|Unknown Reason|7|||
144382022|NCT01332799|520609980|FG000|Overall Study|Insufficient funding|10|||
144382023|NCT01332799|520609981|FG001|Overall Study|Insufficient funding|10|||
144382024|NCT00668733|520609982|FG000|Overall Study|Lost to Follow-up|2|||
144382025|NCT00668733|520609983|FG001|Overall Study|Lost to Follow-up|3|||
144382026|NCT00668733|520609982|FG000|Overall Study|Withdrawal by Subject|0|||
144382027|NCT00668733|520609983|FG001|Overall Study|Withdrawal by Subject|4|||
144382028|NCT01909791|520609984|FG000|Overall Study|Death|9|||
144382029|NCT01909791|520609985|FG001|Overall Study|Death|8|||
144382030|NCT01909791|520609986|FG002|Overall Study|Death|4|||
144382031|NCT01909791|520609984|FG000|Overall Study|Withdrawal by Subject|5|||
144382032|NCT01909791|520609985|FG001|Overall Study|Withdrawal by Subject|9|||
144382033|NCT01909791|520609986|FG002|Overall Study|Withdrawal by Subject|13|||
144382034|NCT01909791|520609984|FG000|Overall Study|Lost to Follow-up|5|||
144382035|NCT01909791|520609985|FG001|Overall Study|Lost to Follow-up|11|||
144382036|NCT01909791|520609986|FG002|Overall Study|Lost to Follow-up|10|||
144382037|NCT01909791|520609984|FG000|Overall Study|Missed Visit|2|||
144382038|NCT01909791|520609985|FG001|Overall Study|Missed Visit|0|||
144382039|NCT01909791|520609986|FG002|Overall Study|Missed Visit|1|||
144382040|NCT02168387|520609989|FG000|Overall Study|Planned exubation|6|||
144382041|NCT02168387|520609990|FG001|Overall Study|Planned exubation|3|||
144382042|NCT02168387|520609989|FG000|Overall Study|Death|1|||
144382043|NCT02168387|520609990|FG001|Overall Study|Death|0|||
144382044|NCT01659554|520609991|FG000|Overall Study|Study Termination|4|||
144382045|NCT00640224|520609998|FG000|Overall Study|Lost to Follow-up|5|||
144382046|NCT00640224|520609999|FG001|Overall Study|Lost to Follow-up|2|||
144382047|NCT00640224|520610000|FG002|Overall Study|Lost to Follow-up|0|||
144382048|NCT00640224|520610001|FG003|Overall Study|Lost to Follow-up|0|||
144382049|NCT00640224|520609998|FG000|Overall Study|Withdrawal by Subject|1|||
144382050|NCT00640224|520609999|FG001|Overall Study|Withdrawal by Subject|0|||
144382051|NCT00640224|520610000|FG002|Overall Study|Withdrawal by Subject|0|||
144382052|NCT00640224|520610001|FG003|Overall Study|Withdrawal by Subject|0|||
144382053|NCT00640224|520609998|FG000|Overall Study|Headaches|0|||
144382054|NCT00640224|520609999|FG001|Overall Study|Headaches|1|||
144382055|NCT00640224|520610000|FG002|Overall Study|Headaches|0|||
144382056|NCT00640224|520610001|FG003|Overall Study|Headaches|0|||
144382057|NCT00422513|520610002|FG000|Overall Study|Lack of Efficacy|4|||
144382058|NCT00422513|520610003|FG001|Overall Study|Lack of Efficacy|5|||
144382059|NCT00422513|520610002|FG000|Overall Study|Protocol Violation|23|||
144382060|NCT00422513|520610003|FG001|Overall Study|Protocol Violation|7|||
144382061|NCT00422513|520610002|FG000|Overall Study|Refused Treatment|4|||
144382062|NCT00422513|520610003|FG001|Overall Study|Refused Treatment|2|||
144382063|NCT00422513|520610002|FG000|Overall Study|Withdrawal by Subject|2|||
144382064|NCT00422513|520610003|FG001|Overall Study|Withdrawal by Subject|1|||
144382065|NCT00422513|520610002|FG000|Overall Study|early termination of the study|67|||
144382066|NCT00422513|520610003|FG001|Overall Study|early termination of the study|80|||
144382067|NCT00422513|520610002|FG000|Overall Study|Adverse Event|4|||
144382068|NCT00422513|520610003|FG001|Overall Study|Adverse Event|4|||
144382069|NCT00422513|520610002|FG000|Overall Study|Death|3|||
144382070|NCT00422513|520610003|FG001|Overall Study|Death|7|||
144382071|NCT03135119|520610004|FG000|Overall Study|Lost to Follow-up|2|||
144382072|NCT03135119|520610005|FG001|Overall Study|Lost to Follow-up|0|||
144382073|NCT03135119|520610004|FG000|Overall Study|Physician Decision|1|||
144382074|NCT03135119|520610005|FG001|Overall Study|Physician Decision|1|||
144382075|NCT03135119|520610004|FG000|Overall Study|COVID-19 Shutdown|2|||
144382076|NCT03135119|520610005|FG001|Overall Study|COVID-19 Shutdown|2|||
144382077|NCT01478048|520610006|FG000|Overall Study|Disease Progression|52|||
144382078|NCT01478048|520610007|FG001|Overall Study|Disease Progression|35|||
144382079|NCT01478048|520610006|FG000|Overall Study|study drug toxicity|11|||
144382080|NCT01478048|520610007|FG001|Overall Study|study drug toxicity|14|||
144382081|NCT01478048|520610006|FG000|Overall Study|Adverse Event|2|||
144382082|NCT01478048|520610007|FG001|Overall Study|Adverse Event|11|||
144382083|NCT01478048|520610006|FG000|Overall Study|subject request to discontinue treatment|3|||
144382084|NCT01478048|520610007|FG001|Overall Study|subject request to discontinue treatment|5|||
144382085|NCT01478048|520610006|FG000|Overall Study|Withdrawal by Subject|2|||
144382086|NCT01478048|520610007|FG001|Overall Study|Withdrawal by Subject|5|||
144382087|NCT01478048|520610006|FG000|Overall Study|non-specified|6|||
144382088|NCT01478048|520610007|FG001|Overall Study|non-specified|4|||
144382089|NCT01478048|520610006|FG000|Overall Study|poor/non-compliance|0|||
144382090|NCT01478048|520610007|FG001|Overall Study|poor/non-compliance|1|||
144382091|NCT01478048|520610006|FG000|Overall Study|no longer meets study criteria|1|||
144382092|NCT01478048|520610007|FG001|Overall Study|no longer meets study criteria|0|||
144382093|NCT01252667|520610012|FG000|Overall Study|Transplant aborted post-conditioning|0|||
144382094|NCT01252667|520610013|FG001|Overall Study|Transplant aborted post-conditioning|0|||
144382095|NCT01252667|520610014|FG002|Overall Study|Transplant aborted post-conditioning|0|||
144382096|NCT01252667|520610015|FG003|Overall Study|Transplant aborted post-conditioning|0|||
144382097|NCT01252667|520610016|FG004|Overall Study|Transplant aborted post-conditioning|0|||
144382098|NCT01252667|520610017|FG005|Overall Study|Transplant aborted post-conditioning|1|||
144382099|NCT04644315|520610018|FG000|Overall Study|Subject withdrawal of consent|1|||
144382100|NCT03032380|520610019|FG000|Overall Study|Adverse Event|0|||
144382101|NCT03032380|520610020|FG001|Overall Study|Adverse Event|1|||
144382102|NCT03032380|520610019|FG000|Overall Study|Lack of Efficacy|1|||
144382103|NCT03032380|520610020|FG001|Overall Study|Lack of Efficacy|0|||
144382104|NCT03032380|520610019|FG000|Overall Study|Withdrawal by Subject|2|||
144382105|NCT03032380|520610020|FG001|Overall Study|Withdrawal by Subject|3|||
144382106|NCT03032380|520610019|FG000|Overall Study|Recovery|0|||
144382107|NCT03032380|520610020|FG001|Overall Study|Recovery|1|||
144382108|NCT03032380|520610019|FG000|Overall Study|Death|39|||
144382109|NCT03032380|520610020|FG001|Overall Study|Death|34|||
144382110|NCT03032380|520610019|FG000|Overall Study|Other - Miscellaneous|0|||
144382111|NCT03032380|520610020|FG001|Overall Study|Other - Miscellaneous|1|||
144382112|NCT01836276|520610021|FG000|Overall Study|Lost to Follow-up|28|||
144382113|NCT01836276|520610022|FG001|Overall Study|Lost to Follow-up|51|||
144382114|NCT01561898|520610023|FG000|Overall Study|Withdrawal by Subject|0|||
144382115|NCT01561898|520610024|FG001|Overall Study|Withdrawal by Subject|8|||
144382116|NCT01561898|520610025|FG002|Overall Study|Withdrawal by Subject|12|||
144382117|NCT01561898|520610026|FG003|Overall Study|Withdrawal by Subject|5|||
144382118|NCT01561898|520610023|FG000|Overall Study|Lack of Efficacy|0|||
144382119|NCT01561898|520610024|FG001|Overall Study|Lack of Efficacy|8|||
144382120|NCT01561898|520610025|FG002|Overall Study|Lack of Efficacy|10|||
144382121|NCT01561898|520610026|FG003|Overall Study|Lack of Efficacy|5|||
144382122|NCT01561898|520610023|FG000|Overall Study|Worsening of complications|0|||
144382123|NCT01561898|520610024|FG001|Overall Study|Worsening of complications|1|||
144382124|NCT01561898|520610025|FG002|Overall Study|Worsening of complications|0|||
144382125|NCT01561898|520610026|FG003|Overall Study|Worsening of complications|0|||
144382126|NCT01561898|520610023|FG000|Overall Study|Lost to Follow-up|0|||
144382127|NCT01561898|520610024|FG001|Overall Study|Lost to Follow-up|0|||
144382128|NCT01561898|520610025|FG002|Overall Study|Lost to Follow-up|1|||
144382129|NCT01561898|520610026|FG003|Overall Study|Lost to Follow-up|0|||
144382130|NCT01561898|520610023|FG000|Overall Study|Adverse Event|1|||
144382131|NCT01561898|520610024|FG001|Overall Study|Adverse Event|19|||
144382132|NCT01561898|520610025|FG002|Overall Study|Adverse Event|14|||
144382133|NCT01561898|520610026|FG003|Overall Study|Adverse Event|9|||
144382134|NCT01561898|520610023|FG000|Overall Study|Physician Decision|1|||
144382135|NCT01561898|520610024|FG001|Overall Study|Physician Decision|5|||
144382136|NCT01561898|520610025|FG002|Overall Study|Physician Decision|7|||
144382137|NCT01561898|520610026|FG003|Overall Study|Physician Decision|1|||
144382138|NCT00331552|520610029|FG000|Period 3: Phase II|Neurological Symptoms|1|||
144382139|NCT00331552|520610030|FG001|Period 3: Phase II|Neurological Symptoms|0|||
144382140|NCT00331552|520610029|FG000|Period 3: Phase II|Severe Nausea|1|||
144382141|NCT00331552|520610030|FG001|Period 3: Phase II|Severe Nausea|0|||
144382142|NCT01445548|520610031|FG000|Overall Study|Adverse Event|1|||
144382143|NCT01883453|520610032|FG000|Overall Study|No episode of common cold|25|||
144382144|NCT01883453|520610033|FG001|Overall Study|No episode of common cold|23|||
144382145|NCT03642132|520610036|FG000|Chemotherapy Period|Adverse Event|1|||
144382146|NCT03642132|520610037|FG001|Chemotherapy Period|Adverse Event|1|||
144382147|NCT03642132|520610038|FG002|Chemotherapy Period|Adverse Event|0|||
144382148|NCT03642132|520610036|FG000|Chemotherapy Period|Physician's decision|4|||
144382149|NCT03642132|520610037|FG001|Chemotherapy Period|Physician's decision|1|||
144382150|NCT03642132|520610038|FG002|Chemotherapy Period|Physician's decision|0|||
144382151|NCT03642132|520610036|FG000|Chemotherapy Period|Progressive disease|0|||
144382152|NCT03642132|520610037|FG001|Chemotherapy Period|Progressive disease|0|||
144382153|NCT03642132|520610038|FG002|Chemotherapy Period|Progressive disease|1|||
144514773|NCT02201108|521083952|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
144514774|NCT02201108|521083953|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
144382154|NCT03642132|520610036|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
144382155|NCT03642132|520610037|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
144514775|NCT02201108|521083951|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
144514776|NCT02201108|521083952|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
144592396|NCT00790751|521368600|FG001|Overall Study|Physician Decision|0|||
144382156|NCT03642132|520610038|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
144382157|NCT03642132|520610036|FG000|Chemotherapy Period|Other|1|||
144382158|NCT03642132|520610037|FG001|Chemotherapy Period|Other|0|||
144382159|NCT03642132|520610038|FG002|Chemotherapy Period|Other|2|||
144382160|NCT03642132|520610036|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
144382161|NCT03642132|520610037|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
144382162|NCT03642132|520610038|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
144382163|NCT03642132|520610036|FG000|Maintenance Period|Adverse Event|1|||
144382164|NCT03642132|520610037|FG001|Maintenance Period|Adverse Event|2|||
144382165|NCT03642132|520610038|FG002|Maintenance Period|Adverse Event|0|||
144382166|NCT03642132|520610036|FG000|Maintenance Period|Non-compliance with study drug|0|||
144382167|NCT03642132|520610037|FG001|Maintenance Period|Non-compliance with study drug|0|||
144382168|NCT03642132|520610038|FG002|Maintenance Period|Non-compliance with study drug|1|||
144382169|NCT03642132|520610036|FG000|Maintenance Period|Physician's decision|2|||
144382170|NCT03642132|520610037|FG001|Maintenance Period|Physician's decision|2|||
144382171|NCT03642132|520610038|FG002|Maintenance Period|Physician's decision|2|||
144382172|NCT03642132|520610036|FG000|Maintenance Period|Progressive disease|9|||
144382173|NCT03642132|520610037|FG001|Maintenance Period|Progressive disease|3|||
144382174|NCT03642132|520610038|FG002|Maintenance Period|Progressive disease|6|||
144382175|NCT03642132|520610036|FG000|Maintenance Period|Other|0|||
144382176|NCT03642132|520610037|FG001|Maintenance Period|Other|0|||
144382177|NCT03642132|520610038|FG002|Maintenance Period|Other|3|||
144382178|NCT03642132|520610036|FG000|Maintenance Period|Withdrawal by Subject|1|||
144382179|NCT03642132|520610037|FG001|Maintenance Period|Withdrawal by Subject|1|||
144382180|NCT03642132|520610038|FG002|Maintenance Period|Withdrawal by Subject|2|||
144382181|NCT03642132|520610036|FG000|Follow-up Period|Other|0|||
144382182|NCT03642132|520610037|FG001|Follow-up Period|Other|0|||
144382183|NCT03642132|520610038|FG002|Follow-up Period|Other|1|||
144382184|NCT03642132|520610036|FG000|Follow-up Period|Withdrawal by Subject|1|||
144382185|NCT03642132|520610037|FG001|Follow-up Period|Withdrawal by Subject|2|||
144382186|NCT03642132|520610038|FG002|Follow-up Period|Withdrawal by Subject|0|||
144382187|NCT03642132|520610036|FG000|Follow-up Period|Study terminated by sponsor|1|||
144382188|NCT03642132|520610037|FG001|Follow-up Period|Study terminated by sponsor|0|||
144382189|NCT03642132|520610038|FG002|Follow-up Period|Study terminated by sponsor|1|||
144382190|NCT03642132|520610036|FG000|Follow-up Period|Lack of Efficacy|1|||
144382191|NCT03642132|520610037|FG001|Follow-up Period|Lack of Efficacy|0|||
144382192|NCT03642132|520610038|FG002|Follow-up Period|Lack of Efficacy|0|||
144382193|NCT03642132|520610036|FG000|Follow-up Period|Death|1|||
144382194|NCT03642132|520610037|FG001|Follow-up Period|Death|0|||
144382195|NCT03642132|520610038|FG002|Follow-up Period|Death|2|||
144382196|NCT03642132|520610036|FG000|Follow-up Period|Adverse Event|1|||
144382197|NCT03642132|520610037|FG001|Follow-up Period|Adverse Event|0|||
144382198|NCT03642132|520610038|FG002|Follow-up Period|Adverse Event|0|||
144382199|NCT02577887|520610040|FG000|Overall Study|Death|93|||
144382200|NCT02577887|520610040|FG000|Overall Study|Protocol Violation|125|||
144382201|NCT02577887|520610040|FG000|Overall Study|Withdrawal by Subject|80|||
144382202|NCT00913458|520610041|FG000|Phase 1|Non-Responder|54|||
144382203|NCT00913458|520610042|FG001|Phase 1|Non-Responder|0|||
144382204|NCT00913458|520610043|FG002|Phase 1|Non-Responder|0|||
144382205|NCT00913458|520610044|FG003|Phase 1|Non-Responder|0|||
144382206|NCT00913458|520610045|FG004|Phase 1|Non-Responder|0|||
144382207|NCT00913458|520610046|FG005|Phase 1|Non-Responder|0|||
144382208|NCT00913458|520610047|FG006|Phase 1|Non-Responder|0|||
144382209|NCT00913458|520610041|FG000|Phase 1|Subject Request|17|||
144382210|NCT00913458|520610042|FG001|Phase 1|Subject Request|0|||
144382211|NCT00913458|520610043|FG002|Phase 1|Subject Request|0|||
144382212|NCT00913458|520610044|FG003|Phase 1|Subject Request|0|||
144382213|NCT00913458|520610045|FG004|Phase 1|Subject Request|0|||
144382214|NCT00913458|520610046|FG005|Phase 1|Subject Request|0|||
144382215|NCT00913458|520610047|FG006|Phase 1|Subject Request|0|||
144382216|NCT00913458|520610041|FG000|Phase 1|Adverse Event|20|||
144382217|NCT00913458|520610042|FG001|Phase 1|Adverse Event|0|||
144382218|NCT00913458|520610043|FG002|Phase 1|Adverse Event|0|||
144382219|NCT00913458|520610044|FG003|Phase 1|Adverse Event|0|||
144382220|NCT00913458|520610045|FG004|Phase 1|Adverse Event|0|||
144382221|NCT00913458|520610046|FG005|Phase 1|Adverse Event|0|||
144382222|NCT00913458|520610047|FG006|Phase 1|Adverse Event|0|||
144382223|NCT00913458|520610041|FG000|Phase 1|Lost to Follow-up|2|||
144382224|NCT00913458|520610042|FG001|Phase 1|Lost to Follow-up|0|||
144382225|NCT00913458|520610043|FG002|Phase 1|Lost to Follow-up|0|||
144382226|NCT00913458|520610044|FG003|Phase 1|Lost to Follow-up|0|||
144382227|NCT00913458|520610045|FG004|Phase 1|Lost to Follow-up|0|||
144382228|NCT00913458|520610046|FG005|Phase 1|Lost to Follow-up|0|||
144382229|NCT00913458|520610047|FG006|Phase 1|Lost to Follow-up|0|||
144382230|NCT00913458|520610041|FG000|Phase 1|Protocol Violation|10|||
144382231|NCT00913458|520610042|FG001|Phase 1|Protocol Violation|0|||
144382232|NCT00913458|520610043|FG002|Phase 1|Protocol Violation|0|||
144382233|NCT00913458|520610044|FG003|Phase 1|Protocol Violation|0|||
144382234|NCT00913458|520610045|FG004|Phase 1|Protocol Violation|0|||
144382235|NCT00913458|520610046|FG005|Phase 1|Protocol Violation|0|||
144382236|NCT00913458|520610047|FG006|Phase 1|Protocol Violation|0|||
144382237|NCT00913458|520610041|FG000|Phase 1|Sponsor|2|||
144382238|NCT00913458|520610042|FG001|Phase 1|Sponsor|0|||
144382239|NCT00913458|520610043|FG002|Phase 1|Sponsor|0|||
144382240|NCT00913458|520610044|FG003|Phase 1|Sponsor|0|||
144382241|NCT00913458|520610045|FG004|Phase 1|Sponsor|0|||
144382242|NCT00913458|520610046|FG005|Phase 1|Sponsor|0|||
144382243|NCT00913458|520610047|FG006|Phase 1|Sponsor|0|||
144382244|NCT00913458|520610041|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
144382245|NCT00913458|520610042|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
144382246|NCT00913458|520610043|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
144382247|NCT00913458|520610044|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
144382248|NCT00913458|520610045|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
144382249|NCT00913458|520610046|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
144382250|NCT00913458|520610047|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
144382251|NCT00913458|520610041|FG000|Phase 2|Non-Responder|0|||
144382252|NCT00913458|520610042|FG001|Phase 2|Non-Responder|5|||
144382253|NCT00913458|520610043|FG002|Phase 2|Non-Responder|7|||
144382254|NCT00913458|520610044|FG003|Phase 2|Non-Responder|12|||
144382255|NCT00913458|520610045|FG004|Phase 2|Non-Responder|0|||
144382256|NCT00913458|520610046|FG005|Phase 2|Non-Responder|0|||
144382257|NCT00913458|520610047|FG006|Phase 2|Non-Responder|0|||
144382258|NCT00913458|520610041|FG000|Phase 2|Subject Request|0|||
144382259|NCT00913458|520610042|FG001|Phase 2|Subject Request|0|||
144382260|NCT00913458|520610043|FG002|Phase 2|Subject Request|1|||
144382261|NCT00913458|520610044|FG003|Phase 2|Subject Request|2|||
144382262|NCT00913458|520610045|FG004|Phase 2|Subject Request|0|||
144382263|NCT00913458|520610046|FG005|Phase 2|Subject Request|0|||
144382264|NCT00913458|520610047|FG006|Phase 2|Subject Request|0|||
144382265|NCT00913458|520610041|FG000|Phase 2|Adverse Event|0|||
144382266|NCT00913458|520610042|FG001|Phase 2|Adverse Event|3|||
144382267|NCT00913458|520610043|FG002|Phase 2|Adverse Event|0|||
144382268|NCT00913458|520610044|FG003|Phase 2|Adverse Event|1|||
144382269|NCT00913458|520610045|FG004|Phase 2|Adverse Event|0|||
144382270|NCT00913458|520610046|FG005|Phase 2|Adverse Event|0|||
144382271|NCT00913458|520610047|FG006|Phase 2|Adverse Event|0|||
144382272|NCT00913458|520610041|FG000|Phase 2|Lost to Follow-up|0|||
144382273|NCT00913458|520610042|FG001|Phase 2|Lost to Follow-up|0|||
144382274|NCT00913458|520610043|FG002|Phase 2|Lost to Follow-up|0|||
144382275|NCT00913458|520610044|FG003|Phase 2|Lost to Follow-up|1|||
144382276|NCT00913458|520610045|FG004|Phase 2|Lost to Follow-up|0|||
144382277|NCT00913458|520610046|FG005|Phase 2|Lost to Follow-up|0|||
144382278|NCT00913458|520610047|FG006|Phase 2|Lost to Follow-up|0|||
144382279|NCT00913458|520610041|FG000|Phase 2|Protocol Violation|0|||
144382280|NCT00913458|520610042|FG001|Phase 2|Protocol Violation|2|||
144382281|NCT00913458|520610043|FG002|Phase 2|Protocol Violation|0|||
144382282|NCT00913458|520610044|FG003|Phase 2|Protocol Violation|0|||
144382283|NCT00913458|520610045|FG004|Phase 2|Protocol Violation|0|||
144382284|NCT00913458|520610046|FG005|Phase 2|Protocol Violation|0|||
144382285|NCT00913458|520610047|FG006|Phase 2|Protocol Violation|0|||
144382286|NCT00913458|520610041|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
144382287|NCT00913458|520610042|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
144382288|NCT00913458|520610043|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
144382289|NCT00913458|520610044|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
144382290|NCT00913458|520610045|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
144382291|NCT00913458|520610046|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
144382292|NCT00913458|520610047|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
144382293|NCT00913458|520610041|FG000|Phase 3|Adverse Event|0|||
144382294|NCT00913458|520610042|FG001|Phase 3|Adverse Event|0|||
144514777|NCT02201108|521083953|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
144514778|NCT02201108|521083951|FG000|Open Label Period (up to Week 192)|Other reason|4|||
144514779|NCT02201108|521083952|FG001|Open Label Period (up to Week 192)|Other reason|7|||
144514780|NCT02201108|521083953|FG002|Open Label Period (up to Week 192)|Other reason|0|||
144514781|NCT02201108|521083951|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
144514782|NCT02201108|521083952|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
144514783|NCT02201108|521083953|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
144514784|NCT02201108|521083951|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
144514785|NCT02201108|521083952|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
144382295|NCT00913458|520610043|FG002|Phase 3|Adverse Event|0|||
144382296|NCT00913458|520610044|FG003|Phase 3|Adverse Event|0|||
144382297|NCT00913458|520610045|FG004|Phase 3|Adverse Event|5|||
144382298|NCT00913458|520610046|FG005|Phase 3|Adverse Event|4|||
144382299|NCT00913458|520610047|FG006|Phase 3|Adverse Event|1|||
144382300|NCT00913458|520610041|FG000|Phase 3|Lost to Follow-up|0|||
144382301|NCT00913458|520610042|FG001|Phase 3|Lost to Follow-up|0|||
144382302|NCT00913458|520610043|FG002|Phase 3|Lost to Follow-up|0|||
144382303|NCT00913458|520610044|FG003|Phase 3|Lost to Follow-up|0|||
144382304|NCT00913458|520610045|FG004|Phase 3|Lost to Follow-up|2|||
144382305|NCT00913458|520610046|FG005|Phase 3|Lost to Follow-up|0|||
144382306|NCT00913458|520610047|FG006|Phase 3|Lost to Follow-up|0|||
144382307|NCT00913458|520610041|FG000|Phase 3|Non-Responder|0|||
144382308|NCT00913458|520610042|FG001|Phase 3|Non-Responder|0|||
144592397|NCT00790751|521368601|FG002|Overall Study|Physician Decision|0|||
144382309|NCT00913458|520610043|FG002|Phase 3|Non-Responder|0|||
144382310|NCT00913458|520610044|FG003|Phase 3|Non-Responder|0|||
144382311|NCT00913458|520610045|FG004|Phase 3|Non-Responder|0|||
144382312|NCT00913458|520610046|FG005|Phase 3|Non-Responder|1|||
144382313|NCT00913458|520610047|FG006|Phase 3|Non-Responder|3|||
144382314|NCT00913458|520610041|FG000|Phase 3|Withdrawal by Subject|0|||
144382315|NCT00913458|520610042|FG001|Phase 3|Withdrawal by Subject|0|||
144382316|NCT00913458|520610043|FG002|Phase 3|Withdrawal by Subject|0|||
144382317|NCT00913458|520610044|FG003|Phase 3|Withdrawal by Subject|0|||
144382318|NCT00913458|520610045|FG004|Phase 3|Withdrawal by Subject|1|||
144382319|NCT00913458|520610046|FG005|Phase 3|Withdrawal by Subject|2|||
144382320|NCT00913458|520610047|FG006|Phase 3|Withdrawal by Subject|0|||
144382321|NCT00913458|520610041|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
144382322|NCT00913458|520610042|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
144382323|NCT00913458|520610043|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
144382324|NCT00913458|520610044|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
144382325|NCT00913458|520610045|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
144382326|NCT00913458|520610046|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
144382327|NCT00913458|520610047|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
144382328|NCT02366091|520610048|FG000|Overall Study|Withdrawal by Subject|3|||
144382329|NCT02366091|520610049|FG001|Overall Study|Withdrawal by Subject|7|||
144382330|NCT02366091|520610050|FG002|Overall Study|Withdrawal by Subject|3|||
144382331|NCT02366091|520610051|FG003|Overall Study|Withdrawal by Subject|1|||
144382332|NCT03595618|520610052|FG000|Overall Study|Adverse Event|16|||
144382333|NCT03595618|520610053|FG001|Overall Study|Adverse Event|17|||
144382334|NCT03595618|520610054|FG002|Overall Study|Adverse Event|20|||
144382335|NCT03595618|520610055|FG003|Overall Study|Adverse Event|8|||
144382336|NCT03595618|520610052|FG000|Overall Study|Withdrawal by Subject|12|||
144382337|NCT03595618|520610053|FG001|Overall Study|Withdrawal by Subject|14|||
144382338|NCT03595618|520610054|FG002|Overall Study|Withdrawal by Subject|14|||
144382339|NCT03595618|520610055|FG003|Overall Study|Withdrawal by Subject|10|||
144382340|NCT03595618|520610052|FG000|Overall Study|Lost to Follow-up|6|||
144382341|NCT03595618|520610053|FG001|Overall Study|Lost to Follow-up|4|||
144382342|NCT03595618|520610054|FG002|Overall Study|Lost to Follow-up|5|||
144382343|NCT03595618|520610055|FG003|Overall Study|Lost to Follow-up|6|||
144382344|NCT03595618|520610052|FG000|Overall Study|Protocol Violation|2|||
144382345|NCT03595618|520610053|FG001|Overall Study|Protocol Violation|0|||
144382346|NCT03595618|520610054|FG002|Overall Study|Protocol Violation|6|||
144382347|NCT03595618|520610055|FG003|Overall Study|Protocol Violation|2|||
144382348|NCT03595618|520610052|FG000|Overall Study|Physician Decision|0|||
144382349|NCT03595618|520610053|FG001|Overall Study|Physician Decision|0|||
144382350|NCT03595618|520610054|FG002|Overall Study|Physician Decision|1|||
144382351|NCT03595618|520610055|FG003|Overall Study|Physician Decision|2|||
144382352|NCT03595618|520610052|FG000|Overall Study|Miscellaneous|7|||
144382353|NCT03595618|520610053|FG001|Overall Study|Miscellaneous|5|||
144382354|NCT03595618|520610054|FG002|Overall Study|Miscellaneous|10|||
144382355|NCT03595618|520610055|FG003|Overall Study|Miscellaneous|6|||
144382356|NCT02338232|520610056|FG000|Overall Study|Screen Failure|3|||
144382357|NCT02338232|520610056|FG000|Overall Study|Withdrawal by Subject|6|||
144382358|NCT02338232|520610056|FG000|Overall Study|Adverse Event|2|||
144382359|NCT02279407|520610057|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
144382360|NCT02279407|520610058|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
144382361|NCT02279407|520610059|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
144382362|NCT02279407|520610060|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
144382363|NCT02279407|520610057|FG000|Overall Study|Withdrawal by Subject|1|||
144199309|NCT00541970|519928869|FG003|Month 48|Withdrawal by Subject|2|||
144592398|NCT00790751|521368602|FG003|Overall Study|Physician Decision|1|||
144382364|NCT02279407|520610058|FG001|Overall Study|Withdrawal by Subject|0|||
144382365|NCT02279407|520610059|FG002|Overall Study|Withdrawal by Subject|1|||
144382366|NCT02279407|520610060|FG003|Overall Study|Withdrawal by Subject|1|||
144382367|NCT02279407|520610057|FG000|Overall Study|Adverse Event|1|||
144382368|NCT02279407|520610058|FG001|Overall Study|Adverse Event|1|||
144382369|NCT02279407|520610059|FG002|Overall Study|Adverse Event|2|||
144382370|NCT02279407|520610060|FG003|Overall Study|Adverse Event|0|||
144382371|NCT02500056|520610063|FG000|Overall Study|Lost to Follow-up|3|||
144382372|NCT02500056|520610064|FG001|Overall Study|Lost to Follow-up|7|||
144382373|NCT02500056|520610063|FG000|Overall Study|Recurrence|1|||
144382374|NCT02500056|520610064|FG001|Overall Study|Recurrence|0|||
144382375|NCT02500056|520610063|FG000|Overall Study|Death|3|||
144382376|NCT02500056|520610064|FG001|Overall Study|Death|1|||
144382377|NCT00864916|520610065|FG000|Overall Study|Lost to Follow-up|4|||
144382378|NCT00864916|520610066|FG001|Overall Study|Lost to Follow-up|4|||
144382379|NCT00864916|520610065|FG000|Overall Study|Protocol Violation|1|||
144382380|NCT00864916|520610066|FG001|Overall Study|Protocol Violation|0|||
144382381|NCT00864916|520610065|FG000|Overall Study|Withdrawal by Subject|1|||
144382382|NCT00864916|520610066|FG001|Overall Study|Withdrawal by Subject|0|||
144382383|NCT03890666|520610067|FG000|Overall Study|Withdrawal by Subject|0|||
144382384|NCT03890666|520610068|FG001|Overall Study|Withdrawal by Subject|1|||
144382385|NCT03890666|520610067|FG000|Overall Study|Protocol deviation|1|||
144382386|NCT03890666|520610068|FG001|Overall Study|Protocol deviation|4|||
144382387|NCT03890666|520610067|FG000|Overall Study|Lost to Follow-up|2|||
144382388|NCT03890666|520610068|FG001|Overall Study|Lost to Follow-up|5|||
144592399|NCT05590884|521368603|FG000|Overall Study|Withdrawal by Subject|1|||
144592400|NCT05590884|521368604|FG001|Overall Study|Withdrawal by Subject|0|||
144592401|NCT05590884|521368605|FG002|Overall Study|Withdrawal by Subject|0|||
144592402|NCT04948333|521368606|FG000|Overall Study|Adverse Event|6|||
144592403|NCT04948333|521368607|FG001|Overall Study|Adverse Event|4|||
144592404|NCT04948333|521368608|FG002|Overall Study|Adverse Event|0|||
144592405|NCT04948333|521368609|FG003|Overall Study|Adverse Event|2|||
144592406|NCT04948333|521368606|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
144592407|NCT04948333|521368607|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144592408|NCT04948333|521368608|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144592409|NCT04948333|521368609|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144592410|NCT04948333|521368606|FG000|Overall Study|Progressive Disease|1|||
144592411|NCT04948333|521368607|FG001|Overall Study|Progressive Disease|5|||
144592412|NCT04948333|521368608|FG002|Overall Study|Progressive Disease|0|||
144592413|NCT04948333|521368609|FG003|Overall Study|Progressive Disease|0|||
144592414|NCT04948333|521368606|FG000|Overall Study|Physician Decision|2|||
144592415|NCT04948333|521368607|FG001|Overall Study|Physician Decision|2|||
144592416|NCT04948333|521368608|FG002|Overall Study|Physician Decision|0|||
144592417|NCT04948333|521368609|FG003|Overall Study|Physician Decision|0|||
144592418|NCT04948333|521368606|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
144592419|NCT04948333|521368607|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
144592420|NCT04948333|521368608|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
144592421|NCT04948333|521368609|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
144592422|NCT04948333|521368606|FG000|Overall Study|Withdrawal by Subject|2|||
144592423|NCT04948333|521368607|FG001|Overall Study|Withdrawal by Subject|0|||
144592424|NCT04948333|521368608|FG002|Overall Study|Withdrawal by Subject|0|||
144592425|NCT04948333|521368609|FG003|Overall Study|Withdrawal by Subject|1|||
144592426|NCT04948333|521368606|FG000|Overall Study|Protocol Violation|0|||
144592427|NCT04948333|521368607|FG001|Overall Study|Protocol Violation|1|||
144592428|NCT04948333|521368608|FG002|Overall Study|Protocol Violation|0|||
144592429|NCT04948333|521368609|FG003|Overall Study|Protocol Violation|0|||
144592430|NCT04948333|521368606|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
144382389|NCT03890666|520610067|FG000|Overall Study|Other than specified|1|||
144382390|NCT03890666|520610068|FG001|Overall Study|Other than specified|8|||
144382391|NCT01105065|520610070|FG000|Overall Study|Adverse Event|5|||
144382392|NCT01105065|520610070|FG000|Overall Study|Technical Problems|1|||
144382393|NCT01155011|520610075|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
144382394|NCT01155011|520610076|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
144382395|NCT01155011|520610075|FG000|Baseline to 6 Months|investigator decision, moved|4|||
144592431|NCT04948333|521368607|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
144592432|NCT04948333|521368608|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
144592433|NCT04948333|521368609|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
144592434|NCT04443153|521368611|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
144592435|NCT04443153|521368612|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
144382396|NCT01155011|520610076|FG001|Baseline to 6 Months|investigator decision, moved|5|||
144592436|NCT04443153|521368611|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
144592437|NCT04443153|521368612|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
144382397|NCT01155011|520610075|FG000|Baseline to 6 Months|Death|0|||
144382398|NCT01155011|520610076|FG001|Baseline to 6 Months|Death|1|||
144592438|NCT04443153|521368611|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
144382399|NCT01155011|520610075|FG000|6 to 12 Months|Withdrawal by Subject|8|||
144382400|NCT01155011|520610076|FG001|6 to 12 Months|Withdrawal by Subject|5|||
144382401|NCT01155011|520610075|FG000|6 to 12 Months|Death|1|||
144382402|NCT01155011|520610076|FG001|6 to 12 Months|Death|5|||
144382403|NCT00422084|520610077|FG000|Overall Study|Adverse Event|21|||
144382404|NCT00422084|520610078|FG001|Overall Study|Adverse Event|7|||
144382405|NCT00422084|520610077|FG000|Overall Study|Withdrawal by Subject|12|||
144382406|NCT00422084|520610078|FG001|Overall Study|Withdrawal by Subject|9|||
144382407|NCT00422084|520610077|FG000|Overall Study|Lost to Follow-up|14|||
144382408|NCT00422084|520610078|FG001|Overall Study|Lost to Follow-up|9|||
144382409|NCT00422084|520610077|FG000|Overall Study|Protocol Violation|4|||
144382410|NCT00422084|520610078|FG001|Overall Study|Protocol Violation|1|||
144382411|NCT00422084|520610077|FG000|Overall Study|Lack of Efficacy|40|||
144382412|NCT00422084|520610078|FG001|Overall Study|Lack of Efficacy|42|||
144382413|NCT00422084|520610077|FG000|Overall Study|P. vivax infection|3|||
144382414|NCT00422084|520610078|FG001|Overall Study|P. vivax infection|6|||
144382415|NCT00422084|520610077|FG000|Overall Study|Cyesis|1|||
144382416|NCT00422084|520610078|FG001|Overall Study|Cyesis|0|||
144382417|NCT00422084|520610077|FG000|Overall Study|Withdrawn from study accidentally|1|||
144382418|NCT00422084|520610078|FG001|Overall Study|Withdrawn from study accidentally|0|||
144382419|NCT00422084|520610077|FG000|Overall Study|Non-compliance|1|||
144382420|NCT00422084|520610078|FG001|Overall Study|Non-compliance|0|||
144382421|NCT00422084|520610077|FG000|Overall Study|Re-location|0|||
144382422|NCT00422084|520610078|FG001|Overall Study|Re-location|1|||
144382423|NCT00422084|520610077|FG000|Overall Study|Not defined|1|||
144382424|NCT00422084|520610078|FG001|Overall Study|Not defined|1|||
144382425|NCT03774823|520610079|FG000|Overall Study|Withdrawal by Subject|1|||
144721936|NCT04540497|521836884|FG001|Overall Study|Adverse Event|2|||
144382426|NCT03774823|520610080|FG001|Overall Study|Withdrawal by Subject|1|||
144721937|NCT04540497|521836883|FG000|Overall Study|Lost to Follow-up|1|||
144382427|NCT02043899|520611702|FG000|Overall Study|Adverse Event|3|||
144382428|NCT02043899|520611702|FG000|Overall Study|Physician Decision|1|||
144382429|NCT02043899|520611702|FG000|Overall Study|Withdrawal by Subject|2|||
144382430|NCT02043899|520611702|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
144382431|NCT02043899|520611702|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
144382432|NCT02043899|520611702|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
144382433|NCT02043899|520611702|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
144382434|NCT02043899|520611702|FG000|Overall Study|Treatment delayed|1|||
144382435|NCT01771809|520611703|FG000|Overall Study|Adverse Event|4|||
144382436|NCT01771809|520611704|FG001|Overall Study|Adverse Event|12|||
144382437|NCT01771809|520611703|FG000|Overall Study|Protocol Violation|0|||
144382438|NCT01771809|520611704|FG001|Overall Study|Protocol Violation|1|||
144382439|NCT01771809|520611703|FG000|Overall Study|Withdrawal by Subject|34|||
144382440|NCT01771809|520611704|FG001|Overall Study|Withdrawal by Subject|42|||
144382441|NCT01771809|520611703|FG000|Overall Study|Lost to Follow-up|1|||
144382442|NCT01771809|520611704|FG001|Overall Study|Lost to Follow-up|3|||
144382443|NCT01771809|520611703|FG000|Overall Study|Other (Insufficient clinical response)|22|||
144382444|NCT01771809|520611704|FG001|Overall Study|Other (Insufficient clinical response)|20|||
144382445|NCT01771809|520611703|FG000|Overall Study|Death|1|||
144382446|NCT01771809|520611704|FG001|Overall Study|Death|0|||
144382447|NCT01771809|520611703|FG000|Overall Study|Other (other)|9|||
144382448|NCT01771809|520611704|FG001|Overall Study|Other (other)|5|||
144382449|NCT01106092|520611705|FG000|Overall Study|Withdrawal by Subject|0|||
144382450|NCT01106092|520611706|FG001|Overall Study|Withdrawal by Subject|0|||
144382451|NCT01106092|520611707|FG002|Overall Study|Withdrawal by Subject|0|||
144382452|NCT01106092|520611708|FG003|Overall Study|Withdrawal by Subject|1|||
144382453|NCT02434471|520611713|FG000|Overall Study|Physician Decision|9|||
144382454|NCT04839562|520611718|FG000|Overall Study|Withdrawal by Subject|0|||
144382455|NCT04839562|520611719|FG001|Overall Study|Withdrawal by Subject|1|||
144382456|NCT04839562|520611718|FG000|Overall Study|Physician Decision|0|||
144382457|NCT04839562|520611719|FG001|Overall Study|Physician Decision|1|||
144382458|NCT01012219|520611720|FG000|Period 1|Withdrawal by Subject|1|||
144382459|NCT01012219|520611720|FG000|Period 2|Withdrawal by Subject|1|||
144382460|NCT01236547|520611721|FG000|Overall Study|Protocol Violation|0|||
144382461|NCT01236547|520611722|FG001|Overall Study|Protocol Violation|1|||
144382462|NCT01236547|520611723|FG002|Overall Study|Protocol Violation|1|||
144382463|NCT01236547|520611724|FG003|Overall Study|Protocol Violation|6|||
144382464|NCT01236547|520611725|FG004|Overall Study|Protocol Violation|12|||
144382465|NCT00917644|520611726|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
144382466|NCT00917644|520611727|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
144382467|NCT00917644|520611726|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
144382468|NCT00917644|520611727|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
144382469|NCT00917644|520611726|FG000|Period 2: Second Intervention|family emergency|1|||
144382470|NCT00917644|520611727|FG001|Period 2: Second Intervention|family emergency|0|||
144382471|NCT00958438|520611730|FG000|Overall Study|Protocol Violation|3|||
144382472|NCT00958438|520611731|FG001|Overall Study|Protocol Violation|2|||
144382473|NCT00958438|520611732|FG002|Overall Study|Protocol Violation|2|||
144382474|NCT00958438|520611730|FG000|Overall Study|Withdrawal by Subject|4|||
144382475|NCT00958438|520611731|FG001|Overall Study|Withdrawal by Subject|2|||
144382476|NCT00958438|520611732|FG002|Overall Study|Withdrawal by Subject|1|||
144382477|NCT00958438|520611730|FG000|Overall Study|Adverse Event|0|||
144382478|NCT00958438|520611731|FG001|Overall Study|Adverse Event|3|||
144382479|NCT00958438|520611732|FG002|Overall Study|Adverse Event|0|||
144382480|NCT00958438|520611730|FG000|Overall Study|Physician Decision|1|||
144382481|NCT00958438|520611731|FG001|Overall Study|Physician Decision|0|||
144382482|NCT00958438|520611732|FG002|Overall Study|Physician Decision|1|||
144382483|NCT00958438|520611730|FG000|Overall Study|Other than specified above|2|||
144382484|NCT00958438|520611731|FG001|Overall Study|Other than specified above|3|||
144382485|NCT00958438|520611732|FG002|Overall Study|Other than specified above|2|||
144382486|NCT02788279|520611733|FG000|Overall Study|Death|62|||
144382487|NCT02788279|520611734|FG001|Overall Study|Death|136|||
144382488|NCT02788279|520611735|FG002|Overall Study|Death|72|||
144382489|NCT02788279|520611733|FG000|Overall Study|Withdrawal by Subject|10|||
144382490|NCT02788279|520611734|FG001|Overall Study|Withdrawal by Subject|15|||
144382491|NCT02788279|520611735|FG002|Overall Study|Withdrawal by Subject|5|||
144382492|NCT02788279|520611733|FG000|Overall Study|Lost to Follow-up|0|||
144382493|NCT02788279|520611734|FG001|Overall Study|Lost to Follow-up|3|||
144382494|NCT02788279|520611735|FG002|Overall Study|Lost to Follow-up|2|||
144382495|NCT02788279|520611733|FG000|Overall Study|Sponsor decision|18|||
144382496|NCT02788279|520611734|FG001|Overall Study|Sponsor decision|29|||
144382497|NCT02788279|520611735|FG002|Overall Study|Sponsor decision|11|||
144382498|NCT03996369|520611736|FG000|Overall Study|Protocol deviation|1|||
144382499|NCT03996369|520611737|FG001|Overall Study|Protocol deviation|1|||
144382500|NCT03996369|520611736|FG000|Overall Study|Physician Decision|4|||
144382501|NCT03996369|520611737|FG001|Overall Study|Physician Decision|2|||
144382502|NCT03996369|520611736|FG000|Overall Study|Participant decision|0|||
144382503|NCT03996369|520611737|FG001|Overall Study|Participant decision|1|||
144382504|NCT03996369|520611736|FG000|Overall Study|Lack of Efficacy|4|||
144382505|NCT03996369|520611737|FG001|Overall Study|Lack of Efficacy|0|||
144382506|NCT03996369|520611736|FG000|Overall Study|Adverse Event|9|||
144382507|NCT03996369|520611737|FG001|Overall Study|Adverse Event|0|||
144382508|NCT03996369|520611736|FG000|Overall Study|Withdrawal by Subject|6|||
144382509|NCT03996369|520611737|FG001|Overall Study|Withdrawal by Subject|8|||
144382510|NCT03996369|520611736|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
144382511|NCT03996369|520611737|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
144382512|NCT03996369|520611736|FG000|Overall Study|Lost to Follow-up|0|||
144382513|NCT03996369|520611737|FG001|Overall Study|Lost to Follow-up|1|||
144382514|NCT00653432|520611739|FG000|Overall Study|Adverse Event|4|||
144382515|NCT00653432|520611740|FG001|Overall Study|Adverse Event|1|||
144382516|NCT00653432|520611739|FG000|Overall Study|Withdrawal by Subject|4|||
144382517|NCT00653432|520611740|FG001|Overall Study|Withdrawal by Subject|5|||
144382518|NCT00653432|520611739|FG000|Overall Study|Lost to Follow-up|7|||
144382519|NCT00653432|520611740|FG001|Overall Study|Lost to Follow-up|6|||
144382520|NCT00653432|520611739|FG000|Overall Study|Use/Need of Con Therapy|2|||
144382521|NCT00653432|520611740|FG001|Overall Study|Use/Need of Con Therapy|1|||
144382522|NCT00653432|520611739|FG000|Overall Study|Other - Reason Not Provided|5|||
144382523|NCT00653432|520611740|FG001|Overall Study|Other - Reason Not Provided|3|||
144382524|NCT05277337|520611741|FG000|Overall Study|Lost to Follow-up|2|||
144382525|NCT05277337|520611742|FG001|Overall Study|Lost to Follow-up|0|||
144382526|NCT05277337|520611741|FG000|Overall Study|Withdrawal by Subject|1|||
144382527|NCT05277337|520611742|FG001|Overall Study|Withdrawal by Subject|0|||
144514786|NCT02201108|521083953|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
144382528|NCT01782469|520611743|FG000|Overall Study|Lost to Follow-up|1|||
144382529|NCT00357760|520611746|FG000|Overall Study|Disease progression|44|||
144382530|NCT00357760|520611747|FG001|Overall Study|Disease progression|17|||
144382531|NCT00357760|520611746|FG000|Overall Study|Adverse Event|10|||
144382532|NCT00357760|520611747|FG001|Overall Study|Adverse Event|7|||
144382533|NCT00357760|520611746|FG000|Overall Study|Death|0|||
144382534|NCT00357760|520611747|FG001|Overall Study|Death|3|||
144382535|NCT00357760|520611746|FG000|Overall Study|Alternative therapy|1|||
144382536|NCT00357760|520611747|FG001|Overall Study|Alternative therapy|0|||
144382537|NCT00357760|520611746|FG000|Overall Study|Withdrawal by Subject|0|||
144382538|NCT00357760|520611747|FG001|Overall Study|Withdrawal by Subject|2|||
144382539|NCT00357760|520611746|FG000|Overall Study|Never started treatment|2|||
144382540|NCT00357760|520611747|FG001|Overall Study|Never started treatment|1|||
144382541|NCT00357760|520611746|FG000|Overall Study|Ineligible|0|||
144382542|NCT00357760|520611747|FG001|Overall Study|Ineligible|2|||
144382543|NCT00357760|520611746|FG000|Overall Study|Physician Decision|2|||
144382544|NCT00357760|520611747|FG001|Overall Study|Physician Decision|1|||
144382545|NCT00357760|520611746|FG000|Overall Study|Protocol Violation|0|||
144382546|NCT00357760|520611747|FG001|Overall Study|Protocol Violation|1|||
144382547|NCT00357760|520611746|FG000|Overall Study|To receive hospice care|0|||
144382548|NCT00357760|520611747|FG001|Overall Study|To receive hospice care|1|||
144382549|NCT04136444|520611748|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
144382550|NCT04136444|520611749|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
144382551|NCT02350764|520611750|FG000|Overall Study|Adverse Event|4|||
144382552|NCT02350764|520611750|FG000|Overall Study|Death|3|||
144382553|NCT02350764|520611750|FG000|Overall Study|Physician Decision|2|||
144382554|NCT02350764|520611750|FG000|Overall Study|Withdrawal by Subject|2|||
144382555|NCT03241368|520611751|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
144382556|NCT03241368|520611751|FG000|Overall Study|Lost to Follow-up|1|||
144382557|NCT03241368|520611751|FG000|Overall Study|Physician Decision|6|||
144382558|NCT03241368|520611751|FG000|Overall Study|Withdrawal by Subject|6|||
144382559|NCT03241368|520611751|FG000|Overall Study|Protocol Violation|1|||
144382560|NCT01224782|520611757|FG000|Overall Study|Lost to Follow-up|177|||
144382561|NCT01224782|520611757|FG000|Overall Study|Withdrawal by Subject|16|||
144382562|NCT01224782|520611757|FG000|Overall Study|Death|14|||
144382563|NCT01224782|520611757|FG000|Overall Study|Improvement|13|||
144382564|NCT01224782|520611757|FG000|Overall Study|Adverse Event|12|||
144382565|NCT01224782|520611757|FG000|Overall Study|Adverse Reaction|11|||
144382566|NCT01224782|520611757|FG000|Overall Study|Noncompliance|10|||
144382567|NCT01224782|520611757|FG000|Overall Study|Other|4|||
144382568|NCT01224782|520611757|FG000|Overall Study|Start of Dialysis|3|||
144382569|NCT01224782|520611757|FG000|Overall Study|Change of Treatment|1|||
144382570|NCT01224782|520611757|FG000|Overall Study|Financial Reasons|1|||
144382571|NCT01224782|520611757|FG000|Overall Study|Deterioration|1|||
144382572|NCT01224782|520611757|FG000|Overall Study|Transplantation|1|||
144382573|NCT00065429|520611758|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
144382574|NCT00065429|520611759|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
144382575|NCT00065429|520611760|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
144382576|NCT00065429|520611761|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
144382577|NCT00065429|520611762|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
144382578|NCT00065429|520611763|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
144382579|NCT00065429|520611764|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
144382580|NCT00065429|520611758|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
144382581|NCT00065429|520611759|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
144382582|NCT00065429|520611760|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
144382583|NCT00065429|520611761|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
144382584|NCT00065429|520611762|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
144382585|NCT00065429|520611763|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
144382586|NCT00065429|520611764|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
144382587|NCT00065429|520611758|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
144382588|NCT00065429|520611759|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
144382589|NCT00065429|520611760|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
144382590|NCT00065429|520611761|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
144382591|NCT00065429|520611762|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
144382592|NCT00065429|520611763|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
144514787|NCT02201108|521083951|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
144514788|NCT02201108|521083952|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
144514789|NCT02201108|521083953|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
144514790|NCT03438188|521083954|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
144514791|NCT03438188|521083955|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
144514792|NCT03438188|521083956|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
144514793|NCT03438188|521083954|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
144514794|NCT03438188|521083955|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
144514795|NCT03438188|521083956|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
144514796|NCT03438188|521083954|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
144514797|NCT03438188|521083955|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
144382593|NCT00065429|520611764|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
144382594|NCT00065429|520611758|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
144382595|NCT00065429|520611759|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
144382596|NCT00065429|520611760|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
144382597|NCT00065429|520611761|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
144382598|NCT00065429|520611762|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
144382599|NCT00065429|520611763|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
144382600|NCT00065429|520611764|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
144382601|NCT00065429|520611758|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
144382602|NCT00065429|520611759|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
144382603|NCT00065429|520611760|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
144382604|NCT00065429|520611761|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
144382605|NCT00065429|520611762|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
144382606|NCT00065429|520611763|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
144382607|NCT00065429|520611764|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
144382608|NCT00065429|520611758|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
144382609|NCT00065429|520611759|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
144382610|NCT00065429|520611760|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
144382611|NCT00065429|520611761|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
144382612|NCT00065429|520611762|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
144382613|NCT00065429|520611763|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
144382614|NCT00065429|520611764|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
144382615|NCT00065429|520611758|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
144382616|NCT00065429|520611759|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
144382617|NCT00065429|520611760|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
144382618|NCT00065429|520611761|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
144382619|NCT00065429|520611762|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
144382620|NCT00065429|520611763|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
144382621|NCT00065429|520611764|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
144382622|NCT00441116|520611768|FG000|Overall Study|Adverse Event|1|||
144382623|NCT00441116|520611769|FG001|Overall Study|Adverse Event|1|||
144382624|NCT00441116|520611768|FG000|Overall Study|Withdrawal by Subject|1|||
144382625|NCT00441116|520611769|FG001|Overall Study|Withdrawal by Subject|0|||
144382626|NCT00441116|520611768|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
144382627|NCT00441116|520611769|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
144382628|NCT02925338|520611770|FG000|Overall Study|Death|0|||
144382629|NCT02925338|520611771|FG001|Overall Study|Death|2|||
144382630|NCT02925338|520611772|FG002|Overall Study|Death|1|||
144382631|NCT02925338|520611773|FG003|Overall Study|Death|0|||
144382632|NCT02925338|520611774|FG004|Overall Study|Death|0|||
144382633|NCT02925338|520611770|FG000|Overall Study|Lost to Follow-up|30|||
144382634|NCT02925338|520611771|FG001|Overall Study|Lost to Follow-up|10|||
144382635|NCT02925338|520611772|FG002|Overall Study|Lost to Follow-up|1|||
144382636|NCT02925338|520611773|FG003|Overall Study|Lost to Follow-up|16|||
144382637|NCT02925338|520611774|FG004|Overall Study|Lost to Follow-up|3|||
144382638|NCT02925338|520611770|FG000|Overall Study|Withdrawal by Subject|3|||
144592439|NCT04443153|521368612|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
144382639|NCT02925338|520611771|FG001|Overall Study|Withdrawal by Subject|0|||
144382640|NCT02925338|520611772|FG002|Overall Study|Withdrawal by Subject|3|||
144382641|NCT02925338|520611773|FG003|Overall Study|Withdrawal by Subject|2|||
144382642|NCT02925338|520611774|FG004|Overall Study|Withdrawal by Subject|2|||
144382643|NCT02925338|520611770|FG000|Overall Study|Missing|38|||
144382644|NCT02925338|520611771|FG001|Overall Study|Missing|27|||
144382645|NCT02925338|520611772|FG002|Overall Study|Missing|0|||
144382646|NCT02925338|520611773|FG003|Overall Study|Missing|3|||
144382647|NCT02925338|520611774|FG004|Overall Study|Missing|2|||
144382648|NCT02925338|520611770|FG000|Overall Study|Participant's Decision|11|||
144382649|NCT02925338|520611771|FG001|Overall Study|Participant's Decision|7|||
144382650|NCT02925338|520611772|FG002|Overall Study|Participant's Decision|3|||
144382651|NCT02925338|520611773|FG003|Overall Study|Participant's Decision|8|||
144592440|NCT04443153|521368611|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
144592441|NCT04443153|521368612|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
144592442|NCT05182125|521368613|FG000|Overall Study|Withdrawal by Subject|0|||
144592443|NCT05182125|521368614|FG001|Overall Study|Withdrawal by Subject|0|||
144592444|NCT05182125|521368615|FG002|Overall Study|Withdrawal by Subject|0|||
144382652|NCT02925338|520611774|FG004|Overall Study|Participant's Decision|1|||
144382653|NCT02925338|520611770|FG000|Overall Study|Treatment Discontinuation|144|||
144382654|NCT02925338|520611771|FG001|Overall Study|Treatment Discontinuation|65|||
144382655|NCT02925338|520611772|FG002|Overall Study|Treatment Discontinuation|56|||
144382656|NCT02925338|520611773|FG003|Overall Study|Treatment Discontinuation|131|||
144382657|NCT02925338|520611774|FG004|Overall Study|Treatment Discontinuation|22|||
144382658|NCT00832624|520611775|FG000|Overall Study|Study Terminated|10|||
144592445|NCT05182125|521368616|FG003|Overall Study|Withdrawal by Subject|0|||
144592446|NCT05182125|521368617|FG004|Overall Study|Withdrawal by Subject|2|||
144382659|NCT00548184|520611778|FG000|Overall Study|Adverse Event|3|||
144382660|NCT00548184|520611778|FG000|Overall Study|took other drug|1|||
144382661|NCT00548184|520611778|FG000|Overall Study|Found Her2 negative|1|||
144382662|NCT02395172|520611779|FG000|Overall Study|Participants randomized but not treated|3|||
144592447|NCT05182125|521368618|FG005|Overall Study|Withdrawal by Subject|0|||
144382663|NCT02395172|520611780|FG001|Overall Study|Participants randomized but not treated|31|||
144382664|NCT00029146|520611783|FG000|Overall Study|Lost to Follow-up|2|||
144382665|NCT00029146|520611784|FG001|Overall Study|Lost to Follow-up|1|||
144382666|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
144382667|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
144382668|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
144382669|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
144382670|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
144592448|NCT05182125|521368613|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
144592449|NCT05182125|521368614|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
144592450|NCT05182125|521368615|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
144592451|NCT05182125|521368616|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
144592452|NCT05182125|521368617|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
144592453|NCT05182125|521368618|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
144592454|NCT05182125|521368613|FG000|Overall Study|Death|0|||
144592455|NCT05182125|521368614|FG001|Overall Study|Death|0|||
144592456|NCT05182125|521368615|FG002|Overall Study|Death|0|||
144592457|NCT05182125|521368616|FG003|Overall Study|Death|0|||
144592458|NCT05182125|521368617|FG004|Overall Study|Death|1|||
144592459|NCT05182125|521368618|FG005|Overall Study|Death|0|||
144592460|NCT01078454|521368619|FG000|Overall Study|Adverse Event|1|||
144592461|NCT01078454|521368620|FG001|Overall Study|Adverse Event|1|||
144592462|NCT01078454|521368619|FG000|Overall Study|Death|0|||
144592463|NCT01078454|521368620|FG001|Overall Study|Death|1|||
144592464|NCT01919814|521370552|FG000|Overall Study|Adverse Event|1|||
144592465|NCT01919814|521370553|FG001|Overall Study|Adverse Event|0|||
144592466|NCT01919814|521370552|FG000|Overall Study|Protocol Violation|1|||
144592467|NCT01919814|521370553|FG001|Overall Study|Protocol Violation|0|||
144592468|NCT01919814|521370552|FG000|Overall Study|Withdrawal by Subject|1|||
144592469|NCT01919814|521370553|FG001|Overall Study|Withdrawal by Subject|0|||
144592470|NCT05220254|521370557|FG000|Overall Study|Withdrawal by Subject|4|||
144592471|NCT05220254|521370557|FG000|Overall Study|Removed due to ineligibility|1|||
144592472|NCT05220254|521370557|FG000|Overall Study|Lost to Follow-up|7|||
144592473|NCT04363801|521370559|FG000|Overall Study|Death|18|||
144592474|NCT04363801|521370560|FG001|Overall Study|Death|14|||
144592475|NCT04363801|521370561|FG002|Overall Study|Death|16|||
144592476|NCT04363801|521370562|FG003|Overall Study|Death|48|||
144592477|NCT04363801|521370563|FG004|Overall Study|Death|38|||
144592478|NCT04363801|521370559|FG000|Overall Study|Withdrawal by Subject|1|||
144592479|NCT04363801|521370560|FG001|Overall Study|Withdrawal by Subject|6|||
144592480|NCT04363801|521370561|FG002|Overall Study|Withdrawal by Subject|1|||
144592481|NCT04363801|521370562|FG003|Overall Study|Withdrawal by Subject|4|||
144592482|NCT04363801|521370563|FG004|Overall Study|Withdrawal by Subject|14|||
144592483|NCT04363801|521370559|FG000|Overall Study|Sponsor Decision|6|||
144592484|NCT04363801|521370560|FG001|Overall Study|Sponsor Decision|4|||
144592485|NCT04363801|521370561|FG002|Overall Study|Sponsor Decision|10|||
144592486|NCT04363801|521370562|FG003|Overall Study|Sponsor Decision|33|||
144592487|NCT04363801|521370563|FG004|Overall Study|Sponsor Decision|32|||
144382671|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
144382672|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
144514798|NCT03438188|521083956|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
144514799|NCT03438188|521083954|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
144514800|NCT03438188|521083955|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
144514801|NCT03438188|521083956|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
144514802|NCT03438188|521083954|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
144514803|NCT03438188|521083955|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
144514804|NCT03438188|521083956|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
144514805|NCT02819843|521083958|FG000|Overall Study|Disease progression before RT|0|||
144514806|NCT02819843|521083959|FG001|Overall Study|Disease progression before RT|1|||
144514807|NCT04732494|521083960|FG000|Overall Study|Death|39|||
144514808|NCT04732494|521083961|FG001|Overall Study|Death|36|||
144514809|NCT04732494|521083960|FG000|Overall Study|Study Closed by Sponsor|20|||
144514810|NCT04732494|521083961|FG001|Overall Study|Study Closed by Sponsor|15|||
144514811|NCT04732494|521083960|FG000|Overall Study|Withdrawal by Subject|2|||
144514812|NCT04732494|521083961|FG001|Overall Study|Withdrawal by Subject|7|||
144721938|NCT04540497|521836884|FG001|Overall Study|Lost to Follow-up|0|||
144514813|NCT04732494|521083960|FG000|Overall Study|Lost to Follow-up|1|||
144592488|NCT04363801|521370559|FG000|Overall Study|Lost to Follow-up|0|||
144592489|NCT04363801|521370560|FG001|Overall Study|Lost to Follow-up|0|||
144592490|NCT04363801|521370561|FG002|Overall Study|Lost to Follow-up|1|||
144592491|NCT04363801|521370562|FG003|Overall Study|Lost to Follow-up|0|||
144592492|NCT04363801|521370563|FG004|Overall Study|Lost to Follow-up|1|||
144592493|NCT00448279|521370564|FG000|Overall Study|Lost to Follow-up|2|||
144592494|NCT00448279|521370565|FG001|Overall Study|Lost to Follow-up|2|||
144592495|NCT00448279|521370564|FG000|Overall Study|Adverse Event|1|||
144592496|NCT00448279|521370565|FG001|Overall Study|Adverse Event|1|||
144382673|NCT00946985|520611785|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
144382674|NCT00946985|520611785|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
144382675|NCT01546623|520611786|FG000|Overall Study|Adverse Event|2|||
144382676|NCT01546623|520611787|FG001|Overall Study|Adverse Event|3|||
144382677|NCT01546623|520611786|FG000|Overall Study|Major Protocol Deviation|1|||
144382678|NCT01546623|520611787|FG001|Overall Study|Major Protocol Deviation|1|||
144382679|NCT01546623|520611786|FG000|Overall Study|High Prostate specific antigen|2|||
144382680|NCT01546623|520611787|FG001|Overall Study|High Prostate specific antigen|1|||
144382681|NCT01546623|520611786|FG000|Overall Study|Did Not Receive Study Drug|1|||
144382682|NCT01546623|520611787|FG001|Overall Study|Did Not Receive Study Drug|1|||
144382683|NCT01590758|520611788|FG000|Overall Study|Withdrawal by Subject|0|||
144382684|NCT01590758|520611789|FG001|Overall Study|Withdrawal by Subject|3|||
144382685|NCT01590758|520611788|FG000|Overall Study|Physician Decision|1|||
144382686|NCT01590758|520611789|FG001|Overall Study|Physician Decision|2|||
144382687|NCT01590758|520611788|FG000|Overall Study|Lost to Follow-up|4|||
144382688|NCT01590758|520611789|FG001|Overall Study|Lost to Follow-up|2|||
144382689|NCT04525885|520611790|FG000|Overall Study|Screen Failure|1|||
144382690|NCT04525885|520611791|FG001|Overall Study|Screen Failure|0|||
144382691|NCT04525885|520611792|FG002|Overall Study|Screen Failure|0|||
144382692|NCT04525885|520611790|FG000|Overall Study|Withdrawal by Subject|14|||
144382693|NCT04525885|520611791|FG001|Overall Study|Withdrawal by Subject|6|||
144382694|NCT04525885|520611792|FG002|Overall Study|Withdrawal by Subject|20|||
144382695|NCT04525885|520611790|FG000|Overall Study|Physician Decision|1|||
144382696|NCT04525885|520611791|FG001|Overall Study|Physician Decision|0|||
144382697|NCT04525885|520611792|FG002|Overall Study|Physician Decision|1|||
144382698|NCT02717832|520611793|FG000|Overall Study|Inability to place IV|3|||
144382699|NCT00978757|520611796|FG000|Overall Study|Physician Decision|1|||
144382700|NCT00978757|520611797|FG001|Overall Study|Physician Decision|3|||
144382701|NCT01185353|520611798|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
144382702|NCT01185353|520611799|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
144382703|NCT01185353|520611800|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
144382704|NCT01185353|520611801|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
144382705|NCT01185353|520611802|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
144382706|NCT01185353|520611803|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
144382707|NCT01185353|520611804|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
144382708|NCT01185353|520611805|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
144382709|NCT01185353|520611806|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
144382710|NCT01185353|520611807|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
144382711|NCT01185353|520611798|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382712|NCT01185353|520611799|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382713|NCT01185353|520611800|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382714|NCT01185353|520611801|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382715|NCT01185353|520611802|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
144382716|NCT01185353|520611803|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382717|NCT01185353|520611804|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382718|NCT01185353|520611805|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382719|NCT01185353|520611806|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382720|NCT01185353|520611807|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
144382721|NCT01185353|520611798|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
144382722|NCT01185353|520611799|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382723|NCT01185353|520611800|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382724|NCT01185353|520611801|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382725|NCT01185353|520611802|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
144382726|NCT01185353|520611803|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382727|NCT01185353|520611804|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382728|NCT01185353|520611805|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382729|NCT01185353|520611806|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382730|NCT01185353|520611807|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
144382731|NCT01185353|520611798|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382732|NCT01185353|520611799|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382733|NCT01185353|520611800|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
144382734|NCT01185353|520611801|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382735|NCT01185353|520611802|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
144382736|NCT01185353|520611803|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382737|NCT01185353|520611804|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382738|NCT01185353|520611805|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382739|NCT01185353|520611806|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382740|NCT01185353|520611807|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
144382741|NCT01185353|520611798|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382742|NCT01185353|520611799|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382743|NCT01185353|520611800|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382744|NCT01185353|520611801|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144199310|NCT00541970|519928866|FG000|Month 48|Other|3|||
144382745|NCT01185353|520611802|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
144382746|NCT01185353|520611803|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382747|NCT01185353|520611804|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382748|NCT01185353|520611805|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382749|NCT01185353|520611806|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382750|NCT01185353|520611807|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
144382751|NCT01185353|520611798|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
144382752|NCT01185353|520611799|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382753|NCT01185353|520611800|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382754|NCT01185353|520611801|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382755|NCT01185353|520611802|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
144382756|NCT01185353|520611803|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382757|NCT01185353|520611804|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382758|NCT01185353|520611805|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382759|NCT01185353|520611806|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382760|NCT01185353|520611807|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
144382761|NCT01185353|520611798|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382762|NCT01185353|520611799|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382763|NCT01185353|520611800|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
144382764|NCT01185353|520611801|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382765|NCT01185353|520611802|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382766|NCT01185353|520611803|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
144382767|NCT01185353|520611804|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382768|NCT01185353|520611805|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382769|NCT01185353|520611806|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382770|NCT01185353|520611807|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
144382771|NCT01185353|520611798|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382772|NCT01185353|520611799|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
144382773|NCT01185353|520611800|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382774|NCT01185353|520611801|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
144382775|NCT01185353|520611802|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382776|NCT01185353|520611803|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382777|NCT01185353|520611804|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382778|NCT01185353|520611805|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382779|NCT01185353|520611806|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382780|NCT01185353|520611807|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
144382781|NCT01185353|520611798|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382782|NCT01185353|520611799|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382783|NCT01185353|520611800|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382784|NCT01185353|520611801|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
144382785|NCT01185353|520611802|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382786|NCT01185353|520611803|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382787|NCT01185353|520611804|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
144382788|NCT01185353|520611805|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382789|NCT01185353|520611806|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382790|NCT01185353|520611807|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
144382791|NCT01185353|520611798|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
144382792|NCT01185353|520611799|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
144382793|NCT01185353|520611800|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
144382794|NCT01185353|520611801|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
144514814|NCT04732494|521083961|FG001|Overall Study|Lost to Follow-up|5|||
144514815|NCT03055858|521083962|FG000|Overall Study|Death|9|||
144514816|NCT03055858|521083962|FG000|Overall Study|Withdrawal by Subject|11|||
144514817|NCT03055858|521083962|FG000|Overall Study|Lost to Follow-up|6|||
144382795|NCT01185353|520611802|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
144382796|NCT01185353|520611803|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
144382797|NCT01185353|520611804|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
144514818|NCT03055858|521083962|FG000|Overall Study|Missed Follow-Up Visits|18|||
144382798|NCT01185353|520611805|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
144382799|NCT01185353|520611806|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
144382800|NCT01185353|520611807|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
144382801|NCT01185353|520611798|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382802|NCT01185353|520611799|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382803|NCT01185353|520611800|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382804|NCT01185353|520611801|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382805|NCT01185353|520611802|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382806|NCT01185353|520611803|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382807|NCT01185353|520611804|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
144382808|NCT01185353|520611805|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382809|NCT01185353|520611806|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382810|NCT01185353|520611807|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
144382811|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382812|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382813|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382814|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382815|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382816|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382817|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
144382818|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
144382819|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
144382820|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
144382821|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144382822|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144382823|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144382824|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144382825|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144382826|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144382827|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
144199311|NCT00541970|519928867|FG001|Month 48|Other|1|||
144382828|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
144382829|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
144382830|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
144382831|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382832|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382833|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382834|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382835|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382836|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382837|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
144382838|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
144382839|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
144382840|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
144382841|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382842|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382843|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382844|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382845|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382846|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382847|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382848|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382849|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
144382850|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
144382851|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Death|0|||
144382852|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Death|0|||
144382853|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Death|0|||
144382854|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Death|0|||
144382855|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Death|0|||
144382856|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Death|0|||
144382857|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Death|0|||
144382858|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Death|0|||
144382859|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Death|0|||
144382860|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Death|1|||
144382861|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382862|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382863|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382864|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382865|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382866|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382867|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382868|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382869|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
144382870|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
144382871|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382872|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382873|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382874|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382875|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382876|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382877|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382878|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382879|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
144382880|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
144382881|NCT01185353|520611798|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382882|NCT01185353|520611799|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382883|NCT01185353|520611800|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
144514819|NCT04586920|521083963|FG000|Overall Study|Lost to Follow-up|0|||
144514820|NCT04586920|521083964|FG001|Overall Study|Lost to Follow-up|0|||
144382884|NCT01185353|520611801|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382885|NCT01185353|520611802|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382886|NCT01185353|520611803|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382887|NCT01185353|520611804|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382888|NCT01185353|520611805|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382889|NCT01185353|520611806|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
144382890|NCT01185353|520611807|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
144382891|NCT01185353|520611798|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382892|NCT01185353|520611799|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382893|NCT01185353|520611800|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382894|NCT01185353|520611801|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382895|NCT01185353|520611802|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382896|NCT01185353|520611803|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382897|NCT01185353|520611804|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382898|NCT01185353|520611805|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
144382899|NCT01185353|520611806|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
144382900|NCT01185353|520611807|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
144382901|NCT01185353|520611798|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382902|NCT01185353|520611799|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382903|NCT01185353|520611800|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382904|NCT01185353|520611801|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382905|NCT01185353|520611802|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382906|NCT01185353|520611803|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382907|NCT01185353|520611804|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
144382908|NCT01185353|520611805|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
144382909|NCT01185353|520611806|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
144382910|NCT01185353|520611807|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
144382911|NCT01185353|520611798|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382912|NCT01185353|520611799|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382913|NCT01185353|520611800|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382914|NCT01185353|520611801|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382915|NCT01185353|520611802|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382916|NCT01185353|520611803|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382917|NCT01185353|520611804|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382918|NCT01185353|520611805|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
144382919|NCT01185353|520611806|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
144382920|NCT01185353|520611807|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
144382921|NCT02270944|520611811|FG000|Overall Study|Lost to Follow-up|9|||
144382922|NCT02270944|520611812|FG001|Overall Study|Lost to Follow-up|4|||
144382923|NCT02270944|520611811|FG000|Overall Study|Withdrawal by Subject|2|||
144382924|NCT02270944|520611812|FG001|Overall Study|Withdrawal by Subject|1|||
144514821|NCT04586920|521083965|FG002|Overall Study|Lost to Follow-up|0|||
144382925|NCT01144299|520611813|FG000|Overall Study|Lost to Follow-up|1|||
144514822|NCT04586920|521083966|FG003|Overall Study|Lost to Follow-up|0|||
144382926|NCT01144299|520611814|FG001|Overall Study|Lost to Follow-up|0|||
144514823|NCT04586920|521083967|FG004|Overall Study|Lost to Follow-up|0|||
144382927|NCT01144299|520611813|FG000|Overall Study|Withdrawal by Subject|1|||
144382928|NCT01144299|520611814|FG001|Overall Study|Withdrawal by Subject|0|||
144382929|NCT02342418|520611817|FG000|Overall Study|Adverse Event|0|||
144382930|NCT02342418|520611818|FG001|Overall Study|Adverse Event|1|||
144382931|NCT04255394|520611819|FG000|Overall Study|Death|35|||
144382932|NCT04255394|520611820|FG001|Overall Study|Death|25|||
144382933|NCT04255394|520611819|FG000|Overall Study|Device removed|2|||
144382934|NCT04255394|520611820|FG001|Overall Study|Device removed|10|||
144382935|NCT04255394|520611819|FG000|Overall Study|Withdrawal by Subject|9|||
144382936|NCT04255394|520611820|FG001|Overall Study|Withdrawal by Subject|8|||
144382937|NCT04255394|520611819|FG000|Overall Study|Screen Failure/Not treated|12|||
144382938|NCT04255394|520611820|FG001|Overall Study|Screen Failure/Not treated|8|||
144382939|NCT04255394|520611819|FG000|Overall Study|Lost to Follow-up|123|||
144382940|NCT04255394|520611820|FG001|Overall Study|Lost to Follow-up|265|||
144382941|NCT04255394|520611819|FG000|Overall Study|Adverse Event|1|||
144382942|NCT04255394|520611820|FG001|Overall Study|Adverse Event|3|||
144382943|NCT03612856|520611830|FG000|Pre-dose Period|Physician Decision|0|||
144382944|NCT03612856|520611831|FG001|Pre-dose Period|Physician Decision|1|||
144382945|NCT03612856|520611832|FG002|Pre-dose Period|Physician Decision|1|||
144382946|NCT03612856|520611830|FG000|Pre-dose Period|Withdrawal by Subject|0|||
144382947|NCT03612856|520611831|FG001|Pre-dose Period|Withdrawal by Subject|1|||
144382948|NCT03612856|520611832|FG002|Pre-dose Period|Withdrawal by Subject|0|||
144382949|NCT01576159|520611833|FG000|Overall Study|Withdrawal by Subject|0|||
144382950|NCT01576159|520611834|FG001|Overall Study|Withdrawal by Subject|1|||
144382951|NCT01576159|520611835|FG002|Overall Study|Withdrawal by Subject|0|||
144382952|NCT01576159|520611836|FG003|Overall Study|Withdrawal by Subject|0|||
144382953|NCT01576159|520611833|FG000|Overall Study|Physician Decision|0|||
144382954|NCT01576159|520611834|FG001|Overall Study|Physician Decision|0|||
144382955|NCT01576159|520611835|FG002|Overall Study|Physician Decision|1|||
144382956|NCT01576159|520611836|FG003|Overall Study|Physician Decision|0|||
144382957|NCT01576159|520611833|FG000|Overall Study|Lost to Follow-up|0|||
144382958|NCT01576159|520611834|FG001|Overall Study|Lost to Follow-up|0|||
144382959|NCT01576159|520611835|FG002|Overall Study|Lost to Follow-up|0|||
144382960|NCT01576159|520611836|FG003|Overall Study|Lost to Follow-up|1|||
144382961|NCT01576159|520611833|FG000|Overall Study|Protocol Violation|1|||
144382962|NCT01576159|520611834|FG001|Overall Study|Protocol Violation|0|||
144382963|NCT01576159|520611835|FG002|Overall Study|Protocol Violation|0|||
144382964|NCT01576159|520611836|FG003|Overall Study|Protocol Violation|0|||
144382965|NCT01181986|520611837|FG000|Phase 1|Lost to Follow-up|0|||
144382966|NCT01181986|520611838|FG001|Phase 1|Lost to Follow-up|1|||
144382967|NCT01181986|520611839|FG002|Phase 1|Lost to Follow-up|1|||
144382968|NCT01181986|520611837|FG000|Phase 1|Adverse Event|0|||
144382969|NCT01181986|520611838|FG001|Phase 1|Adverse Event|0|||
144382970|NCT01181986|520611839|FG002|Phase 1|Adverse Event|1|||
144382971|NCT01181986|520611837|FG000|Phase 1|Protocol Violation|1|||
144382972|NCT01181986|520611838|FG001|Phase 1|Protocol Violation|0|||
144382973|NCT01181986|520611839|FG002|Phase 1|Protocol Violation|0|||
144382974|NCT01181986|520611837|FG000|Phase 2|Adverse Event|0|||
144382975|NCT01181986|520611838|FG001|Phase 2|Adverse Event|3|||
144382976|NCT01181986|520611839|FG002|Phase 2|Adverse Event|0|||
144382977|NCT01181986|520611837|FG000|Phase 2|Medical condition|0|||
144382978|NCT01181986|520611838|FG001|Phase 2|Medical condition|1|||
144382979|NCT01181986|520611839|FG002|Phase 2|Medical condition|0|||
144382980|NCT01011309|520611840|FG000|Overall Study|Adverse Event|2|||
144382981|NCT01011309|520611841|FG001|Overall Study|Adverse Event|1|||
144382982|NCT01011309|520611842|FG002|Overall Study|Adverse Event|2|||
144382983|NCT01011309|520611840|FG000|Overall Study|Lack of Efficacy|0|||
144382984|NCT01011309|520611841|FG001|Overall Study|Lack of Efficacy|1|||
144382985|NCT01011309|520611842|FG002|Overall Study|Lack of Efficacy|0|||
144382986|NCT01011309|520611840|FG000|Overall Study|Protocol Violation|0|||
144382987|NCT01011309|520611841|FG001|Overall Study|Protocol Violation|1|||
144382988|NCT01011309|520611842|FG002|Overall Study|Protocol Violation|3|||
144382989|NCT01182844|520611852|FG000|Overall Study|Withdrawal by Subject|0|||
144382990|NCT01182844|520611853|FG001|Overall Study|Withdrawal by Subject|2|||
144382991|NCT01330017|520613663|FG000|Overall Study|Adverse Event|0|||
144382992|NCT01330017|520613664|FG001|Overall Study|Adverse Event|1|||
144382993|NCT01330017|520613665|FG002|Overall Study|Adverse Event|1|||
144382994|NCT01330017|520613666|FG003|Overall Study|Adverse Event|4|||
144382995|NCT01330017|520613667|FG004|Overall Study|Adverse Event|0|||
144382996|NCT01330017|520613663|FG000|Overall Study|Withdrawal by Subject|0|||
144382997|NCT01330017|520613664|FG001|Overall Study|Withdrawal by Subject|0|||
144382998|NCT01330017|520613665|FG002|Overall Study|Withdrawal by Subject|1|||
144382999|NCT01330017|520613666|FG003|Overall Study|Withdrawal by Subject|0|||
144383000|NCT01330017|520613667|FG004|Overall Study|Withdrawal by Subject|1|||
144383001|NCT01330017|520613663|FG000|Overall Study|Lost to Follow-up|0|||
144383002|NCT01330017|520613664|FG001|Overall Study|Lost to Follow-up|0|||
144383003|NCT01330017|520613665|FG002|Overall Study|Lost to Follow-up|1|||
144383004|NCT01330017|520613666|FG003|Overall Study|Lost to Follow-up|0|||
144383005|NCT01330017|520613667|FG004|Overall Study|Lost to Follow-up|0|||
144383006|NCT01330017|520613663|FG000|Overall Study|Protocol Violation|0|||
144383007|NCT01330017|520613664|FG001|Overall Study|Protocol Violation|0|||
144383008|NCT01330017|520613665|FG002|Overall Study|Protocol Violation|0|||
144383009|NCT01330017|520613666|FG003|Overall Study|Protocol Violation|1|||
144383010|NCT01330017|520613667|FG004|Overall Study|Protocol Violation|0|||
144383011|NCT01330017|520613663|FG000|Overall Study|Unknown Reason|5|||
144383012|NCT01330017|520613664|FG001|Overall Study|Unknown Reason|3|||
144383013|NCT01330017|520613665|FG002|Overall Study|Unknown Reason|5|||
144383014|NCT01330017|520613666|FG003|Overall Study|Unknown Reason|7|||
144383015|NCT01330017|520613667|FG004|Overall Study|Unknown Reason|2|||
144383016|NCT01221272|520613668|FG000|Period 1|Adverse Event|2|||
144383017|NCT01221272|520613669|FG001|Period 1|Adverse Event|0|||
144383018|NCT01221272|520613668|FG000|Period 1|Consent Withdrawal|0|||
144383019|NCT01221272|520613669|FG001|Period 1|Consent Withdrawal|1|||
144383020|NCT01221272|520613668|FG000|Period 1|Significant Dosing Noncompliance|0|||
144383021|NCT01221272|520613669|FG001|Period 1|Significant Dosing Noncompliance|1|||
144383022|NCT01221272|520613668|FG000|Period 2|Adverse Event|0|||
144383023|NCT01221272|520613669|FG001|Period 2|Adverse Event|2|||
144383024|NCT03254108|520613671|FG000|Overall Study|Adverse Event|0|||
144383025|NCT03254108|520613672|FG001|Overall Study|Adverse Event|2|||
144383026|NCT03254108|520613673|FG002|Overall Study|Adverse Event|0|||
144383027|NCT03254108|520613674|FG003|Overall Study|Adverse Event|1|||
144383028|NCT03254108|520613675|FG004|Overall Study|Adverse Event|1|||
144383029|NCT03254108|520613671|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
144383030|NCT03254108|520613672|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
144383031|NCT03254108|520613673|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
144383032|NCT03254108|520613674|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
144383033|NCT03254108|520613675|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
144383034|NCT00362180|520613676|FG000|Treated Period|Withdrawal by Subject|1|||
144383035|NCT00362180|520613677|FG001|Treated Period|Withdrawal by Subject|0|||
144383036|NCT00362180|520613678|FG002|Treated Period|Withdrawal by Subject|0|||
144383037|NCT00362180|520613679|FG003|Treated Period|Withdrawal by Subject|0|||
144383038|NCT00362180|520613680|FG004|Treated Period|Withdrawal by Subject|0|||
144383039|NCT00362180|520613681|FG005|Treated Period|Withdrawal by Subject|0|||
144383040|NCT00362180|520613682|FG006|Treated Period|Withdrawal by Subject|0|||
144383041|NCT00362180|520613683|FG007|Treated Period|Withdrawal by Subject|0|||
144383042|NCT00362180|520613684|FG008|Treated Period|Withdrawal by Subject|0|||
144383043|NCT00362180|520613676|FG000|Treated Period|Adverse Event|0|||
144383044|NCT00362180|520613677|FG001|Treated Period|Adverse Event|0|||
144383045|NCT00362180|520613678|FG002|Treated Period|Adverse Event|0|||
144383046|NCT00362180|520613679|FG003|Treated Period|Adverse Event|0|||
144383047|NCT00362180|520613680|FG004|Treated Period|Adverse Event|0|||
144383048|NCT00362180|520613681|FG005|Treated Period|Adverse Event|1|||
144383049|NCT00362180|520613682|FG006|Treated Period|Adverse Event|0|||
144383050|NCT00362180|520613683|FG007|Treated Period|Adverse Event|1|||
144383051|NCT00362180|520613684|FG008|Treated Period|Adverse Event|0|||
144383052|NCT00003472|520613690|FG000|Overall Study|Not evaluable|3|||
144383053|NCT01444092|520613697|FG000|Overall Study|Adverse Event|8|||
144383054|NCT01444092|520613697|FG000|Overall Study|Protocol Violation|1|||
144383055|NCT01444092|520613697|FG000|Overall Study|Withdrawal by Subject|1|||
144383056|NCT01444092|520613697|FG000|Overall Study|Other Eligibility criteria|7|||
144383057|NCT01328366|520613698|FG000|Overall Study|Death|1|||
144383058|NCT01328366|520613698|FG000|Overall Study|Withdrawal by Subject|2|||
144383059|NCT01328366|520613698|FG000|Overall Study|Lost to Follow-up|7|||
144383060|NCT00910624|520613699|FG000|Treatment Phase|Adverse Event|2|||
144383061|NCT00910624|520613700|FG001|Treatment Phase|Adverse Event|6|||
144383062|NCT00910624|520613701|FG002|Treatment Phase|Adverse Event|6|||
144383063|NCT00910624|520613702|FG003|Treatment Phase|Adverse Event|0|||
144383064|NCT00910624|520613699|FG000|Treatment Phase|Treatment Failure|23|||
144383065|NCT00910624|520613700|FG001|Treatment Phase|Treatment Failure|10|||
144383066|NCT00910624|520613701|FG002|Treatment Phase|Treatment Failure|0|||
144383067|NCT00910624|520613702|FG003|Treatment Phase|Treatment Failure|0|||
144383068|NCT00910624|520613699|FG000|Treatment Phase|Lost to Follow-up|0|||
144383069|NCT00910624|520613700|FG001|Treatment Phase|Lost to Follow-up|0|||
144383070|NCT00910624|520613701|FG002|Treatment Phase|Lost to Follow-up|1|||
144383071|NCT00910624|520613702|FG003|Treatment Phase|Lost to Follow-up|0|||
144383072|NCT00910624|520613699|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
144383073|NCT00910624|520613700|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
144721939|NCT04540497|521836883|FG000|Overall Study|Withdrawal by Subject|1|||
144514824|NCT04586920|521083968|FG005|Overall Study|Lost to Follow-up|0|||
144514825|NCT04586920|521083969|FG006|Overall Study|Lost to Follow-up|1|||
144514826|NCT04586920|521083970|FG007|Overall Study|Lost to Follow-up|1|||
144514827|NCT04586920|521083971|FG008|Overall Study|Lost to Follow-up|0|||
144514828|NCT04586920|521083972|FG009|Overall Study|Lost to Follow-up|1|||
144514829|NCT04586920|521083973|FG010|Overall Study|Lost to Follow-up|0|||
144514830|NCT04586920|521083974|FG011|Overall Study|Lost to Follow-up|0|||
144514831|NCT04586920|521083975|FG012|Overall Study|Lost to Follow-up|0|||
144514832|NCT04586920|521083976|FG013|Overall Study|Lost to Follow-up|1|||
144514833|NCT04586920|521083977|FG014|Overall Study|Lost to Follow-up|0|||
144383074|NCT00910624|520613701|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
144383075|NCT00910624|520613702|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
144383076|NCT00910624|520613699|FG000|Treatment Phase|Withdrawal by Subject|2|||
144383077|NCT00910624|520613700|FG001|Treatment Phase|Withdrawal by Subject|1|||
144383078|NCT00910624|520613701|FG002|Treatment Phase|Withdrawal by Subject|0|||
144383079|NCT00910624|520613702|FG003|Treatment Phase|Withdrawal by Subject|0|||
144383080|NCT00910624|520613699|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
144383081|NCT00910624|520613700|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
144383082|NCT00910624|520613701|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
144383083|NCT00910624|520613702|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
144383084|NCT00910624|520613699|FG000|Follow-Up Phase|Adverse Event|0|||
144383085|NCT00910624|520613700|FG001|Follow-Up Phase|Adverse Event|0|||
144383086|NCT00910624|520613701|FG002|Follow-Up Phase|Adverse Event|1|||
144383087|NCT00910624|520613702|FG003|Follow-Up Phase|Adverse Event|0|||
144383088|NCT00910624|520613699|FG000|Follow-Up Phase|Lost to Follow-up|3|||
144383089|NCT00910624|520613700|FG001|Follow-Up Phase|Lost to Follow-up|1|||
144383090|NCT00910624|520613701|FG002|Follow-Up Phase|Lost to Follow-up|2|||
144383091|NCT00910624|520613702|FG003|Follow-Up Phase|Lost to Follow-up|0|||
144383092|NCT00910624|520613699|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
144383093|NCT00910624|520613700|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
144383094|NCT00910624|520613701|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
144383095|NCT00910624|520613702|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
144383096|NCT00910624|520613699|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
144383097|NCT00910624|520613700|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
144383098|NCT00910624|520613701|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
144383099|NCT00910624|520613702|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
144383100|NCT00910624|520613699|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
144383101|NCT00910624|520613700|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
144383102|NCT00910624|520613701|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
144383103|NCT00910624|520613702|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
144383104|NCT00910624|520613699|FG000|Follow-Up Phase|Administrative|0|||
144383105|NCT00910624|520613700|FG001|Follow-Up Phase|Administrative|1|||
144383106|NCT00910624|520613701|FG002|Follow-Up Phase|Administrative|1|||
144383107|NCT00910624|520613702|FG003|Follow-Up Phase|Administrative|0|||
144383108|NCT01122264|520613703|FG000|Overall Study|Adverse Event|6|||
144383109|NCT01122264|520613704|FG001|Overall Study|Adverse Event|5|||
144383110|NCT01122264|520613705|FG002|Overall Study|Adverse Event|7|||
144383111|NCT01122264|520613703|FG000|Overall Study|Death|1|||
144383112|NCT01122264|520613704|FG001|Overall Study|Death|0|||
144383113|NCT01122264|520613705|FG002|Overall Study|Death|0|||
144383114|NCT01122264|520613703|FG000|Overall Study|Lost to Follow-up|5|||
144383115|NCT01122264|520613704|FG001|Overall Study|Lost to Follow-up|9|||
144383116|NCT01122264|520613705|FG002|Overall Study|Lost to Follow-up|13|||
144383117|NCT01122264|520613703|FG000|Overall Study|Entry Criteria Not Met|1|||
144383118|NCT01122264|520613704|FG001|Overall Study|Entry Criteria Not Met|0|||
144383119|NCT01122264|520613705|FG002|Overall Study|Entry Criteria Not Met|0|||
144383120|NCT01122264|520613703|FG000|Overall Study|Protocol Violation|7|||
144383121|NCT01122264|520613704|FG001|Overall Study|Protocol Violation|7|||
144383122|NCT01122264|520613705|FG002|Overall Study|Protocol Violation|9|||
144383123|NCT01122264|520613703|FG000|Overall Study|Withdrawal by Subject|6|||
144383124|NCT01122264|520613704|FG001|Overall Study|Withdrawal by Subject|6|||
144383125|NCT01122264|520613705|FG002|Overall Study|Withdrawal by Subject|16|||
144383126|NCT01122264|520613703|FG000|Overall Study|Physician Decision|3|||
144383127|NCT01122264|520613704|FG001|Overall Study|Physician Decision|1|||
144383128|NCT01122264|520613705|FG002|Overall Study|Physician Decision|1|||
144383129|NCT01122264|520613703|FG000|Overall Study|Lack of Efficacy|3|||
144592497|NCT00448279|521370564|FG000|Overall Study|Disease progression|16|||
144592498|NCT00448279|521370565|FG001|Overall Study|Disease progression|18|||
144592499|NCT00448279|521370564|FG000|Overall Study|Withdrawal by Subject|4|||
144592500|NCT00448279|521370565|FG001|Overall Study|Withdrawal by Subject|3|||
144592501|NCT00448279|521370564|FG000|Overall Study|Other|6|||
144592502|NCT00448279|521370565|FG001|Overall Study|Other|4|||
144383130|NCT01122264|520613704|FG001|Overall Study|Lack of Efficacy|1|||
144383131|NCT01122264|520613705|FG002|Overall Study|Lack of Efficacy|1|||
144383132|NCT03005873|520613706|FG000|Overall Study|Prohibited medication use post radnomization|1|||
144383133|NCT03005873|520613707|FG001|Overall Study|Prohibited medication use post radnomization|1|||
144383134|NCT03005873|520613708|FG002|Overall Study|Prohibited medication use post radnomization|1|||
144592503|NCT00448279|521370564|FG000|Overall Study|Protocol Violation|0|||
144592504|NCT00448279|521370565|FG001|Overall Study|Protocol Violation|1|||
144721940|NCT04540497|521836884|FG001|Overall Study|Withdrawal by Subject|1|||
144721941|NCT04540497|521836883|FG000|Overall Study|Miscellaneous|2|||
144383135|NCT03005873|520613706|FG000|Overall Study|Withdrew consent|0|||
144383136|NCT03005873|520613707|FG001|Overall Study|Withdrew consent|1|||
144383137|NCT03005873|520613708|FG002|Overall Study|Withdrew consent|2|||
144383138|NCT03005873|520613706|FG000|Overall Study|Lost to Follow-up|0|||
144383139|NCT03005873|520613707|FG001|Overall Study|Lost to Follow-up|1|||
144383140|NCT03005873|520613708|FG002|Overall Study|Lost to Follow-up|0|||
144383141|NCT03005873|520613706|FG000|Overall Study|Ineligible post randomization|0|||
144383142|NCT03005873|520613707|FG001|Overall Study|Ineligible post randomization|0|||
144383143|NCT03005873|520613708|FG002|Overall Study|Ineligible post randomization|1|||
144383144|NCT04585009|520613709|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
144383145|NCT04585009|520613710|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383146|NCT04585009|520613711|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383147|NCT04585009|520613712|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383148|NCT04585009|520613713|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383149|NCT04585009|520613714|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383150|NCT04585009|520613715|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383151|NCT04585009|520613716|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383152|NCT04585009|520613717|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383153|NCT04585009|520613718|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383154|NCT04585009|520613719|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383155|NCT04585009|520613720|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
144383156|NCT04585009|520613709|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
144383157|NCT04585009|520613710|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383158|NCT04585009|520613711|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383159|NCT04585009|520613712|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383160|NCT04585009|520613713|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383161|NCT04585009|520613714|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383162|NCT04585009|520613715|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383163|NCT04585009|520613716|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144514834|NCT04586920|521083978|FG015|Overall Study|Lost to Follow-up|0|||
144514835|NCT04586920|521083979|FG016|Overall Study|Lost to Follow-up|0|||
144514836|NCT04586920|521083980|FG017|Overall Study|Lost to Follow-up|0|||
144514837|NCT04586920|521083963|FG000|Overall Study|Withdrawal by Subject|0|||
144514838|NCT04586920|521083964|FG001|Overall Study|Withdrawal by Subject|0|||
144514839|NCT04586920|521083965|FG002|Overall Study|Withdrawal by Subject|0|||
144514840|NCT04586920|521083966|FG003|Overall Study|Withdrawal by Subject|0|||
144514841|NCT04586920|521083967|FG004|Overall Study|Withdrawal by Subject|0|||
144514842|NCT04586920|521083968|FG005|Overall Study|Withdrawal by Subject|0|||
144514843|NCT04586920|521083969|FG006|Overall Study|Withdrawal by Subject|0|||
144514844|NCT04586920|521083970|FG007|Overall Study|Withdrawal by Subject|1|||
144514845|NCT04586920|521083971|FG008|Overall Study|Withdrawal by Subject|0|||
144514846|NCT04586920|521083972|FG009|Overall Study|Withdrawal by Subject|1|||
144514847|NCT04586920|521083973|FG010|Overall Study|Withdrawal by Subject|0|||
144514848|NCT04586920|521083974|FG011|Overall Study|Withdrawal by Subject|1|||
144514849|NCT04586920|521083975|FG012|Overall Study|Withdrawal by Subject|0|||
144514850|NCT04586920|521083976|FG013|Overall Study|Withdrawal by Subject|0|||
144514851|NCT04586920|521083977|FG014|Overall Study|Withdrawal by Subject|0|||
144514852|NCT04586920|521083978|FG015|Overall Study|Withdrawal by Subject|0|||
144514853|NCT04586920|521083979|FG016|Overall Study|Withdrawal by Subject|0|||
144514854|NCT04586920|521083980|FG017|Overall Study|Withdrawal by Subject|0|||
144514855|NCT01718743|521083981|FG000|Overall Study|Physician Decision|7|||
144514856|NCT01718743|521083981|FG000|Overall Study|Withdrawal by Subject|14|||
144514857|NCT01718743|521083981|FG000|Overall Study|Progressive Disease|22|||
144514858|NCT01718743|521083981|FG000|Overall Study|Toxicity|1|||
144514859|NCT01718743|521083981|FG000|Overall Study|Malignancy|1|||
144514860|NCT02728557|521083982|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
144514861|NCT02728557|521083983|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
144514862|NCT02728557|521083982|FG000|Overall Study|Dissatisfaction with research tasks|0|||
144514863|NCT02728557|521083983|FG001|Overall Study|Dissatisfaction with research tasks|1|||
144514864|NCT02728557|521083982|FG000|Overall Study|Scheduling or change in availability|1|||
144514865|NCT02728557|521083983|FG001|Overall Study|Scheduling or change in availability|1|||
144514866|NCT03416010|521083984|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
144514867|NCT03416010|521083985|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
144514868|NCT03416010|521083984|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
144514869|NCT03416010|521083985|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
144514870|NCT03416010|521083984|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
144514871|NCT03416010|521083985|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
144514872|NCT03416010|521083984|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
144514873|NCT03416010|521083985|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
144514874|NCT03416010|521083984|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
144721942|NCT04540497|521836884|FG001|Overall Study|Miscellaneous|1|||
144383164|NCT04585009|520613717|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383165|NCT04585009|520613718|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383166|NCT04585009|520613719|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383167|NCT04585009|520613720|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
144383168|NCT04585009|520613709|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383169|NCT04585009|520613710|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383170|NCT04585009|520613711|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383171|NCT04585009|520613712|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383172|NCT04585009|520613713|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383173|NCT04585009|520613714|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383174|NCT04585009|520613715|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383175|NCT04585009|520613716|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
144383176|NCT04585009|520613717|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383177|NCT04585009|520613718|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383178|NCT04585009|520613719|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383179|NCT04585009|520613720|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
144383180|NCT04585009|520613709|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383181|NCT04585009|520613710|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383182|NCT04585009|520613711|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383183|NCT04585009|520613712|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383184|NCT04585009|520613713|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
144383185|NCT04585009|520613714|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383186|NCT04585009|520613715|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383187|NCT04585009|520613716|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383188|NCT04585009|520613717|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383189|NCT04585009|520613718|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383190|NCT04585009|520613719|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383191|NCT04585009|520613720|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
144383192|NCT04585009|520613709|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383193|NCT04585009|520613710|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383194|NCT04585009|520613711|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383195|NCT04585009|520613712|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383196|NCT04585009|520613713|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383197|NCT04585009|520613714|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383198|NCT04585009|520613715|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383199|NCT04585009|520613716|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383200|NCT04585009|520613717|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383201|NCT04585009|520613718|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
144383202|NCT04585009|520613719|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383203|NCT04585009|520613720|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
144383204|NCT04585009|520613709|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383205|NCT04585009|520613710|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383206|NCT04585009|520613711|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383207|NCT04585009|520613712|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383208|NCT04585009|520613713|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383209|NCT04585009|520613714|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383210|NCT04585009|520613715|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383211|NCT04585009|520613716|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383212|NCT04585009|520613717|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383213|NCT04585009|520613718|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383214|NCT04585009|520613719|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
144383215|NCT04585009|520613720|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
144383216|NCT00097981|520613729|FG000|Overall Study|Adverse Event|31|||
144383217|NCT00097981|520613730|FG001|Overall Study|Adverse Event|44|||
144383218|NCT00097981|520613729|FG000|Overall Study|Withdrawal by Subject|10|||
144383219|NCT00097981|520613730|FG001|Overall Study|Withdrawal by Subject|8|||
144383220|NCT00097981|520613729|FG000|Overall Study|Protocol Violation|1|||
144383221|NCT00097981|520613730|FG001|Overall Study|Protocol Violation|1|||
144383222|NCT00097981|520613729|FG000|Overall Study|Death|2|||
144383223|NCT00097981|520613730|FG001|Overall Study|Death|4|||
144383224|NCT00097981|520613729|FG000|Overall Study|Physician Decision|7|||
144383225|NCT00097981|520613730|FG001|Overall Study|Physician Decision|1|||
144383226|NCT00097981|520613729|FG000|Overall Study|Disease Progression|8|||
144383227|NCT00097981|520613730|FG001|Overall Study|Disease Progression|2|||
144383228|NCT00097981|520613729|FG000|Overall Study|Transplant planned|28|||
144383229|NCT00097981|520613730|FG001|Overall Study|Transplant planned|27|||
144383230|NCT00097981|520613729|FG000|Overall Study|Other|19|||
144383231|NCT00097981|520613730|FG001|Overall Study|Other|13|||
144383232|NCT01713933|520613733|FG000|Overall Study|Lost to Follow-up|2|||
144383233|NCT01713933|520613733|FG000|Overall Study|Withdrawal by Subject|3|||
144383234|NCT01713933|520613733|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
144383235|NCT00412373|520613734|FG000|Overall Study|Adverse Event|8|||
144383236|NCT00412373|520613735|FG001|Overall Study|Adverse Event|13|||
144383237|NCT00412373|520613734|FG000|Overall Study|Lack of Efficacy|16|||
144383238|NCT00412373|520613735|FG001|Overall Study|Lack of Efficacy|22|||
144383239|NCT00412373|520613734|FG000|Overall Study|Lost to Follow-up|7|||
144383240|NCT00412373|520613735|FG001|Overall Study|Lost to Follow-up|13|||
144383241|NCT00412373|520613734|FG000|Overall Study|Withdrawal by Subject|8|||
144383242|NCT00412373|520613735|FG001|Overall Study|Withdrawal by Subject|27|||
144383243|NCT00412373|520613734|FG000|Overall Study|Other|2|||
144383244|NCT00412373|520613735|FG001|Overall Study|Other|2|||
144383245|NCT01009840|520613738|FG000|Overall Study|Lost to Follow-up|1|||
144383246|NCT01009840|520613738|FG000|Overall Study|Adverse Event|4|||
144383247|NCT01009840|520613738|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
144383248|NCT01009840|520613738|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
144383249|NCT01009840|520613738|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
144383250|NCT01104376|520613743|FG000|Overall Study|Withdrawal by Subject|15|||
144383251|NCT01104376|520613743|FG000|Overall Study|Consented but excluded after labs|13|||
144383252|NCT00797966|520613744|FG000|Phase A|Lost to Follow-up|0|||
144383253|NCT00797966|520613745|FG001|Phase A|Lost to Follow-up|0|||
144383254|NCT00797966|520613746|FG002|Phase A|Lost to Follow-up|0|||
144383255|NCT00797966|520613747|FG003|Phase A|Lost to Follow-up|0|||
144383256|NCT00797966|520613748|FG004|Phase A|Lost to Follow-up|33|||
144383257|NCT00797966|520613749|FG005|Phase A|Lost to Follow-up|0|||
144383258|NCT00797966|520613744|FG000|Phase A|Adverse Event|0|||
144383259|NCT00797966|520613745|FG001|Phase A|Adverse Event|0|||
144383260|NCT00797966|520613746|FG002|Phase A|Adverse Event|0|||
144383261|NCT00797966|520613747|FG003|Phase A|Adverse Event|0|||
144383262|NCT00797966|520613748|FG004|Phase A|Adverse Event|46|||
144383263|NCT00797966|520613749|FG005|Phase A|Adverse Event|0|||
144383264|NCT00797966|520613744|FG000|Phase A|Met withdrawal criteria|0|||
144383265|NCT00797966|520613745|FG001|Phase A|Met withdrawal criteria|0|||
144383266|NCT00797966|520613746|FG002|Phase A|Met withdrawal criteria|0|||
144383267|NCT00797966|520613747|FG003|Phase A|Met withdrawal criteria|0|||
144383268|NCT00797966|520613748|FG004|Phase A|Met withdrawal criteria|4|||
144383269|NCT00797966|520613749|FG005|Phase A|Met withdrawal criteria|0|||
144383270|NCT00797966|520613744|FG000|Phase A|Physician Decision|0|||
144383271|NCT00797966|520613745|FG001|Phase A|Physician Decision|0|||
144383272|NCT00797966|520613746|FG002|Phase A|Physician Decision|0|||
144383273|NCT00797966|520613747|FG003|Phase A|Physician Decision|0|||
144383274|NCT00797966|520613748|FG004|Phase A|Physician Decision|13|||
144383275|NCT00797966|520613749|FG005|Phase A|Physician Decision|0|||
144383276|NCT00797966|520613744|FG000|Phase A|Withdrawal by Subject|0|||
144383277|NCT00797966|520613745|FG001|Phase A|Withdrawal by Subject|0|||
144383278|NCT00797966|520613746|FG002|Phase A|Withdrawal by Subject|0|||
144383279|NCT00797966|520613747|FG003|Phase A|Withdrawal by Subject|0|||
144383280|NCT00797966|520613748|FG004|Phase A|Withdrawal by Subject|33|||
144383281|NCT00797966|520613749|FG005|Phase A|Withdrawal by Subject|0|||
144383282|NCT00797966|520613744|FG000|Phase A|Protocol deviation|0|||
144383283|NCT00797966|520613745|FG001|Phase A|Protocol deviation|0|||
144383284|NCT00797966|520613746|FG002|Phase A|Protocol deviation|0|||
144383285|NCT00797966|520613747|FG003|Phase A|Protocol deviation|0|||
144383286|NCT00797966|520613748|FG004|Phase A|Protocol deviation|56|||
144383287|NCT00797966|520613749|FG005|Phase A|Protocol deviation|0|||
144592505|NCT00440999|521370566|FG000|Overall Study|Adverse Event|0|||
144383288|NCT00797966|520613744|FG000|Phase B|Lost to Follow-up|0|||
144383289|NCT00797966|520613745|FG001|Phase B|Lost to Follow-up|1|||
144383290|NCT00797966|520613746|FG002|Phase B|Lost to Follow-up|3|||
144383291|NCT00797966|520613747|FG003|Phase B|Lost to Follow-up|0|||
144383292|NCT00797966|520613748|FG004|Phase B|Lost to Follow-up|0|||
144383293|NCT00797966|520613749|FG005|Phase B|Lost to Follow-up|0|||
144383294|NCT00797966|520613744|FG000|Phase B|Adverse Event|2|||
144383295|NCT00797966|520613745|FG001|Phase B|Adverse Event|1|||
144383296|NCT00797966|520613746|FG002|Phase B|Adverse Event|3|||
144383297|NCT00797966|520613747|FG003|Phase B|Adverse Event|1|||
144383298|NCT00797966|520613748|FG004|Phase B|Adverse Event|0|||
144383299|NCT00797966|520613749|FG005|Phase B|Adverse Event|0|||
144383300|NCT00797966|520613744|FG000|Phase B|Met Withdrawal Criteria|3|||
144383301|NCT00797966|520613745|FG001|Phase B|Met Withdrawal Criteria|3|||
144383302|NCT00797966|520613746|FG002|Phase B|Met Withdrawal Criteria|6|||
144383303|NCT00797966|520613747|FG003|Phase B|Met Withdrawal Criteria|1|||
144383304|NCT00797966|520613748|FG004|Phase B|Met Withdrawal Criteria|0|||
144383305|NCT00797966|520613749|FG005|Phase B|Met Withdrawal Criteria|0|||
144383306|NCT00797966|520613744|FG000|Phase B|Physician Decision|1|||
144383307|NCT00797966|520613745|FG001|Phase B|Physician Decision|0|||
144383308|NCT00797966|520613746|FG002|Phase B|Physician Decision|3|||
144383309|NCT00797966|520613747|FG003|Phase B|Physician Decision|1|||
144383310|NCT00797966|520613748|FG004|Phase B|Physician Decision|0|||
144383311|NCT00797966|520613749|FG005|Phase B|Physician Decision|0|||
144383312|NCT00797966|520613744|FG000|Phase B|Withdrawal by Subject|1|||
144383313|NCT00797966|520613745|FG001|Phase B|Withdrawal by Subject|4|||
144383314|NCT00797966|520613746|FG002|Phase B|Withdrawal by Subject|3|||
144383315|NCT00797966|520613747|FG003|Phase B|Withdrawal by Subject|3|||
144383316|NCT00797966|520613748|FG004|Phase B|Withdrawal by Subject|0|||
144383317|NCT00797966|520613749|FG005|Phase B|Withdrawal by Subject|0|||
144383318|NCT00797966|520613744|FG000|Phase B|Protocol Deviation|4|||
144383319|NCT00797966|520613745|FG001|Phase B|Protocol Deviation|8|||
144383320|NCT00797966|520613746|FG002|Phase B|Protocol Deviation|2|||
144383321|NCT00797966|520613747|FG003|Phase B|Protocol Deviation|6|||
144383322|NCT00797966|520613748|FG004|Phase B|Protocol Deviation|0|||
144383323|NCT00797966|520613749|FG005|Phase B|Protocol Deviation|0|||
144383324|NCT00797966|520613744|FG000|Phase B|Lack of Efficacy|0|||
144383325|NCT00797966|520613745|FG001|Phase B|Lack of Efficacy|1|||
144383326|NCT00797966|520613746|FG002|Phase B|Lack of Efficacy|1|||
144383327|NCT00797966|520613747|FG003|Phase B|Lack of Efficacy|4|||
144383328|NCT00797966|520613748|FG004|Phase B|Lack of Efficacy|0|||
144383329|NCT00797966|520613749|FG005|Phase B|Lack of Efficacy|0|||
144383330|NCT00797966|520613744|FG000|Phase A+|Lost to Follow-up|0|||
144383331|NCT00797966|520613745|FG001|Phase A+|Lost to Follow-up|0|||
144383332|NCT00797966|520613746|FG002|Phase A+|Lost to Follow-up|0|||
144383333|NCT00797966|520613747|FG003|Phase A+|Lost to Follow-up|0|||
144383334|NCT00797966|520613748|FG004|Phase A+|Lost to Follow-up|0|||
144383335|NCT00797966|520613749|FG005|Phase A+|Lost to Follow-up|9|||
144383336|NCT00797966|520613744|FG000|Phase A+|Met withdrawal criteria|0|||
144383337|NCT00797966|520613745|FG001|Phase A+|Met withdrawal criteria|0|||
144383338|NCT00797966|520613746|FG002|Phase A+|Met withdrawal criteria|0|||
144383339|NCT00797966|520613747|FG003|Phase A+|Met withdrawal criteria|0|||
144383340|NCT00797966|520613748|FG004|Phase A+|Met withdrawal criteria|0|||
144383341|NCT00797966|520613749|FG005|Phase A+|Met withdrawal criteria|5|||
144383342|NCT00797966|520613744|FG000|Phase A+|Withdrawal by Subject|0|||
144383343|NCT00797966|520613745|FG001|Phase A+|Withdrawal by Subject|0|||
144383344|NCT00797966|520613746|FG002|Phase A+|Withdrawal by Subject|0|||
144383345|NCT00797966|520613747|FG003|Phase A+|Withdrawal by Subject|0|||
144383346|NCT00797966|520613748|FG004|Phase A+|Withdrawal by Subject|0|||
144383347|NCT00797966|520613749|FG005|Phase A+|Withdrawal by Subject|6|||
144383348|NCT00797966|520613744|FG000|Phase A+|Adverse Event|0|||
144383349|NCT00797966|520613745|FG001|Phase A+|Adverse Event|0|||
144383350|NCT00797966|520613746|FG002|Phase A+|Adverse Event|0|||
144383351|NCT00797966|520613747|FG003|Phase A+|Adverse Event|0|||
144383352|NCT00797966|520613748|FG004|Phase A+|Adverse Event|0|||
144383353|NCT00797966|520613749|FG005|Phase A+|Adverse Event|4|||
144383354|NCT00797966|520613744|FG000|Phase A+|Protocol deviation|0|||
144383355|NCT00797966|520613745|FG001|Phase A+|Protocol deviation|0|||
144383356|NCT00797966|520613746|FG002|Phase A+|Protocol deviation|0|||
144199312|NCT00541970|519928868|FG002|Month 48|Other|1|||
144383357|NCT00797966|520613747|FG003|Phase A+|Protocol deviation|0|||
144383358|NCT00797966|520613748|FG004|Phase A+|Protocol deviation|0|||
144383359|NCT00797966|520613749|FG005|Phase A+|Protocol deviation|4|||
144383360|NCT01002820|520613755|FG000|Overall Study|Adverse Event|1|||
144383361|NCT01002820|520613755|FG000|Overall Study|Withdrawal by Subject|2|||
144383362|NCT01002820|520613755|FG000|Overall Study|Lack of Efficacy|1|||
144383363|NCT01673347|520613756|FG000|Overall Study|failure of allograft|7|||
144383364|NCT00895011|520613762|FG000|Overall Study|Withdrawal by Subject|14|||
144383365|NCT00895011|520613763|FG001|Overall Study|Withdrawal by Subject|7|||
144383366|NCT00895011|520613764|FG002|Overall Study|Withdrawal by Subject|2|||
144383367|NCT00895011|520613762|FG000|Overall Study|Lost to Follow-up|5|||
144383368|NCT00895011|520613763|FG001|Overall Study|Lost to Follow-up|4|||
144383369|NCT00895011|520613764|FG002|Overall Study|Lost to Follow-up|1|||
144383370|NCT00895011|520613762|FG000|Overall Study|Protocol Violation|3|||
144383371|NCT00895011|520613763|FG001|Overall Study|Protocol Violation|1|||
144383372|NCT00895011|520613764|FG002|Overall Study|Protocol Violation|3|||
144383373|NCT00895011|520613762|FG000|Overall Study|Adverse Event|1|||
144383374|NCT00895011|520613763|FG001|Overall Study|Adverse Event|2|||
144383375|NCT00895011|520613764|FG002|Overall Study|Adverse Event|2|||
144383376|NCT00895011|520613762|FG000|Overall Study|schedule conflict|1|||
144383377|NCT00895011|520613763|FG001|Overall Study|schedule conflict|0|||
144383378|NCT00895011|520613764|FG002|Overall Study|schedule conflict|0|||
144383379|NCT02661178|520613772|FG000|Part 1|Protocol Violation|1|||
144383380|NCT02661178|520613773|FG001|Part 1|Protocol Violation|0|||
144383381|NCT02661178|520613774|FG002|Part 1|Protocol Violation|0|||
144383382|NCT02661178|520613775|FG003|Part 1|Protocol Violation|0|||
144383383|NCT02661178|520613776|FG004|Part 1|Protocol Violation|0|||
144383384|NCT02661178|520613777|FG005|Part 1|Protocol Violation|0|||
144383385|NCT02661178|520613778|FG006|Part 1|Protocol Violation|0|||
144383386|NCT02661178|520613779|FG007|Part 1|Protocol Violation|0|||
144383387|NCT02661178|520613780|FG008|Part 1|Protocol Violation|0|||
144383388|NCT02661178|520613781|FG009|Part 1|Protocol Violation|0|||
144383389|NCT02661178|520613782|FG010|Part 1|Protocol Violation|0|||
144383390|NCT02661178|520613783|FG011|Part 1|Protocol Violation|0|||
144383391|NCT02661178|520613784|FG012|Part 1|Protocol Violation|0|||
144383392|NCT02661178|520613785|FG013|Part 1|Protocol Violation|0|||
144383393|NCT02661178|520613786|FG014|Part 1|Protocol Violation|0|||
144383394|NCT03859973|520613787|FG000|Overall Study|Other reason than listed|3|||
144383395|NCT03859973|520613788|FG001|Overall Study|Other reason than listed|2|||
144383396|NCT03859973|520613787|FG000|Overall Study|COVID-19 related, not due to AE|3|||
144383397|NCT03859973|520613788|FG001|Overall Study|COVID-19 related, not due to AE|4|||
144383398|NCT03859973|520613787|FG000|Overall Study|Withdrawal by Subject|8|||
144383399|NCT03859973|520613788|FG001|Overall Study|Withdrawal by Subject|9|||
144592506|NCT00440999|521370567|FG001|Overall Study|Adverse Event|2|||
144592507|NCT00440999|521370566|FG000|Overall Study|Lack of Efficacy|6|||
144592508|NCT00440999|521370567|FG001|Overall Study|Lack of Efficacy|7|||
144592509|NCT00440999|521370566|FG000|Overall Study|Lost to Follow-up|19|||
144592510|NCT00440999|521370567|FG001|Overall Study|Lost to Follow-up|12|||
144592511|NCT00440999|521370566|FG000|Overall Study|Protocol Violation|1|||
144592512|NCT00440999|521370567|FG001|Overall Study|Protocol Violation|0|||
144592513|NCT00440999|521370566|FG000|Overall Study|Withdrawal by Subject|2|||
144592514|NCT00440999|521370567|FG001|Overall Study|Withdrawal by Subject|5|||
144592515|NCT00440999|521370566|FG000|Overall Study|Subjets missed the visit|1|||
144592516|NCT00440999|521370567|FG001|Overall Study|Subjets missed the visit|0|||
144592517|NCT00440999|521370566|FG000|Overall Study|Mixed infection at entry|1|||
144592518|NCT00440999|521370567|FG001|Overall Study|Mixed infection at entry|0|||
144592519|NCT00440999|521370566|FG000|Overall Study|P. falciparum malaria|5|||
144592520|NCT00440999|521370567|FG001|Overall Study|P. falciparum malaria|14|||
144592521|NCT00440999|521370566|FG000|Overall Study|Subj left hosp without inform staff|0|||
144592522|NCT00440999|521370567|FG001|Overall Study|Subj left hosp without inform staff|1|||
144592523|NCT04572841|521370568|FG000|Overall Study|Adverse Event|1|||
144592524|NCT04572841|521370569|FG001|Overall Study|Adverse Event|1|||
144592525|NCT04572841|521370568|FG000|Overall Study|Withdrawal by Subject|2|||
144592526|NCT04572841|521370569|FG001|Overall Study|Withdrawal by Subject|1|||
144592527|NCT05041101|521370570|FG000|Overall Study|Adverse Event|1|||
144592528|NCT05041101|521370571|FG001|Overall Study|Adverse Event|0|||
144592529|NCT05041101|521370572|FG002|Overall Study|Adverse Event|0|||
144592530|NCT05041101|521370570|FG000|Overall Study|Diease Progression|5|||
144592531|NCT05041101|521370571|FG001|Overall Study|Diease Progression|0|||
144592532|NCT05041101|521370572|FG002|Overall Study|Diease Progression|0|||
144592533|NCT01205152|521370573|FG000|Overall Study|Death|1|||
144592534|NCT00249002|521370574|FG000|Overall Study|Adverse Event|2|||
144592535|NCT00249002|521370574|FG000|Overall Study|Study cancellation|3|||
144383400|NCT03859973|520613787|FG000|Overall Study|Lost to Follow-up|2|||
144592536|NCT00249002|521370574|FG000|Overall Study|Other|2|||
144592537|NCT00069108|521370575|FG000|Overall Study|Withdrawal by Subject|5|||
144592538|NCT00069108|521370576|FG001|Overall Study|Withdrawal by Subject|9|||
144592539|NCT00069108|521370575|FG000|Overall Study|Adverse Event|64|||
144592540|NCT00069108|521370576|FG001|Overall Study|Adverse Event|42|||
144592541|NCT00069108|521370575|FG000|Overall Study|Death|6|||
144383401|NCT03859973|520613788|FG001|Overall Study|Lost to Follow-up|3|||
144383402|NCT03859973|520613787|FG000|Overall Study|Protocol Violation|1|||
144592542|NCT00069108|521370576|FG001|Overall Study|Death|6|||
144383403|NCT03859973|520613788|FG001|Overall Study|Protocol Violation|3|||
144383404|NCT03859973|520613787|FG000|Overall Study|Adverse Event|3|||
144383405|NCT03859973|520613788|FG001|Overall Study|Adverse Event|5|||
144592543|NCT00069108|521370575|FG000|Overall Study|Administration|15|||
144592544|NCT00069108|521370576|FG001|Overall Study|Administration|4|||
144592545|NCT00069108|521370575|FG000|Overall Study|Insufficient therapy|117|||
144592546|NCT00069108|521370576|FG001|Overall Study|Insufficient therapy|144|||
144592547|NCT00069108|521370575|FG000|Overall Study|Violation criteria|1|||
144514875|NCT03416010|521083985|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
144514876|NCT03416010|521083984|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
144514877|NCT03416010|521083985|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
144514878|NCT03416010|521083984|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
144514879|NCT03416010|521083985|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
144514880|NCT03948763|521083989|FG000|Overall Study|Sponsor's decision|0|||
144514881|NCT03948763|521083990|FG001|Overall Study|Sponsor's decision|2|||
144514882|NCT03948763|521083991|FG002|Overall Study|Sponsor's decision|6|||
144514883|NCT03948763|521083992|FG003|Overall Study|Sponsor's decision|4|||
144514884|NCT03948763|521083993|FG004|Overall Study|Sponsor's decision|0|||
144514885|NCT03948763|521083989|FG000|Overall Study|Physician Decision|0|||
144514886|NCT03948763|521083990|FG001|Overall Study|Physician Decision|0|||
144514887|NCT03948763|521083991|FG002|Overall Study|Physician Decision|1|||
144514888|NCT03948763|521083992|FG003|Overall Study|Physician Decision|0|||
144514889|NCT03948763|521083993|FG004|Overall Study|Physician Decision|0|||
144514890|NCT03948763|521083989|FG000|Overall Study|Lost to Follow-up|0|||
144514891|NCT03948763|521083990|FG001|Overall Study|Lost to Follow-up|0|||
144514892|NCT03948763|521083991|FG002|Overall Study|Lost to Follow-up|0|||
144514893|NCT03948763|521083992|FG003|Overall Study|Lost to Follow-up|0|||
144514894|NCT03948763|521083993|FG004|Overall Study|Lost to Follow-up|1|||
144514895|NCT03948763|521083989|FG000|Overall Study|Death|2|||
144514896|NCT03948763|521083990|FG001|Overall Study|Death|12|||
144514897|NCT03948763|521083991|FG002|Overall Study|Death|13|||
144514898|NCT03948763|521083992|FG003|Overall Study|Death|10|||
144514899|NCT03948763|521083993|FG004|Overall Study|Death|11|||
144514900|NCT03948763|521083989|FG000|Overall Study|Withdrawal by Subject|1|||
144514901|NCT03948763|521083990|FG001|Overall Study|Withdrawal by Subject|1|||
144514902|NCT03948763|521083991|FG002|Overall Study|Withdrawal by Subject|0|||
144514903|NCT03948763|521083992|FG003|Overall Study|Withdrawal by Subject|2|||
144514904|NCT03948763|521083993|FG004|Overall Study|Withdrawal by Subject|4|||
144514905|NCT06023082|521083995|FG000|Overall Study|Withdrawal by Subject|2|||
144514906|NCT06023082|521083995|FG000|Overall Study|Lost to Follow-up|15|||
144514907|NCT06023082|521083995|FG000|Overall Study|Side effects|5|||
144514908|NCT05846646|521083996|FG000|Overall Study|Physician Decision|1|||
144514909|NCT05846646|521083997|FG001|Overall Study|Physician Decision|0|||
144514910|NCT05846646|521083998|FG002|Overall Study|Physician Decision|0|||
144514911|NCT05846646|521083996|FG000|Overall Study|Lack of Efficacy|1|||
144514912|NCT05846646|521083997|FG001|Overall Study|Lack of Efficacy|1|||
144514913|NCT05846646|521083998|FG002|Overall Study|Lack of Efficacy|0|||
144514914|NCT05846646|521083996|FG000|Overall Study|Early Study Termination|1|||
144514915|NCT05846646|521083997|FG001|Overall Study|Early Study Termination|2|||
144514916|NCT05846646|521083998|FG002|Overall Study|Early Study Termination|0|||
144514917|NCT03380390|521084003|FG000|Overall Study|Adverse Event|3|||
144514918|NCT00522951|521084006|FG000|Period 1|body motion|0|||
144514919|NCT00522951|521084007|FG001|Period 1|body motion|1|||
144514920|NCT00522951|521084006|FG000|Washout Period|Adverse Event|0|||
144514921|NCT00522951|521084007|FG001|Washout Period|Adverse Event|1|||
144514922|NCT00522951|521084006|FG000|Washout Period|Death|0|||
144514923|NCT00522951|521084007|FG001|Washout Period|Death|1|||
144514924|NCT00522951|521084006|FG000|Period 2|Withdrawal by Subject|1|||
144514925|NCT00522951|521084007|FG001|Period 2|Withdrawal by Subject|0|||
144514926|NCT00522951|521084006|FG000|Period 2|residual contrast medium|1|||
144514927|NCT00522951|521084007|FG001|Period 2|residual contrast medium|1|||
144514928|NCT01426412|521084010|FG000|Overall Study|Withdrawal by Subject|1|||
144514929|NCT01426412|521084011|FG001|Overall Study|Withdrawal by Subject|0|||
144514930|NCT01426412|521084012|FG002|Overall Study|Withdrawal by Subject|0|||
144514931|NCT01426412|521084013|FG003|Overall Study|Withdrawal by Subject|0|||
144514932|NCT01426412|521084014|FG004|Overall Study|Withdrawal by Subject|1|||
144514933|NCT01426412|521084015|FG005|Overall Study|Withdrawal by Subject|0|||
144514934|NCT01426412|521084016|FG006|Overall Study|Withdrawal by Subject|0|||
144514935|NCT01426412|521084017|FG007|Overall Study|Withdrawal by Subject|3|||
144514936|NCT01426412|521084018|FG008|Overall Study|Withdrawal by Subject|1|||
144514937|NCT02376790|521084019|FG000|Overall Study|Withdrawal by Subject|43|||
144514938|NCT02376790|521084020|FG001|Overall Study|Withdrawal by Subject|36|||
144514939|NCT02376790|521084021|FG002|Overall Study|Withdrawal by Subject|37|||
144514940|NCT02376790|521084019|FG000|Overall Study|Decision by Sponsor|2|||
144514941|NCT02376790|521084020|FG001|Overall Study|Decision by Sponsor|1|||
144514942|NCT02376790|521084021|FG002|Overall Study|Decision by Sponsor|4|||
144514943|NCT02376790|521084019|FG000|Overall Study|Lost to Follow-up|15|||
144514944|NCT02376790|521084020|FG001|Overall Study|Lost to Follow-up|10|||
144514945|NCT02376790|521084021|FG002|Overall Study|Lost to Follow-up|12|||
144514946|NCT03014453|521084022|FG000|Overall Study|Lost to Follow-up|12|||
144514947|NCT03014453|521084022|FG000|Overall Study|Discontinued GER|3|||
144514948|NCT03014453|521084022|FG000|Overall Study|Excluded|19|||
144514949|NCT03014453|521084022|FG000|Overall Study|Refused to take part in|37|||
144514950|NCT02141074|521084027|FG000|Pre-prophylaxis|Adverse Event|3|||
144514951|NCT02141074|521084028|FG001|Pre-prophylaxis|Adverse Event|0|||
144514952|NCT02141074|521084027|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
144383406|NCT02855541|520613789|FG000|Overall Study|Change in health status|2|||
144383407|NCT02855541|520613789|FG000|Overall Study|Withdrawal by Subject|2|||
144383408|NCT01242813|520613790|FG000|Overall Study|Lost to Follow-up|2|||
144383409|NCT03337490|520613797|FG000|Overall Study|Withdrawal by Subject|1|||
144383410|NCT03337490|520613798|FG001|Overall Study|Withdrawal by Subject|0|||
144383411|NCT03337490|520613799|FG002|Overall Study|Withdrawal by Subject|0|||
144383412|NCT03337490|520613797|FG000|Overall Study|Lack of Efficacy|10|||
144383413|NCT03337490|520613798|FG001|Overall Study|Lack of Efficacy|12|||
144383414|NCT03337490|520613799|FG002|Overall Study|Lack of Efficacy|35|||
144383415|NCT03337490|520613797|FG000|Overall Study|Physician Decision|0|||
144383416|NCT03337490|520613798|FG001|Overall Study|Physician Decision|1|||
144383417|NCT03337490|520613799|FG002|Overall Study|Physician Decision|0|||
144383418|NCT03337490|520613797|FG000|Overall Study|Lost to Follow-up|0|||
144383419|NCT03337490|520613798|FG001|Overall Study|Lost to Follow-up|1|||
144383420|NCT03337490|520613799|FG002|Overall Study|Lost to Follow-up|0|||
144383421|NCT04493892|520613800|FG000|Overall Study|Withdrawal by Subject|15|||
144383422|NCT03560518|520613801|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
144383423|NCT03560518|520613802|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
144383424|NCT03560518|520613803|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
144383425|NCT03560518|520613801|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
144383426|NCT03560518|520613802|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
144383427|NCT03560518|520613803|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
144383428|NCT03560518|520613801|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144383429|NCT03560518|520613802|FG001|Double Blind Treatment Period|Protocol Violation|2|||
144383430|NCT03560518|520613803|FG002|Double Blind Treatment Period|Protocol Violation|0|||
144383431|NCT03560518|520613801|FG000|Double Blind Treatment Period|Pregnancy|0|||
144383432|NCT03560518|520613802|FG001|Double Blind Treatment Period|Pregnancy|2|||
144383433|NCT03560518|520613803|FG002|Double Blind Treatment Period|Pregnancy|0|||
144383434|NCT03560518|520613801|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
144383435|NCT03560518|520613802|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
144383436|NCT03560518|520613803|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
144383437|NCT03560518|520613801|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
144383438|NCT03560518|520613802|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
144383439|NCT03560518|520613803|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
144383440|NCT03560518|520613801|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
144383441|NCT03560518|520613802|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
144383442|NCT03560518|520613803|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
144383443|NCT03560518|520613801|FG000|Double Blind Treatment Period|Adverse Event|0|||
144383444|NCT03560518|520613802|FG001|Double Blind Treatment Period|Adverse Event|3|||
144383445|NCT03560518|520613803|FG002|Double Blind Treatment Period|Adverse Event|1|||
144383446|NCT01689532|520613804|FG000|Overall Study|Adverse Event|9|||
144383447|NCT01689532|520613805|FG001|Overall Study|Adverse Event|5|||
144383448|NCT01689532|520613804|FG000|Overall Study|Lack of Efficacy|2|||
144383449|NCT01689532|520613805|FG001|Overall Study|Lack of Efficacy|2|||
144383450|NCT01689532|520613804|FG000|Overall Study|Withdrawal by Subject|1|||
144383451|NCT01689532|520613805|FG001|Overall Study|Withdrawal by Subject|2|||
144383452|NCT01689532|520613804|FG000|Overall Study|Physician Decision|2|||
144383453|NCT01689532|520613805|FG001|Overall Study|Physician Decision|0|||
144383454|NCT01363349|520613806|FG000|Overall Study|Adverse Event|6|||
144383455|NCT01363349|520613807|FG001|Overall Study|Adverse Event|7|||
144383456|NCT01363349|520613806|FG000|Overall Study|Lack of Efficacy|3|||
144383457|NCT01363349|520613807|FG001|Overall Study|Lack of Efficacy|10|||
144383458|NCT01363349|520613806|FG000|Overall Study|Non compliance/Protocol deviations|2|||
144383459|NCT01363349|520613807|FG001|Overall Study|Non compliance/Protocol deviations|2|||
144383460|NCT01363349|520613806|FG000|Overall Study|Withdrawal by Subject|14|||
144383461|NCT01363349|520613807|FG001|Overall Study|Withdrawal by Subject|6|||
144383462|NCT01363349|520613806|FG000|Overall Study|Lost to Follow-up|5|||
144514953|NCT02141074|521084028|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
144514954|NCT02141074|521084027|FG000|Prophylaxis|Adverse Event|0|||
144514955|NCT02141074|521084028|FG001|Prophylaxis|Adverse Event|4|||
144514956|NCT02141074|521084027|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
144721943|NCT01829464|521836889|FG000|Overall Study|Adverse Event|1|||
144383463|NCT01363349|520613807|FG001|Overall Study|Lost to Follow-up|6|||
144383464|NCT01363349|520613806|FG000|Overall Study|Not reported|36|||
144383465|NCT01363349|520613807|FG001|Overall Study|Not reported|37|||
144383466|NCT01363349|520613806|FG000|Overall Study|missing|1|||
144383467|NCT01363349|520613807|FG001|Overall Study|missing|2|||
144383468|NCT01958489|520613808|FG000|Period 2|Adverse Event|0|||
144383469|NCT01958489|520613809|FG001|Period 2|Adverse Event|1|||
144514957|NCT02141074|521084028|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
144383470|NCT01579812|520613810|FG000|Overall Study|Ineligible after treatment start|40|||
144383471|NCT01579812|520613810|FG000|Overall Study|Patient choice|3|||
144383472|NCT01579812|520613810|FG000|Overall Study|Noncompliance|3|||
144383473|NCT01579812|520613810|FG000|Overall Study|Withdrawal by Subject|6|||
144383474|NCT04987944|520613812|FG000|Overall Study|Adverse Event|0|||
144383475|NCT04987944|520613813|FG001|Overall Study|Adverse Event|1|||
144383476|NCT04987944|520613812|FG000|Overall Study|Withdrawal by Subject|0|||
144383477|NCT04987944|520613813|FG001|Overall Study|Withdrawal by Subject|1|||
144383478|NCT02946931|520613823|FG000|Overall Study|Did not require collection of CRFs|588|||
144383479|NCT02946931|520613823|FG000|Overall Study|Other than listed|37|||
144383480|NCT02946931|520613823|FG000|Overall Study|Discharge from hospital|118|||
144383481|NCT02946931|520613823|FG000|Overall Study|Adverse Event|81|||
144383482|NCT02946931|520613823|FG000|Overall Study|CRFs not valid|1|||
144383483|NCT02946931|520613823|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
144383484|NCT01270802|520613824|FG000|Overall Study|Withdrawal by Subject|1|||
144383485|NCT01270802|520613825|FG001|Overall Study|Withdrawal by Subject|0|||
144383486|NCT01270802|520613824|FG000|Overall Study|Adverse Event|1|||
144383487|NCT01270802|520613825|FG001|Overall Study|Adverse Event|0|||
144383488|NCT01270802|520613824|FG000|Overall Study|Lost to Follow-up|0|||
144383489|NCT01270802|520613825|FG001|Overall Study|Lost to Follow-up|1|||
144383490|NCT04740905|520613826|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
144383491|NCT04740905|520613827|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
144383492|NCT04740905|520613826|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
144383493|NCT04740905|520613827|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
144383494|NCT04740905|520613826|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
144383495|NCT04740905|520613827|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
144383496|NCT04740905|520613826|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
144383497|NCT04740905|520613827|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
144383498|NCT04740905|520613826|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
144383499|NCT04740905|520613827|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
144383500|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
144383501|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
144383502|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
144383503|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
144383504|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
144383505|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
144383506|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
144383507|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
144383508|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
144383509|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
144383510|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
144383511|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
144383512|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
144383513|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
144383514|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
144383515|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
144383516|NCT04740905|520613826|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
144383517|NCT04740905|520613827|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
144383518|NCT01700387|520613835|FG000|Overall Study|Withdrawal by Subject|1|||
144383519|NCT01700387|520613836|FG001|Overall Study|Withdrawal by Subject|2|||
144383520|NCT01700387|520613835|FG000|Overall Study|Adverse Event|1|||
144383521|NCT01700387|520613836|FG001|Overall Study|Adverse Event|1|||
144383522|NCT01700387|520613835|FG000|Overall Study|Lost to Follow-up|2|||
144383523|NCT01700387|520613836|FG001|Overall Study|Lost to Follow-up|1|||
144383524|NCT00995566|520613837|FG000|Overall Study|Adverse Event|2|||
144383525|NCT00995566|520613837|FG000|Overall Study|Early study termination|52|||
144383526|NCT03678870|520613838|FG000|Overall Study|prescribed non- protocol medications|10|||
144592548|NCT00069108|521370576|FG001|Overall Study|Violation criteria|4|||
144592549|NCT00069108|521370575|FG000|Overall Study|Refused treatment|5|||
144592550|NCT00069108|521370576|FG001|Overall Study|Refused treatment|10|||
144592551|NCT02783768|521370577|FG000|Overall Study|Lost to Follow-up|1|||
144592552|NCT02783768|521370578|FG001|Overall Study|Lost to Follow-up|0|||
144592553|NCT01323647|521370579|FG000|Overall Study|Migrated/moved from study area|2|||
144383527|NCT03678870|520613839|FG001|Overall Study|prescribed non- protocol medications|6|||
144383528|NCT03678870|520613838|FG000|Overall Study|Lost to Follow-up|3|||
144383529|NCT03678870|520613839|FG001|Overall Study|Lost to Follow-up|2|||
144383530|NCT01454778|520613840|FG000|Overall Study|Lost to Follow-up|2|||
144383531|NCT01454778|520613840|FG000|Overall Study|Death|1|||
144383532|NCT00348881|520613841|FG000|Overall Study|Lost to Follow-up|12|||
144383533|NCT00348881|520613842|FG001|Overall Study|Lost to Follow-up|6|||
144383534|NCT00348881|520613841|FG000|Overall Study|Withdrawal by Subject|3|||
144383535|NCT00348881|520613842|FG001|Overall Study|Withdrawal by Subject|4|||
144383536|NCT00348881|520613841|FG000|Overall Study|Adverse Event|2|||
144383537|NCT00348881|520613842|FG001|Overall Study|Adverse Event|0|||
144383538|NCT00348881|520613841|FG000|Overall Study|Serious Adverse Event|0|||
144383539|NCT00348881|520613842|FG001|Overall Study|Serious Adverse Event|2|||
144383540|NCT01981551|520613849|FG000|Overall Study|Refused further treatment|8|||
144383541|NCT01981551|520613849|FG000|Overall Study|Adverse Event|1|||
144383542|NCT00960570|520613850|FG000|21 Day Washout Period|Adverse Event|1|||
144383543|NCT00960570|520613850|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
144383544|NCT00960570|520613850|FG000|1 Day Period Between Dosing|Adverse Event|2|||
144383545|NCT00960570|520613850|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
144383546|NCT02880956|520613851|FG000|Overall Study|Adverse Event|3|||
144383547|NCT02880956|520613852|FG001|Overall Study|Adverse Event|6|||
144383548|NCT02880956|520613853|FG002|Overall Study|Adverse Event|5|||
144383549|NCT02880956|520613854|FG003|Overall Study|Adverse Event|4|||
144383550|NCT02880956|520613851|FG000|Overall Study|Withdrawal by Subject|9|||
144383551|NCT02880956|520613852|FG001|Overall Study|Withdrawal by Subject|4|||
144383552|NCT02880956|520613853|FG002|Overall Study|Withdrawal by Subject|6|||
144383553|NCT02880956|520613854|FG003|Overall Study|Withdrawal by Subject|11|||
144383554|NCT02880956|520613851|FG000|Overall Study|Lost to Follow-up|0|||
144383555|NCT02880956|520613852|FG001|Overall Study|Lost to Follow-up|1|||
144383556|NCT02880956|520613853|FG002|Overall Study|Lost to Follow-up|0|||
144383557|NCT02880956|520613854|FG003|Overall Study|Lost to Follow-up|0|||
144383558|NCT02880956|520613851|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
144383559|NCT02880956|520613852|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
144383560|NCT02880956|520613853|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
144383561|NCT02880956|520613854|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
144383562|NCT02880956|520613851|FG000|Overall Study|Other, Not Specified|4|||
144383563|NCT02880956|520613852|FG001|Overall Study|Other, Not Specified|2|||
144383564|NCT02880956|520613853|FG002|Overall Study|Other, Not Specified|0|||
144383565|NCT02880956|520613854|FG003|Overall Study|Other, Not Specified|3|||
144383566|NCT01350544|520615676|FG000|Overall Study|Administrative Withdrawal|0|||
144383567|NCT01350544|520615677|FG001|Overall Study|Administrative Withdrawal|1|||
144383568|NCT01350544|520615676|FG000|Overall Study|Death|1|||
144383569|NCT01350544|520615677|FG001|Overall Study|Death|2|||
144383570|NCT01350544|520615676|FG000|Overall Study|Moved out of LA County|2|||
144383571|NCT01350544|520615677|FG001|Overall Study|Moved out of LA County|2|||
144383572|NCT01350544|520615676|FG000|Overall Study|Medical Issues|1|||
144383573|NCT01350544|520615677|FG001|Overall Study|Medical Issues|1|||
144383574|NCT01350544|520615676|FG000|Overall Study|Withdrawal by Subject|0|||
144383575|NCT01350544|520615677|FG001|Overall Study|Withdrawal by Subject|1|||
144383576|NCT01350544|520615676|FG000|Overall Study|Incarceration|1|||
144383577|NCT01350544|520615677|FG001|Overall Study|Incarceration|0|||
144383578|NCT01350544|520615676|FG000|Overall Study|Lost to Follow-up|18|||
144383579|NCT01350544|520615677|FG001|Overall Study|Lost to Follow-up|15|||
144383580|NCT01133990|520615684|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
144383581|NCT01133990|520615685|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144383582|NCT01133990|520615686|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144383583|NCT01133990|520615687|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144383584|NCT01133990|520615688|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144383585|NCT01133990|520615689|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144383586|NCT01133990|520615684|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
144514958|NCT02141074|521084027|FG000|Prophylaxis|Withdrawal by Subject|0|||
144514959|NCT02141074|521084028|FG001|Prophylaxis|Withdrawal by Subject|1|||
144514960|NCT00262301|521084031|FG000|Double-blind Phase|Lost to Follow-up|1|||
144383587|NCT01133990|520615685|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
144383588|NCT01133990|520615686|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
144383589|NCT01133990|520615687|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
144383590|NCT01133990|520615688|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
144514961|NCT00262301|521084032|FG001|Double-blind Phase|Lost to Follow-up|0|||
144383591|NCT01133990|520615689|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
144383592|NCT01133990|520615684|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
144383593|NCT01133990|520615685|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144383594|NCT01133990|520615686|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144383595|NCT01133990|520615687|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144383596|NCT01133990|520615688|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144383597|NCT01133990|520615689|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144383598|NCT01133990|520615684|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
144383599|NCT01133990|520615685|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
144383600|NCT01133990|520615686|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
144383601|NCT01133990|520615687|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
144383602|NCT01133990|520615688|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
144383603|NCT01133990|520615689|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
144383604|NCT02282345|520615691|FG000|Overall Study|Progression|0|||
144383605|NCT02282345|520615692|FG001|Overall Study|Progression|1|||
144383606|NCT02683746|520615693|FG000|Overall Study|Adverse Event|3|||
144383607|NCT02683746|520615694|FG001|Overall Study|Adverse Event|2|||
144383608|NCT02683746|520615693|FG000|Overall Study|Lost to Follow-up|5|||
144383609|NCT02683746|520615694|FG001|Overall Study|Lost to Follow-up|6|||
144383610|NCT02683746|520615693|FG000|Overall Study|Withdrawal by Subject|6|||
144383611|NCT02683746|520615694|FG001|Overall Study|Withdrawal by Subject|5|||
144383612|NCT02683746|520615693|FG000|Overall Study|Physician Decision|2|||
144383613|NCT02683746|520615694|FG001|Overall Study|Physician Decision|1|||
144383614|NCT04905498|520615705|FG000|Overall Study|Lost to Follow-up|0|||
144383615|NCT04905498|520615706|FG001|Overall Study|Lost to Follow-up|2|||
144383616|NCT04905498|520615705|FG000|Overall Study|COVID lockdown|1|||
144383617|NCT04905498|520615706|FG001|Overall Study|COVID lockdown|0|||
144383618|NCT00869778|520615707|FG000|Overall Study|Adverse Event|2|||
144383619|NCT00869778|520615708|FG001|Overall Study|Adverse Event|0|||
144383620|NCT00869778|520615709|FG002|Overall Study|Adverse Event|0|||
144383621|NCT00869778|520615707|FG000|Overall Study|Withdrawal by Subject|3|||
144383622|NCT00869778|520615708|FG001|Overall Study|Withdrawal by Subject|4|||
144383623|NCT00869778|520615709|FG002|Overall Study|Withdrawal by Subject|5|||
144383624|NCT00869778|520615707|FG000|Overall Study|Pregnancy|1|||
144383625|NCT00869778|520615708|FG001|Overall Study|Pregnancy|0|||
144383626|NCT00869778|520615709|FG002|Overall Study|Pregnancy|0|||
144383627|NCT00869778|520615707|FG000|Overall Study|Protocol Violation|5|||
144383628|NCT00869778|520615708|FG001|Overall Study|Protocol Violation|3|||
144383629|NCT00869778|520615709|FG002|Overall Study|Protocol Violation|5|||
144383630|NCT00869778|520615707|FG000|Overall Study|Unblinding|1|||
144383631|NCT00869778|520615708|FG001|Overall Study|Unblinding|0|||
144383632|NCT00869778|520615709|FG002|Overall Study|Unblinding|0|||
144383633|NCT03339297|520615710|FG000|Overall Study|Relapse of Hematologic Disease|1|||
144383634|NCT03339297|520615711|FG001|Overall Study|Relapse of Hematologic Disease|0|||
144383635|NCT03339297|520615710|FG000|Overall Study|Death|10|||
144383636|NCT03339297|520615711|FG001|Overall Study|Death|7|||
144383637|NCT03339297|520615710|FG000|Overall Study|Hepatic Candidosis|1|||
144383638|NCT03339297|520615711|FG001|Overall Study|Hepatic Candidosis|0|||
144383639|NCT03339297|520615710|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
144383640|NCT03339297|520615711|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
144383641|NCT03339297|520615710|FG000|Overall Study|Consent Withdrawn by Participant|3|||
144383642|NCT03339297|520615711|FG001|Overall Study|Consent Withdrawn by Participant|3|||
144383643|NCT03339297|520615710|FG000|Overall Study|Disease Relapse|2|||
144383644|NCT03339297|520615711|FG001|Overall Study|Disease Relapse|0|||
144383645|NCT03339297|520615710|FG000|Overall Study|Physician Decision|1|||
144514962|NCT00262301|521084033|FG002|Double-blind Phase|Lost to Follow-up|0|||
144383646|NCT03339297|520615711|FG001|Overall Study|Physician Decision|1|||
144383647|NCT03339297|520615710|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
144383648|NCT03339297|520615711|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
144514963|NCT00262301|521084031|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
144383649|NCT03339297|520615710|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
144721944|NCT01829464|521836890|FG001|Overall Study|Adverse Event|0|||
144383650|NCT03339297|520615711|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
144383651|NCT03339297|520615710|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
144383652|NCT03339297|520615711|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
144383653|NCT03339297|520615710|FG000|Overall Study|Adverse Event, Non-fatal|1|||
144383654|NCT03339297|520615711|FG001|Overall Study|Adverse Event, Non-fatal|0|||
144383655|NCT03339297|520615710|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
144383656|NCT03339297|520615711|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
144383657|NCT03339297|520615710|FG000|Overall Study|Patient Was Not Eligible|1|||
144383658|NCT03339297|520615711|FG001|Overall Study|Patient Was Not Eligible|0|||
144383659|NCT03316911|520615721|FG000|Overall Study|Lost to Follow-up|33|||
144383660|NCT03316911|520615722|FG001|Overall Study|Lost to Follow-up|29|||
144383661|NCT01119937|520615723|FG000|Overall Study|Adverse Event|11|||
144383662|NCT01119937|520615724|FG001|Overall Study|Adverse Event|5|||
144383663|NCT01119937|520615723|FG000|Overall Study|Protocol deviation|3|||
144383664|NCT01119937|520615724|FG001|Overall Study|Protocol deviation|1|||
144383665|NCT01119937|520615723|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
144383666|NCT01119937|520615724|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144383667|NCT01119937|520615723|FG000|Overall Study|Withdrawal by Subject|2|||
144383668|NCT01119937|520615724|FG001|Overall Study|Withdrawal by Subject|1|||
144383669|NCT01566214|520615725|FG000|Overall Study|Lost to Follow-up|3|||
144383670|NCT01566214|520615726|FG001|Overall Study|Lost to Follow-up|0|||
144383671|NCT03051620|520615727|FG000|Overall Study|Lost to Follow-up|6|||
144383672|NCT03051620|520615727|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
144383673|NCT01073462|520615731|FG000|Overall Study|Death|14|||
144383674|NCT01073462|520615731|FG000|Overall Study|Kidney transplant|10|||
144383675|NCT01073462|520615731|FG000|Overall Study|Low parathyroid hormone levels|8|||
144383676|NCT01073462|520615731|FG000|Overall Study|Serious adverse event|2|||
144383677|NCT01073462|520615731|FG000|Overall Study|Lost to Follow-up|7|||
144383678|NCT03554486|520615732|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
144383679|NCT03554486|520615733|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
144383680|NCT03554486|520615734|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
144383681|NCT03554486|520615732|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
144383682|NCT03554486|520615733|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
144383683|NCT03554486|520615734|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
144383684|NCT03554486|520615732|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
144383685|NCT03554486|520615733|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
144383686|NCT03554486|520615734|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
144383687|NCT02509117|520615738|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383688|NCT02509117|520615739|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
144383689|NCT02509117|520615740|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383690|NCT02509117|520615741|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383691|NCT02509117|520615742|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144514964|NCT00262301|521084032|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
144721945|NCT01829464|521836891|FG002|Overall Study|Adverse Event|0|||
144383692|NCT02509117|520615743|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383693|NCT02509117|520615744|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383694|NCT02509117|520615745|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383695|NCT02509117|520615746|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144721946|NCT01829464|521836889|FG000|Overall Study|Lost to Follow-up|0|||
144383696|NCT02509117|520615747|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
144383697|NCT02509117|520615738|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383698|NCT02509117|520615739|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383699|NCT02509117|520615740|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383700|NCT02509117|520615741|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383701|NCT02509117|520615742|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383702|NCT02509117|520615743|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383703|NCT02509117|520615744|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383704|NCT02509117|520615745|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383705|NCT02509117|520615746|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
144383706|NCT02509117|520615747|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
144383707|NCT02509117|520615738|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383708|NCT02509117|520615739|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383709|NCT02509117|520615740|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383710|NCT02509117|520615741|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383711|NCT02509117|520615742|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383712|NCT02509117|520615743|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383713|NCT02509117|520615744|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383714|NCT02509117|520615745|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383715|NCT02509117|520615746|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
144383716|NCT02509117|520615747|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
144383717|NCT00636363|520615748|FG000|Overall Study|Conjunctivitis|0|||
144383718|NCT00636363|520615749|FG001|Overall Study|Conjunctivitis|0|||
144383719|NCT00636363|520615750|FG002|Overall Study|Conjunctivitis|1|||
144383720|NCT00636363|520615748|FG000|Overall Study|Adverse Event|0|||
144383721|NCT00636363|520615749|FG001|Overall Study|Adverse Event|0|||
144383722|NCT00636363|520615750|FG002|Overall Study|Adverse Event|1|||
144383723|NCT00636363|520615748|FG000|Overall Study|Positive slit lamp finding|0|||
144383724|NCT00636363|520615749|FG001|Overall Study|Positive slit lamp finding|2|||
144383725|NCT00636363|520615750|FG002|Overall Study|Positive slit lamp finding|1|||
144383726|NCT00636363|520615748|FG000|Overall Study|Study related symptoms/complaints|8|||
144383727|NCT00636363|520615749|FG001|Overall Study|Study related symptoms/complaints|7|||
144383728|NCT00636363|520615750|FG002|Overall Study|Study related symptoms/complaints|4|||
144383729|NCT00636363|520615748|FG000|Overall Study|Met ineligibility criteria|0|||
144383730|NCT00636363|520615749|FG001|Overall Study|Met ineligibility criteria|0|||
144383731|NCT00636363|520615750|FG002|Overall Study|Met ineligibility criteria|3|||
144383732|NCT00636363|520615748|FG000|Overall Study|Missed > 1 visit|0|||
144383733|NCT00636363|520615749|FG001|Overall Study|Missed > 1 visit|1|||
144383734|NCT00636363|520615750|FG002|Overall Study|Missed > 1 visit|3|||
144383735|NCT00636363|520615748|FG000|Overall Study|Lack of motivation|1|||
144383736|NCT00636363|520615749|FG001|Overall Study|Lack of motivation|0|||
144383737|NCT00636363|520615750|FG002|Overall Study|Lack of motivation|1|||
144383738|NCT00636363|520615748|FG000|Overall Study|Protocol Violation|0|||
144383739|NCT00636363|520615749|FG001|Overall Study|Protocol Violation|3|||
144383740|NCT00636363|520615750|FG002|Overall Study|Protocol Violation|0|||
144383741|NCT00636363|520615748|FG000|Overall Study|Lost to Follow-up|3|||
144383742|NCT00636363|520615749|FG001|Overall Study|Lost to Follow-up|4|||
144383743|NCT00636363|520615750|FG002|Overall Study|Lost to Follow-up|2|||
144383744|NCT00636363|520615748|FG000|Overall Study|Withdrawal by Subject|1|||
144383745|NCT00636363|520615749|FG001|Overall Study|Withdrawal by Subject|3|||
144383746|NCT00636363|520615750|FG002|Overall Study|Withdrawal by Subject|2|||
144383747|NCT00280748|520615751|FG000|Overall Study|Decline in performance|3|||
144383748|NCT00280748|520615751|FG000|Overall Study|Extra-cranial disease progression|1|||
144383749|NCT01765218|520615752|FG000|Overall Study|Protocol Violation|1|||
144514965|NCT00262301|521084033|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
144514966|NCT03101930|521084034|FG000|Overall Study|Withdrawal by Subject|2|||
144514967|NCT03101930|521084035|FG001|Overall Study|Withdrawal by Subject|1|||
144514968|NCT03101930|521084036|FG002|Overall Study|Withdrawal by Subject|2|||
144514969|NCT01017146|521084037|FG000|Overall Study|Adverse Event|11|||
144514970|NCT01017146|521084038|FG001|Overall Study|Adverse Event|1|||
144514971|NCT01017146|521084037|FG000|Overall Study|Lost to Follow-up|14|||
144383750|NCT01765218|520615753|FG001|Overall Study|Protocol Violation|2|||
144383751|NCT00313781|520615754|FG000|Before Crossover|Death|22|||
144383752|NCT00313781|520615755|FG001|Before Crossover|Death|8|||
144383753|NCT00313781|520615756|FG002|Before Crossover|Death|0|||
144383754|NCT00313781|520615754|FG000|Before Crossover|Lost to Follow-up|0|||
144383755|NCT00313781|520615755|FG001|Before Crossover|Lost to Follow-up|3|||
144514972|NCT01017146|521084038|FG001|Overall Study|Lost to Follow-up|14|||
144383756|NCT00313781|520615756|FG002|Before Crossover|Lost to Follow-up|0|||
144383757|NCT00313781|520615754|FG000|Before Crossover|Withdrawal by Subject|3|||
144383758|NCT00313781|520615755|FG001|Before Crossover|Withdrawal by Subject|1|||
144383759|NCT00313781|520615756|FG002|Before Crossover|Withdrawal by Subject|0|||
144383760|NCT00313781|520615754|FG000|Before Crossover|Other|45|||
144383761|NCT00313781|520615755|FG001|Before Crossover|Other|30|||
144383762|NCT00313781|520615756|FG002|Before Crossover|Other|0|||
144383763|NCT00313781|520615754|FG000|Before Crossover|Crossover|0|||
144383764|NCT00313781|520615755|FG001|Before Crossover|Crossover|37|||
144383765|NCT00313781|520615756|FG002|Before Crossover|Crossover|0|||
144383766|NCT00313781|520615754|FG000|Before Crossover|Randomized, not treated|5|||
144383767|NCT00313781|520615755|FG001|Before Crossover|Randomized, not treated|0|||
144383768|NCT00313781|520615756|FG002|Before Crossover|Randomized, not treated|0|||
144383769|NCT00313781|520615754|FG000|After Crossover|Death|0|||
144383770|NCT00313781|520615755|FG001|After Crossover|Death|0|||
144383771|NCT00313781|520615756|FG002|After Crossover|Death|6|||
144383772|NCT00313781|520615754|FG000|After Crossover|Withdrawal by Subject|0|||
144383773|NCT00313781|520615755|FG001|After Crossover|Withdrawal by Subject|0|||
144383774|NCT00313781|520615756|FG002|After Crossover|Withdrawal by Subject|3|||
144383775|NCT00313781|520615754|FG000|After Crossover|Other|0|||
144383776|NCT00313781|520615755|FG001|After Crossover|Other|0|||
144383777|NCT00313781|520615756|FG002|After Crossover|Other|18|||
144383778|NCT03567343|520615758|FG000|Overall Study|Lost to Follow-up|2|||
144383779|NCT03567343|520615759|FG001|Overall Study|Lost to Follow-up|1|||
144383780|NCT03567343|520615758|FG000|Overall Study|No longer eligible|2|||
144383781|NCT03567343|520615759|FG001|Overall Study|No longer eligible|1|||
144383782|NCT03567343|520615758|FG000|Overall Study|Adverse Event|1|||
144383783|NCT03567343|520615759|FG001|Overall Study|Adverse Event|0|||
144383784|NCT03567343|520615758|FG000|Overall Study|Protocol Violation|1|||
144383785|NCT03567343|520615759|FG001|Overall Study|Protocol Violation|1|||
144383786|NCT01433250|520615760|FG000|Overall Study|Protocol Violation|0|||
144383787|NCT01433250|520615761|FG001|Overall Study|Protocol Violation|1|||
144383788|NCT01433250|520615760|FG000|Overall Study|Withdrawal by Subject|3|||
144383789|NCT01433250|520615761|FG001|Overall Study|Withdrawal by Subject|2|||
144383790|NCT03148691|520615762|FG000|Overall Study|Protocol Violation|1|||
144383791|NCT03148691|520615763|FG001|Overall Study|Protocol Violation|2|||
144199313|NCT00541970|519928869|FG003|Month 48|Other|0|||
144383792|NCT03148691|520615764|FG002|Overall Study|Protocol Violation|7|||
144383793|NCT03148691|520615762|FG000|Overall Study|Lost to Follow-up|0|||
144383794|NCT03148691|520615763|FG001|Overall Study|Lost to Follow-up|0|||
144383795|NCT03148691|520615764|FG002|Overall Study|Lost to Follow-up|1|||
144383796|NCT03148691|520615762|FG000|Overall Study|Other|1|||
144383797|NCT03148691|520615763|FG001|Overall Study|Other|0|||
144383798|NCT03148691|520615764|FG002|Overall Study|Other|0|||
144383799|NCT03148691|520615762|FG000|Overall Study|Withdrawal by Subject|1|||
144383800|NCT03148691|520615763|FG001|Overall Study|Withdrawal by Subject|0|||
144383801|NCT03148691|520615764|FG002|Overall Study|Withdrawal by Subject|0|||
144383802|NCT04345367|520615765|FG000|Overall Study|Other|3|||
144383803|NCT04345367|520615766|FG001|Overall Study|Other|4|||
144383804|NCT04345367|520615765|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
144383805|NCT04345367|520615766|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
144383806|NCT04345367|520615765|FG000|Overall Study|Withdrawal by Subject|11|||
144383807|NCT04345367|520615766|FG001|Overall Study|Withdrawal by Subject|11|||
144383808|NCT04345367|520615765|FG000|Overall Study|Protocol Violation|4|||
144383809|NCT04345367|520615766|FG001|Overall Study|Protocol Violation|3|||
144383810|NCT04345367|520615765|FG000|Overall Study|Lost to Follow-up|2|||
144383811|NCT04345367|520615766|FG001|Overall Study|Lost to Follow-up|4|||
144383812|NCT04345367|520615765|FG000|Overall Study|Lack of Efficacy|2|||
144383813|NCT04345367|520615766|FG001|Overall Study|Lack of Efficacy|0|||
144383814|NCT04345367|520615765|FG000|Overall Study|Death|2|||
144383815|NCT04345367|520615766|FG001|Overall Study|Death|0|||
144383816|NCT04345367|520615765|FG000|Overall Study|Adverse Event|10|||
144383817|NCT04345367|520615766|FG001|Overall Study|Adverse Event|9|||
144383818|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
144383819|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
144383820|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
144383821|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
144383822|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
144383823|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
144383824|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
144383825|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
144383826|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
144383827|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
144383828|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
144383829|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
144592554|NCT01323647|521370580|FG001|Overall Study|Migrated/moved from study area|0|||
144592555|NCT01323647|521370579|FG000|Overall Study|Withdrawal by Subject|5|||
144592556|NCT01323647|521370580|FG001|Overall Study|Withdrawal by Subject|0|||
144592557|NCT01323647|521370579|FG000|Overall Study|Lost to Follow-up|2|||
144592558|NCT01323647|521370580|FG001|Overall Study|Lost to Follow-up|0|||
144592559|NCT00262951|521370581|FG000|Overall Study|Progressive disease/relapse|3|||
144592560|NCT00262951|521370581|FG000|Overall Study|Adverse Event|7|||
144592561|NCT00262951|521370581|FG000|Overall Study|Death|1|||
144592562|NCT00262951|521370581|FG000|Overall Study|Withdrawal by Subject|1|||
144592563|NCT00262951|521370581|FG000|Overall Study|Alternative treatment|3|||
144592564|NCT00262951|521370581|FG000|Overall Study|Off treatment for other disease|1|||
144592565|NCT01853137|521370582|FG000|Overall Study|Lost to Follow-up|4|||
144592566|NCT01853137|521370583|FG001|Overall Study|Lost to Follow-up|1|||
144592567|NCT03401229|521370584|FG000|Overall Study|Lost to Follow-up|2|||
144592568|NCT03401229|521370585|FG001|Overall Study|Lost to Follow-up|1|||
144592569|NCT03401229|521370584|FG000|Overall Study|Other|1|||
144592570|NCT03401229|521370585|FG001|Overall Study|Other|3|||
144592571|NCT03401229|521370584|FG000|Overall Study|Adverse Event|8|||
144592572|NCT03401229|521370585|FG001|Overall Study|Adverse Event|6|||
144592573|NCT03401229|521370584|FG000|Overall Study|Withdrawal by Subject|29|||
144592574|NCT03401229|521370585|FG001|Overall Study|Withdrawal by Subject|26|||
144592575|NCT03401229|521370584|FG000|Overall Study|COVID-19|0|||
144592576|NCT03401229|521370585|FG001|Overall Study|COVID-19|1|||
144592577|NCT03305731|521370587|FG000|Overall Study|Protocol Violation|1|||
144592578|NCT00455325|521370593|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
144592579|NCT00455325|521370594|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
144592580|NCT00455325|521370595|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
144592581|NCT00455325|521370596|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
144383830|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
144592582|NCT00455325|521370593|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
144592583|NCT00455325|521370594|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
144592584|NCT00455325|521370595|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
144592585|NCT00455325|521370596|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
144592586|NCT00455325|521370593|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
144592587|NCT00455325|521370594|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
144592588|NCT00455325|521370595|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
144592589|NCT00455325|521370596|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
144592590|NCT00455325|521370593|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
144592591|NCT00455325|521370594|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
144592592|NCT00455325|521370595|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
144592593|NCT00455325|521370596|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
144592594|NCT00455325|521370593|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
144592595|NCT00455325|521370594|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
144721947|NCT01829464|521836890|FG001|Overall Study|Lost to Follow-up|0|||
144383831|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
144383832|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
144592596|NCT00455325|521370595|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
144592597|NCT00455325|521370596|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
144592598|NCT00455325|521370593|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
144592599|NCT00455325|521370594|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
144592600|NCT00455325|521370595|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
144592601|NCT00455325|521370596|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
144592602|NCT00455325|521370593|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
144592603|NCT00455325|521370594|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
144592604|NCT00455325|521370595|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
144592605|NCT00455325|521370596|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
144592606|NCT04620811|521370597|FG000|Overall Study|Withdrawal by Subject|18|||
144592607|NCT04620811|521370598|FG001|Overall Study|Withdrawal by Subject|15|||
144592608|NCT04620811|521370597|FG000|Overall Study|Adverse Event|6|||
144592609|NCT04620811|521370598|FG001|Overall Study|Adverse Event|11|||
144592610|NCT04620811|521370597|FG000|Overall Study|Lost to Follow-up|4|||
144592611|NCT04620811|521370598|FG001|Overall Study|Lost to Follow-up|8|||
144592612|NCT04620811|521370597|FG000|Overall Study|Physician Decision|1|||
144592613|NCT04620811|521370598|FG001|Overall Study|Physician Decision|4|||
144383833|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
144383834|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
144383835|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
144383836|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
144383837|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
144383838|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
144383839|NCT01227824|520615768|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
144383840|NCT01227824|520615769|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
144383841|NCT01227824|520615770|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
144383842|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
144383843|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
144383844|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
144383845|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
144383846|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
144383847|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
144383848|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
144383849|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
144592614|NCT04620811|521370597|FG000|Overall Study|Sponsor Decision|0|||
144592615|NCT04620811|521370598|FG001|Overall Study|Sponsor Decision|1|||
144592616|NCT04620811|521370597|FG000|Overall Study|Elevation of ALT or AST|1|||
144592617|NCT04620811|521370598|FG001|Overall Study|Elevation of ALT or AST|0|||
144592618|NCT04620811|521370597|FG000|Overall Study|Other|3|||
144592619|NCT04620811|521370598|FG001|Overall Study|Other|5|||
144592620|NCT00928746|521370604|FG000|Overall Study|Adverse Event|2|||
144592621|NCT00928746|521370604|FG000|Overall Study|Protocol Violation|1|||
144592622|NCT00928746|521370604|FG000|Overall Study|Withdrawal by Subject|1|||
144592623|NCT00928746|521370604|FG000|Overall Study|Other|2|||
144592624|NCT02004353|521370609|FG000|Overall Study|Voluntary participation|1334|||
144592625|NCT01759368|521370613|FG000|Overall Study|Lost to Follow-up|1|||
144592626|NCT01759368|521370614|FG001|Overall Study|Lost to Follow-up|0|||
144592627|NCT01191268|521370621|FG000|Overall Study|Withdrawal by Subject|19|||
144592628|NCT01191268|521370622|FG001|Overall Study|Withdrawal by Subject|25|||
144592629|NCT01191268|521370623|FG002|Overall Study|Withdrawal by Subject|21|||
144592630|NCT01191268|521370621|FG000|Overall Study|Adverse Event|21|||
144592631|NCT01191268|521370622|FG001|Overall Study|Adverse Event|13|||
144592632|NCT01191268|521370623|FG002|Overall Study|Adverse Event|8|||
144592633|NCT01191268|521370621|FG000|Overall Study|Physician Decision|6|||
144592634|NCT01191268|521370622|FG001|Overall Study|Physician Decision|8|||
144592635|NCT01191268|521370623|FG002|Overall Study|Physician Decision|9|||
144592636|NCT01191268|521370621|FG000|Overall Study|Lost to Follow-up|8|||
144592637|NCT01191268|521370622|FG001|Overall Study|Lost to Follow-up|5|||
144592638|NCT01191268|521370623|FG002|Overall Study|Lost to Follow-up|9|||
144592639|NCT01191268|521370621|FG000|Overall Study|Entry Criteria Not Met|3|||
144592640|NCT01191268|521370622|FG001|Overall Study|Entry Criteria Not Met|1|||
144383850|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
144383851|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
144471746|NCT01591382|520925278|FG000|Overall Study|Discharged Prior to Study Completion|2|||
144592641|NCT01191268|521370623|FG002|Overall Study|Entry Criteria Not Met|1|||
144592642|NCT01191268|521370621|FG000|Overall Study|Death|0|||
144383852|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
144383853|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
144383854|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
144383855|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
144383856|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
144383857|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
144383858|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
144383859|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
144383860|NCT01227824|520615768|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
144383861|NCT01227824|520615769|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
144383862|NCT01227824|520615770|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
144383863|NCT02576145|520615771|FG000|Overall Study|Adverse Event|1|||
144383864|NCT02576145|520615772|FG001|Overall Study|Adverse Event|0|||
144383865|NCT02576145|520615771|FG000|Overall Study|Withdrawal by Subject|1|||
144383866|NCT02576145|520615772|FG001|Overall Study|Withdrawal by Subject|0|||
144383867|NCT02576145|520615771|FG000|Overall Study|Acute rejection|1|||
144383868|NCT02576145|520615772|FG001|Overall Study|Acute rejection|0|||
144383869|NCT02576145|520615771|FG000|Overall Study|Tetanus Titers Decreased|0|||
144383870|NCT02576145|520615772|FG001|Overall Study|Tetanus Titers Decreased|1|||
144383871|NCT00781885|520615773|FG000|Overall Study|Physician Decision|1|||
144383872|NCT01755026|520615774|FG000|Overall Study|Adverse Event|1|||
144383873|NCT01755026|520615775|FG001|Overall Study|Adverse Event|0|||
144383874|NCT01755026|520615774|FG000|Overall Study|Withdrawal by Subject|1|||
144383875|NCT01755026|520615775|FG001|Overall Study|Withdrawal by Subject|1|||
144383876|NCT02730793|520615785|FG000|Overall Study|Physician Decision|0|||
144383877|NCT02730793|520615786|FG001|Overall Study|Physician Decision|1|||
144383878|NCT02730793|520615785|FG000|Overall Study|Withdrawal by Subject|0|||
144383879|NCT02730793|520615786|FG001|Overall Study|Withdrawal by Subject|1|||
144383880|NCT02365233|520615787|FG000|Overall Study|IRB withheld the data|1|||
144383881|NCT02365233|520615788|FG001|Overall Study|IRB withheld the data|2|||
144383882|NCT02365233|520615789|FG002|Overall Study|IRB withheld the data|2|||
144383883|NCT01806662|520615793|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
144383884|NCT01806662|520615794|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
144383885|NCT01806662|520615793|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
144383886|NCT01806662|520615794|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
144383887|NCT01806662|520615793|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
144383888|NCT01806662|520615794|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
144383889|NCT01806662|520615793|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
144383890|NCT01806662|520615794|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
144383891|NCT00043550|520615795|FG000|Overall Study|Withdrawal by Subject|22|||
144383892|NCT00043550|520615796|FG001|Overall Study|Withdrawal by Subject|12|||
144383893|NCT00043550|520615797|FG002|Overall Study|Withdrawal by Subject|20|||
144383894|NCT03709576|520615800|FG000|Overall Study|progression prior to enrollment|1|||
144383895|NCT00710762|520615805|FG000|Overall Study|Progressive disease|27|||
144383896|NCT00710762|520615806|FG001|Overall Study|Progressive disease|30|||
144383897|NCT00710762|520615805|FG000|Overall Study|Adverse Event other disease worsening|2|||
144383898|NCT00710762|520615806|FG001|Overall Study|Adverse Event other disease worsening|1|||
144383899|NCT00710762|520615805|FG000|Overall Study|Other Adverse Event|7|||
144383900|NCT00710762|520615806|FG001|Overall Study|Other Adverse Event|7|||
144383901|NCT00710762|520615805|FG000|Overall Study|Lost to Follow-up|1|||
144383902|NCT00710762|520615806|FG001|Overall Study|Lost to Follow-up|0|||
144383903|NCT00710762|520615805|FG000|Overall Study|Reason other than listed above|2|||
144383904|NCT00710762|520615806|FG001|Overall Study|Reason other than listed above|2|||
144383905|NCT01375075|520615807|FG000|Overall Study|Adverse Event|0|||
144383906|NCT01375075|520615808|FG001|Overall Study|Adverse Event|0|||
144383907|NCT01375075|520615809|FG002|Overall Study|Adverse Event|3|||
144383908|NCT01375075|520615810|FG003|Overall Study|Adverse Event|1|||
144383909|NCT01375075|520615811|FG004|Overall Study|Adverse Event|0|||
144383910|NCT01375075|520615812|FG005|Overall Study|Adverse Event|1|||
144383911|NCT01375075|520615807|FG000|Overall Study|Entry Criterion Not Met|1|||
144383912|NCT01375075|520615808|FG001|Overall Study|Entry Criterion Not Met|0|||
144383913|NCT01375075|520615809|FG002|Overall Study|Entry Criterion Not Met|0|||
144383914|NCT01375075|520615810|FG003|Overall Study|Entry Criterion Not Met|0|||
144383915|NCT01375075|520615811|FG004|Overall Study|Entry Criterion Not Met|0|||
144383916|NCT01375075|520615812|FG005|Overall Study|Entry Criterion Not Met|1|||
144383917|NCT01375075|520615807|FG000|Overall Study|Withdrawal by Subject|0|||
144383918|NCT01375075|520615808|FG001|Overall Study|Withdrawal by Subject|1|||
144383919|NCT01375075|520615809|FG002|Overall Study|Withdrawal by Subject|0|||
144383920|NCT01375075|520615810|FG003|Overall Study|Withdrawal by Subject|0|||
144383921|NCT01375075|520615811|FG004|Overall Study|Withdrawal by Subject|0|||
144514973|NCT01017146|521084037|FG000|Overall Study|Noncompliance with Study Product|1|||
144514974|NCT01017146|521084038|FG001|Overall Study|Noncompliance with Study Product|1|||
144514975|NCT01017146|521084037|FG000|Overall Study|Withdrawal by Subject|32|||
144514976|NCT01017146|521084038|FG001|Overall Study|Withdrawal by Subject|16|||
144514977|NCT01017146|521084037|FG000|Overall Study|Relocation|0|||
144514978|NCT01017146|521084038|FG001|Overall Study|Relocation|4|||
144514979|NCT01017146|521084037|FG000|Overall Study|Pregnancy|2|||
144514980|NCT01017146|521084038|FG001|Overall Study|Pregnancy|1|||
144383922|NCT01375075|520615812|FG005|Overall Study|Withdrawal by Subject|1|||
144383923|NCT03104816|520615814|FG000|Overall Study|Lack of Efficacy|0|||
144383924|NCT03104816|520615815|FG001|Overall Study|Lack of Efficacy|2|||
144383925|NCT03104816|520615816|FG002|Overall Study|Lack of Efficacy|0|||
144383926|NCT03104816|520615814|FG000|Overall Study|Protocol Violation|2|||
144383927|NCT03104816|520615815|FG001|Overall Study|Protocol Violation|0|||
144383928|NCT03104816|520615816|FG002|Overall Study|Protocol Violation|2|||
144383929|NCT00807573|520615817|FG000|Overall Study|Withdrawal by Subject|1|||
144383930|NCT00807573|520615817|FG000|Overall Study|Adverse Event|1|||
144383931|NCT01227629|520615818|FG000|Overall Study|Adverse Event|2|||
144383932|NCT01227629|520615819|FG001|Overall Study|Adverse Event|2|||
144383933|NCT01227629|520615820|FG002|Overall Study|Adverse Event|1|||
144383934|NCT01227629|520615821|FG003|Overall Study|Adverse Event|6|||
144383935|NCT01227629|520615822|FG004|Overall Study|Adverse Event|1|||
144383936|NCT01227629|520615823|FG005|Overall Study|Adverse Event|1|||
144383937|NCT01227629|520615824|FG006|Overall Study|Adverse Event|6|||
144383938|NCT01227629|520615825|FG007|Overall Study|Adverse Event|6|||
144383939|NCT01227629|520615826|FG008|Overall Study|Adverse Event|4|||
144383940|NCT01227629|520615827|FG009|Overall Study|Adverse Event|0|||
144383941|NCT01227629|520615818|FG000|Overall Study|Protocol Violation|0|||
144383942|NCT01227629|520615819|FG001|Overall Study|Protocol Violation|0|||
144383943|NCT01227629|520615820|FG002|Overall Study|Protocol Violation|0|||
144383944|NCT01227629|520615821|FG003|Overall Study|Protocol Violation|1|||
144383945|NCT01227629|520615822|FG004|Overall Study|Protocol Violation|0|||
144383946|NCT01227629|520615823|FG005|Overall Study|Protocol Violation|0|||
144383947|NCT01227629|520615824|FG006|Overall Study|Protocol Violation|0|||
144383948|NCT01227629|520615825|FG007|Overall Study|Protocol Violation|0|||
144383949|NCT01227629|520615826|FG008|Overall Study|Protocol Violation|0|||
144383950|NCT01227629|520615827|FG009|Overall Study|Protocol Violation|0|||
144383951|NCT01227629|520615818|FG000|Overall Study|Lost to Follow-up|0|||
144383952|NCT01227629|520615819|FG001|Overall Study|Lost to Follow-up|0|||
144383953|NCT01227629|520615820|FG002|Overall Study|Lost to Follow-up|0|||
144383954|NCT01227629|520615821|FG003|Overall Study|Lost to Follow-up|0|||
144383955|NCT01227629|520615822|FG004|Overall Study|Lost to Follow-up|1|||
144383956|NCT01227629|520615823|FG005|Overall Study|Lost to Follow-up|0|||
144383957|NCT01227629|520615824|FG006|Overall Study|Lost to Follow-up|0|||
144383958|NCT01227629|520615825|FG007|Overall Study|Lost to Follow-up|0|||
144383959|NCT01227629|520615826|FG008|Overall Study|Lost to Follow-up|0|||
144383960|NCT01227629|520615827|FG009|Overall Study|Lost to Follow-up|0|||
144383961|NCT01227629|520615818|FG000|Overall Study|Withdrawal by Subject|0|||
144383962|NCT01227629|520615819|FG001|Overall Study|Withdrawal by Subject|0|||
144383963|NCT01227629|520615820|FG002|Overall Study|Withdrawal by Subject|0|||
144383964|NCT01227629|520615821|FG003|Overall Study|Withdrawal by Subject|0|||
144383965|NCT01227629|520615822|FG004|Overall Study|Withdrawal by Subject|0|||
144383966|NCT01227629|520615823|FG005|Overall Study|Withdrawal by Subject|0|||
144383967|NCT01227629|520615824|FG006|Overall Study|Withdrawal by Subject|2|||
144383968|NCT01227629|520615825|FG007|Overall Study|Withdrawal by Subject|0|||
144383969|NCT01227629|520615826|FG008|Overall Study|Withdrawal by Subject|0|||
144383970|NCT01227629|520615827|FG009|Overall Study|Withdrawal by Subject|1|||
144383971|NCT01227629|520615818|FG000|Overall Study|Other|0|||
144383972|NCT01227629|520615819|FG001|Overall Study|Other|0|||
144383973|NCT01227629|520615820|FG002|Overall Study|Other|0|||
144383974|NCT01227629|520615821|FG003|Overall Study|Other|1|||
144383975|NCT01227629|520615822|FG004|Overall Study|Other|0|||
144383976|NCT01227629|520615823|FG005|Overall Study|Other|0|||
144383977|NCT01227629|520615824|FG006|Overall Study|Other|0|||
144383978|NCT01227629|520615825|FG007|Overall Study|Other|0|||
144383979|NCT01227629|520615826|FG008|Overall Study|Other|2|||
144383980|NCT01227629|520615827|FG009|Overall Study|Other|1|||
144383981|NCT03976648|520615829|FG000|Overall Study|Adverse Event|0|||
144383982|NCT03976648|520615830|FG001|Overall Study|Adverse Event|2|||
144592643|NCT01191268|521370622|FG001|Overall Study|Death|1|||
144383983|NCT03976648|520615829|FG000|Overall Study|Study terminated by sponsor|21|||
144383984|NCT03976648|520615830|FG001|Overall Study|Study terminated by sponsor|8|||
144383985|NCT00881868|520615831|FG000|Overall Study|Adverse Event|0|||
144383986|NCT00881868|520615832|FG001|Overall Study|Adverse Event|1|||
144383987|NCT00881868|520615831|FG000|Overall Study|Lost to Follow-up|2|||
144383988|NCT00881868|520615832|FG001|Overall Study|Lost to Follow-up|1|||
144383989|NCT00881868|520615831|FG000|Overall Study|Physician Decision|4|||
144383990|NCT00881868|520615832|FG001|Overall Study|Physician Decision|0|||
144383991|NCT00881868|520615831|FG000|Overall Study|Protocol Violation|2|||
144383992|NCT00881868|520615832|FG001|Overall Study|Protocol Violation|0|||
144383993|NCT01451437|520615833|FG000|Overall Study|Adverse Event|0|||
144383994|NCT01451437|520615834|FG001|Overall Study|Adverse Event|0|||
144383995|NCT01451437|520615835|FG002|Overall Study|Adverse Event|0|||
144383996|NCT01451437|520615836|FG003|Overall Study|Adverse Event|0|||
144383997|NCT01451437|520615837|FG004|Overall Study|Adverse Event|0|||
144383998|NCT01451437|520615838|FG005|Overall Study|Adverse Event|1|||
144383999|NCT01451437|520615839|FG006|Overall Study|Adverse Event|1|||
144384000|NCT01451437|520615840|FG007|Overall Study|Adverse Event|2|||
144384001|NCT01451437|520615841|FG008|Overall Study|Adverse Event|1|||
144384002|NCT01451437|520615833|FG000|Overall Study|Physician Decision|1|||
144384003|NCT01451437|520615834|FG001|Overall Study|Physician Decision|1|||
144384004|NCT01451437|520615835|FG002|Overall Study|Physician Decision|2|||
144384005|NCT01451437|520615836|FG003|Overall Study|Physician Decision|0|||
144384006|NCT01451437|520615837|FG004|Overall Study|Physician Decision|0|||
144384007|NCT01451437|520615838|FG005|Overall Study|Physician Decision|0|||
144384008|NCT01451437|520615839|FG006|Overall Study|Physician Decision|0|||
144384009|NCT01451437|520615840|FG007|Overall Study|Physician Decision|0|||
144384010|NCT01451437|520615841|FG008|Overall Study|Physician Decision|0|||
144384011|NCT01451437|520615833|FG000|Overall Study|Disease Progression|0|||
144384012|NCT01451437|520615834|FG001|Overall Study|Disease Progression|0|||
144384013|NCT01451437|520615835|FG002|Overall Study|Disease Progression|1|||
144384014|NCT01451437|520615836|FG003|Overall Study|Disease Progression|1|||
144384015|NCT01451437|520615837|FG004|Overall Study|Disease Progression|3|||
144384016|NCT01451437|520615838|FG005|Overall Study|Disease Progression|2|||
144384017|NCT01451437|520615839|FG006|Overall Study|Disease Progression|3|||
144384018|NCT01451437|520615840|FG007|Overall Study|Disease Progression|1|||
144384019|NCT01451437|520615841|FG008|Overall Study|Disease Progression|3|||
144384020|NCT01451437|520615833|FG000|Overall Study|Protocol Violation|0|||
144384021|NCT01451437|520615834|FG001|Overall Study|Protocol Violation|0|||
144384022|NCT01451437|520615835|FG002|Overall Study|Protocol Violation|0|||
144384023|NCT01451437|520615836|FG003|Overall Study|Protocol Violation|0|||
144384024|NCT01451437|520615837|FG004|Overall Study|Protocol Violation|0|||
144384025|NCT01451437|520615838|FG005|Overall Study|Protocol Violation|0|||
144384026|NCT01451437|520615839|FG006|Overall Study|Protocol Violation|1|||
144384027|NCT01451437|520615840|FG007|Overall Study|Protocol Violation|0|||
144384028|NCT01451437|520615841|FG008|Overall Study|Protocol Violation|0|||
144384029|NCT01451437|520615833|FG000|Overall Study|Withdrawal by Subject|0|||
144384030|NCT01451437|520615834|FG001|Overall Study|Withdrawal by Subject|0|||
144384031|NCT01451437|520615835|FG002|Overall Study|Withdrawal by Subject|0|||
144384032|NCT01451437|520615836|FG003|Overall Study|Withdrawal by Subject|0|||
144384033|NCT01451437|520615837|FG004|Overall Study|Withdrawal by Subject|1|||
144384034|NCT01451437|520615838|FG005|Overall Study|Withdrawal by Subject|0|||
144384035|NCT01451437|520615839|FG006|Overall Study|Withdrawal by Subject|1|||
144384036|NCT01451437|520615840|FG007|Overall Study|Withdrawal by Subject|0|||
144384037|NCT01451437|520615841|FG008|Overall Study|Withdrawal by Subject|0|||
144384038|NCT02081859|520615844|FG000|Overall Study|No fertilization|2|||
144384039|NCT02081859|520615845|FG001|Overall Study|No fertilization|2|||
144384040|NCT02081859|520615844|FG000|Overall Study|No sperm|1|||
144384041|NCT02081859|520615845|FG001|Overall Study|No sperm|0|||
144384042|NCT02081859|520615844|FG000|Overall Study|Unanticipated freeze all cycle|2|||
144384043|NCT02081859|520615845|FG001|Overall Study|Unanticipated freeze all cycle|6|||
144384044|NCT02081859|520615844|FG000|Overall Study|< 4 embryos|27|||
144384045|NCT02081859|520615845|FG001|Overall Study|< 4 embryos|23|||
144384046|NCT02081859|520615844|FG000|Overall Study|Other reasons|2|||
144384047|NCT02081859|520615845|FG001|Overall Study|Other reasons|0|||
144384048|NCT00576420|520617969|FG000|Overall Study|Death|0|||
144384049|NCT00576420|520617970|FG001|Overall Study|Death|0|||
144384050|NCT00576420|520617971|FG002|Overall Study|Death|1|||
144384051|NCT01340872|520617973|FG000|Double-blind Phase|Adverse Event|6|||
144384052|NCT01340872|520617974|FG001|Double-blind Phase|Adverse Event|4|||
144384053|NCT01340872|520617975|FG002|Double-blind Phase|Adverse Event|0|||
144384054|NCT01340872|520617976|FG003|Double-blind Phase|Adverse Event|0|||
144384055|NCT01340872|520617973|FG000|Double-blind Phase|Withdrawal by Subject|3|||
144384056|NCT01340872|520617974|FG001|Double-blind Phase|Withdrawal by Subject|5|||
144384057|NCT01340872|520617975|FG002|Double-blind Phase|Withdrawal by Subject|0|||
144384058|NCT01340872|520617976|FG003|Double-blind Phase|Withdrawal by Subject|0|||
144384059|NCT01340872|520617973|FG000|Double-blind Phase|Lost to Follow-up|0|||
144384060|NCT01340872|520617974|FG001|Double-blind Phase|Lost to Follow-up|1|||
144384061|NCT01340872|520617975|FG002|Double-blind Phase|Lost to Follow-up|0|||
144384062|NCT01340872|520617976|FG003|Double-blind Phase|Lost to Follow-up|0|||
144384063|NCT01340872|520617973|FG000|Double-blind Phase|Protocol Violation|0|||
144384064|NCT01340872|520617974|FG001|Double-blind Phase|Protocol Violation|1|||
144384065|NCT01340872|520617975|FG002|Double-blind Phase|Protocol Violation|0|||
144384066|NCT01340872|520617976|FG003|Double-blind Phase|Protocol Violation|0|||
144384067|NCT01340872|520617973|FG000|Open-label Phase|Physician Decision|0|||
144384068|NCT01340872|520617974|FG001|Open-label Phase|Physician Decision|0|||
144384069|NCT01340872|520617975|FG002|Open-label Phase|Physician Decision|2|||
144384070|NCT01340872|520617976|FG003|Open-label Phase|Physician Decision|1|||
144384071|NCT01340872|520617973|FG000|Open-label Phase|Pregnancy|0|||
144384072|NCT01340872|520617974|FG001|Open-label Phase|Pregnancy|0|||
144384073|NCT01340872|520617975|FG002|Open-label Phase|Pregnancy|1|||
144384074|NCT01340872|520617976|FG003|Open-label Phase|Pregnancy|0|||
144384075|NCT01340872|520617973|FG000|Open-label Phase|Adverse Event|0|||
144384076|NCT01340872|520617974|FG001|Open-label Phase|Adverse Event|0|||
144384077|NCT01340872|520617975|FG002|Open-label Phase|Adverse Event|8|||
144384078|NCT01340872|520617976|FG003|Open-label Phase|Adverse Event|4|||
144384079|NCT01340872|520617973|FG000|Open-label Phase|Withdrawal by Subject|0|||
144384080|NCT01340872|520617974|FG001|Open-label Phase|Withdrawal by Subject|0|||
144384081|NCT01340872|520617975|FG002|Open-label Phase|Withdrawal by Subject|1|||
144384082|NCT01340872|520617976|FG003|Open-label Phase|Withdrawal by Subject|6|||
144384083|NCT01340872|520617973|FG000|Open-label Phase|Worsening of IBD|0|||
144384084|NCT01340872|520617974|FG001|Open-label Phase|Worsening of IBD|0|||
144384085|NCT01340872|520617975|FG002|Open-label Phase|Worsening of IBD|1|||
144384086|NCT01340872|520617976|FG003|Open-label Phase|Worsening of IBD|0|||
144384087|NCT02656680|520617979|FG000|Overall Study|Lost to Follow-up|0|||
144384088|NCT02656680|520617980|FG001|Overall Study|Lost to Follow-up|1|||
144384089|NCT02656680|520617981|FG002|Overall Study|Lost to Follow-up|7|||
144384090|NCT01246466|520617984|FG000|Overall Study|Death|1|||
144384091|NCT01246466|520617984|FG000|Overall Study|Withdrawal by Subject|1|||
144384092|NCT00877773|520617985|FG000|Overall Study|Disease Progression|44|||
144384093|NCT02882152|520617986|FG000|Overall Study|Lost to Follow-up|1|||
144384094|NCT02882152|520617987|FG001|Overall Study|Lost to Follow-up|0|||
144384095|NCT01430754|520617988|FG000|Run-In Phase|Circadian Period Ineligible|24|||
144384096|NCT01430754|520617989|FG001|Run-In Phase|Circadian Period Ineligible|0|||
144384097|NCT01430754|520617988|FG000|Run-In Phase|Protocol Violation|6|||
144384098|NCT01430754|520617989|FG001|Run-In Phase|Protocol Violation|0|||
144384099|NCT01430754|520617988|FG000|Run-In Phase|Adverse Event|2|||
144384100|NCT01430754|520617989|FG001|Run-In Phase|Adverse Event|0|||
144384101|NCT01430754|520617988|FG000|Run-In Phase|Other|2|||
144384102|NCT01430754|520617989|FG001|Run-In Phase|Other|0|||
144384103|NCT01430754|520617988|FG000|Run-In Phase|Withdrawal by Subject|2|||
144384104|NCT01430754|520617989|FG001|Run-In Phase|Withdrawal by Subject|0|||
144384105|NCT01430754|520617988|FG000|Run-In Phase|Lost to Follow-up|1|||
144384106|NCT01430754|520617989|FG001|Run-In Phase|Lost to Follow-up|0|||
144384107|NCT01369329|520617992|FG000|Overall Study|Withdrawal by Subject|8|||
144384108|NCT01369329|520617993|FG001|Overall Study|Withdrawal by Subject|6|||
144384109|NCT01369329|520617994|FG002|Overall Study|Withdrawal by Subject|10|||
144384110|NCT01369329|520617992|FG000|Overall Study|Lost to Follow-up|2|||
144384111|NCT01369329|520617993|FG001|Overall Study|Lost to Follow-up|2|||
144384112|NCT01369329|520617994|FG002|Overall Study|Lost to Follow-up|2|||
144384113|NCT01369329|520617992|FG000|Overall Study|Other|2|||
144384114|NCT01369329|520617993|FG001|Overall Study|Other|3|||
144384115|NCT01369329|520617994|FG002|Overall Study|Other|2|||
144384116|NCT00701662|520617995|FG000|Overall Study|Lack of Efficacy|1|||
144384117|NCT00159822|520617996|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
144384118|NCT00159822|520617996|FG000|Voriconazole Treatment Period|Adverse Event|9|||
144384119|NCT00159822|520617996|FG000|Voriconazole Treatment Period|Death|4|||
144384120|NCT00159822|520617996|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
144384121|NCT00159822|520617996|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
144384122|NCT00159822|520617996|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
144384123|NCT00159822|520617996|FG000|Post-treatment Follow-up Period|Death|1|||
144384124|NCT00159822|520617996|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
144384125|NCT00159822|520617996|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
144384126|NCT00275821|520617997|FG000|Overall Study|Adverse Event|4|||
144592644|NCT01191268|521370623|FG002|Overall Study|Death|3|||
144592645|NCT01191268|521370621|FG000|Overall Study|Protocol Violation|1|||
144384127|NCT00275821|520617998|FG001|Overall Study|Adverse Event|12|||
144384128|NCT00275821|520617999|FG002|Overall Study|Adverse Event|5|||
144384129|NCT00275821|520617997|FG000|Overall Study|Administrative problems|3|||
144384130|NCT00275821|520617998|FG001|Overall Study|Administrative problems|4|||
144384131|NCT00275821|520617999|FG002|Overall Study|Administrative problems|4|||
144384132|NCT00275821|520617997|FG000|Overall Study|Withdrawal by Subject|0|||
144384133|NCT00275821|520617998|FG001|Overall Study|Withdrawal by Subject|2|||
144384134|NCT00275821|520617999|FG002|Overall Study|Withdrawal by Subject|1|||
144384135|NCT00275821|520617997|FG000|Overall Study|Lost to Follow-up|0|||
144384136|NCT00275821|520617998|FG001|Overall Study|Lost to Follow-up|1|||
144384137|NCT00275821|520617999|FG002|Overall Study|Lost to Follow-up|1|||
144384138|NCT00275821|520617997|FG000|Overall Study|Death|0|||
144384139|NCT00275821|520617998|FG001|Overall Study|Death|2|||
144592646|NCT01191268|521370622|FG001|Overall Study|Protocol Violation|0|||
144592647|NCT01191268|521370623|FG002|Overall Study|Protocol Violation|1|||
144592648|NCT01191268|521370621|FG000|Overall Study|Sponsor Decision|0|||
144592649|NCT01191268|521370622|FG001|Overall Study|Sponsor Decision|2|||
144592650|NCT01191268|521370623|FG002|Overall Study|Sponsor Decision|0|||
144592651|NCT00336895|521370624|FG000|Overall Study|diarrhea|1|||
144592652|NCT00336895|521370624|FG000|Overall Study|nausea and upset stomach|1|||
144592653|NCT00336895|521370624|FG000|Overall Study|Physician Decision|1|||
144592654|NCT00336895|521370624|FG000|Overall Study|screen failed|1|||
144592655|NCT03333837|521370629|FG000|Overall Study|Adverse Event|2|||
144592656|NCT03333837|521370630|FG001|Overall Study|Adverse Event|1|||
144592657|NCT03333837|521370631|FG002|Overall Study|Adverse Event|1|||
144592658|NCT03333837|521370632|FG003|Overall Study|Adverse Event|1|||
144592659|NCT03333837|521370633|FG004|Overall Study|Adverse Event|0|||
144592660|NCT03333837|521370629|FG000|Overall Study|Caregiver withdrew|0|||
144592661|NCT03333837|521370630|FG001|Overall Study|Caregiver withdrew|2|||
144592662|NCT03333837|521370631|FG002|Overall Study|Caregiver withdrew|1|||
144592663|NCT03333837|521370632|FG003|Overall Study|Caregiver withdrew|0|||
144592664|NCT03333837|521370633|FG004|Overall Study|Caregiver withdrew|0|||
144592665|NCT03333837|521370629|FG000|Overall Study|Withdrawal by Subject|0|||
144592666|NCT03333837|521370630|FG001|Overall Study|Withdrawal by Subject|0|||
144592667|NCT03333837|521370631|FG002|Overall Study|Withdrawal by Subject|1|||
144592668|NCT03333837|521370632|FG003|Overall Study|Withdrawal by Subject|1|||
144592669|NCT03333837|521370633|FG004|Overall Study|Withdrawal by Subject|3|||
144592670|NCT03333837|521370629|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
144592671|NCT03333837|521370630|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
144592672|NCT03333837|521370631|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
144592673|NCT03333837|521370632|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
144592674|NCT03333837|521370633|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
144592675|NCT01013285|521370634|FG000|Overall Study|Death|48|||
144592676|NCT01013285|521370635|FG001|Overall Study|Death|89|||
144592677|NCT02112708|521370649|FG000|Baseline|Physician Decision|16|||
144592678|NCT02112708|521370650|FG001|Baseline|Physician Decision|11|||
144592679|NCT02112708|521370649|FG000|Baseline|Lost to Follow-up|12|||
144592680|NCT02112708|521370650|FG001|Baseline|Lost to Follow-up|0|||
144592681|NCT02112708|521370649|FG000|4 Month|Death|0|||
144592682|NCT02112708|521370650|FG001|4 Month|Death|1|||
144592683|NCT02112708|521370649|FG000|4 Month|Withdrawal by Subject|12|||
144592684|NCT02112708|521370650|FG001|4 Month|Withdrawal by Subject|0|||
144592685|NCT03866473|521370653|FG000|Phase 1|Death|1|||
144592686|NCT03866473|521370654|FG001|Phase 1|Death|0|||
144592687|NCT03866473|521370653|FG000|Phase 2|Death|0|||
144592688|NCT03866473|521370654|FG001|Phase 2|Death|2|||
144592689|NCT03866473|521370653|FG000|Phase 2|Dropped|1|||
144592690|NCT03866473|521370654|FG001|Phase 2|Dropped|1|||
144592691|NCT03866473|521370653|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
144592692|NCT03866473|521370654|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
144592693|NCT03110185|521370655|FG000|Overall Study|Death|0|||
144592694|NCT03110185|521370656|FG001|Overall Study|Death|1|||
144592695|NCT03110185|521370655|FG000|Overall Study|Withdrawal by Subject|2|||
144592696|NCT03110185|521370656|FG001|Overall Study|Withdrawal by Subject|7|||
144592697|NCT03110185|521370655|FG000|Overall Study|Time Constraints|0|||
144592698|NCT03110185|521370656|FG001|Overall Study|Time Constraints|6|||
144592699|NCT03110185|521370655|FG000|Overall Study|Conflict with care|5|||
144592700|NCT03110185|521370656|FG001|Overall Study|Conflict with care|12|||
144592701|NCT03110185|521370655|FG000|Overall Study|Protocol Violation|1|||
144592702|NCT03110185|521370656|FG001|Overall Study|Protocol Violation|4|||
144592703|NCT03110185|521370655|FG000|Overall Study|MRI Incompatible|2|||
144592704|NCT03110185|521370656|FG001|Overall Study|MRI Incompatible|0|||
144592705|NCT03110185|521370655|FG000|Overall Study|Patient Refusal|0|||
144592706|NCT03110185|521370656|FG001|Overall Study|Patient Refusal|1|||
144592707|NCT02641496|521370657|FG000|Overall Study|Lost to Follow-up|13|||
144592708|NCT02641496|521370658|FG001|Overall Study|Lost to Follow-up|12|||
144592709|NCT02641496|521370657|FG000|Overall Study|Withdrawal by Subject|1|||
144592710|NCT02641496|521370658|FG001|Overall Study|Withdrawal by Subject|0|||
144592711|NCT03075410|521370661|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
144592712|NCT03075410|521370662|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592713|NCT03075410|521370663|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
144592714|NCT03075410|521370664|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592715|NCT03075410|521370665|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592716|NCT03075410|521370666|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592717|NCT03075410|521370667|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592718|NCT03075410|521370668|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592719|NCT03075410|521370669|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
144592720|NCT03075410|521370661|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
144592721|NCT03075410|521370662|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144384140|NCT00275821|520617999|FG002|Overall Study|Death|1|||
144384141|NCT00275821|520617997|FG000|Overall Study|Lack of Efficacy|2|||
144384142|NCT00275821|520617998|FG001|Overall Study|Lack of Efficacy|1|||
144384143|NCT00275821|520617999|FG002|Overall Study|Lack of Efficacy|0|||
144384144|NCT00275821|520617997|FG000|Overall Study|Protocol Violation|5|||
144384145|NCT00275821|520617998|FG001|Overall Study|Protocol Violation|1|||
144384146|NCT00275821|520617999|FG002|Overall Study|Protocol Violation|0|||
144384147|NCT01185301|520618000|FG000|Overall Study|Adverse Event|3|||
144384148|NCT01185301|520618001|FG001|Overall Study|Adverse Event|0|||
144384149|NCT01185301|520618002|FG002|Overall Study|Adverse Event|2|||
144384150|NCT01185301|520618003|FG003|Overall Study|Adverse Event|3|||
144384151|NCT01185301|520618000|FG000|Overall Study|Withdrawal by Subject|7|||
144384152|NCT01185301|520618001|FG001|Overall Study|Withdrawal by Subject|5|||
144384153|NCT01185301|520618002|FG002|Overall Study|Withdrawal by Subject|2|||
144384154|NCT01185301|520618003|FG003|Overall Study|Withdrawal by Subject|3|||
144384155|NCT01185301|520618000|FG000|Overall Study|Lost to Follow-up|2|||
144384156|NCT01185301|520618001|FG001|Overall Study|Lost to Follow-up|0|||
144384157|NCT01185301|520618002|FG002|Overall Study|Lost to Follow-up|0|||
144384158|NCT01185301|520618003|FG003|Overall Study|Lost to Follow-up|1|||
144384159|NCT01185301|520618000|FG000|Overall Study|Other Reason|3|||
144384160|NCT01185301|520618001|FG001|Overall Study|Other Reason|2|||
144384161|NCT01185301|520618002|FG002|Overall Study|Other Reason|2|||
144384162|NCT01185301|520618003|FG003|Overall Study|Other Reason|2|||
144384163|NCT02095132|520618004|FG000|Overall Study|Adverse Event|0|||
144384164|NCT02095132|520618005|FG001|Overall Study|Adverse Event|0|||
144384165|NCT02095132|520618006|FG002|Overall Study|Adverse Event|0|||
144384166|NCT02095132|520618007|FG003|Overall Study|Adverse Event|0|||
144384167|NCT02095132|520618008|FG004|Overall Study|Adverse Event|1|||
144384168|NCT02095132|520618009|FG005|Overall Study|Adverse Event|0|||
144384169|NCT02095132|520618010|FG006|Overall Study|Adverse Event|1|||
144384170|NCT02095132|520618011|FG007|Overall Study|Adverse Event|0|||
144384171|NCT02095132|520618012|FG008|Overall Study|Adverse Event|0|||
144384172|NCT02095132|520618004|FG000|Overall Study|Death|0|||
144384173|NCT02095132|520618005|FG001|Overall Study|Death|0|||
144384174|NCT02095132|520618006|FG002|Overall Study|Death|0|||
144384175|NCT02095132|520618007|FG003|Overall Study|Death|0|||
144384176|NCT02095132|520618008|FG004|Overall Study|Death|0|||
144384177|NCT02095132|520618009|FG005|Overall Study|Death|0|||
144384178|NCT02095132|520618010|FG006|Overall Study|Death|1|||
144384179|NCT02095132|520618011|FG007|Overall Study|Death|0|||
144384180|NCT02095132|520618012|FG008|Overall Study|Death|0|||
144384181|NCT02095132|520618004|FG000|Overall Study|Lack of Efficacy|3|||
144384182|NCT02095132|520618005|FG001|Overall Study|Lack of Efficacy|5|||
144384183|NCT02095132|520618006|FG002|Overall Study|Lack of Efficacy|2|||
144384184|NCT02095132|520618007|FG003|Overall Study|Lack of Efficacy|8|||
144384185|NCT02095132|520618008|FG004|Overall Study|Lack of Efficacy|3|||
144384186|NCT02095132|520618009|FG005|Overall Study|Lack of Efficacy|6|||
144384187|NCT02095132|520618010|FG006|Overall Study|Lack of Efficacy|10|||
144384188|NCT02095132|520618011|FG007|Overall Study|Lack of Efficacy|9|||
144384189|NCT02095132|520618012|FG008|Overall Study|Lack of Efficacy|8|||
144384190|NCT02095132|520618004|FG000|Overall Study|Physician Decision|1|||
144384191|NCT02095132|520618005|FG001|Overall Study|Physician Decision|0|||
144384192|NCT02095132|520618006|FG002|Overall Study|Physician Decision|0|||
144384193|NCT02095132|520618007|FG003|Overall Study|Physician Decision|0|||
144384194|NCT02095132|520618008|FG004|Overall Study|Physician Decision|0|||
144514981|NCT01017146|521084037|FG000|Overall Study|Protocol Violation|2|||
144514982|NCT01017146|521084038|FG001|Overall Study|Protocol Violation|0|||
144514983|NCT01017146|521084037|FG000|Overall Study|Took Excluded Medication|2|||
144514984|NCT01017146|521084038|FG001|Overall Study|Took Excluded Medication|0|||
144384195|NCT02095132|520618009|FG005|Overall Study|Physician Decision|0|||
144384196|NCT02095132|520618010|FG006|Overall Study|Physician Decision|1|||
144384197|NCT02095132|520618011|FG007|Overall Study|Physician Decision|0|||
144384198|NCT02095132|520618012|FG008|Overall Study|Physician Decision|2|||
144384199|NCT02095132|520618004|FG000|Overall Study|Withdrawal by Subject|0|||
144384200|NCT02095132|520618005|FG001|Overall Study|Withdrawal by Subject|0|||
144384201|NCT02095132|520618006|FG002|Overall Study|Withdrawal by Subject|2|||
144384202|NCT02095132|520618007|FG003|Overall Study|Withdrawal by Subject|2|||
144384203|NCT02095132|520618008|FG004|Overall Study|Withdrawal by Subject|3|||
144384204|NCT02095132|520618009|FG005|Overall Study|Withdrawal by Subject|0|||
144384205|NCT02095132|520618010|FG006|Overall Study|Withdrawal by Subject|5|||
144384206|NCT02095132|520618011|FG007|Overall Study|Withdrawal by Subject|0|||
144384207|NCT02095132|520618012|FG008|Overall Study|Withdrawal by Subject|0|||
144384208|NCT00409175|520618013|FG000|Overall Study|Adverse Event|4|||
144384209|NCT00409175|520618014|FG001|Overall Study|Adverse Event|3|||
144384210|NCT00409175|520618013|FG000|Overall Study|Withdrawal by Subject|1|||
144514985|NCT01017146|521084037|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
144384211|NCT00409175|520618014|FG001|Overall Study|Withdrawal by Subject|2|||
144384212|NCT00409175|520618013|FG000|Overall Study|Negative genotype|0|||
144384213|NCT00409175|520618014|FG001|Overall Study|Negative genotype|1|||
144384214|NCT00409175|520618013|FG000|Overall Study|Liver transplantation|13|||
144384215|NCT00409175|520618014|FG001|Overall Study|Liver transplantation|13|||
144384216|NCT02108262|520618020|FG000|Overall Study|Non-compliance|0|||
144384217|NCT02108262|520618021|FG001|Overall Study|Non-compliance|2|||
144384218|NCT02108262|520618022|FG002|Overall Study|Non-compliance|1|||
144384219|NCT02108262|520618023|FG003|Overall Study|Non-compliance|1|||
144384220|NCT02108262|520618020|FG000|Overall Study|Randomized by error/screen failure|0|||
144384221|NCT02108262|520618021|FG001|Overall Study|Randomized by error/screen failure|0|||
144384222|NCT02108262|520618022|FG002|Overall Study|Randomized by error/screen failure|1|||
144384223|NCT02108262|520618023|FG003|Overall Study|Randomized by error/screen failure|0|||
144384224|NCT02108262|520618020|FG000|Overall Study|Distance to center|0|||
144384225|NCT02108262|520618021|FG001|Overall Study|Distance to center|1|||
144384226|NCT02108262|520618022|FG002|Overall Study|Distance to center|1|||
144384227|NCT02108262|520618023|FG003|Overall Study|Distance to center|0|||
144384228|NCT02108262|520618020|FG000|Overall Study|Adverse Event|0|||
144384229|NCT02108262|520618021|FG001|Overall Study|Adverse Event|11|||
144384230|NCT02108262|520618022|FG002|Overall Study|Adverse Event|6|||
144384231|NCT02108262|520618023|FG003|Overall Study|Adverse Event|12|||
144384232|NCT02108262|520618020|FG000|Overall Study|Death|0|||
144384233|NCT02108262|520618021|FG001|Overall Study|Death|2|||
144384234|NCT02108262|520618022|FG002|Overall Study|Death|2|||
144384235|NCT02108262|520618023|FG003|Overall Study|Death|1|||
144384236|NCT02108262|520618020|FG000|Overall Study|Lost to Follow-up|0|||
144384237|NCT02108262|520618021|FG001|Overall Study|Lost to Follow-up|0|||
144384238|NCT02108262|520618022|FG002|Overall Study|Lost to Follow-up|1|||
144384239|NCT02108262|520618023|FG003|Overall Study|Lost to Follow-up|0|||
144384240|NCT02108262|520618020|FG000|Overall Study|Physician Decision|0|||
144384241|NCT02108262|520618021|FG001|Overall Study|Physician Decision|0|||
144384242|NCT02108262|520618022|FG002|Overall Study|Physician Decision|2|||
144384243|NCT02108262|520618023|FG003|Overall Study|Physician Decision|0|||
144384244|NCT02108262|520618020|FG000|Overall Study|Withdrawal by Subject|0|||
144384245|NCT02108262|520618021|FG001|Overall Study|Withdrawal by Subject|7|||
144384246|NCT02108262|520618022|FG002|Overall Study|Withdrawal by Subject|3|||
144384247|NCT02108262|520618023|FG003|Overall Study|Withdrawal by Subject|4|||
144384248|NCT02108262|520618020|FG000|Overall Study|Due to key hepatic values|0|||
144384249|NCT02108262|520618021|FG001|Overall Study|Due to key hepatic values|1|||
144384250|NCT02108262|520618022|FG002|Overall Study|Due to key hepatic values|0|||
144384251|NCT02108262|520618023|FG003|Overall Study|Due to key hepatic values|0|||
144384252|NCT02108262|520618020|FG000|Overall Study|Unable to contact patient|0|||
144384253|NCT02108262|520618021|FG001|Overall Study|Unable to contact patient|3|||
144384254|NCT02108262|520618022|FG002|Overall Study|Unable to contact patient|1|||
144384255|NCT02108262|520618023|FG003|Overall Study|Unable to contact patient|2|||
144384256|NCT02108262|520618020|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
144384257|NCT02108262|520618021|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
144384258|NCT02108262|520618022|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
144384259|NCT02108262|520618023|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
144384260|NCT02108262|520618020|FG000|Overall Study|Patient did not want another infusion|0|||
144384261|NCT02108262|520618021|FG001|Overall Study|Patient did not want another infusion|3|||
144384262|NCT02108262|520618022|FG002|Overall Study|Patient did not want another infusion|3|||
144384263|NCT02108262|520618023|FG003|Overall Study|Patient did not want another infusion|2|||
144384264|NCT02108262|520618020|FG000|Overall Study|Vacation|0|||
144384265|NCT02108262|520618021|FG001|Overall Study|Vacation|1|||
144384266|NCT02108262|520618022|FG002|Overall Study|Vacation|0|||
144384267|NCT02108262|520618023|FG003|Overall Study|Vacation|0|||
144384268|NCT02108262|520618020|FG000|Overall Study|Patient decision|0|||
144384269|NCT02108262|520618021|FG001|Overall Study|Patient decision|7|||
144384270|NCT02108262|520618022|FG002|Overall Study|Patient decision|9|||
144384271|NCT02108262|520618023|FG003|Overall Study|Patient decision|14|||
144384272|NCT02108262|520618020|FG000|Overall Study|Missed IV due to pharmacy error|0|||
144384273|NCT02108262|520618021|FG001|Overall Study|Missed IV due to pharmacy error|0|||
144384274|NCT02108262|520618022|FG002|Overall Study|Missed IV due to pharmacy error|1|||
144384275|NCT02108262|520618023|FG003|Overall Study|Missed IV due to pharmacy error|0|||
144384276|NCT00393510|520618034|FG000|Overall Study|Physician Decision|3|||
144384277|NCT00393510|520618035|FG001|Overall Study|Physician Decision|9|||
144514986|NCT01017146|521084038|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
144514987|NCT01017146|521084037|FG000|Overall Study|Change in Work Situation|1|||
144514988|NCT01017146|521084038|FG001|Overall Study|Change in Work Situation|0|||
144514989|NCT01084707|521084039|FG000|Overall Study|Withdrawal by Subject|6|||
144514990|NCT01747486|521084040|FG000|Stage 1|Physician Decision|3|||
144514991|NCT01747486|521084041|FG001|Stage 1|Physician Decision|0|||
144514992|NCT01747486|521084040|FG000|Stage 1|Withdrawal by Subject|4|||
144514993|NCT01747486|521084041|FG001|Stage 1|Withdrawal by Subject|3|||
144514994|NCT01747486|521084040|FG000|Stage 1|Disease progression|4|||
144514995|NCT01747486|521084041|FG001|Stage 1|Disease progression|9|||
144514996|NCT01747486|521084040|FG000|Stage 1|Death|1|||
144514997|NCT01747486|521084041|FG001|Stage 1|Death|1|||
144514998|NCT01747486|521084040|FG000|Stage 2|Physician Decision|2|||
144514999|NCT01747486|521084041|FG001|Stage 2|Physician Decision|0|||
144515000|NCT01747486|521084040|FG000|Stage 2|Withdrawal by Subject|1|||
144515001|NCT01747486|521084041|FG001|Stage 2|Withdrawal by Subject|0|||
144515002|NCT01747486|521084040|FG000|Stage 2|New Cancer Therapy|3|||
144515003|NCT01747486|521084041|FG001|Stage 2|New Cancer Therapy|0|||
144515004|NCT01747486|521084040|FG000|Stage 2|Disease Progression|3|||
144515005|NCT01747486|521084041|FG001|Stage 2|Disease Progression|0|||
144515006|NCT00976495|521084045|FG000|Overall Study|Withdrawal by Subject|0|||
144515007|NCT00976495|521084046|FG001|Overall Study|Withdrawal by Subject|1|||
144515008|NCT00976495|521084047|FG002|Overall Study|Withdrawal by Subject|0|||
144515009|NCT02272816|521084048|FG000|Overall Study|Adverse Event|1|||
144515010|NCT04048382|521084052|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
144515011|NCT04048382|521084053|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
144515012|NCT04048382|521084052|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
144515013|NCT04048382|521084053|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
144515014|NCT04048382|521084052|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
144515015|NCT04048382|521084053|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
144515016|NCT03481816|521084054|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
144515017|NCT03481816|521084055|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
144515018|NCT03481816|521084054|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
144515019|NCT03481816|521084055|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
144515020|NCT03481816|521084054|FG000|Dose Expansion|Withdrawal by Subject|0|||
144515021|NCT03481816|521084055|FG001|Dose Expansion|Withdrawal by Subject|2|||
144515022|NCT03481816|521084054|FG000|Dose Expansion|Physician Decision|0|||
144515023|NCT03481816|521084055|FG001|Dose Expansion|Physician Decision|5|||
144515024|NCT02269475|521084056|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
144515025|NCT02269475|521084057|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
144515026|NCT02269475|521084056|FG000|Overall Study|Withdrawal by Subject|0|||
144515027|NCT02269475|521084057|FG001|Overall Study|Withdrawal by Subject|1|||
144515028|NCT04579380|521085791|FG000|Overall Study|Death|9|||
144515029|NCT04579380|521085792|FG001|Overall Study|Death|22|||
144515030|NCT04579380|521085793|FG002|Overall Study|Death|22|||
144515031|NCT04579380|521085794|FG003|Overall Study|Death|17|||
144515032|NCT04579380|521085795|FG004|Overall Study|Death|6|||
144384278|NCT01534182|520618039|FG000|Overall Study|Administrative problems|1|||
144515033|NCT04579380|521085796|FG005|Overall Study|Death|21|||
144515034|NCT04579380|521085797|FG006|Overall Study|Death|10|||
144515035|NCT04579380|521085798|FG007|Overall Study|Death|11|||
144515036|NCT04579380|521085799|FG008|Overall Study|Death|25|||
144515037|NCT04579380|521085791|FG000|Overall Study|Withdrawal by Subject|0|||
144515038|NCT04579380|521085792|FG001|Overall Study|Withdrawal by Subject|3|||
144515039|NCT04579380|521085793|FG002|Overall Study|Withdrawal by Subject|4|||
144515040|NCT04579380|521085794|FG003|Overall Study|Withdrawal by Subject|0|||
144515041|NCT04579380|521085795|FG004|Overall Study|Withdrawal by Subject|1|||
144515042|NCT04579380|521085796|FG005|Overall Study|Withdrawal by Subject|2|||
144515043|NCT04579380|521085797|FG006|Overall Study|Withdrawal by Subject|0|||
144515044|NCT04579380|521085798|FG007|Overall Study|Withdrawal by Subject|1|||
144515045|NCT04579380|521085799|FG008|Overall Study|Withdrawal by Subject|2|||
144515046|NCT04579380|521085791|FG000|Overall Study|Ongoing|2|||
144515047|NCT04579380|521085792|FG001|Overall Study|Ongoing|6|||
144515048|NCT04579380|521085793|FG002|Overall Study|Ongoing|4|||
144515049|NCT04579380|521085794|FG003|Overall Study|Ongoing|8|||
144515050|NCT04579380|521085795|FG004|Overall Study|Ongoing|5|||
144515051|NCT04579380|521085796|FG005|Overall Study|Ongoing|8|||
144515052|NCT04579380|521085797|FG006|Overall Study|Ongoing|3|||
144515053|NCT04579380|521085798|FG007|Overall Study|Ongoing|19|||
144515054|NCT04579380|521085799|FG008|Overall Study|Ongoing|6|||
144515055|NCT03821844|521085800|FG000|Overall Study|Death|37|||
144515056|NCT03821844|521085801|FG001|Overall Study|Death|31|||
144515057|NCT03821844|521085800|FG000|Overall Study|Discharged|10|||
144515058|NCT03821844|521085801|FG001|Overall Study|Discharged|14|||
144515059|NCT03821844|521085800|FG000|Overall Study|Not present in facility at followup|2|||
144515060|NCT03821844|521085801|FG001|Overall Study|Not present in facility at followup|3|||
144515061|NCT03913195|521085802|FG000|Overall Study|Adverse Event|0|||
144384279|NCT01534182|520618040|FG001|Overall Study|Administrative problems|0|||
144384280|NCT01534182|520618039|FG000|Overall Study|Withdrawal by Subject|4|||
144384281|NCT01534182|520618040|FG001|Overall Study|Withdrawal by Subject|7|||
144384282|NCT01534182|520618039|FG000|Overall Study|Adverse Event|7|||
144384283|NCT01534182|520618040|FG001|Overall Study|Adverse Event|3|||
144384284|NCT03077087|520618041|FG000|Overall Study|Physician Decision|2|||
144384285|NCT00770146|520618042|FG000|Treatment Period|Withdrawal by Subject|6|||
144384286|NCT00770146|520618043|FG001|Treatment Period|Withdrawal by Subject|13|||
144384287|NCT00770146|520618042|FG000|Treatment Period|Adverse Event|2|||
144384288|NCT00770146|520618043|FG001|Treatment Period|Adverse Event|26|||
144384289|NCT00770146|520618042|FG000|Treatment Period|Other|1|||
144384290|NCT00770146|520618043|FG001|Treatment Period|Other|5|||
144384291|NCT00770146|520618042|FG000|Treatment Period|Protocol non-compliance|0|||
144384292|NCT00770146|520618043|FG001|Treatment Period|Protocol non-compliance|1|||
144384293|NCT00770146|520618042|FG000|Follow-up Period|Withdrawal by Subject|7|||
144384294|NCT00770146|520618043|FG001|Follow-up Period|Withdrawal by Subject|13|||
144384295|NCT00770146|520618042|FG000|Follow-up Period|Adverse Event|0|||
144384296|NCT00770146|520618043|FG001|Follow-up Period|Adverse Event|2|||
144384297|NCT00770146|520618042|FG000|Follow-up Period|Other|4|||
144384298|NCT00770146|520618043|FG001|Follow-up Period|Other|5|||
144384299|NCT02412488|520618046|FG000|Overall Study|Lost to Follow-up|10|||
144384300|NCT02412488|520618046|FG000|Overall Study|Withdrawal by Subject|5|||
144384301|NCT02412488|520618046|FG000|Overall Study|Physician Decision|1|||
144384302|NCT02412488|520618046|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
144384303|NCT02412488|520618046|FG000|Overall Study|Reveal LINQ explant|1|||
144384304|NCT01989468|520618047|FG000|Overall Study|Adverse Event|10|||
144515062|NCT03913195|521085803|FG001|Overall Study|Adverse Event|0|||
144515063|NCT03913195|521085804|FG002|Overall Study|Adverse Event|1|||
144515064|NCT03913195|521085805|FG003|Overall Study|Adverse Event|1|||
144384305|NCT01989468|520618048|FG001|Overall Study|Adverse Event|15|||
144384306|NCT01989468|520618049|FG002|Overall Study|Adverse Event|4|||
144384307|NCT01989468|520618050|FG003|Overall Study|Adverse Event|5|||
144384308|NCT01989468|520618051|FG004|Overall Study|Adverse Event|4|||
144384309|NCT01989468|520618047|FG000|Overall Study|Lack of Efficacy|11|||
144384310|NCT01989468|520618048|FG001|Overall Study|Lack of Efficacy|11|||
144384311|NCT01989468|520618049|FG002|Overall Study|Lack of Efficacy|7|||
144384312|NCT01989468|520618050|FG003|Overall Study|Lack of Efficacy|4|||
144515065|NCT03913195|521085806|FG004|Overall Study|Adverse Event|0|||
144515066|NCT03913195|521085802|FG000|Overall Study|Withdrawal by Subject|0|||
144515067|NCT03913195|521085803|FG001|Overall Study|Withdrawal by Subject|0|||
144384313|NCT01989468|520618051|FG004|Overall Study|Lack of Efficacy|2|||
144592722|NCT03075410|521370663|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592723|NCT03075410|521370664|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592724|NCT03075410|521370665|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592725|NCT03075410|521370666|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592726|NCT03075410|521370667|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592727|NCT03075410|521370668|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592728|NCT03075410|521370669|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
144592729|NCT01427751|521370670|FG000|Overall Study|Adverse Event|18|||
144592730|NCT01427751|521370671|FG001|Overall Study|Adverse Event|2|||
144592731|NCT01427751|521370670|FG000|Overall Study|No further treatment benefit expected|5|||
144592732|NCT01427751|521370671|FG001|Overall Study|No further treatment benefit expected|1|||
144592733|NCT01427751|521370670|FG000|Overall Study|Lost to Follow-up|3|||
144592734|NCT01427751|521370671|FG001|Overall Study|Lost to Follow-up|1|||
144592735|NCT01427751|521370670|FG000|Overall Study|Withdrawal of consent|2|||
144592736|NCT01427751|521370671|FG001|Overall Study|Withdrawal of consent|2|||
144592737|NCT01427751|521370670|FG000|Overall Study|Protocol Violation|6|||
144592738|NCT01427751|521370671|FG001|Overall Study|Protocol Violation|4|||
144592739|NCT01427751|521370670|FG000|Overall Study|Death|2|||
144592740|NCT01427751|521370671|FG001|Overall Study|Death|0|||
144592741|NCT01427751|521370670|FG000|Overall Study|Other miscellaneous reasons|6|||
144592742|NCT01427751|521370671|FG001|Overall Study|Other miscellaneous reasons|4|||
144592743|NCT01028027|521370672|FG000|Overall Study|Lost to Follow-up|4|||
144592744|NCT01028027|521370673|FG001|Overall Study|Lost to Follow-up|1|||
144592745|NCT01028027|521370672|FG000|Overall Study|Withdrawal by Subject|5|||
144592746|NCT01028027|521370673|FG001|Overall Study|Withdrawal by Subject|3|||
144592747|NCT01028027|521370672|FG000|Overall Study|Adverse Event|4|||
144592748|NCT01028027|521370673|FG001|Overall Study|Adverse Event|7|||
144592749|NCT01028027|521370672|FG000|Overall Study|Protocol Violation|3|||
144592750|NCT01028027|521370673|FG001|Overall Study|Protocol Violation|1|||
144592751|NCT01028027|521370672|FG000|Overall Study|Lack of Efficacy|0|||
144592752|NCT01028027|521370673|FG001|Overall Study|Lack of Efficacy|1|||
144592753|NCT04976621|521370675|FG000|Overall Study|Lost to Follow-up|2|||
144592754|NCT04976621|521370676|FG001|Overall Study|Lost to Follow-up|2|||
144592755|NCT04976621|521370675|FG000|Overall Study|Withdrawal by Subject|1|||
144592756|NCT04976621|521370676|FG001|Overall Study|Withdrawal by Subject|1|||
144592757|NCT05330312|521370681|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
144592758|NCT05330312|521370682|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
144592759|NCT05330312|521370683|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
144592760|NCT05330312|521370681|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
144592761|NCT05330312|521370682|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
144592762|NCT05330312|521370683|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
144592763|NCT05330312|521370681|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
144592764|NCT05330312|521370682|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
144592765|NCT05330312|521370683|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
144592766|NCT05330312|521370681|FG000|Pivotal Investigation - Part 2|Death|1|||
144592767|NCT05330312|521370682|FG001|Pivotal Investigation - Part 2|Death|4|||
144592768|NCT05330312|521370683|FG002|Pivotal Investigation - Part 2|Death|0|||
144592769|NCT03519971|521370684|FG000|Overall Study|Death|142|||
144592770|NCT03519971|521370685|FG001|Overall Study|Death|69|||
144592771|NCT03519971|521370684|FG000|Overall Study|Lost to Follow-up|0|||
144592772|NCT03519971|521370685|FG001|Overall Study|Lost to Follow-up|1|||
144592773|NCT03519971|521370684|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
144592774|NCT03519971|521370685|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
144592775|NCT03519971|521370684|FG000|Overall Study|Withdrawal by Subject|3|||
144592776|NCT03519971|521370685|FG001|Overall Study|Withdrawal by Subject|2|||
144592777|NCT03519971|521370684|FG000|Overall Study|Other|1|||
144592778|NCT03519971|521370685|FG001|Overall Study|Other|0|||
144592779|NCT02572843|521370686|FG000|Accrual|Brain metastasis retrospectively detected|1|||
144592780|NCT02572843|521370686|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
144592781|NCT02572843|521370686|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
144592782|NCT02572843|521370686|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
144592783|NCT02572843|521370686|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
144592784|NCT02572843|521370686|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
144592785|NCT02572843|521370686|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
144592786|NCT02572843|521370686|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
144384314|NCT01989468|520618047|FG000|Overall Study|Lost to Follow-up|5|||
144384315|NCT01989468|520618048|FG001|Overall Study|Lost to Follow-up|2|||
144384316|NCT01989468|520618049|FG002|Overall Study|Lost to Follow-up|0|||
144384317|NCT01989468|520618050|FG003|Overall Study|Lost to Follow-up|1|||
144384318|NCT01989468|520618051|FG004|Overall Study|Lost to Follow-up|1|||
144384319|NCT01989468|520618047|FG000|Overall Study|Physician Decision|4|||
144384320|NCT01989468|520618048|FG001|Overall Study|Physician Decision|1|||
144384321|NCT01989468|520618049|FG002|Overall Study|Physician Decision|0|||
144384322|NCT01989468|520618050|FG003|Overall Study|Physician Decision|1|||
144384323|NCT01989468|520618051|FG004|Overall Study|Physician Decision|0|||
144384324|NCT01989468|520618047|FG000|Overall Study|Pregnancy|0|||
144384325|NCT01989468|520618048|FG001|Overall Study|Pregnancy|1|||
144384326|NCT01989468|520618049|FG002|Overall Study|Pregnancy|0|||
144384327|NCT01989468|520618050|FG003|Overall Study|Pregnancy|0|||
144384328|NCT01989468|520618051|FG004|Overall Study|Pregnancy|0|||
144515068|NCT03913195|521085804|FG002|Overall Study|Withdrawal by Subject|1|||
144515069|NCT03913195|521085805|FG003|Overall Study|Withdrawal by Subject|0|||
144515070|NCT03913195|521085806|FG004|Overall Study|Withdrawal by Subject|1|||
144515071|NCT03913195|521085802|FG000|Overall Study|non adherence to study|0|||
144515072|NCT03913195|521085803|FG001|Overall Study|non adherence to study|0|||
144515073|NCT03913195|521085804|FG002|Overall Study|non adherence to study|1|||
144515074|NCT03913195|521085805|FG003|Overall Study|non adherence to study|0|||
144515075|NCT03913195|521085806|FG004|Overall Study|non adherence to study|0|||
144515076|NCT03517553|521085809|FG000|Overall Study|Withdrawal by Subject|2|||
144515077|NCT05215847|521085810|FG000|Overall Study|Lost to Follow-up|1|||
144515078|NCT04143061|521085811|FG000|Overall Study|Protocol Deviation|0|||
144515079|NCT04143061|521085812|FG001|Overall Study|Protocol Deviation|0|||
144515080|NCT04143061|521085813|FG002|Overall Study|Protocol Deviation|0|||
144515081|NCT04143061|521085814|FG003|Overall Study|Protocol Deviation|0|||
144515082|NCT04143061|521085815|FG004|Overall Study|Protocol Deviation|0|||
144515083|NCT04143061|521085816|FG005|Overall Study|Protocol Deviation|0|||
144515084|NCT04143061|521085817|FG006|Overall Study|Protocol Deviation|5|||
144515085|NCT04143061|521085818|FG007|Overall Study|Protocol Deviation|5|||
144515086|NCT04143061|521085811|FG000|Overall Study|Withdrawal by Subject|2|||
144515087|NCT04143061|521085812|FG001|Overall Study|Withdrawal by Subject|0|||
144515088|NCT04143061|521085813|FG002|Overall Study|Withdrawal by Subject|0|||
144515089|NCT04143061|521085814|FG003|Overall Study|Withdrawal by Subject|0|||
144515090|NCT04143061|521085815|FG004|Overall Study|Withdrawal by Subject|0|||
144515091|NCT04143061|521085816|FG005|Overall Study|Withdrawal by Subject|1|||
144515092|NCT04143061|521085817|FG006|Overall Study|Withdrawal by Subject|0|||
144515093|NCT04143061|521085818|FG007|Overall Study|Withdrawal by Subject|0|||
144515094|NCT04143061|521085811|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144515095|NCT04143061|521085812|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144515096|NCT04143061|521085813|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144515097|NCT04143061|521085814|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144515098|NCT04143061|521085815|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
144515099|NCT04143061|521085816|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
144515100|NCT04143061|521085817|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
144515101|NCT04143061|521085818|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
144515102|NCT03602014|521085828|FG000|Overall Study|Lost to Follow-up|2|||
144515103|NCT03602014|521085829|FG001|Overall Study|Lost to Follow-up|0|||
144515104|NCT03602014|521085830|FG002|Overall Study|Lost to Follow-up|0|||
144515105|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
144515106|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
144515107|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
144515108|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
144515109|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
144515110|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
144515111|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
144515112|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
144515113|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
144515114|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
144515115|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
144515116|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
144515117|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
144515118|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
144515119|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
144515120|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
144515121|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
144515122|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
144515123|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
144515124|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
144515125|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
144515126|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
144515127|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
144515128|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
144515129|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
144515130|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
144515131|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
144384329|NCT01989468|520618047|FG000|Overall Study|Technical Problems|3|||
144384330|NCT01989468|520618048|FG001|Overall Study|Technical Problems|1|||
144384331|NCT01989468|520618049|FG002|Overall Study|Technical Problems|3|||
144384332|NCT01989468|520618050|FG003|Overall Study|Technical Problems|1|||
144384333|NCT01989468|520618051|FG004|Overall Study|Technical Problems|0|||
144384334|NCT01989468|520618047|FG000|Overall Study|Subject Guardian Decision|11|||
144384335|NCT01989468|520618048|FG001|Overall Study|Subject Guardian Decision|6|||
144384336|NCT01989468|520618049|FG002|Overall Study|Subject Guardian Decision|4|||
144384337|NCT01989468|520618050|FG003|Overall Study|Subject Guardian Decision|4|||
144384338|NCT01989468|520618051|FG004|Overall Study|Subject Guardian Decision|1|||
144384339|NCT01989468|520618047|FG000|Overall Study|Death|3|||
144384340|NCT01989468|520618048|FG001|Overall Study|Death|0|||
144384341|NCT01989468|520618049|FG002|Overall Study|Death|1|||
144384342|NCT01989468|520618050|FG003|Overall Study|Death|0|||
144384343|NCT01989468|520618051|FG004|Overall Study|Death|0|||
144384344|NCT00674154|520618055|FG000|Overall Study|Withdrawal by Subject|3|||
144384345|NCT00674154|520618056|FG001|Overall Study|Withdrawal by Subject|1|||
144384346|NCT00674154|520618055|FG000|Overall Study|Did not want parathyroidectomy|0|||
144384347|NCT00674154|520618056|FG001|Overall Study|Did not want parathyroidectomy|2|||
144384348|NCT03222492|520618057|FG000|Overall Study|Withdrawal by Subject|0|||
144384349|NCT03222492|520618058|FG001|Overall Study|Withdrawal by Subject|0|||
144384350|NCT03222492|520618059|FG002|Overall Study|Withdrawal by Subject|1|||
144384351|NCT03222492|520618060|FG003|Overall Study|Withdrawal by Subject|0|||
144384352|NCT03222492|520618057|FG000|Overall Study|COVID-19 related|0|||
144384353|NCT03222492|520618058|FG001|Overall Study|COVID-19 related|0|||
144384354|NCT03222492|520618059|FG002|Overall Study|COVID-19 related|1|||
144384355|NCT03222492|520618060|FG003|Overall Study|COVID-19 related|0|||
144384356|NCT00816023|520618061|FG000|Overall Study|Lost to Follow-up|1|||
144384357|NCT00816023|520618062|FG001|Overall Study|Lost to Follow-up|1|||
144384358|NCT00816023|520618063|FG002|Overall Study|Lost to Follow-up|0|||
144384359|NCT00816023|520618064|FG003|Overall Study|Lost to Follow-up|0|||
144384360|NCT00816023|520618061|FG000|Overall Study|Withdrawal by Subject|1|||
144384361|NCT00816023|520618062|FG001|Overall Study|Withdrawal by Subject|0|||
144384362|NCT00816023|520618063|FG002|Overall Study|Withdrawal by Subject|0|||
144384363|NCT00816023|520618064|FG003|Overall Study|Withdrawal by Subject|0|||
144384364|NCT00816023|520618061|FG000|Overall Study|Physician Decision|0|||
144384365|NCT00816023|520618062|FG001|Overall Study|Physician Decision|0|||
144384366|NCT00816023|520618063|FG002|Overall Study|Physician Decision|1|||
144384367|NCT00816023|520618064|FG003|Overall Study|Physician Decision|0|||
144384368|NCT00816023|520618061|FG000|Overall Study|assessments complete prior to window|1|||
144384369|NCT00816023|520618062|FG001|Overall Study|assessments complete prior to window|1|||
144384370|NCT00816023|520618063|FG002|Overall Study|assessments complete prior to window|2|||
144384371|NCT00816023|520618064|FG003|Overall Study|assessments complete prior to window|1|||
144384372|NCT00816023|520618061|FG000|Overall Study|Randomized Not Treated|6|||
144384373|NCT00816023|520618062|FG001|Overall Study|Randomized Not Treated|4|||
144384374|NCT00816023|520618063|FG002|Overall Study|Randomized Not Treated|6|||
144384375|NCT00816023|520618064|FG003|Overall Study|Randomized Not Treated|11|||
144384376|NCT01525901|520618065|FG000|Period 2: 12 Weeks|Adverse Event|0|||
144384377|NCT01525901|520618066|FG001|Period 2: 12 Weeks|Adverse Event|1|||
144384378|NCT01525901|520618067|FG002|Period 2: 12 Weeks|Adverse Event|0|||
144384379|NCT01525901|520618068|FG003|Period 2: 12 Weeks|Adverse Event|0|||
144384380|NCT04449029|520618072|FG000|Overall Study|Adverse Event|0|||
144384381|NCT04449029|520618073|FG001|Overall Study|Adverse Event|1|||
144384382|NCT04449029|520618074|FG002|Overall Study|Adverse Event|1|||
144384383|NCT04449029|520618075|FG003|Overall Study|Adverse Event|0|||
144384384|NCT04449029|520618076|FG004|Overall Study|Adverse Event|1|||
144384385|NCT04449029|520618077|FG005|Overall Study|Adverse Event|0|||
144384386|NCT04449029|520618078|FG006|Overall Study|Adverse Event|1|||
144384387|NCT04449029|520618079|FG007|Overall Study|Adverse Event|0|||
144384388|NCT04449029|520618072|FG000|Overall Study|Lost to Follow-up|0|||
144384389|NCT04449029|520618073|FG001|Overall Study|Lost to Follow-up|1|||
144384390|NCT04449029|520618074|FG002|Overall Study|Lost to Follow-up|0|||
144384391|NCT04449029|520618075|FG003|Overall Study|Lost to Follow-up|0|||
144515132|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
144515133|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
144515134|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
144592787|NCT02572843|521370686|FG000|Surgery|lost to follow up|7|||
144384392|NCT04449029|520618076|FG004|Overall Study|Lost to Follow-up|0|||
144384393|NCT04449029|520618077|FG005|Overall Study|Lost to Follow-up|0|||
144384394|NCT04449029|520618078|FG006|Overall Study|Lost to Follow-up|0|||
144384395|NCT04449029|520618079|FG007|Overall Study|Lost to Follow-up|0|||
144384396|NCT04449029|520618072|FG000|Overall Study|Protocol Violation|0|||
144384397|NCT04449029|520618073|FG001|Overall Study|Protocol Violation|1|||
144384398|NCT04449029|520618074|FG002|Overall Study|Protocol Violation|0|||
144384399|NCT04449029|520618075|FG003|Overall Study|Protocol Violation|0|||
144384400|NCT04449029|520618076|FG004|Overall Study|Protocol Violation|0|||
144384401|NCT04449029|520618077|FG005|Overall Study|Protocol Violation|0|||
144384402|NCT04449029|520618078|FG006|Overall Study|Protocol Violation|0|||
144384403|NCT04449029|520618079|FG007|Overall Study|Protocol Violation|0|||
144384404|NCT04449029|520618072|FG000|Overall Study|Physician Decision|0|||
144384405|NCT04449029|520618073|FG001|Overall Study|Physician Decision|0|||
144384406|NCT04449029|520618074|FG002|Overall Study|Physician Decision|0|||
144384407|NCT04449029|520618075|FG003|Overall Study|Physician Decision|0|||
144384408|NCT04449029|520618076|FG004|Overall Study|Physician Decision|0|||
144384409|NCT04449029|520618077|FG005|Overall Study|Physician Decision|1|||
144384410|NCT04449029|520618078|FG006|Overall Study|Physician Decision|0|||
144384411|NCT04449029|520618079|FG007|Overall Study|Physician Decision|0|||
144384412|NCT04449029|520618072|FG000|Overall Study|Withdrawal by Subject|3|||
144384413|NCT04449029|520618073|FG001|Overall Study|Withdrawal by Subject|0|||
144384414|NCT04449029|520618074|FG002|Overall Study|Withdrawal by Subject|1|||
144384415|NCT04449029|520618075|FG003|Overall Study|Withdrawal by Subject|1|||
144384416|NCT04449029|520618076|FG004|Overall Study|Withdrawal by Subject|5|||
144384417|NCT04449029|520618077|FG005|Overall Study|Withdrawal by Subject|1|||
144384418|NCT04449029|520618078|FG006|Overall Study|Withdrawal by Subject|4|||
144384419|NCT04449029|520618079|FG007|Overall Study|Withdrawal by Subject|0|||
144384420|NCT05027971|520618084|FG000|Overall Study|Physician Decision|7|||
144384421|NCT05027971|520618085|FG001|Overall Study|Physician Decision|3|||
144384422|NCT05027971|520618084|FG000|Overall Study|Lost to Follow-up|1|||
144384423|NCT05027971|520618085|FG001|Overall Study|Lost to Follow-up|1|||
144384424|NCT05027971|520618084|FG000|Overall Study|Withdrawal by Subject|0|||
144384425|NCT05027971|520618085|FG001|Overall Study|Withdrawal by Subject|2|||
144384426|NCT05027971|520618084|FG000|Overall Study|Non-study fiber used.|0|||
144384427|NCT05027971|520618085|FG001|Overall Study|Non-study fiber used.|1|||
144384428|NCT05027971|520618084|FG000|Overall Study|Protocol Violation|0|||
144384429|NCT05027971|520618085|FG001|Overall Study|Protocol Violation|2|||
144384430|NCT02025556|520618086|FG000|Overall Study|Adverse Event|0|||
144384431|NCT02025556|520618087|FG001|Overall Study|Adverse Event|4|||
144384432|NCT02025556|520618088|FG002|Overall Study|Adverse Event|2|||
144384433|NCT02025556|520618086|FG000|Overall Study|Lack of Efficacy|2|||
144384434|NCT02025556|520618087|FG001|Overall Study|Lack of Efficacy|1|||
144384435|NCT02025556|520618088|FG002|Overall Study|Lack of Efficacy|0|||
144384436|NCT02025556|520618086|FG000|Overall Study|Protocol Violation|2|||
144384437|NCT02025556|520618087|FG001|Overall Study|Protocol Violation|1|||
144384438|NCT02025556|520618088|FG002|Overall Study|Protocol Violation|0|||
144384439|NCT02025556|520618086|FG000|Overall Study|Withdrawal by Subject|0|||
144384440|NCT02025556|520618087|FG001|Overall Study|Withdrawal by Subject|3|||
144384441|NCT02025556|520618088|FG002|Overall Study|Withdrawal by Subject|6|||
144384442|NCT02025556|520618086|FG000|Overall Study|Lost to Follow-up|2|||
144384443|NCT02025556|520618087|FG001|Overall Study|Lost to Follow-up|4|||
144384444|NCT02025556|520618088|FG002|Overall Study|Lost to Follow-up|0|||
144384445|NCT02025556|520618086|FG000|Overall Study|Reason not reported|0|||
144384446|NCT02025556|520618087|FG001|Overall Study|Reason not reported|0|||
144384447|NCT02025556|520618088|FG002|Overall Study|Reason not reported|1|||
144384448|NCT02486627|520618089|FG000|Overall Study|Death|1|||
144384449|NCT02486627|520618090|FG001|Overall Study|Death|0|||
144384450|NCT02486627|520618089|FG000|Overall Study|Other Unspecified|0|||
144384451|NCT02486627|520618090|FG001|Overall Study|Other Unspecified|2|||
144384452|NCT02486627|520618089|FG000|Overall Study|Consent Withdrawn by Participant|4|||
144384453|NCT02486627|520618090|FG001|Overall Study|Consent Withdrawn by Participant|3|||
144384454|NCT02486627|520618089|FG000|Overall Study|Significant Participant Noncompliance|1|||
144384455|NCT02486627|520618090|FG001|Overall Study|Significant Participant Noncompliance|1|||
144384456|NCT02486627|520618089|FG000|Overall Study|Lost to Follow-up|1|||
144384457|NCT02486627|520618090|FG001|Overall Study|Lost to Follow-up|3|||
144384458|NCT02112045|520618094|FG000|Overall Study|Withdrawal by Subject|1|||
144384459|NCT02112045|520618095|FG001|Overall Study|Withdrawal by Subject|0|||
144384460|NCT00627445|520618096|FG000|Overall Study|Adverse Event|3|||
144384461|NCT00627445|520618097|FG001|Overall Study|Adverse Event|3|||
144384462|NCT00627445|520618096|FG000|Overall Study|Lack of Efficacy|0|||
144384463|NCT00627445|520618097|FG001|Overall Study|Lack of Efficacy|1|||
144384464|NCT00627445|520618096|FG000|Overall Study|Other|6|||
144384465|NCT00627445|520618097|FG001|Overall Study|Other|8|||
144384466|NCT01238588|520618104|FG000|Overall Study|Withdrawal by Subject|1|||
144384467|NCT01238588|520618104|FG000|Overall Study|Physician Decision|2|||
144384468|NCT00247611|520618105|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
144384469|NCT00247611|520618106|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
144515135|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
144515136|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
144515137|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
144384470|NCT00247611|520618105|FG000|Baselined|Completed baseline only|9|||
144384471|NCT00247611|520618106|FG001|Baselined|Completed baseline only|8|||
144384472|NCT05395091|520618107|FG000|Baseline to Month 12|Adverse Event|7|||
144515138|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
144384473|NCT05395091|520618108|FG001|Baseline to Month 12|Adverse Event|2|||
144384474|NCT05395091|520618109|FG002|Baseline to Month 12|Adverse Event|0|||
144384475|NCT05395091|520618107|FG000|Baseline to Month 12|Death|3|||
144384476|NCT05395091|520618108|FG001|Baseline to Month 12|Death|1|||
144384477|NCT05395091|520618109|FG002|Baseline to Month 12|Death|0|||
144384478|NCT05395091|520618107|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
144384479|NCT05395091|520618108|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
144384480|NCT05395091|520618109|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
144384481|NCT05395091|520618107|FG000|Baseline to Month 12|Protocol Violation|2|||
144384482|NCT05395091|520618108|FG001|Baseline to Month 12|Protocol Violation|3|||
144384483|NCT05395091|520618109|FG002|Baseline to Month 12|Protocol Violation|0|||
144384484|NCT05395091|520618107|FG000|Baseline to Month 12|Physician Decision|1|||
144384485|NCT05395091|520618108|FG001|Baseline to Month 12|Physician Decision|0|||
144384486|NCT05395091|520618109|FG002|Baseline to Month 12|Physician Decision|0|||
144384487|NCT05395091|520618107|FG000|Month 12 to Month 18|Death|1|||
144384488|NCT05395091|520618108|FG001|Month 12 to Month 18|Death|0|||
144384489|NCT05395091|520618109|FG002|Month 12 to Month 18|Death|0|||
144384490|NCT05395091|520618107|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
144384491|NCT05395091|520618108|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
144384492|NCT05395091|520618109|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
144384493|NCT05395091|520618107|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
144384494|NCT05395091|520618108|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
144384495|NCT05395091|520618109|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
144384496|NCT05395091|520618107|FG000|Month 12 to Month 18|Other reasons|0|||
144384497|NCT05395091|520618108|FG001|Month 12 to Month 18|Other reasons|0|||
144384498|NCT05395091|520618109|FG002|Month 12 to Month 18|Other reasons|1|||
144384499|NCT01509053|520618111|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
144384500|NCT01509053|520618111|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
144384501|NCT01509053|520618111|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
144384502|NCT01509053|520618111|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
144384503|NCT01509053|520618111|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
144384504|NCT01509053|520618111|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
144384505|NCT01915303|520618114|FG000|Core Phase|Adverse Event|7|||
144384506|NCT01915303|520618114|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
144384507|NCT01915303|520618114|FG000|Core Phase|Death|2|||
144384508|NCT01915303|520618114|FG000|Core Phase|Protocol Violation|2|||
144384509|NCT01915303|520618114|FG000|Core Phase|Abnormal lab value|1|||
144384510|NCT01915303|520618114|FG000|Core Phase|Withdrawal by Subject|1|||
144384511|NCT01915303|520618114|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
144384512|NCT01915303|520618114|FG000|Extension Phase|Withdrawal by Subject|4|||
144384513|NCT01915303|520618114|FG000|Extension Phase|Adverse Event|3|||
144384514|NCT01915303|520618114|FG000|Extension Phase|Death|1|||
144384515|NCT01915303|520618114|FG000|Extension Phase|Protocol Violation|1|||
144384516|NCT00796991|520618121|FG000|Overall Study|Adverse Event|0|||
144384517|NCT00796991|520618122|FG001|Overall Study|Adverse Event|0|||
144384518|NCT00796991|520618123|FG002|Overall Study|Adverse Event|1|||
144384519|NCT00796991|520618121|FG000|Overall Study|Death|2|||
144384520|NCT00796991|520618122|FG001|Overall Study|Death|0|||
144384521|NCT00796991|520618123|FG002|Overall Study|Death|0|||
144384522|NCT00796991|520618121|FG000|Overall Study|Disease Progression|10|||
144384523|NCT00796991|520618122|FG001|Overall Study|Disease Progression|9|||
144515139|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
144515140|NCT01898494|521085831|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
144199314|NCT00541970|519928866|FG000|Month 48|Lost to Follow-up|66|||
144384524|NCT00796991|520618123|FG002|Overall Study|Disease Progression|7|||
144515141|NCT01898494|521085832|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
144515142|NCT01898494|521085833|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
144515143|NCT01898494|521085834|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
144515144|NCT01898494|521085835|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
144515145|NCT01898494|521085831|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
144515146|NCT01898494|521085832|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
144515147|NCT01898494|521085833|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
144515148|NCT01898494|521085834|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
144515149|NCT01898494|521085835|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
144515150|NCT01898494|521085831|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
144384525|NCT00796991|520618121|FG000|Overall Study|Study Drug Toxicity|3|||
144384526|NCT00796991|520618122|FG001|Overall Study|Study Drug Toxicity|3|||
144384527|NCT00796991|520618123|FG002|Overall Study|Study Drug Toxicity|5|||
144384528|NCT00796991|520618121|FG000|Overall Study|Withdrawal by Subject|0|||
144384529|NCT00796991|520618122|FG001|Overall Study|Withdrawal by Subject|0|||
144592788|NCT02572843|521370686|FG000|Surgery|Death|1|||
144384530|NCT00796991|520618123|FG002|Overall Study|Withdrawal by Subject|1|||
144721948|NCT01829464|521836891|FG002|Overall Study|Lost to Follow-up|1|||
144384531|NCT00171834|520618125|FG000|Overall Study|Adverse Event|2|||
144384532|NCT00171834|520618126|FG001|Overall Study|Adverse Event|1|||
144384533|NCT00171834|520618127|FG002|Overall Study|Adverse Event|3|||
144384534|NCT00171834|520618128|FG003|Overall Study|Adverse Event|2|||
144384535|NCT00171834|520618129|FG004|Overall Study|Adverse Event|2|||
144384536|NCT00171834|520618130|FG005|Overall Study|Adverse Event|15|||
144384537|NCT00171834|520618131|FG006|Overall Study|Adverse Event|1|||
144384538|NCT00171834|520618125|FG000|Overall Study|Withdrawal by Subject|0|||
144384539|NCT00171834|520618126|FG001|Overall Study|Withdrawal by Subject|2|||
144384540|NCT00171834|520618127|FG002|Overall Study|Withdrawal by Subject|0|||
144384541|NCT00171834|520618128|FG003|Overall Study|Withdrawal by Subject|1|||
144384542|NCT00171834|520618129|FG004|Overall Study|Withdrawal by Subject|1|||
144384543|NCT00171834|520618130|FG005|Overall Study|Withdrawal by Subject|1|||
144384544|NCT00171834|520618131|FG006|Overall Study|Withdrawal by Subject|0|||
144384545|NCT00171834|520618125|FG000|Overall Study|Death from study indication|0|||
144384546|NCT00171834|520618126|FG001|Overall Study|Death from study indication|1|||
144384547|NCT00171834|520618127|FG002|Overall Study|Death from study indication|0|||
144384548|NCT00171834|520618128|FG003|Overall Study|Death from study indication|0|||
144384549|NCT00171834|520618129|FG004|Overall Study|Death from study indication|1|||
144384550|NCT00171834|520618130|FG005|Overall Study|Death from study indication|0|||
144384551|NCT00171834|520618131|FG006|Overall Study|Death from study indication|0|||
144384552|NCT00171834|520618125|FG000|Overall Study|Disease Progression|4|||
144384553|NCT00171834|520618126|FG001|Overall Study|Disease Progression|8|||
144384554|NCT00171834|520618127|FG002|Overall Study|Disease Progression|8|||
144384555|NCT00171834|520618128|FG003|Overall Study|Disease Progression|9|||
144384556|NCT00171834|520618129|FG004|Overall Study|Disease Progression|2|||
144384557|NCT00171834|520618130|FG005|Overall Study|Disease Progression|18|||
144384558|NCT00171834|520618131|FG006|Overall Study|Disease Progression|3|||
144384559|NCT00171834|520618125|FG000|Overall Study|Treatment Duration Completed|0|||
144384560|NCT00171834|520618126|FG001|Overall Study|Treatment Duration Completed|0|||
144384561|NCT00171834|520618127|FG002|Overall Study|Treatment Duration Completed|1|||
144384562|NCT00171834|520618128|FG003|Overall Study|Treatment Duration Completed|0|||
144384563|NCT00171834|520618129|FG004|Overall Study|Treatment Duration Completed|2|||
144384564|NCT00171834|520618130|FG005|Overall Study|Treatment Duration Completed|1|||
144384565|NCT00171834|520618131|FG006|Overall Study|Treatment Duration Completed|0|||
144384566|NCT02431260|520618132|FG000|Overall Study|Subject Decision|0|||
144384567|NCT02431260|520618133|FG001|Overall Study|Subject Decision|1|||
144384568|NCT02431260|520618134|FG002|Overall Study|Subject Decision|1|||
144384569|NCT02431260|520618135|FG003|Overall Study|Subject Decision|0|||
144384570|NCT02431260|520618136|FG004|Overall Study|Subject Decision|0|||
144384571|NCT02431260|520618137|FG005|Overall Study|Subject Decision|0|||
144384572|NCT02431260|520618138|FG006|Overall Study|Subject Decision|0|||
144384573|NCT02431260|520618139|FG007|Overall Study|Subject Decision|0|||
144384574|NCT02431260|520618140|FG008|Overall Study|Subject Decision|1|||
144384575|NCT02431260|520618141|FG009|Overall Study|Subject Decision|1|||
144384576|NCT02431260|520618142|FG010|Overall Study|Subject Decision|0|||
144384577|NCT02431260|520618143|FG011|Overall Study|Subject Decision|1|||
144384578|NCT02431260|520618144|FG012|Overall Study|Subject Decision|0|||
144384579|NCT02431260|520618145|FG013|Overall Study|Subject Decision|0|||
144384580|NCT02431260|520618132|FG000|Overall Study|Death|4|||
144384581|NCT02431260|520618133|FG001|Overall Study|Death|4|||
144384582|NCT02431260|520618134|FG002|Overall Study|Death|3|||
144384583|NCT02431260|520618135|FG003|Overall Study|Death|4|||
144384584|NCT02431260|520618136|FG004|Overall Study|Death|2|||
144384585|NCT02431260|520618137|FG005|Overall Study|Death|2|||
144384586|NCT02431260|520618138|FG006|Overall Study|Death|3|||
144384587|NCT02431260|520618139|FG007|Overall Study|Death|1|||
144384588|NCT02431260|520618140|FG008|Overall Study|Death|6|||
144384589|NCT02431260|520618141|FG009|Overall Study|Death|6|||
144384590|NCT02431260|520618142|FG010|Overall Study|Death|3|||
144384591|NCT02431260|520618143|FG011|Overall Study|Death|2|||
144384592|NCT02431260|520618144|FG012|Overall Study|Death|5|||
144384593|NCT02431260|520618145|FG013|Overall Study|Death|1|||
144384594|NCT02431260|520618132|FG000|Overall Study|Lost to Follow-up|0|||
144384595|NCT02431260|520618133|FG001|Overall Study|Lost to Follow-up|0|||
144384596|NCT02431260|520618134|FG002|Overall Study|Lost to Follow-up|0|||
144384597|NCT02431260|520618135|FG003|Overall Study|Lost to Follow-up|0|||
144384598|NCT02431260|520618136|FG004|Overall Study|Lost to Follow-up|0|||
144384599|NCT02431260|520618137|FG005|Overall Study|Lost to Follow-up|1|||
144384600|NCT02431260|520618138|FG006|Overall Study|Lost to Follow-up|0|||
144384601|NCT02431260|520618139|FG007|Overall Study|Lost to Follow-up|0|||
144384602|NCT02431260|520618140|FG008|Overall Study|Lost to Follow-up|0|||
144384603|NCT02431260|520618141|FG009|Overall Study|Lost to Follow-up|0|||
144384604|NCT02431260|520618142|FG010|Overall Study|Lost to Follow-up|0|||
144384605|NCT02431260|520618143|FG011|Overall Study|Lost to Follow-up|0|||
144384606|NCT02431260|520618144|FG012|Overall Study|Lost to Follow-up|0|||
144384607|NCT02431260|520618145|FG013|Overall Study|Lost to Follow-up|0|||
144384608|NCT02431260|520618132|FG000|Overall Study|Study Terminated by the Sponsor|0|||
144384609|NCT02431260|520618133|FG001|Overall Study|Study Terminated by the Sponsor|0|||
144384610|NCT02431260|520618134|FG002|Overall Study|Study Terminated by the Sponsor|2|||
144384611|NCT02431260|520618135|FG003|Overall Study|Study Terminated by the Sponsor|1|||
144384612|NCT02431260|520618136|FG004|Overall Study|Study Terminated by the Sponsor|1|||
144384613|NCT02431260|520618137|FG005|Overall Study|Study Terminated by the Sponsor|0|||
144384614|NCT02431260|520618138|FG006|Overall Study|Study Terminated by the Sponsor|1|||
144384615|NCT02431260|520618139|FG007|Overall Study|Study Terminated by the Sponsor|2|||
144384616|NCT02431260|520618140|FG008|Overall Study|Study Terminated by the Sponsor|1|||
144384617|NCT02431260|520618141|FG009|Overall Study|Study Terminated by the Sponsor|1|||
144384618|NCT02431260|520618142|FG010|Overall Study|Study Terminated by the Sponsor|1|||
144384619|NCT02431260|520618143|FG011|Overall Study|Study Terminated by the Sponsor|0|||
144384620|NCT02431260|520618144|FG012|Overall Study|Study Terminated by the Sponsor|4|||
144384621|NCT02431260|520618145|FG013|Overall Study|Study Terminated by the Sponsor|0|||
144384622|NCT02431260|520618132|FG000|Overall Study|Physician Decision|0|||
144384623|NCT02431260|520618133|FG001|Overall Study|Physician Decision|0|||
144384624|NCT02431260|520618134|FG002|Overall Study|Physician Decision|0|||
144384625|NCT02431260|520618135|FG003|Overall Study|Physician Decision|0|||
144384626|NCT02431260|520618136|FG004|Overall Study|Physician Decision|0|||
144384627|NCT02431260|520618137|FG005|Overall Study|Physician Decision|1|||
144384628|NCT02431260|520618138|FG006|Overall Study|Physician Decision|0|||
144384629|NCT02431260|520618139|FG007|Overall Study|Physician Decision|0|||
144384630|NCT02431260|520618140|FG008|Overall Study|Physician Decision|0|||
144384631|NCT02431260|520618141|FG009|Overall Study|Physician Decision|0|||
144384632|NCT02431260|520618142|FG010|Overall Study|Physician Decision|0|||
144384633|NCT02431260|520618143|FG011|Overall Study|Physician Decision|0|||
144384634|NCT02431260|520618144|FG012|Overall Study|Physician Decision|0|||
144384635|NCT02431260|520618145|FG013|Overall Study|Physician Decision|0|||
144384636|NCT02431260|520618132|FG000|Overall Study|Other Unspecified|0|||
144384637|NCT02431260|520618133|FG001|Overall Study|Other Unspecified|0|||
144384638|NCT02431260|520618134|FG002|Overall Study|Other Unspecified|0|||
144384639|NCT02431260|520618135|FG003|Overall Study|Other Unspecified|0|||
144384640|NCT02431260|520618136|FG004|Overall Study|Other Unspecified|0|||
144384641|NCT02431260|520618137|FG005|Overall Study|Other Unspecified|0|||
144384642|NCT02431260|520618138|FG006|Overall Study|Other Unspecified|0|||
144384643|NCT02431260|520618139|FG007|Overall Study|Other Unspecified|0|||
144384644|NCT02431260|520618140|FG008|Overall Study|Other Unspecified|0|||
144384645|NCT02431260|520618141|FG009|Overall Study|Other Unspecified|0|||
144384646|NCT02431260|520618142|FG010|Overall Study|Other Unspecified|0|||
144384647|NCT02431260|520618143|FG011|Overall Study|Other Unspecified|1|||
144384648|NCT02431260|520618144|FG012|Overall Study|Other Unspecified|1|||
144384649|NCT02431260|520618145|FG013|Overall Study|Other Unspecified|0|||
144384650|NCT00439738|520618147|FG000|Overall Study|Withdrawal by Subject|16|||
144384651|NCT00439738|520618148|FG001|Overall Study|Withdrawal by Subject|13|||
144384652|NCT00439738|520618147|FG000|Overall Study|Adverse Event|6|||
144384653|NCT00439738|520618148|FG001|Overall Study|Adverse Event|4|||
144384654|NCT00439738|520618147|FG000|Overall Study|Lost to Follow-up|5|||
144384655|NCT00439738|520618148|FG001|Overall Study|Lost to Follow-up|6|||
144384656|NCT00439738|520618147|FG000|Overall Study|Protocol Violation|6|||
144384657|NCT00439738|520618148|FG001|Overall Study|Protocol Violation|3|||
144384658|NCT00439738|520618147|FG000|Overall Study|Lack of Efficacy|2|||
144384659|NCT00439738|520618148|FG001|Overall Study|Lack of Efficacy|2|||
144199315|NCT00541970|519928867|FG001|Month 48|Lost to Follow-up|68|||
144384660|NCT00439738|520618147|FG000|Overall Study|Abnormal Lab Values|1|||
144384661|NCT00439738|520618148|FG001|Overall Study|Abnormal Lab Values|0|||
144384662|NCT00392379|520618149|FG000|Overall Study|Withdrawal by Subject|17|||
144384663|NCT00392379|520618150|FG001|Overall Study|Withdrawal by Subject|28|||
144384664|NCT00392379|520618149|FG000|Overall Study|Lost to Follow-up|4|||
144384665|NCT00392379|520618150|FG001|Overall Study|Lost to Follow-up|9|||
144384666|NCT00392379|520618149|FG000|Overall Study|Adverse Event|1|||
144384667|NCT00392379|520618150|FG001|Overall Study|Adverse Event|1|||
144384668|NCT01978938|520618151|FG000|Overall Study|Lost to Follow-up|12|||
144384669|NCT01978938|520618152|FG001|Overall Study|Lost to Follow-up|6|||
144384670|NCT01978938|520618151|FG000|Overall Study|Withdrawal by Subject|8|||
144384671|NCT01978938|520618152|FG001|Overall Study|Withdrawal by Subject|4|||
144384672|NCT01978938|520618151|FG000|Overall Study|Adverse Event, non-fatal|2|||
144384673|NCT01978938|520618152|FG001|Overall Study|Adverse Event, non-fatal|1|||
144384674|NCT01978938|520618151|FG000|Overall Study|Participant noncompliance|1|||
144384675|NCT01978938|520618152|FG001|Overall Study|Participant noncompliance|1|||
144384676|NCT01978938|520618151|FG000|Overall Study|Did not meet inclusion criteria|0|||
144384677|NCT01978938|520618152|FG001|Overall Study|Did not meet inclusion criteria|1|||
144384678|NCT01978938|520618151|FG000|Overall Study|Previously scheduled procedure|0|||
144384679|NCT01978938|520618152|FG001|Overall Study|Previously scheduled procedure|1|||
144384680|NCT01155167|520618159|FG000|Overall Study|Insufficient ultrasound data|2|||
144384681|NCT01155167|520618160|FG001|Overall Study|Insufficient ultrasound data|0|||
144384682|NCT01155167|520618159|FG000|Overall Study|Access site changed to femoral artery|1|||
144384683|NCT01155167|520618160|FG001|Overall Study|Access site changed to femoral artery|0|||
144384684|NCT01258998|520620363|FG000|Overall Study|Ineligible|1|||
144384685|NCT04966910|520620364|FG000|Baseline|Participant did not complete measure|0|||
144384686|NCT04966910|520620365|FG001|Baseline|Participant did not complete measure|0|||
144384687|NCT04966910|520620366|FG002|Baseline|Participant did not complete measure|1|||
144384688|NCT04966910|520620367|FG003|Baseline|Participant did not complete measure|0|||
144384689|NCT04966910|520620364|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
144384690|NCT04966910|520620365|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
144384691|NCT04966910|520620366|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
144384692|NCT04966910|520620367|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
144384693|NCT04966910|520620364|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
144384694|NCT04966910|520620365|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
144384695|NCT04966910|520620366|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
144384696|NCT04966910|520620367|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
144384697|NCT04966910|520620364|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
144384698|NCT04966910|520620365|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
144384699|NCT04966910|520620366|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
144384700|NCT04966910|520620367|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
144384701|NCT00002931|520620371|FG000|Overall Study|rapidly progressing disease during|2|||
144384702|NCT02276027|520620372|FG000|Overall Study|Death|1|||
144384703|NCT02276027|520620373|FG001|Overall Study|Death|0|||
144384704|NCT02276027|520620374|FG002|Overall Study|Death|0|||
144384705|NCT02276027|520620375|FG003|Overall Study|Death|2|||
144384706|NCT02276027|520620372|FG000|Overall Study|Physician Decision|0|||
144384707|NCT02276027|520620373|FG001|Overall Study|Physician Decision|0|||
144384708|NCT02276027|520620374|FG002|Overall Study|Physician Decision|0|||
144384709|NCT02276027|520620375|FG003|Overall Study|Physician Decision|1|||
144384710|NCT02276027|520620372|FG000|Overall Study|Progressive disease|1|||
144384711|NCT02276027|520620373|FG001|Overall Study|Progressive disease|13|||
144384712|NCT02276027|520620374|FG002|Overall Study|Progressive disease|12|||
144384713|NCT02276027|520620375|FG003|Overall Study|Progressive disease|14|||
144384714|NCT02276027|520620372|FG000|Overall Study|Subject/guardian decision|0|||
144384715|NCT02276027|520620373|FG001|Overall Study|Subject/guardian decision|1|||
144384716|NCT02276027|520620374|FG002|Overall Study|Subject/guardian decision|0|||
144384717|NCT02276027|520620375|FG003|Overall Study|Subject/guardian decision|3|||
144384718|NCT02276027|520620372|FG000|Overall Study|Adverse Event|0|||
144384719|NCT02276027|520620373|FG001|Overall Study|Adverse Event|2|||
144384720|NCT02276027|520620374|FG002|Overall Study|Adverse Event|8|||
144384721|NCT02276027|520620375|FG003|Overall Study|Adverse Event|2|||
144384722|NCT03224598|520620376|FG000|Overall Study|Lost to Follow-up|0|||
144384723|NCT03224598|520620377|FG001|Overall Study|Lost to Follow-up|2|||
144384724|NCT03224598|520620378|FG002|Overall Study|Lost to Follow-up|0|||
144384725|NCT03224598|520620376|FG000|Overall Study|Other|0|||
144384726|NCT03224598|520620377|FG001|Overall Study|Other|1|||
144384727|NCT03224598|520620378|FG002|Overall Study|Other|0|||
144384728|NCT02446171|520620388|FG000|Overall Study|Withdrawal by Subject|0|||
144384729|NCT02446171|520620389|FG001|Overall Study|Withdrawal by Subject|0|||
144384730|NCT02446171|520620390|FG002|Overall Study|Withdrawal by Subject|2|||
144384731|NCT02446171|520620391|FG003|Overall Study|Withdrawal by Subject|0|||
144384732|NCT01142089|520620392|FG000|Overall Study|Physician Decision|1|||
144384733|NCT01142089|520620393|FG001|Overall Study|Physician Decision|0|||
144384734|NCT01142089|520620392|FG000|Overall Study|Withdrawal by Subject|1|||
144384735|NCT01142089|520620393|FG001|Overall Study|Withdrawal by Subject|2|||
144384736|NCT01142089|520620392|FG000|Overall Study|Use of prohibited medications|0|||
144384737|NCT01142089|520620393|FG001|Overall Study|Use of prohibited medications|1|||
144384738|NCT01142089|520620392|FG000|Overall Study|Noncompliance with study procedures|2|||
144384739|NCT01142089|520620393|FG001|Overall Study|Noncompliance with study procedures|1|||
144384740|NCT01142089|520620392|FG000|Overall Study|Patient required rescue medication|8|||
144384741|NCT01142089|520620393|FG001|Overall Study|Patient required rescue medication|17|||
144384742|NCT03328182|520620396|FG000|Overall Study|Withdrawal by Subject|1|||
144384743|NCT03328182|520620396|FG000|Overall Study|Protocol Violation|2|||
144384744|NCT03328182|520620396|FG000|Overall Study|No Product Evaluated|1|||
144384745|NCT01489111|520620397|FG000|Overall Study|Withdrawal criterion|1|||
144384746|NCT00603590|520620403|FG000|Overall Study|Did not attend study clinic|39|||
144384747|NCT00603590|520620404|FG001|Overall Study|Did not attend study clinic|30|||
144384748|NCT00603590|520620403|FG000|Overall Study|Refused blood test|5|||
144384749|NCT00603590|520620404|FG001|Overall Study|Refused blood test|1|||
144384750|NCT00603590|520620403|FG000|Overall Study|Patient discontinued study drug|22|||
144384751|NCT00603590|520620404|FG001|Overall Study|Patient discontinued study drug|15|||
144384752|NCT00603590|520620403|FG000|Overall Study|Adverse Event|2|||
144592789|NCT05227703|521370689|FG000|Overall Study|Adverse Event|2|||
144592790|NCT05227703|521370690|FG001|Overall Study|Adverse Event|6|||
144592791|NCT05227703|521370691|FG002|Overall Study|Adverse Event|4|||
144592792|NCT05227703|521370689|FG000|Overall Study|Lack of Efficacy|4|||
144592793|NCT05227703|521370690|FG001|Overall Study|Lack of Efficacy|0|||
144592794|NCT05227703|521370691|FG002|Overall Study|Lack of Efficacy|1|||
144592795|NCT05227703|521370689|FG000|Overall Study|Physician Decision|2|||
144592796|NCT05227703|521370690|FG001|Overall Study|Physician Decision|2|||
144592797|NCT05227703|521370691|FG002|Overall Study|Physician Decision|1|||
144592798|NCT05227703|521370689|FG000|Overall Study|Protocol Violation|2|||
144592799|NCT05227703|521370690|FG001|Overall Study|Protocol Violation|1|||
144592800|NCT05227703|521370691|FG002|Overall Study|Protocol Violation|0|||
144592801|NCT05227703|521370689|FG000|Overall Study|Withdrawal by Subject|17|||
144592802|NCT05227703|521370690|FG001|Overall Study|Withdrawal by Subject|26|||
144592803|NCT05227703|521370691|FG002|Overall Study|Withdrawal by Subject|32|||
144592804|NCT05227703|521370689|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
144592805|NCT05227703|521370690|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
144592806|NCT05227703|521370691|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
144384753|NCT00603590|520620404|FG001|Overall Study|Adverse Event|0|||
144592807|NCT05227703|521370689|FG000|Overall Study|Other|1|||
144384754|NCT00603590|520620403|FG000|Overall Study|Lost to Follow-up|8|||
144384755|NCT00603590|520620404|FG001|Overall Study|Lost to Follow-up|4|||
144384756|NCT00603590|520620403|FG000|Overall Study|Cardiovascular event|0|||
144592808|NCT05227703|521370690|FG001|Overall Study|Other|1|||
144592809|NCT05227703|521370691|FG002|Overall Study|Other|0|||
144384757|NCT00603590|520620404|FG001|Overall Study|Cardiovascular event|1|||
144592810|NCT03464097|521370696|FG000|Overall Study|Withdrawal by Subject|15|||
144384758|NCT05338671|520620405|FG000|Overall Study|Lost to Follow-up|2|||
144384759|NCT05338671|520620406|FG001|Overall Study|Lost to Follow-up|2|||
144384760|NCT05338671|520620405|FG000|Overall Study|Root canal completed in a single visit|1|||
144384761|NCT05338671|520620406|FG001|Overall Study|Root canal completed in a single visit|0|||
144384762|NCT03085914|520620409|FG000|Overall Study|Death|6|||
144384763|NCT03085914|520620410|FG001|Overall Study|Death|6|||
144384764|NCT03085914|520620411|FG002|Overall Study|Death|4|||
144384765|NCT03085914|520620412|FG003|Overall Study|Death|1|||
144384766|NCT03085914|520620413|FG004|Overall Study|Death|5|||
144384767|NCT03085914|520620414|FG005|Overall Study|Death|2|||
144384768|NCT03085914|520620415|FG006|Overall Study|Death|2|||
144384769|NCT03085914|520620409|FG000|Overall Study|Withdrawal by Subject|1|||
144384770|NCT03085914|520620410|FG001|Overall Study|Withdrawal by Subject|1|||
144384771|NCT03085914|520620411|FG002|Overall Study|Withdrawal by Subject|2|||
144384772|NCT03085914|520620412|FG003|Overall Study|Withdrawal by Subject|2|||
144384773|NCT03085914|520620413|FG004|Overall Study|Withdrawal by Subject|2|||
144384774|NCT03085914|520620414|FG005|Overall Study|Withdrawal by Subject|0|||
144384775|NCT03085914|520620415|FG006|Overall Study|Withdrawal by Subject|1|||
144384776|NCT03085914|520620409|FG000|Overall Study|Lost to Follow-up|0|||
144384777|NCT03085914|520620410|FG001|Overall Study|Lost to Follow-up|0|||
144384778|NCT03085914|520620411|FG002|Overall Study|Lost to Follow-up|1|||
144384779|NCT03085914|520620412|FG003|Overall Study|Lost to Follow-up|0|||
144384780|NCT03085914|520620413|FG004|Overall Study|Lost to Follow-up|0|||
144384781|NCT03085914|520620414|FG005|Overall Study|Lost to Follow-up|1|||
144384782|NCT03085914|520620415|FG006|Overall Study|Lost to Follow-up|1|||
144384783|NCT03085914|520620409|FG000|Overall Study|Reason was not specified,|2|||
144384784|NCT03085914|520620410|FG001|Overall Study|Reason was not specified,|2|||
144384785|NCT03085914|520620411|FG002|Overall Study|Reason was not specified,|2|||
144384786|NCT03085914|520620412|FG003|Overall Study|Reason was not specified,|3|||
144515151|NCT01898494|521085832|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
144515152|NCT01898494|521085833|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
144515153|NCT01898494|521085834|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
144515154|NCT01898494|521085835|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
144515155|NCT01898494|521085831|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
144515156|NCT01898494|521085832|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
144515157|NCT01898494|521085833|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
144515158|NCT01898494|521085834|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
144515159|NCT01898494|521085835|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
144515160|NCT01898494|521085831|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
144515161|NCT01898494|521085832|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
144515162|NCT01898494|521085833|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
144515163|NCT01898494|521085834|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
144515164|NCT01898494|521085835|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
144515165|NCT01898494|521085831|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
144515166|NCT01898494|521085832|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
144515167|NCT01898494|521085833|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
144515168|NCT01898494|521085834|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
144515169|NCT01898494|521085835|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
144515170|NCT01898494|521085831|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
144515171|NCT01898494|521085832|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
144515172|NCT01898494|521085833|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
144515173|NCT01898494|521085834|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
144515174|NCT01898494|521085835|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
144515175|NCT03289039|521085838|FG000|Overall Study|Withdrawal by Subject|0|||
144515176|NCT03289039|521085839|FG001|Overall Study|Withdrawal by Subject|1|||
144515177|NCT03289039|521085838|FG000|Overall Study|Became ineligible prior to treatment start|0|||
144515178|NCT03289039|521085839|FG001|Overall Study|Became ineligible prior to treatment start|1|||
144515179|NCT03289039|521085838|FG000|Overall Study|progressed before treatment start|1|||
144515180|NCT03289039|521085839|FG001|Overall Study|progressed before treatment start|0|||
144515181|NCT04791709|521085840|FG000|Overall Study|Withdrawal by Subject|3|||
144515182|NCT00792636|521085841|FG000|Overall Study|Protocol Violation|17|||
144515183|NCT00792636|521085842|FG001|Overall Study|Protocol Violation|23|||
144515184|NCT00792636|521085843|FG002|Overall Study|Protocol Violation|20|||
144515185|NCT00792636|521085841|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
144515186|NCT00792636|521085842|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
144515187|NCT00792636|521085843|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
144515188|NCT00792636|521085841|FG000|Overall Study|Lost to Follow-up|13|||
144515189|NCT00792636|521085842|FG001|Overall Study|Lost to Follow-up|19|||
144384787|NCT03085914|520620413|FG004|Overall Study|Reason was not specified,|3|||
144384788|NCT03085914|520620414|FG005|Overall Study|Reason was not specified,|3|||
144384789|NCT03085914|520620415|FG006|Overall Study|Reason was not specified,|6|||
144384790|NCT03085914|520620409|FG000|Overall Study|Progressive Disease|0|||
144384791|NCT03085914|520620410|FG001|Overall Study|Progressive Disease|0|||
144384792|NCT03085914|520620411|FG002|Overall Study|Progressive Disease|2|||
144384793|NCT03085914|520620412|FG003|Overall Study|Progressive Disease|2|||
144384794|NCT03085914|520620413|FG004|Overall Study|Progressive Disease|1|||
144384795|NCT03085914|520620414|FG005|Overall Study|Progressive Disease|1|||
144384796|NCT03085914|520620415|FG006|Overall Study|Progressive Disease|1|||
144384797|NCT03085914|520620409|FG000|Overall Study|Study Terminated by the Sponsor|0|||
144384798|NCT03085914|520620410|FG001|Overall Study|Study Terminated by the Sponsor|0|||
144384799|NCT03085914|520620411|FG002|Overall Study|Study Terminated by the Sponsor|0|||
144384800|NCT03085914|520620412|FG003|Overall Study|Study Terminated by the Sponsor|1|||
144384801|NCT03085914|520620413|FG004|Overall Study|Study Terminated by the Sponsor|2|||
144384802|NCT03085914|520620414|FG005|Overall Study|Study Terminated by the Sponsor|1|||
144384803|NCT03085914|520620415|FG006|Overall Study|Study Terminated by the Sponsor|0|||
144384804|NCT01215916|520620416|FG000|Overall Study|Progressive Disease|0|||
144384805|NCT01215916|520620417|FG001|Overall Study|Progressive Disease|2|||
144384806|NCT01215916|520620418|FG002|Overall Study|Progressive Disease|1|||
144384807|NCT01215916|520620419|FG003|Overall Study|Progressive Disease|2|||
144384808|NCT01215916|520620420|FG004|Overall Study|Progressive Disease|5|||
144384809|NCT01215916|520620421|FG005|Overall Study|Progressive Disease|4|||
144384810|NCT01215916|520620422|FG006|Overall Study|Progressive Disease|5|||
144384811|NCT01215916|520620423|FG007|Overall Study|Progressive Disease|3|||
144384812|NCT01215916|520620424|FG008|Overall Study|Progressive Disease|1|||
144384813|NCT01215916|520620416|FG000|Overall Study|Adverse Event|1|||
144384814|NCT01215916|520620417|FG001|Overall Study|Adverse Event|1|||
144384815|NCT01215916|520620418|FG002|Overall Study|Adverse Event|0|||
144384816|NCT01215916|520620419|FG003|Overall Study|Adverse Event|1|||
144384817|NCT01215916|520620420|FG004|Overall Study|Adverse Event|0|||
144384818|NCT01215916|520620421|FG005|Overall Study|Adverse Event|0|||
144384819|NCT01215916|520620422|FG006|Overall Study|Adverse Event|3|||
144384820|NCT01215916|520620423|FG007|Overall Study|Adverse Event|0|||
144384821|NCT01215916|520620424|FG008|Overall Study|Adverse Event|0|||
144384822|NCT01215916|520620416|FG000|Overall Study|Withdrawal by Subject|0|||
144384823|NCT01215916|520620417|FG001|Overall Study|Withdrawal by Subject|1|||
144384824|NCT01215916|520620418|FG002|Overall Study|Withdrawal by Subject|1|||
144384825|NCT01215916|520620419|FG003|Overall Study|Withdrawal by Subject|2|||
144384826|NCT01215916|520620420|FG004|Overall Study|Withdrawal by Subject|0|||
144384827|NCT01215916|520620421|FG005|Overall Study|Withdrawal by Subject|0|||
144384828|NCT01215916|520620422|FG006|Overall Study|Withdrawal by Subject|1|||
144384829|NCT01215916|520620423|FG007|Overall Study|Withdrawal by Subject|0|||
144384830|NCT01215916|520620424|FG008|Overall Study|Withdrawal by Subject|0|||
144384831|NCT01215916|520620416|FG000|Overall Study|Death|0|||
144384832|NCT01215916|520620417|FG001|Overall Study|Death|1|||
144384833|NCT01215916|520620418|FG002|Overall Study|Death|0|||
144384834|NCT01215916|520620419|FG003|Overall Study|Death|0|||
144384835|NCT01215916|520620420|FG004|Overall Study|Death|1|||
144384836|NCT01215916|520620421|FG005|Overall Study|Death|0|||
144384837|NCT01215916|520620422|FG006|Overall Study|Death|0|||
144384838|NCT01215916|520620423|FG007|Overall Study|Death|0|||
144384839|NCT01215916|520620424|FG008|Overall Study|Death|1|||
144384840|NCT01215916|520620416|FG000|Overall Study|Physician Decision|0|||
144384841|NCT01215916|520620417|FG001|Overall Study|Physician Decision|0|||
144384842|NCT01215916|520620418|FG002|Overall Study|Physician Decision|1|||
144384843|NCT01215916|520620419|FG003|Overall Study|Physician Decision|1|||
144384844|NCT01215916|520620420|FG004|Overall Study|Physician Decision|0|||
144384845|NCT01215916|520620421|FG005|Overall Study|Physician Decision|0|||
144384846|NCT01215916|520620422|FG006|Overall Study|Physician Decision|0|||
144384847|NCT01215916|520620423|FG007|Overall Study|Physician Decision|0|||
144384848|NCT01215916|520620424|FG008|Overall Study|Physician Decision|0|||
144384849|NCT04575597|520620425|FG000|Overall Study|Death|0|||
144384850|NCT04575597|520620426|FG001|Overall Study|Death|0|||
144384851|NCT04575597|520620427|FG002|Overall Study|Death|0|||
144384852|NCT04575597|520620428|FG003|Overall Study|Death|1|||
144384853|NCT04575597|520620429|FG004|Overall Study|Death|3|||
144384854|NCT04575597|520620430|FG005|Overall Study|Death|14|||
144384855|NCT04575597|520620425|FG000|Overall Study|Lost to Follow-up|2|||
144384856|NCT04575597|520620426|FG001|Overall Study|Lost to Follow-up|1|||
144384857|NCT04575597|520620427|FG002|Overall Study|Lost to Follow-up|1|||
144384858|NCT04575597|520620428|FG003|Overall Study|Lost to Follow-up|2|||
144384859|NCT04575597|520620429|FG004|Overall Study|Lost to Follow-up|10|||
144384860|NCT04575597|520620430|FG005|Overall Study|Lost to Follow-up|8|||
144384861|NCT04575597|520620425|FG000|Overall Study|Withdrawal by Subject|2|||
144384862|NCT04575597|520620426|FG001|Overall Study|Withdrawal by Subject|2|||
144384863|NCT04575597|520620427|FG002|Overall Study|Withdrawal by Subject|4|||
144384864|NCT04575597|520620428|FG003|Overall Study|Withdrawal by Subject|2|||
144384865|NCT04575597|520620429|FG004|Overall Study|Withdrawal by Subject|25|||
144384866|NCT04575597|520620430|FG005|Overall Study|Withdrawal by Subject|28|||
144384867|NCT04575597|520620425|FG000|Overall Study|Not Recorded|0|||
144384868|NCT04575597|520620426|FG001|Overall Study|Not Recorded|0|||
144384869|NCT04575597|520620427|FG002|Overall Study|Not Recorded|0|||
144384870|NCT04575597|520620428|FG003|Overall Study|Not Recorded|0|||
144384871|NCT04575597|520620429|FG004|Overall Study|Not Recorded|0|||
144384872|NCT04575597|520620430|FG005|Overall Study|Not Recorded|2|||
144384873|NCT04575597|520620425|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144384874|NCT04575597|520620426|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144384875|NCT04575597|520620427|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144384876|NCT04575597|520620428|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144384877|NCT04575597|520620429|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
144384878|NCT04575597|520620430|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
144384879|NCT02353143|520620431|FG000|Overall Study|Withdrawal by Subject|1|||
144384880|NCT02353143|520620432|FG001|Overall Study|Withdrawal by Subject|0|||
144384881|NCT02353143|520620433|FG002|Overall Study|Withdrawal by Subject|0|||
144384882|NCT02353143|520620434|FG003|Overall Study|Withdrawal by Subject|0|||
144384883|NCT02353143|520620435|FG004|Overall Study|Withdrawal by Subject|1|||
144384884|NCT02353143|520620436|FG005|Overall Study|Withdrawal by Subject|0|||
144384885|NCT02353143|520620437|FG006|Overall Study|Withdrawal by Subject|0|||
144384886|NCT02353143|520620438|FG007|Overall Study|Withdrawal by Subject|1|||
144384887|NCT02353143|520620439|FG008|Overall Study|Withdrawal by Subject|1|||
144384888|NCT02353143|520620431|FG000|Overall Study|Lack of Efficacy|2|||
144384889|NCT02353143|520620432|FG001|Overall Study|Lack of Efficacy|1|||
144384890|NCT02353143|520620433|FG002|Overall Study|Lack of Efficacy|2|||
144384891|NCT02353143|520620434|FG003|Overall Study|Lack of Efficacy|4|||
144384892|NCT02353143|520620435|FG004|Overall Study|Lack of Efficacy|13|||
144384893|NCT02353143|520620436|FG005|Overall Study|Lack of Efficacy|2|||
144384894|NCT02353143|520620437|FG006|Overall Study|Lack of Efficacy|2|||
144384895|NCT02353143|520620438|FG007|Overall Study|Lack of Efficacy|2|||
144384896|NCT02353143|520620439|FG008|Overall Study|Lack of Efficacy|1|||
144384897|NCT02353143|520620431|FG000|Overall Study|reason not specified|1|||
144384898|NCT02353143|520620432|FG001|Overall Study|reason not specified|2|||
144384899|NCT02353143|520620433|FG002|Overall Study|reason not specified|0|||
144384900|NCT02353143|520620434|FG003|Overall Study|reason not specified|0|||
144384901|NCT02353143|520620435|FG004|Overall Study|reason not specified|6|||
144384902|NCT02353143|520620436|FG005|Overall Study|reason not specified|1|||
144384903|NCT02353143|520620437|FG006|Overall Study|reason not specified|0|||
144384904|NCT02353143|520620438|FG007|Overall Study|reason not specified|3|||
144384905|NCT02353143|520620439|FG008|Overall Study|reason not specified|1|||
144384906|NCT02353143|520620431|FG000|Overall Study|Physician Decision|0|||
144384907|NCT02353143|520620432|FG001|Overall Study|Physician Decision|4|||
144384908|NCT02353143|520620433|FG002|Overall Study|Physician Decision|2|||
144384909|NCT02353143|520620434|FG003|Overall Study|Physician Decision|3|||
144384910|NCT02353143|520620435|FG004|Overall Study|Physician Decision|4|||
144384911|NCT02353143|520620436|FG005|Overall Study|Physician Decision|0|||
144384912|NCT02353143|520620437|FG006|Overall Study|Physician Decision|1|||
144384913|NCT02353143|520620438|FG007|Overall Study|Physician Decision|2|||
144384914|NCT02353143|520620439|FG008|Overall Study|Physician Decision|0|||
144384915|NCT02353143|520620431|FG000|Overall Study|Adverse Event|0|||
144384916|NCT02353143|520620432|FG001|Overall Study|Adverse Event|0|||
144384917|NCT02353143|520620433|FG002|Overall Study|Adverse Event|1|||
144384918|NCT02353143|520620434|FG003|Overall Study|Adverse Event|0|||
144384919|NCT02353143|520620435|FG004|Overall Study|Adverse Event|1|||
144384920|NCT02353143|520620436|FG005|Overall Study|Adverse Event|1|||
144384921|NCT02353143|520620437|FG006|Overall Study|Adverse Event|0|||
144384922|NCT02353143|520620438|FG007|Overall Study|Adverse Event|0|||
144384923|NCT02353143|520620439|FG008|Overall Study|Adverse Event|0|||
144384924|NCT02353143|520620431|FG000|Overall Study|patient receiving other treatment for AML|0|||
144384925|NCT02353143|520620432|FG001|Overall Study|patient receiving other treatment for AML|0|||
144384926|NCT02353143|520620433|FG002|Overall Study|patient receiving other treatment for AML|1|||
144384927|NCT02353143|520620434|FG003|Overall Study|patient receiving other treatment for AML|0|||
144515190|NCT00792636|521085843|FG002|Overall Study|Lost to Follow-up|14|||
144515191|NCT00792636|521085841|FG000|Overall Study|Withdrew Consent|10|||
144515192|NCT00792636|521085842|FG001|Overall Study|Withdrew Consent|13|||
144515193|NCT00792636|521085843|FG002|Overall Study|Withdrew Consent|9|||
144384928|NCT02353143|520620435|FG004|Overall Study|patient receiving other treatment for AML|0|||
144384929|NCT02353143|520620436|FG005|Overall Study|patient receiving other treatment for AML|0|||
144384930|NCT02353143|520620437|FG006|Overall Study|patient receiving other treatment for AML|0|||
144384931|NCT02353143|520620438|FG007|Overall Study|patient receiving other treatment for AML|0|||
144384932|NCT02353143|520620439|FG008|Overall Study|patient receiving other treatment for AML|0|||
144384933|NCT02353143|520620431|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
144515194|NCT00792636|521085841|FG000|Overall Study|Lack of Efficacy|3|||
144384934|NCT02353143|520620432|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
144384935|NCT02353143|520620433|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
144384936|NCT02353143|520620434|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
144384937|NCT02353143|520620435|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
144515195|NCT00792636|521085842|FG001|Overall Study|Lack of Efficacy|4|||
144515196|NCT00792636|521085843|FG002|Overall Study|Lack of Efficacy|13|||
144384938|NCT02353143|520620436|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
144515197|NCT00792636|521085841|FG000|Overall Study|Adverse Event|4|||
144384939|NCT02353143|520620437|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
144384940|NCT02353143|520620438|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
144384941|NCT02353143|520620439|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
144384942|NCT01029405|520620440|FG000|Overall Study|Withdrawal by Subject|0|||
144384943|NCT01029405|520620441|FG001|Overall Study|Withdrawal by Subject|1|||
144384944|NCT01029405|520620442|FG002|Overall Study|Withdrawal by Subject|2|||
144384945|NCT01029405|520620443|FG003|Overall Study|Withdrawal by Subject|0|||
144384946|NCT01029405|520620440|FG000|Overall Study|Protocol Violation|0|||
144384947|NCT01029405|520620441|FG001|Overall Study|Protocol Violation|0|||
144384948|NCT01029405|520620442|FG002|Overall Study|Protocol Violation|0|||
144384949|NCT01029405|520620443|FG003|Overall Study|Protocol Violation|1|||
144384950|NCT01029405|520620440|FG000|Overall Study|Adverse Event|0|||
144384951|NCT01029405|520620441|FG001|Overall Study|Adverse Event|0|||
144384952|NCT01029405|520620442|FG002|Overall Study|Adverse Event|1|||
144384953|NCT01029405|520620443|FG003|Overall Study|Adverse Event|1|||
144384954|NCT01029405|520620440|FG000|Overall Study|Lost to Follow-up|2|||
144384955|NCT01029405|520620441|FG001|Overall Study|Lost to Follow-up|1|||
144384956|NCT01029405|520620442|FG002|Overall Study|Lost to Follow-up|1|||
144384957|NCT01029405|520620443|FG003|Overall Study|Lost to Follow-up|2|||
144384958|NCT01029405|520620440|FG000|Overall Study|Other|0|||
144384959|NCT01029405|520620441|FG001|Overall Study|Other|1|||
144384960|NCT01029405|520620442|FG002|Overall Study|Other|0|||
144384961|NCT01029405|520620443|FG003|Overall Study|Other|1|||
144384962|NCT00834080|520620444|FG000|Overall Study|Adverse Event|7|||
144384963|NCT00834080|520620444|FG000|Overall Study|Lost to Follow-up|7|||
144384964|NCT00834080|520620444|FG000|Overall Study|Withdrawal by Subject|5|||
144384965|NCT00834080|520620444|FG000|Overall Study|Other - Pregnancy|1|||
144384966|NCT00834080|520620444|FG000|Overall Study|Other - False positive tests of the UDS|1|||
144384967|NCT00834080|520620444|FG000|Overall Study|Physician Decision|1|||
144384968|NCT00834080|520620444|FG000|Overall Study|Subject Relocated|1|||
144384969|NCT00796523|520620448|FG000|Overall Study|Lost to Follow-up|9|||
144384970|NCT00796523|520620449|FG001|Overall Study|Lost to Follow-up|7|||
144384971|NCT00321646|520620451|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
144384972|NCT00321646|520620451|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
144384973|NCT00321646|520620451|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
144384974|NCT02694757|520620453|FG000|Overall Study|Lack of Efficacy|3|||
144384975|NCT00095147|520620454|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
144515198|NCT00792636|521085842|FG001|Overall Study|Adverse Event|2|||
144515199|NCT00792636|521085843|FG002|Overall Study|Adverse Event|3|||
144515200|NCT00792636|521085841|FG000|Overall Study|Investigator Discretion|2|||
144515201|NCT00792636|521085842|FG001|Overall Study|Investigator Discretion|0|||
144515202|NCT00792636|521085843|FG002|Overall Study|Investigator Discretion|2|||
144515203|NCT01046136|521085844|FG000|Overall Study|Withdrawal by Subject|0|||
144515204|NCT01046136|521085845|FG001|Overall Study|Withdrawal by Subject|4|||
144515205|NCT01046136|521085844|FG000|Overall Study|Physician Decision|1|||
144515206|NCT01046136|521085845|FG001|Overall Study|Physician Decision|1|||
144515207|NCT01046136|521085844|FG000|Overall Study|Lost to Follow-up|3|||
144515208|NCT01046136|521085845|FG001|Overall Study|Lost to Follow-up|3|||
144515209|NCT04579250|521085846|FG000|Overall Study|Withdrawal by Subject|1|||
144515210|NCT04579250|521085847|FG001|Overall Study|Withdrawal by Subject|1|||
144515211|NCT04579250|521085848|FG002|Overall Study|Withdrawal by Subject|0|||
144515212|NCT04579250|521085846|FG000|Overall Study|Lost to Follow-up|1|||
144515213|NCT04579250|521085847|FG001|Overall Study|Lost to Follow-up|1|||
144515214|NCT04579250|521085848|FG002|Overall Study|Lost to Follow-up|0|||
144515215|NCT04579250|521085846|FG000|Overall Study|Moved from area|0|||
144515216|NCT04579250|521085847|FG001|Overall Study|Moved from area|1|||
144515217|NCT04579250|521085848|FG002|Overall Study|Moved from area|2|||
144515218|NCT04600752|521085849|FG000|Overall Study|Physician Decision|0|||
144384976|NCT00095147|520620455|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
144515219|NCT04600752|521085850|FG001|Overall Study|Physician Decision|0|||
144515220|NCT04600752|521085851|FG002|Overall Study|Physician Decision|1|||
144515221|NCT04600752|521085849|FG000|Overall Study|Adverse Event|0|||
144515222|NCT04600752|521085850|FG001|Overall Study|Adverse Event|1|||
144515223|NCT04600752|521085851|FG002|Overall Study|Adverse Event|0|||
144384977|NCT00095147|520620456|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
144384978|NCT00095147|520620457|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
144384979|NCT00095147|520620458|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
144384980|NCT00095147|520620454|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
144384981|NCT00095147|520620455|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
144384982|NCT00095147|520620456|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
144721949|NCT01829464|521836889|FG000|Overall Study|Withdrawal by Subject|2|||
144721950|NCT01829464|521836890|FG001|Overall Study|Withdrawal by Subject|0|||
144721951|NCT01829464|521836891|FG002|Overall Study|Withdrawal by Subject|0|||
144721952|NCT01829464|521836889|FG000|Overall Study|Study terminated by sponsor|25|||
144721953|NCT01829464|521836890|FG001|Overall Study|Study terminated by sponsor|28|||
144384983|NCT00095147|520620457|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
144384984|NCT00095147|520620458|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
144384985|NCT00095147|520620454|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
144515224|NCT04600752|521085849|FG000|Overall Study|Withdrawal by Subject|2|||
144515225|NCT04600752|521085850|FG001|Overall Study|Withdrawal by Subject|1|||
144515226|NCT04600752|521085851|FG002|Overall Study|Withdrawal by Subject|0|||
144515227|NCT04600752|521085849|FG000|Overall Study|Lack of Efficacy|1|||
144721954|NCT01829464|521836891|FG002|Overall Study|Study terminated by sponsor|25|||
144721955|NCT01829464|521836889|FG000|Overall Study|Lack of Efficacy|0|||
144515228|NCT04600752|521085850|FG001|Overall Study|Lack of Efficacy|0|||
144515229|NCT04600752|521085851|FG002|Overall Study|Lack of Efficacy|0|||
144515230|NCT03732820|521085852|FG000|Overall Study|Death|168|||
144515231|NCT03732820|521085853|FG001|Overall Study|Death|203|||
144515232|NCT03732820|521085852|FG000|Overall Study|Other|2|||
144515233|NCT03732820|521085853|FG001|Overall Study|Other|2|||
144515234|NCT03732820|521085852|FG000|Overall Study|Failure to meet randomisation criteria|1|||
144721956|NCT01829464|521836890|FG001|Overall Study|Lack of Efficacy|1|||
144721957|NCT01829464|521836891|FG002|Overall Study|Lack of Efficacy|0|||
144721958|NCT03738332|521836896|FG000|Overall Study|Withdrawal by Subject|1|||
144721959|NCT02336737|521836897|FG000|Overall Study|Withdrawal by Subject|5|||
144721960|NCT02336737|521836897|FG000|Overall Study|Physician Decision|8|||
144721961|NCT02750761|521836903|FG000|Overall Study|Lost to Follow-up|0|||
144721962|NCT02750761|521836904|FG001|Overall Study|Lost to Follow-up|0|||
144721963|NCT02750761|521836905|FG002|Overall Study|Lost to Follow-up|1|||
144721964|NCT02750761|521836906|FG003|Overall Study|Lost to Follow-up|0|||
144721965|NCT02750761|521836907|FG004|Overall Study|Lost to Follow-up|0|||
144721966|NCT02750761|521836908|FG005|Overall Study|Lost to Follow-up|0|||
144721967|NCT02866175|521836913|FG000|Overall Study|Adverse Event|56|||
144721968|NCT02866175|521836914|FG001|Overall Study|Adverse Event|54|||
144721969|NCT02866175|521836913|FG000|Overall Study|Withdrawal by Subject|31|||
144721970|NCT02866175|521836914|FG001|Overall Study|Withdrawal by Subject|52|||
144721971|NCT02866175|521836913|FG000|Overall Study|Death|30|||
144721972|NCT02866175|521836914|FG001|Overall Study|Death|23|||
144721973|NCT02866175|521836913|FG000|Overall Study|Other|7|||
144721974|NCT02866175|521836914|FG001|Overall Study|Other|14|||
144721975|NCT02866175|521836913|FG000|Overall Study|Progressive disease|1|||
144721976|NCT02866175|521836914|FG001|Overall Study|Progressive disease|1|||
144721977|NCT02866175|521836913|FG000|Overall Study|Lost to Follow-up|2|||
144721978|NCT02866175|521836914|FG001|Overall Study|Lost to Follow-up|0|||
144721979|NCT02866175|521836913|FG000|Overall Study|Lack of Efficacy|0|||
144721980|NCT02866175|521836914|FG001|Overall Study|Lack of Efficacy|1|||
144721981|NCT02866175|521836913|FG000|Overall Study|Physician Decision|3|||
144721982|NCT02866175|521836914|FG001|Overall Study|Physician Decision|15|||
144721983|NCT02866175|521836913|FG000|Overall Study|Did not receive treatment|5|||
144721984|NCT02866175|521836914|FG001|Overall Study|Did not receive treatment|15|||
144721985|NCT04956666|521836915|FG000|Overall Study|Adverse Event|18|||
144721986|NCT04956666|521836915|FG000|Overall Study|Physician Decision|5|||
144721987|NCT02035137|521836921|FG000|Overall Study|Physician Decision|0|||
144721988|NCT02035137|521836922|FG001|Overall Study|Physician Decision|0|||
144721989|NCT02035137|521836923|FG002|Overall Study|Physician Decision|1|||
144721990|NCT02035137|521836921|FG000|Overall Study|Withdrawal by Subject|0|||
144721991|NCT02035137|521836922|FG001|Overall Study|Withdrawal by Subject|1|||
144721992|NCT02035137|521836923|FG002|Overall Study|Withdrawal by Subject|2|||
144721993|NCT02035137|521836921|FG000|Overall Study|Ineligible|0|||
144721994|NCT02035137|521836922|FG001|Overall Study|Ineligible|1|||
144721995|NCT02035137|521836923|FG002|Overall Study|Ineligible|2|||
144721996|NCT02035137|521836921|FG000|Overall Study|Disease progression prior to treatment start|2|||
144721997|NCT02035137|521836922|FG001|Overall Study|Disease progression prior to treatment start|0|||
144515235|NCT03732820|521085853|FG001|Overall Study|Failure to meet randomisation criteria|1|||
144721998|NCT02035137|521836923|FG002|Overall Study|Disease progression prior to treatment start|0|||
144384986|NCT00095147|520620455|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
144384987|NCT00095147|520620456|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
144384988|NCT00095147|520620457|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
144384989|NCT00095147|520620458|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
144384990|NCT00095147|520620454|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
144384991|NCT00095147|520620455|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
144384992|NCT00095147|520620456|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
144384993|NCT00095147|520620457|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
144384994|NCT00095147|520620458|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
144384995|NCT00095147|520620454|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
144384996|NCT00095147|520620455|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
144384997|NCT00095147|520620456|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
144384998|NCT00095147|520620457|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
144384999|NCT00095147|520620458|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
144385000|NCT00095147|520620454|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
144385001|NCT00095147|520620455|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
144385002|NCT00095147|520620456|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
144385003|NCT00095147|520620457|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
144385004|NCT00095147|520620458|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
144385005|NCT00095147|520620454|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
144385006|NCT00095147|520620455|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
144385007|NCT00095147|520620456|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
144385008|NCT00095147|520620457|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
144385009|NCT00095147|520620458|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
144385010|NCT00095147|520620454|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
144721999|NCT00290745|521836930|FG000|Overall Study|Withdrawal by Subject|4|||
144722000|NCT00290745|521836930|FG000|Overall Study|Physician Decision|2|||
144385011|NCT00095147|520620455|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
144385012|NCT00095147|520620456|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
144385013|NCT00095147|520620457|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
144385014|NCT00095147|520620458|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
144385015|NCT00095147|520620454|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
144385016|NCT00095147|520620455|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
144385017|NCT00095147|520620456|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
144385018|NCT00095147|520620457|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
144385019|NCT00095147|520620458|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
144385020|NCT00095147|520620454|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
144385021|NCT00095147|520620455|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
144385022|NCT00095147|520620456|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
144385023|NCT00095147|520620457|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
144385024|NCT00095147|520620458|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
144385025|NCT00095147|520620454|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
144385026|NCT00095147|520620455|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
144385027|NCT00095147|520620456|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
144385028|NCT00095147|520620457|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
144385029|NCT00095147|520620458|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
144385030|NCT00095147|520620454|FG000|Long-term Extension Period|Death|0|||
144385031|NCT00095147|520620455|FG001|Long-term Extension Period|Death|0|||
144385032|NCT00095147|520620456|FG002|Long-term Extension Period|Death|0|||
144385033|NCT00095147|520620457|FG003|Long-term Extension Period|Death|0|||
144385034|NCT00095147|520620458|FG004|Long-term Extension Period|Death|3|||
144385035|NCT00095147|520620454|FG000|Long-term Extension Period|Adverse Event|0|||
144385036|NCT00095147|520620455|FG001|Long-term Extension Period|Adverse Event|0|||
144385037|NCT00095147|520620456|FG002|Long-term Extension Period|Adverse Event|0|||
144385038|NCT00095147|520620457|FG003|Long-term Extension Period|Adverse Event|0|||
144385039|NCT00095147|520620458|FG004|Long-term Extension Period|Adverse Event|11|||
144385040|NCT00095147|520620454|FG000|Long-term Extension Period|Lack of Efficacy|0|||
144385041|NCT00095147|520620455|FG001|Long-term Extension Period|Lack of Efficacy|0|||
144385042|NCT00095147|520620456|FG002|Long-term Extension Period|Lack of Efficacy|0|||
144385043|NCT00095147|520620457|FG003|Long-term Extension Period|Lack of Efficacy|0|||
144515236|NCT03732820|521085852|FG000|Overall Study|Patient decision|14|||
144722001|NCT00290745|521836930|FG000|Overall Study|Surgery after 3 months for progression|3|||
144722002|NCT00290745|521836930|FG000|Overall Study|Baseline MRI not available|3|||
144722003|NCT00783796|521836931|FG000|Overall Study|Did not receive any stent|4|||
144722004|NCT00783796|521836931|FG000|Overall Study|Received non-XIENCE V stent|1|||
144385044|NCT00095147|520620458|FG004|Long-term Extension Period|Lack of Efficacy|9|||
144385045|NCT00095147|520620454|FG000|Long-term Extension Period|Lost to Follow-up|0|||
144722005|NCT00783796|521836931|FG000|Overall Study|Received commercial XIENCE V stent|1|||
144722006|NCT00626925|521836936|FG000|Overall Study|Lost to Follow-up|1|||
144722007|NCT00626925|521836937|FG001|Overall Study|Lost to Follow-up|2|||
144722008|NCT00626925|521836936|FG000|Overall Study|relapse|1|||
144722009|NCT00626925|521836937|FG001|Overall Study|relapse|0|||
144722010|NCT00626925|521836936|FG000|Overall Study|Adverse effect|6|||
144722011|NCT00626925|521836937|FG001|Overall Study|Adverse effect|2|||
144722012|NCT00626925|521836936|FG000|Overall Study|Lack of Efficacy|1|||
144722013|NCT00626925|521836937|FG001|Overall Study|Lack of Efficacy|4|||
144722014|NCT00626925|521836936|FG000|Overall Study|Time constraints|3|||
144722015|NCT00626925|521836937|FG001|Overall Study|Time constraints|1|||
144722016|NCT01215942|521836940|FG000|Treatment Period|Adverse Event|15|||
144722017|NCT01215942|521836941|FG001|Treatment Period|Adverse Event|26|||
144722018|NCT01215942|521836940|FG000|Treatment Period|Death|2|||
144722019|NCT01215942|521836941|FG001|Treatment Period|Death|4|||
144722020|NCT01215942|521836940|FG000|Treatment Period|Lack of Efficacy|23|||
144722021|NCT01215942|521836941|FG001|Treatment Period|Lack of Efficacy|62|||
144722022|NCT01215942|521836940|FG000|Treatment Period|Lost to Follow-up|3|||
144722023|NCT01215942|521836941|FG001|Treatment Period|Lost to Follow-up|4|||
144722024|NCT01215942|521836940|FG000|Treatment Period|Withdrawal by Subject|17|||
144722025|NCT01215942|521836941|FG001|Treatment Period|Withdrawal by Subject|40|||
144722026|NCT01215942|521836940|FG000|Treatment Period|Physician Decision|5|||
144722027|NCT01215942|521836941|FG001|Treatment Period|Physician Decision|5|||
144722028|NCT01215942|521836940|FG000|Treatment Period|Protocol Violation|0|||
144722029|NCT01215942|521836941|FG001|Treatment Period|Protocol Violation|1|||
144722030|NCT01215942|521836940|FG000|Treatment Period|Sponsor Decision|349|||
144722031|NCT01215942|521836941|FG001|Treatment Period|Sponsor Decision|530|||
144722032|NCT01215942|521836940|FG000|Post-Treatment Follow-Up Period|Death|0|||
144722033|NCT01215942|521836941|FG001|Post-Treatment Follow-Up Period|Death|1|||
144722034|NCT01215942|521836940|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
144722035|NCT01215942|521836941|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
144722036|NCT01215942|521836940|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
144722037|NCT01215942|521836941|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
144722038|NCT01215942|521836940|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
144722039|NCT01215942|521836941|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
144722040|NCT01215942|521836940|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
144722041|NCT01215942|521836941|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
144722042|NCT00113490|521836942|FG000|Overall Study|Withdrawal by Subject|1|||
144722043|NCT00113490|521836943|FG001|Overall Study|Withdrawal by Subject|3|||
144722044|NCT00113490|521836942|FG000|Overall Study|Lost to Follow-up|1|||
144722045|NCT00113490|521836943|FG001|Overall Study|Lost to Follow-up|0|||
144722046|NCT00819247|521836944|FG000|Overall Study|Adverse Event|0|||
144722047|NCT00819247|521836945|FG001|Overall Study|Adverse Event|5|||
144722048|NCT00819247|521836946|FG002|Overall Study|Adverse Event|3|||
144722049|NCT00819247|521836944|FG000|Overall Study|Insufficient testosterone response|5|||
144722050|NCT00819247|521836945|FG001|Overall Study|Insufficient testosterone response|8|||
144722051|NCT00819247|521836946|FG002|Overall Study|Insufficient testosterone response|10|||
144722052|NCT00819247|521836944|FG000|Overall Study|Withdrawal by Subject|1|||
144722053|NCT00819247|521836945|FG001|Overall Study|Withdrawal by Subject|0|||
144722054|NCT00819247|521836946|FG002|Overall Study|Withdrawal by Subject|0|||
144722055|NCT00819247|521836944|FG000|Overall Study|Protocol Violation|1|||
144385046|NCT00095147|520620455|FG001|Long-term Extension Period|Lost to Follow-up|0|||
144385047|NCT00095147|520620456|FG002|Long-term Extension Period|Lost to Follow-up|0|||
144385048|NCT00095147|520620457|FG003|Long-term Extension Period|Lost to Follow-up|0|||
144385049|NCT00095147|520620458|FG004|Long-term Extension Period|Lost to Follow-up|6|||
144385050|NCT00095147|520620454|FG000|Long-term Extension Period|Withdrawal of consent|0|||
144385051|NCT00095147|520620455|FG001|Long-term Extension Period|Withdrawal of consent|0|||
144385052|NCT00095147|520620456|FG002|Long-term Extension Period|Withdrawal of consent|0|||
144385053|NCT00095147|520620457|FG003|Long-term Extension Period|Withdrawal of consent|0|||
144385054|NCT00095147|520620458|FG004|Long-term Extension Period|Withdrawal of consent|12|||
144385055|NCT00095147|520620454|FG000|Long-term Extension Period|Pregnancy|0|||
144385056|NCT00095147|520620455|FG001|Long-term Extension Period|Pregnancy|0|||
144515237|NCT03732820|521085853|FG001|Overall Study|Patient decision|10|||
144722056|NCT00819247|521836945|FG001|Overall Study|Protocol Violation|0|||
144722057|NCT00819247|521836946|FG002|Overall Study|Protocol Violation|1|||
144722058|NCT00819247|521836944|FG000|Overall Study|Mistakenly withdrawn|0|||
144722059|NCT00819247|521836945|FG001|Overall Study|Mistakenly withdrawn|1|||
144722060|NCT00819247|521836946|FG002|Overall Study|Mistakenly withdrawn|0|||
144722061|NCT00819247|521836944|FG000|Overall Study|Bad prostate-specific antigen response|3|||
144722062|NCT00819247|521836945|FG001|Overall Study|Bad prostate-specific antigen response|2|||
144722063|NCT00819247|521836946|FG002|Overall Study|Bad prostate-specific antigen response|0|||
144722064|NCT00819247|521836944|FG000|Overall Study|Other|1|||
144722065|NCT00819247|521836945|FG001|Overall Study|Other|0|||
144722066|NCT00819247|521836946|FG002|Overall Study|Other|0|||
144722067|NCT00708422|521836947|FG000|Overall Study|Adverse Event|3|||
144385057|NCT00095147|520620456|FG002|Long-term Extension Period|Pregnancy|0|||
144385058|NCT00095147|520620457|FG003|Long-term Extension Period|Pregnancy|0|||
144385059|NCT00095147|520620458|FG004|Long-term Extension Period|Pregnancy|1|||
144385060|NCT00095147|520620454|FG000|Long-term Extension Period|No longer meets study criteria|0|||
144385061|NCT00095147|520620455|FG001|Long-term Extension Period|No longer meets study criteria|0|||
144385062|NCT00095147|520620456|FG002|Long-term Extension Period|No longer meets study criteria|0|||
144385063|NCT00095147|520620457|FG003|Long-term Extension Period|No longer meets study criteria|0|||
144385064|NCT00095147|520620458|FG004|Long-term Extension Period|No longer meets study criteria|1|||
144385065|NCT00095147|520620454|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
144385066|NCT00095147|520620455|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
144385067|NCT00095147|520620456|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
144385068|NCT00095147|520620457|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
144385069|NCT00095147|520620458|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
144385070|NCT00095147|520620454|FG000|Long-term Extension Period|Leaving country|0|||
144385071|NCT00095147|520620455|FG001|Long-term Extension Period|Leaving country|0|||
144385072|NCT00095147|520620456|FG002|Long-term Extension Period|Leaving country|0|||
144385073|NCT00095147|520620457|FG003|Long-term Extension Period|Leaving country|0|||
144385074|NCT00095147|520620458|FG004|Long-term Extension Period|Leaving country|1|||
144385075|NCT02650921|520620459|FG000|Overall Study|Withdrawal by Subject|4|||
144385076|NCT02650921|520620459|FG000|Overall Study|Lost to Follow-up|2|||
144385077|NCT02650921|520620459|FG000|Overall Study|Adverse Event|1|||
144385078|NCT02650921|520620459|FG000|Overall Study|Due to Medical Condition|1|||
144385079|NCT02395302|520620460|FG000|Overall Study|Screen Failure|3|||
144385080|NCT02395302|520620460|FG000|Overall Study|Run In Failure|7|||
144385081|NCT02395302|520620460|FG000|Overall Study|Withdrawal by Subject|2|||
144385082|NCT02395302|520620460|FG000|Overall Study|Physician Decision|2|||
144385083|NCT00783302|520620461|FG000|Overall Study|Lost to Follow-up|17|||
144385084|NCT00783302|520620461|FG000|Overall Study|Technical Problems|11|||
144385085|NCT00783302|520620461|FG000|Overall Study|Protocol Violation|3|||
144385086|NCT00783302|520620461|FG000|Overall Study|Physician Decision|1|||
144385087|NCT00783302|520620461|FG000|Overall Study|Withdrawal by Subject|3|||
144385088|NCT00160667|520620462|FG000|Overall Study|Adverse Event|3|||
144385089|NCT00160667|520620463|FG001|Overall Study|Adverse Event|1|||
144385090|NCT00160667|520620464|FG002|Overall Study|Adverse Event|4|||
144385091|NCT00160667|520620462|FG000|Overall Study|Withdrawal by Subject|2|||
144385092|NCT00160667|520620463|FG001|Overall Study|Withdrawal by Subject|0|||
144385093|NCT00160667|520620464|FG002|Overall Study|Withdrawal by Subject|1|||
144385094|NCT00160667|520620462|FG000|Overall Study|Lack of Efficacy|0|||
144385095|NCT00160667|520620463|FG001|Overall Study|Lack of Efficacy|1|||
144385096|NCT00160667|520620464|FG002|Overall Study|Lack of Efficacy|0|||
144385097|NCT00160667|520620462|FG000|Overall Study|Protocol Violation|0|||
144385098|NCT00160667|520620463|FG001|Overall Study|Protocol Violation|1|||
144385099|NCT00160667|520620464|FG002|Overall Study|Protocol Violation|0|||
144385100|NCT00160667|520620462|FG000|Overall Study|Patient decision|0|||
144385101|NCT00160667|520620463|FG001|Overall Study|Patient decision|0|||
144515238|NCT03732820|521085852|FG000|Overall Study|Screen failure|0|||
144515239|NCT03732820|521085853|FG001|Overall Study|Screen failure|1|||
144515240|NCT03732820|521085852|FG000|Overall Study|Patients ongoing study at data cut off|210|||
144515241|NCT03732820|521085853|FG001|Overall Study|Patients ongoing study at data cut off|178|||
144515242|NCT03732820|521085852|FG000|Overall Study|Lost to Follow-up|4|||
144515243|NCT03732820|521085853|FG001|Overall Study|Lost to Follow-up|2|||
144515244|NCT00999167|521085856|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
144515245|NCT00999167|521085857|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
144515246|NCT00999167|521085858|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
144515247|NCT00999167|521085856|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
144515248|NCT00999167|521085857|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
144515249|NCT00999167|521085858|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
144515250|NCT00999167|521085856|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
144515251|NCT00999167|521085857|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
144592811|NCT03464097|521370697|FG001|Overall Study|Withdrawal by Subject|13|||
144592812|NCT03464097|521370698|FG002|Overall Study|Withdrawal by Subject|11|||
144385102|NCT00160667|520620464|FG002|Overall Study|Patient decision|1|||
144385103|NCT01917656|520620468|FG000|Overall Study|Adverse Event|11|||
144385104|NCT01917656|520620469|FG001|Overall Study|Adverse Event|0|||
144385105|NCT01917656|520620468|FG000|Overall Study|Withdrawal criteria|8|||
144515252|NCT00999167|521085858|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
144515253|NCT00999167|521085856|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
144515254|NCT00999167|521085857|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
144385106|NCT01917656|520620469|FG001|Overall Study|Withdrawal criteria|14|||
144385107|NCT01917656|520620468|FG000|Overall Study|Unclassified|0|||
144385108|NCT01917656|520620469|FG001|Overall Study|Unclassified|3|||
144385109|NCT01917656|520620468|FG000|Overall Study|Withdrawal by Subject|4|||
144385110|NCT01917656|520620469|FG001|Overall Study|Withdrawal by Subject|3|||
144385111|NCT01917656|520620468|FG000|Overall Study|Lost to Follow-up|3|||
144385112|NCT01917656|520620469|FG001|Overall Study|Lost to Follow-up|4|||
144385113|NCT02285062|520620470|FG000|Pre-Treatment Period|Protocol Violation|0|||
144385114|NCT02285062|520620471|FG001|Pre-Treatment Period|Protocol Violation|2|||
144385115|NCT02285062|520620470|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
144385116|NCT02285062|520620471|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
144385117|NCT02015221|520620472|FG000|Overall Study|Withdrawal by Subject|8|||
144385118|NCT02015221|520620473|FG001|Overall Study|Withdrawal by Subject|6|||
144385119|NCT02015221|520620472|FG000|Overall Study|Lost to Follow-up|1|||
144385120|NCT02015221|520620473|FG001|Overall Study|Lost to Follow-up|0|||
144385121|NCT01306929|520620474|FG000|Overall Study|Withdrawal by Subject|23|||
144385122|NCT01306929|520620474|FG000|Overall Study|Adverse Event|21|||
144385123|NCT01306929|520620474|FG000|Overall Study|Physician Decision|13|||
144385124|NCT01306929|520620474|FG000|Overall Study|Death|8|||
144385125|NCT01306929|520620474|FG000|Overall Study|Withdrawal by parent/guardian|5|||
144385126|NCT01306929|520620474|FG000|Overall Study|Protocol Violation|3|||
144385127|NCT01306929|520620474|FG000|Overall Study|Non-compliance with study drug|2|||
144385128|NCT01306929|520620474|FG000|Overall Study|Lost to Follow-up|2|||
144385129|NCT01306929|520620474|FG000|Overall Study|Various|17|||
144385130|NCT03041129|520620483|FG000|Overall Study|Withdrawal by Subject|2|||
144385131|NCT03041129|520620484|FG001|Overall Study|Withdrawal by Subject|0|||
144385132|NCT03041129|520620485|FG002|Overall Study|Withdrawal by Subject|0|||
144385133|NCT03041129|520620486|FG003|Overall Study|Withdrawal by Subject|0|||
144385134|NCT00890045|520620489|FG000|Overall Study|Death|0|||
144385135|NCT00890045|520620490|FG001|Overall Study|Death|1|||
144385136|NCT00890045|520620489|FG000|Overall Study|Did not receive HeRO Graft|0|||
144385137|NCT00890045|520620490|FG001|Overall Study|Did not receive HeRO Graft|2|||
144385138|NCT00890045|520620489|FG000|Overall Study|Lost to Follow-up|5|||
144385139|NCT00890045|520620490|FG001|Overall Study|Lost to Follow-up|7|||
144385140|NCT00510653|520620491|FG000|Overall Study|Withdrawal by Subject|8|||
144385141|NCT00510653|520620491|FG000|Overall Study|Monetary|3|||
144385142|NCT00483756|520620494|FG000|Overall Study|Death|2|||
144385143|NCT00483756|520620495|FG001|Overall Study|Death|0|||
144385144|NCT00483756|520620496|FG002|Overall Study|Death|1|||
144385145|NCT00483756|520620494|FG000|Overall Study|Adverse Event|19|||
144385146|NCT00483756|520620495|FG001|Overall Study|Adverse Event|38|||
144385147|NCT00483756|520620496|FG002|Overall Study|Adverse Event|40|||
144385148|NCT00483756|520620494|FG000|Overall Study|Lack of Efficacy|1|||
144385149|NCT00483756|520620495|FG001|Overall Study|Lack of Efficacy|0|||
144385150|NCT00483756|520620496|FG002|Overall Study|Lack of Efficacy|0|||
144385151|NCT00483756|520620494|FG000|Overall Study|Lost to Follow-up|3|||
144385152|NCT00483756|520620495|FG001|Overall Study|Lost to Follow-up|1|||
144385153|NCT00483756|520620496|FG002|Overall Study|Lost to Follow-up|0|||
144385154|NCT00483756|520620494|FG000|Overall Study|Withdrawal by Subject|5|||
144385155|NCT00483756|520620495|FG001|Overall Study|Withdrawal by Subject|3|||
144385156|NCT00483756|520620496|FG002|Overall Study|Withdrawal by Subject|4|||
144385157|NCT00483756|520620494|FG000|Overall Study|Other|2|||
144385158|NCT00483756|520620495|FG001|Overall Study|Other|4|||
144515255|NCT00999167|521085858|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
144515256|NCT00999167|521085856|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
144515257|NCT00999167|521085857|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
144515258|NCT00999167|521085858|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
144515259|NCT00999167|521085856|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
144515260|NCT00999167|521085857|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
144515261|NCT00999167|521085858|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
144515262|NCT00999167|521085856|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
144515263|NCT00999167|521085857|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
144515264|NCT00999167|521085858|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
144515265|NCT00999167|521085856|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
144515266|NCT00999167|521085857|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
144515267|NCT00999167|521085858|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
144515268|NCT04287985|521085866|FG000|Overall Study|Adverse Event|1|||
144515269|NCT04287985|521085867|FG001|Overall Study|Adverse Event|0|||
144515270|NCT04287985|521085868|FG002|Overall Study|Adverse Event|0|||
144722068|NCT00708422|521836948|FG001|Overall Study|Adverse Event|1|||
144385159|NCT00483756|520620496|FG002|Overall Study|Other|3|||
144385160|NCT00483756|520620494|FG000|Overall Study|Randomized, Not Treated|1|||
144385161|NCT00483756|520620495|FG001|Overall Study|Randomized, Not Treated|4|||
144385162|NCT00483756|520620496|FG002|Overall Study|Randomized, Not Treated|4|||
144385163|NCT00436501|520620497|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
144385164|NCT00436501|520620498|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
144385165|NCT00436501|520620497|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
144385166|NCT00436501|520620498|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
144385167|NCT00495040|520620499|FG000|Overall Study|Withdrawal by Subject|3|||
144385168|NCT00621621|520620502|FG000|Overall Study|Subjects were exited at EP study|30|||
144385169|NCT00621621|520620503|FG001|Overall Study|Subjects were exited at EP study|0|||
144385170|NCT00906971|520620507|FG000|Overall Study|Withdrawal by Subject|8|||
144385171|NCT00906971|520620508|FG001|Overall Study|Withdrawal by Subject|2|||
144385172|NCT00906971|520620507|FG000|Overall Study|Lost to Follow-up|0|||
144385173|NCT00906971|520620508|FG001|Overall Study|Lost to Follow-up|1|||
144385174|NCT00545129|520620509|FG000|Overall Study|Lack of Efficacy|2|||
144385175|NCT00545129|520620510|FG001|Overall Study|Lack of Efficacy|5|||
144385176|NCT00545129|520620509|FG000|Overall Study|Death|2|||
144385177|NCT00545129|520620510|FG001|Overall Study|Death|1|||
144385178|NCT00545129|520620509|FG000|Overall Study|Adverse Event|1|||
144385179|NCT00545129|520620510|FG001|Overall Study|Adverse Event|1|||
144385180|NCT00545129|520620509|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
144385181|NCT00545129|520620510|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
144385182|NCT00545129|520620509|FG000|Overall Study|Other|3|||
144385183|NCT00545129|520620510|FG001|Overall Study|Other|3|||
144385184|NCT00821509|520620511|FG000|Overall Study|Withdrawal by Subject|12|||
144385185|NCT00821509|520620512|FG001|Overall Study|Withdrawal by Subject|11|||
144385186|NCT00821509|520620513|FG002|Overall Study|Withdrawal by Subject|34|||
144385187|NCT01894568|520620514|FG000|Overall Study|Adverse Event|2|||
144385188|NCT01894568|520620515|FG001|Overall Study|Adverse Event|3|||
144385189|NCT01894568|520620514|FG000|Overall Study|Protocol required discontinuation|2|||
144385190|NCT01894568|520620515|FG001|Overall Study|Protocol required discontinuation|1|||
144385191|NCT01894568|520620514|FG000|Overall Study|Withdrawal by Subject|5|||
144385192|NCT01894568|520620515|FG001|Overall Study|Withdrawal by Subject|5|||
144385193|NCT01894568|520620514|FG000|Overall Study|Physician Decision|1|||
144385194|NCT01894568|520620515|FG001|Overall Study|Physician Decision|0|||
144385195|NCT01894568|520620514|FG000|Overall Study|Lost to Follow-up|0|||
144385196|NCT01894568|520620515|FG001|Overall Study|Lost to Follow-up|1|||
144385197|NCT01551420|520620516|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
144385198|NCT01551420|520620517|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
144385199|NCT01551420|520620516|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
144385200|NCT01551420|520620517|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
144385201|NCT01551420|520620516|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
144385202|NCT01551420|520620517|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
144385203|NCT01551420|520620516|FG000|Screened for Part B Eligibility|Declined participation|8|||
144385204|NCT01551420|520620517|FG001|Screened for Part B Eligibility|Declined participation|1|||
144385205|NCT01551420|520620516|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
144385206|NCT01551420|520620517|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
144385207|NCT01551420|520620516|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
144385208|NCT01551420|520620517|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
144385209|NCT01551420|520620516|FG000|Home Use (Part B)|Withdrawal by staff|0|||
144385210|NCT01551420|520620517|FG001|Home Use (Part B)|Withdrawal by staff|1|||
144385211|NCT00169442|520620518|FG000|Overall Study|Withdrawal by Subject|0|||
144385212|NCT00169442|520620519|FG001|Overall Study|Withdrawal by Subject|0|||
144385213|NCT00169442|520620520|FG002|Overall Study|Withdrawal by Subject|1|||
144385214|NCT00169442|520620521|FG003|Overall Study|Withdrawal by Subject|0|||
144385215|NCT00169442|520620522|FG004|Overall Study|Withdrawal by Subject|0|||
144385216|NCT00169442|520620523|FG005|Overall Study|Withdrawal by Subject|0|||
144385217|NCT00169442|520620518|FG000|Overall Study|Migrated/moved from study area|0|||
144385218|NCT00169442|520620519|FG001|Overall Study|Migrated/moved from study area|0|||
144385219|NCT00169442|520620520|FG002|Overall Study|Migrated/moved from study area|0|||
144385220|NCT00169442|520620521|FG003|Overall Study|Migrated/moved from study area|0|||
144385221|NCT00169442|520620522|FG004|Overall Study|Migrated/moved from study area|0|||
144385222|NCT00169442|520620523|FG005|Overall Study|Migrated/moved from study area|2|||
144385223|NCT00169442|520620518|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
144385224|NCT00169442|520620519|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
144385225|NCT00169442|520620520|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
144385226|NCT00169442|520620521|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
144385227|NCT00169442|520620522|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
144385228|NCT00169442|520620523|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
144385229|NCT00169442|520620518|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
144385230|NCT00169442|520620519|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
144385231|NCT00169442|520620520|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
144385232|NCT00169442|520620521|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
144385233|NCT00169442|520620522|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
144385234|NCT00169442|520620523|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
144385235|NCT01426789|520620524|FG000|Part 1|Protocol deviation|0|||
144385236|NCT01426789|520620525|FG001|Part 1|Protocol deviation|1|||
144385237|NCT01426789|520620526|FG002|Part 1|Protocol deviation|0|||
144385238|NCT01426789|520620527|FG003|Part 1|Protocol deviation|0|||
144385239|NCT01426789|520620528|FG004|Part 1|Protocol deviation|0|||
144385240|NCT01426789|520620529|FG005|Part 1|Protocol deviation|0|||
144385241|NCT01426789|520620524|FG000|Part 1|Lost to Follow-up|1|||
144385242|NCT01426789|520620525|FG001|Part 1|Lost to Follow-up|2|||
144385243|NCT01426789|520620526|FG002|Part 1|Lost to Follow-up|0|||
144385244|NCT01426789|520620527|FG003|Part 1|Lost to Follow-up|0|||
144385245|NCT01426789|520620528|FG004|Part 1|Lost to Follow-up|0|||
144385246|NCT01426789|520620529|FG005|Part 1|Lost to Follow-up|0|||
144385247|NCT01426789|520620524|FG000|Part 1|Lack of Efficacy|2|||
144385248|NCT01426789|520620525|FG001|Part 1|Lack of Efficacy|1|||
144385249|NCT01426789|520620526|FG002|Part 1|Lack of Efficacy|0|||
144385250|NCT01426789|520620527|FG003|Part 1|Lack of Efficacy|0|||
144385251|NCT01426789|520620528|FG004|Part 1|Lack of Efficacy|0|||
144385252|NCT01426789|520620529|FG005|Part 1|Lack of Efficacy|0|||
144385253|NCT01426789|520620524|FG000|Part 1|Adverse Event|3|||
144385254|NCT01426789|520620525|FG001|Part 1|Adverse Event|0|||
144385255|NCT01426789|520620526|FG002|Part 1|Adverse Event|0|||
144385256|NCT01426789|520620527|FG003|Part 1|Adverse Event|0|||
144385257|NCT01426789|520620528|FG004|Part 1|Adverse Event|0|||
144385258|NCT01426789|520620529|FG005|Part 1|Adverse Event|0|||
144385259|NCT01426789|520620524|FG000|Part 2|Protocol deviation|0|||
144385260|NCT01426789|520620525|FG001|Part 2|Protocol deviation|0|||
144385261|NCT01426789|520620526|FG002|Part 2|Protocol deviation|1|||
144385262|NCT01426789|520620527|FG003|Part 2|Protocol deviation|0|||
144385263|NCT01426789|520620528|FG004|Part 2|Protocol deviation|0|||
144385264|NCT01426789|520620529|FG005|Part 2|Protocol deviation|0|||
144385265|NCT01426789|520620524|FG000|Part 2|Death|0|||
144385266|NCT01426789|520620525|FG001|Part 2|Death|0|||
144385267|NCT01426789|520620526|FG002|Part 2|Death|1|||
144385268|NCT01426789|520620527|FG003|Part 2|Death|0|||
144385269|NCT01426789|520620528|FG004|Part 2|Death|1|||
144385270|NCT01426789|520620529|FG005|Part 2|Death|0|||
144385271|NCT01426789|520620524|FG000|Part 2|Administrative problems|0|||
144385272|NCT01426789|520620525|FG001|Part 2|Administrative problems|0|||
144385273|NCT01426789|520620526|FG002|Part 2|Administrative problems|2|||
144385274|NCT01426789|520620527|FG003|Part 2|Administrative problems|0|||
144385275|NCT01426789|520620528|FG004|Part 2|Administrative problems|1|||
144385276|NCT01426789|520620529|FG005|Part 2|Administrative problems|0|||
144385277|NCT01426789|520620524|FG000|Part 2|Lost to Follow-up|0|||
144385278|NCT01426789|520620525|FG001|Part 2|Lost to Follow-up|0|||
144385279|NCT01426789|520620526|FG002|Part 2|Lost to Follow-up|4|||
144385280|NCT01426789|520620527|FG003|Part 2|Lost to Follow-up|0|||
144385281|NCT01426789|520620528|FG004|Part 2|Lost to Follow-up|1|||
144385282|NCT01426789|520620529|FG005|Part 2|Lost to Follow-up|0|||
144385283|NCT01426789|520620524|FG000|Part 2|Withdrawal by Subject|0|||
144385284|NCT01426789|520620525|FG001|Part 2|Withdrawal by Subject|0|||
144385285|NCT01426789|520620526|FG002|Part 2|Withdrawal by Subject|0|||
144385286|NCT01426789|520620527|FG003|Part 2|Withdrawal by Subject|1|||
144385287|NCT01426789|520620528|FG004|Part 2|Withdrawal by Subject|2|||
144385288|NCT01426789|520620529|FG005|Part 2|Withdrawal by Subject|0|||
144385289|NCT01426789|520620524|FG000|Part 2|Lack of Efficacy|0|||
144385290|NCT01426789|520620525|FG001|Part 2|Lack of Efficacy|0|||
144385291|NCT01426789|520620526|FG002|Part 2|Lack of Efficacy|5|||
144385292|NCT01426789|520620527|FG003|Part 2|Lack of Efficacy|0|||
144385293|NCT01426789|520620528|FG004|Part 2|Lack of Efficacy|2|||
144385294|NCT01426789|520620529|FG005|Part 2|Lack of Efficacy|0|||
144385295|NCT01426789|520620524|FG000|Part 2|Adverse Event|0|||
144385296|NCT01426789|520620525|FG001|Part 2|Adverse Event|0|||
144385297|NCT01426789|520620526|FG002|Part 2|Adverse Event|2|||
144385298|NCT01426789|520620527|FG003|Part 2|Adverse Event|0|||
144385299|NCT01426789|520620528|FG004|Part 2|Adverse Event|1|||
144385300|NCT01426789|520620529|FG005|Part 2|Adverse Event|0|||
144385301|NCT04054947|520620530|FG000|Overall Study|Withdrawal by Subject|1|||
144385302|NCT04054947|520620531|FG001|Overall Study|Withdrawal by Subject|0|||
144385303|NCT04054947|520620530|FG000|Overall Study|Lost to Follow-up|2|||
144385304|NCT04054947|520620531|FG001|Overall Study|Lost to Follow-up|5|||
144385305|NCT04463069|520620534|FG000|Overall Study|Withdrawal by Subject|2|||
144385306|NCT04463069|520620535|FG001|Overall Study|Withdrawal by Subject|10|||
144471747|NCT01591382|520925279|FG001|Overall Study|Discharged Prior to Study Completion|1|||
144471748|NCT01591382|520925278|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
144471749|NCT01591382|520925279|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
144471750|NCT00409682|520925291|FG000|Open-label Induction Period|Adverse Event|1|||
144471751|NCT00409682|520925292|FG001|Open-label Induction Period|Adverse Event|0|||
144471752|NCT00409682|520925293|FG002|Open-label Induction Period|Adverse Event|0|||
144471753|NCT00409682|520925291|FG000|Open-label Induction Period|Lack of Efficacy|1|||
144471754|NCT00409682|520925292|FG001|Open-label Induction Period|Lack of Efficacy|0|||
144471755|NCT00409682|520925293|FG002|Open-label Induction Period|Lack of Efficacy|0|||
144471756|NCT00409682|520925291|FG000|Open-label Induction Period|Protocol Violation|1|||
144471757|NCT00409682|520925292|FG001|Open-label Induction Period|Protocol Violation|0|||
144471758|NCT00409682|520925293|FG002|Open-label Induction Period|Protocol Violation|0|||
144471759|NCT00409682|520925291|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
144471760|NCT00409682|520925292|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
144471761|NCT00409682|520925293|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
144471762|NCT00409682|520925291|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
144471763|NCT00409682|520925292|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
144385307|NCT04463069|520620534|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
144385308|NCT04463069|520620535|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
144385309|NCT00311584|520620536|FG000|Overall Study|Death|1|||
144385310|NCT00311584|520620537|FG001|Overall Study|Death|0|||
144385311|NCT00311584|520620536|FG000|Overall Study|Lack of Efficacy|12|||
144385312|NCT00311584|520620537|FG001|Overall Study|Lack of Efficacy|15|||
144385313|NCT00311584|520620536|FG000|Overall Study|Physician Decision|4|||
144385314|NCT00311584|520620537|FG001|Overall Study|Physician Decision|5|||
144385315|NCT00311584|520620536|FG000|Overall Study|Withdrawal by Subject|1|||
144385316|NCT00311584|520620537|FG001|Overall Study|Withdrawal by Subject|1|||
144385317|NCT00311584|520620536|FG000|Overall Study|ineligible|2|||
144385318|NCT00311584|520620537|FG001|Overall Study|ineligible|2|||
144385319|NCT03720652|520620538|FG000|Overall Study|Withdrawal by Subject|2|||
144385320|NCT03720652|520620539|FG001|Overall Study|Withdrawal by Subject|7|||
144385321|NCT03720652|520620538|FG000|Overall Study|Lost to Follow-up|0|||
144385322|NCT03720652|520620539|FG001|Overall Study|Lost to Follow-up|4|||
144385323|NCT03073733|520620540|FG000|Overall Study|Lost to Follow-up|1|||
144385324|NCT03073733|520620541|FG001|Overall Study|Lost to Follow-up|0|||
144385325|NCT03073733|520620542|FG002|Overall Study|Lost to Follow-up|0|||
144385326|NCT03073733|520620540|FG000|Overall Study|Physician Decision|0|||
144385327|NCT03073733|520620541|FG001|Overall Study|Physician Decision|1|||
144385328|NCT03073733|520620542|FG002|Overall Study|Physician Decision|0|||
144385329|NCT03073733|520620540|FG000|Overall Study|Withdrawal by Subject|0|||
144385330|NCT03073733|520620541|FG001|Overall Study|Withdrawal by Subject|0|||
144385331|NCT03073733|520620542|FG002|Overall Study|Withdrawal by Subject|1|||
144385332|NCT00835731|520620543|FG000|Overall Study|Withdrawal by Subject|1|||
144385333|NCT00835731|520620544|FG001|Overall Study|Withdrawal by Subject|0|||
144385334|NCT00835731|520620543|FG000|Overall Study|Physician Decision|1|||
144385335|NCT00835731|520620544|FG001|Overall Study|Physician Decision|1|||
144385336|NCT03658876|520621966|FG000|Overall Study|Protocol Violation|3|||
144385337|NCT03658876|520621967|FG001|Overall Study|Protocol Violation|2|||
144385338|NCT03658876|520621966|FG000|Overall Study|Withdrawal by Subject|2|||
144385339|NCT03658876|520621967|FG001|Overall Study|Withdrawal by Subject|0|||
144385340|NCT03658876|520621966|FG000|Overall Study|Death|0|||
144385341|NCT03658876|520621967|FG001|Overall Study|Death|1|||
144385342|NCT03658876|520621966|FG000|Overall Study|Intercurrent illness|6|||
144385343|NCT03658876|520621967|FG001|Overall Study|Intercurrent illness|4|||
144385344|NCT03658876|520621966|FG000|Overall Study|Transplantation/other operation|1|||
144385345|NCT03658876|520621967|FG001|Overall Study|Transplantation/other operation|5|||
144385346|NCT02616146|520621968|FG000|Overall Study|Adverse Event|64|||
144385347|NCT02616146|520621969|FG001|Overall Study|Adverse Event|24|||
144385348|NCT02616146|520621968|FG000|Overall Study|Lost to Follow-up|23|||
144385349|NCT02616146|520621969|FG001|Overall Study|Lost to Follow-up|13|||
144385350|NCT02616146|520621968|FG000|Overall Study|Non-compliance with study protocol|2|||
144385351|NCT02616146|520621969|FG001|Overall Study|Non-compliance with study protocol|0|||
144385352|NCT02616146|520621968|FG000|Overall Study|Non-compliance with study drug|4|||
144385353|NCT02616146|520621969|FG001|Overall Study|Non-compliance with study drug|2|||
144385354|NCT02616146|520621968|FG000|Overall Study|Pregnancy|2|||
144385355|NCT02616146|520621969|FG001|Overall Study|Pregnancy|2|||
144385356|NCT02616146|520621968|FG000|Overall Study|Pregnancy wish|3|||
144385357|NCT02616146|520621969|FG001|Overall Study|Pregnancy wish|0|||
144385358|NCT02616146|520621968|FG000|Overall Study|Protocol Violation|6|||
144385359|NCT02616146|520621969|FG001|Overall Study|Protocol Violation|3|||
144515271|NCT04287985|521085869|FG003|Overall Study|Adverse Event|0|||
144515272|NCT04287985|521085866|FG000|Overall Study|Protocol Violation|0|||
144515273|NCT04287985|521085867|FG001|Overall Study|Protocol Violation|1|||
144515274|NCT04287985|521085868|FG002|Overall Study|Protocol Violation|0|||
144515275|NCT04287985|521085869|FG003|Overall Study|Protocol Violation|0|||
144515276|NCT04287985|521085866|FG000|Overall Study|Physician Decision|0|||
144515277|NCT04287985|521085867|FG001|Overall Study|Physician Decision|0|||
144515278|NCT04287985|521085868|FG002|Overall Study|Physician Decision|0|||
144515279|NCT04287985|521085869|FG003|Overall Study|Physician Decision|1|||
144385360|NCT02616146|520621968|FG000|Overall Study|Study terminated by sponsor|1372|||
144385361|NCT02616146|520621969|FG001|Overall Study|Study terminated by sponsor|432|||
144385362|NCT02616146|520621968|FG000|Overall Study|Participant moved|4|||
144385363|NCT02616146|520621969|FG001|Overall Study|Participant moved|3|||
144515280|NCT04287985|521085866|FG000|Overall Study|Withdrawal by Subject|2|||
144515281|NCT04287985|521085867|FG001|Overall Study|Withdrawal by Subject|1|||
144385364|NCT02616146|520621968|FG000|Overall Study|Withdrawal by Subject|30|||
144385365|NCT02616146|520621969|FG001|Overall Study|Withdrawal by Subject|24|||
144385366|NCT02616146|520621968|FG000|Overall Study|Physician Decision|2|||
144385367|NCT02616146|520621969|FG001|Overall Study|Physician Decision|1|||
144385368|NCT03039621|520621970|FG000|Overall Study|Violation of inclusion criteria|3|||
144385369|NCT03039621|520621971|FG001|Overall Study|Violation of inclusion criteria|2|||
144385370|NCT03039621|520621970|FG000|Overall Study|Non-compliance with protocol requirement|4|||
144385371|NCT03039621|520621971|FG001|Overall Study|Non-compliance with protocol requirement|5|||
144515282|NCT04287985|521085868|FG002|Overall Study|Withdrawal by Subject|1|||
144385372|NCT03039621|520621970|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
144385373|NCT03039621|520621971|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
144385374|NCT03039621|520621970|FG000|Overall Study|Violation of non-inclusion criteria|1|||
144385375|NCT03039621|520621971|FG001|Overall Study|Violation of non-inclusion criteria|2|||
144385376|NCT01143389|520621972|FG000|Overall Study|Lost to Follow-up|26|||
144385377|NCT01143389|520621973|FG001|Overall Study|Lost to Follow-up|25|||
144385378|NCT02907892|520621976|FG000|Overall Study|Lost to Follow-up|27|||
144385379|NCT02907892|520621977|FG001|Overall Study|Lost to Follow-up|40|||
144385380|NCT01974765|520621978|FG000|Overall Study|Withdrawal by Subject|1|||
144385381|NCT01974765|520621978|FG000|Overall Study|Death|1|||
144385382|NCT01974765|520621978|FG000|Overall Study|Adverse Event|2|||
144385383|NCT04531462|520621981|FG000|Overall Study|Withdrawal by Subject|3|||
144385384|NCT04531462|520621982|FG001|Overall Study|Withdrawal by Subject|1|||
144385385|NCT04531462|520621981|FG000|Overall Study|Adverse Event|3|||
144385386|NCT04531462|520621982|FG001|Overall Study|Adverse Event|3|||
144385387|NCT00504582|520621983|FG000|Overall Study|Lost to Follow-up|1|||
144385388|NCT00504582|520621984|FG001|Overall Study|Lost to Follow-up|0|||
144385389|NCT00504582|520621985|FG002|Overall Study|Lost to Follow-up|0|||
144385390|NCT00348933|520621988|FG000|Overall Study|Withdrawal by Subject|10|||
144385391|NCT00348933|520621988|FG000|Overall Study|Lost to Follow-up|6|||
144385392|NCT00348933|520621988|FG000|Overall Study|Protocol Violation|2|||
144385393|NCT00348933|520621988|FG000|Overall Study|Adverse Event|7|||
144385394|NCT01757691|520621993|FG000|Overall Study|Administrative problems|2|||
144385395|NCT01757691|520621994|FG001|Overall Study|Administrative problems|0|||
144385396|NCT00464490|520621995|FG000|Overall Study|Physician Decision|11|||
144385397|NCT00464490|520621996|FG001|Overall Study|Physician Decision|11|||
144385398|NCT03188042|520621997|FG000|Overall Study|Withdrawal by Subject|1|||
144385399|NCT03188042|520621998|FG001|Overall Study|Withdrawal by Subject|1|||
144385400|NCT03860935|520622003|FG000|Overall Study|Withdrawal of Consent|15|||
144385401|NCT03860935|520622004|FG001|Overall Study|Withdrawal of Consent|6|||
144385402|NCT03860935|520622003|FG000|Overall Study|Death|75|||
144385403|NCT03860935|520622004|FG001|Overall Study|Death|51|||
144385404|NCT03086967|520622005|FG000|Overall Study|Screen Failure|2|||
144385405|NCT03086967|520622006|FG001|Overall Study|Screen Failure|2|||
144385406|NCT01475071|520622013|FG000|Overall Study|Physician Decision|1|||
144385407|NCT01475071|520622013|FG000|Overall Study|Withdrawal by Subject|6|||
144385408|NCT01475071|520622013|FG000|Overall Study|Lost to Follow-up|1|||
144385409|NCT01209832|520622015|FG000|Period 1|Sponsor Decision and was not dosed|1|||
144385410|NCT01209832|520622015|FG000|Period 2|Sponsor Decision|1|||
144385411|NCT01268579|520622016|FG000|Overall Study|Adverse Event|1|||
144385412|NCT01268579|520622016|FG000|Overall Study|Withdrawal by Subject|2|||
144385413|NCT02480712|520622017|FG000|Overall Study|Enrolled but Never Treated|1|||
144385414|NCT02480712|520622017|FG000|Overall Study|Lost to Follow-up|5|||
144385415|NCT02480712|520622017|FG000|Overall Study|Withdrew Consent|3|||
144385416|NCT02480712|520622017|FG000|Overall Study|Death|1|||
144385417|NCT02480712|520622017|FG000|Overall Study|Lack of Efficacy|1|||
144385418|NCT01860846|520622018|FG000|Overall Study|Lost to Follow-up|33|||
144385419|NCT00466687|520622019|FG000|Overall Study|Adverse Event|1|||
144385420|NCT00466687|520622019|FG000|Overall Study|Other complicating illness|3|||
144385421|NCT00466687|520622019|FG000|Overall Study|Withdrawal by Subject|1|||
144385422|NCT00466687|520622019|FG000|Overall Study|Disease progression|29|||
144385423|NCT01284491|520622026|FG000|Overall Study|Study termination|13|||
144385424|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
144385425|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
144385426|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
144385427|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
144385428|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
144385429|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
144385430|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
144385431|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
144385432|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
144385433|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
144385434|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
144385435|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
144385436|NCT01087788|520622027|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
144385437|NCT01087788|520622028|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
144385438|NCT01087788|520622029|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
144385439|NCT01087788|520622027|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
144592813|NCT03464097|521370696|FG000|Overall Study|Study terminated by sponsor|47|||
144385440|NCT01087788|520622028|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
144385441|NCT01087788|520622029|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
144385442|NCT01087788|520622027|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
144385443|NCT01087788|520622028|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
144385444|NCT01087788|520622029|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
144385445|NCT01087788|520622027|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
144385446|NCT01087788|520622028|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
144385447|NCT01087788|520622029|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
144385448|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
144385449|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
144385450|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
144385451|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
144385452|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
144385453|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
144385454|NCT01087788|520622027|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
144385455|NCT01087788|520622028|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
144385456|NCT01087788|520622029|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
144385457|NCT01087788|520622027|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
144385458|NCT01087788|520622028|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
144385459|NCT01087788|520622029|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
144385460|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
144385461|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
144385462|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
144385463|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
144385464|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
144385465|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
144385466|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
144385467|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
144385468|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
144385469|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
144385470|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
144385471|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
144385472|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
144385473|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
144385474|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
144385475|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
144385476|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
144385477|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
144385478|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
144385479|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
144385480|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
144385481|NCT01087788|520622027|FG000|24-weeks Dose-blind Period|Patient moved|0|||
144385482|NCT01087788|520622028|FG001|24-weeks Dose-blind Period|Patient moved|0|||
144385483|NCT01087788|520622029|FG002|24-weeks Dose-blind Period|Patient moved|1|||
144385484|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
144385485|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
144385486|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
144385487|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
144385488|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
144385489|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
144385490|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
144385491|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
144385492|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
144385493|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
144385494|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
144385495|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
144385496|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
144385497|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
144385498|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
144385499|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
144385500|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
144385501|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
144385502|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
144385503|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
144385504|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
144385505|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
144385506|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
144385507|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
144385508|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
144385509|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
144385510|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
144385511|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
144385512|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
144385513|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
144385514|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
144385515|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
144385516|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
144385517|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
144385518|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
144385519|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
144385520|NCT01087788|520622027|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
144385521|NCT01087788|520622028|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
144385522|NCT01087788|520622029|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
144385523|NCT04604132|520622030|FG000|Overall Study|Adverse Event|2|||
144385524|NCT04604132|520622031|FG001|Overall Study|Adverse Event|0|||
144385525|NCT04604132|520622032|FG002|Overall Study|Adverse Event|0|||
144385526|NCT04604132|520622033|FG003|Overall Study|Adverse Event|1|||
144385527|NCT04604132|520622034|FG004|Overall Study|Adverse Event|2|||
144385528|NCT04604132|520622030|FG000|Overall Study|Study terminated by sponsor|0|||
144385529|NCT04604132|520622031|FG001|Overall Study|Study terminated by sponsor|0|||
144385530|NCT04604132|520622032|FG002|Overall Study|Study terminated by sponsor|0|||
144385531|NCT04604132|520622033|FG003|Overall Study|Study terminated by sponsor|0|||
144385532|NCT04604132|520622034|FG004|Overall Study|Study terminated by sponsor|1|||
144385533|NCT04604132|520622030|FG000|Overall Study|Progressive disease: Clinical progression|0|||
144385534|NCT04604132|520622031|FG001|Overall Study|Progressive disease: Clinical progression|0|||
144385535|NCT04604132|520622032|FG002|Overall Study|Progressive disease: Clinical progression|1|||
144385536|NCT04604132|520622033|FG003|Overall Study|Progressive disease: Clinical progression|0|||
144385537|NCT04604132|520622034|FG004|Overall Study|Progressive disease: Clinical progression|0|||
144385538|NCT04604132|520622030|FG000|Overall Study|Progressive disease: Radiological progression|8|||
144385539|NCT04604132|520622031|FG001|Overall Study|Progressive disease: Radiological progression|7|||
144385540|NCT04604132|520622032|FG002|Overall Study|Progressive disease: Radiological progression|10|||
144385541|NCT04604132|520622033|FG003|Overall Study|Progressive disease: Radiological progression|4|||
144385542|NCT04604132|520622034|FG004|Overall Study|Progressive disease: Radiological progression|3|||
144385543|NCT04604132|520622030|FG000|Overall Study|Death|3|||
144385544|NCT04604132|520622031|FG001|Overall Study|Death|1|||
144385545|NCT04604132|520622032|FG002|Overall Study|Death|2|||
144385546|NCT04604132|520622033|FG003|Overall Study|Death|1|||
144385547|NCT04604132|520622034|FG004|Overall Study|Death|0|||
144385548|NCT00952380|520622035|FG000|Overall Study|Other|0|||
144385549|NCT00952380|520622036|FG001|Overall Study|Other|0|||
144385550|NCT00952380|520622037|FG002|Overall Study|Other|0|||
144385551|NCT00952380|520622038|FG003|Overall Study|Other|0|||
144385552|NCT00952380|520622039|FG004|Overall Study|Other|1|||
144385553|NCT00952380|520622035|FG000|Overall Study|Withdrawal by Subject|0|||
144385554|NCT00952380|520622036|FG001|Overall Study|Withdrawal by Subject|0|||
144385555|NCT00952380|520622037|FG002|Overall Study|Withdrawal by Subject|1|||
144385556|NCT00952380|520622038|FG003|Overall Study|Withdrawal by Subject|0|||
144385557|NCT00952380|520622039|FG004|Overall Study|Withdrawal by Subject|2|||
144385558|NCT00952380|520622035|FG000|Overall Study|Adverse Event|0|||
144385559|NCT00952380|520622036|FG001|Overall Study|Adverse Event|1|||
144385560|NCT00952380|520622037|FG002|Overall Study|Adverse Event|0|||
144385561|NCT00952380|520622038|FG003|Overall Study|Adverse Event|0|||
144385562|NCT00952380|520622039|FG004|Overall Study|Adverse Event|3|||
144385563|NCT00952380|520622035|FG000|Overall Study|Physician Decision|0|||
144385564|NCT00952380|520622036|FG001|Overall Study|Physician Decision|0|||
144385565|NCT00952380|520622037|FG002|Overall Study|Physician Decision|1|||
144385566|NCT00952380|520622038|FG003|Overall Study|Physician Decision|2|||
144385567|NCT00952380|520622039|FG004|Overall Study|Physician Decision|0|||
144385568|NCT00952380|520622035|FG000|Overall Study|Non-compliant to protocol|0|||
144385569|NCT00952380|520622036|FG001|Overall Study|Non-compliant to protocol|0|||
144722069|NCT00708422|521836947|FG000|Overall Study|Withdrawal by Subject|1|||
144722070|NCT00708422|521836948|FG001|Overall Study|Withdrawal by Subject|0|||
144722071|NCT05476679|521836952|FG000|Overall Study|Withdrawal by Subject|0|||
144722072|NCT05476679|521836953|FG001|Overall Study|Withdrawal by Subject|0|||
144385570|NCT00952380|520622037|FG002|Overall Study|Non-compliant to protocol|0|||
144385571|NCT00952380|520622038|FG003|Overall Study|Non-compliant to protocol|1|||
144385572|NCT00952380|520622039|FG004|Overall Study|Non-compliant to protocol|0|||
144385573|NCT00534313|520622043|FG000|Short-term Period|Adverse Event|1|||
144385574|NCT00534313|520622044|FG001|Short-term Period|Adverse Event|2|||
144722073|NCT05476679|521836954|FG002|Overall Study|Withdrawal by Subject|0|||
144385575|NCT00534313|520622045|FG002|Short-term Period|Adverse Event|1|||
144385576|NCT00534313|520622046|FG003|Short-term Period|Adverse Event|3|||
144385577|NCT00534313|520622043|FG000|Short-term Period|Lack of Efficacy|3|||
144385578|NCT00534313|520622044|FG001|Short-term Period|Lack of Efficacy|4|||
144385579|NCT00534313|520622045|FG002|Short-term Period|Lack of Efficacy|0|||
144722074|NCT05476679|521836955|FG003|Overall Study|Withdrawal by Subject|1|||
144385580|NCT00534313|520622046|FG003|Short-term Period|Lack of Efficacy|3|||
144385581|NCT00534313|520622043|FG000|Short-term Period|Participant not meeting study criteria|0|||
144385582|NCT00534313|520622044|FG001|Short-term Period|Participant not meeting study criteria|0|||
144385583|NCT00534313|520622045|FG002|Short-term Period|Participant not meeting study criteria|0|||
144385584|NCT00534313|520622046|FG003|Short-term Period|Participant not meeting study criteria|1|||
144385585|NCT00534313|520622043|FG000|Short-term Period|Participant withdrew consent|2|||
144385586|NCT00534313|520622044|FG001|Short-term Period|Participant withdrew consent|0|||
144385587|NCT00534313|520622045|FG002|Short-term Period|Participant withdrew consent|0|||
144385588|NCT00534313|520622046|FG003|Short-term Period|Participant withdrew consent|2|||
144385589|NCT00534313|520622043|FG000|Short-term Period|Pregnancy|0|||
144385590|NCT00534313|520622044|FG001|Short-term Period|Pregnancy|0|||
144385591|NCT00534313|520622045|FG002|Short-term Period|Pregnancy|1|||
144385592|NCT00534313|520622046|FG003|Short-term Period|Pregnancy|0|||
144385593|NCT00534313|520622043|FG000|Long-term Period|Adverse Event|2|||
144385594|NCT00534313|520622044|FG001|Long-term Period|Adverse Event|1|||
144385595|NCT00534313|520622045|FG002|Long-term Period|Adverse Event|0|||
144385596|NCT00534313|520622046|FG003|Long-term Period|Adverse Event|1|||
144385597|NCT00534313|520622043|FG000|Long-term Period|Lack of Efficacy|14|||
144385598|NCT00534313|520622044|FG001|Long-term Period|Lack of Efficacy|10|||
144385599|NCT00534313|520622045|FG002|Long-term Period|Lack of Efficacy|14|||
144385600|NCT00534313|520622046|FG003|Long-term Period|Lack of Efficacy|12|||
144385601|NCT00534313|520622043|FG000|Long-term Period|Lost to Follow-up|1|||
144385602|NCT00534313|520622044|FG001|Long-term Period|Lost to Follow-up|2|||
144385603|NCT00534313|520622045|FG002|Long-term Period|Lost to Follow-up|0|||
144385604|NCT00534313|520622046|FG003|Long-term Period|Lost to Follow-up|0|||
144385605|NCT00534313|520622043|FG000|Long-term Period|Withdrawal by Subject|2|||
144385606|NCT00534313|520622044|FG001|Long-term Period|Withdrawal by Subject|2|||
144385607|NCT00534313|520622045|FG002|Long-term Period|Withdrawal by Subject|0|||
144385608|NCT00534313|520622046|FG003|Long-term Period|Withdrawal by Subject|0|||
144385609|NCT00534313|520622043|FG000|Long-term Period|No longer meets study criteria|0|||
144385610|NCT00534313|520622044|FG001|Long-term Period|No longer meets study criteria|1|||
144385611|NCT00534313|520622045|FG002|Long-term Period|No longer meets study criteria|0|||
144385612|NCT00534313|520622046|FG003|Long-term Period|No longer meets study criteria|0|||
144385613|NCT00534313|520622043|FG000|Long-term Period|Poor compliance/noncompliance|0|||
144385614|NCT00534313|520622044|FG001|Long-term Period|Poor compliance/noncompliance|1|||
144385615|NCT00534313|520622045|FG002|Long-term Period|Poor compliance/noncompliance|1|||
144385616|NCT00534313|520622046|FG003|Long-term Period|Poor compliance/noncompliance|0|||
144385617|NCT00534313|520622043|FG000|Long-term Period|Administrative reason by sponsor|17|||
144385618|NCT00534313|520622044|FG001|Long-term Period|Administrative reason by sponsor|15|||
144385619|NCT00534313|520622045|FG002|Long-term Period|Administrative reason by sponsor|26|||
144385620|NCT00534313|520622046|FG003|Long-term Period|Administrative reason by sponsor|18|||
144385621|NCT00534313|520622043|FG000|Long-term Period|Other|1|||
144385622|NCT00534313|520622044|FG001|Long-term Period|Other|2|||
144385623|NCT00534313|520622045|FG002|Long-term Period|Other|2|||
144385624|NCT00534313|520622046|FG003|Long-term Period|Other|2|||
144385625|NCT00927940|520622047|FG000|Overall Study|Death|1|||
144385626|NCT03007888|520622048|FG000|First Intervention (14 Days)|Adverse Event|1|||
144385627|NCT03007888|520622049|FG001|First Intervention (14 Days)|Adverse Event|0|||
144385628|NCT00827931|520622051|FG000|Overall Study|Death|3|||
144385629|NCT00827931|520622052|FG001|Overall Study|Death|5|||
144385630|NCT00827931|520622051|FG000|Overall Study|Adverse Event|1|||
144385631|NCT00827931|520622052|FG001|Overall Study|Adverse Event|0|||
144385632|NCT00827931|520622051|FG000|Overall Study|Lost to Follow-up|1|||
144385633|NCT00827931|520622052|FG001|Overall Study|Lost to Follow-up|0|||
144385634|NCT00827931|520622051|FG000|Overall Study|Withdrawal by Subject|0|||
144385635|NCT00827931|520622052|FG001|Overall Study|Withdrawal by Subject|1|||
144385636|NCT00827931|520622051|FG000|Overall Study|Other|1|||
144385637|NCT00827931|520622052|FG001|Overall Study|Other|0|||
144385638|NCT00492063|520622053|FG000|Overall Study|Death|0|||
144515283|NCT04287985|521085869|FG003|Overall Study|Withdrawal by Subject|2|||
144515284|NCT01340066|521085870|FG000|Placebo Run in Period|Screen Failures|27|||
144515285|NCT01340066|521085871|FG001|Placebo Run in Period|Screen Failures|0|||
144515286|NCT01340066|521085872|FG002|Placebo Run in Period|Screen Failures|0|||
144515287|NCT01340066|521085870|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
144515288|NCT01340066|521085871|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
144385639|NCT00492063|520622054|FG001|Overall Study|Death|0|||
144385640|NCT00492063|520622055|FG002|Overall Study|Death|1|||
144385641|NCT00492063|520622056|FG003|Overall Study|Death|2|||
144385642|NCT00492063|520622053|FG000|Overall Study|Withdrawal by Subject|4|||
144385643|NCT00492063|520622054|FG001|Overall Study|Withdrawal by Subject|3|||
144385644|NCT00492063|520622055|FG002|Overall Study|Withdrawal by Subject|5|||
144385645|NCT00492063|520622056|FG003|Overall Study|Withdrawal by Subject|4|||
144515289|NCT01340066|521085872|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
144385646|NCT00492063|520622053|FG000|Overall Study|Lost to Follow-up|6|||
144385647|NCT00492063|520622054|FG001|Overall Study|Lost to Follow-up|11|||
144385648|NCT00492063|520622055|FG002|Overall Study|Lost to Follow-up|5|||
144385649|NCT00492063|520622056|FG003|Overall Study|Lost to Follow-up|3|||
144385650|NCT00492063|520622053|FG000|Overall Study|Protocol Violation|0|||
144385651|NCT00492063|520622054|FG001|Overall Study|Protocol Violation|0|||
144385652|NCT00492063|520622055|FG002|Overall Study|Protocol Violation|0|||
144385653|NCT00492063|520622056|FG003|Overall Study|Protocol Violation|1|||
144385654|NCT01870076|520622057|FG000|Overall Study|Withdrawal by Subject|1|||
144385655|NCT01870076|520622058|FG001|Overall Study|Withdrawal by Subject|0|||
144385656|NCT01870076|520622059|FG002|Overall Study|Withdrawal by Subject|1|||
144385657|NCT01870076|520622060|FG003|Overall Study|Withdrawal by Subject|0|||
144385658|NCT01947855|520622063|FG000|Overall Study|Withdrawal by Subject|1|||
144385659|NCT01947855|520622064|FG001|Overall Study|Withdrawal by Subject|0|||
144385660|NCT01947855|520622065|FG002|Overall Study|Withdrawal by Subject|0|||
144385661|NCT00608569|520622069|FG000|Overall Study|Death|4|||
144385662|NCT00608569|520622070|FG001|Overall Study|Death|3|||
144385663|NCT00608569|520622069|FG000|Overall Study|Lost to Follow-up|4|||
144385664|NCT00608569|520622070|FG001|Overall Study|Lost to Follow-up|5|||
144385665|NCT00608569|520622069|FG000|Overall Study|Withdrawal by Subject|1|||
144385666|NCT00608569|520622070|FG001|Overall Study|Withdrawal by Subject|0|||
144385667|NCT00608569|520622069|FG000|Overall Study|Adverse Event|1|||
144385668|NCT00608569|520622070|FG001|Overall Study|Adverse Event|0|||
144385669|NCT00608569|520622069|FG000|Overall Study|Unable to adhere with study requirements|0|||
144385670|NCT00608569|520622070|FG001|Overall Study|Unable to adhere with study requirements|1|||
144385671|NCT03011892|520622071|FG000|Double Blind (DB) Period|Adverse Event|0|||
144385672|NCT03011892|520622072|FG001|Double Blind (DB) Period|Adverse Event|1|||
144385673|NCT03011892|520622073|FG002|Double Blind (DB) Period|Adverse Event|1|||
144385674|NCT03011892|520622074|FG003|Double Blind (DB) Period|Adverse Event|0|||
144385675|NCT03011892|520622075|FG004|Double Blind (DB) Period|Adverse Event|0|||
144385676|NCT03011892|520622076|FG005|Double Blind (DB) Period|Adverse Event|0|||
144385677|NCT03011892|520622077|FG006|Double Blind (DB) Period|Adverse Event|0|||
144385678|NCT03011892|520622078|FG007|Double Blind (DB) Period|Adverse Event|0|||
144385679|NCT03011892|520622079|FG008|Double Blind (DB) Period|Adverse Event|0|||
144385680|NCT03011892|520622080|FG009|Double Blind (DB) Period|Adverse Event|0|||
144385681|NCT03011892|520622081|FG010|Double Blind (DB) Period|Adverse Event|0|||
144385682|NCT03011892|520622082|FG011|Double Blind (DB) Period|Adverse Event|0|||
144385683|NCT03011892|520622071|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
144385684|NCT03011892|520622072|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
144385685|NCT03011892|520622073|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
144385686|NCT03011892|520622074|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
144385687|NCT03011892|520622075|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
144385688|NCT03011892|520622076|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
144385689|NCT03011892|520622077|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
144385690|NCT03011892|520622078|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
144385691|NCT03011892|520622079|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
144385692|NCT03011892|520622080|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
144385693|NCT03011892|520622081|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
144385694|NCT03011892|520622082|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
144385695|NCT03011892|520622071|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
144385696|NCT03011892|520622072|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
144385697|NCT03011892|520622073|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
144385698|NCT03011892|520622074|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
144385699|NCT03011892|520622075|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
144385700|NCT03011892|520622076|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
144385701|NCT03011892|520622077|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
144385702|NCT03011892|520622078|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
144385703|NCT03011892|520622079|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
144385704|NCT03011892|520622080|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
144385705|NCT03011892|520622081|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
144385706|NCT03011892|520622082|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
144385707|NCT03011892|520622071|FG000|Double Blind (DB) Period|Other|1|||
144385708|NCT03011892|520622072|FG001|Double Blind (DB) Period|Other|1|||
144385709|NCT03011892|520622073|FG002|Double Blind (DB) Period|Other|1|||
144385710|NCT03011892|520622074|FG003|Double Blind (DB) Period|Other|0|||
144385711|NCT03011892|520622075|FG004|Double Blind (DB) Period|Other|1|||
144385712|NCT03011892|520622076|FG005|Double Blind (DB) Period|Other|0|||
144385713|NCT03011892|520622077|FG006|Double Blind (DB) Period|Other|0|||
144385714|NCT03011892|520622078|FG007|Double Blind (DB) Period|Other|0|||
144385715|NCT03011892|520622079|FG008|Double Blind (DB) Period|Other|0|||
144385716|NCT03011892|520622080|FG009|Double Blind (DB) Period|Other|0|||
144385717|NCT03011892|520622081|FG010|Double Blind (DB) Period|Other|0|||
144385718|NCT03011892|520622082|FG011|Double Blind (DB) Period|Other|0|||
144385719|NCT03011892|520622071|FG000|Double Blind (DB) Period|Physician Decision|1|||
144385720|NCT03011892|520622072|FG001|Double Blind (DB) Period|Physician Decision|0|||
144385721|NCT03011892|520622073|FG002|Double Blind (DB) Period|Physician Decision|1|||
144385722|NCT03011892|520622074|FG003|Double Blind (DB) Period|Physician Decision|0|||
144385723|NCT03011892|520622075|FG004|Double Blind (DB) Period|Physician Decision|0|||
144385724|NCT03011892|520622076|FG005|Double Blind (DB) Period|Physician Decision|0|||
144385725|NCT03011892|520622077|FG006|Double Blind (DB) Period|Physician Decision|0|||
144385726|NCT03011892|520622078|FG007|Double Blind (DB) Period|Physician Decision|0|||
144385727|NCT03011892|520622079|FG008|Double Blind (DB) Period|Physician Decision|0|||
144385728|NCT03011892|520622080|FG009|Double Blind (DB) Period|Physician Decision|0|||
144385729|NCT03011892|520622081|FG010|Double Blind (DB) Period|Physician Decision|0|||
144385730|NCT03011892|520622082|FG011|Double Blind (DB) Period|Physician Decision|0|||
144385731|NCT03011892|520622071|FG000|Double Blind (DB) Period|Pregnancy|0|||
144385732|NCT03011892|520622072|FG001|Double Blind (DB) Period|Pregnancy|0|||
144385733|NCT03011892|520622073|FG002|Double Blind (DB) Period|Pregnancy|0|||
144385734|NCT03011892|520622074|FG003|Double Blind (DB) Period|Pregnancy|0|||
144385735|NCT03011892|520622075|FG004|Double Blind (DB) Period|Pregnancy|1|||
144385736|NCT03011892|520622076|FG005|Double Blind (DB) Period|Pregnancy|0|||
144385737|NCT03011892|520622077|FG006|Double Blind (DB) Period|Pregnancy|0|||
144385738|NCT03011892|520622078|FG007|Double Blind (DB) Period|Pregnancy|0|||
144385739|NCT03011892|520622079|FG008|Double Blind (DB) Period|Pregnancy|0|||
144385740|NCT03011892|520622080|FG009|Double Blind (DB) Period|Pregnancy|0|||
144385741|NCT03011892|520622081|FG010|Double Blind (DB) Period|Pregnancy|0|||
144385742|NCT03011892|520622082|FG011|Double Blind (DB) Period|Pregnancy|0|||
144385743|NCT03011892|520622071|FG000|Double Blind (DB) Period|Protocol Violation|1|||
144385744|NCT03011892|520622072|FG001|Double Blind (DB) Period|Protocol Violation|0|||
144385745|NCT03011892|520622073|FG002|Double Blind (DB) Period|Protocol Violation|0|||
144385746|NCT03011892|520622074|FG003|Double Blind (DB) Period|Protocol Violation|0|||
144385747|NCT03011892|520622075|FG004|Double Blind (DB) Period|Protocol Violation|0|||
144385748|NCT03011892|520622076|FG005|Double Blind (DB) Period|Protocol Violation|0|||
144385749|NCT03011892|520622077|FG006|Double Blind (DB) Period|Protocol Violation|0|||
144385750|NCT03011892|520622078|FG007|Double Blind (DB) Period|Protocol Violation|0|||
144385751|NCT03011892|520622079|FG008|Double Blind (DB) Period|Protocol Violation|0|||
144385752|NCT03011892|520622080|FG009|Double Blind (DB) Period|Protocol Violation|0|||
144385753|NCT03011892|520622081|FG010|Double Blind (DB) Period|Protocol Violation|0|||
144385754|NCT03011892|520622082|FG011|Double Blind (DB) Period|Protocol Violation|0|||
144385755|NCT03011892|520622071|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
144385756|NCT03011892|520622072|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
144385757|NCT03011892|520622073|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
144385758|NCT03011892|520622074|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
144385759|NCT03011892|520622075|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
144385760|NCT03011892|520622076|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
144385761|NCT03011892|520622077|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
144385762|NCT03011892|520622078|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
144385763|NCT03011892|520622079|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
144385764|NCT03011892|520622080|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
144385765|NCT03011892|520622081|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
144385766|NCT03011892|520622082|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
144385767|NCT03011892|520622071|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
144385768|NCT03011892|520622072|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
144385769|NCT03011892|520622073|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
144385770|NCT03011892|520622074|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
144385771|NCT03011892|520622075|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
144385772|NCT03011892|520622076|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
144385773|NCT03011892|520622077|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
144385774|NCT03011892|520622078|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
144515290|NCT01340066|521085870|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
144515291|NCT01340066|521085871|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
144515292|NCT01340066|521085872|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
144515293|NCT01340066|521085870|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
144515294|NCT01340066|521085871|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
144515295|NCT01340066|521085872|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
144515296|NCT02789020|521085873|FG000|Overall Study|Withdrawal by Subject|6|||
144515297|NCT02789020|521085874|FG001|Overall Study|Withdrawal by Subject|5|||
144515298|NCT03771352|521085880|FG000|Overall Study|Screen failure|2|||
144515299|NCT03771352|521085880|FG000|Overall Study|Withdrawal by Subject|2|||
144385775|NCT03011892|520622079|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
144385776|NCT03011892|520622080|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
144385777|NCT03011892|520622081|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
144385778|NCT03011892|520622082|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
144385779|NCT03011892|520622071|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
144385780|NCT03011892|520622072|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
144385781|NCT03011892|520622073|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
144385782|NCT03011892|520622074|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
144515300|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
144515301|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
144385783|NCT03011892|520622075|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
144385784|NCT03011892|520622076|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
144385785|NCT03011892|520622077|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
144385786|NCT03011892|520622078|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
144385787|NCT03011892|520622079|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
144385788|NCT03011892|520622080|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
144722075|NCT05476679|521836956|FG004|Overall Study|Withdrawal by Subject|0|||
144722076|NCT05476679|521836952|FG000|Overall Study|Lost to Follow-up|0|||
144722077|NCT05476679|521836953|FG001|Overall Study|Lost to Follow-up|0|||
144722078|NCT05476679|521836954|FG002|Overall Study|Lost to Follow-up|0|||
144722079|NCT05476679|521836955|FG003|Overall Study|Lost to Follow-up|1|||
144722080|NCT05476679|521836956|FG004|Overall Study|Lost to Follow-up|0|||
144722081|NCT00601354|521836957|FG000|Overall Study|Lost to Follow-up|4|||
144722082|NCT00601354|521836958|FG001|Overall Study|Lost to Follow-up|5|||
144722083|NCT00619385|521836963|FG000|Overall Study|Adverse Event|0|||
144722084|NCT00619385|521836964|FG001|Overall Study|Adverse Event|0|||
144722085|NCT00619385|521836965|FG002|Overall Study|Adverse Event|3|||
144722086|NCT00619385|521836963|FG000|Overall Study|Other|1|||
144722087|NCT00619385|521836964|FG001|Overall Study|Other|2|||
144722088|NCT00619385|521836965|FG002|Overall Study|Other|1|||
144722089|NCT02041702|521836968|FG000|Overall Study|Lost to Follow-up|1|||
144722090|NCT02041702|521836969|FG001|Overall Study|Lost to Follow-up|6|||
144385789|NCT03011892|520622081|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
144385790|NCT03011892|520622082|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
144722091|NCT02041702|521836968|FG000|Overall Study|Death|4|||
144722092|NCT02041702|521836969|FG001|Overall Study|Death|0|||
144722093|NCT02041702|521836968|FG000|Overall Study|Withdrawal by Subject|4|||
144722094|NCT02041702|521836969|FG001|Overall Study|Withdrawal by Subject|3|||
144722095|NCT02041702|521836968|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
144385791|NCT03011892|520622071|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
144385792|NCT03011892|520622072|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
144385793|NCT03011892|520622073|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
144385794|NCT03011892|520622074|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
144385795|NCT03011892|520622075|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
144385796|NCT03011892|520622076|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
144385797|NCT03011892|520622077|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
144385798|NCT03011892|520622078|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
144385799|NCT03011892|520622079|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
144385800|NCT03011892|520622080|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
144385801|NCT03011892|520622081|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
144385802|NCT03011892|520622082|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
144385803|NCT03011892|520622071|FG000|Open Label (OL) Period|Reason not specified|0|||
144385804|NCT03011892|520622072|FG001|Open Label (OL) Period|Reason not specified|0|||
144385805|NCT03011892|520622073|FG002|Open Label (OL) Period|Reason not specified|0|||
144385806|NCT03011892|520622074|FG003|Open Label (OL) Period|Reason not specified|0|||
144385807|NCT03011892|520622075|FG004|Open Label (OL) Period|Reason not specified|0|||
144385808|NCT03011892|520622076|FG005|Open Label (OL) Period|Reason not specified|0|||
144385809|NCT03011892|520622077|FG006|Open Label (OL) Period|Reason not specified|0|||
144385810|NCT03011892|520622078|FG007|Open Label (OL) Period|Reason not specified|1|||
144385811|NCT03011892|520622079|FG008|Open Label (OL) Period|Reason not specified|0|||
144385812|NCT03011892|520622080|FG009|Open Label (OL) Period|Reason not specified|0|||
144199316|NCT00541970|519928868|FG002|Month 48|Lost to Follow-up|68|||
144385813|NCT03011892|520622081|FG010|Open Label (OL) Period|Reason not specified|0|||
144385814|NCT03011892|520622082|FG011|Open Label (OL) Period|Reason not specified|0|||
144385815|NCT02282293|520622083|FG000|Overall Study|Lost to Follow-up|2|||
144385816|NCT02282293|520622084|FG001|Overall Study|Lost to Follow-up|2|||
144722096|NCT02041702|521836969|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
144722097|NCT02041702|521836968|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
144722098|NCT02041702|521836969|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
144722099|NCT00203307|521836970|FG000|First Intervention|Adverse Event|2|||
144385817|NCT02282293|520622083|FG000|Overall Study|Unable to comply with study procedures|1|||
144385818|NCT02282293|520622084|FG001|Overall Study|Unable to comply with study procedures|0|||
144385819|NCT02282293|520622083|FG000|Overall Study|Moved out of study area|0|||
144385820|NCT02282293|520622084|FG001|Overall Study|Moved out of study area|1|||
144385821|NCT02312687|520622097|FG000|Overall Study|Other, Not Specified|1|||
144385822|NCT00384111|520622098|FG000|Overall Study|Disease Progression|3|||
144385823|NCT00384111|520622098|FG000|Overall Study|Adverse Event|1|||
144385824|NCT00384111|520622098|FG000|Overall Study|Investigator Decision|3|||
144385825|NCT00384111|520622098|FG000|Overall Study|Study Terminated by the Sponsor|19|||
144385826|NCT01159431|520622104|FG000|Overall Study|Adverse Event|1|||
144385827|NCT01159431|520622105|FG001|Overall Study|Adverse Event|2|||
144385828|NCT01159431|520622104|FG000|Overall Study|non-compliance|1|||
144385829|NCT01159431|520622105|FG001|Overall Study|non-compliance|1|||
144385830|NCT01159431|520622104|FG000|Overall Study|Lack of Efficacy|0|||
144385831|NCT01159431|520622105|FG001|Overall Study|Lack of Efficacy|3|||
144385832|NCT00534599|520622107|FG000|Overall Study|Adverse Event|25|||
144385833|NCT00534599|520622108|FG001|Overall Study|Adverse Event|4|||
144385834|NCT00534599|520622107|FG000|Overall Study|Incorrect enrollment|2|||
144385835|NCT00534599|520622108|FG001|Overall Study|Incorrect enrollment|1|||
144385836|NCT00534599|520622107|FG000|Overall Study|Mis-randomization|2|||
144385837|NCT00534599|520622108|FG001|Overall Study|Mis-randomization|2|||
144385838|NCT00534599|520622107|FG000|Overall Study|Developed study-specific d/c criteria|5|||
144385839|NCT00534599|520622108|FG001|Overall Study|Developed study-specific d/c criteria|0|||
144385840|NCT00534599|520622107|FG000|Overall Study|Lack of Efficacy|0|||
144385841|NCT00534599|520622108|FG001|Overall Study|Lack of Efficacy|1|||
144385842|NCT00534599|520622107|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
144385843|NCT00534599|520622108|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
144385844|NCT00534599|520622107|FG000|Overall Study|Protocol Violation|1|||
144385845|NCT00534599|520622108|FG001|Overall Study|Protocol Violation|3|||
144385846|NCT00534599|520622107|FG000|Overall Study|Lost to Follow-up|11|||
144385847|NCT00534599|520622108|FG001|Overall Study|Lost to Follow-up|14|||
144385848|NCT00534599|520622107|FG000|Overall Study|Withdrawal by Subject|4|||
144385849|NCT00534599|520622108|FG001|Overall Study|Withdrawal by Subject|6|||
144385850|NCT00534599|520622107|FG000|Overall Study|Other|7|||
144385851|NCT00534599|520622108|FG001|Overall Study|Other|0|||
144385852|NCT03645434|520622111|FG000|Period 1|Adverse Event|0|||
144385853|NCT03645434|520622112|FG001|Period 1|Adverse Event|0|||
144385854|NCT03645434|520622113|FG002|Period 1|Adverse Event|0|||
144385855|NCT03645434|520622114|FG003|Period 1|Adverse Event|1|||
144385856|NCT03645434|520622115|FG004|Period 1|Adverse Event|0|||
144385857|NCT03645434|520622116|FG005|Period 1|Adverse Event|0|||
144385858|NCT03645434|520622111|FG000|Period 1|COPD exacerbation|0|||
144385859|NCT03645434|520622112|FG001|Period 1|COPD exacerbation|0|||
144385860|NCT03645434|520622113|FG002|Period 1|COPD exacerbation|0|||
144385861|NCT03645434|520622114|FG003|Period 1|COPD exacerbation|0|||
144385862|NCT03645434|520622115|FG004|Period 1|COPD exacerbation|1|||
144385863|NCT03645434|520622116|FG005|Period 1|COPD exacerbation|0|||
144385864|NCT00167778|520622117|FG000|Overall Study|Withdrawal by Subject|1|||
144385865|NCT02654717|520622118|FG000|Overall Study|Adverse Event|2|||
144385866|NCT02654717|520622119|FG001|Overall Study|Adverse Event|2|||
144385867|NCT02654717|520622118|FG000|Overall Study|Protocol Violation|1|||
144385868|NCT02654717|520622119|FG001|Overall Study|Protocol Violation|2|||
144385869|NCT02654717|520622118|FG000|Overall Study|Withdrawal by Subject|0|||
144385870|NCT02654717|520622119|FG001|Overall Study|Withdrawal by Subject|1|||
144515302|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
144515303|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
144515304|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
144515305|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
144515306|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
144515307|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
144515308|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
144515309|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
144515310|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
144515311|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
144515312|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
144385871|NCT02654717|520622118|FG000|Overall Study|Non-permitted medication|3|||
144385872|NCT02654717|520622119|FG001|Overall Study|Non-permitted medication|0|||
144385873|NCT02055365|520623619|FG000|Overall Study|Prematurely Withdrawn|1|||
144385874|NCT00336583|520623621|FG000|Overall Study|Lost to Follow-up|1|||
144515313|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
144385875|NCT00336583|520623621|FG000|Overall Study|Death|1|||
144385876|NCT01264081|520623622|FG000|Participants Screened|Screening failures|30|||
144385877|NCT01264081|520623622|FG000|Started Treatment|Withdrawal by Subject|1|||
144385878|NCT01264081|520623622|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
144385879|NCT02716896|520623623|FG000|Overall Study|Physician Decision|0|||
144385880|NCT02716896|520623624|FG001|Overall Study|Physician Decision|1|||
144385881|NCT01727700|520623625|FG000|Overall Study|Adverse Event|0|||
144385882|NCT01727700|520623626|FG001|Overall Study|Adverse Event|7|||
144385883|NCT01727700|520623627|FG002|Overall Study|Adverse Event|1|||
144385884|NCT01727700|520623625|FG000|Overall Study|Particpant withdrew consent|0|||
144385885|NCT01727700|520623626|FG001|Overall Study|Particpant withdrew consent|3|||
144385886|NCT01727700|520623627|FG002|Overall Study|Particpant withdrew consent|1|||
144385887|NCT01727700|520623625|FG000|Overall Study|Protocol Violation|2|||
144385888|NCT01727700|520623626|FG001|Overall Study|Protocol Violation|0|||
144385889|NCT01727700|520623627|FG002|Overall Study|Protocol Violation|0|||
144385890|NCT02054481|520623630|FG000|Overall Study|Adverse Event|1|||
144385891|NCT02054481|520623631|FG001|Overall Study|Adverse Event|1|||
144385892|NCT02054481|520623632|FG002|Overall Study|Adverse Event|0|||
144385893|NCT02054481|520623633|FG003|Overall Study|Adverse Event|1|||
144385894|NCT02054481|520623630|FG000|Overall Study|Lost to Follow-up|1|||
144385895|NCT02054481|520623631|FG001|Overall Study|Lost to Follow-up|0|||
144385896|NCT02054481|520623632|FG002|Overall Study|Lost to Follow-up|0|||
144385897|NCT02054481|520623633|FG003|Overall Study|Lost to Follow-up|0|||
144385898|NCT02054481|520623630|FG000|Overall Study|Other reason|2|||
144385899|NCT02054481|520623631|FG001|Overall Study|Other reason|1|||
144385900|NCT02054481|520623632|FG002|Overall Study|Other reason|2|||
144385901|NCT02054481|520623633|FG003|Overall Study|Other reason|0|||
144385902|NCT02320903|520623634|FG000|Overall Study|Withdrawal by Subject|0|||
144385903|NCT02320903|520623635|FG001|Overall Study|Withdrawal by Subject|9|||
144385904|NCT02320903|520623636|FG002|Overall Study|Withdrawal by Subject|9|||
144385905|NCT02320903|520623634|FG000|Overall Study|Exited therapy; no longer eligible|8|||
144385906|NCT02320903|520623635|FG001|Overall Study|Exited therapy; no longer eligible|2|||
144385907|NCT02320903|520623636|FG002|Overall Study|Exited therapy; no longer eligible|2|||
144385908|NCT02320903|520623634|FG000|Overall Study|Lost to Follow-up|0|||
144385909|NCT02320903|520623635|FG001|Overall Study|Lost to Follow-up|5|||
144385910|NCT02320903|520623636|FG002|Overall Study|Lost to Follow-up|5|||
144385911|NCT00883688|520623637|FG000|Overall Study|Ineligible|2|||
144385912|NCT04461600|520623640|FG000|Overall Study|Death|6|||
144385913|NCT04461600|520623641|FG001|Overall Study|Death|5|||
144385914|NCT04461600|520623640|FG000|Overall Study|Withdrawal by Subject|0|||
144385915|NCT04461600|520623641|FG001|Overall Study|Withdrawal by Subject|1|||
144385916|NCT02278471|520623645|FG000|Overall Study|Lost to Follow-up|6|||
144385917|NCT02278471|520623646|FG001|Overall Study|Lost to Follow-up|15|||
144385918|NCT02278471|520623645|FG000|Overall Study|Death|2|||
144385919|NCT02278471|520623646|FG001|Overall Study|Death|2|||
144385920|NCT02278471|520623645|FG000|Overall Study|Withdrawal by Subject|0|||
144385921|NCT02278471|520623646|FG001|Overall Study|Withdrawal by Subject|3|||
144385922|NCT00640835|520623647|FG000|Overall Study|Adverse Event|5|||
144385923|NCT00640835|520623648|FG001|Overall Study|Adverse Event|3|||
144385924|NCT00640835|520623647|FG000|Overall Study|Withdrawal by Subject|12|||
144385925|NCT00640835|520623648|FG001|Overall Study|Withdrawal by Subject|14|||
144385926|NCT00640835|520623647|FG000|Overall Study|Physician Decision|10|||
144385927|NCT00640835|520623648|FG001|Overall Study|Physician Decision|14|||
144385928|NCT00640835|520623647|FG000|Overall Study|Sponsor's Decision|11|||
144385929|NCT00640835|520623648|FG001|Overall Study|Sponsor's Decision|7|||
144385930|NCT00640835|520623647|FG000|Overall Study|Protocol Violation|2|||
144385931|NCT00640835|520623648|FG001|Overall Study|Protocol Violation|2|||
144385932|NCT00640835|520623647|FG000|Overall Study|Lost to Follow-up|17|||
144385933|NCT00640835|520623648|FG001|Overall Study|Lost to Follow-up|13|||
144385934|NCT00640835|520623647|FG000|Overall Study|Other Reason|19|||
144385935|NCT00640835|520623648|FG001|Overall Study|Other Reason|4|||
144515314|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
144515315|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
144515316|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
144515317|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
144515318|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
144515319|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
144515320|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
144515321|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
144515322|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
144385936|NCT01437995|520623649|FG000|Overall Study|Lost to Follow-up|11|||
144385937|NCT01437995|520623650|FG001|Overall Study|Lost to Follow-up|18|||
144385938|NCT01437995|520623651|FG002|Overall Study|Lost to Follow-up|20|||
144385939|NCT03874429|520623652|FG000|Overall Study|Adverse Event|2|||
144385940|NCT03874429|520623653|FG001|Overall Study|Adverse Event|2|||
144385941|NCT03874429|520623652|FG000|Overall Study|Lack of Efficacy|0|||
144385942|NCT03874429|520623653|FG001|Overall Study|Lack of Efficacy|1|||
144385943|NCT03874429|520623652|FG000|Overall Study|Covid-19 pandemic|4|||
144385944|NCT03874429|520623653|FG001|Overall Study|Covid-19 pandemic|2|||
144385945|NCT00704522|520623654|FG000|Overall Study|Lack of Efficacy|65|||
144385946|NCT00704522|520623655|FG001|Overall Study|Lack of Efficacy|17|||
144385947|NCT00704522|520623654|FG000|Overall Study|Failure to appear again at hospital|56|||
144385948|NCT00704522|520623655|FG001|Overall Study|Failure to appear again at hospital|10|||
144385949|NCT00704522|520623654|FG000|Overall Study|Withdrawal by Subject|17|||
144385950|NCT00704522|520623655|FG001|Overall Study|Withdrawal by Subject|8|||
144385951|NCT00704522|520623654|FG000|Overall Study|Adverse Event|9|||
144385952|NCT00704522|520623655|FG001|Overall Study|Adverse Event|1|||
144385953|NCT00704522|520623654|FG000|Overall Study|Undefined causes|9|||
144385954|NCT00704522|520623655|FG001|Overall Study|Undefined causes|7|||
144385955|NCT00704522|520623654|FG000|Overall Study|No information on therapy end|27|||
144385956|NCT00704522|520623655|FG001|Overall Study|No information on therapy end|2|||
144385957|NCT00775203|520623656|FG000|Overall Study|Adverse Event|25|||
144385958|NCT00775203|520623657|FG001|Overall Study|Adverse Event|6|||
144385959|NCT00775203|520623656|FG000|Overall Study|Lack of Efficacy|8|||
144385960|NCT00775203|520623657|FG001|Overall Study|Lack of Efficacy|9|||
144385961|NCT00775203|520623656|FG000|Overall Study|Withdrawal by Subject|11|||
144385962|NCT00775203|520623657|FG001|Overall Study|Withdrawal by Subject|9|||
144385963|NCT00775203|520623656|FG000|Overall Study|Lost to Follow-up|11|||
144385964|NCT00775203|520623657|FG001|Overall Study|Lost to Follow-up|15|||
144385965|NCT00775203|520623656|FG000|Overall Study|Administrative reason|2|||
144385966|NCT00775203|520623657|FG001|Overall Study|Administrative reason|0|||
144385967|NCT00775203|520623656|FG000|Overall Study|Noncompliance|4|||
144385968|NCT00775203|520623657|FG001|Overall Study|Noncompliance|2|||
144385969|NCT00775203|520623656|FG000|Overall Study|Protocol Violation|0|||
144385970|NCT00775203|520623657|FG001|Overall Study|Protocol Violation|1|||
144385971|NCT00775203|520623656|FG000|Overall Study|Entered other study|1|||
144385972|NCT00775203|520623657|FG001|Overall Study|Entered other study|0|||
144385973|NCT00775203|520623656|FG000|Overall Study|Physician Decision|0|||
144385974|NCT00775203|520623657|FG001|Overall Study|Physician Decision|1|||
144385975|NCT04896229|520623659|FG000|Overall Study|Lost to Follow-up|113|||
144385976|NCT04896229|520623660|FG001|Overall Study|Lost to Follow-up|113|||
144385977|NCT04418661|520623661|FG000|Overall Study|Adverse Event|0|||
144385978|NCT04418661|520623662|FG001|Overall Study|Adverse Event|1|||
144385979|NCT04418661|520623663|FG002|Overall Study|Adverse Event|5|||
144385980|NCT04418661|520623664|FG003|Overall Study|Adverse Event|3|||
144385981|NCT04418661|520623665|FG004|Overall Study|Adverse Event|0|||
144385982|NCT04418661|520623666|FG005|Overall Study|Adverse Event|2|||
144385983|NCT04418661|520623661|FG000|Overall Study|Progressive disease|4|||
144385984|NCT04418661|520623662|FG001|Overall Study|Progressive disease|11|||
144385985|NCT04418661|520623663|FG002|Overall Study|Progressive disease|6|||
144385986|NCT04418661|520623664|FG003|Overall Study|Progressive disease|11|||
144385987|NCT04418661|520623665|FG004|Overall Study|Progressive disease|1|||
144385988|NCT04418661|520623666|FG005|Overall Study|Progressive disease|12|||
144385989|NCT04418661|520623661|FG000|Overall Study|Withdrawal by Subject|0|||
144385990|NCT04418661|520623662|FG001|Overall Study|Withdrawal by Subject|1|||
144385991|NCT04418661|520623663|FG002|Overall Study|Withdrawal by Subject|0|||
144385992|NCT04418661|520623664|FG003|Overall Study|Withdrawal by Subject|1|||
144385993|NCT04418661|520623665|FG004|Overall Study|Withdrawal by Subject|0|||
144385994|NCT04418661|520623666|FG005|Overall Study|Withdrawal by Subject|0|||
144385995|NCT04418661|520623661|FG000|Overall Study|Other|0|||
144515323|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
144515324|NCT03338816|521085895|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
144515325|NCT03338816|521085896|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
144515326|NCT03338816|521085897|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
144515327|NCT03338816|521085898|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
144515328|NCT04238247|521085899|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
144515329|NCT04238247|521085900|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
144515330|NCT04238247|521085901|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
144515331|NCT04238247|521085902|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
144515332|NCT04238247|521085899|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
144515333|NCT04238247|521085900|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
144515334|NCT04238247|521085901|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
144515335|NCT04238247|521085902|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
144515336|NCT04238247|521085899|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
144515337|NCT04238247|521085900|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
144515338|NCT04238247|521085901|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
144515339|NCT04238247|521085902|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
144515340|NCT04238247|521085899|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
144385996|NCT04418661|520623662|FG001|Overall Study|Other|0|||
144385997|NCT04418661|520623663|FG002|Overall Study|Other|1|||
144385998|NCT04418661|520623664|FG003|Overall Study|Other|3|||
144385999|NCT04418661|520623665|FG004|Overall Study|Other|0|||
144386000|NCT04418661|520623666|FG005|Overall Study|Other|1|||
144386001|NCT00329901|520623669|FG000|Overall Study|Withdrawal by Subject|4|||
144386002|NCT00329901|520623670|FG001|Overall Study|Withdrawal by Subject|3|||
144386003|NCT00329901|520623671|FG002|Overall Study|Withdrawal by Subject|2|||
144386004|NCT00329901|520623669|FG000|Overall Study|Lost to Follow-up|2|||
144386005|NCT00329901|520623670|FG001|Overall Study|Lost to Follow-up|0|||
144386006|NCT00329901|520623671|FG002|Overall Study|Lost to Follow-up|1|||
144386007|NCT00329901|520623669|FG000|Overall Study|Protocol Violation|1|||
144386008|NCT00329901|520623670|FG001|Overall Study|Protocol Violation|0|||
144386009|NCT00329901|520623671|FG002|Overall Study|Protocol Violation|1|||
144386010|NCT00329901|520623669|FG000|Overall Study|Unable to classify|2|||
144386011|NCT00329901|520623670|FG001|Overall Study|Unable to classify|2|||
144386012|NCT00329901|520623671|FG002|Overall Study|Unable to classify|0|||
144386013|NCT00992589|520623672|FG000|Open-Label Phase|Adverse Event|4|||
144386014|NCT00992589|520623673|FG001|Open-Label Phase|Adverse Event|0|||
144386015|NCT00992589|520623674|FG002|Open-Label Phase|Adverse Event|0|||
144386016|NCT00992589|520623675|FG003|Open-Label Phase|Adverse Event|0|||
144386017|NCT00992589|520623672|FG000|Open-Label Phase|Withdrawal by Subject|20|||
144386018|NCT00992589|520623673|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144386019|NCT00992589|520623674|FG002|Open-Label Phase|Withdrawal by Subject|0|||
144386020|NCT00992589|520623675|FG003|Open-Label Phase|Withdrawal by Subject|0|||
144386021|NCT00992589|520623672|FG000|Open-Label Phase|Lost to Follow-up|1|||
144386022|NCT00992589|520623673|FG001|Open-Label Phase|Lost to Follow-up|0|||
144386023|NCT00992589|520623674|FG002|Open-Label Phase|Lost to Follow-up|0|||
144386024|NCT00992589|520623675|FG003|Open-Label Phase|Lost to Follow-up|0|||
144386025|NCT00992589|520623672|FG000|Open-Label Phase|Protocol Violation|3|||
144386026|NCT00992589|520623673|FG001|Open-Label Phase|Protocol Violation|0|||
144386027|NCT00992589|520623674|FG002|Open-Label Phase|Protocol Violation|0|||
144386028|NCT00992589|520623675|FG003|Open-Label Phase|Protocol Violation|0|||
144386029|NCT00992589|520623672|FG000|Open-Label Phase|Physician Decision|4|||
144386030|NCT00992589|520623673|FG001|Open-Label Phase|Physician Decision|0|||
144386031|NCT00992589|520623674|FG002|Open-Label Phase|Physician Decision|0|||
144386032|NCT00992589|520623675|FG003|Open-Label Phase|Physician Decision|0|||
144386033|NCT00992589|520623672|FG000|Open-Label Phase|Other|45|||
144386034|NCT00992589|520623673|FG001|Open-Label Phase|Other|0|||
144386035|NCT00992589|520623674|FG002|Open-Label Phase|Other|0|||
144386036|NCT00992589|520623675|FG003|Open-Label Phase|Other|0|||
144386037|NCT00992589|520623672|FG000|Double-Blind Phase|Adverse Event|0|||
144386038|NCT00992589|520623673|FG001|Double-Blind Phase|Adverse Event|6|||
144386039|NCT00992589|520623674|FG002|Double-Blind Phase|Adverse Event|2|||
144386040|NCT00992589|520623675|FG003|Double-Blind Phase|Adverse Event|3|||
144386041|NCT00992589|520623672|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
144386042|NCT00992589|520623673|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
144386043|NCT00992589|520623674|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
144386044|NCT00992589|520623675|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
144386045|NCT00992589|520623672|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144386046|NCT00992589|520623673|FG001|Double-Blind Phase|Lost to Follow-up|0|||
144386047|NCT00992589|520623674|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144386048|NCT00992589|520623675|FG003|Double-Blind Phase|Lost to Follow-up|2|||
144386049|NCT00992589|520623672|FG000|Double-Blind Phase|Other|0|||
144386050|NCT00992589|520623673|FG001|Double-Blind Phase|Other|1|||
144386051|NCT00992589|520623674|FG002|Double-Blind Phase|Other|6|||
144386052|NCT00992589|520623675|FG003|Double-Blind Phase|Other|3|||
144386053|NCT00045942|520623676|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
144386054|NCT00045942|520623677|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386055|NCT00045942|520623678|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386056|NCT00045942|520623679|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386057|NCT00045942|520623680|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386058|NCT00045942|520623681|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386059|NCT00045942|520623682|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386060|NCT00045942|520623683|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386061|NCT00045942|520623684|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
144386062|NCT00045942|520623676|FG000|PKC412A2104 (Core)|Adverse Event|5|||
144386063|NCT00045942|520623677|FG001|PKC412A2104 (Core)|Adverse Event|0|||
144386064|NCT00045942|520623678|FG002|PKC412A2104 (Core)|Adverse Event|0|||
144386065|NCT00045942|520623679|FG003|PKC412A2104 (Core)|Adverse Event|0|||
144386066|NCT00045942|520623680|FG004|PKC412A2104 (Core)|Adverse Event|0|||
144386067|NCT00045942|520623681|FG005|PKC412A2104 (Core)|Adverse Event|0|||
144386068|NCT00045942|520623682|FG006|PKC412A2104 (Core)|Adverse Event|0|||
144386069|NCT00045942|520623683|FG007|PKC412A2104 (Core)|Adverse Event|0|||
144386070|NCT00045942|520623684|FG008|PKC412A2104 (Core)|Adverse Event|0|||
144386071|NCT00045942|520623676|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
144386072|NCT00045942|520623677|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386073|NCT00045942|520623678|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386074|NCT00045942|520623679|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386075|NCT00045942|520623680|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386076|NCT00045942|520623681|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386077|NCT00045942|520623682|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386078|NCT00045942|520623683|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386079|NCT00045942|520623684|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
144386080|NCT00045942|520623676|FG000|PKC412A2104 (Core)|Death|1|||
144386081|NCT00045942|520623677|FG001|PKC412A2104 (Core)|Death|0|||
144515341|NCT04238247|521085900|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
144386082|NCT00045942|520623678|FG002|PKC412A2104 (Core)|Death|0|||
144386083|NCT00045942|520623679|FG003|PKC412A2104 (Core)|Death|0|||
144386084|NCT00045942|520623680|FG004|PKC412A2104 (Core)|Death|0|||
144386085|NCT00045942|520623681|FG005|PKC412A2104 (Core)|Death|0|||
144386086|NCT00045942|520623682|FG006|PKC412A2104 (Core)|Death|0|||
144386087|NCT00045942|520623683|FG007|PKC412A2104 (Core)|Death|0|||
144386088|NCT00045942|520623684|FG008|PKC412A2104 (Core)|Death|0|||
144386089|NCT00045942|520623676|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
144386090|NCT00045942|520623677|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
144386091|NCT00045942|520623678|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
144386092|NCT00045942|520623679|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
144386093|NCT00045942|520623680|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
144386094|NCT00045942|520623681|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
144386095|NCT00045942|520623682|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
144386096|NCT00045942|520623683|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
144386097|NCT00045942|520623684|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
144386098|NCT00045942|520623676|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
144386099|NCT00045942|520623677|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
144386100|NCT00045942|520623678|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
144386101|NCT00045942|520623679|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
144386102|NCT00045942|520623680|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
144386103|NCT00045942|520623681|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
144386104|NCT00045942|520623682|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
144386105|NCT00045942|520623683|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
144386106|NCT00045942|520623684|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
144386107|NCT00045942|520623676|FG000|PKC412A2104E1|Lack of Efficacy|0|||
144386108|NCT00045942|520623677|FG001|PKC412A2104E1|Lack of Efficacy|11|||
144386109|NCT00045942|520623678|FG002|PKC412A2104E1|Lack of Efficacy|11|||
144386110|NCT00045942|520623679|FG003|PKC412A2104E1|Lack of Efficacy|23|||
144386111|NCT00045942|520623680|FG004|PKC412A2104E1|Lack of Efficacy|17|||
144386112|NCT00045942|520623681|FG005|PKC412A2104E1|Lack of Efficacy|0|||
144386113|NCT00045942|520623682|FG006|PKC412A2104E1|Lack of Efficacy|0|||
144386114|NCT00045942|520623683|FG007|PKC412A2104E1|Lack of Efficacy|0|||
144386115|NCT00045942|520623684|FG008|PKC412A2104E1|Lack of Efficacy|0|||
144386116|NCT00045942|520623676|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
144386117|NCT00045942|520623677|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
144386118|NCT00045942|520623678|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
144386119|NCT00045942|520623679|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
144386120|NCT00045942|520623680|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
144386121|NCT00045942|520623681|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
144386122|NCT00045942|520623682|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
144386123|NCT00045942|520623683|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
144386124|NCT00045942|520623684|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
144386125|NCT00045942|520623676|FG000|PKC412A2104E1|Adverse Event|0|||
144386126|NCT00045942|520623677|FG001|PKC412A2104E1|Adverse Event|1|||
144386127|NCT00045942|520623678|FG002|PKC412A2104E1|Adverse Event|1|||
144386128|NCT00045942|520623679|FG003|PKC412A2104E1|Adverse Event|3|||
144515342|NCT04238247|521085901|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
144515343|NCT04238247|521085902|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
144515344|NCT03833167|521085903|FG000|Overall Study|Withdrawal by Subject|4|||
144515345|NCT03833167|521085904|FG001|Overall Study|Withdrawal by Subject|6|||
144515346|NCT03833167|521085903|FG000|Overall Study|Ongoing|186|||
144515347|NCT03833167|521085904|FG001|Overall Study|Ongoing|194|||
144515348|NCT03833167|521085903|FG000|Overall Study|Lost to Follow-up|1|||
144515349|NCT03833167|521085904|FG001|Overall Study|Lost to Follow-up|1|||
144515350|NCT03833167|521085903|FG000|Overall Study|Physician Decision|0|||
144515351|NCT03833167|521085904|FG001|Overall Study|Physician Decision|2|||
144515352|NCT03833167|521085903|FG000|Overall Study|Death|34|||
144515353|NCT03833167|521085904|FG001|Overall Study|Death|22|||
144386129|NCT00045942|520623680|FG004|PKC412A2104E1|Adverse Event|6|||
144386130|NCT00045942|520623681|FG005|PKC412A2104E1|Adverse Event|0|||
144386131|NCT00045942|520623682|FG006|PKC412A2104E1|Adverse Event|0|||
144386132|NCT00045942|520623683|FG007|PKC412A2104E1|Adverse Event|0|||
144386133|NCT00045942|520623684|FG008|PKC412A2104E1|Adverse Event|0|||
144386134|NCT00045942|520623676|FG000|PKC412A2104E1|Death|0|||
144386135|NCT00045942|520623677|FG001|PKC412A2104E1|Death|4|||
144386136|NCT00045942|520623678|FG002|PKC412A2104E1|Death|1|||
144386137|NCT00045942|520623679|FG003|PKC412A2104E1|Death|1|||
144386138|NCT00045942|520623680|FG004|PKC412A2104E1|Death|1|||
144386139|NCT00045942|520623681|FG005|PKC412A2104E1|Death|0|||
144386140|NCT00045942|520623682|FG006|PKC412A2104E1|Death|0|||
144386141|NCT00045942|520623683|FG007|PKC412A2104E1|Death|0|||
144386142|NCT00045942|520623684|FG008|PKC412A2104E1|Death|0|||
144386143|NCT00045942|520623676|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144515354|NCT01948661|521085905|FG000|Overall Study|Withdrawal by Subject|2|||
144515355|NCT01948661|521085906|FG001|Overall Study|Withdrawal by Subject|4|||
144386144|NCT00045942|520623677|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144386145|NCT00045942|520623678|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
144386146|NCT00045942|520623679|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
144386147|NCT00045942|520623680|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144386148|NCT00045942|520623681|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144386149|NCT00045942|520623682|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144386150|NCT00045942|520623683|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144386151|NCT00045942|520623684|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
144386152|NCT00045942|520623676|FG000|PKC412A2104E2|Lost to Follow-up|0|||
144386153|NCT00045942|520623677|FG001|PKC412A2104E2|Lost to Follow-up|0|||
144386154|NCT00045942|520623678|FG002|PKC412A2104E2|Lost to Follow-up|0|||
144386155|NCT00045942|520623679|FG003|PKC412A2104E2|Lost to Follow-up|0|||
144386156|NCT00045942|520623680|FG004|PKC412A2104E2|Lost to Follow-up|0|||
144386157|NCT00045942|520623681|FG005|PKC412A2104E2|Lost to Follow-up|0|||
144386158|NCT00045942|520623682|FG006|PKC412A2104E2|Lost to Follow-up|0|||
144386159|NCT00045942|520623683|FG007|PKC412A2104E2|Lost to Follow-up|3|||
144386160|NCT00045942|520623684|FG008|PKC412A2104E2|Lost to Follow-up|0|||
144386161|NCT00045942|520623676|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
144386162|NCT00045942|520623677|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
144386163|NCT00045942|520623678|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
144386164|NCT00045942|520623679|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
144386165|NCT00045942|520623680|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
144386166|NCT00045942|520623681|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
144386167|NCT00045942|520623682|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
144386168|NCT00045942|520623683|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
144515356|NCT06061081|521085907|FG000|Overall Study|Withdrawal by Subject|1|||
144515357|NCT06061081|521085908|FG001|Overall Study|Withdrawal by Subject|0|||
144515358|NCT06061081|521085909|FG002|Overall Study|Withdrawal by Subject|0|||
144515359|NCT06061081|521085910|FG003|Overall Study|Withdrawal by Subject|0|||
144515360|NCT06061081|521085911|FG004|Overall Study|Withdrawal by Subject|0|||
144515361|NCT02252172|521085912|FG000|Overall Study|Lost to Follow-up|9|||
144515362|NCT02252172|521085913|FG001|Overall Study|Lost to Follow-up|6|||
144515363|NCT02252172|521085912|FG000|Overall Study|Death|218|||
144515364|NCT02252172|521085913|FG001|Overall Study|Death|175|||
144515365|NCT02252172|521085912|FG000|Overall Study|Withdrawal by Subject|20|||
144515366|NCT02252172|521085913|FG001|Overall Study|Withdrawal by Subject|15|||
144515367|NCT02252172|521085912|FG000|Overall Study|Physician Decision|0|||
144515368|NCT02252172|521085913|FG001|Overall Study|Physician Decision|1|||
144515369|NCT02252172|521085912|FG000|Overall Study|End of data collection|122|||
144515370|NCT02252172|521085913|FG001|Overall Study|End of data collection|170|||
144515371|NCT02252172|521085912|FG000|Overall Study|Site closure|0|||
144515372|NCT02252172|521085913|FG001|Overall Study|Site closure|1|||
144515373|NCT05575076|521085914|FG000|Overall Study|Adverse Event|24|||
144515374|NCT05575076|521085914|FG000|Overall Study|Death|7|||
144515375|NCT05575076|521085914|FG000|Overall Study|Lost to Follow-up|16|||
144515376|NCT05575076|521085914|FG000|Overall Study|Non-Compliance|3|||
144515377|NCT05575076|521085914|FG000|Overall Study|Physician Decision|6|||
144515378|NCT05575076|521085914|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
144515379|NCT05575076|521085914|FG000|Overall Study|Withdrawal by Subject|71|||
144515380|NCT05575076|521085914|FG000|Overall Study|Study Terminated by Sponsor|630|||
144515381|NCT05575076|521085914|FG000|Overall Study|Other|17|||
144515382|NCT02886286|521085915|FG000|Overall Study|pump motor stall|0|||
144515383|NCT02886286|521085916|FG001|Overall Study|pump motor stall|1|||
144515384|NCT01127373|521085917|FG000|Overall Study|Not Treated|3|||
144515385|NCT01127373|521085917|FG000|Overall Study|Lost to Follow-up|7|||
144515386|NCT01127373|521085917|FG000|Overall Study|Withdrawal by Subject|1|||
144515387|NCT01127373|521085917|FG000|Overall Study|Disease progression|1|||
144515388|NCT05450458|521085923|FG000|Overall Study|Lost to Follow-up|4|||
144515389|NCT00087139|521085924|FG000|Overall Study|Adverse Event|18|||
144515390|NCT00087139|521085925|FG001|Overall Study|Adverse Event|17|||
144515391|NCT00087139|521085926|FG002|Overall Study|Adverse Event|13|||
144515392|NCT00087139|521085924|FG000|Overall Study|Death|2|||
144515393|NCT00087139|521085925|FG001|Overall Study|Death|1|||
144386169|NCT00045942|520623684|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
144386170|NCT00045942|520623676|FG000|PKC412A2104E2|Lack of Efficacy|0|||
144515394|NCT00087139|521085926|FG002|Overall Study|Death|0|||
144515395|NCT00087139|521085924|FG000|Overall Study|Withdrawal by Subject|3|||
144515396|NCT00087139|521085925|FG001|Overall Study|Withdrawal by Subject|2|||
144515397|NCT00087139|521085926|FG002|Overall Study|Withdrawal by Subject|2|||
144515398|NCT00087139|521085924|FG000|Overall Study|Physician Decision|1|||
144515399|NCT00087139|521085925|FG001|Overall Study|Physician Decision|1|||
144515400|NCT00087139|521085926|FG002|Overall Study|Physician Decision|1|||
144386171|NCT00045942|520623677|FG001|PKC412A2104E2|Lack of Efficacy|0|||
144515401|NCT00087139|521085924|FG000|Overall Study|Disease progression|9|||
144515402|NCT00087139|521085925|FG001|Overall Study|Disease progression|19|||
144515403|NCT00087139|521085926|FG002|Overall Study|Disease progression|12|||
144515404|NCT00087139|521085924|FG000|Overall Study|Ineligible|4|||
144515405|NCT00087139|521085925|FG001|Overall Study|Ineligible|7|||
144386172|NCT00045942|520623678|FG002|PKC412A2104E2|Lack of Efficacy|0|||
144386173|NCT00045942|520623679|FG003|PKC412A2104E2|Lack of Efficacy|0|||
144386174|NCT00045942|520623680|FG004|PKC412A2104E2|Lack of Efficacy|0|||
144386175|NCT00045942|520623681|FG005|PKC412A2104E2|Lack of Efficacy|3|||
144386176|NCT00045942|520623682|FG006|PKC412A2104E2|Lack of Efficacy|2|||
144386177|NCT00045942|520623683|FG007|PKC412A2104E2|Lack of Efficacy|2|||
144386178|NCT00045942|520623684|FG008|PKC412A2104E2|Lack of Efficacy|6|||
144386179|NCT00045942|520623676|FG000|PKC412A2104E2|Adverse Event|0|||
144386180|NCT00045942|520623677|FG001|PKC412A2104E2|Adverse Event|0|||
144386181|NCT00045942|520623678|FG002|PKC412A2104E2|Adverse Event|0|||
144386182|NCT00045942|520623679|FG003|PKC412A2104E2|Adverse Event|0|||
144386183|NCT00045942|520623680|FG004|PKC412A2104E2|Adverse Event|0|||
144386184|NCT00045942|520623681|FG005|PKC412A2104E2|Adverse Event|4|||
144386185|NCT00045942|520623682|FG006|PKC412A2104E2|Adverse Event|3|||
144386186|NCT00045942|520623683|FG007|PKC412A2104E2|Adverse Event|1|||
144386187|NCT00045942|520623684|FG008|PKC412A2104E2|Adverse Event|0|||
144386188|NCT00045942|520623676|FG000|PKC412A2104E2|Death|0|||
144386189|NCT00045942|520623677|FG001|PKC412A2104E2|Death|0|||
144386190|NCT00045942|520623678|FG002|PKC412A2104E2|Death|0|||
144386191|NCT00045942|520623679|FG003|PKC412A2104E2|Death|0|||
144386192|NCT00045942|520623680|FG004|PKC412A2104E2|Death|0|||
144386193|NCT00045942|520623681|FG005|PKC412A2104E2|Death|1|||
144386194|NCT00045942|520623682|FG006|PKC412A2104E2|Death|2|||
144386195|NCT00045942|520623683|FG007|PKC412A2104E2|Death|0|||
144386196|NCT00045942|520623684|FG008|PKC412A2104E2|Death|0|||
144386197|NCT01101308|520623685|FG000|Period 1|Adverse Event|2|||
144386198|NCT01101308|520623686|FG001|Period 1|Adverse Event|1|||
144386199|NCT01101308|520623685|FG000|Period 1|Positive for cotinine|1|||
144386200|NCT01101308|520623686|FG001|Period 1|Positive for cotinine|0|||
144386201|NCT02984943|520623687|FG000|Overall Study|Withdrawal by Subject|3|||
144386202|NCT02984943|520623687|FG000|Overall Study|Physician Decision|1|||
144386203|NCT00711516|520623692|FG000|Overall Study|Adverse Event|1|||
144386204|NCT00711516|520623693|FG001|Overall Study|Adverse Event|1|||
144386205|NCT00711516|520623692|FG000|Overall Study|Withdrawal by Subject|0|||
144386206|NCT00711516|520623693|FG001|Overall Study|Withdrawal by Subject|1|||
144386207|NCT00711516|520623692|FG000|Overall Study|Protocol Violation|0|||
144386208|NCT00711516|520623693|FG001|Overall Study|Protocol Violation|1|||
144386209|NCT01895361|520623697|FG000|Overall Study|Adverse Event|1|||
144386210|NCT01895361|520623698|FG001|Overall Study|Adverse Event|1|||
144386211|NCT01895361|520623699|FG002|Overall Study|Adverse Event|3|||
144386212|NCT01895361|520623697|FG000|Overall Study|Death|2|||
144386213|NCT01895361|520623698|FG001|Overall Study|Death|1|||
144386214|NCT01895361|520623699|FG002|Overall Study|Death|2|||
144386215|NCT01895361|520623697|FG000|Overall Study|Lost to Follow-up|4|||
144386216|NCT01895361|520623698|FG001|Overall Study|Lost to Follow-up|4|||
144386217|NCT01895361|520623699|FG002|Overall Study|Lost to Follow-up|6|||
144386218|NCT01895361|520623697|FG000|Overall Study|Non-compliance with study|1|||
144386219|NCT01895361|520623698|FG001|Overall Study|Non-compliance with study|3|||
144386220|NCT01895361|520623699|FG002|Overall Study|Non-compliance with study|1|||
144386221|NCT01895361|520623697|FG000|Overall Study|Physician Decision|2|||
144386222|NCT01895361|520623698|FG001|Overall Study|Physician Decision|2|||
144386223|NCT01895361|520623699|FG002|Overall Study|Physician Decision|2|||
144386224|NCT01895361|520623697|FG000|Overall Study|Withdrawal by Subject|7|||
144386225|NCT01895361|520623698|FG001|Overall Study|Withdrawal by Subject|6|||
144386226|NCT01895361|520623699|FG002|Overall Study|Withdrawal by Subject|6|||
144386227|NCT01895361|520623697|FG000|Overall Study|Lack of Efficacy|0|||
144386228|NCT01895361|520623698|FG001|Overall Study|Lack of Efficacy|1|||
144386229|NCT01895361|520623699|FG002|Overall Study|Lack of Efficacy|0|||
144386230|NCT01895361|520623697|FG000|Overall Study|Reasons different from categories above|7|||
144386231|NCT01895361|520623698|FG001|Overall Study|Reasons different from categories above|3|||
144386232|NCT01895361|520623699|FG002|Overall Study|Reasons different from categories above|4|||
144386233|NCT02692651|520623703|FG000|Study Treatment|Death|7|||
144386234|NCT02692651|520623704|FG001|Study Treatment|Death|3|||
144386235|NCT02692651|520623703|FG000|Study Treatment|comfort care|1|||
144386236|NCT02692651|520623704|FG001|Study Treatment|comfort care|1|||
144199317|NCT00541970|519928869|FG003|Month 48|Lost to Follow-up|73|||
144386237|NCT02692651|520623703|FG000|Study Treatment|Protocol violation per treating team preference|8|||
144386238|NCT02692651|520623704|FG001|Study Treatment|Protocol violation per treating team preference|6|||
144386239|NCT02692651|520623703|FG000|Post Study Treatment Follow-up|Death|4|||
144386240|NCT02692651|520623704|FG001|Post Study Treatment Follow-up|Death|4|||
144386241|NCT05463198|520623711|FG000|Overall Study|Withdrawal by Subject|19|||
144386242|NCT05463198|520623711|FG000|Overall Study|Procedure Notes Missing|18|||
144386243|NCT02239120|520623714|FG000|Overall Study|Death|56|||
144386244|NCT02239120|520623715|FG001|Overall Study|Death|58|||
144386245|NCT02239120|520623714|FG000|Overall Study|Lost to Follow-up|19|||
144386246|NCT02239120|520623715|FG001|Overall Study|Lost to Follow-up|14|||
144386247|NCT00420641|520623718|FG000|Overall Study|Adverse Event|3|||
144386248|NCT00420641|520623719|FG001|Overall Study|Adverse Event|25|||
144386249|NCT00420641|520623720|FG002|Overall Study|Adverse Event|10|||
144386250|NCT00420641|520623718|FG000|Overall Study|Lost to Follow-up|2|||
144386251|NCT00420641|520623719|FG001|Overall Study|Lost to Follow-up|4|||
144386252|NCT00420641|520623720|FG002|Overall Study|Lost to Follow-up|2|||
144386253|NCT00420641|520623718|FG000|Overall Study|Protocol Violation|8|||
144386254|NCT00420641|520623719|FG001|Overall Study|Protocol Violation|8|||
144386255|NCT00420641|520623720|FG002|Overall Study|Protocol Violation|7|||
144386256|NCT00420641|520623718|FG000|Overall Study|Withdrawal by Subject|15|||
144386257|NCT00420641|520623719|FG001|Overall Study|Withdrawal by Subject|21|||
144386258|NCT00420641|520623720|FG002|Overall Study|Withdrawal by Subject|14|||
144386259|NCT00420641|520623718|FG000|Overall Study|Lack of Efficacy|6|||
144386260|NCT00420641|520623719|FG001|Overall Study|Lack of Efficacy|5|||
144386261|NCT00420641|520623720|FG002|Overall Study|Lack of Efficacy|4|||
144386262|NCT00420641|520623718|FG000|Overall Study|Non-compliance|7|||
144386263|NCT00420641|520623719|FG001|Overall Study|Non-compliance|5|||
144386264|NCT00420641|520623720|FG002|Overall Study|Non-compliance|4|||
144386265|NCT00420641|520623718|FG000|Overall Study|Other|4|||
144386266|NCT00420641|520623719|FG001|Overall Study|Other|4|||
144386267|NCT00420641|520623720|FG002|Overall Study|Other|3|||
144386268|NCT03459690|520623722|FG000|Overall Study|Lost to Follow-up|0|||
144386269|NCT03459690|520623723|FG001|Overall Study|Lost to Follow-up|1|||
144386270|NCT03459690|520623722|FG000|Overall Study|Withdrawal by Subject|1|||
144386271|NCT03459690|520623723|FG001|Overall Study|Withdrawal by Subject|1|||
144386272|NCT01381562|520623724|FG000|Overall Study|Adverse Event|0|||
144386273|NCT01381562|520623725|FG001|Overall Study|Adverse Event|1|||
144386274|NCT01381562|520623726|FG002|Overall Study|Adverse Event|0|||
144386275|NCT02660138|520623728|FG000|Overall Study|Adverse Event|0|||
144386276|NCT02660138|520623729|FG001|Overall Study|Adverse Event|3|||
144386277|NCT02660138|520623730|FG002|Overall Study|Adverse Event|2|||
144386278|NCT02660138|520623728|FG000|Overall Study|Lack of Efficacy|1|||
144386279|NCT02660138|520623729|FG001|Overall Study|Lack of Efficacy|2|||
144386280|NCT02660138|520623730|FG002|Overall Study|Lack of Efficacy|1|||
144386281|NCT02660138|520623728|FG000|Overall Study|Withdrawal by Subject|7|||
144386282|NCT02660138|520623729|FG001|Overall Study|Withdrawal by Subject|6|||
144386283|NCT02660138|520623730|FG002|Overall Study|Withdrawal by Subject|6|||
144386284|NCT02660138|520623728|FG000|Overall Study|Lost to Follow-up|4|||
144386285|NCT02660138|520623729|FG001|Overall Study|Lost to Follow-up|4|||
144386286|NCT02660138|520623730|FG002|Overall Study|Lost to Follow-up|1|||
144386287|NCT02660138|520623728|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
144386288|NCT02660138|520623729|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
144386289|NCT02660138|520623730|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
144386290|NCT02660138|520623728|FG000|Overall Study|Other|1|||
144386291|NCT02660138|520623729|FG001|Overall Study|Other|1|||
144386292|NCT02660138|520623730|FG002|Overall Study|Other|0|||
144386293|NCT02660138|520623728|FG000|Overall Study|Not treated|0|||
144386294|NCT02660138|520623729|FG001|Overall Study|Not treated|1|||
144386295|NCT02660138|520623730|FG002|Overall Study|Not treated|0|||
144386296|NCT00899353|520623734|FG000|Overall Study|Adverse Event|2|||
144386297|NCT00899353|520623734|FG000|Overall Study|Lost to Follow-up|1|||
144386298|NCT00899353|520623734|FG000|Overall Study|Withdrawal by Subject|2|||
144386299|NCT01892384|520623740|FG000|Overall Study|Withdrawal by Subject|1|||
144386300|NCT01892384|520623741|FG001|Overall Study|Withdrawal by Subject|1|||
144386301|NCT01892384|520623742|FG002|Overall Study|Withdrawal by Subject|0|||
144386302|NCT01892384|520623743|FG003|Overall Study|Withdrawal by Subject|0|||
144386303|NCT00592774|520623744|FG000|Overall Study|Adverse Event|5|||
144386304|NCT00592774|520623745|FG001|Overall Study|Adverse Event|19|||
144386305|NCT00592774|520623746|FG002|Overall Study|Adverse Event|2|||
144386306|NCT00592774|520623747|FG003|Overall Study|Adverse Event|14|||
144386307|NCT00592774|520623748|FG004|Overall Study|Adverse Event|8|||
144515406|NCT00087139|521085926|FG002|Overall Study|Ineligible|4|||
144515407|NCT00087139|521085924|FG000|Overall Study|Symptomatic deterioration|1|||
144515408|NCT00087139|521085925|FG001|Overall Study|Symptomatic deterioration|1|||
144515409|NCT00087139|521085926|FG002|Overall Study|Symptomatic deterioration|3|||
144515410|NCT00087139|521085924|FG000|Overall Study|Use of coumadin|1|||
144515411|NCT00087139|521085925|FG001|Overall Study|Use of coumadin|0|||
144515412|NCT00087139|521085926|FG002|Overall Study|Use of coumadin|0|||
144515413|NCT00087139|521085924|FG000|Overall Study|Response achieved|0|||
144515414|NCT00087139|521085925|FG001|Overall Study|Response achieved|1|||
144386308|NCT00592774|520623744|FG000|Overall Study|Protocol Violation|0|||
144386309|NCT00592774|520623745|FG001|Overall Study|Protocol Violation|1|||
144386310|NCT00592774|520623746|FG002|Overall Study|Protocol Violation|0|||
144386311|NCT00592774|520623747|FG003|Overall Study|Protocol Violation|0|||
144386312|NCT00592774|520623748|FG004|Overall Study|Protocol Violation|1|||
144386313|NCT00592774|520623744|FG000|Overall Study|Withdrawal by Subject|3|||
144386314|NCT00592774|520623745|FG001|Overall Study|Withdrawal by Subject|7|||
144386315|NCT00592774|520623746|FG002|Overall Study|Withdrawal by Subject|0|||
144386316|NCT00592774|520623747|FG003|Overall Study|Withdrawal by Subject|0|||
144386317|NCT00592774|520623748|FG004|Overall Study|Withdrawal by Subject|0|||
144386318|NCT00592774|520623744|FG000|Overall Study|Lack of Efficacy|3|||
144386319|NCT00592774|520623745|FG001|Overall Study|Lack of Efficacy|3|||
144386320|NCT00592774|520623746|FG002|Overall Study|Lack of Efficacy|0|||
144386321|NCT00592774|520623747|FG003|Overall Study|Lack of Efficacy|0|||
144386322|NCT00592774|520623748|FG004|Overall Study|Lack of Efficacy|2|||
144386323|NCT00592774|520623744|FG000|Overall Study|Physician Decision|0|||
144386324|NCT00592774|520623745|FG001|Overall Study|Physician Decision|1|||
144386325|NCT00592774|520623746|FG002|Overall Study|Physician Decision|1|||
144386326|NCT00592774|520623747|FG003|Overall Study|Physician Decision|0|||
144386327|NCT00592774|520623748|FG004|Overall Study|Physician Decision|1|||
144386328|NCT00592774|520623744|FG000|Overall Study|Other|0|||
144386329|NCT00592774|520623745|FG001|Overall Study|Other|1|||
144386330|NCT00592774|520623746|FG002|Overall Study|Other|1|||
144386331|NCT00592774|520623747|FG003|Overall Study|Other|0|||
144386332|NCT00592774|520623748|FG004|Overall Study|Other|2|||
144386333|NCT01924429|520623749|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
144386334|NCT01924429|520623750|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
144386335|NCT01514370|520623754|FG000|Overall Study|Protocol Violation|2|||
144386336|NCT01514370|520623755|FG001|Overall Study|Protocol Violation|3|||
144386337|NCT01514370|520623754|FG000|Overall Study|Lost to Follow-up|0|||
144386338|NCT01514370|520623755|FG001|Overall Study|Lost to Follow-up|2|||
144386339|NCT01514370|520623754|FG000|Overall Study|Withdrawal by Subject|2|||
144386340|NCT01514370|520623755|FG001|Overall Study|Withdrawal by Subject|1|||
144386341|NCT01514370|520623754|FG000|Overall Study|Adverse Event|1|||
144386342|NCT01514370|520623755|FG001|Overall Study|Adverse Event|3|||
144386343|NCT01514370|520623754|FG000|Overall Study|Other|6|||
144386344|NCT01514370|520623755|FG001|Overall Study|Other|7|||
144386345|NCT00604214|520623758|FG000|Baseline to Day 28|Death|223|||
144386346|NCT00604214|520623759|FG001|Baseline to Day 28|Death|202|||
144386347|NCT00604214|520623758|FG000|Baseline to Day 28|Lost to Follow-up|2|||
144386348|NCT00604214|520623759|FG001|Baseline to Day 28|Lost to Follow-up|4|||
144386349|NCT00604214|520623758|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
144386350|NCT00604214|520623759|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
144386351|NCT00604214|520623758|FG000|Day 29 to Day 90|Death|64|||
144386352|NCT00604214|520623759|FG001|Day 29 to Day 90|Death|67|||
144386353|NCT00604214|520623758|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
144386354|NCT00604214|520623759|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
144386355|NCT00604214|520623758|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
144386356|NCT00604214|520623759|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
144386357|NCT00604214|520623758|FG000|Day 91 to Day 180|Death|19|||
144386358|NCT00604214|520623759|FG001|Day 91 to Day 180|Death|23|||
144386359|NCT00604214|520623758|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
144386360|NCT00604214|520623759|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
144386361|NCT00604214|520623758|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
144386362|NCT00604214|520623759|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
144386363|NCT00773383|520625561|FG000|Overall Study|Adverse Event|4|||
144386364|NCT00773383|520625561|FG000|Overall Study|Death|1|||
144386365|NCT00773383|520625561|FG000|Overall Study|Progression of Disease|23|||
144386366|NCT00773383|520625561|FG000|Overall Study|Other|2|||
144386367|NCT00773383|520625561|FG000|Overall Study|No study dose received|1|||
144386368|NCT03384693|520625562|FG000|Overall Study|Adverse Event|3|||
144386369|NCT01095094|520625565|FG000|Overall Study|Withdrawal by Subject|1|||
144386370|NCT01095094|520625565|FG000|Overall Study|Death|1|||
144386371|NCT01095094|520625565|FG000|Overall Study|Physician Decision|1|||
144386372|NCT03699475|520625567|FG000|Overall Study|Death|1|||
144386373|NCT00137839|520625568|FG000|Overall Study|Adverse Event|7|||
144386374|NCT00137839|520625568|FG000|Overall Study|Physician Decision|7|||
144386375|NCT00137839|520625568|FG000|Overall Study|Death|8|||
144386376|NCT00137839|520625568|FG000|Overall Study|Disease Progression|60|||
144386377|NCT00137839|520625568|FG000|Overall Study|Not Start Treatment|1|||
144515415|NCT00087139|521085926|FG002|Overall Study|Response achieved|0|||
144199318|NCT00541970|519928866|FG000|Month 60|Protocol Violation|78|||
144515416|NCT00087139|521085924|FG000|Overall Study|Extradural disease|0|||
144515417|NCT00087139|521085925|FG001|Overall Study|Extradural disease|0|||
144515418|NCT00087139|521085926|FG002|Overall Study|Extradural disease|1|||
144515419|NCT05171777|521085927|FG000|Treatment Crossover Period|Adverse Event|9|||
144386378|NCT00137839|520625568|FG000|Overall Study|Prolonged Treatment Delay|1|||
144386379|NCT00528970|520625569|FG000|Overall Study|Adverse Event|6|||
144386380|NCT00528970|520625570|FG001|Overall Study|Adverse Event|8|||
144386381|NCT00528970|520625571|FG002|Overall Study|Adverse Event|5|||
144515420|NCT05171777|521085928|FG001|Treatment Crossover Period|Adverse Event|6|||
144515421|NCT05171777|521085929|FG002|Treatment Crossover Period|Adverse Event|0|||
144515422|NCT05171777|521085930|FG003|Treatment Crossover Period|Adverse Event|0|||
144386382|NCT00528970|520625569|FG000|Overall Study|Lost to Follow-up|0|||
144386383|NCT00528970|520625570|FG001|Overall Study|Lost to Follow-up|0|||
144386384|NCT00528970|520625571|FG002|Overall Study|Lost to Follow-up|1|||
144386385|NCT00528970|520625569|FG000|Overall Study|Other than specified|2|||
144386386|NCT00528970|520625570|FG001|Overall Study|Other than specified|3|||
144386387|NCT00528970|520625571|FG002|Overall Study|Other than specified|3|||
144386388|NCT00528970|520625569|FG000|Overall Study|Protocol Violation|2|||
144386389|NCT00528970|520625570|FG001|Overall Study|Protocol Violation|1|||
144515423|NCT05171777|521085927|FG000|Treatment Crossover Period|Death|5|||
144592814|NCT03464097|521370697|FG001|Overall Study|Study terminated by sponsor|44|||
144592815|NCT03464097|521370698|FG002|Overall Study|Study terminated by sponsor|40|||
144592816|NCT03464097|521370696|FG000|Overall Study|Pregnancy|0|||
144592817|NCT03464097|521370697|FG001|Overall Study|Pregnancy|1|||
144592818|NCT03464097|521370698|FG002|Overall Study|Pregnancy|0|||
144592819|NCT03464097|521370696|FG000|Overall Study|Other reasons|5|||
144592820|NCT03464097|521370697|FG001|Overall Study|Other reasons|12|||
144592821|NCT03464097|521370698|FG002|Overall Study|Other reasons|14|||
144592822|NCT03464097|521370696|FG000|Overall Study|Lost to Follow-up|0|||
144592823|NCT03464097|521370697|FG001|Overall Study|Lost to Follow-up|1|||
144592824|NCT03464097|521370698|FG002|Overall Study|Lost to Follow-up|1|||
144592825|NCT03464097|521370696|FG000|Overall Study|Lack of Efficacy|11|||
144592826|NCT03464097|521370697|FG001|Overall Study|Lack of Efficacy|18|||
144722100|NCT00203307|521836971|FG001|First Intervention|Adverse Event|0|||
144199319|NCT00541970|519928867|FG001|Month 60|Protocol Violation|77|||
144592827|NCT03464097|521370698|FG002|Overall Study|Lack of Efficacy|30|||
144592828|NCT03464097|521370696|FG000|Overall Study|Death|1|||
144592829|NCT03464097|521370697|FG001|Overall Study|Death|0|||
144592830|NCT03464097|521370698|FG002|Overall Study|Death|0|||
144722101|NCT02789111|521836972|FG000|Overall Study|Withdrawal by Subject|1|||
144386390|NCT00528970|520625571|FG002|Overall Study|Protocol Violation|4|||
144386391|NCT00528970|520625569|FG000|Overall Study|Lack of Efficacy|0|||
144386392|NCT00528970|520625570|FG001|Overall Study|Lack of Efficacy|0|||
144386393|NCT00528970|520625571|FG002|Overall Study|Lack of Efficacy|1|||
144386394|NCT00528970|520625569|FG000|Overall Study|Withdrawal by Subject|4|||
144386395|NCT00528970|520625570|FG001|Overall Study|Withdrawal by Subject|3|||
144386396|NCT00528970|520625571|FG002|Overall Study|Withdrawal by Subject|5|||
144386397|NCT00528970|520625569|FG000|Overall Study|Randomized but not treated|0|||
144386398|NCT00528970|520625570|FG001|Overall Study|Randomized but not treated|0|||
144386399|NCT00528970|520625571|FG002|Overall Study|Randomized but not treated|1|||
144386400|NCT03739242|520625579|FG000|Overall Study|Withdrawal by Subject|1|||
144386401|NCT03739242|520625580|FG001|Overall Study|Withdrawal by Subject|1|||
144386402|NCT03739242|520625579|FG000|Overall Study|Protocol Violation|0|||
144386403|NCT03739242|520625580|FG001|Overall Study|Protocol Violation|1|||
144386404|NCT01122394|520625581|FG000|Overall Study|Withdrawal by Subject|1|||
144386405|NCT01122394|520625582|FG001|Overall Study|Withdrawal by Subject|1|||
144386406|NCT01122394|520625581|FG000|Overall Study|Lost to Follow-up|2|||
144386407|NCT01122394|520625582|FG001|Overall Study|Lost to Follow-up|2|||
144386408|NCT01122394|520625581|FG000|Overall Study|Adverse Event|0|||
144386409|NCT01122394|520625582|FG001|Overall Study|Adverse Event|1|||
144386410|NCT02446743|520625583|FG000|Overall Study|Withdrawal by Subject|1|||
144386411|NCT02446743|520625584|FG001|Overall Study|Withdrawal by Subject|1|||
144386412|NCT02446743|520625583|FG000|Overall Study|Lost to Follow-up|1|||
144386413|NCT02446743|520625584|FG001|Overall Study|Lost to Follow-up|0|||
144386414|NCT02446743|520625583|FG000|Overall Study|Adverse Event|1|||
144386415|NCT02446743|520625584|FG001|Overall Study|Adverse Event|1|||
144386416|NCT02446743|520625583|FG000|Overall Study|Other|2|||
144386417|NCT02446743|520625584|FG001|Overall Study|Other|3|||
144386418|NCT00039871|520625585|FG000|Overall Study|Adverse Event|165|||
144386419|NCT00039871|520625585|FG000|Overall Study|Lost to Follow-up|18|||
144386420|NCT00039871|520625585|FG000|Overall Study|Protocol Violation|24|||
144386421|NCT00039871|520625585|FG000|Overall Study|Withdrawal by Subject|97|||
144386422|NCT00039871|520625585|FG000|Overall Study|Did not meet eligibility criteria|11|||
144386423|NCT00039871|520625585|FG000|Overall Study|Administrative|1|||
144386424|NCT00039871|520625585|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
144386425|NCT00039871|520625585|FG000|Overall Study|Never entered follow-up|7|||
144386426|NCT03361176|520625586|FG000|Overall Study|Lost to Follow-up|1|||
144386427|NCT03361176|520625587|FG001|Overall Study|Lost to Follow-up|2|||
144386428|NCT03361176|520625586|FG000|Overall Study|Adverse Event|0|||
144386429|NCT03361176|520625587|FG001|Overall Study|Adverse Event|2|||
144386430|NCT03361176|520625586|FG000|Overall Study|Withdrawal by Subject|0|||
144386431|NCT03361176|520625587|FG001|Overall Study|Withdrawal by Subject|1|||
144515424|NCT05171777|521085928|FG001|Treatment Crossover Period|Death|5|||
144515425|NCT05171777|521085929|FG002|Treatment Crossover Period|Death|0|||
144515426|NCT05171777|521085930|FG003|Treatment Crossover Period|Death|0|||
144515427|NCT05171777|521085927|FG000|Treatment Crossover Period|Disease Relapse|0|||
144515428|NCT05171777|521085928|FG001|Treatment Crossover Period|Disease Relapse|1|||
144515429|NCT05171777|521085929|FG002|Treatment Crossover Period|Disease Relapse|0|||
144515430|NCT05171777|521085930|FG003|Treatment Crossover Period|Disease Relapse|0|||
144515431|NCT05171777|521085927|FG000|Treatment Crossover Period|Reason not Specified|2|||
144515432|NCT05171777|521085928|FG001|Treatment Crossover Period|Reason not Specified|1|||
144515433|NCT05171777|521085929|FG002|Treatment Crossover Period|Reason not Specified|0|||
144515434|NCT05171777|521085930|FG003|Treatment Crossover Period|Reason not Specified|0|||
144515435|NCT05171777|521085927|FG000|Treatment Crossover Period|Physician Decision|0|||
144515436|NCT05171777|521085928|FG001|Treatment Crossover Period|Physician Decision|1|||
144515437|NCT05171777|521085929|FG002|Treatment Crossover Period|Physician Decision|0|||
144515438|NCT05171777|521085930|FG003|Treatment Crossover Period|Physician Decision|0|||
144515439|NCT05171777|521085927|FG000|Treatment Crossover Period|Progressive Disease|13|||
144515440|NCT05171777|521085928|FG001|Treatment Crossover Period|Progressive Disease|9|||
144515441|NCT05171777|521085929|FG002|Treatment Crossover Period|Progressive Disease|0|||
144515442|NCT05171777|521085930|FG003|Treatment Crossover Period|Progressive Disease|0|||
144515443|NCT05171777|521085927|FG000|Treatment Crossover Period|Protocol Violation|0|||
144199320|NCT00541970|519928868|FG002|Month 60|Protocol Violation|82|||
144515444|NCT05171777|521085928|FG001|Treatment Crossover Period|Protocol Violation|2|||
144515445|NCT05171777|521085929|FG002|Treatment Crossover Period|Protocol Violation|0|||
144515446|NCT05171777|521085930|FG003|Treatment Crossover Period|Protocol Violation|0|||
144515447|NCT05171777|521085927|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
144515448|NCT05171777|521085928|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
144386432|NCT02478398|520625588|FG000|Overall Study|Adverse Event|20|||
144386433|NCT02478398|520625589|FG001|Overall Study|Adverse Event|5|||
144386434|NCT02478398|520625588|FG000|Overall Study|Lost to Follow-up|5|||
144386435|NCT02478398|520625589|FG001|Overall Study|Lost to Follow-up|4|||
144386436|NCT02478398|520625588|FG000|Overall Study|Non-Compliance With Study Drug|5|||
144386437|NCT02478398|520625589|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144386438|NCT02478398|520625588|FG000|Overall Study|Protocol Violation|3|||
144386439|NCT02478398|520625589|FG001|Overall Study|Protocol Violation|1|||
144386440|NCT02478398|520625588|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
144386441|NCT02478398|520625589|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
144386442|NCT02478398|520625588|FG000|Overall Study|Withdrawal By Participant|10|||
144386443|NCT02478398|520625589|FG001|Overall Study|Withdrawal By Participant|4|||
144386444|NCT02230527|520625590|FG000|Overall Study|Withdrawal by Subject|1|||
144386445|NCT02230527|520625591|FG001|Overall Study|Withdrawal by Subject|1|||
144386446|NCT02230527|520625590|FG000|Overall Study|Death|1|||
144386447|NCT02230527|520625591|FG001|Overall Study|Death|0|||
144386448|NCT02230527|520625590|FG000|Overall Study|Lost to Follow-up|2|||
144386449|NCT02230527|520625591|FG001|Overall Study|Lost to Follow-up|1|||
144386450|NCT02230527|520625590|FG000|Overall Study|Other|1|||
144386451|NCT02230527|520625591|FG001|Overall Study|Other|0|||
144386452|NCT01752036|520625592|FG000|Overall Study|Death|2|||
144386453|NCT01011478|520625593|FG000|Overall Study|No follow up data|12|||
144386454|NCT01011478|520625594|FG001|Overall Study|No follow up data|7|||
144386455|NCT04618770|520625595|FG000|Overall Study|Censored from Analysis|12|||
144386456|NCT04618770|520625595|FG000|Overall Study|Early Termination|25|||
144386457|NCT04456673|520625596|FG000|Overall Study|Adverse Event|7|||
144386458|NCT04456673|520625597|FG001|Overall Study|Adverse Event|14|||
144386459|NCT04456673|520625596|FG000|Overall Study|Poor compliance to protocol|1|||
144386460|NCT04456673|520625597|FG001|Overall Study|Poor compliance to protocol|0|||
144386461|NCT04456673|520625596|FG000|Overall Study|Withdrawal by Subject|31|||
144386462|NCT04456673|520625597|FG001|Overall Study|Withdrawal by Subject|23|||
144386463|NCT04456673|520625596|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
144386464|NCT04456673|520625597|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
144386465|NCT04391049|520625598|FG000|Overall Study|Protocol Violation|1|||
144386466|NCT04395001|520625599|FG000|Overall Study|Lost to Follow-up|8|||
144386467|NCT04395001|520625600|FG001|Overall Study|Lost to Follow-up|9|||
144386468|NCT04395001|520625601|FG002|Overall Study|Lost to Follow-up|5|||
144386469|NCT04395001|520625599|FG000|Overall Study|Withdrawal by Subject|3|||
144386470|NCT04395001|520625600|FG001|Overall Study|Withdrawal by Subject|1|||
144386471|NCT04395001|520625601|FG002|Overall Study|Withdrawal by Subject|3|||
144386472|NCT04395001|520625599|FG000|Overall Study|missed appointment|7|||
144386473|NCT04395001|520625600|FG001|Overall Study|missed appointment|4|||
144386474|NCT04395001|520625601|FG002|Overall Study|missed appointment|1|||
144386475|NCT00635024|520625602|FG000|Overall Study|Adverse Event|1|||
144386476|NCT02142387|520625604|FG000|Overall Study|<19 years old|49|||
144386477|NCT02142387|520625605|FG001|Overall Study|<19 years old|326|||
144386478|NCT02142387|520625604|FG000|Overall Study|non-cardiac etiology|504|||
144386479|NCT02142387|520625605|FG001|Overall Study|non-cardiac etiology|3431|||
144386480|NCT02142387|520625604|FG000|Overall Study|CPR not performed|74|||
144386481|NCT02142387|520625605|FG001|Overall Study|CPR not performed|473|||
144386482|NCT02142387|520625604|FG000|Overall Study|witnessed by paramedic|139|||
144386483|NCT02142387|520625605|FG001|Overall Study|witnessed by paramedic|917|||
144386484|NCT02142387|520625604|FG000|Overall Study|incomplete data|1|||
144386485|NCT02142387|520625605|FG001|Overall Study|incomplete data|9|||
144386486|NCT02142387|520625604|FG000|Overall Study|occurred not at home|298|||
144386487|NCT02142387|520625605|FG001|Overall Study|occurred not at home|2474|||
144386488|NCT00046891|520625606|FG000|Overall Study|Cancels|5|||
144386489|NCT00046891|520625607|FG001|Overall Study|Cancels|9|||
144386490|NCT00046891|520625606|FG000|Overall Study|Ineligible|1|||
144386491|NCT00046891|520625607|FG001|Overall Study|Ineligible|1|||
144386492|NCT00046891|520625606|FG000|Overall Study|Withdrawal by Subject|18|||
144386493|NCT00046891|520625607|FG001|Overall Study|Withdrawal by Subject|15|||
144386494|NCT00046891|520625606|FG000|Overall Study|Adverse Event|5|||
144386495|NCT00046891|520625607|FG001|Overall Study|Adverse Event|5|||
144386496|NCT02586506|520625613|FG000|Overall Study|Protocol Violation|6|||
144386497|NCT02586506|520625613|FG000|Overall Study|Lost to Follow-up|1|||
144386498|NCT02586506|520625613|FG000|Overall Study|Other Reason|2|||
144386499|NCT02536404|520625621|FG000|Overall Study|Adverse Event|5|||
144386500|NCT02536404|520625622|FG001|Overall Study|Adverse Event|0|||
144386501|NCT02536404|520625621|FG000|Overall Study|Withdrawal by Subject|4|||
144592831|NCT03464097|521370696|FG000|Overall Study|Adverse Event|13|||
144592832|NCT03464097|521370697|FG001|Overall Study|Adverse Event|6|||
144592833|NCT03464097|521370698|FG002|Overall Study|Adverse Event|8|||
144592834|NCT03035201|521370699|FG000|Overall Study|Death|9|||
144386502|NCT02536404|520625622|FG001|Overall Study|Withdrawal by Subject|1|||
144386503|NCT02536404|520625621|FG000|Overall Study|Physician Decision|10|||
144386504|NCT02536404|520625622|FG001|Overall Study|Physician Decision|0|||
144592835|NCT03035201|521370700|FG001|Overall Study|Death|12|||
144386505|NCT02536404|520625621|FG000|Overall Study|Sponsor decision|1|||
144386506|NCT02536404|520625622|FG001|Overall Study|Sponsor decision|0|||
144386507|NCT02158364|520625623|FG000|Overall Study|Case report forms uncollected|10|||
144386508|NCT02158364|520625623|FG000|Overall Study|Protocol Deviation|50|||
144386509|NCT04381988|520625626|FG000|Overall Study|The study was terminated|4|||
144386510|NCT04381988|520625627|FG001|Overall Study|The study was terminated|0|||
144386511|NCT01944839|520625628|FG000|Overall Study|Physician Decision|2|||
144386512|NCT01944839|520625629|FG001|Overall Study|Physician Decision|2|||
144592836|NCT03035201|521370701|FG002|Overall Study|Death|9|||
144386513|NCT01944839|520625628|FG000|Overall Study|Protocol Violation|0|||
144386514|NCT01944839|520625629|FG001|Overall Study|Protocol Violation|1|||
144386515|NCT01944839|520625628|FG000|Overall Study|Adverse Event|10|||
144386516|NCT01944839|520625629|FG001|Overall Study|Adverse Event|5|||
144386517|NCT01944839|520625628|FG000|Overall Study|Withdrawal by Subject|9|||
144386518|NCT01944839|520625629|FG001|Overall Study|Withdrawal by Subject|17|||
144386519|NCT01944839|520625628|FG000|Overall Study|Lost to Follow-up|1|||
144386520|NCT01944839|520625629|FG001|Overall Study|Lost to Follow-up|0|||
144386521|NCT01944839|520625628|FG000|Overall Study|Subject non-compliance|0|||
144386522|NCT01944839|520625629|FG001|Overall Study|Subject non-compliance|3|||
144386523|NCT01107379|520625633|FG000|Overall Study|Withdrawal by Subject|18|||
144386524|NCT01107379|520625633|FG000|Overall Study|Lost to Follow-up|3|||
144386525|NCT04559529|520625634|FG000|First Intervention (1 Day)|Adverse Event|0|||
144386526|NCT04559529|520625635|FG001|First Intervention (1 Day)|Adverse Event|0|||
144386527|NCT04559529|520625636|FG002|First Intervention (1 Day)|Adverse Event|0|||
144386528|NCT04559529|520625637|FG003|First Intervention (1 Day)|Adverse Event|1|||
144386529|NCT04559529|520625634|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
144386530|NCT04559529|520625635|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
144386531|NCT04559529|520625636|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
144386532|NCT04559529|520625637|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
144386533|NCT04559529|520625634|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
144386534|NCT04559529|520625635|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
144386535|NCT04559529|520625636|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
144386536|NCT04559529|520625637|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
144386537|NCT00609362|520625638|FG000|Overall Study|Withdrawal by Subject|2|||
144386538|NCT00609362|520625639|FG001|Overall Study|Withdrawal by Subject|1|||
144386539|NCT00609362|520625638|FG000|Overall Study|Adverse Event|1|||
144386540|NCT00609362|520625639|FG001|Overall Study|Adverse Event|0|||
144386541|NCT05093790|520625640|FG000|Overall Study|Failure to meet continuation criteria|0|||
144386542|NCT05093790|520625641|FG001|Overall Study|Failure to meet continuation criteria|0|||
144386543|NCT05093790|520625642|FG002|Overall Study|Failure to meet continuation criteria|1|||
144386544|NCT05093790|520625643|FG003|Overall Study|Failure to meet continuation criteria|0|||
144386545|NCT05093790|520625640|FG000|Overall Study|Adverse Event|1|||
144386546|NCT05093790|520625641|FG001|Overall Study|Adverse Event|0|||
144386547|NCT05093790|520625642|FG002|Overall Study|Adverse Event|0|||
144386548|NCT05093790|520625643|FG003|Overall Study|Adverse Event|0|||
144386549|NCT00924170|520625644|FG000|Overall Study|Refused further treatment|0|||
144386550|NCT00924170|520625645|FG001|Overall Study|Refused further treatment|1|||
144386551|NCT00924170|520625644|FG000|Overall Study|Physician Decision|0|||
144386552|NCT00924170|520625645|FG001|Overall Study|Physician Decision|1|||
144386553|NCT00924170|520625644|FG000|Overall Study|Progressive disease|3|||
144386554|NCT00924170|520625645|FG001|Overall Study|Progressive disease|6|||
144386555|NCT00924170|520625644|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
144386556|NCT00924170|520625645|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
144386557|NCT00924170|520625644|FG000|Overall Study|Death|1|||
144386558|NCT00924170|520625645|FG001|Overall Study|Death|0|||
144386559|NCT04098224|520625648|FG000|Overall Study|Adverse Event|1|||
144386560|NCT04098224|520625649|FG001|Overall Study|Adverse Event|0|||
144386561|NCT04098224|520625648|FG000|Overall Study|Physician Decision|1|||
144386562|NCT04098224|520625649|FG001|Overall Study|Physician Decision|0|||
144386563|NCT04098224|520625648|FG000|Overall Study|Patient not required enteral feeding|1|||
144386564|NCT04098224|520625649|FG001|Overall Study|Patient not required enteral feeding|0|||
144386565|NCT04098224|520625648|FG000|Overall Study|Patient failure nasogastric tube|1|||
144386566|NCT04098224|520625649|FG001|Overall Study|Patient failure nasogastric tube|0|||
144386567|NCT04098224|520625648|FG000|Overall Study|Patient early extubation|1|||
144386568|NCT04098224|520625649|FG001|Overall Study|Patient early extubation|3|||
144386569|NCT01203852|520625653|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
144386570|NCT01203852|520625653|FG000|Washout 2 Weeks|Physician Decision|46|||
144386571|NCT01878149|520625656|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
144386572|NCT01878149|520625657|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
144386573|NCT04672252|520625660|FG000|Overall Study|Protocol Violation|1|||
144386574|NCT04672252|520625661|FG001|Overall Study|Protocol Violation|0|||
144386575|NCT01587898|520625668|FG000|Overall Study|Adverse Event|1|||
144386576|NCT01587898|520625669|FG001|Overall Study|Adverse Event|1|||
144386577|NCT01587898|520625670|FG002|Overall Study|Adverse Event|0|||
144386578|NCT01587898|520625671|FG003|Overall Study|Adverse Event|0|||
144386579|NCT01587898|520625668|FG000|Overall Study|Protocol Violation|0|||
144386580|NCT01587898|520625669|FG001|Overall Study|Protocol Violation|2|||
144386581|NCT01587898|520625670|FG002|Overall Study|Protocol Violation|1|||
144386582|NCT01587898|520625671|FG003|Overall Study|Protocol Violation|1|||
144386583|NCT01587898|520625668|FG000|Overall Study|Lost to Follow-up|0|||
144386584|NCT01587898|520625669|FG001|Overall Study|Lost to Follow-up|0|||
144386585|NCT01587898|520625670|FG002|Overall Study|Lost to Follow-up|0|||
144386586|NCT01587898|520625671|FG003|Overall Study|Lost to Follow-up|1|||
144386587|NCT01587898|520625668|FG000|Overall Study|Withdrawal by Subject|2|||
144386588|NCT01587898|520625669|FG001|Overall Study|Withdrawal by Subject|1|||
144386589|NCT01587898|520625670|FG002|Overall Study|Withdrawal by Subject|0|||
144386590|NCT01587898|520625671|FG003|Overall Study|Withdrawal by Subject|0|||
144386591|NCT01587898|520625668|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
144386592|NCT01587898|520625669|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
144386593|NCT01587898|520625670|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
144386594|NCT01587898|520625671|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
144386595|NCT01738477|520625672|FG000|Overall Study|Lost to Follow-up|1|||
144386596|NCT01738477|520625673|FG001|Overall Study|Lost to Follow-up|4|||
144386597|NCT00502203|520625674|FG000|Overall Study|Inevaluable|1|||
144386598|NCT01302834|520625679|FG000|Overall Study|Protocol Violation|17|||
144386599|NCT01302834|520625680|FG001|Overall Study|Protocol Violation|23|||
144386600|NCT01302834|520625679|FG000|Overall Study|HIV positive|1|||
144386601|NCT01302834|520625680|FG001|Overall Study|HIV positive|3|||
144386602|NCT00899392|520625681|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
144386603|NCT00899392|520625682|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
144386604|NCT01903252|520625683|FG000|Double-Blind Induction|Adverse Event|20|||
144386605|NCT01903252|520625684|FG001|Double-Blind Induction|Adverse Event|18|||
144386606|NCT01903252|520625685|FG002|Double-Blind Induction|Adverse Event|0|||
144386607|NCT01903252|520625686|FG003|Double-Blind Induction|Adverse Event|0|||
144386608|NCT01903252|520625687|FG004|Double-Blind Induction|Adverse Event|0|||
144386609|NCT01903252|520625688|FG005|Double-Blind Induction|Adverse Event|0|||
144386610|NCT01903252|520625683|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
144386611|NCT01903252|520625684|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
144386612|NCT01903252|520625685|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
144386613|NCT01903252|520625686|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
144386614|NCT01903252|520625687|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
144386615|NCT01903252|520625688|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
144386616|NCT01903252|520625683|FG000|Double-Blind Induction|Physician Decision|2|||
144386617|NCT01903252|520625684|FG001|Double-Blind Induction|Physician Decision|3|||
144386618|NCT01903252|520625685|FG002|Double-Blind Induction|Physician Decision|0|||
144386619|NCT01903252|520625686|FG003|Double-Blind Induction|Physician Decision|0|||
144386620|NCT01903252|520625687|FG004|Double-Blind Induction|Physician Decision|0|||
144386621|NCT01903252|520625688|FG005|Double-Blind Induction|Physician Decision|0|||
144386622|NCT01903252|520625683|FG000|Double-Blind Induction|non-compliance,|7|||
144386623|NCT01903252|520625684|FG001|Double-Blind Induction|non-compliance,|7|||
144386624|NCT01903252|520625685|FG002|Double-Blind Induction|non-compliance,|0|||
144386625|NCT01903252|520625686|FG003|Double-Blind Induction|non-compliance,|0|||
144386626|NCT01903252|520625687|FG004|Double-Blind Induction|non-compliance,|0|||
144592837|NCT03035201|521370702|FG003|Overall Study|Death|10|||
144592838|NCT03035201|521370699|FG000|Overall Study|Withdrawal by Subject|51|||
144592839|NCT03035201|521370700|FG001|Overall Study|Withdrawal by Subject|49|||
144592840|NCT03035201|521370701|FG002|Overall Study|Withdrawal by Subject|37|||
144592841|NCT03035201|521370702|FG003|Overall Study|Withdrawal by Subject|46|||
144592842|NCT03035201|521370699|FG000|Overall Study|Lost to Follow-up|67|||
144386627|NCT01903252|520625688|FG005|Double-Blind Induction|non-compliance,|0|||
144592843|NCT03035201|521370700|FG001|Overall Study|Lost to Follow-up|51|||
144592844|NCT03035201|521370701|FG002|Overall Study|Lost to Follow-up|64|||
144386628|NCT01903252|520625683|FG000|Extended Induction, Open-Label|Adverse Event|0|||
144386629|NCT01903252|520625684|FG001|Extended Induction, Open-Label|Adverse Event|0|||
144386630|NCT01903252|520625685|FG002|Extended Induction, Open-Label|Adverse Event|17|||
144386631|NCT01903252|520625686|FG003|Extended Induction, Open-Label|Adverse Event|0|||
144386632|NCT01903252|520625687|FG004|Extended Induction, Open-Label|Adverse Event|0|||
144386633|NCT01903252|520625688|FG005|Extended Induction, Open-Label|Adverse Event|0|||
144386634|NCT01903252|520625683|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
144386635|NCT01903252|520625684|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
144386636|NCT01903252|520625685|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
144386637|NCT01903252|520625686|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
144386638|NCT01903252|520625687|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
144386639|NCT01903252|520625688|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
144386640|NCT01903252|520625683|FG000|Extended Induction, Open-Label|Physician Decision|0|||
144386641|NCT01903252|520625684|FG001|Extended Induction, Open-Label|Physician Decision|0|||
144386642|NCT01903252|520625685|FG002|Extended Induction, Open-Label|Physician Decision|1|||
144386643|NCT01903252|520625686|FG003|Extended Induction, Open-Label|Physician Decision|0|||
144386644|NCT01903252|520625687|FG004|Extended Induction, Open-Label|Physician Decision|0|||
144386645|NCT01903252|520625688|FG005|Extended Induction, Open-Label|Physician Decision|0|||
144386646|NCT01903252|520625683|FG000|Maintenance, Open-Label|Adverse Event|0|||
144386647|NCT01903252|520625684|FG001|Maintenance, Open-Label|Adverse Event|0|||
144386648|NCT01903252|520625685|FG002|Maintenance, Open-Label|Adverse Event|0|||
144386649|NCT01903252|520625686|FG003|Maintenance, Open-Label|Adverse Event|3|||
144386650|NCT01903252|520625687|FG004|Maintenance, Open-Label|Adverse Event|9|||
144386651|NCT01903252|520625688|FG005|Maintenance, Open-Label|Adverse Event|14|||
144386652|NCT01903252|520625683|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
144386653|NCT01903252|520625684|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
144386654|NCT01903252|520625685|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
144386655|NCT01903252|520625686|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
144386656|NCT01903252|520625687|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
144386657|NCT01903252|520625688|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
144386658|NCT01903252|520625683|FG000|Maintenance, Open-Label|Other|0|||
144386659|NCT01903252|520625684|FG001|Maintenance, Open-Label|Other|0|||
144386660|NCT01903252|520625685|FG002|Maintenance, Open-Label|Other|0|||
144386661|NCT01903252|520625686|FG003|Maintenance, Open-Label|Other|2|||
144386662|NCT01903252|520625687|FG004|Maintenance, Open-Label|Other|6|||
144386663|NCT01903252|520625688|FG005|Maintenance, Open-Label|Other|2|||
144386664|NCT02437110|520625689|FG000|Screening|Lost to Follow-up|3|||
144386665|NCT02437110|520625689|FG000|Screening|Physician Decision|1|||
144386666|NCT02437110|520625689|FG000|ART|Adverse Event|3|||
144386667|NCT02437110|520625689|FG000|ART|Protocol Violation|3|||
144386668|NCT02437110|520625689|FG000|ART|Withdrawal by Subject|4|||
144386669|NCT02437110|520625689|FG000|ART|Lost to follow-up prior to start of intervention|1|||
144386670|NCT02437110|520625689|FG000|ART|Physician decision prior to start of intervention|2|||
144386671|NCT02437110|520625689|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
144386672|NCT02437110|520625689|FG000|Post-ART|Lost to Follow-up|3|||
144386673|NCT02437110|520625689|FG000|Post-ART|Protocol Violation|4|||
144386674|NCT02437110|520625689|FG000|Post-ART|Withdrawal by Subject|3|||
144386675|NCT03735238|520625690|FG000|Overall Study|Did not want to participate in research|3|||
144386676|NCT03735238|520625690|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
144386677|NCT01431638|520625691|FG000|Overall Study|Adverse Event|1|||
144386678|NCT01431638|520625692|FG001|Overall Study|Adverse Event|3|||
144386679|NCT01431638|520625693|FG002|Overall Study|Adverse Event|1|||
144386680|NCT01431638|520625691|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144386681|NCT01431638|520625692|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144386682|NCT01431638|520625693|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
144386683|NCT01431638|520625691|FG000|Overall Study|Participants condition no longer requires study drug|0|||
144386684|NCT01431638|520625692|FG001|Overall Study|Participants condition no longer requires study drug|1|||
144386685|NCT01431638|520625693|FG002|Overall Study|Participants condition no longer requires study drug|0|||
144515449|NCT05171777|521085929|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
144515450|NCT05171777|521085930|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
144515451|NCT05171777|521085927|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
144515452|NCT05171777|521085928|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
144515453|NCT05171777|521085929|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
144722102|NCT02789111|521836973|FG001|Overall Study|Withdrawal by Subject|4|||
144722103|NCT03271528|521836974|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
144722104|NCT03271528|521836975|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
144386686|NCT01431638|520625691|FG000|Overall Study|Participant withdrew consent|14|||
144386687|NCT01431638|520625692|FG001|Overall Study|Participant withdrew consent|5|||
144386688|NCT01431638|520625693|FG002|Overall Study|Participant withdrew consent|8|||
144386689|NCT01431638|520625691|FG000|Overall Study|Lost to Follow-up|7|||
144722105|NCT03271528|521836974|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
144386690|NCT01431638|520625692|FG001|Overall Study|Lost to Follow-up|9|||
144386691|NCT01431638|520625693|FG002|Overall Study|Lost to Follow-up|7|||
144386692|NCT01431638|520625691|FG000|Overall Study|Administrative problems|1|||
144386693|NCT01431638|520625692|FG001|Overall Study|Administrative problems|4|||
144386694|NCT01431638|520625693|FG002|Overall Study|Administrative problems|6|||
144386695|NCT01431638|520625691|FG000|Overall Study|Death|1|||
144386696|NCT01431638|520625692|FG001|Overall Study|Death|0|||
144386697|NCT01431638|520625693|FG002|Overall Study|Death|0|||
144515454|NCT05171777|521085930|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
144515455|NCT05171777|521085927|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
144386698|NCT01431638|520625691|FG000|Overall Study|Protocol deviation|1|||
144386699|NCT01431638|520625692|FG001|Overall Study|Protocol deviation|1|||
144515456|NCT05171777|521085928|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
144515457|NCT05171777|521085929|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
144515458|NCT05171777|521085930|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
144386700|NCT01431638|520625693|FG002|Overall Study|Protocol deviation|4|||
144386701|NCT01431638|520625691|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
144515459|NCT05171777|521085927|FG000|Treatment Continuation Period|Death|0|||
144515460|NCT05171777|521085928|FG001|Treatment Continuation Period|Death|0|||
144515461|NCT05171777|521085929|FG002|Treatment Continuation Period|Death|1|||
144386702|NCT01431638|520625692|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
144386703|NCT01431638|520625693|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
144592845|NCT03035201|521370702|FG003|Overall Study|Lost to Follow-up|69|||
144592846|NCT05572021|521370709|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
144592847|NCT05572021|521370710|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
144592848|NCT04576455|521370711|FG000|Overall Study|Ongoing in the Study|48|||
144592849|NCT04576455|521370712|FG001|Overall Study|Ongoing in the Study|58|||
144592850|NCT04576455|521370711|FG000|Overall Study|Death|83|||
144592851|NCT04576455|521370712|FG001|Overall Study|Death|77|||
144592852|NCT04576455|521370711|FG000|Overall Study|Lost to Follow-up|4|||
144592853|NCT04576455|521370712|FG001|Overall Study|Lost to Follow-up|5|||
144592854|NCT04576455|521370711|FG000|Overall Study|Withdrawal by Subject|16|||
144592855|NCT04576455|521370712|FG001|Overall Study|Withdrawal by Subject|12|||
144386704|NCT01261780|520625694|FG000|Overall Study|Withdrawal by Subject|1|||
144386705|NCT01261780|520625695|FG001|Overall Study|Withdrawal by Subject|0|||
144386706|NCT01261780|520625694|FG000|Overall Study|Event not related to subject|1|||
144386707|NCT01261780|520625695|FG001|Overall Study|Event not related to subject|2|||
144515462|NCT05171777|521085930|FG003|Treatment Continuation Period|Death|6|||
144515463|NCT05171777|521085927|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
144515464|NCT05171777|521085928|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
144515465|NCT05171777|521085929|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
144515466|NCT05171777|521085930|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
144515467|NCT04154384|521085931|FG000|Overall Study|Lost to Follow-up|24|||
144515468|NCT04154384|521085932|FG001|Overall Study|Lost to Follow-up|33|||
144515469|NCT04154384|521085933|FG002|Overall Study|Lost to Follow-up|0|||
144515470|NCT04154384|521085931|FG000|Overall Study|Withdrawal by Subject|7|||
144515471|NCT04154384|521085932|FG001|Overall Study|Withdrawal by Subject|18|||
144515472|NCT04154384|521085933|FG002|Overall Study|Withdrawal by Subject|0|||
144515473|NCT04154384|521085931|FG000|Overall Study|Missing outcome data|1|||
144515474|NCT04154384|521085932|FG001|Overall Study|Missing outcome data|0|||
144515475|NCT04154384|521085933|FG002|Overall Study|Missing outcome data|0|||
144515476|NCT01136876|521085934|FG000|Overall Study|Lost to Follow-up|0|||
144515477|NCT01136876|521085935|FG001|Overall Study|Lost to Follow-up|1|||
144515478|NCT01136876|521085934|FG000|Overall Study|Physician Decision|3|||
144592856|NCT03432260|521370713|FG000|Overall Study|Lost to Follow-up|1|||
144386708|NCT01239732|520625696|FG000|Overall Study|Termination of study per protocol|667|||
144386709|NCT01239732|520625696|FG000|Overall Study|Death|226|||
144515479|NCT01136876|521085935|FG001|Overall Study|Physician Decision|5|||
144515480|NCT01136876|521085934|FG000|Overall Study|Missing NGAL measurement|2|||
144515481|NCT01136876|521085935|FG001|Overall Study|Missing NGAL measurement|5|||
144515482|NCT05321069|521085936|FG000|Overall Study|Adverse Event|52|||
144515483|NCT05321069|521085937|FG001|Overall Study|Adverse Event|52|||
144515484|NCT05321069|521085938|FG002|Overall Study|Adverse Event|64|||
144199321|NCT00541970|519928869|FG003|Month 60|Protocol Violation|72|||
144386710|NCT01239732|520625696|FG000|Overall Study|Withdrawal by Subject|87|||
144386711|NCT01239732|520625696|FG000|Overall Study|Adverse Event|6|||
144386712|NCT01239732|520625696|FG000|Overall Study|Protocol Violation|3|||
144386713|NCT01239732|520625696|FG000|Overall Study|Participant non compliance|5|||
144386714|NCT01239732|520625696|FG000|Overall Study|Study termination by sponsor|2|||
144386715|NCT01239732|520625696|FG000|Overall Study|Investigator's decision|4|||
144386716|NCT01239732|520625696|FG000|Overall Study|Treatment failure|2|||
144386717|NCT01239732|520625696|FG000|Overall Study|Other|19|||
144386718|NCT00308581|520625697|FG000|Induction Phase|Adverse Event|0|||
144386719|NCT00308581|520625698|FG001|Induction Phase|Adverse Event|0|||
144386720|NCT00308581|520625699|FG002|Induction Phase|Adverse Event|37|||
144386721|NCT00308581|520625697|FG000|Induction Phase|Lack of Efficacy|0|||
144386722|NCT00308581|520625698|FG001|Induction Phase|Lack of Efficacy|0|||
144386723|NCT00308581|520625699|FG002|Induction Phase|Lack of Efficacy|121|||
144386724|NCT00308581|520625697|FG000|Induction Phase|Withdrawal by Subject|0|||
144386725|NCT00308581|520625698|FG001|Induction Phase|Withdrawal by Subject|0|||
144386726|NCT00308581|520625699|FG002|Induction Phase|Withdrawal by Subject|5|||
144386727|NCT00308581|520625697|FG000|Induction Phase|Unknown reason|0|||
144386728|NCT00308581|520625698|FG001|Induction Phase|Unknown reason|0|||
144386729|NCT00308581|520625699|FG002|Induction Phase|Unknown reason|3|||
144386730|NCT00308581|520625697|FG000|Randomized Maintenance Phase|Adverse Event|10|||
144386731|NCT00308581|520625698|FG001|Randomized Maintenance Phase|Adverse Event|17|||
144386732|NCT00308581|520625699|FG002|Randomized Maintenance Phase|Adverse Event|0|||
144386733|NCT00308581|520625697|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
144386734|NCT00308581|520625698|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
144515485|NCT05321069|521085936|FG000|Overall Study|Protocol Violation|1|||
144515486|NCT05321069|521085937|FG001|Overall Study|Protocol Violation|1|||
144515487|NCT05321069|521085938|FG002|Overall Study|Protocol Violation|0|||
144515488|NCT05321069|521085936|FG000|Overall Study|Withdrawal by Subject|23|||
144515489|NCT05321069|521085937|FG001|Overall Study|Withdrawal by Subject|18|||
144515490|NCT05321069|521085938|FG002|Overall Study|Withdrawal by Subject|12|||
144515491|NCT05321069|521085936|FG000|Overall Study|Lost to Follow-up|1|||
144515492|NCT05321069|521085937|FG001|Overall Study|Lost to Follow-up|0|||
144515493|NCT05321069|521085938|FG002|Overall Study|Lost to Follow-up|1|||
144515494|NCT05321069|521085936|FG000|Overall Study|No reason stated by the participants|23|||
144515495|NCT05321069|521085937|FG001|Overall Study|No reason stated by the participants|22|||
144515496|NCT05321069|521085938|FG002|Overall Study|No reason stated by the participants|16|||
144515497|NCT05321069|521085936|FG000|Overall Study|Lack of Efficacy|1|||
144515498|NCT05321069|521085937|FG001|Overall Study|Lack of Efficacy|1|||
144515499|NCT05321069|521085938|FG002|Overall Study|Lack of Efficacy|0|||
144515500|NCT02412748|521085941|FG000|Overall Study|Lost to Follow-up|38|||
144515501|NCT02412748|521085942|FG001|Overall Study|Lost to Follow-up|39|||
144515502|NCT04128319|521085943|FG000|Overall Study|Death|3|||
144515503|NCT00976937|521085946|FG000|Overall Study|Adverse Event|4|||
144515504|NCT00976937|521085947|FG001|Overall Study|Adverse Event|5|||
144515505|NCT00976937|521085946|FG000|Overall Study|Lost to Follow-up|2|||
144515506|NCT00976937|521085947|FG001|Overall Study|Lost to Follow-up|1|||
144515507|NCT00976937|521085946|FG000|Overall Study|Withdrawal by Subject|5|||
144515508|NCT00976937|521085947|FG001|Overall Study|Withdrawal by Subject|3|||
144515509|NCT00976937|521085946|FG000|Overall Study|Poor compliance to protocol|3|||
144515510|NCT00976937|521085947|FG001|Overall Study|Poor compliance to protocol|0|||
144515511|NCT00976937|521085946|FG000|Overall Study|Personal and Familial Reason|2|||
144515512|NCT00976937|521085947|FG001|Overall Study|Personal and Familial Reason|2|||
144515513|NCT03069313|521085948|FG000|Overall Study|Adverse Event|5|||
144515514|NCT04218266|521085949|FG000|Overall Study|Death|1|||
144515515|NCT04218266|521085950|FG001|Overall Study|Death|2|||
144515516|NCT04218266|521085951|FG002|Overall Study|Death|3|||
144515517|NCT04218266|521085949|FG000|Overall Study|Adverse Event|13|||
144515518|NCT04218266|521085950|FG001|Overall Study|Adverse Event|14|||
144515519|NCT04218266|521085951|FG002|Overall Study|Adverse Event|11|||
144515520|NCT04218266|521085949|FG000|Overall Study|Other|7|||
144515521|NCT04218266|521085950|FG001|Overall Study|Other|5|||
144515522|NCT04218266|521085951|FG002|Overall Study|Other|14|||
144515523|NCT04218266|521085949|FG000|Overall Study|Physician Decision|1|||
144515524|NCT04218266|521085950|FG001|Overall Study|Physician Decision|3|||
144515525|NCT04218266|521085951|FG002|Overall Study|Physician Decision|2|||
144515526|NCT04218266|521085949|FG000|Overall Study|Non-compliance with study drug|0|||
144199322|NCT03107026|519928870|FG000|Overall Study|Adverse Event|2|||
144386735|NCT00308581|520625699|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
144386736|NCT00308581|520625697|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
144386737|NCT00308581|520625698|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
144386738|NCT00308581|520625699|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
144386739|NCT00308581|520625697|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
144515527|NCT04218266|521085950|FG001|Overall Study|Non-compliance with study drug|0|||
144515528|NCT04218266|521085951|FG002|Overall Study|Non-compliance with study drug|1|||
144515529|NCT04218266|521085949|FG000|Overall Study|Withdrawal by Subject|1|||
144592857|NCT03432260|521370714|FG001|Overall Study|Lost to Follow-up|1|||
144592858|NCT03432260|521370715|FG002|Overall Study|Lost to Follow-up|0|||
144386740|NCT00308581|520625698|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
144386741|NCT00308581|520625699|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
144386742|NCT00308581|520625697|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
144386743|NCT00308581|520625698|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
144386744|NCT00308581|520625699|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
144386745|NCT00308581|520625697|FG000|Randomized Maintenance Phase|Unknown reason|3|||
144386746|NCT00308581|520625698|FG001|Randomized Maintenance Phase|Unknown reason|0|||
144386747|NCT00308581|520625699|FG002|Randomized Maintenance Phase|Unknown reason|0|||
144386748|NCT03400956|520625703|FG000|Treatment Period 1|Adverse Event|0|||
144386749|NCT03400956|520625704|FG001|Treatment Period 1|Adverse Event|1|||
144592859|NCT03432260|521370716|FG003|Overall Study|Lost to Follow-up|0|||
144592860|NCT03432260|521370717|FG004|Overall Study|Lost to Follow-up|1|||
144592861|NCT02186847|521370718|FG000|Overall Study|Protocol Violation|3|||
144592862|NCT02186847|521370719|FG001|Overall Study|Protocol Violation|0|||
144592863|NCT04873232|521370723|FG000|Overall Study|Lost to Follow-up|1|||
144592864|NCT04873232|521370724|FG001|Overall Study|Lost to Follow-up|4|||
144592865|NCT04873232|521370723|FG000|Overall Study|Withdrawal by Subject|1|||
144592866|NCT04873232|521370724|FG001|Overall Study|Withdrawal by Subject|0|||
144592867|NCT03170349|521370725|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
144592868|NCT03170349|521370725|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
144199323|NCT03107026|519928871|FG001|Overall Study|Adverse Event|14|||
144386750|NCT03400956|520625705|FG002|Treatment Period 1|Adverse Event|0|||
144386751|NCT03400956|520625703|FG000|Treatment Period 1|Lost to Follow-up|0|||
144386752|NCT03400956|520625704|FG001|Treatment Period 1|Lost to Follow-up|0|||
144386753|NCT03400956|520625705|FG002|Treatment Period 1|Lost to Follow-up|1|||
144592869|NCT03170349|521370725|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
144592870|NCT03170349|521370725|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
144592871|NCT03170349|521370725|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
144592872|NCT03170349|521370725|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
144592873|NCT03170349|521370725|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
144386754|NCT03400956|520625703|FG000|Treatment Period 1|Protocol Violation|0|||
144386755|NCT03400956|520625704|FG001|Treatment Period 1|Protocol Violation|2|||
144386756|NCT03400956|520625705|FG002|Treatment Period 1|Protocol Violation|0|||
144386757|NCT03400956|520625703|FG000|Treatment Period 1|Study terminated by sponsor|3|||
144386758|NCT03400956|520625704|FG001|Treatment Period 1|Study terminated by sponsor|1|||
144386759|NCT03400956|520625705|FG002|Treatment Period 1|Study terminated by sponsor|1|||
144386760|NCT03400956|520625703|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144386761|NCT03400956|520625704|FG001|Treatment Period 1|Withdrawal by Subject|2|||
144386762|NCT03400956|520625705|FG002|Treatment Period 1|Withdrawal by Subject|4|||
144386763|NCT03400956|520625703|FG000|Treatment Period 1|Other|1|||
144386764|NCT03400956|520625704|FG001|Treatment Period 1|Other|2|||
144386765|NCT03400956|520625705|FG002|Treatment Period 1|Other|3|||
144386766|NCT03400956|520625703|FG000|Post-treatment Period 1|Adverse Event|0|||
144386767|NCT03400956|520625704|FG001|Post-treatment Period 1|Adverse Event|0|||
144386768|NCT03400956|520625705|FG002|Post-treatment Period 1|Adverse Event|1|||
144386769|NCT03400956|520625703|FG000|Post-treatment Period 1|Physician Decision|2|||
144386770|NCT03400956|520625704|FG001|Post-treatment Period 1|Physician Decision|3|||
144386771|NCT03400956|520625705|FG002|Post-treatment Period 1|Physician Decision|0|||
144386772|NCT03400956|520625703|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
144386773|NCT03400956|520625704|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
144386774|NCT03400956|520625705|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
144386775|NCT03400956|520625703|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
144386776|NCT03400956|520625704|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
144386777|NCT03400956|520625705|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
144386778|NCT03400956|520625703|FG000|Post-treatment Period 1|Other|4|||
144386779|NCT03400956|520625704|FG001|Post-treatment Period 1|Other|3|||
144386780|NCT03400956|520625705|FG002|Post-treatment Period 1|Other|4|||
144386781|NCT03400956|520625703|FG000|Treatment Period 2|Adverse Event|2|||
144515530|NCT04218266|521085950|FG001|Overall Study|Withdrawal by Subject|3|||
144515531|NCT04218266|521085951|FG002|Overall Study|Withdrawal by Subject|1|||
144515532|NCT04218266|521085949|FG000|Overall Study|Study drug never administered|2|||
144515533|NCT04218266|521085950|FG001|Overall Study|Study drug never administered|0|||
144515534|NCT04218266|521085951|FG002|Overall Study|Study drug never administered|0|||
144515535|NCT01011946|521085953|FG000|Overall Study|Transferred to another hospital|2|||
144515536|NCT01011946|521085953|FG000|Overall Study|No pathological lab value|1|||
144515537|NCT01227265|521085956|FG000|Overall Study|Did Not Receive Treatment|1|||
144515538|NCT01227265|521085957|FG001|Overall Study|Did Not Receive Treatment|2|||
144515539|NCT01227265|521085958|FG002|Overall Study|Did Not Receive Treatment|0|||
144515540|NCT01227265|521085956|FG000|Overall Study|Administrative|1|||
144515541|NCT01227265|521085957|FG001|Overall Study|Administrative|0|||
144515542|NCT01227265|521085958|FG002|Overall Study|Administrative|2|||
144515543|NCT01227265|521085956|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
144515544|NCT01227265|521085957|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
144515545|NCT01227265|521085958|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
144515546|NCT01227265|521085956|FG000|Overall Study|Protocol Violation|2|||
144515547|NCT01227265|521085957|FG001|Overall Study|Protocol Violation|1|||
144515548|NCT01227265|521085958|FG002|Overall Study|Protocol Violation|0|||
144515549|NCT01227265|521085956|FG000|Overall Study|Withdrawal by Subject|7|||
144515550|NCT01227265|521085957|FG001|Overall Study|Withdrawal by Subject|7|||
144515551|NCT01227265|521085958|FG002|Overall Study|Withdrawal by Subject|3|||
144515552|NCT01227265|521085956|FG000|Overall Study|Lost to Follow-up|2|||
144515553|NCT01227265|521085957|FG001|Overall Study|Lost to Follow-up|0|||
144515554|NCT01227265|521085958|FG002|Overall Study|Lost to Follow-up|3|||
144515555|NCT01227265|521085956|FG000|Overall Study|Adverse Event|6|||
144515556|NCT01227265|521085957|FG001|Overall Study|Adverse Event|10|||
144515557|NCT01227265|521085958|FG002|Overall Study|Adverse Event|5|||
144515558|NCT05368558|521085964|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
144515559|NCT05368558|521085965|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
144515560|NCT05368558|521085966|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
144515561|NCT05368558|521085967|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515562|NCT05368558|521085968|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515563|NCT05368558|521085969|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515564|NCT05368558|521085970|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515565|NCT05368558|521085971|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515566|NCT05368558|521085972|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515567|NCT05368558|521085973|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515568|NCT05368558|521085974|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144386782|NCT03400956|520625704|FG001|Treatment Period 2|Adverse Event|1|||
144386783|NCT03400956|520625705|FG002|Treatment Period 2|Adverse Event|1|||
144386784|NCT03400956|520625703|FG000|Treatment Period 2|Lost to Follow-up|1|||
144386785|NCT03400956|520625704|FG001|Treatment Period 2|Lost to Follow-up|1|||
144386786|NCT03400956|520625705|FG002|Treatment Period 2|Lost to Follow-up|0|||
144386787|NCT03400956|520625703|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144386788|NCT03400956|520625704|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144386789|NCT03400956|520625705|FG002|Treatment Period 2|Withdrawal by Subject|3|||
144386790|NCT03400956|520625703|FG000|Treatment Period 2|Other|1|||
144386791|NCT03400956|520625704|FG001|Treatment Period 2|Other|1|||
144592874|NCT03170349|521370725|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
144592875|NCT03170349|521370725|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
144592876|NCT03170349|521370725|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
144592877|NCT03170349|521370725|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
144592878|NCT03170349|521370725|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
144592879|NCT03170349|521370725|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
144592880|NCT03170349|521370725|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
144592881|NCT03170349|521370725|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
144592882|NCT03170349|521370725|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
144592883|NCT05195489|521372322|FG000|Overall Study|Lost to Follow-up|1|||
144592884|NCT05195489|521372323|FG001|Overall Study|Lost to Follow-up|0|||
144592885|NCT05195489|521372322|FG000|Overall Study|Protocol Violation|0|||
144592886|NCT05195489|521372323|FG001|Overall Study|Protocol Violation|2|||
144592887|NCT05195489|521372322|FG000|Overall Study|Withdrawal by Subject|1|||
144722106|NCT03271528|521836975|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
144386792|NCT03400956|520625705|FG002|Treatment Period 2|Other|0|||
144386793|NCT03400956|520625703|FG000|Follow-up Period|Withdrawal by Subject|0|||
144386794|NCT03400956|520625704|FG001|Follow-up Period|Withdrawal by Subject|0|||
144386795|NCT03400956|520625705|FG002|Follow-up Period|Withdrawal by Subject|1|||
144515569|NCT05368558|521085975|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
144515570|NCT05368558|521085964|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515571|NCT05368558|521085965|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515572|NCT05368558|521085966|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515573|NCT05368558|521085967|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
144515574|NCT05368558|521085968|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515575|NCT05368558|521085969|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
144515576|NCT05368558|521085970|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515577|NCT05368558|521085971|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515578|NCT05368558|521085972|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515579|NCT05368558|521085973|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515580|NCT05368558|521085974|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515581|NCT05368558|521085975|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
144515582|NCT05368558|521085964|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515583|NCT05368558|521085965|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515584|NCT05368558|521085966|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515585|NCT05368558|521085967|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
144515586|NCT05368558|521085968|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515587|NCT05368558|521085969|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515588|NCT05368558|521085970|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515589|NCT05368558|521085971|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515590|NCT05368558|521085972|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515591|NCT05368558|521085973|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515592|NCT05368558|521085974|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515593|NCT05368558|521085975|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
144515594|NCT05368558|521085964|FG000|Blinded Extension Period (BEP)|other|0|||
144515595|NCT05368558|521085965|FG001|Blinded Extension Period (BEP)|other|0|||
144515596|NCT05368558|521085966|FG002|Blinded Extension Period (BEP)|other|0|||
144515597|NCT05368558|521085967|FG003|Blinded Extension Period (BEP)|other|0|||
144386796|NCT03400956|520625703|FG000|Follow-up Period|Other|0|||
144386797|NCT03400956|520625704|FG001|Follow-up Period|Other|0|||
144386798|NCT03400956|520625705|FG002|Follow-up Period|Other|1|||
144386799|NCT03044574|520625711|FG000|Overall Study|Lost to Follow-up|37|||
144386800|NCT03044574|520625712|FG001|Overall Study|Lost to Follow-up|45|||
144386801|NCT00853970|520625728|FG000|Overall Study|Withdrawal by Subject|2|||
144386802|NCT00853970|520625729|FG001|Overall Study|Withdrawal by Subject|1|||
144386803|NCT00853970|520625728|FG000|Overall Study|Cancelled surgery|4|||
144386804|NCT00853970|520625729|FG001|Overall Study|Cancelled surgery|2|||
144386805|NCT03603509|520627454|FG000|Overall Study|Lost to Follow-up|3|||
144386806|NCT03603509|520627455|FG001|Overall Study|Lost to Follow-up|4|||
144386807|NCT01527357|520627457|FG000|Overall Study|Death|8|||
144386808|NCT01527357|520627458|FG001|Overall Study|Death|2|||
144386809|NCT01527357|520627457|FG000|Overall Study|Lost to Follow-up|6|||
144386810|NCT01527357|520627458|FG001|Overall Study|Lost to Follow-up|4|||
144386811|NCT01527357|520627457|FG000|Overall Study|Withdrew Consent|1|||
144386812|NCT01527357|520627458|FG001|Overall Study|Withdrew Consent|1|||
144386813|NCT01527357|520627457|FG000|Overall Study|Non-compliance|0|||
144386814|NCT01527357|520627458|FG001|Overall Study|Non-compliance|1|||
144386815|NCT01527357|520627457|FG000|Overall Study|No Day 29 Visit|0|||
144386816|NCT01527357|520627458|FG001|Overall Study|No Day 29 Visit|1|||
144386817|NCT01527357|520627457|FG000|Overall Study|Did Not Receive Treatment|2|||
144386818|NCT01527357|520627458|FG001|Overall Study|Did Not Receive Treatment|0|||
144386819|NCT00910247|520627459|FG000|Overall Study|Adverse Event|15|||
144386820|NCT00910247|520627459|FG000|Overall Study|Death|2|||
144386821|NCT00910247|520627459|FG000|Overall Study|Lost to Follow-up|10|||
144386822|NCT00910247|520627459|FG000|Overall Study|Physician Decision|3|||
144386823|NCT00910247|520627459|FG000|Overall Study|Protocol Violation|10|||
144386824|NCT00910247|520627459|FG000|Overall Study|Withdrawal by Subject|25|||
144386825|NCT00910247|520627459|FG000|Overall Study|Not collected|4|||
144386826|NCT02519855|520627461|FG000|Overall Study|Adverse Event|0|||
144386827|NCT02519855|520627462|FG001|Overall Study|Adverse Event|1|||
144386828|NCT02519855|520627461|FG000|Overall Study|Lost to Follow-up|3|||
144386829|NCT02519855|520627462|FG001|Overall Study|Lost to Follow-up|3|||
144386830|NCT00003830|520627478|FG000|Overall Study|No follow up data|3|||
144386831|NCT00003830|520627479|FG001|Overall Study|No follow up data|0|||
144386832|NCT00003830|520627478|FG000|Overall Study|Sentinel node positive patients|829|||
144386833|NCT00003830|520627479|FG001|Overall Study|Sentinel node positive patients|793|||
144386834|NCT03811093|520627480|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
144386835|NCT03811093|520627481|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
144386836|NCT03811093|520627480|FG000|Overall Study|Unable to measure body fat percentage|2|||
144386837|NCT03811093|520627481|FG001|Overall Study|Unable to measure body fat percentage|0|||
144592888|NCT05195489|521372323|FG001|Overall Study|Withdrawal by Subject|1|||
144592889|NCT05195489|521372322|FG000|Overall Study|Removed|0|||
144592890|NCT05195489|521372323|FG001|Overall Study|Removed|1|||
144592891|NCT01036763|521372324|FG000|Overall Study|Adverse Event|25|||
144592892|NCT01036763|521372324|FG000|Overall Study|Lost to Follow-up|28|||
144592893|NCT01036763|521372324|FG000|Overall Study|Other reason (not specified)|40|||
144199324|NCT03107026|519928872|FG002|Overall Study|Adverse Event|23|||
144386838|NCT05347147|520627483|FG000|Overall Study|Lost to Follow-up|0|||
144386839|NCT05347147|520627484|FG001|Overall Study|Lost to Follow-up|1|||
144386840|NCT05347147|520627483|FG000|Overall Study|Sponsor request|3|||
144592894|NCT04812548|521372325|FG000|Overall Study|Adverse Event|2|||
144592895|NCT04812548|521372326|FG001|Overall Study|Adverse Event|7|||
144592896|NCT04812548|521372325|FG000|Overall Study|HSCT Planned|2|||
144515598|NCT05368558|521085968|FG004|Blinded Extension Period (BEP)|other|0|||
144515599|NCT05368558|521085969|FG005|Blinded Extension Period (BEP)|other|1|||
144515600|NCT05368558|521085970|FG006|Blinded Extension Period (BEP)|other|0|||
144515601|NCT05368558|521085971|FG007|Blinded Extension Period (BEP)|other|0|||
144515602|NCT05368558|521085972|FG008|Blinded Extension Period (BEP)|other|0|||
144515603|NCT05368558|521085973|FG009|Blinded Extension Period (BEP)|other|0|||
144515604|NCT05368558|521085974|FG010|Blinded Extension Period (BEP)|other|0|||
144515605|NCT05368558|521085975|FG011|Blinded Extension Period (BEP)|other|0|||
144515606|NCT04623775|521085976|FG000|Randomization|No Longer Meets Study Criteria|2|||
144515607|NCT04623775|521085977|FG001|Randomization|No Longer Meets Study Criteria|1|||
144515608|NCT04623775|521085978|FG002|Randomization|No Longer Meets Study Criteria|0|||
144515609|NCT04623775|521085979|FG003|Randomization|No Longer Meets Study Criteria|0|||
144515610|NCT04623775|521085976|FG000|Randomization|Withdrew Consent|0|||
144515611|NCT04623775|521085977|FG001|Randomization|Withdrew Consent|0|||
144515612|NCT04623775|521085978|FG002|Randomization|Withdrew Consent|0|||
144515613|NCT04623775|521085979|FG003|Randomization|Withdrew Consent|1|||
144515614|NCT04623775|521085976|FG000|Randomization|Other Reasons|0|||
144515615|NCT04623775|521085977|FG001|Randomization|Other Reasons|0|||
144515616|NCT04623775|521085978|FG002|Randomization|Other Reasons|0|||
144515617|NCT04623775|521085979|FG003|Randomization|Other Reasons|1|||
144515618|NCT04623775|521085976|FG000|Treatment Period|participant withdrew consent|4|||
144515619|NCT04623775|521085977|FG001|Treatment Period|participant withdrew consent|0|||
144515620|NCT04623775|521085978|FG002|Treatment Period|participant withdrew consent|1|||
144515621|NCT04623775|521085979|FG003|Treatment Period|participant withdrew consent|2|||
144515622|NCT04623775|521085976|FG000|Treatment Period|Death|3|||
144515623|NCT04623775|521085977|FG001|Treatment Period|Death|1|||
144515624|NCT04623775|521085978|FG002|Treatment Period|Death|4|||
144515625|NCT04623775|521085979|FG003|Treatment Period|Death|2|||
144515626|NCT04623775|521085976|FG000|Treatment Period|Lost to Follow-up|0|||
144515627|NCT04623775|521085977|FG001|Treatment Period|Lost to Follow-up|2|||
144515628|NCT04623775|521085978|FG002|Treatment Period|Lost to Follow-up|0|||
144515629|NCT04623775|521085979|FG003|Treatment Period|Lost to Follow-up|0|||
144515630|NCT04623775|521085976|FG000|Treatment Period|poor/non compliance|0|||
144515631|NCT04623775|521085977|FG001|Treatment Period|poor/non compliance|0|||
144515632|NCT04623775|521085978|FG002|Treatment Period|poor/non compliance|1|||
144515633|NCT04623775|521085979|FG003|Treatment Period|poor/non compliance|0|||
144515634|NCT04623775|521085976|FG000|Treatment Period|participant no longer meets study criteria|0|||
144515635|NCT04623775|521085977|FG001|Treatment Period|participant no longer meets study criteria|1|||
144515636|NCT04623775|521085978|FG002|Treatment Period|participant no longer meets study criteria|0|||
144515637|NCT04623775|521085979|FG003|Treatment Period|participant no longer meets study criteria|0|||
144515638|NCT04623775|521085976|FG000|Treatment Period|administrative reasons by sponsor|3|||
144515639|NCT04623775|521085977|FG001|Treatment Period|administrative reasons by sponsor|2|||
144515640|NCT04623775|521085978|FG002|Treatment Period|administrative reasons by sponsor|0|||
144515641|NCT04623775|521085979|FG003|Treatment Period|administrative reasons by sponsor|0|||
144515642|NCT04623775|521085976|FG000|Treatment Period|other reasons|2|||
144515643|NCT04623775|521085977|FG001|Treatment Period|other reasons|0|||
144515644|NCT04623775|521085978|FG002|Treatment Period|other reasons|1|||
144515645|NCT04623775|521085979|FG003|Treatment Period|other reasons|1|||
144515646|NCT04623775|521085976|FG000|Treatment Period|disease progression|40|||
144515647|NCT04623775|521085977|FG001|Treatment Period|disease progression|35|||
144515648|NCT04623775|521085978|FG002|Treatment Period|disease progression|63|||
144515649|NCT04623775|521085979|FG003|Treatment Period|disease progression|63|||
144386841|NCT05347147|520627484|FG001|Overall Study|Sponsor request|3|||
144592897|NCT04812548|521372326|FG001|Overall Study|HSCT Planned|3|||
144592898|NCT04812548|521372325|FG000|Overall Study|Progressive Disease|0|||
144592899|NCT04812548|521372326|FG001|Overall Study|Progressive Disease|2|||
144592900|NCT04812548|521372325|FG000|Overall Study|Death|0|||
144592901|NCT04812548|521372326|FG001|Overall Study|Death|1|||
144592902|NCT04812548|521372325|FG000|Overall Study|Post Study Access to Treatment|0|||
144592903|NCT04812548|521372326|FG001|Overall Study|Post Study Access to Treatment|1|||
144592904|NCT04812548|521372325|FG000|Overall Study|Withdrawal by Subject|0|||
144592905|NCT04812548|521372326|FG001|Overall Study|Withdrawal by Subject|1|||
144386842|NCT05347147|520627483|FG000|Overall Study|Study termination|2|||
144592906|NCT04812548|521372325|FG000|Overall Study|Physician Decision|1|||
144592907|NCT04812548|521372326|FG001|Overall Study|Physician Decision|0|||
144592908|NCT03938545|521372328|FG000|Overall Study|Lost to Follow-up|0|||
144592909|NCT03938545|521372329|FG001|Overall Study|Lost to Follow-up|0|||
144592910|NCT03938545|521372330|FG002|Overall Study|Lost to Follow-up|0|||
144592911|NCT03938545|521372331|FG003|Overall Study|Lost to Follow-up|1|||
144592912|NCT03938545|521372328|FG000|Overall Study|Non-compliance with study drug|0|||
144592913|NCT03938545|521372329|FG001|Overall Study|Non-compliance with study drug|0|||
144592914|NCT03938545|521372330|FG002|Overall Study|Non-compliance with study drug|1|||
144592915|NCT03938545|521372331|FG003|Overall Study|Non-compliance with study drug|0|||
144592916|NCT03938545|521372328|FG000|Overall Study|Pregnancy|1|||
144592917|NCT03938545|521372329|FG001|Overall Study|Pregnancy|0|||
144592918|NCT03938545|521372330|FG002|Overall Study|Pregnancy|0|||
144592919|NCT03938545|521372331|FG003|Overall Study|Pregnancy|0|||
144592920|NCT03938545|521372328|FG000|Overall Study|Study terminated by sponsor|6|||
144592921|NCT03938545|521372329|FG001|Overall Study|Study terminated by sponsor|4|||
144592922|NCT03938545|521372330|FG002|Overall Study|Study terminated by sponsor|2|||
144515650|NCT04623775|521085976|FG000|Treatment Period|study drug toxicity|12|||
144515651|NCT04623775|521085977|FG001|Treatment Period|study drug toxicity|15|||
144515652|NCT04623775|521085978|FG002|Treatment Period|study drug toxicity|13|||
144515653|NCT04623775|521085979|FG003|Treatment Period|study drug toxicity|12|||
144515654|NCT04623775|521085976|FG000|Treatment Period|AE unrelated to study drug|4|||
144515655|NCT04623775|521085977|FG001|Treatment Period|AE unrelated to study drug|9|||
144515656|NCT04623775|521085978|FG002|Treatment Period|AE unrelated to study drug|12|||
144386843|NCT05347147|520627484|FG001|Overall Study|Study termination|1|||
144386844|NCT03565367|520627485|FG000|Overall Study|No scan due to technical issues|4|||
144386845|NCT03565367|520627486|FG001|Overall Study|No scan due to technical issues|0|||
144386846|NCT00923364|520627489|FG000|Overall Study|Death|3|||
144386847|NCT00923364|520627490|FG001|Overall Study|Death|0|||
144386848|NCT00923364|520627489|FG000|Overall Study|Did not go to transplant|1|||
144386849|NCT00923364|520627490|FG001|Overall Study|Did not go to transplant|0|||
144386850|NCT01397825|520627493|FG000|Overall Study|Progressive Disease|10|||
144515657|NCT04623775|521085979|FG003|Treatment Period|AE unrelated to study drug|9|||
144515658|NCT04623775|521085976|FG000|Treatment Period|participant request to discontinue treatment|0|||
144515659|NCT04623775|521085977|FG001|Treatment Period|participant request to discontinue treatment|2|||
144515660|NCT04623775|521085978|FG002|Treatment Period|participant request to discontinue treatment|2|||
144515661|NCT04623775|521085979|FG003|Treatment Period|participant request to discontinue treatment|0|||
144515662|NCT01303445|521085981|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
144515663|NCT01303445|521085982|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
144515664|NCT01303445|521085981|FG000|Second Intervention (7 Days)|Adverse Event|0|||
144515665|NCT01303445|521085982|FG001|Second Intervention (7 Days)|Adverse Event|2|||
144515666|NCT01303445|521085981|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
144515667|NCT01303445|521085982|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
144515668|NCT01303445|521085981|FG000|Washout (14 Days)|Protocol Violation|1|||
144515669|NCT01303445|521085982|FG001|Washout (14 Days)|Protocol Violation|0|||
144515670|NCT01303445|521085981|FG000|Washout (14 Days)|Lost to Follow-up|0|||
144515671|NCT01303445|521085982|FG001|Washout (14 Days)|Lost to Follow-up|2|||
144515672|NCT01303445|521085981|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
144515673|NCT01303445|521085982|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
144515674|NCT01303445|521085981|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
144515675|NCT01303445|521085982|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
144515676|NCT03582722|521085983|FG000|Overall Study|Lost to Follow-up|1|||
144515677|NCT03582722|521085984|FG001|Overall Study|Lost to Follow-up|4|||
144515678|NCT03582722|521085983|FG000|Overall Study|Withdrawal by Subject|3|||
144515679|NCT03582722|521085984|FG001|Overall Study|Withdrawal by Subject|3|||
144515680|NCT01959698|521085985|FG000|Overall Study|Adverse Event|0|||
144515681|NCT01959698|521085986|FG001|Overall Study|Adverse Event|0|||
144515682|NCT01959698|521085987|FG002|Overall Study|Adverse Event|0|||
144515683|NCT01959698|521085988|FG003|Overall Study|Adverse Event|0|||
144515684|NCT01959698|521085989|FG004|Overall Study|Adverse Event|0|||
144386851|NCT01397825|520627494|FG001|Overall Study|Progressive Disease|3|||
144386852|NCT01397825|520627495|FG002|Overall Study|Progressive Disease|11|||
144386853|NCT01397825|520627496|FG003|Overall Study|Progressive Disease|1|||
144515685|NCT01959698|521085990|FG005|Overall Study|Adverse Event|0|||
144515686|NCT01959698|521085991|FG006|Overall Study|Adverse Event|1|||
144515687|NCT01959698|521085985|FG000|Overall Study|Physician Decision|1|||
144515688|NCT01959698|521085986|FG001|Overall Study|Physician Decision|0|||
144386854|NCT01397825|520627497|FG004|Overall Study|Progressive Disease|0|||
144386855|NCT01397825|520627493|FG000|Overall Study|Symptomatic Deterioration|2|||
144386856|NCT01397825|520627494|FG001|Overall Study|Symptomatic Deterioration|0|||
144386857|NCT01397825|520627495|FG002|Overall Study|Symptomatic Deterioration|4|||
144386858|NCT01397825|520627496|FG003|Overall Study|Symptomatic Deterioration|0|||
144386859|NCT01397825|520627497|FG004|Overall Study|Symptomatic Deterioration|0|||
144386860|NCT01397825|520627493|FG000|Overall Study|Adverse Event|0|||
144386861|NCT01397825|520627494|FG001|Overall Study|Adverse Event|1|||
144386862|NCT01397825|520627495|FG002|Overall Study|Adverse Event|5|||
144386863|NCT01397825|520627496|FG003|Overall Study|Adverse Event|1|||
144386864|NCT01397825|520627497|FG004|Overall Study|Adverse Event|0|||
144386865|NCT01397825|520627493|FG000|Overall Study|Withdrawal by Subject|1|||
144386866|NCT01397825|520627494|FG001|Overall Study|Withdrawal by Subject|0|||
144386867|NCT01397825|520627495|FG002|Overall Study|Withdrawal by Subject|5|||
144386868|NCT01397825|520627496|FG003|Overall Study|Withdrawal by Subject|1|||
144386869|NCT01397825|520627497|FG004|Overall Study|Withdrawal by Subject|0|||
144386870|NCT01931670|520627499|FG000|Treatment Period|Exclusionary Medication Received|1|||
144386871|NCT01931670|520627500|FG001|Treatment Period|Exclusionary Medication Received|1|||
144386872|NCT01931670|520627501|FG002|Treatment Period|Exclusionary Medication Received|1|||
144386873|NCT01931670|520627499|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
144386874|NCT01931670|520627500|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
144386875|NCT01931670|520627501|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
144515689|NCT01959698|521085987|FG002|Overall Study|Physician Decision|1|||
144386876|NCT01931670|520627499|FG000|Treatment Period|Subject Noncompliant|4|||
144386877|NCT01931670|520627500|FG001|Treatment Period|Subject Noncompliant|9|||
144386878|NCT01931670|520627501|FG002|Treatment Period|Subject Noncompliant|5|||
144386879|NCT01931670|520627499|FG000|Treatment Period|Adverse Event|19|||
144386880|NCT01931670|520627500|FG001|Treatment Period|Adverse Event|8|||
144386881|NCT01931670|520627501|FG002|Treatment Period|Adverse Event|21|||
144386882|NCT01931670|520627499|FG000|Treatment Period|Lack of Efficacy|11|||
144386883|NCT01931670|520627500|FG001|Treatment Period|Lack of Efficacy|2|||
144386884|NCT01931670|520627501|FG002|Treatment Period|Lack of Efficacy|2|||
144386885|NCT01931670|520627499|FG000|Treatment Period|Pregnancy|7|||
144386886|NCT01931670|520627500|FG001|Treatment Period|Pregnancy|2|||
144386887|NCT01931670|520627501|FG002|Treatment Period|Pregnancy|0|||
144386888|NCT01931670|520627499|FG000|Treatment Period|Other|8|||
144386889|NCT01931670|520627500|FG001|Treatment Period|Other|7|||
144386890|NCT01931670|520627501|FG002|Treatment Period|Other|2|||
144386891|NCT01931670|520627499|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
144386892|NCT01931670|520627500|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
144386893|NCT01931670|520627501|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
144386894|NCT01931670|520627499|FG000|Treatment Period|Lost to Follow-up|19|||
144386895|NCT01931670|520627500|FG001|Treatment Period|Lost to Follow-up|5|||
144386896|NCT01931670|520627501|FG002|Treatment Period|Lost to Follow-up|7|||
144386897|NCT01931670|520627499|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
144386898|NCT01931670|520627500|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
144386899|NCT01931670|520627501|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
144386900|NCT01931670|520627499|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
144386901|NCT01931670|520627500|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
144386902|NCT01931670|520627501|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
144386903|NCT01931670|520627499|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
144386904|NCT01931670|520627500|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
144515690|NCT01959698|521085988|FG003|Overall Study|Physician Decision|2|||
144515691|NCT01959698|521085989|FG004|Overall Study|Physician Decision|0|||
144386905|NCT01931670|520627501|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
144386906|NCT01931670|520627499|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
144386907|NCT01931670|520627500|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
144515692|NCT01959698|521085990|FG005|Overall Study|Physician Decision|3|||
144515693|NCT01959698|521085991|FG006|Overall Study|Physician Decision|3|||
144515694|NCT02525692|521088869|FG000|Overall Study|Withdrawal by Subject|1|||
144386908|NCT01931670|520627501|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
144592923|NCT03938545|521372331|FG003|Overall Study|Study terminated by sponsor|4|||
144592924|NCT03938545|521372328|FG000|Overall Study|Withdrawal by Subject|0|||
144386909|NCT01931670|520627499|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
144386910|NCT01931670|520627500|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
144386911|NCT01931670|520627501|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
144386912|NCT01931670|520627499|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
144386913|NCT01931670|520627500|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
144386914|NCT01931670|520627501|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
144386915|NCT04352127|520627503|FG000|Overall Study|Unable to obtain readings|4|||
144386916|NCT04352127|520627504|FG001|Overall Study|Unable to obtain readings|1|||
144386917|NCT03023046|520627508|FG000|Overall Study|Withdrawal by Subject|1|||
144386918|NCT01205581|520627509|FG000|Overall Study|Withdrawal by Subject|1|||
144386919|NCT01205581|520627510|FG001|Overall Study|Withdrawal by Subject|0|||
144386920|NCT01205581|520627511|FG002|Overall Study|Withdrawal by Subject|0|||
144386921|NCT01205581|520627512|FG003|Overall Study|Withdrawal by Subject|0|||
144386922|NCT01205581|520627513|FG004|Overall Study|Withdrawal by Subject|0|||
144386923|NCT01205581|520627514|FG005|Overall Study|Withdrawal by Subject|0|||
144386924|NCT01236118|520627515|FG000|Overall Study|Adverse Event|2|||
144386925|NCT01236118|520627516|FG001|Overall Study|Adverse Event|0|||
144386926|NCT01236118|520627517|FG002|Overall Study|Adverse Event|2|||
144386927|NCT01236118|520627515|FG000|Overall Study|Physician Decision|0|||
144386928|NCT01236118|520627516|FG001|Overall Study|Physician Decision|1|||
144386929|NCT01236118|520627517|FG002|Overall Study|Physician Decision|0|||
144386930|NCT01236118|520627515|FG000|Overall Study|Withdrawal by Subject|0|||
144386931|NCT01236118|520627516|FG001|Overall Study|Withdrawal by Subject|0|||
144515695|NCT02525692|521088870|FG001|Overall Study|Withdrawal by Subject|1|||
144515696|NCT02525692|521088871|FG002|Overall Study|Withdrawal by Subject|0|||
144515697|NCT02525692|521088872|FG003|Overall Study|Withdrawal by Subject|5|||
144386932|NCT01236118|520627517|FG002|Overall Study|Withdrawal by Subject|1|||
144386933|NCT04535167|520627518|FG000|Treatment|Adverse Event|0|||
144386934|NCT04535167|520627519|FG001|Treatment|Adverse Event|0|||
144386935|NCT04535167|520627520|FG002|Treatment|Adverse Event|0|||
144386936|NCT04535167|520627521|FG003|Treatment|Adverse Event|0|||
144386937|NCT04535167|520627522|FG004|Treatment|Adverse Event|0|||
144386938|NCT04535167|520627523|FG005|Treatment|Adverse Event|0|||
144386939|NCT04535167|520627524|FG006|Treatment|Adverse Event|1|||
144386940|NCT04535167|520627518|FG000|Follow-Up|Death|0|||
144386941|NCT04535167|520627519|FG001|Follow-Up|Death|0|||
144386942|NCT04535167|520627520|FG002|Follow-Up|Death|0|||
144386943|NCT04535167|520627521|FG003|Follow-Up|Death|0|||
144386944|NCT04535167|520627522|FG004|Follow-Up|Death|0|||
144386945|NCT04535167|520627523|FG005|Follow-Up|Death|0|||
144386946|NCT04535167|520627524|FG006|Follow-Up|Death|1|||
144386947|NCT04535167|520627518|FG000|Follow-Up|Lost to Follow-up|0|||
144386948|NCT04535167|520627519|FG001|Follow-Up|Lost to Follow-up|0|||
144386949|NCT04535167|520627520|FG002|Follow-Up|Lost to Follow-up|0|||
144386950|NCT04535167|520627521|FG003|Follow-Up|Lost to Follow-up|1|||
144386951|NCT04535167|520627522|FG004|Follow-Up|Lost to Follow-up|0|||
144386952|NCT04535167|520627523|FG005|Follow-Up|Lost to Follow-up|0|||
144386953|NCT04535167|520627524|FG006|Follow-Up|Lost to Follow-up|0|||
144386954|NCT00075270|520627525|FG000|Overall Study|Withdrawal by Subject|28|||
144386955|NCT00075270|520627526|FG001|Overall Study|Withdrawal by Subject|21|||
144386956|NCT00075270|520627525|FG000|Overall Study|Lost to Follow-up|25|||
144386957|NCT00075270|520627526|FG001|Overall Study|Lost to Follow-up|28|||
144386958|NCT00075270|520627525|FG000|Overall Study|Protocol Violation|0|||
144386959|NCT00075270|520627526|FG001|Overall Study|Protocol Violation|2|||
144722107|NCT03271528|521836974|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
144386960|NCT00075270|520627525|FG000|Overall Study|Death|198|||
144722108|NCT03271528|521836975|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
144386961|NCT00075270|520627526|FG001|Overall Study|Death|215|||
144386962|NCT00075270|520627525|FG000|Overall Study|Other/Unknown|9|||
144386963|NCT00075270|520627526|FG001|Overall Study|Other/Unknown|5|||
144386964|NCT00075270|520627525|FG000|Overall Study|Missing|26|||
144386965|NCT00075270|520627526|FG001|Overall Study|Missing|13|||
144386966|NCT02160002|520627527|FG000|Overall Study|Withdrawal by Subject|2|||
144386967|NCT02160002|520627528|FG001|Overall Study|Withdrawal by Subject|1|||
144386968|NCT00713310|520627531|FG000|Overall Study|Adverse Event|5|||
144386969|NCT00713310|520627532|FG001|Overall Study|Adverse Event|2|||
144386970|NCT00713310|520627531|FG000|Overall Study|Lack of Efficacy|0|||
144386971|NCT00713310|520627532|FG001|Overall Study|Lack of Efficacy|2|||
144386972|NCT00713310|520627531|FG000|Overall Study|Withdrawal by Subject|0|||
144386973|NCT00713310|520627532|FG001|Overall Study|Withdrawal by Subject|2|||
144386974|NCT05508074|520627535|FG000|Overall Study|Death|2|||
144386975|NCT05508074|520627536|FG001|Overall Study|Death|5|||
144386976|NCT05508074|520627535|FG000|Overall Study|Withdrawal by Subject|1|||
144386977|NCT05508074|520627536|FG001|Overall Study|Withdrawal by Subject|2|||
144386978|NCT05508074|520627535|FG000|Overall Study|Adverse Event|0|||
144592925|NCT03938545|521372329|FG001|Overall Study|Withdrawal by Subject|1|||
144592926|NCT03938545|521372330|FG002|Overall Study|Withdrawal by Subject|0|||
144592927|NCT03938545|521372331|FG003|Overall Study|Withdrawal by Subject|0|||
144592928|NCT03938545|521372328|FG000|Overall Study|Adverse Event|1|||
144592929|NCT03938545|521372329|FG001|Overall Study|Adverse Event|0|||
144727086|NCT05097989|521854431|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
144515698|NCT02525692|521088873|FG004|Overall Study|Withdrawal by Subject|0|||
144515699|NCT02525692|521088874|FG005|Overall Study|Withdrawal by Subject|1|||
144515700|NCT02525692|521088869|FG000|Overall Study|Death|16|||
144515701|NCT02525692|521088870|FG001|Overall Study|Death|18|||
144515702|NCT02525692|521088871|FG002|Overall Study|Death|7|||
144515703|NCT02525692|521088872|FG003|Overall Study|Death|20|||
144515704|NCT02525692|521088873|FG004|Overall Study|Death|3|||
144515705|NCT02525692|521088874|FG005|Overall Study|Death|6|||
144515706|NCT02525692|521088869|FG000|Overall Study|Lost to Follow-up|0|||
144515707|NCT02525692|521088870|FG001|Overall Study|Lost to Follow-up|0|||
144515708|NCT02525692|521088871|FG002|Overall Study|Lost to Follow-up|1|||
144515709|NCT02525692|521088872|FG003|Overall Study|Lost to Follow-up|5|||
144515710|NCT02525692|521088873|FG004|Overall Study|Lost to Follow-up|0|||
144515711|NCT02525692|521088874|FG005|Overall Study|Lost to Follow-up|0|||
144515712|NCT05510232|521088875|FG000|Overall Study|Withdrawal by Subject|2|||
144515713|NCT05510232|521088876|FG001|Overall Study|Withdrawal by Subject|7|||
144515714|NCT05510232|521088877|FG002|Overall Study|Withdrawal by Subject|6|||
144515715|NCT00979576|521088885|FG000|Combination Treatment Phase|Progressive disease|3|||
144515716|NCT00979576|521088886|FG001|Combination Treatment Phase|Progressive disease|1|||
144515717|NCT00979576|521088887|FG002|Combination Treatment Phase|Progressive disease|5|||
144592930|NCT03938545|521372330|FG002|Overall Study|Adverse Event|0|||
144592931|NCT03938545|521372331|FG003|Overall Study|Adverse Event|0|||
144592932|NCT00320541|521372332|FG000|Overall Study|Adverse Event|21|||
144386979|NCT05508074|520627536|FG001|Overall Study|Adverse Event|1|||
144386980|NCT05508074|520627535|FG000|Overall Study|Physician Decision|0|||
144515718|NCT00979576|521088885|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
144592933|NCT00320541|521372333|FG001|Overall Study|Adverse Event|19|||
144386981|NCT05508074|520627536|FG001|Overall Study|Physician Decision|1|||
144515719|NCT00979576|521088886|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
144515720|NCT00979576|521088887|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
144515721|NCT00979576|521088885|FG000|Combination Treatment Phase|Adverse Event|0|||
144386982|NCT05508074|520627535|FG000|Overall Study|wrongly randomized|0|||
144386983|NCT05508074|520627536|FG001|Overall Study|wrongly randomized|1|||
144515722|NCT00979576|521088886|FG001|Combination Treatment Phase|Adverse Event|2|||
144515723|NCT00979576|521088887|FG002|Combination Treatment Phase|Adverse Event|2|||
144592934|NCT00320541|521372332|FG000|Overall Study|Protocol Violation|0|||
144592935|NCT00320541|521372333|FG001|Overall Study|Protocol Violation|1|||
144727087|NCT05097989|521854423|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
144515724|NCT00979576|521088885|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
144515725|NCT00979576|521088886|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
144515726|NCT00979576|521088887|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
144515727|NCT04855760|521088890|FG000|Overall Study|Adverse Event|21|||
144515728|NCT04855760|521088890|FG000|Overall Study|Withdrawal by Subject|116|||
144515729|NCT04855760|521088890|FG000|Overall Study|Lack of Efficacy|21|||
144515730|NCT04855760|521088890|FG000|Overall Study|Lost to Follow-up|49|||
144515731|NCT04855760|521088890|FG000|Overall Study|Protocol Violation|2|||
144515732|NCT04855760|521088890|FG000|Overall Study|Physician Decision|5|||
144515733|NCT04855760|521088890|FG000|Overall Study|Pregnancy|1|||
144515734|NCT04855760|521088890|FG000|Overall Study|Non-Compliance with Study Drug|11|||
144515735|NCT04855760|521088890|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
144515736|NCT04855760|521088890|FG000|Overall Study|Study Completed by Sponsor|202|||
144515737|NCT04855760|521088890|FG000|Overall Study|Other|13|||
144592936|NCT00320541|521372332|FG000|Overall Study|Withdrawal by Subject|12|||
144592937|NCT00320541|521372333|FG001|Overall Study|Withdrawal by Subject|16|||
144199325|NCT03107026|519928870|FG000|Overall Study|Lost to Follow-up|12|||
144386984|NCT05508074|520627535|FG000|Overall Study|non-compliance|0|||
144386985|NCT05508074|520627536|FG001|Overall Study|non-compliance|1|||
144386986|NCT05028361|520627537|FG000|Overall Study|Withdrawal by Subject|1|||
144386987|NCT05028361|520627538|FG001|Overall Study|Withdrawal by Subject|0|||
144386988|NCT01993836|520627541|FG000|Overall Study|Surgery Cancelled|3|||
144386989|NCT01993836|520627542|FG001|Overall Study|Surgery Cancelled|0|||
144386990|NCT01993836|520627543|FG002|Overall Study|Surgery Cancelled|0|||
144386991|NCT01993836|520627541|FG000|Overall Study|Physician Decision|2|||
144386992|NCT01993836|520627542|FG001|Overall Study|Physician Decision|1|||
144386993|NCT01993836|520627543|FG002|Overall Study|Physician Decision|0|||
144386994|NCT01993836|520627541|FG000|Overall Study|Death|0|||
144386995|NCT01993836|520627542|FG001|Overall Study|Death|2|||
144386996|NCT01993836|520627543|FG002|Overall Study|Death|0|||
144386997|NCT01993836|520627541|FG000|Overall Study|Withdrawal by Subject|12|||
144515738|NCT04840199|521088891|FG000|Overall Study|Study Terminated by Sponsor|8|||
144515739|NCT04840199|521088892|FG001|Overall Study|Study Terminated by Sponsor|9|||
144515740|NCT04840199|521088891|FG000|Overall Study|Lost to Follow-up|0|||
144515741|NCT04840199|521088892|FG001|Overall Study|Lost to Follow-up|2|||
144515742|NCT04840199|521088891|FG000|Overall Study|Withdrawal by Subject|2|||
144515743|NCT04840199|521088892|FG001|Overall Study|Withdrawal by Subject|0|||
144515744|NCT04840199|521088891|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
144386998|NCT01993836|520627542|FG001|Overall Study|Withdrawal by Subject|10|||
144386999|NCT01993836|520627543|FG002|Overall Study|Withdrawal by Subject|5|||
144387000|NCT00779259|520627544|FG000|Quinine Alone|Adverse Event|2|||
144387001|NCT02047318|520627545|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
144387002|NCT02047318|520627545|FG000|Core Study Period|Adverse Event|1|||
144387003|NCT02047318|520627545|FG000|Core Study Period|Withdrawal by caregiver|3|||
144387004|NCT02047318|520627545|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
144387005|NCT03490981|520627546|FG000|Overall Study|Lost to Follow-up|1|||
144387006|NCT03490981|520627547|FG001|Overall Study|Lost to Follow-up|2|||
144387007|NCT02582684|520627548|FG000|Overall Study|Unable to contact subject/parent|4|||
144387008|NCT02582684|520627548|FG000|Overall Study|Subject not able to get to clinic|10|||
144387009|NCT02582684|520627548|FG000|Overall Study|Subject withdrew consent|1|||
144387010|NCT02582684|520627548|FG000|Overall Study|Found to be ineligible after enrollment|2|||
144387011|NCT02048241|520627551|FG000|Overall Study|Withdrawal by Subject|0|||
144387012|NCT02048241|520627552|FG001|Overall Study|Withdrawal by Subject|1|||
144387013|NCT01829243|520627555|FG000|First Intervention|Screen Failure|4|||
144387014|NCT01829243|520627556|FG001|First Intervention|Screen Failure|2|||
144387015|NCT00053898|520627561|FG000|Overall Study|No follow-up data from any source|9|||
144387016|NCT00053898|520627562|FG001|Overall Study|No follow-up data from any source|12|||
144387017|NCT00053898|520627561|FG000|Overall Study|Follow-up from telephone contact only|5|||
144387018|NCT00053898|520627562|FG001|Overall Study|Follow-up from telephone contact only|1|||
144387019|NCT00266877|520627563|FG000|Overall Study|Death|1|||
144387020|NCT00266877|520627564|FG001|Overall Study|Death|1|||
144387021|NCT00266877|520627565|FG002|Overall Study|Death|1|||
144387022|NCT00266877|520627563|FG000|Overall Study|Adverse Event|6|||
144387023|NCT00266877|520627564|FG001|Overall Study|Adverse Event|4|||
144387024|NCT00266877|520627565|FG002|Overall Study|Adverse Event|1|||
144387025|NCT00266877|520627563|FG000|Overall Study|Physician Decision|2|||
144387026|NCT00266877|520627564|FG001|Overall Study|Physician Decision|1|||
144387027|NCT00266877|520627565|FG002|Overall Study|Physician Decision|1|||
144387028|NCT00266877|520627563|FG000|Overall Study|Withdrawal by Subject|3|||
144387029|NCT00266877|520627564|FG001|Overall Study|Withdrawal by Subject|1|||
144387030|NCT00266877|520627565|FG002|Overall Study|Withdrawal by Subject|1|||
144387031|NCT00266877|520627563|FG000|Overall Study|Disease Progression|72|||
144387032|NCT00266877|520627564|FG001|Overall Study|Disease Progression|37|||
144387033|NCT00266877|520627565|FG002|Overall Study|Disease Progression|23|||
144387034|NCT00266877|520627563|FG000|Overall Study|Symptomatic Deterioration|6|||
144387035|NCT00266877|520627564|FG001|Overall Study|Symptomatic Deterioration|3|||
144387036|NCT00266877|520627565|FG002|Overall Study|Symptomatic Deterioration|1|||
144387037|NCT00266877|520627563|FG000|Overall Study|Hospitalization|1|||
144387038|NCT00266877|520627564|FG001|Overall Study|Hospitalization|0|||
144387039|NCT00266877|520627565|FG002|Overall Study|Hospitalization|0|||
144387040|NCT00266877|520627563|FG000|Overall Study|Concomitant Radiotherapy|0|||
144387041|NCT00266877|520627564|FG001|Overall Study|Concomitant Radiotherapy|1|||
144387042|NCT00266877|520627565|FG002|Overall Study|Concomitant Radiotherapy|0|||
144387043|NCT01077375|520627568|FG000|Overall Study|Adverse Event|2|||
144387044|NCT01077375|520627569|FG001|Overall Study|Adverse Event|15|||
144387045|NCT01077375|520627568|FG000|Overall Study|Lack of Efficacy|6|||
144387046|NCT01077375|520627569|FG001|Overall Study|Lack of Efficacy|8|||
144387047|NCT01077375|520627568|FG000|Overall Study|Withdrawal by Subject|0|||
144387048|NCT01077375|520627569|FG001|Overall Study|Withdrawal by Subject|6|||
144387049|NCT01077375|520627568|FG000|Overall Study|Lost to Follow-up|2|||
144387050|NCT01077375|520627569|FG001|Overall Study|Lost to Follow-up|5|||
144387051|NCT01077375|520627568|FG000|Overall Study|Other Reason|0|||
144387052|NCT01077375|520627569|FG001|Overall Study|Other Reason|1|||
144387053|NCT03985878|520627570|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
144387054|NCT03985878|520627570|FG000|Overall Study|Study Terminated by Sponsor|12|||
144387055|NCT03985878|520627570|FG000|Overall Study|Withdrawal by Subject|1|||
144387056|NCT01606878|520627574|FG000|Overall Study|Adverse Event|1|||
144387057|NCT01606878|520627575|FG001|Overall Study|Adverse Event|1|||
144387058|NCT01606878|520627576|FG002|Overall Study|Adverse Event|0|||
144387059|NCT01606878|520627577|FG003|Overall Study|Adverse Event|0|||
144387060|NCT01606878|520627578|FG004|Overall Study|Adverse Event|0|||
144387061|NCT01606878|520627579|FG005|Overall Study|Adverse Event|0|||
144387062|NCT01606878|520627580|FG006|Overall Study|Adverse Event|1|||
144387063|NCT01606878|520627581|FG007|Overall Study|Adverse Event|0|||
144387064|NCT01606878|520627582|FG008|Overall Study|Adverse Event|1|||
144387065|NCT01606878|520627583|FG009|Overall Study|Adverse Event|3|||
144387066|NCT01606878|520627584|FG010|Overall Study|Adverse Event|0|||
144387067|NCT01606878|520627574|FG000|Overall Study|Lack of Efficacy|1|||
144387068|NCT01606878|520627575|FG001|Overall Study|Lack of Efficacy|1|||
144387069|NCT01606878|520627576|FG002|Overall Study|Lack of Efficacy|1|||
144387070|NCT01606878|520627577|FG003|Overall Study|Lack of Efficacy|2|||
144387071|NCT01606878|520627578|FG004|Overall Study|Lack of Efficacy|1|||
144387072|NCT01606878|520627579|FG005|Overall Study|Lack of Efficacy|2|||
144387073|NCT01606878|520627580|FG006|Overall Study|Lack of Efficacy|1|||
144515745|NCT04840199|521088892|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
144515746|NCT03424811|521088899|FG000|Overall Study|Lost to Follow-up|9|||
144592938|NCT00320541|521372332|FG000|Overall Study|Physician Decision|9|||
144592939|NCT00320541|521372333|FG001|Overall Study|Physician Decision|13|||
144592940|NCT00320541|521372332|FG000|Overall Study|Other|3|||
144592941|NCT00320541|521372333|FG001|Overall Study|Other|4|||
144592942|NCT00320541|521372332|FG000|Overall Study|Sponsor Decision|2|||
144592943|NCT00320541|521372333|FG001|Overall Study|Sponsor Decision|1|||
144592944|NCT00320541|521372332|FG000|Overall Study|Death due to Study Disease|1|||
144515747|NCT03424811|521088900|FG001|Overall Study|Lost to Follow-up|0|||
144515748|NCT04112316|521088902|FG000|First Period (8 Weeks)|Protocol Violation|1|||
144515749|NCT04112316|521088903|FG001|First Period (8 Weeks)|Protocol Violation|0|||
144515750|NCT04112316|521088902|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
144515751|NCT04112316|521088903|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
144515752|NCT00567398|521088904|FG000|Overall Study|Adverse Event|6|||
144592945|NCT00320541|521372333|FG001|Overall Study|Death due to Study Disease|3|||
144592946|NCT00320541|521372332|FG000|Overall Study|Death due to Adverse Event(s)|1|||
144592947|NCT00320541|521372333|FG001|Overall Study|Death due to Adverse Event(s)|0|||
144387074|NCT01606878|520627581|FG007|Overall Study|Lack of Efficacy|2|||
144387075|NCT01606878|520627582|FG008|Overall Study|Lack of Efficacy|2|||
144387076|NCT01606878|520627583|FG009|Overall Study|Lack of Efficacy|0|||
144387077|NCT01606878|520627584|FG010|Overall Study|Lack of Efficacy|1|||
144387078|NCT01606878|520627574|FG000|Overall Study|Physician Decision|1|||
144387079|NCT01606878|520627575|FG001|Overall Study|Physician Decision|0|||
144387080|NCT01606878|520627576|FG002|Overall Study|Physician Decision|2|||
144387081|NCT01606878|520627577|FG003|Overall Study|Physician Decision|1|||
144387082|NCT01606878|520627578|FG004|Overall Study|Physician Decision|1|||
144515753|NCT00567398|521088905|FG001|Overall Study|Adverse Event|14|||
144515754|NCT00567398|521088904|FG000|Overall Study|Physician Decision|0|||
144592948|NCT00320541|521372332|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
144387083|NCT01606878|520627579|FG005|Overall Study|Physician Decision|1|||
144387084|NCT01606878|520627580|FG006|Overall Study|Physician Decision|2|||
144387085|NCT01606878|520627581|FG007|Overall Study|Physician Decision|0|||
144387086|NCT01606878|520627582|FG008|Overall Study|Physician Decision|1|||
144387087|NCT01606878|520627583|FG009|Overall Study|Physician Decision|0|||
144387088|NCT01606878|520627584|FG010|Overall Study|Physician Decision|0|||
144387089|NCT01606878|520627574|FG000|Overall Study|Withdrawal by Subject|3|||
144387090|NCT01606878|520627575|FG001|Overall Study|Withdrawal by Subject|2|||
144387091|NCT01606878|520627576|FG002|Overall Study|Withdrawal by Subject|2|||
144387092|NCT01606878|520627577|FG003|Overall Study|Withdrawal by Subject|0|||
144387093|NCT01606878|520627578|FG004|Overall Study|Withdrawal by Subject|1|||
144387094|NCT01606878|520627579|FG005|Overall Study|Withdrawal by Subject|1|||
144387095|NCT01606878|520627580|FG006|Overall Study|Withdrawal by Subject|2|||
144387096|NCT01606878|520627581|FG007|Overall Study|Withdrawal by Subject|1|||
144387097|NCT01606878|520627582|FG008|Overall Study|Withdrawal by Subject|2|||
144387098|NCT01606878|520627583|FG009|Overall Study|Withdrawal by Subject|0|||
144387099|NCT01606878|520627584|FG010|Overall Study|Withdrawal by Subject|2|||
144387100|NCT03353740|520627586|FG000|Overall Study|Images for these participants not viable|52|||
144387101|NCT00129311|520627588|FG000|Overall Study|Withdrawal by Subject|12|||
144387102|NCT00129311|520627589|FG001|Overall Study|Withdrawal by Subject|19|||
144387103|NCT02232880|520627590|FG000|Overall Study|study stopped prior to randomization|1|||
144387104|NCT04085367|520628787|FG000|Overall Study|Adverse Event|1|||
144387105|NCT04085367|520628788|FG001|Overall Study|Adverse Event|1|||
144387106|NCT04085367|520628787|FG000|Overall Study|Withdrawal by Subject|13|||
144387107|NCT04085367|520628788|FG001|Overall Study|Withdrawal by Subject|4|||
144387108|NCT04085367|520628787|FG000|Overall Study|Lost to Follow-up|3|||
144387109|NCT04085367|520628788|FG001|Overall Study|Lost to Follow-up|1|||
144387110|NCT04085367|520628787|FG000|Overall Study|Other unspecified|2|||
144387111|NCT04085367|520628788|FG001|Overall Study|Other unspecified|1|||
144515755|NCT00567398|521088905|FG001|Overall Study|Physician Decision|4|||
144515756|NCT00567398|521088904|FG000|Overall Study|Withdrawal by Subject|0|||
144515757|NCT00567398|521088905|FG001|Overall Study|Withdrawal by Subject|2|||
144515758|NCT00567398|521088904|FG000|Overall Study|Renal Transplantation|0|||
144515759|NCT00567398|521088905|FG001|Overall Study|Renal Transplantation|3|||
144515760|NCT00567398|521088904|FG000|Overall Study|Other|1|||
144515761|NCT00567398|521088905|FG001|Overall Study|Other|0|||
144515762|NCT02553642|521088912|FG000|Overall Study|Withdrawal by Subject|0|||
144387112|NCT04085367|520628787|FG000|Overall Study|Status Unknown|1|||
144387113|NCT04085367|520628788|FG001|Overall Study|Status Unknown|1|||
144515763|NCT02553642|521088913|FG001|Overall Study|Withdrawal by Subject|3|||
144387114|NCT00130442|520628791|FG000|Overall Study|Withdrawal by Subject|0|||
144387115|NCT00130442|520628792|FG001|Overall Study|Withdrawal by Subject|1|||
144515764|NCT02553642|521088912|FG000|Overall Study|Physician Decision|0|||
144515765|NCT02553642|521088913|FG001|Overall Study|Physician Decision|1|||
144515766|NCT02553642|521088912|FG000|Overall Study|Additional cancer dx|0|||
144387116|NCT00130442|520628791|FG000|Overall Study|did not meet criteria|1|||
144387117|NCT00130442|520628792|FG001|Overall Study|did not meet criteria|1|||
144387118|NCT00814333|520628793|FG000|Enrollment|Lost to Follow-up|1|||
144387119|NCT00814333|520628794|FG001|Enrollment|Lost to Follow-up|0|||
144387120|NCT02233946|520628795|FG000|Baseline|Withdrawal by Subject|2|||
144387121|NCT02233946|520628796|FG001|Baseline|Withdrawal by Subject|0|||
144387122|NCT02233946|520628795|FG000|3-months Follow-up|Lost to Follow-up|53|||
144387123|NCT02233946|520628796|FG001|3-months Follow-up|Lost to Follow-up|29|||
144387124|NCT02233946|520628795|FG000|6-months Follow-up|Lost to Follow-up|21|||
144387125|NCT02233946|520628796|FG001|6-months Follow-up|Lost to Follow-up|2|||
144387126|NCT02233946|520628795|FG000|9-month Follow-up|Lost to Follow-up|20|||
144387127|NCT02233946|520628796|FG001|9-month Follow-up|Lost to Follow-up|11|||
144387128|NCT02233946|520628795|FG000|12-month Follow-up|Lost to Follow-up|28|||
144387129|NCT02233946|520628796|FG001|12-month Follow-up|Lost to Follow-up|11|||
144387130|NCT01879579|520628799|FG000|Overall Study|Phone incompatible with texting platform|3|||
144387131|NCT01879579|520628800|FG001|Overall Study|Phone incompatible with texting platform|0|||
144387132|NCT01879579|520628799|FG000|Overall Study|Did not enroll in texting platform|1|||
144387133|NCT01879579|520628800|FG001|Overall Study|Did not enroll in texting platform|0|||
144387134|NCT01879579|520628799|FG000|Overall Study|Did not initiate insulin treatment|1|||
144387135|NCT01879579|520628800|FG001|Overall Study|Did not initiate insulin treatment|0|||
144387136|NCT01879579|520628799|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
144387137|NCT01879579|520628800|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
144387138|NCT01879579|520628799|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
144387139|NCT01879579|520628800|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
144387140|NCT02927067|520628801|FG000|Overall Study|Withdrawn Consent|20|||
144387141|NCT02927067|520628802|FG001|Overall Study|Withdrawn Consent|12|||
144387142|NCT02927067|520628801|FG000|Overall Study|Death|18|||
144387143|NCT02927067|520628802|FG001|Overall Study|Death|31|||
144387144|NCT02927067|520628801|FG000|Overall Study|Adverse Event|13|||
144387145|NCT02927067|520628802|FG001|Overall Study|Adverse Event|10|||
144387146|NCT02927067|520628801|FG000|Overall Study|Noncompliance|5|||
144387147|NCT02927067|520628802|FG001|Overall Study|Noncompliance|2|||
144387148|NCT02927067|520628801|FG000|Overall Study|Reason not Specified|4|||
144387149|NCT02927067|520628802|FG001|Overall Study|Reason not Specified|6|||
144387150|NCT02292784|520628805|FG000|Overall Study|Lost to Follow-up|1|||
144387151|NCT02292784|520628806|FG001|Overall Study|Lost to Follow-up|17|||
144387152|NCT02292784|520628807|FG002|Overall Study|Lost to Follow-up|18|||
144387153|NCT02292784|520628805|FG000|Overall Study|Withdrawal by Subject|0|||
144387154|NCT02292784|520628806|FG001|Overall Study|Withdrawal by Subject|3|||
144387155|NCT02292784|520628807|FG002|Overall Study|Withdrawal by Subject|3|||
144387156|NCT00134784|520628808|FG000|Overall Study|Withdrawal by Subject|2|||
144387157|NCT00134784|520628809|FG001|Overall Study|Withdrawal by Subject|2|||
144387158|NCT00134784|520628810|FG002|Overall Study|Withdrawal by Subject|2|||
144387159|NCT00134784|520628811|FG003|Overall Study|Withdrawal by Subject|1|||
144387160|NCT02919969|520628812|FG000|Overall Study|Lack of Efficacy|22|||
144387161|NCT02919969|520628812|FG000|Overall Study|Death|4|||
144387162|NCT02919969|520628812|FG000|Overall Study|Physician Decision|3|||
144387163|NCT02919969|520628812|FG000|Overall Study|Withdrawal by Subject|2|||
144387164|NCT03621475|520628813|FG000|Overall Study|No longer required restraints at initiation|0|||
144387165|NCT03621475|520628814|FG001|Overall Study|No longer required restraints at initiation|1|||
144387166|NCT01842633|520628815|FG000|Overall Study|Screen Failure|1|||
144387167|NCT01842633|520628816|FG001|Overall Study|Screen Failure|0|||
144387168|NCT01842633|520628817|FG002|Overall Study|Screen Failure|0|||
144387169|NCT01842633|520628815|FG000|Overall Study|Adverse Event|1|||
144387170|NCT01842633|520628816|FG001|Overall Study|Adverse Event|1|||
144387171|NCT01842633|520628817|FG002|Overall Study|Adverse Event|0|||
144387172|NCT01842633|520628815|FG000|Overall Study|Withdrawal by Subject|0|||
144387173|NCT01842633|520628816|FG001|Overall Study|Withdrawal by Subject|1|||
144387174|NCT01842633|520628817|FG002|Overall Study|Withdrawal by Subject|0|||
144387175|NCT01842633|520628815|FG000|Overall Study|Technical issues|1|||
144387176|NCT01842633|520628816|FG001|Overall Study|Technical issues|0|||
144387177|NCT01842633|520628817|FG002|Overall Study|Technical issues|0|||
144387178|NCT00706849|520628823|FG000|Treatment Period|Adverse Event|0|||
144387179|NCT00706849|520628824|FG001|Treatment Period|Adverse Event|9|||
144387180|NCT00706849|520628823|FG000|Treatment Period|Other|0|||
144387181|NCT00706849|520628824|FG001|Treatment Period|Other|1|||
144387182|NCT00706849|520628823|FG000|Follow-up Period|Withdrawal by Subject|0|||
144387183|NCT00706849|520628824|FG001|Follow-up Period|Withdrawal by Subject|2|||
144387184|NCT00706849|520628823|FG000|Follow-up Period|Protocol non-compliance|0|||
144387185|NCT00706849|520628824|FG001|Follow-up Period|Protocol non-compliance|1|||
144387186|NCT02616601|520628825|FG000|Overall Study|Withdrawal by Subject|4|||
144387187|NCT02616601|520628826|FG001|Overall Study|Withdrawal by Subject|4|||
144592949|NCT00320541|521372333|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
144387188|NCT02616601|520628827|FG002|Overall Study|Withdrawal by Subject|3|||
144387189|NCT02616601|520628825|FG000|Overall Study|Adverse Event|2|||
144387190|NCT02616601|520628826|FG001|Overall Study|Adverse Event|0|||
144387191|NCT02616601|520628827|FG002|Overall Study|Adverse Event|2|||
144387192|NCT02616601|520628825|FG000|Overall Study|Death|1|||
144387193|NCT02616601|520628826|FG001|Overall Study|Death|0|||
144387194|NCT02616601|520628827|FG002|Overall Study|Death|0|||
144387195|NCT02616601|520628825|FG000|Overall Study|Lost to Follow-up|1|||
144387196|NCT02616601|520628826|FG001|Overall Study|Lost to Follow-up|0|||
144387197|NCT02616601|520628827|FG002|Overall Study|Lost to Follow-up|1|||
144387198|NCT02616601|520628825|FG000|Overall Study|Non-Compliance with Test Article|1|||
144387199|NCT02616601|520628826|FG001|Overall Study|Non-Compliance with Test Article|0|||
144387200|NCT02616601|520628827|FG002|Overall Study|Non-Compliance with Test Article|1|||
144387201|NCT03718299|520628828|FG000|Overall Study|Adverse Event|1|||
144387202|NCT03718299|520628828|FG000|Overall Study|Withdrawal by Subject|6|||
144387203|NCT03718299|520628828|FG000|Overall Study|Physician Decision|2|||
144387204|NCT03718299|520628828|FG000|Overall Study|Lost to Follow-up|1|||
144387205|NCT04389970|520628829|FG000|Overall Study|Lost to Follow-up|1|||
144387206|NCT01343823|520628830|FG000|Overall Study|Study Terminated|1|||
144387207|NCT01343823|520628831|FG001|Overall Study|Study Terminated|0|||
144387208|NCT01343823|520628832|FG002|Overall Study|Study Terminated|0|||
144387209|NCT01343823|520628833|FG003|Overall Study|Study Terminated|1|||
144387210|NCT01343823|520628830|FG000|Overall Study|Withdrawal by Subject|1|||
144387211|NCT01343823|520628831|FG001|Overall Study|Withdrawal by Subject|0|||
144387212|NCT01343823|520628832|FG002|Overall Study|Withdrawal by Subject|0|||
144387213|NCT01343823|520628833|FG003|Overall Study|Withdrawal by Subject|0|||
144387214|NCT00976508|520628836|FG000|Overall Study|Death|7|||
144387215|NCT00976508|520628837|FG001|Overall Study|Death|1|||
144387216|NCT00976508|520628836|FG000|Overall Study|Lost to Follow-up|1|||
144387217|NCT00976508|520628837|FG001|Overall Study|Lost to Follow-up|0|||
144387218|NCT00976508|520628836|FG000|Overall Study|Withdrawal by Subject|1|||
144387219|NCT00976508|520628837|FG001|Overall Study|Withdrawal by Subject|0|||
144387220|NCT00976508|520628836|FG000|Overall Study|Disease Progression|4|||
144387221|NCT00976508|520628837|FG001|Overall Study|Disease Progression|4|||
144387222|NCT00976508|520628836|FG000|Overall Study|Subject Enrolled in Hospice|1|||
144387223|NCT00976508|520628837|FG001|Overall Study|Subject Enrolled in Hospice|0|||
144387224|NCT00976508|520628836|FG000|Overall Study|Terminated by the Sponsor|0|||
144387225|NCT00976508|520628837|FG001|Overall Study|Terminated by the Sponsor|1|||
144387226|NCT01992159|520628838|FG000|Overall Study|Withdrawal by Subject|4|||
144387227|NCT01992159|520628839|FG001|Overall Study|Withdrawal by Subject|7|||
144387228|NCT01992159|520628840|FG002|Overall Study|Withdrawal by Subject|0|||
144387229|NCT01992159|520628841|FG003|Overall Study|Withdrawal by Subject|3|||
144387230|NCT01992159|520628838|FG000|Overall Study|Adverse Event|0|||
144387231|NCT01992159|520628839|FG001|Overall Study|Adverse Event|1|||
144387232|NCT01992159|520628840|FG002|Overall Study|Adverse Event|0|||
144387233|NCT01992159|520628841|FG003|Overall Study|Adverse Event|1|||
144387234|NCT01992159|520628838|FG000|Overall Study|Death|0|||
144387235|NCT01992159|520628839|FG001|Overall Study|Death|0|||
144387236|NCT01992159|520628840|FG002|Overall Study|Death|1|||
144387237|NCT01992159|520628841|FG003|Overall Study|Death|0|||
144387238|NCT00686634|520628847|FG000|Overall Study|Protocol Violation|6|||
144387239|NCT02296138|520628850|FG000|Overall Study|Adverse Event|348|||
144387240|NCT02296138|520628851|FG001|Overall Study|Adverse Event|259|||
144387241|NCT02296138|520628850|FG000|Overall Study|Lack of Efficacy|59|||
144387242|NCT02296138|520628851|FG001|Overall Study|Lack of Efficacy|37|||
144387243|NCT02296138|520628850|FG000|Overall Study|Protocol Violation|35|||
144387244|NCT02296138|520628851|FG001|Overall Study|Protocol Violation|36|||
144387245|NCT02296138|520628850|FG000|Overall Study|Lost to Follow-up|9|||
144387246|NCT02296138|520628851|FG001|Overall Study|Lost to Follow-up|12|||
144387247|NCT02296138|520628850|FG000|Overall Study|Withdrawal by Subject|184|||
144387248|NCT02296138|520628851|FG001|Overall Study|Withdrawal by Subject|131|||
144515767|NCT02553642|521088913|FG001|Overall Study|Additional cancer dx|1|||
144515768|NCT02553642|521088912|FG000|Overall Study|Never started treatment|0|||
144515769|NCT02553642|521088913|FG001|Overall Study|Never started treatment|1|||
144515770|NCT05444192|521088916|FG000|Overall Study|Lost to Follow-up|1|||
144515771|NCT05444192|521088917|FG001|Overall Study|Lost to Follow-up|0|||
144515772|NCT04424927|521088919|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
144387249|NCT02296138|520628850|FG000|Overall Study|Not Treated|1|||
144387250|NCT02296138|520628851|FG001|Overall Study|Not Treated|1|||
144387251|NCT02296138|520628850|FG000|Overall Study|Patients with data irregularities|10|||
144387252|NCT02296138|520628851|FG001|Overall Study|Patients with data irregularities|11|||
144387253|NCT02296138|520628850|FG000|Overall Study|Other than specified|15|||
144515773|NCT04424927|521088920|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
144592950|NCT02401867|521372334|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
144387254|NCT02296138|520628851|FG001|Overall Study|Other than specified|13|||
144387255|NCT01653132|520628852|FG000|First Intervention|Protocol Violation|1|||
144387256|NCT01653132|520628853|FG001|First Intervention|Protocol Violation|0|||
144387257|NCT02677324|520628854|FG000|Overall Study|Disease Progression|6|||
144387258|NCT02677324|520628854|FG000|Overall Study|Inability to Swallow pills|1|||
144515774|NCT04424927|521088921|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
144387259|NCT02677324|520628854|FG000|Overall Study|Non-compliance|1|||
144387260|NCT02677324|520628854|FG000|Overall Study|Lack of Efficacy|1|||
144387261|NCT02677324|520628854|FG000|Overall Study|Medical insurance coverage|1|||
144387262|NCT02677324|520628854|FG000|Overall Study|Adverse Event|1|||
144387263|NCT02677324|520628854|FG000|Overall Study|IgM Myeloma diagnosis|1|||
144387264|NCT00761150|520628857|FG000|Open-label Period|Adverse Event|36|||
144387265|NCT00761150|520628858|FG001|Open-label Period|Adverse Event|0|||
144387266|NCT00761150|520628859|FG002|Open-label Period|Adverse Event|0|||
144387267|NCT00761150|520628857|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
144387268|NCT00761150|520628858|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
144387269|NCT00761150|520628859|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
144387270|NCT00761150|520628857|FG000|Open-label Period|Lost to Follow-up|7|||
144387271|NCT00761150|520628858|FG001|Open-label Period|Lost to Follow-up|0|||
144387272|NCT00761150|520628859|FG002|Open-label Period|Lost to Follow-up|0|||
144387273|NCT00761150|520628857|FG000|Open-label Period|Lack of Efficacy|4|||
144387274|NCT00761150|520628858|FG001|Open-label Period|Lack of Efficacy|0|||
144387275|NCT00761150|520628859|FG002|Open-label Period|Lack of Efficacy|0|||
144387276|NCT00761150|520628857|FG000|Open-label Period|Withdrawal by Subject|5|||
144387277|NCT00761150|520628858|FG001|Open-label Period|Withdrawal by Subject|0|||
144387278|NCT00761150|520628859|FG002|Open-label Period|Withdrawal by Subject|0|||
144387279|NCT00761150|520628857|FG000|Open-label Period|Noncompliance|2|||
144387280|NCT00761150|520628858|FG001|Open-label Period|Noncompliance|0|||
144387281|NCT00761150|520628859|FG002|Open-label Period|Noncompliance|0|||
144387282|NCT00761150|520628857|FG000|Open-label Period|Other|5|||
144387283|NCT00761150|520628858|FG001|Open-label Period|Other|0|||
144387284|NCT00761150|520628859|FG002|Open-label Period|Other|0|||
144387285|NCT00761150|520628857|FG000|Double-blind Period|Lack of Efficacy|0|||
144387286|NCT00761150|520628858|FG001|Double-blind Period|Lack of Efficacy|2|||
144387287|NCT00761150|520628859|FG002|Double-blind Period|Lack of Efficacy|19|||
144387288|NCT00761150|520628857|FG000|Double-blind Period|Adverse Event|0|||
144387289|NCT00761150|520628858|FG001|Double-blind Period|Adverse Event|3|||
144387290|NCT00761150|520628859|FG002|Double-blind Period|Adverse Event|3|||
144387291|NCT00761150|520628857|FG000|Double-blind Period|Withdrawal by Subject|0|||
144387292|NCT00761150|520628858|FG001|Double-blind Period|Withdrawal by Subject|3|||
144387293|NCT00761150|520628859|FG002|Double-blind Period|Withdrawal by Subject|2|||
144387294|NCT00761150|520628857|FG000|Double-blind Period|Lost to Follow-up|0|||
144387295|NCT00761150|520628858|FG001|Double-blind Period|Lost to Follow-up|2|||
144387296|NCT00761150|520628859|FG002|Double-blind Period|Lost to Follow-up|1|||
144387297|NCT00761150|520628857|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
144387298|NCT00761150|520628858|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
144387299|NCT00761150|520628859|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
144387300|NCT00761150|520628857|FG000|Double-blind Period|Noncompliance|0|||
144387301|NCT00761150|520628858|FG001|Double-blind Period|Noncompliance|1|||
144387302|NCT00761150|520628859|FG002|Double-blind Period|Noncompliance|0|||
144387303|NCT00761150|520628857|FG000|Double-blind Period|Other|0|||
144387304|NCT00761150|520628858|FG001|Double-blind Period|Other|3|||
144387305|NCT00761150|520628859|FG002|Double-blind Period|Other|3|||
144387306|NCT03312751|520628860|FG000|Overall Study|Death|7|||
144592951|NCT02401867|521372334|FG000|Analysis|Cervical assay could not be conducted|9|||
144592952|NCT01640054|521372335|FG000|Overall Study|Study-specific disc criteria|1|||
144592953|NCT01640054|521372335|FG000|Overall Study|Lack of Efficacy|3|||
144592954|NCT01640054|521372335|FG000|Overall Study|Adverse Event|2|||
144387307|NCT03312751|520628861|FG001|Overall Study|Death|9|||
144592955|NCT01206777|521372337|FG000|Overall Study|Death|1|||
144592956|NCT01206777|521372337|FG000|Overall Study|Adverse Event|1|||
144592957|NCT02080221|521372340|FG000|Overall Study|Withdrawal by Subject|1|||
144592958|NCT02080221|521372340|FG000|Overall Study|Clinical Progression of Disease|1|||
144592959|NCT03184870|521372344|FG000|Initial Treatment|Death|6|||
144592960|NCT03184870|521372345|FG001|Initial Treatment|Death|6|||
144592961|NCT03184870|521372346|FG002|Initial Treatment|Death|8|||
144592962|NCT03184870|521372347|FG003|Initial Treatment|Death|8|||
144592963|NCT03184870|521372348|FG004|Initial Treatment|Death|6|||
144592964|NCT03184870|521372349|FG005|Initial Treatment|Death|6|||
144387308|NCT03312751|520628860|FG000|Overall Study|Study discontinuation due to other reason|0|||
144592965|NCT03184870|521372350|FG006|Initial Treatment|Death|6|||
144387309|NCT03312751|520628861|FG001|Overall Study|Study discontinuation due to other reason|1|||
144592966|NCT03184870|521372351|FG007|Initial Treatment|Death|7|||
144592967|NCT03184870|521372352|FG008|Initial Treatment|Death|1|||
144592968|NCT03184870|521372353|FG009|Initial Treatment|Death|2|||
144387310|NCT00282464|520628862|FG000|Overall Study|Adverse Event|26|||
144387311|NCT00282464|520628863|FG001|Overall Study|Adverse Event|20|||
144387312|NCT00282464|520628862|FG000|Overall Study|Lack of Efficacy|8|||
144387313|NCT00282464|520628863|FG001|Overall Study|Lack of Efficacy|8|||
144387314|NCT00282464|520628862|FG000|Overall Study|Lost to Follow-up|10|||
144387315|NCT00282464|520628863|FG001|Overall Study|Lost to Follow-up|10|||
144387316|NCT00282464|520628862|FG000|Overall Study|Withdrawal by Subject|24|||
144387317|NCT00282464|520628863|FG001|Overall Study|Withdrawal by Subject|10|||
144387318|NCT00282464|520628862|FG000|Overall Study|laboratory abnormality|1|||
144387319|NCT00282464|520628863|FG001|Overall Study|laboratory abnormality|2|||
144387320|NCT00282464|520628862|FG000|Overall Study|Protocol Violation|0|||
144387321|NCT00282464|520628863|FG001|Overall Study|Protocol Violation|7|||
144387322|NCT00282464|520628862|FG000|Overall Study|Patient moved|1|||
144387323|NCT00282464|520628863|FG001|Overall Study|Patient moved|0|||
144387324|NCT00282464|520628862|FG000|Overall Study|patient non-compliant|3|||
144387325|NCT00282464|520628863|FG001|Overall Study|patient non-compliant|0|||
144387326|NCT00282464|520628862|FG000|Overall Study|patient no show|0|||
144387327|NCT00282464|520628863|FG001|Overall Study|patient no show|1|||
144387328|NCT00282464|520628862|FG000|Overall Study|patient incarcerated|0|||
144387329|NCT00282464|520628863|FG001|Overall Study|patient incarcerated|1|||
144387330|NCT00282464|520628862|FG000|Overall Study|family crisis|0|||
144387331|NCT00282464|520628863|FG001|Overall Study|family crisis|1|||
144387332|NCT00282464|520628862|FG000|Overall Study|dispensed wrong kit|0|||
144387333|NCT00282464|520628863|FG001|Overall Study|dispensed wrong kit|1|||
144387334|NCT00282464|520628862|FG000|Overall Study|dropped due to missed visits|0|||
144387335|NCT00282464|520628863|FG001|Overall Study|dropped due to missed visits|1|||
144387336|NCT00475423|520628864|FG000|Overall Study|Protocol Violation|5|||
144387337|NCT00475423|520628864|FG000|Overall Study|Adverse Event|4|||
144387338|NCT00475423|520628864|FG000|Overall Study|Withdrawal by Subject|6|||
144387339|NCT00475423|520628864|FG000|Overall Study|Lack of Efficacy|8|||
144387340|NCT00475423|520628864|FG000|Overall Study|Death|1|||
144387341|NCT00475423|520628864|FG000|Overall Study|Reason not specified|1|||
144387342|NCT00475423|520628864|FG000|Overall Study|Lost to Follow-up|7|||
144387343|NCT01214174|520628865|FG000|Overall Study|Withdrawal by Subject|0|||
144387344|NCT01214174|520628866|FG001|Overall Study|Withdrawal by Subject|0|||
144387345|NCT01214174|520628867|FG002|Overall Study|Withdrawal by Subject|1|||
144387346|NCT00290407|520628868|FG000|Overall Study|Physician Decision|2|||
144387347|NCT01925989|520628881|FG000|Period 1|Sponsor Decision|1|||
144387348|NCT01925989|520628882|FG001|Period 1|Sponsor Decision|1|||
144387349|NCT01925989|520628883|FG002|Period 1|Sponsor Decision|0|||
144387350|NCT01925989|520628881|FG000|Period 1|Withdrawal by Subject|0|||
144387351|NCT01925989|520628882|FG001|Period 1|Withdrawal by Subject|1|||
144387352|NCT01925989|520628883|FG002|Period 1|Withdrawal by Subject|0|||
144387353|NCT00868517|520628885|FG000|Overall Study|Withdrawal by Subject|3|||
144387354|NCT00868517|520628886|FG001|Overall Study|Withdrawal by Subject|3|||
144387355|NCT00868517|520628887|FG002|Overall Study|Withdrawal by Subject|2|||
144387356|NCT00868517|520628885|FG000|Overall Study|Protocol Violation|1|||
144387357|NCT00868517|520628886|FG001|Overall Study|Protocol Violation|1|||
144387358|NCT00868517|520628887|FG002|Overall Study|Protocol Violation|0|||
144387359|NCT02496676|520628889|FG000|Phase 1 - Period 1|Adverse Event|0|||
144387360|NCT02496676|520628890|FG001|Phase 1 - Period 1|Adverse Event|1|||
144387361|NCT02496676|520628889|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
144387362|NCT02496676|520628890|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
144387363|NCT02514473|520628895|FG000|Overall Study|Adverse Event|0|||
144387364|NCT02514473|520628896|FG001|Overall Study|Adverse Event|2|||
144387365|NCT02514473|520628895|FG000|Overall Study|Withdrawal by Subject|2|||
144387366|NCT02514473|520628896|FG001|Overall Study|Withdrawal by Subject|1|||
144387367|NCT02514473|520628895|FG000|Overall Study|Lost to Follow-up|0|||
144387368|NCT02514473|520628896|FG001|Overall Study|Lost to Follow-up|1|||
144387369|NCT02514473|520628895|FG000|Overall Study|Other|1|||
144387370|NCT02514473|520628896|FG001|Overall Study|Other|1|||
144387371|NCT00548405|520628897|FG000|Overall Study|Adverse Event|6|||
144387372|NCT00548405|520628898|FG001|Overall Study|Adverse Event|2|||
144387373|NCT00548405|520628899|FG002|Overall Study|Adverse Event|0|||
144387374|NCT00548405|520628897|FG000|Overall Study|Lack of Efficacy|6|||
144592969|NCT03184870|521372354|FG010|Initial Treatment|Death|26|||
144592970|NCT03184870|521372355|FG011|Initial Treatment|Death|28|||
144592971|NCT03184870|521372356|FG012|Initial Treatment|Death|10|||
144592972|NCT03184870|521372357|FG013|Initial Treatment|Death|33|||
144592973|NCT03184870|521372358|FG014|Initial Treatment|Death|34|||
144592974|NCT03184870|521372359|FG015|Initial Treatment|Death|26|||
144387375|NCT00548405|520628898|FG001|Overall Study|Lack of Efficacy|0|||
144387376|NCT00548405|520628899|FG002|Overall Study|Lack of Efficacy|0|||
144387377|NCT00548405|520628897|FG000|Overall Study|Physician Decision|3|||
144387378|NCT00548405|520628898|FG001|Overall Study|Physician Decision|4|||
144387379|NCT00548405|520628899|FG002|Overall Study|Physician Decision|1|||
144387380|NCT00548405|520628897|FG000|Overall Study|Pregnancy|1|||
144387381|NCT00548405|520628898|FG001|Overall Study|Pregnancy|0|||
144387382|NCT00548405|520628899|FG002|Overall Study|Pregnancy|0|||
144387383|NCT00548405|520628897|FG000|Overall Study|Protocol Violation|1|||
144387384|NCT00548405|520628898|FG001|Overall Study|Protocol Violation|0|||
144387385|NCT00548405|520628899|FG002|Overall Study|Protocol Violation|0|||
144387386|NCT00548405|520628897|FG000|Overall Study|Withdrawal by Subject|36|||
144592975|NCT03184870|521372360|FG016|Initial Treatment|Death|20|||
144387387|NCT00548405|520628898|FG001|Overall Study|Withdrawal by Subject|12|||
144387388|NCT00548405|520628899|FG002|Overall Study|Withdrawal by Subject|5|||
144387389|NCT00548405|520628897|FG000|Overall Study|Lost to Follow-up|1|||
144387390|NCT00548405|520628898|FG001|Overall Study|Lost to Follow-up|1|||
144387391|NCT00548405|520628899|FG002|Overall Study|Lost to Follow-up|2|||
144592976|NCT03184870|521372361|FG017|Initial Treatment|Death|18|||
144592977|NCT03184870|521372344|FG000|Initial Treatment|Other Reasons|2|||
144592978|NCT03184870|521372345|FG001|Initial Treatment|Other Reasons|2|||
144592979|NCT03184870|521372346|FG002|Initial Treatment|Other Reasons|0|||
144592980|NCT03184870|521372347|FG003|Initial Treatment|Other Reasons|1|||
144592981|NCT03184870|521372348|FG004|Initial Treatment|Other Reasons|0|||
144592982|NCT03184870|521372349|FG005|Initial Treatment|Other Reasons|0|||
144592983|NCT03184870|521372350|FG006|Initial Treatment|Other Reasons|0|||
144592984|NCT03184870|521372351|FG007|Initial Treatment|Other Reasons|2|||
144592985|NCT03184870|521372352|FG008|Initial Treatment|Other Reasons|0|||
144592986|NCT03184870|521372353|FG009|Initial Treatment|Other Reasons|0|||
144592987|NCT03184870|521372354|FG010|Initial Treatment|Other Reasons|4|||
144592988|NCT03184870|521372355|FG011|Initial Treatment|Other Reasons|2|||
144592989|NCT03184870|521372356|FG012|Initial Treatment|Other Reasons|2|||
144592990|NCT03184870|521372357|FG013|Initial Treatment|Other Reasons|0|||
144592991|NCT03184870|521372358|FG014|Initial Treatment|Other Reasons|0|||
144592992|NCT03184870|521372359|FG015|Initial Treatment|Other Reasons|1|||
144387392|NCT00548405|520628897|FG000|Overall Study|Death|0|||
144592993|NCT03184870|521372360|FG016|Initial Treatment|Other Reasons|0|||
144592994|NCT03184870|521372361|FG017|Initial Treatment|Other Reasons|2|||
144592995|NCT03184870|521372344|FG000|Initial Treatment|Lost to Follow-up|2|||
144592996|NCT03184870|521372345|FG001|Initial Treatment|Lost to Follow-up|0|||
144592997|NCT03184870|521372346|FG002|Initial Treatment|Lost to Follow-up|0|||
144592998|NCT03184870|521372347|FG003|Initial Treatment|Lost to Follow-up|1|||
144592999|NCT03184870|521372348|FG004|Initial Treatment|Lost to Follow-up|1|||
144593000|NCT03184870|521372349|FG005|Initial Treatment|Lost to Follow-up|1|||
144593001|NCT03184870|521372350|FG006|Initial Treatment|Lost to Follow-up|0|||
144593002|NCT03184870|521372351|FG007|Initial Treatment|Lost to Follow-up|2|||
144593003|NCT03184870|521372352|FG008|Initial Treatment|Lost to Follow-up|0|||
144593004|NCT03184870|521372353|FG009|Initial Treatment|Lost to Follow-up|0|||
144593005|NCT03184870|521372354|FG010|Initial Treatment|Lost to Follow-up|2|||
144593006|NCT03184870|521372355|FG011|Initial Treatment|Lost to Follow-up|0|||
144593007|NCT03184870|521372356|FG012|Initial Treatment|Lost to Follow-up|2|||
144593008|NCT03184870|521372357|FG013|Initial Treatment|Lost to Follow-up|2|||
144593009|NCT03184870|521372358|FG014|Initial Treatment|Lost to Follow-up|0|||
144593010|NCT03184870|521372359|FG015|Initial Treatment|Lost to Follow-up|0|||
144593011|NCT03184870|521372360|FG016|Initial Treatment|Lost to Follow-up|2|||
144593012|NCT03184870|521372361|FG017|Initial Treatment|Lost to Follow-up|2|||
144387393|NCT00548405|520628898|FG001|Overall Study|Death|1|||
144387394|NCT00548405|520628899|FG002|Overall Study|Death|1|||
144387395|NCT00548405|520628897|FG000|Overall Study|Sponsor decision|1|||
144387396|NCT00548405|520628898|FG001|Overall Study|Sponsor decision|0|||
144387397|NCT00548405|520628899|FG002|Overall Study|Sponsor decision|0|||
144387398|NCT00548405|520628897|FG000|Overall Study|Randomized but not treated|1|||
144387399|NCT00548405|520628898|FG001|Overall Study|Randomized but not treated|0|||
144387400|NCT00548405|520628899|FG002|Overall Study|Randomized but not treated|0|||
144387401|NCT01624870|520628901|FG000|Overall Study|Death|19|||
144387402|NCT01624870|520628901|FG000|Overall Study|Withdrawal by Subject|1|||
144387403|NCT01624870|520628901|FG000|Overall Study|CoreValve not implanted|6|||
144387404|NCT01624870|520628901|FG000|Overall Study|Lost to follow up|1|||
144387405|NCT02217527|520628903|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
144387406|NCT02217527|520628904|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
144387407|NCT02217527|520628903|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
144387408|NCT02217527|520628904|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
144387409|NCT04658940|520628906|FG000|Overall Study|Withdrawal by Subject|1|||
144387410|NCT01700439|520628907|FG000|Overall Study|Lost to Follow-up|47|||
144387411|NCT01700439|520628907|FG000|Overall Study|Withdrawal by Subject|183|||
144387412|NCT01700439|520628907|FG000|Overall Study|Death|186|||
144387413|NCT02518464|520628908|FG000|Overall Study|Adverse Event|2|||
144387414|NCT02093351|520630223|FG000|Part A|Adverse Event|0|||
144387415|NCT02093351|520630224|FG001|Part A|Adverse Event|1|||
144387416|NCT02093351|520630225|FG002|Part A|Adverse Event|1|||
144593013|NCT03184870|521372344|FG000|Initial Treatment|Withdrawal by Subject|0|||
144593014|NCT03184870|521372345|FG001|Initial Treatment|Withdrawal by Subject|0|||
144593015|NCT03184870|521372346|FG002|Initial Treatment|Withdrawal by Subject|2|||
144593016|NCT03184870|521372347|FG003|Initial Treatment|Withdrawal by Subject|1|||
144593017|NCT03184870|521372348|FG004|Initial Treatment|Withdrawal by Subject|1|||
144593018|NCT03184870|521372349|FG005|Initial Treatment|Withdrawal by Subject|0|||
144387417|NCT02093351|520630226|FG003|Part A|Adverse Event|0|||
144387418|NCT02093351|520630223|FG000|Part A|Condition under investigation worsened|2|||
144387419|NCT02093351|520630224|FG001|Part A|Condition under investigation worsened|0|||
144387420|NCT02093351|520630225|FG002|Part A|Condition under investigation worsened|2|||
144593019|NCT03184870|521372350|FG006|Initial Treatment|Withdrawal by Subject|1|||
144593020|NCT03184870|521372351|FG007|Initial Treatment|Withdrawal by Subject|0|||
144387421|NCT02093351|520630226|FG003|Part A|Condition under investigation worsened|0|||
144387422|NCT02093351|520630223|FG000|Part A|Death|0|||
144387423|NCT02093351|520630224|FG001|Part A|Death|1|||
144387424|NCT02093351|520630225|FG002|Part A|Death|0|||
144387425|NCT02093351|520630226|FG003|Part A|Death|0|||
144387426|NCT02093351|520630223|FG000|Part B|Patient decision|0|||
144387427|NCT02093351|520630224|FG001|Part B|Patient decision|0|||
144387428|NCT02093351|520630225|FG002|Part B|Patient decision|0|||
144387429|NCT02093351|520630226|FG003|Part B|Patient decision|3|||
144387430|NCT02093351|520630223|FG000|Part B|Disease progression|0|||
144387431|NCT02093351|520630224|FG001|Part B|Disease progression|0|||
144387432|NCT02093351|520630225|FG002|Part B|Disease progression|0|||
144387433|NCT02093351|520630226|FG003|Part B|Disease progression|4|||
144387434|NCT02093351|520630223|FG000|Part B|Complete response|0|||
144387435|NCT02093351|520630224|FG001|Part B|Complete response|0|||
144387436|NCT02093351|520630225|FG002|Part B|Complete response|0|||
144387437|NCT02093351|520630226|FG003|Part B|Complete response|1|||
144387438|NCT02093351|520630223|FG000|Part B|Adverse event + disease progression|0|||
144387439|NCT02093351|520630224|FG001|Part B|Adverse event + disease progression|0|||
144387440|NCT02093351|520630225|FG002|Part B|Adverse event + disease progression|0|||
144387441|NCT02093351|520630226|FG003|Part B|Adverse event + disease progression|1|||
144387442|NCT02093351|520630223|FG000|Part B|Lack of therapeutic response|0|||
144387443|NCT02093351|520630224|FG001|Part B|Lack of therapeutic response|0|||
144387444|NCT02093351|520630225|FG002|Part B|Lack of therapeutic response|0|||
144387445|NCT02093351|520630226|FG003|Part B|Lack of therapeutic response|12|||
144387446|NCT02093351|520630223|FG000|Part B|Condition under investigation worsened|0|||
144387447|NCT02093351|520630224|FG001|Part B|Condition under investigation worsened|0|||
144387448|NCT02093351|520630225|FG002|Part B|Condition under investigation worsened|0|||
144387449|NCT02093351|520630226|FG003|Part B|Condition under investigation worsened|39|||
144387450|NCT02093351|520630223|FG000|Part B|Adverse Event|0|||
144387451|NCT02093351|520630224|FG001|Part B|Adverse Event|0|||
144387452|NCT02093351|520630225|FG002|Part B|Adverse Event|0|||
144387453|NCT02093351|520630226|FG003|Part B|Adverse Event|2|||
144387454|NCT02093351|520630223|FG000|Part B|Death|0|||
144387455|NCT02093351|520630224|FG001|Part B|Death|0|||
144387456|NCT02093351|520630225|FG002|Part B|Death|0|||
144515775|NCT04424927|521088922|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
144515776|NCT04424927|521088923|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
144515777|NCT04424927|521088919|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
144387457|NCT02093351|520630226|FG003|Part B|Death|1|||
144387458|NCT01099709|520630227|FG000|Period 1|Withdrawal by Subject|0|||
144515778|NCT04424927|521088920|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
144515779|NCT04424927|521088921|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
144515780|NCT04424927|521088922|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
144515781|NCT04424927|521088923|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
144515782|NCT04424927|521088919|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
144515783|NCT04424927|521088920|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
144515784|NCT04424927|521088921|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
144515785|NCT04424927|521088922|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
144515786|NCT04424927|521088923|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
144515787|NCT04424927|521088919|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
144515788|NCT04424927|521088920|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
144515789|NCT04424927|521088921|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
144515790|NCT04424927|521088922|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
144515791|NCT04424927|521088923|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
144515792|NCT04424927|521088919|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
144515793|NCT04424927|521088920|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
144515794|NCT04424927|521088921|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
144515795|NCT04424927|521088922|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
144593021|NCT03184870|521372352|FG008|Initial Treatment|Withdrawal by Subject|0|||
144593022|NCT03184870|521372353|FG009|Initial Treatment|Withdrawal by Subject|0|||
144593023|NCT03184870|521372354|FG010|Initial Treatment|Withdrawal by Subject|0|||
144387459|NCT01099709|520630228|FG001|Period 1|Withdrawal by Subject|1|||
144387460|NCT01099709|520630227|FG000|Period 1|Positive cotinine test|0|||
144387461|NCT01099709|520630228|FG001|Period 1|Positive cotinine test|1|||
144387462|NCT01099709|520630227|FG000|Period 1|Adverse Event|1|||
144387463|NCT01099709|520630228|FG001|Period 1|Adverse Event|0|||
144387464|NCT01611454|520630229|FG000|Overall Study|Lack of Efficacy|18|||
144387465|NCT01611454|520630230|FG001|Overall Study|Lack of Efficacy|10|||
144515796|NCT04424927|521088923|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
144515797|NCT04424927|521088919|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
144515798|NCT04424927|521088920|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
144387466|NCT00920907|520630231|FG000|Induction Period|Adverse Event|0|||
144387467|NCT00920907|520630232|FG001|Induction Period|Adverse Event|2|||
144387468|NCT00920907|520630231|FG000|Induction Period|Death|1|||
144387469|NCT00920907|520630232|FG001|Induction Period|Death|1|||
144515799|NCT04424927|521088921|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
144515800|NCT04424927|521088922|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
144515801|NCT04424927|521088923|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
144515802|NCT04424927|521088919|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
144515803|NCT04424927|521088920|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
144387470|NCT00920907|520630231|FG000|Induction Period|Disease Progression|12|||
144387471|NCT00920907|520630232|FG001|Induction Period|Disease Progression|11|||
144387472|NCT00920907|520630231|FG000|Induction Period|Study Drug Toxicity|8|||
144387473|NCT00920907|520630232|FG001|Induction Period|Study Drug Toxicity|6|||
144387474|NCT00920907|520630231|FG000|Induction Period|No longer meets study criteria|0|||
144387475|NCT00920907|520630232|FG001|Induction Period|No longer meets study criteria|1|||
144387476|NCT00920907|520630231|FG000|Induction Period|Withdrawal by Subject|1|||
144387477|NCT00920907|520630232|FG001|Induction Period|Withdrawal by Subject|1|||
144387478|NCT00920907|520630231|FG000|Maintenance Period|Disease Progression|3|||
144387479|NCT00920907|520630232|FG001|Maintenance Period|Disease Progression|7|||
144387480|NCT00920907|520630231|FG000|Maintenance Period|Administrative (study closure)|7|||
144387481|NCT00920907|520630232|FG001|Maintenance Period|Administrative (study closure)|2|||
144387482|NCT00920907|520630231|FG000|Maintenance Period|Study Drug Toxicity|0|||
144387483|NCT00920907|520630232|FG001|Maintenance Period|Study Drug Toxicity|2|||
144387484|NCT00920907|520630231|FG000|Maintenance Period|Death|1|||
144387485|NCT00920907|520630232|FG001|Maintenance Period|Death|1|||
144387486|NCT00920907|520630231|FG000|Maintenance Period|Withdrawal by Subject|1|||
144387487|NCT00920907|520630232|FG001|Maintenance Period|Withdrawal by Subject|0|||
144387488|NCT00920907|520630231|FG000|Maintenance Period|Adverse Event|0|||
144387489|NCT00920907|520630232|FG001|Maintenance Period|Adverse Event|1|||
144387490|NCT01275339|520630233|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
144387491|NCT01275339|520630234|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
144387492|NCT01275339|520630235|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
144387493|NCT01275339|520630236|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
144387494|NCT01275339|520630233|FG000|Overall Study|Withdrawal by Subject|0|||
144387495|NCT01275339|520630234|FG001|Overall Study|Withdrawal by Subject|0|||
144387496|NCT01275339|520630235|FG002|Overall Study|Withdrawal by Subject|1|||
144387497|NCT01275339|520630236|FG003|Overall Study|Withdrawal by Subject|0|||
144387498|NCT04656275|520630237|FG000|Overall Study|Study terminated by sponsor|2|||
144387499|NCT04656275|520630238|FG001|Overall Study|Study terminated by sponsor|4|||
144387500|NCT00934648|520630242|FG000|Overall Study|Failure to return|8|||
144387501|NCT00934648|520630242|FG000|Overall Study|Withdrawal by Subject|1|||
144387502|NCT05442775|520630243|FG000|Overall Study|Trial terminated|61|||
144387503|NCT05442775|520630243|FG000|Overall Study|Lack of Efficacy|4|||
144387504|NCT05442775|520630243|FG000|Overall Study|Withdrawal by Subject|4|||
144387505|NCT05442775|520630243|FG000|Overall Study|Death|1|||
144387506|NCT05442775|520630243|FG000|Overall Study|Participant removed at Sponsor request|1|||
144387507|NCT02963831|520630244|FG000|Overall Study|Progressive Disease|3|||
144387508|NCT02963831|520630245|FG001|Overall Study|Progressive Disease|3|||
144387509|NCT02963831|520630246|FG002|Overall Study|Progressive Disease|16|||
144387510|NCT02963831|520630247|FG003|Overall Study|Progressive Disease|27|||
144387511|NCT02963831|520630244|FG000|Overall Study|Withdrawal by Subject|1|||
144387512|NCT02963831|520630245|FG001|Overall Study|Withdrawal by Subject|0|||
144387513|NCT02963831|520630246|FG002|Overall Study|Withdrawal by Subject|2|||
144387514|NCT02963831|520630247|FG003|Overall Study|Withdrawal by Subject|4|||
144387515|NCT02963831|520630244|FG000|Overall Study|Adverse Event|0|||
144387516|NCT02963831|520630245|FG001|Overall Study|Adverse Event|1|||
144387517|NCT02963831|520630246|FG002|Overall Study|Adverse Event|1|||
144387518|NCT02963831|520630247|FG003|Overall Study|Adverse Event|2|||
144387519|NCT02963831|520630244|FG000|Overall Study|Death|0|||
144387520|NCT02963831|520630245|FG001|Overall Study|Death|0|||
144387521|NCT02963831|520630246|FG002|Overall Study|Death|0|||
144387522|NCT02963831|520630247|FG003|Overall Study|Death|2|||
144387523|NCT01966432|520630249|FG000|Overall Study|Lost to Follow-up|3|||
144387524|NCT01966432|520630250|FG001|Overall Study|Lost to Follow-up|2|||
144387525|NCT01966432|520630251|FG002|Overall Study|Lost to Follow-up|5|||
144387526|NCT01966432|520630249|FG000|Overall Study|Withdrawal by Subject|1|||
144387527|NCT01966432|520630250|FG001|Overall Study|Withdrawal by Subject|3|||
144387528|NCT01966432|520630251|FG002|Overall Study|Withdrawal by Subject|0|||
144387529|NCT01966432|520630249|FG000|Overall Study|Subject Incarcerated|0|||
144387530|NCT01966432|520630250|FG001|Overall Study|Subject Incarcerated|0|||
144515804|NCT04424927|521088921|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
144515805|NCT04424927|521088922|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
144515806|NCT04424927|521088923|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
144515807|NCT04424927|521088919|FG000|Double-blind Period (24 Weeks)|Other|0|||
144515808|NCT04424927|521088920|FG001|Double-blind Period (24 Weeks)|Other|1|||
144515809|NCT04424927|521088921|FG002|Double-blind Period (24 Weeks)|Other|3|||
144515810|NCT04424927|521088922|FG003|Double-blind Period (24 Weeks)|Other|1|||
144387531|NCT01966432|520630251|FG002|Overall Study|Subject Incarcerated|1|||
144199326|NCT03107026|519928871|FG001|Overall Study|Lost to Follow-up|12|||
144387532|NCT01966432|520630249|FG000|Overall Study|SBIRT program ended|1|||
144387533|NCT01966432|520630250|FG001|Overall Study|SBIRT program ended|8|||
144387534|NCT01966432|520630251|FG002|Overall Study|SBIRT program ended|20|||
144387535|NCT02815280|520630256|FG000|Double-Blind Phase|Adverse Event|1|||
144387536|NCT02815280|520630257|FG001|Double-Blind Phase|Adverse Event|1|||
144515811|NCT04424927|521088923|FG004|Double-blind Period (24 Weeks)|Other|0|||
144387537|NCT02815280|520630256|FG000|Double-Blind Phase|Lost to Follow-up|10|||
144387538|NCT02815280|520630257|FG001|Double-Blind Phase|Lost to Follow-up|9|||
144387539|NCT02815280|520630256|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
144387540|NCT02815280|520630257|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
144593024|NCT03184870|521372355|FG011|Initial Treatment|Withdrawal by Subject|2|||
144593025|NCT03184870|521372356|FG012|Initial Treatment|Withdrawal by Subject|3|||
144387541|NCT02815280|520630256|FG000|Double-Blind Phase|Protocol Violation|2|||
144387542|NCT02815280|520630257|FG001|Double-Blind Phase|Protocol Violation|2|||
144387543|NCT02815280|520630256|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
144387544|NCT02815280|520630257|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
144387545|NCT02815280|520630256|FG000|Open-Label Phase|Adverse Event|2|||
144387546|NCT02815280|520630257|FG001|Open-Label Phase|Adverse Event|3|||
144387547|NCT02815280|520630256|FG000|Open-Label Phase|Lost to Follow-up|18|||
144387548|NCT02815280|520630257|FG001|Open-Label Phase|Lost to Follow-up|9|||
144387549|NCT02815280|520630256|FG000|Open-Label Phase|Withdrawal by Subject|33|||
144387550|NCT02815280|520630257|FG001|Open-Label Phase|Withdrawal by Subject|18|||
144387551|NCT02815280|520630256|FG000|Open-Label Phase|Protocol Violation|3|||
144387552|NCT02815280|520630257|FG001|Open-Label Phase|Protocol Violation|0|||
144387553|NCT02815280|520630256|FG000|Open-Label Phase|Administrative|26|||
144387554|NCT02815280|520630257|FG001|Open-Label Phase|Administrative|12|||
144387555|NCT02815280|520630256|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
144387556|NCT02815280|520630257|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
144387557|NCT02106923|520630270|FG000|Overall Study|Protocol Violation|0|||
144387558|NCT02106923|520630271|FG001|Overall Study|Protocol Violation|0|||
144387559|NCT02106923|520630272|FG002|Overall Study|Protocol Violation|0|||
144387560|NCT02106923|520630273|FG003|Overall Study|Protocol Violation|0|||
144387561|NCT02106923|520630274|FG004|Overall Study|Protocol Violation|0|||
144387562|NCT02106923|520630275|FG005|Overall Study|Protocol Violation|1|||
144387563|NCT03485495|520630276|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
144387564|NCT03485495|520630277|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
144387565|NCT03915860|520630279|FG000|Overall Study|Adverse Event|3|||
144387566|NCT03915860|520630279|FG000|Overall Study|Withdrawal by Subject|6|||
144387567|NCT03915860|520630279|FG000|Overall Study|Lost to Follow-up|2|||
144387568|NCT03915860|520630279|FG000|Overall Study|Other than specified|3|||
144387569|NCT01009281|520630280|FG000|Overall Study|Administrative problems|7|||
144387570|NCT03901456|520630281|FG000|Overall Study|Withdrawal by Subject|0|||
144387571|NCT03901456|520630282|FG001|Overall Study|Withdrawal by Subject|0|||
144387572|NCT03901456|520630283|FG002|Overall Study|Withdrawal by Subject|1|||
144387573|NCT03901456|520630281|FG000|Overall Study|Lost to Follow-up|0|||
144387574|NCT03901456|520630282|FG001|Overall Study|Lost to Follow-up|1|||
144387575|NCT03901456|520630283|FG002|Overall Study|Lost to Follow-up|0|||
144387576|NCT03836001|520630286|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
144387577|NCT03836001|520630287|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
144387578|NCT03836001|520630288|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
144387579|NCT03836001|520630286|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
144387580|NCT03836001|520630287|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
144387581|NCT03836001|520630288|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
144387582|NCT03836001|520630286|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
144387583|NCT03836001|520630287|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
144387584|NCT03836001|520630288|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
144387585|NCT03836001|520630286|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
144387586|NCT03836001|520630287|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
144387587|NCT03836001|520630288|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
144387588|NCT01642732|520630289|FG000|Overall Study|Withdrawal by Subject|1|||
144387589|NCT03562767|520630292|FG000|Overall Study|Physician Decision|2|||
144387590|NCT03562767|520630293|FG001|Overall Study|Physician Decision|0|||
144387591|NCT03562767|520630294|FG002|Overall Study|Physician Decision|0|||
144387592|NCT03562767|520630292|FG000|Overall Study|Logistic Reason|1|||
144387593|NCT03562767|520630293|FG001|Overall Study|Logistic Reason|3|||
144387594|NCT03562767|520630294|FG002|Overall Study|Logistic Reason|0|||
144387595|NCT00402233|520630297|FG000|Overall Study|Adverse Event|1|||
144387596|NCT00402233|520630298|FG001|Overall Study|Adverse Event|7|||
144387597|NCT00402233|520630299|FG002|Overall Study|Adverse Event|9|||
144387598|NCT00402233|520630300|FG003|Overall Study|Adverse Event|9|||
144387599|NCT00402233|520630297|FG000|Overall Study|Protocol Violation|0|||
144387600|NCT00402233|520630298|FG001|Overall Study|Protocol Violation|1|||
144387601|NCT00402233|520630299|FG002|Overall Study|Protocol Violation|0|||
144387602|NCT00402233|520630300|FG003|Overall Study|Protocol Violation|0|||
144387603|NCT00402233|520630297|FG000|Overall Study|Withdrawal by Subject|2|||
144387604|NCT00402233|520630298|FG001|Overall Study|Withdrawal by Subject|1|||
144387605|NCT00402233|520630299|FG002|Overall Study|Withdrawal by Subject|2|||
144387606|NCT00402233|520630300|FG003|Overall Study|Withdrawal by Subject|2|||
144387607|NCT00402233|520630297|FG000|Overall Study|Worsening of disease under study|2|||
144387608|NCT00402233|520630298|FG001|Overall Study|Worsening of disease under study|0|||
144387609|NCT00402233|520630299|FG002|Overall Study|Worsening of disease under study|0|||
144387610|NCT00402233|520630300|FG003|Overall Study|Worsening of disease under study|0|||
144387611|NCT00402233|520630297|FG000|Overall Study|Worsening of other pre-existing disease|0|||
144387612|NCT00402233|520630298|FG001|Overall Study|Worsening of other pre-existing disease|1|||
144387613|NCT00402233|520630299|FG002|Overall Study|Worsening of other pre-existing disease|0|||
144387614|NCT00402233|520630300|FG003|Overall Study|Worsening of other pre-existing disease|0|||
144387615|NCT00938886|520630301|FG000|Overall Study|Death|0|||
144387616|NCT00938886|520630302|FG001|Overall Study|Death|1|||
144387617|NCT00938886|520630301|FG000|Overall Study|Withdrawal by Subject|4|||
144387618|NCT00938886|520630302|FG001|Overall Study|Withdrawal by Subject|7|||
144387619|NCT00938886|520630301|FG000|Overall Study|Lost to Follow-up|3|||
144387620|NCT00938886|520630302|FG001|Overall Study|Lost to Follow-up|2|||
144387621|NCT03579602|520630303|FG000|Overall Study|Subject unable to receive study drug|0|||
144387622|NCT03579602|520630304|FG001|Overall Study|Subject unable to receive study drug|2|||
144387623|NCT03579602|520630303|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
144387624|NCT03579602|520630304|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
144387625|NCT01120067|520630308|FG000|Overall Study|Lost to Follow-up|3|||
144387626|NCT01120067|520630309|FG001|Overall Study|Lost to Follow-up|1|||
144387627|NCT01120067|520630308|FG000|Overall Study|fail to engage >3 sessions|2|||
144387628|NCT01120067|520630309|FG001|Overall Study|fail to engage >3 sessions|0|||
144387629|NCT03021564|520630315|FG000|Overall Study|Death|84|||
144387630|NCT03021564|520630316|FG001|Overall Study|Death|466|||
144387631|NCT03021564|520630315|FG000|Overall Study|Lost to Follow-up|0|||
144387632|NCT03021564|520630316|FG001|Overall Study|Lost to Follow-up|2|||
144387633|NCT02889562|520630317|FG000|Overall Study|Physician Decision|0|||
144387634|NCT02889562|520630318|FG001|Overall Study|Physician Decision|1|||
144387635|NCT02889562|520630317|FG000|Overall Study|Withdrawal by Subject|0|||
144387636|NCT02889562|520630318|FG001|Overall Study|Withdrawal by Subject|1|||
144387637|NCT01470989|520630321|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
144387638|NCT01470989|520630322|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
144387639|NCT01470989|520630321|FG000|Overall Study|Adverse Event|2|||
144387640|NCT01470989|520630322|FG001|Overall Study|Adverse Event|5|||
144387641|NCT01470989|520630321|FG000|Overall Study|Abnormal laboratory value|1|||
144387642|NCT01470989|520630322|FG001|Overall Study|Abnormal laboratory value|1|||
144515812|NCT02724956|521088927|FG000|Overall Study|Physician Decision|1|||
144515813|NCT02724956|521088928|FG001|Overall Study|Physician Decision|0|||
144515814|NCT02724956|521088927|FG000|Overall Study|Lack of Efficacy|0|||
144515815|NCT02724956|521088928|FG001|Overall Study|Lack of Efficacy|1|||
144515816|NCT02724956|521088927|FG000|Overall Study|Withdrawal by Subject|0|||
144515817|NCT02724956|521088928|FG001|Overall Study|Withdrawal by Subject|1|||
144515818|NCT01532388|521088929|FG000|3-month Follow-up|Lost to Follow-up|68|||
144593026|NCT03184870|521372357|FG013|Initial Treatment|Withdrawal by Subject|0|||
144593027|NCT03184870|521372358|FG014|Initial Treatment|Withdrawal by Subject|1|||
144593028|NCT03184870|521372359|FG015|Initial Treatment|Withdrawal by Subject|5|||
144593029|NCT03184870|521372360|FG016|Initial Treatment|Withdrawal by Subject|2|||
144593030|NCT03184870|521372361|FG017|Initial Treatment|Withdrawal by Subject|2|||
144387643|NCT01470989|520630321|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144387644|NCT01470989|520630322|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
144387645|NCT01470989|520630321|FG000|Overall Study|Withdrawal by Subject|19|||
144387646|NCT01470989|520630322|FG001|Overall Study|Withdrawal by Subject|17|||
144387647|NCT01470989|520630321|FG000|Overall Study|Lost to Follow-up|18|||
144387648|NCT01470989|520630322|FG001|Overall Study|Lost to Follow-up|13|||
144387649|NCT01470989|520630321|FG000|Overall Study|Administrative problems|2|||
144387650|NCT01470989|520630322|FG001|Overall Study|Administrative problems|4|||
144387651|NCT01470989|520630321|FG000|Overall Study|Death|2|||
144515819|NCT01532388|521088930|FG001|3-month Follow-up|Lost to Follow-up|68|||
144515820|NCT01532388|521088929|FG000|6-month Follow-up|Lost to Follow-up|74|||
144515821|NCT01532388|521088930|FG001|6-month Follow-up|Lost to Follow-up|66|||
144387652|NCT01470989|520630322|FG001|Overall Study|Death|2|||
144387653|NCT01470989|520630321|FG000|Overall Study|Protocol deviation|1|||
144387654|NCT01470989|520630322|FG001|Overall Study|Protocol deviation|2|||
144387655|NCT00969280|520630323|FG000|Overall Study|Protocol Violation|2|||
144387656|NCT00969280|520630324|FG001|Overall Study|Protocol Violation|1|||
144387657|NCT00969280|520630323|FG000|Overall Study|Withdrawal by Subject|0|||
144387658|NCT00969280|520630324|FG001|Overall Study|Withdrawal by Subject|1|||
144387659|NCT00969280|520630323|FG000|Overall Study|infection of influenza A(H1N1)|0|||
144387660|NCT00969280|520630324|FG001|Overall Study|infection of influenza A(H1N1)|1|||
144387661|NCT00821327|520630325|FG000|Overall Study|Adverse Event|13|||
144387662|NCT00821327|520630325|FG000|Overall Study|Patient Request|1|||
144387663|NCT00821327|520630325|FG000|Overall Study|Investigator Request|2|||
144387664|NCT00821327|520630325|FG000|Overall Study|Sponsor Request|1|||
144387665|NCT00821327|520630325|FG000|Overall Study|Disease Progression|13|||
144387666|NCT00821327|520630325|FG000|Overall Study|Other/Unknown|5|||
144387667|NCT02119676|520630326|FG000|Overall Study|Adverse Event|9|||
144387668|NCT02119676|520630327|FG001|Overall Study|Adverse Event|17|||
144387669|NCT02119676|520630328|FG002|Overall Study|Adverse Event|10|||
144387670|NCT02119676|520630329|FG003|Overall Study|Adverse Event|10|||
144387671|NCT02119676|520630326|FG000|Overall Study|Disease progression|53|||
144387672|NCT02119676|520630327|FG001|Overall Study|Disease progression|55|||
144387673|NCT02119676|520630328|FG002|Overall Study|Disease progression|68|||
144387674|NCT02119676|520630329|FG003|Overall Study|Disease progression|73|||
144387675|NCT02119676|520630326|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
144387676|NCT02119676|520630327|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
144387677|NCT02119676|520630328|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
144387678|NCT02119676|520630329|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
144387679|NCT02119676|520630326|FG000|Overall Study|Physician Decision|4|||
144387680|NCT02119676|520630327|FG001|Overall Study|Physician Decision|2|||
144387681|NCT02119676|520630328|FG002|Overall Study|Physician Decision|3|||
144387682|NCT02119676|520630329|FG003|Overall Study|Physician Decision|2|||
144387683|NCT02119676|520630326|FG000|Overall Study|Death|9|||
144515822|NCT01532388|521088929|FG000|12-month Follow-up|Lost to Follow-up|69|||
144515823|NCT01532388|521088930|FG001|12-month Follow-up|Lost to Follow-up|67|||
144515824|NCT02058108|521088931|FG000|Overall Study|Abnormal Laboratory Values|0|||
144515825|NCT02058108|521088932|FG001|Overall Study|Abnormal Laboratory Values|1|||
144515826|NCT02058108|521088931|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
144515827|NCT02058108|521088932|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
144515828|NCT02058108|521088931|FG000|Overall Study|No longer requires study drug|0|||
144515829|NCT02058108|521088932|FG001|Overall Study|No longer requires study drug|1|||
144515830|NCT02058108|521088931|FG000|Overall Study|Withdrawal by Subject|1|||
144515831|NCT02058108|521088932|FG001|Overall Study|Withdrawal by Subject|0|||
144515832|NCT02058108|521088931|FG000|Overall Study|Administrative problems|3|||
144515833|NCT02058108|521088932|FG001|Overall Study|Administrative problems|3|||
144515834|NCT02058108|521088931|FG000|Overall Study|Protocol Violation|0|||
144515835|NCT02058108|521088932|FG001|Overall Study|Protocol Violation|1|||
144515836|NCT01376700|521088936|FG000|Overall Study|Sponsor terminated study early|8|||
144515837|NCT01376700|521088936|FG000|Overall Study|Low or high titer inhibitor|8|||
144515838|NCT00727909|521088937|FG000|Overall Study|Withdrawal by Subject|5|||
144515839|NCT00727909|521088938|FG001|Overall Study|Withdrawal by Subject|11|||
144515840|NCT00727909|521088939|FG002|Overall Study|Withdrawal by Subject|8|||
144515841|NCT00727909|521088940|FG003|Overall Study|Withdrawal by Subject|5|||
144515842|NCT00727909|521088937|FG000|Overall Study|Death|0|||
144515843|NCT00727909|521088938|FG001|Overall Study|Death|0|||
144515844|NCT00727909|521088939|FG002|Overall Study|Death|1|||
144515845|NCT00727909|521088940|FG003|Overall Study|Death|0|||
144515846|NCT01696773|521088941|FG000|Days 15-27, Washout|Adverse Event|1|||
144515847|NCT01696773|521088942|FG001|Days 15-27, Washout|Adverse Event|0|||
144515848|NCT05623345|521088951|FG000|Overall Study|Withdrawal by Subject|14|||
144515849|NCT05623345|521088952|FG001|Overall Study|Withdrawal by Subject|0|||
144515850|NCT05623345|521088953|FG002|Overall Study|Withdrawal by Subject|9|||
144515851|NCT05623345|521088954|FG003|Overall Study|Withdrawal by Subject|20|||
144515852|NCT05623345|521088951|FG000|Overall Study|Lost to Follow-up|3|||
144515853|NCT05623345|521088952|FG001|Overall Study|Lost to Follow-up|0|||
144515854|NCT05623345|521088953|FG002|Overall Study|Lost to Follow-up|7|||
144515855|NCT05623345|521088954|FG003|Overall Study|Lost to Follow-up|2|||
144515856|NCT05623345|521088951|FG000|Overall Study|Termination of Study By Sponsor|37|||
144515857|NCT05623345|521088952|FG001|Overall Study|Termination of Study By Sponsor|4|||
144515858|NCT05623345|521088953|FG002|Overall Study|Termination of Study By Sponsor|40|||
144387684|NCT02119676|520630327|FG001|Overall Study|Death|3|||
144387685|NCT02119676|520630328|FG002|Overall Study|Death|2|||
144387686|NCT02119676|520630329|FG003|Overall Study|Death|1|||
144387687|NCT02119676|520630326|FG000|Overall Study|Noncompliance|0|||
144387688|NCT02119676|520630327|FG001|Overall Study|Noncompliance|1|||
144387689|NCT02119676|520630328|FG002|Overall Study|Noncompliance|0|||
144387690|NCT02119676|520630329|FG003|Overall Study|Noncompliance|0|||
144387691|NCT02119676|520630326|FG000|Overall Study|Lost to Follow-up|0|||
144387692|NCT02119676|520630327|FG001|Overall Study|Lost to Follow-up|0|||
144387693|NCT02119676|520630328|FG002|Overall Study|Lost to Follow-up|1|||
144387694|NCT02119676|520630329|FG003|Overall Study|Lost to Follow-up|0|||
144387695|NCT02119676|520630326|FG000|Overall Study|Protocol deviation|0|||
144387696|NCT02119676|520630327|FG001|Overall Study|Protocol deviation|0|||
144387697|NCT02119676|520630328|FG002|Overall Study|Protocol deviation|1|||
144387698|NCT02119676|520630329|FG003|Overall Study|Protocol deviation|0|||
144387699|NCT02119676|520630326|FG000|Overall Study|Other, unspecified|2|||
144387700|NCT02119676|520630327|FG001|Overall Study|Other, unspecified|1|||
144387701|NCT02119676|520630328|FG002|Overall Study|Other, unspecified|3|||
144387702|NCT02119676|520630329|FG003|Overall Study|Other, unspecified|4|||
144387703|NCT02119676|520630326|FG000|Overall Study|Did not receive study med|2|||
144387704|NCT02119676|520630327|FG001|Overall Study|Did not receive study med|2|||
144387705|NCT02119676|520630328|FG002|Overall Study|Did not receive study med|4|||
144387706|NCT02119676|520630329|FG003|Overall Study|Did not receive study med|5|||
144387707|NCT00217464|520630330|FG000|Overall Study|Progression|15|||
144387708|NCT00217464|520630330|FG000|Overall Study|Other|2|||
144387709|NCT01089361|520630331|FG000|Overall Study|Death|1|||
144387710|NCT01089361|520630332|FG001|Overall Study|Death|0|||
144387711|NCT00278915|520630335|FG000|Overall Study|Disease progression|1|||
144387712|NCT01007253|520630336|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
144387713|NCT01007253|520630337|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
144387714|NCT01007253|520630338|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
144387715|NCT01007253|520630339|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
144387716|NCT00814801|520630340|FG000|Overall Study|Adverse Event|15|||
144387717|NCT00814801|520630341|FG001|Overall Study|Adverse Event|16|||
144387718|NCT00814801|520630342|FG002|Overall Study|Adverse Event|19|||
144387719|NCT00814801|520630340|FG000|Overall Study|Withdrawal by Subject|9|||
144387720|NCT00814801|520630341|FG001|Overall Study|Withdrawal by Subject|11|||
144387721|NCT00814801|520630342|FG002|Overall Study|Withdrawal by Subject|14|||
144387722|NCT00814801|520630340|FG000|Overall Study|Inappropriate as a subject|1|||
144387723|NCT00814801|520630341|FG001|Overall Study|Inappropriate as a subject|1|||
144387724|NCT00814801|520630342|FG002|Overall Study|Inappropriate as a subject|1|||
144387725|NCT00814801|520630340|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
144387726|NCT00814801|520630341|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
144387727|NCT00814801|520630342|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
144387728|NCT00814801|520630340|FG000|Overall Study|Missing or change of caregiver|6|||
144387729|NCT00814801|520630341|FG001|Overall Study|Missing or change of caregiver|2|||
144387730|NCT00814801|520630342|FG002|Overall Study|Missing or change of caregiver|4|||
144387731|NCT00814801|520630340|FG000|Overall Study|Non-compliance|0|||
144387732|NCT00814801|520630341|FG001|Overall Study|Non-compliance|1|||
144387733|NCT00814801|520630342|FG002|Overall Study|Non-compliance|1|||
144387734|NCT00814801|520630340|FG000|Overall Study|Other|2|||
144387735|NCT00814801|520630341|FG001|Overall Study|Other|6|||
144387736|NCT00814801|520630342|FG002|Overall Study|Other|4|||
144387737|NCT02486718|520630343|FG000|Enrollment Phase|Death|19|||
144387738|NCT02486718|520630344|FG001|Enrollment Phase|Death|0|||
144387739|NCT02486718|520630345|FG002|Enrollment Phase|Death|0|||
144387740|NCT02486718|520630343|FG000|Enrollment Phase|Symptomatic deterioration|1|||
144387741|NCT02486718|520630344|FG001|Enrollment Phase|Symptomatic deterioration|0|||
144387742|NCT02486718|520630345|FG002|Enrollment Phase|Symptomatic deterioration|0|||
144515859|NCT05623345|521088954|FG003|Overall Study|Termination of Study By Sponsor|38|||
144515860|NCT05384730|521088955|FG000|Overall Study|Adverse Event|1|||
144515861|NCT05384730|521088956|FG001|Overall Study|Adverse Event|0|||
144515862|NCT05384730|521088955|FG000|Overall Study|Lack of social support|2|||
144515863|NCT05384730|521088956|FG001|Overall Study|Lack of social support|0|||
144515864|NCT05384730|521088955|FG000|Overall Study|Hospital readmission|2|||
144515865|NCT05384730|521088956|FG001|Overall Study|Hospital readmission|0|||
144515866|NCT05384730|521088955|FG000|Overall Study|Disease progression|5|||
144515867|NCT05384730|521088956|FG001|Overall Study|Disease progression|0|||
144722109|NCT03271528|521836974|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
144387743|NCT02486718|520630343|FG000|Enrollment Phase|Withdrawal by Subject|86|||
144387744|NCT02486718|520630344|FG001|Enrollment Phase|Withdrawal by Subject|0|||
144387745|NCT02486718|520630345|FG002|Enrollment Phase|Withdrawal by Subject|0|||
144387746|NCT02486718|520630343|FG000|Enrollment Phase|Protocol Violation|18|||
144387747|NCT02486718|520630344|FG001|Enrollment Phase|Protocol Violation|0|||
144387748|NCT02486718|520630345|FG002|Enrollment Phase|Protocol Violation|0|||
144387749|NCT02486718|520630343|FG000|Enrollment Phase|Physician Decision|18|||
144387750|NCT02486718|520630344|FG001|Enrollment Phase|Physician Decision|0|||
144387751|NCT02486718|520630345|FG002|Enrollment Phase|Physician Decision|0|||
144387752|NCT02486718|520630343|FG000|Enrollment Phase|Reason not provided|41|||
144387753|NCT02486718|520630344|FG001|Enrollment Phase|Reason not provided|0|||
144387754|NCT02486718|520630345|FG002|Enrollment Phase|Reason not provided|0|||
144387755|NCT02486718|520630343|FG000|Enrollment Phase|Disease relapse|54|||
144387756|NCT02486718|520630344|FG001|Enrollment Phase|Disease relapse|0|||
144387757|NCT02486718|520630345|FG002|Enrollment Phase|Disease relapse|0|||
144387758|NCT02486718|520630343|FG000|Enrollment Phase|Lost to Follow-up|4|||
144387759|NCT02486718|520630344|FG001|Enrollment Phase|Lost to Follow-up|0|||
144387760|NCT02486718|520630345|FG002|Enrollment Phase|Lost to Follow-up|0|||
144387761|NCT02486718|520630343|FG000|Enrollment Phase|Adverse Event|34|||
144387762|NCT02486718|520630344|FG001|Enrollment Phase|Adverse Event|0|||
144387763|NCT02486718|520630345|FG002|Enrollment Phase|Adverse Event|0|||
144387764|NCT02486718|520630343|FG000|Randomized Phase|Withdrawal by Subject|0|||
144387765|NCT02486718|520630344|FG001|Randomized Phase|Withdrawal by Subject|44|||
144387766|NCT02486718|520630345|FG002|Randomized Phase|Withdrawal by Subject|47|||
144387767|NCT02486718|520630343|FG000|Randomized Phase|Protocol Violation|0|||
144387768|NCT02486718|520630344|FG001|Randomized Phase|Protocol Violation|2|||
144387769|NCT02486718|520630345|FG002|Randomized Phase|Protocol Violation|0|||
144387770|NCT02486718|520630343|FG000|Randomized Phase|Physician Decision|0|||
144387771|NCT02486718|520630344|FG001|Randomized Phase|Physician Decision|0|||
144387772|NCT02486718|520630345|FG002|Randomized Phase|Physician Decision|3|||
144387773|NCT02486718|520630343|FG000|Randomized Phase|Lost to Follow-up|0|||
144387774|NCT02486718|520630344|FG001|Randomized Phase|Lost to Follow-up|5|||
144387775|NCT02486718|520630345|FG002|Randomized Phase|Lost to Follow-up|11|||
144387776|NCT02486718|520630343|FG000|Randomized Phase|Disease Relapse|0|||
144387777|NCT02486718|520630344|FG001|Randomized Phase|Disease Relapse|1|||
144387778|NCT02486718|520630345|FG002|Randomized Phase|Disease Relapse|0|||
144387779|NCT02486718|520630343|FG000|Randomized Phase|Death|0|||
144387780|NCT02486718|520630344|FG001|Randomized Phase|Death|154|||
144387781|NCT02486718|520630345|FG002|Randomized Phase|Death|155|||
144387782|NCT02486718|520630343|FG000|Randomized Phase|Ongoing|0|||
144387783|NCT02486718|520630344|FG001|Randomized Phase|Ongoing|301|||
144387784|NCT02486718|520630345|FG002|Randomized Phase|Ongoing|282|||
144387785|NCT02520089|520630346|FG000|Overall Study|Lost to Follow-up|3|||
144387786|NCT02520089|520630347|FG001|Overall Study|Lost to Follow-up|4|||
144387787|NCT02216812|520630350|FG000|Overall Study|Lost to Follow-up|10|||
144387788|NCT02216812|520630351|FG001|Overall Study|Lost to Follow-up|5|||
144387789|NCT00527488|520630356|FG000|Overall Study|Withdrawn prior to dosing|0|||
144387790|NCT00527488|520630357|FG001|Overall Study|Withdrawn prior to dosing|1|||
144387791|NCT00527488|520630358|FG002|Overall Study|Withdrawn prior to dosing|1|||
144387792|NCT00527488|520630359|FG003|Overall Study|Withdrawn prior to dosing|0|||
144387793|NCT02545543|520630360|FG000|Overall Study|Lost to Follow-up|67|||
144387794|NCT02545543|520630361|FG001|Overall Study|Lost to Follow-up|25|||
144387795|NCT02545543|520630360|FG000|Overall Study|Physician Decision|3|||
144387796|NCT02545543|520630361|FG001|Overall Study|Physician Decision|0|||
144387797|NCT02545543|520630360|FG000|Overall Study|Withdrawal by Subject|9|||
144387798|NCT02545543|520630361|FG001|Overall Study|Withdrawal by Subject|8|||
144387799|NCT02545543|520630360|FG000|Overall Study|Noncomplaince|1|||
144387800|NCT02545543|520630361|FG001|Overall Study|Noncomplaince|0|||
144387801|NCT02545543|520630360|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
144387802|NCT02545543|520630361|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
144387803|NCT02829944|520630365|FG000|Overall Study|Physician Decision|0|||
144387804|NCT02829944|520630366|FG001|Overall Study|Physician Decision|1|||
144387805|NCT02829944|520630365|FG000|Overall Study|Screen Failure|2|||
144387806|NCT02829944|520630366|FG001|Overall Study|Screen Failure|2|||
144387807|NCT02829944|520630365|FG000|Overall Study|Inadequate Neuraxial Block|1|||
144387808|NCT02829944|520630366|FG001|Overall Study|Inadequate Neuraxial Block|1|||
144387809|NCT02829944|520630365|FG000|Overall Study|Withdrawal by Subject|2|||
144387810|NCT02829944|520630366|FG001|Overall Study|Withdrawal by Subject|1|||
144722110|NCT03271528|521836975|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
144387811|NCT02829944|520630365|FG000|Overall Study|Catheter Displacement|1|||
144387812|NCT02829944|520630366|FG001|Overall Study|Catheter Displacement|0|||
144387813|NCT02829944|520630365|FG000|Overall Study|Catheter broke|0|||
144387814|NCT02829944|520630366|FG001|Overall Study|Catheter broke|1|||
144387815|NCT02829944|520630365|FG000|Overall Study|Staff unavailable|0|||
144387816|NCT02829944|520630366|FG001|Overall Study|Staff unavailable|1|||
144387817|NCT04675151|520630367|FG000|Overall Study|Protocol Violation|1|||
144387818|NCT04675151|520630368|FG001|Overall Study|Protocol Violation|0|||
144387819|NCT04675151|520630369|FG002|Overall Study|Protocol Violation|0|||
144387820|NCT04675151|520630370|FG003|Overall Study|Protocol Violation|1|||
144387821|NCT04035486|520630371|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
144387822|NCT04035486|520630372|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
144387823|NCT04035486|520630373|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
144387824|NCT04035486|520630374|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
144387825|NCT04035486|520630371|FG000|Overall Study|Death|6|||
144387826|NCT04035486|520630372|FG001|Overall Study|Death|3|||
144387827|NCT04035486|520630373|FG002|Overall Study|Death|70|||
144387828|NCT04035486|520630374|FG003|Overall Study|Death|77|||
144387829|NCT04035486|520630371|FG000|Overall Study|Screen Failure|0|||
144387830|NCT04035486|520630372|FG001|Overall Study|Screen Failure|0|||
144387831|NCT04035486|520630373|FG002|Overall Study|Screen Failure|1|||
144387832|NCT04035486|520630374|FG003|Overall Study|Screen Failure|1|||
144387833|NCT04035486|520630371|FG000|Overall Study|Withdrawal by Subject|1|||
144387834|NCT04035486|520630372|FG001|Overall Study|Withdrawal by Subject|1|||
144387835|NCT04035486|520630373|FG002|Overall Study|Withdrawal by Subject|11|||
144515868|NCT05384730|521088955|FG000|Overall Study|Overwhelmed with College commitments|0|||
144515869|NCT05384730|521088956|FG001|Overall Study|Overwhelmed with College commitments|2|||
144387836|NCT04035486|520630374|FG003|Overall Study|Withdrawal by Subject|9|||
144387837|NCT01730937|520630375|FG000|Overall Study|Protocol Violation|5|||
144387838|NCT01730937|520630376|FG001|Overall Study|Protocol Violation|11|||
144387839|NCT03947684|520630377|FG000|Overall Study|Lost to Follow-up|13|||
144387840|NCT03947684|520630378|FG001|Overall Study|Lost to Follow-up|5|||
144387841|NCT03947684|520630379|FG002|Overall Study|Lost to Follow-up|1|||
144387842|NCT03947684|520630377|FG000|Overall Study|Withdrawal by Subject|11|||
144387843|NCT03947684|520630378|FG001|Overall Study|Withdrawal by Subject|4|||
144387844|NCT03947684|520630379|FG002|Overall Study|Withdrawal by Subject|0|||
144387845|NCT03947684|520630377|FG000|Overall Study|Physician Decision|1|||
144387846|NCT03947684|520630378|FG001|Overall Study|Physician Decision|0|||
144387847|NCT03947684|520630379|FG002|Overall Study|Physician Decision|0|||
144387848|NCT03947684|520630377|FG000|Overall Study|Lack of adherence to study protocol|2|||
144387849|NCT03947684|520630378|FG001|Overall Study|Lack of adherence to study protocol|0|||
144387850|NCT03947684|520630379|FG002|Overall Study|Lack of adherence to study protocol|0|||
144387851|NCT03875235|520630380|FG000|Overall Study|Ongoing study treatment|63|||
144387852|NCT03875235|520630381|FG001|Overall Study|Ongoing study treatment|20|||
144387853|NCT03875235|520630380|FG000|Overall Study|Off treatment|77|||
144387854|NCT03875235|520630381|FG001|Overall Study|Off treatment|91|||
144387855|NCT03875235|520630380|FG000|Overall Study|Withdrawal by Subject|3|||
144387856|NCT03875235|520630381|FG001|Overall Study|Withdrawal by Subject|10|||
144387857|NCT03875235|520630380|FG000|Overall Study|Death|198|||
144387858|NCT03875235|520630381|FG001|Overall Study|Death|223|||
144387859|NCT04268823|520630382|FG000|Overall Study|Adverse Event|1|||
144387860|NCT04268823|520630383|FG001|Overall Study|Adverse Event|0|||
144387861|NCT04268823|520630382|FG000|Overall Study|Participant Decision|1|||
144387862|NCT04268823|520630383|FG001|Overall Study|Participant Decision|0|||
144387863|NCT00622739|520631939|FG000|Overall Study|Physician Decision|1|||
144387864|NCT00622739|520631940|FG001|Overall Study|Physician Decision|0|||
144387865|NCT00622739|520631939|FG000|Overall Study|Adverse Event|1|||
144387866|NCT00622739|520631940|FG001|Overall Study|Adverse Event|2|||
144387867|NCT00622739|520631939|FG000|Overall Study|Lack of Efficacy|0|||
144387868|NCT00622739|520631940|FG001|Overall Study|Lack of Efficacy|2|||
144387869|NCT00622739|520631939|FG000|Overall Study|Withdrawal by Subject|0|||
144387870|NCT00622739|520631940|FG001|Overall Study|Withdrawal by Subject|1|||
144387871|NCT00622739|520631939|FG000|Overall Study|Lost to Follow-up|0|||
144387872|NCT00622739|520631940|FG001|Overall Study|Lost to Follow-up|1|||
144387873|NCT03123185|520631948|FG000|Overall Study|Withdrawal by Subject|0|||
144387874|NCT03123185|520631949|FG001|Overall Study|Withdrawal by Subject|0|||
144387875|NCT03123185|520631950|FG002|Overall Study|Withdrawal by Subject|0|||
144387876|NCT03123185|520631951|FG003|Overall Study|Withdrawal by Subject|0|||
144387877|NCT03123185|520631952|FG004|Overall Study|Withdrawal by Subject|0|||
144387878|NCT03123185|520631953|FG005|Overall Study|Withdrawal by Subject|0|||
144387879|NCT03123185|520631954|FG006|Overall Study|Withdrawal by Subject|0|||
144387880|NCT03123185|520631955|FG007|Overall Study|Withdrawal by Subject|0|||
144387881|NCT03123185|520631956|FG008|Overall Study|Withdrawal by Subject|0|||
144387882|NCT03123185|520631957|FG009|Overall Study|Withdrawal by Subject|0|||
144387883|NCT03123185|520631958|FG010|Overall Study|Withdrawal by Subject|0|||
144387884|NCT03123185|520631959|FG011|Overall Study|Withdrawal by Subject|0|||
144387885|NCT03123185|520631960|FG012|Overall Study|Withdrawal by Subject|1|||
144387886|NCT03123185|520631961|FG013|Overall Study|Withdrawal by Subject|0|||
144387887|NCT00718081|520631962|FG000|Overall Study|Adverse Event|0|||
144387888|NCT00718081|520631963|FG001|Overall Study|Adverse Event|1|||
144387889|NCT00718081|520631964|FG002|Overall Study|Adverse Event|0|||
144387890|NCT00718081|520631962|FG000|Overall Study|Lack of Efficacy|7|||
144387891|NCT00718081|520631963|FG001|Overall Study|Lack of Efficacy|3|||
144387892|NCT00718081|520631964|FG002|Overall Study|Lack of Efficacy|21|||
144387893|NCT00815516|520631965|FG000|Overall Study|Death|3|||
144387894|NCT00815516|520631966|FG001|Overall Study|Death|1|||
144387895|NCT00815516|520631965|FG000|Overall Study|Physician Decision|1|||
144387896|NCT00815516|520631966|FG001|Overall Study|Physician Decision|0|||
144387897|NCT03468543|520631980|FG000|Overall Study|Protocol stopping rules met|3|||
144387898|NCT00470158|520631981|FG000|Overall Study|Death|0|||
144387899|NCT00470158|520631982|FG001|Overall Study|Death|0|||
144387900|NCT00470158|520631983|FG002|Overall Study|Death|0|||
144387901|NCT00470158|520631984|FG003|Overall Study|Death|0|||
144387902|NCT00470158|520631985|FG004|Overall Study|Death|2|||
144387903|NCT00470158|520631981|FG000|Overall Study|Lost to Follow-up|7|||
144387904|NCT00470158|520631982|FG001|Overall Study|Lost to Follow-up|8|||
144387905|NCT00470158|520631983|FG002|Overall Study|Lost to Follow-up|8|||
144387906|NCT00470158|520631984|FG003|Overall Study|Lost to Follow-up|5|||
144387907|NCT00470158|520631985|FG004|Overall Study|Lost to Follow-up|4|||
144387908|NCT00470158|520631981|FG000|Overall Study|Protocol Violation|1|||
144387909|NCT00470158|520631982|FG001|Overall Study|Protocol Violation|0|||
144387910|NCT00470158|520631983|FG002|Overall Study|Protocol Violation|0|||
144387911|NCT00470158|520631984|FG003|Overall Study|Protocol Violation|0|||
144387912|NCT00470158|520631985|FG004|Overall Study|Protocol Violation|0|||
144387913|NCT00880685|520631986|FG000|Memantine 10mg|Lost to Follow-up|2|||
144387914|NCT00880685|520631986|FG000|Memantine 20mg|Withdrawal by Subject|1|||
144387915|NCT01249118|520631987|FG000|First Washout Period|Physician Decision|0|||
144387916|NCT01249118|520631988|FG001|First Washout Period|Physician Decision|1|||
144387917|NCT01249118|520631989|FG002|First Washout Period|Physician Decision|0|||
144387918|NCT04179890|520631990|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
144387919|NCT04179890|520631991|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
144387920|NCT04179890|520631990|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
144387921|NCT04179890|520631991|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
144387922|NCT04179890|520631990|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
144387923|NCT04179890|520631991|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
144387924|NCT04179890|520631990|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
144387925|NCT04179890|520631991|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
144387926|NCT04179890|520631990|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
144387927|NCT04179890|520631991|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
144387928|NCT04179890|520631990|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
144387929|NCT04179890|520631991|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
144387930|NCT04179890|520631990|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
144387931|NCT04179890|520631991|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
144387932|NCT04179890|520631990|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
144387933|NCT04179890|520631991|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
144387934|NCT04179890|520631990|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
144387935|NCT04179890|520631991|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
144387936|NCT00978432|520631993|FG000|Overall Study|Withdrawal by Subject|0|||
144387937|NCT00978432|520631994|FG001|Overall Study|Withdrawal by Subject|0|||
144387938|NCT00978432|520631995|FG002|Overall Study|Withdrawal by Subject|1|||
144387939|NCT00978432|520631993|FG000|Overall Study|Lack of Efficacy|1|||
144387940|NCT00978432|520631994|FG001|Overall Study|Lack of Efficacy|1|||
144387941|NCT00978432|520631995|FG002|Overall Study|Lack of Efficacy|3|||
144387942|NCT00978432|520631993|FG000|Overall Study|Adverse Event|2|||
144387943|NCT00978432|520631994|FG001|Overall Study|Adverse Event|0|||
144387944|NCT00978432|520631995|FG002|Overall Study|Adverse Event|1|||
144387945|NCT02579928|520631996|FG000|Overall Study|Withdrawal by Subject|1|||
144387946|NCT02579928|520631997|FG001|Overall Study|Withdrawal by Subject|0|||
144387947|NCT02311582|520632002|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
144387948|NCT02311582|520632003|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
144387949|NCT02311582|520632004|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
144387950|NCT02311582|520632005|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
144387951|NCT02311582|520632006|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
144387952|NCT03404960|520632008|FG000|Overall Study|Adverse Event|0|||
144387953|NCT03404960|520632009|FG001|Overall Study|Adverse Event|2|||
144387954|NCT03404960|520632008|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
144387955|NCT03404960|520632009|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
144387956|NCT03404960|520632008|FG000|Overall Study|Bowel obstruction|0|||
144387957|NCT03404960|520632009|FG001|Overall Study|Bowel obstruction|1|||
144387958|NCT03404960|520632008|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
144387959|NCT03404960|520632009|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
144387960|NCT04972630|520632010|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
144387961|NCT04972630|520632011|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
144387962|NCT04972630|520632012|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
144387963|NCT00246571|520632015|FG000|Overall Study|Adverse Event|7|||
144387964|NCT00246571|520632016|FG001|Overall Study|Adverse Event|0|||
144387965|NCT00246571|520632015|FG000|Overall Study|Protocol Violation|0|||
144387966|NCT00246571|520632016|FG001|Overall Study|Protocol Violation|1|||
144387967|NCT00246571|520632015|FG000|Overall Study|Withdrawal by Subject|2|||
144387968|NCT00246571|520632016|FG001|Overall Study|Withdrawal by Subject|3|||
144387969|NCT00246571|520632015|FG000|Overall Study|Lack of Efficacy|84|||
144387970|NCT00246571|520632016|FG001|Overall Study|Lack of Efficacy|21|||
144387971|NCT00246571|520632015|FG000|Overall Study|Death|17|||
144387972|NCT00246571|520632016|FG001|Overall Study|Death|3|||
144387973|NCT00246571|520632015|FG000|Overall Study|Sponsor|0|||
144387974|NCT00246571|520632016|FG001|Overall Study|Sponsor|1|||
144387975|NCT00246571|520632015|FG000|Overall Study|Did not meet entrance criteria|2|||
144387976|NCT00246571|520632016|FG001|Overall Study|Did not meet entrance criteria|1|||
144387977|NCT00246571|520632015|FG000|Overall Study|Laboratory abnormalities|1|||
144387978|NCT00246571|520632016|FG001|Overall Study|Laboratory abnormalities|0|||
144387979|NCT00246571|520632015|FG000|Overall Study|Crossover participants|0|||
144387980|NCT00246571|520632016|FG001|Overall Study|Crossover participants|74|||
144387981|NCT03422627|520632017|FG000|Overall Study|Protocol-specified Criteria|1|||
144387982|NCT03422627|520632018|FG001|Overall Study|Protocol-specified Criteria|1|||
144387983|NCT03422627|520632019|FG002|Overall Study|Protocol-specified Criteria|0|||
144387984|NCT03422627|520632020|FG003|Overall Study|Protocol-specified Criteria|0|||
144387985|NCT03422627|520632021|FG004|Overall Study|Protocol-specified Criteria|2|||
144387986|NCT03422627|520632017|FG000|Overall Study|Requirement for Alternative Therapy|1|||
144387987|NCT03422627|520632018|FG001|Overall Study|Requirement for Alternative Therapy|1|||
144387988|NCT03422627|520632019|FG002|Overall Study|Requirement for Alternative Therapy|2|||
144387989|NCT03422627|520632020|FG003|Overall Study|Requirement for Alternative Therapy|0|||
144387990|NCT03422627|520632021|FG004|Overall Study|Requirement for Alternative Therapy|0|||
144387991|NCT03422627|520632017|FG000|Overall Study|Disease Progression|1|||
144387992|NCT03422627|520632018|FG001|Overall Study|Disease Progression|0|||
144387993|NCT03422627|520632019|FG002|Overall Study|Disease Progression|1|||
144387994|NCT03422627|520632020|FG003|Overall Study|Disease Progression|2|||
144387995|NCT03422627|520632021|FG004|Overall Study|Disease Progression|0|||
144387996|NCT03422627|520632017|FG000|Overall Study|Adverse Event|2|||
144387997|NCT03422627|520632018|FG001|Overall Study|Adverse Event|1|||
144387998|NCT03422627|520632019|FG002|Overall Study|Adverse Event|0|||
144387999|NCT03422627|520632020|FG003|Overall Study|Adverse Event|0|||
144388000|NCT03422627|520632021|FG004|Overall Study|Adverse Event|2|||
144388001|NCT03422627|520632017|FG000|Overall Study|Ineligibility Determined|0|||
144388002|NCT03422627|520632018|FG001|Overall Study|Ineligibility Determined|1|||
144388003|NCT03422627|520632019|FG002|Overall Study|Ineligibility Determined|0|||
144388004|NCT03422627|520632020|FG003|Overall Study|Ineligibility Determined|0|||
144388005|NCT03422627|520632021|FG004|Overall Study|Ineligibility Determined|0|||
144388006|NCT03422627|520632017|FG000|Overall Study|Death|0|||
144388007|NCT03422627|520632018|FG001|Overall Study|Death|1|||
144388008|NCT03422627|520632019|FG002|Overall Study|Death|1|||
144388009|NCT03422627|520632020|FG003|Overall Study|Death|0|||
144388010|NCT03422627|520632021|FG004|Overall Study|Death|0|||
144388011|NCT03422627|520632017|FG000|Overall Study|Withdrawal by Subject|0|||
144388012|NCT03422627|520632018|FG001|Overall Study|Withdrawal by Subject|0|||
144388013|NCT03422627|520632019|FG002|Overall Study|Withdrawal by Subject|0|||
144388014|NCT03422627|520632020|FG003|Overall Study|Withdrawal by Subject|1|||
144388015|NCT03422627|520632021|FG004|Overall Study|Withdrawal by Subject|0|||
144388016|NCT04251156|520632025|FG000|Overall Study|Lost to Follow-up|1|||
144388017|NCT04251156|520632026|FG001|Overall Study|Lost to Follow-up|1|||
144388018|NCT04251156|520632025|FG000|Overall Study|Withdrawal by Subject|4|||
144388019|NCT04251156|520632026|FG001|Overall Study|Withdrawal by Subject|4|||
144388020|NCT02455557|520632027|FG000|Overall Study|Withdrawal by Subject|2|||
144388021|NCT00807027|520632028|FG000|Overall Study|Withdrawal by Subject|13|||
144388022|NCT00807027|520632029|FG001|Overall Study|Withdrawal by Subject|14|||
144388023|NCT00807027|520632028|FG000|Overall Study|Protocol Violation|1|||
144388024|NCT00807027|520632029|FG001|Overall Study|Protocol Violation|1|||
144388025|NCT00807027|520632028|FG000|Overall Study|Adverse Event|2|||
144388026|NCT00807027|520632029|FG001|Overall Study|Adverse Event|2|||
144388027|NCT01129024|520632030|FG000|Overall Study|Physician Decision|5|||
144388028|NCT01129024|520632030|FG000|Overall Study|Study Terminated by Sponsor|8|||
144388029|NCT01129024|520632030|FG000|Overall Study|Withdrawal by Subject|2|||
144388030|NCT01129024|520632030|FG000|Overall Study|Lack of Efficacy|3|||
144388031|NCT01129024|520632030|FG000|Overall Study|Needed a Platelet Transfusion|1|||
144388032|NCT02195687|520632031|FG000|Overall Study|Personal Reasons|1|||
144388033|NCT02195687|520632032|FG001|Overall Study|Personal Reasons|1|||
144388034|NCT02195687|520632031|FG000|Overall Study|Lost to Follow-up|4|||
144388035|NCT02195687|520632032|FG001|Overall Study|Lost to Follow-up|1|||
144388036|NCT02361580|520632033|FG000|Overall Study|Lost to Follow-up|6|||
144388037|NCT02361580|520632034|FG001|Overall Study|Lost to Follow-up|3|||
144388038|NCT00924781|520632037|FG000|Overall Study|Study terminated by sponsor|12|||
144388039|NCT00924781|520632038|FG001|Overall Study|Study terminated by sponsor|10|||
144388040|NCT04369924|520632039|FG000|Overall Study|Lost to Follow-up|302|||
144388041|NCT04369924|520632040|FG001|Overall Study|Lost to Follow-up|339|||
144388042|NCT00708201|520632041|FG000|Overall Study|Adverse Event|4|||
144388043|NCT00708201|520632042|FG001|Overall Study|Adverse Event|4|||
144388044|NCT00708201|520632041|FG000|Overall Study|Withdrawal by Subject|1|||
144388045|NCT00708201|520632042|FG001|Overall Study|Withdrawal by Subject|1|||
144388046|NCT00708201|520632041|FG000|Overall Study|Lost to Follow-up|2|||
144388047|NCT00708201|520632042|FG001|Overall Study|Lost to Follow-up|0|||
144388048|NCT00708201|520632041|FG000|Overall Study|Protocol Violation|0|||
144388049|NCT00708201|520632042|FG001|Overall Study|Protocol Violation|1|||
144388050|NCT03828370|520632043|FG000|3 Month Follow-up|Lost to Follow-up|4|||
144388051|NCT03828370|520632044|FG001|3 Month Follow-up|Lost to Follow-up|12|||
144388052|NCT03828370|520632043|FG000|9 Month Follow up|Lost to Follow-up|12|||
144388053|NCT03828370|520632044|FG001|9 Month Follow up|Lost to Follow-up|20|||
144388054|NCT00761748|520632045|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
144388055|NCT00761748|520632046|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
144388056|NCT00761748|520632045|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
144388057|NCT00761748|520632046|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
144388058|NCT01857310|520632047|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
144388059|NCT01857310|520632048|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
144388060|NCT02554279|520632049|FG000|Overall Study|Adverse Event|2|||
144388061|NCT02554279|520632050|FG001|Overall Study|Adverse Event|5|||
144388062|NCT02554279|520632049|FG000|Overall Study|Lost to Follow-up|3|||
144388063|NCT02554279|520632050|FG001|Overall Study|Lost to Follow-up|2|||
144388064|NCT02554279|520632049|FG000|Overall Study|Withdrawal by Subject|6|||
144388065|NCT02554279|520632050|FG001|Overall Study|Withdrawal by Subject|4|||
144388066|NCT02554279|520632049|FG000|Overall Study|Protocol Violation|2|||
144388067|NCT02554279|520632050|FG001|Overall Study|Protocol Violation|1|||
144388068|NCT02554279|520632049|FG000|Overall Study|Other reason|19|||
144388069|NCT02554279|520632050|FG001|Overall Study|Other reason|6|||
144388070|NCT00812487|520632051|FG000|Overall Study|Lost to Follow-up|2|||
144388071|NCT00812487|520632052|FG001|Overall Study|Lost to Follow-up|0|||
144388072|NCT00812487|520632051|FG000|Overall Study|Withdrawal by Subject|3|||
144388073|NCT00812487|520632052|FG001|Overall Study|Withdrawal by Subject|2|||
144388074|NCT00812487|520632051|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
144388075|NCT00812487|520632052|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
144388076|NCT00812487|520632051|FG000|Overall Study|Protocol Violation|0|||
144388077|NCT00812487|520632052|FG001|Overall Study|Protocol Violation|1|||
144388078|NCT00998764|520632053|FG000|Overall Study|Lack of Efficacy|3|||
144388079|NCT00998764|520632054|FG001|Overall Study|Lack of Efficacy|6|||
144388080|NCT00998764|520632053|FG000|Overall Study|Adverse Event|17|||
144388081|NCT00998764|520632054|FG001|Overall Study|Adverse Event|12|||
144388082|NCT00998764|520632053|FG000|Overall Study|Withdrawal by Subject|19|||
144388083|NCT00998764|520632054|FG001|Overall Study|Withdrawal by Subject|25|||
144388084|NCT00998764|520632053|FG000|Overall Study|Physician Decision|3|||
144388085|NCT00998764|520632054|FG001|Overall Study|Physician Decision|3|||
144388086|NCT00998764|520632053|FG000|Overall Study|Death|3|||
144388087|NCT00998764|520632054|FG001|Overall Study|Death|1|||
144388088|NCT00998764|520632053|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
144388089|NCT00998764|520632054|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
144388090|NCT00998764|520632053|FG000|Overall Study|Protocol Violation|0|||
144388091|NCT00998764|520632054|FG001|Overall Study|Protocol Violation|1|||
144388092|NCT00998764|520632053|FG000|Overall Study|Failed to Return|1|||
144388093|NCT00998764|520632054|FG001|Overall Study|Failed to Return|1|||
144388094|NCT00998764|520632053|FG000|Overall Study|Lost to Follow-up|1|||
144388095|NCT00998764|520632054|FG001|Overall Study|Lost to Follow-up|1|||
144388096|NCT00998764|520632053|FG000|Overall Study|Loss of Caregiver|0|||
144388097|NCT00998764|520632054|FG001|Overall Study|Loss of Caregiver|3|||
144388098|NCT00998764|520632053|FG000|Overall Study|Other|4|||
144388099|NCT00998764|520632054|FG001|Overall Study|Other|4|||
144388100|NCT00998764|520632053|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
144388101|NCT00998764|520632054|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
144593031|NCT03184870|521372344|FG000|Initial Treatment|Moved to crossover treatment|0|||
144593032|NCT03184870|521372345|FG001|Initial Treatment|Moved to crossover treatment|0|||
144593033|NCT03184870|521372346|FG002|Initial Treatment|Moved to crossover treatment|0|||
144722111|NCT03271528|521836974|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
144388102|NCT04761627|520632057|FG000|Run-in Period|Death|1|||
144388103|NCT04761627|520632058|FG001|Run-in Period|Death|0|||
144388104|NCT04761627|520632059|FG002|Run-in Period|Death|0|||
144388105|NCT04761627|520632057|FG000|Run-in Period|Required alternative therapy|2|||
144388106|NCT04761627|520632058|FG001|Run-in Period|Required alternative therapy|0|||
144388107|NCT04761627|520632059|FG002|Run-in Period|Required alternative therapy|0|||
144388108|NCT04761627|520632057|FG000|Run-in Period|Lost to Follow-up|2|||
144388109|NCT04761627|520632058|FG001|Run-in Period|Lost to Follow-up|0|||
144388110|NCT04761627|520632059|FG002|Run-in Period|Lost to Follow-up|0|||
144388111|NCT04761627|520632057|FG000|Run-in Period|Protocol Violation|3|||
144388112|NCT04761627|520632058|FG001|Run-in Period|Protocol Violation|0|||
144388113|NCT04761627|520632059|FG002|Run-in Period|Protocol Violation|0|||
144388114|NCT04761627|520632057|FG000|Run-in Period|Abnormal liver function|1|||
144388115|NCT04761627|520632058|FG001|Run-in Period|Abnormal liver function|0|||
144388116|NCT04761627|520632059|FG002|Run-in Period|Abnormal liver function|0|||
144388117|NCT04761627|520632057|FG000|Run-in Period|Adverse Event|6|||
144388118|NCT04761627|520632058|FG001|Run-in Period|Adverse Event|0|||
144388119|NCT04761627|520632059|FG002|Run-in Period|Adverse Event|0|||
144388120|NCT04761627|520632057|FG000|Run-in Period|Withdrawal by Subject|7|||
144388121|NCT04761627|520632058|FG001|Run-in Period|Withdrawal by Subject|0|||
144388122|NCT04761627|520632059|FG002|Run-in Period|Withdrawal by Subject|0|||
144388123|NCT04761627|520632057|FG000|Run-in Period|Did not meet PASI 50|15|||
144388124|NCT04761627|520632058|FG001|Run-in Period|Did not meet PASI 50|0|||
144388125|NCT04761627|520632059|FG002|Run-in Period|Did not meet PASI 50|0|||
144388126|NCT04761627|520632057|FG000|Run-in Period|Study site closure|2|||
144388127|NCT04761627|520632058|FG001|Run-in Period|Study site closure|0|||
144388128|NCT04761627|520632059|FG002|Run-in Period|Study site closure|0|||
144388129|NCT04761627|520632057|FG000|Run-in Period|Pregnancy|2|||
144388130|NCT04761627|520632058|FG001|Run-in Period|Pregnancy|0|||
144388131|NCT04761627|520632059|FG002|Run-in Period|Pregnancy|0|||
144388132|NCT04761627|520632057|FG000|Post-randomization Period|Military service|0|||
144388133|NCT04761627|520632058|FG001|Post-randomization Period|Military service|1|||
144388134|NCT04761627|520632059|FG002|Post-randomization Period|Military service|0|||
144388135|NCT04761627|520632057|FG000|Post-randomization Period|Adverse Event|0|||
144388136|NCT04761627|520632058|FG001|Post-randomization Period|Adverse Event|4|||
144388137|NCT04761627|520632059|FG002|Post-randomization Period|Adverse Event|2|||
144388138|NCT04761627|520632057|FG000|Post-randomization Period|Lost to Follow-up|0|||
144388139|NCT04761627|520632058|FG001|Post-randomization Period|Lost to Follow-up|6|||
144388140|NCT04761627|520632059|FG002|Post-randomization Period|Lost to Follow-up|6|||
144388141|NCT04761627|520632057|FG000|Post-randomization Period|Withdrawal by Subject|0|||
144388142|NCT04761627|520632058|FG001|Post-randomization Period|Withdrawal by Subject|7|||
144388143|NCT04761627|520632059|FG002|Post-randomization Period|Withdrawal by Subject|6|||
144388144|NCT04761627|520632057|FG000|Post-randomization Period|Pregnancy|0|||
144388145|NCT04761627|520632058|FG001|Post-randomization Period|Pregnancy|0|||
144388146|NCT04761627|520632059|FG002|Post-randomization Period|Pregnancy|1|||
144388147|NCT04761627|520632057|FG000|Post-randomization Period|Study site closure|0|||
144388148|NCT04761627|520632058|FG001|Post-randomization Period|Study site closure|0|||
144388149|NCT04761627|520632059|FG002|Post-randomization Period|Study site closure|1|||
144388150|NCT04761627|520632057|FG000|Post-randomization Period|Family planning|0|||
144388151|NCT04761627|520632058|FG001|Post-randomization Period|Family planning|1|||
144388152|NCT04761627|520632059|FG002|Post-randomization Period|Family planning|0|||
144388153|NCT01933789|520632060|FG000|Overall Study|Death|0|||
144388154|NCT01933789|520632061|FG001|Overall Study|Death|0|||
144388155|NCT01933789|520632062|FG002|Overall Study|Death|0|||
144388156|NCT01933789|520632063|FG003|Overall Study|Death|0|||
144388157|NCT01933789|520632064|FG004|Overall Study|Death|21|||
144388158|NCT01933789|520632065|FG005|Overall Study|Death|32|||
144388159|NCT01933789|520632066|FG006|Overall Study|Death|0|||
144388160|NCT01933789|520632067|FG007|Overall Study|Death|0|||
144388161|NCT01933789|520632068|FG008|Overall Study|Death|0|||
144388162|NCT01933789|520632060|FG000|Overall Study|Lost to Follow-up|0|||
144388163|NCT01933789|520632061|FG001|Overall Study|Lost to Follow-up|0|||
144388164|NCT01933789|520632062|FG002|Overall Study|Lost to Follow-up|0|||
144388165|NCT01933789|520632063|FG003|Overall Study|Lost to Follow-up|1|||
144388166|NCT01933789|520632064|FG004|Overall Study|Lost to Follow-up|8|||
144388167|NCT01933789|520632065|FG005|Overall Study|Lost to Follow-up|9|||
144388168|NCT01933789|520632066|FG006|Overall Study|Lost to Follow-up|1|||
144388169|NCT01933789|520632067|FG007|Overall Study|Lost to Follow-up|4|||
144388170|NCT01933789|520632068|FG008|Overall Study|Lost to Follow-up|0|||
144388171|NCT01933789|520632060|FG000|Overall Study|Withdrawal by Subject|2|||
144388172|NCT01933789|520632061|FG001|Overall Study|Withdrawal by Subject|1|||
144388173|NCT01933789|520632062|FG002|Overall Study|Withdrawal by Subject|0|||
144388174|NCT01933789|520632063|FG003|Overall Study|Withdrawal by Subject|0|||
144388175|NCT01933789|520632064|FG004|Overall Study|Withdrawal by Subject|17|||
144388176|NCT01933789|520632065|FG005|Overall Study|Withdrawal by Subject|16|||
144388177|NCT01933789|520632066|FG006|Overall Study|Withdrawal by Subject|1|||
144388178|NCT01933789|520632067|FG007|Overall Study|Withdrawal by Subject|4|||
144515870|NCT00411151|521088957|FG000|Overall Study|Death|38|||
144515871|NCT00411151|521088957|FG000|Overall Study|Withdrawal by Subject|2|||
144515872|NCT00411151|521088957|FG000|Overall Study|Lost to Follow-up|2|||
144515873|NCT00411151|521088957|FG000|Overall Study|Protocol Violation|1|||
144515874|NCT00411151|521088957|FG000|Overall Study|Trial prematurely closed|4|||
144515875|NCT04711135|521088958|FG000|Overall Study|Physician Decision|0|||
144515876|NCT04711135|521088959|FG001|Overall Study|Physician Decision|1|||
144515877|NCT04711135|521088958|FG000|Overall Study|Ongoing treatment|0|||
144515878|NCT04711135|521088959|FG001|Overall Study|Ongoing treatment|1|||
144515879|NCT04431726|521088965|FG000|Overall Study|Ongoing in the Study|55|||
144515880|NCT05198310|521088966|FG000|Overall Study|Lost to Follow-up|0|||
144515881|NCT05198310|521088967|FG001|Overall Study|Lost to Follow-up|1|||
144515882|NCT05198310|521088968|FG002|Overall Study|Lost to Follow-up|0|||
144388179|NCT01933789|520632068|FG008|Overall Study|Withdrawal by Subject|0|||
144388180|NCT01933789|520632060|FG000|Overall Study|Became Ineligible|4|||
144388181|NCT01933789|520632061|FG001|Overall Study|Became Ineligible|0|||
144515883|NCT05198310|521088969|FG003|Overall Study|Lost to Follow-up|0|||
144515884|NCT05198310|521088970|FG004|Overall Study|Lost to Follow-up|0|||
144515885|NCT05198310|521088971|FG005|Overall Study|Lost to Follow-up|0|||
144388182|NCT01933789|520632062|FG002|Overall Study|Became Ineligible|0|||
144388183|NCT01933789|520632063|FG003|Overall Study|Became Ineligible|0|||
144388184|NCT01933789|520632064|FG004|Overall Study|Became Ineligible|13|||
144388185|NCT01933789|520632065|FG005|Overall Study|Became Ineligible|10|||
144388186|NCT01933789|520632066|FG006|Overall Study|Became Ineligible|13|||
144388187|NCT01933789|520632067|FG007|Overall Study|Became Ineligible|6|||
144388188|NCT01933789|520632068|FG008|Overall Study|Became Ineligible|0|||
144388189|NCT01323920|520632069|FG000|Overall Study|Death|5|||
144388190|NCT01323920|520632069|FG000|Overall Study|Withdrawal by Subject|1|||
144388191|NCT01395784|520632079|FG000|Overall Study|Lost to Follow-up|7|||
144388192|NCT01395784|520632079|FG000|Overall Study|Withdrawal by Subject|3|||
144388193|NCT01395784|520632079|FG000|Overall Study|Physician Decision|5|||
144388194|NCT05772702|520632080|FG000|Overall Study|Adverse Event|1|||
144388195|NCT04300751|520633254|FG000|Overall Study|Withdrawal by Subject|1|||
144388196|NCT05247398|520633257|FG000|Overall Study|Withdrawal by Subject|1|||
144388197|NCT04214288|520633258|FG000|Overall Study|Ongoing in the study|41|||
144388198|NCT04214288|520633259|FG001|Overall Study|Ongoing in the study|51|||
144388199|NCT04214288|520633260|FG002|Overall Study|Ongoing in the study|12|||
144388200|NCT04214288|520633261|FG003|Overall Study|Ongoing in the study|39|||
144388201|NCT04214288|520633258|FG000|Overall Study|Adverse Event|1|||
144388202|NCT04214288|520633259|FG001|Overall Study|Adverse Event|0|||
144388203|NCT04214288|520633260|FG002|Overall Study|Adverse Event|0|||
144388204|NCT04214288|520633261|FG003|Overall Study|Adverse Event|0|||
144388205|NCT04214288|520633258|FG000|Overall Study|Death|22|||
144388206|NCT04214288|520633259|FG001|Overall Study|Death|13|||
144388207|NCT04214288|520633260|FG002|Overall Study|Death|7|||
144388208|NCT04214288|520633261|FG003|Overall Study|Death|19|||
144388209|NCT04214288|520633258|FG000|Overall Study|Lost to Follow-up|1|||
144388210|NCT04214288|520633259|FG001|Overall Study|Lost to Follow-up|2|||
144388211|NCT04214288|520633260|FG002|Overall Study|Lost to Follow-up|1|||
144388212|NCT04214288|520633261|FG003|Overall Study|Lost to Follow-up|0|||
144388213|NCT04214288|520633258|FG000|Overall Study|Other|1|||
144388214|NCT04214288|520633259|FG001|Overall Study|Other|2|||
144388215|NCT04214288|520633260|FG002|Overall Study|Other|0|||
144388216|NCT04214288|520633261|FG003|Overall Study|Other|6|||
144388217|NCT04214288|520633258|FG000|Overall Study|Protocol Violation|0|||
144388218|NCT04214288|520633259|FG001|Overall Study|Protocol Violation|1|||
144388219|NCT04214288|520633260|FG002|Overall Study|Protocol Violation|0|||
144388220|NCT04214288|520633261|FG003|Overall Study|Protocol Violation|0|||
144388221|NCT04214288|520633258|FG000|Overall Study|Withdrawal by Subject|8|||
144388222|NCT04214288|520633259|FG001|Overall Study|Withdrawal by Subject|4|||
144388223|NCT04214288|520633260|FG002|Overall Study|Withdrawal by Subject|0|||
144388224|NCT04214288|520633261|FG003|Overall Study|Withdrawal by Subject|9|||
144388225|NCT03997383|520633262|FG000|Double-blind Treatment Period|Adverse Event|4|||
144388226|NCT03997383|520633263|FG001|Double-blind Treatment Period|Adverse Event|3|||
144388227|NCT03997383|520633262|FG000|Double-blind Treatment Period|Death|4|||
144388228|NCT03997383|520633263|FG001|Double-blind Treatment Period|Death|4|||
144388229|NCT03997383|520633262|FG000|Double-blind Treatment Period|Physician Decision|2|||
144388230|NCT03997383|520633263|FG001|Double-blind Treatment Period|Physician Decision|0|||
144388231|NCT03997383|520633262|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
144388232|NCT03997383|520633263|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
144388233|NCT03997383|520633262|FG000|Open-label Extension Period|Ongoing|148|||
144388234|NCT03997383|520633263|FG001|Open-label Extension Period|Ongoing|151|||
144388235|NCT03997383|520633262|FG000|Open-label Extension Period|Adverse Event|4|||
144388236|NCT03997383|520633263|FG001|Open-label Extension Period|Adverse Event|1|||
144388237|NCT03997383|520633262|FG000|Open-label Extension Period|Death|8|||
144388238|NCT03997383|520633263|FG001|Open-label Extension Period|Death|9|||
144388239|NCT03997383|520633262|FG000|Open-label Extension Period|Physician Decision|1|||
144388240|NCT03997383|520633263|FG001|Open-label Extension Period|Physician Decision|1|||
144388241|NCT03997383|520633262|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
144388242|NCT03997383|520633263|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
144388243|NCT03997383|520633262|FG000|Open-label Extension Period|Reason Not Specified|2|||
144388244|NCT03997383|520633263|FG001|Open-label Extension Period|Reason Not Specified|0|||
144388245|NCT04798781|520633264|FG000|Overall Study|Withdrawal by Subject|1|||
144388246|NCT05954143|520633265|FG000|Overall Study|Progressive Disease|1|||
144388247|NCT05954143|520633266|FG001|Overall Study|Progressive Disease|0|||
144199327|NCT03107026|519928872|FG002|Overall Study|Lost to Follow-up|13|||
144388248|NCT05954143|520633265|FG000|Overall Study|Physician Decision|1|||
144388249|NCT05954143|520633266|FG001|Overall Study|Physician Decision|0|||
144388250|NCT05954143|520633265|FG000|Overall Study|Study Terminated by Sponsor|2|||
144388251|NCT05954143|520633266|FG001|Overall Study|Study Terminated by Sponsor|4|||
144388252|NCT05954143|520633265|FG000|Overall Study|Death|1|||
144388253|NCT05954143|520633266|FG001|Overall Study|Death|0|||
144388254|NCT05954143|520633265|FG000|Overall Study|Withdrawal by Subject|0|||
144388255|NCT05954143|520633266|FG001|Overall Study|Withdrawal by Subject|1|||
144388256|NCT05954143|520633265|FG000|Overall Study|Other|1|||
144388257|NCT05954143|520633266|FG001|Overall Study|Other|0|||
144388258|NCT01117792|520633267|FG000|Overall Study|Death|1|||
144388259|NCT01117792|520633267|FG000|Overall Study|Adverse Event|3|||
144388260|NCT05867342|520633268|FG000|Overall Study|Investigator Decision|3|||
144388261|NCT05867342|520633269|FG001|Overall Study|Investigator Decision|3|||
144388262|NCT00723203|520633270|FG000|Overall Study|Withdrawal by Subject|3|||
144388263|NCT00274924|520633274|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
144388264|NCT00274924|520633275|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
144388265|NCT00274924|520633276|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
144388266|NCT00274924|520633274|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
144388267|NCT00274924|520633275|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
144388268|NCT00274924|520633276|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
144388269|NCT00274924|520633274|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
144388270|NCT00274924|520633275|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
144388271|NCT00274924|520633276|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
144388272|NCT00274924|520633274|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
144388273|NCT00274924|520633275|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
144388274|NCT00274924|520633276|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
144388275|NCT00274924|520633274|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
144388276|NCT00274924|520633275|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
144388277|NCT00274924|520633276|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
144388278|NCT00274924|520633274|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
144388279|NCT00274924|520633275|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
144388280|NCT00274924|520633276|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
144388281|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
144388282|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
144388283|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
144388284|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
144388285|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
144388286|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
144388287|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
144388288|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
144388289|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
144388290|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
144388291|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
144388292|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
144388293|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
144388294|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
144388295|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
144388296|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
144388297|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
144388298|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
144388299|NCT00274924|520633274|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
144515886|NCT05198310|521088972|FG006|Overall Study|Lost to Follow-up|0|||
144515887|NCT05198310|521088973|FG007|Overall Study|Lost to Follow-up|0|||
144515888|NCT05198310|521088966|FG000|Overall Study|Withdrawal by Subject|0|||
144515889|NCT05198310|521088967|FG001|Overall Study|Withdrawal by Subject|0|||
144388300|NCT00274924|520633275|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
144515890|NCT05198310|521088968|FG002|Overall Study|Withdrawal by Subject|0|||
144515891|NCT05198310|521088969|FG003|Overall Study|Withdrawal by Subject|2|||
144515892|NCT05198310|521088970|FG004|Overall Study|Withdrawal by Subject|0|||
144515893|NCT05198310|521088971|FG005|Overall Study|Withdrawal by Subject|2|||
144388301|NCT00274924|520633276|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
144515894|NCT05198310|521088972|FG006|Overall Study|Withdrawal by Subject|1|||
144515895|NCT05198310|521088973|FG007|Overall Study|Withdrawal by Subject|3|||
144515896|NCT04281485|521088974|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
144515897|NCT04281485|521088975|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
144388302|NCT01055496|520633277|FG000|Overall Study|Withdrawal by Subject|2|||
144388303|NCT01055496|520633278|FG001|Overall Study|Withdrawal by Subject|4|||
144388304|NCT01055496|520633277|FG000|Overall Study|Death|13|||
144388305|NCT01055496|520633278|FG001|Overall Study|Death|23|||
144388306|NCT01055496|520633277|FG000|Overall Study|Lost to Follow-up|0|||
144388307|NCT01055496|520633278|FG001|Overall Study|Lost to Follow-up|2|||
144388308|NCT01055496|520633277|FG000|Overall Study|Other - Unspecified|0|||
144388309|NCT01055496|520633278|FG001|Overall Study|Other - Unspecified|1|||
144388310|NCT00584740|520633279|FG000|Overall Study|Adverse Event|1|||
144388311|NCT00584740|520633280|FG001|Overall Study|Adverse Event|1|||
144388312|NCT00584740|520633279|FG000|Overall Study|Lack of Efficacy|8|||
144388313|NCT00584740|520633280|FG001|Overall Study|Lack of Efficacy|2|||
144388314|NCT00584740|520633279|FG000|Overall Study|Withdrawal by Subject|3|||
144388315|NCT00584740|520633280|FG001|Overall Study|Withdrawal by Subject|2|||
144388316|NCT00584740|520633279|FG000|Overall Study|Lost to Follow-up|0|||
144388317|NCT00584740|520633280|FG001|Overall Study|Lost to Follow-up|1|||
144388318|NCT01673282|520633281|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
144388319|NCT01673282|520633282|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
144388320|NCT01673282|520633281|FG000|Overall Study|Lack of Efficacy|9|||
144388321|NCT01673282|520633282|FG001|Overall Study|Lack of Efficacy|2|||
144388322|NCT01673282|520633281|FG000|Overall Study|Lost to Follow-up|11|||
144388323|NCT01673282|520633282|FG001|Overall Study|Lost to Follow-up|10|||
144388324|NCT01673282|520633281|FG000|Overall Study|Withdrawal by Subject|3|||
144388325|NCT01673282|520633282|FG001|Overall Study|Withdrawal by Subject|3|||
144388326|NCT01673282|520633281|FG000|Overall Study|Other|1|||
144388327|NCT01673282|520633282|FG001|Overall Study|Other|6|||
144388328|NCT02915874|520633283|FG000|Overall Study|Lost to Follow-up|5|||
144388329|NCT02915874|520633284|FG001|Overall Study|Lost to Follow-up|4|||
144388330|NCT02915874|520633283|FG000|Overall Study|Withdrawal by Subject|1|||
144388331|NCT02915874|520633284|FG001|Overall Study|Withdrawal by Subject|1|||
144388332|NCT02915874|520633283|FG000|Overall Study|Started New Anxiety Medication|0|||
144388333|NCT02915874|520633284|FG001|Overall Study|Started New Anxiety Medication|1|||
144388334|NCT05318183|520633286|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
144388335|NCT05318183|520633287|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
144388336|NCT05318183|520633286|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
144388337|NCT05318183|520633287|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144388338|NCT05318183|520633286|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
144388339|NCT05318183|520633287|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
144388340|NCT05318183|520633286|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
144388341|NCT05318183|520633287|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
144388342|NCT01046825|520633288|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
144388343|NCT01046825|520633289|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
144388344|NCT01046825|520633290|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
144388345|NCT01046825|520633291|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
144388346|NCT01046825|520633292|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
144388347|NCT01046825|520633288|FG000|Overall Study|Physician Decision|0|||
144388348|NCT01046825|520633289|FG001|Overall Study|Physician Decision|1|||
144388349|NCT01046825|520633290|FG002|Overall Study|Physician Decision|2|||
144388350|NCT01046825|520633291|FG003|Overall Study|Physician Decision|0|||
144388351|NCT01046825|520633292|FG004|Overall Study|Physician Decision|0|||
144388352|NCT01046825|520633288|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
144388353|NCT01046825|520633289|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
144388354|NCT01046825|520633290|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
144388355|NCT01046825|520633291|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
144388356|NCT01046825|520633292|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
144388357|NCT01046825|520633288|FG000|Overall Study|Found to be ineligible|0|||
144388358|NCT01046825|520633289|FG001|Overall Study|Found to be ineligible|1|||
144388359|NCT01046825|520633290|FG002|Overall Study|Found to be ineligible|0|||
144388360|NCT01046825|520633291|FG003|Overall Study|Found to be ineligible|0|||
144388361|NCT01046825|520633292|FG004|Overall Study|Found to be ineligible|0|||
144388362|NCT01046825|520633288|FG000|Overall Study|Death|0|||
144388363|NCT01046825|520633289|FG001|Overall Study|Death|0|||
144388364|NCT01046825|520633290|FG002|Overall Study|Death|0|||
144388365|NCT01046825|520633291|FG003|Overall Study|Death|1|||
144388366|NCT01046825|520633292|FG004|Overall Study|Death|0|||
144388367|NCT01046825|520633288|FG000|Overall Study|Did not submit biology samples|0|||
144388368|NCT01046825|520633289|FG001|Overall Study|Did not submit biology samples|0|||
144388369|NCT01046825|520633290|FG002|Overall Study|Did not submit biology samples|0|||
144388370|NCT01046825|520633291|FG003|Overall Study|Did not submit biology samples|0|||
144388371|NCT01046825|520633292|FG004|Overall Study|Did not submit biology samples|13|||
144388372|NCT04391569|520633294|FG000|Overall Study|Death|15|||
144388373|NCT04391569|520633295|FG001|Overall Study|Death|10|||
144388374|NCT04391569|520633294|FG000|Overall Study|Withdrawal by Subject|1|||
144388375|NCT04391569|520633295|FG001|Overall Study|Withdrawal by Subject|0|||
144388376|NCT04391569|520633294|FG000|Overall Study|Lost to Follow-up|3|||
144388377|NCT04391569|520633295|FG001|Overall Study|Lost to Follow-up|2|||
144388378|NCT04391569|520633294|FG000|Overall Study|Lack of Efficacy|0|||
144388379|NCT04391569|520633295|FG001|Overall Study|Lack of Efficacy|1|||
144388380|NCT04391569|520633294|FG000|Overall Study|Participant discharged to hospice facility|0|||
144388381|NCT04391569|520633295|FG001|Overall Study|Participant discharged to hospice facility|1|||
144388382|NCT04391569|520633294|FG000|Overall Study|Participant family decision|1|||
144388383|NCT04391569|520633295|FG001|Overall Study|Participant family decision|0|||
144388384|NCT04391569|520633294|FG000|Overall Study|Participant discharged prematurely|1|||
144388385|NCT04391569|520633295|FG001|Overall Study|Participant discharged prematurely|0|||
144388386|NCT06390839|520633296|FG000|Overall Study|Ineligible|2|||
144388387|NCT06390839|520633296|FG000|Overall Study|Never start protocol therapy|3|||
144388388|NCT06390839|520633296|FG000|Overall Study|Adverse Event|1|||
144388389|NCT06390839|520633296|FG000|Overall Study|Alternative therapy|2|||
144388390|NCT06390839|520633296|FG000|Overall Study|Death|3|||
144388391|NCT06390839|520633296|FG000|Overall Study|Disease progression|28|||
144388392|NCT06390839|520633296|FG000|Overall Study|Withdrawal by Subject|2|||
144388393|NCT06390839|520633296|FG000|Overall Study|Complicating disease|1|||
144388394|NCT06390839|520633296|FG000|Overall Study|Noncompliance|1|||
144388395|NCT03025035|520633297|FG000|Overall Study|Death|2|||
144388396|NCT03025035|520633297|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
144388397|NCT02720094|520633303|FG000|Overall Study|Ongoing|2210|||
144388398|NCT02720094|520633304|FG001|Overall Study|Ongoing|2203|||
144388399|NCT02720094|520633303|FG000|Overall Study|Scheduled exit visit/end of study|2|||
144388400|NCT02720094|520633304|FG001|Overall Study|Scheduled exit visit/end of study|1|||
144388401|NCT02720094|520633303|FG000|Overall Study|Death|4|||
144388402|NCT02720094|520633304|FG001|Overall Study|Death|7|||
144388403|NCT02720094|520633303|FG000|Overall Study|Withdrawal by Subject|55|||
144388404|NCT02720094|520633304|FG001|Overall Study|Withdrawal by Subject|56|||
144388405|NCT02720094|520633303|FG000|Overall Study|Lost to Follow-up|2|||
144388406|NCT02720094|520633304|FG001|Overall Study|Lost to Follow-up|7|||
144388407|NCT02720094|520633303|FG000|Overall Study|Physician Decision|1|||
144388408|NCT02720094|520633304|FG001|Overall Study|Physician Decision|3|||
144388409|NCT02720094|520633303|FG000|Overall Study|Inappropriate enrollment|1|||
144388410|NCT02720094|520633304|FG001|Overall Study|Inappropriate enrollment|3|||
144388411|NCT02720094|520633303|FG000|Overall Study|Relocation|1|||
144388412|NCT02720094|520633304|FG001|Overall Study|Relocation|1|||
144388413|NCT00732940|520633311|FG000|Overall Study|Withdrawal by Subject|1|||
144388414|NCT00732940|520633312|FG001|Overall Study|Withdrawal by Subject|2|||
144388415|NCT00732940|520633311|FG000|Overall Study|Adverse Event|0|||
144388416|NCT00732940|520633312|FG001|Overall Study|Adverse Event|1|||
144388417|NCT00732940|520633311|FG000|Overall Study|Lost to Follow-up|1|||
144388418|NCT00732940|520633312|FG001|Overall Study|Lost to Follow-up|0|||
144388419|NCT01150474|520633316|FG000|Overall Study|Withdrawal by Subject|5|||
144388420|NCT01150474|520633317|FG001|Overall Study|Withdrawal by Subject|2|||
144388421|NCT01150474|520633316|FG000|Overall Study|Cancer found|1|||
144388422|NCT01150474|520633317|FG001|Overall Study|Cancer found|0|||
144388423|NCT01150474|520633316|FG000|Overall Study|Multiple Studies|0|||
144388424|NCT01150474|520633317|FG001|Overall Study|Multiple Studies|1|||
144388425|NCT01150474|520633316|FG000|Overall Study|Rectotomy|1|||
144388426|NCT01150474|520633317|FG001|Overall Study|Rectotomy|0|||
144388427|NCT01150474|520633316|FG000|Overall Study|Drug did not arrive in time|1|||
144388428|NCT01150474|520633317|FG001|Overall Study|Drug did not arrive in time|0|||
144388429|NCT01150474|520633316|FG000|Overall Study|Drug not administered|1|||
144388430|NCT01150474|520633317|FG001|Overall Study|Drug not administered|0|||
144515898|NCT04281485|521088974|FG000|Overall Study|Ongoing (Safety data collection)|10|||
144515899|NCT04281485|521088975|FG001|Overall Study|Ongoing (Safety data collection)|5|||
144515900|NCT01095796|521088976|FG000|Overall Study|Randomized but Not Treated|5|||
144515901|NCT01095796|521088977|FG001|Overall Study|Randomized but Not Treated|2|||
144515902|NCT01095796|521088976|FG000|Overall Study|Adverse Event|9|||
144515903|NCT01095796|521088977|FG001|Overall Study|Adverse Event|19|||
144515904|NCT01095796|521088976|FG000|Overall Study|Death|3|||
144515905|NCT01095796|521088977|FG001|Overall Study|Death|2|||
144388431|NCT01150474|520633316|FG000|Overall Study|Surgery Changed|1|||
144388432|NCT01150474|520633317|FG001|Overall Study|Surgery Changed|0|||
144388433|NCT00459979|520633318|FG000|Overall Study|Withdrawal by Subject|1|||
144388434|NCT00459979|520633318|FG000|Overall Study|Protocol Violation|1|||
144388435|NCT00219544|520633319|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
144388436|NCT00219544|520633320|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
144388437|NCT00219544|520633319|FG000|Single Blind Treatment Period|Adverse Event|9|||
144388438|NCT00219544|520633320|FG001|Single Blind Treatment Period|Adverse Event|0|||
144515906|NCT01095796|521088976|FG000|Overall Study|Pregnancy|2|||
144515907|NCT01095796|521088977|FG001|Overall Study|Pregnancy|0|||
144388439|NCT00219544|520633319|FG000|Single Blind Treatment Period|Protocol Violation|4|||
144388440|NCT00219544|520633320|FG001|Single Blind Treatment Period|Protocol Violation|0|||
144388441|NCT00219544|520633319|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
144388442|NCT00219544|520633320|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
144388443|NCT00219544|520633319|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
144388444|NCT00219544|520633320|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
144388445|NCT00219544|520633319|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
144388446|NCT00219544|520633320|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
144388447|NCT00989573|520633321|FG000|Overall Study|Adverse Event|8|||
144388448|NCT00989573|520633322|FG001|Overall Study|Adverse Event|12|||
144388449|NCT00989573|520633323|FG002|Overall Study|Adverse Event|4|||
144388450|NCT00989573|520633321|FG000|Overall Study|Physician Decision|0|||
144388451|NCT00989573|520633322|FG001|Overall Study|Physician Decision|2|||
144388452|NCT00989573|520633323|FG002|Overall Study|Physician Decision|0|||
144388453|NCT00989573|520633321|FG000|Overall Study|Protocol Violation|1|||
144388454|NCT00989573|520633322|FG001|Overall Study|Protocol Violation|1|||
144388455|NCT00989573|520633323|FG002|Overall Study|Protocol Violation|1|||
144388456|NCT00989573|520633321|FG000|Overall Study|Withdrawal by Subject|4|||
144388457|NCT00989573|520633322|FG001|Overall Study|Withdrawal by Subject|7|||
144388458|NCT00989573|520633323|FG002|Overall Study|Withdrawal by Subject|3|||
144388459|NCT05214573|520633326|FG000|Overall Study|Physician Decision|5924|||
144388460|NCT05214573|520633327|FG001|Overall Study|Physician Decision|0|||
144388461|NCT01163032|520633330|FG000|Randomization Phase|Withdrawal by Subject|2|||
144388462|NCT01163032|520633331|FG001|Randomization Phase|Withdrawal by Subject|3|||
144388463|NCT01163032|520633332|FG002|Randomization Phase|Withdrawal by Subject|0|||
144388464|NCT01163032|520633330|FG000|Randomization Phase|Adverse Event|3|||
144388465|NCT01163032|520633331|FG001|Randomization Phase|Adverse Event|3|||
144388466|NCT01163032|520633332|FG002|Randomization Phase|Adverse Event|0|||
144515908|NCT01095796|521088976|FG000|Overall Study|Lack of Efficacy|5|||
144515909|NCT01095796|521088977|FG001|Overall Study|Lack of Efficacy|3|||
144593034|NCT03184870|521372347|FG003|Initial Treatment|Moved to crossover treatment|0|||
144593035|NCT03184870|521372348|FG004|Initial Treatment|Moved to crossover treatment|0|||
144515910|NCT01095796|521088976|FG000|Overall Study|Investigator's Discretion|7|||
144515911|NCT01095796|521088977|FG001|Overall Study|Investigator's Discretion|2|||
144515912|NCT01095796|521088976|FG000|Overall Study|Withdrew Consent|16|||
144515913|NCT01095796|521088977|FG001|Overall Study|Withdrew Consent|22|||
144515914|NCT01095796|521088976|FG000|Overall Study|Lost to Follow-up|27|||
144515915|NCT01095796|521088977|FG001|Overall Study|Lost to Follow-up|29|||
144515916|NCT01095796|521088976|FG000|Overall Study|Participant Noncompliance|5|||
144515917|NCT01095796|521088977|FG001|Overall Study|Participant Noncompliance|10|||
144515918|NCT01095796|521088976|FG000|Overall Study|Protocol Violation|1|||
144515919|NCT01095796|521088977|FG001|Overall Study|Protocol Violation|0|||
144515920|NCT01095796|521088976|FG000|Overall Study|Participant Transferred to Another Study|215|||
144515921|NCT01095796|521088977|FG001|Overall Study|Participant Transferred to Another Study|200|||
144515922|NCT02638337|521088982|FG000|Overall Study|Adverse Event|6|||
144515923|NCT02638337|521088983|FG001|Overall Study|Adverse Event|10|||
144515924|NCT02638337|521088982|FG000|Overall Study|Protocol Violation|3|||
144515925|NCT02638337|521088983|FG001|Overall Study|Protocol Violation|0|||
144515926|NCT02638337|521088982|FG000|Overall Study|Withdrawal by Subject|13|||
144515927|NCT02638337|521088983|FG001|Overall Study|Withdrawal by Subject|16|||
144515928|NCT02638337|521088982|FG000|Overall Study|Lost to Follow-up|7|||
144515929|NCT02638337|521088983|FG001|Overall Study|Lost to Follow-up|7|||
144515930|NCT02638337|521088982|FG000|Overall Study|Other - Miscellaneous|4|||
144515931|NCT02638337|521088983|FG001|Overall Study|Other - Miscellaneous|3|||
144515932|NCT04950127|521088984|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
144515933|NCT04950127|521088985|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
144515934|NCT04950127|521088986|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
144515935|NCT04950127|521088987|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
144515936|NCT04950127|521088988|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
144515937|NCT04950127|521088989|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
144515938|NCT04950127|521088984|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
144515939|NCT04950127|521088985|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
144515940|NCT04950127|521088986|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
144515941|NCT04950127|521088987|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
144515942|NCT04950127|521088988|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
144515943|NCT04950127|521088989|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
144515944|NCT04950127|521088984|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
144388467|NCT01163032|520633330|FG000|Randomization Phase|Protocol Violation|0|||
144388468|NCT01163032|520633331|FG001|Randomization Phase|Protocol Violation|1|||
144388469|NCT01163032|520633332|FG002|Randomization Phase|Protocol Violation|0|||
144388470|NCT01163032|520633330|FG000|Randomization Phase|Various*|5|||
144515945|NCT04950127|521088985|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
144515946|NCT04950127|521088986|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
144388471|NCT01163032|520633331|FG001|Randomization Phase|Various*|4|||
144515947|NCT04950127|521088987|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
144388472|NCT01163032|520633332|FG002|Randomization Phase|Various*|0|||
144388473|NCT01163032|520633330|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
144388474|NCT01163032|520633331|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
144388475|NCT01163032|520633332|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
144388476|NCT01163032|520633330|FG000|Open Label Extension Phase|Adverse Event|0|||
144388477|NCT01163032|520633331|FG001|Open Label Extension Phase|Adverse Event|0|||
144388478|NCT01163032|520633332|FG002|Open Label Extension Phase|Adverse Event|3|||
144388479|NCT01163032|520633330|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
144388480|NCT01163032|520633331|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
144388481|NCT01163032|520633332|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
144388482|NCT01163032|520633330|FG000|Open Label Extension Phase|Protocol Violation|0|||
144388483|NCT01163032|520633331|FG001|Open Label Extension Phase|Protocol Violation|0|||
144388484|NCT01163032|520633332|FG002|Open Label Extension Phase|Protocol Violation|1|||
144388485|NCT01163032|520633330|FG000|Open Label Extension Phase|Study Termination|0|||
144388486|NCT01163032|520633331|FG001|Open Label Extension Phase|Study Termination|0|||
144388487|NCT01163032|520633332|FG002|Open Label Extension Phase|Study Termination|7|||
144388488|NCT01163032|520633330|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
144388489|NCT01163032|520633331|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
144388490|NCT01163032|520633332|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
144388491|NCT01037088|520633335|FG000|Overall Study|Withdrawal by Subject|3|||
144388492|NCT01958827|520633336|FG000|Overall Study|Adverse Event|3|||
144388493|NCT01958827|520633336|FG000|Overall Study|Lack of Efficacy|6|||
144388494|NCT01958827|520633336|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
144388495|NCT03036800|520633337|FG000|Overall Study|Protocol Violation|1|||
144388496|NCT03036800|520633338|FG001|Overall Study|Protocol Violation|0|||
144388497|NCT03036800|520633337|FG000|Overall Study|Non-compliance|1|||
144388498|NCT03036800|520633338|FG001|Overall Study|Non-compliance|0|||
144388499|NCT03036800|520633337|FG000|Overall Study|Lost to Follow-up|1|||
144388500|NCT03036800|520633338|FG001|Overall Study|Lost to Follow-up|0|||
144388501|NCT03036800|520633337|FG000|Overall Study|Death|1|||
144388502|NCT03036800|520633338|FG001|Overall Study|Death|0|||
144388503|NCT03036800|520633337|FG000|Overall Study|Tolerance|5|||
144388504|NCT03036800|520633338|FG001|Overall Study|Tolerance|0|||
144388505|NCT03036800|520633337|FG000|Overall Study|Unknown/no reason given|50|||
144388506|NCT03036800|520633338|FG001|Overall Study|Unknown/no reason given|39|||
144388507|NCT01077154|520633343|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
144388508|NCT01077154|520633344|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
144388509|NCT01077154|520633343|FG000|Overall Study|Withdrawal by Subject|369|||
144388510|NCT01077154|520633344|FG001|Overall Study|Withdrawal by Subject|385|||
144388511|NCT01077154|520633343|FG000|Overall Study|Death|215|||
144388512|NCT01077154|520633344|FG001|Overall Study|Death|214|||
144388513|NCT01077154|520633343|FG000|Overall Study|Lost to Follow-up|43|||
144388514|NCT01077154|520633344|FG001|Overall Study|Lost to Follow-up|35|||
144388515|NCT01077154|520633343|FG000|Overall Study|Noncompliance|22|||
144388516|NCT01077154|520633344|FG001|Overall Study|Noncompliance|20|||
144388517|NCT01077154|520633343|FG000|Overall Study|Disease Progression|18|||
144388518|NCT01077154|520633344|FG001|Overall Study|Disease Progression|20|||
144388519|NCT01077154|520633343|FG000|Overall Study|Ineligibility Determined|10|||
144388520|NCT01077154|520633344|FG001|Overall Study|Ineligibility Determined|14|||
144388521|NCT01077154|520633343|FG000|Overall Study|Other|14|||
144388522|NCT01077154|520633344|FG001|Overall Study|Other|11|||
144388523|NCT01077154|520633343|FG000|Overall Study|Adverse Event|9|||
144388524|NCT01077154|520633344|FG001|Overall Study|Adverse Event|9|||
144388525|NCT01077154|520633343|FG000|Overall Study|Administrative Decision|1|||
144388526|NCT01077154|520633344|FG001|Overall Study|Administrative Decision|6|||
144388527|NCT01077154|520633343|FG000|Overall Study|Protocol Deviation|1|||
144388528|NCT01077154|520633344|FG001|Overall Study|Protocol Deviation|0|||
144388529|NCT02207946|520633345|FG000|Overall Study|Lost to Follow-up|1|||
144388530|NCT02207946|520633346|FG001|Overall Study|Lost to Follow-up|0|||
144388531|NCT02207946|520633345|FG000|Overall Study|Adverse Event|0|||
144388532|NCT02207946|520633346|FG001|Overall Study|Adverse Event|1|||
144388533|NCT01006603|520633355|FG000|Overall Study|Withdrawal by Subject|17|||
144388534|NCT01006603|520633356|FG001|Overall Study|Withdrawal by Subject|19|||
144388535|NCT01006603|520633355|FG000|Overall Study|Lost to Follow-up|0|||
144388536|NCT01006603|520633356|FG001|Overall Study|Lost to Follow-up|1|||
144388537|NCT01006603|520633355|FG000|Overall Study|Safety reason|1|||
144515948|NCT04950127|521088988|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
144515949|NCT04950127|521088989|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
144515950|NCT04950127|521088984|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
144388538|NCT01006603|520633356|FG001|Overall Study|Safety reason|1|||
144388539|NCT01006603|520633355|FG000|Overall Study|Protocol Violation|1|||
144388540|NCT01006603|520633356|FG001|Overall Study|Protocol Violation|3|||
144388541|NCT01006603|520633355|FG000|Overall Study|Incorrect enrolment|0|||
144388542|NCT01006603|520633356|FG001|Overall Study|Incorrect enrolment|2|||
144388543|NCT01006603|520633355|FG000|Overall Study|Adverse Event|15|||
144388544|NCT01006603|520633356|FG001|Overall Study|Adverse Event|7|||
144388545|NCT01006603|520633355|FG000|Overall Study|Death|1|||
144388546|NCT01006603|520633356|FG001|Overall Study|Death|1|||
144388547|NCT01006603|520633355|FG000|Overall Study|Study specific discontinuation criteria|33|||
144388548|NCT01006603|520633356|FG001|Overall Study|Study specific discontinuation criteria|34|||
144388549|NCT01006603|520633355|FG000|Overall Study|Other|3|||
144388550|NCT01006603|520633356|FG001|Overall Study|Other|7|||
144388551|NCT02316548|520633754|FG000|Overall Study|Protocol Violation|0|||
144388552|NCT02316548|520633755|FG001|Overall Study|Protocol Violation|1|||
144388553|NCT05171816|520633758|FG000|Overall Study|Death|18|||
144388554|NCT05171816|520633759|FG001|Overall Study|Death|16|||
144388555|NCT02937571|520633760|FG000|Overall Study|Adverse Event|0|||
144388556|NCT02937571|520633761|FG001|Overall Study|Adverse Event|0|||
144388557|NCT02937571|520633762|FG002|Overall Study|Adverse Event|4|||
144388558|NCT02937571|520633760|FG000|Overall Study|Withdrawal by Subject|0|||
144388559|NCT02937571|520633761|FG001|Overall Study|Withdrawal by Subject|0|||
144388560|NCT02937571|520633762|FG002|Overall Study|Withdrawal by Subject|3|||
144388561|NCT03675321|520633763|FG000|Overall Study|Lack of Efficacy|2|||
144388562|NCT03675321|520633764|FG001|Overall Study|Lack of Efficacy|2|||
144388563|NCT03675321|520633763|FG000|Overall Study|Withdrawal by Subject|1|||
144388564|NCT03675321|520633764|FG001|Overall Study|Withdrawal by Subject|3|||
144388565|NCT06400251|520633765|FG000|Overall Study|Never Start Protocol Therapy|1|||
144388566|NCT06400251|520633765|FG000|Overall Study|Ineligible|2|||
144388567|NCT06400251|520633765|FG000|Overall Study|Mutation Status Not Confirmed|3|||
144388568|NCT06400251|520633765|FG000|Overall Study|Disease Progression|25|||
144388569|NCT06400251|520633765|FG000|Overall Study|Adverse Event|1|||
144388570|NCT06400251|520633765|FG000|Overall Study|Complicating Disease|1|||
144388571|NCT06400251|520633765|FG000|Overall Study|Physician Decision|2|||
144388572|NCT03764033|520633790|FG000|Treatment Phase|Withdrawal by Subject|8|||
144388573|NCT03764033|520633791|FG001|Treatment Phase|Withdrawal by Subject|3|||
144388574|NCT03764033|520633790|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
144388575|NCT03764033|520633791|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
144388576|NCT03764033|520633790|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
144388577|NCT03764033|520633791|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
144388578|NCT05856760|520633792|FG000|Overall Study|Adverse Event|2|||
144388579|NCT05856760|520633792|FG000|Overall Study|Physician Decision|1|||
144388580|NCT05856760|520633792|FG000|Overall Study|Protocol Violation|1|||
144388581|NCT05856760|520633792|FG000|Overall Study|Withdrawal by Subject|3|||
144388582|NCT01892722|520633795|FG000|Overall Study|Protocol deviation|0|||
144388583|NCT01892722|520633796|FG001|Overall Study|Protocol deviation|1|||
144388584|NCT01892722|520633795|FG000|Overall Study|Administrative problems|0|||
144388585|NCT01892722|520633796|FG001|Overall Study|Administrative problems|1|||
144388586|NCT01892722|520633795|FG000|Overall Study|Patient/guardian decision|0|||
144388587|NCT01892722|520633796|FG001|Overall Study|Patient/guardian decision|2|||
144388588|NCT01892722|520633795|FG000|Overall Study|Physician Decision|1|||
144388589|NCT01892722|520633796|FG001|Overall Study|Physician Decision|2|||
144388590|NCT01892722|520633795|FG000|Overall Study|Adverse Event|3|||
144388591|NCT01892722|520633796|FG001|Overall Study|Adverse Event|2|||
144388592|NCT01892722|520633795|FG000|Overall Study|Lack of Efficacy|0|||
144388593|NCT01892722|520633796|FG001|Overall Study|Lack of Efficacy|7|||
144388594|NCT01892722|520633795|FG000|Overall Study|Withdrawal by Subject|3|||
144388595|NCT01892722|520633796|FG001|Overall Study|Withdrawal by Subject|5|||
144388596|NCT05568888|520633797|FG000|Overall Study|Physician Decision|1|||
144515951|NCT04950127|521088985|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
144515952|NCT04950127|521088986|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
144515953|NCT04950127|521088987|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
144515954|NCT04950127|521088988|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
144388597|NCT05568888|520633798|FG001|Overall Study|Physician Decision|0|||
144388598|NCT05568888|520633797|FG000|Overall Study|Protocol Deviation|2|||
144388599|NCT05568888|520633798|FG001|Overall Study|Protocol Deviation|1|||
144388600|NCT05568888|520633797|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
144388601|NCT05568888|520633798|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
144388602|NCT05568888|520633797|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
144388603|NCT05568888|520633798|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
144388604|NCT05568888|520633797|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
144388605|NCT05568888|520633798|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
144388606|NCT02477696|520633801|FG000|Overall Study|Death|89|||
144388607|NCT02477696|520633802|FG001|Overall Study|Death|106|||
144388608|NCT02477696|520633801|FG000|Overall Study|Lost to Follow-up|7|||
144388609|NCT02477696|520633802|FG001|Overall Study|Lost to Follow-up|5|||
144388610|NCT02477696|520633801|FG000|Overall Study|Withdrawal by Subject|37|||
144388611|NCT02477696|520633802|FG001|Overall Study|Withdrawal by Subject|34|||
144388612|NCT02477696|520633801|FG000|Overall Study|Physician Decision|7|||
144388613|NCT02477696|520633802|FG001|Overall Study|Physician Decision|9|||
144388614|NCT02477696|520633801|FG000|Overall Study|Study terminated by sponsor|103|||
144388615|NCT02477696|520633802|FG001|Overall Study|Study terminated by sponsor|99|||
144388616|NCT02477696|520633801|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
144388617|NCT02477696|520633802|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
144388618|NCT02477696|520633801|FG000|Overall Study|Missing/Unknown|2|||
144388619|NCT02477696|520633802|FG001|Overall Study|Missing/Unknown|0|||
144388620|NCT00884377|520633978|FG000|Overall Study|Withdrawal by Subject|1|||
144388621|NCT00884377|520633979|FG001|Overall Study|Withdrawal by Subject|0|||
144388622|NCT00884377|520633978|FG000|Overall Study|Could not confirm diagnosis|1|||
144388623|NCT00884377|520633979|FG001|Overall Study|Could not confirm diagnosis|0|||
144515955|NCT04950127|521088989|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
144515956|NCT04950127|521088984|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
144515957|NCT04950127|521088985|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
144515958|NCT04950127|521088986|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
144515959|NCT04950127|521088987|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
144388624|NCT00884377|520633978|FG000|Overall Study|Physician Decision|0|||
144388625|NCT00884377|520633979|FG001|Overall Study|Physician Decision|1|||
144388626|NCT02003365|520633980|FG000|Overall Study|Lost to Follow-up|0|||
144515960|NCT04950127|521088988|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
144515961|NCT04950127|521088989|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
144515962|NCT01711632|521088990|FG000|Overall Study|Adverse Event|4|||
144388627|NCT02003365|520633981|FG001|Overall Study|Lost to Follow-up|0|||
144388628|NCT02003365|520633982|FG002|Overall Study|Lost to Follow-up|1|||
144388629|NCT02197234|520633983|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
144515963|NCT01711632|521088990|FG000|Overall Study|Death|3|||
144515964|NCT01711632|521088990|FG000|Overall Study|Lost to Follow-up|3|||
144515965|NCT01711632|521088990|FG000|Overall Study|Withdrawal by Subject|4|||
144388630|NCT02197234|520633983|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
144388631|NCT02197234|520633983|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
144388632|NCT02197234|520633983|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
144388633|NCT02197234|520633983|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
144388634|NCT02197234|520633983|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
144388635|NCT01602666|520633984|FG000|Induction Chemotherapy|Death|2|||
144388636|NCT01602666|520633985|FG001|Induction Chemotherapy|Death|1|||
144388637|NCT01602666|520633984|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
144388638|NCT01602666|520633985|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
144388639|NCT01602666|520633984|FG000|Induction Chemotherapy|Physician Decision|12|||
144388640|NCT01602666|520633985|FG001|Induction Chemotherapy|Physician Decision|5|||
144388641|NCT01602666|520633984|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
144388642|NCT01602666|520633985|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
144388643|NCT01602666|520633984|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
144388644|NCT01602666|520633985|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
144388645|NCT01602666|520633984|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
144388646|NCT01602666|520633985|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
144388647|NCT01602666|520633984|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
144515966|NCT01711632|521088990|FG000|Overall Study|Progressive disease|2|||
144515967|NCT01711632|521088990|FG000|Overall Study|No follow up required in re-treatment|3|||
144515968|NCT01711632|521088990|FG000|Overall Study|No follow up required in re-treatment|3|||
144515969|NCT04315181|521088991|FG000|Overall Study|Non-responsive to drug conditions.|1|||
144515970|NCT03517969|521088992|FG000|Overall Study|Never started protocol treatment|3|||
144515971|NCT03517969|521088993|FG001|Overall Study|Never started protocol treatment|5|||
144515972|NCT03517969|521088992|FG000|Overall Study|Disease progression|11|||
144515973|NCT03517969|521088993|FG001|Overall Study|Disease progression|16|||
144515974|NCT03517969|521088992|FG000|Overall Study|PSA progression|8|||
144515975|NCT03517969|521088993|FG001|Overall Study|PSA progression|1|||
144515976|NCT03517969|521088992|FG000|Overall Study|Clinical progression|4|||
144515977|NCT03517969|521088993|FG001|Overall Study|Clinical progression|2|||
144515978|NCT03517969|521088992|FG000|Overall Study|Adverse Event|5|||
144515979|NCT03517969|521088993|FG001|Overall Study|Adverse Event|4|||
144515980|NCT03517969|521088992|FG000|Overall Study|Intercurrent illness|1|||
144515981|NCT03517969|521088993|FG001|Overall Study|Intercurrent illness|2|||
144515982|NCT03517969|521088992|FG000|Overall Study|Death|1|||
144515983|NCT03517969|521088993|FG001|Overall Study|Death|1|||
144515984|NCT03517969|521088992|FG000|Overall Study|Withdrawal by Subject|1|||
144515985|NCT03517969|521088993|FG001|Overall Study|Withdrawal by Subject|2|||
144515986|NCT03517969|521088992|FG000|Overall Study|Physician Decision|1|||
144515987|NCT03517969|521088993|FG001|Overall Study|Physician Decision|1|||
144515988|NCT03517969|521088992|FG000|Overall Study|No clinical benefit|1|||
144515989|NCT03517969|521088993|FG001|Overall Study|No clinical benefit|0|||
144515990|NCT03517969|521088992|FG000|Overall Study|Delayed treatment for dental treatment|1|||
144515991|NCT03517969|521088993|FG001|Overall Study|Delayed treatment for dental treatment|0|||
144515992|NCT03517969|521088992|FG000|Overall Study|Difficult to maintain appointment|0|||
144515993|NCT03517969|521088993|FG001|Overall Study|Difficult to maintain appointment|1|||
144515994|NCT03517969|521088992|FG000|Overall Study|Protocol Violation|0|||
144515995|NCT03517969|521088993|FG001|Overall Study|Protocol Violation|1|||
144515996|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Adverse Event|4|||
144515997|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Adverse Event|1|||
144515998|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
144515999|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
144516000|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
144516001|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
144516002|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
144516003|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
144516004|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
144516005|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
144516006|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Other|6|||
144388648|NCT01602666|520633985|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
144516007|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Other|1|||
144516008|NCT03271489|521088994|FG000|Double-Blind (DB) Period|Missing|1|||
144516009|NCT03271489|521088995|FG001|Double-Blind (DB) Period|Missing|0|||
144516010|NCT03271489|521088994|FG000|Open-Label (OL) Period|Adverse Event|2|||
144516011|NCT03271489|521088995|FG001|Open-Label (OL) Period|Adverse Event|0|||
144388649|NCT01602666|520633984|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
144388650|NCT01602666|520633985|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
144388651|NCT01602666|520633984|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
144388652|NCT01602666|520633985|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
144388653|NCT01602666|520633984|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
144388654|NCT01602666|520633985|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
144388655|NCT01602666|520633984|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
144388656|NCT01602666|520633985|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
144388657|NCT04153149|520633988|FG000|Double Blind Period|Death|63|||
144388658|NCT04153149|520633989|FG001|Double Blind Period|Death|49|||
144388659|NCT04153149|520633990|FG002|Double Blind Period|Death|0|||
144388660|NCT04153149|520633991|FG003|Double Blind Period|Death|0|||
144388661|NCT04153149|520633988|FG000|Double Blind Period|Withdrawal by Subject|16|||
144388662|NCT04153149|520633989|FG001|Double Blind Period|Withdrawal by Subject|11|||
144388663|NCT04153149|520633990|FG002|Double Blind Period|Withdrawal by Subject|0|||
144388664|NCT04153149|520633991|FG003|Double Blind Period|Withdrawal by Subject|0|||
144388665|NCT04153149|520633988|FG000|Double Blind Period|Adverse Event|6|||
144388666|NCT04153149|520633989|FG001|Double Blind Period|Adverse Event|2|||
144388667|NCT04153149|520633990|FG002|Double Blind Period|Adverse Event|0|||
144388668|NCT04153149|520633991|FG003|Double Blind Period|Adverse Event|0|||
144388669|NCT04153149|520633988|FG000|Double Blind Period|Lost to Follow-up|2|||
144388670|NCT04153149|520633989|FG001|Double Blind Period|Lost to Follow-up|1|||
144388671|NCT04153149|520633990|FG002|Double Blind Period|Lost to Follow-up|0|||
144388672|NCT04153149|520633991|FG003|Double Blind Period|Lost to Follow-up|0|||
144388673|NCT04153149|520633988|FG000|Double Blind Period|Withdrawal by guardian|0|||
144388674|NCT04153149|520633989|FG001|Double Blind Period|Withdrawal by guardian|2|||
144388675|NCT04153149|520633990|FG002|Double Blind Period|Withdrawal by guardian|0|||
144388676|NCT04153149|520633991|FG003|Double Blind Period|Withdrawal by guardian|0|||
144388677|NCT04153149|520633988|FG000|Double Blind Period|Reason Not Specified|5|||
144388678|NCT04153149|520633989|FG001|Double Blind Period|Reason Not Specified|4|||
144388679|NCT04153149|520633990|FG002|Double Blind Period|Reason Not Specified|0|||
144388680|NCT04153149|520633991|FG003|Double Blind Period|Reason Not Specified|0|||
144388681|NCT04153149|520633988|FG000|Double Blind Period|Physician Decision|2|||
144388682|NCT04153149|520633989|FG001|Double Blind Period|Physician Decision|0|||
144388683|NCT04153149|520633990|FG002|Double Blind Period|Physician Decision|0|||
144388684|NCT04153149|520633991|FG003|Double Blind Period|Physician Decision|0|||
144388685|NCT04153149|520633988|FG000|Open Label Extension Period|Death|0|||
144388686|NCT04153149|520633989|FG001|Open Label Extension Period|Death|0|||
144388687|NCT04153149|520633990|FG002|Open Label Extension Period|Death|7|||
144388688|NCT04153149|520633991|FG003|Open Label Extension Period|Death|3|||
144388689|NCT04153149|520633988|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
144388690|NCT04153149|520633989|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
144388691|NCT04153149|520633990|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
144388692|NCT04153149|520633991|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
144388693|NCT04153149|520633988|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
144388694|NCT04153149|520633989|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
144388695|NCT04153149|520633990|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
144388696|NCT04153149|520633991|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
144388697|NCT04153149|520633988|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
144388698|NCT04153149|520633989|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
144516012|NCT03271489|521088994|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
144516013|NCT03271489|521088995|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
144516014|NCT03271489|521088994|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
144516015|NCT03271489|521088995|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
144516016|NCT03271489|521088994|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
144516017|NCT03271489|521088995|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
144516018|NCT03271489|521088994|FG000|Open-Label (OL) Period|No Specified|2|||
144516019|NCT03271489|521088995|FG001|Open-Label (OL) Period|No Specified|2|||
144516020|NCT03271489|521088994|FG000|Open-Label (OL) Period|Missing|2|||
144516021|NCT03271489|521088995|FG001|Open-Label (OL) Period|Missing|0|||
144516022|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
144516023|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
144516024|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
144516025|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
144516026|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
144516027|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
144516028|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
144516029|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
144516030|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
144516031|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
144516032|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
144516033|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
144516034|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
144516035|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
144516036|NCT03271489|521088994|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
144516037|NCT03271489|521088995|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
144516038|NCT02860130|521088996|FG000|Overall Study|Adverse Event|2|||
144516039|NCT02860130|521088997|FG001|Overall Study|Adverse Event|3|||
144516040|NCT02860130|521088996|FG000|Overall Study|Protocol Violation|1|||
144516041|NCT02860130|521088997|FG001|Overall Study|Protocol Violation|1|||
144516042|NCT02860130|521088996|FG000|Overall Study|Withdrawal by Subject|0|||
144516043|NCT02860130|521088997|FG001|Overall Study|Withdrawal by Subject|2|||
144516044|NCT02860130|521088996|FG000|Overall Study|Physician Decision|2|||
144516045|NCT02860130|521088997|FG001|Overall Study|Physician Decision|2|||
144516046|NCT02860130|521088996|FG000|Overall Study|Other|2|||
144516047|NCT02860130|521088997|FG001|Overall Study|Other|1|||
144516048|NCT01467427|521088998|FG000|Overall Study|Withdrawal by Subject|1|||
144722112|NCT03271528|521836975|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
144516049|NCT01467427|521088999|FG001|Overall Study|Withdrawal by Subject|0|||
144388699|NCT04153149|520633990|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
144388700|NCT04153149|520633991|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
144388701|NCT00625742|520635519|FG000|Overall Study|Disease Progression|2|||
144388702|NCT00625742|520635519|FG000|Overall Study|Withdrawal by Subject|1|||
144388703|NCT00625742|520635519|FG000|Overall Study|Adverse Event|4|||
144388704|NCT00625742|520635519|FG000|Overall Study|Lost to Follow-up|4|||
144388705|NCT00625742|520635519|FG000|Overall Study|Ineligible|1|||
144516050|NCT01467427|521088998|FG000|Overall Study|Not continuing in extension phase|0|||
144516051|NCT01467427|521088999|FG001|Overall Study|Not continuing in extension phase|2|||
144516052|NCT01467427|521088998|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
144516053|NCT01467427|521088999|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
144388706|NCT00371761|520635520|FG000|Overall Study|Adverse Event|1|||
144388707|NCT00371761|520635521|FG001|Overall Study|Adverse Event|1|||
144388708|NCT00371761|520635520|FG000|Overall Study|Withdrawal by Subject|1|||
144388709|NCT00371761|520635521|FG001|Overall Study|Withdrawal by Subject|3|||
144388710|NCT00371761|520635520|FG000|Overall Study|Investigator Judgment|2|||
144388711|NCT00371761|520635521|FG001|Overall Study|Investigator Judgment|3|||
144388712|NCT00371761|520635520|FG000|Overall Study|Study termination|4|||
144388713|NCT00371761|520635521|FG001|Overall Study|Study termination|3|||
144388714|NCT05040971|520635523|FG000|Overall Study|Withdrawal by Subject|0|||
144388715|NCT05040971|520635524|FG001|Overall Study|Withdrawal by Subject|2|||
144388716|NCT05040971|520635523|FG000|Overall Study|Lost to Follow-up|8|||
144388717|NCT05040971|520635524|FG001|Overall Study|Lost to Follow-up|3|||
144388718|NCT05040971|520635523|FG000|Overall Study|Death|2|||
144388719|NCT05040971|520635524|FG001|Overall Study|Death|0|||
144516054|NCT01467427|521088998|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
144516055|NCT01467427|521088999|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
144516056|NCT01467427|521088998|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
144516057|NCT01467427|521088999|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
144516058|NCT01467427|521088998|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
144516059|NCT01467427|521088999|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
144516060|NCT02137850|521089004|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
144516061|NCT02137850|521089005|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
144516062|NCT02137850|521089006|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
144516063|NCT02137850|521089004|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
144516064|NCT02137850|521089005|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
144516065|NCT02137850|521089006|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
144516066|NCT02137850|521089004|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
144516067|NCT02137850|521089005|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
144516068|NCT02137850|521089006|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
144516069|NCT02137850|521089004|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
144516070|NCT02137850|521089005|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
144516071|NCT02137850|521089006|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
144516072|NCT02137850|521089004|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
144516073|NCT02137850|521089005|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
144516074|NCT02137850|521089006|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
144516075|NCT02137850|521089004|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
144516076|NCT02137850|521089005|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
144516077|NCT02137850|521089006|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
144516078|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
144516079|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
144516080|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
144516081|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
144516082|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
144516083|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
144516084|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
144516085|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
144516086|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
144516087|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
144516088|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
144516089|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
144516090|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Other|0|||
144516091|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Other|1|||
144516092|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Other|0|||
144516093|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
144516094|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
144516095|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
144516096|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Early site closure|0|||
144516097|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Early site closure|2|||
144516098|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Early site closure|0|||
144516099|NCT02137850|521089004|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
144516100|NCT02137850|521089005|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
144516101|NCT02137850|521089006|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
144722113|NCT03271528|521836974|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
144722114|NCT03271528|521836975|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
144388720|NCT02241889|520635530|FG000|Overall Study|device issues|0|||
144388721|NCT02241889|520635531|FG001|Overall Study|device issues|0|||
144516102|NCT02137850|521089004|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
144722115|NCT03271528|521836974|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
144388722|NCT02241889|520635532|FG002|Overall Study|device issues|1|||
144388723|NCT02241889|520635533|FG003|Overall Study|device issues|0|||
144388724|NCT02241889|520635534|FG004|Overall Study|device issues|0|||
144388725|NCT02241889|520635535|FG005|Overall Study|device issues|0|||
144388726|NCT02241889|520635530|FG000|Overall Study|Withdrawal by Subject|0|||
144388727|NCT02241889|520635531|FG001|Overall Study|Withdrawal by Subject|0|||
144388728|NCT02241889|520635532|FG002|Overall Study|Withdrawal by Subject|0|||
144388729|NCT02241889|520635533|FG003|Overall Study|Withdrawal by Subject|0|||
144388730|NCT02241889|520635534|FG004|Overall Study|Withdrawal by Subject|0|||
144388731|NCT02241889|520635535|FG005|Overall Study|Withdrawal by Subject|1|||
144388732|NCT00773838|520635536|FG000|Overall Study|Adverse Event|29|||
144516103|NCT02137850|521089005|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
144388733|NCT00773838|520635536|FG000|Overall Study|Lost to Follow-up|1|||
144388734|NCT00773838|520635536|FG000|Overall Study|Physician Decision|8|||
144388735|NCT00773838|520635536|FG000|Overall Study|Progressive Disease|82|||
144388736|NCT00773838|520635536|FG000|Overall Study|Protocol Violation|2|||
144388737|NCT00773838|520635536|FG000|Overall Study|Withdrawal by Subject|21|||
144388738|NCT01589770|520635538|FG000|Overall Study|EGFR <60ml/min|6|||
144388739|NCT01589770|520635539|FG001|Overall Study|EGFR <60ml/min|4|||
144388740|NCT01589770|520635538|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
144516104|NCT02137850|521089006|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
144516105|NCT02137850|521089004|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
144516106|NCT02137850|521089005|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
144516107|NCT02137850|521089006|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
144516108|NCT02137850|521089004|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
144516109|NCT02137850|521089005|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
144516110|NCT02137850|521089006|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
144516111|NCT02137850|521089004|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
144516112|NCT02137850|521089005|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
144516113|NCT02137850|521089006|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
144516114|NCT02137850|521089004|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
144516115|NCT02137850|521089005|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
144516116|NCT02137850|521089006|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
144516117|NCT02137850|521089004|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
144516118|NCT02137850|521089005|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
144516119|NCT02137850|521089006|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
144516120|NCT02137850|521089004|FG000|Extension Phase: Prophylaxis|Other|0|||
144516121|NCT02137850|521089005|FG001|Extension Phase: Prophylaxis|Other|1|||
144516122|NCT02137850|521089006|FG002|Extension Phase: Prophylaxis|Other|0|||
144516123|NCT02137850|521089004|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
144516124|NCT02137850|521089005|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
144516125|NCT02137850|521089006|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
144516126|NCT05494788|521089007|FG000|Initial Treatment Period|Adverse Event|2|||
144516127|NCT05494788|521089007|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
144516128|NCT05494788|521089007|FG000|Extension Period|Adverse Event|1|||
144516129|NCT05494788|521089007|FG000|Extension Period|Withdrawal by Subject|1|||
144516130|NCT05480943|521089008|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
144516131|NCT05480943|521089008|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
144388741|NCT01589770|520635539|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
144388742|NCT01853618|520635542|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
144516132|NCT05480943|521089008|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
144516133|NCT05480943|521089008|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
144516134|NCT00136435|521089009|FG000|Overall Study|Ineligible|8|||
144516135|NCT00136435|521089009|FG000|Overall Study|Induction Death|1|||
144516136|NCT00136435|521089009|FG000|Overall Study|Induction Failure|10|||
144516137|NCT00136435|521089009|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
144516138|NCT00136435|521089009|FG000|Overall Study|Withdrawal by Subject|3|||
144516139|NCT00136435|521089009|FG000|Overall Study|Adverse Event|19|||
144516140|NCT00136435|521089009|FG000|Overall Study|Relapse|4|||
144516141|NCT00136435|521089009|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
144516142|NCT02794480|521089010|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
144516143|NCT02794480|521089011|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
144516144|NCT02794480|521089012|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
144516145|NCT02794480|521089013|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
144516146|NCT02794480|521089010|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
144516147|NCT02794480|521089011|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
144516148|NCT02794480|521089012|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
144516149|NCT02794480|521089013|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
144516150|NCT02794480|521089010|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144516151|NCT02794480|521089011|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144516152|NCT02794480|521089012|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144516153|NCT02794480|521089013|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
144516154|NCT02794480|521089010|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144516155|NCT02794480|521089011|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
144516156|NCT02794480|521089012|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144516157|NCT02794480|521089013|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
144516158|NCT02794480|521089010|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
144516159|NCT02794480|521089011|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144516160|NCT02794480|521089012|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144516161|NCT02794480|521089013|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
144516162|NCT00901901|521089014|FG000|Treatment Period|Adverse Event|120|||
144516163|NCT00901901|521089015|FG001|Treatment Period|Adverse Event|128|||
144516164|NCT00901901|521089014|FG000|Treatment Period|Withdrawal by Subject|26|||
144516165|NCT00901901|521089015|FG001|Treatment Period|Withdrawal by Subject|24|||
144516166|NCT00901901|521089014|FG000|Treatment Period|Physician Decision|2|||
144516167|NCT00901901|521089015|FG001|Treatment Period|Physician Decision|2|||
144516168|NCT00901901|521089014|FG000|Treatment Period|Lost to Follow-up|3|||
144516169|NCT00901901|521089015|FG001|Treatment Period|Lost to Follow-up|5|||
144516170|NCT00901901|521089014|FG000|Treatment Period|Noncompliance with study medication|4|||
144516171|NCT00901901|521089015|FG001|Treatment Period|Noncompliance with study medication|1|||
144516172|NCT00901901|521089014|FG000|Treatment Period|Missing|1|||
144516173|NCT00901901|521089015|FG001|Treatment Period|Missing|0|||
144516174|NCT00901901|521089014|FG000|Treatment Period|Never treated|0|||
144516175|NCT00901901|521089015|FG001|Treatment Period|Never treated|3|||
144516176|NCT00901901|521089014|FG000|Treatment Period|Protocol driven decision point|0|||
144516177|NCT00901901|521089015|FG001|Treatment Period|Protocol driven decision point|2|||
144516178|NCT00901901|521089014|FG000|Treatment Period|Study terminated by sponsor|2|||
144516179|NCT00901901|521089015|FG001|Treatment Period|Study terminated by sponsor|0|||
144516180|NCT00901901|521089014|FG000|Treatment Period|Protocol Violation|5|||
144516181|NCT00901901|521089015|FG001|Treatment Period|Protocol Violation|9|||
144516182|NCT00901901|521089014|FG000|Treatment Period|Switch to commercial drug|1|||
144516183|NCT00901901|521089015|FG001|Treatment Period|Switch to commercial drug|1|||
144516184|NCT00901901|521089014|FG000|Treatment Period|Transfer to treatment continuation study|5|||
144516185|NCT00901901|521089015|FG001|Treatment Period|Transfer to treatment continuation study|2|||
144516186|NCT00901901|521089014|FG000|Follow-up Period|Death|181|||
144516187|NCT00901901|521089015|FG001|Follow-up Period|Death|208|||
144516188|NCT00901901|521089014|FG000|Follow-up Period|Protocol driven decision point|47|||
144516189|NCT00901901|521089015|FG001|Follow-up Period|Protocol driven decision point|36|||
144516190|NCT00901901|521089014|FG000|Follow-up Period|Withdrawal by Subject|6|||
144516191|NCT00901901|521089015|FG001|Follow-up Period|Withdrawal by Subject|9|||
144516192|NCT00901901|521089014|FG000|Follow-up Period|Lost to Follow-up|12|||
144516193|NCT00901901|521089015|FG001|Follow-up Period|Lost to Follow-up|8|||
144516194|NCT00901901|521089014|FG000|Follow-up Period|Missing|94|||
144516195|NCT00901901|521089015|FG001|Follow-up Period|Missing|80|||
144516196|NCT00632749|521089018|FG000|Overall Study|Progressive disease|3|||
144516197|NCT00632749|521089019|FG001|Overall Study|Progressive disease|2|||
144516198|NCT00632749|521089020|FG002|Overall Study|Progressive disease|2|||
144516199|NCT00632749|521089021|FG003|Overall Study|Progressive disease|2|||
144593036|NCT03184870|521372349|FG005|Initial Treatment|Moved to crossover treatment|0|||
144516200|NCT00632749|521089022|FG004|Overall Study|Progressive disease|4|||
144516201|NCT00632749|521089023|FG005|Overall Study|Progressive disease|4|||
144516202|NCT00632749|521089024|FG006|Overall Study|Progressive disease|3|||
144593037|NCT03184870|521372350|FG006|Initial Treatment|Moved to crossover treatment|0|||
144516203|NCT00632749|521089025|FG007|Overall Study|Progressive disease|2|||
144593038|NCT03184870|521372351|FG007|Initial Treatment|Moved to crossover treatment|0|||
144516204|NCT00632749|521089026|FG008|Overall Study|Progressive disease|3|||
144388743|NCT01853618|520635543|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
144388744|NCT01853618|520635544|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
144388745|NCT01853618|520635545|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
144388746|NCT01853618|520635546|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
144516205|NCT00632749|521089027|FG009|Overall Study|Progressive disease|2|||
144593039|NCT03184870|521372352|FG008|Initial Treatment|Moved to crossover treatment|0|||
144593040|NCT03184870|521372353|FG009|Initial Treatment|Moved to crossover treatment|0|||
144593041|NCT03184870|521372354|FG010|Initial Treatment|Moved to crossover treatment|0|||
144593042|NCT03184870|521372355|FG011|Initial Treatment|Moved to crossover treatment|0|||
144593043|NCT03184870|521372356|FG012|Initial Treatment|Moved to crossover treatment|9|||
144593044|NCT03184870|521372357|FG013|Initial Treatment|Moved to crossover treatment|0|||
144388747|NCT01853618|520635542|FG000|Overall Study|Progressive disease|1|||
144516206|NCT00632749|521089028|FG010|Overall Study|Progressive disease|4|||
144516207|NCT00632749|521089029|FG011|Overall Study|Progressive disease|3|||
144516208|NCT00632749|521089030|FG012|Overall Study|Progressive disease|2|||
144516209|NCT00632749|521089031|FG013|Overall Study|Progressive disease|4|||
144516210|NCT00632749|521089018|FG000|Overall Study|Other Adverse event|1|||
144516211|NCT00632749|521089019|FG001|Overall Study|Other Adverse event|1|||
144516212|NCT00632749|521089020|FG002|Overall Study|Other Adverse event|1|||
144516213|NCT00632749|521089021|FG003|Overall Study|Other Adverse event|1|||
144516214|NCT00632749|521089022|FG004|Overall Study|Other Adverse event|2|||
144516215|NCT00632749|521089023|FG005|Overall Study|Other Adverse event|4|||
144516216|NCT00632749|521089024|FG006|Overall Study|Other Adverse event|1|||
144516217|NCT00632749|521089025|FG007|Overall Study|Other Adverse event|2|||
144516218|NCT00632749|521089026|FG008|Overall Study|Other Adverse event|2|||
144516219|NCT00632749|521089027|FG009|Overall Study|Other Adverse event|0|||
144516220|NCT00632749|521089028|FG010|Overall Study|Other Adverse event|1|||
144516221|NCT00632749|521089029|FG011|Overall Study|Other Adverse event|0|||
144516222|NCT00632749|521089030|FG012|Overall Study|Other Adverse event|1|||
144516223|NCT00632749|521089031|FG013|Overall Study|Other Adverse event|0|||
144516224|NCT00632749|521089018|FG000|Overall Study|Refuse to continue medication|0|||
144516225|NCT00632749|521089019|FG001|Overall Study|Refuse to continue medication|0|||
144516226|NCT00632749|521089020|FG002|Overall Study|Refuse to continue medication|0|||
144516227|NCT00632749|521089021|FG003|Overall Study|Refuse to continue medication|1|||
144516228|NCT00632749|521089022|FG004|Overall Study|Refuse to continue medication|0|||
144516229|NCT00632749|521089023|FG005|Overall Study|Refuse to continue medication|0|||
144516230|NCT00632749|521089024|FG006|Overall Study|Refuse to continue medication|0|||
144516231|NCT00632749|521089025|FG007|Overall Study|Refuse to continue medication|0|||
144516232|NCT00632749|521089026|FG008|Overall Study|Refuse to continue medication|0|||
144516233|NCT00632749|521089027|FG009|Overall Study|Refuse to continue medication|1|||
144516234|NCT00632749|521089028|FG010|Overall Study|Refuse to continue medication|0|||
144516235|NCT00632749|521089029|FG011|Overall Study|Refuse to continue medication|0|||
144516236|NCT00632749|521089030|FG012|Overall Study|Refuse to continue medication|0|||
144516237|NCT00632749|521089031|FG013|Overall Study|Refuse to continue medication|0|||
144516238|NCT00632749|521089018|FG000|Overall Study|Reason other than those specified above|0|||
144516239|NCT00632749|521089019|FG001|Overall Study|Reason other than those specified above|2|||
144516240|NCT00632749|521089020|FG002|Overall Study|Reason other than those specified above|0|||
144516241|NCT00632749|521089021|FG003|Overall Study|Reason other than those specified above|0|||
144516242|NCT00632749|521089022|FG004|Overall Study|Reason other than those specified above|1|||
144516243|NCT00632749|521089023|FG005|Overall Study|Reason other than those specified above|0|||
144516244|NCT00632749|521089024|FG006|Overall Study|Reason other than those specified above|1|||
144516245|NCT00632749|521089025|FG007|Overall Study|Reason other than those specified above|0|||
144516246|NCT00632749|521089026|FG008|Overall Study|Reason other than those specified above|0|||
144516247|NCT00632749|521089027|FG009|Overall Study|Reason other than those specified above|0|||
144516248|NCT00632749|521089028|FG010|Overall Study|Reason other than those specified above|2|||
144516249|NCT00632749|521089029|FG011|Overall Study|Reason other than those specified above|1|||
144516250|NCT00632749|521089030|FG012|Overall Study|Reason other than those specified above|0|||
144516251|NCT00632749|521089031|FG013|Overall Study|Reason other than those specified above|2|||
144516252|NCT03210714|521089032|FG000|Overall Study|Adverse Event|6|||
144516253|NCT03210714|521089032|FG000|Overall Study|Physician Decision|1|||
144516254|NCT03210714|521089032|FG000|Overall Study|Progressive disease|11|||
144516255|NCT03210714|521089032|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
144516256|NCT00879333|521089033|FG000|Overall Study|Adverse Event|94|||
144516257|NCT00879333|521089034|FG001|Overall Study|Adverse Event|34|||
144593045|NCT03184870|521372358|FG014|Initial Treatment|Moved to crossover treatment|0|||
144593046|NCT03184870|521372359|FG015|Initial Treatment|Moved to crossover treatment|0|||
144593047|NCT03184870|521372360|FG016|Initial Treatment|Moved to crossover treatment|0|||
144516258|NCT00879333|521089033|FG000|Overall Study|Abnormal Laboratory Value|1|||
144516259|NCT00879333|521089034|FG001|Overall Study|Abnormal Laboratory Value|0|||
144516260|NCT00879333|521089033|FG000|Overall Study|Withdrawal by Subject|20|||
144516261|NCT00879333|521089034|FG001|Overall Study|Withdrawal by Subject|7|||
144516262|NCT00879333|521089033|FG000|Overall Study|Lost to Follow-up|2|||
144593048|NCT03184870|521372361|FG017|Initial Treatment|Moved to crossover treatment|0|||
144388748|NCT01853618|520635543|FG001|Overall Study|Progressive disease|1|||
144516263|NCT00879333|521089034|FG001|Overall Study|Lost to Follow-up|1|||
144516264|NCT00879333|521089033|FG000|Overall Study|Administrative Problems|2|||
144516265|NCT00879333|521089034|FG001|Overall Study|Administrative Problems|0|||
144516266|NCT00879333|521089033|FG000|Overall Study|Death|16|||
144516267|NCT00879333|521089034|FG001|Overall Study|Death|5|||
144516268|NCT00879333|521089033|FG000|Overall Study|Disease Progression|292|||
144516269|NCT00879333|521089034|FG001|Overall Study|Disease Progression|169|||
144516270|NCT00879333|521089033|FG000|Overall Study|Protocol Violation|1|||
144516271|NCT00879333|521089034|FG001|Overall Study|Protocol Violation|1|||
144388749|NCT01853618|520635544|FG002|Overall Study|Progressive disease|1|||
144388750|NCT01853618|520635545|FG003|Overall Study|Progressive disease|1|||
144388751|NCT01853618|520635546|FG004|Overall Study|Progressive disease|2|||
144388752|NCT01853618|520635542|FG000|Overall Study|Physician Decision|0|||
144388753|NCT01853618|520635543|FG001|Overall Study|Physician Decision|1|||
144388754|NCT01853618|520635544|FG002|Overall Study|Physician Decision|1|||
144388755|NCT01853618|520635545|FG003|Overall Study|Physician Decision|0|||
144388756|NCT01853618|520635546|FG004|Overall Study|Physician Decision|0|||
144388757|NCT01853618|520635542|FG000|Overall Study|Refused further treatment|0|||
144388758|NCT01853618|520635543|FG001|Overall Study|Refused further treatment|0|||
144388759|NCT01853618|520635544|FG002|Overall Study|Refused further treatment|0|||
144516272|NCT02671435|521089042|FG000|Overall Study|Death|1|||
144516273|NCT02671435|521089043|FG001|Overall Study|Death|3|||
144516274|NCT02671435|521089044|FG002|Overall Study|Death|0|||
144516275|NCT02671435|521089045|FG003|Overall Study|Death|16|||
144516276|NCT02671435|521089046|FG004|Overall Study|Death|14|||
144516277|NCT02671435|521089047|FG005|Overall Study|Death|29|||
144516278|NCT02671435|521089048|FG006|Overall Study|Death|34|||
144516279|NCT02671435|521089049|FG007|Overall Study|Death|28|||
144516280|NCT02671435|521089050|FG008|Overall Study|Death|19|||
144516281|NCT02671435|521089051|FG009|Overall Study|Death|10|||
144516282|NCT02671435|521089052|FG010|Overall Study|Death|8|||
144516283|NCT02671435|521089053|FG011|Overall Study|Death|29|||
144516284|NCT02671435|521089054|FG012|Overall Study|Death|29|||
144516285|NCT02671435|521089055|FG013|Overall Study|Death|29|||
144516286|NCT02671435|521089056|FG014|Overall Study|Death|27|||
144516287|NCT02671435|521089042|FG000|Overall Study|Lost to Follow-up|0|||
144516288|NCT02671435|521089043|FG001|Overall Study|Lost to Follow-up|0|||
144516289|NCT02671435|521089044|FG002|Overall Study|Lost to Follow-up|1|||
144516290|NCT02671435|521089045|FG003|Overall Study|Lost to Follow-up|0|||
144516291|NCT02671435|521089046|FG004|Overall Study|Lost to Follow-up|1|||
144516292|NCT02671435|521089047|FG005|Overall Study|Lost to Follow-up|1|||
144516293|NCT02671435|521089048|FG006|Overall Study|Lost to Follow-up|2|||
144516294|NCT02671435|521089049|FG007|Overall Study|Lost to Follow-up|2|||
144516295|NCT02671435|521089050|FG008|Overall Study|Lost to Follow-up|0|||
144516296|NCT02671435|521089051|FG009|Overall Study|Lost to Follow-up|2|||
144516297|NCT02671435|521089052|FG010|Overall Study|Lost to Follow-up|0|||
144516298|NCT02671435|521089053|FG011|Overall Study|Lost to Follow-up|3|||
144516299|NCT02671435|521089054|FG012|Overall Study|Lost to Follow-up|3|||
144516300|NCT02671435|521089055|FG013|Overall Study|Lost to Follow-up|2|||
144516301|NCT02671435|521089056|FG014|Overall Study|Lost to Follow-up|0|||
144516302|NCT02671435|521089042|FG000|Overall Study|Withdrawal by Subject|2|||
144516303|NCT02671435|521089043|FG001|Overall Study|Withdrawal by Subject|0|||
144516304|NCT02671435|521089044|FG002|Overall Study|Withdrawal by Subject|2|||
144516305|NCT02671435|521089045|FG003|Overall Study|Withdrawal by Subject|2|||
144516306|NCT02671435|521089046|FG004|Overall Study|Withdrawal by Subject|2|||
144516307|NCT02671435|521089047|FG005|Overall Study|Withdrawal by Subject|7|||
144388760|NCT01853618|520635545|FG003|Overall Study|Refused further treatment|0|||
144516308|NCT02671435|521089048|FG006|Overall Study|Withdrawal by Subject|2|||
144516309|NCT02671435|521089049|FG007|Overall Study|Withdrawal by Subject|7|||
144516310|NCT02671435|521089050|FG008|Overall Study|Withdrawal by Subject|1|||
144516311|NCT02671435|521089051|FG009|Overall Study|Withdrawal by Subject|1|||
144516312|NCT02671435|521089052|FG010|Overall Study|Withdrawal by Subject|2|||
144516313|NCT02671435|521089053|FG011|Overall Study|Withdrawal by Subject|4|||
144516314|NCT02671435|521089054|FG012|Overall Study|Withdrawal by Subject|4|||
144516315|NCT02671435|521089055|FG013|Overall Study|Withdrawal by Subject|4|||
144516316|NCT02671435|521089056|FG014|Overall Study|Withdrawal by Subject|2|||
144516317|NCT02671435|521089042|FG000|Overall Study|Un-specified|0|||
144516318|NCT02671435|521089043|FG001|Overall Study|Un-specified|0|||
144516319|NCT02671435|521089044|FG002|Overall Study|Un-specified|0|||
144388761|NCT01853618|520635546|FG004|Overall Study|Refused further treatment|1|||
144516320|NCT02671435|521089045|FG003|Overall Study|Un-specified|0|||
144516321|NCT02671435|521089046|FG004|Overall Study|Un-specified|1|||
144516322|NCT02671435|521089047|FG005|Overall Study|Un-specified|3|||
144388762|NCT01658813|520635547|FG000|Overall Study|Disease progression|3|||
144388763|NCT02283177|520635548|FG000|Overall Study|Withdrawal by Subject|1|||
144388764|NCT02283177|520635549|FG001|Overall Study|Withdrawal by Subject|1|||
144388765|NCT01101191|520635554|FG000|Period 1|Withdrawal by Subject|1|||
144388766|NCT01101191|520635555|FG001|Period 1|Withdrawal by Subject|0|||
144388767|NCT01101191|520635554|FG000|Period 1|Adverse Event|1|||
144388768|NCT01101191|520635555|FG001|Period 1|Adverse Event|2|||
144516323|NCT02671435|521089048|FG006|Overall Study|Un-specified|2|||
144516324|NCT02671435|521089049|FG007|Overall Study|Un-specified|3|||
144516325|NCT02671435|521089050|FG008|Overall Study|Un-specified|0|||
144516326|NCT02671435|521089051|FG009|Overall Study|Un-specified|5|||
144516327|NCT02671435|521089052|FG010|Overall Study|Un-specified|8|||
144516328|NCT02671435|521089053|FG011|Overall Study|Un-specified|4|||
144516329|NCT02671435|521089054|FG012|Overall Study|Un-specified|5|||
144516330|NCT02671435|521089055|FG013|Overall Study|Un-specified|9|||
144516331|NCT02671435|521089056|FG014|Overall Study|Un-specified|8|||
144516332|NCT03432858|521089057|FG000|Overall Study|Protocol Violation|2|||
144516333|NCT03432858|521089058|FG001|Overall Study|Protocol Violation|1|||
144516334|NCT03432858|521089059|FG002|Overall Study|Protocol Violation|9|||
144516335|NCT03432858|521089057|FG000|Overall Study|Withdrawal by Subject|0|||
144516336|NCT03432858|521089058|FG001|Overall Study|Withdrawal by Subject|1|||
144516337|NCT03432858|521089059|FG002|Overall Study|Withdrawal by Subject|1|||
144516338|NCT03432858|521089057|FG000|Overall Study|Procedure canceled/rescheduled|0|||
144516339|NCT03432858|521089058|FG001|Overall Study|Procedure canceled/rescheduled|9|||
144516340|NCT03432858|521089059|FG002|Overall Study|Procedure canceled/rescheduled|6|||
144516341|NCT03432858|521089057|FG000|Overall Study|Required postop mobilization with splinting|0|||
144516342|NCT03432858|521089058|FG001|Overall Study|Required postop mobilization with splinting|0|||
144516343|NCT03432858|521089059|FG002|Overall Study|Required postop mobilization with splinting|1|||
144516344|NCT01424670|521089060|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
144516345|NCT01424670|521089061|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
144516346|NCT01424670|521089060|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
144516347|NCT01424670|521089061|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
144516348|NCT01424670|521089060|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
144516349|NCT01424670|521089061|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
144516350|NCT01424670|521089060|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
144516351|NCT01424670|521089061|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
144516352|NCT01424670|521089060|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
144516353|NCT01424670|521089061|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
144516354|NCT01424670|521089060|FG000|Continuation Period|Adverse Event|13|||
144516355|NCT01424670|521089061|FG001|Continuation Period|Adverse Event|5|||
144516356|NCT01424670|521089060|FG000|Continuation Period|Lost to Follow-up|2|||
144516357|NCT01424670|521089061|FG001|Continuation Period|Lost to Follow-up|0|||
144516358|NCT01424670|521089060|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
144516359|NCT01424670|521089061|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
144516360|NCT01424670|521089060|FG000|Continuation Period|Physician Decision|5|||
144516361|NCT01424670|521089061|FG001|Continuation Period|Physician Decision|4|||
144593049|NCT03184870|521372344|FG000|Crossover Treatment|Other reasons|0|||
144593050|NCT03184870|521372345|FG001|Crossover Treatment|Other reasons|0|||
144593051|NCT03184870|521372346|FG002|Crossover Treatment|Other reasons|0|||
144593052|NCT03184870|521372347|FG003|Crossover Treatment|Other reasons|0|||
144388769|NCT02009384|520635556|FG000|Overall Study|Death|2|||
144388770|NCT01092832|520635557|FG000|Overall Study|Other|1|||
144516362|NCT01424670|521089060|FG000|Continuation Period|Withdrawal by Subject|13|||
144593053|NCT03184870|521372348|FG004|Crossover Treatment|Other reasons|0|||
144388771|NCT01092832|520635558|FG001|Overall Study|Other|0|||
144593054|NCT03184870|521372349|FG005|Crossover Treatment|Other reasons|0|||
144388772|NCT00722371|520635559|FG000|Overall Study|Adverse Event|6|||
144388773|NCT00722371|520635560|FG001|Overall Study|Adverse Event|13|||
144388774|NCT00722371|520635561|FG002|Overall Study|Adverse Event|9|||
144388775|NCT00722371|520635562|FG003|Overall Study|Adverse Event|10|||
144388776|NCT00722371|520635563|FG004|Overall Study|Adverse Event|6|||
144388777|NCT00722371|520635564|FG005|Overall Study|Adverse Event|8|||
144388778|NCT00722371|520635565|FG006|Overall Study|Adverse Event|4|||
144388779|NCT00722371|520635559|FG000|Overall Study|Contraindication|0|||
144388780|NCT00722371|520635560|FG001|Overall Study|Contraindication|0|||
144388781|NCT00722371|520635561|FG002|Overall Study|Contraindication|1|||
144388782|NCT00722371|520635562|FG003|Overall Study|Contraindication|0|||
144388783|NCT00722371|520635563|FG004|Overall Study|Contraindication|0|||
144388784|NCT00722371|520635564|FG005|Overall Study|Contraindication|0|||
144388785|NCT00722371|520635565|FG006|Overall Study|Contraindication|0|||
144388786|NCT00722371|520635559|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
144388787|NCT00722371|520635560|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
144388788|NCT00722371|520635561|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
144388789|NCT00722371|520635562|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
144388790|NCT00722371|520635563|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
144388791|NCT00722371|520635564|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
144388792|NCT00722371|520635565|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
144388793|NCT00722371|520635559|FG000|Overall Study|Excluded medication|0|||
144388794|NCT00722371|520635560|FG001|Overall Study|Excluded medication|1|||
144388795|NCT00722371|520635561|FG002|Overall Study|Excluded medication|1|||
144388796|NCT00722371|520635562|FG003|Overall Study|Excluded medication|0|||
144388797|NCT00722371|520635563|FG004|Overall Study|Excluded medication|0|||
144388798|NCT00722371|520635564|FG005|Overall Study|Excluded medication|0|||
144388799|NCT00722371|520635565|FG006|Overall Study|Excluded medication|1|||
144388800|NCT00722371|520635559|FG000|Overall Study|Hyperglycemia|2|||
144388801|NCT00722371|520635560|FG001|Overall Study|Hyperglycemia|6|||
144388802|NCT00722371|520635561|FG002|Overall Study|Hyperglycemia|4|||
144388803|NCT00722371|520635562|FG003|Overall Study|Hyperglycemia|2|||
144388804|NCT00722371|520635563|FG004|Overall Study|Hyperglycemia|5|||
144516363|NCT01424670|521089061|FG001|Continuation Period|Withdrawal by Subject|4|||
144516364|NCT00761189|521089062|FG000|Overall Study|Adverse Event|42|||
144516365|NCT00761189|521089062|FG000|Overall Study|Lack of Efficacy|45|||
144516366|NCT00761189|521089062|FG000|Overall Study|Lost to Follow-up|36|||
144516367|NCT00761189|521089062|FG000|Overall Study|Withdrawal by Subject|49|||
144516368|NCT00761189|521089062|FG000|Overall Study|Other|13|||
144516369|NCT01494922|521089063|FG000|Overall Study|Adverse Event|1|||
144516370|NCT03988842|521089064|FG000|Overall Study|Death|1|||
144516371|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
144516372|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
144516373|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
144516374|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
144516375|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
144516376|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
144516377|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
144516378|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
144516379|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
144516380|NCT03939312|521089066|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
144516381|NCT03939312|521089066|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
144388805|NCT00722371|520635564|FG005|Overall Study|Hyperglycemia|1|||
144388806|NCT00722371|520635565|FG006|Overall Study|Hyperglycemia|1|||
144388807|NCT00722371|520635559|FG000|Overall Study|Hypoglycemia|1|||
144388808|NCT00722371|520635560|FG001|Overall Study|Hypoglycemia|0|||
144388809|NCT00722371|520635561|FG002|Overall Study|Hypoglycemia|0|||
144388810|NCT00722371|520635562|FG003|Overall Study|Hypoglycemia|0|||
144388811|NCT00722371|520635563|FG004|Overall Study|Hypoglycemia|0|||
144388812|NCT00722371|520635564|FG005|Overall Study|Hypoglycemia|0|||
144388813|NCT00722371|520635565|FG006|Overall Study|Hypoglycemia|0|||
144388814|NCT00722371|520635559|FG000|Overall Study|Lack of Efficacy|4|||
144593055|NCT03184870|521372350|FG006|Crossover Treatment|Other reasons|0|||
144388815|NCT00722371|520635560|FG001|Overall Study|Lack of Efficacy|6|||
144388816|NCT00722371|520635561|FG002|Overall Study|Lack of Efficacy|6|||
144388817|NCT00722371|520635562|FG003|Overall Study|Lack of Efficacy|6|||
144388818|NCT00722371|520635563|FG004|Overall Study|Lack of Efficacy|2|||
144388819|NCT00722371|520635564|FG005|Overall Study|Lack of Efficacy|3|||
144388820|NCT00722371|520635565|FG006|Overall Study|Lack of Efficacy|0|||
144388821|NCT00722371|520635559|FG000|Overall Study|Lost to Follow-up|11|||
144388822|NCT00722371|520635560|FG001|Overall Study|Lost to Follow-up|14|||
144516382|NCT03939312|521089066|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
144516383|NCT02119650|521089067|FG000|Overall Study|Adverse Event|3|||
144516384|NCT02119650|521089068|FG001|Overall Study|Adverse Event|4|||
144516385|NCT02119650|521089067|FG000|Overall Study|Subject decision|2|||
144516386|NCT02119650|521089068|FG001|Overall Study|Subject decision|3|||
144516387|NCT02119650|521089067|FG000|Overall Study|Disease progression|11|||
144516388|NCT02119650|521089068|FG001|Overall Study|Disease progression|14|||
144516389|NCT02119650|521089067|FG000|Overall Study|Death|5|||
144516390|NCT02119650|521089068|FG001|Overall Study|Death|1|||
144516391|NCT02119650|521089067|FG000|Overall Study|Noncompliance with study treatment|1|||
144516392|NCT02119650|521089068|FG001|Overall Study|Noncompliance with study treatment|1|||
144516393|NCT02119650|521089067|FG000|Overall Study|Study terminated by the sponsor|1|||
144516394|NCT02119650|521089068|FG001|Overall Study|Study terminated by the sponsor|0|||
144516395|NCT02119650|521089067|FG000|Overall Study|Physician Decision|0|||
144516396|NCT02119650|521089068|FG001|Overall Study|Physician Decision|2|||
144516397|NCT02119650|521089067|FG000|Overall Study|Multiple reasons for termination|2|||
144516398|NCT02119650|521089068|FG001|Overall Study|Multiple reasons for termination|1|||
144516399|NCT02730871|521089069|FG000|Overall Study|Adverse Event|6|||
144516400|NCT02730871|521089070|FG001|Overall Study|Adverse Event|0|||
144516401|NCT03690206|521089071|FG000|Overall Study|Withdrawal by Subject|2|||
144516402|NCT03690206|521089072|FG001|Overall Study|Withdrawal by Subject|0|||
144516403|NCT03690206|521089073|FG002|Overall Study|Withdrawal by Subject|0|||
144516404|NCT03690206|521089071|FG000|Overall Study|ICF withdrawal|2|||
144516405|NCT03690206|521089072|FG001|Overall Study|ICF withdrawal|0|||
144516406|NCT03690206|521089073|FG002|Overall Study|ICF withdrawal|0|||
144516407|NCT03978637|521089074|FG000|Overall Study|Death|0|||
144388823|NCT00722371|520635561|FG002|Overall Study|Lost to Follow-up|21|||
144516408|NCT03978637|521089075|FG001|Overall Study|Death|2|||
144516409|NCT03978637|521089076|FG002|Overall Study|Death|2|||
144516410|NCT03978637|521089077|FG003|Overall Study|Death|0|||
144593056|NCT03184870|521372351|FG007|Crossover Treatment|Other reasons|0|||
144593057|NCT03184870|521372352|FG008|Crossover Treatment|Other reasons|0|||
144593058|NCT03184870|521372353|FG009|Crossover Treatment|Other reasons|0|||
144593059|NCT03184870|521372354|FG010|Crossover Treatment|Other reasons|0|||
144593060|NCT03184870|521372355|FG011|Crossover Treatment|Other reasons|0|||
144593061|NCT03184870|521372356|FG012|Crossover Treatment|Other reasons|0|||
144593062|NCT03184870|521372357|FG013|Crossover Treatment|Other reasons|0|||
144593063|NCT03184870|521372358|FG014|Crossover Treatment|Other reasons|0|||
144593064|NCT03184870|521372359|FG015|Crossover Treatment|Other reasons|0|||
144593065|NCT03184870|521372360|FG016|Crossover Treatment|Other reasons|0|||
144593066|NCT03184870|521372361|FG017|Crossover Treatment|Other reasons|2|||
144593067|NCT03184870|521372344|FG000|Crossover Treatment|Death|0|||
144593068|NCT03184870|521372345|FG001|Crossover Treatment|Death|0|||
144593069|NCT03184870|521372346|FG002|Crossover Treatment|Death|0|||
144593070|NCT03184870|521372347|FG003|Crossover Treatment|Death|0|||
144593071|NCT03184870|521372348|FG004|Crossover Treatment|Death|0|||
144593072|NCT03184870|521372349|FG005|Crossover Treatment|Death|0|||
144388824|NCT00722371|520635562|FG003|Overall Study|Lost to Follow-up|13|||
144388825|NCT00722371|520635563|FG004|Overall Study|Lost to Follow-up|8|||
144388826|NCT00722371|520635564|FG005|Overall Study|Lost to Follow-up|16|||
144388827|NCT00722371|520635565|FG006|Overall Study|Lost to Follow-up|13|||
144388828|NCT00722371|520635559|FG000|Overall Study|Physician Decision|5|||
144516411|NCT03978637|521089074|FG000|Overall Study|Withdrawal by Subject|0|||
144516412|NCT03978637|521089075|FG001|Overall Study|Withdrawal by Subject|0|||
144516413|NCT03978637|521089076|FG002|Overall Study|Withdrawal by Subject|1|||
144516414|NCT03978637|521089077|FG003|Overall Study|Withdrawal by Subject|0|||
144516415|NCT03978637|521089074|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
144516416|NCT03978637|521089075|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
144516417|NCT03978637|521089076|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
144593073|NCT03184870|521372350|FG006|Crossover Treatment|Death|0|||
144593074|NCT03184870|521372351|FG007|Crossover Treatment|Death|0|||
144593075|NCT03184870|521372352|FG008|Crossover Treatment|Death|0|||
144593076|NCT03184870|521372353|FG009|Crossover Treatment|Death|0|||
144593077|NCT03184870|521372354|FG010|Crossover Treatment|Death|0|||
144593078|NCT03184870|521372355|FG011|Crossover Treatment|Death|0|||
144593079|NCT03184870|521372356|FG012|Crossover Treatment|Death|0|||
144593080|NCT03184870|521372357|FG013|Crossover Treatment|Death|0|||
144593081|NCT03184870|521372358|FG014|Crossover Treatment|Death|0|||
144593082|NCT03184870|521372359|FG015|Crossover Treatment|Death|0|||
144593083|NCT03184870|521372360|FG016|Crossover Treatment|Death|0|||
144593084|NCT03184870|521372361|FG017|Crossover Treatment|Death|7|||
144593085|NCT03786783|521372362|FG000|Overall Study|Death|1|||
144593086|NCT03786783|521372362|FG000|Overall Study|Physician Decision|6|||
144593087|NCT03786783|521372362|FG000|Overall Study|Withdrawal by Subject|2|||
144593088|NCT03786783|521372362|FG000|Overall Study|Disease Progression|7|||
144593089|NCT03786783|521372362|FG000|Overall Study|Patient/Parent Refusal|4|||
144593090|NCT00250679|521372365|FG000|Overall Study|Adverse Event|12|||
144593091|NCT00250679|521372366|FG001|Overall Study|Adverse Event|15|||
144593092|NCT00250679|521372367|FG002|Overall Study|Adverse Event|16|||
144593093|NCT00250679|521372365|FG000|Overall Study|Protocol Violation|2|||
144593094|NCT00250679|521372366|FG001|Overall Study|Protocol Violation|4|||
144388829|NCT00722371|520635560|FG001|Overall Study|Physician Decision|2|||
144516418|NCT03978637|521089077|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
144516419|NCT03744312|521090530|FG000|Overall Study|Withdrawal by Subject|0|||
144516420|NCT03744312|521090531|FG001|Overall Study|Withdrawal by Subject|1|||
144516421|NCT03744312|521090530|FG000|Overall Study|Screen fail|0|||
144516422|NCT03744312|521090531|FG001|Overall Study|Screen fail|1|||
144516423|NCT04924062|521090532|FG000|Overall Study|Death|49|||
144516424|NCT04924062|521090533|FG001|Overall Study|Death|63|||
144516425|NCT04924062|521090532|FG000|Overall Study|Participant On-going|26|||
144516426|NCT04924062|521090533|FG001|Overall Study|Participant On-going|20|||
144516427|NCT03899961|521090534|FG000|Overall Study|-delivery prior to|2|||
144516428|NCT03899961|521090535|FG001|Overall Study|-delivery prior to|7|||
144516429|NCT03899961|521090534|FG000|Overall Study|req general anesth|1|||
144593095|NCT00250679|521372367|FG002|Overall Study|Protocol Violation|3|||
144593096|NCT00250679|521372365|FG000|Overall Study|Withdrawal by Subject|15|||
144593097|NCT00250679|521372366|FG001|Overall Study|Withdrawal by Subject|18|||
144593098|NCT00250679|521372367|FG002|Overall Study|Withdrawal by Subject|15|||
144593099|NCT00250679|521372365|FG000|Overall Study|Lost to Follow-up|3|||
144593100|NCT00250679|521372366|FG001|Overall Study|Lost to Follow-up|4|||
144516430|NCT03899961|521090535|FG001|Overall Study|req general anesth|2|||
144516431|NCT03899961|521090534|FG000|Overall Study|capacity|5|||
144593101|NCT00250679|521372367|FG002|Overall Study|Lost to Follow-up|2|||
144593102|NCT00250679|521372365|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
144388830|NCT00722371|520635561|FG002|Overall Study|Physician Decision|2|||
144388831|NCT00722371|520635562|FG003|Overall Study|Physician Decision|5|||
144516432|NCT03899961|521090535|FG001|Overall Study|capacity|6|||
144516433|NCT03899961|521090534|FG000|Overall Study|Withdrawal by Subject|1|||
144516434|NCT03899961|521090535|FG001|Overall Study|Withdrawal by Subject|1|||
144516435|NCT04059354|521090542|FG000|Overall Study|COVID-19 pandemic|3|||
144516436|NCT02396199|521090544|FG000|Overall Study|Lost to Follow-up|1|||
144516437|NCT02396199|521090544|FG000|Overall Study|Death|4|||
144516438|NCT04093362|521090545|FG000|Overall Study|Study Termination|1|||
144516439|NCT04093362|521090546|FG001|Overall Study|Study Termination|1|||
144516440|NCT04093362|521090545|FG000|Overall Study|Withdrawal of Consent|1|||
144516441|NCT04093362|521090546|FG001|Overall Study|Withdrawal of Consent|0|||
144516442|NCT04093362|521090545|FG000|Overall Study|Death|1|||
144516443|NCT04093362|521090546|FG001|Overall Study|Death|3|||
144516444|NCT04093362|521090545|FG000|Overall Study|Reason not Specified|1|||
144516445|NCT04093362|521090546|FG001|Overall Study|Reason not Specified|2|||
144516446|NCT03055377|521090556|FG000|Treatment Phase|Lost to Follow-up|28|||
144516447|NCT03055377|521090557|FG001|Treatment Phase|Lost to Follow-up|24|||
144516448|NCT03055377|521090556|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
144516449|NCT03055377|521090557|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
144593103|NCT00250679|521372366|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
144388832|NCT00722371|520635563|FG004|Overall Study|Physician Decision|2|||
144516450|NCT04905407|521090558|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
144516451|NCT04905407|521090559|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
144516452|NCT04905407|521090560|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
144516453|NCT04905407|521090561|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
144593104|NCT00250679|521372367|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
144593105|NCT00250679|521372365|FG000|Overall Study|Lack of Efficacy|0|||
144593106|NCT00250679|521372366|FG001|Overall Study|Lack of Efficacy|1|||
144593107|NCT00250679|521372367|FG002|Overall Study|Lack of Efficacy|3|||
144593108|NCT00250679|521372365|FG000|Overall Study|Technical Holter issues|1|||
144593109|NCT00250679|521372366|FG001|Overall Study|Technical Holter issues|0|||
144593110|NCT00250679|521372367|FG002|Overall Study|Technical Holter issues|2|||
144593111|NCT00250679|521372365|FG000|Overall Study|Moved|1|||
144593112|NCT00250679|521372366|FG001|Overall Study|Moved|1|||
144593113|NCT00250679|521372367|FG002|Overall Study|Moved|0|||
144593114|NCT00250679|521372365|FG000|Overall Study|Non-compliance|1|||
144593115|NCT00250679|521372366|FG001|Overall Study|Non-compliance|1|||
144593116|NCT00250679|521372367|FG002|Overall Study|Non-compliance|0|||
144593117|NCT00250679|521372365|FG000|Overall Study|various single events: hip surgery,diary|3|||
144593118|NCT00250679|521372366|FG001|Overall Study|various single events: hip surgery,diary|1|||
144593119|NCT00250679|521372367|FG002|Overall Study|various single events: hip surgery,diary|1|||
144593120|NCT03907410|521372368|FG000|Overall Study|Lost to Follow-up|4|||
144593121|NCT03907410|521372369|FG001|Overall Study|Lost to Follow-up|1|||
144593122|NCT03907410|521372370|FG002|Overall Study|Lost to Follow-up|1|||
144593123|NCT03907410|521372368|FG000|Overall Study|Lost to follow-up and research burden|0|||
144593124|NCT03907410|521372369|FG001|Overall Study|Lost to follow-up and research burden|0|||
144593125|NCT03907410|521372370|FG002|Overall Study|Lost to follow-up and research burden|1|||
144593126|NCT04776148|521372371|FG000|Overall Study|Death|249|||
144593127|NCT04776148|521372372|FG001|Overall Study|Death|260|||
144593128|NCT04776148|521372371|FG000|Overall Study|Lost to Follow-up|0|||
144593129|NCT04776148|521372372|FG001|Overall Study|Lost to Follow-up|1|||
144593130|NCT04776148|521372371|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144593131|NCT04776148|521372372|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144593132|NCT04776148|521372371|FG000|Overall Study|Withdrawal by Subject|3|||
144593133|NCT04776148|521372372|FG001|Overall Study|Withdrawal by Subject|4|||
144593134|NCT04776148|521372371|FG000|Overall Study|Sponsor Decision|30|||
144593135|NCT04776148|521372372|FG001|Overall Study|Sponsor Decision|15|||
144593136|NCT00666679|521372376|FG000|First Intervention|Lost to Follow-up|1|||
144593137|NCT00666679|521372377|FG001|First Intervention|Lost to Follow-up|0|||
144593138|NCT00666679|521372376|FG000|First Intervention|Protocol Violation|1|||
144516454|NCT04905407|521090558|FG000|Part 1 and Part 2|Death|7|||
144516455|NCT04905407|521090559|FG001|Part 1 and Part 2|Death|7|||
144516456|NCT04905407|521090560|FG002|Part 1 and Part 2|Death|7|||
144516457|NCT04905407|521090561|FG003|Part 1 and Part 2|Death|0|||
144516458|NCT04905407|521090558|FG000|Part 1 and Part 2|Other than specified|0|||
144516459|NCT04905407|521090559|FG001|Part 1 and Part 2|Other than specified|0|||
144516460|NCT04905407|521090560|FG002|Part 1 and Part 2|Other than specified|1|||
144516461|NCT04905407|521090561|FG003|Part 1 and Part 2|Other than specified|0|||
144516462|NCT04905407|521090558|FG000|Part 3|Death|0|||
144516463|NCT04905407|521090559|FG001|Part 3|Death|0|||
144516464|NCT04905407|521090560|FG002|Part 3|Death|0|||
144516465|NCT04905407|521090561|FG003|Part 3|Death|2|||
144516466|NCT01938547|521090564|FG000|Overall Study|Physician Decision|1|||
144516467|NCT04823611|521090567|FG000|Overall Study|Adverse Event|2|||
144516468|NCT04823611|521090568|FG001|Overall Study|Adverse Event|0|||
144516469|NCT04823611|521090569|FG002|Overall Study|Adverse Event|1|||
144516470|NCT04823611|521090570|FG003|Overall Study|Adverse Event|0|||
144516471|NCT04823611|521090571|FG004|Overall Study|Adverse Event|0|||
144516472|NCT04823611|521090572|FG005|Overall Study|Adverse Event|0|||
144516473|NCT04823611|521090573|FG006|Overall Study|Adverse Event|0|||
144593139|NCT00666679|521372377|FG001|First Intervention|Protocol Violation|0|||
144593140|NCT00666679|521372376|FG000|First Intervention|Withdrawal by Subject|1|||
144593141|NCT00666679|521372377|FG001|First Intervention|Withdrawal by Subject|0|||
144516474|NCT03739996|521090577|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
144593142|NCT00666679|521372376|FG000|First Intervention|Randomized did not start treatment|1|||
144593143|NCT00666679|521372377|FG001|First Intervention|Randomized did not start treatment|1|||
144593144|NCT00666679|521372376|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
144516475|NCT03739996|521090577|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
144516476|NCT03739996|521090577|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
144593145|NCT00666679|521372377|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
144593146|NCT00666679|521372376|FG000|Washout Period of 1 Week|Protocol Violation|0|||
144593147|NCT00666679|521372377|FG001|Washout Period of 1 Week|Protocol Violation|1|||
144593148|NCT00666679|521372376|FG000|Second Intervention|Adverse Event|1|||
144516477|NCT03739996|521090577|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
144516478|NCT03739996|521090577|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
144388833|NCT00722371|520635564|FG005|Overall Study|Physician Decision|3|||
144388834|NCT00722371|520635565|FG006|Overall Study|Physician Decision|4|||
144388835|NCT00722371|520635559|FG000|Overall Study|Pregnancy|1|||
144388836|NCT00722371|520635560|FG001|Overall Study|Pregnancy|1|||
144388837|NCT00722371|520635561|FG002|Overall Study|Pregnancy|0|||
144388838|NCT00722371|520635562|FG003|Overall Study|Pregnancy|0|||
144388839|NCT00722371|520635563|FG004|Overall Study|Pregnancy|0|||
144388840|NCT00722371|520635564|FG005|Overall Study|Pregnancy|1|||
144388841|NCT00722371|520635565|FG006|Overall Study|Pregnancy|0|||
144388842|NCT00722371|520635559|FG000|Overall Study|Protocol Violation|6|||
144388843|NCT00722371|520635560|FG001|Overall Study|Protocol Violation|1|||
144388844|NCT00722371|520635561|FG002|Overall Study|Protocol Violation|0|||
144388845|NCT00722371|520635562|FG003|Overall Study|Protocol Violation|1|||
144388846|NCT00722371|520635563|FG004|Overall Study|Protocol Violation|4|||
144388847|NCT00722371|520635564|FG005|Overall Study|Protocol Violation|2|||
144388848|NCT00722371|520635565|FG006|Overall Study|Protocol Violation|1|||
144388849|NCT00722371|520635559|FG000|Overall Study|Withdrawal by Subject|18|||
144388850|NCT00722371|520635560|FG001|Overall Study|Withdrawal by Subject|27|||
144388851|NCT00722371|520635561|FG002|Overall Study|Withdrawal by Subject|19|||
144388852|NCT00722371|520635562|FG003|Overall Study|Withdrawal by Subject|23|||
144516479|NCT03739996|521090577|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
144516480|NCT03739996|521090577|FG000|Step 3 (SOC ART)|Death|1|||
144516481|NCT03739996|521090577|FG000|Step 3 (SOC ART)|Participant moved|1|||
144516482|NCT04716634|521090578|FG000|Overall Study|Death|24|||
144516483|NCT04716634|521090579|FG001|Overall Study|Death|24|||
144516484|NCT04716634|521090580|FG002|Overall Study|Death|8|||
144516485|NCT04716634|521090578|FG000|Overall Study|Closed by Sponsor|4|||
144516486|NCT04716634|521090579|FG001|Overall Study|Closed by Sponsor|4|||
144516487|NCT04716634|521090580|FG002|Overall Study|Closed by Sponsor|5|||
144516488|NCT04716634|521090578|FG000|Overall Study|Lost to Follow-up|1|||
144516489|NCT04716634|521090579|FG001|Overall Study|Lost to Follow-up|0|||
144516490|NCT04716634|521090580|FG002|Overall Study|Lost to Follow-up|1|||
144516491|NCT04716634|521090578|FG000|Overall Study|Withdrawal by Subject|0|||
144516492|NCT04716634|521090579|FG001|Overall Study|Withdrawal by Subject|0|||
144516493|NCT04716634|521090580|FG002|Overall Study|Withdrawal by Subject|1|||
144516494|NCT01673984|521090584|FG000|Overall Study|Adverse Event|1|||
144516495|NCT01673984|521090585|FG001|Overall Study|Adverse Event|0|||
144516496|NCT01673984|521090584|FG000|Overall Study|Study termination|9|||
144516497|NCT01673984|521090585|FG001|Overall Study|Study termination|6|||
144516498|NCT00150813|521090586|FG000|Overall Study|Adverse Event|1|||
144516499|NCT00150813|521090586|FG000|Overall Study|Lack of Efficacy|1|||
144516500|NCT00150813|521090586|FG000|Overall Study|Lost to Follow-up|5|||
144516501|NCT00150813|521090586|FG000|Overall Study|Withdrawal by Subject|5|||
144516502|NCT00150813|521090586|FG000|Overall Study|Remission|3|||
144516503|NCT00150813|521090586|FG000|Overall Study|Planned pregancy|1|||
144388853|NCT00722371|520635563|FG004|Overall Study|Withdrawal by Subject|19|||
144199328|NCT03107026|519928870|FG000|Overall Study|Protocol Violation|1|||
144388854|NCT00722371|520635564|FG005|Overall Study|Withdrawal by Subject|18|||
144388855|NCT00722371|520635565|FG006|Overall Study|Withdrawal by Subject|26|||
144388856|NCT00913692|520635566|FG000|Screening (4 Months)|Physician Decision|3|||
144516504|NCT00150813|521090586|FG000|Overall Study|Switch to commercially available LEV|2|||
144516505|NCT01820260|521090588|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516506|NCT01820260|521090589|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516507|NCT01820260|521090590|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144538273|NCT03801148|521174146|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
144516508|NCT01820260|521090591|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516509|NCT01820260|521090592|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516510|NCT01820260|521090593|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516511|NCT01820260|521090594|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
144516512|NCT01820260|521090595|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516513|NCT01820260|521090596|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144722116|NCT03271528|521836975|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
144516514|NCT01820260|521090597|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516515|NCT01820260|521090598|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516516|NCT01820260|521090599|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144516517|NCT01820260|521090600|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144538274|NCT01750684|521174147|FG000|Overall Study|Death|1|||
144538275|NCT01750684|521174148|FG001|Overall Study|Death|0|||
144538276|NCT01750684|521174147|FG000|Overall Study|Non-compliance with Study Drug|0|||
144538277|NCT01750684|521174148|FG001|Overall Study|Non-compliance with Study Drug|1|||
144538278|NCT01750684|521174147|FG000|Overall Study|Withdrawn by Sponsor|0|||
144538279|NCT01750684|521174148|FG001|Overall Study|Withdrawn by Sponsor|1|||
144538280|NCT01750684|521174147|FG000|Overall Study|Protocol Violation|1|||
144538281|NCT01750684|521174148|FG001|Overall Study|Protocol Violation|0|||
144538282|NCT00372775|521174149|FG000|Overall Study|Adverse Event|8|||
144538283|NCT00372775|521174149|FG000|Overall Study|Death|15|||
144538284|NCT00372775|521174149|FG000|Overall Study|Objective progression or relapse|30|||
144538285|NCT00372775|521174149|FG000|Overall Study|Global deterioration of health status|6|||
144538286|NCT00372775|521174149|FG000|Overall Study|Withdrawal by Subject|1|||
144538287|NCT00372775|521174149|FG000|Overall Study|Other|1|||
144538288|NCT00372775|521174149|FG000|Overall Study|Not Treated|2|||
144538289|NCT02185794|521174152|FG000|Overall Study|Enrolled but Never Dosed|1|||
144538290|NCT02185794|521174153|FG001|Overall Study|Enrolled but Never Dosed|6|||
144538291|NCT02185794|521174154|FG002|Overall Study|Enrolled but Never Dosed|3|||
144538292|NCT02185794|521174155|FG003|Overall Study|Enrolled but Never Dosed|1|||
144538293|NCT02185794|521174156|FG004|Overall Study|Enrolled but Never Dosed|1|||
144538294|NCT02185794|521174157|FG005|Overall Study|Enrolled but Never Dosed|0|||
144538295|NCT02185794|521174152|FG000|Overall Study|Investigator's Discretion|1|||
144538296|NCT02185794|521174153|FG001|Overall Study|Investigator's Discretion|0|||
144538297|NCT02185794|521174154|FG002|Overall Study|Investigator's Discretion|1|||
144538298|NCT02185794|521174155|FG003|Overall Study|Investigator's Discretion|2|||
144538299|NCT02185794|521174156|FG004|Overall Study|Investigator's Discretion|2|||
144538300|NCT02185794|521174157|FG005|Overall Study|Investigator's Discretion|15|||
144538301|NCT02185794|521174152|FG000|Overall Study|Withdrew Consent|2|||
144538302|NCT02185794|521174153|FG001|Overall Study|Withdrew Consent|5|||
144538303|NCT02185794|521174154|FG002|Overall Study|Withdrew Consent|10|||
144538304|NCT02185794|521174155|FG003|Overall Study|Withdrew Consent|2|||
144538305|NCT02185794|521174156|FG004|Overall Study|Withdrew Consent|0|||
144538306|NCT02185794|521174157|FG005|Overall Study|Withdrew Consent|0|||
144538307|NCT02185794|521174152|FG000|Overall Study|Lost to Follow-up|1|||
144538308|NCT02185794|521174153|FG001|Overall Study|Lost to Follow-up|2|||
144538309|NCT02185794|521174154|FG002|Overall Study|Lost to Follow-up|2|||
144538310|NCT02185794|521174155|FG003|Overall Study|Lost to Follow-up|3|||
144538311|NCT02185794|521174156|FG004|Overall Study|Lost to Follow-up|0|||
144538312|NCT02185794|521174157|FG005|Overall Study|Lost to Follow-up|1|||
144538313|NCT00336505|521174158|FG000|Overall Study|Adverse Event|10|||
144538314|NCT00336505|521174159|FG001|Overall Study|Adverse Event|9|||
144538315|NCT00336505|521174158|FG000|Overall Study|Lack of Efficacy|8|||
144538316|NCT00336505|521174159|FG001|Overall Study|Lack of Efficacy|4|||
144538317|NCT00336505|521174158|FG000|Overall Study|Lost to Follow-up|7|||
144538318|NCT00336505|521174159|FG001|Overall Study|Lost to Follow-up|4|||
144388857|NCT00913692|520635566|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
144388858|NCT00913692|520635566|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
144388859|NCT03761797|520635567|FG000|Overall Study|Changing hospital|11|||
144388860|NCT03761797|520635567|FG000|Overall Study|Improvement/remission|6|||
144388861|NCT03761797|520635567|FG000|Overall Study|Withdrawal by Subject|19|||
144388862|NCT03761797|520635567|FG000|Overall Study|Lost to Follow-up|33|||
144388863|NCT03761797|520635567|FG000|Overall Study|Adverse Event|37|||
144388864|NCT03761797|520635567|FG000|Overall Study|Case report form (CRF) not collected|5|||
144388865|NCT03761797|520635567|FG000|Overall Study|No patient visit after entry|13|||
144516518|NCT01820260|521090601|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
144388866|NCT03761797|520635567|FG000|Overall Study|Switch to other diabetes medication|10|||
144516519|NCT01820260|521090588|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516520|NCT01820260|521090589|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516521|NCT01820260|521090590|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516522|NCT01820260|521090591|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516523|NCT01820260|521090592|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516524|NCT01820260|521090593|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516525|NCT01820260|521090594|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516526|NCT01820260|521090595|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516527|NCT01820260|521090596|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516528|NCT01820260|521090597|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
144516529|NCT01820260|521090598|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516530|NCT01820260|521090599|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516531|NCT01820260|521090600|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516532|NCT01820260|521090601|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
144516533|NCT05415410|521090602|FG000|Overall Study|Death|3|||
144516534|NCT05415410|521090603|FG001|Overall Study|Death|6|||
144516535|NCT05415410|521090604|FG002|Overall Study|Death|1|||
144516536|NCT05415410|521090602|FG000|Overall Study|Trial Terminated by Sponsor|1|||
144516537|NCT05415410|521090603|FG001|Overall Study|Trial Terminated by Sponsor|5|||
144516538|NCT05415410|521090604|FG002|Overall Study|Trial Terminated by Sponsor|0|||
144516539|NCT05415410|521090602|FG000|Overall Study|Adverse Event|2|||
144516540|NCT05415410|521090603|FG001|Overall Study|Adverse Event|1|||
144516541|NCT05415410|521090604|FG002|Overall Study|Adverse Event|0|||
144516542|NCT05415410|521090602|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
144516543|NCT05415410|521090603|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
144516544|NCT05415410|521090604|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
144516545|NCT05415410|521090602|FG000|Overall Study|Withdrawal by Subject|1|||
144516546|NCT05415410|521090603|FG001|Overall Study|Withdrawal by Subject|0|||
144516547|NCT05415410|521090604|FG002|Overall Study|Withdrawal by Subject|0|||
144593149|NCT00666679|521372377|FG001|Second Intervention|Adverse Event|0|||
144593150|NCT00666679|521372376|FG000|Second Intervention|Death|0|||
144593151|NCT00666679|521372377|FG001|Second Intervention|Death|1|||
144593152|NCT04882995|521372380|FG000|Overall Study|Withdrawal by Subject|1|||
144516548|NCT05415410|521090602|FG000|Overall Study|Pregnancy|5|||
144516549|NCT05415410|521090603|FG001|Overall Study|Pregnancy|2|||
144516550|NCT05415410|521090604|FG002|Overall Study|Pregnancy|0|||
144516551|NCT03578536|521090608|FG000|Overall Study|Lost to Follow-up|1|||
144516552|NCT04436107|521090609|FG000|Overall Study|Sponsor Ended Study|2|||
144516553|NCT04436107|521090610|FG001|Overall Study|Sponsor Ended Study|4|||
144516554|NCT04436107|521090611|FG002|Overall Study|Sponsor Ended Study|8|||
144516555|NCT04436107|521090612|FG003|Overall Study|Sponsor Ended Study|20|||
144516556|NCT04436107|521090609|FG000|Overall Study|Death|3|||
144516557|NCT04436107|521090610|FG001|Overall Study|Death|5|||
144516558|NCT04436107|521090611|FG002|Overall Study|Death|3|||
144516559|NCT04436107|521090612|FG003|Overall Study|Death|18|||
144593153|NCT04882995|521372381|FG001|Overall Study|Withdrawal by Subject|2|||
144593154|NCT04882995|521372380|FG000|Overall Study|Protocol Violation|4|||
144593155|NCT04882995|521372381|FG001|Overall Study|Protocol Violation|4|||
144593156|NCT04882995|521372380|FG000|Overall Study|Surgery postponed due to COVID|1|||
144593157|NCT04882995|521372381|FG001|Overall Study|Surgery postponed due to COVID|1|||
144593158|NCT04371198|521372382|FG000|Overall Study|inadequate sample|4|||
144593159|NCT04754477|521372383|FG000|Overall Study|Withdrawal by Subject|1|||
144593160|NCT06469242|521372384|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
144593161|NCT06469242|521372385|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
144593162|NCT06469242|521372384|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
144593163|NCT06469242|521372385|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
144593164|NCT00690820|521372386|FG000|Period 1|Withdrawal by Subject|0|||
144593165|NCT00690820|521372387|FG001|Period 1|Withdrawal by Subject|1|||
144593166|NCT05333224|521372388|FG000|Overall Study - Infants|Lost to Follow-up|1|||
144593167|NCT05333224|521372389|FG001|Overall Study - Infants|Lost to Follow-up|1|||
144593168|NCT01768117|521372391|FG000|Overall Study|Lost to Follow-up|1|||
144593169|NCT01768117|521372391|FG000|Overall Study|Withdrawal by Subject|2|||
144593170|NCT01768117|521372391|FG000|Overall Study|Protocol Violation|3|||
144593171|NCT00966277|521372393|FG000|Overall Study|Withdrawal by Subject|3|||
144593172|NCT00966277|521372394|FG001|Overall Study|Withdrawal by Subject|0|||
144516560|NCT04436107|521090609|FG000|Overall Study|Withdrawal by Subject|1|||
144516561|NCT04436107|521090610|FG001|Overall Study|Withdrawal by Subject|1|||
144516562|NCT04436107|521090611|FG002|Overall Study|Withdrawal by Subject|0|||
144516563|NCT04436107|521090612|FG003|Overall Study|Withdrawal by Subject|1|||
144516564|NCT00448669|521090613|FG000|Overall Study|Lost to Follow-up|52|||
144516565|NCT00448669|521090614|FG001|Overall Study|Lost to Follow-up|63|||
144593173|NCT00966277|521372393|FG000|Overall Study|Ineligible|1|||
144593174|NCT00966277|521372394|FG001|Overall Study|Ineligible|3|||
144593175|NCT00966277|521372393|FG000|Overall Study|Treatment Plan Changed|0|||
144593176|NCT00966277|521372394|FG001|Overall Study|Treatment Plan Changed|1|||
144593177|NCT03658668|521372395|FG000|Overall Study|Time Commitment|1|||
144593178|NCT03658668|521372396|FG001|Overall Study|Time Commitment|1|||
144593179|NCT01952054|521372397|FG000|Overall Study|Physician Decision|1|||
144593180|NCT01127139|521372398|FG000|Overall Study|Adverse Event|40|||
144593181|NCT01127139|521372398|FG000|Overall Study|Incompliance|12|||
144593182|NCT01127139|521372398|FG000|Overall Study|Lack of Efficacy|4|||
144593183|NCT01127139|521372398|FG000|Overall Study|Reason not specified|1|||
144593184|NCT03881553|521372401|FG000|Overall Study|Discharged prior to participation|1|||
144516566|NCT00448669|521090613|FG000|Overall Study|Withdrawal by Subject|90|||
144516567|NCT00448669|521090614|FG001|Overall Study|Withdrawal by Subject|74|||
144516568|NCT00448669|521090613|FG000|Overall Study|Relocated|49|||
144516569|NCT00448669|521090614|FG001|Overall Study|Relocated|36|||
144593185|NCT03881553|521372402|FG001|Overall Study|Discharged prior to participation|1|||
144593186|NCT03881553|521372403|FG002|Overall Study|Discharged prior to participation|0|||
144722117|NCT00717756|521836976|FG000|Overall Study|Withdrawal by Subject|1|||
144722118|NCT00745251|521836977|FG000|Overall Study|Adverse Event|1|||
144516570|NCT00448669|521090613|FG000|Overall Study|Were withdrawn by investigator|10|||
144722119|NCT00745251|521836978|FG001|Overall Study|Adverse Event|2|||
144593187|NCT03881553|521372401|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
144593188|NCT03881553|521372402|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
144593189|NCT03881553|521372403|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
144593190|NCT01718353|521372404|FG000|Overall Study|Lost to Follow-up|0|||
144593191|NCT01718353|521372405|FG001|Overall Study|Lost to Follow-up|1|||
144593192|NCT01718353|521372404|FG000|Overall Study|Principal Investigator's Decision|10|||
144593193|NCT01718353|521372405|FG001|Overall Study|Principal Investigator's Decision|4|||
144593194|NCT01718353|521372404|FG000|Overall Study|Randomized but not treated|2|||
144593195|NCT01718353|521372405|FG001|Overall Study|Randomized but not treated|0|||
144593196|NCT01959516|521372406|FG000|Epoch 1|Adverse Event|4|||
144593197|NCT01959516|521372407|FG001|Epoch 1|Adverse Event|1|||
144593198|NCT01959516|521372406|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
144593199|NCT01959516|521372407|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
144593200|NCT01959516|521372406|FG000|Epoch 1|Subject withdrew consent|3|||
144593201|NCT01959516|521372407|FG001|Epoch 1|Subject withdrew consent|2|||
144593202|NCT01959516|521372406|FG000|Epoch 1|Administrative problems|1|||
144593203|NCT01959516|521372407|FG001|Epoch 1|Administrative problems|0|||
144593204|NCT01959516|521372406|FG000|Epoch 1|Use of prohibited treatment|1|||
144593205|NCT01959516|521372407|FG001|Epoch 1|Use of prohibited treatment|0|||
144593206|NCT01959516|521372406|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
144593207|NCT01959516|521372407|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
144593208|NCT01959516|521372406|FG000|Epoch 1|Protocol deviation|0|||
144593209|NCT01959516|521372407|FG001|Epoch 1|Protocol deviation|1|||
144593210|NCT01959516|521372406|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
144593211|NCT01959516|521372407|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
144593212|NCT01959516|521372406|FG000|Epoch 2|Subject withdrew consent|1|||
144593213|NCT01959516|521372407|FG001|Epoch 2|Subject withdrew consent|0|||
144593214|NCT01959516|521372406|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
144593215|NCT01959516|521372407|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
144593216|NCT01477333|521372408|FG000|Overall Study|Adverse Event|1|||
144593217|NCT01477333|521372408|FG000|Overall Study|Withdrawal by Subject|1|||
144593218|NCT01477333|521372408|FG000|Overall Study|Clinical Deterioration|1|||
144593219|NCT01078675|521372409|FG000|Overall Study|Withdrawal by Subject|7|||
144593220|NCT01078675|521372410|FG001|Overall Study|Withdrawal by Subject|3|||
144593221|NCT01078675|521372409|FG000|Overall Study|Protocol Violation|56|||
144593222|NCT01078675|521372410|FG001|Overall Study|Protocol Violation|0|||
144593223|NCT01078675|521372409|FG000|Overall Study|Provided in CRF for specific reasons|2|||
144593224|NCT01078675|521372410|FG001|Overall Study|Provided in CRF for specific reasons|3|||
144593225|NCT01078675|521372409|FG000|Overall Study|Adverse Event|3|||
144593226|NCT01078675|521372410|FG001|Overall Study|Adverse Event|0|||
144593227|NCT02513303|521372416|FG000|Overall Study|Withdrawal by Subject|9|||
144593228|NCT02513303|521372417|FG001|Overall Study|Withdrawal by Subject|7|||
144593229|NCT02513303|521372418|FG002|Overall Study|Withdrawal by Subject|2|||
144593230|NCT02513303|521372416|FG000|Overall Study|Lost to Follow-up|2|||
144593231|NCT02513303|521372417|FG001|Overall Study|Lost to Follow-up|4|||
144593232|NCT02513303|521372418|FG002|Overall Study|Lost to Follow-up|0|||
144593233|NCT02513303|521372416|FG000|Overall Study|Adverse Event|0|||
144593234|NCT02513303|521372417|FG001|Overall Study|Adverse Event|1|||
144593235|NCT02513303|521372418|FG002|Overall Study|Adverse Event|0|||
144593236|NCT02513303|521372416|FG000|Overall Study|Physician Decision|1|||
144593237|NCT02513303|521372417|FG001|Overall Study|Physician Decision|1|||
144593238|NCT02513303|521372418|FG002|Overall Study|Physician Decision|0|||
144593239|NCT02513303|521372416|FG000|Overall Study|Death|8|||
144593240|NCT02513303|521372417|FG001|Overall Study|Death|4|||
144593241|NCT02513303|521372418|FG002|Overall Study|Death|2|||
144593242|NCT01691768|521372419|FG000|Overall Study|Death|0|||
144593243|NCT01691768|521372420|FG001|Overall Study|Death|2|||
144593244|NCT01691768|521372419|FG000|Overall Study|Lost to Follow-up|4|||
144593245|NCT01691768|521372420|FG001|Overall Study|Lost to Follow-up|3|||
144593246|NCT01691768|521372419|FG000|Overall Study|Withdrawal by Subject|10|||
144593247|NCT01691768|521372420|FG001|Overall Study|Withdrawal by Subject|9|||
144593248|NCT01691768|521372419|FG000|Overall Study|Relocated|0|||
144593249|NCT01691768|521372420|FG001|Overall Study|Relocated|1|||
144593250|NCT01691768|521372419|FG000|Overall Study|Investigator decision|1|||
144593251|NCT01691768|521372420|FG001|Overall Study|Investigator decision|1|||
144593252|NCT02294227|521372423|FG000|Overall Study|Death|0|||
144593253|NCT02294227|521372424|FG001|Overall Study|Death|0|||
144593254|NCT02294227|521372425|FG002|Overall Study|Death|1|||
144593255|NCT02294227|521372423|FG000|Overall Study|Subject/Guardian Decision|6|||
144593256|NCT02294227|521372424|FG001|Overall Study|Subject/Guardian Decision|3|||
144516571|NCT00448669|521090614|FG001|Overall Study|Were withdrawn by investigator|6|||
144516572|NCT00448669|521090613|FG000|Overall Study|Death|2|||
144516573|NCT00448669|521090614|FG001|Overall Study|Death|4|||
144516574|NCT00448669|521090613|FG000|Overall Study|Had other reasons|5|||
144516575|NCT00448669|521090614|FG001|Overall Study|Had other reasons|6|||
144516576|NCT00448669|521090613|FG000|Overall Study|HIV-infected at enrollment|1|||
144516577|NCT00448669|521090614|FG001|Overall Study|HIV-infected at enrollment|2|||
144516578|NCT00448669|521090613|FG000|Overall Study|Never started drug|9|||
144516579|NCT00448669|521090614|FG001|Overall Study|Never started drug|7|||
144516580|NCT04116736|521090615|FG000|Overall Study|Withdrew consent during study|3|||
144516581|NCT04116736|521090616|FG001|Overall Study|Withdrew consent during study|1|||
144516582|NCT04116736|521090615|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
144516583|NCT04116736|521090616|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
144516584|NCT04116736|521090615|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
144516585|NCT04116736|521090616|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
144516586|NCT04116736|521090615|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
144516587|NCT04116736|521090616|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
144516588|NCT04116736|521090615|FG000|Overall Study|Subject was enrolled in error|2|||
144516589|NCT04116736|521090616|FG001|Overall Study|Subject was enrolled in error|0|||
144516590|NCT04116736|521090615|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
144516591|NCT04116736|521090616|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
144516592|NCT04116736|521090615|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
144516593|NCT04116736|521090616|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
144516594|NCT04116736|521090615|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
144516595|NCT04116736|521090616|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
144516596|NCT00274469|521090617|FG000|Overall Study|Death|63|||
144516597|NCT00274469|521090618|FG001|Overall Study|Death|74|||
144516598|NCT00274469|521090617|FG000|Overall Study|Did not consent to OS follow-up|16|||
144516599|NCT00274469|521090618|FG001|Overall Study|Did not consent to OS follow-up|19|||
144516600|NCT05512962|521090619|FG000|Overall Study|Withdrawal by Subject|1|||
144516601|NCT05512962|521090620|FG001|Overall Study|Withdrawal by Subject|0|||
144516602|NCT04838613|521090623|FG000|Overall Study|Withdrawal by Subject|3|||
144516603|NCT04838613|521090624|FG001|Overall Study|Withdrawal by Subject|6|||
144516604|NCT04838613|521090623|FG000|Overall Study|Protocol Deviation|3|||
144516605|NCT04838613|521090624|FG001|Overall Study|Protocol Deviation|2|||
144516606|NCT04838613|521090623|FG000|Overall Study|Technical Problems|0|||
144516607|NCT04838613|521090624|FG001|Overall Study|Technical Problems|5|||
144516608|NCT04838613|521090623|FG000|Overall Study|Physician Decision|2|||
144516609|NCT04838613|521090624|FG001|Overall Study|Physician Decision|0|||
144516610|NCT04970654|521090625|FG000|Overall Study|Withdrawal by parents/guardian|1|||
144516611|NCT04970654|521090626|FG001|Overall Study|Withdrawal by parents/guardian|2|||
144516612|NCT04970654|521090625|FG000|Overall Study|Unclassified|2|||
144516613|NCT04970654|521090626|FG001|Overall Study|Unclassified|1|||
144516614|NCT04970654|521090625|FG000|Overall Study|Lost to Follow-up|1|||
144516615|NCT04970654|521090626|FG001|Overall Study|Lost to Follow-up|0|||
144516616|NCT04854096|521090627|FG000|Overall Study|Adverse Event|1|||
144516617|NCT04854096|521090628|FG001|Overall Study|Adverse Event|0|||
144516618|NCT04854096|521090627|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
144516619|NCT04854096|521090628|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
144516620|NCT04854096|521090627|FG000|Overall Study|Withdrawal by Subject|1|||
144516621|NCT04854096|521090628|FG001|Overall Study|Withdrawal by Subject|0|||
144516622|NCT04854096|521090627|FG000|Overall Study|Other reasons|1|||
144516623|NCT04854096|521090628|FG001|Overall Study|Other reasons|0|||
144516624|NCT04999592|521090629|FG000|Overall Study|Withdrawal by Subject|1|||
144516625|NCT04999592|521090630|FG001|Overall Study|Withdrawal by Subject|0|||
144516626|NCT04095104|521090632|FG000|Overall Study|Withdrawal by Subject|0|||
144516627|NCT04095104|521090633|FG001|Overall Study|Withdrawal by Subject|1|||
144593257|NCT02294227|521372425|FG002|Overall Study|Subject/Guardian Decision|7|||
144388867|NCT03761797|520635567|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
144593258|NCT02294227|521372423|FG000|Overall Study|Physician Decision|1|||
144593259|NCT02294227|521372424|FG001|Overall Study|Physician Decision|2|||
144593260|NCT02294227|521372425|FG002|Overall Study|Physician Decision|1|||
144593261|NCT02294227|521372423|FG000|Overall Study|Lost to Follow-up|1|||
144593262|NCT02294227|521372424|FG001|Overall Study|Lost to Follow-up|0|||
144593263|NCT02294227|521372425|FG002|Overall Study|Lost to Follow-up|0|||
144593264|NCT02294227|521372423|FG000|Overall Study|Lack of Efficacy|11|||
144593265|NCT02294227|521372424|FG001|Overall Study|Lack of Efficacy|12|||
144593266|NCT02294227|521372425|FG002|Overall Study|Lack of Efficacy|8|||
144593267|NCT02294227|521372423|FG000|Overall Study|Adverse Event|6|||
144593268|NCT02294227|521372424|FG001|Overall Study|Adverse Event|8|||
144593269|NCT02294227|521372425|FG002|Overall Study|Adverse Event|2|||
144593270|NCT01768637|521372428|FG000|Overall Study|Lost to Follow-up|2|||
144593271|NCT01768637|521372429|FG001|Overall Study|Lost to Follow-up|7|||
144388868|NCT03761797|520635567|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
144388869|NCT03761797|520635567|FG000|Overall Study|Insufficient effectives|2|||
144593272|NCT01768637|521372428|FG000|Overall Study|Difficult blood draw|1|||
144593273|NCT01768637|521372429|FG001|Overall Study|Difficult blood draw|0|||
144593274|NCT02481947|521372430|FG000|Overall Study|Withdrawal by Subject|24|||
144593275|NCT02481947|521372431|FG001|Overall Study|Withdrawal by Subject|10|||
144593276|NCT02481947|521372430|FG000|Overall Study|Lost to Follow-up|11|||
144593277|NCT02481947|521372431|FG001|Overall Study|Lost to Follow-up|5|||
144593278|NCT02481947|521372430|FG000|Overall Study|Adverse Event|6|||
144593279|NCT02481947|521372431|FG001|Overall Study|Adverse Event|11|||
144593280|NCT02481947|521372430|FG000|Overall Study|Physician Decision|4|||
144593281|NCT02481947|521372431|FG001|Overall Study|Physician Decision|5|||
144593282|NCT02481947|521372430|FG000|Overall Study|Protocol Violation|1|||
144593283|NCT02481947|521372431|FG001|Overall Study|Protocol Violation|5|||
144593284|NCT03426267|521372437|FG000|Overall Study|Physician Decision|1|||
144593285|NCT03426267|521372438|FG001|Overall Study|Physician Decision|4|||
144593286|NCT03426267|521372437|FG000|Overall Study|Lost to Follow-up|1|||
144593287|NCT03426267|521372438|FG001|Overall Study|Lost to Follow-up|0|||
144593288|NCT03426267|521372437|FG000|Overall Study|Withdrawal by Subject|4|||
144593289|NCT03426267|521372438|FG001|Overall Study|Withdrawal by Subject|10|||
144593290|NCT03426267|521372437|FG000|Overall Study|Protocol Violation|1|||
144593291|NCT03426267|521372438|FG001|Overall Study|Protocol Violation|3|||
144593292|NCT03426267|521372437|FG000|Overall Study|Adverse Event|9|||
144593293|NCT03426267|521372438|FG001|Overall Study|Adverse Event|27|||
144593294|NCT03426267|521372437|FG000|Overall Study|Prohibited Treatment Intake|2|||
144593295|NCT03426267|521372438|FG001|Overall Study|Prohibited Treatment Intake|3|||
144593296|NCT03426267|521372437|FG000|Overall Study|Lack of Efficacy|0|||
144593297|NCT03426267|521372438|FG001|Overall Study|Lack of Efficacy|25|||
144593298|NCT03426267|521372437|FG000|Overall Study|other|3|||
144593299|NCT03426267|521372438|FG001|Overall Study|other|0|||
144199329|NCT03107026|519928871|FG001|Overall Study|Protocol Violation|2|||
144388870|NCT03761797|520635567|FG000|Overall Study|Excessive alcohol intake|1|||
144388871|NCT00879879|520635572|FG000|Overall Study|Death|1|||
144593300|NCT00448123|521372443|FG000|Overall Study|Lost to Follow-up|9|||
144593301|NCT00448123|521372444|FG001|Overall Study|Lost to Follow-up|6|||
144593302|NCT00448123|521372443|FG000|Overall Study|Physician Decision|6|||
144593303|NCT00448123|521372444|FG001|Overall Study|Physician Decision|6|||
144593304|NCT02027623|521372446|FG000|Overall Study|Lost to Follow-up|3|||
144593305|NCT02027623|521372447|FG001|Overall Study|Lost to Follow-up|3|||
144593306|NCT02027623|521372446|FG000|Overall Study|Withdrawal by Subject|6|||
144593307|NCT02027623|521372447|FG001|Overall Study|Withdrawal by Subject|9|||
144593308|NCT01275131|521372451|FG000|Period 1|Withdrawal by Subject|1|||
144593309|NCT01275131|521372452|FG001|Period 1|Withdrawal by Subject|0|||
144593310|NCT01275131|521372453|FG002|Period 1|Withdrawal by Subject|3|||
144593311|NCT01275131|521372454|FG003|Period 1|Withdrawal by Subject|2|||
144593312|NCT01275131|521372451|FG000|Period 1|Physician Decision|1|||
144593313|NCT01275131|521372452|FG001|Period 1|Physician Decision|0|||
144593314|NCT01275131|521372453|FG002|Period 1|Physician Decision|0|||
144593315|NCT01275131|521372454|FG003|Period 1|Physician Decision|0|||
144593316|NCT01275131|521372451|FG000|Period 2 (Crossover)|Adverse Event|0|||
144593317|NCT01275131|521372452|FG001|Period 2 (Crossover)|Adverse Event|1|||
144593318|NCT01275131|521372453|FG002|Period 2 (Crossover)|Adverse Event|0|||
144593319|NCT01275131|521372454|FG003|Period 2 (Crossover)|Adverse Event|0|||
144593320|NCT01275131|521372451|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
144593321|NCT01275131|521372452|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
144593322|NCT01275131|521372453|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
144593323|NCT01275131|521372454|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
144593324|NCT03440320|521373912|FG000|Overall Study|Withdrawal by Subject|0|||
144593325|NCT03440320|521373913|FG001|Overall Study|Withdrawal by Subject|1|||
144593326|NCT00409773|521373914|FG000|Overall Study|Adverse Event|3|||
144593327|NCT00409773|521373915|FG001|Overall Study|Adverse Event|4|||
144593328|NCT00409773|521373916|FG002|Overall Study|Adverse Event|4|||
144593329|NCT00409773|521373917|FG003|Overall Study|Adverse Event|2|||
144593330|NCT00409773|521373918|FG004|Overall Study|Adverse Event|6|||
144593331|NCT00409773|521373914|FG000|Overall Study|Lost to Follow-up|6|||
144593332|NCT00409773|521373915|FG001|Overall Study|Lost to Follow-up|1|||
144593333|NCT00409773|521373916|FG002|Overall Study|Lost to Follow-up|2|||
144593334|NCT00409773|521373917|FG003|Overall Study|Lost to Follow-up|3|||
144593335|NCT00409773|521373918|FG004|Overall Study|Lost to Follow-up|1|||
144593336|NCT00409773|521373914|FG000|Overall Study|Physician Decision|0|||
144593337|NCT00409773|521373915|FG001|Overall Study|Physician Decision|0|||
144593338|NCT00409773|521373916|FG002|Overall Study|Physician Decision|0|||
144593339|NCT00409773|521373917|FG003|Overall Study|Physician Decision|2|||
144593340|NCT00409773|521373918|FG004|Overall Study|Physician Decision|0|||
144593341|NCT00409773|521373914|FG000|Overall Study|Protocol Violation|0|||
144593342|NCT00409773|521373915|FG001|Overall Study|Protocol Violation|2|||
144593343|NCT00409773|521373916|FG002|Overall Study|Protocol Violation|3|||
144593344|NCT00409773|521373917|FG003|Overall Study|Protocol Violation|3|||
144593345|NCT00409773|521373918|FG004|Overall Study|Protocol Violation|1|||
144593346|NCT00409773|521373914|FG000|Overall Study|Withdrawal by Subject|0|||
144593347|NCT00409773|521373915|FG001|Overall Study|Withdrawal by Subject|0|||
144593348|NCT00409773|521373916|FG002|Overall Study|Withdrawal by Subject|0|||
144593349|NCT00409773|521373917|FG003|Overall Study|Withdrawal by Subject|2|||
144593350|NCT00409773|521373918|FG004|Overall Study|Withdrawal by Subject|1|||
144593351|NCT00409773|521373914|FG000|Overall Study|Lack of Eligibility|0|||
144593352|NCT00409773|521373915|FG001|Overall Study|Lack of Eligibility|0|||
144593353|NCT00409773|521373916|FG002|Overall Study|Lack of Eligibility|0|||
144593354|NCT00409773|521373917|FG003|Overall Study|Lack of Eligibility|0|||
144593355|NCT00409773|521373918|FG004|Overall Study|Lack of Eligibility|1|||
144593356|NCT01201343|521373919|FG000|Overall Study|Adverse Event|6|||
144593357|NCT01201343|521373919|FG000|Overall Study|Withdrawal by Subject|5|||
144593358|NCT01201343|521373919|FG000|Overall Study|Lost to Follow-up|2|||
144593359|NCT01201343|521373919|FG000|Overall Study|Lack of Efficacy|2|||
144593360|NCT01201343|521373919|FG000|Overall Study|Participant wrongly included in trial|1|||
144593361|NCT01201343|521373919|FG000|Overall Study|Randomized, not treated|3|||
144593362|NCT01440374|521373924|FG000|Part 1: Open-label Phase|Adverse Event|5|||
144593363|NCT01440374|521373925|FG001|Part 1: Open-label Phase|Adverse Event|0|||
144593364|NCT01440374|521373926|FG002|Part 1: Open-label Phase|Adverse Event|0|||
144593365|NCT01440374|521373927|FG003|Part 1: Open-label Phase|Adverse Event|0|||
144593366|NCT01440374|521373924|FG000|Part 1: Open-label Phase|Physician Decision|1|||
144593367|NCT01440374|521373925|FG001|Part 1: Open-label Phase|Physician Decision|0|||
144593368|NCT01440374|521373926|FG002|Part 1: Open-label Phase|Physician Decision|0|||
144593369|NCT01440374|521373927|FG003|Part 1: Open-label Phase|Physician Decision|0|||
144593370|NCT01440374|521373924|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
144593371|NCT01440374|521373925|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
144593372|NCT01440374|521373926|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
144593373|NCT01440374|521373927|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
144593374|NCT01440374|521373924|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
144593375|NCT01440374|521373925|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
144593376|NCT01440374|521373926|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
144593377|NCT01440374|521373927|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
144593378|NCT01440374|521373924|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
144593379|NCT01440374|521373925|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
144593380|NCT01440374|521373926|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
144593381|NCT01440374|521373927|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
144593382|NCT01440374|521373924|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
144593383|NCT01440374|521373925|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
144593384|NCT01440374|521373926|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
144593385|NCT01440374|521373927|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
144593386|NCT01440374|521373924|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
144593387|NCT01440374|521373925|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
144593388|NCT01440374|521373926|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
144593389|NCT01440374|521373927|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
144593390|NCT01440374|521373924|FG000|Part 2; Double-blind Phase|Not treated|0|||
144593391|NCT01440374|521373925|FG001|Part 2; Double-blind Phase|Not treated|0|||
144593392|NCT01440374|521373926|FG002|Part 2; Double-blind Phase|Not treated|1|||
144593393|NCT01440374|521373927|FG003|Part 2; Double-blind Phase|Not treated|0|||
144593394|NCT01440374|521373924|FG000|Part 3: Extension|Withdrawal by Subject|0|||
144593395|NCT01440374|521373925|FG001|Part 3: Extension|Withdrawal by Subject|0|||
144593396|NCT01440374|521373926|FG002|Part 3: Extension|Withdrawal by Subject|0|||
144593397|NCT01440374|521373927|FG003|Part 3: Extension|Withdrawal by Subject|5|||
144593398|NCT01440374|521373924|FG000|Part 3: Extension|Adverse Event|0|||
144593399|NCT01440374|521373925|FG001|Part 3: Extension|Adverse Event|0|||
144593400|NCT01440374|521373926|FG002|Part 3: Extension|Adverse Event|0|||
144593401|NCT01440374|521373927|FG003|Part 3: Extension|Adverse Event|13|||
144593402|NCT01440374|521373924|FG000|Part 3: Extension|Physician Decision|0|||
144593403|NCT01440374|521373925|FG001|Part 3: Extension|Physician Decision|0|||
144593404|NCT01440374|521373926|FG002|Part 3: Extension|Physician Decision|0|||
144593405|NCT01440374|521373927|FG003|Part 3: Extension|Physician Decision|14|||
144593406|NCT02141984|521373931|FG000|Overall Study|Lack of Efficacy|2|||
144593407|NCT01060540|521373932|FG000|Overall Study|Withdrawal by Subject|10|||
144593408|NCT01060540|521373933|FG001|Overall Study|Withdrawal by Subject|20|||
144593409|NCT01060540|521373932|FG000|Overall Study|Lost to Follow-up|52|||
144593410|NCT01060540|521373933|FG001|Overall Study|Lost to Follow-up|43|||
144593411|NCT01060540|521373932|FG000|Overall Study|Death|2|||
144593412|NCT01060540|521373933|FG001|Overall Study|Death|1|||
144593413|NCT01060540|521373932|FG000|Overall Study|Physician Decision|0|||
144593414|NCT01060540|521373933|FG001|Overall Study|Physician Decision|1|||
144593415|NCT01222507|521373937|FG000|Overall Study|Physician Decision|1|||
144593416|NCT01222507|521373937|FG000|Overall Study|Withdrawal by Subject|1|||
144593417|NCT01650246|521373939|FG000|Overall Study|Adverse Event|23|||
144516628|NCT04820686|521090635|FG000|Overall Study|Withdrawal by Subject|5|||
144516629|NCT04820686|521090636|FG001|Overall Study|Withdrawal by Subject|2|||
144516630|NCT04820686|521090637|FG002|Overall Study|Withdrawal by Subject|3|||
144516631|NCT04820686|521090635|FG000|Overall Study|Study Termination|25|||
144516632|NCT04820686|521090636|FG001|Overall Study|Study Termination|13|||
144516633|NCT04820686|521090637|FG002|Overall Study|Study Termination|14|||
144516634|NCT04820686|521090635|FG000|Overall Study|Adverse Event|0|||
144516635|NCT04820686|521090636|FG001|Overall Study|Adverse Event|1|||
144593418|NCT01650246|521373939|FG000|Overall Study|Protocol Violation|5|||
144593419|NCT01650246|521373939|FG000|Overall Study|Sponsor terminated study|53|||
144593420|NCT01650246|521373939|FG000|Overall Study|Lost to Follow-up|5|||
144593421|NCT01650246|521373939|FG000|Overall Study|Withdrawal by Subject|26|||
144593422|NCT01650246|521373939|FG000|Overall Study|Death|1|||
144593423|NCT01650246|521373939|FG000|Overall Study|Lack of Efficacy|30|||
144516636|NCT04820686|521090637|FG002|Overall Study|Adverse Event|0|||
144516637|NCT02759016|521090640|FG000|Overall Study|Not treated with BI 836826|1|||
144593424|NCT00081770|521373940|FG000|Overall Study|Adverse Event|130|||
144593425|NCT00081770|521373941|FG001|Overall Study|Adverse Event|98|||
144593426|NCT00081770|521373942|FG002|Overall Study|Adverse Event|136|||
144593427|NCT00081770|521373940|FG000|Overall Study|Lack of Efficacy|262|||
144593428|NCT00081770|521373941|FG001|Overall Study|Lack of Efficacy|357|||
144593429|NCT00081770|521373942|FG002|Overall Study|Lack of Efficacy|211|||
144593430|NCT00081770|521373940|FG000|Overall Study|Lost to Follow-up|45|||
144593431|NCT00081770|521373941|FG001|Overall Study|Lost to Follow-up|34|||
144516638|NCT02759016|521090641|FG001|Overall Study|Not treated with BI 836826|0|||
144516639|NCT02759016|521090640|FG000|Overall Study|Progressive disease|1|||
144516640|NCT02759016|521090641|FG001|Overall Study|Progressive disease|0|||
144516641|NCT02759016|521090640|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
144516642|NCT02759016|521090641|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
144516643|NCT02759016|521090640|FG000|Overall Study|Other not defined above|2|||
144516644|NCT02759016|521090641|FG001|Overall Study|Other not defined above|1|||
144516645|NCT04377308|521090642|FG000|Overall Study|Withdrawal by Subject|0|||
144516646|NCT04377308|521090643|FG001|Overall Study|Withdrawal by Subject|1|||
144516647|NCT02891915|521090646|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
144516648|NCT02891915|521090647|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
144516649|NCT02891915|521090646|FG000|Overall Study|Withdrawal by Subject|3|||
144516650|NCT02891915|521090647|FG001|Overall Study|Withdrawal by Subject|3|||
144516651|NCT02891915|521090646|FG000|Overall Study|Became Ineligible After Enrollment|2|||
144516652|NCT02891915|521090647|FG001|Overall Study|Became Ineligible After Enrollment|1|||
144516653|NCT02891915|521090646|FG000|Overall Study|Lost to Follow-up|1|||
144516654|NCT02891915|521090647|FG001|Overall Study|Lost to Follow-up|4|||
144516655|NCT02891915|521090646|FG000|Overall Study|Physician Decision|1|||
144516656|NCT02891915|521090647|FG001|Overall Study|Physician Decision|0|||
144516657|NCT00709098|521090648|FG000|Double-blind Period|Withdrawal of consent|3|||
144516658|NCT00709098|521090649|FG001|Double-blind Period|Withdrawal of consent|3|||
144516659|NCT00709098|521090650|FG002|Double-blind Period|Withdrawal of consent|0|||
144516660|NCT00709098|521090648|FG000|Double-blind Period|Administrative reason|1|||
144516661|NCT00709098|521090649|FG001|Double-blind Period|Administrative reason|3|||
144516662|NCT00709098|521090650|FG002|Double-blind Period|Administrative reason|0|||
144516663|NCT00709098|521090648|FG000|Double-blind Period|Death|1|||
144516664|NCT00709098|521090649|FG001|Double-blind Period|Death|1|||
144516665|NCT00709098|521090650|FG002|Double-blind Period|Death|0|||
144516666|NCT00709098|521090648|FG000|Double-blind Period|Lost to Follow-up|1|||
144516667|NCT00709098|521090649|FG001|Double-blind Period|Lost to Follow-up|1|||
144516668|NCT00709098|521090650|FG002|Double-blind Period|Lost to Follow-up|0|||
144516669|NCT00709098|521090648|FG000|Open-label Period|Withdrawal of consent|0|||
144516670|NCT00709098|521090649|FG001|Open-label Period|Withdrawal of consent|0|||
144516671|NCT00709098|521090650|FG002|Open-label Period|Withdrawal of consent|7|||
144516672|NCT00709098|521090648|FG000|Open-label Period|Administrative reason|0|||
144516673|NCT00709098|521090649|FG001|Open-label Period|Administrative reason|0|||
144516674|NCT00709098|521090650|FG002|Open-label Period|Administrative reason|5|||
144516675|NCT00709098|521090648|FG000|Open-label Period|Death|0|||
144516676|NCT00709098|521090649|FG001|Open-label Period|Death|0|||
144516677|NCT00709098|521090650|FG002|Open-label Period|Death|1|||
144516678|NCT00709098|521090648|FG000|Open-label Period|Lost to Follow-up|0|||
144516679|NCT00709098|521090649|FG001|Open-label Period|Lost to Follow-up|0|||
144516680|NCT00709098|521090650|FG002|Open-label Period|Lost to Follow-up|1|||
144516681|NCT01721291|521090652|FG000|Overall Study|Withdrawal by Subject|1|||
144516682|NCT01721291|521090653|FG001|Overall Study|Withdrawal by Subject|0|||
144516683|NCT01721291|521090652|FG000|Overall Study|did not like the treatment|1|||
144516684|NCT01721291|521090653|FG001|Overall Study|did not like the treatment|0|||
144516685|NCT01091168|521090654|FG000|Overall Study|Progressive disease|250|||
144516686|NCT01091168|521090655|FG001|Overall Study|Progressive disease|234|||
144516687|NCT01091168|521090654|FG000|Overall Study|Adverse Event|21|||
144516688|NCT01091168|521090655|FG001|Overall Study|Adverse Event|24|||
144516689|NCT01091168|521090654|FG000|Overall Study|Lost to Follow-up|0|||
144516690|NCT01091168|521090655|FG001|Overall Study|Lost to Follow-up|1|||
144593432|NCT00081770|521373942|FG002|Overall Study|Lost to Follow-up|45|||
144593433|NCT00081770|521373940|FG000|Overall Study|Protocol Violation|15|||
144593434|NCT00081770|521373941|FG001|Overall Study|Protocol Violation|10|||
144516691|NCT01091168|521090654|FG000|Overall Study|Physician, patient's decision, other|27|||
144516692|NCT01091168|521090655|FG001|Overall Study|Physician, patient's decision, other|37|||
144516693|NCT04533022|521091735|FG000|Overall Study|Withdrawal by Subject|15|||
144516694|NCT04533022|521091735|FG000|Overall Study|Adverse Event|6|||
144516695|NCT04533022|521091735|FG000|Overall Study|Death|1|||
144516696|NCT04533022|521091735|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
144516697|NCT04533022|521091735|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
144516698|NCT02163447|521091736|FG000|Overall Study|Withdrawal by Subject|2|||
144516699|NCT02163447|521091737|FG001|Overall Study|Withdrawal by Subject|0|||
144593435|NCT00081770|521373942|FG002|Overall Study|Protocol Violation|10|||
144516700|NCT02163447|521091738|FG002|Overall Study|Withdrawal by Subject|1|||
144516701|NCT02163447|521091736|FG000|Overall Study|Lost to Follow-up|1|||
144593436|NCT00081770|521373940|FG000|Overall Study|Withdrawal by Subject|45|||
144388872|NCT00879879|520635572|FG000|Overall Study|Withdrawal by Subject|1|||
144388873|NCT00879879|520635572|FG000|Overall Study|Physician Decision|1|||
144388874|NCT00400153|520635579|FG000|Overall Study|AE due to study disease worsening|14|||
144388875|NCT00400153|520635580|FG001|Overall Study|AE due to study disease worsening|19|||
144388876|NCT00400153|520635581|FG002|Overall Study|AE due to study disease worsening|20|||
144388877|NCT00400153|520635579|FG000|Overall Study|AE due to other disease worsening|2|||
144388878|NCT00400153|520635580|FG001|Overall Study|AE due to other disease worsening|1|||
144388879|NCT00400153|520635581|FG002|Overall Study|AE due to other disease worsening|0|||
144388880|NCT00400153|520635579|FG000|Overall Study|AE due to other condition|3|||
144516702|NCT02163447|521091737|FG001|Overall Study|Lost to Follow-up|3|||
144516703|NCT02163447|521091738|FG002|Overall Study|Lost to Follow-up|0|||
144516704|NCT02163447|521091736|FG000|Overall Study|Moved out of study area|2|||
144516705|NCT02163447|521091737|FG001|Overall Study|Moved out of study area|3|||
144516706|NCT02163447|521091738|FG002|Overall Study|Moved out of study area|2|||
144516707|NCT02163447|521091736|FG000|Overall Study|Became HIV infected at time of delivery|1|||
144516708|NCT02163447|521091737|FG001|Overall Study|Became HIV infected at time of delivery|0|||
144516709|NCT02163447|521091738|FG002|Overall Study|Became HIV infected at time of delivery|0|||
144516710|NCT03897686|521091739|FG000|Overall Study|Protocol Violation|1|||
144516711|NCT03897686|521091740|FG001|Overall Study|Protocol Violation|1|||
144516712|NCT03897686|521091739|FG000|Overall Study|Withdrawal by Subject|1|||
144516713|NCT03897686|521091740|FG001|Overall Study|Withdrawal by Subject|1|||
144516714|NCT05415436|521091741|FG000|Overall Study|Surgeon cancelled procedure|1|||
144516715|NCT05415436|521091742|FG001|Overall Study|Surgeon cancelled procedure|0|||
144516716|NCT05415436|521091741|FG000|Overall Study|Death|1|||
144516717|NCT05415436|521091742|FG001|Overall Study|Death|0|||
144516718|NCT03819686|521091744|FG000|Overall Study|Lost to Follow-up|2|||
144516719|NCT03819686|521091745|FG001|Overall Study|Lost to Follow-up|3|||
144516720|NCT03157167|521091756|FG000|Overall Study|Withdrawal by Subject|1|||
144516721|NCT03157167|521091757|FG001|Overall Study|Withdrawal by Subject|0|||
144516722|NCT03157167|521091758|FG002|Overall Study|Withdrawal by Subject|0|||
144516723|NCT02597946|521091759|FG000|Overall Study|Withdrawal by Subject|1|||
144516724|NCT02597946|521091759|FG000|Overall Study|Progressive disease|16|||
144516725|NCT02597946|521091759|FG000|Overall Study|Other than above|1|||
144516726|NCT04868110|521091768|FG000|Overall Study|Withdrawal by Subject|3|||
144516727|NCT04868110|521091769|FG001|Overall Study|Withdrawal by Subject|4|||
144516728|NCT03263026|521091770|FG000|Overall Study|Withdrawal by Subject|1|||
144516729|NCT03263026|521091771|FG001|Overall Study|Withdrawal by Subject|0|||
144516730|NCT03263026|521091770|FG000|Overall Study|Death|1|||
144516731|NCT03263026|521091771|FG001|Overall Study|Death|0|||
144516732|NCT03263026|521091770|FG000|Overall Study|Other/ Various|41|||
144516733|NCT03263026|521091771|FG001|Overall Study|Other/ Various|29|||
144516734|NCT05320432|521091782|FG000|Overall Study|Withdrawal by Subject|0|||
144516735|NCT05320432|521091783|FG001|Overall Study|Withdrawal by Subject|2|||
144516736|NCT05038566|521091784|FG000|Overall Study|Technical Difficulties with the Device|0|||
144516737|NCT05038566|521091785|FG001|Overall Study|Technical Difficulties with the Device|1|||
144516738|NCT02365766|521091790|FG000|Overall Study|Withdrawal by Subject|0|||
144516739|NCT02365766|521091791|FG001|Overall Study|Withdrawal by Subject|0|||
144516740|NCT02365766|521091792|FG002|Overall Study|Withdrawal by Subject|1|||
144516741|NCT02365766|521091790|FG000|Overall Study|Eligibility Criteria Not Met|0|||
144516742|NCT02365766|521091791|FG001|Overall Study|Eligibility Criteria Not Met|0|||
144516743|NCT02365766|521091792|FG002|Overall Study|Eligibility Criteria Not Met|1|||
144516744|NCT00650104|521091799|FG000|Overall Study|Adverse Event|17|||
144516745|NCT00650104|521091799|FG000|Overall Study|Death|2|||
144516746|NCT00650104|521091799|FG000|Overall Study|Withdrawal by Subject|11|||
144516747|NCT00650104|521091799|FG000|Overall Study|Physician Decision|7|||
144516748|NCT00650104|521091799|FG000|Overall Study|Lost to Follow-up|1|||
144516749|NCT00650104|521091799|FG000|Overall Study|Non-compliance|2|||
144516750|NCT00650104|521091799|FG000|Overall Study|Sponsor Terminated Dosing|1|||
144516751|NCT00894543|521091800|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
144516752|NCT00894543|521091801|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
144516753|NCT00894543|521091800|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
144516754|NCT00894543|521091801|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
144516755|NCT04048681|521091802|FG000|Overall Study|family emergency|0|||
144516756|NCT04048681|521091803|FG001|Overall Study|family emergency|0|||
144516757|NCT04048681|521091804|FG002|Overall Study|family emergency|0|||
144516758|NCT04048681|521091805|FG003|Overall Study|family emergency|1|||
144516759|NCT04048681|521091806|FG004|Overall Study|family emergency|0|||
144516760|NCT03385629|521091812|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
144516761|NCT03385629|521091813|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
144516762|NCT03385629|521091812|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
144516763|NCT03385629|521091813|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
144516764|NCT03385629|521091812|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
144516765|NCT03385629|521091813|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
144516766|NCT02919449|521091814|FG000|Overall Study|Withdrawal by Subject|1|||
144516767|NCT02919449|521091814|FG000|Overall Study|Investigator decision|1|||
144516768|NCT02538900|521091818|FG000|Overall Study|Death|2|||
144516769|NCT02538900|521091819|FG001|Overall Study|Death|2|||
144516770|NCT02538900|521091820|FG002|Overall Study|Death|2|||
144516771|NCT02538900|521091818|FG000|Overall Study|Withdrawal by Subject|18|||
144516772|NCT02538900|521091819|FG001|Overall Study|Withdrawal by Subject|16|||
144516773|NCT02538900|521091820|FG002|Overall Study|Withdrawal by Subject|15|||
144516774|NCT02874534|521091821|FG000|Overall Study|Withdrawal by Subject|5|||
144516775|NCT02874534|521091822|FG001|Overall Study|Withdrawal by Subject|8|||
144516776|NCT02874534|521091821|FG000|Overall Study|Lost to Follow-up|2|||
144516777|NCT02874534|521091822|FG001|Overall Study|Lost to Follow-up|2|||
144516778|NCT02874534|521091821|FG000|Overall Study|Ongoing in study|1|||
144516779|NCT02874534|521091822|FG001|Overall Study|Ongoing in study|1|||
144516780|NCT02923180|521091823|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
144516781|NCT02923180|521091823|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
144516782|NCT01989455|521091828|FG000|Overall Study|Adverse Event|0|||
144516783|NCT01989455|521091829|FG001|Overall Study|Adverse Event|1|||
144516784|NCT01989455|521091830|FG002|Overall Study|Adverse Event|0|||
144516785|NCT01989455|521091831|FG003|Overall Study|Adverse Event|0|||
144516786|NCT01989455|521091832|FG004|Overall Study|Adverse Event|0|||
144516787|NCT01989455|521091828|FG000|Overall Study|Withdrawal by Subject|0|||
144516788|NCT01989455|521091829|FG001|Overall Study|Withdrawal by Subject|1|||
144516789|NCT01989455|521091830|FG002|Overall Study|Withdrawal by Subject|0|||
144516790|NCT01989455|521091831|FG003|Overall Study|Withdrawal by Subject|0|||
144516791|NCT01989455|521091832|FG004|Overall Study|Withdrawal by Subject|0|||
144516792|NCT01989455|521091828|FG000|Overall Study|Technical problems with infusion|0|||
144516793|NCT01989455|521091829|FG001|Overall Study|Technical problems with infusion|0|||
144516794|NCT01989455|521091830|FG002|Overall Study|Technical problems with infusion|1|||
144516795|NCT01989455|521091831|FG003|Overall Study|Technical problems with infusion|0|||
144516796|NCT01989455|521091832|FG004|Overall Study|Technical problems with infusion|1|||
144516797|NCT01872078|521091833|FG000|Overall Study|Adverse Event|0|||
144516798|NCT01872078|521091834|FG001|Overall Study|Adverse Event|0|||
144516799|NCT01872078|521091835|FG002|Overall Study|Adverse Event|1|||
144516800|NCT01872078|521091836|FG003|Overall Study|Adverse Event|0|||
144722120|NCT00745251|521836977|FG000|Overall Study|Withdrawal by Subject|1|||
144722121|NCT00745251|521836978|FG001|Overall Study|Withdrawal by Subject|1|||
144722122|NCT02928848|521836979|FG000|Arm 2|Withdrawal by Subject|1|||
144722123|NCT02928848|521836980|FG001|Arm 2|Withdrawal by Subject|0|||
144722124|NCT03850509|521836981|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
144722125|NCT03850509|521836982|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
144722126|NCT00969332|521836983|FG000|Overall Study|Physician Decision|8|||
144722127|NCT00969332|521836983|FG000|Overall Study|Withdrawal by Subject|3|||
144722128|NCT02666430|521836984|FG000|Period 1|Lost to Follow-up|1|||
144722129|NCT02666430|521836985|FG001|Period 1|Lost to Follow-up|0|||
144722130|NCT02666430|521836984|FG000|Period 1|Adverse Event|0|||
144722131|NCT02666430|521836985|FG001|Period 1|Adverse Event|1|||
144722132|NCT02666430|521836984|FG000|Period 2|Withdrawal by Subject|1|||
144722133|NCT02666430|521836985|FG001|Period 2|Withdrawal by Subject|4|||
144722134|NCT02666430|521836984|FG000|Period 3|Lost to Follow-up|1|||
144722135|NCT02666430|521836985|FG001|Period 3|Lost to Follow-up|0|||
144722136|NCT03828461|521836986|FG000|Overall Study|Lost to Follow-up|1|||
144722137|NCT03828461|521836986|FG000|Overall Study|Withdrawal by Subject|3|||
144722138|NCT00576199|521836987|FG000|Overall Study|Adverse Event|12|||
144722139|NCT00576199|521836987|FG000|Overall Study|Insufficient Therapeutic Response|14|||
144722140|NCT00576199|521836987|FG000|Overall Study|Refused Treatment|2|||
144722141|NCT00576199|521836987|FG000|Overall Study|Reason Unspecified|2|||
144388881|NCT00400153|520635580|FG001|Overall Study|AE due to other condition|14|||
144388882|NCT00400153|520635581|FG002|Overall Study|AE due to other condition|15|||
144388883|NCT00400153|520635579|FG000|Overall Study|Protocol Violation|7|||
144516801|NCT01872078|521091833|FG000|Overall Study|Dose administration non-compliance|0|||
144516802|NCT01872078|521091834|FG001|Overall Study|Dose administration non-compliance|0|||
144516803|NCT01872078|521091835|FG002|Overall Study|Dose administration non-compliance|0|||
144516804|NCT01872078|521091836|FG003|Overall Study|Dose administration non-compliance|1|||
144516805|NCT01872078|521091833|FG000|Overall Study|Protocol Violation|0|||
144722142|NCT03111147|521836989|FG000|Overall Study|Lost to Follow-up|2|||
144722143|NCT03111147|521836990|FG001|Overall Study|Lost to Follow-up|5|||
144516806|NCT01872078|521091834|FG001|Overall Study|Protocol Violation|0|||
144516807|NCT01872078|521091835|FG002|Overall Study|Protocol Violation|1|||
144593437|NCT00081770|521373941|FG001|Overall Study|Withdrawal by Subject|40|||
144593438|NCT00081770|521373942|FG002|Overall Study|Withdrawal by Subject|42|||
144593439|NCT00081770|521373940|FG000|Overall Study|Did not meet protocol eligibility|2|||
144593440|NCT00081770|521373941|FG001|Overall Study|Did not meet protocol eligibility|0|||
144593441|NCT00081770|521373942|FG002|Overall Study|Did not meet protocol eligibility|3|||
144593442|NCT00081770|521373940|FG000|Overall Study|Administrative|1|||
144593443|NCT00081770|521373941|FG001|Overall Study|Administrative|0|||
144593444|NCT00081770|521373942|FG002|Overall Study|Administrative|1|||
144593445|NCT00081770|521373940|FG000|Overall Study|Other|2|||
144593446|NCT00081770|521373941|FG001|Overall Study|Other|7|||
144593447|NCT00081770|521373942|FG002|Overall Study|Other|8|||
144593448|NCT02795429|521373953|FG000|Overall Study|Adverse Event|1|||
144593449|NCT02795429|521373954|FG001|Overall Study|Adverse Event|2|||
144593450|NCT02795429|521373955|FG002|Overall Study|Adverse Event|1|||
144593451|NCT02795429|521373956|FG003|Overall Study|Adverse Event|2|||
144593452|NCT02795429|521373957|FG004|Overall Study|Adverse Event|1|||
144593453|NCT02795429|521373953|FG000|Overall Study|Death|1|||
144593454|NCT02795429|521373954|FG001|Overall Study|Death|0|||
144593455|NCT02795429|521373955|FG002|Overall Study|Death|1|||
144593456|NCT02795429|521373956|FG003|Overall Study|Death|2|||
144593457|NCT02795429|521373957|FG004|Overall Study|Death|1|||
144593458|NCT02795429|521373953|FG000|Overall Study|Physician Decision|0|||
144593459|NCT02795429|521373954|FG001|Overall Study|Physician Decision|0|||
144593460|NCT02795429|521373955|FG002|Overall Study|Physician Decision|2|||
144593461|NCT02795429|521373956|FG003|Overall Study|Physician Decision|1|||
144593462|NCT02795429|521373957|FG004|Overall Study|Physician Decision|5|||
144388884|NCT00400153|520635580|FG001|Overall Study|Protocol Violation|4|||
144388885|NCT00400153|520635581|FG002|Overall Study|Protocol Violation|9|||
144388886|NCT00400153|520635579|FG000|Overall Study|Lost to Follow-up|2|||
144388887|NCT00400153|520635580|FG001|Overall Study|Lost to Follow-up|1|||
144388888|NCT00400153|520635581|FG002|Overall Study|Lost to Follow-up|4|||
144388889|NCT00400153|520635579|FG000|Overall Study|Withdrawal by Subject|12|||
144388890|NCT00400153|520635580|FG001|Overall Study|Withdrawal by Subject|11|||
144388891|NCT00400153|520635581|FG002|Overall Study|Withdrawal by Subject|10|||
144388892|NCT00400153|520635579|FG000|Overall Study|Other reasons - not mentioned above|8|||
144388893|NCT00400153|520635580|FG001|Overall Study|Other reasons - not mentioned above|5|||
144388894|NCT00400153|520635581|FG002|Overall Study|Other reasons - not mentioned above|3|||
144388895|NCT00327470|520635586|FG000|Overall Study|Randomized, but not treated|0|||
144388896|NCT00327470|520635587|FG001|Overall Study|Randomized, but not treated|2|||
144388897|NCT00327470|520635586|FG000|Overall Study|Adverse Event|9|||
144388898|NCT00327470|520635587|FG001|Overall Study|Adverse Event|14|||
144388899|NCT00327470|520635586|FG000|Overall Study|Lack of Efficacy|7|||
144388900|NCT00327470|520635587|FG001|Overall Study|Lack of Efficacy|19|||
144388901|NCT00327470|520635586|FG000|Overall Study|Other|5|||
144388902|NCT00327470|520635587|FG001|Overall Study|Other|9|||
144388903|NCT00327470|520635586|FG000|Overall Study|Lost to Follow-up|1|||
144388904|NCT00327470|520635587|FG001|Overall Study|Lost to Follow-up|3|||
144388905|NCT00327470|520635586|FG000|Overall Study|Withdrawal by Subject|6|||
144388906|NCT00327470|520635587|FG001|Overall Study|Withdrawal by Subject|12|||
144388907|NCT00327470|520635586|FG000|Overall Study|Death|1|||
144388908|NCT00327470|520635587|FG001|Overall Study|Death|4|||
144388909|NCT04738318|520635588|FG000|Overall Study|Protocol Violation|1|||
144388910|NCT04738318|520635589|FG001|Overall Study|Protocol Violation|0|||
144388911|NCT01226121|520635590|FG000|Overall Study|Lost to Follow-up|2|||
144388912|NCT01226121|520635591|FG001|Overall Study|Lost to Follow-up|0|||
144388913|NCT01226121|520635592|FG002|Overall Study|Lost to Follow-up|1|||
144516808|NCT01872078|521091836|FG003|Overall Study|Protocol Violation|0|||
144199330|NCT03107026|519928872|FG002|Overall Study|Protocol Violation|0|||
144388914|NCT04231981|520635593|FG000|Overall Study|Adverse Event|1|||
144388915|NCT04231981|520635593|FG000|Overall Study|Death|16|||
144388916|NCT04231981|520635593|FG000|Overall Study|Lost to Follow-up|1|||
144516809|NCT01872078|521091833|FG000|Overall Study|Withdrawal by Subject|0|||
144388917|NCT02581943|520635594|FG000|Overall Study|Death|5|||
144388918|NCT02581943|520635595|FG001|Overall Study|Death|2|||
144388919|NCT02581943|520635594|FG000|Overall Study|Disease Progression|12|||
144388920|NCT02581943|520635595|FG001|Overall Study|Disease Progression|15|||
144388921|NCT02581943|520635594|FG000|Overall Study|Withdrawal by Subject|1|||
144388922|NCT02581943|520635595|FG001|Overall Study|Withdrawal by Subject|2|||
144388923|NCT00378079|520635596|FG000|Overall Study|Lost to Follow-up|6|||
144388924|NCT00378079|520635597|FG001|Overall Study|Lost to Follow-up|1|||
144388925|NCT00378079|520635598|FG002|Overall Study|Lost to Follow-up|0|||
144388926|NCT01233687|520635599|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
144388927|NCT01233687|520635599|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
144388928|NCT01233687|520635599|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
144388929|NCT02290431|520635600|FG000|Overall Study|Adverse Event|20|||
144388930|NCT02290431|520635600|FG000|Overall Study|Progressive disease|4|||
144388931|NCT02290431|520635600|FG000|Overall Study|Study terminated by Sponsor|1|||
144388932|NCT02290431|520635600|FG000|Overall Study|Physician Decision|2|||
144388933|NCT00745615|520635611|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
144388934|NCT00745615|520635612|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
144388935|NCT00745615|520635613|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
144388936|NCT00745615|520635614|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
144388937|NCT00745615|520635615|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
144388938|NCT00745615|520635616|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
144388939|NCT00745615|520635611|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
144388940|NCT00745615|520635612|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
144388941|NCT00745615|520635613|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
144388942|NCT00745615|520635614|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
144388943|NCT00745615|520635615|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
144388944|NCT00745615|520635616|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
144388945|NCT00745615|520635611|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
144388946|NCT00745615|520635612|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
144388947|NCT00745615|520635613|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
144516810|NCT01872078|521091834|FG001|Overall Study|Withdrawal by Subject|0|||
144516811|NCT01872078|521091835|FG002|Overall Study|Withdrawal by Subject|1|||
144516812|NCT01872078|521091836|FG003|Overall Study|Withdrawal by Subject|0|||
144516813|NCT01872078|521091833|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
144516814|NCT01872078|521091834|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
144516815|NCT01872078|521091835|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
144516816|NCT01872078|521091836|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
144516817|NCT03767517|521091837|FG000|Overall Study|Lost to Follow-up|16|||
144388948|NCT00745615|520635614|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
144388949|NCT00745615|520635615|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
144516818|NCT03767517|521091838|FG001|Overall Study|Lost to Follow-up|10|||
144516819|NCT03767517|521091837|FG000|Overall Study|Death|2|||
144388950|NCT00745615|520635616|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
144388951|NCT00745615|520635611|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
144388952|NCT00745615|520635612|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
144388953|NCT00745615|520635613|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
144388954|NCT00745615|520635614|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
144388955|NCT00745615|520635615|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
144388956|NCT00745615|520635616|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
144388957|NCT00745615|520635611|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
144388958|NCT00745615|520635612|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
144388959|NCT00745615|520635613|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
144388960|NCT00745615|520635614|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
144388961|NCT00745615|520635615|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
144388962|NCT00745615|520635616|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
144388963|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
144388964|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
144388965|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
144388966|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
144388967|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
144388968|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
144388969|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
144388970|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
144516820|NCT03767517|521091838|FG001|Overall Study|Death|3|||
144516821|NCT05239039|521091839|FG000|Overall Study|Withdrawal by Subject|0|||
144516822|NCT05239039|521091840|FG001|Overall Study|Withdrawal by Subject|1|||
144516823|NCT03152786|521092765|FG000|Overall Study|Withdrawal by Subject|2|||
144516824|NCT03152786|521092766|FG001|Overall Study|Withdrawal by Subject|1|||
144516825|NCT04923347|521092767|FG000|Overall Study|Withdrawal by Subject|14|||
144516826|NCT02349412|521092772|FG000|Overall Study|Withdrawal by Subject|7|||
144516827|NCT02349412|521092773|FG001|Overall Study|Withdrawal by Subject|7|||
144516828|NCT06066541|521092774|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
144516829|NCT06066541|521092775|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
144516830|NCT06066541|521092776|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
144516831|NCT06066541|521092777|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
144516832|NCT06066541|521092778|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
144516833|NCT06066541|521092779|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
144516834|NCT06066541|521092780|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
144516835|NCT06066541|521092774|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
144516836|NCT06066541|521092775|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
144516837|NCT06066541|521092776|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
144516838|NCT06066541|521092777|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
144516839|NCT06066541|521092778|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
144516840|NCT06066541|521092779|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
144516841|NCT06066541|521092780|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
144516842|NCT00739648|521092785|FG000|Overall Study|Adverse Event|3|||
144516843|NCT00739648|521092786|FG001|Overall Study|Adverse Event|15|||
144516844|NCT00739648|521092785|FG000|Overall Study|Withdrawal by Subject|13|||
144516845|NCT00739648|521092786|FG001|Overall Study|Withdrawal by Subject|25|||
144516846|NCT00739648|521092785|FG000|Overall Study|Lost to Follow-up|4|||
144516847|NCT00739648|521092786|FG001|Overall Study|Lost to Follow-up|7|||
144516848|NCT00739648|521092785|FG000|Overall Study|Death|2|||
144516849|NCT00739648|521092786|FG001|Overall Study|Death|0|||
144516850|NCT00739648|521092785|FG000|Overall Study|Do not know|4|||
144516851|NCT00739648|521092786|FG001|Overall Study|Do not know|6|||
144516852|NCT02840474|521092789|FG000|Overall Study|Lost to Follow-up|1|||
144516853|NCT02840474|521092790|FG001|Overall Study|Lost to Follow-up|0|||
144516854|NCT03192891|521092791|FG000|Overall Study|Lost to Follow-up|55|||
144516855|NCT04850807|521092792|FG000|Overall Study|Death|50|||
144516856|NCT04850807|521092793|FG001|Overall Study|Death|55|||
144516857|NCT04850807|521092792|FG000|Overall Study|Discharged|17|||
144516858|NCT04850807|521092793|FG001|Overall Study|Discharged|13|||
144516859|NCT04850807|521092792|FG000|Overall Study|Incomplete baseline data|3|||
144516860|NCT04850807|521092793|FG001|Overall Study|Incomplete baseline data|2|||
144516861|NCT05387447|521092794|FG000|Overall Study|Participants changed their minds about study participation.|3|||
144516862|NCT05387447|521092795|FG001|Overall Study|Participants changed their minds about study participation.|5|||
144593463|NCT02795429|521373953|FG000|Overall Study|Progressive disease|3|||
144516863|NCT03655132|521092796|FG000|Overall Study|Lost to Follow-up|2|||
144516864|NCT03655132|521092797|FG001|Overall Study|Lost to Follow-up|1|||
144516865|NCT03655132|521092796|FG000|Overall Study|Withdrawal by Subject|0|||
144516866|NCT03655132|521092797|FG001|Overall Study|Withdrawal by Subject|1|||
144593464|NCT02795429|521373954|FG001|Overall Study|Progressive disease|7|||
144593465|NCT02795429|521373955|FG002|Overall Study|Progressive disease|6|||
144593466|NCT02795429|521373956|FG003|Overall Study|Progressive disease|26|||
144593467|NCT02795429|521373957|FG004|Overall Study|Progressive disease|20|||
144593468|NCT02795429|521373953|FG000|Overall Study|Subject/guardian decision|1|||
144593469|NCT02795429|521373954|FG001|Overall Study|Subject/guardian decision|1|||
144593470|NCT02795429|521373955|FG002|Overall Study|Subject/guardian decision|1|||
144516867|NCT03655132|521092796|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
144516868|NCT03655132|521092797|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
144516869|NCT04538417|521092803|FG000|Overall Study|Withdrawal by Subject|2|||
144516870|NCT04649359|521092824|FG000|Overall Study|Withdrawal by Subject|7|||
144516871|NCT04649359|521092825|FG001|Overall Study|Withdrawal by Subject|7|||
144516872|NCT04649359|521092824|FG000|Overall Study|Death|41|||
144516873|NCT04649359|521092825|FG001|Overall Study|Death|26|||
144516874|NCT04649359|521092824|FG000|Overall Study|Ongoing in the study|75|||
144516875|NCT04649359|521092825|FG001|Overall Study|Ongoing in the study|31|||
144516876|NCT02500758|521092826|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
144516877|NCT02500758|521092827|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
144516878|NCT02500758|521092826|FG000|Washout (1 Week)|Lost to Follow-up|2|||
144516879|NCT02500758|521092827|FG001|Washout (1 Week)|Lost to Follow-up|2|||
144516880|NCT02500758|521092826|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
144516881|NCT02500758|521092827|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
144516882|NCT02500758|521092826|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
144516883|NCT02500758|521092827|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
144516884|NCT02500758|521092826|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
144516885|NCT02500758|521092827|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
144516886|NCT02140645|521092831|FG000|Overall Study|Not linked|5489|||
144516887|NCT02140645|521092832|FG001|Overall Study|Not linked|61654|||
144516888|NCT02140645|521092833|FG002|Overall Study|Not linked|4236|||
144516889|NCT02140645|521092834|FG003|Overall Study|Not linked|13833|||
144516890|NCT02140645|521092835|FG004|Overall Study|Not linked|3286|||
144516891|NCT02140645|521092836|FG005|Overall Study|Not linked|70896|||
144516892|NCT01101451|521092837|FG000|Overall Study|Eligible and never treated|0|||
144516893|NCT01101451|521092838|FG001|Overall Study|Eligible and never treated|5|||
144516894|NCT01101451|521092837|FG000|Overall Study|Ineligible and treated|12|||
144516895|NCT01101451|521092838|FG001|Overall Study|Ineligible and treated|8|||
144516896|NCT01101451|521092837|FG000|Overall Study|Ineligible and never treated|2|||
144516897|NCT01101451|521092838|FG001|Overall Study|Ineligible and never treated|2|||
144516898|NCT02965846|521092843|FG000|Overall Study|Lost to Follow-up|1|||
144516899|NCT02965846|521092844|FG001|Overall Study|Lost to Follow-up|0|||
144516900|NCT02965846|521092845|FG002|Overall Study|Lost to Follow-up|0|||
144516901|NCT02965846|521092843|FG000|Overall Study|Withdrawal by Subject|0|||
144516902|NCT02965846|521092844|FG001|Overall Study|Withdrawal by Subject|1|||
144516903|NCT02965846|521092845|FG002|Overall Study|Withdrawal by Subject|0|||
144516904|NCT02965846|521092843|FG000|Overall Study|Study Terminated By Sponsor|4|||
144516905|NCT02965846|521092844|FG001|Overall Study|Study Terminated By Sponsor|4|||
144516906|NCT02965846|521092845|FG002|Overall Study|Study Terminated By Sponsor|0|||
144516907|NCT02965846|521092843|FG000|Overall Study|Participants not randomized|0|||
144516908|NCT02965846|521092844|FG001|Overall Study|Participants not randomized|0|||
144516909|NCT02965846|521092845|FG002|Overall Study|Participants not randomized|33|||
144516910|NCT02814838|521092846|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
144516911|NCT02814838|521092847|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
144516912|NCT02814838|521092846|FG000|Overall Study|Consent withdrawal|1|||
144516913|NCT02814838|521092847|FG001|Overall Study|Consent withdrawal|1|||
144593471|NCT02795429|521373956|FG003|Overall Study|Subject/guardian decision|1|||
144593472|NCT02795429|521373957|FG004|Overall Study|Subject/guardian decision|3|||
144593473|NCT04281004|521373960|FG000|Overall Study|Physician Decision|1|||
144516914|NCT00593489|521092848|FG000|Allocation|did not attend workshop; allocation not|2|||
144516915|NCT00593489|521092849|FG001|Allocation|did not attend workshop; allocation not|1|||
144516916|NCT00073749|521092850|FG000|Overall Study|Disease Progression|2|||
144516917|NCT00073749|521092851|FG001|Overall Study|Disease Progression|0|||
144516918|NCT00073749|521092852|FG002|Overall Study|Disease Progression|3|||
144516919|NCT00073749|521092853|FG003|Overall Study|Disease Progression|2|||
144516920|NCT00073749|521092854|FG004|Overall Study|Disease Progression|3|||
144516921|NCT00073749|521092855|FG005|Overall Study|Disease Progression|1|||
144516922|NCT00073749|521092856|FG006|Overall Study|Disease Progression|3|||
144516923|NCT00073749|521092850|FG000|Overall Study|Death|0|||
144516924|NCT00073749|521092851|FG001|Overall Study|Death|1|||
144516925|NCT00073749|521092852|FG002|Overall Study|Death|1|||
144516926|NCT00073749|521092853|FG003|Overall Study|Death|0|||
144516927|NCT00073749|521092854|FG004|Overall Study|Death|0|||
144516928|NCT00073749|521092855|FG005|Overall Study|Death|0|||
144516929|NCT00073749|521092856|FG006|Overall Study|Death|29|||
144516930|NCT00073749|521092850|FG000|Overall Study|Adverse Event|0|||
144516931|NCT00073749|521092851|FG001|Overall Study|Adverse Event|3|||
144516932|NCT00073749|521092852|FG002|Overall Study|Adverse Event|6|||
144516933|NCT00073749|521092853|FG003|Overall Study|Adverse Event|4|||
144516934|NCT00073749|521092854|FG004|Overall Study|Adverse Event|2|||
144516935|NCT00073749|521092855|FG005|Overall Study|Adverse Event|1|||
144516936|NCT00073749|521092856|FG006|Overall Study|Adverse Event|0|||
144516937|NCT00073749|521092850|FG000|Overall Study|Physician Decision|0|||
144516938|NCT00073749|521092851|FG001|Overall Study|Physician Decision|0|||
144516939|NCT00073749|521092852|FG002|Overall Study|Physician Decision|1|||
144516940|NCT00073749|521092853|FG003|Overall Study|Physician Decision|0|||
144516941|NCT00073749|521092854|FG004|Overall Study|Physician Decision|0|||
144516942|NCT00073749|521092855|FG005|Overall Study|Physician Decision|2|||
144516943|NCT00073749|521092856|FG006|Overall Study|Physician Decision|0|||
144516944|NCT00073749|521092850|FG000|Overall Study|Withdrawal by Subject|0|||
144516945|NCT00073749|521092851|FG001|Overall Study|Withdrawal by Subject|1|||
144516946|NCT00073749|521092852|FG002|Overall Study|Withdrawal by Subject|0|||
144516947|NCT00073749|521092853|FG003|Overall Study|Withdrawal by Subject|0|||
144516948|NCT00073749|521092854|FG004|Overall Study|Withdrawal by Subject|1|||
144516949|NCT00073749|521092855|FG005|Overall Study|Withdrawal by Subject|0|||
144516950|NCT00073749|521092856|FG006|Overall Study|Withdrawal by Subject|2|||
144516951|NCT00073749|521092850|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
144516952|NCT00073749|521092851|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
144516953|NCT00073749|521092852|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
144516954|NCT00073749|521092853|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
144516955|NCT00073749|521092854|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
144516956|NCT00073749|521092855|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
144516957|NCT00073749|521092856|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
144516958|NCT00073749|521092850|FG000|Overall Study|Lost to Follow-up|0|||
144516959|NCT00073749|521092851|FG001|Overall Study|Lost to Follow-up|0|||
144516960|NCT00073749|521092852|FG002|Overall Study|Lost to Follow-up|0|||
144516961|NCT00073749|521092853|FG003|Overall Study|Lost to Follow-up|0|||
144516962|NCT00073749|521092854|FG004|Overall Study|Lost to Follow-up|0|||
144516963|NCT00073749|521092855|FG005|Overall Study|Lost to Follow-up|0|||
144516964|NCT00073749|521092856|FG006|Overall Study|Lost to Follow-up|2|||
144516965|NCT00073749|521092850|FG000|Overall Study|Other|0|||
144516966|NCT00073749|521092851|FG001|Overall Study|Other|0|||
144516967|NCT00073749|521092852|FG002|Overall Study|Other|0|||
144516968|NCT00073749|521092853|FG003|Overall Study|Other|0|||
144516969|NCT00073749|521092854|FG004|Overall Study|Other|0|||
144516970|NCT00073749|521092855|FG005|Overall Study|Other|2|||
144516971|NCT00073749|521092856|FG006|Overall Study|Other|0|||
144516972|NCT00611559|521092857|FG000|Overall Study|Lost to Follow-up|0|||
144516973|NCT00611559|521092858|FG001|Overall Study|Lost to Follow-up|1|||
144516974|NCT00611559|521092859|FG002|Overall Study|Lost to Follow-up|0|||
144516975|NCT00611559|521092857|FG000|Overall Study|Protocol Violation|1|||
144516976|NCT00611559|521092858|FG001|Overall Study|Protocol Violation|0|||
144516977|NCT00611559|521092859|FG002|Overall Study|Protocol Violation|1|||
144516978|NCT05048186|521092862|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
144516979|NCT05048186|521092863|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
144516980|NCT05048186|521092862|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
144516981|NCT05048186|521092863|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
144516982|NCT00951379|521092864|FG000|Overall Study|Adverse Event|4|||
144516983|NCT00951379|521092865|FG001|Overall Study|Adverse Event|1|||
144516984|NCT00951379|521092864|FG000|Overall Study|Withdrawal by Subject|1|||
144516985|NCT00951379|521092865|FG001|Overall Study|Withdrawal by Subject|0|||
144516986|NCT00951379|521092864|FG000|Overall Study|Noncompliance|1|||
144516987|NCT00951379|521092865|FG001|Overall Study|Noncompliance|0|||
144516988|NCT00951379|521092864|FG000|Overall Study|Disease Progression|0|||
144516989|NCT00951379|521092865|FG001|Overall Study|Disease Progression|1|||
144516990|NCT02742519|521092869|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
144516991|NCT02742519|521092870|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
144516992|NCT02742519|521092871|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
144516993|NCT02742519|521092869|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
144516994|NCT02742519|521092870|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
144516995|NCT02742519|521092871|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
144516996|NCT02742519|521092869|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
144516997|NCT02742519|521092870|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
144516998|NCT02742519|521092871|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
144516999|NCT03580369|521092872|FG000|Overall Study|No treatment due to mis-randomization|1|||
144517000|NCT03580369|521092873|FG001|Overall Study|No treatment due to mis-randomization|0|||
144517001|NCT03580369|521092874|FG002|Overall Study|No treatment due to mis-randomization|0|||
144517002|NCT03580369|521092875|FG003|Overall Study|No treatment due to mis-randomization|0|||
144517003|NCT03580369|521092876|FG004|Overall Study|No treatment due to mis-randomization|3|||
144517004|NCT03580369|521092877|FG005|Overall Study|No treatment due to mis-randomization|0|||
144517005|NCT03580369|521092878|FG006|Overall Study|No treatment due to mis-randomization|0|||
144517006|NCT03580369|521092879|FG007|Overall Study|No treatment due to mis-randomization|0|||
144517007|NCT03580369|521092872|FG000|Overall Study|Reason unknown|0|||
144517008|NCT03580369|521092873|FG001|Overall Study|Reason unknown|0|||
144517009|NCT03580369|521092874|FG002|Overall Study|Reason unknown|1|||
144517010|NCT03580369|521092875|FG003|Overall Study|Reason unknown|0|||
144517011|NCT03580369|521092876|FG004|Overall Study|Reason unknown|0|||
144517012|NCT03580369|521092877|FG005|Overall Study|Reason unknown|0|||
144517013|NCT03580369|521092878|FG006|Overall Study|Reason unknown|0|||
144517014|NCT03580369|521092879|FG007|Overall Study|Reason unknown|0|||
144517015|NCT03580369|521092872|FG000|Overall Study|Technical problems|0|||
144517016|NCT03580369|521092873|FG001|Overall Study|Technical problems|0|||
144517017|NCT03580369|521092874|FG002|Overall Study|Technical problems|0|||
144517018|NCT03580369|521092875|FG003|Overall Study|Technical problems|0|||
144517019|NCT03580369|521092876|FG004|Overall Study|Technical problems|1|||
144517020|NCT03580369|521092877|FG005|Overall Study|Technical problems|0|||
144517021|NCT03580369|521092878|FG006|Overall Study|Technical problems|2|||
144517022|NCT03580369|521092879|FG007|Overall Study|Technical problems|0|||
144517023|NCT03580369|521092872|FG000|Overall Study|Pregnancy|2|||
144517024|NCT03580369|521092873|FG001|Overall Study|Pregnancy|0|||
144517025|NCT03580369|521092874|FG002|Overall Study|Pregnancy|3|||
144517026|NCT03580369|521092875|FG003|Overall Study|Pregnancy|0|||
144517027|NCT03580369|521092876|FG004|Overall Study|Pregnancy|2|||
144517028|NCT03580369|521092877|FG005|Overall Study|Pregnancy|0|||
144517029|NCT03580369|521092878|FG006|Overall Study|Pregnancy|0|||
144517030|NCT03580369|521092879|FG007|Overall Study|Pregnancy|0|||
144517031|NCT03580369|521092872|FG000|Overall Study|Lost to Follow-up|2|||
144517032|NCT03580369|521092873|FG001|Overall Study|Lost to Follow-up|0|||
144517033|NCT03580369|521092874|FG002|Overall Study|Lost to Follow-up|2|||
144517034|NCT03580369|521092875|FG003|Overall Study|Lost to Follow-up|0|||
144388971|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
144388972|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
144388973|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
144388974|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
144388975|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
144388976|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
144388977|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
144388978|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
144388979|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
144388980|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
144388981|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
144388982|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
144388983|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
144388984|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
144388985|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
144388986|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
144388987|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
144388988|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
144388989|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
144388990|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
144517035|NCT03580369|521092876|FG004|Overall Study|Lost to Follow-up|3|||
144388991|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
144517036|NCT03580369|521092877|FG005|Overall Study|Lost to Follow-up|0|||
144517037|NCT03580369|521092878|FG006|Overall Study|Lost to Follow-up|1|||
144517038|NCT03580369|521092879|FG007|Overall Study|Lost to Follow-up|0|||
144517039|NCT03580369|521092872|FG000|Overall Study|Physician Decision|4|||
144388992|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
144388993|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
144517040|NCT03580369|521092873|FG001|Overall Study|Physician Decision|0|||
144517041|NCT03580369|521092874|FG002|Overall Study|Physician Decision|4|||
144517042|NCT03580369|521092875|FG003|Overall Study|Physician Decision|1|||
144517043|NCT03580369|521092876|FG004|Overall Study|Physician Decision|1|||
144517044|NCT03580369|521092877|FG005|Overall Study|Physician Decision|0|||
144517045|NCT03580369|521092878|FG006|Overall Study|Physician Decision|0|||
144517046|NCT03580369|521092879|FG007|Overall Study|Physician Decision|0|||
144517047|NCT03580369|521092872|FG000|Overall Study|Lack of Efficacy|3|||
144517048|NCT03580369|521092873|FG001|Overall Study|Lack of Efficacy|0|||
144517049|NCT03580369|521092874|FG002|Overall Study|Lack of Efficacy|7|||
144517050|NCT03580369|521092875|FG003|Overall Study|Lack of Efficacy|0|||
144517051|NCT03580369|521092876|FG004|Overall Study|Lack of Efficacy|2|||
144517052|NCT03580369|521092877|FG005|Overall Study|Lack of Efficacy|0|||
144517053|NCT03580369|521092878|FG006|Overall Study|Lack of Efficacy|3|||
144517054|NCT03580369|521092879|FG007|Overall Study|Lack of Efficacy|0|||
144517055|NCT03580369|521092872|FG000|Overall Study|Protocol Violation|6|||
144517056|NCT03580369|521092873|FG001|Overall Study|Protocol Violation|0|||
144517057|NCT03580369|521092874|FG002|Overall Study|Protocol Violation|6|||
144517058|NCT03580369|521092875|FG003|Overall Study|Protocol Violation|1|||
144517059|NCT03580369|521092876|FG004|Overall Study|Protocol Violation|8|||
144517060|NCT03580369|521092877|FG005|Overall Study|Protocol Violation|2|||
144517061|NCT03580369|521092878|FG006|Overall Study|Protocol Violation|1|||
144517062|NCT03580369|521092879|FG007|Overall Study|Protocol Violation|0|||
144517063|NCT03580369|521092872|FG000|Overall Study|Adverse Event|7|||
144517064|NCT03580369|521092873|FG001|Overall Study|Adverse Event|0|||
144517065|NCT03580369|521092874|FG002|Overall Study|Adverse Event|14|||
144517066|NCT03580369|521092875|FG003|Overall Study|Adverse Event|1|||
144517067|NCT03580369|521092876|FG004|Overall Study|Adverse Event|6|||
144517068|NCT03580369|521092877|FG005|Overall Study|Adverse Event|0|||
144517069|NCT03580369|521092878|FG006|Overall Study|Adverse Event|1|||
144517070|NCT03580369|521092879|FG007|Overall Study|Adverse Event|0|||
144517071|NCT03580369|521092872|FG000|Overall Study|Withdrawal by Subject|19|||
144517072|NCT03580369|521092873|FG001|Overall Study|Withdrawal by Subject|0|||
144517073|NCT03580369|521092874|FG002|Overall Study|Withdrawal by Subject|17|||
144517074|NCT03580369|521092875|FG003|Overall Study|Withdrawal by Subject|0|||
144517075|NCT03580369|521092876|FG004|Overall Study|Withdrawal by Subject|16|||
144517076|NCT03580369|521092877|FG005|Overall Study|Withdrawal by Subject|1|||
144517077|NCT03580369|521092878|FG006|Overall Study|Withdrawal by Subject|7|||
144517078|NCT03580369|521092879|FG007|Overall Study|Withdrawal by Subject|0|||
144517079|NCT02112916|521092885|FG000|Overall Study|Adverse Event|6|||
144517080|NCT02112916|521092886|FG001|Overall Study|Adverse Event|9|||
144517081|NCT02112916|521092887|FG002|Overall Study|Adverse Event|3|||
144517082|NCT02112916|521092888|FG003|Overall Study|Adverse Event|2|||
144517083|NCT02112916|521092885|FG000|Overall Study|Death|9|||
144593474|NCT04281004|521373961|FG001|Overall Study|Physician Decision|0|||
144593475|NCT03442985|521373962|FG000|Overall Study|Sponsor Request|55|||
144388994|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
144388995|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
144388996|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
144388997|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
144388998|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
144388999|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
144389000|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
144389001|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
144389002|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
144389003|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
144389004|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
144389005|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
144389006|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
144389007|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
144389008|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
144389009|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
144389010|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
144389011|NCT00745615|520635611|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
144389012|NCT00745615|520635612|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
144389013|NCT00745615|520635613|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
144517084|NCT02112916|521092886|FG001|Overall Study|Death|9|||
144517085|NCT02112916|521092887|FG002|Overall Study|Death|3|||
144517086|NCT02112916|521092888|FG003|Overall Study|Death|4|||
144517087|NCT02112916|521092885|FG000|Overall Study|Lost to Follow-up|1|||
144517088|NCT02112916|521092886|FG001|Overall Study|Lost to Follow-up|0|||
144517089|NCT02112916|521092887|FG002|Overall Study|Lost to Follow-up|0|||
144517090|NCT02112916|521092888|FG003|Overall Study|Lost to Follow-up|0|||
144389014|NCT00745615|520635614|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
144389015|NCT00745615|520635615|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
144389016|NCT00745615|520635616|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
144389017|NCT00586664|520635617|FG000|Overall Study|Withdrawal by Subject|3|||
144389018|NCT00586664|520635618|FG001|Overall Study|Withdrawal by Subject|7|||
144517091|NCT02112916|521092885|FG000|Overall Study|Physician Decision|94|||
144517092|NCT02112916|521092886|FG001|Overall Study|Physician Decision|72|||
144517093|NCT02112916|521092887|FG002|Overall Study|Physician Decision|24|||
144517094|NCT02112916|521092888|FG003|Overall Study|Physician Decision|15|||
144517095|NCT02112916|521092885|FG000|Overall Study|Withdrawal by Subject|5|||
144517096|NCT02112916|521092886|FG001|Overall Study|Withdrawal by Subject|3|||
144517097|NCT02112916|521092887|FG002|Overall Study|Withdrawal by Subject|1|||
144517098|NCT02112916|521092888|FG003|Overall Study|Withdrawal by Subject|1|||
144517099|NCT02112916|521092885|FG000|Overall Study|Ineligible|4|||
144517100|NCT02112916|521092886|FG001|Overall Study|Ineligible|8|||
144517101|NCT02112916|521092887|FG002|Overall Study|Ineligible|3|||
144517102|NCT02112916|521092888|FG003|Overall Study|Ineligible|8|||
144517103|NCT02112916|521092885|FG000|Overall Study|Inevaluable|6|||
144517104|NCT02112916|521092886|FG001|Overall Study|Inevaluable|4|||
144517105|NCT02112916|521092887|FG002|Overall Study|Inevaluable|5|||
144517106|NCT02112916|521092888|FG003|Overall Study|Inevaluable|5|||
144517107|NCT02112916|521092885|FG000|Overall Study|Refusal of further protocol therapy|19|||
144517108|NCT02112916|521092886|FG001|Overall Study|Refusal of further protocol therapy|16|||
144517109|NCT02112916|521092887|FG002|Overall Study|Refusal of further protocol therapy|1|||
144517110|NCT02112916|521092888|FG003|Overall Study|Refusal of further protocol therapy|7|||
144517111|NCT02112916|521092885|FG000|Overall Study|Development of SMN|1|||
144517112|NCT02112916|521092886|FG001|Overall Study|Development of SMN|0|||
144517113|NCT02112916|521092887|FG002|Overall Study|Development of SMN|0|||
144517114|NCT02112916|521092888|FG003|Overall Study|Development of SMN|1|||
144517115|NCT02112916|521092885|FG000|Overall Study|Relapse/Progression|10|||
144517116|NCT02112916|521092886|FG001|Overall Study|Relapse/Progression|18|||
144517117|NCT02112916|521092887|FG002|Overall Study|Relapse/Progression|15|||
144517118|NCT02112916|521092888|FG003|Overall Study|Relapse/Progression|2|||
144517119|NCT02112916|521092885|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
144517120|NCT02112916|521092886|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
144517121|NCT02112916|521092887|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
144517122|NCT02112916|521092888|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
144517123|NCT02112916|521092885|FG000|Overall Study|Still on Therapy|44|||
144517124|NCT02112916|521092886|FG001|Overall Study|Still on Therapy|47|||
144517125|NCT02112916|521092887|FG002|Overall Study|Still on Therapy|3|||
144517126|NCT02112916|521092888|FG003|Overall Study|Still on Therapy|2|||
144517127|NCT02112916|521092885|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
144517128|NCT02112916|521092886|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
144517129|NCT02112916|521092887|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
144517130|NCT02112916|521092888|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
144517131|NCT02112916|521092885|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
144517132|NCT02112916|521092886|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
144517133|NCT02112916|521092887|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
144517134|NCT02112916|521092888|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
144517135|NCT03940703|521094251|FG000|Overall Study|Still under treatment|31|||
144517136|NCT03940703|521094252|FG001|Overall Study|Still under treatment|0|||
144517137|NCT00753090|521094255|FG000|Overall Study|Withdrawal by Subject|10|||
144517138|NCT00753090|521094256|FG001|Overall Study|Withdrawal by Subject|10|||
144517139|NCT00753090|521094255|FG000|Overall Study|Death|17|||
144517140|NCT00753090|521094256|FG001|Overall Study|Death|6|||
144517141|NCT00753090|521094255|FG000|Overall Study|Study Prosthesis Removed|12|||
144517142|NCT00753090|521094256|FG001|Overall Study|Study Prosthesis Removed|3|||
144517143|NCT00753090|521094255|FG000|Overall Study|Lost to Follow-up|2|||
144517144|NCT00753090|521094256|FG001|Overall Study|Lost to Follow-up|2|||
144517145|NCT00753090|521094255|FG000|Overall Study|Other|127|||
144389019|NCT00586664|520635619|FG002|Overall Study|Withdrawal by Subject|1|||
144389020|NCT00586664|520635617|FG000|Overall Study|Exclusion criteria met|2|||
144517146|NCT00753090|521094256|FG001|Overall Study|Other|75|||
144517147|NCT05113966|521094258|FG000|Overall Study|Death|21|||
144517148|NCT05113966|521094258|FG000|Overall Study|Study Terminated by Sponsor|9|||
144517149|NCT04521478|521094263|FG000|Overall Study|Protocol Violation|2|||
144517150|NCT04521478|521094264|FG001|Overall Study|Protocol Violation|0|||
144517151|NCT04521478|521094265|FG002|Overall Study|Protocol Violation|1|||
144517152|NCT04521478|521094266|FG003|Overall Study|Protocol Violation|0|||
144517153|NCT04521478|521094267|FG004|Overall Study|Protocol Violation|0|||
144517154|NCT04521478|521094268|FG005|Overall Study|Protocol Violation|0|||
144517155|NCT04521478|521094263|FG000|Overall Study|Technical Problems|0|||
144517156|NCT04521478|521094264|FG001|Overall Study|Technical Problems|0|||
144517157|NCT04521478|521094265|FG002|Overall Study|Technical Problems|0|||
144517158|NCT04521478|521094266|FG003|Overall Study|Technical Problems|1|||
144517159|NCT04521478|521094267|FG004|Overall Study|Technical Problems|0|||
144517160|NCT04521478|521094268|FG005|Overall Study|Technical Problems|0|||
144517161|NCT04521478|521094263|FG000|Overall Study|Burden of Study Procedures|1|||
144517162|NCT04521478|521094264|FG001|Overall Study|Burden of Study Procedures|0|||
144517163|NCT04521478|521094265|FG002|Overall Study|Burden of Study Procedures|0|||
144517164|NCT04521478|521094266|FG003|Overall Study|Burden of Study Procedures|1|||
144517165|NCT04521478|521094267|FG004|Overall Study|Burden of Study Procedures|0|||
144517166|NCT04521478|521094268|FG005|Overall Study|Burden of Study Procedures|1|||
144517167|NCT04521478|521094263|FG000|Overall Study|Lack of Efficacy|0|||
144517168|NCT04521478|521094264|FG001|Overall Study|Lack of Efficacy|0|||
144517169|NCT04521478|521094265|FG002|Overall Study|Lack of Efficacy|0|||
144517170|NCT04521478|521094266|FG003|Overall Study|Lack of Efficacy|0|||
144517171|NCT04521478|521094267|FG004|Overall Study|Lack of Efficacy|1|||
144517172|NCT04521478|521094268|FG005|Overall Study|Lack of Efficacy|1|||
144517173|NCT04521478|521094263|FG000|Overall Study|Adverse Event|7|||
144517174|NCT04521478|521094264|FG001|Overall Study|Adverse Event|0|||
144517175|NCT04521478|521094265|FG002|Overall Study|Adverse Event|2|||
144517176|NCT04521478|521094266|FG003|Overall Study|Adverse Event|1|||
144517177|NCT04521478|521094267|FG004|Overall Study|Adverse Event|2|||
144517178|NCT04521478|521094268|FG005|Overall Study|Adverse Event|7|||
144517179|NCT04521478|521094263|FG000|Overall Study|No Reason Available|0|||
144517180|NCT04521478|521094264|FG001|Overall Study|No Reason Available|2|||
144517181|NCT04521478|521094265|FG002|Overall Study|No Reason Available|0|||
144517182|NCT04521478|521094266|FG003|Overall Study|No Reason Available|0|||
144517183|NCT04521478|521094267|FG004|Overall Study|No Reason Available|1|||
144517184|NCT04521478|521094268|FG005|Overall Study|No Reason Available|0|||
144517185|NCT04521478|521094263|FG000|Overall Study|Other than listed|3|||
144517186|NCT04521478|521094264|FG001|Overall Study|Other than listed|3|||
144517187|NCT04521478|521094265|FG002|Overall Study|Other than listed|3|||
144517188|NCT04521478|521094266|FG003|Overall Study|Other than listed|2|||
144517189|NCT04521478|521094267|FG004|Overall Study|Other than listed|3|||
144517190|NCT04521478|521094268|FG005|Overall Study|Other than listed|3|||
144517191|NCT04521478|521094263|FG000|Overall Study|Not treated|0|||
144517192|NCT04521478|521094264|FG001|Overall Study|Not treated|0|||
144517193|NCT04521478|521094265|FG002|Overall Study|Not treated|0|||
144517194|NCT04521478|521094266|FG003|Overall Study|Not treated|0|||
144517195|NCT04521478|521094267|FG004|Overall Study|Not treated|0|||
144517196|NCT04521478|521094268|FG005|Overall Study|Not treated|1|||
144517197|NCT05058391|521094271|FG000|Overall Study|Adverse Event|1|||
144517198|NCT03775109|521094272|FG000|Overall Study|Adverse Event|1|||
144517199|NCT03775109|521094273|FG001|Overall Study|Adverse Event|0|||
144517200|NCT03775109|521094272|FG000|Overall Study|COVID-19 outbreak|2|||
144517201|NCT03775109|521094273|FG001|Overall Study|COVID-19 outbreak|0|||
144517202|NCT03775109|521094272|FG000|Overall Study|Lost to Follow-up|0|||
144517203|NCT03775109|521094273|FG001|Overall Study|Lost to Follow-up|2|||
144517204|NCT03775109|521094272|FG000|Overall Study|Withdrawal by Subject|1|||
144517205|NCT03775109|521094273|FG001|Overall Study|Withdrawal by Subject|1|||
144517206|NCT03775109|521094272|FG000|Overall Study|Death|0|||
144517207|NCT03775109|521094273|FG001|Overall Study|Death|1|||
144517208|NCT03775109|521094272|FG000|Overall Study|Lack of Efficacy|1|||
144517209|NCT03775109|521094273|FG001|Overall Study|Lack of Efficacy|0|||
144517210|NCT01894061|521094277|FG000|Overall Study|Screen failure|1|||
144517211|NCT01894061|521094277|FG000|Overall Study|Withdrawal by Subject|1|||
144517212|NCT05110495|521094278|FG000|Overall Study|Lost to Follow-up|1|||
144517213|NCT05110495|521094278|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
144517214|NCT02651324|521094281|FG000|Overall Study|drug not administered, due dispensing issue|1|||
144517215|NCT02651324|521094282|FG001|Overall Study|drug not administered, due dispensing issue|0|||
144517216|NCT05919082|521094283|FG000|Overall Study|Adverse Event|3|||
144517217|NCT05919082|521094284|FG001|Overall Study|Adverse Event|0|||
144517218|NCT05919082|521094283|FG000|Overall Study|Lost to Follow-up|0|||
144517219|NCT05919082|521094284|FG001|Overall Study|Lost to Follow-up|1|||
144517220|NCT05919082|521094283|FG000|Overall Study|Withdrawal by Subject|8|||
144517221|NCT05919082|521094284|FG001|Overall Study|Withdrawal by Subject|9|||
144517222|NCT05919082|521094283|FG000|Overall Study|Lack of Efficacy|0|||
144517223|NCT05919082|521094284|FG001|Overall Study|Lack of Efficacy|1|||
144517224|NCT05919082|521094283|FG000|Overall Study|Investigator Decision|1|||
144517225|NCT05919082|521094284|FG001|Overall Study|Investigator Decision|0|||
144517226|NCT05461131|521094286|FG000|Overall Study|Lost to Follow-up|0|||
144517227|NCT05461131|521094287|FG001|Overall Study|Lost to Follow-up|2|||
144517228|NCT00676715|521094292|FG000|Treatment Period (TP)|Adverse Event|0|||
144517229|NCT00676715|521094293|FG001|Treatment Period (TP)|Adverse Event|3|||
144517230|NCT00676715|521094294|FG002|Treatment Period (TP)|Adverse Event|2|||
144517231|NCT00676715|521094295|FG003|Treatment Period (TP)|Adverse Event|2|||
144517232|NCT00676715|521094292|FG000|Treatment Period (TP)|Death|0|||
144517233|NCT00676715|521094293|FG001|Treatment Period (TP)|Death|0|||
144517234|NCT00676715|521094294|FG002|Treatment Period (TP)|Death|1|||
144517235|NCT00676715|521094295|FG003|Treatment Period (TP)|Death|0|||
144517236|NCT00676715|521094292|FG000|Treatment Period (TP)|Failure to return|1|||
144517237|NCT00676715|521094293|FG001|Treatment Period (TP)|Failure to return|0|||
144517238|NCT00676715|521094294|FG002|Treatment Period (TP)|Failure to return|0|||
144517239|NCT00676715|521094295|FG003|Treatment Period (TP)|Failure to return|0|||
144517240|NCT00676715|521094292|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
144517241|NCT00676715|521094293|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
144517242|NCT00676715|521094294|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
144517243|NCT00676715|521094295|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
144517244|NCT00676715|521094292|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
144517245|NCT00676715|521094293|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
144517246|NCT00676715|521094294|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
144517247|NCT00676715|521094295|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
144517248|NCT00676715|521094292|FG000|Treatment Period (TP)|Withdrew consent|3|||
144517249|NCT00676715|521094293|FG001|Treatment Period (TP)|Withdrew consent|3|||
144517250|NCT00676715|521094294|FG002|Treatment Period (TP)|Withdrew consent|3|||
144517251|NCT00676715|521094295|FG003|Treatment Period (TP)|Withdrew consent|3|||
144517252|NCT00676715|521094292|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
144517253|NCT00676715|521094293|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
144517254|NCT00676715|521094294|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
144517255|NCT00676715|521094295|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
144517256|NCT00676715|521094292|FG000|Treatment Period (TP)|Administrative|0|||
144517257|NCT00676715|521094293|FG001|Treatment Period (TP)|Administrative|0|||
144517258|NCT00676715|521094294|FG002|Treatment Period (TP)|Administrative|0|||
144517259|NCT00676715|521094295|FG003|Treatment Period (TP)|Administrative|1|||
144517260|NCT00676715|521094292|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
144517261|NCT00676715|521094293|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
144517262|NCT00676715|521094294|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
144517263|NCT00676715|521094295|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
144517264|NCT00676715|521094292|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
144517265|NCT00676715|521094293|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
144517266|NCT00676715|521094294|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
144517267|NCT00676715|521094295|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
144517268|NCT00676715|521094292|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
144517269|NCT00676715|521094293|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
144517270|NCT00676715|521094294|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
144517271|NCT00676715|521094295|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
144517272|NCT00676715|521094292|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
144517273|NCT00676715|521094293|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
144517274|NCT00676715|521094294|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
144517275|NCT00676715|521094295|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
144517276|NCT00676715|521094292|FG000|Treatment-free Period (TFP)|Death|1|||
144517277|NCT00676715|521094293|FG001|Treatment-free Period (TFP)|Death|1|||
144517278|NCT00676715|521094294|FG002|Treatment-free Period (TFP)|Death|1|||
144517279|NCT00676715|521094295|FG003|Treatment-free Period (TFP)|Death|0|||
144593476|NCT03442985|521373963|FG001|Overall Study|Sponsor Request|60|||
144517280|NCT00676715|521094292|FG000|Open Label Extension (OLE)|Reason not provided|3|||
144517281|NCT00676715|521094293|FG001|Open Label Extension (OLE)|Reason not provided|4|||
144593477|NCT03442985|521373964|FG002|Overall Study|Sponsor Request|54|||
144517282|NCT00676715|521094294|FG002|Open Label Extension (OLE)|Reason not provided|1|||
144517283|NCT00676715|521094295|FG003|Open Label Extension (OLE)|Reason not provided|4|||
144517284|NCT00676715|521094292|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
144517285|NCT00676715|521094293|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
144517286|NCT00676715|521094294|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
144593478|NCT03442985|521373962|FG000|Overall Study|Lost to Follow-up|5|||
144593479|NCT03442985|521373963|FG001|Overall Study|Lost to Follow-up|2|||
144593480|NCT03442985|521373964|FG002|Overall Study|Lost to Follow-up|7|||
144593481|NCT03442985|521373962|FG000|Overall Study|Withdrawal by Subject|2|||
144593482|NCT03442985|521373963|FG001|Overall Study|Withdrawal by Subject|3|||
144593483|NCT03442985|521373964|FG002|Overall Study|Withdrawal by Subject|4|||
144593484|NCT03442985|521373962|FG000|Overall Study|Adverse Event|0|||
144593485|NCT03442985|521373963|FG001|Overall Study|Adverse Event|1|||
144593486|NCT03442985|521373964|FG002|Overall Study|Adverse Event|0|||
144593487|NCT01620255|521373968|FG000|Overall Study|Withdrawal by Subject|4|||
144593488|NCT01620255|521373969|FG001|Overall Study|Withdrawal by Subject|1|||
144593489|NCT01620255|521373970|FG002|Overall Study|Withdrawal by Subject|1|||
144593490|NCT01620255|521373971|FG003|Overall Study|Withdrawal by Subject|2|||
144593491|NCT01620255|521373972|FG004|Overall Study|Withdrawal by Subject|4|||
144593492|NCT01620255|521373968|FG000|Overall Study|Participant underwent fecal transplant|0|||
144593493|NCT01620255|521373969|FG001|Overall Study|Participant underwent fecal transplant|0|||
144593494|NCT01620255|521373970|FG002|Overall Study|Participant underwent fecal transplant|1|||
144593495|NCT01620255|521373971|FG003|Overall Study|Participant underwent fecal transplant|0|||
144593496|NCT01620255|521373972|FG004|Overall Study|Participant underwent fecal transplant|0|||
144593497|NCT01620255|521373968|FG000|Overall Study|Non-compliance|0|||
144593498|NCT01620255|521373969|FG001|Overall Study|Non-compliance|1|||
144593499|NCT01620255|521373970|FG002|Overall Study|Non-compliance|0|||
144593500|NCT01620255|521373971|FG003|Overall Study|Non-compliance|0|||
144593501|NCT01620255|521373972|FG004|Overall Study|Non-compliance|0|||
144593502|NCT01620255|521373968|FG000|Overall Study|Adverse Event|0|||
144593503|NCT01620255|521373969|FG001|Overall Study|Adverse Event|4|||
144593504|NCT01620255|521373970|FG002|Overall Study|Adverse Event|0|||
144593505|NCT01620255|521373971|FG003|Overall Study|Adverse Event|1|||
144593506|NCT01620255|521373972|FG004|Overall Study|Adverse Event|1|||
144593507|NCT01620255|521373968|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
144593508|NCT01620255|521373969|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
144593509|NCT01620255|521373970|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
144593510|NCT01620255|521373971|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
144593511|NCT01620255|521373972|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
144593512|NCT01557283|521373973|FG000|Overall Study|Lost to Follow-up|7|||
144593513|NCT01557283|521373973|FG000|Overall Study|Non-responder|19|||
144593514|NCT01557283|521373973|FG000|Overall Study|Adverse Event|7|||
144593515|NCT01557283|521373973|FG000|Overall Study|Lack of Efficacy|1|||
144593516|NCT01557283|521373973|FG000|Overall Study|Non-compliance|1|||
144593517|NCT01557283|521373973|FG000|Overall Study|Withdrawal by Subject|1|||
144593518|NCT01557283|521373973|FG000|Overall Study|Participant's weight too high for dose|1|||
144593519|NCT01557283|521373973|FG000|Overall Study|Worsening of psoriasis|1|||
144593520|NCT01557283|521373973|FG000|Overall Study|Other|6|||
144593521|NCT01716117|521373974|FG000|Overall Study|Death|5|||
144593522|NCT01716117|521373975|FG001|Overall Study|Death|2|||
144593523|NCT01716117|521373974|FG000|Overall Study|Withdrawal by Subject|2|||
144593524|NCT01716117|521373975|FG001|Overall Study|Withdrawal by Subject|0|||
144593525|NCT03645057|521373979|FG000|Randomization to Baseline|Lost to Follow-up|1|||
144593526|NCT03645057|521373980|FG001|Randomization to Baseline|Lost to Follow-up|0|||
144593527|NCT03645057|521373981|FG002|Randomization to Baseline|Lost to Follow-up|1|||
144593528|NCT03645057|521373982|FG003|Randomization to Baseline|Lost to Follow-up|0|||
144593529|NCT03645057|521373979|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
144593530|NCT03645057|521373980|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
144593531|NCT03645057|521373981|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
144593532|NCT03645057|521373982|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
144593533|NCT03645057|521373979|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
144593534|NCT03645057|521373980|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
144593535|NCT03645057|521373981|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
144593536|NCT03645057|521373982|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
144593537|NCT03645057|521373979|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
144593538|NCT03645057|521373980|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
144593539|NCT03645057|521373981|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
144593540|NCT03645057|521373982|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
144593541|NCT01873495|521373983|FG000|Overall Study|Withdrawal by Subject|1|||
144593542|NCT01873495|521373983|FG000|Overall Study|Physician Decision|3|||
144593543|NCT01873495|521373983|FG000|Overall Study|Adverse Event|1|||
144593544|NCT01873495|521373983|FG000|Overall Study|Removed for Transplantation|1|||
144593545|NCT01873495|521373983|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
144593546|NCT03214094|521373984|FG000|Overall Study|Case Report Forms Uncollected|14|||
144593547|NCT03214094|521373984|FG000|Overall Study|Protocol Deviation|46|||
144722144|NCT03111147|521836989|FG000|Overall Study|Withdrawal by Subject|4|||
144722145|NCT03111147|521836990|FG001|Overall Study|Withdrawal by Subject|3|||
144593548|NCT00795951|521373985|FG000|Overall Study|Lost to Follow-up|1|||
144593549|NCT00795951|521373985|FG000|Overall Study|Withdrawal by Subject|1|||
144593550|NCT00655486|521373986|FG000|Overall Study|Adverse Event|10|||
144593551|NCT00655486|521373986|FG000|Overall Study|Lack of Efficacy|8|||
144593552|NCT00655486|521373986|FG000|Overall Study|Withdrawal by Subject|4|||
144593553|NCT00655486|521373986|FG000|Overall Study|Protocol Violation|1|||
144593554|NCT00655486|521373986|FG000|Overall Study|Unsatisfactory compliance|2|||
144593555|NCT00655486|521373986|FG000|Overall Study|Other: Pregnancy|1|||
144593556|NCT00655486|521373986|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
144593557|NCT00655486|521373986|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
144593558|NCT02435966|521373989|FG000|Overall Study|Withdrawal by Subject|0|||
144593559|NCT02435966|521373990|FG001|Overall Study|Withdrawal by Subject|1|||
144593560|NCT02435966|521373991|FG002|Overall Study|Withdrawal by Subject|0|||
144593561|NCT02745392|521373995|FG000|Overall Study|Lost to Follow-up|0|||
144593562|NCT02745392|521373996|FG001|Overall Study|Lost to Follow-up|1|||
144593563|NCT02745392|521373997|FG002|Overall Study|Lost to Follow-up|0|||
144593564|NCT02745392|521373998|FG003|Overall Study|Lost to Follow-up|0|||
144593565|NCT01959334|521373999|FG000|Second Dose|Adverse Event|1|||
144593566|NCT01959334|521374000|FG001|Second Dose|Adverse Event|0|||
144593567|NCT01959334|521373999|FG000|Third Dose|Adverse Event|0|||
144593568|NCT01959334|521374000|FG001|Third Dose|Adverse Event|1|||
144593569|NCT01007448|521374002|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
144593570|NCT01007448|521374003|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
144593571|NCT01007448|521374002|FG000|Overall Study|Staph Skin Infection Flare|1|||
144593572|NCT01007448|521374003|FG001|Overall Study|Staph Skin Infection Flare|0|||
144593573|NCT01007448|521374002|FG000|Overall Study|Participant Leaving the Country|1|||
144593574|NCT01007448|521374003|FG001|Overall Study|Participant Leaving the Country|0|||
144593575|NCT01007448|521374002|FG000|Overall Study|Participant Given Prohibited Medication|1|||
144593576|NCT01007448|521374003|FG001|Overall Study|Participant Given Prohibited Medication|0|||
144593577|NCT01007448|521374002|FG000|Overall Study|Progressive Disease|1|||
144593578|NCT01007448|521374003|FG001|Overall Study|Progressive Disease|2|||
144593579|NCT01007448|521374002|FG000|Overall Study|Lack of Efficacy|2|||
144593580|NCT01007448|521374003|FG001|Overall Study|Lack of Efficacy|0|||
144593581|NCT01007448|521374002|FG000|Overall Study|Withdrawal by Subject|2|||
144593582|NCT01007448|521374003|FG001|Overall Study|Withdrawal by Subject|3|||
144593583|NCT01007448|521374002|FG000|Overall Study|Adverse Event|1|||
144593584|NCT01007448|521374003|FG001|Overall Study|Adverse Event|4|||
144593585|NCT00887432|521374004|FG000|Overall Study|Start Excluded Therapy|3|||
144593586|NCT00887432|521374005|FG001|Overall Study|Start Excluded Therapy|0|||
144593587|NCT00887432|521374004|FG000|Overall Study|Did not complete treatment|6|||
144593588|NCT00887432|521374005|FG001|Overall Study|Did not complete treatment|8|||
144593589|NCT00887432|521374004|FG000|Overall Study|Protocol Violation|2|||
144593590|NCT00887432|521374005|FG001|Overall Study|Protocol Violation|3|||
144593591|NCT00887432|521374004|FG000|Overall Study|Withdrawal by Subject|3|||
144593592|NCT00887432|521374005|FG001|Overall Study|Withdrawal by Subject|2|||
144593593|NCT00887432|521374004|FG000|Overall Study|Lost to Follow-up|1|||
144593594|NCT00887432|521374005|FG001|Overall Study|Lost to Follow-up|0|||
144593595|NCT00887432|521374004|FG000|Overall Study|No reason provided|0|||
144593596|NCT00887432|521374005|FG001|Overall Study|No reason provided|1|||
144593597|NCT00899548|521374006|FG000|Overall Study|Physician Decision|3|||
144593598|NCT01337115|521374007|FG000|Overall Study|Protocol Violation|2|||
144593599|NCT01337115|521374008|FG001|Overall Study|Protocol Violation|0|||
144593600|NCT01636960|521374009|FG000|Induction Phase|Adverse Event|2|||
144593601|NCT01636960|521374009|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
144593602|NCT01636960|521374009|FG000|Maintenance Phase|Adverse Event|3|||
144593603|NCT01636960|521374009|FG000|Maintenance Phase|Progressive disease|1|||
144593604|NCT01209780|521374010|FG000|Overall Study|Adverse Event|0|||
144593605|NCT01209780|521374011|FG001|Overall Study|Adverse Event|1|||
144593606|NCT01209780|521374012|FG002|Overall Study|Adverse Event|0|||
144593607|NCT01209780|521374013|FG003|Overall Study|Adverse Event|0|||
144593608|NCT01209780|521374014|FG004|Overall Study|Adverse Event|0|||
144593609|NCT01209780|521374010|FG000|Overall Study|Withdrawal by Subject|9|||
144389021|NCT00586664|520635618|FG001|Overall Study|Exclusion criteria met|0|||
144389022|NCT00586664|520635619|FG002|Overall Study|Exclusion criteria met|0|||
144593610|NCT01209780|521374011|FG001|Overall Study|Withdrawal by Subject|2|||
144593611|NCT01209780|521374012|FG002|Overall Study|Withdrawal by Subject|1|||
144593612|NCT01209780|521374013|FG003|Overall Study|Withdrawal by Subject|1|||
144593613|NCT01209780|521374014|FG004|Overall Study|Withdrawal by Subject|0|||
144593614|NCT01209780|521374010|FG000|Overall Study|Lost to Follow-up|17|||
144593615|NCT01209780|521374011|FG001|Overall Study|Lost to Follow-up|12|||
144593616|NCT01209780|521374012|FG002|Overall Study|Lost to Follow-up|3|||
144593617|NCT01209780|521374013|FG003|Overall Study|Lost to Follow-up|9|||
144593618|NCT01209780|521374014|FG004|Overall Study|Lost to Follow-up|4|||
144593619|NCT01209780|521374010|FG000|Overall Study|Protocol Violation|0|||
144593620|NCT01209780|521374011|FG001|Overall Study|Protocol Violation|1|||
144593621|NCT01209780|521374012|FG002|Overall Study|Protocol Violation|0|||
144593622|NCT01209780|521374013|FG003|Overall Study|Protocol Violation|0|||
144593623|NCT01209780|521374014|FG004|Overall Study|Protocol Violation|0|||
144593624|NCT01209780|521374010|FG000|Overall Study|Inappropriate enrollment|0|||
144389023|NCT02751931|520635623|FG000|Overall Study|Adverse Event|3|||
144722146|NCT03111147|521836989|FG000|Overall Study|Protocol Violation|2|||
144593625|NCT01209780|521374011|FG001|Overall Study|Inappropriate enrollment|2|||
144593626|NCT01209780|521374012|FG002|Overall Study|Inappropriate enrollment|0|||
144593627|NCT01209780|521374013|FG003|Overall Study|Inappropriate enrollment|0|||
144593628|NCT01209780|521374014|FG004|Overall Study|Inappropriate enrollment|1|||
144593629|NCT01580969|521374015|FG000|Overall Study|Physician Decision|3|||
144593630|NCT01580969|521374016|FG001|Overall Study|Physician Decision|0|||
144593631|NCT01580969|521374017|FG002|Overall Study|Physician Decision|0|||
144593632|NCT01745848|521374018|FG000|Overall Study|Adverse Event|6|||
144593633|NCT01886378|521374021|FG000|Overall Study|Adverse Event|1|||
144593634|NCT01886378|521374021|FG000|Overall Study|Withdrawal by Subject|4|||
144593635|NCT02318797|521374022|FG000|Overall Study|Death|3|||
144593636|NCT02318797|521374023|FG001|Overall Study|Death|6|||
144593637|NCT02318797|521374022|FG000|Overall Study|Lost to Follow-up|85|||
144593638|NCT02318797|521374023|FG001|Overall Study|Lost to Follow-up|96|||
144593639|NCT00406653|521374024|FG000|Induction Period|Adverse Event|1|||
144593640|NCT00406653|521374025|FG001|Induction Period|Adverse Event|10|||
144593641|NCT00406653|521374026|FG002|Induction Period|Adverse Event|4|||
144593642|NCT00406653|521374027|FG003|Induction Period|Adverse Event|11|||
144593643|NCT00406653|521374028|FG004|Induction Period|Adverse Event|0|||
144593644|NCT00406653|521374029|FG005|Induction Period|Adverse Event|0|||
144593645|NCT00406653|521374030|FG006|Induction Period|Adverse Event|0|||
144593646|NCT00406653|521374024|FG000|Induction Period|Lack of Efficacy|11|||
144593647|NCT00406653|521374025|FG001|Induction Period|Lack of Efficacy|14|||
144593648|NCT00406653|521374026|FG002|Induction Period|Lack of Efficacy|8|||
144593649|NCT00406653|521374027|FG003|Induction Period|Lack of Efficacy|10|||
144593650|NCT00406653|521374028|FG004|Induction Period|Lack of Efficacy|0|||
144593651|NCT00406653|521374029|FG005|Induction Period|Lack of Efficacy|0|||
144593652|NCT00406653|521374030|FG006|Induction Period|Lack of Efficacy|0|||
144593653|NCT00406653|521374024|FG000|Induction Period|Lost to Follow-up|0|||
144593654|NCT00406653|521374025|FG001|Induction Period|Lost to Follow-up|2|||
144593655|NCT00406653|521374026|FG002|Induction Period|Lost to Follow-up|0|||
144593656|NCT00406653|521374027|FG003|Induction Period|Lost to Follow-up|0|||
144593657|NCT00406653|521374028|FG004|Induction Period|Lost to Follow-up|0|||
144593658|NCT00406653|521374029|FG005|Induction Period|Lost to Follow-up|0|||
144593659|NCT00406653|521374030|FG006|Induction Period|Lost to Follow-up|0|||
144593660|NCT00406653|521374024|FG000|Induction Period|Withdrawal of Consent|2|||
144593661|NCT00406653|521374025|FG001|Induction Period|Withdrawal of Consent|5|||
144593662|NCT00406653|521374026|FG002|Induction Period|Withdrawal of Consent|1|||
144593663|NCT00406653|521374027|FG003|Induction Period|Withdrawal of Consent|2|||
144593664|NCT00406653|521374028|FG004|Induction Period|Withdrawal of Consent|0|||
144593665|NCT00406653|521374029|FG005|Induction Period|Withdrawal of Consent|0|||
144593666|NCT00406653|521374030|FG006|Induction Period|Withdrawal of Consent|0|||
144593667|NCT00406653|521374024|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
144593668|NCT00406653|521374025|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
144593669|NCT00406653|521374026|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
144593670|NCT00406653|521374027|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
144593671|NCT00406653|521374028|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
144593672|NCT00406653|521374029|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
144593673|NCT00406653|521374030|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
144593674|NCT00406653|521374024|FG000|Induction Period|Pregnancy|1|||
144593675|NCT00406653|521374025|FG001|Induction Period|Pregnancy|0|||
144593676|NCT00406653|521374026|FG002|Induction Period|Pregnancy|0|||
144593677|NCT00406653|521374027|FG003|Induction Period|Pregnancy|0|||
144593678|NCT00406653|521374028|FG004|Induction Period|Pregnancy|0|||
144593679|NCT00406653|521374029|FG005|Induction Period|Pregnancy|0|||
144593680|NCT00406653|521374030|FG006|Induction Period|Pregnancy|0|||
144593681|NCT00406653|521374024|FG000|Induction Period|Declined participation but followup done|0|||
144593682|NCT00406653|521374025|FG001|Induction Period|Declined participation but followup done|2|||
144593683|NCT00406653|521374026|FG002|Induction Period|Declined participation but followup done|1|||
144593684|NCT00406653|521374027|FG003|Induction Period|Declined participation but followup done|1|||
144593685|NCT00406653|521374028|FG004|Induction Period|Declined participation but followup done|0|||
144593686|NCT00406653|521374029|FG005|Induction Period|Declined participation but followup done|0|||
144722147|NCT03111147|521836990|FG001|Overall Study|Protocol Violation|1|||
144593687|NCT00406653|521374030|FG006|Induction Period|Declined participation but followup done|0|||
144593688|NCT00406653|521374024|FG000|Induction Period|Given prohibited drug|0|||
144593689|NCT00406653|521374025|FG001|Induction Period|Given prohibited drug|1|||
144593690|NCT00406653|521374026|FG002|Induction Period|Given prohibited drug|2|||
144593691|NCT00406653|521374027|FG003|Induction Period|Given prohibited drug|0|||
144593692|NCT00406653|521374028|FG004|Induction Period|Given prohibited drug|0|||
144593693|NCT00406653|521374029|FG005|Induction Period|Given prohibited drug|0|||
144722148|NCT03111147|521836989|FG000|Overall Study|Death|1|||
144593694|NCT00406653|521374030|FG006|Induction Period|Given prohibited drug|0|||
144593695|NCT00406653|521374024|FG000|Induction Period|Incarcerated|0|||
144593696|NCT00406653|521374025|FG001|Induction Period|Incarcerated|0|||
144593697|NCT00406653|521374026|FG002|Induction Period|Incarcerated|1|||
144593698|NCT00406653|521374027|FG003|Induction Period|Incarcerated|0|||
144517287|NCT00676715|521094295|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
144517288|NCT00676715|521094292|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
144517289|NCT00676715|521094293|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
144517290|NCT00676715|521094294|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
144517291|NCT00676715|521094295|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
144517292|NCT00676715|521094292|FG000|Open Label Extension (OLE)|Adverse Event|0|||
144517293|NCT00676715|521094293|FG001|Open Label Extension (OLE)|Adverse Event|3|||
144517294|NCT00676715|521094294|FG002|Open Label Extension (OLE)|Adverse Event|1|||
144517295|NCT00676715|521094295|FG003|Open Label Extension (OLE)|Adverse Event|0|||
144517296|NCT00676715|521094292|FG000|Open Label Extension (OLE)|Death|2|||
144517297|NCT00676715|521094293|FG001|Open Label Extension (OLE)|Death|0|||
144517298|NCT00676715|521094294|FG002|Open Label Extension (OLE)|Death|2|||
144517299|NCT00676715|521094295|FG003|Open Label Extension (OLE)|Death|2|||
144517300|NCT05249439|521094296|FG000|Overall Study|Withdrawal by Subject|2|||
144517301|NCT05249439|521094297|FG001|Overall Study|Withdrawal by Subject|5|||
144517302|NCT05249439|521094296|FG000|Overall Study|Physician Decision|3|||
144517303|NCT05249439|521094297|FG001|Overall Study|Physician Decision|1|||
144517304|NCT02249949|521094298|FG000|Overall Study|Cancelled prior to treatment|2|||
144517305|NCT02097420|521094301|FG000|Overall Study|Death|6|||
144517306|NCT02097420|521094301|FG000|Overall Study|Valve explanted|13|||
144517307|NCT02097420|521094301|FG000|Overall Study|Other Reason|1|||
144517308|NCT02549339|521094304|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
144517309|NCT02549339|521094305|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
144517310|NCT02549339|521094304|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
144517311|NCT02549339|521094305|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
144517312|NCT02549339|521094304|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
144517313|NCT02549339|521094305|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
144517314|NCT02549339|521094304|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
144517315|NCT02549339|521094305|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
144517316|NCT02549339|521094304|FG000|12-month Follow-up|Lack of Efficacy|0|||
144517317|NCT02549339|521094305|FG001|12-month Follow-up|Lack of Efficacy|2|||
144517318|NCT02549339|521094304|FG000|12-month Follow-up|Withdrawal by Subject|8|||
144517319|NCT02549339|521094305|FG001|12-month Follow-up|Withdrawal by Subject|3|||
144517320|NCT02549339|521094304|FG000|12-month Follow-up|Lost to Follow-up|1|||
144517321|NCT02549339|521094305|FG001|12-month Follow-up|Lost to Follow-up|3|||
144517322|NCT02549339|521094304|FG000|12-month Follow-up|Other|0|||
144517323|NCT02549339|521094305|FG001|12-month Follow-up|Other|3|||
144517324|NCT05691309|521094306|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
144517325|NCT05691309|521094306|FG000|Overall Study|vancomycin levels not evaluable|2|||
144517326|NCT01707030|521094307|FG000|Overall Study|Death|1|||
144517327|NCT01707030|521094308|FG001|Overall Study|Death|1|||
144517328|NCT01707030|521094307|FG000|Overall Study|Withdrawal by Subject|2|||
144517329|NCT01707030|521094308|FG001|Overall Study|Withdrawal by Subject|3|||
144517330|NCT01707030|521094307|FG000|Overall Study|Lost to Follow-up|8|||
144517331|NCT01707030|521094308|FG001|Overall Study|Lost to Follow-up|13|||
144517332|NCT04820855|521094310|FG000|Overall Study|Lost to Follow-up|6|||
144517333|NCT04820855|521094311|FG001|Overall Study|Lost to Follow-up|9|||
144517334|NCT04838262|521094312|FG000|Overall Study|Withdrawal by Subject|9|||
144517335|NCT04838262|521094313|FG001|Overall Study|Withdrawal by Subject|4|||
144517336|NCT05229120|521094314|FG000|Overall Study|Withdrawal by Subject|8|||
144517337|NCT00601900|521094321|FG000|Overall Study|Withdrawal by Subject|0|||
144517338|NCT00601900|521094322|FG001|Overall Study|Withdrawal by Subject|3|||
144517339|NCT02697136|521094324|FG000|Overall Study|Adverse Event|3|||
144517340|NCT02697136|521094325|FG001|Overall Study|Adverse Event|0|||
144517341|NCT02323321|521094334|FG000|Overall Study|Re-Transplant|1|||
144517342|NCT02323321|521094334|FG000|Overall Study|Death|12|||
144517343|NCT00446225|521094335|FG000|Overall Study|Protocol Violation|1|||
144517344|NCT00446225|521094336|FG001|Overall Study|Protocol Violation|0|||
144517345|NCT04450342|521094337|FG000|Overall Study|Adverse Event|1|||
144517346|NCT04450342|521094338|FG001|Overall Study|Adverse Event|1|||
144517347|NCT04450342|521094339|FG002|Overall Study|Adverse Event|0|||
144517348|NCT04450342|521094337|FG000|Overall Study|Device not used|1|||
144517349|NCT04450342|521094338|FG001|Overall Study|Device not used|0|||
144517350|NCT04450342|521094339|FG002|Overall Study|Device not used|0|||
144517351|NCT04450342|521094337|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
144517352|NCT04450342|521094338|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
144517353|NCT04450342|521094339|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
144517354|NCT04450342|521094337|FG000|Overall Study|Physician Decision|1|||
144517355|NCT04450342|521094338|FG001|Overall Study|Physician Decision|0|||
144517356|NCT04450342|521094339|FG002|Overall Study|Physician Decision|1|||
144517357|NCT04450342|521094337|FG000|Overall Study|Protocol Deviation|0|||
144517358|NCT04450342|521094338|FG001|Overall Study|Protocol Deviation|1|||
144517359|NCT04450342|521094339|FG002|Overall Study|Protocol Deviation|0|||
144517360|NCT04450342|521094337|FG000|Overall Study|Reoperation|1|||
144517361|NCT04450342|521094338|FG001|Overall Study|Reoperation|1|||
144517362|NCT04450342|521094339|FG002|Overall Study|Reoperation|0|||
144593699|NCT00406653|521374028|FG004|Induction Period|Incarcerated|0|||
144593700|NCT00406653|521374029|FG005|Induction Period|Incarcerated|0|||
144593701|NCT00406653|521374030|FG006|Induction Period|Incarcerated|0|||
144593702|NCT00406653|521374024|FG000|Induction Period|Patient relocated|0|||
144593703|NCT00406653|521374025|FG001|Induction Period|Patient relocated|0|||
144593704|NCT00406653|521374026|FG002|Induction Period|Patient relocated|1|||
144593705|NCT00406653|521374027|FG003|Induction Period|Patient relocated|0|||
144593706|NCT00406653|521374028|FG004|Induction Period|Patient relocated|0|||
144593707|NCT00406653|521374029|FG005|Induction Period|Patient relocated|0|||
144593708|NCT00406653|521374030|FG006|Induction Period|Patient relocated|0|||
144593709|NCT00406653|521374024|FG000|Maintenance Period|Adverse Event|0|||
144593710|NCT00406653|521374025|FG001|Maintenance Period|Adverse Event|0|||
144593711|NCT00406653|521374026|FG002|Maintenance Period|Adverse Event|0|||
144593712|NCT00406653|521374027|FG003|Maintenance Period|Adverse Event|0|||
144593713|NCT00406653|521374028|FG004|Maintenance Period|Adverse Event|1|||
144593714|NCT00406653|521374029|FG005|Maintenance Period|Adverse Event|1|||
144593715|NCT00406653|521374030|FG006|Maintenance Period|Adverse Event|0|||
144593716|NCT00406653|521374024|FG000|Maintenance Period|Lack of Efficacy|0|||
144593717|NCT00406653|521374025|FG001|Maintenance Period|Lack of Efficacy|0|||
144593718|NCT00406653|521374026|FG002|Maintenance Period|Lack of Efficacy|0|||
144593719|NCT00406653|521374027|FG003|Maintenance Period|Lack of Efficacy|0|||
144593720|NCT00406653|521374028|FG004|Maintenance Period|Lack of Efficacy|20|||
144593721|NCT00406653|521374029|FG005|Maintenance Period|Lack of Efficacy|26|||
144593722|NCT00406653|521374030|FG006|Maintenance Period|Lack of Efficacy|0|||
144593723|NCT00406653|521374024|FG000|Maintenance Period|Lost to Follow-up|0|||
144593724|NCT00406653|521374025|FG001|Maintenance Period|Lost to Follow-up|0|||
144593725|NCT00406653|521374026|FG002|Maintenance Period|Lost to Follow-up|0|||
144593726|NCT00406653|521374027|FG003|Maintenance Period|Lost to Follow-up|0|||
144593727|NCT00406653|521374028|FG004|Maintenance Period|Lost to Follow-up|2|||
144593728|NCT00406653|521374029|FG005|Maintenance Period|Lost to Follow-up|1|||
144593729|NCT00406653|521374030|FG006|Maintenance Period|Lost to Follow-up|0|||
144593730|NCT00406653|521374024|FG000|Maintenance Period|Withdrawal of Consent|0|||
144593731|NCT00406653|521374025|FG001|Maintenance Period|Withdrawal of Consent|0|||
144593732|NCT00406653|521374026|FG002|Maintenance Period|Withdrawal of Consent|0|||
144593733|NCT00406653|521374027|FG003|Maintenance Period|Withdrawal of Consent|0|||
144593734|NCT00406653|521374028|FG004|Maintenance Period|Withdrawal of Consent|2|||
144593735|NCT00406653|521374029|FG005|Maintenance Period|Withdrawal of Consent|0|||
144593736|NCT00406653|521374030|FG006|Maintenance Period|Withdrawal of Consent|0|||
144593737|NCT00406653|521374024|FG000|Maintenance Period|Pregnancy|0|||
144593738|NCT00406653|521374025|FG001|Maintenance Period|Pregnancy|0|||
144593739|NCT00406653|521374026|FG002|Maintenance Period|Pregnancy|0|||
144593740|NCT00406653|521374027|FG003|Maintenance Period|Pregnancy|0|||
144593741|NCT00406653|521374028|FG004|Maintenance Period|Pregnancy|0|||
144593742|NCT00406653|521374029|FG005|Maintenance Period|Pregnancy|1|||
144593743|NCT00406653|521374030|FG006|Maintenance Period|Pregnancy|0|||
144593744|NCT00406653|521374024|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
144593745|NCT00406653|521374025|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
144593746|NCT00406653|521374026|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
144389024|NCT02751931|520635624|FG001|Overall Study|Adverse Event|0|||
144593747|NCT00406653|521374027|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
144593748|NCT00406653|521374028|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
144593749|NCT00406653|521374029|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
144593750|NCT00406653|521374030|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
144593751|NCT00406653|521374024|FG000|Maintenance Period|Error in disease score evaluation|0|||
144593752|NCT00406653|521374025|FG001|Maintenance Period|Error in disease score evaluation|0|||
144593753|NCT00406653|521374026|FG002|Maintenance Period|Error in disease score evaluation|0|||
144593754|NCT00406653|521374027|FG003|Maintenance Period|Error in disease score evaluation|0|||
144593755|NCT00406653|521374028|FG004|Maintenance Period|Error in disease score evaluation|1|||
144593756|NCT00406653|521374029|FG005|Maintenance Period|Error in disease score evaluation|0|||
144593757|NCT00406653|521374030|FG006|Maintenance Period|Error in disease score evaluation|0|||
144593758|NCT00406653|521374024|FG000|Open-Label Period|Death|0|||
144593759|NCT00406653|521374025|FG001|Open-Label Period|Death|0|||
144593760|NCT00406653|521374026|FG002|Open-Label Period|Death|0|||
144593761|NCT00406653|521374027|FG003|Open-Label Period|Death|0|||
144593762|NCT00406653|521374028|FG004|Open-Label Period|Death|0|||
144593763|NCT00406653|521374029|FG005|Open-Label Period|Death|0|||
144593764|NCT00406653|521374030|FG006|Open-Label Period|Death|1|||
144593765|NCT00406653|521374024|FG000|Open-Label Period|Adverse Event|0|||
144593766|NCT00406653|521374025|FG001|Open-Label Period|Adverse Event|0|||
144593767|NCT00406653|521374026|FG002|Open-Label Period|Adverse Event|0|||
144593768|NCT00406653|521374027|FG003|Open-Label Period|Adverse Event|0|||
144593769|NCT00406653|521374028|FG004|Open-Label Period|Adverse Event|0|||
144593770|NCT00406653|521374029|FG005|Open-Label Period|Adverse Event|0|||
144593771|NCT00406653|521374030|FG006|Open-Label Period|Adverse Event|18|||
144593772|NCT00406653|521374024|FG000|Open-Label Period|Lack of Efficacy|0|||
144593773|NCT00406653|521374025|FG001|Open-Label Period|Lack of Efficacy|0|||
144593774|NCT00406653|521374026|FG002|Open-Label Period|Lack of Efficacy|0|||
144593775|NCT00406653|521374027|FG003|Open-Label Period|Lack of Efficacy|0|||
144593776|NCT00406653|521374028|FG004|Open-Label Period|Lack of Efficacy|0|||
144593777|NCT00406653|521374029|FG005|Open-Label Period|Lack of Efficacy|0|||
144593778|NCT00406653|521374030|FG006|Open-Label Period|Lack of Efficacy|160|||
144593779|NCT00406653|521374024|FG000|Open-Label Period|Lost to Follow-up|0|||
144593780|NCT00406653|521374025|FG001|Open-Label Period|Lost to Follow-up|0|||
144593781|NCT00406653|521374026|FG002|Open-Label Period|Lost to Follow-up|0|||
144593782|NCT00406653|521374027|FG003|Open-Label Period|Lost to Follow-up|0|||
144593783|NCT00406653|521374028|FG004|Open-Label Period|Lost to Follow-up|0|||
144593784|NCT00406653|521374029|FG005|Open-Label Period|Lost to Follow-up|0|||
144593785|NCT00406653|521374030|FG006|Open-Label Period|Lost to Follow-up|6|||
144593786|NCT00406653|521374024|FG000|Open-Label Period|Withdrawal of Consent|0|||
144593787|NCT00406653|521374025|FG001|Open-Label Period|Withdrawal of Consent|0|||
144593788|NCT00406653|521374026|FG002|Open-Label Period|Withdrawal of Consent|0|||
144593789|NCT00406653|521374027|FG003|Open-Label Period|Withdrawal of Consent|0|||
144593790|NCT00406653|521374028|FG004|Open-Label Period|Withdrawal of Consent|0|||
144593791|NCT00406653|521374029|FG005|Open-Label Period|Withdrawal of Consent|0|||
144593792|NCT00406653|521374030|FG006|Open-Label Period|Withdrawal of Consent|11|||
144593793|NCT00406653|521374024|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
144593794|NCT00406653|521374025|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
144593795|NCT00406653|521374026|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
144593796|NCT00406653|521374027|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
144593797|NCT00406653|521374028|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
144593798|NCT00406653|521374029|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
144593799|NCT00406653|521374030|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
144593800|NCT00406653|521374024|FG000|Open-Label Period|Pregnancy|0|||
144593801|NCT00406653|521374025|FG001|Open-Label Period|Pregnancy|0|||
144593802|NCT00406653|521374026|FG002|Open-Label Period|Pregnancy|0|||
144593803|NCT00406653|521374027|FG003|Open-Label Period|Pregnancy|0|||
144593804|NCT00406653|521374028|FG004|Open-Label Period|Pregnancy|0|||
144593805|NCT00406653|521374029|FG005|Open-Label Period|Pregnancy|0|||
144593806|NCT00406653|521374030|FG006|Open-Label Period|Pregnancy|2|||
144593807|NCT00406653|521374024|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
144593808|NCT00406653|521374025|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
144593809|NCT00406653|521374026|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
144593810|NCT00406653|521374027|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
144593811|NCT00406653|521374028|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
144593812|NCT00406653|521374029|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
144593813|NCT00406653|521374030|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
144593814|NCT00406653|521374024|FG000|Open-Label Period|Declined participation but followup done|0|||
144593815|NCT00406653|521374025|FG001|Open-Label Period|Declined participation but followup done|0|||
144593816|NCT00406653|521374026|FG002|Open-Label Period|Declined participation but followup done|0|||
144593817|NCT00406653|521374027|FG003|Open-Label Period|Declined participation but followup done|0|||
144593818|NCT00406653|521374028|FG004|Open-Label Period|Declined participation but followup done|0|||
144593819|NCT00406653|521374029|FG005|Open-Label Period|Declined participation but followup done|0|||
144593820|NCT00406653|521374030|FG006|Open-Label Period|Declined participation but followup done|8|||
144593821|NCT00406653|521374024|FG000|Open-Label Period|Discontinued by Sponsor|0|||
144593822|NCT00406653|521374025|FG001|Open-Label Period|Discontinued by Sponsor|0|||
144593823|NCT00406653|521374026|FG002|Open-Label Period|Discontinued by Sponsor|0|||
144593824|NCT00406653|521374027|FG003|Open-Label Period|Discontinued by Sponsor|0|||
144593825|NCT00406653|521374028|FG004|Open-Label Period|Discontinued by Sponsor|0|||
144593826|NCT00406653|521374029|FG005|Open-Label Period|Discontinued by Sponsor|0|||
144593827|NCT00406653|521374030|FG006|Open-Label Period|Discontinued by Sponsor|1|||
144593828|NCT00406653|521374024|FG000|Open-Label Period|Refused followup|0|||
144593829|NCT00406653|521374025|FG001|Open-Label Period|Refused followup|0|||
144593830|NCT00406653|521374026|FG002|Open-Label Period|Refused followup|0|||
144593831|NCT00406653|521374027|FG003|Open-Label Period|Refused followup|0|||
144593832|NCT00406653|521374028|FG004|Open-Label Period|Refused followup|0|||
144389025|NCT02751931|520635623|FG000|Overall Study|Other: Miscelleneous|10|||
144593833|NCT00406653|521374029|FG005|Open-Label Period|Refused followup|0|||
144593834|NCT00406653|521374030|FG006|Open-Label Period|Refused followup|1|||
144389026|NCT02751931|520635624|FG001|Overall Study|Other: Miscelleneous|8|||
144517363|NCT04450342|521094337|FG000|Overall Study|Screen Failures|0|||
144517364|NCT04450342|521094338|FG001|Overall Study|Screen Failures|0|||
144517365|NCT04450342|521094339|FG002|Overall Study|Screen Failures|2|||
144517366|NCT04450342|521094337|FG000|Overall Study|Site Terminated by Sponsor|1|||
144517367|NCT04450342|521094338|FG001|Overall Study|Site Terminated by Sponsor|1|||
144517368|NCT04450342|521094339|FG002|Overall Study|Site Terminated by Sponsor|1|||
144517369|NCT04450342|521094337|FG000|Overall Study|Study Terminated by Sponsor|31|||
144517370|NCT04450342|521094338|FG001|Overall Study|Study Terminated by Sponsor|29|||
144517371|NCT04450342|521094339|FG002|Overall Study|Study Terminated by Sponsor|6|||
144517372|NCT04450342|521094337|FG000|Overall Study|Withdrawal by Subject|0|||
144517373|NCT04450342|521094338|FG001|Overall Study|Withdrawal by Subject|1|||
144517374|NCT04450342|521094339|FG002|Overall Study|Withdrawal by Subject|2|||
144517375|NCT05633407|521094340|FG000|Overall Study|Physician Decision|2|||
144517376|NCT05633407|521094341|FG001|Overall Study|Physician Decision|0|||
144517377|NCT05633407|521094340|FG000|Overall Study|Adverse Event|1|||
144517378|NCT05633407|521094341|FG001|Overall Study|Adverse Event|0|||
144517379|NCT05633407|521094340|FG000|Overall Study|Withdrawal by Subject|1|||
144517380|NCT05633407|521094341|FG001|Overall Study|Withdrawal by Subject|0|||
144517381|NCT05633407|521094340|FG000|Overall Study|Other|1|||
144517382|NCT05633407|521094341|FG001|Overall Study|Other|1|||
144517383|NCT00220740|521094342|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
144517384|NCT00220740|521094343|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
144517385|NCT00220740|521094342|FG000|Efficacy Period|Adverse Event|1|||
144517386|NCT00220740|521094343|FG001|Efficacy Period|Adverse Event|1|||
144517387|NCT00220740|521094342|FG000|Efficacy Period|Withdrawal by Subject|1|||
144517388|NCT00220740|521094343|FG001|Efficacy Period|Withdrawal by Subject|0|||
144517389|NCT00220740|521094342|FG000|Efficacy Period|Protocol Violation|1|||
144517390|NCT00220740|521094343|FG001|Efficacy Period|Protocol Violation|0|||
144517391|NCT00220740|521094342|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
144517392|NCT00220740|521094343|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
144517393|NCT04093752|521094347|FG000|Overall Study|Adverse Event|7|||
144517394|NCT04093752|521094348|FG001|Overall Study|Adverse Event|19|||
144517395|NCT04093752|521094349|FG002|Overall Study|Adverse Event|18|||
144517396|NCT04093752|521094350|FG003|Overall Study|Adverse Event|4|||
144517397|NCT04093752|521094347|FG000|Overall Study|Withdrawal by Subject|6|||
144517398|NCT04093752|521094348|FG001|Overall Study|Withdrawal by Subject|6|||
144517399|NCT04093752|521094349|FG002|Overall Study|Withdrawal by Subject|8|||
144517400|NCT04093752|521094350|FG003|Overall Study|Withdrawal by Subject|20|||
144517401|NCT04093752|521094347|FG000|Overall Study|Lost to Follow-up|2|||
144517402|NCT04093752|521094348|FG001|Overall Study|Lost to Follow-up|1|||
144517403|NCT04093752|521094349|FG002|Overall Study|Lost to Follow-up|1|||
144517404|NCT04093752|521094350|FG003|Overall Study|Lost to Follow-up|1|||
144517405|NCT04093752|521094347|FG000|Overall Study|Death|0|||
144517406|NCT04093752|521094348|FG001|Overall Study|Death|0|||
144517407|NCT04093752|521094349|FG002|Overall Study|Death|1|||
144517408|NCT04093752|521094350|FG003|Overall Study|Death|2|||
144517409|NCT04093752|521094347|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
144517410|NCT04093752|521094348|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
144517411|NCT04093752|521094349|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
144517412|NCT04093752|521094350|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
144517413|NCT04093752|521094347|FG000|Overall Study|Covid 19|0|||
144517414|NCT04093752|521094348|FG001|Overall Study|Covid 19|0|||
144517415|NCT04093752|521094349|FG002|Overall Study|Covid 19|0|||
144517416|NCT04093752|521094350|FG003|Overall Study|Covid 19|1|||
144517417|NCT04093752|521094347|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
144538319|NCT00336505|521174158|FG000|Overall Study|Withdrawal by Subject|5|||
144538320|NCT00336505|521174159|FG001|Overall Study|Withdrawal by Subject|3|||
144538321|NCT00336505|521174158|FG000|Overall Study|Other|7|||
144538322|NCT00336505|521174159|FG001|Overall Study|Other|7|||
144538323|NCT01092416|521174160|FG000|Enrollment|Atherectomy device not inserted|3|||
144538324|NCT01092416|521174160|FG000|30-Day Follow-up|Death|2|||
144538325|NCT01092416|521174160|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
144538326|NCT01092416|521174160|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
144538327|NCT01092416|521174160|FG000|12-Month Follow-up|Death|16|||
144538328|NCT01092416|521174160|FG000|12-Month Follow-up|Lost to Follow-up|4|||
144538329|NCT01092416|521174160|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
144538330|NCT01092416|521174160|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
144538331|NCT01092416|521174160|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
144538332|NCT00366249|521174161|FG000|Overall Study|Adverse Event|53|||
144538333|NCT00366249|521174162|FG001|Overall Study|Adverse Event|28|||
144538334|NCT00366249|521174161|FG000|Overall Study|Death|0|||
144538335|NCT00366249|521174162|FG001|Overall Study|Death|1|||
144538336|NCT00366249|521174161|FG000|Overall Study|Physician Decision|5|||
144538337|NCT00366249|521174162|FG001|Overall Study|Physician Decision|2|||
144389027|NCT03473548|520635627|FG000|Overall Study|Did not attempt HST testing|3|||
144389028|NCT03473548|520635628|FG001|Overall Study|Did not attempt HST testing|0|||
144389029|NCT01585584|520635637|FG000|Overall Study|Lack of Efficacy|1|||
144389030|NCT01585584|520635637|FG000|Overall Study|Withdrawal by Subject|1|||
144389031|NCT01585584|520635637|FG000|Overall Study|Physician Decision|2|||
144389032|NCT00686998|520635638|FG000|Overall Study|Adverse Event|3|||
144389033|NCT00686998|520635639|FG001|Overall Study|Adverse Event|2|||
144389034|NCT00686998|520635640|FG002|Overall Study|Adverse Event|1|||
144389035|NCT00686998|520635638|FG000|Overall Study|Withdrawal by Subject|2|||
144389036|NCT00686998|520635639|FG001|Overall Study|Withdrawal by Subject|1|||
144389037|NCT00686998|520635640|FG002|Overall Study|Withdrawal by Subject|2|||
144517418|NCT04093752|521094348|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
144517419|NCT04093752|521094349|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
144517420|NCT04093752|521094350|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
144517421|NCT04093752|521094347|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
144517422|NCT04093752|521094348|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
144389038|NCT00686998|520635638|FG000|Overall Study|Lack of Efficacy|7|||
144517423|NCT04093752|521094349|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
144517424|NCT04093752|521094350|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
144517425|NCT04093752|521094347|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
144517426|NCT04093752|521094348|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
144517427|NCT04093752|521094349|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
144517428|NCT04093752|521094350|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
144517429|NCT04757610|521094352|FG000|Overall Study|Adverse Event|13|||
144517430|NCT04757610|521094353|FG001|Overall Study|Adverse Event|10|||
144517431|NCT04757610|521094354|FG002|Overall Study|Adverse Event|5|||
144517432|NCT04757610|521094352|FG000|Overall Study|Death|5|||
144517433|NCT04757610|521094353|FG001|Overall Study|Death|13|||
144517434|NCT04757610|521094354|FG002|Overall Study|Death|8|||
144517435|NCT04757610|521094352|FG000|Overall Study|Lack of Efficacy|1|||
144517436|NCT04757610|521094353|FG001|Overall Study|Lack of Efficacy|2|||
144517437|NCT04757610|521094354|FG002|Overall Study|Lack of Efficacy|3|||
144517438|NCT04757610|521094352|FG000|Overall Study|Lost to Follow-up|7|||
144517439|NCT04757610|521094353|FG001|Overall Study|Lost to Follow-up|2|||
144517440|NCT04757610|521094354|FG002|Overall Study|Lost to Follow-up|7|||
144517441|NCT04757610|521094352|FG000|Overall Study|Physician Decision|4|||
144517442|NCT04757610|521094353|FG001|Overall Study|Physician Decision|1|||
144517443|NCT04757610|521094354|FG002|Overall Study|Physician Decision|2|||
144517444|NCT04757610|521094352|FG000|Overall Study|Withdrawal by Subject|26|||
144517445|NCT04757610|521094353|FG001|Overall Study|Withdrawal by Subject|25|||
144517446|NCT04757610|521094354|FG002|Overall Study|Withdrawal by Subject|25|||
144517447|NCT04757610|521094352|FG000|Overall Study|Study Terminated by Sponsor|105|||
144517448|NCT04757610|521094353|FG001|Overall Study|Study Terminated by Sponsor|105|||
144517449|NCT04757610|521094354|FG002|Overall Study|Study Terminated by Sponsor|110|||
144517450|NCT04757610|521094352|FG000|Overall Study|Randomized in Error|1|||
144517451|NCT04757610|521094353|FG001|Overall Study|Randomized in Error|0|||
144517452|NCT04757610|521094354|FG002|Overall Study|Randomized in Error|0|||
144517453|NCT03912831|521094359|FG000|Overall Study|Death|1|||
144517454|NCT03912831|521094360|FG001|Overall Study|Death|1|||
144517455|NCT03912831|521094361|FG002|Overall Study|Death|1|||
144517456|NCT03912831|521094362|FG003|Overall Study|Death|1|||
144517457|NCT03912831|521094363|FG004|Overall Study|Death|1|||
144517458|NCT03912831|521094364|FG005|Overall Study|Death|1|||
144517459|NCT03912831|521094359|FG000|Overall Study|Reason not Specified|0|||
144517460|NCT03912831|521094360|FG001|Overall Study|Reason not Specified|0|||
144517461|NCT03912831|521094361|FG002|Overall Study|Reason not Specified|0|||
144517462|NCT03912831|521094362|FG003|Overall Study|Reason not Specified|0|||
144517463|NCT03912831|521094363|FG004|Overall Study|Reason not Specified|1|||
144517464|NCT03912831|521094364|FG005|Overall Study|Reason not Specified|0|||
144722149|NCT03111147|521836990|FG001|Overall Study|Death|1|||
144722150|NCT01463683|521836991|FG000|Overall Study|Adverse Event|2|||
144517465|NCT03912831|521094359|FG000|Overall Study|Withdrawal by Participant|0|||
144517466|NCT03912831|521094360|FG001|Overall Study|Withdrawal by Participant|0|||
144517467|NCT03912831|521094361|FG002|Overall Study|Withdrawal by Participant|0|||
144517468|NCT03912831|521094362|FG003|Overall Study|Withdrawal by Participant|0|||
144538338|NCT00366249|521174161|FG000|Overall Study|Lost to Follow-up|2|||
144389039|NCT00686998|520635639|FG001|Overall Study|Lack of Efficacy|5|||
144389040|NCT00686998|520635640|FG002|Overall Study|Lack of Efficacy|0|||
144389041|NCT00686998|520635638|FG000|Overall Study|Other|0|||
144389042|NCT00686998|520635639|FG001|Overall Study|Other|0|||
144389043|NCT00686998|520635640|FG002|Overall Study|Other|1|||
144389044|NCT00686998|520635638|FG000|Overall Study|Safety Reasons|1|||
144389045|NCT00686998|520635639|FG001|Overall Study|Safety Reasons|0|||
144389046|NCT00686998|520635640|FG002|Overall Study|Safety Reasons|0|||
144389047|NCT05985980|520635641|FG000|Overall Study|Withdrawal by Subject|1|||
144389048|NCT05985980|520635641|FG000|Overall Study|Withdrawal by Subject|1|||
144389049|NCT05985980|520635641|FG000|Overall Study|Withdrawal by Subject|1|||
144389050|NCT05985980|520635641|FG000|Overall Study|Withdrawal by Subject|1|||
144389051|NCT03370276|520635642|FG000|Overall Study|Death|0|||
144389052|NCT03370276|520635643|FG001|Overall Study|Death|2|||
144389053|NCT03370276|520635644|FG002|Overall Study|Death|5|||
144389054|NCT04030026|520635645|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
144389055|NCT04030026|520635646|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
144389056|NCT04030026|520635645|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
144389057|NCT04030026|520635646|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
144389058|NCT04030026|520635645|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
144389059|NCT04030026|520635646|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
144593835|NCT00953745|521374031|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
144593836|NCT00953745|521374032|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
144593837|NCT00953745|521374031|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
144593838|NCT00953745|521374032|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
144593839|NCT00953745|521374031|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
144593840|NCT00953745|521374032|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
144593841|NCT00953745|521374031|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
144593842|NCT00953745|521374032|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
144593843|NCT00953745|521374031|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
144593844|NCT00953745|521374032|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
144593845|NCT00953745|521374031|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
144593846|NCT00953745|521374032|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
144593847|NCT02427464|521374035|FG000|Overall Study|Adverse Event|6|||
144593848|NCT02427464|521374036|FG001|Overall Study|Adverse Event|1|||
144593849|NCT02427464|521374035|FG000|Overall Study|Lost to Follow-up|16|||
144593850|NCT02427464|521374036|FG001|Overall Study|Lost to Follow-up|5|||
144593851|NCT02427464|521374035|FG000|Overall Study|Physician Decision|2|||
144593852|NCT02427464|521374036|FG001|Overall Study|Physician Decision|0|||
144593853|NCT02427464|521374035|FG000|Overall Study|Withdrawal by Subject|10|||
144593854|NCT02427464|521374036|FG001|Overall Study|Withdrawal by Subject|8|||
144593855|NCT02427464|521374035|FG000|Overall Study|Noncompliance|16|||
144593856|NCT02427464|521374036|FG001|Overall Study|Noncompliance|10|||
144593857|NCT04737187|521374038|FG000|Overall Study|Switched to marketed drug|32|||
144593858|NCT04737187|521374039|FG001|Overall Study|Switched to marketed drug|4|||
144593859|NCT04737187|521374038|FG000|Overall Study|Radiological Progressive Disease|145|||
144593860|NCT04737187|521374039|FG001|Overall Study|Radiological Progressive Disease|146|||
144593861|NCT04737187|521374038|FG000|Overall Study|Clinical Progressive Disease|20|||
144593862|NCT04737187|521374039|FG001|Overall Study|Clinical Progressive Disease|20|||
144593863|NCT04737187|521374038|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
144593864|NCT04737187|521374039|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
144593865|NCT04737187|521374038|FG000|Overall Study|Adverse Event|16|||
144593866|NCT04737187|521374039|FG001|Overall Study|Adverse Event|16|||
144593867|NCT04737187|521374038|FG000|Overall Study|Physician Decision|2|||
144593868|NCT04737187|521374039|FG001|Overall Study|Physician Decision|0|||
144593869|NCT04737187|521374038|FG000|Overall Study|Withdrawal by Subject|5|||
144593870|NCT04737187|521374039|FG001|Overall Study|Withdrawal by Subject|8|||
144593871|NCT03756129|521374040|FG000|Overall Study|Adverse Event|1|||
144593872|NCT03756129|521374041|FG001|Overall Study|Adverse Event|1|||
144593873|NCT03756129|521374042|FG002|Overall Study|Adverse Event|0|||
144593874|NCT03756129|521374043|FG003|Overall Study|Adverse Event|2|||
144593875|NCT03756129|521374044|FG004|Overall Study|Adverse Event|0|||
144593876|NCT03756129|521374045|FG005|Overall Study|Adverse Event|0|||
144593877|NCT03756129|521374040|FG000|Overall Study|Withdrawal by Subject|2|||
144593878|NCT03756129|521374041|FG001|Overall Study|Withdrawal by Subject|1|||
144389060|NCT04030026|520635645|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
144389061|NCT04030026|520635646|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
144389062|NCT04030026|520635645|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
144389063|NCT04030026|520635646|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
144389064|NCT04030026|520635645|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
144389065|NCT04030026|520635646|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
144389066|NCT04030026|520635645|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
144389067|NCT04030026|520635646|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
144389068|NCT00811642|520635647|FG000|Overall Study|Adverse Event|3|||
144389069|NCT00811642|520635647|FG000|Overall Study|Protocol Violation|1|||
144389070|NCT00811642|520635647|FG000|Overall Study|Death|2|||
144389071|NCT00811642|520635647|FG000|Overall Study|Withdrawal by Subject|7|||
144389072|NCT00811642|520635647|FG000|Overall Study|Cumulative use of antifungal agent|2|||
144389073|NCT02361346|520635648|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389074|NCT02361346|520635649|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389075|NCT02361346|520635650|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389076|NCT02361346|520635651|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
144389077|NCT02361346|520635652|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389078|NCT02361346|520635653|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389079|NCT02361346|520635654|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389080|NCT02361346|520635655|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389081|NCT02361346|520635656|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
144389082|NCT02361346|520635648|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389083|NCT02361346|520635649|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389084|NCT02361346|520635650|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389085|NCT02361346|520635651|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389086|NCT02361346|520635652|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
144389087|NCT02361346|520635653|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144593879|NCT03756129|521374042|FG002|Overall Study|Withdrawal by Subject|3|||
144389088|NCT02361346|520635654|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389089|NCT02361346|520635655|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389090|NCT02361346|520635656|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
144389091|NCT02361346|520635648|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
144389092|NCT02361346|520635649|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
144389093|NCT02361346|520635650|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
144389094|NCT02361346|520635651|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
144389095|NCT02361346|520635652|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
144389096|NCT02361346|520635653|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
144389097|NCT02361346|520635654|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
144389098|NCT02361346|520635655|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
144389099|NCT02361346|520635656|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
144389100|NCT02361346|520635648|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389101|NCT02361346|520635649|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389102|NCT02361346|520635650|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389103|NCT02361346|520635651|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389104|NCT02361346|520635652|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389105|NCT02361346|520635653|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389106|NCT02361346|520635654|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389107|NCT02361346|520635655|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
144389108|NCT02361346|520635656|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
144389109|NCT02361346|520635648|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389110|NCT02361346|520635649|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389111|NCT02361346|520635650|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389112|NCT02361346|520635651|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389113|NCT02361346|520635652|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389114|NCT02361346|520635653|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389115|NCT02361346|520635654|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389116|NCT02361346|520635655|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
144389117|NCT02361346|520635656|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
144389118|NCT02361346|520635648|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389119|NCT02361346|520635649|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389120|NCT02361346|520635650|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389121|NCT02361346|520635651|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389122|NCT02361346|520635652|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389123|NCT02361346|520635653|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389124|NCT02361346|520635654|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389125|NCT02361346|520635655|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
144389126|NCT02361346|520635656|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
144389127|NCT01163318|520635657|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
144389128|NCT01163318|520635657|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
144389129|NCT01163318|520635657|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
144389130|NCT01163318|520635657|FG000|Overall Study|Participants Without Case Report Form|7|||
144389131|NCT01163318|520635657|FG000|Overall Study|Multiple Reasons Per Participant|224|||
144389132|NCT03587727|520635662|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
144389133|NCT03587727|520635662|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
144389134|NCT04102189|520635663|FG000|Overall Study|Withdrawal by Subject|1|||
144389135|NCT04102189|520635664|FG001|Overall Study|Withdrawal by Subject|2|||
144389136|NCT04102189|520635663|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144389137|NCT04102189|520635664|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144389138|NCT04102189|520635663|FG000|Overall Study|Lost to Follow-up|1|||
144389139|NCT04102189|520635664|FG001|Overall Study|Lost to Follow-up|0|||
144389140|NCT03576274|520635666|FG000|Overall Study|Lost to Follow-up|3|||
144389141|NCT03576274|520635667|FG001|Overall Study|Lost to Follow-up|2|||
144389142|NCT03576274|520635668|FG002|Overall Study|Lost to Follow-up|3|||
144538339|NCT00366249|521174162|FG001|Overall Study|Lost to Follow-up|0|||
144389143|NCT03576274|520635669|FG003|Overall Study|Lost to Follow-up|1|||
144389144|NCT03576274|520635670|FG004|Overall Study|Lost to Follow-up|3|||
144389145|NCT03576274|520635666|FG000|Overall Study|Withdrawal by Subject|5|||
144389146|NCT03576274|520635667|FG001|Overall Study|Withdrawal by Subject|3|||
144389147|NCT03576274|520635668|FG002|Overall Study|Withdrawal by Subject|2|||
144389148|NCT03576274|520635669|FG003|Overall Study|Withdrawal by Subject|8|||
144517469|NCT03912831|521094363|FG004|Overall Study|Withdrawal by Participant|1|||
144517470|NCT03912831|521094364|FG005|Overall Study|Withdrawal by Participant|0|||
144517471|NCT03527160|521094365|FG000|Overall Study|No urine collected|13|||
144517472|NCT03527160|521094365|FG000|Overall Study|No clinical serum creatinine collected|6|||
144517473|NCT03527160|521094365|FG000|Overall Study|Did not meet inclusion|2|||
144517474|NCT02910713|521094366|FG000|Overall Study|Protocol Violation|2|||
144517475|NCT02910713|521094366|FG000|Overall Study|Subject Choice|4|||
144517476|NCT02910713|521094366|FG000|Overall Study|Received One Application|10|||
144517477|NCT02910713|521094366|FG000|Overall Study|Received Neither Application|18|||
144517478|NCT02910713|521094366|FG000|Overall Study|Enrollment cap|7|||
144517479|NCT02910713|521094366|FG000|Overall Study|Investigator Discretion|1|||
144517480|NCT04442126|521094375|FG000|Overall Study|Withdrawal by Subject|0|||
144517481|NCT04442126|521094376|FG001|Overall Study|Withdrawal by Subject|0|||
144517482|NCT04442126|521094377|FG002|Overall Study|Withdrawal by Subject|0|||
144517483|NCT04442126|521094378|FG003|Overall Study|Withdrawal by Subject|2|||
144389149|NCT03576274|520635670|FG004|Overall Study|Withdrawal by Subject|6|||
144389150|NCT00562627|520637104|FG000|Overall Study|Protocol Violation|1|||
144389151|NCT00562627|520637105|FG001|Overall Study|Protocol Violation|1|||
144389152|NCT00562627|520637106|FG002|Overall Study|Protocol Violation|1|||
144389153|NCT03387150|520637110|FG000|Overall Study|Withdrawal by Subject|3|||
144389154|NCT03387150|520637111|FG001|Overall Study|Withdrawal by Subject|0|||
144389155|NCT03387150|520637112|FG002|Overall Study|Withdrawal by Subject|3|||
144389156|NCT03387150|520637113|FG003|Overall Study|Withdrawal by Subject|4|||
144389157|NCT03387150|520637114|FG004|Overall Study|Withdrawal by Subject|1|||
144389158|NCT03387150|520637115|FG005|Overall Study|Withdrawal by Subject|2|||
144389159|NCT03387150|520637116|FG006|Overall Study|Withdrawal by Subject|0|||
144389160|NCT03387150|520637110|FG000|Overall Study|Lost to Follow-up|3|||
144389161|NCT03387150|520637111|FG001|Overall Study|Lost to Follow-up|2|||
144389162|NCT03387150|520637112|FG002|Overall Study|Lost to Follow-up|2|||
144389163|NCT03387150|520637113|FG003|Overall Study|Lost to Follow-up|3|||
144389164|NCT03387150|520637114|FG004|Overall Study|Lost to Follow-up|3|||
144389165|NCT03387150|520637115|FG005|Overall Study|Lost to Follow-up|3|||
144389166|NCT03387150|520637116|FG006|Overall Study|Lost to Follow-up|0|||
144389167|NCT03387150|520637110|FG000|Overall Study|Participant unable to adhere to visit|0|||
144389168|NCT03387150|520637111|FG001|Overall Study|Participant unable to adhere to visit|1|||
144389169|NCT03387150|520637112|FG002|Overall Study|Participant unable to adhere to visit|0|||
144389170|NCT03387150|520637113|FG003|Overall Study|Participant unable to adhere to visit|0|||
144389171|NCT03387150|520637114|FG004|Overall Study|Participant unable to adhere to visit|2|||
144517484|NCT04442126|521094379|FG004|Overall Study|Withdrawal by Subject|1|||
144517485|NCT04442126|521094380|FG005|Overall Study|Withdrawal by Subject|0|||
144517486|NCT04442126|521094381|FG006|Overall Study|Withdrawal by Subject|1|||
144517487|NCT04442126|521094382|FG007|Overall Study|Withdrawal by Subject|1|||
144722151|NCT01463683|521836992|FG001|Overall Study|Adverse Event|0|||
144722152|NCT01463683|521836993|FG002|Overall Study|Adverse Event|0|||
144389172|NCT03387150|520637115|FG005|Overall Study|Participant unable to adhere to visit|2|||
144389173|NCT03387150|520637116|FG006|Overall Study|Participant unable to adhere to visit|0|||
144389174|NCT03269552|520637117|FG000|Overall Study|Adverse Event|2|||
144389175|NCT02186301|520637118|FG000|Overall Study|Progressive Disease|7|||
144389176|NCT02186301|520637119|FG001|Overall Study|Progressive Disease|22|||
144389177|NCT02186301|520637120|FG002|Overall Study|Progressive Disease|27|||
144389178|NCT02186301|520637118|FG000|Overall Study|Adverse Event|5|||
144389179|NCT02186301|520637119|FG001|Overall Study|Adverse Event|5|||
144389180|NCT02186301|520637120|FG002|Overall Study|Adverse Event|5|||
144389181|NCT02186301|520637118|FG000|Overall Study|Death|1|||
144389182|NCT02186301|520637119|FG001|Overall Study|Death|0|||
144389183|NCT02186301|520637120|FG002|Overall Study|Death|0|||
144389184|NCT02186301|520637118|FG000|Overall Study|Withdrawal by Subject|5|||
144389185|NCT02186301|520637119|FG001|Overall Study|Withdrawal by Subject|1|||
144389186|NCT02186301|520637120|FG002|Overall Study|Withdrawal by Subject|3|||
144389187|NCT02186301|520637118|FG000|Overall Study|Physician Decision|1|||
144389188|NCT02186301|520637119|FG001|Overall Study|Physician Decision|0|||
144389189|NCT02186301|520637120|FG002|Overall Study|Physician Decision|1|||
144389190|NCT02186301|520637118|FG000|Overall Study|Study Terminated by Sponsor|1|||
144389191|NCT02186301|520637119|FG001|Overall Study|Study Terminated by Sponsor|0|||
144389192|NCT02186301|520637120|FG002|Overall Study|Study Terminated by Sponsor|11|||
144389193|NCT02186301|520637118|FG000|Overall Study|Protocol Deviation|0|||
144389194|NCT02186301|520637119|FG001|Overall Study|Protocol Deviation|2|||
144389195|NCT02186301|520637120|FG002|Overall Study|Protocol Deviation|0|||
144389196|NCT02186301|520637118|FG000|Overall Study|Missing|0|||
144389197|NCT02186301|520637119|FG001|Overall Study|Missing|0|||
144389198|NCT02186301|520637120|FG002|Overall Study|Missing|2|||
144389199|NCT02186301|520637118|FG000|Overall Study|Other|0|||
144389200|NCT02186301|520637119|FG001|Overall Study|Other|0|||
144389201|NCT02186301|520637120|FG002|Overall Study|Other|1|||
144389202|NCT03560739|520637122|FG000|Overall Study|Adverse Event|0|||
144389203|NCT03560739|520637123|FG001|Overall Study|Adverse Event|1|||
144389204|NCT03560739|520637124|FG002|Overall Study|Adverse Event|0|||
144389205|NCT03560739|520637125|FG003|Overall Study|Adverse Event|0|||
144389206|NCT03505671|520637129|FG000|Overall Study|Withdrawal by Subject|2|||
144389207|NCT03505671|520637130|FG001|Overall Study|Withdrawal by Subject|1|||
144389208|NCT03505671|520637129|FG000|Overall Study|Lost to Follow-up|1|||
144389209|NCT03505671|520637130|FG001|Overall Study|Lost to Follow-up|0|||
144389210|NCT04393298|520637131|FG000|Overall Study|Adverse Event|0|||
144389211|NCT04393298|520637132|FG001|Overall Study|Adverse Event|0|||
144389212|NCT04393298|520637133|FG002|Overall Study|Adverse Event|0|||
144389213|NCT04393298|520637134|FG003|Overall Study|Adverse Event|0|||
144389214|NCT04393298|520637135|FG004|Overall Study|Adverse Event|1|||
144389215|NCT04393298|520637136|FG005|Overall Study|Adverse Event|0|||
144389216|NCT04393298|520637137|FG006|Overall Study|Adverse Event|0|||
144389217|NCT04393298|520637138|FG007|Overall Study|Adverse Event|0|||
144389218|NCT04393298|520637139|FG008|Overall Study|Adverse Event|2|||
144389219|NCT04393298|520637140|FG009|Overall Study|Adverse Event|0|||
144593880|NCT03756129|521374043|FG003|Overall Study|Withdrawal by Subject|1|||
144593881|NCT03756129|521374044|FG004|Overall Study|Withdrawal by Subject|1|||
144593882|NCT03756129|521374045|FG005|Overall Study|Withdrawal by Subject|3|||
144593883|NCT03756129|521374040|FG000|Overall Study|Lost to Follow-up|0|||
144593884|NCT03756129|521374041|FG001|Overall Study|Lost to Follow-up|0|||
144593885|NCT03756129|521374042|FG002|Overall Study|Lost to Follow-up|0|||
144593886|NCT03756129|521374043|FG003|Overall Study|Lost to Follow-up|0|||
144389220|NCT04393298|520637141|FG010|Overall Study|Adverse Event|0|||
144389221|NCT04393298|520637142|FG011|Overall Study|Adverse Event|0|||
144593887|NCT03756129|521374044|FG004|Overall Study|Lost to Follow-up|0|||
144593888|NCT03756129|521374045|FG005|Overall Study|Lost to Follow-up|1|||
144593889|NCT03756129|521374040|FG000|Overall Study|Physician Decision|0|||
144199331|NCT03107026|519928870|FG000|Overall Study|Pregnancy|1|||
144389222|NCT04393298|520637143|FG012|Overall Study|Adverse Event|1|||
144389223|NCT04393298|520637144|FG013|Overall Study|Adverse Event|1|||
144389224|NCT04393298|520637145|FG014|Overall Study|Adverse Event|0|||
144389225|NCT04393298|520637131|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389226|NCT04393298|520637132|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389227|NCT04393298|520637133|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
144389228|NCT04393298|520637134|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389229|NCT04393298|520637135|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389230|NCT04393298|520637136|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389231|NCT04393298|520637137|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389232|NCT04393298|520637138|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389233|NCT04393298|520637139|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389234|NCT04393298|520637140|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144593890|NCT03756129|521374041|FG001|Overall Study|Physician Decision|0|||
144389235|NCT04393298|520637141|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389236|NCT04393298|520637142|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389237|NCT04393298|520637143|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389238|NCT04393298|520637144|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
144389239|NCT04393298|520637145|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
144389240|NCT04393298|520637131|FG000|Overall Study|Lack of Efficacy|0|||
144389241|NCT04393298|520637132|FG001|Overall Study|Lack of Efficacy|0|||
144389242|NCT04393298|520637133|FG002|Overall Study|Lack of Efficacy|0|||
144389243|NCT04393298|520637134|FG003|Overall Study|Lack of Efficacy|0|||
144389244|NCT04393298|520637135|FG004|Overall Study|Lack of Efficacy|0|||
144389245|NCT04393298|520637136|FG005|Overall Study|Lack of Efficacy|0|||
144389246|NCT04393298|520637137|FG006|Overall Study|Lack of Efficacy|0|||
144389247|NCT04393298|520637138|FG007|Overall Study|Lack of Efficacy|0|||
144389248|NCT04393298|520637139|FG008|Overall Study|Lack of Efficacy|0|||
144389249|NCT04393298|520637140|FG009|Overall Study|Lack of Efficacy|0|||
144389250|NCT04393298|520637141|FG010|Overall Study|Lack of Efficacy|0|||
144389251|NCT04393298|520637142|FG011|Overall Study|Lack of Efficacy|0|||
144389252|NCT04393298|520637143|FG012|Overall Study|Lack of Efficacy|0|||
144389253|NCT04393298|520637144|FG013|Overall Study|Lack of Efficacy|0|||
144389254|NCT04393298|520637145|FG014|Overall Study|Lack of Efficacy|1|||
144389255|NCT04393298|520637131|FG000|Overall Study|Progression|1|||
144389256|NCT04393298|520637132|FG001|Overall Study|Progression|0|||
144389257|NCT04393298|520637133|FG002|Overall Study|Progression|0|||
144389258|NCT04393298|520637134|FG003|Overall Study|Progression|0|||
144389259|NCT04393298|520637135|FG004|Overall Study|Progression|0|||
144389260|NCT04393298|520637136|FG005|Overall Study|Progression|0|||
144389261|NCT04393298|520637137|FG006|Overall Study|Progression|0|||
144389262|NCT04393298|520637138|FG007|Overall Study|Progression|0|||
144389263|NCT04393298|520637139|FG008|Overall Study|Progression|0|||
144389264|NCT04393298|520637140|FG009|Overall Study|Progression|0|||
144389265|NCT04393298|520637141|FG010|Overall Study|Progression|1|||
144389266|NCT04393298|520637142|FG011|Overall Study|Progression|1|||
144389267|NCT04393298|520637143|FG012|Overall Study|Progression|0|||
144389268|NCT04393298|520637144|FG013|Overall Study|Progression|0|||
144389269|NCT04393298|520637145|FG014|Overall Study|Progression|0|||
144389270|NCT04393298|520637131|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
144389271|NCT04393298|520637132|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389272|NCT04393298|520637133|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389273|NCT04393298|520637134|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389274|NCT04393298|520637135|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389275|NCT04393298|520637136|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389276|NCT04393298|520637137|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389277|NCT04393298|520637138|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389278|NCT04393298|520637139|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389279|NCT04393298|520637140|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389280|NCT04393298|520637141|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389281|NCT04393298|520637142|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389282|NCT04393298|520637143|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389283|NCT04393298|520637144|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389284|NCT04393298|520637145|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
144389285|NCT04393298|520637131|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389286|NCT04393298|520637132|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
144517488|NCT04442126|521094383|FG008|Overall Study|Withdrawal by Subject|3|||
144517489|NCT04442126|521094375|FG000|Overall Study|Death|1|||
144517490|NCT04442126|521094376|FG001|Overall Study|Death|0|||
144517491|NCT04442126|521094377|FG002|Overall Study|Death|0|||
144517492|NCT04442126|521094378|FG003|Overall Study|Death|1|||
144517493|NCT04442126|521094379|FG004|Overall Study|Death|2|||
144517494|NCT04442126|521094380|FG005|Overall Study|Death|2|||
144517495|NCT04442126|521094381|FG006|Overall Study|Death|4|||
144517496|NCT04442126|521094382|FG007|Overall Study|Death|1|||
144517497|NCT04442126|521094383|FG008|Overall Study|Death|5|||
144517498|NCT04442126|521094375|FG000|Overall Study|Study Terminated by Sponsor|0|||
144389287|NCT04393298|520637133|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389288|NCT04393298|520637134|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389289|NCT04393298|520637135|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389290|NCT04393298|520637136|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389291|NCT04393298|520637137|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389292|NCT04393298|520637138|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389293|NCT04393298|520637139|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389294|NCT04393298|520637140|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389295|NCT04393298|520637141|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389296|NCT04393298|520637142|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144517499|NCT04442126|521094376|FG001|Overall Study|Study Terminated by Sponsor|0|||
144517500|NCT04442126|521094377|FG002|Overall Study|Study Terminated by Sponsor|0|||
144389297|NCT04393298|520637143|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389298|NCT04393298|520637144|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389299|NCT04393298|520637145|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
144389300|NCT04393298|520637131|FG000|Overall Study|Clinical Progression|0|||
144389301|NCT04393298|520637132|FG001|Overall Study|Clinical Progression|2|||
144389302|NCT04393298|520637133|FG002|Overall Study|Clinical Progression|0|||
144389303|NCT04393298|520637134|FG003|Overall Study|Clinical Progression|0|||
144389304|NCT04393298|520637135|FG004|Overall Study|Clinical Progression|0|||
144389305|NCT04393298|520637136|FG005|Overall Study|Clinical Progression|0|||
144389306|NCT04393298|520637137|FG006|Overall Study|Clinical Progression|0|||
144389307|NCT04393298|520637138|FG007|Overall Study|Clinical Progression|0|||
144389308|NCT04393298|520637139|FG008|Overall Study|Clinical Progression|0|||
144389309|NCT04393298|520637140|FG009|Overall Study|Clinical Progression|0|||
144389310|NCT04393298|520637141|FG010|Overall Study|Clinical Progression|0|||
144389311|NCT04393298|520637142|FG011|Overall Study|Clinical Progression|0|||
144389312|NCT04393298|520637143|FG012|Overall Study|Clinical Progression|0|||
144389313|NCT04393298|520637144|FG013|Overall Study|Clinical Progression|0|||
144389314|NCT04393298|520637145|FG014|Overall Study|Clinical Progression|0|||
144389315|NCT04393298|520637131|FG000|Overall Study|Disease Progression|0|||
144389316|NCT04393298|520637132|FG001|Overall Study|Disease Progression|1|||
144389317|NCT04393298|520637133|FG002|Overall Study|Disease Progression|0|||
144389318|NCT04393298|520637134|FG003|Overall Study|Disease Progression|0|||
144389319|NCT04393298|520637135|FG004|Overall Study|Disease Progression|0|||
144389320|NCT04393298|520637136|FG005|Overall Study|Disease Progression|3|||
144389321|NCT04393298|520637137|FG006|Overall Study|Disease Progression|2|||
144389322|NCT04393298|520637138|FG007|Overall Study|Disease Progression|1|||
144389323|NCT04393298|520637139|FG008|Overall Study|Disease Progression|2|||
144389324|NCT04393298|520637140|FG009|Overall Study|Disease Progression|1|||
144389325|NCT04393298|520637141|FG010|Overall Study|Disease Progression|0|||
144389326|NCT04393298|520637142|FG011|Overall Study|Disease Progression|3|||
144389327|NCT04393298|520637143|FG012|Overall Study|Disease Progression|0|||
144389328|NCT04393298|520637144|FG013|Overall Study|Disease Progression|0|||
144593891|NCT03756129|521374042|FG002|Overall Study|Physician Decision|0|||
144593892|NCT03756129|521374043|FG003|Overall Study|Physician Decision|0|||
144593893|NCT03756129|521374044|FG004|Overall Study|Physician Decision|0|||
144593894|NCT03756129|521374045|FG005|Overall Study|Physician Decision|1|||
144593895|NCT01439360|521374046|FG000|Overall Study|Adverse Event|4|||
144593896|NCT01439360|521374047|FG001|Overall Study|Adverse Event|16|||
144593897|NCT01439360|521374046|FG000|Overall Study|Lost to Follow-up|43|||
144593898|NCT01439360|521374047|FG001|Overall Study|Lost to Follow-up|58|||
144593899|NCT01439360|521374046|FG000|Overall Study|Others|10|||
144593900|NCT01439360|521374047|FG001|Overall Study|Others|5|||
144593901|NCT01439360|521374046|FG000|Overall Study|Protocol Violation|1|||
144722153|NCT01463683|521836991|FG000|Overall Study|Lost to Follow-up|10|||
144199332|NCT03107026|519928871|FG001|Overall Study|Pregnancy|0|||
144389329|NCT04393298|520637145|FG014|Overall Study|Disease Progression|1|||
144389330|NCT04393298|520637131|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389331|NCT04393298|520637132|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389332|NCT04393298|520637133|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
144389333|NCT04393298|520637134|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389334|NCT04393298|520637135|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389335|NCT04393298|520637136|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389336|NCT04393298|520637137|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389337|NCT04393298|520637138|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389338|NCT04393298|520637139|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389339|NCT04393298|520637140|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389340|NCT04393298|520637141|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144517501|NCT04442126|521094378|FG003|Overall Study|Study Terminated by Sponsor|0|||
144517502|NCT04442126|521094379|FG004|Overall Study|Study Terminated by Sponsor|0|||
144517503|NCT04442126|521094380|FG005|Overall Study|Study Terminated by Sponsor|1|||
144517504|NCT04442126|521094381|FG006|Overall Study|Study Terminated by Sponsor|4|||
144517505|NCT04442126|521094382|FG007|Overall Study|Study Terminated by Sponsor|2|||
144517506|NCT04442126|521094383|FG008|Overall Study|Study Terminated by Sponsor|10|||
144517507|NCT04442126|521094375|FG000|Overall Study|Lost to Follow-up|0|||
144517508|NCT04442126|521094376|FG001|Overall Study|Lost to Follow-up|0|||
144517509|NCT04442126|521094377|FG002|Overall Study|Lost to Follow-up|0|||
144517510|NCT04442126|521094378|FG003|Overall Study|Lost to Follow-up|0|||
144517511|NCT04442126|521094379|FG004|Overall Study|Lost to Follow-up|0|||
144517512|NCT04442126|521094380|FG005|Overall Study|Lost to Follow-up|0|||
144517513|NCT04442126|521094381|FG006|Overall Study|Lost to Follow-up|0|||
144593902|NCT01439360|521374047|FG001|Overall Study|Protocol Violation|0|||
144593903|NCT01439360|521374046|FG000|Overall Study|Withdrawal by Subject|140|||
144593904|NCT01439360|521374047|FG001|Overall Study|Withdrawal by Subject|129|||
144593905|NCT00345293|521374048|FG000|Overall Study|Unable to access line for sample|1|||
144593906|NCT00345293|521374049|FG001|Overall Study|Unable to access line for sample|0|||
144389341|NCT04393298|520637142|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389342|NCT04393298|520637143|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389343|NCT04393298|520637144|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389344|NCT04393298|520637145|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
144389345|NCT04393298|520637131|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389346|NCT04393298|520637132|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389347|NCT04393298|520637133|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
144389348|NCT04393298|520637134|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389349|NCT04393298|520637135|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389350|NCT04393298|520637136|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389351|NCT04393298|520637137|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389352|NCT04393298|520637138|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389353|NCT04393298|520637139|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389354|NCT04393298|520637140|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389355|NCT04393298|520637141|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389356|NCT04393298|520637142|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389357|NCT04393298|520637143|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389358|NCT04393298|520637144|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389359|NCT04393298|520637145|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
144389360|NCT04393298|520637131|FG000|Overall Study|Progressive Disease (PD)|0|||
144389361|NCT04393298|520637132|FG001|Overall Study|Progressive Disease (PD)|0|||
144389362|NCT04393298|520637133|FG002|Overall Study|Progressive Disease (PD)|0|||
144389363|NCT04393298|520637134|FG003|Overall Study|Progressive Disease (PD)|3|||
144389364|NCT04393298|520637135|FG004|Overall Study|Progressive Disease (PD)|0|||
144389365|NCT04393298|520637136|FG005|Overall Study|Progressive Disease (PD)|0|||
144389366|NCT04393298|520637137|FG006|Overall Study|Progressive Disease (PD)|0|||
144389367|NCT04393298|520637138|FG007|Overall Study|Progressive Disease (PD)|0|||
144389368|NCT04393298|520637139|FG008|Overall Study|Progressive Disease (PD)|0|||
144389369|NCT04393298|520637140|FG009|Overall Study|Progressive Disease (PD)|0|||
144389370|NCT04393298|520637141|FG010|Overall Study|Progressive Disease (PD)|0|||
144389371|NCT04393298|520637142|FG011|Overall Study|Progressive Disease (PD)|0|||
144389372|NCT04393298|520637143|FG012|Overall Study|Progressive Disease (PD)|0|||
144389373|NCT04393298|520637144|FG013|Overall Study|Progressive Disease (PD)|0|||
144389374|NCT04393298|520637145|FG014|Overall Study|Progressive Disease (PD)|0|||
144389375|NCT04393298|520637131|FG000|Overall Study|Started a New Cancer Treatment|0|||
144389376|NCT04393298|520637132|FG001|Overall Study|Started a New Cancer Treatment|0|||
144389377|NCT04393298|520637133|FG002|Overall Study|Started a New Cancer Treatment|0|||
144389378|NCT04393298|520637134|FG003|Overall Study|Started a New Cancer Treatment|0|||
144517514|NCT04442126|521094382|FG007|Overall Study|Lost to Follow-up|1|||
144517515|NCT04442126|521094383|FG008|Overall Study|Lost to Follow-up|2|||
144517516|NCT04442126|521094375|FG000|Overall Study|Progressive Disease|0|||
144517517|NCT04442126|521094376|FG001|Overall Study|Progressive Disease|1|||
144517518|NCT04442126|521094377|FG002|Overall Study|Progressive Disease|3|||
144517519|NCT04442126|521094378|FG003|Overall Study|Progressive Disease|0|||
144517520|NCT04442126|521094379|FG004|Overall Study|Progressive Disease|3|||
144517521|NCT04442126|521094380|FG005|Overall Study|Progressive Disease|0|||
144517522|NCT04442126|521094381|FG006|Overall Study|Progressive Disease|0|||
144517523|NCT04442126|521094382|FG007|Overall Study|Progressive Disease|0|||
144517524|NCT04442126|521094383|FG008|Overall Study|Progressive Disease|0|||
144517525|NCT04442126|521094375|FG000|Overall Study|Other|0|||
144517526|NCT04442126|521094376|FG001|Overall Study|Other|0|||
144517527|NCT04442126|521094377|FG002|Overall Study|Other|0|||
144517528|NCT04442126|521094378|FG003|Overall Study|Other|0|||
144517529|NCT04442126|521094379|FG004|Overall Study|Other|0|||
144517530|NCT04442126|521094380|FG005|Overall Study|Other|0|||
144517531|NCT04442126|521094381|FG006|Overall Study|Other|0|||
144517532|NCT04442126|521094382|FG007|Overall Study|Other|0|||
144517533|NCT04442126|521094383|FG008|Overall Study|Other|1|||
144389379|NCT04393298|520637135|FG004|Overall Study|Started a New Cancer Treatment|1|||
144389380|NCT04393298|520637136|FG005|Overall Study|Started a New Cancer Treatment|0|||
144517534|NCT06450405|521094384|FG000|Overall Study|Study funding terminated.|0|||
144517535|NCT06450405|521094385|FG001|Overall Study|Study funding terminated.|2|||
144517536|NCT05338086|521096128|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
144517537|NCT05338086|521096129|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
144389381|NCT04393298|520637137|FG006|Overall Study|Started a New Cancer Treatment|0|||
144389382|NCT04393298|520637138|FG007|Overall Study|Started a New Cancer Treatment|0|||
144389383|NCT04393298|520637139|FG008|Overall Study|Started a New Cancer Treatment|0|||
144517538|NCT05338086|521096130|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
144517539|NCT05338086|521096131|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
144517540|NCT05338086|521096132|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
144517541|NCT05338086|521096128|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
144722154|NCT01463683|521836992|FG001|Overall Study|Lost to Follow-up|9|||
144389384|NCT04393298|520637140|FG009|Overall Study|Started a New Cancer Treatment|0|||
144389385|NCT04393298|520637141|FG010|Overall Study|Started a New Cancer Treatment|0|||
144389386|NCT04393298|520637142|FG011|Overall Study|Started a New Cancer Treatment|0|||
144389387|NCT04393298|520637143|FG012|Overall Study|Started a New Cancer Treatment|0|||
144389388|NCT04393298|520637144|FG013|Overall Study|Started a New Cancer Treatment|0|||
144389389|NCT04393298|520637145|FG014|Overall Study|Started a New Cancer Treatment|0|||
144389390|NCT04393298|520637131|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389391|NCT04393298|520637132|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389392|NCT04393298|520637133|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389393|NCT04393298|520637134|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389394|NCT04393298|520637135|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
144389395|NCT04393298|520637136|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389396|NCT04393298|520637137|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389397|NCT04393298|520637138|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389398|NCT04393298|520637139|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389399|NCT04393298|520637140|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389400|NCT04393298|520637141|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389401|NCT04393298|520637142|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389402|NCT04393298|520637143|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389403|NCT04393298|520637144|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389404|NCT04393298|520637145|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
144389405|NCT04393298|520637131|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389406|NCT04393298|520637132|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389407|NCT04393298|520637133|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389408|NCT04393298|520637134|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389409|NCT04393298|520637135|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389410|NCT04393298|520637136|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
144389411|NCT04393298|520637137|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389412|NCT04393298|520637138|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389413|NCT04393298|520637139|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389414|NCT04393298|520637140|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389415|NCT04393298|520637141|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389416|NCT04393298|520637142|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389417|NCT04393298|520637143|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389418|NCT04393298|520637144|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389419|NCT04393298|520637145|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
144389420|NCT04393298|520637131|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389421|NCT04393298|520637132|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389422|NCT04393298|520637133|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389423|NCT04393298|520637134|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389424|NCT04393298|520637135|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389425|NCT04393298|520637136|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
144389426|NCT04393298|520637137|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389427|NCT04393298|520637138|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389428|NCT04393298|520637139|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144517542|NCT05338086|521096129|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
144517543|NCT05338086|521096130|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
144517544|NCT05338086|521096131|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
144389429|NCT04393298|520637140|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389430|NCT04393298|520637141|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389431|NCT04393298|520637142|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389432|NCT04393298|520637143|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389433|NCT04393298|520637144|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
144389434|NCT04393298|520637145|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
144389435|NCT04393298|520637131|FG000|Overall Study|Death|0|||
144389436|NCT04393298|520637132|FG001|Overall Study|Death|0|||
144389437|NCT04393298|520637133|FG002|Overall Study|Death|0|||
144389438|NCT04393298|520637134|FG003|Overall Study|Death|0|||
144389439|NCT04393298|520637135|FG004|Overall Study|Death|0|||
144389440|NCT04393298|520637136|FG005|Overall Study|Death|1|||
144389441|NCT04393298|520637137|FG006|Overall Study|Death|1|||
144389442|NCT04393298|520637138|FG007|Overall Study|Death|0|||
144389443|NCT04393298|520637139|FG008|Overall Study|Death|1|||
144389444|NCT04393298|520637140|FG009|Overall Study|Death|1|||
144389445|NCT04393298|520637141|FG010|Overall Study|Death|0|||
144389446|NCT04393298|520637142|FG011|Overall Study|Death|1|||
144389447|NCT04393298|520637143|FG012|Overall Study|Death|1|||
144389448|NCT04393298|520637144|FG013|Overall Study|Death|0|||
144389449|NCT04393298|520637145|FG014|Overall Study|Death|1|||
144389450|NCT04393298|520637131|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389451|NCT04393298|520637132|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389452|NCT04393298|520637133|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389453|NCT04393298|520637134|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389454|NCT04393298|520637135|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389455|NCT04393298|520637136|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
144389456|NCT04393298|520637137|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389457|NCT04393298|520637138|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389458|NCT04393298|520637139|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389459|NCT04393298|520637140|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389460|NCT04393298|520637141|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389461|NCT04393298|520637142|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389462|NCT04393298|520637143|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389463|NCT04393298|520637144|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389464|NCT04393298|520637145|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
144389465|NCT04393298|520637131|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
144389466|NCT04393298|520637132|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
144389467|NCT04393298|520637133|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
144389468|NCT04393298|520637134|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
144389469|NCT04393298|520637135|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
144389470|NCT04393298|520637136|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
144389471|NCT04393298|520637137|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
144389472|NCT04393298|520637138|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
144389473|NCT04393298|520637139|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
144389474|NCT04393298|520637140|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
144389475|NCT04393298|520637141|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
144389476|NCT04393298|520637142|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
144389477|NCT04393298|520637143|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
144389478|NCT04393298|520637144|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
144389479|NCT04393298|520637145|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
144389480|NCT04393298|520637131|FG000|Overall Study|Patient Passed Away|0|||
144389481|NCT04393298|520637132|FG001|Overall Study|Patient Passed Away|0|||
144389482|NCT04393298|520637133|FG002|Overall Study|Patient Passed Away|0|||
144389483|NCT04393298|520637134|FG003|Overall Study|Patient Passed Away|0|||
144389484|NCT04393298|520637135|FG004|Overall Study|Patient Passed Away|0|||
144389485|NCT04393298|520637136|FG005|Overall Study|Patient Passed Away|0|||
144389486|NCT04393298|520637137|FG006|Overall Study|Patient Passed Away|0|||
144389487|NCT04393298|520637138|FG007|Overall Study|Patient Passed Away|1|||
144389488|NCT04393298|520637139|FG008|Overall Study|Patient Passed Away|0|||
144389489|NCT04393298|520637140|FG009|Overall Study|Patient Passed Away|0|||
144389490|NCT04393298|520637141|FG010|Overall Study|Patient Passed Away|0|||
144389491|NCT04393298|520637142|FG011|Overall Study|Patient Passed Away|0|||
144389492|NCT04393298|520637143|FG012|Overall Study|Patient Passed Away|0|||
144389493|NCT04393298|520637144|FG013|Overall Study|Patient Passed Away|0|||
144389494|NCT04393298|520637145|FG014|Overall Study|Patient Passed Away|0|||
144389495|NCT04393298|520637131|FG000|Overall Study|Patient Deceased|0|||
144389496|NCT04393298|520637132|FG001|Overall Study|Patient Deceased|0|||
144389497|NCT04393298|520637133|FG002|Overall Study|Patient Deceased|0|||
144389498|NCT04393298|520637134|FG003|Overall Study|Patient Deceased|0|||
144389499|NCT04393298|520637135|FG004|Overall Study|Patient Deceased|0|||
144389500|NCT04393298|520637136|FG005|Overall Study|Patient Deceased|0|||
144389501|NCT04393298|520637137|FG006|Overall Study|Patient Deceased|0|||
144389502|NCT04393298|520637138|FG007|Overall Study|Patient Deceased|1|||
144389503|NCT04393298|520637139|FG008|Overall Study|Patient Deceased|0|||
144389504|NCT04393298|520637140|FG009|Overall Study|Patient Deceased|0|||
144389505|NCT04393298|520637141|FG010|Overall Study|Patient Deceased|0|||
144389506|NCT04393298|520637142|FG011|Overall Study|Patient Deceased|0|||
144389507|NCT04393298|520637143|FG012|Overall Study|Patient Deceased|0|||
144389508|NCT04393298|520637144|FG013|Overall Study|Patient Deceased|0|||
144389509|NCT04393298|520637145|FG014|Overall Study|Patient Deceased|0|||
144389510|NCT04393298|520637131|FG000|Overall Study|Patient Discharged to Hospice|0|||
144389511|NCT04393298|520637132|FG001|Overall Study|Patient Discharged to Hospice|0|||
144389512|NCT04393298|520637133|FG002|Overall Study|Patient Discharged to Hospice|0|||
144517545|NCT05338086|521096132|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
144517546|NCT05338086|521096128|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
144517547|NCT05338086|521096129|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
144517548|NCT05338086|521096130|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
144517549|NCT05338086|521096131|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
144517550|NCT05338086|521096132|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
144517551|NCT05338086|521096128|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
144517552|NCT05338086|521096129|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
144517553|NCT05338086|521096130|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
144517554|NCT05338086|521096131|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
144517555|NCT05338086|521096132|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
144517556|NCT05338086|521096128|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
144517557|NCT05338086|521096129|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
144517558|NCT05338086|521096130|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
144517559|NCT05338086|521096131|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
144538340|NCT00366249|521174161|FG000|Overall Study|Protocol Violation|1|||
144389513|NCT04393298|520637134|FG003|Overall Study|Patient Discharged to Hospice|0|||
144389514|NCT04393298|520637135|FG004|Overall Study|Patient Discharged to Hospice|0|||
144389515|NCT04393298|520637136|FG005|Overall Study|Patient Discharged to Hospice|0|||
144389516|NCT04393298|520637137|FG006|Overall Study|Patient Discharged to Hospice|0|||
144389517|NCT04393298|520637138|FG007|Overall Study|Patient Discharged to Hospice|0|||
144389518|NCT04393298|520637139|FG008|Overall Study|Patient Discharged to Hospice|1|||
144389519|NCT04393298|520637140|FG009|Overall Study|Patient Discharged to Hospice|0|||
144389520|NCT04393298|520637141|FG010|Overall Study|Patient Discharged to Hospice|0|||
144389521|NCT04393298|520637142|FG011|Overall Study|Patient Discharged to Hospice|0|||
144389522|NCT04393298|520637143|FG012|Overall Study|Patient Discharged to Hospice|0|||
144389523|NCT04393298|520637144|FG013|Overall Study|Patient Discharged to Hospice|0|||
144389524|NCT04393298|520637145|FG014|Overall Study|Patient Discharged to Hospice|0|||
144389525|NCT04393298|520637131|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389526|NCT04393298|520637132|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389527|NCT04393298|520637133|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389528|NCT04393298|520637134|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389529|NCT04393298|520637135|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389530|NCT04393298|520637136|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389531|NCT04393298|520637137|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389532|NCT04393298|520637138|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389533|NCT04393298|520637139|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389534|NCT04393298|520637140|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
144389535|NCT04393298|520637141|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389536|NCT04393298|520637142|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389537|NCT04393298|520637143|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389538|NCT04393298|520637144|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389539|NCT04393298|520637145|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
144389540|NCT04393298|520637131|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
144389541|NCT04393298|520637132|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
144389542|NCT04393298|520637133|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
144389543|NCT04393298|520637134|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
144389544|NCT04393298|520637135|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
144389545|NCT04393298|520637136|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
144389546|NCT04393298|520637137|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
144389547|NCT04393298|520637138|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
144389548|NCT04393298|520637139|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
144389549|NCT04393298|520637140|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
144389550|NCT04393298|520637141|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
144389551|NCT04393298|520637142|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
144389552|NCT04393298|520637143|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
144389553|NCT04393298|520637144|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
144389554|NCT04393298|520637145|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
144389555|NCT03754972|520637148|FG000|Overall Study|Protocol Violation|25|||
144389556|NCT03410823|520637149|FG000|Overall Study|Death|1|||
144389557|NCT03410823|520637149|FG000|Overall Study|Withdrawal by Subject|2|||
144389558|NCT03410823|520637149|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
144389559|NCT06460493|520637156|FG000|Overall Study|Withdrawal by Subject|2|||
144389560|NCT05128929|520637157|FG000|Overall Study|Adverse Event|0|||
144389561|NCT05128929|520637158|FG001|Overall Study|Adverse Event|1|||
144389562|NCT02987660|520637163|FG000|Overall Study|Study terminated by sponsor|10|||
144389563|NCT02987660|520637164|FG001|Overall Study|Study terminated by sponsor|10|||
144389564|NCT05007717|520637165|FG000|Overall Study|Death|3|||
144389565|NCT05007717|520637166|FG001|Overall Study|Death|2|||
144389566|NCT03553836|520637167|FG000|Overall Study|Ongoing in Study|460|||
144389567|NCT03553836|520637168|FG001|Overall Study|Ongoing in Study|459|||
144389568|NCT03553836|520637167|FG000|Overall Study|Withdrawal by Subject|9|||
144389569|NCT03553836|520637168|FG001|Overall Study|Withdrawal by Subject|10|||
144389570|NCT03553836|520637167|FG000|Overall Study|Lost to Follow-up|1|||
144389571|NCT03553836|520637168|FG001|Overall Study|Lost to Follow-up|3|||
144389572|NCT03553836|520637167|FG000|Overall Study|Death|17|||
144389573|NCT03553836|520637168|FG001|Overall Study|Death|17|||
144389574|NCT04062123|520637169|FG000|Overall Study|Withdrawal by Subject|0|||
144389575|NCT04062123|520637170|FG001|Overall Study|Withdrawal by Subject|1|||
144389576|NCT04062123|520637171|FG002|Overall Study|Withdrawal by Subject|0|||
144389577|NCT02360605|520637172|FG000|Overall Study|Withdrawal by Subject|4|||
144389578|NCT02360605|520637173|FG001|Overall Study|Withdrawal by Subject|9|||
144517560|NCT05338086|521096132|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
144389579|NCT02360605|520637172|FG000|Overall Study|Lost to Follow-up|7|||
144389580|NCT02360605|520637173|FG001|Overall Study|Lost to Follow-up|8|||
144389581|NCT02360605|520637172|FG000|Overall Study|Death|0|||
144389582|NCT02360605|520637173|FG001|Overall Study|Death|1|||
144517561|NCT05338086|521096128|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
144517562|NCT05338086|521096129|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
144517563|NCT05338086|521096130|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
144517564|NCT05338086|521096131|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
144517565|NCT05338086|521096132|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
144517566|NCT05338086|521096128|FG000|Transition Period (M12 to M18)|Death|0|||
144517567|NCT05338086|521096129|FG001|Transition Period (M12 to M18)|Death|0|||
144517568|NCT05338086|521096130|FG002|Transition Period (M12 to M18)|Death|1|||
144517569|NCT05338086|521096131|FG003|Transition Period (M12 to M18)|Death|0|||
144517570|NCT05338086|521096132|FG004|Transition Period (M12 to M18)|Death|0|||
144517571|NCT05338086|521096128|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
144517572|NCT05338086|521096129|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
144517573|NCT05338086|521096130|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
144517574|NCT05338086|521096131|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
144517575|NCT05338086|521096132|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
144517576|NCT05338086|521096128|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
144517577|NCT05338086|521096129|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
144517578|NCT05338086|521096130|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
144517579|NCT05338086|521096131|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
144517580|NCT05338086|521096132|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
144517581|NCT05338086|521096128|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
144517582|NCT05338086|521096129|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
144517583|NCT05338086|521096130|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
144517584|NCT05338086|521096131|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
144517585|NCT05338086|521096132|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
144517586|NCT04052516|521096142|FG000|Overall Study|Withdrawal by Subject|4|||
144517587|NCT04052516|521096143|FG001|Overall Study|Withdrawal by Subject|5|||
144517588|NCT04052516|521096144|FG002|Overall Study|Withdrawal by Subject|6|||
144389583|NCT01634178|520637177|FG000|Treatment Period 1|Adverse Event|0|||
144389584|NCT01634178|520637178|FG001|Treatment Period 1|Adverse Event|1|||
144389585|NCT01634178|520637177|FG000|Treatment Period 2|Adverse Event|1|||
144389586|NCT01634178|520637178|FG001|Treatment Period 2|Adverse Event|0|||
144389587|NCT01721577|520637181|FG000|Overall Study|Lack of Efficacy|1|||
144389588|NCT01721577|520637182|FG001|Overall Study|Lack of Efficacy|0|||
144389589|NCT01721577|520637181|FG000|Overall Study|Death|1|||
144389590|NCT01721577|520637182|FG001|Overall Study|Death|0|||
144389591|NCT01721577|520637181|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
144389592|NCT01721577|520637182|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
144389593|NCT01721577|520637181|FG000|Overall Study|Adverse Event|0|||
144389594|NCT01721577|520637182|FG001|Overall Study|Adverse Event|2|||
144389595|NCT02497976|520637183|FG000|Overall Study|Withdrawal by Subject|2|||
144389596|NCT02497976|520637184|FG001|Overall Study|Withdrawal by Subject|0|||
144389597|NCT02497976|520637183|FG000|Overall Study|Moved out of area|0|||
144389598|NCT02497976|520637184|FG001|Overall Study|Moved out of area|1|||
144389599|NCT01282203|520637185|FG000|Overall Study|Adverse Event|1|||
144389600|NCT00058539|520637188|FG000|Overall Study|Disease progression|24|||
144389601|NCT00058539|520637188|FG000|Overall Study|Adverse Event|3|||
144389602|NCT00058539|520637188|FG000|Overall Study|Withdrawal by Subject|5|||
144389603|NCT00058539|520637188|FG000|Overall Study|Physician Decision|9|||
144389604|NCT00058539|520637188|FG000|Overall Study|Death|1|||
144389605|NCT00740051|520637189|FG000|Overall Study|Lack of Efficacy|2|||
144389606|NCT00740051|520637190|FG001|Overall Study|Lack of Efficacy|5|||
144517589|NCT04052516|521096142|FG000|Overall Study|Adverse Event|3|||
144517590|NCT04052516|521096143|FG001|Overall Study|Adverse Event|2|||
144517591|NCT04052516|521096144|FG002|Overall Study|Adverse Event|8|||
144517592|NCT04052516|521096142|FG000|Overall Study|Lost to Follow-up|2|||
144517593|NCT04052516|521096143|FG001|Overall Study|Lost to Follow-up|5|||
144389607|NCT00740051|520637189|FG000|Overall Study|Adverse Event|1|||
144389608|NCT00740051|520637190|FG001|Overall Study|Adverse Event|4|||
144389609|NCT00740051|520637189|FG000|Overall Study|Protocol Violation|2|||
144389610|NCT00740051|520637190|FG001|Overall Study|Protocol Violation|6|||
144389611|NCT00740051|520637189|FG000|Overall Study|Lost to Follow-up|3|||
144389612|NCT00740051|520637190|FG001|Overall Study|Lost to Follow-up|8|||
144389613|NCT00740051|520637189|FG000|Overall Study|Withdrawal by Subject|6|||
144389614|NCT00740051|520637190|FG001|Overall Study|Withdrawal by Subject|8|||
144389615|NCT00740051|520637189|FG000|Overall Study|Other reason (not specified)|4|||
144389616|NCT00740051|520637190|FG001|Overall Study|Other reason (not specified)|1|||
144389617|NCT01903525|520637193|FG000|Overall Study|Lost to Follow-up|5|||
144389618|NCT01903525|520637194|FG001|Overall Study|Lost to Follow-up|9|||
144389619|NCT01903525|520637193|FG000|Overall Study|Adverse Event|0|||
144389620|NCT01903525|520637194|FG001|Overall Study|Adverse Event|1|||
144389621|NCT03977454|520637195|FG000|Overall Study|immediate postoperative revision|2|||
144389622|NCT03977454|520637196|FG001|Overall Study|immediate postoperative revision|2|||
144389623|NCT00930982|520637197|FG000|Overall Study|Adverse Event|19|||
144389624|NCT00930982|520637198|FG001|Overall Study|Adverse Event|23|||
144389625|NCT00930982|520637197|FG000|Overall Study|Protocol Violation|1|||
144389626|NCT00930982|520637198|FG001|Overall Study|Protocol Violation|5|||
144389627|NCT00930982|520637197|FG000|Overall Study|Withdrawal by Subject|1|||
144389628|NCT00930982|520637198|FG001|Overall Study|Withdrawal by Subject|1|||
144389629|NCT00991952|520637199|FG000|Overall Study|Adverse Event|0|||
144389630|NCT00991952|520637200|FG001|Overall Study|Adverse Event|1|||
144389631|NCT02483533|520637203|FG000|Overall Study|Lack of Efficacy|50|||
144389632|NCT02483533|520637204|FG001|Overall Study|Lack of Efficacy|50|||
144389633|NCT04365257|520637205|FG000|Overall Study|Physician Decision|1|||
144389634|NCT04365257|520637206|FG001|Overall Study|Physician Decision|0|||
144389635|NCT04365257|520637205|FG000|Overall Study|Patient Noncompliance|1|||
144389636|NCT04365257|520637206|FG001|Overall Study|Patient Noncompliance|0|||
144389637|NCT04365257|520637205|FG000|Overall Study|Withdrawal by Subject|0|||
144389638|NCT04365257|520637206|FG001|Overall Study|Withdrawal by Subject|1|||
144389639|NCT01609478|520637209|FG000|Overall Study|Adverse Event|3|||
144389640|NCT01609478|520637210|FG001|Overall Study|Adverse Event|1|||
144389641|NCT01609478|520637211|FG002|Overall Study|Adverse Event|5|||
144389642|NCT01609478|520637209|FG000|Overall Study|Protocol Deviation|0|||
144389643|NCT01609478|520637210|FG001|Overall Study|Protocol Deviation|1|||
144389644|NCT01609478|520637211|FG002|Overall Study|Protocol Deviation|1|||
144389645|NCT01609478|520637209|FG000|Overall Study|Non-Compliance with study treatment|1|||
144389646|NCT01609478|520637210|FG001|Overall Study|Non-Compliance with study treatment|0|||
144389647|NCT01609478|520637211|FG002|Overall Study|Non-Compliance with study treatment|0|||
144389648|NCT01609478|520637209|FG000|Overall Study|Physician Decision|1|||
144389649|NCT01609478|520637210|FG001|Overall Study|Physician Decision|0|||
144389650|NCT01609478|520637211|FG002|Overall Study|Physician Decision|1|||
144389651|NCT01609478|520637209|FG000|Overall Study|Withdrawal by Subject|2|||
144389652|NCT01609478|520637210|FG001|Overall Study|Withdrawal by Subject|0|||
144389653|NCT01609478|520637211|FG002|Overall Study|Withdrawal by Subject|2|||
144389654|NCT00509262|520637216|FG000|Overall Study|Adverse Event|16|||
144389655|NCT00509262|520637217|FG001|Overall Study|Adverse Event|18|||
144389656|NCT00509262|520637216|FG000|Overall Study|Other|2|||
144389657|NCT00509262|520637217|FG001|Overall Study|Other|2|||
144389658|NCT00509262|520637216|FG000|Overall Study|Lack of Efficacy|1|||
144389659|NCT00509262|520637217|FG001|Overall Study|Lack of Efficacy|0|||
144389660|NCT00509262|520637216|FG000|Overall Study|Lost to Follow-up|1|||
144389661|NCT00509262|520637217|FG001|Overall Study|Lost to Follow-up|6|||
144389662|NCT00509262|520637216|FG000|Overall Study|Physician Decision|1|||
144389663|NCT00509262|520637217|FG001|Overall Study|Physician Decision|3|||
144389664|NCT00509262|520637216|FG000|Overall Study|Protocol Violation|2|||
144389665|NCT00509262|520637217|FG001|Overall Study|Protocol Violation|2|||
144389666|NCT00509262|520637216|FG000|Overall Study|Withdrawal by Subject|24|||
144389667|NCT00509262|520637217|FG001|Overall Study|Withdrawal by Subject|11|||
144389668|NCT02398227|520637218|FG000|Overall Study|Lost to Follow-up|21|||
144389669|NCT02398227|520637219|FG001|Overall Study|Lost to Follow-up|12|||
144389670|NCT02398227|520637218|FG000|Overall Study|Withdrawal by Subject|5|||
144389671|NCT02398227|520637219|FG001|Overall Study|Withdrawal by Subject|6|||
144389672|NCT02398227|520637218|FG000|Overall Study|Removed from treatment and dropped out|1|||
144389673|NCT02398227|520637219|FG001|Overall Study|Removed from treatment and dropped out|0|||
144389674|NCT01715129|520637220|FG000|Overall Study|Adverse Event, fatal|1|||
144389675|NCT01715129|520637220|FG000|Overall Study|Lack of Efficacy|3|||
144389676|NCT01715129|520637220|FG000|Overall Study|Protocol Violation|1|||
144389677|NCT01715129|520637220|FG000|Overall Study|Consent Withdrawn|2|||
144389678|NCT01715129|520637220|FG000|Overall Study|Lost to Follow-up|1|||
144389679|NCT01715129|520637220|FG000|Overall Study|Other|1|||
144517594|NCT04052516|521096144|FG002|Overall Study|Lost to Follow-up|3|||
144389680|NCT01146860|520637221|FG000|Overall Study|Withdrawal by Subject|0|||
144389681|NCT01146860|520637222|FG001|Overall Study|Withdrawal by Subject|1|||
144389682|NCT02674854|520637223|FG000|Overall Study|Adverse Event|17|||
144389683|NCT02674854|520637224|FG001|Overall Study|Adverse Event|15|||
144389684|NCT02674854|520637225|FG002|Overall Study|Adverse Event|5|||
144389685|NCT02674854|520637223|FG000|Overall Study|Withdrawal by Subject|1|||
144389686|NCT02674854|520637224|FG001|Overall Study|Withdrawal by Subject|5|||
144389687|NCT02674854|520637225|FG002|Overall Study|Withdrawal by Subject|4|||
144389688|NCT02674854|520637223|FG000|Overall Study|No-compliant subject|1|||
144389689|NCT02674854|520637224|FG001|Overall Study|No-compliant subject|0|||
144389690|NCT02674854|520637225|FG002|Overall Study|No-compliant subject|1|||
144389691|NCT02674854|520637223|FG000|Overall Study|Lost to Follow-up|1|||
144389692|NCT02674854|520637224|FG001|Overall Study|Lost to Follow-up|0|||
144389693|NCT02674854|520637225|FG002|Overall Study|Lost to Follow-up|2|||
144389694|NCT02674854|520637223|FG000|Overall Study|Lack of Efficacy|0|||
144389695|NCT02674854|520637224|FG001|Overall Study|Lack of Efficacy|3|||
144389696|NCT02674854|520637225|FG002|Overall Study|Lack of Efficacy|0|||
144389697|NCT02674854|520637223|FG000|Overall Study|Disallowed Concurrent Medication|2|||
144389698|NCT02674854|520637224|FG001|Overall Study|Disallowed Concurrent Medication|2|||
144389699|NCT02674854|520637225|FG002|Overall Study|Disallowed Concurrent Medication|0|||
144389700|NCT02674854|520637223|FG000|Overall Study|Protocol Violation|1|||
144389701|NCT02674854|520637224|FG001|Overall Study|Protocol Violation|1|||
144389702|NCT02674854|520637225|FG002|Overall Study|Protocol Violation|2|||
144389703|NCT02674854|520637223|FG000|Overall Study|Death|0|||
144389704|NCT02674854|520637224|FG001|Overall Study|Death|1|||
144389705|NCT02674854|520637225|FG002|Overall Study|Death|0|||
144389706|NCT02674854|520637223|FG000|Overall Study|Subject missed V6.2|1|||
144389707|NCT02674854|520637224|FG001|Overall Study|Subject missed V6.2|0|||
144389708|NCT02674854|520637225|FG002|Overall Study|Subject missed V6.2|0|||
144517595|NCT04052516|521096142|FG000|Overall Study|Protocol Violation|1|||
144389709|NCT02635646|520637227|FG000|Overall Study|Lost to Follow-up|24|||
144517596|NCT04052516|521096143|FG001|Overall Study|Protocol Violation|1|||
144517597|NCT04052516|521096144|FG002|Overall Study|Protocol Violation|0|||
144517598|NCT04052516|521096142|FG000|Overall Study|Death|1|||
144517599|NCT04052516|521096143|FG001|Overall Study|Death|0|||
144517600|NCT04052516|521096144|FG002|Overall Study|Death|0|||
144517601|NCT04052516|521096142|FG000|Overall Study|Physician Decision|0|||
144517602|NCT04052516|521096143|FG001|Overall Study|Physician Decision|1|||
144517603|NCT04052516|521096144|FG002|Overall Study|Physician Decision|0|||
144517604|NCT04052516|521096142|FG000|Overall Study|Pregnancy|1|||
144517605|NCT04052516|521096143|FG001|Overall Study|Pregnancy|0|||
144517606|NCT04052516|521096144|FG002|Overall Study|Pregnancy|0|||
144517607|NCT04052516|521096142|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
144517608|NCT04052516|521096143|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
144517609|NCT04052516|521096144|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
144517610|NCT04052516|521096142|FG000|Overall Study|Reason not recorded|0|||
144517611|NCT04052516|521096143|FG001|Overall Study|Reason not recorded|1|||
144517612|NCT04052516|521096144|FG002|Overall Study|Reason not recorded|0|||
144517613|NCT05386355|521096147|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
144517614|NCT05386355|521096148|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
144517615|NCT05386355|521096149|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
144517616|NCT05386355|521096150|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
144517617|NCT06143670|521096151|FG000|Overall Study|Lost to Follow-up|0|||
144517618|NCT06143670|521096152|FG001|Overall Study|Lost to Follow-up|1|||
144517619|NCT06143670|521096151|FG000|Overall Study|Withdrawal by Subject|3|||
144517620|NCT06143670|521096152|FG001|Overall Study|Withdrawal by Subject|0|||
144517621|NCT03625882|521096153|FG000|Overall Study|Protocol Violation|3|||
144517622|NCT03833245|521096154|FG000|Overall Study|Death|0|||
144517623|NCT03833245|521096155|FG001|Overall Study|Death|1|||
144517624|NCT03347383|521096157|FG000|Overall Study|Death|39|||
144517625|NCT03347383|521096157|FG000|Overall Study|Withdrawal by Subject|3|||
144517626|NCT03347383|521096157|FG000|Overall Study|Lost to Follow-up|9|||
144517627|NCT04842643|521096158|FG000|Overall Study|Physician Decision|1|||
144517628|NCT04842643|521096158|FG000|Overall Study|Other|1|||
144517629|NCT03484702|521096159|FG000|Treatment Period|Death|3|||
144517630|NCT03484702|521096160|FG001|Treatment Period|Death|1|||
144517631|NCT03484702|521096161|FG002|Treatment Period|Death|0|||
144517632|NCT03484702|521096162|FG003|Treatment Period|Death|0|||
144517633|NCT03484702|521096163|FG004|Treatment Period|Death|0|||
144517634|NCT03484702|521096164|FG005|Treatment Period|Death|0|||
144517635|NCT03484702|521096159|FG000|Treatment Period|Adverse Event|1|||
144517636|NCT03484702|521096160|FG001|Treatment Period|Adverse Event|0|||
144517637|NCT03484702|521096161|FG002|Treatment Period|Adverse Event|0|||
144517638|NCT03484702|521096162|FG003|Treatment Period|Adverse Event|0|||
144517639|NCT03484702|521096163|FG004|Treatment Period|Adverse Event|0|||
144517640|NCT03484702|521096164|FG005|Treatment Period|Adverse Event|0|||
144517641|NCT03484702|521096159|FG000|Treatment Period|Participant Withdrew from Study|0|||
144517642|NCT03484702|521096160|FG001|Treatment Period|Participant Withdrew from Study|1|||
144517643|NCT03484702|521096161|FG002|Treatment Period|Participant Withdrew from Study|0|||
144389710|NCT02635646|520637228|FG001|Overall Study|Lost to Follow-up|25|||
144389711|NCT02635646|520637227|FG000|Overall Study|Pregnancy|1|||
144517644|NCT03484702|521096162|FG003|Treatment Period|Participant Withdrew from Study|0|||
144517645|NCT03484702|521096163|FG004|Treatment Period|Participant Withdrew from Study|0|||
144517646|NCT03484702|521096164|FG005|Treatment Period|Participant Withdrew from Study|0|||
144389712|NCT02635646|520637228|FG001|Overall Study|Pregnancy|1|||
144389713|NCT00645788|520637229|FG000|Overall Study|Did not receive study drug|1|||
144389714|NCT00645788|520637230|FG001|Overall Study|Did not receive study drug|1|||
144389715|NCT00645788|520637231|FG002|Overall Study|Did not receive study drug|0|||
144389716|NCT00645788|520637232|FG003|Overall Study|Did not receive study drug|0|||
144389717|NCT00645788|520637229|FG000|Overall Study|Adverse Event|4|||
144389718|NCT00645788|520637230|FG001|Overall Study|Adverse Event|9|||
144389719|NCT00645788|520637231|FG002|Overall Study|Adverse Event|5|||
144389720|NCT00645788|520637232|FG003|Overall Study|Adverse Event|3|||
144389721|NCT00645788|520637229|FG000|Overall Study|Lost to Follow-up|1|||
144389722|NCT00645788|520637230|FG001|Overall Study|Lost to Follow-up|0|||
144389723|NCT00645788|520637231|FG002|Overall Study|Lost to Follow-up|0|||
144389724|NCT00645788|520637232|FG003|Overall Study|Lost to Follow-up|0|||
144389725|NCT00645788|520637229|FG000|Overall Study|Protocol Violation|1|||
144389726|NCT00645788|520637230|FG001|Overall Study|Protocol Violation|0|||
144389727|NCT00645788|520637231|FG002|Overall Study|Protocol Violation|2|||
144389728|NCT00645788|520637232|FG003|Overall Study|Protocol Violation|0|||
144389729|NCT00645788|520637229|FG000|Overall Study|Withdrawal by Subject|0|||
144389730|NCT00645788|520637230|FG001|Overall Study|Withdrawal by Subject|1|||
144389731|NCT00645788|520637231|FG002|Overall Study|Withdrawal by Subject|0|||
144389732|NCT00645788|520637232|FG003|Overall Study|Withdrawal by Subject|2|||
144389733|NCT00645788|520637229|FG000|Overall Study|Pulmonary exacerbation|13|||
144389734|NCT00645788|520637230|FG001|Overall Study|Pulmonary exacerbation|16|||
144389735|NCT00645788|520637231|FG002|Overall Study|Pulmonary exacerbation|11|||
144389736|NCT00645788|520637232|FG003|Overall Study|Pulmonary exacerbation|9|||
144389737|NCT03149848|520637234|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
144389738|NCT03149848|520637234|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
144389739|NCT03783702|520637236|FG000|Overall Study|Lost to Follow-up|6|||
144389740|NCT03783702|520637237|FG001|Overall Study|Lost to Follow-up|8|||
144389741|NCT03783702|520637236|FG000|Overall Study|Protocol Violation|1|||
144389742|NCT03783702|520637237|FG001|Overall Study|Protocol Violation|3|||
144389743|NCT02274038|520637238|FG000|Overall Study|Death|1|||
144389744|NCT04473482|520637239|FG000|Overall Study|Death|0|||
144389745|NCT04473482|520637240|FG001|Overall Study|Death|3|||
144389746|NCT04473482|520637239|FG000|Overall Study|Lost to Follow-up|9|||
144389747|NCT04473482|520637240|FG001|Overall Study|Lost to Follow-up|7|||
144389748|NCT04473482|520637239|FG000|Overall Study|Withdrawal by Subject|2|||
144389749|NCT04473482|520637240|FG001|Overall Study|Withdrawal by Subject|1|||
144389750|NCT00570232|520637241|FG000|Overall Study|Adverse Event|10|||
144389751|NCT00570232|520637241|FG000|Overall Study|discontinued due to medical condition|3|||
144389752|NCT00570232|520637241|FG000|Overall Study|discontinued due to recurrence|8|||
144389753|NCT00570232|520637241|FG000|Overall Study|discontinued due to noncompliance|2|||
144389754|NCT01076075|520637242|FG000|Overall Study|Adverse Event|3|||
144389755|NCT01076075|520637243|FG001|Overall Study|Adverse Event|9|||
144389756|NCT01076075|520637242|FG000|Overall Study|Lack of Efficacy|5|||
144389757|NCT01076075|520637243|FG001|Overall Study|Lack of Efficacy|4|||
144389758|NCT01076075|520637242|FG000|Overall Study|Lost to Follow-up|6|||
144389759|NCT01076075|520637243|FG001|Overall Study|Lost to Follow-up|5|||
144389760|NCT01076075|520637242|FG000|Overall Study|other|19|||
144389761|NCT01076075|520637243|FG001|Overall Study|other|9|||
144389762|NCT01076075|520637242|FG000|Overall Study|Protocol Violation|0|||
144389763|NCT01076075|520637243|FG001|Overall Study|Protocol Violation|1|||
144389764|NCT01076075|520637242|FG000|Overall Study|Withdrawal by Subject|8|||
144389765|NCT01076075|520637243|FG001|Overall Study|Withdrawal by Subject|19|||
144389766|NCT01445886|520637249|FG000|Overall Study|Lost to Follow-up|2|||
144389767|NCT01445886|520637249|FG000|Overall Study|Protocol Violation|3|||
144389768|NCT01986933|520637250|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
144389769|NCT01986933|520637251|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
144389770|NCT01986933|520637252|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
144389771|NCT01986933|520637253|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
144389772|NCT01986933|520637254|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
144389773|NCT01986933|520637250|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
144389774|NCT01986933|520637251|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
144389775|NCT01986933|520637252|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
144389776|NCT01986933|520637253|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
144389777|NCT01986933|520637254|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
144389778|NCT01986933|520637250|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
144389779|NCT01986933|520637251|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
144389780|NCT01986933|520637252|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
144389781|NCT01986933|520637253|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
144389782|NCT01986933|520637254|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
144389783|NCT01986933|520637250|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
144389784|NCT01986933|520637251|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
144389785|NCT01986933|520637252|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
144389786|NCT01986933|520637253|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
144389787|NCT01986933|520637254|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
144389788|NCT01986933|520637250|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
144389789|NCT01986933|520637251|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
144389790|NCT01986933|520637252|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
144389791|NCT01986933|520637253|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
144389792|NCT01986933|520637254|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
144389793|NCT01986933|520637250|FG000|Active-to-active (Part B)|Adverse Event|0|||
144389794|NCT01986933|520637251|FG001|Active-to-active (Part B)|Adverse Event|2|||
144389795|NCT01986933|520637252|FG002|Active-to-active (Part B)|Adverse Event|0|||
144389796|NCT01986933|520637253|FG003|Active-to-active (Part B)|Adverse Event|1|||
144389797|NCT01986933|520637254|FG004|Active-to-active (Part B)|Adverse Event|3|||
144389798|NCT01986933|520637250|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
144389799|NCT01986933|520637251|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
144389800|NCT01986933|520637252|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
144389801|NCT01986933|520637253|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
144389802|NCT01986933|520637254|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
144389803|NCT01986933|520637250|FG000|Active-to-active (Part B)|Pregnancy|0|||
144389804|NCT01986933|520637251|FG001|Active-to-active (Part B)|Pregnancy|0|||
144389805|NCT01986933|520637252|FG002|Active-to-active (Part B)|Pregnancy|0|||
144389806|NCT01986933|520637253|FG003|Active-to-active (Part B)|Pregnancy|0|||
144389807|NCT01986933|520637254|FG004|Active-to-active (Part B)|Pregnancy|1|||
144389808|NCT01986933|520637250|FG000|Active-to-active (Part B)|Physician Decision|0|||
144389809|NCT01986933|520637251|FG001|Active-to-active (Part B)|Physician Decision|0|||
144389810|NCT01986933|520637252|FG002|Active-to-active (Part B)|Physician Decision|1|||
144389811|NCT01986933|520637253|FG003|Active-to-active (Part B)|Physician Decision|1|||
144389812|NCT01986933|520637254|FG004|Active-to-active (Part B)|Physician Decision|0|||
144389813|NCT01986933|520637250|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
144389814|NCT01986933|520637251|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
144389815|NCT01986933|520637252|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
144389816|NCT01986933|520637253|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
144389817|NCT01986933|520637254|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
144389818|NCT01986933|520637250|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
144389819|NCT01986933|520637251|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
144389820|NCT01986933|520637252|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
144389821|NCT01986933|520637253|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
144389822|NCT01986933|520637254|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
144389823|NCT01986933|520637250|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
144389824|NCT01986933|520637251|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
144389825|NCT01986933|520637252|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
144389826|NCT01986933|520637253|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
144389827|NCT01986933|520637254|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
144389828|NCT01986933|520637250|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
144389829|NCT01986933|520637251|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
144389830|NCT01986933|520637252|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
144389831|NCT01986933|520637253|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
144389832|NCT01986933|520637254|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
144389833|NCT01986933|520637250|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
144389834|NCT01986933|520637251|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
144389835|NCT01986933|520637252|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
144389836|NCT01986933|520637253|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
144389837|NCT01986933|520637254|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
144389838|NCT01986933|520637250|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
144389839|NCT01986933|520637251|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
144389840|NCT01986933|520637252|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
144389841|NCT01986933|520637253|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
144389842|NCT01986933|520637254|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
144389843|NCT01986933|520637250|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
144389844|NCT01986933|520637251|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
144389845|NCT01986933|520637252|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
144389846|NCT01986933|520637253|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
144389847|NCT01986933|520637254|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
144389848|NCT01986933|520637250|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
144389849|NCT01986933|520637251|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
144389850|NCT01986933|520637252|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
144389851|NCT01986933|520637253|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
144389852|NCT01986933|520637254|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
144389853|NCT04854642|520638940|FG000|Overall Study|Adverse Event|1|||
144389854|NCT04854642|520638941|FG001|Overall Study|Adverse Event|2|||
144389855|NCT04854642|520638940|FG000|Overall Study|Withdrawal by Subject|0|||
144389856|NCT04854642|520638941|FG001|Overall Study|Withdrawal by Subject|1|||
144389857|NCT04078178|520638943|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
144199333|NCT03107026|519928872|FG002|Overall Study|Pregnancy|0|||
144389858|NCT04078178|520638944|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
144389859|NCT04078178|520638943|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
144389860|NCT04078178|520638944|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
144389861|NCT04078178|520638943|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
144389862|NCT04078178|520638944|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
144389863|NCT04078178|520638943|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
144389864|NCT04078178|520638944|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
144389865|NCT04078178|520638943|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
144389866|NCT04078178|520638944|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
144389867|NCT04006119|520638945|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
144389868|NCT04006119|520638945|FG000|End of Treatment Veledimex|Adverse Event|2|||
144389869|NCT04006119|520638945|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
144389870|NCT04006119|520638945|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
144389871|NCT04006119|520638945|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
144389872|NCT04006119|520638945|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
144389873|NCT04617795|520638946|FG000|Main Study|Lost to Follow-up|1|||
144389874|NCT04617795|520638947|FG001|Main Study|Lost to Follow-up|0|||
144389875|NCT00472459|520638948|FG000|Overall Study|Adverse Event|13|||
144389876|NCT00472459|520638949|FG001|Overall Study|Adverse Event|13|||
144389877|NCT00472459|520638948|FG000|Overall Study|Withdrawal by Subject|5|||
144389878|NCT00472459|520638949|FG001|Overall Study|Withdrawal by Subject|5|||
144389879|NCT00472459|520638948|FG000|Overall Study|Protocol Violation|3|||
144389880|NCT00472459|520638949|FG001|Overall Study|Protocol Violation|3|||
144389881|NCT00472459|520638948|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
144389882|NCT00472459|520638949|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
144389883|NCT00472459|520638948|FG000|Overall Study|Lost to Follow-up|1|||
144389884|NCT00472459|520638949|FG001|Overall Study|Lost to Follow-up|1|||
144389885|NCT04850313|520638950|FG000|Overall Study|Withdrawal by Subject|0|||
144389886|NCT04850313|520638951|FG001|Overall Study|Withdrawal by Subject|1|||
144389887|NCT01741012|520638952|FG000|Overall Study|Lost to Follow-up|1|||
144389888|NCT01741012|520638952|FG000|Overall Study|Withdrawal by Subject|2|||
144389889|NCT00997438|520638953|FG000|Overall Study|Blood draw difficulty|2|||
144389890|NCT00997438|520638954|FG001|Overall Study|Blood draw difficulty|0|||
144389891|NCT00997438|520638955|FG002|Overall Study|Blood draw difficulty|1|||
144389892|NCT00997438|520638953|FG000|Overall Study|Withdrawal by Subject|1|||
144389893|NCT00997438|520638954|FG001|Overall Study|Withdrawal by Subject|1|||
144389894|NCT00997438|520638955|FG002|Overall Study|Withdrawal by Subject|0|||
144389895|NCT00997438|520638953|FG000|Overall Study|Exclusion criteria at visit 1|2|||
144389896|NCT00997438|520638954|FG001|Overall Study|Exclusion criteria at visit 1|2|||
144517647|NCT03484702|521096159|FG000|Treatment Period|Physician Decision|0|||
144517648|NCT03484702|521096160|FG001|Treatment Period|Physician Decision|1|||
144517649|NCT03484702|521096161|FG002|Treatment Period|Physician Decision|0|||
144517650|NCT03484702|521096162|FG003|Treatment Period|Physician Decision|0|||
144517651|NCT03484702|521096163|FG004|Treatment Period|Physician Decision|0|||
144517652|NCT03484702|521096164|FG005|Treatment Period|Physician Decision|1|||
144517653|NCT04173663|521096165|FG000|Overall Study|Withdrawal by Subject|1|||
144517654|NCT04173663|521096166|FG001|Overall Study|Withdrawal by Subject|6|||
144517655|NCT04173663|521096165|FG000|Overall Study|Lost to Follow-up|17|||
144517656|NCT04173663|521096166|FG001|Overall Study|Lost to Follow-up|24|||
144517657|NCT05141903|521096168|FG000|Overall Study|Withdrawal by Subject|0|||
144517658|NCT05141903|521096169|FG001|Overall Study|Withdrawal by Subject|1|||
144517659|NCT05141903|521096170|FG002|Overall Study|Withdrawal by Subject|1|||
144517660|NCT05141903|521096171|FG003|Overall Study|Withdrawal by Subject|0|||
144517661|NCT05141903|521096172|FG004|Overall Study|Withdrawal by Subject|0|||
144517662|NCT05141903|521096168|FG000|Overall Study|Other|1|||
144517663|NCT05141903|521096169|FG001|Overall Study|Other|1|||
144389897|NCT00997438|520638955|FG002|Overall Study|Exclusion criteria at visit 1|3|||
144389898|NCT00095238|520638956|FG000|Overall Study|Lack of Efficacy|9|||
144389899|NCT00095238|520638957|FG001|Overall Study|Lack of Efficacy|9|||
144389900|NCT00095238|520638956|FG000|Overall Study|Adverse Event|331|||
144389901|NCT00095238|520638957|FG001|Overall Study|Adverse Event|287|||
144389902|NCT00095238|520638956|FG000|Overall Study|Subject Withdrew Consent|208|||
144517664|NCT05141903|521096170|FG002|Overall Study|Other|0|||
144593907|NCT00345293|521374048|FG000|Overall Study|Withdrawal by Subject|1|||
144389903|NCT00095238|520638957|FG001|Overall Study|Subject Withdrew Consent|223|||
144389904|NCT00095238|520638956|FG000|Overall Study|Death|154|||
144517665|NCT05141903|521096171|FG003|Overall Study|Other|0|||
144389905|NCT00095238|520638957|FG001|Overall Study|Death|170|||
144517666|NCT05141903|521096172|FG004|Overall Study|Other|0|||
144389906|NCT00095238|520638956|FG000|Overall Study|Lost to Follow-up|19|||
144389907|NCT00095238|520638957|FG001|Overall Study|Lost to Follow-up|24|||
144389908|NCT00095238|520638956|FG000|Overall Study|Noncompliance|44|||
144389909|NCT00095238|520638957|FG001|Overall Study|Noncompliance|45|||
144389910|NCT00095238|520638956|FG000|Overall Study|No longer met study criteria|4|||
144389911|NCT00095238|520638957|FG001|Overall Study|No longer met study criteria|5|||
144389912|NCT00095238|520638956|FG000|Overall Study|Study terminated by sponsor|0|||
144389913|NCT00095238|520638957|FG001|Overall Study|Study terminated by sponsor|1|||
144389914|NCT00095238|520638956|FG000|Overall Study|Missing|1|||
144389915|NCT00095238|520638957|FG001|Overall Study|Missing|0|||
144389916|NCT00095238|520638956|FG000|Overall Study|Other Reasons|87|||
144389917|NCT00095238|520638957|FG001|Overall Study|Other Reasons|88|||
144389918|NCT02038829|520638960|FG000|Washout Period 1|Death|0|||
144517667|NCT02630823|521096178|FG000|Overall Study|Withdrawal by Subject|1|||
144517668|NCT02630823|521096178|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
144517669|NCT04178733|521096179|FG000|Overall Study|Investigator Decision|0|||
144517670|NCT04178733|521096180|FG001|Overall Study|Investigator Decision|0|||
144517671|NCT04178733|521096181|FG002|Overall Study|Investigator Decision|0|||
144517672|NCT04178733|521096182|FG003|Overall Study|Investigator Decision|1|||
144517673|NCT04178733|521096183|FG004|Overall Study|Investigator Decision|2|||
144517674|NCT02682316|521096190|FG000|Overall Study|Benign Final Pathology|27|||
144517675|NCT02682316|521096191|FG001|Overall Study|Benign Final Pathology|26|||
144517676|NCT02682316|521096190|FG000|Overall Study|Reoperation before 30 days|7|||
144517677|NCT02682316|521096191|FG001|Overall Study|Reoperation before 30 days|6|||
144517678|NCT02682316|521096190|FG000|Overall Study|Ineligible|1|||
144517679|NCT02682316|521096191|FG001|Overall Study|Ineligible|0|||
144517680|NCT02682316|521096190|FG000|Overall Study|Death|1|||
144517681|NCT02682316|521096191|FG001|Overall Study|Death|0|||
144517682|NCT02682316|521096190|FG000|Overall Study|Lost to Follow-up|7|||
144517683|NCT02682316|521096191|FG001|Overall Study|Lost to Follow-up|3|||
144517684|NCT04549168|521096195|FG000|Randomization Phase|Adverse Event|0|||
144517685|NCT04549168|521096196|FG001|Randomization Phase|Adverse Event|0|||
144517686|NCT04549168|521096197|FG002|Randomization Phase|Adverse Event|1|||
144517687|NCT04549168|521096195|FG000|Randomization Phase|Other|0|||
144517688|NCT04549168|521096196|FG001|Randomization Phase|Other|2|||
144517689|NCT04549168|521096197|FG002|Randomization Phase|Other|0|||
144517690|NCT04549168|521096195|FG000|Randomization Phase|Withdrawal by Subject|0|||
144517691|NCT04549168|521096196|FG001|Randomization Phase|Withdrawal by Subject|2|||
144517692|NCT04549168|521096197|FG002|Randomization Phase|Withdrawal by Subject|1|||
144517693|NCT05021640|521096205|FG000|Overall Study|Lost to Follow-up|0|||
144517694|NCT05021640|521096206|FG001|Overall Study|Lost to Follow-up|0|||
144517695|NCT05021640|521096207|FG002|Overall Study|Lost to Follow-up|0|||
144517696|NCT05021640|521096208|FG003|Overall Study|Lost to Follow-up|0|||
144517697|NCT05021640|521096209|FG004|Overall Study|Lost to Follow-up|1|||
144517698|NCT04737772|521096210|FG000|Phase 2 Study|Lost to Follow-up|15|||
144517699|NCT04737772|521096211|FG001|Phase 2 Study|Lost to Follow-up|15|||
144517700|NCT04737772|521096210|FG000|Phase 2 Study|Withdrawal by Subject|0|||
144517701|NCT04737772|521096211|FG001|Phase 2 Study|Withdrawal by Subject|1|||
144517702|NCT04737772|521096210|FG000|Phase 2 Study|Did not take any coaching calls|4|||
144517703|NCT04737772|521096211|FG001|Phase 2 Study|Did not take any coaching calls|0|||
144517704|NCT04737772|521096210|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
144517705|NCT04737772|521096211|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
144517706|NCT04737772|521096210|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
144517707|NCT04737772|521096211|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
144517708|NCT02728076|521096212|FG000|Overall Study|Physician Decision|4|||
144517709|NCT05054374|521096213|FG000|Overall Study|Withdrawal by Subject|1|||
144517710|NCT05054374|521096214|FG001|Overall Study|Withdrawal by Subject|0|||
144517711|NCT05054374|521096215|FG002|Overall Study|Withdrawal by Subject|0|||
144517712|NCT05054374|521096216|FG003|Overall Study|Withdrawal by Subject|0|||
144517713|NCT05054374|521096213|FG000|Overall Study|Progressive Disease|5|||
144517714|NCT05054374|521096214|FG001|Overall Study|Progressive Disease|0|||
144517715|NCT05054374|521096215|FG002|Overall Study|Progressive Disease|0|||
144517716|NCT05054374|521096216|FG003|Overall Study|Progressive Disease|0|||
144517717|NCT04437433|521096219|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
144517718|NCT04437433|521096220|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
144517719|NCT04437433|521096219|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
144517720|NCT04437433|521096220|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
144389919|NCT02038829|520638961|FG001|Washout Period 1|Death|0|||
144389920|NCT02038829|520638962|FG002|Washout Period 1|Death|0|||
144389921|NCT02038829|520638963|FG003|Washout Period 1|Death|0|||
144517721|NCT04437433|521096219|FG000|Overall Study|Adverse Event|9|||
144517722|NCT04437433|521096220|FG001|Overall Study|Adverse Event|0|||
144517723|NCT04437433|521096219|FG000|Overall Study|Lack of Efficacy|4|||
144517724|NCT04437433|521096220|FG001|Overall Study|Lack of Efficacy|0|||
144389922|NCT02038829|520638964|FG004|Washout Period 1|Death|1|||
144389923|NCT02038829|520638965|FG005|Washout Period 1|Death|0|||
144389924|NCT02038829|520638966|FG006|Washout Period 1|Death|0|||
144389925|NCT02038829|520638967|FG007|Washout Period 1|Death|0|||
144389926|NCT02038829|520638968|FG008|Washout Period 1|Death|0|||
144389927|NCT02038829|520638969|FG009|Washout Period 1|Death|0|||
144389928|NCT02038829|520638970|FG010|Washout Period 1|Death|0|||
144389929|NCT02038829|520638971|FG011|Washout Period 1|Death|0|||
144389930|NCT02038829|520638960|FG000|Treatment Period 2|Adverse Event|0|||
144389931|NCT02038829|520638961|FG001|Treatment Period 2|Adverse Event|0|||
144389932|NCT02038829|520638962|FG002|Treatment Period 2|Adverse Event|0|||
144389933|NCT02038829|520638963|FG003|Treatment Period 2|Adverse Event|0|||
144389934|NCT02038829|520638964|FG004|Treatment Period 2|Adverse Event|0|||
144389935|NCT02038829|520638965|FG005|Treatment Period 2|Adverse Event|0|||
144389936|NCT02038829|520638966|FG006|Treatment Period 2|Adverse Event|0|||
144389937|NCT02038829|520638967|FG007|Treatment Period 2|Adverse Event|0|||
144389938|NCT02038829|520638968|FG008|Treatment Period 2|Adverse Event|0|||
144389939|NCT02038829|520638969|FG009|Treatment Period 2|Adverse Event|0|||
144389940|NCT02038829|520638970|FG010|Treatment Period 2|Adverse Event|1|||
144389941|NCT02038829|520638971|FG011|Treatment Period 2|Adverse Event|0|||
144389942|NCT02038829|520638960|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144389943|NCT02038829|520638961|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144389944|NCT02038829|520638962|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144389945|NCT02038829|520638963|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144389946|NCT02038829|520638964|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144389947|NCT02038829|520638965|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144389948|NCT02038829|520638966|FG006|Treatment Period 2|Withdrawal by Subject|0|||
144389949|NCT02038829|520638967|FG007|Treatment Period 2|Withdrawal by Subject|0|||
144389950|NCT02038829|520638968|FG008|Treatment Period 2|Withdrawal by Subject|0|||
144389951|NCT02038829|520638969|FG009|Treatment Period 2|Withdrawal by Subject|0|||
144389952|NCT02038829|520638970|FG010|Treatment Period 2|Withdrawal by Subject|0|||
144389953|NCT02038829|520638971|FG011|Treatment Period 2|Withdrawal by Subject|0|||
144389954|NCT02038829|520638960|FG000|Washout Period 2|Adverse Event|0|||
144389955|NCT02038829|520638961|FG001|Washout Period 2|Adverse Event|0|||
144389956|NCT02038829|520638962|FG002|Washout Period 2|Adverse Event|0|||
144389957|NCT02038829|520638963|FG003|Washout Period 2|Adverse Event|0|||
144389958|NCT02038829|520638964|FG004|Washout Period 2|Adverse Event|0|||
144389959|NCT02038829|520638965|FG005|Washout Period 2|Adverse Event|0|||
144389960|NCT02038829|520638966|FG006|Washout Period 2|Adverse Event|0|||
144389961|NCT02038829|520638967|FG007|Washout Period 2|Adverse Event|0|||
144389962|NCT02038829|520638968|FG008|Washout Period 2|Adverse Event|1|||
144389963|NCT02038829|520638969|FG009|Washout Period 2|Adverse Event|0|||
144389964|NCT02038829|520638970|FG010|Washout Period 2|Adverse Event|0|||
144389965|NCT02038829|520638971|FG011|Washout Period 2|Adverse Event|0|||
144389966|NCT02038829|520638960|FG000|Washout Period 2|Withdrawal by Subject|0|||
144389967|NCT02038829|520638961|FG001|Washout Period 2|Withdrawal by Subject|0|||
144389968|NCT02038829|520638962|FG002|Washout Period 2|Withdrawal by Subject|0|||
144389969|NCT02038829|520638963|FG003|Washout Period 2|Withdrawal by Subject|0|||
144389970|NCT02038829|520638964|FG004|Washout Period 2|Withdrawal by Subject|0|||
144389971|NCT02038829|520638965|FG005|Washout Period 2|Withdrawal by Subject|1|||
144389972|NCT02038829|520638966|FG006|Washout Period 2|Withdrawal by Subject|0|||
144389973|NCT02038829|520638967|FG007|Washout Period 2|Withdrawal by Subject|0|||
144389974|NCT02038829|520638968|FG008|Washout Period 2|Withdrawal by Subject|0|||
144389975|NCT02038829|520638969|FG009|Washout Period 2|Withdrawal by Subject|0|||
144389976|NCT02038829|520638970|FG010|Washout Period 2|Withdrawal by Subject|0|||
144389977|NCT02038829|520638971|FG011|Washout Period 2|Withdrawal by Subject|0|||
144389978|NCT02038829|520638960|FG000|Treatment Period 4|Adverse Event|0|||
144389979|NCT02038829|520638961|FG001|Treatment Period 4|Adverse Event|1|||
144389980|NCT02038829|520638962|FG002|Treatment Period 4|Adverse Event|0|||
144389981|NCT02038829|520638963|FG003|Treatment Period 4|Adverse Event|0|||
144389982|NCT02038829|520638964|FG004|Treatment Period 4|Adverse Event|0|||
144389983|NCT02038829|520638965|FG005|Treatment Period 4|Adverse Event|0|||
144389984|NCT02038829|520638966|FG006|Treatment Period 4|Adverse Event|0|||
144389985|NCT02038829|520638967|FG007|Treatment Period 4|Adverse Event|0|||
144389986|NCT02038829|520638968|FG008|Treatment Period 4|Adverse Event|0|||
144389987|NCT02038829|520638969|FG009|Treatment Period 4|Adverse Event|0|||
144389988|NCT02038829|520638970|FG010|Treatment Period 4|Adverse Event|0|||
144389989|NCT02038829|520638971|FG011|Treatment Period 4|Adverse Event|0|||
144389990|NCT02038829|520638960|FG000|Washout Period 4|Adverse Event|0|||
144389991|NCT02038829|520638961|FG001|Washout Period 4|Adverse Event|0|||
144389992|NCT02038829|520638962|FG002|Washout Period 4|Adverse Event|0|||
144389993|NCT02038829|520638963|FG003|Washout Period 4|Adverse Event|0|||
144389994|NCT02038829|520638964|FG004|Washout Period 4|Adverse Event|0|||
144389995|NCT02038829|520638965|FG005|Washout Period 4|Adverse Event|0|||
144389996|NCT02038829|520638966|FG006|Washout Period 4|Adverse Event|1|||
144389997|NCT02038829|520638967|FG007|Washout Period 4|Adverse Event|0|||
144389998|NCT02038829|520638968|FG008|Washout Period 4|Adverse Event|0|||
144389999|NCT02038829|520638969|FG009|Washout Period 4|Adverse Event|0|||
144390000|NCT02038829|520638970|FG010|Washout Period 4|Adverse Event|0|||
144390001|NCT02038829|520638971|FG011|Washout Period 4|Adverse Event|0|||
144390002|NCT02038829|520638960|FG000|Treatment Period 6|Adverse Event|0|||
144390003|NCT02038829|520638961|FG001|Treatment Period 6|Adverse Event|0|||
144390004|NCT02038829|520638962|FG002|Treatment Period 6|Adverse Event|1|||
144390005|NCT02038829|520638963|FG003|Treatment Period 6|Adverse Event|0|||
144390006|NCT02038829|520638964|FG004|Treatment Period 6|Adverse Event|0|||
144390007|NCT02038829|520638965|FG005|Treatment Period 6|Adverse Event|0|||
144390008|NCT02038829|520638966|FG006|Treatment Period 6|Adverse Event|0|||
144390009|NCT02038829|520638967|FG007|Treatment Period 6|Adverse Event|0|||
144390010|NCT02038829|520638968|FG008|Treatment Period 6|Adverse Event|0|||
144390011|NCT02038829|520638969|FG009|Treatment Period 6|Adverse Event|0|||
144390012|NCT02038829|520638970|FG010|Treatment Period 6|Adverse Event|0|||
144390013|NCT02038829|520638971|FG011|Treatment Period 6|Adverse Event|0|||
144390014|NCT04626310|520638978|FG000|Overall Study|4-miss from treatment|6|||
144390015|NCT04626310|520638979|FG001|Overall Study|4-miss from treatment|5|||
144390016|NCT04626310|520638980|FG002|Overall Study|4-miss from treatment|5|||
144390017|NCT04626310|520638978|FG000|Overall Study|Withdrawal by Subject|1|||
144390018|NCT04626310|520638979|FG001|Overall Study|Withdrawal by Subject|0|||
144390019|NCT04626310|520638980|FG002|Overall Study|Withdrawal by Subject|3|||
144390020|NCT02278341|520638981|FG000|Overall Study|Randomized but never received study drug|1|||
144390021|NCT02278341|520638982|FG001|Overall Study|Randomized but never received study drug|1|||
144390022|NCT02278341|520638981|FG000|Overall Study|Adverse Event|3|||
144390023|NCT02278341|520638982|FG001|Overall Study|Adverse Event|0|||
144390024|NCT02278341|520638981|FG000|Overall Study|Death|68|||
144390025|NCT02278341|520638982|FG001|Overall Study|Death|56|||
144390026|NCT02278341|520638981|FG000|Overall Study|Withdrawal by Subject|30|||
144390027|NCT02278341|520638982|FG001|Overall Study|Withdrawal by Subject|19|||
144390028|NCT02278341|520638981|FG000|Overall Study|Lost to Follow-up|0|||
144390029|NCT02278341|520638982|FG001|Overall Study|Lost to Follow-up|1|||
144390030|NCT02278341|520638981|FG000|Overall Study|Physician Decision|1|||
144390031|NCT02278341|520638982|FG001|Overall Study|Physician Decision|1|||
144390032|NCT02278341|520638981|FG000|Overall Study|Miscellaneous|15|||
144390033|NCT02278341|520638982|FG001|Overall Study|Miscellaneous|14|||
144390034|NCT04902326|520638983|FG000|Overall Study|Withdrawal by Subject|1|||
144390035|NCT04902326|520638984|FG001|Overall Study|Withdrawal by Subject|3|||
144517725|NCT04437433|521096219|FG000|Overall Study|Withdrawal by Subject|4|||
144517726|NCT04437433|521096220|FG001|Overall Study|Withdrawal by Subject|1|||
144517727|NCT04437433|521096219|FG000|Overall Study|Protocol Deviation|0|||
144517728|NCT04437433|521096220|FG001|Overall Study|Protocol Deviation|1|||
144517729|NCT04437433|521096219|FG000|Overall Study|Other, not specified|0|||
144517730|NCT04437433|521096220|FG001|Overall Study|Other, not specified|1|||
144517731|NCT04245501|521096221|FG000|Overall Study|Adverse Event|2|||
144517732|NCT04245501|521096222|FG001|Overall Study|Adverse Event|0|||
144517733|NCT04245501|521096221|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
144517734|NCT04245501|521096222|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
144517735|NCT03526861|521096223|FG000|Initial Treatment Period|Not dosed|1|||
144517736|NCT03526861|521096224|FG001|Initial Treatment Period|Not dosed|1|||
144517737|NCT03526861|521096225|FG002|Initial Treatment Period|Not dosed|1|||
144517738|NCT03526861|521096226|FG003|Initial Treatment Period|Not dosed|0|||
144517739|NCT03526861|521096227|FG004|Initial Treatment Period|Not dosed|0|||
144517740|NCT03526861|521096228|FG005|Initial Treatment Period|Not dosed|0|||
144517741|NCT03526861|521096229|FG006|Initial Treatment Period|Not dosed|0|||
144517742|NCT03526861|521096230|FG007|Initial Treatment Period|Not dosed|0|||
144517743|NCT03526861|521096231|FG008|Initial Treatment Period|Not dosed|0|||
144517744|NCT03526861|521096223|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
144517745|NCT03526861|521096224|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
144517746|NCT03526861|521096225|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
144517747|NCT03526861|521096226|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517748|NCT03526861|521096227|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144538341|NCT00366249|521174162|FG001|Overall Study|Protocol Violation|2|||
144390036|NCT04902326|520638985|FG002|Overall Study|Withdrawal by Subject|0|||
144390037|NCT04902326|520638986|FG003|Overall Study|Withdrawal by Subject|1|||
144390038|NCT04902326|520638983|FG000|Overall Study|Lost to Follow-up|14|||
144390039|NCT04902326|520638984|FG001|Overall Study|Lost to Follow-up|14|||
144390040|NCT04902326|520638985|FG002|Overall Study|Lost to Follow-up|14|||
144390041|NCT04902326|520638986|FG003|Overall Study|Lost to Follow-up|6|||
144390042|NCT02604017|520638988|FG000|Overall Study|Withdrew Consent|0|||
144390043|NCT02604017|520638989|FG001|Overall Study|Withdrew Consent|2|||
144390044|NCT02604017|520638988|FG000|Overall Study|Lost to Follow-up|5|||
144390045|NCT02604017|520638989|FG001|Overall Study|Lost to Follow-up|6|||
144390046|NCT02604017|520638988|FG000|Overall Study|Other|1|||
144390047|NCT02604017|520638989|FG001|Overall Study|Other|0|||
144390048|NCT01041495|520638990|FG000|Overall Study|Withdrawal by Subject|2|||
144390049|NCT01041495|520638991|FG001|Overall Study|Withdrawal by Subject|5|||
144390050|NCT01041495|520638990|FG000|Overall Study|Adverse Event|2|||
144390051|NCT01041495|520638991|FG001|Overall Study|Adverse Event|1|||
144390052|NCT01041495|520638990|FG000|Overall Study|Lost to Follow-up|0|||
144390053|NCT01041495|520638991|FG001|Overall Study|Lost to Follow-up|1|||
144390054|NCT01117051|520638992|FG000|Overall Study|Withdrawal by Subject|5|||
144390055|NCT01117051|520638993|FG001|Overall Study|Withdrawal by Subject|3|||
144390056|NCT01117051|520638992|FG000|Overall Study|Adverse Event|4|||
144390057|NCT01117051|520638993|FG001|Overall Study|Adverse Event|3|||
144390058|NCT01117051|520638992|FG000|Overall Study|Lost to Follow-up|0|||
144390059|NCT01117051|520638993|FG001|Overall Study|Lost to Follow-up|1|||
144390060|NCT01117051|520638992|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
144390061|NCT01117051|520638993|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
144390062|NCT01117051|520638992|FG000|Overall Study|Sponsor's decision|3|||
144390063|NCT01117051|520638993|FG001|Overall Study|Sponsor's decision|1|||
144390064|NCT01117051|520638992|FG000|Overall Study|Surgical procedure|0|||
144390065|NCT01117051|520638993|FG001|Overall Study|Surgical procedure|1|||
144390066|NCT01117051|520638992|FG000|Overall Study|Randomized by mistake|0|||
144390067|NCT01117051|520638993|FG001|Overall Study|Randomized by mistake|1|||
144390068|NCT01117051|520638992|FG000|Overall Study|Convenience issue|1|||
144390069|NCT01117051|520638993|FG001|Overall Study|Convenience issue|0|||
144390070|NCT03780400|520638997|FG000|Overall Study|Lost to Follow-up|5|||
144390071|NCT03780400|520638997|FG000|Overall Study|Withdrawal by Subject|2|||
144390072|NCT01479985|520638998|FG000|Overall Study|Tablet malfunction, no data saved|1|||
144390073|NCT01479985|520638999|FG001|Overall Study|Tablet malfunction, no data saved|1|||
144390074|NCT01479985|520638998|FG000|Overall Study|No decisional conflict scale responses|0|||
144390075|NCT01479985|520638999|FG001|Overall Study|No decisional conflict scale responses|2|||
144390076|NCT01479985|520638998|FG000|Overall Study|No post-visit survey|5|||
144390077|NCT01479985|520638999|FG001|Overall Study|No post-visit survey|3|||
144390078|NCT01653782|520639000|FG000|Overall Study|Withdrawal by Subject|9|||
144390079|NCT01653782|520639001|FG001|Overall Study|Withdrawal by Subject|15|||
144390080|NCT01653782|520639002|FG002|Overall Study|Withdrawal by Subject|4|||
144390081|NCT01653782|520639000|FG000|Overall Study|Lost to Follow-up|7|||
144390082|NCT01653782|520639001|FG001|Overall Study|Lost to Follow-up|3|||
144390083|NCT01653782|520639002|FG002|Overall Study|Lost to Follow-up|2|||
144390084|NCT01850602|520639008|FG000|Overall Study|Adverse Event|7|||
144390085|NCT01850602|520639009|FG001|Overall Study|Adverse Event|10|||
144390086|NCT01850602|520639008|FG000|Overall Study|Physician Decision|2|||
144390087|NCT01850602|520639009|FG001|Overall Study|Physician Decision|1|||
144390088|NCT01850602|520639008|FG000|Overall Study|Withdrawal by Subject|2|||
144390089|NCT01850602|520639009|FG001|Overall Study|Withdrawal by Subject|4|||
144390090|NCT01850602|520639008|FG000|Overall Study|Decrease in serum calcium|2|||
144390091|NCT01850602|520639009|FG001|Overall Study|Decrease in serum calcium|3|||
144390092|NCT01850602|520639008|FG000|Overall Study|Increase in serum ferritin|1|||
144517749|NCT03526861|521096228|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517750|NCT03526861|521096229|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517751|NCT03526861|521096230|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517752|NCT03526861|521096231|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517753|NCT03526861|521096223|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
144517754|NCT03526861|521096224|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
144517755|NCT03526861|521096225|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
144517756|NCT03526861|521096226|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
144517757|NCT03526861|521096227|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
144390093|NCT01850602|520639009|FG001|Overall Study|Increase in serum ferritin|0|||
144390094|NCT00367770|520639010|FG000|Overall Study|Adverse Event|1|||
144390095|NCT00367770|520639010|FG000|Overall Study|Withdrawal by Subject|1|||
144390096|NCT01155479|520639011|FG000|Part I|Adverse Event|13|||
144390097|NCT01155479|520639012|FG001|Part I|Adverse Event|8|||
144390098|NCT01155479|520639013|FG002|Part I|Adverse Event|18|||
144390099|NCT01155479|520639014|FG003|Part I|Adverse Event|7|||
144390100|NCT01155479|520639015|FG004|Part I|Adverse Event|6|||
144390101|NCT01155479|520639011|FG000|Part I|Administrative|2|||
144390102|NCT01155479|520639012|FG001|Part I|Administrative|2|||
144390103|NCT01155479|520639013|FG002|Part I|Administrative|2|||
144390104|NCT01155479|520639014|FG003|Part I|Administrative|0|||
144390105|NCT01155479|520639015|FG004|Part I|Administrative|0|||
144390106|NCT01155479|520639011|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
144390107|NCT01155479|520639012|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
144390108|NCT01155479|520639013|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
144390109|NCT01155479|520639014|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
144390110|NCT01155479|520639015|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
144390111|NCT01155479|520639011|FG000|Part I|Withdrawal by Subject|11|||
144390112|NCT01155479|520639012|FG001|Part I|Withdrawal by Subject|13|||
144390113|NCT01155479|520639013|FG002|Part I|Withdrawal by Subject|8|||
144390114|NCT01155479|520639014|FG003|Part I|Withdrawal by Subject|8|||
144390115|NCT01155479|520639015|FG004|Part I|Withdrawal by Subject|9|||
144390116|NCT01155479|520639011|FG000|Part I|Lost to Follow-up|0|||
144390117|NCT01155479|520639012|FG001|Part I|Lost to Follow-up|0|||
144390118|NCT01155479|520639013|FG002|Part I|Lost to Follow-up|1|||
144390119|NCT01155479|520639014|FG003|Part I|Lost to Follow-up|1|||
144390120|NCT01155479|520639015|FG004|Part I|Lost to Follow-up|0|||
144390121|NCT01155479|520639011|FG000|Part I|Treatment Failure|3|||
144390122|NCT01155479|520639012|FG001|Part I|Treatment Failure|0|||
144390123|NCT01155479|520639013|FG002|Part I|Treatment Failure|3|||
144390124|NCT01155479|520639014|FG003|Part I|Treatment Failure|1|||
144390125|NCT01155479|520639015|FG004|Part I|Treatment Failure|2|||
144390126|NCT01155479|520639011|FG000|Part I|Did Not Receive Treatment|4|||
144390127|NCT01155479|520639012|FG001|Part I|Did Not Receive Treatment|2|||
144390128|NCT01155479|520639013|FG002|Part I|Did Not Receive Treatment|2|||
144390129|NCT01155479|520639014|FG003|Part I|Did Not Receive Treatment|6|||
144390130|NCT01155479|520639015|FG004|Part I|Did Not Receive Treatment|1|||
144390131|NCT01155479|520639011|FG000|Part I|Non-Compliance with Protocol|2|||
144390132|NCT01155479|520639012|FG001|Part I|Non-Compliance with Protocol|1|||
144390133|NCT01155479|520639013|FG002|Part I|Non-Compliance with Protocol|3|||
144390134|NCT01155479|520639014|FG003|Part I|Non-Compliance with Protocol|3|||
144390135|NCT01155479|520639015|FG004|Part I|Non-Compliance with Protocol|2|||
144390136|NCT01155479|520639011|FG000|Part II|Adverse Event|7|||
144390137|NCT01155479|520639012|FG001|Part II|Adverse Event|6|||
144390138|NCT01155479|520639013|FG002|Part II|Adverse Event|8|||
144390139|NCT01155479|520639014|FG003|Part II|Adverse Event|3|||
144390140|NCT01155479|520639015|FG004|Part II|Adverse Event|4|||
144390141|NCT01155479|520639011|FG000|Part II|Administrative|43|||
144390142|NCT01155479|520639012|FG001|Part II|Administrative|49|||
144390143|NCT01155479|520639013|FG002|Part II|Administrative|36|||
144390144|NCT01155479|520639014|FG003|Part II|Administrative|38|||
144390145|NCT01155479|520639015|FG004|Part II|Administrative|46|||
144390146|NCT01155479|520639011|FG000|Part II|Withdrawal by Subject|8|||
144390147|NCT01155479|520639012|FG001|Part II|Withdrawal by Subject|4|||
144390148|NCT01155479|520639013|FG002|Part II|Withdrawal by Subject|12|||
144390149|NCT01155479|520639014|FG003|Part II|Withdrawal by Subject|7|||
144390150|NCT01155479|520639015|FG004|Part II|Withdrawal by Subject|3|||
144390151|NCT01155479|520639011|FG000|Part II|Lost to Follow-up|1|||
144390152|NCT01155479|520639012|FG001|Part II|Lost to Follow-up|0|||
144390153|NCT01155479|520639013|FG002|Part II|Lost to Follow-up|0|||
144390154|NCT01155479|520639014|FG003|Part II|Lost to Follow-up|0|||
144390155|NCT01155479|520639015|FG004|Part II|Lost to Follow-up|1|||
144390156|NCT01155479|520639011|FG000|Part II|Treatment Failure|0|||
144390157|NCT01155479|520639012|FG001|Part II|Treatment Failure|1|||
144390158|NCT01155479|520639013|FG002|Part II|Treatment Failure|2|||
144390159|NCT01155479|520639014|FG003|Part II|Treatment Failure|0|||
144390160|NCT01155479|520639015|FG004|Part II|Treatment Failure|1|||
144390161|NCT01155479|520639011|FG000|Part II|Non-Compliance with Protocol|0|||
144390162|NCT01155479|520639012|FG001|Part II|Non-Compliance with Protocol|1|||
144390163|NCT01155479|520639013|FG002|Part II|Non-Compliance with Protocol|0|||
144390164|NCT01155479|520639014|FG003|Part II|Non-Compliance with Protocol|2|||
144390165|NCT01155479|520639015|FG004|Part II|Non-Compliance with Protocol|0|||
144517758|NCT03526861|521096228|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
144517759|NCT03526861|521096229|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
144517760|NCT03526861|521096230|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
144517761|NCT03526861|521096231|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
144390166|NCT00287079|520639020|FG000|Overall Study|Qualifying relapse|12|||
144390167|NCT00287079|520639021|FG001|Overall Study|Qualifying relapse|1|||
144390168|NCT00287079|520639020|FG000|Overall Study|Non-qualifying relapse|1|||
144390169|NCT00287079|520639021|FG001|Overall Study|Non-qualifying relapse|0|||
144390170|NCT00287079|520639020|FG000|Overall Study|Adverse Event|5|||
144390171|NCT00287079|520639021|FG001|Overall Study|Adverse Event|0|||
144390172|NCT00287079|520639020|FG000|Overall Study|Protocol Violation|1|||
144390173|NCT00287079|520639021|FG001|Overall Study|Protocol Violation|0|||
144517762|NCT03526861|521096223|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144538342|NCT00366249|521174161|FG000|Overall Study|Withdrawal by Subject|18|||
144390174|NCT00287079|520639020|FG000|Overall Study|Other|3|||
144390175|NCT00287079|520639021|FG001|Overall Study|Other|0|||
144390176|NCT00470184|520639022|FG000|Overall Study|Not Treated(became ineligible)|4|||
144390177|NCT00470184|520639022|FG000|Overall Study|Not treated (other)|1|||
144390178|NCT00470184|520639022|FG000|Overall Study|disease Progression|4|||
144390179|NCT00470184|520639022|FG000|Overall Study|Adverse Event|3|||
144390180|NCT00470184|520639022|FG000|Overall Study|Withdrawal by Subject|4|||
144390181|NCT00470184|520639022|FG000|Overall Study|other|5|||
144390182|NCT00470184|520639022|FG000|Overall Study|recurrence|1|||
144390183|NCT03282565|520639025|FG000|Overall Study|COVID-19 Research Shutdown|0|||
144390184|NCT03282565|520639026|FG001|Overall Study|COVID-19 Research Shutdown|2|||
144390185|NCT03282565|520639027|FG002|Overall Study|COVID-19 Research Shutdown|2|||
144390186|NCT00518973|520639028|FG000|Overall Study|Withdrawal by Subject|3|||
144390187|NCT00518973|520639029|FG001|Overall Study|Withdrawal by Subject|2|||
144390188|NCT03452527|520639030|FG000|Overall Study|Withdrawal by Subject|1|||
144390189|NCT03452527|520639031|FG001|Overall Study|Withdrawal by Subject|1|||
144390190|NCT03452527|520639030|FG000|Overall Study|Study Terminated|2|||
144390191|NCT03452527|520639031|FG001|Overall Study|Study Terminated|3|||
144390192|NCT00582816|520639032|FG000|Overall Study|Engraftment Failure|3|||
144390193|NCT02129777|520639033|FG000|Double-Blind Period|Adverse Event|0|||
144390194|NCT02129777|520639034|FG001|Double-Blind Period|Adverse Event|0|||
144390195|NCT02129777|520639035|FG002|Double-Blind Period|Adverse Event|0|||
144390196|NCT02129777|520639036|FG003|Double-Blind Period|Adverse Event|0|||
144390197|NCT02129777|520639037|FG004|Double-Blind Period|Adverse Event|1|||
144390198|NCT02129777|520639038|FG005|Double-Blind Period|Adverse Event|0|||
144390199|NCT02129777|520639039|FG006|Double-Blind Period|Adverse Event|0|||
144390200|NCT02129777|520639033|FG000|Double-Blind Period|Lost to Follow-up|1|||
144390201|NCT02129777|520639034|FG001|Double-Blind Period|Lost to Follow-up|1|||
144390202|NCT02129777|520639035|FG002|Double-Blind Period|Lost to Follow-up|1|||
144390203|NCT02129777|520639036|FG003|Double-Blind Period|Lost to Follow-up|2|||
144390204|NCT02129777|520639037|FG004|Double-Blind Period|Lost to Follow-up|0|||
144390205|NCT02129777|520639038|FG005|Double-Blind Period|Lost to Follow-up|0|||
144390206|NCT02129777|520639039|FG006|Double-Blind Period|Lost to Follow-up|0|||
144390207|NCT02129777|520639033|FG000|Double-Blind Period|Withdrawal by Subject|2|||
144390208|NCT02129777|520639034|FG001|Double-Blind Period|Withdrawal by Subject|4|||
144390209|NCT02129777|520639035|FG002|Double-Blind Period|Withdrawal by Subject|3|||
144390210|NCT02129777|520639036|FG003|Double-Blind Period|Withdrawal by Subject|2|||
144390211|NCT02129777|520639037|FG004|Double-Blind Period|Withdrawal by Subject|3|||
144390212|NCT02129777|520639038|FG005|Double-Blind Period|Withdrawal by Subject|0|||
144390213|NCT02129777|520639039|FG006|Double-Blind Period|Withdrawal by Subject|0|||
144390214|NCT02129777|520639033|FG000|Double-Blind Period|Pregnancy|0|||
144390215|NCT02129777|520639034|FG001|Double-Blind Period|Pregnancy|0|||
144390216|NCT02129777|520639035|FG002|Double-Blind Period|Pregnancy|0|||
144390217|NCT02129777|520639036|FG003|Double-Blind Period|Pregnancy|0|||
144390218|NCT02129777|520639037|FG004|Double-Blind Period|Pregnancy|1|||
144390219|NCT02129777|520639038|FG005|Double-Blind Period|Pregnancy|0|||
144390220|NCT02129777|520639039|FG006|Double-Blind Period|Pregnancy|0|||
144390221|NCT02129777|520639033|FG000|Double-Blind Period|Lack of Efficacy|3|||
144390222|NCT02129777|520639034|FG001|Double-Blind Period|Lack of Efficacy|1|||
144390223|NCT02129777|520639035|FG002|Double-Blind Period|Lack of Efficacy|0|||
144390224|NCT02129777|520639036|FG003|Double-Blind Period|Lack of Efficacy|3|||
144390225|NCT02129777|520639037|FG004|Double-Blind Period|Lack of Efficacy|2|||
144390226|NCT02129777|520639038|FG005|Double-Blind Period|Lack of Efficacy|0|||
144390227|NCT02129777|520639039|FG006|Double-Blind Period|Lack of Efficacy|0|||
144517763|NCT03526861|521096224|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517764|NCT03526861|521096225|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517765|NCT03526861|521096226|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
144517766|NCT03526861|521096227|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
144517767|NCT03526861|521096228|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517768|NCT03526861|521096229|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
144517769|NCT03526861|521096230|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517770|NCT03526861|521096231|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517771|NCT03526861|521096223|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
144517772|NCT03526861|521096224|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
144517773|NCT03526861|521096225|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
144538343|NCT00366249|521174162|FG001|Overall Study|Withdrawal by Subject|4|||
144390228|NCT02129777|520639033|FG000|Double-Blind Period|Other|1|||
144390229|NCT02129777|520639034|FG001|Double-Blind Period|Other|2|||
144390230|NCT02129777|520639035|FG002|Double-Blind Period|Other|0|||
144390231|NCT02129777|520639036|FG003|Double-Blind Period|Other|0|||
144390232|NCT02129777|520639037|FG004|Double-Blind Period|Other|0|||
144390233|NCT02129777|520639038|FG005|Double-Blind Period|Other|0|||
144390234|NCT02129777|520639039|FG006|Double-Blind Period|Other|0|||
144390235|NCT02129777|520639033|FG000|Open-Label Period|Lack of Efficacy|0|||
144390236|NCT02129777|520639034|FG001|Open-Label Period|Lack of Efficacy|0|||
144390237|NCT02129777|520639035|FG002|Open-Label Period|Lack of Efficacy|0|||
144390238|NCT02129777|520639036|FG003|Open-Label Period|Lack of Efficacy|0|||
144390239|NCT02129777|520639037|FG004|Open-Label Period|Lack of Efficacy|0|||
144390240|NCT02129777|520639038|FG005|Open-Label Period|Lack of Efficacy|0|||
144390241|NCT02129777|520639039|FG006|Open-Label Period|Lack of Efficacy|5|||
144390242|NCT02129777|520639033|FG000|Open-Label Period|Lost to Follow-up|0|||
144390243|NCT02129777|520639034|FG001|Open-Label Period|Lost to Follow-up|0|||
144390244|NCT02129777|520639035|FG002|Open-Label Period|Lost to Follow-up|0|||
144390245|NCT02129777|520639036|FG003|Open-Label Period|Lost to Follow-up|0|||
144390246|NCT02129777|520639037|FG004|Open-Label Period|Lost to Follow-up|0|||
144390247|NCT02129777|520639038|FG005|Open-Label Period|Lost to Follow-up|1|||
144390248|NCT02129777|520639039|FG006|Open-Label Period|Lost to Follow-up|1|||
144390249|NCT02129777|520639033|FG000|Open-Label Period|Withdrawal by Subject|0|||
144390250|NCT02129777|520639034|FG001|Open-Label Period|Withdrawal by Subject|0|||
144390251|NCT02129777|520639035|FG002|Open-Label Period|Withdrawal by Subject|0|||
144390252|NCT02129777|520639036|FG003|Open-Label Period|Withdrawal by Subject|0|||
144390253|NCT02129777|520639037|FG004|Open-Label Period|Withdrawal by Subject|0|||
144390254|NCT02129777|520639038|FG005|Open-Label Period|Withdrawal by Subject|1|||
144390255|NCT02129777|520639039|FG006|Open-Label Period|Withdrawal by Subject|3|||
144390256|NCT02129777|520639033|FG000|Open-Label Period|Study Termination|0|||
144390257|NCT02129777|520639034|FG001|Open-Label Period|Study Termination|0|||
144390258|NCT02129777|520639035|FG002|Open-Label Period|Study Termination|0|||
144390259|NCT02129777|520639036|FG003|Open-Label Period|Study Termination|0|||
144390260|NCT02129777|520639037|FG004|Open-Label Period|Study Termination|0|||
144390261|NCT02129777|520639038|FG005|Open-Label Period|Study Termination|10|||
144390262|NCT02129777|520639039|FG006|Open-Label Period|Study Termination|39|||
144390263|NCT01001299|520639041|FG000|Overall Study|Insufficient Therapeutic Response|20|||
144390264|NCT01001299|520639041|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
144390265|NCT01001299|520639041|FG000|Overall Study|Death|1|||
144390266|NCT01001299|520639041|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
144390267|NCT01001299|520639041|FG000|Overall Study|Withdrew Consent|1|||
144390268|NCT01565499|520639042|FG000|Overall Study|Physician Decision|1|||
144390269|NCT01565499|520639042|FG000|Overall Study|Adverse Event|5|||
144390270|NCT01565499|520639042|FG000|Overall Study|Withdrawal by Subject|2|||
144390271|NCT01923168|520639049|FG000|Overall Study|Protocol Violation|1|||
144390272|NCT01923168|520639050|FG001|Overall Study|Protocol Violation|1|||
144390273|NCT01923168|520639051|FG002|Overall Study|Protocol Violation|0|||
144390274|NCT01923168|520639049|FG000|Overall Study|Subject/guardian decision|14|||
144390275|NCT01923168|520639050|FG001|Overall Study|Subject/guardian decision|14|||
144390276|NCT01923168|520639051|FG002|Overall Study|Subject/guardian decision|4|||
144390277|NCT01923168|520639049|FG000|Overall Study|Adverse Event|12|||
144390278|NCT01923168|520639050|FG001|Overall Study|Adverse Event|12|||
144390279|NCT01923168|520639051|FG002|Overall Study|Adverse Event|0|||
144390280|NCT01923168|520639049|FG000|Overall Study|Physician Decision|6|||
144390281|NCT01923168|520639050|FG001|Overall Study|Physician Decision|9|||
144390282|NCT01923168|520639051|FG002|Overall Study|Physician Decision|5|||
144390283|NCT01923168|520639049|FG000|Overall Study|Progressive disease|4|||
144390284|NCT01923168|520639050|FG001|Overall Study|Progressive disease|3|||
144390285|NCT01923168|520639051|FG002|Overall Study|Progressive disease|7|||
144517774|NCT03526861|521096226|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
144517775|NCT03526861|521096227|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
144517776|NCT03526861|521096228|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
144517777|NCT03526861|521096229|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
144517778|NCT03526861|521096230|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
144517779|NCT03526861|521096231|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
144517780|NCT03526861|521096223|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517781|NCT03526861|521096224|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144390286|NCT01923168|520639049|FG000|Overall Study|Death|0|||
144390287|NCT01923168|520639050|FG001|Overall Study|Death|0|||
144390288|NCT01923168|520639051|FG002|Overall Study|Death|1|||
144390289|NCT03116347|520639052|FG000|Overall Study|Withdrawal by Subject|1|||
144390290|NCT03116347|520639053|FG001|Overall Study|Withdrawal by Subject|2|||
144390291|NCT01255787|520639054|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
144390292|NCT01255787|520639055|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
144390293|NCT01255787|520639056|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
144390294|NCT01255787|520639057|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
144390295|NCT01255787|520639054|FG000|Overall Study|Major Protocol Deviation|1|||
144390296|NCT01255787|520639055|FG001|Overall Study|Major Protocol Deviation|1|||
144390297|NCT01255787|520639056|FG002|Overall Study|Major Protocol Deviation|0|||
144390298|NCT01255787|520639057|FG003|Overall Study|Major Protocol Deviation|4|||
144390299|NCT01255787|520639054|FG000|Overall Study|Lost to Follow-up|1|||
144390300|NCT01255787|520639055|FG001|Overall Study|Lost to Follow-up|2|||
144390301|NCT01255787|520639056|FG002|Overall Study|Lost to Follow-up|4|||
144390302|NCT01255787|520639057|FG003|Overall Study|Lost to Follow-up|2|||
144390303|NCT01255787|520639054|FG000|Overall Study|Withdrawal of Consent|3|||
144390304|NCT01255787|520639055|FG001|Overall Study|Withdrawal of Consent|9|||
144390305|NCT01255787|520639056|FG002|Overall Study|Withdrawal of Consent|3|||
144390306|NCT01255787|520639057|FG003|Overall Study|Withdrawal of Consent|4|||
144390307|NCT01255787|520639054|FG000|Overall Study|Pregnancy|0|||
144390308|NCT01255787|520639055|FG001|Overall Study|Pregnancy|0|||
144390309|NCT01255787|520639056|FG002|Overall Study|Pregnancy|0|||
144390310|NCT01255787|520639057|FG003|Overall Study|Pregnancy|1|||
144390311|NCT01255787|520639054|FG000|Overall Study|Lack of Efficacy|2|||
144390312|NCT01255787|520639055|FG001|Overall Study|Lack of Efficacy|2|||
144390313|NCT01255787|520639056|FG002|Overall Study|Lack of Efficacy|2|||
144390314|NCT01255787|520639057|FG003|Overall Study|Lack of Efficacy|2|||
144390315|NCT01255787|520639054|FG000|Overall Study|Noncompliance with Study Drug|3|||
144390316|NCT01255787|520639055|FG001|Overall Study|Noncompliance with Study Drug|1|||
144390317|NCT01255787|520639056|FG002|Overall Study|Noncompliance with Study Drug|0|||
144390318|NCT01255787|520639057|FG003|Overall Study|Noncompliance with Study Drug|0|||
144390319|NCT00476047|520639058|FG000|Overall Study|Lost to Follow-up|1|||
144390320|NCT01056380|520639059|FG000|Overall Study|Lost to Follow-up|2|||
144390321|NCT01056380|520639060|FG001|Overall Study|Lost to Follow-up|3|||
144390322|NCT03170232|520639061|FG000|Overall Study|Adverse Event|0|||
144517782|NCT03526861|521096225|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517783|NCT03526861|521096226|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
144517784|NCT03526861|521096227|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517785|NCT03526861|521096228|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517786|NCT03526861|521096229|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517787|NCT03526861|521096230|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517788|NCT03526861|521096231|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517789|NCT03526861|521096223|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517790|NCT03526861|521096224|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517791|NCT03526861|521096225|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517792|NCT03526861|521096226|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517793|NCT03526861|521096227|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517794|NCT03526861|521096228|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517795|NCT03526861|521096229|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517796|NCT03526861|521096230|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
144517797|NCT03526861|521096231|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
144517798|NCT03526861|521096223|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517799|NCT03526861|521096224|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517800|NCT03526861|521096225|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517801|NCT03526861|521096226|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517802|NCT03526861|521096227|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517803|NCT03526861|521096228|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517804|NCT03526861|521096229|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517805|NCT03526861|521096230|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
144517806|NCT03526861|521096231|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
144538344|NCT00366249|521174161|FG000|Overall Study|Lack of Efficacy|21|||
144538345|NCT00366249|521174162|FG001|Overall Study|Lack of Efficacy|21|||
144538346|NCT00366249|521174161|FG000|Overall Study|Most due to osteomylitis status|31|||
144538347|NCT00366249|521174162|FG001|Overall Study|Most due to osteomylitis status|20|||
144538348|NCT01561300|521174163|FG000|Run in on Placebo|Adverse Event|1|||
144538349|NCT01561300|521174164|FG001|Run in on Placebo|Adverse Event|0|||
144390323|NCT03170232|520639062|FG001|Overall Study|Adverse Event|1|||
144390324|NCT03170232|520639061|FG000|Overall Study|Protocol Violation|0|||
144390325|NCT03170232|520639062|FG001|Overall Study|Protocol Violation|1|||
144390326|NCT03170232|520639061|FG000|Overall Study|Lack of Efficacy|0|||
144390327|NCT03170232|520639062|FG001|Overall Study|Lack of Efficacy|1|||
144390328|NCT03170232|520639061|FG000|Overall Study|Study closed/terminated|26|||
144390329|NCT03170232|520639062|FG001|Overall Study|Study closed/terminated|23|||
144390330|NCT03170232|520639061|FG000|Overall Study|Lost to Follow-up|1|||
144390331|NCT03170232|520639062|FG001|Overall Study|Lost to Follow-up|0|||
144390332|NCT03170232|520639061|FG000|Overall Study|Withdrawal by Subject|0|||
144390333|NCT03170232|520639062|FG001|Overall Study|Withdrawal by Subject|1|||
144390334|NCT03882008|520639063|FG000|Overall Study|Withdrawal by Subject|1|||
144390335|NCT03882008|520639063|FG000|Overall Study|Lost to Follow-up|1|||
144390336|NCT00768469|520639065|FG000|Overall Study|Adverse Event|0|||
144390337|NCT00768469|520639066|FG001|Overall Study|Adverse Event|2|||
144390338|NCT00768469|520639065|FG000|Overall Study|Disease Progression|3|||
144390339|NCT00768469|520639066|FG001|Overall Study|Disease Progression|4|||
144390340|NCT00768469|520639065|FG000|Overall Study|Withdrawal by Subject|0|||
144390341|NCT00768469|520639066|FG001|Overall Study|Withdrawal by Subject|1|||
144390342|NCT04966741|520639067|FG000|Overall Study|Lost to Follow-up|1|||
144390343|NCT04966741|520639068|FG001|Overall Study|Lost to Follow-up|0|||
144390344|NCT02953509|520639069|FG000|Overall Study|Death|1|||
144390345|NCT02953509|520639070|FG001|Overall Study|Death|3|||
144390346|NCT02953509|520639071|FG002|Overall Study|Death|3|||
144390347|NCT02953509|520639072|FG003|Overall Study|Death|4|||
144390348|NCT02953509|520639073|FG004|Overall Study|Death|12|||
144390349|NCT02953509|520639074|FG005|Overall Study|Death|3|||
144390350|NCT02953509|520639075|FG006|Overall Study|Death|25|||
144390351|NCT02953509|520639076|FG007|Overall Study|Death|10|||
144390352|NCT02953509|520639077|FG008|Overall Study|Death|21|||
144390353|NCT02953509|520639078|FG009|Overall Study|Death|20|||
144390354|NCT02953509|520639069|FG000|Overall Study|Reason Not Specified|0|||
144390355|NCT02953509|520639070|FG001|Overall Study|Reason Not Specified|2|||
144390356|NCT02953509|520639071|FG002|Overall Study|Reason Not Specified|8|||
144390357|NCT02953509|520639072|FG003|Overall Study|Reason Not Specified|2|||
144390358|NCT02953509|520639073|FG004|Overall Study|Reason Not Specified|11|||
144390359|NCT02953509|520639074|FG005|Overall Study|Reason Not Specified|4|||
144390360|NCT02953509|520639075|FG006|Overall Study|Reason Not Specified|12|||
144390361|NCT02953509|520639076|FG007|Overall Study|Reason Not Specified|2|||
144390362|NCT02953509|520639077|FG008|Overall Study|Reason Not Specified|7|||
144390363|NCT02953509|520639078|FG009|Overall Study|Reason Not Specified|2|||
144390364|NCT02953509|520639069|FG000|Overall Study|Consent Withdrawn|1|||
144390365|NCT02953509|520639070|FG001|Overall Study|Consent Withdrawn|1|||
144390366|NCT02953509|520639071|FG002|Overall Study|Consent Withdrawn|2|||
144390367|NCT02953509|520639072|FG003|Overall Study|Consent Withdrawn|1|||
144390368|NCT02953509|520639073|FG004|Overall Study|Consent Withdrawn|3|||
144390369|NCT02953509|520639074|FG005|Overall Study|Consent Withdrawn|0|||
144390370|NCT02953509|520639075|FG006|Overall Study|Consent Withdrawn|4|||
144390371|NCT02953509|520639076|FG007|Overall Study|Consent Withdrawn|1|||
144390372|NCT02953509|520639077|FG008|Overall Study|Consent Withdrawn|1|||
144390373|NCT02953509|520639078|FG009|Overall Study|Consent Withdrawn|4|||
144390374|NCT02953509|520639069|FG000|Overall Study|Lost to Follow-up|0|||
144390375|NCT02953509|520639070|FG001|Overall Study|Lost to Follow-up|0|||
144390376|NCT02953509|520639071|FG002|Overall Study|Lost to Follow-up|0|||
144390377|NCT02953509|520639072|FG003|Overall Study|Lost to Follow-up|0|||
144390378|NCT02953509|520639073|FG004|Overall Study|Lost to Follow-up|0|||
144390379|NCT02953509|520639074|FG005|Overall Study|Lost to Follow-up|0|||
144390380|NCT02953509|520639075|FG006|Overall Study|Lost to Follow-up|1|||
144390381|NCT02953509|520639076|FG007|Overall Study|Lost to Follow-up|1|||
144390382|NCT02953509|520639077|FG008|Overall Study|Lost to Follow-up|1|||
144390383|NCT02953509|520639078|FG009|Overall Study|Lost to Follow-up|1|||
144390384|NCT02953509|520639069|FG000|Overall Study|Study terminated by sponsor|1|||
144390385|NCT02953509|520639070|FG001|Overall Study|Study terminated by sponsor|0|||
144390386|NCT02953509|520639071|FG002|Overall Study|Study terminated by sponsor|0|||
144390387|NCT02953509|520639072|FG003|Overall Study|Study terminated by sponsor|0|||
144390388|NCT02953509|520639073|FG004|Overall Study|Study terminated by sponsor|0|||
144390389|NCT02953509|520639074|FG005|Overall Study|Study terminated by sponsor|0|||
144390390|NCT02953509|520639075|FG006|Overall Study|Study terminated by sponsor|1|||
144390391|NCT02953509|520639076|FG007|Overall Study|Study terminated by sponsor|0|||
144390392|NCT02953509|520639077|FG008|Overall Study|Study terminated by sponsor|1|||
144390393|NCT02953509|520639078|FG009|Overall Study|Study terminated by sponsor|1|||
144390394|NCT00484185|520639081|FG000|Overall Study|Lost to Follow-up|44|||
144390395|NCT00484185|520639081|FG000|Overall Study|Other|20|||
144390396|NCT00484185|520639081|FG000|Overall Study|Randomized but not treated|5|||
144390397|NCT00484185|520639081|FG000|Overall Study|Death|2|||
144390398|NCT00725842|520639084|FG000|Overall Study|Lost to Follow-up|19|||
144390399|NCT00725842|520639084|FG000|Overall Study|Death|1|||
144390400|NCT00725842|520639084|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
144390401|NCT00725842|520639084|FG000|Overall Study|Consent date prior to study start date|5|||
144390402|NCT00725842|520639084|FG000|Overall Study|Inclusion criterion not met|1|||
144390403|NCT00725842|520639084|FG000|Overall Study|No Visit 1 data|1|||
144390404|NCT02793622|520639088|FG000|Overall Study|Lost to Follow-up|31|||
144390405|NCT02793622|520639089|FG001|Overall Study|Lost to Follow-up|19|||
144390406|NCT02793622|520639088|FG000|Overall Study|Withdrawal by Subject|21|||
144722155|NCT01463683|521836993|FG002|Overall Study|Lost to Follow-up|7|||
144390407|NCT02793622|520639089|FG001|Overall Study|Withdrawal by Subject|17|||
144390408|NCT02793622|520639088|FG000|Overall Study|Adverse Event|0|||
144390409|NCT02793622|520639089|FG001|Overall Study|Adverse Event|1|||
144390410|NCT02793622|520639088|FG000|Overall Study|Protocol Violation|1|||
144249506|NCT01716520|520111655|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
144249507|NCT01716520|520111656|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
144249508|NCT01716520|520111657|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
144249509|NCT01716520|520111658|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
144390411|NCT02793622|520639089|FG001|Overall Study|Protocol Violation|5|||
144390412|NCT01075191|520639091|FG000|Overall Study|Death|1|||
144390413|NCT01075191|520639091|FG000|Overall Study|Intensification|3|||
144390414|NCT01075191|520639091|FG000|Overall Study|Co-morbidities|1|||
144390415|NCT01075191|520639091|FG000|Overall Study|Adverse Event|4|||
144390416|NCT01075191|520639091|FG000|Overall Study|Noncompliance|3|||
144390417|NCT01075191|520639091|FG000|Overall Study|Therapy Break|3|||
144390418|NCT01075191|520639091|FG000|Overall Study|Patient's Wish|2|||
144390419|NCT01075191|520639091|FG000|Overall Study|Unknown Reasons|1|||
144390420|NCT00718237|520639096|FG000|Overall Study|Adverse Event|1|||
144390421|NCT00718237|520639097|FG001|Overall Study|Adverse Event|3|||
144390422|NCT00718237|520639096|FG000|Overall Study|Lost to Follow-up|2|||
144390423|NCT00718237|520639097|FG001|Overall Study|Lost to Follow-up|2|||
144390424|NCT00718237|520639096|FG000|Overall Study|Physician Decision|1|||
144390425|NCT00718237|520639097|FG001|Overall Study|Physician Decision|0|||
144390426|NCT00718237|520639096|FG000|Overall Study|Withdrawal by Subject|9|||
144390427|NCT00718237|520639097|FG001|Overall Study|Withdrawal by Subject|10|||
144390428|NCT02068768|520639098|FG000|Overall Study|Lost to Follow-up|5|||
144390429|NCT02068768|520639098|FG000|Overall Study|Early Termination by Sponsor|2|||
144390430|NCT01423604|520639102|FG000|Safety Run-In|Adverse Event|3|||
144390431|NCT01423604|520639103|FG001|Safety Run-In|Adverse Event|0|||
144390432|NCT01423604|520639102|FG000|Safety Run-In|Death|1|||
144390433|NCT01423604|520639103|FG001|Safety Run-In|Death|0|||
144390434|NCT01423604|520639102|FG000|Safety Run-In|Physician Decision|1|||
144390435|NCT01423604|520639103|FG001|Safety Run-In|Physician Decision|0|||
144390436|NCT01423604|520639102|FG000|Safety Run-In|Disease progression|3|||
144390437|NCT01423604|520639103|FG001|Safety Run-In|Disease progression|0|||
144390438|NCT01423604|520639102|FG000|Safety Run-In|Patient decision|1|||
144390439|NCT01423604|520639103|FG001|Safety Run-In|Patient decision|0|||
144390440|NCT01423604|520639102|FG000|Randomized|Adverse Event|4|||
144390441|NCT01423604|520639103|FG001|Randomized|Adverse Event|10|||
144390442|NCT01423604|520639102|FG000|Randomized|Death|1|||
144390443|NCT01423604|520639103|FG001|Randomized|Death|0|||
144390444|NCT01423604|520639102|FG000|Randomized|Physician Decision|16|||
144390445|NCT01423604|520639103|FG001|Randomized|Physician Decision|13|||
144390446|NCT01423604|520639102|FG000|Randomized|Other - unspecified|37|||
144390447|NCT01423604|520639103|FG001|Randomized|Other - unspecified|31|||
144390448|NCT01423604|520639102|FG000|Randomized|Patient decision|5|||
144390449|NCT01423604|520639103|FG001|Randomized|Patient decision|9|||
144390450|NCT03324581|520639105|FG000|Overall Study|Adverse Event|18|||
144390451|NCT03324581|520639106|FG001|Overall Study|Adverse Event|11|||
144390452|NCT03324581|520639107|FG002|Overall Study|Adverse Event|7|||
144390453|NCT03324581|520639105|FG000|Overall Study|Lack of Efficacy|0|||
144390454|NCT03324581|520639106|FG001|Overall Study|Lack of Efficacy|1|||
144390455|NCT03324581|520639107|FG002|Overall Study|Lack of Efficacy|0|||
144390456|NCT03324581|520639105|FG000|Overall Study|Lost to Follow-up|5|||
144390457|NCT03324581|520639106|FG001|Overall Study|Lost to Follow-up|3|||
144390458|NCT03324581|520639107|FG002|Overall Study|Lost to Follow-up|6|||
144390459|NCT03324581|520639105|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
144390460|NCT03324581|520639106|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
144390461|NCT03324581|520639107|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
144593908|NCT00345293|521374049|FG001|Overall Study|Withdrawal by Subject|0|||
144593909|NCT03319849|521374050|FG000|Overall Study|Adverse Event|1|||
144593910|NCT03319849|521374051|FG001|Overall Study|Adverse Event|0|||
144593911|NCT03319849|521374050|FG000|Overall Study|Physician Decision|0|||
144390462|NCT03324581|520639105|FG000|Overall Study|Physician Decision|0|||
144593912|NCT03319849|521374051|FG001|Overall Study|Physician Decision|1|||
144390463|NCT03324581|520639106|FG001|Overall Study|Physician Decision|1|||
144390464|NCT03324581|520639107|FG002|Overall Study|Physician Decision|2|||
144390465|NCT03324581|520639105|FG000|Overall Study|Protocol Deviation|8|||
144390466|NCT03324581|520639106|FG001|Overall Study|Protocol Deviation|9|||
144390467|NCT03324581|520639107|FG002|Overall Study|Protocol Deviation|4|||
144390468|NCT03324581|520639105|FG000|Overall Study|Withdrawal by Subject|6|||
144390469|NCT03324581|520639106|FG001|Overall Study|Withdrawal by Subject|8|||
144390470|NCT03324581|520639107|FG002|Overall Study|Withdrawal by Subject|6|||
144390471|NCT03324581|520639105|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
144390472|NCT03324581|520639106|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
144593913|NCT03319849|521374050|FG000|Overall Study|Withdrawal by Subject|0|||
144593914|NCT03319849|521374051|FG001|Overall Study|Withdrawal by Subject|1|||
144593915|NCT03319849|521374050|FG000|Overall Study|COVID-19|0|||
144390473|NCT03324581|520639107|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
144390474|NCT00321893|520639109|FG000|Overall Study|Non-Compliance/Refusal|16|||
144390475|NCT00321893|520639110|FG001|Overall Study|Non-Compliance/Refusal|10|||
144390476|NCT00321893|520639109|FG000|Overall Study|Lost to Follow-up|2|||
144390477|NCT00321893|520639110|FG001|Overall Study|Lost to Follow-up|1|||
144390478|NCT00321893|520639109|FG000|Overall Study|Adverse Event|6|||
144390479|NCT00321893|520639110|FG001|Overall Study|Adverse Event|3|||
144390480|NCT03455764|520639111|FG000|Overall Study|Adverse Event|1|||
144390481|NCT03455764|520639112|FG001|Overall Study|Adverse Event|0|||
144390482|NCT03455764|520639113|FG002|Overall Study|Adverse Event|0|||
144390483|NCT03455764|520639114|FG003|Overall Study|Adverse Event|0|||
144390484|NCT03455764|520639115|FG004|Overall Study|Adverse Event|0|||
144390485|NCT03455764|520639111|FG000|Overall Study|Disease Progression|4|||
144390486|NCT03455764|520639112|FG001|Overall Study|Disease Progression|0|||
144390487|NCT03455764|520639113|FG002|Overall Study|Disease Progression|0|||
144390488|NCT03455764|520639114|FG003|Overall Study|Disease Progression|0|||
144390489|NCT03455764|520639115|FG004|Overall Study|Disease Progression|0|||
144390490|NCT03455764|520639111|FG000|Overall Study|On Treatment|1|||
144390491|NCT03455764|520639112|FG001|Overall Study|On Treatment|0|||
144390492|NCT03455764|520639113|FG002|Overall Study|On Treatment|0|||
144199334|NCT03107026|519928870|FG000|Overall Study|Withdrawal by Subject|13|||
144390493|NCT03455764|520639114|FG003|Overall Study|On Treatment|0|||
144390494|NCT03455764|520639115|FG004|Overall Study|On Treatment|0|||
144390495|NCT00523367|520639116|FG000|Overall Study|19 screen failures|19|||
144390496|NCT00523367|520639116|FG000|Overall Study|4 Withdrawn by PI|4|||
144390497|NCT04050371|520640614|FG000|Overall Study|Withdrawal by Subject|1|||
144390498|NCT04050371|520640615|FG001|Overall Study|Withdrawal by Subject|0|||
144390499|NCT01394718|520640620|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
144390500|NCT01394718|520640621|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
144390501|NCT01547780|520640622|FG000|Baseline PET Scan|Physician Decision|1|||
144390502|NCT01547780|520640623|FG001|Baseline PET Scan|Physician Decision|0|||
144390503|NCT01547780|520640624|FG002|Baseline PET Scan|Physician Decision|1|||
144390504|NCT01547780|520640625|FG003|Baseline PET Scan|Physician Decision|0|||
144390505|NCT01547780|520640622|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
144390506|NCT01547780|520640623|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
144390507|NCT01547780|520640624|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
144390508|NCT01547780|520640625|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
144390509|NCT01362595|520640629|FG000|Overall Study|Screen failure|10|||
144390510|NCT01362595|520640629|FG000|Overall Study|Withdrawal by Subject|2|||
144390511|NCT00959374|520640630|FG000|Overall Study|Withdrawal by Subject|2|||
144390512|NCT00959374|520640630|FG000|Overall Study|Lost to Follow-up|14|||
144390513|NCT00959374|520640630|FG000|Overall Study|Death|1|||
144390514|NCT00959374|520640630|FG000|Overall Study|Protocol Violation|1|||
144390515|NCT00959374|520640630|FG000|Overall Study|Implant Removed/Not Replaced|4|||
144390516|NCT00959374|520640630|FG000|Overall Study|Physician Decision|1|||
144390517|NCT02448680|520640631|FG000|Overall Study|Physician Decision|1|||
144390518|NCT02448680|520640632|FG001|Overall Study|Physician Decision|1|||
144390519|NCT02448680|520640631|FG000|Overall Study|Withdrawal by Subject|0|||
144390520|NCT02448680|520640632|FG001|Overall Study|Withdrawal by Subject|2|||
144390521|NCT01736657|520640633|FG000|Overall Study|insufficient vascular access|1|||
144390522|NCT00749580|520640642|FG000|Overall Study|Lost to Follow-up|4|||
144390523|NCT00749580|520640643|FG001|Overall Study|Lost to Follow-up|8|||
144390524|NCT00749580|520640642|FG000|Overall Study|Adverse Event|0|||
144390525|NCT00749580|520640643|FG001|Overall Study|Adverse Event|1|||
144390526|NCT03707184|520640646|FG000|Overall Study|Withdrawal by Subject|2|||
144390527|NCT04704154|520640647|FG000|Overall Study|Adverse Event|3|||
144390528|NCT04704154|520640648|FG001|Overall Study|Adverse Event|2|||
144390529|NCT04704154|520640649|FG002|Overall Study|Adverse Event|4|||
144390530|NCT04704154|520640650|FG003|Overall Study|Adverse Event|2|||
144390531|NCT04704154|520640651|FG004|Overall Study|Adverse Event|3|||
144390532|NCT04704154|520640652|FG005|Overall Study|Adverse Event|0|||
144390533|NCT04704154|520640647|FG000|Overall Study|Death|3|||
144390534|NCT04704154|520640648|FG001|Overall Study|Death|0|||
144390535|NCT04704154|520640649|FG002|Overall Study|Death|0|||
144390536|NCT04704154|520640650|FG003|Overall Study|Death|0|||
144390537|NCT04704154|520640651|FG004|Overall Study|Death|3|||
144390538|NCT04704154|520640652|FG005|Overall Study|Death|0|||
144390539|NCT04704154|520640647|FG000|Overall Study|Physician Decision|1|||
144390540|NCT04704154|520640648|FG001|Overall Study|Physician Decision|0|||
144390541|NCT04704154|520640649|FG002|Overall Study|Physician Decision|1|||
144390542|NCT04704154|520640650|FG003|Overall Study|Physician Decision|0|||
144390543|NCT04704154|520640651|FG004|Overall Study|Physician Decision|2|||
144390544|NCT04704154|520640652|FG005|Overall Study|Physician Decision|0|||
144390545|NCT04704154|520640647|FG000|Overall Study|Participant Decision|1|||
144390546|NCT04704154|520640648|FG001|Overall Study|Participant Decision|1|||
144390547|NCT04704154|520640649|FG002|Overall Study|Participant Decision|0|||
144390548|NCT04704154|520640650|FG003|Overall Study|Participant Decision|0|||
144390549|NCT04704154|520640651|FG004|Overall Study|Participant Decision|0|||
144390550|NCT04704154|520640652|FG005|Overall Study|Participant Decision|0|||
144390551|NCT04704154|520640647|FG000|Overall Study|Progressive Disease|19|||
144390552|NCT04704154|520640648|FG001|Overall Study|Progressive Disease|17|||
144390553|NCT04704154|520640649|FG002|Overall Study|Progressive Disease|20|||
144390554|NCT04704154|520640650|FG003|Overall Study|Progressive Disease|18|||
144390555|NCT04704154|520640651|FG004|Overall Study|Progressive Disease|36|||
144390556|NCT04704154|520640652|FG005|Overall Study|Progressive Disease|30|||
144390557|NCT04704154|520640647|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
144390558|NCT04704154|520640648|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
144390559|NCT04704154|520640649|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
144390560|NCT04704154|520640650|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
144390561|NCT04704154|520640651|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
144390562|NCT04704154|520640652|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
144390563|NCT04704154|520640647|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
144390564|NCT04704154|520640648|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
144390565|NCT04704154|520640649|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
144390566|NCT04704154|520640650|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
144390567|NCT04704154|520640651|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
144390568|NCT04704154|520640652|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
144390569|NCT04950608|520640653|FG000|Overall Study|Withdrawal by Subject|2|||
144390570|NCT04950608|520640653|FG000|Overall Study|Physician Decision|3|||
144390571|NCT03220438|520640654|FG000|Overall Study|Lost to Follow-up|0|||
144390572|NCT03220438|520640655|FG001|Overall Study|Lost to Follow-up|0|||
144390573|NCT03220438|520640656|FG002|Overall Study|Lost to Follow-up|1|||
144390574|NCT03220438|520640657|FG003|Overall Study|Lost to Follow-up|0|||
144390575|NCT04565236|520640658|FG000|Overall Study|Patient/Guardian Decision|0|||
144390576|NCT04565236|520640659|FG001|Overall Study|Patient/Guardian Decision|0|||
144390577|NCT04565236|520640660|FG002|Overall Study|Patient/Guardian Decision|1|||
144390578|NCT04565236|520640661|FG003|Overall Study|Patient/Guardian Decision|0|||
144390579|NCT00740246|520640665|FG000|Overall Study|Received Blood Transfusion|0|||
144390580|NCT00740246|520640666|FG001|Overall Study|Received Blood Transfusion|1|||
144390581|NCT00740246|520640665|FG000|Overall Study|Adverse Event|1|||
144390582|NCT00740246|520640666|FG001|Overall Study|Adverse Event|2|||
144390583|NCT00740246|520640665|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
144390584|NCT00740246|520640666|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
144390585|NCT00740246|520640665|FG000|Overall Study|Lost to Follow-up|2|||
144390586|NCT00740246|520640666|FG001|Overall Study|Lost to Follow-up|2|||
144390587|NCT00740246|520640665|FG000|Overall Study|Withdrawal by Subject|4|||
144390588|NCT00740246|520640666|FG001|Overall Study|Withdrawal by Subject|3|||
144390589|NCT00740246|520640665|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
144390590|NCT00740246|520640666|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
144390591|NCT00740246|520640665|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
144390592|NCT00740246|520640666|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
144390593|NCT00740246|520640665|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
144390594|NCT00740246|520640666|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
144390595|NCT00740246|520640665|FG000|Overall Study|Unable To Comply With Study Visits|2|||
144390596|NCT00740246|520640666|FG001|Overall Study|Unable To Comply With Study Visits|0|||
144390597|NCT00740246|520640665|FG000|Overall Study|Unable to Access Vein|0|||
144390598|NCT00740246|520640666|FG001|Overall Study|Unable to Access Vein|2|||
144390599|NCT00740246|520640665|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
144390600|NCT00740246|520640666|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
144517807|NCT03526861|521096223|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144390601|NCT03584373|520640669|FG000|Overall Study|Lost to Follow-up|7|||
144390602|NCT03584373|520640670|FG001|Overall Study|Lost to Follow-up|8|||
144390603|NCT01487577|520640671|FG000|Overall Study|Became ineligible after signing consent|1|||
144390604|NCT00662532|520640672|FG000|Overall Study|Adverse Event|0|||
144390605|NCT00662532|520640673|FG001|Overall Study|Adverse Event|1|||
144390606|NCT00662532|520640672|FG000|Overall Study|Lost to Follow-up|0|||
144390607|NCT00662532|520640673|FG001|Overall Study|Lost to Follow-up|1|||
144390608|NCT01315236|520640674|FG000|Double-blind Phase|Death|1|||
144390609|NCT01315236|520640675|FG001|Double-blind Phase|Death|0|||
144390610|NCT01315236|520640674|FG000|Double-blind Phase|Adverse Event|1|||
144390611|NCT01315236|520640675|FG001|Double-blind Phase|Adverse Event|0|||
144390612|NCT01315236|520640674|FG000|Double-blind Phase|Withdrawal of Consent|1|||
144517808|NCT03526861|521096224|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144390613|NCT01315236|520640675|FG001|Double-blind Phase|Withdrawal of Consent|0|||
144390614|NCT01315236|520640674|FG000|Double-blind Phase|Lost to Follow-up|1|||
144390615|NCT01315236|520640675|FG001|Double-blind Phase|Lost to Follow-up|0|||
144390616|NCT01315236|520640674|FG000|Open-label Phase|Death|1|||
144390617|NCT01315236|520640675|FG001|Open-label Phase|Death|0|||
144390618|NCT01315236|520640674|FG000|Open-label Phase|Adverse Event|0|||
144390619|NCT01315236|520640675|FG001|Open-label Phase|Adverse Event|1|||
144390620|NCT01315236|520640674|FG000|Open-label Phase|Other|0|||
144390621|NCT01315236|520640675|FG001|Open-label Phase|Other|1|||
144390622|NCT01315236|520640674|FG000|12-Month Follow-up Period|Death|0|||
144390623|NCT01315236|520640675|FG001|12-Month Follow-up Period|Death|1|||
144390624|NCT01315236|520640674|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
144390625|NCT01315236|520640675|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
144390626|NCT03823378|520640679|FG000|Overall Study|Adverse Event|2|||
144390627|NCT03823378|520640680|FG001|Overall Study|Adverse Event|2|||
144390628|NCT03823378|520640681|FG002|Overall Study|Adverse Event|0|||
144390629|NCT03823378|520640682|FG003|Overall Study|Adverse Event|0|||
144390630|NCT03823378|520640683|FG004|Overall Study|Adverse Event|0|||
144390631|NCT03823378|520640684|FG005|Overall Study|Adverse Event|0|||
144390632|NCT03823378|520640679|FG000|Overall Study|Lost to Follow-up|0|||
144390633|NCT03823378|520640680|FG001|Overall Study|Lost to Follow-up|1|||
144390634|NCT03823378|520640681|FG002|Overall Study|Lost to Follow-up|0|||
144390635|NCT03823378|520640682|FG003|Overall Study|Lost to Follow-up|0|||
144390636|NCT03823378|520640683|FG004|Overall Study|Lost to Follow-up|1|||
144390637|NCT03823378|520640684|FG005|Overall Study|Lost to Follow-up|0|||
144390638|NCT03823378|520640679|FG000|Overall Study|Withdrawal by Subject|0|||
144390639|NCT03823378|520640680|FG001|Overall Study|Withdrawal by Subject|1|||
144390640|NCT03823378|520640681|FG002|Overall Study|Withdrawal by Subject|4|||
144390641|NCT03823378|520640682|FG003|Overall Study|Withdrawal by Subject|2|||
144390642|NCT03823378|520640683|FG004|Overall Study|Withdrawal by Subject|0|||
144390643|NCT03823378|520640684|FG005|Overall Study|Withdrawal by Subject|1|||
144390644|NCT03823378|520640679|FG000|Overall Study|Other, not specified|19|||
144390645|NCT03823378|520640680|FG001|Overall Study|Other, not specified|12|||
144390646|NCT03823378|520640681|FG002|Overall Study|Other, not specified|6|||
144390647|NCT03823378|520640682|FG003|Overall Study|Other, not specified|8|||
144390648|NCT03823378|520640683|FG004|Overall Study|Other, not specified|17|||
144390649|NCT03823378|520640684|FG005|Overall Study|Other, not specified|7|||
144390650|NCT03190369|520640685|FG000|Overall Study|Poor compliance to protocol|0|||
144390651|NCT03190369|520640686|FG001|Overall Study|Poor compliance to protocol|1|||
144390652|NCT03190369|520640685|FG000|Overall Study|Withdraw before treatment|1|||
144390653|NCT03190369|520640686|FG001|Overall Study|Withdraw before treatment|5|||
144390654|NCT03190369|520640685|FG000|Overall Study|Randomized but not treated|0|||
144390655|NCT03190369|520640686|FG001|Overall Study|Randomized but not treated|2|||
144390656|NCT01606254|520640687|FG000|Overall Study|Withdrawal by Subject|1|||
144390657|NCT01606254|520640688|FG001|Overall Study|Withdrawal by Subject|3|||
144390658|NCT01606254|520640689|FG002|Overall Study|Withdrawal by Subject|0|||
144390659|NCT01606254|520640690|FG003|Overall Study|Withdrawal by Subject|2|||
144390660|NCT01606254|520640687|FG000|Overall Study|Adverse Event|1|||
144390661|NCT01606254|520640688|FG001|Overall Study|Adverse Event|1|||
144390662|NCT01606254|520640689|FG002|Overall Study|Adverse Event|0|||
144390663|NCT01606254|520640690|FG003|Overall Study|Adverse Event|1|||
144390664|NCT02011893|520640691|FG000|Enrollment to Randomization|Adverse Event|2|||
144390665|NCT02011893|520640692|FG001|Enrollment to Randomization|Adverse Event|0|||
144390666|NCT02011893|520640693|FG002|Enrollment to Randomization|Adverse Event|0|||
144390667|NCT02011893|520640691|FG000|Enrollment to Randomization|Physician Decision|10|||
144390668|NCT02011893|520640692|FG001|Enrollment to Randomization|Physician Decision|0|||
144390669|NCT02011893|520640693|FG002|Enrollment to Randomization|Physician Decision|0|||
144390670|NCT02011893|520640691|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
144390671|NCT02011893|520640692|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
144390672|NCT02011893|520640693|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
144390673|NCT02011893|520640691|FG000|Enrollment to Randomization|Screening Failure|29|||
144390674|NCT02011893|520640692|FG001|Enrollment to Randomization|Screening Failure|0|||
144390675|NCT02011893|520640693|FG002|Enrollment to Randomization|Screening Failure|0|||
144390676|NCT02011893|520640691|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
144390677|NCT02011893|520640692|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
144390678|NCT02011893|520640693|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
144390679|NCT02011893|520640691|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
144390680|NCT02011893|520640692|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
144390681|NCT02011893|520640693|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
144390682|NCT02011893|520640691|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
144390683|NCT02011893|520640692|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
144390684|NCT02011893|520640693|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
144390685|NCT02011893|520640691|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
144390686|NCT02011893|520640692|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
144390687|NCT02011893|520640693|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
144390688|NCT02011893|520640691|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
144390689|NCT02011893|520640692|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
144390690|NCT02011893|520640693|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
144390691|NCT01582854|520640702|FG000|Overall Study|Death|8|||
144390692|NCT01582854|520640703|FG001|Overall Study|Death|5|||
144390693|NCT01582854|520640702|FG000|Overall Study|Adverse Event|2|||
144390694|NCT01582854|520640703|FG001|Overall Study|Adverse Event|3|||
144390695|NCT01582854|520640702|FG000|Overall Study|Withdrawal by Participant|8|||
144390696|NCT01582854|520640703|FG001|Overall Study|Withdrawal by Participant|11|||
144390697|NCT01582854|520640702|FG000|Overall Study|Lost to Follow-up|1|||
144390698|NCT01582854|520640703|FG001|Overall Study|Lost to Follow-up|2|||
144390699|NCT01582854|520640702|FG000|Overall Study|Physician Decision|0|||
144390700|NCT01582854|520640703|FG001|Overall Study|Physician Decision|1|||
144390701|NCT01582854|520640702|FG000|Overall Study|Recurrent Stroke|13|||
144390702|NCT01582854|520640703|FG001|Overall Study|Recurrent Stroke|8|||
144390703|NCT01582854|520640702|FG000|Overall Study|Disallowed Concomitant Medication|3|||
144390704|NCT01582854|520640703|FG001|Overall Study|Disallowed Concomitant Medication|2|||
144390705|NCT01582854|520640702|FG000|Overall Study|Carotid or Neurosurgery|0|||
144390706|NCT01582854|520640703|FG001|Overall Study|Carotid or Neurosurgery|1|||
144390707|NCT01582854|520640702|FG000|Overall Study|General Anaesthesia|0|||
144390708|NCT01582854|520640703|FG001|Overall Study|General Anaesthesia|1|||
144390709|NCT01582854|520640702|FG000|Overall Study|Other Miscellaneous Reason|1|||
144390710|NCT01582854|520640703|FG001|Overall Study|Other Miscellaneous Reason|0|||
144390711|NCT04068896|520640704|FG000|Overall Study|Adverse Event|2|||
144390712|NCT04068896|520640705|FG001|Overall Study|Adverse Event|0|||
144390713|NCT04068896|520640706|FG002|Overall Study|Adverse Event|1|||
144390714|NCT04068896|520640707|FG003|Overall Study|Adverse Event|0|||
144517809|NCT03526861|521096225|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517810|NCT03526861|521096226|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517811|NCT03526861|521096227|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517812|NCT03526861|521096228|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517813|NCT03526861|521096229|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517814|NCT03526861|521096230|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
144517815|NCT03526861|521096231|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
144517816|NCT04089371|521096233|FG000|Overall Study|Withdrawal by Subject|0|||
144517817|NCT04089371|521096234|FG001|Overall Study|Withdrawal by Subject|1|||
144517818|NCT04089371|521096233|FG000|Overall Study|Study terminated early|0|||
144517819|NCT04089371|521096234|FG001|Overall Study|Study terminated early|9|||
144517820|NCT04382898|521096235|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
144517821|NCT04382898|521096236|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
144517822|NCT04382898|521096237|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
144517823|NCT04382898|521096238|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
144517824|NCT04382898|521096239|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
144517825|NCT04382898|521096235|FG000|Part 1: Dose Titration|Death|6|||
144517826|NCT04382898|521096236|FG001|Part 1: Dose Titration|Death|0|||
144517827|NCT04382898|521096237|FG002|Part 1: Dose Titration|Death|0|||
144517828|NCT04382898|521096238|FG003|Part 1: Dose Titration|Death|0|||
144517829|NCT04382898|521096239|FG004|Part 1: Dose Titration|Death|0|||
144517830|NCT04382898|521096235|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144517831|NCT04382898|521096236|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144517832|NCT04382898|521096237|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
144517833|NCT04382898|521096238|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144517834|NCT04382898|521096239|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144517835|NCT04382898|521096235|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
144517836|NCT04382898|521096236|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
144517837|NCT04382898|521096237|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
144517838|NCT04382898|521096238|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
144517839|NCT04382898|521096239|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
144517840|NCT04382898|521096235|FG000|Part 2: Dose Expansion|Death|0|||
144517841|NCT04382898|521096236|FG001|Part 2: Dose Expansion|Death|17|||
144517842|NCT04382898|521096237|FG002|Part 2: Dose Expansion|Death|13|||
144390715|NCT04068896|520640708|FG004|Overall Study|Adverse Event|0|||
144390716|NCT04068896|520640709|FG005|Overall Study|Adverse Event|0|||
144390717|NCT04068896|520640704|FG000|Overall Study|Death|3|||
144390718|NCT04068896|520640705|FG001|Overall Study|Death|1|||
144390719|NCT04068896|520640706|FG002|Overall Study|Death|3|||
144517843|NCT04382898|521096238|FG003|Part 2: Dose Expansion|Death|1|||
144390720|NCT04068896|520640707|FG003|Overall Study|Death|19|||
144390721|NCT04068896|520640708|FG004|Overall Study|Death|17|||
144390722|NCT04068896|520640709|FG005|Overall Study|Death|0|||
144390723|NCT04068896|520640704|FG000|Overall Study|Physician Decision|0|||
144390724|NCT04068896|520640705|FG001|Overall Study|Physician Decision|0|||
144390725|NCT04068896|520640706|FG002|Overall Study|Physician Decision|0|||
144390726|NCT04068896|520640707|FG003|Overall Study|Physician Decision|1|||
144390727|NCT04068896|520640708|FG004|Overall Study|Physician Decision|0|||
144390728|NCT04068896|520640709|FG005|Overall Study|Physician Decision|0|||
144390729|NCT04068896|520640704|FG000|Overall Study|progressive disease|3|||
144390730|NCT04068896|520640705|FG001|Overall Study|progressive disease|5|||
144390731|NCT04068896|520640706|FG002|Overall Study|progressive disease|3|||
144390732|NCT04068896|520640707|FG003|Overall Study|progressive disease|2|||
144390733|NCT04068896|520640708|FG004|Overall Study|progressive disease|1|||
144390734|NCT04068896|520640709|FG005|Overall Study|progressive disease|2|||
144390735|NCT04068896|520640704|FG000|Overall Study|Study terminated by sponsor|0|||
144390736|NCT04068896|520640705|FG001|Overall Study|Study terminated by sponsor|0|||
144390737|NCT04068896|520640706|FG002|Overall Study|Study terminated by sponsor|1|||
144390738|NCT04068896|520640707|FG003|Overall Study|Study terminated by sponsor|2|||
144390739|NCT04068896|520640708|FG004|Overall Study|Study terminated by sponsor|1|||
144390740|NCT04068896|520640709|FG005|Overall Study|Study terminated by sponsor|4|||
144390741|NCT04068896|520640704|FG000|Overall Study|Protocol Violation|0|||
144390742|NCT04068896|520640705|FG001|Overall Study|Protocol Violation|0|||
144390743|NCT04068896|520640706|FG002|Overall Study|Protocol Violation|0|||
144390744|NCT04068896|520640707|FG003|Overall Study|Protocol Violation|1|||
144390745|NCT04068896|520640708|FG004|Overall Study|Protocol Violation|0|||
144390746|NCT04068896|520640709|FG005|Overall Study|Protocol Violation|0|||
144390747|NCT04068896|520640704|FG000|Overall Study|Withdrawal by Subject|0|||
144390748|NCT04068896|520640705|FG001|Overall Study|Withdrawal by Subject|3|||
144390749|NCT04068896|520640706|FG002|Overall Study|Withdrawal by Subject|0|||
144390750|NCT04068896|520640707|FG003|Overall Study|Withdrawal by Subject|2|||
144390751|NCT04068896|520640708|FG004|Overall Study|Withdrawal by Subject|1|||
144390752|NCT04068896|520640709|FG005|Overall Study|Withdrawal by Subject|0|||
144390753|NCT04068896|520640704|FG000|Overall Study|Symptomatic deterioration|2|||
144390754|NCT04068896|520640705|FG001|Overall Study|Symptomatic deterioration|0|||
144390755|NCT04068896|520640706|FG002|Overall Study|Symptomatic deterioration|0|||
144390756|NCT04068896|520640707|FG003|Overall Study|Symptomatic deterioration|0|||
144390757|NCT04068896|520640708|FG004|Overall Study|Symptomatic deterioration|0|||
144390758|NCT04068896|520640709|FG005|Overall Study|Symptomatic deterioration|0|||
144390759|NCT00459056|520640710|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
144390760|NCT00459056|520640711|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
144390761|NCT02522871|520640712|FG000|Overall Study|Protocol Violation|1|||
144390762|NCT02522871|520640713|FG001|Overall Study|Protocol Violation|4|||
144390763|NCT02522871|520640712|FG000|Overall Study|Treated without randomization|1|||
144390764|NCT02522871|520640713|FG001|Overall Study|Treated without randomization|0|||
144390765|NCT02522871|520640712|FG000|Overall Study|Death|9|||
144390766|NCT02522871|520640713|FG001|Overall Study|Death|9|||
144390767|NCT02522871|520640712|FG000|Overall Study|Died in operating room prior to transplant|0|||
144390768|NCT02522871|520640713|FG001|Overall Study|Died in operating room prior to transplant|1|||
144390769|NCT01222403|520640714|FG000|Overall Study|Inappropriate enrollment|0|||
144390770|NCT01222403|520640715|FG001|Overall Study|Inappropriate enrollment|2|||
144390771|NCT01262352|520640716|FG000|Period 1|Illness after randomization|1|||
144390772|NCT01262352|520640717|FG001|Period 1|Illness after randomization|0|||
144390773|NCT01262352|520640716|FG000|Washout|Adverse Event|1|||
144390774|NCT01262352|520640717|FG001|Washout|Adverse Event|1|||
144390775|NCT01262352|520640716|FG000|Washout|Extended Washout|0|||
144390776|NCT01262352|520640717|FG001|Washout|Extended Washout|1|||
144390777|NCT01185834|520640718|FG000|Overall Study|Lost to Follow-up|2|||
144390778|NCT01185834|520640718|FG000|Overall Study|Discomfort|4|||
144390779|NCT01185834|520640718|FG000|Overall Study|Biomicroscopy|4|||
144390780|NCT01185834|520640718|FG000|Overall Study|Time/Job Conflict|2|||
144390781|NCT01185834|520640718|FG000|Overall Study|Early exit - Site error|2|||
144390782|NCT03189381|520640719|FG000|Overall Study|Death|1|||
144390783|NCT03189381|520640720|FG001|Overall Study|Death|0|||
144390784|NCT01975831|520640721|FG000|Overall Study|Adverse Event|1|||
144390785|NCT01975831|520640722|FG001|Overall Study|Adverse Event|2|||
144390786|NCT01975831|520640723|FG002|Overall Study|Adverse Event|2|||
144390787|NCT01975831|520640724|FG003|Overall Study|Adverse Event|0|||
144390788|NCT01975831|520640725|FG004|Overall Study|Adverse Event|1|||
144390789|NCT01975831|520640726|FG005|Overall Study|Adverse Event|1|||
144390790|NCT01975831|520640727|FG006|Overall Study|Adverse Event|3|||
144390791|NCT01975831|520640728|FG007|Overall Study|Adverse Event|4|||
144390792|NCT01975831|520640729|FG008|Overall Study|Adverse Event|1|||
144390793|NCT01975831|520640721|FG000|Overall Study|Death|1|||
144390794|NCT01975831|520640722|FG001|Overall Study|Death|1|||
144390795|NCT01975831|520640723|FG002|Overall Study|Death|0|||
144390796|NCT01975831|520640724|FG003|Overall Study|Death|0|||
144390797|NCT01975831|520640725|FG004|Overall Study|Death|1|||
144390798|NCT01975831|520640726|FG005|Overall Study|Death|0|||
144390799|NCT01975831|520640727|FG006|Overall Study|Death|1|||
144390800|NCT01975831|520640728|FG007|Overall Study|Death|0|||
144390801|NCT01975831|520640729|FG008|Overall Study|Death|0|||
144517844|NCT04382898|521096239|FG004|Part 2: Dose Expansion|Death|0|||
144517845|NCT04382898|521096235|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
144517846|NCT04382898|521096236|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
144517847|NCT04382898|521096237|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
144517848|NCT04382898|521096238|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
144517849|NCT04382898|521096239|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
144517850|NCT04382898|521096235|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
144390802|NCT01975831|520640721|FG000|Overall Study|Progressive Disease|1|||
144390803|NCT01975831|520640722|FG001|Overall Study|Progressive Disease|3|||
144390804|NCT01975831|520640723|FG002|Overall Study|Progressive Disease|2|||
144390805|NCT01975831|520640724|FG003|Overall Study|Progressive Disease|4|||
144517851|NCT04382898|521096236|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
144517852|NCT04382898|521096237|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
144517853|NCT04382898|521096238|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
144517854|NCT04382898|521096239|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
144517855|NCT04382898|521096235|FG000|Part 2: Dose Expansion|Other|0|||
144517856|NCT04382898|521096236|FG001|Part 2: Dose Expansion|Other|0|||
144517857|NCT04382898|521096237|FG002|Part 2: Dose Expansion|Other|1|||
144517858|NCT04382898|521096238|FG003|Part 2: Dose Expansion|Other|0|||
144517859|NCT04382898|521096239|FG004|Part 2: Dose Expansion|Other|0|||
144390806|NCT01975831|520640725|FG004|Overall Study|Progressive Disease|13|||
144390807|NCT01975831|520640726|FG005|Overall Study|Progressive Disease|9|||
144390808|NCT01975831|520640727|FG006|Overall Study|Progressive Disease|10|||
144390809|NCT01975831|520640728|FG007|Overall Study|Progressive Disease|8|||
144390810|NCT01975831|520640729|FG008|Overall Study|Progressive Disease|10|||
144390811|NCT01975831|520640721|FG000|Overall Study|Withdrawal by Subject|0|||
144390812|NCT01975831|520640722|FG001|Overall Study|Withdrawal by Subject|3|||
144390813|NCT01975831|520640723|FG002|Overall Study|Withdrawal by Subject|0|||
144390814|NCT01975831|520640724|FG003|Overall Study|Withdrawal by Subject|0|||
144390815|NCT01975831|520640725|FG004|Overall Study|Withdrawal by Subject|3|||
144390816|NCT01975831|520640726|FG005|Overall Study|Withdrawal by Subject|1|||
144390817|NCT01975831|520640727|FG006|Overall Study|Withdrawal by Subject|1|||
144390818|NCT01975831|520640728|FG007|Overall Study|Withdrawal by Subject|0|||
144390819|NCT01975831|520640729|FG008|Overall Study|Withdrawal by Subject|0|||
144390820|NCT01975831|520640721|FG000|Overall Study|Physician Decision|0|||
144390821|NCT01975831|520640722|FG001|Overall Study|Physician Decision|0|||
144390822|NCT01975831|520640723|FG002|Overall Study|Physician Decision|0|||
144390823|NCT01975831|520640724|FG003|Overall Study|Physician Decision|0|||
144390824|NCT01975831|520640725|FG004|Overall Study|Physician Decision|0|||
144390825|NCT01975831|520640726|FG005|Overall Study|Physician Decision|1|||
144390826|NCT01975831|520640727|FG006|Overall Study|Physician Decision|0|||
144390827|NCT01975831|520640728|FG007|Overall Study|Physician Decision|1|||
144390828|NCT01975831|520640729|FG008|Overall Study|Physician Decision|0|||
144390829|NCT01975831|520640721|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
144390830|NCT01975831|520640722|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
144390831|NCT01975831|520640723|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
144390832|NCT01975831|520640724|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
144390833|NCT01975831|520640725|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
144390834|NCT01975831|520640726|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
144390835|NCT01975831|520640727|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
144390836|NCT01975831|520640728|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
144390837|NCT01975831|520640729|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
144390838|NCT01975831|520640721|FG000|Overall Study|Entered Hospice|0|||
144390839|NCT01975831|520640722|FG001|Overall Study|Entered Hospice|0|||
144390840|NCT01975831|520640723|FG002|Overall Study|Entered Hospice|0|||
144390841|NCT01975831|520640724|FG003|Overall Study|Entered Hospice|0|||
144517860|NCT03932682|521096242|FG000|Overall Study|Death|1|||
144517861|NCT03932682|521096243|FG001|Overall Study|Death|2|||
144517862|NCT03932682|521096242|FG000|Overall Study|Withdrawal by Subject|37|||
144517863|NCT03932682|521096243|FG001|Overall Study|Withdrawal by Subject|45|||
144390842|NCT01975831|520640725|FG004|Overall Study|Entered Hospice|0|||
144390843|NCT01975831|520640726|FG005|Overall Study|Entered Hospice|1|||
144517864|NCT03932682|521096242|FG000|Overall Study|Lost to Follow-up|19|||
144390844|NCT01975831|520640727|FG006|Overall Study|Entered Hospice|0|||
144390845|NCT01975831|520640728|FG007|Overall Study|Entered Hospice|0|||
144390846|NCT01975831|520640729|FG008|Overall Study|Entered Hospice|0|||
144390847|NCT01975831|520640721|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390848|NCT01975831|520640722|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390849|NCT01975831|520640723|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390850|NCT01975831|520640724|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390851|NCT01975831|520640725|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390852|NCT01975831|520640726|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390853|NCT01975831|520640727|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
144390854|NCT01975831|520640728|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
144390855|NCT01975831|520640729|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
144390856|NCT01401959|520640730|FG000|Enrolled|Withdrawal by Subject|1|||
144390857|NCT01401959|520640731|FG001|Enrolled|Withdrawal by Subject|0|||
144390858|NCT01401959|520640732|FG002|Enrolled|Withdrawal by Subject|0|||
144390859|NCT01401959|520640730|FG000|Treated|Disease Progression|2|||
144390860|NCT01401959|520640731|FG001|Treated|Disease Progression|2|||
144390861|NCT01401959|520640732|FG002|Treated|Disease Progression|1|||
144390862|NCT01401959|520640730|FG000|Treated|Adverse Event|4|||
144390863|NCT01401959|520640731|FG001|Treated|Adverse Event|3|||
144390864|NCT01401959|520640732|FG002|Treated|Adverse Event|2|||
144390865|NCT01401959|520640730|FG000|Treated|Withdrawal by Subject|1|||
144390866|NCT01401959|520640731|FG001|Treated|Withdrawal by Subject|2|||
144390867|NCT01401959|520640732|FG002|Treated|Withdrawal by Subject|2|||
144390868|NCT01401959|520640730|FG000|Treated|Protocol Violation|0|||
144390869|NCT01401959|520640731|FG001|Treated|Protocol Violation|1|||
144390870|NCT01401959|520640732|FG002|Treated|Protocol Violation|0|||
144390871|NCT00251004|520640733|FG000|Overall Study|Withdrawal by Subject|23|||
144390872|NCT00251004|520640734|FG001|Overall Study|Withdrawal by Subject|16|||
144390873|NCT00251004|520640735|FG002|Overall Study|Withdrawal by Subject|14|||
144390874|NCT00251004|520640733|FG000|Overall Study|Death|9|||
144390875|NCT00251004|520640734|FG001|Overall Study|Death|10|||
144390876|NCT00251004|520640735|FG002|Overall Study|Death|8|||
144390877|NCT00251004|520640733|FG000|Overall Study|Lost to Follow-up|1|||
144390878|NCT00251004|520640734|FG001|Overall Study|Lost to Follow-up|2|||
144390879|NCT00251004|520640735|FG002|Overall Study|Lost to Follow-up|1|||
144390880|NCT00251004|520640733|FG000|Overall Study|Graft Loss|12|||
144390881|NCT00251004|520640734|FG001|Overall Study|Graft Loss|13|||
144390882|NCT00251004|520640735|FG002|Overall Study|Graft Loss|8|||
144390883|NCT02694718|520640740|FG000|Overall Study|Death|1|||
144390884|NCT02694718|520640740|FG000|Overall Study|Withdrawal by Subject|1|||
144390885|NCT02925793|520640741|FG000|Overall Study|Adverse Event|3|||
144390886|NCT02925793|520640742|FG001|Overall Study|Adverse Event|3|||
144390887|NCT02925793|520640743|FG002|Overall Study|Adverse Event|6|||
144390888|NCT02925793|520640741|FG000|Overall Study|Withdrawal by Subject|16|||
144390889|NCT02925793|520640742|FG001|Overall Study|Withdrawal by Subject|15|||
144390890|NCT02925793|520640743|FG002|Overall Study|Withdrawal by Subject|13|||
144390891|NCT02925793|520640741|FG000|Overall Study|Investigator Discretion|0|||
144390892|NCT02925793|520640742|FG001|Overall Study|Investigator Discretion|1|||
144390893|NCT02925793|520640743|FG002|Overall Study|Investigator Discretion|1|||
144390894|NCT02925793|520640741|FG000|Overall Study|Lost to Follow-up|2|||
144390895|NCT02925793|520640742|FG001|Overall Study|Lost to Follow-up|3|||
144390896|NCT02925793|520640743|FG002|Overall Study|Lost to Follow-up|1|||
144390897|NCT02925793|520640741|FG000|Overall Study|Lack of Efficacy|2|||
144390898|NCT02925793|520640742|FG001|Overall Study|Lack of Efficacy|6|||
144390899|NCT02925793|520640743|FG002|Overall Study|Lack of Efficacy|4|||
144390900|NCT02925793|520640741|FG000|Overall Study|Other:|2|||
144390901|NCT02925793|520640742|FG001|Overall Study|Other:|1|||
144390902|NCT02925793|520640743|FG002|Overall Study|Other:|3|||
144390903|NCT01244490|520640744|FG000|Overall Study|Lack of Efficacy|14|||
144390904|NCT01244490|520640745|FG001|Overall Study|Lack of Efficacy|5|||
144390905|NCT01244490|520640746|FG002|Overall Study|Lack of Efficacy|5|||
144390906|NCT01244490|520640744|FG000|Overall Study|Withdrawal by Subject|4|||
144390907|NCT01244490|520640745|FG001|Overall Study|Withdrawal by Subject|4|||
144390908|NCT01244490|520640746|FG002|Overall Study|Withdrawal by Subject|9|||
144390909|NCT01244490|520640744|FG000|Overall Study|Adverse Event|1|||
144390910|NCT01244490|520640745|FG001|Overall Study|Adverse Event|9|||
144390911|NCT01244490|520640746|FG002|Overall Study|Adverse Event|5|||
144390912|NCT01244490|520640744|FG000|Overall Study|Lost to Follow-up|0|||
144390913|NCT01244490|520640745|FG001|Overall Study|Lost to Follow-up|6|||
144390914|NCT01244490|520640746|FG002|Overall Study|Lost to Follow-up|3|||
144390915|NCT01244490|520640744|FG000|Overall Study|Other|0|||
144390916|NCT01244490|520640745|FG001|Overall Study|Other|0|||
144390917|NCT01244490|520640746|FG002|Overall Study|Other|1|||
144390918|NCT00393042|520640747|FG000|First Intervention|Withdrawal by Subject|1|||
144390919|NCT00393042|520640748|FG001|First Intervention|Withdrawal by Subject|2|||
144390920|NCT00393042|520640747|FG000|First Intervention|Lost to Follow-up|3|||
144390921|NCT00393042|520640748|FG001|First Intervention|Lost to Follow-up|3|||
144390922|NCT00393042|520640747|FG000|First Intervention|Protocol Violation|1|||
144390923|NCT00393042|520640748|FG001|First Intervention|Protocol Violation|0|||
144593916|NCT03319849|521374051|FG001|Overall Study|COVID-19|1|||
144390924|NCT00393042|520640747|FG000|First Intervention|Adverse Event|0|||
144390925|NCT00393042|520640748|FG001|First Intervention|Adverse Event|1|||
144390926|NCT00393042|520640747|FG000|Second Intervetion|Adverse Event|0|||
144390927|NCT00393042|520640748|FG001|Second Intervetion|Adverse Event|3|||
144390928|NCT00393042|520640747|FG000|Second Intervetion|Withdrawal by Subject|0|||
144390929|NCT00393042|520640748|FG001|Second Intervetion|Withdrawal by Subject|2|||
144390930|NCT00393042|520640747|FG000|Second Intervetion|Lack of Efficacy|1|||
144390931|NCT00393042|520640748|FG001|Second Intervetion|Lack of Efficacy|0|||
144390932|NCT00393042|520640747|FG000|Second Intervetion|Lost to Follow-up|0|||
144390933|NCT00393042|520640748|FG001|Second Intervetion|Lost to Follow-up|2|||
144390934|NCT00393042|520640747|FG000|Second Intervetion|Protocol Violation|1|||
144390935|NCT00393042|520640748|FG001|Second Intervetion|Protocol Violation|1|||
144390936|NCT00727532|520640749|FG000|Overall Study|Adverse Event|1|||
144390937|NCT00727532|520640749|FG000|Overall Study|Withdrawal by Subject|1|||
144390938|NCT00829933|520640750|FG000|Overall Study|Adverse Event|2|||
144390939|NCT00829933|520640751|FG001|Overall Study|Adverse Event|3|||
144390940|NCT00829933|520640752|FG002|Overall Study|Adverse Event|2|||
144390941|NCT00829933|520640753|FG003|Overall Study|Adverse Event|1|||
144390942|NCT00829933|520640750|FG000|Overall Study|Death|0|||
144390943|NCT00829933|520640751|FG001|Overall Study|Death|0|||
144390944|NCT00829933|520640752|FG002|Overall Study|Death|1|||
144390945|NCT00829933|520640753|FG003|Overall Study|Death|1|||
144390946|NCT00829933|520640750|FG000|Overall Study|Lack of Efficacy|0|||
144390947|NCT00829933|520640751|FG001|Overall Study|Lack of Efficacy|1|||
144390948|NCT00829933|520640752|FG002|Overall Study|Lack of Efficacy|0|||
144390949|NCT00829933|520640753|FG003|Overall Study|Lack of Efficacy|0|||
144390950|NCT00829933|520640750|FG000|Overall Study|Physician Decision|5|||
144390951|NCT00829933|520640751|FG001|Overall Study|Physician Decision|7|||
144390952|NCT00829933|520640752|FG002|Overall Study|Physician Decision|8|||
144390953|NCT00829933|520640753|FG003|Overall Study|Physician Decision|1|||
144390954|NCT00829933|520640750|FG000|Overall Study|Pregnancy|0|||
144390955|NCT00829933|520640751|FG001|Overall Study|Pregnancy|0|||
144390956|NCT00829933|520640752|FG002|Overall Study|Pregnancy|0|||
144390957|NCT00829933|520640753|FG003|Overall Study|Pregnancy|2|||
144390958|NCT00829933|520640750|FG000|Overall Study|Protocol Violation|2|||
144390959|NCT00829933|520640751|FG001|Overall Study|Protocol Violation|1|||
144390960|NCT00829933|520640752|FG002|Overall Study|Protocol Violation|0|||
144390961|NCT00829933|520640753|FG003|Overall Study|Protocol Violation|0|||
144390962|NCT00829933|520640750|FG000|Overall Study|withdrew before treatment started|5|||
144390963|NCT00829933|520640751|FG001|Overall Study|withdrew before treatment started|1|||
144390964|NCT00829933|520640752|FG002|Overall Study|withdrew before treatment started|2|||
144390965|NCT00829933|520640753|FG003|Overall Study|withdrew before treatment started|9|||
144471764|NCT00409682|520925293|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
144471765|NCT00409682|520925291|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
144471766|NCT00409682|520925292|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
144471767|NCT00409682|520925293|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
144471768|NCT00409682|520925291|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
144471769|NCT00409682|520925292|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
144471770|NCT00409682|520925293|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
144471771|NCT00409682|520925291|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
144471772|NCT00409682|520925292|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
144471773|NCT00409682|520925293|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
144471774|NCT00409682|520925291|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
144471775|NCT00409682|520925292|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
144471776|NCT00409682|520925293|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
144593917|NCT03319849|521374050|FG000|Overall Study|Other|1|||
144593918|NCT03319849|521374051|FG001|Overall Study|Other|2|||
144593919|NCT03319849|521374050|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
144593920|NCT03319849|521374051|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
144593921|NCT03319849|521374050|FG000|Overall Study|Lost to Follow-up|0|||
144471777|NCT00409682|520925291|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
144471778|NCT00409682|520925292|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
144471779|NCT00409682|520925293|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
144471780|NCT01896869|520925296|FG000|Overall Study|Withdrawal by Subject|0|||
144471781|NCT01896869|520925297|FG001|Overall Study|Withdrawal by Subject|6|||
144593922|NCT03319849|521374051|FG001|Overall Study|Lost to Follow-up|2|||
144593923|NCT01912456|521376064|FG000|Period 1|Physician Decision|0|||
144471782|NCT01896869|520925296|FG000|Overall Study|Lost to Follow-up|1|||
144471783|NCT01896869|520925297|FG001|Overall Study|Lost to Follow-up|0|||
144471784|NCT04710927|520925303|FG000|Overall Study|Lost to Follow-up|7|||
144471785|NCT04710927|520925304|FG001|Overall Study|Lost to Follow-up|6|||
144471786|NCT04710927|520925305|FG002|Overall Study|Lost to Follow-up|5|||
144471787|NCT00454571|520925311|FG000|Overall Study|Adverse Event|2|||
144593924|NCT01912456|521376065|FG001|Period 1|Physician Decision|0|||
144593925|NCT01912456|521376066|FG002|Period 1|Physician Decision|1|||
144390966|NCT01683019|520642409|FG000|Overall Study|Withdrawal by Subject|2|||
144390967|NCT01683019|520642410|FG001|Overall Study|Withdrawal by Subject|1|||
144390968|NCT01683019|520642411|FG002|Overall Study|Withdrawal by Subject|4|||
144390969|NCT00597701|520642416|FG000|Overall Study|Withdrawal by Subject|5|||
144390970|NCT00597701|520642417|FG001|Overall Study|Withdrawal by Subject|5|||
144390971|NCT00597701|520642416|FG000|Overall Study|Death|0|||
144390972|NCT00597701|520642417|FG001|Overall Study|Death|1|||
144390973|NCT00597701|520642416|FG000|Overall Study|Physician Decision|2|||
144390974|NCT00597701|520642417|FG001|Overall Study|Physician Decision|0|||
144390975|NCT00597701|520642416|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
144390976|NCT00597701|520642417|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
144390977|NCT01107418|520642418|FG000|Overall Study|Disease Progression|45|||
144390978|NCT01107418|520642418|FG000|Overall Study|Adverse Event|3|||
144390979|NCT01107418|520642418|FG000|Overall Study|Withdrawal by Subject|1|||
144390980|NCT01107418|520642418|FG000|Overall Study|Study Closing|1|||
144390981|NCT01107418|520642418|FG000|Overall Study|Started Other Therapy|1|||
144390982|NCT01107418|520642418|FG000|Overall Study|Entered Extension Study|1|||
144390983|NCT01155219|520642419|FG000|Overall Study|Adverse Event|3|||
144390984|NCT01155219|520642420|FG001|Overall Study|Adverse Event|1|||
144390985|NCT01155219|520642419|FG000|Overall Study|non-medical reason|1|||
144390986|NCT01155219|520642420|FG001|Overall Study|non-medical reason|2|||
144390987|NCT01314911|520642422|FG000|Overall Study|Lost to Follow-up|3|||
144390988|NCT01314911|520642423|FG001|Overall Study|Lost to Follow-up|2|||
144390989|NCT01314911|520642422|FG000|Overall Study|Withdrawal by Subject|1|||
144390990|NCT01314911|520642423|FG001|Overall Study|Withdrawal by Subject|3|||
144390991|NCT01314911|520642422|FG000|Overall Study|Received Non-randomized Study Drug|0|||
144390992|NCT01314911|520642423|FG001|Overall Study|Received Non-randomized Study Drug|1|||
144390993|NCT01314911|520642422|FG000|Overall Study|Never Started Treatment|1|||
144390994|NCT01314911|520642423|FG001|Overall Study|Never Started Treatment|0|||
144390995|NCT03150485|520642424|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
144390996|NCT03150485|520642425|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
144390997|NCT03150485|520642426|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
144390998|NCT03150485|520642427|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
144390999|NCT03150485|520642428|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
144391000|NCT03150485|520642429|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
144391001|NCT05828095|520642430|FG000|Overall Study|Lost to Follow-up|1|||
144391002|NCT05828095|520642431|FG001|Overall Study|Lost to Follow-up|0|||
144391003|NCT05828095|520642430|FG000|Overall Study|Reactogenicity symptom|0|||
144391004|NCT05828095|520642431|FG001|Overall Study|Reactogenicity symptom|1|||
144391005|NCT00096954|520642437|FG000|Overall Study|Adverse Event|3|||
144391006|NCT00096954|520642438|FG001|Overall Study|Adverse Event|1|||
144391007|NCT00096954|520642437|FG000|Overall Study|Withdrawal by Subject|9|||
144391008|NCT00096954|520642438|FG001|Overall Study|Withdrawal by Subject|8|||
144391009|NCT00096954|520642437|FG000|Overall Study|Physician Decision|1|||
144391010|NCT00096954|520642438|FG001|Overall Study|Physician Decision|1|||
144391011|NCT00096954|520642437|FG000|Overall Study|Sponsors Decision|1|||
144391012|NCT00096954|520642438|FG001|Overall Study|Sponsors Decision|1|||
144391013|NCT00096954|520642437|FG000|Overall Study|Pregnancy|1|||
144391014|NCT00096954|520642438|FG001|Overall Study|Pregnancy|1|||
144391015|NCT00096954|520642437|FG000|Overall Study|Initiation of immunotherapy|1|||
144391016|NCT00096954|520642438|FG001|Overall Study|Initiation of immunotherapy|0|||
144391017|NCT00096954|520642437|FG000|Overall Study|Non-compliance|0|||
144722156|NCT01463683|521836991|FG000|Overall Study|Physician Decision|0|||
144391018|NCT00096954|520642438|FG001|Overall Study|Non-compliance|3|||
144391019|NCT00096954|520642437|FG000|Overall Study|Lost to Follow-up|8|||
144391020|NCT00096954|520642438|FG001|Overall Study|Lost to Follow-up|5|||
144391021|NCT03442764|520642439|FG000|Overall Study|Adverse Event|1|||
144391022|NCT03442764|520642440|FG001|Overall Study|Adverse Event|0|||
144391023|NCT03442764|520642441|FG002|Overall Study|Adverse Event|0|||
144391024|NCT04478123|520642442|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
144391025|NCT04478123|520642442|FG000|Overall Study|NE|1|||
144391026|NCT02395016|520642443|FG000|Overall Study|Adverse Event|4|||
144391027|NCT02395016|520642444|FG001|Overall Study|Adverse Event|3|||
144391028|NCT02395016|520642443|FG000|Overall Study|Withdrawal by Subject|9|||
144391029|NCT02395016|520642444|FG001|Overall Study|Withdrawal by Subject|6|||
144391030|NCT02395016|520642443|FG000|Overall Study|Protocol Violation|2|||
144391031|NCT02395016|520642444|FG001|Overall Study|Protocol Violation|3|||
144391032|NCT04444895|520642445|FG000|Overall Study|Adverse Event|2|||
144391033|NCT04444895|520642445|FG000|Overall Study|Lost to Follow-up|2|||
144391034|NCT04444895|520642445|FG000|Overall Study|Withdrawal by Subject|5|||
144517865|NCT03932682|521096243|FG001|Overall Study|Lost to Follow-up|25|||
144517866|NCT03932682|521096242|FG000|Overall Study|Protocol Violation|0|||
144517867|NCT03932682|521096243|FG001|Overall Study|Protocol Violation|2|||
144517868|NCT03932682|521096242|FG000|Overall Study|Other|9|||
144722157|NCT01463683|521836992|FG001|Overall Study|Physician Decision|3|||
144391035|NCT00719264|520642446|FG000|Overall Study|Adverse Event|41|||
144391036|NCT00719264|520642447|FG001|Overall Study|Adverse Event|49|||
144391037|NCT00719264|520642446|FG000|Overall Study|Death|13|||
144391038|NCT00719264|520642447|FG001|Overall Study|Death|10|||
144593926|NCT01912456|521376067|FG003|Period 1|Physician Decision|0|||
144593927|NCT01912456|521376064|FG000|Period 1|non-compliance|1|||
144593928|NCT01912456|521376065|FG001|Period 1|non-compliance|0|||
144722158|NCT01463683|521836993|FG002|Overall Study|Physician Decision|1|||
144722159|NCT01463683|521836991|FG000|Overall Study|Pregnancy|2|||
144391039|NCT00719264|520642446|FG000|Overall Study|Administrative Problems|6|||
144391040|NCT00719264|520642447|FG001|Overall Study|Administrative Problems|4|||
144391041|NCT00719264|520642446|FG000|Overall Study|Lost to Follow-up|1|||
144391042|NCT00719264|520642447|FG001|Overall Study|Lost to Follow-up|1|||
144391043|NCT00719264|520642446|FG000|Overall Study|Withdrawal by Subject|12|||
144391044|NCT00719264|520642447|FG001|Overall Study|Withdrawal by Subject|7|||
144391045|NCT00719264|520642446|FG000|Overall Study|Protocol Deviation|1|||
144391046|NCT00719264|520642447|FG001|Overall Study|Protocol Deviation|3|||
144391047|NCT00719264|520642446|FG000|Overall Study|New Cancer Therapy|4|||
144391048|NCT00719264|520642447|FG001|Overall Study|New Cancer Therapy|2|||
144391049|NCT00719264|520642446|FG000|Overall Study|Disease Progression|104|||
144391050|NCT00719264|520642447|FG001|Overall Study|Disease Progression|107|||
144391051|NCT00814879|520642448|FG000|By Week 24|Cancer Diagnosis|1|||
144391052|NCT00814879|520642449|FG001|By Week 24|Cancer Diagnosis|0|||
144391053|NCT00814879|520642448|FG000|By Week 24|Incarceration|0|||
144391054|NCT00814879|520642449|FG001|By Week 24|Incarceration|1|||
144391055|NCT00814879|520642448|FG000|By Week 48|Lost to Follow-up|2|||
144391056|NCT00814879|520642449|FG001|By Week 48|Lost to Follow-up|2|||
144391057|NCT00814879|520642448|FG000|By Week 48|Death|0|||
144391058|NCT00814879|520642449|FG001|By Week 48|Death|1|||
144391059|NCT00588952|520642450|FG000|Overall Study|Adverse Event|0|||
144391060|NCT00588952|520642451|FG001|Overall Study|Adverse Event|2|||
144391061|NCT00588952|520642450|FG000|Overall Study|Withdrawal by Subject|3|||
144471788|NCT00454571|520925312|FG001|Overall Study|Adverse Event|0|||
144471789|NCT00454571|520925311|FG000|Overall Study|Physician Decision|0|||
144471790|NCT00454571|520925312|FG001|Overall Study|Physician Decision|1|||
144471791|NCT00454571|520925311|FG000|Overall Study|Protocol Violation|1|||
144471792|NCT00454571|520925312|FG001|Overall Study|Protocol Violation|0|||
144471793|NCT00454571|520925311|FG000|Overall Study|Withdrawal by Subject|10|||
144471794|NCT00454571|520925312|FG001|Overall Study|Withdrawal by Subject|5|||
144471795|NCT04681729|520925313|FG000|Overall Study|Lack of Efficacy|2|||
144471796|NCT04681729|520925314|FG001|Overall Study|Lack of Efficacy|2|||
144471797|NCT04681729|520925313|FG000|Overall Study|Withdrawal by Subject|8|||
144471798|NCT04681729|520925314|FG001|Overall Study|Withdrawal by Subject|9|||
144471799|NCT02856113|520925315|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
144471800|NCT02856113|520925316|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
144471801|NCT02856113|520925315|FG000|Overall Study|Significant Protocol Deviation|1|||
144471802|NCT02856113|520925316|FG001|Overall Study|Significant Protocol Deviation|0|||
144471803|NCT02856113|520925315|FG000|Overall Study|Lost to Follow-up|3|||
144471804|NCT02856113|520925316|FG001|Overall Study|Lost to Follow-up|5|||
144471805|NCT02856113|520925315|FG000|Overall Study|Voluntary Withdrawal|3|||
144471806|NCT02856113|520925316|FG001|Overall Study|Voluntary Withdrawal|5|||
144471807|NCT02856113|520925315|FG000|Overall Study|Pregnancy|0|||
144471808|NCT02856113|520925316|FG001|Overall Study|Pregnancy|1|||
144471809|NCT02856113|520925315|FG000|Overall Study|Principal Investigator Discretion|2|||
144471810|NCT02856113|520925316|FG001|Overall Study|Principal Investigator Discretion|1|||
144471811|NCT02856113|520925315|FG000|Overall Study|Randomized but not Treated|1|||
144471812|NCT02856113|520925316|FG001|Overall Study|Randomized but not Treated|0|||
144471813|NCT02856113|520925315|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
144471814|NCT02856113|520925316|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
144471815|NCT02110901|520925317|FG000|Overall Study|Death|6|||
144471816|NCT02110901|520925318|FG001|Overall Study|Death|3|||
144471817|NCT02110901|520925317|FG000|Overall Study|Lost to Follow-up|12|||
144471818|NCT02110901|520925318|FG001|Overall Study|Lost to Follow-up|8|||
144471819|NCT02110901|520925317|FG000|Overall Study|Withdrawal by Subject|7|||
144471820|NCT02110901|520925318|FG001|Overall Study|Withdrawal by Subject|3|||
144471821|NCT02110901|520925317|FG000|Overall Study|received a kidney transplant|5|||
144471822|NCT02110901|520925318|FG001|Overall Study|received a kidney transplant|0|||
144471823|NCT00758459|520925319|FG000|Overall Study|Adverse Event|3|||
144471824|NCT00758459|520925320|FG001|Overall Study|Adverse Event|2|||
144471825|NCT00758459|520925319|FG000|Overall Study|Protocol Violation|0|||
144471826|NCT00758459|520925320|FG001|Overall Study|Protocol Violation|1|||
144471827|NCT00758459|520925319|FG000|Overall Study|Withdrawal by Subject|0|||
144391062|NCT00588952|520642451|FG001|Overall Study|Withdrawal by Subject|5|||
144391063|NCT01277042|520642452|FG000|Overall Study|Adverse Event|4|||
144391064|NCT01277042|520642453|FG001|Overall Study|Adverse Event|3|||
144391065|NCT01277042|520642452|FG000|Overall Study|Lost to Follow-up|2|||
144391066|NCT01277042|520642453|FG001|Overall Study|Lost to Follow-up|2|||
144391067|NCT01277042|520642452|FG000|Overall Study|Withdrawal by Subject|2|||
144391068|NCT01277042|520642453|FG001|Overall Study|Withdrawal by Subject|0|||
144391069|NCT01461057|520642454|FG000|Overall Study|Death|10|||
144391070|NCT01461057|520642455|FG001|Overall Study|Death|9|||
144391071|NCT01461057|520642454|FG000|Overall Study|Withdrawal by Subject|2|||
144391072|NCT01461057|520642455|FG001|Overall Study|Withdrawal by Subject|3|||
144391073|NCT01461057|520642454|FG000|Overall Study|Physician Decision|0|||
144391074|NCT01461057|520642455|FG001|Overall Study|Physician Decision|2|||
144391075|NCT01461057|520642454|FG000|Overall Study|Adverse Event|0|||
144391076|NCT01461057|520642455|FG001|Overall Study|Adverse Event|1|||
144391077|NCT01461057|520642454|FG000|Overall Study|Progression of Disease|1|||
144391078|NCT01461057|520642455|FG001|Overall Study|Progression of Disease|0|||
144391079|NCT01461057|520642454|FG000|Overall Study|Study Terminated by Sponsor|2|||
144391080|NCT01461057|520642455|FG001|Overall Study|Study Terminated by Sponsor|0|||
144391081|NCT03034200|520642456|FG000|Overall Study|Disease progression|8|||
144391082|NCT03034200|520642457|FG001|Overall Study|Disease progression|10|||
144391083|NCT03034200|520642458|FG002|Overall Study|Disease progression|4|||
144391084|NCT03034200|520642456|FG000|Overall Study|Physician Decision|2|||
144391085|NCT03034200|520642457|FG001|Overall Study|Physician Decision|0|||
144391086|NCT03034200|520642458|FG002|Overall Study|Physician Decision|3|||
144391087|NCT03034200|520642456|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
144391088|NCT03034200|520642457|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
144391089|NCT03034200|520642458|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
144391090|NCT03034200|520642456|FG000|Overall Study|Adjuvant Therapy|0|||
144391091|NCT03034200|520642457|FG001|Overall Study|Adjuvant Therapy|0|||
144391092|NCT03034200|520642458|FG002|Overall Study|Adjuvant Therapy|1|||
144391093|NCT01288976|520642459|FG000|Overall Study|Withdrawal by Subject|58|||
144391094|NCT01288976|520642460|FG001|Overall Study|Withdrawal by Subject|12|||
144391095|NCT01288976|520642461|FG002|Overall Study|Withdrawal by Subject|9|||
144391096|NCT01288976|520642459|FG000|Overall Study|Death|98|||
144391097|NCT01288976|520642460|FG001|Overall Study|Death|6|||
144391098|NCT01288976|520642461|FG002|Overall Study|Death|4|||
144391099|NCT01288976|520642459|FG000|Overall Study|Data unavailable|22|||
144391100|NCT01288976|520642460|FG001|Overall Study|Data unavailable|9|||
144391101|NCT01288976|520642461|FG002|Overall Study|Data unavailable|7|||
144391102|NCT05523323|520642468|FG000|Overall Study|Death|26|||
144391103|NCT05523323|520642469|FG001|Overall Study|Death|21|||
144391104|NCT05523323|520642468|FG000|Overall Study|Ongoing participants|35|||
144391105|NCT05523323|520642469|FG001|Overall Study|Ongoing participants|30|||
144391106|NCT02469038|520642470|FG000|Overall Study|Physician Decision|4|||
144391107|NCT02469038|520642471|FG001|Overall Study|Physician Decision|5|||
144391108|NCT03435640|520642472|FG000|Overall Study|Withdrawal by Subject|0|||
144391109|NCT03435640|520642473|FG001|Overall Study|Withdrawal by Subject|1|||
144391110|NCT03435640|520642474|FG002|Overall Study|Withdrawal by Subject|0|||
144391111|NCT03435640|520642475|FG003|Overall Study|Withdrawal by Subject|2|||
144391112|NCT03435640|520642476|FG004|Overall Study|Withdrawal by Subject|0|||
144391113|NCT03435640|520642477|FG005|Overall Study|Withdrawal by Subject|0|||
144391114|NCT03435640|520642478|FG006|Overall Study|Withdrawal by Subject|3|||
144391115|NCT03435640|520642479|FG007|Overall Study|Withdrawal by Subject|0|||
144391116|NCT03435640|520642480|FG008|Overall Study|Withdrawal by Subject|0|||
144391117|NCT03435640|520642481|FG009|Overall Study|Withdrawal by Subject|2|||
144391118|NCT03435640|520642482|FG010|Overall Study|Withdrawal by Subject|3|||
144391119|NCT03435640|520642472|FG000|Overall Study|Lost to Follow-up|0|||
144593929|NCT01912456|521376066|FG002|Period 1|non-compliance|0|||
144593930|NCT01912456|521376067|FG003|Period 1|non-compliance|1|||
144391120|NCT03435640|520642473|FG001|Overall Study|Lost to Follow-up|0|||
144391121|NCT03435640|520642474|FG002|Overall Study|Lost to Follow-up|1|||
144391122|NCT03435640|520642475|FG003|Overall Study|Lost to Follow-up|0|||
144391123|NCT03435640|520642476|FG004|Overall Study|Lost to Follow-up|0|||
144593931|NCT01912456|521376064|FG000|Period 1|Adverse Event|1|||
144391124|NCT03435640|520642477|FG005|Overall Study|Lost to Follow-up|0|||
144391125|NCT03435640|520642478|FG006|Overall Study|Lost to Follow-up|0|||
144391126|NCT03435640|520642479|FG007|Overall Study|Lost to Follow-up|0|||
144391127|NCT03435640|520642480|FG008|Overall Study|Lost to Follow-up|0|||
144391128|NCT03435640|520642481|FG009|Overall Study|Lost to Follow-up|0|||
144391129|NCT03435640|520642482|FG010|Overall Study|Lost to Follow-up|0|||
144391130|NCT00636987|520642483|FG000|Overall Study|Death|44|||
144391131|NCT00636987|520642483|FG000|Overall Study|Explanted|13|||
144391132|NCT00636987|520642483|FG000|Overall Study|Lost to Follow-up|63|||
144391133|NCT00636987|520642483|FG000|Overall Study|5 year visit window not complete|69|||
144391134|NCT01251146|520642484|FG000|Overall Study|Lost to Follow-up|3|||
144391135|NCT01251146|520642485|FG001|Overall Study|Lost to Follow-up|10|||
144391136|NCT01739400|520642486|FG000|Overall Study|Physician Decision|3|||
144391137|NCT01739400|520642487|FG001|Overall Study|Physician Decision|0|||
144391138|NCT01739400|520642486|FG000|Overall Study|Lost to Follow-up|2|||
144391139|NCT01739400|520642487|FG001|Overall Study|Lost to Follow-up|0|||
144391140|NCT01739400|520642486|FG000|Overall Study|Death|5|||
144391141|NCT01739400|520642487|FG001|Overall Study|Death|2|||
144391142|NCT01739400|520642486|FG000|Overall Study|Withdrawal by Subject|7|||
144391143|NCT01739400|520642487|FG001|Overall Study|Withdrawal by Subject|7|||
144391144|NCT03350984|520642488|FG000|Overall Study|Death|1|||
144391145|NCT03350984|520642489|FG001|Overall Study|Death|0|||
144391146|NCT03350984|520642488|FG000|Overall Study|Lost to Follow-up|5|||
144391147|NCT03350984|520642489|FG001|Overall Study|Lost to Follow-up|6|||
144391148|NCT03350984|520642488|FG000|Overall Study|Protocol Violation|1|||
144391149|NCT03350984|520642489|FG001|Overall Study|Protocol Violation|2|||
144391150|NCT03350984|520642488|FG000|Overall Study|Physician Decision|1|||
144391151|NCT03350984|520642489|FG001|Overall Study|Physician Decision|0|||
144391152|NCT01347307|520642490|FG000|Overall Study|Death|0|||
144391153|NCT01347307|520642491|FG001|Overall Study|Death|4|||
144391154|NCT01347307|520642490|FG000|Overall Study|Physician Decision|0|||
144391155|NCT01347307|520642491|FG001|Overall Study|Physician Decision|1|||
144391156|NCT00642473|520642492|FG000|Overall Study|Withdrawal by Subject|0|||
144391157|NCT00642473|520642493|FG001|Overall Study|Withdrawal by Subject|5|||
144391158|NCT00642473|520642492|FG000|Overall Study|Progression or death|2|||
144593932|NCT01912456|521376065|FG001|Period 1|Adverse Event|0|||
144593933|NCT01912456|521376066|FG002|Period 1|Adverse Event|0|||
144593934|NCT01912456|521376067|FG003|Period 1|Adverse Event|1|||
144593935|NCT01912456|521376064|FG000|Period 1|Withdrawal by Subject|0|||
144391159|NCT00642473|520642493|FG001|Overall Study|Progression or death|4|||
144593936|NCT01912456|521376065|FG001|Period 1|Withdrawal by Subject|1|||
144593937|NCT01912456|521376066|FG002|Period 1|Withdrawal by Subject|1|||
144593938|NCT01912456|521376067|FG003|Period 1|Withdrawal by Subject|1|||
144593939|NCT01912456|521376064|FG000|Period 2|Lack of Efficacy|0|||
144593940|NCT01912456|521376065|FG001|Period 2|Lack of Efficacy|2|||
144593941|NCT01912456|521376066|FG002|Period 2|Lack of Efficacy|0|||
144593942|NCT01912456|521376067|FG003|Period 2|Lack of Efficacy|0|||
144593943|NCT01912456|521376064|FG000|Period 2|Adverse Event|0|||
144593944|NCT01912456|521376065|FG001|Period 2|Adverse Event|0|||
144593945|NCT01912456|521376066|FG002|Period 2|Adverse Event|0|||
144593946|NCT01912456|521376067|FG003|Period 2|Adverse Event|1|||
144593947|NCT00171704|521376068|FG000|Overall Study|Adverse Event|24|||
144593948|NCT00171704|521376069|FG001|Overall Study|Adverse Event|33|||
144593949|NCT00171704|521376068|FG000|Overall Study|Disease Progression|14|||
144391160|NCT00642473|520642492|FG000|Overall Study|Other|2|||
144391161|NCT00642473|520642493|FG001|Overall Study|Other|2|||
144391162|NCT04533880|520642496|FG000|Overall Study|Lost to Follow-up|0|||
144391163|NCT04533880|520642497|FG001|Overall Study|Lost to Follow-up|1|||
144391164|NCT04533880|520642498|FG002|Overall Study|Lost to Follow-up|1|||
144391165|NCT02284178|520642501|FG000|Overall Study|Met exclusion criteria|49|||
144593950|NCT00171704|521376069|FG001|Overall Study|Disease Progression|9|||
144593951|NCT00171704|521376068|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
144391166|NCT02284178|520642502|FG001|Overall Study|Met exclusion criteria|54|||
144391167|NCT01483690|520642505|FG000|Overall Study|Adverse Event|1|||
144391168|NCT01483690|520642506|FG001|Overall Study|Adverse Event|2|||
144391169|NCT01483690|520642505|FG000|Overall Study|clinical deterioration|1|||
144391170|NCT01483690|520642506|FG001|Overall Study|clinical deterioration|0|||
144593952|NCT00171704|521376069|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
144593953|NCT00171704|521376068|FG000|Overall Study|Administrative Problems|2|||
144593954|NCT00171704|521376069|FG001|Overall Study|Administrative Problems|1|||
144593955|NCT00171704|521376068|FG000|Overall Study|Death|2|||
144391171|NCT01483690|520642505|FG000|Overall Study|Physician Decision|0|||
144391172|NCT01483690|520642506|FG001|Overall Study|Physician Decision|2|||
144391173|NCT01483690|520642505|FG000|Overall Study|exclusionary procedure|0|||
144391174|NCT01483690|520642506|FG001|Overall Study|exclusionary procedure|1|||
144391175|NCT00958789|520642510|FG000|Overall Study|Death|5|||
144391176|NCT00958789|520642510|FG000|Overall Study|Lost to Follow-up|14|||
144391177|NCT00958789|520642510|FG000|Overall Study|Withdrawal by Subject|17|||
144391178|NCT00958789|520642510|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
144391179|NCT00958789|520642510|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
144391180|NCT00958789|520642510|FG000|Overall Study|Subject terminated|2|||
144391181|NCT00958789|520642510|FG000|Overall Study|Revision|7|||
144391182|NCT00478881|520642511|FG000|Overall Study|Adverse Event|31|||
144391183|NCT00478881|520642512|FG001|Overall Study|Adverse Event|12|||
144391184|NCT00478881|520642511|FG000|Overall Study|Lack of Efficacy|0|||
144391185|NCT00478881|520642512|FG001|Overall Study|Lack of Efficacy|3|||
144391186|NCT00478881|520642511|FG000|Overall Study|Lost to Follow-up|0|||
144391187|NCT00478881|520642512|FG001|Overall Study|Lost to Follow-up|1|||
144391188|NCT00478881|520642511|FG000|Overall Study|Protocol Violation|2|||
144391189|NCT00478881|520642512|FG001|Overall Study|Protocol Violation|2|||
144391190|NCT00478881|520642511|FG000|Overall Study|Withdrawal by Subject|6|||
144391191|NCT00478881|520642512|FG001|Overall Study|Withdrawal by Subject|2|||
144391192|NCT00478881|520642511|FG000|Overall Study|Non-Compliance with Study Medication|0|||
144391193|NCT00478881|520642512|FG001|Overall Study|Non-Compliance with Study Medication|2|||
144391194|NCT01083173|520642513|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
144391195|NCT01083173|520642514|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
144391196|NCT01083173|520642513|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
144391197|NCT01083173|520642514|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
144391198|NCT01083173|520642513|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
144391199|NCT01083173|520642514|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
144391200|NCT01083173|520642513|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
144391201|NCT01083173|520642514|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
144391202|NCT01083173|520642513|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
144391203|NCT01083173|520642514|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
144391204|NCT01083173|520642513|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
144391205|NCT01083173|520642514|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
144391206|NCT01083173|520642513|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
144391207|NCT01083173|520642514|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
144391208|NCT01083173|520642513|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
144391209|NCT01083173|520642514|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
144391210|NCT01083173|520642513|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
144391211|NCT01083173|520642514|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
144391212|NCT01083173|520642513|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
144391213|NCT01083173|520642514|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
144391214|NCT01083173|520642513|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
144391215|NCT01083173|520642514|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
144391216|NCT00442468|520642516|FG000|Overall Study|Adverse Event|4|||
144391217|NCT00442468|520642516|FG000|Overall Study|Withdrawal by Subject|91|||
144391218|NCT00442468|520642516|FG000|Overall Study|Did not complete all study procedures|88|||
144391219|NCT00589784|520642517|FG000|Overall Study|Withdrawal by Subject|0|||
144391220|NCT00589784|520642518|FG001|Overall Study|Withdrawal by Subject|6|||
144391221|NCT00589784|520642517|FG000|Overall Study|Patient inevaluable|1|||
144391222|NCT00589784|520642518|FG001|Overall Study|Patient inevaluable|0|||
144593956|NCT00171704|521376069|FG001|Overall Study|Death|2|||
144391223|NCT00589784|520642517|FG000|Overall Study|Adverse Event|0|||
144593957|NCT00171704|521376068|FG000|Overall Study|Withdrawal by Subject|1|||
144722160|NCT01463683|521836992|FG001|Overall Study|Pregnancy|2|||
144391224|NCT00589784|520642518|FG001|Overall Study|Adverse Event|4|||
144391225|NCT04543409|520642519|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144391226|NCT04543409|520642520|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144391227|NCT04543409|520642519|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
144391228|NCT04543409|520642520|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
144391229|NCT04543409|520642519|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
144391230|NCT04543409|520642520|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
144391231|NCT04543409|520642519|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
144391232|NCT04543409|520642520|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
144391233|NCT04543409|520642519|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
144391234|NCT04543409|520642520|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
144391235|NCT04543409|520642519|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
144391236|NCT04543409|520642520|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
144391237|NCT04543409|520642519|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
144391238|NCT04543409|520642520|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
144391239|NCT04543409|520642519|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
144391240|NCT04543409|520642520|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
144391241|NCT04543409|520642519|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
144391242|NCT04543409|520642520|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
144391243|NCT04543409|520642519|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
144391244|NCT04543409|520642520|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
144391245|NCT04543409|520642519|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
144391246|NCT04543409|520642520|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
144391247|NCT01289782|520642521|FG000|Overall Study|Lost to Follow-up|14|||
144391248|NCT01289782|520642522|FG001|Overall Study|Lost to Follow-up|7|||
144391249|NCT01289782|520642521|FG000|Overall Study|Protocol Violation|1|||
144391250|NCT01289782|520642522|FG001|Overall Study|Protocol Violation|1|||
144391251|NCT01289782|520642521|FG000|Overall Study|Withdrawal by Subject|8|||
144391252|NCT01289782|520642522|FG001|Overall Study|Withdrawal by Subject|2|||
144391253|NCT01289782|520642521|FG000|Overall Study|Sponsor's Decision|1|||
144391254|NCT01289782|520642522|FG001|Overall Study|Sponsor's Decision|0|||
144391255|NCT01289782|520642521|FG000|Overall Study|Reason not specified|1|||
144391256|NCT01289782|520642522|FG001|Overall Study|Reason not specified|2|||
144391257|NCT02131532|520642523|FG000|Overall Study|Withdrawal by Subject|1|||
144391258|NCT02131532|520642523|FG000|Overall Study|Physician Decision|1|||
144391259|NCT02131532|520642523|FG000|Overall Study|Other health conditions|2|||
144391260|NCT02093026|520642524|FG000|Overall Study|Adverse Event|26|||
144391261|NCT02093026|520642524|FG000|Overall Study|Death|10|||
144391262|NCT02093026|520642524|FG000|Overall Study|Other|157|||
144391263|NCT02195011|520642539|FG000|Overall Study|Adverse Event|4|||
144391264|NCT02195011|520642540|FG001|Overall Study|Adverse Event|0|||
144391265|NCT02195011|520642539|FG000|Overall Study|Progressive Disease|18|||
144391266|NCT02195011|520642540|FG001|Overall Study|Progressive Disease|1|||
144391267|NCT02195011|520642539|FG000|Overall Study|Withdrawal by Subject|3|||
144391268|NCT02195011|520642540|FG001|Overall Study|Withdrawal by Subject|0|||
144391269|NCT00174291|520642543|FG000|Overall Study|Lost to Follow-up|1|||
144391270|NCT00174291|520642544|FG001|Overall Study|Lost to Follow-up|1|||
144391271|NCT00174291|520642543|FG000|Overall Study|Protocol Violation|0|||
144391272|NCT00174291|520642544|FG001|Overall Study|Protocol Violation|2|||
144391273|NCT00174291|520642543|FG000|Overall Study|Study terminated by sponsor|1|||
144391274|NCT00174291|520642544|FG001|Overall Study|Study terminated by sponsor|0|||
144391275|NCT00174291|520642543|FG000|Overall Study|Withdrawal by Subject|3|||
144391276|NCT00174291|520642544|FG001|Overall Study|Withdrawal by Subject|3|||
144391277|NCT00450112|520642545|FG000|Overall Study|Other Treatment Required|5|||
144593958|NCT00171704|521376069|FG001|Overall Study|Withdrawal by Subject|3|||
144593959|NCT00171704|521376068|FG000|Overall Study|Protocol Violation|0|||
144593960|NCT00171704|521376069|FG001|Overall Study|Protocol Violation|1|||
144593961|NCT00816400|521376072|FG000|Overall Study|Death|2|||
144593962|NCT00816400|521376073|FG001|Overall Study|Death|3|||
144593963|NCT00816400|521376074|FG002|Overall Study|Death|3|||
144593964|NCT00816400|521376075|FG003|Overall Study|Death|3|||
144593965|NCT00816400|521376076|FG004|Overall Study|Death|2|||
144593966|NCT00816400|521376077|FG005|Overall Study|Death|3|||
144391278|NCT00450112|520642546|FG001|Overall Study|Other Treatment Required|1|||
144391279|NCT00450112|520642545|FG000|Overall Study|Withdrawal by Subject|4|||
144391280|NCT00450112|520642546|FG001|Overall Study|Withdrawal by Subject|1|||
144391281|NCT00450112|520642545|FG000|Overall Study|Lost to Follow-up|2|||
144391282|NCT00450112|520642546|FG001|Overall Study|Lost to Follow-up|1|||
144391283|NCT00450112|520642545|FG000|Overall Study|Others|2|||
144391284|NCT00450112|520642546|FG001|Overall Study|Others|3|||
144391285|NCT00555425|520642547|FG000|Overall Study|Missed Medication > 1 wk|34|||
144593967|NCT00816400|521376078|FG006|Overall Study|Death|2|||
144593968|NCT00816400|521376079|FG007|Overall Study|Death|5|||
144593969|NCT00816400|521376080|FG008|Overall Study|Death|6|||
144391286|NCT00555425|520642548|FG001|Overall Study|Missed Medication > 1 wk|15|||
144391287|NCT00555425|520642547|FG000|Overall Study|Missed 3 physician management visits|1|||
144391288|NCT00555425|520642548|FG001|Overall Study|Missed 3 physician management visits|0|||
144391289|NCT00555425|520642547|FG000|Overall Study|Met criteria for protective transfer|16|||
144391290|NCT00555425|520642548|FG001|Overall Study|Met criteria for protective transfer|3|||
144391291|NCT00555425|520642547|FG000|Overall Study|Became pregnant and transferred care|0|||
144391292|NCT00555425|520642548|FG001|Overall Study|Became pregnant and transferred care|1|||
144391293|NCT00424255|520642550|FG000|Overall Study|Death|115|||
144391294|NCT00424255|520642551|FG001|Overall Study|Death|111|||
144391295|NCT00424255|520642550|FG000|Overall Study|Lost to Follow-up|26|||
144391296|NCT00424255|520642551|FG001|Overall Study|Lost to Follow-up|20|||
144391297|NCT00424255|520642550|FG000|Overall Study|Protocol Violation|0|||
144391298|NCT00424255|520642551|FG001|Overall Study|Protocol Violation|1|||
144391299|NCT00424255|520642550|FG000|Overall Study|Withdrawal by Subject|34|||
144391300|NCT00424255|520642551|FG001|Overall Study|Withdrawal by Subject|38|||
144391301|NCT00424255|520642550|FG000|Overall Study|Physician Decision|3|||
144391302|NCT00424255|520642551|FG001|Overall Study|Physician Decision|7|||
144391303|NCT00424255|520642550|FG000|Overall Study|Cognitive Disturbance|1|||
144391304|NCT00424255|520642551|FG001|Overall Study|Cognitive Disturbance|0|||
144391305|NCT00424255|520642550|FG000|Overall Study|Non-compliance by Participants|1|||
144391306|NCT00424255|520642551|FG001|Overall Study|Non-compliance by Participants|0|||
144391307|NCT00424255|520642550|FG000|Overall Study|Fatigue|1|||
144391308|NCT00424255|520642551|FG001|Overall Study|Fatigue|0|||
144391309|NCT00424255|520642550|FG000|Overall Study|Disease Progression|0|||
144391310|NCT00424255|520642551|FG001|Overall Study|Disease Progression|2|||
144391311|NCT00424255|520642550|FG000|Overall Study|Sponsor Terminated Study|161|||
144391312|NCT00424255|520642551|FG001|Overall Study|Sponsor Terminated Study|167|||
144391313|NCT03523000|520642552|FG000|Overall Study|Withdrawal by Subject|3|||
144391314|NCT03523000|520642553|FG001|Overall Study|Withdrawal by Subject|0|||
144391315|NCT03523000|520642552|FG000|Overall Study|Unsuccessful trial|2|||
144391316|NCT03523000|520642553|FG001|Overall Study|Unsuccessful trial|0|||
144391317|NCT00495131|520642554|FG000|Overall Study|Adverse Event|6|||
144391318|NCT00495131|520642555|FG001|Overall Study|Adverse Event|2|||
144391319|NCT00495131|520642554|FG000|Overall Study|Lack of Efficacy|0|||
144391320|NCT00495131|520642555|FG001|Overall Study|Lack of Efficacy|2|||
144391321|NCT00495131|520642554|FG000|Overall Study|Lost to Follow-up|0|||
144391322|NCT00495131|520642555|FG001|Overall Study|Lost to Follow-up|2|||
144391323|NCT00495131|520642554|FG000|Overall Study|Withdrawal by Subject|1|||
144391324|NCT00495131|520642555|FG001|Overall Study|Withdrawal by Subject|0|||
144391325|NCT01307020|520642557|FG000|Overall Study|Lost to Follow-up|0|||
144391326|NCT01307020|520642558|FG001|Overall Study|Lost to Follow-up|0|||
144391327|NCT01307020|520642559|FG002|Overall Study|Lost to Follow-up|1|||
144391328|NCT01307020|520642560|FG003|Overall Study|Lost to Follow-up|1|||
144391329|NCT01307020|520642561|FG004|Overall Study|Lost to Follow-up|0|||
144391330|NCT01307020|520642562|FG005|Overall Study|Lost to Follow-up|0|||
144391331|NCT01307020|520642563|FG006|Overall Study|Lost to Follow-up|1|||
144391332|NCT01307020|520642564|FG007|Overall Study|Lost to Follow-up|0|||
144391333|NCT01307020|520642565|FG008|Overall Study|Lost to Follow-up|0|||
144391334|NCT01307020|520642566|FG009|Overall Study|Lost to Follow-up|0|||
144391335|NCT01307020|520642557|FG000|Overall Study|Electronic data capture failure|0|||
144391336|NCT01307020|520642558|FG001|Overall Study|Electronic data capture failure|1|||
144391337|NCT01307020|520642559|FG002|Overall Study|Electronic data capture failure|0|||
144391338|NCT01307020|520642560|FG003|Overall Study|Electronic data capture failure|0|||
144391339|NCT01307020|520642561|FG004|Overall Study|Electronic data capture failure|0|||
144391340|NCT01307020|520642562|FG005|Overall Study|Electronic data capture failure|0|||
144391341|NCT01307020|520642563|FG006|Overall Study|Electronic data capture failure|0|||
144391342|NCT01307020|520642564|FG007|Overall Study|Electronic data capture failure|0|||
144391343|NCT01307020|520642565|FG008|Overall Study|Electronic data capture failure|0|||
144391344|NCT01307020|520642566|FG009|Overall Study|Electronic data capture failure|0|||
144391345|NCT02380690|520642567|FG000|Overall Study|Lost to Follow-up|14|||
144391346|NCT02380690|520642568|FG001|Overall Study|Lost to Follow-up|4|||
144391347|NCT02380690|520642567|FG000|Overall Study|Withdrawal by Subject|20|||
144391348|NCT02380690|520642568|FG001|Overall Study|Withdrawal by Subject|8|||
144391349|NCT00266864|520642569|FG000|Overall Study|Lost to Follow-up|4|||
144517869|NCT03932682|521096243|FG001|Overall Study|Other|23|||
144517870|NCT02307565|521096244|FG000|Overall Study|Adverse Event|3|||
144517871|NCT02307565|521096245|FG001|Overall Study|Adverse Event|2|||
144391350|NCT00266864|520642570|FG001|Overall Study|Lost to Follow-up|1|||
144391351|NCT00266864|520642569|FG000|Overall Study|Withdrawal by Subject|1|||
144391352|NCT00266864|520642570|FG001|Overall Study|Withdrawal by Subject|1|||
144391353|NCT03687970|520642578|FG000|Overall Study|visit scheduling conflicts|2|||
144391354|NCT03687970|520642579|FG001|Overall Study|visit scheduling conflicts|0|||
144391355|NCT03119701|520642580|FG000|6-day Dosing|Death|4|||
144391356|NCT03119701|520642581|FG001|6-day Dosing|Death|1|||
144391357|NCT03119701|520642580|FG000|6-day Dosing|Adverse Event|3|||
144391358|NCT03119701|520642581|FG001|6-day Dosing|Adverse Event|0|||
144391359|NCT03119701|520642580|FG000|6-day Dosing|Physician Decision|0|||
144391360|NCT03119701|520642581|FG001|6-day Dosing|Physician Decision|1|||
144391361|NCT03119701|520642580|FG000|6-day Dosing|Withdrawal by Subject|0|||
144391362|NCT03119701|520642581|FG001|6-day Dosing|Withdrawal by Subject|1|||
144391363|NCT03119701|520642580|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
144391364|NCT03119701|520642581|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
144391365|NCT01909453|520642591|FG000|Overall Study|Ongoing|118|||
144391366|NCT01909453|520642592|FG001|Overall Study|Ongoing|103|||
144391367|NCT01909453|520642593|FG002|Overall Study|Ongoing|83|||
144391368|NCT01909453|520642594|FG003|Overall Study|Ongoing|164|||
144391369|NCT01909453|520642595|FG004|Overall Study|Ongoing|50|||
144391370|NCT01909453|520642591|FG000|Overall Study|Death|69|||
144391371|NCT01909453|520642592|FG001|Overall Study|Death|74|||
144391372|NCT01909453|520642593|FG002|Overall Study|Death|88|||
144391373|NCT01909453|520642594|FG003|Overall Study|Death|86|||
144391374|NCT01909453|520642595|FG004|Overall Study|Death|29|||
144391375|NCT01909453|520642591|FG000|Overall Study|Lost to Follow-up|3|||
144391376|NCT01909453|520642592|FG001|Overall Study|Lost to Follow-up|4|||
144391377|NCT01909453|520642593|FG002|Overall Study|Lost to Follow-up|4|||
144391378|NCT01909453|520642594|FG003|Overall Study|Lost to Follow-up|3|||
144391379|NCT01909453|520642595|FG004|Overall Study|Lost to Follow-up|3|||
144391380|NCT01909453|520642591|FG000|Overall Study|Withdrawal by Subject|2|||
144391381|NCT01909453|520642592|FG001|Overall Study|Withdrawal by Subject|13|||
144391382|NCT01909453|520642593|FG002|Overall Study|Withdrawal by Subject|16|||
144391383|NCT01909453|520642594|FG003|Overall Study|Withdrawal by Subject|5|||
144391384|NCT01909453|520642595|FG004|Overall Study|Withdrawal by Subject|4|||
144391385|NCT00543855|520644049|FG000|Overall Study|Adverse Event|3|||
144391386|NCT00543855|520644050|FG001|Overall Study|Adverse Event|1|||
144391387|NCT00543855|520644051|FG002|Overall Study|Adverse Event|3|||
144391388|NCT00543855|520644052|FG003|Overall Study|Adverse Event|4|||
144391389|NCT00543855|520644049|FG000|Overall Study|Lost to Follow-up|0|||
144391390|NCT00543855|520644050|FG001|Overall Study|Lost to Follow-up|0|||
144391391|NCT00543855|520644051|FG002|Overall Study|Lost to Follow-up|1|||
144391392|NCT00543855|520644052|FG003|Overall Study|Lost to Follow-up|0|||
144391393|NCT00543855|520644049|FG000|Overall Study|Withdrawal by Subject|0|||
144391394|NCT00543855|520644050|FG001|Overall Study|Withdrawal by Subject|1|||
144391395|NCT00543855|520644051|FG002|Overall Study|Withdrawal by Subject|2|||
144391396|NCT00543855|520644052|FG003|Overall Study|Withdrawal by Subject|0|||
144517872|NCT02307565|521096244|FG000|Overall Study|Withdrawal by Subject|2|||
144517873|NCT02307565|521096245|FG001|Overall Study|Withdrawal by Subject|2|||
144517874|NCT00931710|521096248|FG000|Overall Study|Adverse Event|16|||
144391397|NCT00543855|520644049|FG000|Overall Study|Protocol Violation|1|||
144391398|NCT00543855|520644050|FG001|Overall Study|Protocol Violation|0|||
144391399|NCT00543855|520644051|FG002|Overall Study|Protocol Violation|0|||
144391400|NCT00543855|520644052|FG003|Overall Study|Protocol Violation|0|||
144391401|NCT04285580|520644053|FG000|Overall Study|Protocol Violation|0|||
144391402|NCT04285580|520644054|FG001|Overall Study|Protocol Violation|1|||
144391403|NCT02582255|520644055|FG000|Overall Study|Protocol Violation|0|||
144391404|NCT02582255|520644056|FG001|Overall Study|Protocol Violation|3|||
144391405|NCT01709578|520644058|FG000|Overall Study|Rescued and entered in long term safety|63|||
144391406|NCT01709578|520644059|FG001|Overall Study|Rescued and entered in long term safety|25|||
144391407|NCT01709578|520644060|FG002|Overall Study|Rescued and entered in long term safety|26|||
144391408|NCT01709578|520644058|FG000|Overall Study|Adverse Event|9|||
144391409|NCT01709578|520644059|FG001|Overall Study|Adverse Event|18|||
144517875|NCT00931710|521096249|FG001|Overall Study|Adverse Event|10|||
144517876|NCT00931710|521096248|FG000|Overall Study|Abnormal test procedure results|2|||
144391410|NCT01709578|520644060|FG002|Overall Study|Adverse Event|17|||
144391411|NCT01709578|520644058|FG000|Overall Study|Lack of Efficacy|5|||
144391412|NCT01709578|520644059|FG001|Overall Study|Lack of Efficacy|4|||
144391413|NCT01709578|520644060|FG002|Overall Study|Lack of Efficacy|2|||
144391414|NCT01709578|520644058|FG000|Overall Study|Poor compliance to protocol|1|||
144391415|NCT01709578|520644059|FG001|Overall Study|Poor compliance to protocol|2|||
144391416|NCT01709578|520644060|FG002|Overall Study|Poor compliance to protocol|1|||
144391417|NCT01709578|520644058|FG000|Overall Study|Other, not related to safety or efficacy|2|||
144391418|NCT01709578|520644059|FG001|Overall Study|Other, not related to safety or efficacy|7|||
144391419|NCT01709578|520644060|FG002|Overall Study|Other, not related to safety or efficacy|5|||
144391420|NCT00076024|520644063|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
144391421|NCT00076024|520644064|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
144391422|NCT00076024|520644065|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
144391423|NCT00076024|520644066|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
144391424|NCT00076024|520644063|FG000|Phase 1, Lead-in|Adverse Event|1|||
144391425|NCT00076024|520644064|FG001|Phase 1, Lead-in|Adverse Event|0|||
144391426|NCT00076024|520644065|FG002|Phase 1, Lead-in|Adverse Event|0|||
144391427|NCT00076024|520644066|FG003|Phase 1, Lead-in|Adverse Event|0|||
144391428|NCT00076024|520644063|FG000|Phase 1, Lead-in|Clinical progression|1|||
144391429|NCT00076024|520644064|FG001|Phase 1, Lead-in|Clinical progression|0|||
144391430|NCT00076024|520644065|FG002|Phase 1, Lead-in|Clinical progression|0|||
144391431|NCT00076024|520644066|FG003|Phase 1, Lead-in|Clinical progression|0|||
144391432|NCT00076024|520644063|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
144391433|NCT00076024|520644064|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
144391434|NCT00076024|520644065|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
144391435|NCT00076024|520644066|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
144391436|NCT00076024|520644063|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
144391437|NCT00076024|520644064|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
144391438|NCT00076024|520644065|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
144391439|NCT00076024|520644066|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
144391440|NCT00076024|520644063|FG000|Phase 2, Double-blind|Adverse Event|0|||
144391441|NCT00076024|520644064|FG001|Phase 2, Double-blind|Adverse Event|25|||
144391442|NCT00076024|520644065|FG002|Phase 2, Double-blind|Adverse Event|6|||
144391443|NCT00076024|520644066|FG003|Phase 2, Double-blind|Adverse Event|0|||
144391444|NCT00076024|520644063|FG000|Phase 2, Double-blind|Un-specified|0|||
144391445|NCT00076024|520644064|FG001|Phase 2, Double-blind|Un-specified|14|||
144391446|NCT00076024|520644065|FG002|Phase 2, Double-blind|Un-specified|6|||
144391447|NCT00076024|520644066|FG003|Phase 2, Double-blind|Un-specified|0|||
144391448|NCT00076024|520644063|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
144391449|NCT00076024|520644064|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
144391450|NCT00076024|520644065|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
144391451|NCT00076024|520644066|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
144391452|NCT00076024|520644063|FG000|Phase 2, Open-label|Adverse Event|0|||
144391453|NCT00076024|520644064|FG001|Phase 2, Open-label|Adverse Event|0|||
144391454|NCT00076024|520644065|FG002|Phase 2, Open-label|Adverse Event|0|||
144391455|NCT00076024|520644066|FG003|Phase 2, Open-label|Adverse Event|2|||
144391456|NCT00076024|520644063|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
144391457|NCT00076024|520644064|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
144391458|NCT00076024|520644065|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
144391459|NCT00076024|520644066|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
144391460|NCT00076024|520644063|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
144391461|NCT00076024|520644064|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
144391462|NCT00076024|520644065|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
144391463|NCT00076024|520644066|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
144391464|NCT00076024|520644063|FG000|Phase 2, Open-label|Other|0|||
144391465|NCT00076024|520644064|FG001|Phase 2, Open-label|Other|0|||
144391466|NCT00076024|520644065|FG002|Phase 2, Open-label|Other|0|||
144391467|NCT00076024|520644066|FG003|Phase 2, Open-label|Other|2|||
144391468|NCT00301821|520644071|FG000|Overall Study|Ineligible|25|||
144391469|NCT00301821|520644071|FG000|Overall Study|Cancel|1|||
144391470|NCT02294773|520644072|FG000|Overall Study|Withdrawal by Subject|0|||
144391471|NCT02294773|520644073|FG001|Overall Study|Withdrawal by Subject|2|||
144391472|NCT03052764|520644074|FG000|Double-Blind Treatment Period|Adverse Event|2|||
144391473|NCT03052764|520644075|FG001|Double-Blind Treatment Period|Adverse Event|0|||
144391474|NCT03052764|520644074|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
144391475|NCT03052764|520644075|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
144391476|NCT03052764|520644074|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
144391477|NCT03052764|520644075|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
144391478|NCT03052764|520644074|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
144391479|NCT03052764|520644075|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144199335|NCT03107026|519928871|FG001|Overall Study|Withdrawal by Subject|5|||
144391480|NCT03052764|520644074|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
144391481|NCT03052764|520644075|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
144391482|NCT03206073|520644076|FG000|Overall Study|Participant Noncompliance|0|||
144517877|NCT00931710|521096249|FG001|Overall Study|Abnormal test procedure results|0|||
144517878|NCT00931710|521096248|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
144517879|NCT00931710|521096249|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
144517880|NCT00931710|521096248|FG000|Overall Study|Patient withdrew consent|4|||
144517881|NCT00931710|521096249|FG001|Overall Study|Patient withdrew consent|9|||
144391483|NCT03206073|520644077|FG001|Overall Study|Participant Noncompliance|1|||
144517882|NCT00931710|521096248|FG000|Overall Study|Lost to Follow-up|6|||
144722161|NCT01463683|521836993|FG002|Overall Study|Pregnancy|1|||
144391484|NCT03206073|520644078|FG002|Overall Study|Participant Noncompliance|0|||
144722162|NCT01463683|521836991|FG000|Overall Study|Withdrawal by Subject|5|||
144391485|NCT03206073|520644079|FG003|Overall Study|Participant Noncompliance|0|||
144391486|NCT03206073|520644076|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
144391487|NCT03206073|520644077|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
144391488|NCT03206073|520644078|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
144391489|NCT03206073|520644079|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
144391490|NCT03206073|520644076|FG000|Overall Study|Death|0|||
144391491|NCT03206073|520644077|FG001|Overall Study|Death|0|||
144391492|NCT03206073|520644078|FG002|Overall Study|Death|1|||
144391493|NCT03206073|520644079|FG003|Overall Study|Death|0|||
144391494|NCT03206073|520644076|FG000|Overall Study|Taken off active treatment|0|||
144391495|NCT03206073|520644077|FG001|Overall Study|Taken off active treatment|0|||
144391496|NCT03206073|520644078|FG002|Overall Study|Taken off active treatment|3|||
144391497|NCT03206073|520644079|FG003|Overall Study|Taken off active treatment|0|||
144391498|NCT03332771|520644080|FG000|Overall Study|Adverse Event|6|||
144391499|NCT03332771|520644081|FG001|Overall Study|Adverse Event|4|||
144391500|NCT03332771|520644082|FG002|Overall Study|Adverse Event|1|||
144391501|NCT03332771|520644083|FG003|Overall Study|Adverse Event|3|||
144391502|NCT03332771|520644080|FG000|Overall Study|Poor Compliance to Protocol|0|||
144391503|NCT03332771|520644081|FG001|Overall Study|Poor Compliance to Protocol|1|||
144391504|NCT03332771|520644082|FG002|Overall Study|Poor Compliance to Protocol|0|||
144391505|NCT03332771|520644083|FG003|Overall Study|Poor Compliance to Protocol|1|||
144391506|NCT03332771|520644080|FG000|Overall Study|Lost to Follow-up|2|||
144391507|NCT03332771|520644081|FG001|Overall Study|Lost to Follow-up|2|||
144391508|NCT03332771|520644082|FG002|Overall Study|Lost to Follow-up|1|||
144391509|NCT03332771|520644083|FG003|Overall Study|Lost to Follow-up|2|||
144391510|NCT03332771|520644080|FG000|Overall Study|At the Participant's own request|20|||
144391511|NCT03332771|520644081|FG001|Overall Study|At the Participant's own request|26|||
144391512|NCT03332771|520644082|FG002|Overall Study|At the Participant's own request|14|||
144391513|NCT03332771|520644083|FG003|Overall Study|At the Participant's own request|23|||
144391514|NCT03332771|520644080|FG000|Overall Study|Reason Not Specified|6|||
144391515|NCT03332771|520644081|FG001|Overall Study|Reason Not Specified|18|||
144391516|NCT03332771|520644082|FG002|Overall Study|Reason Not Specified|16|||
144391517|NCT03332771|520644083|FG003|Overall Study|Reason Not Specified|19|||
144391518|NCT00920829|520644085|FG000|Allocation|No post randomization data|3|||
144391519|NCT00920829|520644086|FG001|Allocation|No post randomization data|1|||
144391520|NCT00920829|520644087|FG002|Allocation|No post randomization data|0|||
144391521|NCT00920829|520644088|FG003|Allocation|No post randomization data|2|||
144391522|NCT00920829|520644085|FG000|Available for Analysis|Withdrawal by Subject|6|||
144391523|NCT00920829|520644086|FG001|Available for Analysis|Withdrawal by Subject|6|||
144391524|NCT00920829|520644087|FG002|Available for Analysis|Withdrawal by Subject|6|||
144391525|NCT00920829|520644088|FG003|Available for Analysis|Withdrawal by Subject|10|||
144391526|NCT00920829|520644085|FG000|Available for Analysis|Required Medical Treatment|0|||
144391527|NCT00920829|520644086|FG001|Available for Analysis|Required Medical Treatment|1|||
144391528|NCT00920829|520644087|FG002|Available for Analysis|Required Medical Treatment|2|||
144391529|NCT00920829|520644088|FG003|Available for Analysis|Required Medical Treatment|0|||
144391530|NCT00920829|520644085|FG000|Available for Analysis|Adverse Event|1|||
144391531|NCT00920829|520644086|FG001|Available for Analysis|Adverse Event|2|||
144391532|NCT00920829|520644087|FG002|Available for Analysis|Adverse Event|1|||
144391533|NCT00920829|520644088|FG003|Available for Analysis|Adverse Event|0|||
144391534|NCT00920829|520644085|FG000|Available for Analysis|Death|1|||
144391535|NCT00920829|520644086|FG001|Available for Analysis|Death|0|||
144517883|NCT00931710|521096249|FG001|Overall Study|Lost to Follow-up|5|||
144517884|NCT00931710|521096248|FG000|Overall Study|Protocol deviation|1|||
144391536|NCT00920829|520644087|FG002|Available for Analysis|Death|0|||
144391537|NCT00920829|520644088|FG003|Available for Analysis|Death|0|||
144391538|NCT00920829|520644085|FG000|Available for Analysis|Protocol Violation|0|||
144391539|NCT00920829|520644086|FG001|Available for Analysis|Protocol Violation|0|||
144391540|NCT00920829|520644087|FG002|Available for Analysis|Protocol Violation|1|||
144391541|NCT00920829|520644088|FG003|Available for Analysis|Protocol Violation|0|||
144391542|NCT00920829|520644085|FG000|Available for Analysis|Required more treatment|0|||
144391543|NCT00920829|520644086|FG001|Available for Analysis|Required more treatment|2|||
144391544|NCT00920829|520644087|FG002|Available for Analysis|Required more treatment|0|||
144391545|NCT00920829|520644088|FG003|Available for Analysis|Required more treatment|1|||
144391546|NCT04123665|520644089|FG000|Overall Study|Withdrawal by Subject|7|||
144391547|NCT04123665|520644090|FG001|Overall Study|Withdrawal by Subject|0|||
144391548|NCT04123665|520644089|FG000|Overall Study|Lost to Follow-up|1|||
144391549|NCT04123665|520644090|FG001|Overall Study|Lost to Follow-up|0|||
144391550|NCT01711879|520644095|FG000|Overall Study|Death|1|||
144391551|NCT01711879|520644096|FG001|Overall Study|Death|0|||
144391552|NCT02239224|520644104|FG000|Overall Study|Administrative|0|||
144391553|NCT02239224|520644105|FG001|Overall Study|Administrative|0|||
144391554|NCT02239224|520644106|FG002|Overall Study|Administrative|3|||
144391555|NCT02239224|520644107|FG003|Overall Study|Administrative|1|||
144391556|NCT01466179|520644109|FG000|Overall Study|Ongoing in core study|2|||
144391557|NCT01466179|520644109|FG000|Overall Study|Physician Decision|46|||
144391558|NCT01466179|520644109|FG000|Overall Study|Progressive disease|43|||
144391559|NCT01466179|520644109|FG000|Overall Study|Adverse Event|32|||
144391560|NCT01466179|520644109|FG000|Overall Study|Disease relapse|23|||
144391561|NCT01466179|520644109|FG000|Overall Study|Lack of Efficacy|14|||
144391562|NCT01466179|520644109|FG000|Overall Study|Death|7|||
144391563|NCT01466179|520644109|FG000|Overall Study|Withdrawal by Subject|7|||
144391564|NCT01466179|520644109|FG000|Overall Study|Protocol Violation|2|||
144391565|NCT01466179|520644109|FG000|Overall Study|Other|3|||
144391566|NCT00737464|520644110|FG000|Overall Study|Adverse Event|1|||
144391567|NCT00737464|520644110|FG000|Overall Study|Death|6|||
144391568|NCT00737464|520644110|FG000|Overall Study|Other - Failure to Return|1|||
144391569|NCT00737464|520644110|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
144391570|NCT00737464|520644110|FG000|Overall Study|Other reasons|4|||
144391571|NCT04177355|520644119|FG000|Overall Study|Lost to Follow-up|0|||
144391572|NCT04177355|520644120|FG001|Overall Study|Lost to Follow-up|2|||
144391573|NCT04177355|520644121|FG002|Overall Study|Lost to Follow-up|0|||
144391574|NCT04177355|520644122|FG003|Overall Study|Lost to Follow-up|1|||
144391575|NCT04177355|520644123|FG004|Overall Study|Lost to Follow-up|2|||
144391576|NCT04177355|520644124|FG005|Overall Study|Lost to Follow-up|0|||
144391577|NCT04177355|520644125|FG006|Overall Study|Lost to Follow-up|1|||
144391578|NCT04177355|520644126|FG007|Overall Study|Lost to Follow-up|0|||
144391579|NCT04177355|520644127|FG008|Overall Study|Lost to Follow-up|0|||
144391580|NCT04177355|520644128|FG009|Overall Study|Lost to Follow-up|0|||
144391581|NCT04177355|520644129|FG010|Overall Study|Lost to Follow-up|0|||
144391582|NCT04177355|520644119|FG000|Overall Study|Withdrawal by Subject|0|||
144391583|NCT04177355|520644120|FG001|Overall Study|Withdrawal by Subject|0|||
144391584|NCT04177355|520644121|FG002|Overall Study|Withdrawal by Subject|0|||
144391585|NCT04177355|520644122|FG003|Overall Study|Withdrawal by Subject|1|||
144391586|NCT04177355|520644123|FG004|Overall Study|Withdrawal by Subject|1|||
144391587|NCT04177355|520644124|FG005|Overall Study|Withdrawal by Subject|0|||
144391588|NCT04177355|520644125|FG006|Overall Study|Withdrawal by Subject|0|||
144391589|NCT04177355|520644126|FG007|Overall Study|Withdrawal by Subject|0|||
144391590|NCT04177355|520644127|FG008|Overall Study|Withdrawal by Subject|1|||
144391591|NCT04177355|520644128|FG009|Overall Study|Withdrawal by Subject|0|||
144391592|NCT04177355|520644129|FG010|Overall Study|Withdrawal by Subject|0|||
144391593|NCT03101267|520644131|FG000|Primary Study Period|Withdrawal by Subject|1|||
144391594|NCT03101267|520644132|FG001|Primary Study Period|Withdrawal by Subject|2|||
144391595|NCT03101267|520644133|FG002|Primary Study Period|Withdrawal by Subject|3|||
144391596|NCT03101267|520644131|FG000|Primary Study Period|Miscellaneous|2|||
144391597|NCT03101267|520644132|FG001|Primary Study Period|Miscellaneous|0|||
144391598|NCT03101267|520644133|FG002|Primary Study Period|Miscellaneous|0|||
144391599|NCT00107952|520644134|FG000|Overall Study|Death|75|||
144391600|NCT00107952|520644135|FG001|Overall Study|Death|61|||
144391601|NCT00107952|520644134|FG000|Overall Study|Lost to Follow-up|0|||
144391602|NCT00107952|520644135|FG001|Overall Study|Lost to Follow-up|3|||
144391603|NCT00107952|520644134|FG000|Overall Study|Withdrawal by Subject|9|||
144391604|NCT00107952|520644135|FG001|Overall Study|Withdrawal by Subject|6|||
144391605|NCT00107952|520644134|FG000|Overall Study|Other|2|||
144391606|NCT00107952|520644135|FG001|Overall Study|Other|5|||
144391607|NCT00107952|520644134|FG000|Overall Study|Never received study treatment|9|||
144391608|NCT00107952|520644135|FG001|Overall Study|Never received study treatment|6|||
144391609|NCT02045303|520644143|FG000|Overall Study|Protocol Violation|2|||
144391610|NCT02045303|520644144|FG001|Overall Study|Protocol Violation|1|||
144391611|NCT02045303|520644145|FG002|Overall Study|Protocol Violation|0|||
144391612|NCT02045303|520644143|FG000|Overall Study|Withdrawal by Subject|0|||
144391613|NCT02045303|520644144|FG001|Overall Study|Withdrawal by Subject|2|||
144391614|NCT02045303|520644145|FG002|Overall Study|Withdrawal by Subject|0|||
144391615|NCT01856023|520644146|FG000|Overall Study|Death|1|||
144391616|NCT01856023|520644147|FG001|Overall Study|Death|2|||
144391617|NCT01856023|520644146|FG000|Overall Study|Adverse Event|2|||
144391618|NCT01856023|520644147|FG001|Overall Study|Adverse Event|1|||
144517885|NCT00931710|521096249|FG001|Overall Study|Protocol deviation|2|||
144517886|NCT04936035|521096250|FG000|Overall Study|Adverse Event|0|||
144517887|NCT04936035|521096251|FG001|Overall Study|Adverse Event|1|||
144391619|NCT01856023|520644146|FG000|Overall Study|Lack of Efficacy|5|||
144391620|NCT01856023|520644147|FG001|Overall Study|Lack of Efficacy|5|||
144391621|NCT01856023|520644146|FG000|Overall Study|non compliance, study closure|1|||
144391622|NCT01856023|520644147|FG001|Overall Study|non compliance, study closure|3|||
144391623|NCT01856023|520644146|FG000|Overall Study|Withdrawal by Subject|1|||
144391624|NCT01856023|520644147|FG001|Overall Study|Withdrawal by Subject|1|||
144517888|NCT04936035|521096252|FG002|Overall Study|Adverse Event|0|||
144391625|NCT00256282|520644148|FG000|Overall Study|Disease progression, relapse during acti|12|||
144391626|NCT00256282|520644148|FG000|Overall Study|Adverse Event|3|||
144391627|NCT00256282|520644148|FG000|Overall Study|Physician Decision|1|||
144391628|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
144391629|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
144391630|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Other|2|||
144391631|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Other|2|||
144391632|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Personal reasons|2|||
144391633|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Personal reasons|2|||
144391634|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
144391635|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
144391636|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
144391637|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
144391638|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
144391639|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
144391640|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
144391641|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
144391642|NCT00667446|520644149|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
144391643|NCT00667446|520644150|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
144391644|NCT00667446|520644149|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
144391645|NCT00667446|520644150|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
144391646|NCT03945175|520644152|FG000|Overall Study|Did not meet inclusion criteria|31|||
144391647|NCT03945175|520644152|FG000|Overall Study|Withdrew consent|2|||
144391648|NCT03945175|520644152|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
144391649|NCT03945175|520644152|FG000|Overall Study|Early termination during Mydayis treatment|1|||
144391650|NCT00769483|520644160|FG000|Overall Study|Withdrawal by Subject|0|||
144391651|NCT00769483|520644161|FG001|Overall Study|Withdrawal by Subject|1|||
144391652|NCT00769483|520644162|FG002|Overall Study|Withdrawal by Subject|0|||
144391653|NCT00769483|520644163|FG003|Overall Study|Withdrawal by Subject|0|||
144391654|NCT00769483|520644164|FG004|Overall Study|Withdrawal by Subject|1|||
144391655|NCT00769483|520644165|FG005|Overall Study|Withdrawal by Subject|0|||
144391656|NCT01306877|520644166|FG000|Overall Study|Lost to Follow-up|3|||
144391657|NCT01306877|520644167|FG001|Overall Study|Lost to Follow-up|3|||
144391658|NCT01306877|520644166|FG000|Overall Study|Physician Decision|0|||
144391659|NCT01306877|520644167|FG001|Overall Study|Physician Decision|1|||
144391660|NCT00006389|520644168|FG000|Overall Study|Adverse Event|1|||
144391661|NCT00999921|520644173|FG000|Overall Study|Lost to Follow-up|10|||
144391662|NCT00999921|520644174|FG001|Overall Study|Lost to Follow-up|19|||
144391663|NCT00772070|520644181|FG000|Overall Study|Lost to Follow-up|0|||
144391664|NCT00772070|520644182|FG001|Overall Study|Lost to Follow-up|8|||
144391665|NCT00772070|520644181|FG000|Overall Study|Withdrawal by Subject|0|||
144391666|NCT00772070|520644182|FG001|Overall Study|Withdrawal by Subject|2|||
144391667|NCT00772070|520644181|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
144391668|NCT00772070|520644182|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
144391669|NCT01309308|520644183|FG000|Overall Study|Lost to Follow-up|6|||
144391670|NCT01309308|520644184|FG001|Overall Study|Lost to Follow-up|4|||
144391671|NCT01962922|520644185|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
144391672|NCT01962922|520644186|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
144391673|NCT01962922|520644185|FG000|PK Portion Day 7|non-compliance|1|||
144391674|NCT01962922|520644186|FG001|PK Portion Day 7|non-compliance|0|||
144391675|NCT01962922|520644185|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
144391676|NCT01962922|520644186|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
144391677|NCT01962922|520644185|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
144391678|NCT01962922|520644186|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
144391679|NCT00596362|520644187|FG000|Overall Study|Progressive Disease|1|||
144391680|NCT00817479|520644188|FG000|Overall Study|Physician Decision|1|||
144391681|NCT00817479|520644189|FG001|Overall Study|Physician Decision|1|||
144391682|NCT00282347|520644192|FG000|Treatment Period|Death|2|||
144391683|NCT00282347|520644193|FG001|Treatment Period|Death|0|||
144391684|NCT00282347|520644192|FG000|Treatment Period|Lost to Follow-up|2|||
144391685|NCT00282347|520644193|FG001|Treatment Period|Lost to Follow-up|5|||
144391686|NCT00282347|520644192|FG000|Treatment Period|Withdrawal by Subject|1|||
144391687|NCT00282347|520644193|FG001|Treatment Period|Withdrawal by Subject|3|||
144391688|NCT00282347|520644192|FG000|Treatment Period|Physician Decision|0|||
144391689|NCT00282347|520644193|FG001|Treatment Period|Physician Decision|1|||
144391690|NCT00282347|520644192|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
144391691|NCT00282347|520644193|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
144391692|NCT00282347|520644192|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
144391693|NCT00282347|520644193|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
144391694|NCT00282347|520644192|FG000|Safety Follow-up Period|Physician Decision|1|||
144517889|NCT04936035|521096253|FG003|Overall Study|Adverse Event|0|||
144517890|NCT04936035|521096254|FG004|Overall Study|Adverse Event|0|||
144391695|NCT00282347|520644193|FG001|Safety Follow-up Period|Physician Decision|1|||
144391696|NCT00282347|520644192|FG000|Safety Follow-up Period|Protocol Deviation|0|||
144391697|NCT00282347|520644193|FG001|Safety Follow-up Period|Protocol Deviation|2|||
144391698|NCT00282347|520644192|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
144391699|NCT00282347|520644193|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
144391700|NCT00282347|520644192|FG000|B Cell Follow-up Period|Physician Decision|1|||
144391701|NCT00282347|520644193|FG001|B Cell Follow-up Period|Physician Decision|0|||
144391702|NCT00282347|520644192|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
144391703|NCT00282347|520644193|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
144391704|NCT00053365|520645919|FG000|Overall Study|Incorrect cell type|1|||
144391705|NCT00053365|520645919|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
144391706|NCT00053365|520645919|FG000|Overall Study|Never treated|4|||
144391707|NCT03183778|520645922|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
144391708|NCT00721123|520645923|FG000|Overall Study|Adverse Event|96|||
144391709|NCT00721123|520645923|FG000|Overall Study|Death|10|||
144391710|NCT00721123|520645923|FG000|Overall Study|Insufficient Therapeutic Response|21|||
144391711|NCT00721123|520645923|FG000|Overall Study|Protocol Violation|1|||
144391712|NCT00721123|520645923|FG000|Overall Study|Refused Treatment|41|||
144391713|NCT00721123|520645923|FG000|Overall Study|Failure to Return|9|||
144391714|NCT00721123|520645923|FG000|Overall Study|Withdrawal by Subject|5|||
144391715|NCT03228420|520645929|FG000|Overall Study|Lost to Follow-up|5|||
144391716|NCT03228420|520645930|FG001|Overall Study|Lost to Follow-up|3|||
144391717|NCT03228420|520645929|FG000|Overall Study|Withdrawal by Subject|10|||
144391718|NCT03228420|520645930|FG001|Overall Study|Withdrawal by Subject|0|||
144391719|NCT03228420|520645929|FG000|Overall Study|Adverse Event|5|||
144391720|NCT03228420|520645930|FG001|Overall Study|Adverse Event|2|||
144391721|NCT03954041|520645933|FG000|Overall Study|Lost to Follow-up|3|||
144391722|NCT03954041|520645934|FG001|Overall Study|Lost to Follow-up|3|||
144391723|NCT03954041|520645935|FG002|Overall Study|Lost to Follow-up|6|||
144391724|NCT03954041|520645933|FG000|Overall Study|Death|4|||
144391725|NCT03954041|520645934|FG001|Overall Study|Death|0|||
144391726|NCT03954041|520645935|FG002|Overall Study|Death|1|||
144391727|NCT03954041|520645933|FG000|Overall Study|Death by neurologic criteria|0|||
144593970|NCT00816400|521376072|FG000|Overall Study|In hospice care at the end of the study|0|||
144593971|NCT00816400|521376073|FG001|Overall Study|In hospice care at the end of the study|0|||
144593972|NCT00816400|521376074|FG002|Overall Study|In hospice care at the end of the study|2|||
144593973|NCT00816400|521376075|FG003|Overall Study|In hospice care at the end of the study|0|||
144593974|NCT00816400|521376076|FG004|Overall Study|In hospice care at the end of the study|0|||
144391728|NCT03954041|520645934|FG001|Overall Study|Death by neurologic criteria|0|||
144593975|NCT00816400|521376077|FG005|Overall Study|In hospice care at the end of the study|0|||
144593976|NCT00816400|521376078|FG006|Overall Study|In hospice care at the end of the study|0|||
144593977|NCT00816400|521376079|FG007|Overall Study|In hospice care at the end of the study|0|||
144593978|NCT00816400|521376080|FG008|Overall Study|In hospice care at the end of the study|0|||
144593979|NCT02647320|521376081|FG000|Overall Study|Adverse Event|0|||
144593980|NCT02647320|521376082|FG001|Overall Study|Adverse Event|1|||
144593981|NCT02647320|521376083|FG002|Overall Study|Adverse Event|3|||
144593982|NCT02647320|521376084|FG003|Overall Study|Adverse Event|2|||
144593983|NCT02647320|521376085|FG004|Overall Study|Adverse Event|1|||
144593984|NCT02647320|521376081|FG000|Overall Study|Protocol Violation|0|||
144593985|NCT02647320|521376082|FG001|Overall Study|Protocol Violation|0|||
144593986|NCT02647320|521376083|FG002|Overall Study|Protocol Violation|3|||
144593987|NCT02647320|521376084|FG003|Overall Study|Protocol Violation|0|||
144593988|NCT02647320|521376085|FG004|Overall Study|Protocol Violation|0|||
144593989|NCT02647320|521376081|FG000|Overall Study|Withdrawal by Subject|7|||
144593990|NCT02647320|521376082|FG001|Overall Study|Withdrawal by Subject|4|||
144593991|NCT02647320|521376083|FG002|Overall Study|Withdrawal by Subject|2|||
144593992|NCT02647320|521376084|FG003|Overall Study|Withdrawal by Subject|2|||
144593993|NCT02647320|521376085|FG004|Overall Study|Withdrawal by Subject|7|||
144391729|NCT03954041|520645935|FG002|Overall Study|Death by neurologic criteria|1|||
144391730|NCT03954041|520645933|FG000|Overall Study|Reason not specified|7|||
144391731|NCT03954041|520645934|FG001|Overall Study|Reason not specified|4|||
144391732|NCT03954041|520645935|FG002|Overall Study|Reason not specified|2|||
144391733|NCT03954041|520645933|FG000|Overall Study|Withdrew prior to dosing|4|||
144391734|NCT03954041|520645934|FG001|Overall Study|Withdrew prior to dosing|2|||
144593994|NCT02647320|521376081|FG000|Overall Study|Persistent hyperglycemia|0|||
144593995|NCT02647320|521376082|FG001|Overall Study|Persistent hyperglycemia|1|||
144593996|NCT02647320|521376083|FG002|Overall Study|Persistent hyperglycemia|1|||
144391735|NCT03954041|520645935|FG002|Overall Study|Withdrew prior to dosing|0|||
144391736|NCT03981822|520645938|FG000|Overall Study|Lost to Follow-up|0|||
144391737|NCT03981822|520645939|FG001|Overall Study|Lost to Follow-up|1|||
144391738|NCT03981822|520645940|FG002|Overall Study|Lost to Follow-up|1|||
144391739|NCT03981822|520645941|FG003|Overall Study|Lost to Follow-up|0|||
144391740|NCT03981822|520645942|FG004|Overall Study|Lost to Follow-up|6|||
144391741|NCT03981822|520645943|FG005|Overall Study|Lost to Follow-up|4|||
144391742|NCT03981822|520645944|FG006|Overall Study|Lost to Follow-up|4|||
144391743|NCT03981822|520645945|FG007|Overall Study|Lost to Follow-up|2|||
144391744|NCT03981822|520645938|FG000|Overall Study|Withdrawal by Subject|0|||
144391745|NCT03981822|520645939|FG001|Overall Study|Withdrawal by Subject|1|||
144391746|NCT03981822|520645940|FG002|Overall Study|Withdrawal by Subject|0|||
144391747|NCT03981822|520645941|FG003|Overall Study|Withdrawal by Subject|0|||
144391748|NCT03981822|520645942|FG004|Overall Study|Withdrawal by Subject|0|||
144391749|NCT03981822|520645943|FG005|Overall Study|Withdrawal by Subject|1|||
144391750|NCT03981822|520645944|FG006|Overall Study|Withdrawal by Subject|0|||
144391751|NCT03981822|520645945|FG007|Overall Study|Withdrawal by Subject|2|||
144391752|NCT03981822|520645938|FG000|Overall Study|COVID-19 Related|0|||
144391753|NCT03981822|520645939|FG001|Overall Study|COVID-19 Related|0|||
144391754|NCT03981822|520645940|FG002|Overall Study|COVID-19 Related|0|||
144391755|NCT03981822|520645941|FG003|Overall Study|COVID-19 Related|0|||
144391756|NCT03981822|520645942|FG004|Overall Study|COVID-19 Related|2|||
144391757|NCT03981822|520645943|FG005|Overall Study|COVID-19 Related|1|||
144391758|NCT03981822|520645944|FG006|Overall Study|COVID-19 Related|2|||
144391759|NCT03981822|520645945|FG007|Overall Study|COVID-19 Related|1|||
144391760|NCT02742246|520645946|FG000|Overall Study|Never initiated treatment|5|||
144391761|NCT02742246|520645947|FG001|Overall Study|Never initiated treatment|3|||
144391762|NCT02742246|520645948|FG002|Overall Study|Never initiated treatment|1|||
144391763|NCT02742246|520645946|FG000|Overall Study|dropped out during treatment|7|||
144391764|NCT02742246|520645947|FG001|Overall Study|dropped out during treatment|13|||
144391765|NCT02742246|520645948|FG002|Overall Study|dropped out during treatment|10|||
144391766|NCT02742246|520645946|FG000|Overall Study|Death|1|||
144391767|NCT02742246|520645947|FG001|Overall Study|Death|0|||
144391768|NCT02742246|520645948|FG002|Overall Study|Death|0|||
144391769|NCT03489551|520645949|FG000|Overall Study|Withdrawal by Subject|2|||
144391770|NCT00054717|520645951|FG000|Overall Study|Randomized but not treated|2|||
144391771|NCT00054717|520645952|FG001|Overall Study|Randomized but not treated|8|||
144391772|NCT00054717|520645951|FG000|Overall Study|Adverse Event|70|||
144391773|NCT00054717|520645952|FG001|Overall Study|Adverse Event|22|||
144391774|NCT00054717|520645951|FG000|Overall Study|Protocol Violation|18|||
144391775|NCT00054717|520645952|FG001|Overall Study|Protocol Violation|19|||
144391776|NCT00054717|520645951|FG000|Overall Study|Lost to Follow-up|23|||
144391777|NCT00054717|520645952|FG001|Overall Study|Lost to Follow-up|13|||
144391778|NCT00054717|520645951|FG000|Overall Study|Withdrawal by Subject|32|||
144391779|NCT00054717|520645952|FG001|Overall Study|Withdrawal by Subject|20|||
144391780|NCT00054717|520645951|FG000|Overall Study|Other reason not defined above|117|||
144391781|NCT00054717|520645952|FG001|Overall Study|Other reason not defined above|217|||
144391782|NCT03139604|520645955|FG000|Overall Study|Other|7|||
144391783|NCT03139604|520645956|FG001|Overall Study|Other|3|||
144391784|NCT03139604|520645955|FG000|Overall Study|Withdrawal by Subject|16|||
144391785|NCT03139604|520645956|FG001|Overall Study|Withdrawal by Subject|17|||
144391786|NCT03139604|520645955|FG000|Overall Study|Physician Decision|1|||
144391787|NCT03139604|520645956|FG001|Overall Study|Physician Decision|2|||
144391788|NCT03139604|520645955|FG000|Overall Study|Lost to Follow-up|3|||
144391789|NCT03139604|520645956|FG001|Overall Study|Lost to Follow-up|1|||
144391790|NCT03139604|520645955|FG000|Overall Study|Death|65|||
144391791|NCT03139604|520645956|FG001|Overall Study|Death|67|||
144391792|NCT03139604|520645955|FG000|Overall Study|Study Terminated by Sponsor|122|||
144391793|NCT03139604|520645956|FG001|Overall Study|Study Terminated by Sponsor|127|||
144391794|NCT03139604|520645955|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
144391795|NCT03139604|520645956|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
144391796|NCT00206076|520645958|FG000|Overall Study|Physician Decision|2|||
144391797|NCT00206076|520645959|FG001|Overall Study|Physician Decision|0|||
144391798|NCT00206076|520645958|FG000|Overall Study|Withdrawal by Subject|1|||
144391799|NCT00206076|520645959|FG001|Overall Study|Withdrawal by Subject|1|||
144391800|NCT00427960|520645961|FG000|Overall Study|Adverse Event|2|||
144391801|NCT00427960|520645962|FG001|Overall Study|Adverse Event|0|||
144391802|NCT00427960|520645961|FG000|Overall Study|Withdrawal by Subject|0|||
144391803|NCT00427960|520645962|FG001|Overall Study|Withdrawal by Subject|3|||
144391804|NCT00427960|520645961|FG000|Overall Study|Other|0|||
144391805|NCT00427960|520645962|FG001|Overall Study|Other|1|||
144391806|NCT01142128|520645963|FG000|Overall Study|Physician Decision|1|||
144391807|NCT01142128|520645963|FG000|Overall Study|Lost to Follow-up|1|||
144391808|NCT01142128|520645963|FG000|Overall Study|Withdrawal by Subject|2|||
144391809|NCT00366340|520645964|FG000|Infant Series|Protocol Violation|3|||
144391810|NCT00366340|520645965|FG001|Infant Series|Protocol Violation|4|||
144391811|NCT00366340|520645964|FG000|Infant Series|Withdrawal by Subject|3|||
144391812|NCT00366340|520645965|FG001|Infant Series|Withdrawal by Subject|3|||
144391813|NCT00366340|520645964|FG000|Infant Series|Adverse Event|0|||
144391814|NCT00366340|520645965|FG001|Infant Series|Adverse Event|2|||
144391815|NCT00366340|520645964|FG000|Infant Series|Lost to Follow-up|1|||
144391816|NCT00366340|520645965|FG001|Infant Series|Lost to Follow-up|1|||
144391817|NCT00366340|520645964|FG000|Infant Series|Failure to return|1|||
144391818|NCT00366340|520645965|FG001|Infant Series|Failure to return|0|||
144391819|NCT00366340|520645964|FG000|After the Infant Series|Parent/legal guardian request|1|||
144391820|NCT00366340|520645965|FG001|After the Infant Series|Parent/legal guardian request|1|||
144391821|NCT00366340|520645964|FG000|After the Infant Series|Failed to return|0|||
144391822|NCT00366340|520645965|FG001|After the Infant Series|Failed to return|1|||
144391823|NCT00366340|520645964|FG000|After the Infant Series|Protocol Violation|2|||
144391824|NCT00366340|520645965|FG001|After the Infant Series|Protocol Violation|2|||
144391825|NCT00366340|520645964|FG000|After the Infant Series|Adverse Event|0|||
144391826|NCT00366340|520645965|FG001|After the Infant Series|Adverse Event|1|||
144391827|NCT00366340|520645964|FG000|After the Infant Series|Lost to Follow-up|0|||
144391828|NCT00366340|520645965|FG001|After the Infant Series|Lost to Follow-up|1|||
144391829|NCT00366340|520645964|FG000|Toddler Dose|Failed to return|1|||
144391830|NCT00366340|520645965|FG001|Toddler Dose|Failed to return|0|||
144391831|NCT00366340|520645964|FG000|Toddler Dose|Parent/legal guardian request|0|||
144391832|NCT00366340|520645965|FG001|Toddler Dose|Parent/legal guardian request|1|||
144391833|NCT03355664|520645966|FG000|Overall Study|Adverse Event|1|||
144391834|NCT03355664|520645967|FG001|Overall Study|Adverse Event|2|||
144391835|NCT03355664|520645966|FG000|Overall Study|Lost to Follow-up|11|||
144391836|NCT03355664|520645967|FG001|Overall Study|Lost to Follow-up|7|||
144391837|NCT03355664|520645966|FG000|Overall Study|Protocol Violation|1|||
144391838|NCT03355664|520645967|FG001|Overall Study|Protocol Violation|2|||
144391839|NCT03355664|520645966|FG000|Overall Study|Withdrawal by Subject|2|||
144391840|NCT03355664|520645967|FG001|Overall Study|Withdrawal by Subject|1|||
144391841|NCT00423670|520645973|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
144391842|NCT00423670|520645974|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391843|NCT00423670|520645975|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391844|NCT00423670|520645976|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391845|NCT00423670|520645977|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391846|NCT00423670|520645978|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391847|NCT00423670|520645979|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391848|NCT00423670|520645980|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
144391849|NCT00423670|520645973|FG000|Treatment Period|Adverse Event|8|||
144391850|NCT00423670|520645974|FG001|Treatment Period|Adverse Event|12|||
144391851|NCT00423670|520645975|FG002|Treatment Period|Adverse Event|15|||
144391852|NCT00423670|520645976|FG003|Treatment Period|Adverse Event|20|||
144391853|NCT00423670|520645977|FG004|Treatment Period|Adverse Event|9|||
144391854|NCT00423670|520645978|FG005|Treatment Period|Adverse Event|4|||
144391855|NCT00423670|520645979|FG006|Treatment Period|Adverse Event|7|||
144391856|NCT00423670|520645980|FG007|Treatment Period|Adverse Event|2|||
144391857|NCT00423670|520645973|FG000|Treatment Period|Protocol-defined clinical event|0|||
144391858|NCT00423670|520645974|FG001|Treatment Period|Protocol-defined clinical event|7|||
144391859|NCT00423670|520645975|FG002|Treatment Period|Protocol-defined clinical event|4|||
144391860|NCT00423670|520645976|FG003|Treatment Period|Protocol-defined clinical event|12|||
144517891|NCT04936035|521096250|FG000|Overall Study|Death|0|||
144517892|NCT04936035|521096251|FG001|Overall Study|Death|0|||
144517893|NCT04936035|521096252|FG002|Overall Study|Death|0|||
144391861|NCT00423670|520645977|FG004|Treatment Period|Protocol-defined clinical event|5|||
144391862|NCT00423670|520645978|FG005|Treatment Period|Protocol-defined clinical event|4|||
144391863|NCT00423670|520645979|FG006|Treatment Period|Protocol-defined clinical event|16|||
144391864|NCT00423670|520645980|FG007|Treatment Period|Protocol-defined clinical event|15|||
144391865|NCT00423670|520645973|FG000|Treatment Period|Lost to Follow-up|2|||
144391866|NCT00423670|520645974|FG001|Treatment Period|Lost to Follow-up|1|||
144391867|NCT00423670|520645975|FG002|Treatment Period|Lost to Follow-up|3|||
144391868|NCT00423670|520645976|FG003|Treatment Period|Lost to Follow-up|1|||
144391869|NCT00423670|520645977|FG004|Treatment Period|Lost to Follow-up|6|||
144391870|NCT00423670|520645978|FG005|Treatment Period|Lost to Follow-up|0|||
144391871|NCT00423670|520645979|FG006|Treatment Period|Lost to Follow-up|3|||
144391872|NCT00423670|520645980|FG007|Treatment Period|Lost to Follow-up|1|||
144391873|NCT00423670|520645973|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
144391874|NCT00423670|520645974|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
144391875|NCT00423670|520645975|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
144391876|NCT00423670|520645976|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
144391877|NCT00423670|520645977|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
144391878|NCT00423670|520645978|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
144391879|NCT00423670|520645979|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
144391880|NCT00423670|520645980|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
144391881|NCT00423670|520645973|FG000|Treatment Period|Investigator decision|0|||
144391882|NCT00423670|520645974|FG001|Treatment Period|Investigator decision|0|||
144391883|NCT00423670|520645975|FG002|Treatment Period|Investigator decision|0|||
144391884|NCT00423670|520645976|FG003|Treatment Period|Investigator decision|0|||
144391885|NCT00423670|520645977|FG004|Treatment Period|Investigator decision|0|||
144391886|NCT00423670|520645978|FG005|Treatment Period|Investigator decision|0|||
144391887|NCT00423670|520645979|FG006|Treatment Period|Investigator decision|0|||
144391888|NCT00423670|520645980|FG007|Treatment Period|Investigator decision|1|||
144391889|NCT00423670|520645973|FG000|Treatment Period|Non-compliance with protocol|3|||
144391890|NCT00423670|520645974|FG001|Treatment Period|Non-compliance with protocol|1|||
144391891|NCT00423670|520645975|FG002|Treatment Period|Non-compliance with protocol|1|||
144391892|NCT00423670|520645976|FG003|Treatment Period|Non-compliance with protocol|3|||
144517894|NCT04936035|521096253|FG003|Overall Study|Death|1|||
144517895|NCT04936035|521096254|FG004|Overall Study|Death|0|||
144517896|NCT04936035|521096250|FG000|Overall Study|Lost to Follow-up|0|||
144517897|NCT04936035|521096251|FG001|Overall Study|Lost to Follow-up|1|||
144517898|NCT04936035|521096252|FG002|Overall Study|Lost to Follow-up|1|||
144517899|NCT04936035|521096253|FG003|Overall Study|Lost to Follow-up|2|||
144517900|NCT04936035|521096254|FG004|Overall Study|Lost to Follow-up|1|||
144391893|NCT00423670|520645977|FG004|Treatment Period|Non-compliance with protocol|2|||
144391894|NCT00423670|520645978|FG005|Treatment Period|Non-compliance with protocol|0|||
144391895|NCT00423670|520645979|FG006|Treatment Period|Non-compliance with protocol|2|||
144391896|NCT00423670|520645980|FG007|Treatment Period|Non-compliance with protocol|2|||
144391897|NCT00423670|520645973|FG000|Follow-up Period|Lost to Follow-up|0|||
144391898|NCT00423670|520645974|FG001|Follow-up Period|Lost to Follow-up|12|||
144391899|NCT00423670|520645975|FG002|Follow-up Period|Lost to Follow-up|8|||
144391900|NCT00423670|520645976|FG003|Follow-up Period|Lost to Follow-up|3|||
144391901|NCT00423670|520645977|FG004|Follow-up Period|Lost to Follow-up|1|||
144391902|NCT00423670|520645978|FG005|Follow-up Period|Lost to Follow-up|0|||
144391903|NCT00423670|520645979|FG006|Follow-up Period|Lost to Follow-up|5|||
144391904|NCT00423670|520645980|FG007|Follow-up Period|Lost to Follow-up|0|||
144391905|NCT00423670|520645973|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
144391906|NCT00423670|520645974|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
144517901|NCT04936035|521096250|FG000|Overall Study|Physician Decision|0|||
144517902|NCT04936035|521096251|FG001|Overall Study|Physician Decision|1|||
144517903|NCT04936035|521096252|FG002|Overall Study|Physician Decision|0|||
144517904|NCT04936035|521096253|FG003|Overall Study|Physician Decision|0|||
144517905|NCT04936035|521096254|FG004|Overall Study|Physician Decision|0|||
144391907|NCT00423670|520645975|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
144391908|NCT00423670|520645976|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
144391909|NCT00423670|520645977|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
144391910|NCT00423670|520645978|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
144391911|NCT00423670|520645979|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
144391912|NCT00423670|520645980|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
144391913|NCT00423670|520645973|FG000|Follow-up Period|Non-compliance with protocol|2|||
144391914|NCT00423670|520645974|FG001|Follow-up Period|Non-compliance with protocol|0|||
144391915|NCT00423670|520645975|FG002|Follow-up Period|Non-compliance with protocol|1|||
144391916|NCT00423670|520645976|FG003|Follow-up Period|Non-compliance with protocol|1|||
144391917|NCT00423670|520645977|FG004|Follow-up Period|Non-compliance with protocol|0|||
144391918|NCT00423670|520645978|FG005|Follow-up Period|Non-compliance with protocol|0|||
144391919|NCT00423670|520645979|FG006|Follow-up Period|Non-compliance with protocol|3|||
144391920|NCT00423670|520645980|FG007|Follow-up Period|Non-compliance with protocol|2|||
144391921|NCT04163718|520645981|FG000|Overall Study|Study terminated|12|||
144391922|NCT03418571|520645985|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
144391923|NCT03418571|520645986|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
144391924|NCT00586326|520645987|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
144391925|NCT00586326|520645987|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
144391926|NCT00586326|520645987|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
144391927|NCT00586326|520645987|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
144391928|NCT00586326|520645987|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
144391929|NCT00586326|520645987|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
144391930|NCT00586326|520645987|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
144391931|NCT00586326|520645987|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
144391932|NCT00586326|520645987|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
144391933|NCT00586326|520645987|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
144391934|NCT00586326|520645987|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
144391935|NCT00586326|520645987|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
144391936|NCT00586326|520645987|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
144391937|NCT00586326|520645987|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
144391938|NCT00586326|520645987|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
144391939|NCT00586326|520645987|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
144391940|NCT00586326|520645987|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
144391941|NCT01439347|520645988|FG000|Overall Study|Death|10|||
144391942|NCT01439347|520645989|FG001|Overall Study|Death|9|||
144391943|NCT01439347|520645988|FG000|Overall Study|Withdrawal by Subject|0|||
144391944|NCT01439347|520645989|FG001|Overall Study|Withdrawal by Subject|1|||
144391945|NCT01439347|520645988|FG000|Overall Study|Physician Decision|1|||
144391946|NCT01439347|520645989|FG001|Overall Study|Physician Decision|0|||
144391947|NCT01439347|520645988|FG000|Overall Study|Sponsor Terminated Study|2|||
144391948|NCT01439347|520645989|FG001|Overall Study|Sponsor Terminated Study|3|||
144391949|NCT03595774|520645990|FG000|Overall Study|Adverse Event|1|||
144391950|NCT03595774|520645991|FG001|Overall Study|Adverse Event|0|||
144391951|NCT03595774|520645992|FG002|Overall Study|Adverse Event|1|||
144391952|NCT03595774|520645993|FG003|Overall Study|Adverse Event|0|||
144391953|NCT03595774|520645990|FG000|Overall Study|screen failure|0|||
144391954|NCT03595774|520645991|FG001|Overall Study|screen failure|1|||
144391955|NCT03595774|520645992|FG002|Overall Study|screen failure|0|||
144391956|NCT03595774|520645993|FG003|Overall Study|screen failure|1|||
144391957|NCT00542451|520645994|FG000|Overall Study|Adverse Event|31|||
144391958|NCT00542451|520645994|FG000|Overall Study|Withdrawal by Subject|30|||
144391959|NCT00542451|520645994|FG000|Overall Study|Physician Decision|4|||
144391960|NCT00542451|520645994|FG000|Overall Study|Recurrent disease|1|||
144391961|NCT00542451|520645994|FG000|Overall Study|unknown reason|1|||
144391962|NCT00542451|520645994|FG000|Overall Study|Death|2|||
144391963|NCT00542451|520645994|FG000|Overall Study|Lost to Follow-up|10|||
144391964|NCT03519386|520645995|FG000|Overall Study|Withdrawal by Subject|4|||
144517906|NCT04936035|521096250|FG000|Overall Study|Protocol Deviation|0|||
144391965|NCT03519386|520645996|FG001|Overall Study|Withdrawal by Subject|1|||
144391966|NCT03519386|520645997|FG002|Overall Study|Withdrawal by Subject|2|||
144517907|NCT04936035|521096251|FG001|Overall Study|Protocol Deviation|0|||
144517908|NCT04936035|521096252|FG002|Overall Study|Protocol Deviation|1|||
144517909|NCT04936035|521096253|FG003|Overall Study|Protocol Deviation|0|||
144517910|NCT04936035|521096254|FG004|Overall Study|Protocol Deviation|0|||
144517911|NCT04936035|521096250|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
144517912|NCT04936035|521096251|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
144391967|NCT03519386|520645995|FG000|Overall Study|Physician Decision|1|||
144391968|NCT03519386|520645996|FG001|Overall Study|Physician Decision|1|||
144517913|NCT04936035|521096252|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
144517914|NCT04936035|521096253|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
144391969|NCT03519386|520645997|FG002|Overall Study|Physician Decision|1|||
144391970|NCT03519386|520645995|FG000|Overall Study|Lost to Follow-up|0|||
144391971|NCT03519386|520645996|FG001|Overall Study|Lost to Follow-up|1|||
144391972|NCT03519386|520645997|FG002|Overall Study|Lost to Follow-up|1|||
144391973|NCT03519386|520645995|FG000|Overall Study|Death|1|||
144391974|NCT03519386|520645996|FG001|Overall Study|Death|0|||
144391975|NCT03519386|520645997|FG002|Overall Study|Death|4|||
144391976|NCT03519386|520645995|FG000|Overall Study|Adverse Event|2|||
144391977|NCT03519386|520645996|FG001|Overall Study|Adverse Event|1|||
144391978|NCT03519386|520645997|FG002|Overall Study|Adverse Event|2|||
144391979|NCT03519386|520645995|FG000|Overall Study|Explanted|2|||
144391980|NCT03519386|520645996|FG001|Overall Study|Explanted|1|||
144391981|NCT03519386|520645997|FG002|Overall Study|Explanted|0|||
144391982|NCT03519386|520645995|FG000|Overall Study|Ongoing in study|190|||
144391983|NCT03519386|520645996|FG001|Overall Study|Ongoing in study|192|||
144391984|NCT03519386|520645997|FG002|Overall Study|Ongoing in study|183|||
144391985|NCT01642407|520645998|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
144391986|NCT01642407|520645998|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
144391987|NCT01642407|520645998|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
144391988|NCT03063203|520645999|FG000|Overall Study|Chose alternative therapy|3|||
144391989|NCT03063203|520645999|FG000|Overall Study|Death|2|||
144391990|NCT03063203|520645999|FG000|Overall Study|Disease progression|4|||
144391991|NCT03063203|520645999|FG000|Overall Study|Physician Decision|5|||
144391992|NCT00829283|520646000|FG000|Overall Study|Lost to Follow-up|7|||
144391993|NCT00829283|520646001|FG001|Overall Study|Lost to Follow-up|25|||
144391994|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
144391995|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
144391996|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
144391997|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
144391998|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
144391999|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
144392000|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
144392001|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
144392002|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
144392003|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
144392004|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
144392005|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
144392006|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
144392007|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
144392008|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
144392009|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
144392010|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
144392011|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
144392012|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
144392013|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
144392014|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
144392015|NCT02431247|520646002|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
144392016|NCT02431247|520646003|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
144392017|NCT02431247|520646004|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
144392018|NCT02431247|520646002|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
144392019|NCT02431247|520646003|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
144392020|NCT02431247|520646004|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
144392021|NCT02431247|520646002|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
144392022|NCT02431247|520646003|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
144392023|NCT02431247|520646004|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
144392024|NCT02431247|520646002|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
144392025|NCT02431247|520646003|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
144392026|NCT02431247|520646004|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
144392027|NCT02431247|520646002|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
144392028|NCT02431247|520646003|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
144392029|NCT02431247|520646004|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
144392030|NCT02431247|520646002|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
144392031|NCT02431247|520646003|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
144392032|NCT02431247|520646004|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
144392033|NCT02431247|520646002|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
144392034|NCT02431247|520646003|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
144392035|NCT02431247|520646004|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
144392036|NCT00322153|520646007|FG000|Overall Study|Adverse Event|21|||
144392037|NCT00322153|520646008|FG001|Overall Study|Adverse Event|34|||
144392038|NCT00322153|520646007|FG000|Overall Study|Protocol Violation|6|||
144392039|NCT00322153|520646008|FG001|Overall Study|Protocol Violation|14|||
144517915|NCT04936035|521096254|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
144517916|NCT04936035|521096250|FG000|Overall Study|Reason Unknown|0|||
144392040|NCT00322153|520646007|FG000|Overall Study|Withdrawal by Subject|18|||
144392041|NCT00322153|520646008|FG001|Overall Study|Withdrawal by Subject|10|||
144392042|NCT00322153|520646007|FG000|Overall Study|Lack of Efficacy|8|||
144392043|NCT00322153|520646008|FG001|Overall Study|Lack of Efficacy|3|||
144392044|NCT00322153|520646007|FG000|Overall Study|Lost to Follow-up|5|||
144392045|NCT00322153|520646008|FG001|Overall Study|Lost to Follow-up|4|||
144392046|NCT00322153|520646007|FG000|Overall Study|Withdrawn for other reasons|5|||
144392047|NCT00322153|520646008|FG001|Overall Study|Withdrawn for other reasons|4|||
144392048|NCT02414139|520646009|FG000|Treatment Period|Adverse Event|11|||
144392049|NCT02414139|520646010|FG001|Treatment Period|Adverse Event|6|||
144392050|NCT02414139|520646011|FG002|Treatment Period|Adverse Event|8|||
144392051|NCT02414139|520646012|FG003|Treatment Period|Adverse Event|5|||
144392052|NCT02414139|520646013|FG004|Treatment Period|Adverse Event|14|||
144392053|NCT02414139|520646014|FG005|Treatment Period|Adverse Event|3|||
144392054|NCT02414139|520646015|FG006|Treatment Period|Adverse Event|6|||
144392055|NCT02414139|520646016|FG007|Treatment Period|Adverse Event|1|||
144392056|NCT02414139|520646017|FG008|Treatment Period|Adverse Event|6|||
144392057|NCT02414139|520646018|FG009|Treatment Period|Adverse Event|8|||
144392058|NCT02414139|520646009|FG000|Treatment Period|Death|0|||
144392059|NCT02414139|520646010|FG001|Treatment Period|Death|0|||
144392060|NCT02414139|520646011|FG002|Treatment Period|Death|1|||
144392061|NCT02414139|520646012|FG003|Treatment Period|Death|1|||
144392062|NCT02414139|520646013|FG004|Treatment Period|Death|0|||
144392063|NCT02414139|520646014|FG005|Treatment Period|Death|0|||
144392064|NCT02414139|520646015|FG006|Treatment Period|Death|0|||
144392065|NCT02414139|520646016|FG007|Treatment Period|Death|0|||
144392066|NCT02414139|520646017|FG008|Treatment Period|Death|0|||
144392067|NCT02414139|520646018|FG009|Treatment Period|Death|1|||
144392068|NCT02414139|520646009|FG000|Treatment Period|Physician Decision|5|||
144392069|NCT02414139|520646010|FG001|Treatment Period|Physician Decision|4|||
144392070|NCT02414139|520646011|FG002|Treatment Period|Physician Decision|6|||
144392071|NCT02414139|520646012|FG003|Treatment Period|Physician Decision|1|||
144392072|NCT02414139|520646013|FG004|Treatment Period|Physician Decision|4|||
144392073|NCT02414139|520646014|FG005|Treatment Period|Physician Decision|0|||
144392074|NCT02414139|520646015|FG006|Treatment Period|Physician Decision|2|||
144392075|NCT02414139|520646016|FG007|Treatment Period|Physician Decision|0|||
144392076|NCT02414139|520646017|FG008|Treatment Period|Physician Decision|1|||
144593997|NCT02647320|521376084|FG003|Overall Study|Persistent hyperglycemia|1|||
144593998|NCT02647320|521376085|FG004|Overall Study|Persistent hyperglycemia|1|||
144593999|NCT02647320|521376081|FG000|Overall Study|Study terminated by sponsor|1|||
144594000|NCT02647320|521376082|FG001|Overall Study|Study terminated by sponsor|1|||
144594001|NCT02647320|521376083|FG002|Overall Study|Study terminated by sponsor|1|||
144594002|NCT02647320|521376084|FG003|Overall Study|Study terminated by sponsor|1|||
144594003|NCT02647320|521376085|FG004|Overall Study|Study terminated by sponsor|2|||
144594004|NCT02647320|521376081|FG000|Overall Study|Reason not provided|0|||
144594005|NCT02647320|521376082|FG001|Overall Study|Reason not provided|0|||
144392077|NCT02414139|520646018|FG009|Treatment Period|Physician Decision|4|||
144392078|NCT02414139|520646009|FG000|Treatment Period|Progressive disease|48|||
144392079|NCT02414139|520646010|FG001|Treatment Period|Progressive disease|31|||
144594006|NCT02647320|521376083|FG002|Overall Study|Reason not provided|1|||
144594007|NCT02647320|521376084|FG003|Overall Study|Reason not provided|0|||
144594008|NCT02647320|521376085|FG004|Overall Study|Reason not provided|2|||
144594009|NCT02647320|521376081|FG000|Overall Study|Lost to Follow-up|1|||
144392080|NCT02414139|520646011|FG002|Treatment Period|Progressive disease|37|||
144392081|NCT02414139|520646012|FG003|Treatment Period|Progressive disease|21|||
144392082|NCT02414139|520646013|FG004|Treatment Period|Progressive disease|43|||
144392083|NCT02414139|520646014|FG005|Treatment Period|Progressive disease|12|||
144392084|NCT02414139|520646015|FG006|Treatment Period|Progressive disease|16|||
144392085|NCT02414139|520646016|FG007|Treatment Period|Progressive disease|2|||
144594010|NCT02647320|521376082|FG001|Overall Study|Lost to Follow-up|1|||
144594011|NCT02647320|521376083|FG002|Overall Study|Lost to Follow-up|0|||
144594012|NCT02647320|521376084|FG003|Overall Study|Lost to Follow-up|0|||
144594013|NCT02647320|521376085|FG004|Overall Study|Lost to Follow-up|0|||
144594014|NCT02647320|521376081|FG000|Overall Study|Develop anemia|1|||
144392086|NCT02414139|520646017|FG008|Treatment Period|Progressive disease|20|||
144392087|NCT02414139|520646018|FG009|Treatment Period|Progressive disease|14|||
144392088|NCT02414139|520646009|FG000|Treatment Period|Protocol deviation|0|||
144392089|NCT02414139|520646010|FG001|Treatment Period|Protocol deviation|0|||
144594015|NCT02647320|521376082|FG001|Overall Study|Develop anemia|0|||
144594016|NCT02647320|521376083|FG002|Overall Study|Develop anemia|0|||
144594017|NCT02647320|521376084|FG003|Overall Study|Develop anemia|0|||
144594018|NCT02647320|521376085|FG004|Overall Study|Develop anemia|0|||
144594019|NCT02647320|521376081|FG000|Overall Study|Lack of Efficacy|0|||
144392090|NCT02414139|520646011|FG002|Treatment Period|Protocol deviation|1|||
144392091|NCT02414139|520646012|FG003|Treatment Period|Protocol deviation|0|||
144392092|NCT02414139|520646013|FG004|Treatment Period|Protocol deviation|0|||
144392093|NCT02414139|520646014|FG005|Treatment Period|Protocol deviation|0|||
144594020|NCT02647320|521376082|FG001|Overall Study|Lack of Efficacy|0|||
144392094|NCT02414139|520646015|FG006|Treatment Period|Protocol deviation|0|||
144392095|NCT02414139|520646016|FG007|Treatment Period|Protocol deviation|0|||
144392096|NCT02414139|520646017|FG008|Treatment Period|Protocol deviation|0|||
144392097|NCT02414139|520646018|FG009|Treatment Period|Protocol deviation|0|||
144392098|NCT02414139|520646009|FG000|Treatment Period|Subject/Guardian decision|5|||
144392099|NCT02414139|520646010|FG001|Treatment Period|Subject/Guardian decision|1|||
144392100|NCT02414139|520646011|FG002|Treatment Period|Subject/Guardian decision|1|||
144392101|NCT02414139|520646012|FG003|Treatment Period|Subject/Guardian decision|2|||
144392102|NCT02414139|520646013|FG004|Treatment Period|Subject/Guardian decision|5|||
144392103|NCT02414139|520646014|FG005|Treatment Period|Subject/Guardian decision|0|||
144392104|NCT02414139|520646015|FG006|Treatment Period|Subject/Guardian decision|2|||
144392105|NCT02414139|520646016|FG007|Treatment Period|Subject/Guardian decision|0|||
144392106|NCT02414139|520646017|FG008|Treatment Period|Subject/Guardian decision|1|||
144392107|NCT02414139|520646018|FG009|Treatment Period|Subject/Guardian decision|1|||
144392108|NCT02414139|520646009|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
144392109|NCT02414139|520646010|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
144392110|NCT02414139|520646011|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
144392111|NCT02414139|520646012|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
144392112|NCT02414139|520646013|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
144392113|NCT02414139|520646014|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
144392114|NCT02414139|520646015|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
144392115|NCT02414139|520646016|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
144392116|NCT02414139|520646017|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
144392117|NCT02414139|520646018|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
144392118|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
144392119|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392120|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392121|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392122|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
144392123|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392124|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392125|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392126|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392127|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144392128|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Death|0|||
144392129|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Death|1|||
144392130|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Death|0|||
144392131|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Death|0|||
144392132|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Death|1|||
144392133|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Death|0|||
144392134|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Death|0|||
144392135|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Death|0|||
144392136|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Death|0|||
144392137|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Death|1|||
144392138|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
144392139|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392140|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392141|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392142|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392143|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392144|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392145|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392146|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392147|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144392148|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
144392149|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
144392150|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
144392151|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
144392152|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
144392153|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
144392154|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144392155|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
144392156|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
144392157|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144392158|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
144392159|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
144392160|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
144392161|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
144392162|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
144392163|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
144392164|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
144392165|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
144392166|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
144392167|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
144392168|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392169|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
144392170|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392171|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392172|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392173|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392174|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392175|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392176|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
144392177|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
144392178|NCT02414139|520646009|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
144392179|NCT02414139|520646010|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
144392180|NCT02414139|520646011|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
144392181|NCT02414139|520646012|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
144392182|NCT02414139|520646013|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
144392183|NCT02414139|520646014|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
144392184|NCT02414139|520646015|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
144392185|NCT02414139|520646016|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
144392186|NCT02414139|520646017|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
144392187|NCT02414139|520646018|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
144392188|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
144392189|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
144392190|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
144392191|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
144392192|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
144392193|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
144392194|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
144392195|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
144392196|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
144594021|NCT02647320|521376083|FG002|Overall Study|Lack of Efficacy|0|||
144594022|NCT02647320|521376084|FG003|Overall Study|Lack of Efficacy|1|||
144594023|NCT02647320|521376085|FG004|Overall Study|Lack of Efficacy|0|||
144594024|NCT02647320|521376081|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
144594025|NCT02647320|521376082|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
144594026|NCT02647320|521376083|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
144594027|NCT02647320|521376084|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
144594028|NCT02647320|521376085|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
144594029|NCT00596427|521376086|FG000|Overall Study|Withdrawal by Subject|2|||
144594030|NCT00596427|521376087|FG001|Overall Study|Withdrawal by Subject|2|||
144594031|NCT00596427|521376086|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
144594032|NCT00596427|521376087|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
144594033|NCT00596427|521376086|FG000|Overall Study|Protocol Violation|1|||
144594034|NCT00596427|521376087|FG001|Overall Study|Protocol Violation|0|||
144594035|NCT03435497|521376092|FG000|Overall Study|Lost to Follow-up|1|||
144594036|NCT03435497|521376093|FG001|Overall Study|Lost to Follow-up|0|||
144392197|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
144392198|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
144392199|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
144594037|NCT03435497|521376092|FG000|Overall Study|Death|1|||
144594038|NCT03435497|521376093|FG001|Overall Study|Death|0|||
144594039|NCT03435497|521376092|FG000|Overall Study|Withdrawal by Subject|0|||
144392200|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
144392201|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
144392202|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
144392203|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
144392204|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
144392205|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
144392206|NCT00591578|520646019|FG000|Double-Blind Treatment Phase|Other|4|||
144392207|NCT00591578|520646020|FG001|Double-Blind Treatment Phase|Other|9|||
144392208|NCT00591578|520646021|FG002|Double-Blind Treatment Phase|Other|4|||
144392209|NCT00591578|520646019|FG000|Open-Label Extension Phase|Adverse Event|3|||
144392210|NCT00591578|520646020|FG001|Open-Label Extension Phase|Adverse Event|5|||
144392211|NCT00591578|520646021|FG002|Open-Label Extension Phase|Adverse Event|0|||
144392212|NCT00591578|520646019|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
144392213|NCT00591578|520646020|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
144392214|NCT00591578|520646021|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
144392215|NCT00591578|520646019|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
144392216|NCT00591578|520646020|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
144392217|NCT00591578|520646021|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
144392218|NCT00591578|520646019|FG000|Open-Label Extension Phase|Other|1|||
144392219|NCT00591578|520646020|FG001|Open-Label Extension Phase|Other|0|||
144392220|NCT00591578|520646021|FG002|Open-Label Extension Phase|Other|0|||
144594040|NCT03435497|521376093|FG001|Overall Study|Withdrawal by Subject|4|||
144594041|NCT03435497|521376092|FG000|Overall Study|Wrong survey administered|0|||
144594042|NCT03435497|521376093|FG001|Overall Study|Wrong survey administered|2|||
144594043|NCT01786174|521376094|FG000|Overall Study|Discontinued Study Drug|2|||
144594044|NCT01786174|521376095|FG001|Overall Study|Discontinued Study Drug|0|||
144594045|NCT00701779|521376096|FG000|Overall Study|Adverse Event|6|||
144594046|NCT00701779|521376096|FG000|Overall Study|Lost to Follow-up|1|||
144594047|NCT00701779|521376096|FG000|Overall Study|Withdrawal by Subject|2|||
144392221|NCT02632838|520646022|FG000|Overall Study|Withdrawal by Subject|3|||
144392222|NCT02632838|520646023|FG001|Overall Study|Withdrawal by Subject|0|||
144392223|NCT02632838|520646022|FG000|Overall Study|Lost to Follow-up|0|||
144392224|NCT02632838|520646023|FG001|Overall Study|Lost to Follow-up|2|||
144392225|NCT03631355|520646024|FG000|Overall Study|Lost to Follow-up|1|||
144392226|NCT03631355|520646025|FG001|Overall Study|Lost to Follow-up|2|||
144392227|NCT02810340|520646026|FG000|Overall Study|Withdrawal by Subject|1|||
144392228|NCT02810340|520646027|FG001|Overall Study|Withdrawal by Subject|0|||
144392229|NCT02810340|520646028|FG002|Overall Study|Withdrawal by Subject|0|||
144392230|NCT02810340|520646026|FG000|Overall Study|Incarceration|0|||
144392231|NCT02810340|520646027|FG001|Overall Study|Incarceration|1|||
144392232|NCT02810340|520646028|FG002|Overall Study|Incarceration|0|||
144392233|NCT02810340|520646026|FG000|Overall Study|Lost to Follow-up|0|||
144392234|NCT02810340|520646027|FG001|Overall Study|Lost to Follow-up|0|||
144392235|NCT02810340|520646028|FG002|Overall Study|Lost to Follow-up|1|||
144392236|NCT00870233|520646031|FG000|Overall Study|Withdrawal by Subject|18|||
144392237|NCT00870233|520646031|FG000|Overall Study|Did not undergo laparotomy|3|||
144392238|NCT00870233|520646031|FG000|Overall Study|Incompatible internet browser|2|||
144392239|NCT00870233|520646031|FG000|Overall Study|Death|1|||
144392240|NCT02793128|520646045|FG000|Overall Study|Death|4|||
144392241|NCT02793128|520646045|FG000|Overall Study|Withdrawal by Subject|2|||
144392242|NCT02793128|520646045|FG000|Overall Study|Physician Decision|1|||
144392243|NCT02793128|520646045|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
144392244|NCT02793128|520646045|FG000|Overall Study|Patient elected nephroureterectomy|1|||
144392245|NCT02125604|520646049|FG000|Overall Study|Other|4|||
144392246|NCT02125604|520646049|FG000|Overall Study|Investigator Decision|1|||
144392247|NCT02125604|520646049|FG000|Overall Study|Lost to Follow-up|2|||
144392248|NCT02125604|520646049|FG000|Overall Study|Consent Withdrawn|4|||
144392249|NCT02125604|520646049|FG000|Overall Study|Adverse Event|20|||
144392250|NCT04340063|520646050|FG000|Overall Study|Withdrawal by Subject|1|||
144392251|NCT04340063|520646051|FG001|Overall Study|Withdrawal by Subject|2|||
144392252|NCT04340063|520646050|FG000|Overall Study|Lost to Follow-up|3|||
144392253|NCT04340063|520646051|FG001|Overall Study|Lost to Follow-up|1|||
144392254|NCT04340063|520646050|FG000|Overall Study|Protocol Violation|0|||
144392255|NCT04340063|520646051|FG001|Overall Study|Protocol Violation|1|||
144392256|NCT00356122|520646052|FG000|TREATMENT|Lack of Efficacy|26|||
144392257|NCT00356122|520646052|FG000|TREATMENT|Adverse Event|10|||
144594048|NCT00876694|521376099|FG000|Overall Study|Adverse Event|10|||
144594049|NCT00876694|521376100|FG001|Overall Study|Adverse Event|7|||
144392258|NCT00356122|520646052|FG000|TREATMENT|Subject's request|4|||
144594050|NCT00876694|521376099|FG000|Overall Study|Subject withdrew consent|6|||
144392259|NCT00356122|520646052|FG000|TREATMENT|Other|4|||
144392260|NCT00356122|520646052|FG000|TREATMENT|Did not receive study medication|1|||
144392261|NCT00356122|520646052|FG000|FOLLOW-UP|Death|37|||
144392262|NCT00356122|520646052|FG000|FOLLOW-UP|Lost to Follow-up|2|||
144392263|NCT00356122|520646052|FG000|FOLLOW-UP|Other|2|||
144392264|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
144392265|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
144392266|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
144392267|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
144392268|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
144392269|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
144392270|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
144392271|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
144392272|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
144392273|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
144392274|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
144392275|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
144392276|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
144392277|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
144392278|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
144392279|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
144392280|NCT00491556|520646053|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
144392281|NCT00491556|520646054|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
144392282|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
144392283|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
144392284|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
144392285|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
144392286|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
144392287|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
144392288|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
144392289|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
144392290|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
144392291|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
144392292|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
144392293|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
144392294|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
144392295|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
144392296|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
144392297|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
144392298|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
144392299|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
144392300|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
144392301|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
144392302|NCT00491556|520646053|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
144392303|NCT00491556|520646054|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
144392304|NCT04480424|520646055|FG000|Overall Study|Withdrawal by Subject|0|||
144392305|NCT04480424|520646056|FG001|Overall Study|Withdrawal by Subject|2|||
144392306|NCT04480424|520646055|FG000|Overall Study|Lost to Follow-up|3|||
144392307|NCT04480424|520646056|FG001|Overall Study|Lost to Follow-up|3|||
144392308|NCT04480424|520646055|FG000|Overall Study|Death|14|||
144392309|NCT04480424|520646056|FG001|Overall Study|Death|16|||
144392310|NCT04480424|520646055|FG000|Overall Study|Reason not Specified|5|||
144392311|NCT04480424|520646056|FG001|Overall Study|Reason not Specified|5|||
144392312|NCT00734747|520646060|FG000|SRS Procedure|No staples placed|3|||
144392313|NCT00734747|520646060|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
144392314|NCT03670836|520646061|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
144392315|NCT03670836|520646062|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
144392316|NCT03670836|520646061|FG000|Per Protocol Population (PP)|Physician Decision|9|||
144392317|NCT03670836|520646062|FG001|Per Protocol Population (PP)|Physician Decision|10|||
144392318|NCT03670836|520646061|FG000|Per Protocol Population (PP)|Physician Decision|4|||
144392319|NCT03670836|520646062|FG001|Per Protocol Population (PP)|Physician Decision|6|||
144392320|NCT03670836|520646061|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
144392321|NCT03670836|520646062|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
144392322|NCT03287635|520646063|FG000|Overall Study|Lost to Follow-up|5|||
144392323|NCT03287635|520646063|FG000|Overall Study|Withdrawal by Subject|1|||
144392324|NCT03287635|520646063|FG000|Overall Study|Physician Decision|1|||
144392325|NCT00323869|520646066|FG000|Overall Study|Death|1|||
144392326|NCT01994590|520647904|FG000|Overall Study|Adverse Event|1|||
144392327|NCT01994590|520647904|FG000|Overall Study|Trial Terminated|1|||
144392328|NCT03607422|520647905|FG000|Overall Study|Adverse Event|7|||
144392329|NCT03607422|520647906|FG001|Overall Study|Adverse Event|3|||
144392330|NCT03607422|520647907|FG002|Overall Study|Adverse Event|2|||
144392331|NCT03607422|520647908|FG003|Overall Study|Adverse Event|0|||
144392332|NCT03607422|520647909|FG004|Overall Study|Adverse Event|2|||
144392333|NCT03607422|520647910|FG005|Overall Study|Adverse Event|0|||
144392334|NCT03607422|520647905|FG000|Overall Study|Withdrawal by Subject|11|||
144392335|NCT03607422|520647906|FG001|Overall Study|Withdrawal by Subject|3|||
144392336|NCT03607422|520647907|FG002|Overall Study|Withdrawal by Subject|6|||
144392337|NCT03607422|520647908|FG003|Overall Study|Withdrawal by Subject|2|||
144392338|NCT03607422|520647909|FG004|Overall Study|Withdrawal by Subject|0|||
144392339|NCT03607422|520647910|FG005|Overall Study|Withdrawal by Subject|0|||
144392340|NCT03607422|520647905|FG000|Overall Study|Lost to Follow-up|0|||
144392341|NCT03607422|520647906|FG001|Overall Study|Lost to Follow-up|0|||
144392342|NCT03607422|520647907|FG002|Overall Study|Lost to Follow-up|1|||
144392343|NCT03607422|520647908|FG003|Overall Study|Lost to Follow-up|0|||
144392344|NCT03607422|520647909|FG004|Overall Study|Lost to Follow-up|0|||
144392345|NCT03607422|520647910|FG005|Overall Study|Lost to Follow-up|0|||
144392346|NCT03607422|520647905|FG000|Overall Study|Other|12|||
144392347|NCT03607422|520647906|FG001|Overall Study|Other|4|||
144392348|NCT03607422|520647907|FG002|Overall Study|Other|1|||
144392349|NCT03607422|520647908|FG003|Overall Study|Other|2|||
144392350|NCT03607422|520647909|FG004|Overall Study|Other|0|||
144392351|NCT03607422|520647910|FG005|Overall Study|Other|2|||
144392352|NCT03607422|520647905|FG000|Overall Study|Ongoing at Time of Analysis|8|||
144392353|NCT03607422|520647906|FG001|Overall Study|Ongoing at Time of Analysis|0|||
144392354|NCT03607422|520647907|FG002|Overall Study|Ongoing at Time of Analysis|2|||
144392355|NCT03607422|520647908|FG003|Overall Study|Ongoing at Time of Analysis|1|||
144392356|NCT03607422|520647909|FG004|Overall Study|Ongoing at Time of Analysis|1|||
144392357|NCT03607422|520647910|FG005|Overall Study|Ongoing at Time of Analysis|1|||
144392358|NCT01801072|520647911|FG000|Overall Study|Lost to Follow-up|17|||
144392359|NCT01801072|520647912|FG001|Overall Study|Lost to Follow-up|14|||
144392360|NCT01801072|520647911|FG000|Overall Study|Physician Decision|2|||
144392361|NCT01801072|520647912|FG001|Overall Study|Physician Decision|3|||
144392362|NCT01801072|520647911|FG000|Overall Study|Withdrawal by Subject|1|||
144392363|NCT01801072|520647912|FG001|Overall Study|Withdrawal by Subject|0|||
144392364|NCT01801072|520647911|FG000|Overall Study|Protocol Violation|2|||
144392365|NCT01801072|520647912|FG001|Overall Study|Protocol Violation|0|||
144392366|NCT01801072|520647911|FG000|Overall Study|Death|7|||
144392367|NCT01801072|520647912|FG001|Overall Study|Death|8|||
144392368|NCT03868124|520647913|FG000|Overall Study|Withdrawal by Subject|4|||
144392369|NCT03868124|520647914|FG001|Overall Study|Withdrawal by Subject|0|||
144392370|NCT03868124|520647915|FG002|Overall Study|Withdrawal by Subject|1|||
144392371|NCT03868124|520647913|FG000|Overall Study|Physician Decision|1|||
144392372|NCT03868124|520647914|FG001|Overall Study|Physician Decision|0|||
144392373|NCT03868124|520647915|FG002|Overall Study|Physician Decision|1|||
144392374|NCT03868124|520647913|FG000|Overall Study|Lost to Follow-up|1|||
144392375|NCT03868124|520647914|FG001|Overall Study|Lost to Follow-up|1|||
144392376|NCT03868124|520647915|FG002|Overall Study|Lost to Follow-up|2|||
144392377|NCT03868124|520647913|FG000|Overall Study|Death|1|||
144392378|NCT03868124|520647914|FG001|Overall Study|Death|1|||
144392379|NCT03868124|520647915|FG002|Overall Study|Death|2|||
144392380|NCT03868124|520647913|FG000|Overall Study|Adverse Event|0|||
144392381|NCT03868124|520647914|FG001|Overall Study|Adverse Event|0|||
144392382|NCT03868124|520647915|FG002|Overall Study|Adverse Event|3|||
144392383|NCT03868124|520647913|FG000|Overall Study|Explanted|2|||
144392384|NCT03868124|520647914|FG001|Overall Study|Explanted|1|||
144392385|NCT03868124|520647915|FG002|Overall Study|Explanted|0|||
144392386|NCT03868124|520647913|FG000|Overall Study|Ongoing in study|176|||
144594051|NCT00876694|521376100|FG001|Overall Study|Subject withdrew consent|4|||
144594052|NCT00876694|521376099|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144392387|NCT03868124|520647914|FG001|Overall Study|Ongoing in study|180|||
144392388|NCT03868124|520647915|FG002|Overall Study|Ongoing in study|183|||
144392389|NCT02806973|520647918|FG000|Period 1|Withdrawal by Subject|0|||
144392390|NCT02806973|520647919|FG001|Period 1|Withdrawal by Subject|2|||
144392391|NCT02806973|520647920|FG002|Period 1|Withdrawal by Subject|1|||
144392392|NCT02806973|520647921|FG003|Period 1|Withdrawal by Subject|1|||
144392393|NCT02806973|520647918|FG000|Period 1|Adverse Event|0|||
144594053|NCT00876694|521376100|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144392394|NCT02806973|520647919|FG001|Period 1|Adverse Event|0|||
144392395|NCT02806973|520647920|FG002|Period 1|Adverse Event|0|||
144392396|NCT02806973|520647921|FG003|Period 1|Adverse Event|1|||
144392397|NCT02806973|520647918|FG000|Period 3|Withdrawal by Subject|0|||
144392398|NCT02806973|520647919|FG001|Period 3|Withdrawal by Subject|0|||
144392399|NCT02806973|520647920|FG002|Period 3|Withdrawal by Subject|0|||
144392400|NCT02806973|520647921|FG003|Period 3|Withdrawal by Subject|3|||
144392401|NCT02806973|520647918|FG000|Period 3|Adverse Event|0|||
144392402|NCT02806973|520647919|FG001|Period 3|Adverse Event|0|||
144392403|NCT02806973|520647920|FG002|Period 3|Adverse Event|1|||
144392404|NCT02806973|520647921|FG003|Period 3|Adverse Event|0|||
144392405|NCT04209426|520647924|FG000|Overall Study|Lost to Follow-up|3|||
144392406|NCT04209426|520647925|FG001|Overall Study|Lost to Follow-up|2|||
144392407|NCT01751802|520647930|FG000|Overall Study|Adverse Event|4|||
144392408|NCT01751802|520647931|FG001|Overall Study|Adverse Event|2|||
144392409|NCT01052844|520647939|FG000|Overall Study|Adverse Event|0|||
144392410|NCT01052844|520647940|FG001|Overall Study|Adverse Event|1|||
144392411|NCT02376829|520647943|FG000|Overall Study|Withdrawal by Subject|27|||
144392412|NCT02376829|520647944|FG001|Overall Study|Withdrawal by Subject|44|||
144392413|NCT02964507|520647945|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
144392414|NCT02964507|520647946|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
144392415|NCT02964507|520647947|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
144392416|NCT02964507|520647948|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
144392417|NCT02964507|520647949|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
144392418|NCT02964507|520647950|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
144392419|NCT02964507|520647951|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
144392420|NCT02964507|520647952|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
144392421|NCT02964507|520647945|FG000|Overall Study|Study terminated by Sponsor|9|||
144392422|NCT02964507|520647946|FG001|Overall Study|Study terminated by Sponsor|1|||
144392423|NCT02964507|520647947|FG002|Overall Study|Study terminated by Sponsor|9|||
144392424|NCT02964507|520647948|FG003|Overall Study|Study terminated by Sponsor|3|||
144392425|NCT02964507|520647949|FG004|Overall Study|Study terminated by Sponsor|3|||
144392426|NCT02964507|520647950|FG005|Overall Study|Study terminated by Sponsor|2|||
144392427|NCT02964507|520647951|FG006|Overall Study|Study terminated by Sponsor|0|||
144392428|NCT02964507|520647952|FG007|Overall Study|Study terminated by Sponsor|0|||
144392429|NCT02964507|520647945|FG000|Overall Study|Other|3|||
144392430|NCT02964507|520647946|FG001|Overall Study|Other|0|||
144392431|NCT02964507|520647947|FG002|Overall Study|Other|0|||
144392432|NCT02964507|520647948|FG003|Overall Study|Other|0|||
144392433|NCT02964507|520647949|FG004|Overall Study|Other|1|||
144392434|NCT02964507|520647950|FG005|Overall Study|Other|0|||
144392435|NCT02964507|520647951|FG006|Overall Study|Other|0|||
144392436|NCT02964507|520647952|FG007|Overall Study|Other|0|||
144392437|NCT02964507|520647945|FG000|Overall Study|Death|11|||
144392438|NCT02964507|520647946|FG001|Overall Study|Death|9|||
144392439|NCT02964507|520647947|FG002|Overall Study|Death|12|||
144392440|NCT02964507|520647948|FG003|Overall Study|Death|2|||
144392441|NCT02964507|520647949|FG004|Overall Study|Death|10|||
144392442|NCT02964507|520647950|FG005|Overall Study|Death|5|||
144392443|NCT02964507|520647951|FG006|Overall Study|Death|0|||
144392444|NCT02964507|520647952|FG007|Overall Study|Death|0|||
144392445|NCT02964507|520647945|FG000|Overall Study|Withdrawal by Subject|1|||
144392446|NCT02964507|520647946|FG001|Overall Study|Withdrawal by Subject|0|||
144392447|NCT02964507|520647947|FG002|Overall Study|Withdrawal by Subject|1|||
144392448|NCT02964507|520647948|FG003|Overall Study|Withdrawal by Subject|1|||
144392449|NCT02964507|520647949|FG004|Overall Study|Withdrawal by Subject|0|||
144392450|NCT02964507|520647950|FG005|Overall Study|Withdrawal by Subject|1|||
144392451|NCT02964507|520647951|FG006|Overall Study|Withdrawal by Subject|0|||
144392452|NCT02964507|520647952|FG007|Overall Study|Withdrawal by Subject|0|||
144392453|NCT02964507|520647945|FG000|Overall Study|Physician Decision|2|||
144392454|NCT02964507|520647946|FG001|Overall Study|Physician Decision|0|||
144392455|NCT02964507|520647947|FG002|Overall Study|Physician Decision|3|||
144517917|NCT04936035|521096251|FG001|Overall Study|Reason Unknown|0|||
144517918|NCT04936035|521096252|FG002|Overall Study|Reason Unknown|0|||
144517919|NCT04936035|521096253|FG003|Overall Study|Reason Unknown|0|||
144517920|NCT04936035|521096254|FG004|Overall Study|Reason Unknown|1|||
144517921|NCT04936035|521096250|FG000|Overall Study|Withdrawal by Subject|1|||
144517922|NCT04936035|521096251|FG001|Overall Study|Withdrawal by Subject|0|||
144517923|NCT04936035|521096252|FG002|Overall Study|Withdrawal by Subject|0|||
144517924|NCT04936035|521096253|FG003|Overall Study|Withdrawal by Subject|0|||
144517925|NCT04936035|521096254|FG004|Overall Study|Withdrawal by Subject|0|||
144517926|NCT04936035|521096250|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
144392456|NCT02964507|520647948|FG003|Overall Study|Physician Decision|0|||
144392457|NCT02964507|520647949|FG004|Overall Study|Physician Decision|1|||
144517927|NCT04936035|521096251|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
144392458|NCT02964507|520647950|FG005|Overall Study|Physician Decision|0|||
144392459|NCT02964507|520647951|FG006|Overall Study|Physician Decision|0|||
144392460|NCT02964507|520647952|FG007|Overall Study|Physician Decision|0|||
144392461|NCT04341662|520647953|FG000|Overall Study|Did not have source-verified blood loss data|423|||
144392462|NCT04341662|520647954|FG001|Overall Study|Did not have source-verified blood loss data|514|||
144392463|NCT01309893|520647955|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
144392464|NCT01309893|520647956|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
144392465|NCT01309893|520647955|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
144392466|NCT01309893|520647956|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
144392467|NCT01343901|520647958|FG000|Overall Study|Death|85|||
144392468|NCT01343901|520647958|FG000|Overall Study|Physician Decision|4|||
144392469|NCT01343901|520647958|FG000|Overall Study|Lost to Follow-up|12|||
144392470|NCT01343901|520647958|FG000|Overall Study|Management by another medical team|11|||
144392471|NCT01343901|520647958|FG000|Overall Study|Participant decision|1|||
144392472|NCT01369485|520647959|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
144392473|NCT01369485|520647960|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
144392474|NCT01369485|520647959|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
144392475|NCT01369485|520647960|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
144392476|NCT01369485|520647959|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
144392477|NCT01369485|520647960|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
144392478|NCT01369485|520647959|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
144392479|NCT01369485|520647960|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
144392480|NCT01369485|520647959|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
144392481|NCT01369485|520647960|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
144392482|NCT01369485|520647959|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
144392483|NCT01369485|520647960|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
144392484|NCT01369485|520647959|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
144392485|NCT01369485|520647960|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
144392486|NCT01369485|520647959|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
144392487|NCT01369485|520647960|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
144392488|NCT01369485|520647959|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
144392489|NCT01369485|520647960|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
144392490|NCT01369485|520647959|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
144392491|NCT01369485|520647960|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
144392492|NCT00873860|520647961|FG000|Overall Study|Lost to Follow-up|1|||
144392493|NCT00873860|520647962|FG001|Overall Study|Lost to Follow-up|0|||
144392494|NCT00873860|520647963|FG002|Overall Study|Lost to Follow-up|0|||
144392495|NCT00873860|520647964|FG003|Overall Study|Lost to Follow-up|1|||
144392496|NCT00873860|520647961|FG000|Overall Study|Withdrawal by Subject|1|||
144392497|NCT00873860|520647962|FG001|Overall Study|Withdrawal by Subject|0|||
144392498|NCT00873860|520647963|FG002|Overall Study|Withdrawal by Subject|2|||
144392499|NCT00873860|520647964|FG003|Overall Study|Withdrawal by Subject|0|||
144392500|NCT00873860|520647961|FG000|Overall Study|Death|1|||
144392501|NCT00873860|520647962|FG001|Overall Study|Death|0|||
144392502|NCT00873860|520647963|FG002|Overall Study|Death|0|||
144392503|NCT00873860|520647964|FG003|Overall Study|Death|0|||
144392504|NCT00873860|520647961|FG000|Overall Study|Other|1|||
144392505|NCT00873860|520647962|FG001|Overall Study|Other|0|||
144392506|NCT00873860|520647963|FG002|Overall Study|Other|1|||
144392507|NCT00873860|520647964|FG003|Overall Study|Other|0|||
144392508|NCT01484938|520647965|FG000|Overall Study|Adverse Event|2|||
144392509|NCT01484938|520647965|FG000|Overall Study|Lost to Follow-up|1|||
144392510|NCT01484938|520647965|FG000|Overall Study|Noncompliance|1|||
144392511|NCT00938964|520647966|FG000|Overall Study|Death|3|||
144392512|NCT00938964|520647967|FG001|Overall Study|Death|3|||
144392513|NCT00938964|520647966|FG000|Overall Study|Lost to Follow-up|2|||
144392514|NCT00938964|520647967|FG001|Overall Study|Lost to Follow-up|3|||
144392515|NCT00938964|520647966|FG000|Overall Study|Withdrawal by Subject|22|||
144392516|NCT00938964|520647967|FG001|Overall Study|Withdrawal by Subject|18|||
144392517|NCT00938964|520647966|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
144392518|NCT00938964|520647967|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
144392519|NCT01227564|520647968|FG000|Overall Study|No Longer Willing to Participate|4|||
144392520|NCT01227564|520647969|FG001|Overall Study|No Longer Willing to Participate|2|||
144392521|NCT01227564|520647970|FG002|Overall Study|No Longer Willing to Participate|5|||
144392522|NCT01227564|520647968|FG000|Overall Study|Participant moved to another town|0|||
144392523|NCT01227564|520647969|FG001|Overall Study|Participant moved to another town|0|||
144392524|NCT01227564|520647970|FG002|Overall Study|Participant moved to another town|1|||
144392525|NCT02862600|520647981|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
144392526|NCT02862600|520647981|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
144392527|NCT02862600|520647981|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
144392528|NCT02862600|520647981|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
144392529|NCT00704808|520647991|FG000|Overall Study|Discontinued prior to starting treatment|14|||
144392530|NCT00704808|520647991|FG000|Overall Study|Death|7|||
144392531|NCT00704808|520647991|FG000|Overall Study|Tumor progression|80|||
144392532|NCT00704808|520647991|FG000|Overall Study|Patient's decision|11|||
144392533|NCT00704808|520647991|FG000|Overall Study|Early therapy discontinuation|16|||
144392534|NCT00704808|520647991|FG000|Overall Study|Adverse Event|1|||
144392535|NCT00704808|520647991|FG000|Overall Study|Lost to Follow-up|1|||
144392536|NCT00704808|520647991|FG000|Overall Study|Treatment change|1|||
144392537|NCT05308290|520647997|FG000|Overall Study|Death|1|||
144392538|NCT05308290|520647998|FG001|Overall Study|Death|0|||
144392539|NCT05308290|520647997|FG000|Overall Study|Lost to Follow-up|2|||
144392540|NCT05308290|520647998|FG001|Overall Study|Lost to Follow-up|1|||
144392541|NCT05308290|520647997|FG000|Overall Study|still in study followup|0|||
144392542|NCT05308290|520647998|FG001|Overall Study|still in study followup|1|||
144392543|NCT01017575|520647999|FG000|Overall Study|Lack of Efficacy|0|||
144392544|NCT01017575|520648000|FG001|Overall Study|Lack of Efficacy|1|||
144392545|NCT01017575|520648001|FG002|Overall Study|Lack of Efficacy|0|||
144392546|NCT01017575|520648002|FG003|Overall Study|Lack of Efficacy|1|||
144392547|NCT01017575|520648003|FG004|Overall Study|Lack of Efficacy|1|||
144392548|NCT01017575|520647999|FG000|Overall Study|Adverse Event|0|||
144392549|NCT01017575|520648000|FG001|Overall Study|Adverse Event|1|||
144392550|NCT01017575|520648001|FG002|Overall Study|Adverse Event|0|||
144392551|NCT01017575|520648002|FG003|Overall Study|Adverse Event|0|||
144392552|NCT01017575|520648003|FG004|Overall Study|Adverse Event|2|||
144392553|NCT01017575|520647999|FG000|Overall Study|Withdrawal by Subject|1|||
144392554|NCT01017575|520648000|FG001|Overall Study|Withdrawal by Subject|0|||
144392555|NCT01017575|520648001|FG002|Overall Study|Withdrawal by Subject|0|||
144392556|NCT01017575|520648002|FG003|Overall Study|Withdrawal by Subject|0|||
144392557|NCT01017575|520648003|FG004|Overall Study|Withdrawal by Subject|0|||
144392558|NCT03500679|520648013|FG000|Overall Study|Lost to Follow-up|6|||
144392559|NCT03500679|520648014|FG001|Overall Study|Lost to Follow-up|3|||
144392560|NCT03500679|520648013|FG000|Overall Study|Withdrawal by Subject|3|||
144392561|NCT03500679|520648014|FG001|Overall Study|Withdrawal by Subject|0|||
144392562|NCT00095628|520648015|FG000|Overall Study|Disease progression prior to treatment|1|||
144392563|NCT00744471|520648019|FG000|Overall Study|Randomized but not treated|1|||
144392564|NCT00744471|520648020|FG001|Overall Study|Randomized but not treated|1|||
144392565|NCT00744471|520648021|FG002|Overall Study|Randomized but not treated|4|||
144392566|NCT00744471|520648022|FG003|Overall Study|Randomized but not treated|0|||
144392567|NCT00744471|520648019|FG000|Overall Study|Death|0|||
144392568|NCT00744471|520648020|FG001|Overall Study|Death|0|||
144392569|NCT00744471|520648021|FG002|Overall Study|Death|0|||
144392570|NCT00744471|520648022|FG003|Overall Study|Death|1|||
144392571|NCT00744471|520648019|FG000|Overall Study|Adverse Event|6|||
144392572|NCT00744471|520648020|FG001|Overall Study|Adverse Event|7|||
144392573|NCT00744471|520648021|FG002|Overall Study|Adverse Event|5|||
144392574|NCT00744471|520648022|FG003|Overall Study|Adverse Event|9|||
144392575|NCT00744471|520648019|FG000|Overall Study|Withdrawal by Subject|9|||
144392576|NCT00744471|520648020|FG001|Overall Study|Withdrawal by Subject|9|||
144392577|NCT00744471|520648021|FG002|Overall Study|Withdrawal by Subject|15|||
144392578|NCT00744471|520648022|FG003|Overall Study|Withdrawal by Subject|12|||
144392579|NCT00744471|520648019|FG000|Overall Study|Protocol Violation|1|||
144392580|NCT00744471|520648020|FG001|Overall Study|Protocol Violation|4|||
144392581|NCT00744471|520648021|FG002|Overall Study|Protocol Violation|1|||
144392582|NCT00744471|520648022|FG003|Overall Study|Protocol Violation|2|||
144392583|NCT00744471|520648019|FG000|Overall Study|Entered extension study|41|||
144392584|NCT00744471|520648020|FG001|Overall Study|Entered extension study|84|||
144392585|NCT00744471|520648021|FG002|Overall Study|Entered extension study|100|||
144392586|NCT00744471|520648022|FG003|Overall Study|Entered extension study|91|||
144392587|NCT00744471|520648019|FG000|Overall Study|Other|2|||
144392588|NCT00744471|520648020|FG001|Overall Study|Other|3|||
144392589|NCT00744471|520648021|FG002|Overall Study|Other|6|||
144392590|NCT00744471|520648022|FG003|Overall Study|Other|2|||
144392591|NCT00744471|520648019|FG000|Overall Study|Lack of Efficacy|83|||
144392592|NCT00744471|520648020|FG001|Overall Study|Lack of Efficacy|37|||
144392593|NCT00744471|520648021|FG002|Overall Study|Lack of Efficacy|19|||
144392594|NCT00744471|520648022|FG003|Overall Study|Lack of Efficacy|31|||
144392595|NCT00744471|520648019|FG000|Overall Study|Lost to Follow-up|0|||
144392596|NCT00744471|520648020|FG001|Overall Study|Lost to Follow-up|0|||
144392597|NCT00744471|520648021|FG002|Overall Study|Lost to Follow-up|2|||
144392598|NCT00744471|520648022|FG003|Overall Study|Lost to Follow-up|0|||
144392599|NCT04706416|520648023|FG000|Overall Study|Lost to Follow-up|2|||
144392600|NCT04706416|520648024|FG001|Overall Study|Lost to Follow-up|0|||
144392601|NCT00976573|520648028|FG000|Overall Study|Ineligible|0|||
144392602|NCT00976573|520648029|FG001|Overall Study|Ineligible|1|||
144392603|NCT00976573|520648028|FG000|Overall Study|Cancel prior to receiving treatment|4|||
144392604|NCT00976573|520648029|FG001|Overall Study|Cancel prior to receiving treatment|2|||
144392605|NCT02117427|520648030|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
144392606|NCT02117427|520648031|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
144392607|NCT02117427|520648032|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
144392608|NCT02117427|520648030|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
144392609|NCT02117427|520648031|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
144392610|NCT02117427|520648032|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
144392611|NCT02117427|520648030|FG000|Overall Study|Physician Decision|0|||
144392612|NCT02117427|520648031|FG001|Overall Study|Physician Decision|2|||
144392613|NCT02117427|520648032|FG002|Overall Study|Physician Decision|0|||
144392614|NCT02117427|520648030|FG000|Overall Study|No longer meets inclusion criteria|0|||
144392615|NCT02117427|520648031|FG001|Overall Study|No longer meets inclusion criteria|1|||
144392616|NCT02117427|520648032|FG002|Overall Study|No longer meets inclusion criteria|0|||
144392617|NCT02117427|520648030|FG000|Overall Study|Death|0|||
144392618|NCT02117427|520648031|FG001|Overall Study|Death|1|||
144392619|NCT02117427|520648032|FG002|Overall Study|Death|0|||
144392620|NCT02730208|520648033|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
144392621|NCT02730208|520648034|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
144392622|NCT00995865|520648035|FG000|Overall Study|Protocol Violation|2|||
144392623|NCT00995865|520648036|FG001|Overall Study|Protocol Violation|0|||
144392624|NCT00995865|520648037|FG002|Overall Study|Protocol Violation|0|||
144392625|NCT00995865|520648035|FG000|Overall Study|Lost to Follow-up|0|||
144392626|NCT00995865|520648036|FG001|Overall Study|Lost to Follow-up|0|||
144392627|NCT00995865|520648037|FG002|Overall Study|Lost to Follow-up|1|||
144392628|NCT00410202|520648039|FG000|On-Treatment|Continuing treatment|69|||
144392629|NCT00410202|520648040|FG001|On-Treatment|Continuing treatment|71|||
144392630|NCT00410202|520648041|FG002|On-Treatment|Continuing treatment|66|||
144392631|NCT00410202|520648039|FG000|On-Treatment|Adverse Event|1|||
144392632|NCT00410202|520648040|FG001|On-Treatment|Adverse Event|3|||
144392633|NCT00410202|520648041|FG002|On-Treatment|Adverse Event|2|||
144392634|NCT00410202|520648039|FG000|On-Treatment|Death|1|||
144392635|NCT00410202|520648040|FG001|On-Treatment|Death|0|||
144392636|NCT00410202|520648041|FG002|On-Treatment|Death|0|||
144392637|NCT00410202|520648039|FG000|On-Treatment|Lost to Follow-up|1|||
144392638|NCT00410202|520648040|FG001|On-Treatment|Lost to Follow-up|0|||
144392639|NCT00410202|520648041|FG002|On-Treatment|Lost to Follow-up|1|||
144392640|NCT00410202|520648039|FG000|On-Treatment|Lack of Efficacy|1|||
144392641|NCT00410202|520648040|FG001|On-Treatment|Lack of Efficacy|4|||
144392642|NCT00410202|520648041|FG002|On-Treatment|Lack of Efficacy|0|||
144392643|NCT00410202|520648039|FG000|On-Treatment|Withdrawal by Subject|2|||
144392644|NCT00410202|520648040|FG001|On-Treatment|Withdrawal by Subject|1|||
144392645|NCT00410202|520648041|FG002|On-Treatment|Withdrawal by Subject|1|||
144392646|NCT00410202|520648039|FG000|On-Treatment|Other Reason|0|||
144392647|NCT00410202|520648040|FG001|On-Treatment|Other Reason|0|||
144392648|NCT00410202|520648041|FG002|On-Treatment|Other Reason|1|||
144392649|NCT00410202|520648039|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
144392650|NCT00410202|520648040|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
144392651|NCT00410202|520648041|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
144392652|NCT00410202|520648039|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
144392653|NCT00410202|520648040|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
144392654|NCT00410202|520648041|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
144392655|NCT00410202|520648039|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
144392656|NCT00410202|520648040|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
144392657|NCT00410202|520648041|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
144392658|NCT05080660|520648042|FG000|Overall Study|Adverse Event|4|||
144392659|NCT05080660|520648043|FG001|Overall Study|Adverse Event|0|||
144392660|NCT05080660|520648042|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
144392661|NCT05080660|520648043|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
144392662|NCT05080660|520648042|FG000|Overall Study|Physician Decision|1|||
144392663|NCT05080660|520648043|FG001|Overall Study|Physician Decision|0|||
144392664|NCT05080660|520648042|FG000|Overall Study|Protocol Deviation|2|||
144392665|NCT05080660|520648043|FG001|Overall Study|Protocol Deviation|0|||
144392666|NCT05080660|520648042|FG000|Overall Study|Withdrawal by Subject|5|||
144392667|NCT05080660|520648043|FG001|Overall Study|Withdrawal by Subject|2|||
144392668|NCT02021656|520648063|FG000|Overall Study|Adverse Event|1|||
144392669|NCT02021656|520648063|FG000|Overall Study|Lack of Efficacy|2|||
144392670|NCT02021656|520648063|FG000|Overall Study|Lost to Follow-up|1|||
144392671|NCT02021656|520648063|FG000|Overall Study|Withdrew Consent|2|||
144392672|NCT00510952|520648066|FG000|Overall Study|Adverse Event|1|||
144392673|NCT00510952|520648067|FG001|Overall Study|Adverse Event|0|||
144392674|NCT00510952|520648066|FG000|Overall Study|Entry Criteria Not Met|3|||
144392675|NCT00510952|520648067|FG001|Overall Study|Entry Criteria Not Met|1|||
144392676|NCT00510952|520648066|FG000|Overall Study|Lost to Follow-up|5|||
144517928|NCT04936035|521096252|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
144392677|NCT00510952|520648067|FG001|Overall Study|Lost to Follow-up|3|||
144392678|NCT00510952|520648066|FG000|Overall Study|Physician Decision|1|||
144392679|NCT00510952|520648067|FG001|Overall Study|Physician Decision|1|||
144392680|NCT00510952|520648066|FG000|Overall Study|Protocol Violation|7|||
144392681|NCT00510952|520648067|FG001|Overall Study|Protocol Violation|4|||
144517929|NCT04936035|521096253|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
144392682|NCT00510952|520648066|FG000|Overall Study|Sponsor Decision|1|||
144392683|NCT00510952|520648067|FG001|Overall Study|Sponsor Decision|0|||
144392684|NCT00510952|520648066|FG000|Overall Study|Withdrawal by Subject|6|||
144392685|NCT00510952|520648067|FG001|Overall Study|Withdrawal by Subject|7|||
144392686|NCT00510952|520648066|FG000|Overall Study|Did Not Receive Study Drug|2|||
144392687|NCT00510952|520648067|FG001|Overall Study|Did Not Receive Study Drug|0|||
144392688|NCT02101112|520648073|FG000|Overall Study|Adverse Event|0|||
144392689|NCT02101112|520648074|FG001|Overall Study|Adverse Event|0|||
144392690|NCT02101112|520648075|FG002|Overall Study|Adverse Event|1|||
144392691|NCT02101112|520648076|FG003|Overall Study|Adverse Event|0|||
144392692|NCT02101112|520648077|FG004|Overall Study|Adverse Event|0|||
144392693|NCT02101112|520648078|FG005|Overall Study|Adverse Event|0|||
144392694|NCT02101112|520648073|FG000|Overall Study|Withdrawal by Subject|0|||
144392695|NCT02101112|520648074|FG001|Overall Study|Withdrawal by Subject|0|||
144392696|NCT02101112|520648075|FG002|Overall Study|Withdrawal by Subject|0|||
144517930|NCT04936035|521096254|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
144517931|NCT04936035|521096250|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
144517932|NCT04936035|521096251|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
144517933|NCT04936035|521096252|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
144517934|NCT04936035|521096253|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
144392697|NCT02101112|520648076|FG003|Overall Study|Withdrawal by Subject|0|||
144392698|NCT02101112|520648077|FG004|Overall Study|Withdrawal by Subject|1|||
144392699|NCT02101112|520648078|FG005|Overall Study|Withdrawal by Subject|0|||
144392700|NCT00782795|520648081|FG000|Overall Study|Withdrawal by Subject|1|||
144392701|NCT00782795|520648082|FG001|Overall Study|Withdrawal by Subject|2|||
144392702|NCT02782923|520648083|FG000|Overall Study|Lost to Follow-up|15|||
144392703|NCT02418156|520648084|FG000|Overall Study|Lost to Follow-up|12|||
144392704|NCT02418156|520648084|FG000|Overall Study|Death|2|||
144392705|NCT02418156|520648084|FG000|Overall Study|Physician Decision|1|||
144392706|NCT02418156|520648084|FG000|Overall Study|Withdrawal by Subject|1|||
144392707|NCT02418156|520648084|FG000|Overall Study|Subject refused to return|1|||
144392708|NCT00521001|520649844|FG000|Overall Study|Ineligible|1|||
144517935|NCT04936035|521096254|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
144392709|NCT02821910|520649845|FG000|Overall Study|Withdrawal by Subject|0|||
144392710|NCT02821910|520649846|FG001|Overall Study|Withdrawal by Subject|0|||
144392711|NCT02821910|520649847|FG002|Overall Study|Withdrawal by Subject|1|||
144392712|NCT02821910|520649848|FG003|Overall Study|Withdrawal by Subject|0|||
144392713|NCT02821910|520649849|FG004|Overall Study|Withdrawal by Subject|0|||
144392714|NCT02821910|520649850|FG005|Overall Study|Withdrawal by Subject|1|||
144392715|NCT02821910|520649845|FG000|Overall Study|Other than specified|1|||
144392716|NCT02821910|520649846|FG001|Overall Study|Other than specified|0|||
144392717|NCT02821910|520649847|FG002|Overall Study|Other than specified|1|||
144392718|NCT02821910|520649848|FG003|Overall Study|Other than specified|0|||
144392719|NCT02821910|520649849|FG004|Overall Study|Other than specified|0|||
144392720|NCT02821910|520649850|FG005|Overall Study|Other than specified|0|||
144392721|NCT00900601|520649851|FG000|Overall Study|Physician Decision|1|||
144392722|NCT01082640|520649852|FG000|Overall Study|Adverse Event|9|||
144392723|NCT01082640|520649853|FG001|Overall Study|Adverse Event|5|||
144392724|NCT01082640|520649854|FG002|Overall Study|Adverse Event|3|||
144392725|NCT01082640|520649852|FG000|Overall Study|Withdrawal by Subject|3|||
144392726|NCT01082640|520649853|FG001|Overall Study|Withdrawal by Subject|3|||
144392727|NCT01082640|520649854|FG002|Overall Study|Withdrawal by Subject|2|||
144392728|NCT01082640|520649852|FG000|Overall Study|Major protocol deviation|3|||
144392729|NCT01082640|520649853|FG001|Overall Study|Major protocol deviation|3|||
144392730|NCT01082640|520649854|FG002|Overall Study|Major protocol deviation|0|||
144392731|NCT01082640|520649852|FG000|Overall Study|Lost to Follow-up|0|||
144392732|NCT01082640|520649853|FG001|Overall Study|Lost to Follow-up|3|||
144392733|NCT01082640|520649854|FG002|Overall Study|Lost to Follow-up|0|||
144392734|NCT01082640|520649852|FG000|Overall Study|Other|2|||
144392735|NCT01082640|520649853|FG001|Overall Study|Other|1|||
144517936|NCT04936035|521096250|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
144392736|NCT01082640|520649854|FG002|Overall Study|Other|3|||
144392737|NCT01241240|520649858|FG000|Overall Study|Adverse Event|5|||
144392738|NCT01241240|520649859|FG001|Overall Study|Adverse Event|4|||
144392739|NCT01241240|520649858|FG000|Overall Study|Lost to Follow-up|2|||
144392740|NCT01241240|520649859|FG001|Overall Study|Lost to Follow-up|4|||
144392741|NCT01241240|520649858|FG000|Overall Study|Personal Reasons|1|||
144392742|NCT01241240|520649859|FG001|Overall Study|Personal Reasons|1|||
144392743|NCT01025154|520649860|FG000|Overall Study|Lost to Follow-up|1|||
144392744|NCT01025154|520649860|FG000|Overall Study|Withdrawal by Subject|1|||
144392745|NCT01466595|520649861|FG000|Overall Study|Withdrawal by Subject|0|||
144392746|NCT01466595|520649862|FG001|Overall Study|Withdrawal by Subject|1|||
144392747|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
144392748|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
144392749|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
144392750|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
144392751|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
144392752|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
144392753|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
144392754|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
144392755|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
144392756|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
144392757|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
144392758|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
144392759|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
144392760|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
144392761|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
144392762|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
144392763|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Program Termination|3|||
144392764|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Program Termination|0|||
144392765|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Program Termination|1|||
144392766|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Program Termination|1|||
144392767|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
144392768|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
144392769|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
144392770|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
144392771|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
144392772|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
144392773|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
144392774|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
144392775|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
144392776|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
144392777|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
144392778|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
144392779|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
144392780|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
144392781|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
144392782|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
144392783|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
144392784|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
144392785|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
144392786|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
144392787|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
144392788|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
144392789|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
144392790|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
144392791|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
144392792|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
144392793|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
144392794|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
144392795|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
144392796|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
144392797|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
144392798|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
144392799|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
144392800|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
144392801|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
144392802|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
144392803|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
144392804|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
144392805|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
144392806|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
144392807|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
144392808|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
144392809|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
144392810|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
144392811|NCT03739840|520649864|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
144392812|NCT03739840|520649865|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
144392813|NCT03739840|520649866|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
144392814|NCT03739840|520649867|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
144392815|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
144392816|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
144392817|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
144392818|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
144392819|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
144392820|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
144392821|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
144392822|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
144392823|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
144392824|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
144392825|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
144392826|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
144392827|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
144392828|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
144392829|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
144392830|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
144392831|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
144392832|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
144392833|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
144392834|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
144392835|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
144392836|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
144392837|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
144392838|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
144392839|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
144392840|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
144392841|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
144392842|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
144392843|NCT03739840|520649864|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
144392844|NCT03739840|520649865|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
144392845|NCT03739840|520649866|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
144392846|NCT03739840|520649867|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
144392847|NCT02788474|520649868|FG000|Double Blind Treatment Period|Not treated|1|||
144392848|NCT02788474|520649869|FG001|Double Blind Treatment Period|Not treated|0|||
144392849|NCT02788474|520649868|FG000|Double Blind Treatment Period|Patient's refusal|3|||
144392850|NCT02788474|520649869|FG001|Double Blind Treatment Period|Patient's refusal|0|||
144392851|NCT02788474|520649868|FG000|Double Blind Treatment Period|Adverse Event|6|||
144392852|NCT02788474|520649869|FG001|Double Blind Treatment Period|Adverse Event|4|||
144392853|NCT02788474|520649868|FG000|Open Label Treatment Period|Adverse Event|29|||
144392854|NCT02788474|520649869|FG001|Open Label Treatment Period|Adverse Event|9|||
144392855|NCT02788474|520649868|FG000|Open Label Treatment Period|Other than reason specified|1|||
144392856|NCT02788474|520649869|FG001|Open Label Treatment Period|Other than reason specified|0|||
144392857|NCT02788474|520649868|FG000|Open Label Treatment Period|Patient's refusal|1|||
144392858|NCT02788474|520649869|FG001|Open Label Treatment Period|Patient's refusal|3|||
144392859|NCT02788474|520649868|FG000|Open Label Treatment Period|Non-compliance|1|||
144392860|NCT02788474|520649869|FG001|Open Label Treatment Period|Non-compliance|0|||
144392861|NCT05153473|520649870|FG000|Overall Study|Death|46|||
144392862|NCT05153473|520649870|FG000|Overall Study|Lost to Follow-up|3|||
144392863|NCT00048061|520649871|FG000|Overall Study|Adverse Event|41|||
144392864|NCT00048061|520649872|FG001|Overall Study|Adverse Event|32|||
144392865|NCT00048061|520649873|FG002|Overall Study|Adverse Event|44|||
144392866|NCT00048061|520649874|FG003|Overall Study|Adverse Event|37|||
144392867|NCT00048061|520649871|FG000|Overall Study|Lost to Follow-up|3|||
144392868|NCT00048061|520649872|FG001|Overall Study|Lost to Follow-up|2|||
144392869|NCT00048061|520649873|FG002|Overall Study|Lost to Follow-up|4|||
144392870|NCT00048061|520649874|FG003|Overall Study|Lost to Follow-up|5|||
144392871|NCT00048061|520649871|FG000|Overall Study|Withdrawal by Subject|20|||
144392872|NCT00048061|520649872|FG001|Overall Study|Withdrawal by Subject|29|||
144392873|NCT00048061|520649873|FG002|Overall Study|Withdrawal by Subject|29|||
144392874|NCT00048061|520649874|FG003|Overall Study|Withdrawal by Subject|32|||
144392875|NCT00048061|520649871|FG000|Overall Study|Did not follow-up|5|||
144392876|NCT00048061|520649872|FG001|Overall Study|Did not follow-up|5|||
144392877|NCT00048061|520649873|FG002|Overall Study|Did not follow-up|4|||
144392878|NCT00048061|520649874|FG003|Overall Study|Did not follow-up|5|||
144392879|NCT00048061|520649871|FG000|Overall Study|Early improvement|6|||
144392880|NCT00048061|520649872|FG001|Overall Study|Early improvement|5|||
144392881|NCT00048061|520649873|FG002|Overall Study|Early improvement|3|||
144392882|NCT00048061|520649874|FG003|Overall Study|Early improvement|0|||
144392883|NCT03555435|520649875|FG000|Overall Study|Lost to Follow-up|17|||
144392884|NCT03555435|520649876|FG001|Overall Study|Lost to Follow-up|19|||
144392885|NCT03555435|520649877|FG002|Overall Study|Lost to Follow-up|8|||
144392886|NCT01058265|520649880|FG000|Overall Study|Lost to Follow-up|11|||
144392887|NCT01058265|520649881|FG001|Overall Study|Lost to Follow-up|12|||
144392888|NCT02869438|520649882|FG000|Overall Study|Lost to Follow-up|1|||
144392889|NCT02869438|520649883|FG001|Overall Study|Lost to Follow-up|0|||
144392890|NCT02869438|520649882|FG000|Overall Study|Adverse Event|1|||
144392891|NCT02869438|520649883|FG001|Overall Study|Adverse Event|0|||
144392892|NCT02869438|520649882|FG000|Overall Study|Withdrawal by Subject|1|||
144392893|NCT02869438|520649883|FG001|Overall Study|Withdrawal by Subject|2|||
144392894|NCT05323656|520649887|FG000|Overall Study|Still On-Treatment|6|||
144392895|NCT05323656|520649888|FG001|Overall Study|Still On-Treatment|6|||
144392896|NCT05323656|520649887|FG000|Overall Study|Progressive Disease|15|||
144392897|NCT05323656|520649888|FG001|Overall Study|Progressive Disease|14|||
144392898|NCT05323656|520649887|FG000|Overall Study|Adverse Event|2|||
144392899|NCT05323656|520649888|FG001|Overall Study|Adverse Event|3|||
144392900|NCT05323656|520649887|FG000|Overall Study|Death|1|||
144392901|NCT05323656|520649888|FG001|Overall Study|Death|2|||
144392902|NCT05323656|520649887|FG000|Overall Study|Withdrawal by Subject|1|||
144392903|NCT05323656|520649888|FG001|Overall Study|Withdrawal by Subject|0|||
144392904|NCT05323656|520649887|FG000|Overall Study|Clinical disease progression|0|||
144392905|NCT05323656|520649888|FG001|Overall Study|Clinical disease progression|1|||
144392906|NCT05323656|520649887|FG000|Overall Study|Patient and Investigator decision|1|||
144392907|NCT05323656|520649888|FG001|Overall Study|Patient and Investigator decision|0|||
144392908|NCT05323656|520649887|FG000|Overall Study|Physician Decision|0|||
144392909|NCT05323656|520649888|FG001|Overall Study|Physician Decision|1|||
144392910|NCT02495233|520649889|FG000|Overall Study|Miscellaneous|0|||
144392911|NCT02495233|520649890|FG001|Overall Study|Miscellaneous|1|||
144392912|NCT03880461|520649892|FG000|Overall Study|Determined ineligible after enrollment|45|||
144392913|NCT03880461|520649893|FG001|Overall Study|Determined ineligible after enrollment|44|||
144392914|NCT03880461|520649892|FG000|Overall Study|No weight measurement after enrollment|24|||
144392915|NCT03880461|520649893|FG001|Overall Study|No weight measurement after enrollment|17|||
144392916|NCT00064298|520649895|FG000|Overall Study|Withdrawal by Subject|2|||
144392917|NCT00064298|520649896|FG001|Overall Study|Withdrawal by Subject|1|||
144392918|NCT00064298|520649895|FG000|Overall Study|Lost to Follow-up|2|||
144392919|NCT00064298|520649896|FG001|Overall Study|Lost to Follow-up|2|||
144392920|NCT00064298|520649895|FG000|Overall Study|Death|0|||
144392921|NCT00064298|520649896|FG001|Overall Study|Death|1|||
144392922|NCT00064298|520649895|FG000|Overall Study|Disease Progression|2|||
144392923|NCT00064298|520649896|FG001|Overall Study|Disease Progression|1|||
144392924|NCT00450385|520649897|FG000|Overall Study|Death|3|||
144392925|NCT00450385|520649897|FG000|Overall Study|Protocol Violation|1|||
144392926|NCT00450385|520649897|FG000|Overall Study|Withdrawal by Subject|2|||
144392927|NCT00450385|520649897|FG000|Overall Study|Lack of Efficacy|2|||
144392928|NCT00450385|520649897|FG000|Overall Study|Adverse Event|1|||
144392929|NCT00450385|520649897|FG000|Overall Study|Physician Decision|1|||
144392930|NCT00450385|520649897|FG000|Overall Study|Other|3|||
144392931|NCT03614975|520649898|FG000|Overall Study|Physician Decision|7|||
144392932|NCT03614975|520649899|FG001|Overall Study|Physician Decision|5|||
144392933|NCT03614975|520649898|FG000|Overall Study|Withdrawal by Subject|2|||
144392934|NCT03614975|520649899|FG001|Overall Study|Withdrawal by Subject|2|||
144392935|NCT03614975|520649898|FG000|Overall Study|Specimens not in lab batch shipment|1|||
144392936|NCT03614975|520649899|FG001|Overall Study|Specimens not in lab batch shipment|1|||
144392937|NCT01569464|520649900|FG000|Overall Study|Adverse Event|4|||
144392938|NCT01569464|520649901|FG001|Overall Study|Adverse Event|0|||
144392939|NCT01569464|520649900|FG000|Overall Study|Lack of Efficacy|1|||
144392940|NCT01569464|520649901|FG001|Overall Study|Lack of Efficacy|0|||
144392941|NCT01569464|520649900|FG000|Overall Study|Protocol Violation|1|||
144392942|NCT01569464|520649901|FG001|Overall Study|Protocol Violation|0|||
144392943|NCT01569464|520649900|FG000|Overall Study|Lost to Follow-up|2|||
144392944|NCT01569464|520649901|FG001|Overall Study|Lost to Follow-up|3|||
144392945|NCT01569464|520649900|FG000|Overall Study|Withdrawal by Subject|1|||
144392946|NCT01569464|520649901|FG001|Overall Study|Withdrawal by Subject|1|||
144392947|NCT01569464|520649900|FG000|Overall Study|Other|1|||
144392948|NCT01569464|520649901|FG001|Overall Study|Other|1|||
144392949|NCT04025710|520649902|FG000|Overall Study|Death|3|||
144392950|NCT04025710|520649902|FG000|Overall Study|Lost to Follow-up|5|||
144392951|NCT04025710|520649902|FG000|Overall Study|Withdrawal by Subject|1|||
144392952|NCT04025710|520649902|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
144517937|NCT04936035|521096251|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
144392953|NCT04025710|520649902|FG000|Overall Study|Drop-out according to protocol|34|||
144392954|NCT02273739|520649903|FG000|Overall Study|Progression of Disease|3|||
144392955|NCT02273739|520649904|FG001|Overall Study|Progression of Disease|4|||
144392956|NCT02273739|520649905|FG002|Overall Study|Progression of Disease|5|||
144392957|NCT02273739|520649906|FG003|Overall Study|Progression of Disease|2|||
144392958|NCT02273739|520649903|FG000|Overall Study|Death|0|||
144392959|NCT02273739|520649904|FG001|Overall Study|Death|0|||
144392960|NCT02273739|520649905|FG002|Overall Study|Death|0|||
144392961|NCT02273739|520649906|FG003|Overall Study|Death|2|||
144392962|NCT02273739|520649903|FG000|Overall Study|Adverse Event|0|||
144392963|NCT02273739|520649904|FG001|Overall Study|Adverse Event|0|||
144594054|NCT00876694|521376099|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144594055|NCT00876694|521376100|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144594056|NCT00876694|521376099|FG000|Overall Study|Administrative problems|1|||
144594057|NCT00876694|521376100|FG001|Overall Study|Administrative problems|1|||
144594058|NCT00876694|521376099|FG000|Overall Study|Death|1|||
144722163|NCT01463683|521836992|FG001|Overall Study|Withdrawal by Subject|17|||
144392964|NCT02273739|520649905|FG002|Overall Study|Adverse Event|0|||
144392965|NCT02273739|520649906|FG003|Overall Study|Adverse Event|1|||
144392966|NCT02273739|520649903|FG000|Overall Study|Withdrawal by Subject|0|||
144392967|NCT02273739|520649904|FG001|Overall Study|Withdrawal by Subject|0|||
144392968|NCT02273739|520649905|FG002|Overall Study|Withdrawal by Subject|2|||
144392969|NCT02273739|520649906|FG003|Overall Study|Withdrawal by Subject|1|||
144392970|NCT02273739|520649903|FG000|Overall Study|Physician Decision|0|||
144392971|NCT02273739|520649904|FG001|Overall Study|Physician Decision|0|||
144392972|NCT02273739|520649905|FG002|Overall Study|Physician Decision|0|||
144392973|NCT02273739|520649906|FG003|Overall Study|Physician Decision|1|||
144392974|NCT04718103|520649907|FG000|Overall Study|Adverse Event|1|||
144392975|NCT04718103|520649908|FG001|Overall Study|Adverse Event|1|||
144392976|NCT04718103|520649907|FG000|Overall Study|Lack of Efficacy|4|||
144392977|NCT04718103|520649908|FG001|Overall Study|Lack of Efficacy|1|||
144392978|NCT04718103|520649907|FG000|Overall Study|Lost to Follow-up|2|||
144392979|NCT04718103|520649908|FG001|Overall Study|Lost to Follow-up|2|||
144392980|NCT04718103|520649907|FG000|Overall Study|Physician Decision|2|||
144392981|NCT04718103|520649908|FG001|Overall Study|Physician Decision|0|||
144392982|NCT04718103|520649907|FG000|Overall Study|Pregnancy|0|||
144392983|NCT04718103|520649908|FG001|Overall Study|Pregnancy|1|||
144392984|NCT04718103|520649907|FG000|Overall Study|Withdrawal by Subject|10|||
144392985|NCT04718103|520649908|FG001|Overall Study|Withdrawal by Subject|6|||
144392986|NCT04718103|520649907|FG000|Overall Study|Randomized, not treated|4|||
144392987|NCT04718103|520649908|FG001|Overall Study|Randomized, not treated|1|||
144392988|NCT04718103|520649907|FG000|Overall Study|GCP violations|7|||
144392989|NCT04718103|520649908|FG001|Overall Study|GCP violations|5|||
144392990|NCT02017171|520649909|FG000|Overall Study|Death|10|||
144392991|NCT02017171|520649910|FG001|Overall Study|Death|4|||
144392992|NCT02017171|520649909|FG000|Overall Study|Withdrawal by Subject|23|||
144392993|NCT02017171|520649910|FG001|Overall Study|Withdrawal by Subject|17|||
144392994|NCT02017171|520649909|FG000|Overall Study|Lost to Follow-up|21|||
144392995|NCT02017171|520649910|FG001|Overall Study|Lost to Follow-up|20|||
144392996|NCT02017171|520649909|FG000|Overall Study|ESKD|6|||
144392997|NCT02017171|520649910|FG001|Overall Study|ESKD|2|||
144392998|NCT02017171|520649909|FG000|Overall Study|Miscellaneous|2|||
144392999|NCT02017171|520649910|FG001|Overall Study|Miscellaneous|3|||
144393000|NCT02536833|520649912|FG000|Overall Study|Discontinued Before Treatment|0|||
144393001|NCT02536833|520649913|FG001|Overall Study|Discontinued Before Treatment|0|||
144393002|NCT02536833|520649914|FG002|Overall Study|Discontinued Before Treatment|1|||
144393003|NCT02536833|520649915|FG003|Overall Study|Discontinued Before Treatment|2|||
144393004|NCT02536833|520649912|FG000|Overall Study|Adverse Event|1|||
144393005|NCT02536833|520649913|FG001|Overall Study|Adverse Event|3|||
144393006|NCT02536833|520649914|FG002|Overall Study|Adverse Event|4|||
144393007|NCT02536833|520649915|FG003|Overall Study|Adverse Event|1|||
144393008|NCT02536833|520649912|FG000|Overall Study|Lost to Follow-up|2|||
144393009|NCT02536833|520649913|FG001|Overall Study|Lost to Follow-up|1|||
144393010|NCT02536833|520649914|FG002|Overall Study|Lost to Follow-up|2|||
144594059|NCT00876694|521376100|FG001|Overall Study|Death|0|||
144393011|NCT02536833|520649915|FG003|Overall Study|Lost to Follow-up|2|||
144393012|NCT02536833|520649912|FG000|Overall Study|Physician Decision|0|||
144393013|NCT02536833|520649913|FG001|Overall Study|Physician Decision|0|||
144393014|NCT02536833|520649914|FG002|Overall Study|Physician Decision|0|||
144393015|NCT02536833|520649915|FG003|Overall Study|Physician Decision|1|||
144393016|NCT02536833|520649912|FG000|Overall Study|Site Terminated by Sponsor|2|||
144393017|NCT02536833|520649913|FG001|Overall Study|Site Terminated by Sponsor|2|||
144393018|NCT02536833|520649914|FG002|Overall Study|Site Terminated by Sponsor|2|||
144393019|NCT02536833|520649915|FG003|Overall Study|Site Terminated by Sponsor|2|||
144393020|NCT02536833|520649912|FG000|Overall Study|Subject Non-Compliance|0|||
144393021|NCT02536833|520649913|FG001|Overall Study|Subject Non-Compliance|1|||
144393022|NCT02536833|520649914|FG002|Overall Study|Subject Non-Compliance|1|||
144393023|NCT02536833|520649915|FG003|Overall Study|Subject Non-Compliance|0|||
144393024|NCT02536833|520649912|FG000|Overall Study|Withdrawal by Subject|4|||
144393025|NCT02536833|520649913|FG001|Overall Study|Withdrawal by Subject|3|||
144393026|NCT02536833|520649914|FG002|Overall Study|Withdrawal by Subject|5|||
144393027|NCT02536833|520649915|FG003|Overall Study|Withdrawal by Subject|11|||
144393028|NCT02140775|520649920|FG000|Overall Study|Withdrawal by Subject|30|||
144393029|NCT02140775|520649921|FG001|Overall Study|Withdrawal by Subject|7|||
144393030|NCT02942576|520649923|FG000|Overall Study|Adverse Event|28|||
144393031|NCT02942576|520649924|FG001|Overall Study|Adverse Event|6|||
144393032|NCT02942576|520649923|FG000|Overall Study|Withdrawal by Subject|7|||
144393033|NCT02942576|520649924|FG001|Overall Study|Withdrawal by Subject|5|||
144393034|NCT02942576|520649923|FG000|Overall Study|Physician Decision|1|||
144393035|NCT02942576|520649924|FG001|Overall Study|Physician Decision|4|||
144393036|NCT02942576|520649923|FG000|Overall Study|Other|10|||
144393037|NCT02942576|520649924|FG001|Overall Study|Other|8|||
144393038|NCT01858636|520649927|FG000|Overall Study|No Device Deployment Attempted|24|||
144393039|NCT01858636|520649927|FG000|Overall Study|Physician Decision|1|||
144393040|NCT01858636|520649927|FG000|Overall Study|Death|1|||
144393041|NCT01858636|520649927|FG000|Overall Study|Lost to Follow-up|1|||
144393042|NCT01858636|520649927|FG000|Overall Study|Withdrawal by Subject|1|||
144393043|NCT01172275|520649930|FG000|Overall Study|Lost to Follow-up|1|||
144393044|NCT01172275|520649931|FG001|Overall Study|Lost to Follow-up|0|||
144393045|NCT01172275|520649930|FG000|Overall Study|Protocol Violation|1|||
144393046|NCT01172275|520649931|FG001|Overall Study|Protocol Violation|0|||
144393047|NCT04650854|520649935|FG000|Overall Study|Adverse Event|1|||
144393048|NCT04650854|520649936|FG001|Overall Study|Adverse Event|12|||
144393049|NCT04650854|520649937|FG002|Overall Study|Adverse Event|14|||
144393050|NCT04650854|520649935|FG000|Overall Study|Lack of Efficacy|1|||
144393051|NCT04650854|520649936|FG001|Overall Study|Lack of Efficacy|3|||
144393052|NCT04650854|520649937|FG002|Overall Study|Lack of Efficacy|6|||
144393053|NCT04650854|520649935|FG000|Overall Study|Lost to Follow-up|1|||
144393054|NCT04650854|520649936|FG001|Overall Study|Lost to Follow-up|1|||
144393055|NCT04650854|520649937|FG002|Overall Study|Lost to Follow-up|0|||
144393056|NCT04650854|520649935|FG000|Overall Study|Withdrawal by Subject|2|||
144393057|NCT04650854|520649936|FG001|Overall Study|Withdrawal by Subject|17|||
144393058|NCT04650854|520649937|FG002|Overall Study|Withdrawal by Subject|9|||
144393059|NCT04650854|520649935|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
144393060|NCT04650854|520649936|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
144393061|NCT04650854|520649937|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
144393062|NCT04650854|520649935|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
144393063|NCT04650854|520649936|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
144393064|NCT04650854|520649937|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
144393065|NCT04650854|520649935|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
144393066|NCT04650854|520649936|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
144393067|NCT04650854|520649937|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
144393068|NCT04650854|520649935|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
144393069|NCT04650854|520649936|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
144393070|NCT04650854|520649937|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
144393071|NCT04650854|520649935|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
144517938|NCT04936035|521096252|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
144393072|NCT04650854|520649936|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
144393073|NCT04650854|520649937|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
144517939|NCT04936035|521096253|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
144517940|NCT04936035|521096254|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
144393074|NCT04650854|520649935|FG000|Overall Study|Use of Rescue Medication|0|||
144393075|NCT04650854|520649936|FG001|Overall Study|Use of Rescue Medication|0|||
144393076|NCT04650854|520649937|FG002|Overall Study|Use of Rescue Medication|1|||
144393077|NCT04650854|520649935|FG000|Overall Study|Last Treatment Per Sponsor|0|||
144393078|NCT04650854|520649936|FG001|Overall Study|Last Treatment Per Sponsor|0|||
144393079|NCT04650854|520649937|FG002|Overall Study|Last Treatment Per Sponsor|2|||
144393080|NCT04650854|520649935|FG000|Overall Study|Rescue Medication|0|||
144393081|NCT04650854|520649936|FG001|Overall Study|Rescue Medication|0|||
144393082|NCT04650854|520649937|FG002|Overall Study|Rescue Medication|1|||
144393083|NCT04650854|520649935|FG000|Overall Study|Participant Want to Start a Family|0|||
144393084|NCT04650854|520649936|FG001|Overall Study|Participant Want to Start a Family|0|||
144393085|NCT04650854|520649937|FG002|Overall Study|Participant Want to Start a Family|1|||
144393086|NCT04650854|520649935|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
144393087|NCT04650854|520649936|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
144393088|NCT04650854|520649937|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
144393089|NCT04650854|520649935|FG000|Overall Study|Participant Screened For MG0020|0|||
144393090|NCT04650854|520649936|FG001|Overall Study|Participant Screened For MG0020|2|||
144393091|NCT04650854|520649937|FG002|Overall Study|Participant Screened For MG0020|3|||
144393092|NCT04650854|520649935|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
144393093|NCT04650854|520649936|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
144393094|NCT04650854|520649937|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
144393095|NCT04650854|520649935|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
144393096|NCT04650854|520649936|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
144393097|NCT04650854|520649937|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
144393098|NCT04650854|520649935|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
144393099|NCT04650854|520649936|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
144393100|NCT04650854|520649937|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
144393101|NCT04650854|520649935|FG000|Overall Study|End Of Study|0|||
144393102|NCT04650854|520649936|FG001|Overall Study|End Of Study|2|||
144393103|NCT04650854|520649937|FG002|Overall Study|End Of Study|1|||
144393104|NCT04650854|520649935|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
144393105|NCT04650854|520649936|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
144393106|NCT04650854|520649937|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
144393107|NCT04650854|520649935|FG000|Overall Study|Participant Received Rescue Medication|0|||
144393108|NCT04650854|520649936|FG001|Overall Study|Participant Received Rescue Medication|1|||
144393109|NCT04650854|520649937|FG002|Overall Study|Participant Received Rescue Medication|0|||
144393110|NCT04650854|520649935|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
144393111|NCT04650854|520649936|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
144393112|NCT04650854|520649937|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
144393113|NCT04650854|520649935|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
144517941|NCT04401800|521096255|FG000|Overall Study|Death|17|||
144517942|NCT04401800|521096255|FG000|Overall Study|Lost to Follow-up|5|||
144517943|NCT04401800|521096255|FG000|Overall Study|Withdrawal by Subject|4|||
144517944|NCT03338790|521096261|FG000|Overall Study|Disease Progression|65|||
144517945|NCT03338790|521096262|FG001|Overall Study|Disease Progression|43|||
144517946|NCT03338790|521096263|FG002|Overall Study|Disease Progression|50|||
144517947|NCT03338790|521096264|FG003|Overall Study|Disease Progression|37|||
144517948|NCT03338790|521096261|FG000|Overall Study|Study Drug Toxicity|9|||
144517949|NCT03338790|521096262|FG001|Overall Study|Study Drug Toxicity|8|||
144517950|NCT03338790|521096263|FG002|Overall Study|Study Drug Toxicity|15|||
144517951|NCT03338790|521096264|FG003|Overall Study|Study Drug Toxicity|0|||
144517952|NCT03338790|521096261|FG000|Overall Study|Death|1|||
144517953|NCT03338790|521096262|FG001|Overall Study|Death|1|||
144517954|NCT03338790|521096263|FG002|Overall Study|Death|1|||
144517955|NCT03338790|521096264|FG003|Overall Study|Death|0|||
144517956|NCT03338790|521096261|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
144517957|NCT03338790|521096262|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
144517958|NCT03338790|521096263|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
144517959|NCT03338790|521096264|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
144393114|NCT04650854|520649936|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
144393115|NCT04650854|520649937|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
144393116|NCT04650854|520649935|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
144393117|NCT04650854|520649936|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
144393118|NCT04650854|520649937|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
144393119|NCT04650854|520649935|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
144517960|NCT03338790|521096261|FG000|Overall Study|Participant request to discontinue study treatment|3|||
144517961|NCT03338790|521096262|FG001|Overall Study|Participant request to discontinue study treatment|3|||
144517962|NCT03338790|521096263|FG002|Overall Study|Participant request to discontinue study treatment|2|||
144517963|NCT03338790|521096264|FG003|Overall Study|Participant request to discontinue study treatment|1|||
144517964|NCT03338790|521096261|FG000|Overall Study|Poor/non-compliance|0|||
144517965|NCT03338790|521096262|FG001|Overall Study|Poor/non-compliance|1|||
144517966|NCT03338790|521096263|FG002|Overall Study|Poor/non-compliance|0|||
144517967|NCT03338790|521096264|FG003|Overall Study|Poor/non-compliance|0|||
144517968|NCT03338790|521096261|FG000|Overall Study|Participant withdrew consent|1|||
144517969|NCT03338790|521096262|FG001|Overall Study|Participant withdrew consent|0|||
144517970|NCT03338790|521096263|FG002|Overall Study|Participant withdrew consent|1|||
144517971|NCT03338790|521096264|FG003|Overall Study|Participant withdrew consent|1|||
144517972|NCT03338790|521096261|FG000|Overall Study|Other reasons|0|||
144517973|NCT03338790|521096262|FG001|Overall Study|Other reasons|5|||
144393120|NCT04650854|520649936|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
144393121|NCT04650854|520649937|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
144393122|NCT04650854|520649935|FG000|Overall Study|Enrollment Cup|0|||
144393123|NCT04650854|520649936|FG001|Overall Study|Enrollment Cup|0|||
144393124|NCT04650854|520649937|FG002|Overall Study|Enrollment Cup|1|||
144393125|NCT01285960|520649940|FG000|Overall Study|Withdrawal by Subject|2|||
144594060|NCT01386788|521376105|FG000|Overall Study|Lost to Follow-up|2|||
144393126|NCT01285960|520649940|FG000|Overall Study|Lost to Follow-up|2|||
144393127|NCT01285960|520649940|FG000|Overall Study|2 subjects received less 10 sonications|2|||
144594061|NCT00120406|521376108|FG000|Overall Study|Death|9|||
144594062|NCT00120406|521376109|FG001|Overall Study|Death|4|||
144594063|NCT00120406|521376108|FG000|Overall Study|Withdrawal by Subject|5|||
144594064|NCT00120406|521376109|FG001|Overall Study|Withdrawal by Subject|7|||
144594065|NCT00120406|521376108|FG000|Overall Study|Lost to Follow-up|5|||
144594066|NCT00120406|521376109|FG001|Overall Study|Lost to Follow-up|2|||
144594067|NCT00120406|521376108|FG000|Overall Study|received non-study stent|0|||
144594068|NCT00120406|521376109|FG001|Overall Study|received non-study stent|2|||
144594069|NCT00120406|521376108|FG000|Overall Study|patient moved but has not withdrawn|0|||
144594070|NCT00120406|521376109|FG001|Overall Study|patient moved but has not withdrawn|1|||
144594071|NCT01155375|521376110|FG000|Overall Study|Adverse Event|1|||
144594072|NCT01155375|521376111|FG001|Overall Study|Adverse Event|0|||
144594073|NCT00762970|521376112|FG000|Overall Study|Withdrawal by Subject|7|||
144594074|NCT00762970|521376113|FG001|Overall Study|Withdrawal by Subject|4|||
144594075|NCT00762970|521376114|FG002|Overall Study|Withdrawal by Subject|0|||
144594076|NCT00762970|521376112|FG000|Overall Study|Protocol Violation|3|||
144594077|NCT00762970|521376113|FG001|Overall Study|Protocol Violation|1|||
144594078|NCT00762970|521376114|FG002|Overall Study|Protocol Violation|1|||
144594079|NCT00762970|521376112|FG000|Overall Study|Lost to Follow-up|1|||
144594080|NCT00762970|521376113|FG001|Overall Study|Lost to Follow-up|2|||
144594081|NCT00762970|521376114|FG002|Overall Study|Lost to Follow-up|0|||
144594082|NCT00762970|521376112|FG000|Overall Study|Difficulty of handling lens|1|||
144594083|NCT00762970|521376113|FG001|Overall Study|Difficulty of handling lens|2|||
144594084|NCT00762970|521376114|FG002|Overall Study|Difficulty of handling lens|0|||
144594085|NCT00975507|521376115|FG000|Overall Study|Adverse Event|1|||
144594086|NCT00975507|521376116|FG001|Overall Study|Adverse Event|0|||
144594087|NCT00975507|521376115|FG000|Overall Study|Lost to Follow-up|7|||
144594088|NCT00975507|521376116|FG001|Overall Study|Lost to Follow-up|1|||
144594089|NCT00975507|521376115|FG000|Overall Study|Protocol Violation|2|||
144594090|NCT00975507|521376116|FG001|Overall Study|Protocol Violation|0|||
144594091|NCT00975507|521376115|FG000|Overall Study|Withdrawal by Subject|10|||
144594092|NCT00975507|521376116|FG001|Overall Study|Withdrawal by Subject|3|||
144594093|NCT01295034|521376117|FG000|Overall Study|Lost to Follow-up|5|||
144594094|NCT01295034|521376118|FG001|Overall Study|Lost to Follow-up|5|||
144594095|NCT03818204|521376119|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594096|NCT03818204|521376120|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594097|NCT03818204|521376121|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594098|NCT03818204|521376122|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594099|NCT03818204|521376123|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
144594100|NCT03818204|521376124|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594101|NCT03818204|521376125|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594102|NCT03818204|521376126|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594103|NCT03818204|521376127|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594104|NCT03818204|521376128|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594105|NCT03818204|521376129|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594106|NCT03818204|521376130|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594107|NCT03818204|521376131|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594108|NCT03818204|521376132|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
144393128|NCT00667420|520649941|FG000|Overall Study|Adverse Event|2|||
144393129|NCT00667420|520649941|FG000|Overall Study|Lack of Efficacy|5|||
144594109|NCT03818204|521376133|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594110|NCT03818204|521376134|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594111|NCT03818204|521376135|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144393130|NCT00667420|520649941|FG000|Overall Study|Physician Decision|1|||
144393131|NCT00667420|520649941|FG000|Overall Study|Withdrawal by Subject|2|||
144393132|NCT04437368|520649942|FG000|Overall Study|Death|3|||
144393133|NCT04437368|520649943|FG001|Overall Study|Death|0|||
144594112|NCT03818204|521376136|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594113|NCT03818204|521376137|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
144594114|NCT03818204|521376119|FG000|Overall Study|Physician Decision|0|||
144594115|NCT03818204|521376120|FG001|Overall Study|Physician Decision|0|||
144594116|NCT03818204|521376121|FG002|Overall Study|Physician Decision|0|||
144594117|NCT03818204|521376122|FG003|Overall Study|Physician Decision|0|||
144393134|NCT04437368|520649944|FG002|Overall Study|Death|2|||
144393135|NCT04437368|520649942|FG000|Overall Study|Study terminated by sponsor|16|||
144393136|NCT04437368|520649943|FG001|Overall Study|Study terminated by sponsor|1|||
144393137|NCT04437368|520649944|FG002|Overall Study|Study terminated by sponsor|25|||
144393138|NCT04437368|520649942|FG000|Overall Study|Withdrawal by Subject|4|||
144393139|NCT04437368|520649943|FG001|Overall Study|Withdrawal by Subject|0|||
144393140|NCT04437368|520649944|FG002|Overall Study|Withdrawal by Subject|3|||
144393141|NCT04437368|520649942|FG000|Overall Study|Sponsor instructions|23|||
144393142|NCT04437368|520649943|FG001|Overall Study|Sponsor instructions|0|||
144393143|NCT04437368|520649944|FG002|Overall Study|Sponsor instructions|0|||
144393144|NCT04271280|520649948|FG000|Overall Study|Lost to Follow-up|300|||
144393145|NCT04271280|520649948|FG000|Overall Study|Death|153|||
144393146|NCT04271280|520649948|FG000|Overall Study|Withdrawal of consent by patient|59|||
144517974|NCT03338790|521096263|FG002|Overall Study|Other reasons|0|||
144517975|NCT03338790|521096264|FG003|Overall Study|Other reasons|2|||
144517976|NCT03338790|521096261|FG000|Overall Study|Not reported|0|||
144517977|NCT03338790|521096262|FG001|Overall Study|Not reported|0|||
144517978|NCT03338790|521096263|FG002|Overall Study|Not reported|1|||
144517979|NCT03338790|521096264|FG003|Overall Study|Not reported|0|||
144517980|NCT03338790|521096261|FG000|Overall Study|Completed treatment period|1|||
144393147|NCT04271280|520649948|FG000|Overall Study|Other|51|||
144393148|NCT04271280|520649948|FG000|Overall Study|No end of study information|42|||
144393149|NCT03224546|520649949|FG000|Overall Study|Lost to Follow-up|9|||
144393150|NCT03224546|520649950|FG001|Overall Study|Lost to Follow-up|8|||
144393151|NCT03224546|520649951|FG002|Overall Study|Lost to Follow-up|3|||
144393152|NCT03224546|520649949|FG000|Overall Study|Withdrawal by Subject|7|||
144393153|NCT03224546|520649950|FG001|Overall Study|Withdrawal by Subject|14|||
144517981|NCT03338790|521096262|FG001|Overall Study|Completed treatment period|2|||
144517982|NCT03338790|521096263|FG002|Overall Study|Completed treatment period|0|||
144517983|NCT03338790|521096264|FG003|Overall Study|Completed treatment period|0|||
144517984|NCT01772472|521096267|FG000|Overall Study|Death|126|||
144517985|NCT01772472|521096268|FG001|Overall Study|Death|94|||
144517986|NCT01772472|521096267|FG000|Overall Study|Lost to Follow-up|51|||
144517987|NCT01772472|521096268|FG001|Overall Study|Lost to Follow-up|50|||
144517988|NCT01772472|521096267|FG000|Overall Study|Other|9|||
144517989|NCT01772472|521096268|FG001|Overall Study|Other|7|||
144517990|NCT01772472|521096267|FG000|Overall Study|Physician Decision|1|||
144517991|NCT01772472|521096268|FG001|Overall Study|Physician Decision|7|||
144517992|NCT01772472|521096267|FG000|Overall Study|Withdrawal by Subject|115|||
144517993|NCT01772472|521096268|FG001|Overall Study|Withdrawal by Subject|90|||
144517994|NCT01772472|521096267|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
144517995|NCT01772472|521096268|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
144517996|NCT04391894|521096269|FG000|Overall Study|Adverse Event|1|||
144517997|NCT04391894|521096270|FG001|Overall Study|Adverse Event|1|||
144517998|NCT04391894|521096271|FG002|Overall Study|Adverse Event|1|||
144517999|NCT04391894|521096272|FG003|Overall Study|Adverse Event|1|||
144518000|NCT04391894|521096273|FG004|Overall Study|Adverse Event|1|||
144518001|NCT04391894|521096269|FG000|Overall Study|Lost to Follow-up|1|||
144518002|NCT04391894|521096270|FG001|Overall Study|Lost to Follow-up|0|||
144518003|NCT04391894|521096271|FG002|Overall Study|Lost to Follow-up|0|||
144518004|NCT04391894|521096272|FG003|Overall Study|Lost to Follow-up|0|||
144518005|NCT04391894|521096273|FG004|Overall Study|Lost to Follow-up|0|||
144518006|NCT04391894|521096269|FG000|Overall Study|Protocol Violation|0|||
144518007|NCT04391894|521096270|FG001|Overall Study|Protocol Violation|0|||
144518008|NCT04391894|521096271|FG002|Overall Study|Protocol Violation|0|||
144518009|NCT04391894|521096272|FG003|Overall Study|Protocol Violation|1|||
144393154|NCT03224546|520649951|FG002|Overall Study|Withdrawal by Subject|12|||
144518010|NCT04391894|521096273|FG004|Overall Study|Protocol Violation|0|||
144518011|NCT04391894|521096269|FG000|Overall Study|Withdrawal by Subject|2|||
144518012|NCT04391894|521096270|FG001|Overall Study|Withdrawal by Subject|0|||
144518013|NCT04391894|521096271|FG002|Overall Study|Withdrawal by Subject|3|||
144518014|NCT04391894|521096272|FG003|Overall Study|Withdrawal by Subject|0|||
144518015|NCT04391894|521096273|FG004|Overall Study|Withdrawal by Subject|1|||
144518016|NCT04391894|521096269|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
144518017|NCT04391894|521096270|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
144518018|NCT04391894|521096271|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
144393155|NCT01280955|520649954|FG000|Overall Study|Death|2|||
144393156|NCT01280955|520649954|FG000|Overall Study|Withdrawal by Subject|1|||
144518019|NCT04391894|521096272|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
144518020|NCT04391894|521096273|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
144518021|NCT01057433|521096281|FG000|Overall Study|Adverse Event|1|||
144518022|NCT05268302|521096282|FG000|Overall Study|Death|0|||
144518023|NCT05268302|521096283|FG001|Overall Study|Death|1|||
144518024|NCT04774237|521096291|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
144518025|NCT04774237|521096292|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
144518026|NCT04774237|521096293|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
144518027|NCT04774237|521096294|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
144393157|NCT01539317|520649955|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
144518028|NCT04774237|521096295|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
144393158|NCT01539317|520649956|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
144393159|NCT00364130|520649957|FG000|Intervention Period|Lost to Follow-up|4|||
144393160|NCT00364130|520649958|FG001|Intervention Period|Lost to Follow-up|3|||
144393161|NCT00364130|520649957|FG000|Intervention Period|Pregnancy|1|||
144393162|NCT00364130|520649958|FG001|Intervention Period|Pregnancy|0|||
144393163|NCT00364130|520649957|FG000|Intervention Period|Withdrawal by Subject|4|||
144393164|NCT00364130|520649958|FG001|Intervention Period|Withdrawal by Subject|5|||
144393165|NCT00364130|520649957|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
144393166|NCT00364130|520649958|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
144393167|NCT00144027|520649964|FG000|Overall Study|Lost to Follow-up|1|||
144393168|NCT00144027|520649965|FG001|Overall Study|Lost to Follow-up|3|||
144393169|NCT00144027|520649964|FG000|Overall Study|Withdrawal by Subject|2|||
144393170|NCT00144027|520649965|FG001|Overall Study|Withdrawal by Subject|2|||
144393171|NCT00144027|520649964|FG000|Overall Study|did not complete baseline assessment|0|||
144393172|NCT00144027|520649965|FG001|Overall Study|did not complete baseline assessment|6|||
144393173|NCT01674634|520649966|FG000|Overall Study|Withdrawal by Subject|3|||
144393174|NCT01674634|520649966|FG000|Overall Study|Lost to Follow-up|3|||
144393175|NCT00937391|520649967|FG000|Stage 2|Withdrawal by Subject|1|||
144393176|NCT04221230|520649968|FG000|Overall Study|Lost to Follow-up|12|||
144393177|NCT04221230|520649969|FG001|Overall Study|Lost to Follow-up|12|||
144393178|NCT04221230|520649968|FG000|Overall Study|Protocol Violation|2|||
144393179|NCT04221230|520649969|FG001|Overall Study|Protocol Violation|2|||
144393180|NCT04221230|520649968|FG000|Overall Study|Adverse Event|0|||
144393181|NCT04221230|520649969|FG001|Overall Study|Adverse Event|8|||
144393182|NCT04221230|520649968|FG000|Overall Study|Physician Decision|1|||
144393183|NCT04221230|520649969|FG001|Overall Study|Physician Decision|0|||
144393184|NCT04221230|520649968|FG000|Overall Study|Withdrawal by Subject|13|||
144393185|NCT04221230|520649969|FG001|Overall Study|Withdrawal by Subject|11|||
144393186|NCT04221230|520649968|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144393187|NCT04221230|520649969|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144393188|NCT04221230|520649968|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144393189|NCT04221230|520649969|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
144393190|NCT04221230|520649968|FG000|Overall Study|Pregnancy|0|||
144393191|NCT04221230|520649969|FG001|Overall Study|Pregnancy|1|||
144393192|NCT04221230|520649968|FG000|Overall Study|Other|1|||
144393193|NCT04221230|520649969|FG001|Overall Study|Other|2|||
144393194|NCT02359851|520649972|FG000|Overall Study|Death|1|||
144393195|NCT02359851|520649972|FG000|Overall Study|Disease progression|1|||
144393196|NCT00055471|520649973|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
144393197|NCT00055471|520649974|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
144393198|NCT00055471|520649975|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
144393199|NCT00055471|520649973|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
144393200|NCT00055471|520649974|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
144393201|NCT00055471|520649975|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
144393202|NCT00055471|520649973|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
144393203|NCT00055471|520649974|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
144393204|NCT00055471|520649975|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
144393205|NCT01854944|520649976|FG000|Overall Study|Withdrawal by Subject|0|||
144393206|NCT01854944|520649977|FG001|Overall Study|Withdrawal by Subject|0|||
144393207|NCT01854944|520649978|FG002|Overall Study|Withdrawal by Subject|1|||
144393208|NCT00993044|520649979|FG000|Irinotecan 50 mg|Physician Decision|1|||
144393209|NCT05063318|520649982|FG000|Overall Study|Progressive disease|2|||
144393210|NCT05063318|520649983|FG001|Overall Study|Progressive disease|0|||
144393211|NCT05063318|520649984|FG002|Overall Study|Progressive disease|3|||
144518029|NCT04774237|521096296|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
144518030|NCT03747484|521097673|FG000|Overall Study|Lack of Efficacy|0|||
144518031|NCT03747484|521097674|FG001|Overall Study|Lack of Efficacy|1|||
144518032|NCT03747484|521097675|FG002|Overall Study|Lack of Efficacy|1|||
144393212|NCT05063318|520649982|FG000|Overall Study|Compassionate use|1|||
144393213|NCT05063318|520649983|FG001|Overall Study|Compassionate use|3|||
144393214|NCT05063318|520649984|FG002|Overall Study|Compassionate use|3|||
144393215|NCT05063318|520649982|FG000|Overall Study|Adverse Event|0|||
144518033|NCT03747484|521097676|FG003|Overall Study|Lack of Efficacy|2|||
144518034|NCT03747484|521097677|FG004|Overall Study|Lack of Efficacy|2|||
144393216|NCT05063318|520649983|FG001|Overall Study|Adverse Event|1|||
144393217|NCT05063318|520649984|FG002|Overall Study|Adverse Event|0|||
144393218|NCT05063318|520649982|FG000|Overall Study|Withdrawal by Subject|0|||
144393219|NCT05063318|520649983|FG001|Overall Study|Withdrawal by Subject|1|||
144393220|NCT05063318|520649984|FG002|Overall Study|Withdrawal by Subject|0|||
144393221|NCT03172910|520652120|FG000|Overall Study|Adverse Event|0|||
144393222|NCT03172910|520652121|FG001|Overall Study|Adverse Event|0|||
144393223|NCT03172910|520652122|FG002|Overall Study|Adverse Event|0|||
144393224|NCT03172910|520652123|FG003|Overall Study|Adverse Event|0|||
144393225|NCT03172910|520652124|FG004|Overall Study|Adverse Event|1|||
144393226|NCT03437512|520652125|FG000|Randomized|Withdrawal by Subject|0|||
144393227|NCT03437512|520652126|FG001|Randomized|Withdrawal by Subject|2|||
144393228|NCT03437512|520652125|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
144393229|NCT03437512|520652126|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
144393230|NCT01897714|520652127|FG000|Phase I (Dose Escalation)|Disease progression|3|||
144393231|NCT01897714|520652128|FG001|Phase I (Dose Escalation)|Disease progression|5|||
144393232|NCT01897714|520652129|FG002|Phase I (Dose Escalation)|Disease progression|1|||
144393233|NCT01897714|520652130|FG003|Phase I (Dose Escalation)|Disease progression|3|||
144393234|NCT01897714|520652131|FG004|Phase I (Dose Escalation)|Disease progression|0|||
144393235|NCT01897714|520652132|FG005|Phase I (Dose Escalation)|Disease progression|0|||
144393236|NCT01897714|520652127|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
144393237|NCT01897714|520652128|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
144393238|NCT01897714|520652129|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
144393239|NCT01897714|520652130|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
144393240|NCT01897714|520652131|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
144393241|NCT01897714|520652132|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
144393242|NCT01897714|520652127|FG000|Phase I (Dose Escalation)|Other|0|||
144393243|NCT01897714|520652128|FG001|Phase I (Dose Escalation)|Other|1|||
144393244|NCT01897714|520652129|FG002|Phase I (Dose Escalation)|Other|0|||
144393245|NCT01897714|520652130|FG003|Phase I (Dose Escalation)|Other|0|||
144393246|NCT01897714|520652131|FG004|Phase I (Dose Escalation)|Other|0|||
144393247|NCT01897714|520652132|FG005|Phase I (Dose Escalation)|Other|0|||
144518035|NCT04402489|521097685|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
144518036|NCT04402489|521097686|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
144518037|NCT04402489|521097687|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
144518038|NCT04402489|521097688|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
144518039|NCT04402489|521097689|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
144518040|NCT04402489|521097685|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
144518041|NCT04402489|521097686|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
144518042|NCT04402489|521097687|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
144518043|NCT04402489|521097688|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
144518044|NCT04402489|521097689|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
144518045|NCT04402489|521097685|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
144518046|NCT04402489|521097686|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
144518047|NCT04402489|521097687|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
144518048|NCT04402489|521097688|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
144518049|NCT04402489|521097689|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
144518050|NCT04402489|521097685|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
144518051|NCT04402489|521097686|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
144518052|NCT04402489|521097687|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
144518053|NCT04402489|521097688|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
144518054|NCT04402489|521097689|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
144518055|NCT04402489|521097685|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
144518056|NCT04402489|521097686|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
144518057|NCT04402489|521097687|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
144518058|NCT04402489|521097688|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
144518059|NCT04402489|521097689|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
144518060|NCT04402489|521097685|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
144518061|NCT04402489|521097686|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
144518062|NCT04402489|521097687|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
144518063|NCT04402489|521097688|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
144518064|NCT04402489|521097689|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
144518065|NCT05816551|521097696|FG000|Overall Study|Withdrawal by Subject|0|||
144518066|NCT05816551|521097697|FG001|Overall Study|Withdrawal by Subject|1|||
144518067|NCT05816551|521097696|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
144518068|NCT05816551|521097697|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
144518069|NCT03391466|521097704|FG000|Overall Study|Death|82|||
144518070|NCT03391466|521097705|FG001|Overall Study|Death|85|||
144518071|NCT03391466|521097704|FG000|Overall Study|Still on study|93|||
144518072|NCT03391466|521097705|FG001|Overall Study|Still on study|74|||
144538350|NCT00777049|521174165|FG000|Overall Study|Withdrawal by Subject|1|||
144393248|NCT01897714|520652127|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
144393249|NCT01897714|520652128|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
144393250|NCT01897714|520652129|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
144518073|NCT03391466|521097704|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
144518074|NCT03391466|521097705|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
144518075|NCT03391466|521097704|FG000|Overall Study|Lost to Follow-up|5|||
144518076|NCT03391466|521097705|FG001|Overall Study|Lost to Follow-up|5|||
144518077|NCT03391466|521097704|FG000|Overall Study|Investigator decision|0|||
144518078|NCT03391466|521097705|FG001|Overall Study|Investigator decision|1|||
144518079|NCT03391466|521097704|FG000|Overall Study|Other|0|||
144518080|NCT03391466|521097705|FG001|Overall Study|Other|1|||
144393251|NCT01897714|520652130|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
144393252|NCT01897714|520652131|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
144393253|NCT01897714|520652132|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
144393254|NCT01897714|520652127|FG000|Phase II (MTD)|Lost to Follow-up|0|||
144594118|NCT03818204|521376123|FG004|Overall Study|Physician Decision|0|||
144594119|NCT03818204|521376124|FG005|Overall Study|Physician Decision|0|||
144594120|NCT03818204|521376125|FG006|Overall Study|Physician Decision|0|||
144594121|NCT03818204|521376126|FG007|Overall Study|Physician Decision|0|||
144594122|NCT03818204|521376127|FG008|Overall Study|Physician Decision|0|||
144594123|NCT03818204|521376128|FG009|Overall Study|Physician Decision|0|||
144594124|NCT03818204|521376129|FG010|Overall Study|Physician Decision|0|||
144594125|NCT03818204|521376130|FG011|Overall Study|Physician Decision|0|||
144594126|NCT03818204|521376131|FG012|Overall Study|Physician Decision|0|||
144594127|NCT03818204|521376132|FG013|Overall Study|Physician Decision|0|||
144594128|NCT03818204|521376133|FG014|Overall Study|Physician Decision|1|||
144594129|NCT03818204|521376134|FG015|Overall Study|Physician Decision|0|||
144594130|NCT03818204|521376135|FG016|Overall Study|Physician Decision|0|||
144594131|NCT03818204|521376136|FG017|Overall Study|Physician Decision|0|||
144594132|NCT03818204|521376137|FG018|Overall Study|Physician Decision|0|||
144594133|NCT00887250|521376138|FG000|Overall Study|Adverse Event|3|||
144594134|NCT00887250|521376139|FG001|Overall Study|Adverse Event|0|||
144594135|NCT00887250|521376140|FG002|Overall Study|Adverse Event|7|||
144594136|NCT00887250|521376138|FG000|Overall Study|Lack of Efficacy|9|||
144594137|NCT00887250|521376139|FG001|Overall Study|Lack of Efficacy|6|||
144594138|NCT00887250|521376140|FG002|Overall Study|Lack of Efficacy|1|||
144594139|NCT00887250|521376138|FG000|Overall Study|Lost to Follow-up|2|||
144594140|NCT00887250|521376139|FG001|Overall Study|Lost to Follow-up|3|||
144594141|NCT00887250|521376140|FG002|Overall Study|Lost to Follow-up|1|||
144594142|NCT00887250|521376138|FG000|Overall Study|Protocol Violation|2|||
144594143|NCT00887250|521376139|FG001|Overall Study|Protocol Violation|2|||
144594144|NCT00887250|521376140|FG002|Overall Study|Protocol Violation|1|||
144594145|NCT00887250|521376138|FG000|Overall Study|Withdrawal by Subject|2|||
144594146|NCT00887250|521376139|FG001|Overall Study|Withdrawal by Subject|1|||
144594147|NCT00887250|521376140|FG002|Overall Study|Withdrawal by Subject|2|||
144594148|NCT00887250|521376138|FG000|Overall Study|Patient uncooperative|0|||
144594149|NCT00887250|521376139|FG001|Overall Study|Patient uncooperative|0|||
144594150|NCT00887250|521376140|FG002|Overall Study|Patient uncooperative|1|||
144594151|NCT05754333|521376141|FG000|Overall Study|Miscellaneous|3|||
144594152|NCT05754333|521376142|FG001|Overall Study|Miscellaneous|0|||
144594153|NCT05754333|521376143|FG002|Overall Study|Miscellaneous|0|||
144594154|NCT05754333|521376144|FG003|Overall Study|Miscellaneous|0|||
144594155|NCT05754333|521376141|FG000|Overall Study|Lost to Follow-up|2|||
144594156|NCT05754333|521376142|FG001|Overall Study|Lost to Follow-up|1|||
144594157|NCT05754333|521376143|FG002|Overall Study|Lost to Follow-up|0|||
144594158|NCT05754333|521376144|FG003|Overall Study|Lost to Follow-up|1|||
144594159|NCT03864146|521376145|FG000|Overall Study|Lost to Follow-up|14|||
144594160|NCT03864146|521376146|FG001|Overall Study|Lost to Follow-up|23|||
144594161|NCT03864146|521376145|FG000|Overall Study|Withdrawal by Subject|3|||
144594162|NCT03864146|521376146|FG001|Overall Study|Withdrawal by Subject|2|||
144594163|NCT00824161|521376147|FG000|Overall Study|Withdrawal by Subject|1|||
144594164|NCT00824161|521376147|FG000|Overall Study|Screen Failure|1|||
144594165|NCT00879762|521376148|FG000|Overall Study|Lost to Follow-up|3|||
144594166|NCT00879762|521376149|FG001|Overall Study|Lost to Follow-up|1|||
144594167|NCT04981366|521376150|FG000|Overall Study|Withdrawal by Subject|5|||
144594168|NCT04981366|521376151|FG001|Overall Study|Withdrawal by Subject|4|||
144594169|NCT04981366|521376152|FG002|Overall Study|Withdrawal by Subject|8|||
144594170|NCT04981366|521376150|FG000|Overall Study|Health issues unrelated to the trial|1|||
144594171|NCT04981366|521376151|FG001|Overall Study|Health issues unrelated to the trial|2|||
144722164|NCT01463683|521836993|FG002|Overall Study|Withdrawal by Subject|2|||
144722165|NCT01565083|521836994|FG000|Overall Study|Withdrawal by Subject|6|||
144722166|NCT01565083|521836995|FG001|Overall Study|Withdrawal by Subject|4|||
144393255|NCT01897714|520652128|FG001|Phase II (MTD)|Lost to Follow-up|0|||
144393256|NCT01897714|520652129|FG002|Phase II (MTD)|Lost to Follow-up|0|||
144594172|NCT04981366|521376152|FG002|Overall Study|Health issues unrelated to the trial|0|||
144594173|NCT01112306|521376153|FG000|Overall Study|Death|175|||
144594174|NCT01112306|521376153|FG000|Overall Study|Lost to Follow-up|9|||
144393257|NCT01897714|520652130|FG003|Phase II (MTD)|Lost to Follow-up|0|||
144594175|NCT01112306|521376153|FG000|Overall Study|Withdrawal by Subject|31|||
144594176|NCT01112306|521376153|FG000|Overall Study|Other|70|||
144594177|NCT00881608|521376154|FG000|Overall Study|Study prematurely terminated|11|||
144594178|NCT01313637|521376157|FG000|Overall Study|Adverse Event|17|||
144594179|NCT01313637|521376158|FG001|Overall Study|Adverse Event|24|||
144594180|NCT01313637|521376159|FG002|Overall Study|Adverse Event|25|||
144393258|NCT01897714|520652131|FG004|Phase II (MTD)|Lost to Follow-up|1|||
144393259|NCT01897714|520652132|FG005|Phase II (MTD)|Lost to Follow-up|0|||
144393260|NCT01897714|520652127|FG000|Phase II (MTD)|Death|0|||
144393261|NCT01897714|520652128|FG001|Phase II (MTD)|Death|0|||
144393262|NCT01897714|520652129|FG002|Phase II (MTD)|Death|0|||
144393263|NCT01897714|520652130|FG003|Phase II (MTD)|Death|0|||
144393264|NCT01897714|520652131|FG004|Phase II (MTD)|Death|25|||
144393265|NCT01897714|520652132|FG005|Phase II (MTD)|Death|10|||
144393266|NCT01897714|520652127|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
144393267|NCT01897714|520652128|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
144393268|NCT01897714|520652129|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
144518081|NCT03089398|521097714|FG000|Overall Study|Death|4|||
144518082|NCT03089398|521097715|FG001|Overall Study|Death|9|||
144518083|NCT03089398|521097714|FG000|Overall Study|Lost to Follow-up|21|||
144518084|NCT03089398|521097715|FG001|Overall Study|Lost to Follow-up|30|||
144518085|NCT03089398|521097714|FG000|Overall Study|Withdrawal by Subject|2|||
144594181|NCT01313637|521376160|FG003|Overall Study|Adverse Event|18|||
144594182|NCT01313637|521376157|FG000|Overall Study|Lack of Efficacy|44|||
144594183|NCT01313637|521376158|FG001|Overall Study|Lack of Efficacy|38|||
144594184|NCT01313637|521376159|FG002|Overall Study|Lack of Efficacy|37|||
144594185|NCT01313637|521376160|FG003|Overall Study|Lack of Efficacy|24|||
144594186|NCT01313637|521376157|FG000|Overall Study|Protocol Violation|4|||
144594187|NCT01313637|521376158|FG001|Overall Study|Protocol Violation|3|||
144594188|NCT01313637|521376159|FG002|Overall Study|Protocol Violation|11|||
144594189|NCT01313637|521376160|FG003|Overall Study|Protocol Violation|5|||
144594190|NCT01313637|521376157|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
144594191|NCT01313637|521376158|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
144594192|NCT01313637|521376159|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
144594193|NCT01313637|521376160|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
144594194|NCT01313637|521376157|FG000|Overall Study|Lost to Follow-up|0|||
144594195|NCT01313637|521376158|FG001|Overall Study|Lost to Follow-up|2|||
144594196|NCT01313637|521376159|FG002|Overall Study|Lost to Follow-up|1|||
144594197|NCT01313637|521376160|FG003|Overall Study|Lost to Follow-up|3|||
144594198|NCT01313637|521376157|FG000|Overall Study|Withdrawal by Subject|11|||
144594199|NCT01313637|521376158|FG001|Overall Study|Withdrawal by Subject|13|||
144594200|NCT01313637|521376159|FG002|Overall Study|Withdrawal by Subject|18|||
144594201|NCT01313637|521376160|FG003|Overall Study|Withdrawal by Subject|15|||
144594202|NCT04218084|521376172|FG000|Overall Study|Adverse Event|7|||
144594203|NCT04218084|521376173|FG001|Overall Study|Adverse Event|2|||
144594204|NCT04218084|521376172|FG000|Overall Study|Withdrawal of Consent|4|||
144393269|NCT01897714|520652130|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
144393270|NCT01897714|520652131|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
144393271|NCT01897714|520652132|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
144393272|NCT01897714|520652127|FG000|Phase II (MTD)|Other|0|||
144393273|NCT01897714|520652128|FG001|Phase II (MTD)|Other|0|||
144393274|NCT01897714|520652129|FG002|Phase II (MTD)|Other|0|||
144393275|NCT01897714|520652130|FG003|Phase II (MTD)|Other|0|||
144393276|NCT01897714|520652131|FG004|Phase II (MTD)|Other|3|||
144393277|NCT01897714|520652132|FG005|Phase II (MTD)|Other|0|||
144393278|NCT00451451|520652141|FG000|Overall Study|Adverse Event|11|||
144393279|NCT00451451|520652142|FG001|Overall Study|Adverse Event|21|||
144393280|NCT00451451|520652143|FG002|Overall Study|Adverse Event|26|||
144518086|NCT03089398|521097715|FG001|Overall Study|Withdrawal by Subject|2|||
144518087|NCT05062265|521097716|FG000|Overall Study|Withdrawal by Subject|1|||
144518088|NCT05062265|521097717|FG001|Overall Study|Withdrawal by Subject|0|||
144518089|NCT05439603|521097718|FG000|Overall Study|met withdrawal criteria|2|||
144518090|NCT02287311|521097724|FG000|Cohort 1: Dose Level 1|Death|2|||
144518091|NCT02287311|521097725|FG001|Cohort 1: Dose Level 1|Death|0|||
144518092|NCT02287311|521097726|FG002|Cohort 1: Dose Level 1|Death|0|||
144518093|NCT02287311|521097727|FG003|Cohort 1: Dose Level 1|Death|3|||
144518094|NCT02287311|521097728|FG004|Cohort 1: Dose Level 1|Death|0|||
144518095|NCT02287311|521097729|FG005|Cohort 1: Dose Level 1|Death|0|||
144518096|NCT02287311|521097730|FG006|Cohort 1: Dose Level 1|Death|1|||
144518097|NCT02287311|521097731|FG007|Cohort 1: Dose Level 1|Death|0|||
144518098|NCT02287311|521097732|FG008|Cohort 1: Dose Level 1|Death|0|||
144594205|NCT04218084|521376173|FG001|Overall Study|Withdrawal of Consent|5|||
144594206|NCT04218084|521376172|FG000|Overall Study|Physician Decision|1|||
144594207|NCT04218084|521376173|FG001|Overall Study|Physician Decision|1|||
144722167|NCT01565083|521836994|FG000|Overall Study|Lost to Follow-up|2|||
144722168|NCT01565083|521836995|FG001|Overall Study|Lost to Follow-up|7|||
144722169|NCT01565083|521836994|FG000|Overall Study|Death|22|||
144722170|NCT01565083|521836995|FG001|Overall Study|Death|23|||
144722171|NCT01565083|521836994|FG000|Overall Study|Other|3|||
144393281|NCT00451451|520652144|FG003|Overall Study|Adverse Event|10|||
144393282|NCT00451451|520652141|FG000|Overall Study|Lost to Follow-up|11|||
144393283|NCT00451451|520652142|FG001|Overall Study|Lost to Follow-up|9|||
144393284|NCT00451451|520652143|FG002|Overall Study|Lost to Follow-up|8|||
144393285|NCT00451451|520652144|FG003|Overall Study|Lost to Follow-up|11|||
144393286|NCT00451451|520652141|FG000|Overall Study|Consent Withdrawn|14|||
144518099|NCT02287311|521097724|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144518100|NCT02287311|521097725|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144518101|NCT02287311|521097726|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144594208|NCT04218084|521376172|FG000|Overall Study|Lost to Follow-up|1|||
144594209|NCT04218084|521376173|FG001|Overall Study|Lost to Follow-up|1|||
144594210|NCT04218084|521376172|FG000|Overall Study|Non-compliance with study drug|1|||
144722172|NCT01565083|521836995|FG001|Overall Study|Other|5|||
144722173|NCT02178709|521838610|FG000|Overall Study|Adverse Event|5|||
144722174|NCT02178709|521838610|FG000|Overall Study|Death|2|||
144722175|NCT02178709|521838610|FG000|Overall Study|Withdrawal by Subject|2|||
144722176|NCT02178709|521838610|FG000|Overall Study|Physician Decision|2|||
144722177|NCT02178709|521838610|FG000|Overall Study|Disease Progression|5|||
144722178|NCT02946385|521838611|FG000|Overall Study|Lost to Follow-up|0|||
144722179|NCT02946385|521838612|FG001|Overall Study|Lost to Follow-up|0|||
144722180|NCT02946385|521838613|FG002|Overall Study|Lost to Follow-up|3|||
144722181|NCT02946385|521838614|FG003|Overall Study|Lost to Follow-up|0|||
144722182|NCT02946385|521838615|FG004|Overall Study|Lost to Follow-up|2|||
144722183|NCT02946385|521838616|FG005|Overall Study|Lost to Follow-up|1|||
144722184|NCT00313703|521838617|FG000|Overall Study|Lost to Follow-up|11|||
144722185|NCT00313703|521838618|FG001|Overall Study|Lost to Follow-up|2|||
144722186|NCT00313703|521838619|FG002|Overall Study|Lost to Follow-up|5|||
144722187|NCT00313703|521838620|FG003|Overall Study|Lost to Follow-up|12|||
144722188|NCT03329027|521838623|FG000|Overall Study|Lost to Follow-up|1|||
144722189|NCT03329027|521838624|FG001|Overall Study|Lost to Follow-up|0|||
144722190|NCT03329027|521838625|FG002|Overall Study|Lost to Follow-up|1|||
144722191|NCT03329027|521838623|FG000|Overall Study|Protocol Violation|9|||
144722192|NCT03329027|521838624|FG001|Overall Study|Protocol Violation|5|||
144393287|NCT00451451|520652142|FG001|Overall Study|Consent Withdrawn|9|||
144393288|NCT00451451|520652143|FG002|Overall Study|Consent Withdrawn|17|||
144393289|NCT00451451|520652144|FG003|Overall Study|Consent Withdrawn|17|||
144518102|NCT02287311|521097727|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
144518103|NCT02287311|521097728|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144518104|NCT02287311|521097729|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144518105|NCT02287311|521097730|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
144518106|NCT02287311|521097731|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144518107|NCT02287311|521097732|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
144518108|NCT02287311|521097724|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
144518109|NCT02287311|521097725|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
144518110|NCT02287311|521097726|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
144518111|NCT02287311|521097727|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
144518112|NCT02287311|521097728|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
144518113|NCT02287311|521097729|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
144518114|NCT02287311|521097730|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
144518115|NCT02287311|521097731|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
144518116|NCT02287311|521097732|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
144518117|NCT02287311|521097724|FG000|Cohort 2: Dose Level 2|Death|0|||
144518118|NCT02287311|521097725|FG001|Cohort 2: Dose Level 2|Death|2|||
144518119|NCT02287311|521097726|FG002|Cohort 2: Dose Level 2|Death|0|||
144518120|NCT02287311|521097727|FG003|Cohort 2: Dose Level 2|Death|0|||
144518121|NCT02287311|521097728|FG004|Cohort 2: Dose Level 2|Death|2|||
144518122|NCT02287311|521097729|FG005|Cohort 2: Dose Level 2|Death|0|||
144518123|NCT02287311|521097730|FG006|Cohort 2: Dose Level 2|Death|0|||
144518124|NCT02287311|521097731|FG007|Cohort 2: Dose Level 2|Death|2|||
144518125|NCT02287311|521097732|FG008|Cohort 2: Dose Level 2|Death|0|||
144518126|NCT02287311|521097724|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518127|NCT02287311|521097725|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518128|NCT02287311|521097726|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518129|NCT02287311|521097727|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518130|NCT02287311|521097728|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
144518131|NCT02287311|521097729|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518132|NCT02287311|521097730|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518133|NCT02287311|521097731|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144393290|NCT00451451|520652141|FG000|Overall Study|Investigator Decision|6|||
144393291|NCT00451451|520652142|FG001|Overall Study|Investigator Decision|2|||
144393292|NCT00451451|520652143|FG002|Overall Study|Investigator Decision|1|||
144393293|NCT00451451|520652144|FG003|Overall Study|Investigator Decision|2|||
144393294|NCT00451451|520652141|FG000|Overall Study|Subject Non-Compliance|8|||
144393295|NCT00451451|520652142|FG001|Overall Study|Subject Non-Compliance|4|||
144393296|NCT00451451|520652143|FG002|Overall Study|Subject Non-Compliance|3|||
144393297|NCT00451451|520652144|FG003|Overall Study|Subject Non-Compliance|3|||
144393298|NCT00451451|520652141|FG000|Overall Study|Death|1|||
144393299|NCT00451451|520652142|FG001|Overall Study|Death|0|||
144393300|NCT00451451|520652143|FG002|Overall Study|Death|0|||
144393301|NCT00451451|520652144|FG003|Overall Study|Death|1|||
144393302|NCT00451451|520652141|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
144393303|NCT00451451|520652142|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
144393304|NCT00451451|520652143|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
144393305|NCT00451451|520652144|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
144518134|NCT02287311|521097732|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
144518135|NCT02287311|521097724|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
144722193|NCT03329027|521838625|FG002|Overall Study|Protocol Violation|7|||
144722194|NCT04849988|521838628|FG000|Overall Study|Lack of Efficacy|3|||
144722195|NCT04849988|521838629|FG001|Overall Study|Lack of Efficacy|4|||
144722196|NCT04849988|521838630|FG002|Overall Study|Lack of Efficacy|1|||
144722197|NCT04849988|521838631|FG003|Overall Study|Lack of Efficacy|4|||
144722198|NCT04849988|521838628|FG000|Overall Study|Other reasons|1|||
144393306|NCT03693170|520652145|FG000|Overall Study|Disease Progression|48|||
144393307|NCT03693170|520652145|FG000|Overall Study|Adverse Event|16|||
144393308|NCT03693170|520652145|FG000|Overall Study|Physician Decision|6|||
144393309|NCT03693170|520652145|FG000|Overall Study|Protocol Violation|2|||
144393310|NCT03693170|520652145|FG000|Overall Study|Death|1|||
144393311|NCT03693170|520652145|FG000|Overall Study|Non compliance with study drug|1|||
144393312|NCT03693170|520652145|FG000|Overall Study|Withdrawal by Subject|1|||
144393313|NCT03581786|520652146|FG000|Overall Study|Death|67|||
144518136|NCT02287311|521097725|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
144393314|NCT03581786|520652147|FG001|Overall Study|Death|47|||
144393315|NCT03581786|520652146|FG000|Overall Study|Withdrawal by Subject|2|||
144393316|NCT03581786|520652147|FG001|Overall Study|Withdrawal by Subject|5|||
144393317|NCT03581786|520652146|FG000|Overall Study|Lost to Follow-up|7|||
144393318|NCT03581786|520652147|FG001|Overall Study|Lost to Follow-up|4|||
144393319|NCT03581786|520652146|FG000|Overall Study|reason other than specified above|0|||
144393320|NCT03581786|520652147|FG001|Overall Study|reason other than specified above|1|||
144594211|NCT04218084|521376173|FG001|Overall Study|Non-compliance with study drug|1|||
144594212|NCT04218084|521376172|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
144518137|NCT02287311|521097726|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518138|NCT02287311|521097727|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518139|NCT02287311|521097728|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518140|NCT02287311|521097729|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518141|NCT02287311|521097730|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518142|NCT02287311|521097731|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518143|NCT02287311|521097732|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
144518144|NCT02287311|521097724|FG000|Cohort 3: Dose Level 3|Death|0|||
144518145|NCT02287311|521097725|FG001|Cohort 3: Dose Level 3|Death|0|||
144518146|NCT02287311|521097726|FG002|Cohort 3: Dose Level 3|Death|4|||
144518147|NCT02287311|521097727|FG003|Cohort 3: Dose Level 3|Death|0|||
144518148|NCT02287311|521097728|FG004|Cohort 3: Dose Level 3|Death|0|||
144518149|NCT02287311|521097729|FG005|Cohort 3: Dose Level 3|Death|4|||
144518150|NCT02287311|521097730|FG006|Cohort 3: Dose Level 3|Death|0|||
144518151|NCT02287311|521097731|FG007|Cohort 3: Dose Level 3|Death|0|||
144518152|NCT02287311|521097732|FG008|Cohort 3: Dose Level 3|Death|2|||
144518153|NCT02287311|521097724|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518154|NCT02287311|521097725|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518155|NCT02287311|521097726|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
144594213|NCT04218084|521376173|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
144518156|NCT02287311|521097727|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518157|NCT02287311|521097728|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518158|NCT02287311|521097729|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
144518159|NCT02287311|521097730|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518160|NCT02287311|521097731|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518161|NCT02287311|521097732|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
144518162|NCT02287311|521097724|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518163|NCT02287311|521097725|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518164|NCT02287311|521097726|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518165|NCT02287311|521097727|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518166|NCT02287311|521097728|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518167|NCT02287311|521097729|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
144518168|NCT02287311|521097730|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518169|NCT02287311|521097731|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
144518170|NCT02287311|521097732|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
144518171|NCT03896516|521097733|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
144518172|NCT03896516|521097734|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
144518173|NCT03896516|521097733|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
144518174|NCT03896516|521097734|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
144518175|NCT03896516|521097733|FG000|Washout Period|Physician Decision|3|||
144518176|NCT03896516|521097734|FG001|Washout Period|Physician Decision|1|||
144518177|NCT03896516|521097733|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
144518178|NCT03896516|521097734|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
144518179|NCT03101904|521097737|FG000|Wash Out (10 Days)|Adverse Event|1|||
144518180|NCT03101904|521097738|FG001|Wash Out (10 Days)|Adverse Event|0|||
144518181|NCT03101904|521097737|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
144518182|NCT03101904|521097738|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
144518183|NCT04703322|521097739|FG000|Overall Study|Ongoing|8|||
144518184|NCT04703322|521097739|FG000|Overall Study|Withdrawal by Subject|1|||
144518185|NCT03713086|521097742|FG000|Overall Study|Withdrawal by Subject|0|||
144518186|NCT03713086|521097743|FG001|Overall Study|Withdrawal by Subject|2|||
144518187|NCT03713086|521097744|FG002|Overall Study|Withdrawal by Subject|1|||
144518188|NCT03713086|521097745|FG003|Overall Study|Withdrawal by Subject|0|||
144518189|NCT03713086|521097742|FG000|Overall Study|Lost to Follow-up|0|||
144518190|NCT03713086|521097743|FG001|Overall Study|Lost to Follow-up|1|||
144518191|NCT03713086|521097744|FG002|Overall Study|Lost to Follow-up|0|||
144518192|NCT03713086|521097745|FG003|Overall Study|Lost to Follow-up|1|||
144518193|NCT05009251|521097746|FG000|Overall Study|Protocol Violation|100|||
144518194|NCT05009251|521097747|FG001|Overall Study|Protocol Violation|105|||
144518195|NCT05009251|521097748|FG002|Overall Study|Protocol Violation|119|||
144594214|NCT04218084|521376172|FG000|Overall Study|Other|0|||
144594215|NCT04218084|521376173|FG001|Overall Study|Other|1|||
144393321|NCT00510874|520652148|FG000|Overall Study|Withdrawal by Subject|1|||
144518196|NCT05009251|521097749|FG003|Overall Study|Protocol Violation|120|||
144518197|NCT05009251|521097750|FG004|Overall Study|Protocol Violation|119|||
144518198|NCT05009251|521097746|FG000|Overall Study|Death|25|||
144518199|NCT05009251|521097747|FG001|Overall Study|Death|22|||
144518200|NCT05009251|521097748|FG002|Overall Study|Death|24|||
144518201|NCT05009251|521097749|FG003|Overall Study|Death|19|||
144518202|NCT05009251|521097750|FG004|Overall Study|Death|15|||
144518203|NCT02662062|521097752|FG000|Overall Study|Withdrawal by Subject|1|||
144594216|NCT04218084|521376172|FG000|Overall Study|Ongoing at data cut-off date|62|||
144594217|NCT04218084|521376173|FG001|Overall Study|Ongoing at data cut-off date|58|||
144594218|NCT00211185|521376176|FG000|Overall Study|Death|2|||
144594219|NCT00211185|521376176|FG000|Overall Study|Disease progression|7|||
144594220|NCT00211185|521376176|FG000|Overall Study|Withdrawal by Subject|6|||
144594221|NCT00211185|521376176|FG000|Overall Study|Physician Decision|5|||
144594222|NCT00986674|521376177|FG000|Overall Study|Lack of Efficacy|28|||
144594223|NCT00986674|521376178|FG001|Overall Study|Lack of Efficacy|25|||
144594224|NCT00986674|521376179|FG002|Overall Study|Lack of Efficacy|23|||
144594225|NCT00986674|521376177|FG000|Overall Study|Adverse Event|4|||
144594226|NCT00986674|521376178|FG001|Overall Study|Adverse Event|8|||
144594227|NCT00986674|521376179|FG002|Overall Study|Adverse Event|9|||
144594228|NCT00986674|521376177|FG000|Overall Study|Death|5|||
144594229|NCT00986674|521376178|FG001|Overall Study|Death|0|||
144594230|NCT00986674|521376179|FG002|Overall Study|Death|4|||
144594231|NCT00986674|521376177|FG000|Overall Study|Withdrawal by Subject|6|||
144594232|NCT00986674|521376178|FG001|Overall Study|Withdrawal by Subject|2|||
144594233|NCT00986674|521376179|FG002|Overall Study|Withdrawal by Subject|1|||
144594234|NCT00986674|521376177|FG000|Overall Study|alternative therapy|0|||
144594235|NCT00986674|521376178|FG001|Overall Study|alternative therapy|0|||
144594236|NCT00986674|521376179|FG002|Overall Study|alternative therapy|1|||
144594237|NCT00986674|521376177|FG000|Overall Study|not start protocol therapy|4|||
144594238|NCT00986674|521376178|FG001|Overall Study|not start protocol therapy|3|||
144594239|NCT00986674|521376179|FG002|Overall Study|not start protocol therapy|1|||
144594240|NCT00986674|521376177|FG000|Overall Study|unknown/not specify|0|||
144594241|NCT00986674|521376178|FG001|Overall Study|unknown/not specify|7|||
144594242|NCT00986674|521376179|FG002|Overall Study|unknown/not specify|9|||
144594243|NCT00842985|521376182|FG000|Screening|Did not meet entrance requirements|27|||
144594244|NCT00842985|521376182|FG000|First Intervention|Withdrawal by Subject|3|||
144594245|NCT00842985|521376182|FG000|First Intervention|Protocol Violation|3|||
144594246|NCT00842985|521376182|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
144594247|NCT00842985|521376182|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
144594248|NCT01037244|521376183|FG000|Overall Study|Adverse Event|3|||
144594249|NCT01037244|521376184|FG001|Overall Study|Adverse Event|2|||
144594250|NCT01037244|521376185|FG002|Overall Study|Adverse Event|6|||
144594251|NCT01037244|521376186|FG003|Overall Study|Adverse Event|3|||
144594252|NCT01037244|521376183|FG000|Overall Study|Lack of Efficacy|1|||
144594253|NCT01037244|521376184|FG001|Overall Study|Lack of Efficacy|1|||
144594254|NCT01037244|521376185|FG002|Overall Study|Lack of Efficacy|0|||
144594255|NCT01037244|521376186|FG003|Overall Study|Lack of Efficacy|1|||
144594256|NCT01037244|521376183|FG000|Overall Study|Lost to Follow-up|3|||
144594257|NCT01037244|521376184|FG001|Overall Study|Lost to Follow-up|3|||
144594258|NCT01037244|521376185|FG002|Overall Study|Lost to Follow-up|4|||
144594259|NCT01037244|521376186|FG003|Overall Study|Lost to Follow-up|4|||
144594260|NCT01037244|521376183|FG000|Overall Study|Withdrawal by Subject|1|||
144594261|NCT01037244|521376184|FG001|Overall Study|Withdrawal by Subject|5|||
144594262|NCT01037244|521376185|FG002|Overall Study|Withdrawal by Subject|3|||
144594263|NCT01037244|521376186|FG003|Overall Study|Withdrawal by Subject|5|||
144594264|NCT01037244|521376183|FG000|Overall Study|Partner Withdrew Consent|2|||
144594265|NCT01037244|521376184|FG001|Overall Study|Partner Withdrew Consent|1|||
144594266|NCT01037244|521376185|FG002|Overall Study|Partner Withdrew Consent|0|||
144594267|NCT01037244|521376186|FG003|Overall Study|Partner Withdrew Consent|0|||
144594268|NCT01037244|521376183|FG000|Overall Study|Various|3|||
144594269|NCT01037244|521376184|FG001|Overall Study|Various|2|||
144594270|NCT01037244|521376185|FG002|Overall Study|Various|1|||
144594271|NCT01037244|521376186|FG003|Overall Study|Various|1|||
144594272|NCT04507126|521376187|FG000|Overall Study|Withdrawal by Subject|1|||
144594273|NCT04507126|521376187|FG000|Overall Study|Protocol Violation|2|||
144594274|NCT04507126|521376187|FG000|Overall Study|Physician Decision|1|||
144594275|NCT02875977|521376188|FG000|Overall Study|Lost to Follow-up|42|||
144594276|NCT02875977|521376189|FG001|Overall Study|Lost to Follow-up|29|||
144594277|NCT03421431|521376192|FG000|Overall Study|Adverse Event|2|||
144594278|NCT03421431|521376193|FG001|Overall Study|Adverse Event|1|||
144594279|NCT03421431|521376194|FG002|Overall Study|Adverse Event|12|||
144594280|NCT03421431|521376192|FG000|Overall Study|Lost to Follow-up|1|||
144594281|NCT03421431|521376193|FG001|Overall Study|Lost to Follow-up|1|||
144594282|NCT03421431|521376194|FG002|Overall Study|Lost to Follow-up|1|||
144594283|NCT03421431|521376192|FG000|Overall Study|Withdrawal by Subject|3|||
144594284|NCT03421431|521376193|FG001|Overall Study|Withdrawal by Subject|2|||
144594285|NCT03421431|521376194|FG002|Overall Study|Withdrawal by Subject|1|||
144594286|NCT03421431|521376192|FG000|Overall Study|Protocol Violation|0|||
144594287|NCT03421431|521376193|FG001|Overall Study|Protocol Violation|1|||
144594288|NCT03421431|521376194|FG002|Overall Study|Protocol Violation|0|||
144594289|NCT03421431|521376192|FG000|Overall Study|Participant met Stopping Rules|0|||
144594290|NCT03421431|521376193|FG001|Overall Study|Participant met Stopping Rules|1|||
144594291|NCT03421431|521376194|FG002|Overall Study|Participant met Stopping Rules|0|||
144393322|NCT00510874|520652149|FG001|Overall Study|Withdrawal by Subject|1|||
144393323|NCT00510874|520652150|FG002|Overall Study|Withdrawal by Subject|0|||
144393324|NCT00510874|520652151|FG003|Overall Study|Withdrawal by Subject|0|||
144393325|NCT00510874|520652152|FG004|Overall Study|Withdrawal by Subject|3|||
144393326|NCT00510874|520652153|FG005|Overall Study|Withdrawal by Subject|0|||
144393327|NCT00510874|520652154|FG006|Overall Study|Withdrawal by Subject|0|||
144393328|NCT00510874|520652148|FG000|Overall Study|Lost to Follow-up|2|||
144393329|NCT00510874|520652149|FG001|Overall Study|Lost to Follow-up|3|||
144393330|NCT00510874|520652150|FG002|Overall Study|Lost to Follow-up|1|||
144393331|NCT00510874|520652151|FG003|Overall Study|Lost to Follow-up|3|||
144393332|NCT00510874|520652152|FG004|Overall Study|Lost to Follow-up|4|||
144393333|NCT00510874|520652153|FG005|Overall Study|Lost to Follow-up|0|||
144393334|NCT00510874|520652154|FG006|Overall Study|Lost to Follow-up|1|||
144393335|NCT00397943|520652156|FG000|Overall Study|Unspecified reasons|12|||
144393336|NCT00397943|520652157|FG001|Overall Study|Unspecified reasons|9|||
144393337|NCT00397943|520652158|FG002|Overall Study|Unspecified reasons|0|||
144393338|NCT00397943|520652159|FG003|Overall Study|Unspecified reasons|0|||
144393339|NCT00397943|520652160|FG004|Overall Study|Unspecified reasons|0|||
144393340|NCT04521777|520652161|FG000|Overall Study|Death|2|||
144393341|NCT04521777|520652161|FG000|Overall Study|Withdrawal by Subject|2|||
144393342|NCT01869725|520652163|FG000|Overall Study|ineligible after registration|1|||
144393343|NCT01869725|520652163|FG000|Overall Study|Death|1|||
144393344|NCT01869725|520652163|FG000|Overall Study|Lost to Follow-up|2|||
144393345|NCT01143207|520652164|FG000|Overall Study|Lost to Follow-up|2|||
144393346|NCT00057954|520652169|FG000|Overall Study|Death|1|||
144518204|NCT06311084|521097753|FG000|Overall Study|Lost to Follow-up|14|||
144518205|NCT05374837|521097754|FG000|Overall Study|Lost to Follow-up|17|||
144518206|NCT05374837|521097755|FG001|Overall Study|Lost to Follow-up|18|||
144393347|NCT00057954|520652169|FG000|Overall Study|Disease progression|1|||
144393348|NCT00559754|520652170|FG000|Overall Study|Disease progression|1|||
144393349|NCT00559754|520652170|FG000|Overall Study|Adverse Event|5|||
144393350|NCT00559754|520652170|FG000|Overall Study|Protocol Violation|1|||
144393351|NCT00559754|520652170|FG000|Overall Study|Investigator criteria|2|||
144518207|NCT04831281|521097759|FG000|Overall Study|Adverse Event|1|||
144722199|NCT04849988|521838629|FG001|Overall Study|Other reasons|2|||
144722200|NCT04849988|521838630|FG002|Overall Study|Other reasons|2|||
144393352|NCT00559754|520652170|FG000|Overall Study|Withdrawal by Subject|2|||
144393353|NCT02117414|520652171|FG000|Overall Study|Death|5|||
144393354|NCT02117414|520652172|FG001|Overall Study|Death|2|||
144518208|NCT04831281|521097760|FG001|Overall Study|Adverse Event|0|||
144722201|NCT04849988|521838631|FG003|Overall Study|Other reasons|1|||
144518209|NCT04831281|521097761|FG002|Overall Study|Adverse Event|3|||
144518210|NCT04831281|521097759|FG000|Overall Study|Withdrawal by Subject|0|||
144518211|NCT04831281|521097760|FG001|Overall Study|Withdrawal by Subject|1|||
144518212|NCT04831281|521097761|FG002|Overall Study|Withdrawal by Subject|2|||
144518213|NCT04831281|521097759|FG000|Overall Study|Undetermined|1|||
144518214|NCT04831281|521097760|FG001|Overall Study|Undetermined|1|||
144518215|NCT04831281|521097761|FG002|Overall Study|Undetermined|0|||
144518216|NCT00616967|521097762|FG000|Overall Study|Withdrawal by Subject|0|||
144518217|NCT00616967|521097763|FG001|Overall Study|Withdrawal by Subject|0|||
144518218|NCT00616967|521097764|FG002|Overall Study|Withdrawal by Subject|1|||
144518219|NCT02910583|521097765|FG000|Overall Study|Death|7|||
144518220|NCT02910583|521097766|FG001|Overall Study|Death|3|||
144518221|NCT02910583|521097765|FG000|Overall Study|Lost to Follow-up|1|||
144518222|NCT02910583|521097766|FG001|Overall Study|Lost to Follow-up|0|||
144518223|NCT02910583|521097765|FG000|Overall Study|Withdrawal by Subject|12|||
144518224|NCT02910583|521097766|FG001|Overall Study|Withdrawal by Subject|8|||
144518225|NCT02910583|521097765|FG000|Overall Study|Other, Not Specified|6|||
144518226|NCT02910583|521097766|FG001|Overall Study|Other, Not Specified|3|||
144518227|NCT05059262|521097767|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
144518228|NCT05059262|521097768|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
144518229|NCT05059262|521097767|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
144518230|NCT05059262|521097768|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
144518231|NCT05059262|521097767|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
144518232|NCT05059262|521097768|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
144594292|NCT00141726|521376195|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
144594293|NCT02216357|521376196|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
144594294|NCT02216357|521376197|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
144594295|NCT00235326|521376202|FG000|Overall Study|Lost to Follow-up|746|||
144518233|NCT05059262|521097767|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
144518234|NCT05059262|521097768|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
144594296|NCT00235326|521376203|FG001|Overall Study|Lost to Follow-up|1400|||
144393355|NCT02117414|520652171|FG000|Overall Study|Withdrawal by Subject|10|||
144393356|NCT02117414|520652172|FG001|Overall Study|Withdrawal by Subject|4|||
144393357|NCT01629706|520652173|FG000|Phase 1 PureVision|Screen Failure|4|||
144393358|NCT01629706|520652173|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
144393359|NCT01629706|520652173|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
144518235|NCT05059262|521097767|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
144518236|NCT05059262|521097768|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
144518237|NCT05059262|521097767|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
144518238|NCT05059262|521097768|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
144518239|NCT05059262|521097767|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
144518240|NCT05059262|521097768|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
144518241|NCT05059262|521097767|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
144393360|NCT01629706|520652173|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
144393361|NCT01629706|520652173|FG000|Phase 2 Habitual|Screen Failure|6|||
144393362|NCT01629706|520652173|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
144393363|NCT01629706|520652173|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
144393364|NCT01629706|520652173|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
144393365|NCT01629706|520652173|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
144393366|NCT02537574|520652174|FG000|Overall Study|Adverse Event|1|||
144393367|NCT02537574|520652175|FG001|Overall Study|Adverse Event|3|||
144393368|NCT02537574|520652176|FG002|Overall Study|Adverse Event|2|||
144393369|NCT02537574|520652174|FG000|Overall Study|Lost to Follow-up|40|||
144393370|NCT02537574|520652175|FG001|Overall Study|Lost to Follow-up|51|||
144393371|NCT02537574|520652176|FG002|Overall Study|Lost to Follow-up|55|||
144393372|NCT02537574|520652174|FG000|Overall Study|Noncompliance with study drug|0|||
144393373|NCT02537574|520652175|FG001|Overall Study|Noncompliance with study drug|1|||
144393374|NCT02537574|520652176|FG002|Overall Study|Noncompliance with study drug|1|||
144393375|NCT02537574|520652174|FG000|Overall Study|Physician Decision|2|||
144393376|NCT02537574|520652175|FG001|Overall Study|Physician Decision|0|||
144393377|NCT02537574|520652176|FG002|Overall Study|Physician Decision|0|||
144393378|NCT02537574|520652174|FG000|Overall Study|Protocol Violation|4|||
144393379|NCT02537574|520652175|FG001|Overall Study|Protocol Violation|2|||
144393380|NCT02537574|520652176|FG002|Overall Study|Protocol Violation|3|||
144393381|NCT02537574|520652174|FG000|Overall Study|Withdrawal by Subject|37|||
144393382|NCT02537574|520652175|FG001|Overall Study|Withdrawal by Subject|27|||
144393383|NCT02537574|520652176|FG002|Overall Study|Withdrawal by Subject|29|||
144393384|NCT02537574|520652174|FG000|Overall Study|Lack of Efficacy|14|||
144393385|NCT02537574|520652175|FG001|Overall Study|Lack of Efficacy|16|||
144393386|NCT02537574|520652176|FG002|Overall Study|Lack of Efficacy|15|||
144393387|NCT02537574|520652174|FG000|Overall Study|Duplicate Patient|1|||
144393388|NCT02537574|520652175|FG001|Overall Study|Duplicate Patient|0|||
144393389|NCT02537574|520652176|FG002|Overall Study|Duplicate Patient|0|||
144393390|NCT02537574|520652174|FG000|Overall Study|Patient not Stable|0|||
144393391|NCT02537574|520652175|FG001|Overall Study|Patient not Stable|1|||
144393392|NCT02537574|520652176|FG002|Overall Study|Patient not Stable|0|||
144393393|NCT02537574|520652174|FG000|Overall Study|Incarceration|0|||
144393394|NCT02537574|520652175|FG001|Overall Study|Incarceration|1|||
144393395|NCT02537574|520652176|FG002|Overall Study|Incarceration|0|||
144393396|NCT02537574|520652174|FG000|Overall Study|Failed Naloxone Challenge|0|||
144393397|NCT02537574|520652175|FG001|Overall Study|Failed Naloxone Challenge|1|||
144393398|NCT02537574|520652176|FG002|Overall Study|Failed Naloxone Challenge|0|||
144393399|NCT02537574|520652174|FG000|Overall Study|Transportation Issues|0|||
144393400|NCT02537574|520652175|FG001|Overall Study|Transportation Issues|0|||
144393401|NCT02537574|520652176|FG002|Overall Study|Transportation Issues|1|||
144393402|NCT02537574|520652174|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
144393403|NCT02537574|520652175|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
144393404|NCT02537574|520652176|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
144393405|NCT02537574|520652174|FG000|Overall Study|Noncompliance with Protocol|0|||
144393406|NCT02537574|520652175|FG001|Overall Study|Noncompliance with Protocol|0|||
144393407|NCT02537574|520652176|FG002|Overall Study|Noncompliance with Protocol|1|||
144393408|NCT02663687|520652177|FG000|Overall Study|Adverse Event|1|||
144393409|NCT02663687|520652178|FG001|Overall Study|Adverse Event|0|||
144393410|NCT02663687|520652179|FG002|Overall Study|Adverse Event|0|||
144393411|NCT02663687|520652180|FG003|Overall Study|Adverse Event|0|||
144393412|NCT02663687|520652181|FG004|Overall Study|Adverse Event|0|||
144393413|NCT02663687|520652177|FG000|Overall Study|Other|1|||
144393414|NCT02663687|520652178|FG001|Overall Study|Other|0|||
144393415|NCT02663687|520652179|FG002|Overall Study|Other|1|||
144393416|NCT02663687|520652180|FG003|Overall Study|Other|0|||
144393417|NCT02663687|520652181|FG004|Overall Study|Other|0|||
144393418|NCT01151098|520652182|FG000|Overall Study|Adverse Event|82|||
144393419|NCT01151098|520652182|FG000|Overall Study|Lost to Follow-up|6|||
144393420|NCT01151098|520652182|FG000|Overall Study|Lack of Efficacy|15|||
144393421|NCT01151098|520652182|FG000|Overall Study|Protocol Violation|1|||
144393422|NCT01151098|520652182|FG000|Overall Study|Miscellaneous|13|||
144393423|NCT03343067|520652185|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
144518242|NCT05059262|521097768|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
144518243|NCT05059262|521097767|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
144518244|NCT05059262|521097768|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
144518245|NCT03161379|521097771|FG000|Overall Study|Withdrawal by Subject|4|||
144518246|NCT03161379|521097771|FG000|Overall Study|disease progression during chemotherapy|5|||
144518247|NCT03161379|521097771|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
144518248|NCT03161379|521097771|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
144518249|NCT02900924|521097775|FG000|Overall Study|Death|52|||
144393424|NCT03343067|520652186|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
144393425|NCT03343067|520652187|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
144393426|NCT00116168|520652188|FG000|Overall Study|Lost to Follow-up|6|||
144393427|NCT00116168|520652189|FG001|Overall Study|Lost to Follow-up|5|||
144393428|NCT00116168|520652190|FG002|Overall Study|Lost to Follow-up|0|||
144393429|NCT00116168|520652191|FG003|Overall Study|Lost to Follow-up|0|||
144393430|NCT01323946|520652192|FG000|Overall Study|Lost to Follow-up|0|||
144393431|NCT01323946|520652193|FG001|Overall Study|Lost to Follow-up|1|||
144393432|NCT01323946|520652194|FG002|Overall Study|Lost to Follow-up|0|||
144393433|NCT01323946|520652192|FG000|Overall Study|Parents refused the last blood draw|1|||
144393434|NCT01323946|520652193|FG001|Overall Study|Parents refused the last blood draw|0|||
144393435|NCT01323946|520652194|FG002|Overall Study|Parents refused the last blood draw|0|||
144393436|NCT01323946|520652192|FG000|Overall Study|Withdrawal by Subject|2|||
144393437|NCT01323946|520652193|FG001|Overall Study|Withdrawal by Subject|2|||
144393438|NCT01323946|520652194|FG002|Overall Study|Withdrawal by Subject|0|||
144393439|NCT01243671|520652197|FG000|Overall Study|Adverse Event|3|||
144393440|NCT01243671|520652197|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
144393441|NCT01243671|520652197|FG000|Overall Study|Other|1|||
144393442|NCT02962765|520652198|FG000|Overall Study|Protocol Violation|9|||
144393443|NCT02962765|520652198|FG000|Overall Study|Withdrawal by Subject|3|||
144393444|NCT02962765|520652198|FG000|Overall Study|Lost to Follow-up|1|||
144393445|NCT02962765|520652198|FG000|Overall Study|Death|1|||
144393446|NCT02962765|520652198|FG000|Overall Study|Limited access to study medication|3|||
144393447|NCT00750880|520652203|FG000|Overall Study|Adverse Event|76|||
144393448|NCT00750880|520652203|FG000|Overall Study|Death|4|||
144393449|NCT00750880|520652203|FG000|Overall Study|Lack of Efficacy|46|||
144393450|NCT00750880|520652203|FG000|Overall Study|Lost to Follow-up|10|||
144393451|NCT00750880|520652203|FG000|Overall Study|Protocol Violation|15|||
144393452|NCT00750880|520652203|FG000|Overall Study|Withdrawal by Subject|33|||
144393453|NCT00750880|520652203|FG000|Overall Study|Physician Decision|20|||
144393454|NCT00750880|520652203|FG000|Overall Study|Administrative|11|||
144393455|NCT02169284|520652207|FG000|Overall Study|Physician Decision|0|||
144393456|NCT02169284|520652208|FG001|Overall Study|Physician Decision|1|||
144393457|NCT03583073|520652209|FG000|Overall Study|Lost to Follow-up|8|||
144393458|NCT03583073|520652210|FG001|Overall Study|Lost to Follow-up|12|||
144393459|NCT05342532|520652211|FG000|Overall Study|Adverse Event|5|||
144393460|NCT05342532|520652212|FG001|Overall Study|Adverse Event|20|||
144393461|NCT05342532|520652211|FG000|Overall Study|Lost to Follow-up|10|||
144393462|NCT05342532|520652212|FG001|Overall Study|Lost to Follow-up|15|||
144393463|NCT02675231|520652216|FG000|Overall Study|Withdrawal by Subject|2|||
144393464|NCT02675231|520652217|FG001|Overall Study|Withdrawal by Subject|4|||
144393465|NCT02675231|520652218|FG002|Overall Study|Withdrawal by Subject|2|||
144393466|NCT02675231|520652216|FG000|Overall Study|Lost to Follow-up|3|||
144393467|NCT02675231|520652217|FG001|Overall Study|Lost to Follow-up|4|||
144393468|NCT02675231|520652218|FG002|Overall Study|Lost to Follow-up|3|||
144393469|NCT02325791|520652221|FG000|Overall Study|Adverse Event|0|||
144393470|NCT02325791|520652222|FG001|Overall Study|Adverse Event|1|||
144393471|NCT02325791|520652223|FG002|Overall Study|Adverse Event|1|||
144393472|NCT02325791|520652224|FG003|Overall Study|Adverse Event|0|||
144393473|NCT02325791|520652221|FG000|Overall Study|Death|0|||
144393474|NCT02325791|520652222|FG001|Overall Study|Death|3|||
144393475|NCT02325791|520652223|FG002|Overall Study|Death|0|||
144393476|NCT02325791|520652224|FG003|Overall Study|Death|1|||
144393477|NCT02325791|520652221|FG000|Overall Study|Lost to Follow-up|0|||
144393478|NCT02325791|520652222|FG001|Overall Study|Lost to Follow-up|15|||
144393479|NCT02325791|520652223|FG002|Overall Study|Lost to Follow-up|14|||
144393480|NCT02325791|520652224|FG003|Overall Study|Lost to Follow-up|9|||
144393481|NCT02325791|520652221|FG000|Overall Study|Physician Decision|0|||
144393482|NCT02325791|520652222|FG001|Overall Study|Physician Decision|1|||
144393483|NCT02325791|520652223|FG002|Overall Study|Physician Decision|1|||
144393484|NCT02325791|520652224|FG003|Overall Study|Physician Decision|0|||
144393485|NCT02325791|520652221|FG000|Overall Study|Protocol Violation|0|||
144393486|NCT02325791|520652222|FG001|Overall Study|Protocol Violation|0|||
144393487|NCT02325791|520652223|FG002|Overall Study|Protocol Violation|1|||
144393488|NCT02325791|520652224|FG003|Overall Study|Protocol Violation|0|||
144393489|NCT02325791|520652221|FG000|Overall Study|Withdrawal by Subject|0|||
144518250|NCT02900924|521097775|FG000|Overall Study|Lost to Follow-up|4|||
144518251|NCT02900924|521097775|FG000|Overall Study|Withdrawal by Subject|20|||
144518252|NCT02900924|521097775|FG000|Overall Study|Missed Visit|33|||
144393490|NCT02325791|520652222|FG001|Overall Study|Withdrawal by Subject|5|||
144393491|NCT02325791|520652223|FG002|Overall Study|Withdrawal by Subject|8|||
144393492|NCT02325791|520652224|FG003|Overall Study|Withdrawal by Subject|16|||
144518253|NCT05956002|521097776|FG000|Treatment Period 3|Adverse Event|0|||
144518254|NCT05956002|521097777|FG001|Treatment Period 3|Adverse Event|0|||
144518255|NCT05956002|521097778|FG002|Treatment Period 3|Adverse Event|1|||
144518256|NCT05956002|521097779|FG003|Treatment Period 3|Adverse Event|0|||
144518257|NCT01494662|521097782|FG000|Overall Study|Withdrawal by Subject|0|||
144393493|NCT01028378|520652226|FG000|Overall Study|Lost to Follow-up|12|||
144393494|NCT01028378|520652226|FG000|Overall Study|Withdrawal by Subject|1|||
144393495|NCT01028378|520652226|FG000|Overall Study|Adminstrative Reasons|4|||
144393496|NCT01298193|520652227|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
144393497|NCT01298193|520652227|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
144518258|NCT01494662|521097783|FG001|Overall Study|Withdrawal by Subject|0|||
144518259|NCT01494662|521097784|FG002|Overall Study|Withdrawal by Subject|1|||
144393498|NCT01298193|520652227|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
144594297|NCT01178671|521376204|FG000|Overall Study|Adverse Event|4|||
144393499|NCT01298193|520652227|FG000|Efficacy Phase (Second Cycle)|Death|1|||
144393500|NCT00887744|520652231|FG000|Overall Study|Adverse Event|3|||
144393501|NCT00887744|520652231|FG000|Overall Study|Death|1|||
144393502|NCT00887744|520652231|FG000|Overall Study|Lost to Follow-up|3|||
144393503|NCT00887744|520652231|FG000|Overall Study|Withdrawal by Subject|18|||
144393504|NCT00887744|520652231|FG000|Overall Study|Various reasons|9|||
144393505|NCT01115803|520652232|FG000|Overall Study|Withdrawal by Subject|0|||
144393506|NCT01115803|520652233|FG001|Overall Study|Withdrawal by Subject|0|||
144393507|NCT01115803|520652234|FG002|Overall Study|Withdrawal by Subject|0|||
144393508|NCT01115803|520652235|FG003|Overall Study|Withdrawal by Subject|0|||
144393509|NCT01115803|520652236|FG004|Overall Study|Withdrawal by Subject|0|||
144393510|NCT01115803|520652237|FG005|Overall Study|Withdrawal by Subject|0|||
144393511|NCT01115803|520652238|FG006|Overall Study|Withdrawal by Subject|1|||
144518260|NCT01494662|521097785|FG003|Overall Study|Withdrawal by Subject|0|||
144518261|NCT01494662|521097786|FG004|Overall Study|Withdrawal by Subject|0|||
144518262|NCT01494662|521097787|FG005|Overall Study|Withdrawal by Subject|0|||
144518263|NCT01494662|521097788|FG006|Overall Study|Withdrawal by Subject|0|||
144518264|NCT01494662|521097782|FG000|Overall Study|Physician Decision|0|||
144518265|NCT01494662|521097783|FG001|Overall Study|Physician Decision|0|||
144518266|NCT01494662|521097784|FG002|Overall Study|Physician Decision|1|||
144518267|NCT01494662|521097785|FG003|Overall Study|Physician Decision|0|||
144518268|NCT01494662|521097786|FG004|Overall Study|Physician Decision|0|||
144518269|NCT01494662|521097787|FG005|Overall Study|Physician Decision|0|||
144518270|NCT01494662|521097788|FG006|Overall Study|Physician Decision|0|||
144518271|NCT04072822|521097789|FG000|Treatment|Adverse Event|9|||
144518272|NCT04072822|521097790|FG001|Treatment|Adverse Event|5|||
144518273|NCT04072822|521097789|FG000|Treatment|Met Stopping Criteria|13|||
144518274|NCT04072822|521097790|FG001|Treatment|Met Stopping Criteria|24|||
144518275|NCT04072822|521097789|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
144518276|NCT04072822|521097790|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
144518277|NCT04072822|521097789|FG000|Treatment|Withdrawal by Subject|0|||
144518278|NCT04072822|521097790|FG001|Treatment|Withdrawal by Subject|2|||
144518279|NCT04072822|521097789|FG000|Treatment|Death|0|||
144518280|NCT04072822|521097790|FG001|Treatment|Death|2|||
144518281|NCT04072822|521097789|FG000|Treatment|Lost to Follow-up|11|||
144518282|NCT04072822|521097790|FG001|Treatment|Lost to Follow-up|3|||
144518283|NCT04072822|521097789|FG000|Treatment|Physician Decision|1|||
144518284|NCT04072822|521097790|FG001|Treatment|Physician Decision|0|||
144518285|NCT04072822|521097789|FG000|Treatment|Other|7|||
144518286|NCT04072822|521097790|FG001|Treatment|Other|9|||
144518287|NCT04072822|521097789|FG000|Follow-up|Withdrawal by Subject|1|||
144518288|NCT04072822|521097790|FG001|Follow-up|Withdrawal by Subject|0|||
144518289|NCT04072822|521097789|FG000|Follow-up|Lost to Follow-up|5|||
144518290|NCT04072822|521097790|FG001|Follow-up|Lost to Follow-up|4|||
144518291|NCT03648840|521099029|FG000|First IV Infusion Session|Adverse Event|0|||
144518292|NCT03648840|521099030|FG001|First IV Infusion Session|Adverse Event|2|||
144518293|NCT03648840|521099029|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
144518294|NCT03648840|521099030|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
144518295|NCT03648840|521099029|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
144518296|NCT03648840|521099030|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
144518297|NCT03648840|521099029|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
144518298|NCT03648840|521099030|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
144518299|NCT05418296|521099033|FG000|Overall Study|Withdrawal by Subject|4|||
144518300|NCT05418296|521099034|FG001|Overall Study|Withdrawal by Subject|1|||
144518301|NCT05382936|521099035|FG000|Overall Study|Progressive Disease|3|||
144518302|NCT05382936|521099036|FG001|Overall Study|Progressive Disease|5|||
144518303|NCT05382936|521099037|FG002|Overall Study|Progressive Disease|2|||
144518304|NCT05382936|521099038|FG003|Overall Study|Progressive Disease|5|||
144518305|NCT05382936|521099035|FG000|Overall Study|Adverse Event|0|||
144518306|NCT05382936|521099036|FG001|Overall Study|Adverse Event|1|||
144518307|NCT05382936|521099037|FG002|Overall Study|Adverse Event|1|||
144518308|NCT05382936|521099038|FG003|Overall Study|Adverse Event|0|||
144518309|NCT05382936|521099035|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
144518310|NCT05382936|521099036|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
144518311|NCT05382936|521099037|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
144393512|NCT01115803|520652232|FG000|Overall Study|Lost to Follow-up|0|||
144393513|NCT01115803|520652233|FG001|Overall Study|Lost to Follow-up|0|||
144393514|NCT01115803|520652234|FG002|Overall Study|Lost to Follow-up|1|||
144393515|NCT01115803|520652235|FG003|Overall Study|Lost to Follow-up|0|||
144393516|NCT01115803|520652236|FG004|Overall Study|Lost to Follow-up|0|||
144393517|NCT01115803|520652237|FG005|Overall Study|Lost to Follow-up|0|||
144393518|NCT01115803|520652238|FG006|Overall Study|Lost to Follow-up|0|||
144393519|NCT01115803|520652232|FG000|Overall Study|Progressive Disease during Cycle1|0|||
144393520|NCT01115803|520652233|FG001|Overall Study|Progressive Disease during Cycle1|0|||
144393521|NCT01115803|520652234|FG002|Overall Study|Progressive Disease during Cycle1|0|||
144393522|NCT01115803|520652235|FG003|Overall Study|Progressive Disease during Cycle1|0|||
144393523|NCT01115803|520652236|FG004|Overall Study|Progressive Disease during Cycle1|0|||
144393524|NCT01115803|520652237|FG005|Overall Study|Progressive Disease during Cycle1|0|||
144518312|NCT05382936|521099038|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
144518313|NCT05382936|521099035|FG000|Overall Study|Withdrawal by Subject|0|||
144518314|NCT05382936|521099036|FG001|Overall Study|Withdrawal by Subject|0|||
144393525|NCT01115803|520652238|FG006|Overall Study|Progressive Disease during Cycle1|1|||
144393526|NCT03475875|520652239|FG000|Period 1|Lost to Follow-up|1|||
144393527|NCT03475875|520652240|FG001|Period 1|Lost to Follow-up|0|||
144393528|NCT03475875|520652239|FG000|Period 1|Adverse Event|2|||
144393529|NCT03475875|520652240|FG001|Period 1|Adverse Event|1|||
144393530|NCT03475875|520652239|FG000|Period 2|Adverse Event|3|||
144393531|NCT03475875|520652240|FG001|Period 2|Adverse Event|0|||
144393532|NCT03475875|520652239|FG000|Period 2|Protocol Violation|0|||
144393533|NCT03475875|520652240|FG001|Period 2|Protocol Violation|1|||
144393534|NCT01390220|520652241|FG000|Test Dose Phase|Adverse Event|17|||
144393535|NCT01390220|520652242|FG001|Test Dose Phase|Adverse Event|0|||
144393536|NCT01390220|520652243|FG002|Test Dose Phase|Adverse Event|0|||
144393537|NCT01390220|520652241|FG000|Test Dose Phase|Withdrawal by Subject|8|||
144393538|NCT01390220|520652242|FG001|Test Dose Phase|Withdrawal by Subject|0|||
144393539|NCT01390220|520652243|FG002|Test Dose Phase|Withdrawal by Subject|0|||
144393540|NCT01390220|520652241|FG000|Test Dose Phase|Lost to Follow-up|2|||
144393541|NCT01390220|520652242|FG001|Test Dose Phase|Lost to Follow-up|0|||
144393542|NCT01390220|520652243|FG002|Test Dose Phase|Lost to Follow-up|0|||
144393543|NCT01390220|520652241|FG000|Test Dose Phase|Protocol Violation|8|||
144393544|NCT01390220|520652242|FG001|Test Dose Phase|Protocol Violation|0|||
144393545|NCT01390220|520652243|FG002|Test Dose Phase|Protocol Violation|0|||
144518315|NCT05382936|521099037|FG002|Overall Study|Withdrawal by Subject|1|||
144518316|NCT05382936|521099038|FG003|Overall Study|Withdrawal by Subject|1|||
144518317|NCT05063994|521099041|FG000|Cortef Run-In|Withdrawal of Consent|1|||
144518318|NCT05063994|521099042|FG001|Cortef Run-In|Withdrawal of Consent|0|||
144518319|NCT05063994|521099043|FG002|Cortef Run-In|Withdrawal of Consent|0|||
144518320|NCT05063994|521099041|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
144518321|NCT05063994|521099042|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
144518322|NCT05063994|521099043|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
144518323|NCT05063994|521099041|FG000|Treatment|Physician Decision|0|||
144518324|NCT05063994|521099042|FG001|Treatment|Physician Decision|0|||
144518325|NCT05063994|521099043|FG002|Treatment|Physician Decision|1|||
144518326|NCT05063994|521099041|FG000|Treatment|Withdrawal by Subject|0|||
144518327|NCT05063994|521099042|FG001|Treatment|Withdrawal by Subject|0|||
144518328|NCT05063994|521099043|FG002|Treatment|Withdrawal by Subject|1|||
144518329|NCT05063994|521099041|FG000|Treatment|Withdrawal of Consent|0|||
144518330|NCT05063994|521099042|FG001|Treatment|Withdrawal of Consent|0|||
144518331|NCT05063994|521099043|FG002|Treatment|Withdrawal of Consent|1|||
144518332|NCT04630262|521099049|FG000|Overall Study|Intraoperative Screen Failure|5|||
144518333|NCT04630262|521099049|FG000|Overall Study|Study terminated prematurely|71|||
144518334|NCT04630262|521099049|FG000|Overall Study|Withdrawal by Subject|2|||
144518335|NCT04630262|521099049|FG000|Overall Study|Physician Decision|2|||
144518336|NCT01195831|521099051|FG000|Overall Study|Lost to Follow-up|2|||
144518337|NCT01195831|521099052|FG001|Overall Study|Lost to Follow-up|4|||
144518338|NCT01195831|521099051|FG000|Overall Study|Withdrawal by Subject|2|||
144594298|NCT01178671|521376205|FG001|Overall Study|Adverse Event|6|||
144393546|NCT01390220|520652241|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
144393547|NCT01390220|520652242|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
144393548|NCT01390220|520652243|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
144518339|NCT01195831|521099052|FG001|Overall Study|Withdrawal by Subject|2|||
144518340|NCT01195831|521099051|FG000|Overall Study|Adverse Event|4|||
144518341|NCT01195831|521099052|FG001|Overall Study|Adverse Event|2|||
144393549|NCT01390220|520652241|FG000|Test Dose Phase|Study/Site closure|6|||
144393550|NCT01390220|520652242|FG001|Test Dose Phase|Study/Site closure|0|||
144393551|NCT01390220|520652243|FG002|Test Dose Phase|Study/Site closure|0|||
144518342|NCT01195831|521099051|FG000|Overall Study|Protocol Violation|0|||
144518343|NCT01195831|521099052|FG001|Overall Study|Protocol Violation|2|||
144518344|NCT03692676|521099054|FG000|Overall Study|exclude patients with prior use|4424|||
144518345|NCT03692676|521099055|FG001|Overall Study|exclude patients with prior use|24726|||
144518346|NCT03692676|521099056|FG002|Overall Study|exclude patients with prior use|0|||
144518347|NCT03692676|521099057|FG003|Overall Study|exclude patients with prior use|0|||
144518348|NCT03692676|521099054|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
144518349|NCT03692676|521099055|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
144518350|NCT03692676|521099056|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
144518351|NCT03692676|521099057|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
144518352|NCT03692676|521099054|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
144518353|NCT03692676|521099055|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
144518354|NCT03692676|521099056|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
144518355|NCT03692676|521099057|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
144518356|NCT03692676|521099054|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
144518357|NCT03692676|521099055|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
144518358|NCT03692676|521099056|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
144518359|NCT03692676|521099057|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
144518360|NCT03692676|521099054|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
144518361|NCT03692676|521099055|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
144594299|NCT01178671|521376204|FG000|Overall Study|Protocol Violation|1|||
144393552|NCT01390220|520652241|FG000|Test Dose Phase|Caregiver no longer available|5|||
144393553|NCT01390220|520652242|FG001|Test Dose Phase|Caregiver no longer available|0|||
144393554|NCT01390220|520652243|FG002|Test Dose Phase|Caregiver no longer available|0|||
144393555|NCT01390220|520652241|FG000|Test Dose Phase|Noncompliance|2|||
144393556|NCT01390220|520652242|FG001|Test Dose Phase|Noncompliance|0|||
144393557|NCT01390220|520652243|FG002|Test Dose Phase|Noncompliance|0|||
144393558|NCT01390220|520652241|FG000|Test Dose Phase|Logistical|6|||
144393559|NCT01390220|520652242|FG001|Test Dose Phase|Logistical|0|||
144393560|NCT01390220|520652243|FG002|Test Dose Phase|Logistical|0|||
144393561|NCT01390220|520652241|FG000|Comparative Phase|Withdrawal by Subject|0|||
144393562|NCT01390220|520652242|FG001|Comparative Phase|Withdrawal by Subject|1|||
144393563|NCT01390220|520652243|FG002|Comparative Phase|Withdrawal by Subject|0|||
144393564|NCT03533686|520652246|FG000|Overall Study|Withdrawal by Subject|1|||
144393565|NCT03533686|520652247|FG001|Overall Study|Withdrawal by Subject|0|||
144393566|NCT03533686|520652248|FG002|Overall Study|Withdrawal by Subject|0|||
144393567|NCT03533686|520652249|FG003|Overall Study|Withdrawal by Subject|3|||
144393568|NCT03533686|520652250|FG004|Overall Study|Withdrawal by Subject|5|||
144393569|NCT03533686|520652251|FG005|Overall Study|Withdrawal by Subject|1|||
144393570|NCT03533686|520652246|FG000|Overall Study|Lost to Follow-up|0|||
144393571|NCT03533686|520652247|FG001|Overall Study|Lost to Follow-up|1|||
144393572|NCT03533686|520652248|FG002|Overall Study|Lost to Follow-up|0|||
144393573|NCT03533686|520652249|FG003|Overall Study|Lost to Follow-up|0|||
144393574|NCT03533686|520652250|FG004|Overall Study|Lost to Follow-up|2|||
144393575|NCT03533686|520652251|FG005|Overall Study|Lost to Follow-up|0|||
144393576|NCT03533686|520652246|FG000|Overall Study|Screen Failure|0|||
144393577|NCT03533686|520652247|FG001|Overall Study|Screen Failure|0|||
144393578|NCT03533686|520652248|FG002|Overall Study|Screen Failure|0|||
144393579|NCT03533686|520652249|FG003|Overall Study|Screen Failure|2|||
144393580|NCT03533686|520652250|FG004|Overall Study|Screen Failure|0|||
144393581|NCT03533686|520652251|FG005|Overall Study|Screen Failure|0|||
144393582|NCT00245583|520652252|FG000|Overall Study|Lost to Follow-up|1|||
144393583|NCT00245583|520652253|FG001|Overall Study|Lost to Follow-up|5|||
144393584|NCT00245583|520652252|FG000|Overall Study|Adverse Event|2|||
144393585|NCT00245583|520652253|FG001|Overall Study|Adverse Event|1|||
144393586|NCT00245583|520652252|FG000|Overall Study|Lack of Efficacy|1|||
144393587|NCT00245583|520652253|FG001|Overall Study|Lack of Efficacy|0|||
144393588|NCT00245583|520652252|FG000|Overall Study|Withdrawal by Subject|2|||
144393589|NCT00245583|520652253|FG001|Overall Study|Withdrawal by Subject|3|||
144393590|NCT00136604|520652254|FG000|Overall Study|Lost to Follow-up|1|||
144393591|NCT00136604|520652255|FG001|Overall Study|Lost to Follow-up|0|||
144393592|NCT00136604|520652256|FG002|Overall Study|Lost to Follow-up|0|||
144393593|NCT00136604|520652257|FG003|Overall Study|Lost to Follow-up|0|||
144393594|NCT00136604|520652258|FG004|Overall Study|Lost to Follow-up|1|||
144393595|NCT00136604|520652254|FG000|Overall Study|Migrated/moved from study area|0|||
144393596|NCT00136604|520652255|FG001|Overall Study|Migrated/moved from study area|1|||
144393597|NCT00136604|520652256|FG002|Overall Study|Migrated/moved from study area|0|||
144393598|NCT00136604|520652257|FG003|Overall Study|Migrated/moved from study area|0|||
144393599|NCT00136604|520652258|FG004|Overall Study|Migrated/moved from study area|0|||
144393600|NCT01562873|520652259|FG000|Overall Study|Disease Progression per RECIST|10|||
144393601|NCT01562873|520652260|FG001|Overall Study|Disease Progression per RECIST|0|||
144393602|NCT01562873|520652259|FG000|Overall Study|Adverse Event|1|||
144594300|NCT01178671|521376205|FG001|Overall Study|Protocol Violation|1|||
144594301|NCT01178671|521376204|FG000|Overall Study|Lack of Efficacy|0|||
144594302|NCT01178671|521376205|FG001|Overall Study|Lack of Efficacy|1|||
144594303|NCT01178671|521376204|FG000|Overall Study|Lost to Follow-up|3|||
144594304|NCT01178671|521376205|FG001|Overall Study|Lost to Follow-up|1|||
144594305|NCT01178671|521376204|FG000|Overall Study|Physician Decision|4|||
144393603|NCT01562873|520652260|FG001|Overall Study|Adverse Event|0|||
144393604|NCT01562873|520652259|FG000|Overall Study|Clinical Disease Progression|9|||
144393605|NCT01562873|520652260|FG001|Overall Study|Clinical Disease Progression|0|||
144393606|NCT01562873|520652259|FG000|Overall Study|Clinical PD and adverse event|1|||
144393607|NCT01562873|520652260|FG001|Overall Study|Clinical PD and adverse event|0|||
144393608|NCT03370289|520652261|FG000|Overall Study|Screen Failure|1|||
144393609|NCT03370289|520652261|FG000|Overall Study|Sample Size Sufficient|4|||
144594306|NCT01178671|521376205|FG001|Overall Study|Physician Decision|6|||
144393610|NCT02220998|520652263|FG000|Overall Study|Randomized but Never Treated|1|||
144393611|NCT02220998|520652264|FG001|Overall Study|Randomized but Never Treated|2|||
144393612|NCT02220998|520652263|FG000|Overall Study|Death|2|||
144393613|NCT02220998|520652264|FG001|Overall Study|Death|0|||
144393614|NCT02220998|520652263|FG000|Overall Study|Lack of Efficacy|0|||
144393615|NCT02220998|520652264|FG001|Overall Study|Lack of Efficacy|5|||
144393616|NCT02220998|520652263|FG000|Overall Study|Lost to Follow-up|4|||
144393617|NCT02220998|520652264|FG001|Overall Study|Lost to Follow-up|4|||
144594307|NCT01313689|521376206|FG000|24-Week Randomization 1|Adverse Event|10|||
144594308|NCT01313689|521376207|FG001|24-Week Randomization 1|Adverse Event|5|||
144393618|NCT02764190|520652265|FG000|Overall Study|Lost to Follow-up|17|||
144393619|NCT02764190|520652266|FG001|Overall Study|Lost to Follow-up|13|||
144393620|NCT00194675|520652271|FG000|Overall Study|Lost to Follow-up|1|||
144393621|NCT00194675|520652272|FG001|Overall Study|Lost to Follow-up|1|||
144393622|NCT00194675|520652271|FG000|Overall Study|lack of interest|1|||
144393623|NCT00194675|520652272|FG001|Overall Study|lack of interest|1|||
144393624|NCT00194675|520652271|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
144393625|NCT00194675|520652272|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
144594309|NCT01313689|521376208|FG002|24-Week Randomization 1|Adverse Event|0|||
144594310|NCT01313689|521376209|FG003|24-Week Randomization 1|Adverse Event|0|||
144594311|NCT01313689|521376210|FG004|24-Week Randomization 1|Adverse Event|0|||
144594312|NCT01313689|521376206|FG000|24-Week Randomization 1|Physician Decision|4|||
144594313|NCT01313689|521376207|FG001|24-Week Randomization 1|Physician Decision|5|||
144594314|NCT01313689|521376208|FG002|24-Week Randomization 1|Physician Decision|0|||
144594315|NCT01313689|521376209|FG003|24-Week Randomization 1|Physician Decision|0|||
144594316|NCT01313689|521376210|FG004|24-Week Randomization 1|Physician Decision|0|||
144594317|NCT01313689|521376206|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
144594318|NCT01313689|521376207|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
144594319|NCT01313689|521376208|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
144594320|NCT01313689|521376209|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
144594321|NCT01313689|521376210|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
144594322|NCT01313689|521376206|FG000|24-Week Randomization 2|Adverse Event|0|||
144594323|NCT01313689|521376207|FG001|24-Week Randomization 2|Adverse Event|0|||
144594324|NCT01313689|521376208|FG002|24-Week Randomization 2|Adverse Event|2|||
144594325|NCT01313689|521376209|FG003|24-Week Randomization 2|Adverse Event|0|||
144594326|NCT01313689|521376210|FG004|24-Week Randomization 2|Adverse Event|8|||
144594327|NCT01313689|521376206|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
144594328|NCT01313689|521376207|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
144594329|NCT01313689|521376208|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
144594330|NCT01313689|521376209|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
144594331|NCT01313689|521376210|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
144594332|NCT01313689|521376206|FG000|24-Week Randomization 2|Physician Decision|0|||
144594333|NCT01313689|521376207|FG001|24-Week Randomization 2|Physician Decision|0|||
144594334|NCT01313689|521376208|FG002|24-Week Randomization 2|Physician Decision|0|||
144594335|NCT01313689|521376209|FG003|24-Week Randomization 2|Physician Decision|0|||
144594336|NCT01313689|521376210|FG004|24-Week Randomization 2|Physician Decision|4|||
144594337|NCT00551460|521376213|FG000|Overall Study|Adverse Event|1|||
144594338|NCT00551460|521376213|FG000|Overall Study|Withdrawal by Subject|1|||
144594339|NCT00551460|521376213|FG000|Overall Study|Physician Decision|1|||
144594340|NCT00551460|521376213|FG000|Overall Study|Death|7|||
144594341|NCT00551460|521376213|FG000|Overall Study|Ineligible|4|||
144594342|NCT00551460|521376213|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
144594343|NCT04781387|521376214|FG000|Overall Study|Withdrawal by Subject|1|||
144594344|NCT04781387|521376215|FG001|Overall Study|Withdrawal by Subject|0|||
144594345|NCT04781387|521376216|FG002|Overall Study|Withdrawal by Subject|1|||
144594346|NCT04781387|521376214|FG000|Overall Study|Lost to Follow-up|1|||
144594347|NCT04781387|521376215|FG001|Overall Study|Lost to Follow-up|0|||
144594348|NCT04781387|521376216|FG002|Overall Study|Lost to Follow-up|0|||
144594349|NCT02709096|521376224|FG000|Overall Study|non-compliance|1|||
144594350|NCT02709096|521376225|FG001|Overall Study|non-compliance|1|||
144594351|NCT00511472|521376226|FG000|Overall Study|Clinical Adverse Event|1|||
144594352|NCT00511472|521376227|FG001|Overall Study|Clinical Adverse Event|2|||
144594353|NCT00511472|521376226|FG000|Overall Study|Laboratory Adverse Event|0|||
144594354|NCT00511472|521376227|FG001|Overall Study|Laboratory Adverse Event|2|||
144594355|NCT00511472|521376226|FG000|Overall Study|Not reported|2|||
144393626|NCT00194675|520652271|FG000|Overall Study|Protocol Violation|1|||
144594356|NCT00511472|521376227|FG001|Overall Study|Not reported|2|||
144393627|NCT00194675|520652272|FG001|Overall Study|Protocol Violation|0|||
144393628|NCT00194675|520652271|FG000|Overall Study|Death|1|||
144393629|NCT00194675|520652272|FG001|Overall Study|Death|0|||
144393630|NCT00473746|520652273|FG000|Period 1 (Phase 1)|Adverse Event|1|||
144393631|NCT00473746|520652274|FG001|Period 1 (Phase 1)|Adverse Event|0|||
144393632|NCT00473746|520652275|FG002|Period 1 (Phase 1)|Adverse Event|0|||
144393633|NCT00473746|520652276|FG003|Period 1 (Phase 1)|Adverse Event|0|||
144393634|NCT00473746|520652277|FG004|Period 1 (Phase 1)|Adverse Event|0|||
144393635|NCT00473746|520652273|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
144594357|NCT01079741|521376228|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
144594358|NCT01079741|521376229|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
144393636|NCT00473746|520652274|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
144594359|NCT01079741|521376230|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
144594360|NCT01079741|521376231|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
144594361|NCT01079741|521376232|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
144594362|NCT01079741|521376228|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
144594363|NCT01079741|521376229|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
144594364|NCT01079741|521376230|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
144594365|NCT01079741|521376231|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
144594366|NCT01079741|521376232|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
144594367|NCT00446992|521376233|FG000|Overall Study|Adverse Event|11|||
144594368|NCT00446992|521376233|FG000|Overall Study|Lost to Follow-up|5|||
144594369|NCT00818649|521376234|FG000|Overall Study|Declining performance status|2|||
144393637|NCT00473746|520652275|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
144393638|NCT00473746|520652276|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
144393639|NCT00473746|520652277|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
144393640|NCT00473746|520652273|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
144393641|NCT00473746|520652274|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
144393642|NCT00473746|520652275|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
144393643|NCT00473746|520652276|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
144393644|NCT00473746|520652277|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
144594370|NCT00818649|521376234|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
144594371|NCT00818649|521376234|FG000|Overall Study|Adverse Event|1|||
144594372|NCT03513588|521376235|FG000|Overall Study|Lost to Follow-up|0|||
144594373|NCT03513588|521376236|FG001|Overall Study|Lost to Follow-up|1|||
144594374|NCT03513588|521376237|FG002|Overall Study|Lost to Follow-up|1|||
144594375|NCT03513588|521376235|FG000|Overall Study|Study dosing paused by sponsor|1|||
144594376|NCT03513588|521376236|FG001|Overall Study|Study dosing paused by sponsor|1|||
144594377|NCT03513588|521376237|FG002|Overall Study|Study dosing paused by sponsor|0|||
144594378|NCT03513588|521376235|FG000|Overall Study|Death|0|||
144594379|NCT03513588|521376236|FG001|Overall Study|Death|0|||
144594380|NCT03513588|521376237|FG002|Overall Study|Death|1|||
144594381|NCT00505284|521376238|FG000|Overall Study|Adverse Event|3|||
144594382|NCT00505284|521376239|FG001|Overall Study|Adverse Event|7|||
144594383|NCT00505284|521376240|FG002|Overall Study|Adverse Event|9|||
144594384|NCT00505284|521376241|FG003|Overall Study|Adverse Event|14|||
144594385|NCT00505284|521376242|FG004|Overall Study|Adverse Event|22|||
144594386|NCT00505284|521376238|FG000|Overall Study|Protocol Violation|0|||
144594387|NCT00505284|521376239|FG001|Overall Study|Protocol Violation|1|||
144594388|NCT00505284|521376240|FG002|Overall Study|Protocol Violation|1|||
144594389|NCT00505284|521376241|FG003|Overall Study|Protocol Violation|0|||
144594390|NCT00505284|521376242|FG004|Overall Study|Protocol Violation|0|||
144594391|NCT00505284|521376238|FG000|Overall Study|Withdrawal by Subject|2|||
144594392|NCT00505284|521376239|FG001|Overall Study|Withdrawal by Subject|6|||
144594393|NCT00505284|521376240|FG002|Overall Study|Withdrawal by Subject|1|||
144594394|NCT00505284|521376241|FG003|Overall Study|Withdrawal by Subject|0|||
144594395|NCT00505284|521376242|FG004|Overall Study|Withdrawal by Subject|6|||
144594396|NCT00505284|521376238|FG000|Overall Study|Lack of Efficacy|0|||
144594397|NCT00505284|521376239|FG001|Overall Study|Lack of Efficacy|1|||
144594398|NCT00505284|521376240|FG002|Overall Study|Lack of Efficacy|1|||
144594399|NCT00505284|521376241|FG003|Overall Study|Lack of Efficacy|1|||
144594400|NCT00505284|521376242|FG004|Overall Study|Lack of Efficacy|1|||
144594401|NCT00505284|521376238|FG000|Overall Study|Physician Decision|0|||
144594402|NCT00505284|521376239|FG001|Overall Study|Physician Decision|1|||
144594403|NCT00505284|521376240|FG002|Overall Study|Physician Decision|0|||
144594404|NCT00505284|521376241|FG003|Overall Study|Physician Decision|0|||
144594405|NCT00505284|521376242|FG004|Overall Study|Physician Decision|0|||
144594406|NCT00505284|521376238|FG000|Overall Study|Other|5|||
144594407|NCT00505284|521376239|FG001|Overall Study|Other|0|||
144594408|NCT00505284|521376240|FG002|Overall Study|Other|0|||
144393645|NCT00473746|520652273|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
144594409|NCT00505284|521376241|FG003|Overall Study|Other|4|||
144594410|NCT00505284|521376242|FG004|Overall Study|Other|4|||
144594411|NCT01740323|521376246|FG000|Overall Study|Adverse Event|1|||
144594412|NCT01740323|521376247|FG001|Overall Study|Adverse Event|0|||
144594413|NCT01740323|521376246|FG000|Overall Study|Randomized but did not take study drug|1|||
144594414|NCT01740323|521376247|FG001|Overall Study|Randomized but did not take study drug|0|||
144594415|NCT06338462|521376252|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
144594416|NCT00069238|521376253|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
144594417|NCT00069238|521376254|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
144393646|NCT00473746|520652274|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
144594418|NCT00069238|521376255|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
144594419|NCT00069238|521376253|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
144594420|NCT00069238|521376254|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
144594421|NCT00069238|521376255|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
144594422|NCT00069238|521376253|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
144393647|NCT00473746|520652275|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
144393648|NCT00473746|520652276|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
144393649|NCT00473746|520652277|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
144393650|NCT00473746|520652273|FG000|Period 1 (Phase 1)|Reason not specified|0|||
144594423|NCT00069238|521376254|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
144594424|NCT00069238|521376255|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
144594425|NCT03567434|521376258|FG000|Overall Study|Lost to Follow-up|1|||
144594426|NCT03567434|521376259|FG001|Overall Study|Lost to Follow-up|3|||
144594427|NCT03573401|521376260|FG000|Overall Study|Withdrawal by Subject|2|||
144594428|NCT03573401|521376261|FG001|Overall Study|Withdrawal by Subject|0|||
144594429|NCT03573401|521376260|FG000|Overall Study|Subject non-compliance with study schedule|1|||
144594430|NCT03573401|521376261|FG001|Overall Study|Subject non-compliance with study schedule|0|||
144594431|NCT03573401|521376260|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
144594432|NCT03573401|521376261|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
144594433|NCT03573401|521376260|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
144594434|NCT03573401|521376261|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
144594435|NCT00001962|521377863|FG000|Overall Study|Lack of Efficacy|18|||
144594436|NCT00001962|521377863|FG000|Overall Study|Lack of Accrual|6|||
144594437|NCT00001962|521377863|FG000|Overall Study|Death|1|||
144594438|NCT00001962|521377863|FG000|Overall Study|Lost to Follow-up|2|||
144594439|NCT00001962|521377863|FG000|Overall Study|Adverse Event|1|||
144594440|NCT00063154|521377864|FG000|Overall Study|Disease progression|27|||
144594441|NCT00063154|521377864|FG000|Overall Study|Adverse Event|2|||
144594442|NCT00063154|521377864|FG000|Overall Study|Physician Decision|10|||
144594443|NCT00063154|521377864|FG000|Overall Study|Death|3|||
144594444|NCT00063154|521377864|FG000|Overall Study|Reason unspecified|1|||
144594445|NCT00063154|521377864|FG000|Overall Study|Did not receive treatment|8|||
144594446|NCT02699983|521377866|FG000|Overall Study|Withdrawal by Subject|1|||
144594447|NCT02699983|521377867|FG001|Overall Study|Withdrawal by Subject|0|||
144594448|NCT02070588|521377873|FG000|Overall Study|Withdrawal by Subject|29|||
144594449|NCT02070588|521377874|FG001|Overall Study|Withdrawal by Subject|1|||
144594450|NCT02070588|521377875|FG002|Overall Study|Withdrawal by Subject|0|||
144594451|NCT02070588|521377873|FG000|Overall Study|Writhdrawal due to early termination|9|||
144594452|NCT02070588|521377874|FG001|Overall Study|Writhdrawal due to early termination|0|||
144594453|NCT02070588|521377875|FG002|Overall Study|Writhdrawal due to early termination|0|||
144594454|NCT02070588|521377873|FG000|Overall Study|Adverse Event|1|||
144594455|NCT02070588|521377874|FG001|Overall Study|Adverse Event|0|||
144594456|NCT02070588|521377875|FG002|Overall Study|Adverse Event|0|||
144594457|NCT01790126|521377881|FG000|Overall Study|PSA Progression|12|||
144594458|NCT01790126|521377882|FG001|Overall Study|PSA Progression|16|||
144594459|NCT01790126|521377883|FG002|Overall Study|PSA Progression|16|||
144594460|NCT01790126|521377881|FG000|Overall Study|Other|5|||
144594461|NCT01790126|521377882|FG001|Overall Study|Other|4|||
144594462|NCT01790126|521377883|FG002|Overall Study|Other|8|||
144594463|NCT01790126|521377881|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
144594464|NCT01790126|521377882|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
144594465|NCT01790126|521377883|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
144594466|NCT01790126|521377881|FG000|Overall Study|Withdrawal by Physician|1|||
144594467|NCT01790126|521377882|FG001|Overall Study|Withdrawal by Physician|1|||
144594468|NCT01790126|521377883|FG002|Overall Study|Withdrawal by Physician|2|||
144594469|NCT01790126|521377881|FG000|Overall Study|Withdrawal by Subject|3|||
144594470|NCT01790126|521377882|FG001|Overall Study|Withdrawal by Subject|1|||
144594471|NCT01790126|521377883|FG002|Overall Study|Withdrawal by Subject|2|||
144594472|NCT01790126|521377881|FG000|Overall Study|Lost to Follow-up|1|||
144594473|NCT01790126|521377882|FG001|Overall Study|Lost to Follow-up|0|||
144594474|NCT01790126|521377883|FG002|Overall Study|Lost to Follow-up|1|||
144594475|NCT01790126|521377881|FG000|Overall Study|Adverse Event|0|||
144594476|NCT01790126|521377882|FG001|Overall Study|Adverse Event|2|||
144594477|NCT01790126|521377883|FG002|Overall Study|Adverse Event|0|||
144594478|NCT01790126|521377881|FG000|Overall Study|Death|2|||
144594479|NCT01790126|521377882|FG001|Overall Study|Death|0|||
144594480|NCT01790126|521377883|FG002|Overall Study|Death|0|||
144594481|NCT01790126|521377881|FG000|Overall Study|Radiographic Progression|3|||
144594482|NCT01790126|521377882|FG001|Overall Study|Radiographic Progression|1|||
144594483|NCT01790126|521377883|FG002|Overall Study|Radiographic Progression|0|||
144594484|NCT00679627|521377885|FG000|Overall Study|Death|41|||
144594485|NCT00679627|521377886|FG001|Overall Study|Death|29|||
144594486|NCT00679627|521377885|FG000|Overall Study|Adverse Event|43|||
144594487|NCT00679627|521377886|FG001|Overall Study|Adverse Event|53|||
144594488|NCT00679627|521377885|FG000|Overall Study|Withdrawal by Subject|168|||
144594489|NCT00679627|521377886|FG001|Overall Study|Withdrawal by Subject|172|||
144594490|NCT00679627|521377885|FG000|Overall Study|Lost to Follow-up|22|||
144594491|NCT00679627|521377886|FG001|Overall Study|Lost to Follow-up|26|||
144594492|NCT00679627|521377885|FG000|Overall Study|Early Study Closure|425|||
144594493|NCT00679627|521377886|FG001|Overall Study|Early Study Closure|405|||
144594494|NCT00940108|521377889|FG000|Overall Study|Adverse Event|2|||
144594495|NCT00940108|521377890|FG001|Overall Study|Adverse Event|4|||
144594496|NCT00940108|521377891|FG002|Overall Study|Adverse Event|0|||
144594497|NCT00940108|521377892|FG003|Overall Study|Adverse Event|2|||
144594498|NCT00940108|521377889|FG000|Overall Study|Withdrew Consent|2|||
144594499|NCT00940108|521377890|FG001|Overall Study|Withdrew Consent|1|||
144393651|NCT00473746|520652274|FG001|Period 1 (Phase 1)|Reason not specified|1|||
144393652|NCT00473746|520652275|FG002|Period 1 (Phase 1)|Reason not specified|0|||
144393653|NCT00473746|520652276|FG003|Period 1 (Phase 1)|Reason not specified|0|||
144393654|NCT00473746|520652277|FG004|Period 1 (Phase 1)|Reason not specified|0|||
144393655|NCT00473746|520652273|FG000|Period 2 (Phase 2)|Adverse Event|0|||
144393656|NCT00473746|520652274|FG001|Period 2 (Phase 2)|Adverse Event|0|||
144393657|NCT00473746|520652275|FG002|Period 2 (Phase 2)|Adverse Event|0|||
144393658|NCT00473746|520652276|FG003|Period 2 (Phase 2)|Adverse Event|0|||
144393659|NCT00473746|520652277|FG004|Period 2 (Phase 2)|Adverse Event|3|||
144393660|NCT00473746|520652273|FG000|Period 2 (Phase 2)|Death|0|||
144393661|NCT00473746|520652274|FG001|Period 2 (Phase 2)|Death|0|||
144393662|NCT00473746|520652275|FG002|Period 2 (Phase 2)|Death|0|||
144393663|NCT00473746|520652276|FG003|Period 2 (Phase 2)|Death|0|||
144393664|NCT00473746|520652277|FG004|Period 2 (Phase 2)|Death|1|||
144393665|NCT00473746|520652273|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
144393666|NCT00473746|520652274|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
144393667|NCT00473746|520652275|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
144393668|NCT00473746|520652276|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
144594500|NCT00940108|521377891|FG002|Overall Study|Withdrew Consent|0|||
144393669|NCT00473746|520652277|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
144393670|NCT00473746|520652273|FG000|Period 2 (Phase 2)|Reason not specified|0|||
144393671|NCT00473746|520652274|FG001|Period 2 (Phase 2)|Reason not specified|0|||
144393672|NCT00473746|520652275|FG002|Period 2 (Phase 2)|Reason not specified|0|||
144393673|NCT00473746|520652276|FG003|Period 2 (Phase 2)|Reason not specified|0|||
144393674|NCT00473746|520652277|FG004|Period 2 (Phase 2)|Reason not specified|3|||
144393675|NCT02280473|520652278|FG000|Overall Study|Adverse Event|1|||
144393676|NCT02280473|520652279|FG001|Overall Study|Adverse Event|1|||
144393677|NCT02280473|520652278|FG000|Overall Study|Lack of Efficacy|0|||
144393678|NCT02280473|520652279|FG001|Overall Study|Lack of Efficacy|1|||
144393679|NCT02280473|520652278|FG000|Overall Study|Lost to Follow-up|0|||
144393680|NCT02280473|520652279|FG001|Overall Study|Lost to Follow-up|1|||
144393681|NCT01484054|520652284|FG000|Period 1|Withdrawal by Subject|0|||
144393682|NCT01484054|520652285|FG001|Period 1|Withdrawal by Subject|1|||
144393683|NCT04223232|520652286|FG000|Overall Study|Withdrawal by Subject|1|||
144393684|NCT05281601|520652292|FG000|Overall Study|Physician Decision|2|||
144393685|NCT05281601|520652293|FG001|Overall Study|Physician Decision|0|||
144393686|NCT05281601|520652292|FG000|Overall Study|Lost to Follow-up|2|||
144393687|NCT05281601|520652293|FG001|Overall Study|Lost to Follow-up|0|||
144393688|NCT05281601|520652292|FG000|Overall Study|Death|1|||
144393689|NCT05281601|520652293|FG001|Overall Study|Death|0|||
144393690|NCT05281601|520652292|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144393691|NCT05281601|520652293|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144393692|NCT00122278|520653470|FG000|Overall Study|Lost to Follow-up|2|||
144393693|NCT00122278|520653471|FG001|Overall Study|Lost to Follow-up|0|||
144393694|NCT01002482|520653472|FG000|Overall Study|Withdrawal by Subject|14|||
144393695|NCT01002482|520653473|FG001|Overall Study|Withdrawal by Subject|21|||
144393696|NCT01002482|520653472|FG000|Overall Study|Included twice|1|||
144393697|NCT01002482|520653473|FG001|Overall Study|Included twice|0|||
144393698|NCT01865084|520653474|FG000|Double Blind Period (DB)|Adverse Event|2|||
144393699|NCT01865084|520653475|FG001|Double Blind Period (DB)|Adverse Event|2|||
144393700|NCT01865084|520653476|FG002|Double Blind Period (DB)|Adverse Event|1|||
144393701|NCT01865084|520653474|FG000|Double Blind Period (DB)|Protocol Violation|0|||
144393702|NCT01865084|520653475|FG001|Double Blind Period (DB)|Protocol Violation|0|||
144393703|NCT01865084|520653476|FG002|Double Blind Period (DB)|Protocol Violation|1|||
144393704|NCT01865084|520653474|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
144393705|NCT01865084|520653475|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
144393706|NCT01865084|520653476|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
144393707|NCT01865084|520653474|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
144393708|NCT01865084|520653475|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
144393709|NCT01865084|520653476|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
144393710|NCT01865084|520653474|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
144393711|NCT01865084|520653475|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
144393712|NCT01865084|520653476|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
144393713|NCT01865084|520653474|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
144393714|NCT01865084|520653475|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
144393715|NCT01865084|520653476|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
144393716|NCT01865084|520653474|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
144393717|NCT01865084|520653475|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
144393718|NCT01865084|520653476|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
144393719|NCT01865084|520653474|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
144393720|NCT01865084|520653475|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
144393721|NCT01865084|520653476|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
144393722|NCT01865084|520653474|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
144393723|NCT01865084|520653475|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
144393724|NCT01865084|520653476|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
144393725|NCT02247531|520653480|FG000|Overall Study|Adverse Event|3|||
144393726|NCT02247531|520653481|FG001|Overall Study|Adverse Event|4|||
144393727|NCT02247531|520653482|FG002|Overall Study|Adverse Event|9|||
144393728|NCT02247531|520653480|FG000|Overall Study|Death|8|||
144393729|NCT02247531|520653481|FG001|Overall Study|Death|9|||
144393730|NCT02247531|520653482|FG002|Overall Study|Death|5|||
144393731|NCT02247531|520653480|FG000|Overall Study|Lost to Follow-up|1|||
144393732|NCT02247531|520653481|FG001|Overall Study|Lost to Follow-up|8|||
144393733|NCT02247531|520653482|FG002|Overall Study|Lost to Follow-up|3|||
144393734|NCT02247531|520653480|FG000|Overall Study|Non-compliance|2|||
144393735|NCT02247531|520653481|FG001|Overall Study|Non-compliance|2|||
144393736|NCT02247531|520653482|FG002|Overall Study|Non-compliance|0|||
144393737|NCT02247531|520653480|FG000|Overall Study|Withdrawal by Subject|26|||
144393738|NCT02247531|520653481|FG001|Overall Study|Withdrawal by Subject|31|||
144393739|NCT02247531|520653482|FG002|Overall Study|Withdrawal by Subject|25|||
144393740|NCT02247531|520653480|FG000|Overall Study|Study Terminated by Sponsor|64|||
144393741|NCT02247531|520653481|FG001|Overall Study|Study Terminated by Sponsor|66|||
144393742|NCT02247531|520653482|FG002|Overall Study|Study Terminated by Sponsor|62|||
144393743|NCT02247531|520653480|FG000|Overall Study|Physician Decision|0|||
144393744|NCT02247531|520653481|FG001|Overall Study|Physician Decision|2|||
144393745|NCT02247531|520653482|FG002|Overall Study|Physician Decision|2|||
144393746|NCT02247531|520653480|FG000|Overall Study|Unspecified Reason|2|||
144393747|NCT02247531|520653481|FG001|Overall Study|Unspecified Reason|3|||
144393748|NCT02247531|520653482|FG002|Overall Study|Unspecified Reason|4|||
144393749|NCT03875118|520653497|FG000|Overall Study|Withdrawal by Subject|4|||
144393750|NCT03875118|520653498|FG001|Overall Study|Withdrawal by Subject|4|||
144393751|NCT01442038|520653501|FG000|Overall Study|Death|35|||
144393752|NCT01442038|520653502|FG001|Overall Study|Death|29|||
144393753|NCT01442038|520653501|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
144393754|NCT01442038|520653502|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
144393755|NCT01442038|520653501|FG000|Overall Study|Participant Withdrew Consent|137|||
144393756|NCT01442038|520653502|FG001|Overall Study|Participant Withdrew Consent|102|||
144393757|NCT01442038|520653501|FG000|Overall Study|Lost to Follow-up|37|||
144393758|NCT01442038|520653502|FG001|Overall Study|Lost to Follow-up|51|||
144393759|NCT01442038|520653501|FG000|Overall Study|Adverse Event|26|||
144393760|NCT01442038|520653502|FG001|Overall Study|Adverse Event|15|||
144393761|NCT01442038|520653501|FG000|Overall Study|Protocol Deviation|9|||
144393762|NCT01442038|520653502|FG001|Overall Study|Protocol Deviation|20|||
144393763|NCT01442038|520653501|FG000|Overall Study|Investigator's Discretion|13|||
144393764|NCT01442038|520653502|FG001|Overall Study|Investigator's Discretion|16|||
144393765|NCT01442038|520653501|FG000|Overall Study|Study Terminated By Sponsor|2|||
144393766|NCT01442038|520653502|FG001|Overall Study|Study Terminated By Sponsor|3|||
144393767|NCT00089284|520653503|FG000|Overall Study|Adverse event before starting treatment|0|||
144393768|NCT00089284|520653504|FG001|Overall Study|Adverse event before starting treatment|0|||
144518362|NCT03692676|521099056|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
144518363|NCT03692676|521099057|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
144518364|NCT03692676|521099054|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
144518365|NCT03692676|521099055|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
144518366|NCT03692676|521099056|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
144518367|NCT03692676|521099057|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
144518368|NCT03692676|521099054|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
144518369|NCT03692676|521099055|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
144518370|NCT03692676|521099056|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
144518371|NCT03692676|521099057|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
144518372|NCT03692676|521099054|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
144518373|NCT03692676|521099055|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
144518374|NCT03692676|521099056|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
144518375|NCT03692676|521099057|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
144518376|NCT03692676|521099054|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
144538351|NCT00777049|521174166|FG001|Overall Study|Withdrawal by Subject|0|||
144538352|NCT00777049|521174165|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
144393769|NCT00089284|520653505|FG002|Overall Study|Adverse event before starting treatment|0|||
144393770|NCT00089284|520653506|FG003|Overall Study|Adverse event before starting treatment|0|||
144393771|NCT00089284|520653507|FG004|Overall Study|Adverse event before starting treatment|0|||
144393772|NCT00089284|520653508|FG005|Overall Study|Adverse event before starting treatment|0|||
144393773|NCT00089284|520653509|FG006|Overall Study|Adverse event before starting treatment|1|||
144393774|NCT02237911|520653510|FG000|Overall Study|Withdrawal by Subject|4|||
144393775|NCT02237911|520653511|FG001|Overall Study|Withdrawal by Subject|7|||
144393776|NCT02237911|520653512|FG002|Overall Study|Withdrawal by Subject|2|||
144393777|NCT02237911|520653510|FG000|Overall Study|Lost to Follow-up|3|||
144393778|NCT02237911|520653511|FG001|Overall Study|Lost to Follow-up|1|||
144393779|NCT02237911|520653512|FG002|Overall Study|Lost to Follow-up|1|||
144393780|NCT02423109|520653513|FG000|Lens 1|Adverse Event|1|||
144393781|NCT02423109|520653514|FG001|Lens 1|Adverse Event|0|||
144393782|NCT02428608|520653516|FG000|Overall Study|Pregnancy|2|||
144393783|NCT02428608|520653516|FG000|Overall Study|Lost to Follow-up|37|||
144393784|NCT02428608|520653516|FG000|Overall Study|Withdrawal by Subject|2|||
144393785|NCT02428608|520653516|FG000|Overall Study|scheduling conflicts|15|||
144393786|NCT02428608|520653516|FG000|Overall Study|moved away|10|||
144393787|NCT02428608|520653516|FG000|Overall Study|Death|1|||
144393788|NCT02428608|520653516|FG000|Overall Study|various|16|||
144393789|NCT01092507|520653517|FG000|Overall Study|Withdrawal by Subject|2|||
144393790|NCT01092507|520653518|FG001|Overall Study|Withdrawal by Subject|0|||
144393791|NCT03468985|520653519|FG000|Overall Study|Adverse Event|0|||
144393792|NCT03468985|520653520|FG001|Overall Study|Adverse Event|2|||
144393793|NCT03468985|520653521|FG002|Overall Study|Adverse Event|0|||
144393794|NCT03468985|520653522|FG003|Overall Study|Adverse Event|0|||
144393795|NCT03468985|520653519|FG000|Overall Study|Withdrawal by Subject|0|||
144393796|NCT03468985|520653520|FG001|Overall Study|Withdrawal by Subject|0|||
144393797|NCT03468985|520653521|FG002|Overall Study|Withdrawal by Subject|0|||
144393798|NCT03468985|520653522|FG003|Overall Study|Withdrawal by Subject|1|||
144393799|NCT04060862|520653523|FG000|Overall Study|Symptomatic Deterioration|1|||
144393800|NCT04060862|520653523|FG000|Overall Study|Un-specified|6|||
144393801|NCT04060862|520653523|FG000|Overall Study|Progressive disease|12|||
144393802|NCT04060862|520653523|FG000|Overall Study|Physician Decision|1|||
144393803|NCT03416374|520653529|FG000|Between Treatment Period I and II|Other|0|||
144393804|NCT03416374|520653530|FG001|Between Treatment Period I and II|Other|9|||
144393805|NCT03416374|520653529|FG000|Treatment Period II|Lack of Efficacy|3|||
144393806|NCT03416374|520653530|FG001|Treatment Period II|Lack of Efficacy|11|||
144393807|NCT03416374|520653529|FG000|Treatment Period II|Adverse Event|1|||
144393808|NCT03416374|520653530|FG001|Treatment Period II|Adverse Event|4|||
144393809|NCT03416374|520653529|FG000|Treatment Period II|Death|0|||
144393810|NCT03416374|520653530|FG001|Treatment Period II|Death|1|||
144393811|NCT03416374|520653529|FG000|Treatment Period II|Other|0|||
144393812|NCT03416374|520653530|FG001|Treatment Period II|Other|2|||
144393813|NCT03463031|520653533|FG000|Overall Study|Withdrawal by Subject|4|||
144393814|NCT03463031|520653534|FG001|Overall Study|Withdrawal by Subject|2|||
144393815|NCT03463031|520653533|FG000|Overall Study|Investigator/Sponsor Decision|0|||
144393816|NCT03463031|520653534|FG001|Overall Study|Investigator/Sponsor Decision|1|||
144393817|NCT03463031|520653533|FG000|Overall Study|Lost to Follow-up|1|||
144393818|NCT03463031|520653534|FG001|Overall Study|Lost to Follow-up|1|||
144393819|NCT03463031|520653533|FG000|Overall Study|Adverse Event|4|||
144393820|NCT03463031|520653534|FG001|Overall Study|Adverse Event|1|||
144393821|NCT03463031|520653533|FG000|Overall Study|Use of prohibited medication by subject|1|||
144393822|NCT03463031|520653534|FG001|Overall Study|Use of prohibited medication by subject|0|||
144393823|NCT01810432|520653535|FG000|Washout|Protocol Violation|0|||
144393824|NCT01810432|520653536|FG001|Washout|Protocol Violation|1|||
144393825|NCT01810432|520653535|FG000|Washout|Adverse Event|1|||
144393826|NCT01810432|520653536|FG001|Washout|Adverse Event|0|||
144393827|NCT01810432|520653535|FG000|Period 2|Withdrawal by Subject|2|||
144393828|NCT01810432|520653536|FG001|Period 2|Withdrawal by Subject|1|||
144393829|NCT01810432|520653535|FG000|Period 2|Physician Decision|1|||
144393830|NCT01810432|520653536|FG001|Period 2|Physician Decision|0|||
144393831|NCT01810432|520653535|FG000|Period 2|Lost to Follow-up|1|||
144393832|NCT01810432|520653536|FG001|Period 2|Lost to Follow-up|1|||
144393833|NCT01264016|520653537|FG000|Overall Study|Withdrawal by Subject|1|||
144393834|NCT01264016|520653537|FG000|Overall Study|Felt faint at sight of blood|1|||
144393835|NCT02652767|520653538|FG000|Overall Study|Death|2|||
144393836|NCT02652767|520653538|FG000|Overall Study|Lost to Follow-up|1|||
144393837|NCT02652767|520653538|FG000|Overall Study|Withdrawal by Subject|1|||
144393838|NCT00901927|520653548|FG000|Overall Study|Lack of Efficacy|1|||
144393839|NCT00901927|520653548|FG000|Overall Study|Protocol Violation|3|||
144393840|NCT00901927|520653548|FG000|Overall Study|Withdrawal by Subject|2|||
144393841|NCT00586846|520653549|FG000|Overall Study|Physician Decision|1|||
144393842|NCT00586846|520653549|FG000|Overall Study|Death|1|||
144393843|NCT00586846|520653549|FG000|Overall Study|Evaluable for Toxicity Only|4|||
144393844|NCT05298306|520653553|FG000|Overall Study|Physician Decision|0|||
144393845|NCT05298306|520653554|FG001|Overall Study|Physician Decision|0|||
144393846|NCT05298306|520653555|FG002|Overall Study|Physician Decision|0|||
144393847|NCT05298306|520653556|FG003|Overall Study|Physician Decision|1|||
144393848|NCT05298306|520653557|FG004|Overall Study|Physician Decision|0|||
144393849|NCT05298306|520653558|FG005|Overall Study|Physician Decision|0|||
144393850|NCT01702571|520653566|FG000|Overall Study|Death|1067|||
144393851|NCT01702571|520653567|FG001|Overall Study|Death|76|||
144393852|NCT01702571|520653566|FG000|Overall Study|Lost to Follow-up|144|||
144393853|NCT01702571|520653567|FG001|Overall Study|Lost to Follow-up|10|||
144393854|NCT01702571|520653566|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
144393855|NCT01702571|520653567|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
144393856|NCT01702571|520653566|FG000|Overall Study|Investigator Decision|5|||
144393857|NCT01702571|520653567|FG001|Overall Study|Investigator Decision|0|||
144393858|NCT01702571|520653566|FG000|Overall Study|Not Classifiable|1|||
144393859|NCT01702571|520653567|FG001|Overall Study|Not Classifiable|0|||
144393860|NCT01702571|520653566|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
144393861|NCT01702571|520653567|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
144393862|NCT01702571|520653566|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
144393863|NCT01702571|520653567|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
144393864|NCT01702571|520653566|FG000|Overall Study|Progressive Disease|3|||
144393865|NCT01702571|520653567|FG001|Overall Study|Progressive Disease|0|||
144393866|NCT01702571|520653566|FG000|Overall Study|Protocol Violation|2|||
144393867|NCT01702571|520653567|FG001|Overall Study|Protocol Violation|0|||
144393868|NCT01702571|520653566|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
144393869|NCT01702571|520653567|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
144393870|NCT01702571|520653566|FG000|Overall Study|Termination By Sponsor|4|||
144393871|NCT01702571|520653567|FG001|Overall Study|Termination By Sponsor|0|||
144393872|NCT01702571|520653566|FG000|Overall Study|Withdrawal by Subject|177|||
144393873|NCT01702571|520653567|FG001|Overall Study|Withdrawal by Subject|29|||
144393874|NCT00191646|520653568|FG000|Overall Study|Toxicity|26|||
144393875|NCT00191646|520653569|FG001|Overall Study|Toxicity|37|||
144393876|NCT00191646|520653568|FG000|Overall Study|Disease Progression|5|||
144393877|NCT00191646|520653569|FG001|Overall Study|Disease Progression|6|||
144393878|NCT00191646|520653568|FG000|Overall Study|Physician Decision|20|||
144393879|NCT00191646|520653569|FG001|Overall Study|Physician Decision|11|||
144393880|NCT00191646|520653568|FG000|Overall Study|Withdrawal by Subject|58|||
144393881|NCT00191646|520653569|FG001|Overall Study|Withdrawal by Subject|39|||
144393882|NCT00191646|520653568|FG000|Overall Study|Protocol Violation|5|||
144393883|NCT00191646|520653569|FG001|Overall Study|Protocol Violation|7|||
144393884|NCT00191646|520653568|FG000|Overall Study|Death|6|||
144393885|NCT00191646|520653569|FG001|Overall Study|Death|8|||
144393886|NCT00191646|520653568|FG000|Overall Study|Other|33|||
144393887|NCT00191646|520653569|FG001|Overall Study|Other|34|||
144393888|NCT00191646|520653568|FG000|Overall Study|Missing Data|18|||
144393889|NCT00191646|520653569|FG001|Overall Study|Missing Data|11|||
144393890|NCT03194490|520653575|FG000|Overall Study|Lost to Follow-up|1|||
144393891|NCT03194490|520653576|FG001|Overall Study|Lost to Follow-up|3|||
144393892|NCT03194490|520653575|FG000|Overall Study|participant developed specific neck pain|1|||
144393893|NCT03194490|520653576|FG001|Overall Study|participant developed specific neck pain|0|||
144393894|NCT01574079|520653577|FG000|Overall Study|Physician Decision|0|||
144393895|NCT01574079|520653578|FG001|Overall Study|Physician Decision|2|||
144393896|NCT01574079|520653577|FG000|Overall Study|Lost to Follow-up|1|||
144393897|NCT01574079|520653578|FG001|Overall Study|Lost to Follow-up|0|||
144393898|NCT00406718|520653579|FG000|Overall Study|Withdrawal by Subject|2|||
144393899|NCT00406718|520653580|FG001|Overall Study|Withdrawal by Subject|9|||
144393900|NCT00406718|520653581|FG002|Overall Study|Withdrawal by Subject|4|||
144393901|NCT00406718|520653579|FG000|Overall Study|Lost to Follow-up|2|||
144393902|NCT00406718|520653580|FG001|Overall Study|Lost to Follow-up|5|||
144393903|NCT00406718|520653581|FG002|Overall Study|Lost to Follow-up|4|||
144393904|NCT03640559|520653582|FG000|Overall Study|Physician Decision|1|||
144393905|NCT03640559|520653583|FG001|Overall Study|Physician Decision|1|||
144518377|NCT03692676|521099055|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
144393906|NCT03640559|520653582|FG000|Overall Study|Withdrawal by Subject|1|||
144393907|NCT03640559|520653583|FG001|Overall Study|Withdrawal by Subject|0|||
144393908|NCT01436162|520653584|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
144393909|NCT01436162|520653585|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
144393910|NCT01436162|520653586|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
144393911|NCT01436162|520653584|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
144393912|NCT01436162|520653585|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
144393913|NCT01436162|520653586|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
144393914|NCT01436162|520653584|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
144393915|NCT01436162|520653585|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
144393916|NCT01436162|520653586|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
144393917|NCT01436162|520653584|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
144393918|NCT01436162|520653585|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
144393919|NCT01436162|520653586|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
144393920|NCT01436162|520653584|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
144594501|NCT00940108|521377892|FG003|Overall Study|Withdrew Consent|1|||
144594502|NCT00940108|521377889|FG000|Overall Study|Dose 2 contraindicated|1|||
144594503|NCT00940108|521377890|FG001|Overall Study|Dose 2 contraindicated|1|||
144594504|NCT00940108|521377891|FG002|Overall Study|Dose 2 contraindicated|0|||
144594505|NCT00940108|521377892|FG003|Overall Study|Dose 2 contraindicated|1|||
144594506|NCT00940108|521377889|FG000|Overall Study|Declined further vaccination|0|||
144594507|NCT00940108|521377890|FG001|Overall Study|Declined further vaccination|1|||
144594508|NCT00940108|521377891|FG002|Overall Study|Declined further vaccination|3|||
144594509|NCT00940108|521377892|FG003|Overall Study|Declined further vaccination|0|||
144594510|NCT00940108|521377889|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
144594511|NCT00940108|521377890|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
144594512|NCT00940108|521377891|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
144594513|NCT00940108|521377892|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
144594514|NCT00940108|521377889|FG000|Overall Study|Viral illness after Dose 1|0|||
144722202|NCT00101582|521838638|FG000|Overall Study|Ineligibility determined|0|||
144722203|NCT00101582|521838639|FG001|Overall Study|Ineligibility determined|1|||
144722204|NCT00101582|521838638|FG000|Overall Study|Adverse Event|1|||
144393921|NCT01436162|520653585|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144393922|NCT01436162|520653586|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144393923|NCT01436162|520653584|FG000|Single-blind Lead-in Phase|Other|107|||
144393924|NCT01436162|520653585|FG001|Single-blind Lead-in Phase|Other|0|||
144393925|NCT01436162|520653586|FG002|Single-blind Lead-in Phase|Other|0|||
144393926|NCT01436162|520653584|FG000|Randomized Phase|Adverse Event|1|||
144393927|NCT01436162|520653585|FG001|Randomized Phase|Adverse Event|5|||
144393928|NCT01436162|520653586|FG002|Randomized Phase|Adverse Event|6|||
144393929|NCT01436162|520653584|FG000|Randomized Phase|Protocol Violation|4|||
144393930|NCT01436162|520653585|FG001|Randomized Phase|Protocol Violation|4|||
144393931|NCT01436162|520653586|FG002|Randomized Phase|Protocol Violation|2|||
144393932|NCT01436162|520653584|FG000|Randomized Phase|Withdrawal by Subject|16|||
144393933|NCT01436162|520653585|FG001|Randomized Phase|Withdrawal by Subject|9|||
144393934|NCT01436162|520653586|FG002|Randomized Phase|Withdrawal by Subject|8|||
144393935|NCT01436162|520653584|FG000|Randomized Phase|Lost to Follow-up|17|||
144393936|NCT01436162|520653585|FG001|Randomized Phase|Lost to Follow-up|5|||
144393937|NCT01436162|520653586|FG002|Randomized Phase|Lost to Follow-up|4|||
144393938|NCT01436162|520653584|FG000|Randomized Phase|Lack of Efficacy|0|||
144393939|NCT01436162|520653585|FG001|Randomized Phase|Lack of Efficacy|1|||
144393940|NCT01436162|520653586|FG002|Randomized Phase|Lack of Efficacy|1|||
144393941|NCT01436162|520653584|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
144393942|NCT01436162|520653585|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
144393943|NCT01436162|520653586|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
144393944|NCT01436162|520653584|FG000|Randomized Phase|Other|2|||
144393945|NCT01436162|520653585|FG001|Randomized Phase|Other|5|||
144393946|NCT01436162|520653586|FG002|Randomized Phase|Other|4|||
144393947|NCT01888003|520653587|FG000|Overall Study|Study Terminated|5|||
144393948|NCT01888003|520653588|FG001|Overall Study|Study Terminated|6|||
144393949|NCT01888003|520653589|FG002|Overall Study|Study Terminated|40|||
144393950|NCT03187756|520653590|FG000|Overall Study|Termination of study|4|||
144393951|NCT01931202|520653594|FG000|Overall Study|Withdrawal by Subject|0|||
144393952|NCT01931202|520653595|FG001|Overall Study|Withdrawal by Subject|0|||
144393953|NCT01931202|520653596|FG002|Overall Study|Withdrawal by Subject|2|||
144393954|NCT01931202|520653594|FG000|Overall Study|Lost to Follow-up|0|||
144393955|NCT01931202|520653595|FG001|Overall Study|Lost to Follow-up|5|||
144393956|NCT01931202|520653596|FG002|Overall Study|Lost to Follow-up|2|||
144393957|NCT04597918|520653599|FG000|Overall Study|Withdrawal by Subject|6|||
144393958|NCT04597918|520653599|FG000|Overall Study|Lost to Follow-up|3|||
144393959|NCT04597918|520653599|FG000|Overall Study|Death|1|||
144393960|NCT01876810|520653600|FG000|Overall Study|Physician Decision|0|||
144393961|NCT01876810|520653601|FG001|Overall Study|Physician Decision|1|||
144393962|NCT05140382|520653604|FG000|Overall Study|Death|3|||
144393963|NCT05140382|520653605|FG001|Overall Study|Death|0|||
144393964|NCT05140382|520653606|FG002|Overall Study|Death|0|||
144393965|NCT05140382|520653604|FG000|Overall Study|Investigator decision|1|||
144393966|NCT05140382|520653605|FG001|Overall Study|Investigator decision|0|||
144393967|NCT05140382|520653606|FG002|Overall Study|Investigator decision|0|||
144393968|NCT05140382|520653604|FG000|Overall Study|Other|4|||
144393969|NCT05140382|520653605|FG001|Overall Study|Other|0|||
144393970|NCT05140382|520653606|FG002|Overall Study|Other|1|||
144594515|NCT00940108|521377890|FG001|Overall Study|Viral illness after Dose 1|1|||
144594516|NCT00940108|521377891|FG002|Overall Study|Viral illness after Dose 1|0|||
144594517|NCT00940108|521377892|FG003|Overall Study|Viral illness after Dose 1|0|||
144594518|NCT00940108|521377889|FG000|Overall Study|Diagnosed with H1N1|0|||
144594519|NCT00940108|521377890|FG001|Overall Study|Diagnosed with H1N1|0|||
144722205|NCT00101582|521838639|FG001|Overall Study|Adverse Event|4|||
144393971|NCT05140382|520653604|FG000|Overall Study|Progressive disease|20|||
144393972|NCT05140382|520653605|FG001|Overall Study|Progressive disease|1|||
144393973|NCT05140382|520653606|FG002|Overall Study|Progressive disease|12|||
144393974|NCT05140382|520653604|FG000|Overall Study|Subjective disease progression|2|||
144393975|NCT05140382|520653605|FG001|Overall Study|Subjective disease progression|1|||
144393976|NCT05140382|520653606|FG002|Overall Study|Subjective disease progression|0|||
144393977|NCT05140382|520653604|FG000|Overall Study|Unknown at data cut-off|0|||
144393978|NCT05140382|520653605|FG001|Overall Study|Unknown at data cut-off|0|||
144393979|NCT05140382|520653606|FG002|Overall Study|Unknown at data cut-off|1|||
144393980|NCT05140382|520653604|FG000|Overall Study|Withdrawal by Subject|1|||
144393981|NCT05140382|520653605|FG001|Overall Study|Withdrawal by Subject|0|||
144393982|NCT05140382|520653606|FG002|Overall Study|Withdrawal by Subject|4|||
144393983|NCT05140382|520653604|FG000|Overall Study|Withdrawal of consent|0|||
144393984|NCT05140382|520653605|FG001|Overall Study|Withdrawal of consent|0|||
144393985|NCT05140382|520653606|FG002|Overall Study|Withdrawal of consent|1|||
144393986|NCT04629508|520655095|FG000|Overall Study|Adverse Event|1|||
144393987|NCT04629508|520655095|FG000|Overall Study|Death|2|||
144393988|NCT04629508|520655095|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
144393989|NCT01229397|520655100|FG000|Overall Study|Withdrawal by Subject|3|||
144393990|NCT01229397|520655101|FG001|Overall Study|Withdrawal by Subject|3|||
144393991|NCT01229397|520655100|FG000|Overall Study|Lost to Follow-up|7|||
144393992|NCT01229397|520655101|FG001|Overall Study|Lost to Follow-up|6|||
144393993|NCT01229397|520655100|FG000|Overall Study|Migrated/moved from study area|1|||
144393994|NCT01229397|520655101|FG001|Overall Study|Migrated/moved from study area|0|||
144393995|NCT00608543|520655102|FG000|Overall Study|Adverse Event|4|||
144393996|NCT04087213|520655107|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
144393997|NCT04087213|520655107|FG000|In-Facility Introduction|Adverse Event|1|||
144393998|NCT04087213|520655107|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
144393999|NCT04087213|520655107|FG000|Assisted Evaluable Period|Personal reasons|3|||
144394000|NCT04087213|520655107|FG000|Transition Period B|Renal Transplantation|1|||
144394001|NCT02545075|520655110|FG000|Randomization|Lost to Follow-up|0|||
144394002|NCT02545075|520655111|FG001|Randomization|Lost to Follow-up|1|||
144394003|NCT02545075|520655110|FG000|Randomization|Withdrawal by Subject|0|||
144394004|NCT02545075|520655111|FG001|Randomization|Withdrawal by Subject|6|||
144394005|NCT02545075|520655110|FG000|Treatment|Disease progression|71|||
144394006|NCT02545075|520655111|FG001|Treatment|Disease progression|32|||
144394007|NCT02545075|520655110|FG000|Treatment|Participant dicontinued study treatment|7|||
144394008|NCT02545075|520655111|FG001|Treatment|Participant dicontinued study treatment|9|||
144394009|NCT02545075|520655110|FG000|Treatment|Withdrawal by Subject|1|||
144394010|NCT02545075|520655111|FG001|Treatment|Withdrawal by Subject|0|||
144394011|NCT02545075|520655110|FG000|Treatment|Adverse event not related to study drug|1|||
144394012|NCT02545075|520655111|FG001|Treatment|Adverse event not related to study drug|0|||
144394013|NCT02545075|520655110|FG000|Treatment|Death|1|||
144394014|NCT02545075|520655111|FG001|Treatment|Death|0|||
144394015|NCT02545075|520655110|FG000|Treatment|Participant drug toxicity|1|||
144394016|NCT02545075|520655111|FG001|Treatment|Participant drug toxicity|0|||
144394017|NCT02545075|520655110|FG000|Treatment|Completed treatment|40|||
144394018|NCT02545075|520655111|FG001|Treatment|Completed treatment|12|||
144394019|NCT01068652|520655113|FG000|Overall Study|Adverse Event|4|||
144394020|NCT01068652|520655114|FG001|Overall Study|Adverse Event|0|||
144394021|NCT01068652|520655113|FG000|Overall Study|Lack of Efficacy|0|||
144394022|NCT01068652|520655114|FG001|Overall Study|Lack of Efficacy|2|||
144394023|NCT01068652|520655113|FG000|Overall Study|Lost to Follow-up|2|||
144394024|NCT01068652|520655114|FG001|Overall Study|Lost to Follow-up|1|||
144394025|NCT01068652|520655113|FG000|Overall Study|Protocol Violation|3|||
144394026|NCT01068652|520655114|FG001|Overall Study|Protocol Violation|6|||
144394027|NCT01068652|520655113|FG000|Overall Study|Withdrawal criteria|1|||
144394028|NCT01068652|520655114|FG001|Overall Study|Withdrawal criteria|2|||
144394029|NCT01068652|520655113|FG000|Overall Study|Patient was not eligible|1|||
144394030|NCT01068652|520655114|FG001|Overall Study|Patient was not eligible|0|||
144394031|NCT01068652|520655113|FG000|Overall Study|Unclassified|7|||
144394032|NCT01068652|520655114|FG001|Overall Study|Unclassified|4|||
144394033|NCT02147184|520655115|FG000|Overall Study|Lost to Follow-up|28|||
144394034|NCT02147184|520655116|FG001|Overall Study|Lost to Follow-up|15|||
144394035|NCT02147184|520655115|FG000|Overall Study|Study Burden|11|||
144394036|NCT02147184|520655116|FG001|Overall Study|Study Burden|7|||
144394037|NCT02147184|520655115|FG000|Overall Study|Pregnancy|6|||
144394038|NCT02147184|520655116|FG001|Overall Study|Pregnancy|0|||
144394039|NCT02147184|520655115|FG000|Overall Study|Moved out of state|3|||
144394040|NCT02147184|520655116|FG001|Overall Study|Moved out of state|3|||
144394041|NCT02147184|520655115|FG000|Overall Study|Physician Decision|0|||
144394042|NCT02147184|520655116|FG001|Overall Study|Physician Decision|2|||
144394043|NCT02147184|520655115|FG000|Overall Study|Other|1|||
144394044|NCT02147184|520655116|FG001|Overall Study|Other|0|||
144394045|NCT00417482|520655121|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
144394046|NCT00417482|520655122|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
144394047|NCT00417482|520655123|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
144394048|NCT00417482|520655121|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
144394049|NCT00417482|520655122|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
144394050|NCT00417482|520655123|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
144394051|NCT00417482|520655121|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
144394052|NCT00417482|520655122|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
144394053|NCT00417482|520655123|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
144394054|NCT00417482|520655121|FG000|Phase B 1st 16 Weeks|Death|1|||
144394055|NCT00417482|520655122|FG001|Phase B 1st 16 Weeks|Death|0|||
144394056|NCT00417482|520655123|FG002|Phase B 1st 16 Weeks|Death|0|||
144394057|NCT00417482|520655121|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
144394058|NCT00417482|520655122|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
144394059|NCT00417482|520655123|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
144394060|NCT00417482|520655121|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
144394061|NCT00417482|520655122|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
144394062|NCT00417482|520655123|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
144394063|NCT00417482|520655121|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
144394064|NCT00417482|520655122|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
144394065|NCT00417482|520655123|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
144394066|NCT00417482|520655121|FG000|Phase B 2nd 16 Weeks|Death|1|||
144394067|NCT00417482|520655122|FG001|Phase B 2nd 16 Weeks|Death|1|||
144394068|NCT00417482|520655123|FG002|Phase B 2nd 16 Weeks|Death|0|||
144394069|NCT06400979|520655124|FG000|Overall Study|Lost to Follow-up|29|||
144394070|NCT06400979|520655124|FG000|Overall Study|Withdrawal by Subject|1|||
144394071|NCT00117286|520655125|FG000|Overall Study|Adverse Event|12|||
144394072|NCT00117286|520655126|FG001|Overall Study|Adverse Event|6|||
144394073|NCT00117286|520655125|FG000|Overall Study|Lost to Follow-up|2|||
144394074|NCT00117286|520655126|FG001|Overall Study|Lost to Follow-up|0|||
144394075|NCT00117286|520655125|FG000|Overall Study|Protocol Violation|3|||
144394076|NCT00117286|520655126|FG001|Overall Study|Protocol Violation|3|||
144394077|NCT00117286|520655125|FG000|Overall Study|Withdrawal by Subject|6|||
144394078|NCT00117286|520655126|FG001|Overall Study|Withdrawal by Subject|2|||
144394079|NCT00117286|520655125|FG000|Overall Study|Physician Decision|3|||
144394080|NCT00117286|520655126|FG001|Overall Study|Physician Decision|7|||
144394081|NCT00117286|520655125|FG000|Overall Study|Lack of Efficacy|2|||
144394082|NCT00117286|520655126|FG001|Overall Study|Lack of Efficacy|1|||
144394083|NCT00117286|520655125|FG000|Overall Study|Research site closing|0|||
144394084|NCT00117286|520655126|FG001|Overall Study|Research site closing|2|||
144394085|NCT01272661|520655127|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
144394086|NCT01272661|520655128|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
144394087|NCT01272661|520655129|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
144394088|NCT02314143|520655130|FG000|Overall Study|Adverse Event|0|||
144394089|NCT02314143|520655131|FG001|Overall Study|Adverse Event|6|||
144394090|NCT02314143|520655132|FG002|Overall Study|Adverse Event|4|||
144394091|NCT02314143|520655130|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
144394092|NCT02314143|520655131|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
144394093|NCT02314143|520655132|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
144394094|NCT02314143|520655130|FG000|Overall Study|Physician Decision|2|||
144518378|NCT03692676|521099056|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
144518379|NCT03692676|521099057|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
144518380|NCT03692676|521099054|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
144518381|NCT03692676|521099055|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
144518382|NCT03692676|521099056|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
144518383|NCT03692676|521099057|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
144518384|NCT03692676|521099054|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
144518385|NCT03692676|521099055|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
144518386|NCT03692676|521099056|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
144518387|NCT03692676|521099057|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
144518388|NCT03692676|521099054|FG000|Overall Study|Other|0|||
144518389|NCT03692676|521099055|FG001|Overall Study|Other|805|||
144518390|NCT03692676|521099056|FG002|Overall Study|Other|758|||
144518391|NCT03692676|521099057|FG003|Overall Study|Other|277|||
144518392|NCT03692676|521099054|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
144518393|NCT03692676|521099055|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
144518394|NCT03692676|521099056|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
144518395|NCT03692676|521099057|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
144518396|NCT04638998|521099058|FG000|Overall Study|Withdrawal by Subject|1|||
144518397|NCT04638998|521099059|FG001|Overall Study|Withdrawal by Subject|3|||
144518398|NCT01180634|521099060|FG000|Overall Study|Adverse Event|4|||
144518399|NCT01180634|521099061|FG001|Overall Study|Adverse Event|1|||
144518400|NCT01180634|521099060|FG000|Overall Study|Miscellaneous|2|||
144518401|NCT01180634|521099061|FG001|Overall Study|Miscellaneous|0|||
144518402|NCT01180634|521099060|FG000|Overall Study|Withdrawal by Subject|4|||
144518403|NCT01180634|521099061|FG001|Overall Study|Withdrawal by Subject|0|||
144394095|NCT02314143|520655131|FG001|Overall Study|Physician Decision|1|||
144394096|NCT02314143|520655132|FG002|Overall Study|Physician Decision|0|||
144394097|NCT02314143|520655130|FG000|Overall Study|Withdrawal by Subject|1|||
144394098|NCT02314143|520655131|FG001|Overall Study|Withdrawal by Subject|0|||
144594520|NCT00940108|521377891|FG002|Overall Study|Diagnosed with H1N1|0|||
144394099|NCT02314143|520655132|FG002|Overall Study|Withdrawal by Subject|1|||
144394100|NCT01982331|520655133|FG000|Received Vaccination 2|Adverse Event|1|||
144394101|NCT01982331|520655134|FG001|Received Vaccination 2|Adverse Event|2|||
144394102|NCT01982331|520655133|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
144394103|NCT01982331|520655134|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
144394104|NCT01982331|520655133|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
144394105|NCT01982331|520655134|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
144394106|NCT01528215|520655135|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
144394107|NCT01528215|520655136|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
144394108|NCT01528215|520655135|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
144394109|NCT01528215|520655136|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
144394110|NCT01528215|520655135|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
144394111|NCT01528215|520655136|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
144394112|NCT01528215|520655135|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
144394113|NCT01528215|520655136|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
144394114|NCT01610271|520655137|FG000|Overall Study|Surgery not complete|0|||
144394115|NCT01610271|520655138|FG001|Overall Study|Surgery not complete|1|||
144394116|NCT01610271|520655137|FG000|Overall Study|Prosthesis not implanted|2|||
144394117|NCT01610271|520655138|FG001|Overall Study|Prosthesis not implanted|3|||
144394118|NCT02961218|520655139|FG000|Overall Study|Lost to Follow-up|0|||
144394119|NCT02961218|520655140|FG001|Overall Study|Lost to Follow-up|2|||
144394120|NCT02961218|520655139|FG000|Overall Study|Physician Decision|0|||
144394121|NCT02961218|520655140|FG001|Overall Study|Physician Decision|2|||
144394122|NCT02961218|520655139|FG000|Overall Study|Subject/Guardian Decision|3|||
144394123|NCT02961218|520655140|FG001|Overall Study|Subject/Guardian Decision|1|||
144394124|NCT01462227|520655141|FG000|Second Assignment|Lost to Follow-up|1|||
144394125|NCT01462227|520655142|FG001|Second Assignment|Lost to Follow-up|0|||
144394126|NCT01462227|520655143|FG002|Second Assignment|Lost to Follow-up|0|||
144394127|NCT01462227|520655144|FG003|Second Assignment|Lost to Follow-up|0|||
144394128|NCT01462227|520655141|FG000|Second Assignment|Protocol Violation|0|||
144394129|NCT01462227|520655142|FG001|Second Assignment|Protocol Violation|1|||
144394130|NCT01462227|520655143|FG002|Second Assignment|Protocol Violation|1|||
144394131|NCT01462227|520655144|FG003|Second Assignment|Protocol Violation|0|||
144394132|NCT00591266|520655145|FG000|Overall Study|Adverse Event|2|||
144394133|NCT00591266|520655146|FG001|Overall Study|Adverse Event|2|||
144394134|NCT00591266|520655147|FG002|Overall Study|Adverse Event|3|||
144394135|NCT00591266|520655145|FG000|Overall Study|Lost to Follow-up|0|||
144394136|NCT00591266|520655146|FG001|Overall Study|Lost to Follow-up|1|||
144394137|NCT00591266|520655147|FG002|Overall Study|Lost to Follow-up|0|||
144394138|NCT00591266|520655145|FG000|Overall Study|Protocol Violation|0|||
144394139|NCT00591266|520655146|FG001|Overall Study|Protocol Violation|0|||
144394140|NCT00591266|520655147|FG002|Overall Study|Protocol Violation|1|||
144394141|NCT00591266|520655145|FG000|Overall Study|Withdrawal by Subject|6|||
144394142|NCT00591266|520655146|FG001|Overall Study|Withdrawal by Subject|2|||
144394143|NCT00591266|520655147|FG002|Overall Study|Withdrawal by Subject|5|||
144394144|NCT00591266|520655145|FG000|Overall Study|Lack of Efficacy|0|||
144394145|NCT00591266|520655146|FG001|Overall Study|Lack of Efficacy|2|||
144394146|NCT00591266|520655147|FG002|Overall Study|Lack of Efficacy|0|||
144394147|NCT00591266|520655145|FG000|Overall Study|Other|1|||
144394148|NCT00591266|520655146|FG001|Overall Study|Other|4|||
144394149|NCT00591266|520655147|FG002|Overall Study|Other|5|||
144394150|NCT01178073|520655150|FG000|Overall Study|Adverse Event|34|||
144394151|NCT01178073|520655151|FG001|Overall Study|Adverse Event|27|||
144394152|NCT01178073|520655152|FG002|Overall Study|Adverse Event|24|||
144394153|NCT01178073|520655150|FG000|Overall Study|Protocol Violation|1|||
144394154|NCT01178073|520655151|FG001|Overall Study|Protocol Violation|1|||
144394155|NCT01178073|520655152|FG002|Overall Study|Protocol Violation|1|||
144394156|NCT01178073|520655150|FG000|Overall Study|Lost to Follow-up|2|||
144394157|NCT01178073|520655151|FG001|Overall Study|Lost to Follow-up|0|||
144394158|NCT01178073|520655152|FG002|Overall Study|Lost to Follow-up|3|||
144394159|NCT01178073|520655150|FG000|Overall Study|Physician Decision|14|||
144394160|NCT01178073|520655151|FG001|Overall Study|Physician Decision|10|||
144394161|NCT01178073|520655152|FG002|Overall Study|Physician Decision|10|||
144394162|NCT01178073|520655150|FG000|Overall Study|Withdrawal by Subject|10|||
144394163|NCT01178073|520655151|FG001|Overall Study|Withdrawal by Subject|6|||
144394164|NCT01178073|520655152|FG002|Overall Study|Withdrawal by Subject|8|||
144394165|NCT01178073|520655150|FG000|Overall Study|Missing Completion Status|1|||
144518404|NCT03692611|521099062|FG000|Overall Study|Found to be ineligible postrandomization|3|||
144518405|NCT03692611|521099063|FG001|Overall Study|Found to be ineligible postrandomization|0|||
144394166|NCT01178073|520655151|FG001|Overall Study|Missing Completion Status|0|||
144394167|NCT01178073|520655152|FG002|Overall Study|Missing Completion Status|0|||
144394168|NCT01226043|520655158|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
144518406|NCT04419168|521099064|FG000|Overall Study|Protocol Violation|1|||
144518407|NCT04419168|521099065|FG001|Overall Study|Protocol Violation|1|||
144518408|NCT04419168|521099064|FG000|Overall Study|Lost to Follow-up|7|||
144518409|NCT04419168|521099065|FG001|Overall Study|Lost to Follow-up|7|||
144518410|NCT04419168|521099064|FG000|Overall Study|Missed 6-month Visit|48|||
144518411|NCT04419168|521099065|FG001|Overall Study|Missed 6-month Visit|45|||
144518412|NCT03988634|521099070|FG000|Double-Blind|Adverse Event|4|||
144518413|NCT03988634|521099071|FG001|Double-Blind|Adverse Event|0|||
144518414|NCT03988634|521099072|FG002|Double-Blind|Adverse Event|0|||
144518415|NCT03988634|521099070|FG000|Double-Blind|Death|18|||
144518416|NCT03988634|521099071|FG001|Double-Blind|Death|26|||
144518417|NCT03988634|521099072|FG002|Double-Blind|Death|0|||
144518418|NCT03988634|521099070|FG000|Double-Blind|Lost to Follow-up|6|||
144518419|NCT03988634|521099071|FG001|Double-Blind|Lost to Follow-up|7|||
144518420|NCT03988634|521099072|FG002|Double-Blind|Lost to Follow-up|0|||
144518421|NCT03988634|521099070|FG000|Double-Blind|Physician Decision|9|||
144518422|NCT03988634|521099071|FG001|Double-Blind|Physician Decision|5|||
144518423|NCT03988634|521099072|FG002|Double-Blind|Physician Decision|0|||
144518424|NCT03988634|521099070|FG000|Double-Blind|Subject decision|24|||
144518425|NCT03988634|521099071|FG001|Double-Blind|Subject decision|13|||
144518426|NCT03988634|521099072|FG002|Double-Blind|Subject decision|0|||
144518427|NCT03988634|521099070|FG000|Open-Label|Adverse Event|0|||
144518428|NCT03988634|521099071|FG001|Open-Label|Adverse Event|0|||
144518429|NCT03988634|521099072|FG002|Open-Label|Adverse Event|7|||
144518430|NCT03988634|521099070|FG000|Open-Label|Physician Decision|0|||
144518431|NCT03988634|521099071|FG001|Open-Label|Physician Decision|0|||
144518432|NCT03988634|521099072|FG002|Open-Label|Physician Decision|1|||
144518433|NCT03988634|521099070|FG000|Open-Label|Technical problems|0|||
144518434|NCT03988634|521099071|FG001|Open-Label|Technical problems|0|||
144518435|NCT03988634|521099072|FG002|Open-Label|Technical problems|1|||
144518436|NCT04725240|521099073|FG000|Overall Study|Adverse Event|2|||
144518437|NCT05406921|521099079|FG000|Overall Study|Withdrawal by Subject|25|||
144518438|NCT05406921|521099080|FG001|Overall Study|Withdrawal by Subject|0|||
144518439|NCT05406921|521099081|FG002|Overall Study|Withdrawal by Subject|25|||
144518440|NCT05406921|521099079|FG000|Overall Study|Protocol Violation|0|||
144518441|NCT05406921|521099080|FG001|Overall Study|Protocol Violation|12|||
144518442|NCT05406921|521099081|FG002|Overall Study|Protocol Violation|0|||
144394169|NCT01226043|520655159|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
144394170|NCT01226043|520655160|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
144394171|NCT01226043|520655161|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
144394172|NCT01226043|520655158|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
144394173|NCT01226043|520655159|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
144394174|NCT01226043|520655160|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
144394175|NCT01226043|520655161|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
144394176|NCT01226043|520655158|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
144394177|NCT01226043|520655159|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
144394178|NCT01226043|520655160|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
144394179|NCT01226043|520655161|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
144394180|NCT01226043|520655158|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
144394181|NCT01226043|520655159|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
144518443|NCT03393975|521099089|FG000|Urgent Treatment Period|Physician Decision|0|||
144518444|NCT03393975|521099090|FG001|Urgent Treatment Period|Physician Decision|0|||
144518445|NCT03393975|521099091|FG002|Urgent Treatment Period|Physician Decision|0|||
144518446|NCT03393975|521099092|FG003|Urgent Treatment Period|Physician Decision|1|||
144518447|NCT03393975|521099089|FG000|Prophylaxis Period 1|Reason not Specified|0|||
144394182|NCT01226043|520655160|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
144394183|NCT01226043|520655161|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
144394184|NCT01226043|520655158|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
144394185|NCT01226043|520655159|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
144394186|NCT01226043|520655160|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
144394187|NCT01226043|520655161|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
144394188|NCT01226043|520655158|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
144394189|NCT01226043|520655159|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
144394190|NCT01226043|520655160|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
144394191|NCT01226043|520655161|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
144394192|NCT01226043|520655158|FG000|6-week Re-randomization Phase|Adverse Event|0|||
144394193|NCT01226043|520655159|FG001|6-week Re-randomization Phase|Adverse Event|0|||
144394194|NCT01226043|520655160|FG002|6-week Re-randomization Phase|Adverse Event|1|||
144394195|NCT01226043|520655161|FG003|6-week Re-randomization Phase|Adverse Event|1|||
144394196|NCT01226043|520655158|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
144518448|NCT03393975|521099090|FG001|Prophylaxis Period 1|Reason not Specified|1|||
144518449|NCT03393975|521099091|FG002|Prophylaxis Period 1|Reason not Specified|0|||
144518450|NCT03393975|521099092|FG003|Prophylaxis Period 1|Reason not Specified|0|||
144518451|NCT03393975|521099089|FG000|Prophylaxis Period 2|Reason not Specified|0|||
144518452|NCT03393975|521099090|FG001|Prophylaxis Period 2|Reason not Specified|1|||
144518453|NCT03393975|521099091|FG002|Prophylaxis Period 2|Reason not Specified|0|||
144518454|NCT03393975|521099092|FG003|Prophylaxis Period 2|Reason not Specified|0|||
144518455|NCT02312960|521099094|FG000|Overall Study|Death|24|||
144518456|NCT02312960|521099095|FG001|Overall Study|Death|32|||
144518457|NCT02312960|521099096|FG002|Overall Study|Death|25|||
144518458|NCT02312960|521099097|FG003|Overall Study|Death|11|||
144518459|NCT02312960|521099098|FG004|Overall Study|Death|5|||
144518460|NCT02312960|521099099|FG005|Overall Study|Death|5|||
144518461|NCT02312960|521099100|FG006|Overall Study|Death|8|||
144518462|NCT02312960|521099101|FG007|Overall Study|Death|5|||
144518463|NCT02312960|521099102|FG008|Overall Study|Death|7|||
144518464|NCT02312960|521099103|FG009|Overall Study|Death|3|||
144518465|NCT02312960|521099104|FG010|Overall Study|Death|3|||
144518466|NCT02312960|521099105|FG011|Overall Study|Death|1|||
144518467|NCT02312960|521099106|FG012|Overall Study|Death|25|||
144518468|NCT02312960|521099107|FG013|Overall Study|Death|19|||
144518469|NCT02312960|521099094|FG000|Overall Study|Missing|0|||
144518470|NCT02312960|521099095|FG001|Overall Study|Missing|0|||
144518471|NCT02312960|521099096|FG002|Overall Study|Missing|2|||
144518472|NCT02312960|521099097|FG003|Overall Study|Missing|0|||
144518473|NCT02312960|521099098|FG004|Overall Study|Missing|0|||
144518474|NCT02312960|521099099|FG005|Overall Study|Missing|0|||
144518475|NCT02312960|521099100|FG006|Overall Study|Missing|0|||
144518476|NCT02312960|521099101|FG007|Overall Study|Missing|0|||
144518477|NCT02312960|521099102|FG008|Overall Study|Missing|0|||
144518478|NCT02312960|521099103|FG009|Overall Study|Missing|0|||
144394197|NCT01226043|520655159|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
144394198|NCT01226043|520655160|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
144394199|NCT01226043|520655161|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
144394200|NCT01226043|520655158|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
144394201|NCT01226043|520655159|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
144394202|NCT01226043|520655160|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
144394203|NCT01226043|520655161|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
144394204|NCT01226043|520655158|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
144394205|NCT01226043|520655159|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
144394206|NCT01226043|520655160|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
144394207|NCT01226043|520655161|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
144394208|NCT01226043|520655158|FG000|6-week Re-randomization Phase|Physician Decision|0|||
144394209|NCT01226043|520655159|FG001|6-week Re-randomization Phase|Physician Decision|0|||
144394210|NCT01226043|520655160|FG002|6-week Re-randomization Phase|Physician Decision|3|||
144394211|NCT01226043|520655161|FG003|6-week Re-randomization Phase|Physician Decision|2|||
144394212|NCT01226043|520655158|FG000|6-week Re-randomization Phase|completed in error|0|||
144394213|NCT01226043|520655159|FG001|6-week Re-randomization Phase|completed in error|0|||
144394214|NCT01226043|520655160|FG002|6-week Re-randomization Phase|completed in error|0|||
144394215|NCT01226043|520655161|FG003|6-week Re-randomization Phase|completed in error|1|||
144394216|NCT01226043|520655158|FG000|30-week Observational Phase|Adverse Event|0|||
144394217|NCT01226043|520655159|FG001|30-week Observational Phase|Adverse Event|0|||
144394218|NCT01226043|520655160|FG002|30-week Observational Phase|Adverse Event|1|||
144394219|NCT01226043|520655161|FG003|30-week Observational Phase|Adverse Event|1|||
144394220|NCT01226043|520655158|FG000|30-week Observational Phase|Protocol Violation|0|||
144518479|NCT02312960|521099104|FG010|Overall Study|Missing|0|||
144518480|NCT02312960|521099105|FG011|Overall Study|Missing|0|||
144518481|NCT02312960|521099106|FG012|Overall Study|Missing|0|||
144518482|NCT02312960|521099107|FG013|Overall Study|Missing|0|||
144518483|NCT02312960|521099094|FG000|Overall Study|Lost to Follow-up|0|||
144518484|NCT02312960|521099095|FG001|Overall Study|Lost to Follow-up|0|||
144518485|NCT02312960|521099096|FG002|Overall Study|Lost to Follow-up|1|||
144518486|NCT02312960|521099097|FG003|Overall Study|Lost to Follow-up|0|||
144518487|NCT02312960|521099098|FG004|Overall Study|Lost to Follow-up|0|||
144518488|NCT02312960|521099099|FG005|Overall Study|Lost to Follow-up|0|||
144518489|NCT02312960|521099100|FG006|Overall Study|Lost to Follow-up|1|||
144518490|NCT02312960|521099101|FG007|Overall Study|Lost to Follow-up|1|||
144518491|NCT02312960|521099102|FG008|Overall Study|Lost to Follow-up|0|||
144394221|NCT01226043|520655159|FG001|30-week Observational Phase|Protocol Violation|0|||
144394222|NCT01226043|520655160|FG002|30-week Observational Phase|Protocol Violation|0|||
144394223|NCT01226043|520655161|FG003|30-week Observational Phase|Protocol Violation|1|||
144394224|NCT01226043|520655158|FG000|30-week Observational Phase|Lost to Follow-up|0|||
144394225|NCT01226043|520655159|FG001|30-week Observational Phase|Lost to Follow-up|0|||
144394226|NCT01226043|520655160|FG002|30-week Observational Phase|Lost to Follow-up|2|||
144394227|NCT01226043|520655161|FG003|30-week Observational Phase|Lost to Follow-up|2|||
144394228|NCT01226043|520655158|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
144394229|NCT01226043|520655159|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
144394230|NCT01226043|520655160|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
144394231|NCT01226043|520655161|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
144394232|NCT01226043|520655158|FG000|30-week Observational Phase|Physician Decision|0|||
144394233|NCT01226043|520655159|FG001|30-week Observational Phase|Physician Decision|0|||
144394234|NCT01226043|520655160|FG002|30-week Observational Phase|Physician Decision|2|||
144394235|NCT01226043|520655161|FG003|30-week Observational Phase|Physician Decision|2|||
144394236|NCT00910988|520655162|FG000|Overall Study|Lost to Follow-up|2|||
144394237|NCT00910988|520655163|FG001|Overall Study|Lost to Follow-up|4|||
144394238|NCT00910988|520655164|FG002|Overall Study|Lost to Follow-up|3|||
144394239|NCT00910988|520655165|FG003|Overall Study|Lost to Follow-up|0|||
144394240|NCT01977937|520655168|FG000|Overall Study|Withdrawal by Subject|2|||
144394241|NCT01977937|520655169|FG001|Overall Study|Withdrawal by Subject|1|||
144394242|NCT01977937|520655168|FG000|Overall Study|Adverse Event|1|||
144394243|NCT01977937|520655169|FG001|Overall Study|Adverse Event|0|||
144394244|NCT01977937|520655168|FG000|Overall Study|Physician Decision|0|||
144394245|NCT01977937|520655169|FG001|Overall Study|Physician Decision|1|||
144394246|NCT03004443|520655173|FG000|Overall Study|Pregnancy|0|||
144394247|NCT03004443|520655174|FG001|Overall Study|Pregnancy|1|||
144394248|NCT00828854|520655175|FG000|Overall Study|Disease Progression|17|||
144394249|NCT00828854|520655175|FG000|Overall Study|Adverse Event|9|||
144394250|NCT00828854|520655175|FG000|Overall Study|Reason not Specified|1|||
144394251|NCT00915356|520655176|FG000|Overall Study|Withdrawal by Subject|1|||
144394252|NCT00915356|520655177|FG001|Overall Study|Withdrawal by Subject|0|||
144394253|NCT00915356|520655178|FG002|Overall Study|Withdrawal by Subject|0|||
144394254|NCT00915356|520655179|FG003|Overall Study|Withdrawal by Subject|0|||
144394255|NCT00915356|520655180|FG004|Overall Study|Withdrawal by Subject|0|||
144394256|NCT05211284|520655186|FG000|Overall Study|Study Terminated|3|||
144394257|NCT05211284|520655187|FG001|Overall Study|Study Terminated|1|||
144518492|NCT02312960|521099103|FG009|Overall Study|Lost to Follow-up|1|||
144394258|NCT03911843|520655193|FG000|Overall Study|Adverse Event|2|||
144394259|NCT03911843|520655194|FG001|Overall Study|Adverse Event|0|||
144394260|NCT03911843|520655193|FG000|Overall Study|Protocol Violation|2|||
144394261|NCT03911843|520655194|FG001|Overall Study|Protocol Violation|0|||
144394262|NCT03911843|520655193|FG000|Overall Study|Lost to Follow-up|0|||
144394263|NCT03911843|520655194|FG001|Overall Study|Lost to Follow-up|1|||
144394264|NCT02819518|520655195|FG000|Overall Study|Death|9|||
144394265|NCT02819518|520655196|FG001|Overall Study|Death|12|||
144394266|NCT02819518|520655197|FG002|Overall Study|Death|9|||
144394267|NCT02819518|520655198|FG003|Overall Study|Death|475|||
144394268|NCT02819518|520655199|FG004|Overall Study|Death|244|||
144394269|NCT02819518|520655195|FG000|Overall Study|Withdrawal by Subject|0|||
144394270|NCT02819518|520655196|FG001|Overall Study|Withdrawal by Subject|0|||
144394271|NCT02819518|520655197|FG002|Overall Study|Withdrawal by Subject|0|||
144394272|NCT02819518|520655198|FG003|Overall Study|Withdrawal by Subject|25|||
144394273|NCT02819518|520655199|FG004|Overall Study|Withdrawal by Subject|8|||
144394274|NCT02819518|520655195|FG000|Overall Study|Lost to Follow-up|0|||
144394275|NCT02819518|520655196|FG001|Overall Study|Lost to Follow-up|0|||
144394276|NCT02819518|520655197|FG002|Overall Study|Lost to Follow-up|0|||
144394277|NCT02819518|520655198|FG003|Overall Study|Lost to Follow-up|0|||
144394278|NCT02819518|520655199|FG004|Overall Study|Lost to Follow-up|1|||
144394279|NCT02819518|520655195|FG000|Overall Study|Sponsor Decision|1|||
144394280|NCT02819518|520655196|FG001|Overall Study|Sponsor Decision|1|||
144394281|NCT02819518|520655197|FG002|Overall Study|Sponsor Decision|0|||
144394282|NCT02819518|520655198|FG003|Overall Study|Sponsor Decision|34|||
144394283|NCT02819518|520655199|FG004|Overall Study|Sponsor Decision|17|||
144394284|NCT02819518|520655195|FG000|Overall Study|Transferred to extension study|1|||
144394285|NCT02819518|520655196|FG001|Overall Study|Transferred to extension study|1|||
144394286|NCT02819518|520655197|FG002|Overall Study|Transferred to extension study|1|||
144394287|NCT02819518|520655198|FG003|Overall Study|Transferred to extension study|32|||
144394288|NCT02819518|520655199|FG004|Overall Study|Transferred to extension study|11|||
144394289|NCT00880165|520655200|FG000|Overall Study|Withdrawal by Subject|27|||
144394290|NCT00880165|520655201|FG001|Overall Study|Withdrawal by Subject|23|||
144394291|NCT00880165|520655200|FG000|Overall Study|Not diagnosed with OSA|14|||
144394292|NCT00880165|520655201|FG001|Overall Study|Not diagnosed with OSA|8|||
144394293|NCT00880165|520655200|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
144394294|NCT00880165|520655201|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
144394295|NCT00880165|520655200|FG000|Overall Study|Lost to follow|9|||
144394296|NCT00880165|520655201|FG001|Overall Study|Lost to follow|15|||
144394297|NCT01505647|520655202|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
144394298|NCT01505647|520655203|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
144394299|NCT01505647|520655202|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
144394300|NCT01505647|520655203|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
144394301|NCT01505647|520655202|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
144394302|NCT01505647|520655203|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
144394303|NCT01505647|520655202|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
144394304|NCT01505647|520655203|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
144394305|NCT01505647|520655202|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
144394306|NCT01505647|520655203|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
144394307|NCT01907100|520655204|FG000|Overall Study|PD based on modified RECIST criteria|31|||
144394308|NCT01907100|520655205|FG001|Overall Study|PD based on modified RECIST criteria|32|||
144394309|NCT01907100|520655206|FG002|Overall Study|PD based on modified RECIST criteria|95|||
144394310|NCT01907100|520655207|FG003|Overall Study|PD based on modified RECIST criteria|92|||
144394311|NCT01907100|520655204|FG000|Overall Study|Withdrawal by Subject|2|||
144394312|NCT01907100|520655205|FG001|Overall Study|Withdrawal by Subject|5|||
144394313|NCT01907100|520655206|FG002|Overall Study|Withdrawal by Subject|10|||
144394314|NCT01907100|520655207|FG003|Overall Study|Withdrawal by Subject|13|||
144394315|NCT01907100|520655204|FG000|Overall Study|Protocol Violation|0|||
144394316|NCT01907100|520655205|FG001|Overall Study|Protocol Violation|0|||
144394317|NCT01907100|520655206|FG002|Overall Study|Protocol Violation|1|||
144394318|NCT01907100|520655207|FG003|Overall Study|Protocol Violation|1|||
144394319|NCT01907100|520655204|FG000|Overall Study|Lost to Follow-up|0|||
144394320|NCT01907100|520655205|FG001|Overall Study|Lost to Follow-up|0|||
144394321|NCT01907100|520655206|FG002|Overall Study|Lost to Follow-up|0|||
144394322|NCT01907100|520655207|FG003|Overall Study|Lost to Follow-up|1|||
144394323|NCT01907100|520655204|FG000|Overall Study|Not treated|2|||
144394324|NCT01907100|520655205|FG001|Overall Study|Not treated|0|||
144394325|NCT01907100|520655206|FG002|Overall Study|Not treated|1|||
144394326|NCT01907100|520655207|FG003|Overall Study|Not treated|2|||
144394327|NCT01907100|520655204|FG000|Overall Study|Other than reasons specified|1|||
144394328|NCT01907100|520655205|FG001|Overall Study|Other than reasons specified|0|||
144394329|NCT01907100|520655206|FG002|Overall Study|Other than reasons specified|10|||
144394330|NCT01907100|520655207|FG003|Overall Study|Other than reasons specified|6|||
144394331|NCT01907100|520655204|FG000|Overall Study|Adverse event (AE)|6|||
144394332|NCT01907100|520655205|FG001|Overall Study|Adverse event (AE)|3|||
144394333|NCT01907100|520655206|FG002|Overall Study|Adverse event (AE)|22|||
144394334|NCT01907100|520655207|FG003|Overall Study|Adverse event (AE)|23|||
144394335|NCT01907100|520655204|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
144394336|NCT01907100|520655205|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
144394337|NCT01907100|520655206|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
144394338|NCT01907100|520655207|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
144394339|NCT01758289|520655208|FG000|Overall Study|Premature Study Termination|44|||
144394340|NCT01758289|520655208|FG000|Overall Study|Adverse Event|9|||
144394341|NCT00667602|520655211|FG000|Overall Study|Withdrawal by Subject|4|||
144394342|NCT00667602|520655212|FG001|Overall Study|Withdrawal by Subject|9|||
144394343|NCT00667602|520655213|FG002|Overall Study|Withdrawal by Subject|10|||
144394344|NCT00667602|520655211|FG000|Overall Study|Lost to Follow-up|4|||
144394345|NCT00667602|520655212|FG001|Overall Study|Lost to Follow-up|5|||
144394346|NCT00667602|520655213|FG002|Overall Study|Lost to Follow-up|6|||
144394347|NCT00667602|520655211|FG000|Overall Study|Administrative reason|0|||
144394348|NCT00667602|520655212|FG001|Overall Study|Administrative reason|0|||
144394349|NCT00667602|520655213|FG002|Overall Study|Administrative reason|2|||
144394350|NCT00667602|520655211|FG000|Overall Study|Protocol Violation|0|||
144394351|NCT00667602|520655212|FG001|Overall Study|Protocol Violation|1|||
144394352|NCT00667602|520655213|FG002|Overall Study|Protocol Violation|0|||
144394353|NCT00395538|520655221|FG000|Overall Study|Did not re-consent to revised protocol|1|||
144394354|NCT00395538|520655222|FG001|Overall Study|Did not re-consent to revised protocol|10|||
144394355|NCT00395538|520655223|FG002|Overall Study|Did not re-consent to revised protocol|0|||
144394356|NCT00395538|520655221|FG000|Overall Study|FDA partial hold on PTH|0|||
144394357|NCT00395538|520655222|FG001|Overall Study|FDA partial hold on PTH|0|||
144394358|NCT00395538|520655223|FG002|Overall Study|FDA partial hold on PTH|11|||
144394359|NCT00395538|520655221|FG000|Overall Study|Failed screening|0|||
144394360|NCT00395538|520655222|FG001|Overall Study|Failed screening|0|||
144394361|NCT00395538|520655223|FG002|Overall Study|Failed screening|4|||
144394362|NCT00395538|520655221|FG000|Overall Study|Switch to Natpara|0|||
144394363|NCT00395538|520655222|FG001|Overall Study|Switch to Natpara|0|||
144394364|NCT00395538|520655223|FG002|Overall Study|Switch to Natpara|3|||
144394365|NCT00395538|520655221|FG000|Overall Study|Adverse Event|1|||
144394366|NCT00395538|520655222|FG001|Overall Study|Adverse Event|0|||
144394367|NCT00395538|520655223|FG002|Overall Study|Adverse Event|2|||
144394368|NCT00395538|520655221|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
144394369|NCT00395538|520655222|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
144394370|NCT00395538|520655223|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
144394371|NCT00395538|520655221|FG000|Overall Study|Non-compliance with study protocol|0|||
144394372|NCT00395538|520655222|FG001|Overall Study|Non-compliance with study protocol|1|||
144394373|NCT00395538|520655223|FG002|Overall Study|Non-compliance with study protocol|0|||
144394374|NCT00395538|520655221|FG000|Overall Study|PTH resistance|0|||
144394375|NCT00395538|520655222|FG001|Overall Study|PTH resistance|0|||
144394376|NCT00395538|520655223|FG002|Overall Study|PTH resistance|1|||
144518493|NCT02312960|521099104|FG010|Overall Study|Lost to Follow-up|0|||
144518494|NCT02312960|521099105|FG011|Overall Study|Lost to Follow-up|0|||
144518495|NCT02312960|521099106|FG012|Overall Study|Lost to Follow-up|1|||
144518496|NCT02312960|521099107|FG013|Overall Study|Lost to Follow-up|0|||
144518497|NCT02312960|521099094|FG000|Overall Study|Withdrawal by Subject|1|||
144518498|NCT02312960|521099095|FG001|Overall Study|Withdrawal by Subject|2|||
144394377|NCT00395538|520655221|FG000|Overall Study|Pregnancy|1|||
144394378|NCT00395538|520655222|FG001|Overall Study|Pregnancy|0|||
144394379|NCT00395538|520655223|FG002|Overall Study|Pregnancy|0|||
144394380|NCT00395538|520655221|FG000|Overall Study|Partial recovery of parathyroid function|0|||
144394381|NCT00395538|520655222|FG001|Overall Study|Partial recovery of parathyroid function|0|||
144518499|NCT02312960|521099096|FG002|Overall Study|Withdrawal by Subject|0|||
144518500|NCT02312960|521099097|FG003|Overall Study|Withdrawal by Subject|0|||
144518501|NCT02312960|521099098|FG004|Overall Study|Withdrawal by Subject|1|||
144394382|NCT00395538|520655223|FG002|Overall Study|Partial recovery of parathyroid function|1|||
144394383|NCT00395538|520655221|FG000|Overall Study|Participant elected to discontinue|0|||
144394384|NCT00395538|520655222|FG001|Overall Study|Participant elected to discontinue|0|||
144394385|NCT00395538|520655223|FG002|Overall Study|Participant elected to discontinue|1|||
144394386|NCT01857583|520655224|FG000|Overall Study|Adverse Event|0|||
144394387|NCT01857583|520655225|FG001|Overall Study|Adverse Event|0|||
144394388|NCT01857583|520655226|FG002|Overall Study|Adverse Event|1|||
144518502|NCT02312960|521099099|FG005|Overall Study|Withdrawal by Subject|0|||
144394389|NCT01857583|520655227|FG003|Overall Study|Adverse Event|1|||
144394390|NCT01857583|520655224|FG000|Overall Study|Death|0|||
144394391|NCT01857583|520655225|FG001|Overall Study|Death|1|||
144394392|NCT01857583|520655226|FG002|Overall Study|Death|1|||
144394393|NCT01857583|520655227|FG003|Overall Study|Death|0|||
144394394|NCT01857583|520655224|FG000|Overall Study|Physician Decision|0|||
144394395|NCT01857583|520655225|FG001|Overall Study|Physician Decision|0|||
144394396|NCT01857583|520655226|FG002|Overall Study|Physician Decision|0|||
144394397|NCT01857583|520655227|FG003|Overall Study|Physician Decision|1|||
144394398|NCT01857583|520655224|FG000|Overall Study|Withdrawal by Subject|1|||
144394399|NCT01857583|520655225|FG001|Overall Study|Withdrawal by Subject|0|||
144394400|NCT01857583|520655226|FG002|Overall Study|Withdrawal by Subject|1|||
144394401|NCT01857583|520655227|FG003|Overall Study|Withdrawal by Subject|2|||
144394402|NCT02211638|520655228|FG000|Overall Study|Case Report Forms Uncollected|291|||
144394403|NCT02211638|520655228|FG000|Overall Study|Protocol Violation|692|||
144394404|NCT02775903|520655233|FG000|Overall Study|Death|7|||
144518503|NCT02312960|521099100|FG006|Overall Study|Withdrawal by Subject|1|||
144518504|NCT02312960|521099101|FG007|Overall Study|Withdrawal by Subject|2|||
144518505|NCT02312960|521099102|FG008|Overall Study|Withdrawal by Subject|2|||
144518506|NCT02312960|521099103|FG009|Overall Study|Withdrawal by Subject|3|||
144518507|NCT02312960|521099104|FG010|Overall Study|Withdrawal by Subject|0|||
144518508|NCT02312960|521099105|FG011|Overall Study|Withdrawal by Subject|0|||
144518509|NCT02312960|521099106|FG012|Overall Study|Withdrawal by Subject|2|||
144518510|NCT02312960|521099107|FG013|Overall Study|Withdrawal by Subject|0|||
144518511|NCT04263311|521099108|FG000|Overall Study|Lost to Follow-up|1|||
144518512|NCT04263311|521099109|FG001|Overall Study|Lost to Follow-up|2|||
144518513|NCT04263311|521099110|FG002|Overall Study|Lost to Follow-up|0|||
144518514|NCT04263311|521099108|FG000|Overall Study|Health Issues|1|||
144518515|NCT04263311|521099109|FG001|Overall Study|Health Issues|0|||
144518516|NCT04263311|521099110|FG002|Overall Study|Health Issues|0|||
144518517|NCT04263311|521099108|FG000|Overall Study|Left the country|1|||
144518518|NCT04263311|521099109|FG001|Overall Study|Left the country|0|||
144518519|NCT04263311|521099110|FG002|Overall Study|Left the country|0|||
144518520|NCT04263311|521099108|FG000|Overall Study|Unable to maintain time commitment|1|||
144518521|NCT04263311|521099109|FG001|Overall Study|Unable to maintain time commitment|0|||
144518522|NCT04263311|521099110|FG002|Overall Study|Unable to maintain time commitment|0|||
144518523|NCT04263311|521099108|FG000|Overall Study|No longer interested|1|||
144518524|NCT04263311|521099109|FG001|Overall Study|No longer interested|0|||
144518525|NCT04263311|521099110|FG002|Overall Study|No longer interested|0|||
144518526|NCT04263311|521099108|FG000|Overall Study|Ineligible post consent|0|||
144518527|NCT04263311|521099109|FG001|Overall Study|Ineligible post consent|0|||
144518528|NCT04263311|521099110|FG002|Overall Study|Ineligible post consent|5|||
144518529|NCT03958955|521099111|FG000|Overall Study|Adverse Event|1|||
144518530|NCT04673929|521099112|FG000|Overall Study|Death|73|||
144518531|NCT04673929|521099112|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
144518532|NCT03315754|521099113|FG000|Overall Study|COVID-19 complications leading to death|1|||
144518533|NCT03315754|521099113|FG000|Overall Study|insurance coverage issue|1|||
144518534|NCT04024813|521099114|FG000|Overall Study|Study terminated by Sponsor|1|||
144518535|NCT05569252|521099117|FG000|Overall Study|Adverse event (central vision loss)|1|||
144518536|NCT05569252|521099118|FG001|Overall Study|Adverse event (central vision loss)|0|||
144518537|NCT05569252|521099119|FG002|Overall Study|Adverse event (central vision loss)|0|||
144518538|NCT05569252|521099120|FG003|Overall Study|Adverse event (central vision loss)|0|||
144518539|NCT03665597|521099121|FG000|Period 1|Adverse Event|1|||
144518540|NCT03665597|521099122|FG001|Period 1|Adverse Event|0|||
144518541|NCT03665597|521099123|FG002|Period 1|Adverse Event|0|||
144518542|NCT03665597|521099124|FG003|Period 1|Adverse Event|1|||
144394405|NCT02775903|520655234|FG001|Overall Study|Death|11|||
144394406|NCT02775903|520655235|FG002|Overall Study|Death|12|||
144394407|NCT02775903|520655236|FG003|Overall Study|Death|11|||
144394408|NCT02775903|520655233|FG000|Overall Study|Adverse Event|0|||
144394409|NCT02775903|520655234|FG001|Overall Study|Adverse Event|1|||
144394410|NCT02775903|520655235|FG002|Overall Study|Adverse Event|12|||
144394411|NCT02775903|520655236|FG003|Overall Study|Adverse Event|3|||
144394412|NCT02775903|520655233|FG000|Overall Study|Progressive disease|15|||
144394413|NCT02775903|520655234|FG001|Overall Study|Progressive disease|14|||
144394414|NCT02775903|520655235|FG002|Overall Study|Progressive disease|30|||
144394415|NCT02775903|520655236|FG003|Overall Study|Progressive disease|20|||
144394416|NCT02775903|520655233|FG000|Overall Study|Lack of Efficacy|2|||
144394417|NCT02775903|520655234|FG001|Overall Study|Lack of Efficacy|2|||
144394418|NCT02775903|520655235|FG002|Overall Study|Lack of Efficacy|2|||
144394419|NCT02775903|520655236|FG003|Overall Study|Lack of Efficacy|6|||
144394420|NCT02775903|520655233|FG000|Overall Study|Withdrawal by Subject|7|||
144394421|NCT02775903|520655234|FG001|Overall Study|Withdrawal by Subject|5|||
144394422|NCT02775903|520655235|FG002|Overall Study|Withdrawal by Subject|5|||
144394423|NCT02775903|520655236|FG003|Overall Study|Withdrawal by Subject|8|||
144394424|NCT02775903|520655233|FG000|Overall Study|Other reasons|7|||
144394425|NCT02775903|520655234|FG001|Overall Study|Other reasons|8|||
144394426|NCT02775903|520655235|FG002|Overall Study|Other reasons|2|||
144394427|NCT02775903|520655236|FG003|Overall Study|Other reasons|12|||
144394428|NCT04041700|520655237|FG000|Overall Study|Pregnancy|1|||
144394429|NCT04041700|520655237|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
144394430|NCT00458536|520655240|FG000|Overall Study|Disease progression prior to treatment|7|||
144394431|NCT00458536|520655240|FG000|Overall Study|Unable to make vaccine|3|||
144394432|NCT00458536|520655240|FG000|Overall Study|No measurable disease after surgery|2|||
144394433|NCT00458536|520655240|FG000|Overall Study|Did not have renal cell carcinoma|2|||
144394434|NCT00458536|520655240|FG000|Overall Study|Patient did not have surgery|1|||
144394435|NCT00458536|520655240|FG000|Overall Study|Ineligible due to toxicity|1|||
144394436|NCT00458536|520655240|FG000|Overall Study|Withdrawal by Subject|1|||
144394437|NCT00458536|520655240|FG000|Overall Study|Progressive disease during treatment|2|||
144394438|NCT00285207|520655241|FG000|Overall Study|Lost to Follow-up|3|||
144394439|NCT00285207|520655242|FG001|Overall Study|Lost to Follow-up|2|||
144394440|NCT00285207|520655241|FG000|Overall Study|Withdrawal by Subject|5|||
144394441|NCT00285207|520655242|FG001|Overall Study|Withdrawal by Subject|2|||
144394442|NCT00285207|520655241|FG000|Overall Study|Pregnancy|1|||
144394443|NCT00285207|520655242|FG001|Overall Study|Pregnancy|1|||
144394444|NCT00285207|520655241|FG000|Overall Study|non-compliance|0|||
144394445|NCT00285207|520655242|FG001|Overall Study|non-compliance|1|||
144394446|NCT04571515|520655243|FG000|Overall Study|Physician Decision|0|||
144394447|NCT04571515|520655244|FG001|Overall Study|Physician Decision|0|||
144394448|NCT04571515|520655245|FG002|Overall Study|Physician Decision|0|||
144394449|NCT04571515|520655246|FG003|Overall Study|Physician Decision|0|||
144394450|NCT04571515|520655247|FG004|Overall Study|Physician Decision|1|||
144394451|NCT04571515|520655243|FG000|Overall Study|Withdrawal by Subject|0|||
144394452|NCT04571515|520655244|FG001|Overall Study|Withdrawal by Subject|0|||
144394453|NCT04571515|520655245|FG002|Overall Study|Withdrawal by Subject|0|||
144394454|NCT04571515|520655246|FG003|Overall Study|Withdrawal by Subject|0|||
144394455|NCT04571515|520655247|FG004|Overall Study|Withdrawal by Subject|1|||
144394456|NCT04571515|520655243|FG000|Overall Study|insufficient pain|1|||
144394457|NCT04571515|520655244|FG001|Overall Study|insufficient pain|0|||
144394458|NCT04571515|520655245|FG002|Overall Study|insufficient pain|0|||
144394459|NCT04571515|520655246|FG003|Overall Study|insufficient pain|0|||
144394460|NCT04571515|520655247|FG004|Overall Study|insufficient pain|1|||
144394461|NCT01659658|520657114|FG000|Overall Study|Withdrawal by Patient|18|||
144518543|NCT03665597|521099125|FG004|Period 1|Adverse Event|0|||
144518544|NCT03665597|521099126|FG005|Period 1|Adverse Event|0|||
144518545|NCT03665597|521099127|FG006|Period 1|Adverse Event|0|||
144518546|NCT03665597|521099121|FG000|Period 1|Screen Failure|0|||
144518547|NCT03665597|521099122|FG001|Period 1|Screen Failure|0|||
144518548|NCT03665597|521099123|FG002|Period 1|Screen Failure|0|||
144518549|NCT03665597|521099124|FG003|Period 1|Screen Failure|1|||
144518550|NCT03665597|521099125|FG004|Period 1|Screen Failure|0|||
144518551|NCT03665597|521099126|FG005|Period 1|Screen Failure|0|||
144518552|NCT03665597|521099127|FG006|Period 1|Screen Failure|0|||
144394462|NCT01659658|520657115|FG001|Overall Study|Withdrawal by Patient|4|||
144394463|NCT01659658|520657116|FG002|Overall Study|Withdrawal by Patient|2|||
144394464|NCT01659658|520657117|FG003|Overall Study|Withdrawal by Patient|0|||
144394465|NCT01659658|520657118|FG004|Overall Study|Withdrawal by Patient|11|||
144394466|NCT01659658|520657114|FG000|Overall Study|Study Terminated by Sponsor|9|||
144394467|NCT01659658|520657115|FG001|Overall Study|Study Terminated by Sponsor|7|||
144394468|NCT01659658|520657116|FG002|Overall Study|Study Terminated by Sponsor|0|||
144518553|NCT03665597|521099121|FG000|Period 1|Death|0|||
144518554|NCT03665597|521099122|FG001|Period 1|Death|0|||
144394469|NCT01659658|520657117|FG003|Overall Study|Study Terminated by Sponsor|1|||
144394470|NCT01659658|520657118|FG004|Overall Study|Study Terminated by Sponsor|4|||
144518555|NCT03665597|521099123|FG002|Period 1|Death|0|||
144518556|NCT03665597|521099124|FG003|Period 1|Death|0|||
144394471|NCT01659658|520657114|FG000|Overall Study|Reason not Specified|61|||
144394472|NCT01659658|520657115|FG001|Overall Study|Reason not Specified|15|||
144394473|NCT01659658|520657116|FG002|Overall Study|Reason not Specified|8|||
144394474|NCT01659658|520657117|FG003|Overall Study|Reason not Specified|1|||
144394475|NCT01659658|520657118|FG004|Overall Study|Reason not Specified|34|||
144394476|NCT01659658|520657114|FG000|Overall Study|Lost to Follow-up|2|||
144394477|NCT01659658|520657115|FG001|Overall Study|Lost to Follow-up|0|||
144394478|NCT01659658|520657116|FG002|Overall Study|Lost to Follow-up|0|||
144394479|NCT01659658|520657117|FG003|Overall Study|Lost to Follow-up|0|||
144394480|NCT01659658|520657118|FG004|Overall Study|Lost to Follow-up|0|||
144394481|NCT01927341|520657120|FG000|Phase 1b|Lost to Follow-up|1|||
144394482|NCT01927341|520657121|FG001|Phase 1b|Lost to Follow-up|0|||
144394483|NCT01927341|520657122|FG002|Phase 1b|Lost to Follow-up|0|||
144394484|NCT01927341|520657123|FG003|Phase 1b|Lost to Follow-up|0|||
144394485|NCT01927341|520657124|FG004|Phase 1b|Lost to Follow-up|0|||
144394486|NCT01927341|520657120|FG000|Phase 1b|Death|2|||
144394487|NCT01927341|520657121|FG001|Phase 1b|Death|0|||
144594521|NCT00940108|521377892|FG003|Overall Study|Diagnosed with H1N1|1|||
144594522|NCT02434939|521377893|FG000|Overall Study|Lack of Efficacy|34|||
144594523|NCT02434939|521377894|FG001|Overall Study|Lack of Efficacy|48|||
144594524|NCT02434939|521377893|FG000|Overall Study|Withdrawal by Subject|3|||
144594525|NCT02434939|521377894|FG001|Overall Study|Withdrawal by Subject|0|||
144594526|NCT02434939|521377893|FG000|Overall Study|Adverse Event|0|||
144594527|NCT02434939|521377894|FG001|Overall Study|Adverse Event|1|||
144594528|NCT00051363|521377908|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
144594529|NCT00051363|521377909|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
144594530|NCT00051363|521377908|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
144594531|NCT00051363|521377909|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
144594532|NCT00051363|521377908|FG000|Overall Study|Death|2|||
144594533|NCT00051363|521377909|FG001|Overall Study|Death|2|||
144594534|NCT00051363|521377908|FG000|Overall Study|Excluded Pre-Randomization|2|||
144594535|NCT00051363|521377909|FG001|Overall Study|Excluded Pre-Randomization|5|||
144594536|NCT02640157|521377911|FG000|Overall Study|Adverse Event|2|||
144594537|NCT02640157|521377912|FG001|Overall Study|Adverse Event|2|||
144594538|NCT02640157|521377913|FG002|Overall Study|Adverse Event|1|||
144594539|NCT02640157|521377911|FG000|Overall Study|Withdrew consent|2|||
144594540|NCT02640157|521377912|FG001|Overall Study|Withdrew consent|0|||
144594541|NCT02640157|521377913|FG002|Overall Study|Withdrew consent|2|||
144594542|NCT02640157|521377911|FG000|Overall Study|Lost to Follow-up|9|||
144594543|NCT02640157|521377912|FG001|Overall Study|Lost to Follow-up|2|||
144594544|NCT02640157|521377913|FG002|Overall Study|Lost to Follow-up|7|||
144594545|NCT02640157|521377911|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
144594546|NCT02640157|521377912|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
144594547|NCT02640157|521377913|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
144594548|NCT01679405|521377915|FG000|Overall Study|Death|2|||
144594549|NCT01679405|521377916|FG001|Overall Study|Death|5|||
144594550|NCT04677179|521377917|FG000|Induction Treatment Period|Adverse Event|1|||
144594551|NCT04677179|521377918|FG001|Induction Treatment Period|Adverse Event|0|||
144594552|NCT04677179|521377919|FG002|Induction Treatment Period|Adverse Event|0|||
144594553|NCT04677179|521377920|FG003|Induction Treatment Period|Adverse Event|0|||
144594554|NCT04677179|521377921|FG004|Induction Treatment Period|Adverse Event|0|||
144594555|NCT04677179|521377922|FG005|Induction Treatment Period|Adverse Event|0|||
144594556|NCT04677179|521377923|FG006|Induction Treatment Period|Adverse Event|0|||
144594557|NCT04677179|521377924|FG007|Induction Treatment Period|Adverse Event|0|||
144594558|NCT04677179|521377925|FG008|Induction Treatment Period|Adverse Event|0|||
144594559|NCT04677179|521377926|FG009|Induction Treatment Period|Adverse Event|0|||
144594560|NCT04677179|521377917|FG000|Induction Treatment Period|Physician Decision|1|||
144594561|NCT04677179|521377918|FG001|Induction Treatment Period|Physician Decision|0|||
144594562|NCT04677179|521377919|FG002|Induction Treatment Period|Physician Decision|1|||
144594563|NCT04677179|521377920|FG003|Induction Treatment Period|Physician Decision|0|||
144594564|NCT04677179|521377921|FG004|Induction Treatment Period|Physician Decision|0|||
144594565|NCT04677179|521377922|FG005|Induction Treatment Period|Physician Decision|0|||
144594566|NCT04677179|521377923|FG006|Induction Treatment Period|Physician Decision|0|||
144594567|NCT04677179|521377924|FG007|Induction Treatment Period|Physician Decision|0|||
144594568|NCT04677179|521377925|FG008|Induction Treatment Period|Physician Decision|0|||
144594569|NCT04677179|521377926|FG009|Induction Treatment Period|Physician Decision|0|||
144394488|NCT01927341|520657122|FG002|Phase 1b|Death|0|||
144394489|NCT01927341|520657123|FG003|Phase 1b|Death|0|||
144394490|NCT01927341|520657124|FG004|Phase 1b|Death|0|||
144394491|NCT01927341|520657120|FG000|Phase 1b|Follow-up completed|7|||
144594570|NCT04677179|521377917|FG000|Induction Treatment Period|Protocol Violation|0|||
144394492|NCT01927341|520657121|FG001|Phase 1b|Follow-up completed|0|||
144394493|NCT01927341|520657122|FG002|Phase 1b|Follow-up completed|0|||
144394494|NCT01927341|520657123|FG003|Phase 1b|Follow-up completed|0|||
144394495|NCT01927341|520657124|FG004|Phase 1b|Follow-up completed|0|||
144394496|NCT01927341|520657120|FG000|Phase 2|Lost to Follow-up|0|||
144394497|NCT01927341|520657121|FG001|Phase 2|Lost to Follow-up|1|||
144394498|NCT01927341|520657122|FG002|Phase 2|Lost to Follow-up|0|||
144394499|NCT01927341|520657123|FG003|Phase 2|Lost to Follow-up|0|||
144394500|NCT01927341|520657124|FG004|Phase 2|Lost to Follow-up|0|||
144394501|NCT01927341|520657120|FG000|Phase 2|Participant withdrew consent|0|||
144394502|NCT01927341|520657121|FG001|Phase 2|Participant withdrew consent|2|||
144394503|NCT01927341|520657122|FG002|Phase 2|Participant withdrew consent|1|||
144394504|NCT01927341|520657123|FG003|Phase 2|Participant withdrew consent|2|||
144394505|NCT01927341|520657124|FG004|Phase 2|Participant withdrew consent|3|||
144394506|NCT01927341|520657120|FG000|Phase 2|Death|0|||
144394507|NCT01927341|520657121|FG001|Phase 2|Death|4|||
144394508|NCT01927341|520657122|FG002|Phase 2|Death|0|||
144394509|NCT01927341|520657123|FG003|Phase 2|Death|3|||
144394510|NCT01927341|520657124|FG004|Phase 2|Death|2|||
144394511|NCT01927341|520657120|FG000|Phase 2|New cancer therapy|0|||
144394512|NCT01927341|520657121|FG001|Phase 2|New cancer therapy|1|||
144394513|NCT01927341|520657122|FG002|Phase 2|New cancer therapy|0|||
144394514|NCT01927341|520657123|FG003|Phase 2|New cancer therapy|4|||
144394515|NCT01927341|520657124|FG004|Phase 2|New cancer therapy|1|||
144394516|NCT01927341|520657120|FG000|Phase 2|Disease progression|0|||
144394517|NCT01927341|520657121|FG001|Phase 2|Disease progression|1|||
144394518|NCT01927341|520657122|FG002|Phase 2|Disease progression|1|||
144394519|NCT01927341|520657123|FG003|Phase 2|Disease progression|1|||
144394520|NCT01927341|520657124|FG004|Phase 2|Disease progression|0|||
144394521|NCT01927341|520657120|FG000|Phase 2|Follow-up completed|0|||
144394522|NCT01927341|520657121|FG001|Phase 2|Follow-up completed|6|||
144394523|NCT01927341|520657122|FG002|Phase 2|Follow-up completed|3|||
144394524|NCT01927341|520657123|FG003|Phase 2|Follow-up completed|5|||
144394525|NCT01927341|520657124|FG004|Phase 2|Follow-up completed|2|||
144394526|NCT01397201|520657125|FG000|Overall Study|Not treated|0|||
144394527|NCT01397201|520657126|FG001|Overall Study|Not treated|0|||
144394528|NCT01397201|520657127|FG002|Overall Study|Not treated|1|||
144394529|NCT01397201|520657128|FG003|Overall Study|Not treated|0|||
144394530|NCT01397201|520657129|FG004|Overall Study|Not treated|0|||
144394531|NCT01397201|520657125|FG000|Overall Study|Not yet defined|3|||
144394532|NCT01397201|520657126|FG001|Overall Study|Not yet defined|6|||
144394533|NCT01397201|520657127|FG002|Overall Study|Not yet defined|5|||
144394534|NCT01397201|520657128|FG003|Overall Study|Not yet defined|5|||
144394535|NCT01397201|520657129|FG004|Overall Study|Not yet defined|4|||
144394536|NCT01397201|520657125|FG000|Overall Study|Adverse Event|2|||
144394537|NCT01397201|520657126|FG001|Overall Study|Adverse Event|0|||
144394538|NCT01397201|520657127|FG002|Overall Study|Adverse Event|0|||
144394539|NCT01397201|520657128|FG003|Overall Study|Adverse Event|0|||
144394540|NCT01397201|520657129|FG004|Overall Study|Adverse Event|0|||
144394541|NCT00084838|520657130|FG000|Overall Study|Death|1|||
144394542|NCT00084838|520657130|FG000|Overall Study|Adverse Event|2|||
144394543|NCT00084838|520657130|FG000|Overall Study|Withdrawal by Subject|1|||
144394544|NCT00084838|520657130|FG000|Overall Study|Progressive Disease|4|||
144518557|NCT03665597|521099125|FG004|Period 1|Death|0|||
144518558|NCT03665597|521099126|FG005|Period 1|Death|0|||
144518559|NCT03665597|521099127|FG006|Period 1|Death|45|||
144518560|NCT03665597|521099121|FG000|Period 1|Withdrawal by Subject|0|||
144518561|NCT03665597|521099122|FG001|Period 1|Withdrawal by Subject|0|||
144518562|NCT03665597|521099123|FG002|Period 1|Withdrawal by Subject|0|||
144518563|NCT03665597|521099124|FG003|Period 1|Withdrawal by Subject|0|||
144518564|NCT03665597|521099125|FG004|Period 1|Withdrawal by Subject|0|||
144518565|NCT03665597|521099126|FG005|Period 1|Withdrawal by Subject|0|||
144518566|NCT03665597|521099127|FG006|Period 1|Withdrawal by Subject|5|||
144518567|NCT03665597|521099121|FG000|Period 2|Adverse Event|0|||
144518568|NCT03665597|521099122|FG001|Period 2|Adverse Event|0|||
144518569|NCT03665597|521099123|FG002|Period 2|Adverse Event|0|||
144518570|NCT03665597|521099124|FG003|Period 2|Adverse Event|0|||
144518571|NCT03665597|521099125|FG004|Period 2|Adverse Event|0|||
144518572|NCT03665597|521099126|FG005|Period 2|Adverse Event|1|||
144518573|NCT03665597|521099127|FG006|Period 2|Adverse Event|0|||
144394545|NCT00084838|520657130|FG000|Overall Study|Pt Non-Compliance|1|||
144394546|NCT00084838|520657130|FG000|Overall Study|Ineligible|4|||
144394547|NCT01298531|520657131|FG000|Overall Study|Lack of Efficacy|0|||
144394548|NCT01298531|520657132|FG001|Overall Study|Lack of Efficacy|1|||
144394549|NCT01298531|520657131|FG000|Overall Study|Lost to Follow-up|2|||
144394550|NCT01298531|520657132|FG001|Overall Study|Lost to Follow-up|0|||
144394551|NCT01298531|520657131|FG000|Overall Study|Protocol Violation|1|||
144518574|NCT03665597|521099121|FG000|Period 3|Adverse Event|0|||
144518575|NCT03665597|521099122|FG001|Period 3|Adverse Event|1|||
144518576|NCT03665597|521099123|FG002|Period 3|Adverse Event|0|||
144394552|NCT01298531|520657132|FG001|Overall Study|Protocol Violation|1|||
144394553|NCT01298531|520657131|FG000|Overall Study|Adverse Event|4|||
144394554|NCT01298531|520657132|FG001|Overall Study|Adverse Event|3|||
144394555|NCT01298531|520657131|FG000|Overall Study|Does not meet entrance criteria|0|||
144394556|NCT01298531|520657132|FG001|Overall Study|Does not meet entrance criteria|1|||
144518577|NCT03665597|521099124|FG003|Period 3|Adverse Event|0|||
144518578|NCT03665597|521099125|FG004|Period 3|Adverse Event|0|||
144394557|NCT01298531|520657131|FG000|Overall Study|Other|2|||
144394558|NCT01298531|520657132|FG001|Overall Study|Other|1|||
144394559|NCT03646643|520657133|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
144394560|NCT03646643|520657134|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
144394561|NCT03646643|520657133|FG000|Overall Study|Lost to Follow-up|0|||
144394562|NCT03646643|520657134|FG001|Overall Study|Lost to Follow-up|1|||
144394563|NCT02213042|520657135|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
144394564|NCT02213042|520657136|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
144394565|NCT02213042|520657137|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
144394566|NCT02213042|520657135|FG000|Overall Study|Adverse Event|2|||
144394567|NCT02213042|520657136|FG001|Overall Study|Adverse Event|1|||
144394568|NCT02213042|520657137|FG002|Overall Study|Adverse Event|0|||
144394569|NCT02213042|520657135|FG000|Overall Study|Withdrawal by Subject|0|||
144394570|NCT02213042|520657136|FG001|Overall Study|Withdrawal by Subject|1|||
144394571|NCT02213042|520657137|FG002|Overall Study|Withdrawal by Subject|1|||
144394572|NCT02213042|520657135|FG000|Overall Study|Protocol Violation|1|||
144394573|NCT02213042|520657136|FG001|Overall Study|Protocol Violation|0|||
144394574|NCT02213042|520657137|FG002|Overall Study|Protocol Violation|0|||
144394575|NCT02213042|520657135|FG000|Overall Study|Investigator discretion|0|||
144518579|NCT03665597|521099126|FG005|Period 3|Adverse Event|0|||
144518580|NCT03665597|521099127|FG006|Period 3|Adverse Event|0|||
144518581|NCT03665597|521099121|FG000|Period 3|Death|0|||
144518582|NCT03665597|521099122|FG001|Period 3|Death|0|||
144518583|NCT03665597|521099123|FG002|Period 3|Death|0|||
144518584|NCT03665597|521099124|FG003|Period 3|Death|0|||
144518585|NCT03665597|521099125|FG004|Period 3|Death|1|||
144518586|NCT03665597|521099126|FG005|Period 3|Death|0|||
144518587|NCT03665597|521099127|FG006|Period 3|Death|0|||
144518588|NCT03665597|521099121|FG000|Period 4|Adverse Event|2|||
144518589|NCT03665597|521099122|FG001|Period 4|Adverse Event|2|||
144518590|NCT03665597|521099123|FG002|Period 4|Adverse Event|2|||
144518591|NCT03665597|521099124|FG003|Period 4|Adverse Event|2|||
144518592|NCT03665597|521099125|FG004|Period 4|Adverse Event|1|||
144518593|NCT03665597|521099126|FG005|Period 4|Adverse Event|0|||
144518594|NCT03665597|521099127|FG006|Period 4|Adverse Event|0|||
144518595|NCT03665597|521099121|FG000|Period 4|Death|0|||
144518596|NCT03665597|521099122|FG001|Period 4|Death|0|||
144518597|NCT03665597|521099123|FG002|Period 4|Death|2|||
144518598|NCT03665597|521099124|FG003|Period 4|Death|0|||
144518599|NCT03665597|521099125|FG004|Period 4|Death|0|||
144518600|NCT03665597|521099126|FG005|Period 4|Death|0|||
144518601|NCT03665597|521099127|FG006|Period 4|Death|0|||
144518602|NCT03665597|521099121|FG000|Period 4|Physician Decision|1|||
144518603|NCT03665597|521099122|FG001|Period 4|Physician Decision|2|||
144518604|NCT03665597|521099123|FG002|Period 4|Physician Decision|0|||
144518605|NCT03665597|521099124|FG003|Period 4|Physician Decision|0|||
144518606|NCT03665597|521099125|FG004|Period 4|Physician Decision|0|||
144518607|NCT03665597|521099126|FG005|Period 4|Physician Decision|0|||
144518608|NCT03665597|521099127|FG006|Period 4|Physician Decision|0|||
144518609|NCT02596126|521099131|FG000|Overall Study|Lost to Follow-up|12|||
144518610|NCT02596126|521099132|FG001|Overall Study|Lost to Follow-up|21|||
144518611|NCT02596126|521099131|FG000|Overall Study|Protocol Violation|7|||
144518612|NCT02596126|521099132|FG001|Overall Study|Protocol Violation|9|||
144518613|NCT05792423|521099133|FG000|Overall Study|Withdrawal by Subject|2|||
144518614|NCT05691452|521100874|FG000|Overall Study|Withdrawal by Subject|1|||
144518615|NCT05691452|521100875|FG001|Overall Study|Withdrawal by Subject|1|||
144518616|NCT05691452|521100876|FG002|Overall Study|Withdrawal by Subject|0|||
144518617|NCT05691452|521100874|FG000|Overall Study|Physician Decision|1|||
144518618|NCT05691452|521100875|FG001|Overall Study|Physician Decision|0|||
144518619|NCT05691452|521100876|FG002|Overall Study|Physician Decision|0|||
144518620|NCT05691452|521100874|FG000|Overall Study|Lost to Follow-up|0|||
144518621|NCT05691452|521100875|FG001|Overall Study|Lost to Follow-up|0|||
144518622|NCT05691452|521100876|FG002|Overall Study|Lost to Follow-up|1|||
144518623|NCT05691452|521100874|FG000|Overall Study|Adverse Event|0|||
144518624|NCT05691452|521100875|FG001|Overall Study|Adverse Event|0|||
144518625|NCT05691452|521100876|FG002|Overall Study|Adverse Event|1|||
144518626|NCT04593472|521100877|FG000|Overall Study|Death|31|||
144518627|NCT04593472|521100878|FG001|Overall Study|Death|27|||
144518628|NCT04593472|521100877|FG000|Overall Study|Withdrawal by Subject|12|||
144518629|NCT04593472|521100878|FG001|Overall Study|Withdrawal by Subject|12|||
144518630|NCT04593472|521100877|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
144518631|NCT04593472|521100878|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
144518632|NCT04593472|521100877|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
144518633|NCT04593472|521100878|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
144518634|NCT04593472|521100877|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
144722206|NCT00101582|521838638|FG000|Overall Study|Withdrawal by Subject|6|||
144722207|NCT00101582|521838639|FG001|Overall Study|Withdrawal by Subject|4|||
144722208|NCT00101582|521838638|FG000|Overall Study|Physician Decision|1|||
144722209|NCT00101582|521838639|FG001|Overall Study|Physician Decision|0|||
144722210|NCT00101582|521838638|FG000|Overall Study|Death|3|||
144394576|NCT02213042|520657136|FG001|Overall Study|Investigator discretion|0|||
144394577|NCT02213042|520657137|FG002|Overall Study|Investigator discretion|1|||
144394578|NCT04622735|520657140|FG000|Overall Study|Lost to Follow-up|1|||
144394579|NCT04622735|520657141|FG001|Overall Study|Lost to Follow-up|2|||
144394580|NCT04622735|520657142|FG002|Overall Study|Lost to Follow-up|1|||
144394581|NCT04622735|520657140|FG000|Overall Study|Adverse Event|0|||
144394582|NCT04622735|520657141|FG001|Overall Study|Adverse Event|0|||
144394583|NCT04622735|520657142|FG002|Overall Study|Adverse Event|1|||
144394584|NCT04622735|520657140|FG000|Overall Study|Protocol Violation|1|||
144394585|NCT04622735|520657141|FG001|Overall Study|Protocol Violation|0|||
144394586|NCT04622735|520657142|FG002|Overall Study|Protocol Violation|0|||
144394587|NCT05314478|520657143|FG000|Overall Study|Physician Decision|1|||
144394588|NCT04073368|520657144|FG000|Overall Study|Adverse Event|2|||
144394589|NCT04073368|520657145|FG001|Overall Study|Adverse Event|0|||
144394590|NCT04073368|520657146|FG002|Overall Study|Adverse Event|1|||
144394591|NCT04073368|520657147|FG003|Overall Study|Adverse Event|1|||
144394592|NCT04073368|520657144|FG000|Overall Study|Withdrawal by Subject|2|||
144394593|NCT04073368|520657145|FG001|Overall Study|Withdrawal by Subject|2|||
144394594|NCT04073368|520657146|FG002|Overall Study|Withdrawal by Subject|1|||
144394595|NCT04073368|520657147|FG003|Overall Study|Withdrawal by Subject|1|||
144394596|NCT04073368|520657144|FG000|Overall Study|Lost to Follow-up|1|||
144394597|NCT04073368|520657145|FG001|Overall Study|Lost to Follow-up|1|||
144394598|NCT04073368|520657146|FG002|Overall Study|Lost to Follow-up|1|||
144394599|NCT04073368|520657147|FG003|Overall Study|Lost to Follow-up|0|||
144394600|NCT04073368|520657144|FG000|Overall Study|Protocol Violation|0|||
144394601|NCT04073368|520657145|FG001|Overall Study|Protocol Violation|1|||
144394602|NCT04073368|520657146|FG002|Overall Study|Protocol Violation|0|||
144394603|NCT04073368|520657147|FG003|Overall Study|Protocol Violation|0|||
144394604|NCT04073368|520657144|FG000|Overall Study|Subject noncompliance|7|||
144394605|NCT04073368|520657145|FG001|Overall Study|Subject noncompliance|4|||
144394606|NCT04073368|520657146|FG002|Overall Study|Subject noncompliance|0|||
144394607|NCT04073368|520657147|FG003|Overall Study|Subject noncompliance|0|||
144394608|NCT00145600|520657148|FG000|Overall Study|Death|1|||
144394609|NCT00145600|520657149|FG001|Overall Study|Death|2|||
144394610|NCT00145600|520657150|FG002|Overall Study|Death|2|||
144394611|NCT00145600|520657151|FG003|Overall Study|Death|6|||
144394612|NCT00145600|520657148|FG000|Overall Study|Ineligible|3|||
144394613|NCT00145600|520657149|FG001|Overall Study|Ineligible|0|||
144394614|NCT00145600|520657150|FG002|Overall Study|Ineligible|1|||
144394615|NCT00145600|520657151|FG003|Overall Study|Ineligible|5|||
144394616|NCT00145600|520657148|FG000|Overall Study|Lost to Follow-up|2|||
144394617|NCT00145600|520657149|FG001|Overall Study|Lost to Follow-up|6|||
144394618|NCT00145600|520657150|FG002|Overall Study|Lost to Follow-up|2|||
144394619|NCT00145600|520657151|FG003|Overall Study|Lost to Follow-up|4|||
144394620|NCT00145600|520657148|FG000|Overall Study|Noncompliance|1|||
144394621|NCT00145600|520657149|FG001|Overall Study|Noncompliance|0|||
144394622|NCT00145600|520657150|FG002|Overall Study|Noncompliance|0|||
144394623|NCT00145600|520657151|FG003|Overall Study|Noncompliance|0|||
144394624|NCT00145600|520657148|FG000|Overall Study|Withdrawal by Subject|1|||
144518635|NCT04593472|521100878|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
144518636|NCT04593472|521100877|FG000|Overall Study|Lost to Follow-up|0|||
144518637|NCT04593472|521100878|FG001|Overall Study|Lost to Follow-up|2|||
144394625|NCT00145600|520657149|FG001|Overall Study|Withdrawal by Subject|2|||
144394626|NCT00145600|520657150|FG002|Overall Study|Withdrawal by Subject|0|||
144394627|NCT00145600|520657151|FG003|Overall Study|Withdrawal by Subject|1|||
144394628|NCT01134315|520657153|FG000|Overall Study|Adverse Event|1|||
144518638|NCT04593472|521100877|FG000|Overall Study|Still collecting 24-month assessment|17|||
144518639|NCT04593472|521100878|FG001|Overall Study|Still collecting 24-month assessment|10|||
144518640|NCT04833777|521100882|FG000|Overall Study|Lost to Follow-up|1|||
144518641|NCT04833777|521100883|FG001|Overall Study|Lost to Follow-up|0|||
144518642|NCT04490915|521100886|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
144518643|NCT04490915|521100887|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
144394629|NCT01134315|520657154|FG001|Overall Study|Adverse Event|2|||
144394630|NCT01134315|520657153|FG000|Overall Study|Other Reason|8|||
144394631|NCT01134315|520657154|FG001|Overall Study|Other Reason|17|||
144394632|NCT00736879|520657155|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
144394633|NCT00736879|520657156|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
144722211|NCT00101582|521838639|FG001|Overall Study|Death|5|||
144722212|NCT00101582|521838638|FG000|Overall Study|Other|0|||
144394634|NCT00736879|520657157|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
144394635|NCT00736879|520657158|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
144394636|NCT00736879|520657155|FG000|Double Blind Treatment Period|Adverse Event|0|||
144722213|NCT00101582|521838639|FG001|Overall Study|Other|1|||
144394637|NCT00736879|520657156|FG001|Double Blind Treatment Period|Adverse Event|1|||
144394638|NCT00736879|520657157|FG002|Double Blind Treatment Period|Adverse Event|1|||
144394639|NCT00736879|520657158|FG003|Double Blind Treatment Period|Adverse Event|0|||
144394640|NCT00736879|520657155|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
144394641|NCT00736879|520657156|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
144394642|NCT00736879|520657157|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
144394643|NCT00736879|520657158|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
144394644|NCT00736879|520657155|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
144394645|NCT00736879|520657156|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
144722214|NCT01919190|521838640|FG000|Overall Study|Intra-op findings, etc.|3|||
144722215|NCT01919190|521838641|FG001|Overall Study|Intra-op findings, etc.|0|||
144722216|NCT02146430|521838642|FG000|Overall Study|Protocol Violation|5|||
144722217|NCT02146430|521838643|FG001|Overall Study|Protocol Violation|4|||
144394646|NCT00736879|520657157|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
144722218|NCT02146430|521838644|FG002|Overall Study|Protocol Violation|8|||
144394647|NCT00736879|520657158|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
144394648|NCT00736879|520657155|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
144394649|NCT00736879|520657156|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
144394650|NCT00736879|520657157|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
144394651|NCT00736879|520657158|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
144394652|NCT00736879|520657155|FG000|Double Blind Treatment Period|No longer met criteria|0|||
144518644|NCT04490915|521100886|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144518645|NCT04490915|521100887|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144518646|NCT04490915|521100886|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144518647|NCT04490915|521100887|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
144518648|NCT04490915|521100886|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
144518649|NCT04490915|521100887|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
144518650|NCT04490915|521100886|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
144518651|NCT04490915|521100887|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
144518652|NCT04490915|521100886|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
144518653|NCT04490915|521100887|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
144518654|NCT04490915|521100886|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
144518655|NCT04490915|521100887|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
144518656|NCT04060355|521100892|FG000|Overall Study|Lost to Follow-up|41|||
144518657|NCT02724878|521100893|FG000|Overall Study|Still on Active Therapy|15|||
144518658|NCT02724878|521100893|FG000|Overall Study|Disease Progression|31|||
144518659|NCT02724878|521100893|FG000|Overall Study|Toxicity|5|||
144518660|NCT02724878|521100893|FG000|Overall Study|Death|1|||
144518661|NCT02724878|521100893|FG000|Overall Study|Withdrawal by Subject|4|||
144518662|NCT02724878|521100893|FG000|Overall Study|Lost to Follow-up|2|||
144518663|NCT02724878|521100893|FG000|Overall Study|Protocol Violation|1|||
144518664|NCT02724878|521100893|FG000|Overall Study|Ineligible for Study Drug|5|||
144518665|NCT02724878|521100893|FG000|Overall Study|not started|1|||
144518666|NCT03779204|521100897|FG000|Overall Study|Lost to Follow-up|2|||
144518667|NCT03779204|521100898|FG001|Overall Study|Lost to Follow-up|0|||
144518668|NCT04421378|521100899|FG000|Overall Study|Adverse Event|2|||
144518669|NCT04421378|521100900|FG001|Overall Study|Adverse Event|7|||
144518670|NCT04421378|521100901|FG002|Overall Study|Adverse Event|0|||
144518671|NCT04421378|521100902|FG003|Overall Study|Adverse Event|1|||
144518672|NCT04421378|521100903|FG004|Overall Study|Adverse Event|0|||
144518673|NCT04421378|521100899|FG000|Overall Study|Physician Decision|1|||
144518674|NCT04421378|521100900|FG001|Overall Study|Physician Decision|2|||
144518675|NCT04421378|521100901|FG002|Overall Study|Physician Decision|0|||
144518676|NCT04421378|521100902|FG003|Overall Study|Physician Decision|0|||
144518677|NCT04421378|521100903|FG004|Overall Study|Physician Decision|0|||
144518678|NCT04421378|521100899|FG000|Overall Study|Progressive Disease|16|||
144518679|NCT04421378|521100900|FG001|Overall Study|Progressive Disease|4|||
144518680|NCT04421378|521100901|FG002|Overall Study|Progressive Disease|18|||
144394653|NCT00736879|520657156|FG001|Double Blind Treatment Period|No longer met criteria|1|||
144394654|NCT00736879|520657157|FG002|Double Blind Treatment Period|No longer met criteria|0|||
144518681|NCT04421378|521100902|FG003|Overall Study|Progressive Disease|11|||
144518682|NCT04421378|521100903|FG004|Overall Study|Progressive Disease|3|||
144518683|NCT04421378|521100899|FG000|Overall Study|Study Terminated by Sponsor|0|||
144518684|NCT04421378|521100900|FG001|Overall Study|Study Terminated by Sponsor|1|||
144518685|NCT04421378|521100901|FG002|Overall Study|Study Terminated by Sponsor|1|||
144518686|NCT04421378|521100902|FG003|Overall Study|Study Terminated by Sponsor|0|||
144518687|NCT04421378|521100903|FG004|Overall Study|Study Terminated by Sponsor|0|||
144518688|NCT04421378|521100899|FG000|Overall Study|Withdrawal by Subject|3|||
144518689|NCT04421378|521100900|FG001|Overall Study|Withdrawal by Subject|1|||
144518690|NCT04421378|521100901|FG002|Overall Study|Withdrawal by Subject|0|||
144518691|NCT04421378|521100902|FG003|Overall Study|Withdrawal by Subject|2|||
144722219|NCT02146430|521838645|FG003|Overall Study|Protocol Violation|6|||
144722220|NCT02146430|521838642|FG000|Overall Study|Lack of Efficacy|13|||
144394655|NCT00736879|520657158|FG003|Double Blind Treatment Period|No longer met criteria|0|||
144394656|NCT00736879|520657155|FG000|Double Blind Treatment Period|non-specified|0|||
144394657|NCT00736879|520657156|FG001|Double Blind Treatment Period|non-specified|1|||
144394658|NCT00736879|520657157|FG002|Double Blind Treatment Period|non-specified|0|||
144394659|NCT00736879|520657158|FG003|Double Blind Treatment Period|non-specified|0|||
144394660|NCT00736879|520657155|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
144394661|NCT00736879|520657156|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
144394662|NCT00736879|520657157|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
144394663|NCT00736879|520657158|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
144394664|NCT00736879|520657155|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
144394665|NCT00736879|520657156|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
144394666|NCT00736879|520657157|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
144394667|NCT00736879|520657158|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
144394668|NCT00984568|520657167|FG000|Overall Study|Withdrawal by Subject|1|||
144394669|NCT00984568|520657168|FG001|Overall Study|Withdrawal by Subject|2|||
144394670|NCT00984568|520657167|FG000|Overall Study|Lack of Efficacy|2|||
144394671|NCT00984568|520657168|FG001|Overall Study|Lack of Efficacy|0|||
144394672|NCT00984568|520657167|FG000|Overall Study|Adverse Event|2|||
144394673|NCT00984568|520657168|FG001|Overall Study|Adverse Event|0|||
144394674|NCT00984568|520657167|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
144394675|NCT00984568|520657168|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
144394676|NCT00984568|520657167|FG000|Overall Study|Lost to Follow-up|0|||
144394677|NCT00984568|520657168|FG001|Overall Study|Lost to Follow-up|1|||
144394678|NCT00984568|520657167|FG000|Overall Study|Opportunistic Infection|1|||
144394679|NCT00984568|520657168|FG001|Overall Study|Opportunistic Infection|0|||
144394680|NCT00984568|520657167|FG000|Overall Study|Unknown Reason|1|||
144394681|NCT00984568|520657168|FG001|Overall Study|Unknown Reason|3|||
144394682|NCT00573248|520657169|FG000|Overall Study|scheduling conflicts|15|||
144394683|NCT00573248|520657170|FG001|Overall Study|scheduling conflicts|11|||
144394684|NCT04505540|520657173|FG000|Baseline|Protocol Violation|10|||
144394685|NCT04505540|520657173|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
144394686|NCT04505540|520657173|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
144394687|NCT04505540|520657173|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
144394688|NCT04505540|520657173|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
144394689|NCT04505540|520657173|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
144394690|NCT04505540|520657173|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
144394691|NCT04505540|520657173|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
144394692|NCT04505540|520657173|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
144394693|NCT04505540|520657173|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
144394694|NCT04505540|520657173|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
144394695|NCT04505540|520657173|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
144394696|NCT04505540|520657173|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
144394697|NCT02791594|520657174|FG000|Overall Study|Physician Decision|2|||
144394698|NCT01367119|520657175|FG000|Overall Study|Adverse Event|1|||
144394699|NCT01367119|520657176|FG001|Overall Study|Adverse Event|0|||
144394700|NCT01367119|520657175|FG000|Overall Study|Withdrawal by Subject|1|||
144394701|NCT01367119|520657176|FG001|Overall Study|Withdrawal by Subject|1|||
144394702|NCT02057393|520657179|FG000|Overall Study|Withdrawal by Subject|1|||
144394703|NCT02057393|520657179|FG000|Overall Study|Patient did not meet criteria|1|||
144394704|NCT03180684|520657180|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
144394705|NCT03180684|520657181|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
144394706|NCT03180684|520657180|FG000|Overall Study|Physician Decision|1|||
144394707|NCT03180684|520657181|FG001|Overall Study|Physician Decision|0|||
144394708|NCT03180684|520657180|FG000|Overall Study|Lost to Follow-up|1|||
144394709|NCT03180684|520657181|FG001|Overall Study|Lost to Follow-up|0|||
144394710|NCT03180684|520657180|FG000|Overall Study|Progressive Disease|1|||
144518692|NCT04421378|521100903|FG004|Overall Study|Withdrawal by Subject|0|||
144518693|NCT04421378|521100899|FG000|Overall Study|Other|1|||
144518694|NCT04421378|521100900|FG001|Overall Study|Other|0|||
144518695|NCT04421378|521100901|FG002|Overall Study|Other|0|||
144518696|NCT04421378|521100902|FG003|Overall Study|Other|0|||
144518697|NCT04421378|521100903|FG004|Overall Study|Other|0|||
144518698|NCT04258709|521100904|FG000|Overall Study|Lost to Follow-up|10|||
144518699|NCT04258709|521100905|FG001|Overall Study|Lost to Follow-up|4|||
144518700|NCT04258709|521100904|FG000|Overall Study|Withdrawal by Subject|1|||
144518701|NCT04258709|521100905|FG001|Overall Study|Withdrawal by Subject|0|||
144518702|NCT04258709|521100904|FG000|Overall Study|Fetal demise|0|||
144394711|NCT03180684|520657181|FG001|Overall Study|Progressive Disease|0|||
144518703|NCT04258709|521100905|FG001|Overall Study|Fetal demise|1|||
144518704|NCT04258709|521100904|FG000|Overall Study|Protocol Violation|1|||
144394712|NCT03953183|520657187|FG000|Overall Study|Physician Decision|0|||
144394713|NCT03953183|520657188|FG001|Overall Study|Physician Decision|1|||
144518705|NCT04258709|521100905|FG001|Overall Study|Protocol Violation|1|||
144394714|NCT03953183|520657187|FG000|Overall Study|Withdrawal by Subject|0|||
144394715|NCT03953183|520657188|FG001|Overall Study|Withdrawal by Subject|1|||
144394716|NCT00857415|520657189|FG000|Overall Study|Image acquisition failure|2|||
144394717|NCT00857415|520657190|FG001|Overall Study|Image acquisition failure|0|||
144394718|NCT00857415|520657189|FG000|Overall Study|Invalid image or not imaged|3|||
144394719|NCT00857415|520657190|FG001|Overall Study|Invalid image or not imaged|0|||
144394720|NCT00857415|520657189|FG000|Overall Study|Subject still living at end of study|110|||
144394721|NCT00857415|520657190|FG001|Overall Study|Subject still living at end of study|0|||
144394722|NCT00857415|520657189|FG000|Overall Study|Deceased with no autopsy|2|||
144394723|NCT00857415|520657190|FG001|Overall Study|Deceased with no autopsy|0|||
144394724|NCT04508140|520657191|FG000|Overall Study|Adverse Event|2|||
144394725|NCT04508140|520657192|FG001|Overall Study|Adverse Event|2|||
144394726|NCT04508140|520657191|FG000|Overall Study|Withdrawal by Subject|0|||
144394727|NCT04508140|520657192|FG001|Overall Study|Withdrawal by Subject|2|||
144394728|NCT04508140|520657191|FG000|Overall Study|progressive disease|9|||
144518706|NCT05082909|521100906|FG000|Overall Study|Protocol Violation|0|||
144249510|NCT01716520|520111653|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
144249511|NCT01716520|520111654|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
144249512|NCT01716520|520111655|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
144249513|NCT01716520|520111656|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
144249514|NCT01716520|520111657|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
144249515|NCT01716520|520111658|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
144249516|NCT01716520|520111653|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144249517|NCT01716520|520111654|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144249518|NCT01716520|520111655|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144249519|NCT01716520|520111656|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144249520|NCT01716520|520111657|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144249521|NCT01716520|520111658|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
144249522|NCT01716520|520111653|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144518707|NCT05082909|521100907|FG001|Overall Study|Protocol Violation|0|||
144518708|NCT05082909|521100908|FG002|Overall Study|Protocol Violation|1|||
144518709|NCT05082909|521100909|FG003|Overall Study|Protocol Violation|0|||
144518710|NCT05082909|521100910|FG004|Overall Study|Protocol Violation|0|||
144518711|NCT05082909|521100911|FG005|Overall Study|Protocol Violation|0|||
144518712|NCT04088630|521100912|FG000|Overall Study|Lost to Follow-up|3|||
144518713|NCT04088630|521100913|FG001|Overall Study|Lost to Follow-up|2|||
144518714|NCT04088630|521100914|FG002|Overall Study|Lost to Follow-up|6|||
144518715|NCT04088630|521100912|FG000|Overall Study|Death|3|||
144518716|NCT04088630|521100913|FG001|Overall Study|Death|1|||
144518717|NCT04088630|521100914|FG002|Overall Study|Death|1|||
144518718|NCT04088630|521100912|FG000|Overall Study|Physician Decision|0|||
144518719|NCT04088630|521100913|FG001|Overall Study|Physician Decision|1|||
144518720|NCT04088630|521100914|FG002|Overall Study|Physician Decision|1|||
144518721|NCT03175029|521100915|FG000|Overall Study|Withdrawal by Subject|2|||
144518722|NCT03175029|521100916|FG001|Overall Study|Withdrawal by Subject|1|||
144518723|NCT03175029|521100915|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
144518724|NCT03175029|521100916|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
144518725|NCT02954341|521100919|FG000|Overall Study|Attempted Implant unsuccessful|5|||
144518726|NCT02954341|521100919|FG000|Overall Study|Death|90|||
144518727|NCT02954341|521100919|FG000|Overall Study|Withdrawal by Subject|4|||
144249523|NCT01716520|520111654|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144249524|NCT01716520|520111655|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
144249525|NCT01716520|520111656|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144249526|NCT01716520|520111657|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144249527|NCT01716520|520111658|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144249528|NCT00253370|520111659|FG000|Overall Study|Adverse Event|18|||
144249529|NCT00253370|520111659|FG000|Overall Study|Disease progression|13|||
144518728|NCT02954341|521100919|FG000|Overall Study|Physician Decision|13|||
144249530|NCT00253370|520111659|FG000|Overall Study|Death|2|||
144249531|NCT00253370|520111659|FG000|Overall Study|Withdrawal by Subject|6|||
144249532|NCT00253370|520111659|FG000|Overall Study|Non-protocol therapy|1|||
144249533|NCT00253370|520111659|FG000|Overall Study|Physician Decision|1|||
144249534|NCT00253370|520111659|FG000|Overall Study|Protocol Violation|1|||
144249535|NCT00253370|520111659|FG000|Overall Study|Abdominal pain due to disease|1|||
144249536|NCT00004088|520111663|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
144722221|NCT02146430|521838643|FG001|Overall Study|Lack of Efficacy|11|||
144594571|NCT04677179|521377918|FG001|Induction Treatment Period|Protocol Violation|1|||
144594572|NCT04677179|521377919|FG002|Induction Treatment Period|Protocol Violation|0|||
144594573|NCT04677179|521377920|FG003|Induction Treatment Period|Protocol Violation|0|||
144594574|NCT04677179|521377921|FG004|Induction Treatment Period|Protocol Violation|0|||
144594575|NCT04677179|521377922|FG005|Induction Treatment Period|Protocol Violation|0|||
144594576|NCT04677179|521377923|FG006|Induction Treatment Period|Protocol Violation|0|||
144594577|NCT04677179|521377924|FG007|Induction Treatment Period|Protocol Violation|0|||
144594578|NCT04677179|521377925|FG008|Induction Treatment Period|Protocol Violation|0|||
144594579|NCT04677179|521377926|FG009|Induction Treatment Period|Protocol Violation|0|||
144594580|NCT04677179|521377917|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
144594581|NCT04677179|521377918|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
144594582|NCT04677179|521377919|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
144594583|NCT04677179|521377920|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
144594584|NCT04677179|521377921|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
144594585|NCT04677179|521377922|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
144594586|NCT04677179|521377923|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
144594587|NCT04677179|521377924|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
144594588|NCT04677179|521377925|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
144594589|NCT04677179|521377926|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
144594590|NCT04677179|521377917|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
144594591|NCT04677179|521377918|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
144594592|NCT04677179|521377919|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
144594593|NCT04677179|521377920|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
144594594|NCT04677179|521377921|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
144594595|NCT04677179|521377922|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
144594596|NCT04677179|521377923|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
144594597|NCT04677179|521377924|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
144518729|NCT02954341|521100919|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
144518730|NCT02954341|521100919|FG000|Overall Study|Not implanted due to physician's decision|1|||
144518731|NCT02954341|521100919|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
144518732|NCT00512070|521100924|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
144518733|NCT00512070|521100925|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
144518734|NCT00512070|521100926|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
144518735|NCT00512070|521100924|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
144518736|NCT00512070|521100925|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
144518737|NCT00512070|521100926|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
144518738|NCT05524233|521100927|FG000|Overall Study|Lost to Follow-up|2|||
144518739|NCT05524233|521100927|FG000|Overall Study|Adverse Event|2|||
144518740|NCT05524233|521100927|FG000|Overall Study|Withdrawal by Subject|1|||
144518741|NCT03453619|521100930|FG000|Core Study (Part A)|Physician Decision|0|||
144518742|NCT03453619|521100931|FG001|Core Study (Part A)|Physician Decision|0|||
144518743|NCT03453619|521100932|FG002|Core Study (Part A)|Physician Decision|2|||
144518744|NCT03453619|521100933|FG003|Core Study (Part A)|Physician Decision|0|||
144518745|NCT03453619|521100930|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
144518746|NCT03453619|521100931|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
144518747|NCT03453619|521100932|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
144518748|NCT03453619|521100933|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
144518749|NCT03453619|521100930|FG000|Core Study (Part A)|Other|0|||
144518750|NCT03453619|521100931|FG001|Core Study (Part A)|Other|1|||
144518751|NCT03453619|521100932|FG002|Core Study (Part A)|Other|0|||
144518752|NCT03453619|521100933|FG003|Core Study (Part A)|Other|0|||
144518753|NCT03453619|521100930|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
144518754|NCT03453619|521100931|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
144518755|NCT03453619|521100932|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
144518756|NCT03453619|521100933|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
144518757|NCT03453619|521100930|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
144518758|NCT03453619|521100931|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
144518759|NCT03453619|521100932|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
144518760|NCT03453619|521100933|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
144518761|NCT03453619|521100930|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
144518762|NCT03453619|521100931|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
144518763|NCT03453619|521100932|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
144594598|NCT04677179|521377925|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
144518764|NCT03453619|521100933|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
144518765|NCT03453619|521100930|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
144249537|NCT00004088|520111663|FG000|Overall Study|Withdrawal by Subject|1|||
144249538|NCT00004088|520111663|FG000|Overall Study|Protocol Violation|3|||
144249539|NCT00004088|520111663|FG000|Overall Study|Physician Decision|1|||
144249540|NCT05916131|520111672|FG000|Overall Study|Lost to Follow-up|0|||
144249541|NCT05916131|520111673|FG001|Overall Study|Lost to Follow-up|0|||
144249542|NCT05916131|520111674|FG002|Overall Study|Lost to Follow-up|1|||
144249543|NCT05916131|520111675|FG003|Overall Study|Lost to Follow-up|0|||
144249544|NCT02305446|520111682|FG000|Overall Study|Adverse Event|1|||
144249545|NCT01211483|520111688|FG000|Phase 1b|Death|6|||
144249546|NCT01211483|520111689|FG001|Phase 1b|Death|0|||
144249547|NCT01211483|520111690|FG002|Phase 1b|Death|0|||
144249548|NCT01211483|520111691|FG003|Phase 1b|Death|0|||
144249549|NCT01211483|520111688|FG000|Phase 1b|Withdrawal by Subject|1|||
144249550|NCT01211483|520111689|FG001|Phase 1b|Withdrawal by Subject|0|||
144394729|NCT04508140|520657192|FG001|Overall Study|progressive disease|3|||
144394730|NCT03091777|520657198|FG000|Overall Study|Pregnancy|2|||
144394731|NCT03091777|520657199|FG001|Overall Study|Pregnancy|1|||
144394732|NCT03091777|520657200|FG002|Overall Study|Pregnancy|0|||
144394733|NCT03091777|520657198|FG000|Overall Study|Adverse Event|2|||
144394734|NCT03091777|520657199|FG001|Overall Study|Adverse Event|1|||
144394735|NCT03091777|520657200|FG002|Overall Study|Adverse Event|4|||
144394736|NCT03091777|520657198|FG000|Overall Study|Withdrawal by Subject|4|||
144394737|NCT03091777|520657199|FG001|Overall Study|Withdrawal by Subject|2|||
144394738|NCT03091777|520657200|FG002|Overall Study|Withdrawal by Subject|6|||
144394739|NCT03091777|520657198|FG000|Overall Study|Protocol Violation|2|||
144394740|NCT03091777|520657199|FG001|Overall Study|Protocol Violation|1|||
144394741|NCT03091777|520657200|FG002|Overall Study|Protocol Violation|1|||
144394742|NCT03091777|520657198|FG000|Overall Study|Lost to Follow-up|12|||
144394743|NCT03091777|520657199|FG001|Overall Study|Lost to Follow-up|14|||
144394744|NCT03091777|520657200|FG002|Overall Study|Lost to Follow-up|7|||
144394745|NCT03091777|520657198|FG000|Overall Study|Lack of Efficacy|0|||
144394746|NCT03091777|520657199|FG001|Overall Study|Lack of Efficacy|0|||
144394747|NCT03091777|520657200|FG002|Overall Study|Lack of Efficacy|5|||
144394748|NCT03091777|520657198|FG000|Overall Study|Noncompliance with study drug|2|||
144394749|NCT03091777|520657199|FG001|Overall Study|Noncompliance with study drug|3|||
144394750|NCT03091777|520657200|FG002|Overall Study|Noncompliance with study drug|1|||
144394751|NCT03091777|520657198|FG000|Overall Study|Physician Decision|1|||
144394752|NCT03091777|520657199|FG001|Overall Study|Physician Decision|0|||
144394753|NCT03091777|520657200|FG002|Overall Study|Physician Decision|1|||
144394754|NCT03091777|520657198|FG000|Overall Study|Abnormal Laboratory Value|7|||
144394755|NCT03091777|520657199|FG001|Overall Study|Abnormal Laboratory Value|11|||
144394756|NCT03091777|520657200|FG002|Overall Study|Abnormal Laboratory Value|12|||
144394757|NCT03309046|520657201|FG000|Overall Study|Withdrawal by Subject|4|||
144394758|NCT03309046|520657202|FG001|Overall Study|Withdrawal by Subject|17|||
144394759|NCT00089674|520657204|FG000|Overall Study|Physician Decision|4|||
144394760|NCT00089674|520657205|FG001|Overall Study|Physician Decision|2|||
144394761|NCT00089674|520657204|FG000|Overall Study|Adverse Event|23|||
144394762|NCT00089674|520657205|FG001|Overall Study|Adverse Event|29|||
144394763|NCT00089674|520657204|FG000|Overall Study|Withdrawal by Subject|143|||
144394764|NCT00089674|520657205|FG001|Overall Study|Withdrawal by Subject|127|||
144394765|NCT00089674|520657204|FG000|Overall Study|Death|43|||
144394766|NCT00089674|520657205|FG001|Overall Study|Death|43|||
144394767|NCT00089674|520657204|FG000|Overall Study|Disease progression|21|||
144394768|NCT00089674|520657205|FG001|Overall Study|Disease progression|23|||
144394769|NCT00089674|520657204|FG000|Overall Study|Ineligibility determined|8|||
144394770|NCT00089674|520657205|FG001|Overall Study|Ineligibility determined|10|||
144394771|NCT00089674|520657204|FG000|Overall Study|Lost to Follow-up|21|||
144394772|NCT00089674|520657205|FG001|Overall Study|Lost to Follow-up|17|||
144394773|NCT00089674|520657204|FG000|Overall Study|Noncompliance|7|||
144394774|NCT00089674|520657205|FG001|Overall Study|Noncompliance|3|||
144394775|NCT00089674|520657204|FG000|Overall Study|Other|5|||
144394776|NCT00089674|520657205|FG001|Overall Study|Other|9|||
144394777|NCT00089674|520657204|FG000|Overall Study|Requirement for alternative therapy|14|||
144394778|NCT00089674|520657205|FG001|Overall Study|Requirement for alternative therapy|4|||
144394779|NCT03963401|520657206|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
144394780|NCT03963401|520657207|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
144394781|NCT03963401|520657208|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
144394782|NCT03963401|520657209|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
144394783|NCT03963401|520657210|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
144394784|NCT03963401|520657211|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
144394785|NCT03963401|520657206|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
144394786|NCT03963401|520657207|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
144394787|NCT03963401|520657208|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
144394788|NCT03963401|520657209|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
144394789|NCT03963401|520657210|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
144249551|NCT01211483|520111690|FG002|Phase 1b|Withdrawal by Subject|0|||
144249552|NCT01211483|520111691|FG003|Phase 1b|Withdrawal by Subject|0|||
144249553|NCT01211483|520111688|FG000|Phase 2|Lost to Follow-up|0|||
144249554|NCT01211483|520111689|FG001|Phase 2|Lost to Follow-up|1|||
144518766|NCT03453619|521100931|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
144518767|NCT03453619|521100932|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
144518768|NCT03453619|521100933|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
144518769|NCT05862870|521100934|FG000|Overall Study|Lost to Follow-up|3|||
144518770|NCT04321031|521100935|FG000|Overall Study|Adverse Event|0|||
144518771|NCT04321031|521100936|FG001|Overall Study|Adverse Event|2|||
144518772|NCT04321031|521100937|FG002|Overall Study|Adverse Event|2|||
144518773|NCT04321031|521100938|FG003|Overall Study|Adverse Event|2|||
144518774|NCT04321031|521100939|FG004|Overall Study|Adverse Event|2|||
144518775|NCT04321031|521100940|FG005|Overall Study|Adverse Event|2|||
144518776|NCT04321031|521100941|FG006|Overall Study|Adverse Event|0|||
144518777|NCT04321031|521100935|FG000|Overall Study|Lost to Follow-up|0|||
144518778|NCT04321031|521100936|FG001|Overall Study|Lost to Follow-up|0|||
144518779|NCT04321031|521100937|FG002|Overall Study|Lost to Follow-up|0|||
144518780|NCT04321031|521100938|FG003|Overall Study|Lost to Follow-up|1|||
144518781|NCT04321031|521100939|FG004|Overall Study|Lost to Follow-up|0|||
144518782|NCT04321031|521100940|FG005|Overall Study|Lost to Follow-up|2|||
144518783|NCT04321031|521100941|FG006|Overall Study|Lost to Follow-up|1|||
144518784|NCT04321031|521100935|FG000|Overall Study|Withdrawal by Subject|2|||
144518785|NCT04321031|521100936|FG001|Overall Study|Withdrawal by Subject|2|||
144518786|NCT04321031|521100937|FG002|Overall Study|Withdrawal by Subject|1|||
144518787|NCT04321031|521100938|FG003|Overall Study|Withdrawal by Subject|3|||
144518788|NCT04321031|521100939|FG004|Overall Study|Withdrawal by Subject|1|||
144518789|NCT04321031|521100940|FG005|Overall Study|Withdrawal by Subject|0|||
144518790|NCT04321031|521100941|FG006|Overall Study|Withdrawal by Subject|1|||
144518791|NCT04321031|521100935|FG000|Overall Study|Non-compliance with study drug|0|||
144518792|NCT04321031|521100936|FG001|Overall Study|Non-compliance with study drug|0|||
144518793|NCT04321031|521100937|FG002|Overall Study|Non-compliance with study drug|0|||
144518794|NCT04321031|521100938|FG003|Overall Study|Non-compliance with study drug|0|||
144518795|NCT04321031|521100939|FG004|Overall Study|Non-compliance with study drug|0|||
144518796|NCT04321031|521100940|FG005|Overall Study|Non-compliance with study drug|1|||
144518797|NCT04321031|521100941|FG006|Overall Study|Non-compliance with study drug|0|||
144518798|NCT04321031|521100935|FG000|Overall Study|Other|0|||
144518799|NCT04321031|521100936|FG001|Overall Study|Other|0|||
144518800|NCT04321031|521100937|FG002|Overall Study|Other|0|||
144518801|NCT04321031|521100938|FG003|Overall Study|Other|1|||
144518802|NCT04321031|521100939|FG004|Overall Study|Other|0|||
144518803|NCT04321031|521100940|FG005|Overall Study|Other|0|||
144518804|NCT04321031|521100941|FG006|Overall Study|Other|0|||
144518805|NCT04237298|521100944|FG000|Overall Study|Lost to Follow-up|4|||
144518806|NCT04237298|521100945|FG001|Overall Study|Lost to Follow-up|5|||
144518807|NCT02530671|521100946|FG000|Overall Study|Lost to Follow-up|2|||
144518808|NCT02530671|521100947|FG001|Overall Study|Lost to Follow-up|0|||
144518809|NCT02530671|521100946|FG000|Overall Study|Withdrawal by Subject|1|||
144518810|NCT02530671|521100947|FG001|Overall Study|Withdrawal by Subject|0|||
144518811|NCT05536440|521100957|FG000|Overall Study|Adverse Event|0|||
144518812|NCT05536440|521100958|FG001|Overall Study|Adverse Event|0|||
144518813|NCT05536440|521100959|FG002|Overall Study|Adverse Event|0|||
144518814|NCT05536440|521100960|FG003|Overall Study|Adverse Event|0|||
144518815|NCT05536440|521100961|FG004|Overall Study|Adverse Event|0|||
144518816|NCT05536440|521100962|FG005|Overall Study|Adverse Event|0|||
144518817|NCT05536440|521100963|FG006|Overall Study|Adverse Event|0|||
144394790|NCT03963401|520657211|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
144394791|NCT03963401|520657206|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
144394792|NCT03963401|520657207|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
144394793|NCT03963401|520657208|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
144394794|NCT03963401|520657209|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
144394795|NCT03963401|520657210|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
144394796|NCT03963401|520657211|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
144394797|NCT03963401|520657206|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
144394798|NCT03963401|520657207|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
144394799|NCT03963401|520657208|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
144394800|NCT03963401|520657209|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
144394801|NCT03963401|520657210|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
144394802|NCT03963401|520657211|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
144394803|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
144394804|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
144518818|NCT05536440|521100964|FG007|Overall Study|Adverse Event|0|||
144518819|NCT05536440|521100965|FG008|Overall Study|Adverse Event|1|||
144518820|NCT01566695|521100966|FG000|Overall Study|Lack of Efficacy|1|||
144518821|NCT01566695|521100967|FG001|Overall Study|Lack of Efficacy|0|||
144518822|NCT01566695|521100966|FG000|Overall Study|Adverse Event|3|||
144518823|NCT01566695|521100967|FG001|Overall Study|Adverse Event|0|||
144518824|NCT01566695|521100966|FG000|Overall Study|Death|79|||
144518825|NCT01566695|521100967|FG001|Overall Study|Death|86|||
144518826|NCT01566695|521100966|FG000|Overall Study|Withdrawal by Subject|13|||
144518827|NCT01566695|521100967|FG001|Overall Study|Withdrawal by Subject|12|||
144518828|NCT01566695|521100966|FG000|Overall Study|Lost to Follow-up|0|||
144518829|NCT01566695|521100967|FG001|Overall Study|Lost to Follow-up|3|||
144518830|NCT01566695|521100966|FG000|Overall Study|Other reasons|11|||
144518831|NCT01566695|521100967|FG001|Overall Study|Other reasons|8|||
144518832|NCT04812535|521100974|FG000|Overall Study|Withdrawal by Subject|0|||
144518833|NCT04812535|521100975|FG001|Overall Study|Withdrawal by Subject|0|||
144518834|NCT04812535|521100976|FG002|Overall Study|Withdrawal by Subject|0|||
144518835|NCT04812535|521100977|FG003|Overall Study|Withdrawal by Subject|1|||
144518836|NCT04812535|521100974|FG000|Overall Study|Death|7|||
144518837|NCT04812535|521100975|FG001|Overall Study|Death|2|||
144518838|NCT04812535|521100976|FG002|Overall Study|Death|4|||
144518839|NCT04812535|521100977|FG003|Overall Study|Death|1|||
144518840|NCT04812535|521100974|FG000|Overall Study|Due to premature study termination by sponsor|2|||
144518841|NCT04812535|521100975|FG001|Overall Study|Due to premature study termination by sponsor|0|||
144518842|NCT04812535|521100976|FG002|Overall Study|Due to premature study termination by sponsor|1|||
144518843|NCT04812535|521100977|FG003|Overall Study|Due to premature study termination by sponsor|3|||
144518844|NCT03436745|521100978|FG000|Overall Study|Ineligible|0|||
144518845|NCT03436745|521100979|FG001|Overall Study|Ineligible|0|||
144518846|NCT03436745|521100980|FG002|Overall Study|Ineligible|1|||
144518847|NCT04588298|521100983|FG000|Overall Study|Adverse Event|0|||
144518848|NCT04588298|521100984|FG001|Overall Study|Adverse Event|0|||
144518849|NCT04588298|521100985|FG002|Overall Study|Adverse Event|1|||
144518850|NCT04588298|521100986|FG003|Overall Study|Adverse Event|0|||
144518851|NCT04588298|521100987|FG004|Overall Study|Adverse Event|2|||
144518852|NCT04588298|521100983|FG000|Overall Study|Withdrawal by Subject|1|||
144518853|NCT04588298|521100984|FG001|Overall Study|Withdrawal by Subject|0|||
144518854|NCT04588298|521100985|FG002|Overall Study|Withdrawal by Subject|0|||
144518855|NCT04588298|521100986|FG003|Overall Study|Withdrawal by Subject|1|||
144518856|NCT04588298|521100987|FG004|Overall Study|Withdrawal by Subject|0|||
144518857|NCT03846505|521100988|FG000|Treatment Phase|Withdrawal by Subject|9|||
144518858|NCT03846505|521100989|FG001|Treatment Phase|Withdrawal by Subject|11|||
144518859|NCT03846505|521100988|FG000|Treatment Phase|Lost to Follow-up|6|||
144518860|NCT03846505|521100989|FG001|Treatment Phase|Lost to Follow-up|2|||
144518861|NCT03846505|521100988|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
144518862|NCT03846505|521100989|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
144518863|NCT03846505|521100988|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
144518864|NCT03846505|521100989|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
144518865|NCT05592418|521100990|FG000|Overall Study|Adverse Event|1|||
144518866|NCT05592418|521100991|FG001|Overall Study|Adverse Event|0|||
144249555|NCT01211483|520111690|FG002|Phase 2|Lost to Follow-up|1|||
144518867|NCT05592418|521100990|FG000|Overall Study|Lost to Follow-up|1|||
144518868|NCT05592418|521100991|FG001|Overall Study|Lost to Follow-up|3|||
144518869|NCT05592418|521100990|FG000|Overall Study|Withdrawal by Subject|2|||
144518870|NCT05592418|521100991|FG001|Overall Study|Withdrawal by Subject|7|||
144518871|NCT04831216|521100992|FG000|Overall Study|Lost to Follow-up|32|||
144518872|NCT03519581|521100997|FG000|Overall Study|Lost to Follow-up|3|||
144518873|NCT03519581|521100998|FG001|Overall Study|Lost to Follow-up|2|||
144518874|NCT03519581|521100997|FG000|Overall Study|Adverse Event|5|||
144518875|NCT03519581|521100998|FG001|Overall Study|Adverse Event|2|||
144394805|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
144394806|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
144394807|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
144394808|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
144394809|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
144394810|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
144394811|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
144394812|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
144394813|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
144518876|NCT03519581|521100997|FG000|Overall Study|Withdrawal by Subject|2|||
144518877|NCT03519581|521100998|FG001|Overall Study|Withdrawal by Subject|0|||
144518878|NCT03519581|521100997|FG000|Overall Study|Change to insurance|2|||
144518879|NCT03519581|521100998|FG001|Overall Study|Change to insurance|1|||
144518880|NCT03519581|521100997|FG000|Overall Study|Other|2|||
144518881|NCT03519581|521100998|FG001|Overall Study|Other|4|||
144518882|NCT04410042|521100999|FG000|Overall Study|Not Eligible|1|||
144518883|NCT04410042|521101000|FG001|Overall Study|Not Eligible|1|||
144518884|NCT05481320|521101002|FG000|Overall Study|Withdrawal by Subject|1|||
144518885|NCT05481320|521101003|FG001|Overall Study|Withdrawal by Subject|1|||
144518886|NCT05481320|521101002|FG000|Overall Study|Care recipent passed away|0|||
144518887|NCT05481320|521101003|FG001|Overall Study|Care recipent passed away|1|||
144518888|NCT05481320|521101002|FG000|Overall Study|Out-of-window assessment|0|||
144518889|NCT05481320|521101003|FG001|Overall Study|Out-of-window assessment|1|||
144518890|NCT05481320|521101002|FG000|Overall Study|No longer a primary caregiver|3|||
144518891|NCT05481320|521101003|FG001|Overall Study|No longer a primary caregiver|0|||
144518892|NCT05481320|521101002|FG000|Overall Study|Unable to contact|1|||
144518893|NCT05481320|521101003|FG001|Overall Study|Unable to contact|0|||
144518894|NCT02811679|521101004|FG000|Overall Study|Adverse Event|1|||
144518895|NCT02811679|521101004|FG000|Overall Study|Lack of Efficacy|6|||
144518896|NCT02811679|521101004|FG000|Overall Study|Early study closure due to slow accrual|3|||
144518897|NCT05319860|521101008|FG000|Overall Study|Death|1|||
144518898|NCT05319860|521101009|FG001|Overall Study|Death|1|||
144518899|NCT05319860|521101008|FG000|Overall Study|Lost to Follow-up|3|||
144518900|NCT05319860|521101009|FG001|Overall Study|Lost to Follow-up|1|||
144518901|NCT05319860|521101008|FG000|Overall Study|Withdrawal by Subject|1|||
144518902|NCT05319860|521101009|FG001|Overall Study|Withdrawal by Subject|7|||
144518903|NCT04314895|521101010|FG000|Overall Study|Lost to Follow-up|1|||
144518904|NCT04314895|521101010|FG000|Overall Study|Death|10|||
144518905|NCT04314895|521101010|FG000|Overall Study|Physician Decision|2|||
144518906|NCT03941860|521101011|FG000|Overall Study|Withdrawal by Subject|0|||
144518907|NCT03941860|521101012|FG001|Overall Study|Withdrawal by Subject|1|||
144518908|NCT03361748|521101016|FG000|Overall Study|Death|77|||
144518909|NCT03361748|521101016|FG000|Overall Study|Lost to Follow-up|4|||
144518910|NCT03361748|521101016|FG000|Overall Study|Withdrawal by Subject|20|||
144518911|NCT01361711|521101017|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
144518912|NCT01361711|521101017|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
144518913|NCT01361711|521101017|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
144518914|NCT01361711|521101017|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
144518915|NCT01361711|521101017|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
144518916|NCT01361711|521101017|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
144518917|NCT01361711|521101017|FG000|Completed Week 18 of Treatment|Other|9|||
144518918|NCT01361711|521101017|FG000|10 Year Follow-up|Still in follow-up|22|||
144518919|NCT01361711|521101017|FG000|10 Year Follow-up|Death|7|||
144518920|NCT01361711|521101017|FG000|10 Year Follow-up|Developed new cancer|1|||
144518921|NCT01361711|521101017|FG000|10 Year Follow-up|Lost to Follow-up|2|||
144518922|NCT01361711|521101017|FG000|10 Year Follow-up|New treatment started|6|||
144518923|NCT01361711|521101017|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
144518924|NCT01361711|521101017|FG000|10 Year Follow-up|Progressive Disease|1|||
144518925|NCT03930342|521101018|FG000|Overall Study|Lost to Follow-up|70|||
144518926|NCT03930342|521101019|FG001|Overall Study|Lost to Follow-up|77|||
144518927|NCT02471638|521101028|FG000|Overall Study|Early Term Withdrawal|10|||
144518928|NCT02187003|521103179|FG000|Overall Study|Adverse Event|2|||
144518929|NCT02187003|521103180|FG001|Overall Study|Adverse Event|0|||
144518930|NCT02187003|521103179|FG000|Overall Study|Lost to Follow-up|14|||
144518931|NCT02187003|521103180|FG001|Overall Study|Lost to Follow-up|10|||
144518932|NCT02187003|521103179|FG000|Overall Study|Withdrawal by Subject|3|||
144518933|NCT02187003|521103180|FG001|Overall Study|Withdrawal by Subject|7|||
144518934|NCT02187003|521103179|FG000|Overall Study|Protocol Violation|2|||
144518935|NCT02187003|521103180|FG001|Overall Study|Protocol Violation|4|||
144394814|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
144394815|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
144394816|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
144518936|NCT02187003|521103179|FG000|Overall Study|Other|5|||
144518937|NCT02187003|521103180|FG001|Overall Study|Other|5|||
144518938|NCT02187003|521103179|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144518939|NCT02187003|521103180|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
144518940|NCT01331005|521103186|FG000|Overall Study|Lost to Follow-up|2|||
144518941|NCT01331005|521103187|FG001|Overall Study|Lost to Follow-up|1|||
144518942|NCT01331005|521103186|FG000|Overall Study|Withdrawal by Subject|2|||
144518943|NCT01331005|521103187|FG001|Overall Study|Withdrawal by Subject|3|||
144518944|NCT04083235|521103205|FG000|Overall Study|Death|252|||
144518945|NCT04083235|521103206|FG001|Overall Study|Death|277|||
144518946|NCT04083235|521103205|FG000|Overall Study|Withdrawal by Subject|13|||
144518947|NCT04083235|521103206|FG001|Overall Study|Withdrawal by Subject|17|||
144518948|NCT04083235|521103205|FG000|Overall Study|Lost to Follow-up|1|||
144518949|NCT04083235|521103206|FG001|Overall Study|Lost to Follow-up|1|||
144518950|NCT04083235|521103205|FG000|Overall Study|Does not meet entry criteria|1|||
144518951|NCT04083235|521103206|FG001|Overall Study|Does not meet entry criteria|0|||
144518952|NCT04083235|521103205|FG000|Overall Study|Did not receive treatment|13|||
144518953|NCT04083235|521103206|FG001|Overall Study|Did not receive treatment|8|||
144518954|NCT04083235|521103205|FG000|Overall Study|Ongoing at the time of DCO|44|||
144518955|NCT04083235|521103206|FG001|Overall Study|Ongoing at the time of DCO|7|||
144518956|NCT03016169|521103207|FG000|Overall Study|Lost to Follow-up|4|||
144518957|NCT03016169|521103207|FG000|Overall Study|Death|54|||
144518958|NCT03016169|521103207|FG000|Overall Study|Device Explant|11|||
144518959|NCT03016169|521103207|FG000|Overall Study|Withdrawal by Subject|19|||
144518960|NCT03016169|521103207|FG000|Overall Study|Other Reasons|1|||
144518961|NCT01140880|521103209|FG000|Overall Study|Death|0|||
144518962|NCT01140880|521103210|FG001|Overall Study|Death|1|||
144518963|NCT01140880|521103209|FG000|Overall Study|Withdrawal by Subject|6|||
144518964|NCT01140880|521103210|FG001|Overall Study|Withdrawal by Subject|3|||
144518965|NCT01140880|521103209|FG000|Overall Study|Lost to Follow-up|8|||
144518966|NCT01140880|521103210|FG001|Overall Study|Lost to Follow-up|10|||
144518967|NCT01140880|521103209|FG000|Overall Study|Protocol Violation|0|||
144518968|NCT01140880|521103210|FG001|Overall Study|Protocol Violation|30|||
144518969|NCT02592330|521103211|FG000|Overall Study|Withdrawal by Subject|1|||
144518970|NCT02592330|521103212|FG001|Overall Study|Withdrawal by Subject|0|||
144518971|NCT02592330|521103211|FG000|Overall Study|Failed Biopsy|1|||
144518972|NCT02592330|521103212|FG001|Overall Study|Failed Biopsy|0|||
144518973|NCT03090152|521103213|FG000|Overall Study|Withdrawal by Subject|0|||
144518974|NCT03090152|521103214|FG001|Overall Study|Withdrawal by Subject|2|||
144518975|NCT03090152|521103215|FG002|Overall Study|Withdrawal by Subject|1|||
144518976|NCT03090152|521103213|FG000|Overall Study|Surgery Canceled|1|||
144518977|NCT03090152|521103214|FG001|Overall Study|Surgery Canceled|0|||
144518978|NCT03090152|521103215|FG002|Overall Study|Surgery Canceled|0|||
144518979|NCT03090152|521103213|FG000|Overall Study|Epidural catheter could not be placed|0|||
144518980|NCT03090152|521103214|FG001|Overall Study|Epidural catheter could not be placed|2|||
144518981|NCT03090152|521103215|FG002|Overall Study|Epidural catheter could not be placed|0|||
144518982|NCT02927769|521103217|FG000|Induction Phase|Study drug toxicity|1|||
144518983|NCT02927769|521103218|FG001|Induction Phase|Study drug toxicity|1|||
144518984|NCT02927769|521103217|FG000|Induction Phase|Disease progression|0|||
144518985|NCT02927769|521103218|FG001|Induction Phase|Disease progression|1|||
144518986|NCT02927769|521103217|FG000|Intensification Phase|Study drug toxicity|1|||
144518987|NCT02927769|521103218|FG001|Intensification Phase|Study drug toxicity|0|||
144518988|NCT02807636|521103221|FG000|Overall Study|Lost to Follow-up|10|||
144518989|NCT02807636|521103222|FG001|Overall Study|Lost to Follow-up|13|||
144518990|NCT02807636|521103223|FG002|Overall Study|Lost to Follow-up|6|||
144518991|NCT02807636|521103221|FG000|Overall Study|Protocol Deviation|1|||
144518992|NCT02807636|521103222|FG001|Overall Study|Protocol Deviation|0|||
144518993|NCT02807636|521103223|FG002|Overall Study|Protocol Deviation|0|||
144518994|NCT02807636|521103221|FG000|Overall Study|Symptomatic Deterioration|0|||
144518995|NCT02807636|521103222|FG001|Overall Study|Symptomatic Deterioration|1|||
144594599|NCT04677179|521377926|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
144518996|NCT02807636|521103223|FG002|Overall Study|Symptomatic Deterioration|0|||
144518997|NCT02807636|521103221|FG000|Overall Study|Withdrawal by Subject|39|||
144518998|NCT02807636|521103222|FG001|Overall Study|Withdrawal by Subject|28|||
144518999|NCT02807636|521103223|FG002|Overall Study|Withdrawal by Subject|24|||
144519000|NCT02807636|521103221|FG000|Overall Study|Death|303|||
144519001|NCT02807636|521103222|FG001|Overall Study|Death|332|||
144519002|NCT02807636|521103223|FG002|Overall Study|Death|272|||
144519003|NCT02807636|521103221|FG000|Overall Study|Study Terminated By Sponsor|47|||
144519004|NCT02807636|521103222|FG001|Overall Study|Study Terminated By Sponsor|76|||
144519005|NCT02807636|521103223|FG002|Overall Study|Study Terminated By Sponsor|60|||
144519006|NCT02807636|521103221|FG000|Overall Study|Physician Decision|0|||
144519007|NCT02807636|521103222|FG001|Overall Study|Physician Decision|1|||
144519008|NCT02807636|521103223|FG002|Overall Study|Physician Decision|0|||
144394817|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
144394818|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
144394819|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
144394820|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
144394821|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
144394822|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
144394823|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
144394824|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
144394825|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
144394826|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
144394827|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
144394828|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
144394829|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
144394830|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
144394831|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
144394832|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
144394833|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
144394834|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
144394835|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
144394836|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
144394837|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
144394838|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
144394839|NCT03963401|520657206|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
144394840|NCT03963401|520657207|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
144394841|NCT03963401|520657208|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
144394842|NCT03963401|520657209|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
144394843|NCT03963401|520657210|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
144394844|NCT03963401|520657211|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
144394845|NCT01437878|520657212|FG000|Overall Study|Withdrawal by Subject|1|||
144394846|NCT01437878|520657213|FG001|Overall Study|Withdrawal by Subject|0|||
144394847|NCT01070043|520657215|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
144394848|NCT01070043|520657216|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
144394849|NCT01070043|520657217|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
144394850|NCT01070043|520657215|FG000|Double-Blind Treatment|Adverse Event|0|||
144394851|NCT01070043|520657216|FG001|Double-Blind Treatment|Adverse Event|0|||
144394852|NCT01070043|520657217|FG002|Double-Blind Treatment|Adverse Event|2|||
144394853|NCT01476644|520657221|FG000|Overall Study|Death|5|||
144394854|NCT01476644|520657221|FG000|Overall Study|moved to another state|2|||
144394855|NCT01476644|520657221|FG000|Overall Study|Lost to Follow-up|19|||
144394856|NCT01476644|520657221|FG000|Overall Study|Withdrawal by Subject|13|||
144394857|NCT02393690|520657222|FG000|Overall Study|Ineligible|0|||
144394858|NCT02393690|520657223|FG001|Overall Study|Ineligible|1|||
144394859|NCT03488927|520657224|FG000|Overall Study|Withdrawal by Subject|44|||
144394860|NCT03488927|520657225|FG001|Overall Study|Withdrawal by Subject|118|||
144394861|NCT03488927|520657226|FG002|Overall Study|Withdrawal by Subject|217|||
144394862|NCT00586066|520657232|FG000|Overall Study|Lost to Follow-up|6|||
144394863|NCT00586066|520657233|FG001|Overall Study|Lost to Follow-up|3|||
144394864|NCT00586066|520657232|FG000|Overall Study|Lack of Efficacy|5|||
144394865|NCT00586066|520657233|FG001|Overall Study|Lack of Efficacy|3|||
144394866|NCT00586066|520657232|FG000|Overall Study|Adverse Event|2|||
144394867|NCT00586066|520657233|FG001|Overall Study|Adverse Event|2|||
144394868|NCT00586066|520657232|FG000|Overall Study|Physician Decision|1|||
144394869|NCT00586066|520657233|FG001|Overall Study|Physician Decision|0|||
144394870|NCT00586066|520657232|FG000|Overall Study|Withdrawal of consent|4|||
144394871|NCT00586066|520657233|FG001|Overall Study|Withdrawal of consent|2|||
144394872|NCT02676466|520657234|FG000|Overall Study|Death|0|||
144394873|NCT02676466|520657235|FG001|Overall Study|Death|2|||
144394874|NCT02676466|520657236|FG002|Overall Study|Death|1|||
144394875|NCT02676466|520657237|FG003|Overall Study|Death|0|||
144394876|NCT02676466|520657238|FG004|Overall Study|Death|0|||
144394877|NCT02676466|520657239|FG005|Overall Study|Death|0|||
144394878|NCT02676466|520657240|FG006|Overall Study|Death|0|||
144394879|NCT02676466|520657241|FG007|Overall Study|Death|0|||
144394880|NCT02676466|520657234|FG000|Overall Study|Withdrawal by Subject|4|||
144394881|NCT02676466|520657235|FG001|Overall Study|Withdrawal by Subject|3|||
144249556|NCT01211483|520111691|FG003|Phase 2|Lost to Follow-up|2|||
144394882|NCT02676466|520657236|FG002|Overall Study|Withdrawal by Subject|1|||
144394883|NCT02676466|520657237|FG003|Overall Study|Withdrawal by Subject|0|||
144394884|NCT02676466|520657238|FG004|Overall Study|Withdrawal by Subject|3|||
144394885|NCT02676466|520657239|FG005|Overall Study|Withdrawal by Subject|1|||
144394886|NCT02676466|520657240|FG006|Overall Study|Withdrawal by Subject|1|||
144394887|NCT02676466|520657241|FG007|Overall Study|Withdrawal by Subject|1|||
144394888|NCT03497676|520657242|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
144394889|NCT03497676|520657243|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
144394890|NCT03497676|520657244|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
144394891|NCT03497676|520657245|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
144394892|NCT03497676|520657242|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
144394893|NCT03497676|520657243|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
144394894|NCT03497676|520657244|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
144394895|NCT03497676|520657245|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
144394896|NCT03497676|520657242|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
144394897|NCT03497676|520657243|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
144394898|NCT03497676|520657244|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
144394899|NCT03497676|520657245|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
144394900|NCT03497676|520657242|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
144394901|NCT03497676|520657243|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
144394902|NCT03497676|520657244|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
144394903|NCT03497676|520657245|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
144394904|NCT03497676|520657242|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
144394905|NCT03497676|520657243|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
144394906|NCT03497676|520657244|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
144394907|NCT03497676|520657245|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
144394908|NCT03497676|520657242|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
144394909|NCT03497676|520657243|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
144394910|NCT03497676|520657244|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
144394911|NCT03497676|520657245|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
144394912|NCT03497676|520657242|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
144394913|NCT03497676|520657243|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
144394914|NCT03497676|520657244|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
144394915|NCT03497676|520657245|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
144394916|NCT03497676|520657242|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
144394917|NCT03497676|520657243|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
144394918|NCT03497676|520657244|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
144394919|NCT03497676|520657245|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
144394920|NCT00237185|520657246|FG000|Core|Adverse Event|3|||
144394921|NCT00237185|520657247|FG001|Core|Adverse Event|4|||
144394922|NCT00237185|520657246|FG000|Core|Abnormal laboratory value|0|||
144394923|NCT00237185|520657247|FG001|Core|Abnormal laboratory value|4|||
144394924|NCT00237185|520657246|FG000|Core|Abnormal test procedure results|1|||
144394925|NCT00237185|520657247|FG001|Core|Abnormal test procedure results|0|||
144394926|NCT00237185|520657246|FG000|Core|Lack of Efficacy|30|||
144394927|NCT00237185|520657247|FG001|Core|Lack of Efficacy|23|||
144394928|NCT00237185|520657246|FG000|Core|Protocol Violation|1|||
144394929|NCT00237185|520657247|FG001|Core|Protocol Violation|1|||
144394930|NCT00237185|520657246|FG000|Core|Withdrawal by Subject|4|||
144394931|NCT00237185|520657247|FG001|Core|Withdrawal by Subject|4|||
144394932|NCT00237185|520657246|FG000|Core|Administrative problems|0|||
144394933|NCT00237185|520657247|FG001|Core|Administrative problems|1|||
144394934|NCT00237185|520657246|FG000|Core|Death|4|||
144394935|NCT00237185|520657247|FG001|Core|Death|0|||
144394936|NCT00237185|520657246|FG000|Core|Determined ineligible post randomization|1|||
144394937|NCT00237185|520657247|FG001|Core|Determined ineligible post randomization|0|||
144394938|NCT00237185|520657246|FG000|Extension|Adverse Event|1|||
144394939|NCT00237185|520657247|FG001|Extension|Adverse Event|0|||
144394940|NCT00237185|520657246|FG000|Extension|Abnormal laboratory value|0|||
144394941|NCT00237185|520657247|FG001|Extension|Abnormal laboratory value|1|||
144394942|NCT00237185|520657246|FG000|Extension|Lack of Efficacy|9|||
144394943|NCT00237185|520657247|FG001|Extension|Lack of Efficacy|14|||
144394944|NCT00237185|520657246|FG000|Extension|Condition no longer required study drug|0|||
144394945|NCT00237185|520657247|FG001|Extension|Condition no longer required study drug|1|||
144394946|NCT00237185|520657246|FG000|Extension|Withdrawal by Subject|3|||
144394947|NCT00237185|520657247|FG001|Extension|Withdrawal by Subject|2|||
144394948|NCT00237185|520657246|FG000|Extension|Lost to Follow-up|1|||
144394949|NCT00237185|520657247|FG001|Extension|Lost to Follow-up|0|||
144394950|NCT00237185|520657246|FG000|Extension|Administrative problems|1|||
144394951|NCT00237185|520657247|FG001|Extension|Administrative problems|0|||
144394952|NCT00237185|520657246|FG000|Extension|Death|1|||
144394953|NCT00237185|520657247|FG001|Extension|Death|1|||
144394954|NCT02204007|520657248|FG000|Overall Study|Surgery Canceled|1|||
144394955|NCT02204007|520657249|FG001|Overall Study|Surgery Canceled|1|||
144394956|NCT00760084|520657250|FG000|Overall Study|Physician Decision|5|||
144394957|NCT00760084|520657250|FG000|Overall Study|Withdrawal by Subject|2|||
144394958|NCT00760084|520657250|FG000|Overall Study|Progressive Disease|3|||
144394959|NCT02750943|520657253|FG000|Overall Study|Lost to Follow-up|1|||
144394960|NCT02750943|520657254|FG001|Overall Study|Lost to Follow-up|2|||
144394961|NCT02750943|520657253|FG000|Overall Study|Withdrawal by Subject|5|||
144394962|NCT02750943|520657254|FG001|Overall Study|Withdrawal by Subject|7|||
144394963|NCT04382755|520657255|FG000|Overall Study|Withdrawal by Subject|1|||
144394964|NCT04382755|520657256|FG001|Overall Study|Withdrawal by Subject|0|||
144394965|NCT04382755|520657255|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
144394966|NCT04382755|520657256|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
144394967|NCT04382755|520657255|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
144519009|NCT05227209|521103225|FG000|Overall Study|Adverse Event|11|||
144519010|NCT05227209|521103225|FG000|Overall Study|Lost to Follow-up|1|||
144519011|NCT05227209|521103225|FG000|Overall Study|Withdrawal by Subject|7|||
144519012|NCT05227209|521103225|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
144519013|NCT02287610|521103226|FG000|Overall Study|Lost to Follow-up|3|||
144519014|NCT02287610|521103226|FG000|Overall Study|Withdrawal by Subject|8|||
144519015|NCT02287610|521103226|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
144519016|NCT04950660|521103227|FG000|Overall Study|Protocol Violation|4|||
144394968|NCT04382755|520657256|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
144394969|NCT03552965|520657260|FG000|Overall Study|Death|1|||
144394970|NCT03552965|520657261|FG001|Overall Study|Death|1|||
144394971|NCT03552965|520657260|FG000|Overall Study|Lost to Follow-up|1|||
144394972|NCT03552965|520657261|FG001|Overall Study|Lost to Follow-up|1|||
144394973|NCT03552965|520657260|FG000|Overall Study|Physician Decision|1|||
144394974|NCT03552965|520657261|FG001|Overall Study|Physician Decision|1|||
144394975|NCT03552965|520657260|FG000|Overall Study|Withdrawal by Subject|0|||
144394976|NCT03552965|520657261|FG001|Overall Study|Withdrawal by Subject|2|||
144519017|NCT04950660|521103228|FG001|Overall Study|Protocol Violation|2|||
144394977|NCT03552965|520657260|FG000|Overall Study|Continuation not in patient best interest|1|||
144722222|NCT02146430|521838644|FG002|Overall Study|Lack of Efficacy|8|||
144394978|NCT03552965|520657261|FG001|Overall Study|Continuation not in patient best interest|0|||
144394979|NCT03552965|520657260|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
144394980|NCT03552965|520657261|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
144519018|NCT04950660|521103227|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
144519019|NCT04950660|521103228|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
144519020|NCT04950660|521103227|FG000|Overall Study|Withdrawal by Subject|0|||
144519021|NCT04950660|521103228|FG001|Overall Study|Withdrawal by Subject|1|||
144519022|NCT04950660|521103227|FG000|Overall Study|Hypotension|1|||
144519023|NCT04950660|521103228|FG001|Overall Study|Hypotension|0|||
144394981|NCT03120624|520657262|FG000|Overall Study|Withdrawal by Subject|0|||
144394982|NCT03120624|520657263|FG001|Overall Study|Withdrawal by Subject|1|||
144394983|NCT03120624|520657264|FG002|Overall Study|Withdrawal by Subject|0|||
144394984|NCT03120624|520657265|FG003|Overall Study|Withdrawal by Subject|0|||
144394985|NCT03120624|520657266|FG004|Overall Study|Withdrawal by Subject|0|||
144594600|NCT04677179|521377917|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
144594601|NCT04677179|521377918|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
144594602|NCT04677179|521377919|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
144594603|NCT04677179|521377920|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
144594604|NCT04677179|521377921|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
144594605|NCT04677179|521377922|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
144594606|NCT04677179|521377923|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
144594607|NCT04677179|521377924|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
144594608|NCT04677179|521377925|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
144594609|NCT04677179|521377926|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
144594610|NCT04677179|521377917|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594611|NCT04677179|521377918|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594612|NCT04677179|521377919|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594613|NCT04677179|521377920|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
144594614|NCT04677179|521377921|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594615|NCT04677179|521377922|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594616|NCT04677179|521377923|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594617|NCT04677179|521377924|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594618|NCT04677179|521377925|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594619|NCT04677179|521377926|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
144594620|NCT04677179|521377917|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594621|NCT04677179|521377918|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594622|NCT04677179|521377919|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594623|NCT04677179|521377920|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
144594624|NCT04677179|521377921|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
144594625|NCT04677179|521377922|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
144594626|NCT04677179|521377923|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594627|NCT04677179|521377924|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594628|NCT04677179|521377925|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594629|NCT04677179|521377926|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
144594630|NCT04677179|521377917|FG000|Extension Treatment Period|Lack of Efficacy|0|||
144594631|NCT04677179|521377918|FG001|Extension Treatment Period|Lack of Efficacy|0|||
144594632|NCT04677179|521377919|FG002|Extension Treatment Period|Lack of Efficacy|0|||
144594633|NCT04677179|521377920|FG003|Extension Treatment Period|Lack of Efficacy|0|||
144594634|NCT04677179|521377921|FG004|Extension Treatment Period|Lack of Efficacy|0|||
144594635|NCT04677179|521377922|FG005|Extension Treatment Period|Lack of Efficacy|0|||
144594636|NCT04677179|521377923|FG006|Extension Treatment Period|Lack of Efficacy|6|||
144594637|NCT04677179|521377924|FG007|Extension Treatment Period|Lack of Efficacy|0|||
144594638|NCT04677179|521377925|FG008|Extension Treatment Period|Lack of Efficacy|0|||
144594639|NCT04677179|521377926|FG009|Extension Treatment Period|Lack of Efficacy|0|||
144594640|NCT04677179|521377917|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
144594641|NCT04677179|521377918|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
144594642|NCT04677179|521377919|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
144594643|NCT04677179|521377920|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
144594644|NCT04677179|521377921|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
144594645|NCT04677179|521377922|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
144594646|NCT04677179|521377923|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
144594647|NCT04677179|521377924|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
144594648|NCT04677179|521377925|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
144594649|NCT04677179|521377926|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
144394986|NCT03120624|520657267|FG005|Overall Study|Withdrawal by Subject|0|||
144394987|NCT03120624|520657268|FG006|Overall Study|Withdrawal by Subject|0|||
144394988|NCT03120624|520657269|FG007|Overall Study|Withdrawal by Subject|0|||
144394989|NCT01846104|520658604|FG000|Overall Study|Withdrawal by Subject|1|||
144394990|NCT00851630|520658605|FG000|Overall Study|Death|2|||
144394991|NCT00851630|520658606|FG001|Overall Study|Death|1|||
144394992|NCT00851630|520658605|FG000|Overall Study|Clinical failure|0|||
144394993|NCT00851630|520658606|FG001|Overall Study|Clinical failure|1|||
144394994|NCT00401531|520658607|FG000|Overall Study|Adverse Event|2|||
144394995|NCT00401531|520658608|FG001|Overall Study|Adverse Event|0|||
144594650|NCT04677179|521377917|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
144594651|NCT04677179|521377918|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
144594652|NCT04677179|521377919|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
144394996|NCT00401531|520658607|FG000|Overall Study|Protocol Violation|3|||
144394997|NCT00401531|520658608|FG001|Overall Study|Protocol Violation|7|||
144394998|NCT00401531|520658607|FG000|Overall Study|Lost to Follow-up|1|||
144394999|NCT00401531|520658608|FG001|Overall Study|Lost to Follow-up|1|||
144395000|NCT00401531|520658607|FG000|Overall Study|Withdrawal by Subject|3|||
144395001|NCT00401531|520658608|FG001|Overall Study|Withdrawal by Subject|2|||
144395002|NCT02437513|520658609|FG000|Overall Study|Withdrawal by Subject|2|||
144519024|NCT04783935|521103235|FG000|Overall Study|Withdrawal by Subject|6|||
144519025|NCT04783935|521103235|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
144519026|NCT04783935|521103235|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
144519027|NCT04783935|521103235|FG000|Overall Study|Lost to Follow-up|3|||
144519028|NCT04783935|521103235|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
144519029|NCT02437318|521103237|FG000|Overall Study|Progressive disease|207|||
144519030|NCT02437318|521103238|FG001|Overall Study|Progressive disease|240|||
144519031|NCT02437318|521103237|FG000|Overall Study|Subject/guardian decision|24|||
144519032|NCT02437318|521103238|FG001|Overall Study|Subject/guardian decision|11|||
144519033|NCT02437318|521103237|FG000|Overall Study|Physician Decision|29|||
144519034|NCT02437318|521103238|FG001|Overall Study|Physician Decision|22|||
144519035|NCT02437318|521103237|FG000|Overall Study|Adverse Event|14|||
144519036|NCT02437318|521103238|FG001|Overall Study|Adverse Event|4|||
144519037|NCT02437318|521103237|FG000|Overall Study|Death|4|||
144519038|NCT02437318|521103238|FG001|Overall Study|Death|4|||
144519039|NCT02437318|521103237|FG000|Overall Study|Protocol deviation|5|||
144519040|NCT02437318|521103238|FG001|Overall Study|Protocol deviation|7|||
144519041|NCT02437318|521103237|FG000|Overall Study|Sponsor decision|1|||
144519042|NCT02437318|521103238|FG001|Overall Study|Sponsor decision|0|||
144519043|NCT01426425|521103240|FG000|Overall Study|Exited prior to EP study|22|||
144519044|NCT01426425|521103240|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
144722223|NCT02146430|521838645|FG003|Overall Study|Lack of Efficacy|5|||
144395003|NCT03956056|520658612|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
144519045|NCT01426425|521103240|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
144519046|NCT00961571|521103246|FG000|Overall Study|Physician Decision|39|||
144519047|NCT05337748|521103248|FG000|Overall Study|Withdrawal by Subject|1|||
144519048|NCT05337748|521103249|FG001|Overall Study|Withdrawal by Subject|0|||
144519049|NCT05337748|521103248|FG000|Overall Study|Death|1|||
144519050|NCT05337748|521103249|FG001|Overall Study|Death|0|||
144519051|NCT02506959|521103250|FG000|Overall Study|Physician Decision|2|||
144519052|NCT02506959|521103251|FG001|Overall Study|Physician Decision|1|||
144519053|NCT03143153|521103257|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
144519054|NCT03143153|521103258|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
144519055|NCT03143153|521103259|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
144519056|NCT03143153|521103257|FG000|Pre-Treatment|Participant withdrew consent|0|||
144519057|NCT03143153|521103258|FG001|Pre-Treatment|Participant withdrew consent|1|||
144519058|NCT03143153|521103259|FG002|Pre-Treatment|Participant withdrew consent|12|||
144519059|NCT03143153|521103257|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
144722224|NCT02146430|521838642|FG000|Overall Study|Adverse Event|20|||
144722225|NCT02146430|521838643|FG001|Overall Study|Adverse Event|40|||
144519060|NCT03143153|521103258|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
144519061|NCT03143153|521103259|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
144519062|NCT03143153|521103257|FG000|Pre-Treatment|Other Reasons|1|||
144722226|NCT02146430|521838644|FG002|Overall Study|Adverse Event|32|||
144722227|NCT02146430|521838645|FG003|Overall Study|Adverse Event|49|||
144395004|NCT03956056|520658612|FG000|Overall Study|Lack of Efficacy|1|||
144395005|NCT03347188|520658613|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
144395006|NCT03347188|520658614|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
144395007|NCT03347188|520658613|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
144519063|NCT03143153|521103258|FG001|Pre-Treatment|Other Reasons|2|||
144519064|NCT03143153|521103259|FG002|Pre-Treatment|Other Reasons|1|||
144519065|NCT03143153|521103257|FG000|Pre-Treatment|Disease Progression|1|||
144519066|NCT03143153|521103258|FG001|Pre-Treatment|Disease Progression|1|||
144519067|NCT03143153|521103259|FG002|Pre-Treatment|Disease Progression|2|||
144519068|NCT03143153|521103257|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
144519069|NCT03143153|521103258|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
144519070|NCT03143153|521103259|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
144519071|NCT03143153|521103257|FG000|Treatment|Disease progression|174|||
144519072|NCT03143153|521103258|FG001|Treatment|Disease progression|184|||
144519073|NCT03143153|521103259|FG002|Treatment|Disease progression|193|||
144519074|NCT03143153|521103257|FG000|Treatment|Study drug toxicity|59|||
144519075|NCT03143153|521103258|FG001|Treatment|Study drug toxicity|33|||
144519076|NCT03143153|521103259|FG002|Treatment|Study drug toxicity|40|||
144395008|NCT03347188|520658614|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
144395009|NCT03347188|520658613|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
144395010|NCT03347188|520658614|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
144395011|NCT03347188|520658613|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
144395012|NCT03347188|520658614|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
144395013|NCT03347188|520658613|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
144395014|NCT03347188|520658614|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
144395015|NCT03347188|520658613|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
144395016|NCT03347188|520658614|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
144395017|NCT03347188|520658613|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
144395018|NCT03347188|520658614|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
144395019|NCT03347188|520658613|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
144395020|NCT03347188|520658614|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
144395021|NCT03403374|520658615|FG000|Overall Study|Lost to Follow-up|1|||
144395022|NCT00107783|520658616|FG000|Overall Study|Adverse Event|0|||
144395023|NCT00107783|520658617|FG001|Overall Study|Adverse Event|2|||
144395024|NCT00107783|520658616|FG000|Overall Study|Death|0|||
144395025|NCT00107783|520658617|FG001|Overall Study|Death|1|||
144395026|NCT00107783|520658616|FG000|Overall Study|Withdrawal by Subject|2|||
144395027|NCT00107783|520658617|FG001|Overall Study|Withdrawal by Subject|0|||
144395028|NCT00107783|520658616|FG000|Overall Study|Second hip replacement|1|||
144395029|NCT00107783|520658617|FG001|Overall Study|Second hip replacement|1|||
144395030|NCT04879225|520658618|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
144395031|NCT04879225|520658618|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
144395032|NCT00736957|520658621|FG000|Overall Study|Adverse Event|43|||
144395033|NCT00736957|520658621|FG000|Overall Study|Withdrawal by Subject|49|||
144395034|NCT00736957|520658621|FG000|Overall Study|violation of eligibility criteria|2|||
144395035|NCT00736957|520658621|FG000|Overall Study|did not attend hospital appointments|1|||
144395036|NCT00736957|520658621|FG000|Overall Study|not eligible for Treatment Period I|22|||
144395037|NCT00736957|520658621|FG000|Overall Study|Physician Decision|5|||
144395038|NCT00422097|520658622|FG000|Dose Level 2|Still on treatment|0|||
144395039|NCT00422097|520658623|FG001|Dose Level 2|Still on treatment|1|||
144395040|NCT00422097|520658624|FG002|Dose Level 2|Still on treatment|0|||
144395041|NCT00422097|520658625|FG003|Dose Level 2|Still on treatment|0|||
144395042|NCT00422097|520658626|FG004|Dose Level 2|Still on treatment|0|||
144395043|NCT00422097|520658627|FG005|Dose Level 2|Still on treatment|0|||
144395044|NCT00422097|520658628|FG006|Dose Level 2|Still on treatment|0|||
144395045|NCT00422097|520658629|FG007|Dose Level 2|Still on treatment|0|||
144395046|NCT02360995|520658630|FG000|Overall Study|Lost to Follow-up|2|||
144395047|NCT02360995|520658631|FG001|Overall Study|Lost to Follow-up|0|||
144395048|NCT02360995|520658632|FG002|Overall Study|Lost to Follow-up|2|||
144395049|NCT02360995|520658630|FG000|Overall Study|Withdrawal by Subject|0|||
144395050|NCT02360995|520658631|FG001|Overall Study|Withdrawal by Subject|1|||
144395051|NCT02360995|520658632|FG002|Overall Study|Withdrawal by Subject|0|||
144395052|NCT01409434|520658633|FG000|Overall Study|Protocol Violation|4|||
144395053|NCT01229371|520658636|FG000|Overall Study|Withdrawal by Subject|0|||
144395054|NCT01229371|520658637|FG001|Overall Study|Withdrawal by Subject|1|||
144395055|NCT01229371|520658638|FG002|Overall Study|Withdrawal by Subject|0|||
144395056|NCT01229371|520658639|FG003|Overall Study|Withdrawal by Subject|0|||
144395057|NCT02007512|520658640|FG000|Double Blind Treatment Period|Adverse Event|4|||
144395058|NCT02007512|520658641|FG001|Double Blind Treatment Period|Adverse Event|6|||
144395059|NCT02007512|520658642|FG002|Double Blind Treatment Period|Adverse Event|2|||
144395060|NCT02007512|520658643|FG003|Double Blind Treatment Period|Adverse Event|2|||
144395061|NCT02007512|520658640|FG000|Double Blind Treatment Period|Death|1|||
144395062|NCT02007512|520658641|FG001|Double Blind Treatment Period|Death|0|||
144395063|NCT02007512|520658642|FG002|Double Blind Treatment Period|Death|0|||
144395064|NCT02007512|520658643|FG003|Double Blind Treatment Period|Death|0|||
144395065|NCT02007512|520658640|FG000|Double Blind Treatment Period|Disease progression|51|||
144395066|NCT02007512|520658641|FG001|Double Blind Treatment Period|Disease progression|50|||
144395067|NCT02007512|520658642|FG002|Double Blind Treatment Period|Disease progression|57|||
144395068|NCT02007512|520658643|FG003|Double Blind Treatment Period|Disease progression|52|||
144519077|NCT03143153|521103257|FG000|Treatment|Death|5|||
144519078|NCT03143153|521103258|FG001|Treatment|Death|3|||
144519079|NCT03143153|521103259|FG002|Treatment|Death|4|||
144519080|NCT03143153|521103257|FG000|Treatment|Adverse event unrelated to study drug|19|||
144395069|NCT02007512|520658640|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
144519081|NCT03143153|521103258|FG001|Treatment|Adverse event unrelated to study drug|28|||
144519082|NCT03143153|521103259|FG002|Treatment|Adverse event unrelated to study drug|12|||
144519083|NCT03143153|521103257|FG000|Treatment|Participant request to discontinue study treatment|13|||
144395070|NCT02007512|520658641|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
144395071|NCT02007512|520658642|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
144395072|NCT02007512|520658643|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
144395073|NCT02007512|520658640|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144395074|NCT02007512|520658641|FG001|Double Blind Treatment Period|Protocol Violation|0|||
144395075|NCT02007512|520658642|FG002|Double Blind Treatment Period|Protocol Violation|0|||
144395076|NCT02007512|520658643|FG003|Double Blind Treatment Period|Protocol Violation|1|||
144395077|NCT02007512|520658640|FG000|Double Blind Treatment Period|Other|2|||
144395078|NCT02007512|520658641|FG001|Double Blind Treatment Period|Other|1|||
144395079|NCT02007512|520658642|FG002|Double Blind Treatment Period|Other|1|||
144395080|NCT02007512|520658643|FG003|Double Blind Treatment Period|Other|2|||
144395081|NCT02007512|520658640|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
144395082|NCT02007512|520658641|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
144395083|NCT02007512|520658642|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
144395084|NCT02007512|520658643|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
144395085|NCT02007512|520658640|FG000|Open Label Treatment Period|Adverse Event|1|||
144395086|NCT02007512|520658641|FG001|Open Label Treatment Period|Adverse Event|0|||
144395087|NCT02007512|520658642|FG002|Open Label Treatment Period|Adverse Event|0|||
144395088|NCT02007512|520658643|FG003|Open Label Treatment Period|Adverse Event|0|||
144395089|NCT02007512|520658640|FG000|Open Label Treatment Period|Other|1|||
144395090|NCT02007512|520658641|FG001|Open Label Treatment Period|Other|1|||
144395091|NCT02007512|520658642|FG002|Open Label Treatment Period|Other|0|||
144395092|NCT02007512|520658643|FG003|Open Label Treatment Period|Other|0|||
144395093|NCT02007512|520658640|FG000|Open Label Treatment Period|Disease progression|23|||
144395094|NCT02007512|520658641|FG001|Open Label Treatment Period|Disease progression|11|||
144395095|NCT02007512|520658642|FG002|Open Label Treatment Period|Disease progression|0|||
144395096|NCT02007512|520658643|FG003|Open Label Treatment Period|Disease progression|0|||
144395097|NCT03026088|520658644|FG000|Overall Study|Study termination|20|||
144395098|NCT00760214|520658652|FG000|Overall Study|Adverse Event|8|||
144395099|NCT00760214|520658653|FG001|Overall Study|Adverse Event|9|||
144395100|NCT00760214|520658654|FG002|Overall Study|Adverse Event|12|||
144395101|NCT00760214|520658652|FG000|Overall Study|Protocol Violation|3|||
144395102|NCT00760214|520658653|FG001|Overall Study|Protocol Violation|0|||
144395103|NCT00760214|520658654|FG002|Overall Study|Protocol Violation|3|||
144395104|NCT00760214|520658652|FG000|Overall Study|Lost to Follow-up|0|||
144395105|NCT00760214|520658653|FG001|Overall Study|Lost to Follow-up|0|||
144395106|NCT00760214|520658654|FG002|Overall Study|Lost to Follow-up|1|||
144395107|NCT00760214|520658652|FG000|Overall Study|Withdrawal by Subject|12|||
144395108|NCT00760214|520658653|FG001|Overall Study|Withdrawal by Subject|14|||
144395109|NCT00760214|520658654|FG002|Overall Study|Withdrawal by Subject|13|||
144395110|NCT00760214|520658652|FG000|Overall Study|Lack of Efficacy|3|||
144395111|NCT00760214|520658653|FG001|Overall Study|Lack of Efficacy|2|||
144395112|NCT00760214|520658654|FG002|Overall Study|Lack of Efficacy|4|||
144395113|NCT00760214|520658652|FG000|Overall Study|Pregnancy|0|||
144395114|NCT00760214|520658653|FG001|Overall Study|Pregnancy|0|||
144395115|NCT00760214|520658654|FG002|Overall Study|Pregnancy|1|||
144395116|NCT00760214|520658652|FG000|Overall Study|Physician Decision|1|||
144395117|NCT00760214|520658653|FG001|Overall Study|Physician Decision|1|||
144395118|NCT00760214|520658654|FG002|Overall Study|Physician Decision|1|||
144395119|NCT00760214|520658652|FG000|Overall Study|Other|3|||
144395120|NCT00760214|520658653|FG001|Overall Study|Other|4|||
144395121|NCT00760214|520658654|FG002|Overall Study|Other|6|||
144395122|NCT03960554|520658658|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
144395123|NCT03960554|520658659|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
144395124|NCT02360111|520658660|FG000|Overall Study|Death|2|||
144395125|NCT01933217|520658665|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
144395126|NCT01933217|520658666|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
144395127|NCT01933217|520658665|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
144395128|NCT01933217|520658666|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
144395129|NCT03923738|520658669|FG000|Period 1|Adverse Event|1|||
144395130|NCT03923738|520658669|FG000|Period 1|Withdrawal by Subject|1|||
144395131|NCT05246397|520658671|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
144395132|NCT03583164|520658674|FG000|Overall Study|Death in Main Phase|35|||
144395133|NCT03583164|520658674|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
144395134|NCT03583164|520658674|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
144395135|NCT03583164|520658674|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
144395136|NCT03583164|520658674|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
144395137|NCT03583164|520658674|FG000|Overall Study|Physician decision in Main Phase|1|||
144395138|NCT03583164|520658674|FG000|Overall Study|Physician decision in Extended Phase|2|||
144519084|NCT03143153|521103258|FG001|Treatment|Participant request to discontinue study treatment|15|||
144519085|NCT03143153|521103259|FG002|Treatment|Participant request to discontinue study treatment|20|||
144395139|NCT03583164|520658674|FG000|Overall Study|Death in Extended Phase|13|||
144395140|NCT03583164|520658674|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
144395141|NCT03583164|520658674|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
144395142|NCT03583164|520658674|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
144395143|NCT03583164|520658674|FG000|Overall Study|Treatment failure in Main Phase|2|||
144395144|NCT03583164|520658674|FG000|Overall Study|Treatment failure in Extended Phase|4|||
144395145|NCT03583164|520658674|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
144395146|NCT03583164|520658674|FG000|Overall Study|Other not specified reason in Main Phase|2|||
144395147|NCT00735254|520658675|FG000|Overall Study|Protocol Violation|1|||
144395148|NCT00735254|520658676|FG001|Overall Study|Protocol Violation|1|||
144395149|NCT00735254|520658677|FG002|Overall Study|Protocol Violation|1|||
144395150|NCT00735254|520658678|FG003|Overall Study|Protocol Violation|0|||
144395151|NCT01251744|520658682|FG000|Overall Study|Lost to Follow-up|1|||
144395152|NCT01251744|520658683|FG001|Overall Study|Lost to Follow-up|0|||
144395153|NCT00214500|520658688|FG000|Treatment Period|Adverse Event|1|||
144395154|NCT00214500|520658688|FG000|Extension Period|Withdrawal by Subject|2|||
144395155|NCT00147251|520658689|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
144395156|NCT00147251|520658690|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
144395157|NCT00751621|520658691|FG000|Overall Study|Adverse Event|1|||
144395158|NCT00751621|520658691|FG000|Overall Study|Withdrawal by Subject|1|||
144594653|NCT04677179|521377920|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
144594654|NCT04677179|521377921|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
144594655|NCT04677179|521377922|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
144594656|NCT04677179|521377923|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
144594657|NCT04677179|521377924|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
144594658|NCT04677179|521377925|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
144594659|NCT04677179|521377926|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
144594660|NCT04677179|521377917|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
144594661|NCT04677179|521377918|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
144594662|NCT04677179|521377919|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
144594663|NCT04677179|521377920|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
144594664|NCT04677179|521377921|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
144395159|NCT00751621|520658691|FG000|Overall Study|Subject moved to another country|1|||
144395160|NCT00751621|520658691|FG000|Overall Study|Poor adherence to asthma treatment|1|||
144395161|NCT02694523|520658693|FG000|Part A|Adverse Event|7|||
144395162|NCT02694523|520658694|FG001|Part A|Adverse Event|3|||
144395163|NCT02694523|520658695|FG002|Part A|Adverse Event|0|||
144395164|NCT02694523|520658696|FG003|Part A|Adverse Event|0|||
144395165|NCT02694523|520658697|FG004|Part A|Adverse Event|0|||
144395166|NCT02694523|520658698|FG005|Part A|Adverse Event|0|||
144395167|NCT02694523|520658699|FG006|Part A|Adverse Event|0|||
144395168|NCT02694523|520658693|FG000|Part A|Protocol Violation|1|||
144395169|NCT02694523|520658694|FG001|Part A|Protocol Violation|0|||
144594665|NCT04677179|521377922|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
144594666|NCT04677179|521377923|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
144594667|NCT04677179|521377924|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
144594668|NCT04677179|521377925|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
144594669|NCT04677179|521377926|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
144594670|NCT04677179|521377917|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144395170|NCT02694523|520658695|FG002|Part A|Protocol Violation|0|||
144395171|NCT02694523|520658696|FG003|Part A|Protocol Violation|0|||
144722228|NCT02146430|521838642|FG000|Overall Study|Reason missing or not reported|2|||
144395172|NCT02694523|520658697|FG004|Part A|Protocol Violation|0|||
144395173|NCT02694523|520658698|FG005|Part A|Protocol Violation|0|||
144395174|NCT02694523|520658699|FG006|Part A|Protocol Violation|0|||
144395175|NCT02694523|520658693|FG000|Part A|Lost to Follow-up|1|||
144395176|NCT02694523|520658694|FG001|Part A|Lost to Follow-up|2|||
144395177|NCT02694523|520658695|FG002|Part A|Lost to Follow-up|0|||
144594671|NCT04677179|521377918|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144594672|NCT04677179|521377919|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144395178|NCT02694523|520658696|FG003|Part A|Lost to Follow-up|0|||
144395179|NCT02694523|520658697|FG004|Part A|Lost to Follow-up|0|||
144395180|NCT02694523|520658698|FG005|Part A|Lost to Follow-up|0|||
144395181|NCT02694523|520658699|FG006|Part A|Lost to Follow-up|0|||
144395182|NCT02694523|520658693|FG000|Part A|Withdrawal by Subject|3|||
144395183|NCT02694523|520658694|FG001|Part A|Withdrawal by Subject|1|||
144395184|NCT02694523|520658695|FG002|Part A|Withdrawal by Subject|0|||
144395185|NCT02694523|520658696|FG003|Part A|Withdrawal by Subject|0|||
144395186|NCT02694523|520658697|FG004|Part A|Withdrawal by Subject|0|||
144395187|NCT02694523|520658698|FG005|Part A|Withdrawal by Subject|0|||
144594673|NCT04677179|521377920|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144594674|NCT04677179|521377921|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144395188|NCT02694523|520658699|FG006|Part A|Withdrawal by Subject|0|||
144395189|NCT02694523|520658693|FG000|Part A|Other|1|||
144395190|NCT02694523|520658694|FG001|Part A|Other|1|||
144395191|NCT02694523|520658695|FG002|Part A|Other|0|||
144395192|NCT02694523|520658696|FG003|Part A|Other|0|||
144395193|NCT02694523|520658697|FG004|Part A|Other|0|||
144594675|NCT04677179|521377922|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144594676|NCT04677179|521377923|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144594677|NCT04677179|521377924|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
144594678|NCT04677179|521377925|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
144594679|NCT04677179|521377926|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
144594680|NCT04677179|521377917|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594681|NCT04677179|521377918|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594682|NCT04677179|521377919|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594683|NCT04677179|521377920|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594684|NCT04677179|521377921|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594685|NCT04677179|521377922|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594686|NCT04677179|521377923|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594687|NCT04677179|521377924|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
144594688|NCT04677179|521377925|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594689|NCT04677179|521377926|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144594690|NCT04677179|521377917|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594691|NCT04677179|521377918|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594692|NCT04677179|521377919|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594693|NCT04677179|521377920|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594694|NCT04677179|521377921|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594695|NCT04677179|521377922|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594696|NCT04677179|521377923|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594697|NCT04677179|521377924|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
144594698|NCT04677179|521377925|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
144594699|NCT04677179|521377926|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144594700|NCT04677179|521377917|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144594701|NCT04677179|521377918|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144594702|NCT04677179|521377919|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144594703|NCT04677179|521377920|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144594704|NCT04677179|521377921|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144594705|NCT04677179|521377922|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144395194|NCT02694523|520658698|FG005|Part A|Other|0|||
144395195|NCT02694523|520658699|FG006|Part A|Other|0|||
144722229|NCT02146430|521838643|FG001|Overall Study|Reason missing or not reported|3|||
144594706|NCT04677179|521377923|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
144594707|NCT04677179|521377924|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
144594708|NCT04677179|521377925|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
144594709|NCT04677179|521377926|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
144395196|NCT02694523|520658693|FG000|Part B|Adverse Event|0|||
144395197|NCT02694523|520658694|FG001|Part B|Adverse Event|0|||
144395198|NCT02694523|520658695|FG002|Part B|Adverse Event|7|||
144395199|NCT02694523|520658696|FG003|Part B|Adverse Event|1|||
144395200|NCT02694523|520658697|FG004|Part B|Adverse Event|1|||
144594710|NCT00511901|521377931|FG000|Overall Study|Withdrawal by Subject|1|||
144594711|NCT00511901|521377932|FG001|Overall Study|Withdrawal by Subject|3|||
144594712|NCT04640077|521377936|FG000|Period 1|Withdrawal by Subject|4|||
144594713|NCT04640077|521377937|FG001|Period 1|Withdrawal by Subject|5|||
144594714|NCT04640077|521377938|FG002|Period 1|Withdrawal by Subject|0|||
144594715|NCT04640077|521377936|FG000|Period 1|Adverse Event|1|||
144594716|NCT04640077|521377937|FG001|Period 1|Adverse Event|1|||
144594717|NCT04640077|521377938|FG002|Period 1|Adverse Event|0|||
144594718|NCT04640077|521377936|FG000|Period 1|Screen Failure|2|||
144594719|NCT04640077|521377937|FG001|Period 1|Screen Failure|0|||
144594720|NCT04640077|521377938|FG002|Period 1|Screen Failure|0|||
144594721|NCT04640077|521377936|FG000|Period 2|Withdrawal by Subject|0|||
144594722|NCT04640077|521377937|FG001|Period 2|Withdrawal by Subject|0|||
144594723|NCT04640077|521377938|FG002|Period 2|Withdrawal by Subject|18|||
144594724|NCT04640077|521377936|FG000|Period 2|Adverse Event|0|||
144395201|NCT02694523|520658698|FG005|Part B|Adverse Event|2|||
144395202|NCT02694523|520658699|FG006|Part B|Adverse Event|0|||
144395203|NCT02694523|520658693|FG000|Part B|Protocol Violation|0|||
144395204|NCT02694523|520658694|FG001|Part B|Protocol Violation|0|||
144395205|NCT02694523|520658695|FG002|Part B|Protocol Violation|1|||
144395206|NCT02694523|520658696|FG003|Part B|Protocol Violation|0|||
144395207|NCT02694523|520658697|FG004|Part B|Protocol Violation|0|||
144395208|NCT02694523|520658698|FG005|Part B|Protocol Violation|0|||
144395209|NCT02694523|520658699|FG006|Part B|Protocol Violation|0|||
144395210|NCT02694523|520658693|FG000|Part B|Lost to Follow-up|0|||
144395211|NCT02694523|520658694|FG001|Part B|Lost to Follow-up|0|||
144395212|NCT02694523|520658695|FG002|Part B|Lost to Follow-up|2|||
144395213|NCT02694523|520658696|FG003|Part B|Lost to Follow-up|3|||
144395214|NCT02694523|520658697|FG004|Part B|Lost to Follow-up|2|||
144395215|NCT02694523|520658698|FG005|Part B|Lost to Follow-up|0|||
144395216|NCT02694523|520658699|FG006|Part B|Lost to Follow-up|1|||
144395217|NCT02694523|520658693|FG000|Part B|Withdrawal by Subject|0|||
144395218|NCT02694523|520658694|FG001|Part B|Withdrawal by Subject|0|||
144395219|NCT02694523|520658695|FG002|Part B|Withdrawal by Subject|9|||
144395220|NCT02694523|520658696|FG003|Part B|Withdrawal by Subject|0|||
144395221|NCT02694523|520658697|FG004|Part B|Withdrawal by Subject|1|||
144395222|NCT02694523|520658698|FG005|Part B|Withdrawal by Subject|3|||
144395223|NCT02694523|520658699|FG006|Part B|Withdrawal by Subject|0|||
144395224|NCT02694523|520658693|FG000|Part B|Other|0|||
144395225|NCT02694523|520658694|FG001|Part B|Other|0|||
144395226|NCT02694523|520658695|FG002|Part B|Other|1|||
144395227|NCT02694523|520658696|FG003|Part B|Other|0|||
144395228|NCT02694523|520658697|FG004|Part B|Other|0|||
144395229|NCT02694523|520658698|FG005|Part B|Other|0|||
144395230|NCT02694523|520658699|FG006|Part B|Other|1|||
144395231|NCT01086423|520658700|FG000|Overall Study|Protocol Violation|0|||
144395232|NCT01086423|520658701|FG001|Overall Study|Protocol Violation|0|||
144395233|NCT01086423|520658702|FG002|Overall Study|Protocol Violation|1|||
144395234|NCT01086423|520658700|FG000|Overall Study|Migrated/moved from study area|2|||
144395235|NCT01086423|520658701|FG001|Overall Study|Migrated/moved from study area|0|||
144395236|NCT01086423|520658702|FG002|Overall Study|Migrated/moved from study area|4|||
144395237|NCT01086423|520658700|FG000|Overall Study|Adverse event, fatal|1|||
144395238|NCT01086423|520658701|FG001|Overall Study|Adverse event, fatal|1|||
144395239|NCT01086423|520658702|FG002|Overall Study|Adverse event, fatal|0|||
144395240|NCT01086423|520658700|FG000|Overall Study|Adverse event, non-fatal|2|||
144395241|NCT01086423|520658701|FG001|Overall Study|Adverse event, non-fatal|1|||
144395242|NCT01086423|520658702|FG002|Overall Study|Adverse event, non-fatal|0|||
144395243|NCT01086423|520658700|FG000|Overall Study|Withdrawal by Subject|5|||
144395244|NCT01086423|520658701|FG001|Overall Study|Withdrawal by Subject|1|||
144722230|NCT02146430|521838644|FG002|Overall Study|Reason missing or not reported|4|||
144722231|NCT02146430|521838645|FG003|Overall Study|Reason missing or not reported|5|||
144722232|NCT02146430|521838642|FG000|Overall Study|Withdrawal by Subject|27|||
144395245|NCT01086423|520658702|FG002|Overall Study|Withdrawal by Subject|3|||
144395246|NCT01086423|520658700|FG000|Overall Study|Lost to Follow-up|0|||
144395247|NCT01086423|520658701|FG001|Overall Study|Lost to Follow-up|0|||
144395248|NCT01086423|520658702|FG002|Overall Study|Lost to Follow-up|1|||
144395249|NCT04950166|520658704|FG000|Overall Study|Withdrawal by Subject|1|||
144395250|NCT05896748|520658705|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
144395251|NCT05896748|520658705|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
144594725|NCT04640077|521377937|FG001|Period 2|Adverse Event|0|||
144594726|NCT04640077|521377938|FG002|Period 2|Adverse Event|6|||
144594727|NCT04640077|521377936|FG000|Period 2|Lost to Follow-up|0|||
144395252|NCT05896748|520658705|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
144594728|NCT04640077|521377937|FG001|Period 2|Lost to Follow-up|0|||
144395253|NCT05896748|520658705|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
144395254|NCT05896748|520658705|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
144395255|NCT01130103|520658708|FG000|Randomized Treatment|Adverse Event|1|||
144594729|NCT04640077|521377938|FG002|Period 2|Lost to Follow-up|2|||
144594730|NCT04640077|521377936|FG000|Period 2|Death|0|||
144594731|NCT04640077|521377937|FG001|Period 2|Death|0|||
144722233|NCT02146430|521838643|FG001|Overall Study|Withdrawal by Subject|29|||
144395256|NCT01130103|520658709|FG001|Randomized Treatment|Adverse Event|1|||
144395257|NCT01130103|520658708|FG000|Randomized Treatment|Lost to Follow-up|1|||
144395258|NCT01130103|520658709|FG001|Randomized Treatment|Lost to Follow-up|0|||
144395259|NCT01130103|520658708|FG000|Randomized Treatment|Protocol Violation|3|||
144395260|NCT01130103|520658709|FG001|Randomized Treatment|Protocol Violation|2|||
144395261|NCT01130103|520658708|FG000|Randomized Treatment|Withdrawal by Subject|1|||
144395262|NCT01130103|520658709|FG001|Randomized Treatment|Withdrawal by Subject|2|||
144395263|NCT01130103|520658708|FG000|Maintenance Treatment|Lack of Efficacy|0|||
144395264|NCT01130103|520658709|FG001|Maintenance Treatment|Lack of Efficacy|1|||
144395265|NCT01130103|520658708|FG000|Maintenance Treatment|Lost to Follow-up|1|||
144395266|NCT01130103|520658709|FG001|Maintenance Treatment|Lost to Follow-up|1|||
144519086|NCT03143153|521103257|FG000|Treatment|Participant withdrew consent|3|||
144519087|NCT03143153|521103258|FG001|Treatment|Participant withdrew consent|4|||
144519088|NCT03143153|521103259|FG002|Treatment|Participant withdrew consent|12|||
144519089|NCT03143153|521103257|FG000|Treatment|Pregnancy|1|||
144519090|NCT03143153|521103258|FG001|Treatment|Pregnancy|0|||
144519091|NCT03143153|521103259|FG002|Treatment|Pregnancy|0|||
144519092|NCT03143153|521103257|FG000|Treatment|Maximum clinical benefit|1|||
144519093|NCT03143153|521103258|FG001|Treatment|Maximum clinical benefit|3|||
144519094|NCT03143153|521103259|FG002|Treatment|Maximum clinical benefit|4|||
144519095|NCT03143153|521103257|FG000|Treatment|Completed treatment as per Protocol|13|||
144519096|NCT03143153|521103258|FG001|Treatment|Completed treatment as per Protocol|8|||
144519097|NCT03143153|521103259|FG002|Treatment|Completed treatment as per Protocol|0|||
144519098|NCT03143153|521103257|FG000|Treatment|Other reasons|12|||
144519099|NCT03143153|521103258|FG001|Treatment|Other reasons|7|||
144519100|NCT03143153|521103259|FG002|Treatment|Other reasons|15|||
144519101|NCT03143153|521103257|FG000|Treatment|Not reported|1|||
144519102|NCT03143153|521103258|FG001|Treatment|Not reported|0|||
144519103|NCT03143153|521103259|FG002|Treatment|Not reported|0|||
144594732|NCT04640077|521377938|FG002|Period 2|Death|2|||
144594733|NCT04640077|521377936|FG000|Period 2|Progressive Disease|0|||
144395267|NCT01130103|520658708|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
144395268|NCT01130103|520658709|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
144249557|NCT01211483|520111688|FG000|Phase 2|Death|0|||
144395269|NCT01822678|520658712|FG000|Overall Study|Withdrawal by Subject|5|||
144395270|NCT01822678|520658713|FG001|Overall Study|Withdrawal by Subject|4|||
144395271|NCT01822678|520658714|FG002|Overall Study|Withdrawal by Subject|4|||
144519104|NCT03126019|521103260|FG000|Overall Study|Death|5|||
144519105|NCT03126019|521103261|FG001|Overall Study|Death|27|||
144519106|NCT03126019|521103260|FG000|Overall Study|Lost to Follow-up|2|||
144519107|NCT03126019|521103261|FG001|Overall Study|Lost to Follow-up|4|||
144519108|NCT03126019|521103260|FG000|Overall Study|Withdrawal by Subject|1|||
144519109|NCT03126019|521103261|FG001|Overall Study|Withdrawal by Subject|9|||
144519110|NCT03126019|521103260|FG000|Overall Study|Physician Decision|1|||
144519111|NCT03126019|521103261|FG001|Overall Study|Physician Decision|0|||
144519112|NCT03126019|521103260|FG000|Overall Study|Transitioned to Rollover Study|0|||
144519113|NCT03126019|521103261|FG001|Overall Study|Transitioned to Rollover Study|11|||
144519114|NCT03126019|521103260|FG000|Overall Study|Did Not Return to Site for Care|0|||
144519115|NCT03126019|521103261|FG001|Overall Study|Did Not Return to Site for Care|1|||
144519116|NCT03126019|521103260|FG000|Overall Study|Site Closed|0|||
144519117|NCT03126019|521103261|FG001|Overall Study|Site Closed|1|||
144519118|NCT00170573|521103263|FG000|Overall Study|Violation of inclusion criteria|13|||
144519119|NCT04556656|521103264|FG000|Overall Study|Withdrawal by Subject|14|||
144519120|NCT04556656|521103265|FG001|Overall Study|Withdrawal by Subject|12|||
144395272|NCT01822678|520658712|FG000|Overall Study|Adverse Event|4|||
144395273|NCT01822678|520658713|FG001|Overall Study|Adverse Event|3|||
144395274|NCT01822678|520658714|FG002|Overall Study|Adverse Event|1|||
144395275|NCT01822678|520658712|FG000|Overall Study|Lack of Efficacy|3|||
144395276|NCT01822678|520658713|FG001|Overall Study|Lack of Efficacy|6|||
144395277|NCT01822678|520658714|FG002|Overall Study|Lack of Efficacy|5|||
144519121|NCT04556656|521103264|FG000|Overall Study|Physician Decision|1|||
144519122|NCT04556656|521103265|FG001|Overall Study|Physician Decision|0|||
144519123|NCT04556656|521103264|FG000|Overall Study|Adverse Event|4|||
144519124|NCT04556656|521103265|FG001|Overall Study|Adverse Event|7|||
144519125|NCT04556656|521103264|FG000|Overall Study|Death|4|||
144519126|NCT04556656|521103265|FG001|Overall Study|Death|0|||
144519127|NCT04556656|521103264|FG000|Overall Study|Lost to Follow-up|3|||
144519128|NCT04556656|521103265|FG001|Overall Study|Lost to Follow-up|2|||
144519129|NCT04556656|521103264|FG000|Overall Study|Not further specified|2|||
144519130|NCT04556656|521103265|FG001|Overall Study|Not further specified|1|||
144519131|NCT04541706|521103266|FG000|Overall Study|Withdrawal by Subject|3|||
144519132|NCT04541706|521103266|FG000|Overall Study|Progressive disease|33|||
144519133|NCT04541706|521103266|FG000|Overall Study|Physician Decision|1|||
144519134|NCT04541706|521103266|FG000|Overall Study|Lost to Follow-up|2|||
144519135|NCT04541706|521103266|FG000|Overall Study|Death|5|||
144519136|NCT04541706|521103266|FG000|Overall Study|Adverse Event|1|||
144519137|NCT05563246|521103277|FG000|Overall Study|Withdrawal by Subject|1|||
144519138|NCT05563246|521103278|FG001|Overall Study|Withdrawal by Subject|2|||
144519139|NCT05563246|521103279|FG002|Overall Study|Withdrawal by Subject|0|||
144519140|NCT05563246|521103280|FG003|Overall Study|Withdrawal by Subject|0|||
144519141|NCT05563246|521103277|FG000|Overall Study|Protocol Deviation|0|||
144519142|NCT05563246|521103278|FG001|Overall Study|Protocol Deviation|1|||
144519143|NCT05563246|521103279|FG002|Overall Study|Protocol Deviation|0|||
144519144|NCT05563246|521103280|FG003|Overall Study|Protocol Deviation|0|||
144519145|NCT05563246|521103277|FG000|Overall Study|Physician Decision|0|||
144519146|NCT05563246|521103278|FG001|Overall Study|Physician Decision|1|||
144519147|NCT05563246|521103279|FG002|Overall Study|Physician Decision|0|||
144519148|NCT05563246|521103280|FG003|Overall Study|Physician Decision|0|||
144519149|NCT05563246|521103277|FG000|Overall Study|Adverse Event|0|||
144519150|NCT05563246|521103278|FG001|Overall Study|Adverse Event|0|||
144519151|NCT05563246|521103279|FG002|Overall Study|Adverse Event|2|||
144519152|NCT05563246|521103280|FG003|Overall Study|Adverse Event|0|||
144519153|NCT05563246|521103277|FG000|Overall Study|Lost to Follow-up|0|||
144519154|NCT05563246|521103278|FG001|Overall Study|Lost to Follow-up|0|||
144519155|NCT05563246|521103279|FG002|Overall Study|Lost to Follow-up|1|||
144395278|NCT01822678|520658712|FG000|Overall Study|Lost to Follow-up|0|||
144519156|NCT05563246|521103280|FG003|Overall Study|Lost to Follow-up|0|||
144249558|NCT01211483|520111689|FG001|Phase 2|Death|64|||
144395279|NCT01822678|520658713|FG001|Overall Study|Lost to Follow-up|2|||
144395280|NCT01822678|520658714|FG002|Overall Study|Lost to Follow-up|1|||
144395281|NCT04795622|520658717|FG000|Overall Study|Adverse Event|1|||
144395282|NCT04795622|520658718|FG001|Overall Study|Adverse Event|0|||
144395283|NCT04795622|520658717|FG000|Overall Study|Withdrawal by Subject|3|||
144395284|NCT04795622|520658718|FG001|Overall Study|Withdrawal by Subject|3|||
144395285|NCT04795622|520658717|FG000|Overall Study|Protocol Violation|0|||
144395286|NCT04795622|520658718|FG001|Overall Study|Protocol Violation|2|||
144395287|NCT04795622|520658717|FG000|Overall Study|Lost to Follow-up|2|||
144395288|NCT04795622|520658718|FG001|Overall Study|Lost to Follow-up|3|||
144395289|NCT04795622|520658717|FG000|Overall Study|Other|7|||
144395290|NCT04795622|520658718|FG001|Overall Study|Other|8|||
144395291|NCT02059005|520658723|FG000|Overall Study|Death|1|||
144395292|NCT02059005|520658724|FG001|Overall Study|Death|3|||
144395293|NCT02059005|520658723|FG000|Overall Study|Lost to Follow-up|19|||
144395294|NCT02059005|520658724|FG001|Overall Study|Lost to Follow-up|19|||
144395295|NCT02059005|520658723|FG000|Overall Study|Incarceration|0|||
144395296|NCT02059005|520658724|FG001|Overall Study|Incarceration|1|||
144395297|NCT02059005|520658723|FG000|Overall Study|Inpatient|0|||
144395298|NCT02059005|520658724|FG001|Overall Study|Inpatient|1|||
144395299|NCT00739596|520658729|FG000|Overall Study|Adverse Event|12|||
144395300|NCT00739596|520658730|FG001|Overall Study|Adverse Event|6|||
144395301|NCT00739596|520658729|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
144395302|NCT00739596|520658730|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144395303|NCT00739596|520658729|FG000|Overall Study|Patient Withdrew Consent|8|||
144395304|NCT00739596|520658730|FG001|Overall Study|Patient Withdrew Consent|8|||
144395305|NCT00739596|520658729|FG000|Overall Study|Lost to Follow-up|0|||
144395306|NCT00739596|520658730|FG001|Overall Study|Lost to Follow-up|2|||
144395307|NCT00739596|520658729|FG000|Overall Study|Protocol Deviation|1|||
144395308|NCT00739596|520658730|FG001|Overall Study|Protocol Deviation|1|||
144395309|NCT00908011|520658731|FG000|Overall Study|Withdrawal by Subject|2|||
144395310|NCT00908011|520658732|FG001|Overall Study|Withdrawal by Subject|2|||
144395311|NCT02301988|520658734|FG000|Overall Study|Withdrawal by Subject|2|||
144395312|NCT02301988|520658735|FG001|Overall Study|Withdrawal by Subject|1|||
144395313|NCT02301988|520658734|FG000|Overall Study|Physician Decision|2|||
144395314|NCT02301988|520658735|FG001|Overall Study|Physician Decision|2|||
144395315|NCT02301988|520658734|FG000|Overall Study|Unknown Reason|1|||
144395316|NCT02301988|520658735|FG001|Overall Study|Unknown Reason|3|||
144395317|NCT02301988|520658734|FG000|Overall Study|Lack of Efficacy|3|||
144395318|NCT02301988|520658735|FG001|Overall Study|Lack of Efficacy|2|||
144519157|NCT03763708|521103284|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
144519158|NCT03763708|521103285|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519159|NCT03763708|521103286|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519160|NCT03763708|521103287|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519161|NCT03763708|521103288|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519162|NCT03763708|521103289|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519163|NCT03763708|521103290|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519164|NCT03763708|521103291|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519165|NCT03763708|521103292|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
144519166|NCT03763708|521103284|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519167|NCT03763708|521103285|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519168|NCT03763708|521103286|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
144519169|NCT03763708|521103287|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519170|NCT03763708|521103288|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519171|NCT03763708|521103289|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519172|NCT03763708|521103290|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519173|NCT03763708|521103291|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519174|NCT03763708|521103292|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
144519175|NCT03763708|521103284|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519176|NCT03763708|521103285|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519177|NCT03763708|521103286|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519178|NCT03763708|521103287|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
144594734|NCT04640077|521377937|FG001|Period 2|Progressive Disease|0|||
144395319|NCT02301988|520658734|FG000|Overall Study|Death|1|||
144395320|NCT02301988|520658735|FG001|Overall Study|Death|0|||
144395321|NCT02301988|520658734|FG000|Overall Study|Adverse Event|1|||
144395322|NCT02301988|520658735|FG001|Overall Study|Adverse Event|1|||
144395323|NCT04669535|520658736|FG000|Overall Study|Death|1|||
144395324|NCT04669535|520658737|FG001|Overall Study|Death|1|||
144395325|NCT04669535|520658738|FG002|Overall Study|Death|0|||
144395326|NCT04669535|520658739|FG003|Overall Study|Death|0|||
144395327|NCT05169567|520658741|FG000|Overall Study|On study treatment|116|||
144395328|NCT05169567|520658742|FG001|Overall Study|On study treatment|128|||
144395329|NCT05169567|520658741|FG000|Overall Study|Lost to Follow-up|1|||
144395330|NCT05169567|520658742|FG001|Overall Study|Lost to Follow-up|0|||
144395331|NCT05169567|520658741|FG000|Overall Study|Withdrawal by Subject|25|||
144519179|NCT03763708|521103288|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519180|NCT03763708|521103289|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519181|NCT03763708|521103290|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519182|NCT03763708|521103291|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519183|NCT03763708|521103292|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
144519184|NCT03763708|521103284|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519185|NCT03763708|521103285|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519186|NCT03763708|521103286|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519187|NCT03763708|521103287|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519188|NCT03763708|521103288|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
144519189|NCT03763708|521103289|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519190|NCT03763708|521103290|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519191|NCT03763708|521103291|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519192|NCT03763708|521103292|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
144519193|NCT03763708|521103284|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519194|NCT03763708|521103285|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519195|NCT03763708|521103286|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519196|NCT03763708|521103287|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519197|NCT03763708|521103288|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519198|NCT03763708|521103289|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
144519199|NCT03763708|521103290|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519200|NCT03763708|521103291|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519201|NCT03763708|521103292|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
144519202|NCT03763708|521103284|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519203|NCT03763708|521103285|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519204|NCT03763708|521103286|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519205|NCT03763708|521103287|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519206|NCT03763708|521103288|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519207|NCT03763708|521103289|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519208|NCT03763708|521103290|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
144519209|NCT03763708|521103291|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519210|NCT03763708|521103292|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
144519211|NCT03763708|521103284|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
144519212|NCT03763708|521103285|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
144519213|NCT03763708|521103286|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
144519214|NCT03763708|521103287|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
144519215|NCT03763708|521103288|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
144519216|NCT03763708|521103289|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
144519217|NCT03763708|521103290|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
144519218|NCT03763708|521103291|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
144519219|NCT03763708|521103292|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
144519220|NCT03763708|521103284|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
144519221|NCT03763708|521103285|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
144519222|NCT03763708|521103286|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
144519223|NCT03763708|521103287|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
144519224|NCT03763708|521103288|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
144519225|NCT03763708|521103289|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
144519226|NCT03763708|521103290|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
144519227|NCT03763708|521103291|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
144519228|NCT03763708|521103292|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
144519229|NCT03763708|521103284|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
144519230|NCT03763708|521103285|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
144519231|NCT03763708|521103286|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
144519232|NCT03763708|521103287|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
144519233|NCT03763708|521103288|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
144519234|NCT03763708|521103289|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
144519235|NCT03763708|521103290|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
144519236|NCT03763708|521103291|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
144519237|NCT03763708|521103292|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
144519238|NCT01416831|521103293|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
144519239|NCT01416831|521103294|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
144519240|NCT05470400|521103295|FG000|Overall Study|Lost to Follow-up|0|||
144519241|NCT05470400|521103296|FG001|Overall Study|Lost to Follow-up|0|||
144519242|NCT05470400|521103297|FG002|Overall Study|Lost to Follow-up|0|||
144519243|NCT05470400|521103298|FG003|Overall Study|Lost to Follow-up|0|||
144519244|NCT05470400|521103299|FG004|Overall Study|Lost to Follow-up|0|||
144519245|NCT05470400|521103300|FG005|Overall Study|Lost to Follow-up|0|||
144519246|NCT05470400|521103301|FG006|Overall Study|Lost to Follow-up|0|||
144519247|NCT05470400|521103302|FG007|Overall Study|Lost to Follow-up|1|||
144519248|NCT05470400|521103295|FG000|Overall Study|Withdrawal by Subject|1|||
144594735|NCT04640077|521377938|FG002|Period 2|Progressive Disease|1|||
144519249|NCT05470400|521103296|FG001|Overall Study|Withdrawal by Subject|0|||
144519250|NCT05470400|521103297|FG002|Overall Study|Withdrawal by Subject|0|||
144519251|NCT05470400|521103298|FG003|Overall Study|Withdrawal by Subject|0|||
144519252|NCT05470400|521103299|FG004|Overall Study|Withdrawal by Subject|0|||
144519253|NCT05470400|521103300|FG005|Overall Study|Withdrawal by Subject|1|||
144519254|NCT05470400|521103301|FG006|Overall Study|Withdrawal by Subject|0|||
144519255|NCT05470400|521103302|FG007|Overall Study|Withdrawal by Subject|2|||
144519256|NCT04294225|521103309|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
144519257|NCT04294225|521103309|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
144519258|NCT04294225|521103309|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
144519259|NCT04294225|521103309|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
144519260|NCT04294225|521103309|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
144519261|NCT01809691|521103310|FG000|Overall Study|Currently on Treatment|192|||
144519262|NCT01809691|521103311|FG001|Overall Study|Currently on Treatment|100|||
144519263|NCT01809691|521103310|FG000|Overall Study|No Protocol Treatment|10|||
144519264|NCT01809691|521103311|FG001|Overall Study|No Protocol Treatment|11|||
144519265|NCT01809691|521103310|FG000|Overall Study|Adverse Event|80|||
144519266|NCT01809691|521103311|FG001|Overall Study|Adverse Event|21|||
144519267|NCT01809691|521103310|FG000|Overall Study|Disease Progression|226|||
144519268|NCT01809691|521103311|FG001|Overall Study|Disease Progression|372|||
144519269|NCT01809691|521103310|FG000|Overall Study|Death|26|||
144519270|NCT01809691|521103311|FG001|Overall Study|Death|13|||
144519271|NCT01809691|521103310|FG000|Overall Study|Participant Refusal|70|||
144519272|NCT01809691|521103311|FG001|Overall Study|Participant Refusal|72|||
144519273|NCT01809691|521103310|FG000|Overall Study|Other, Not Specified|34|||
144519274|NCT01809691|521103311|FG001|Overall Study|Other, Not Specified|52|||
144519275|NCT02281955|521103325|FG000|Overall Study|Death|1|||
144519276|NCT02783300|521103331|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519277|NCT02783300|521103332|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519278|NCT02783300|521103333|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519279|NCT02783300|521103334|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519280|NCT02783300|521103335|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519281|NCT02783300|521103336|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519282|NCT02783300|521103337|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
144519283|NCT02783300|521103338|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519284|NCT02783300|521103339|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519285|NCT02783300|521103340|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519286|NCT02783300|521103341|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519287|NCT02783300|521103342|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519288|NCT02783300|521103343|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519289|NCT02783300|521103344|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519290|NCT02783300|521103345|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519291|NCT02783300|521103346|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519292|NCT02783300|521103347|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519293|NCT02783300|521103348|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519294|NCT02783300|521103349|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519295|NCT02783300|521103350|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519296|NCT02783300|521103351|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519297|NCT02783300|521103352|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519298|NCT02783300|521103353|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519299|NCT02783300|521103354|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519300|NCT02783300|521103355|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519301|NCT02783300|521103356|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519302|NCT02783300|521103357|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
144519303|NCT02783300|521103331|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519304|NCT02783300|521103332|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519305|NCT02783300|521103333|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519306|NCT02783300|521103334|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
144519307|NCT02783300|521103335|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519308|NCT02783300|521103336|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519309|NCT02783300|521103337|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519310|NCT02783300|521103338|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519311|NCT02783300|521103339|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519312|NCT02783300|521103340|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519313|NCT02783300|521103341|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144594736|NCT04640077|521377936|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
144519314|NCT02783300|521103342|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519315|NCT02783300|521103343|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519316|NCT02783300|521103344|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519317|NCT02783300|521103345|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144395332|NCT05169567|520658742|FG001|Overall Study|Withdrawal by Subject|21|||
144395333|NCT05069259|520658746|FG000|Overall Study|Withdrawal by Subject|1|||
144594737|NCT04640077|521377937|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
144594738|NCT04640077|521377938|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
144594739|NCT01257425|521377939|FG000|Overall Study|Lack of Efficacy|3|||
144395334|NCT05069259|520658746|FG000|Overall Study|Sponsor decision|1|||
144519318|NCT02783300|521103346|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519319|NCT02783300|521103347|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519320|NCT02783300|521103348|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519321|NCT02783300|521103349|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519322|NCT02783300|521103350|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519323|NCT02783300|521103351|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519324|NCT02783300|521103352|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519325|NCT02783300|521103353|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519326|NCT02783300|521103354|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519327|NCT02783300|521103355|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519328|NCT02783300|521103356|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519329|NCT02783300|521103357|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
144519330|NCT02783300|521103331|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
144519331|NCT02783300|521103332|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
144519332|NCT02783300|521103333|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
144594740|NCT01257425|521377940|FG001|Overall Study|Lack of Efficacy|3|||
144395335|NCT01828320|520658748|FG000|Overall Study|Lost to Follow-up|1|||
144395336|NCT01828320|520658749|FG001|Overall Study|Lost to Follow-up|3|||
144395337|NCT01828320|520658748|FG000|Overall Study|Withdrawal by Subject|7|||
144519333|NCT02783300|521103334|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
144519334|NCT02783300|521103335|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
144395338|NCT01828320|520658749|FG001|Overall Study|Withdrawal by Subject|2|||
144395339|NCT02160782|520659973|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
144395340|NCT02160782|520659974|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
144395341|NCT02160782|520659975|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
144395342|NCT02160782|520659976|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
144395343|NCT02160782|520659977|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
144395344|NCT02160782|520659973|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
144395345|NCT02160782|520659974|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
144395346|NCT02160782|520659975|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
144395347|NCT02160782|520659976|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
144395348|NCT02160782|520659977|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
144395349|NCT02160782|520659973|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
144395350|NCT02160782|520659974|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
144395351|NCT02160782|520659975|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
144395352|NCT02160782|520659976|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
144395353|NCT02160782|520659977|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
144395354|NCT02160782|520659973|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
144395355|NCT02160782|520659974|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
144395356|NCT02160782|520659975|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
144395357|NCT02160782|520659976|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
144395358|NCT02160782|520659977|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
144395359|NCT02160782|520659973|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
144395360|NCT02160782|520659974|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
144395361|NCT02160782|520659975|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
144395362|NCT02160782|520659976|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
144395363|NCT02160782|520659977|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
144395364|NCT02160782|520659973|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
144395365|NCT02160782|520659974|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
144395366|NCT02160782|520659975|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
144395367|NCT02160782|520659976|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
144395368|NCT02160782|520659977|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
144395369|NCT02160782|520659973|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
144395370|NCT02160782|520659974|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
144395371|NCT02160782|520659975|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
144395372|NCT02160782|520659976|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
144395373|NCT02160782|520659977|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
144395374|NCT01104701|520659982|FG000|Overall Study|Withdrawal by Subject|0|||
144395375|NCT01104701|520659983|FG001|Overall Study|Withdrawal by Subject|1|||
144395376|NCT01104701|520659984|FG002|Overall Study|Withdrawal by Subject|2|||
144395377|NCT01104701|520659985|FG003|Overall Study|Withdrawal by Subject|1|||
144519335|NCT02783300|521103336|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
144519336|NCT02783300|521103337|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
144519337|NCT02783300|521103338|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
144519338|NCT02783300|521103339|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
144519339|NCT02783300|521103340|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
144519340|NCT02783300|521103341|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
144519341|NCT02783300|521103342|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
144519342|NCT02783300|521103343|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
144519343|NCT02783300|521103344|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
144519344|NCT02783300|521103345|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
144519345|NCT02783300|521103346|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
144519346|NCT02783300|521103347|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
144519347|NCT02783300|521103348|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
144519348|NCT02783300|521103349|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
144519349|NCT02783300|521103350|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
144519350|NCT02783300|521103351|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
144519351|NCT02783300|521103352|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
144519352|NCT02783300|521103353|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
144519353|NCT02783300|521103354|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
144519354|NCT02783300|521103355|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
144519355|NCT02783300|521103356|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
144519356|NCT02783300|521103357|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
144519357|NCT02783300|521103331|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144249559|NCT01211483|520111690|FG002|Phase 2|Death|53|||
144395378|NCT01104701|520659982|FG000|Overall Study|Adverse Event|0|||
144395379|NCT01104701|520659983|FG001|Overall Study|Adverse Event|0|||
144395380|NCT01104701|520659984|FG002|Overall Study|Adverse Event|0|||
144395381|NCT01104701|520659985|FG003|Overall Study|Adverse Event|1|||
144395382|NCT01104701|520659982|FG000|Overall Study|Physician Decision|0|||
144395383|NCT01104701|520659983|FG001|Overall Study|Physician Decision|2|||
144395384|NCT01104701|520659984|FG002|Overall Study|Physician Decision|0|||
144395385|NCT01104701|520659985|FG003|Overall Study|Physician Decision|0|||
144395386|NCT00891462|520659986|FG000|Overall Study|Withdrawal by Subject|9|||
144395387|NCT00891462|520659987|FG001|Overall Study|Withdrawal by Subject|6|||
144395388|NCT00891462|520659988|FG002|Overall Study|Withdrawal by Subject|7|||
144395389|NCT00891462|520659986|FG000|Overall Study|Adverse Event|7|||
144395390|NCT00891462|520659987|FG001|Overall Study|Adverse Event|8|||
144395391|NCT00891462|520659988|FG002|Overall Study|Adverse Event|7|||
144519358|NCT02783300|521103332|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519359|NCT02783300|521103333|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519360|NCT02783300|521103334|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519361|NCT02783300|521103335|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519362|NCT02783300|521103336|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519363|NCT02783300|521103337|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
144519364|NCT02783300|521103338|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519365|NCT02783300|521103339|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519366|NCT02783300|521103340|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519367|NCT02783300|521103341|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519368|NCT02783300|521103342|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519369|NCT02783300|521103343|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
144519370|NCT02783300|521103344|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519371|NCT02783300|521103345|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519372|NCT02783300|521103346|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519373|NCT02783300|521103347|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519374|NCT02783300|521103348|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519375|NCT02783300|521103349|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519376|NCT02783300|521103350|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519377|NCT02783300|521103351|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519378|NCT02783300|521103352|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519379|NCT02783300|521103353|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519380|NCT02783300|521103354|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519381|NCT02783300|521103355|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519382|NCT02783300|521103356|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519383|NCT02783300|521103357|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
144519384|NCT02783300|521103331|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519385|NCT02783300|521103332|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519386|NCT02783300|521103333|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519387|NCT02783300|521103334|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519388|NCT02783300|521103335|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
144519389|NCT02783300|521103336|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519390|NCT02783300|521103337|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
144519391|NCT02783300|521103338|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519392|NCT02783300|521103339|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519393|NCT02783300|521103340|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
144395392|NCT00891462|520659986|FG000|Overall Study|Lack of Efficacy|10|||
144395393|NCT00891462|520659987|FG001|Overall Study|Lack of Efficacy|5|||
144519394|NCT02783300|521103341|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144395394|NCT00891462|520659988|FG002|Overall Study|Lack of Efficacy|1|||
144395395|NCT00891462|520659986|FG000|Overall Study|COPD exacerbation|7|||
144395396|NCT00891462|520659987|FG001|Overall Study|COPD exacerbation|4|||
144722234|NCT02146430|521838644|FG002|Overall Study|Withdrawal by Subject|30|||
144722235|NCT02146430|521838645|FG003|Overall Study|Withdrawal by Subject|34|||
144722236|NCT01893905|521838646|FG000|Overall Study|Withdrawal by Subject|1|||
144722237|NCT01893905|521838647|FG001|Overall Study|Withdrawal by Subject|0|||
144722238|NCT01893905|521838646|FG000|Overall Study|Adverse Event|9|||
144519395|NCT02783300|521103342|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519396|NCT02783300|521103343|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
144519397|NCT02783300|521103344|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519398|NCT02783300|521103345|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519399|NCT02783300|521103346|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519400|NCT02783300|521103347|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519401|NCT02783300|521103348|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519402|NCT02783300|521103349|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519403|NCT02783300|521103350|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519404|NCT02783300|521103351|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519405|NCT02783300|521103352|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519406|NCT02783300|521103353|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519407|NCT02783300|521103354|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519408|NCT02783300|521103355|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519409|NCT02783300|521103356|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519410|NCT02783300|521103357|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
144519411|NCT02783300|521103331|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519412|NCT02783300|521103332|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519413|NCT02783300|521103333|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519414|NCT02783300|521103334|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519415|NCT02783300|521103335|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519416|NCT02783300|521103336|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519417|NCT02783300|521103337|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519418|NCT02783300|521103338|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519419|NCT02783300|521103339|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519420|NCT02783300|521103340|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144722239|NCT01893905|521838647|FG001|Overall Study|Adverse Event|3|||
144722240|NCT01893905|521838646|FG000|Overall Study|Lack of Efficacy|5|||
144594741|NCT01257425|521377939|FG000|Overall Study|Adverse Event|1|||
144722241|NCT01893905|521838647|FG001|Overall Study|Lack of Efficacy|7|||
144722242|NCT01893905|521838646|FG000|Overall Study|Lost to Follow-up|1|||
144722243|NCT01893905|521838647|FG001|Overall Study|Lost to Follow-up|0|||
144249560|NCT01211483|520111691|FG003|Phase 2|Death|53|||
144519421|NCT02783300|521103341|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519422|NCT02783300|521103342|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519423|NCT02783300|521103343|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519424|NCT02783300|521103344|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519425|NCT02783300|521103345|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519426|NCT02783300|521103346|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
144519427|NCT02783300|521103347|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519428|NCT02783300|521103348|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
144519429|NCT02783300|521103349|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
144519430|NCT02783300|521103350|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
144519431|NCT02783300|521103351|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519432|NCT02783300|521103352|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519433|NCT02783300|521103353|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519434|NCT02783300|521103354|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519435|NCT02783300|521103355|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
144519436|NCT02783300|521103356|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519437|NCT02783300|521103357|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
144519438|NCT02783300|521103331|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519439|NCT02783300|521103332|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519440|NCT02783300|521103333|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519441|NCT02783300|521103334|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519442|NCT02783300|521103335|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519443|NCT02783300|521103336|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519444|NCT02783300|521103337|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519445|NCT02783300|521103338|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519446|NCT02783300|521103339|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519447|NCT02783300|521103340|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519448|NCT02783300|521103341|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519449|NCT02783300|521103342|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519450|NCT02783300|521103343|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519451|NCT02783300|521103344|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519452|NCT02783300|521103345|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519453|NCT02783300|521103346|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519454|NCT02783300|521103347|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
144519455|NCT02783300|521103348|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519456|NCT02783300|521103349|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
144519457|NCT02783300|521103350|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
144519458|NCT02783300|521103351|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519459|NCT02783300|521103352|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519460|NCT02783300|521103353|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519461|NCT02783300|521103354|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519462|NCT02783300|521103355|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519463|NCT02783300|521103356|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519464|NCT02783300|521103357|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
144519465|NCT02783300|521103331|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519466|NCT02783300|521103332|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519467|NCT02783300|521103333|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519468|NCT02783300|521103334|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519469|NCT02783300|521103335|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519470|NCT02783300|521103336|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519471|NCT02783300|521103337|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144594742|NCT01257425|521377940|FG001|Overall Study|Adverse Event|1|||
144722244|NCT01893905|521838646|FG000|Overall Study|Protocol Violation|6|||
144722245|NCT01893905|521838647|FG001|Overall Study|Protocol Violation|1|||
144722246|NCT01893905|521838646|FG000|Overall Study|Lack of adherence to treatment|2|||
144395397|NCT00891462|520659988|FG002|Overall Study|COPD exacerbation|1|||
144395398|NCT00891462|520659986|FG000|Overall Study|Other Reason|2|||
144395399|NCT00891462|520659987|FG001|Overall Study|Other Reason|5|||
144395400|NCT00891462|520659988|FG002|Overall Study|Other Reason|3|||
144395401|NCT00891462|520659986|FG000|Overall Study|Protocol Violation|2|||
144395402|NCT00891462|520659987|FG001|Overall Study|Protocol Violation|1|||
144395403|NCT00891462|520659988|FG002|Overall Study|Protocol Violation|3|||
144395404|NCT00891462|520659986|FG000|Overall Study|Inclusion/exclusion criteria|0|||
144395405|NCT00891462|520659987|FG001|Overall Study|Inclusion/exclusion criteria|2|||
144395406|NCT00891462|520659988|FG002|Overall Study|Inclusion/exclusion criteria|2|||
144395407|NCT00891462|520659986|FG000|Overall Study|Lost to Follow-up|0|||
144395408|NCT00891462|520659987|FG001|Overall Study|Lost to Follow-up|2|||
144395409|NCT00891462|520659988|FG002|Overall Study|Lost to Follow-up|0|||
144395410|NCT00423722|520659992|FG000|Overall Study|Death|4|||
144395411|NCT00423722|520659993|FG001|Overall Study|Death|4|||
144395412|NCT00423722|520659992|FG000|Overall Study|Declined to participate|2|||
144395413|NCT00423722|520659993|FG001|Overall Study|Declined to participate|3|||
144395414|NCT00423722|520659992|FG000|Overall Study|Unable to complete questionnaires|4|||
144395415|NCT00423722|520659993|FG001|Overall Study|Unable to complete questionnaires|4|||
144395416|NCT00423722|520659992|FG000|Overall Study|Withdrawal by Subject|4|||
144395417|NCT00423722|520659993|FG001|Overall Study|Withdrawal by Subject|2|||
144395418|NCT00215683|520659996|FG000|Overall Study|Adverse Event|15|||
144395419|NCT00215683|520659997|FG001|Overall Study|Adverse Event|16|||
144395420|NCT00215683|520659998|FG002|Overall Study|Adverse Event|15|||
144395421|NCT00215683|520659996|FG000|Overall Study|Lack of Efficacy|5|||
144395422|NCT00215683|520659997|FG001|Overall Study|Lack of Efficacy|1|||
144395423|NCT00215683|520659998|FG002|Overall Study|Lack of Efficacy|2|||
144395424|NCT00215683|520659996|FG000|Overall Study|Lost to Follow-up|0|||
144395425|NCT00215683|520659997|FG001|Overall Study|Lost to Follow-up|2|||
144395426|NCT00215683|520659998|FG002|Overall Study|Lost to Follow-up|1|||
144395427|NCT00215683|520659996|FG000|Overall Study|Withdrawal by Subject|9|||
144395428|NCT00215683|520659997|FG001|Overall Study|Withdrawal by Subject|4|||
144395429|NCT00215683|520659998|FG002|Overall Study|Withdrawal by Subject|13|||
144395430|NCT00215683|520659996|FG000|Overall Study|Physician Decision|0|||
144395431|NCT00215683|520659997|FG001|Overall Study|Physician Decision|0|||
144395432|NCT00215683|520659998|FG002|Overall Study|Physician Decision|1|||
144395433|NCT00215683|520659996|FG000|Overall Study|Difficult to attend visits|0|||
144395434|NCT00215683|520659997|FG001|Overall Study|Difficult to attend visits|1|||
144395435|NCT00215683|520659998|FG002|Overall Study|Difficult to attend visits|0|||
144519472|NCT02783300|521103338|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519473|NCT02783300|521103339|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519474|NCT02783300|521103340|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519475|NCT02783300|521103341|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519476|NCT02783300|521103342|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519477|NCT02783300|521103343|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519478|NCT02783300|521103344|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519479|NCT02783300|521103345|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519480|NCT02783300|521103346|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519481|NCT02783300|521103347|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
144519482|NCT02783300|521103348|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519483|NCT02783300|521103349|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
144519484|NCT02783300|521103350|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
144519485|NCT02783300|521103351|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
144519486|NCT02783300|521103352|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519487|NCT02783300|521103353|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519488|NCT02783300|521103354|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519489|NCT02783300|521103355|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519490|NCT02783300|521103356|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519491|NCT02783300|521103357|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
144519492|NCT02783300|521103331|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519493|NCT02783300|521103332|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144395436|NCT00215683|520659996|FG000|Overall Study|No study drug available|0|||
144395437|NCT00215683|520659997|FG001|Overall Study|No study drug available|1|||
144395438|NCT00215683|520659998|FG002|Overall Study|No study drug available|0|||
144395439|NCT00215683|520659996|FG000|Overall Study|Intermittent therapy required|0|||
144395440|NCT00215683|520659997|FG001|Overall Study|Intermittent therapy required|1|||
144395441|NCT00215683|520659998|FG002|Overall Study|Intermittent therapy required|0|||
144395442|NCT01083485|520659999|FG000|Overall Study|Adverse Event|0|||
144395443|NCT01083485|520660000|FG001|Overall Study|Adverse Event|1|||
144395444|NCT01083485|520659999|FG000|Overall Study|Protocol Violation|1|||
144395445|NCT01083485|520660000|FG001|Overall Study|Protocol Violation|0|||
144395446|NCT01083485|520659999|FG000|Overall Study|Withdrawal by Subject|5|||
144519494|NCT02783300|521103333|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144249561|NCT01211483|520111688|FG000|Phase 2|Withdrawal by Subject|0|||
144249562|NCT01211483|520111689|FG001|Phase 2|Withdrawal by Subject|1|||
144249563|NCT01211483|520111690|FG002|Phase 2|Withdrawal by Subject|10|||
144249564|NCT01211483|520111691|FG003|Phase 2|Withdrawal by Subject|5|||
144249565|NCT01211483|520111688|FG000|Phase 2|Study terminated by Sponsor|0|||
144249566|NCT01211483|520111689|FG001|Phase 2|Study terminated by Sponsor|6|||
144249567|NCT01211483|520111690|FG002|Phase 2|Study terminated by Sponsor|8|||
144249568|NCT01211483|520111691|FG003|Phase 2|Study terminated by Sponsor|11|||
144249569|NCT02284568|520111692|FG000|Overall Study|Adverse Event|2|||
144249570|NCT02284568|520111693|FG001|Overall Study|Adverse Event|9|||
144249571|NCT02284568|520111694|FG002|Overall Study|Adverse Event|4|||
144249572|NCT02284568|520111692|FG000|Overall Study|Withdrawal by Subject|22|||
144249573|NCT02284568|520111693|FG001|Overall Study|Withdrawal by Subject|21|||
144249574|NCT02284568|520111694|FG002|Overall Study|Withdrawal by Subject|1|||
144249575|NCT02284568|520111692|FG000|Overall Study|Noncompliance with study drug admin|1|||
144249576|NCT02284568|520111693|FG001|Overall Study|Noncompliance with study drug admin|2|||
144249577|NCT02284568|520111694|FG002|Overall Study|Noncompliance with study drug admin|0|||
144249578|NCT02284568|520111692|FG000|Overall Study|Noncompliance|1|||
144249579|NCT02284568|520111693|FG001|Overall Study|Noncompliance|0|||
144249580|NCT02284568|520111694|FG002|Overall Study|Noncompliance|0|||
144249581|NCT02284568|520111692|FG000|Overall Study|Protocol Violation|0|||
144249582|NCT02284568|520111693|FG001|Overall Study|Protocol Violation|1|||
144249583|NCT02284568|520111694|FG002|Overall Study|Protocol Violation|0|||
144249584|NCT02284568|520111692|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
144249585|NCT02284568|520111693|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
144249586|NCT02284568|520111694|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
144249587|NCT02284568|520111692|FG000|Overall Study|Lost to Follow-up|0|||
144249588|NCT02284568|520111693|FG001|Overall Study|Lost to Follow-up|3|||
144249589|NCT02284568|520111694|FG002|Overall Study|Lost to Follow-up|0|||
144249590|NCT02284568|520111692|FG000|Overall Study|Lack of Efficacy|4|||
144249591|NCT02284568|520111693|FG001|Overall Study|Lack of Efficacy|7|||
144249592|NCT02284568|520111694|FG002|Overall Study|Lack of Efficacy|0|||
144249593|NCT02284568|520111692|FG000|Overall Study|Other|1|||
144249594|NCT02284568|520111693|FG001|Overall Study|Other|2|||
144249595|NCT02284568|520111694|FG002|Overall Study|Other|0|||
144249596|NCT02284568|520111692|FG000|Overall Study|Withdrew before taking study drug|0|||
144249597|NCT02284568|520111693|FG001|Overall Study|Withdrew before taking study drug|1|||
144249598|NCT02284568|520111694|FG002|Overall Study|Withdrew before taking study drug|0|||
144249599|NCT02854605|520111695|FG000|Overall Study|Adverse Event|1|||
144249600|NCT02854605|520111696|FG001|Overall Study|Adverse Event|5|||
144249601|NCT02854605|520111697|FG002|Overall Study|Adverse Event|2|||
144249602|NCT02854605|520111695|FG000|Overall Study|Lost to Follow-up|0|||
144249603|NCT02854605|520111696|FG001|Overall Study|Lost to Follow-up|2|||
144249604|NCT02854605|520111697|FG002|Overall Study|Lost to Follow-up|0|||
144249605|NCT02854605|520111695|FG000|Overall Study|Withdrew Consent|1|||
144249606|NCT02854605|520111696|FG001|Overall Study|Withdrew Consent|0|||
144519495|NCT02783300|521103334|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519496|NCT02783300|521103335|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144594743|NCT01257425|521377939|FG000|Overall Study|Protocol Violation|1|||
144395447|NCT01083485|520660000|FG001|Overall Study|Withdrawal by Subject|2|||
144395448|NCT01083485|520659999|FG000|Overall Study|Other|1|||
144395449|NCT01083485|520660000|FG001|Overall Study|Other|0|||
144395450|NCT02171065|520660001|FG000|Overall Study|Withdrawal by Subject|1|||
144395451|NCT02171065|520660002|FG001|Overall Study|Withdrawal by Subject|0|||
144395452|NCT02171065|520660003|FG002|Overall Study|Withdrawal by Subject|0|||
144395453|NCT02171065|520660001|FG000|Overall Study|Lost to Follow-up|0|||
144395454|NCT02171065|520660002|FG001|Overall Study|Lost to Follow-up|0|||
144395455|NCT02171065|520660003|FG002|Overall Study|Lost to Follow-up|1|||
144395456|NCT04493333|520660004|FG000|Overall Study|Withdrawal by Subject|1|||
144395457|NCT04493333|520660005|FG001|Overall Study|Withdrawal by Subject|1|||
144395458|NCT04493333|520660004|FG000|Overall Study|Ineligible|0|||
144395459|NCT04493333|520660005|FG001|Overall Study|Ineligible|1|||
144395460|NCT04493333|520660004|FG000|Overall Study|Noncompliance|2|||
144395461|NCT04493333|520660005|FG001|Overall Study|Noncompliance|1|||
144395462|NCT00674973|520660008|FG000|Overall Study|Insufficient Therapeutic Response|77|||
144395463|NCT00674973|520660009|FG001|Overall Study|Insufficient Therapeutic Response|72|||
144395464|NCT00674973|520660008|FG000|Overall Study|Refused Treatment|1|||
144395465|NCT00674973|520660009|FG001|Overall Study|Refused Treatment|5|||
144395466|NCT00674973|520660008|FG000|Overall Study|Failure to Return|1|||
144722247|NCT01893905|521838647|FG001|Overall Study|Lack of adherence to treatment|0|||
144395467|NCT00674973|520660009|FG001|Overall Study|Failure to Return|0|||
144395468|NCT00674973|520660008|FG000|Overall Study|Adverse Event|2|||
144395469|NCT00674973|520660009|FG001|Overall Study|Adverse Event|9|||
144395470|NCT00674973|520660008|FG000|Overall Study|Death|19|||
144395471|NCT00674973|520660009|FG001|Overall Study|Death|15|||
144395472|NCT00674973|520660008|FG000|Overall Study|Protocol Violation|0|||
144395473|NCT00674973|520660009|FG001|Overall Study|Protocol Violation|1|||
144395474|NCT00518687|520660013|FG000|Overall Study|Adverse Event|201|||
144395475|NCT00518687|520660014|FG001|Overall Study|Adverse Event|177|||
144395476|NCT00518687|520660013|FG000|Overall Study|Lost to Follow-up|144|||
144395477|NCT00518687|520660014|FG001|Overall Study|Lost to Follow-up|155|||
144395478|NCT00518687|520660013|FG000|Overall Study|Physician Decision|42|||
144395479|NCT00518687|520660014|FG001|Overall Study|Physician Decision|48|||
144395480|NCT00518687|520660013|FG000|Overall Study|Progressive disease|2|||
144395481|NCT00518687|520660014|FG001|Overall Study|Progressive disease|2|||
144395482|NCT00518687|520660013|FG000|Overall Study|Protocol Violation|8|||
144395483|NCT00518687|520660014|FG001|Overall Study|Protocol Violation|10|||
144395484|NCT00518687|520660013|FG000|Overall Study|Study terminated by sponsor|930|||
144395485|NCT00518687|520660014|FG001|Overall Study|Study terminated by sponsor|918|||
144395486|NCT00518687|520660013|FG000|Overall Study|Withdrawal by Subject|110|||
144395487|NCT00518687|520660014|FG001|Overall Study|Withdrawal by Subject|110|||
144395488|NCT02598960|520660015|FG000|Treatment Period|Disease Progression|4|||
144395489|NCT02598960|520660016|FG001|Treatment Period|Disease Progression|4|||
144395490|NCT02598960|520660017|FG002|Treatment Period|Disease Progression|4|||
144395491|NCT02598960|520660018|FG003|Treatment Period|Disease Progression|6|||
144395492|NCT02598960|520660019|FG004|Treatment Period|Disease Progression|8|||
144395493|NCT02598960|520660020|FG005|Treatment Period|Disease Progression|2|||
144395494|NCT02598960|520660021|FG006|Treatment Period|Disease Progression|2|||
144395495|NCT02598960|520660022|FG007|Treatment Period|Disease Progression|3|||
144395496|NCT02598960|520660023|FG008|Treatment Period|Disease Progression|7|||
144395497|NCT02598960|520660024|FG009|Treatment Period|Disease Progression|9|||
144395498|NCT02598960|520660025|FG010|Treatment Period|Disease Progression|7|||
144395499|NCT02598960|520660026|FG011|Treatment Period|Disease Progression|143|||
144395500|NCT02598960|520660027|FG012|Treatment Period|Disease Progression|23|||
144395501|NCT02598960|520660015|FG000|Treatment Period|Study drug toxicity|0|||
144395502|NCT02598960|520660016|FG001|Treatment Period|Study drug toxicity|0|||
144395503|NCT02598960|520660017|FG002|Treatment Period|Study drug toxicity|0|||
144395504|NCT02598960|520660018|FG003|Treatment Period|Study drug toxicity|0|||
144395505|NCT02598960|520660019|FG004|Treatment Period|Study drug toxicity|0|||
144395506|NCT02598960|520660020|FG005|Treatment Period|Study drug toxicity|0|||
144395507|NCT02598960|520660021|FG006|Treatment Period|Study drug toxicity|0|||
144395508|NCT02598960|520660022|FG007|Treatment Period|Study drug toxicity|0|||
144395509|NCT02598960|520660023|FG008|Treatment Period|Study drug toxicity|0|||
144395510|NCT02598960|520660024|FG009|Treatment Period|Study drug toxicity|1|||
144395511|NCT02598960|520660025|FG010|Treatment Period|Study drug toxicity|0|||
144395512|NCT02598960|520660026|FG011|Treatment Period|Study drug toxicity|3|||
144395513|NCT02598960|520660027|FG012|Treatment Period|Study drug toxicity|0|||
144395514|NCT02598960|520660015|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
144395515|NCT02598960|520660016|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
144395516|NCT02598960|520660017|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
144395517|NCT02598960|520660018|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
144395518|NCT02598960|520660019|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
144395519|NCT02598960|520660020|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
144395520|NCT02598960|520660021|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
144395521|NCT02598960|520660022|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
144395522|NCT02598960|520660023|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
144395523|NCT02598960|520660024|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
144395524|NCT02598960|520660025|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
144395525|NCT02598960|520660026|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
144395526|NCT02598960|520660027|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
144395527|NCT02598960|520660015|FG000|Treatment Period|participant request to discontinue|0|||
144395528|NCT02598960|520660016|FG001|Treatment Period|participant request to discontinue|1|||
144395529|NCT02598960|520660017|FG002|Treatment Period|participant request to discontinue|0|||
144395530|NCT02598960|520660018|FG003|Treatment Period|participant request to discontinue|0|||
144395531|NCT02598960|520660019|FG004|Treatment Period|participant request to discontinue|1|||
144395532|NCT02598960|520660020|FG005|Treatment Period|participant request to discontinue|0|||
144395533|NCT02598960|520660021|FG006|Treatment Period|participant request to discontinue|0|||
144395534|NCT02598960|520660022|FG007|Treatment Period|participant request to discontinue|0|||
144395535|NCT02598960|520660023|FG008|Treatment Period|participant request to discontinue|0|||
144395536|NCT02598960|520660024|FG009|Treatment Period|participant request to discontinue|0|||
144395537|NCT02598960|520660025|FG010|Treatment Period|participant request to discontinue|1|||
144395538|NCT02598960|520660026|FG011|Treatment Period|participant request to discontinue|4|||
144395539|NCT02598960|520660027|FG012|Treatment Period|participant request to discontinue|0|||
144395540|NCT02598960|520660015|FG000|Treatment Period|participant withdrew consent|0|||
144594744|NCT01257425|521377940|FG001|Overall Study|Protocol Violation|1|||
144249607|NCT02854605|520111697|FG002|Overall Study|Withdrew Consent|1|||
144249608|NCT02854605|520111695|FG000|Overall Study|Investigator's Discretion|1|||
144395541|NCT02598960|520660016|FG001|Treatment Period|participant withdrew consent|0|||
144395542|NCT02598960|520660017|FG002|Treatment Period|participant withdrew consent|0|||
144395543|NCT02598960|520660018|FG003|Treatment Period|participant withdrew consent|0|||
144395544|NCT02598960|520660019|FG004|Treatment Period|participant withdrew consent|0|||
144395545|NCT02598960|520660020|FG005|Treatment Period|participant withdrew consent|0|||
144395546|NCT02598960|520660021|FG006|Treatment Period|participant withdrew consent|0|||
144395547|NCT02598960|520660022|FG007|Treatment Period|participant withdrew consent|0|||
144395548|NCT02598960|520660023|FG008|Treatment Period|participant withdrew consent|0|||
144395549|NCT02598960|520660024|FG009|Treatment Period|participant withdrew consent|0|||
144395550|NCT02598960|520660025|FG010|Treatment Period|participant withdrew consent|0|||
144395551|NCT02598960|520660026|FG011|Treatment Period|participant withdrew consent|3|||
144395552|NCT02598960|520660027|FG012|Treatment Period|participant withdrew consent|0|||
144395553|NCT02598960|520660015|FG000|Treatment Period|No longer meets study criteria|0|||
144395554|NCT02598960|520660016|FG001|Treatment Period|No longer meets study criteria|0|||
144395555|NCT02598960|520660017|FG002|Treatment Period|No longer meets study criteria|0|||
144395556|NCT02598960|520660018|FG003|Treatment Period|No longer meets study criteria|0|||
144395557|NCT02598960|520660019|FG004|Treatment Period|No longer meets study criteria|0|||
144395558|NCT02598960|520660020|FG005|Treatment Period|No longer meets study criteria|0|||
144395559|NCT02598960|520660021|FG006|Treatment Period|No longer meets study criteria|0|||
144395560|NCT02598960|520660022|FG007|Treatment Period|No longer meets study criteria|0|||
144395561|NCT02598960|520660023|FG008|Treatment Period|No longer meets study criteria|0|||
144395562|NCT02598960|520660024|FG009|Treatment Period|No longer meets study criteria|0|||
144395563|NCT02598960|520660025|FG010|Treatment Period|No longer meets study criteria|0|||
144395564|NCT02598960|520660026|FG011|Treatment Period|No longer meets study criteria|1|||
144395565|NCT02598960|520660027|FG012|Treatment Period|No longer meets study criteria|0|||
144249609|NCT02854605|520111696|FG001|Overall Study|Investigator's Discretion|0|||
144249610|NCT02854605|520111697|FG002|Overall Study|Investigator's Discretion|0|||
144249611|NCT02854605|520111695|FG000|Overall Study|Protocol Violation|0|||
144249612|NCT02854605|520111696|FG001|Overall Study|Protocol Violation|0|||
144395566|NCT02598960|520660015|FG000|Treatment Period|Other Reasons|0|||
144395567|NCT02598960|520660016|FG001|Treatment Period|Other Reasons|0|||
144395568|NCT02598960|520660017|FG002|Treatment Period|Other Reasons|0|||
144395569|NCT02598960|520660018|FG003|Treatment Period|Other Reasons|0|||
144395570|NCT02598960|520660019|FG004|Treatment Period|Other Reasons|0|||
144519497|NCT02783300|521103336|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519498|NCT02783300|521103337|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519499|NCT02783300|521103338|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519500|NCT02783300|521103339|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519501|NCT02783300|521103340|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519502|NCT02783300|521103341|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519503|NCT02783300|521103342|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144249613|NCT02854605|520111697|FG002|Overall Study|Protocol Violation|1|||
144395571|NCT02598960|520660020|FG005|Treatment Period|Other Reasons|0|||
144395572|NCT02598960|520660021|FG006|Treatment Period|Other Reasons|0|||
144395573|NCT02598960|520660022|FG007|Treatment Period|Other Reasons|0|||
144395574|NCT02598960|520660023|FG008|Treatment Period|Other Reasons|0|||
144395575|NCT02598960|520660024|FG009|Treatment Period|Other Reasons|0|||
144395576|NCT02598960|520660025|FG010|Treatment Period|Other Reasons|0|||
144395577|NCT02598960|520660026|FG011|Treatment Period|Other Reasons|0|||
144395578|NCT02598960|520660027|FG012|Treatment Period|Other Reasons|1|||
144395579|NCT02598960|520660015|FG000|Participants Entering Follow Up Period|Death|1|||
144395580|NCT02598960|520660016|FG001|Participants Entering Follow Up Period|Death|0|||
144395581|NCT02598960|520660017|FG002|Participants Entering Follow Up Period|Death|0|||
144395582|NCT02598960|520660018|FG003|Participants Entering Follow Up Period|Death|0|||
144395583|NCT02598960|520660019|FG004|Participants Entering Follow Up Period|Death|0|||
144395584|NCT02598960|520660020|FG005|Participants Entering Follow Up Period|Death|0|||
144395585|NCT02598960|520660021|FG006|Participants Entering Follow Up Period|Death|0|||
144594745|NCT01257425|521377939|FG000|Overall Study|Withdrawal by Subject|0|||
144594746|NCT01257425|521377940|FG001|Overall Study|Withdrawal by Subject|1|||
144594747|NCT01257425|521377939|FG000|Overall Study|Death|1|||
144594748|NCT01257425|521377940|FG001|Overall Study|Death|0|||
144594749|NCT00368992|521377945|FG000|Overall Study|Ineligible|5|||
144594750|NCT00368992|521377945|FG000|Overall Study|Refused treatment|3|||
144594751|NCT00368992|521377945|FG000|Overall Study|Lack of Efficacy|63|||
144594752|NCT00368992|521377945|FG000|Overall Study|Adverse Event|26|||
144594753|NCT00368992|521377945|FG000|Overall Study|Death|4|||
144594754|NCT00368992|521377945|FG000|Overall Study|Other|9|||
144594755|NCT01013597|521377952|FG000|Overall Study|Withdrawal by Subject|1|||
144594756|NCT00427895|521377953|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144594757|NCT00427895|521377954|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144249614|NCT00568334|520111698|FG000|Overall Study|Withdrawal by Subject|0|||
144395586|NCT02598960|520660022|FG007|Participants Entering Follow Up Period|Death|0|||
144395587|NCT02598960|520660023|FG008|Participants Entering Follow Up Period|Death|0|||
144395588|NCT02598960|520660024|FG009|Participants Entering Follow Up Period|Death|1|||
144395589|NCT02598960|520660025|FG010|Participants Entering Follow Up Period|Death|0|||
144395590|NCT02598960|520660026|FG011|Participants Entering Follow Up Period|Death|11|||
144395591|NCT02598960|520660027|FG012|Participants Entering Follow Up Period|Death|2|||
144395592|NCT02598960|520660015|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395593|NCT02598960|520660016|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395594|NCT02598960|520660017|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395595|NCT02598960|520660018|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395596|NCT02598960|520660019|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395597|NCT02598960|520660020|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395598|NCT02598960|520660021|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395599|NCT02598960|520660022|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395600|NCT02598960|520660023|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395601|NCT02598960|520660024|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395602|NCT02598960|520660025|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395603|NCT02598960|520660026|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
144395604|NCT02598960|520660027|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
144395605|NCT02598960|520660015|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
144395606|NCT02598960|520660016|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
144395607|NCT02598960|520660017|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
144395608|NCT02598960|520660018|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
144395609|NCT02598960|520660019|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
144395610|NCT02598960|520660020|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
144519504|NCT02783300|521103343|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519505|NCT02783300|521103344|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519506|NCT02783300|521103345|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519507|NCT02783300|521103346|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
144519508|NCT02783300|521103347|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519509|NCT02783300|521103348|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519510|NCT02783300|521103349|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519511|NCT02783300|521103350|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519512|NCT02783300|521103351|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144594758|NCT00427895|521377955|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144594759|NCT00427895|521377956|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
144594760|NCT00427895|521377957|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144395611|NCT02598960|520660021|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
144395612|NCT02598960|520660022|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
144395613|NCT02598960|520660023|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
144395614|NCT02598960|520660024|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
144395615|NCT02598960|520660025|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
144395616|NCT02598960|520660026|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
144395617|NCT02598960|520660027|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
144395618|NCT02598960|520660015|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395619|NCT02598960|520660016|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395620|NCT02598960|520660017|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395621|NCT02598960|520660018|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395622|NCT02598960|520660019|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144519513|NCT02783300|521103352|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519514|NCT02783300|521103353|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
144519515|NCT02783300|521103354|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519516|NCT02783300|521103355|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519517|NCT02783300|521103356|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519518|NCT02783300|521103357|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
144519519|NCT02783300|521103331|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519520|NCT02783300|521103332|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519521|NCT02783300|521103333|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519522|NCT02783300|521103334|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519523|NCT02783300|521103335|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519524|NCT02783300|521103336|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519525|NCT02783300|521103337|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519526|NCT02783300|521103338|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519527|NCT02783300|521103339|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519528|NCT02783300|521103340|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519529|NCT02783300|521103341|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519530|NCT02783300|521103342|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519531|NCT02783300|521103343|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519532|NCT02783300|521103344|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
144519533|NCT02783300|521103345|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
144519534|NCT02783300|521103346|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
144519535|NCT02783300|521103347|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
144519536|NCT02783300|521103348|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519537|NCT02783300|521103349|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
144519538|NCT02783300|521103350|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
144519539|NCT02783300|521103351|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519540|NCT02783300|521103352|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519541|NCT02783300|521103353|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519542|NCT02783300|521103354|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519543|NCT02783300|521103355|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519544|NCT02783300|521103356|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519545|NCT02783300|521103357|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
144519546|NCT02783300|521103331|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519547|NCT02783300|521103332|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519548|NCT02783300|521103333|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519549|NCT02783300|521103334|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519550|NCT02783300|521103335|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519551|NCT02783300|521103336|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519552|NCT02783300|521103337|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519553|NCT02783300|521103338|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519554|NCT02783300|521103339|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519555|NCT02783300|521103340|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519556|NCT02783300|521103341|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519557|NCT02783300|521103342|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144722248|NCT01893905|521838646|FG000|Overall Study|Other reason|1|||
144395623|NCT02598960|520660020|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395624|NCT02598960|520660021|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395625|NCT02598960|520660022|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395626|NCT02598960|520660023|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395627|NCT02598960|520660024|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395628|NCT02598960|520660025|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395629|NCT02598960|520660026|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
144395630|NCT02598960|520660027|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
144395631|NCT02598960|520660015|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
144395632|NCT02598960|520660016|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
144395633|NCT02598960|520660017|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
144395634|NCT02598960|520660018|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
144395635|NCT02598960|520660019|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
144395636|NCT02598960|520660020|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
144395637|NCT02598960|520660021|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
144395638|NCT02598960|520660022|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
144395639|NCT02598960|520660023|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
144395640|NCT02598960|520660024|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
144395641|NCT02598960|520660025|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
144519558|NCT02783300|521103343|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519559|NCT02783300|521103344|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
144519560|NCT02783300|521103345|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
144519561|NCT02783300|521103346|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
144519562|NCT02783300|521103347|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
144519563|NCT02783300|521103348|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
144519564|NCT02783300|521103349|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
144519565|NCT02783300|521103350|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
144519566|NCT02783300|521103351|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
144519567|NCT02783300|521103352|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
144519568|NCT02783300|521103353|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
144519569|NCT02783300|521103354|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
144519570|NCT02783300|521103355|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
144519571|NCT02783300|521103356|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
144519572|NCT02783300|521103357|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
144519573|NCT02783300|521103331|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519574|NCT02783300|521103332|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519575|NCT02783300|521103333|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519576|NCT02783300|521103334|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519577|NCT02783300|521103335|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519578|NCT02783300|521103336|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519579|NCT02783300|521103337|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519580|NCT02783300|521103338|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519581|NCT02783300|521103339|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519582|NCT02783300|521103340|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519583|NCT02783300|521103341|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519584|NCT02783300|521103342|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519585|NCT02783300|521103343|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519586|NCT02783300|521103344|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519587|NCT02783300|521103345|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519588|NCT02783300|521103346|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519589|NCT02783300|521103347|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519590|NCT02783300|521103348|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519591|NCT02783300|521103349|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519592|NCT02783300|521103350|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519593|NCT02783300|521103351|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519594|NCT02783300|521103352|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519595|NCT02783300|521103353|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519596|NCT02783300|521103354|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519597|NCT02783300|521103355|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519598|NCT02783300|521103356|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
144519599|NCT02783300|521103357|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
144519600|NCT02783300|521103331|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519601|NCT02783300|521103332|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519602|NCT02783300|521103333|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519603|NCT02783300|521103334|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519604|NCT02783300|521103335|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519605|NCT02783300|521103336|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519606|NCT02783300|521103337|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519607|NCT02783300|521103338|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519608|NCT02783300|521103339|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519609|NCT02783300|521103340|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519610|NCT02783300|521103341|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519611|NCT02783300|521103342|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519612|NCT02783300|521103343|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519613|NCT02783300|521103344|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519614|NCT02783300|521103345|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519615|NCT02783300|521103346|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519616|NCT02783300|521103347|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519617|NCT02783300|521103348|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519618|NCT02783300|521103349|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519619|NCT02783300|521103350|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519620|NCT02783300|521103351|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519621|NCT02783300|521103352|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519622|NCT02783300|521103353|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519623|NCT02783300|521103354|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519624|NCT02783300|521103355|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519625|NCT02783300|521103356|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
144519626|NCT02783300|521103357|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
144519627|NCT03535272|521103358|FG000|Overall Study|Lost to Follow-up|71|||
144519628|NCT03535272|521103359|FG001|Overall Study|Lost to Follow-up|73|||
144519629|NCT02913872|521103364|FG000|Overall Study|Withdrawal by Subject|1|||
144519630|NCT03110315|521103365|FG000|Overall Study|Withdrawal by Subject|1|||
144519631|NCT03110315|521103366|FG001|Overall Study|Withdrawal by Subject|0|||
144519632|NCT05371652|521103371|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
144519633|NCT05371652|521103371|FG000|Overall Study|Withdrawal by Subject|12|||
144519634|NCT05371652|521103371|FG000|Overall Study|Adverse Event|1|||
144519635|NCT05371652|521103371|FG000|Overall Study|Other|11|||
144519636|NCT03978871|521103372|FG000|Overall Study|Lost to Follow-up|11|||
144519637|NCT03978871|521103373|FG001|Overall Study|Lost to Follow-up|12|||
144519638|NCT03131648|521104674|FG000|Initial Treatment Period|Not dosed|2|||
144519639|NCT03131648|521104675|FG001|Initial Treatment Period|Not dosed|2|||
144519640|NCT03131648|521104676|FG002|Initial Treatment Period|Not dosed|0|||
144519641|NCT03131648|521104677|FG003|Initial Treatment Period|Not dosed|0|||
144519642|NCT03131648|521104678|FG004|Initial Treatment Period|Not dosed|0|||
144519643|NCT03131648|521104679|FG005|Initial Treatment Period|Not dosed|0|||
144519644|NCT03131648|521104680|FG006|Initial Treatment Period|Not dosed|0|||
144519645|NCT03131648|521104681|FG007|Initial Treatment Period|Not dosed|0|||
144519646|NCT03131648|521104674|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
144519647|NCT03131648|521104675|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
144519648|NCT03131648|521104676|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144519649|NCT03131648|521104677|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144519650|NCT03131648|521104678|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144519651|NCT03131648|521104679|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144519652|NCT03131648|521104680|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144519653|NCT03131648|521104681|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144519654|NCT03131648|521104674|FG000|Open-label Treatment|Discontinued IMP|0|||
144519655|NCT03131648|521104675|FG001|Open-label Treatment|Discontinued IMP|0|||
144519656|NCT03131648|521104676|FG002|Open-label Treatment|Discontinued IMP|0|||
144519657|NCT03131648|521104677|FG003|Open-label Treatment|Discontinued IMP|0|||
144519658|NCT03131648|521104678|FG004|Open-label Treatment|Discontinued IMP|0|||
144519659|NCT03131648|521104679|FG005|Open-label Treatment|Discontinued IMP|0|||
144519660|NCT03131648|521104680|FG006|Open-label Treatment|Discontinued IMP|112|||
144519661|NCT03131648|521104681|FG007|Open-label Treatment|Discontinued IMP|0|||
144519662|NCT03131648|521104674|FG000|Open-label Treatment|Completed Week 50|0|||
144519663|NCT03131648|521104675|FG001|Open-label Treatment|Completed Week 50|0|||
144519664|NCT03131648|521104676|FG002|Open-label Treatment|Completed Week 50|0|||
144519665|NCT03131648|521104677|FG003|Open-label Treatment|Completed Week 50|0|||
144519666|NCT03131648|521104678|FG004|Open-label Treatment|Completed Week 50|0|||
144519667|NCT03131648|521104679|FG005|Open-label Treatment|Completed Week 50|0|||
144395642|NCT02598960|520660026|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
144395643|NCT02598960|520660027|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
144395644|NCT05108922|520660028|FG000|Overall Study|Adverse Event|2|||
144395645|NCT05108922|520660029|FG001|Overall Study|Adverse Event|3|||
144395646|NCT05108922|520660028|FG000|Overall Study|Lost to Follow-up|2|||
144395647|NCT05108922|520660029|FG001|Overall Study|Lost to Follow-up|1|||
144395648|NCT05108922|520660028|FG000|Overall Study|Inadvertent enrollment|0|||
144395649|NCT05108922|520660029|FG001|Overall Study|Inadvertent enrollment|1|||
144519668|NCT03131648|521104680|FG006|Open-label Treatment|Completed Week 50|6|||
144519669|NCT03131648|521104681|FG007|Open-label Treatment|Completed Week 50|0|||
144519670|NCT03131648|521104674|FG000|Maintenance Treatment Period|Not dosed|0|||
144519671|NCT03131648|521104675|FG001|Maintenance Treatment Period|Not dosed|0|||
144519672|NCT03131648|521104676|FG002|Maintenance Treatment Period|Not dosed|3|||
144519673|NCT03131648|521104677|FG003|Maintenance Treatment Period|Not dosed|2|||
144519674|NCT03131648|521104678|FG004|Maintenance Treatment Period|Not dosed|1|||
144519675|NCT03131648|521104679|FG005|Maintenance Treatment Period|Not dosed|0|||
144519676|NCT03131648|521104680|FG006|Maintenance Treatment Period|Not dosed|0|||
144519677|NCT03131648|521104681|FG007|Maintenance Treatment Period|Not dosed|0|||
144519678|NCT03131648|521104674|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
144519679|NCT03131648|521104675|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
144519680|NCT03131648|521104676|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
144519681|NCT03131648|521104677|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
144519682|NCT03131648|521104678|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
144519683|NCT03131648|521104679|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
144519684|NCT03131648|521104680|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
144519685|NCT03131648|521104681|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
144519686|NCT03131648|521104674|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144519687|NCT03131648|521104675|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144519688|NCT03131648|521104676|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
144519689|NCT03131648|521104677|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
144519690|NCT03131648|521104678|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
144519691|NCT03131648|521104679|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
144519692|NCT03131648|521104680|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144519693|NCT03131648|521104681|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144519694|NCT03131648|521104674|FG000|Maintenance Treatment Period|Completed Week 50|0|||
144519695|NCT03131648|521104675|FG001|Maintenance Treatment Period|Completed Week 50|0|||
144519696|NCT03131648|521104676|FG002|Maintenance Treatment Period|Completed Week 50|0|||
144519697|NCT03131648|521104677|FG003|Maintenance Treatment Period|Completed Week 50|0|||
144519698|NCT03131648|521104678|FG004|Maintenance Treatment Period|Completed Week 50|1|||
144519699|NCT03131648|521104679|FG005|Maintenance Treatment Period|Completed Week 50|0|||
144519700|NCT03131648|521104680|FG006|Maintenance Treatment Period|Completed Week 50|0|||
144519701|NCT03131648|521104681|FG007|Maintenance Treatment Period|Completed Week 50|0|||
144519702|NCT03131648|521104674|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
144519703|NCT03131648|521104675|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
144519704|NCT03131648|521104676|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
144519705|NCT03131648|521104677|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
144722249|NCT01893905|521838647|FG001|Overall Study|Other reason|3|||
144395650|NCT05108922|520660028|FG000|Overall Study|Physician Decision|2|||
144395651|NCT05108922|520660029|FG001|Overall Study|Physician Decision|3|||
144594761|NCT00427895|521377958|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144594762|NCT00427895|521377959|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144594763|NCT00427895|521377960|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
144594764|NCT00427895|521377953|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594765|NCT00427895|521377954|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594766|NCT00427895|521377955|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594767|NCT00427895|521377956|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594768|NCT00427895|521377957|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594769|NCT00427895|521377958|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594770|NCT00427895|521377959|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
144594771|NCT00427895|521377960|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
144594772|NCT00427895|521377953|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594773|NCT00427895|521377954|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594774|NCT00427895|521377955|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594775|NCT00427895|521377956|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594776|NCT00427895|521377957|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594777|NCT00427895|521377958|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594778|NCT00427895|521377959|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
144594779|NCT00427895|521377960|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
144594780|NCT00427895|521377953|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
144594781|NCT00427895|521377954|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
144594782|NCT00427895|521377955|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
144594783|NCT00427895|521377956|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
144594784|NCT00427895|521377957|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
144594785|NCT00427895|521377958|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
144594786|NCT00427895|521377959|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
144594787|NCT00427895|521377960|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
144594788|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
144395652|NCT05108922|520660028|FG000|Overall Study|Protocol deviation|1|||
144395653|NCT05108922|520660029|FG001|Overall Study|Protocol deviation|0|||
144395654|NCT05108922|520660028|FG000|Overall Study|Screen failure|1|||
144395655|NCT05108922|520660029|FG001|Overall Study|Screen failure|0|||
144395656|NCT05108922|520660028|FG000|Overall Study|Withdrawal by Subject|11|||
144395657|NCT05108922|520660029|FG001|Overall Study|Withdrawal by Subject|8|||
144395658|NCT05036369|520660031|FG000|Overall Study|Run In non compliance|1|||
144395659|NCT05036369|520660032|FG001|Overall Study|Run In non compliance|2|||
144395660|NCT05036369|520660031|FG000|Overall Study|Change in eligibility criteria|0|||
144395661|NCT05036369|520660032|FG001|Overall Study|Change in eligibility criteria|1|||
144519706|NCT03131648|521104678|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
144519707|NCT03131648|521104679|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
144519708|NCT03131648|521104680|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
144519709|NCT03131648|521104681|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
144519710|NCT04150718|521104689|FG000|Overall Study|Withdrawal by Subject|2|||
144519711|NCT04150718|521104690|FG001|Overall Study|Withdrawal by Subject|7|||
144519712|NCT04150718|521104691|FG002|Overall Study|Withdrawal by Subject|1|||
144519713|NCT04150718|521104689|FG000|Overall Study|Lost to Follow-up|1|||
144519714|NCT04150718|521104690|FG001|Overall Study|Lost to Follow-up|2|||
144519715|NCT04150718|521104691|FG002|Overall Study|Lost to Follow-up|0|||
144519716|NCT04150718|521104689|FG000|Overall Study|Ineligible|1|||
144519717|NCT04150718|521104690|FG001|Overall Study|Ineligible|0|||
144519718|NCT04150718|521104691|FG002|Overall Study|Ineligible|10|||
144519719|NCT05633953|521104692|FG000|Overall Study|Adverse Event|7|||
144519720|NCT05633953|521104692|FG000|Overall Study|Death|30|||
144519721|NCT05633953|521104692|FG000|Overall Study|Lost to Follow-up|1|||
144519722|NCT05633953|521104692|FG000|Overall Study|Osilodrostat discontinued|4|||
144519723|NCT05633953|521104692|FG000|Overall Study|Physician Decision|1|||
144519724|NCT05633953|521104692|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
144519725|NCT05633953|521104692|FG000|Overall Study|Progressive disease|2|||
144519726|NCT02729311|521104693|FG000|Overall Study|Withdrawal by Subject|8|||
144519727|NCT02729311|521104694|FG001|Overall Study|Withdrawal by Subject|2|||
144519728|NCT05324124|521104695|FG000|Period 1|Withdrawal by Subject|1|||
144519729|NCT05324124|521104696|FG001|Period 1|Withdrawal by Subject|0|||
144519730|NCT05324124|521104695|FG000|Period 1|Physician Decision|0|||
144519731|NCT05324124|521104696|FG001|Period 1|Physician Decision|1|||
144519732|NCT04034251|521104697|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
144519733|NCT04034251|521104698|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
144519734|NCT04034251|521104699|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
144519735|NCT00920621|521104716|FG000|Overall Study|Lost to Follow-up|16|||
144519736|NCT00920621|521104717|FG001|Overall Study|Lost to Follow-up|17|||
144519737|NCT00920621|521104718|FG002|Overall Study|Lost to Follow-up|19|||
144519738|NCT00920621|521104719|FG003|Overall Study|Lost to Follow-up|21|||
144519739|NCT00920621|521104716|FG000|Overall Study|Fetal/neonatal deaths|16|||
144519740|NCT00920621|521104717|FG001|Overall Study|Fetal/neonatal deaths|14|||
144519741|NCT00920621|521104718|FG002|Overall Study|Fetal/neonatal deaths|16|||
144519742|NCT00920621|521104719|FG003|Overall Study|Fetal/neonatal deaths|14|||
144519743|NCT00920621|521104716|FG000|Overall Study|Blood sample not collected|22|||
144519744|NCT00920621|521104717|FG001|Overall Study|Blood sample not collected|14|||
144519745|NCT00920621|521104718|FG002|Overall Study|Blood sample not collected|0|||
144519746|NCT00920621|521104719|FG003|Overall Study|Blood sample not collected|0|||
144519747|NCT02312557|521104720|FG000|Overall Study|Survival follow-up|4|||
144519748|NCT02736409|521104721|FG000|Overall Study|Withdrawal by Subject|4|||
144519749|NCT02736409|521104722|FG001|Overall Study|Withdrawal by Subject|2|||
144519750|NCT02736409|521104723|FG002|Overall Study|Withdrawal by Subject|17|||
144519751|NCT02736409|521104724|FG003|Overall Study|Withdrawal by Subject|3|||
144519752|NCT02736409|521104721|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144519753|NCT02736409|521104722|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144519754|NCT02736409|521104723|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144519755|NCT02736409|521104724|FG003|Overall Study|Non-Compliance with Study Drug|1|||
144519756|NCT02736409|521104721|FG000|Overall Study|Adverse Event|0|||
144519757|NCT02736409|521104722|FG001|Overall Study|Adverse Event|1|||
144519758|NCT02736409|521104723|FG002|Overall Study|Adverse Event|5|||
144519759|NCT02736409|521104724|FG003|Overall Study|Adverse Event|4|||
144519760|NCT02736409|521104721|FG000|Overall Study|Other|0|||
144519761|NCT02736409|521104722|FG001|Overall Study|Other|0|||
144519762|NCT02736409|521104723|FG002|Overall Study|Other|1|||
144395662|NCT00398411|520660037|FG000|Overall Study|Death|0|||
144395663|NCT00398411|520660038|FG001|Overall Study|Death|1|||
144519763|NCT02736409|521104724|FG003|Overall Study|Other|1|||
144519764|NCT02736409|521104721|FG000|Overall Study|Pregnancy|0|||
144519765|NCT02736409|521104722|FG001|Overall Study|Pregnancy|0|||
144519766|NCT02736409|521104723|FG002|Overall Study|Pregnancy|1|||
144519767|NCT02736409|521104724|FG003|Overall Study|Pregnancy|0|||
144519768|NCT02736409|521104721|FG000|Overall Study|Lost to Follow-up|0|||
144519769|NCT02736409|521104722|FG001|Overall Study|Lost to Follow-up|0|||
144519770|NCT02736409|521104723|FG002|Overall Study|Lost to Follow-up|2|||
144519771|NCT02736409|521104724|FG003|Overall Study|Lost to Follow-up|1|||
144519772|NCT02736409|521104721|FG000|Overall Study|Physician Decision|0|||
144519773|NCT02736409|521104722|FG001|Overall Study|Physician Decision|0|||
144519774|NCT02736409|521104723|FG002|Overall Study|Physician Decision|0|||
144519775|NCT02736409|521104724|FG003|Overall Study|Physician Decision|2|||
144519776|NCT04390048|521104725|FG000|Overall Study|Withdrawal by Subject|1|||
144519777|NCT04390048|521104726|FG001|Overall Study|Withdrawal by Subject|3|||
144519778|NCT01415154|521104727|FG000|Overall Study|Lack of Efficacy|4|||
144519779|NCT01415154|521104728|FG001|Overall Study|Lack of Efficacy|5|||
144519780|NCT01415154|521104727|FG000|Overall Study|Withdrawal by Subject|7|||
144519781|NCT01415154|521104728|FG001|Overall Study|Withdrawal by Subject|8|||
144519782|NCT01415154|521104727|FG000|Overall Study|Lost to Follow-up|1|||
144519783|NCT01415154|521104728|FG001|Overall Study|Lost to Follow-up|4|||
144519784|NCT01415154|521104727|FG000|Overall Study|Protocol Violation|0|||
144519785|NCT01415154|521104728|FG001|Overall Study|Protocol Violation|1|||
144519786|NCT01415154|521104727|FG000|Overall Study|Satisfactory Response|0|||
144519787|NCT01415154|521104728|FG001|Overall Study|Satisfactory Response|1|||
144519788|NCT01415154|521104727|FG000|Overall Study|Adverse Event|1|||
144519789|NCT01415154|521104728|FG001|Overall Study|Adverse Event|1|||
144519790|NCT04784559|521104763|FG000|Overall Study|Withdrawal by Subject|3|||
144519791|NCT04784559|521104764|FG001|Overall Study|Withdrawal by Subject|2|||
144519792|NCT04784559|521104765|FG002|Overall Study|Withdrawal by Subject|1|||
144519793|NCT04784559|521104763|FG000|Overall Study|Death|2|||
144519794|NCT04784559|521104764|FG001|Overall Study|Death|1|||
144519795|NCT04784559|521104765|FG002|Overall Study|Death|2|||
144519796|NCT04784559|521104763|FG000|Overall Study|Lost to Follow-up|0|||
144519797|NCT04784559|521104764|FG001|Overall Study|Lost to Follow-up|0|||
144519798|NCT04784559|521104765|FG002|Overall Study|Lost to Follow-up|2|||
144519799|NCT04784559|521104763|FG000|Overall Study|Participant worsened, PI decision|1|||
144519800|NCT04784559|521104764|FG001|Overall Study|Participant worsened, PI decision|0|||
144519801|NCT04784559|521104765|FG002|Overall Study|Participant worsened, PI decision|0|||
144519802|NCT04784559|521104763|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
144519803|NCT04784559|521104764|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
144519804|NCT04784559|521104765|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
144519805|NCT04784559|521104763|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
144519806|NCT04784559|521104764|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
144519807|NCT04784559|521104765|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
144519808|NCT04784559|521104763|FG000|Overall Study|Did not meet all inclusion criteria|0|||
144519809|NCT04784559|521104764|FG001|Overall Study|Did not meet all inclusion criteria|1|||
144519810|NCT04784559|521104765|FG002|Overall Study|Did not meet all inclusion criteria|0|||
144519811|NCT04784559|521104763|FG000|Overall Study|The participant was transferred to IRCU|0|||
144519812|NCT04784559|521104764|FG001|Overall Study|The participant was transferred to IRCU|1|||
144519813|NCT04784559|521104765|FG002|Overall Study|The participant was transferred to IRCU|0|||
144519814|NCT04784559|521104763|FG000|Overall Study|SAE|0|||
144519815|NCT04784559|521104764|FG001|Overall Study|SAE|1|||
144519816|NCT04784559|521104765|FG002|Overall Study|SAE|0|||
144519817|NCT04784559|521104763|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
144519818|NCT04784559|521104764|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
144519819|NCT04784559|521104765|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
144519820|NCT03138512|521104767|FG000|Randomization|Participants withdrew consent|0|||
144519821|NCT03138512|521104768|FG001|Randomization|Participants withdrew consent|1|||
144519822|NCT03138512|521104769|FG002|Randomization|Participants withdrew consent|1|||
144519823|NCT03138512|521104770|FG003|Randomization|Participants withdrew consent|0|||
144519824|NCT03138512|521104771|FG004|Randomization|Participants withdrew consent|0|||
144519825|NCT03138512|521104767|FG000|Randomization|Participant no longer meets study criteria|0|||
144519826|NCT03138512|521104768|FG001|Randomization|Participant no longer meets study criteria|3|||
144519827|NCT03138512|521104769|FG002|Randomization|Participant no longer meets study criteria|1|||
144519828|NCT03138512|521104770|FG003|Randomization|Participant no longer meets study criteria|1|||
144519829|NCT03138512|521104771|FG004|Randomization|Participant no longer meets study criteria|3|||
144519830|NCT03138512|521104767|FG000|Randomization|Other reasons|1|||
144519831|NCT03138512|521104768|FG001|Randomization|Other reasons|0|||
144519832|NCT03138512|521104769|FG002|Randomization|Other reasons|0|||
144519833|NCT03138512|521104770|FG003|Randomization|Other reasons|0|||
144519834|NCT03138512|521104771|FG004|Randomization|Other reasons|0|||
144519835|NCT03138512|521104767|FG000|Treatment Part A|Disease recurrence|10|||
144519836|NCT03138512|521104768|FG001|Treatment Part A|Disease recurrence|20|||
144519837|NCT03138512|521104769|FG002|Treatment Part A|Disease recurrence|0|||
144395664|NCT02095223|520660041|FG000|Overall Study|Withdrawal by Subject|1|||
144395665|NCT02095223|520660042|FG001|Overall Study|Withdrawal by Subject|0|||
144395666|NCT01397162|520660043|FG000|Overall Study|Adverse Event|4|||
144395667|NCT01397162|520660044|FG001|Overall Study|Adverse Event|0|||
144395668|NCT01397162|520660045|FG002|Overall Study|Adverse Event|0|||
144395669|NCT01397162|520660046|FG003|Overall Study|Adverse Event|0|||
144395670|NCT01397162|520660047|FG004|Overall Study|Adverse Event|0|||
144395671|NCT01397162|520660043|FG000|Overall Study|Not yet defined|3|||
144395672|NCT01397162|520660044|FG001|Overall Study|Not yet defined|4|||
144395673|NCT01397162|520660045|FG002|Overall Study|Not yet defined|3|||
144395674|NCT01397162|520660046|FG003|Overall Study|Not yet defined|5|||
144395675|NCT01397162|520660047|FG004|Overall Study|Not yet defined|3|||
144395676|NCT03906461|520660050|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
144395677|NCT03906461|520660050|FG000|Completed 12-month Follow-up|Missed Visit|6|||
144395678|NCT00426231|520660053|FG000|Overall Study|Withdrawal by Subject|9|||
144395679|NCT00426231|520660054|FG001|Overall Study|Withdrawal by Subject|12|||
144395680|NCT01795638|520660055|FG000|Overall Study|Death|0|||
144395681|NCT01795638|520660056|FG001|Overall Study|Death|3|||
144395682|NCT01795638|520660055|FG000|Overall Study|transferred to quaternary hospital|2|||
144395683|NCT01795638|520660056|FG001|Overall Study|transferred to quaternary hospital|3|||
144395684|NCT01795638|520660055|FG000|Overall Study|Protocol Violation|3|||
144395685|NCT01795638|520660056|FG001|Overall Study|Protocol Violation|0|||
144395686|NCT01795638|520660055|FG000|Overall Study|discharged from hospital|7|||
144395687|NCT01795638|520660056|FG001|Overall Study|discharged from hospital|5|||
144395688|NCT01795638|520660055|FG000|Overall Study|Withdrawal by Subject|1|||
144395689|NCT01795638|520660056|FG001|Overall Study|Withdrawal by Subject|0|||
144395690|NCT03061097|520660057|FG000|Overall Study|Withdrawal by Subject|0|||
144395691|NCT03061097|520660058|FG001|Overall Study|Withdrawal by Subject|3|||
144395692|NCT01614600|520660065|FG000|Overall Study|Unacceptable fit|1|||
144395693|NCT01614600|520660065|FG000|Overall Study|Discomfort|1|||
144395694|NCT01614600|520660065|FG000|Overall Study|Unable to remove lens at the end of day|1|||
144395695|NCT01614600|520660065|FG000|Overall Study|Protocol deviation|1|||
144395696|NCT00595465|520660066|FG000|Overall Study|Adverse Event|4|||
144395697|NCT00595465|520660067|FG001|Overall Study|Adverse Event|3|||
144395698|NCT00595465|520660068|FG002|Overall Study|Adverse Event|3|||
144395699|NCT00595465|520660066|FG000|Overall Study|Pregnancy|0|||
144395700|NCT00595465|520660067|FG001|Overall Study|Pregnancy|0|||
144395701|NCT00595465|520660068|FG002|Overall Study|Pregnancy|1|||
144395702|NCT00595465|520660066|FG000|Overall Study|Protocol Violation|2|||
144395703|NCT00595465|520660067|FG001|Overall Study|Protocol Violation|1|||
144395704|NCT00595465|520660068|FG002|Overall Study|Protocol Violation|0|||
144395705|NCT00595465|520660066|FG000|Overall Study|Lost to Follow-up|0|||
144395706|NCT00595465|520660067|FG001|Overall Study|Lost to Follow-up|0|||
144395707|NCT00595465|520660068|FG002|Overall Study|Lost to Follow-up|2|||
144395708|NCT00595465|520660066|FG000|Overall Study|administrative reason|0|||
144395709|NCT00595465|520660067|FG001|Overall Study|administrative reason|0|||
144395710|NCT00595465|520660068|FG002|Overall Study|administrative reason|1|||
144395711|NCT01051466|520660069|FG000|Overall Study|Adverse Event|1|||
144395712|NCT01051466|520660070|FG001|Overall Study|Adverse Event|0|||
144395713|NCT01051466|520660069|FG000|Overall Study|Lost to Follow-up|1|||
144395714|NCT01051466|520660070|FG001|Overall Study|Lost to Follow-up|1|||
144395715|NCT01051466|520660069|FG000|Overall Study|Withdrawal by Subject|5|||
144395716|NCT01051466|520660070|FG001|Overall Study|Withdrawal by Subject|1|||
144395717|NCT01051466|520660069|FG000|Overall Study|Entry Criteria Not Met|0|||
144395718|NCT01051466|520660070|FG001|Overall Study|Entry Criteria Not Met|3|||
144395719|NCT01051466|520660069|FG000|Overall Study|Physician Decision|1|||
144395720|NCT01051466|520660070|FG001|Overall Study|Physician Decision|0|||
144395721|NCT02231918|520660071|FG000|Overall Study|Withdrawal by Subject|0|||
144395722|NCT02231918|520660072|FG001|Overall Study|Withdrawal by Subject|1|||
144519838|NCT03138512|521104770|FG003|Treatment Part A|Disease recurrence|0|||
144519839|NCT03138512|521104771|FG004|Treatment Part A|Disease recurrence|0|||
144519840|NCT03138512|521104767|FG000|Treatment Part A|Study Drug Toxicity|132|||
144519841|NCT03138512|521104768|FG001|Treatment Part A|Study Drug Toxicity|5|||
144519842|NCT03138512|521104769|FG002|Treatment Part A|Study Drug Toxicity|0|||
144519843|NCT03138512|521104770|FG003|Treatment Part A|Study Drug Toxicity|0|||
144519844|NCT03138512|521104771|FG004|Treatment Part A|Study Drug Toxicity|0|||
144519845|NCT03138512|521104767|FG000|Treatment Part A|Death|1|||
144395723|NCT02231918|520660073|FG002|Overall Study|Withdrawal by Subject|0|||
144395724|NCT02231918|520660071|FG000|Overall Study|Adverse Event|0|||
144395725|NCT02231918|520660072|FG001|Overall Study|Adverse Event|0|||
144395726|NCT02231918|520660073|FG002|Overall Study|Adverse Event|1|||
144519846|NCT03138512|521104768|FG001|Treatment Part A|Death|0|||
144395727|NCT00085709|520660081|FG000|Overall Study|Adverse Event|8|||
144395728|NCT00085709|520660082|FG001|Overall Study|Adverse Event|0|||
144395729|NCT00085709|520660081|FG000|Overall Study|Death|8|||
144395730|NCT00085709|520660082|FG001|Overall Study|Death|2|||
144395731|NCT00085709|520660081|FG000|Overall Study|Refusal unrelated to adverse events|1|||
144519847|NCT03138512|521104769|FG002|Treatment Part A|Death|0|||
144519848|NCT03138512|521104770|FG003|Treatment Part A|Death|0|||
144395732|NCT00085709|520660082|FG001|Overall Study|Refusal unrelated to adverse events|2|||
144395733|NCT00085709|520660081|FG000|Overall Study|Progression|3|||
144395734|NCT00085709|520660082|FG001|Overall Study|Progression|4|||
144395735|NCT00085709|520660081|FG000|Overall Study|Not protocol specified|12|||
144395736|NCT00085709|520660082|FG001|Overall Study|Not protocol specified|22|||
144395737|NCT00085709|520660081|FG000|Overall Study|Not eligible|19|||
144395738|NCT00085709|520660082|FG001|Overall Study|Not eligible|19|||
144395739|NCT00085709|520660081|FG000|Overall Study|Withdrawal by Subject|2|||
144395740|NCT00085709|520660082|FG001|Overall Study|Withdrawal by Subject|1|||
144395741|NCT04131556|520660083|FG000|Overall Study|Adverse Event|1|||
144395742|NCT04131556|520660083|FG000|Overall Study|Withdrawal by Subject|1|||
144395743|NCT01369615|520660095|FG000|Overall Study|Withdrawal by Subject|0|||
144395744|NCT01369615|520660096|FG001|Overall Study|Withdrawal by Subject|1|||
144395745|NCT01369615|520660095|FG000|Overall Study|Lost to Follow-up|0|||
144395746|NCT01369615|520660096|FG001|Overall Study|Lost to Follow-up|1|||
144395747|NCT04263454|520660097|FG000|Overall Study|Adverse Event|0|||
144395748|NCT04263454|520660098|FG001|Overall Study|Adverse Event|2|||
144395749|NCT04263454|520660097|FG000|Overall Study|Physician Decision|3|||
144395750|NCT04263454|520660098|FG001|Overall Study|Physician Decision|5|||
144395751|NCT04263454|520660097|FG000|Overall Study|Poor Data Quality|0|||
144395752|NCT04263454|520660098|FG001|Overall Study|Poor Data Quality|1|||
144395753|NCT00986479|520660100|FG000|Period 1|Improved mood|1|||
144395754|NCT00986479|520660101|FG001|Period 1|Improved mood|0|||
144395755|NCT00986479|520660100|FG000|Period 1|Administrative reasons|1|||
144395756|NCT00986479|520660101|FG001|Period 1|Administrative reasons|0|||
144395757|NCT01721070|520660102|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
144395758|NCT02035475|520660103|FG000|Overall Study|Withdrawal by Subject|4|||
144395759|NCT02035475|520660103|FG000|Overall Study|Physician Decision|1|||
144395760|NCT02035475|520660103|FG000|Overall Study|Equipment Error|1|||
144395761|NCT02047227|520660104|FG000|Overall Study|Adverse Event|2|||
144395762|NCT02047227|520660105|FG001|Overall Study|Adverse Event|4|||
144395763|NCT02047227|520660104|FG000|Overall Study|Lost to Follow-up|0|||
144395764|NCT02047227|520660105|FG001|Overall Study|Lost to Follow-up|3|||
144395765|NCT02047227|520660104|FG000|Overall Study|Protocol Violation|1|||
144395766|NCT02047227|520660105|FG001|Overall Study|Protocol Violation|0|||
144395767|NCT02047227|520660104|FG000|Overall Study|Spontaneous pregnancy|1|||
144395768|NCT02047227|520660105|FG001|Overall Study|Spontaneous pregnancy|0|||
144395769|NCT02047227|520660104|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
144395770|NCT02047227|520660105|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
144395771|NCT02047227|520660104|FG000|Overall Study|No oocytes retrieved|21|||
144395772|NCT02047227|520660105|FG001|Overall Study|No oocytes retrieved|20|||
144395773|NCT02047227|520660104|FG000|Overall Study|No fertilization|61|||
144395774|NCT02047227|520660105|FG001|Overall Study|No fertilization|51|||
144395775|NCT02047227|520660104|FG000|Overall Study|Intention to freeze all embryos|1|||
144395776|NCT02047227|520660105|FG001|Overall Study|Intention to freeze all embryos|0|||
144519849|NCT03138512|521104771|FG004|Treatment Part A|Death|0|||
144519850|NCT03138512|521104767|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
144519851|NCT03138512|521104768|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
144395777|NCT02047227|520660104|FG000|Overall Study|All embryos discarded|12|||
144395778|NCT02047227|520660105|FG001|Overall Study|All embryos discarded|11|||
144519852|NCT03138512|521104769|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
144519853|NCT03138512|521104770|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
144519854|NCT03138512|521104771|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
144519855|NCT03138512|521104767|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
144519856|NCT03138512|521104768|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
144519857|NCT03138512|521104769|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
144519858|NCT03138512|521104770|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
144519859|NCT03138512|521104771|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
144519860|NCT03138512|521104767|FG000|Treatment Part A|Participant withdrew consent|2|||
144519861|NCT03138512|521104768|FG001|Treatment Part A|Participant withdrew consent|4|||
144519862|NCT03138512|521104769|FG002|Treatment Part A|Participant withdrew consent|0|||
144519863|NCT03138512|521104770|FG003|Treatment Part A|Participant withdrew consent|0|||
144395779|NCT02047227|520660104|FG000|Overall Study|Other|10|||
144395780|NCT02047227|520660105|FG001|Overall Study|Other|9|||
144395781|NCT02567552|520660114|FG000|Overall Study|Adverse Event|0|||
144395782|NCT02567552|520660115|FG001|Overall Study|Adverse Event|1|||
144395783|NCT02891161|520660116|FG000|Study Treatment|Disease Progression|2|||
144395784|NCT02891161|520660117|FG001|Study Treatment|Disease Progression|4|||
144395785|NCT02891161|520660116|FG000|Study Treatment|AE/Side Effects/Complications|1|||
144395786|NCT02891161|520660117|FG001|Study Treatment|AE/Side Effects/Complications|5|||
144395787|NCT02891161|520660116|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
144395788|NCT02891161|520660117|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
144395789|NCT02891161|520660116|FG000|Follow up|Death|4|||
144395790|NCT02891161|520660117|FG001|Follow up|Death|8|||
144395791|NCT02891161|520660116|FG000|Follow up|Refused to Follow up|0|||
144395792|NCT02891161|520660117|FG001|Follow up|Refused to Follow up|2|||
144395793|NCT02891161|520660116|FG000|Follow up|Symptomatic deterioration|0|||
144395794|NCT02891161|520660117|FG001|Follow up|Symptomatic deterioration|1|||
144395795|NCT02891161|520660116|FG000|Follow up|Study terminated|0|||
144395796|NCT02891161|520660117|FG001|Follow up|Study terminated|6|||
144395797|NCT05419908|520660124|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
144395798|NCT05419908|520660125|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
144395799|NCT05419908|520660124|FG000|Overall Study|Serious Adverse Event|0|||
144395800|NCT05419908|520660125|FG001|Overall Study|Serious Adverse Event|2|||
144395801|NCT05419908|520660124|FG000|Overall Study|Withdrawal by Subject|2|||
144395802|NCT05419908|520660125|FG001|Overall Study|Withdrawal by Subject|0|||
144395803|NCT05419908|520660124|FG000|Overall Study|Miscellaneous|1|||
144395804|NCT05419908|520660125|FG001|Overall Study|Miscellaneous|1|||
144395805|NCT02572388|520661604|FG000|Overall Study|Withdrawal by Subject|1|||
144395806|NCT02572388|520661605|FG001|Overall Study|Withdrawal by Subject|1|||
144395807|NCT02572388|520661606|FG002|Overall Study|Withdrawal by Subject|2|||
144395808|NCT02572388|520661607|FG003|Overall Study|Withdrawal by Subject|2|||
144395809|NCT00331864|520661608|FG000|Overall Study|Adverse Event|30|||
144395810|NCT00331864|520661609|FG001|Overall Study|Adverse Event|1|||
144395811|NCT00331864|520661608|FG000|Overall Study|Lack of Efficacy|4|||
144395812|NCT00331864|520661609|FG001|Overall Study|Lack of Efficacy|0|||
144395813|NCT00331864|520661608|FG000|Overall Study|Protocol Violation|3|||
144395814|NCT00331864|520661609|FG001|Overall Study|Protocol Violation|0|||
144395815|NCT00331864|520661608|FG000|Overall Study|Withdrawal by Subject|10|||
144395816|NCT00331864|520661609|FG001|Overall Study|Withdrawal by Subject|0|||
144395817|NCT00331864|520661608|FG000|Overall Study|Lost to Follow-up|4|||
144395818|NCT00331864|520661609|FG001|Overall Study|Lost to Follow-up|3|||
144395819|NCT00331864|520661608|FG000|Overall Study|Administrative Problems|1|||
144395820|NCT00331864|520661609|FG001|Overall Study|Administrative Problems|0|||
144395821|NCT00331864|520661608|FG000|Overall Study|Death|6|||
144395822|NCT00331864|520661609|FG001|Overall Study|Death|0|||
144395823|NCT00137631|520661610|FG000|Overall Study|Lost to Follow-up|37|||
144395824|NCT00137631|520661611|FG001|Overall Study|Lost to Follow-up|41|||
144395825|NCT02611960|520661612|FG000|Overall Study|Adverse Event|7|||
144395826|NCT02611960|520661613|FG001|Overall Study|Adverse Event|8|||
144395827|NCT02611960|520661612|FG000|Overall Study|Death|98|||
144395828|NCT02611960|520661613|FG001|Overall Study|Death|92|||
144395829|NCT02611960|520661612|FG000|Overall Study|Withdrawal by Subject|1|||
144395830|NCT02611960|520661613|FG001|Overall Study|Withdrawal by Subject|5|||
144395831|NCT02611960|520661612|FG000|Overall Study|Sponsor Decision|11|||
144395832|NCT02611960|520661613|FG001|Overall Study|Sponsor Decision|11|||
144395833|NCT02395666|520661614|FG000|Overall Study|Physician Decision|3|||
144395834|NCT02395666|520661615|FG001|Overall Study|Physician Decision|0|||
144395835|NCT02395666|520661614|FG000|Overall Study|Lost to Follow-up|1|||
144395836|NCT02395666|520661615|FG001|Overall Study|Lost to Follow-up|0|||
144395837|NCT02395666|520661614|FG000|Overall Study|Withdrawal by Subject|2|||
144395838|NCT02395666|520661615|FG001|Overall Study|Withdrawal by Subject|1|||
144594789|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
144594790|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
144594791|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
144594792|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
144594793|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
144594794|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
144594795|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
144594796|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
144594797|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
144594798|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
144594799|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
144395839|NCT00293215|520661627|FG000|Overall Study|Progressive disease|3|||
144395840|NCT00293215|520661628|FG001|Overall Study|Progressive disease|1|||
144395841|NCT00293215|520661627|FG000|Overall Study|Adverse Event|2|||
144395842|NCT00293215|520661628|FG001|Overall Study|Adverse Event|2|||
144395843|NCT00761579|520661630|FG000|Overall Study|Adverse Event|10|||
144395844|NCT00761579|520661630|FG000|Overall Study|Death|2|||
144395845|NCT00761579|520661630|FG000|Overall Study|Lack of Efficacy|21|||
144395846|NCT00761579|520661630|FG000|Overall Study|Lost to Follow-up|16|||
144395847|NCT00761579|520661630|FG000|Overall Study|Pregnancy|1|||
144395848|NCT00761579|520661630|FG000|Overall Study|Withdrawal by Subject|34|||
144395849|NCT00761579|520661630|FG000|Overall Study|Lack of compliance|2|||
144395850|NCT00761579|520661630|FG000|Overall Study|Protocol deviation|1|||
144395851|NCT00761579|520661630|FG000|Overall Study|Drug overdose|1|||
144395852|NCT00761579|520661630|FG000|Overall Study|Aggravation of depression|1|||
144395853|NCT00761579|520661630|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
144395854|NCT00761579|520661630|FG000|Overall Study|Lost survey form|1|||
144395855|NCT00761579|520661630|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
144395856|NCT03611010|520661631|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
144395857|NCT03611010|520661632|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
144395858|NCT03611010|520661633|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
144395859|NCT03611010|520661634|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
144395860|NCT00950911|520661636|FG000|Overall Study|Adverse Event|0|||
144395861|NCT00950911|520661637|FG001|Overall Study|Adverse Event|2|||
144395862|NCT00950911|520661636|FG000|Overall Study|Death|4|||
144395863|NCT00950911|520661637|FG001|Overall Study|Death|6|||
144395864|NCT00950911|520661636|FG000|Overall Study|Disease progression|2|||
144395865|NCT00950911|520661637|FG001|Overall Study|Disease progression|2|||
144395866|NCT00950911|520661636|FG000|Overall Study|Consent withdrawn|1|||
144395867|NCT00950911|520661637|FG001|Overall Study|Consent withdrawn|3|||
144395868|NCT00950911|520661636|FG000|Overall Study|Administrative decision|3|||
144395869|NCT00950911|520661637|FG001|Overall Study|Administrative decision|1|||
144395870|NCT00950911|520661636|FG000|Overall Study|Ineligibility determined|1|||
144395871|NCT00950911|520661637|FG001|Overall Study|Ineligibility determined|0|||
144395872|NCT00950911|520661636|FG000|Overall Study|Noncompliance|1|||
144395873|NCT00950911|520661637|FG001|Overall Study|Noncompliance|0|||
144395874|NCT00950911|520661636|FG000|Overall Study|Poor performance status|0|||
144519864|NCT03138512|521104771|FG004|Treatment Part A|Participant withdrew consent|0|||
144519865|NCT03138512|521104767|FG000|Treatment Part A|Lost to Follow-up|0|||
144519866|NCT03138512|521104768|FG001|Treatment Part A|Lost to Follow-up|1|||
144519867|NCT03138512|521104769|FG002|Treatment Part A|Lost to Follow-up|0|||
144519868|NCT03138512|521104770|FG003|Treatment Part A|Lost to Follow-up|0|||
144519869|NCT03138512|521104771|FG004|Treatment Part A|Lost to Follow-up|0|||
144519870|NCT03138512|521104767|FG000|Treatment Part A|Poor/non-compliance|1|||
144519871|NCT03138512|521104768|FG001|Treatment Part A|Poor/non-compliance|0|||
144519872|NCT03138512|521104769|FG002|Treatment Part A|Poor/non-compliance|0|||
144519873|NCT03138512|521104770|FG003|Treatment Part A|Poor/non-compliance|0|||
144519874|NCT03138512|521104771|FG004|Treatment Part A|Poor/non-compliance|0|||
144519875|NCT03138512|521104767|FG000|Treatment Part A|Pregnancy|0|||
144519876|NCT03138512|521104768|FG001|Treatment Part A|Pregnancy|1|||
144519877|NCT03138512|521104769|FG002|Treatment Part A|Pregnancy|0|||
144519878|NCT03138512|521104770|FG003|Treatment Part A|Pregnancy|0|||
144519879|NCT03138512|521104771|FG004|Treatment Part A|Pregnancy|0|||
144519880|NCT03138512|521104767|FG000|Treatment Part A|Other reasons|11|||
144519881|NCT03138512|521104768|FG001|Treatment Part A|Other reasons|8|||
144519882|NCT03138512|521104769|FG002|Treatment Part A|Other reasons|0|||
144519883|NCT03138512|521104770|FG003|Treatment Part A|Other reasons|0|||
144519884|NCT03138512|521104771|FG004|Treatment Part A|Other reasons|0|||
144519885|NCT03138512|521104767|FG000|Treatment Part B|Disease recurrence|0|||
144519886|NCT03138512|521104768|FG001|Treatment Part B|Disease recurrence|0|||
144519887|NCT03138512|521104769|FG002|Treatment Part B|Disease recurrence|6|||
144519888|NCT03138512|521104770|FG003|Treatment Part B|Disease recurrence|12|||
144519889|NCT03138512|521104771|FG004|Treatment Part B|Disease recurrence|10|||
144519890|NCT03138512|521104767|FG000|Treatment Part B|Study drug toxicity|0|||
144519891|NCT03138512|521104768|FG001|Treatment Part B|Study drug toxicity|0|||
144519892|NCT03138512|521104769|FG002|Treatment Part B|Study drug toxicity|63|||
144519893|NCT03138512|521104770|FG003|Treatment Part B|Study drug toxicity|3|||
144519894|NCT03138512|521104771|FG004|Treatment Part B|Study drug toxicity|45|||
144519895|NCT03138512|521104767|FG000|Treatment Part B|Death|0|||
144519896|NCT03138512|521104768|FG001|Treatment Part B|Death|0|||
144519897|NCT03138512|521104769|FG002|Treatment Part B|Death|1|||
144395875|NCT00950911|520661637|FG001|Overall Study|Poor performance status|1|||
144395876|NCT02476422|520661638|FG000|Overall Study|Subject/guardian decision|0|||
144519898|NCT03138512|521104770|FG003|Treatment Part B|Death|0|||
144519899|NCT03138512|521104771|FG004|Treatment Part B|Death|0|||
144519900|NCT03138512|521104767|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
144519901|NCT03138512|521104768|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
144519902|NCT03138512|521104769|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
144519903|NCT03138512|521104770|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
144519904|NCT03138512|521104771|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
144395877|NCT02476422|520661639|FG001|Overall Study|Subject/guardian decision|1|||
144395878|NCT01859143|520661640|FG000|Overall Study|Lost to Follow-up|2|||
144519905|NCT03138512|521104767|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
144395879|NCT01859143|520661641|FG001|Overall Study|Lost to Follow-up|0|||
144395880|NCT02413372|520661645|FG000|Treatment|Lost to Follow-up|0|||
144395881|NCT02413372|520661646|FG001|Treatment|Lost to Follow-up|2|||
144395882|NCT02413372|520661647|FG002|Treatment|Lost to Follow-up|1|||
144395883|NCT02413372|520661645|FG000|Treatment|Withdrawal by Subject|1|||
144395884|NCT02413372|520661646|FG001|Treatment|Withdrawal by Subject|0|||
144395885|NCT02413372|520661647|FG002|Treatment|Withdrawal by Subject|0|||
144395886|NCT02413372|520661645|FG000|Follow-up|Lost to Follow-up|1|||
144395887|NCT02413372|520661646|FG001|Follow-up|Lost to Follow-up|1|||
144395888|NCT02413372|520661647|FG002|Follow-up|Lost to Follow-up|0|||
144395889|NCT02413372|520661645|FG000|Follow-up|Subject Withdrew Consent|1|||
144395890|NCT02413372|520661646|FG001|Follow-up|Subject Withdrew Consent|0|||
144395891|NCT02413372|520661647|FG002|Follow-up|Subject Withdrew Consent|1|||
144395892|NCT02413372|520661645|FG000|Follow-up|Subject unable to return for visit|0|||
144395893|NCT02413372|520661646|FG001|Follow-up|Subject unable to return for visit|0|||
144395894|NCT02413372|520661647|FG002|Follow-up|Subject unable to return for visit|1|||
144395895|NCT04587271|520661650|FG000|Overall Study|Lost to Follow-up|2|||
144395896|NCT04587271|520661651|FG001|Overall Study|Lost to Follow-up|2|||
144395897|NCT04587271|520661652|FG002|Overall Study|Lost to Follow-up|0|||
144395898|NCT04587271|520661653|FG003|Overall Study|Lost to Follow-up|2|||
144395899|NCT04587271|520661654|FG004|Overall Study|Lost to Follow-up|2|||
144395900|NCT04587271|520661655|FG005|Overall Study|Lost to Follow-up|0|||
144395901|NCT04587271|520661650|FG000|Overall Study|Caregiver brought child to visits|0|||
144395902|NCT04587271|520661651|FG001|Overall Study|Caregiver brought child to visits|0|||
144395903|NCT04587271|520661652|FG002|Overall Study|Caregiver brought child to visits|0|||
144395904|NCT04587271|520661653|FG003|Overall Study|Caregiver brought child to visits|1|||
144395905|NCT04587271|520661654|FG004|Overall Study|Caregiver brought child to visits|0|||
144395906|NCT04587271|520661655|FG005|Overall Study|Caregiver brought child to visits|0|||
144395907|NCT02180165|520661656|FG000|Overall Study|Not Treated|0|||
144395908|NCT02180165|520661657|FG001|Overall Study|Not Treated|0|||
144395909|NCT02180165|520661658|FG002|Overall Study|Not Treated|1|||
144395910|NCT02180165|520661659|FG003|Overall Study|Not Treated|0|||
144395911|NCT02180165|520661656|FG000|Overall Study|Adverse Event|7|||
144395912|NCT02180165|520661657|FG001|Overall Study|Adverse Event|0|||
144395913|NCT02180165|520661658|FG002|Overall Study|Adverse Event|18|||
144395914|NCT02180165|520661659|FG003|Overall Study|Adverse Event|3|||
144519906|NCT03138512|521104768|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
144519907|NCT03138512|521104769|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
144519908|NCT03138512|521104770|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
144519909|NCT03138512|521104771|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
144519910|NCT03138512|521104767|FG000|Treatment Part B|Participant withdrew consent|0|||
144519911|NCT03138512|521104768|FG001|Treatment Part B|Participant withdrew consent|0|||
144519912|NCT03138512|521104769|FG002|Treatment Part B|Participant withdrew consent|1|||
144519913|NCT03138512|521104770|FG003|Treatment Part B|Participant withdrew consent|1|||
144519914|NCT03138512|521104771|FG004|Treatment Part B|Participant withdrew consent|2|||
144519915|NCT03138512|521104767|FG000|Treatment Part B|Lost to Follow-up|0|||
144519916|NCT03138512|521104768|FG001|Treatment Part B|Lost to Follow-up|0|||
144519917|NCT03138512|521104769|FG002|Treatment Part B|Lost to Follow-up|0|||
144519918|NCT03138512|521104770|FG003|Treatment Part B|Lost to Follow-up|1|||
144519919|NCT03138512|521104771|FG004|Treatment Part B|Lost to Follow-up|0|||
144519920|NCT03138512|521104767|FG000|Treatment Part B|Poor/non-compliance|0|||
144519921|NCT03138512|521104768|FG001|Treatment Part B|Poor/non-compliance|0|||
144519922|NCT03138512|521104769|FG002|Treatment Part B|Poor/non-compliance|1|||
144519923|NCT03138512|521104770|FG003|Treatment Part B|Poor/non-compliance|1|||
144519924|NCT03138512|521104771|FG004|Treatment Part B|Poor/non-compliance|1|||
144519925|NCT03138512|521104767|FG000|Treatment Part B|Other reasons|0|||
144519926|NCT03138512|521104768|FG001|Treatment Part B|Other reasons|0|||
144519927|NCT03138512|521104769|FG002|Treatment Part B|Other reasons|3|||
144519928|NCT03138512|521104770|FG003|Treatment Part B|Other reasons|1|||
144519929|NCT03138512|521104771|FG004|Treatment Part B|Other reasons|5|||
144519930|NCT05323084|521104773|FG000|Period 2 - Washout|Lost to Follow-up|0|||
144519931|NCT05323084|521104774|FG001|Period 2 - Washout|Lost to Follow-up|1|||
144519932|NCT04382404|521104775|FG000|Overall Study|Adverse Event|1|||
144519933|NCT04382404|521104775|FG000|Overall Study|Lost to Follow-up|2|||
144519934|NCT03332017|521104780|FG000|Overall Study|Lost to Follow-up|1|||
144519935|NCT03332017|521104781|FG001|Overall Study|Lost to Follow-up|2|||
144519936|NCT03332017|521104780|FG000|Overall Study|Death|17|||
144519937|NCT03332017|521104781|FG001|Overall Study|Death|16|||
144594800|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
144395915|NCT02180165|520661656|FG000|Overall Study|Lack of Efficacy|0|||
144395916|NCT02180165|520661657|FG001|Overall Study|Lack of Efficacy|1|||
144395917|NCT02180165|520661658|FG002|Overall Study|Lack of Efficacy|3|||
144395918|NCT02180165|520661659|FG003|Overall Study|Lack of Efficacy|2|||
144395919|NCT02180165|520661656|FG000|Overall Study|Physician Decision|1|||
144395920|NCT02180165|520661657|FG001|Overall Study|Physician Decision|0|||
144395921|NCT02180165|520661658|FG002|Overall Study|Physician Decision|5|||
144395922|NCT02180165|520661659|FG003|Overall Study|Physician Decision|0|||
144395923|NCT02180165|520661656|FG000|Overall Study|Withdrawal by Subject|3|||
144395924|NCT02180165|520661657|FG001|Overall Study|Withdrawal by Subject|0|||
144395925|NCT02180165|520661658|FG002|Overall Study|Withdrawal by Subject|2|||
144395926|NCT02180165|520661659|FG003|Overall Study|Withdrawal by Subject|1|||
144395927|NCT01031381|520661660|FG000|Overall Study|Physician Decision|3|||
144395928|NCT01031381|520661660|FG000|Overall Study|Withdrawal by Subject|6|||
144395929|NCT00723398|520661661|FG000|Overall Study|Withdrawal by Subject|2|||
144395930|NCT00723398|520661662|FG001|Overall Study|Withdrawal by Subject|6|||
144395931|NCT00723398|520661663|FG002|Overall Study|Withdrawal by Subject|4|||
144395932|NCT00723398|520661664|FG003|Overall Study|Withdrawal by Subject|4|||
144395933|NCT00723398|520661665|FG004|Overall Study|Withdrawal by Subject|4|||
144395934|NCT00723398|520661661|FG000|Overall Study|Protocol Violation|2|||
144395935|NCT00723398|520661662|FG001|Overall Study|Protocol Violation|1|||
144395936|NCT00723398|520661663|FG002|Overall Study|Protocol Violation|5|||
144395937|NCT00723398|520661664|FG003|Overall Study|Protocol Violation|0|||
144395938|NCT00723398|520661665|FG004|Overall Study|Protocol Violation|0|||
144395939|NCT00723398|520661661|FG000|Overall Study|Physician Decision|2|||
144395940|NCT00723398|520661662|FG001|Overall Study|Physician Decision|2|||
144395941|NCT00723398|520661663|FG002|Overall Study|Physician Decision|5|||
144395942|NCT00723398|520661664|FG003|Overall Study|Physician Decision|0|||
144395943|NCT00723398|520661665|FG004|Overall Study|Physician Decision|1|||
144395944|NCT00723398|520661661|FG000|Overall Study|Adverse Event|0|||
144395945|NCT00723398|520661662|FG001|Overall Study|Adverse Event|5|||
144395946|NCT00723398|520661663|FG002|Overall Study|Adverse Event|3|||
144395947|NCT00723398|520661664|FG003|Overall Study|Adverse Event|1|||
144395948|NCT00723398|520661665|FG004|Overall Study|Adverse Event|4|||
144395949|NCT00723398|520661661|FG000|Overall Study|Lost to Follow-up|0|||
144395950|NCT00723398|520661662|FG001|Overall Study|Lost to Follow-up|1|||
144395951|NCT00723398|520661663|FG002|Overall Study|Lost to Follow-up|0|||
144395952|NCT00723398|520661664|FG003|Overall Study|Lost to Follow-up|0|||
144395953|NCT00723398|520661665|FG004|Overall Study|Lost to Follow-up|0|||
144395954|NCT00267189|520661668|FG000|Overall Study|Patient withdrew consent|1|||
144395955|NCT00267189|520661669|FG001|Overall Study|Patient withdrew consent|1|||
144395956|NCT00267189|520661668|FG000|Overall Study|Death|1|||
144395957|NCT00267189|520661669|FG001|Overall Study|Death|0|||
144395958|NCT00267189|520661668|FG000|Overall Study|Missing|3|||
144395959|NCT00267189|520661669|FG001|Overall Study|Missing|0|||
144395960|NCT04137224|520661671|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
144395961|NCT04137224|520661672|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
144395962|NCT04137224|520661671|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
144395963|NCT04137224|520661672|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
144395964|NCT04137224|520661671|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
144395965|NCT04137224|520661672|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
144395966|NCT01225887|520661673|FG000|Overall Study|Ineligible:required test not done|2|||
144395967|NCT01225887|520661673|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
144395968|NCT01225887|520661673|FG000|Overall Study|Ineligible:inadequate pathology|2|||
144395969|NCT00566501|520661674|FG000|Overall Study|Adverse Event|68|||
144395970|NCT00566501|520661675|FG001|Overall Study|Adverse Event|59|||
144395971|NCT00566501|520661674|FG000|Overall Study|Medication Non-compliance|5|||
144395972|NCT00566501|520661675|FG001|Overall Study|Medication Non-compliance|0|||
144395973|NCT00566501|520661674|FG000|Overall Study|Protocol Violation|2|||
144395974|NCT00566501|520661675|FG001|Overall Study|Protocol Violation|2|||
144395975|NCT00566501|520661674|FG000|Overall Study|Request of Investigator or Sponsor|6|||
144395976|NCT00566501|520661675|FG001|Overall Study|Request of Investigator or Sponsor|7|||
144395977|NCT00566501|520661674|FG000|Overall Study|Withdrawal by Subject|33|||
144395978|NCT00566501|520661675|FG001|Overall Study|Withdrawal by Subject|30|||
144395979|NCT00566501|520661674|FG000|Overall Study|Lack of Efficacy|8|||
144395980|NCT00566501|520661675|FG001|Overall Study|Lack of Efficacy|3|||
144395981|NCT00566501|520661674|FG000|Overall Study|Other|25|||
144395982|NCT00566501|520661675|FG001|Overall Study|Other|21|||
144395983|NCT00925990|520661676|FG000|Overall Study|Adverse Event|1|||
144395984|NCT00925990|520661677|FG001|Overall Study|Adverse Event|3|||
144395985|NCT00925990|520661676|FG000|Overall Study|Withdrawal by Subject|2|||
144395986|NCT00925990|520661677|FG001|Overall Study|Withdrawal by Subject|2|||
144519938|NCT03332017|521104780|FG000|Overall Study|Withdrawal by Subject|6|||
144519939|NCT03332017|521104781|FG001|Overall Study|Withdrawal by Subject|14|||
144519940|NCT03332017|521104780|FG000|Overall Study|Other|1|||
144395987|NCT00925990|520661676|FG000|Overall Study|Lost to Follow-up|1|||
144395988|NCT00925990|520661677|FG001|Overall Study|Lost to Follow-up|3|||
144395989|NCT00925990|520661676|FG000|Overall Study|Physician Decision|1|||
144395990|NCT00925990|520661677|FG001|Overall Study|Physician Decision|1|||
144395991|NCT00925990|520661676|FG000|Overall Study|moved out of state, missed medication|0|||
144395992|NCT00925990|520661677|FG001|Overall Study|moved out of state, missed medication|2|||
144395993|NCT01368432|520661680|FG000|Overall Study|Lost to Follow-up|0|||
144395994|NCT01368432|520661681|FG001|Overall Study|Lost to Follow-up|1|||
144395995|NCT02310321|520661696|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
144395996|NCT02310321|520661697|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
144395997|NCT02310321|520661698|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
144395998|NCT02310321|520661696|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
144395999|NCT02310321|520661697|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
144396000|NCT02310321|520661698|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
144396001|NCT02310321|520661696|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
144396002|NCT02310321|520661697|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
144396003|NCT02310321|520661698|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
144396004|NCT02310321|520661696|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
144396005|NCT02310321|520661697|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
144396006|NCT02310321|520661698|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
144396007|NCT02310321|520661696|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
144396008|NCT02310321|520661697|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
144396009|NCT02310321|520661698|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
144396010|NCT02310321|520661696|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
144396011|NCT02310321|520661697|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
144396012|NCT02310321|520661698|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
144396013|NCT02310321|520661696|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
144396014|NCT02310321|520661697|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
144396015|NCT02310321|520661698|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
144396016|NCT02310321|520661696|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
144396017|NCT02310321|520661697|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
144396018|NCT02310321|520661698|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
144396019|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
144396020|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
144396021|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
144396022|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
144396023|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
144396024|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
144396025|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
144396026|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
144396027|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
144396028|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
144396029|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
144396030|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
144519941|NCT03332017|521104781|FG001|Overall Study|Other|3|||
144519942|NCT03332017|521104780|FG000|Overall Study|Remained in Study (Ongoing)|47|||
144519943|NCT03332017|521104781|FG001|Overall Study|Remained in Study (Ongoing)|110|||
144519944|NCT01580488|521104787|FG000|Overall Study|Withdrawal by Subject|1|||
144519945|NCT03699709|521104792|FG000|Overall Study|Death|1|||
144519946|NCT03699709|521104793|FG001|Overall Study|Death|2|||
144519947|NCT03699709|521104792|FG000|Overall Study|Lost to Follow-up|10|||
144519948|NCT03699709|521104793|FG001|Overall Study|Lost to Follow-up|3|||
144519949|NCT03699709|521104792|FG000|Overall Study|Withdrawal by Subject|5|||
144519950|NCT03699709|521104793|FG001|Overall Study|Withdrawal by Subject|0|||
144519951|NCT03699709|521104792|FG000|Overall Study|incarcerated|1|||
144519952|NCT03699709|521104793|FG001|Overall Study|incarcerated|0|||
144519953|NCT03699709|521104792|FG000|Overall Study|scheduled, but no show|0|||
144519954|NCT03699709|521104793|FG001|Overall Study|scheduled, but no show|1|||
144519955|NCT02907099|521104794|FG000|Overall Study|Adverse Event|1|||
144396031|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
144396032|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
144396033|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
144396034|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
144396035|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
144396036|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
144396037|NCT02310321|520661696|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
144396038|NCT02310321|520661697|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
144396039|NCT02310321|520661698|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
144396040|NCT02310321|520661696|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
144396041|NCT02310321|520661697|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
144519956|NCT02907099|521104794|FG000|Overall Study|Withdrawal by Subject|2|||
144594801|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
144594802|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
144594803|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
144594804|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
144594805|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
144594806|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
144594807|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
144594808|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
144594809|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
144594810|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
144594811|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
144594812|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
144594813|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
144594814|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
144594815|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
144594816|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
144594817|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
144594818|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
144594819|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
144594820|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594821|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594822|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594823|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
144594824|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594825|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594826|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594827|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
144594828|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
144594829|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
144594830|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
144594831|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
144594832|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
144594833|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
144594834|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
144594835|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
144594836|NCT00427895|521377953|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
144594837|NCT00427895|521377954|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
144594838|NCT00427895|521377955|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
144594839|NCT00427895|521377956|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
144594840|NCT00427895|521377957|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
144594841|NCT00427895|521377958|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
144594842|NCT00427895|521377959|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
144594843|NCT00427895|521377960|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
144594844|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
144594845|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
144594846|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
144594847|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
144594848|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
144594849|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
144594850|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
144594851|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
144594852|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
144594853|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
144594854|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
144594855|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
144594856|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
144594857|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
144594858|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
144594859|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
144594860|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
144594861|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
144594862|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
144594863|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
144594864|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
144594865|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
144594866|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
144594867|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
144396042|NCT02310321|520661698|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
144594868|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144396043|NCT02310321|520661696|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
144594869|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
144594870|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144594871|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144594872|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144594873|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144594874|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144594875|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
144594876|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Death|1|||
144594877|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Death|0|||
144594878|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Death|0|||
144594879|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Death|0|||
144594880|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Death|0|||
144594881|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Death|0|||
144396044|NCT02310321|520661697|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
144396045|NCT02310321|520661698|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
144396046|NCT02310321|520661696|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
144396047|NCT02310321|520661697|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
144396048|NCT02310321|520661698|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
144396049|NCT02310321|520661696|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
144396050|NCT02310321|520661697|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
144396051|NCT02310321|520661698|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
144396052|NCT02310321|520661696|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
144396053|NCT02310321|520661697|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
144396054|NCT02310321|520661698|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
144396055|NCT02310321|520661696|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
144396056|NCT02310321|520661697|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
144396057|NCT02310321|520661698|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
144396058|NCT02310321|520661696|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
144396059|NCT02310321|520661697|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
144396060|NCT02310321|520661698|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
144396061|NCT02310321|520661696|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
144396062|NCT02310321|520661697|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
144396063|NCT02310321|520661698|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
144396064|NCT01698905|520661699|FG000|Overall Study|Adverse Event|4|||
144396065|NCT01698905|520661699|FG000|Overall Study|Physician Decision|2|||
144396066|NCT01698905|520661699|FG000|Overall Study|Pregnancy|1|||
144396067|NCT01698905|520661699|FG000|Overall Study|Protocol Violation|1|||
144396068|NCT01698905|520661699|FG000|Overall Study|Subject/guardian decision|2|||
144396069|NCT01698905|520661699|FG000|Overall Study|Death|1|||
144396070|NCT00764504|520661701|FG000|Overall Study|Death|12|||
144396071|NCT00764504|520661702|FG001|Overall Study|Death|6|||
144396072|NCT00764504|520661703|FG002|Overall Study|Death|13|||
144396073|NCT00764504|520661701|FG000|Overall Study|Revision of Device|12|||
144396074|NCT00764504|520661702|FG001|Overall Study|Revision of Device|23|||
144396075|NCT00764504|520661703|FG002|Overall Study|Revision of Device|14|||
144396076|NCT00764504|520661701|FG000|Overall Study|Physician Decision|1|||
144396077|NCT00764504|520661702|FG001|Overall Study|Physician Decision|0|||
144396078|NCT00764504|520661703|FG002|Overall Study|Physician Decision|0|||
144396079|NCT00764504|520661701|FG000|Overall Study|Withdrawal by Subject|1|||
144396080|NCT00764504|520661702|FG001|Overall Study|Withdrawal by Subject|7|||
144396081|NCT00764504|520661703|FG002|Overall Study|Withdrawal by Subject|4|||
144396082|NCT00764504|520661701|FG000|Overall Study|Lost to Follow-up|40|||
144396083|NCT00764504|520661702|FG001|Overall Study|Lost to Follow-up|34|||
144396084|NCT00764504|520661703|FG002|Overall Study|Lost to Follow-up|72|||
144396085|NCT02456103|520661704|FG000|Overall Study|Study Closure|207|||
144396086|NCT02456103|520661704|FG000|Overall Study|Physician Decision|1|||
144396087|NCT02456103|520661704|FG000|Overall Study|Required prohibited medications|5|||
144396088|NCT02456103|520661704|FG000|Overall Study|Protocol Violation|1|||
144396089|NCT02456103|520661704|FG000|Overall Study|Adverse Event|5|||
144594882|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Death|0|||
144722250|NCT01768858|521838648|FG000|Overall Study|Lost to Follow-up|9|||
144722251|NCT01768858|521838648|FG000|Overall Study|Lack of Efficacy|8|||
144396090|NCT02456103|520661704|FG000|Overall Study|Abnormal Laboratory Value|2|||
144594883|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Death|0|||
144594884|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
144594885|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
144594886|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
144722252|NCT01768858|521838648|FG000|Overall Study|Serious Adverse Event|1|||
144396091|NCT02456103|520661704|FG000|Overall Study|Lost to Follow-up|1|||
144396092|NCT02456103|520661704|FG000|Overall Study|Withdrawal by Subject|24|||
144396093|NCT04010539|520661705|FG000|Overall Study|Withdrawal by Subject|4|||
144396094|NCT04010539|520661706|FG001|Overall Study|Withdrawal by Subject|1|||
144396095|NCT04010539|520661705|FG000|Overall Study|Physician Decision|0|||
144396096|NCT04010539|520661706|FG001|Overall Study|Physician Decision|2|||
144396097|NCT04010539|520661705|FG000|Overall Study|Lost to Follow-up|10|||
144396098|NCT04010539|520661706|FG001|Overall Study|Lost to Follow-up|14|||
144396099|NCT04010539|520661705|FG000|Overall Study|Adverse Event|3|||
144396100|NCT04010539|520661706|FG001|Overall Study|Adverse Event|0|||
144396101|NCT04010539|520661705|FG000|Overall Study|Participant Did Not Receive IP|0|||
144396102|NCT04010539|520661706|FG001|Overall Study|Participant Did Not Receive IP|1|||
144396103|NCT04010539|520661705|FG000|Overall Study|Protocol Deviation|0|||
144396104|NCT04010539|520661706|FG001|Overall Study|Protocol Deviation|1|||
144396105|NCT04010539|520661705|FG000|Overall Study|Randomized in Error/ Mistake|2|||
144396106|NCT04010539|520661706|FG001|Overall Study|Randomized in Error/ Mistake|0|||
144396107|NCT04010539|520661705|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
144396108|NCT04010539|520661706|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
144396109|NCT00249288|520661707|FG000|Overall Study|Lost to Follow-up|3|||
144396110|NCT00249288|520661708|FG001|Overall Study|Lost to Follow-up|3|||
144396111|NCT00249288|520661707|FG000|Overall Study|Withdrawal by Subject|2|||
144396112|NCT00249288|520661708|FG001|Overall Study|Withdrawal by Subject|2|||
144396113|NCT03059446|520661709|FG000|Overall Study|Adverse Event|11|||
144396114|NCT03059446|520661709|FG000|Overall Study|Withdrawal of Consent|16|||
144396115|NCT03059446|520661709|FG000|Overall Study|Lost to Follow-up|3|||
144396116|NCT03059446|520661709|FG000|Overall Study|Protocol Violation|1|||
144396117|NCT03059446|520661709|FG000|Overall Study|Study Terminated by Sponsor|131|||
144396118|NCT03059446|520661709|FG000|Overall Study|Reason not Specified|5|||
144396119|NCT00171054|520661719|FG000|Overall Study|Protocol Violation|1|||
144396120|NCT00171054|520661720|FG001|Overall Study|Protocol Violation|2|||
144396121|NCT00171054|520661719|FG000|Overall Study|Patient withdrew consent|1|||
144396122|NCT00171054|520661720|FG001|Overall Study|Patient withdrew consent|0|||
144396123|NCT00171054|520661719|FG000|Overall Study|Lost to Follow-up|0|||
144396124|NCT00171054|520661720|FG001|Overall Study|Lost to Follow-up|1|||
144396125|NCT00171054|520661719|FG000|Overall Study|Adverse Event|8|||
144396126|NCT00171054|520661720|FG001|Overall Study|Adverse Event|8|||
144396127|NCT00171054|520661719|FG000|Overall Study|Condition no longer required study drug|0|||
144396128|NCT00171054|520661720|FG001|Overall Study|Condition no longer required study drug|1|||
144396129|NCT01074047|520661727|FG000|Treatment Phase|Adverse Event|89|||
144519957|NCT02907099|521104794|FG000|Overall Study|Screen Fail|2|||
144519958|NCT04739956|521104795|FG000|Overall Study|Withdrawal by Subject|1|||
144519959|NCT04739956|521104796|FG001|Overall Study|Withdrawal by Subject|1|||
144519960|NCT05134233|521104801|FG000|Overall Study|Pregnancy|1|||
144519961|NCT05134233|521104801|FG000|Overall Study|MEP value too low|2|||
144519962|NCT05134233|521104801|FG000|Overall Study|Lost to Follow-up|1|||
144396130|NCT01074047|520661728|FG001|Treatment Phase|Adverse Event|66|||
144396131|NCT01074047|520661727|FG000|Treatment Phase|Disease Progression|16|||
144396132|NCT01074047|520661728|FG001|Treatment Phase|Disease Progression|21|||
144519963|NCT03652688|521104806|FG000|Baseline|Withdrawal by Subject|0|||
144519964|NCT03652688|521104807|FG001|Baseline|Withdrawal by Subject|3|||
144519965|NCT03652688|521104806|FG000|Follow-up|Lost to Follow-up|56|||
144519966|NCT03652688|521104807|FG001|Follow-up|Lost to Follow-up|54|||
144519967|NCT03468218|521104808|FG000|Overall Study|Adverse Event|5|||
144519968|NCT03468218|521104808|FG000|Overall Study|Progressive Disease|16|||
144519969|NCT03468218|521104808|FG000|Overall Study|Death|1|||
144519970|NCT03468218|521104808|FG000|Overall Study|Alternate therapy|1|||
144519971|NCT03468218|521104808|FG000|Overall Study|Withdrawal by Subject|2|||
144519972|NCT05089734|521104811|FG000|Overall Study|Still on study|122|||
144519973|NCT05089734|521104812|FG001|Overall Study|Still on study|101|||
144519974|NCT05089734|521104811|FG000|Overall Study|Death|161|||
144519975|NCT05089734|521104812|FG001|Overall Study|Death|179|||
144519976|NCT05089734|521104811|FG000|Overall Study|Withdrew consent|11|||
144722253|NCT01768858|521838648|FG000|Overall Study|Participant moved to Germany|1|||
144396133|NCT01074047|520661727|FG000|Treatment Phase|Withdrawal by Subject|27|||
144396134|NCT01074047|520661728|FG001|Treatment Phase|Withdrawal by Subject|48|||
144396135|NCT01074047|520661727|FG000|Treatment Phase|Death|53|||
144396136|NCT01074047|520661728|FG001|Treatment Phase|Death|58|||
144396137|NCT01074047|520661727|FG000|Treatment Phase|Lost to Follow-up|0|||
144519977|NCT05089734|521104812|FG001|Overall Study|Withdrew consent|24|||
144396138|NCT01074047|520661728|FG001|Treatment Phase|Lost to Follow-up|1|||
144396139|NCT01074047|520661727|FG000|Treatment Phase|Protocol Violation|0|||
144396140|NCT01074047|520661728|FG001|Treatment Phase|Protocol Violation|1|||
144396141|NCT01074047|520661727|FG000|Treatment Phase|Miscellaneous|32|||
144396142|NCT01074047|520661728|FG001|Treatment Phase|Miscellaneous|39|||
144396143|NCT01074047|520661727|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
144396144|NCT01074047|520661728|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
144396145|NCT01074047|520661727|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
144396146|NCT01074047|520661728|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
144396147|NCT01074047|520661727|FG000|Survival Follow-Up Phase|Death|116|||
144519978|NCT05089734|521104811|FG000|Overall Study|Lost to Follow-up|5|||
144519979|NCT05089734|521104812|FG001|Overall Study|Lost to Follow-up|0|||
144519980|NCT05034952|521106252|FG000|Overall Study|Adverse Event|1|||
144519981|NCT05034952|521106253|FG001|Overall Study|Adverse Event|0|||
144396148|NCT01074047|520661728|FG001|Survival Follow-Up Phase|Death|124|||
144396149|NCT01074047|520661727|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
144396150|NCT01074047|520661728|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
144396151|NCT01074047|520661727|FG000|Extension Phase|Physician Decision|1|||
144396152|NCT01074047|520661728|FG001|Extension Phase|Physician Decision|0|||
144396153|NCT01074047|520661727|FG000|Extension Phase|Adverse Event|5|||
144396154|NCT01074047|520661728|FG001|Extension Phase|Adverse Event|0|||
144396155|NCT01074047|520661727|FG000|Extension Phase|Disease Progression|9|||
144396156|NCT01074047|520661728|FG001|Extension Phase|Disease Progression|0|||
144396157|NCT01074047|520661727|FG000|Extension Phase|Withdrawal by Subject|2|||
144396158|NCT01074047|520661728|FG001|Extension Phase|Withdrawal by Subject|0|||
144396159|NCT01074047|520661727|FG000|Extension Phase|Death|5|||
144396160|NCT01074047|520661728|FG001|Extension Phase|Death|0|||
144396161|NCT03635788|520661730|FG000|Step 1|Death|1|||
144396162|NCT03635788|520661731|FG001|Step 1|Death|0|||
144396163|NCT03635788|520661732|FG002|Step 1|Death|0|||
144396164|NCT03635788|520661730|FG000|Step 1|Lost to Follow-up|31|||
144396165|NCT03635788|520661731|FG001|Step 1|Lost to Follow-up|0|||
144396166|NCT03635788|520661732|FG002|Step 1|Lost to Follow-up|0|||
144396167|NCT03635788|520661730|FG000|Step 1|Pregnancy|1|||
144396168|NCT03635788|520661731|FG001|Step 1|Pregnancy|0|||
144396169|NCT03635788|520661732|FG002|Step 1|Pregnancy|0|||
144396170|NCT03635788|520661730|FG000|Step 1|Protocol Violation|8|||
144396171|NCT03635788|520661731|FG001|Step 1|Protocol Violation|0|||
144519982|NCT05034952|521106254|FG002|Overall Study|Adverse Event|0|||
144519983|NCT05034952|521106255|FG003|Overall Study|Adverse Event|0|||
144519984|NCT05034952|521106252|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
144519985|NCT05034952|521106253|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
144519986|NCT05034952|521106254|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
144519987|NCT05034952|521106255|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
144519988|NCT05034952|521106252|FG000|Overall Study|Lost to Follow-up|1|||
144519989|NCT05034952|521106253|FG001|Overall Study|Lost to Follow-up|4|||
144519990|NCT05034952|521106254|FG002|Overall Study|Lost to Follow-up|3|||
144519991|NCT05034952|521106255|FG003|Overall Study|Lost to Follow-up|3|||
144519992|NCT05034952|521106252|FG000|Overall Study|Other|0|||
144519993|NCT05034952|521106253|FG001|Overall Study|Other|0|||
144519994|NCT05034952|521106254|FG002|Overall Study|Other|0|||
144519995|NCT05034952|521106255|FG003|Overall Study|Other|1|||
144519996|NCT06074523|521106256|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
144519997|NCT06074523|521106256|FG000|Overall Study|Withdrawal by Subject|1|||
144519998|NCT03281291|521106257|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
144519999|NCT03281291|521106258|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
144520000|NCT03281291|521106259|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
144520001|NCT03281291|521106260|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
144520002|NCT03281291|521106261|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
144520003|NCT03281291|521106257|FG000|Overall Study|Protocol Deviation|2|||
144520004|NCT03281291|521106258|FG001|Overall Study|Protocol Deviation|0|||
144520005|NCT03281291|521106259|FG002|Overall Study|Protocol Deviation|1|||
144520006|NCT03281291|521106260|FG003|Overall Study|Protocol Deviation|2|||
144520007|NCT03281291|521106261|FG004|Overall Study|Protocol Deviation|1|||
144520008|NCT03281291|521106257|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
144520009|NCT03281291|521106258|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
144520010|NCT03281291|521106259|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
144520011|NCT03281291|521106260|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
144594887|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
144594888|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
144594889|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
144520012|NCT03281291|521106261|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
144594890|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
144594891|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
144396172|NCT03635788|520661732|FG002|Step 1|Protocol Violation|0|||
144396173|NCT03635788|520661730|FG000|Step 1|Withdrawal by Subject|13|||
144396174|NCT03635788|520661731|FG001|Step 1|Withdrawal by Subject|0|||
144396175|NCT03635788|520661732|FG002|Step 1|Withdrawal by Subject|0|||
144396176|NCT03635788|520661730|FG000|Step 1|Other reasons|12|||
144396177|NCT03635788|520661731|FG001|Step 1|Other reasons|0|||
144396178|NCT03635788|520661732|FG002|Step 1|Other reasons|0|||
144396179|NCT03635788|520661730|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
144520013|NCT03281291|521106257|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
144520014|NCT03281291|521106258|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
144520015|NCT03281291|521106259|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
144520016|NCT03281291|521106260|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
144520017|NCT03281291|521106261|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
144520018|NCT03281291|521106257|FG000|Overall Study|Lost to Follow-up|10|||
144520019|NCT03281291|521106258|FG001|Overall Study|Lost to Follow-up|10|||
144520020|NCT03281291|521106259|FG002|Overall Study|Lost to Follow-up|4|||
144520021|NCT03281291|521106260|FG003|Overall Study|Lost to Follow-up|6|||
144520022|NCT03281291|521106261|FG004|Overall Study|Lost to Follow-up|10|||
144520023|NCT03281291|521106257|FG000|Overall Study|Other|0|||
144520024|NCT03281291|521106258|FG001|Overall Study|Other|2|||
144520025|NCT03281291|521106259|FG002|Overall Study|Other|0|||
144520026|NCT03281291|521106260|FG003|Overall Study|Other|2|||
144520027|NCT03281291|521106261|FG004|Overall Study|Other|1|||
144520028|NCT04956861|521106262|FG000|Overall Study|Withdrawal by Subject|4|||
144520029|NCT04956861|521106263|FG001|Overall Study|Withdrawal by Subject|4|||
144520030|NCT04956861|521106264|FG002|Overall Study|Withdrawal by Subject|2|||
144520031|NCT04956861|521106262|FG000|Overall Study|Physician Decision|4|||
144520032|NCT04956861|521106263|FG001|Overall Study|Physician Decision|5|||
144520033|NCT04956861|521106264|FG002|Overall Study|Physician Decision|1|||
144520034|NCT06283173|521106268|FG000|Overall Study|Did not show for first visit|10|||
144520035|NCT06283173|521106268|FG000|Overall Study|Lost to Follow-up|12|||
144520036|NCT06283173|521106268|FG000|Overall Study|Physician Decision|7|||
144520037|NCT03336333|521106271|FG000|Overall Study|Remained on study at time of data cut-off|202|||
144520038|NCT03336333|521106272|FG001|Overall Study|Remained on study at time of data cut-off|219|||
144520039|NCT03336333|521106273|FG002|Overall Study|Remained on study at time of data cut-off|102|||
144520040|NCT03336333|521106271|FG000|Overall Study|Death|14|||
144520041|NCT03336333|521106272|FG001|Overall Study|Death|16|||
144520042|NCT03336333|521106273|FG002|Overall Study|Death|8|||
144520043|NCT03336333|521106271|FG000|Overall Study|Withdrawal by Subject|16|||
144520044|NCT03336333|521106272|FG001|Overall Study|Withdrawal by Subject|5|||
144520045|NCT03336333|521106273|FG002|Overall Study|Withdrawal by Subject|1|||
144520046|NCT03336333|521106271|FG000|Overall Study|Physician Decision|5|||
144520047|NCT03336333|521106272|FG001|Overall Study|Physician Decision|1|||
144520048|NCT03336333|521106273|FG002|Overall Study|Physician Decision|0|||
144520049|NCT03336333|521106271|FG000|Overall Study|Lost to Follow-up|1|||
144520050|NCT03336333|521106272|FG001|Overall Study|Lost to Follow-up|0|||
144520051|NCT03336333|521106273|FG002|Overall Study|Lost to Follow-up|0|||
144520052|NCT04927065|521106274|FG000|First Booster|Adverse Event|1|||
144520053|NCT04927065|521106275|FG001|First Booster|Adverse Event|0|||
144520054|NCT04927065|521106276|FG002|First Booster|Adverse Event|0|||
144520055|NCT04927065|521106277|FG003|First Booster|Adverse Event|0|||
144520056|NCT04927065|521106278|FG004|First Booster|Adverse Event|0|||
144520057|NCT04927065|521106279|FG005|First Booster|Adverse Event|0|||
144520058|NCT04927065|521106280|FG006|First Booster|Adverse Event|0|||
144520059|NCT04927065|521106281|FG007|First Booster|Adverse Event|1|||
144520060|NCT04927065|521106282|FG008|First Booster|Adverse Event|0|||
144520061|NCT04927065|521106283|FG009|First Booster|Adverse Event|0|||
144520062|NCT04927065|521106284|FG010|First Booster|Adverse Event|0|||
144520063|NCT04927065|521106285|FG011|First Booster|Adverse Event|0|||
144520064|NCT04927065|521106286|FG012|First Booster|Adverse Event|0|||
144520065|NCT04927065|521106287|FG013|First Booster|Adverse Event|0|||
144520066|NCT04927065|521106288|FG014|First Booster|Adverse Event|0|||
144520067|NCT04927065|521106289|FG015|First Booster|Adverse Event|0|||
144520068|NCT04927065|521106274|FG000|First Booster|Death|1|||
144520069|NCT04927065|521106275|FG001|First Booster|Death|0|||
144520070|NCT04927065|521106276|FG002|First Booster|Death|0|||
144520071|NCT04927065|521106277|FG003|First Booster|Death|1|||
144520072|NCT04927065|521106278|FG004|First Booster|Death|0|||
144594892|NCT00427895|521377953|FG000|Vax 1/Year 1 Follow-up|Other|0|||
144594893|NCT00427895|521377954|FG001|Vax 1/Year 1 Follow-up|Other|0|||
144520073|NCT04927065|521106279|FG005|First Booster|Death|1|||
144520074|NCT04927065|521106280|FG006|First Booster|Death|0|||
144520075|NCT04927065|521106281|FG007|First Booster|Death|0|||
144520076|NCT04927065|521106282|FG008|First Booster|Death|0|||
144520077|NCT04927065|521106283|FG009|First Booster|Death|0|||
144520078|NCT04927065|521106284|FG010|First Booster|Death|0|||
144520079|NCT04927065|521106285|FG011|First Booster|Death|0|||
144520080|NCT04927065|521106286|FG012|First Booster|Death|0|||
144520081|NCT04927065|521106287|FG013|First Booster|Death|0|||
144520082|NCT04927065|521106288|FG014|First Booster|Death|0|||
144520083|NCT04927065|521106289|FG015|First Booster|Death|0|||
144520084|NCT04927065|521106274|FG000|First Booster|Lost to Follow-up|8|||
144520085|NCT04927065|521106275|FG001|First Booster|Lost to Follow-up|20|||
144520086|NCT04927065|521106276|FG002|First Booster|Lost to Follow-up|0|||
144520087|NCT04927065|521106277|FG003|First Booster|Lost to Follow-up|11|||
144520088|NCT04927065|521106278|FG004|First Booster|Lost to Follow-up|43|||
144520089|NCT04927065|521106279|FG005|First Booster|Lost to Follow-up|30|||
144520090|NCT04927065|521106280|FG006|First Booster|Lost to Follow-up|28|||
144520091|NCT04927065|521106281|FG007|First Booster|Lost to Follow-up|23|||
144520092|NCT04927065|521106282|FG008|First Booster|Lost to Follow-up|4|||
144520093|NCT04927065|521106283|FG009|First Booster|Lost to Follow-up|15|||
144520094|NCT04927065|521106284|FG010|First Booster|Lost to Follow-up|0|||
144520095|NCT04927065|521106285|FG011|First Booster|Lost to Follow-up|0|||
144520096|NCT04927065|521106286|FG012|First Booster|Lost to Follow-up|0|||
144520097|NCT04927065|521106287|FG013|First Booster|Lost to Follow-up|0|||
144520098|NCT04927065|521106288|FG014|First Booster|Lost to Follow-up|0|||
144520099|NCT04927065|521106289|FG015|First Booster|Lost to Follow-up|0|||
144520100|NCT04927065|521106274|FG000|First Booster|Physician Decision|1|||
144520101|NCT04927065|521106275|FG001|First Booster|Physician Decision|0|||
144520102|NCT04927065|521106276|FG002|First Booster|Physician Decision|0|||
144520103|NCT04927065|521106277|FG003|First Booster|Physician Decision|3|||
144520104|NCT04927065|521106278|FG004|First Booster|Physician Decision|1|||
144520105|NCT04927065|521106279|FG005|First Booster|Physician Decision|1|||
144520106|NCT04927065|521106280|FG006|First Booster|Physician Decision|0|||
144520107|NCT04927065|521106281|FG007|First Booster|Physician Decision|3|||
144520108|NCT04927065|521106282|FG008|First Booster|Physician Decision|0|||
144520109|NCT04927065|521106283|FG009|First Booster|Physician Decision|0|||
144520110|NCT04927065|521106284|FG010|First Booster|Physician Decision|0|||
144520111|NCT04927065|521106285|FG011|First Booster|Physician Decision|0|||
144520112|NCT04927065|521106286|FG012|First Booster|Physician Decision|0|||
144520113|NCT04927065|521106287|FG013|First Booster|Physician Decision|0|||
144520114|NCT04927065|521106288|FG014|First Booster|Physician Decision|0|||
144520115|NCT04927065|521106289|FG015|First Booster|Physician Decision|0|||
144520116|NCT04927065|521106274|FG000|First Booster|Protocol Violation|4|||
144520117|NCT04927065|521106275|FG001|First Booster|Protocol Violation|4|||
144520118|NCT04927065|521106276|FG002|First Booster|Protocol Violation|0|||
144520119|NCT04927065|521106277|FG003|First Booster|Protocol Violation|3|||
144520120|NCT04927065|521106278|FG004|First Booster|Protocol Violation|0|||
144520121|NCT04927065|521106279|FG005|First Booster|Protocol Violation|0|||
144520122|NCT04927065|521106280|FG006|First Booster|Protocol Violation|0|||
144520123|NCT04927065|521106281|FG007|First Booster|Protocol Violation|2|||
144520124|NCT04927065|521106282|FG008|First Booster|Protocol Violation|0|||
144520125|NCT04927065|521106283|FG009|First Booster|Protocol Violation|0|||
144520126|NCT04927065|521106284|FG010|First Booster|Protocol Violation|0|||
144520127|NCT04927065|521106285|FG011|First Booster|Protocol Violation|0|||
144520128|NCT04927065|521106286|FG012|First Booster|Protocol Violation|0|||
144520129|NCT04927065|521106287|FG013|First Booster|Protocol Violation|0|||
144520130|NCT04927065|521106288|FG014|First Booster|Protocol Violation|0|||
144520131|NCT04927065|521106289|FG015|First Booster|Protocol Violation|0|||
144520132|NCT04927065|521106274|FG000|First Booster|Withdrawal by Subject|8|||
144520133|NCT04927065|521106275|FG001|First Booster|Withdrawal by Subject|23|||
144520134|NCT04927065|521106276|FG002|First Booster|Withdrawal by Subject|0|||
144520135|NCT04927065|521106277|FG003|First Booster|Withdrawal by Subject|19|||
144520136|NCT04927065|521106278|FG004|First Booster|Withdrawal by Subject|20|||
144520137|NCT04927065|521106279|FG005|First Booster|Withdrawal by Subject|15|||
144520138|NCT04927065|521106280|FG006|First Booster|Withdrawal by Subject|6|||
144520139|NCT04927065|521106281|FG007|First Booster|Withdrawal by Subject|24|||
144520140|NCT04927065|521106282|FG008|First Booster|Withdrawal by Subject|0|||
144520141|NCT04927065|521106283|FG009|First Booster|Withdrawal by Subject|4|||
144520142|NCT04927065|521106284|FG010|First Booster|Withdrawal by Subject|0|||
144520143|NCT04927065|521106285|FG011|First Booster|Withdrawal by Subject|0|||
144520144|NCT04927065|521106286|FG012|First Booster|Withdrawal by Subject|0|||
144520145|NCT04927065|521106287|FG013|First Booster|Withdrawal by Subject|0|||
144520146|NCT04927065|521106288|FG014|First Booster|Withdrawal by Subject|0|||
144520147|NCT04927065|521106289|FG015|First Booster|Withdrawal by Subject|0|||
144520148|NCT04927065|521106274|FG000|First Booster|Other Than Specified|1|||
144520149|NCT04927065|521106275|FG001|First Booster|Other Than Specified|1|||
144520150|NCT04927065|521106276|FG002|First Booster|Other Than Specified|0|||
144520151|NCT04927065|521106277|FG003|First Booster|Other Than Specified|1|||
144520152|NCT04927065|521106278|FG004|First Booster|Other Than Specified|2|||
144396180|NCT03635788|520661731|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
144396181|NCT03635788|520661732|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
144520153|NCT04927065|521106279|FG005|First Booster|Other Than Specified|3|||
144520154|NCT04927065|521106280|FG006|First Booster|Other Than Specified|2|||
144520155|NCT04927065|521106281|FG007|First Booster|Other Than Specified|6|||
144520156|NCT04927065|521106282|FG008|First Booster|Other Than Specified|0|||
144520157|NCT04927065|521106283|FG009|First Booster|Other Than Specified|4|||
144520158|NCT04927065|521106284|FG010|First Booster|Other Than Specified|0|||
144520159|NCT04927065|521106285|FG011|First Booster|Other Than Specified|0|||
144520160|NCT04927065|521106286|FG012|First Booster|Other Than Specified|0|||
144520161|NCT04927065|521106287|FG013|First Booster|Other Than Specified|0|||
144520162|NCT04927065|521106288|FG014|First Booster|Other Than Specified|0|||
144520163|NCT04927065|521106289|FG015|First Booster|Other Than Specified|0|||
144520164|NCT04927065|521106274|FG000|Second Booster|Death|0|||
144520165|NCT04927065|521106275|FG001|Second Booster|Death|0|||
144520166|NCT04927065|521106276|FG002|Second Booster|Death|0|||
144520167|NCT04927065|521106277|FG003|Second Booster|Death|0|||
144520168|NCT04927065|521106278|FG004|Second Booster|Death|0|||
144520169|NCT04927065|521106279|FG005|Second Booster|Death|0|||
144520170|NCT04927065|521106280|FG006|Second Booster|Death|0|||
144520171|NCT04927065|521106281|FG007|Second Booster|Death|0|||
144520172|NCT04927065|521106282|FG008|Second Booster|Death|0|||
144520173|NCT04927065|521106283|FG009|Second Booster|Death|0|||
144520174|NCT04927065|521106284|FG010|Second Booster|Death|2|||
144520175|NCT04927065|521106285|FG011|Second Booster|Death|0|||
144520176|NCT04927065|521106286|FG012|Second Booster|Death|2|||
144520177|NCT04927065|521106287|FG013|Second Booster|Death|2|||
144520178|NCT04927065|521106288|FG014|Second Booster|Death|0|||
144520179|NCT04927065|521106289|FG015|Second Booster|Death|0|||
144520180|NCT04927065|521106274|FG000|Second Booster|Lost to Follow-up|0|||
144520181|NCT04927065|521106275|FG001|Second Booster|Lost to Follow-up|0|||
144520182|NCT04927065|521106276|FG002|Second Booster|Lost to Follow-up|3|||
144520183|NCT04927065|521106277|FG003|Second Booster|Lost to Follow-up|0|||
144520184|NCT04927065|521106278|FG004|Second Booster|Lost to Follow-up|0|||
144520185|NCT04927065|521106279|FG005|Second Booster|Lost to Follow-up|0|||
144520186|NCT04927065|521106280|FG006|Second Booster|Lost to Follow-up|0|||
144520187|NCT04927065|521106281|FG007|Second Booster|Lost to Follow-up|0|||
144520188|NCT04927065|521106282|FG008|Second Booster|Lost to Follow-up|0|||
144520189|NCT04927065|521106283|FG009|Second Booster|Lost to Follow-up|0|||
144520190|NCT04927065|521106284|FG010|Second Booster|Lost to Follow-up|14|||
144520191|NCT04927065|521106285|FG011|Second Booster|Lost to Follow-up|10|||
144520192|NCT04927065|521106286|FG012|Second Booster|Lost to Follow-up|13|||
144520193|NCT04927065|521106287|FG013|Second Booster|Lost to Follow-up|16|||
144520194|NCT04927065|521106288|FG014|Second Booster|Lost to Follow-up|0|||
144520195|NCT04927065|521106289|FG015|Second Booster|Lost to Follow-up|0|||
144520196|NCT04927065|521106274|FG000|Second Booster|Physician Decision|0|||
144520197|NCT04927065|521106275|FG001|Second Booster|Physician Decision|0|||
144520198|NCT04927065|521106276|FG002|Second Booster|Physician Decision|0|||
144520199|NCT04927065|521106277|FG003|Second Booster|Physician Decision|0|||
144520200|NCT04927065|521106278|FG004|Second Booster|Physician Decision|0|||
144520201|NCT04927065|521106279|FG005|Second Booster|Physician Decision|0|||
144520202|NCT04927065|521106280|FG006|Second Booster|Physician Decision|0|||
144520203|NCT04927065|521106281|FG007|Second Booster|Physician Decision|0|||
144520204|NCT04927065|521106282|FG008|Second Booster|Physician Decision|0|||
144520205|NCT04927065|521106283|FG009|Second Booster|Physician Decision|0|||
144520206|NCT04927065|521106284|FG010|Second Booster|Physician Decision|0|||
144520207|NCT04927065|521106285|FG011|Second Booster|Physician Decision|3|||
144520208|NCT04927065|521106286|FG012|Second Booster|Physician Decision|0|||
144520209|NCT04927065|521106287|FG013|Second Booster|Physician Decision|1|||
144520210|NCT04927065|521106288|FG014|Second Booster|Physician Decision|0|||
144520211|NCT04927065|521106289|FG015|Second Booster|Physician Decision|0|||
144520212|NCT04927065|521106274|FG000|Second Booster|Withdrawal by Subject|0|||
144520213|NCT04927065|521106275|FG001|Second Booster|Withdrawal by Subject|0|||
144520214|NCT04927065|521106276|FG002|Second Booster|Withdrawal by Subject|4|||
144520215|NCT04927065|521106277|FG003|Second Booster|Withdrawal by Subject|0|||
144520216|NCT04927065|521106278|FG004|Second Booster|Withdrawal by Subject|0|||
144520217|NCT04927065|521106279|FG005|Second Booster|Withdrawal by Subject|0|||
144520218|NCT04927065|521106280|FG006|Second Booster|Withdrawal by Subject|0|||
144520219|NCT04927065|521106281|FG007|Second Booster|Withdrawal by Subject|0|||
144520220|NCT04927065|521106282|FG008|Second Booster|Withdrawal by Subject|0|||
144520221|NCT04927065|521106283|FG009|Second Booster|Withdrawal by Subject|0|||
144520222|NCT04927065|521106284|FG010|Second Booster|Withdrawal by Subject|3|||
144520223|NCT04927065|521106285|FG011|Second Booster|Withdrawal by Subject|16|||
144594894|NCT00427895|521377955|FG002|Vax 1/Year 1 Follow-up|Other|0|||
144594895|NCT00427895|521377956|FG003|Vax 1/Year 1 Follow-up|Other|2|||
144594896|NCT00427895|521377957|FG004|Vax 1/Year 1 Follow-up|Other|0|||
144594897|NCT00427895|521377958|FG005|Vax 1/Year 1 Follow-up|Other|0|||
144594898|NCT00427895|521377959|FG006|Vax 1/Year 1 Follow-up|Other|0|||
144594899|NCT00427895|521377960|FG007|Vax 1/Year 1 Follow-up|Other|0|||
144594900|NCT00427895|521377953|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
144594901|NCT00427895|521377954|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
144594902|NCT00427895|521377955|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
144594903|NCT00427895|521377956|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
144594904|NCT00427895|521377957|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
144594905|NCT00427895|521377958|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
144594906|NCT00427895|521377959|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
144594907|NCT00427895|521377960|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
144594908|NCT00585195|521377962|FG000|Overall Study|Adverse Event|0|||
144594909|NCT00585195|521377963|FG001|Overall Study|Adverse Event|0|||
144594910|NCT00585195|521377964|FG002|Overall Study|Adverse Event|0|||
144594911|NCT00585195|521377965|FG003|Overall Study|Adverse Event|0|||
144594912|NCT00585195|521377966|FG004|Overall Study|Adverse Event|2|||
144594913|NCT00585195|521377967|FG005|Overall Study|Adverse Event|1|||
144594914|NCT00585195|521377968|FG006|Overall Study|Adverse Event|0|||
144594915|NCT00585195|521377969|FG007|Overall Study|Adverse Event|1|||
144594916|NCT00585195|521377970|FG008|Overall Study|Adverse Event|0|||
144594917|NCT00585195|521377971|FG009|Overall Study|Adverse Event|0|||
144594918|NCT00585195|521377972|FG010|Overall Study|Adverse Event|3|||
144594919|NCT00585195|521377973|FG011|Overall Study|Adverse Event|0|||
144594920|NCT00585195|521377974|FG012|Overall Study|Adverse Event|8|||
144594921|NCT00585195|521377975|FG013|Overall Study|Adverse Event|6|||
144594922|NCT00585195|521377976|FG014|Overall Study|Adverse Event|4|||
144594923|NCT00585195|521377977|FG015|Overall Study|Adverse Event|1|||
144594924|NCT00585195|521377978|FG016|Overall Study|Adverse Event|14|||
144594925|NCT00585195|521377979|FG017|Overall Study|Adverse Event|9|||
144594926|NCT00585195|521377980|FG018|Overall Study|Adverse Event|2|||
144594927|NCT00585195|521377981|FG019|Overall Study|Adverse Event|3|||
144594928|NCT00585195|521377982|FG020|Overall Study|Adverse Event|1|||
144594929|NCT00585195|521377962|FG000|Overall Study|Progressive Disease|2|||
144594930|NCT00585195|521377963|FG001|Overall Study|Progressive Disease|2|||
144594931|NCT00585195|521377964|FG002|Overall Study|Progressive Disease|5|||
144594932|NCT00585195|521377965|FG003|Overall Study|Progressive Disease|4|||
144594933|NCT00585195|521377966|FG004|Overall Study|Progressive Disease|6|||
144594934|NCT00585195|521377967|FG005|Overall Study|Progressive Disease|4|||
144594935|NCT00585195|521377968|FG006|Overall Study|Progressive Disease|6|||
144594936|NCT00585195|521377969|FG007|Overall Study|Progressive Disease|3|||
144594937|NCT00585195|521377970|FG008|Overall Study|Progressive Disease|0|||
144594938|NCT00585195|521377971|FG009|Overall Study|Progressive Disease|5|||
144594939|NCT00585195|521377972|FG010|Overall Study|Progressive Disease|2|||
144594940|NCT00585195|521377973|FG011|Overall Study|Progressive Disease|25|||
144594941|NCT00585195|521377974|FG012|Overall Study|Progressive Disease|29|||
144594942|NCT00585195|521377975|FG013|Overall Study|Progressive Disease|26|||
144594943|NCT00585195|521377976|FG014|Overall Study|Progressive Disease|21|||
144594944|NCT00585195|521377977|FG015|Overall Study|Progressive Disease|12|||
144594945|NCT00585195|521377978|FG016|Overall Study|Progressive Disease|94|||
144594946|NCT00585195|521377979|FG017|Overall Study|Progressive Disease|42|||
144594947|NCT00585195|521377980|FG018|Overall Study|Progressive Disease|4|||
144396182|NCT03635788|520661730|FG000|Step 2|Lost to Follow-up|0|||
144594948|NCT00585195|521377981|FG019|Overall Study|Progressive Disease|9|||
144594949|NCT00585195|521377982|FG020|Overall Study|Progressive Disease|8|||
144594950|NCT00585195|521377962|FG000|Overall Study|Withdrawal by Subject|1|||
144594951|NCT00585195|521377963|FG001|Overall Study|Withdrawal by Subject|1|||
144594952|NCT00585195|521377964|FG002|Overall Study|Withdrawal by Subject|2|||
144594953|NCT00585195|521377965|FG003|Overall Study|Withdrawal by Subject|2|||
144594954|NCT00585195|521377966|FG004|Overall Study|Withdrawal by Subject|0|||
144594955|NCT00585195|521377967|FG005|Overall Study|Withdrawal by Subject|0|||
144594956|NCT00585195|521377968|FG006|Overall Study|Withdrawal by Subject|0|||
144594957|NCT00585195|521377969|FG007|Overall Study|Withdrawal by Subject|1|||
144594958|NCT00585195|521377970|FG008|Overall Study|Withdrawal by Subject|0|||
144594959|NCT00585195|521377971|FG009|Overall Study|Withdrawal by Subject|0|||
144594960|NCT00585195|521377972|FG010|Overall Study|Withdrawal by Subject|3|||
144396183|NCT03635788|520661731|FG001|Step 2|Lost to Follow-up|8|||
144396184|NCT03635788|520661732|FG002|Step 2|Lost to Follow-up|15|||
144396185|NCT03635788|520661730|FG000|Step 2|Withdrawal by Subject|0|||
144396186|NCT03635788|520661731|FG001|Step 2|Withdrawal by Subject|6|||
144396187|NCT03635788|520661732|FG002|Step 2|Withdrawal by Subject|6|||
144396188|NCT03635788|520661730|FG000|Step 2|Death|0|||
144396189|NCT03635788|520661731|FG001|Step 2|Death|2|||
144396190|NCT03635788|520661732|FG002|Step 2|Death|0|||
144396191|NCT03635788|520661730|FG000|Step 2|Incarceration|0|||
144594961|NCT00585195|521377973|FG011|Overall Study|Withdrawal by Subject|8|||
144594962|NCT00585195|521377974|FG012|Overall Study|Withdrawal by Subject|15|||
144594963|NCT00585195|521377975|FG013|Overall Study|Withdrawal by Subject|0|||
144594964|NCT00585195|521377976|FG014|Overall Study|Withdrawal by Subject|3|||
144594965|NCT00585195|521377977|FG015|Overall Study|Withdrawal by Subject|0|||
144594966|NCT00585195|521377978|FG016|Overall Study|Withdrawal by Subject|7|||
144594967|NCT00585195|521377979|FG017|Overall Study|Withdrawal by Subject|1|||
144594968|NCT00585195|521377980|FG018|Overall Study|Withdrawal by Subject|2|||
144594969|NCT00585195|521377981|FG019|Overall Study|Withdrawal by Subject|2|||
144594970|NCT00585195|521377982|FG020|Overall Study|Withdrawal by Subject|0|||
144594971|NCT00585195|521377962|FG000|Overall Study|Other|0|||
144594972|NCT00585195|521377963|FG001|Overall Study|Other|1|||
144594973|NCT00585195|521377964|FG002|Overall Study|Other|1|||
144594974|NCT00585195|521377965|FG003|Overall Study|Other|1|||
144594975|NCT00585195|521377966|FG004|Overall Study|Other|0|||
144594976|NCT00585195|521377967|FG005|Overall Study|Other|1|||
144594977|NCT00585195|521377968|FG006|Overall Study|Other|0|||
144594978|NCT00585195|521377969|FG007|Overall Study|Other|0|||
144594979|NCT00585195|521377970|FG008|Overall Study|Other|2|||
144594980|NCT00585195|521377971|FG009|Overall Study|Other|1|||
144594981|NCT00585195|521377972|FG010|Overall Study|Other|0|||
144594982|NCT00585195|521377973|FG011|Overall Study|Other|19|||
144594983|NCT00585195|521377974|FG012|Overall Study|Other|24|||
144594984|NCT00585195|521377975|FG013|Overall Study|Other|7|||
144594985|NCT00585195|521377976|FG014|Overall Study|Other|11|||
144594986|NCT00585195|521377977|FG015|Overall Study|Other|3|||
144594987|NCT00585195|521377978|FG016|Overall Study|Other|28|||
144594988|NCT00585195|521377979|FG017|Overall Study|Other|12|||
144594989|NCT00585195|521377980|FG018|Overall Study|Other|10|||
144594990|NCT00585195|521377981|FG019|Overall Study|Other|4|||
144594991|NCT00585195|521377982|FG020|Overall Study|Other|2|||
144594992|NCT00585195|521377962|FG000|Overall Study|Randomized not treated|0|||
144594993|NCT00585195|521377963|FG001|Overall Study|Randomized not treated|0|||
144594994|NCT00585195|521377964|FG002|Overall Study|Randomized not treated|1|||
144594995|NCT00585195|521377965|FG003|Overall Study|Randomized not treated|0|||
144594996|NCT00585195|521377966|FG004|Overall Study|Randomized not treated|1|||
144594997|NCT00585195|521377967|FG005|Overall Study|Randomized not treated|0|||
144594998|NCT00585195|521377968|FG006|Overall Study|Randomized not treated|1|||
144594999|NCT00585195|521377969|FG007|Overall Study|Randomized not treated|0|||
144595000|NCT00585195|521377970|FG008|Overall Study|Randomized not treated|0|||
144595001|NCT00585195|521377971|FG009|Overall Study|Randomized not treated|0|||
144595002|NCT00585195|521377972|FG010|Overall Study|Randomized not treated|2|||
144595003|NCT00585195|521377973|FG011|Overall Study|Randomized not treated|0|||
144595004|NCT00585195|521377974|FG012|Overall Study|Randomized not treated|0|||
144595005|NCT00585195|521377975|FG013|Overall Study|Randomized not treated|0|||
144595006|NCT00585195|521377976|FG014|Overall Study|Randomized not treated|0|||
144396192|NCT03635788|520661731|FG001|Step 2|Incarceration|2|||
144396193|NCT03635788|520661732|FG002|Step 2|Incarceration|0|||
144595007|NCT00585195|521377977|FG015|Overall Study|Randomized not treated|1|||
144595008|NCT00585195|521377978|FG016|Overall Study|Randomized not treated|0|||
144595009|NCT00585195|521377979|FG017|Overall Study|Randomized not treated|1|||
144396194|NCT03635788|520661730|FG000|Step 2|Non-Compliance With Study Requirements|0|||
144595010|NCT00585195|521377980|FG018|Overall Study|Randomized not treated|3|||
144595011|NCT00585195|521377981|FG019|Overall Study|Randomized not treated|0|||
144595012|NCT00585195|521377982|FG020|Overall Study|Randomized not treated|2|||
144396195|NCT03635788|520661731|FG001|Step 2|Non-Compliance With Study Requirements|1|||
144595013|NCT00585195|521377962|FG000|Overall Study|Death|0|||
144595014|NCT00585195|521377963|FG001|Overall Study|Death|0|||
144595015|NCT00585195|521377964|FG002|Overall Study|Death|0|||
144595016|NCT00585195|521377965|FG003|Overall Study|Death|0|||
144595017|NCT00585195|521377966|FG004|Overall Study|Death|0|||
144595018|NCT00585195|521377967|FG005|Overall Study|Death|0|||
144595019|NCT00585195|521377968|FG006|Overall Study|Death|0|||
144595020|NCT00585195|521377969|FG007|Overall Study|Death|0|||
144595021|NCT00585195|521377970|FG008|Overall Study|Death|1|||
144595022|NCT00585195|521377971|FG009|Overall Study|Death|0|||
144595023|NCT00585195|521377972|FG010|Overall Study|Death|1|||
144595024|NCT00585195|521377973|FG011|Overall Study|Death|1|||
144595025|NCT00585195|521377974|FG012|Overall Study|Death|7|||
144595026|NCT00585195|521377975|FG013|Overall Study|Death|2|||
144595027|NCT00585195|521377976|FG014|Overall Study|Death|8|||
144595028|NCT00585195|521377977|FG015|Overall Study|Death|2|||
144595029|NCT00585195|521377978|FG016|Overall Study|Death|11|||
144595030|NCT00585195|521377979|FG017|Overall Study|Death|0|||
144595031|NCT00585195|521377980|FG018|Overall Study|Death|0|||
144595032|NCT00585195|521377981|FG019|Overall Study|Death|0|||
144595033|NCT00585195|521377982|FG020|Overall Study|Death|1|||
144595034|NCT00585195|521377962|FG000|Overall Study|Lost to Follow-up|0|||
144595035|NCT00585195|521377963|FG001|Overall Study|Lost to Follow-up|0|||
144595036|NCT00585195|521377964|FG002|Overall Study|Lost to Follow-up|0|||
144595037|NCT00585195|521377965|FG003|Overall Study|Lost to Follow-up|0|||
144595038|NCT00585195|521377966|FG004|Overall Study|Lost to Follow-up|0|||
144595039|NCT00585195|521377967|FG005|Overall Study|Lost to Follow-up|0|||
144595040|NCT00585195|521377968|FG006|Overall Study|Lost to Follow-up|0|||
144595041|NCT00585195|521377969|FG007|Overall Study|Lost to Follow-up|0|||
144595042|NCT00585195|521377970|FG008|Overall Study|Lost to Follow-up|0|||
144595043|NCT00585195|521377971|FG009|Overall Study|Lost to Follow-up|0|||
144595044|NCT00585195|521377972|FG010|Overall Study|Lost to Follow-up|0|||
144595045|NCT00585195|521377973|FG011|Overall Study|Lost to Follow-up|0|||
144595046|NCT00585195|521377974|FG012|Overall Study|Lost to Follow-up|1|||
144595047|NCT00585195|521377975|FG013|Overall Study|Lost to Follow-up|0|||
144595048|NCT00585195|521377976|FG014|Overall Study|Lost to Follow-up|0|||
144595049|NCT00585195|521377977|FG015|Overall Study|Lost to Follow-up|0|||
144595050|NCT00585195|521377978|FG016|Overall Study|Lost to Follow-up|0|||
144595051|NCT00585195|521377979|FG017|Overall Study|Lost to Follow-up|2|||
144595052|NCT00585195|521377980|FG018|Overall Study|Lost to Follow-up|0|||
144595053|NCT00585195|521377981|FG019|Overall Study|Lost to Follow-up|0|||
144595054|NCT00585195|521377982|FG020|Overall Study|Lost to Follow-up|0|||
144595055|NCT00585195|521377962|FG000|Overall Study|Site Terminated by Sponsor|0|||
144595056|NCT00585195|521377963|FG001|Overall Study|Site Terminated by Sponsor|0|||
144595057|NCT00585195|521377964|FG002|Overall Study|Site Terminated by Sponsor|0|||
144595058|NCT00585195|521377965|FG003|Overall Study|Site Terminated by Sponsor|0|||
144595059|NCT00585195|521377966|FG004|Overall Study|Site Terminated by Sponsor|0|||
144595060|NCT00585195|521377967|FG005|Overall Study|Site Terminated by Sponsor|0|||
144595061|NCT00585195|521377968|FG006|Overall Study|Site Terminated by Sponsor|0|||
144595062|NCT00585195|521377969|FG007|Overall Study|Site Terminated by Sponsor|0|||
144595063|NCT00585195|521377970|FG008|Overall Study|Site Terminated by Sponsor|0|||
144595064|NCT00585195|521377971|FG009|Overall Study|Site Terminated by Sponsor|0|||
144595065|NCT00585195|521377972|FG010|Overall Study|Site Terminated by Sponsor|0|||
144595066|NCT00585195|521377973|FG011|Overall Study|Site Terminated by Sponsor|0|||
144595067|NCT00585195|521377974|FG012|Overall Study|Site Terminated by Sponsor|1|||
144396196|NCT03635788|520661732|FG002|Step 2|Non-Compliance With Study Requirements|1|||
144396197|NCT03635788|520661730|FG000|Step 2|Confounding Medical Condition|0|||
144396198|NCT03635788|520661731|FG001|Step 2|Confounding Medical Condition|0|||
144396199|NCT03635788|520661732|FG002|Step 2|Confounding Medical Condition|1|||
144396200|NCT03635788|520661730|FG000|Step 2|Out Of State With No Plan To Return|0|||
144396201|NCT03635788|520661731|FG001|Step 2|Out Of State With No Plan To Return|1|||
144396202|NCT03635788|520661732|FG002|Step 2|Out Of State With No Plan To Return|0|||
144595068|NCT00585195|521377975|FG013|Overall Study|Site Terminated by Sponsor|0|||
144595069|NCT00585195|521377976|FG014|Overall Study|Site Terminated by Sponsor|0|||
144595070|NCT00585195|521377977|FG015|Overall Study|Site Terminated by Sponsor|0|||
144595071|NCT00585195|521377978|FG016|Overall Study|Site Terminated by Sponsor|0|||
144595072|NCT00585195|521377979|FG017|Overall Study|Site Terminated by Sponsor|0|||
144595073|NCT00585195|521377980|FG018|Overall Study|Site Terminated by Sponsor|0|||
144595074|NCT00585195|521377981|FG019|Overall Study|Site Terminated by Sponsor|0|||
144595075|NCT00585195|521377982|FG020|Overall Study|Site Terminated by Sponsor|0|||
144396203|NCT03635788|520661730|FG000|Step 2|Switched To Injectables|0|||
144595076|NCT00585195|521377962|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
144595077|NCT00585195|521377963|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
144595078|NCT00585195|521377964|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
144595079|NCT00585195|521377965|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
144595080|NCT00585195|521377966|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
144595081|NCT00585195|521377967|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
144595082|NCT00585195|521377968|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
144595083|NCT00585195|521377969|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
144595084|NCT00585195|521377970|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
144595085|NCT00585195|521377971|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
144595086|NCT00585195|521377972|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
144595087|NCT00585195|521377973|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
144595088|NCT00585195|521377974|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
144595089|NCT00585195|521377975|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
144595090|NCT00585195|521377976|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
144595091|NCT00585195|521377977|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
144595092|NCT00585195|521377978|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
144595093|NCT00585195|521377979|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
144595094|NCT00585195|521377980|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
144595095|NCT00585195|521377981|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
144595096|NCT00585195|521377982|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
144595097|NCT02796560|521377988|FG000|Overall Study|Adverse Event|2|||
144595098|NCT02796560|521377989|FG001|Overall Study|Adverse Event|0|||
144595099|NCT02796560|521377988|FG000|Overall Study|Withdrawal by Subject|2|||
144595100|NCT02796560|521377989|FG001|Overall Study|Withdrawal by Subject|2|||
144595101|NCT02533570|521377990|FG000|Overall Study|Adverse Event|0|||
144595102|NCT02533570|521377991|FG001|Overall Study|Adverse Event|1|||
144595103|NCT02533570|521377992|FG002|Overall Study|Adverse Event|1|||
144595104|NCT00529958|521377993|FG000|2-Year Follow-up|Lost to Follow-up|1|||
144595105|NCT00529958|521377994|FG001|2-Year Follow-up|Lost to Follow-up|2|||
144595106|NCT00529958|521377995|FG002|2-Year Follow-up|Lost to Follow-up|2|||
144595107|NCT00529958|521377993|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
144595108|NCT00529958|521377994|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
144595109|NCT00529958|521377995|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
144595110|NCT00529958|521377993|FG000|5-Year Follow-up|Lost to Follow-up|2|||
144595111|NCT00529958|521377994|FG001|5-Year Follow-up|Lost to Follow-up|3|||
144595112|NCT00529958|521377995|FG002|5-Year Follow-up|Lost to Follow-up|1|||
144595113|NCT00529958|521377993|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
144595114|NCT00529958|521377994|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
144595115|NCT00529958|521377995|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
144595116|NCT03816332|521377996|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
144595117|NCT03816332|521377996|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
144595118|NCT03534284|521377999|FG000|Overall Study|Death|2|||
144595119|NCT03534284|521378000|FG001|Overall Study|Death|3|||
144595120|NCT03534284|521378001|FG002|Overall Study|Death|3|||
144595121|NCT03534284|521377999|FG000|Overall Study|Withdrawal by Subject|5|||
144595122|NCT03534284|521378000|FG001|Overall Study|Withdrawal by Subject|0|||
144595123|NCT03534284|521378001|FG002|Overall Study|Withdrawal by Subject|0|||
144595124|NCT03164564|521378002|FG000|Overall Study|Death|3|||
144595125|NCT03164564|521378003|FG001|Overall Study|Death|0|||
144595126|NCT03164564|521378002|FG000|Overall Study|Withdrawal by Subject|20|||
144595127|NCT03164564|521378003|FG001|Overall Study|Withdrawal by Subject|15|||
144595128|NCT03164564|521378002|FG000|Overall Study|Lost to Follow-up|2|||
144595129|NCT03164564|521378003|FG001|Overall Study|Lost to Follow-up|0|||
144595130|NCT03164564|521378002|FG000|Overall Study|Physician Decision|0|||
144595131|NCT03164564|521378003|FG001|Overall Study|Physician Decision|1|||
144595132|NCT03164564|521378002|FG000|Overall Study|Adverse Event|0|||
144595133|NCT03164564|521378003|FG001|Overall Study|Adverse Event|1|||
144595134|NCT03164564|521378002|FG000|Overall Study|Ongoing|1586|||
144595135|NCT03164564|521378003|FG001|Overall Study|Ongoing|1586|||
144595136|NCT02656823|521378004|FG000|Overall Study|Adverse Event|3|||
144595137|NCT02656823|521378004|FG000|Overall Study|Lost to Follow-up|2|||
144595138|NCT01315353|521378005|FG000|Overall Study|Death|2|||
144595139|NCT01315353|521378006|FG001|Overall Study|Death|1|||
144595140|NCT01315353|521378007|FG002|Overall Study|Death|0|||
144595141|NCT01315353|521378005|FG000|Overall Study|Withdrawal by Subject|2|||
144595142|NCT01315353|521378006|FG001|Overall Study|Withdrawal by Subject|6|||
144595143|NCT01315353|521378007|FG002|Overall Study|Withdrawal by Subject|1|||
144595144|NCT01315353|521378005|FG000|Overall Study|Lost to Follow-up|13|||
144595145|NCT01315353|521378006|FG001|Overall Study|Lost to Follow-up|6|||
144595146|NCT01315353|521378007|FG002|Overall Study|Lost to Follow-up|6|||
144722254|NCT01768858|521838648|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
144722255|NCT01768858|521838648|FG000|Overall Study|Exanthema|1|||
144722256|NCT01768858|521838648|FG000|Overall Study|Withdrawal by Subject|1|||
144595147|NCT01315353|521378005|FG000|Overall Study|Unwilling to adhere to requirements|5|||
144595148|NCT01315353|521378006|FG001|Overall Study|Unwilling to adhere to requirements|5|||
144595149|NCT01315353|521378007|FG002|Overall Study|Unwilling to adhere to requirements|4|||
144595150|NCT01315353|521378005|FG000|Overall Study|Site closing|7|||
144595151|NCT01315353|521378006|FG001|Overall Study|Site closing|4|||
144595152|NCT01315353|521378007|FG002|Overall Study|Site closing|0|||
144595153|NCT01315353|521378005|FG000|Overall Study|Taken off study by site in error|0|||
144595154|NCT01315353|521378006|FG001|Overall Study|Taken off study by site in error|1|||
144722257|NCT03312530|521838649|FG000|Overall Study|Death|5|||
144595155|NCT01315353|521378007|FG002|Overall Study|Taken off study by site in error|0|||
144520224|NCT04927065|521106286|FG012|Second Booster|Withdrawal by Subject|13|||
144520225|NCT04927065|521106287|FG013|Second Booster|Withdrawal by Subject|9|||
144520226|NCT04927065|521106288|FG014|Second Booster|Withdrawal by Subject|0|||
144520227|NCT04927065|521106289|FG015|Second Booster|Withdrawal by Subject|0|||
144520228|NCT04927065|521106274|FG000|Second Booster|Other Than Specified|0|||
144520229|NCT04927065|521106275|FG001|Second Booster|Other Than Specified|0|||
144520230|NCT04927065|521106276|FG002|Second Booster|Other Than Specified|0|||
144520231|NCT04927065|521106277|FG003|Second Booster|Other Than Specified|0|||
144520232|NCT04927065|521106278|FG004|Second Booster|Other Than Specified|0|||
144520233|NCT04927065|521106279|FG005|Second Booster|Other Than Specified|0|||
144520234|NCT04927065|521106280|FG006|Second Booster|Other Than Specified|0|||
144520235|NCT04927065|521106281|FG007|Second Booster|Other Than Specified|0|||
144520236|NCT04927065|521106282|FG008|Second Booster|Other Than Specified|0|||
144520237|NCT04927065|521106283|FG009|Second Booster|Other Than Specified|0|||
144520238|NCT04927065|521106284|FG010|Second Booster|Other Than Specified|1|||
144520239|NCT04927065|521106285|FG011|Second Booster|Other Than Specified|1|||
144520240|NCT04927065|521106286|FG012|Second Booster|Other Than Specified|4|||
144520241|NCT04927065|521106287|FG013|Second Booster|Other Than Specified|0|||
144520242|NCT04927065|521106288|FG014|Second Booster|Other Than Specified|0|||
144520243|NCT04927065|521106289|FG015|Second Booster|Other Than Specified|0|||
144520244|NCT04927065|521106274|FG000|Third Booster|Lost to Follow-up|0|||
144520245|NCT04927065|521106275|FG001|Third Booster|Lost to Follow-up|0|||
144520246|NCT04927065|521106276|FG002|Third Booster|Lost to Follow-up|0|||
144520247|NCT04927065|521106277|FG003|Third Booster|Lost to Follow-up|0|||
144520248|NCT04927065|521106278|FG004|Third Booster|Lost to Follow-up|0|||
144520249|NCT04927065|521106279|FG005|Third Booster|Lost to Follow-up|0|||
144520250|NCT04927065|521106280|FG006|Third Booster|Lost to Follow-up|0|||
144520251|NCT04927065|521106281|FG007|Third Booster|Lost to Follow-up|0|||
144520252|NCT04927065|521106282|FG008|Third Booster|Lost to Follow-up|0|||
144520253|NCT04927065|521106283|FG009|Third Booster|Lost to Follow-up|0|||
144520254|NCT04927065|521106284|FG010|Third Booster|Lost to Follow-up|0|||
144520255|NCT04927065|521106285|FG011|Third Booster|Lost to Follow-up|0|||
144520256|NCT04927065|521106286|FG012|Third Booster|Lost to Follow-up|0|||
144520257|NCT04927065|521106287|FG013|Third Booster|Lost to Follow-up|0|||
144520258|NCT04927065|521106288|FG014|Third Booster|Lost to Follow-up|0|||
144520259|NCT04927065|521106289|FG015|Third Booster|Lost to Follow-up|1|||
144520260|NCT04927065|521106274|FG000|Third Booster|Withdrawal by Subject|0|||
144520261|NCT04927065|521106275|FG001|Third Booster|Withdrawal by Subject|0|||
144520262|NCT04927065|521106276|FG002|Third Booster|Withdrawal by Subject|0|||
144520263|NCT04927065|521106277|FG003|Third Booster|Withdrawal by Subject|0|||
144520264|NCT04927065|521106278|FG004|Third Booster|Withdrawal by Subject|0|||
144520265|NCT04927065|521106279|FG005|Third Booster|Withdrawal by Subject|0|||
144520266|NCT04927065|521106280|FG006|Third Booster|Withdrawal by Subject|0|||
144520267|NCT04927065|521106281|FG007|Third Booster|Withdrawal by Subject|0|||
144520268|NCT04927065|521106282|FG008|Third Booster|Withdrawal by Subject|0|||
144520269|NCT04927065|521106283|FG009|Third Booster|Withdrawal by Subject|0|||
144520270|NCT04927065|521106284|FG010|Third Booster|Withdrawal by Subject|0|||
144520271|NCT04927065|521106285|FG011|Third Booster|Withdrawal by Subject|0|||
144520272|NCT04927065|521106286|FG012|Third Booster|Withdrawal by Subject|0|||
144520273|NCT04927065|521106287|FG013|Third Booster|Withdrawal by Subject|0|||
144520274|NCT04927065|521106288|FG014|Third Booster|Withdrawal by Subject|0|||
144520275|NCT04927065|521106289|FG015|Third Booster|Withdrawal by Subject|1|||
144520276|NCT04005716|521106294|FG000|Overall Study|Death|175|||
144520277|NCT04005716|521106295|FG001|Overall Study|Death|196|||
144520278|NCT04005716|521106294|FG000|Overall Study|Withdrawal by Subject|1|||
144520279|NCT04005716|521106295|FG001|Overall Study|Withdrawal by Subject|6|||
144520280|NCT04005716|521106294|FG000|Overall Study|Lost to Follow-up|2|||
144520281|NCT04005716|521106295|FG001|Overall Study|Lost to Follow-up|2|||
144520282|NCT04021602|521106296|FG000|Overall Study|Lost to Follow-up|3|||
144520283|NCT04021602|521106297|FG001|Overall Study|Lost to Follow-up|3|||
144520284|NCT04021602|521106298|FG002|Overall Study|Lost to Follow-up|1|||
144520285|NCT04021602|521106296|FG000|Overall Study|Adverse Event|1|||
144520286|NCT04021602|521106297|FG001|Overall Study|Adverse Event|0|||
144520287|NCT04021602|521106298|FG002|Overall Study|Adverse Event|1|||
144520288|NCT03892616|521106299|FG000|Washout Period 2|Met discontinuation criterion|0|||
144520289|NCT03892616|521106300|FG001|Washout Period 2|Met discontinuation criterion|0|||
144520290|NCT03892616|521106301|FG002|Washout Period 2|Met discontinuation criterion|0|||
144520291|NCT03892616|521106302|FG003|Washout Period 2|Met discontinuation criterion|0|||
144520292|NCT03892616|521106303|FG004|Washout Period 2|Met discontinuation criterion|0|||
144520293|NCT03892616|521106304|FG005|Washout Period 2|Met discontinuation criterion|0|||
144722258|NCT03312530|521838650|FG001|Overall Study|Death|5|||
144520294|NCT03892616|521106305|FG006|Washout Period 2|Met discontinuation criterion|0|||
144520295|NCT03892616|521106306|FG007|Washout Period 2|Met discontinuation criterion|0|||
144520296|NCT03892616|521106307|FG008|Washout Period 2|Met discontinuation criterion|1|||
144520297|NCT03892616|521106308|FG009|Washout Period 2|Met discontinuation criterion|0|||
144722259|NCT03312530|521838651|FG002|Overall Study|Death|4|||
144396204|NCT03635788|520661731|FG001|Step 2|Switched To Injectables|0|||
144396205|NCT03635788|520661732|FG002|Step 2|Switched To Injectables|1|||
144520298|NCT03892616|521106309|FG010|Washout Period 2|Met discontinuation criterion|0|||
144520299|NCT03892616|521106310|FG011|Washout Period 2|Met discontinuation criterion|0|||
144520300|NCT02243709|521106311|FG000|Phase 1|Lost to Follow-up|0|||
144520301|NCT02243709|521106312|FG001|Phase 1|Lost to Follow-up|1|||
144520302|NCT02243709|521106311|FG000|Phase 1|Withdrawal by Subject|1|||
144520303|NCT02243709|521106312|FG001|Phase 1|Withdrawal by Subject|0|||
144520304|NCT02243709|521106311|FG000|Phase 1|Protocol Violation|0|||
144520305|NCT02243709|521106312|FG001|Phase 1|Protocol Violation|1|||
144520306|NCT02243709|521106311|FG000|Phase 1|Adverse Event|0|||
144520307|NCT02243709|521106312|FG001|Phase 1|Adverse Event|1|||
144520308|NCT04169373|521106315|FG000|Week 1 to Week 14|Adverse Event|1|||
144520309|NCT04169373|521106316|FG001|Week 1 to Week 14|Adverse Event|0|||
144520310|NCT04169373|521106317|FG002|Week 1 to Week 14|Adverse Event|1|||
144520311|NCT04169373|521106318|FG003|Week 1 to Week 14|Adverse Event|2|||
144520312|NCT04169373|521106315|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
144520313|NCT04169373|521106316|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
144520314|NCT04169373|521106317|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
144520315|NCT04169373|521106318|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
144520316|NCT04169373|521106315|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
144520317|NCT04169373|521106316|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
144520318|NCT04169373|521106317|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
144520319|NCT04169373|521106318|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
144520320|NCT04169373|521106315|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
144520321|NCT04169373|521106316|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
144520322|NCT04169373|521106317|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
144520323|NCT04169373|521106318|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
144520324|NCT04169373|521106315|FG000|Week 1 to Week 14|Other|1|||
144520325|NCT04169373|521106316|FG001|Week 1 to Week 14|Other|3|||
144520326|NCT04169373|521106317|FG002|Week 1 to Week 14|Other|3|||
144520327|NCT04169373|521106318|FG003|Week 1 to Week 14|Other|5|||
144520328|NCT04169373|521106315|FG000|Week 14 to Week 52|Adverse Event|1|||
144520329|NCT04169373|521106316|FG001|Week 14 to Week 52|Adverse Event|0|||
144520330|NCT04169373|521106317|FG002|Week 14 to Week 52|Adverse Event|0|||
144520331|NCT04169373|521106318|FG003|Week 14 to Week 52|Adverse Event|1|||
144520332|NCT04169373|521106315|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
144520333|NCT04169373|521106316|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
144520334|NCT04169373|521106317|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
144520335|NCT04169373|521106318|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
144520336|NCT04169373|521106315|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
144520337|NCT04169373|521106316|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
144520338|NCT04169373|521106317|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
144520339|NCT04169373|521106318|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
144520340|NCT04169373|521106315|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
144520341|NCT04169373|521106316|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
144520342|NCT04169373|521106317|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
144520343|NCT04169373|521106318|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
144520344|NCT04169373|521106315|FG000|Week 14 to Week 52|Other|4|||
144520345|NCT04169373|521106316|FG001|Week 14 to Week 52|Other|5|||
144520346|NCT04169373|521106317|FG002|Week 14 to Week 52|Other|4|||
144520347|NCT04169373|521106318|FG003|Week 14 to Week 52|Other|5|||
144520348|NCT04169373|521106315|FG000|Week 14 to Week 52|Ongoing|0|||
144520349|NCT04169373|521106316|FG001|Week 14 to Week 52|Ongoing|1|||
144520350|NCT04169373|521106317|FG002|Week 14 to Week 52|Ongoing|0|||
144520351|NCT04169373|521106318|FG003|Week 14 to Week 52|Ongoing|0|||
144520352|NCT04533347|521106319|FG000|Overall Study|Adverse Event|1|||
144520353|NCT04533347|521106320|FG001|Overall Study|Adverse Event|2|||
144520354|NCT04533347|521106319|FG000|Overall Study|Lost to Follow-up|2|||
144595156|NCT01315353|521378005|FG000|Overall Study|Inadvertent randomization/assignment|0|||
144595157|NCT01315353|521378006|FG001|Overall Study|Inadvertent randomization/assignment|0|||
144595158|NCT01315353|521378007|FG002|Overall Study|Inadvertent randomization/assignment|2|||
144595159|NCT01009580|521378008|FG000|Overall Study|Adverse Event|4|||
144595160|NCT01009580|521378009|FG001|Overall Study|Adverse Event|4|||
144595161|NCT01009580|521378008|FG000|Overall Study|Lack of Efficacy|0|||
144520355|NCT04533347|521106320|FG001|Overall Study|Lost to Follow-up|0|||
144595162|NCT01009580|521378009|FG001|Overall Study|Lack of Efficacy|1|||
144520356|NCT04533347|521106319|FG000|Overall Study|Withdrawal by Subject|1|||
144520357|NCT04533347|521106320|FG001|Overall Study|Withdrawal by Subject|0|||
144520358|NCT04610892|521106321|FG000|Overall Study|Adverse Event|1|||
144520359|NCT04610892|521106322|FG001|Overall Study|Adverse Event|0|||
144520360|NCT04610892|521106323|FG002|Overall Study|Adverse Event|0|||
144520361|NCT04610892|521106324|FG003|Overall Study|Adverse Event|1|||
144520362|NCT04610892|521106325|FG004|Overall Study|Adverse Event|3|||
144595163|NCT01009580|521378008|FG000|Overall Study|Protocol Violation|2|||
144520363|NCT04610892|521106321|FG000|Overall Study|Death|0|||
144520364|NCT04610892|521106322|FG001|Overall Study|Death|1|||
144595164|NCT01009580|521378009|FG001|Overall Study|Protocol Violation|3|||
144595165|NCT01009580|521378008|FG000|Overall Study|Withdrawal Criteria|4|||
144595166|NCT01009580|521378009|FG001|Overall Study|Withdrawal Criteria|6|||
144595167|NCT01009580|521378008|FG000|Overall Study|Unclassified|17|||
144595168|NCT01009580|521378009|FG001|Overall Study|Unclassified|21|||
144595169|NCT04469270|521378010|FG000|Overall Study|Adverse Event|2|||
144595170|NCT04469270|521378011|FG001|Overall Study|Adverse Event|0|||
144595171|NCT04469270|521378010|FG000|Overall Study|Lost to Follow-up|4|||
144595172|NCT04469270|521378011|FG001|Overall Study|Lost to Follow-up|3|||
144595173|NCT04469270|521378010|FG000|Overall Study|Withdrawal by Subject|7|||
144595174|NCT04469270|521378011|FG001|Overall Study|Withdrawal by Subject|3|||
144595175|NCT04469270|521378010|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
144595176|NCT04469270|521378011|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
144595177|NCT04469270|521378010|FG000|Overall Study|missing|1|||
144595178|NCT04469270|521378011|FG001|Overall Study|missing|0|||
144595179|NCT02254278|521378014|FG000|Overall Study|Protocol Violation|1|||
144595180|NCT02254278|521378015|FG001|Overall Study|Protocol Violation|1|||
144595181|NCT05437510|521378020|FG000|Overall Study|Adverse Event|2|||
144595182|NCT05437510|521378021|FG001|Overall Study|Adverse Event|1|||
144595183|NCT05437510|521378020|FG000|Overall Study|Protocol Deviation|1|||
144595184|NCT05437510|521378021|FG001|Overall Study|Protocol Deviation|6|||
144595185|NCT05437510|521378020|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
144595186|NCT05437510|521378021|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
144595187|NCT05437510|521378020|FG000|Overall Study|Lost to Follow-up|265|||
144595188|NCT05437510|521378021|FG001|Overall Study|Lost to Follow-up|358|||
144595189|NCT01340196|521379310|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
144595190|NCT00604279|521379315|FG000|Overall Study|Lack of Efficacy|22|||
144595191|NCT00604279|521379316|FG001|Overall Study|Lack of Efficacy|9|||
144595192|NCT00604279|521379315|FG000|Overall Study|Lost to Follow-up|9|||
144595193|NCT00604279|521379316|FG001|Overall Study|Lost to Follow-up|14|||
144595194|NCT00604279|521379315|FG000|Overall Study|Pregnancy|2|||
144595195|NCT00604279|521379316|FG001|Overall Study|Pregnancy|0|||
144595196|NCT00604279|521379315|FG000|Overall Study|Protocol Violation|3|||
144595197|NCT00604279|521379316|FG001|Overall Study|Protocol Violation|1|||
144595198|NCT00604279|521379315|FG000|Overall Study|Withdrawal by Subject|16|||
144595199|NCT00604279|521379316|FG001|Overall Study|Withdrawal by Subject|5|||
144595200|NCT00604279|521379315|FG000|Overall Study|Adverse Event|4|||
144595201|NCT00604279|521379316|FG001|Overall Study|Adverse Event|5|||
144595202|NCT00604279|521379315|FG000|Overall Study|Other|8|||
144595203|NCT00604279|521379316|FG001|Overall Study|Other|4|||
144595204|NCT00601419|521379317|FG000|Overall Study|Lost to Follow-up|3|||
144595205|NCT00601419|521379317|FG000|Overall Study|Missed Visits|1|||
144595206|NCT01614197|521379318|FG000|Overall Study|Withdrawal by Subject|0|||
144595207|NCT01614197|521379319|FG001|Overall Study|Withdrawal by Subject|1|||
144595208|NCT01614197|521379320|FG002|Overall Study|Withdrawal by Subject|0|||
144595209|NCT01614197|521379321|FG003|Overall Study|Withdrawal by Subject|0|||
144595210|NCT03628898|521379323|FG000|Overall Study|Device deficiency|1|||
144595211|NCT01217957|521379324|FG000|Phase 1|Withdrawal by Patient|1|||
144595212|NCT01217957|521379325|FG001|Phase 1|Withdrawal by Patient|0|||
144595213|NCT01217957|521379326|FG002|Phase 1|Withdrawal by Patient|1|||
144595214|NCT01217957|521379327|FG003|Phase 1|Withdrawal by Patient|1|||
144595215|NCT01217957|521379328|FG004|Phase 1|Withdrawal by Patient|0|||
144595216|NCT01217957|521379324|FG000|Phase 2|Withdrawal by Patient|0|||
144595217|NCT01217957|521379325|FG001|Phase 2|Withdrawal by Patient|0|||
144595218|NCT01217957|521379326|FG002|Phase 2|Withdrawal by Patient|0|||
144595219|NCT01217957|521379327|FG003|Phase 2|Withdrawal by Patient|0|||
144595220|NCT01217957|521379328|FG004|Phase 2|Withdrawal by Patient|1|||
144595221|NCT00971932|521379329|FG000|Overall Study|Withdrawal by Subject|1|||
144595222|NCT00971932|521379329|FG000|Overall Study|Investigator's decision|2|||
144595223|NCT00971932|521379329|FG000|Overall Study|Ongoing|4|||
144595224|NCT02986334|521379336|FG000|Overall Study|Withdrawal by Subject|0|||
144595225|NCT02986334|521379337|FG001|Overall Study|Withdrawal by Subject|1|||
144595226|NCT02986334|521379338|FG002|Overall Study|Withdrawal by Subject|2|||
144595227|NCT02986334|521379336|FG000|Overall Study|Lost to Follow-up|1|||
144595228|NCT02986334|521379337|FG001|Overall Study|Lost to Follow-up|2|||
144595229|NCT02986334|521379338|FG002|Overall Study|Lost to Follow-up|1|||
144595230|NCT02986334|521379336|FG000|Overall Study|Adverse Event|0|||
144595231|NCT02986334|521379337|FG001|Overall Study|Adverse Event|2|||
144396206|NCT03635788|520661730|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
144396207|NCT03635788|520661731|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
144595232|NCT02986334|521379338|FG002|Overall Study|Adverse Event|1|||
144595233|NCT02986334|521379336|FG000|Overall Study|non compliance in phone ratings|2|||
144595234|NCT02986334|521379337|FG001|Overall Study|non compliance in phone ratings|1|||
144595235|NCT02986334|521379338|FG002|Overall Study|non compliance in phone ratings|2|||
144595236|NCT02986334|521379336|FG000|Overall Study|undisclosed comorbidities|0|||
144595237|NCT02986334|521379337|FG001|Overall Study|undisclosed comorbidities|1|||
144595238|NCT02986334|521379338|FG002|Overall Study|undisclosed comorbidities|1|||
144595239|NCT05580588|521379339|FG000|Overall Study|Lack of Efficacy|12|||
144396208|NCT03635788|520661732|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
144396209|NCT01015131|520661733|FG000|Overall Study|Physician Decision|1|||
144396210|NCT01015131|520661733|FG000|Overall Study|Protocol Violation|1|||
144396211|NCT01015131|520661733|FG000|Overall Study|Withdrawal by Subject|2|||
144520365|NCT04610892|521106323|FG002|Overall Study|Death|0|||
144520366|NCT04610892|521106324|FG003|Overall Study|Death|1|||
144520367|NCT04610892|521106325|FG004|Overall Study|Death|0|||
144520368|NCT04610892|521106321|FG000|Overall Study|Withdrawal by Subject|3|||
144520369|NCT04610892|521106322|FG001|Overall Study|Withdrawal by Subject|2|||
144520370|NCT04610892|521106323|FG002|Overall Study|Withdrawal by Subject|0|||
144520371|NCT04610892|521106324|FG003|Overall Study|Withdrawal by Subject|6|||
144520372|NCT04610892|521106325|FG004|Overall Study|Withdrawal by Subject|6|||
144520373|NCT04610892|521106321|FG000|Overall Study|Subjects who did not receive treatment|1|||
144520374|NCT04610892|521106322|FG001|Overall Study|Subjects who did not receive treatment|0|||
144520375|NCT04610892|521106323|FG002|Overall Study|Subjects who did not receive treatment|0|||
144520376|NCT04610892|521106324|FG003|Overall Study|Subjects who did not receive treatment|0|||
144520377|NCT04610892|521106325|FG004|Overall Study|Subjects who did not receive treatment|2|||
144520378|NCT05520190|521106326|FG000|Overall Study|Lost to Follow-up|7|||
144520379|NCT05520190|521106326|FG000|Overall Study|Withdrawal by Subject|2|||
144520380|NCT01748448|521106330|FG000|Treatment Period|Consent withdrawn by subject|1|||
144520381|NCT01748448|521106331|FG001|Treatment Period|Consent withdrawn by subject|0|||
144520382|NCT01748448|521106330|FG000|Treatment Period|Adverse Event|1|||
144520383|NCT01748448|521106331|FG001|Treatment Period|Adverse Event|0|||
144520384|NCT01748448|521106330|FG000|Treatment Period|Personal|0|||
144520385|NCT01748448|521106331|FG001|Treatment Period|Personal|1|||
144520386|NCT03924986|521106332|FG000|Overall Study|Death|57|||
144520387|NCT03924986|521106333|FG001|Overall Study|Death|66|||
144595240|NCT00712673|521379342|FG000|Overall Study|Adverse Event|3|||
144595241|NCT00712673|521379343|FG001|Overall Study|Adverse Event|3|||
144595242|NCT00712673|521379344|FG002|Overall Study|Adverse Event|21|||
144595243|NCT00712673|521379345|FG003|Overall Study|Adverse Event|26|||
144595244|NCT00712673|521379342|FG000|Overall Study|Lack of Efficacy|2|||
144595245|NCT00712673|521379343|FG001|Overall Study|Lack of Efficacy|8|||
144595246|NCT00712673|521379344|FG002|Overall Study|Lack of Efficacy|8|||
144595247|NCT00712673|521379345|FG003|Overall Study|Lack of Efficacy|6|||
144595248|NCT00712673|521379342|FG000|Overall Study|Poor Compliance to Protocol|3|||
144595249|NCT00712673|521379343|FG001|Overall Study|Poor Compliance to Protocol|3|||
144595250|NCT00712673|521379344|FG002|Overall Study|Poor Compliance to Protocol|4|||
144595251|NCT00712673|521379345|FG003|Overall Study|Poor Compliance to Protocol|16|||
144595252|NCT00712673|521379342|FG000|Overall Study|Lost to Follow-up|1|||
144722260|NCT03312530|521838652|FG003|Overall Study|Death|10|||
144595253|NCT00712673|521379343|FG001|Overall Study|Lost to Follow-up|0|||
144595254|NCT00712673|521379344|FG002|Overall Study|Lost to Follow-up|2|||
144722261|NCT03312530|521838653|FG004|Overall Study|Death|8|||
144722262|NCT03312530|521838649|FG000|Overall Study|Lost to Follow-up|0|||
144722263|NCT03312530|521838650|FG001|Overall Study|Lost to Follow-up|0|||
144722264|NCT03312530|521838651|FG002|Overall Study|Lost to Follow-up|0|||
144722265|NCT03312530|521838652|FG003|Overall Study|Lost to Follow-up|1|||
144722266|NCT03312530|521838653|FG004|Overall Study|Lost to Follow-up|0|||
144722267|NCT03312530|521838649|FG000|Overall Study|Participant in another sponsor study.|0|||
144722268|NCT03312530|521838650|FG001|Overall Study|Participant in another sponsor study.|0|||
144722269|NCT03312530|521838651|FG002|Overall Study|Participant in another sponsor study.|0|||
144722270|NCT03312530|521838652|FG003|Overall Study|Participant in another sponsor study.|1|||
144722271|NCT03312530|521838653|FG004|Overall Study|Participant in another sponsor study.|0|||
144722272|NCT03312530|521838649|FG000|Overall Study|Study terminated by sponsor|1|||
144722273|NCT03312530|521838650|FG001|Overall Study|Study terminated by sponsor|0|||
144722274|NCT03312530|521838651|FG002|Overall Study|Study terminated by sponsor|2|||
144722275|NCT03312530|521838652|FG003|Overall Study|Study terminated by sponsor|3|||
144722276|NCT03312530|521838653|FG004|Overall Study|Study terminated by sponsor|7|||
144722277|NCT03312530|521838649|FG000|Overall Study|Withdrawal by Subject|0|||
144722278|NCT03312530|521838650|FG001|Overall Study|Withdrawal by Subject|1|||
144722279|NCT03312530|521838651|FG002|Overall Study|Withdrawal by Subject|0|||
144722280|NCT03312530|521838652|FG003|Overall Study|Withdrawal by Subject|0|||
144722281|NCT03312530|521838653|FG004|Overall Study|Withdrawal by Subject|0|||
144722282|NCT03312530|521838649|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
144722283|NCT03312530|521838650|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
144722284|NCT03312530|521838651|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
144722285|NCT03312530|521838652|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
144722286|NCT03312530|521838653|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
144722287|NCT03093324|521838655|FG000|Overall Study|Adverse Event|4|||
144722288|NCT03093324|521838656|FG001|Overall Study|Adverse Event|15|||
144722289|NCT03093324|521838655|FG000|Overall Study|Lost to Follow-up|1|||
144722290|NCT03093324|521838656|FG001|Overall Study|Lost to Follow-up|0|||
144722291|NCT03093324|521838655|FG000|Overall Study|Protocol Deviation|2|||
144520388|NCT03924986|521106332|FG000|Overall Study|Study Concluded by Sponsor|51|||
144520389|NCT03924986|521106333|FG001|Overall Study|Study Concluded by Sponsor|41|||
144520390|NCT03924986|521106332|FG000|Overall Study|Withdrawal by Subject|15|||
144520391|NCT03924986|521106333|FG001|Overall Study|Withdrawal by Subject|20|||
144520392|NCT03924986|521106332|FG000|Overall Study|Lost to Follow-up|7|||
144520393|NCT03924986|521106333|FG001|Overall Study|Lost to Follow-up|5|||
144520394|NCT03924986|521106332|FG000|Overall Study|Miscellaneous|1|||
144520395|NCT03924986|521106333|FG001|Overall Study|Miscellaneous|0|||
144520396|NCT02689284|521106339|FG000|Overall Study|Adverse Event|1|||
144520397|NCT02689284|521106340|FG001|Overall Study|Adverse Event|8|||
144520398|NCT02689284|521106339|FG000|Overall Study|Death|0|||
144520399|NCT02689284|521106340|FG001|Overall Study|Death|1|||
144520400|NCT02689284|521106339|FG000|Overall Study|Physician Decision|1|||
144520401|NCT02689284|521106340|FG001|Overall Study|Physician Decision|2|||
144520402|NCT02689284|521106339|FG000|Overall Study|Withdrawal by Subject|0|||
144520403|NCT02689284|521106340|FG001|Overall Study|Withdrawal by Subject|1|||
144520404|NCT02689284|521106339|FG000|Overall Study|progression of cancer|1|||
144595255|NCT00712673|521379345|FG003|Overall Study|Lost to Follow-up|0|||
144595256|NCT00712673|521379342|FG000|Overall Study|Withdrawal by Subject|6|||
144595257|NCT00712673|521379343|FG001|Overall Study|Withdrawal by Subject|7|||
144595258|NCT00712673|521379344|FG002|Overall Study|Withdrawal by Subject|15|||
144595259|NCT00712673|521379345|FG003|Overall Study|Withdrawal by Subject|20|||
144595260|NCT00712673|521379342|FG000|Overall Study|Familial and Personal Reasons|5|||
144595261|NCT00712673|521379343|FG001|Overall Study|Familial and Personal Reasons|0|||
144595262|NCT00712673|521379344|FG002|Overall Study|Familial and Personal Reasons|5|||
144595263|NCT00712673|521379345|FG003|Overall Study|Familial and Personal Reasons|2|||
144595264|NCT00712673|521379342|FG000|Overall Study|Investigator's Decision|1|||
144595265|NCT00712673|521379343|FG001|Overall Study|Investigator's Decision|0|||
144595266|NCT00712673|521379344|FG002|Overall Study|Investigator's Decision|0|||
144595267|NCT00712673|521379345|FG003|Overall Study|Investigator's Decision|0|||
144595268|NCT00712673|521379342|FG000|Overall Study|Protocol Violation|0|||
144595269|NCT00712673|521379343|FG001|Overall Study|Protocol Violation|0|||
144595270|NCT00712673|521379344|FG002|Overall Study|Protocol Violation|2|||
144595271|NCT00712673|521379345|FG003|Overall Study|Protocol Violation|0|||
144595272|NCT03603028|521379346|FG000|Overall Study|Withdrawal by Subject|1|||
144595273|NCT02963610|521379349|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
144595274|NCT01122862|521379350|FG000|Period 1|Protocol Violation|0|||
144520405|NCT02689284|521106340|FG001|Overall Study|progression of cancer|72|||
144595275|NCT01122862|521379351|FG001|Period 1|Protocol Violation|1|||
144595276|NCT01122862|521379352|FG002|Period 1|Protocol Violation|0|||
144722292|NCT03093324|521838656|FG001|Overall Study|Protocol Deviation|2|||
144722293|NCT03093324|521838655|FG000|Overall Study|Withdrawal by Subject|2|||
144722294|NCT03093324|521838656|FG001|Overall Study|Withdrawal by Subject|2|||
144249615|NCT00568334|520111699|FG001|Overall Study|Withdrawal by Subject|1|||
144396212|NCT01015131|520661733|FG000|Overall Study|Other Protocol Specified Criteria|4|||
144396213|NCT05521906|520661734|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
144396214|NCT05521906|520661735|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
144396215|NCT03148275|520661736|FG000|Overall Study|Death|6|||
144396216|NCT03148275|520661736|FG000|Overall Study|Adverse Event|3|||
144396217|NCT03148275|520661736|FG000|Overall Study|Liver transplant|2|||
144396218|NCT03148275|520661736|FG000|Overall Study|Patient decision|5|||
144396219|NCT03148275|520661736|FG000|Overall Study|transition to commercial drug|1|||
144396220|NCT03148275|520661736|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
144396221|NCT05098938|520661737|FG000|Overall Study|Adverse Event|4|||
144396222|NCT05098938|520661738|FG001|Overall Study|Adverse Event|3|||
144396223|NCT05098938|520661737|FG000|Overall Study|inclusion/exclusion criteria change|11|||
144396224|NCT05098938|520661738|FG001|Overall Study|inclusion/exclusion criteria change|5|||
144396225|NCT05098938|520661737|FG000|Overall Study|lack of compliance|26|||
144396226|NCT05098938|520661738|FG001|Overall Study|lack of compliance|19|||
144396227|NCT05098938|520661737|FG000|Overall Study|Lost to Follow-up|37|||
144396228|NCT05098938|520661738|FG001|Overall Study|Lost to Follow-up|40|||
144396229|NCT05098938|520661737|FG000|Overall Study|Lost in treatment period|17|||
144396230|NCT05098938|520661738|FG001|Overall Study|Lost in treatment period|13|||
144396231|NCT05098938|520661737|FG000|Overall Study|Met an exclusion criterion|0|||
144396232|NCT05098938|520661738|FG001|Overall Study|Met an exclusion criterion|3|||
144396233|NCT05098938|520661737|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
144396234|NCT05098938|520661738|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
144396235|NCT05098938|520661737|FG000|Overall Study|Physician Decision|25|||
144396236|NCT05098938|520661738|FG001|Overall Study|Physician Decision|32|||
144396237|NCT05098938|520661737|FG000|Overall Study|Run in failure in treatment phase|1|||
144520406|NCT02689284|521106339|FG000|Overall Study|decreased heart function|0|||
144520407|NCT02689284|521106340|FG001|Overall Study|decreased heart function|1|||
144520408|NCT02689284|521106339|FG000|Overall Study|concern for anemia|0|||
144520409|NCT02689284|521106340|FG001|Overall Study|concern for anemia|1|||
144520410|NCT02689284|521106339|FG000|Overall Study|no measurable cancer for evaluation|0|||
144520411|NCT02689284|521106340|FG001|Overall Study|no measurable cancer for evaluation|1|||
144520412|NCT05268393|521106344|FG000|Overall Study|Withdrawal by Subject|2|||
144520413|NCT05268393|521106345|FG001|Overall Study|Withdrawal by Subject|1|||
144520414|NCT03396926|521106347|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
144520415|NCT03396926|521106348|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
144520416|NCT00450658|521106350|FG000|Overall Study|Adverse Event|24|||
144520417|NCT00450658|521106351|FG001|Overall Study|Adverse Event|15|||
144520418|NCT00450658|521106350|FG000|Overall Study|Withdrawal by Subject|43|||
144520419|NCT00450658|521106351|FG001|Overall Study|Withdrawal by Subject|26|||
144520420|NCT00450658|521106350|FG000|Overall Study|Lost to Follow-up|22|||
144520421|NCT00450658|521106351|FG001|Overall Study|Lost to Follow-up|5|||
144520422|NCT00450658|521106350|FG000|Overall Study|UGI ulcer|33|||
144520423|NCT00450658|521106351|FG001|Overall Study|UGI ulcer|34|||
144520424|NCT00450658|521106350|FG000|Overall Study|misc|21|||
144520425|NCT00450658|521106351|FG001|Overall Study|misc|10|||
144520426|NCT04727554|521106352|FG000|Overall Study|Lost to Follow-up|0|||
144520427|NCT04727554|521106353|FG001|Overall Study|Lost to Follow-up|1|||
144520428|NCT04727554|521106352|FG000|Overall Study|Death|2|||
144520429|NCT04727554|521106353|FG001|Overall Study|Death|6|||
144520430|NCT04727554|521106352|FG000|Overall Study|Withdrawal by Subject|1|||
144520431|NCT04727554|521106353|FG001|Overall Study|Withdrawal by Subject|0|||
144520432|NCT05763823|521106354|FG000|Overall Study|Death|6|||
144520433|NCT05763823|521106354|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144520434|NCT05763823|521106354|FG000|Overall Study|Withdrawal by Subject|6|||
144520435|NCT01997840|521106358|FG000|Overall Study|Lost to Follow-up|0|||
144520436|NCT01997840|521106359|FG001|Overall Study|Lost to Follow-up|0|||
144249616|NCT00568334|520111698|FG000|Overall Study|Lost to Follow-up|1|||
144396238|NCT05098938|520661738|FG001|Overall Study|Run in failure in treatment phase|1|||
144396239|NCT05098938|520661737|FG000|Overall Study|Withdrawal by Subject|0|||
144396240|NCT05098938|520661738|FG001|Overall Study|Withdrawal by Subject|3|||
144396241|NCT05098938|520661737|FG000|Overall Study|Run-in Failure in early study|505|||
144396242|NCT05098938|520661738|FG001|Overall Study|Run-in Failure in early study|514|||
144520437|NCT01997840|521106360|FG002|Overall Study|Lost to Follow-up|1|||
144520438|NCT01997840|521106361|FG003|Overall Study|Lost to Follow-up|0|||
144520439|NCT01997840|521106358|FG000|Overall Study|Withdrawal by participant|0|||
144520440|NCT01997840|521106359|FG001|Overall Study|Withdrawal by participant|0|||
144520441|NCT01997840|521106360|FG002|Overall Study|Withdrawal by participant|8|||
144520442|NCT01997840|521106361|FG003|Overall Study|Withdrawal by participant|1|||
144249617|NCT00568334|520111699|FG001|Overall Study|Lost to Follow-up|0|||
144396243|NCT05098938|520661737|FG000|Overall Study|IMP delivery missed|1|||
144396244|NCT05098938|520661738|FG001|Overall Study|IMP delivery missed|5|||
144396245|NCT05098938|520661737|FG000|Overall Study|6 months visit was missed|2|||
144396246|NCT05098938|520661738|FG001|Overall Study|6 months visit was missed|0|||
144396247|NCT05098938|520661737|FG000|Overall Study|fit for use was not completed within window|3|||
144396248|NCT05098938|520661738|FG001|Overall Study|fit for use was not completed within window|0|||
144396249|NCT05098938|520661737|FG000|Overall Study|V2 visit was not completed within window|0|||
144396250|NCT05098938|520661738|FG001|Overall Study|V2 visit was not completed within window|1|||
144249618|NCT01897571|520111700|FG000|Overall Study|Lost to Follow-up|3|||
144249619|NCT01897571|520111701|FG001|Overall Study|Lost to Follow-up|0|||
144249620|NCT01897571|520111702|FG002|Overall Study|Lost to Follow-up|0|||
144249621|NCT01897571|520111703|FG003|Overall Study|Lost to Follow-up|0|||
144396251|NCT05098938|520661737|FG000|Overall Study|exclusionary medication use|1|||
144396252|NCT05098938|520661738|FG001|Overall Study|exclusionary medication use|2|||
144396253|NCT05098938|520661737|FG000|Overall Study|change in medication|1|||
144396254|NCT05098938|520661738|FG001|Overall Study|change in medication|0|||
144396255|NCT05098938|520661737|FG000|Overall Study|treatment failure|2|||
144396256|NCT05098938|520661738|FG001|Overall Study|treatment failure|1|||
144396257|NCT03803683|520661739|FG000|Overall Study|Lost to Follow-up|41|||
144396258|NCT03803683|520661740|FG001|Overall Study|Lost to Follow-up|18|||
144396259|NCT03803683|520661741|FG002|Overall Study|Lost to Follow-up|12|||
144396260|NCT03803683|520661739|FG000|Overall Study|Withdrawal by Subject|9|||
144396261|NCT03803683|520661740|FG001|Overall Study|Withdrawal by Subject|1|||
144396262|NCT03803683|520661741|FG002|Overall Study|Withdrawal by Subject|4|||
144396263|NCT00492050|520661742|FG000|Overall Study|Adverse Event|1|||
144396264|NCT00492050|520661742|FG000|Overall Study|Lack of Efficacy|1|||
144396265|NCT00492050|520661742|FG000|Overall Study|Withdrawal by Subject|3|||
144520443|NCT01997840|521106358|FG000|Overall Study|Physician Decision|0|||
144520444|NCT01997840|521106359|FG001|Overall Study|Physician Decision|0|||
144520445|NCT01997840|521106360|FG002|Overall Study|Physician Decision|3|||
144520446|NCT01997840|521106361|FG003|Overall Study|Physician Decision|0|||
144520447|NCT01997840|521106358|FG000|Overall Study|Progressive disease|3|||
144520448|NCT01997840|521106359|FG001|Overall Study|Progressive disease|4|||
144520449|NCT01997840|521106360|FG002|Overall Study|Progressive disease|57|||
144520450|NCT01997840|521106361|FG003|Overall Study|Progressive disease|8|||
144520451|NCT01997840|521106358|FG000|Overall Study|Other reasons|0|||
144520452|NCT01997840|521106359|FG001|Overall Study|Other reasons|0|||
144520453|NCT01997840|521106360|FG002|Overall Study|Other reasons|1|||
144520454|NCT01997840|521106361|FG003|Overall Study|Other reasons|0|||
144520455|NCT01997840|521106358|FG000|Overall Study|Adverse Event|0|||
144520456|NCT01997840|521106359|FG001|Overall Study|Adverse Event|0|||
144520457|NCT01997840|521106360|FG002|Overall Study|Adverse Event|15|||
144520458|NCT01997840|521106361|FG003|Overall Study|Adverse Event|2|||
144520459|NCT05256706|521106362|FG000|Overall Study|Lost to Follow-up|9|||
144520460|NCT05256706|521106363|FG001|Overall Study|Lost to Follow-up|3|||
144520461|NCT05256706|521106362|FG000|Overall Study|Withdrawal by Subject|7|||
144520462|NCT05256706|521106363|FG001|Overall Study|Withdrawal by Subject|11|||
144520463|NCT05256706|521106362|FG000|Overall Study|Screen Failures|3|||
144520464|NCT05256706|521106363|FG001|Overall Study|Screen Failures|0|||
144520465|NCT03850678|521106368|FG000|Overall Study|Withdrawal by Subject|3|||
144520466|NCT03850678|521106369|FG001|Overall Study|Withdrawal by Subject|0|||
144520467|NCT03850678|521106368|FG000|Overall Study|Experimenter Error|1|||
144520468|NCT03850678|521106369|FG001|Overall Study|Experimenter Error|1|||
144520469|NCT03850678|521106368|FG000|Overall Study|Did Not Condition To Experiment|7|||
144520470|NCT03850678|521106369|FG001|Overall Study|Did Not Condition To Experiment|2|||
144595277|NCT01122862|521379350|FG000|Period 2|Adverse Event|0|||
144396266|NCT00492050|520661742|FG000|Overall Study|Unable to collect SCT|2|||
144520471|NCT03720795|521106370|FG000|Phase 1|Lost to Follow-up|4|||
144520472|NCT03720795|521106370|FG000|Phase 1|Withdrawal by Subject|6|||
144520473|NCT03720795|521106370|FG000|Phase 1|Protocol Violation|1|||
144520474|NCT03720795|521106370|FG000|Phase 1|Other|1|||
144520475|NCT03720795|521106370|FG000|Phase 2|Lost to Follow-up|5|||
144520476|NCT03720795|521106370|FG000|Phase 2|Withdrawal by Subject|10|||
144520477|NCT03720795|521106370|FG000|Phase 2|Protocol Violation|2|||
144520478|NCT03720795|521106370|FG000|3 Month Follow Up|Lost to Follow-up|2|||
144520479|NCT05311384|521106374|FG000|Overall Study|Uncontrolled health conditions|2|||
144520480|NCT05311384|521106374|FG000|Overall Study|Withdrawal by Subject|1|||
144520481|NCT04322643|521106375|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
144520482|NCT03302494|521106376|FG000|Overall Study|Other|7|||
144520483|NCT03302494|521106377|FG001|Overall Study|Other|4|||
144595278|NCT01122862|521379351|FG001|Period 2|Adverse Event|0|||
144520484|NCT03302494|521106378|FG002|Overall Study|Other|6|||
144520485|NCT03302494|521106376|FG000|Overall Study|Withdrawal by Subject|10|||
144520486|NCT03302494|521106377|FG001|Overall Study|Withdrawal by Subject|2|||
144520487|NCT03302494|521106378|FG002|Overall Study|Withdrawal by Subject|9|||
144520488|NCT03302494|521106376|FG000|Overall Study|Study Terminated by Sponsor|32|||
144249622|NCT01897571|520111704|FG004|Overall Study|Lost to Follow-up|2|||
144396267|NCT00492050|520661742|FG000|Overall Study|Progressive Disease|2|||
144396268|NCT00810108|520662854|FG000|Overall Study|Withdrawal by Subject|1|||
144396269|NCT00810108|520662855|FG001|Overall Study|Withdrawal by Subject|0|||
144396270|NCT02600351|520662857|FG000|Overall Study|Lack of Efficacy|3|||
144520489|NCT03302494|521106377|FG001|Overall Study|Study Terminated by Sponsor|29|||
144396271|NCT02600351|520662858|FG001|Overall Study|Lack of Efficacy|0|||
144396272|NCT02600351|520662859|FG002|Overall Study|Lack of Efficacy|5|||
144396273|NCT02600351|520662860|FG003|Overall Study|Lack of Efficacy|2|||
144396274|NCT02600351|520662857|FG000|Overall Study|Lost to Follow-up|1|||
144396275|NCT02600351|520662858|FG001|Overall Study|Lost to Follow-up|0|||
144396276|NCT02600351|520662859|FG002|Overall Study|Lost to Follow-up|0|||
144396277|NCT02600351|520662860|FG003|Overall Study|Lost to Follow-up|0|||
144396278|NCT02600351|520662857|FG000|Overall Study|Randomized but Not Treated|1|||
144396279|NCT02600351|520662858|FG001|Overall Study|Randomized but Not Treated|0|||
144396280|NCT02600351|520662859|FG002|Overall Study|Randomized but Not Treated|1|||
144396281|NCT02600351|520662860|FG003|Overall Study|Randomized but Not Treated|3|||
144396282|NCT02063880|520662861|FG000|Overall Study|Death|21|||
144396283|NCT02063880|520662862|FG001|Overall Study|Death|18|||
144396284|NCT02063880|520662861|FG000|Overall Study|Lost to Follow-up|7|||
144396285|NCT02063880|520662862|FG001|Overall Study|Lost to Follow-up|7|||
144396286|NCT02063880|520662861|FG000|Overall Study|Ineligible|0|||
144396287|NCT02063880|520662862|FG001|Overall Study|Ineligible|2|||
144396288|NCT03875768|520662865|FG000|Overall Study|Lost to Follow-up|16|||
144396289|NCT03875768|520662866|FG001|Overall Study|Lost to Follow-up|13|||
144396290|NCT03875768|520662865|FG000|Overall Study|Withdrawal by Subject|10|||
144396291|NCT03875768|520662866|FG001|Overall Study|Withdrawal by Subject|21|||
144396292|NCT03875768|520662865|FG000|Overall Study|Did not complete assessment|21|||
144396293|NCT03875768|520662866|FG001|Overall Study|Did not complete assessment|12|||
144396294|NCT03875768|520662865|FG000|Overall Study|Became ineligible|1|||
144396295|NCT03875768|520662866|FG001|Overall Study|Became ineligible|0|||
144396296|NCT01925274|520662867|FG000|Overall Study|Death|1|||
144396297|NCT01925274|520662868|FG001|Overall Study|Death|0|||
144396298|NCT01925274|520662869|FG002|Overall Study|Death|0|||
144396299|NCT01925274|520662867|FG000|Overall Study|Lost to Follow-up|0|||
144396300|NCT01925274|520662868|FG001|Overall Study|Lost to Follow-up|1|||
144520490|NCT03302494|521106378|FG002|Overall Study|Study Terminated by Sponsor|30|||
144520491|NCT03302494|521106376|FG000|Overall Study|Physician Decision|1|||
144520492|NCT03302494|521106377|FG001|Overall Study|Physician Decision|0|||
144520493|NCT03302494|521106378|FG002|Overall Study|Physician Decision|1|||
144520494|NCT03302494|521106376|FG000|Overall Study|Lost to Follow-up|1|||
144520495|NCT03302494|521106377|FG001|Overall Study|Lost to Follow-up|3|||
144520496|NCT03302494|521106378|FG002|Overall Study|Lost to Follow-up|3|||
144520497|NCT03302494|521106376|FG000|Overall Study|Death|13|||
144520498|NCT03302494|521106377|FG001|Overall Study|Death|11|||
144520499|NCT03302494|521106378|FG002|Overall Study|Death|4|||
144520500|NCT03302494|521106376|FG000|Overall Study|Adverse Event|1|||
144520501|NCT03302494|521106377|FG001|Overall Study|Adverse Event|2|||
144520502|NCT03302494|521106378|FG002|Overall Study|Adverse Event|0|||
144520503|NCT03302494|521106376|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
144520504|NCT03302494|521106377|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
144722295|NCT02688400|521838662|FG000|Overall Study|Protocol Violation|2|||
144396301|NCT01925274|520662869|FG002|Overall Study|Lost to Follow-up|0|||
144396302|NCT01925274|520662867|FG000|Overall Study|Withdrawal by Subject|1|||
144396303|NCT01925274|520662868|FG001|Overall Study|Withdrawal by Subject|2|||
144396304|NCT01925274|520662869|FG002|Overall Study|Withdrawal by Subject|0|||
144520505|NCT03302494|521106378|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
144520506|NCT01573442|521106379|FG000|Overall Study|Cancels|9|||
144520507|NCT01573442|521106380|FG001|Overall Study|Cancels|10|||
144520508|NCT05710107|521106384|FG000|Overall Study|Withdrawal by Subject|1|||
144520509|NCT05710107|521106385|FG001|Overall Study|Withdrawal by Subject|1|||
144520510|NCT05710107|521106384|FG000|Overall Study|Lost to Follow-up|8|||
144520511|NCT05710107|521106385|FG001|Overall Study|Lost to Follow-up|9|||
144396305|NCT01925274|520662867|FG000|Overall Study|Study terminated by sponsor|4|||
144396306|NCT01925274|520662868|FG001|Overall Study|Study terminated by sponsor|0|||
144520512|NCT05710107|521106384|FG000|Overall Study|Unable to place assigned block|2|||
144520513|NCT05710107|521106385|FG001|Overall Study|Unable to place assigned block|0|||
144520514|NCT05710107|521106384|FG000|Overall Study|Withdrawn by study team|0|||
144520515|NCT05710107|521106385|FG001|Overall Study|Withdrawn by study team|1|||
144520516|NCT04166773|521106386|FG000|Overall Study|Adverse Event|2|||
144520517|NCT04166773|521106387|FG001|Overall Study|Adverse Event|0|||
144396307|NCT01925274|520662869|FG002|Overall Study|Study terminated by sponsor|0|||
144396308|NCT01925274|520662867|FG000|Overall Study|Protocol amendment|1|||
144396309|NCT01925274|520662868|FG001|Overall Study|Protocol amendment|3|||
144396310|NCT01925274|520662869|FG002|Overall Study|Protocol amendment|6|||
144396311|NCT04327674|520662870|FG000|Overall Study|Protocol Violation|19|||
144396312|NCT00437320|520662875|FG000|Overall Study|Participant request|2|||
144396313|NCT00437320|520662876|FG001|Overall Study|Participant request|1|||
144396314|NCT00437320|520662877|FG002|Overall Study|Participant request|4|||
144520518|NCT04166773|521106388|FG002|Overall Study|Adverse Event|2|||
144520519|NCT04166773|521106389|FG003|Overall Study|Adverse Event|1|||
144520520|NCT04166773|521106386|FG000|Overall Study|Lost to Follow-up|4|||
144520521|NCT04166773|521106387|FG001|Overall Study|Lost to Follow-up|2|||
144520522|NCT04166773|521106388|FG002|Overall Study|Lost to Follow-up|1|||
144520523|NCT04166773|521106389|FG003|Overall Study|Lost to Follow-up|3|||
144520524|NCT04166773|521106386|FG000|Overall Study|Physician Decision|0|||
144520525|NCT04166773|521106387|FG001|Overall Study|Physician Decision|0|||
144520526|NCT04166773|521106388|FG002|Overall Study|Physician Decision|0|||
144520527|NCT04166773|521106389|FG003|Overall Study|Physician Decision|1|||
144520528|NCT04166773|521106386|FG000|Overall Study|Withdrawal by Subject|1|||
144520529|NCT04166773|521106387|FG001|Overall Study|Withdrawal by Subject|1|||
144520530|NCT04166773|521106388|FG002|Overall Study|Withdrawal by Subject|2|||
144520531|NCT04166773|521106389|FG003|Overall Study|Withdrawal by Subject|5|||
144520532|NCT04763265|521106393|FG000|Overall Study|Adverse Event|1|||
144520533|NCT04763265|521106394|FG001|Overall Study|Adverse Event|0|||
144520534|NCT04763265|521106393|FG000|Overall Study|Lost to Follow-up|2|||
144520535|NCT04763265|521106394|FG001|Overall Study|Lost to Follow-up|4|||
144520536|NCT04763265|521106393|FG000|Overall Study|Withdrawal by Subject|0|||
144520537|NCT04763265|521106394|FG001|Overall Study|Withdrawal by Subject|1|||
144520538|NCT03197662|521106398|FG000|Overall Study|Withdrawn by family|0|||
144520539|NCT03197662|521106399|FG001|Overall Study|Withdrawn by family|2|||
144520540|NCT01214616|521106400|FG000|Overall Study|Progressive disease|2|||
144520541|NCT01214616|521106401|FG001|Overall Study|Progressive disease|2|||
144520542|NCT01214616|521106402|FG002|Overall Study|Progressive disease|2|||
144520543|NCT01214616|521106403|FG003|Overall Study|Progressive disease|4|||
144520544|NCT01214616|521106400|FG000|Overall Study|Dose limiting toxicity|0|||
144520545|NCT01214616|521106401|FG001|Overall Study|Dose limiting toxicity|2|||
144520546|NCT01214616|521106402|FG002|Overall Study|Dose limiting toxicity|0|||
144520547|NCT01214616|521106403|FG003|Overall Study|Dose limiting toxicity|0|||
144249623|NCT01897571|520111705|FG005|Overall Study|Lost to Follow-up|0|||
144249624|NCT01897571|520111706|FG006|Overall Study|Lost to Follow-up|0|||
144520548|NCT01214616|521106400|FG000|Overall Study|Other adverse events|0|||
144520549|NCT01214616|521106401|FG001|Overall Study|Other adverse events|1|||
144520550|NCT01214616|521106402|FG002|Overall Study|Other adverse events|1|||
144520551|NCT01214616|521106403|FG003|Overall Study|Other adverse events|1|||
144520552|NCT01214616|521106400|FG000|Overall Study|Withdrawal by Subject|1|||
144520553|NCT01214616|521106401|FG001|Overall Study|Withdrawal by Subject|0|||
144396315|NCT01400815|520662879|FG000|Overall Study|Adverse Event|3|||
144396316|NCT01400815|520662880|FG001|Overall Study|Adverse Event|0|||
144396317|NCT01400815|520662879|FG000|Overall Study|Death|0|||
144396318|NCT01400815|520662880|FG001|Overall Study|Death|1|||
144396319|NCT01400815|520662879|FG000|Overall Study|Lost to Follow-up|18|||
144396320|NCT01400815|520662880|FG001|Overall Study|Lost to Follow-up|11|||
144396321|NCT01400815|520662879|FG000|Overall Study|Protocol Violation|0|||
144396322|NCT01400815|520662880|FG001|Overall Study|Protocol Violation|1|||
144396323|NCT01400815|520662879|FG000|Overall Study|Physician Decision|1|||
144396324|NCT01400815|520662880|FG001|Overall Study|Physician Decision|0|||
144396325|NCT01400815|520662879|FG000|Overall Study|Withdrawal by Subject|15|||
144396326|NCT01400815|520662880|FG001|Overall Study|Withdrawal by Subject|8|||
144396327|NCT01400815|520662879|FG000|Overall Study|Subject in jail|1|||
144396328|NCT01400815|520662880|FG001|Overall Study|Subject in jail|0|||
144396329|NCT01123850|520662881|FG000|Overall Study|Slow enrollment|45|||
144396330|NCT00470847|520662884|FG000|Overall Study|Pt still receiving treatment|1|||
144396331|NCT00381381|520662885|FG000|Overall Study|Adverse Event|3|||
144520554|NCT01214616|521106402|FG002|Overall Study|Withdrawal by Subject|0|||
144520555|NCT01214616|521106403|FG003|Overall Study|Withdrawal by Subject|1|||
144520556|NCT05687916|521108017|FG000|Overall Study|Adverse Event|1|||
144520557|NCT05687916|521108018|FG001|Overall Study|Adverse Event|2|||
144520558|NCT05687916|521108019|FG002|Overall Study|Adverse Event|0|||
144520559|NCT05687916|521108017|FG000|Overall Study|Withdrawal by Subject|1|||
144520560|NCT05687916|521108018|FG001|Overall Study|Withdrawal by Subject|0|||
144520561|NCT05687916|521108019|FG002|Overall Study|Withdrawal by Subject|1|||
144520562|NCT05687916|521108017|FG000|Overall Study|Protocol Violation|0|||
144520563|NCT05687916|521108018|FG001|Overall Study|Protocol Violation|2|||
144520564|NCT05687916|521108019|FG002|Overall Study|Protocol Violation|1|||
144520565|NCT05687916|521108017|FG000|Overall Study|Reason not Specified|1|||
144520566|NCT05687916|521108018|FG001|Overall Study|Reason not Specified|0|||
144520567|NCT05687916|521108019|FG002|Overall Study|Reason not Specified|0|||
144520568|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
144520569|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
144520570|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
144520571|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520572|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520573|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520574|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520575|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520576|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520577|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520578|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520579|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520580|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
144520581|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
144520582|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
144520583|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520584|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520585|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520586|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520587|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520588|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520589|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144396332|NCT00381381|520662885|FG000|Overall Study|Lost to Follow-up|52|||
144520590|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520591|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520592|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520593|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
144520594|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
144520595|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
144520596|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520597|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520598|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520599|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520600|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520601|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144396333|NCT00381381|520662885|FG000|Overall Study|Withdrawal by Subject|9|||
144396334|NCT00568685|520662888|FG000|Overall Study|Adverse Event|2|||
144396335|NCT00568685|520662889|FG001|Overall Study|Adverse Event|3|||
144396336|NCT00568685|520662890|FG002|Overall Study|Adverse Event|3|||
144595279|NCT01122862|521379352|FG002|Period 2|Adverse Event|1|||
144595280|NCT00846391|521379354|FG000|Overall Study|Physician Decision|0|||
144595281|NCT00846391|521379355|FG001|Overall Study|Physician Decision|0|||
144595282|NCT00846391|521379356|FG002|Overall Study|Physician Decision|1|||
144595283|NCT00846391|521379354|FG000|Overall Study|Study Terminated by Sponsor|1|||
144595284|NCT00846391|521379355|FG001|Overall Study|Study Terminated by Sponsor|2|||
144595285|NCT00846391|521379356|FG002|Overall Study|Study Terminated by Sponsor|2|||
144595286|NCT02924064|521379357|FG000|Overall Study|Adverse Event|2|||
144595287|NCT02924064|521379358|FG001|Overall Study|Adverse Event|2|||
144595288|NCT02924064|521379357|FG000|Overall Study|Lost to Follow-up|0|||
144595289|NCT02924064|521379358|FG001|Overall Study|Lost to Follow-up|2|||
144595290|NCT02924064|521379357|FG000|Overall Study|Physician Decision|0|||
144595291|NCT02924064|521379358|FG001|Overall Study|Physician Decision|2|||
144595292|NCT02924064|521379357|FG000|Overall Study|Protocol Violation|1|||
144595293|NCT02924064|521379358|FG001|Overall Study|Protocol Violation|3|||
144595294|NCT02924064|521379357|FG000|Overall Study|Withdrawal by Subject|4|||
144595295|NCT02924064|521379358|FG001|Overall Study|Withdrawal by Subject|5|||
144595296|NCT02924064|521379357|FG000|Overall Study|Other|17|||
144595297|NCT02924064|521379358|FG001|Overall Study|Other|29|||
144595298|NCT03575143|521379359|FG000|Overall Study|Lost to Follow-up|0|||
144595299|NCT03575143|521379360|FG001|Overall Study|Lost to Follow-up|0|||
144595300|NCT03575143|521379361|FG002|Overall Study|Lost to Follow-up|4|||
144249625|NCT01897571|520111707|FG007|Overall Study|Lost to Follow-up|0|||
144595301|NCT03575143|521379359|FG000|Overall Study|Withdrawal by Subject|0|||
144595302|NCT03575143|521379360|FG001|Overall Study|Withdrawal by Subject|0|||
144595303|NCT03575143|521379361|FG002|Overall Study|Withdrawal by Subject|5|||
144249626|NCT01897571|520111708|FG008|Overall Study|Lost to Follow-up|1|||
144595304|NCT03575143|521379359|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
144396337|NCT00568685|520662888|FG000|Overall Study|Withdrawal by Subject|7|||
144396338|NCT00568685|520662889|FG001|Overall Study|Withdrawal by Subject|2|||
144396339|NCT00568685|520662890|FG002|Overall Study|Withdrawal by Subject|2|||
144396340|NCT00568685|520662888|FG000|Overall Study|Protocol Violation|1|||
144396341|NCT00568685|520662889|FG001|Overall Study|Protocol Violation|0|||
144396342|NCT00568685|520662890|FG002|Overall Study|Protocol Violation|0|||
144396343|NCT01638819|520662892|FG000|Overall Study|Lost to Follow-up|1|||
144396344|NCT01638819|520662893|FG001|Overall Study|Lost to Follow-up|0|||
144396345|NCT00471146|520662896|FG000|Overall Study|Adverse Event|32|||
144396346|NCT00471146|520662897|FG001|Overall Study|Adverse Event|33|||
144396347|NCT00471146|520662896|FG000|Overall Study|Withdrawal by Subject|14|||
144396348|NCT00471146|520662897|FG001|Overall Study|Withdrawal by Subject|11|||
144396349|NCT00471146|520662896|FG000|Overall Study|Death|11|||
144396350|NCT00471146|520662897|FG001|Overall Study|Death|12|||
144396351|NCT00471146|520662896|FG000|Overall Study|Lost to Follow-up|4|||
144396352|NCT00471146|520662897|FG001|Overall Study|Lost to Follow-up|2|||
144396353|NCT00471146|520662896|FG000|Overall Study|Protocol Violation|2|||
144396354|NCT00471146|520662897|FG001|Overall Study|Protocol Violation|2|||
144396355|NCT00471146|520662896|FG000|Overall Study|Objective progression or relapse|84|||
144396356|NCT00471146|520662897|FG001|Overall Study|Objective progression or relapse|87|||
144396357|NCT00471146|520662896|FG000|Overall Study|Global deterioration of health status|12|||
144396358|NCT00471146|520662897|FG001|Overall Study|Global deterioration of health status|14|||
144396359|NCT00471146|520662896|FG000|Overall Study|Randomized but not treated|9|||
144396360|NCT00471146|520662897|FG001|Overall Study|Randomized but not treated|8|||
144396361|NCT00471146|520662896|FG000|Overall Study|Other|4|||
144396362|NCT00471146|520662897|FG001|Overall Study|Other|5|||
144396363|NCT03538431|520662898|FG000|Overall Study|Physician Decision|0|||
144396364|NCT03538431|520662899|FG001|Overall Study|Physician Decision|1|||
144396365|NCT03538431|520662898|FG000|Overall Study|Withdrawal by Subject|1|||
144396366|NCT03538431|520662899|FG001|Overall Study|Withdrawal by Subject|0|||
144396367|NCT00467610|520662902|FG000|Overall Study|Withdrawal by Subject|1|||
144396368|NCT02001181|520662905|FG000|Overall Study|Adverse Event|0|||
144396369|NCT02001181|520662906|FG001|Overall Study|Adverse Event|2|||
144396370|NCT02001181|520662905|FG000|Overall Study|Lost to Follow-up|1|||
144396371|NCT02001181|520662906|FG001|Overall Study|Lost to Follow-up|0|||
144396372|NCT02001181|520662905|FG000|Overall Study|Withdrawal by Subject|0|||
144396373|NCT02001181|520662906|FG001|Overall Study|Withdrawal by Subject|1|||
144396374|NCT01090973|520662907|FG000|Overall Study|Disease progression|1|||
144396375|NCT00445978|520662910|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
144595305|NCT03575143|521379360|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
144595306|NCT03575143|521379361|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
144595307|NCT01287065|521379362|FG000|Treatment Period 1|Adverse Event|0|||
144595308|NCT01287065|521379363|FG001|Treatment Period 1|Adverse Event|0|||
144595309|NCT01287065|521379364|FG002|Treatment Period 1|Adverse Event|0|||
144595310|NCT01287065|521379365|FG003|Treatment Period 1|Adverse Event|0|||
144595311|NCT01287065|521379366|FG004|Treatment Period 1|Adverse Event|1|||
144722296|NCT02688400|521838663|FG001|Overall Study|Protocol Violation|5|||
144722297|NCT02688400|521838662|FG000|Overall Study|Lack of Efficacy|7|||
144722298|NCT02688400|521838663|FG001|Overall Study|Lack of Efficacy|7|||
144722299|NCT02688400|521838662|FG000|Overall Study|Adverse Event|21|||
144722300|NCT02688400|521838663|FG001|Overall Study|Adverse Event|12|||
144722301|NCT02688400|521838662|FG000|Overall Study|Withdrawal by Subject|15|||
144722302|NCT02688400|521838663|FG001|Overall Study|Withdrawal by Subject|13|||
144722303|NCT02688400|521838662|FG000|Overall Study|No study medication intake|1|||
144722304|NCT02688400|521838663|FG001|Overall Study|No study medication intake|4|||
144722305|NCT02688400|521838662|FG000|Overall Study|Lost to Follow-up|0|||
144396376|NCT00445978|520662910|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
144396377|NCT00445978|520662910|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
144595312|NCT01287065|521379367|FG005|Treatment Period 1|Adverse Event|0|||
144595313|NCT01287065|521379362|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144396378|NCT00445978|520662910|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
144396379|NCT00445978|520662910|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
144722306|NCT02688400|521838663|FG001|Overall Study|Lost to Follow-up|3|||
144722307|NCT03731182|521838671|FG000|Overall Study|Lost to Follow-up|2|||
144396380|NCT00445978|520662910|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
144396381|NCT00445978|520662910|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
144396382|NCT00445978|520662910|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
144722308|NCT03731182|521838672|FG001|Overall Study|Lost to Follow-up|0|||
144396383|NCT00445978|520662910|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
144396384|NCT02979197|520662913|FG000|Overall Study|Adverse Event|4|||
144396385|NCT02979197|520662914|FG001|Overall Study|Adverse Event|2|||
144396386|NCT02979197|520662915|FG002|Overall Study|Adverse Event|0|||
144396387|NCT02979197|520662913|FG000|Overall Study|Protocol Violation|0|||
144396388|NCT02979197|520662914|FG001|Overall Study|Protocol Violation|1|||
144396389|NCT02979197|520662915|FG002|Overall Study|Protocol Violation|0|||
144722309|NCT03731182|521838671|FG000|Overall Study|Physician Decision|1|||
144722310|NCT03731182|521838672|FG001|Overall Study|Physician Decision|0|||
144396390|NCT02979197|520662913|FG000|Overall Study|Subject unable to commit to study dates|0|||
144396391|NCT02979197|520662914|FG001|Overall Study|Subject unable to commit to study dates|1|||
144396392|NCT02979197|520662915|FG002|Overall Study|Subject unable to commit to study dates|0|||
144396393|NCT03438383|520662916|FG000|Overall Study|Protocol Violation|9|||
144396394|NCT03438383|520662917|FG001|Overall Study|Protocol Violation|3|||
144396395|NCT02766465|520662918|FG000|Overall Study|Withdrawal by Subject|0|||
144396396|NCT02766465|520662919|FG001|Overall Study|Withdrawal by Subject|10|||
144396397|NCT01631812|520662920|FG000|Overall Study|Adverse Event|25|||
144396398|NCT01631812|520662920|FG000|Overall Study|Lack of Efficacy|5|||
144396399|NCT01631812|520662920|FG000|Overall Study|Withdrawal by Subject|4|||
144396400|NCT01631812|520662920|FG000|Overall Study|Physician Decision|3|||
144396401|NCT02435069|520662921|FG000|Dose Response - First Intervention|Adverse Event|0|||
144396402|NCT02435069|520662922|FG001|Dose Response - First Intervention|Adverse Event|1|||
144396403|NCT02435069|520662923|FG002|Dose Response - First Intervention|Adverse Event|1|||
144396404|NCT02435069|520662924|FG003|Dose Response - First Intervention|Adverse Event|0|||
144396405|NCT02435069|520662925|FG004|Dose Response - First Intervention|Adverse Event|0|||
144396406|NCT02435069|520662921|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
144396407|NCT02435069|520662922|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
144396408|NCT02435069|520662923|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
144396409|NCT02435069|520662924|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
144396410|NCT02435069|520662925|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
144396411|NCT03112590|520662926|FG000|Overall Study|Adverse Event|0|||
144396412|NCT03112590|520662927|FG001|Overall Study|Adverse Event|1|||
144520602|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520603|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144396413|NCT03112590|520662928|FG002|Overall Study|Adverse Event|0|||
144396414|NCT00843726|520662931|FG000|Overall Study|Death|1|||
144396415|NCT00843726|520662932|FG001|Overall Study|Death|0|||
144396416|NCT00843726|520662931|FG000|Overall Study|Withdrawal by Subject|0|||
144396417|NCT00843726|520662932|FG001|Overall Study|Withdrawal by Subject|1|||
144520604|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520605|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520606|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
144520607|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
144520608|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
144520609|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520610|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520611|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520612|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520613|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520614|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520615|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520616|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520617|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520618|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520619|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
144520620|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
144520621|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
144520622|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
144520623|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520624|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520625|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520626|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520627|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520628|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520629|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520630|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520631|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520632|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
144520633|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
144595314|NCT01287065|521379363|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144595315|NCT01287065|521379364|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144595316|NCT01287065|521379365|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144396418|NCT02520661|520662933|FG000|Overall Study|Lost to Follow-up|7|||
144396419|NCT02520661|520662934|FG001|Overall Study|Lost to Follow-up|3|||
144396420|NCT02520661|520662933|FG000|Overall Study|Admitted from ED|49|||
144396421|NCT02520661|520662934|FG001|Overall Study|Admitted from ED|48|||
144396422|NCT02520661|520662933|FG000|Overall Study|ED greater than 24 hours|29|||
144396423|NCT02520661|520662934|FG001|Overall Study|ED greater than 24 hours|38|||
144396424|NCT02520661|520662933|FG000|Overall Study|other ineligibility|14|||
144396425|NCT02520661|520662934|FG001|Overall Study|other ineligibility|22|||
144520634|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
144520635|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
144520636|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520637|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520638|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520639|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520640|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520641|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520642|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520643|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520644|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520645|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
144520646|NCT01261312|521108020|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
144520647|NCT01261312|521108021|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520648|NCT01261312|521108022|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
144520649|NCT01261312|521108023|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520650|NCT01261312|521108024|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520651|NCT01261312|521108025|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520652|NCT01261312|521108026|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520653|NCT01261312|521108027|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520654|NCT01261312|521108028|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520655|NCT01261312|521108029|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520656|NCT01261312|521108030|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520657|NCT01261312|521108031|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520658|NCT01261312|521108032|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
144520659|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520660|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520661|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520662|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
144520663|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
144520664|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
144520665|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520666|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520667|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520668|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520669|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520670|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520671|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
144520672|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520673|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520674|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520675|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520676|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
144520677|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
144595317|NCT01287065|521379366|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144595318|NCT01287065|521379367|FG005|Treatment Period 1|Withdrawal by Subject|1|||
144595319|NCT01259726|521379368|FG000|Overall Study|Death|1|||
144595320|NCT01259726|521379369|FG001|Overall Study|Death|0|||
144595321|NCT01259726|521379370|FG002|Overall Study|Death|0|||
144595322|NCT01259726|521379371|FG003|Overall Study|Death|0|||
144595323|NCT01259726|521379368|FG000|Overall Study|Physician Decision|2|||
144595324|NCT01259726|521379369|FG001|Overall Study|Physician Decision|0|||
144595325|NCT01259726|521379370|FG002|Overall Study|Physician Decision|1|||
144595326|NCT01259726|521379371|FG003|Overall Study|Physician Decision|1|||
144595327|NCT01259726|521379368|FG000|Overall Study|Withdrawal by Subject|1|||
144595328|NCT01259726|521379369|FG001|Overall Study|Withdrawal by Subject|3|||
144595329|NCT01259726|521379370|FG002|Overall Study|Withdrawal by Subject|2|||
144595330|NCT01259726|521379371|FG003|Overall Study|Withdrawal by Subject|1|||
144595331|NCT01259726|521379368|FG000|Overall Study|Lost to Follow-up|1|||
144595332|NCT01259726|521379369|FG001|Overall Study|Lost to Follow-up|1|||
144595333|NCT01259726|521379370|FG002|Overall Study|Lost to Follow-up|1|||
144595334|NCT01259726|521379371|FG003|Overall Study|Lost to Follow-up|3|||
144595335|NCT01009203|521379372|FG000|Overall Study|Withdrawal by Subject|1|||
144396426|NCT02520661|520662933|FG000|Overall Study|Withdrawal by Subject|7|||
144396427|NCT02520661|520662934|FG001|Overall Study|Withdrawal by Subject|16|||
144249627|NCT01897571|520111709|FG009|Overall Study|Lost to Follow-up|2|||
144396428|NCT00973349|520662937|FG000|Overall Study|Adverse Event|0|||
144396429|NCT00973349|520662938|FG001|Overall Study|Adverse Event|0|||
144396430|NCT00973349|520662939|FG002|Overall Study|Adverse Event|0|||
144396431|NCT00973349|520662940|FG003|Overall Study|Adverse Event|0|||
144396432|NCT00973349|520662941|FG004|Overall Study|Adverse Event|1|||
144396433|NCT00973349|520662942|FG005|Overall Study|Adverse Event|0|||
144396434|NCT00973349|520662943|FG006|Overall Study|Adverse Event|0|||
144396435|NCT00973349|520662944|FG007|Overall Study|Adverse Event|0|||
144396436|NCT00973349|520662945|FG008|Overall Study|Adverse Event|1|||
144396437|NCT00973349|520662946|FG009|Overall Study|Adverse Event|0|||
144396438|NCT00973349|520662947|FG010|Overall Study|Adverse Event|0|||
144396439|NCT00973349|520662948|FG011|Overall Study|Adverse Event|0|||
144396440|NCT00973349|520662949|FG012|Overall Study|Adverse Event|0|||
144396441|NCT00973349|520662950|FG013|Overall Study|Adverse Event|0|||
144396442|NCT00973349|520662951|FG014|Overall Study|Adverse Event|1|||
144396443|NCT00973349|520662952|FG015|Overall Study|Adverse Event|0|||
144396444|NCT00973349|520662937|FG000|Overall Study|Withdrawal by Subject|1|||
144396445|NCT00973349|520662938|FG001|Overall Study|Withdrawal by Subject|2|||
144396446|NCT00973349|520662939|FG002|Overall Study|Withdrawal by Subject|2|||
144396447|NCT00973349|520662940|FG003|Overall Study|Withdrawal by Subject|3|||
144396448|NCT00973349|520662941|FG004|Overall Study|Withdrawal by Subject|2|||
144396449|NCT00973349|520662942|FG005|Overall Study|Withdrawal by Subject|0|||
144396450|NCT00973349|520662943|FG006|Overall Study|Withdrawal by Subject|2|||
144396451|NCT00973349|520662944|FG007|Overall Study|Withdrawal by Subject|2|||
144396452|NCT00973349|520662945|FG008|Overall Study|Withdrawal by Subject|0|||
144396453|NCT00973349|520662946|FG009|Overall Study|Withdrawal by Subject|2|||
144396454|NCT00973349|520662947|FG010|Overall Study|Withdrawal by Subject|0|||
144396455|NCT00973349|520662948|FG011|Overall Study|Withdrawal by Subject|1|||
144396456|NCT00973349|520662949|FG012|Overall Study|Withdrawal by Subject|0|||
144396457|NCT00973349|520662950|FG013|Overall Study|Withdrawal by Subject|0|||
144396458|NCT00973349|520662951|FG014|Overall Study|Withdrawal by Subject|0|||
144396459|NCT00973349|520662952|FG015|Overall Study|Withdrawal by Subject|0|||
144396460|NCT00973349|520662937|FG000|Overall Study|Lost to Follow-up|3|||
144396461|NCT00973349|520662938|FG001|Overall Study|Lost to Follow-up|1|||
144396462|NCT00973349|520662939|FG002|Overall Study|Lost to Follow-up|2|||
144396463|NCT00973349|520662940|FG003|Overall Study|Lost to Follow-up|2|||
144396464|NCT00973349|520662941|FG004|Overall Study|Lost to Follow-up|1|||
144396465|NCT00973349|520662942|FG005|Overall Study|Lost to Follow-up|3|||
144396466|NCT00973349|520662943|FG006|Overall Study|Lost to Follow-up|0|||
144396467|NCT00973349|520662944|FG007|Overall Study|Lost to Follow-up|1|||
144396468|NCT00973349|520662945|FG008|Overall Study|Lost to Follow-up|2|||
144396469|NCT00973349|520662946|FG009|Overall Study|Lost to Follow-up|1|||
144396470|NCT00973349|520662947|FG010|Overall Study|Lost to Follow-up|0|||
144396471|NCT00973349|520662948|FG011|Overall Study|Lost to Follow-up|1|||
144396472|NCT00973349|520662949|FG012|Overall Study|Lost to Follow-up|0|||
144396473|NCT00973349|520662950|FG013|Overall Study|Lost to Follow-up|0|||
144396474|NCT00973349|520662951|FG014|Overall Study|Lost to Follow-up|0|||
144396475|NCT00973349|520662952|FG015|Overall Study|Lost to Follow-up|1|||
144396476|NCT00973349|520662937|FG000|Overall Study|Inappropriate enrolment|0|||
144396477|NCT00973349|520662938|FG001|Overall Study|Inappropriate enrolment|0|||
144396478|NCT00973349|520662939|FG002|Overall Study|Inappropriate enrolment|1|||
144396479|NCT00973349|520662940|FG003|Overall Study|Inappropriate enrolment|0|||
144396480|NCT00973349|520662941|FG004|Overall Study|Inappropriate enrolment|0|||
144396481|NCT00973349|520662942|FG005|Overall Study|Inappropriate enrolment|0|||
144396482|NCT00973349|520662943|FG006|Overall Study|Inappropriate enrolment|0|||
144396483|NCT00973349|520662944|FG007|Overall Study|Inappropriate enrolment|0|||
144396484|NCT00973349|520662945|FG008|Overall Study|Inappropriate enrolment|0|||
144396485|NCT00973349|520662946|FG009|Overall Study|Inappropriate enrolment|2|||
144396486|NCT00973349|520662947|FG010|Overall Study|Inappropriate enrolment|0|||
144396487|NCT00973349|520662948|FG011|Overall Study|Inappropriate enrolment|0|||
144396488|NCT00973349|520662949|FG012|Overall Study|Inappropriate enrolment|1|||
144396489|NCT00973349|520662950|FG013|Overall Study|Inappropriate enrolment|0|||
144520678|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520679|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144396490|NCT00973349|520662951|FG014|Overall Study|Inappropriate enrolment|1|||
144396491|NCT00973349|520662952|FG015|Overall Study|Inappropriate enrolment|1|||
144520680|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520681|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520682|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520683|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144520684|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
144396492|NCT00973349|520662937|FG000|Overall Study|Protocol Violation|0|||
144396493|NCT00973349|520662938|FG001|Overall Study|Protocol Violation|0|||
144396494|NCT00973349|520662939|FG002|Overall Study|Protocol Violation|0|||
144396495|NCT00973349|520662940|FG003|Overall Study|Protocol Violation|0|||
144396496|NCT00973349|520662941|FG004|Overall Study|Protocol Violation|0|||
144396497|NCT00973349|520662942|FG005|Overall Study|Protocol Violation|0|||
144396498|NCT00973349|520662943|FG006|Overall Study|Protocol Violation|0|||
144396499|NCT00973349|520662944|FG007|Overall Study|Protocol Violation|0|||
144396500|NCT00973349|520662945|FG008|Overall Study|Protocol Violation|1|||
144396501|NCT00973349|520662946|FG009|Overall Study|Protocol Violation|0|||
144396502|NCT00973349|520662947|FG010|Overall Study|Protocol Violation|0|||
144595336|NCT01009203|521379372|FG000|Overall Study|Adverse Event|5|||
144595337|NCT01009203|521379372|FG000|Overall Study|Treatment-unrelated death|1|||
144595338|NCT02076178|521379373|FG000|Oral Phase|Adverse Event|0|||
144595339|NCT02076178|521379374|FG001|Oral Phase|Adverse Event|7|||
144595340|NCT02076178|521379373|FG000|Oral Phase|Withdrawal by Subject|0|||
144595341|NCT02076178|521379374|FG001|Oral Phase|Withdrawal by Subject|4|||
144595342|NCT02076178|521379373|FG000|Oral Phase|Physician Decision|0|||
144595343|NCT02076178|521379374|FG001|Oral Phase|Physician Decision|1|||
144595344|NCT02076178|521379373|FG000|Injection Phase|Protocol defined stopping criteria|1|||
144595345|NCT02076178|521379374|FG001|Injection Phase|Protocol defined stopping criteria|0|||
144595346|NCT02076178|521379373|FG000|Injection Phase|Withdrawal by Subject|0|||
144595347|NCT02076178|521379374|FG001|Injection Phase|Withdrawal by Subject|3|||
144595348|NCT02076178|521379373|FG000|Injection Phase|Physician Decision|0|||
144595349|NCT02076178|521379374|FG001|Injection Phase|Physician Decision|3|||
144595350|NCT02076178|521379373|FG000|Injection Phase|Lost to Follow-up|0|||
144595351|NCT02076178|521379374|FG001|Injection Phase|Lost to Follow-up|1|||
144595352|NCT03021954|521379377|FG000|Overall Study|Lost to Follow-up|10|||
144595353|NCT03021954|521379378|FG001|Overall Study|Lost to Follow-up|43|||
144595354|NCT03021954|521379377|FG000|Overall Study|Subjects had avulsion trauma|4|||
144595355|NCT03021954|521379378|FG001|Overall Study|Subjects had avulsion trauma|1|||
144520685|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520686|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520687|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520688|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520689|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
144520690|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
144520691|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520692|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520693|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520694|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520695|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520696|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520697|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
144520698|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520699|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520700|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520701|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
144520702|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
144520703|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
144520704|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520705|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520706|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520707|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520708|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520709|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520710|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
144520711|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520712|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520713|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520714|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520715|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144595356|NCT01001832|521379379|FG000|Short-term Period|Adverse Event|2|||
144595357|NCT01001832|521379380|FG001|Short-term Period|Adverse Event|3|||
144595358|NCT01001832|521379379|FG000|Long-term Period|Adverse Event|2|||
144595359|NCT01001832|521379380|FG001|Long-term Period|Adverse Event|1|||
144396503|NCT00973349|520662948|FG011|Overall Study|Protocol Violation|0|||
144396504|NCT00973349|520662949|FG012|Overall Study|Protocol Violation|0|||
144520716|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
144520717|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520718|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520719|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520720|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520721|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520722|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520723|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
144520724|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144396505|NCT00973349|520662950|FG013|Overall Study|Protocol Violation|0|||
144396506|NCT00973349|520662951|FG014|Overall Study|Protocol Violation|0|||
144396507|NCT00973349|520662952|FG015|Overall Study|Protocol Violation|0|||
144396508|NCT00973349|520662937|FG000|Overall Study|Unable to classify|0|||
144396509|NCT00973349|520662938|FG001|Overall Study|Unable to classify|0|||
144396510|NCT00973349|520662939|FG002|Overall Study|Unable to classify|0|||
144396511|NCT00973349|520662940|FG003|Overall Study|Unable to classify|0|||
144396512|NCT00973349|520662941|FG004|Overall Study|Unable to classify|1|||
144396513|NCT00973349|520662942|FG005|Overall Study|Unable to classify|1|||
144396514|NCT00973349|520662943|FG006|Overall Study|Unable to classify|0|||
144396515|NCT00973349|520662944|FG007|Overall Study|Unable to classify|0|||
144396516|NCT00973349|520662945|FG008|Overall Study|Unable to classify|0|||
144396517|NCT00973349|520662946|FG009|Overall Study|Unable to classify|1|||
144396518|NCT00973349|520662947|FG010|Overall Study|Unable to classify|0|||
144396519|NCT00973349|520662948|FG011|Overall Study|Unable to classify|0|||
144396520|NCT00973349|520662949|FG012|Overall Study|Unable to classify|0|||
144396521|NCT00973349|520662950|FG013|Overall Study|Unable to classify|0|||
144396522|NCT00973349|520662951|FG014|Overall Study|Unable to classify|0|||
144396523|NCT00973349|520662952|FG015|Overall Study|Unable to classify|0|||
144396524|NCT02898116|520662953|FG000|Overall Study|Adverse Event|1|||
144396525|NCT02898116|520662953|FG000|Overall Study|Progressive disease|1|||
144396526|NCT05597020|520662957|FG000|Washout|Forbidden medication|2|||
144396527|NCT05597020|520662958|FG001|Washout|Forbidden medication|0|||
144396528|NCT05597020|520662957|FG000|Treatment Period II|Advice from primary care physician|1|||
144396529|NCT05597020|520662958|FG001|Treatment Period II|Advice from primary care physician|0|||
144396530|NCT05597020|520662957|FG000|Treatment Period II|Subject lost investigational product|1|||
144396531|NCT05597020|520662958|FG001|Treatment Period II|Subject lost investigational product|0|||
144396532|NCT05597020|520662957|FG000|Treatment Period II|Private reasons|0|||
144520725|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520726|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520727|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
144520728|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
144520729|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
144520730|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520731|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520732|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520733|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520734|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520735|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520736|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
144520737|NCT01261312|521108020|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520738|NCT01261312|521108021|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520739|NCT01261312|521108022|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520740|NCT01261312|521108023|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
144520741|NCT01261312|521108024|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
144520742|NCT01261312|521108025|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
144520743|NCT01261312|521108026|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520744|NCT01261312|521108027|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520745|NCT01261312|521108028|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520746|NCT01261312|521108029|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520747|NCT01261312|521108030|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520748|NCT01261312|521108031|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144520749|NCT01261312|521108032|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
144595360|NCT01001832|521379379|FG000|Long-term Period|Withdrawal by Subject|1|||
144249628|NCT01897571|520111710|FG010|Overall Study|Lost to Follow-up|4|||
144396533|NCT05597020|520662958|FG001|Treatment Period II|Private reasons|1|||
144396534|NCT05430022|520662959|FG000|Overall Study|Withdrawal by Subject|4|||
144520750|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520751|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520752|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520753|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520754|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520755|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520756|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
144520757|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
144520758|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
144520759|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144595361|NCT01001832|521379380|FG001|Long-term Period|Withdrawal by Subject|0|||
144396535|NCT05430022|520662960|FG001|Overall Study|Withdrawal by Subject|4|||
144396536|NCT02718300|520662965|FG000|Overall Study|Death|4|||
144396537|NCT02718300|520662966|FG001|Overall Study|Death|5|||
144396538|NCT02718300|520662967|FG002|Overall Study|Death|17|||
144396539|NCT02718300|520662965|FG000|Overall Study|Lost to Follow-up|1|||
144396540|NCT02718300|520662966|FG001|Overall Study|Lost to Follow-up|0|||
144396541|NCT02718300|520662967|FG002|Overall Study|Lost to Follow-up|2|||
144396542|NCT02718300|520662965|FG000|Overall Study|Physician Decision|1|||
144396543|NCT02718300|520662966|FG001|Overall Study|Physician Decision|0|||
144396544|NCT02718300|520662967|FG002|Overall Study|Physician Decision|2|||
144396545|NCT02718300|520662965|FG000|Overall Study|Study Terminated by Sponsor|6|||
144396546|NCT02718300|520662966|FG001|Overall Study|Study Terminated by Sponsor|3|||
144396547|NCT02718300|520662967|FG002|Overall Study|Study Terminated by Sponsor|4|||
144396548|NCT02718300|520662965|FG000|Overall Study|Withdrawal by Subject|0|||
144396549|NCT02718300|520662966|FG001|Overall Study|Withdrawal by Subject|4|||
144396550|NCT02718300|520662967|FG002|Overall Study|Withdrawal by Subject|3|||
144396551|NCT02718300|520662965|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
144396552|NCT02718300|520662966|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
144396553|NCT02718300|520662967|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
144396554|NCT02452697|520662968|FG000|Overall Study|Physician Decision|4|||
144396555|NCT02452697|520662969|FG001|Overall Study|Physician Decision|4|||
144396556|NCT02452697|520662970|FG002|Overall Study|Physician Decision|3|||
144396557|NCT02452697|520662971|FG003|Overall Study|Physician Decision|2|||
144396558|NCT02452697|520662968|FG000|Overall Study|Withdrawal by Subject|1|||
144396559|NCT02452697|520662969|FG001|Overall Study|Withdrawal by Subject|0|||
144396560|NCT02452697|520662970|FG002|Overall Study|Withdrawal by Subject|0|||
144396561|NCT02452697|520662971|FG003|Overall Study|Withdrawal by Subject|0|||
144396562|NCT02452697|520662968|FG000|Overall Study|still in follow-up|2|||
144396563|NCT02452697|520662969|FG001|Overall Study|still in follow-up|2|||
144396564|NCT02452697|520662970|FG002|Overall Study|still in follow-up|1|||
144396565|NCT02452697|520662971|FG003|Overall Study|still in follow-up|3|||
144396566|NCT02349061|520665337|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
144396567|NCT02349061|520665338|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
144396568|NCT02349061|520665339|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
144396569|NCT02349061|520665337|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
144396570|NCT02349061|520665338|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
144396571|NCT02349061|520665339|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
144396572|NCT02349061|520665337|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
144396573|NCT02349061|520665338|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
144396574|NCT02349061|520665339|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
144396575|NCT02349061|520665337|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
144396576|NCT02349061|520665338|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
144396577|NCT02349061|520665339|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
144396578|NCT02349061|520665337|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
144396579|NCT02349061|520665338|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
144396580|NCT02349061|520665339|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
144396581|NCT02349061|520665337|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
144396582|NCT02349061|520665338|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
144396583|NCT02349061|520665339|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
144396584|NCT02349061|520665337|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
144396585|NCT02349061|520665338|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
144396586|NCT02349061|520665339|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
144396587|NCT02349061|520665337|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
144396588|NCT02349061|520665338|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
144396589|NCT02349061|520665339|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
144396590|NCT02349061|520665337|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
144520760|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520761|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144520762|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
144396591|NCT02349061|520665338|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
144396592|NCT02349061|520665339|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
144520763|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520764|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144396593|NCT02349061|520665337|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
144396594|NCT02349061|520665338|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
144396595|NCT02349061|520665339|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
144396596|NCT02349061|520665337|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
144396597|NCT02349061|520665338|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
144396598|NCT02349061|520665339|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
144396599|NCT02349061|520665337|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
144595362|NCT01001832|521379379|FG000|Long-term Period|Lack of Efficacy|0|||
144595363|NCT01001832|521379380|FG001|Long-term Period|Lack of Efficacy|2|||
144595364|NCT01001832|521379379|FG000|Long-term Period|Other|1|||
144595365|NCT01001832|521379380|FG001|Long-term Period|Other|2|||
144595366|NCT01001832|521379379|FG000|Follow-up Period|Withdrawal by Subject|1|||
144595367|NCT01001832|521379380|FG001|Follow-up Period|Withdrawal by Subject|0|||
144595368|NCT01001832|521379379|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
144595369|NCT01001832|521379380|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
144595370|NCT01001832|521379379|FG000|Follow-up Period|Other|2|||
144595371|NCT01001832|521379380|FG001|Follow-up Period|Other|1|||
144595372|NCT01012713|521379381|FG000|Overall Study|Lack of Efficacy|3|||
144595373|NCT01242800|521379382|FG000|Overall Study|Patient refusal|0|||
144595374|NCT01242800|521379383|FG001|Overall Study|Patient refusal|10|||
144595375|NCT01242800|521379382|FG000|Overall Study|Physician Decision|0|||
144595376|NCT01242800|521379383|FG001|Overall Study|Physician Decision|1|||
144595377|NCT01242800|521379382|FG000|Overall Study|Disease progression|0|||
144595378|NCT01242800|521379383|FG001|Overall Study|Disease progression|3|||
144595379|NCT01242800|521379382|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
144595380|NCT01242800|521379383|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
144595381|NCT01242800|521379382|FG000|Overall Study|Reasons not reported|0|||
144595382|NCT01242800|521379383|FG001|Overall Study|Reasons not reported|4|||
144595383|NCT01596621|521379385|FG000|Overall Study|Death|4|||
144595384|NCT01596621|521379385|FG000|Overall Study|Withdrawal by Subject|9|||
144595385|NCT01596621|521379385|FG000|Overall Study|Disease Progression|49|||
144595386|NCT01596621|521379385|FG000|Overall Study|Lost to Follow-up|3|||
144595387|NCT01596621|521379385|FG000|Overall Study|Other than specified|13|||
144595388|NCT00710021|521379386|FG000|Overall Study|Lost to Follow-up|1|||
144595389|NCT00710021|521379387|FG001|Overall Study|Lost to Follow-up|0|||
144595390|NCT00710021|521379388|FG002|Overall Study|Lost to Follow-up|0|||
144595391|NCT00710021|521379386|FG000|Overall Study|Subject's Decision|0|||
144595392|NCT00710021|521379387|FG001|Overall Study|Subject's Decision|1|||
144595393|NCT00710021|521379388|FG002|Overall Study|Subject's Decision|0|||
144595394|NCT00710021|521379386|FG000|Overall Study|Subject misrandomized|0|||
144595395|NCT00710021|521379387|FG001|Overall Study|Subject misrandomized|1|||
144595396|NCT00710021|521379388|FG002|Overall Study|Subject misrandomized|1|||
144595397|NCT00710021|521379386|FG000|Overall Study|Physician Decision|0|||
144595398|NCT00710021|521379387|FG001|Overall Study|Physician Decision|1|||
144595399|NCT00710021|521379388|FG002|Overall Study|Physician Decision|0|||
144595400|NCT01536015|521379389|FG000|Overall Study|Adverse Event|1|||
144595401|NCT01536015|521379390|FG001|Overall Study|Adverse Event|4|||
144595402|NCT01536015|521379389|FG000|Overall Study|Lost to Follow-up|0|||
144595403|NCT01536015|521379390|FG001|Overall Study|Lost to Follow-up|1|||
144595404|NCT01536015|521379389|FG000|Overall Study|Inclusion Criterion not met|2|||
144595405|NCT01536015|521379390|FG001|Overall Study|Inclusion Criterion not met|0|||
144595406|NCT01536015|521379389|FG000|Overall Study|Study closure|5|||
144595407|NCT01536015|521379390|FG001|Overall Study|Study closure|5|||
144595408|NCT04508023|521379391|FG000|Overall Study|Withdrawal by Subject|1|||
144595409|NCT04508023|521379392|FG001|Overall Study|Withdrawal by Subject|2|||
144595410|NCT03581825|521379400|FG000|Period 1|Lens Discomfort|1|||
144595411|NCT03581825|521379401|FG001|Period 1|Lens Discomfort|0|||
144595412|NCT03581825|521379400|FG000|Period 2|Unsatisfactory Vision to Test|0|||
144595413|NCT03581825|521379401|FG001|Period 2|Unsatisfactory Vision to Test|1|||
144595414|NCT01668667|521379402|FG000|Overall Study|Adverse Event|3|||
144595415|NCT01668667|521379403|FG001|Overall Study|Adverse Event|6|||
144396600|NCT02349061|520665338|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
144595416|NCT01668667|521379404|FG002|Overall Study|Adverse Event|4|||
144595417|NCT01668667|521379405|FG003|Overall Study|Adverse Event|4|||
144595418|NCT01668667|521379402|FG000|Overall Study|Lack of Efficacy|3|||
144595419|NCT01668667|521379403|FG001|Overall Study|Lack of Efficacy|2|||
144595420|NCT01668667|521379404|FG002|Overall Study|Lack of Efficacy|2|||
144595421|NCT01668667|521379405|FG003|Overall Study|Lack of Efficacy|3|||
144595422|NCT01668667|521379402|FG000|Overall Study|Protocol Violation|6|||
144595423|NCT01668667|521379403|FG001|Overall Study|Protocol Violation|10|||
144595424|NCT01668667|521379404|FG002|Overall Study|Protocol Violation|12|||
144595425|NCT01668667|521379405|FG003|Overall Study|Protocol Violation|5|||
144595426|NCT01668667|521379402|FG000|Overall Study|Lost to Follow-up|9|||
144595427|NCT01668667|521379403|FG001|Overall Study|Lost to Follow-up|4|||
144595428|NCT01668667|521379404|FG002|Overall Study|Lost to Follow-up|7|||
144722311|NCT03731182|521838671|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
144722312|NCT03731182|521838672|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
144595429|NCT01668667|521379405|FG003|Overall Study|Lost to Follow-up|6|||
144595430|NCT01668667|521379402|FG000|Overall Study|Physician Decision|3|||
144722313|NCT02006706|521838673|FG000|Overall Study|Lost to Follow-up|1|||
144595431|NCT01668667|521379403|FG001|Overall Study|Physician Decision|0|||
144722314|NCT00958256|521838675|FG000|Overall Study|Adverse Event|3|||
144396601|NCT02349061|520665339|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
144396602|NCT02349061|520665337|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
144396603|NCT02349061|520665338|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
144396604|NCT02349061|520665339|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
144396605|NCT02339285|520665340|FG000|Overall Study|Withdrawal by Subject|0|||
144396606|NCT02339285|520665341|FG001|Overall Study|Withdrawal by Subject|1|||
144396607|NCT02339285|520665342|FG002|Overall Study|Withdrawal by Subject|1|||
144396608|NCT02339285|520665340|FG000|Overall Study|Lost to Follow-up|1|||
144396609|NCT02339285|520665341|FG001|Overall Study|Lost to Follow-up|1|||
144396610|NCT02339285|520665342|FG002|Overall Study|Lost to Follow-up|1|||
144396611|NCT02339285|520665340|FG000|Overall Study|Protocol Deviation|0|||
144396612|NCT02339285|520665341|FG001|Overall Study|Protocol Deviation|1|||
144396613|NCT02339285|520665342|FG002|Overall Study|Protocol Deviation|0|||
144396614|NCT00282412|520665345|FG000|Overall Study|Death|2|||
144396615|NCT01507298|520665348|FG000|Overall Study|Protocol Violation|0|||
144396616|NCT01507298|520665349|FG001|Overall Study|Protocol Violation|6|||
144396617|NCT00537238|520665350|FG000|Overall Study|Death|1|||
144396618|NCT00537238|520665351|FG001|Overall Study|Death|2|||
144396619|NCT00537238|520665350|FG000|Overall Study|Adverse Event|31|||
144396620|NCT00537238|520665351|FG001|Overall Study|Adverse Event|22|||
144396621|NCT00537238|520665350|FG000|Overall Study|Lack of Efficacy|20|||
144396622|NCT00537238|520665351|FG001|Overall Study|Lack of Efficacy|21|||
144396623|NCT00537238|520665350|FG000|Overall Study|Lost to Follow-up|12|||
144396624|NCT00537238|520665351|FG001|Overall Study|Lost to Follow-up|8|||
144396625|NCT00537238|520665350|FG000|Overall Study|Withdrawal by Subject|51|||
144396626|NCT00537238|520665351|FG001|Overall Study|Withdrawal by Subject|47|||
144396627|NCT00537238|520665350|FG000|Overall Study|Protocol Violation|15|||
144396628|NCT00537238|520665351|FG001|Overall Study|Protocol Violation|19|||
144396629|NCT00537238|520665350|FG000|Overall Study|Does not meet entrance criteria|0|||
144396630|NCT00537238|520665351|FG001|Overall Study|Does not meet entrance criteria|2|||
144396631|NCT00537238|520665350|FG000|Overall Study|Other|44|||
144396632|NCT00537238|520665351|FG001|Overall Study|Other|52|||
144396633|NCT01920555|520665352|FG000|Overall Study|Physician Decision|1|||
144396634|NCT01920555|520665353|FG001|Overall Study|Physician Decision|2|||
144396635|NCT01920555|520665354|FG002|Overall Study|Physician Decision|1|||
144396636|NCT01920555|520665355|FG003|Overall Study|Physician Decision|2|||
144396637|NCT01920555|520665356|FG004|Overall Study|Physician Decision|0|||
144396638|NCT01920555|520665352|FG000|Overall Study|Lack of Efficacy|2|||
144396639|NCT01920555|520665353|FG001|Overall Study|Lack of Efficacy|0|||
144396640|NCT01920555|520665354|FG002|Overall Study|Lack of Efficacy|0|||
144396641|NCT01920555|520665355|FG003|Overall Study|Lack of Efficacy|0|||
144396642|NCT01920555|520665356|FG004|Overall Study|Lack of Efficacy|0|||
144396643|NCT01920555|520665352|FG000|Overall Study|Travel Difficulties|1|||
144396644|NCT01920555|520665353|FG001|Overall Study|Travel Difficulties|1|||
144396645|NCT01920555|520665354|FG002|Overall Study|Travel Difficulties|0|||
144396646|NCT01920555|520665355|FG003|Overall Study|Travel Difficulties|0|||
144396647|NCT01920555|520665356|FG004|Overall Study|Travel Difficulties|1|||
144520765|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520766|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520767|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520768|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520769|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520770|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
144520771|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
144520772|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520773|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520774|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144520775|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
144396648|NCT01920555|520665352|FG000|Overall Study|Lost to Follow-up|0|||
144396649|NCT01920555|520665353|FG001|Overall Study|Lost to Follow-up|1|||
144396650|NCT01920555|520665354|FG002|Overall Study|Lost to Follow-up|0|||
144396651|NCT01920555|520665355|FG003|Overall Study|Lost to Follow-up|1|||
144396652|NCT01920555|520665356|FG004|Overall Study|Lost to Follow-up|0|||
144396653|NCT03911713|520665359|FG000|Overall Study|Lost to Follow-up|0|||
144396654|NCT03911713|520665360|FG001|Overall Study|Lost to Follow-up|2|||
144396655|NCT03911713|520665361|FG002|Overall Study|Lost to Follow-up|0|||
144396656|NCT03911713|520665362|FG003|Overall Study|Lost to Follow-up|0|||
144396657|NCT03911713|520665363|FG004|Overall Study|Lost to Follow-up|0|||
144396658|NCT03911713|520665359|FG000|Overall Study|Other|0|||
144396659|NCT03911713|520665360|FG001|Overall Study|Other|0|||
144396660|NCT03911713|520665361|FG002|Overall Study|Other|0|||
144396661|NCT03911713|520665362|FG003|Overall Study|Other|1|||
144396662|NCT03911713|520665363|FG004|Overall Study|Other|0|||
144396663|NCT03911713|520665359|FG000|Overall Study|Randomized, Never Dosed|1|||
144396664|NCT03911713|520665360|FG001|Overall Study|Randomized, Never Dosed|0|||
144595432|NCT01668667|521379404|FG002|Overall Study|Physician Decision|1|||
144595433|NCT01668667|521379405|FG003|Overall Study|Physician Decision|0|||
144595434|NCT01668667|521379402|FG000|Overall Study|Withdrawal by Subject|7|||
144595435|NCT01668667|521379403|FG001|Overall Study|Withdrawal by Subject|4|||
144595436|NCT01668667|521379404|FG002|Overall Study|Withdrawal by Subject|5|||
144595437|NCT01668667|521379405|FG003|Overall Study|Withdrawal by Subject|5|||
144595438|NCT03261700|521379406|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
144595439|NCT03261700|521379407|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
144595440|NCT01204398|521379408|FG000|Overall Study|Adverse Event|1|||
144595441|NCT01723254|521379410|FG000|Overall Study|Conflict with work schedule|0|||
144595442|NCT01723254|521379411|FG001|Overall Study|Conflict with work schedule|0|||
144595443|NCT01723254|521379412|FG002|Overall Study|Conflict with work schedule|0|||
144595444|NCT01723254|521379413|FG003|Overall Study|Conflict with work schedule|0|||
144595445|NCT01723254|521379414|FG004|Overall Study|Conflict with work schedule|0|||
144595446|NCT01723254|521379415|FG005|Overall Study|Conflict with work schedule|0|||
144595447|NCT01723254|521379416|FG006|Overall Study|Conflict with work schedule|0|||
144595448|NCT01723254|521379417|FG007|Overall Study|Conflict with work schedule|1|||
144595449|NCT01723254|521379410|FG000|Overall Study|Personal issues|0|||
144595450|NCT01723254|521379411|FG001|Overall Study|Personal issues|0|||
144595451|NCT01723254|521379412|FG002|Overall Study|Personal issues|0|||
144595452|NCT01723254|521379413|FG003|Overall Study|Personal issues|0|||
144595453|NCT01723254|521379414|FG004|Overall Study|Personal issues|0|||
144595454|NCT01723254|521379415|FG005|Overall Study|Personal issues|1|||
144595455|NCT01723254|521379416|FG006|Overall Study|Personal issues|0|||
144595456|NCT01723254|521379417|FG007|Overall Study|Personal issues|0|||
144396665|NCT03911713|520665361|FG002|Overall Study|Randomized, Never Dosed|0|||
144396666|NCT03911713|520665362|FG003|Overall Study|Randomized, Never Dosed|1|||
144396667|NCT03911713|520665363|FG004|Overall Study|Randomized, Never Dosed|0|||
144396668|NCT01193660|520665366|FG000|Overall Study|Withdrawal by Subject|2|||
144396669|NCT01193660|520665367|FG001|Overall Study|Withdrawal by Subject|3|||
144396670|NCT01193660|520665368|FG002|Overall Study|Withdrawal by Subject|1|||
144396671|NCT01193660|520665366|FG000|Overall Study|Death|1|||
144396672|NCT01193660|520665367|FG001|Overall Study|Death|0|||
144396673|NCT01193660|520665368|FG002|Overall Study|Death|0|||
144396674|NCT01193660|520665366|FG000|Overall Study|Physician Decision|1|||
144595457|NCT01723254|521379410|FG000|Overall Study|No longer have time to participate|0|||
144595458|NCT01723254|521379411|FG001|Overall Study|No longer have time to participate|0|||
144595459|NCT01723254|521379412|FG002|Overall Study|No longer have time to participate|0|||
144595460|NCT01723254|521379413|FG003|Overall Study|No longer have time to participate|1|||
144595461|NCT01723254|521379414|FG004|Overall Study|No longer have time to participate|0|||
144595462|NCT01723254|521379415|FG005|Overall Study|No longer have time to participate|0|||
144595463|NCT01723254|521379416|FG006|Overall Study|No longer have time to participate|0|||
144595464|NCT01723254|521379417|FG007|Overall Study|No longer have time to participate|0|||
144595465|NCT01723254|521379410|FG000|Overall Study|Move/Left to another country/city|0|||
144396675|NCT01193660|520665367|FG001|Overall Study|Physician Decision|0|||
144396676|NCT01193660|520665368|FG002|Overall Study|Physician Decision|1|||
144396677|NCT01845818|520665369|FG000|Overall Study|Withdrawal by Subject|0|||
144396678|NCT01845818|520665370|FG001|Overall Study|Withdrawal by Subject|1|||
144396679|NCT01845818|520665369|FG000|Overall Study|Lost to Follow-up|7|||
144396680|NCT01845818|520665370|FG001|Overall Study|Lost to Follow-up|5|||
144396681|NCT01845818|520665369|FG000|Overall Study|Administrative Reasons|3|||
144396682|NCT01845818|520665370|FG001|Overall Study|Administrative Reasons|1|||
144396683|NCT01845818|520665369|FG000|Overall Study|Serious Adverse Event|1|||
144396684|NCT01845818|520665370|FG001|Overall Study|Serious Adverse Event|1|||
144396685|NCT01845818|520665369|FG000|Overall Study|Other|25|||
144396686|NCT01845818|520665370|FG001|Overall Study|Other|8|||
144396687|NCT01845818|520665369|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
144396688|NCT01845818|520665370|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
144396689|NCT01845818|520665369|FG000|Overall Study|No Follow-Up Data Available|4|||
144595466|NCT01723254|521379411|FG001|Overall Study|Move/Left to another country/city|0|||
144595467|NCT01723254|521379412|FG002|Overall Study|Move/Left to another country/city|2|||
144595468|NCT01723254|521379413|FG003|Overall Study|Move/Left to another country/city|1|||
144595469|NCT01723254|521379414|FG004|Overall Study|Move/Left to another country/city|1|||
144595470|NCT01723254|521379415|FG005|Overall Study|Move/Left to another country/city|0|||
144595471|NCT01723254|521379416|FG006|Overall Study|Move/Left to another country/city|0|||
144722315|NCT03519256|521838676|FG000|Overall Study|Disease recurrence|4|||
144396690|NCT01845818|520665370|FG001|Overall Study|No Follow-Up Data Available|1|||
144396691|NCT01680965|520665371|FG000|Overall Study|Death|0|||
144396692|NCT01680965|520665372|FG001|Overall Study|Death|0|||
144396693|NCT01680965|520665373|FG002|Overall Study|Death|0|||
144396694|NCT01680965|520665374|FG003|Overall Study|Death|6|||
144396695|NCT00195273|520665375|FG000|Overall Study|Adverse Event|9|||
144396696|NCT00195273|520665376|FG001|Overall Study|Adverse Event|9|||
144396697|NCT00195273|520665375|FG000|Overall Study|Protocol deviation|0|||
144396698|NCT00195273|520665376|FG001|Overall Study|Protocol deviation|1|||
144396699|NCT00195273|520665375|FG000|Overall Study|Lack of Efficacy|3|||
144396700|NCT00195273|520665376|FG001|Overall Study|Lack of Efficacy|1|||
144396701|NCT00195273|520665375|FG000|Overall Study|Procedural complications|9|||
144396702|NCT00195273|520665376|FG001|Overall Study|Procedural complications|3|||
144396703|NCT02595970|520665377|FG000|Overall Study|Withdrawal by Subject|2|||
144396704|NCT02595970|520665377|FG000|Overall Study|Physician Decision|2|||
144396705|NCT02595970|520665377|FG000|Overall Study|Protocol Violation|4|||
144396706|NCT02595970|520665377|FG000|Overall Study|Adverse Event|5|||
144396707|NCT02595970|520665377|FG000|Overall Study|Lack of Efficacy|7|||
144396708|NCT02367131|520665378|FG000|Overall Study|Adverse Event|64|||
144396709|NCT02367131|520665378|FG000|Overall Study|No visit since the first visit|3|||
144396710|NCT02367131|520665378|FG000|Overall Study|Request by patient|53|||
144396711|NCT02367131|520665378|FG000|Overall Study|Improvement/remission|2|||
144396712|NCT02367131|520665378|FG000|Overall Study|No change/progressive disease|78|||
144396713|NCT02367131|520665378|FG000|Overall Study|Other than stated above|20|||
144396714|NCT02367131|520665378|FG000|Overall Study|Not treated|2|||
144396715|NCT02570074|520665379|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
144396716|NCT02570074|520665380|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
144396717|NCT02923427|520665386|FG000|Overall Study|convert to laparatomy|2|||
144396718|NCT02923427|520665387|FG001|Overall Study|convert to laparatomy|2|||
144396719|NCT02923427|520665386|FG000|Overall Study|destaturation|1|||
144396720|NCT02923427|520665387|FG001|Overall Study|destaturation|0|||
144396721|NCT02923427|520665386|FG000|Overall Study|can not replace LMA|1|||
144396722|NCT02923427|520665387|FG001|Overall Study|can not replace LMA|0|||
144396723|NCT01325623|520665388|FG000|Overall Study|Withdrawal by Subject|3|||
144396724|NCT01539642|520665394|FG000|Overall Study|Lack of Efficacy|20|||
144396725|NCT01539642|520665395|FG001|Overall Study|Lack of Efficacy|18|||
144396726|NCT01539642|520665394|FG000|Overall Study|Patient ready for early discharge|8|||
144396727|NCT01539642|520665395|FG001|Overall Study|Patient ready for early discharge|7|||
144396728|NCT01539642|520665394|FG000|Overall Study|Adverse Event|6|||
144396729|NCT01539642|520665395|FG001|Overall Study|Adverse Event|4|||
144396730|NCT01539642|520665394|FG000|Overall Study|Withdrawal by Subject|2|||
144396731|NCT01539642|520665395|FG001|Overall Study|Withdrawal by Subject|2|||
144396732|NCT00598702|520665396|FG000|Overall Study|Other|0|||
144396733|NCT00598702|520665397|FG001|Overall Study|Other|2|||
144396734|NCT00598702|520665398|FG002|Overall Study|Other|0|||
144396735|NCT00598702|520665399|FG003|Overall Study|Other|0|||
144396736|NCT00598702|520665400|FG004|Overall Study|Other|0|||
144396737|NCT00598702|520665401|FG005|Overall Study|Other|1|||
144396738|NCT00598702|520665402|FG006|Overall Study|Other|0|||
144396739|NCT00598702|520665403|FG007|Overall Study|Other|0|||
144396740|NCT00598702|520665396|FG000|Overall Study|Early discharge from hospital|0|||
144396741|NCT00598702|520665397|FG001|Overall Study|Early discharge from hospital|0|||
144396742|NCT00598702|520665398|FG002|Overall Study|Early discharge from hospital|2|||
144396743|NCT00598702|520665399|FG003|Overall Study|Early discharge from hospital|5|||
144396744|NCT00598702|520665400|FG004|Overall Study|Early discharge from hospital|0|||
144396745|NCT00598702|520665401|FG005|Overall Study|Early discharge from hospital|10|||
144396746|NCT00598702|520665402|FG006|Overall Study|Early discharge from hospital|1|||
144396747|NCT00598702|520665403|FG007|Overall Study|Early discharge from hospital|0|||
144396748|NCT00598702|520665396|FG000|Overall Study|Adverse Event|0|||
144396749|NCT00598702|520665397|FG001|Overall Study|Adverse Event|0|||
144396750|NCT00598702|520665398|FG002|Overall Study|Adverse Event|0|||
144396751|NCT00598702|520665399|FG003|Overall Study|Adverse Event|1|||
144520776|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520777|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520778|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520779|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520780|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520781|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520782|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
144520783|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
144520784|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
144520785|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520786|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520787|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144520788|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
144396752|NCT00598702|520665400|FG004|Overall Study|Adverse Event|0|||
144396753|NCT00598702|520665401|FG005|Overall Study|Adverse Event|0|||
144520789|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
144396754|NCT00598702|520665402|FG006|Overall Study|Adverse Event|0|||
144396755|NCT00598702|520665403|FG007|Overall Study|Adverse Event|0|||
144396756|NCT00598702|520665396|FG000|Overall Study|Withdrawal by Subject|0|||
144396757|NCT00598702|520665397|FG001|Overall Study|Withdrawal by Subject|0|||
144396758|NCT00598702|520665398|FG002|Overall Study|Withdrawal by Subject|0|||
144396759|NCT00598702|520665399|FG003|Overall Study|Withdrawal by Subject|1|||
144396760|NCT00598702|520665400|FG004|Overall Study|Withdrawal by Subject|1|||
144396761|NCT00598702|520665401|FG005|Overall Study|Withdrawal by Subject|0|||
144396762|NCT00598702|520665402|FG006|Overall Study|Withdrawal by Subject|0|||
144396763|NCT00598702|520665403|FG007|Overall Study|Withdrawal by Subject|0|||
144396764|NCT00598702|520665396|FG000|Overall Study|Physician Decision|0|||
144396765|NCT00598702|520665397|FG001|Overall Study|Physician Decision|0|||
144396766|NCT00598702|520665398|FG002|Overall Study|Physician Decision|0|||
144396767|NCT00598702|520665399|FG003|Overall Study|Physician Decision|0|||
144396768|NCT00598702|520665400|FG004|Overall Study|Physician Decision|1|||
144396769|NCT00598702|520665401|FG005|Overall Study|Physician Decision|0|||
144396770|NCT00598702|520665402|FG006|Overall Study|Physician Decision|0|||
144396771|NCT00598702|520665403|FG007|Overall Study|Physician Decision|0|||
144396772|NCT00598702|520665396|FG000|Overall Study|Dose limiting toxicity|0|||
144396773|NCT00598702|520665397|FG001|Overall Study|Dose limiting toxicity|0|||
144396774|NCT00598702|520665398|FG002|Overall Study|Dose limiting toxicity|0|||
144396775|NCT00598702|520665399|FG003|Overall Study|Dose limiting toxicity|1|||
144396776|NCT00598702|520665400|FG004|Overall Study|Dose limiting toxicity|1|||
144396777|NCT00598702|520665401|FG005|Overall Study|Dose limiting toxicity|1|||
144396778|NCT00598702|520665402|FG006|Overall Study|Dose limiting toxicity|0|||
144396779|NCT00598702|520665403|FG007|Overall Study|Dose limiting toxicity|0|||
144396780|NCT00567593|520665404|FG000|Overall Study|Adverse Event|1|||
144396781|NCT00567593|520665404|FG000|Overall Study|Physician Decision|1|||
144396782|NCT02106910|520665405|FG000|Overall Study|Lost to Follow-up|1|||
144396783|NCT02106910|520665406|FG001|Overall Study|Lost to Follow-up|1|||
144396784|NCT01675427|520665409|FG000|Overall Study|Withdrawal by Subject|7|||
144396785|NCT01675427|520665409|FG000|Overall Study|Participant Refused Sample Collection|18|||
144396786|NCT01675427|520665409|FG000|Overall Study|Sample not Collected by Mistake|2|||
144396787|NCT01675427|520665409|FG000|Overall Study|Lost to Follow-up|5|||
144396788|NCT01675427|520665409|FG000|Overall Study|Other|2|||
144396789|NCT00700570|520665410|FG000|Overall Study|Adverse Event|2|||
144396790|NCT00700570|520665411|FG001|Overall Study|Adverse Event|6|||
144396791|NCT00700570|520665410|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
144396792|NCT00700570|520665411|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
144396793|NCT00700570|520665410|FG000|Overall Study|Disease Progression|8|||
144396794|NCT00700570|520665411|FG001|Overall Study|Disease Progression|11|||
144396795|NCT00700570|520665410|FG000|Overall Study|Withdrawal by Subject|1|||
144396796|NCT00700570|520665411|FG001|Overall Study|Withdrawal by Subject|6|||
144396797|NCT02556203|520665412|FG000|Overall Study|Withdrawal by Subject|21|||
144396798|NCT02556203|520665413|FG001|Overall Study|Withdrawal by Subject|21|||
144396799|NCT02556203|520665412|FG000|Overall Study|Lost to Follow-up|5|||
144396800|NCT02556203|520665413|FG001|Overall Study|Lost to Follow-up|5|||
144396801|NCT02556203|520665412|FG000|Overall Study|Adverse Event|1|||
144396802|NCT02556203|520665413|FG001|Overall Study|Adverse Event|0|||
144396803|NCT00611533|520665418|FG000|First Intervention (6 Weeks)|Never started study|0|||
144396804|NCT00611533|520665419|FG001|First Intervention (6 Weeks)|Never started study|1|||
144396805|NCT00611533|520665418|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
144396806|NCT00611533|520665419|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
144396807|NCT00611533|520665418|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
144396808|NCT00611533|520665419|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
144396809|NCT02943460|520665421|FG000|Blinded Study Phase|Adverse Event|3|||
144396810|NCT02943460|520665422|FG001|Blinded Study Phase|Adverse Event|0|||
144396811|NCT02943460|520665423|FG002|Blinded Study Phase|Adverse Event|0|||
144396812|NCT02943460|520665421|FG000|Blinded Study Phase|Withdrew Consent|0|||
144595472|NCT01723254|521379417|FG007|Overall Study|Move/Left to another country/city|0|||
144595473|NCT01723254|521379410|FG000|Overall Study|Protocol Violation|0|||
144396813|NCT02943460|520665422|FG001|Blinded Study Phase|Withdrew Consent|1|||
144396814|NCT02943460|520665423|FG002|Blinded Study Phase|Withdrew Consent|0|||
144396815|NCT02943460|520665421|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
144396816|NCT02943460|520665422|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
144396817|NCT02943460|520665423|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
144396818|NCT02943460|520665421|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
144396819|NCT02943460|520665422|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
144396820|NCT02943460|520665423|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
144396821|NCT02943460|520665421|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
144396822|NCT02943460|520665422|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
144396823|NCT02943460|520665423|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
144396824|NCT01461980|520665427|FG000|Overall Study|Other|9|||
144396825|NCT01461980|520665428|FG001|Overall Study|Other|8|||
144396826|NCT01461980|520665429|FG002|Overall Study|Other|6|||
144396827|NCT01461980|520665427|FG000|Overall Study|Medication error|7|||
144595474|NCT01723254|521379411|FG001|Overall Study|Protocol Violation|1|||
144595475|NCT01723254|521379412|FG002|Overall Study|Protocol Violation|0|||
144595476|NCT01723254|521379413|FG003|Overall Study|Protocol Violation|0|||
144595477|NCT01723254|521379414|FG004|Overall Study|Protocol Violation|0|||
144595478|NCT01723254|521379415|FG005|Overall Study|Protocol Violation|0|||
144595479|NCT01723254|521379416|FG006|Overall Study|Protocol Violation|0|||
144595480|NCT01723254|521379417|FG007|Overall Study|Protocol Violation|0|||
144595481|NCT01723254|521379410|FG000|Overall Study|Withdrawal by Subject|1|||
144595482|NCT01723254|521379411|FG001|Overall Study|Withdrawal by Subject|2|||
144595483|NCT01723254|521379412|FG002|Overall Study|Withdrawal by Subject|1|||
144249629|NCT01897571|520111700|FG000|Overall Study|Withdrawal by Subject|0|||
144249630|NCT01897571|520111701|FG001|Overall Study|Withdrawal by Subject|0|||
144396828|NCT01461980|520665428|FG001|Overall Study|Medication error|5|||
144595484|NCT01723254|521379413|FG003|Overall Study|Withdrawal by Subject|0|||
144595485|NCT01723254|521379414|FG004|Overall Study|Withdrawal by Subject|1|||
144722316|NCT03519256|521838677|FG001|Overall Study|Disease recurrence|4|||
144396829|NCT01461980|520665429|FG002|Overall Study|Medication error|6|||
144396830|NCT01461980|520665427|FG000|Overall Study|Adverse Event|12|||
144396831|NCT01461980|520665428|FG001|Overall Study|Adverse Event|5|||
144396832|NCT01461980|520665429|FG002|Overall Study|Adverse Event|6|||
144396833|NCT01461980|520665427|FG000|Overall Study|Protocol Violation|12|||
144396834|NCT01461980|520665428|FG001|Overall Study|Protocol Violation|19|||
144396835|NCT01461980|520665429|FG002|Overall Study|Protocol Violation|16|||
144396836|NCT01461980|520665427|FG000|Overall Study|No longer meets eligibility criteria|18|||
144396837|NCT01461980|520665428|FG001|Overall Study|No longer meets eligibility criteria|9|||
144396838|NCT01461980|520665429|FG002|Overall Study|No longer meets eligibility criteria|19|||
144520790|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
144520791|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
144520792|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
144520793|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
144520794|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
144520795|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
144520796|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
144520797|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
144520798|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
144520799|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
144520800|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
144520801|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
144520802|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520803|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520804|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520805|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520806|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520807|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520808|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
144520809|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
144520810|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
144520811|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520812|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520813|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520814|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
144520815|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520816|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520817|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520818|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520819|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520820|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520821|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
144520822|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
144520823|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
144520824|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520825|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520826|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520827|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
144520828|NCT01261312|521108020|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520829|NCT01261312|521108021|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520830|NCT01261312|521108022|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520831|NCT01261312|521108023|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520832|NCT01261312|521108024|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520833|NCT01261312|521108025|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520834|NCT01261312|521108026|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
144520835|NCT01261312|521108027|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
144520836|NCT01261312|521108028|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
144520837|NCT01261312|521108029|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520838|NCT01261312|521108030|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520839|NCT01261312|521108031|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520840|NCT01261312|521108032|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
144520841|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520842|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520843|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520844|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144396839|NCT01461980|520665427|FG000|Overall Study|Lost to Follow-up|52|||
144396840|NCT01461980|520665428|FG001|Overall Study|Lost to Follow-up|53|||
144396841|NCT01461980|520665429|FG002|Overall Study|Lost to Follow-up|51|||
144396842|NCT01461980|520665427|FG000|Overall Study|No longer willing to participate|52|||
144396843|NCT01461980|520665428|FG001|Overall Study|No longer willing to participate|38|||
144396844|NCT01461980|520665429|FG002|Overall Study|No longer willing to participate|54|||
144396845|NCT01461980|520665427|FG000|Overall Study|Randomized but not vaccinated|4|||
144396846|NCT01461980|520665428|FG001|Overall Study|Randomized but not vaccinated|8|||
144396847|NCT01461980|520665429|FG002|Overall Study|Randomized but not vaccinated|7|||
144396848|NCT04171765|520665430|FG000|Overall Study|Adverse Event|2|||
144520845|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520846|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520847|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520848|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520849|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
144520850|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
144520851|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
144520852|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
144520853|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
144520854|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520855|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520856|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520857|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520858|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520859|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520860|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520861|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520862|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520863|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
144520864|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
144520865|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
144520866|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
144520867|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520868|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520869|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520870|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520871|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520872|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520873|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520874|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520875|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
144520876|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
144520877|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
144520878|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
144520879|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
144520880|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520881|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520882|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520883|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520884|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520885|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520886|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520887|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520888|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
144520889|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
144520890|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
144520891|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
144520892|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
144520893|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520894|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520895|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520896|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520897|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520898|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520899|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520900|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144520901|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
144396849|NCT04171765|520665431|FG001|Overall Study|Adverse Event|0|||
144396850|NCT04171765|520665432|FG002|Overall Study|Adverse Event|1|||
144396851|NCT04171765|520665433|FG003|Overall Study|Adverse Event|0|||
144396852|NCT04171765|520665430|FG000|Overall Study|Lost to Follow-up|0|||
144396853|NCT04171765|520665431|FG001|Overall Study|Lost to Follow-up|2|||
144396854|NCT04171765|520665432|FG002|Overall Study|Lost to Follow-up|2|||
144396855|NCT04171765|520665433|FG003|Overall Study|Lost to Follow-up|2|||
144396856|NCT04171765|520665430|FG000|Overall Study|Week 58 visit missed|0|||
144396857|NCT04171765|520665431|FG001|Overall Study|Week 58 visit missed|0|||
144396858|NCT04171765|520665432|FG002|Overall Study|Week 58 visit missed|1|||
144396859|NCT04171765|520665433|FG003|Overall Study|Week 58 visit missed|0|||
144396860|NCT04171765|520665430|FG000|Overall Study|Study terminated by sponsor|2|||
144396861|NCT04171765|520665431|FG001|Overall Study|Study terminated by sponsor|0|||
144396862|NCT04171765|520665432|FG002|Overall Study|Study terminated by sponsor|0|||
144396863|NCT04171765|520665433|FG003|Overall Study|Study terminated by sponsor|0|||
144396864|NCT04171765|520665430|FG000|Overall Study|Withdrawal by Subject|1|||
144396865|NCT04171765|520665431|FG001|Overall Study|Withdrawal by Subject|0|||
144396866|NCT04171765|520665432|FG002|Overall Study|Withdrawal by Subject|0|||
144396867|NCT04171765|520665433|FG003|Overall Study|Withdrawal by Subject|3|||
144396868|NCT00122109|520665435|FG000|Overall Study|Did not meet criteria|6|||
144396869|NCT00122109|520665436|FG001|Overall Study|Did not meet criteria|7|||
144396870|NCT00809354|520665437|FG000|Overall Study|Adverse Event|32|||
144396871|NCT00809354|520665438|FG001|Overall Study|Adverse Event|45|||
144396872|NCT00809354|520665439|FG002|Overall Study|Adverse Event|37|||
144396873|NCT00809354|520665440|FG003|Overall Study|Adverse Event|53|||
144396874|NCT00809354|520665441|FG004|Overall Study|Adverse Event|26|||
144396875|NCT00809354|520665442|FG005|Overall Study|Adverse Event|33|||
144396876|NCT00809354|520665443|FG006|Overall Study|Adverse Event|44|||
144396877|NCT00809354|520665444|FG007|Overall Study|Adverse Event|40|||
144396878|NCT00809354|520665445|FG008|Overall Study|Adverse Event|46|||
144396879|NCT00809354|520665446|FG009|Overall Study|Adverse Event|26|||
144396880|NCT00809354|520665437|FG000|Overall Study|Lack of Efficacy|23|||
144396881|NCT00809354|520665438|FG001|Overall Study|Lack of Efficacy|23|||
144396882|NCT00809354|520665439|FG002|Overall Study|Lack of Efficacy|22|||
144396883|NCT00809354|520665440|FG003|Overall Study|Lack of Efficacy|15|||
144396884|NCT00809354|520665441|FG004|Overall Study|Lack of Efficacy|40|||
144396885|NCT00809354|520665442|FG005|Overall Study|Lack of Efficacy|19|||
144396886|NCT00809354|520665443|FG006|Overall Study|Lack of Efficacy|21|||
144396887|NCT00809354|520665444|FG007|Overall Study|Lack of Efficacy|15|||
144396888|NCT00809354|520665445|FG008|Overall Study|Lack of Efficacy|18|||
144396889|NCT00809354|520665446|FG009|Overall Study|Lack of Efficacy|38|||
144396890|NCT00809354|520665437|FG000|Overall Study|Lost to Follow-up|10|||
144396891|NCT00809354|520665438|FG001|Overall Study|Lost to Follow-up|11|||
144396892|NCT00809354|520665439|FG002|Overall Study|Lost to Follow-up|8|||
144396893|NCT00809354|520665440|FG003|Overall Study|Lost to Follow-up|13|||
144396894|NCT00809354|520665441|FG004|Overall Study|Lost to Follow-up|6|||
144396895|NCT00809354|520665442|FG005|Overall Study|Lost to Follow-up|2|||
144396896|NCT00809354|520665443|FG006|Overall Study|Lost to Follow-up|0|||
144396897|NCT00809354|520665444|FG007|Overall Study|Lost to Follow-up|5|||
144396898|NCT00809354|520665445|FG008|Overall Study|Lost to Follow-up|4|||
144396899|NCT00809354|520665446|FG009|Overall Study|Lost to Follow-up|0|||
144396900|NCT00809354|520665437|FG000|Overall Study|Protocol Violation|7|||
144396901|NCT00809354|520665438|FG001|Overall Study|Protocol Violation|14|||
144396902|NCT00809354|520665439|FG002|Overall Study|Protocol Violation|14|||
144396903|NCT00809354|520665440|FG003|Overall Study|Protocol Violation|12|||
144396904|NCT00809354|520665441|FG004|Overall Study|Protocol Violation|14|||
144595486|NCT01723254|521379415|FG005|Overall Study|Withdrawal by Subject|1|||
144396905|NCT00809354|520665442|FG005|Overall Study|Protocol Violation|6|||
144396906|NCT00809354|520665443|FG006|Overall Study|Protocol Violation|4|||
144396907|NCT00809354|520665444|FG007|Overall Study|Protocol Violation|6|||
144396908|NCT00809354|520665445|FG008|Overall Study|Protocol Violation|9|||
144396909|NCT00809354|520665446|FG009|Overall Study|Protocol Violation|3|||
144396910|NCT00809354|520665437|FG000|Overall Study|Withdrawal by Subject|32|||
144396911|NCT00809354|520665438|FG001|Overall Study|Withdrawal by Subject|27|||
144396912|NCT00809354|520665439|FG002|Overall Study|Withdrawal by Subject|31|||
144595487|NCT01723254|521379416|FG006|Overall Study|Withdrawal by Subject|1|||
144595488|NCT01723254|521379417|FG007|Overall Study|Withdrawal by Subject|2|||
144396913|NCT00809354|520665440|FG003|Overall Study|Withdrawal by Subject|33|||
144396914|NCT00809354|520665441|FG004|Overall Study|Withdrawal by Subject|34|||
144396915|NCT00809354|520665442|FG005|Overall Study|Withdrawal by Subject|29|||
144396916|NCT00809354|520665443|FG006|Overall Study|Withdrawal by Subject|27|||
144396917|NCT00809354|520665444|FG007|Overall Study|Withdrawal by Subject|19|||
144396918|NCT00809354|520665445|FG008|Overall Study|Withdrawal by Subject|18|||
144396919|NCT00809354|520665446|FG009|Overall Study|Withdrawal by Subject|20|||
144396920|NCT00809354|520665437|FG000|Overall Study|Other|10|||
144396921|NCT00809354|520665438|FG001|Overall Study|Other|2|||
144396922|NCT00809354|520665439|FG002|Overall Study|Other|7|||
144396923|NCT00809354|520665440|FG003|Overall Study|Other|10|||
144396924|NCT00809354|520665441|FG004|Overall Study|Other|5|||
144396925|NCT00809354|520665442|FG005|Overall Study|Other|3|||
144396926|NCT00809354|520665443|FG006|Overall Study|Other|2|||
144396927|NCT00809354|520665444|FG007|Overall Study|Other|3|||
144396928|NCT00809354|520665445|FG008|Overall Study|Other|4|||
144396929|NCT00809354|520665446|FG009|Overall Study|Other|3|||
144396930|NCT00809354|520665437|FG000|Overall Study|Study terminated by sponsor|138|||
144396931|NCT00809354|520665438|FG001|Overall Study|Study terminated by sponsor|134|||
144396932|NCT00809354|520665439|FG002|Overall Study|Study terminated by sponsor|129|||
144396933|NCT00809354|520665440|FG003|Overall Study|Study terminated by sponsor|120|||
144396934|NCT00809354|520665441|FG004|Overall Study|Study terminated by sponsor|126|||
144396935|NCT00809354|520665442|FG005|Overall Study|Study terminated by sponsor|133|||
144396936|NCT00809354|520665443|FG006|Overall Study|Study terminated by sponsor|124|||
144396937|NCT00809354|520665444|FG007|Overall Study|Study terminated by sponsor|148|||
144396938|NCT00809354|520665445|FG008|Overall Study|Study terminated by sponsor|127|||
144396939|NCT00809354|520665446|FG009|Overall Study|Study terminated by sponsor|135|||
144396940|NCT00809354|520665437|FG000|Overall Study|Withdrawn due to pregnancy|0|||
144396941|NCT00809354|520665438|FG001|Overall Study|Withdrawn due to pregnancy|1|||
144396942|NCT00809354|520665439|FG002|Overall Study|Withdrawn due to pregnancy|0|||
144396943|NCT00809354|520665440|FG003|Overall Study|Withdrawn due to pregnancy|0|||
144396944|NCT00809354|520665441|FG004|Overall Study|Withdrawn due to pregnancy|0|||
144396945|NCT00809354|520665442|FG005|Overall Study|Withdrawn due to pregnancy|0|||
144396946|NCT00809354|520665443|FG006|Overall Study|Withdrawn due to pregnancy|0|||
144396947|NCT00809354|520665444|FG007|Overall Study|Withdrawn due to pregnancy|0|||
144396948|NCT00809354|520665445|FG008|Overall Study|Withdrawn due to pregnancy|0|||
144396949|NCT00809354|520665446|FG009|Overall Study|Withdrawn due to pregnancy|0|||
144396950|NCT00809354|520665437|FG000|Overall Study|Randomized but not Treated|3|||
144396951|NCT00809354|520665438|FG001|Overall Study|Randomized but not Treated|1|||
144396952|NCT00809354|520665439|FG002|Overall Study|Randomized but not Treated|6|||
144396953|NCT00809354|520665440|FG003|Overall Study|Randomized but not Treated|0|||
144396954|NCT00809354|520665441|FG004|Overall Study|Randomized but not Treated|5|||
144520902|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
144520903|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
144520904|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
144520905|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
144520906|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520907|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520908|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520909|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520910|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520911|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520912|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520913|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520914|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
144520915|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
144520916|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
144520917|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
144520918|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
144520919|NCT01261312|521108020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520920|NCT01261312|521108021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520921|NCT01261312|521108022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520922|NCT01261312|521108023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520923|NCT01261312|521108024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520924|NCT01261312|521108025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520925|NCT01261312|521108026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520926|NCT01261312|521108027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144520927|NCT01261312|521108028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
144396955|NCT00809354|520665442|FG005|Overall Study|Randomized but not Treated|0|||
144396956|NCT00809354|520665443|FG006|Overall Study|Randomized but not Treated|1|||
144396957|NCT00809354|520665444|FG007|Overall Study|Randomized but not Treated|1|||
144396958|NCT00809354|520665445|FG008|Overall Study|Randomized but not Treated|2|||
144396959|NCT00809354|520665446|FG009|Overall Study|Randomized but not Treated|1|||
144396960|NCT00809354|520665437|FG000|Overall Study|Death|0|||
144396961|NCT00809354|520665438|FG001|Overall Study|Death|0|||
144396962|NCT00809354|520665439|FG002|Overall Study|Death|0|||
144396963|NCT00809354|520665440|FG003|Overall Study|Death|0|||
144396964|NCT00809354|520665441|FG004|Overall Study|Death|0|||
144396965|NCT00809354|520665442|FG005|Overall Study|Death|0|||
144396966|NCT00809354|520665443|FG006|Overall Study|Death|0|||
144396967|NCT00809354|520665444|FG007|Overall Study|Death|1|||
144396968|NCT00809354|520665445|FG008|Overall Study|Death|0|||
144396969|NCT00809354|520665446|FG009|Overall Study|Death|0|||
144396970|NCT00100178|520665447|FG000|Overall Study|Lost to Follow-up|0|||
144396971|NCT00100178|520665448|FG001|Overall Study|Lost to Follow-up|6|||
144396972|NCT00100178|520665449|FG002|Overall Study|Lost to Follow-up|5|||
144396973|NCT00100178|520665447|FG000|Overall Study|Adverse Event|2|||
144396974|NCT00100178|520665448|FG001|Overall Study|Adverse Event|2|||
144396975|NCT00100178|520665449|FG002|Overall Study|Adverse Event|1|||
144396976|NCT00100178|520665447|FG000|Overall Study|Withdrawal by Subject|1|||
144396977|NCT00100178|520665448|FG001|Overall Study|Withdrawal by Subject|1|||
144396978|NCT00100178|520665449|FG002|Overall Study|Withdrawal by Subject|1|||
144396979|NCT00100178|520665447|FG000|Overall Study|Physician Decision|6|||
144396980|NCT00100178|520665448|FG001|Overall Study|Physician Decision|1|||
144396981|NCT00100178|520665449|FG002|Overall Study|Physician Decision|3|||
144396982|NCT02477839|520665454|FG000|Overall Study|Adverse Event|0|||
144396983|NCT02477839|520665455|FG001|Overall Study|Adverse Event|1|||
144396984|NCT02477839|520665454|FG000|Overall Study|Protocol Violation|0|||
144396985|NCT02477839|520665455|FG001|Overall Study|Protocol Violation|2|||
144396986|NCT02477839|520665454|FG000|Overall Study|Withdrawal by Subject|3|||
144396987|NCT02477839|520665455|FG001|Overall Study|Withdrawal by Subject|3|||
144396988|NCT02477839|520665454|FG000|Overall Study|Participant had PGS during V6|0|||
144396989|NCT02477839|520665455|FG001|Overall Study|Participant had PGS during V6|1|||
144396990|NCT02477839|520665454|FG000|Overall Study|Parents decided to stop medication|0|||
144396991|NCT02477839|520665455|FG001|Overall Study|Parents decided to stop medication|1|||
144396992|NCT02477839|520665454|FG000|Overall Study|Lack of tolerability|0|||
144396993|NCT02477839|520665455|FG001|Overall Study|Lack of tolerability|1|||
144396994|NCT02477839|520665454|FG000|Overall Study|Exclusion criterion|0|||
144396995|NCT02477839|520665455|FG001|Overall Study|Exclusion criterion|1|||
144396996|NCT00631696|520665458|FG000|Overall Study|Entered, not randomized to treatment|1|||
144396997|NCT00631696|520665459|FG001|Overall Study|Entered, not randomized to treatment|1|||
144396998|NCT00631696|520665458|FG000|Overall Study|Discontinued after database release date|1|||
144396999|NCT00631696|520665459|FG001|Overall Study|Discontinued after database release date|0|||
144397000|NCT00631696|520665458|FG000|Overall Study|Follow up after database release date|1|||
144397001|NCT00631696|520665459|FG001|Overall Study|Follow up after database release date|0|||
144397002|NCT00631696|520665458|FG000|Overall Study|Lost to Follow-up|7|||
144397003|NCT00631696|520665459|FG001|Overall Study|Lost to Follow-up|10|||
144397004|NCT00631696|520665458|FG000|Overall Study|Withdrawal by Subject|2|||
144397005|NCT00631696|520665459|FG001|Overall Study|Withdrawal by Subject|9|||
144397006|NCT00631696|520665458|FG000|Overall Study|Other|8|||
144397007|NCT00631696|520665459|FG001|Overall Study|Other|8|||
144397008|NCT00631696|520665458|FG000|Overall Study|Protocol Violation|9|||
144397009|NCT00631696|520665459|FG001|Overall Study|Protocol Violation|9|||
144397010|NCT00631696|520665458|FG000|Overall Study|Study terminated by sponsor|3|||
144397011|NCT00631696|520665459|FG001|Overall Study|Study terminated by sponsor|3|||
144397012|NCT00631696|520665458|FG000|Overall Study|Adverse Event|5|||
144520928|NCT01261312|521108029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
144520929|NCT01261312|521108030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
144520930|NCT01261312|521108031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
144520931|NCT01261312|521108032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
144520932|NCT03406871|521108034|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
144397013|NCT00631696|520665459|FG001|Overall Study|Adverse Event|0|||
144397014|NCT01439568|520665461|FG000|Overall Study|Lost to Follow-up|1|||
144520933|NCT03406871|521108035|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
144520934|NCT03406871|521108036|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
144520935|NCT03406871|521108034|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
144520936|NCT03406871|521108035|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
144397015|NCT01439568|520665462|FG001|Overall Study|Lost to Follow-up|0|||
144397016|NCT01439568|520665461|FG000|Overall Study|Withdrawal by Subject|2|||
144397017|NCT01439568|520665462|FG001|Overall Study|Withdrawal by Subject|2|||
144397018|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
144397019|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
144397020|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
144397021|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
144397022|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
144397023|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
144397024|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
144397025|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
144397026|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
144397027|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
144397028|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
144397029|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
144397030|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
144397031|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
144397032|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
144397033|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
144397034|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
144397035|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
144397036|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
144397037|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
144397038|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
144397039|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
144397040|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
144397041|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
144397042|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Death|2|||
144397043|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Death|1|||
144397044|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Death|0|||
144397045|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Death|0|||
144397046|NCT02607930|520665463|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
144397047|NCT02607930|520665464|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
144397048|NCT02607930|520665465|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
144397049|NCT02607930|520665466|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
144397050|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
144397051|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
144397052|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
144397053|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
144397054|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
144397055|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
144397056|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
144520937|NCT03406871|521108036|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
144520938|NCT03406871|521108034|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
144520939|NCT03406871|521108035|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
144520940|NCT03406871|521108036|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
144520941|NCT03406871|521108034|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
144520942|NCT03406871|521108035|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
144520943|NCT03406871|521108036|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
144520944|NCT03406871|521108034|FG000|Expansion Cohort(Final Analysis)|Death|0|||
144520945|NCT03406871|521108035|FG001|Expansion Cohort(Final Analysis)|Death|1|||
144520946|NCT03406871|521108036|FG002|Expansion Cohort(Final Analysis)|Death|0|||
144520947|NCT03406871|521108034|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
144520948|NCT03406871|521108035|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
144520949|NCT03406871|521108036|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
144520950|NCT04177823|521108044|FG000|Overall Study|Physician Decision|1|||
144520951|NCT04177823|521108044|FG000|Overall Study|Withdrawal by Subject|1|||
144520952|NCT04347161|521108045|FG000|Overall Study|Death|0|||
144520953|NCT04347161|521108046|FG001|Overall Study|Death|2|||
144520954|NCT04347161|521108045|FG000|Overall Study|Withdrawal by Subject|1|||
144520955|NCT04347161|521108046|FG001|Overall Study|Withdrawal by Subject|0|||
144520956|NCT04347161|521108045|FG000|Overall Study|Lost to Follow-up|0|||
144520957|NCT04347161|521108046|FG001|Overall Study|Lost to Follow-up|1|||
144520958|NCT04347161|521108045|FG000|Overall Study|No longer on study medication|1|||
144397057|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
144397058|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
144520959|NCT04347161|521108046|FG001|Overall Study|No longer on study medication|1|||
144520960|NCT03907397|521108050|FG000|Overall Study|Lost to Follow-up|0|||
144520961|NCT03907397|521108051|FG001|Overall Study|Lost to Follow-up|1|||
144520962|NCT03907397|521108050|FG000|Overall Study|Physician Decision|2|||
144520963|NCT03907397|521108051|FG001|Overall Study|Physician Decision|1|||
144520964|NCT03907397|521108050|FG000|Overall Study|Withdrawal by Subject|5|||
144520965|NCT03907397|521108051|FG001|Overall Study|Withdrawal by Subject|4|||
144538353|NCT00777049|521174166|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
144595489|NCT02668185|521379418|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
144595490|NCT02668185|521379419|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
144595491|NCT02668185|521379418|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
144595492|NCT02668185|521379419|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
144595493|NCT02668185|521379418|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
144595494|NCT02668185|521379419|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
144595495|NCT02668185|521379418|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
144595496|NCT02668185|521379419|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
144595497|NCT00770341|521379420|FG000|Overall Study|Did not meet eligibility criteria|1|||
144595498|NCT00770341|521379421|FG001|Overall Study|Did not meet eligibility criteria|0|||
144595499|NCT00770341|521379422|FG002|Overall Study|Did not meet eligibility criteria|0|||
144595500|NCT00770341|521379420|FG000|Overall Study|Withdrawal by Subject|0|||
144595501|NCT00770341|521379421|FG001|Overall Study|Withdrawal by Subject|1|||
144595502|NCT00770341|521379422|FG002|Overall Study|Withdrawal by Subject|0|||
144595503|NCT00770341|521379420|FG000|Overall Study|Clinical Adverse Event|3|||
144595504|NCT00770341|521379421|FG001|Overall Study|Clinical Adverse Event|1|||
144595505|NCT00770341|521379422|FG002|Overall Study|Clinical Adverse Event|2|||
144595506|NCT00770341|521379420|FG000|Overall Study|Laboratory adverse event|3|||
144595507|NCT00770341|521379421|FG001|Overall Study|Laboratory adverse event|3|||
144595508|NCT00770341|521379422|FG002|Overall Study|Laboratory adverse event|0|||
144595509|NCT00770341|521379420|FG000|Overall Study|Lack of Efficacy|3|||
144595510|NCT00770341|521379421|FG001|Overall Study|Lack of Efficacy|0|||
144595511|NCT00770341|521379422|FG002|Overall Study|Lack of Efficacy|1|||
144595512|NCT00770341|521379420|FG000|Overall Study|Other|1|||
144595513|NCT00770341|521379421|FG001|Overall Study|Other|0|||
144595514|NCT00770341|521379422|FG002|Overall Study|Other|0|||
144595515|NCT00770341|521379420|FG000|Overall Study|Not treated|1|||
144595516|NCT00770341|521379421|FG001|Overall Study|Not treated|0|||
144595517|NCT00770341|521379422|FG002|Overall Study|Not treated|0|||
144595518|NCT03316300|521379424|FG000|Overall Study|Withdrawal by Subject|3|||
144595519|NCT03316300|521379425|FG001|Overall Study|Withdrawal by Subject|2|||
144397059|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
144397060|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
144595520|NCT03316300|521379424|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
144595521|NCT03316300|521379425|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
144595522|NCT03316300|521379424|FG000|Overall Study|Adverse Event|1|||
144595523|NCT03316300|521379425|FG001|Overall Study|Adverse Event|0|||
144595524|NCT03316300|521379424|FG000|Overall Study|COVID-19|0|||
144595525|NCT03316300|521379425|FG001|Overall Study|COVID-19|1|||
144595526|NCT02390245|521379429|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
144595527|NCT02390245|521379430|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
144595528|NCT02390245|521379431|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
144595529|NCT02390245|521379429|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
144595530|NCT02390245|521379430|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
144595531|NCT02390245|521379431|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
144595532|NCT00355056|521381103|FG000|Randomization Period|Early Termination|4|||
144595533|NCT00355056|521381104|FG001|Randomization Period|Early Termination|6|||
144595534|NCT01072877|521381108|FG000|Overall Study|Lost to Follow-up|1|||
144595535|NCT01072877|521381109|FG001|Overall Study|Lost to Follow-up|1|||
144595536|NCT01072877|521381110|FG002|Overall Study|Lost to Follow-up|0|||
144595537|NCT01072877|521381111|FG003|Overall Study|Lost to Follow-up|2|||
144595538|NCT01072877|521381112|FG004|Overall Study|Lost to Follow-up|0|||
144595539|NCT00995020|521381113|FG000|Overall Study|margin analysis not performed|2|||
144595540|NCT00995020|521381114|FG001|Overall Study|margin analysis not performed|5|||
144595541|NCT00995020|521381113|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
144595542|NCT00995020|521381114|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
144595543|NCT02245672|521381115|FG000|Overall Study|Adverse Event|4|||
144595544|NCT02245672|521381116|FG001|Overall Study|Adverse Event|4|||
144595545|NCT02245672|521381117|FG002|Overall Study|Adverse Event|4|||
144595546|NCT02245672|521381115|FG000|Overall Study|Lost to Follow-up|3|||
144595547|NCT02245672|521381116|FG001|Overall Study|Lost to Follow-up|5|||
144595548|NCT02245672|521381117|FG002|Overall Study|Lost to Follow-up|1|||
144595549|NCT02245672|521381115|FG000|Overall Study|Withdrawal by Subject|6|||
144595550|NCT02245672|521381116|FG001|Overall Study|Withdrawal by Subject|3|||
144595551|NCT02245672|521381117|FG002|Overall Study|Withdrawal by Subject|0|||
144595552|NCT02245672|521381115|FG000|Overall Study|Randomized in error (not treated)|0|||
144595553|NCT02245672|521381116|FG001|Overall Study|Randomized in error (not treated)|1|||
144595554|NCT02245672|521381117|FG002|Overall Study|Randomized in error (not treated)|0|||
144595555|NCT01765192|521381118|FG000|Treatment Period 1|Adverse Event|0|||
144595556|NCT01765192|521381119|FG001|Treatment Period 1|Adverse Event|1|||
144595557|NCT01765192|521381118|FG000|Washout Period|Voluntary Withdrawal|1|||
144595558|NCT01765192|521381119|FG001|Washout Period|Voluntary Withdrawal|1|||
144595559|NCT01765192|521381118|FG000|Washout Period|Reason not specified|1|||
144595560|NCT01765192|521381119|FG001|Washout Period|Reason not specified|0|||
144595561|NCT01765192|521381118|FG000|Treatment Period 2|Reason not specified|0|||
144397061|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
144397062|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
144397063|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
144397064|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
144397065|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
144397066|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
144397067|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
144397068|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
144397069|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
144397070|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
144397071|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
144397072|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
144397073|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
144397074|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
144397075|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
144397076|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
144397077|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
144397078|NCT02607930|520665463|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
144397079|NCT02607930|520665464|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
144397080|NCT02607930|520665465|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
144397081|NCT02607930|520665466|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
144397082|NCT01578330|520665469|FG000|Overall Study|Adverse Event|2|||
144397083|NCT01578330|520665469|FG000|Overall Study|Protocol Violation|5|||
144397084|NCT03114488|520665470|FG000|Time Period 2|Withdrawal by Subject|1|||
144397085|NCT03114488|520665471|FG001|Time Period 2|Withdrawal by Subject|3|||
144397086|NCT01669928|520665472|FG000|First Intervention|Withdrawal by Subject|3|||
144397087|NCT01669928|520665473|FG001|First Intervention|Withdrawal by Subject|5|||
144520966|NCT03907397|521108050|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
144520967|NCT03907397|521108051|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
144520968|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
144520969|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
144520970|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
144520971|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
144520972|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
144520973|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
144520974|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
144520975|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
144520976|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
144520977|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
144520978|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
144520979|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
144520980|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
144520981|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
144520982|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
144520983|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
144520984|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
144520985|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
144520986|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
144520987|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
144397088|NCT00679055|520665474|FG000|Overall Study|Adverse Event|0|||
144520988|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
144520989|NCT05369403|521108052|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
144520990|NCT05369403|521108053|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
144520991|NCT05369403|521108054|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
144520992|NCT05369403|521108052|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
144520993|NCT05369403|521108053|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
144520994|NCT05369403|521108054|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
144520995|NCT05369403|521108052|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
144397089|NCT00679055|520665475|FG001|Overall Study|Adverse Event|1|||
144397090|NCT00679055|520665474|FG000|Overall Study|Other|0|||
144397091|NCT00679055|520665475|FG001|Overall Study|Other|3|||
144397092|NCT00679055|520665474|FG000|Overall Study|Study Terminated|2|||
144397093|NCT00679055|520665475|FG001|Overall Study|Study Terminated|1|||
144397094|NCT02758171|520665476|FG000|Wash-out|Withdrawal by Subject|1|||
144397095|NCT02758171|520665477|FG001|Wash-out|Withdrawal by Subject|0|||
144397096|NCT02758171|520665476|FG000|Wash-out|Other reason|1|||
144397097|NCT02758171|520665477|FG001|Wash-out|Other reason|0|||
144397098|NCT01199731|520665478|FG000|Overall Study|Adverse Event|0|||
144397099|NCT01199731|520665479|FG001|Overall Study|Adverse Event|1|||
144397100|NCT01199731|520665480|FG002|Overall Study|Adverse Event|0|||
144397101|NCT01199731|520665478|FG000|Overall Study|Study closed/terminated|7|||
144397102|NCT01199731|520665479|FG001|Overall Study|Study closed/terminated|9|||
144397103|NCT01199731|520665480|FG002|Overall Study|Study closed/terminated|7|||
144397104|NCT01199731|520665478|FG000|Overall Study|Lost to Follow-up|0|||
144397105|NCT01199731|520665479|FG001|Overall Study|Lost to Follow-up|0|||
144397106|NCT01199731|520665480|FG002|Overall Study|Lost to Follow-up|2|||
144397107|NCT01199731|520665478|FG000|Overall Study|Physician Decision|0|||
144397108|NCT01199731|520665479|FG001|Overall Study|Physician Decision|1|||
144397109|NCT01199731|520665480|FG002|Overall Study|Physician Decision|1|||
144397110|NCT01199731|520665478|FG000|Overall Study|Withdrawal by Subject|2|||
144397111|NCT01199731|520665479|FG001|Overall Study|Withdrawal by Subject|0|||
144397112|NCT01199731|520665480|FG002|Overall Study|Withdrawal by Subject|0|||
144397113|NCT01465191|520665481|FG000|Overall Study|Protocol Violation|6|||
144397114|NCT01465191|520665482|FG001|Overall Study|Protocol Violation|3|||
144397115|NCT01465191|520665483|FG002|Overall Study|Protocol Violation|3|||
144397116|NCT01465191|520665481|FG000|Overall Study|Lost to Follow-up|3|||
144397117|NCT01465191|520665482|FG001|Overall Study|Lost to Follow-up|6|||
144397118|NCT01465191|520665483|FG002|Overall Study|Lost to Follow-up|4|||
144397119|NCT00943124|520665484|FG000|Period 1|Withdrawal by Subject|1|||
144397120|NCT00943124|520665485|FG001|Period 1|Withdrawal by Subject|1|||
144397121|NCT00943124|520665484|FG000|Period 1|Did Not Follow Study Procedures|1|||
144397122|NCT00943124|520665485|FG001|Period 1|Did Not Follow Study Procedures|0|||
144397123|NCT00943124|520665484|FG000|Period 1|Personal Reasons|0|||
144397124|NCT00943124|520665485|FG001|Period 1|Personal Reasons|1|||
144397125|NCT02992132|520665486|FG000|Overall Study|Adverse Event|4|||
144397126|NCT02992132|520665487|FG001|Overall Study|Adverse Event|1|||
144397127|NCT02992132|520665488|FG002|Overall Study|Adverse Event|3|||
144397128|NCT02992132|520665486|FG000|Overall Study|Lack of Efficacy|2|||
144397129|NCT02992132|520665487|FG001|Overall Study|Lack of Efficacy|0|||
144397130|NCT02992132|520665488|FG002|Overall Study|Lack of Efficacy|0|||
144397131|NCT02992132|520665486|FG000|Overall Study|Non-compliance with study drug|2|||
144397132|NCT02992132|520665487|FG001|Overall Study|Non-compliance with study drug|0|||
144397133|NCT02992132|520665488|FG002|Overall Study|Non-compliance with study drug|0|||
144595562|NCT01765192|521381119|FG001|Treatment Period 2|Reason not specified|2|||
144595563|NCT01765192|521381118|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
144595564|NCT01765192|521381119|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
144595565|NCT00288509|521381127|FG000|Treatment Cycle 1|Adverse Event|1|||
144595566|NCT00288509|521381127|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
144595567|NCT00288509|521381127|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
144595568|NCT00288509|521381127|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
144595569|NCT00288509|521381127|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
144595570|NCT00288509|521381127|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
144595571|NCT00288509|521381127|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
144397134|NCT02992132|520665486|FG000|Overall Study|Progressive disease|1|||
144397135|NCT02992132|520665487|FG001|Overall Study|Progressive disease|0|||
144397136|NCT02992132|520665488|FG002|Overall Study|Progressive disease|0|||
144595572|NCT00288509|521381127|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
144595573|NCT00288509|521381127|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
144595574|NCT00288509|521381127|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
144595575|NCT00288509|521381127|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
144397137|NCT02992132|520665486|FG000|Overall Study|Protocol Violation|2|||
144397138|NCT02992132|520665487|FG001|Overall Study|Protocol Violation|2|||
144397139|NCT02992132|520665488|FG002|Overall Study|Protocol Violation|0|||
144397140|NCT02992132|520665486|FG000|Overall Study|Caregiver withdrew consent|2|||
144397141|NCT02992132|520665487|FG001|Overall Study|Caregiver withdrew consent|3|||
144397142|NCT02992132|520665488|FG002|Overall Study|Caregiver withdrew consent|2|||
144397143|NCT02992132|520665486|FG000|Overall Study|Withdrawal by Subject|0|||
144397144|NCT02992132|520665487|FG001|Overall Study|Withdrawal by Subject|2|||
144397145|NCT02992132|520665488|FG002|Overall Study|Withdrawal by Subject|1|||
144397146|NCT02992132|520665486|FG000|Overall Study|Physician Decision|0|||
144595576|NCT00288509|521381127|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
144595577|NCT00288509|521381127|FG000|Treatment Cycle 4|Physician Decision|4|||
144595578|NCT00288509|521381127|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
144397147|NCT02992132|520665487|FG001|Overall Study|Physician Decision|0|||
144397148|NCT02992132|520665488|FG002|Overall Study|Physician Decision|1|||
144397149|NCT00764491|520665494|FG000|Overall Study|Lost to Follow-up|35|||
144397150|NCT00764491|520665495|FG001|Overall Study|Lost to Follow-up|17|||
144397151|NCT00620464|520665496|FG000|Overall Study|Adverse Event|15|||
144397152|NCT00620464|520665497|FG001|Overall Study|Adverse Event|17|||
144397153|NCT00620464|520665496|FG000|Overall Study|Lost to Follow-up|1|||
144397154|NCT00620464|520665497|FG001|Overall Study|Lost to Follow-up|1|||
144397155|NCT00620464|520665496|FG000|Overall Study|Planning Pregnancy|1|||
144397156|NCT00620464|520665497|FG001|Overall Study|Planning Pregnancy|4|||
144397157|NCT00620464|520665496|FG000|Overall Study|Personal|2|||
144397158|NCT00620464|520665497|FG001|Overall Study|Personal|2|||
144397159|NCT00620464|520665496|FG000|Overall Study|Used prohibited medication|1|||
144397160|NCT00620464|520665497|FG001|Overall Study|Used prohibited medication|0|||
144397161|NCT05394350|520665498|FG000|Overall Study|Death|2|||
144397162|NCT05394350|520665499|FG001|Overall Study|Death|2|||
144397163|NCT05394350|520665500|FG002|Overall Study|Death|4|||
144397164|NCT05394350|520665501|FG003|Overall Study|Death|0|||
144397165|NCT05394350|520665502|FG004|Overall Study|Death|1|||
144397166|NCT05394350|520665503|FG005|Overall Study|Death|0|||
144397167|NCT05394350|520665498|FG000|Overall Study|Study terminated by sponsor|1|||
144397168|NCT05394350|520665499|FG001|Overall Study|Study terminated by sponsor|1|||
144397169|NCT05394350|520665500|FG002|Overall Study|Study terminated by sponsor|7|||
144397170|NCT05394350|520665501|FG003|Overall Study|Study terminated by sponsor|3|||
144397171|NCT05394350|520665502|FG004|Overall Study|Study terminated by sponsor|2|||
144397172|NCT05394350|520665503|FG005|Overall Study|Study terminated by sponsor|4|||
144397173|NCT03911154|520665504|FG000|Overall Study|Withdrawal by Subject|1|||
144397174|NCT01231347|520665505|FG000|Overall Study|Full Consent withdrawn|19|||
144397175|NCT01231347|520665506|FG001|Overall Study|Full Consent withdrawn|19|||
144397176|NCT01231347|520665507|FG002|Overall Study|Full Consent withdrawn|11|||
144397177|NCT01231347|520665505|FG000|Overall Study|Lost to Follow-up|4|||
144397178|NCT01231347|520665506|FG001|Overall Study|Lost to Follow-up|2|||
144397179|NCT01231347|520665507|FG002|Overall Study|Lost to Follow-up|2|||
144397180|NCT01231347|520665505|FG000|Overall Study|Death|202|||
144397181|NCT01231347|520665506|FG001|Overall Study|Death|210|||
144397182|NCT01231347|520665507|FG002|Overall Study|Death|101|||
144397183|NCT01231347|520665505|FG000|Overall Study|other event|7|||
144397184|NCT01231347|520665506|FG001|Overall Study|other event|9|||
144397185|NCT01231347|520665507|FG002|Overall Study|other event|3|||
144397186|NCT01460368|520665508|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
144397187|NCT01460368|520665509|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
144397188|NCT01460368|520665510|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
144397189|NCT01460368|520665511|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
144397190|NCT01460368|520665512|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
144397191|NCT01460368|520665513|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
144397192|NCT01460368|520665514|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
144397193|NCT01460368|520665508|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
144397194|NCT01460368|520665509|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
144397195|NCT01460368|520665510|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
144397196|NCT01460368|520665511|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
144397197|NCT01460368|520665512|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
144397198|NCT01460368|520665513|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
144397199|NCT01460368|520665514|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
144595579|NCT02382016|521381128|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
144595580|NCT02382016|521381129|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
144595581|NCT02382016|521381128|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
144595582|NCT02382016|521381129|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
144595583|NCT02382016|521381128|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
144595584|NCT02382016|521381129|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
144397200|NCT01460368|520665508|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
144397201|NCT01460368|520665509|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
144397202|NCT01460368|520665510|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
144397203|NCT01460368|520665511|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
144397204|NCT01460368|520665512|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
144397205|NCT01460368|520665513|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
144397206|NCT01460368|520665514|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
144397207|NCT01460368|520665508|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
144397208|NCT01460368|520665509|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
144595585|NCT02382016|521381128|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
144397209|NCT01460368|520665510|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
144520996|NCT05369403|521108053|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
144520997|NCT05369403|521108054|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
144520998|NCT05369403|521108052|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
144520999|NCT05369403|521108053|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
144521000|NCT05369403|521108054|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
144521001|NCT05516147|521108055|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
144521002|NCT02035787|521108056|FG000|Overall Study- 12 Months|Adverse Event|3|||
144521003|NCT02035787|521108057|FG001|Overall Study- 12 Months|Adverse Event|0|||
144521004|NCT02035787|521108056|FG000|Overall Study- 12 Months|Complete response|4|||
144521005|NCT02035787|521108057|FG001|Overall Study- 12 Months|Complete response|1|||
144521006|NCT02035787|521108056|FG000|Overall Study- 12 Months|Protocol Violation|1|||
144397210|NCT01460368|520665511|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
144397211|NCT01460368|520665512|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
144397212|NCT01460368|520665513|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
144397213|NCT01460368|520665514|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
144397214|NCT01460368|520665508|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
144397215|NCT01460368|520665509|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
144397216|NCT01460368|520665510|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
144397217|NCT01460368|520665511|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
144397218|NCT01460368|520665512|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
144397219|NCT01460368|520665513|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
144397220|NCT01460368|520665514|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
144397221|NCT02322021|520665515|FG000|Core Phase|Adverse Event|1|||
144397222|NCT02322021|520665516|FG001|Core Phase|Adverse Event|3|||
144397223|NCT02322021|520665517|FG002|Core Phase|Adverse Event|4|||
144397224|NCT02322021|520665518|FG003|Core Phase|Adverse Event|2|||
144397225|NCT02322021|520665519|FG004|Core Phase|Adverse Event|0|||
144397226|NCT02322021|520665515|FG000|Core Phase|Participant Choice|4|||
144397227|NCT02322021|520665516|FG001|Core Phase|Participant Choice|5|||
144397228|NCT02322021|520665517|FG002|Core Phase|Participant Choice|4|||
144397229|NCT02322021|520665518|FG003|Core Phase|Participant Choice|2|||
144397230|NCT02322021|520665519|FG004|Core Phase|Participant Choice|0|||
144397231|NCT02322021|520665515|FG000|Core Phase|Lost to Follow-up|0|||
144397232|NCT02322021|520665516|FG001|Core Phase|Lost to Follow-up|0|||
144397233|NCT02322021|520665517|FG002|Core Phase|Lost to Follow-up|0|||
144397234|NCT02322021|520665518|FG003|Core Phase|Lost to Follow-up|1|||
144397235|NCT02322021|520665519|FG004|Core Phase|Lost to Follow-up|0|||
144397236|NCT02322021|520665515|FG000|Core Phase|Other|0|||
144397237|NCT02322021|520665516|FG001|Core Phase|Other|0|||
144397238|NCT02322021|520665517|FG002|Core Phase|Other|1|||
144397239|NCT02322021|520665518|FG003|Core Phase|Other|0|||
144397240|NCT02322021|520665519|FG004|Core Phase|Other|0|||
144397241|NCT02322021|520665515|FG000|Extension Phase|Adverse Event|0|||
144397242|NCT02322021|520665516|FG001|Extension Phase|Adverse Event|0|||
144397243|NCT02322021|520665517|FG002|Extension Phase|Adverse Event|0|||
144397244|NCT02322021|520665518|FG003|Extension Phase|Adverse Event|0|||
144397245|NCT02322021|520665519|FG004|Extension Phase|Adverse Event|3|||
144397246|NCT02322021|520665515|FG000|Extension Phase|Participant Choice|0|||
144521007|NCT02035787|521108057|FG001|Overall Study- 12 Months|Protocol Violation|1|||
144521008|NCT06414213|521108058|FG000|Overall Study|Lost to Follow-up|1|||
144521009|NCT06414213|521108059|FG001|Overall Study|Lost to Follow-up|1|||
144521010|NCT06414213|521108060|FG002|Overall Study|Lost to Follow-up|3|||
144521011|NCT03853746|521108062|FG000|Overall Study|Withdrawal by Subject|1|||
144521012|NCT01084876|521108063|FG000|Main Study Treatment Period|Adverse Event|12|||
144521013|NCT01084876|521108064|FG001|Main Study Treatment Period|Adverse Event|7|||
144521014|NCT01084876|521108063|FG000|Main Study Treatment Period|Disease Progression|41|||
144521015|NCT01084876|521108064|FG001|Main Study Treatment Period|Disease Progression|24|||
144521016|NCT01084876|521108063|FG000|Main Study Treatment Period|Physician Decision|2|||
144521017|NCT01084876|521108064|FG001|Main Study Treatment Period|Physician Decision|0|||
144521018|NCT01084876|521108063|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
144521019|NCT01084876|521108064|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
144521020|NCT01084876|521108063|FG000|Main Study Treatment Period|Other Reason|0|||
144521021|NCT01084876|521108064|FG001|Main Study Treatment Period|Other Reason|1|||
144521022|NCT01084876|521108063|FG000|Main Study Treatment Period|Other|0|||
144521023|NCT01084876|521108064|FG001|Main Study Treatment Period|Other|1|||
144521024|NCT01084876|521108063|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
144521025|NCT01084876|521108064|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
144521026|NCT01084876|521108063|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
144521027|NCT01084876|521108064|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
144521028|NCT01084876|521108063|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
144521029|NCT01084876|521108064|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
144521030|NCT01084876|521108063|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
144521031|NCT01084876|521108064|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
144521032|NCT01084876|521108063|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
144521033|NCT01084876|521108064|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
144521034|NCT01084876|521108063|FG000|Treatment Period Beyond Cycle 8|Other|6|||
144521035|NCT01084876|521108064|FG001|Treatment Period Beyond Cycle 8|Other|9|||
144521036|NCT04952909|521108065|FG000|Overall Study|Death|3|||
144521037|NCT05434078|521108068|FG000|Overall Study|Lost to Follow-up|2|||
144397247|NCT02322021|520665516|FG001|Extension Phase|Participant Choice|0|||
144397248|NCT02322021|520665517|FG002|Extension Phase|Participant Choice|0|||
144397249|NCT02322021|520665518|FG003|Extension Phase|Participant Choice|0|||
144397250|NCT02322021|520665519|FG004|Extension Phase|Participant Choice|6|||
144397251|NCT02322021|520665515|FG000|Extension Phase|Other|0|||
144397252|NCT02322021|520665516|FG001|Extension Phase|Other|0|||
144397253|NCT02322021|520665517|FG002|Extension Phase|Other|0|||
144397254|NCT02322021|520665518|FG003|Extension Phase|Other|0|||
144397255|NCT02322021|520665519|FG004|Extension Phase|Other|3|||
144397256|NCT02322021|520665515|FG000|Extension Phase|Lost to Follow-up|0|||
144397257|NCT02322021|520665516|FG001|Extension Phase|Lost to Follow-up|0|||
144397258|NCT02322021|520665517|FG002|Extension Phase|Lost to Follow-up|0|||
144397259|NCT02322021|520665518|FG003|Extension Phase|Lost to Follow-up|0|||
144397260|NCT02322021|520665519|FG004|Extension Phase|Lost to Follow-up|1|||
144397261|NCT02322021|520665515|FG000|Extension Phase|Study terminated by sponsor|0|||
144397262|NCT02322021|520665516|FG001|Extension Phase|Study terminated by sponsor|0|||
144397263|NCT02322021|520665517|FG002|Extension Phase|Study terminated by sponsor|0|||
144397264|NCT02322021|520665518|FG003|Extension Phase|Study terminated by sponsor|0|||
144397265|NCT02322021|520665519|FG004|Extension Phase|Study terminated by sponsor|28|||
144397266|NCT01385371|520665532|FG000|Overall Study|Adverse Event|54|||
144397267|NCT01385371|520665533|FG001|Overall Study|Adverse Event|19|||
144397268|NCT01385371|520665532|FG000|Overall Study|Lost to Follow-up|16|||
144249631|NCT01897571|520111702|FG002|Overall Study|Withdrawal by Subject|0|||
144249632|NCT01897571|520111703|FG003|Overall Study|Withdrawal by Subject|0|||
144249633|NCT01897571|520111704|FG004|Overall Study|Withdrawal by Subject|0|||
144249634|NCT01897571|520111705|FG005|Overall Study|Withdrawal by Subject|0|||
144397269|NCT01385371|520665533|FG001|Overall Study|Lost to Follow-up|16|||
144397270|NCT01385371|520665532|FG000|Overall Study|Withdrawal by Subject|52|||
144397271|NCT01385371|520665533|FG001|Overall Study|Withdrawal by Subject|39|||
144397272|NCT01385371|520665532|FG000|Overall Study|Protocol Violation|25|||
144521038|NCT05434078|521108069|FG001|Overall Study|Lost to Follow-up|1|||
144521039|NCT05434078|521108068|FG000|Overall Study|Withdrawal by Subject|1|||
144521040|NCT05434078|521108069|FG001|Overall Study|Withdrawal by Subject|0|||
144397273|NCT01385371|520665533|FG001|Overall Study|Protocol Violation|21|||
144397274|NCT01385371|520665532|FG000|Overall Study|Administrative|2|||
144397275|NCT01385371|520665533|FG001|Overall Study|Administrative|2|||
144521041|NCT04072380|521108070|FG000|Overall Study|Adverse Event|4|||
144521042|NCT04072380|521108071|FG001|Overall Study|Adverse Event|6|||
144521043|NCT04072380|521108072|FG002|Overall Study|Adverse Event|0|||
144521044|NCT04072380|521108070|FG000|Overall Study|Withdrawal by Subject|3|||
144521045|NCT04072380|521108071|FG001|Overall Study|Withdrawal by Subject|1|||
144521046|NCT04072380|521108072|FG002|Overall Study|Withdrawal by Subject|1|||
144521047|NCT04072380|521108070|FG000|Overall Study|Physician Decision|2|||
144521048|NCT04072380|521108071|FG001|Overall Study|Physician Decision|0|||
144521049|NCT04072380|521108072|FG002|Overall Study|Physician Decision|0|||
144521050|NCT04072380|521108070|FG000|Overall Study|Protocol Violation|0|||
144521051|NCT04072380|521108071|FG001|Overall Study|Protocol Violation|2|||
144521052|NCT04072380|521108072|FG002|Overall Study|Protocol Violation|3|||
144521053|NCT04072380|521108070|FG000|Overall Study|Intercurrent Illness and Others|3|||
144521054|NCT04072380|521108071|FG001|Overall Study|Intercurrent Illness and Others|5|||
144521055|NCT04072380|521108072|FG002|Overall Study|Intercurrent Illness and Others|6|||
144397276|NCT03643159|520665537|FG000|Overall Study|Adverse Event|1|||
144397277|NCT03643159|520665537|FG000|Overall Study|Withdrawal by Subject|1|||
144397278|NCT01528033|520665538|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
144249635|NCT01897571|520111706|FG006|Overall Study|Withdrawal by Subject|0|||
144249636|NCT01897571|520111707|FG007|Overall Study|Withdrawal by Subject|1|||
144249637|NCT01897571|520111708|FG008|Overall Study|Withdrawal by Subject|4|||
144249638|NCT01897571|520111709|FG009|Overall Study|Withdrawal by Subject|3|||
144249639|NCT01897571|520111710|FG010|Overall Study|Withdrawal by Subject|1|||
144249640|NCT01897571|520111700|FG000|Overall Study|Other|1|||
144249641|NCT01897571|520111701|FG001|Overall Study|Other|0|||
144249642|NCT01897571|520111702|FG002|Overall Study|Other|0|||
144249643|NCT01897571|520111703|FG003|Overall Study|Other|3|||
144249644|NCT01897571|520111704|FG004|Overall Study|Other|3|||
144249645|NCT01897571|520111705|FG005|Overall Study|Other|4|||
144521056|NCT03033576|521108080|FG000|Overall Study|Ineligible|1|||
144521057|NCT03033576|521108081|FG001|Overall Study|Ineligible|1|||
144521058|NCT03033576|521108080|FG000|Overall Study|Adverse Event|4|||
144521059|NCT03033576|521108081|FG001|Overall Study|Adverse Event|20|||
144521060|NCT03033576|521108080|FG000|Overall Study|Progression/relapse|9|||
144521061|NCT03033576|521108081|FG001|Overall Study|Progression/relapse|36|||
144521062|NCT03033576|521108080|FG000|Overall Study|Death|1|||
144521063|NCT03033576|521108081|FG001|Overall Study|Death|1|||
144521064|NCT03033576|521108080|FG000|Overall Study|Patient refusal|1|||
144521065|NCT03033576|521108081|FG001|Overall Study|Patient refusal|6|||
144249646|NCT01897571|520111706|FG006|Overall Study|Other|7|||
144521066|NCT03033576|521108080|FG000|Overall Study|Other, unspecified reasons|0|||
144521067|NCT03033576|521108081|FG001|Overall Study|Other, unspecified reasons|4|||
144521068|NCT03033576|521108080|FG000|Overall Study|Currently on protocol therapy|0|||
144521069|NCT03033576|521108081|FG001|Overall Study|Currently on protocol therapy|2|||
144521070|NCT03557697|521108082|FG000|Overall Study|Withdrawal by Subject|2|||
144521071|NCT03557697|521108083|FG001|Overall Study|Withdrawal by Subject|4|||
144521072|NCT06491433|521108084|FG000|Overall Study|Protocol Violation|51|||
144521073|NCT06491433|521108084|FG000|Overall Study|consent withdrawal|2|||
144521074|NCT06491433|521108084|FG000|Overall Study|screen failure|1|||
144521075|NCT05894577|521108090|FG000|Overall Study|No receipt of study drug|14|||
144521076|NCT05894577|521108091|FG001|Overall Study|No receipt of study drug|13|||
144521077|NCT05894577|521108090|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
144521078|NCT05894577|521108091|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
144521079|NCT05894577|521108090|FG000|Overall Study|Screen Fail|2|||
144521080|NCT05894577|521108091|FG001|Overall Study|Screen Fail|0|||
144521081|NCT05894577|521108090|FG000|Overall Study|Study drug recall|86|||
144521082|NCT05894577|521108091|FG001|Overall Study|Study drug recall|63|||
144521083|NCT03721952|521108092|FG000|Overall Study|Lost to Follow-up|0|||
144521084|NCT03721952|521108093|FG001|Overall Study|Lost to Follow-up|0|||
144521085|NCT03721952|521108094|FG002|Overall Study|Lost to Follow-up|2|||
144521086|NCT03721952|521108095|FG003|Overall Study|Lost to Follow-up|0|||
144521087|NCT03721952|521108096|FG004|Overall Study|Lost to Follow-up|0|||
144521088|NCT03721952|521108092|FG000|Overall Study|Protocol Violation|0|||
144521089|NCT03721952|521108093|FG001|Overall Study|Protocol Violation|1|||
144521090|NCT03721952|521108094|FG002|Overall Study|Protocol Violation|0|||
144521091|NCT03721952|521108095|FG003|Overall Study|Protocol Violation|0|||
144521092|NCT03721952|521108096|FG004|Overall Study|Protocol Violation|0|||
144521093|NCT03721952|521108092|FG000|Overall Study|Withdrawal by Subject|1|||
144521094|NCT03721952|521108093|FG001|Overall Study|Withdrawal by Subject|0|||
144521095|NCT03721952|521108094|FG002|Overall Study|Withdrawal by Subject|40|||
144521096|NCT03721952|521108095|FG003|Overall Study|Withdrawal by Subject|28|||
144521097|NCT03721952|521108096|FG004|Overall Study|Withdrawal by Subject|0|||
144521098|NCT02949362|521108100|FG000|Retrospective Period|Inform consent not signed by participant|4|||
144521099|NCT02949362|521108101|FG001|Retrospective Period|Inform consent not signed by participant|1|||
144521100|NCT02949362|521108102|FG002|Retrospective Period|Inform consent not signed by participant|0|||
144521101|NCT02949362|521108103|FG003|Retrospective Period|Inform consent not signed by participant|0|||
144249647|NCT01897571|520111707|FG007|Overall Study|Other|0|||
144521102|NCT02949362|521108100|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
144521103|NCT02949362|521108101|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
144521104|NCT02949362|521108102|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
144521105|NCT02949362|521108103|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
144521106|NCT02949362|521108100|FG000|Prospective Period|Other|0|||
144249648|NCT01897571|520111708|FG008|Overall Study|Other|0|||
144249649|NCT01897571|520111709|FG009|Overall Study|Other|0|||
144397279|NCT01528033|520665539|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
144595586|NCT02382016|521381129|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
144595587|NCT02382016|521381128|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
144595588|NCT02382016|521381129|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
144595589|NCT02382016|521381128|FG000|Open-label (OL) Treatment Period|Death|4|||
144595590|NCT02382016|521381129|FG001|Open-label (OL) Treatment Period|Death|0|||
144595591|NCT02382016|521381128|FG000|OL Extension Period|Physician Decision|3|||
144595592|NCT02382016|521381129|FG001|OL Extension Period|Physician Decision|0|||
144595593|NCT02382016|521381128|FG000|OL Extension Period|Death|2|||
144595594|NCT02382016|521381129|FG001|OL Extension Period|Death|0|||
144595595|NCT02382016|521381128|FG000|OL Extension Period|Withdrawal by Subject|1|||
144595596|NCT02382016|521381129|FG001|OL Extension Period|Withdrawal by Subject|0|||
144595597|NCT00084266|521381130|FG000|Overall Study|Death|42|||
144595598|NCT00084266|521381131|FG001|Overall Study|Death|39|||
144595599|NCT00084266|521381130|FG000|Overall Study|Adverse Event|8|||
144595600|NCT00084266|521381131|FG001|Overall Study|Adverse Event|5|||
144595601|NCT00084266|521381130|FG000|Overall Study|Lack of Efficacy|2|||
144595602|NCT00084266|521381131|FG001|Overall Study|Lack of Efficacy|4|||
144595603|NCT00084266|521381130|FG000|Overall Study|Lost to Follow-up|5|||
144595604|NCT00084266|521381131|FG001|Overall Study|Lost to Follow-up|3|||
144595605|NCT00084266|521381130|FG000|Overall Study|Participant not willing to participate|3|||
144595606|NCT00084266|521381131|FG001|Overall Study|Participant not willing to participate|8|||
144595607|NCT00084266|521381130|FG000|Overall Study|Other|360|||
144595608|NCT00084266|521381131|FG001|Overall Study|Other|344|||
144595609|NCT00084266|521381130|FG000|Overall Study|Randomized not treated|21|||
144595610|NCT00084266|521381131|FG001|Overall Study|Randomized not treated|20|||
144595611|NCT00730171|521381132|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
144595612|NCT00730171|521381132|FG000|Overall Study|Adverse Event|193|||
144595613|NCT00730171|521381132|FG000|Overall Study|Protocol Violation|48|||
144595614|NCT00730171|521381132|FG000|Overall Study|Withdrawal by Subject|202|||
144595615|NCT00730171|521381132|FG000|Overall Study|Lost to Follow-up|121|||
144595616|NCT00730171|521381132|FG000|Overall Study|Insufficient Therapeutic Response|141|||
144595617|NCT00730171|521381132|FG000|Overall Study|Other|61|||
144595618|NCT01729156|521381133|FG000|Overall Study|Withdrawal by Subject|1|||
144595619|NCT01729156|521381134|FG001|Overall Study|Withdrawal by Subject|0|||
144595620|NCT01729156|521381135|FG002|Overall Study|Withdrawal by Subject|0|||
144595621|NCT01215422|521381136|FG000|Overall Study|Relocation|1|||
144595622|NCT01215422|521381137|FG001|Overall Study|Relocation|0|||
144595623|NCT01215422|521381138|FG002|Overall Study|Relocation|0|||
144595624|NCT01215422|521381139|FG003|Overall Study|Relocation|0|||
144595625|NCT01215422|521381136|FG000|Overall Study|Failed intubations|0|||
144595626|NCT01215422|521381137|FG001|Overall Study|Failed intubations|0|||
144595627|NCT01215422|521381138|FG002|Overall Study|Failed intubations|3|||
144595628|NCT01215422|521381139|FG003|Overall Study|Failed intubations|8|||
144595629|NCT01215422|521381136|FG000|Overall Study|Did not complete all intubations|7|||
144595630|NCT01215422|521381137|FG001|Overall Study|Did not complete all intubations|0|||
144595631|NCT01215422|521381138|FG002|Overall Study|Did not complete all intubations|0|||
144595632|NCT01215422|521381139|FG003|Overall Study|Did not complete all intubations|0|||
144595633|NCT01256658|521381140|FG000|Period 1|Lost to Follow-up|837|||
144595634|NCT01256658|521381141|FG001|Period 1|Lost to Follow-up|661|||
144595635|NCT01256658|521381140|FG000|Period 1|Withdrawal by Subject|35|||
144595636|NCT01256658|521381141|FG001|Period 1|Withdrawal by Subject|43|||
144595637|NCT01256658|521381140|FG000|Period 1|Death|48|||
144595638|NCT01256658|521381141|FG001|Period 1|Death|44|||
144595639|NCT00719563|521381146|FG000|Overall Study|Adverse Event|16|||
144595640|NCT00719563|521381147|FG001|Overall Study|Adverse Event|13|||
144595641|NCT00719563|521381146|FG000|Overall Study|Medical condition changed|3|||
144595642|NCT00719563|521381147|FG001|Overall Study|Medical condition changed|5|||
144595643|NCT00719563|521381146|FG000|Overall Study|Lack of Efficacy|3|||
144595644|NCT00719563|521381147|FG001|Overall Study|Lack of Efficacy|7|||
144595645|NCT00719563|521381146|FG000|Overall Study|Personal reasons|6|||
144595646|NCT00719563|521381147|FG001|Overall Study|Personal reasons|7|||
144595647|NCT00719563|521381146|FG000|Overall Study|Unknown reasons|4|||
144595648|NCT00719563|521381147|FG001|Overall Study|Unknown reasons|6|||
144595649|NCT00719563|521381146|FG000|Overall Study|Noncompliant|1|||
144595650|NCT00719563|521381147|FG001|Overall Study|Noncompliant|1|||
144595651|NCT00719563|521381146|FG000|Overall Study|Lost to Follow-up|5|||
144595652|NCT00719563|521381147|FG001|Overall Study|Lost to Follow-up|3|||
144595653|NCT00294554|521381148|FG000|Overall Study|Lack of Efficacy|0|||
144595654|NCT00294554|521381149|FG001|Overall Study|Lack of Efficacy|1|||
144595655|NCT00294554|521381148|FG000|Overall Study|Physician Decision|0|||
144595656|NCT00294554|521381149|FG001|Overall Study|Physician Decision|1|||
144595657|NCT00462865|521381150|FG000|Overall Study|Adverse Event|1|||
144595658|NCT04142450|521381151|FG000|Overall Study|Screen Failure|1|||
144595659|NCT04142450|521381151|FG000|Overall Study|Lost to Follow-up|1|||
144595660|NCT06336603|521381152|FG000|Overall Study|Withdrawal by Subject|1|||
144595661|NCT06336603|521381152|FG000|Overall Study|Lost to Follow-up|2|||
144595662|NCT01146054|521381155|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
144595663|NCT01146054|521381155|FG000|Overall Study|Rapid tumor progression|2|||
144595664|NCT01146054|521381155|FG000|Overall Study|Other illness precluded treatment|2|||
144595665|NCT01146054|521381155|FG000|Overall Study|Lost to Follow-up|1|||
144595666|NCT04335812|521381156|FG000|Overall Study|Withdrawal by Subject|1|||
144595667|NCT04335812|521381157|FG001|Overall Study|Withdrawal by Subject|3|||
144595668|NCT04335812|521381156|FG000|Overall Study|Lost to Follow-up|12|||
144595669|NCT04335812|521381157|FG001|Overall Study|Lost to Follow-up|12|||
144595670|NCT04335812|521381156|FG000|Overall Study|Did not engage in the intervention|22|||
144595671|NCT04335812|521381157|FG001|Overall Study|Did not engage in the intervention|18|||
144595672|NCT02901041|521381163|FG000|Overall Study|Withdrawal by PI|4|||
144595673|NCT02901041|521381164|FG001|Overall Study|Withdrawal by PI|8|||
144595674|NCT02901041|521381163|FG000|Overall Study|Withdrawal by Subject|7|||
144595675|NCT02901041|521381164|FG001|Overall Study|Withdrawal by Subject|3|||
144595676|NCT01480674|521381168|FG000|Overall Study|Death|23|||
144595677|NCT01480674|521381168|FG000|Overall Study|Lost to Follow-up|2|||
144595678|NCT01480674|521381168|FG000|Overall Study|visit not done|10|||
144595679|NCT03249714|521381169|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
144595680|NCT03249714|521381170|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
144595681|NCT03249714|521381169|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
144595682|NCT03249714|521381170|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
144595683|NCT03249714|521381169|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
144595684|NCT03249714|521381170|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
144595685|NCT03249714|521381169|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
144595686|NCT03249714|521381170|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
144595687|NCT00655863|521381178|FG000|Overall Study|Lost to Follow-up|0|||
144595688|NCT00655863|521381179|FG001|Overall Study|Lost to Follow-up|0|||
144595689|NCT00655863|521381180|FG002|Overall Study|Lost to Follow-up|1|||
144595690|NCT01138007|521381181|FG000|Overall Study|Adverse Event|4|||
144595691|NCT01138007|521381182|FG001|Overall Study|Adverse Event|12|||
144595692|NCT01138007|521381183|FG002|Overall Study|Adverse Event|9|||
144595693|NCT01138007|521381181|FG000|Overall Study|Lack of Efficacy|2|||
144595694|NCT01138007|521381182|FG001|Overall Study|Lack of Efficacy|0|||
144595695|NCT01138007|521381183|FG002|Overall Study|Lack of Efficacy|6|||
144595696|NCT01138007|521381181|FG000|Overall Study|Protocol Violation|2|||
144595697|NCT01138007|521381182|FG001|Overall Study|Protocol Violation|3|||
144595698|NCT01138007|521381183|FG002|Overall Study|Protocol Violation|2|||
144595699|NCT01138007|521381181|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
144595700|NCT01138007|521381182|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
144595701|NCT01138007|521381183|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
144595702|NCT01138007|521381181|FG000|Overall Study|Lost to Follow-up|3|||
144595703|NCT01138007|521381182|FG001|Overall Study|Lost to Follow-up|3|||
144595704|NCT01138007|521381183|FG002|Overall Study|Lost to Follow-up|5|||
144595705|NCT01138007|521381181|FG000|Overall Study|Physician Decision|0|||
144595706|NCT01138007|521381182|FG001|Overall Study|Physician Decision|5|||
144595707|NCT01138007|521381183|FG002|Overall Study|Physician Decision|3|||
144595708|NCT01138007|521381181|FG000|Overall Study|Withdrawal by Subject|5|||
144595709|NCT01138007|521381182|FG001|Overall Study|Withdrawal by Subject|6|||
144595710|NCT01138007|521381183|FG002|Overall Study|Withdrawal by Subject|15|||
144595711|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
144595712|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
144595713|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
144595714|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
144595715|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
144595716|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
144397280|NCT01528033|520665538|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
144397281|NCT01528033|520665539|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
144397282|NCT01528033|520665538|FG000|Primary Endpoint Assessment ITT|Death|2|||
144397283|NCT01528033|520665539|FG001|Primary Endpoint Assessment ITT|Death|2|||
144397284|NCT01528033|520665538|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
144397285|NCT01528033|520665539|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
144397286|NCT01528033|520665538|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
144397287|NCT01528033|520665539|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
144397288|NCT01528033|520665538|FG000|Follow Up|No data available|46|||
144397289|NCT01528033|520665539|FG001|Follow Up|No data available|44|||
144397290|NCT02030938|520665542|FG000|Overall Study|Lost to Follow-up|4|||
144397291|NCT02030938|520665542|FG000|Overall Study|Withdrawal by Subject|1|||
144397292|NCT01414608|520665547|FG000|Overall Study|Ineligible|5|||
144397293|NCT01414608|520665548|FG001|Overall Study|Ineligible|2|||
144397294|NCT05156073|520665549|FG000|Overall Study|Patient canceled appointment with PCP|1|||
144397295|NCT02887859|520665550|FG000|Overall Study|Ongoing|6|||
144397296|NCT02887859|520665550|FG000|Overall Study|Adverse Event|7|||
144595717|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
144397297|NCT02887859|520665550|FG000|Overall Study|Death|1|||
144397298|NCT02887859|520665550|FG000|Overall Study|Physician Decision|1|||
144397299|NCT05061966|520667217|FG000|Overall Study|Lost to Follow-up|13|||
144397300|NCT05061966|520667218|FG001|Overall Study|Lost to Follow-up|13|||
144397301|NCT03793556|520667221|FG000|Overall Study|Withdrawal by Subject|12|||
144397302|NCT03793556|520667222|FG001|Overall Study|Withdrawal by Subject|1|||
144397303|NCT03793556|520667221|FG000|Overall Study|Lost to Follow-up|1|||
144397304|NCT03793556|520667222|FG001|Overall Study|Lost to Follow-up|1|||
144397305|NCT03053271|520667223|FG000|Overall Study|Did not meet randomization criteria|3|||
144397306|NCT03053271|520667223|FG000|Overall Study|Withdrawal by Subject|1|||
144397307|NCT00570765|520667224|FG000|DB Phase|Withdrawal by Subject|1|||
144595718|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
144595719|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
144397308|NCT00570765|520667225|FG001|DB Phase|Withdrawal by Subject|0|||
144397309|NCT00570765|520667226|FG002|DB Phase|Withdrawal by Subject|0|||
144397310|NCT00570765|520667227|FG003|DB Phase|Withdrawal by Subject|0|||
144397311|NCT00570765|520667224|FG000|DB Phase|Protocol Violation|0|||
144397312|NCT00570765|520667225|FG001|DB Phase|Protocol Violation|1|||
144397313|NCT00570765|520667226|FG002|DB Phase|Protocol Violation|0|||
144397314|NCT00570765|520667227|FG003|DB Phase|Protocol Violation|0|||
144397315|NCT00570765|520667224|FG000|DB Phase|Adverse Event|3|||
144397316|NCT00570765|520667225|FG001|DB Phase|Adverse Event|6|||
144397317|NCT00570765|520667226|FG002|DB Phase|Adverse Event|0|||
144397318|NCT00570765|520667227|FG003|DB Phase|Adverse Event|0|||
144397319|NCT00570765|520667224|FG000|DB Phase|Did Not Receive Study Drug|0|||
144397320|NCT00570765|520667225|FG001|DB Phase|Did Not Receive Study Drug|0|||
144397321|NCT00570765|520667226|FG002|DB Phase|Did Not Receive Study Drug|1|||
144397322|NCT00570765|520667227|FG003|DB Phase|Did Not Receive Study Drug|0|||
144397323|NCT00570765|520667224|FG000|LTSE Phase|Withdrawal by Subject|0|||
144397324|NCT00570765|520667225|FG001|LTSE Phase|Withdrawal by Subject|0|||
144397325|NCT00570765|520667226|FG002|LTSE Phase|Withdrawal by Subject|0|||
144397326|NCT00570765|520667227|FG003|LTSE Phase|Withdrawal by Subject|1|||
144397327|NCT00570765|520667224|FG000|LTSE Phase|Adverse Event|0|||
144397328|NCT00570765|520667225|FG001|LTSE Phase|Adverse Event|0|||
144397329|NCT00570765|520667226|FG002|LTSE Phase|Adverse Event|0|||
144397330|NCT00570765|520667227|FG003|LTSE Phase|Adverse Event|7|||
144397331|NCT00570765|520667224|FG000|LTSE Phase|Physician Decision|0|||
144397332|NCT00570765|520667225|FG001|LTSE Phase|Physician Decision|0|||
144397333|NCT00570765|520667226|FG002|LTSE Phase|Physician Decision|0|||
144397334|NCT00570765|520667227|FG003|LTSE Phase|Physician Decision|4|||
144397335|NCT02517866|520667228|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
144397336|NCT02517866|520667229|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
144397337|NCT02517866|520667230|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144397338|NCT02517866|520667228|FG000|Overall Study|Significant Protocol Deviation|4|||
144397339|NCT02517866|520667229|FG001|Overall Study|Significant Protocol Deviation|1|||
144397340|NCT02517866|520667230|FG002|Overall Study|Significant Protocol Deviation|0|||
144397341|NCT02517866|520667228|FG000|Overall Study|Lost to Follow-up|1|||
144397342|NCT02517866|520667229|FG001|Overall Study|Lost to Follow-up|0|||
144397343|NCT02517866|520667230|FG002|Overall Study|Lost to Follow-up|0|||
144397344|NCT02517866|520667228|FG000|Overall Study|Voluntary Withdrawal|2|||
144397345|NCT02517866|520667229|FG001|Overall Study|Voluntary Withdrawal|2|||
144397346|NCT02517866|520667230|FG002|Overall Study|Voluntary Withdrawal|0|||
144397347|NCT02517866|520667228|FG000|Overall Study|Investigator Decision|2|||
144397348|NCT02517866|520667229|FG001|Overall Study|Investigator Decision|1|||
144397349|NCT02517866|520667230|FG002|Overall Study|Investigator Decision|0|||
144397350|NCT02517866|520667228|FG000|Overall Study|Reason not specified|2|||
144397351|NCT02517866|520667229|FG001|Overall Study|Reason not specified|0|||
144397352|NCT02517866|520667230|FG002|Overall Study|Reason not specified|0|||
144397353|NCT03711266|520667233|FG000|Overall Study|Lost to Follow-up|10|||
144397354|NCT01954342|520667236|FG000|Overall Study|Missing data from 13-16week study visit|0|||
144397355|NCT01954342|520667237|FG001|Overall Study|Missing data from 13-16week study visit|0|||
144397356|NCT01954342|520667238|FG002|Overall Study|Missing data from 13-16week study visit|0|||
144521107|NCT02949362|521108101|FG001|Prospective Period|Other|0|||
144521108|NCT02949362|521108102|FG002|Prospective Period|Other|0|||
144521109|NCT02949362|521108103|FG003|Prospective Period|Other|4|||
144521110|NCT03476460|521108104|FG000|Overall Study|Withdrawal by Subject|3|||
144521111|NCT03476460|521108105|FG001|Overall Study|Withdrawal by Subject|2|||
144521112|NCT03476460|521108104|FG000|Overall Study|Non-compliance with treatment|3|||
144521113|NCT03476460|521108105|FG001|Overall Study|Non-compliance with treatment|0|||
144521114|NCT03476460|521108104|FG000|Overall Study|Missing laboratory tests|5|||
144521115|NCT03476460|521108105|FG001|Overall Study|Missing laboratory tests|5|||
144521116|NCT03476460|521108104|FG000|Overall Study|Adverse Event|0|||
144521117|NCT03476460|521108105|FG001|Overall Study|Adverse Event|1|||
144521118|NCT04015167|521108117|FG000|Overall Study|Lost to Follow-up|40|||
144521119|NCT04015167|521108117|FG000|Overall Study|Adverse Event|5|||
144521120|NCT04015167|521108117|FG000|Overall Study|Withdrawal by Subject|2|||
144521121|NCT04015167|521108117|FG000|Overall Study|Subject went to jail|1|||
144521122|NCT03640312|521108118|FG000|Overall Study|Lost to Follow-up|3|||
144521123|NCT03640312|521108119|FG001|Overall Study|Lost to Follow-up|6|||
144521124|NCT02761057|521108125|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
144521125|NCT02761057|521108126|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
144521126|NCT02761057|521108127|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
144521127|NCT02761057|521108128|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
144595720|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
144595721|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
144722317|NCT03519256|521838678|FG002|Overall Study|Disease recurrence|5|||
144397357|NCT01954342|520667239|FG003|Overall Study|Missing data from 13-16week study visit|1|||
144397358|NCT01954342|520667236|FG000|Overall Study|Miscarriage|0|||
144397359|NCT01954342|520667237|FG001|Overall Study|Miscarriage|0|||
144397360|NCT01954342|520667238|FG002|Overall Study|Miscarriage|0|||
144397361|NCT01954342|520667239|FG003|Overall Study|Miscarriage|3|||
144397362|NCT01954342|520667236|FG000|Overall Study|Lost to Follow-up|0|||
144397363|NCT01954342|520667237|FG001|Overall Study|Lost to Follow-up|0|||
144397364|NCT01954342|520667238|FG002|Overall Study|Lost to Follow-up|0|||
144397365|NCT01954342|520667239|FG003|Overall Study|Lost to Follow-up|5|||
144397366|NCT01954342|520667236|FG000|Overall Study|Preterm delivery|0|||
144397367|NCT01954342|520667237|FG001|Overall Study|Preterm delivery|0|||
144397368|NCT01954342|520667238|FG002|Overall Study|Preterm delivery|0|||
144397369|NCT01954342|520667239|FG003|Overall Study|Preterm delivery|3|||
144397370|NCT01954342|520667236|FG000|Overall Study|Pre-eclampsia|0|||
144397371|NCT01954342|520667237|FG001|Overall Study|Pre-eclampsia|0|||
144397372|NCT01954342|520667238|FG002|Overall Study|Pre-eclampsia|0|||
144397373|NCT01954342|520667239|FG003|Overall Study|Pre-eclampsia|4|||
144397374|NCT01954342|520667236|FG000|Overall Study|Unreliable Data|0|||
144397375|NCT01954342|520667237|FG001|Overall Study|Unreliable Data|0|||
144397376|NCT01954342|520667238|FG002|Overall Study|Unreliable Data|0|||
144397377|NCT01954342|520667239|FG003|Overall Study|Unreliable Data|2|||
144397378|NCT01646073|520667242|FG000|Period A (12 Weeks)|Adverse Event|0|||
144397379|NCT01646073|520667243|FG001|Period A (12 Weeks)|Adverse Event|2|||
144397380|NCT01646073|520667242|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
144397381|NCT01646073|520667243|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
144397382|NCT01646073|520667242|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
144397383|NCT01646073|520667243|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
144397384|NCT01646073|520667242|FG000|Period A (12 Weeks)|Protocol Violation|0|||
144397385|NCT01646073|520667243|FG001|Period A (12 Weeks)|Protocol Violation|1|||
144397386|NCT01646073|520667242|FG000|Period A (12 Weeks)|Other|0|||
144397387|NCT01646073|520667243|FG001|Period A (12 Weeks)|Other|1|||
144397388|NCT01646073|520667242|FG000|Period B (12 Weeks)|Adverse Event|0|||
144397389|NCT01646073|520667243|FG001|Period B (12 Weeks)|Adverse Event|7|||
144397390|NCT01646073|520667242|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
144397391|NCT01646073|520667243|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
144397392|NCT01646073|520667242|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
144397393|NCT01646073|520667243|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
144397394|NCT05095454|520667246|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
144397395|NCT05095454|520667247|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
144397396|NCT00057876|520667248|FG000|Overall Study|Adverse Event|8|||
144397397|NCT00057876|520667249|FG001|Overall Study|Adverse Event|8|||
144397398|NCT00057876|520667248|FG000|Overall Study|Death|2|||
144397399|NCT00057876|520667249|FG001|Overall Study|Death|1|||
144397400|NCT00057876|520667248|FG000|Overall Study|Withdrawal by Subject|5|||
144397401|NCT00057876|520667249|FG001|Overall Study|Withdrawal by Subject|6|||
144521128|NCT02761057|521108125|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
144521129|NCT02761057|521108126|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
144521130|NCT02761057|521108127|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
144397402|NCT00057876|520667248|FG000|Overall Study|Lack of Efficacy|10|||
144397403|NCT00057876|520667249|FG001|Overall Study|Lack of Efficacy|8|||
144521131|NCT02761057|521108128|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
144521132|NCT02761057|521108125|FG000|Overall Study|Currently On Study Treatment|0|||
144521133|NCT02761057|521108126|FG001|Overall Study|Currently On Study Treatment|3|||
144521134|NCT02761057|521108127|FG002|Overall Study|Currently On Study Treatment|0|||
144521135|NCT02761057|521108128|FG003|Overall Study|Currently On Study Treatment|0|||
144521136|NCT02761057|521108125|FG000|Overall Study|Adverse Event|11|||
144521137|NCT02761057|521108126|FG001|Overall Study|Adverse Event|9|||
144521138|NCT02761057|521108127|FG002|Overall Study|Adverse Event|5|||
144521139|NCT02761057|521108128|FG003|Overall Study|Adverse Event|3|||
144521140|NCT02761057|521108125|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
144521141|NCT02761057|521108126|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
144521142|NCT02761057|521108127|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
144521143|NCT02761057|521108128|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
144521144|NCT02761057|521108125|FG000|Overall Study|Progression/Relapse|29|||
144521145|NCT02761057|521108126|FG001|Overall Study|Progression/Relapse|27|||
144521146|NCT02761057|521108127|FG002|Overall Study|Progression/Relapse|20|||
144521147|NCT02761057|521108128|FG003|Overall Study|Progression/Relapse|23|||
144521148|NCT02761057|521108125|FG000|Overall Study|Death|2|||
144521149|NCT02761057|521108126|FG001|Overall Study|Death|2|||
144521150|NCT02761057|521108127|FG002|Overall Study|Death|1|||
144521151|NCT02761057|521108128|FG003|Overall Study|Death|1|||
144521152|NCT02761057|521108125|FG000|Overall Study|Other - Not Protocol Specified|2|||
144521153|NCT02761057|521108126|FG001|Overall Study|Other - Not Protocol Specified|1|||
144521154|NCT02761057|521108127|FG002|Overall Study|Other - Not Protocol Specified|2|||
144521155|NCT02761057|521108128|FG003|Overall Study|Other - Not Protocol Specified|0|||
144521156|NCT06037369|521108129|FG000|Overall Study|Lost to Follow-up|0|||
144521157|NCT06037369|521108130|FG001|Overall Study|Lost to Follow-up|1|||
144521158|NCT05008835|521108132|FG000|Overall Study|Adverse Event|5|||
144521159|NCT05008835|521108133|FG001|Overall Study|Adverse Event|2|||
144521160|NCT05008835|521108134|FG002|Overall Study|Adverse Event|1|||
144521161|NCT05008835|521108132|FG000|Overall Study|Lack of Efficacy|0|||
144521162|NCT05008835|521108133|FG001|Overall Study|Lack of Efficacy|0|||
144521163|NCT05008835|521108134|FG002|Overall Study|Lack of Efficacy|1|||
144521164|NCT05008835|521108132|FG000|Overall Study|Study terminated by sponsor|0|||
144521165|NCT05008835|521108133|FG001|Overall Study|Study terminated by sponsor|0|||
144521166|NCT05008835|521108134|FG002|Overall Study|Study terminated by sponsor|1|||
144521167|NCT05008835|521108132|FG000|Overall Study|Not further specified|3|||
144521168|NCT05008835|521108133|FG001|Overall Study|Not further specified|2|||
144521169|NCT05008835|521108134|FG002|Overall Study|Not further specified|1|||
144521170|NCT04505904|521108139|FG000|Overall Study|Withdrawal by Subject|1|||
144521171|NCT04505904|521108140|FG001|Overall Study|Withdrawal by Subject|2|||
144521172|NCT04505904|521108141|FG002|Overall Study|Withdrawal by Subject|0|||
144521173|NCT04505904|521108142|FG003|Overall Study|Withdrawal by Subject|0|||
144521174|NCT04505904|521108139|FG000|Overall Study|Physician Decision|1|||
144521175|NCT04505904|521108140|FG001|Overall Study|Physician Decision|0|||
144521176|NCT04505904|521108141|FG002|Overall Study|Physician Decision|0|||
144521177|NCT04505904|521108142|FG003|Overall Study|Physician Decision|0|||
144521178|NCT04505904|521108139|FG000|Overall Study|Adverse Event|0|||
144521179|NCT04505904|521108140|FG001|Overall Study|Adverse Event|1|||
144521180|NCT04505904|521108141|FG002|Overall Study|Adverse Event|0|||
144521181|NCT04505904|521108142|FG003|Overall Study|Adverse Event|0|||
144521182|NCT04876118|521108143|FG000|Overall Study|Pregnancy|1|||
144521183|NCT04876118|521108143|FG000|Overall Study|Withdrawal by Subject|14|||
144521184|NCT05609760|521108151|FG000|Overall Study|Lost to Follow-up|0|||
144521185|NCT05609760|521108152|FG001|Overall Study|Lost to Follow-up|1|||
144521186|NCT05609760|521108151|FG000|Overall Study|Withdrawal by Subject|1|||
144521187|NCT05609760|521108152|FG001|Overall Study|Withdrawal by Subject|0|||
144521188|NCT03396588|521108153|FG000|Overall Study|Physician Decision|2|||
144521189|NCT03396588|521108154|FG001|Overall Study|Physician Decision|3|||
144521190|NCT05179395|521108155|FG000|Overall Study|Lack of Efficacy|1|||
144397404|NCT00057876|520667248|FG000|Overall Study|Ineligible|1|||
144397405|NCT00057876|520667249|FG001|Overall Study|Ineligible|2|||
144521191|NCT00812461|521108156|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
144521192|NCT00812461|521108157|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
144521193|NCT00812461|521108156|FG000|All Treated Patients|Adverse Event|8|||
144521194|NCT00812461|521108157|FG001|All Treated Patients|Adverse Event|15|||
144521195|NCT00812461|521108156|FG000|All Treated Patients|Lack of Efficacy|13|||
144521196|NCT00812461|521108157|FG001|All Treated Patients|Lack of Efficacy|7|||
144595722|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
144595723|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
144595724|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
144595725|NCT03548987|521381184|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
144595726|NCT03548987|521381185|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
144595727|NCT03548987|521381184|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
144595728|NCT03548987|521381185|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
144595729|NCT03548987|521381184|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
144595730|NCT03548987|521381185|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
144595731|NCT03548987|521381184|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
144595732|NCT03548987|521381185|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
144595733|NCT03548987|521381184|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
144595734|NCT03548987|521381185|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
144595735|NCT03548987|521381184|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
144595736|NCT03548987|521381185|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
144595737|NCT03548987|521381184|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
144595738|NCT03548987|521381185|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
144595739|NCT04661878|521381186|FG000|Overall Study|Lost to Follow-up|6|||
144595740|NCT04661878|521381187|FG001|Overall Study|Lost to Follow-up|5|||
144595741|NCT00640016|521381190|FG000|Overall Study|Withdrawal by Subject|0|||
144595742|NCT00640016|521381191|FG001|Overall Study|Withdrawal by Subject|1|||
144595743|NCT00640016|521381192|FG002|Overall Study|Withdrawal by Subject|0|||
144595744|NCT00640016|521381193|FG003|Overall Study|Withdrawal by Subject|0|||
144595745|NCT00640016|521381190|FG000|Overall Study|Study termination|2|||
144595746|NCT00640016|521381191|FG001|Overall Study|Study termination|1|||
144595747|NCT00640016|521381192|FG002|Overall Study|Study termination|3|||
144595748|NCT00640016|521381193|FG003|Overall Study|Study termination|2|||
144595749|NCT00640016|521381190|FG000|Overall Study|Adverse Event|0|||
144595750|NCT00640016|521381191|FG001|Overall Study|Adverse Event|0|||
144595751|NCT00640016|521381192|FG002|Overall Study|Adverse Event|0|||
144595752|NCT00640016|521381193|FG003|Overall Study|Adverse Event|1|||
144595753|NCT00887679|521381195|FG000|Overall Study|Withdrawal by Subject|1|||
144595754|NCT00887679|521381195|FG000|Overall Study|Lost to Follow-up|4|||
144595755|NCT00887679|521381195|FG000|Overall Study|Physician Decision|5|||
144595756|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
144595757|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
144595758|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
144595759|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
144595760|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
144595761|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
144595762|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
144595763|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
144595764|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
144595765|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
144595766|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
144595767|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
144595768|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
144595769|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
144595770|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
144595771|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
144595772|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
144595773|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
144595774|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
144595775|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
144595776|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
144595777|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
144595778|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
144595779|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
144595780|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
144595781|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
144595782|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
144595783|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
144595784|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
144595785|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
144595786|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Other|10|||
144595787|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Other|7|||
144595788|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Other|8|||
144595789|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Other|8|||
144595790|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Other|0|||
144397406|NCT00057876|520667248|FG000|Overall Study|other reason|2|||
144397407|NCT00057876|520667249|FG001|Overall Study|other reason|2|||
144397408|NCT00057876|520667248|FG000|Overall Study|other complicating disease|1|||
144397409|NCT00057876|520667249|FG001|Overall Study|other complicating disease|0|||
144397410|NCT00853073|520667250|FG000|Overall Study|Withdrawal by Subject|3|||
144397411|NCT00853073|520667251|FG001|Overall Study|Withdrawal by Subject|2|||
144397412|NCT01999114|520667252|FG000|Overall Study|Adverse Event|8|||
144397413|NCT01999114|520667253|FG001|Overall Study|Adverse Event|7|||
144397414|NCT01999114|520667254|FG002|Overall Study|Adverse Event|2|||
144521197|NCT00812461|521108156|FG000|All Treated Patients|Non-compliance|6|||
144521198|NCT00812461|521108157|FG001|All Treated Patients|Non-compliance|9|||
144521199|NCT00812461|521108156|FG000|All Treated Patients|Protocol Violation|36|||
144521200|NCT00812461|521108157|FG001|All Treated Patients|Protocol Violation|27|||
144521201|NCT00812461|521108156|FG000|All Treated Patients|Withdrawal by Subject|45|||
144521202|NCT00812461|521108157|FG001|All Treated Patients|Withdrawal by Subject|54|||
144521203|NCT00812461|521108156|FG000|All Treated Patients|Lost to Follow-up|11|||
144521204|NCT00812461|521108157|FG001|All Treated Patients|Lost to Follow-up|14|||
144521205|NCT00812461|521108156|FG000|All Treated Patients|Other Reason|13|||
144521206|NCT00812461|521108157|FG001|All Treated Patients|Other Reason|21|||
144521207|NCT05351554|521108159|FG000|Overall Study|Study terminated by sponsor|1|||
144521208|NCT05093829|521108160|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
144521209|NCT05093829|521108161|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
144521210|NCT05093829|521108162|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
144521211|NCT05093829|521108163|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
144521212|NCT05093829|521108164|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
144521213|NCT03047928|521110104|FG000|Overall Study|Adverse Event|0|||
144521214|NCT03047928|521110105|FG001|Overall Study|Adverse Event|2|||
144521215|NCT03047928|521110106|FG002|Overall Study|Adverse Event|0|||
144521216|NCT03047928|521110104|FG000|Overall Study|Protocol Violation|0|||
144521217|NCT03047928|521110105|FG001|Overall Study|Protocol Violation|1|||
144521218|NCT03047928|521110106|FG002|Overall Study|Protocol Violation|0|||
144521219|NCT03047928|521110104|FG000|Overall Study|included in another protocol|0|||
144521220|NCT03047928|521110105|FG001|Overall Study|included in another protocol|1|||
144521221|NCT03047928|521110106|FG002|Overall Study|included in another protocol|0|||
144521222|NCT03366649|521110115|FG000|Overall Study|Failed preoperative screening|4|||
144521223|NCT03366649|521110116|FG001|Overall Study|Failed preoperative screening|0|||
144521224|NCT03366649|521110117|FG002|Overall Study|Failed preoperative screening|0|||
144521225|NCT03366649|521110115|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
144521226|NCT03366649|521110116|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
144521227|NCT03366649|521110117|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
144521228|NCT03673111|521110118|FG000|Overall Study|Protocol Violation|0|||
144521229|NCT03673111|521110119|FG001|Overall Study|Protocol Violation|0|||
144521230|NCT03673111|521110120|FG002|Overall Study|Protocol Violation|0|||
144521231|NCT03673111|521110121|FG003|Overall Study|Protocol Violation|0|||
144521232|NCT03673111|521110122|FG004|Overall Study|Protocol Violation|0|||
144521233|NCT03673111|521110123|FG005|Overall Study|Protocol Violation|0|||
144521234|NCT03673111|521110124|FG006|Overall Study|Protocol Violation|0|||
144521235|NCT03673111|521110125|FG007|Overall Study|Protocol Violation|0|||
144521236|NCT03673111|521110126|FG008|Overall Study|Protocol Violation|0|||
144521237|NCT03673111|521110127|FG009|Overall Study|Protocol Violation|0|||
144521238|NCT03673111|521110128|FG010|Overall Study|Protocol Violation|1|||
144521239|NCT03673111|521110129|FG011|Overall Study|Protocol Violation|0|||
144521240|NCT03673111|521110130|FG012|Overall Study|Protocol Violation|0|||
144521241|NCT03673111|521110131|FG013|Overall Study|Protocol Violation|0|||
144521242|NCT03673111|521110118|FG000|Overall Study|Adverse Event|1|||
144521243|NCT03673111|521110119|FG001|Overall Study|Adverse Event|0|||
144521244|NCT03673111|521110120|FG002|Overall Study|Adverse Event|0|||
144521245|NCT03673111|521110121|FG003|Overall Study|Adverse Event|0|||
144521246|NCT03673111|521110122|FG004|Overall Study|Adverse Event|0|||
144521247|NCT03673111|521110123|FG005|Overall Study|Adverse Event|0|||
144521248|NCT03673111|521110124|FG006|Overall Study|Adverse Event|0|||
144521249|NCT03673111|521110125|FG007|Overall Study|Adverse Event|0|||
144521250|NCT03673111|521110126|FG008|Overall Study|Adverse Event|0|||
144521251|NCT03673111|521110127|FG009|Overall Study|Adverse Event|0|||
144521252|NCT03673111|521110128|FG010|Overall Study|Adverse Event|0|||
144521253|NCT03673111|521110129|FG011|Overall Study|Adverse Event|0|||
144521254|NCT03673111|521110130|FG012|Overall Study|Adverse Event|0|||
144521255|NCT03673111|521110131|FG013|Overall Study|Adverse Event|0|||
144521256|NCT03792555|521110132|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
144595791|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
144397415|NCT01999114|520667255|FG003|Overall Study|Adverse Event|2|||
144397416|NCT01999114|520667256|FG004|Overall Study|Adverse Event|1|||
144397417|NCT01999114|520667252|FG000|Overall Study|Withdrawal by Subject|0|||
144397418|NCT01999114|520667253|FG001|Overall Study|Withdrawal by Subject|0|||
144397419|NCT01999114|520667254|FG002|Overall Study|Withdrawal by Subject|1|||
144397420|NCT01999114|520667255|FG003|Overall Study|Withdrawal by Subject|0|||
144397421|NCT01999114|520667256|FG004|Overall Study|Withdrawal by Subject|1|||
144397422|NCT01999114|520667252|FG000|Overall Study|Lost to Follow-up|0|||
144397423|NCT01999114|520667253|FG001|Overall Study|Lost to Follow-up|0|||
144397424|NCT01999114|520667254|FG002|Overall Study|Lost to Follow-up|1|||
144397425|NCT01999114|520667255|FG003|Overall Study|Lost to Follow-up|0|||
144397426|NCT01999114|520667256|FG004|Overall Study|Lost to Follow-up|0|||
144397427|NCT01999114|520667252|FG000|Overall Study|Administrative|0|||
144397428|NCT01999114|520667253|FG001|Overall Study|Administrative|0|||
144397429|NCT01999114|520667254|FG002|Overall Study|Administrative|1|||
144397430|NCT01999114|520667255|FG003|Overall Study|Administrative|1|||
144397431|NCT01999114|520667256|FG004|Overall Study|Administrative|2|||
144397432|NCT02448810|520667259|FG000|Overall Study|Adverse Event|0|||
144397433|NCT02448810|520667260|FG001|Overall Study|Adverse Event|0|||
144397434|NCT02448810|520667261|FG002|Overall Study|Adverse Event|1|||
144397435|NCT02448810|520667262|FG003|Overall Study|Adverse Event|0|||
144397436|NCT02448810|520667263|FG004|Overall Study|Adverse Event|0|||
144397437|NCT02448810|520667264|FG005|Overall Study|Adverse Event|0|||
144397438|NCT02448810|520667265|FG006|Overall Study|Adverse Event|0|||
144397439|NCT02448810|520667266|FG007|Overall Study|Adverse Event|0|||
144397440|NCT02448810|520667259|FG000|Overall Study|Withdrawal by Subject|0|||
144397441|NCT02448810|520667260|FG001|Overall Study|Withdrawal by Subject|0|||
144397442|NCT02448810|520667261|FG002|Overall Study|Withdrawal by Subject|1|||
144397443|NCT02448810|520667262|FG003|Overall Study|Withdrawal by Subject|0|||
144397444|NCT02448810|520667263|FG004|Overall Study|Withdrawal by Subject|3|||
144397445|NCT02448810|520667264|FG005|Overall Study|Withdrawal by Subject|5|||
144397446|NCT02448810|520667265|FG006|Overall Study|Withdrawal by Subject|0|||
144397447|NCT02448810|520667266|FG007|Overall Study|Withdrawal by Subject|2|||
144397448|NCT02448810|520667259|FG000|Overall Study|Other (study terminated by sponsor)|0|||
144397449|NCT02448810|520667260|FG001|Overall Study|Other (study terminated by sponsor)|0|||
144397450|NCT02448810|520667261|FG002|Overall Study|Other (study terminated by sponsor)|0|||
144397451|NCT02448810|520667262|FG003|Overall Study|Other (study terminated by sponsor)|0|||
144397452|NCT02448810|520667263|FG004|Overall Study|Other (study terminated by sponsor)|4|||
144397453|NCT02448810|520667264|FG005|Overall Study|Other (study terminated by sponsor)|2|||
144397454|NCT02448810|520667265|FG006|Overall Study|Other (study terminated by sponsor)|2|||
144397455|NCT02448810|520667266|FG007|Overall Study|Other (study terminated by sponsor)|1|||
144397456|NCT02448810|520667259|FG000|Overall Study|Death|1|||
144397457|NCT02448810|520667260|FG001|Overall Study|Death|0|||
144397458|NCT02448810|520667261|FG002|Overall Study|Death|1|||
144397459|NCT02448810|520667262|FG003|Overall Study|Death|0|||
144397460|NCT02448810|520667263|FG004|Overall Study|Death|1|||
144397461|NCT02448810|520667264|FG005|Overall Study|Death|0|||
144397462|NCT02448810|520667265|FG006|Overall Study|Death|0|||
144397463|NCT02448810|520667266|FG007|Overall Study|Death|0|||
144397464|NCT02448810|520667259|FG000|Overall Study|Other (Progressive disease)|2|||
144397465|NCT02448810|520667260|FG001|Overall Study|Other (Progressive disease)|2|||
144397466|NCT02448810|520667261|FG002|Overall Study|Other (Progressive disease)|0|||
144397467|NCT02448810|520667262|FG003|Overall Study|Other (Progressive disease)|3|||
144397468|NCT02448810|520667263|FG004|Overall Study|Other (Progressive disease)|23|||
144397469|NCT02448810|520667264|FG005|Overall Study|Other (Progressive disease)|9|||
144397470|NCT02448810|520667265|FG006|Overall Study|Other (Progressive disease)|14|||
144397471|NCT02448810|520667266|FG007|Overall Study|Other (Progressive disease)|5|||
144397472|NCT02448810|520667259|FG000|Overall Study|Lost to Follow-up|0|||
144397473|NCT02448810|520667260|FG001|Overall Study|Lost to Follow-up|1|||
144397474|NCT02448810|520667261|FG002|Overall Study|Lost to Follow-up|0|||
144397475|NCT02448810|520667262|FG003|Overall Study|Lost to Follow-up|0|||
144397476|NCT02448810|520667263|FG004|Overall Study|Lost to Follow-up|0|||
144397477|NCT02448810|520667264|FG005|Overall Study|Lost to Follow-up|0|||
144397478|NCT02448810|520667265|FG006|Overall Study|Lost to Follow-up|0|||
144397479|NCT02448810|520667266|FG007|Overall Study|Lost to Follow-up|0|||
144397480|NCT02448810|520667259|FG000|Overall Study|Other (unspecified)|0|||
144397481|NCT02448810|520667260|FG001|Overall Study|Other (unspecified)|0|||
144397482|NCT02448810|520667261|FG002|Overall Study|Other (unspecified)|0|||
144397483|NCT02448810|520667262|FG003|Overall Study|Other (unspecified)|0|||
144397484|NCT02448810|520667263|FG004|Overall Study|Other (unspecified)|0|||
144397485|NCT02448810|520667264|FG005|Overall Study|Other (unspecified)|0|||
144397486|NCT02448810|520667265|FG006|Overall Study|Other (unspecified)|2|||
144397487|NCT02448810|520667266|FG007|Overall Study|Other (unspecified)|0|||
144397488|NCT01916967|520667273|FG000|Overall Study|Adverse Event|0|||
144397489|NCT01916967|520667274|FG001|Overall Study|Adverse Event|0|||
144397490|NCT01916967|520667275|FG002|Overall Study|Adverse Event|2|||
144397491|NCT01916967|520667273|FG000|Overall Study|Lack of Efficacy|0|||
144397492|NCT01916967|520667274|FG001|Overall Study|Lack of Efficacy|0|||
144397493|NCT01916967|520667275|FG002|Overall Study|Lack of Efficacy|6|||
144397494|NCT01916967|520667273|FG000|Overall Study|Physician Decision|0|||
144397495|NCT01916967|520667274|FG001|Overall Study|Physician Decision|0|||
144397496|NCT01916967|520667275|FG002|Overall Study|Physician Decision|1|||
144397497|NCT01916967|520667273|FG000|Overall Study|Protocol Violation|0|||
144397498|NCT01916967|520667274|FG001|Overall Study|Protocol Violation|1|||
144397499|NCT01916967|520667275|FG002|Overall Study|Protocol Violation|0|||
144397500|NCT01104155|520667280|FG000|Overall Study|Adverse Event|15|||
144397501|NCT01104155|520667281|FG001|Overall Study|Adverse Event|8|||
144397502|NCT01104155|520667280|FG000|Overall Study|Participant choice|6|||
144397503|NCT01104155|520667281|FG001|Overall Study|Participant choice|5|||
144397504|NCT01104155|520667280|FG000|Overall Study|Withdrawal of consent|1|||
144397505|NCT01104155|520667281|FG001|Overall Study|Withdrawal of consent|1|||
144397506|NCT01104155|520667280|FG000|Overall Study|Other|3|||
144397507|NCT01104155|520667281|FG001|Overall Study|Other|4|||
144397508|NCT02787551|520667287|FG000|Core Period: 26 Weeks|Adverse Event|10|||
144397509|NCT02787551|520667288|FG001|Core Period: 26 Weeks|Adverse Event|0|||
144397510|NCT02787551|520667287|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
144397511|NCT02787551|520667288|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
144397512|NCT02787551|520667287|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
144397513|NCT02787551|520667288|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
144397514|NCT02787551|520667287|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
144397515|NCT02787551|520667288|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
144397516|NCT02787551|520667287|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
144397517|NCT02787551|520667288|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
144397518|NCT02787551|520667287|FG000|Core Period: 26 Weeks|Other than specified|3|||
144397519|NCT02787551|520667288|FG001|Core Period: 26 Weeks|Other than specified|1|||
144249650|NCT01897571|520111710|FG010|Overall Study|Other|0|||
144397520|NCT02787551|520667287|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
144397521|NCT02787551|520667288|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
144397522|NCT02787551|520667287|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
144397523|NCT02787551|520667288|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
144397524|NCT02787551|520667287|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
144397525|NCT02787551|520667288|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
144397526|NCT03799211|520667289|FG000|Overall Study|Lost to Follow-up|2|||
144397527|NCT03799211|520667290|FG001|Overall Study|Lost to Follow-up|13|||
144397528|NCT03799211|520667289|FG000|Overall Study|Withdrawal by Subject|2|||
144397529|NCT03799211|520667290|FG001|Overall Study|Withdrawal by Subject|0|||
144397530|NCT00923936|520667291|FG000|Overall Study|progressive disease on study|2|||
144397531|NCT00923936|520667292|FG001|Overall Study|progressive disease on study|1|||
144397532|NCT00923936|520667291|FG000|Overall Study|Adverse Event|2|||
144397533|NCT00923936|520667292|FG001|Overall Study|Adverse Event|1|||
144397534|NCT00923936|520667291|FG000|Overall Study|Lost to follow up|2|||
144397535|NCT00923936|520667292|FG001|Overall Study|Lost to follow up|0|||
144397536|NCT00923936|520667291|FG000|Overall Study|Continuing in follow up period|2|||
144397537|NCT00923936|520667292|FG001|Overall Study|Continuing in follow up period|1|||
144397538|NCT02038452|520667294|FG000|Overall Study|Withdrawal by Subject|7|||
144397539|NCT02038452|520667295|FG001|Overall Study|Withdrawal by Subject|9|||
144397540|NCT02038452|520667294|FG000|Overall Study|Lost to Follow-up|31|||
144397541|NCT02038452|520667295|FG001|Overall Study|Lost to Follow-up|28|||
144397542|NCT03139279|520667296|FG000|Overall Study|Physician Decision|2|||
144397543|NCT03139279|520667297|FG001|Overall Study|Physician Decision|0|||
144397544|NCT03139279|520667296|FG000|Overall Study|Protocol Violation|5|||
144397545|NCT03139279|520667297|FG001|Overall Study|Protocol Violation|4|||
144397546|NCT03139279|520667296|FG000|Overall Study|Withdrawal by Subject|0|||
144397547|NCT03139279|520667297|FG001|Overall Study|Withdrawal by Subject|2|||
144249651|NCT01897571|520111700|FG000|Overall Study|Enrolled in rollover study|0|||
144249652|NCT01897571|520111701|FG001|Overall Study|Enrolled in rollover study|0|||
144397548|NCT01336569|520667300|FG000|Overall Study|Lost to Follow-up|4|||
144397549|NCT02337738|520667301|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
144397550|NCT02337738|520667302|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
144397551|NCT02337738|520667303|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
144397552|NCT02337738|520667301|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
144397553|NCT02337738|520667302|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
144397554|NCT02337738|520667303|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
144397555|NCT02337738|520667301|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
144397556|NCT02337738|520667302|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
144521257|NCT03792555|521110133|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
144521258|NCT03792555|521110134|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
144397557|NCT02337738|520667303|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
144397558|NCT02337738|520667301|FG000|Overall Study|Voluntary Withdrawal|10|||
144397559|NCT02337738|520667302|FG001|Overall Study|Voluntary Withdrawal|5|||
144397560|NCT02337738|520667303|FG002|Overall Study|Voluntary Withdrawal|2|||
144397561|NCT02337738|520667301|FG000|Overall Study|Lack of Efficacy|2|||
144397562|NCT02337738|520667302|FG001|Overall Study|Lack of Efficacy|4|||
144397563|NCT02337738|520667303|FG002|Overall Study|Lack of Efficacy|0|||
144521259|NCT03792555|521110132|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
144397564|NCT02337738|520667301|FG000|Overall Study|Investigator's Judgment|1|||
144397565|NCT02337738|520667302|FG001|Overall Study|Investigator's Judgment|1|||
144397566|NCT02337738|520667303|FG002|Overall Study|Investigator's Judgment|3|||
144397567|NCT00406354|520667304|FG000|All Randomized Patients|Protocol Violation|0|||
144397568|NCT00406354|520667305|FG001|All Randomized Patients|Protocol Violation|0|||
144397569|NCT00406354|520667306|FG002|All Randomized Patients|Protocol Violation|1|||
144397570|NCT00406354|520667304|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
144397571|NCT00406354|520667305|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
144397572|NCT00406354|520667306|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
144397573|NCT00406354|520667304|FG000|All Randomized and Treated Patients|Adverse Event|6|||
144397574|NCT00406354|520667305|FG001|All Randomized and Treated Patients|Adverse Event|2|||
144397575|NCT00406354|520667306|FG002|All Randomized and Treated Patients|Adverse Event|1|||
144397576|NCT00406354|520667304|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
144397577|NCT00406354|520667305|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
144397578|NCT00406354|520667306|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
144397579|NCT00406354|520667304|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
144397580|NCT00406354|520667305|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
144397581|NCT00406354|520667306|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
144397582|NCT00406354|520667304|FG000|All Randomized and Treated Patients|Physician Decision|0|||
144397583|NCT00406354|520667305|FG001|All Randomized and Treated Patients|Physician Decision|0|||
144538354|NCT00246805|521174167|FG000|Phase 1|Lost to Follow-up|1|||
144538355|NCT00246805|521174168|FG001|Phase 1|Lost to Follow-up|0|||
144397584|NCT00406354|520667306|FG002|All Randomized and Treated Patients|Physician Decision|1|||
144397585|NCT00292318|520667309|FG000|Overall Study|Study terminated by officials|2|||
144397586|NCT00292318|520667310|FG001|Overall Study|Study terminated by officials|1|||
144397587|NCT02027376|520667313|FG000|Overall Study|Death|1|||
144397588|NCT02027376|520667314|FG001|Overall Study|Death|0|||
144397589|NCT02027376|520667315|FG002|Overall Study|Death|0|||
144397590|NCT01626495|520667317|FG000|Overall Study|Adverse Event|3|||
144397591|NCT01626495|520667317|FG000|Overall Study|Disease progression|27|||
144397592|NCT01626495|520667317|FG000|Overall Study|Withdrawal by Subject|1|||
144397593|NCT01626495|520667317|FG000|Overall Study|Administrative problem|1|||
144397594|NCT01626495|520667317|FG000|Overall Study|Death|2|||
144397595|NCT01626495|520667317|FG000|Overall Study|Physician Decision|1|||
144397596|NCT01626495|520667317|FG000|Overall Study|New cancer therapy|16|||
144397597|NCT01626495|520667317|FG000|Overall Study|Manufacturing failure|1|||
144397598|NCT01565642|520667318|FG000|Overall Study|Withdrawal by Subject|2|||
144397599|NCT01565642|520667319|FG001|Overall Study|Withdrawal by Subject|1|||
144397600|NCT01934972|520667320|FG000|Overall Study|Withdrawal by Subject|9|||
144397601|NCT01934972|520667321|FG001|Overall Study|Withdrawal by Subject|6|||
144397602|NCT01278160|520667322|FG000|Overall Study|Adverse Event|1|||
144397603|NCT01278160|520667323|FG001|Overall Study|Adverse Event|1|||
144397604|NCT01278160|520667322|FG000|Overall Study|Lost to Follow-up|0|||
144397605|NCT01278160|520667323|FG001|Overall Study|Lost to Follow-up|1|||
144397606|NCT01278160|520667322|FG000|Overall Study|Withdrawal by Subject|3|||
144397607|NCT01278160|520667323|FG001|Overall Study|Withdrawal by Subject|2|||
144397608|NCT01278160|520667322|FG000|Overall Study|Unclassified|1|||
144397609|NCT01278160|520667323|FG001|Overall Study|Unclassified|2|||
144397610|NCT00304239|520667327|FG000|Overall Study|Protocol Deviations/Violations|15|||
144397611|NCT00304239|520667328|FG001|Overall Study|Protocol Deviations/Violations|0|||
144397612|NCT00304239|520667327|FG000|Overall Study|Adverse Event|2|||
144397613|NCT00304239|520667328|FG001|Overall Study|Adverse Event|0|||
144397614|NCT02436681|520667329|FG000|Overall Study|Lost to Follow-up|10|||
144397615|NCT02436681|520667329|FG000|Overall Study|Withdrawal by Subject|2|||
144397616|NCT02436681|520667329|FG000|Overall Study|Death|2|||
144397617|NCT03954132|520667331|FG000|Overall Study|Adverse Event|2|||
144397618|NCT03954132|520667332|FG001|Overall Study|Adverse Event|0|||
144397619|NCT03954132|520667331|FG000|Overall Study|Patient's wish|5|||
144397620|NCT03954132|520667332|FG001|Overall Study|Patient's wish|0|||
144397621|NCT03954132|520667331|FG000|Overall Study|Lost to Follow-up|10|||
144397622|NCT03954132|520667332|FG001|Overall Study|Lost to Follow-up|0|||
144397623|NCT03954132|520667331|FG000|Overall Study|Screening failure|0|||
144397624|NCT03954132|520667332|FG001|Overall Study|Screening failure|1|||
144397625|NCT03954132|520667331|FG000|Overall Study|No registration after Visit 1|5|||
144397626|NCT03954132|520667332|FG001|Overall Study|No registration after Visit 1|2|||
144397627|NCT03954132|520667331|FG000|Overall Study|Other reason than listed|2|||
144397628|NCT03954132|520667332|FG001|Overall Study|Other reason than listed|2|||
144397629|NCT03954132|520667331|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
144397630|NCT03954132|520667332|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
144397631|NCT03954132|520667331|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
144397632|NCT03954132|520667332|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
144397633|NCT00932737|520667335|FG000|Overall Study|Not treated in second episode|1|||
144397634|NCT00932737|520667336|FG001|Overall Study|Not treated in second episode|0|||
144397635|NCT00932737|520667335|FG000|Overall Study|Adverse Event|0|||
144397636|NCT00932737|520667336|FG001|Overall Study|Adverse Event|1|||
144397637|NCT02906332|520667342|FG000|Overall Study|Withdrawal by Subject|1|||
144397638|NCT02949700|520667343|FG000|Phase I|Withdrawal by Subject|1|||
144397639|NCT02949700|520667344|FG001|Phase I|Withdrawal by Subject|1|||
144521260|NCT03792555|521110133|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
144521261|NCT03792555|521110134|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
144521262|NCT03792555|521110132|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
144521263|NCT03792555|521110133|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
144521264|NCT03792555|521110134|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
144521265|NCT04485039|521110135|FG000|TPOXX Only|Adverse Event|2|||
144521266|NCT04485039|521110135|FG000|TPOXX Only|Physician Decision|1|||
144397640|NCT02949700|520667345|FG002|Phase I|Withdrawal by Subject|0|||
144397641|NCT02949700|520667346|FG003|Phase I|Withdrawal by Subject|0|||
144397642|NCT02949700|520667343|FG000|Phase I|Protocol Violation|1|||
144397643|NCT02949700|520667344|FG001|Phase I|Protocol Violation|0|||
144397644|NCT02949700|520667345|FG002|Phase I|Protocol Violation|0|||
144397645|NCT02949700|520667346|FG003|Phase I|Protocol Violation|0|||
144397646|NCT02949700|520667343|FG000|Phase II|Withdrawal by Subject|0|||
144521267|NCT04485039|521110135|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
144397647|NCT02949700|520667344|FG001|Phase II|Withdrawal by Subject|0|||
144397648|NCT02949700|520667345|FG002|Phase II|Withdrawal by Subject|0|||
144397649|NCT02949700|520667346|FG003|Phase II|Withdrawal by Subject|2|||
144397650|NCT02949700|520667343|FG000|Phase II|Protocol Violation|0|||
144397651|NCT02949700|520667344|FG001|Phase II|Protocol Violation|0|||
144397652|NCT02949700|520667345|FG002|Phase II|Protocol Violation|1|||
144397653|NCT02949700|520667346|FG003|Phase II|Protocol Violation|3|||
144397654|NCT00257608|520669215|FG000|Chemotherapy Phase|Adverse Event|138|||
144397655|NCT00257608|520669216|FG001|Chemotherapy Phase|Adverse Event|0|||
144397656|NCT00257608|520669217|FG002|Chemotherapy Phase|Adverse Event|0|||
144397657|NCT00257608|520669215|FG000|Chemotherapy Phase|Disease progression|139|||
144397658|NCT00257608|520669216|FG001|Chemotherapy Phase|Disease progression|0|||
144397659|NCT00257608|520669217|FG002|Chemotherapy Phase|Disease progression|0|||
144397660|NCT00257608|520669215|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
144397661|NCT00257608|520669216|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
144397662|NCT00257608|520669217|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
144397663|NCT00257608|520669215|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
144397664|NCT00257608|520669216|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
144397665|NCT00257608|520669217|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
144397666|NCT00257608|520669215|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
144397667|NCT00257608|520669216|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
144397668|NCT00257608|520669217|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
144397669|NCT00257608|520669215|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
144397670|NCT00257608|520669216|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
144397671|NCT00257608|520669217|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
144397672|NCT00257608|520669215|FG000|Chemotherapy Phase|Physician Decision|28|||
144397673|NCT00257608|520669216|FG001|Chemotherapy Phase|Physician Decision|0|||
144397674|NCT00257608|520669217|FG002|Chemotherapy Phase|Physician Decision|0|||
144397675|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Adverse Event|0|||
144397676|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Adverse Event|34|||
144397677|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Adverse Event|38|||
144397678|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Disease progression|0|||
144397679|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Disease progression|204|||
144397680|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Disease progression|168|||
144397681|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
144397682|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
144397683|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
144397684|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
144397685|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
144397686|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
144397687|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
144397688|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
144397689|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
144397690|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
144397691|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
144397692|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
144397693|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
144397694|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
144397695|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
144397696|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Physician Decision|0|||
144397697|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Physician Decision|8|||
144397698|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Physician Decision|11|||
144397699|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
144397700|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
144397701|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
144397702|NCT00257608|520669215|FG000|Post Chemotherapy Phase|Not treated|0|||
144397703|NCT00257608|520669216|FG001|Post Chemotherapy Phase|Not treated|4|||
144397704|NCT00257608|520669217|FG002|Post Chemotherapy Phase|Not treated|7|||
144397705|NCT00866788|520669218|FG000|Overall Study|Adverse Event|0|||
144397706|NCT00866788|520669219|FG001|Overall Study|Adverse Event|2|||
144397707|NCT00866788|520669220|FG002|Overall Study|Adverse Event|0|||
144397708|NCT00866788|520669221|FG003|Overall Study|Adverse Event|1|||
144397709|NCT00866788|520669218|FG000|Overall Study|Lost to Follow-up|1|||
144397710|NCT00866788|520669219|FG001|Overall Study|Lost to Follow-up|1|||
144397711|NCT00866788|520669220|FG002|Overall Study|Lost to Follow-up|0|||
144249653|NCT01897571|520111702|FG002|Overall Study|Enrolled in rollover study|0|||
144397712|NCT00866788|520669221|FG003|Overall Study|Lost to Follow-up|2|||
144397713|NCT00866788|520669218|FG000|Overall Study|Withdrawal by Subject|2|||
144397714|NCT00866788|520669219|FG001|Overall Study|Withdrawal by Subject|1|||
144397715|NCT00866788|520669220|FG002|Overall Study|Withdrawal by Subject|0|||
144397716|NCT00866788|520669221|FG003|Overall Study|Withdrawal by Subject|1|||
144397717|NCT00866788|520669218|FG000|Overall Study|Pregnancy|0|||
144397718|NCT00866788|520669219|FG001|Overall Study|Pregnancy|1|||
144397719|NCT00866788|520669220|FG002|Overall Study|Pregnancy|0|||
144397720|NCT00866788|520669221|FG003|Overall Study|Pregnancy|0|||
144397721|NCT00866788|520669218|FG000|Overall Study|Disease progression|3|||
144397722|NCT00866788|520669219|FG001|Overall Study|Disease progression|1|||
144397723|NCT00866788|520669220|FG002|Overall Study|Disease progression|1|||
144397724|NCT00866788|520669221|FG003|Overall Study|Disease progression|0|||
144397725|NCT00866788|520669218|FG000|Overall Study|Physician Decision|0|||
144397726|NCT00866788|520669219|FG001|Overall Study|Physician Decision|0|||
144397727|NCT00866788|520669220|FG002|Overall Study|Physician Decision|1|||
144397728|NCT00866788|520669221|FG003|Overall Study|Physician Decision|1|||
144397729|NCT01854658|520669222|FG000|Overall Study|Protocol Violation|6|||
144397730|NCT01854658|520669223|FG001|Overall Study|Protocol Violation|2|||
144397731|NCT01854658|520669224|FG002|Overall Study|Protocol Violation|2|||
144397732|NCT01854658|520669225|FG003|Overall Study|Protocol Violation|1|||
144397733|NCT01854658|520669222|FG000|Overall Study|Physician Decision|7|||
144397734|NCT01854658|520669223|FG001|Overall Study|Physician Decision|5|||
144397735|NCT01854658|520669224|FG002|Overall Study|Physician Decision|2|||
144397736|NCT01854658|520669225|FG003|Overall Study|Physician Decision|4|||
144397737|NCT01854658|520669222|FG000|Overall Study|Lost to Follow-up|8|||
144397738|NCT01854658|520669223|FG001|Overall Study|Lost to Follow-up|9|||
144397739|NCT01854658|520669224|FG002|Overall Study|Lost to Follow-up|8|||
144397740|NCT01854658|520669225|FG003|Overall Study|Lost to Follow-up|4|||
144397741|NCT01854658|520669222|FG000|Overall Study|Withdrawal by Subject|28|||
144397742|NCT01854658|520669223|FG001|Overall Study|Withdrawal by Subject|21|||
144397743|NCT01854658|520669224|FG002|Overall Study|Withdrawal by Subject|29|||
144397744|NCT01854658|520669225|FG003|Overall Study|Withdrawal by Subject|15|||
144397745|NCT01854658|520669222|FG000|Overall Study|Protocol-specified criteria|15|||
144397746|NCT01854658|520669223|FG001|Overall Study|Protocol-specified criteria|15|||
144397747|NCT01854658|520669224|FG002|Overall Study|Protocol-specified criteria|10|||
144397748|NCT01854658|520669225|FG003|Overall Study|Protocol-specified criteria|7|||
144397749|NCT01854658|520669222|FG000|Overall Study|Lack of Efficacy|3|||
144397750|NCT01854658|520669223|FG001|Overall Study|Lack of Efficacy|8|||
144397751|NCT01854658|520669224|FG002|Overall Study|Lack of Efficacy|4|||
144397752|NCT01854658|520669225|FG003|Overall Study|Lack of Efficacy|7|||
144397753|NCT01854658|520669222|FG000|Overall Study|Adverse Event|21|||
144397754|NCT01854658|520669223|FG001|Overall Study|Adverse Event|14|||
144397755|NCT01854658|520669224|FG002|Overall Study|Adverse Event|23|||
144397756|NCT01854658|520669225|FG003|Overall Study|Adverse Event|19|||
144397757|NCT01854658|520669222|FG000|Overall Study|Administrative reasons|5|||
144397758|NCT01854658|520669223|FG001|Overall Study|Administrative reasons|1|||
144397759|NCT01854658|520669224|FG002|Overall Study|Administrative reasons|2|||
144397760|NCT01854658|520669225|FG003|Overall Study|Administrative reasons|2|||
144397761|NCT00697073|520669226|FG000|Overall Study|Withdrawal by Subject|2|||
144397762|NCT00697073|520669226|FG000|Overall Study|Pregnancy|1|||
144397763|NCT00697073|520669226|FG000|Overall Study|non compliance and other|6|||
144397764|NCT03265665|520669227|FG000|24-week Data Collection|Withdrawal by Subject|2|||
144397765|NCT03265665|520669228|FG001|24-week Data Collection|Withdrawal by Subject|2|||
144397766|NCT03265665|520669227|FG000|24-week Data Collection|Lost to Follow-up|4|||
144397767|NCT03265665|520669228|FG001|24-week Data Collection|Lost to Follow-up|5|||
144397768|NCT03265665|520669227|FG000|36-week Data Collection|Lost to Follow-up|6|||
144397769|NCT03265665|520669228|FG001|36-week Data Collection|Lost to Follow-up|8|||
144397770|NCT01973569|520669235|FG000|Overall Study|Adverse Event|9|||
144397771|NCT01973569|520669236|FG001|Overall Study|Adverse Event|2|||
144397772|NCT01973569|520669237|FG002|Overall Study|Adverse Event|4|||
144397773|NCT01973569|520669235|FG000|Overall Study|Protocol Violation|2|||
144397774|NCT01973569|520669236|FG001|Overall Study|Protocol Violation|1|||
144397775|NCT01973569|520669237|FG002|Overall Study|Protocol Violation|3|||
144397776|NCT01973569|520669235|FG000|Overall Study|Withdrawal by Subject|7|||
144397777|NCT01973569|520669236|FG001|Overall Study|Withdrawal by Subject|5|||
144397778|NCT01973569|520669237|FG002|Overall Study|Withdrawal by Subject|2|||
144397779|NCT01973569|520669235|FG000|Overall Study|Invasive dental treatment|3|||
144397780|NCT01973569|520669236|FG001|Overall Study|Invasive dental treatment|5|||
144397781|NCT01973569|520669237|FG002|Overall Study|Invasive dental treatment|6|||
144397782|NCT01973569|520669235|FG000|Overall Study|Prohibited concomitant d|1|||
144397783|NCT01973569|520669236|FG001|Overall Study|Prohibited concomitant d|5|||
144397784|NCT01973569|520669237|FG002|Overall Study|Prohibited concomitant d|0|||
144397785|NCT01973569|520669235|FG000|Overall Study|Disease progression|0|||
144397786|NCT01973569|520669236|FG001|Overall Study|Disease progression|3|||
144397787|NCT01973569|520669237|FG002|Overall Study|Disease progression|0|||
144397788|NCT01973569|520669235|FG000|Overall Study|Other|1|||
144397789|NCT01973569|520669236|FG001|Overall Study|Other|1|||
144397790|NCT01973569|520669237|FG002|Overall Study|Other|0|||
144397791|NCT01973569|520669235|FG000|Overall Study|Did not receive study drug|6|||
144397792|NCT01973569|520669236|FG001|Overall Study|Did not receive study drug|3|||
144397793|NCT01973569|520669237|FG002|Overall Study|Did not receive study drug|3|||
144397794|NCT02486302|520669243|FG000|Overall Study|Discontinued prematurely|410|||
144397795|NCT02486302|520669243|FG000|Overall Study|Documentation not completed|255|||
144397796|NCT02486302|520669243|FG000|Overall Study|Excluded due to legal reasons|8|||
144397797|NCT02486302|520669243|FG000|Overall Study|Not treated|3|||
144397798|NCT01871142|520669244|FG000|Overall Study|Adverse Event|1|||
144397799|NCT04416633|520669253|FG000|Overall Study|Death|1|||
144722318|NCT03519256|521838679|FG003|Overall Study|Disease recurrence|2|||
144397800|NCT04416633|520669253|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
144397801|NCT04416633|520669253|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
144397802|NCT04416633|520669253|FG000|Overall Study|Adverse Event|6|||
144397803|NCT04416633|520669253|FG000|Overall Study|Withdrawal by Subject|6|||
144397804|NCT00785928|520669254|FG000|Treatment Phase|Adverse Event|1|||
144397805|NCT00785928|520669255|FG001|Treatment Phase|Adverse Event|1|||
144397806|NCT00785928|520669256|FG002|Treatment Phase|Adverse Event|2|||
144397807|NCT00785928|520669257|FG003|Treatment Phase|Adverse Event|0|||
144397808|NCT00785928|520669258|FG004|Treatment Phase|Adverse Event|0|||
144397809|NCT00785928|520669259|FG005|Treatment Phase|Adverse Event|0|||
144397810|NCT00785928|520669260|FG006|Treatment Phase|Adverse Event|2|||
144397811|NCT00785928|520669254|FG000|Treatment Phase|Inadequate Response|0|||
144397812|NCT00785928|520669255|FG001|Treatment Phase|Inadequate Response|1|||
144397813|NCT00785928|520669256|FG002|Treatment Phase|Inadequate Response|0|||
144397814|NCT00785928|520669257|FG003|Treatment Phase|Inadequate Response|0|||
144397815|NCT00785928|520669258|FG004|Treatment Phase|Inadequate Response|0|||
144397816|NCT00785928|520669259|FG005|Treatment Phase|Inadequate Response|0|||
144397817|NCT00785928|520669260|FG006|Treatment Phase|Inadequate Response|0|||
144397818|NCT00785928|520669254|FG000|Treatment Phase|Lack of Efficacy|0|||
144397819|NCT00785928|520669255|FG001|Treatment Phase|Lack of Efficacy|1|||
144397820|NCT00785928|520669256|FG002|Treatment Phase|Lack of Efficacy|1|||
144397821|NCT00785928|520669257|FG003|Treatment Phase|Lack of Efficacy|0|||
144397822|NCT00785928|520669258|FG004|Treatment Phase|Lack of Efficacy|0|||
144397823|NCT00785928|520669259|FG005|Treatment Phase|Lack of Efficacy|0|||
144397824|NCT00785928|520669260|FG006|Treatment Phase|Lack of Efficacy|0|||
144397825|NCT00785928|520669254|FG000|Treatment Phase|Physician Decision|0|||
144397826|NCT00785928|520669255|FG001|Treatment Phase|Physician Decision|0|||
144397827|NCT00785928|520669256|FG002|Treatment Phase|Physician Decision|0|||
144397828|NCT00785928|520669257|FG003|Treatment Phase|Physician Decision|0|||
144397829|NCT00785928|520669258|FG004|Treatment Phase|Physician Decision|1|||
144397830|NCT00785928|520669259|FG005|Treatment Phase|Physician Decision|0|||
144397831|NCT00785928|520669260|FG006|Treatment Phase|Physician Decision|0|||
144397832|NCT00785928|520669254|FG000|Treatment Phase|Sponsor Decision|1|||
144397833|NCT00785928|520669255|FG001|Treatment Phase|Sponsor Decision|0|||
144397834|NCT00785928|520669256|FG002|Treatment Phase|Sponsor Decision|0|||
144397835|NCT00785928|520669257|FG003|Treatment Phase|Sponsor Decision|0|||
144397836|NCT00785928|520669258|FG004|Treatment Phase|Sponsor Decision|0|||
144397837|NCT00785928|520669259|FG005|Treatment Phase|Sponsor Decision|0|||
144397838|NCT00785928|520669260|FG006|Treatment Phase|Sponsor Decision|1|||
144397839|NCT00785928|520669254|FG000|Treatment Phase|Withdrawal by Subject|1|||
144397840|NCT00785928|520669255|FG001|Treatment Phase|Withdrawal by Subject|2|||
144397841|NCT00785928|520669256|FG002|Treatment Phase|Withdrawal by Subject|0|||
144397842|NCT00785928|520669257|FG003|Treatment Phase|Withdrawal by Subject|0|||
144397843|NCT00785928|520669258|FG004|Treatment Phase|Withdrawal by Subject|1|||
144397844|NCT00785928|520669259|FG005|Treatment Phase|Withdrawal by Subject|0|||
144397845|NCT00785928|520669260|FG006|Treatment Phase|Withdrawal by Subject|0|||
144397846|NCT05021081|520669267|FG000|Phase 2|Subject enrolled in error|1|||
144397847|NCT05021081|520669268|FG001|Phase 2|Subject enrolled in error|1|||
144397848|NCT05021081|520669269|FG002|Phase 2|Subject enrolled in error|0|||
144397849|NCT02651467|520669270|FG000|Overall Study|Withdrawal by Subject|0|||
144397850|NCT02651467|520669271|FG001|Overall Study|Withdrawal by Subject|0|||
144397851|NCT02651467|520669272|FG002|Overall Study|Withdrawal by Subject|2|||
144397852|NCT02651467|520669270|FG000|Overall Study|Other (Not specified)|1|||
144397853|NCT02651467|520669271|FG001|Overall Study|Other (Not specified)|0|||
144397854|NCT02651467|520669272|FG002|Overall Study|Other (Not specified)|2|||
144397855|NCT00408629|520669273|FG000|Overall Study|Adverse Event|13|||
144397856|NCT00408629|520669274|FG001|Overall Study|Adverse Event|27|||
144397857|NCT00408629|520669273|FG000|Overall Study|Withdrawal by Subject|8|||
144397858|NCT00408629|520669274|FG001|Overall Study|Withdrawal by Subject|4|||
144397859|NCT00408629|520669273|FG000|Overall Study|Lost to Follow-up|1|||
144397860|NCT00408629|520669274|FG001|Overall Study|Lost to Follow-up|1|||
144397861|NCT00408629|520669273|FG000|Overall Study|Lack of Efficacy|63|||
144397862|NCT00408629|520669274|FG001|Overall Study|Lack of Efficacy|73|||
144397863|NCT00408629|520669273|FG000|Overall Study|Protocol Violation|1|||
144397864|NCT00408629|520669274|FG001|Overall Study|Protocol Violation|5|||
144397865|NCT00408629|520669273|FG000|Overall Study|Miscellaneous|11|||
144397866|NCT00408629|520669274|FG001|Overall Study|Miscellaneous|15|||
144397867|NCT00573937|520669275|FG000|Overall Study|Study Terminated|0|||
144397868|NCT00573937|520669276|FG001|Overall Study|Study Terminated|1|||
144397869|NCT00333801|520669277|FG000|Overall Study|Moved to another state|5|||
144397870|NCT00333801|520669278|FG001|Overall Study|Moved to another state|3|||
144521268|NCT04485039|521110135|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
144521269|NCT00378105|521110136|FG000|Overall Study|Adverse Event|3|||
144397871|NCT00333801|520669277|FG000|Overall Study|Lost to Follow-up|2|||
144397872|NCT00333801|520669278|FG001|Overall Study|Lost to Follow-up|0|||
144397873|NCT00333801|520669277|FG000|Overall Study|Incarcerated|1|||
144397874|NCT00333801|520669278|FG001|Overall Study|Incarcerated|2|||
144521270|NCT00378105|521110137|FG001|Overall Study|Adverse Event|1|||
144397875|NCT00333801|520669277|FG000|Overall Study|Withdrawal by Subject|0|||
144397876|NCT00333801|520669278|FG001|Overall Study|Withdrawal by Subject|1|||
144397877|NCT03633617|520669279|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
144397878|NCT03633617|520669280|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
144397879|NCT03633617|520669281|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397880|NCT03633617|520669282|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397881|NCT03633617|520669283|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397882|NCT03633617|520669284|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397883|NCT03633617|520669285|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397884|NCT03633617|520669286|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397885|NCT03633617|520669287|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397886|NCT03633617|520669288|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397887|NCT03633617|520669289|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
144397888|NCT03633617|520669279|FG000|Part A|Unconfirmed early termination visit|1|||
144397889|NCT03633617|520669280|FG001|Part A|Unconfirmed early termination visit|0|||
144397890|NCT03633617|520669281|FG002|Part A|Unconfirmed early termination visit|0|||
144397891|NCT03633617|520669282|FG003|Part A|Unconfirmed early termination visit|0|||
144397892|NCT03633617|520669283|FG004|Part A|Unconfirmed early termination visit|0|||
144397893|NCT03633617|520669284|FG005|Part A|Unconfirmed early termination visit|0|||
144397894|NCT03633617|520669285|FG006|Part A|Unconfirmed early termination visit|0|||
144397895|NCT03633617|520669286|FG007|Part A|Unconfirmed early termination visit|0|||
144397896|NCT03633617|520669287|FG008|Part A|Unconfirmed early termination visit|0|||
144397897|NCT03633617|520669288|FG009|Part A|Unconfirmed early termination visit|0|||
144397898|NCT03633617|520669289|FG010|Part A|Unconfirmed early termination visit|0|||
144397899|NCT03633617|520669279|FG000|Part A|Adverse Event|0|||
144397900|NCT03633617|520669280|FG001|Part A|Adverse Event|1|||
144397901|NCT03633617|520669281|FG002|Part A|Adverse Event|0|||
144397902|NCT03633617|520669282|FG003|Part A|Adverse Event|0|||
144397903|NCT03633617|520669283|FG004|Part A|Adverse Event|0|||
144397904|NCT03633617|520669284|FG005|Part A|Adverse Event|0|||
144397905|NCT03633617|520669285|FG006|Part A|Adverse Event|0|||
144397906|NCT03633617|520669286|FG007|Part A|Adverse Event|0|||
144397907|NCT03633617|520669287|FG008|Part A|Adverse Event|0|||
144397908|NCT03633617|520669288|FG009|Part A|Adverse Event|0|||
144397909|NCT03633617|520669289|FG010|Part A|Adverse Event|0|||
144397910|NCT03633617|520669279|FG000|Part A|Pregnancy|1|||
144397911|NCT03633617|520669280|FG001|Part A|Pregnancy|0|||
144397912|NCT03633617|520669281|FG002|Part A|Pregnancy|0|||
144397913|NCT03633617|520669282|FG003|Part A|Pregnancy|0|||
144397914|NCT03633617|520669283|FG004|Part A|Pregnancy|0|||
144397915|NCT03633617|520669284|FG005|Part A|Pregnancy|0|||
144397916|NCT03633617|520669285|FG006|Part A|Pregnancy|0|||
144397917|NCT03633617|520669286|FG007|Part A|Pregnancy|0|||
144397918|NCT03633617|520669287|FG008|Part A|Pregnancy|0|||
144397919|NCT03633617|520669288|FG009|Part A|Pregnancy|0|||
144397920|NCT03633617|520669289|FG010|Part A|Pregnancy|0|||
144397921|NCT03633617|520669279|FG000|Part A|Withdrawal by Subject|0|||
144397922|NCT03633617|520669280|FG001|Part A|Withdrawal by Subject|1|||
144397923|NCT03633617|520669281|FG002|Part A|Withdrawal by Subject|0|||
144397924|NCT03633617|520669282|FG003|Part A|Withdrawal by Subject|0|||
144397925|NCT03633617|520669283|FG004|Part A|Withdrawal by Subject|0|||
144397926|NCT03633617|520669284|FG005|Part A|Withdrawal by Subject|0|||
144397927|NCT03633617|520669285|FG006|Part A|Withdrawal by Subject|0|||
144397928|NCT03633617|520669286|FG007|Part A|Withdrawal by Subject|0|||
144397929|NCT03633617|520669287|FG008|Part A|Withdrawal by Subject|0|||
144397930|NCT03633617|520669288|FG009|Part A|Withdrawal by Subject|0|||
144397931|NCT03633617|520669289|FG010|Part A|Withdrawal by Subject|0|||
144397932|NCT03633617|520669279|FG000|Part B|Adverse Event|0|||
144397933|NCT03633617|520669280|FG001|Part B|Adverse Event|0|||
144397934|NCT03633617|520669281|FG002|Part B|Adverse Event|2|||
144397935|NCT03633617|520669282|FG003|Part B|Adverse Event|2|||
144397936|NCT03633617|520669283|FG004|Part B|Adverse Event|1|||
144397937|NCT03633617|520669284|FG005|Part B|Adverse Event|0|||
144397938|NCT03633617|520669285|FG006|Part B|Adverse Event|0|||
144397939|NCT03633617|520669286|FG007|Part B|Adverse Event|0|||
144397940|NCT03633617|520669287|FG008|Part B|Adverse Event|0|||
144397941|NCT03633617|520669288|FG009|Part B|Adverse Event|0|||
144397942|NCT03633617|520669289|FG010|Part B|Adverse Event|0|||
144397943|NCT03633617|520669279|FG000|Part B|Withdrawal by Subject|0|||
144397944|NCT03633617|520669280|FG001|Part B|Withdrawal by Subject|0|||
144595792|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
144397945|NCT03633617|520669281|FG002|Part B|Withdrawal by Subject|1|||
144397946|NCT03633617|520669282|FG003|Part B|Withdrawal by Subject|0|||
144397947|NCT03633617|520669283|FG004|Part B|Withdrawal by Subject|2|||
144397948|NCT03633617|520669284|FG005|Part B|Withdrawal by Subject|0|||
144397949|NCT03633617|520669285|FG006|Part B|Withdrawal by Subject|0|||
144397950|NCT03633617|520669286|FG007|Part B|Withdrawal by Subject|0|||
144397951|NCT03633617|520669287|FG008|Part B|Withdrawal by Subject|0|||
144397952|NCT03633617|520669288|FG009|Part B|Withdrawal by Subject|0|||
144397953|NCT03633617|520669289|FG010|Part B|Withdrawal by Subject|0|||
144397954|NCT03633617|520669279|FG000|Part B|Lost to Follow-up|0|||
144397955|NCT03633617|520669280|FG001|Part B|Lost to Follow-up|0|||
144397956|NCT03633617|520669281|FG002|Part B|Lost to Follow-up|0|||
144397957|NCT03633617|520669282|FG003|Part B|Lost to Follow-up|0|||
144397958|NCT03633617|520669283|FG004|Part B|Lost to Follow-up|1|||
144397959|NCT03633617|520669284|FG005|Part B|Lost to Follow-up|0|||
144397960|NCT03633617|520669285|FG006|Part B|Lost to Follow-up|0|||
144397961|NCT03633617|520669286|FG007|Part B|Lost to Follow-up|0|||
144397962|NCT03633617|520669287|FG008|Part B|Lost to Follow-up|0|||
144397963|NCT03633617|520669288|FG009|Part B|Lost to Follow-up|0|||
144397964|NCT03633617|520669289|FG010|Part B|Lost to Follow-up|0|||
144397965|NCT03633617|520669279|FG000|Part B|Physician Decision|0|||
144397966|NCT03633617|520669280|FG001|Part B|Physician Decision|0|||
144397967|NCT03633617|520669281|FG002|Part B|Physician Decision|0|||
144397968|NCT03633617|520669282|FG003|Part B|Physician Decision|0|||
144397969|NCT03633617|520669283|FG004|Part B|Physician Decision|1|||
144397970|NCT03633617|520669284|FG005|Part B|Physician Decision|0|||
144397971|NCT03633617|520669285|FG006|Part B|Physician Decision|0|||
144397972|NCT03633617|520669286|FG007|Part B|Physician Decision|0|||
144397973|NCT03633617|520669287|FG008|Part B|Physician Decision|0|||
144397974|NCT03633617|520669288|FG009|Part B|Physician Decision|0|||
144397975|NCT03633617|520669289|FG010|Part B|Physician Decision|0|||
144397976|NCT03633617|520669279|FG000|Part B|COVID-19 Restrictions|0|||
144397977|NCT03633617|520669280|FG001|Part B|COVID-19 Restrictions|0|||
144397978|NCT03633617|520669281|FG002|Part B|COVID-19 Restrictions|1|||
144397979|NCT03633617|520669282|FG003|Part B|COVID-19 Restrictions|0|||
144397980|NCT03633617|520669283|FG004|Part B|COVID-19 Restrictions|0|||
144397981|NCT03633617|520669284|FG005|Part B|COVID-19 Restrictions|0|||
144397982|NCT03633617|520669285|FG006|Part B|COVID-19 Restrictions|0|||
144397983|NCT03633617|520669286|FG007|Part B|COVID-19 Restrictions|0|||
144397984|NCT03633617|520669287|FG008|Part B|COVID-19 Restrictions|0|||
144397985|NCT03633617|520669288|FG009|Part B|COVID-19 Restrictions|0|||
144397986|NCT03633617|520669289|FG010|Part B|COVID-19 Restrictions|0|||
144397987|NCT03633617|520669279|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397988|NCT03633617|520669280|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397989|NCT03633617|520669281|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
144397990|NCT03633617|520669282|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397991|NCT03633617|520669283|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397992|NCT03633617|520669284|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397993|NCT03633617|520669285|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397994|NCT03633617|520669286|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397995|NCT03633617|520669287|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397996|NCT03633617|520669288|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397997|NCT03633617|520669289|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
144397998|NCT03633617|520669279|FG000|Part C (& Follow-up)|Adverse Event|0|||
144397999|NCT03633617|520669280|FG001|Part C (& Follow-up)|Adverse Event|0|||
144398000|NCT03633617|520669281|FG002|Part C (& Follow-up)|Adverse Event|0|||
144398001|NCT03633617|520669282|FG003|Part C (& Follow-up)|Adverse Event|0|||
144398002|NCT03633617|520669283|FG004|Part C (& Follow-up)|Adverse Event|0|||
144595793|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
144595794|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
144595795|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
144595796|NCT00615836|521381196|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
144249654|NCT01897571|520111703|FG003|Overall Study|Enrolled in rollover study|0|||
144249655|NCT01897571|520111704|FG004|Overall Study|Enrolled in rollover study|0|||
144249656|NCT01897571|520111705|FG005|Overall Study|Enrolled in rollover study|0|||
144398003|NCT03633617|520669284|FG005|Part C (& Follow-up)|Adverse Event|1|||
144398004|NCT03633617|520669285|FG006|Part C (& Follow-up)|Adverse Event|0|||
144398005|NCT03633617|520669286|FG007|Part C (& Follow-up)|Adverse Event|1|||
144398006|NCT03633617|520669287|FG008|Part C (& Follow-up)|Adverse Event|0|||
144398007|NCT03633617|520669288|FG009|Part C (& Follow-up)|Adverse Event|0|||
144398008|NCT03633617|520669289|FG010|Part C (& Follow-up)|Adverse Event|0|||
144398009|NCT03633617|520669279|FG000|Part C (& Follow-up)|Pregnancy|0|||
144398010|NCT03633617|520669280|FG001|Part C (& Follow-up)|Pregnancy|0|||
144398011|NCT03633617|520669281|FG002|Part C (& Follow-up)|Pregnancy|0|||
144398012|NCT03633617|520669282|FG003|Part C (& Follow-up)|Pregnancy|0|||
144398013|NCT03633617|520669283|FG004|Part C (& Follow-up)|Pregnancy|0|||
144398014|NCT03633617|520669284|FG005|Part C (& Follow-up)|Pregnancy|0|||
144398015|NCT03633617|520669285|FG006|Part C (& Follow-up)|Pregnancy|0|||
144722319|NCT03519256|521838676|FG000|Overall Study|Study drug toxicity|0|||
144398016|NCT03633617|520669286|FG007|Part C (& Follow-up)|Pregnancy|0|||
144398017|NCT03633617|520669287|FG008|Part C (& Follow-up)|Pregnancy|0|||
144398018|NCT03633617|520669288|FG009|Part C (& Follow-up)|Pregnancy|1|||
144398019|NCT03633617|520669289|FG010|Part C (& Follow-up)|Pregnancy|0|||
144398020|NCT03633617|520669279|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
144398021|NCT03633617|520669280|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
144398022|NCT03633617|520669281|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
144398023|NCT03633617|520669282|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
144398024|NCT03633617|520669283|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
144398025|NCT03633617|520669284|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
144398026|NCT03633617|520669285|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
144398027|NCT03633617|520669286|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
144398028|NCT03633617|520669287|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
144398029|NCT03633617|520669288|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
144398030|NCT03633617|520669289|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
144398031|NCT03633617|520669279|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
144398032|NCT03633617|520669280|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
144398033|NCT03633617|520669281|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
144398034|NCT03633617|520669282|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
144398035|NCT03633617|520669283|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
144398036|NCT03633617|520669284|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
144398037|NCT03633617|520669285|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
144398038|NCT03633617|520669286|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
144398039|NCT03633617|520669287|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
144398040|NCT03633617|520669288|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
144398041|NCT03633617|520669289|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
144398042|NCT03633617|520669279|FG000|Part C (& Follow-up)|Physician Decision|0|||
144398043|NCT03633617|520669280|FG001|Part C (& Follow-up)|Physician Decision|0|||
144398044|NCT03633617|520669281|FG002|Part C (& Follow-up)|Physician Decision|0|||
144398045|NCT03633617|520669282|FG003|Part C (& Follow-up)|Physician Decision|0|||
144398046|NCT03633617|520669283|FG004|Part C (& Follow-up)|Physician Decision|0|||
144398047|NCT03633617|520669284|FG005|Part C (& Follow-up)|Physician Decision|0|||
144398048|NCT03633617|520669285|FG006|Part C (& Follow-up)|Physician Decision|0|||
144398049|NCT03633617|520669286|FG007|Part C (& Follow-up)|Physician Decision|1|||
144398050|NCT03633617|520669287|FG008|Part C (& Follow-up)|Physician Decision|0|||
144398051|NCT03633617|520669288|FG009|Part C (& Follow-up)|Physician Decision|0|||
144398052|NCT03633617|520669289|FG010|Part C (& Follow-up)|Physician Decision|1|||
144398053|NCT03633617|520669279|FG000|Part C (& Follow-up)|COVID-19 related|0|||
144398054|NCT03633617|520669280|FG001|Part C (& Follow-up)|COVID-19 related|0|||
144398055|NCT03633617|520669281|FG002|Part C (& Follow-up)|COVID-19 related|0|||
144398056|NCT03633617|520669282|FG003|Part C (& Follow-up)|COVID-19 related|0|||
144398057|NCT03633617|520669283|FG004|Part C (& Follow-up)|COVID-19 related|0|||
144398058|NCT03633617|520669284|FG005|Part C (& Follow-up)|COVID-19 related|1|||
144398059|NCT03633617|520669285|FG006|Part C (& Follow-up)|COVID-19 related|0|||
144398060|NCT03633617|520669286|FG007|Part C (& Follow-up)|COVID-19 related|0|||
144398061|NCT03633617|520669287|FG008|Part C (& Follow-up)|COVID-19 related|0|||
144398062|NCT03633617|520669288|FG009|Part C (& Follow-up)|COVID-19 related|0|||
144398063|NCT03633617|520669289|FG010|Part C (& Follow-up)|COVID-19 related|0|||
144398064|NCT03633617|520669279|FG000|Part C (& Follow-up)|Protocol Violation|0|||
144398065|NCT03633617|520669280|FG001|Part C (& Follow-up)|Protocol Violation|0|||
144398066|NCT03633617|520669281|FG002|Part C (& Follow-up)|Protocol Violation|0|||
144398067|NCT03633617|520669282|FG003|Part C (& Follow-up)|Protocol Violation|0|||
144398068|NCT03633617|520669283|FG004|Part C (& Follow-up)|Protocol Violation|0|||
144398069|NCT03633617|520669284|FG005|Part C (& Follow-up)|Protocol Violation|0|||
144398070|NCT03633617|520669285|FG006|Part C (& Follow-up)|Protocol Violation|0|||
144398071|NCT03633617|520669286|FG007|Part C (& Follow-up)|Protocol Violation|0|||
144398072|NCT03633617|520669287|FG008|Part C (& Follow-up)|Protocol Violation|0|||
144398073|NCT03633617|520669288|FG009|Part C (& Follow-up)|Protocol Violation|3|||
144398074|NCT03633617|520669289|FG010|Part C (& Follow-up)|Protocol Violation|1|||
144398075|NCT03633617|520669279|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
144398076|NCT03633617|520669280|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
144398077|NCT03633617|520669281|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
144398078|NCT03633617|520669282|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
144398079|NCT03633617|520669283|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
144398080|NCT03633617|520669284|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
144398081|NCT03633617|520669285|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
144398082|NCT03633617|520669286|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
144398083|NCT03633617|520669287|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
144398084|NCT03633617|520669288|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
144398085|NCT03633617|520669289|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
144398086|NCT01890746|520669292|FG000|Overall Study|Death|39|||
144398087|NCT01890746|520669293|FG001|Overall Study|Death|30|||
144398088|NCT01890746|520669292|FG000|Overall Study|Adverse Event|1|||
144398089|NCT01890746|520669293|FG001|Overall Study|Adverse Event|0|||
144398090|NCT01890746|520669292|FG000|Overall Study|Lost to Follow-up|4|||
144398091|NCT01890746|520669293|FG001|Overall Study|Lost to Follow-up|1|||
144398092|NCT01890746|520669292|FG000|Overall Study|Physician Decision|3|||
144398093|NCT01890746|520669293|FG001|Overall Study|Physician Decision|2|||
144398094|NCT01890746|520669292|FG000|Overall Study|Withdrawal by Subject|5|||
144398095|NCT01890746|520669293|FG001|Overall Study|Withdrawal by Subject|8|||
144398096|NCT00777205|520669298|FG000|Overall Study|Lost to Follow-up|25|||
144398097|NCT00777205|520669299|FG001|Overall Study|Lost to Follow-up|9|||
144398098|NCT00777205|520669298|FG000|Overall Study|Withdrawal by Subject|6|||
144398099|NCT00777205|520669299|FG001|Overall Study|Withdrawal by Subject|4|||
144398100|NCT00777205|520669298|FG000|Overall Study|Death|0|||
144398101|NCT00777205|520669299|FG001|Overall Study|Death|2|||
144398102|NCT00777205|520669298|FG000|Overall Study|Protocol Violation|0|||
144398103|NCT00777205|520669299|FG001|Overall Study|Protocol Violation|56|||
144398104|NCT03257371|520669300|FG000|Overall Study|Lost to Follow-up|1|||
144398105|NCT03198078|520669303|FG000|Overall Study|Adverse Event|0|||
144398106|NCT03198078|520669304|FG001|Overall Study|Adverse Event|1|||
144398107|NCT03198078|520669305|FG002|Overall Study|Adverse Event|2|||
144398108|NCT03198078|520669303|FG000|Overall Study|Lack of Efficacy|0|||
144398109|NCT03198078|520669304|FG001|Overall Study|Lack of Efficacy|0|||
144398110|NCT03198078|520669305|FG002|Overall Study|Lack of Efficacy|3|||
144398111|NCT03198078|520669303|FG000|Overall Study|Lost to Follow-up|1|||
144398112|NCT03198078|520669304|FG001|Overall Study|Lost to Follow-up|0|||
144398113|NCT03198078|520669305|FG002|Overall Study|Lost to Follow-up|0|||
144398114|NCT03198078|520669303|FG000|Overall Study|Pregnancy|0|||
144398115|NCT03198078|520669304|FG001|Overall Study|Pregnancy|1|||
144398116|NCT03198078|520669305|FG002|Overall Study|Pregnancy|0|||
144398117|NCT03198078|520669303|FG000|Overall Study|Withdrawal by Subject|1|||
144398118|NCT03198078|520669304|FG001|Overall Study|Withdrawal by Subject|0|||
144398119|NCT03198078|520669305|FG002|Overall Study|Withdrawal by Subject|2|||
144398120|NCT03198078|520669303|FG000|Overall Study|Withdrawal by Caregiver|1|||
144398121|NCT03198078|520669304|FG001|Overall Study|Withdrawal by Caregiver|3|||
144398122|NCT03198078|520669305|FG002|Overall Study|Withdrawal by Caregiver|5|||
144398123|NCT01676727|520669306|FG000|Overall Study|Death|18|||
144398124|NCT01676727|520669306|FG000|Overall Study|Withdrawal by Subject|6|||
144398125|NCT01676727|520669306|FG000|Overall Study|Screening failure|5|||
144398126|NCT01676727|520669306|FG000|Overall Study|Not willing to attend 1-year visit|2|||
144398127|NCT01676727|520669306|FG000|Overall Study|Valve explanted|1|||
144398128|NCT01134731|520669307|FG000|Overall Study|Adverse Event|3|||
144398129|NCT01134731|520669308|FG001|Overall Study|Adverse Event|2|||
144398130|NCT01134731|520669309|FG002|Overall Study|Adverse Event|1|||
144521271|NCT00378105|521110136|FG000|Overall Study|Withdrawal by Subject|3|||
144521272|NCT00378105|521110137|FG001|Overall Study|Withdrawal by Subject|3|||
144521273|NCT00378105|521110136|FG000|Overall Study|Death|1|||
144521274|NCT00378105|521110137|FG001|Overall Study|Death|0|||
144521275|NCT00378105|521110136|FG000|Overall Study|Going to transplant|7|||
144521276|NCT00378105|521110137|FG001|Overall Study|Going to transplant|8|||
144521277|NCT00378105|521110136|FG000|Overall Study|Progressive disease|3|||
144521278|NCT00378105|521110137|FG001|Overall Study|Progressive disease|3|||
144521279|NCT00378105|521110136|FG000|Overall Study|remain on study|3|||
144521280|NCT00378105|521110137|FG001|Overall Study|remain on study|11|||
144521281|NCT00378105|521110136|FG000|Overall Study|Physician Decision|0|||
144521282|NCT00378105|521110137|FG001|Overall Study|Physician Decision|2|||
144521283|NCT00378105|521110136|FG000|Overall Study|Going non-protocol therapy|0|||
144521284|NCT00378105|521110137|FG001|Overall Study|Going non-protocol therapy|1|||
144521285|NCT00378105|521110136|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
144521286|NCT00378105|521110137|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
144521287|NCT02120456|521110138|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521288|NCT02120456|521110139|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521289|NCT02120456|521110140|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521290|NCT02120456|521110141|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521291|NCT02120456|521110142|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144595797|NCT00615836|521381197|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
144595798|NCT00615836|521381198|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
144398131|NCT01134731|520669307|FG000|Overall Study|Physician Decision|2|||
144398132|NCT01134731|520669308|FG001|Overall Study|Physician Decision|2|||
144398133|NCT01134731|520669309|FG002|Overall Study|Physician Decision|2|||
144398134|NCT01134731|520669307|FG000|Overall Study|Lack of Efficacy|0|||
144398135|NCT01134731|520669308|FG001|Overall Study|Lack of Efficacy|0|||
144398136|NCT01134731|520669309|FG002|Overall Study|Lack of Efficacy|1|||
144398137|NCT01134731|520669307|FG000|Overall Study|Withdrawal by Subject|3|||
144398138|NCT01134731|520669308|FG001|Overall Study|Withdrawal by Subject|3|||
144398139|NCT01134731|520669309|FG002|Overall Study|Withdrawal by Subject|1|||
144398140|NCT01134731|520669307|FG000|Overall Study|Lost to Follow-up|5|||
144521292|NCT02120456|521110143|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521293|NCT02120456|521110144|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
144521294|NCT02120456|521110145|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521295|NCT02120456|521110146|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
144521296|NCT02120456|521110138|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521297|NCT02120456|521110139|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521298|NCT02120456|521110140|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521299|NCT02120456|521110141|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521300|NCT02120456|521110142|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521301|NCT02120456|521110143|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521302|NCT02120456|521110144|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
144521303|NCT02120456|521110145|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521304|NCT02120456|521110146|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
144521305|NCT02120456|521110138|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521306|NCT02120456|521110139|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521307|NCT02120456|521110140|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521308|NCT02120456|521110141|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521309|NCT02120456|521110142|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521310|NCT02120456|521110143|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521311|NCT02120456|521110144|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521312|NCT02120456|521110145|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
144521313|NCT02120456|521110146|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
144521314|NCT05192200|521110147|FG000|Treatment Period|Other|1|||
144521315|NCT05192200|521110147|FG000|Treatment Period|Lack of Efficacy|1|||
144521316|NCT05192200|521110147|FG000|Treatment Period|Withdrawal by Subject|1|||
144521317|NCT05192200|521110147|FG000|Follow-up|Withdrawal by Subject|1|||
144398141|NCT01134731|520669308|FG001|Overall Study|Lost to Follow-up|4|||
144398142|NCT01134731|520669309|FG002|Overall Study|Lost to Follow-up|3|||
144521318|NCT03623321|521110148|FG000|Overall Study|Adverse Event|32|||
144521319|NCT03623321|521110148|FG000|Overall Study|Death|9|||
144398143|NCT01050543|520669310|FG000|Overall Study|Withdrawal by Subject|0|||
144398144|NCT01050543|520669311|FG001|Overall Study|Withdrawal by Subject|2|||
144398145|NCT01050543|520669310|FG000|Overall Study|Protocol Violation|0|||
144398146|NCT01050543|520669311|FG001|Overall Study|Protocol Violation|1|||
144398147|NCT01050543|520669310|FG000|Overall Study|Administrative|4|||
144398148|NCT01050543|520669311|FG001|Overall Study|Administrative|1|||
144398149|NCT00580970|520669314|FG000|Pre-treatment|Non-compliance|1|||
144398150|NCT00580970|520669314|FG000|Treatment (Lovastatin)|Non-compliance|6|||
144398151|NCT00580970|520669314|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
144398152|NCT00580970|520669314|FG000|Treatment (Lovastatin)|Physician Decision|4|||
144398153|NCT00580970|520669314|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
144398154|NCT00580970|520669314|FG000|Treatment (Lovastatin)|Death|1|||
144398155|NCT03161093|520669317|FG000|Overall Study|Protocol Violation|11|||
144398156|NCT03161093|520669318|FG001|Overall Study|Protocol Violation|14|||
144398157|NCT03161093|520669319|FG002|Overall Study|Protocol Violation|6|||
144398158|NCT03161093|520669320|FG003|Overall Study|Protocol Violation|13|||
144398159|NCT03161093|520669321|FG004|Overall Study|Protocol Violation|1|||
144398160|NCT03161093|520669322|FG005|Overall Study|Protocol Violation|0|||
144398161|NCT03161093|520669317|FG000|Overall Study|Adverse Event|5|||
144398162|NCT03161093|520669318|FG001|Overall Study|Adverse Event|21|||
144521320|NCT03623321|521110148|FG000|Overall Study|Lack of Efficacy|9|||
144521321|NCT03623321|521110148|FG000|Overall Study|Lost to Follow-up|6|||
144521322|NCT03623321|521110148|FG000|Overall Study|Noncompliance with study drug|6|||
144521323|NCT03623321|521110148|FG000|Overall Study|Use of prohibited medication|3|||
144521324|NCT03623321|521110148|FG000|Overall Study|Physician Decision|5|||
144521325|NCT03623321|521110148|FG000|Overall Study|Protocol Violation|1|||
144521326|NCT03623321|521110148|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
144521327|NCT03623321|521110148|FG000|Overall Study|Not further specified|43|||
144521328|NCT04241068|521110152|FG000|Core Treatment Period|Adverse Event|91|||
144521329|NCT04241068|521110152|FG000|Core Treatment Period|Change of Treatment|4|||
144521330|NCT04241068|521110152|FG000|Core Treatment Period|Consent Withdrawn|143|||
144521331|NCT04241068|521110152|FG000|Core Treatment Period|Death|26|||
144398163|NCT03161093|520669319|FG002|Overall Study|Adverse Event|16|||
144398164|NCT03161093|520669320|FG003|Overall Study|Adverse Event|35|||
144398165|NCT03161093|520669321|FG004|Overall Study|Adverse Event|2|||
144398166|NCT03161093|520669322|FG005|Overall Study|Adverse Event|1|||
144398167|NCT03161093|520669317|FG000|Overall Study|Lack of Efficacy|9|||
144398168|NCT03161093|520669318|FG001|Overall Study|Lack of Efficacy|13|||
144398169|NCT03161093|520669319|FG002|Overall Study|Lack of Efficacy|9|||
144398170|NCT03161093|520669320|FG003|Overall Study|Lack of Efficacy|24|||
144398171|NCT03161093|520669321|FG004|Overall Study|Lack of Efficacy|4|||
144398172|NCT03161093|520669322|FG005|Overall Study|Lack of Efficacy|1|||
144398173|NCT03161093|520669317|FG000|Overall Study|Physician Decision|0|||
144398174|NCT03161093|520669318|FG001|Overall Study|Physician Decision|1|||
144398175|NCT03161093|520669319|FG002|Overall Study|Physician Decision|0|||
144398176|NCT03161093|520669320|FG003|Overall Study|Physician Decision|2|||
144521332|NCT04241068|521110152|FG000|Core Treatment Period|Disease Progression|67|||
144521333|NCT04241068|521110152|FG000|Core Treatment Period|Investigator Decision|40|||
144521334|NCT04241068|521110152|FG000|Core Treatment Period|Loss of Capacity|9|||
144521335|NCT04241068|521110152|FG000|Core Treatment Period|Lost to Follow-up|11|||
144521336|NCT04241068|521110152|FG000|Core Treatment Period|Relocation|4|||
144521337|NCT04241068|521110152|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
144398177|NCT03161093|520669321|FG004|Overall Study|Physician Decision|17|||
144398178|NCT03161093|520669322|FG005|Overall Study|Physician Decision|15|||
144398179|NCT03161093|520669317|FG000|Overall Study|Withdrawal by Subject|24|||
144398180|NCT03161093|520669318|FG001|Overall Study|Withdrawal by Subject|73|||
144398181|NCT03161093|520669319|FG002|Overall Study|Withdrawal by Subject|44|||
144398182|NCT03161093|520669320|FG003|Overall Study|Withdrawal by Subject|97|||
144398183|NCT03161093|520669321|FG004|Overall Study|Withdrawal by Subject|11|||
144398184|NCT03161093|520669322|FG005|Overall Study|Withdrawal by Subject|10|||
144398185|NCT03161093|520669317|FG000|Overall Study|Lost to Follow-up|3|||
144398186|NCT03161093|520669318|FG001|Overall Study|Lost to Follow-up|12|||
144398187|NCT03161093|520669319|FG002|Overall Study|Lost to Follow-up|4|||
144398188|NCT03161093|520669320|FG003|Overall Study|Lost to Follow-up|7|||
144398189|NCT03161093|520669321|FG004|Overall Study|Lost to Follow-up|8|||
144398190|NCT03161093|520669322|FG005|Overall Study|Lost to Follow-up|13|||
144398191|NCT03161093|520669317|FG000|Overall Study|Death|3|||
144398192|NCT03161093|520669318|FG001|Overall Study|Death|9|||
144398193|NCT03161093|520669319|FG002|Overall Study|Death|7|||
144398194|NCT03161093|520669320|FG003|Overall Study|Death|9|||
144398195|NCT03161093|520669321|FG004|Overall Study|Death|0|||
144398196|NCT03161093|520669322|FG005|Overall Study|Death|0|||
144398197|NCT03161093|520669317|FG000|Overall Study|Unknown - Not reported|0|||
144398198|NCT03161093|520669318|FG001|Overall Study|Unknown - Not reported|1|||
144398199|NCT03161093|520669319|FG002|Overall Study|Unknown - Not reported|0|||
144398200|NCT03161093|520669320|FG003|Overall Study|Unknown - Not reported|0|||
144398201|NCT03161093|520669321|FG004|Overall Study|Unknown - Not reported|0|||
144398202|NCT03161093|520669322|FG005|Overall Study|Unknown - Not reported|1|||
144398203|NCT01031706|520669323|FG000|Overall Study|Adverse Event|1|||
144398204|NCT01031706|520669324|FG001|Overall Study|Adverse Event|0|||
144398205|NCT01031706|520669323|FG000|Overall Study|Withdrawal by Subject|1|||
144398206|NCT01031706|520669324|FG001|Overall Study|Withdrawal by Subject|1|||
144398207|NCT02124161|520669325|FG000|Overall Study|Other unspecified|0|||
144398208|NCT02124161|520669326|FG001|Overall Study|Other unspecified|1|||
144398209|NCT02124161|520669325|FG000|Overall Study|Death|1|||
144398210|NCT02124161|520669326|FG001|Overall Study|Death|0|||
144398211|NCT02124161|520669325|FG000|Overall Study|Protocol Violation|2|||
144398212|NCT02124161|520669326|FG001|Overall Study|Protocol Violation|1|||
144398213|NCT02124161|520669325|FG000|Overall Study|Withdrawal by Subject|1|||
144398214|NCT02124161|520669326|FG001|Overall Study|Withdrawal by Subject|2|||
144398215|NCT02124161|520669325|FG000|Overall Study|Adverse Event|2|||
144398216|NCT02124161|520669326|FG001|Overall Study|Adverse Event|0|||
144398217|NCT02124161|520669325|FG000|Overall Study|Does not meet entrance criteria|2|||
144398218|NCT02124161|520669326|FG001|Overall Study|Does not meet entrance criteria|3|||
144398219|NCT02124161|520669325|FG000|Overall Study|No longer meets eligibility criteria|5|||
144398220|NCT02124161|520669326|FG001|Overall Study|No longer meets eligibility criteria|4|||
144398221|NCT02124161|520669325|FG000|Overall Study|Lost to Follow-up|3|||
144398222|NCT02124161|520669326|FG001|Overall Study|Lost to Follow-up|4|||
144398223|NCT01008150|520669328|FG000|Overall Study|did not receive study drug|1|||
144398224|NCT01008150|520669329|FG001|Overall Study|did not receive study drug|1|||
144398225|NCT01008150|520669330|FG002|Overall Study|did not receive study drug|1|||
144398226|NCT01008150|520669331|FG003|Overall Study|did not receive study drug|0|||
144398227|NCT01497275|520669333|FG000|Overall Study|Death|1|||
144398228|NCT01497275|520669333|FG000|Overall Study|Adverse Event|1|||
144398229|NCT01938573|520669335|FG000|Overall Study|Lack of Efficacy|1|||
144398230|NCT01938573|520669336|FG001|Overall Study|Lack of Efficacy|0|||
144398231|NCT01938573|520669335|FG000|Overall Study|Operation at other hospital|1|||
144398232|NCT01938573|520669336|FG001|Overall Study|Operation at other hospital|0|||
144398233|NCT00737438|520669339|FG000|Overall Study|Withdrawal by Subject|2|||
144398234|NCT00737438|520669339|FG000|Overall Study|Patient ineligible|1|||
144398235|NCT02410551|520669343|FG000|Overall Study|Adverse Event|1|||
144398236|NCT02410551|520669343|FG000|Overall Study|Withdrawal by Subject|1|||
144398237|NCT02410551|520669343|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
144398238|NCT01739309|520669344|FG000|Overall Study|Adverse Event|1|||
144398239|NCT01739309|520669344|FG000|Overall Study|Withdrawal by Subject|1|||
144398240|NCT05085730|520669345|FG000|Overall Study|Withdrawal by Subject|4|||
144398241|NCT05085730|520669345|FG000|Overall Study|Physician Decision|1|||
144398242|NCT05447897|520669346|FG000|Overall Study|Did not participate in survey|2|||
144398243|NCT03719586|520669347|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
144398244|NCT03719586|520669348|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
144471828|NCT00758459|520925320|FG001|Overall Study|Withdrawal by Subject|1|||
144471829|NCT02597036|520925326|FG000|Overall Study|Progressive Disease|0|||
144471830|NCT02597036|520925327|FG001|Overall Study|Progressive Disease|0|||
144471831|NCT02597036|520925328|FG002|Overall Study|Progressive Disease|0|||
144471832|NCT02597036|520925329|FG003|Overall Study|Progressive Disease|0|||
144471833|NCT02597036|520925330|FG004|Overall Study|Progressive Disease|1|||
144471834|NCT02597036|520925331|FG005|Overall Study|Progressive Disease|1|||
144471835|NCT02597036|520925332|FG006|Overall Study|Progressive Disease|1|||
144471836|NCT02597036|520925333|FG007|Overall Study|Progressive Disease|0|||
144471837|NCT02597036|520925334|FG008|Overall Study|Progressive Disease|0|||
144398245|NCT03719586|520669349|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
144398246|NCT03719586|520669350|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
144398247|NCT00178633|520669351|FG000|Overall Study|Lost to Follow-up|6|||
144398248|NCT03845543|520669352|FG000|Overall Study|Death|25|||
144398249|NCT03845543|520669352|FG000|Overall Study|Withdrawal by Subject|2|||
144398250|NCT03845543|520669352|FG000|Overall Study|Lost to Follow-up|12|||
144398251|NCT03845543|520669352|FG000|Overall Study|Adverse Event|17|||
144398252|NCT01912963|520669360|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
144398253|NCT01912963|520669361|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
144398254|NCT01912963|520669362|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
144398255|NCT01912963|520669360|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
144398256|NCT01912963|520669361|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
144398257|NCT01912963|520669362|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
144398258|NCT01912963|520669360|FG000|Overall Study|Adverse Event|0|||
144398259|NCT01912963|520669361|FG001|Overall Study|Adverse Event|1|||
144398260|NCT01912963|520669362|FG002|Overall Study|Adverse Event|1|||
144398261|NCT01912963|520669360|FG000|Overall Study|Withdrawal by Subject|0|||
144398262|NCT01912963|520669361|FG001|Overall Study|Withdrawal by Subject|1|||
144398263|NCT01912963|520669362|FG002|Overall Study|Withdrawal by Subject|0|||
144398264|NCT01912963|520669360|FG000|Overall Study|Sought treatment locally|0|||
144398265|NCT01912963|520669361|FG001|Overall Study|Sought treatment locally|1|||
144398266|NCT01912963|520669362|FG002|Overall Study|Sought treatment locally|0|||
144398267|NCT01896050|520671069|FG000|Overall Study|Adverse Event|37|||
144398268|NCT01896050|520671070|FG001|Overall Study|Adverse Event|2|||
144398269|NCT01896050|520671069|FG000|Overall Study|Death|1|||
144398270|NCT01896050|520671070|FG001|Overall Study|Death|0|||
144398271|NCT03693300|520671071|FG000|Overall Study|Withdrawal by Subject|6|||
144398272|NCT03693300|520671072|FG001|Overall Study|Withdrawal by Subject|0|||
144398273|NCT03693300|520671071|FG000|Overall Study|Death|50|||
144398274|NCT03693300|520671072|FG001|Overall Study|Death|2|||
144398275|NCT03693300|520671071|FG000|Overall Study|Lost to Follow-up|2|||
144398276|NCT03693300|520671072|FG001|Overall Study|Lost to Follow-up|0|||
144398277|NCT02206048|520671073|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
144398278|NCT01858376|520671074|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
144398279|NCT00108433|520671078|FG000|Overall Study|Lack of Efficacy|1|||
144398280|NCT00108433|520671079|FG001|Overall Study|Lack of Efficacy|2|||
144398281|NCT00108433|520671078|FG000|Overall Study|Death|3|||
144398282|NCT00108433|520671079|FG001|Overall Study|Death|0|||
144398283|NCT00108433|520671078|FG000|Overall Study|Adverse Event|3|||
144398284|NCT00108433|520671079|FG001|Overall Study|Adverse Event|1|||
144398285|NCT00108433|520671078|FG000|Overall Study|Other|14|||
144398286|NCT00108433|520671079|FG001|Overall Study|Other|14|||
144398287|NCT02203071|520671080|FG000|Overall Study|Lost to Follow-up|3|||
144398288|NCT02203071|520671081|FG001|Overall Study|Lost to Follow-up|1|||
144398289|NCT01886716|520671082|FG000|Week 1|Lost to Follow-up|0|||
144398290|NCT01886716|520671083|FG001|Week 1|Lost to Follow-up|0|||
144398291|NCT01886716|520671084|FG002|Week 1|Lost to Follow-up|2|||
144398292|NCT01886716|520671085|FG003|Week 1|Lost to Follow-up|2|||
144398293|NCT01886716|520671082|FG000|Week 2|Lost to Follow-up|3|||
144398294|NCT01886716|520671083|FG001|Week 2|Lost to Follow-up|2|||
144398295|NCT01886716|520671084|FG002|Week 2|Lost to Follow-up|1|||
144398296|NCT01886716|520671085|FG003|Week 2|Lost to Follow-up|3|||
144398297|NCT01886716|520671082|FG000|Week 3|Lost to Follow-up|1|||
144398298|NCT01886716|520671083|FG001|Week 3|Lost to Follow-up|1|||
144595799|NCT00615836|521381199|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
144398299|NCT01886716|520671084|FG002|Week 3|Lost to Follow-up|0|||
144398300|NCT01886716|520671085|FG003|Week 3|Lost to Follow-up|1|||
144398301|NCT03894046|520671088|FG000|Overall Study|Protocol Violation|1|||
144398302|NCT03894046|520671089|FG001|Overall Study|Protocol Violation|0|||
144398303|NCT03894046|520671090|FG002|Overall Study|Protocol Violation|0|||
144398304|NCT03894046|520671088|FG000|Overall Study|Adverse Event|0|||
144398305|NCT03894046|520671089|FG001|Overall Study|Adverse Event|1|||
144398306|NCT03894046|520671090|FG002|Overall Study|Adverse Event|0|||
144398307|NCT03894046|520671088|FG000|Overall Study|Withdrawal by Subject|2|||
144398308|NCT03894046|520671089|FG001|Overall Study|Withdrawal by Subject|3|||
144398309|NCT03894046|520671090|FG002|Overall Study|Withdrawal by Subject|1|||
144398310|NCT03894046|520671088|FG000|Overall Study|Death|15|||
144398311|NCT03894046|520671089|FG001|Overall Study|Death|21|||
144398312|NCT03894046|520671090|FG002|Overall Study|Death|4|||
144398313|NCT03894046|520671088|FG000|Overall Study|No growth of ABC|2|||
144398314|NCT03894046|520671089|FG001|Overall Study|No growth of ABC|1|||
144398315|NCT03894046|520671090|FG002|Overall Study|No growth of ABC|0|||
144398316|NCT03894046|520671088|FG000|Overall Study|Physician Decision|1|||
144398317|NCT03894046|520671089|FG001|Overall Study|Physician Decision|1|||
144398318|NCT03894046|520671090|FG002|Overall Study|Physician Decision|1|||
144398319|NCT03894046|520671088|FG000|Overall Study|Prohibited concomitant medication|1|||
144398320|NCT03894046|520671089|FG001|Overall Study|Prohibited concomitant medication|0|||
144398321|NCT03894046|520671090|FG002|Overall Study|Prohibited concomitant medication|0|||
144398322|NCT03894046|520671088|FG000|Overall Study|Transferred to other arm/group|1|||
144398323|NCT03894046|520671089|FG001|Overall Study|Transferred to other arm/group|1|||
144398324|NCT03894046|520671090|FG002|Overall Study|Transferred to other arm/group|0|||
144398325|NCT04806503|520671093|FG000|Overall Study|Lost to Follow-up|0|||
144398326|NCT04806503|520671094|FG001|Overall Study|Lost to Follow-up|0|||
144398327|NCT04806503|520671095|FG002|Overall Study|Lost to Follow-up|1|||
144398328|NCT04806503|520671096|FG003|Overall Study|Lost to Follow-up|0|||
144398329|NCT04806503|520671097|FG004|Overall Study|Lost to Follow-up|0|||
144398330|NCT04806503|520671093|FG000|Overall Study|Withdrawal by Subject|1|||
144398331|NCT04806503|520671094|FG001|Overall Study|Withdrawal by Subject|0|||
144398332|NCT04806503|520671095|FG002|Overall Study|Withdrawal by Subject|1|||
144398333|NCT04806503|520671096|FG003|Overall Study|Withdrawal by Subject|1|||
144398334|NCT04806503|520671097|FG004|Overall Study|Withdrawal by Subject|1|||
144398335|NCT04806503|520671093|FG000|Overall Study|Adverse Event|1|||
144398336|NCT04806503|520671094|FG001|Overall Study|Adverse Event|1|||
144398337|NCT04806503|520671095|FG002|Overall Study|Adverse Event|0|||
144398338|NCT04806503|520671096|FG003|Overall Study|Adverse Event|1|||
144398339|NCT04806503|520671097|FG004|Overall Study|Adverse Event|0|||
144398340|NCT03589469|520671098|FG000|Overall Study|Withdrawal by Subject|8|||
144398341|NCT03589469|520671098|FG000|Overall Study|Physician Decision|20|||
144398342|NCT03589469|520671098|FG000|Overall Study|Death|97|||
144398343|NCT03589469|520671098|FG000|Overall Study|Lost to Follow-up|8|||
144398344|NCT03589469|520671098|FG000|Overall Study|Miscellaneous|1|||
144398345|NCT02202837|520671100|FG000|Overall Study|Enbrel treatment discontinued|36|||
144398346|NCT02202837|520671101|FG001|Overall Study|Enbrel treatment discontinued|4|||
144398347|NCT02202837|520671100|FG000|Overall Study|Other|10|||
144398348|NCT02202837|520671101|FG001|Overall Study|Other|0|||
144398349|NCT02202837|520671100|FG000|Overall Study|Lost to Follow-up|7|||
144398350|NCT02202837|520671101|FG001|Overall Study|Lost to Follow-up|1|||
144398351|NCT04195906|520671102|FG000|Part 1|Adverse Event|3|||
144398352|NCT04195906|520671103|FG001|Part 1|Adverse Event|7|||
144398353|NCT04195906|520671102|FG000|Part 1|Withdrawal by Subject|0|||
144398354|NCT04195906|520671103|FG001|Part 1|Withdrawal by Subject|1|||
144398355|NCT04195906|520671102|FG000|Part 2|Adverse Event|1|||
144398356|NCT04195906|520671103|FG001|Part 2|Adverse Event|1|||
144398357|NCT04195906|520671102|FG000|Part 2|Withdrawal by Subject|0|||
144398358|NCT04195906|520671103|FG001|Part 2|Withdrawal by Subject|3|||
144398359|NCT04195906|520671102|FG000|Part 2|Other|1|||
144398360|NCT04195906|520671103|FG001|Part 2|Other|3|||
144398361|NCT00371826|520671109|FG000|Core Phase (12 Months)|Adverse Event|15|||
144398362|NCT00371826|520671110|FG001|Core Phase (12 Months)|Adverse Event|4|||
144398363|NCT00371826|520671111|FG002|Core Phase (12 Months)|Adverse Event|9|||
144398364|NCT00371826|520671109|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
144398365|NCT00371826|520671110|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
144398366|NCT00371826|520671111|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
144398367|NCT00371826|520671109|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
144398368|NCT00371826|520671110|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
144398369|NCT00371826|520671111|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
144398370|NCT00371826|520671109|FG000|Core Phase (12 Months)|Protocol Violation|1|||
144398371|NCT00371826|520671110|FG001|Core Phase (12 Months)|Protocol Violation|0|||
144521338|NCT04241068|521110152|FG000|Core Treatment Period|Study Visit Burden|40|||
144521339|NCT04241068|521110152|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
144521340|NCT04241068|521110152|FG000|Core Treatment Period|Missing|2|||
144521341|NCT04241068|521110152|FG000|Core Treatment Period|Reason Not Specified|41|||
144521342|NCT04241068|521110152|FG000|LTE Period|Adverse Event|19|||
144398372|NCT00371826|520671111|FG002|Core Phase (12 Months)|Protocol Violation|1|||
144521343|NCT04241068|521110152|FG000|LTE Period|Change of Treatment|1|||
144521344|NCT04241068|521110152|FG000|LTE Period|Consent Withdrawn|71|||
144521345|NCT04241068|521110152|FG000|LTE Period|Death|8|||
144521346|NCT04241068|521110152|FG000|LTE Period|Disease Progression|11|||
144595800|NCT00615836|521381200|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
144595801|NCT01630434|521381201|FG000|Overall Study|Donor lungs turned down|1|||
144398373|NCT00371826|520671109|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
144521347|NCT04241068|521110152|FG000|LTE Period|Investigator Decision|12|||
144398374|NCT00371826|520671110|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
144398375|NCT00371826|520671111|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
144398376|NCT00371826|520671109|FG000|Core Phase (12 Months)|Administrative problems|1|||
144398377|NCT00371826|520671110|FG001|Core Phase (12 Months)|Administrative problems|0|||
144398378|NCT00371826|520671111|FG002|Core Phase (12 Months)|Administrative problems|8|||
144398379|NCT00371826|520671109|FG000|Core Phase (12 Months)|Graft Loss|0|||
144398380|NCT00371826|520671110|FG001|Core Phase (12 Months)|Graft Loss|1|||
144398381|NCT00371826|520671111|FG002|Core Phase (12 Months)|Graft Loss|0|||
144398382|NCT00371826|520671109|FG000|Extension Phase (24 Months)|Adverse Event|4|||
144398383|NCT00371826|520671110|FG001|Extension Phase (24 Months)|Adverse Event|5|||
144398384|NCT00371826|520671111|FG002|Extension Phase (24 Months)|Adverse Event|0|||
144398385|NCT00371826|520671109|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
144398386|NCT00371826|520671110|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
144398387|NCT00371826|520671111|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
144398388|NCT00371826|520671109|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
144398389|NCT00371826|520671110|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
144398390|NCT00371826|520671111|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
144398391|NCT00371826|520671109|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
144398392|NCT00371826|520671110|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
144398393|NCT00371826|520671111|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
144398394|NCT00371826|520671109|FG000|Extension Phase (24 Months)|Administrative problems|0|||
144398395|NCT00371826|520671110|FG001|Extension Phase (24 Months)|Administrative problems|0|||
144398396|NCT00371826|520671111|FG002|Extension Phase (24 Months)|Administrative problems|2|||
144398397|NCT00734474|520671112|FG000|Overall Study|Entry Criteria Not Met|0|||
144398398|NCT00734474|520671113|FG001|Overall Study|Entry Criteria Not Met|0|||
144521348|NCT04241068|521110152|FG000|LTE Period|Loss of Capacity|2|||
144521349|NCT04241068|521110152|FG000|LTE Period|Lost to Follow-up|7|||
144521350|NCT04241068|521110152|FG000|LTE Period|Relocation|6|||
144521351|NCT04241068|521110152|FG000|LTE Period|Site Terminated by Sponsor|26|||
144521352|NCT04241068|521110152|FG000|LTE Period|Study Terminated by Sponsor|276|||
144521353|NCT04241068|521110152|FG000|LTE Period|Study Visit Burden|10|||
144521354|NCT04241068|521110152|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
144521355|NCT04241068|521110152|FG000|LTE Period|Reason Not Specified|65|||
144521356|NCT03443323|521110153|FG000|Overall Study|Lost to Follow-up|2|||
144521357|NCT03443323|521110154|FG001|Overall Study|Lost to Follow-up|2|||
144521358|NCT03443323|521110153|FG000|Overall Study|PI withdrawal|1|||
144521359|NCT03443323|521110154|FG001|Overall Study|PI withdrawal|0|||
144521360|NCT04492007|521110158|FG000|Overall Study|Lost to Follow-up|1|||
144521361|NCT04492007|521110159|FG001|Overall Study|Lost to Follow-up|1|||
144521362|NCT04492007|521110160|FG002|Overall Study|Lost to Follow-up|2|||
144521363|NCT04492007|521110161|FG003|Overall Study|Lost to Follow-up|2|||
144521364|NCT04492007|521110158|FG000|Overall Study|Protocol Violation|1|||
144521365|NCT04492007|521110159|FG001|Overall Study|Protocol Violation|1|||
144521366|NCT04492007|521110160|FG002|Overall Study|Protocol Violation|1|||
144521367|NCT04492007|521110161|FG003|Overall Study|Protocol Violation|1|||
144521368|NCT04492007|521110158|FG000|Overall Study|Withdrawal by Subject|0|||
144521369|NCT04492007|521110159|FG001|Overall Study|Withdrawal by Subject|0|||
144521370|NCT04492007|521110160|FG002|Overall Study|Withdrawal by Subject|1|||
144521371|NCT04492007|521110161|FG003|Overall Study|Withdrawal by Subject|1|||
144521372|NCT04229992|521110164|FG000|Overall Study|Withdrawal by Subject|0|||
144521373|NCT04229992|521110165|FG001|Overall Study|Withdrawal by Subject|2|||
144521374|NCT04229992|521110166|FG002|Overall Study|Withdrawal by Subject|1|||
144521375|NCT04229992|521110167|FG003|Overall Study|Withdrawal by Subject|1|||
144521376|NCT04229992|521110164|FG000|Overall Study|Adverse Event|1|||
144521377|NCT04229992|521110165|FG001|Overall Study|Adverse Event|1|||
144521378|NCT04229992|521110166|FG002|Overall Study|Adverse Event|3|||
144521379|NCT04229992|521110167|FG003|Overall Study|Adverse Event|1|||
144521380|NCT04229992|521110164|FG000|Overall Study|Lost to Follow-up|0|||
144521381|NCT04229992|521110165|FG001|Overall Study|Lost to Follow-up|0|||
144521382|NCT04229992|521110166|FG002|Overall Study|Lost to Follow-up|0|||
144521383|NCT04229992|521110167|FG003|Overall Study|Lost to Follow-up|1|||
144521384|NCT05178316|521110168|FG000|Overall Study|Adverse Event|5|||
144521385|NCT05178316|521110169|FG001|Overall Study|Adverse Event|4|||
144521386|NCT05178316|521110170|FG002|Overall Study|Adverse Event|9|||
144521387|NCT05178316|521110168|FG000|Overall Study|Enrolled in Error|1|||
144521388|NCT05178316|521110169|FG001|Overall Study|Enrolled in Error|2|||
144521389|NCT05178316|521110170|FG002|Overall Study|Enrolled in Error|1|||
144398399|NCT00734474|520671114|FG002|Overall Study|Entry Criteria Not Met|5|||
144398400|NCT00734474|520671115|FG003|Overall Study|Entry Criteria Not Met|0|||
144521390|NCT05178316|521110168|FG000|Overall Study|Lost to Follow-up|3|||
144521391|NCT05178316|521110169|FG001|Overall Study|Lost to Follow-up|15|||
144521392|NCT05178316|521110170|FG002|Overall Study|Lost to Follow-up|11|||
144521393|NCT05178316|521110168|FG000|Overall Study|Noncompliance|1|||
144521394|NCT05178316|521110169|FG001|Overall Study|Noncompliance|3|||
144521395|NCT05178316|521110170|FG002|Overall Study|Noncompliance|1|||
144521396|NCT05178316|521110168|FG000|Overall Study|Other|0|||
144521397|NCT05178316|521110169|FG001|Overall Study|Other|1|||
144521398|NCT05178316|521110170|FG002|Overall Study|Other|0|||
144521399|NCT05178316|521110168|FG000|Overall Study|Physician Decision|0|||
144521400|NCT05178316|521110169|FG001|Overall Study|Physician Decision|3|||
144521401|NCT05178316|521110170|FG002|Overall Study|Physician Decision|2|||
144521402|NCT05178316|521110168|FG000|Overall Study|Protocol deviation|1|||
144398401|NCT00734474|520671116|FG004|Overall Study|Entry Criteria Not Met|3|||
144398402|NCT00734474|520671117|FG005|Overall Study|Entry Criteria Not Met|1|||
144398403|NCT00734474|520671118|FG006|Overall Study|Entry Criteria Not Met|0|||
144398404|NCT00734474|520671119|FG007|Overall Study|Entry Criteria Not Met|1|||
144398405|NCT00734474|520671120|FG008|Overall Study|Entry Criteria Not Met|1|||
144398406|NCT00734474|520671112|FG000|Overall Study|Lost to Follow-up|1|||
144398407|NCT00734474|520671113|FG001|Overall Study|Lost to Follow-up|0|||
144398408|NCT00734474|520671114|FG002|Overall Study|Lost to Follow-up|13|||
144398409|NCT00734474|520671115|FG003|Overall Study|Lost to Follow-up|0|||
144398410|NCT00734474|520671116|FG004|Overall Study|Lost to Follow-up|11|||
144398411|NCT00734474|520671117|FG005|Overall Study|Lost to Follow-up|1|||
144398412|NCT00734474|520671118|FG006|Overall Study|Lost to Follow-up|0|||
144398413|NCT00734474|520671119|FG007|Overall Study|Lost to Follow-up|9|||
144398414|NCT00734474|520671120|FG008|Overall Study|Lost to Follow-up|4|||
144398415|NCT00734474|520671112|FG000|Overall Study|Withdrawal by Subject|2|||
144398416|NCT00734474|520671113|FG001|Overall Study|Withdrawal by Subject|1|||
144398417|NCT00734474|520671114|FG002|Overall Study|Withdrawal by Subject|18|||
144398418|NCT00734474|520671115|FG003|Overall Study|Withdrawal by Subject|0|||
144398419|NCT00734474|520671116|FG004|Overall Study|Withdrawal by Subject|24|||
144398420|NCT00734474|520671117|FG005|Overall Study|Withdrawal by Subject|2|||
144398421|NCT00734474|520671118|FG006|Overall Study|Withdrawal by Subject|0|||
144398422|NCT00734474|520671119|FG007|Overall Study|Withdrawal by Subject|36|||
144398423|NCT00734474|520671120|FG008|Overall Study|Withdrawal by Subject|21|||
144398424|NCT00734474|520671112|FG000|Overall Study|Physician Decision|0|||
144398425|NCT00734474|520671113|FG001|Overall Study|Physician Decision|0|||
144398426|NCT00734474|520671114|FG002|Overall Study|Physician Decision|4|||
144398427|NCT00734474|520671115|FG003|Overall Study|Physician Decision|1|||
144398428|NCT00734474|520671116|FG004|Overall Study|Physician Decision|11|||
144398429|NCT00734474|520671117|FG005|Overall Study|Physician Decision|0|||
144398430|NCT00734474|520671118|FG006|Overall Study|Physician Decision|0|||
144398431|NCT00734474|520671119|FG007|Overall Study|Physician Decision|9|||
144398432|NCT00734474|520671120|FG008|Overall Study|Physician Decision|9|||
144398433|NCT00734474|520671112|FG000|Overall Study|Adverse Event|4|||
144398434|NCT00734474|520671113|FG001|Overall Study|Adverse Event|4|||
144398435|NCT00734474|520671114|FG002|Overall Study|Adverse Event|63|||
144398436|NCT00734474|520671115|FG003|Overall Study|Adverse Event|1|||
144398437|NCT00734474|520671116|FG004|Overall Study|Adverse Event|64|||
144398438|NCT00734474|520671117|FG005|Overall Study|Adverse Event|0|||
144398439|NCT00734474|520671118|FG006|Overall Study|Adverse Event|1|||
144398440|NCT00734474|520671119|FG007|Overall Study|Adverse Event|65|||
144398441|NCT00734474|520671120|FG008|Overall Study|Adverse Event|39|||
144398442|NCT00734474|520671112|FG000|Overall Study|Protocol Violation|0|||
144398443|NCT00734474|520671113|FG001|Overall Study|Protocol Violation|0|||
144398444|NCT00734474|520671114|FG002|Overall Study|Protocol Violation|4|||
144398445|NCT00734474|520671115|FG003|Overall Study|Protocol Violation|0|||
144398446|NCT00734474|520671116|FG004|Overall Study|Protocol Violation|3|||
144398447|NCT00734474|520671117|FG005|Overall Study|Protocol Violation|0|||
144398448|NCT00734474|520671118|FG006|Overall Study|Protocol Violation|0|||
144398449|NCT00734474|520671119|FG007|Overall Study|Protocol Violation|3|||
144398450|NCT00734474|520671120|FG008|Overall Study|Protocol Violation|1|||
144398451|NCT00734474|520671112|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
144595802|NCT01630434|521381202|FG001|Overall Study|Donor lungs turned down|0|||
144595803|NCT01630434|521381201|FG000|Overall Study|Protocol Violation|9|||
144595804|NCT01630434|521381202|FG001|Overall Study|Protocol Violation|4|||
144595805|NCT01630434|521381201|FG000|Overall Study|Death|20|||
144595806|NCT01630434|521381202|FG001|Overall Study|Death|26|||
144595807|NCT00687973|521381203|FG000|Overall Study|Adverse Event|18|||
144595808|NCT00687973|521381204|FG001|Overall Study|Adverse Event|28|||
144595809|NCT00687973|521381203|FG000|Overall Study|Lack of Efficacy|2|||
144595810|NCT00687973|521381204|FG001|Overall Study|Lack of Efficacy|3|||
144595811|NCT00687973|521381203|FG000|Overall Study|Protocol Violation|1|||
144595812|NCT00687973|521381204|FG001|Overall Study|Protocol Violation|2|||
144595813|NCT00687973|521381203|FG000|Overall Study|Administrative Reasons|0|||
144595814|NCT00687973|521381204|FG001|Overall Study|Administrative Reasons|2|||
144398452|NCT00734474|520671113|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
144398453|NCT00734474|520671114|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
144398454|NCT00734474|520671115|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
144595815|NCT00687973|521381203|FG000|Overall Study|Withdrawal by Subject|3|||
144595816|NCT00687973|521381204|FG001|Overall Study|Withdrawal by Subject|3|||
144722320|NCT03519256|521838677|FG001|Overall Study|Study drug toxicity|2|||
144595817|NCT02578862|521381206|FG000|Overall Study|Withdrawal by Subject|0|||
144595818|NCT02578862|521381207|FG001|Overall Study|Withdrawal by Subject|1|||
144398455|NCT00734474|520671116|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
144398456|NCT00734474|520671117|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
144398457|NCT00734474|520671118|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
144398458|NCT00734474|520671119|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
144398459|NCT00734474|520671120|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
144398460|NCT00734474|520671112|FG000|Overall Study|Sponsor Decision|0|||
144398461|NCT00734474|520671113|FG001|Overall Study|Sponsor Decision|0|||
144398462|NCT00734474|520671114|FG002|Overall Study|Sponsor Decision|0|||
144398463|NCT00734474|520671115|FG003|Overall Study|Sponsor Decision|0|||
144398464|NCT00734474|520671116|FG004|Overall Study|Sponsor Decision|2|||
144398465|NCT00734474|520671117|FG005|Overall Study|Sponsor Decision|0|||
144398466|NCT00734474|520671118|FG006|Overall Study|Sponsor Decision|0|||
144398467|NCT00734474|520671119|FG007|Overall Study|Sponsor Decision|0|||
144398468|NCT00734474|520671120|FG008|Overall Study|Sponsor Decision|0|||
144398469|NCT00734474|520671112|FG000|Overall Study|Death|0|||
144398470|NCT00734474|520671113|FG001|Overall Study|Death|0|||
144398471|NCT00734474|520671114|FG002|Overall Study|Death|1|||
144398472|NCT00734474|520671115|FG003|Overall Study|Death|0|||
144398473|NCT00734474|520671116|FG004|Overall Study|Death|0|||
144398474|NCT00734474|520671117|FG005|Overall Study|Death|0|||
144398475|NCT00734474|520671118|FG006|Overall Study|Death|0|||
144398476|NCT00734474|520671119|FG007|Overall Study|Death|2|||
144398477|NCT00734474|520671120|FG008|Overall Study|Death|1|||
144398478|NCT00734474|520671112|FG000|Overall Study|Lack of Efficacy|0|||
144398479|NCT00734474|520671113|FG001|Overall Study|Lack of Efficacy|0|||
144398480|NCT00734474|520671114|FG002|Overall Study|Lack of Efficacy|4|||
144398481|NCT00734474|520671115|FG003|Overall Study|Lack of Efficacy|0|||
144398482|NCT00734474|520671116|FG004|Overall Study|Lack of Efficacy|0|||
144398483|NCT00734474|520671117|FG005|Overall Study|Lack of Efficacy|0|||
144398484|NCT00734474|520671118|FG006|Overall Study|Lack of Efficacy|0|||
144398485|NCT00734474|520671119|FG007|Overall Study|Lack of Efficacy|4|||
144398486|NCT00734474|520671120|FG008|Overall Study|Lack of Efficacy|6|||
144398487|NCT00231842|520671121|FG000|Overall Study|Withdrawal by Subject|3|||
144398488|NCT00231842|520671121|FG000|Overall Study|Did not complete the last 3 cycle|8|||
144398489|NCT00428792|520671122|FG000|Overall Study|Lack of Efficacy|1|||
144398490|NCT00428792|520671123|FG001|Overall Study|Lack of Efficacy|3|||
144398491|NCT00428792|520671122|FG000|Overall Study|Lost to Follow-up|0|||
144398492|NCT00428792|520671123|FG001|Overall Study|Lost to Follow-up|1|||
144398493|NCT00639678|520671124|FG000|Overall Study|Withdrawal by Subject|3|||
144398494|NCT00639678|520671125|FG001|Overall Study|Withdrawal by Subject|0|||
144398495|NCT00639678|520671126|FG002|Overall Study|Withdrawal by Subject|4|||
144398496|NCT00639678|520671127|FG003|Overall Study|Withdrawal by Subject|0|||
144398497|NCT00639678|520671124|FG000|Overall Study|Lost to Follow-up|1|||
144398498|NCT00639678|520671125|FG001|Overall Study|Lost to Follow-up|0|||
144398499|NCT00639678|520671126|FG002|Overall Study|Lost to Follow-up|6|||
144398500|NCT00639678|520671127|FG003|Overall Study|Lost to Follow-up|0|||
144398501|NCT00639678|520671124|FG000|Overall Study|Adverse Event|0|||
144398502|NCT00639678|520671125|FG001|Overall Study|Adverse Event|1|||
144398503|NCT00639678|520671126|FG002|Overall Study|Adverse Event|0|||
144398504|NCT00639678|520671127|FG003|Overall Study|Adverse Event|0|||
144398505|NCT00639678|520671124|FG000|Overall Study|Lack of Compliance|0|||
144398506|NCT00639678|520671125|FG001|Overall Study|Lack of Compliance|0|||
144398507|NCT00639678|520671126|FG002|Overall Study|Lack of Compliance|1|||
144398508|NCT00639678|520671127|FG003|Overall Study|Lack of Compliance|0|||
144398509|NCT02436304|520671128|FG000|Overall Study|Lost to Follow-up|0|||
144398510|NCT02436304|520671129|FG001|Overall Study|Lost to Follow-up|1|||
144398511|NCT02436304|520671130|FG002|Overall Study|Lost to Follow-up|0|||
144398512|NCT02436304|520671128|FG000|Overall Study|Withdrawal by Subject|0|||
144398513|NCT02436304|520671129|FG001|Overall Study|Withdrawal by Subject|1|||
144398514|NCT02436304|520671130|FG002|Overall Study|Withdrawal by Subject|0|||
144398515|NCT02436304|520671128|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
144398516|NCT02436304|520671129|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
144398517|NCT02436304|520671130|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
144398518|NCT04612790|520671134|FG000|DB Period (Up to 36 Weeks)|Death|1|||
144398519|NCT04612790|520671135|FG001|DB Period (Up to 36 Weeks)|Death|1|||
144398520|NCT04612790|520671136|FG002|DB Period (Up to 36 Weeks)|Death|0|||
144398521|NCT04612790|520671137|FG003|DB Period (Up to 36 Weeks)|Death|0|||
144398522|NCT04612790|520671134|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
144595819|NCT02578862|521381206|FG000|Overall Study|Unplanned unilateral procedure|0|||
144595820|NCT02578862|521381207|FG001|Overall Study|Unplanned unilateral procedure|1|||
144249657|NCT01897571|520111706|FG006|Overall Study|Enrolled in rollover study|0|||
144398523|NCT04612790|520671135|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
144398524|NCT04612790|520671136|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
144398525|NCT04612790|520671137|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
144398526|NCT04612790|520671134|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
144398527|NCT04612790|520671135|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
144398528|NCT04612790|520671136|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
144398529|NCT04612790|520671137|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
144398530|NCT04612790|520671134|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
144398531|NCT04612790|520671135|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
144398532|NCT04612790|520671136|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
144398533|NCT04612790|520671137|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
144398534|NCT04612790|520671134|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
144398535|NCT04612790|520671135|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
144398536|NCT04612790|520671136|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
144398537|NCT04612790|520671137|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
144398538|NCT04612790|520671134|FG000|DB Period (Up to 36 Weeks)|Other|1|||
144398539|NCT04612790|520671135|FG001|DB Period (Up to 36 Weeks)|Other|0|||
144398540|NCT04612790|520671136|FG002|DB Period (Up to 36 Weeks)|Other|0|||
144398541|NCT04612790|520671137|FG003|DB Period (Up to 36 Weeks)|Other|0|||
144398542|NCT04612790|520671134|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
144398543|NCT04612790|520671135|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
144398544|NCT04612790|520671136|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
144398545|NCT04612790|520671137|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
144398546|NCT04612790|520671134|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
144398547|NCT04612790|520671135|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
144398548|NCT04612790|520671136|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
144398549|NCT04612790|520671137|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
144398550|NCT04612790|520671134|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
144398551|NCT04612790|520671135|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
144398552|NCT04612790|520671136|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
144398553|NCT04612790|520671137|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
144398554|NCT04612790|520671134|FG000|OLE Period (Up to 1 Year)|Other|0|||
144398555|NCT04612790|520671135|FG001|OLE Period (Up to 1 Year)|Other|0|||
144398556|NCT04612790|520671136|FG002|OLE Period (Up to 1 Year)|Other|0|||
144398557|NCT04612790|520671137|FG003|OLE Period (Up to 1 Year)|Other|1|||
144398558|NCT00369122|520671146|FG000|Overall Study|Ineligible|10|||
144398559|NCT00369122|520671146|FG000|Overall Study|No protocol treatment|1|||
144398560|NCT00191906|520671149|FG000|Study Period II|Adverse Event|0|||
144398561|NCT00191906|520671150|FG001|Study Period II|Adverse Event|1|||
144398562|NCT00191906|520671151|FG002|Study Period II|Adverse Event|0|||
144398563|NCT00191906|520671152|FG003|Study Period II|Adverse Event|0|||
144398564|NCT00191906|520671149|FG000|Study Period II|Withdrawal by Subject|0|||
144398565|NCT00191906|520671150|FG001|Study Period II|Withdrawal by Subject|3|||
144398566|NCT00191906|520671151|FG002|Study Period II|Withdrawal by Subject|0|||
144398567|NCT00191906|520671152|FG003|Study Period II|Withdrawal by Subject|0|||
144398568|NCT00191906|520671149|FG000|Study Period II|Parent/Caregiver Decision|0|||
144398569|NCT00191906|520671150|FG001|Study Period II|Parent/Caregiver Decision|1|||
144398570|NCT00191906|520671151|FG002|Study Period II|Parent/Caregiver Decision|0|||
144398571|NCT00191906|520671152|FG003|Study Period II|Parent/Caregiver Decision|0|||
144398572|NCT00191906|520671149|FG000|Study Period II|Entry Criteria Exclusion|0|||
144398573|NCT00191906|520671150|FG001|Study Period II|Entry Criteria Exclusion|0|||
144398574|NCT00191906|520671151|FG002|Study Period II|Entry Criteria Exclusion|1|||
144398575|NCT00191906|520671152|FG003|Study Period II|Entry Criteria Exclusion|0|||
144398576|NCT00191906|520671149|FG000|Study Period III|Adverse Event|1|||
144398577|NCT00191906|520671150|FG001|Study Period III|Adverse Event|0|||
144398578|NCT00191906|520671151|FG002|Study Period III|Adverse Event|0|||
144398579|NCT00191906|520671152|FG003|Study Period III|Adverse Event|0|||
144398580|NCT00191906|520671149|FG000|Study Period III|Lost to Follow-up|0|||
144398581|NCT00191906|520671150|FG001|Study Period III|Lost to Follow-up|1|||
144398582|NCT00191906|520671151|FG002|Study Period III|Lost to Follow-up|0|||
144398583|NCT00191906|520671152|FG003|Study Period III|Lost to Follow-up|0|||
144398584|NCT00191906|520671149|FG000|Study Period III|Parent/Caregiver Decision|1|||
144398585|NCT00191906|520671150|FG001|Study Period III|Parent/Caregiver Decision|0|||
144398586|NCT00191906|520671151|FG002|Study Period III|Parent/Caregiver Decision|0|||
144722321|NCT03519256|521838678|FG002|Overall Study|Study drug toxicity|5|||
144398587|NCT00191906|520671152|FG003|Study Period III|Parent/Caregiver Decision|0|||
144398588|NCT00191906|520671149|FG000|Study Period III|Lack of Efficacy|3|||
144398589|NCT00191906|520671150|FG001|Study Period III|Lack of Efficacy|3|||
144398590|NCT00191906|520671151|FG002|Study Period III|Lack of Efficacy|0|||
144398591|NCT00191906|520671152|FG003|Study Period III|Lack of Efficacy|0|||
144398592|NCT03387683|520671154|FG000|Overall Study|In receipt of disallowed medication|1|||
144398593|NCT03387683|520671155|FG001|Overall Study|In receipt of disallowed medication|0|||
144398594|NCT03387683|520671154|FG000|Overall Study|Did not receive treatment|1|||
144398595|NCT03387683|520671155|FG001|Overall Study|Did not receive treatment|0|||
144398596|NCT00629772|520671156|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
144398597|NCT00629772|520671157|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
144398598|NCT00629772|520671156|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
144398599|NCT00629772|520671157|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
144398600|NCT01393301|520671158|FG000|Overall Study|Lost to Follow-up|5|||
144398601|NCT01393301|520671159|FG001|Overall Study|Lost to Follow-up|3|||
144398602|NCT01393301|520671158|FG000|Overall Study|Withdrawal by Subject|2|||
144398603|NCT01393301|520671159|FG001|Overall Study|Withdrawal by Subject|0|||
144398604|NCT01393301|520671158|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
144722322|NCT03519256|521838679|FG003|Overall Study|Study drug toxicity|2|||
144398605|NCT01393301|520671159|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
144398606|NCT01309165|520671160|FG000|Overall Study|Lost to Follow-up|4|||
144398607|NCT01309165|520671161|FG001|Overall Study|Lost to Follow-up|3|||
144398608|NCT01309165|520671160|FG000|Overall Study|Return to work|1|||
144398609|NCT01309165|520671161|FG001|Overall Study|Return to work|2|||
144398610|NCT01309165|520671160|FG000|Overall Study|Left country|0|||
144398611|NCT01309165|520671161|FG001|Overall Study|Left country|1|||
144398612|NCT01309165|520671160|FG000|Overall Study|No transportation|0|||
144398613|NCT01309165|520671161|FG001|Overall Study|No transportation|1|||
144398614|NCT01309165|520671160|FG000|Overall Study|Admitted to hospital for second stroke|1|||
144398615|NCT01309165|520671161|FG001|Overall Study|Admitted to hospital for second stroke|0|||
144398616|NCT01649804|520671165|FG000|Overall Study|Administrative/Other|8|||
144398617|NCT02028871|520671169|FG000|Overall Study|Positive urine drug screen|1|||
144398618|NCT02028871|520671170|FG001|Overall Study|Positive urine drug screen|1|||
144398619|NCT02028871|520671169|FG000|Overall Study|Withdrawal by Subject|1|||
144398620|NCT02028871|520671170|FG001|Overall Study|Withdrawal by Subject|2|||
144398621|NCT02028871|520671169|FG000|Overall Study|IV placement difficulty|1|||
144398622|NCT02028871|520671170|FG001|Overall Study|IV placement difficulty|0|||
144398623|NCT02028871|520671169|FG000|Overall Study|Current Illness|1|||
144398624|NCT02028871|520671170|FG001|Overall Study|Current Illness|0|||
144398625|NCT02633501|520671171|FG000|Overall Study|Adverse Event|0|||
144398626|NCT02633501|520671172|FG001|Overall Study|Adverse Event|0|||
144398627|NCT02633501|520671173|FG002|Overall Study|Adverse Event|1|||
144398628|NCT02633501|520671174|FG003|Overall Study|Adverse Event|0|||
144398629|NCT02633501|520671175|FG004|Overall Study|Adverse Event|1|||
144398630|NCT02633501|520671176|FG005|Overall Study|Adverse Event|1|||
144398631|NCT02633501|520671171|FG000|Overall Study|Withdrawal by Subject|2|||
144398632|NCT02633501|520671172|FG001|Overall Study|Withdrawal by Subject|1|||
144398633|NCT02633501|520671173|FG002|Overall Study|Withdrawal by Subject|2|||
144398634|NCT02633501|520671174|FG003|Overall Study|Withdrawal by Subject|2|||
144398635|NCT02633501|520671175|FG004|Overall Study|Withdrawal by Subject|1|||
144398636|NCT02633501|520671176|FG005|Overall Study|Withdrawal by Subject|3|||
144398637|NCT02633501|520671171|FG000|Overall Study|Various other reasons|0|||
144398638|NCT02633501|520671172|FG001|Overall Study|Various other reasons|2|||
144398639|NCT02633501|520671173|FG002|Overall Study|Various other reasons|4|||
144398640|NCT02633501|520671174|FG003|Overall Study|Various other reasons|1|||
144398641|NCT02633501|520671175|FG004|Overall Study|Various other reasons|7|||
144398642|NCT02633501|520671176|FG005|Overall Study|Various other reasons|11|||
144398643|NCT02633501|520671171|FG000|Overall Study|Lost to Follow-up|0|||
144398644|NCT02633501|520671172|FG001|Overall Study|Lost to Follow-up|0|||
144398645|NCT02633501|520671173|FG002|Overall Study|Lost to Follow-up|0|||
144398646|NCT02633501|520671174|FG003|Overall Study|Lost to Follow-up|1|||
144398647|NCT02633501|520671175|FG004|Overall Study|Lost to Follow-up|2|||
144398648|NCT02633501|520671176|FG005|Overall Study|Lost to Follow-up|0|||
144398649|NCT01147172|520671180|FG000|Overall Study|Withdrawal by Subject|2|||
144398650|NCT01147172|520671180|FG000|Overall Study|Lost to Follow-up|2|||
144398651|NCT01069627|520671181|FG000|Overall Study|Disease progression|7|||
144398652|NCT01069627|520671181|FG000|Overall Study|Adverse Event|12|||
144398653|NCT01069627|520671181|FG000|Overall Study|Protocol Violation|1|||
144398654|NCT02963935|520671186|FG000|Overall Study|Adverse Event|12|||
144398655|NCT02963935|520671187|FG001|Overall Study|Adverse Event|6|||
144398656|NCT02963935|520671186|FG000|Overall Study|Protocol Violation|2|||
144398657|NCT02963935|520671187|FG001|Overall Study|Protocol Violation|1|||
144398658|NCT02963935|520671186|FG000|Overall Study|Lack of Efficacy|0|||
144398659|NCT02963935|520671187|FG001|Overall Study|Lack of Efficacy|2|||
144398660|NCT02963935|520671186|FG000|Overall Study|Lost to Follow-up|1|||
144398661|NCT02963935|520671187|FG001|Overall Study|Lost to Follow-up|6|||
144398662|NCT02963935|520671186|FG000|Overall Study|Unclassified|13|||
144521403|NCT05178316|521110169|FG001|Overall Study|Protocol deviation|0|||
144521404|NCT05178316|521110170|FG002|Overall Study|Protocol deviation|1|||
144521405|NCT05178316|521110168|FG000|Overall Study|Sponsor decision|1|||
144521406|NCT05178316|521110169|FG001|Overall Study|Sponsor decision|0|||
144521407|NCT05178316|521110170|FG002|Overall Study|Sponsor decision|1|||
144521408|NCT05178316|521110168|FG000|Overall Study|Withdrawal by Subject|5|||
144521409|NCT05178316|521110169|FG001|Overall Study|Withdrawal by Subject|11|||
144521410|NCT05178316|521110170|FG002|Overall Study|Withdrawal by Subject|5|||
144521411|NCT03770273|521110171|FG000|Overall Study|Adverse Event|2|||
144398663|NCT02963935|520671187|FG001|Overall Study|Unclassified|22|||
144398664|NCT00464269|520671188|FG000|Overall Study|Lack of Efficacy|1|||
144398665|NCT00464269|520671189|FG001|Overall Study|Lack of Efficacy|0|||
144398666|NCT00464269|520671190|FG002|Overall Study|Lack of Efficacy|0|||
144398667|NCT00464269|520671191|FG003|Overall Study|Lack of Efficacy|0|||
144398668|NCT00464269|520671188|FG000|Overall Study|Lost to Follow-up|0|||
144398669|NCT00464269|520671189|FG001|Overall Study|Lost to Follow-up|4|||
144398670|NCT00464269|520671190|FG002|Overall Study|Lost to Follow-up|0|||
144398671|NCT00464269|520671191|FG003|Overall Study|Lost to Follow-up|1|||
144398672|NCT00464269|520671188|FG000|Overall Study|Withdrawal by Subject|0|||
144521412|NCT03770273|521110172|FG001|Overall Study|Adverse Event|0|||
144521413|NCT03770273|521110171|FG000|Overall Study|Lost to Follow-up|1|||
144398673|NCT00464269|520671189|FG001|Overall Study|Withdrawal by Subject|2|||
144398674|NCT00464269|520671190|FG002|Overall Study|Withdrawal by Subject|1|||
144398675|NCT00464269|520671191|FG003|Overall Study|Withdrawal by Subject|1|||
144398676|NCT00464269|520671188|FG000|Overall Study|Other reason|3|||
144398677|NCT00464269|520671189|FG001|Overall Study|Other reason|3|||
144398678|NCT00464269|520671190|FG002|Overall Study|Other reason|1|||
144398679|NCT00464269|520671191|FG003|Overall Study|Other reason|1|||
144398680|NCT00464269|520671188|FG000|Overall Study|AE, serious fatal|0|||
144398681|NCT00464269|520671189|FG001|Overall Study|AE, serious fatal|0|||
144398682|NCT00464269|520671190|FG002|Overall Study|AE, serious fatal|1|||
144398683|NCT00464269|520671191|FG003|Overall Study|AE, serious fatal|1|||
144398684|NCT00464269|520671188|FG000|Overall Study|SAE, non-fatal|0|||
144398685|NCT00464269|520671189|FG001|Overall Study|SAE, non-fatal|0|||
144398686|NCT00464269|520671190|FG002|Overall Study|SAE, non-fatal|0|||
144398687|NCT00464269|520671191|FG003|Overall Study|SAE, non-fatal|1|||
144398688|NCT00464269|520671188|FG000|Overall Study|AE, non-serious non-fatal|2|||
144398689|NCT00464269|520671189|FG001|Overall Study|AE, non-serious non-fatal|8|||
144398690|NCT00464269|520671190|FG002|Overall Study|AE, non-serious non-fatal|3|||
144398691|NCT00464269|520671191|FG003|Overall Study|AE, non-serious non-fatal|4|||
144398692|NCT00464269|520671188|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
144398693|NCT00464269|520671189|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
144398694|NCT00464269|520671190|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
144398695|NCT00464269|520671191|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
144398696|NCT02955797|520671194|FG000|Overall Study|Protocol Violation|1|||
144398697|NCT02955797|520671195|FG001|Overall Study|Protocol Violation|0|||
144398698|NCT02955797|520671196|FG002|Overall Study|Protocol Violation|0|||
144398699|NCT02955797|520671197|FG003|Overall Study|Protocol Violation|1|||
144398700|NCT02955797|520671194|FG000|Overall Study|Withdrawal by Subject|2|||
144398701|NCT02955797|520671195|FG001|Overall Study|Withdrawal by Subject|2|||
144398702|NCT02955797|520671196|FG002|Overall Study|Withdrawal by Subject|0|||
144398703|NCT02955797|520671197|FG003|Overall Study|Withdrawal by Subject|1|||
144398704|NCT02955797|520671194|FG000|Overall Study|Lost to Follow-up|0|||
144398705|NCT02955797|520671195|FG001|Overall Study|Lost to Follow-up|1|||
144398706|NCT02955797|520671196|FG002|Overall Study|Lost to Follow-up|0|||
144398707|NCT02955797|520671197|FG003|Overall Study|Lost to Follow-up|0|||
144398708|NCT03131453|520671198|FG000|Overall Study|Study terminated by Sponsor|424|||
144398709|NCT03131453|520671199|FG001|Overall Study|Study terminated by Sponsor|222|||
144398710|NCT03131453|520671200|FG002|Overall Study|Study terminated by Sponsor|438|||
144398711|NCT03131453|520671198|FG000|Overall Study|Withdrawal by Subject|18|||
144398712|NCT03131453|520671199|FG001|Overall Study|Withdrawal by Subject|7|||
144398713|NCT03131453|520671200|FG002|Overall Study|Withdrawal by Subject|13|||
144398714|NCT03131453|520671198|FG000|Overall Study|Adverse Event|10|||
144398715|NCT03131453|520671199|FG001|Overall Study|Adverse Event|3|||
144398716|NCT03131453|520671200|FG002|Overall Study|Adverse Event|3|||
144398717|NCT03131453|520671198|FG000|Overall Study|Lost to Follow-up|1|||
144398718|NCT03131453|520671199|FG001|Overall Study|Lost to Follow-up|0|||
144398719|NCT03131453|520671200|FG002|Overall Study|Lost to Follow-up|1|||
144398720|NCT03131453|520671198|FG000|Overall Study|Physician Decision|1|||
144398721|NCT03131453|520671199|FG001|Overall Study|Physician Decision|0|||
144398722|NCT03131453|520671200|FG002|Overall Study|Physician Decision|1|||
144398723|NCT03131453|520671198|FG000|Overall Study|Non-compliance with study treatment|1|||
144398724|NCT03131453|520671199|FG001|Overall Study|Non-compliance with study treatment|0|||
144398725|NCT03131453|520671200|FG002|Overall Study|Non-compliance with study treatment|0|||
144398726|NCT03131453|520671198|FG000|Overall Study|Technical problems|1|||
144398727|NCT03131453|520671199|FG001|Overall Study|Technical problems|0|||
144398728|NCT03131453|520671200|FG002|Overall Study|Technical problems|0|||
144398729|NCT03131453|520671198|FG000|Overall Study|Protocol deviation|0|||
144398730|NCT03131453|520671199|FG001|Overall Study|Protocol deviation|1|||
144398731|NCT03131453|520671200|FG002|Overall Study|Protocol deviation|0|||
144398732|NCT02081183|520671201|FG000|Overall Study|Lost to Follow-up|0|||
144398733|NCT02081183|520671202|FG001|Overall Study|Lost to Follow-up|1|||
144398734|NCT02081183|520671201|FG000|Overall Study|Protocol Violation|1|||
144398735|NCT02081183|520671202|FG001|Overall Study|Protocol Violation|0|||
144398736|NCT02081183|520671201|FG000|Overall Study|Other|3|||
144398737|NCT02081183|520671202|FG001|Overall Study|Other|3|||
144398738|NCT04176705|520671203|FG000|Overall Study|Withdrawal by Subject|4|||
144398739|NCT04176705|520671204|FG001|Overall Study|Withdrawal by Subject|4|||
144398740|NCT04176705|520671203|FG000|Overall Study|Death|1|||
144398741|NCT04176705|520671204|FG001|Overall Study|Death|1|||
144398742|NCT04176705|520671203|FG000|Overall Study|Lost to Follow-up|3|||
144398743|NCT04176705|520671204|FG001|Overall Study|Lost to Follow-up|3|||
144398744|NCT02024555|520671205|FG000|Overall Study|Lost to Follow-up|1|||
144398745|NCT02024555|520671206|FG001|Overall Study|Lost to Follow-up|1|||
144398746|NCT02024555|520671205|FG000|Overall Study|Withdrawal by Subject|5|||
144398747|NCT02024555|520671206|FG001|Overall Study|Withdrawal by Subject|1|||
144398748|NCT03805646|520671219|FG000|Overall Study|Death|40|||
144398749|NCT03805646|520671220|FG001|Overall Study|Death|49|||
144398750|NCT03805646|520671219|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
144398751|NCT03805646|520671220|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
144398752|NCT01066000|520671223|FG000|Overall Study|Protocol Violation|4|||
144398753|NCT01066000|520671223|FG000|Overall Study|Death|3|||
144398754|NCT01066000|520671223|FG000|Overall Study|Withdrawal by Subject|1|||
144398755|NCT01066000|520671223|FG000|Overall Study|Adverse Event|1|||
144398756|NCT00560885|520671226|FG000|Overall Study|Death|7|||
144398757|NCT00560885|520671226|FG000|Overall Study|Withdrawal by Subject|1|||
144398758|NCT01554397|520671234|FG000|Overall Study|Withdrawal by Subject|1|||
144398759|NCT01554397|520671235|FG001|Overall Study|Withdrawal by Subject|0|||
144398760|NCT01554397|520671234|FG000|Overall Study|Ineligible|7|||
144398761|NCT01554397|520671235|FG001|Overall Study|Ineligible|0|||
144398762|NCT02497612|520672650|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
144398763|NCT02497612|520672651|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
144398764|NCT02497612|520672652|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
144398765|NCT02497612|520672653|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
144398766|NCT02497612|520672650|FG000|Overall Study|Participant's request|2|||
144398767|NCT02497612|520672651|FG001|Overall Study|Participant's request|3|||
144398768|NCT02497612|520672652|FG002|Overall Study|Participant's request|4|||
144398769|NCT02497612|520672653|FG003|Overall Study|Participant's request|1|||
144398770|NCT02497612|520672650|FG000|Overall Study|Investigator's judgement|1|||
144398771|NCT02497612|520672651|FG001|Overall Study|Investigator's judgement|0|||
144398772|NCT02497612|520672652|FG002|Overall Study|Investigator's judgement|0|||
144398773|NCT02497612|520672653|FG003|Overall Study|Investigator's judgement|2|||
144398774|NCT02497612|520672650|FG000|Overall Study|Adverse Event|3|||
144398775|NCT02497612|520672651|FG001|Overall Study|Adverse Event|1|||
144398776|NCT02497612|520672652|FG002|Overall Study|Adverse Event|4|||
144398777|NCT02497612|520672653|FG003|Overall Study|Adverse Event|1|||
144595821|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
144595822|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
144595823|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Death|0|||
144595824|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Death|2|||
144595825|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
144595826|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
144595827|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
144595828|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
144595829|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
144398778|NCT02497612|520672650|FG000|Overall Study|Lost to Follow-up|1|||
144398779|NCT02497612|520672651|FG001|Overall Study|Lost to Follow-up|1|||
144398780|NCT02497612|520672652|FG002|Overall Study|Lost to Follow-up|0|||
144398781|NCT02497612|520672653|FG003|Overall Study|Lost to Follow-up|1|||
144398782|NCT02497612|520672650|FG000|Overall Study|Other unspecified|1|||
144398783|NCT02497612|520672651|FG001|Overall Study|Other unspecified|1|||
144398784|NCT02497612|520672652|FG002|Overall Study|Other unspecified|2|||
144398785|NCT02497612|520672653|FG003|Overall Study|Other unspecified|0|||
144398786|NCT02497612|520672650|FG000|Overall Study|Not eligible|1|||
144398787|NCT02497612|520672651|FG001|Overall Study|Not eligible|0|||
144521414|NCT03770273|521110172|FG001|Overall Study|Lost to Follow-up|1|||
144521415|NCT00418886|521110173|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
144521416|NCT00418886|521110174|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
144521417|NCT00418886|521110173|FG000|Randomized Period|Death|122|||
144521418|NCT00418886|521110174|FG001|Randomized Period|Death|147|||
144521419|NCT00418886|521110173|FG000|Randomized Period|Withdrawal by Subject|9|||
144521420|NCT00418886|521110174|FG001|Randomized Period|Withdrawal by Subject|10|||
144521421|NCT00418886|521110173|FG000|Randomized Period|Lost to Follow-up|4|||
144521422|NCT00418886|521110174|FG001|Randomized Period|Lost to Follow-up|6|||
144595830|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
144595831|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
144398788|NCT02497612|520672652|FG002|Overall Study|Not eligible|0|||
144398789|NCT02497612|520672653|FG003|Overall Study|Not eligible|1|||
144398790|NCT03342963|520672656|FG000|Overall Study|Adverse Event|1|||
144398791|NCT03342963|520672657|FG001|Overall Study|Adverse Event|2|||
144521423|NCT00418886|521110173|FG000|Randomized Period|withdrawn due to other reason|1|||
144398792|NCT03342963|520672658|FG002|Overall Study|Adverse Event|0|||
144398793|NCT03342963|520672659|FG003|Overall Study|Adverse Event|0|||
144398794|NCT03342963|520672656|FG000|Overall Study|Withdrawal by Subject|1|||
144398795|NCT03342963|520672657|FG001|Overall Study|Withdrawal by Subject|0|||
144398796|NCT03342963|520672658|FG002|Overall Study|Withdrawal by Subject|0|||
144398797|NCT03342963|520672659|FG003|Overall Study|Withdrawal by Subject|0|||
144398798|NCT00722423|520672660|FG000|Overall Study|Protocol Violation|0|||
144398799|NCT00722423|520672661|FG001|Overall Study|Protocol Violation|1|||
144398800|NCT01950169|520672662|FG000|Overall Study|Withdrawal by Subject|2|||
144398801|NCT01950169|520672663|FG001|Overall Study|Withdrawal by Subject|8|||
144398802|NCT01950169|520672664|FG002|Overall Study|Withdrawal by Subject|1|||
144398803|NCT01950169|520672662|FG000|Overall Study|Death|1|||
144398804|NCT01950169|520672663|FG001|Overall Study|Death|0|||
144398805|NCT01950169|520672664|FG002|Overall Study|Death|0|||
144398806|NCT01495975|520672665|FG000|Overall Study|Lost to Follow-up|1|||
144398807|NCT01495975|520672666|FG001|Overall Study|Lost to Follow-up|0|||
144398808|NCT04553679|520672667|FG000|Overall Study|Withdrawal by Subject|2|||
144398809|NCT04553679|520672668|FG001|Overall Study|Withdrawal by Subject|0|||
144398810|NCT04553679|520672667|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
144398811|NCT04553679|520672668|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
144398812|NCT01254292|520672669|FG000|Comparative Phase|Adverse Event|25|||
144398813|NCT01254292|520672670|FG001|Comparative Phase|Adverse Event|25|||
144398814|NCT01254292|520672669|FG000|Comparative Phase|Lost to Follow-up|3|||
144398815|NCT01254292|520672670|FG001|Comparative Phase|Lost to Follow-up|21|||
144398816|NCT01254292|520672669|FG000|Comparative Phase|Pregnancy|2|||
144398817|NCT01254292|520672670|FG001|Comparative Phase|Pregnancy|6|||
144398818|NCT01254292|520672669|FG000|Comparative Phase|Withdrawal by Subject|20|||
144398819|NCT01254292|520672670|FG001|Comparative Phase|Withdrawal by Subject|21|||
144398820|NCT01254292|520672669|FG000|Comparative Phase|Protocol Violation|1|||
144398821|NCT01254292|520672670|FG001|Comparative Phase|Protocol Violation|2|||
144398822|NCT01254292|520672669|FG000|Comparative Phase|Wish for pregnancy|4|||
144398823|NCT01254292|520672670|FG001|Comparative Phase|Wish for pregnancy|6|||
144398824|NCT01254292|520672669|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
144398825|NCT01254292|520672670|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
144398826|NCT01254292|520672669|FG000|LCS12 Extension Phase|Adverse Event|9|||
144398827|NCT01254292|520672670|FG001|LCS12 Extension Phase|Adverse Event|0|||
144398828|NCT01254292|520672669|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
144398829|NCT01254292|520672670|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
144398830|NCT01254292|520672669|FG000|LCS12 Extension Phase|Other unknown|4|||
144398831|NCT01254292|520672670|FG001|LCS12 Extension Phase|Other unknown|0|||
144398832|NCT01254292|520672669|FG000|LCS12 Extension Phase|Pregnancy|2|||
144398833|NCT01254292|520672670|FG001|LCS12 Extension Phase|Pregnancy|0|||
144398834|NCT01254292|520672669|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
144398835|NCT01254292|520672670|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
144398836|NCT01484132|520672671|FG000|Overall Study|Lost to Follow-up|8|||
144398837|NCT01484132|520672671|FG000|Overall Study|Difficulty with time commitment|2|||
144398838|NCT01484132|520672671|FG000|Overall Study|Ineligible|1|||
144398839|NCT01484132|520672671|FG000|Overall Study|No pre-treatment urine sample collected|1|||
144398840|NCT01484132|520672671|FG000|Overall Study|No post-treatment urine sample collected|10|||
144398841|NCT01697358|520672679|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
144398842|NCT01697358|520672680|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
144521424|NCT00418886|521110174|FG001|Randomized Period|withdrawn due to other reason|0|||
144521425|NCT00418886|521110173|FG000|Randomized Period|randomised but no treatment received|0|||
144521426|NCT00418886|521110174|FG001|Randomized Period|randomised but no treatment received|1|||
144521427|NCT04060654|521110175|FG000|Overall Study|Withdrawal by Subject|1|||
144521428|NCT04060654|521110175|FG000|Overall Study|Lost to Follow-up|5|||
144521429|NCT03707951|521110176|FG000|Overall Study|Lost to Follow-up|8|||
144521430|NCT03707951|521110177|FG001|Overall Study|Lost to Follow-up|17|||
144521431|NCT03707951|521110176|FG000|Overall Study|Withdrawal by Subject|6|||
144521432|NCT03707951|521110177|FG001|Overall Study|Withdrawal by Subject|6|||
144521433|NCT04887129|521110178|FG000|Overall Study|Lost to Follow-up|0|||
144398843|NCT01697358|520672679|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
144398844|NCT01697358|520672680|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
144398845|NCT01697358|520672679|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
144398846|NCT01697358|520672680|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
144398847|NCT01697358|520672679|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
144398848|NCT01697358|520672680|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
144521434|NCT04887129|521110179|FG001|Overall Study|Lost to Follow-up|24|||
144398849|NCT01697358|520672679|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
144398850|NCT01697358|520672680|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
144398851|NCT01697358|520672679|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
144398852|NCT01697358|520672680|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
144398853|NCT01697358|520672679|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
144398854|NCT01697358|520672680|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
144398855|NCT01697358|520672679|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
144398856|NCT01697358|520672680|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
144398857|NCT01697358|520672679|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
144398858|NCT01697358|520672680|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
144398859|NCT01697358|520672679|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
144398860|NCT01697358|520672680|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
144398861|NCT05055128|520672681|FG000|Overall Study|Adverse Event|0|||
144398862|NCT05055128|520672682|FG001|Overall Study|Adverse Event|0|||
144398863|NCT05055128|520672683|FG002|Overall Study|Adverse Event|0|||
144398864|NCT05055128|520672684|FG003|Overall Study|Adverse Event|1|||
144398865|NCT05055128|520672685|FG004|Overall Study|Adverse Event|1|||
144398866|NCT05055128|520672681|FG000|Overall Study|Protocol Violation|0|||
144398867|NCT05055128|520672682|FG001|Overall Study|Protocol Violation|0|||
144398868|NCT05055128|520672683|FG002|Overall Study|Protocol Violation|0|||
144398869|NCT05055128|520672684|FG003|Overall Study|Protocol Violation|1|||
144398870|NCT05055128|520672685|FG004|Overall Study|Protocol Violation|0|||
144398871|NCT05055128|520672681|FG000|Overall Study|Withdrawal by Subject|5|||
144398872|NCT05055128|520672682|FG001|Overall Study|Withdrawal by Subject|2|||
144398873|NCT05055128|520672683|FG002|Overall Study|Withdrawal by Subject|2|||
144398874|NCT05055128|520672684|FG003|Overall Study|Withdrawal by Subject|4|||
144398875|NCT05055128|520672685|FG004|Overall Study|Withdrawal by Subject|2|||
144398876|NCT05055128|520672681|FG000|Overall Study|Randomized By Mistake|0|||
144398877|NCT05055128|520672682|FG001|Overall Study|Randomized By Mistake|1|||
144398878|NCT05055128|520672683|FG002|Overall Study|Randomized By Mistake|0|||
144398879|NCT05055128|520672684|FG003|Overall Study|Randomized By Mistake|0|||
144398880|NCT05055128|520672685|FG004|Overall Study|Randomized By Mistake|0|||
144398881|NCT05055128|520672681|FG000|Overall Study|Other|1|||
144398882|NCT05055128|520672682|FG001|Overall Study|Other|0|||
144398883|NCT05055128|520672683|FG002|Overall Study|Other|0|||
144398884|NCT05055128|520672684|FG003|Overall Study|Other|0|||
144398885|NCT05055128|520672685|FG004|Overall Study|Other|0|||
144398886|NCT00747461|520672692|FG000|Overall Study|study terminated by sponsor|5|||
144398887|NCT02149875|520672693|FG000|Overall Study|Lost to Follow-up|3|||
144398888|NCT02149875|520672694|FG001|Overall Study|Lost to Follow-up|4|||
144398889|NCT02149875|520672695|FG002|Overall Study|Lost to Follow-up|5|||
144398890|NCT02149875|520672693|FG000|Overall Study|Withdrawal by Subject|3|||
144398891|NCT02149875|520672694|FG001|Overall Study|Withdrawal by Subject|2|||
144398892|NCT02149875|520672695|FG002|Overall Study|Withdrawal by Subject|2|||
144398893|NCT02149875|520672693|FG000|Overall Study|Physician Decision|1|||
144398894|NCT02149875|520672694|FG001|Overall Study|Physician Decision|2|||
144398895|NCT02149875|520672695|FG002|Overall Study|Physician Decision|2|||
144398896|NCT00299182|520672696|FG000|Overall Study|Withdrawal by Subject|0|||
144398897|NCT00299182|520672697|FG001|Overall Study|Withdrawal by Subject|0|||
144398898|NCT00299182|520672698|FG002|Overall Study|Withdrawal by Subject|1|||
144521435|NCT04887129|521110178|FG000|Overall Study|Withdrawal by Subject|9|||
144521436|NCT04887129|521110179|FG001|Overall Study|Withdrawal by Subject|57|||
144521437|NCT04887129|521110178|FG000|Overall Study|Other|2|||
144521438|NCT04887129|521110179|FG001|Overall Study|Other|9|||
144521439|NCT01999075|521110181|FG000|Overall Study|Lost to Follow-up|0|||
144398899|NCT00299182|520672699|FG003|Overall Study|Withdrawal by Subject|0|||
144398900|NCT00299182|520672700|FG004|Overall Study|Withdrawal by Subject|1|||
144521440|NCT01999075|521110182|FG001|Overall Study|Lost to Follow-up|2|||
144398901|NCT00299182|520672701|FG005|Overall Study|Withdrawal by Subject|2|||
144398902|NCT00299182|520672702|FG006|Overall Study|Withdrawal by Subject|0|||
144398903|NCT00299182|520672696|FG000|Overall Study|Chemotherapy Changed|0|||
144398904|NCT00299182|520672697|FG001|Overall Study|Chemotherapy Changed|0|||
144398905|NCT00299182|520672698|FG002|Overall Study|Chemotherapy Changed|1|||
144398906|NCT00299182|520672699|FG003|Overall Study|Chemotherapy Changed|0|||
144398907|NCT00299182|520672700|FG004|Overall Study|Chemotherapy Changed|1|||
144398908|NCT00299182|520672701|FG005|Overall Study|Chemotherapy Changed|0|||
144398909|NCT00299182|520672702|FG006|Overall Study|Chemotherapy Changed|1|||
144521441|NCT01999075|521110181|FG000|Overall Study|Withdrawal by Subject|2|||
144521442|NCT01999075|521110182|FG001|Overall Study|Withdrawal by Subject|7|||
144398910|NCT00299182|520672696|FG000|Overall Study|Adverse Event|0|||
144398911|NCT00299182|520672697|FG001|Overall Study|Adverse Event|0|||
144398912|NCT00299182|520672698|FG002|Overall Study|Adverse Event|0|||
144398913|NCT00299182|520672699|FG003|Overall Study|Adverse Event|0|||
144398914|NCT00299182|520672700|FG004|Overall Study|Adverse Event|0|||
144398915|NCT00299182|520672701|FG005|Overall Study|Adverse Event|1|||
144398916|NCT00299182|520672702|FG006|Overall Study|Adverse Event|0|||
144398917|NCT00299182|520672696|FG000|Overall Study|Not Eligible|0|||
144398918|NCT00299182|520672697|FG001|Overall Study|Not Eligible|0|||
144398919|NCT00299182|520672698|FG002|Overall Study|Not Eligible|0|||
144398920|NCT00299182|520672699|FG003|Overall Study|Not Eligible|0|||
144398921|NCT00299182|520672700|FG004|Overall Study|Not Eligible|1|||
144398922|NCT00299182|520672701|FG005|Overall Study|Not Eligible|0|||
144398923|NCT00299182|520672702|FG006|Overall Study|Not Eligible|0|||
144398924|NCT00771316|520672707|FG000|Overall Study|Adverse Event|0|||
144398925|NCT00771316|520672708|FG001|Overall Study|Adverse Event|1|||
144398926|NCT00771316|520672707|FG000|Overall Study|Patient withdrew consent|1|||
144398927|NCT00771316|520672708|FG001|Overall Study|Patient withdrew consent|0|||
144595832|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
144398928|NCT00771316|520672707|FG000|Overall Study|Discontinued due to early termination|1|||
144398929|NCT00771316|520672708|FG001|Overall Study|Discontinued due to early termination|0|||
144398930|NCT00936611|520672709|FG000|Overall Study|Progressive Disease|3|||
144398931|NCT00936611|520672709|FG000|Overall Study|New Systemic Therapy|22|||
144595833|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
144595834|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
144595835|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
144595836|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
144595837|NCT00343252|521381211|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
144595838|NCT00343252|521381212|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
144595839|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
144595840|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
144398932|NCT00936611|520672709|FG000|Overall Study|Lost to Follow-up|1|||
144398933|NCT00936611|520672709|FG000|Overall Study|Withdrawal by Subject|2|||
144398934|NCT00936611|520672709|FG000|Overall Study|Still on Follow-up|1|||
144398935|NCT00936611|520672709|FG000|Overall Study|Still on Active Therapy|7|||
144398936|NCT00936611|520672709|FG000|Overall Study|Ineligible for Study Drug|3|||
144398937|NCT01822496|520672713|FG000|Overall Study|Protocol Violation|2|||
144398938|NCT01822496|520672714|FG001|Overall Study|Protocol Violation|2|||
144398939|NCT01822496|520672715|FG002|Overall Study|Protocol Violation|0|||
144398940|NCT01822496|520672716|FG003|Overall Study|Protocol Violation|1|||
144398941|NCT01822496|520672713|FG000|Overall Study|Withdrawal by Subject|0|||
144398942|NCT01822496|520672714|FG001|Overall Study|Withdrawal by Subject|0|||
144398943|NCT01822496|520672715|FG002|Overall Study|Withdrawal by Subject|0|||
144398944|NCT01822496|520672716|FG003|Overall Study|Withdrawal by Subject|3|||
144398945|NCT03841448|520672719|FG000|Double-blind Treatment (DBT) Period|Death|1|||
144398946|NCT03841448|520672720|FG001|Double-blind Treatment (DBT) Period|Death|1|||
144398947|NCT03841448|520672721|FG002|Double-blind Treatment (DBT) Period|Death|0|||
144398948|NCT03841448|520672722|FG003|Double-blind Treatment (DBT) Period|Death|0|||
144398949|NCT03841448|520672719|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
144398950|NCT03841448|520672720|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
144398951|NCT03841448|520672721|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
144398952|NCT03841448|520672722|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
144398953|NCT03841448|520672719|FG000|Open-Label Extension (OLE) Period|Death|0|||
144398954|NCT03841448|520672720|FG001|Open-Label Extension (OLE) Period|Death|0|||
144398955|NCT03841448|520672721|FG002|Open-Label Extension (OLE) Period|Death|0|||
144398956|NCT03841448|520672722|FG003|Open-Label Extension (OLE) Period|Death|1|||
144398957|NCT03841448|520672719|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
144398958|NCT03841448|520672720|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
144398959|NCT03841448|520672721|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
144398960|NCT03841448|520672722|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
144398961|NCT03841448|520672719|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
144595841|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Death|3|||
144595842|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Death|3|||
144398962|NCT03841448|520672720|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
144398963|NCT03841448|520672721|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
144398964|NCT03841448|520672722|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
144398965|NCT03841448|520672719|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
144398966|NCT03841448|520672720|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
144398967|NCT03841448|520672721|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
144398968|NCT03841448|520672722|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
144398969|NCT00543543|520672723|FG000|Base Study|Adverse Event|1|||
144398970|NCT00543543|520672724|FG001|Base Study|Adverse Event|11|||
144398971|NCT00543543|520672725|FG002|Base Study|Adverse Event|0|||
144398972|NCT00543543|520672726|FG003|Base Study|Adverse Event|5|||
144398973|NCT00543543|520672723|FG000|Base Study|Lost to Follow-up|12|||
144398974|NCT00543543|520672724|FG001|Base Study|Lost to Follow-up|749|||
144398975|NCT00543543|520672725|FG002|Base Study|Lost to Follow-up|9|||
144398976|NCT00543543|520672726|FG003|Base Study|Lost to Follow-up|701|||
144398977|NCT00543543|520672723|FG000|Base Study|Physician Decision|0|||
144398978|NCT00543543|520672724|FG001|Base Study|Physician Decision|4|||
144398979|NCT00543543|520672725|FG002|Base Study|Physician Decision|0|||
144398980|NCT00543543|520672726|FG003|Base Study|Physician Decision|7|||
144398981|NCT00543543|520672723|FG000|Base Study|Protocol Violation|0|||
144398982|NCT00543543|520672724|FG001|Base Study|Protocol Violation|6|||
144398983|NCT00543543|520672725|FG002|Base Study|Protocol Violation|0|||
144398984|NCT00543543|520672726|FG003|Base Study|Protocol Violation|6|||
144398985|NCT00543543|520672723|FG000|Base Study|Withdrawal by Subject|7|||
144398986|NCT00543543|520672724|FG001|Base Study|Withdrawal by Subject|482|||
144398987|NCT00543543|520672725|FG002|Base Study|Withdrawal by Subject|5|||
144398988|NCT00543543|520672726|FG003|Base Study|Withdrawal by Subject|503|||
144398989|NCT00543543|520672723|FG000|Extension Study|Adverse Event|0|||
144398990|NCT00543543|520672724|FG001|Extension Study|Adverse Event|0|||
144398991|NCT00543543|520672725|FG002|Extension Study|Adverse Event|0|||
144398992|NCT00543543|520672726|FG003|Extension Study|Adverse Event|5|||
144398993|NCT00543543|520672723|FG000|Extension Study|Lost to Follow-up|0|||
144398994|NCT00543543|520672724|FG001|Extension Study|Lost to Follow-up|0|||
144398995|NCT00543543|520672725|FG002|Extension Study|Lost to Follow-up|0|||
144398996|NCT00543543|520672726|FG003|Extension Study|Lost to Follow-up|77|||
144398997|NCT00543543|520672723|FG000|Extension Study|Physician Decision|0|||
144398998|NCT00543543|520672724|FG001|Extension Study|Physician Decision|0|||
144398999|NCT00543543|520672725|FG002|Extension Study|Physician Decision|0|||
144399000|NCT00543543|520672726|FG003|Extension Study|Physician Decision|7|||
144399001|NCT00543543|520672723|FG000|Extension Study|Pregnancy|0|||
144399002|NCT00543543|520672724|FG001|Extension Study|Pregnancy|0|||
144399003|NCT00543543|520672725|FG002|Extension Study|Pregnancy|0|||
144399004|NCT00543543|520672726|FG003|Extension Study|Pregnancy|6|||
144399005|NCT00543543|520672723|FG000|Extension Study|Protocol Violation|0|||
144399006|NCT00543543|520672724|FG001|Extension Study|Protocol Violation|0|||
144399007|NCT00543543|520672725|FG002|Extension Study|Protocol Violation|0|||
144399008|NCT00543543|520672726|FG003|Extension Study|Protocol Violation|11|||
144399009|NCT00543543|520672723|FG000|Extension Study|Withdrawal by Subject|0|||
144399010|NCT00543543|520672724|FG001|Extension Study|Withdrawal by Subject|0|||
144399011|NCT00543543|520672725|FG002|Extension Study|Withdrawal by Subject|0|||
144399012|NCT00543543|520672726|FG003|Extension Study|Withdrawal by Subject|120|||
144399013|NCT04308304|520672727|FG000|Overall Study|Withdrawal by Subject|4|||
144399014|NCT04308304|520672728|FG001|Overall Study|Withdrawal by Subject|0|||
144399015|NCT04308304|520672727|FG000|Overall Study|Protocol Violation|1|||
144399016|NCT04308304|520672728|FG001|Overall Study|Protocol Violation|0|||
144399017|NCT00945555|520672729|FG000|Overall Study|Referred to another hospital|5|||
144399018|NCT00945555|520672729|FG000|Overall Study|Worsening condition, intensive care unit|1|||
144399019|NCT00945555|520672729|FG000|Overall Study|Withdrawal by Subject|2|||
144399020|NCT00945555|520672729|FG000|Overall Study|Participant continued treatment at home|1|||
144399021|NCT00945555|520672729|FG000|Overall Study|Death|18|||
144399022|NCT00945555|520672729|FG000|Overall Study|Other|1|||
144399023|NCT00165984|520672731|FG000|Overall Study|Death|15|||
144399024|NCT03945266|520672732|FG000|Overall Study|Withdrawal by Subject|1|||
144399025|NCT03945266|520672733|FG001|Overall Study|Withdrawal by Subject|0|||
144399026|NCT03945266|520672732|FG000|Overall Study|Miscarriage|0|||
144399027|NCT03945266|520672733|FG001|Overall Study|Miscarriage|2|||
144399028|NCT03945266|520672732|FG000|Overall Study|Lost to Follow-up|1|||
144399029|NCT03945266|520672733|FG001|Overall Study|Lost to Follow-up|0|||
144399030|NCT01686828|520672734|FG000|Overall Study|Physician Decision|1|||
144399031|NCT01686828|520672735|FG001|Overall Study|Physician Decision|0|||
144399032|NCT01686828|520672736|FG002|Overall Study|Physician Decision|0|||
144399033|NCT01686828|520672737|FG003|Overall Study|Physician Decision|0|||
144399034|NCT01686828|520672734|FG000|Overall Study|New Job|0|||
144399035|NCT01686828|520672735|FG001|Overall Study|New Job|1|||
144399036|NCT01686828|520672736|FG002|Overall Study|New Job|0|||
144399037|NCT01686828|520672737|FG003|Overall Study|New Job|0|||
144399038|NCT01686828|520672734|FG000|Overall Study|Weight Loss|0|||
144399039|NCT01686828|520672735|FG001|Overall Study|Weight Loss|0|||
144399040|NCT01686828|520672736|FG002|Overall Study|Weight Loss|1|||
144399041|NCT01686828|520672737|FG003|Overall Study|Weight Loss|0|||
144399042|NCT01736124|520672740|FG000|Post-intervention Assessment|Death|2|||
144399043|NCT01736124|520672741|FG001|Post-intervention Assessment|Death|2|||
144399044|NCT01736124|520672740|FG000|Post-intervention Assessment|lost computer access|1|||
144399045|NCT01736124|520672741|FG001|Post-intervention Assessment|lost computer access|1|||
144399046|NCT01736124|520672740|FG000|Post-intervention Assessment|Moved away|3|||
144399047|NCT01736124|520672741|FG001|Post-intervention Assessment|Moved away|1|||
144399048|NCT01736124|520672740|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
144399049|NCT01736124|520672741|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
144399050|NCT01736124|520672740|FG000|Post-intervention Assessment|Illness|3|||
144399051|NCT01736124|520672741|FG001|Post-intervention Assessment|Illness|2|||
144399052|NCT01736124|520672740|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
144399053|NCT01736124|520672741|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
144399054|NCT01736124|520672740|FG000|Post-intervention Assessment|Temporarily away|3|||
144399055|NCT01736124|520672741|FG001|Post-intervention Assessment|Temporarily away|1|||
144399056|NCT01736124|520672740|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
144399057|NCT01736124|520672741|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
144399058|NCT01736124|520672740|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
144399059|NCT01736124|520672741|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
144399060|NCT01736124|520672740|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
144399061|NCT01736124|520672741|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
144399062|NCT01736124|520672740|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
144399063|NCT01736124|520672741|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
144399064|NCT01736124|520672740|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
144399065|NCT01736124|520672741|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
144399066|NCT01736124|520672740|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
144399067|NCT01736124|520672741|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
144399068|NCT01736124|520672740|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
144399069|NCT01736124|520672741|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
144399070|NCT01736124|520672740|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
144399071|NCT01736124|520672741|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
144399072|NCT01736124|520672740|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
144399073|NCT01736124|520672741|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
144399074|NCT02734433|520672752|FG000|Overall Study|Disease progression|1|||
144399075|NCT02734433|520672753|FG001|Overall Study|Disease progression|5|||
144399076|NCT02734433|520672752|FG000|Overall Study|Clinical progression|0|||
144399077|NCT02734433|520672753|FG001|Overall Study|Clinical progression|1|||
144399078|NCT02734433|520672752|FG000|Overall Study|Withdrawal by Subject|1|||
144399079|NCT02734433|520672753|FG001|Overall Study|Withdrawal by Subject|2|||
144399080|NCT02628769|520672754|FG000|First Intervention|Adverse Event|1|||
144399081|NCT02628769|520672755|FG001|First Intervention|Adverse Event|0|||
144399082|NCT02628769|520672754|FG000|First Intervention|Withdrawal by Subject|0|||
144399083|NCT02628769|520672755|FG001|First Intervention|Withdrawal by Subject|1|||
144399084|NCT02628769|520672754|FG000|Second Intervention|Adverse Event|2|||
144399085|NCT02628769|520672755|FG001|Second Intervention|Adverse Event|0|||
144399086|NCT02628769|520672754|FG000|Second Intervention|Physician Decision|0|||
144399087|NCT02628769|520672755|FG001|Second Intervention|Physician Decision|1|||
144399088|NCT02130024|520672759|FG000|Overall Study|Adverse Event|10|||
144399089|NCT02130024|520672760|FG001|Overall Study|Adverse Event|11|||
144399090|NCT02130024|520672759|FG000|Overall Study|Death|2|||
144399091|NCT02130024|520672760|FG001|Overall Study|Death|2|||
144399092|NCT02130024|520672759|FG000|Overall Study|Lost to Follow-up|1|||
144399093|NCT02130024|520672760|FG001|Overall Study|Lost to Follow-up|1|||
144399094|NCT02130024|520672759|FG000|Overall Study|Physician Decision|1|||
144399095|NCT02130024|520672760|FG001|Overall Study|Physician Decision|3|||
144399096|NCT02130024|520672759|FG000|Overall Study|Protocol Deviation|4|||
144399097|NCT02130024|520672760|FG001|Overall Study|Protocol Deviation|0|||
144399098|NCT02130024|520672759|FG000|Overall Study|Site Administration Problems|1|||
144399099|NCT02130024|520672760|FG001|Overall Study|Site Administration Problems|0|||
144399100|NCT02130024|520672759|FG000|Overall Study|Subject Withdrew Consent|6|||
144399101|NCT02130024|520672760|FG001|Overall Study|Subject Withdrew Consent|14|||
144399102|NCT04916769|520672766|FG000|Period 1|Physician Decision|0|||
144521443|NCT01999075|521110181|FG000|Overall Study|Enrolled in drug trial|3|||
144521444|NCT01999075|521110182|FG001|Overall Study|Enrolled in drug trial|1|||
144521445|NCT01999075|521110181|FG000|Overall Study|Became ineligible|0|||
144521446|NCT01999075|521110182|FG001|Overall Study|Became ineligible|2|||
144521447|NCT03683719|521110183|FG000|Overall Study|Lack of Efficacy|1|||
144521448|NCT03683719|521110184|FG001|Overall Study|Lack of Efficacy|3|||
144399103|NCT04916769|520672767|FG001|Period 1|Physician Decision|0|||
144399104|NCT04916769|520672768|FG002|Period 1|Physician Decision|0|||
144399105|NCT04916769|520672769|FG003|Period 1|Physician Decision|0|||
144399106|NCT04916769|520672770|FG004|Period 1|Physician Decision|0|||
144399107|NCT04916769|520672771|FG005|Period 1|Physician Decision|1|||
144399108|NCT04916769|520672766|FG000|Period 2|Physician Decision|0|||
144399109|NCT04916769|520672767|FG001|Period 2|Physician Decision|1|||
144399110|NCT04916769|520672768|FG002|Period 2|Physician Decision|0|||
144521449|NCT03683719|521110185|FG002|Overall Study|Lack of Efficacy|4|||
144521450|NCT03683719|521110186|FG003|Overall Study|Lack of Efficacy|0|||
144399111|NCT04916769|520672769|FG003|Period 2|Physician Decision|0|||
144399112|NCT04916769|520672770|FG004|Period 2|Physician Decision|0|||
144399113|NCT04916769|520672771|FG005|Period 2|Physician Decision|0|||
144399114|NCT02719327|520672775|FG000|Overall Study|Withdrawal by Subject|11|||
144399115|NCT02719327|520672776|FG001|Overall Study|Withdrawal by Subject|8|||
144399116|NCT01386008|520672779|FG000|Overall Study|exited w/o incident /study discontinued|17|||
144399117|NCT01386008|520672779|FG000|Overall Study|Adverse Event|3|||
144399118|NCT03001882|520672780|FG000|Overall Study|Death|1|||
144399119|NCT03001882|520672781|FG001|Overall Study|Death|0|||
144399120|NCT03001882|520672782|FG002|Overall Study|Death|0|||
144399121|NCT03001882|520672783|FG003|Overall Study|Death|3|||
144399122|NCT03001882|520672780|FG000|Overall Study|Participant withdrew consent|0|||
144399123|NCT03001882|520672781|FG001|Overall Study|Participant withdrew consent|1|||
144399124|NCT03001882|520672782|FG002|Overall Study|Participant withdrew consent|0|||
144399125|NCT03001882|520672783|FG003|Overall Study|Participant withdrew consent|5|||
144399126|NCT03001882|520672780|FG000|Overall Study|Other reasons|1|||
144399127|NCT03001882|520672781|FG001|Overall Study|Other reasons|2|||
144399128|NCT03001882|520672782|FG002|Overall Study|Other reasons|0|||
144399129|NCT03001882|520672783|FG003|Overall Study|Other reasons|5|||
144399130|NCT03001882|520672780|FG000|Overall Study|Administrative reason by sponsor|0|||
144399131|NCT03001882|520672781|FG001|Overall Study|Administrative reason by sponsor|0|||
144399132|NCT03001882|520672782|FG002|Overall Study|Administrative reason by sponsor|0|||
144399133|NCT03001882|520672783|FG003|Overall Study|Administrative reason by sponsor|1|||
144399134|NCT03001882|520672780|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
144399135|NCT03001882|520672781|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
144399136|NCT03001882|520672782|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
144399137|NCT03001882|520672783|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
144399138|NCT03001882|520672780|FG000|Overall Study|Not reported|0|||
144399139|NCT03001882|520672781|FG001|Overall Study|Not reported|0|||
144399140|NCT03001882|520672782|FG002|Overall Study|Not reported|0|||
144399141|NCT03001882|520672783|FG003|Overall Study|Not reported|6|||
144399142|NCT03001882|520672780|FG000|Overall Study|Maximum clinical benefit|2|||
144399143|NCT03001882|520672781|FG001|Overall Study|Maximum clinical benefit|3|||
144399144|NCT03001882|520672782|FG002|Overall Study|Maximum clinical benefit|0|||
144399145|NCT03001882|520672783|FG003|Overall Study|Maximum clinical benefit|10|||
144399146|NCT03001882|520672780|FG000|Overall Study|AE unrelated to study drug|3|||
144399147|NCT03001882|520672781|FG001|Overall Study|AE unrelated to study drug|3|||
144471838|NCT02597036|520925335|FG009|Overall Study|Progressive Disease|0|||
144471839|NCT02597036|520925336|FG010|Overall Study|Progressive Disease|0|||
144471840|NCT02597036|520925337|FG011|Overall Study|Progressive Disease|0|||
144471841|NCT02597036|520925326|FG000|Overall Study|Adverse Event|0|||
144471842|NCT02597036|520925327|FG001|Overall Study|Adverse Event|0|||
144471843|NCT02597036|520925328|FG002|Overall Study|Adverse Event|0|||
144471844|NCT02597036|520925329|FG003|Overall Study|Adverse Event|0|||
144471845|NCT02597036|520925330|FG004|Overall Study|Adverse Event|0|||
144471846|NCT02597036|520925331|FG005|Overall Study|Adverse Event|0|||
144471847|NCT02597036|520925332|FG006|Overall Study|Adverse Event|0|||
144471848|NCT02597036|520925333|FG007|Overall Study|Adverse Event|1|||
144471849|NCT02597036|520925334|FG008|Overall Study|Adverse Event|0|||
144471850|NCT02597036|520925335|FG009|Overall Study|Adverse Event|0|||
144471851|NCT02597036|520925336|FG010|Overall Study|Adverse Event|0|||
144471852|NCT02597036|520925337|FG011|Overall Study|Adverse Event|1|||
144471853|NCT02597036|520925326|FG000|Overall Study|Death|0|||
144471854|NCT02597036|520925327|FG001|Overall Study|Death|0|||
144471855|NCT02597036|520925328|FG002|Overall Study|Death|0|||
144471856|NCT02597036|520925329|FG003|Overall Study|Death|0|||
144471857|NCT02597036|520925330|FG004|Overall Study|Death|0|||
144471858|NCT02597036|520925331|FG005|Overall Study|Death|0|||
144471859|NCT02597036|520925332|FG006|Overall Study|Death|0|||
144471860|NCT02597036|520925333|FG007|Overall Study|Death|0|||
144471861|NCT02597036|520925334|FG008|Overall Study|Death|0|||
144471862|NCT02597036|520925335|FG009|Overall Study|Death|1|||
144471863|NCT02597036|520925336|FG010|Overall Study|Death|1|||
144471864|NCT02597036|520925337|FG011|Overall Study|Death|0|||
144399148|NCT03001882|520672782|FG002|Overall Study|AE unrelated to study drug|0|||
144399149|NCT03001882|520672783|FG003|Overall Study|AE unrelated to study drug|11|||
144399150|NCT03001882|520672780|FG000|Overall Study|Study Drug Toxicity|8|||
144399151|NCT03001882|520672781|FG001|Overall Study|Study Drug Toxicity|5|||
144399152|NCT03001882|520672782|FG002|Overall Study|Study Drug Toxicity|0|||
144399153|NCT03001882|520672783|FG003|Overall Study|Study Drug Toxicity|37|||
144399154|NCT03001882|520672780|FG000|Overall Study|Disease progression|16|||
144399155|NCT03001882|520672781|FG001|Overall Study|Disease progression|14|||
144399156|NCT03001882|520672782|FG002|Overall Study|Disease progression|1|||
144399157|NCT03001882|520672783|FG003|Overall Study|Disease progression|90|||
144399158|NCT05268055|520672784|FG000|Overall Study|Lost to Follow-up|68|||
144399159|NCT05268055|520672785|FG001|Overall Study|Lost to Follow-up|68|||
144399160|NCT05268055|520672784|FG000|Overall Study|Withdrawal by Subject|12|||
144399161|NCT05268055|520672785|FG001|Overall Study|Withdrawal by Subject|8|||
144399162|NCT01555983|520672786|FG000|Overall Study|Withdrawal by Subject|1|||
144399163|NCT01555983|520672787|FG001|Overall Study|Withdrawal by Subject|0|||
144399164|NCT01555983|520672788|FG002|Overall Study|Withdrawal by Subject|0|||
144399165|NCT01555983|520672789|FG003|Overall Study|Withdrawal by Subject|0|||
144399166|NCT01555983|520672790|FG004|Overall Study|Withdrawal by Subject|1|||
144399167|NCT01555983|520672791|FG005|Overall Study|Withdrawal by Subject|1|||
144399168|NCT03817879|520674568|FG000|Overall Study|Drop out|5|||
144399169|NCT03817879|520674569|FG001|Overall Study|Drop out|12|||
144399170|NCT03817879|520674568|FG000|Overall Study|Withdrawal by Subject|0|||
144399171|NCT03817879|520674569|FG001|Overall Study|Withdrawal by Subject|1|||
144399172|NCT01543698|520674574|FG000|Phase 1b|Disease progression|2|||
144399173|NCT01543698|520674575|FG001|Phase 1b|Disease progression|4|||
144399174|NCT01543698|520674576|FG002|Phase 1b|Disease progression|3|||
144399175|NCT01543698|520674577|FG003|Phase 1b|Disease progression|2|||
144399176|NCT01543698|520674578|FG004|Phase 1b|Disease progression|10|||
144399177|NCT01543698|520674579|FG005|Phase 1b|Disease progression|6|||
144399178|NCT01543698|520674580|FG006|Phase 1b|Disease progression|5|||
144521451|NCT03683719|521110187|FG004|Overall Study|Lack of Efficacy|4|||
144521452|NCT03683719|521110183|FG000|Overall Study|Adverse Event|6|||
144521453|NCT03683719|521110184|FG001|Overall Study|Adverse Event|6|||
144521454|NCT03683719|521110185|FG002|Overall Study|Adverse Event|0|||
144521455|NCT03683719|521110186|FG003|Overall Study|Adverse Event|1|||
144521456|NCT03683719|521110187|FG004|Overall Study|Adverse Event|3|||
144521457|NCT03683719|521110183|FG000|Overall Study|Withdrawal by Subject|4|||
144521458|NCT03683719|521110184|FG001|Overall Study|Withdrawal by Subject|4|||
144521459|NCT03683719|521110185|FG002|Overall Study|Withdrawal by Subject|3|||
144521460|NCT03683719|521110186|FG003|Overall Study|Withdrawal by Subject|5|||
144521461|NCT03683719|521110187|FG004|Overall Study|Withdrawal by Subject|5|||
144521462|NCT03683719|521110183|FG000|Overall Study|Lost to Follow-up|1|||
144521463|NCT03683719|521110184|FG001|Overall Study|Lost to Follow-up|0|||
144521464|NCT03683719|521110185|FG002|Overall Study|Lost to Follow-up|0|||
144521465|NCT03683719|521110186|FG003|Overall Study|Lost to Follow-up|1|||
144521466|NCT03683719|521110187|FG004|Overall Study|Lost to Follow-up|1|||
144521467|NCT03683719|521110183|FG000|Overall Study|Other personal reasons|0|||
144521468|NCT03683719|521110184|FG001|Overall Study|Other personal reasons|0|||
144521469|NCT03683719|521110185|FG002|Overall Study|Other personal reasons|1|||
144521470|NCT03683719|521110186|FG003|Overall Study|Other personal reasons|0|||
144521471|NCT03683719|521110187|FG004|Overall Study|Other personal reasons|1|||
144521472|NCT03792256|521110191|FG000|Overall Study|Death|0|||
144521473|NCT03792256|521110192|FG001|Overall Study|Death|1|||
144521474|NCT03792256|521110191|FG000|Overall Study|Lack of Efficacy|0|||
144521475|NCT03792256|521110192|FG001|Overall Study|Lack of Efficacy|1|||
144521476|NCT03792256|521110191|FG000|Overall Study|Withdrawal by Subject|0|||
144521477|NCT03792256|521110192|FG001|Overall Study|Withdrawal by Subject|1|||
144521478|NCT04760678|521110193|FG000|Overall Study|Death|13|||
144521479|NCT04760678|521110193|FG000|Overall Study|Lost to Follow-up|48|||
144521480|NCT04760678|521110193|FG000|Overall Study|Withdrawal by Subject|1|||
144521481|NCT04562649|521110194|FG000|Overall Study|Withdrawal by Subject|11|||
144521482|NCT04562649|521110195|FG001|Overall Study|Withdrawal by Subject|8|||
144521483|NCT04562649|521110194|FG000|Overall Study|Lost to Follow-up|26|||
144521484|NCT04562649|521110195|FG001|Overall Study|Lost to Follow-up|20|||
144521485|NCT03056040|521110196|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
144722323|NCT03519256|521838676|FG000|Overall Study|Adverse event unrelated to study drug|0|||
144399179|NCT01543698|520674581|FG007|Phase 1b|Disease progression|3|||
144399180|NCT01543698|520674582|FG008|Phase 1b|Disease progression|4|||
144399181|NCT01543698|520674583|FG009|Phase 1b|Disease progression|5|||
144399182|NCT01543698|520674584|FG010|Phase 1b|Disease progression|1|||
144399183|NCT01543698|520674585|FG011|Phase 1b|Disease progression|0|||
144399184|NCT01543698|520674586|FG012|Phase 1b|Disease progression|0|||
144399185|NCT01543698|520674587|FG013|Phase 1b|Disease progression|0|||
144399186|NCT01543698|520674588|FG014|Phase 1b|Disease progression|0|||
144399187|NCT01543698|520674574|FG000|Phase 1b|Death|0|||
144521486|NCT03056040|521110197|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
144399188|NCT01543698|520674575|FG001|Phase 1b|Death|0|||
144399189|NCT01543698|520674576|FG002|Phase 1b|Death|1|||
144399190|NCT01543698|520674577|FG003|Phase 1b|Death|1|||
144399191|NCT01543698|520674578|FG004|Phase 1b|Death|0|||
144521487|NCT03056040|521110196|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
144521488|NCT03056040|521110197|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
144521489|NCT03056040|521110196|FG000|Primary Evaluation Period|Pregnancy|0|||
144521490|NCT03056040|521110197|FG001|Primary Evaluation Period|Pregnancy|1|||
144399192|NCT01543698|520674579|FG005|Phase 1b|Death|0|||
144399193|NCT01543698|520674580|FG006|Phase 1b|Death|0|||
144399194|NCT01543698|520674581|FG007|Phase 1b|Death|0|||
144399195|NCT01543698|520674582|FG008|Phase 1b|Death|0|||
144399196|NCT01543698|520674583|FG009|Phase 1b|Death|0|||
144399197|NCT01543698|520674584|FG010|Phase 1b|Death|1|||
144399198|NCT01543698|520674585|FG011|Phase 1b|Death|0|||
144399199|NCT01543698|520674586|FG012|Phase 1b|Death|0|||
144399200|NCT01543698|520674587|FG013|Phase 1b|Death|0|||
144399201|NCT01543698|520674588|FG014|Phase 1b|Death|0|||
144399202|NCT01543698|520674574|FG000|Phase 1b|Withdrawal by Subject|0|||
144399203|NCT01543698|520674575|FG001|Phase 1b|Withdrawal by Subject|1|||
144399204|NCT01543698|520674576|FG002|Phase 1b|Withdrawal by Subject|0|||
144399205|NCT01543698|520674577|FG003|Phase 1b|Withdrawal by Subject|1|||
144399206|NCT01543698|520674578|FG004|Phase 1b|Withdrawal by Subject|0|||
144399207|NCT01543698|520674579|FG005|Phase 1b|Withdrawal by Subject|0|||
144399208|NCT01543698|520674580|FG006|Phase 1b|Withdrawal by Subject|1|||
144399209|NCT01543698|520674581|FG007|Phase 1b|Withdrawal by Subject|0|||
144399210|NCT01543698|520674582|FG008|Phase 1b|Withdrawal by Subject|0|||
144399211|NCT01543698|520674583|FG009|Phase 1b|Withdrawal by Subject|0|||
144399212|NCT01543698|520674584|FG010|Phase 1b|Withdrawal by Subject|0|||
144399213|NCT01543698|520674585|FG011|Phase 1b|Withdrawal by Subject|0|||
144399214|NCT01543698|520674586|FG012|Phase 1b|Withdrawal by Subject|0|||
144399215|NCT01543698|520674587|FG013|Phase 1b|Withdrawal by Subject|0|||
144399216|NCT01543698|520674588|FG014|Phase 1b|Withdrawal by Subject|0|||
144399217|NCT01543698|520674574|FG000|Phase 1b|Adverse Event|1|||
144399218|NCT01543698|520674575|FG001|Phase 1b|Adverse Event|0|||
144399219|NCT01543698|520674576|FG002|Phase 1b|Adverse Event|0|||
144399220|NCT01543698|520674577|FG003|Phase 1b|Adverse Event|1|||
144399221|NCT01543698|520674578|FG004|Phase 1b|Adverse Event|2|||
144399222|NCT01543698|520674579|FG005|Phase 1b|Adverse Event|2|||
144399223|NCT01543698|520674580|FG006|Phase 1b|Adverse Event|0|||
144399224|NCT01543698|520674581|FG007|Phase 1b|Adverse Event|0|||
144399225|NCT01543698|520674582|FG008|Phase 1b|Adverse Event|1|||
144399226|NCT01543698|520674583|FG009|Phase 1b|Adverse Event|1|||
144399227|NCT01543698|520674584|FG010|Phase 1b|Adverse Event|2|||
144399228|NCT01543698|520674585|FG011|Phase 1b|Adverse Event|0|||
144399229|NCT01543698|520674586|FG012|Phase 1b|Adverse Event|0|||
144399230|NCT01543698|520674587|FG013|Phase 1b|Adverse Event|0|||
144399231|NCT01543698|520674588|FG014|Phase 1b|Adverse Event|0|||
144399232|NCT01543698|520674574|FG000|Phase 1b|Administrative problems|1|||
144399233|NCT01543698|520674575|FG001|Phase 1b|Administrative problems|0|||
144521491|NCT03056040|521110196|FG000|Primary Evaluation Period|Randomized, not treated|1|||
144521492|NCT03056040|521110197|FG001|Primary Evaluation Period|Randomized, not treated|1|||
144521493|NCT03056040|521110196|FG000|Extension Period|Physician Decision|3|||
144521494|NCT03056040|521110197|FG001|Extension Period|Physician Decision|3|||
144521495|NCT03056040|521110196|FG000|Extension Period|Lost to Follow-up|0|||
144521496|NCT03056040|521110197|FG001|Extension Period|Lost to Follow-up|1|||
144521497|NCT03056040|521110196|FG000|Extension Period|Death|0|||
144521498|NCT03056040|521110197|FG001|Extension Period|Death|3|||
144521499|NCT03056040|521110196|FG000|Extension Period|Withdrawal by Subject|1|||
144521500|NCT03056040|521110197|FG001|Extension Period|Withdrawal by Subject|0|||
144521501|NCT03445988|521110200|FG000|Overall Study|Lost to Follow-up|14|||
144521502|NCT03445988|521110201|FG001|Overall Study|Lost to Follow-up|26|||
144249658|NCT01897571|520111707|FG007|Overall Study|Enrolled in rollover study|9|||
144249659|NCT01897571|520111708|FG008|Overall Study|Enrolled in rollover study|7|||
144399234|NCT01543698|520674576|FG002|Phase 1b|Administrative problems|0|||
144399235|NCT01543698|520674577|FG003|Phase 1b|Administrative problems|0|||
144399236|NCT01543698|520674578|FG004|Phase 1b|Administrative problems|1|||
144399237|NCT01543698|520674579|FG005|Phase 1b|Administrative problems|0|||
144399238|NCT01543698|520674580|FG006|Phase 1b|Administrative problems|0|||
144399239|NCT01543698|520674581|FG007|Phase 1b|Administrative problems|1|||
144399240|NCT01543698|520674582|FG008|Phase 1b|Administrative problems|0|||
144399241|NCT01543698|520674583|FG009|Phase 1b|Administrative problems|0|||
144399242|NCT01543698|520674584|FG010|Phase 1b|Administrative problems|2|||
144399243|NCT01543698|520674585|FG011|Phase 1b|Administrative problems|0|||
144399244|NCT01543698|520674586|FG012|Phase 1b|Administrative problems|0|||
144399245|NCT01543698|520674587|FG013|Phase 1b|Administrative problems|0|||
144399246|NCT01543698|520674588|FG014|Phase 1b|Administrative problems|0|||
144399247|NCT01543698|520674574|FG000|Phase 1b|Protocol Violation|2|||
144399248|NCT01543698|520674575|FG001|Phase 1b|Protocol Violation|0|||
144399249|NCT01543698|520674576|FG002|Phase 1b|Protocol Violation|0|||
144399250|NCT01543698|520674577|FG003|Phase 1b|Protocol Violation|0|||
144399251|NCT01543698|520674578|FG004|Phase 1b|Protocol Violation|0|||
144399252|NCT01543698|520674579|FG005|Phase 1b|Protocol Violation|0|||
144595843|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
144595844|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
144595845|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
144595846|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
144595847|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
144595848|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
144595849|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
144595850|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
144595851|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
144595852|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
144595853|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
144595854|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
144595855|NCT00343252|521381211|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
144595856|NCT00343252|521381212|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
144595857|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
144595858|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
144595859|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Death|4|||
144595860|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Death|5|||
144595861|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
144595862|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
144595863|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
144595864|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
144595865|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
144595866|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
144595867|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
144595868|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
144595869|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
144595870|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
144595871|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
144595872|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
144595873|NCT00343252|521381211|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
144595874|NCT00343252|521381212|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
144595875|NCT00731120|521381213|FG000|Overall Study|Adverse Event|7|||
144595876|NCT00731120|521381214|FG001|Overall Study|Adverse Event|6|||
144595877|NCT00731120|521381215|FG002|Overall Study|Adverse Event|8|||
144595878|NCT00731120|521381213|FG000|Overall Study|Lack of Efficacy|4|||
144595879|NCT00731120|521381214|FG001|Overall Study|Lack of Efficacy|5|||
144595880|NCT00731120|521381215|FG002|Overall Study|Lack of Efficacy|4|||
144595881|NCT00731120|521381213|FG000|Overall Study|Noncompliance with Study Drug|3|||
144399253|NCT01543698|520674580|FG006|Phase 1b|Protocol Violation|0|||
144521503|NCT03445988|521110202|FG002|Overall Study|Lost to Follow-up|27|||
144521504|NCT03445988|521110203|FG003|Overall Study|Lost to Follow-up|66|||
144521505|NCT03445988|521110200|FG000|Overall Study|Withdrawal by Subject|7|||
144521506|NCT03445988|521110201|FG001|Overall Study|Withdrawal by Subject|4|||
144521507|NCT03445988|521110202|FG002|Overall Study|Withdrawal by Subject|3|||
144521508|NCT03445988|521110203|FG003|Overall Study|Withdrawal by Subject|5|||
144521509|NCT03445988|521110200|FG000|Overall Study|Death (unrelated to study)|5|||
144521510|NCT03445988|521110201|FG001|Overall Study|Death (unrelated to study)|1|||
144521511|NCT03445988|521110202|FG002|Overall Study|Death (unrelated to study)|2|||
144521512|NCT03445988|521110203|FG003|Overall Study|Death (unrelated to study)|4|||
144521513|NCT05784662|521110204|FG000|Overall Study|Lost to Follow-up|21|||
144521514|NCT05784662|521110205|FG001|Overall Study|Lost to Follow-up|17|||
144521515|NCT04274764|521110206|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
144521516|NCT04274764|521110207|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
144521517|NCT03611621|521110221|FG000|Overall Study|Graft loss|3|||
144521518|NCT03611621|521110221|FG000|Overall Study|Death|3|||
144521519|NCT03611621|521110221|FG000|Overall Study|Lost to Follow-up|1|||
144521520|NCT03232138|521110226|FG000|Overall Study|Physician Decision|1|||
144521521|NCT03232138|521110227|FG001|Overall Study|Physician Decision|0|||
144521522|NCT03232138|521110226|FG000|Overall Study|Adverse Event|2|||
144521523|NCT03232138|521110227|FG001|Overall Study|Adverse Event|0|||
144595882|NCT00731120|521381214|FG001|Overall Study|Noncompliance with Study Drug|3|||
144595883|NCT00731120|521381215|FG002|Overall Study|Noncompliance with Study Drug|1|||
144399254|NCT01543698|520674581|FG007|Phase 1b|Protocol Violation|0|||
144521524|NCT03232138|521110226|FG000|Overall Study|Withdrawal by Subject|1|||
144521525|NCT03232138|521110227|FG001|Overall Study|Withdrawal by Subject|2|||
144521526|NCT03920111|521110228|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
144521527|NCT03920111|521110229|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
144521528|NCT03920111|521110230|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
144521529|NCT05177848|521110231|FG000|Overall Study|Lost to Follow-up|1|||
144399255|NCT01543698|520674582|FG008|Phase 1b|Protocol Violation|0|||
144399256|NCT01543698|520674583|FG009|Phase 1b|Protocol Violation|0|||
144399257|NCT01543698|520674584|FG010|Phase 1b|Protocol Violation|0|||
144399258|NCT01543698|520674585|FG011|Phase 1b|Protocol Violation|0|||
144399259|NCT01543698|520674586|FG012|Phase 1b|Protocol Violation|0|||
144399260|NCT01543698|520674587|FG013|Phase 1b|Protocol Violation|0|||
144399261|NCT01543698|520674588|FG014|Phase 1b|Protocol Violation|0|||
144399262|NCT01543698|520674574|FG000|Phase 2|Protocol Violation|0|||
144399263|NCT01543698|520674575|FG001|Phase 2|Protocol Violation|0|||
144399264|NCT01543698|520674576|FG002|Phase 2|Protocol Violation|0|||
144399265|NCT01543698|520674577|FG003|Phase 2|Protocol Violation|0|||
144399266|NCT01543698|520674578|FG004|Phase 2|Protocol Violation|0|||
144399267|NCT01543698|520674579|FG005|Phase 2|Protocol Violation|0|||
144399268|NCT01543698|520674580|FG006|Phase 2|Protocol Violation|0|||
144399269|NCT01543698|520674581|FG007|Phase 2|Protocol Violation|0|||
144399270|NCT01543698|520674582|FG008|Phase 2|Protocol Violation|0|||
144399271|NCT01543698|520674583|FG009|Phase 2|Protocol Violation|0|||
144399272|NCT01543698|520674584|FG010|Phase 2|Protocol Violation|0|||
144399273|NCT01543698|520674585|FG011|Phase 2|Protocol Violation|0|||
144399274|NCT01543698|520674586|FG012|Phase 2|Protocol Violation|1|||
144399275|NCT01543698|520674587|FG013|Phase 2|Protocol Violation|0|||
144399276|NCT01543698|520674588|FG014|Phase 2|Protocol Violation|0|||
144399277|NCT01543698|520674574|FG000|Phase 2|Disease progression|0|||
144399278|NCT01543698|520674575|FG001|Phase 2|Disease progression|0|||
144399279|NCT01543698|520674576|FG002|Phase 2|Disease progression|0|||
144399280|NCT01543698|520674577|FG003|Phase 2|Disease progression|0|||
144399281|NCT01543698|520674578|FG004|Phase 2|Disease progression|0|||
144399282|NCT01543698|520674579|FG005|Phase 2|Disease progression|0|||
144399283|NCT01543698|520674580|FG006|Phase 2|Disease progression|0|||
144399284|NCT01543698|520674581|FG007|Phase 2|Disease progression|0|||
144399285|NCT01543698|520674582|FG008|Phase 2|Disease progression|0|||
144399286|NCT01543698|520674583|FG009|Phase 2|Disease progression|0|||
144399287|NCT01543698|520674584|FG010|Phase 2|Disease progression|0|||
144399288|NCT01543698|520674585|FG011|Phase 2|Disease progression|10|||
144399289|NCT01543698|520674586|FG012|Phase 2|Disease progression|21|||
144399290|NCT01543698|520674587|FG013|Phase 2|Disease progression|30|||
144399291|NCT01543698|520674588|FG014|Phase 2|Disease progression|25|||
144399292|NCT01543698|520674574|FG000|Phase 2|Death|0|||
144399293|NCT01543698|520674575|FG001|Phase 2|Death|0|||
144399294|NCT01543698|520674576|FG002|Phase 2|Death|0|||
144399295|NCT01543698|520674577|FG003|Phase 2|Death|0|||
144399296|NCT01543698|520674578|FG004|Phase 2|Death|0|||
144399297|NCT01543698|520674579|FG005|Phase 2|Death|0|||
144399298|NCT01543698|520674580|FG006|Phase 2|Death|0|||
144399299|NCT01543698|520674581|FG007|Phase 2|Death|0|||
144399300|NCT01543698|520674582|FG008|Phase 2|Death|0|||
144399301|NCT01543698|520674583|FG009|Phase 2|Death|0|||
144399302|NCT01543698|520674584|FG010|Phase 2|Death|0|||
144399303|NCT01543698|520674585|FG011|Phase 2|Death|0|||
144399304|NCT01543698|520674586|FG012|Phase 2|Death|1|||
144399305|NCT01543698|520674587|FG013|Phase 2|Death|1|||
144399306|NCT01543698|520674588|FG014|Phase 2|Death|1|||
144399307|NCT01543698|520674574|FG000|Phase 2|Administrative problems|0|||
144399308|NCT01543698|520674575|FG001|Phase 2|Administrative problems|0|||
144399309|NCT01543698|520674576|FG002|Phase 2|Administrative problems|0|||
144399310|NCT01543698|520674577|FG003|Phase 2|Administrative problems|0|||
144399311|NCT01543698|520674578|FG004|Phase 2|Administrative problems|0|||
144399312|NCT01543698|520674579|FG005|Phase 2|Administrative problems|0|||
144399313|NCT01543698|520674580|FG006|Phase 2|Administrative problems|0|||
144399314|NCT01543698|520674581|FG007|Phase 2|Administrative problems|0|||
144399315|NCT01543698|520674582|FG008|Phase 2|Administrative problems|0|||
144399316|NCT01543698|520674583|FG009|Phase 2|Administrative problems|0|||
144399317|NCT01543698|520674584|FG010|Phase 2|Administrative problems|0|||
144399318|NCT01543698|520674585|FG011|Phase 2|Administrative problems|0|||
144399319|NCT01543698|520674586|FG012|Phase 2|Administrative problems|0|||
144399320|NCT01543698|520674587|FG013|Phase 2|Administrative problems|3|||
144399321|NCT01543698|520674588|FG014|Phase 2|Administrative problems|1|||
144399322|NCT01543698|520674574|FG000|Phase 2|Withdrawal by Subject|0|||
144399323|NCT01543698|520674575|FG001|Phase 2|Withdrawal by Subject|0|||
144399324|NCT01543698|520674576|FG002|Phase 2|Withdrawal by Subject|0|||
144399325|NCT01543698|520674577|FG003|Phase 2|Withdrawal by Subject|0|||
144399326|NCT01543698|520674578|FG004|Phase 2|Withdrawal by Subject|0|||
144399327|NCT01543698|520674579|FG005|Phase 2|Withdrawal by Subject|0|||
144399328|NCT01543698|520674580|FG006|Phase 2|Withdrawal by Subject|0|||
144399329|NCT01543698|520674581|FG007|Phase 2|Withdrawal by Subject|0|||
144399330|NCT01543698|520674582|FG008|Phase 2|Withdrawal by Subject|0|||
144399331|NCT01543698|520674583|FG009|Phase 2|Withdrawal by Subject|0|||
144399332|NCT01543698|520674584|FG010|Phase 2|Withdrawal by Subject|0|||
144399333|NCT01543698|520674585|FG011|Phase 2|Withdrawal by Subject|0|||
144399334|NCT01543698|520674586|FG012|Phase 2|Withdrawal by Subject|0|||
144399335|NCT01543698|520674587|FG013|Phase 2|Withdrawal by Subject|3|||
144399336|NCT01543698|520674588|FG014|Phase 2|Withdrawal by Subject|1|||
144399337|NCT01543698|520674574|FG000|Phase 2|Adverse Event|0|||
144399338|NCT01543698|520674575|FG001|Phase 2|Adverse Event|0|||
144399339|NCT01543698|520674576|FG002|Phase 2|Adverse Event|0|||
144399340|NCT01543698|520674577|FG003|Phase 2|Adverse Event|0|||
144399341|NCT01543698|520674578|FG004|Phase 2|Adverse Event|0|||
144399342|NCT01543698|520674579|FG005|Phase 2|Adverse Event|0|||
144399343|NCT01543698|520674580|FG006|Phase 2|Adverse Event|0|||
144399344|NCT01543698|520674581|FG007|Phase 2|Adverse Event|0|||
144399345|NCT01543698|520674582|FG008|Phase 2|Adverse Event|0|||
144399346|NCT01543698|520674583|FG009|Phase 2|Adverse Event|0|||
144399347|NCT01543698|520674584|FG010|Phase 2|Adverse Event|0|||
144399348|NCT01543698|520674585|FG011|Phase 2|Adverse Event|1|||
144399349|NCT01543698|520674586|FG012|Phase 2|Adverse Event|3|||
144399350|NCT01543698|520674587|FG013|Phase 2|Adverse Event|5|||
144399351|NCT01543698|520674588|FG014|Phase 2|Adverse Event|14|||
144399352|NCT00217620|520674589|FG000|Overall Study|Adverse Event|2|||
144399353|NCT00217620|520674589|FG000|Overall Study|Progression|31|||
144399354|NCT00217620|520674589|FG000|Overall Study|Not Protocol Specified|4|||
144399355|NCT00217620|520674589|FG000|Overall Study|Ineligible|13|||
144399356|NCT00217620|520674589|FG000|Overall Study|Never received treatment|1|||
144399357|NCT02925923|520674590|FG000|Overall Study|blood samples hemolyzed|0|||
144399358|NCT02925923|520674591|FG001|Overall Study|blood samples hemolyzed|2|||
144399359|NCT01863953|520674592|FG000|Overall Study|Adverse Event|0|||
144399360|NCT01863953|520674593|FG001|Overall Study|Adverse Event|0|||
144399361|NCT01863953|520674594|FG002|Overall Study|Adverse Event|1|||
144399362|NCT01824342|520674601|FG000|Overall Study|Withdrawal by Subject|0|||
144399363|NCT01824342|520674602|FG001|Overall Study|Withdrawal by Subject|3|||
144399364|NCT01824342|520674601|FG000|Overall Study|Adverse Event|1|||
144399365|NCT01824342|520674602|FG001|Overall Study|Adverse Event|1|||
144249660|NCT01897571|520111709|FG009|Overall Study|Enrolled in rollover study|9|||
144249661|NCT01897571|520111710|FG010|Overall Study|Enrolled in rollover study|1|||
144249662|NCT01897571|520111700|FG000|Overall Study|Death|2|||
144399366|NCT01824342|520674601|FG000|Overall Study|Disease Progression|1|||
144399367|NCT01824342|520674602|FG001|Overall Study|Disease Progression|1|||
144399368|NCT01824342|520674601|FG000|Overall Study|Physician Decision|5|||
144399369|NCT01824342|520674602|FG001|Overall Study|Physician Decision|0|||
144399370|NCT01824342|520674601|FG000|Overall Study|Death|2|||
144399371|NCT01824342|520674602|FG001|Overall Study|Death|0|||
144521530|NCT05177848|521110232|FG001|Overall Study|Lost to Follow-up|4|||
144521531|NCT05177848|521110231|FG000|Overall Study|Discontinued|2|||
144521532|NCT05177848|521110232|FG001|Overall Study|Discontinued|1|||
144521533|NCT02724631|521110237|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
144521534|NCT05076708|521110238|FG000|Overall Study|Withdrawal by Subject|4|||
144521535|NCT05076708|521110238|FG000|Overall Study|Lost to study during switch phase|8|||
144521536|NCT04971395|521110239|FG000|Overall Study|Withdrawal by Subject|0|||
144521537|NCT04971395|521110240|FG001|Overall Study|Withdrawal by Subject|1|||
144521538|NCT04971395|521110241|FG002|Overall Study|Withdrawal by Subject|0|||
144521539|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Other|0|||
144521540|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Other|0|||
144521541|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Other|0|||
144521542|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Other|0|||
144521543|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Other|0|||
144521544|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Other|0|||
144521545|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Other|0|||
144521546|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Other|0|||
144521547|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Other|0|||
144521548|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Other|0|||
144521549|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Other|1|||
144521550|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Other|1|||
144521551|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Other|1|||
144521552|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Other|0|||
144521553|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Other|3|||
144521554|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Other|1|||
144521555|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Other|1|||
144521556|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Other|0|||
144521557|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521558|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521559|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
144722324|NCT03519256|521838677|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144399372|NCT02104752|520674609|FG000|Overall Study|Withdrawal by Subject|1|||
144399373|NCT02104752|520674610|FG001|Overall Study|Withdrawal by Subject|0|||
144399374|NCT02104752|520674609|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
144521560|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521561|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521562|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521563|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
144521564|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
144399375|NCT02104752|520674610|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
144399376|NCT00385762|520674611|FG000|Overall Study|Adverse Event|1|||
144399377|NCT00385762|520674611|FG000|Overall Study|Lost to Follow-up|1|||
144399378|NCT02422303|520674612|FG000|Overall Study|Lost to Follow-up|1|||
144399379|NCT02422303|520674613|FG001|Overall Study|Lost to Follow-up|1|||
144399380|NCT02899299|520674616|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
144399381|NCT02899299|520674617|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
144399382|NCT02899299|520674616|FG000|Pre-treatment|Participant withdrew consent|1|||
144399383|NCT02899299|520674617|FG001|Pre-treatment|Participant withdrew consent|11|||
144399384|NCT02899299|520674616|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
144399385|NCT02899299|520674617|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
144399386|NCT02899299|520674616|FG000|Pre-treatment|Not reported|0|||
144399387|NCT02899299|520674617|FG001|Pre-treatment|Not reported|1|||
144399388|NCT02899299|520674616|FG000|Treatment|Disease Progression|182|||
144399389|NCT02899299|520674617|FG001|Treatment|Disease Progression|43|||
144399390|NCT02899299|520674616|FG000|Treatment|Study Drug Toxicity|60|||
144399391|NCT02899299|520674617|FG001|Treatment|Study Drug Toxicity|24|||
144399392|NCT02899299|520674616|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
144399393|NCT02899299|520674617|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
144399394|NCT02899299|520674616|FG000|Treatment|Participant request to discontinue Study treatment|4|||
144399395|NCT02899299|520674617|FG001|Treatment|Participant request to discontinue Study treatment|10|||
144399396|NCT02899299|520674616|FG000|Treatment|Participant withdrew consent|6|||
144399397|NCT02899299|520674617|FG001|Treatment|Participant withdrew consent|3|||
144399398|NCT02899299|520674616|FG000|Treatment|Lost to Follow-up|0|||
144399399|NCT02899299|520674617|FG001|Treatment|Lost to Follow-up|2|||
144399400|NCT02899299|520674616|FG000|Treatment|Maximum Clinical Benefit|11|||
144399401|NCT02899299|520674617|FG001|Treatment|Maximum Clinical Benefit|2|||
144399402|NCT02899299|520674616|FG000|Treatment|Poor/Non-compliance|1|||
144399403|NCT02899299|520674617|FG001|Treatment|Poor/Non-compliance|0|||
144399404|NCT02899299|520674616|FG000|Treatment|Participant no longer meets Study criteria|4|||
144399405|NCT02899299|520674617|FG001|Treatment|Participant no longer meets Study criteria|0|||
144399406|NCT02899299|520674616|FG000|Treatment|Administrative reason by Sponsor|2|||
144399407|NCT02899299|520674617|FG001|Treatment|Administrative reason by Sponsor|0|||
144399408|NCT02899299|520674616|FG000|Treatment|Other reasons|12|||
144399409|NCT02899299|520674617|FG001|Treatment|Other reasons|2|||
144399410|NCT02899299|520674616|FG000|Treatment|Not reported|7|||
144399411|NCT02899299|520674617|FG001|Treatment|Not reported|0|||
144399412|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
144399413|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
144399414|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
144399415|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
144399416|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
144399417|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
144399418|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
144399419|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
144399420|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
144399421|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
144399422|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
144399423|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
144399424|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
144399425|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
144399426|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
144399427|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
144399428|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
144399429|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
144399430|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
144399431|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
144399432|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
144399433|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
144399434|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
144399435|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
144399436|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
144399437|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
144399438|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
144399439|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
144399440|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
144399441|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
144471865|NCT02597036|520925326|FG000|Overall Study|Lost to Follow-up|0|||
144399442|NCT00313300|520674619|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
144399443|NCT00313300|520674620|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
144399444|NCT00313300|520674621|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
144399445|NCT00313300|520674622|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
144399446|NCT00313300|520674623|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
144399447|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
144399448|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
144399449|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
144399450|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
144399451|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
144399452|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
144399453|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
144399454|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
144399455|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
144399456|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
144399457|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
144399458|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
144399459|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
144399460|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
144399461|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
144399462|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
144399463|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
144399464|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
144399465|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
144399466|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
144399467|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
144521565|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
144521566|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521567|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521568|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521569|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
144521570|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521571|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521572|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521573|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521574|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
144521575|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521576|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521577|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521578|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144722325|NCT03519256|521838678|FG002|Overall Study|Adverse event unrelated to study drug|1|||
144521579|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144399468|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
144399469|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
144399470|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
144399471|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
144399472|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
144399473|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
144399474|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
144399475|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
144399476|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
144399477|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
144399478|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
144399479|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
144399480|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
144399481|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
144399482|NCT00313300|520674619|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
144399483|NCT00313300|520674620|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
144399484|NCT00313300|520674621|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
144399485|NCT00313300|520674622|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
144399486|NCT00313300|520674623|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
144399487|NCT00313300|520674619|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
144521580|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521581|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521582|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
144521583|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521584|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521585|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521586|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521587|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521588|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521589|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521590|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521591|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521592|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
144521593|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521594|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521595|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521596|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521597|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521598|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521599|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521600|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521601|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521602|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
144521603|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521604|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521605|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521606|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521607|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521608|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521609|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521610|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
144521611|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Death|0|||
144521612|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Death|0|||
144521613|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Death|0|||
144521614|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Death|0|||
144521615|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Death|0|||
144521616|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Death|0|||
144521617|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Death|0|||
144521618|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Death|0|||
144399488|NCT00313300|520674620|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
144399489|NCT00313300|520674621|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
144521619|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Death|0|||
144521620|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Death|1|||
144521621|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Death|0|||
144521622|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Death|1|||
144521623|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Death|0|||
144521624|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Death|1|||
144521625|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Death|0|||
144521626|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Death|0|||
144521627|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Death|2|||
144399490|NCT00313300|520674622|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
144399491|NCT00313300|520674623|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
144399492|NCT00313300|520674619|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
144399493|NCT00313300|520674620|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
144399494|NCT00313300|520674621|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
144399495|NCT00313300|520674622|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
144399496|NCT00313300|520674623|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
144399497|NCT00313300|520674619|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
144595884|NCT00731120|521381213|FG000|Overall Study|Protocol Deviations|1|||
144595885|NCT00731120|521381214|FG001|Overall Study|Protocol Deviations|6|||
144595886|NCT00731120|521381215|FG002|Overall Study|Protocol Deviations|1|||
144595887|NCT00731120|521381213|FG000|Overall Study|Withdrawal of Consent|13|||
144595888|NCT00731120|521381214|FG001|Overall Study|Withdrawal of Consent|8|||
144595889|NCT00731120|521381215|FG002|Overall Study|Withdrawal of Consent|4|||
144595890|NCT00731120|521381213|FG000|Overall Study|Lost to Follow-up|10|||
144595891|NCT00731120|521381214|FG001|Overall Study|Lost to Follow-up|15|||
144595892|NCT00731120|521381215|FG002|Overall Study|Lost to Follow-up|17|||
144595893|NCT00731120|521381213|FG000|Overall Study|Other|4|||
144595894|NCT00731120|521381214|FG001|Overall Study|Other|0|||
144595895|NCT00731120|521381215|FG002|Overall Study|Other|1|||
144595896|NCT01142596|521381216|FG000|Overall Study|Withdrawal by Subject|9|||
144595897|NCT01142596|521381217|FG001|Overall Study|Withdrawal by Subject|35|||
144595898|NCT01142596|521381216|FG000|Overall Study|Adverse Event|8|||
144595899|NCT01142596|521381217|FG001|Overall Study|Adverse Event|35|||
144595900|NCT01142596|521381216|FG000|Overall Study|Lack of Efficacy|5|||
144595901|NCT01142596|521381217|FG001|Overall Study|Lack of Efficacy|9|||
144595902|NCT01142596|521381216|FG000|Overall Study|Lost to Follow-up|2|||
144595903|NCT01142596|521381217|FG001|Overall Study|Lost to Follow-up|3|||
144595904|NCT01142596|521381216|FG000|Overall Study|Other reason (not specified)|5|||
144595905|NCT01142596|521381217|FG001|Overall Study|Other reason (not specified)|4|||
144595906|NCT03181451|521381220|FG000|Overall Study|Adverse Event|0|||
144595907|NCT03181451|521381221|FG001|Overall Study|Adverse Event|1|||
144595908|NCT03181451|521381222|FG002|Overall Study|Adverse Event|0|||
144595909|NCT03181451|521381220|FG000|Overall Study|Withdrawal by Subject|0|||
144595910|NCT03181451|521381221|FG001|Overall Study|Withdrawal by Subject|1|||
144595911|NCT03181451|521381222|FG002|Overall Study|Withdrawal by Subject|0|||
144249663|NCT01897571|520111701|FG001|Overall Study|Death|2|||
144249664|NCT01897571|520111702|FG002|Overall Study|Death|3|||
144249665|NCT01897571|520111703|FG003|Overall Study|Death|6|||
144249666|NCT01897571|520111704|FG004|Overall Study|Death|7|||
144249667|NCT01897571|520111705|FG005|Overall Study|Death|9|||
144249668|NCT01897571|520111706|FG006|Overall Study|Death|5|||
144249669|NCT01897571|520111707|FG007|Overall Study|Death|22|||
144595912|NCT00723021|521381229|FG000|Intervention Period 4|Adverse Event|0|||
144595913|NCT00723021|521381230|FG001|Intervention Period 4|Adverse Event|0|||
144595914|NCT00723021|521381231|FG002|Intervention Period 4|Adverse Event|0|||
144595915|NCT00723021|521381232|FG003|Intervention Period 4|Adverse Event|0|||
144595916|NCT00723021|521381233|FG004|Intervention Period 4|Adverse Event|1|||
144595917|NCT04002401|521381234|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
144595918|NCT04002401|521381234|FG000|Overall Study|Death|10|||
144595919|NCT04002401|521381234|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
144595920|NCT04002401|521381234|FG000|Overall Study|Enrolled but Never Treated|1|||
144595921|NCT04002401|521381234|FG000|Overall Study|Lost to Follow-up|1|||
144595922|NCT01910181|521381237|FG000|Overall Study|Death|37|||
144595923|NCT01910181|521381237|FG000|Overall Study|Lost to Follow-up|3|||
144595924|NCT01910181|521381237|FG000|Overall Study|Study Terminated by Sponsor|6|||
144595925|NCT01340651|521381238|FG000|Overall Study|Adverse Event|3|||
144595926|NCT01340651|521381238|FG000|Overall Study|Consent Withdrawn|2|||
144595927|NCT01340651|521381238|FG000|Overall Study|Commercial Supply per Sponsor|12|||
144595928|NCT05269355|521381240|FG000|Overall Study|Progressive Disease|104|||
144595929|NCT05269355|521381241|FG001|Overall Study|Progressive Disease|68|||
144595930|NCT05269355|521381240|FG000|Overall Study|Study Terminated by Sponsor|87|||
144595931|NCT05269355|521381241|FG001|Overall Study|Study Terminated by Sponsor|29|||
144595932|NCT05269355|521381240|FG000|Overall Study|Adverse Event|15|||
144249670|NCT01897571|520111708|FG008|Overall Study|Death|23|||
144399498|NCT00313300|520674620|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
144399499|NCT00313300|520674621|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
144722326|NCT03519256|521838679|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144399500|NCT00313300|520674622|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
144399501|NCT00313300|520674623|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
144595933|NCT05269355|521381241|FG001|Overall Study|Adverse Event|8|||
144595934|NCT05269355|521381240|FG000|Overall Study|Withdrawal by Subject|18|||
144249671|NCT01897571|520111709|FG009|Overall Study|Death|129|||
144249672|NCT01897571|520111710|FG010|Overall Study|Death|59|||
144249673|NCT03217968|520111713|FG000|Overall Study|Withdrawal by Subject|4|||
144249674|NCT03217968|520111713|FG000|Overall Study|Lost to Follow-up|1|||
144521628|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Death|0|||
144521629|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
144521630|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
144521631|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
144521632|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
144521633|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
144521634|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
144521635|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
144521636|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
144521637|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
144521638|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
144521639|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
144521640|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
144521641|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
144521642|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
144521643|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
144521644|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
144521645|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
144521646|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
144521647|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Adverse Event|0|||
144521648|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Adverse Event|0|||
144521649|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Adverse Event|0|||
144521650|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Adverse Event|0|||
144521651|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Adverse Event|0|||
144521652|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Adverse Event|0|||
144521653|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Adverse Event|2|||
144521654|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Adverse Event|0|||
144521655|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Adverse Event|0|||
144521656|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Adverse Event|0|||
144521657|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Adverse Event|1|||
144521658|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Adverse Event|2|||
144521659|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Adverse Event|0|||
144521660|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Adverse Event|1|||
144521661|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Adverse Event|0|||
144521662|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Adverse Event|0|||
144521663|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Adverse Event|1|||
144521664|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Adverse Event|0|||
144521665|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
144521666|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
144521667|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
144521668|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
144521669|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
144521670|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
144521671|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
144521672|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
144521673|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
144521674|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
144521675|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
144521676|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
144521677|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
144521678|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
144521679|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
144521680|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
144521681|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
144521682|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
144521683|NCT03269136|521110242|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521684|NCT03269136|521110243|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144399502|NCT00313300|520674619|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
144399503|NCT00313300|520674620|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
144521685|NCT03269136|521110244|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521686|NCT03269136|521110245|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521687|NCT03269136|521110246|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521688|NCT03269136|521110247|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521689|NCT03269136|521110248|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521690|NCT03269136|521110249|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521691|NCT03269136|521110250|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521692|NCT03269136|521110251|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521693|NCT03269136|521110252|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521694|NCT03269136|521110253|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521695|NCT03269136|521110254|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
144521696|NCT03269136|521110255|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
144521697|NCT03269136|521110256|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
144521698|NCT03269136|521110257|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521699|NCT03269136|521110258|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
144521700|NCT03269136|521110259|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144521701|NCT03269136|521110242|FG000|Part 2A: Dose Expansion|Other|0|||
144521702|NCT03269136|521110243|FG001|Part 2A: Dose Expansion|Other|0|||
144521703|NCT03269136|521110244|FG002|Part 2A: Dose Expansion|Other|0|||
144521704|NCT03269136|521110245|FG003|Part 2A: Dose Expansion|Other|0|||
144521705|NCT03269136|521110246|FG004|Part 2A: Dose Expansion|Other|0|||
144521706|NCT03269136|521110247|FG005|Part 2A: Dose Expansion|Other|0|||
144521707|NCT03269136|521110248|FG006|Part 2A: Dose Expansion|Other|0|||
144521708|NCT03269136|521110249|FG007|Part 2A: Dose Expansion|Other|0|||
144521709|NCT03269136|521110250|FG008|Part 2A: Dose Expansion|Other|0|||
144521710|NCT03269136|521110251|FG009|Part 2A: Dose Expansion|Other|0|||
144521711|NCT03269136|521110252|FG010|Part 2A: Dose Expansion|Other|0|||
144521712|NCT03269136|521110253|FG011|Part 2A: Dose Expansion|Other|0|||
144521713|NCT03269136|521110254|FG012|Part 2A: Dose Expansion|Other|0|||
144521714|NCT03269136|521110255|FG013|Part 2A: Dose Expansion|Other|0|||
144521715|NCT03269136|521110256|FG014|Part 2A: Dose Expansion|Other|0|||
144521716|NCT03269136|521110257|FG015|Part 2A: Dose Expansion|Other|0|||
144521717|NCT03269136|521110258|FG016|Part 2A: Dose Expansion|Other|0|||
144521718|NCT03269136|521110259|FG017|Part 2A: Dose Expansion|Other|1|||
144521719|NCT03269136|521110242|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521720|NCT03269136|521110243|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521721|NCT03269136|521110244|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521722|NCT03269136|521110245|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521723|NCT03269136|521110246|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521724|NCT03269136|521110247|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521725|NCT03269136|521110248|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521726|NCT03269136|521110249|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521727|NCT03269136|521110250|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521728|NCT03269136|521110251|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521729|NCT03269136|521110252|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521730|NCT03269136|521110253|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521731|NCT03269136|521110254|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521732|NCT03269136|521110255|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521733|NCT03269136|521110256|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521734|NCT03269136|521110257|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521735|NCT03269136|521110258|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
144521736|NCT03269136|521110259|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
144521737|NCT03269136|521110242|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
144521738|NCT03269136|521110243|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
144521739|NCT03269136|521110244|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
144521740|NCT03269136|521110245|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
144521741|NCT03269136|521110246|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
144521742|NCT03269136|521110247|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
144521743|NCT03269136|521110248|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
144521744|NCT03269136|521110249|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
144521745|NCT03269136|521110250|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
144521746|NCT03269136|521110251|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
144521747|NCT03269136|521110252|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
144521748|NCT03269136|521110253|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
144521749|NCT03269136|521110254|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
144521750|NCT03269136|521110255|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
144521751|NCT03269136|521110256|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
144521752|NCT03269136|521110257|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
144521753|NCT03269136|521110258|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
144521754|NCT03269136|521110259|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
144521755|NCT03269136|521110242|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
144521756|NCT03269136|521110243|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
144249675|NCT03217968|520111713|FG000|Overall Study|Protocol Violation|6|||
144521757|NCT03269136|521110244|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
144521758|NCT03269136|521110245|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
144521759|NCT03269136|521110246|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
144521760|NCT03269136|521110247|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
144521761|NCT03269136|521110248|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
144521762|NCT03269136|521110249|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
144521763|NCT03269136|521110250|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
144521764|NCT03269136|521110251|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
144521765|NCT03269136|521110252|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
144521766|NCT03269136|521110253|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
144521767|NCT03269136|521110254|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
144521768|NCT03269136|521110255|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
144521769|NCT03269136|521110256|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
144521770|NCT03269136|521110257|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
144521771|NCT03269136|521110258|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
144521772|NCT03269136|521110259|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
144521773|NCT03269136|521110242|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
144521774|NCT03269136|521110243|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
144521775|NCT03269136|521110244|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
144521776|NCT03269136|521110245|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
144521777|NCT03269136|521110246|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
144521778|NCT03269136|521110247|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
144521779|NCT03269136|521110248|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
144521780|NCT03269136|521110249|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
144521781|NCT03269136|521110250|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
144521782|NCT03269136|521110251|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
144521783|NCT03269136|521110252|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
144521784|NCT03269136|521110253|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
144249676|NCT05268016|520111714|FG000|Overall Study|Unacceptable toxicity or AE|2|||
144249677|NCT05268016|520111715|FG001|Overall Study|Unacceptable toxicity or AE|2|||
144249678|NCT05268016|520111716|FG002|Overall Study|Unacceptable toxicity or AE|4|||
144249679|NCT05268016|520111717|FG003|Overall Study|Unacceptable toxicity or AE|3|||
144249680|NCT05268016|520111718|FG004|Overall Study|Unacceptable toxicity or AE|1|||
144249681|NCT05268016|520111714|FG000|Overall Study|Withdrawal by Subject|1|||
144249682|NCT05268016|520111715|FG001|Overall Study|Withdrawal by Subject|3|||
144249683|NCT05268016|520111716|FG002|Overall Study|Withdrawal by Subject|2|||
144249684|NCT05268016|520111717|FG003|Overall Study|Withdrawal by Subject|2|||
144249685|NCT05268016|520111718|FG004|Overall Study|Withdrawal by Subject|1|||
144249686|NCT05268016|520111714|FG000|Overall Study|Lost to Follow-up|4|||
144249687|NCT05268016|520111715|FG001|Overall Study|Lost to Follow-up|7|||
144249688|NCT05268016|520111716|FG002|Overall Study|Lost to Follow-up|1|||
144249689|NCT05268016|520111717|FG003|Overall Study|Lost to Follow-up|3|||
144249690|NCT05268016|520111718|FG004|Overall Study|Lost to Follow-up|5|||
144249691|NCT05268016|520111714|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
144249692|NCT05268016|520111715|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
144249693|NCT05268016|520111716|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
144249694|NCT05268016|520111717|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
144249695|NCT05268016|520111718|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
144249696|NCT05268016|520111714|FG000|Overall Study|Lack of Efficacy|0|||
144249697|NCT05268016|520111715|FG001|Overall Study|Lack of Efficacy|0|||
144249698|NCT05268016|520111716|FG002|Overall Study|Lack of Efficacy|0|||
144249699|NCT05268016|520111717|FG003|Overall Study|Lack of Efficacy|0|||
144249700|NCT05268016|520111718|FG004|Overall Study|Lack of Efficacy|4|||
144249701|NCT05268016|520111714|FG000|Overall Study|Physician Decision|0|||
144249702|NCT05268016|520111715|FG001|Overall Study|Physician Decision|0|||
144249703|NCT05268016|520111716|FG002|Overall Study|Physician Decision|0|||
144249704|NCT05268016|520111717|FG003|Overall Study|Physician Decision|1|||
144249705|NCT05268016|520111718|FG004|Overall Study|Physician Decision|0|||
144249706|NCT05268016|520111714|FG000|Overall Study|Other|1|||
144249707|NCT05268016|520111715|FG001|Overall Study|Other|0|||
144521785|NCT03269136|521110254|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
144521786|NCT03269136|521110255|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
144521787|NCT03269136|521110256|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
144521788|NCT03269136|521110257|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
144249708|NCT05268016|520111716|FG002|Overall Study|Other|1|||
144249709|NCT05268016|520111717|FG003|Overall Study|Other|2|||
144249710|NCT05268016|520111718|FG004|Overall Study|Other|0|||
144249711|NCT00089635|520111719|FG000|Overall Study|Adverse Event|2|||
144249712|NCT00089635|520111719|FG000|Overall Study|Death|17|||
144249713|NCT00089635|520111719|FG000|Overall Study|Disease Progression|12|||
144521789|NCT03269136|521110258|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
144521790|NCT03269136|521110259|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
144249714|NCT00089635|520111719|FG000|Overall Study|Lost to Follow-up|3|||
144249715|NCT00089635|520111719|FG000|Overall Study|Withdrawal by Subject|6|||
144521791|NCT02924272|521110260|FG000|Overall Study|Site Terminated by Sponsor|4|||
144521792|NCT02924272|521110261|FG001|Overall Study|Site Terminated by Sponsor|1|||
144521793|NCT02924272|521110260|FG000|Overall Study|Withdrawal by Subject|2|||
144521794|NCT02924272|521110261|FG001|Overall Study|Withdrawal by Subject|0|||
144521795|NCT02924272|521110260|FG000|Overall Study|Adverse Event|3|||
144521796|NCT02924272|521110261|FG001|Overall Study|Adverse Event|0|||
144521797|NCT02924272|521110260|FG000|Overall Study|Progressive Disease|11|||
144521798|NCT02924272|521110261|FG001|Overall Study|Progressive Disease|8|||
144521799|NCT02924272|521110260|FG000|Overall Study|Clinical Deterioration|1|||
144521800|NCT02924272|521110261|FG001|Overall Study|Clinical Deterioration|0|||
144521801|NCT02924272|521110260|FG000|Overall Study|Death|1|||
144521802|NCT02924272|521110261|FG001|Overall Study|Death|0|||
144521803|NCT02924272|521110260|FG000|Overall Study|Reason Not Specified|1|||
144521804|NCT02924272|521110261|FG001|Overall Study|Reason Not Specified|0|||
144521805|NCT05071807|521110266|FG000|Overall Study|Withdrawal by Subject|4|||
144521806|NCT05071807|521110267|FG001|Overall Study|Withdrawal by Subject|0|||
144521807|NCT05071807|521110266|FG000|Overall Study|Unrelated medical issues|3|||
144521808|NCT05071807|521110267|FG001|Overall Study|Unrelated medical issues|0|||
144521809|NCT05071807|521110266|FG000|Overall Study|Relocated|0|||
144521810|NCT05071807|521110267|FG001|Overall Study|Relocated|1|||
144521811|NCT05308004|521110268|FG000|Overall Study|Not seen by Palliative Care NP|0|||
144521812|NCT05308004|521110269|FG001|Overall Study|Not seen by Palliative Care NP|1|||
144521813|NCT04552223|521110276|FG000|Overall Study|Withdrawal by Subject|1|||
144521814|NCT04856163|521110277|FG000|Overall Study|Lost to Follow-up|97|||
144521815|NCT04856163|521110278|FG001|Overall Study|Lost to Follow-up|100|||
144521816|NCT04359108|521110288|FG000|Overall Study|Withdrawal by Subject|1|||
144521817|NCT04359108|521110289|FG001|Overall Study|Withdrawal by Subject|0|||
144521818|NCT04359108|521110288|FG000|Overall Study|Unable or too feeble to walk independently|0|||
144521819|NCT04359108|521110289|FG001|Overall Study|Unable or too feeble to walk independently|2|||
144521820|NCT04359108|521110288|FG000|Overall Study|Argus II system stopped functioning|0|||
144521821|NCT04359108|521110289|FG001|Overall Study|Argus II system stopped functioning|1|||
144521822|NCT04359108|521110288|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
144521823|NCT04359108|521110289|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
144521824|NCT06393088|521110290|FG000|Overall Study|Withdrawal by Subject|0|||
144521825|NCT06393088|521110291|FG001|Overall Study|Withdrawal by Subject|2|||
144521826|NCT02515773|521110292|FG000|Overall Study|Withdrawal by Subject|12|||
144521827|NCT02515773|521110293|FG001|Overall Study|Withdrawal by Subject|2|||
144521828|NCT02515773|521110292|FG000|Overall Study|Lost to Follow-up|119|||
144521829|NCT02515773|521110293|FG001|Overall Study|Lost to Follow-up|126|||
144521830|NCT02515773|521110292|FG000|Overall Study|Discharged from Clinic Services|53|||
144521831|NCT02515773|521110293|FG001|Overall Study|Discharged from Clinic Services|84|||
144521832|NCT02515773|521110292|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
144521833|NCT02515773|521110293|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
144521834|NCT02515773|521110292|FG000|Overall Study|Follow-up at non-study site|8|||
144521835|NCT02515773|521110293|FG001|Overall Study|Follow-up at non-study site|16|||
144521836|NCT02515773|521110292|FG000|Overall Study|Moved from area|9|||
144521837|NCT02515773|521110293|FG001|Overall Study|Moved from area|14|||
144521838|NCT03903146|521110294|FG000|Overall Study|Lost to Follow-up|6|||
144521839|NCT03903146|521110295|FG001|Overall Study|Lost to Follow-up|4|||
144521840|NCT03903146|521110294|FG000|Overall Study|Withdrawal by Subject|0|||
144521841|NCT03903146|521110295|FG001|Overall Study|Withdrawal by Subject|1|||
144521842|NCT04176965|521110296|FG000|Overall Study|Death|1|||
144521843|NCT04176965|521110297|FG001|Overall Study|Death|2|||
144521844|NCT04176965|521110296|FG000|Overall Study|Lost to Follow-up|10|||
144521845|NCT04176965|521110297|FG001|Overall Study|Lost to Follow-up|2|||
144521846|NCT04176965|521110296|FG000|Overall Study|Withdrawal by Subject|6|||
144521847|NCT04176965|521110297|FG001|Overall Study|Withdrawal by Subject|1|||
144521848|NCT02919683|521110298|FG000|Post-Surgery Follow-Up|Death|2|||
144521849|NCT02919683|521110299|FG001|Post-Surgery Follow-Up|Death|2|||
144521850|NCT02919683|521110298|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
144521851|NCT02919683|521110299|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
144521852|NCT05551637|521110300|FG000|Overall Study|Lack of Efficacy|0|||
144521853|NCT05551637|521110301|FG001|Overall Study|Lack of Efficacy|6|||
144521854|NCT05551637|521110300|FG000|Overall Study|Lost to Follow-up|1|||
144521855|NCT05551637|521110301|FG001|Overall Study|Lost to Follow-up|1|||
144521856|NCT04924660|521110302|FG000|United States|Death|29|||
144521857|NCT04924660|521110303|FG001|United States|Death|32|||
144521858|NCT04924660|521110304|FG002|United States|Death|34|||
144521859|NCT04924660|521110305|FG003|United States|Death|25|||
144521860|NCT04924660|521110306|FG004|United States|Death|26|||
144521861|NCT04924660|521110307|FG005|United States|Death|23|||
144521862|NCT04924660|521110302|FG000|United States|Lost to Follow-up|15|||
144521863|NCT04924660|521110303|FG001|United States|Lost to Follow-up|10|||
144521864|NCT04924660|521110304|FG002|United States|Lost to Follow-up|13|||
144521865|NCT04924660|521110305|FG003|United States|Lost to Follow-up|5|||
144521866|NCT04924660|521110306|FG004|United States|Lost to Follow-up|19|||
144521867|NCT04924660|521110307|FG005|United States|Lost to Follow-up|20|||
144521868|NCT04924660|521110302|FG000|United States|Withdrawal by Subject|8|||
144521869|NCT04924660|521110303|FG001|United States|Withdrawal by Subject|3|||
144521870|NCT04924660|521110304|FG002|United States|Withdrawal by Subject|3|||
144521871|NCT04924660|521110305|FG003|United States|Withdrawal by Subject|3|||
144521872|NCT04924660|521110306|FG004|United States|Withdrawal by Subject|8|||
144521873|NCT04924660|521110307|FG005|United States|Withdrawal by Subject|4|||
144521874|NCT04924660|521110302|FG000|Spain|Death|0|||
144521875|NCT04924660|521110303|FG001|Spain|Death|0|||
144521876|NCT04924660|521110304|FG002|Spain|Death|0|||
144521877|NCT04924660|521110305|FG003|Spain|Death|0|||
144521878|NCT04924660|521110306|FG004|Spain|Death|0|||
144521879|NCT04924660|521110307|FG005|Spain|Death|2|||
144521880|NCT04924660|521110302|FG000|Spain|Lost to Follow-up|0|||
144521881|NCT04924660|521110303|FG001|Spain|Lost to Follow-up|0|||
144521882|NCT04924660|521110304|FG002|Spain|Lost to Follow-up|0|||
144521883|NCT04924660|521110305|FG003|Spain|Lost to Follow-up|0|||
144521884|NCT04924660|521110306|FG004|Spain|Lost to Follow-up|1|||
144521885|NCT04924660|521110307|FG005|Spain|Lost to Follow-up|0|||
144521886|NCT04924660|521110302|FG000|Brazil|Death|0|||
144521887|NCT04924660|521110303|FG001|Brazil|Death|0|||
144521888|NCT04924660|521110304|FG002|Brazil|Death|0|||
144521889|NCT04924660|521110305|FG003|Brazil|Death|0|||
144521890|NCT04924660|521110306|FG004|Brazil|Death|1|||
144521891|NCT04924660|521110307|FG005|Brazil|Death|0|||
144722327|NCT03519256|521838676|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144521892|NCT04924660|521110302|FG000|Italy|Lost to Follow-up|0|||
144521893|NCT04924660|521110303|FG001|Italy|Lost to Follow-up|0|||
144521894|NCT04924660|521110304|FG002|Italy|Lost to Follow-up|0|||
144521895|NCT04924660|521110305|FG003|Italy|Lost to Follow-up|0|||
144521896|NCT04924660|521110306|FG004|Italy|Lost to Follow-up|0|||
144521897|NCT04924660|521110307|FG005|Italy|Lost to Follow-up|1|||
144521898|NCT04924660|521110302|FG000|South Africa|Death|0|||
144521899|NCT04924660|521110303|FG001|South Africa|Death|0|||
144521900|NCT04924660|521110304|FG002|South Africa|Death|0|||
144521901|NCT04924660|521110305|FG003|South Africa|Death|0|||
144521902|NCT04924660|521110306|FG004|South Africa|Death|0|||
144521903|NCT04924660|521110307|FG005|South Africa|Death|1|||
144521904|NCT04924660|521110302|FG000|South Africa|Lost to Follow-up|0|||
144521905|NCT04924660|521110303|FG001|South Africa|Lost to Follow-up|0|||
144521906|NCT04924660|521110304|FG002|South Africa|Lost to Follow-up|0|||
144521907|NCT04924660|521110305|FG003|South Africa|Lost to Follow-up|0|||
144521908|NCT04924660|521110306|FG004|South Africa|Lost to Follow-up|0|||
144521909|NCT04924660|521110307|FG005|South Africa|Lost to Follow-up|1|||
144521910|NCT04277442|521110321|FG000|Overall Study|Death|1|||
144521911|NCT02671903|521112135|FG000|Period 0 (Run-In)|Death|0|||
144521912|NCT02671903|521112136|FG001|Period 0 (Run-In)|Death|0|||
144521913|NCT02671903|521112137|FG002|Period 0 (Run-In)|Death|3|||
144521914|NCT02671903|521112135|FG000|Period 0 (Run-In)|Physician Decision|0|||
144521915|NCT02671903|521112136|FG001|Period 0 (Run-In)|Physician Decision|0|||
144521916|NCT02671903|521112137|FG002|Period 0 (Run-In)|Physician Decision|4|||
144521917|NCT02671903|521112135|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
144521918|NCT02671903|521112136|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
144521919|NCT02671903|521112137|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
144521920|NCT02671903|521112135|FG000|Period 0 (Run-In)|Protocol Violation|0|||
144521921|NCT02671903|521112136|FG001|Period 0 (Run-In)|Protocol Violation|0|||
144521922|NCT02671903|521112137|FG002|Period 0 (Run-In)|Protocol Violation|1|||
144521923|NCT02671903|521112135|FG000|Period 0 (Run-In)|Adverse Event|0|||
144521924|NCT02671903|521112136|FG001|Period 0 (Run-In)|Adverse Event|0|||
144521925|NCT02671903|521112137|FG002|Period 0 (Run-In)|Adverse Event|1|||
144521926|NCT02671903|521112135|FG000|Period 0 (Run-In)|Implantation Failure|0|||
144521927|NCT02671903|521112136|FG001|Period 0 (Run-In)|Implantation Failure|0|||
144521928|NCT02671903|521112137|FG002|Period 0 (Run-In)|Implantation Failure|2|||
144521929|NCT02671903|521112135|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
144521930|NCT02671903|521112136|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
144521931|NCT02671903|521112137|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
144521932|NCT03376321|521112138|FG000|Overall Study|Other|5|||
144521933|NCT03376321|521112139|FG001|Overall Study|Other|1|||
144521934|NCT03376321|521112138|FG000|Overall Study|Withdrawal by Subject|8|||
144521935|NCT03376321|521112139|FG001|Overall Study|Withdrawal by Subject|14|||
144521936|NCT03376321|521112138|FG000|Overall Study|Lost to Follow-up|1|||
144521937|NCT03376321|521112139|FG001|Overall Study|Lost to Follow-up|7|||
144521938|NCT03376321|521112138|FG000|Overall Study|Death|4|||
144521939|NCT03376321|521112139|FG001|Overall Study|Death|0|||
144521940|NCT03376321|521112138|FG000|Overall Study|Randomized, not treated|5|||
144521941|NCT03376321|521112139|FG001|Overall Study|Randomized, not treated|3|||
144521942|NCT02992925|521112140|FG000|Cohort 2|Physician Decision|0|||
144521943|NCT02992925|521112141|FG001|Cohort 2|Physician Decision|0|||
144521944|NCT02992925|521112142|FG002|Cohort 2|Physician Decision|1|||
144521945|NCT02992925|521112143|FG003|Cohort 2|Physician Decision|0|||
144521946|NCT02992925|521112140|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
144521947|NCT02992925|521112141|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
144521948|NCT02992925|521112142|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
144521949|NCT02992925|521112143|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
144521950|NCT02995434|521112144|FG000|Overall Study|Adverse Event|1|||
144521951|NCT02995434|521112145|FG001|Overall Study|Adverse Event|0|||
144521952|NCT02995434|521112144|FG000|Overall Study|Withdrawal by Subject|6|||
144722328|NCT03519256|521838677|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144722329|NCT03519256|521838678|FG002|Overall Study|Participant request to discontinue study treatment|0|||
144521953|NCT02995434|521112145|FG001|Overall Study|Withdrawal by Subject|3|||
144521954|NCT05273749|521112146|FG000|Overall Study|Adverse Event|14|||
144521955|NCT05273749|521112147|FG001|Overall Study|Adverse Event|8|||
144521956|NCT05273749|521112146|FG000|Overall Study|Lack of Efficacy|2|||
144521957|NCT05273749|521112147|FG001|Overall Study|Lack of Efficacy|8|||
144521958|NCT05273749|521112146|FG000|Overall Study|Physician Decision|0|||
144722330|NCT03519256|521838679|FG003|Overall Study|Participant request to discontinue study treatment|2|||
144521959|NCT05273749|521112147|FG001|Overall Study|Physician Decision|2|||
144521960|NCT05273749|521112146|FG000|Overall Study|Withdrawal by Subject|14|||
144521961|NCT05273749|521112147|FG001|Overall Study|Withdrawal by Subject|16|||
144521962|NCT05273749|521112146|FG000|Overall Study|Lost to Follow-up|10|||
144521963|NCT05273749|521112147|FG001|Overall Study|Lost to Follow-up|10|||
144521964|NCT05273749|521112146|FG000|Overall Study|Pregnancy|1|||
144521965|NCT05273749|521112147|FG001|Overall Study|Pregnancy|0|||
144521966|NCT05273749|521112146|FG000|Overall Study|Non-Compliance|3|||
144521967|NCT05273749|521112147|FG001|Overall Study|Non-Compliance|2|||
144521968|NCT05273749|521112146|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
144521969|NCT05273749|521112147|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
144521970|NCT04806594|521112150|FG000|Overall Study|Withdrawal by Subject|2|||
144521971|NCT04806594|521112150|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
144521972|NCT02543281|521112153|FG000|Overall Study|Lost to Follow-up|0|||
144521973|NCT02543281|521112154|FG001|Overall Study|Lost to Follow-up|0|||
144521974|NCT02543281|521112155|FG002|Overall Study|Lost to Follow-up|1|||
144521975|NCT04318548|521112156|FG000|Overall Study|Adverse Event|0|||
144521976|NCT04318548|521112157|FG001|Overall Study|Adverse Event|0|||
144521977|NCT04318548|521112158|FG002|Overall Study|Adverse Event|1|||
144521978|NCT04318548|521112156|FG000|Overall Study|Lost to Follow-up|6|||
144521979|NCT04318548|521112157|FG001|Overall Study|Lost to Follow-up|13|||
144521980|NCT04318548|521112158|FG002|Overall Study|Lost to Follow-up|9|||
144521981|NCT04318548|521112156|FG000|Overall Study|Protocol Violation|1|||
144521982|NCT04318548|521112157|FG001|Overall Study|Protocol Violation|0|||
144521983|NCT04318548|521112158|FG002|Overall Study|Protocol Violation|2|||
144521984|NCT04318548|521112156|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
144521985|NCT04318548|521112157|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
144521986|NCT04318548|521112158|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
144521987|NCT04318548|521112156|FG000|Overall Study|Migrated / moved from the study area|0|||
144521988|NCT04318548|521112157|FG001|Overall Study|Migrated / moved from the study area|0|||
144521989|NCT04318548|521112158|FG002|Overall Study|Migrated / moved from the study area|1|||
144521990|NCT04318548|521112156|FG000|Overall Study|Other|1|||
144521991|NCT04318548|521112157|FG001|Overall Study|Other|2|||
144521992|NCT04318548|521112158|FG002|Overall Study|Other|3|||
144521993|NCT05247489|521112159|FG000|Overall Study|Lost to Follow-up|5|||
144521994|NCT05247489|521112160|FG001|Overall Study|Lost to Follow-up|1|||
144521995|NCT05247489|521112159|FG000|Overall Study|Withdrawal by Subject|6|||
144521996|NCT05247489|521112160|FG001|Overall Study|Withdrawal by Subject|7|||
144521997|NCT05247489|521112159|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
144521998|NCT05247489|521112160|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
144521999|NCT05247489|521112159|FG000|Overall Study|Left Country|1|||
144522000|NCT05247489|521112160|FG001|Overall Study|Left Country|0|||
144522001|NCT05247489|521112159|FG000|Overall Study|Noncompliance with Investigational Product|1|||
144522002|NCT05247489|521112160|FG001|Overall Study|Noncompliance with Investigational Product|0|||
144522003|NCT05247489|521112159|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
144522004|NCT05247489|521112160|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
144522005|NCT05215314|521112167|FG000|Overall Study|Lost to Follow-up|2|||
144522006|NCT05215314|521112168|FG001|Overall Study|Lost to Follow-up|2|||
144522007|NCT05215314|521112167|FG000|Overall Study|Withdrawal by Subject|2|||
144522008|NCT05215314|521112168|FG001|Overall Study|Withdrawal by Subject|0|||
144522009|NCT05215314|521112167|FG000|Overall Study|Physician Decision|1|||
144522010|NCT05215314|521112168|FG001|Overall Study|Physician Decision|0|||
144522011|NCT04179500|521112169|FG000|Treatment|Withdrawal by Subject|1|||
144522012|NCT04179500|521112169|FG000|Treatment|Adverse Event|2|||
144522013|NCT04179500|521112169|FG000|Treatment|pyrazinamide resistance|1|||
144522014|NCT03457142|521112174|FG000|Overall Study|Death|1|||
144522015|NCT01413100|521112175|FG000|Overall Study|Withdrawal by Subject|1|||
144522016|NCT04896476|521112186|FG000|Overall Study|Withdrawal by Subject|1|||
144522017|NCT04896476|521112186|FG000|Overall Study|Lost to Follow-up|2|||
144522018|NCT03476187|521112187|FG000|Overall Study|Protocol Violation|7|||
144522019|NCT03476187|521112187|FG000|Overall Study|Physician Decision|5|||
144522020|NCT05948670|521112189|FG000|Overall Study|Protocol Violation|6|||
144522021|NCT05948670|521112190|FG001|Overall Study|Protocol Violation|8|||
144522022|NCT05948670|521112189|FG000|Overall Study|Withdrawal by Subject|0|||
144522023|NCT05948670|521112190|FG001|Overall Study|Withdrawal by Subject|1|||
144522024|NCT05368103|521112192|FG000|Overall Study|Withdrawal by Subject|4|||
144522025|NCT05368103|521112192|FG000|Overall Study|Lost to Follow-up|1|||
144522026|NCT05368103|521112192|FG000|Overall Study|Lack of Efficacy|3|||
144522027|NCT03675282|521112195|FG000|Overall Study|Lost to Follow-up|4|||
144522028|NCT03675282|521112196|FG001|Overall Study|Lost to Follow-up|8|||
144249716|NCT00089635|520111719|FG000|Overall Study|Ineligibility determined|1|||
144522029|NCT03675282|521112197|FG002|Overall Study|Lost to Follow-up|1|||
144522030|NCT03675282|521112198|FG003|Overall Study|Lost to Follow-up|0|||
144522031|NCT03675282|521112199|FG004|Overall Study|Lost to Follow-up|2|||
144522032|NCT03675282|521112200|FG005|Overall Study|Lost to Follow-up|7|||
144522033|NCT03675282|521112195|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
144522034|NCT03675282|521112196|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
144522035|NCT03675282|521112197|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
144522036|NCT03675282|521112198|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
144722331|NCT03519256|521838676|FG000|Overall Study|Other reasons|0|||
144522037|NCT03675282|521112199|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
144522038|NCT03675282|521112200|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
144522039|NCT03675282|521112195|FG000|Overall Study|Physician Decision|1|||
144522040|NCT03675282|521112196|FG001|Overall Study|Physician Decision|0|||
144522041|NCT03675282|521112197|FG002|Overall Study|Physician Decision|0|||
144522042|NCT03675282|521112198|FG003|Overall Study|Physician Decision|0|||
144522043|NCT03675282|521112199|FG004|Overall Study|Physician Decision|0|||
144522044|NCT03675282|521112200|FG005|Overall Study|Physician Decision|0|||
144522045|NCT02677298|521112221|FG000|Double Blind Phase|Adverse Event|2|||
144522046|NCT02677298|521112222|FG001|Double Blind Phase|Adverse Event|1|||
144522047|NCT02677298|521112223|FG002|Double Blind Phase|Adverse Event|0|||
144522048|NCT02677298|521112221|FG000|Double Blind Phase|Physician Decision|5|||
144522049|NCT02677298|521112222|FG001|Double Blind Phase|Physician Decision|0|||
144522050|NCT02677298|521112223|FG002|Double Blind Phase|Physician Decision|0|||
144522051|NCT02677298|521112221|FG000|Double Blind Phase|Lost to Follow-up|11|||
144522052|NCT02677298|521112222|FG001|Double Blind Phase|Lost to Follow-up|7|||
144522053|NCT02677298|521112223|FG002|Double Blind Phase|Lost to Follow-up|0|||
144522054|NCT02677298|521112221|FG000|Double Blind Phase|Withdrawal by Subject|11|||
144522055|NCT02677298|521112222|FG001|Double Blind Phase|Withdrawal by Subject|8|||
144522056|NCT02677298|521112223|FG002|Double Blind Phase|Withdrawal by Subject|0|||
144522057|NCT02677298|521112221|FG000|Double Blind Phase|No study drug available at site|0|||
144522058|NCT02677298|521112222|FG001|Double Blind Phase|No study drug available at site|1|||
144522059|NCT02677298|521112223|FG002|Double Blind Phase|No study drug available at site|0|||
144522060|NCT02677298|521112221|FG000|Open Label Phase|Adverse Event|0|||
144522061|NCT02677298|521112222|FG001|Open Label Phase|Adverse Event|0|||
144522062|NCT02677298|521112223|FG002|Open Label Phase|Adverse Event|4|||
144522063|NCT02677298|521112221|FG000|Open Label Phase|Physician Decision|0|||
144522064|NCT02677298|521112222|FG001|Open Label Phase|Physician Decision|0|||
144522065|NCT02677298|521112223|FG002|Open Label Phase|Physician Decision|1|||
144522066|NCT02677298|521112221|FG000|Open Label Phase|Lost to Follow-up|0|||
144522067|NCT02677298|521112222|FG001|Open Label Phase|Lost to Follow-up|0|||
144522068|NCT02677298|521112223|FG002|Open Label Phase|Lost to Follow-up|17|||
144522069|NCT02677298|521112221|FG000|Open Label Phase|Withdrawal by Subject|0|||
144522070|NCT02677298|521112222|FG001|Open Label Phase|Withdrawal by Subject|0|||
144522071|NCT02677298|521112223|FG002|Open Label Phase|Withdrawal by Subject|38|||
144522072|NCT03988608|521112224|FG000|Overall Study|Adverse Event|1|||
144522073|NCT03988608|521112224|FG000|Overall Study|Lost to Follow-up|1|||
144522074|NCT03988608|521112224|FG000|Overall Study|Withdrawal by Subject|3|||
144522075|NCT03988608|521112224|FG000|Overall Study|Death|1|||
144522076|NCT03338933|521112235|FG000|Screening Visit|Lost to Follow-up|1|||
144522077|NCT03338933|521112236|FG001|Screening Visit|Lost to Follow-up|3|||
144522078|NCT03338933|521112237|FG002|Screening Visit|Lost to Follow-up|1|||
144522079|NCT03338933|521112238|FG003|Screening Visit|Lost to Follow-up|4|||
144522080|NCT03338933|521112235|FG000|Screening Visit|Screen fail after consent|2|||
144522081|NCT03338933|521112236|FG001|Screening Visit|Screen fail after consent|7|||
144522082|NCT03338933|521112237|FG002|Screening Visit|Screen fail after consent|1|||
144522083|NCT03338933|521112238|FG003|Screening Visit|Screen fail after consent|4|||
144522084|NCT03338933|521112235|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
144522085|NCT03338933|521112236|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
144522086|NCT03338933|521112237|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
144522087|NCT03338933|521112238|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
144522088|NCT03338933|521112235|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
144522089|NCT03338933|521112236|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
144522090|NCT03338933|521112237|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
144522091|NCT03338933|521112238|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
144522092|NCT03338933|521112235|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
144522093|NCT03338933|521112236|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
144522094|NCT03338933|521112237|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
144522095|NCT03338933|521112238|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
144522096|NCT00999804|521112241|FG000|Overall Study|Lack of Efficacy|9|||
144522097|NCT00999804|521112242|FG001|Overall Study|Lack of Efficacy|2|||
144522098|NCT00999804|521112241|FG000|Overall Study|Adverse Event|4|||
144522099|NCT00999804|521112242|FG001|Overall Study|Adverse Event|3|||
144522100|NCT00999804|521112241|FG000|Overall Study|Withdrawal by Subject|4|||
144522101|NCT00999804|521112242|FG001|Overall Study|Withdrawal by Subject|0|||
144522102|NCT00999804|521112241|FG000|Overall Study|Death|1|||
144522103|NCT00999804|521112242|FG001|Overall Study|Death|0|||
144522104|NCT00999804|521112241|FG000|Overall Study|Ineligible|3|||
144522105|NCT00999804|521112242|FG001|Overall Study|Ineligible|0|||
144522106|NCT04256941|521112244|FG000|Overall Study|Withdrawal by Subject|0|||
144522107|NCT04256941|521112245|FG001|Overall Study|Withdrawal by Subject|1|||
144522108|NCT04256941|521112244|FG000|Overall Study|Death|1|||
144522109|NCT04256941|521112245|FG001|Overall Study|Death|0|||
144522110|NCT04256941|521112244|FG000|Overall Study|Disease Progession|0|||
144522111|NCT04256941|521112245|FG001|Overall Study|Disease Progession|2|||
144522112|NCT04717492|521112251|FG000|Overall Study|Withdrawal by Subject|2|||
144522113|NCT04717492|521112252|FG001|Overall Study|Withdrawal by Subject|13|||
144522114|NCT04717492|521112251|FG000|Overall Study|Lost to Follow-up|2|||
144522115|NCT04717492|521112252|FG001|Overall Study|Lost to Follow-up|9|||
144522116|NCT00881621|521112254|FG000|Overall Study|Physician Decision|34|||
144522117|NCT05292365|521112260|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
144522118|NCT05292365|521112261|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
144522119|NCT05292365|521112262|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
144522120|NCT05292365|521112263|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
144522121|NCT04495894|521112267|FG000|Overall Study|Withdrawal by Subject|2|||
144522122|NCT04495894|521112268|FG001|Overall Study|Withdrawal by Subject|0|||
144522123|NCT04495894|521112269|FG002|Overall Study|Withdrawal by Subject|2|||
144522124|NCT04495894|521112270|FG003|Overall Study|Withdrawal by Subject|3|||
144522125|NCT04495894|521112267|FG000|Overall Study|Early termination|0|||
144522126|NCT04495894|521112268|FG001|Overall Study|Early termination|0|||
144522127|NCT04495894|521112269|FG002|Overall Study|Early termination|3|||
144522128|NCT04495894|521112270|FG003|Overall Study|Early termination|0|||
144522129|NCT03364647|521112271|FG000|Overall Study|Withdrawal by Subject|3|||
144522130|NCT03364647|521112272|FG001|Overall Study|Withdrawal by Subject|1|||
144522131|NCT01000961|521112273|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
144522132|NCT01000961|521112274|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144522133|NCT01000961|521112273|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
144522134|NCT01000961|521112274|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
144522135|NCT03896789|521112290|FG000|Baseline|Lost to Follow-up|1|||
144522136|NCT03896789|521112291|FG001|Baseline|Lost to Follow-up|2|||
144522137|NCT03896789|521112290|FG000|Baseline|Death|3|||
144522138|NCT03896789|521112291|FG001|Baseline|Death|6|||
144522139|NCT03896789|521112290|FG000|Post-Randomization|Lost to Follow-up|12|||
144522140|NCT03896789|521112291|FG001|Post-Randomization|Lost to Follow-up|11|||
144522141|NCT03896789|521112290|FG000|Post-Randomization|Death|12|||
144522142|NCT03896789|521112291|FG001|Post-Randomization|Death|13|||
144522143|NCT05603143|521112297|FG000|Overall Study|Withdrew consent|6|||
144522144|NCT05603143|521112298|FG001|Overall Study|Withdrew consent|2|||
144522145|NCT05603143|521112297|FG000|Overall Study|Randomized but never treated|0|||
144522146|NCT05603143|521112298|FG001|Overall Study|Randomized but never treated|3|||
144522147|NCT05603143|521112297|FG000|Overall Study|Adverse Event|2|||
144522148|NCT05603143|521112298|FG001|Overall Study|Adverse Event|0|||
144522149|NCT05603143|521112297|FG000|Overall Study|Death|0|||
144522150|NCT05603143|521112298|FG001|Overall Study|Death|1|||
144522151|NCT05603143|521112297|FG000|Overall Study|Investigator's discretion|1|||
144522152|NCT05603143|521112298|FG001|Overall Study|Investigator's discretion|0|||
144522153|NCT05603143|521112297|FG000|Overall Study|Lost to Follow-up|0|||
144522154|NCT05603143|521112298|FG001|Overall Study|Lost to Follow-up|1|||
144522155|NCT05603143|521112297|FG000|Overall Study|Protocol Violation|0|||
144522156|NCT05603143|521112298|FG001|Overall Study|Protocol Violation|1|||
144522157|NCT05084508|521112299|FG000|Overall Study|Lost to Follow-up|6|||
144522158|NCT05084508|521112300|FG001|Overall Study|Lost to Follow-up|3|||
144522159|NCT05084508|521112301|FG002|Overall Study|Lost to Follow-up|7|||
144522160|NCT05084508|521112302|FG003|Overall Study|Lost to Follow-up|3|||
144522161|NCT05084508|521112299|FG000|Overall Study|Withdrawal by Subject|0|||
144522162|NCT05084508|521112300|FG001|Overall Study|Withdrawal by Subject|2|||
144522163|NCT05084508|521112301|FG002|Overall Study|Withdrawal by Subject|3|||
144522164|NCT05084508|521112302|FG003|Overall Study|Withdrawal by Subject|1|||
144522165|NCT05084508|521112299|FG000|Overall Study|Other|0|||
144522166|NCT05084508|521112300|FG001|Overall Study|Other|0|||
144522167|NCT05084508|521112301|FG002|Overall Study|Other|0|||
144522168|NCT05084508|521112302|FG003|Overall Study|Other|1|||
144522169|NCT05302596|521112303|FG000|Overall Study|Withdrawal by Subject|1|||
144522170|NCT05302596|521112304|FG001|Overall Study|Withdrawal by Subject|1|||
144522171|NCT04353661|521114805|FG000|Overall Study|Protocol Violation|0|||
144522172|NCT04353661|521114806|FG001|Overall Study|Protocol Violation|0|||
144522173|NCT04353661|521114807|FG002|Overall Study|Protocol Violation|1|||
144522174|NCT04353661|521114805|FG000|Overall Study|Study termination by the Sponsor|1|||
144522175|NCT04353661|521114806|FG001|Overall Study|Study termination by the Sponsor|1|||
144522176|NCT04353661|521114807|FG002|Overall Study|Study termination by the Sponsor|1|||
144522177|NCT00667251|521114808|FG000|Overall Study|Disease progression|232|||
144522178|NCT00667251|521114809|FG001|Overall Study|Disease progression|203|||
144522179|NCT00667251|521114808|FG000|Overall Study|Toxicity|44|||
144522180|NCT00667251|521114809|FG001|Overall Study|Toxicity|23|||
144522181|NCT00667251|521114808|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
144595935|NCT05269355|521381241|FG001|Overall Study|Withdrawal by Subject|5|||
144595936|NCT05269355|521381240|FG000|Overall Study|Physician Decision|6|||
144595937|NCT05269355|521381241|FG001|Overall Study|Physician Decision|4|||
144595938|NCT05269355|521381240|FG000|Overall Study|Death|3|||
144595939|NCT05269355|521381241|FG001|Overall Study|Death|5|||
144595940|NCT05269355|521381240|FG000|Overall Study|Other Than Specified|5|||
144595941|NCT05269355|521381241|FG001|Overall Study|Other Than Specified|1|||
144595942|NCT05269355|521381240|FG000|Overall Study|Randomized But Not Treated|1|||
144595943|NCT05269355|521381241|FG001|Overall Study|Randomized But Not Treated|0|||
144595944|NCT01050790|521381242|FG000|Overall Study|Adverse Event|1|||
144595945|NCT03705832|521381243|FG000|Overall Study|Physician Decision|0|||
144595946|NCT03705832|521381244|FG001|Overall Study|Physician Decision|1|||
144595947|NCT03705832|521381243|FG000|Overall Study|Withdrawal by Subject|1|||
144595948|NCT03705832|521381244|FG001|Overall Study|Withdrawal by Subject|0|||
144595949|NCT01880528|521381245|FG000|Overall Study|Other|1|||
144595950|NCT01880528|521381246|FG001|Overall Study|Other|1|||
144595951|NCT00081497|521381247|FG000|Overall Study|Adverse Event|2|||
144595952|NCT00081497|521381248|FG001|Overall Study|Adverse Event|0|||
144595953|NCT00081497|521381247|FG000|Overall Study|Death|0|||
144595954|NCT00081497|521381248|FG001|Overall Study|Death|1|||
144595955|NCT00081497|521381247|FG000|Overall Study|Withdrawal by Subject|1|||
144595956|NCT00081497|521381248|FG001|Overall Study|Withdrawal by Subject|0|||
144595957|NCT00081497|521381247|FG000|Overall Study|Non-compliance|0|||
144595958|NCT00081497|521381248|FG001|Overall Study|Non-compliance|1|||
144595959|NCT00959647|521381249|FG000|Overall Study|Adverse Event|2|||
144595960|NCT00959647|521381249|FG000|Overall Study|Progressive disease|6|||
144595961|NCT00959647|521381249|FG000|Overall Study|Study terminated by sponsor|4|||
144595962|NCT00959647|521381249|FG000|Overall Study|Withdrawal by Subject|7|||
144595963|NCT02768870|521382534|FG000|Overall Study|Death|1|||
144595964|NCT02768870|521382534|FG000|Overall Study|Reoperation|6|||
144595965|NCT02768870|521382534|FG000|Overall Study|Lost to Follow-up|1|||
144595966|NCT02768870|521382534|FG000|Overall Study|Exit|4|||
144595967|NCT01774110|521382535|FG000|Overall Study|Lost to Follow-up|7|||
144595968|NCT01776424|521382536|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
144595969|NCT01776424|521382537|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
144595970|NCT01776424|521382538|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
144595971|NCT01776424|521382536|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
144595972|NCT01776424|521382537|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
144595973|NCT01776424|521382538|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
144595974|NCT01776424|521382536|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
144595975|NCT01776424|521382537|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
144595976|NCT01776424|521382538|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
144595977|NCT01776424|521382536|FG000|LTOLE Part (Open Label)|Refused|5|||
144595978|NCT01776424|521382537|FG001|LTOLE Part (Open Label)|Refused|2|||
144595979|NCT01776424|521382538|FG002|LTOLE Part (Open Label)|Refused|11|||
144595980|NCT01776424|521382536|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
144595981|NCT01776424|521382537|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
144595982|NCT01776424|521382538|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
144595983|NCT02075541|521382543|FG000|Overall Study|Serious Adverse Event|1|||
144595984|NCT02075541|521382544|FG001|Overall Study|Serious Adverse Event|4|||
144595985|NCT02075541|521382543|FG000|Overall Study|Protocol Violation|1|||
144595986|NCT02075541|521382544|FG001|Overall Study|Protocol Violation|0|||
144595987|NCT02075541|521382543|FG000|Overall Study|Withdrawal by Subject|1|||
144595988|NCT02075541|521382544|FG001|Overall Study|Withdrawal by Subject|3|||
144595989|NCT02075541|521382543|FG000|Overall Study|Sponsor study termination|0|||
144595990|NCT02075541|521382544|FG001|Overall Study|Sponsor study termination|1|||
144595991|NCT02075541|521382543|FG000|Overall Study|Other- unable to perform study procedure|1|||
144595992|NCT02075541|521382544|FG001|Overall Study|Other- unable to perform study procedure|0|||
144595993|NCT02019927|521382548|FG000|Overall Study|Lost to Follow-up|2|||
144595994|NCT02019927|521382549|FG001|Overall Study|Lost to Follow-up|4|||
144595995|NCT02019927|521382550|FG002|Overall Study|Lost to Follow-up|1|||
144595996|NCT02019927|521382551|FG003|Overall Study|Lost to Follow-up|2|||
144595997|NCT02019927|521382552|FG004|Overall Study|Lost to Follow-up|3|||
144595998|NCT02019927|521382553|FG005|Overall Study|Lost to Follow-up|1|||
144595999|NCT01054846|521382554|FG000|Overall Study|Lost to Follow-up|76|||
144596000|NCT01054846|521382555|FG001|Overall Study|Lost to Follow-up|17|||
144596001|NCT00394953|521382558|FG000|First Treatment Period|Adverse Event|1|||
144596002|NCT00394953|521382559|FG001|First Treatment Period|Adverse Event|2|||
144596003|NCT00394953|521382558|FG000|First Treatment Period|Death|6|||
144596004|NCT00394953|521382559|FG001|First Treatment Period|Death|7|||
144596005|NCT00394953|521382558|FG000|First Treatment Period|Lack of Efficacy|1|||
144399504|NCT00313300|520674621|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
144399505|NCT00313300|520674622|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
144399506|NCT00313300|520674623|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
144399507|NCT00313300|520674619|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
144399508|NCT00313300|520674620|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
144399509|NCT00313300|520674621|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
144522182|NCT00667251|521114809|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
144522183|NCT00667251|521114808|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
144522184|NCT00667251|521114809|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
144522185|NCT00667251|521114808|FG000|Overall Study|Symptomatic progression|8|||
144522186|NCT00667251|521114809|FG001|Overall Study|Symptomatic progression|4|||
144522187|NCT00667251|521114808|FG000|Overall Study|Death|6|||
144522188|NCT00667251|521114809|FG001|Overall Study|Death|11|||
144522189|NCT00667251|521114808|FG000|Overall Study|Intercurrent illness|5|||
144522190|NCT00667251|521114809|FG001|Overall Study|Intercurrent illness|6|||
144522191|NCT00667251|521114808|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
144522192|NCT00667251|521114809|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
144522193|NCT00667251|521114808|FG000|Overall Study|Randomized not Treated|4|||
144522194|NCT00667251|521114809|FG001|Overall Study|Randomized not Treated|1|||
144522195|NCT02727699|521114811|FG000|Overall Study|Adverse Event|2|||
144522196|NCT02727699|521114812|FG001|Overall Study|Adverse Event|0|||
144522197|NCT02727699|521114811|FG000|Overall Study|Withdrawal by Subject|5|||
144522198|NCT02727699|521114812|FG001|Overall Study|Withdrawal by Subject|3|||
144522199|NCT02727699|521114811|FG000|Overall Study|Protocol Violation|0|||
144522200|NCT02727699|521114812|FG001|Overall Study|Protocol Violation|1|||
144522201|NCT02727699|521114811|FG000|Overall Study|Physician Decision|0|||
144522202|NCT02727699|521114812|FG001|Overall Study|Physician Decision|1|||
144522203|NCT02727699|521114811|FG000|Overall Study|Lost to Follow-up|1|||
144522204|NCT02727699|521114812|FG001|Overall Study|Lost to Follow-up|0|||
144522205|NCT02727699|521114811|FG000|Overall Study|Sponsor Decision|1|||
144522206|NCT02727699|521114812|FG001|Overall Study|Sponsor Decision|0|||
144522207|NCT02921230|521114813|FG000|Overall Study|Withdrawal by Subject|20|||
144522208|NCT02921230|521114814|FG001|Overall Study|Withdrawal by Subject|8|||
144522209|NCT02921230|521114813|FG000|Overall Study|Death|12|||
144522210|NCT02921230|521114814|FG001|Overall Study|Death|3|||
144522211|NCT02921230|521114813|FG000|Overall Study|Protocol Violation|17|||
144522212|NCT02921230|521114814|FG001|Overall Study|Protocol Violation|6|||
144522213|NCT02921230|521114813|FG000|Overall Study|Early completion|5|||
144522214|NCT02921230|521114814|FG001|Overall Study|Early completion|1|||
144522215|NCT02921230|521114813|FG000|Overall Study|Pending data entry|1|||
144522216|NCT02921230|521114814|FG001|Overall Study|Pending data entry|0|||
144522217|NCT04977947|521114815|FG000|Overall Study|Lost to Follow-up|1|||
144522218|NCT04977947|521114816|FG001|Overall Study|Lost to Follow-up|1|||
144522219|NCT05875142|521114817|FG000|Overall Study|Lost to Follow-up|0|||
144522220|NCT05875142|521114818|FG001|Overall Study|Lost to Follow-up|1|||
144522221|NCT05875142|521114819|FG002|Overall Study|Lost to Follow-up|1|||
144522222|NCT03436290|521114820|FG000|Overall Study|Post-randomization Exclusion|1|||
144522223|NCT03436290|521114821|FG001|Overall Study|Post-randomization Exclusion|0|||
144522224|NCT03436290|521114820|FG000|Overall Study|Death|6|||
144522225|NCT03436290|521114821|FG001|Overall Study|Death|0|||
144522226|NCT03436290|521114820|FG000|Overall Study|Withdrawal by Subject|4|||
144522227|NCT03436290|521114821|FG001|Overall Study|Withdrawal by Subject|0|||
144522228|NCT03436290|521114820|FG000|Overall Study|Protocol Violation|30|||
144522229|NCT03436290|521114821|FG001|Overall Study|Protocol Violation|0|||
144522230|NCT05486078|521114829|FG000|Overall Study|4 drop out and one withdrawn|5|||
144522231|NCT02908477|521114841|FG000|Overall Study|Withdrawal by Subject|8|||
144522232|NCT02908477|521114842|FG001|Overall Study|Withdrawal by Subject|28|||
144522233|NCT03766009|521114845|FG000|Usual Care|Death|0|||
144522234|NCT03766009|521114846|FG001|Usual Care|Death|0|||
144522235|NCT03766009|521114847|FG002|Usual Care|Death|0|||
144522236|NCT03766009|521114848|FG003|Usual Care|Death|1|||
144522237|NCT03766009|521114849|FG004|Usual Care|Death|0|||
144522238|NCT03766009|521114850|FG005|Usual Care|Death|0|||
144399510|NCT00313300|520674622|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
144522239|NCT03766009|521114845|FG000|Usual Care|Lost to Follow-up|0|||
144522240|NCT03766009|521114846|FG001|Usual Care|Lost to Follow-up|0|||
144522241|NCT03766009|521114847|FG002|Usual Care|Lost to Follow-up|0|||
144522242|NCT03766009|521114848|FG003|Usual Care|Lost to Follow-up|1|||
144522243|NCT03766009|521114849|FG004|Usual Care|Lost to Follow-up|0|||
144522244|NCT03766009|521114850|FG005|Usual Care|Lost to Follow-up|0|||
144522245|NCT03766009|521114845|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
144522246|NCT03766009|521114846|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
144522247|NCT03766009|521114847|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
144522248|NCT03766009|521114848|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
144522249|NCT03766009|521114849|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
144522250|NCT03766009|521114850|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
144249717|NCT00089635|520111719|FG000|Overall Study|Other|2|||
144249718|NCT02603107|520111720|FG000|Randomized Phase|Withdrew consent|8|||
144249719|NCT02603107|520111721|FG001|Randomized Phase|Withdrew consent|15|||
144722332|NCT03519256|521838677|FG001|Overall Study|Other reasons|0|||
144249720|NCT02603107|520111720|FG000|Randomized Phase|Lost to Follow-up|1|||
144249721|NCT02603107|520111721|FG001|Randomized Phase|Lost to Follow-up|3|||
144249722|NCT02603107|520111720|FG000|Randomized Phase|Adverse Event|2|||
144249723|NCT02603107|520111721|FG001|Randomized Phase|Adverse Event|0|||
144471866|NCT02597036|520925327|FG001|Overall Study|Lost to Follow-up|0|||
144249724|NCT02603107|520111720|FG000|Randomized Phase|Death|1|||
144471867|NCT02597036|520925328|FG002|Overall Study|Lost to Follow-up|0|||
144471868|NCT02597036|520925329|FG003|Overall Study|Lost to Follow-up|0|||
144471869|NCT02597036|520925330|FG004|Overall Study|Lost to Follow-up|0|||
144471870|NCT02597036|520925331|FG005|Overall Study|Lost to Follow-up|0|||
144471871|NCT02597036|520925332|FG006|Overall Study|Lost to Follow-up|0|||
144471872|NCT02597036|520925333|FG007|Overall Study|Lost to Follow-up|0|||
144471873|NCT02597036|520925334|FG008|Overall Study|Lost to Follow-up|0|||
144471874|NCT02597036|520925335|FG009|Overall Study|Lost to Follow-up|0|||
144471875|NCT02597036|520925336|FG010|Overall Study|Lost to Follow-up|1|||
144471876|NCT02597036|520925337|FG011|Overall Study|Lost to Follow-up|0|||
144471877|NCT02597036|520925326|FG000|Overall Study|Withdrawal by Subject|0|||
144471878|NCT02597036|520925327|FG001|Overall Study|Withdrawal by Subject|0|||
144471879|NCT02597036|520925328|FG002|Overall Study|Withdrawal by Subject|0|||
144471880|NCT02597036|520925329|FG003|Overall Study|Withdrawal by Subject|0|||
144471881|NCT02597036|520925330|FG004|Overall Study|Withdrawal by Subject|0|||
144471882|NCT02597036|520925331|FG005|Overall Study|Withdrawal by Subject|0|||
144471883|NCT02597036|520925332|FG006|Overall Study|Withdrawal by Subject|0|||
144471884|NCT02597036|520925333|FG007|Overall Study|Withdrawal by Subject|0|||
144471885|NCT02597036|520925334|FG008|Overall Study|Withdrawal by Subject|0|||
144471886|NCT02597036|520925335|FG009|Overall Study|Withdrawal by Subject|0|||
144471887|NCT02597036|520925336|FG010|Overall Study|Withdrawal by Subject|0|||
144471888|NCT02597036|520925337|FG011|Overall Study|Withdrawal by Subject|1|||
144471889|NCT06351371|520925338|FG000|Overall Study|Mutation Status Not Confirmed|9|||
144471890|NCT06351371|520925338|FG000|Overall Study|Ineligible|1|||
144471891|NCT06351371|520925338|FG000|Overall Study|Adverse Event|4|||
144471892|NCT06351371|520925338|FG000|Overall Study|Death|1|||
144471893|NCT06351371|520925338|FG000|Overall Study|Disease progression|14|||
144471894|NCT06351371|520925338|FG000|Overall Study|Withdrawal by Subject|3|||
144471895|NCT06351371|520925338|FG000|Overall Study|Physician Decision|3|||
144471896|NCT05614089|520925339|FG000|Overall Study|Pregnancy|5|||
144471897|NCT05614089|520925340|FG001|Overall Study|Pregnancy|2|||
144471898|NCT05614089|520925339|FG000|Overall Study|Lost to Follow-up|5|||
144471899|NCT05614089|520925340|FG001|Overall Study|Lost to Follow-up|1|||
144471900|NCT05614089|520925339|FG000|Overall Study|Death|0|||
144471901|NCT05614089|520925340|FG001|Overall Study|Death|1|||
144471902|NCT05614089|520925339|FG000|Overall Study|Adverse Event|1|||
144471903|NCT05614089|520925340|FG001|Overall Study|Adverse Event|0|||
144471904|NCT05701995|520925343|FG000|Pre-Treatment|Randomization Error|1|||
144471905|NCT05701995|520925344|FG001|Pre-Treatment|Randomization Error|1|||
144471906|NCT05701995|520925343|FG000|Treatment|Withdrawal by Subject|8|||
144471907|NCT05701995|520925344|FG001|Treatment|Withdrawal by Subject|4|||
144471908|NCT05701995|520925343|FG000|Treatment|Lost to Follow-up|2|||
144471909|NCT05701995|520925344|FG001|Treatment|Lost to Follow-up|3|||
144471910|NCT05701995|520925343|FG000|Treatment|Adverse Event|3|||
144471911|NCT05701995|520925344|FG001|Treatment|Adverse Event|1|||
144471912|NCT05701995|520925343|FG000|Treatment|Other Reason|1|||
144471913|NCT05701995|520925344|FG001|Treatment|Other Reason|1|||
144471914|NCT05701995|520925343|FG000|Treatment|Death|1|||
144471915|NCT05701995|520925344|FG001|Treatment|Death|0|||
144471916|NCT05701995|520925343|FG000|Treatment|Physician Decision|0|||
144471917|NCT05701995|520925344|FG001|Treatment|Physician Decision|1|||
144471918|NCT04359784|520925345|FG000|Overall Study|Death|2|||
144471919|NCT03937219|520925349|FG000|Overall Study|Death|223|||
144471920|NCT03937219|520925350|FG001|Overall Study|Death|211|||
144471921|NCT03937219|520925349|FG000|Overall Study|Withdrawal by Subject|17|||
144471922|NCT03937219|520925350|FG001|Overall Study|Withdrawal by Subject|25|||
144471923|NCT03937219|520925349|FG000|Overall Study|Lost to Follow-up|3|||
144471924|NCT03937219|520925350|FG001|Overall Study|Lost to Follow-up|4|||
144471925|NCT03217747|520925353|FG000|Overall Study|Adverse Event|0|||
144471926|NCT03217747|520925354|FG001|Overall Study|Adverse Event|1|||
144471927|NCT03217747|520925355|FG002|Overall Study|Adverse Event|0|||
144471928|NCT03217747|520925356|FG003|Overall Study|Adverse Event|0|||
144471929|NCT03217747|520925357|FG004|Overall Study|Adverse Event|0|||
144471930|NCT03217747|520925358|FG005|Overall Study|Adverse Event|0|||
144471931|NCT03217747|520925359|FG006|Overall Study|Adverse Event|0|||
144471932|NCT03217747|520925360|FG007|Overall Study|Adverse Event|0|||
144471933|NCT03217747|520925361|FG008|Overall Study|Adverse Event|0|||
144471934|NCT03217747|520925362|FG009|Overall Study|Adverse Event|0|||
144471935|NCT03217747|520925363|FG010|Overall Study|Adverse Event|0|||
144522251|NCT03766009|521114845|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
144522252|NCT03766009|521114846|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
144522253|NCT03766009|521114847|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
144522254|NCT03766009|521114848|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
144522255|NCT03766009|521114849|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
144522256|NCT03766009|521114850|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
144522257|NCT03766009|521114845|FG000|Usual Care|No treatment or declined surgery|0|||
144522258|NCT03766009|521114846|FG001|Usual Care|No treatment or declined surgery|0|||
144522259|NCT03766009|521114847|FG002|Usual Care|No treatment or declined surgery|0|||
144522260|NCT03766009|521114848|FG003|Usual Care|No treatment or declined surgery|2|||
144522261|NCT03766009|521114849|FG004|Usual Care|No treatment or declined surgery|0|||
144522262|NCT03766009|521114850|FG005|Usual Care|No treatment or declined surgery|0|||
144522263|NCT03766009|521114845|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
144522264|NCT03766009|521114846|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
144522265|NCT03766009|521114847|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
144522266|NCT03766009|521114848|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
144522267|NCT03766009|521114849|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
144522268|NCT03766009|521114850|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
144522269|NCT03766009|521114845|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
144522270|NCT03766009|521114846|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
144522271|NCT03766009|521114847|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
144522272|NCT03766009|521114848|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
144522273|NCT03766009|521114849|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
144522274|NCT03766009|521114850|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
144522275|NCT03766009|521114845|FG000|Usual Care|Ineligible|0|||
144522276|NCT03766009|521114846|FG001|Usual Care|Ineligible|1|||
144522277|NCT03766009|521114847|FG002|Usual Care|Ineligible|0|||
144522278|NCT03766009|521114848|FG003|Usual Care|Ineligible|0|||
144522279|NCT03766009|521114849|FG004|Usual Care|Ineligible|0|||
144522280|NCT03766009|521114850|FG005|Usual Care|Ineligible|0|||
144522281|NCT03766009|521114845|FG000|Usual Care|Other: Staff turnover|0|||
144522282|NCT03766009|521114846|FG001|Usual Care|Other: Staff turnover|0|||
144522283|NCT03766009|521114847|FG002|Usual Care|Other: Staff turnover|0|||
144522284|NCT03766009|521114848|FG003|Usual Care|Other: Staff turnover|0|||
144522285|NCT03766009|521114849|FG004|Usual Care|Other: Staff turnover|0|||
144522286|NCT03766009|521114850|FG005|Usual Care|Other: Staff turnover|2|||
144522287|NCT03150810|521114855|FG000|Overall Study|Death|4|||
144522288|NCT03150810|521114856|FG001|Overall Study|Death|8|||
144522289|NCT03150810|521114857|FG002|Overall Study|Death|7|||
144522290|NCT03150810|521114858|FG003|Overall Study|Death|2|||
144522291|NCT03150810|521114859|FG004|Overall Study|Death|2|||
144522292|NCT03150810|521114860|FG005|Overall Study|Death|10|||
144522293|NCT03150810|521114861|FG006|Overall Study|Death|8|||
144522294|NCT03150810|521114862|FG007|Overall Study|Death|6|||
144522295|NCT03150810|521114863|FG008|Overall Study|Death|18|||
144522296|NCT03150810|521114864|FG009|Overall Study|Death|3|||
144522297|NCT03150810|521114865|FG010|Overall Study|Death|19|||
144522298|NCT03150810|521114866|FG011|Overall Study|Death|1|||
144522299|NCT03150810|521114867|FG012|Overall Study|Death|19|||
144522300|NCT03150810|521114855|FG000|Overall Study|Withdrawal by Subject|0|||
144522301|NCT03150810|521114856|FG001|Overall Study|Withdrawal by Subject|1|||
144522302|NCT03150810|521114857|FG002|Overall Study|Withdrawal by Subject|1|||
144522303|NCT03150810|521114858|FG003|Overall Study|Withdrawal by Subject|1|||
144522304|NCT03150810|521114859|FG004|Overall Study|Withdrawal by Subject|0|||
144522305|NCT03150810|521114860|FG005|Overall Study|Withdrawal by Subject|0|||
144522306|NCT03150810|521114861|FG006|Overall Study|Withdrawal by Subject|2|||
144522307|NCT03150810|521114862|FG007|Overall Study|Withdrawal by Subject|0|||
144522308|NCT03150810|521114863|FG008|Overall Study|Withdrawal by Subject|2|||
144522309|NCT03150810|521114864|FG009|Overall Study|Withdrawal by Subject|0|||
144522310|NCT03150810|521114865|FG010|Overall Study|Withdrawal by Subject|1|||
144522311|NCT03150810|521114866|FG011|Overall Study|Withdrawal by Subject|0|||
144722333|NCT03519256|521838678|FG002|Overall Study|Other reasons|2|||
144722334|NCT03519256|521838679|FG003|Overall Study|Other reasons|0|||
144722335|NCT03519256|521838676|FG000|Overall Study|Disease progression|6|||
144522312|NCT03150810|521114867|FG012|Overall Study|Withdrawal by Subject|1|||
144522313|NCT03150810|521114855|FG000|Overall Study|Sponsor Decision|0|||
144522314|NCT03150810|521114856|FG001|Overall Study|Sponsor Decision|2|||
144522315|NCT03150810|521114857|FG002|Overall Study|Sponsor Decision|0|||
144522316|NCT03150810|521114858|FG003|Overall Study|Sponsor Decision|0|||
144522317|NCT03150810|521114859|FG004|Overall Study|Sponsor Decision|1|||
144522318|NCT03150810|521114860|FG005|Overall Study|Sponsor Decision|1|||
144522319|NCT03150810|521114861|FG006|Overall Study|Sponsor Decision|0|||
144722336|NCT03519256|521838677|FG001|Overall Study|Disease progression|3|||
144596006|NCT00394953|521382559|FG001|First Treatment Period|Lack of Efficacy|1|||
144596007|NCT00394953|521382558|FG000|First Treatment Period|Withdrawal by Subject|6|||
144596008|NCT00394953|521382559|FG001|First Treatment Period|Withdrawal by Subject|3|||
144596009|NCT00394953|521382558|FG000|First Treatment Period|Lost to Follow-up|0|||
144596010|NCT00394953|521382559|FG001|First Treatment Period|Lost to Follow-up|1|||
144596011|NCT00394953|521382558|FG000|First Treatment Period|Renal transplant|11|||
144596012|NCT00394953|521382559|FG001|First Treatment Period|Renal transplant|7|||
144596013|NCT00394953|521382558|FG000|First Treatment Period|Not defined|4|||
144596014|NCT00394953|521382559|FG001|First Treatment Period|Not defined|1|||
144596015|NCT00394953|521382558|FG000|Second Treatment Period|Adverse Event|2|||
144596016|NCT00394953|521382559|FG001|Second Treatment Period|Adverse Event|5|||
144596017|NCT00394953|521382558|FG000|Second Treatment Period|Death|8|||
144596018|NCT00394953|521382559|FG001|Second Treatment Period|Death|4|||
144596019|NCT00394953|521382558|FG000|Second Treatment Period|Lack of Efficacy|9|||
144596020|NCT00394953|521382559|FG001|Second Treatment Period|Lack of Efficacy|47|||
144596021|NCT00394953|521382558|FG000|Second Treatment Period|Withdrawal by Subject|3|||
144596022|NCT00394953|521382559|FG001|Second Treatment Period|Withdrawal by Subject|3|||
144596023|NCT00394953|521382558|FG000|Second Treatment Period|Lost to Follow-up|0|||
144596024|NCT00394953|521382559|FG001|Second Treatment Period|Lost to Follow-up|1|||
144596025|NCT00394953|521382558|FG000|Second Treatment Period|Renal transplant|4|||
144596026|NCT00394953|521382559|FG001|Second Treatment Period|Renal transplant|6|||
144596027|NCT00394953|521382558|FG000|Second Treatment Period|Not defined|3|||
144596028|NCT00394953|521382559|FG001|Second Treatment Period|Not defined|8|||
144596029|NCT00928447|521382566|FG000|Overall Study|Withdrawal by Subject|1|||
144596030|NCT00928447|521382566|FG000|Overall Study|Investigator's decision|1|||
144596031|NCT01259284|521382569|FG000|Overall Study|Study Termination|2|||
144596032|NCT01259284|521382570|FG001|Overall Study|Study Termination|0|||
144596033|NCT01259284|521382571|FG002|Overall Study|Study Termination|0|||
144596034|NCT01592864|521382580|FG000|Overall Study|Withdrawal by Subject|0|||
144596035|NCT01592864|521382581|FG001|Overall Study|Withdrawal by Subject|1|||
144596036|NCT03353350|521382583|FG000|30-week Core Treatment Period|Protocol Violation|1|||
144596037|NCT03353350|521382584|FG001|30-week Core Treatment Period|Protocol Violation|1|||
144596038|NCT03353350|521382585|FG002|30-week Core Treatment Period|Protocol Violation|1|||
144596039|NCT03353350|521382586|FG003|30-week Core Treatment Period|Protocol Violation|0|||
144596040|NCT03353350|521382583|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
144596041|NCT03353350|521382584|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
144596042|NCT03353350|521382585|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
144596043|NCT03353350|521382586|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
144596044|NCT03353350|521382583|FG000|30-week Core Treatment Period|Adverse Event|0|||
144596045|NCT03353350|521382584|FG001|30-week Core Treatment Period|Adverse Event|4|||
144596046|NCT03353350|521382585|FG002|30-week Core Treatment Period|Adverse Event|2|||
144596047|NCT03353350|521382586|FG003|30-week Core Treatment Period|Adverse Event|3|||
144596048|NCT03353350|521382583|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
144596049|NCT03353350|521382584|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
144596050|NCT03353350|521382585|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
144596051|NCT03353350|521382586|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
144596052|NCT03353350|521382583|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
144596053|NCT03353350|521382584|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
144596054|NCT03353350|521382585|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
144596055|NCT03353350|521382586|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
144596056|NCT03353350|521382583|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
144596057|NCT03353350|521382584|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
144596058|NCT03353350|521382585|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
144596059|NCT03353350|521382586|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
144596060|NCT03353350|521382583|FG000|26-week Treatment Extension Period|Adverse Event|1|||
144596061|NCT03353350|521382584|FG001|26-week Treatment Extension Period|Adverse Event|0|||
144596062|NCT03353350|521382585|FG002|26-week Treatment Extension Period|Adverse Event|0|||
144471936|NCT03217747|520925364|FG011|Overall Study|Adverse Event|0|||
144596063|NCT03353350|521382586|FG003|26-week Treatment Extension Period|Adverse Event|1|||
144596064|NCT03353350|521382583|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
144596065|NCT03353350|521382584|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
144596066|NCT03353350|521382585|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
144596067|NCT03353350|521382586|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
144596068|NCT03037619|521382587|FG000|Overall Study|Lost to Follow-up|0|||
144596069|NCT03037619|521382588|FG001|Overall Study|Lost to Follow-up|1|||
144596070|NCT01881750|521382595|FG000|Overall Study|Changes in concomitant therapies|2|||
144596071|NCT01881750|521382596|FG001|Overall Study|Changes in concomitant therapies|3|||
144596072|NCT01881750|521382595|FG000|Overall Study|Lost to Follow-up|0|||
144596073|NCT01881750|521382596|FG001|Overall Study|Lost to Follow-up|1|||
144596074|NCT00985153|521382597|FG000|Overall Study|Lost to Follow-up|16|||
144522320|NCT03150810|521114862|FG007|Overall Study|Sponsor Decision|0|||
144522321|NCT03150810|521114863|FG008|Overall Study|Sponsor Decision|1|||
144522322|NCT03150810|521114864|FG009|Overall Study|Sponsor Decision|0|||
144522323|NCT03150810|521114865|FG010|Overall Study|Sponsor Decision|0|||
144522324|NCT03150810|521114866|FG011|Overall Study|Sponsor Decision|0|||
144522325|NCT03150810|521114867|FG012|Overall Study|Sponsor Decision|5|||
144522326|NCT03150810|521114855|FG000|Overall Study|Lost to Follow-up|0|||
144522327|NCT03150810|521114856|FG001|Overall Study|Lost to Follow-up|1|||
144522328|NCT03150810|521114857|FG002|Overall Study|Lost to Follow-up|1|||
144522329|NCT03150810|521114858|FG003|Overall Study|Lost to Follow-up|0|||
144522330|NCT03150810|521114859|FG004|Overall Study|Lost to Follow-up|0|||
144522331|NCT03150810|521114860|FG005|Overall Study|Lost to Follow-up|0|||
144522332|NCT03150810|521114861|FG006|Overall Study|Lost to Follow-up|1|||
144522333|NCT03150810|521114862|FG007|Overall Study|Lost to Follow-up|0|||
144522334|NCT03150810|521114863|FG008|Overall Study|Lost to Follow-up|0|||
144522335|NCT03150810|521114864|FG009|Overall Study|Lost to Follow-up|0|||
144522336|NCT03150810|521114865|FG010|Overall Study|Lost to Follow-up|1|||
144522337|NCT03150810|521114866|FG011|Overall Study|Lost to Follow-up|0|||
144522338|NCT03150810|521114867|FG012|Overall Study|Lost to Follow-up|0|||
144522339|NCT03150810|521114855|FG000|Overall Study|Physician Decision|0|||
144522340|NCT03150810|521114856|FG001|Overall Study|Physician Decision|0|||
144522341|NCT03150810|521114857|FG002|Overall Study|Physician Decision|0|||
144522342|NCT03150810|521114858|FG003|Overall Study|Physician Decision|0|||
144522343|NCT03150810|521114859|FG004|Overall Study|Physician Decision|0|||
144522344|NCT03150810|521114860|FG005|Overall Study|Physician Decision|1|||
144522345|NCT03150810|521114861|FG006|Overall Study|Physician Decision|1|||
144522346|NCT03150810|521114862|FG007|Overall Study|Physician Decision|0|||
144522347|NCT03150810|521114863|FG008|Overall Study|Physician Decision|0|||
144522348|NCT03150810|521114864|FG009|Overall Study|Physician Decision|0|||
144522349|NCT03150810|521114865|FG010|Overall Study|Physician Decision|0|||
144522350|NCT03150810|521114866|FG011|Overall Study|Physician Decision|0|||
144522351|NCT03150810|521114867|FG012|Overall Study|Physician Decision|0|||
144522352|NCT03150810|521114855|FG000|Overall Study|Site withdrawal from study|0|||
144522353|NCT03150810|521114856|FG001|Overall Study|Site withdrawal from study|1|||
144522354|NCT03150810|521114857|FG002|Overall Study|Site withdrawal from study|0|||
144522355|NCT03150810|521114858|FG003|Overall Study|Site withdrawal from study|0|||
144522356|NCT03150810|521114859|FG004|Overall Study|Site withdrawal from study|0|||
144522357|NCT03150810|521114860|FG005|Overall Study|Site withdrawal from study|0|||
144522358|NCT03150810|521114861|FG006|Overall Study|Site withdrawal from study|0|||
144522359|NCT03150810|521114862|FG007|Overall Study|Site withdrawal from study|0|||
144522360|NCT03150810|521114863|FG008|Overall Study|Site withdrawal from study|0|||
144522361|NCT03150810|521114864|FG009|Overall Study|Site withdrawal from study|1|||
144522362|NCT03150810|521114865|FG010|Overall Study|Site withdrawal from study|1|||
144522363|NCT03150810|521114866|FG011|Overall Study|Site withdrawal from study|0|||
144522364|NCT03150810|521114867|FG012|Overall Study|Site withdrawal from study|0|||
144522365|NCT03150810|521114855|FG000|Overall Study|Hospice|0|||
144596075|NCT00985153|521382598|FG001|Overall Study|Lost to Follow-up|19|||
144522366|NCT03150810|521114856|FG001|Overall Study|Hospice|0|||
144522367|NCT03150810|521114857|FG002|Overall Study|Hospice|0|||
144522368|NCT03150810|521114858|FG003|Overall Study|Hospice|0|||
144522369|NCT03150810|521114859|FG004|Overall Study|Hospice|0|||
144522370|NCT03150810|521114860|FG005|Overall Study|Hospice|1|||
144522371|NCT03150810|521114861|FG006|Overall Study|Hospice|0|||
144522372|NCT03150810|521114862|FG007|Overall Study|Hospice|0|||
144522373|NCT03150810|521114863|FG008|Overall Study|Hospice|0|||
144522374|NCT03150810|521114864|FG009|Overall Study|Hospice|0|||
144522375|NCT03150810|521114865|FG010|Overall Study|Hospice|0|||
144596076|NCT00985153|521382599|FG002|Overall Study|Lost to Follow-up|17|||
144522376|NCT03150810|521114866|FG011|Overall Study|Hospice|0|||
144522377|NCT03150810|521114867|FG012|Overall Study|Hospice|0|||
144522378|NCT03150810|521114855|FG000|Overall Study|Participant relocated abroad.|0|||
144522379|NCT03150810|521114856|FG001|Overall Study|Participant relocated abroad.|0|||
144522380|NCT03150810|521114857|FG002|Overall Study|Participant relocated abroad.|0|||
144522381|NCT03150810|521114858|FG003|Overall Study|Participant relocated abroad.|0|||
144522382|NCT03150810|521114859|FG004|Overall Study|Participant relocated abroad.|0|||
144522383|NCT03150810|521114860|FG005|Overall Study|Participant relocated abroad.|1|||
144522384|NCT03150810|521114861|FG006|Overall Study|Participant relocated abroad.|0|||
144522385|NCT03150810|521114862|FG007|Overall Study|Participant relocated abroad.|0|||
144522386|NCT03150810|521114863|FG008|Overall Study|Participant relocated abroad.|0|||
144522387|NCT03150810|521114864|FG009|Overall Study|Participant relocated abroad.|0|||
144522388|NCT03150810|521114865|FG010|Overall Study|Participant relocated abroad.|0|||
144522389|NCT03150810|521114866|FG011|Overall Study|Participant relocated abroad.|0|||
144522390|NCT03150810|521114867|FG012|Overall Study|Participant relocated abroad.|0|||
144522391|NCT03150810|521114855|FG000|Overall Study|Transferred care to oncologist|0|||
144522392|NCT03150810|521114856|FG001|Overall Study|Transferred care to oncologist|0|||
144522393|NCT03150810|521114857|FG002|Overall Study|Transferred care to oncologist|0|||
144522394|NCT03150810|521114858|FG003|Overall Study|Transferred care to oncologist|0|||
144522395|NCT03150810|521114859|FG004|Overall Study|Transferred care to oncologist|0|||
144522396|NCT03150810|521114860|FG005|Overall Study|Transferred care to oncologist|0|||
144522397|NCT03150810|521114861|FG006|Overall Study|Transferred care to oncologist|2|||
144522398|NCT03150810|521114862|FG007|Overall Study|Transferred care to oncologist|0|||
144522399|NCT03150810|521114863|FG008|Overall Study|Transferred care to oncologist|0|||
144522400|NCT03150810|521114864|FG009|Overall Study|Transferred care to oncologist|0|||
144522401|NCT03150810|521114865|FG010|Overall Study|Transferred care to oncologist|0|||
144522402|NCT03150810|521114866|FG011|Overall Study|Transferred care to oncologist|0|||
144522403|NCT03150810|521114867|FG012|Overall Study|Transferred care to oncologist|0|||
144522404|NCT04526704|521114868|FG000|Overall Study|Adverse Event|1|||
144522405|NCT04526704|521114869|FG001|Overall Study|Adverse Event|0|||
144522406|NCT04526704|521114868|FG000|Overall Study|Physician Decision|1|||
144522407|NCT04526704|521114869|FG001|Overall Study|Physician Decision|0|||
144522408|NCT04526704|521114868|FG000|Overall Study|Withdrawal by Subject|2|||
144522409|NCT04526704|521114869|FG001|Overall Study|Withdrawal by Subject|0|||
144522410|NCT05116787|521114870|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
144522411|NCT05116787|521114871|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
144522412|NCT05116787|521114870|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
144522413|NCT05116787|521114871|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
144522414|NCT05116787|521114870|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
144522415|NCT05116787|521114871|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
144522416|NCT05116787|521114870|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
144522417|NCT05116787|521114871|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
144522418|NCT02737436|521114872|FG000|Washout Period|Lost to Follow-up|5|||
144522419|NCT02737436|521114873|FG001|Washout Period|Lost to Follow-up|11|||
144522420|NCT02737436|521114872|FG000|Data Analysis|Scanning data problems|5|||
144522421|NCT02737436|521114873|FG001|Data Analysis|Scanning data problems|8|||
144522422|NCT03936322|521114874|FG000|Overall Study|Lost to Follow-up|1|||
144522423|NCT03936322|521114874|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
144522424|NCT03829410|521114875|FG000|Overall Study|Adverse Event|1|||
144522425|NCT03829410|521114876|FG001|Overall Study|Adverse Event|0|||
144522426|NCT03829410|521114877|FG002|Overall Study|Adverse Event|1|||
144522427|NCT03829410|521114878|FG003|Overall Study|Adverse Event|4|||
144522428|NCT03829410|521114875|FG000|Overall Study|Physician Decision|0|||
144522429|NCT03829410|521114876|FG001|Overall Study|Physician Decision|0|||
144522430|NCT03829410|521114877|FG002|Overall Study|Physician Decision|0|||
144522431|NCT03829410|521114878|FG003|Overall Study|Physician Decision|2|||
144522432|NCT03829410|521114875|FG000|Overall Study|Disease Progressing|3|||
144522433|NCT03829410|521114876|FG001|Overall Study|Disease Progressing|4|||
144522434|NCT03829410|521114877|FG002|Overall Study|Disease Progressing|2|||
144522435|NCT03829410|521114878|FG003|Overall Study|Disease Progressing|31|||
144522436|NCT03829410|521114875|FG000|Overall Study|Miscellaneous|2|||
144522437|NCT03829410|521114876|FG001|Overall Study|Miscellaneous|4|||
144522438|NCT03829410|521114877|FG002|Overall Study|Miscellaneous|3|||
144522439|NCT03829410|521114878|FG003|Overall Study|Miscellaneous|10|||
144522440|NCT03158129|521114879|FG000|Overall Study|Adverse Event|0|||
144522441|NCT03158129|521114880|FG001|Overall Study|Adverse Event|1|||
144522442|NCT03158129|521114881|FG002|Overall Study|Adverse Event|0|||
144522443|NCT03158129|521114882|FG003|Overall Study|Adverse Event|0|||
144522444|NCT03158129|521114879|FG000|Overall Study|Death|0|||
144522445|NCT03158129|521114880|FG001|Overall Study|Death|0|||
144522446|NCT03158129|521114881|FG002|Overall Study|Death|0|||
144522447|NCT03158129|521114882|FG003|Overall Study|Death|1|||
144522448|NCT03158129|521114879|FG000|Overall Study|High surgical risk|1|||
144522449|NCT03158129|521114880|FG001|Overall Study|High surgical risk|1|||
144522450|NCT03158129|521114881|FG002|Overall Study|High surgical risk|0|||
144596077|NCT00985153|521382600|FG003|Overall Study|Lost to Follow-up|20|||
144596078|NCT00985153|521382597|FG000|Overall Study|Protocol Violation|3|||
144596079|NCT00985153|521382598|FG001|Overall Study|Protocol Violation|2|||
144596080|NCT00985153|521382599|FG002|Overall Study|Protocol Violation|4|||
144399511|NCT00313300|520674623|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
144399512|NCT00313300|520674619|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
144399513|NCT00313300|520674620|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
144399514|NCT00313300|520674621|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
144399515|NCT00313300|520674622|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
144399516|NCT00313300|520674623|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
144399517|NCT02336373|520674624|FG000|Overall Study|Protocol closed early|4|||
144399518|NCT02336373|520674624|FG000|Overall Study|Physician Decision|14|||
144399519|NCT00850343|520674625|FG000|Overall Study|Withdrawal by Subject|11|||
144399520|NCT00850343|520674626|FG001|Overall Study|Withdrawal by Subject|0|||
144399521|NCT00850343|520674627|FG002|Overall Study|Withdrawal by Subject|3|||
144399522|NCT00850343|520674628|FG003|Overall Study|Withdrawal by Subject|2|||
144399523|NCT00850343|520674625|FG000|Overall Study|Adverse Event|15|||
144399524|NCT00850343|520674626|FG001|Overall Study|Adverse Event|2|||
144399525|NCT00850343|520674627|FG002|Overall Study|Adverse Event|6|||
144399526|NCT00850343|520674628|FG003|Overall Study|Adverse Event|6|||
144399527|NCT00850343|520674625|FG000|Overall Study|Pregnancy|0|||
144399528|NCT00850343|520674626|FG001|Overall Study|Pregnancy|0|||
144399529|NCT00850343|520674627|FG002|Overall Study|Pregnancy|0|||
144399530|NCT00850343|520674628|FG003|Overall Study|Pregnancy|1|||
144399531|NCT00850343|520674625|FG000|Overall Study|Lack of Efficacy|17|||
144399532|NCT00850343|520674626|FG001|Overall Study|Lack of Efficacy|0|||
144399533|NCT00850343|520674627|FG002|Overall Study|Lack of Efficacy|3|||
144399534|NCT00850343|520674628|FG003|Overall Study|Lack of Efficacy|2|||
144399535|NCT00850343|520674625|FG000|Overall Study|Non-compliance with Study Procedures|1|||
144399536|NCT00850343|520674626|FG001|Overall Study|Non-compliance with Study Procedures|0|||
144399537|NCT00850343|520674627|FG002|Overall Study|Non-compliance with Study Procedures|1|||
144399538|NCT00850343|520674628|FG003|Overall Study|Non-compliance with Study Procedures|1|||
144399539|NCT00850343|520674625|FG000|Overall Study|Physician Decision|2|||
144399540|NCT00850343|520674626|FG001|Overall Study|Physician Decision|1|||
144399541|NCT00850343|520674627|FG002|Overall Study|Physician Decision|1|||
144399542|NCT00850343|520674628|FG003|Overall Study|Physician Decision|1|||
144399543|NCT00004635|520674629|FG000|Period One|refused|2|||
144399544|NCT00004635|520674630|FG001|Period One|refused|1|||
144399545|NCT00004635|520674629|FG000|Period One|Withdrawal by Subject|1|||
144399546|NCT00004635|520674630|FG001|Period One|Withdrawal by Subject|1|||
144399547|NCT00004635|520674629|FG000|Period One|Protocol Violation|1|||
144399548|NCT00004635|520674630|FG001|Period One|Protocol Violation|0|||
144399549|NCT00004635|520674629|FG000|Period One|PSA did not go <5 ng/mL|1|||
144399550|NCT00004635|520674630|FG001|Period One|PSA did not go <5 ng/mL|0|||
144399551|NCT00004635|520674629|FG000|Period One|second malignancy|1|||
144399552|NCT00004635|520674630|FG001|Period One|second malignancy|0|||
144399553|NCT00004635|520674629|FG000|Period One|progressed|0|||
144399554|NCT00004635|520674630|FG001|Period One|progressed|2|||
144399555|NCT00004635|520674629|FG000|Period One|health problem|0|||
144399556|NCT00004635|520674630|FG001|Period One|health problem|1|||
144399557|NCT00004635|520674629|FG000|Period One|discrepancy in data entry|0|||
144522451|NCT03158129|521114882|FG003|Overall Study|High surgical risk|0|||
144522452|NCT03158129|521114879|FG000|Overall Study|Progression|1|||
144522453|NCT03158129|521114880|FG001|Overall Study|Progression|1|||
144522454|NCT03158129|521114881|FG002|Overall Study|Progression|0|||
144522455|NCT03158129|521114882|FG003|Overall Study|Progression|0|||
144522456|NCT03158129|521114879|FG000|Overall Study|Lack of resectability|0|||
144522457|NCT03158129|521114880|FG001|Overall Study|Lack of resectability|1|||
144596081|NCT00985153|521382600|FG003|Overall Study|Protocol Violation|3|||
144596082|NCT00985153|521382597|FG000|Overall Study|Withdrawal by Subject|6|||
144596083|NCT00985153|521382598|FG001|Overall Study|Withdrawal by Subject|11|||
144249725|NCT02603107|520111721|FG001|Randomized Phase|Death|1|||
144249726|NCT02603107|520111720|FG000|Randomized Phase|Non-compliance with study drug|1|||
144522458|NCT03158129|521114881|FG002|Overall Study|Lack of resectability|0|||
144249727|NCT02603107|520111721|FG001|Randomized Phase|Non-compliance with study drug|1|||
144249728|NCT02603107|520111720|FG000|Randomized Phase|Investigator's discretion|0|||
144399558|NCT00004635|520674630|FG001|Period One|discrepancy in data entry|1|||
144596084|NCT00985153|521382599|FG002|Overall Study|Withdrawal by Subject|11|||
144399559|NCT00004635|520674629|FG000|Period Two|progression|2|||
144399560|NCT00004635|520674630|FG001|Period Two|progression|3|||
144399561|NCT00004635|520674629|FG000|Period Two|Adverse Event|1|||
144399562|NCT00004635|520674630|FG001|Period Two|Adverse Event|0|||
144522459|NCT03158129|521114882|FG003|Overall Study|Lack of resectability|0|||
144399563|NCT00004635|520674629|FG000|Period Two|refused|0|||
144399564|NCT00004635|520674630|FG001|Period Two|refused|2|||
144399565|NCT00004635|520674629|FG000|Period Two|health problem|1|||
144399566|NCT00004635|520674630|FG001|Period Two|health problem|1|||
144522460|NCT03158129|521114879|FG000|Overall Study|Declined surgery|0|||
144522461|NCT03158129|521114880|FG001|Overall Study|Declined surgery|1|||
144399567|NCT00004635|520674629|FG000|Period Two|travel issues|0|||
144399568|NCT00004635|520674630|FG001|Period Two|travel issues|1|||
144399569|NCT00004635|520674629|FG000|Period Two|secondary malignancy|1|||
144399570|NCT00004635|520674630|FG001|Period Two|secondary malignancy|1|||
144399571|NCT00004635|520674629|FG000|Period Two|Lost to Follow-up|1|||
144399572|NCT00004635|520674630|FG001|Period Two|Lost to Follow-up|0|||
144399573|NCT00004635|520674629|FG000|Period Two|discrepancy in data entry|0|||
144399574|NCT00004635|520674630|FG001|Period Two|discrepancy in data entry|1|||
144399575|NCT01788046|520674631|FG000|Overall Study|Withdrawal by Subject|12|||
144399576|NCT01788046|520674632|FG001|Overall Study|Withdrawal by Subject|12|||
144399577|NCT01788046|520674631|FG000|Overall Study|Lost to Follow-up|12|||
144399578|NCT01788046|520674632|FG001|Overall Study|Lost to Follow-up|19|||
144399579|NCT01788046|520674631|FG000|Overall Study|Death|7|||
144399580|NCT01788046|520674632|FG001|Overall Study|Death|5|||
144399581|NCT01788046|520674631|FG000|Overall Study|Protocol Specified Criteria|25|||
144399582|NCT01788046|520674632|FG001|Overall Study|Protocol Specified Criteria|1|||
144399583|NCT03840174|520674633|FG000|Overall Study|Withdrawal by Subject|1|||
144399584|NCT03840174|520674634|FG001|Overall Study|Withdrawal by Subject|0|||
144399585|NCT03840174|520674635|FG002|Overall Study|Withdrawal by Subject|0|||
144399586|NCT03840174|520674636|FG003|Overall Study|Withdrawal by Subject|0|||
144399587|NCT02038881|520674639|FG000|Overall Study|Withdrawal by Subject|0|||
144399588|NCT02038881|520674640|FG001|Overall Study|Withdrawal by Subject|0|||
144399589|NCT02038881|520674641|FG002|Overall Study|Withdrawal by Subject|1|||
144399590|NCT02038881|520674639|FG000|Overall Study|Lost to Follow-up|2|||
144399591|NCT02038881|520674640|FG001|Overall Study|Lost to Follow-up|0|||
144399592|NCT02038881|520674641|FG002|Overall Study|Lost to Follow-up|0|||
144399593|NCT02038881|520674639|FG000|Overall Study|incarcerated|1|||
144399594|NCT02038881|520674640|FG001|Overall Study|incarcerated|0|||
144399595|NCT02038881|520674641|FG002|Overall Study|incarcerated|0|||
144399596|NCT00333840|520674642|FG000|First-line Treatment Period|Adverse Event|38|||
144399597|NCT00333840|520674643|FG001|First-line Treatment Period|Adverse Event|37|||
144399598|NCT00333840|520674644|FG002|First-line Treatment Period|Adverse Event|0|||
144399599|NCT00333840|520674645|FG003|First-line Treatment Period|Adverse Event|0|||
144399600|NCT00333840|520674642|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
144399601|NCT00333840|520674643|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
144399602|NCT00333840|520674644|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
144399603|NCT00333840|520674645|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
144399604|NCT00333840|520674642|FG000|First-line Treatment Period|Abnormal procedure|2|||
144399605|NCT00333840|520674643|FG001|First-line Treatment Period|Abnormal procedure|0|||
144399606|NCT00333840|520674644|FG002|First-line Treatment Period|Abnormal procedure|0|||
144399607|NCT00333840|520674645|FG003|First-line Treatment Period|Abnormal procedure|0|||
144399608|NCT00333840|520674642|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
144399609|NCT00333840|520674643|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
144399610|NCT00333840|520674644|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
144399611|NCT00333840|520674645|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
144399612|NCT00333840|520674642|FG000|First-line Treatment Period|No longer required study drug|21|||
144399613|NCT00333840|520674643|FG001|First-line Treatment Period|No longer required study drug|8|||
144399614|NCT00333840|520674644|FG002|First-line Treatment Period|No longer required study drug|0|||
144399615|NCT00333840|520674645|FG003|First-line Treatment Period|No longer required study drug|0|||
144399616|NCT00333840|520674642|FG000|First-line Treatment Period|Protocol Violation|17|||
144399617|NCT00333840|520674643|FG001|First-line Treatment Period|Protocol Violation|17|||
144399618|NCT00333840|520674644|FG002|First-line Treatment Period|Protocol Violation|0|||
144399619|NCT00333840|520674645|FG003|First-line Treatment Period|Protocol Violation|0|||
144399620|NCT00333840|520674642|FG000|First-line Treatment Period|Subject withdrew consent|57|||
144399621|NCT00333840|520674643|FG001|First-line Treatment Period|Subject withdrew consent|77|||
144399622|NCT00333840|520674644|FG002|First-line Treatment Period|Subject withdrew consent|0|||
144399623|NCT00333840|520674645|FG003|First-line Treatment Period|Subject withdrew consent|0|||
144399624|NCT00333840|520674642|FG000|First-line Treatment Period|Lost to Follow-up|15|||
144399625|NCT00333840|520674643|FG001|First-line Treatment Period|Lost to Follow-up|6|||
144399626|NCT00333840|520674644|FG002|First-line Treatment Period|Lost to Follow-up|0|||
144399627|NCT00333840|520674645|FG003|First-line Treatment Period|Lost to Follow-up|0|||
144399628|NCT00333840|520674642|FG000|First-line Treatment Period|Administrative problems|12|||
144399629|NCT00333840|520674643|FG001|First-line Treatment Period|Administrative problems|6|||
144399630|NCT00333840|520674644|FG002|First-line Treatment Period|Administrative problems|0|||
144399631|NCT00333840|520674645|FG003|First-line Treatment Period|Administrative problems|0|||
144399632|NCT00333840|520674642|FG000|First-line Treatment Period|Death|19|||
144399633|NCT00333840|520674643|FG001|First-line Treatment Period|Death|2|||
144399634|NCT00333840|520674644|FG002|First-line Treatment Period|Death|0|||
144399635|NCT00333840|520674645|FG003|First-line Treatment Period|Death|0|||
144399636|NCT00333840|520674642|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
144399637|NCT00333840|520674643|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
144399638|NCT00333840|520674644|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
144399639|NCT00333840|520674645|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
144399640|NCT00333840|520674642|FG000|Second-line Treatment Period|Adverse Event|0|||
144399641|NCT00333840|520674643|FG001|Second-line Treatment Period|Adverse Event|0|||
144399642|NCT00333840|520674644|FG002|Second-line Treatment Period|Adverse Event|3|||
144399643|NCT00333840|520674645|FG003|Second-line Treatment Period|Adverse Event|34|||
144399644|NCT00333840|520674642|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
144399645|NCT00333840|520674643|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
144399646|NCT00333840|520674644|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
144399647|NCT00333840|520674645|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
144399648|NCT00333840|520674642|FG000|Second-line Treatment Period|Abnormal procedure|0|||
144399649|NCT00333840|520674643|FG001|Second-line Treatment Period|Abnormal procedure|0|||
144399650|NCT00333840|520674644|FG002|Second-line Treatment Period|Abnormal procedure|0|||
144399651|NCT00333840|520674645|FG003|Second-line Treatment Period|Abnormal procedure|1|||
144399652|NCT00333840|520674642|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
144399653|NCT00333840|520674643|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
144399654|NCT00333840|520674644|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
144399655|NCT00333840|520674645|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
144399656|NCT00333840|520674642|FG000|Second-line Treatment Period|No longer required study drug|0|||
144399657|NCT00333840|520674643|FG001|Second-line Treatment Period|No longer required study drug|0|||
144399658|NCT00333840|520674644|FG002|Second-line Treatment Period|No longer required study drug|1|||
144399659|NCT00333840|520674645|FG003|Second-line Treatment Period|No longer required study drug|14|||
144399660|NCT00333840|520674642|FG000|Second-line Treatment Period|Protocol Violation|0|||
144399661|NCT00333840|520674643|FG001|Second-line Treatment Period|Protocol Violation|0|||
144399662|NCT00333840|520674644|FG002|Second-line Treatment Period|Protocol Violation|1|||
144399663|NCT00333840|520674645|FG003|Second-line Treatment Period|Protocol Violation|10|||
144399664|NCT00333840|520674642|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
144399665|NCT00333840|520674643|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
144399666|NCT00333840|520674644|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
144399667|NCT00333840|520674645|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
144399668|NCT00333840|520674642|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
144399669|NCT00333840|520674643|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
144399670|NCT00333840|520674644|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
144399671|NCT00333840|520674645|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
144399672|NCT00333840|520674642|FG000|Second-line Treatment Period|Administrative problems|0|||
144399673|NCT00333840|520674643|FG001|Second-line Treatment Period|Administrative problems|0|||
144399674|NCT00333840|520674644|FG002|Second-line Treatment Period|Administrative problems|0|||
144399675|NCT00333840|520674645|FG003|Second-line Treatment Period|Administrative problems|7|||
144399676|NCT00333840|520674642|FG000|Second-line Treatment Period|Death|0|||
144399677|NCT00333840|520674643|FG001|Second-line Treatment Period|Death|0|||
144399678|NCT00333840|520674644|FG002|Second-line Treatment Period|Death|0|||
144399679|NCT00333840|520674645|FG003|Second-line Treatment Period|Death|9|||
144399680|NCT00875979|520674656|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
144399681|NCT00875979|520674657|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
144399682|NCT00875979|520674656|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
144399683|NCT00875979|520674657|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
144399684|NCT00875979|520674656|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
144399685|NCT00875979|520674657|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
144399686|NCT00875979|520674656|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
144399687|NCT00875979|520674657|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
144399688|NCT00875979|520674656|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
144399689|NCT00875979|520674657|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
144399690|NCT00875979|520674656|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
144399691|NCT00875979|520674657|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
144399692|NCT00875979|520674656|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
144399693|NCT00875979|520674657|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
144399694|NCT00875979|520674656|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
144399695|NCT00875979|520674657|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
144399696|NCT00875979|520674656|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
144399697|NCT00875979|520674657|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
144399698|NCT04209348|520674662|FG000|Overall Study|Lost to Follow-up|1|||
144399699|NCT04209348|520674663|FG001|Overall Study|Lost to Follow-up|0|||
144399700|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
144399701|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
144596085|NCT00985153|521382600|FG003|Overall Study|Withdrawal by Subject|10|||
144596086|NCT00985153|521382597|FG000|Overall Study|Missed One or More Bleeds|7|||
144596087|NCT00985153|521382598|FG001|Overall Study|Missed One or More Bleeds|7|||
144596088|NCT00985153|521382599|FG002|Overall Study|Missed One or More Bleeds|8|||
144596089|NCT00985153|521382600|FG003|Overall Study|Missed One or More Bleeds|10|||
144596090|NCT00985153|521382597|FG000|Overall Study|Incomplete Safety Follow-up|3|||
144596091|NCT00985153|521382598|FG001|Overall Study|Incomplete Safety Follow-up|5|||
144596092|NCT00985153|521382599|FG002|Overall Study|Incomplete Safety Follow-up|4|||
144596093|NCT00985153|521382600|FG003|Overall Study|Incomplete Safety Follow-up|4|||
144596094|NCT02571049|521382601|FG000|Screening|Did not meet entry criteria|2|||
144596095|NCT02571049|521382602|FG001|Screening|Did not meet entry criteria|2|||
144596096|NCT02571049|521382601|FG000|Randomization|No migraine attack|0|||
144596097|NCT02571049|521382602|FG001|Randomization|No migraine attack|1|||
144596098|NCT02571049|521382601|FG000|Randomization|Adverse Event|0|||
144596099|NCT02571049|521382602|FG001|Randomization|Adverse Event|1|||
144596100|NCT01055262|521382605|FG000|Overall Study|Adverse Event|5|||
144596101|NCT01055262|521382605|FG000|Overall Study|Protocol Violation|3|||
144596102|NCT01055262|521382605|FG000|Overall Study|Uncooperativeness|1|||
144596103|NCT03370471|521382607|FG000|Overall Study|Withdrawal by Subject|6|||
144596104|NCT03370471|521382608|FG001|Overall Study|Withdrawal by Subject|1|||
144596105|NCT03370471|521382607|FG000|Overall Study|Unable to access veins for blood draw|0|||
144596106|NCT03370471|521382608|FG001|Overall Study|Unable to access veins for blood draw|1|||
144596107|NCT03370471|521382607|FG000|Overall Study|Screen fail|1|||
144596108|NCT03370471|521382608|FG001|Overall Study|Screen fail|0|||
144596109|NCT00561951|521382609|FG000|Overall Study|Adverse Event|11|||
144596110|NCT00561951|521382610|FG001|Overall Study|Adverse Event|14|||
144596111|NCT00561951|521382611|FG002|Overall Study|Adverse Event|14|||
144596112|NCT00561951|521382609|FG000|Overall Study|Lack of Efficacy|5|||
144596113|NCT00561951|521382610|FG001|Overall Study|Lack of Efficacy|3|||
144596114|NCT00561951|521382611|FG002|Overall Study|Lack of Efficacy|2|||
144596115|NCT00561951|521382609|FG000|Overall Study|Lost to Follow-up|1|||
144596116|NCT00561951|521382610|FG001|Overall Study|Lost to Follow-up|1|||
144596117|NCT00561951|521382611|FG002|Overall Study|Lost to Follow-up|0|||
144596118|NCT00561951|521382609|FG000|Overall Study|Withdrawal by Subject|10|||
144596119|NCT00561951|521382610|FG001|Overall Study|Withdrawal by Subject|9|||
144596120|NCT00561951|521382611|FG002|Overall Study|Withdrawal by Subject|10|||
144596121|NCT00561951|521382609|FG000|Overall Study|Protocol Violation|4|||
144596122|NCT00561951|521382610|FG001|Overall Study|Protocol Violation|3|||
144596123|NCT00561951|521382611|FG002|Overall Study|Protocol Violation|4|||
144399702|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Death|1|||
144399703|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Death|0|||
144399704|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
144399705|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
144399706|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
144522462|NCT03158129|521114881|FG002|Overall Study|Declined surgery|0|||
144522463|NCT03158129|521114882|FG003|Overall Study|Declined surgery|0|||
144522464|NCT03158129|521114879|FG000|Overall Study|No longer surgical candidate|0|||
144596124|NCT00561951|521382609|FG000|Overall Study|Physician Decision|1|||
144596125|NCT00561951|521382610|FG001|Overall Study|Physician Decision|0|||
144596126|NCT00561951|521382611|FG002|Overall Study|Physician Decision|0|||
144596127|NCT00561951|521382609|FG000|Overall Study|Pregnancy|0|||
144249729|NCT02603107|520111721|FG001|Randomized Phase|Investigator's discretion|1|||
144399707|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
144522465|NCT03158129|521114880|FG001|Overall Study|No longer surgical candidate|0|||
144522466|NCT03158129|521114881|FG002|Overall Study|No longer surgical candidate|0|||
144522467|NCT03158129|521114882|FG003|Overall Study|No longer surgical candidate|1|||
144522468|NCT03719443|521114883|FG000|Overall Study|Lost to Follow-up|0|||
144522469|NCT03719443|521114884|FG001|Overall Study|Lost to Follow-up|0|||
144522470|NCT03719443|521114885|FG002|Overall Study|Lost to Follow-up|1|||
144522471|NCT03719443|521114886|FG003|Overall Study|Lost to Follow-up|0|||
144596128|NCT00561951|521382610|FG001|Overall Study|Pregnancy|1|||
144596129|NCT00561951|521382611|FG002|Overall Study|Pregnancy|0|||
144596130|NCT00561951|521382609|FG000|Overall Study|Meet Withdrawal Criterion|0|||
144596131|NCT00561951|521382610|FG001|Overall Study|Meet Withdrawal Criterion|1|||
144596132|NCT00561951|521382611|FG002|Overall Study|Meet Withdrawal Criterion|1|||
144596133|NCT00561951|521382609|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
144399708|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
144522472|NCT03719443|521114887|FG004|Overall Study|Lost to Follow-up|1|||
144522473|NCT03719443|521114888|FG005|Overall Study|Lost to Follow-up|0|||
144522474|NCT03719443|521114889|FG006|Overall Study|Lost to Follow-up|1|||
144522475|NCT03719443|521114883|FG000|Overall Study|Withdrawal by Subject|0|||
144596134|NCT00561951|521382610|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
144596135|NCT00561951|521382611|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
144596136|NCT01765179|521382612|FG000|Overall Study|Adverse Event|3|||
144596137|NCT01765179|521382612|FG000|Overall Study|Lost to Follow-up|5|||
144596138|NCT01765179|521382612|FG000|Overall Study|Non-compliance with study drug|2|||
144399709|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
144399710|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
144399711|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
144399712|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
144399713|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
144399714|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
144399715|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
144399716|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
144399717|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
144399718|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
144399719|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
144399720|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
144399721|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
144399722|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
144399723|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
144399724|NCT02927262|520674664|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
144399725|NCT02927262|520674665|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
144399726|NCT02927262|520674664|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
144399727|NCT02927262|520674665|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
144399728|NCT02927262|520674664|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
144399729|NCT02927262|520674665|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
144399730|NCT02927262|520674664|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
144399731|NCT02927262|520674665|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
144399732|NCT01898208|520674668|FG000|Overall Study|Positive blood culture|17|||
144399733|NCT01898208|520674669|FG001|Overall Study|Positive blood culture|23|||
144399734|NCT01898208|520674670|FG002|Overall Study|Positive blood culture|15|||
144399735|NCT01898208|520674668|FG000|Overall Study|Death/comfort care within 24 hours|10|||
144399736|NCT01898208|520674669|FG001|Overall Study|Death/comfort care within 24 hours|9|||
144399737|NCT01898208|520674670|FG002|Overall Study|Death/comfort care within 24 hours|8|||
144399738|NCT01898208|520674668|FG000|Overall Study|Negative Gram Stain|6|||
144399739|NCT01898208|520674669|FG001|Overall Study|Negative Gram Stain|9|||
144399740|NCT01898208|520674670|FG002|Overall Study|Negative Gram Stain|6|||
144399741|NCT01898208|520674668|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
144399742|NCT01898208|520674669|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
144399743|NCT01898208|520674670|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
144399744|NCT01898208|520674668|FG000|Overall Study|System/Technical Error|1|||
144399745|NCT01898208|520674669|FG001|Overall Study|System/Technical Error|2|||
144399746|NCT01898208|520674670|FG002|Overall Study|System/Technical Error|3|||
144399747|NCT01898208|520674668|FG000|Overall Study|Lost to Follow-up|3|||
144399748|NCT01898208|520674669|FG001|Overall Study|Lost to Follow-up|1|||
144399749|NCT01898208|520674670|FG002|Overall Study|Lost to Follow-up|1|||
144399750|NCT02711345|520674672|FG000|Overall Study|Adverse Event|0|||
144399751|NCT02711345|520674673|FG001|Overall Study|Adverse Event|0|||
144399752|NCT02711345|520674674|FG002|Overall Study|Adverse Event|0|||
144399753|NCT02711345|520674675|FG003|Overall Study|Adverse Event|1|||
144399754|NCT02711345|520674676|FG004|Overall Study|Adverse Event|1|||
144399755|NCT02711345|520674677|FG005|Overall Study|Adverse Event|2|||
144399756|NCT02711345|520674678|FG006|Overall Study|Adverse Event|1|||
144399757|NCT02711345|520674679|FG007|Overall Study|Adverse Event|0|||
144399758|NCT02711345|520674680|FG008|Overall Study|Adverse Event|0|||
144399759|NCT02711345|520674681|FG009|Overall Study|Adverse Event|2|||
144399760|NCT02711345|520674672|FG000|Overall Study|Physician Decision|0|||
144399761|NCT02711345|520674673|FG001|Overall Study|Physician Decision|0|||
144399762|NCT02711345|520674674|FG002|Overall Study|Physician Decision|1|||
144399763|NCT02711345|520674675|FG003|Overall Study|Physician Decision|0|||
144399764|NCT02711345|520674676|FG004|Overall Study|Physician Decision|0|||
144399765|NCT02711345|520674677|FG005|Overall Study|Physician Decision|0|||
144399766|NCT02711345|520674678|FG006|Overall Study|Physician Decision|0|||
144399767|NCT02711345|520674679|FG007|Overall Study|Physician Decision|0|||
144399768|NCT02711345|520674680|FG008|Overall Study|Physician Decision|1|||
144399769|NCT02711345|520674681|FG009|Overall Study|Physician Decision|0|||
144399770|NCT02711345|520674672|FG000|Overall Study|Progressive disease|1|||
144399771|NCT02711345|520674673|FG001|Overall Study|Progressive disease|3|||
144399772|NCT02711345|520674674|FG002|Overall Study|Progressive disease|5|||
144399773|NCT02711345|520674675|FG003|Overall Study|Progressive disease|3|||
144399774|NCT02711345|520674676|FG004|Overall Study|Progressive disease|7|||
144522476|NCT03719443|521114884|FG001|Overall Study|Withdrawal by Subject|0|||
144522477|NCT03719443|521114885|FG002|Overall Study|Withdrawal by Subject|1|||
144522478|NCT03719443|521114886|FG003|Overall Study|Withdrawal by Subject|0|||
144522479|NCT03719443|521114887|FG004|Overall Study|Withdrawal by Subject|0|||
144522480|NCT03719443|521114888|FG005|Overall Study|Withdrawal by Subject|0|||
144522481|NCT03719443|521114889|FG006|Overall Study|Withdrawal by Subject|0|||
144522482|NCT05051124|521114890|FG000|Overall Study|Lost to Follow-up|2|||
144522483|NCT05051124|521114890|FG000|Overall Study|Withdrawal by Subject|1|||
144522484|NCT05051124|521114890|FG000|Overall Study|Residential relocation|2|||
144522485|NCT05051124|521114890|FG000|Overall Study|Death|1|||
144522486|NCT04782973|521114891|FG000|Overall Study|Withdrawal by Subject|5|||
144522487|NCT04782973|521114891|FG000|Overall Study|Protocol Violation|6|||
144522488|NCT04782973|521114891|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
144522489|NCT00554788|521114892|FG000|Overall Study|Adverse Event|0|||
144522490|NCT00554788|521114893|FG001|Overall Study|Adverse Event|1|||
144522491|NCT00554788|521114894|FG002|Overall Study|Adverse Event|2|||
144522492|NCT00554788|521114892|FG000|Overall Study|Lost to Follow-up|4|||
144522493|NCT00554788|521114893|FG001|Overall Study|Lost to Follow-up|3|||
144522494|NCT00554788|521114894|FG002|Overall Study|Lost to Follow-up|3|||
144522495|NCT00554788|521114892|FG000|Overall Study|Physician Decision|1|||
144522496|NCT00554788|521114893|FG001|Overall Study|Physician Decision|1|||
144522497|NCT00554788|521114894|FG002|Overall Study|Physician Decision|3|||
144522498|NCT00554788|521114892|FG000|Overall Study|Withdrawal by Subject|0|||
144522499|NCT00554788|521114893|FG001|Overall Study|Withdrawal by Subject|0|||
144522500|NCT00554788|521114894|FG002|Overall Study|Withdrawal by Subject|1|||
144522501|NCT00554788|521114892|FG000|Overall Study|Refusal of further protocol therapy|0|||
144522502|NCT00554788|521114893|FG001|Overall Study|Refusal of further protocol therapy|1|||
144522503|NCT00554788|521114894|FG002|Overall Study|Refusal of further protocol therapy|1|||
144522504|NCT00554788|521114892|FG000|Overall Study|Progressive disease|0|||
144522505|NCT00554788|521114893|FG001|Overall Study|Progressive disease|0|||
144522506|NCT00554788|521114894|FG002|Overall Study|Progressive disease|3|||
144522507|NCT00554788|521114892|FG000|Overall Study|Ineligible|2|||
144522508|NCT00554788|521114893|FG001|Overall Study|Ineligible|0|||
144522509|NCT00554788|521114894|FG002|Overall Study|Ineligible|1|||
144522510|NCT06205407|521114895|FG000|Period 2|Withdrawal by Subject|0|||
144522511|NCT06205407|521114896|FG001|Period 2|Withdrawal by Subject|1|||
144522512|NCT06205407|521114895|FG000|Period 2|Adverse Event|2|||
144522513|NCT06205407|521114896|FG001|Period 2|Adverse Event|1|||
144522514|NCT02577835|521114898|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
144522515|NCT04749615|521114899|FG000|Overall Study|Lost to Follow-up|6|||
144522516|NCT04749615|521114900|FG001|Overall Study|Lost to Follow-up|10|||
144522517|NCT02274662|521114905|FG000|Overall Study|Death|1|||
144522518|NCT02274662|521114905|FG000|Overall Study|Lost to Follow-up|3|||
144522519|NCT02962895|521114906|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
144522520|NCT02962895|521114907|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
144522521|NCT02962895|521114908|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
144522522|NCT02962895|521114909|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
144522523|NCT02962895|521114910|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
144522524|NCT02962895|521114911|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
144522525|NCT02962895|521114912|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
144522526|NCT02962895|521114906|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
144522527|NCT02962895|521114907|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
144522528|NCT02962895|521114908|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
144522529|NCT02962895|521114909|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
144522530|NCT02962895|521114910|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
144522531|NCT02962895|521114911|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
144522532|NCT02962895|521114912|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
144522533|NCT02962895|521114906|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
144522534|NCT02962895|521114907|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
144522535|NCT02962895|521114908|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
144522536|NCT02962895|521114909|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
144522537|NCT02962895|521114910|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
144399775|NCT02711345|520674677|FG005|Overall Study|Progressive disease|2|||
144399776|NCT02711345|520674678|FG006|Overall Study|Progressive disease|8|||
144399777|NCT02711345|520674679|FG007|Overall Study|Progressive disease|4|||
144399778|NCT02711345|520674680|FG008|Overall Study|Progressive disease|5|||
144399779|NCT02711345|520674681|FG009|Overall Study|Progressive disease|6|||
144399780|NCT02711345|520674672|FG000|Overall Study|Subject/guardian decision|0|||
144399781|NCT02711345|520674673|FG001|Overall Study|Subject/guardian decision|0|||
144399782|NCT02711345|520674674|FG002|Overall Study|Subject/guardian decision|0|||
144399783|NCT02711345|520674675|FG003|Overall Study|Subject/guardian decision|0|||
144399784|NCT02711345|520674676|FG004|Overall Study|Subject/guardian decision|0|||
144399785|NCT02711345|520674677|FG005|Overall Study|Subject/guardian decision|2|||
144399786|NCT02711345|520674678|FG006|Overall Study|Subject/guardian decision|3|||
144399787|NCT02711345|520674679|FG007|Overall Study|Subject/guardian decision|1|||
144399788|NCT02711345|520674680|FG008|Overall Study|Subject/guardian decision|0|||
144399789|NCT02711345|520674681|FG009|Overall Study|Subject/guardian decision|4|||
144399790|NCT02711345|520674672|FG000|Overall Study|Death|1|||
144399791|NCT02711345|520674673|FG001|Overall Study|Death|0|||
144399792|NCT02711345|520674674|FG002|Overall Study|Death|0|||
144399793|NCT02711345|520674675|FG003|Overall Study|Death|0|||
144399794|NCT02711345|520674676|FG004|Overall Study|Death|0|||
144399795|NCT02711345|520674677|FG005|Overall Study|Death|0|||
144399796|NCT02711345|520674678|FG006|Overall Study|Death|0|||
144399797|NCT02711345|520674679|FG007|Overall Study|Death|1|||
144399798|NCT02711345|520674680|FG008|Overall Study|Death|0|||
144399799|NCT02711345|520674681|FG009|Overall Study|Death|0|||
144399800|NCT00961649|520674682|FG000|Overall Study|Adverse Event|4|||
144522538|NCT02962895|521114911|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
144522539|NCT02962895|521114912|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
144522540|NCT02962895|521114906|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
144522541|NCT02962895|521114907|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
144522542|NCT02962895|521114908|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
144399801|NCT00961649|520674683|FG001|Overall Study|Adverse Event|0|||
144399802|NCT00961649|520674684|FG002|Overall Study|Adverse Event|0|||
144399803|NCT00961649|520674685|FG003|Overall Study|Adverse Event|2|||
144399804|NCT00961649|520674682|FG000|Overall Study|Inadequate control of IOP|0|||
144399805|NCT00961649|520674683|FG001|Overall Study|Inadequate control of IOP|0|||
144399806|NCT00961649|520674684|FG002|Overall Study|Inadequate control of IOP|0|||
144399807|NCT00961649|520674685|FG003|Overall Study|Inadequate control of IOP|1|||
144399808|NCT00961649|520674682|FG000|Overall Study|Patient has travel plans during holidays|0|||
144399809|NCT00961649|520674683|FG001|Overall Study|Patient has travel plans during holidays|0|||
144399810|NCT00961649|520674684|FG002|Overall Study|Patient has travel plans during holidays|1|||
144399811|NCT00961649|520674685|FG003|Overall Study|Patient has travel plans during holidays|0|||
144399812|NCT00961649|520674682|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
144399813|NCT00961649|520674683|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
144399814|NCT00961649|520674684|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
144399815|NCT00961649|520674685|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
144399816|NCT00961649|520674682|FG000|Overall Study|Study terminated by sponsor|4|||
144399817|NCT00961649|520674683|FG001|Overall Study|Study terminated by sponsor|4|||
144399818|NCT00961649|520674684|FG002|Overall Study|Study terminated by sponsor|4|||
144399819|NCT00961649|520674685|FG003|Overall Study|Study terminated by sponsor|1|||
144399820|NCT04043728|520674686|FG000|Overall Study|Lost to Follow-up|1|||
144399821|NCT04043728|520674687|FG001|Overall Study|Lost to Follow-up|2|||
144399822|NCT04043728|520674688|FG002|Overall Study|Lost to Follow-up|0|||
144399823|NCT04502979|520674690|FG000|Overall Study|Lost to Follow-up|1|||
144399824|NCT04502979|520674691|FG001|Overall Study|Lost to Follow-up|3|||
144399825|NCT04502979|520674690|FG000|Overall Study|Withdrawal by Subject|2|||
144399826|NCT04502979|520674691|FG001|Overall Study|Withdrawal by Subject|1|||
144399827|NCT00586625|520674695|FG000|Overall Study|Adverse Event|6|||
144399828|NCT00586625|520674696|FG001|Overall Study|Adverse Event|6|||
144399829|NCT00586625|520674695|FG000|Overall Study|Protocol Violation|3|||
144399830|NCT00586625|520674696|FG001|Overall Study|Protocol Violation|0|||
144399831|NCT00586625|520674695|FG000|Overall Study|Withdrawal by Subject|32|||
144399832|NCT00586625|520674696|FG001|Overall Study|Withdrawal by Subject|10|||
144399833|NCT00586625|520674695|FG000|Overall Study|Subject non-compliance|0|||
144399834|NCT00586625|520674696|FG001|Overall Study|Subject non-compliance|1|||
144399835|NCT00586625|520674695|FG000|Overall Study|Subject unable to return for visit|2|||
144399836|NCT00586625|520674696|FG001|Overall Study|Subject unable to return for visit|0|||
144399837|NCT04032652|520674698|FG000|Overall Study|The study was terminated and the PI has|1|||
144399838|NCT04032652|520674699|FG001|Overall Study|The study was terminated and the PI has|1|||
144399839|NCT02423772|520674701|FG000|Overall Study|Lost to Follow-up|3|||
144399840|NCT02423772|520674702|FG001|Overall Study|Lost to Follow-up|3|||
144399841|NCT02423772|520674701|FG000|Overall Study|Did not begin intervention|2|||
144399842|NCT02423772|520674702|FG001|Overall Study|Did not begin intervention|5|||
144399843|NCT03698331|520674703|FG000|Overall Study|Adverse Event|2|||
144399844|NCT03698331|520674704|FG001|Overall Study|Adverse Event|3|||
144596139|NCT01765179|521382612|FG000|Overall Study|Protocol Violation|1|||
144399845|NCT03698331|520674703|FG000|Overall Study|Withdrawal by Subject|1|||
144399846|NCT03698331|520674704|FG001|Overall Study|Withdrawal by Subject|1|||
144399847|NCT03698331|520674703|FG000|Overall Study|Lost to Follow-up|0|||
144399848|NCT03698331|520674704|FG001|Overall Study|Lost to Follow-up|2|||
144399849|NCT03698331|520674703|FG000|Overall Study|Non-compliance with study drug|1|||
144399850|NCT03698331|520674704|FG001|Overall Study|Non-compliance with study drug|0|||
144399851|NCT01193842|520674705|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
144399852|NCT01193842|520674706|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
144399853|NCT01193842|520674707|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
144399854|NCT01193842|520674708|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
144399855|NCT01193842|520674709|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
144399856|NCT01193842|520674705|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
144399857|NCT01193842|520674706|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
144399858|NCT01193842|520674707|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
144399859|NCT01193842|520674708|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
144399860|NCT01193842|520674709|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
144399861|NCT01193842|520674705|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
144399862|NCT01193842|520674706|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
144399863|NCT01193842|520674707|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
144399864|NCT01193842|520674708|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
144399865|NCT01193842|520674709|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
144399866|NCT01193842|520674705|FG000|Phase II: Randomized Groups|Death|0|||
144399867|NCT01193842|520674706|FG001|Phase II: Randomized Groups|Death|0|||
144399868|NCT01193842|520674707|FG002|Phase II: Randomized Groups|Death|0|||
144399869|NCT01193842|520674708|FG003|Phase II: Randomized Groups|Death|1|||
144399870|NCT01193842|520674709|FG004|Phase II: Randomized Groups|Death|1|||
144399871|NCT01193842|520674705|FG000|Phase II: Randomized Groups|Adverse Event|0|||
144399872|NCT01193842|520674706|FG001|Phase II: Randomized Groups|Adverse Event|0|||
144399873|NCT01193842|520674707|FG002|Phase II: Randomized Groups|Adverse Event|0|||
144399874|NCT01193842|520674708|FG003|Phase II: Randomized Groups|Adverse Event|5|||
144399875|NCT01193842|520674709|FG004|Phase II: Randomized Groups|Adverse Event|3|||
144399876|NCT01193842|520674705|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
144399877|NCT01193842|520674706|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
144399878|NCT01193842|520674707|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
144399879|NCT01193842|520674708|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
144399880|NCT01193842|520674709|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
144399881|NCT01193842|520674705|FG000|Phase II: Randomized Groups|Ineligible|0|||
144399882|NCT01193842|520674706|FG001|Phase II: Randomized Groups|Ineligible|0|||
144399883|NCT01193842|520674707|FG002|Phase II: Randomized Groups|Ineligible|0|||
144399884|NCT01193842|520674708|FG003|Phase II: Randomized Groups|Ineligible|0|||
144399885|NCT01193842|520674709|FG004|Phase II: Randomized Groups|Ineligible|1|||
144399886|NCT01193842|520674705|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
144399887|NCT01193842|520674706|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
144399888|NCT01193842|520674707|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
144399889|NCT01193842|520674708|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
144399890|NCT01193842|520674709|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
144399891|NCT01467583|520674712|FG000|Overall Study|Death|1|||
144399892|NCT01467583|520674713|FG001|Overall Study|Death|1|||
144399893|NCT01467583|520674714|FG002|Overall Study|Death|0|||
144399894|NCT01467583|520674712|FG000|Overall Study|Withdrawal by Subject|1|||
144399895|NCT01467583|520674713|FG001|Overall Study|Withdrawal by Subject|0|||
144399896|NCT01467583|520674714|FG002|Overall Study|Withdrawal by Subject|0|||
144399897|NCT01467583|520674712|FG000|Overall Study|Protocol Violation|0|||
144399898|NCT01467583|520674713|FG001|Overall Study|Protocol Violation|0|||
144399899|NCT01467583|520674714|FG002|Overall Study|Protocol Violation|2|||
144399900|NCT05274165|520674716|FG000|Overall Study|Withdrawal by Subject|3|||
144399901|NCT05274165|520674717|FG001|Overall Study|Withdrawal by Subject|3|||
144399902|NCT02484690|520674718|FG000|Overall Study|Adverse Event|1|||
144399903|NCT02484690|520674719|FG001|Overall Study|Adverse Event|3|||
144399904|NCT02484690|520674720|FG002|Overall Study|Adverse Event|0|||
144399905|NCT02484690|520674721|FG003|Overall Study|Adverse Event|0|||
144399906|NCT02484690|520674722|FG004|Overall Study|Adverse Event|5|||
144399907|NCT02484690|520674718|FG000|Overall Study|Death|0|||
144399908|NCT02484690|520674719|FG001|Overall Study|Death|0|||
144399909|NCT02484690|520674720|FG002|Overall Study|Death|0|||
144399910|NCT02484690|520674721|FG003|Overall Study|Death|0|||
144399911|NCT02484690|520674722|FG004|Overall Study|Death|1|||
144399912|NCT02484690|520674718|FG000|Overall Study|Withdrawal by Subject|1|||
144399913|NCT02484690|520674719|FG001|Overall Study|Withdrawal by Subject|3|||
144399914|NCT02484690|520674720|FG002|Overall Study|Withdrawal by Subject|1|||
144399915|NCT02484690|520674721|FG003|Overall Study|Withdrawal by Subject|2|||
144399916|NCT02484690|520674722|FG004|Overall Study|Withdrawal by Subject|0|||
144399917|NCT02484690|520674718|FG000|Overall Study|Physician Decision|2|||
144399918|NCT02484690|520674719|FG001|Overall Study|Physician Decision|0|||
144399919|NCT02484690|520674720|FG002|Overall Study|Physician Decision|1|||
144399920|NCT02484690|520674721|FG003|Overall Study|Physician Decision|0|||
144399921|NCT02484690|520674722|FG004|Overall Study|Physician Decision|0|||
144399922|NCT02484690|520674718|FG000|Overall Study|Lost to Follow-up|0|||
144399923|NCT02484690|520674719|FG001|Overall Study|Lost to Follow-up|0|||
144399924|NCT02484690|520674720|FG002|Overall Study|Lost to Follow-up|1|||
144399925|NCT02484690|520674721|FG003|Overall Study|Lost to Follow-up|0|||
144399926|NCT02484690|520674722|FG004|Overall Study|Lost to Follow-up|0|||
144399927|NCT05736224|520674723|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
144399928|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
144399929|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
144399930|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
144399931|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
144399932|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
144399933|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
144399934|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
144399935|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
144399936|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
144399937|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
144399938|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
144399939|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
144399940|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
144399941|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
144399942|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
144399943|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
144399944|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
144399945|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
144399946|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
144399947|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
144399948|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
144399949|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
144399950|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
144399951|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
144399952|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
144399953|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
144399954|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
144399955|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
144399956|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
144399957|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
144399958|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
144399959|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
144722337|NCT03519256|521838678|FG002|Overall Study|Disease progression|2|||
144399960|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
144399961|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
144399962|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
144399963|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
144399964|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
144399965|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
144399966|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
144399967|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
144399968|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
144399969|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
144399970|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
144399971|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
144399972|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
144399973|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
144399974|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
144399975|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
144399976|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
144399977|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
144399978|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
144399979|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
144399980|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
144399981|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
144399982|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
144399983|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
144399984|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
144471937|NCT03217747|520925365|FG012|Overall Study|Adverse Event|1|||
144596140|NCT01765179|521382612|FG000|Overall Study|Withdrawal by Subject|8|||
144596141|NCT01765179|521382612|FG000|Overall Study|Hematocrit >54%|3|||
144596142|NCT01765179|521382612|FG000|Overall Study|prohibited med|1|||
144596143|NCT01765179|521382612|FG000|Overall Study|Out of country unable to finish study|1|||
144596144|NCT01765179|521382612|FG000|Overall Study|lack of venous access|1|||
144596145|NCT01765179|521382612|FG000|Overall Study|work conflict|1|||
144596146|NCT01765179|521382612|FG000|Overall Study|Ca elevated 10.6|1|||
144596147|NCT00392327|521382626|FG000|Overall Study|Death|1|||
144596148|NCT00392327|521382627|FG001|Overall Study|Death|0|||
144596149|NCT00392327|521382628|FG002|Overall Study|Death|1|||
144596150|NCT00392327|521382629|FG003|Overall Study|Death|0|||
144596151|NCT00392327|521382630|FG004|Overall Study|Death|0|||
144596152|NCT00392327|521382631|FG005|Overall Study|Death|0|||
144596153|NCT00392327|521382632|FG006|Overall Study|Death|0|||
144596154|NCT00392327|521382633|FG007|Overall Study|Death|0|||
144596155|NCT00392327|521382626|FG000|Overall Study|Lack of Efficacy|8|||
144596156|NCT00392327|521382627|FG001|Overall Study|Lack of Efficacy|8|||
144596157|NCT00392327|521382628|FG002|Overall Study|Lack of Efficacy|9|||
144596158|NCT00392327|521382629|FG003|Overall Study|Lack of Efficacy|6|||
144596159|NCT00392327|521382630|FG004|Overall Study|Lack of Efficacy|3|||
144596160|NCT00392327|521382631|FG005|Overall Study|Lack of Efficacy|3|||
144596161|NCT00392327|521382632|FG006|Overall Study|Lack of Efficacy|3|||
144596162|NCT00392327|521382633|FG007|Overall Study|Lack of Efficacy|3|||
144596163|NCT00392327|521382626|FG000|Overall Study|Physician Decision|3|||
144596164|NCT00392327|521382627|FG001|Overall Study|Physician Decision|5|||
144722338|NCT03519256|521838679|FG003|Overall Study|Disease progression|1|||
144249730|NCT02603107|520111720|FG000|Randomized Phase|Lack of Efficacy|1|||
144596165|NCT00392327|521382628|FG002|Overall Study|Physician Decision|2|||
144596166|NCT00392327|521382629|FG003|Overall Study|Physician Decision|2|||
144596167|NCT00392327|521382630|FG004|Overall Study|Physician Decision|0|||
144596168|NCT00392327|521382631|FG005|Overall Study|Physician Decision|1|||
144596169|NCT00392327|521382632|FG006|Overall Study|Physician Decision|5|||
144596170|NCT00392327|521382633|FG007|Overall Study|Physician Decision|3|||
144596171|NCT00392327|521382626|FG000|Overall Study|Protocol Violation|0|||
144596172|NCT00392327|521382627|FG001|Overall Study|Protocol Violation|0|||
144596173|NCT00392327|521382628|FG002|Overall Study|Protocol Violation|1|||
144596174|NCT00392327|521382629|FG003|Overall Study|Protocol Violation|0|||
144596175|NCT00392327|521382630|FG004|Overall Study|Protocol Violation|0|||
144596176|NCT00392327|521382631|FG005|Overall Study|Protocol Violation|0|||
144596177|NCT00392327|521382632|FG006|Overall Study|Protocol Violation|0|||
144596178|NCT00392327|521382633|FG007|Overall Study|Protocol Violation|0|||
144722339|NCT03519256|521838676|FG000|Overall Study|Lost to Follow-up|0|||
144522543|NCT02962895|521114909|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
144522544|NCT02962895|521114910|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
144522545|NCT02962895|521114911|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
144522546|NCT02962895|521114912|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
144522547|NCT02962895|521114906|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
144522548|NCT02962895|521114907|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
144522549|NCT02962895|521114908|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
144522550|NCT02962895|521114909|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
144522551|NCT02962895|521114910|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
144522552|NCT02962895|521114911|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
144522553|NCT02962895|521114912|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
144522554|NCT02962895|521114906|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
144522555|NCT02962895|521114907|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
144522556|NCT02962895|521114908|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
144522557|NCT02962895|521114909|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
144522558|NCT02962895|521114910|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
144522559|NCT02962895|521114911|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
144522560|NCT02962895|521114912|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
144522561|NCT02962895|521114906|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
144522562|NCT02962895|521114907|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
144596179|NCT00392327|521382626|FG000|Overall Study|Withdrawal by Subject|3|||
144596180|NCT00392327|521382627|FG001|Overall Study|Withdrawal by Subject|2|||
144596181|NCT00392327|521382628|FG002|Overall Study|Withdrawal by Subject|4|||
144596182|NCT00392327|521382629|FG003|Overall Study|Withdrawal by Subject|6|||
144399985|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
144399986|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
144399987|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
144399988|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
144471938|NCT03217747|520925366|FG013|Overall Study|Adverse Event|1|||
144471939|NCT03217747|520925353|FG000|Overall Study|Death|0|||
144596183|NCT00392327|521382630|FG004|Overall Study|Withdrawal by Subject|0|||
144471940|NCT03217747|520925354|FG001|Overall Study|Death|0|||
144471941|NCT03217747|520925355|FG002|Overall Study|Death|0|||
144471942|NCT03217747|520925356|FG003|Overall Study|Death|0|||
144471943|NCT03217747|520925357|FG004|Overall Study|Death|0|||
144471944|NCT03217747|520925358|FG005|Overall Study|Death|0|||
144471945|NCT03217747|520925359|FG006|Overall Study|Death|0|||
144471946|NCT03217747|520925360|FG007|Overall Study|Death|0|||
144471947|NCT03217747|520925361|FG008|Overall Study|Death|1|||
144471948|NCT03217747|520925362|FG009|Overall Study|Death|0|||
144471949|NCT03217747|520925363|FG010|Overall Study|Death|0|||
144471950|NCT03217747|520925364|FG011|Overall Study|Death|0|||
144471951|NCT03217747|520925365|FG012|Overall Study|Death|0|||
144471952|NCT03217747|520925366|FG013|Overall Study|Death|0|||
144471953|NCT03217747|520925353|FG000|Overall Study|Lack of Efficacy|12|||
144471954|NCT03217747|520925354|FG001|Overall Study|Lack of Efficacy|6|||
144471955|NCT03217747|520925355|FG002|Overall Study|Lack of Efficacy|15|||
144471956|NCT03217747|520925356|FG003|Overall Study|Lack of Efficacy|11|||
144399989|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
144399990|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
144399991|NCT04526509|520674724|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
144399992|NCT04526509|520674725|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
144399993|NCT04526509|520674726|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
144399994|NCT04526509|520674727|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
144399995|NCT04526509|520674728|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
144399996|NCT04526509|520674729|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
144399997|NCT04526509|520674730|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
144399998|NCT04526509|520674724|FG000|Enrolled|Study Terminated by Sponsor|0|||
144399999|NCT04526509|520674725|FG001|Enrolled|Study Terminated by Sponsor|0|||
144400000|NCT04526509|520674726|FG002|Enrolled|Study Terminated by Sponsor|0|||
144400001|NCT04526509|520674727|FG003|Enrolled|Study Terminated by Sponsor|0|||
144400002|NCT04526509|520674728|FG004|Enrolled|Study Terminated by Sponsor|0|||
144400003|NCT04526509|520674729|FG005|Enrolled|Study Terminated by Sponsor|0|||
144400004|NCT04526509|520674730|FG006|Enrolled|Study Terminated by Sponsor|1|||
144400005|NCT04526509|520674724|FG000|Enrolled|Death prior to lymphodepletion|0|||
144400006|NCT04526509|520674725|FG001|Enrolled|Death prior to lymphodepletion|0|||
144400007|NCT04526509|520674726|FG002|Enrolled|Death prior to lymphodepletion|0|||
144400008|NCT04526509|520674727|FG003|Enrolled|Death prior to lymphodepletion|1|||
144400009|NCT04526509|520674728|FG004|Enrolled|Death prior to lymphodepletion|0|||
144400010|NCT04526509|520674729|FG005|Enrolled|Death prior to lymphodepletion|0|||
144400011|NCT04526509|520674730|FG006|Enrolled|Death prior to lymphodepletion|0|||
144400012|NCT04526509|520674724|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
144400013|NCT04526509|520674725|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
144400014|NCT04526509|520674726|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
144400015|NCT04526509|520674727|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
144400016|NCT04526509|520674728|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
144596184|NCT00392327|521382631|FG005|Overall Study|Withdrawal by Subject|1|||
144596185|NCT00392327|521382632|FG006|Overall Study|Withdrawal by Subject|1|||
144596186|NCT00392327|521382633|FG007|Overall Study|Withdrawal by Subject|5|||
144596187|NCT00392327|521382626|FG000|Overall Study|Ineligible|0|||
144596188|NCT00392327|521382627|FG001|Overall Study|Ineligible|4|||
144596189|NCT00392327|521382628|FG002|Overall Study|Ineligible|3|||
144596190|NCT00392327|521382629|FG003|Overall Study|Ineligible|2|||
144596191|NCT00392327|521382630|FG004|Overall Study|Ineligible|0|||
144596192|NCT00392327|521382631|FG005|Overall Study|Ineligible|0|||
144596193|NCT00392327|521382632|FG006|Overall Study|Ineligible|0|||
144596194|NCT00392327|521382633|FG007|Overall Study|Ineligible|0|||
144596195|NCT02988622|521382634|FG000|Overall Study|Lost to Follow-up|17|||
144596196|NCT02447172|521382635|FG000|Overall Study|Adverse Event|11|||
144596197|NCT02447172|521382636|FG001|Overall Study|Adverse Event|8|||
144596198|NCT02447172|521382637|FG002|Overall Study|Adverse Event|7|||
144722340|NCT03519256|521838677|FG001|Overall Study|Lost to Follow-up|1|||
144722341|NCT03519256|521838678|FG002|Overall Study|Lost to Follow-up|0|||
144522563|NCT02962895|521114908|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
144522564|NCT02962895|521114909|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
144522565|NCT02962895|521114910|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
144522566|NCT02962895|521114911|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
144522567|NCT02962895|521114912|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
144522568|NCT02962895|521114906|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
144522569|NCT02962895|521114907|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
144522570|NCT02962895|521114908|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
144522571|NCT02962895|521114909|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
144522572|NCT02962895|521114910|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
144522573|NCT02962895|521114911|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
144722342|NCT03519256|521838679|FG003|Overall Study|Lost to Follow-up|0|||
144249731|NCT02603107|520111721|FG001|Randomized Phase|Lack of Efficacy|0|||
144400017|NCT04526509|520674729|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
144400018|NCT04526509|520674730|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
144522574|NCT02962895|521114912|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
144522575|NCT02962895|521114906|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
144522576|NCT02962895|521114907|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
144522577|NCT02962895|521114908|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
144522578|NCT02962895|521114909|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
144522579|NCT02962895|521114910|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
144522580|NCT02962895|521114911|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
144522581|NCT02962895|521114912|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
144522582|NCT02962895|521114906|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
144522583|NCT02962895|521114907|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
144522584|NCT02962895|521114908|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
144522585|NCT02962895|521114909|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
144522586|NCT02962895|521114910|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
144522587|NCT02962895|521114911|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
144522588|NCT02962895|521114912|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
144522589|NCT02962895|521114906|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
144522590|NCT02962895|521114907|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
144522591|NCT02962895|521114908|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
144522592|NCT02962895|521114909|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
144522593|NCT02962895|521114910|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
144522594|NCT02962895|521114911|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
144522595|NCT02962895|521114912|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
144522596|NCT02962895|521114906|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
144522597|NCT02962895|521114907|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
144522598|NCT02962895|521114908|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
144522599|NCT02962895|521114909|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
144522600|NCT02962895|521114910|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
144522601|NCT02962895|521114911|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
144522602|NCT02962895|521114912|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
144522603|NCT02962895|521114906|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
144522604|NCT02962895|521114907|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
144522605|NCT02962895|521114908|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
144522606|NCT02962895|521114909|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
144522607|NCT02962895|521114910|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
144522608|NCT02962895|521114911|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
144522609|NCT02962895|521114912|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
144522610|NCT02962895|521114906|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
144522611|NCT02962895|521114907|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
144522612|NCT02962895|521114908|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
144522613|NCT02962895|521114909|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
144522614|NCT02962895|521114910|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
144522615|NCT02962895|521114911|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
144522616|NCT02962895|521114912|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
144522617|NCT02936752|521114913|FG000|Overall Study|Death|2|||
144522618|NCT02936752|521114914|FG001|Overall Study|Death|1|||
144522619|NCT02936752|521114913|FG000|Overall Study|Physician Decision|4|||
144522620|NCT02936752|521114914|FG001|Overall Study|Physician Decision|0|||
144522621|NCT02936752|521114913|FG000|Overall Study|Withdrawal by Subject|0|||
144522622|NCT02936752|521114914|FG001|Overall Study|Withdrawal by Subject|2|||
144522623|NCT05282173|521114919|FG000|Overall Study|Missed|3|||
144522624|NCT05282173|521114920|FG001|Overall Study|Missed|2|||
144522625|NCT05282173|521114921|FG002|Overall Study|Missed|4|||
144522626|NCT04719390|521114927|FG000|Overall Study|Withdrawal by Subject|1|||
144522627|NCT04292223|521114928|FG000|Overall Study|Adverse Event|1|||
144522628|NCT04292223|521114928|FG000|Overall Study|Lost to Follow-up|1|||
144522629|NCT04292223|521114928|FG000|Overall Study|Noncompliance with study drug|2|||
144522630|NCT04292223|521114928|FG000|Overall Study|Patient moved out of the state|1|||
144522631|NCT05746455|521114929|FG000|Overall Study|Discharged from Clinical Service|1|||
144522632|NCT05746455|521114929|FG000|Overall Study|Lost to Follow-up|1|||
144522633|NCT03447470|521114931|FG000|Overall Study|Death|0|||
144522634|NCT03447470|521114932|FG001|Overall Study|Death|1|||
144522635|NCT03447470|521114933|FG002|Overall Study|Death|3|||
144522636|NCT03447470|521114934|FG003|Overall Study|Death|0|||
144522637|NCT03447470|521114935|FG004|Overall Study|Death|1|||
144522638|NCT03447470|521114936|FG005|Overall Study|Death|0|||
144522639|NCT03447470|521114937|FG006|Overall Study|Death|3|||
144522640|NCT03447470|521114938|FG007|Overall Study|Death|3|||
144522641|NCT03447470|521114939|FG008|Overall Study|Death|1|||
144522642|NCT03447470|521114931|FG000|Overall Study|Withdrawal by Subject|1|||
144522643|NCT03447470|521114932|FG001|Overall Study|Withdrawal by Subject|0|||
144522644|NCT03447470|521114933|FG002|Overall Study|Withdrawal by Subject|0|||
144522645|NCT03447470|521114934|FG003|Overall Study|Withdrawal by Subject|0|||
144522646|NCT03447470|521114935|FG004|Overall Study|Withdrawal by Subject|1|||
144522647|NCT03447470|521114936|FG005|Overall Study|Withdrawal by Subject|0|||
144522648|NCT03447470|521114937|FG006|Overall Study|Withdrawal by Subject|1|||
144522649|NCT03447470|521114938|FG007|Overall Study|Withdrawal by Subject|1|||
144522650|NCT03447470|521114939|FG008|Overall Study|Withdrawal by Subject|3|||
144522651|NCT03447470|521114931|FG000|Overall Study|Treatment discontinued|3|||
144522652|NCT03447470|521114932|FG001|Overall Study|Treatment discontinued|2|||
144400019|NCT04526509|520674724|FG000|Enrolled|Physician Decision|0|||
144400020|NCT04526509|520674725|FG001|Enrolled|Physician Decision|1|||
144596199|NCT02447172|521382635|FG000|Overall Study|Death|3|||
144596200|NCT02447172|521382636|FG001|Overall Study|Death|1|||
144596201|NCT02447172|521382637|FG002|Overall Study|Death|0|||
144596202|NCT02447172|521382635|FG000|Overall Study|Protocol Violation|2|||
144596203|NCT02447172|521382636|FG001|Overall Study|Protocol Violation|1|||
144596204|NCT02447172|521382637|FG002|Overall Study|Protocol Violation|2|||
144596205|NCT02447172|521382635|FG000|Overall Study|Lost to Follow-up|7|||
144596206|NCT02447172|521382636|FG001|Overall Study|Lost to Follow-up|4|||
144596207|NCT02447172|521382637|FG002|Overall Study|Lost to Follow-up|4|||
144596208|NCT02447172|521382635|FG000|Overall Study|Withdrawal by Subject|5|||
144596209|NCT02447172|521382636|FG001|Overall Study|Withdrawal by Subject|1|||
144596210|NCT02447172|521382637|FG002|Overall Study|Withdrawal by Subject|3|||
144596211|NCT02447172|521382635|FG000|Overall Study|protocol specific treatment unrelated|3|||
144596212|NCT02447172|521382636|FG001|Overall Study|protocol specific treatment unrelated|0|||
144596213|NCT02447172|521382637|FG002|Overall Study|protocol specific treatment unrelated|2|||
144596214|NCT03562247|521382641|FG000|Overall Study|Lost to Follow-up|3|||
144596215|NCT03562247|521382642|FG001|Overall Study|Lost to Follow-up|1|||
144596216|NCT03562247|521382643|FG002|Overall Study|Lost to Follow-up|1|||
144596217|NCT00983931|521382644|FG000|14 Day Washout Period|Physician Decision|1|||
144596218|NCT01281969|521382647|FG000|Overall Study|not randomized didn't meet criteria|0|||
144596219|NCT01281969|521382648|FG001|Overall Study|not randomized didn't meet criteria|0|||
144596220|NCT01281969|521382649|FG002|Overall Study|not randomized didn't meet criteria|7|||
144596221|NCT01281969|521382647|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
144596222|NCT01281969|521382648|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
144596223|NCT01281969|521382649|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
144596224|NCT01281969|521382647|FG000|Overall Study|not randomized, child consent not given|0|||
144596225|NCT01281969|521382648|FG001|Overall Study|not randomized, child consent not given|0|||
144596226|NCT01281969|521382649|FG002|Overall Study|not randomized, child consent not given|2|||
144596227|NCT01201265|521382650|FG000|Overall Study|Death|14|||
144596228|NCT01201265|521382650|FG000|Overall Study|Insufficient Therapeutic Response|3|||
144596229|NCT01201265|521382650|FG000|Overall Study|Lost to Follow-up|10|||
144596230|NCT01201265|521382650|FG000|Overall Study|Withdrawal by Subject|7|||
144596231|NCT01201265|521382650|FG000|Overall Study|Disease Progression|4|||
144596232|NCT01323634|521382651|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
144596233|NCT01323634|521382652|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
144596234|NCT01323634|521382653|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
144596235|NCT01323634|521382651|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
144596236|NCT01323634|521382652|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
144596237|NCT01323634|521382653|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
144596238|NCT01323634|521382651|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
144596239|NCT01323634|521382652|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144596240|NCT01323634|521382653|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144596241|NCT01323634|521382651|FG000|2-week Run-in Period|Physician Decision|5|||
144596242|NCT01323634|521382652|FG001|2-week Run-in Period|Physician Decision|0|||
144596243|NCT01323634|521382653|FG002|2-week Run-in Period|Physician Decision|0|||
144596244|NCT01323634|521382651|FG000|2-week Run-in Period|Protocol Violation|1|||
144596245|NCT01323634|521382652|FG001|2-week Run-in Period|Protocol Violation|0|||
144596246|NCT01323634|521382653|FG002|2-week Run-in Period|Protocol Violation|0|||
144596247|NCT01323634|521382651|FG000|2-week Run-in Period|Adverse Event|1|||
144596248|NCT01323634|521382652|FG001|2-week Run-in Period|Adverse Event|0|||
144596249|NCT01323634|521382653|FG002|2-week Run-in Period|Adverse Event|0|||
144400021|NCT04526509|520674726|FG002|Enrolled|Physician Decision|0|||
144596250|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144596251|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
144596252|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
144596253|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144596254|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144596255|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
144596256|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144596257|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
144596258|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
144596259|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144596260|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
144596261|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
144400022|NCT04526509|520674727|FG003|Enrolled|Physician Decision|0|||
144400023|NCT04526509|520674728|FG004|Enrolled|Physician Decision|0|||
144400024|NCT04526509|520674729|FG005|Enrolled|Physician Decision|0|||
144400025|NCT04526509|520674730|FG006|Enrolled|Physician Decision|0|||
144400026|NCT04340193|520674732|FG000|Overall Study|Other reason|0|||
144400027|NCT04340193|520674733|FG001|Overall Study|Other reason|0|||
144400028|NCT04340193|520674734|FG002|Overall Study|Other reason|1|||
144400029|NCT04340193|520674732|FG000|Overall Study|Disease recurrence|0|||
144400030|NCT04340193|520674733|FG001|Overall Study|Disease recurrence|1|||
144400031|NCT04340193|520674734|FG002|Overall Study|Disease recurrence|0|||
144400032|NCT04340193|520674732|FG000|Overall Study|Study drug toxicity|1|||
144400033|NCT04340193|520674733|FG001|Overall Study|Study drug toxicity|0|||
144400034|NCT04340193|520674734|FG002|Overall Study|Study drug toxicity|0|||
144400035|NCT04340193|520674732|FG000|Overall Study|Disease progression|1|||
144400036|NCT04340193|520674733|FG001|Overall Study|Disease progression|2|||
144400037|NCT04340193|520674734|FG002|Overall Study|Disease progression|3|||
144400038|NCT04340193|520674732|FG000|Overall Study|Administrative reasons by sponsor|0|||
144400039|NCT04340193|520674733|FG001|Overall Study|Administrative reasons by sponsor|1|||
144400040|NCT04340193|520674734|FG002|Overall Study|Administrative reasons by sponsor|0|||
144400041|NCT04340193|520674732|FG000|Overall Study|Adverse Event|1|||
144400042|NCT04340193|520674733|FG001|Overall Study|Adverse Event|1|||
144400043|NCT04340193|520674734|FG002|Overall Study|Adverse Event|0|||
144400044|NCT03350620|520674735|FG000|Stage 2|Adverse Event|0|||
144400045|NCT03350620|520674736|FG001|Stage 2|Adverse Event|1|||
144400046|NCT03350620|520674737|FG002|Stage 2|Adverse Event|1|||
144400047|NCT03350620|520674735|FG000|Stage 2|Lack of Efficacy|0|||
144400048|NCT03350620|520674736|FG001|Stage 2|Lack of Efficacy|2|||
144400049|NCT03350620|520674737|FG002|Stage 2|Lack of Efficacy|0|||
144400050|NCT03350620|520674735|FG000|Stage 2|Lost to Follow-up|1|||
144400051|NCT03350620|520674736|FG001|Stage 2|Lost to Follow-up|2|||
144400052|NCT03350620|520674737|FG002|Stage 2|Lost to Follow-up|2|||
144400053|NCT03350620|520674735|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
144400054|NCT03350620|520674736|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
144400055|NCT03350620|520674737|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
144400056|NCT01067976|520674738|FG000|Overall Study|Study drug never administered|20|||
144400057|NCT01067976|520674738|FG000|Overall Study|Study prematurely discontinued|2|||
144400058|NCT00589290|520674739|FG000|Overall Study|Withdrawal by Subject|1|||
144400059|NCT00566111|520674740|FG000|Overall Study|Adverse Event|0|||
144400060|NCT00566111|520674741|FG001|Overall Study|Adverse Event|2|||
144400061|NCT04449861|520674742|FG000|Overall Study|Withdrawal by Subject|4|||
144400062|NCT04449861|520674742|FG000|Overall Study|Lost to Follow-up|5|||
144400063|NCT04449861|520674742|FG000|Overall Study|Death|112|||
144400064|NCT00976677|520674743|FG000|Overall Study|Adverse Event|1|||
144400065|NCT00976677|520674744|FG001|Overall Study|Adverse Event|0|||
144400066|NCT00976677|520674743|FG000|Overall Study|Withdrawal by Subject|0|||
144400067|NCT00976677|520674744|FG001|Overall Study|Withdrawal by Subject|2|||
144400068|NCT00976677|520674743|FG000|Overall Study|Disease progression|1|||
144400069|NCT00976677|520674744|FG001|Overall Study|Disease progression|1|||
144400070|NCT00976677|520674743|FG000|Overall Study|Trial unblinded|2|||
144596262|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
144400071|NCT00976677|520674744|FG001|Overall Study|Trial unblinded|2|||
144400072|NCT00976677|520674743|FG000|Overall Study|Unknown/Missing|1|||
144400073|NCT00976677|520674744|FG001|Overall Study|Unknown/Missing|0|||
144400074|NCT03507400|520674745|FG000|Overall Study|discontinued|5|||
144400075|NCT03507400|520674746|FG001|Overall Study|discontinued|1|||
144400076|NCT03507400|520674745|FG000|Overall Study|Lost to Follow-up|8|||
144596263|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
144596264|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
144596265|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144596266|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
144596267|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
144596268|NCT01323634|521382651|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
144596269|NCT01323634|521382652|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
144596270|NCT01323634|521382653|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
144596271|NCT01575028|521382654|FG000|Overall Study|Physician Decision|0|||
144596272|NCT01575028|521382655|FG001|Overall Study|Physician Decision|1|||
144596273|NCT01182194|521382656|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
144596274|NCT01182194|521382657|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
144596275|NCT03343301|521382658|FG000|Overall Study|Withdrawal by Subject|1|||
144596276|NCT03343301|521382659|FG001|Overall Study|Withdrawal by Subject|1|||
144596277|NCT03343301|521382658|FG000|Overall Study|Death|0|||
144596278|NCT03343301|521382659|FG001|Overall Study|Death|2|||
144596279|NCT03343301|521382658|FG000|Overall Study|Other|0|||
144596280|NCT03343301|521382659|FG001|Overall Study|Other|6|||
144596281|NCT03343301|521382658|FG000|Overall Study|Missing|2|||
144596282|NCT03343301|521382659|FG001|Overall Study|Missing|0|||
144596283|NCT05959629|521382675|FG000|Overall Study|partially necrotic/technical issues|2|||
144596284|NCT05959629|521382676|FG001|Overall Study|partially necrotic/technical issues|2|||
144596285|NCT01717989|521384449|FG000|Overall Study|Ineligibility determined|6|||
144596286|NCT01717989|521384449|FG000|Overall Study|Protocol deviation|6|||
144596287|NCT01717989|521384449|FG000|Overall Study|Withdrawal by Subject|11|||
144596288|NCT01717989|521384449|FG000|Overall Study|Physician Decision|2|||
144596289|NCT01717989|521384449|FG000|Overall Study|Lost to Follow-up|11|||
144596290|NCT01717989|521384449|FG000|Overall Study|Death|439|||
144596291|NCT01717989|521384449|FG000|Overall Study|Protocol-specified criteria|551|||
144596292|NCT01717989|521384449|FG000|Overall Study|Other|40|||
144596293|NCT03224325|521384450|FG000|Overall Study|Adverse Event|1|||
144596294|NCT03224325|521384451|FG001|Overall Study|Adverse Event|0|||
144596295|NCT03224325|521384452|FG002|Overall Study|Adverse Event|0|||
144596296|NCT03224325|521384453|FG003|Overall Study|Adverse Event|0|||
144596297|NCT03224325|521384454|FG004|Overall Study|Adverse Event|0|||
144596298|NCT03224325|521384455|FG005|Overall Study|Adverse Event|0|||
144596299|NCT03224325|521384456|FG006|Overall Study|Adverse Event|1|||
144596300|NCT03224325|521384450|FG000|Overall Study|Withdrawal by Subject|0|||
144400077|NCT03507400|520674746|FG001|Overall Study|Lost to Follow-up|6|||
144400078|NCT03507400|520674745|FG000|Overall Study|Protocol Violation|0|||
144400079|NCT03507400|520674746|FG001|Overall Study|Protocol Violation|1|||
144596301|NCT03224325|521384451|FG001|Overall Study|Withdrawal by Subject|0|||
144400080|NCT00392015|520676420|FG000|Overall Study|Lost to Follow-up|2|||
144596302|NCT03224325|521384452|FG002|Overall Study|Withdrawal by Subject|0|||
144596303|NCT03224325|521384453|FG003|Overall Study|Withdrawal by Subject|1|||
144596304|NCT03224325|521384454|FG004|Overall Study|Withdrawal by Subject|0|||
144596305|NCT03224325|521384455|FG005|Overall Study|Withdrawal by Subject|0|||
144596306|NCT03224325|521384456|FG006|Overall Study|Withdrawal by Subject|0|||
144722343|NCT02524379|521838685|FG000|Overall Study|Death|1|||
144596307|NCT02864381|521384457|FG000|Overall Study|Death|58|||
144400081|NCT00392015|520676421|FG001|Overall Study|Lost to Follow-up|0|||
144400082|NCT00392015|520676422|FG002|Overall Study|Lost to Follow-up|2|||
144400083|NCT00392015|520676423|FG003|Overall Study|Lost to Follow-up|1|||
144400084|NCT00392015|520676424|FG004|Overall Study|Lost to Follow-up|1|||
144400085|NCT00392015|520676425|FG005|Overall Study|Lost to Follow-up|0|||
144400086|NCT00392015|520676420|FG000|Overall Study|Withdrawal by Subject|0|||
144400087|NCT00392015|520676421|FG001|Overall Study|Withdrawal by Subject|0|||
144400088|NCT00392015|520676422|FG002|Overall Study|Withdrawal by Subject|2|||
144400089|NCT00392015|520676423|FG003|Overall Study|Withdrawal by Subject|0|||
144400090|NCT00392015|520676424|FG004|Overall Study|Withdrawal by Subject|0|||
144400091|NCT00392015|520676425|FG005|Overall Study|Withdrawal by Subject|0|||
144400092|NCT00392015|520676420|FG000|Overall Study|Adverse Event|0|||
144400093|NCT00392015|520676421|FG001|Overall Study|Adverse Event|0|||
144400094|NCT00392015|520676422|FG002|Overall Study|Adverse Event|0|||
144400095|NCT00392015|520676423|FG003|Overall Study|Adverse Event|0|||
144400096|NCT00392015|520676424|FG004|Overall Study|Adverse Event|1|||
144400097|NCT00392015|520676425|FG005|Overall Study|Adverse Event|0|||
144400098|NCT00392015|520676420|FG000|Overall Study|Previous trial recipient|0|||
144400099|NCT00392015|520676421|FG001|Overall Study|Previous trial recipient|0|||
144400100|NCT00392015|520676422|FG002|Overall Study|Previous trial recipient|0|||
144400101|NCT00392015|520676423|FG003|Overall Study|Previous trial recipient|0|||
144400102|NCT00392015|520676424|FG004|Overall Study|Previous trial recipient|1|||
144400103|NCT00392015|520676425|FG005|Overall Study|Previous trial recipient|0|||
144400104|NCT00717093|520676427|FG000|Overall Study|Adverse Event|19|||
144400105|NCT00717093|520676428|FG001|Overall Study|Adverse Event|9|||
144400106|NCT00717093|520676427|FG000|Overall Study|Lack of Efficacy|3|||
144400107|NCT00717093|520676428|FG001|Overall Study|Lack of Efficacy|13|||
144400108|NCT00717093|520676427|FG000|Overall Study|Lost to Follow-up|9|||
144522653|NCT03447470|521114933|FG002|Overall Study|Treatment discontinued|4|||
144522654|NCT03447470|521114934|FG003|Overall Study|Treatment discontinued|6|||
144522655|NCT03447470|521114935|FG004|Overall Study|Treatment discontinued|2|||
144522656|NCT03447470|521114936|FG005|Overall Study|Treatment discontinued|1|||
144522657|NCT03447470|521114937|FG006|Overall Study|Treatment discontinued|2|||
144522658|NCT03447470|521114938|FG007|Overall Study|Treatment discontinued|4|||
144522659|NCT03447470|521114939|FG008|Overall Study|Treatment discontinued|3|||
144522660|NCT01606215|521114940|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
144400109|NCT00717093|520676428|FG001|Overall Study|Lost to Follow-up|6|||
144400110|NCT00717093|520676427|FG000|Overall Study|Withdrawal by Subject|12|||
144400111|NCT00717093|520676428|FG001|Overall Study|Withdrawal by Subject|19|||
144400112|NCT00717093|520676427|FG000|Overall Study|Other|0|||
144522661|NCT01606215|521114941|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
144522662|NCT04592549|521114943|FG000|Overall Study|Withdrawal by Subject|0|||
144522663|NCT04592549|521114944|FG001|Overall Study|Withdrawal by Subject|1|||
144400113|NCT00717093|520676428|FG001|Overall Study|Other|1|||
144400114|NCT00717093|520676427|FG000|Overall Study|Randomized but not treated|1|||
144400115|NCT00717093|520676428|FG001|Overall Study|Randomized but not treated|0|||
144400116|NCT02742441|520676436|FG000|Overall Study|Lost to Follow-up|4|||
144400117|NCT02742441|520676437|FG001|Overall Study|Lost to Follow-up|4|||
144400118|NCT02742441|520676436|FG000|Overall Study|Withdrawal by Subject|2|||
144722344|NCT00812253|521838686|FG000|Overall Study|Withdrawal by Subject|3|||
144722345|NCT00812253|521838687|FG001|Overall Study|Withdrawal by Subject|2|||
144400119|NCT02742441|520676437|FG001|Overall Study|Withdrawal by Subject|2|||
144400120|NCT02742441|520676436|FG000|Overall Study|Adverse Event|0|||
144400121|NCT02742441|520676437|FG001|Overall Study|Adverse Event|2|||
144400122|NCT02008318|520676441|FG000|Overall Study|Adverse Event|4|||
144400123|NCT02008318|520676442|FG001|Overall Study|Adverse Event|0|||
144400124|NCT02008318|520676441|FG000|Overall Study|Physician Decision|2|||
144400125|NCT02008318|520676442|FG001|Overall Study|Physician Decision|0|||
144249732|NCT02603107|520111720|FG000|Randomized Phase|Protocol Violation|1|||
144249733|NCT02603107|520111721|FG001|Randomized Phase|Protocol Violation|0|||
144249734|NCT02603107|520111720|FG000|Optional Extension Phase|Lost to Follow-up|3|||
144249735|NCT02603107|520111721|FG001|Optional Extension Phase|Lost to Follow-up|3|||
144249736|NCT02603107|520111720|FG000|Optional Extension Phase|Withdrew consent|3|||
144249737|NCT02603107|520111721|FG001|Optional Extension Phase|Withdrew consent|2|||
144249738|NCT02603107|520111720|FG000|Optional Extension Phase|Investigator's discretion|2|||
144249739|NCT02603107|520111721|FG001|Optional Extension Phase|Investigator's discretion|2|||
144249740|NCT02603107|520111720|FG000|Optional Extension Phase|Pregnancy|0|||
144249741|NCT02603107|520111721|FG001|Optional Extension Phase|Pregnancy|3|||
144249742|NCT02603107|520111720|FG000|Optional Extension Phase|Adverse Event|0|||
144249743|NCT02603107|520111721|FG001|Optional Extension Phase|Adverse Event|2|||
144249744|NCT02603107|520111720|FG000|Optional Extension Phase|Not treated in extension phase|0|||
144249745|NCT02603107|520111721|FG001|Optional Extension Phase|Not treated in extension phase|1|||
144249746|NCT02603107|520111720|FG000|Optional Extension Phase|Protocol Violation|1|||
144400126|NCT02008318|520676441|FG000|Overall Study|Progressive Disease|2|||
144400127|NCT02008318|520676442|FG001|Overall Study|Progressive Disease|0|||
144522664|NCT04592549|521114945|FG002|Overall Study|Withdrawal by Subject|0|||
144522665|NCT04592549|521114946|FG003|Overall Study|Withdrawal by Subject|1|||
144522666|NCT04592549|521114947|FG004|Overall Study|Withdrawal by Subject|1|||
144522667|NCT04592549|521114948|FG005|Overall Study|Withdrawal by Subject|0|||
144522668|NCT04592549|521114943|FG000|Overall Study|Lost to Follow-up|2|||
144522669|NCT04592549|521114944|FG001|Overall Study|Lost to Follow-up|0|||
144522670|NCT04592549|521114945|FG002|Overall Study|Lost to Follow-up|0|||
144522671|NCT04592549|521114946|FG003|Overall Study|Lost to Follow-up|1|||
144522672|NCT04592549|521114947|FG004|Overall Study|Lost to Follow-up|1|||
144522673|NCT04592549|521114948|FG005|Overall Study|Lost to Follow-up|1|||
144522674|NCT05184192|521114949|FG000|Overall Study|Lost to Follow-up|4|||
144249747|NCT02603107|520111721|FG001|Optional Extension Phase|Protocol Violation|0|||
144249748|NCT01857102|520111728|FG000|Period 1|No longer meets Eligibility Criteria|0|||
144400128|NCT02008318|520676441|FG000|Overall Study|Protocol Violation|1|||
144522675|NCT05184192|521114950|FG001|Overall Study|Lost to Follow-up|7|||
144522676|NCT05184192|521114949|FG000|Overall Study|Adverse Event|1|||
144400129|NCT02008318|520676442|FG001|Overall Study|Protocol Violation|1|||
144400130|NCT02008318|520676441|FG000|Overall Study|Withdrawal by Subject|3|||
144522677|NCT05184192|521114950|FG001|Overall Study|Adverse Event|4|||
144522678|NCT05184192|521114949|FG000|Overall Study|PI withdrawal|1|||
144522679|NCT05184192|521114950|FG001|Overall Study|PI withdrawal|2|||
144400131|NCT02008318|520676442|FG001|Overall Study|Withdrawal by Subject|0|||
144400132|NCT02281773|520676443|FG000|Overall Study|Adverse Event|6|||
144400133|NCT02281773|520676444|FG001|Overall Study|Adverse Event|1|||
144400134|NCT02281773|520676445|FG002|Overall Study|Adverse Event|4|||
144400135|NCT02281773|520676446|FG003|Overall Study|Adverse Event|8|||
144400136|NCT02281773|520676447|FG004|Overall Study|Adverse Event|9|||
144400137|NCT02281773|520676443|FG000|Overall Study|Protocol Violation|1|||
144400138|NCT02281773|520676444|FG001|Overall Study|Protocol Violation|0|||
144400139|NCT02281773|520676445|FG002|Overall Study|Protocol Violation|0|||
144400140|NCT02281773|520676446|FG003|Overall Study|Protocol Violation|2|||
144400141|NCT02281773|520676447|FG004|Overall Study|Protocol Violation|2|||
144249749|NCT01857102|520111729|FG001|Period 1|No longer meets Eligibility Criteria|2|||
144249750|NCT01857102|520111728|FG000|Period 1|Lost to Follow-up|0|||
144400142|NCT02281773|520676443|FG000|Overall Study|Lost to Follow-up|2|||
144400143|NCT02281773|520676444|FG001|Overall Study|Lost to Follow-up|2|||
144400144|NCT02281773|520676445|FG002|Overall Study|Lost to Follow-up|6|||
144522680|NCT05184192|521114949|FG000|Overall Study|Withdrew due to adverse effect|1|||
144249751|NCT01857102|520111729|FG001|Period 1|Lost to Follow-up|3|||
144400145|NCT02281773|520676446|FG003|Overall Study|Lost to Follow-up|2|||
144400146|NCT02281773|520676447|FG004|Overall Study|Lost to Follow-up|10|||
144522681|NCT05184192|521114950|FG001|Overall Study|Withdrew due to adverse effect|0|||
144522682|NCT05184192|521114949|FG000|Overall Study|Medication schedule|1|||
144400147|NCT02281773|520676443|FG000|Overall Study|Withdrawal by Subject|2|||
144522683|NCT05184192|521114950|FG001|Overall Study|Medication schedule|0|||
144522684|NCT05184192|521114949|FG000|Overall Study|Concern for adverse effects|0|||
144522685|NCT05184192|521114950|FG001|Overall Study|Concern for adverse effects|4|||
144522686|NCT04295798|521114955|FG000|Overall Study|Lost to Follow-up|1|||
144522687|NCT04927364|521114959|FG000|Overall Study|Withdrawal by Subject|3|||
144522688|NCT04927364|521114959|FG000|Overall Study|Unable to complete preassessment MRI|1|||
144522689|NCT04624633|521114966|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
144522690|NCT04624633|521114967|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
144522691|NCT04624633|521114966|FG000|Overall Study|Death|1|||
144522692|NCT04624633|521114967|FG001|Overall Study|Death|0|||
144522693|NCT05087992|521114968|FG000|Overall Study|Adverse Event|0|||
144522694|NCT05087992|521114969|FG001|Overall Study|Adverse Event|1|||
144522695|NCT05087992|521114970|FG002|Overall Study|Adverse Event|0|||
144522696|NCT05087992|521114968|FG000|Overall Study|Withdrawal by Subject|2|||
144522697|NCT05087992|521114969|FG001|Overall Study|Withdrawal by Subject|0|||
144522698|NCT05087992|521114970|FG002|Overall Study|Withdrawal by Subject|0|||
144522699|NCT05087992|521114968|FG000|Overall Study|clinical disease progression|3|||
144522700|NCT05087992|521114969|FG001|Overall Study|clinical disease progression|1|||
144522701|NCT05087992|521114970|FG002|Overall Study|clinical disease progression|0|||
144522702|NCT05087992|521114968|FG000|Overall Study|objective disease progression|4|||
144522703|NCT05087992|521114969|FG001|Overall Study|objective disease progression|1|||
144522704|NCT05087992|521114970|FG002|Overall Study|objective disease progression|0|||
144522705|NCT01959425|521114971|FG000|Overall Study|Withdrawal by Subject|5|||
144249752|NCT01857102|520111728|FG000|Period 1|Unsatisfactory Lens Fit|1|||
144400148|NCT02281773|520676444|FG001|Overall Study|Withdrawal by Subject|8|||
144400149|NCT02281773|520676445|FG002|Overall Study|Withdrawal by Subject|6|||
144522706|NCT01959425|521114972|FG001|Overall Study|Withdrawal by Subject|4|||
144522707|NCT01959425|521114971|FG000|Overall Study|Lost to Follow-up|1|||
144522708|NCT01959425|521114972|FG001|Overall Study|Lost to Follow-up|0|||
144522709|NCT01959425|521114971|FG000|Overall Study|Discontinued Subjects|6|||
144522710|NCT01959425|521114972|FG001|Overall Study|Discontinued Subjects|4|||
144522711|NCT01902173|521114973|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
144596308|NCT02864381|521384458|FG001|Overall Study|Death|61|||
144596309|NCT02864381|521384457|FG000|Overall Study|Withdrew Consent|5|||
144596310|NCT02864381|521384458|FG001|Overall Study|Withdrew Consent|6|||
144596311|NCT02864381|521384457|FG000|Overall Study|Reason Unknown|7|||
144596312|NCT02864381|521384458|FG001|Overall Study|Reason Unknown|3|||
144596313|NCT02864381|521384457|FG000|Overall Study|Lost to Follow-up|1|||
144596314|NCT02864381|521384458|FG001|Overall Study|Lost to Follow-up|1|||
144596315|NCT02864381|521384457|FG000|Overall Study|Investigator's Discretion|1|||
144596316|NCT02864381|521384458|FG001|Overall Study|Investigator's Discretion|0|||
144596317|NCT02864381|521384457|FG000|Overall Study|Protocol Violation|0|||
144596318|NCT02864381|521384458|FG001|Overall Study|Protocol Violation|1|||
144596319|NCT02120625|521384460|FG000|Overall Study|Physician Decision|2|||
144596320|NCT02525861|521384461|FG000|Overall Study|Adverse Event|1|||
144596321|NCT02525861|521384462|FG001|Overall Study|Adverse Event|0|||
144596322|NCT02525861|521384461|FG000|Overall Study|Withdrawal by Subject|0|||
144596323|NCT02525861|521384462|FG001|Overall Study|Withdrawal by Subject|1|||
144596324|NCT02525861|521384461|FG000|Overall Study|Physician Decision|0|||
144596325|NCT02525861|521384462|FG001|Overall Study|Physician Decision|1|||
144596326|NCT03278106|521384463|FG000|Overall Study|No protocol treatment|1|||
144596327|NCT03952806|521384465|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
144596328|NCT03952806|521384466|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
144596329|NCT03952806|521384465|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
144596330|NCT03952806|521384466|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
144596331|NCT03952806|521384465|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
144596332|NCT03952806|521384466|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
144596333|NCT03952806|521384465|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
144596334|NCT03952806|521384466|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
144596335|NCT03952806|521384465|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
144596336|NCT03952806|521384466|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
144596337|NCT03952806|521384465|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
144596338|NCT03952806|521384466|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
144596339|NCT03952806|521384465|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
144596340|NCT03952806|521384466|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
144596341|NCT03952806|521384465|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
144596342|NCT03952806|521384466|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
144596343|NCT03952806|521384465|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
144596344|NCT03952806|521384466|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
144596345|NCT03952806|521384465|FG000|OLE Phase (48 Weeks)|Other|16|||
144596346|NCT03952806|521384466|FG001|OLE Phase (48 Weeks)|Other|13|||
144596347|NCT05116046|521384471|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144596348|NCT05116046|521384472|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144596349|NCT05116046|521384473|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144596350|NCT05116046|521384471|FG000|Overall Study|Study terminated by sponsor|14|||
144596351|NCT05116046|521384472|FG001|Overall Study|Study terminated by sponsor|16|||
144596352|NCT05116046|521384473|FG002|Overall Study|Study terminated by sponsor|1|||
144596353|NCT02683941|521384474|FG000|Double-blind Phase|Adverse Event|0|||
144596354|NCT02683941|521384475|FG001|Double-blind Phase|Adverse Event|1|||
144596355|NCT02683941|521384474|FG000|Double-blind Phase|Withdrawal by Subject|4|||
144596356|NCT02683941|521384475|FG001|Double-blind Phase|Withdrawal by Subject|2|||
144596357|NCT02683941|521384474|FG000|Double-blind Phase|Lost to Follow-up|1|||
144596358|NCT02683941|521384475|FG001|Double-blind Phase|Lost to Follow-up|0|||
144596359|NCT02683941|521384474|FG000|Double-blind Phase|Disease Progression|5|||
144596360|NCT02683941|521384475|FG001|Double-blind Phase|Disease Progression|2|||
144522712|NCT01902173|521114974|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
144522713|NCT01902173|521114975|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
144522714|NCT01902173|521114976|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
144522715|NCT01902173|521114977|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
144522716|NCT01902173|521114978|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
144522717|NCT01902173|521114973|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
144522718|NCT01902173|521114974|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
144522719|NCT01902173|521114975|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
144522720|NCT01902173|521114976|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
144522721|NCT01902173|521114977|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
144522722|NCT01902173|521114978|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
144522723|NCT01902173|521114973|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
144522724|NCT01902173|521114974|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
144522725|NCT01902173|521114975|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
144522726|NCT01902173|521114976|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
144522727|NCT01902173|521114977|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
144522728|NCT01902173|521114978|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
144522729|NCT01902173|521114973|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
144522730|NCT01902173|521114974|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
144522731|NCT01902173|521114975|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
144522732|NCT01902173|521114976|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
144522733|NCT01902173|521114977|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
144522734|NCT01902173|521114978|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
144522735|NCT01902173|521114973|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
144522736|NCT01902173|521114974|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
144522737|NCT01902173|521114975|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
144522738|NCT01902173|521114976|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
144522739|NCT01902173|521114977|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
144522740|NCT01902173|521114978|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
144522741|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
144522742|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
144522743|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
144522744|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
144522745|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
144522746|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
144522747|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
144522748|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
144522749|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
144522750|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
144522751|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
144522752|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
144522753|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
144522754|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
144522755|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
144522756|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
144522757|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
144522758|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
144522759|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
144522760|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
144400150|NCT02281773|520676446|FG003|Overall Study|Withdrawal by Subject|6|||
144400151|NCT02281773|520676447|FG004|Overall Study|Withdrawal by Subject|8|||
144400152|NCT02281773|520676443|FG000|Overall Study|Other Reason|0|||
144400153|NCT02281773|520676444|FG001|Overall Study|Other Reason|4|||
144522761|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
144522762|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
144722346|NCT00812253|521838686|FG000|Overall Study|Protocol Violation|1|||
144400154|NCT02281773|520676445|FG002|Overall Study|Other Reason|2|||
144249753|NCT01857102|520111729|FG001|Period 1|Unsatisfactory Lens Fit|0|||
144249754|NCT01857102|520111728|FG000|Period 1|Unsatisfactory Visual Response|1|||
144249755|NCT01857102|520111729|FG001|Period 1|Unsatisfactory Visual Response|0|||
144249756|NCT01857102|520111728|FG000|Period 1|Physician Decision|1|||
144249757|NCT01857102|520111729|FG001|Period 1|Physician Decision|0|||
144249758|NCT01857102|520111728|FG000|Period 2|Lens Discomfort|1|||
144249759|NCT01857102|520111729|FG001|Period 2|Lens Discomfort|0|||
144249760|NCT01857102|520111728|FG000|Period 2|Unsatisfactory Lens Fit|1|||
144249761|NCT01857102|520111729|FG001|Period 2|Unsatisfactory Lens Fit|0|||
144249762|NCT00090584|520111732|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
144249763|NCT00090584|520111733|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
144522763|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
144522764|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
144522765|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
144522766|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
144522767|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
144522768|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
144522769|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
144522770|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
144522771|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
144522772|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
144522773|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
144522774|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
144522775|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
144522776|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
144522777|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
144522778|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
144522779|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
144522780|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
144522781|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
144522782|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
144522783|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
144522784|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
144522785|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
144522786|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
144522787|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
144522788|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
144522789|NCT01902173|521114973|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
144522790|NCT01902173|521114974|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
144522791|NCT01902173|521114975|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
144522792|NCT01902173|521114976|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
144522793|NCT01902173|521114977|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
144522794|NCT01902173|521114978|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
144522795|NCT04625283|521114980|FG000|Overall Study|post randomization exclusion|28|||
144522796|NCT04625283|521114981|FG001|Overall Study|post randomization exclusion|20|||
144522797|NCT02262728|521114982|FG000|Follow-up Phase (3 Years)|Death|0|||
144522798|NCT02262728|521114983|FG001|Follow-up Phase (3 Years)|Death|1|||
144522799|NCT02262728|521114982|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
144522800|NCT02262728|521114983|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
144522801|NCT02262728|521114982|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
144522802|NCT02262728|521114983|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
144522803|NCT01824394|521114986|FG000|Overall Study|Early Termination|1|||
144522804|NCT01824394|521114987|FG001|Overall Study|Early Termination|1|||
144522805|NCT01824394|521114988|FG002|Overall Study|Early Termination|3|||
144522806|NCT01824394|521114986|FG000|Overall Study|Withdrawn due to Study Termination|91|||
144522807|NCT01824394|521114987|FG001|Overall Study|Withdrawn due to Study Termination|83|||
144522808|NCT01824394|521114988|FG002|Overall Study|Withdrawn due to Study Termination|41|||
144522809|NCT01824394|521114986|FG000|Overall Study|Lost to Follow-up|0|||
144522810|NCT01824394|521114987|FG001|Overall Study|Lost to Follow-up|9|||
144522811|NCT01824394|521114988|FG002|Overall Study|Lost to Follow-up|3|||
144522812|NCT01824394|521114986|FG000|Overall Study|Death|3|||
144522813|NCT01824394|521114987|FG001|Overall Study|Death|2|||
144522814|NCT01824394|521114988|FG002|Overall Study|Death|4|||
144522815|NCT01824394|521114986|FG000|Overall Study|Discontinued Subjects|1|||
144522816|NCT01824394|521114987|FG001|Overall Study|Discontinued Subjects|1|||
144522817|NCT01824394|521114988|FG002|Overall Study|Discontinued Subjects|2|||
144522818|NCT01824394|521114986|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
144522819|NCT01824394|521114987|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
144522820|NCT01824394|521114988|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
144522821|NCT05020249|521114989|FG000|Overall Study|Protocol Violation|1|||
144522822|NCT05020249|521114990|FG001|Overall Study|Protocol Violation|0|||
144522823|NCT05364671|521114991|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
144249764|NCT00090584|520111732|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
144400155|NCT02281773|520676446|FG003|Overall Study|Other Reason|3|||
144400156|NCT02281773|520676447|FG004|Overall Study|Other Reason|1|||
144522824|NCT05364671|521114992|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
144522825|NCT05364671|521114991|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
144522826|NCT05364671|521114992|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
144400157|NCT05439941|520676449|FG000|Overall Study|Lack of Efficacy|8|||
144400158|NCT05439941|520676450|FG001|Overall Study|Lack of Efficacy|5|||
144400159|NCT05439941|520676451|FG002|Overall Study|Lack of Efficacy|3|||
144400160|NCT05439941|520676449|FG000|Overall Study|Treatment Failure|0|||
144400161|NCT05439941|520676450|FG001|Overall Study|Treatment Failure|1|||
144400162|NCT05439941|520676451|FG002|Overall Study|Treatment Failure|0|||
144400163|NCT05439941|520676449|FG000|Overall Study|Adverse Event|1|||
144400164|NCT05439941|520676450|FG001|Overall Study|Adverse Event|3|||
144400165|NCT05439941|520676451|FG002|Overall Study|Adverse Event|0|||
144400166|NCT05439941|520676449|FG000|Overall Study|Adverse Event - Parent Study|1|||
144400167|NCT05439941|520676450|FG001|Overall Study|Adverse Event - Parent Study|0|||
144400168|NCT05439941|520676451|FG002|Overall Study|Adverse Event - Parent Study|0|||
144400169|NCT05439941|520676449|FG000|Overall Study|Pregnancy|1|||
144400170|NCT05439941|520676450|FG001|Overall Study|Pregnancy|0|||
144400171|NCT05439941|520676451|FG002|Overall Study|Pregnancy|0|||
144400172|NCT05439941|520676449|FG000|Overall Study|Withdrawal by Subject|9|||
144400173|NCT05439941|520676450|FG001|Overall Study|Withdrawal by Subject|6|||
144400174|NCT05439941|520676451|FG002|Overall Study|Withdrawal by Subject|10|||
144400175|NCT05439941|520676449|FG000|Overall Study|Non-Compliance|1|||
144400176|NCT05439941|520676450|FG001|Overall Study|Non-Compliance|1|||
144400177|NCT05439941|520676451|FG002|Overall Study|Non-Compliance|1|||
144400178|NCT05439941|520676449|FG000|Overall Study|Lost to Follow-up|2|||
144400179|NCT05439941|520676450|FG001|Overall Study|Lost to Follow-up|2|||
144400180|NCT05439941|520676451|FG002|Overall Study|Lost to Follow-up|0|||
144400181|NCT05439941|520676449|FG000|Overall Study|Physician Decision|1|||
144400182|NCT05439941|520676450|FG001|Overall Study|Physician Decision|0|||
144400183|NCT05439941|520676451|FG002|Overall Study|Physician Decision|0|||
144400184|NCT05439941|520676449|FG000|Overall Study|Trial Termination by Sponsor|78|||
144400185|NCT05439941|520676450|FG001|Overall Study|Trial Termination by Sponsor|83|||
144400186|NCT05439941|520676451|FG002|Overall Study|Trial Termination by Sponsor|65|||
144400187|NCT05439941|520676449|FG000|Overall Study|Other than Reasons Listed|2|||
144400188|NCT05439941|520676450|FG001|Overall Study|Other than Reasons Listed|1|||
144400189|NCT05439941|520676451|FG002|Overall Study|Other than Reasons Listed|0|||
144400190|NCT00573183|520676452|FG000|Overall Study|Lost to Follow-up|52|||
144400191|NCT00573183|520676453|FG001|Overall Study|Lost to Follow-up|50|||
144400192|NCT00573183|520676452|FG000|Overall Study|Withdrawal by Subject|8|||
144400193|NCT00573183|520676453|FG001|Overall Study|Withdrawal by Subject|2|||
144400194|NCT00573183|520676452|FG000|Overall Study|Death|0|||
144400195|NCT00573183|520676453|FG001|Overall Study|Death|1|||
144522827|NCT05364671|521114991|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
144522828|NCT05364671|521114992|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
144522829|NCT05364671|521114991|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
144522830|NCT05364671|521114992|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
144522831|NCT05364671|521114991|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
144522832|NCT05364671|521114992|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
144722347|NCT00812253|521838687|FG001|Overall Study|Protocol Violation|1|||
144400196|NCT00573183|520676452|FG000|Overall Study|Adverse Event|2|||
144400197|NCT00573183|520676453|FG001|Overall Study|Adverse Event|0|||
144400198|NCT00573183|520676452|FG000|Overall Study|Incarceration|5|||
144400199|NCT00573183|520676453|FG001|Overall Study|Incarceration|8|||
144400200|NCT00573183|520676452|FG000|Overall Study|Other|5|||
144400201|NCT00573183|520676453|FG001|Overall Study|Other|2|||
144400202|NCT01926015|520676456|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144400203|NCT01926015|520676457|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144400204|NCT01926015|520676456|FG000|Overall Study|Randomized not treated|2|||
144400205|NCT01926015|520676457|FG001|Overall Study|Randomized not treated|0|||
144400206|NCT01364649|520676458|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
144400207|NCT01364649|520676459|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
144400208|NCT01364649|520676458|FG000|Overall Study|Lack of Efficacy|6|||
144400209|NCT01364649|520676459|FG001|Overall Study|Lack of Efficacy|0|||
144400210|NCT01364649|520676458|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
144400211|NCT01364649|520676459|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
144400212|NCT01364649|520676458|FG000|Overall Study|Protocol Deviations|4|||
144400213|NCT01364649|520676459|FG001|Overall Study|Protocol Deviations|8|||
144400214|NCT01364649|520676458|FG000|Overall Study|Withdrawal of Consent|9|||
144400215|NCT01364649|520676459|FG001|Overall Study|Withdrawal of Consent|7|||
144400216|NCT01364649|520676458|FG000|Overall Study|Lost to Follow-up|12|||
144400217|NCT01364649|520676459|FG001|Overall Study|Lost to Follow-up|13|||
144400218|NCT01364649|520676458|FG000|Overall Study|Other|4|||
144400219|NCT01364649|520676459|FG001|Overall Study|Other|1|||
144400220|NCT02468232|520676462|FG000|Core Part of Study|Adverse Event|0|||
144400221|NCT02468232|520676463|FG001|Core Part of Study|Adverse Event|1|||
144400222|NCT02468232|520676464|FG002|Core Part of Study|Adverse Event|0|||
144400223|NCT02468232|520676465|FG003|Core Part of Study|Adverse Event|0|||
144400224|NCT02468232|520676462|FG000|Core Part of Study|Death|20|||
144400225|NCT02468232|520676463|FG001|Core Part of Study|Death|17|||
144400226|NCT02468232|520676464|FG002|Core Part of Study|Death|0|||
144400227|NCT02468232|520676465|FG003|Core Part of Study|Death|0|||
144400228|NCT02468232|520676462|FG000|Core Part of Study|Technical Problems|1|||
144400229|NCT02468232|520676463|FG001|Core Part of Study|Technical Problems|1|||
144400230|NCT02468232|520676464|FG002|Core Part of Study|Technical Problems|0|||
144400231|NCT02468232|520676465|FG003|Core Part of Study|Technical Problems|0|||
144400232|NCT02468232|520676462|FG000|OLE Part of Study|Adverse Event|0|||
144400233|NCT02468232|520676463|FG001|OLE Part of Study|Adverse Event|0|||
144400234|NCT02468232|520676464|FG002|OLE Part of Study|Adverse Event|4|||
144400235|NCT02468232|520676465|FG003|OLE Part of Study|Adverse Event|5|||
144400236|NCT02468232|520676462|FG000|OLE Part of Study|Death|0|||
144400237|NCT02468232|520676463|FG001|OLE Part of Study|Death|0|||
144400238|NCT02468232|520676464|FG002|OLE Part of Study|Death|4|||
144400239|NCT02468232|520676465|FG003|OLE Part of Study|Death|2|||
144522833|NCT05780437|521114995|FG000|Overall Study|Withdrawal by Subject|22|||
144522834|NCT05780437|521114996|FG001|Overall Study|Withdrawal by Subject|16|||
144522835|NCT03536754|521114997|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
144522836|NCT03536754|521114998|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
144522837|NCT03536754|521114999|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
144522838|NCT03536754|521115000|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
144522839|NCT03536754|521115001|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
144522840|NCT03536754|521114997|FG000|Open Label Extension|Other|0|||
144522841|NCT03536754|521114998|FG001|Open Label Extension|Other|0|||
144522842|NCT03536754|521114999|FG002|Open Label Extension|Other|0|||
144522843|NCT03536754|521115000|FG003|Open Label Extension|Other|0|||
144522844|NCT03536754|521115001|FG004|Open Label Extension|Other|1|||
144522845|NCT03382652|521115002|FG000|Overall Study|Lost to Follow-up|6|||
144522846|NCT03382652|521115002|FG000|Overall Study|Death|4|||
144522847|NCT03382652|521115002|FG000|Overall Study|Revision|5|||
144522848|NCT03382652|521115002|FG000|Overall Study|Patient withdrew|3|||
144522849|NCT03382652|521115002|FG000|Overall Study|Other reasons|21|||
144400240|NCT02468232|520676462|FG000|OLE Part of Study|Physician Decision|0|||
144400241|NCT02468232|520676463|FG001|OLE Part of Study|Physician Decision|0|||
144400242|NCT02468232|520676464|FG002|OLE Part of Study|Physician Decision|4|||
144400243|NCT02468232|520676465|FG003|OLE Part of Study|Physician Decision|0|||
144522850|NCT04810650|521115004|FG000|Overall Study|Disenrolled in error|0|||
144522851|NCT04810650|521115005|FG001|Overall Study|Disenrolled in error|0|||
144522852|NCT04810650|521115006|FG002|Overall Study|Disenrolled in error|0|||
144400244|NCT02468232|520676462|FG000|OLE Part of Study|Subject/Guardian decision|0|||
144400245|NCT02468232|520676463|FG001|OLE Part of Study|Subject/Guardian decision|0|||
144400246|NCT02468232|520676464|FG002|OLE Part of Study|Subject/Guardian decision|2|||
144400247|NCT02468232|520676465|FG003|OLE Part of Study|Subject/Guardian decision|5|||
144400248|NCT00902668|520676466|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
144400249|NCT00615108|520676467|FG000|Overall Study|Adverse Event|122|||
144400250|NCT00615108|520676467|FG000|Overall Study|Other|370|||
144400251|NCT00615108|520676467|FG000|Overall Study|Lost to Follow-up|15|||
144522853|NCT04810650|521115007|FG003|Overall Study|Disenrolled in error|0|||
144522854|NCT04810650|521115008|FG004|Overall Study|Disenrolled in error|0|||
144522855|NCT04810650|521115009|FG005|Overall Study|Disenrolled in error|0|||
144522856|NCT04810650|521115010|FG006|Overall Study|Disenrolled in error|0|||
144400252|NCT01914757|520676468|FG000|Overall Study|Severe non-compliance to protocol|3|||
144400253|NCT01914757|520676469|FG001|Overall Study|Severe non-compliance to protocol|1|||
144400254|NCT01914757|520676470|FG002|Overall Study|Severe non-compliance to protocol|2|||
144400255|NCT01914757|520676468|FG000|Overall Study|Lost to Follow-up|5|||
144400256|NCT01914757|520676469|FG001|Overall Study|Lost to Follow-up|8|||
144400257|NCT01914757|520676470|FG002|Overall Study|Lost to Follow-up|6|||
144400258|NCT01914757|520676468|FG000|Overall Study|Withdrawal by Subject|15|||
144400259|NCT01914757|520676469|FG001|Overall Study|Withdrawal by Subject|27|||
144400260|NCT01914757|520676470|FG002|Overall Study|Withdrawal by Subject|19|||
144400261|NCT01914757|520676468|FG000|Overall Study|Death|2|||
144400262|NCT01914757|520676469|FG001|Overall Study|Death|2|||
144400263|NCT01914757|520676470|FG002|Overall Study|Death|1|||
144400264|NCT01914757|520676468|FG000|Overall Study|Adverse Event|4|||
144400265|NCT01914757|520676469|FG001|Overall Study|Adverse Event|3|||
144400266|NCT01914757|520676470|FG002|Overall Study|Adverse Event|4|||
144400267|NCT01914757|520676468|FG000|Overall Study|Study specific withdrawal criteria|0|||
144400268|NCT01914757|520676469|FG001|Overall Study|Study specific withdrawal criteria|1|||
144400269|NCT01914757|520676470|FG002|Overall Study|Study specific withdrawal criteria|0|||
144400270|NCT01914757|520676468|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144400271|NCT01914757|520676469|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144400272|NCT01914757|520676470|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
144400273|NCT01914757|520676468|FG000|Overall Study|Other reasons|5|||
144400274|NCT01914757|520676469|FG001|Overall Study|Other reasons|9|||
144400275|NCT01914757|520676470|FG002|Overall Study|Other reasons|4|||
144400276|NCT01147640|520676474|FG000|Overall Study|Adverse Event|2|||
144400277|NCT01147640|520676475|FG001|Overall Study|Adverse Event|0|||
144400278|NCT01147640|520676474|FG000|Overall Study|Physician Decision|1|||
144400279|NCT01147640|520676475|FG001|Overall Study|Physician Decision|0|||
144400280|NCT01147640|520676474|FG000|Overall Study|Withdrawal by Subject|1|||
144400281|NCT01147640|520676475|FG001|Overall Study|Withdrawal by Subject|0|||
144400282|NCT01147640|520676474|FG000|Overall Study|Lost to Follow-up|0|||
144400283|NCT01147640|520676475|FG001|Overall Study|Lost to Follow-up|1|||
144400284|NCT01147640|520676474|FG000|Overall Study|Didn't meet eligibility criteria|1|||
144400285|NCT01147640|520676475|FG001|Overall Study|Didn't meet eligibility criteria|0|||
144400286|NCT01856907|520676478|FG000|Overall Study|Pregnancy|0|||
144400287|NCT01856907|520676479|FG001|Overall Study|Pregnancy|1|||
144522857|NCT04810650|521115011|FG007|Overall Study|Disenrolled in error|0|||
144522858|NCT04810650|521115012|FG008|Overall Study|Disenrolled in error|1|||
144522859|NCT04810650|521115013|FG009|Overall Study|Disenrolled in error|0|||
144522860|NCT04810650|521115014|FG010|Overall Study|Disenrolled in error|0|||
144522861|NCT04810650|521115015|FG011|Overall Study|Disenrolled in error|0|||
144522862|NCT04810650|521115016|FG012|Overall Study|Disenrolled in error|0|||
144522863|NCT04810650|521115017|FG013|Overall Study|Disenrolled in error|0|||
144522864|NCT04810650|521115004|FG000|Overall Study|Death|0|||
144522865|NCT04810650|521115005|FG001|Overall Study|Death|0|||
144522866|NCT04810650|521115006|FG002|Overall Study|Death|0|||
144522867|NCT04810650|521115007|FG003|Overall Study|Death|0|||
144522868|NCT04810650|521115008|FG004|Overall Study|Death|0|||
144522869|NCT04810650|521115009|FG005|Overall Study|Death|0|||
144522870|NCT04810650|521115010|FG006|Overall Study|Death|2|||
144522871|NCT04810650|521115011|FG007|Overall Study|Death|2|||
144522872|NCT04810650|521115012|FG008|Overall Study|Death|0|||
144522873|NCT04810650|521115013|FG009|Overall Study|Death|1|||
144522874|NCT04810650|521115014|FG010|Overall Study|Death|0|||
144522875|NCT04810650|521115015|FG011|Overall Study|Death|0|||
144522876|NCT04810650|521115016|FG012|Overall Study|Death|2|||
144522877|NCT04810650|521115017|FG013|Overall Study|Death|1|||
144522878|NCT04810650|521115004|FG000|Overall Study|Moved/transferred care|0|||
144522879|NCT04810650|521115005|FG001|Overall Study|Moved/transferred care|0|||
144522880|NCT04810650|521115006|FG002|Overall Study|Moved/transferred care|0|||
144522881|NCT04810650|521115007|FG003|Overall Study|Moved/transferred care|0|||
144522882|NCT04810650|521115008|FG004|Overall Study|Moved/transferred care|0|||
144522883|NCT04810650|521115009|FG005|Overall Study|Moved/transferred care|0|||
144522884|NCT04810650|521115010|FG006|Overall Study|Moved/transferred care|0|||
144522885|NCT04810650|521115011|FG007|Overall Study|Moved/transferred care|1|||
144522886|NCT04810650|521115012|FG008|Overall Study|Moved/transferred care|12|||
144522887|NCT04810650|521115013|FG009|Overall Study|Moved/transferred care|10|||
144522888|NCT04810650|521115014|FG010|Overall Study|Moved/transferred care|0|||
144400288|NCT01856907|520676480|FG002|Overall Study|Pregnancy|0|||
144400289|NCT01856907|520676478|FG000|Overall Study|Pregnancy|0|||
144522889|NCT04810650|521115015|FG011|Overall Study|Moved/transferred care|0|||
144400290|NCT01856907|520676479|FG001|Overall Study|Pregnancy|1|||
144400291|NCT01856907|520676480|FG002|Overall Study|Pregnancy|0|||
144400292|NCT01856907|520676478|FG000|Overall Study|Withdrawal by Subject|0|||
144400293|NCT01856907|520676479|FG001|Overall Study|Withdrawal by Subject|1|||
144522890|NCT04810650|521115016|FG012|Overall Study|Moved/transferred care|0|||
144400294|NCT01856907|520676480|FG002|Overall Study|Withdrawal by Subject|0|||
144400295|NCT01797731|520676481|FG000|Overall Study|Didn't have proper radiographs required|3|||
144400296|NCT01797731|520676482|FG001|Overall Study|Didn't have proper radiographs required|3|||
144400297|NCT00091442|520676484|FG000|Overall Study|Progressive Disease|220|||
144400298|NCT00091442|520676485|FG001|Overall Study|Progressive Disease|189|||
144400299|NCT00091442|520676484|FG000|Overall Study|Physician Decision|61|||
144400300|NCT00091442|520676485|FG001|Overall Study|Physician Decision|58|||
144400301|NCT00091442|520676484|FG000|Overall Study|Withdrawal by Subject|38|||
144400302|NCT00091442|520676485|FG001|Overall Study|Withdrawal by Subject|46|||
144400303|NCT00091442|520676484|FG000|Overall Study|Adverse Event|29|||
144400304|NCT00091442|520676485|FG001|Overall Study|Adverse Event|48|||
144400305|NCT00091442|520676484|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
144400306|NCT00091442|520676485|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
144400307|NCT00091442|520676484|FG000|Overall Study|Death|9|||
144400308|NCT00091442|520676485|FG001|Overall Study|Death|7|||
144400309|NCT00091442|520676484|FG000|Overall Study|Lost to Follow-up|1|||
144596361|NCT02683941|521384474|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
144596362|NCT02683941|521384475|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
144596363|NCT02683941|521384474|FG000|Open-label Treatment Phase|Disease Progression|1|||
144249765|NCT00090584|520111733|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
144400310|NCT00091442|520676485|FG001|Overall Study|Lost to Follow-up|3|||
144596364|NCT02683941|521384475|FG001|Open-label Treatment Phase|Disease Progression|2|||
144596365|NCT02683941|521384474|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
144400311|NCT00091442|520676484|FG000|Overall Study|Other|2|||
144596366|NCT02683941|521384475|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
144400312|NCT00091442|520676485|FG001|Overall Study|Other|6|||
144400313|NCT00917501|520676486|FG000|Overall Study|Lost to Follow-up|4|||
144400314|NCT00917501|520676487|FG001|Overall Study|Lost to Follow-up|1|||
144596367|NCT02683941|521384474|FG000|Open-label Treatment Phase|Other|1|||
144596368|NCT02683941|521384475|FG001|Open-label Treatment Phase|Other|0|||
144400315|NCT00917501|520676486|FG000|Overall Study|Withdrawal by Subject|3|||
144400316|NCT00917501|520676487|FG001|Overall Study|Withdrawal by Subject|1|||
144400317|NCT00917501|520676486|FG000|Overall Study|Lack of Efficacy|1|||
144522891|NCT04810650|521115017|FG013|Overall Study|Moved/transferred care|0|||
144522892|NCT04810650|521115004|FG000|Overall Study|Lost to Follow-up|15|||
144400318|NCT00917501|520676487|FG001|Overall Study|Lack of Efficacy|2|||
144400319|NCT00917501|520676486|FG000|Overall Study|trouble swollowing capsules|0|||
144400320|NCT00917501|520676487|FG001|Overall Study|trouble swollowing capsules|1|||
144522893|NCT04810650|521115005|FG001|Overall Study|Lost to Follow-up|12|||
144522894|NCT04810650|521115006|FG002|Overall Study|Lost to Follow-up|7|||
144522895|NCT04810650|521115007|FG003|Overall Study|Lost to Follow-up|9|||
144522896|NCT04810650|521115008|FG004|Overall Study|Lost to Follow-up|10|||
144522897|NCT04810650|521115009|FG005|Overall Study|Lost to Follow-up|6|||
144522898|NCT04810650|521115010|FG006|Overall Study|Lost to Follow-up|0|||
144522899|NCT04810650|521115011|FG007|Overall Study|Lost to Follow-up|0|||
144522900|NCT04810650|521115012|FG008|Overall Study|Lost to Follow-up|0|||
144522901|NCT04810650|521115013|FG009|Overall Study|Lost to Follow-up|0|||
144522902|NCT04810650|521115014|FG010|Overall Study|Lost to Follow-up|1|||
144522903|NCT04810650|521115015|FG011|Overall Study|Lost to Follow-up|0|||
144522904|NCT04810650|521115016|FG012|Overall Study|Lost to Follow-up|3|||
144522905|NCT04810650|521115017|FG013|Overall Study|Lost to Follow-up|9|||
144522906|NCT04810650|521115004|FG000|Overall Study|Participant declined|0|||
144522907|NCT04810650|521115005|FG001|Overall Study|Participant declined|0|||
144522908|NCT04810650|521115006|FG002|Overall Study|Participant declined|0|||
144522909|NCT04810650|521115007|FG003|Overall Study|Participant declined|0|||
144522910|NCT04810650|521115008|FG004|Overall Study|Participant declined|0|||
144522911|NCT04810650|521115009|FG005|Overall Study|Participant declined|0|||
144522912|NCT04810650|521115010|FG006|Overall Study|Participant declined|0|||
144522913|NCT04810650|521115011|FG007|Overall Study|Participant declined|0|||
144522914|NCT04810650|521115012|FG008|Overall Study|Participant declined|0|||
144596369|NCT02683941|521384474|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
144522915|NCT04810650|521115013|FG009|Overall Study|Participant declined|0|||
144522916|NCT04810650|521115014|FG010|Overall Study|Participant declined|2|||
144522917|NCT04810650|521115015|FG011|Overall Study|Participant declined|0|||
144522918|NCT04810650|521115016|FG012|Overall Study|Participant declined|0|||
144522919|NCT04810650|521115017|FG013|Overall Study|Participant declined|0|||
144522920|NCT05794243|521115018|FG000|Overall Study|Withdrawal by Subject|1|||
144522921|NCT05794243|521115019|FG001|Overall Study|Withdrawal by Subject|0|||
144522922|NCT05794243|521115020|FG002|Overall Study|Withdrawal by Subject|1|||
144522923|NCT05794243|521115018|FG000|Overall Study|Physician Decision|0|||
144522924|NCT05794243|521115019|FG001|Overall Study|Physician Decision|3|||
144522925|NCT05794243|521115020|FG002|Overall Study|Physician Decision|1|||
144522926|NCT04788511|521115023|FG000|Overall Study|Withdrawal by Subject|2|||
144522927|NCT04788511|521115024|FG001|Overall Study|Withdrawal by Subject|1|||
144522928|NCT04788511|521115023|FG000|Overall Study|Lost to Follow-up|2|||
144522929|NCT04788511|521115024|FG001|Overall Study|Lost to Follow-up|7|||
144522930|NCT04788511|521115023|FG000|Overall Study|Death|3|||
144522931|NCT04788511|521115024|FG001|Overall Study|Death|4|||
144522932|NCT04652700|521115025|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
144522933|NCT04652700|521115026|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
144400321|NCT00986830|520676496|FG000|Overall Study|Death|1|||
144522934|NCT04652700|521115025|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
144522935|NCT04652700|521115026|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
144522936|NCT04652700|521115025|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
144522937|NCT04652700|521115026|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
144522938|NCT04652700|521115025|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
144522939|NCT04652700|521115026|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
144522940|NCT04652700|521115025|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
144522941|NCT04652700|521115026|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
144522942|NCT04652700|521115025|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
144522943|NCT04652700|521115026|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
144522944|NCT04652700|521115025|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
144522945|NCT04652700|521115026|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
144522946|NCT04652700|521115025|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
144522947|NCT04652700|521115026|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
144522948|NCT04652700|521115025|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
144522949|NCT04652700|521115026|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
144522950|NCT04187833|521115027|FG000|Overall Study|Withdrawal by Subject|1|||
144522951|NCT04209465|521115030|FG000|Overall Study|Adverse Event|0|||
144522952|NCT04209465|521115031|FG001|Overall Study|Adverse Event|0|||
144522953|NCT04209465|521115032|FG002|Overall Study|Adverse Event|0|||
144522954|NCT04209465|521115033|FG003|Overall Study|Adverse Event|0|||
144522955|NCT04209465|521115034|FG004|Overall Study|Adverse Event|0|||
144522956|NCT04209465|521115035|FG005|Overall Study|Adverse Event|1|||
144522957|NCT04209465|521115036|FG006|Overall Study|Adverse Event|0|||
144522958|NCT04209465|521115037|FG007|Overall Study|Adverse Event|0|||
144522959|NCT04209465|521115038|FG008|Overall Study|Adverse Event|1|||
144522960|NCT04209465|521115039|FG009|Overall Study|Adverse Event|0|||
144596370|NCT02683941|521384475|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
144249766|NCT01080391|520111737|FG000|Overall Study|Randomized but not treated|7|||
144522961|NCT04209465|521115040|FG010|Overall Study|Adverse Event|2|||
144522962|NCT04209465|521115041|FG011|Overall Study|Adverse Event|1|||
144522963|NCT04209465|521115042|FG012|Overall Study|Adverse Event|1|||
144522964|NCT04209465|521115030|FG000|Overall Study|Death|1|||
144522965|NCT04209465|521115031|FG001|Overall Study|Death|0|||
144522966|NCT04209465|521115032|FG002|Overall Study|Death|0|||
144522967|NCT04209465|521115033|FG003|Overall Study|Death|0|||
144400322|NCT00986830|520676496|FG000|Overall Study|Lost to Follow-up|1|||
144400323|NCT00986830|520676496|FG000|Overall Study|Lack of Efficacy|1|||
144400324|NCT00986830|520676496|FG000|Overall Study|Unable to access sinus with device|5|||
144400325|NCT00808483|520676497|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
144400326|NCT00808483|520676498|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
144596371|NCT02683941|521384474|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
144596372|NCT02683941|521384475|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
144596373|NCT02683941|521384474|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
144596374|NCT02683941|521384475|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
144596375|NCT02683941|521384474|FG000|Open-label Follow-up Phase|Other|8|||
144596376|NCT02683941|521384475|FG001|Open-label Follow-up Phase|Other|1|||
144596377|NCT00261846|521384476|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
144596378|NCT00261846|521384477|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
144596379|NCT00261846|521384478|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
144596380|NCT00261846|521384479|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596381|NCT00261846|521384480|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596382|NCT00261846|521384481|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596383|NCT00261846|521384482|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596384|NCT00261846|521384483|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596385|NCT00261846|521384484|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596386|NCT00261846|521384485|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596387|NCT00261846|521384486|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596388|NCT00261846|521384487|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
144596389|NCT00261846|521384476|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596390|NCT00261846|521384477|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596391|NCT00261846|521384478|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144400327|NCT00808483|520676497|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
144400328|NCT00808483|520676498|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
144400329|NCT00808483|520676497|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
144400330|NCT00808483|520676498|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
144400331|NCT01453725|520676499|FG000|Overall Study|Adverse Event|3|||
144400332|NCT01453725|520676500|FG001|Overall Study|Adverse Event|3|||
144596392|NCT00261846|521384479|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
144596393|NCT00261846|521384480|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596394|NCT00261846|521384481|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596395|NCT00261846|521384482|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596396|NCT00261846|521384483|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596397|NCT00261846|521384484|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
144596398|NCT00261846|521384485|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596399|NCT00261846|521384486|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596400|NCT00261846|521384487|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
144596401|NCT00261846|521384476|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
144596402|NCT00261846|521384477|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
144596403|NCT00261846|521384478|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
144596404|NCT00261846|521384479|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
144596405|NCT00261846|521384480|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
144596406|NCT00261846|521384481|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
144596407|NCT00261846|521384482|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
144596408|NCT00261846|521384483|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
144596409|NCT00261846|521384484|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
144596410|NCT00261846|521384485|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
144400333|NCT01453725|520676499|FG000|Overall Study|Lost to Follow-up|4|||
144596411|NCT00261846|521384486|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
144596412|NCT00261846|521384487|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
144596413|NCT00261846|521384476|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
144596414|NCT00261846|521384477|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
144596415|NCT00261846|521384478|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
144596416|NCT00261846|521384479|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
144596417|NCT00261846|521384480|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
144596418|NCT00261846|521384481|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
144596419|NCT00261846|521384482|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
144596420|NCT00261846|521384483|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
144596421|NCT00261846|521384484|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
144596422|NCT00261846|521384485|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
144596423|NCT00261846|521384486|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
144596424|NCT00261846|521384487|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
144596425|NCT00261846|521384476|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
144596426|NCT00261846|521384477|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
144596427|NCT00261846|521384478|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
144596428|NCT00261846|521384479|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
144596429|NCT00261846|521384480|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
144596430|NCT00261846|521384481|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
144596431|NCT00261846|521384482|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
144596432|NCT00261846|521384483|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
144596433|NCT00261846|521384484|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
144596434|NCT00261846|521384485|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
144596435|NCT00261846|521384486|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
144596436|NCT00261846|521384487|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
144596437|NCT00261846|521384476|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
144596438|NCT00261846|521384477|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
144596439|NCT00261846|521384478|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
144596440|NCT00261846|521384479|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
144596441|NCT00261846|521384480|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
144596442|NCT00261846|521384481|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
144596443|NCT00261846|521384482|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
144400334|NCT01453725|520676500|FG001|Overall Study|Lost to Follow-up|0|||
144400335|NCT01453725|520676499|FG000|Overall Study|Non-compliance With Protocol|1|||
144596444|NCT00261846|521384483|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
144596445|NCT00261846|521384484|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
144596446|NCT00261846|521384485|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
144596447|NCT00261846|521384486|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
144596448|NCT00261846|521384487|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
144596449|NCT00261846|521384476|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
144596450|NCT00261846|521384477|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
144596451|NCT00261846|521384478|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
144596452|NCT00261846|521384479|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
144596453|NCT00261846|521384480|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
144596454|NCT00261846|521384481|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
144596455|NCT00261846|521384482|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
144596456|NCT00261846|521384483|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
144596457|NCT00261846|521384484|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
144400336|NCT01453725|520676500|FG001|Overall Study|Non-compliance With Protocol|2|||
144400337|NCT01453725|520676499|FG000|Overall Study|Protocol Violation|1|||
144400338|NCT01453725|520676500|FG001|Overall Study|Protocol Violation|0|||
144400339|NCT01453725|520676499|FG000|Overall Study|Withdrawal by Subject|2|||
144400340|NCT01453725|520676500|FG001|Overall Study|Withdrawal by Subject|3|||
144400341|NCT01453725|520676499|FG000|Overall Study|Pregnancy Wish|0|||
144400342|NCT01453725|520676500|FG001|Overall Study|Pregnancy Wish|2|||
144400343|NCT01453725|520676499|FG000|Overall Study|Pregnancy|1|||
144596458|NCT00261846|521384485|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
144596459|NCT00261846|521384486|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
144596460|NCT00261846|521384487|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
144596461|NCT02168842|521384491|FG000|Overall Study|Withdrawal by Subject|5|||
144596462|NCT02168842|521384492|FG001|Overall Study|Withdrawal by Subject|3|||
144596463|NCT02168842|521384491|FG000|Overall Study|Lost to Follow-up|0|||
144596464|NCT02168842|521384492|FG001|Overall Study|Lost to Follow-up|2|||
144596465|NCT02168842|521384491|FG000|Overall Study|Death|2|||
144596466|NCT02168842|521384492|FG001|Overall Study|Death|1|||
144596467|NCT02168842|521384491|FG000|Overall Study|Physician Decision|1|||
144596468|NCT02168842|521384492|FG001|Overall Study|Physician Decision|2|||
144596469|NCT00325039|521384493|FG000|Overall Study|Lost to Follow-up|18|||
144596470|NCT00325039|521384494|FG001|Overall Study|Lost to Follow-up|14|||
144400344|NCT01453725|520676500|FG001|Overall Study|Pregnancy|0|||
144400345|NCT01453725|520676499|FG000|Overall Study|Physician Decision|1|||
144400346|NCT01453725|520676500|FG001|Overall Study|Physician Decision|1|||
144400347|NCT03945214|520676501|FG000|Overall Study|Lost to Follow-up|3|||
144400348|NCT03945214|520676502|FG001|Overall Study|Lost to Follow-up|4|||
144400349|NCT03945214|520676503|FG002|Overall Study|Lost to Follow-up|7|||
144400350|NCT03945214|520676504|FG003|Overall Study|Lost to Follow-up|4|||
144596471|NCT02147353|521384495|FG000|Overall Study|Lost to Follow-up|2|||
144596472|NCT02147353|521384496|FG001|Overall Study|Lost to Follow-up|0|||
144596473|NCT02147353|521384495|FG000|Overall Study|unable to make visits|4|||
144596474|NCT02147353|521384496|FG001|Overall Study|unable to make visits|0|||
144596475|NCT02147353|521384495|FG000|Overall Study|medication noncompliance|3|||
144400351|NCT01436396|520676505|FG000|Overall Study|Protocol Violation|7|||
144400352|NCT01436396|520676506|FG001|Overall Study|Protocol Violation|5|||
144400353|NCT01436396|520676505|FG000|Overall Study|Adverse Event|1|||
144400354|NCT01436396|520676506|FG001|Overall Study|Adverse Event|2|||
144400355|NCT01436396|520676505|FG000|Overall Study|Withdrawal by Subject|19|||
144400356|NCT01436396|520676506|FG001|Overall Study|Withdrawal by Subject|29|||
144400357|NCT01436396|520676505|FG000|Overall Study|Serious adverse event|2|||
144400358|NCT01436396|520676506|FG001|Overall Study|Serious adverse event|3|||
144400359|NCT01436396|520676505|FG000|Overall Study|Lost to Follow-up|3|||
144400360|NCT01436396|520676506|FG001|Overall Study|Lost to Follow-up|3|||
144400361|NCT02191137|520676509|FG000|Treatment|Death|4|||
144400362|NCT02191137|520676509|FG000|Treatment|Withdrawal by Subject|3|||
144400363|NCT02191137|520676509|FG000|Treatment|Adverse Event|2|||
144400364|NCT02191137|520676509|FG000|Treatment|Other|1|||
144400365|NCT02191137|520676509|FG000|Follow-up|Lost to Follow-up|2|||
144400366|NCT02191137|520676509|FG000|Follow-up|Ongoing/unknown|2|||
144400367|NCT02191137|520676509|FG000|Follow-up|Adverse Event|1|||
144400368|NCT01332331|520676510|FG000|Overall Study|Lost to Follow-up|0|||
144400369|NCT01332331|520676511|FG001|Overall Study|Lost to Follow-up|1|||
144400370|NCT01332331|520676510|FG000|Overall Study|Adverse Event|1|||
144400371|NCT01332331|520676511|FG001|Overall Study|Adverse Event|1|||
144400372|NCT01332331|520676510|FG000|Overall Study|Physician Decision|1|||
144400373|NCT01332331|520676511|FG001|Overall Study|Physician Decision|0|||
144400374|NCT00369707|520676515|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
144596476|NCT02147353|521384496|FG001|Overall Study|medication noncompliance|0|||
144596477|NCT02974088|521384500|FG000|Overall Study|Lost to Follow-up|0|||
144596478|NCT02974088|521384501|FG001|Overall Study|Lost to Follow-up|2|||
144596479|NCT02974088|521384500|FG000|Overall Study|Adverse Event|0|||
144596480|NCT02974088|521384501|FG001|Overall Study|Adverse Event|1|||
144596481|NCT00892723|521384502|FG000|Overall Study|Lost to Follow-up|1|||
144596482|NCT00892723|521384503|FG001|Overall Study|Lost to Follow-up|3|||
144596483|NCT00892723|521384504|FG002|Overall Study|Lost to Follow-up|1|||
144596484|NCT00892723|521384502|FG000|Overall Study|Withdrawal by Subject|1|||
144596485|NCT00892723|521384503|FG001|Overall Study|Withdrawal by Subject|1|||
144596486|NCT00892723|521384504|FG002|Overall Study|Withdrawal by Subject|1|||
144596487|NCT02121834|521384507|FG000|Overall Study|Protocol Violation|0|||
144596488|NCT02121834|521384508|FG001|Overall Study|Protocol Violation|1|||
144596489|NCT02121834|521384509|FG002|Overall Study|Protocol Violation|0|||
144596490|NCT02121834|521384510|FG003|Overall Study|Protocol Violation|0|||
144596491|NCT02121834|521384511|FG004|Overall Study|Protocol Violation|0|||
144596492|NCT02121834|521384512|FG005|Overall Study|Protocol Violation|0|||
144596493|NCT02121834|521384513|FG006|Overall Study|Protocol Violation|0|||
144400375|NCT00369707|520676515|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
144400376|NCT00369707|520676515|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
144400377|NCT00369707|520676515|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
144400378|NCT00369707|520676515|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
144400379|NCT00369707|520676515|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
144400380|NCT00369707|520676515|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
144400381|NCT00369707|520676515|FG000|Follow up for 2 Years After Treatment|Death|1|||
144400382|NCT00369707|520676515|FG000|Follow up for 2 Years After Treatment|Other|2|||
144400383|NCT03605212|520676521|FG000|Treatment Period|Adverse Event|1|||
144400384|NCT03605212|520676522|FG001|Treatment Period|Adverse Event|0|||
144400385|NCT03605212|520676523|FG002|Treatment Period|Adverse Event|0|||
144596494|NCT02121834|521384507|FG000|Overall Study|Withdrawal by Subject|0|||
144722348|NCT00812253|521838686|FG000|Overall Study|Lost to Follow-up|2|||
144596495|NCT02121834|521384508|FG001|Overall Study|Withdrawal by Subject|1|||
144596496|NCT02121834|521384509|FG002|Overall Study|Withdrawal by Subject|1|||
144596497|NCT02121834|521384510|FG003|Overall Study|Withdrawal by Subject|0|||
144596498|NCT02121834|521384511|FG004|Overall Study|Withdrawal by Subject|0|||
144400386|NCT03605212|520676524|FG003|Treatment Period|Adverse Event|0|||
144400387|NCT03605212|520676525|FG004|Treatment Period|Adverse Event|0|||
144400388|NCT03605212|520676521|FG000|Treatment Period|Physician Decision|0|||
144400389|NCT03605212|520676522|FG001|Treatment Period|Physician Decision|0|||
144400390|NCT03605212|520676523|FG002|Treatment Period|Physician Decision|0|||
144400391|NCT03605212|520676524|FG003|Treatment Period|Physician Decision|0|||
144400392|NCT03605212|520676525|FG004|Treatment Period|Physician Decision|1|||
144400393|NCT01756053|520676526|FG000|Period 1 (10 Days)|Protocol Violation|1|||
144471957|NCT03217747|520925357|FG004|Overall Study|Lack of Efficacy|3|||
144596499|NCT02121834|521384512|FG005|Overall Study|Withdrawal by Subject|0|||
144596500|NCT02121834|521384513|FG006|Overall Study|Withdrawal by Subject|0|||
144596501|NCT02121834|521384507|FG000|Overall Study|Lost to Follow-up|0|||
144596502|NCT02121834|521384508|FG001|Overall Study|Lost to Follow-up|0|||
144596503|NCT02121834|521384509|FG002|Overall Study|Lost to Follow-up|1|||
144522968|NCT04209465|521115034|FG004|Overall Study|Death|2|||
144522969|NCT04209465|521115035|FG005|Overall Study|Death|7|||
144522970|NCT04209465|521115036|FG006|Overall Study|Death|2|||
144522971|NCT04209465|521115037|FG007|Overall Study|Death|2|||
144522972|NCT04209465|521115038|FG008|Overall Study|Death|1|||
144522973|NCT04209465|521115039|FG009|Overall Study|Death|1|||
144522974|NCT04209465|521115040|FG010|Overall Study|Death|1|||
144522975|NCT04209465|521115041|FG011|Overall Study|Death|0|||
144522976|NCT04209465|521115042|FG012|Overall Study|Death|10|||
144596504|NCT02121834|521384510|FG003|Overall Study|Lost to Follow-up|0|||
144596505|NCT02121834|521384511|FG004|Overall Study|Lost to Follow-up|0|||
144596506|NCT02121834|521384512|FG005|Overall Study|Lost to Follow-up|0|||
144596507|NCT02121834|521384513|FG006|Overall Study|Lost to Follow-up|0|||
144596508|NCT01026454|521384514|FG000|Second Intervention|Pregnancy|1|||
144596509|NCT01026454|521384515|FG001|Second Intervention|Pregnancy|1|||
144596510|NCT02196714|521384516|FG000|Overall Study|Protocol Violation|0|||
144596511|NCT02196714|521384517|FG001|Overall Study|Protocol Violation|0|||
144596512|NCT02196714|521384518|FG002|Overall Study|Protocol Violation|1|||
144596513|NCT02196714|521384519|FG003|Overall Study|Protocol Violation|0|||
144596514|NCT01326533|521384522|FG000|Overall Study|Lost to Follow-up|2|||
144596515|NCT01326533|521384523|FG001|Overall Study|Lost to Follow-up|0|||
144596516|NCT01326533|521384522|FG000|Overall Study|Withdrawal by Subject|1|||
144596517|NCT01326533|521384523|FG001|Overall Study|Withdrawal by Subject|0|||
144596518|NCT01326533|521384522|FG000|Overall Study|Adverse Event|1|||
144596519|NCT01326533|521384523|FG001|Overall Study|Adverse Event|0|||
144596520|NCT04079803|521384524|FG000|Overall Study|Withdrawal by Subject|0|||
144596521|NCT04079803|521384525|FG001|Overall Study|Withdrawal by Subject|0|||
144596522|NCT04079803|521384526|FG002|Overall Study|Withdrawal by Subject|1|||
144596523|NCT01971203|521384527|FG000|Overall Study|Protocol Violation|3|||
144596524|NCT01971203|521384528|FG001|Overall Study|Protocol Violation|2|||
144596525|NCT01971203|521384527|FG000|Overall Study|Withdrawal by Subject|5|||
144596526|NCT01971203|521384528|FG001|Overall Study|Withdrawal by Subject|6|||
144596527|NCT01971203|521384527|FG000|Overall Study|Adverse Event|1|||
144596528|NCT01971203|521384528|FG001|Overall Study|Adverse Event|0|||
144596529|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
144596530|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
144596531|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
144596532|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
144596533|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
144596534|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
144596535|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
144596536|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
144596537|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
144596538|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
144596539|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
144596540|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
144596541|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
144596542|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
144596543|NCT01294683|521384530|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
144596544|NCT01294683|521384531|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
144596545|NCT01294683|521384530|FG000|Post Crossover (Period III)|Adverse Event|6|||
144596546|NCT01294683|521384531|FG001|Post Crossover (Period III)|Adverse Event|6|||
144596547|NCT01294683|521384530|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
144596548|NCT01294683|521384531|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
144596549|NCT01294683|521384530|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
144596550|NCT01294683|521384531|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
144596551|NCT01294683|521384530|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
144596552|NCT01294683|521384531|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
144596553|NCT01794923|521384532|FG000|Overall Study|Adverse Event|0|||
144596554|NCT01794923|521384533|FG001|Overall Study|Adverse Event|0|||
144596555|NCT01794923|521384534|FG002|Overall Study|Adverse Event|1|||
144522977|NCT04209465|521115030|FG000|Overall Study|Physician Decision|0|||
144596556|NCT00307125|521384537|FG000|Screening Phase|Adverse Event|1|||
144596557|NCT00307125|521384538|FG001|Screening Phase|Adverse Event|0|||
144596558|NCT00307125|521384539|FG002|Screening Phase|Adverse Event|0|||
144522978|NCT04209465|521115031|FG001|Overall Study|Physician Decision|1|||
144522979|NCT04209465|521115032|FG002|Overall Study|Physician Decision|0|||
144522980|NCT04209465|521115033|FG003|Overall Study|Physician Decision|0|||
144522981|NCT04209465|521115034|FG004|Overall Study|Physician Decision|0|||
144596559|NCT00307125|521384537|FG000|Screening Phase|Protocol Violation|27|||
144596560|NCT00307125|521384538|FG001|Screening Phase|Protocol Violation|0|||
144596561|NCT00307125|521384539|FG002|Screening Phase|Protocol Violation|0|||
144596562|NCT00307125|521384537|FG000|Screening Phase|Lost to Follow-up|87|||
144596563|NCT00307125|521384538|FG001|Screening Phase|Lost to Follow-up|0|||
144596564|NCT00307125|521384539|FG002|Screening Phase|Lost to Follow-up|0|||
144596565|NCT00307125|521384537|FG000|Screening Phase|Death|10|||
144596566|NCT00307125|521384538|FG001|Screening Phase|Death|0|||
144400394|NCT01756053|520676527|FG001|Period 1 (10 Days)|Protocol Violation|1|||
144400395|NCT01756053|520676526|FG000|Period 2 (10 Days)|Protocol Violation|0|||
144400396|NCT01756053|520676527|FG001|Period 2 (10 Days)|Protocol Violation|2|||
144400397|NCT00285818|520676528|FG000|Overall Study|Withdrawal by Subject|3|||
144596567|NCT00307125|521384539|FG002|Screening Phase|Death|0|||
144596568|NCT00307125|521384537|FG000|Screening Phase|Withdrawal by Subject|77|||
144596569|NCT00307125|521384538|FG001|Screening Phase|Withdrawal by Subject|0|||
144596570|NCT00307125|521384539|FG002|Screening Phase|Withdrawal by Subject|0|||
144596571|NCT00307125|521384537|FG000|Screening Phase|Physician Decision|26|||
144596572|NCT00307125|521384538|FG001|Screening Phase|Physician Decision|0|||
144596573|NCT00307125|521384539|FG002|Screening Phase|Physician Decision|0|||
144596574|NCT00307125|521384537|FG000|Screening Phase|Sponsor Decision|4|||
144596575|NCT00307125|521384538|FG001|Screening Phase|Sponsor Decision|0|||
144596576|NCT00307125|521384539|FG002|Screening Phase|Sponsor Decision|0|||
144596577|NCT00307125|521384537|FG000|Screening Phase|Study Terminated|17|||
144596578|NCT00307125|521384538|FG001|Screening Phase|Study Terminated|0|||
144596579|NCT00307125|521384539|FG002|Screening Phase|Study Terminated|0|||
144596580|NCT00307125|521384537|FG000|Screening Phase|Graft Loss|3|||
144596581|NCT00307125|521384538|FG001|Screening Phase|Graft Loss|0|||
144596582|NCT00307125|521384539|FG002|Screening Phase|Graft Loss|0|||
144596583|NCT00307125|521384537|FG000|Screening Phase|Graft Failure|8|||
144596584|NCT00307125|521384538|FG001|Screening Phase|Graft Failure|0|||
144596585|NCT00307125|521384539|FG002|Screening Phase|Graft Failure|0|||
144596586|NCT00307125|521384537|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
144596587|NCT00307125|521384538|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
144596588|NCT00307125|521384539|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
144596589|NCT00307125|521384537|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
144596590|NCT00307125|521384538|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
144596591|NCT00307125|521384539|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
144596592|NCT00307125|521384537|FG000|Screening Phase|Moved or transferred facilities|34|||
144596593|NCT00307125|521384538|FG001|Screening Phase|Moved or transferred facilities|0|||
144596594|NCT00307125|521384539|FG002|Screening Phase|Moved or transferred facilities|0|||
144596595|NCT00307125|521384537|FG000|Screening Phase|Received Pancreas Transplant|8|||
144596596|NCT00307125|521384538|FG001|Screening Phase|Received Pancreas Transplant|0|||
144596597|NCT00307125|521384539|FG002|Screening Phase|Received Pancreas Transplant|0|||
144596598|NCT00307125|521384537|FG000|Screening Phase|Ineligible for pilot|4|||
144596599|NCT00307125|521384538|FG001|Screening Phase|Ineligible for pilot|0|||
144596600|NCT00307125|521384539|FG002|Screening Phase|Ineligible for pilot|0|||
144596601|NCT00307125|521384537|FG000|Screening Phase|Try to get pregnant|1|||
144596602|NCT00307125|521384538|FG001|Screening Phase|Try to get pregnant|0|||
144596603|NCT00307125|521384539|FG002|Screening Phase|Try to get pregnant|0|||
144596604|NCT00307125|521384537|FG000|Screening Phase|Developed acute leukemia|1|||
144596605|NCT00307125|521384538|FG001|Screening Phase|Developed acute leukemia|0|||
144596606|NCT00307125|521384539|FG002|Screening Phase|Developed acute leukemia|0|||
144596607|NCT00307125|521384537|FG000|Screening Phase|Metastatic colon cancer|1|||
144596608|NCT00307125|521384538|FG001|Screening Phase|Metastatic colon cancer|0|||
144596609|NCT00307125|521384539|FG002|Screening Phase|Metastatic colon cancer|0|||
144596610|NCT00307125|521384537|FG000|Screening Phase|Malignancy|1|||
144596611|NCT00307125|521384538|FG001|Screening Phase|Malignancy|0|||
144596612|NCT00307125|521384539|FG002|Screening Phase|Malignancy|0|||
144596613|NCT00307125|521384537|FG000|Screening Phase|PAK|1|||
144596614|NCT00307125|521384538|FG001|Screening Phase|PAK|0|||
144596615|NCT00307125|521384539|FG002|Screening Phase|PAK|0|||
144596616|NCT00307125|521384537|FG000|Screening Phase|Ineligible|1|||
144596617|NCT00307125|521384538|FG001|Screening Phase|Ineligible|0|||
144596618|NCT00307125|521384539|FG002|Screening Phase|Ineligible|0|||
144596619|NCT00307125|521384537|FG000|Screening Phase|Screen Error|1|||
144596620|NCT00307125|521384538|FG001|Screening Phase|Screen Error|0|||
144596621|NCT00307125|521384539|FG002|Screening Phase|Screen Error|0|||
144596622|NCT00307125|521384537|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
144596623|NCT00307125|521384538|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
144596624|NCT00307125|521384539|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
144596625|NCT00307125|521384537|FG000|Screening Phase|AMR and treated with rituximab|1|||
144596626|NCT00307125|521384538|FG001|Screening Phase|AMR and treated with rituximab|0|||
144596627|NCT00307125|521384539|FG002|Screening Phase|AMR and treated with rituximab|0|||
144522982|NCT04209465|521115035|FG005|Overall Study|Physician Decision|0|||
144522983|NCT04209465|521115036|FG006|Overall Study|Physician Decision|0|||
144522984|NCT04209465|521115037|FG007|Overall Study|Physician Decision|0|||
144522985|NCT04209465|521115038|FG008|Overall Study|Physician Decision|0|||
144522986|NCT04209465|521115039|FG009|Overall Study|Physician Decision|0|||
144522987|NCT04209465|521115040|FG010|Overall Study|Physician Decision|0|||
144522988|NCT04209465|521115041|FG011|Overall Study|Physician Decision|0|||
144522989|NCT04209465|521115042|FG012|Overall Study|Physician Decision|0|||
144522990|NCT04209465|521115030|FG000|Overall Study|Progressive Disease|0|||
144522991|NCT04209465|521115031|FG001|Overall Study|Progressive Disease|0|||
144522992|NCT04209465|521115032|FG002|Overall Study|Progressive Disease|1|||
144596628|NCT00307125|521384537|FG000|Screening Phase|Coronary artery bypass|1|||
144596629|NCT00307125|521384538|FG001|Screening Phase|Coronary artery bypass|0|||
144596630|NCT00307125|521384539|FG002|Screening Phase|Coronary artery bypass|0|||
144596631|NCT00307125|521384537|FG000|Pilot Phase|Lost to Follow-up|0|||
144596632|NCT00307125|521384538|FG001|Pilot Phase|Lost to Follow-up|1|||
144596633|NCT00307125|521384539|FG002|Pilot Phase|Lost to Follow-up|0|||
144596634|NCT00307125|521384537|FG000|Pilot Phase|Withdrawal by Subject|0|||
144596635|NCT00307125|521384538|FG001|Pilot Phase|Withdrawal by Subject|1|||
144596636|NCT00307125|521384539|FG002|Pilot Phase|Withdrawal by Subject|1|||
144596637|NCT00807235|521384542|FG000|Overall Study|Adverse Event|1|||
144596638|NCT00807235|521384543|FG001|Overall Study|Adverse Event|0|||
144596639|NCT00926211|521384544|FG000|Overall Study|Lost to Follow-up|1|||
144596640|NCT02804178|521384547|FG000|Overall Study|Adverse Event|1|||
144596641|NCT01032382|521384548|FG000|Overall Study|Disease dissemination|1|||
144400398|NCT00285818|520676529|FG001|Overall Study|Withdrawal by Subject|2|||
144596642|NCT01032382|521384549|FG001|Overall Study|Disease dissemination|1|||
144400399|NCT00285818|520676528|FG000|Overall Study|Lost to Follow-up|1|||
144596643|NCT01032382|521384548|FG000|Overall Study|Treatment failure|3|||
144596644|NCT01032382|521384549|FG001|Overall Study|Treatment failure|1|||
144596645|NCT01032382|521384548|FG000|Overall Study|Index lesion relapse|1|||
144596646|NCT01032382|521384549|FG001|Overall Study|Index lesion relapse|3|||
144596647|NCT00178126|521384550|FG000|Overall Study|Lost to Follow-up|21|||
144596648|NCT00178126|521384551|FG001|Overall Study|Lost to Follow-up|21|||
144596649|NCT00178126|521384550|FG000|Overall Study|did not receive intervention|4|||
144596650|NCT00178126|521384551|FG001|Overall Study|did not receive intervention|6|||
144596651|NCT00421707|521384552|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
144596652|NCT00421707|521384553|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
144596653|NCT00421707|521384552|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
144596654|NCT00421707|521384553|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
144596655|NCT00421707|521384552|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
144596656|NCT00421707|521384553|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
144596657|NCT00421707|521384552|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
144596658|NCT00421707|521384553|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
144596659|NCT00421707|521384552|FG000|Period 2: Washout|Adverse Event|1|||
144596660|NCT00421707|521384553|FG001|Period 2: Washout|Adverse Event|1|||
144596661|NCT00421707|521384552|FG000|Period 2: Washout|Withdrawal by Subject|0|||
144596662|NCT00421707|521384553|FG001|Period 2: Washout|Withdrawal by Subject|1|||
144596663|NCT00421707|521384552|FG000|Period 2: Washout|Lost to Follow-up|0|||
144596664|NCT00421707|521384553|FG001|Period 2: Washout|Lost to Follow-up|1|||
144596665|NCT00421707|521384552|FG000|Period 2: Washout|Other: Pregnancy|0|||
144596666|NCT00421707|521384553|FG001|Period 2: Washout|Other: Pregnancy|1|||
144596667|NCT00421707|521384552|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
144596668|NCT00421707|521384553|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
144596669|NCT00421707|521384552|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
144596670|NCT00421707|521384553|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
144596671|NCT00421707|521384552|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
144596672|NCT00421707|521384553|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
144596673|NCT02739360|521384556|FG000|Overall Study|Adverse Event|1|||
144596674|NCT02739360|521384556|FG000|Overall Study|Study terminated by Sponsor|2|||
144596675|NCT01163916|521384557|FG000|Overall Study|Withdrawal by Subject|2|||
144596676|NCT01163916|521384558|FG001|Overall Study|Withdrawal by Subject|0|||
144596677|NCT01163916|521384559|FG002|Overall Study|Withdrawal by Subject|2|||
144596678|NCT01163916|521384557|FG000|Overall Study|Adverse Event|2|||
144596679|NCT01163916|521384558|FG001|Overall Study|Adverse Event|0|||
144596680|NCT01163916|521384559|FG002|Overall Study|Adverse Event|1|||
144596681|NCT01163916|521384557|FG000|Overall Study|Lack of Efficacy|2|||
144400400|NCT00285818|520676529|FG001|Overall Study|Lost to Follow-up|0|||
144400401|NCT02083081|520676530|FG000|Overall Study|Lost to Follow-up|31|||
144400402|NCT02083081|520676531|FG001|Overall Study|Lost to Follow-up|9|||
144596682|NCT01163916|521384558|FG001|Overall Study|Lack of Efficacy|0|||
144596683|NCT01163916|521384559|FG002|Overall Study|Lack of Efficacy|1|||
144596684|NCT01163916|521384557|FG000|Overall Study|Other|24|||
144596685|NCT01163916|521384558|FG001|Overall Study|Other|4|||
144596686|NCT01163916|521384559|FG002|Overall Study|Other|16|||
144596687|NCT00423930|521384560|FG000|Overall Study|Withdrawal by Subject|2|||
144596688|NCT02337751|521384561|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
144596689|NCT02337751|521384562|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
144596690|NCT02337751|521384561|FG000|Overall Study|Voluntary Withdrawal|6|||
144596691|NCT02337751|521384562|FG001|Overall Study|Voluntary Withdrawal|8|||
144596692|NCT02337751|521384561|FG000|Overall Study|Lack of Efficacy|2|||
144596693|NCT02337751|521384562|FG001|Overall Study|Lack of Efficacy|5|||
144596694|NCT02337751|521384561|FG000|Overall Study|Investigator's Judgement|1|||
144596695|NCT02337751|521384562|FG001|Overall Study|Investigator's Judgement|0|||
144596696|NCT02881957|521384564|FG000|Overall Study|Comfort care|0|||
144596697|NCT02881957|521384565|FG001|Overall Study|Comfort care|1|||
144596698|NCT02881957|521384564|FG000|Overall Study|Concurrent trial enrollment|0|||
144596699|NCT02881957|521384565|FG001|Overall Study|Concurrent trial enrollment|1|||
144596700|NCT02881957|521384564|FG000|Overall Study|Discharged within 48 hours|0|||
144596701|NCT02881957|521384565|FG001|Overall Study|Discharged within 48 hours|1|||
144596702|NCT02881957|521384564|FG000|Overall Study|Withdrawal by Subject|2|||
144596703|NCT02881957|521384565|FG001|Overall Study|Withdrawal by Subject|1|||
144596704|NCT02881957|521384564|FG000|Overall Study|Protocol Violation|1|||
144596705|NCT02881957|521384565|FG001|Overall Study|Protocol Violation|0|||
144596706|NCT04223856|521384571|FG000|Overall Study|Progressive disease|153|||
144596707|NCT04223856|521384572|FG001|Overall Study|Progressive disease|73|||
144596708|NCT04223856|521384571|FG000|Overall Study|Adverse Event|97|||
144596709|NCT04223856|521384572|FG001|Overall Study|Adverse Event|62|||
144596710|NCT04223856|521384571|FG000|Overall Study|Physician Decision|9|||
144596711|NCT04223856|521384572|FG001|Overall Study|Physician Decision|28|||
144596712|NCT04223856|521384571|FG000|Overall Study|Withdrawal by Subject|22|||
144596713|NCT04223856|521384572|FG001|Overall Study|Withdrawal by Subject|24|||
144596714|NCT04223856|521384571|FG000|Overall Study|Other|7|||
144596715|NCT04223856|521384572|FG001|Overall Study|Other|2|||
144596716|NCT04223856|521384571|FG000|Overall Study|Randomized but not treated|2|||
144596717|NCT04223856|521384572|FG001|Overall Study|Randomized but not treated|11|||
144596718|NCT04223856|521384571|FG000|Overall Study|On-treatment|144|||
144596719|NCT04223856|521384572|FG001|Overall Study|On-treatment|0|||
144596720|NCT03442114|521384573|FG000|Overall Study|Lost to Follow-up|13|||
144596721|NCT03442114|521384574|FG001|Overall Study|Lost to Follow-up|13|||
144400403|NCT04041375|520676535|FG000|Intervention Phase|Withdrawal by Subject|2|||
144400404|NCT04041375|520676536|FG001|Intervention Phase|Withdrawal by Subject|2|||
144400405|NCT04041375|520676535|FG000|Follow-up Phase|Death|2|||
144400406|NCT04041375|520676536|FG001|Follow-up Phase|Death|0|||
144400407|NCT04041375|520676535|FG000|Follow-up Phase|Lost to Follow-up|2|||
144400408|NCT04041375|520676536|FG001|Follow-up Phase|Lost to Follow-up|1|||
144400409|NCT04041375|520676535|FG000|Follow-up Phase|Too ill|3|||
144400410|NCT04041375|520676536|FG001|Follow-up Phase|Too ill|0|||
144596722|NCT03442114|521384573|FG000|Overall Study|Physician Decision|2|||
144596723|NCT03442114|521384574|FG001|Overall Study|Physician Decision|2|||
144596724|NCT03442114|521384573|FG000|Overall Study|Protocol Violation|0|||
144596725|NCT03442114|521384574|FG001|Overall Study|Protocol Violation|2|||
144596726|NCT03442114|521384573|FG000|Overall Study|Withdrawal by Subject|1|||
144596727|NCT03442114|521384574|FG001|Overall Study|Withdrawal by Subject|3|||
144596728|NCT03442114|521384573|FG000|Overall Study|Guardianship Change|0|||
144596729|NCT03442114|521384574|FG001|Overall Study|Guardianship Change|1|||
144596730|NCT02903368|521384575|FG000|Part 1|Adverse Event|3|||
144596731|NCT02903368|521384576|FG001|Part 1|Adverse Event|0|||
144596732|NCT02903368|521384577|FG002|Part 1|Adverse Event|0|||
144596733|NCT02903368|521384578|FG003|Part 1|Adverse Event|0|||
144596734|NCT02903368|521384575|FG000|Part 1|Withdrawal by Subject|1|||
144596735|NCT02903368|521384576|FG001|Part 1|Withdrawal by Subject|0|||
144596736|NCT02903368|521384577|FG002|Part 1|Withdrawal by Subject|0|||
144596737|NCT02903368|521384578|FG003|Part 1|Withdrawal by Subject|0|||
144596738|NCT02903368|521384575|FG000|Part 2|Adverse Event|0|||
144596739|NCT02903368|521384576|FG001|Part 2|Adverse Event|0|||
144596740|NCT02903368|521384577|FG002|Part 2|Adverse Event|5|||
144596741|NCT02903368|521384578|FG003|Part 2|Adverse Event|0|||
144596742|NCT02903368|521384575|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
144596743|NCT02903368|521384576|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
144596744|NCT02903368|521384577|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
144596745|NCT02903368|521384578|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
144596746|NCT02903368|521384575|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
144596747|NCT02903368|521384576|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
144596748|NCT02903368|521384577|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
144596749|NCT02903368|521384578|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
144596750|NCT02903368|521384575|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
144596751|NCT02903368|521384576|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
144596752|NCT02903368|521384577|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
144400411|NCT04674644|520676542|FG000|Overall Study|with missing data|37|||
144400412|NCT01230710|520676543|FG000|Overall Study|Disease Progression|41|||
144400413|NCT01230710|520676543|FG000|Overall Study|Lost to Follow-up|3|||
144400414|NCT01230710|520676543|FG000|Overall Study|Death|4|||
144596753|NCT02903368|521384578|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
144596754|NCT06515483|521384579|FG000|Overall Study|Subject withdraw due to family issues|1|||
144596755|NCT06515483|521384580|FG001|Overall Study|Subject withdraw due to family issues|0|||
144596756|NCT00147823|521384581|FG000|Overall Study|Lost to Follow-up|6|||
144722349|NCT00812253|521838687|FG001|Overall Study|Lost to Follow-up|0|||
144400415|NCT01230710|520676543|FG000|Overall Study|Withdrawal of Consent|1|||
144400416|NCT03277690|520676544|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
144596757|NCT00147823|521384582|FG001|Overall Study|Lost to Follow-up|12|||
144596758|NCT00147823|521384581|FG000|Overall Study|Physician Decision|1|||
144596759|NCT00147823|521384582|FG001|Overall Study|Physician Decision|0|||
144596760|NCT00147823|521384581|FG000|Overall Study|Withdrawal by Subject|0|||
144596761|NCT00147823|521384582|FG001|Overall Study|Withdrawal by Subject|1|||
144596762|NCT00147823|521384581|FG000|Overall Study|Did not receive vitoss due to infection|6|||
144596763|NCT00147823|521384582|FG001|Overall Study|Did not receive vitoss due to infection|2|||
144596764|NCT00720941|521386941|FG000|Overall Study|Protocol Violation|1|||
144596765|NCT00720941|521386942|FG001|Overall Study|Protocol Violation|2|||
144596766|NCT00720941|521386941|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
144596767|NCT00720941|521386942|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
144596768|NCT00720941|521386941|FG000|Overall Study|Lost to Follow-up|20|||
144596769|NCT00720941|521386942|FG001|Overall Study|Lost to Follow-up|15|||
144596770|NCT00720941|521386941|FG000|Overall Study|Physician Decision|14|||
144596771|NCT00720941|521386942|FG001|Overall Study|Physician Decision|12|||
144596772|NCT00720941|521386941|FG000|Overall Study|Withdrawal by Subject|29|||
144596773|NCT00720941|521386942|FG001|Overall Study|Withdrawal by Subject|36|||
144596774|NCT02544217|521386943|FG000|Overall Study|Withdrawal by Subject|1|||
144596775|NCT02544217|521386944|FG001|Overall Study|Withdrawal by Subject|1|||
144596776|NCT02544217|521386945|FG002|Overall Study|Withdrawal by Subject|0|||
144596777|NCT02544217|521386946|FG003|Overall Study|Withdrawal by Subject|0|||
144596778|NCT02544217|521386947|FG004|Overall Study|Withdrawal by Subject|0|||
144522993|NCT04209465|521115033|FG003|Overall Study|Progressive Disease|2|||
144522994|NCT04209465|521115034|FG004|Overall Study|Progressive Disease|8|||
144522995|NCT04209465|521115035|FG005|Overall Study|Progressive Disease|5|||
144522996|NCT04209465|521115036|FG006|Overall Study|Progressive Disease|3|||
144522997|NCT04209465|521115037|FG007|Overall Study|Progressive Disease|4|||
144522998|NCT04209465|521115038|FG008|Overall Study|Progressive Disease|1|||
144522999|NCT04209465|521115039|FG009|Overall Study|Progressive Disease|3|||
144523000|NCT04209465|521115040|FG010|Overall Study|Progressive Disease|2|||
144523001|NCT04209465|521115041|FG011|Overall Study|Progressive Disease|1|||
144523002|NCT04209465|521115042|FG012|Overall Study|Progressive Disease|0|||
144523003|NCT04209465|521115030|FG000|Overall Study|Withdrawal by Subject|0|||
144523004|NCT04209465|521115031|FG001|Overall Study|Withdrawal by Subject|0|||
144523005|NCT04209465|521115032|FG002|Overall Study|Withdrawal by Subject|0|||
144523006|NCT04209465|521115033|FG003|Overall Study|Withdrawal by Subject|0|||
144523007|NCT04209465|521115034|FG004|Overall Study|Withdrawal by Subject|0|||
144523008|NCT04209465|521115035|FG005|Overall Study|Withdrawal by Subject|1|||
144523009|NCT04209465|521115036|FG006|Overall Study|Withdrawal by Subject|2|||
144523010|NCT04209465|521115037|FG007|Overall Study|Withdrawal by Subject|0|||
144523011|NCT04209465|521115038|FG008|Overall Study|Withdrawal by Subject|1|||
144523012|NCT04209465|521115039|FG009|Overall Study|Withdrawal by Subject|0|||
144523013|NCT04209465|521115040|FG010|Overall Study|Withdrawal by Subject|0|||
144523014|NCT04209465|521115041|FG011|Overall Study|Withdrawal by Subject|2|||
144523015|NCT04209465|521115042|FG012|Overall Study|Withdrawal by Subject|2|||
144523016|NCT04209465|521115030|FG000|Overall Study|Lost to Follow-up|0|||
144523017|NCT04209465|521115031|FG001|Overall Study|Lost to Follow-up|0|||
144523018|NCT04209465|521115032|FG002|Overall Study|Lost to Follow-up|0|||
144523019|NCT04209465|521115033|FG003|Overall Study|Lost to Follow-up|0|||
144523020|NCT04209465|521115034|FG004|Overall Study|Lost to Follow-up|0|||
144523021|NCT04209465|521115035|FG005|Overall Study|Lost to Follow-up|1|||
144523022|NCT04209465|521115036|FG006|Overall Study|Lost to Follow-up|0|||
144523023|NCT04209465|521115037|FG007|Overall Study|Lost to Follow-up|0|||
144523024|NCT04209465|521115038|FG008|Overall Study|Lost to Follow-up|1|||
144523025|NCT04209465|521115039|FG009|Overall Study|Lost to Follow-up|0|||
144523026|NCT04209465|521115040|FG010|Overall Study|Lost to Follow-up|0|||
144523027|NCT04209465|521115041|FG011|Overall Study|Lost to Follow-up|1|||
144523028|NCT04209465|521115042|FG012|Overall Study|Lost to Follow-up|0|||
144523029|NCT04209465|521115030|FG000|Overall Study|Started new therapy|0|||
144523030|NCT04209465|521115031|FG001|Overall Study|Started new therapy|0|||
144523031|NCT04209465|521115032|FG002|Overall Study|Started new therapy|0|||
144523032|NCT04209465|521115033|FG003|Overall Study|Started new therapy|0|||
144523033|NCT04209465|521115034|FG004|Overall Study|Started new therapy|0|||
144523034|NCT04209465|521115035|FG005|Overall Study|Started new therapy|1|||
144523035|NCT04209465|521115036|FG006|Overall Study|Started new therapy|0|||
144523036|NCT04209465|521115037|FG007|Overall Study|Started new therapy|0|||
144523037|NCT04209465|521115038|FG008|Overall Study|Started new therapy|0|||
144523038|NCT04209465|521115039|FG009|Overall Study|Started new therapy|0|||
144523039|NCT04209465|521115040|FG010|Overall Study|Started new therapy|0|||
144523040|NCT04209465|521115041|FG011|Overall Study|Started new therapy|0|||
144523041|NCT04209465|521115042|FG012|Overall Study|Started new therapy|0|||
144596779|NCT02544217|521386948|FG005|Overall Study|Withdrawal by Subject|0|||
144596780|NCT00937833|521386949|FG000|Overall Study|Protocol Violation|1|||
144523042|NCT04209465|521115030|FG000|Overall Study|Study terminated early by sponsor|0|||
144523043|NCT04209465|521115031|FG001|Overall Study|Study terminated early by sponsor|0|||
144523044|NCT04209465|521115032|FG002|Overall Study|Study terminated early by sponsor|0|||
144523045|NCT04209465|521115033|FG003|Overall Study|Study terminated early by sponsor|0|||
144523046|NCT04209465|521115034|FG004|Overall Study|Study terminated early by sponsor|0|||
144523047|NCT04209465|521115035|FG005|Overall Study|Study terminated early by sponsor|0|||
144596781|NCT00937833|521386950|FG001|Overall Study|Protocol Violation|2|||
144596782|NCT00937833|521386949|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
144596783|NCT00937833|521386950|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
144596784|NCT00937833|521386949|FG000|Overall Study|Lost to Follow-up|10|||
144596785|NCT00937833|521386950|FG001|Overall Study|Lost to Follow-up|8|||
144596786|NCT00937833|521386949|FG000|Overall Study|Withdrawal by Subject|4|||
144596787|NCT00937833|521386950|FG001|Overall Study|Withdrawal by Subject|6|||
144596788|NCT01607554|521386954|FG000|Overall Study|Disease progression|2|||
144596789|NCT00818389|521386955|FG000|Overall Study|Death|1|||
144596790|NCT00818389|521386956|FG001|Overall Study|Death|3|||
144596791|NCT00818389|521386955|FG000|Overall Study|ALS Disease Progression|1|||
144596792|NCT00818389|521386956|FG001|Overall Study|ALS Disease Progression|0|||
144596793|NCT00818389|521386955|FG000|Overall Study|Withdrawal by Subject|2|||
144596794|NCT00818389|521386956|FG001|Overall Study|Withdrawal by Subject|2|||
144596795|NCT00818389|521386955|FG000|Overall Study|Adverse Event|0|||
144596796|NCT00818389|521386956|FG001|Overall Study|Adverse Event|1|||
144596797|NCT01137955|521386957|FG000|Overall Study|Withdrawal by Subject|5|||
144596798|NCT01137955|521386958|FG001|Overall Study|Withdrawal by Subject|4|||
144596799|NCT04442737|521386961|FG000|Overall Study|Lost to Follow-up|1|||
144596800|NCT04442737|521386962|FG001|Overall Study|Lost to Follow-up|3|||
144596801|NCT04442737|521386961|FG000|Overall Study|Withdrawal by Subject|3|||
144596802|NCT04442737|521386962|FG001|Overall Study|Withdrawal by Subject|2|||
144596803|NCT04442737|521386961|FG000|Overall Study|Adverse Event|3|||
144596804|NCT04442737|521386962|FG001|Overall Study|Adverse Event|2|||
144596805|NCT04442737|521386961|FG000|Overall Study|Death|0|||
144596806|NCT04442737|521386962|FG001|Overall Study|Death|1|||
144596807|NCT04442737|521386961|FG000|Overall Study|Protocol Violation|0|||
144596808|NCT04442737|521386962|FG001|Overall Study|Protocol Violation|2|||
144596809|NCT04442737|521386961|FG000|Overall Study|Other|1|||
144596810|NCT04442737|521386962|FG001|Overall Study|Other|1|||
144596811|NCT00744523|521386963|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
144596812|NCT00744523|521386964|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
144596813|NCT01139021|521386967|FG000|Overall Study|Adverse Event|0|||
144596814|NCT01139021|521386968|FG001|Overall Study|Adverse Event|0|||
144596815|NCT01139021|521386969|FG002|Overall Study|Adverse Event|0|||
144596816|NCT01139021|521386970|FG003|Overall Study|Adverse Event|0|||
144596817|NCT01139021|521386971|FG004|Overall Study|Adverse Event|1|||
144596818|NCT01139021|521386972|FG005|Overall Study|Adverse Event|0|||
144596819|NCT01139021|521386967|FG000|Overall Study|Lost to Follow-up|0|||
144596820|NCT01139021|521386968|FG001|Overall Study|Lost to Follow-up|0|||
144596821|NCT01139021|521386969|FG002|Overall Study|Lost to Follow-up|0|||
144596822|NCT01139021|521386970|FG003|Overall Study|Lost to Follow-up|0|||
144596823|NCT01139021|521386971|FG004|Overall Study|Lost to Follow-up|2|||
144596824|NCT01139021|521386972|FG005|Overall Study|Lost to Follow-up|0|||
144596825|NCT01139021|521386967|FG000|Overall Study|Protocol Violation|1|||
144596826|NCT01139021|521386968|FG001|Overall Study|Protocol Violation|0|||
144596827|NCT01139021|521386969|FG002|Overall Study|Protocol Violation|0|||
144596828|NCT01139021|521386970|FG003|Overall Study|Protocol Violation|0|||
144596829|NCT01139021|521386971|FG004|Overall Study|Protocol Violation|2|||
144596830|NCT01139021|521386972|FG005|Overall Study|Protocol Violation|0|||
144596831|NCT01139021|521386967|FG000|Overall Study|Withdrawal by Subject|0|||
144596832|NCT01139021|521386968|FG001|Overall Study|Withdrawal by Subject|0|||
144596833|NCT01139021|521386969|FG002|Overall Study|Withdrawal by Subject|0|||
144596834|NCT01139021|521386970|FG003|Overall Study|Withdrawal by Subject|1|||
144596835|NCT01139021|521386971|FG004|Overall Study|Withdrawal by Subject|4|||
144596836|NCT01139021|521386972|FG005|Overall Study|Withdrawal by Subject|0|||
144596837|NCT03588728|521386974|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
144596838|NCT03588728|521386975|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
144596839|NCT03588728|521386976|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
144596840|NCT03588728|521386977|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
144596841|NCT03588728|521386974|FG000|Overall Study|Lab shut down due to COVID-19|0|||
144596842|NCT03588728|521386975|FG001|Overall Study|Lab shut down due to COVID-19|0|||
144596843|NCT03588728|521386976|FG002|Overall Study|Lab shut down due to COVID-19|0|||
144596844|NCT03588728|521386977|FG003|Overall Study|Lab shut down due to COVID-19|1|||
144596845|NCT03588728|521386974|FG000|Overall Study|multiple technical issues|1|||
144596846|NCT03588728|521386975|FG001|Overall Study|multiple technical issues|0|||
144596847|NCT03588728|521386976|FG002|Overall Study|multiple technical issues|0|||
144722350|NCT01884025|521838688|FG000|Overall Study|Lost to Follow-up|3|||
144596848|NCT03588728|521386977|FG003|Overall Study|multiple technical issues|0|||
144596849|NCT03588728|521386974|FG000|Overall Study|Hospitalized for COVID|1|||
144596850|NCT03588728|521386975|FG001|Overall Study|Hospitalized for COVID|0|||
144596851|NCT03588728|521386976|FG002|Overall Study|Hospitalized for COVID|0|||
144596852|NCT03588728|521386977|FG003|Overall Study|Hospitalized for COVID|0|||
144596853|NCT03588728|521386974|FG000|Overall Study|Schedule change unable to attend sessions|1|||
144596854|NCT03588728|521386975|FG001|Overall Study|Schedule change unable to attend sessions|0|||
144596855|NCT03588728|521386976|FG002|Overall Study|Schedule change unable to attend sessions|0|||
144722351|NCT01884025|521838689|FG001|Overall Study|Lost to Follow-up|4|||
144596856|NCT03588728|521386977|FG003|Overall Study|Schedule change unable to attend sessions|0|||
144596857|NCT02027701|521386978|FG000|Overall Study|Adverse Event|3|||
144596858|NCT02027701|521386978|FG000|Overall Study|Lack of Efficacy|8|||
144596859|NCT02027701|521386978|FG000|Overall Study|Physician Decision|2|||
144596860|NCT02027701|521386978|FG000|Overall Study|Withdrawal by Subject|3|||
144596861|NCT01978262|521386979|FG000|Overall Study|Withdrawal by Subject|9|||
144596862|NCT01978262|521386979|FG000|Overall Study|Lost to Follow-up|2|||
144596863|NCT02982187|521386980|FG000|Overall Study|Withdrawal by Subject|0|||
144596864|NCT02982187|521386981|FG001|Overall Study|Withdrawal by Subject|0|||
144596865|NCT02982187|521386982|FG002|Overall Study|Withdrawal by Subject|0|||
144596866|NCT02982187|521386983|FG003|Overall Study|Withdrawal by Subject|0|||
144596867|NCT02982187|521386984|FG004|Overall Study|Withdrawal by Subject|0|||
144596868|NCT02982187|521386985|FG005|Overall Study|Withdrawal by Subject|0|||
144596869|NCT02982187|521386986|FG006|Overall Study|Withdrawal by Subject|1|||
144596870|NCT02982187|521386987|FG007|Overall Study|Withdrawal by Subject|0|||
144596871|NCT02604433|521386988|FG000|Overall Study|Withdrawal by Subject|37|||
144596872|NCT02604433|521386989|FG001|Overall Study|Withdrawal by Subject|16|||
144596873|NCT02604433|521386988|FG000|Overall Study|Adverse Event|4|||
144596874|NCT02604433|521386989|FG001|Overall Study|Adverse Event|0|||
144596875|NCT02604433|521386988|FG000|Overall Study|Other reasons|3|||
144596876|NCT02604433|521386989|FG001|Overall Study|Other reasons|5|||
144596877|NCT02604433|521386988|FG000|Overall Study|Death|4|||
144596878|NCT02604433|521386989|FG001|Overall Study|Death|1|||
144596879|NCT02604433|521386988|FG000|Overall Study|Transition to Rollover Protocol|169|||
144596880|NCT02604433|521386989|FG001|Overall Study|Transition to Rollover Protocol|82|||
144596881|NCT02604433|521386988|FG000|Overall Study|Physician Decision|1|||
144596882|NCT02604433|521386989|FG001|Overall Study|Physician Decision|1|||
144596883|NCT02604433|521386988|FG000|Overall Study|Lack of Efficacy|0|||
144596884|NCT02604433|521386989|FG001|Overall Study|Lack of Efficacy|1|||
144596885|NCT03285178|521386990|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
144596886|NCT03285178|521386991|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
144596887|NCT03285178|521386992|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
144596888|NCT03285178|521386993|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
144596889|NCT03285178|521386994|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
144596890|NCT03285178|521386995|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
144596891|NCT03285178|521386996|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
144596892|NCT03285178|521386990|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
144596893|NCT03285178|521386991|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
144596894|NCT03285178|521386992|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
144596895|NCT03285178|521386993|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
144596896|NCT03285178|521386994|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
144596897|NCT03285178|521386995|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
144596898|NCT03285178|521386996|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
144596899|NCT03285178|521386990|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
144596900|NCT03285178|521386991|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
144596901|NCT03285178|521386992|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
144596902|NCT03285178|521386993|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
144596903|NCT03285178|521386994|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
144596904|NCT03285178|521386995|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
144596905|NCT03285178|521386996|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
144523048|NCT04209465|521115036|FG006|Overall Study|Study terminated early by sponsor|3|||
144523049|NCT04209465|521115037|FG007|Overall Study|Study terminated early by sponsor|0|||
144523050|NCT04209465|521115038|FG008|Overall Study|Study terminated early by sponsor|0|||
144523051|NCT04209465|521115039|FG009|Overall Study|Study terminated early by sponsor|0|||
144523052|NCT04209465|521115040|FG010|Overall Study|Study terminated early by sponsor|0|||
144523053|NCT04209465|521115041|FG011|Overall Study|Study terminated early by sponsor|0|||
144523054|NCT04209465|521115042|FG012|Overall Study|Study terminated early by sponsor|3|||
144523055|NCT04209465|521115030|FG000|Overall Study|Other|0|||
144523056|NCT04209465|521115031|FG001|Overall Study|Other|0|||
144523057|NCT04209465|521115032|FG002|Overall Study|Other|0|||
144523058|NCT04209465|521115033|FG003|Overall Study|Other|0|||
144523059|NCT04209465|521115034|FG004|Overall Study|Other|0|||
144523060|NCT04209465|521115035|FG005|Overall Study|Other|0|||
144523061|NCT04209465|521115036|FG006|Overall Study|Other|0|||
144523062|NCT04209465|521115037|FG007|Overall Study|Other|0|||
144523063|NCT04209465|521115038|FG008|Overall Study|Other|1|||
144596906|NCT03285178|521386990|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
144523064|NCT04209465|521115039|FG009|Overall Study|Other|0|||
144523065|NCT04209465|521115040|FG010|Overall Study|Other|0|||
144596907|NCT03285178|521386991|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
144596908|NCT03285178|521386992|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
144596909|NCT03285178|521386993|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
144596910|NCT03285178|521386994|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
144596911|NCT03285178|521386995|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
144596912|NCT03285178|521386996|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
144596913|NCT03285178|521386990|FG000|Single-Blind Run-In Period|Physician Decision|2|||
144596914|NCT03285178|521386991|FG001|Single-Blind Run-In Period|Physician Decision|0|||
144596915|NCT03285178|521386992|FG002|Single-Blind Run-In Period|Physician Decision|0|||
144596916|NCT03285178|521386993|FG003|Single-Blind Run-In Period|Physician Decision|0|||
144596917|NCT03285178|521386994|FG004|Single-Blind Run-In Period|Physician Decision|0|||
144596918|NCT03285178|521386995|FG005|Single-Blind Run-In Period|Physician Decision|0|||
144596919|NCT03285178|521386996|FG006|Single-Blind Run-In Period|Physician Decision|0|||
144596920|NCT03285178|521386990|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
144596921|NCT03285178|521386991|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
144596922|NCT03285178|521386992|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
144596923|NCT03285178|521386993|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
144596924|NCT03285178|521386994|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
144596925|NCT03285178|521386995|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
144596926|NCT03285178|521386996|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
144596927|NCT03285178|521386990|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144596928|NCT03285178|521386991|FG001|Double-Blind Treatment Period|Adverse Event|0|||
144596929|NCT03285178|521386992|FG002|Double-Blind Treatment Period|Adverse Event|0|||
144596930|NCT03285178|521386993|FG003|Double-Blind Treatment Period|Adverse Event|0|||
144596931|NCT03285178|521386994|FG004|Double-Blind Treatment Period|Adverse Event|0|||
144596932|NCT03285178|521386995|FG005|Double-Blind Treatment Period|Adverse Event|0|||
144596933|NCT03285178|521386996|FG006|Double-Blind Treatment Period|Adverse Event|2|||
144596934|NCT03285178|521386990|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144596935|NCT03285178|521386991|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
144596936|NCT03285178|521386992|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
144596937|NCT03285178|521386993|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
144596938|NCT03285178|521386994|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
144596939|NCT03285178|521386995|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
144596940|NCT03285178|521386996|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
144596941|NCT03285178|521386990|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144596942|NCT03285178|521386991|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144596943|NCT03285178|521386992|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144596944|NCT03285178|521386993|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144596945|NCT03285178|521386994|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144596946|NCT03285178|521386995|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144596947|NCT03285178|521386996|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144596948|NCT03285178|521386990|FG000|Double-Blind Treatment Period|COVID-19|0|||
144596949|NCT03285178|521386991|FG001|Double-Blind Treatment Period|COVID-19|0|||
144596950|NCT03285178|521386992|FG002|Double-Blind Treatment Period|COVID-19|1|||
144596951|NCT03285178|521386993|FG003|Double-Blind Treatment Period|COVID-19|0|||
144596952|NCT03285178|521386994|FG004|Double-Blind Treatment Period|COVID-19|0|||
144596953|NCT03285178|521386995|FG005|Double-Blind Treatment Period|COVID-19|0|||
144596954|NCT03285178|521386996|FG006|Double-Blind Treatment Period|COVID-19|0|||
144596955|NCT01388790|521386997|FG000|Overall Study|Ongoing at data cut-off date|8|||
144596956|NCT00195507|521386998|FG000|Overall Study|Adverse Event|24|||
144596957|NCT00195507|521386999|FG001|Overall Study|Adverse Event|13|||
144596958|NCT00195507|521386998|FG000|Overall Study|Death|0|||
144596959|NCT00195507|521386999|FG001|Overall Study|Death|1|||
144596960|NCT00195507|521386998|FG000|Overall Study|Failed to Return|4|||
144596961|NCT00195507|521386999|FG001|Overall Study|Failed to Return|3|||
144596962|NCT00195507|521386998|FG000|Overall Study|Physician Decision|1|||
144596963|NCT00195507|521386999|FG001|Overall Study|Physician Decision|2|||
144596964|NCT00195507|521386998|FG000|Overall Study|Lost to Follow-up|3|||
144596965|NCT00195507|521386999|FG001|Overall Study|Lost to Follow-up|2|||
144596966|NCT00195507|521386998|FG000|Overall Study|Protocol Violation|5|||
144596967|NCT00195507|521386999|FG001|Overall Study|Protocol Violation|4|||
144596968|NCT00195507|521386998|FG000|Overall Study|Lack of Efficacy|40|||
144596969|NCT00195507|521386999|FG001|Overall Study|Lack of Efficacy|67|||
144596970|NCT00195507|521386998|FG000|Overall Study|Withdrawal by Subject|16|||
144596971|NCT00195507|521386999|FG001|Overall Study|Withdrawal by Subject|23|||
144596972|NCT00195507|521386998|FG000|Overall Study|Protocol Deviation|6|||
144596973|NCT00195507|521386999|FG001|Overall Study|Protocol Deviation|3|||
144596974|NCT01128738|521387000|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
144596975|NCT01128738|521387001|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
144596976|NCT01128738|521387000|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
144596977|NCT01128738|521387001|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
144596978|NCT01128738|521387000|FG000|Second TP|Lost to Follow-up|0|||
144596979|NCT01128738|521387001|FG001|Second TP|Lost to Follow-up|1|||
144596980|NCT01128738|521387000|FG000|Second TP|Withdrawal by Subject|0|||
144596981|NCT01128738|521387001|FG001|Second TP|Withdrawal by Subject|2|||
144596982|NCT01211197|521387002|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144596983|NCT01211197|521387003|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144596984|NCT01211197|521387004|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
144596985|NCT01211197|521387005|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144596986|NCT01211197|521387006|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144596987|NCT01211197|521387007|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144596988|NCT01211197|521387002|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
144596989|NCT01211197|521387003|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
144596990|NCT01211197|521387004|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
144596991|NCT01211197|521387005|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
144596992|NCT01211197|521387006|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
144596993|NCT01211197|521387007|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
144596994|NCT00150969|521387009|FG000|24 Month Main Study|Adverse Event|3|||
144596995|NCT00150969|521387010|FG001|24 Month Main Study|Adverse Event|4|||
144596996|NCT00150969|521387009|FG000|24 Month Main Study|Death|1|||
144596997|NCT00150969|521387010|FG001|24 Month Main Study|Death|1|||
144596998|NCT00150969|521387009|FG000|24 Month Main Study|Lack of Efficacy|1|||
144596999|NCT00150969|521387010|FG001|24 Month Main Study|Lack of Efficacy|8|||
144597000|NCT00150969|521387009|FG000|24 Month Main Study|Lost to Follow-up|3|||
144597001|NCT00150969|521387010|FG001|24 Month Main Study|Lost to Follow-up|2|||
144597002|NCT00150969|521387009|FG000|24 Month Main Study|Protocol Violation|4|||
144597003|NCT00150969|521387010|FG001|24 Month Main Study|Protocol Violation|2|||
144597004|NCT00150969|521387009|FG000|24 Month Main Study|Withdrawal by Subject|7|||
144597005|NCT00150969|521387010|FG001|24 Month Main Study|Withdrawal by Subject|4|||
144597006|NCT00150969|521387009|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
144597007|NCT00150969|521387010|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
144597008|NCT00150969|521387009|FG000|24-48 Month Extension|Lack of Efficacy|0|||
144597009|NCT00150969|521387010|FG001|24-48 Month Extension|Lack of Efficacy|1|||
144597010|NCT00150969|521387009|FG000|24-48 Month Extension|Adverse Event|1|||
144597011|NCT00150969|521387010|FG001|24-48 Month Extension|Adverse Event|3|||
144597012|NCT00150969|521387009|FG000|24-48 Month Extension|Other Reason|81|||
144597013|NCT00150969|521387010|FG001|24-48 Month Extension|Other Reason|91|||
144597014|NCT00146757|521387011|FG000|Overall Study|Death|1|||
144597015|NCT00146757|521387012|FG001|Overall Study|Death|0|||
144597016|NCT00146757|521387011|FG000|Overall Study|Adverse Event|1|||
144597017|NCT00146757|521387012|FG001|Overall Study|Adverse Event|0|||
144597018|NCT02893930|521387024|FG000|Overall Study|Adverse Event|3|||
144597019|NCT02893930|521387024|FG000|Overall Study|Death|1|||
144597020|NCT02893930|521387024|FG000|Overall Study|Disease progression|5|||
144597021|NCT02893930|521387024|FG000|Overall Study|Withdrawal by Subject|2|||
144597022|NCT02893930|521387024|FG000|Overall Study|Physician Decision|1|||
144597023|NCT02893930|521387024|FG000|Overall Study|Ineligible|1|||
144597024|NCT01176773|521387025|FG000|Overall Study|Screen Failure|2|||
144597025|NCT01176773|521387025|FG000|Overall Study|Withdrew consent|1|||
144597026|NCT02446886|521387031|FG000|Overall Study|Adverse Event|1|||
144597027|NCT02446886|521387032|FG001|Overall Study|Adverse Event|3|||
144597028|NCT02446886|521387031|FG000|Overall Study|Withdrawal by Subject|1|||
144597029|NCT02446886|521387032|FG001|Overall Study|Withdrawal by Subject|1|||
144597030|NCT01498289|521387035|FG000|Overall Study|Adverse Event|16|||
144597031|NCT01498289|521387036|FG001|Overall Study|Adverse Event|18|||
144597032|NCT01498289|521387035|FG000|Overall Study|Death|6|||
144597033|NCT01498289|521387036|FG001|Overall Study|Death|8|||
144597034|NCT01498289|521387035|FG000|Overall Study|Withdrawal unrelated to AE|16|||
144597035|NCT01498289|521387036|FG001|Overall Study|Withdrawal unrelated to AE|16|||
144597036|NCT01498289|521387035|FG000|Overall Study|Progression/relapse|53|||
144597037|NCT01498289|521387036|FG001|Overall Study|Progression/relapse|59|||
144597038|NCT01498289|521387035|FG000|Overall Study|Not protocol specified|7|||
144597039|NCT01498289|521387036|FG001|Overall Study|Not protocol specified|2|||
144597040|NCT01498289|521387035|FG000|Overall Study|Reason under review|0|||
144597041|NCT01498289|521387036|FG001|Overall Study|Reason under review|1|||
144597042|NCT01423253|521387037|FG000|Overall Study|Adverse Event|2|||
144597043|NCT01423253|521387037|FG000|Overall Study|Lack of Efficacy|2|||
144597044|NCT01423253|521387037|FG000|Overall Study|Lost to Follow-up|1|||
144597045|NCT01423253|521387037|FG000|Overall Study|Protocol Violation|2|||
144597046|NCT01423253|521387037|FG000|Overall Study|Withdrawal by Subject|2|||
144597047|NCT01290601|521387041|FG000|Overall Study|Adverse Event|0|||
144597048|NCT01290601|521387042|FG001|Overall Study|Adverse Event|2|||
144597049|NCT01290601|521387043|FG002|Overall Study|Adverse Event|0|||
144597050|NCT01290601|521387044|FG003|Overall Study|Adverse Event|0|||
144597051|NCT01290601|521387041|FG000|Overall Study|Lack of Efficacy|2|||
144471958|NCT03217747|520925358|FG005|Overall Study|Lack of Efficacy|14|||
144597052|NCT01290601|521387042|FG001|Overall Study|Lack of Efficacy|1|||
144597053|NCT01290601|521387043|FG002|Overall Study|Lack of Efficacy|0|||
144597054|NCT01290601|521387044|FG003|Overall Study|Lack of Efficacy|0|||
144597055|NCT01290601|521387041|FG000|Overall Study|Lost to Follow-up|7|||
144597056|NCT01290601|521387042|FG001|Overall Study|Lost to Follow-up|2|||
144597057|NCT01290601|521387043|FG002|Overall Study|Lost to Follow-up|0|||
144597058|NCT01290601|521387044|FG003|Overall Study|Lost to Follow-up|0|||
144597059|NCT01290601|521387041|FG000|Overall Study|Other|1|||
144597060|NCT01290601|521387042|FG001|Overall Study|Other|0|||
144597061|NCT01290601|521387043|FG002|Overall Study|Other|0|||
144597062|NCT01290601|521387044|FG003|Overall Study|Other|0|||
144597063|NCT01290601|521387041|FG000|Overall Study|Protocol Violation|1|||
144597064|NCT01290601|521387042|FG001|Overall Study|Protocol Violation|0|||
144597065|NCT01290601|521387043|FG002|Overall Study|Protocol Violation|0|||
144597066|NCT01290601|521387044|FG003|Overall Study|Protocol Violation|0|||
144597067|NCT00775450|521387045|FG000|Overall Study|Serious Adverse Event|2|||
144597068|NCT00775450|521387046|FG001|Overall Study|Serious Adverse Event|0|||
144597069|NCT00775450|521387047|FG002|Overall Study|Serious Adverse Event|0|||
144597070|NCT00775450|521387048|FG003|Overall Study|Serious Adverse Event|0|||
144597071|NCT00775450|521387049|FG004|Overall Study|Serious Adverse Event|0|||
144597072|NCT00775450|521387045|FG000|Overall Study|Protocol Violation|0|||
144597073|NCT00775450|521387046|FG001|Overall Study|Protocol Violation|0|||
144597074|NCT00775450|521387047|FG002|Overall Study|Protocol Violation|0|||
144597075|NCT00775450|521387048|FG003|Overall Study|Protocol Violation|0|||
144597076|NCT00775450|521387049|FG004|Overall Study|Protocol Violation|1|||
144597077|NCT00775450|521387045|FG000|Overall Study|Withdrawal by Subject|1|||
144597078|NCT00775450|521387046|FG001|Overall Study|Withdrawal by Subject|0|||
144597079|NCT00775450|521387047|FG002|Overall Study|Withdrawal by Subject|0|||
144597080|NCT00775450|521387048|FG003|Overall Study|Withdrawal by Subject|0|||
144597081|NCT00775450|521387049|FG004|Overall Study|Withdrawal by Subject|1|||
144597082|NCT00894686|521387050|FG000|Overall Study|Withdrawal by Subject|50|||
144597083|NCT00894686|521387050|FG000|Overall Study|Physician Decision|1|||
144597084|NCT00894686|521387050|FG000|Overall Study|Other|5|||
144597085|NCT00564018|521387051|FG000|Overall Study|Withdrawal by Subject|2|||
144597086|NCT00564018|521387052|FG001|Overall Study|Withdrawal by Subject|3|||
144597087|NCT00564018|521387053|FG002|Overall Study|Withdrawal by Subject|1|||
144597088|NCT00986440|521387054|FG000|Overall Study|Progressive disease|27|||
144597089|NCT00986440|521387055|FG001|Overall Study|Progressive disease|37|||
144597090|NCT00986440|521387054|FG000|Overall Study|Serious adverse event or adverse event|9|||
144597091|NCT00986440|521387055|FG001|Overall Study|Serious adverse event or adverse event|2|||
144249767|NCT01080391|520111738|FG001|Overall Study|Randomized but not treated|4|||
144249768|NCT00586508|520111755|FG000|Overall Study|Progressive disease|52|||
144249769|NCT00586508|520111756|FG001|Overall Study|Progressive disease|8|||
144249770|NCT00586508|520111755|FG000|Overall Study|Death|0|||
144249771|NCT00586508|520111756|FG001|Overall Study|Death|1|||
144249772|NCT00586508|520111755|FG000|Overall Study|Adverse Event|12|||
144249773|NCT00586508|520111756|FG001|Overall Study|Adverse Event|4|||
144249774|NCT00586508|520111755|FG000|Overall Study|Withdrawal by Subject|4|||
144249775|NCT00586508|520111756|FG001|Overall Study|Withdrawal by Subject|0|||
144249776|NCT03325894|520111758|FG000|Overall Study|Adverse Event|2|||
144249777|NCT03325894|520111759|FG001|Overall Study|Adverse Event|3|||
144249778|NCT03325894|520111758|FG000|Overall Study|Protocol Violation|1|||
144249779|NCT03325894|520111759|FG001|Overall Study|Protocol Violation|2|||
144249780|NCT03325894|520111758|FG000|Overall Study|Withdrawal by Subject|10|||
144249781|NCT03325894|520111759|FG001|Overall Study|Withdrawal by Subject|6|||
144249782|NCT03325894|520111758|FG000|Overall Study|Lost to Follow-up|4|||
144249783|NCT03325894|520111759|FG001|Overall Study|Lost to Follow-up|9|||
144249784|NCT03325894|520111758|FG000|Overall Study|Lack of Efficacy|8|||
144249785|NCT03325894|520111759|FG001|Overall Study|Lack of Efficacy|14|||
144249786|NCT03325894|520111758|FG000|Overall Study|Study Terminated by Sponsor|38|||
144249787|NCT03325894|520111759|FG001|Overall Study|Study Terminated by Sponsor|43|||
144597092|NCT00986440|521387054|FG000|Overall Study|Withdrawal by Subject|1|||
144597093|NCT00986440|521387055|FG001|Overall Study|Withdrawal by Subject|2|||
144597094|NCT00986440|521387054|FG000|Overall Study|Screen failure (not dosed)|4|||
144597095|NCT00986440|521387055|FG001|Overall Study|Screen failure (not dosed)|2|||
144597096|NCT05056987|521387058|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
144597097|NCT05056987|521387059|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
144597098|NCT05056987|521387058|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
144249788|NCT03325894|520111758|FG000|Overall Study|Other (Not received Treatment)|1|||
144249789|NCT03325894|520111759|FG001|Overall Study|Other (Not received Treatment)|0|||
144249790|NCT01524783|520111761|FG000|Blinded Period|Adverse Event|64|||
144597099|NCT05056987|521387059|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
144597100|NCT02409368|521387060|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
144597101|NCT02409368|521387061|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
144597102|NCT02409368|521387062|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
144249791|NCT01524783|520111762|FG001|Blinded Period|Adverse Event|7|||
144249792|NCT01524783|520111763|FG002|Blinded Period|Adverse Event|0|||
144249793|NCT01524783|520111761|FG000|Blinded Period|Disease Progression|89|||
144722352|NCT02655237|521838690|FG000|Overall Study|Adverse Event|10|||
144523066|NCT04209465|521115041|FG011|Overall Study|Other|0|||
144523067|NCT04209465|521115042|FG012|Overall Study|Other|0|||
144523068|NCT03097549|521115043|FG000|Overall Study|Withdrawal by Subject|1|||
144523069|NCT03097549|521115044|FG001|Overall Study|Withdrawal by Subject|0|||
144523070|NCT03097549|521115043|FG000|Overall Study|Lost to Follow-up|1|||
144523071|NCT03097549|521115044|FG001|Overall Study|Lost to Follow-up|0|||
144523072|NCT05783102|521115045|FG000|Overall Study|Lost to Follow-up|1|||
144523073|NCT05783102|521115045|FG000|Overall Study|Withdrawal by Subject|2|||
144523074|NCT04142788|521116827|FG000|Overall Study|Trial terminated prematurely|2|||
144523075|NCT04142788|521116828|FG001|Overall Study|Trial terminated prematurely|2|||
144523076|NCT01396278|521116829|FG000|Overall Study|Adverse Event|0|||
144523077|NCT01396278|521116830|FG001|Overall Study|Adverse Event|0|||
144523078|NCT01396278|521116831|FG002|Overall Study|Adverse Event|0|||
144523079|NCT01396278|521116832|FG003|Overall Study|Adverse Event|2|||
144523080|NCT01396278|521116833|FG004|Overall Study|Adverse Event|0|||
144523081|NCT01396278|521116829|FG000|Overall Study|Withdraw due to trial termination|2|||
144523082|NCT01396278|521116830|FG001|Overall Study|Withdraw due to trial termination|1|||
144523083|NCT01396278|521116831|FG002|Overall Study|Withdraw due to trial termination|1|||
144523084|NCT01396278|521116832|FG003|Overall Study|Withdraw due to trial termination|0|||
144523085|NCT01396278|521116833|FG004|Overall Study|Withdraw due to trial termination|2|||
144523086|NCT04764448|521116836|FG000|Overall Study|Study terminated by sponsor|2|||
144523087|NCT04764448|521116837|FG001|Overall Study|Study terminated by sponsor|2|||
144523088|NCT04764448|521116838|FG002|Overall Study|Study terminated by sponsor|5|||
144523089|NCT04764448|521116836|FG000|Overall Study|Withdrawal by Subject|3|||
144523090|NCT04764448|521116837|FG001|Overall Study|Withdrawal by Subject|3|||
144523091|NCT04764448|521116838|FG002|Overall Study|Withdrawal by Subject|1|||
144523092|NCT04515576|521116839|FG000|Overall Study|Withdrawal by Subject|0|||
144523093|NCT04515576|521116840|FG001|Overall Study|Withdrawal by Subject|0|||
144523094|NCT04515576|521116841|FG002|Overall Study|Withdrawal by Subject|0|||
144523095|NCT04515576|521116842|FG003|Overall Study|Withdrawal by Subject|0|||
144523096|NCT04515576|521116843|FG004|Overall Study|Withdrawal by Subject|0|||
144523097|NCT04515576|521116844|FG005|Overall Study|Withdrawal by Subject|1|||
144523098|NCT03812679|521116845|FG000|Overall Study|Adverse Event|2|||
144523099|NCT03812679|521116845|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
144523100|NCT03812679|521116845|FG000|Overall Study|Renal transplant|1|||
144523101|NCT03812679|521116845|FG000|Overall Study|Withdrawal by Subject|1|||
144523102|NCT03812679|521116845|FG000|Overall Study|Termination of study|2|||
144523103|NCT03812679|521116845|FG000|Overall Study|Water device replacement|1|||
144523104|NCT05653427|521116846|FG000|Overall Study|Study Terminated by Sponsor|13|||
144523105|NCT03891667|521116854|FG000|Overall Study|Physician Decision|1|||
144523106|NCT03891667|521116855|FG001|Overall Study|Physician Decision|1|||
144523107|NCT03891667|521116854|FG000|Overall Study|COVID related pause|1|||
144523108|NCT03891667|521116855|FG001|Overall Study|COVID related pause|0|||
144523109|NCT03891667|521116854|FG000|Overall Study|Withdrawal by Subject|0|||
144523110|NCT03891667|521116855|FG001|Overall Study|Withdrawal by Subject|1|||
144523111|NCT03891667|521116854|FG000|Overall Study|Adverse Event|0|||
144523112|NCT03891667|521116855|FG001|Overall Study|Adverse Event|1|||
144523113|NCT04456517|521116856|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
144523114|NCT04456517|521116857|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
144523115|NCT01160211|521116859|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
144523116|NCT01160211|521116860|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
144523117|NCT01160211|521116861|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
144523118|NCT01160211|521116859|FG000|Overall Study|Lost to Follow-up|4|||
144523119|NCT01160211|521116860|FG001|Overall Study|Lost to Follow-up|8|||
144523120|NCT01160211|521116861|FG002|Overall Study|Lost to Follow-up|4|||
144523121|NCT01160211|521116859|FG000|Overall Study|Physician Decision|1|||
144523122|NCT01160211|521116860|FG001|Overall Study|Physician Decision|0|||
144523123|NCT01160211|521116861|FG002|Overall Study|Physician Decision|0|||
144523124|NCT01160211|521116859|FG000|Overall Study|Withdrawal by Subject|4|||
144523125|NCT01160211|521116860|FG001|Overall Study|Withdrawal by Subject|2|||
144523126|NCT01160211|521116861|FG002|Overall Study|Withdrawal by Subject|2|||
144523127|NCT01160211|521116859|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
144523128|NCT01160211|521116860|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
144523129|NCT01160211|521116861|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
144523130|NCT02734290|521116862|FG000|Overall Study|Adverse Event|1|||
144523131|NCT02734290|521116863|FG001|Overall Study|Adverse Event|0|||
144523132|NCT02734290|521116862|FG000|Overall Study|Death|1|||
144523133|NCT02734290|521116863|FG001|Overall Study|Death|0|||
144523134|NCT05179837|521116865|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
144523135|NCT05179837|521116865|FG000|Overall Study|Device malfunctioned|1|||
144523136|NCT05179837|521116865|FG000|Overall Study|Image quality too low|2|||
144523137|NCT03611491|521116870|FG000|Overall Study|Lost to Follow-up|1|||
144523138|NCT04676022|521116871|FG000|Overall Study|Screen Failure/|1|||
144523139|NCT04676022|521116872|FG001|Overall Study|Screen Failure/|1|||
144722353|NCT02655237|521838691|FG001|Overall Study|Adverse Event|7|||
144523140|NCT04676022|521116873|FG002|Overall Study|Screen Failure/|85|||
144523141|NCT04676022|521116871|FG000|Overall Study|Lost to Follow-up|1|||
144523142|NCT04676022|521116872|FG001|Overall Study|Lost to Follow-up|1|||
144523143|NCT04676022|521116873|FG002|Overall Study|Lost to Follow-up|0|||
144523144|NCT04676022|521116871|FG000|Overall Study|Adverse Event|2|||
144523145|NCT04676022|521116872|FG001|Overall Study|Adverse Event|0|||
144523146|NCT04676022|521116873|FG002|Overall Study|Adverse Event|1|||
144523147|NCT04676022|521116871|FG000|Overall Study|Physician Decision|2|||
144523148|NCT04676022|521116872|FG001|Overall Study|Physician Decision|0|||
144523149|NCT04676022|521116873|FG002|Overall Study|Physician Decision|1|||
144523150|NCT04676022|521116871|FG000|Overall Study|Withdrawal by Subject|3|||
144523151|NCT04676022|521116872|FG001|Overall Study|Withdrawal by Subject|1|||
144523152|NCT04676022|521116873|FG002|Overall Study|Withdrawal by Subject|6|||
144523153|NCT04676022|521116871|FG000|Overall Study|Will not move forward with permanent implant|6|||
144523154|NCT04676022|521116872|FG001|Overall Study|Will not move forward with permanent implant|0|||
144523155|NCT04676022|521116873|FG002|Overall Study|Will not move forward with permanent implant|0|||
144523156|NCT04676022|521116871|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
144523157|NCT04676022|521116872|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
144523158|NCT04676022|521116873|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
144523159|NCT05409183|521116875|FG000|Complete Study|Adverse Event|1|||
144523160|NCT05409183|521116876|FG001|Complete Study|Adverse Event|2|||
144523161|NCT05409183|521116875|FG000|Complete Study|Withdrawal by Subject|3|||
144523162|NCT05409183|521116876|FG001|Complete Study|Withdrawal by Subject|0|||
144523163|NCT03194217|521116877|FG000|Overall Study|Adverse Event|0|||
144523164|NCT03194217|521116878|FG001|Overall Study|Adverse Event|2|||
144523165|NCT03194217|521116879|FG002|Overall Study|Adverse Event|3|||
144597103|NCT02409368|521387063|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
144597104|NCT02409368|521387060|FG000|ECOG Reclassification|Death|1|||
144597105|NCT02409368|521387061|FG001|ECOG Reclassification|Death|5|||
144597106|NCT02409368|521387062|FG002|ECOG Reclassification|Death|0|||
144597107|NCT02409368|521387063|FG003|ECOG Reclassification|Death|0|||
144597108|NCT02409368|521387060|FG000|ECOG Reclassification|Disease Progression|113|||
144523166|NCT03194217|521116880|FG003|Overall Study|Adverse Event|3|||
144523167|NCT03194217|521116877|FG000|Overall Study|Failure to meet randomisation criteria|0|||
144523168|NCT03194217|521116878|FG001|Overall Study|Failure to meet randomisation criteria|0|||
144523169|NCT03194217|521116879|FG002|Overall Study|Failure to meet randomisation criteria|0|||
144523170|NCT03194217|521116880|FG003|Overall Study|Failure to meet randomisation criteria|1|||
144523171|NCT03194217|521116877|FG000|Overall Study|Other|0|||
144597109|NCT02409368|521387061|FG001|ECOG Reclassification|Disease Progression|382|||
144597110|NCT02409368|521387062|FG002|ECOG Reclassification|Disease Progression|70|||
144597111|NCT02409368|521387063|FG003|ECOG Reclassification|Disease Progression|1|||
144597112|NCT02409368|521387060|FG000|ECOG Reclassification|Lost to Follow-up|1|||
144597113|NCT02409368|521387061|FG001|ECOG Reclassification|Lost to Follow-up|5|||
144597114|NCT02409368|521387062|FG002|ECOG Reclassification|Lost to Follow-up|0|||
144597115|NCT02409368|521387063|FG003|ECOG Reclassification|Lost to Follow-up|0|||
144597116|NCT02409368|521387060|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
144597117|NCT02409368|521387061|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
144597118|NCT02409368|521387062|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
144597119|NCT02409368|521387063|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
144597120|NCT02409368|521387060|FG000|ECOG Reclassification|Poor/non-compliance|0|||
144597121|NCT02409368|521387061|FG001|ECOG Reclassification|Poor/non-compliance|3|||
144597122|NCT02409368|521387062|FG002|ECOG Reclassification|Poor/non-compliance|2|||
144597123|NCT02409368|521387063|FG003|ECOG Reclassification|Poor/non-compliance|0|||
144597124|NCT02409368|521387060|FG000|ECOG Reclassification|Study drug toxicity|17|||
144597125|NCT02409368|521387061|FG001|ECOG Reclassification|Study drug toxicity|42|||
144597126|NCT02409368|521387062|FG002|ECOG Reclassification|Study drug toxicity|7|||
144597127|NCT02409368|521387063|FG003|ECOG Reclassification|Study drug toxicity|0|||
144597128|NCT02409368|521387060|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
144249794|NCT01524783|520111762|FG001|Blinded Period|Disease Progression|75|||
144249795|NCT01524783|520111763|FG002|Blinded Period|Disease Progression|0|||
144523172|NCT03194217|521116878|FG001|Overall Study|Other|1|||
144523173|NCT03194217|521116879|FG002|Overall Study|Other|1|||
144523174|NCT03194217|521116880|FG003|Overall Study|Other|0|||
144523175|NCT04806451|521116881|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
144523176|NCT04806451|521116882|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
144597129|NCT02409368|521387061|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
144597130|NCT02409368|521387062|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
144597131|NCT02409368|521387063|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
144597132|NCT02409368|521387060|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
144597133|NCT02409368|521387061|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
144597134|NCT02409368|521387062|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
144597135|NCT02409368|521387063|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
144597136|NCT02409368|521387060|FG000|ECOG Reclassification|Participant withdrew consent|2|||
144597137|NCT02409368|521387061|FG001|ECOG Reclassification|Participant withdrew consent|3|||
144597138|NCT02409368|521387062|FG002|ECOG Reclassification|Participant withdrew consent|4|||
144597139|NCT02409368|521387063|FG003|ECOG Reclassification|Participant withdrew consent|0|||
144597140|NCT02409368|521387060|FG000|ECOG Reclassification|Other Reasons|5|||
144597141|NCT02409368|521387061|FG001|ECOG Reclassification|Other Reasons|26|||
144597142|NCT02409368|521387062|FG002|ECOG Reclassification|Other Reasons|2|||
144597143|NCT02409368|521387063|FG003|ECOG Reclassification|Other Reasons|0|||
144597144|NCT02409368|521387060|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
144597145|NCT02409368|521387061|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
144597146|NCT02409368|521387062|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
144597147|NCT02409368|521387063|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
144597148|NCT01296347|521387064|FG000|Allocation|Withdrawal by Subject|1|||
144597149|NCT01296347|521387065|FG001|Allocation|Withdrawal by Subject|2|||
144597150|NCT01296347|521387064|FG000|Allocation|Lack of Efficacy|1|||
144597151|NCT01296347|521387065|FG001|Allocation|Lack of Efficacy|2|||
144597152|NCT01296347|521387064|FG000|Allocation|not received infusion|1|||
144597153|NCT01296347|521387065|FG001|Allocation|not received infusion|0|||
144597154|NCT01296347|521387064|FG000|6 Week Follow up|Death|0|||
144597155|NCT01296347|521387065|FG001|6 Week Follow up|Death|1|||
144597156|NCT01296347|521387064|FG000|3 Month Follow up|Death|1|||
144597157|NCT01296347|521387065|FG001|3 Month Follow up|Death|0|||
144597158|NCT01296347|521387064|FG000|3 Month Follow up|Lost to Follow-up|0|||
144597159|NCT01296347|521387065|FG001|3 Month Follow up|Lost to Follow-up|1|||
144597160|NCT01296347|521387064|FG000|6 Month Follow up|Death|2|||
144597161|NCT01296347|521387065|FG001|6 Month Follow up|Death|1|||
144597162|NCT01296347|521387064|FG000|6 Month Follow up|Lost to Follow-up|0|||
144597163|NCT01296347|521387065|FG001|6 Month Follow up|Lost to Follow-up|1|||
144597164|NCT01296347|521387064|FG000|12 Month Follow up|Lost to Follow-up|3|||
144597165|NCT01296347|521387065|FG001|12 Month Follow up|Lost to Follow-up|1|||
144597166|NCT01296347|521387064|FG000|12 Month Follow up|Death|1|||
144597167|NCT01296347|521387065|FG001|12 Month Follow up|Death|1|||
144597168|NCT01296347|521387064|FG000|12 Month Follow up|Withdrawal by Subject|0|||
144597169|NCT01296347|521387065|FG001|12 Month Follow up|Withdrawal by Subject|1|||
144597170|NCT01948908|521387066|FG000|Overall Study|Protocol Violation|1|||
144597171|NCT01948908|521387067|FG001|Overall Study|Protocol Violation|0|||
144597172|NCT01948908|521387068|FG002|Overall Study|Protocol Violation|2|||
144597173|NCT02240693|521387069|FG000|Overall Study|Adverse Event|0|||
144597174|NCT02240693|521387070|FG001|Overall Study|Adverse Event|0|||
144597175|NCT02240693|521387071|FG002|Overall Study|Adverse Event|0|||
144597176|NCT02240693|521387072|FG003|Overall Study|Adverse Event|0|||
144597177|NCT02240693|521387073|FG004|Overall Study|Adverse Event|1|||
144597178|NCT02240693|521387069|FG000|Overall Study|Withdrawal by Subject|0|||
144597179|NCT02240693|521387070|FG001|Overall Study|Withdrawal by Subject|0|||
144597180|NCT02240693|521387071|FG002|Overall Study|Withdrawal by Subject|2|||
144597181|NCT02240693|521387072|FG003|Overall Study|Withdrawal by Subject|1|||
144597182|NCT02240693|521387073|FG004|Overall Study|Withdrawal by Subject|0|||
144597183|NCT02240693|521387069|FG000|Overall Study|Other than specified|0|||
144597184|NCT02240693|521387070|FG001|Overall Study|Other than specified|0|||
144400417|NCT03277690|520676545|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
144400418|NCT03277690|520676544|FG000|Dose Titration and Maintenance|Physician Decision|1|||
144400419|NCT03277690|520676545|FG001|Dose Titration and Maintenance|Physician Decision|0|||
144400420|NCT03277690|520676544|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
144400421|NCT03277690|520676545|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
144400422|NCT03277690|520676544|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
144400423|NCT03277690|520676545|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
144400424|NCT03277690|520676544|FG000|Dose Titration and Maintenance|Adverse Event|15|||
144400425|NCT03277690|520676545|FG001|Dose Titration and Maintenance|Adverse Event|0|||
144597185|NCT02240693|521387071|FG002|Overall Study|Other than specified|2|||
144597186|NCT02240693|521387072|FG003|Overall Study|Other than specified|0|||
144597187|NCT02240693|521387073|FG004|Overall Study|Other than specified|0|||
144597188|NCT01585987|521387074|FG000|Randomized|Withdrawal by Subject|0|||
144597189|NCT01585987|521387075|FG001|Randomized|Withdrawal by Subject|4|||
144597190|NCT01585987|521387074|FG000|Randomized|No longer met criteria|0|||
144597191|NCT01585987|521387075|FG001|Randomized|No longer met criteria|2|||
144597192|NCT01585987|521387074|FG000|Treated|Disease Progression|39|||
144597193|NCT01585987|521387075|FG001|Treated|Disease Progression|36|||
144597194|NCT01585987|521387074|FG000|Treated|Study Drug Toxicity|9|||
144597195|NCT01585987|521387075|FG001|Treated|Study Drug Toxicity|5|||
144597196|NCT01585987|521387074|FG000|Treated|Adverse Event|3|||
144597197|NCT01585987|521387075|FG001|Treated|Adverse Event|0|||
144597198|NCT01585987|521387074|FG000|Treated|Withdrawal by Subject|1|||
144597199|NCT01585987|521387075|FG001|Treated|Withdrawal by Subject|2|||
144597200|NCT01585987|521387074|FG000|Treated|Death|1|||
144597201|NCT01585987|521387075|FG001|Treated|Death|0|||
144597202|NCT01585987|521387074|FG000|Treated|Lost to Follow-up|0|||
144597203|NCT01585987|521387075|FG001|Treated|Lost to Follow-up|1|||
144400426|NCT03277690|520676544|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
144400427|NCT03277690|520676545|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
144400428|NCT03277690|520676544|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
144523177|NCT04806451|521116881|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
144523178|NCT04806451|521116882|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
144523179|NCT04806451|521116881|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
144523180|NCT04806451|521116882|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
144523181|NCT05835336|521116883|FG000|Overall Study|Withdrawal by Subject|5|||
144523182|NCT05835336|521116883|FG000|Overall Study|Did not complete the personalization process|3|||
144523183|NCT03134196|521116899|FG000|Overall Study|Death|2|||
144523184|NCT03134196|521116900|FG001|Overall Study|Death|1|||
144523185|NCT03134196|521116899|FG000|Overall Study|Lost to Follow-up|13|||
144523186|NCT03134196|521116900|FG001|Overall Study|Lost to Follow-up|15|||
144523187|NCT03134196|521116899|FG000|Overall Study|Physician Decision|0|||
144523188|NCT03134196|521116900|FG001|Overall Study|Physician Decision|1|||
144523189|NCT03134196|521116899|FG000|Overall Study|Withdrawal by Subject|19|||
144523190|NCT03134196|521116900|FG001|Overall Study|Withdrawal by Subject|12|||
144523191|NCT03134196|521116899|FG000|Overall Study|Site Unable to Contact Participant|2|||
144523192|NCT03134196|521116900|FG001|Overall Study|Site Unable to Contact Participant|0|||
144523193|NCT03134196|521116899|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
144523194|NCT03134196|521116900|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
144523195|NCT03134196|521116899|FG000|Overall Study|Scheduling Conflict|1|||
144523196|NCT03134196|521116900|FG001|Overall Study|Scheduling Conflict|0|||
144523197|NCT04059484|521116908|FG000|Overall Study|Adverse Event|2|||
144523198|NCT04059484|521116909|FG001|Overall Study|Adverse Event|5|||
144523199|NCT04059484|521116908|FG000|Overall Study|Withdrawal by Subject|5|||
144523200|NCT04059484|521116909|FG001|Overall Study|Withdrawal by Subject|3|||
144523201|NCT04059484|521116908|FG000|Overall Study|Progressive disease|112|||
144523202|NCT04059484|521116909|FG001|Overall Study|Progressive disease|112|||
144523203|NCT04059484|521116908|FG000|Overall Study|Other|8|||
144523204|NCT04059484|521116909|FG001|Overall Study|Other|3|||
144523205|NCT04059484|521116908|FG000|Overall Study|Ongoing|20|||
144523206|NCT04059484|521116909|FG001|Overall Study|Ongoing|20|||
144523207|NCT02023866|521116910|FG000|Overall Study|Non-compliance|2|||
144523208|NCT02023866|521116910|FG000|Overall Study|Adverse Event|3|||
144523209|NCT02023866|521116910|FG000|Overall Study|Withdrawal by Subject|1|||
144523210|NCT03307343|521116911|FG000|Overall Study|Withdrawal by Subject|1|||
144523211|NCT03307343|521116912|FG001|Overall Study|Withdrawal by Subject|2|||
144523212|NCT03307343|521116911|FG000|Overall Study|Pregnancy|0|||
144523213|NCT03307343|521116912|FG001|Overall Study|Pregnancy|2|||
144523214|NCT03307343|521116911|FG000|Overall Study|Physician Decision|1|||
144722354|NCT02655237|521838690|FG000|Overall Study|Protocol Deviation|2|||
144597204|NCT01585987|521387074|FG000|Treated|Maximum Clinical Benefit|0|||
144597205|NCT01585987|521387075|FG001|Treated|Maximum Clinical Benefit|1|||
144597206|NCT01585987|521387074|FG000|Treated|Non-Specified|1|||
144597207|NCT01585987|521387075|FG001|Treated|Non-Specified|2|||
144597208|NCT01585987|521387074|FG000|Treated|Subject Request|0|||
144597209|NCT01585987|521387075|FG001|Treated|Subject Request|1|||
144597210|NCT01585987|521387074|FG000|Treated|Poor/Non-Compliance|0|||
144597211|NCT01585987|521387075|FG001|Treated|Poor/Non-Compliance|1|||
144597212|NCT02041520|521387077|FG000|Overall Study|Adverse Event|2|||
144597213|NCT02041520|521387078|FG001|Overall Study|Adverse Event|1|||
144597214|NCT02041520|521387077|FG000|Overall Study|Withdrawal by Subject|3|||
144597215|NCT02041520|521387078|FG001|Overall Study|Withdrawal by Subject|4|||
144597216|NCT02041520|521387077|FG000|Overall Study|Protocol Violation|1|||
144597217|NCT02041520|521387078|FG001|Overall Study|Protocol Violation|0|||
144597218|NCT02041520|521387077|FG000|Overall Study|Lost to Follow-up|0|||
144597219|NCT02041520|521387078|FG001|Overall Study|Lost to Follow-up|1|||
144597220|NCT02041520|521387077|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
144597221|NCT02041520|521387078|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
144597222|NCT00413972|521387081|FG000|Overall Study|Adverse Event|2|||
144597223|NCT00413972|521387082|FG001|Overall Study|Adverse Event|1|||
144722355|NCT02655237|521838691|FG001|Overall Study|Protocol Deviation|0|||
144400429|NCT03277690|520676545|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
144523215|NCT03307343|521116912|FG001|Overall Study|Physician Decision|0|||
144523216|NCT03307343|521116911|FG000|Overall Study|Lost to Follow-up|0|||
144523217|NCT03307343|521116912|FG001|Overall Study|Lost to Follow-up|2|||
144523218|NCT03016754|521116915|FG000|Overall Study|Death|5|||
144523219|NCT03016754|521116916|FG001|Overall Study|Death|4|||
144523220|NCT03016754|521116917|FG002|Overall Study|Death|5|||
144523221|NCT03016754|521116918|FG003|Overall Study|Death|1|||
144523222|NCT03016754|521116915|FG000|Overall Study|Lost to Follow-up|23|||
144523223|NCT03016754|521116916|FG001|Overall Study|Lost to Follow-up|17|||
144523224|NCT03016754|521116917|FG002|Overall Study|Lost to Follow-up|4|||
144597224|NCT00413972|521387083|FG002|Overall Study|Adverse Event|0|||
144597225|NCT00413972|521387084|FG003|Overall Study|Adverse Event|0|||
144597226|NCT00413972|521387081|FG000|Overall Study|Lost to Follow-up|1|||
144597227|NCT00413972|521387082|FG001|Overall Study|Lost to Follow-up|2|||
144722356|NCT02655237|521838690|FG000|Overall Study|Withdrawal by Participant|1|||
144400430|NCT00747812|520676546|FG000|Overall Study|Research Site Staff Relocation|5|||
144400431|NCT00747812|520676547|FG001|Overall Study|Research Site Staff Relocation|3|||
144400432|NCT01708161|520676548|FG000|Overall Study|Adverse Event|1|||
144400433|NCT01708161|520676549|FG001|Overall Study|Adverse Event|3|||
144400434|NCT01708161|520676550|FG002|Overall Study|Adverse Event|4|||
144400435|NCT01708161|520676551|FG003|Overall Study|Adverse Event|2|||
144400436|NCT01708161|520676552|FG004|Overall Study|Adverse Event|3|||
144400437|NCT01708161|520676553|FG005|Overall Study|Adverse Event|0|||
144400438|NCT01708161|520676548|FG000|Overall Study|Death|0|||
144400439|NCT01708161|520676549|FG001|Overall Study|Death|0|||
144400440|NCT01708161|520676550|FG002|Overall Study|Death|0|||
144400441|NCT01708161|520676551|FG003|Overall Study|Death|1|||
144249796|NCT01524783|520111761|FG000|Blinded Period|Withdrawal by Subject|19|||
144249797|NCT01524783|520111762|FG001|Blinded Period|Withdrawal by Subject|6|||
144400442|NCT01708161|520676552|FG004|Overall Study|Death|0|||
144400443|NCT01708161|520676553|FG005|Overall Study|Death|1|||
144523225|NCT03016754|521116918|FG003|Overall Study|Lost to Follow-up|2|||
144523226|NCT03016754|521116915|FG000|Overall Study|Withdrawal by Subject|6|||
144523227|NCT03016754|521116916|FG001|Overall Study|Withdrawal by Subject|6|||
144523228|NCT03016754|521116917|FG002|Overall Study|Withdrawal by Subject|2|||
144523229|NCT03016754|521116918|FG003|Overall Study|Withdrawal by Subject|2|||
144523230|NCT03016754|521116915|FG000|Overall Study|Other/Unknown|2|||
144523231|NCT03016754|521116916|FG001|Overall Study|Other/Unknown|4|||
144523232|NCT03016754|521116917|FG002|Overall Study|Other/Unknown|2|||
144523233|NCT03016754|521116918|FG003|Overall Study|Other/Unknown|1|||
144523234|NCT03016754|521116915|FG000|Overall Study|Protocol Violation|0|||
144523235|NCT03016754|521116916|FG001|Overall Study|Protocol Violation|0|||
144523236|NCT03016754|521116917|FG002|Overall Study|Protocol Violation|0|||
144523237|NCT03016754|521116918|FG003|Overall Study|Protocol Violation|4|||
144523238|NCT04185298|521116925|FG000|Overall Study|Lost to Follow-up|1|||
144523239|NCT04185298|521116926|FG001|Overall Study|Lost to Follow-up|3|||
144523240|NCT04185298|521116925|FG000|Overall Study|Withdrawal by Subject|0|||
144523241|NCT04185298|521116926|FG001|Overall Study|Withdrawal by Subject|3|||
144523242|NCT01798498|521116927|FG000|Overall Study|Lost to Follow-up|1|||
144523243|NCT01369355|521116935|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
144523244|NCT01369355|521116936|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
144523245|NCT01369355|521116937|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
144523246|NCT01369355|521116938|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
144523247|NCT01369355|521116939|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
144523248|NCT01369355|521116940|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
144523249|NCT01369355|521116941|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
144523250|NCT01369355|521116942|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
144523251|NCT01369355|521116943|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
144523252|NCT01369355|521116935|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
144523253|NCT01369355|521116936|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
144523254|NCT01369355|521116937|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
144523255|NCT01369355|521116938|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
144523256|NCT01369355|521116939|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
144523257|NCT01369355|521116940|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
144523258|NCT01369355|521116941|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
144523259|NCT01369355|521116942|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
144523260|NCT01369355|521116943|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
144523261|NCT01369355|521116935|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
144523262|NCT01369355|521116936|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
144523263|NCT01369355|521116937|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
144523264|NCT01369355|521116938|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
144523265|NCT01369355|521116939|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
144523266|NCT01369355|521116940|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
144523267|NCT01369355|521116941|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
144523268|NCT01369355|521116942|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
144523269|NCT01369355|521116943|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
144523270|NCT01369355|521116935|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
144523271|NCT01369355|521116936|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
144523272|NCT01369355|521116937|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
144523273|NCT01369355|521116938|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
144523274|NCT01369355|521116939|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
144523275|NCT01369355|521116940|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
144523276|NCT01369355|521116941|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
144523277|NCT01369355|521116942|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
144523278|NCT01369355|521116943|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
144523279|NCT01369355|521116935|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
144523280|NCT01369355|521116936|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
144400444|NCT01708161|520676548|FG000|Overall Study|Withdrawal by Subject|0|||
144523281|NCT01369355|521116937|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
144597228|NCT00413972|521387083|FG002|Overall Study|Lost to Follow-up|1|||
144597229|NCT00413972|521387084|FG003|Overall Study|Lost to Follow-up|0|||
144597230|NCT00413972|521387081|FG000|Overall Study|Withdrawal by Subject|4|||
144597231|NCT00413972|521387082|FG001|Overall Study|Withdrawal by Subject|5|||
144597232|NCT00413972|521387083|FG002|Overall Study|Withdrawal by Subject|7|||
144597233|NCT00413972|521387084|FG003|Overall Study|Withdrawal by Subject|2|||
144597234|NCT00413972|521387081|FG000|Overall Study|Protocol Violation|0|||
144597235|NCT00413972|521387082|FG001|Overall Study|Protocol Violation|0|||
144597236|NCT00413972|521387083|FG002|Overall Study|Protocol Violation|2|||
144597237|NCT00413972|521387084|FG003|Overall Study|Protocol Violation|0|||
144597238|NCT00413972|521387081|FG000|Overall Study|Other|0|||
144597239|NCT00413972|521387082|FG001|Overall Study|Other|0|||
144597240|NCT00413972|521387083|FG002|Overall Study|Other|0|||
144597241|NCT00413972|521387084|FG003|Overall Study|Other|1|||
144597242|NCT01759407|521387085|FG000|Overall Study|Protocol Violation|0|||
144597243|NCT01759407|521387086|FG001|Overall Study|Protocol Violation|2|||
144597244|NCT02520284|521387087|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
144597245|NCT02520284|521387088|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
144597246|NCT02520284|521387089|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
144597247|NCT02520284|521387087|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
144597248|NCT02520284|521387088|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
144597249|NCT02520284|521387089|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
144597250|NCT02520284|521387087|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
144597251|NCT02520284|521387088|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
144597252|NCT02520284|521387089|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
144597253|NCT02520284|521387087|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
144597254|NCT02520284|521387088|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
144597255|NCT02520284|521387089|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
144597256|NCT02520284|521387087|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
144597257|NCT02520284|521387088|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
144597258|NCT02520284|521387089|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
144597259|NCT02520284|521387087|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
144597260|NCT02520284|521387088|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
144597261|NCT02520284|521387089|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
144597262|NCT02520284|521387087|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
144597263|NCT02520284|521387088|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
144597264|NCT02520284|521387089|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
144597265|NCT02520284|521387087|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
144597266|NCT02520284|521387088|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
144597267|NCT02520284|521387089|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
144597268|NCT02520284|521387087|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
144597269|NCT02520284|521387088|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
144597270|NCT02520284|521387089|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
144597271|NCT02520284|521387087|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
144597272|NCT02520284|521387088|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
144597273|NCT02520284|521387089|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
144597274|NCT02520284|521387087|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
144597275|NCT02520284|521387088|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
144597276|NCT02520284|521387089|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
144597277|NCT01898923|521387090|FG000|Overall Study|Lack of Efficacy|5|||
144597278|NCT01898923|521387091|FG001|Overall Study|Lack of Efficacy|6|||
144597279|NCT01898923|521387090|FG000|Overall Study|Adverse Event|3|||
144597280|NCT01898923|521387091|FG001|Overall Study|Adverse Event|1|||
144597281|NCT01898923|521387090|FG000|Overall Study|Lost to Follow-up|0|||
144597282|NCT01898923|521387091|FG001|Overall Study|Lost to Follow-up|1|||
144597283|NCT01898923|521387090|FG000|Overall Study|Withdrawal by Subject|4|||
144597284|NCT01898923|521387091|FG001|Overall Study|Withdrawal by Subject|7|||
144597285|NCT01898923|521387090|FG000|Overall Study|Physician Decision|3|||
144597286|NCT01898923|521387091|FG001|Overall Study|Physician Decision|4|||
144722357|NCT02655237|521838691|FG001|Overall Study|Withdrawal by Participant|2|||
144722358|NCT02655237|521838690|FG000|Overall Study|Lack of Efficacy|0|||
144722359|NCT02655237|521838691|FG001|Overall Study|Lack of Efficacy|1|||
144400445|NCT01708161|520676549|FG001|Overall Study|Withdrawal by Subject|1|||
144597287|NCT01898923|521387090|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
144597288|NCT01898923|521387091|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
144597289|NCT02678247|521387092|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
144597290|NCT02678247|521387093|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
144597291|NCT02678247|521387092|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
144597292|NCT02678247|521387093|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
144597293|NCT02678247|521387092|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
144597294|NCT02678247|521387093|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
144597295|NCT02678247|521387092|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
144597296|NCT02678247|521387093|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
144597297|NCT02678247|521387092|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
144597298|NCT02678247|521387093|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
144597299|NCT02678247|521387092|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
144597300|NCT02678247|521387093|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
144597301|NCT00026208|521387096|FG000|Overall Study|Complications of auto accident|1|||
144597302|NCT00026208|521387097|FG001|Overall Study|Complications of auto accident|0|||
144597303|NCT02225353|521387098|FG000|Overall Study|Lost to Follow-up|0|||
144597304|NCT02225353|521387099|FG001|Overall Study|Lost to Follow-up|1|||
144597305|NCT02225353|521387100|FG002|Overall Study|Lost to Follow-up|3|||
144597306|NCT02225353|521387098|FG000|Overall Study|Protocol Violation|4|||
144597307|NCT02225353|521387099|FG001|Overall Study|Protocol Violation|5|||
144597308|NCT02225353|521387100|FG002|Overall Study|Protocol Violation|12|||
144597309|NCT02910739|521387102|FG000|Overall Study|Adverse Event|1|||
144597310|NCT02910739|521387103|FG001|Overall Study|Adverse Event|0|||
144597311|NCT02910739|521387104|FG002|Overall Study|Adverse Event|0|||
144597312|NCT02910739|521387105|FG003|Overall Study|Adverse Event|0|||
144597313|NCT03226275|521387109|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
144597314|NCT03226275|521387110|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
144597315|NCT03226275|521387111|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
144597316|NCT03226275|521387112|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
144597317|NCT03226275|521387109|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
144597318|NCT03226275|521387110|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
144597319|NCT03226275|521387111|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
144597320|NCT03226275|521387112|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
144597321|NCT05677893|521388930|FG000|Overall Study|Withdrawal by Subject|0|||
144597322|NCT05677893|521388931|FG001|Overall Study|Withdrawal by Subject|0|||
144597323|NCT05677893|521388932|FG002|Overall Study|Withdrawal by Subject|0|||
144597324|NCT05677893|521388933|FG003|Overall Study|Withdrawal by Subject|0|||
144597325|NCT05677893|521388934|FG004|Overall Study|Withdrawal by Subject|1|||
144597326|NCT05677893|521388935|FG005|Overall Study|Withdrawal by Subject|1|||
144597327|NCT05677893|521388936|FG006|Overall Study|Withdrawal by Subject|0|||
144597328|NCT05677893|521388930|FG000|Overall Study|Others|1|||
144597329|NCT05677893|521388931|FG001|Overall Study|Others|0|||
144597330|NCT05677893|521388932|FG002|Overall Study|Others|0|||
144597331|NCT05677893|521388933|FG003|Overall Study|Others|0|||
144597332|NCT05677893|521388934|FG004|Overall Study|Others|0|||
144597333|NCT05677893|521388935|FG005|Overall Study|Others|0|||
144597334|NCT05677893|521388936|FG006|Overall Study|Others|0|||
144597335|NCT03217266|521388937|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
144597336|NCT03217266|521388938|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
144597337|NCT03217266|521388939|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
144597338|NCT03217266|521388940|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
144523282|NCT01369355|521116938|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
144523283|NCT01369355|521116939|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
144523284|NCT01369355|521116940|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
144523285|NCT01369355|521116941|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
144523286|NCT01369355|521116942|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
144523287|NCT01369355|521116943|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
144523288|NCT01369355|521116935|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
144523289|NCT01369355|521116936|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
144523290|NCT01369355|521116937|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
144523291|NCT01369355|521116938|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
144523292|NCT01369355|521116939|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
144523293|NCT01369355|521116940|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
144523294|NCT01369355|521116941|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
144523295|NCT01369355|521116942|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
144523296|NCT01369355|521116943|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
144523297|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
144597339|NCT03217266|521388937|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
144597340|NCT03217266|521388938|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
144597341|NCT03217266|521388939|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
144597342|NCT03217266|521388940|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
144597343|NCT03217266|521388937|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
144597344|NCT03217266|521388938|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
144597345|NCT03217266|521388939|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
144597346|NCT03217266|521388940|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
144523298|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
144597347|NCT02101034|521388941|FG000|Overall Study|Enrolled but did not start treatment|0|||
144597348|NCT02101034|521388942|FG001|Overall Study|Enrolled but did not start treatment|0|||
144597349|NCT02101034|521388943|FG002|Overall Study|Enrolled but did not start treatment|1|||
144597350|NCT02101034|521388944|FG003|Overall Study|Enrolled but did not start treatment|0|||
144597351|NCT02101034|521388945|FG004|Overall Study|Enrolled but did not start treatment|0|||
144597352|NCT00792805|521388957|FG000|Overall Study|Adverse Event|12|||
144597353|NCT00792805|521388958|FG001|Overall Study|Adverse Event|10|||
144597354|NCT00792805|521388959|FG002|Overall Study|Adverse Event|10|||
144597355|NCT00792805|521388957|FG000|Overall Study|Subject withdrew consent|5|||
144597356|NCT00792805|521388958|FG001|Overall Study|Subject withdrew consent|6|||
144597357|NCT00792805|521388959|FG002|Overall Study|Subject withdrew consent|5|||
144597358|NCT00792805|521388957|FG000|Overall Study|Administrative problems|2|||
144597359|NCT00792805|521388958|FG001|Overall Study|Administrative problems|0|||
144597360|NCT00792805|521388959|FG002|Overall Study|Administrative problems|4|||
144597361|NCT00792805|521388957|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144597362|NCT00792805|521388958|FG001|Overall Study|Abnormal test procedure result(s)|2|||
144597363|NCT00792805|521388959|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144597364|NCT00792805|521388957|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144597365|NCT00792805|521388958|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
144597366|NCT00792805|521388959|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
144597367|NCT00792805|521388957|FG000|Overall Study|Lost to Follow-up|1|||
144597368|NCT00792805|521388958|FG001|Overall Study|Lost to Follow-up|1|||
144597369|NCT00792805|521388959|FG002|Overall Study|Lost to Follow-up|6|||
144597370|NCT00792805|521388957|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144597371|NCT00792805|521388958|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144597372|NCT00792805|521388959|FG002|Overall Study|Abnormal laboratory value(s)|1|||
144597373|NCT00792805|521388957|FG000|Overall Study|Protocol deviation|0|||
144597374|NCT00792805|521388958|FG001|Overall Study|Protocol deviation|1|||
144597375|NCT00792805|521388959|FG002|Overall Study|Protocol deviation|1|||
144597376|NCT02276872|521388962|FG000|Overall Study|Adverse Event|1|||
144597377|NCT02276872|521388963|FG001|Overall Study|Adverse Event|0|||
144597378|NCT02276872|521388964|FG002|Overall Study|Adverse Event|0|||
144597379|NCT04356183|521388966|FG000|Overall Study|Lost to Follow-up|1|||
144597380|NCT04356183|521388967|FG001|Overall Study|Lost to Follow-up|0|||
144597381|NCT04356183|521388966|FG000|Overall Study|Withdrawal by Subject|1|||
144597382|NCT04356183|521388967|FG001|Overall Study|Withdrawal by Subject|1|||
144597383|NCT00667355|521388969|FG000|Overall Study|Adverse Event|5|||
144597384|NCT00667355|521388969|FG000|Overall Study|Lost to Follow-up|1|||
144597385|NCT00667355|521388969|FG000|Overall Study|Other reason was not specified|5|||
144597386|NCT02175004|521388970|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
144597387|NCT02175004|521388971|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
144597388|NCT02175004|521388970|FG000|Overall Study|Investigator Judgment|1|||
144597389|NCT02175004|521388971|FG001|Overall Study|Investigator Judgment|4|||
144597390|NCT02175004|521388970|FG000|Overall Study|Voluntary Withdrawal|6|||
144597391|NCT02175004|521388971|FG001|Overall Study|Voluntary Withdrawal|19|||
144597392|NCT02175004|521388970|FG000|Overall Study|Liver Transplant|1|||
144597393|NCT02175004|521388971|FG001|Overall Study|Liver Transplant|0|||
144597394|NCT02175004|521388970|FG000|Overall Study|Disease Progression|1|||
144597395|NCT02175004|521388971|FG001|Overall Study|Disease Progression|0|||
144597396|NCT02175004|521388970|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
144597397|NCT02175004|521388971|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
144597398|NCT00162032|521388972|FG000|Overall Study|Lost to Follow-up|4|||
144597399|NCT00162032|521388973|FG001|Overall Study|Lost to Follow-up|2|||
144597400|NCT00162032|521388972|FG000|Overall Study|Reason not specified|1|||
144597401|NCT00162032|521388973|FG001|Overall Study|Reason not specified|0|||
144597402|NCT04263909|521388974|FG000|Overall Study|Physician Decision|1|||
144597403|NCT04263909|521388975|FG001|Overall Study|Physician Decision|0|||
144597404|NCT04263909|521388976|FG002|Overall Study|Physician Decision|0|||
144597405|NCT04263909|521388974|FG000|Overall Study|Adverse Event|3|||
144597406|NCT04263909|521388975|FG001|Overall Study|Adverse Event|0|||
144597407|NCT04263909|521388976|FG002|Overall Study|Adverse Event|0|||
144597408|NCT04263909|521388974|FG000|Overall Study|Protocol Violation|5|||
144597409|NCT04263909|521388975|FG001|Overall Study|Protocol Violation|0|||
144597410|NCT04263909|521388976|FG002|Overall Study|Protocol Violation|0|||
144597411|NCT05193500|521388977|FG000|Overall Study|Withdrawal by Subject|7|||
144597412|NCT05193500|521388978|FG001|Overall Study|Withdrawal by Subject|4|||
144249798|NCT01524783|520111763|FG002|Blinded Period|Withdrawal by Subject|0|||
144249799|NCT01524783|520111761|FG000|Blinded Period|Protocol deviation|2|||
144597413|NCT05193500|521388979|FG002|Overall Study|Withdrawal by Subject|3|||
144597414|NCT05193500|521388980|FG003|Overall Study|Withdrawal by Subject|5|||
144597415|NCT03840486|521388981|FG000|Overall Study|Withdrawal by Subject|0|||
144597416|NCT03840486|521388982|FG001|Overall Study|Withdrawal by Subject|1|||
144597417|NCT03840486|521388983|FG002|Overall Study|Withdrawal by Subject|0|||
144597418|NCT03840486|521388984|FG003|Overall Study|Withdrawal by Subject|0|||
144597419|NCT03840486|521388985|FG004|Overall Study|Withdrawal by Subject|0|||
144597420|NCT03840486|521388986|FG005|Overall Study|Withdrawal by Subject|0|||
144597421|NCT03840486|521388987|FG006|Overall Study|Withdrawal by Subject|0|||
144597422|NCT03840486|521388988|FG007|Overall Study|Withdrawal by Subject|0|||
144597423|NCT03840486|521388989|FG008|Overall Study|Withdrawal by Subject|0|||
144597424|NCT03840486|521388990|FG009|Overall Study|Withdrawal by Subject|0|||
144597425|NCT03840486|521388991|FG010|Overall Study|Withdrawal by Subject|0|||
144597426|NCT03840486|521388992|FG011|Overall Study|Withdrawal by Subject|0|||
144597427|NCT00756470|521388996|FG000|Overall Study|Withdrawal by Subject|1|||
144597428|NCT00756470|521388996|FG000|Overall Study|Adverse Event|4|||
144597429|NCT00820027|521388997|FG000|Overall Study|Adverse Event|15|||
144597430|NCT00820027|521388998|FG001|Overall Study|Adverse Event|8|||
144597431|NCT00820027|521388999|FG002|Overall Study|Adverse Event|10|||
144597432|NCT00820027|521389000|FG003|Overall Study|Adverse Event|5|||
144597433|NCT00820027|521388997|FG000|Overall Study|Lack of Efficacy|2|||
144597434|NCT00820027|521388998|FG001|Overall Study|Lack of Efficacy|1|||
144597435|NCT00820027|521388999|FG002|Overall Study|Lack of Efficacy|2|||
144597436|NCT00820027|521389000|FG003|Overall Study|Lack of Efficacy|2|||
144597437|NCT00820027|521388997|FG000|Overall Study|Physician Decision|0|||
144597438|NCT00820027|521388998|FG001|Overall Study|Physician Decision|1|||
144597439|NCT00820027|521388999|FG002|Overall Study|Physician Decision|1|||
144597440|NCT00820027|521389000|FG003|Overall Study|Physician Decision|0|||
144597441|NCT00820027|521388997|FG000|Overall Study|Protocol Violation|3|||
144597442|NCT00820027|521388998|FG001|Overall Study|Protocol Violation|0|||
144597443|NCT00820027|521388999|FG002|Overall Study|Protocol Violation|4|||
144597444|NCT00820027|521389000|FG003|Overall Study|Protocol Violation|0|||
144597445|NCT00820027|521388997|FG000|Overall Study|Withdrawal by Subject|6|||
144597446|NCT00820027|521388998|FG001|Overall Study|Withdrawal by Subject|4|||
144597447|NCT00820027|521388999|FG002|Overall Study|Withdrawal by Subject|4|||
144597448|NCT00820027|521389000|FG003|Overall Study|Withdrawal by Subject|6|||
144597449|NCT01128894|521389001|FG000|Overall Study|Adverse Event|31|||
144597450|NCT01128894|521389002|FG001|Overall Study|Adverse Event|41|||
144597451|NCT01128894|521389001|FG000|Overall Study|Protocol Violation|2|||
144597452|NCT01128894|521389002|FG001|Overall Study|Protocol Violation|1|||
144597453|NCT01128894|521389001|FG000|Overall Study|Noncompliance|4|||
144597454|NCT01128894|521389002|FG001|Overall Study|Noncompliance|5|||
144597455|NCT01128894|521389001|FG000|Overall Study|Lost to Follow-up|8|||
144597456|NCT01128894|521389002|FG001|Overall Study|Lost to Follow-up|8|||
144597457|NCT01128894|521389001|FG000|Overall Study|Withdrawal by Subject|10|||
144597458|NCT01128894|521389002|FG001|Overall Study|Withdrawal by Subject|12|||
144597459|NCT01128894|521389001|FG000|Overall Study|Physician Decision|2|||
144597460|NCT01128894|521389002|FG001|Overall Study|Physician Decision|1|||
144597461|NCT01128894|521389001|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
144597462|NCT01128894|521389002|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
144597463|NCT03437278|521389003|FG000|Overall Study|Adverse Event|0|||
144597464|NCT03437278|521389004|FG001|Overall Study|Adverse Event|0|||
144597465|NCT03437278|521389005|FG002|Overall Study|Adverse Event|1|||
144597466|NCT03437278|521389003|FG000|Overall Study|Progressive disease|1|||
144597467|NCT03437278|521389004|FG001|Overall Study|Progressive disease|0|||
144597468|NCT03437278|521389005|FG002|Overall Study|Progressive disease|0|||
144597469|NCT03437278|521389003|FG000|Overall Study|Physician Decision|1|||
144597470|NCT03437278|521389004|FG001|Overall Study|Physician Decision|0|||
144597471|NCT03437278|521389005|FG002|Overall Study|Physician Decision|1|||
144597472|NCT00973362|521389006|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
144597473|NCT00973362|521389007|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
144597474|NCT00973362|521389006|FG000|Baseline Evaluation|No colposcopy visit|62|||
144597475|NCT00973362|521389007|FG001|Baseline Evaluation|No colposcopy visit|0|||
144597476|NCT00973362|521389006|FG000|Baseline Evaluation|Inevaluable|686|||
144597477|NCT00973362|521389007|FG001|Baseline Evaluation|Inevaluable|223|||
144597478|NCT00973362|521389006|FG000|3-Year Follow-up|Lost to Follow-up|17|||
144597479|NCT00973362|521389007|FG001|3-Year Follow-up|Lost to Follow-up|0|||
144597480|NCT02202551|521389008|FG000|Overall Study|Adverse Event|8|||
144597481|NCT02202551|521389009|FG001|Overall Study|Adverse Event|19|||
144597482|NCT02202551|521389010|FG002|Overall Study|Adverse Event|5|||
144597483|NCT02202551|521389011|FG003|Overall Study|Adverse Event|9|||
144597484|NCT02202551|521389008|FG000|Overall Study|Death|3|||
144597485|NCT02202551|521389009|FG001|Overall Study|Death|2|||
144597486|NCT02202551|521389010|FG002|Overall Study|Death|1|||
144597487|NCT02202551|521389011|FG003|Overall Study|Death|1|||
144597488|NCT02202551|521389008|FG000|Overall Study|Lost to Follow-up|0|||
144597489|NCT02202551|521389009|FG001|Overall Study|Lost to Follow-up|1|||
144597490|NCT02202551|521389010|FG002|Overall Study|Lost to Follow-up|0|||
144597491|NCT02202551|521389011|FG003|Overall Study|Lost to Follow-up|1|||
144597492|NCT02202551|521389008|FG000|Overall Study|Needed to take excluded medication|0|||
144597493|NCT02202551|521389009|FG001|Overall Study|Needed to take excluded medication|2|||
144597494|NCT02202551|521389010|FG002|Overall Study|Needed to take excluded medication|0|||
144597495|NCT02202551|521389011|FG003|Overall Study|Needed to take excluded medication|1|||
144597496|NCT02202551|521389008|FG000|Overall Study|Subject moved away|0|||
144597497|NCT02202551|521389009|FG001|Overall Study|Subject moved away|1|||
144523299|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
144523300|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
144523301|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
144523302|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
144523303|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
144523304|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
144523305|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
144523306|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Death|0|||
144523307|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Death|0|||
144523308|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Death|0|||
144523309|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Death|0|||
144523310|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Death|0|||
144523311|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Death|0|||
144523312|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Death|0|||
144523313|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Death|1|||
144523314|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Death|3|||
144523315|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
144523316|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
144523317|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
144523318|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
144523319|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
144523320|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
144523321|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
144523322|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
144523323|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
144523324|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523325|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523326|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523327|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523328|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523329|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523330|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
144523331|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
144523332|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
144523333|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
144523334|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
144523335|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
144523336|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
144523337|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
144523338|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
144523339|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
144523340|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
144523341|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
144523342|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
144523343|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
144523344|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
144523345|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
144523346|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
144523347|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
144523348|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
144523349|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
144523350|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
144523351|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
144523352|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
144523353|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
144523354|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
144523355|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
144523356|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
144523357|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
144523358|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
144523359|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
144523360|NCT01369355|521116935|FG000|Long-term Extension (Week 44-272)|Other|0|||
144523361|NCT01369355|521116936|FG001|Long-term Extension (Week 44-272)|Other|0|||
144523362|NCT01369355|521116937|FG002|Long-term Extension (Week 44-272)|Other|0|||
144523363|NCT01369355|521116938|FG003|Long-term Extension (Week 44-272)|Other|0|||
144523364|NCT01369355|521116939|FG004|Long-term Extension (Week 44-272)|Other|0|||
144523365|NCT01369355|521116940|FG005|Long-term Extension (Week 44-272)|Other|0|||
144523366|NCT01369355|521116941|FG006|Long-term Extension (Week 44-272)|Other|110|||
144597498|NCT02202551|521389010|FG002|Overall Study|Subject moved away|0|||
144597499|NCT02202551|521389011|FG003|Overall Study|Subject moved away|0|||
144597500|NCT02202551|521389008|FG000|Overall Study|DBS surgery|3|||
144597501|NCT02202551|521389009|FG001|Overall Study|DBS surgery|0|||
144597502|NCT02202551|521389010|FG002|Overall Study|DBS surgery|0|||
144597503|NCT02202551|521389011|FG003|Overall Study|DBS surgery|0|||
144722360|NCT02655237|521838690|FG000|Overall Study|Recovery Leading to Surgery|2|||
144722361|NCT02655237|521838691|FG001|Overall Study|Recovery Leading to Surgery|1|||
144597504|NCT02202551|521389008|FG000|Overall Study|Dyskinesia upon taper|1|||
144597505|NCT02202551|521389009|FG001|Overall Study|Dyskinesia upon taper|0|||
144597506|NCT02202551|521389010|FG002|Overall Study|Dyskinesia upon taper|0|||
144597507|NCT02202551|521389011|FG003|Overall Study|Dyskinesia upon taper|0|||
144597508|NCT02202551|521389008|FG000|Overall Study|Lack of Efficacy|0|||
144597509|NCT02202551|521389009|FG001|Overall Study|Lack of Efficacy|1|||
144597510|NCT02202551|521389010|FG002|Overall Study|Lack of Efficacy|0|||
144597511|NCT02202551|521389011|FG003|Overall Study|Lack of Efficacy|0|||
144597512|NCT02202551|521389008|FG000|Overall Study|Physician Decision|1|||
144597513|NCT02202551|521389009|FG001|Overall Study|Physician Decision|0|||
144597514|NCT02202551|521389010|FG002|Overall Study|Physician Decision|0|||
144597515|NCT02202551|521389011|FG003|Overall Study|Physician Decision|0|||
144597516|NCT02202551|521389008|FG000|Overall Study|Site closure|3|||
144597517|NCT02202551|521389009|FG001|Overall Study|Site closure|0|||
144597518|NCT02202551|521389010|FG002|Overall Study|Site closure|0|||
144597519|NCT02202551|521389011|FG003|Overall Study|Site closure|1|||
144597520|NCT02202551|521389008|FG000|Overall Study|Unable to complete visits per protocol|1|||
144597521|NCT02202551|521389009|FG001|Overall Study|Unable to complete visits per protocol|0|||
144597522|NCT02202551|521389010|FG002|Overall Study|Unable to complete visits per protocol|0|||
144597523|NCT02202551|521389011|FG003|Overall Study|Unable to complete visits per protocol|0|||
144597524|NCT02202551|521389008|FG000|Overall Study|Worsening Dyskinesia|0|||
144597525|NCT02202551|521389009|FG001|Overall Study|Worsening Dyskinesia|0|||
144523367|NCT01369355|521116942|FG007|Long-term Extension (Week 44-272)|Other|9|||
144523368|NCT01369355|521116943|FG008|Long-term Extension (Week 44-272)|Other|17|||
144523369|NCT02319759|521116944|FG000|Week 0 - 16|Lack of Efficacy|1|||
144523370|NCT02319759|521116945|FG001|Week 0 - 16|Lack of Efficacy|0|||
144523371|NCT02319759|521116946|FG002|Week 0 - 16|Lack of Efficacy|0|||
144523372|NCT02319759|521116947|FG003|Week 0 - 16|Lack of Efficacy|0|||
144523373|NCT02319759|521116948|FG004|Week 0 - 16|Lack of Efficacy|0|||
144523374|NCT02319759|521116944|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
144523375|NCT02319759|521116945|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
144523376|NCT02319759|521116946|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
144523377|NCT02319759|521116947|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
144523378|NCT02319759|521116948|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
144523379|NCT02319759|521116944|FG000|Week 16 - 24|Lack of Efficacy|1|||
144523380|NCT02319759|521116945|FG001|Week 16 - 24|Lack of Efficacy|0|||
144523381|NCT02319759|521116946|FG002|Week 16 - 24|Lack of Efficacy|1|||
144523382|NCT02319759|521116947|FG003|Week 16 - 24|Lack of Efficacy|0|||
144523383|NCT02319759|521116948|FG004|Week 16 - 24|Lack of Efficacy|0|||
144523384|NCT02319759|521116944|FG000|Week 16 - 24|Lost to Follow-up|1|||
144523385|NCT02319759|521116945|FG001|Week 16 - 24|Lost to Follow-up|0|||
144523386|NCT02319759|521116946|FG002|Week 16 - 24|Lost to Follow-up|0|||
144523387|NCT02319759|521116947|FG003|Week 16 - 24|Lost to Follow-up|0|||
144523388|NCT02319759|521116948|FG004|Week 16 - 24|Lost to Follow-up|0|||
144523389|NCT02319759|521116944|FG000|Week 16 - 24|Withdrawal by Subject|0|||
144523390|NCT02319759|521116945|FG001|Week 16 - 24|Withdrawal by Subject|0|||
144523391|NCT02319759|521116946|FG002|Week 16 - 24|Withdrawal by Subject|2|||
144523392|NCT02319759|521116947|FG003|Week 16 - 24|Withdrawal by Subject|0|||
144597526|NCT02202551|521389010|FG002|Overall Study|Worsening Dyskinesia|0|||
144597527|NCT02202551|521389011|FG003|Overall Study|Worsening Dyskinesia|1|||
144597528|NCT02202551|521389008|FG000|Overall Study|Protocol Violation|0|||
144597529|NCT02202551|521389009|FG001|Overall Study|Protocol Violation|1|||
144597530|NCT02202551|521389010|FG002|Overall Study|Protocol Violation|0|||
144597531|NCT02202551|521389011|FG003|Overall Study|Protocol Violation|0|||
144597532|NCT02202551|521389008|FG000|Overall Study|Sponsor's decision|2|||
144597533|NCT02202551|521389009|FG001|Overall Study|Sponsor's decision|0|||
144597534|NCT02202551|521389010|FG002|Overall Study|Sponsor's decision|0|||
144523393|NCT02319759|521116948|FG004|Week 16 - 24|Withdrawal by Subject|0|||
144597535|NCT02202551|521389011|FG003|Overall Study|Sponsor's decision|0|||
144523394|NCT02319759|521116944|FG000|Week 24 - 56|Adverse Event|0|||
144523395|NCT02319759|521116945|FG001|Week 24 - 56|Adverse Event|0|||
144523396|NCT02319759|521116946|FG002|Week 24 - 56|Adverse Event|2|||
144597536|NCT02202551|521389008|FG000|Overall Study|Subject unwilling to proceed|1|||
144597537|NCT02202551|521389009|FG001|Overall Study|Subject unwilling to proceed|5|||
144523397|NCT02319759|521116947|FG003|Week 24 - 56|Adverse Event|0|||
144523398|NCT02319759|521116948|FG004|Week 24 - 56|Adverse Event|0|||
144523399|NCT02319759|521116944|FG000|Week 24 - 56|Lack of Efficacy|0|||
144597538|NCT02202551|521389010|FG002|Overall Study|Subject unwilling to proceed|3|||
144597539|NCT02202551|521389011|FG003|Overall Study|Subject unwilling to proceed|5|||
144597540|NCT02202551|521389008|FG000|Overall Study|Subject consent withdrawn|0|||
144597541|NCT02202551|521389009|FG001|Overall Study|Subject consent withdrawn|3|||
144597542|NCT02202551|521389010|FG002|Overall Study|Subject consent withdrawn|1|||
144597543|NCT02202551|521389011|FG003|Overall Study|Subject consent withdrawn|2|||
144597544|NCT02202551|521389008|FG000|Overall Study|eGFR<50mL/min/m2|2|||
144597545|NCT02202551|521389009|FG001|Overall Study|eGFR<50mL/min/m2|2|||
144597546|NCT02202551|521389010|FG002|Overall Study|eGFR<50mL/min/m2|0|||
144597547|NCT02202551|521389011|FG003|Overall Study|eGFR<50mL/min/m2|1|||
144597548|NCT02349451|521389012|FG000|Overall Study|Withdrawal by Subject|0|||
144597549|NCT02349451|521389013|FG001|Overall Study|Withdrawal by Subject|1|||
144597550|NCT02349451|521389014|FG002|Overall Study|Withdrawal by Subject|2|||
144597551|NCT02349451|521389015|FG003|Overall Study|Withdrawal by Subject|1|||
144597552|NCT02349360|521389018|FG000|Overall Study|Withdrawal by Subject|0|||
144597553|NCT02349360|521389019|FG001|Overall Study|Withdrawal by Subject|1|||
144597554|NCT00412971|521389032|FG000|Overall Study|Lost to Follow-up|17|||
144597555|NCT00412971|521389033|FG001|Overall Study|Lost to Follow-up|9|||
144597556|NCT00412971|521389032|FG000|Overall Study|Protocol Violation|13|||
144597557|NCT00412971|521389033|FG001|Overall Study|Protocol Violation|1|||
144597558|NCT01106404|521389034|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
144597559|NCT01106404|521389035|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
144597560|NCT01106404|521389034|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
144597561|NCT01106404|521389035|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
144597562|NCT01106404|521389034|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
144597563|NCT01106404|521389035|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
144597564|NCT01106404|521389034|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
144597565|NCT01106404|521389035|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
144597566|NCT01749540|521389043|FG000|Overall Study|Protocol Violation|0|||
144597567|NCT01749540|521389044|FG001|Overall Study|Protocol Violation|0|||
144597568|NCT01749540|521389045|FG002|Overall Study|Protocol Violation|0|||
144597569|NCT01749540|521389046|FG003|Overall Study|Protocol Violation|0|||
144597570|NCT01749540|521389047|FG004|Overall Study|Protocol Violation|0|||
144597571|NCT01749540|521389048|FG005|Overall Study|Protocol Violation|1|||
144597572|NCT01749540|521389049|FG006|Overall Study|Protocol Violation|1|||
144597573|NCT01749540|521389043|FG000|Overall Study|Withdrawal by Subject|0|||
144597574|NCT01749540|521389044|FG001|Overall Study|Withdrawal by Subject|0|||
144597575|NCT01749540|521389045|FG002|Overall Study|Withdrawal by Subject|0|||
144597576|NCT01749540|521389046|FG003|Overall Study|Withdrawal by Subject|1|||
144597577|NCT01749540|521389047|FG004|Overall Study|Withdrawal by Subject|0|||
144597578|NCT01749540|521389048|FG005|Overall Study|Withdrawal by Subject|0|||
144597579|NCT01749540|521389049|FG006|Overall Study|Withdrawal by Subject|0|||
144597580|NCT01749540|521389043|FG000|Overall Study|Initiated into extension study A536-06|0|||
144249800|NCT01524783|520111762|FG001|Blinded Period|Protocol deviation|1|||
144249801|NCT01524783|520111763|FG002|Blinded Period|Protocol deviation|0|||
144249802|NCT01524783|520111761|FG000|Blinded Period|Death|5|||
144249803|NCT01524783|520111762|FG001|Blinded Period|Death|2|||
144249804|NCT01524783|520111763|FG002|Blinded Period|Death|0|||
144249805|NCT01524783|520111761|FG000|Open-label Period|Disease progression|13|||
144249806|NCT01524783|520111762|FG001|Open-label Period|Disease progression|0|||
144249807|NCT01524783|520111763|FG002|Open-label Period|Disease progression|2|||
144249808|NCT01524783|520111761|FG000|Open-label Period|Administrative problems|5|||
144249809|NCT01524783|520111762|FG001|Open-label Period|Administrative problems|0|||
144249810|NCT01524783|520111763|FG002|Open-label Period|Administrative problems|2|||
144400446|NCT01708161|520676550|FG002|Overall Study|Withdrawal by Subject|1|||
144400447|NCT01708161|520676551|FG003|Overall Study|Withdrawal by Subject|0|||
144597581|NCT01749540|521389044|FG001|Overall Study|Initiated into extension study A536-06|0|||
144249811|NCT01524783|520111761|FG000|Open-label Period|Adverse Event|5|||
144400448|NCT01708161|520676552|FG004|Overall Study|Withdrawal by Subject|0|||
144523400|NCT02319759|521116945|FG001|Week 24 - 56|Lack of Efficacy|0|||
144523401|NCT02319759|521116946|FG002|Week 24 - 56|Lack of Efficacy|0|||
144523402|NCT02319759|521116947|FG003|Week 24 - 56|Lack of Efficacy|2|||
144523403|NCT02319759|521116948|FG004|Week 24 - 56|Lack of Efficacy|1|||
144523404|NCT02319759|521116944|FG000|Week 24 - 56|Withdrawal by Subject|0|||
144523405|NCT02319759|521116945|FG001|Week 24 - 56|Withdrawal by Subject|1|||
144523406|NCT02319759|521116946|FG002|Week 24 - 56|Withdrawal by Subject|0|||
144523407|NCT02319759|521116947|FG003|Week 24 - 56|Withdrawal by Subject|0|||
144523408|NCT02319759|521116948|FG004|Week 24 - 56|Withdrawal by Subject|0|||
144523409|NCT02319759|521116944|FG000|Week 24 - 56|Lost to Follow-up|0|||
144523410|NCT02319759|521116945|FG001|Week 24 - 56|Lost to Follow-up|0|||
144400449|NCT01708161|520676553|FG005|Overall Study|Withdrawal by Subject|0|||
144523411|NCT02319759|521116946|FG002|Week 24 - 56|Lost to Follow-up|0|||
144597582|NCT01749540|521389045|FG002|Overall Study|Initiated into extension study A536-06|0|||
144597583|NCT01749540|521389046|FG003|Overall Study|Initiated into extension study A536-06|0|||
144597584|NCT01749540|521389047|FG004|Overall Study|Initiated into extension study A536-06|0|||
144597585|NCT01749540|521389048|FG005|Overall Study|Initiated into extension study A536-06|2|||
144249812|NCT01524783|520111762|FG001|Open-label Period|Adverse Event|0|||
144249813|NCT01524783|520111763|FG002|Open-label Period|Adverse Event|1|||
144597586|NCT01749540|521389049|FG006|Overall Study|Initiated into extension study A536-06|24|||
144597587|NCT00752622|521389050|FG000|Induction Phase|Adverse Event|3|||
144597588|NCT00752622|521389050|FG000|Induction Phase|Other|3|||
144597589|NCT00752622|521389050|FG000|Induction Phase|Non-responder|14|||
144597590|NCT00752622|521389050|FG000|Induction Phase|Withdrawal by Subject|1|||
144597591|NCT00752622|521389050|FG000|Induction Phase|Premature study termination|14|||
144597592|NCT00752622|521389050|FG000|Observational Phase|Premature Study Termination|36|||
144597593|NCT00752622|521389050|FG000|Observational Phase|Non-responder|2|||
144597594|NCT00752622|521389050|FG000|Observational Phase|Withdrawal by Subject|2|||
144597595|NCT00752622|521389050|FG000|Observational Phase|Adverse Event|1|||
144597596|NCT00752622|521389050|FG000|Observational Phase|Other|2|||
144597597|NCT00752622|521389050|FG000|Interventional Phase|Non-responder|2|||
144597598|NCT00752622|521389050|FG000|Interventional Phase|Physician Decision|1|||
144597599|NCT00752622|521389050|FG000|Interventional Phase|Premature Study Termination|5|||
144597600|NCT00576836|521389051|FG000|Overall Study|Death|0|||
144597601|NCT00576836|521389052|FG001|Overall Study|Death|1|||
144597602|NCT00576836|521389051|FG000|Overall Study|Physician Decision|0|||
144597603|NCT00576836|521389052|FG001|Overall Study|Physician Decision|1|||
144597604|NCT03267940|521389055|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
144597605|NCT03267940|521389056|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
144597606|NCT03267940|521389057|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
144597607|NCT03267940|521389058|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
144597608|NCT03267940|521389059|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
144597609|NCT03267940|521389060|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
144597610|NCT03267940|521389055|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
144597611|NCT03267940|521389056|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
144597612|NCT03267940|521389057|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
144597613|NCT03267940|521389058|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
144597614|NCT03267940|521389059|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
144597615|NCT03267940|521389060|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
144597616|NCT03267940|521389055|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
144597617|NCT03267940|521389056|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
144597618|NCT03267940|521389057|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
144597619|NCT03267940|521389058|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
144597620|NCT03267940|521389059|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
144400450|NCT01708161|520676548|FG000|Overall Study|Administrative problems|0|||
144400451|NCT01708161|520676549|FG001|Overall Study|Administrative problems|1|||
144400452|NCT01708161|520676550|FG002|Overall Study|Administrative problems|0|||
144400453|NCT01708161|520676551|FG003|Overall Study|Administrative problems|0|||
144400454|NCT01708161|520676552|FG004|Overall Study|Administrative problems|0|||
144400455|NCT01708161|520676553|FG005|Overall Study|Administrative problems|0|||
144400456|NCT01708161|520676548|FG000|Overall Study|Disease progression|3|||
144400457|NCT01708161|520676549|FG001|Overall Study|Disease progression|5|||
144400458|NCT01708161|520676550|FG002|Overall Study|Disease progression|5|||
144400459|NCT01708161|520676551|FG003|Overall Study|Disease progression|13|||
144400460|NCT01708161|520676552|FG004|Overall Study|Disease progression|3|||
144400461|NCT01708161|520676553|FG005|Overall Study|Disease progression|0|||
144400462|NCT03725852|520676555|FG000|Overall Study|Death|1|||
144400463|NCT03725852|520676556|FG001|Overall Study|Death|0|||
144400464|NCT03725852|520676555|FG000|Overall Study|Withdrawal by Subject|1|||
144400465|NCT03725852|520676556|FG001|Overall Study|Withdrawal by Subject|0|||
144400466|NCT03725852|520676555|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
144400467|NCT03725852|520676556|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
144400468|NCT01986140|520676557|FG000|Overall Study|Withdrawal by Subject|31|||
144400469|NCT01986140|520676558|FG001|Overall Study|Withdrawal by Subject|25|||
144400470|NCT01986140|520676557|FG000|Overall Study|alternative treatment|1|||
144400471|NCT01986140|520676558|FG001|Overall Study|alternative treatment|1|||
144400472|NCT01986140|520676557|FG000|Overall Study|found not eligible|3|||
144400473|NCT01986140|520676558|FG001|Overall Study|found not eligible|0|||
144400474|NCT01986140|520676557|FG000|Overall Study|Adverse Event|0|||
144400475|NCT01986140|520676558|FG001|Overall Study|Adverse Event|1|||
144597621|NCT03267940|521389060|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
144597622|NCT03267940|521389055|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
144597623|NCT03267940|521389056|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
144597624|NCT03267940|521389057|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
144597625|NCT03267940|521389058|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
144597626|NCT03267940|521389059|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
144400476|NCT01986140|520676557|FG000|Overall Study|progression disease|0|||
144400477|NCT01986140|520676558|FG001|Overall Study|progression disease|1|||
144400478|NCT02913612|520676559|FG000|Overall Study|Lost to Follow-up|6|||
144597627|NCT03267940|521389060|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
144400479|NCT02913612|520676560|FG001|Overall Study|Lost to Follow-up|5|||
144400480|NCT02913612|520676561|FG002|Overall Study|Lost to Follow-up|2|||
144523412|NCT02319759|521116947|FG003|Week 24 - 56|Lost to Follow-up|0|||
144523413|NCT02319759|521116948|FG004|Week 24 - 56|Lost to Follow-up|1|||
144523414|NCT06424236|521116951|FG000|Overall Study|Adverse Event|0|||
144523415|NCT06424236|521116952|FG001|Overall Study|Adverse Event|1|||
144523416|NCT06424236|521116953|FG002|Overall Study|Adverse Event|0|||
144523417|NCT06424236|521116951|FG000|Overall Study|Withdrawal by Subject|3|||
144523418|NCT06424236|521116952|FG001|Overall Study|Withdrawal by Subject|1|||
144597628|NCT03267940|521389055|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
144597629|NCT03267940|521389056|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
144597630|NCT03267940|521389057|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
144597631|NCT03267940|521389058|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
144597632|NCT03267940|521389059|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
144597633|NCT03267940|521389060|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
144597634|NCT03267940|521389055|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
144597635|NCT03267940|521389056|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
144597636|NCT03267940|521389057|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
144597637|NCT03267940|521389058|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
144597638|NCT03267940|521389059|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
144597639|NCT03267940|521389060|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
144597640|NCT03267940|521389055|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
144597641|NCT03267940|521389056|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
144597642|NCT03267940|521389057|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
144597643|NCT03267940|521389058|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
144597644|NCT03267940|521389059|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
144597645|NCT03267940|521389060|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
144597646|NCT03267940|521389055|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
144597647|NCT03267940|521389056|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
144597648|NCT03267940|521389057|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
144597649|NCT03267940|521389058|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
144597650|NCT03267940|521389059|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
144597651|NCT03267940|521389060|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
144597652|NCT03267940|521389055|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
144597653|NCT03267940|521389056|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
144597654|NCT03267940|521389057|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
144597655|NCT03267940|521389058|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
144597656|NCT03267940|521389059|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
144597657|NCT03267940|521389060|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
144597658|NCT00388154|521389061|FG000|Overall Study|Withdrawal by Subject|1|||
144597659|NCT01074216|521389068|FG000|Overall Study|Physician Decision|1|||
144597660|NCT01074216|521389068|FG000|Overall Study|Not Treated|12|||
144597661|NCT03291587|521389069|FG000|Overall Study|Lost to Follow-up|62|||
144597662|NCT03291587|521389070|FG001|Overall Study|Lost to Follow-up|43|||
144597663|NCT03291587|521389069|FG000|Overall Study|Refused to Answer|5|||
144597664|NCT03291587|521389070|FG001|Overall Study|Refused to Answer|2|||
144597665|NCT03291587|521389069|FG000|Overall Study|Death|2|||
144597666|NCT03291587|521389070|FG001|Overall Study|Death|4|||
144597667|NCT03291587|521389069|FG000|Overall Study|Not interested in participating|8|||
144597668|NCT03291587|521389070|FG001|Overall Study|Not interested in participating|6|||
144597669|NCT03291587|521389069|FG000|Overall Study|Too busy to participate|4|||
144597670|NCT03291587|521389070|FG001|Overall Study|Too busy to participate|2|||
144597671|NCT00796120|521389071|FG000|Overall Study|Death|3|||
144597672|NCT00796120|521389072|FG001|Overall Study|Death|0|||
144597673|NCT00796120|521389071|FG000|Overall Study|Adverse Event|11|||
144597674|NCT00796120|521389072|FG001|Overall Study|Adverse Event|6|||
144597675|NCT00796120|521389071|FG000|Overall Study|Progressive disease|22|||
144597676|NCT00796120|521389072|FG001|Overall Study|Progressive disease|13|||
144597677|NCT00796120|521389071|FG000|Overall Study|Participant refusal|3|||
144597678|NCT00796120|521389072|FG001|Overall Study|Participant refusal|4|||
144597679|NCT00796120|521389071|FG000|Overall Study|Other|6|||
144597680|NCT00796120|521389072|FG001|Overall Study|Other|17|||
144523419|NCT06424236|521116953|FG002|Overall Study|Withdrawal by Subject|2|||
144523420|NCT06424236|521116951|FG000|Overall Study|Physician Decision|0|||
144597681|NCT00796120|521389071|FG000|Overall Study|Physician Decision|16|||
144597682|NCT00796120|521389072|FG001|Overall Study|Physician Decision|17|||
144597683|NCT00796120|521389071|FG000|Overall Study|Randomized but not treated|0|||
144597684|NCT00796120|521389072|FG001|Overall Study|Randomized but not treated|3|||
144597685|NCT03737474|521389076|FG000|Overall Study|Adverse Event|18|||
144523421|NCT06424236|521116952|FG001|Overall Study|Physician Decision|1|||
144597686|NCT03737474|521389077|FG001|Overall Study|Adverse Event|48|||
144597687|NCT03737474|521389076|FG000|Overall Study|Lack of Efficacy|1|||
144249814|NCT01524783|520111761|FG000|Open-label Period|Withdrawal by Subject|2|||
144597688|NCT03737474|521389077|FG001|Overall Study|Lack of Efficacy|3|||
144597689|NCT03737474|521389076|FG000|Overall Study|Protocol Violation|0|||
144597690|NCT03737474|521389077|FG001|Overall Study|Protocol Violation|8|||
144722362|NCT02655237|521838690|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
144597691|NCT03737474|521389076|FG000|Overall Study|Withdrawal by Subject|5|||
144597692|NCT03737474|521389077|FG001|Overall Study|Withdrawal by Subject|20|||
144597693|NCT03737474|521389076|FG000|Overall Study|Non-compliance With Study Drug|0|||
144597694|NCT03737474|521389077|FG001|Overall Study|Non-compliance With Study Drug|1|||
144597695|NCT03737474|521389076|FG000|Overall Study|Physician Decision|1|||
144597696|NCT03737474|521389077|FG001|Overall Study|Physician Decision|4|||
144597697|NCT02513745|521389080|FG000|Overall Study|Criteria at time of surgery not met.|3|||
144597698|NCT02513745|521389081|FG001|Overall Study|Criteria at time of surgery not met.|3|||
144597699|NCT01209143|521389082|FG000|Overall Study|Adverse Event|2|||
144597700|NCT01209143|521389083|FG001|Overall Study|Adverse Event|1|||
144597701|NCT01209143|521389082|FG000|Overall Study|Death|0|||
144597702|NCT01209143|521389083|FG001|Overall Study|Death|1|||
144597703|NCT01209143|521389082|FG000|Overall Study|Physician Decision|3|||
144597704|NCT01209143|521389083|FG001|Overall Study|Physician Decision|1|||
144597705|NCT01209143|521389082|FG000|Overall Study|Lost to Follow-up|1|||
144597706|NCT01209143|521389083|FG001|Overall Study|Lost to Follow-up|0|||
144597707|NCT01209143|521389082|FG000|Overall Study|Withdrawal by Subject|2|||
144597708|NCT01209143|521389083|FG001|Overall Study|Withdrawal by Subject|1|||
144597709|NCT01209143|521389082|FG000|Overall Study|Disease progression|11|||
144597710|NCT01209143|521389083|FG001|Overall Study|Disease progression|16|||
144597711|NCT00381303|521389086|FG000|Overall Study|Lost to Follow-up|25|||
144597712|NCT00381303|521389087|FG001|Overall Study|Lost to Follow-up|9|||
144597713|NCT00381303|521389086|FG000|Overall Study|AE/HIV-related event|22|||
144597714|NCT00381303|521389087|FG001|Overall Study|AE/HIV-related event|6|||
144597715|NCT00381303|521389086|FG000|Overall Study|Non-Adherence|13|||
144597716|NCT00381303|521389087|FG001|Overall Study|Non-Adherence|6|||
144597717|NCT00381303|521389086|FG000|Overall Study|Withdrawal by Subject|13|||
144597718|NCT00381303|521389087|FG001|Overall Study|Withdrawal by Subject|6|||
144597719|NCT00381303|521389086|FG000|Overall Study|Virologic failure|6|||
144597720|NCT00381303|521389087|FG001|Overall Study|Virologic failure|4|||
144597721|NCT00381303|521389086|FG000|Overall Study|Ineligible to continue the trial|2|||
144597722|NCT00381303|521389087|FG001|Overall Study|Ineligible to continue the trial|1|||
144597723|NCT00381303|521389086|FG000|Overall Study|Pregnancy|2|||
144597724|NCT00381303|521389087|FG001|Overall Study|Pregnancy|0|||
144597725|NCT00381303|521389086|FG000|Overall Study|Physician Decision|1|||
144523422|NCT06424236|521116953|FG002|Overall Study|Physician Decision|0|||
144523423|NCT06424236|521116951|FG000|Overall Study|Study Terminated by Sponsor|11|||
144523424|NCT06424236|521116952|FG001|Overall Study|Study Terminated by Sponsor|20|||
144523425|NCT06424236|521116953|FG002|Overall Study|Study Terminated by Sponsor|16|||
144523426|NCT06424236|521116951|FG000|Overall Study|Lost to Follow-up|0|||
144523427|NCT06424236|521116952|FG001|Overall Study|Lost to Follow-up|1|||
144523428|NCT06424236|521116953|FG002|Overall Study|Lost to Follow-up|0|||
144523429|NCT06424236|521116951|FG000|Overall Study|Disease Progression|0|||
144523430|NCT06424236|521116952|FG001|Overall Study|Disease Progression|1|||
144523431|NCT06424236|521116953|FG002|Overall Study|Disease Progression|2|||
144523432|NCT06424236|521116951|FG000|Overall Study|Other|0|||
144523433|NCT06424236|521116952|FG001|Overall Study|Other|0|||
144523434|NCT06424236|521116953|FG002|Overall Study|Other|1|||
144523435|NCT02619838|521116955|FG000|Overall Study|Lost to Follow-up|9|||
144523436|NCT02619838|521116955|FG000|Overall Study|Withdrawal by Subject|15|||
144523437|NCT00227344|521116956|FG000|Overall Study|study terminated early|12|||
144523438|NCT00227344|521116957|FG001|Overall Study|study terminated early|5|||
144523439|NCT01987895|521116958|FG000|Overall Study|Withdrawal by Subject|12|||
144523440|NCT01987895|521116959|FG001|Overall Study|Withdrawal by Subject|7|||
144523441|NCT01987895|521116958|FG000|Overall Study|Physician Decision|8|||
144523442|NCT01987895|521116959|FG001|Overall Study|Physician Decision|10|||
144523443|NCT01987895|521116958|FG000|Overall Study|Death|7|||
144523444|NCT01987895|521116959|FG001|Overall Study|Death|7|||
144523445|NCT01987895|521116958|FG000|Overall Study|Lost to Follow-up|3|||
144523446|NCT01987895|521116959|FG001|Overall Study|Lost to Follow-up|5|||
144523447|NCT01987895|521116958|FG000|Overall Study|randomized before giving IC|0|||
144523448|NCT01987895|521116959|FG001|Overall Study|randomized before giving IC|1|||
144523449|NCT03452579|521116966|FG000|Overall Study|Death|0|||
144523450|NCT03452579|521116967|FG001|Overall Study|Death|1|||
144523451|NCT03452579|521116966|FG000|Overall Study|Withdrawal by Subject|2|||
144523452|NCT03452579|521116967|FG001|Overall Study|Withdrawal by Subject|0|||
144523453|NCT03452579|521116966|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
144523454|NCT03452579|521116967|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
144523455|NCT03452579|521116966|FG000|Overall Study|Physician Decision|1|||
144597726|NCT00381303|521389087|FG001|Overall Study|Physician Decision|0|||
144597727|NCT00381303|521389086|FG000|Overall Study|Physician's decision to close the site|3|||
144597728|NCT00381303|521389087|FG001|Overall Study|Physician's decision to close the site|1|||
144722363|NCT02655237|521838691|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
144523456|NCT03452579|521116967|FG001|Overall Study|Physician Decision|1|||
144523457|NCT03452579|521116966|FG000|Overall Study|Adverse Event|1|||
144597729|NCT00381303|521389086|FG000|Overall Study|Subject moved out of state|2|||
144597730|NCT00381303|521389087|FG001|Overall Study|Subject moved out of state|0|||
144597731|NCT00381303|521389086|FG000|Overall Study|Subject taking too many different meds|1|||
144597732|NCT00381303|521389087|FG001|Overall Study|Subject taking too many different meds|0|||
144597733|NCT00381303|521389086|FG000|Overall Study|No virologic response by week 12|1|||
144597734|NCT00381303|521389087|FG001|Overall Study|No virologic response by week 12|0|||
144597735|NCT00381303|521389086|FG000|Overall Study|Subject was too busy for appointments|1|||
144597736|NCT00381303|521389087|FG001|Overall Study|Subject was too busy for appointments|0|||
144597737|NCT00381303|521389086|FG000|Overall Study|Subject did not continue visits|1|||
144597738|NCT00381303|521389087|FG001|Overall Study|Subject did not continue visits|0|||
144597739|NCT00381303|521389086|FG000|Overall Study|Subject primary physician's decision|1|||
144597740|NCT00381303|521389087|FG001|Overall Study|Subject primary physician's decision|0|||
144597741|NCT01145755|521389089|FG000|Overall Study|Adverse Event|2|||
144597742|NCT01145755|521389090|FG001|Overall Study|Adverse Event|4|||
144597743|NCT01145755|521389091|FG002|Overall Study|Adverse Event|2|||
144597744|NCT01145755|521389089|FG000|Overall Study|Withdrawal by Subject|2|||
144597745|NCT01145755|521389090|FG001|Overall Study|Withdrawal by Subject|2|||
144597746|NCT01145755|521389091|FG002|Overall Study|Withdrawal by Subject|2|||
144597747|NCT01145755|521389089|FG000|Overall Study|Lost to Follow-up|2|||
144597748|NCT01145755|521389090|FG001|Overall Study|Lost to Follow-up|3|||
144597749|NCT01145755|521389091|FG002|Overall Study|Lost to Follow-up|1|||
144597750|NCT01145755|521389089|FG000|Overall Study|Protocol Violation|0|||
144597751|NCT01145755|521389090|FG001|Overall Study|Protocol Violation|3|||
144597752|NCT01145755|521389091|FG002|Overall Study|Protocol Violation|1|||
144597753|NCT01145755|521389089|FG000|Overall Study|Study Closure|14|||
144597754|NCT01145755|521389090|FG001|Overall Study|Study Closure|14|||
144597755|NCT01145755|521389091|FG002|Overall Study|Study Closure|17|||
144597756|NCT01145755|521389089|FG000|Overall Study|Lack of Efficacy|0|||
144597757|NCT01145755|521389090|FG001|Overall Study|Lack of Efficacy|1|||
144597758|NCT01145755|521389091|FG002|Overall Study|Lack of Efficacy|0|||
144597759|NCT01145755|521389089|FG000|Overall Study|Patient could not swollow medication|0|||
144597760|NCT01145755|521389090|FG001|Overall Study|Patient could not swollow medication|0|||
144597761|NCT01145755|521389091|FG002|Overall Study|Patient could not swollow medication|1|||
144597762|NCT01145755|521389089|FG000|Overall Study|Withdrawal by Subject|0|||
144597763|NCT01145755|521389090|FG001|Overall Study|Withdrawal by Subject|0|||
144597764|NCT01145755|521389091|FG002|Overall Study|Withdrawal by Subject|1|||
144597765|NCT01145755|521389089|FG000|Overall Study|Positive urine ethanol|0|||
144597766|NCT01145755|521389090|FG001|Overall Study|Positive urine ethanol|1|||
144597767|NCT01145755|521389091|FG002|Overall Study|Positive urine ethanol|0|||
144597768|NCT01211522|521389092|FG000|Overall Study|Withdrawal by Subject|3|||
144597769|NCT01211522|521389093|FG001|Overall Study|Withdrawal by Subject|7|||
144597770|NCT01211522|521389094|FG002|Overall Study|Withdrawal by Subject|5|||
144597771|NCT01116882|521389100|FG000|30-day|Lost to Follow-up|50|||
144597772|NCT01116882|521389101|FG001|30-day|Lost to Follow-up|21|||
144597773|NCT01116882|521389100|FG000|30-day|Withdrawal by Subject|2|||
144597774|NCT01116882|521389101|FG001|30-day|Withdrawal by Subject|4|||
144597775|NCT01116882|521389100|FG000|30-day|Other Reasons|16|||
144597776|NCT01116882|521389101|FG001|30-day|Other Reasons|6|||
144597777|NCT01116882|521389100|FG000|12-month|Lost to Follow-up|111|||
144597778|NCT01116882|521389101|FG001|12-month|Lost to Follow-up|42|||
144597779|NCT01116882|521389100|FG000|12-month|Other Reasons|151|||
144597780|NCT01116882|521389101|FG001|12-month|Other Reasons|49|||
144597781|NCT01116882|521389100|FG000|12-month|Withdrawal by Subject|5|||
144597782|NCT01116882|521389101|FG001|12-month|Withdrawal by Subject|8|||
144597783|NCT00547365|521389102|FG000|Overall Study|Physician Decision|1|||
144597784|NCT00547365|521389102|FG000|Overall Study|Lost to Follow-up|1|||
144597785|NCT00547365|521389102|FG000|Overall Study|Protocol Violation|2|||
144597786|NCT00547365|521389102|FG000|Overall Study|death (not related to study)|4|||
144597787|NCT00504881|521389105|FG000|Overall Study|Lack of Efficacy|1|||
144597788|NCT00504881|521389106|FG001|Overall Study|Lack of Efficacy|5|||
144597789|NCT00504881|521389105|FG000|Overall Study|Lost to Follow-up|0|||
144597790|NCT00504881|521389106|FG001|Overall Study|Lost to Follow-up|2|||
144597791|NCT00504881|521389105|FG000|Overall Study|Withdrawal by Subject|1|||
144597792|NCT00504881|521389106|FG001|Overall Study|Withdrawal by Subject|4|||
144597793|NCT00504881|521389105|FG000|Overall Study|Non-Compliance|1|||
144597794|NCT00504881|521389106|FG001|Overall Study|Non-Compliance|0|||
144597795|NCT00504881|521389105|FG000|Overall Study|No Birth Control|0|||
144597796|NCT00504881|521389106|FG001|Overall Study|No Birth Control|1|||
144597797|NCT00504881|521389105|FG000|Overall Study|Safety Visit not performed|0|||
144597798|NCT00504881|521389106|FG001|Overall Study|Safety Visit not performed|1|||
144597799|NCT00504881|521389105|FG000|Overall Study|AE, serious fatal|0|||
144722364|NCT02655237|521838690|FG000|Overall Study|Randomized but Not Treated|1|||
144722365|NCT02655237|521838691|FG001|Overall Study|Randomized but Not Treated|0|||
144597800|NCT00504881|521389106|FG001|Overall Study|AE, serious fatal|1|||
144597801|NCT00504881|521389105|FG000|Overall Study|SAE, non-fatal|2|||
144597802|NCT00504881|521389106|FG001|Overall Study|SAE, non-fatal|6|||
144597803|NCT00504881|521389105|FG000|Overall Study|AE, non-serious non-fatal|4|||
144523458|NCT03452579|521116967|FG001|Overall Study|Adverse Event|4|||
144523459|NCT05006872|521116973|FG000|Overall Study|Lost to Follow-up|37|||
144523460|NCT05006872|521116974|FG001|Overall Study|Lost to Follow-up|31|||
144523461|NCT02573493|521116975|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
144523462|NCT02573493|521116976|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
144523463|NCT02573493|521116977|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
144523464|NCT02573493|521116978|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
144523465|NCT04971681|521116979|FG000|Followup|Lost to Follow-up|1|||
144523466|NCT04971681|521116980|FG001|Followup|Lost to Follow-up|0|||
144523467|NCT00686335|521116981|FG000|Run-in Period|Adverse Event|1|||
144523468|NCT00686335|521116981|FG000|Run-in Period|asthma exacerbation|1|||
144523469|NCT00686335|521116981|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
144523470|NCT06181760|521116982|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
144523471|NCT06181760|521116983|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
144523472|NCT06181760|521116984|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
144523473|NCT06181760|521116985|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
144523474|NCT03524612|521116986|FG000|Overall Study|Lack of Efficacy|10|||
144523475|NCT03524612|521116986|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
144523476|NCT03524612|521116986|FG000|Overall Study|Adverse Event|10|||
144523477|NCT03524612|521116986|FG000|Overall Study|Withdrawal by Subject|7|||
144523478|NCT03524612|521116986|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
144523479|NCT03524612|521116986|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
144523480|NCT03524612|521116986|FG000|Overall Study|New therapy for study indication|6|||
144523481|NCT03524612|521116986|FG000|Overall Study|Death|3|||
144523482|NCT03524612|521116986|FG000|Overall Study|Lost to Follow-up|2|||
144523483|NCT03524612|521116986|FG000|Overall Study|Protocol Violation|1|||
144523484|NCT01420237|521116989|FG000|Overall Study|Death|13|||
144523485|NCT01420237|521116989|FG000|Overall Study|Withdrawal by Subject|41|||
144523486|NCT01420237|521116989|FG000|Overall Study|Lost to Follow-up|32|||
144523487|NCT01420237|521116989|FG000|Overall Study|Adverse Event|10|||
144523488|NCT01420237|521116989|FG000|Overall Study|Investigative Site Termination|43|||
144523489|NCT01420237|521116989|FG000|Overall Study|Censored because study device not implanted|21|||
144523490|NCT01420237|521116989|FG000|Overall Study|Censored because surgery not performed|2|||
144523491|NCT01420237|521116989|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
144523492|NCT01420237|521116989|FG000|Overall Study|Sponsor terminated study early|127|||
144523493|NCT01744782|521119400|FG000|Overall Study|Death|1|||
144523494|NCT01785719|521119401|FG000|4-week Baseline Evaluation|Physician Decision|1|||
144523495|NCT01785719|521119402|FG001|4-week Baseline Evaluation|Physician Decision|0|||
144523496|NCT01785719|521119401|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
144523497|NCT01785719|521119402|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
144523498|NCT01785719|521119401|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
144523499|NCT01785719|521119402|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
144523500|NCT01785719|521119401|FG000|4-week Baseline Evaluation|Pregnancy|0|||
144523501|NCT01785719|521119402|FG001|4-week Baseline Evaluation|Pregnancy|2|||
144523502|NCT01785719|521119401|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
144523503|NCT01785719|521119402|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
144523504|NCT01785719|521119401|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
144523505|NCT01785719|521119402|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
144523506|NCT01785719|521119401|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
144523507|NCT01785719|521119402|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
144523508|NCT01785719|521119401|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
144523509|NCT01785719|521119402|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
144523510|NCT01785719|521119401|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
144523511|NCT01785719|521119402|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
144523512|NCT01785719|521119401|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
144523513|NCT01785719|521119402|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
144523514|NCT01785719|521119401|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
144523515|NCT01785719|521119402|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
144523516|NCT01785719|521119401|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
144523517|NCT01785719|521119402|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
144523518|NCT01785719|521119401|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
144523519|NCT01785719|521119402|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
144523520|NCT01785719|521119401|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
144523521|NCT01785719|521119402|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
144523522|NCT01785719|521119401|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
144523523|NCT01785719|521119402|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
144523524|NCT04029688|521119411|FG000|Overall Study|Death|8|||
144523525|NCT04029688|521119412|FG001|Overall Study|Death|3|||
144523526|NCT04029688|521119413|FG002|Overall Study|Death|6|||
144523527|NCT04029688|521119414|FG003|Overall Study|Death|2|||
144523528|NCT04029688|521119415|FG004|Overall Study|Death|5|||
144523529|NCT04029688|521119416|FG005|Overall Study|Death|0|||
144523530|NCT04029688|521119417|FG006|Overall Study|Death|2|||
144523531|NCT04029688|521119418|FG007|Overall Study|Death|3|||
144523532|NCT04029688|521119411|FG000|Overall Study|Study Terminated by Sponsor|0|||
144523533|NCT04029688|521119412|FG001|Overall Study|Study Terminated by Sponsor|0|||
144523534|NCT04029688|521119413|FG002|Overall Study|Study Terminated by Sponsor|0|||
144523535|NCT04029688|521119414|FG003|Overall Study|Study Terminated by Sponsor|0|||
144523536|NCT04029688|521119415|FG004|Overall Study|Study Terminated by Sponsor|1|||
144523537|NCT04029688|521119416|FG005|Overall Study|Study Terminated by Sponsor|3|||
144523538|NCT04029688|521119417|FG006|Overall Study|Study Terminated by Sponsor|1|||
144523539|NCT04029688|521119418|FG007|Overall Study|Study Terminated by Sponsor|3|||
144523540|NCT04029688|521119411|FG000|Overall Study|Withdrawal by Subject|0|||
144523541|NCT04029688|521119412|FG001|Overall Study|Withdrawal by Subject|0|||
144523542|NCT04029688|521119413|FG002|Overall Study|Withdrawal by Subject|0|||
144523543|NCT04029688|521119414|FG003|Overall Study|Withdrawal by Subject|1|||
144523544|NCT04029688|521119415|FG004|Overall Study|Withdrawal by Subject|0|||
144523545|NCT04029688|521119416|FG005|Overall Study|Withdrawal by Subject|0|||
144523546|NCT04029688|521119417|FG006|Overall Study|Withdrawal by Subject|0|||
144523547|NCT04029688|521119418|FG007|Overall Study|Withdrawal by Subject|0|||
144523548|NCT04130438|521119419|FG000|Overall Study|Lost to Follow-up|0|||
144523549|NCT04130438|521119420|FG001|Overall Study|Lost to Follow-up|0|||
144523550|NCT04130438|521119421|FG002|Overall Study|Lost to Follow-up|1|||
144523551|NCT02140554|521119423|FG000|Overall Study|Withdrawal of consent|1|||
144523552|NCT02140554|521119424|FG001|Overall Study|Withdrawal of consent|0|||
144523553|NCT02140554|521119425|FG002|Overall Study|Withdrawal of consent|4|||
144597804|NCT00504881|521389106|FG001|Overall Study|AE, non-serious non-fatal|14|||
144523554|NCT02140554|521119423|FG000|Overall Study|Physician Decision|1|||
144597805|NCT00504881|521389105|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
144597806|NCT00504881|521389106|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
144597807|NCT00504881|521389105|FG000|Overall Study|AE of unknown type|1|||
144597808|NCT00504881|521389106|FG001|Overall Study|AE of unknown type|0|||
144597809|NCT01777269|521389107|FG000|Overall Study|Adverse Event|24|||
144597810|NCT01777269|521389108|FG001|Overall Study|Adverse Event|33|||
144597811|NCT01777269|521389107|FG000|Overall Study|Lack of Efficacy|8|||
144523555|NCT02140554|521119424|FG001|Overall Study|Physician Decision|0|||
144597812|NCT01777269|521389108|FG001|Overall Study|Lack of Efficacy|10|||
144597813|NCT01777269|521389107|FG000|Overall Study|Protocol Violation|4|||
144597814|NCT01777269|521389108|FG001|Overall Study|Protocol Violation|4|||
144597815|NCT01777269|521389107|FG000|Overall Study|Participants reached stopping criteria|1|||
144597816|NCT01777269|521389108|FG001|Overall Study|Participants reached stopping criteria|1|||
144597817|NCT01777269|521389107|FG000|Overall Study|Lost to Follow-up|4|||
144597818|NCT01777269|521389108|FG001|Overall Study|Lost to Follow-up|0|||
144597819|NCT01777269|521389107|FG000|Overall Study|Physician Decision|5|||
144597820|NCT01777269|521389108|FG001|Overall Study|Physician Decision|2|||
144597821|NCT01777269|521389107|FG000|Overall Study|Withdrawal by Subject|9|||
144597822|NCT01777269|521389108|FG001|Overall Study|Withdrawal by Subject|9|||
144597823|NCT01390181|521390876|FG000|Overall Study|Lost to Follow-up|1|||
144597824|NCT01390181|521390876|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
144597825|NCT01101477|521390877|FG000|Overall Study|Protocol Violation|5|||
144597826|NCT01101477|521390878|FG001|Overall Study|Protocol Violation|3|||
144597827|NCT01101477|521390879|FG002|Overall Study|Protocol Violation|1|||
144597828|NCT00146328|521390880|FG000|Overall Study|Adverse Event|39|||
144597829|NCT00146328|521390881|FG001|Overall Study|Adverse Event|48|||
144597830|NCT00146328|521390882|FG002|Overall Study|Adverse Event|79|||
144523556|NCT02140554|521119425|FG002|Overall Study|Physician Decision|2|||
144523557|NCT02140554|521119423|FG000|Overall Study|Death|0|||
144523558|NCT02140554|521119424|FG001|Overall Study|Death|0|||
144523559|NCT02140554|521119425|FG002|Overall Study|Death|1|||
144523560|NCT02140554|521119423|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
144523561|NCT02140554|521119424|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
144523562|NCT02140554|521119425|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
144523563|NCT05590403|521119426|FG000|Overall Study|Lost to Follow-up|13|||
144523564|NCT05590403|521119427|FG001|Overall Study|Lost to Follow-up|1|||
144523565|NCT05590403|521119428|FG002|Overall Study|Lost to Follow-up|7|||
144523566|NCT05590403|521119429|FG003|Overall Study|Lost to Follow-up|3|||
144523567|NCT05590403|521119430|FG004|Overall Study|Lost to Follow-up|4|||
144523568|NCT05590403|521119426|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
144597831|NCT00146328|521390880|FG000|Overall Study|Protocol Violation|11|||
144597832|NCT00146328|521390881|FG001|Overall Study|Protocol Violation|6|||
144523569|NCT05590403|521119427|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
144523570|NCT05590403|521119428|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
144523571|NCT05590403|521119429|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
144597833|NCT00146328|521390882|FG002|Overall Study|Protocol Violation|12|||
144400481|NCT02913612|520676562|FG003|Overall Study|Lost to Follow-up|0|||
144400482|NCT02913612|520676559|FG000|Overall Study|Physician Decision|1|||
144400483|NCT02913612|520676560|FG001|Overall Study|Physician Decision|4|||
144400484|NCT02913612|520676561|FG002|Overall Study|Physician Decision|1|||
144400485|NCT02913612|520676562|FG003|Overall Study|Physician Decision|0|||
144400486|NCT02913612|520676559|FG000|Overall Study|Withdrawal by Subject|2|||
144400487|NCT02913612|520676560|FG001|Overall Study|Withdrawal by Subject|4|||
144400488|NCT02913612|520676561|FG002|Overall Study|Withdrawal by Subject|0|||
144400489|NCT02913612|520676562|FG003|Overall Study|Withdrawal by Subject|0|||
144400490|NCT02913612|520676559|FG000|Overall Study|Hemangioma resolved|1|||
144523572|NCT05590403|521119430|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
144523573|NCT05590403|521119426|FG000|Overall Study|Other|2|||
144523574|NCT05590403|521119427|FG001|Overall Study|Other|0|||
144523575|NCT05590403|521119428|FG002|Overall Study|Other|2|||
144523576|NCT05590403|521119429|FG003|Overall Study|Other|2|||
144523577|NCT05590403|521119430|FG004|Overall Study|Other|0|||
144523578|NCT05590403|521119426|FG000|Overall Study|Migrated / moved from the study area|1|||
144523579|NCT05590403|521119427|FG001|Overall Study|Migrated / moved from the study area|1|||
144523580|NCT05590403|521119428|FG002|Overall Study|Migrated / moved from the study area|0|||
144523581|NCT05590403|521119429|FG003|Overall Study|Migrated / moved from the study area|3|||
144523582|NCT05590403|521119430|FG004|Overall Study|Migrated / moved from the study area|1|||
144523583|NCT05590403|521119426|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
144523584|NCT05590403|521119427|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
144523585|NCT05590403|521119428|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
144523586|NCT05590403|521119429|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
144523587|NCT05590403|521119430|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
144523588|NCT05659537|521119431|FG000|Overall Study|Adverse Event|5|||
144523589|NCT05659537|521119431|FG000|Overall Study|Lost to Follow-up|4|||
144523590|NCT05659537|521119431|FG000|Overall Study|Withdrawal by Subject|13|||
144523591|NCT05659537|521119431|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
144523592|NCT05659537|521119431|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
144523593|NCT05659537|521119431|FG000|Overall Study|Participant was suffering from anaemia|1|||
144523594|NCT03953508|521119435|FG000|Baseline|Lost to Follow-up|3|||
144523595|NCT03953508|521119436|FG001|Baseline|Lost to Follow-up|2|||
144523596|NCT03953508|521119435|FG000|6-month Follow-up|Lost to Follow-up|62|||
144523597|NCT03953508|521119436|FG001|6-month Follow-up|Lost to Follow-up|70|||
144523598|NCT03771417|521119437|FG000|Overall Study|Withdrawal by Subject|1|||
144523599|NCT03771417|521119438|FG001|Overall Study|Withdrawal by Subject|0|||
144523600|NCT03771417|521119439|FG002|Overall Study|Withdrawal by Subject|0|||
144523601|NCT03771417|521119437|FG000|Overall Study|Covid-19 Shutdown|0|||
144523602|NCT03771417|521119438|FG001|Overall Study|Covid-19 Shutdown|1|||
144523603|NCT03771417|521119439|FG002|Overall Study|Covid-19 Shutdown|0|||
144523604|NCT02100813|521119440|FG000|Overall Study|Adverse Event|0|||
144523605|NCT02100813|521119441|FG001|Overall Study|Adverse Event|0|||
144523606|NCT02100813|521119442|FG002|Overall Study|Adverse Event|0|||
144523607|NCT02100813|521119443|FG003|Overall Study|Adverse Event|0|||
144523608|NCT02100813|521119444|FG004|Overall Study|Adverse Event|0|||
144523609|NCT02100813|521119445|FG005|Overall Study|Adverse Event|0|||
144523610|NCT02100813|521119446|FG006|Overall Study|Adverse Event|0|||
144523611|NCT02100813|521119447|FG007|Overall Study|Adverse Event|1|||
144523612|NCT03575897|521119449|FG000|Overall Study|Lost to Follow-up|12|||
144523613|NCT03575897|521119450|FG001|Overall Study|Lost to Follow-up|13|||
144523614|NCT04489771|521119454|FG000|Overall Study|Death|27|||
144523615|NCT04489771|521119455|FG001|Overall Study|Death|25|||
144523616|NCT04489771|521119454|FG000|Overall Study|Withdrawal by Subject|1|||
144523617|NCT04489771|521119455|FG001|Overall Study|Withdrawal by Subject|0|||
144523618|NCT04489771|521119454|FG000|Overall Study|Participants Ongoing in Study|50|||
144523619|NCT04489771|521119455|FG001|Overall Study|Participants Ongoing in Study|51|||
144523620|NCT04509674|521119456|FG000|Overall Study|Not treated|33|||
144523621|NCT04509674|521119457|FG001|Overall Study|Not treated|26|||
144523622|NCT04509674|521119456|FG000|Overall Study|Protocol Violation|9|||
144523623|NCT04509674|521119457|FG001|Overall Study|Protocol Violation|10|||
144523624|NCT04509674|521119456|FG000|Overall Study|Lost to Follow-up|31|||
144523625|NCT04509674|521119457|FG001|Overall Study|Lost to Follow-up|39|||
144523626|NCT04509674|521119456|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
144523627|NCT04509674|521119457|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
144523628|NCT04509674|521119456|FG000|Overall Study|Adverse event, serious fatal event|11|||
144523629|NCT04509674|521119457|FG001|Overall Study|Adverse event, serious fatal event|4|||
144523630|NCT04509674|521119456|FG000|Overall Study|Adverse event, non-fatal event|107|||
144523631|NCT04509674|521119457|FG001|Overall Study|Adverse event, non-fatal event|118|||
144400491|NCT02913612|520676560|FG001|Overall Study|Hemangioma resolved|0|||
144400492|NCT02913612|520676561|FG002|Overall Study|Hemangioma resolved|0|||
144523632|NCT04509674|521119456|FG000|Overall Study|Other reason than listed|106|||
144523633|NCT04509674|521119457|FG001|Overall Study|Other reason than listed|95|||
144400493|NCT02913612|520676562|FG003|Overall Study|Hemangioma resolved|0|||
144249815|NCT01524783|520111762|FG001|Open-label Period|Withdrawal by Subject|0|||
144249816|NCT01524783|520111763|FG002|Open-label Period|Withdrawal by Subject|1|||
144597834|NCT00146328|521390880|FG000|Overall Study|Lost to Follow-up|7|||
144249817|NCT01524783|520111761|FG000|Open-label Period|Protocol deviation|1|||
144249818|NCT01524783|520111762|FG001|Open-label Period|Protocol deviation|0|||
144249819|NCT01524783|520111763|FG002|Open-label Period|Protocol deviation|0|||
144249820|NCT02920177|520111764|FG000|Overall Study|Withdrawal by Subject|1|||
144249821|NCT02920177|520111765|FG001|Overall Study|Withdrawal by Subject|1|||
144249822|NCT02920177|520111764|FG000|Overall Study|Physician Decision|1|||
144249823|NCT02920177|520111765|FG001|Overall Study|Physician Decision|0|||
144249824|NCT02920177|520111764|FG000|Overall Study|Lost to Follow-up|0|||
144249825|NCT02920177|520111765|FG001|Overall Study|Lost to Follow-up|1|||
144249826|NCT02054910|520111766|FG000|Overall Study|Lost to Follow-up|4|||
144249827|NCT02054910|520111767|FG001|Overall Study|Lost to Follow-up|1|||
144249828|NCT04907227|520111768|FG000|Overall Study|Death|12|||
144249829|NCT04907227|520111769|FG001|Overall Study|Death|8|||
144249830|NCT04907227|520111768|FG000|Overall Study|Withdrawal by Subject|2|||
144249831|NCT04907227|520111769|FG001|Overall Study|Withdrawal by Subject|2|||
144249832|NCT04907227|520111768|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
144249833|NCT04907227|520111769|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
144249834|NCT04907227|520111768|FG000|Overall Study|Sponsor Decision|25|||
144249835|NCT04907227|520111769|FG001|Overall Study|Sponsor Decision|30|||
144249836|NCT04907227|520111768|FG000|Overall Study|Physician Decision|1|||
144249837|NCT04907227|520111769|FG001|Overall Study|Physician Decision|0|||
144249838|NCT02240069|520111770|FG000|Overall Study|Withdrawal by Subject|5|||
144249839|NCT02240069|520111771|FG001|Overall Study|Withdrawal by Subject|5|||
144249840|NCT02240069|520111772|FG002|Overall Study|Withdrawal by Subject|2|||
144249841|NCT00106639|520111773|FG000|Overall Study|Adverse Event|3|||
144249842|NCT00106639|520111774|FG001|Overall Study|Adverse Event|4|||
144249843|NCT00106639|520111775|FG002|Overall Study|Adverse Event|1|||
144249844|NCT00106639|520111773|FG000|Overall Study|Protocol Violation|0|||
144249845|NCT00106639|520111774|FG001|Overall Study|Protocol Violation|1|||
144249846|NCT00106639|520111775|FG002|Overall Study|Protocol Violation|0|||
144249847|NCT00106639|520111773|FG000|Overall Study|Withdrawal by Subject|0|||
144249848|NCT00106639|520111774|FG001|Overall Study|Withdrawal by Subject|1|||
144249849|NCT00106639|520111775|FG002|Overall Study|Withdrawal by Subject|0|||
144249850|NCT00106639|520111773|FG000|Overall Study|Participant defaulted|0|||
144249851|NCT00106639|520111774|FG001|Overall Study|Participant defaulted|1|||
144249852|NCT00106639|520111775|FG002|Overall Study|Participant defaulted|1|||
144249853|NCT01876979|520111776|FG000|Overall Study|Physician Decision|2|||
144249854|NCT01876979|520111777|FG001|Overall Study|Physician Decision|3|||
144249855|NCT01096589|520111778|FG000|Overall Study|Adverse Event|2|||
144249856|NCT01096589|520111779|FG001|Overall Study|Adverse Event|1|||
144249857|NCT01096589|520111780|FG002|Overall Study|Adverse Event|2|||
144249858|NCT01096589|520111781|FG003|Overall Study|Adverse Event|1|||
144249859|NCT01096589|520111778|FG000|Overall Study|Withdrawal by Subject|2|||
144249860|NCT01096589|520111779|FG001|Overall Study|Withdrawal by Subject|1|||
144249861|NCT01096589|520111780|FG002|Overall Study|Withdrawal by Subject|1|||
144249862|NCT01096589|520111781|FG003|Overall Study|Withdrawal by Subject|1|||
144249863|NCT01096589|520111778|FG000|Overall Study|Compliance with protocol|0|||
144597835|NCT00146328|521390881|FG001|Overall Study|Lost to Follow-up|4|||
144597836|NCT00146328|521390882|FG002|Overall Study|Lost to Follow-up|7|||
144597837|NCT00146328|521390880|FG000|Overall Study|Withdrawal by Subject|16|||
144597838|NCT00146328|521390881|FG001|Overall Study|Withdrawal by Subject|16|||
144597839|NCT00146328|521390882|FG002|Overall Study|Withdrawal by Subject|22|||
144597840|NCT00146328|521390880|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
144597841|NCT00146328|521390881|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
144597842|NCT00146328|521390882|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
144597843|NCT00146328|521390880|FG000|Overall Study|Trial ended/site closed|8|||
144597844|NCT00146328|521390881|FG001|Overall Study|Trial ended/site closed|2|||
144597845|NCT00146328|521390882|FG002|Overall Study|Trial ended/site closed|19|||
144249864|NCT01096589|520111779|FG001|Overall Study|Compliance with protocol|0|||
144249865|NCT01096589|520111780|FG002|Overall Study|Compliance with protocol|1|||
144249866|NCT01096589|520111781|FG003|Overall Study|Compliance with protocol|0|||
144249867|NCT01096589|520111778|FG000|Overall Study|found treatment exhausting|0|||
144249868|NCT01096589|520111779|FG001|Overall Study|found treatment exhausting|0|||
144249869|NCT01096589|520111780|FG002|Overall Study|found treatment exhausting|0|||
144249870|NCT01096589|520111781|FG003|Overall Study|found treatment exhausting|1|||
144597846|NCT00146328|521390880|FG000|Overall Study|Patient decision to end|0|||
144249871|NCT03417024|520111784|FG000|Overall Study|Study Termination prior to follow-up|11|||
144597847|NCT00146328|521390881|FG001|Overall Study|Patient decision to end|1|||
144597848|NCT00146328|521390882|FG002|Overall Study|Patient decision to end|6|||
144722366|NCT03679741|521838692|FG000|Period 1|No longer meet eligibility criteria|1|||
144249872|NCT03417024|520111784|FG000|Overall Study|Physician Decision|2|||
144249873|NCT00386425|520111785|FG000|Overall Study|Physician Decision|3|||
144249874|NCT00386425|520111786|FG001|Overall Study|Physician Decision|0|||
144249875|NCT00386425|520111787|FG002|Overall Study|Physician Decision|0|||
144400494|NCT02913612|520676559|FG000|Overall Study|Local IRB decision|1|||
144400495|NCT02913612|520676560|FG001|Overall Study|Local IRB decision|0|||
144400496|NCT02913612|520676561|FG002|Overall Study|Local IRB decision|0|||
144400497|NCT02913612|520676562|FG003|Overall Study|Local IRB decision|0|||
144400498|NCT02913612|520676559|FG000|Overall Study|Study drug non-compliance|1|||
144400499|NCT02913612|520676560|FG001|Overall Study|Study drug non-compliance|1|||
144400500|NCT02913612|520676561|FG002|Overall Study|Study drug non-compliance|0|||
144400501|NCT02913612|520676562|FG003|Overall Study|Study drug non-compliance|0|||
144400502|NCT02913612|520676559|FG000|Overall Study|Insurance issues|0|||
144400503|NCT02913612|520676560|FG001|Overall Study|Insurance issues|1|||
144400504|NCT02913612|520676561|FG002|Overall Study|Insurance issues|0|||
144400505|NCT02913612|520676562|FG003|Overall Study|Insurance issues|0|||
144400506|NCT02913612|520676559|FG000|Overall Study|Needed to treat second hemangioma|0|||
144400507|NCT02913612|520676560|FG001|Overall Study|Needed to treat second hemangioma|1|||
144400508|NCT02913612|520676561|FG002|Overall Study|Needed to treat second hemangioma|0|||
144400509|NCT02913612|520676562|FG003|Overall Study|Needed to treat second hemangioma|0|||
144400510|NCT02913612|520676559|FG000|Overall Study|Study completion criteria not met|0|||
144400511|NCT02913612|520676560|FG001|Overall Study|Study completion criteria not met|1|||
144400512|NCT02913612|520676561|FG002|Overall Study|Study completion criteria not met|0|||
144400513|NCT02913612|520676562|FG003|Overall Study|Study completion criteria not met|0|||
144400514|NCT02913612|520676559|FG000|Overall Study|Ineligible|0|||
144400515|NCT02913612|520676560|FG001|Overall Study|Ineligible|1|||
144400516|NCT02913612|520676561|FG002|Overall Study|Ineligible|0|||
144400517|NCT02913612|520676562|FG003|Overall Study|Ineligible|0|||
144400518|NCT01011738|520676563|FG000|Overall Study|Death|12|||
144400519|NCT01011738|520676564|FG001|Overall Study|Death|3|||
144400520|NCT01011738|520676565|FG002|Overall Study|Death|0|||
144400521|NCT01011738|520676563|FG000|Overall Study|Unknown reasons|312|||
144400522|NCT01011738|520676564|FG001|Overall Study|Unknown reasons|291|||
144400523|NCT01011738|520676565|FG002|Overall Study|Unknown reasons|17|||
144400524|NCT00072176|520676568|FG000|Overall Study|Withdrawal by Subject|1|||
144400525|NCT00072176|520676569|FG001|Overall Study|Withdrawal by Subject|0|||
144400526|NCT00072176|520676568|FG000|Overall Study|Protocol Violation|0|||
144400527|NCT00072176|520676569|FG001|Overall Study|Protocol Violation|1|||
144400528|NCT03181893|520676570|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400529|NCT03181893|520676571|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
144400530|NCT03181893|520676572|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400531|NCT03181893|520676573|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400532|NCT03181893|520676574|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400533|NCT03181893|520676575|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400534|NCT03181893|520676576|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400535|NCT03181893|520676577|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400536|NCT03181893|520676578|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400537|NCT03181893|520676579|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400538|NCT03181893|520676580|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
144400539|NCT03181893|520676570|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
144400540|NCT03181893|520676571|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
144400541|NCT03181893|520676572|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400542|NCT03181893|520676573|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400543|NCT03181893|520676574|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400544|NCT03181893|520676575|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400545|NCT03181893|520676576|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400546|NCT03181893|520676577|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400547|NCT03181893|520676578|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400548|NCT03181893|520676579|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400549|NCT03181893|520676580|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
144400550|NCT03181893|520676570|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400551|NCT03181893|520676571|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400552|NCT03181893|520676572|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400553|NCT03181893|520676573|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400554|NCT03181893|520676574|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400555|NCT03181893|520676575|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400556|NCT03181893|520676576|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400557|NCT03181893|520676577|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
144523634|NCT04064164|521119460|FG000|Overall Study|Withdrawal by Subject|8|||
144523635|NCT04064164|521119461|FG001|Overall Study|Withdrawal by Subject|8|||
144400558|NCT03181893|520676578|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
144400559|NCT03181893|520676579|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400560|NCT03181893|520676580|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
144400561|NCT03181893|520676570|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400562|NCT03181893|520676571|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400563|NCT03181893|520676572|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144523636|NCT06190691|521119463|FG000|Overall Study|Adverse Event|2|||
144400564|NCT03181893|520676573|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400565|NCT03181893|520676574|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400566|NCT03181893|520676575|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400567|NCT03181893|520676576|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400568|NCT03181893|520676577|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400569|NCT03181893|520676578|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400570|NCT03181893|520676579|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
144400571|NCT03181893|520676580|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
144400572|NCT03181893|520676570|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400573|NCT03181893|520676571|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400574|NCT03181893|520676572|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400575|NCT03181893|520676573|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400576|NCT03181893|520676574|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400577|NCT03181893|520676575|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400578|NCT03181893|520676576|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400579|NCT03181893|520676577|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400580|NCT03181893|520676578|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400581|NCT03181893|520676579|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
144400582|NCT03181893|520676580|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
144400583|NCT04128371|520676581|FG000|Overall Study|Lack of Efficacy|1|||
144400584|NCT00968864|520676585|FG000|Overall Study|Protocol exception/ not evaluable|1|||
144400585|NCT01558739|520676586|FG000|Overall Study|Adverse Event|7|||
144400586|NCT01558739|520676586|FG000|Overall Study|Withdrawal by Subject|2|||
144400587|NCT01558739|520676586|FG000|Overall Study|Death|3|||
144400588|NCT01558739|520676586|FG000|Overall Study|Disease Progression|4|||
144400589|NCT01558739|520676586|FG000|Overall Study|Protocol Violation|1|||
144400590|NCT03672643|520676587|FG000|Overall Study|Adverse Event|3|||
144400591|NCT03672643|520676587|FG000|Overall Study|Death|2|||
144400592|NCT03672643|520676587|FG000|Overall Study|Withdrawal by Subject|1|||
144400593|NCT03672643|520676587|FG000|Overall Study|Progressive disease|11|||
144400594|NCT03672643|520676587|FG000|Overall Study|Global deterioration of health status|1|||
144400595|NCT03672643|520676587|FG000|Overall Study|Refused further treatment|7|||
144400596|NCT03672643|520676587|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
144400597|NCT03673046|520678072|FG000|Overall Study|Adverse Event|1|||
144400598|NCT03673046|520678073|FG001|Overall Study|Adverse Event|1|||
144400599|NCT03673046|520678072|FG000|Overall Study|Withdrawal by Subject|8|||
144400600|NCT03673046|520678073|FG001|Overall Study|Withdrawal by Subject|2|||
144400601|NCT02024529|520678080|FG000|Overall Study|Withdrawal by Subject|11|||
144400602|NCT02024529|520678081|FG001|Overall Study|Withdrawal by Subject|21|||
144400603|NCT02024529|520678080|FG000|Overall Study|Lost to Follow-up|2|||
144400604|NCT02024529|520678081|FG001|Overall Study|Lost to Follow-up|4|||
144400605|NCT00354614|520678082|FG000|Overall Study|Lack of Efficacy|28|||
144400606|NCT03650556|520678083|FG000|Overall Study|Death|2|||
144523637|NCT06190691|521119464|FG001|Overall Study|Adverse Event|0|||
144523638|NCT06190691|521119465|FG002|Overall Study|Adverse Event|0|||
144523639|NCT06190691|521119466|FG003|Overall Study|Adverse Event|0|||
144523640|NCT03839940|521119468|FG000|Overall Study|Withdrawal by Subject|3|||
144523641|NCT03839940|521119469|FG001|Overall Study|Withdrawal by Subject|0|||
144523642|NCT03839940|521119468|FG000|Overall Study|Protocol Violation|0|||
144523643|NCT03839940|521119469|FG001|Overall Study|Protocol Violation|1|||
144523644|NCT03839940|521119468|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
144523645|NCT03839940|521119469|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
144523646|NCT03241745|521119470|FG000|Overall Study|Adverse Event|7|||
144523647|NCT03241745|521119470|FG000|Overall Study|Death|1|||
144523648|NCT03241745|521119470|FG000|Overall Study|Withdrawal by Subject|5|||
144523649|NCT03241745|521119470|FG000|Overall Study|Treatment delay >28 days|2|||
144523650|NCT03241745|521119470|FG000|Overall Study|Lack of Efficacy|14|||
144523651|NCT04019873|521119472|FG000|Overall Study|Discontinued from the treatment|1|||
144523652|NCT04019873|521119473|FG001|Overall Study|Discontinued from the treatment|39|||
144523653|NCT04019873|521119474|FG002|Overall Study|Discontinued from the treatment|2|||
144523654|NCT04683744|521119475|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
144523655|NCT04683744|521119476|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
144523656|NCT04683744|521119477|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
144523657|NCT04316871|521119479|FG000|Overall Study|Protocol Violation|2|||
144523658|NCT04316871|521119480|FG001|Overall Study|Protocol Violation|2|||
144523659|NCT04316871|521119481|FG002|Overall Study|Protocol Violation|2|||
144523660|NCT04316871|521119482|FG003|Overall Study|Protocol Violation|2|||
144523661|NCT04650269|521119483|FG000|Overall Study|Death|3|||
144523662|NCT04650269|521119483|FG000|Overall Study|Lost to Follow-up|6|||
144523663|NCT01437709|521119484|FG000|Overall Study|Adverse Event|0|||
144523664|NCT01437709|521119485|FG001|Overall Study|Adverse Event|1|||
144523665|NCT01437709|521119486|FG002|Overall Study|Adverse Event|0|||
144523666|NCT01437709|521119484|FG000|Overall Study|Pt trasnferred care|0|||
144597849|NCT00146328|521390880|FG000|Overall Study|Enroll into other trial|2|||
144597850|NCT00146328|521390881|FG001|Overall Study|Enroll into other trial|4|||
144597851|NCT00146328|521390882|FG002|Overall Study|Enroll into other trial|2|||
144597852|NCT00146328|521390880|FG000|Overall Study|Death|0|||
144597853|NCT00146328|521390881|FG001|Overall Study|Death|1|||
144597854|NCT00146328|521390882|FG002|Overall Study|Death|1|||
144597855|NCT00146328|521390880|FG000|Overall Study|Moved|2|||
144597856|NCT00146328|521390881|FG001|Overall Study|Moved|0|||
144597857|NCT00146328|521390882|FG002|Overall Study|Moved|0|||
144597858|NCT00146328|521390880|FG000|Overall Study|Interaction with other medication|2|||
144597859|NCT00146328|521390881|FG001|Overall Study|Interaction with other medication|0|||
144597860|NCT00146328|521390882|FG002|Overall Study|Interaction with other medication|1|||
144597861|NCT02952001|521390888|FG000|Overall Study|Adverse Event|3|||
144597862|NCT02952001|521390889|FG001|Overall Study|Adverse Event|0|||
144597863|NCT02952001|521390888|FG000|Overall Study|Prohibited therapy|10|||
144597864|NCT02952001|521390889|FG001|Overall Study|Prohibited therapy|3|||
144597865|NCT02952001|521390888|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
144597866|NCT02952001|521390889|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
144597867|NCT01794520|521390890|FG000|Overall Study|Adverse events- related to progression|0|||
144597868|NCT01794520|521390891|FG001|Overall Study|Adverse events- related to progression|0|||
144597869|NCT01794520|521390892|FG002|Overall Study|Adverse events- related to progression|1|||
144597870|NCT01794520|521390893|FG003|Overall Study|Adverse events- related to progression|2|||
144597871|NCT01794520|521390894|FG004|Overall Study|Adverse events- related to progression|0|||
144597872|NCT01794520|521390895|FG005|Overall Study|Adverse events- related to progression|1|||
144597873|NCT01794520|521390896|FG006|Overall Study|Adverse events- related to progression|0|||
144597874|NCT01794520|521390890|FG000|Overall Study|Adverse event- not related to progression|1|||
144597875|NCT01794520|521390891|FG001|Overall Study|Adverse event- not related to progression|1|||
144597876|NCT01794520|521390892|FG002|Overall Study|Adverse event- not related to progression|0|||
144597877|NCT01794520|521390893|FG003|Overall Study|Adverse event- not related to progression|0|||
144597878|NCT01794520|521390894|FG004|Overall Study|Adverse event- not related to progression|2|||
144597879|NCT01794520|521390895|FG005|Overall Study|Adverse event- not related to progression|0|||
144597880|NCT01794520|521390896|FG006|Overall Study|Adverse event- not related to progression|0|||
144597881|NCT01794520|521390890|FG000|Overall Study|Progressive disease|5|||
144597882|NCT01794520|521390891|FG001|Overall Study|Progressive disease|6|||
144597883|NCT01794520|521390892|FG002|Overall Study|Progressive disease|2|||
144597884|NCT01794520|521390893|FG003|Overall Study|Progressive disease|5|||
144597885|NCT01794520|521390894|FG004|Overall Study|Progressive disease|27|||
144597886|NCT01794520|521390895|FG005|Overall Study|Progressive disease|18|||
144597887|NCT01794520|521390896|FG006|Overall Study|Progressive disease|0|||
144597888|NCT01794520|521390890|FG000|Overall Study|Withdrew consent|0|||
144597889|NCT01794520|521390891|FG001|Overall Study|Withdrew consent|0|||
144597890|NCT01794520|521390892|FG002|Overall Study|Withdrew consent|1|||
144597891|NCT01794520|521390893|FG003|Overall Study|Withdrew consent|1|||
144597892|NCT01794520|521390894|FG004|Overall Study|Withdrew consent|0|||
144597893|NCT01794520|521390895|FG005|Overall Study|Withdrew consent|0|||
144597894|NCT01794520|521390896|FG006|Overall Study|Withdrew consent|0|||
144597895|NCT01794520|521390890|FG000|Overall Study|Lost to Follow-up|0|||
144597896|NCT01794520|521390891|FG001|Overall Study|Lost to Follow-up|0|||
144597897|NCT01794520|521390892|FG002|Overall Study|Lost to Follow-up|0|||
144597898|NCT01794520|521390893|FG003|Overall Study|Lost to Follow-up|0|||
144597899|NCT01794520|521390894|FG004|Overall Study|Lost to Follow-up|1|||
144597900|NCT01794520|521390895|FG005|Overall Study|Lost to Follow-up|0|||
144597901|NCT01794520|521390896|FG006|Overall Study|Lost to Follow-up|0|||
144597902|NCT01794520|521390890|FG000|Overall Study|Toxicity|0|||
144597903|NCT01794520|521390891|FG001|Overall Study|Toxicity|2|||
144597904|NCT01794520|521390892|FG002|Overall Study|Toxicity|0|||
144597905|NCT01794520|521390893|FG003|Overall Study|Toxicity|0|||
144597906|NCT01794520|521390894|FG004|Overall Study|Toxicity|0|||
144597907|NCT01794520|521390895|FG005|Overall Study|Toxicity|0|||
144597908|NCT01794520|521390896|FG006|Overall Study|Toxicity|0|||
144597909|NCT01794520|521390890|FG000|Overall Study|Study terminated by sponsor|0|||
144597910|NCT01794520|521390891|FG001|Overall Study|Study terminated by sponsor|0|||
144597911|NCT01794520|521390892|FG002|Overall Study|Study terminated by sponsor|1|||
144597912|NCT01794520|521390893|FG003|Overall Study|Study terminated by sponsor|0|||
144597913|NCT01794520|521390894|FG004|Overall Study|Study terminated by sponsor|1|||
144597914|NCT01794520|521390895|FG005|Overall Study|Study terminated by sponsor|0|||
144597915|NCT01794520|521390896|FG006|Overall Study|Study terminated by sponsor|7|||
144597916|NCT01794520|521390890|FG000|Overall Study|Death|0|||
144597917|NCT01794520|521390891|FG001|Overall Study|Death|0|||
144597918|NCT01794520|521390892|FG002|Overall Study|Death|0|||
144597919|NCT01794520|521390893|FG003|Overall Study|Death|0|||
144597920|NCT01794520|521390894|FG004|Overall Study|Death|1|||
144597921|NCT01794520|521390895|FG005|Overall Study|Death|0|||
144597922|NCT01794520|521390896|FG006|Overall Study|Death|22|||
144597923|NCT01794520|521390890|FG000|Overall Study|Other, not specified|0|||
144597924|NCT01794520|521390891|FG001|Overall Study|Other, not specified|0|||
144597925|NCT01794520|521390892|FG002|Overall Study|Other, not specified|1|||
144597926|NCT01794520|521390893|FG003|Overall Study|Other, not specified|1|||
144400607|NCT03650556|520678083|FG000|Overall Study|Withdrawal by Subject|20|||
144400608|NCT03650556|520678083|FG000|Overall Study|Physician Decision|2|||
144400609|NCT03650556|520678083|FG000|Overall Study|Lost to Follow-up|8|||
144400610|NCT03650556|520678083|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
144400611|NCT03650556|520678083|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
144400612|NCT03917459|520678086|FG000|Overall Study|Adverse Event|1|||
144400613|NCT03917459|520678087|FG001|Overall Study|Adverse Event|0|||
144400614|NCT03917459|520678086|FG000|Overall Study|Withdrawal by Subject|0|||
144400615|NCT03917459|520678087|FG001|Overall Study|Withdrawal by Subject|1|||
144400616|NCT00676338|520678088|FG000|Overall Study|Adverse Event|6|||
144400617|NCT00676338|520678089|FG001|Overall Study|Adverse Event|6|||
144400618|NCT00676338|520678090|FG002|Overall Study|Adverse Event|5|||
144400619|NCT00676338|520678091|FG003|Overall Study|Adverse Event|1|||
144400620|NCT00676338|520678088|FG000|Overall Study|Lost to Follow-up|4|||
144400621|NCT00676338|520678089|FG001|Overall Study|Lost to Follow-up|1|||
144400622|NCT00676338|520678090|FG002|Overall Study|Lost to Follow-up|3|||
144400623|NCT00676338|520678091|FG003|Overall Study|Lost to Follow-up|4|||
144400624|NCT00676338|520678088|FG000|Overall Study|Physician Decision|3|||
144400625|NCT00676338|520678089|FG001|Overall Study|Physician Decision|3|||
144400626|NCT00676338|520678090|FG002|Overall Study|Physician Decision|2|||
144400627|NCT00676338|520678091|FG003|Overall Study|Physician Decision|3|||
144400628|NCT00676338|520678088|FG000|Overall Study|Protocol Violation|5|||
144400629|NCT00676338|520678089|FG001|Overall Study|Protocol Violation|9|||
144400630|NCT00676338|520678090|FG002|Overall Study|Protocol Violation|2|||
144400631|NCT00676338|520678091|FG003|Overall Study|Protocol Violation|5|||
144400632|NCT00676338|520678088|FG000|Overall Study|Withdrawal by Subject|17|||
144400633|NCT00676338|520678089|FG001|Overall Study|Withdrawal by Subject|9|||
144400634|NCT00676338|520678090|FG002|Overall Study|Withdrawal by Subject|12|||
144400635|NCT00676338|520678091|FG003|Overall Study|Withdrawal by Subject|6|||
144400636|NCT00676338|520678088|FG000|Overall Study|Entry Criteria Not Met|0|||
144400637|NCT00676338|520678089|FG001|Overall Study|Entry Criteria Not Met|2|||
144400638|NCT00676338|520678090|FG002|Overall Study|Entry Criteria Not Met|1|||
144400639|NCT00676338|520678091|FG003|Overall Study|Entry Criteria Not Met|1|||
144400640|NCT00676338|520678088|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
144400641|NCT00676338|520678089|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
144400642|NCT00676338|520678090|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
144400643|NCT00676338|520678091|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
144400644|NCT02122458|520678092|FG000|Overall Study|Withdrawal by Subject|0|||
144400645|NCT02122458|520678093|FG001|Overall Study|Withdrawal by Subject|0|||
144400646|NCT02122458|520678094|FG002|Overall Study|Withdrawal by Subject|0|||
144400647|NCT02122458|520678095|FG003|Overall Study|Withdrawal by Subject|4|||
144400648|NCT02122458|520678096|FG004|Overall Study|Withdrawal by Subject|4|||
144400649|NCT02122458|520678097|FG005|Overall Study|Withdrawal by Subject|4|||
144400650|NCT02122458|520678098|FG006|Overall Study|Withdrawal by Subject|0|||
144400651|NCT02122458|520678092|FG000|Overall Study|Lost to Follow-up|1|||
144400652|NCT02122458|520678093|FG001|Overall Study|Lost to Follow-up|3|||
144400653|NCT02122458|520678094|FG002|Overall Study|Lost to Follow-up|0|||
144400654|NCT02122458|520678095|FG003|Overall Study|Lost to Follow-up|7|||
144400655|NCT02122458|520678096|FG004|Overall Study|Lost to Follow-up|5|||
144400656|NCT02122458|520678097|FG005|Overall Study|Lost to Follow-up|15|||
144400657|NCT02122458|520678098|FG006|Overall Study|Lost to Follow-up|1|||
144400658|NCT02122458|520678092|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
144400659|NCT02122458|520678093|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
144400660|NCT02122458|520678094|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
144400661|NCT02122458|520678095|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
144400662|NCT02122458|520678096|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
144400663|NCT02122458|520678097|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
144400664|NCT02122458|520678098|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
144400665|NCT02122458|520678092|FG000|Overall Study|Adverse Event|1|||
144400666|NCT02122458|520678093|FG001|Overall Study|Adverse Event|0|||
144400667|NCT02122458|520678094|FG002|Overall Study|Adverse Event|0|||
144400668|NCT02122458|520678095|FG003|Overall Study|Adverse Event|0|||
144400669|NCT02122458|520678096|FG004|Overall Study|Adverse Event|0|||
144400670|NCT02122458|520678097|FG005|Overall Study|Adverse Event|0|||
144400671|NCT02122458|520678098|FG006|Overall Study|Adverse Event|0|||
144400672|NCT02122458|520678092|FG000|Overall Study|Experimental Error|0|||
144400673|NCT02122458|520678093|FG001|Overall Study|Experimental Error|0|||
144400674|NCT02122458|520678094|FG002|Overall Study|Experimental Error|0|||
144400675|NCT02122458|520678095|FG003|Overall Study|Experimental Error|0|||
144400676|NCT02122458|520678096|FG004|Overall Study|Experimental Error|3|||
144400677|NCT02122458|520678097|FG005|Overall Study|Experimental Error|0|||
144400678|NCT02122458|520678098|FG006|Overall Study|Experimental Error|0|||
144400679|NCT02122458|520678092|FG000|Overall Study|Deployed or Moved|0|||
144400680|NCT02122458|520678093|FG001|Overall Study|Deployed or Moved|0|||
144400681|NCT02122458|520678094|FG002|Overall Study|Deployed or Moved|0|||
144400682|NCT02122458|520678095|FG003|Overall Study|Deployed or Moved|0|||
144400683|NCT02122458|520678096|FG004|Overall Study|Deployed or Moved|1|||
144400684|NCT02122458|520678097|FG005|Overall Study|Deployed or Moved|0|||
144400685|NCT02122458|520678098|FG006|Overall Study|Deployed or Moved|0|||
144400686|NCT02122458|520678092|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
144400687|NCT02122458|520678093|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
144400688|NCT02122458|520678094|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
144400689|NCT02122458|520678095|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
144400690|NCT02122458|520678096|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
144400691|NCT02122458|520678097|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
144400692|NCT02122458|520678098|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
144400693|NCT02122458|520678092|FG000|Overall Study|Noncompliance|0|||
144400694|NCT02122458|520678093|FG001|Overall Study|Noncompliance|1|||
144400695|NCT02122458|520678094|FG002|Overall Study|Noncompliance|0|||
144400696|NCT02122458|520678095|FG003|Overall Study|Noncompliance|0|||
144400697|NCT02122458|520678096|FG004|Overall Study|Noncompliance|0|||
144400698|NCT02122458|520678097|FG005|Overall Study|Noncompliance|0|||
144400699|NCT02122458|520678098|FG006|Overall Study|Noncompliance|0|||
144400700|NCT00412542|520678099|FG000|Overall Study|Withdrawal by Subject|0|||
144400701|NCT00412542|520678100|FG001|Overall Study|Withdrawal by Subject|2|||
144400702|NCT00412542|520678099|FG000|Overall Study|Not Eligible|0|||
144400703|NCT00412542|520678100|FG001|Overall Study|Not Eligible|1|||
144400704|NCT02833350|520678101|FG000|Overall Study|Adverse Event|0|||
144400705|NCT02833350|520678102|FG001|Overall Study|Adverse Event|3|||
144400706|NCT02833350|520678103|FG002|Overall Study|Adverse Event|4|||
144400707|NCT02833350|520678104|FG003|Overall Study|Adverse Event|4|||
144400708|NCT02833350|520678105|FG004|Overall Study|Adverse Event|1|||
144400709|NCT02833350|520678106|FG005|Overall Study|Adverse Event|0|||
144400710|NCT02833350|520678107|FG006|Overall Study|Adverse Event|1|||
144400711|NCT02833350|520678101|FG000|Overall Study|Death|0|||
144400712|NCT02833350|520678102|FG001|Overall Study|Death|0|||
144400713|NCT02833350|520678103|FG002|Overall Study|Death|1|||
144400714|NCT02833350|520678104|FG003|Overall Study|Death|0|||
144400715|NCT02833350|520678105|FG004|Overall Study|Death|0|||
144400716|NCT02833350|520678106|FG005|Overall Study|Death|0|||
144400717|NCT02833350|520678107|FG006|Overall Study|Death|0|||
144400718|NCT02833350|520678101|FG000|Overall Study|Lack of Efficacy|0|||
144400719|NCT02833350|520678102|FG001|Overall Study|Lack of Efficacy|2|||
144400720|NCT02833350|520678103|FG002|Overall Study|Lack of Efficacy|1|||
144400721|NCT02833350|520678104|FG003|Overall Study|Lack of Efficacy|4|||
144400722|NCT02833350|520678105|FG004|Overall Study|Lack of Efficacy|0|||
144400723|NCT02833350|520678106|FG005|Overall Study|Lack of Efficacy|1|||
144400724|NCT02833350|520678107|FG006|Overall Study|Lack of Efficacy|1|||
144400725|NCT02833350|520678101|FG000|Overall Study|Lost to Follow-up|0|||
144400726|NCT02833350|520678102|FG001|Overall Study|Lost to Follow-up|1|||
144400727|NCT02833350|520678103|FG002|Overall Study|Lost to Follow-up|0|||
144400728|NCT02833350|520678104|FG003|Overall Study|Lost to Follow-up|0|||
144400729|NCT02833350|520678105|FG004|Overall Study|Lost to Follow-up|0|||
144400730|NCT02833350|520678106|FG005|Overall Study|Lost to Follow-up|0|||
144523667|NCT01437709|521119485|FG001|Overall Study|Pt trasnferred care|1|||
144523668|NCT01437709|521119486|FG002|Overall Study|Pt trasnferred care|0|||
144523669|NCT04091750|521119487|FG000|Overall Study|Adverse Event|4|||
144523670|NCT04091750|521119487|FG000|Overall Study|Withdrawal by Subject|1|||
144523671|NCT01842542|521119488|FG000|Overall Study|Withdrawal by Subject|2|||
144523672|NCT01842542|521119488|FG000|Overall Study|Lack of Efficacy|1|||
144400731|NCT02833350|520678107|FG006|Overall Study|Lost to Follow-up|1|||
144400732|NCT02833350|520678101|FG000|Overall Study|Withdrawal by Subject|3|||
144400733|NCT02833350|520678102|FG001|Overall Study|Withdrawal by Subject|3|||
144400734|NCT02833350|520678103|FG002|Overall Study|Withdrawal by Subject|2|||
144400735|NCT02833350|520678104|FG003|Overall Study|Withdrawal by Subject|0|||
144400736|NCT02833350|520678105|FG004|Overall Study|Withdrawal by Subject|2|||
144400737|NCT02833350|520678106|FG005|Overall Study|Withdrawal by Subject|0|||
144523673|NCT01842542|521119488|FG000|Overall Study|Protocol Non-compliance|2|||
144523674|NCT01842542|521119488|FG000|Overall Study|Lost to Follow-up|1|||
144523675|NCT02919306|521119489|FG000|Overall Study|Withdrawal by Subject|1|||
144523676|NCT02919306|521119490|FG001|Overall Study|Withdrawal by Subject|0|||
144523677|NCT02919306|521119489|FG000|Overall Study|Protocol Violation|1|||
144523678|NCT02919306|521119490|FG001|Overall Study|Protocol Violation|0|||
144523679|NCT04473222|521119491|FG000|Overall Study|Lost to Follow-up|13|||
144523680|NCT04473222|521119492|FG001|Overall Study|Lost to Follow-up|13|||
144523681|NCT04473222|521119491|FG000|Overall Study|Withdrawal by Subject|0|||
144400738|NCT02833350|520678107|FG006|Overall Study|Withdrawal by Subject|2|||
144400739|NCT01500031|520678110|FG000|Overall Study|Death|1|||
144400740|NCT01500031|520678110|FG000|Overall Study|Withdrawal by Subject|4|||
144400741|NCT01604408|520678113|FG000|Treatment Period 1|Protocol Violation|0|||
144400742|NCT01604408|520678114|FG001|Treatment Period 1|Protocol Violation|1|||
144400743|NCT01604408|520678113|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144400744|NCT01604408|520678114|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144400745|NCT01604408|520678113|FG000|Treatment Period 2|Protocol Violation|1|||
144400746|NCT01604408|520678114|FG001|Treatment Period 2|Protocol Violation|0|||
144400747|NCT01604408|520678113|FG000|Treatment Period 2|Adverse Event|0|||
144400748|NCT01604408|520678114|FG001|Treatment Period 2|Adverse Event|1|||
144400749|NCT01604408|520678113|FG000|Treatment Period 3|Protocol Violation|1|||
144400750|NCT01604408|520678114|FG001|Treatment Period 3|Protocol Violation|1|||
144400751|NCT01604408|520678113|FG000|Treatment Period 3|Adverse Event|0|||
144400752|NCT01604408|520678114|FG001|Treatment Period 3|Adverse Event|3|||
144400753|NCT01604408|520678113|FG000|Treatment Period 3|Withdrawal by Subject|3|||
144400754|NCT01604408|520678114|FG001|Treatment Period 3|Withdrawal by Subject|1|||
144249876|NCT00386425|520111785|FG000|Overall Study|Withdrawal by Subject|0|||
144400755|NCT01604408|520678113|FG000|Treatment Period 3|Sponsor Decision|1|||
144400756|NCT01604408|520678114|FG001|Treatment Period 3|Sponsor Decision|0|||
144400757|NCT01604408|520678113|FG000|Treatment Period 4|Death|1|||
144400758|NCT01604408|520678114|FG001|Treatment Period 4|Death|0|||
144400759|NCT01604408|520678113|FG000|Treatment Period 4|Withdrawal by Subject|2|||
144400760|NCT01604408|520678114|FG001|Treatment Period 4|Withdrawal by Subject|1|||
144400761|NCT01604408|520678113|FG000|Treatment Period 4|Adverse Event|0|||
144400762|NCT01604408|520678114|FG001|Treatment Period 4|Adverse Event|1|||
144400763|NCT01604408|520678113|FG000|Treatment Period 5|Adverse Event|4|||
144400764|NCT01604408|520678114|FG001|Treatment Period 5|Adverse Event|0|||
144400765|NCT01604408|520678113|FG000|Treatment Period 6|Lost to Follow-up|0|||
144400766|NCT01604408|520678114|FG001|Treatment Period 6|Lost to Follow-up|1|||
144400767|NCT01604408|520678113|FG000|Treatment Period 6|Adverse Event|2|||
144400768|NCT01604408|520678114|FG001|Treatment Period 6|Adverse Event|0|||
144400769|NCT01604408|520678113|FG000|Treatment Period 6|Sponsor decision|0|||
144400770|NCT01604408|520678114|FG001|Treatment Period 6|Sponsor decision|1|||
144400771|NCT01604408|520678113|FG000|Observation Period|Adverse Event|1|||
144400772|NCT01604408|520678114|FG001|Observation Period|Adverse Event|1|||
144400773|NCT01604408|520678113|FG000|Observation Period|Withdrawal by Subject|0|||
144400774|NCT01604408|520678114|FG001|Observation Period|Withdrawal by Subject|2|||
144400775|NCT00075218|520678115|FG000|Double-Blind Treatment|Adverse Event|23|||
144400776|NCT00075218|520678116|FG001|Double-Blind Treatment|Adverse Event|4|||
144400777|NCT00075218|520678117|FG002|Double-Blind Treatment|Adverse Event|0|||
144400778|NCT00075218|520678115|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
144400779|NCT00075218|520678116|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
144400780|NCT00075218|520678117|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
144400781|NCT00075218|520678115|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
144400782|NCT00075218|520678116|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
144400783|NCT00075218|520678117|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
144400784|NCT00075218|520678115|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
144400785|NCT00075218|520678116|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
144400786|NCT00075218|520678117|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
144400787|NCT00075218|520678115|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
144400788|NCT00075218|520678116|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
144400789|NCT00075218|520678117|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
144400790|NCT00075218|520678115|FG000|Double-Blind Treatment|No study medication taken|2|||
144400791|NCT00075218|520678116|FG001|Double-Blind Treatment|No study medication taken|0|||
144400792|NCT00075218|520678117|FG002|Double-Blind Treatment|No study medication taken|0|||
144400793|NCT00075218|520678115|FG000|Open-Label Treatment|Lack of Efficacy|0|||
144400794|NCT00075218|520678116|FG001|Open-Label Treatment|Lack of Efficacy|0|||
144400795|NCT00075218|520678117|FG002|Open-Label Treatment|Lack of Efficacy|174|||
144400796|NCT00075218|520678115|FG000|Open-Label Treatment|Adverse Event|0|||
144400797|NCT00075218|520678116|FG001|Open-Label Treatment|Adverse Event|0|||
144400798|NCT00075218|520678117|FG002|Open-Label Treatment|Adverse Event|51|||
144400799|NCT00075218|520678115|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
144400800|NCT00075218|520678116|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
144400801|NCT00075218|520678117|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
144249877|NCT00386425|520111786|FG001|Overall Study|Withdrawal by Subject|1|||
144249878|NCT00386425|520111787|FG002|Overall Study|Withdrawal by Subject|0|||
144249879|NCT03053427|520111788|FG000|Overall Study|Adverse Event|4|||
144400802|NCT00075218|520678115|FG000|Open-Label Treatment|Decision of Sponsor|0|||
144400803|NCT00075218|520678116|FG001|Open-Label Treatment|Decision of Sponsor|0|||
144400804|NCT00075218|520678117|FG002|Open-Label Treatment|Decision of Sponsor|8|||
144400805|NCT00075218|520678115|FG000|Open-Label Treatment|Protocol Violation|0|||
144400806|NCT00075218|520678116|FG001|Open-Label Treatment|Protocol Violation|0|||
144400807|NCT00075218|520678117|FG002|Open-Label Treatment|Protocol Violation|1|||
144523682|NCT04473222|521119492|FG001|Overall Study|Withdrawal by Subject|1|||
144249880|NCT03053427|520111789|FG001|Overall Study|Adverse Event|4|||
144400808|NCT00075218|520678115|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
144400809|NCT00075218|520678116|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
144400810|NCT00075218|520678117|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
144523683|NCT04473222|521119491|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
144400811|NCT05047770|520678118|FG000|Overall Study|Withdrawal by Subject|15|||
144400812|NCT05047770|520678119|FG001|Overall Study|Withdrawal by Subject|10|||
144400813|NCT05047770|520678120|FG002|Overall Study|Withdrawal by Subject|6|||
144400814|NCT05047770|520678121|FG003|Overall Study|Withdrawal by Subject|12|||
144400815|NCT05047770|520678118|FG000|Overall Study|Lost to Follow-up|7|||
144400816|NCT05047770|520678119|FG001|Overall Study|Lost to Follow-up|5|||
144400817|NCT05047770|520678120|FG002|Overall Study|Lost to Follow-up|12|||
144400818|NCT05047770|520678121|FG003|Overall Study|Lost to Follow-up|13|||
144400819|NCT05047770|520678118|FG000|Overall Study|Other|1|||
144400820|NCT05047770|520678119|FG001|Overall Study|Other|0|||
144400821|NCT05047770|520678120|FG002|Overall Study|Other|1|||
144400822|NCT05047770|520678121|FG003|Overall Study|Other|0|||
144400823|NCT00216476|520678122|FG000|Overall Study|Withdrawal by Subject|59|||
144400824|NCT00216476|520678123|FG001|Overall Study|Withdrawal by Subject|72|||
144523684|NCT04473222|521119492|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
144523685|NCT03560609|521119493|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
144523686|NCT03560609|521119494|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
144523687|NCT04293055|521119495|FG000|Overall Study|Lost to Follow-up|1|||
144523688|NCT04293055|521119496|FG001|Overall Study|Lost to Follow-up|1|||
144523689|NCT04293055|521119495|FG000|Overall Study|Did not trigger randomization|6|||
144523690|NCT04293055|521119496|FG001|Overall Study|Did not trigger randomization|5|||
144523691|NCT04908722|521119505|FG000|Overall Study|Protocol deviation|1|||
144400825|NCT00216476|520678124|FG002|Overall Study|Withdrawal by Subject|9|||
144400826|NCT00216476|520678122|FG000|Overall Study|Lost to Follow-up|10|||
144400827|NCT00216476|520678123|FG001|Overall Study|Lost to Follow-up|9|||
144400828|NCT00216476|520678124|FG002|Overall Study|Lost to Follow-up|1|||
144400829|NCT00216476|520678122|FG000|Overall Study|Adverse Event|6|||
144400830|NCT00216476|520678123|FG001|Overall Study|Adverse Event|10|||
144400831|NCT00216476|520678124|FG002|Overall Study|Adverse Event|1|||
144400832|NCT00216476|520678122|FG000|Overall Study|Lack of Efficacy|4|||
144400833|NCT00216476|520678123|FG001|Overall Study|Lack of Efficacy|3|||
144400834|NCT00216476|520678124|FG002|Overall Study|Lack of Efficacy|0|||
144400835|NCT00216476|520678122|FG000|Overall Study|Death|2|||
144400836|NCT00216476|520678123|FG001|Overall Study|Death|0|||
144400837|NCT00216476|520678124|FG002|Overall Study|Death|0|||
144400838|NCT00216476|520678122|FG000|Overall Study|Pregnancy|0|||
144400839|NCT00216476|520678123|FG001|Overall Study|Pregnancy|1|||
144400840|NCT00216476|520678124|FG002|Overall Study|Pregnancy|1|||
144400841|NCT00216476|520678122|FG000|Overall Study|Other|0|||
144400842|NCT00216476|520678123|FG001|Overall Study|Other|0|||
144400843|NCT00216476|520678124|FG002|Overall Study|Other|1|||
144400844|NCT00216476|520678122|FG000|Overall Study|Refuses Injection|11|||
144597927|NCT01794520|521390894|FG004|Overall Study|Other, not specified|4|||
144597928|NCT01794520|521390895|FG005|Overall Study|Other, not specified|1|||
144400845|NCT00216476|520678123|FG001|Overall Study|Refuses Injection|0|||
144400846|NCT00216476|520678124|FG002|Overall Study|Refuses Injection|0|||
144400847|NCT00216476|520678122|FG000|Overall Study|No Further Need for Treatment|3|||
144400848|NCT00216476|520678123|FG001|Overall Study|No Further Need for Treatment|4|||
144400849|NCT00216476|520678124|FG002|Overall Study|No Further Need for Treatment|1|||
144523692|NCT04908722|521119506|FG001|Overall Study|Protocol deviation|0|||
144523693|NCT04908722|521119507|FG002|Overall Study|Protocol deviation|0|||
144523694|NCT04908722|521119508|FG003|Overall Study|Protocol deviation|0|||
144523695|NCT04908722|521119509|FG004|Overall Study|Protocol deviation|0|||
144523696|NCT04908722|521119510|FG005|Overall Study|Protocol deviation|1|||
144523697|NCT04908722|521119505|FG000|Overall Study|Lost to Follow-up|33|||
144523698|NCT04908722|521119506|FG001|Overall Study|Lost to Follow-up|33|||
144523699|NCT04908722|521119507|FG002|Overall Study|Lost to Follow-up|36|||
144523700|NCT04908722|521119508|FG003|Overall Study|Lost to Follow-up|30|||
144523701|NCT04908722|521119509|FG004|Overall Study|Lost to Follow-up|32|||
144523702|NCT04908722|521119510|FG005|Overall Study|Lost to Follow-up|34|||
144523703|NCT04908722|521119505|FG000|Overall Study|Physician Decision|1|||
144523704|NCT04908722|521119506|FG001|Overall Study|Physician Decision|1|||
144523705|NCT04908722|521119507|FG002|Overall Study|Physician Decision|1|||
144597929|NCT01794520|521390896|FG006|Overall Study|Other, not specified|2|||
144597930|NCT00402363|521390897|FG000|Overall Study|Adverse Event|9|||
144597931|NCT00402363|521390898|FG001|Overall Study|Adverse Event|14|||
144400850|NCT00216476|520678122|FG000|Overall Study|Non-compliance|0|||
144400851|NCT00216476|520678123|FG001|Overall Study|Non-compliance|4|||
144400852|NCT00216476|520678124|FG002|Overall Study|Non-compliance|1|||
144400853|NCT00216476|520678122|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
144400854|NCT00216476|520678123|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
144400855|NCT00216476|520678124|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
144523706|NCT04908722|521119508|FG003|Overall Study|Physician Decision|2|||
144523707|NCT04908722|521119509|FG004|Overall Study|Physician Decision|0|||
144400856|NCT00216476|520678122|FG000|Overall Study|Administrative Reasons|1|||
144400857|NCT00216476|520678123|FG001|Overall Study|Administrative Reasons|1|||
144400858|NCT00216476|520678124|FG002|Overall Study|Administrative Reasons|0|||
144400859|NCT00216476|520678122|FG000|Overall Study|Protocol Deviation|5|||
144523708|NCT04908722|521119510|FG005|Overall Study|Physician Decision|0|||
144597932|NCT00402363|521390899|FG002|Overall Study|Adverse Event|2|||
144400860|NCT00216476|520678123|FG001|Overall Study|Protocol Deviation|1|||
144400861|NCT00216476|520678124|FG002|Overall Study|Protocol Deviation|0|||
144400862|NCT00216476|520678122|FG000|Overall Study|Patient Moved|2|||
144400863|NCT00216476|520678123|FG001|Overall Study|Patient Moved|2|||
144400864|NCT00216476|520678124|FG002|Overall Study|Patient Moved|0|||
144400865|NCT00538291|520678125|FG000|Overall Study|Adverse Event|2|||
144400866|NCT00538291|520678125|FG000|Overall Study|Withdrawal by Subject|1|||
144400867|NCT00694707|520678126|FG000|Overall Study|Did Not Receive Treatment|0|||
144400868|NCT00694707|520678127|FG001|Overall Study|Did Not Receive Treatment|0|||
144400869|NCT00694707|520678128|FG002|Overall Study|Did Not Receive Treatment|1|||
144400870|NCT00694707|520678129|FG003|Overall Study|Did Not Receive Treatment|1|||
144400871|NCT00694707|520678130|FG004|Overall Study|Did Not Receive Treatment|1|||
144400872|NCT00694707|520678126|FG000|Overall Study|Adverse Event|22|||
144400873|NCT00694707|520678127|FG001|Overall Study|Adverse Event|14|||
144400874|NCT00694707|520678128|FG002|Overall Study|Adverse Event|8|||
144400875|NCT00694707|520678129|FG003|Overall Study|Adverse Event|12|||
144400876|NCT00694707|520678130|FG004|Overall Study|Adverse Event|13|||
144400877|NCT00694707|520678126|FG000|Overall Study|Insufficient Therapeutic Response|33|||
144400878|NCT00694707|520678127|FG001|Overall Study|Insufficient Therapeutic Response|18|||
144400879|NCT00694707|520678128|FG002|Overall Study|Insufficient Therapeutic Response|17|||
144400880|NCT00694707|520678129|FG003|Overall Study|Insufficient Therapeutic Response|15|||
144400881|NCT00694707|520678130|FG004|Overall Study|Insufficient Therapeutic Response|10|||
144400882|NCT00694707|520678126|FG000|Overall Study|Protocol Violation|1|||
144400883|NCT00694707|520678127|FG001|Overall Study|Protocol Violation|2|||
144400884|NCT00694707|520678128|FG002|Overall Study|Protocol Violation|1|||
144400885|NCT00694707|520678129|FG003|Overall Study|Protocol Violation|3|||
144400886|NCT00694707|520678130|FG004|Overall Study|Protocol Violation|1|||
144400887|NCT00694707|520678126|FG000|Overall Study|Withdrawal of Consent|14|||
144400888|NCT00694707|520678127|FG001|Overall Study|Withdrawal of Consent|18|||
144400889|NCT00694707|520678128|FG002|Overall Study|Withdrawal of Consent|22|||
144400890|NCT00694707|520678129|FG003|Overall Study|Withdrawal of Consent|16|||
144400891|NCT00694707|520678130|FG004|Overall Study|Withdrawal of Consent|15|||
144400892|NCT00694707|520678126|FG000|Overall Study|Lost to Follow-up|0|||
144400893|NCT00694707|520678127|FG001|Overall Study|Lost to Follow-up|1|||
144400894|NCT00694707|520678128|FG002|Overall Study|Lost to Follow-up|2|||
144400895|NCT00694707|520678129|FG003|Overall Study|Lost to Follow-up|0|||
144400896|NCT00694707|520678130|FG004|Overall Study|Lost to Follow-up|0|||
144400897|NCT00694707|520678126|FG000|Overall Study|Jeopardizing Parole Status|1|||
144400898|NCT00694707|520678127|FG001|Overall Study|Jeopardizing Parole Status|0|||
144400899|NCT00694707|520678128|FG002|Overall Study|Jeopardizing Parole Status|0|||
144400900|NCT00694707|520678129|FG003|Overall Study|Jeopardizing Parole Status|0|||
144400901|NCT00694707|520678130|FG004|Overall Study|Jeopardizing Parole Status|0|||
144400902|NCT00694707|520678126|FG000|Overall Study|Death in the Family|1|||
144400903|NCT00694707|520678127|FG001|Overall Study|Death in the Family|0|||
144400904|NCT00694707|520678128|FG002|Overall Study|Death in the Family|0|||
144400905|NCT00694707|520678129|FG003|Overall Study|Death in the Family|0|||
144400906|NCT00694707|520678130|FG004|Overall Study|Death in the Family|0|||
144400907|NCT00694707|520678126|FG000|Overall Study|Arrest by Police|0|||
144400908|NCT00694707|520678127|FG001|Overall Study|Arrest by Police|1|||
144400909|NCT00694707|520678128|FG002|Overall Study|Arrest by Police|0|||
144400910|NCT00694707|520678129|FG003|Overall Study|Arrest by Police|0|||
144400911|NCT00694707|520678130|FG004|Overall Study|Arrest by Police|0|||
144523709|NCT04908722|521119505|FG000|Overall Study|Death|1|||
144523710|NCT04908722|521119506|FG001|Overall Study|Death|0|||
144523711|NCT04908722|521119507|FG002|Overall Study|Death|0|||
144249881|NCT03053427|520111788|FG000|Overall Study|Lack of Efficacy|1|||
144249882|NCT03053427|520111789|FG001|Overall Study|Lack of Efficacy|3|||
144400912|NCT00694707|520678126|FG000|Overall Study|Administrative Reasons|0|||
144400913|NCT00694707|520678127|FG001|Overall Study|Administrative Reasons|1|||
144400914|NCT00694707|520678128|FG002|Overall Study|Administrative Reasons|0|||
144400915|NCT00694707|520678129|FG003|Overall Study|Administrative Reasons|2|||
144400916|NCT00694707|520678130|FG004|Overall Study|Administrative Reasons|0|||
144400917|NCT00694707|520678126|FG000|Overall Study|Notification of Past Head Injury|0|||
144400918|NCT00694707|520678127|FG001|Overall Study|Notification of Past Head Injury|0|||
144400919|NCT00694707|520678128|FG002|Overall Study|Notification of Past Head Injury|0|||
144400920|NCT00694707|520678129|FG003|Overall Study|Notification of Past Head Injury|1|||
144400921|NCT00694707|520678130|FG004|Overall Study|Notification of Past Head Injury|0|||
144400922|NCT01904058|520678137|FG000|Overall Study|Adverse Event|2|||
144400923|NCT01904058|520678138|FG001|Overall Study|Adverse Event|0|||
144400924|NCT01904058|520678139|FG002|Overall Study|Adverse Event|0|||
144249883|NCT03053427|520111788|FG000|Overall Study|Lost to Follow-up|2|||
144400925|NCT01904058|520678140|FG003|Overall Study|Adverse Event|0|||
144400926|NCT01904058|520678137|FG000|Overall Study|Withdrawal by Subject|1|||
144400927|NCT01904058|520678138|FG001|Overall Study|Withdrawal by Subject|0|||
144400928|NCT01904058|520678139|FG002|Overall Study|Withdrawal by Subject|1|||
144400929|NCT01904058|520678140|FG003|Overall Study|Withdrawal by Subject|0|||
144400930|NCT01904058|520678137|FG000|Overall Study|Pregnancy|0|||
144523712|NCT04908722|521119508|FG003|Overall Study|Death|0|||
144597933|NCT00402363|521390900|FG003|Overall Study|Adverse Event|2|||
144597934|NCT00402363|521390897|FG000|Overall Study|Withdrew Consent|10|||
144597935|NCT00402363|521390898|FG001|Overall Study|Withdrew Consent|5|||
144597936|NCT00402363|521390899|FG002|Overall Study|Withdrew Consent|2|||
144597937|NCT00402363|521390900|FG003|Overall Study|Withdrew Consent|1|||
144597938|NCT00402363|521390897|FG000|Overall Study|Protocol Violation|3|||
144597939|NCT00402363|521390898|FG001|Overall Study|Protocol Violation|5|||
144597940|NCT00402363|521390899|FG002|Overall Study|Protocol Violation|0|||
144597941|NCT00402363|521390900|FG003|Overall Study|Protocol Violation|3|||
144597942|NCT00402363|521390897|FG000|Overall Study|Lost to Follow-up|5|||
144597943|NCT00402363|521390898|FG001|Overall Study|Lost to Follow-up|4|||
144597944|NCT00402363|521390899|FG002|Overall Study|Lost to Follow-up|0|||
144597945|NCT00402363|521390900|FG003|Overall Study|Lost to Follow-up|2|||
144597946|NCT00402363|521390897|FG000|Overall Study|"Captured as Other"|6|||
144597947|NCT00402363|521390898|FG001|Overall Study|"Captured as Other"|2|||
144597948|NCT00402363|521390899|FG002|Overall Study|"Captured as Other"|2|||
144597949|NCT00402363|521390900|FG003|Overall Study|"Captured as Other"|2|||
144597950|NCT00753272|521390916|FG000|Overall Study|Adverse Event|878|||
144597951|NCT00753272|521390917|FG001|Overall Study|Adverse Event|869|||
144597952|NCT00753272|521390916|FG000|Overall Study|Protocol Violation|28|||
144597953|NCT00753272|521390917|FG001|Overall Study|Protocol Violation|46|||
144597954|NCT00753272|521390916|FG000|Overall Study|Withdrawal by Subject|2481|||
144597955|NCT00753272|521390917|FG001|Overall Study|Withdrawal by Subject|2407|||
144597956|NCT00753272|521390916|FG000|Overall Study|Lost to Follow-up|491|||
144597957|NCT00753272|521390917|FG001|Overall Study|Lost to Follow-up|497|||
144597958|NCT00753272|521390916|FG000|Overall Study|Other|1104|||
144597959|NCT00753272|521390917|FG001|Overall Study|Other|1088|||
144597960|NCT00971243|521390918|FG000|Double Blind Period|Adverse Event|2|||
144597961|NCT00971243|521390919|FG001|Double Blind Period|Adverse Event|3|||
144597962|NCT00971243|521390920|FG002|Double Blind Period|Adverse Event|2|||
144597963|NCT00971243|521390921|FG003|Double Blind Period|Adverse Event|2|||
144597964|NCT00971243|521390922|FG004|Double Blind Period|Adverse Event|3|||
144597965|NCT00971243|521390918|FG000|Double Blind Period|Lost to Follow-up|0|||
144597966|NCT00971243|521390919|FG001|Double Blind Period|Lost to Follow-up|1|||
144597967|NCT00971243|521390920|FG002|Double Blind Period|Lost to Follow-up|1|||
144597968|NCT00971243|521390921|FG003|Double Blind Period|Lost to Follow-up|0|||
144597969|NCT00971243|521390922|FG004|Double Blind Period|Lost to Follow-up|1|||
144597970|NCT00971243|521390918|FG000|Double Blind Period|Physician Decision|10|||
144597971|NCT00971243|521390919|FG001|Double Blind Period|Physician Decision|6|||
144597972|NCT00971243|521390920|FG002|Double Blind Period|Physician Decision|7|||
144597973|NCT00971243|521390921|FG003|Double Blind Period|Physician Decision|6|||
144597974|NCT00971243|521390922|FG004|Double Blind Period|Physician Decision|7|||
144597975|NCT00971243|521390918|FG000|Double Blind Period|Protocol Violation|2|||
144597976|NCT00971243|521390919|FG001|Double Blind Period|Protocol Violation|0|||
144597977|NCT00971243|521390920|FG002|Double Blind Period|Protocol Violation|3|||
144597978|NCT00971243|521390921|FG003|Double Blind Period|Protocol Violation|2|||
144597979|NCT00971243|521390922|FG004|Double Blind Period|Protocol Violation|2|||
144597980|NCT00971243|521390918|FG000|Double Blind Period|Withdrawal by Subject|4|||
144597981|NCT00971243|521390919|FG001|Double Blind Period|Withdrawal by Subject|1|||
144597982|NCT00971243|521390920|FG002|Double Blind Period|Withdrawal by Subject|4|||
144597983|NCT00971243|521390921|FG003|Double Blind Period|Withdrawal by Subject|4|||
144597984|NCT00971243|521390922|FG004|Double Blind Period|Withdrawal by Subject|4|||
144597985|NCT00971243|521390918|FG000|Double Blind Period|Other reasons|1|||
144597986|NCT00971243|521390919|FG001|Double Blind Period|Other reasons|0|||
144597987|NCT00971243|521390920|FG002|Double Blind Period|Other reasons|2|||
144597988|NCT00971243|521390921|FG003|Double Blind Period|Other reasons|0|||
144597989|NCT00971243|521390922|FG004|Double Blind Period|Other reasons|1|||
144597990|NCT00971243|521390918|FG000|Open-label Period|Adverse Event|1|||
144597991|NCT00971243|521390919|FG001|Open-label Period|Adverse Event|0|||
144597992|NCT00971243|521390920|FG002|Open-label Period|Adverse Event|1|||
144597993|NCT00971243|521390921|FG003|Open-label Period|Adverse Event|1|||
144597994|NCT00971243|521390922|FG004|Open-label Period|Adverse Event|0|||
144597995|NCT00971243|521390918|FG000|Open-label Period|Physician Decision|5|||
144597996|NCT00971243|521390919|FG001|Open-label Period|Physician Decision|9|||
144597997|NCT00971243|521390920|FG002|Open-label Period|Physician Decision|3|||
144597998|NCT00971243|521390921|FG003|Open-label Period|Physician Decision|7|||
144597999|NCT00971243|521390922|FG004|Open-label Period|Physician Decision|2|||
144598000|NCT00971243|521390918|FG000|Open-label Period|Protocol Violation|1|||
144598001|NCT00971243|521390919|FG001|Open-label Period|Protocol Violation|1|||
144722367|NCT03679741|521838693|FG001|Period 1|No longer meet eligibility criteria|0|||
144598002|NCT00971243|521390920|FG002|Open-label Period|Protocol Violation|1|||
144598003|NCT00971243|521390921|FG003|Open-label Period|Protocol Violation|0|||
144598004|NCT00971243|521390922|FG004|Open-label Period|Protocol Violation|1|||
144598005|NCT00971243|521390918|FG000|Open-label Period|Withdrawal by Subject|1|||
144598006|NCT00971243|521390919|FG001|Open-label Period|Withdrawal by Subject|0|||
144598007|NCT00971243|521390920|FG002|Open-label Period|Withdrawal by Subject|0|||
144598008|NCT00971243|521390921|FG003|Open-label Period|Withdrawal by Subject|2|||
144598009|NCT00971243|521390922|FG004|Open-label Period|Withdrawal by Subject|1|||
144400931|NCT01904058|520678138|FG001|Overall Study|Pregnancy|0|||
144400932|NCT01904058|520678139|FG002|Overall Study|Pregnancy|0|||
144400933|NCT01904058|520678140|FG003|Overall Study|Pregnancy|1|||
144400934|NCT04810481|520678144|FG000|Overall Study|Disqualified data sets|10|||
144400935|NCT04810481|520678145|FG001|Overall Study|Disqualified data sets|28|||
144400936|NCT03096483|520678148|FG000|Overall Study|Withdrawal by site|1|||
144400937|NCT02046733|520678150|FG000|Overall Study|never initiated 'treatment visits'|6|||
144400938|NCT02046733|520678151|FG001|Overall Study|never initiated 'treatment visits'|0|||
144400939|NCT02905149|520678155|FG000|Overall Study|Lost to Follow-up|2|||
144400940|NCT02905149|520678156|FG001|Overall Study|Lost to Follow-up|0|||
144400941|NCT02019277|520678157|FG000|Overall Study|Withdrawal by Subject|3|||
144400942|NCT02019277|520678157|FG000|Overall Study|Death|7|||
144400943|NCT02019277|520678157|FG000|Overall Study|Did no Cooperate|1|||
144400944|NCT02019277|520678157|FG000|Overall Study|Adverse Event|1|||
144400945|NCT01268150|520678158|FG000|Treatment Phase|Progression of disease|18|||
144400946|NCT01268150|520678158|FG000|Treatment Phase|Adverse Event|3|||
144400947|NCT01268150|520678158|FG000|Treatment Phase|Withdrawal by Subject|3|||
144400948|NCT01268150|520678158|FG000|Treatment Phase|Other|4|||
144400949|NCT01268150|520678158|FG000|Extension Phase|Adverse Event|3|||
144400950|NCT01268150|520678158|FG000|Extension Phase|Disease progression|18|||
144400951|NCT01268150|520678158|FG000|Extension Phase|Other|6|||
144400952|NCT00395733|520678160|FG000|Period 2|Withdrawal by Subject|1|||
144400953|NCT00395733|520678161|FG001|Period 2|Withdrawal by Subject|2|||
144400954|NCT00395733|520678160|FG000|Period 2|Protocol Violation|0|||
144400955|NCT00395733|520678161|FG001|Period 2|Protocol Violation|1|||
144400956|NCT00395733|520678160|FG000|Period 2|Adverse Event|0|||
144400957|NCT00395733|520678161|FG001|Period 2|Adverse Event|2|||
144400958|NCT00395733|520678160|FG000|Period 2|Technical problems|1|||
144400959|NCT00395733|520678161|FG001|Period 2|Technical problems|0|||
144400960|NCT02808650|520678165|FG000|Overall Study|Death|0|||
144400961|NCT02808650|520678166|FG001|Overall Study|Death|0|||
144400962|NCT02808650|520678167|FG002|Overall Study|Death|0|||
144400963|NCT02808650|520678168|FG003|Overall Study|Death|0|||
144400964|NCT02808650|520678169|FG004|Overall Study|Death|1|||
144400965|NCT02808650|520678165|FG000|Overall Study|Lack of Efficacy|5|||
144400966|NCT02808650|520678166|FG001|Overall Study|Lack of Efficacy|5|||
144400967|NCT02808650|520678167|FG002|Overall Study|Lack of Efficacy|6|||
144400968|NCT02808650|520678168|FG003|Overall Study|Lack of Efficacy|5|||
144400969|NCT02808650|520678169|FG004|Overall Study|Lack of Efficacy|4|||
144400970|NCT02808650|520678165|FG000|Overall Study|Physician Decision|1|||
144523713|NCT04908722|521119509|FG004|Overall Study|Death|0|||
144523714|NCT04908722|521119510|FG005|Overall Study|Death|1|||
144523715|NCT04908722|521119505|FG000|Overall Study|Withdrawal by Subject|12|||
144523716|NCT04908722|521119506|FG001|Overall Study|Withdrawal by Subject|8|||
144523717|NCT04908722|521119507|FG002|Overall Study|Withdrawal by Subject|7|||
144523718|NCT04908722|521119508|FG003|Overall Study|Withdrawal by Subject|6|||
144523719|NCT04908722|521119509|FG004|Overall Study|Withdrawal by Subject|12|||
144523720|NCT04908722|521119510|FG005|Overall Study|Withdrawal by Subject|14|||
144523721|NCT04908722|521119505|FG000|Overall Study|Other|3|||
144523722|NCT04908722|521119506|FG001|Overall Study|Other|1|||
144523723|NCT04908722|521119507|FG002|Overall Study|Other|3|||
144523724|NCT04908722|521119508|FG003|Overall Study|Other|2|||
144523725|NCT04908722|521119509|FG004|Overall Study|Other|4|||
144523726|NCT04908722|521119510|FG005|Overall Study|Other|1|||
144523727|NCT04908722|521119505|FG000|Overall Study|Initiated prohibited medication|0|||
144523728|NCT04908722|521119506|FG001|Overall Study|Initiated prohibited medication|0|||
144523729|NCT04908722|521119507|FG002|Overall Study|Initiated prohibited medication|0|||
144523730|NCT04908722|521119508|FG003|Overall Study|Initiated prohibited medication|1|||
144523731|NCT04908722|521119509|FG004|Overall Study|Initiated prohibited medication|0|||
144523732|NCT04908722|521119510|FG005|Overall Study|Initiated prohibited medication|1|||
144523733|NCT04908722|521119505|FG000|Overall Study|Randomized but not vaccinated|3|||
144523734|NCT04908722|521119506|FG001|Overall Study|Randomized but not vaccinated|1|||
144523735|NCT04908722|521119507|FG002|Overall Study|Randomized but not vaccinated|2|||
144523736|NCT04908722|521119508|FG003|Overall Study|Randomized but not vaccinated|2|||
144400971|NCT02808650|520678166|FG001|Overall Study|Physician Decision|1|||
144400972|NCT02808650|520678167|FG002|Overall Study|Physician Decision|0|||
144400973|NCT02808650|520678168|FG003|Overall Study|Physician Decision|0|||
144400974|NCT02808650|520678169|FG004|Overall Study|Physician Decision|0|||
144400975|NCT02808650|520678165|FG000|Overall Study|Withdrawal by Subject|0|||
144400976|NCT02808650|520678166|FG001|Overall Study|Withdrawal by Subject|0|||
144400977|NCT02808650|520678167|FG002|Overall Study|Withdrawal by Subject|0|||
144400978|NCT02808650|520678168|FG003|Overall Study|Withdrawal by Subject|1|||
144400979|NCT02808650|520678169|FG004|Overall Study|Withdrawal by Subject|1|||
144400980|NCT01672736|520678173|FG000|Overall Study|Available drug expired on 31 May 16|3|||
144523737|NCT04908722|521119509|FG004|Overall Study|Randomized but not vaccinated|3|||
144523738|NCT04908722|521119510|FG005|Overall Study|Randomized but not vaccinated|4|||
144523739|NCT05647304|521119512|FG000|Overall Study|Withdrawal by Subject|1|||
144523740|NCT05647304|521119513|FG001|Overall Study|Withdrawal by Subject|0|||
144523741|NCT03544281|521119514|FG000|Main Study Phase|Death|3|||
144400981|NCT02853344|520678176|FG000|Overall Study|Lost to Follow-up|1|||
144400982|NCT02853344|520678177|FG001|Overall Study|Lost to Follow-up|1|||
144400983|NCT02853344|520678176|FG000|Overall Study|Withdrawal by Subject|2|||
144400984|NCT02853344|520678177|FG001|Overall Study|Withdrawal by Subject|4|||
144400985|NCT02853344|520678176|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
144400986|NCT02853344|520678177|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
144400987|NCT02853344|520678176|FG000|Overall Study|Death|70|||
144400988|NCT02853344|520678177|FG001|Overall Study|Death|112|||
144400989|NCT04251273|520678178|FG000|Overall Study|Lost to Follow-up|331|||
144400990|NCT04251273|520678179|FG001|Overall Study|Lost to Follow-up|290|||
144400991|NCT00810693|520678180|FG000|Treatment Period|Adverse Event|8|||
144400992|NCT00810693|520678181|FG001|Treatment Period|Adverse Event|1|||
144400993|NCT00810693|520678182|FG002|Treatment Period|Adverse Event|7|||
144400994|NCT00810693|520678180|FG000|Treatment Period|Death|0|||
144400995|NCT00810693|520678181|FG001|Treatment Period|Death|1|||
144400996|NCT00810693|520678182|FG002|Treatment Period|Death|2|||
144400997|NCT00810693|520678180|FG000|Treatment Period|Lack of Efficacy|0|||
144400998|NCT00810693|520678181|FG001|Treatment Period|Lack of Efficacy|0|||
144400999|NCT00810693|520678182|FG002|Treatment Period|Lack of Efficacy|1|||
144401000|NCT00810693|520678180|FG000|Treatment Period|Lost to Follow-up|1|||
144401001|NCT00810693|520678181|FG001|Treatment Period|Lost to Follow-up|0|||
144401002|NCT00810693|520678182|FG002|Treatment Period|Lost to Follow-up|0|||
144401003|NCT00810693|520678180|FG000|Treatment Period|Non-compliance|1|||
144401004|NCT00810693|520678181|FG001|Treatment Period|Non-compliance|0|||
144401005|NCT00810693|520678182|FG002|Treatment Period|Non-compliance|0|||
144401006|NCT00810693|520678180|FG000|Treatment Period|Protocol Violation|1|||
144401007|NCT00810693|520678181|FG001|Treatment Period|Protocol Violation|2|||
144401008|NCT00810693|520678182|FG002|Treatment Period|Protocol Violation|2|||
144401009|NCT00810693|520678180|FG000|Treatment Period|Withdrawal by Subject|6|||
144401010|NCT00810693|520678181|FG001|Treatment Period|Withdrawal by Subject|2|||
144401011|NCT00810693|520678182|FG002|Treatment Period|Withdrawal by Subject|3|||
144401012|NCT00810693|520678180|FG000|Treatment Period|Not treated|0|||
144401013|NCT00810693|520678181|FG001|Treatment Period|Not treated|1|||
144523742|NCT03544281|521119515|FG001|Main Study Phase|Death|2|||
144523743|NCT03544281|521119516|FG002|Main Study Phase|Death|6|||
144523744|NCT03544281|521119517|FG003|Main Study Phase|Death|8|||
144523745|NCT03544281|521119518|FG004|Main Study Phase|Death|4|||
144523746|NCT03544281|521119519|FG005|Main Study Phase|Death|2|||
144523747|NCT03544281|521119520|FG006|Main Study Phase|Death|4|||
144523748|NCT03544281|521119521|FG007|Main Study Phase|Death|5|||
144523749|NCT03544281|521119522|FG008|Main Study Phase|Death|5|||
144523750|NCT03544281|521119523|FG009|Main Study Phase|Death|8|||
144598010|NCT00971243|521390918|FG000|Open-label Period|Other reason|0|||
144598011|NCT00971243|521390919|FG001|Open-label Period|Other reason|0|||
144598012|NCT00971243|521390920|FG002|Open-label Period|Other reason|0|||
144598013|NCT00971243|521390921|FG003|Open-label Period|Other reason|0|||
144598014|NCT00971243|521390922|FG004|Open-label Period|Other reason|2|||
144598015|NCT00803270|521390923|FG000|Overall Study|Lost to Follow-up|1|||
144598016|NCT00803270|521390924|FG001|Overall Study|Lost to Follow-up|2|||
144598017|NCT01966471|521390927|FG000|Overall Study|Death|44|||
144598018|NCT01966471|521390928|FG001|Overall Study|Death|56|||
144598019|NCT01966471|521390927|FG000|Overall Study|Lost to Follow-up|46|||
144598020|NCT01966471|521390928|FG001|Overall Study|Lost to Follow-up|39|||
144598021|NCT01966471|521390927|FG000|Overall Study|Various reasons|4|||
144598022|NCT01966471|521390928|FG001|Overall Study|Various reasons|4|||
144598023|NCT01966471|521390927|FG000|Overall Study|Physician Decision|7|||
144598024|NCT01966471|521390928|FG001|Overall Study|Physician Decision|5|||
144598025|NCT01966471|521390927|FG000|Overall Study|Study Terminated By Sponsor|758|||
144598026|NCT01966471|521390928|FG001|Overall Study|Study Terminated By Sponsor|773|||
144249884|NCT03053427|520111789|FG001|Overall Study|Lost to Follow-up|2|||
144598027|NCT01966471|521390927|FG000|Overall Study|Withdrawal by Subject|59|||
144598028|NCT01966471|521390928|FG001|Overall Study|Withdrawal by Subject|51|||
144249885|NCT03053427|520111788|FG000|Overall Study|Worsening of the target disease|0|||
144401014|NCT00810693|520678182|FG002|Treatment Period|Not treated|1|||
144401015|NCT00810693|520678180|FG000|Follow-up Period (FUP)|Adverse Event|3|||
144401016|NCT00810693|520678181|FG001|Follow-up Period (FUP)|Adverse Event|1|||
144401017|NCT00810693|520678182|FG002|Follow-up Period (FUP)|Adverse Event|1|||
144401018|NCT00810693|520678180|FG000|Follow-up Period (FUP)|Death|2|||
144401019|NCT00810693|520678181|FG001|Follow-up Period (FUP)|Death|0|||
144401020|NCT00810693|520678182|FG002|Follow-up Period (FUP)|Death|1|||
144401021|NCT00810693|520678180|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
144401022|NCT00810693|520678181|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
144401023|NCT00810693|520678182|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
144401024|NCT00810693|520678180|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
144523751|NCT03544281|521119524|FG010|Main Study Phase|Death|6|||
144523752|NCT03544281|521119525|FG011|Main Study Phase|Death|4|||
144523753|NCT03544281|521119526|FG012|Main Study Phase|Death|0|||
144523754|NCT03544281|521119527|FG013|Main Study Phase|Death|0|||
144598029|NCT00960531|521390929|FG000|Overall Study|Lack of Efficacy|1|||
144598030|NCT00960531|521390930|FG001|Overall Study|Lack of Efficacy|0|||
144598031|NCT00960531|521390931|FG002|Overall Study|Lack of Efficacy|0|||
144598032|NCT00960531|521390932|FG003|Overall Study|Lack of Efficacy|0|||
144598033|NCT00960531|521390933|FG004|Overall Study|Lack of Efficacy|0|||
144598034|NCT00960531|521390934|FG005|Overall Study|Lack of Efficacy|0|||
144598035|NCT00960531|521390935|FG006|Overall Study|Lack of Efficacy|0|||
144598036|NCT00960531|521390936|FG007|Overall Study|Lack of Efficacy|0|||
144598037|NCT00960531|521390937|FG008|Overall Study|Lack of Efficacy|0|||
144598038|NCT00960531|521390938|FG009|Overall Study|Lack of Efficacy|0|||
144598039|NCT00960531|521390929|FG000|Overall Study|Withdrawal by Subject|1|||
144598040|NCT00960531|521390930|FG001|Overall Study|Withdrawal by Subject|0|||
144598041|NCT00960531|521390931|FG002|Overall Study|Withdrawal by Subject|5|||
144598042|NCT00960531|521390932|FG003|Overall Study|Withdrawal by Subject|2|||
144598043|NCT00960531|521390933|FG004|Overall Study|Withdrawal by Subject|0|||
144598044|NCT00960531|521390934|FG005|Overall Study|Withdrawal by Subject|0|||
144598045|NCT00960531|521390935|FG006|Overall Study|Withdrawal by Subject|2|||
144598046|NCT00960531|521390936|FG007|Overall Study|Withdrawal by Subject|0|||
144598047|NCT00960531|521390937|FG008|Overall Study|Withdrawal by Subject|1|||
144598048|NCT00960531|521390938|FG009|Overall Study|Withdrawal by Subject|0|||
144401025|NCT00810693|520678181|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
144401026|NCT00810693|520678182|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
144401027|NCT00810693|520678180|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
144401028|NCT00810693|520678181|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
144401029|NCT00810693|520678182|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
144401030|NCT01033851|520678187|FG000|Overall Study|Withdrawal by Subject|3|||
144401031|NCT01033851|520678188|FG001|Overall Study|Withdrawal by Subject|7|||
144598049|NCT00960531|521390929|FG000|Overall Study|Caregiver Request|2|||
144598050|NCT00960531|521390930|FG001|Overall Study|Caregiver Request|0|||
144598051|NCT00960531|521390931|FG002|Overall Study|Caregiver Request|6|||
144598052|NCT00960531|521390932|FG003|Overall Study|Caregiver Request|5|||
144598053|NCT00960531|521390933|FG004|Overall Study|Caregiver Request|0|||
144598054|NCT00960531|521390934|FG005|Overall Study|Caregiver Request|2|||
144598055|NCT00960531|521390935|FG006|Overall Study|Caregiver Request|3|||
144598056|NCT00960531|521390936|FG007|Overall Study|Caregiver Request|1|||
144598057|NCT00960531|521390937|FG008|Overall Study|Caregiver Request|3|||
144598058|NCT00960531|521390938|FG009|Overall Study|Caregiver Request|0|||
144598059|NCT00960531|521390929|FG000|Overall Study|Investigator Request|0|||
144598060|NCT00960531|521390930|FG001|Overall Study|Investigator Request|0|||
144598061|NCT00960531|521390931|FG002|Overall Study|Investigator Request|1|||
144598062|NCT00960531|521390932|FG003|Overall Study|Investigator Request|0|||
144598063|NCT00960531|521390933|FG004|Overall Study|Investigator Request|0|||
144598064|NCT00960531|521390934|FG005|Overall Study|Investigator Request|0|||
144598065|NCT00960531|521390935|FG006|Overall Study|Investigator Request|0|||
144598066|NCT00960531|521390936|FG007|Overall Study|Investigator Request|0|||
144598067|NCT00960531|521390937|FG008|Overall Study|Investigator Request|0|||
144598068|NCT00960531|521390938|FG009|Overall Study|Investigator Request|0|||
144598069|NCT00960531|521390929|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
144598070|NCT00960531|521390930|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
144598071|NCT00960531|521390931|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
144598072|NCT00960531|521390932|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
144598073|NCT00960531|521390933|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
144598074|NCT00960531|521390934|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
144598075|NCT00960531|521390935|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
144598076|NCT00960531|521390936|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
144598077|NCT00960531|521390937|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
144598078|NCT00960531|521390938|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
144598079|NCT00960531|521390929|FG000|Overall Study|Lost to Follow-up|0|||
144598080|NCT00960531|521390930|FG001|Overall Study|Lost to Follow-up|0|||
144598081|NCT00960531|521390931|FG002|Overall Study|Lost to Follow-up|1|||
144598082|NCT00960531|521390932|FG003|Overall Study|Lost to Follow-up|0|||
144598083|NCT00960531|521390933|FG004|Overall Study|Lost to Follow-up|0|||
144598084|NCT00960531|521390934|FG005|Overall Study|Lost to Follow-up|0|||
144598085|NCT00960531|521390935|FG006|Overall Study|Lost to Follow-up|1|||
144598086|NCT00960531|521390936|FG007|Overall Study|Lost to Follow-up|0|||
144598087|NCT00960531|521390937|FG008|Overall Study|Lost to Follow-up|0|||
144401032|NCT02919696|520678189|FG000|Overall Study|Adverse Event|1|||
144598088|NCT00960531|521390938|FG009|Overall Study|Lost to Follow-up|0|||
144598089|NCT00960531|521390929|FG000|Overall Study|Failed to Return|2|||
144598090|NCT00960531|521390930|FG001|Overall Study|Failed to Return|0|||
144598091|NCT00960531|521390931|FG002|Overall Study|Failed to Return|0|||
144598092|NCT00960531|521390932|FG003|Overall Study|Failed to Return|0|||
144401033|NCT02919696|520678190|FG001|Overall Study|Adverse Event|2|||
144401034|NCT02919696|520678189|FG000|Overall Study|Withdrawal by Subject|2|||
144401035|NCT02919696|520678190|FG001|Overall Study|Withdrawal by Subject|1|||
144598093|NCT00960531|521390933|FG004|Overall Study|Failed to Return|0|||
144598094|NCT00960531|521390934|FG005|Overall Study|Failed to Return|0|||
144598095|NCT00960531|521390935|FG006|Overall Study|Failed to Return|0|||
144598096|NCT00960531|521390936|FG007|Overall Study|Failed to Return|2|||
144401036|NCT02919696|520678189|FG000|Overall Study|Sponsor Decision|1|||
144401037|NCT02919696|520678190|FG001|Overall Study|Sponsor Decision|1|||
144401038|NCT02919696|520678189|FG000|Overall Study|Never Treated|0|||
144401039|NCT02919696|520678190|FG001|Overall Study|Never Treated|1|||
144401040|NCT01346969|520678191|FG000|Overall Study|Withdrawal by Subject|0|||
144401041|NCT01346969|520678192|FG001|Overall Study|Withdrawal by Subject|0|||
144401042|NCT01346969|520678193|FG002|Overall Study|Withdrawal by Subject|1|||
144401043|NCT01346969|520678194|FG003|Overall Study|Withdrawal by Subject|0|||
144401044|NCT01346969|520678191|FG000|Overall Study|Lost to Follow-up|1|||
144401045|NCT01346969|520678192|FG001|Overall Study|Lost to Follow-up|0|||
144401046|NCT01346969|520678193|FG002|Overall Study|Lost to Follow-up|2|||
144401047|NCT01346969|520678194|FG003|Overall Study|Lost to Follow-up|0|||
144401048|NCT01346969|520678191|FG000|Overall Study|Physician Decision|0|||
144401049|NCT01346969|520678192|FG001|Overall Study|Physician Decision|0|||
144401050|NCT01346969|520678193|FG002|Overall Study|Physician Decision|0|||
144401051|NCT01346969|520678194|FG003|Overall Study|Physician Decision|1|||
144401052|NCT01346969|520678191|FG000|Overall Study|Randomized but not treated|1|||
144401053|NCT01346969|520678192|FG001|Overall Study|Randomized but not treated|0|||
144401054|NCT01346969|520678193|FG002|Overall Study|Randomized but not treated|0|||
144401055|NCT01346969|520678194|FG003|Overall Study|Randomized but not treated|0|||
144401056|NCT04815031|520678195|FG000|Overall Study|No adverse event information (missing information)|33|||
144401057|NCT00397215|520678196|FG000|Month 0 (Day 0)|Adverse Event|0|||
144401058|NCT00397215|520678197|FG001|Month 0 (Day 0)|Adverse Event|1|||
144401059|NCT00397215|520678198|FG002|Month 0 (Day 0)|Adverse Event|0|||
144401060|NCT00397215|520678199|FG003|Month 0 (Day 0)|Adverse Event|0|||
144401061|NCT00397215|520678196|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
144401062|NCT00397215|520678197|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
144401063|NCT00397215|520678198|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
144401064|NCT00397215|520678199|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
144401065|NCT00397215|520678196|FG000|Month 0 (Day 0)|Other|4|||
144401066|NCT00397215|520678197|FG001|Month 0 (Day 0)|Other|1|||
144401067|NCT00397215|520678198|FG002|Month 0 (Day 0)|Other|3|||
144401068|NCT00397215|520678199|FG003|Month 0 (Day 0)|Other|3|||
144401069|NCT00397215|520678196|FG000|Month 6 (Day 180)|Adverse Event|0|||
144401070|NCT00397215|520678197|FG001|Month 6 (Day 180)|Adverse Event|3|||
144401071|NCT00397215|520678198|FG002|Month 6 (Day 180)|Adverse Event|2|||
144401072|NCT00397215|520678199|FG003|Month 6 (Day 180)|Adverse Event|0|||
144401073|NCT00397215|520678196|FG000|Month 6 (Day 180)|Other|2|||
144598097|NCT00960531|521390937|FG008|Overall Study|Failed to Return|0|||
144598098|NCT00960531|521390938|FG009|Overall Study|Failed to Return|0|||
144598099|NCT00960531|521390929|FG000|Overall Study|Adverse Event (AE)|2|||
144598100|NCT00960531|521390930|FG001|Overall Study|Adverse Event (AE)|0|||
144598101|NCT00960531|521390931|FG002|Overall Study|Adverse Event (AE)|0|||
144598102|NCT00960531|521390932|FG003|Overall Study|Adverse Event (AE)|0|||
144598103|NCT00960531|521390933|FG004|Overall Study|Adverse Event (AE)|0|||
144598104|NCT00960531|521390934|FG005|Overall Study|Adverse Event (AE)|1|||
144598105|NCT00960531|521390935|FG006|Overall Study|Adverse Event (AE)|2|||
144598106|NCT00960531|521390936|FG007|Overall Study|Adverse Event (AE)|0|||
144598107|NCT00960531|521390937|FG008|Overall Study|Adverse Event (AE)|2|||
144598108|NCT00960531|521390938|FG009|Overall Study|Adverse Event (AE)|0|||
144598109|NCT00960531|521390929|FG000|Overall Study|Reason not Specified|2|||
144598110|NCT00960531|521390930|FG001|Overall Study|Reason not Specified|1|||
144598111|NCT00960531|521390931|FG002|Overall Study|Reason not Specified|13|||
144598112|NCT00960531|521390932|FG003|Overall Study|Reason not Specified|1|||
144598113|NCT00960531|521390933|FG004|Overall Study|Reason not Specified|2|||
144598114|NCT00960531|521390934|FG005|Overall Study|Reason not Specified|0|||
144598115|NCT00960531|521390935|FG006|Overall Study|Reason not Specified|16|||
144598116|NCT00960531|521390936|FG007|Overall Study|Reason not Specified|0|||
144598117|NCT00960531|521390937|FG008|Overall Study|Reason not Specified|8|||
144598118|NCT00960531|521390938|FG009|Overall Study|Reason not Specified|1|||
144598119|NCT00494481|521390939|FG000|Overall Study|Condition under investigation worsened|11|||
144598120|NCT00494481|521390940|FG001|Overall Study|Condition under investigation worsened|13|||
144598121|NCT00494481|521390939|FG000|Overall Study|Adverse Event|15|||
144598122|NCT00494481|521390940|FG001|Overall Study|Adverse Event|11|||
144598123|NCT00494481|521390939|FG000|Overall Study|Other|1|||
144598124|NCT00494481|521390940|FG001|Overall Study|Other|0|||
144598125|NCT00494481|521390939|FG000|Overall Study|Never received IP|2|||
144598126|NCT00494481|521390940|FG001|Overall Study|Never received IP|0|||
144401074|NCT00397215|520678197|FG001|Month 6 (Day 180)|Other|0|||
144401075|NCT00397215|520678198|FG002|Month 6 (Day 180)|Other|3|||
144401076|NCT00397215|520678199|FG003|Month 6 (Day 180)|Other|0|||
144401077|NCT01254630|520678200|FG000|Overall Study|Adverse Event|36|||
144401078|NCT01254630|520678201|FG001|Overall Study|Adverse Event|15|||
144401079|NCT01254630|520678202|FG002|Overall Study|Adverse Event|40|||
144401080|NCT01254630|520678203|FG003|Overall Study|Adverse Event|8|||
144401081|NCT01254630|520678200|FG000|Overall Study|Death|461|||
144598127|NCT01193920|521390941|FG000|Overall Study|Withdrawal by Subject|1|||
144598128|NCT01193920|521390942|FG001|Overall Study|Withdrawal by Subject|0|||
144598129|NCT01193920|521390943|FG002|Overall Study|Withdrawal by Subject|5|||
144401082|NCT01254630|520678201|FG001|Overall Study|Death|151|||
144401083|NCT01254630|520678202|FG002|Overall Study|Death|478|||
144401084|NCT01254630|520678203|FG003|Overall Study|Death|139|||
144401085|NCT01254630|520678200|FG000|Overall Study|Lost to Follow-up|80|||
144401086|NCT01254630|520678201|FG001|Overall Study|Lost to Follow-up|26|||
144401087|NCT01254630|520678202|FG002|Overall Study|Lost to Follow-up|89|||
144401088|NCT01254630|520678203|FG003|Overall Study|Lost to Follow-up|32|||
144401089|NCT01254630|520678200|FG000|Overall Study|Physician Decision|24|||
144401090|NCT01254630|520678201|FG001|Overall Study|Physician Decision|8|||
144401091|NCT01254630|520678202|FG002|Overall Study|Physician Decision|16|||
144401092|NCT01254630|520678203|FG003|Overall Study|Physician Decision|7|||
144401093|NCT01254630|520678200|FG000|Overall Study|Withdrawal by Subject|201|||
144401094|NCT01254630|520678201|FG001|Overall Study|Withdrawal by Subject|94|||
144401095|NCT01254630|520678202|FG002|Overall Study|Withdrawal by Subject|188|||
144401096|NCT01254630|520678203|FG003|Overall Study|Withdrawal by Subject|89|||
144401097|NCT01254630|520678200|FG000|Overall Study|Study terminated by sponsor|0|||
144401098|NCT01254630|520678201|FG001|Overall Study|Study terminated by sponsor|994|||
144401099|NCT01254630|520678202|FG002|Overall Study|Study terminated by sponsor|0|||
144401100|NCT01254630|520678203|FG003|Overall Study|Study terminated by sponsor|1010|||
144401101|NCT01254630|520678200|FG000|Overall Study|Status not recorded|0|||
144401102|NCT01254630|520678201|FG001|Overall Study|Status not recorded|0|||
144401103|NCT01254630|520678202|FG002|Overall Study|Status not recorded|1|||
144401104|NCT01254630|520678203|FG003|Overall Study|Status not recorded|0|||
144401105|NCT02959983|520678204|FG000|Overall Study|Protocol Violation|0|||
144401106|NCT02959983|520678205|FG001|Overall Study|Protocol Violation|1|||
144401107|NCT02959983|520678204|FG000|Overall Study|Lack of Efficacy|0|||
144401108|NCT02959983|520678205|FG001|Overall Study|Lack of Efficacy|1|||
144401109|NCT02959983|520678204|FG000|Overall Study|Lost to Follow-up|12|||
144401110|NCT02959983|520678205|FG001|Overall Study|Lost to Follow-up|9|||
144401111|NCT02959983|520678204|FG000|Overall Study|Other|1|||
144401112|NCT02959983|520678205|FG001|Overall Study|Other|1|||
144401113|NCT02959983|520678204|FG000|Overall Study|Physician Decision|1|||
144401114|NCT02959983|520678205|FG001|Overall Study|Physician Decision|0|||
144401115|NCT02959983|520678204|FG000|Overall Study|Adverse Event|5|||
144401116|NCT02959983|520678205|FG001|Overall Study|Adverse Event|1|||
144401117|NCT02959983|520678204|FG000|Overall Study|Withdrawal by Subject|7|||
144401118|NCT02959983|520678205|FG001|Overall Study|Withdrawal by Subject|12|||
144401119|NCT00484094|520678206|FG000|Overall Study|Discontinued|39|||
144401120|NCT00484094|520678206|FG000|Overall Study|Other|3|||
144401121|NCT02728596|520678207|FG000|Overall Study|Refusal unrelated to adverse event|3|||
144401122|NCT02728596|520678208|FG001|Overall Study|Refusal unrelated to adverse event|6|||
144401123|NCT02728596|520678209|FG002|Overall Study|Refusal unrelated to adverse event|7|||
144401124|NCT02728596|520678210|FG003|Overall Study|Refusal unrelated to adverse event|7|||
144401125|NCT02728596|520678207|FG000|Overall Study|Death|44|||
144401126|NCT02728596|520678208|FG001|Overall Study|Death|42|||
144401127|NCT02728596|520678209|FG002|Overall Study|Death|123|||
144598130|NCT01193920|521390944|FG003|Overall Study|Withdrawal by Subject|1|||
144598131|NCT01193920|521390945|FG004|Overall Study|Withdrawal by Subject|3|||
144598132|NCT01193920|521390946|FG005|Overall Study|Withdrawal by Subject|1|||
144598133|NCT01193920|521390947|FG006|Overall Study|Withdrawal by Subject|3|||
144598134|NCT01193920|521390948|FG007|Overall Study|Withdrawal by Subject|0|||
144598135|NCT01193920|521390949|FG008|Overall Study|Withdrawal by Subject|1|||
144598136|NCT01193920|521390950|FG009|Overall Study|Withdrawal by Subject|0|||
144598137|NCT01193920|521390941|FG000|Overall Study|Lost to Follow-up|1|||
144598138|NCT01193920|521390942|FG001|Overall Study|Lost to Follow-up|0|||
144401128|NCT02728596|520678210|FG003|Overall Study|Death|68|||
144401129|NCT03439657|520678215|FG000|Overall Study|Adverse Event|2|||
144401130|NCT03439657|520678216|FG001|Overall Study|Adverse Event|3|||
144401131|NCT03439657|520678215|FG000|Overall Study|Lost to Follow-up|1|||
144401132|NCT03439657|520678216|FG001|Overall Study|Lost to Follow-up|0|||
144401133|NCT03439657|520678215|FG000|Overall Study|Protocol Violation|1|||
144401134|NCT03439657|520678216|FG001|Overall Study|Protocol Violation|1|||
144401135|NCT03439657|520678215|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
144401136|NCT03439657|520678216|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
144401137|NCT00370071|520678217|FG000|Overall Study|Withdrawal by Subject|2|||
144401138|NCT03553927|520678220|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
144401139|NCT03553927|520678221|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
144401140|NCT03553927|520678220|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
144471959|NCT03217747|520925359|FG006|Overall Study|Lack of Efficacy|10|||
144471960|NCT03217747|520925360|FG007|Overall Study|Lack of Efficacy|4|||
144471961|NCT03217747|520925361|FG008|Overall Study|Lack of Efficacy|2|||
144471962|NCT03217747|520925362|FG009|Overall Study|Lack of Efficacy|7|||
144471963|NCT03217747|520925363|FG010|Overall Study|Lack of Efficacy|3|||
144471964|NCT03217747|520925364|FG011|Overall Study|Lack of Efficacy|1|||
144471965|NCT03217747|520925365|FG012|Overall Study|Lack of Efficacy|3|||
144471966|NCT03217747|520925366|FG013|Overall Study|Lack of Efficacy|1|||
144471967|NCT03217747|520925353|FG000|Overall Study|Withdrawal by Subject|2|||
144471968|NCT03217747|520925354|FG001|Overall Study|Withdrawal by Subject|1|||
144401141|NCT03553927|520678221|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
144401142|NCT01826604|520679525|FG000|Overall Study|Lost to Follow-up|8|||
144401143|NCT01826604|520679526|FG001|Overall Study|Lost to Follow-up|9|||
144401144|NCT01303861|520679540|FG000|Overall Study|Lost to Follow-up|34|||
144401145|NCT01303861|520679541|FG001|Overall Study|Lost to Follow-up|14|||
144401146|NCT01303861|520679542|FG002|Overall Study|Lost to Follow-up|27|||
144401147|NCT01303861|520679543|FG003|Overall Study|Lost to Follow-up|31|||
144401148|NCT01303861|520679540|FG000|Overall Study|Lack of Efficacy|3|||
144401149|NCT01303861|520679541|FG001|Overall Study|Lack of Efficacy|2|||
144401150|NCT01303861|520679542|FG002|Overall Study|Lack of Efficacy|1|||
144401151|NCT01303861|520679543|FG003|Overall Study|Lack of Efficacy|0|||
144401152|NCT01303861|520679540|FG000|Overall Study|Withdrawal by Subject|16|||
144598139|NCT01193920|521390943|FG002|Overall Study|Lost to Follow-up|1|||
144598140|NCT01193920|521390944|FG003|Overall Study|Lost to Follow-up|1|||
144598141|NCT01193920|521390945|FG004|Overall Study|Lost to Follow-up|3|||
144598142|NCT01193920|521390946|FG005|Overall Study|Lost to Follow-up|3|||
144598143|NCT01193920|521390947|FG006|Overall Study|Lost to Follow-up|1|||
144598144|NCT01193920|521390948|FG007|Overall Study|Lost to Follow-up|0|||
144598145|NCT01193920|521390949|FG008|Overall Study|Lost to Follow-up|2|||
144598146|NCT01193920|521390950|FG009|Overall Study|Lost to Follow-up|3|||
144598147|NCT01193920|521390941|FG000|Overall Study|Protocol Violation|1|||
144598148|NCT01193920|521390942|FG001|Overall Study|Protocol Violation|0|||
144598149|NCT01193920|521390943|FG002|Overall Study|Protocol Violation|0|||
144598150|NCT01193920|521390944|FG003|Overall Study|Protocol Violation|0|||
144598151|NCT01193920|521390945|FG004|Overall Study|Protocol Violation|0|||
144598152|NCT01193920|521390946|FG005|Overall Study|Protocol Violation|0|||
144598153|NCT01193920|521390947|FG006|Overall Study|Protocol Violation|0|||
144598154|NCT01193920|521390948|FG007|Overall Study|Protocol Violation|0|||
144598155|NCT01193920|521390949|FG008|Overall Study|Protocol Violation|0|||
144598156|NCT01193920|521390950|FG009|Overall Study|Protocol Violation|0|||
144598157|NCT01193920|521390941|FG000|Overall Study|Death|0|||
144598158|NCT01193920|521390942|FG001|Overall Study|Death|0|||
144598159|NCT01193920|521390943|FG002|Overall Study|Death|0|||
144598160|NCT01193920|521390944|FG003|Overall Study|Death|1|||
144598161|NCT01193920|521390945|FG004|Overall Study|Death|0|||
144598162|NCT01193920|521390946|FG005|Overall Study|Death|0|||
144598163|NCT01193920|521390947|FG006|Overall Study|Death|2|||
144598164|NCT01193920|521390948|FG007|Overall Study|Death|3|||
144598165|NCT01193920|521390949|FG008|Overall Study|Death|2|||
144598166|NCT01193920|521390950|FG009|Overall Study|Death|4|||
144598167|NCT01193920|521390941|FG000|Overall Study|Unable to classify|0|||
144598168|NCT01193920|521390942|FG001|Overall Study|Unable to classify|0|||
144598169|NCT01193920|521390943|FG002|Overall Study|Unable to classify|0|||
144598170|NCT01193920|521390944|FG003|Overall Study|Unable to classify|1|||
144598171|NCT01193920|521390945|FG004|Overall Study|Unable to classify|0|||
144598172|NCT01193920|521390946|FG005|Overall Study|Unable to classify|0|||
144598173|NCT01193920|521390947|FG006|Overall Study|Unable to classify|0|||
144598174|NCT01193920|521390948|FG007|Overall Study|Unable to classify|1|||
144598175|NCT01193920|521390949|FG008|Overall Study|Unable to classify|0|||
144598176|NCT01193920|521390950|FG009|Overall Study|Unable to classify|0|||
144598177|NCT01030198|521390951|FG000|Overall Study|Could not measure efficacy accurately|0|||
144598178|NCT01030198|521390952|FG001|Overall Study|Could not measure efficacy accurately|7|||
144598179|NCT00332189|521390953|FG000|Overall Study|Adverse Event|3|||
144598180|NCT00332189|521390953|FG000|Overall Study|Uncooperative/Noncompliant|3|||
144598181|NCT00332189|521390953|FG000|Overall Study|Withdrawal by Subject|9|||
144401153|NCT01303861|520679541|FG001|Overall Study|Withdrawal by Subject|8|||
144401154|NCT01303861|520679542|FG002|Overall Study|Withdrawal by Subject|8|||
144401155|NCT01303861|520679543|FG003|Overall Study|Withdrawal by Subject|23|||
144598182|NCT00332189|521390953|FG000|Overall Study|Lack of Efficacy|4|||
144401156|NCT01303861|520679540|FG000|Overall Study|Adverse Event|4|||
144401157|NCT01303861|520679541|FG001|Overall Study|Adverse Event|1|||
144401158|NCT01303861|520679542|FG002|Overall Study|Adverse Event|0|||
144401159|NCT01303861|520679543|FG003|Overall Study|Adverse Event|5|||
144598183|NCT00332189|521390953|FG000|Overall Study|Moved out of country|2|||
144598184|NCT02370043|521390954|FG000|Overall Study|Withdrawal by Subject|0|||
144722368|NCT03679741|521838692|FG000|Period 1|Lost to Follow-up|0|||
144598185|NCT02370043|521390955|FG001|Overall Study|Withdrawal by Subject|0|||
144598186|NCT02370043|521390956|FG002|Overall Study|Withdrawal by Subject|0|||
144598187|NCT02370043|521390957|FG003|Overall Study|Withdrawal by Subject|0|||
144722369|NCT03679741|521838693|FG001|Period 1|Lost to Follow-up|1|||
144598188|NCT02370043|521390958|FG004|Overall Study|Withdrawal by Subject|1|||
144598189|NCT02370043|521390959|FG005|Overall Study|Withdrawal by Subject|1|||
144401160|NCT01303861|520679540|FG000|Overall Study|Pregnancy|1|||
144401161|NCT01303861|520679541|FG001|Overall Study|Pregnancy|0|||
144598190|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
144598191|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
144401162|NCT01303861|520679542|FG002|Overall Study|Pregnancy|0|||
144598192|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
144598193|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
144722370|NCT03679741|521838692|FG000|Period 1|Adverse Event|1|||
144598194|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
144598195|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
144598196|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
144598197|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
144598198|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
144598199|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
144598200|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
144598201|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
144598202|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
144598203|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
144598204|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
144598205|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
144598206|NCT01231516|521390960|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
144598207|NCT01231516|521390961|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
144598208|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
144598209|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
144598210|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
144598211|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
144598212|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
144598213|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
144598214|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
144598215|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
144598216|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
144598217|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
144598218|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
144598219|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
144598220|NCT01231516|521390960|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
144598221|NCT01231516|521390961|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
144598222|NCT05266586|521390962|FG000|Overall Study|Adverse Event|2|||
144598223|NCT05266586|521390963|FG001|Overall Study|Adverse Event|2|||
144598224|NCT05266586|521390964|FG002|Overall Study|Adverse Event|1|||
144598225|NCT05266586|521390962|FG000|Overall Study|Withdrawal by Subject|1|||
144598226|NCT05266586|521390963|FG001|Overall Study|Withdrawal by Subject|0|||
144598227|NCT05266586|521390964|FG002|Overall Study|Withdrawal by Subject|1|||
144598228|NCT05266586|521390962|FG000|Overall Study|Non-compliance with study drug|0|||
144598229|NCT05266586|521390963|FG001|Overall Study|Non-compliance with study drug|1|||
144598230|NCT05266586|521390964|FG002|Overall Study|Non-compliance with study drug|0|||
144598231|NCT05266586|521390962|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
144598232|NCT05266586|521390963|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
144598233|NCT05266586|521390964|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
144598234|NCT03707925|521390965|FG000|Overall Study|Inevaluable|1|||
144598235|NCT02876835|521390968|FG000|Treatment Period (51.1 Month)|Other|1|||
144598236|NCT02876835|521390969|FG001|Treatment Period (51.1 Month)|Other|0|||
144598237|NCT02876835|521390968|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
144598238|NCT02876835|521390969|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
144598239|NCT02876835|521390968|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
144598240|NCT02876835|521390969|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
144598241|NCT02876835|521390968|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
144598242|NCT02876835|521390969|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
144598243|NCT05245097|521390970|FG000|Overall Study|Adverse Event|13|||
144598244|NCT05245097|521390971|FG001|Overall Study|Adverse Event|2|||
144598245|NCT05245097|521390970|FG000|Overall Study|Protocol Violation|8|||
144598246|NCT05245097|521390971|FG001|Overall Study|Protocol Violation|6|||
144598247|NCT05245097|521390970|FG000|Overall Study|Withdrawal by Subject|18|||
144598248|NCT05245097|521390971|FG001|Overall Study|Withdrawal by Subject|0|||
144598249|NCT05245097|521390970|FG000|Overall Study|Death|6|||
144598250|NCT05245097|521390971|FG001|Overall Study|Death|7|||
144598251|NCT05245097|521390970|FG000|Overall Study|Physician Decision|6|||
144722371|NCT03679741|521838693|FG001|Period 1|Adverse Event|1|||
144401163|NCT01303861|520679543|FG003|Overall Study|Pregnancy|0|||
144401164|NCT03270644|520679547|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
144401165|NCT03270644|520679547|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
144598252|NCT05245097|521390971|FG001|Overall Study|Physician Decision|0|||
144598253|NCT05245097|521390970|FG000|Overall Study|Relocation|4|||
144598254|NCT05245097|521390971|FG001|Overall Study|Relocation|3|||
144598255|NCT04683731|521390976|FG000|Overall Study|Withdrawal by Subject|1|||
144598256|NCT04683731|521390977|FG001|Overall Study|Withdrawal by Subject|0|||
144401166|NCT01868503|520679548|FG000|Overall Study|Withdrawal by Subject|1|||
144401167|NCT01868503|520679548|FG000|Overall Study|Protocol Violation|1|||
144401168|NCT02476201|520679553|FG000|Overall Study|Unable to program MPP|9|||
144401169|NCT02476201|520679553|FG000|Overall Study|Study echo not performed|5|||
144401170|NCT02476201|520679553|FG000|Overall Study|Adverse Event|4|||
144401171|NCT02476201|520679553|FG000|Overall Study|Death|2|||
144401172|NCT02476201|520679553|FG000|Overall Study|Lost to Follow-up|2|||
144401173|NCT02476201|520679553|FG000|Overall Study|MPP programmed to OFF|2|||
144401174|NCT02476201|520679553|FG000|Overall Study|Withdrawal by Subject|1|||
144401175|NCT02476201|520679553|FG000|Overall Study|Unsuccessful implant|1|||
144401176|NCT00691301|520679554|FG000|Overall Study|Adverse Event|10|||
144523755|NCT03544281|521119528|FG014|Main Study Phase|Death|0|||
144523756|NCT03544281|521119529|FG015|Main Study Phase|Death|0|||
144523757|NCT03544281|521119530|FG016|Main Study Phase|Death|0|||
144523758|NCT03544281|521119531|FG017|Main Study Phase|Death|0|||
144523759|NCT03544281|521119532|FG018|Main Study Phase|Death|0|||
144523760|NCT03544281|521119533|FG019|Main Study Phase|Death|0|||
144523761|NCT03544281|521119534|FG020|Main Study Phase|Death|0|||
144523762|NCT03544281|521119535|FG021|Main Study Phase|Death|0|||
144523763|NCT03544281|521119514|FG000|Main Study Phase|Lost to Follow-up|0|||
144523764|NCT03544281|521119515|FG001|Main Study Phase|Lost to Follow-up|0|||
144523765|NCT03544281|521119516|FG002|Main Study Phase|Lost to Follow-up|0|||
144523766|NCT03544281|521119517|FG003|Main Study Phase|Lost to Follow-up|0|||
144523767|NCT03544281|521119518|FG004|Main Study Phase|Lost to Follow-up|0|||
144523768|NCT03544281|521119519|FG005|Main Study Phase|Lost to Follow-up|0|||
144523769|NCT03544281|521119520|FG006|Main Study Phase|Lost to Follow-up|0|||
144523770|NCT03544281|521119521|FG007|Main Study Phase|Lost to Follow-up|0|||
144523771|NCT03544281|521119522|FG008|Main Study Phase|Lost to Follow-up|0|||
144523772|NCT03544281|521119523|FG009|Main Study Phase|Lost to Follow-up|0|||
144523773|NCT03544281|521119524|FG010|Main Study Phase|Lost to Follow-up|1|||
144523774|NCT03544281|521119525|FG011|Main Study Phase|Lost to Follow-up|0|||
144523775|NCT03544281|521119526|FG012|Main Study Phase|Lost to Follow-up|0|||
144523776|NCT03544281|521119527|FG013|Main Study Phase|Lost to Follow-up|0|||
144523777|NCT03544281|521119528|FG014|Main Study Phase|Lost to Follow-up|0|||
144523778|NCT03544281|521119529|FG015|Main Study Phase|Lost to Follow-up|0|||
144523779|NCT03544281|521119530|FG016|Main Study Phase|Lost to Follow-up|0|||
144523780|NCT03544281|521119531|FG017|Main Study Phase|Lost to Follow-up|0|||
144523781|NCT03544281|521119532|FG018|Main Study Phase|Lost to Follow-up|0|||
144523782|NCT03544281|521119533|FG019|Main Study Phase|Lost to Follow-up|0|||
144523783|NCT03544281|521119534|FG020|Main Study Phase|Lost to Follow-up|0|||
144523784|NCT03544281|521119535|FG021|Main Study Phase|Lost to Follow-up|0|||
144523785|NCT03544281|521119514|FG000|Main Study Phase|Physician Decision|0|||
144523786|NCT03544281|521119515|FG001|Main Study Phase|Physician Decision|0|||
144523787|NCT03544281|521119516|FG002|Main Study Phase|Physician Decision|0|||
144523788|NCT03544281|521119517|FG003|Main Study Phase|Physician Decision|0|||
144523789|NCT03544281|521119518|FG004|Main Study Phase|Physician Decision|0|||
144523790|NCT03544281|521119519|FG005|Main Study Phase|Physician Decision|0|||
144523791|NCT03544281|521119520|FG006|Main Study Phase|Physician Decision|0|||
144523792|NCT03544281|521119521|FG007|Main Study Phase|Physician Decision|1|||
144523793|NCT03544281|521119522|FG008|Main Study Phase|Physician Decision|0|||
144523794|NCT03544281|521119523|FG009|Main Study Phase|Physician Decision|0|||
144523795|NCT03544281|521119524|FG010|Main Study Phase|Physician Decision|0|||
144523796|NCT03544281|521119525|FG011|Main Study Phase|Physician Decision|0|||
144523797|NCT03544281|521119526|FG012|Main Study Phase|Physician Decision|0|||
144523798|NCT03544281|521119527|FG013|Main Study Phase|Physician Decision|0|||
144523799|NCT03544281|521119528|FG014|Main Study Phase|Physician Decision|0|||
144523800|NCT03544281|521119529|FG015|Main Study Phase|Physician Decision|0|||
144523801|NCT03544281|521119530|FG016|Main Study Phase|Physician Decision|0|||
144523802|NCT03544281|521119531|FG017|Main Study Phase|Physician Decision|0|||
144523803|NCT03544281|521119532|FG018|Main Study Phase|Physician Decision|0|||
144523804|NCT03544281|521119533|FG019|Main Study Phase|Physician Decision|0|||
144523805|NCT03544281|521119534|FG020|Main Study Phase|Physician Decision|0|||
144523806|NCT03544281|521119535|FG021|Main Study Phase|Physician Decision|0|||
144523807|NCT03544281|521119514|FG000|Main Study Phase|Withdrawal by Subject|2|||
144401177|NCT00691301|520679554|FG000|Overall Study|Death|2|||
144401178|NCT00691301|520679554|FG000|Overall Study|Lack of Efficacy|32|||
144523808|NCT03544281|521119515|FG001|Main Study Phase|Withdrawal by Subject|0|||
144401179|NCT00691301|520679554|FG000|Overall Study|Withdrawal by Subject|4|||
144401180|NCT00691301|520679554|FG000|Overall Study|Concurrent illness|2|||
144523809|NCT03544281|521119516|FG002|Main Study Phase|Withdrawal by Subject|1|||
144523810|NCT03544281|521119517|FG003|Main Study Phase|Withdrawal by Subject|2|||
144523811|NCT03544281|521119518|FG004|Main Study Phase|Withdrawal by Subject|0|||
144523812|NCT03544281|521119519|FG005|Main Study Phase|Withdrawal by Subject|0|||
144523813|NCT03544281|521119520|FG006|Main Study Phase|Withdrawal by Subject|0|||
144523814|NCT03544281|521119521|FG007|Main Study Phase|Withdrawal by Subject|0|||
144523815|NCT03544281|521119522|FG008|Main Study Phase|Withdrawal by Subject|2|||
144523816|NCT03544281|521119523|FG009|Main Study Phase|Withdrawal by Subject|3|||
144523817|NCT03544281|521119524|FG010|Main Study Phase|Withdrawal by Subject|0|||
144598257|NCT04683731|521390978|FG002|Overall Study|Withdrawal by Subject|3|||
144401181|NCT00691301|520679554|FG000|Overall Study|other reason|3|||
144401182|NCT00691301|520679554|FG000|Overall Study|Did not initiate study treatment|1|||
144401183|NCT02642029|520679555|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
144401184|NCT02642029|520679556|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
144401185|NCT02642029|520679557|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
144401186|NCT02642029|520679558|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
144401187|NCT02642029|520679559|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
144401188|NCT02642029|520679560|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
144401189|NCT02642029|520679555|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
144401190|NCT02642029|520679556|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
144401191|NCT02642029|520679557|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
144401192|NCT02642029|520679558|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
144401193|NCT02642029|520679559|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
144401194|NCT02642029|520679560|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
144401195|NCT02642029|520679555|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
144401196|NCT02642029|520679556|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
144401197|NCT02642029|520679557|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
144401198|NCT02642029|520679558|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
144401199|NCT02642029|520679559|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
144401200|NCT02642029|520679560|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
144401201|NCT02642029|520679555|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
144401202|NCT02642029|520679556|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
144401203|NCT02642029|520679557|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
144401204|NCT02642029|520679558|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
144401205|NCT02642029|520679559|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
144401206|NCT02642029|520679560|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
144401207|NCT02642029|520679555|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
144401208|NCT02642029|520679556|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
144401209|NCT02642029|520679557|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
144523818|NCT03544281|521119525|FG011|Main Study Phase|Withdrawal by Subject|4|||
144523819|NCT03544281|521119526|FG012|Main Study Phase|Withdrawal by Subject|0|||
144523820|NCT03544281|521119527|FG013|Main Study Phase|Withdrawal by Subject|0|||
144523821|NCT03544281|521119528|FG014|Main Study Phase|Withdrawal by Subject|0|||
144523822|NCT03544281|521119529|FG015|Main Study Phase|Withdrawal by Subject|0|||
144523823|NCT03544281|521119530|FG016|Main Study Phase|Withdrawal by Subject|0|||
144523824|NCT03544281|521119531|FG017|Main Study Phase|Withdrawal by Subject|0|||
144523825|NCT03544281|521119532|FG018|Main Study Phase|Withdrawal by Subject|0|||
144523826|NCT03544281|521119533|FG019|Main Study Phase|Withdrawal by Subject|0|||
144523827|NCT03544281|521119534|FG020|Main Study Phase|Withdrawal by Subject|0|||
144523828|NCT03544281|521119535|FG021|Main Study Phase|Withdrawal by Subject|0|||
144523829|NCT03544281|521119514|FG000|Main Study Phase|Ongoing|3|||
144523830|NCT03544281|521119515|FG001|Main Study Phase|Ongoing|1|||
144523831|NCT03544281|521119516|FG002|Main Study Phase|Ongoing|2|||
144523832|NCT03544281|521119517|FG003|Main Study Phase|Ongoing|4|||
144523833|NCT03544281|521119518|FG004|Main Study Phase|Ongoing|2|||
144523834|NCT03544281|521119519|FG005|Main Study Phase|Ongoing|4|||
144523835|NCT03544281|521119520|FG006|Main Study Phase|Ongoing|4|||
144523836|NCT03544281|521119521|FG007|Main Study Phase|Ongoing|0|||
144523837|NCT03544281|521119522|FG008|Main Study Phase|Ongoing|2|||
144523838|NCT03544281|521119523|FG009|Main Study Phase|Ongoing|2|||
144523839|NCT03544281|521119524|FG010|Main Study Phase|Ongoing|1|||
144523840|NCT03544281|521119525|FG011|Main Study Phase|Ongoing|0|||
144523841|NCT03544281|521119526|FG012|Main Study Phase|Ongoing|0|||
144523842|NCT03544281|521119527|FG013|Main Study Phase|Ongoing|0|||
144523843|NCT03544281|521119528|FG014|Main Study Phase|Ongoing|0|||
144523844|NCT03544281|521119529|FG015|Main Study Phase|Ongoing|0|||
144401210|NCT02642029|520679558|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
144401211|NCT02642029|520679559|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
144401212|NCT02642029|520679560|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
144401213|NCT02642029|520679555|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
144401214|NCT02642029|520679556|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
144523845|NCT03544281|521119530|FG016|Main Study Phase|Ongoing|0|||
144523846|NCT03544281|521119531|FG017|Main Study Phase|Ongoing|0|||
144523847|NCT03544281|521119532|FG018|Main Study Phase|Ongoing|0|||
144523848|NCT03544281|521119533|FG019|Main Study Phase|Ongoing|0|||
144523849|NCT03544281|521119534|FG020|Main Study Phase|Ongoing|0|||
144523850|NCT03544281|521119535|FG021|Main Study Phase|Ongoing|0|||
144722372|NCT03679741|521838692|FG000|Period 1|Withdrawal by Subject|0|||
144523851|NCT03544281|521119514|FG000|Main Study Phase|Investigator Site Closed|0|||
144523852|NCT03544281|521119515|FG001|Main Study Phase|Investigator Site Closed|0|||
144523853|NCT03544281|521119516|FG002|Main Study Phase|Investigator Site Closed|0|||
144523854|NCT03544281|521119517|FG003|Main Study Phase|Investigator Site Closed|0|||
144523855|NCT03544281|521119518|FG004|Main Study Phase|Investigator Site Closed|0|||
144401215|NCT02642029|520679557|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
144401216|NCT02642029|520679558|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
144401217|NCT02642029|520679559|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
144598258|NCT04683731|521390979|FG003|Overall Study|Withdrawal by Subject|2|||
144401218|NCT02642029|520679560|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
144401219|NCT01823146|520679561|FG000|Overall Study|Withdrawal by Subject|0|||
144401220|NCT01823146|520679562|FG001|Overall Study|Withdrawal by Subject|1|||
144401221|NCT01823146|520679561|FG000|Overall Study|Lost to Follow-up|2|||
144401222|NCT01823146|520679562|FG001|Overall Study|Lost to Follow-up|1|||
144401223|NCT00463580|520679564|FG000|Overall Study|Lost to Follow-up|1|||
144401224|NCT00463580|520679565|FG001|Overall Study|Lost to Follow-up|0|||
144401225|NCT00463580|520679564|FG000|Overall Study|Schedule conflict|2|||
144401226|NCT00463580|520679565|FG001|Overall Study|Schedule conflict|0|||
144401227|NCT00463580|520679564|FG000|Overall Study|Medical/psychiatric complications|0|||
144401228|NCT00463580|520679565|FG001|Overall Study|Medical/psychiatric complications|2|||
144401229|NCT00736944|520679566|FG000|Induction|Death|1|||
144401230|NCT00736944|520679566|FG000|Definitive Treatment|Physician Decision|1|||
144401231|NCT01426438|520679567|FG000|Overall Study|Lost to Follow-up|1|||
144401232|NCT01426438|520679568|FG001|Overall Study|Lost to Follow-up|3|||
144401233|NCT01426438|520679567|FG000|Overall Study|Off study Treatment|9|||
144401234|NCT01426438|520679568|FG001|Overall Study|Off study Treatment|3|||
144401235|NCT01426438|520679567|FG000|Overall Study|Poor scan quality|3|||
144401236|NCT01426438|520679568|FG001|Overall Study|Poor scan quality|2|||
144401237|NCT01426438|520679567|FG000|Overall Study|Missed Scan|2|||
144401238|NCT01426438|520679568|FG001|Overall Study|Missed Scan|2|||
144401239|NCT03643575|520679569|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
144401240|NCT03643575|520679570|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
144401241|NCT03643575|520679571|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
144401242|NCT03643575|520679572|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
144401243|NCT03643575|520679573|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
144401244|NCT03643575|520679574|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
144401245|NCT03643575|520679569|FG000|Washout: 7 Days|Adverse Event|1|||
144401246|NCT03643575|520679570|FG001|Washout: 7 Days|Adverse Event|0|||
144401247|NCT03643575|520679571|FG002|Washout: 7 Days|Adverse Event|0|||
144401248|NCT03643575|520679572|FG003|Washout: 7 Days|Adverse Event|0|||
144401249|NCT03643575|520679573|FG004|Washout: 7 Days|Adverse Event|0|||
144401250|NCT03643575|520679574|FG005|Washout: 7 Days|Adverse Event|0|||
144401251|NCT03643575|520679569|FG000|Washout: 7 Days|Non compliance check in|0|||
144401252|NCT03643575|520679570|FG001|Washout: 7 Days|Non compliance check in|1|||
144401253|NCT03643575|520679571|FG002|Washout: 7 Days|Non compliance check in|0|||
144598259|NCT04683731|521390976|FG000|Overall Study|Determined patient was not eligible|3|||
144249886|NCT03053427|520111789|FG001|Overall Study|Worsening of the target disease|1|||
144523856|NCT03544281|521119519|FG005|Main Study Phase|Investigator Site Closed|0|||
144523857|NCT03544281|521119520|FG006|Main Study Phase|Investigator Site Closed|0|||
144523858|NCT03544281|521119521|FG007|Main Study Phase|Investigator Site Closed|0|||
144523859|NCT03544281|521119522|FG008|Main Study Phase|Investigator Site Closed|0|||
144523860|NCT03544281|521119523|FG009|Main Study Phase|Investigator Site Closed|1|||
144523861|NCT03544281|521119524|FG010|Main Study Phase|Investigator Site Closed|0|||
144523862|NCT03544281|521119525|FG011|Main Study Phase|Investigator Site Closed|0|||
144523863|NCT03544281|521119526|FG012|Main Study Phase|Investigator Site Closed|0|||
144523864|NCT03544281|521119527|FG013|Main Study Phase|Investigator Site Closed|0|||
144523865|NCT03544281|521119528|FG014|Main Study Phase|Investigator Site Closed|0|||
144523866|NCT03544281|521119529|FG015|Main Study Phase|Investigator Site Closed|0|||
144523867|NCT03544281|521119530|FG016|Main Study Phase|Investigator Site Closed|0|||
144523868|NCT03544281|521119531|FG017|Main Study Phase|Investigator Site Closed|0|||
144523869|NCT03544281|521119532|FG018|Main Study Phase|Investigator Site Closed|0|||
144523870|NCT03544281|521119533|FG019|Main Study Phase|Investigator Site Closed|0|||
144523871|NCT03544281|521119534|FG020|Main Study Phase|Investigator Site Closed|0|||
144523872|NCT03544281|521119535|FG021|Main Study Phase|Investigator Site Closed|0|||
144523873|NCT03544281|521119514|FG000|Main Study Phase|Did not receive study treatment|0|||
144523874|NCT03544281|521119515|FG001|Main Study Phase|Did not receive study treatment|0|||
144598260|NCT04683731|521390977|FG001|Overall Study|Determined patient was not eligible|3|||
144598261|NCT04683731|521390978|FG002|Overall Study|Determined patient was not eligible|12|||
144249887|NCT03053427|520111788|FG000|Overall Study|Protocol Deviation|3|||
144401254|NCT03643575|520679572|FG003|Washout: 7 Days|Non compliance check in|0|||
144523875|NCT03544281|521119516|FG002|Main Study Phase|Did not receive study treatment|0|||
144401255|NCT03643575|520679573|FG004|Washout: 7 Days|Non compliance check in|0|||
144401256|NCT03643575|520679574|FG005|Washout: 7 Days|Non compliance check in|0|||
144523876|NCT03544281|521119517|FG003|Main Study Phase|Did not receive study treatment|0|||
144523877|NCT03544281|521119518|FG004|Main Study Phase|Did not receive study treatment|0|||
144722373|NCT03679741|521838693|FG001|Period 1|Withdrawal by Subject|1|||
144401257|NCT00131508|520679575|FG000|Overall Study|Disease progression|0|||
144401258|NCT00131508|520679576|FG001|Overall Study|Disease progression|2|||
144401259|NCT00131508|520679575|FG000|Overall Study|Non-Compliance|2|||
144523878|NCT03544281|521119519|FG005|Main Study Phase|Did not receive study treatment|0|||
144401260|NCT00131508|520679576|FG001|Overall Study|Non-Compliance|4|||
144401261|NCT00131508|520679575|FG000|Overall Study|Withdrawal by Subject|1|||
144401262|NCT00131508|520679576|FG001|Overall Study|Withdrawal by Subject|2|||
144401263|NCT01189604|520679577|FG000|Overall Study|Impossible to visit|0|||
144401264|NCT01189604|520679578|FG001|Overall Study|Impossible to visit|0|||
144401265|NCT01189604|520679579|FG002|Overall Study|Impossible to visit|0|||
144598262|NCT04683731|521390979|FG003|Overall Study|Determined patient was not eligible|3|||
144598263|NCT00883051|521390981|FG000|Overall Study|Lost to Follow-up|0|||
144598264|NCT00883051|521390982|FG001|Overall Study|Lost to Follow-up|0|||
144598265|NCT00883051|521390983|FG002|Overall Study|Lost to Follow-up|0|||
144598266|NCT00883051|521390984|FG003|Overall Study|Lost to Follow-up|0|||
144598267|NCT00883051|521390985|FG004|Overall Study|Lost to Follow-up|1|||
144598268|NCT00883051|521390981|FG000|Overall Study|Did not use study medication|24|||
144401266|NCT01189604|520679580|FG003|Overall Study|Impossible to visit|0|||
144401267|NCT01189604|520679581|FG004|Overall Study|Impossible to visit|0|||
144401268|NCT01189604|520679582|FG005|Overall Study|Impossible to visit|1|||
144401269|NCT01189604|520679583|FG006|Overall Study|Impossible to visit|0|||
144401270|NCT01189604|520679577|FG000|Overall Study|Adverse Event|0|||
144401271|NCT01189604|520679578|FG001|Overall Study|Adverse Event|1|||
144401272|NCT01189604|520679579|FG002|Overall Study|Adverse Event|0|||
144401273|NCT01189604|520679580|FG003|Overall Study|Adverse Event|0|||
144401274|NCT01189604|520679581|FG004|Overall Study|Adverse Event|2|||
144401275|NCT01189604|520679582|FG005|Overall Study|Adverse Event|0|||
144401276|NCT01189604|520679583|FG006|Overall Study|Adverse Event|1|||
144401277|NCT01189604|520679577|FG000|Overall Study|Withdrawal by Subject|1|||
144401278|NCT01189604|520679578|FG001|Overall Study|Withdrawal by Subject|0|||
144523879|NCT03544281|521119520|FG006|Main Study Phase|Did not receive study treatment|1|||
144523880|NCT03544281|521119521|FG007|Main Study Phase|Did not receive study treatment|0|||
144523881|NCT03544281|521119522|FG008|Main Study Phase|Did not receive study treatment|0|||
144523882|NCT03544281|521119523|FG009|Main Study Phase|Did not receive study treatment|0|||
144523883|NCT03544281|521119524|FG010|Main Study Phase|Did not receive study treatment|0|||
144401279|NCT01189604|520679579|FG002|Overall Study|Withdrawal by Subject|0|||
144523884|NCT03544281|521119525|FG011|Main Study Phase|Did not receive study treatment|0|||
144523885|NCT03544281|521119526|FG012|Main Study Phase|Did not receive study treatment|0|||
144523886|NCT03544281|521119527|FG013|Main Study Phase|Did not receive study treatment|0|||
144523887|NCT03544281|521119528|FG014|Main Study Phase|Did not receive study treatment|0|||
144523888|NCT03544281|521119529|FG015|Main Study Phase|Did not receive study treatment|0|||
144523889|NCT03544281|521119530|FG016|Main Study Phase|Did not receive study treatment|0|||
144523890|NCT03544281|521119531|FG017|Main Study Phase|Did not receive study treatment|0|||
144523891|NCT03544281|521119532|FG018|Main Study Phase|Did not receive study treatment|0|||
144523892|NCT03544281|521119533|FG019|Main Study Phase|Did not receive study treatment|0|||
144523893|NCT03544281|521119534|FG020|Main Study Phase|Did not receive study treatment|0|||
144523894|NCT03544281|521119535|FG021|Main Study Phase|Did not receive study treatment|0|||
144523895|NCT03544281|521119514|FG000|PACT Phase|Adverse Event|0|||
144523896|NCT03544281|521119515|FG001|PACT Phase|Adverse Event|0|||
144523897|NCT03544281|521119516|FG002|PACT Phase|Adverse Event|0|||
144523898|NCT03544281|521119517|FG003|PACT Phase|Adverse Event|0|||
144523899|NCT03544281|521119518|FG004|PACT Phase|Adverse Event|0|||
144523900|NCT03544281|521119519|FG005|PACT Phase|Adverse Event|0|||
144523901|NCT03544281|521119520|FG006|PACT Phase|Adverse Event|0|||
144523902|NCT03544281|521119521|FG007|PACT Phase|Adverse Event|0|||
144523903|NCT03544281|521119522|FG008|PACT Phase|Adverse Event|0|||
144523904|NCT03544281|521119523|FG009|PACT Phase|Adverse Event|0|||
144523905|NCT03544281|521119524|FG010|PACT Phase|Adverse Event|0|||
144523906|NCT03544281|521119525|FG011|PACT Phase|Adverse Event|0|||
144523907|NCT03544281|521119526|FG012|PACT Phase|Adverse Event|1|||
144523908|NCT03544281|521119527|FG013|PACT Phase|Adverse Event|0|||
144523909|NCT03544281|521119528|FG014|PACT Phase|Adverse Event|0|||
144523910|NCT03544281|521119529|FG015|PACT Phase|Adverse Event|0|||
144523911|NCT03544281|521119530|FG016|PACT Phase|Adverse Event|0|||
144523912|NCT03544281|521119531|FG017|PACT Phase|Adverse Event|1|||
144523913|NCT03544281|521119532|FG018|PACT Phase|Adverse Event|1|||
144598269|NCT00883051|521390982|FG001|Overall Study|Did not use study medication|22|||
144598270|NCT00883051|521390983|FG002|Overall Study|Did not use study medication|29|||
144401280|NCT01189604|520679580|FG003|Overall Study|Withdrawal by Subject|0|||
144523914|NCT03544281|521119533|FG019|PACT Phase|Adverse Event|0|||
144523915|NCT03544281|521119534|FG020|PACT Phase|Adverse Event|0|||
144523916|NCT03544281|521119535|FG021|PACT Phase|Adverse Event|0|||
144523917|NCT04282148|521119536|FG000|Overall Study|Death|7|||
144523918|NCT04282148|521119536|FG000|Overall Study|Withdrawal by Subject|1|||
144523919|NCT04282148|521119536|FG000|Overall Study|Physician Decision|1|||
144722374|NCT03679741|521838692|FG000|Period 2|Adverse Event|2|||
144523920|NCT04938492|521119537|FG000|Overall Study|Lost to Follow-up|17|||
144523921|NCT04938492|521119538|FG001|Overall Study|Lost to Follow-up|18|||
144598271|NCT00883051|521390984|FG003|Overall Study|Did not use study medication|29|||
144401281|NCT01189604|520679581|FG004|Overall Study|Withdrawal by Subject|0|||
144523922|NCT04025554|521119540|FG000|Overall Study|Adverse Event|3|||
144523923|NCT03115476|521119541|FG000|LP0084-1369|Death|1|||
144598272|NCT00883051|521390985|FG004|Overall Study|Did not use study medication|17|||
144598273|NCT01411839|521390988|FG000|Overall Study|Lost to Follow-up|4|||
144598274|NCT01411839|521390989|FG001|Overall Study|Lost to Follow-up|3|||
144598275|NCT03604523|521390990|FG000|Overall Study|Physician Decision|1|||
144598276|NCT03604523|521390991|FG001|Overall Study|Physician Decision|0|||
144598277|NCT00810394|521390998|FG000|Overall Study|Withdrawal by Subject|3|||
144598278|NCT03282240|521390999|FG000|Overall Study|Adverse Event|2|||
144598279|NCT03282240|521391000|FG001|Overall Study|Adverse Event|2|||
144598280|NCT03282240|521391001|FG002|Overall Study|Adverse Event|0|||
144598281|NCT03282240|521390999|FG000|Overall Study|Lost to Follow-up|3|||
144598282|NCT03282240|521391000|FG001|Overall Study|Lost to Follow-up|0|||
144598283|NCT03282240|521391001|FG002|Overall Study|Lost to Follow-up|0|||
144598284|NCT03282240|521390999|FG000|Overall Study|Protocol Deviation|4|||
144598285|NCT03282240|521391000|FG001|Overall Study|Protocol Deviation|1|||
144598286|NCT03282240|521391001|FG002|Overall Study|Protocol Deviation|2|||
144598287|NCT03282240|521390999|FG000|Overall Study|Withdrawal by Subject|1|||
144598288|NCT03282240|521391000|FG001|Overall Study|Withdrawal by Subject|0|||
144598289|NCT03282240|521391001|FG002|Overall Study|Withdrawal by Subject|1|||
144598290|NCT01675479|521391002|FG000|Overall Study|Lost to Follow-up|11|||
144598291|NCT03254485|521391003|FG000|Overall Study|Adverse Event|3|||
144598292|NCT03254485|521391004|FG001|Overall Study|Adverse Event|0|||
144598293|NCT03254485|521391005|FG002|Overall Study|Adverse Event|0|||
144598294|NCT03254485|521391006|FG003|Overall Study|Adverse Event|6|||
144598295|NCT03254485|521391003|FG000|Overall Study|Protocol Violation|6|||
144598296|NCT03254485|521391004|FG001|Overall Study|Protocol Violation|0|||
144598297|NCT03254485|521391005|FG002|Overall Study|Protocol Violation|0|||
144598298|NCT03254485|521391006|FG003|Overall Study|Protocol Violation|2|||
144598299|NCT03254485|521391003|FG000|Overall Study|Withdrawal by Subject|1|||
144598300|NCT03254485|521391004|FG001|Overall Study|Withdrawal by Subject|0|||
144598301|NCT03254485|521391005|FG002|Overall Study|Withdrawal by Subject|0|||
144598302|NCT03254485|521391006|FG003|Overall Study|Withdrawal by Subject|4|||
144598303|NCT03254485|521391003|FG000|Overall Study|Death|0|||
144598304|NCT03254485|521391004|FG001|Overall Study|Death|0|||
144598305|NCT03254485|521391005|FG002|Overall Study|Death|0|||
144598306|NCT03254485|521391006|FG003|Overall Study|Death|1|||
144598307|NCT03254485|521391003|FG000|Overall Study|Lost to Follow-up|1|||
144598308|NCT03254485|521391004|FG001|Overall Study|Lost to Follow-up|0|||
144598309|NCT03254485|521391005|FG002|Overall Study|Lost to Follow-up|0|||
144598310|NCT03254485|521391006|FG003|Overall Study|Lost to Follow-up|0|||
144598311|NCT03254485|521391003|FG000|Overall Study|Other|1|||
144598312|NCT03254485|521391004|FG001|Overall Study|Other|0|||
144722375|NCT03679741|521838693|FG001|Period 2|Adverse Event|1|||
144523924|NCT03115476|521119542|FG001|LP0084-1369|Death|0|||
144523925|NCT03115476|521119543|FG002|LP0084-1369|Death|2|||
144523926|NCT03115476|521119541|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
144523927|NCT03115476|521119542|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
144523928|NCT03115476|521119543|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
144523929|NCT05257486|521119547|FG000|Overall Study|Protocol Violation|3|||
144523930|NCT00613106|521119548|FG000|Overall Study|Adverse Event|3|||
144523931|NCT00613106|521119549|FG001|Overall Study|Adverse Event|1|||
144523932|NCT00613106|521119548|FG000|Overall Study|Withdrawal by Subject|6|||
144523933|NCT00613106|521119549|FG001|Overall Study|Withdrawal by Subject|3|||
144523934|NCT00613106|521119548|FG000|Overall Study|Lost to Follow-up|7|||
144523935|NCT00613106|521119549|FG001|Overall Study|Lost to Follow-up|2|||
144523936|NCT00613106|521119548|FG000|Overall Study|misc|4|||
144523937|NCT00613106|521119549|FG001|Overall Study|misc|3|||
144523938|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
144523939|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
144523940|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
144523941|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
144523942|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
144523943|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
144523944|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
144523945|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
144523946|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
144523947|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
144523948|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
144598313|NCT03254485|521391005|FG002|Overall Study|Other|0|||
144598314|NCT03254485|521391006|FG003|Overall Study|Other|2|||
144598315|NCT00467285|521391007|FG000|Overall Study|Lost to Follow-up|4|||
144598316|NCT00467285|521391008|FG001|Overall Study|Lost to Follow-up|4|||
144598317|NCT03891524|521391009|FG000|Overall Study|Death|0|||
144598318|NCT03891524|521391010|FG001|Overall Study|Death|0|||
144598319|NCT03891524|521391011|FG002|Overall Study|Death|0|||
144523949|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
144598320|NCT03891524|521391012|FG003|Overall Study|Death|0|||
144598321|NCT03891524|521391013|FG004|Overall Study|Death|0|||
144598322|NCT03891524|521391014|FG005|Overall Study|Death|0|||
144598323|NCT03891524|521391015|FG006|Overall Study|Death|0|||
144598324|NCT03891524|521391016|FG007|Overall Study|Death|1|||
144401282|NCT01189604|520679582|FG005|Overall Study|Withdrawal by Subject|0|||
144401283|NCT01189604|520679583|FG006|Overall Study|Withdrawal by Subject|0|||
144401284|NCT03626168|520679584|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144401285|NCT03626168|520679585|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
144401286|NCT03626168|520679584|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
144523950|NCT04338061|521119552|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
144523951|NCT04338061|521119553|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
144523952|NCT04338061|521119552|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
144523953|NCT04338061|521119553|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
144523954|NCT04338061|521119552|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
144523955|NCT04338061|521119553|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
144523956|NCT04338061|521119552|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
144523957|NCT04338061|521119553|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
144523958|NCT04338061|521119552|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
144523959|NCT04338061|521119553|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
144523960|NCT04338061|521119552|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
144523961|NCT04338061|521119553|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
144523962|NCT04492722|521119557|FG000|Overall Study|Adverse Event|7|||
144523963|NCT04492722|521119558|FG001|Overall Study|Adverse Event|2|||
144523964|NCT04492722|521119559|FG002|Overall Study|Adverse Event|3|||
144523965|NCT04492722|521119560|FG003|Overall Study|Adverse Event|0|||
144523966|NCT04492722|521119557|FG000|Overall Study|Death|0|||
144523967|NCT04492722|521119558|FG001|Overall Study|Death|0|||
144523968|NCT04492722|521119559|FG002|Overall Study|Death|0|||
144523969|NCT04492722|521119560|FG003|Overall Study|Death|1|||
144523970|NCT04492722|521119557|FG000|Overall Study|Lost to Follow-up|0|||
144523971|NCT04492722|521119558|FG001|Overall Study|Lost to Follow-up|1|||
144523972|NCT04492722|521119559|FG002|Overall Study|Lost to Follow-up|0|||
144523973|NCT04492722|521119560|FG003|Overall Study|Lost to Follow-up|1|||
144523974|NCT04492722|521119557|FG000|Overall Study|Physician Decision|0|||
144523975|NCT04492722|521119558|FG001|Overall Study|Physician Decision|3|||
144523976|NCT04492722|521119559|FG002|Overall Study|Physician Decision|1|||
144523977|NCT04492722|521119560|FG003|Overall Study|Physician Decision|1|||
144523978|NCT04492722|521119557|FG000|Overall Study|Withdrawal by Subject|6|||
144523979|NCT04492722|521119558|FG001|Overall Study|Withdrawal by Subject|6|||
144523980|NCT04492722|521119559|FG002|Overall Study|Withdrawal by Subject|0|||
144523981|NCT04492722|521119560|FG003|Overall Study|Withdrawal by Subject|3|||
144523982|NCT04492722|521119557|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
144523983|NCT04492722|521119558|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
144523984|NCT04492722|521119559|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
144523985|NCT04492722|521119560|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
144523986|NCT04492722|521119557|FG000|Overall Study|Due to Covid-19 pandemic|7|||
144523987|NCT04492722|521119558|FG001|Overall Study|Due to Covid-19 pandemic|3|||
144523988|NCT04492722|521119559|FG002|Overall Study|Due to Covid-19 pandemic|7|||
144523989|NCT04492722|521119560|FG003|Overall Study|Due to Covid-19 pandemic|6|||
144523990|NCT04492722|521119557|FG000|Overall Study|Failure to meet randomisation criteria|2|||
144401287|NCT03626168|520679585|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
144523991|NCT04492722|521119558|FG001|Overall Study|Failure to meet randomisation criteria|3|||
144523992|NCT04492722|521119559|FG002|Overall Study|Failure to meet randomisation criteria|4|||
144523993|NCT04492722|521119560|FG003|Overall Study|Failure to meet randomisation criteria|2|||
144523994|NCT04492722|521119557|FG000|Overall Study|Early termination from the study|54|||
144523995|NCT04492722|521119558|FG001|Overall Study|Early termination from the study|51|||
144523996|NCT04492722|521119559|FG002|Overall Study|Early termination from the study|50|||
144523997|NCT04492722|521119560|FG003|Overall Study|Early termination from the study|50|||
144523998|NCT04492722|521119557|FG000|Overall Study|Missing|3|||
144523999|NCT04492722|521119558|FG001|Overall Study|Missing|0|||
144524000|NCT04492722|521119559|FG002|Overall Study|Missing|0|||
144524001|NCT04492722|521119560|FG003|Overall Study|Missing|5|||
144524002|NCT04492722|521119557|FG000|Overall Study|Participants who did not receive treatment|0|||
144524003|NCT04492722|521119558|FG001|Overall Study|Participants who did not receive treatment|1|||
144524004|NCT04492722|521119559|FG002|Overall Study|Participants who did not receive treatment|4|||
144524005|NCT04492722|521119560|FG003|Overall Study|Participants who did not receive treatment|0|||
144524006|NCT04074759|521119561|FG000|Overall Study|Withdrawal by Subject|0|||
144524007|NCT04074759|521119562|FG001|Overall Study|Withdrawal by Subject|0|||
144524008|NCT04074759|521119563|FG002|Overall Study|Withdrawal by Subject|0|||
144524009|NCT04074759|521119564|FG003|Overall Study|Withdrawal by Subject|0|||
144524010|NCT04074759|521119565|FG004|Overall Study|Withdrawal by Subject|0|||
144524011|NCT04074759|521119566|FG005|Overall Study|Withdrawal by Subject|2|||
144524012|NCT04074759|521119567|FG006|Overall Study|Withdrawal by Subject|0|||
144524013|NCT04074759|521119568|FG007|Overall Study|Withdrawal by Subject|2|||
144524014|NCT04074759|521119569|FG008|Overall Study|Withdrawal by Subject|1|||
144722376|NCT03679741|521838692|FG000|Period 2|Withdrawal by Subject|1|||
144524015|NCT04074759|521119570|FG009|Overall Study|Withdrawal by Subject|2|||
144524016|NCT04074759|521119571|FG010|Overall Study|Withdrawal by Subject|9|||
144524017|NCT04074759|521119572|FG011|Overall Study|Withdrawal by Subject|2|||
144524018|NCT04074759|521119573|FG012|Overall Study|Withdrawal by Subject|1|||
144524019|NCT04074759|521119574|FG013|Overall Study|Withdrawal by Subject|3|||
144524020|NCT04074759|521119575|FG014|Overall Study|Withdrawal by Subject|2|||
144524021|NCT04074759|521119576|FG015|Overall Study|Withdrawal by Subject|0|||
144524022|NCT04074759|521119577|FG016|Overall Study|Withdrawal by Subject|0|||
144524023|NCT04074759|521119578|FG017|Overall Study|Withdrawal by Subject|3|||
144524024|NCT04074759|521119579|FG018|Overall Study|Withdrawal by Subject|1|||
144524025|NCT04074759|521119561|FG000|Overall Study|Death|1|||
144524026|NCT04074759|521119562|FG001|Overall Study|Death|0|||
144524027|NCT04074759|521119563|FG002|Overall Study|Death|1|||
144524028|NCT04074759|521119564|FG003|Overall Study|Death|1|||
144524029|NCT04074759|521119565|FG004|Overall Study|Death|2|||
144524030|NCT04074759|521119566|FG005|Overall Study|Death|0|||
144524031|NCT04074759|521119567|FG006|Overall Study|Death|1|||
144524032|NCT04074759|521119568|FG007|Overall Study|Death|0|||
144524033|NCT04074759|521119569|FG008|Overall Study|Death|3|||
144524034|NCT04074759|521119570|FG009|Overall Study|Death|2|||
144524035|NCT04074759|521119571|FG010|Overall Study|Death|4|||
144524036|NCT04074759|521119572|FG011|Overall Study|Death|1|||
144524037|NCT04074759|521119573|FG012|Overall Study|Death|0|||
144524038|NCT04074759|521119574|FG013|Overall Study|Death|2|||
144524039|NCT04074759|521119575|FG014|Overall Study|Death|1|||
144524040|NCT04074759|521119576|FG015|Overall Study|Death|0|||
144524041|NCT04074759|521119577|FG016|Overall Study|Death|1|||
144524042|NCT04074759|521119578|FG017|Overall Study|Death|0|||
144524043|NCT04074759|521119579|FG018|Overall Study|Death|1|||
144524044|NCT04074759|521119561|FG000|Overall Study|Lost to Follow-up|0|||
144524045|NCT04074759|521119562|FG001|Overall Study|Lost to Follow-up|0|||
144524046|NCT04074759|521119563|FG002|Overall Study|Lost to Follow-up|0|||
144524047|NCT04074759|521119564|FG003|Overall Study|Lost to Follow-up|0|||
144524048|NCT04074759|521119565|FG004|Overall Study|Lost to Follow-up|0|||
144524049|NCT04074759|521119566|FG005|Overall Study|Lost to Follow-up|0|||
144524050|NCT04074759|521119567|FG006|Overall Study|Lost to Follow-up|0|||
144524051|NCT04074759|521119568|FG007|Overall Study|Lost to Follow-up|0|||
144524052|NCT04074759|521119569|FG008|Overall Study|Lost to Follow-up|0|||
144524053|NCT04074759|521119570|FG009|Overall Study|Lost to Follow-up|0|||
144524054|NCT04074759|521119571|FG010|Overall Study|Lost to Follow-up|1|||
144524055|NCT04074759|521119572|FG011|Overall Study|Lost to Follow-up|0|||
144524056|NCT04074759|521119573|FG012|Overall Study|Lost to Follow-up|0|||
144524057|NCT04074759|521119574|FG013|Overall Study|Lost to Follow-up|0|||
144524058|NCT04074759|521119575|FG014|Overall Study|Lost to Follow-up|0|||
144524059|NCT04074759|521119576|FG015|Overall Study|Lost to Follow-up|0|||
144524060|NCT04074759|521119577|FG016|Overall Study|Lost to Follow-up|1|||
144524061|NCT04074759|521119578|FG017|Overall Study|Lost to Follow-up|0|||
144524062|NCT04074759|521119579|FG018|Overall Study|Lost to Follow-up|1|||
144524063|NCT04074759|521119561|FG000|Overall Study|Other|0|||
144524064|NCT04074759|521119562|FG001|Overall Study|Other|1|||
144524065|NCT04074759|521119563|FG002|Overall Study|Other|1|||
144524066|NCT04074759|521119564|FG003|Overall Study|Other|0|||
144524067|NCT04074759|521119565|FG004|Overall Study|Other|2|||
144524068|NCT04074759|521119566|FG005|Overall Study|Other|1|||
144524069|NCT04074759|521119567|FG006|Overall Study|Other|2|||
144524070|NCT04074759|521119568|FG007|Overall Study|Other|1|||
144524071|NCT04074759|521119569|FG008|Overall Study|Other|1|||
144524072|NCT04074759|521119570|FG009|Overall Study|Other|4|||
144524073|NCT04074759|521119571|FG010|Overall Study|Other|4|||
144524074|NCT04074759|521119572|FG011|Overall Study|Other|2|||
144524075|NCT04074759|521119573|FG012|Overall Study|Other|0|||
144524076|NCT04074759|521119574|FG013|Overall Study|Other|0|||
144722377|NCT03679741|521838693|FG001|Period 2|Withdrawal by Subject|1|||
144524077|NCT04074759|521119575|FG014|Overall Study|Other|0|||
144524078|NCT04074759|521119576|FG015|Overall Study|Other|1|||
144524079|NCT04074759|521119577|FG016|Overall Study|Other|0|||
144524080|NCT04074759|521119578|FG017|Overall Study|Other|0|||
144524081|NCT04074759|521119579|FG018|Overall Study|Other|0|||
144524082|NCT04074759|521119561|FG000|Overall Study|Missing end of study status|0|||
144524083|NCT04074759|521119562|FG001|Overall Study|Missing end of study status|0|||
144524084|NCT04074759|521119563|FG002|Overall Study|Missing end of study status|0|||
144524085|NCT04074759|521119564|FG003|Overall Study|Missing end of study status|0|||
144524086|NCT04074759|521119565|FG004|Overall Study|Missing end of study status|0|||
144524087|NCT04074759|521119566|FG005|Overall Study|Missing end of study status|0|||
144524088|NCT04074759|521119567|FG006|Overall Study|Missing end of study status|0|||
144524089|NCT04074759|521119568|FG007|Overall Study|Missing end of study status|0|||
144524090|NCT04074759|521119569|FG008|Overall Study|Missing end of study status|0|||
144524091|NCT04074759|521119570|FG009|Overall Study|Missing end of study status|0|||
144524092|NCT04074759|521119571|FG010|Overall Study|Missing end of study status|2|||
144524093|NCT04074759|521119572|FG011|Overall Study|Missing end of study status|0|||
144524094|NCT04074759|521119573|FG012|Overall Study|Missing end of study status|0|||
144524095|NCT04074759|521119574|FG013|Overall Study|Missing end of study status|0|||
144598325|NCT03891524|521391009|FG000|Overall Study|Withdrawal by Subject|0|||
144598326|NCT03891524|521391010|FG001|Overall Study|Withdrawal by Subject|1|||
144598327|NCT03891524|521391011|FG002|Overall Study|Withdrawal by Subject|2|||
144598328|NCT03891524|521391012|FG003|Overall Study|Withdrawal by Subject|1|||
144598329|NCT03891524|521391013|FG004|Overall Study|Withdrawal by Subject|2|||
144598330|NCT03891524|521391014|FG005|Overall Study|Withdrawal by Subject|2|||
144598331|NCT03891524|521391015|FG006|Overall Study|Withdrawal by Subject|2|||
144598332|NCT03891524|521391016|FG007|Overall Study|Withdrawal by Subject|1|||
144598333|NCT01572922|521391018|FG000|Overall Study|Adverse Event|1|||
144598334|NCT01572922|521391018|FG000|Overall Study|Protocol Violation|1|||
144598335|NCT01572922|521391018|FG000|Overall Study|Death|1|||
144598336|NCT02818920|521391019|FG000|Overall Study|Unresectable|4|||
144598337|NCT02818920|521391019|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
144598338|NCT02818920|521391019|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
144598339|NCT02818920|521391019|FG000|Overall Study|Adverse Event|3|||
144598340|NCT02818920|521391019|FG000|Overall Study|Developed Other Disease|1|||
144598341|NCT02818920|521391019|FG000|Overall Study|Refused Further Treatment|1|||
144598342|NCT01335009|521391020|FG000|Overall Study|Too ill to travel to study sites|1|||
144598343|NCT01335009|521391021|FG001|Overall Study|Too ill to travel to study sites|0|||
144598344|NCT01335009|521391020|FG000|Overall Study|Death|28|||
144598345|NCT01335009|521391021|FG001|Overall Study|Death|32|||
144598346|NCT01335009|521391020|FG000|Overall Study|Withdrawal by Subject|1|||
144598347|NCT01335009|521391021|FG001|Overall Study|Withdrawal by Subject|1|||
144598348|NCT01335009|521391020|FG000|Overall Study|Lost to Follow-up|1|||
144598349|NCT01335009|521391021|FG001|Overall Study|Lost to Follow-up|0|||
144598350|NCT00445068|521391022|FG000|Overall Study|Disease progression|26|||
144598351|NCT00445068|521391022|FG000|Overall Study|Adverse Event|5|||
144598352|NCT00445068|521391022|FG000|Overall Study|Abnormal laboratory value|2|||
144598353|NCT00445068|521391022|FG000|Overall Study|Withdrawal by Subject|2|||
144598354|NCT00445068|521391022|FG000|Overall Study|Death|1|||
144598355|NCT04824521|521391023|FG000|Overall Study|Lost to Follow-up|1|||
144598356|NCT04821869|521391024|FG000|Overall Study|Adverse Event|4|||
144598357|NCT04821869|521391024|FG000|Overall Study|Withdrawal by Subject|2|||
144598358|NCT04821869|521391024|FG000|Overall Study|Did not meet FEV1 criteria|1|||
144598359|NCT03444324|521391025|FG000|Overall Study|Withdrawal by Subject|0|||
144598360|NCT03444324|521391026|FG001|Overall Study|Withdrawal by Subject|1|||
144598361|NCT03444324|521391025|FG000|Overall Study|Lost to Follow-up|4|||
144598362|NCT03444324|521391026|FG001|Overall Study|Lost to Follow-up|2|||
144598363|NCT03444324|521391025|FG000|Overall Study|Protocol Violation|0|||
144598364|NCT03444324|521391026|FG001|Overall Study|Protocol Violation|1|||
144598365|NCT03444324|521391025|FG000|Overall Study|Lack of Trial Compliance|1|||
144598366|NCT03444324|521391026|FG001|Overall Study|Lack of Trial Compliance|1|||
144598367|NCT03444324|521391025|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
144598368|NCT03444324|521391026|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
144598369|NCT01598311|521391027|FG000|Overall Study|Physician Decision|4|||
144598370|NCT01598311|521391028|FG001|Overall Study|Physician Decision|5|||
144598371|NCT01598311|521391027|FG000|Overall Study|Adverse Event|9|||
144598372|NCT01598311|521391028|FG001|Overall Study|Adverse Event|13|||
144598373|NCT01598311|521391027|FG000|Overall Study|Lost to Follow-up|7|||
144598374|NCT01598311|521391028|FG001|Overall Study|Lost to Follow-up|12|||
144598375|NCT01598311|521391027|FG000|Overall Study|Withdrawal by Subject|9|||
144598376|NCT01598311|521391028|FG001|Overall Study|Withdrawal by Subject|13|||
144598377|NCT01598311|521391027|FG000|Overall Study|No reason provided.|0|||
144598378|NCT01598311|521391028|FG001|Overall Study|No reason provided.|5|||
144598379|NCT01598311|521391027|FG000|Overall Study|Randomized but never treated|8|||
144598380|NCT01598311|521391028|FG001|Overall Study|Randomized but never treated|5|||
144598381|NCT01598311|521391027|FG000|Overall Study|Treated but no confirmed CDAD|9|||
144598382|NCT01598311|521391028|FG001|Overall Study|Treated but no confirmed CDAD|8|||
144598383|NCT01598311|521391027|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
144598384|NCT01598311|521391028|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
144598385|NCT00658684|521391029|FG000|Overall Study|Adverse Event|10|||
144598386|NCT00658684|521391030|FG001|Overall Study|Adverse Event|8|||
144598387|NCT00658684|521391031|FG002|Overall Study|Adverse Event|2|||
144598388|NCT00658684|521391032|FG003|Overall Study|Adverse Event|0|||
144598389|NCT00658684|521391029|FG000|Overall Study|Withdrawal by Subject|6|||
144598390|NCT00658684|521391030|FG001|Overall Study|Withdrawal by Subject|4|||
144598391|NCT00658684|521391031|FG002|Overall Study|Withdrawal by Subject|1|||
144598392|NCT00658684|521391032|FG003|Overall Study|Withdrawal by Subject|1|||
144598393|NCT00658684|521391029|FG000|Overall Study|Lack of Efficacy|1|||
144598394|NCT00658684|521391030|FG001|Overall Study|Lack of Efficacy|1|||
144598395|NCT00658684|521391031|FG002|Overall Study|Lack of Efficacy|0|||
144598396|NCT00658684|521391032|FG003|Overall Study|Lack of Efficacy|0|||
144598397|NCT00658684|521391029|FG000|Overall Study|Protocol Violation|1|||
144598398|NCT00658684|521391030|FG001|Overall Study|Protocol Violation|1|||
144598399|NCT00658684|521391031|FG002|Overall Study|Protocol Violation|0|||
144598400|NCT00658684|521391032|FG003|Overall Study|Protocol Violation|0|||
144598401|NCT00658684|521391029|FG000|Overall Study|Pregnancy|1|||
144598402|NCT00658684|521391030|FG001|Overall Study|Pregnancy|1|||
144598403|NCT00658684|521391031|FG002|Overall Study|Pregnancy|0|||
144598404|NCT00658684|521391032|FG003|Overall Study|Pregnancy|0|||
144598405|NCT00688103|521391033|FG000|Overall Study|Adverse Event|4|||
144598406|NCT00688103|521391034|FG001|Overall Study|Adverse Event|1|||
144598407|NCT00688103|521391033|FG000|Overall Study|Lack of Efficacy|11|||
144598408|NCT00688103|521391034|FG001|Overall Study|Lack of Efficacy|1|||
144598409|NCT00688103|521391033|FG000|Overall Study|Withdrawal by Subject|4|||
144598410|NCT00688103|521391034|FG001|Overall Study|Withdrawal by Subject|2|||
144598411|NCT00688103|521391033|FG000|Overall Study|complex reasons|11|||
144598412|NCT00688103|521391034|FG001|Overall Study|complex reasons|9|||
144598413|NCT04751656|521392430|FG000|Overall Study|Lost to Follow-up|1|||
144598414|NCT01485354|521392433|FG000|Overall Study|Withdrawal by Subject|5|||
144598415|NCT03566810|521392434|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
144598416|NCT03566810|521392435|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
144598417|NCT03566810|521392436|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
144598418|NCT03566810|521392437|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
144598419|NCT01103245|521392438|FG000|Overall Study|Withdrawal by Subject|1|||
144598420|NCT01103245|521392439|FG001|Overall Study|Withdrawal by Subject|0|||
144598421|NCT01103245|521392440|FG002|Overall Study|Withdrawal by Subject|3|||
144598422|NCT01103245|521392441|FG003|Overall Study|Withdrawal by Subject|0|||
144598423|NCT01103245|521392438|FG000|Overall Study|Inadequate IV access|1|||
144598424|NCT01103245|521392439|FG001|Overall Study|Inadequate IV access|0|||
144598425|NCT01103245|521392440|FG002|Overall Study|Inadequate IV access|0|||
144598426|NCT01103245|521392441|FG003|Overall Study|Inadequate IV access|0|||
144598427|NCT01103245|521392438|FG000|Overall Study|Adverse Event|0|||
144598428|NCT01103245|521392439|FG001|Overall Study|Adverse Event|2|||
144598429|NCT01103245|521392440|FG002|Overall Study|Adverse Event|1|||
144598430|NCT01103245|521392441|FG003|Overall Study|Adverse Event|0|||
144598431|NCT01103245|521392438|FG000|Overall Study|Physician Decision|1|||
144598432|NCT01103245|521392439|FG001|Overall Study|Physician Decision|0|||
144598433|NCT01103245|521392440|FG002|Overall Study|Physician Decision|0|||
144598434|NCT01103245|521392441|FG003|Overall Study|Physician Decision|0|||
144598435|NCT00826111|521392442|FG000|Overall Study|Lost to Follow-up|0|||
144598436|NCT00826111|521392443|FG001|Overall Study|Lost to Follow-up|1|||
144598437|NCT00826111|521392442|FG000|Overall Study|Protocol Violation|1|||
144598438|NCT00826111|521392443|FG001|Overall Study|Protocol Violation|0|||
144598439|NCT00826111|521392442|FG000|Overall Study|Withdrawal by Subject|5|||
144598440|NCT00826111|521392443|FG001|Overall Study|Withdrawal by Subject|0|||
144598441|NCT00826111|521392442|FG000|Overall Study|Physician Decision|1|||
144598442|NCT00826111|521392443|FG001|Overall Study|Physician Decision|1|||
144598443|NCT02805725|521392444|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
144598444|NCT02805725|521392445|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
144598445|NCT02805725|521392446|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
144598446|NCT02805725|521392447|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
144598447|NCT02805725|521392448|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
144598448|NCT02805725|521392444|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
144598449|NCT02805725|521392445|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
144598450|NCT02805725|521392446|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
144598451|NCT02805725|521392447|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
144598452|NCT02805725|521392448|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
144598453|NCT02805725|521392444|FG000|Phase II|Protocol Violation|0|||
144598454|NCT02805725|521392445|FG001|Phase II|Protocol Violation|0|||
144598455|NCT02805725|521392446|FG002|Phase II|Protocol Violation|0|||
144598456|NCT02805725|521392447|FG003|Phase II|Protocol Violation|0|||
144598457|NCT02805725|521392448|FG004|Phase II|Protocol Violation|6|||
144598458|NCT01195545|521392451|FG000|Overall Study|Protocol Violation|4|||
144598459|NCT03511053|521392454|FG000|Overall Study|Withdrawal by Subject|1|||
144598460|NCT02425644|521392455|FG000|Overall Study|Lost to Follow-up|2|||
144598461|NCT02425644|521392456|FG001|Overall Study|Lost to Follow-up|3|||
144598462|NCT02425644|521392455|FG000|Overall Study|Withdrawal by Subject|41|||
144598463|NCT02425644|521392456|FG001|Overall Study|Withdrawal by Subject|36|||
144598464|NCT02425644|521392455|FG000|Overall Study|Lack of Efficacy|3|||
144598465|NCT02425644|521392456|FG001|Overall Study|Lack of Efficacy|10|||
144598466|NCT02425644|521392455|FG000|Overall Study|Adverse Event|13|||
144598467|NCT02425644|521392456|FG001|Overall Study|Adverse Event|3|||
144598468|NCT02425644|521392455|FG000|Overall Study|Death|0|||
144598469|NCT02425644|521392456|FG001|Overall Study|Death|2|||
144598470|NCT02425644|521392455|FG000|Overall Study|Other|18|||
144598471|NCT02425644|521392456|FG001|Overall Study|Other|17|||
144598472|NCT02720536|521392459|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
144598473|NCT02720536|521392459|FG000|Overall Study|PR - pregnancy|2|||
144598474|NCT02720536|521392459|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
144598475|NCT02720536|521392459|FG000|Overall Study|PR - death|1|||
144722378|NCT02227862|521838695|FG000|Overall Study|Protocol Violation|7|||
144598476|NCT02720536|521392459|FG000|Overall Study|PR - adverse event|1|||
144598477|NCT02720536|521392459|FG000|Overall Study|PR - abnormal lab value(s)|1|||
144598478|NCT02720536|521392459|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
144598479|NCT01028222|521392460|FG000|Overall Study|Protocol deviation|1|||
144598480|NCT01028222|521392461|FG001|Overall Study|Protocol deviation|0|||
144598481|NCT01028222|521392460|FG000|Overall Study|Disease progression|33|||
144401288|NCT03626168|520679584|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
144401289|NCT03626168|520679585|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
144401290|NCT02357979|520679586|FG000|Overall Study|Lost to Follow-up|5|||
144401291|NCT02357979|520679587|FG001|Overall Study|Lost to Follow-up|5|||
144401292|NCT01772160|520679592|FG000|Overall Study|Death|3|||
144401293|NCT01772160|520679592|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
144598482|NCT01028222|521392461|FG001|Overall Study|Disease progression|9|||
144598483|NCT01028222|521392460|FG000|Overall Study|Administrative problems|1|||
144401294|NCT01772160|520679592|FG000|Overall Study|Consent withdrawal|3|||
144401295|NCT01772160|520679592|FG000|Overall Study|Migrated / moved from the study area|4|||
144401296|NCT01772160|520679592|FG000|Overall Study|Lost to Follow-up|30|||
144401297|NCT01772160|520679592|FG000|Overall Study|Other|5|||
144401298|NCT04738734|520679599|FG000|Overall Study|Withdrawal by Subject|2|||
144401299|NCT04738734|520679600|FG001|Overall Study|Withdrawal by Subject|4|||
144401300|NCT04738734|520679599|FG000|Overall Study|Lost to Follow-up|5|||
144598484|NCT01028222|521392461|FG001|Overall Study|Administrative problems|1|||
144598485|NCT01028222|521392460|FG000|Overall Study|Lost to Follow-up|0|||
144598486|NCT01028222|521392461|FG001|Overall Study|Lost to Follow-up|1|||
144598487|NCT01028222|521392460|FG000|Overall Study|Withdrawal by Subject|1|||
144598488|NCT01028222|521392461|FG001|Overall Study|Withdrawal by Subject|0|||
144598489|NCT01028222|521392460|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
144598490|NCT01028222|521392461|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
144598491|NCT01028222|521392460|FG000|Overall Study|Adverse Event|2|||
144598492|NCT01028222|521392461|FG001|Overall Study|Adverse Event|0|||
144598493|NCT00300781|521392462|FG000|Overall Study|Disease Progression|55|||
144598494|NCT00300781|521392463|FG001|Overall Study|Disease Progression|52|||
144598495|NCT00300781|521392462|FG000|Overall Study|Adverse Event|5|||
144598496|NCT00300781|521392463|FG001|Overall Study|Adverse Event|6|||
144598497|NCT00300781|521392462|FG000|Overall Study|Withdrawal by Subject|1|||
144598498|NCT00300781|521392463|FG001|Overall Study|Withdrawal by Subject|2|||
144598499|NCT00300781|521392462|FG000|Overall Study|Physician Decision|1|||
144598500|NCT00300781|521392463|FG001|Overall Study|Physician Decision|0|||
144401301|NCT04738734|520679600|FG001|Overall Study|Lost to Follow-up|2|||
144401302|NCT04738734|520679599|FG000|Overall Study|Physician Decision|0|||
144401303|NCT04738734|520679600|FG001|Overall Study|Physician Decision|1|||
144401304|NCT04738734|520679599|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
144401305|NCT04738734|520679600|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
144401306|NCT00331422|520679601|FG000|Overall Study|Did not receive entire study regimen|5|||
144401307|NCT02345226|520679602|FG000|Double-Blind Phase|Adverse Event|5|||
144598501|NCT00300781|521392462|FG000|Overall Study|Not Recorded|0|||
144598502|NCT00300781|521392463|FG001|Overall Study|Not Recorded|1|||
144598503|NCT00300781|521392462|FG000|Overall Study|Symptomatic Deterioration|1|||
144598504|NCT00300781|521392463|FG001|Overall Study|Symptomatic Deterioration|0|||
144598505|NCT00300781|521392462|FG000|Overall Study|Lost to Follow-up|0|||
144598506|NCT00300781|521392463|FG001|Overall Study|Lost to Follow-up|1|||
144598507|NCT00567268|521392464|FG000|Overall Study|Protocol Violation|7|||
144598508|NCT00567268|521392464|FG000|Overall Study|Lost to Follow-up|36|||
144598509|NCT00567268|521392464|FG000|Overall Study|No Visit After First Day of Treatment|2|||
144598510|NCT00567268|521392464|FG000|Overall Study|No Drug Administration|4|||
144598511|NCT00567268|521392464|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
144598512|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
144598513|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
144598514|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
144401308|NCT02345226|520679603|FG001|Double-Blind Phase|Adverse Event|6|||
144598515|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
144598516|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
144598517|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
144598518|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
144598519|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
144598520|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
144598521|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
144598522|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
144598523|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
144401309|NCT02345226|520679602|FG000|Double-Blind Phase|Death|3|||
144401310|NCT02345226|520679603|FG001|Double-Blind Phase|Death|0|||
144401311|NCT02345226|520679602|FG000|Double-Blind Phase|Pregnancy|0|||
144598524|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Death|3|||
144598525|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Death|1|||
144722379|NCT02227862|521838696|FG001|Overall Study|Protocol Violation|9|||
144401312|NCT02345226|520679603|FG001|Double-Blind Phase|Pregnancy|1|||
144401313|NCT02345226|520679602|FG000|Double-Blind Phase|Lack of Efficacy|1|||
144401314|NCT02345226|520679603|FG001|Double-Blind Phase|Lack of Efficacy|0|||
144401315|NCT02345226|520679602|FG000|Double-Blind Phase|Investigator's Discretion|4|||
144401316|NCT02345226|520679603|FG001|Double-Blind Phase|Investigator's Discretion|3|||
144401317|NCT02345226|520679602|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
144401318|NCT02345226|520679603|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
144401319|NCT02345226|520679602|FG000|Double-Blind Phase|Withdrew Consent|41|||
144401320|NCT02345226|520679603|FG001|Double-Blind Phase|Withdrew Consent|39|||
144401321|NCT02345226|520679602|FG000|Double-Blind Phase|Lost to Follow-up|12|||
144401322|NCT02345226|520679603|FG001|Double-Blind Phase|Lost to Follow-up|16|||
144401323|NCT02345226|520679602|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
144401324|NCT02345226|520679603|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
144401325|NCT02345226|520679602|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
144401326|NCT02345226|520679603|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
144401327|NCT01710046|520679609|FG000|Overall Study|Lost to Follow-up|1|||
144401328|NCT01710046|520679610|FG001|Overall Study|Lost to Follow-up|0|||
144401329|NCT03386474|520679617|FG000|Overall Study|Death|1|||
144401330|NCT03386474|520679618|FG001|Overall Study|Death|0|||
144401331|NCT03386474|520679617|FG000|Overall Study|Adverse Event|0|||
144401332|NCT03386474|520679618|FG001|Overall Study|Adverse Event|1|||
144401333|NCT02282358|520679619|FG000|Overall Study|Nonevaluable|1|||
144401334|NCT03896165|520679620|FG000|Overall Study|Withdrawal by Subject|2|||
144401335|NCT01163266|520679621|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
144401336|NCT01163266|520679622|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
144401337|NCT01163266|520679623|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
144401338|NCT01163266|520679621|FG000|Overall Study|Lack of Efficacy|1|||
144401339|NCT01163266|520679622|FG001|Overall Study|Lack of Efficacy|3|||
144401340|NCT01163266|520679623|FG002|Overall Study|Lack of Efficacy|1|||
144401341|NCT01163266|520679621|FG000|Overall Study|Noncompliance with Study Drug|0|||
144401342|NCT01163266|520679622|FG001|Overall Study|Noncompliance with Study Drug|2|||
144401343|NCT01163266|520679623|FG002|Overall Study|Noncompliance with Study Drug|0|||
144401344|NCT01163266|520679621|FG000|Overall Study|Protocol Deviations|2|||
144401345|NCT01163266|520679622|FG001|Overall Study|Protocol Deviations|2|||
144401346|NCT01163266|520679623|FG002|Overall Study|Protocol Deviations|5|||
144401347|NCT01163266|520679621|FG000|Overall Study|Withdrawal of Consent|5|||
144401348|NCT01163266|520679622|FG001|Overall Study|Withdrawal of Consent|7|||
144401349|NCT01163266|520679623|FG002|Overall Study|Withdrawal of Consent|3|||
144401350|NCT01163266|520679621|FG000|Overall Study|Lost to Follow-up|7|||
144401351|NCT01163266|520679622|FG001|Overall Study|Lost to Follow-up|7|||
144401352|NCT01163266|520679623|FG002|Overall Study|Lost to Follow-up|10|||
144401353|NCT01163266|520679621|FG000|Overall Study|Other|1|||
144401354|NCT01163266|520679622|FG001|Overall Study|Other|1|||
144401355|NCT01163266|520679623|FG002|Overall Study|Other|2|||
144401356|NCT02586064|520679624|FG000|Overall Study|Other Obligations|6|||
144401357|NCT02586064|520679625|FG001|Overall Study|Other Obligations|6|||
144401358|NCT02586064|520679624|FG000|Overall Study|Other|3|||
144401359|NCT02586064|520679625|FG001|Overall Study|Other|7|||
144401360|NCT02586064|520679624|FG000|Overall Study|Never Started|3|||
144401361|NCT02586064|520679625|FG001|Overall Study|Never Started|3|||
144401362|NCT02586064|520679624|FG000|Overall Study|Lost Interest|1|||
144401363|NCT02586064|520679625|FG001|Overall Study|Lost Interest|4|||
144401364|NCT02586064|520679624|FG000|Overall Study|Miscellaneous Life Issues|0|||
144401365|NCT02586064|520679625|FG001|Overall Study|Miscellaneous Life Issues|5|||
144401366|NCT02586064|520679624|FG000|Overall Study|Infrequent Attendance|2|||
144401367|NCT02586064|520679625|FG001|Overall Study|Infrequent Attendance|1|||
144401368|NCT02586064|520679624|FG000|Overall Study|Timed Out|2|||
144401369|NCT02586064|520679625|FG001|Overall Study|Timed Out|0|||
144401370|NCT02586064|520679624|FG000|Overall Study|AUD relapse|0|||
144401371|NCT02586064|520679625|FG001|Overall Study|AUD relapse|2|||
144401372|NCT02586064|520679624|FG000|Overall Study|Legal Issue|1|||
144401373|NCT02586064|520679625|FG001|Overall Study|Legal Issue|0|||
144401374|NCT02158975|520679626|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
144401375|NCT03666624|520679629|FG000|Overall Study|participant grieving over recent death of parent|1|||
144401376|NCT03666624|520679630|FG001|Overall Study|participant grieving over recent death of parent|0|||
144401377|NCT02128932|520679638|FG000|Overall Study|Withdrawal by Subject|11|||
144401378|NCT02128932|520679639|FG001|Overall Study|Withdrawal by Subject|7|||
144401379|NCT02128932|520679640|FG002|Overall Study|Withdrawal by Subject|8|||
144401380|NCT02128932|520679638|FG000|Overall Study|Death|2|||
144401381|NCT02128932|520679639|FG001|Overall Study|Death|0|||
144401382|NCT02128932|520679640|FG002|Overall Study|Death|2|||
144401383|NCT02128932|520679638|FG000|Overall Study|Lost to Follow-up|2|||
144401384|NCT02128932|520679639|FG001|Overall Study|Lost to Follow-up|1|||
144401385|NCT02128932|520679640|FG002|Overall Study|Lost to Follow-up|1|||
144401386|NCT02128932|520679638|FG000|Overall Study|No reason for withdrawal|12|||
144401387|NCT02128932|520679639|FG001|Overall Study|No reason for withdrawal|11|||
144401388|NCT02128932|520679640|FG002|Overall Study|No reason for withdrawal|7|||
144401389|NCT01361568|520679641|FG000|Overall Study|Adverse Event|0|||
144401390|NCT01361568|520679642|FG001|Overall Study|Adverse Event|0|||
144401391|NCT01361568|520679643|FG002|Overall Study|Adverse Event|0|||
144598526|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
144598527|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
144598528|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Adverse Event|7|||
144598529|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Adverse Event|8|||
144598530|NCT03236246|521392465|FG000|24-Week Dose Titration Period|Captured as Other|1|||
144598531|NCT03236246|521392466|FG001|24-Week Dose Titration Period|Captured as Other|2|||
144598532|NCT03236246|521392465|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
144598533|NCT03236246|521392466|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
144598534|NCT03236246|521392465|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
144598535|NCT03236246|521392466|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
144598536|NCT03236246|521392465|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
144598537|NCT03236246|521392466|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
144598538|NCT03236246|521392465|FG000|24-Week Dose Maintenance Period|Death|0|||
144598539|NCT03236246|521392466|FG001|24-Week Dose Maintenance Period|Death|1|||
144598540|NCT03236246|521392465|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
144598541|NCT03236246|521392466|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
144401392|NCT01361568|520679644|FG003|Overall Study|Adverse Event|0|||
144401393|NCT01361568|520679645|FG004|Overall Study|Adverse Event|1|||
144401394|NCT01361568|520679646|FG005|Overall Study|Adverse Event|0|||
144401395|NCT01361568|520679641|FG000|Overall Study|Physician Decision|0|||
144401396|NCT01361568|520679642|FG001|Overall Study|Physician Decision|0|||
144401397|NCT01361568|520679643|FG002|Overall Study|Physician Decision|0|||
144401398|NCT01361568|520679644|FG003|Overall Study|Physician Decision|0|||
144401399|NCT01361568|520679645|FG004|Overall Study|Physician Decision|0|||
144401400|NCT01361568|520679646|FG005|Overall Study|Physician Decision|1|||
144401401|NCT01361568|520679641|FG000|Overall Study|Withdrawal by Subject|2|||
144401402|NCT01361568|520679642|FG001|Overall Study|Withdrawal by Subject|1|||
144401403|NCT01361568|520679643|FG002|Overall Study|Withdrawal by Subject|0|||
144401404|NCT01361568|520679644|FG003|Overall Study|Withdrawal by Subject|0|||
144401405|NCT01361568|520679645|FG004|Overall Study|Withdrawal by Subject|0|||
144401406|NCT01361568|520679646|FG005|Overall Study|Withdrawal by Subject|1|||
144401407|NCT02020577|520679651|FG000|Overall Study|Progressive disease|3|||
144401408|NCT02020577|520679652|FG001|Overall Study|Progressive disease|38|||
144401409|NCT02020577|520679651|FG000|Overall Study|Other AE or clinical progression|0|||
144401410|NCT02020577|520679652|FG001|Overall Study|Other AE or clinical progression|15|||
144401411|NCT02020577|520679651|FG000|Overall Study|Withdrawal by Subject|0|||
144401412|NCT02020577|520679652|FG001|Overall Study|Withdrawal by Subject|1|||
144401413|NCT02020577|520679651|FG000|Overall Study|Other than stated above|0|||
144401414|NCT02020577|520679652|FG001|Overall Study|Other than stated above|1|||
144401415|NCT02663908|520679653|FG000|Overall Study|Withdrawal by Subject|8|||
144401416|NCT02663908|520679654|FG001|Overall Study|Withdrawal by Subject|5|||
144401417|NCT02663908|520679653|FG000|Overall Study|Lost to Follow-up|1|||
144401418|NCT02663908|520679654|FG001|Overall Study|Lost to Follow-up|5|||
144401419|NCT02663908|520679653|FG000|Overall Study|Adverse Event|13|||
144401420|NCT02663908|520679654|FG001|Overall Study|Adverse Event|11|||
144401421|NCT02663908|520679653|FG000|Overall Study|Protocol Violation|1|||
144401422|NCT02663908|520679654|FG001|Overall Study|Protocol Violation|2|||
144401423|NCT02663908|520679653|FG000|Overall Study|Lack of therapeutic response|2|||
144598542|NCT02598557|521392467|FG000|Overall Study|Withdrawal by Subject|1|||
144598543|NCT02598557|521392468|FG001|Overall Study|Withdrawal by Subject|0|||
144598544|NCT02598557|521392469|FG002|Overall Study|Withdrawal by Subject|1|||
144598545|NCT02598557|521392467|FG000|Overall Study|Participant did not start treatment|2|||
144598546|NCT02598557|521392468|FG001|Overall Study|Participant did not start treatment|1|||
144598547|NCT02598557|521392469|FG002|Overall Study|Participant did not start treatment|1|||
144401424|NCT02663908|520679654|FG001|Overall Study|Lack of therapeutic response|0|||
144401425|NCT02663908|520679653|FG000|Overall Study|COVID-19|1|||
144401426|NCT02663908|520679654|FG001|Overall Study|COVID-19|0|||
144401427|NCT02663908|520679653|FG000|Overall Study|Site closed|1|||
144401428|NCT02663908|520679654|FG001|Overall Study|Site closed|0|||
144401429|NCT02663908|520679653|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
144401430|NCT02663908|520679654|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
144401431|NCT02663908|520679653|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
144401432|NCT02663908|520679654|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
144401433|NCT02663908|520679653|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
144401434|NCT02663908|520679654|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
144401435|NCT02663908|520679653|FG000|Overall Study|Death|1|||
144401436|NCT02663908|520679654|FG001|Overall Study|Death|0|||
144401437|NCT02663908|520679653|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
144401438|NCT02663908|520679654|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
144401439|NCT02663908|520679653|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
144401440|NCT02663908|520679654|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
144401441|NCT02557295|520679659|FG000|Overall Study|Withdrawal by Subject|9|||
144401442|NCT02557295|520679660|FG001|Overall Study|Withdrawal by Subject|2|||
144401443|NCT02557295|520679661|FG002|Overall Study|Withdrawal by Subject|4|||
144401444|NCT02557295|520679662|FG003|Overall Study|Withdrawal by Subject|0|||
144401445|NCT02557295|520679663|FG004|Overall Study|Withdrawal by Subject|0|||
144401446|NCT02557295|520679664|FG005|Overall Study|Withdrawal by Subject|0|||
144401447|NCT02557295|520679665|FG006|Overall Study|Withdrawal by Subject|15|||
144401448|NCT02557295|520679666|FG007|Overall Study|Withdrawal by Subject|1|||
144401449|NCT02557295|520679667|FG008|Overall Study|Withdrawal by Subject|3|||
144401450|NCT02557295|520679659|FG000|Overall Study|Disease Progression|0|||
144401451|NCT02557295|520679660|FG001|Overall Study|Disease Progression|0|||
144401452|NCT02557295|520679661|FG002|Overall Study|Disease Progression|0|||
144401453|NCT02557295|520679662|FG003|Overall Study|Disease Progression|0|||
144401454|NCT02557295|520679663|FG004|Overall Study|Disease Progression|0|||
144401455|NCT02557295|520679664|FG005|Overall Study|Disease Progression|0|||
144401456|NCT02557295|520679665|FG006|Overall Study|Disease Progression|1|||
144401457|NCT02557295|520679666|FG007|Overall Study|Disease Progression|0|||
144401458|NCT02557295|520679667|FG008|Overall Study|Disease Progression|0|||
144401459|NCT02557295|520679659|FG000|Overall Study|Lack of Efficacy|24|||
144401460|NCT02557295|520679660|FG001|Overall Study|Lack of Efficacy|1|||
144401461|NCT02557295|520679661|FG002|Overall Study|Lack of Efficacy|3|||
144401462|NCT02557295|520679662|FG003|Overall Study|Lack of Efficacy|0|||
144401463|NCT02557295|520679663|FG004|Overall Study|Lack of Efficacy|0|||
144401464|NCT02557295|520679664|FG005|Overall Study|Lack of Efficacy|0|||
144401465|NCT02557295|520679665|FG006|Overall Study|Lack of Efficacy|12|||
144401466|NCT02557295|520679666|FG007|Overall Study|Lack of Efficacy|1|||
144401467|NCT02557295|520679667|FG008|Overall Study|Lack of Efficacy|0|||
144401468|NCT02557295|520679659|FG000|Overall Study|Adverse Event|16|||
144401469|NCT02557295|520679660|FG001|Overall Study|Adverse Event|2|||
144401470|NCT02557295|520679661|FG002|Overall Study|Adverse Event|3|||
144401471|NCT02557295|520679662|FG003|Overall Study|Adverse Event|0|||
144401472|NCT02557295|520679663|FG004|Overall Study|Adverse Event|0|||
144401473|NCT02557295|520679664|FG005|Overall Study|Adverse Event|0|||
144401474|NCT02557295|520679665|FG006|Overall Study|Adverse Event|2|||
144401475|NCT02557295|520679666|FG007|Overall Study|Adverse Event|1|||
144401476|NCT02557295|520679667|FG008|Overall Study|Adverse Event|1|||
144401477|NCT02557295|520679659|FG000|Overall Study|Lost to Follow-up|4|||
144401478|NCT02557295|520679660|FG001|Overall Study|Lost to Follow-up|0|||
144401479|NCT02557295|520679661|FG002|Overall Study|Lost to Follow-up|0|||
144401480|NCT02557295|520679662|FG003|Overall Study|Lost to Follow-up|0|||
144401481|NCT02557295|520679663|FG004|Overall Study|Lost to Follow-up|0|||
144401482|NCT02557295|520679664|FG005|Overall Study|Lost to Follow-up|0|||
144401483|NCT02557295|520679665|FG006|Overall Study|Lost to Follow-up|9|||
144401484|NCT02557295|520679666|FG007|Overall Study|Lost to Follow-up|0|||
144401485|NCT02557295|520679667|FG008|Overall Study|Lost to Follow-up|0|||
144401486|NCT02557295|520679659|FG000|Overall Study|Study Close|54|||
144401487|NCT02557295|520679660|FG001|Overall Study|Study Close|3|||
144401488|NCT02557295|520679661|FG002|Overall Study|Study Close|5|||
144401489|NCT02557295|520679662|FG003|Overall Study|Study Close|3|||
144401490|NCT02557295|520679663|FG004|Overall Study|Study Close|0|||
144401491|NCT02557295|520679664|FG005|Overall Study|Study Close|0|||
144401492|NCT02557295|520679665|FG006|Overall Study|Study Close|37|||
144401493|NCT02557295|520679666|FG007|Overall Study|Study Close|3|||
144401494|NCT02557295|520679667|FG008|Overall Study|Study Close|19|||
144401495|NCT02557295|520679659|FG000|Overall Study|except for study close|4|||
144401496|NCT02557295|520679660|FG001|Overall Study|except for study close|0|||
144401497|NCT02557295|520679661|FG002|Overall Study|except for study close|0|||
144401498|NCT02557295|520679662|FG003|Overall Study|except for study close|0|||
144598548|NCT02598557|521392467|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
144598549|NCT02598557|521392468|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
144598550|NCT02598557|521392469|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
144598551|NCT02598557|521392467|FG000|Overall Study|Adverse Event|1|||
144401499|NCT02557295|520679663|FG004|Overall Study|except for study close|0|||
144401500|NCT02557295|520679664|FG005|Overall Study|except for study close|0|||
144401501|NCT02557295|520679665|FG006|Overall Study|except for study close|5|||
144401502|NCT02557295|520679666|FG007|Overall Study|except for study close|1|||
144401503|NCT02557295|520679667|FG008|Overall Study|except for study close|0|||
144401504|NCT03487549|520679668|FG000|Overall Study|Protocol Violation|0|||
144401505|NCT03487549|520679669|FG001|Overall Study|Protocol Violation|1|||
144401506|NCT03487549|520679668|FG000|Overall Study|Lost to Follow-up|2|||
144401507|NCT03487549|520679669|FG001|Overall Study|Lost to Follow-up|1|||
144401508|NCT03487549|520679668|FG000|Overall Study|Withdrawal by Subject|2|||
144401509|NCT03487549|520679669|FG001|Overall Study|Withdrawal by Subject|0|||
144401510|NCT01313858|520681471|FG000|Overall Study|Premature Treatment Termination|251|||
144401511|NCT01313858|520681472|FG001|Overall Study|Premature Treatment Termination|219|||
144401512|NCT01313858|520681473|FG002|Overall Study|Premature Treatment Termination|191|||
144401513|NCT01313858|520681471|FG000|Overall Study|Lost to Follow-up|35|||
144401514|NCT01313858|520681472|FG001|Overall Study|Lost to Follow-up|51|||
144401515|NCT01313858|520681473|FG002|Overall Study|Lost to Follow-up|47|||
144401516|NCT01816074|520681476|FG000|Phase 1|Time commitment issues|0|||
144401517|NCT01816074|520681477|FG001|Phase 1|Time commitment issues|0|||
144401518|NCT01816074|520681478|FG002|Phase 1|Time commitment issues|1|||
144401519|NCT01816074|520681479|FG003|Phase 1|Time commitment issues|0|||
144401520|NCT01816074|520681476|FG000|Phase 2|Time commitment Issues|0|||
144401521|NCT01816074|520681477|FG001|Phase 2|Time commitment Issues|2|||
144401522|NCT01816074|520681478|FG002|Phase 2|Time commitment Issues|0|||
144401523|NCT01816074|520681479|FG003|Phase 2|Time commitment Issues|0|||
144401524|NCT01816074|520681476|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
144401525|NCT01816074|520681477|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
144401526|NCT01816074|520681478|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
144401527|NCT01816074|520681479|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
144401528|NCT01816074|520681476|FG000|Phase 2|Physician Decision|0|||
144401529|NCT01816074|520681477|FG001|Phase 2|Physician Decision|0|||
144401530|NCT01816074|520681478|FG002|Phase 2|Physician Decision|0|||
144401531|NCT01816074|520681479|FG003|Phase 2|Physician Decision|1|||
144401532|NCT01816074|520681476|FG000|Phase 2|Withdrawal by Subject|1|||
144401533|NCT01816074|520681477|FG001|Phase 2|Withdrawal by Subject|0|||
144401534|NCT01816074|520681478|FG002|Phase 2|Withdrawal by Subject|0|||
144401535|NCT01816074|520681479|FG003|Phase 2|Withdrawal by Subject|0|||
144401536|NCT01330030|520681487|FG000|Overall Study|Lost to Follow-up|16|||
144401537|NCT01330030|520681488|FG001|Overall Study|Lost to Follow-up|17|||
144401538|NCT00845858|520681489|FG000|Overall Study|Withdrawal by Subject|5|||
144401539|NCT00845858|520681490|FG001|Overall Study|Withdrawal by Subject|1|||
144401540|NCT00845858|520681491|FG002|Overall Study|Withdrawal by Subject|1|||
144401541|NCT00845858|520681489|FG000|Overall Study|Adverse Event|3|||
144401542|NCT00845858|520681490|FG001|Overall Study|Adverse Event|8|||
144401543|NCT00845858|520681491|FG002|Overall Study|Adverse Event|4|||
144401544|NCT00845858|520681489|FG000|Overall Study|Protocol Violation|0|||
144401545|NCT00845858|520681490|FG001|Overall Study|Protocol Violation|0|||
144401546|NCT00845858|520681491|FG002|Overall Study|Protocol Violation|1|||
144401547|NCT00845858|520681489|FG000|Overall Study|not eligible|0|||
144401548|NCT00845858|520681490|FG001|Overall Study|not eligible|3|||
144401549|NCT00845858|520681491|FG002|Overall Study|not eligible|2|||
144401550|NCT03758443|520681492|FG000|Induction Period|Adverse Event|2|||
144401551|NCT03758443|520681493|FG001|Induction Period|Adverse Event|4|||
144401552|NCT03758443|520681494|FG002|Induction Period|Adverse Event|2|||
144401553|NCT03758443|520681495|FG003|Induction Period|Adverse Event|3|||
144401554|NCT03758443|520681492|FG000|Induction Period|Physician Decision|1|||
144401555|NCT03758443|520681493|FG001|Induction Period|Physician Decision|1|||
144401556|NCT03758443|520681494|FG002|Induction Period|Physician Decision|3|||
144401557|NCT03758443|520681495|FG003|Induction Period|Physician Decision|0|||
144401558|NCT03758443|520681492|FG000|Induction Period|Protocol Violation|0|||
144401559|NCT03758443|520681493|FG001|Induction Period|Protocol Violation|0|||
144401560|NCT03758443|520681494|FG002|Induction Period|Protocol Violation|0|||
144401561|NCT03758443|520681495|FG003|Induction Period|Protocol Violation|1|||
144401562|NCT03758443|520681492|FG000|Induction Period|Withdrawal by Subject|3|||
144401563|NCT03758443|520681493|FG001|Induction Period|Withdrawal by Subject|2|||
144401564|NCT03758443|520681494|FG002|Induction Period|Withdrawal by Subject|2|||
144401565|NCT03758443|520681495|FG003|Induction Period|Withdrawal by Subject|4|||
144401566|NCT03758443|520681492|FG000|Extended Induction Period|Adverse Event|1|||
144401567|NCT03758443|520681493|FG001|Extended Induction Period|Adverse Event|1|||
144401568|NCT03758443|520681494|FG002|Extended Induction Period|Adverse Event|0|||
144401569|NCT03758443|520681495|FG003|Extended Induction Period|Adverse Event|1|||
144401570|NCT03758443|520681492|FG000|Extended Induction Period|Lost to Follow-up|1|||
144401571|NCT03758443|520681493|FG001|Extended Induction Period|Lost to Follow-up|0|||
144401572|NCT03758443|520681494|FG002|Extended Induction Period|Lost to Follow-up|0|||
144401573|NCT03758443|520681495|FG003|Extended Induction Period|Lost to Follow-up|0|||
144401574|NCT03758443|520681492|FG000|Extended Induction Period|Physician Decision|2|||
144401575|NCT03758443|520681493|FG001|Extended Induction Period|Physician Decision|1|||
144401576|NCT03758443|520681494|FG002|Extended Induction Period|Physician Decision|2|||
144401577|NCT03758443|520681495|FG003|Extended Induction Period|Physician Decision|2|||
144401578|NCT03758443|520681492|FG000|Extended Induction Period|Protocol Violation|0|||
144401579|NCT03758443|520681493|FG001|Extended Induction Period|Protocol Violation|0|||
144401580|NCT03758443|520681494|FG002|Extended Induction Period|Protocol Violation|0|||
144401581|NCT03758443|520681495|FG003|Extended Induction Period|Protocol Violation|1|||
144401582|NCT03758443|520681492|FG000|Extended Induction Period|Withdrawal by Subject|8|||
144401583|NCT03758443|520681493|FG001|Extended Induction Period|Withdrawal by Subject|1|||
144401584|NCT03758443|520681494|FG002|Extended Induction Period|Withdrawal by Subject|7|||
144401585|NCT03758443|520681495|FG003|Extended Induction Period|Withdrawal by Subject|3|||
144401586|NCT03758443|520681492|FG000|Extended Induction Period|Miscellaneous|1|||
144401587|NCT03758443|520681493|FG001|Extended Induction Period|Miscellaneous|0|||
144401588|NCT03758443|520681494|FG002|Extended Induction Period|Miscellaneous|0|||
144401589|NCT03758443|520681495|FG003|Extended Induction Period|Miscellaneous|0|||
144401590|NCT03758443|520681492|FG000|Maintenance Period|Adverse Event|1|||
144401591|NCT03758443|520681493|FG001|Maintenance Period|Adverse Event|2|||
144401592|NCT03758443|520681494|FG002|Maintenance Period|Adverse Event|0|||
144401593|NCT03758443|520681495|FG003|Maintenance Period|Adverse Event|0|||
144401594|NCT03758443|520681492|FG000|Maintenance Period|Lost to Follow-up|0|||
144401595|NCT03758443|520681493|FG001|Maintenance Period|Lost to Follow-up|0|||
144401596|NCT03758443|520681494|FG002|Maintenance Period|Lost to Follow-up|0|||
144401597|NCT03758443|520681495|FG003|Maintenance Period|Lost to Follow-up|1|||
144401598|NCT03758443|520681492|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
144401599|NCT03758443|520681493|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
144401600|NCT03758443|520681494|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
144401601|NCT03758443|520681495|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
144401602|NCT03758443|520681492|FG000|Maintenance Period|Protocol Violation|0|||
144401603|NCT03758443|520681493|FG001|Maintenance Period|Protocol Violation|1|||
144401604|NCT03758443|520681494|FG002|Maintenance Period|Protocol Violation|0|||
144401605|NCT03758443|520681495|FG003|Maintenance Period|Protocol Violation|0|||
144401606|NCT03758443|520681492|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
144401607|NCT03758443|520681493|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
144401608|NCT03758443|520681494|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
144401609|NCT03758443|520681495|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
144401610|NCT03758443|520681492|FG000|Maintenance Period|Withdrawal by Subject|1|||
144401611|NCT03758443|520681493|FG001|Maintenance Period|Withdrawal by Subject|0|||
144401612|NCT03758443|520681494|FG002|Maintenance Period|Withdrawal by Subject|1|||
144401613|NCT03758443|520681495|FG003|Maintenance Period|Withdrawal by Subject|1|||
144401614|NCT03758443|520681492|FG000|Maintenance Period|Miscellaneous|0|||
144401615|NCT03758443|520681493|FG001|Maintenance Period|Miscellaneous|0|||
144401616|NCT03758443|520681494|FG002|Maintenance Period|Miscellaneous|1|||
144401617|NCT03758443|520681495|FG003|Maintenance Period|Miscellaneous|0|||
144401618|NCT00696800|520681497|FG000|Overall Study|Adverse Event|16|||
144401619|NCT00696800|520681498|FG001|Overall Study|Adverse Event|3|||
144401620|NCT00696800|520681497|FG000|Overall Study|Insufficient compliance with medication|2|||
144401621|NCT00696800|520681498|FG001|Overall Study|Insufficient compliance with medication|1|||
144401622|NCT00696800|520681497|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
144401623|NCT00696800|520681498|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
144401624|NCT00696800|520681497|FG000|Overall Study|Insufficient ovarian response|4|||
144401625|NCT00696800|520681498|FG001|Overall Study|Insufficient ovarian response|1|||
144401626|NCT00696800|520681497|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
144401627|NCT00696800|520681498|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
144401628|NCT00696800|520681497|FG000|Overall Study|Too high ovarian response|6|||
144401629|NCT00696800|520681498|FG001|Overall Study|Too high ovarian response|1|||
144401630|NCT00696800|520681497|FG000|Overall Study|No/too few/bad quality oocytes|4|||
144401631|NCT00696800|520681498|FG001|Overall Study|No/too few/bad quality oocytes|3|||
144401632|NCT00696800|520681497|FG000|Overall Study|No/abnormal fertilization|11|||
144401633|NCT00696800|520681498|FG001|Overall Study|No/abnormal fertilization|13|||
144401634|NCT00696800|520681497|FG000|Overall Study|No/too few/bad quality embryos|24|||
144401635|NCT00696800|520681498|FG001|Overall Study|No/too few/bad quality embryos|18|||
144401636|NCT00696800|520681497|FG000|Overall Study|Other Reasons|5|||
144401637|NCT00696800|520681498|FG001|Overall Study|Other Reasons|3|||
144401638|NCT00696800|520681497|FG000|Overall Study|Not treated|1|||
144401639|NCT00696800|520681498|FG001|Overall Study|Not treated|2|||
144524096|NCT04074759|521119575|FG014|Overall Study|Missing end of study status|0|||
144524097|NCT04074759|521119576|FG015|Overall Study|Missing end of study status|0|||
144524098|NCT04074759|521119577|FG016|Overall Study|Missing end of study status|1|||
144524099|NCT04074759|521119578|FG017|Overall Study|Missing end of study status|0|||
144524100|NCT04074759|521119579|FG018|Overall Study|Missing end of study status|0|||
144524101|NCT03631784|521119581|FG000|Overall Study|Participants Ongoing|1|||
144524102|NCT03631784|521119582|FG001|Overall Study|Participants Ongoing|0|||
144524103|NCT03631784|521119581|FG000|Overall Study|Withdrawal by Subject|3|||
144524104|NCT03631784|521119582|FG001|Overall Study|Withdrawal by Subject|3|||
144524105|NCT03631784|521119581|FG000|Overall Study|Sponsor's Decision|36|||
144524106|NCT03631784|521119582|FG001|Overall Study|Sponsor's Decision|52|||
144524107|NCT03631784|521119581|FG000|Overall Study|Lost to Follow-up|1|||
144524108|NCT03631784|521119582|FG001|Overall Study|Lost to Follow-up|0|||
144524109|NCT03631784|521119581|FG000|Overall Study|Death|71|||
144524110|NCT03631784|521119582|FG001|Overall Study|Death|49|||
144524111|NCT05329220|521119583|FG000|Active Trial Period|Adverse Event|0|||
144524112|NCT05329220|521119584|FG001|Active Trial Period|Adverse Event|0|||
144524113|NCT05329220|521119585|FG002|Active Trial Period|Adverse Event|0|||
144524114|NCT05329220|521119586|FG003|Active Trial Period|Adverse Event|0|||
144722380|NCT02227862|521838695|FG000|Overall Study|Other|0|||
144401640|NCT00199875|520681500|FG000|Overall Study|Withdrawal by Subject|0|||
144401641|NCT00199875|520681501|FG001|Overall Study|Withdrawal by Subject|0|||
144401642|NCT00199875|520681502|FG002|Overall Study|Withdrawal by Subject|0|||
144401643|NCT00199875|520681503|FG003|Overall Study|Withdrawal by Subject|0|||
144401644|NCT00199875|520681504|FG004|Overall Study|Withdrawal by Subject|1|||
144401645|NCT03469934|520681507|FG000|Overall Study|Withdrawal by Subject|0|||
144401646|NCT03469934|520681508|FG001|Overall Study|Withdrawal by Subject|1|||
144524115|NCT05329220|521119587|FG004|Active Trial Period|Adverse Event|1|||
144401647|NCT01024231|520681511|FG000|Overall Study|Other Reasons|1|||
144401648|NCT01024231|520681512|FG001|Overall Study|Other Reasons|2|||
144401649|NCT01024231|520681513|FG002|Overall Study|Other Reasons|0|||
144401650|NCT01024231|520681514|FG003|Overall Study|Other Reasons|0|||
144401651|NCT01024231|520681515|FG004|Overall Study|Other Reasons|2|||
144401652|NCT01024231|520681516|FG005|Overall Study|Other Reasons|0|||
144401653|NCT01024231|520681517|FG006|Overall Study|Other Reasons|1|||
144401654|NCT01024231|520681511|FG000|Overall Study|Maximum Clinical Benefit|1|||
144401655|NCT01024231|520681512|FG001|Overall Study|Maximum Clinical Benefit|2|||
144401656|NCT01024231|520681513|FG002|Overall Study|Maximum Clinical Benefit|0|||
144401657|NCT01024231|520681514|FG003|Overall Study|Maximum Clinical Benefit|1|||
144401658|NCT01024231|520681515|FG004|Overall Study|Maximum Clinical Benefit|1|||
144401659|NCT01024231|520681516|FG005|Overall Study|Maximum Clinical Benefit|0|||
144401660|NCT01024231|520681517|FG006|Overall Study|Maximum Clinical Benefit|0|||
144401661|NCT01024231|520681511|FG000|Overall Study|Disease Progression|3|||
144401662|NCT01024231|520681512|FG001|Overall Study|Disease Progression|1|||
144401663|NCT01024231|520681513|FG002|Overall Study|Disease Progression|3|||
144401664|NCT01024231|520681514|FG003|Overall Study|Disease Progression|0|||
144401665|NCT01024231|520681515|FG004|Overall Study|Disease Progression|4|||
144401666|NCT01024231|520681516|FG005|Overall Study|Disease Progression|11|||
144401667|NCT01024231|520681517|FG006|Overall Study|Disease Progression|6|||
144401668|NCT01024231|520681511|FG000|Overall Study|AE unrelated to Study Drug|0|||
144401669|NCT01024231|520681512|FG001|Overall Study|AE unrelated to Study Drug|1|||
144401670|NCT01024231|520681513|FG002|Overall Study|AE unrelated to Study Drug|0|||
144401671|NCT01024231|520681514|FG003|Overall Study|AE unrelated to Study Drug|0|||
144401672|NCT01024231|520681515|FG004|Overall Study|AE unrelated to Study Drug|0|||
144401673|NCT01024231|520681516|FG005|Overall Study|AE unrelated to Study Drug|0|||
144401674|NCT01024231|520681517|FG006|Overall Study|AE unrelated to Study Drug|0|||
144401675|NCT01024231|520681511|FG000|Overall Study|No longer meets criteria|0|||
144401676|NCT01024231|520681512|FG001|Overall Study|No longer meets criteria|0|||
144401677|NCT01024231|520681513|FG002|Overall Study|No longer meets criteria|0|||
144401678|NCT01024231|520681514|FG003|Overall Study|No longer meets criteria|0|||
144401679|NCT01024231|520681515|FG004|Overall Study|No longer meets criteria|1|||
144401680|NCT01024231|520681516|FG005|Overall Study|No longer meets criteria|0|||
144401681|NCT01024231|520681517|FG006|Overall Study|No longer meets criteria|1|||
144401682|NCT01024231|520681511|FG000|Overall Study|Study Drug Toxicity|1|||
144401683|NCT01024231|520681512|FG001|Overall Study|Study Drug Toxicity|6|||
144401684|NCT01024231|520681513|FG002|Overall Study|Study Drug Toxicity|6|||
144401685|NCT01024231|520681514|FG003|Overall Study|Study Drug Toxicity|4|||
144401686|NCT01024231|520681515|FG004|Overall Study|Study Drug Toxicity|2|||
144401687|NCT01024231|520681516|FG005|Overall Study|Study Drug Toxicity|0|||
144401688|NCT01024231|520681517|FG006|Overall Study|Study Drug Toxicity|7|||
144401689|NCT01024231|520681511|FG000|Overall Study|Death|6|||
144401690|NCT01024231|520681512|FG001|Overall Study|Death|2|||
144401691|NCT01024231|520681513|FG002|Overall Study|Death|1|||
144401692|NCT01024231|520681514|FG003|Overall Study|Death|0|||
144401693|NCT01024231|520681515|FG004|Overall Study|Death|4|||
144401694|NCT01024231|520681516|FG005|Overall Study|Death|3|||
144401695|NCT01024231|520681517|FG006|Overall Study|Death|5|||
144401696|NCT01024231|520681511|FG000|Overall Study|Lost to Follow-up|0|||
144401697|NCT01024231|520681512|FG001|Overall Study|Lost to Follow-up|0|||
144401698|NCT01024231|520681513|FG002|Overall Study|Lost to Follow-up|0|||
144401699|NCT01024231|520681514|FG003|Overall Study|Lost to Follow-up|0|||
144401700|NCT01024231|520681515|FG004|Overall Study|Lost to Follow-up|0|||
144401701|NCT01024231|520681516|FG005|Overall Study|Lost to Follow-up|0|||
144401702|NCT01024231|520681517|FG006|Overall Study|Lost to Follow-up|1|||
144401703|NCT01024231|520681511|FG000|Overall Study|Withdrew Consent|0|||
144401704|NCT01024231|520681512|FG001|Overall Study|Withdrew Consent|1|||
144401705|NCT01024231|520681513|FG002|Overall Study|Withdrew Consent|0|||
144401706|NCT01024231|520681514|FG003|Overall Study|Withdrew Consent|0|||
144401707|NCT01024231|520681515|FG004|Overall Study|Withdrew Consent|0|||
144401708|NCT01024231|520681516|FG005|Overall Study|Withdrew Consent|0|||
144401709|NCT01024231|520681517|FG006|Overall Study|Withdrew Consent|0|||
144401710|NCT01024231|520681511|FG000|Overall Study|Continuing on Treatment|0|||
144401711|NCT01024231|520681512|FG001|Overall Study|Continuing on Treatment|0|||
144401712|NCT01024231|520681513|FG002|Overall Study|Continuing on Treatment|0|||
144401713|NCT01024231|520681514|FG003|Overall Study|Continuing on Treatment|0|||
144401714|NCT01024231|520681515|FG004|Overall Study|Continuing on Treatment|3|||
144401715|NCT01024231|520681516|FG005|Overall Study|Continuing on Treatment|2|||
144401716|NCT01024231|520681517|FG006|Overall Study|Continuing on Treatment|0|||
144401717|NCT01691898|520681518|FG000|Overall Study|Death|34|||
144401718|NCT01691898|520681519|FG001|Overall Study|Death|32|||
144401719|NCT01691898|520681520|FG002|Overall Study|Death|6|||
144401720|NCT01691898|520681521|FG003|Overall Study|Death|3|||
144401721|NCT01691898|520681522|FG004|Overall Study|Death|8|||
144401722|NCT01691898|520681523|FG005|Overall Study|Death|31|||
144401723|NCT01691898|520681518|FG000|Overall Study|Adverse Event|0|||
144401724|NCT01691898|520681519|FG001|Overall Study|Adverse Event|1|||
144401725|NCT01691898|520681520|FG002|Overall Study|Adverse Event|0|||
144401726|NCT01691898|520681521|FG003|Overall Study|Adverse Event|1|||
144249888|NCT03053427|520111789|FG001|Overall Study|Protocol Deviation|3|||
144249889|NCT03053427|520111788|FG000|Overall Study|Withdrawal by Subject|3|||
144401727|NCT01691898|520681522|FG004|Overall Study|Adverse Event|1|||
144401728|NCT01691898|520681523|FG005|Overall Study|Adverse Event|0|||
144401729|NCT01691898|520681518|FG000|Overall Study|Progression of Disease|1|||
144401730|NCT01691898|520681519|FG001|Overall Study|Progression of Disease|2|||
144401731|NCT01691898|520681520|FG002|Overall Study|Progression of Disease|1|||
144401732|NCT01691898|520681521|FG003|Overall Study|Progression of Disease|0|||
144401733|NCT01691898|520681522|FG004|Overall Study|Progression of Disease|0|||
144401734|NCT01691898|520681523|FG005|Overall Study|Progression of Disease|1|||
144401735|NCT01691898|520681518|FG000|Overall Study|Lost to Follow-up|3|||
144401736|NCT01691898|520681519|FG001|Overall Study|Lost to Follow-up|1|||
144401737|NCT01691898|520681520|FG002|Overall Study|Lost to Follow-up|0|||
144401738|NCT01691898|520681521|FG003|Overall Study|Lost to Follow-up|0|||
144401739|NCT01691898|520681522|FG004|Overall Study|Lost to Follow-up|1|||
144401740|NCT01691898|520681523|FG005|Overall Study|Lost to Follow-up|0|||
144401741|NCT01691898|520681518|FG000|Overall Study|Withdrawal by Subject|9|||
144401742|NCT01691898|520681519|FG001|Overall Study|Withdrawal by Subject|8|||
144401743|NCT01691898|520681520|FG002|Overall Study|Withdrawal by Subject|2|||
144401744|NCT01691898|520681521|FG003|Overall Study|Withdrawal by Subject|1|||
144401745|NCT01691898|520681522|FG004|Overall Study|Withdrawal by Subject|3|||
144401746|NCT01691898|520681523|FG005|Overall Study|Withdrawal by Subject|3|||
144401747|NCT01691898|520681518|FG000|Overall Study|Non-Compliance|0|||
144401748|NCT01691898|520681519|FG001|Overall Study|Non-Compliance|0|||
144401749|NCT01691898|520681520|FG002|Overall Study|Non-Compliance|0|||
144401750|NCT01691898|520681521|FG003|Overall Study|Non-Compliance|0|||
144401751|NCT01691898|520681522|FG004|Overall Study|Non-Compliance|1|||
144401752|NCT01691898|520681523|FG005|Overall Study|Non-Compliance|0|||
144524116|NCT05329220|521119588|FG005|Active Trial Period|Adverse Event|0|||
144524117|NCT05329220|521119583|FG000|Active Trial Period|Lost to Follow-up|0|||
144524118|NCT05329220|521119584|FG001|Active Trial Period|Lost to Follow-up|0|||
144524119|NCT05329220|521119585|FG002|Active Trial Period|Lost to Follow-up|0|||
144524120|NCT05329220|521119586|FG003|Active Trial Period|Lost to Follow-up|0|||
144524121|NCT05329220|521119587|FG004|Active Trial Period|Lost to Follow-up|32|||
144524122|NCT05329220|521119588|FG005|Active Trial Period|Lost to Follow-up|28|||
144524123|NCT05329220|521119583|FG000|Active Trial Period|Physician Decision|0|||
144524124|NCT05329220|521119584|FG001|Active Trial Period|Physician Decision|0|||
144524125|NCT05329220|521119585|FG002|Active Trial Period|Physician Decision|0|||
144524126|NCT05329220|521119586|FG003|Active Trial Period|Physician Decision|0|||
144524127|NCT05329220|521119587|FG004|Active Trial Period|Physician Decision|2|||
144524128|NCT05329220|521119588|FG005|Active Trial Period|Physician Decision|0|||
144524129|NCT05329220|521119583|FG000|Active Trial Period|Protocol Violation|0|||
144524130|NCT05329220|521119584|FG001|Active Trial Period|Protocol Violation|0|||
144524131|NCT05329220|521119585|FG002|Active Trial Period|Protocol Violation|0|||
144524132|NCT05329220|521119586|FG003|Active Trial Period|Protocol Violation|0|||
144524133|NCT05329220|521119587|FG004|Active Trial Period|Protocol Violation|1|||
144524134|NCT05329220|521119588|FG005|Active Trial Period|Protocol Violation|3|||
144524135|NCT05329220|521119583|FG000|Active Trial Period|Withdrawal by Subject|0|||
144524136|NCT05329220|521119584|FG001|Active Trial Period|Withdrawal by Subject|0|||
144524137|NCT05329220|521119585|FG002|Active Trial Period|Withdrawal by Subject|0|||
144524138|NCT05329220|521119586|FG003|Active Trial Period|Withdrawal by Subject|1|||
144524139|NCT05329220|521119587|FG004|Active Trial Period|Withdrawal by Subject|12|||
144524140|NCT05329220|521119588|FG005|Active Trial Period|Withdrawal by Subject|13|||
144524141|NCT05329220|521119583|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
144524142|NCT05329220|521119584|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
144524143|NCT05329220|521119585|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
144524144|NCT05329220|521119586|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
144524145|NCT05329220|521119587|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
144524146|NCT05329220|521119588|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
144524147|NCT05329220|521119583|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
144524148|NCT05329220|521119584|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
144524149|NCT05329220|521119585|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
144524150|NCT05329220|521119586|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
144524151|NCT05329220|521119587|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
144524152|NCT05329220|521119588|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
144524153|NCT05329220|521119583|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
144524154|NCT05329220|521119584|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
144401753|NCT01013350|520681524|FG000|Overall Study|Lost to Follow-up|15|||
144401754|NCT01013350|520681525|FG001|Overall Study|Lost to Follow-up|95|||
144401755|NCT01013350|520681524|FG000|Overall Study|Adverse Event|0|||
144401756|NCT01013350|520681525|FG001|Overall Study|Adverse Event|1|||
144401757|NCT01013350|520681524|FG000|Overall Study|Physician Decision|4|||
144401758|NCT01013350|520681525|FG001|Overall Study|Physician Decision|20|||
144401759|NCT01013350|520681524|FG000|Overall Study|Withdrawal by Subject|15|||
144401760|NCT01013350|520681525|FG001|Overall Study|Withdrawal by Subject|38|||
144401761|NCT01013350|520681524|FG000|Overall Study|Death|3|||
144401762|NCT01013350|520681525|FG001|Overall Study|Death|5|||
144401763|NCT01013350|520681524|FG000|Overall Study|Participant entered interventional study|0|||
144401764|NCT01013350|520681525|FG001|Overall Study|Participant entered interventional study|8|||
144401765|NCT01013350|520681524|FG000|Overall Study|Other|1|||
144401766|NCT01013350|520681525|FG001|Overall Study|Other|25|||
144401767|NCT02639546|520681527|FG000|Overall Study|Death|2|||
144401768|NCT02639546|520681528|FG001|Overall Study|Death|2|||
144401769|NCT02639546|520681529|FG002|Overall Study|Death|1|||
144401770|NCT02639546|520681530|FG003|Overall Study|Death|2|||
144401771|NCT02639546|520681531|FG004|Overall Study|Death|2|||
144401772|NCT02639546|520681532|FG005|Overall Study|Death|2|||
144401773|NCT02639546|520681533|FG006|Overall Study|Death|0|||
144401774|NCT02639546|520681534|FG007|Overall Study|Death|0|||
144401775|NCT02639546|520681527|FG000|Overall Study|Lost to Follow-up|0|||
144401776|NCT02639546|520681528|FG001|Overall Study|Lost to Follow-up|0|||
144401777|NCT02639546|520681529|FG002|Overall Study|Lost to Follow-up|1|||
144401778|NCT02639546|520681530|FG003|Overall Study|Lost to Follow-up|0|||
144401779|NCT02639546|520681531|FG004|Overall Study|Lost to Follow-up|1|||
144401780|NCT02639546|520681532|FG005|Overall Study|Lost to Follow-up|1|||
144401781|NCT02639546|520681533|FG006|Overall Study|Lost to Follow-up|0|||
144401782|NCT02639546|520681534|FG007|Overall Study|Lost to Follow-up|1|||
144401783|NCT02639546|520681527|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
144401784|NCT02639546|520681528|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
144401785|NCT02639546|520681529|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
144401786|NCT02639546|520681530|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
144401787|NCT02639546|520681531|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
144401788|NCT02639546|520681532|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
144401789|NCT02639546|520681533|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
144401790|NCT02639546|520681534|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
144401791|NCT02639546|520681527|FG000|Overall Study|Study Terminated By Sponsor|0|||
144401792|NCT02639546|520681528|FG001|Overall Study|Study Terminated By Sponsor|2|||
144401793|NCT02639546|520681529|FG002|Overall Study|Study Terminated By Sponsor|3|||
144401794|NCT02639546|520681530|FG003|Overall Study|Study Terminated By Sponsor|4|||
144401795|NCT02639546|520681531|FG004|Overall Study|Study Terminated By Sponsor|4|||
144401796|NCT02639546|520681532|FG005|Overall Study|Study Terminated By Sponsor|3|||
144401797|NCT02639546|520681533|FG006|Overall Study|Study Terminated By Sponsor|3|||
144401798|NCT02639546|520681534|FG007|Overall Study|Study Terminated By Sponsor|9|||
144401799|NCT02639546|520681527|FG000|Overall Study|Withdrawal by Subject|2|||
144401800|NCT02639546|520681528|FG001|Overall Study|Withdrawal by Subject|2|||
144401801|NCT02639546|520681529|FG002|Overall Study|Withdrawal by Subject|1|||
144401802|NCT02639546|520681530|FG003|Overall Study|Withdrawal by Subject|0|||
144401803|NCT02639546|520681531|FG004|Overall Study|Withdrawal by Subject|0|||
144401804|NCT02639546|520681532|FG005|Overall Study|Withdrawal by Subject|1|||
144401805|NCT02639546|520681533|FG006|Overall Study|Withdrawal by Subject|2|||
144401806|NCT02639546|520681534|FG007|Overall Study|Withdrawal by Subject|1|||
144524155|NCT05329220|521119585|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
144524156|NCT05329220|521119586|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
144524157|NCT05329220|521119587|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
144524158|NCT05329220|521119588|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
144524159|NCT05329220|521119583|FG000|Follow-up Period|Adverse Event|0|||
144524160|NCT05329220|521119584|FG001|Follow-up Period|Adverse Event|0|||
144524161|NCT05329220|521119585|FG002|Follow-up Period|Adverse Event|0|||
144524162|NCT05329220|521119586|FG003|Follow-up Period|Adverse Event|0|||
144524163|NCT05329220|521119587|FG004|Follow-up Period|Adverse Event|2|||
144524164|NCT05329220|521119588|FG005|Follow-up Period|Adverse Event|1|||
144524165|NCT05329220|521119583|FG000|Follow-up Period|Death|0|||
144524166|NCT05329220|521119584|FG001|Follow-up Period|Death|0|||
144524167|NCT05329220|521119585|FG002|Follow-up Period|Death|1|||
144524168|NCT05329220|521119586|FG003|Follow-up Period|Death|1|||
144524169|NCT05329220|521119587|FG004|Follow-up Period|Death|0|||
144524170|NCT05329220|521119588|FG005|Follow-up Period|Death|1|||
144524171|NCT05329220|521119583|FG000|Follow-up Period|Lost to Follow-up|0|||
144524172|NCT05329220|521119584|FG001|Follow-up Period|Lost to Follow-up|1|||
144524173|NCT05329220|521119585|FG002|Follow-up Period|Lost to Follow-up|2|||
144524174|NCT05329220|521119586|FG003|Follow-up Period|Lost to Follow-up|2|||
144524175|NCT05329220|521119587|FG004|Follow-up Period|Lost to Follow-up|113|||
144524176|NCT05329220|521119588|FG005|Follow-up Period|Lost to Follow-up|89|||
144524177|NCT05329220|521119583|FG000|Follow-up Period|Physician Decision|0|||
144524178|NCT05329220|521119584|FG001|Follow-up Period|Physician Decision|0|||
144524179|NCT05329220|521119585|FG002|Follow-up Period|Physician Decision|0|||
144401807|NCT02478372|520681535|FG000|Overall Study|Protocol Violation|12|||
144401808|NCT02478372|520681536|FG001|Overall Study|Protocol Violation|8|||
144401809|NCT02478372|520681535|FG000|Overall Study|Lost to Follow-up|1|||
144401810|NCT02478372|520681536|FG001|Overall Study|Lost to Follow-up|4|||
144401811|NCT02478372|520681535|FG000|Overall Study|Death|0|||
144401812|NCT02478372|520681536|FG001|Overall Study|Death|2|||
144401813|NCT00669396|520681537|FG000|Overall Study|Lost to Follow-up|10|||
144401814|NCT00669396|520681538|FG001|Overall Study|Lost to Follow-up|12|||
144401815|NCT01262573|520681539|FG000|Overall Study|Withdrawal by Subject|0|||
144401816|NCT01262573|520681540|FG001|Overall Study|Withdrawal by Subject|1|||
144401817|NCT04402060|520681541|FG000|Overall Study|Death|1|||
144401818|NCT04402060|520681542|FG001|Overall Study|Death|12|||
144401819|NCT04402060|520681543|FG002|Overall Study|Death|7|||
144401820|NCT04402060|520681541|FG000|Overall Study|Adverse Event|0|||
144401821|NCT04402060|520681542|FG001|Overall Study|Adverse Event|0|||
144401822|NCT04402060|520681543|FG002|Overall Study|Adverse Event|1|||
144401823|NCT04402060|520681541|FG000|Overall Study|Withdrawal by Subject|0|||
144401824|NCT04402060|520681542|FG001|Overall Study|Withdrawal by Subject|1|||
144401825|NCT04402060|520681543|FG002|Overall Study|Withdrawal by Subject|2|||
144401826|NCT04402060|520681541|FG000|Overall Study|Sponsor Request|0|||
144401827|NCT04402060|520681542|FG001|Overall Study|Sponsor Request|2|||
144401828|NCT04402060|520681543|FG002|Overall Study|Sponsor Request|0|||
144401829|NCT04402060|520681541|FG000|Overall Study|Physician Decision|0|||
144401830|NCT04402060|520681542|FG001|Overall Study|Physician Decision|0|||
144401831|NCT04402060|520681543|FG002|Overall Study|Physician Decision|1|||
144401832|NCT04402060|520681541|FG000|Overall Study|Other|0|||
144401833|NCT04402060|520681542|FG001|Overall Study|Other|1|||
144401834|NCT04402060|520681543|FG002|Overall Study|Other|0|||
144401835|NCT03212690|520681546|FG000|Overall Study|Protocol Violation|1|||
144401836|NCT01297920|520681547|FG000|Overall Study|Adverse Event|42|||
144401837|NCT01297920|520681548|FG001|Overall Study|Adverse Event|10|||
144401838|NCT01297920|520681549|FG002|Overall Study|Adverse Event|38|||
144401839|NCT01297920|520681547|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
144401840|NCT01297920|520681548|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
144401841|NCT01297920|520681549|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
144401842|NCT01297920|520681547|FG000|Overall Study|Noncompliance|1|||
144401843|NCT01297920|520681548|FG001|Overall Study|Noncompliance|0|||
144401844|NCT01297920|520681549|FG002|Overall Study|Noncompliance|0|||
144401845|NCT01297920|520681547|FG000|Overall Study|Protocol Violation|1|||
144401846|NCT01297920|520681548|FG001|Overall Study|Protocol Violation|3|||
144401847|NCT01297920|520681549|FG002|Overall Study|Protocol Violation|0|||
144524180|NCT05329220|521119586|FG003|Follow-up Period|Physician Decision|0|||
144524181|NCT05329220|521119587|FG004|Follow-up Period|Physician Decision|2|||
144524182|NCT05329220|521119588|FG005|Follow-up Period|Physician Decision|2|||
144524183|NCT05329220|521119583|FG000|Follow-up Period|Protocol Violation|0|||
144524184|NCT05329220|521119584|FG001|Follow-up Period|Protocol Violation|0|||
144524185|NCT05329220|521119585|FG002|Follow-up Period|Protocol Violation|0|||
144524186|NCT05329220|521119586|FG003|Follow-up Period|Protocol Violation|0|||
144524187|NCT05329220|521119587|FG004|Follow-up Period|Protocol Violation|0|||
144524188|NCT05329220|521119588|FG005|Follow-up Period|Protocol Violation|1|||
144524189|NCT05329220|521119583|FG000|Follow-up Period|Withdrawal by Subject|0|||
144524190|NCT05329220|521119584|FG001|Follow-up Period|Withdrawal by Subject|0|||
144524191|NCT05329220|521119585|FG002|Follow-up Period|Withdrawal by Subject|1|||
144524192|NCT05329220|521119586|FG003|Follow-up Period|Withdrawal by Subject|1|||
144524193|NCT05329220|521119587|FG004|Follow-up Period|Withdrawal by Subject|34|||
144524194|NCT05329220|521119588|FG005|Follow-up Period|Withdrawal by Subject|35|||
144524195|NCT05329220|521119583|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
144524196|NCT05329220|521119584|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
144524197|NCT05329220|521119585|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
144524198|NCT05329220|521119586|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
144524199|NCT05329220|521119587|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
144524200|NCT05329220|521119588|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
144524201|NCT05329220|521119583|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
144722381|NCT02227862|521838696|FG001|Overall Study|Other|2|||
144401848|NCT01297920|520681547|FG000|Overall Study|Inadequate Control of IOP|7|||
144401849|NCT01297920|520681548|FG001|Overall Study|Inadequate Control of IOP|9|||
144401850|NCT01297920|520681549|FG002|Overall Study|Inadequate Control of IOP|17|||
144401851|NCT01297920|520681547|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
144524202|NCT05329220|521119584|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
144524203|NCT05329220|521119585|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
144722382|NCT02227862|521838695|FG000|Overall Study|Adverse Event|4|||
144401852|NCT01297920|520681548|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
144401853|NCT01297920|520681549|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
144401854|NCT02507973|520681551|FG000|Overall Study|Adverse Event|1|||
144401855|NCT00474760|520681552|FG000|Overall Study|Death|0|||
144401856|NCT00474760|520681553|FG001|Overall Study|Death|0|||
144401857|NCT00474760|520681554|FG002|Overall Study|Death|0|||
144401858|NCT00474760|520681555|FG003|Overall Study|Death|0|||
144401859|NCT00474760|520681556|FG004|Overall Study|Death|2|||
144401860|NCT00474760|520681557|FG005|Overall Study|Death|0|||
144401861|NCT00474760|520681558|FG006|Overall Study|Death|0|||
144401862|NCT00474760|520681552|FG000|Overall Study|Adverse Event|0|||
144401863|NCT00474760|520681553|FG001|Overall Study|Adverse Event|0|||
144401864|NCT00474760|520681554|FG002|Overall Study|Adverse Event|0|||
144401865|NCT00474760|520681555|FG003|Overall Study|Adverse Event|0|||
144401866|NCT00474760|520681556|FG004|Overall Study|Adverse Event|1|||
144401867|NCT00474760|520681557|FG005|Overall Study|Adverse Event|7|||
144401868|NCT00474760|520681558|FG006|Overall Study|Adverse Event|0|||
144401869|NCT00474760|520681552|FG000|Overall Study|Laboratory abnormality|0|||
144401870|NCT00474760|520681553|FG001|Overall Study|Laboratory abnormality|0|||
144401871|NCT00474760|520681554|FG002|Overall Study|Laboratory abnormality|0|||
144401872|NCT00474760|520681555|FG003|Overall Study|Laboratory abnormality|0|||
144401873|NCT00474760|520681556|FG004|Overall Study|Laboratory abnormality|0|||
144401874|NCT00474760|520681557|FG005|Overall Study|Laboratory abnormality|1|||
144401875|NCT00474760|520681558|FG006|Overall Study|Laboratory abnormality|0|||
144401876|NCT00474760|520681552|FG000|Overall Study|Withdrawal by Subject|0|||
144401877|NCT00474760|520681553|FG001|Overall Study|Withdrawal by Subject|0|||
144401878|NCT00474760|520681554|FG002|Overall Study|Withdrawal by Subject|0|||
144401879|NCT00474760|520681555|FG003|Overall Study|Withdrawal by Subject|1|||
144401880|NCT00474760|520681556|FG004|Overall Study|Withdrawal by Subject|0|||
144401881|NCT00474760|520681557|FG005|Overall Study|Withdrawal by Subject|1|||
144401882|NCT00474760|520681558|FG006|Overall Study|Withdrawal by Subject|1|||
144401883|NCT00474760|520681552|FG000|Overall Study|Other|0|||
144401884|NCT00474760|520681553|FG001|Overall Study|Other|1|||
144401885|NCT00474760|520681554|FG002|Overall Study|Other|0|||
144401886|NCT00474760|520681555|FG003|Overall Study|Other|0|||
144401887|NCT00474760|520681556|FG004|Overall Study|Other|1|||
144401888|NCT00474760|520681557|FG005|Overall Study|Other|0|||
144401889|NCT00474760|520681558|FG006|Overall Study|Other|0|||
144401890|NCT00474760|520681552|FG000|Overall Study|Progressive disease|3|||
144401891|NCT00474760|520681553|FG001|Overall Study|Progressive disease|2|||
144401892|NCT00474760|520681554|FG002|Overall Study|Progressive disease|3|||
144401893|NCT00474760|520681555|FG003|Overall Study|Progressive disease|2|||
144401894|NCT00474760|520681556|FG004|Overall Study|Progressive disease|8|||
144401895|NCT00474760|520681557|FG005|Overall Study|Progressive disease|20|||
144401896|NCT00474760|520681558|FG006|Overall Study|Progressive disease|7|||
144401897|NCT00474760|520681552|FG000|Overall Study|Terminated by sponsor|0|||
144401898|NCT00474760|520681553|FG001|Overall Study|Terminated by sponsor|0|||
144401899|NCT00474760|520681554|FG002|Overall Study|Terminated by sponsor|0|||
144401900|NCT00474760|520681555|FG003|Overall Study|Terminated by sponsor|0|||
144401901|NCT00474760|520681556|FG004|Overall Study|Terminated by sponsor|0|||
144401902|NCT00474760|520681557|FG005|Overall Study|Terminated by sponsor|0|||
144401903|NCT00474760|520681558|FG006|Overall Study|Terminated by sponsor|2|||
144401904|NCT01927627|520681559|FG000|Overall Study|Adverse Event|3|||
144401905|NCT01927627|520681559|FG000|Overall Study|Lack of Efficacy|1|||
144401906|NCT01927627|520681559|FG000|Overall Study|Financial Concerns|1|||
144401907|NCT00910273|520681562|FG000|Overall Study|Lack of Efficacy|6|||
144401908|NCT00910273|520681563|FG001|Overall Study|Lack of Efficacy|9|||
144401909|NCT00910273|520681562|FG000|Overall Study|Adverse Event|1|||
144401910|NCT00910273|520681563|FG001|Overall Study|Adverse Event|1|||
144401911|NCT00910273|520681562|FG000|Overall Study|Withdrawal by Subject|1|||
144401912|NCT00910273|520681563|FG001|Overall Study|Withdrawal by Subject|0|||
144524204|NCT05329220|521119586|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
144524205|NCT05329220|521119587|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
144524206|NCT05329220|521119588|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
144524207|NCT05329220|521119583|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
144524208|NCT05329220|521119584|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
144524209|NCT05329220|521119585|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
144524210|NCT05329220|521119586|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
144524211|NCT05329220|521119587|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
144524212|NCT05329220|521119588|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
144524213|NCT05329220|521119583|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
144401913|NCT00910273|520681562|FG000|Overall Study|Discontinuation of study by sponsor|8|||
144401914|NCT00910273|520681563|FG001|Overall Study|Discontinuation of study by sponsor|2|||
144401915|NCT00910273|520681562|FG000|Overall Study|Protocol Violation|1|||
144401916|NCT00910273|520681563|FG001|Overall Study|Protocol Violation|0|||
144401917|NCT00910273|520681562|FG000|Overall Study|Lost to Follow-up|1|||
144401918|NCT00910273|520681563|FG001|Overall Study|Lost to Follow-up|1|||
144401919|NCT02155881|520681564|FG000|Overall Study|Withdrawal by Subject|0|||
144401920|NCT02155881|520681565|FG001|Overall Study|Withdrawal by Subject|2|||
144401921|NCT02155881|520681564|FG000|Overall Study|Inappropriately randomized|2|||
144401922|NCT02155881|520681565|FG001|Overall Study|Inappropriately randomized|2|||
144401923|NCT04357782|520681566|FG000|Overall Study|Discharged from hospital|1|||
144401924|NCT04357782|520681567|FG001|Overall Study|Discharged from hospital|0|||
144401925|NCT04357782|520681566|FG000|Overall Study|Death|0|||
144401926|NCT04357782|520681567|FG001|Overall Study|Death|2|||
144401927|NCT01786148|520681568|FG000|Overall Study|Lost to Follow-up|21|||
144401928|NCT01786148|520681569|FG001|Overall Study|Lost to Follow-up|13|||
144401929|NCT01786148|520681568|FG000|Overall Study|Death|0|||
144401930|NCT01786148|520681569|FG001|Overall Study|Death|1|||
144401931|NCT01786148|520681568|FG000|Overall Study|Withdrawal by Subject|0|||
144401932|NCT01786148|520681569|FG001|Overall Study|Withdrawal by Subject|7|||
144401933|NCT01786148|520681568|FG000|Overall Study|Incarceration|1|||
144401934|NCT01786148|520681569|FG001|Overall Study|Incarceration|1|||
144401935|NCT03780543|520681571|FG000|Overall Study|Adverse Event|1|||
144401936|NCT03780543|520681572|FG001|Overall Study|Adverse Event|0|||
144401937|NCT03780543|520681573|FG002|Overall Study|Adverse Event|2|||
144401938|NCT03780543|520681571|FG000|Overall Study|Lost to Follow-up|2|||
144401939|NCT03780543|520681572|FG001|Overall Study|Lost to Follow-up|0|||
144401940|NCT03780543|520681573|FG002|Overall Study|Lost to Follow-up|1|||
144401941|NCT03780543|520681571|FG000|Overall Study|Study terminated by Sponsor|8|||
144401942|NCT03780543|520681572|FG001|Overall Study|Study terminated by Sponsor|7|||
144401943|NCT03780543|520681573|FG002|Overall Study|Study terminated by Sponsor|13|||
144401944|NCT03780543|520681571|FG000|Overall Study|Withdrawal by Subject|1|||
144401945|NCT03780543|520681572|FG001|Overall Study|Withdrawal by Subject|8|||
144401946|NCT03780543|520681573|FG002|Overall Study|Withdrawal by Subject|1|||
144401947|NCT03780543|520681571|FG000|Overall Study|Noncompliance with study drug|1|||
144401948|NCT03780543|520681572|FG001|Overall Study|Noncompliance with study drug|0|||
144401949|NCT03780543|520681573|FG002|Overall Study|Noncompliance with study drug|0|||
144401950|NCT00066729|520681574|FG000|Overall Study|Lost to Follow-up|1|||
144401951|NCT00066729|520681574|FG000|Overall Study|Disease progression|1|||
144401952|NCT02215096|520681575|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
144401953|NCT02215096|520681576|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
144401954|NCT02215096|520681577|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
144401955|NCT02215096|520681578|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
144401956|NCT02215096|520681579|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
144401957|NCT02215096|520681575|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
144401958|NCT02215096|520681576|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
144401959|NCT02215096|520681577|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
144401960|NCT02215096|520681578|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
144401961|NCT02215096|520681579|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
144401962|NCT02215096|520681575|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
144401963|NCT02215096|520681576|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
144401964|NCT02215096|520681577|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
144401965|NCT02215096|520681578|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
144401966|NCT02215096|520681579|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
144401967|NCT02215096|520681575|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
144401968|NCT02215096|520681576|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
144401969|NCT02215096|520681577|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
144401970|NCT02215096|520681578|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
144401971|NCT02215096|520681579|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
144401972|NCT02349542|520681580|FG000|Overall Study|Withdrawal by Subject|5|||
144401973|NCT02840721|520681581|FG000|Treatment Period|Adverse Event|1|||
144401974|NCT02840721|520681581|FG000|Follow-Up|Lack of Efficacy|1|||
144401975|NCT02840721|520681581|FG000|Follow-Up|Withdrawal by Subject|4|||
144401976|NCT02840721|520681581|FG000|Follow-Up|Withdrawal of Consent|2|||
144401977|NCT01967173|520681582|FG000|Overall Study|Lost to Follow-up|5|||
144401978|NCT01967173|520681583|FG001|Overall Study|Lost to Follow-up|3|||
144401979|NCT01967173|520681584|FG002|Overall Study|Lost to Follow-up|2|||
144401980|NCT01967173|520681585|FG003|Overall Study|Lost to Follow-up|4|||
144401981|NCT01967173|520681586|FG004|Overall Study|Lost to Follow-up|8|||
144401982|NCT01967173|520681587|FG005|Overall Study|Lost to Follow-up|12|||
144401983|NCT01967173|520681588|FG006|Overall Study|Lost to Follow-up|6|||
144401984|NCT01967173|520681589|FG007|Overall Study|Lost to Follow-up|8|||
144401985|NCT01967173|520681582|FG000|Overall Study|Physician Decision|2|||
144401986|NCT01967173|520681583|FG001|Overall Study|Physician Decision|0|||
144401987|NCT01967173|520681584|FG002|Overall Study|Physician Decision|2|||
144401988|NCT01967173|520681585|FG003|Overall Study|Physician Decision|1|||
144401989|NCT01967173|520681586|FG004|Overall Study|Physician Decision|1|||
144401990|NCT01967173|520681587|FG005|Overall Study|Physician Decision|1|||
144401991|NCT01967173|520681588|FG006|Overall Study|Physician Decision|1|||
144401992|NCT01967173|520681589|FG007|Overall Study|Physician Decision|0|||
144401993|NCT01967173|520681582|FG000|Overall Study|Lack of Efficacy|2|||
144401994|NCT01967173|520681583|FG001|Overall Study|Lack of Efficacy|0|||
144401995|NCT01967173|520681584|FG002|Overall Study|Lack of Efficacy|2|||
144401996|NCT01967173|520681585|FG003|Overall Study|Lack of Efficacy|2|||
144401997|NCT01967173|520681586|FG004|Overall Study|Lack of Efficacy|0|||
144524214|NCT05329220|521119584|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
144401998|NCT01967173|520681587|FG005|Overall Study|Lack of Efficacy|1|||
144401999|NCT01967173|520681588|FG006|Overall Study|Lack of Efficacy|0|||
144402000|NCT01967173|520681589|FG007|Overall Study|Lack of Efficacy|2|||
144402001|NCT01967173|520681582|FG000|Overall Study|Pregnancy|0|||
144402002|NCT01967173|520681583|FG001|Overall Study|Pregnancy|0|||
144402003|NCT01967173|520681584|FG002|Overall Study|Pregnancy|0|||
144402004|NCT01967173|520681585|FG003|Overall Study|Pregnancy|0|||
144402005|NCT01967173|520681586|FG004|Overall Study|Pregnancy|0|||
144402006|NCT01967173|520681587|FG005|Overall Study|Pregnancy|0|||
144402007|NCT01967173|520681588|FG006|Overall Study|Pregnancy|1|||
144402008|NCT01967173|520681589|FG007|Overall Study|Pregnancy|1|||
144402009|NCT01967173|520681582|FG000|Overall Study|Adverse Event|0|||
144402010|NCT01967173|520681583|FG001|Overall Study|Adverse Event|0|||
144402011|NCT01967173|520681584|FG002|Overall Study|Adverse Event|0|||
144402012|NCT01967173|520681585|FG003|Overall Study|Adverse Event|0|||
144402013|NCT01967173|520681586|FG004|Overall Study|Adverse Event|0|||
144402014|NCT01967173|520681587|FG005|Overall Study|Adverse Event|0|||
144402015|NCT01967173|520681588|FG006|Overall Study|Adverse Event|0|||
144402016|NCT01967173|520681589|FG007|Overall Study|Adverse Event|1|||
144402017|NCT01967173|520681582|FG000|Overall Study|Withdrawal by Subject|15|||
144402018|NCT01967173|520681583|FG001|Overall Study|Withdrawal by Subject|14|||
144402019|NCT01967173|520681584|FG002|Overall Study|Withdrawal by Subject|10|||
144402020|NCT01967173|520681585|FG003|Overall Study|Withdrawal by Subject|7|||
144402021|NCT01967173|520681586|FG004|Overall Study|Withdrawal by Subject|8|||
144402022|NCT01967173|520681587|FG005|Overall Study|Withdrawal by Subject|9|||
144402023|NCT01967173|520681588|FG006|Overall Study|Withdrawal by Subject|10|||
144402024|NCT01967173|520681589|FG007|Overall Study|Withdrawal by Subject|12|||
144402025|NCT03021304|520681593|FG000|Overall Study|Lack of Efficacy|1|||
144402026|NCT04122534|520681599|FG000|Overall Study|Lost to Follow-up|4|||
144402027|NCT03113916|520681600|FG000|Overall Study|Withdrawal by Subject|9|||
144402028|NCT03113916|520681601|FG001|Overall Study|Withdrawal by Subject|7|||
144402029|NCT03113916|520681600|FG000|Overall Study|Pregnancy|1|||
144402030|NCT03113916|520681601|FG001|Overall Study|Pregnancy|3|||
144402031|NCT03113916|520681600|FG000|Overall Study|Lost to Follow-up|1|||
144402032|NCT03113916|520681601|FG001|Overall Study|Lost to Follow-up|2|||
144598552|NCT02598557|521392468|FG001|Overall Study|Adverse Event|1|||
144598553|NCT02598557|521392469|FG002|Overall Study|Adverse Event|0|||
144598554|NCT02072434|521392470|FG000|Overall Study|Protocol Violation|10|||
144598555|NCT02072434|521392471|FG001|Overall Study|Protocol Violation|9|||
144598556|NCT02072434|521392470|FG000|Overall Study|Physician Decision|5|||
144598557|NCT02072434|521392471|FG001|Overall Study|Physician Decision|10|||
144598558|NCT02072434|521392470|FG000|Overall Study|Adverse event, serious fatal|1|||
144598559|NCT02072434|521392471|FG001|Overall Study|Adverse event, serious fatal|6|||
144598560|NCT02072434|521392470|FG000|Overall Study|Adverse Event|7|||
144598561|NCT02072434|521392471|FG001|Overall Study|Adverse Event|6|||
144402033|NCT01999868|520681602|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
144402034|NCT01999868|520681603|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
144598562|NCT02072434|521392470|FG000|Overall Study|Withdrawal by Subject|17|||
144598563|NCT02072434|521392471|FG001|Overall Study|Withdrawal by Subject|29|||
144598564|NCT02072434|521392470|FG000|Overall Study|Other|14|||
144598565|NCT02072434|521392471|FG001|Overall Study|Other|29|||
144598566|NCT02072434|521392470|FG000|Overall Study|Lost to Follow-up|0|||
144598567|NCT02072434|521392471|FG001|Overall Study|Lost to Follow-up|1|||
144598568|NCT00888433|521392476|FG000|Overall Study|Withdrawal by Subject|1|||
144402035|NCT01999868|520681604|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
144402036|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
144402037|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
144402038|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
144402039|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
144402040|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
144402041|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
144402042|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
144402043|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
144402044|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
144402045|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
144598569|NCT00888433|521392477|FG001|Overall Study|Withdrawal by Subject|2|||
144402046|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
144402047|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
144402048|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
144402049|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
144402050|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
144402051|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
144402052|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
144402053|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
144598570|NCT00888433|521392476|FG000|Overall Study|Missed Visit|2|||
144402054|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
144402055|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
144402056|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
144402057|NCT01999868|520681602|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
144402058|NCT01999868|520681603|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
144402059|NCT01999868|520681604|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
144402060|NCT01999868|520681602|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
144402061|NCT01999868|520681603|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
144402062|NCT01999868|520681604|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
144402063|NCT01999868|520681602|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
144598571|NCT00888433|521392477|FG001|Overall Study|Missed Visit|1|||
144598572|NCT04175808|521392478|FG000|Part A|Miscellaneous|2|||
144598573|NCT04175808|521392479|FG001|Part A|Miscellaneous|0|||
144598574|NCT04175808|521392480|FG002|Part A|Miscellaneous|0|||
144598575|NCT04175808|521392481|FG003|Part A|Miscellaneous|0|||
144598576|NCT04175808|521392482|FG004|Part A|Miscellaneous|0|||
144598577|NCT04175808|521392483|FG005|Part A|Miscellaneous|0|||
144598578|NCT04175808|521392484|FG006|Part A|Miscellaneous|0|||
144598579|NCT04796896|521392486|FG000|Overall Study|Adverse Event|1|||
144598580|NCT04796896|521392487|FG001|Overall Study|Adverse Event|0|||
144598581|NCT04796896|521392488|FG002|Overall Study|Adverse Event|0|||
144598582|NCT04796896|521392489|FG003|Overall Study|Adverse Event|0|||
144598583|NCT04796896|521392490|FG004|Overall Study|Adverse Event|0|||
144598584|NCT04796896|521392491|FG005|Overall Study|Adverse Event|1|||
144598585|NCT04796896|521392492|FG006|Overall Study|Adverse Event|1|||
144598586|NCT04796896|521392493|FG007|Overall Study|Adverse Event|0|||
144598587|NCT04796896|521392494|FG008|Overall Study|Adverse Event|1|||
144598588|NCT04796896|521392495|FG009|Overall Study|Adverse Event|1|||
144598589|NCT04796896|521392496|FG010|Overall Study|Adverse Event|1|||
144598590|NCT04796896|521392497|FG011|Overall Study|Adverse Event|0|||
144598591|NCT04796896|521392486|FG000|Overall Study|Lost to Follow-up|24|||
144598592|NCT04796896|521392487|FG001|Overall Study|Lost to Follow-up|15|||
144598593|NCT04796896|521392488|FG002|Overall Study|Lost to Follow-up|6|||
144598594|NCT04796896|521392489|FG003|Overall Study|Lost to Follow-up|4|||
144598595|NCT04796896|521392490|FG004|Overall Study|Lost to Follow-up|21|||
144598596|NCT04796896|521392491|FG005|Overall Study|Lost to Follow-up|55|||
144598597|NCT04796896|521392492|FG006|Overall Study|Lost to Follow-up|237|||
144598598|NCT04796896|521392493|FG007|Overall Study|Lost to Follow-up|52|||
144598599|NCT04796896|521392494|FG008|Overall Study|Lost to Follow-up|221|||
144598600|NCT04796896|521392495|FG009|Overall Study|Lost to Follow-up|43|||
144598601|NCT04796896|521392496|FG010|Overall Study|Lost to Follow-up|142|||
144598602|NCT04796896|521392497|FG011|Overall Study|Lost to Follow-up|18|||
144598603|NCT04796896|521392486|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
144598604|NCT04796896|521392487|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
144598605|NCT04796896|521392488|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
144598606|NCT04796896|521392489|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
144598607|NCT04796896|521392490|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
144598608|NCT04796896|521392491|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
144598609|NCT04796896|521392492|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
144598610|NCT04796896|521392493|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
144598611|NCT04796896|521392494|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
144598612|NCT04796896|521392495|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
144598613|NCT04796896|521392496|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
144598614|NCT04796896|521392497|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
144598615|NCT04796896|521392486|FG000|Overall Study|Physician Decision|1|||
144598616|NCT04796896|521392487|FG001|Overall Study|Physician Decision|0|||
144598617|NCT04796896|521392488|FG002|Overall Study|Physician Decision|0|||
144598618|NCT04796896|521392489|FG003|Overall Study|Physician Decision|0|||
144598619|NCT04796896|521392490|FG004|Overall Study|Physician Decision|0|||
144598620|NCT04796896|521392491|FG005|Overall Study|Physician Decision|3|||
144598621|NCT04796896|521392492|FG006|Overall Study|Physician Decision|18|||
144598622|NCT04796896|521392493|FG007|Overall Study|Physician Decision|1|||
144598623|NCT04796896|521392494|FG008|Overall Study|Physician Decision|7|||
144598624|NCT04796896|521392495|FG009|Overall Study|Physician Decision|0|||
144598625|NCT04796896|521392496|FG010|Overall Study|Physician Decision|5|||
144598626|NCT04796896|521392497|FG011|Overall Study|Physician Decision|0|||
144598627|NCT04796896|521392486|FG000|Overall Study|Withdrawal by Subject|36|||
144598628|NCT04796896|521392487|FG001|Overall Study|Withdrawal by Subject|31|||
144598629|NCT04796896|521392488|FG002|Overall Study|Withdrawal by Subject|11|||
144598630|NCT04796896|521392489|FG003|Overall Study|Withdrawal by Subject|8|||
144722383|NCT02227862|521838696|FG001|Overall Study|Adverse Event|3|||
144402064|NCT01999868|520681603|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
144598631|NCT04796896|521392490|FG004|Overall Study|Withdrawal by Subject|16|||
144598632|NCT04796896|521392491|FG005|Overall Study|Withdrawal by Subject|162|||
144402065|NCT01999868|520681604|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
144402066|NCT01999868|520681602|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
144402067|NCT01999868|520681603|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
144402068|NCT01999868|520681604|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
144402069|NCT01999868|520681602|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
144402070|NCT01999868|520681603|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
144402071|NCT01999868|520681604|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
144402072|NCT01999868|520681602|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
144402073|NCT01999868|520681603|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
144402074|NCT01999868|520681604|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
144402075|NCT01999868|520681602|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
144402076|NCT01999868|520681603|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
144402077|NCT01999868|520681604|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
144402078|NCT00761631|520681605|FG000|Overall Study|Parent/legal guardian request|8|||
144402079|NCT00761631|520681606|FG001|Overall Study|Parent/legal guardian request|3|||
144402080|NCT00761631|520681607|FG002|Overall Study|Parent/legal guardian request|8|||
144402081|NCT00761631|520681608|FG003|Overall Study|Parent/legal guardian request|0|||
144402082|NCT00761631|520681609|FG004|Overall Study|Parent/legal guardian request|5|||
144402083|NCT00761631|520681610|FG005|Overall Study|Parent/legal guardian request|0|||
144402084|NCT00761631|520681605|FG000|Overall Study|Lost to Follow-up|2|||
144402085|NCT00761631|520681606|FG001|Overall Study|Lost to Follow-up|4|||
144402086|NCT00761631|520681607|FG002|Overall Study|Lost to Follow-up|7|||
144402087|NCT00761631|520681608|FG003|Overall Study|Lost to Follow-up|1|||
144402088|NCT00761631|520681609|FG004|Overall Study|Lost to Follow-up|6|||
144402089|NCT00761631|520681610|FG005|Overall Study|Lost to Follow-up|1|||
144402090|NCT00761631|520681605|FG000|Overall Study|Protocol Violation|2|||
144402091|NCT00761631|520681606|FG001|Overall Study|Protocol Violation|0|||
144402092|NCT00761631|520681607|FG002|Overall Study|Protocol Violation|0|||
144402093|NCT00761631|520681608|FG003|Overall Study|Protocol Violation|1|||
144402094|NCT00761631|520681609|FG004|Overall Study|Protocol Violation|5|||
144402095|NCT00761631|520681610|FG005|Overall Study|Protocol Violation|1|||
144402096|NCT00761631|520681605|FG000|Overall Study|Randomized, not treated|1|||
144402097|NCT00761631|520681606|FG001|Overall Study|Randomized, not treated|0|||
144402098|NCT00761631|520681607|FG002|Overall Study|Randomized, not treated|0|||
144402099|NCT00761631|520681608|FG003|Overall Study|Randomized, not treated|0|||
144402100|NCT00761631|520681609|FG004|Overall Study|Randomized, not treated|0|||
144402101|NCT00761631|520681610|FG005|Overall Study|Randomized, not treated|0|||
144402102|NCT00761631|520681605|FG000|Overall Study|Failed to return|1|||
144402103|NCT00761631|520681606|FG001|Overall Study|Failed to return|0|||
144402104|NCT00761631|520681607|FG002|Overall Study|Failed to return|1|||
144402105|NCT00761631|520681608|FG003|Overall Study|Failed to return|1|||
144402106|NCT00761631|520681609|FG004|Overall Study|Failed to return|5|||
144402107|NCT00761631|520681610|FG005|Overall Study|Failed to return|2|||
144402108|NCT00761631|520681605|FG000|Overall Study|Physician Decision|1|||
144402109|NCT00761631|520681606|FG001|Overall Study|Physician Decision|0|||
144402110|NCT00761631|520681607|FG002|Overall Study|Physician Decision|0|||
144402111|NCT00761631|520681608|FG003|Overall Study|Physician Decision|0|||
144402112|NCT00761631|520681609|FG004|Overall Study|Physician Decision|0|||
144402113|NCT00761631|520681610|FG005|Overall Study|Physician Decision|0|||
144402114|NCT00761631|520681605|FG000|Overall Study|Other|0|||
144402115|NCT00761631|520681606|FG001|Overall Study|Other|0|||
144402116|NCT00761631|520681607|FG002|Overall Study|Other|0|||
144402117|NCT00761631|520681608|FG003|Overall Study|Other|0|||
144402118|NCT00761631|520681609|FG004|Overall Study|Other|1|||
144402119|NCT00761631|520681610|FG005|Overall Study|Other|1|||
144402120|NCT00289016|520681613|FG000|Overall Study|Disease Progression|29|||
144402121|NCT00289016|520681613|FG000|Overall Study|Death|2|||
144402122|NCT00289016|520681613|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
144402123|NCT00289016|520681613|FG000|Overall Study|Withdrawal by Subject|2|||
144402124|NCT00289016|520681613|FG000|Overall Study|Adverse Event|1|||
144402125|NCT00289016|520681613|FG000|Overall Study|Other|1|||
144402126|NCT00319501|520681614|FG000|Double-blind Period|Withdrawal by Subject|0|||
144402127|NCT00319501|520681615|FG001|Double-blind Period|Withdrawal by Subject|3|||
144402128|NCT00319501|520681614|FG000|Double-blind Period|Sponsor Request|1|||
144524215|NCT05329220|521119585|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
144524216|NCT05329220|521119586|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
144524217|NCT05329220|521119587|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
144524218|NCT05329220|521119588|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
144402129|NCT00319501|520681615|FG001|Double-blind Period|Sponsor Request|0|||
144402130|NCT00319501|520681614|FG000|Double-blind Period|Did not receive treatment|42|||
144402131|NCT00319501|520681615|FG001|Double-blind Period|Did not receive treatment|29|||
144402132|NCT00319501|520681614|FG000|Open-label Period|Adverse Event|5|||
144524219|NCT05329220|521119583|FG000|Follow-up Period|EARLY TERMINATION|0|||
144524220|NCT05329220|521119584|FG001|Follow-up Period|EARLY TERMINATION|0|||
144598633|NCT04796896|521392492|FG006|Overall Study|Withdrawal by Subject|299|||
144598634|NCT04796896|521392493|FG007|Overall Study|Withdrawal by Subject|149|||
144598635|NCT04796896|521392494|FG008|Overall Study|Withdrawal by Subject|303|||
144598636|NCT04796896|521392495|FG009|Overall Study|Withdrawal by Subject|94|||
144598637|NCT04796896|521392496|FG010|Overall Study|Withdrawal by Subject|192|||
144402133|NCT00319501|520681615|FG001|Open-label Period|Adverse Event|0|||
144402134|NCT00319501|520681614|FG000|Open-label Period|Protocol Violation|6|||
144402135|NCT00319501|520681615|FG001|Open-label Period|Protocol Violation|0|||
144402136|NCT00319501|520681614|FG000|Open-label Period|Withdrawal by Subject|38|||
144402137|NCT00319501|520681615|FG001|Open-label Period|Withdrawal by Subject|0|||
144402138|NCT00319501|520681614|FG000|Open-label Period|Principal Investigator decision|6|||
144402139|NCT00319501|520681615|FG001|Open-label Period|Principal Investigator decision|0|||
144402140|NCT00319501|520681614|FG000|Open-label Period|Sponsor request|12|||
144402141|NCT00319501|520681615|FG001|Open-label Period|Sponsor request|0|||
144402142|NCT00319501|520681614|FG000|Open-label Period|Lost to Follow-up|5|||
144402143|NCT00319501|520681615|FG001|Open-label Period|Lost to Follow-up|0|||
144402144|NCT00319501|520681614|FG000|Open-label Period|Did not receive treatment|33|||
144402145|NCT00319501|520681615|FG001|Open-label Period|Did not receive treatment|0|||
144402146|NCT00319501|520681614|FG000|Open-label Period|Other|11|||
144402147|NCT00319501|520681615|FG001|Open-label Period|Other|0|||
144402148|NCT00319501|520681614|FG000|Open-label Extension Period|Adverse Event|2|||
144402149|NCT00319501|520681615|FG001|Open-label Extension Period|Adverse Event|0|||
144402150|NCT00319501|520681614|FG000|Open-label Extension Period|Did not receive treatment|18|||
144402151|NCT00319501|520681615|FG001|Open-label Extension Period|Did not receive treatment|0|||
144402152|NCT00319501|520681614|FG000|Open-label Extension Period|Other|1|||
144402153|NCT00319501|520681615|FG001|Open-label Extension Period|Other|0|||
144402154|NCT00319501|520681614|FG000|Open-label Extension Period|Principal investigator decision|2|||
144402155|NCT00319501|520681615|FG001|Open-label Extension Period|Principal investigator decision|0|||
144402156|NCT00319501|520681614|FG000|Open-label Extension Period|Sponsor request|26|||
144402157|NCT00319501|520681615|FG001|Open-label Extension Period|Sponsor request|0|||
144598638|NCT04796896|521392497|FG011|Overall Study|Withdrawal by Subject|16|||
144598639|NCT04796896|521392486|FG000|Overall Study|Other Than Specified|6|||
144249890|NCT03053427|520111789|FG001|Overall Study|Withdrawal by Subject|2|||
144249891|NCT03053427|520111788|FG000|Overall Study|Miscellaneous|0|||
144524221|NCT05329220|521119585|FG002|Follow-up Period|EARLY TERMINATION|0|||
144524222|NCT05329220|521119586|FG003|Follow-up Period|EARLY TERMINATION|0|||
144524223|NCT05329220|521119587|FG004|Follow-up Period|EARLY TERMINATION|0|||
144402158|NCT00319501|520681614|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
144402159|NCT00319501|520681615|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
144402160|NCT00667875|520681617|FG000|Overall Study|Adverse Event|0|||
144402161|NCT00667875|520681618|FG001|Overall Study|Adverse Event|2|||
144402162|NCT00667875|520681619|FG002|Overall Study|Adverse Event|6|||
144402163|NCT00667875|520681617|FG000|Overall Study|Withdrawal by Subject|10|||
144402164|NCT00667875|520681618|FG001|Overall Study|Withdrawal by Subject|9|||
144524224|NCT05329220|521119588|FG005|Follow-up Period|EARLY TERMINATION|1|||
144524225|NCT05329220|521119583|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
144402165|NCT00667875|520681619|FG002|Overall Study|Withdrawal by Subject|7|||
144402166|NCT00450255|520681620|FG000|Overall Study|Prior RFA ablation of liver|1|||
144402167|NCT01441180|520681626|FG000|Overall Study|Lost to Follow-up|1|||
144402168|NCT01441180|520681627|FG001|Overall Study|Lost to Follow-up|1|||
144402169|NCT01441180|520681628|FG002|Overall Study|Lost to Follow-up|1|||
144402170|NCT01441180|520681626|FG000|Overall Study|Discontinued|0|||
144402171|NCT01441180|520681627|FG001|Overall Study|Discontinued|0|||
144402172|NCT01441180|520681628|FG002|Overall Study|Discontinued|2|||
144402173|NCT03360747|520681631|FG000|Overall Study|Voluntary Withdrawal|1|||
144402174|NCT01759511|520681632|FG000|Overall Study|Adverse Event|4|||
144402175|NCT01759511|520681632|FG000|Overall Study|Death|2|||
144402176|NCT01759511|520681632|FG000|Overall Study|Lack of Efficacy|2|||
144402177|NCT01759511|520681632|FG000|Overall Study|Physician Decision|1|||
144402178|NCT01759511|520681632|FG000|Overall Study|Progressive Disease|5|||
144402179|NCT01759511|520681632|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
144402180|NCT01759511|520681632|FG000|Overall Study|Study Terminated by Sponsor|13|||
144402181|NCT01759511|520681632|FG000|Overall Study|Withdrawal by Subject|3|||
144524226|NCT05329220|521119584|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
144402182|NCT02612129|520681633|FG000|Single Dose Treatment Period|Screening Failure|1|||
144402183|NCT02612129|520681634|FG001|Single Dose Treatment Period|Screening Failure|0|||
144524227|NCT05329220|521119585|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
144598640|NCT04796896|521392487|FG001|Overall Study|Other Than Specified|5|||
144598641|NCT04796896|521392488|FG002|Overall Study|Other Than Specified|3|||
144249892|NCT03053427|520111789|FG001|Overall Study|Miscellaneous|1|||
144402184|NCT02612129|520681635|FG002|Single Dose Treatment Period|Screening Failure|0|||
144402185|NCT02612129|520681633|FG000|Continuous Treatment Period|Early Escape|0|||
144402186|NCT02612129|520681634|FG001|Continuous Treatment Period|Early Escape|2|||
144598642|NCT04796896|521392489|FG003|Overall Study|Other Than Specified|2|||
144402187|NCT02612129|520681635|FG002|Continuous Treatment Period|Early Escape|0|||
144402188|NCT02612129|520681633|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
144402189|NCT02612129|520681634|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
144402190|NCT02612129|520681635|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
144402191|NCT02612129|520681633|FG000|Continuous Treatment Period|Safety Reasons|0|||
144402192|NCT02612129|520681634|FG001|Continuous Treatment Period|Safety Reasons|3|||
144402193|NCT02612129|520681635|FG002|Continuous Treatment Period|Safety Reasons|0|||
144402194|NCT02612129|520681633|FG000|Continuous Treatment Period|Death|0|||
144402195|NCT02612129|520681634|FG001|Continuous Treatment Period|Death|1|||
144402196|NCT02612129|520681635|FG002|Continuous Treatment Period|Death|0|||
144402197|NCT02612129|520681633|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
144402198|NCT02612129|520681634|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
144402199|NCT02612129|520681635|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
144598643|NCT04796896|521392490|FG004|Overall Study|Other Than Specified|6|||
144598644|NCT04796896|521392491|FG005|Overall Study|Other Than Specified|31|||
144598645|NCT04796896|521392492|FG006|Overall Study|Other Than Specified|86|||
144598646|NCT04796896|521392493|FG007|Overall Study|Other Than Specified|66|||
144402200|NCT06238362|520681636|FG000|Overall Study|Insufficient total sleep time|1|||
144402201|NCT06238362|520681637|FG001|Overall Study|Insufficient total sleep time|0|||
144402202|NCT06238362|520681636|FG000|Overall Study|Inadequate signal quality|1|||
144402203|NCT06238362|520681637|FG001|Overall Study|Inadequate signal quality|0|||
144402204|NCT01644565|520682968|FG000|Overall Study|Undisclosed Medical History|1|||
144402205|NCT01644565|520682969|FG001|Overall Study|Undisclosed Medical History|0|||
144402206|NCT01644565|520682970|FG002|Overall Study|Undisclosed Medical History|0|||
144402207|NCT01644565|520682971|FG003|Overall Study|Undisclosed Medical History|0|||
144402208|NCT01644565|520682972|FG004|Overall Study|Undisclosed Medical History|0|||
144402209|NCT01644565|520682973|FG005|Overall Study|Undisclosed Medical History|0|||
144402210|NCT01644565|520682974|FG006|Overall Study|Undisclosed Medical History|0|||
144402211|NCT01644565|520682975|FG007|Overall Study|Undisclosed Medical History|0|||
144402212|NCT01644565|520682976|FG008|Overall Study|Undisclosed Medical History|0|||
144524228|NCT05329220|521119586|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
144524229|NCT05329220|521119587|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
144524230|NCT05329220|521119588|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
144524231|NCT05329220|521119583|FG000|Follow-up Period|DROPPED|0|||
144524232|NCT05329220|521119584|FG001|Follow-up Period|DROPPED|0|||
144524233|NCT05329220|521119585|FG002|Follow-up Period|DROPPED|0|||
144524234|NCT05329220|521119586|FG003|Follow-up Period|DROPPED|0|||
144524235|NCT05329220|521119587|FG004|Follow-up Period|DROPPED|0|||
144524236|NCT05329220|521119588|FG005|Follow-up Period|DROPPED|1|||
144524237|NCT05329220|521119583|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
144524238|NCT05329220|521119584|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
144524239|NCT05329220|521119585|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
144524240|NCT05329220|521119586|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
144524241|NCT05329220|521119587|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
144524242|NCT05329220|521119588|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
144524243|NCT02465268|521119590|FG000|Overall Study|Withdrawal by Subject|4|||
144524244|NCT02465268|521119591|FG001|Overall Study|Withdrawal by Subject|3|||
144524245|NCT02465268|521119592|FG002|Overall Study|Withdrawal by Subject|1|||
144524246|NCT02465268|521119590|FG000|Overall Study|Not evaluable per protocol criteria|3|||
144524247|NCT02465268|521119591|FG001|Overall Study|Not evaluable per protocol criteria|2|||
144524248|NCT02465268|521119592|FG002|Overall Study|Not evaluable per protocol criteria|1|||
144524249|NCT02465268|521119590|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
144524250|NCT02465268|521119591|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
144524251|NCT02465268|521119592|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
144524252|NCT02465268|521119590|FG000|Overall Study|Study drug did not pass QA/QC|1|||
144524253|NCT02465268|521119591|FG001|Overall Study|Study drug did not pass QA/QC|0|||
144524254|NCT02465268|521119592|FG002|Overall Study|Study drug did not pass QA/QC|0|||
144524255|NCT02465268|521119590|FG000|Overall Study|Adverse Event|0|||
144524256|NCT02465268|521119591|FG001|Overall Study|Adverse Event|1|||
144598647|NCT04796896|521392494|FG008|Overall Study|Other Than Specified|388|||
144598648|NCT04796896|521392495|FG009|Overall Study|Other Than Specified|48|||
144598649|NCT04796896|521392496|FG010|Overall Study|Other Than Specified|258|||
144598650|NCT04796896|521392497|FG011|Overall Study|Other Than Specified|4|||
144598651|NCT04796896|521392486|FG000|Overall Study|Protocol Deviation|0|||
144598652|NCT04796896|521392487|FG001|Overall Study|Protocol Deviation|0|||
144598653|NCT04796896|521392488|FG002|Overall Study|Protocol Deviation|0|||
144598654|NCT04796896|521392489|FG003|Overall Study|Protocol Deviation|1|||
144598655|NCT04796896|521392490|FG004|Overall Study|Protocol Deviation|1|||
144598656|NCT04796896|521392491|FG005|Overall Study|Protocol Deviation|2|||
144598657|NCT04796896|521392492|FG006|Overall Study|Protocol Deviation|2|||
144598658|NCT04796896|521392493|FG007|Overall Study|Protocol Deviation|2|||
144598659|NCT04796896|521392494|FG008|Overall Study|Protocol Deviation|2|||
144598660|NCT04796896|521392495|FG009|Overall Study|Protocol Deviation|1|||
144598661|NCT04796896|521392496|FG010|Overall Study|Protocol Deviation|0|||
144598662|NCT04796896|521392497|FG011|Overall Study|Protocol Deviation|0|||
144598663|NCT04796896|521392486|FG000|Overall Study|Missing|0|||
144598664|NCT04796896|521392487|FG001|Overall Study|Missing|0|||
144598665|NCT04796896|521392488|FG002|Overall Study|Missing|0|||
144598666|NCT04796896|521392489|FG003|Overall Study|Missing|0|||
144402213|NCT01644565|520682968|FG000|Overall Study|Lost to Follow-up|0|||
144402214|NCT01644565|520682969|FG001|Overall Study|Lost to Follow-up|0|||
144402215|NCT01644565|520682970|FG002|Overall Study|Lost to Follow-up|0|||
144402216|NCT01644565|520682971|FG003|Overall Study|Lost to Follow-up|1|||
144402217|NCT01644565|520682972|FG004|Overall Study|Lost to Follow-up|0|||
144402218|NCT01644565|520682973|FG005|Overall Study|Lost to Follow-up|0|||
144402219|NCT01644565|520682974|FG006|Overall Study|Lost to Follow-up|0|||
144402220|NCT01644565|520682975|FG007|Overall Study|Lost to Follow-up|2|||
144402221|NCT01644565|520682976|FG008|Overall Study|Lost to Follow-up|0|||
144402222|NCT01644565|520682968|FG000|Overall Study|Family emergency|0|||
144402223|NCT01644565|520682969|FG001|Overall Study|Family emergency|0|||
144402224|NCT01644565|520682970|FG002|Overall Study|Family emergency|0|||
144402225|NCT01644565|520682971|FG003|Overall Study|Family emergency|0|||
144402226|NCT01644565|520682972|FG004|Overall Study|Family emergency|1|||
144402227|NCT01644565|520682973|FG005|Overall Study|Family emergency|0|||
144402228|NCT01644565|520682974|FG006|Overall Study|Family emergency|0|||
144402229|NCT01644565|520682975|FG007|Overall Study|Family emergency|0|||
144402230|NCT01644565|520682976|FG008|Overall Study|Family emergency|0|||
144402231|NCT01644565|520682968|FG000|Overall Study|Relocation|0|||
144402232|NCT01644565|520682969|FG001|Overall Study|Relocation|0|||
144402233|NCT01644565|520682970|FG002|Overall Study|Relocation|0|||
144402234|NCT01644565|520682971|FG003|Overall Study|Relocation|0|||
144402235|NCT01644565|520682972|FG004|Overall Study|Relocation|0|||
144402236|NCT01644565|520682973|FG005|Overall Study|Relocation|0|||
144524257|NCT02465268|521119592|FG002|Overall Study|Adverse Event|0|||
144524258|NCT02465268|521119590|FG000|Overall Study|Physician Decision|0|||
144524259|NCT02465268|521119591|FG001|Overall Study|Physician Decision|1|||
144524260|NCT02465268|521119592|FG002|Overall Study|Physician Decision|0|||
144524261|NCT00506519|521121897|FG000|Overall Study|Death|4|||
144524262|NCT00506519|521121898|FG001|Overall Study|Death|6|||
144524263|NCT00506519|521121899|FG002|Overall Study|Death|0|||
144524264|NCT00506519|521121897|FG000|Overall Study|Adverse Event|1|||
144524265|NCT00506519|521121898|FG001|Overall Study|Adverse Event|0|||
144524266|NCT00506519|521121899|FG002|Overall Study|Adverse Event|0|||
144524267|NCT02975882|521121900|FG000|Overall Study|Adverse Event|1|||
144524268|NCT02975882|521121901|FG001|Overall Study|Adverse Event|2|||
144524269|NCT02975882|521121902|FG002|Overall Study|Adverse Event|1|||
144524270|NCT02975882|521121903|FG003|Overall Study|Adverse Event|1|||
144524271|NCT02975882|521121900|FG000|Overall Study|Death|0|||
144524272|NCT02975882|521121901|FG001|Overall Study|Death|1|||
144524273|NCT02975882|521121902|FG002|Overall Study|Death|0|||
144524274|NCT02975882|521121903|FG003|Overall Study|Death|0|||
144524275|NCT02975882|521121900|FG000|Overall Study|Lack of Efficacy|3|||
144524276|NCT02975882|521121901|FG001|Overall Study|Lack of Efficacy|7|||
144524277|NCT02975882|521121902|FG002|Overall Study|Lack of Efficacy|4|||
144524278|NCT02975882|521121903|FG003|Overall Study|Lack of Efficacy|3|||
144524279|NCT02975882|521121900|FG000|Overall Study|Physician Decision|0|||
144524280|NCT02975882|521121901|FG001|Overall Study|Physician Decision|2|||
144524281|NCT02975882|521121902|FG002|Overall Study|Physician Decision|4|||
144524282|NCT02975882|521121903|FG003|Overall Study|Physician Decision|2|||
144524283|NCT02975882|521121900|FG000|Overall Study|Ineligible|0|||
144524284|NCT02975882|521121901|FG001|Overall Study|Ineligible|1|||
144598667|NCT04796896|521392490|FG004|Overall Study|Missing|0|||
144524285|NCT02975882|521121902|FG002|Overall Study|Ineligible|0|||
144524286|NCT02975882|521121903|FG003|Overall Study|Ineligible|0|||
144598668|NCT04796896|521392491|FG005|Overall Study|Missing|0|||
144598669|NCT04796896|521392492|FG006|Overall Study|Missing|2|||
144402237|NCT01644565|520682974|FG006|Overall Study|Relocation|0|||
144402238|NCT01644565|520682975|FG007|Overall Study|Relocation|0|||
144402239|NCT01644565|520682976|FG008|Overall Study|Relocation|1|||
144402240|NCT03689530|520682984|FG000|Overall Study|Withdrawal by Subject|53|||
144402241|NCT03689530|520682985|FG001|Overall Study|Withdrawal by Subject|16|||
144402242|NCT01392443|520682986|FG000|Overall Study|Disease progression|30|||
144524287|NCT02105766|521121904|FG000|Overall Study|Physician Decision|1|||
144402243|NCT01392443|520682986|FG000|Overall Study|Adverse Event|24|||
144524288|NCT02105766|521121905|FG001|Overall Study|Physician Decision|1|||
144524289|NCT02105766|521121906|FG002|Overall Study|Physician Decision|0|||
144524290|NCT02105766|521121904|FG000|Overall Study|Lost to Follow-up|2|||
144524291|NCT02105766|521121905|FG001|Overall Study|Lost to Follow-up|0|||
144524292|NCT02105766|521121906|FG002|Overall Study|Lost to Follow-up|0|||
144598670|NCT04796896|521392493|FG007|Overall Study|Missing|1|||
144524293|NCT02105766|521121904|FG000|Overall Study|Death|1|||
144524294|NCT02105766|521121905|FG001|Overall Study|Death|1|||
144524295|NCT02105766|521121906|FG002|Overall Study|Death|0|||
144524296|NCT02985957|521121908|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144524297|NCT02985957|521121909|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144524298|NCT02985957|521121910|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144524299|NCT02985957|521121911|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144524300|NCT02985957|521121912|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144524301|NCT02985957|521121913|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144524302|NCT02985957|521121914|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144524303|NCT02985957|521121908|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
144524304|NCT02985957|521121909|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
144524305|NCT02985957|521121910|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
144524306|NCT02985957|521121911|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
144524307|NCT02985957|521121912|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
144524308|NCT02985957|521121913|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
144524309|NCT02985957|521121914|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
144524310|NCT02985957|521121908|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144524311|NCT02985957|521121909|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144524312|NCT02985957|521121910|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144524313|NCT02985957|521121911|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144524314|NCT02985957|521121912|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144524315|NCT02985957|521121913|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144524316|NCT02985957|521121914|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
144524317|NCT02985957|521121908|FG000|Treatment Period|Death|0|||
144524318|NCT02985957|521121909|FG001|Treatment Period|Death|0|||
144524319|NCT02985957|521121910|FG002|Treatment Period|Death|0|||
144524320|NCT02985957|521121911|FG003|Treatment Period|Death|0|||
144524321|NCT02985957|521121912|FG004|Treatment Period|Death|1|||
144524322|NCT02985957|521121913|FG005|Treatment Period|Death|0|||
144524323|NCT02985957|521121914|FG006|Treatment Period|Death|0|||
144524324|NCT02985957|521121908|FG000|Treatment Period|Participant withdrew consent|0|||
144524325|NCT02985957|521121909|FG001|Treatment Period|Participant withdrew consent|0|||
144524326|NCT02985957|521121910|FG002|Treatment Period|Participant withdrew consent|0|||
144524327|NCT02985957|521121911|FG003|Treatment Period|Participant withdrew consent|1|||
144524328|NCT02985957|521121912|FG004|Treatment Period|Participant withdrew consent|3|||
144524329|NCT02985957|521121913|FG005|Treatment Period|Participant withdrew consent|0|||
144524330|NCT02985957|521121914|FG006|Treatment Period|Participant withdrew consent|1|||
144524331|NCT02985957|521121908|FG000|Treatment Period|Lost to Follow-up|0|||
144524332|NCT02985957|521121909|FG001|Treatment Period|Lost to Follow-up|0|||
144524333|NCT02985957|521121910|FG002|Treatment Period|Lost to Follow-up|0|||
144524334|NCT02985957|521121911|FG003|Treatment Period|Lost to Follow-up|0|||
144524335|NCT02985957|521121912|FG004|Treatment Period|Lost to Follow-up|1|||
144524336|NCT02985957|521121913|FG005|Treatment Period|Lost to Follow-up|0|||
144524337|NCT02985957|521121914|FG006|Treatment Period|Lost to Follow-up|0|||
144524338|NCT02985957|521121908|FG000|Treatment Period|Other reasons|0|||
144524339|NCT02985957|521121909|FG001|Treatment Period|Other reasons|0|||
144524340|NCT02985957|521121910|FG002|Treatment Period|Other reasons|1|||
144524341|NCT02985957|521121911|FG003|Treatment Period|Other reasons|3|||
144524342|NCT02985957|521121912|FG004|Treatment Period|Other reasons|6|||
144524343|NCT02985957|521121913|FG005|Treatment Period|Other reasons|0|||
144524344|NCT02985957|521121914|FG006|Treatment Period|Other reasons|1|||
144524345|NCT02985957|521121908|FG000|Treatment Period|Not reported|0|||
144524346|NCT02985957|521121909|FG001|Treatment Period|Not reported|1|||
144524347|NCT02985957|521121910|FG002|Treatment Period|Not reported|2|||
144524348|NCT02985957|521121911|FG003|Treatment Period|Not reported|5|||
144524349|NCT02985957|521121912|FG004|Treatment Period|Not reported|0|||
144524350|NCT02985957|521121913|FG005|Treatment Period|Not reported|0|||
144524351|NCT02985957|521121914|FG006|Treatment Period|Not reported|0|||
144524352|NCT02985957|521121908|FG000|Treatment Period|Maximum clinical benefit|0|||
144524353|NCT02985957|521121909|FG001|Treatment Period|Maximum clinical benefit|0|||
144524354|NCT02985957|521121910|FG002|Treatment Period|Maximum clinical benefit|1|||
144524355|NCT02985957|521121911|FG003|Treatment Period|Maximum clinical benefit|1|||
144524356|NCT02985957|521121912|FG004|Treatment Period|Maximum clinical benefit|0|||
144524357|NCT02985957|521121913|FG005|Treatment Period|Maximum clinical benefit|0|||
144524358|NCT02985957|521121914|FG006|Treatment Period|Maximum clinical benefit|2|||
144524359|NCT02985957|521121908|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
144524360|NCT02985957|521121909|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
144524361|NCT02985957|521121910|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
144524362|NCT02985957|521121911|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
144524363|NCT02985957|521121912|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
144524364|NCT02985957|521121913|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
144598671|NCT04796896|521392494|FG008|Overall Study|Missing|2|||
144402244|NCT01392443|520682986|FG000|Overall Study|Death|7|||
144402245|NCT01392443|520682986|FG000|Overall Study|Withdrawal by Subject|5|||
144402246|NCT01392443|520682986|FG000|Overall Study|Lost to Follow-up|1|||
144402247|NCT01392443|520682986|FG000|Overall Study|Protocol Violation|1|||
144402248|NCT01977794|520682989|FG000|Overall Study|Adverse Event|2|||
144402249|NCT01977794|520682990|FG001|Overall Study|Adverse Event|2|||
144402250|NCT01977794|520682989|FG000|Overall Study|Lost to Follow-up|2|||
144402251|NCT01977794|520682990|FG001|Overall Study|Lost to Follow-up|1|||
144402252|NCT01977794|520682989|FG000|Overall Study|Protocol Violation|1|||
144402253|NCT01977794|520682990|FG001|Overall Study|Protocol Violation|0|||
144402254|NCT01977794|520682989|FG000|Overall Study|Death|1|||
144402255|NCT01977794|520682990|FG001|Overall Study|Death|1|||
144402256|NCT01977794|520682989|FG000|Overall Study|Withdrew consent|2|||
144402257|NCT01977794|520682990|FG001|Overall Study|Withdrew consent|1|||
144402258|NCT01977794|520682989|FG000|Overall Study|Other|0|||
144402259|NCT01977794|520682990|FG001|Overall Study|Other|1|||
144402260|NCT01626456|520682991|FG000|Overall Study|Withdrawal by Subject|21|||
144402261|NCT01626456|520682992|FG001|Overall Study|Withdrawal by Subject|46|||
144402262|NCT01626456|520682991|FG000|Overall Study|Adverse Event|2|||
144402263|NCT01626456|520682992|FG001|Overall Study|Adverse Event|27|||
144402264|NCT01626456|520682991|FG000|Overall Study|Lost to Follow-up|2|||
144402265|NCT01626456|520682992|FG001|Overall Study|Lost to Follow-up|27|||
144598672|NCT04796896|521392495|FG009|Overall Study|Missing|1|||
144598673|NCT04796896|521392496|FG010|Overall Study|Missing|1|||
144598674|NCT04796896|521392497|FG011|Overall Study|Missing|0|||
144598675|NCT04796896|521392486|FG000|Overall Study|Death|0|||
144598676|NCT04796896|521392487|FG001|Overall Study|Death|0|||
144598677|NCT04796896|521392488|FG002|Overall Study|Death|0|||
144598678|NCT04796896|521392489|FG003|Overall Study|Death|0|||
144598679|NCT04796896|521392490|FG004|Overall Study|Death|0|||
144598680|NCT04796896|521392491|FG005|Overall Study|Death|0|||
144598681|NCT04796896|521392492|FG006|Overall Study|Death|0|||
144402266|NCT01626456|520682991|FG000|Overall Study|Lack of Efficacy|6|||
144402267|NCT01626456|520682992|FG001|Overall Study|Lack of Efficacy|7|||
144402268|NCT01626456|520682991|FG000|Overall Study|Physician Decision|1|||
144402269|NCT01626456|520682992|FG001|Overall Study|Physician Decision|4|||
144402270|NCT01626456|520682991|FG000|Overall Study|Protocol Violation|1|||
144402271|NCT01626456|520682992|FG001|Overall Study|Protocol Violation|1|||
144598682|NCT04796896|521392493|FG007|Overall Study|Death|0|||
144402272|NCT01626456|520682991|FG000|Overall Study|Site Closure|2|||
144402273|NCT01626456|520682992|FG001|Overall Study|Site Closure|3|||
144402274|NCT01626456|520682991|FG000|Overall Study|Incarceration|0|||
144402275|NCT01626456|520682992|FG001|Overall Study|Incarceration|2|||
144402276|NCT00246753|520682994|FG000|Overall Study|Withdrawal by Subject|2|||
144402277|NCT00246753|520682994|FG000|Overall Study|Physician Decision|2|||
144402278|NCT00246753|520682994|FG000|Overall Study|Adverse Event|2|||
144402279|NCT00246753|520682994|FG000|Overall Study|Unacceptable toxicity|2|||
144402280|NCT03019185|520682997|FG000|Overall Study|Lost to Follow-up|3|||
144402281|NCT03019185|520682998|FG001|Overall Study|Lost to Follow-up|0|||
144402282|NCT03019185|520682999|FG002|Overall Study|Lost to Follow-up|2|||
144402283|NCT03019185|520682997|FG000|Overall Study|Withdrawal by Subject|1|||
144402284|NCT03019185|520682998|FG001|Overall Study|Withdrawal by Subject|1|||
144402285|NCT03019185|520682999|FG002|Overall Study|Withdrawal by Subject|0|||
144402286|NCT03019185|520682997|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
144402287|NCT03019185|520682998|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
144402288|NCT03019185|520682999|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
144402289|NCT03019185|520682997|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
144402290|NCT03019185|520682998|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
144402291|NCT03019185|520682999|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
144402292|NCT00617851|520683000|FG000|Overall Study|Death|0|||
144402293|NCT00617851|520683001|FG001|Overall Study|Death|0|||
144402294|NCT00617851|520683002|FG002|Overall Study|Death|0|||
144402295|NCT00617851|520683003|FG003|Overall Study|Death|1|||
144402296|NCT00617851|520683000|FG000|Overall Study|Withdrawal by Subject|14|||
144402297|NCT00617851|520683001|FG001|Overall Study|Withdrawal by Subject|7|||
144402298|NCT00617851|520683002|FG002|Overall Study|Withdrawal by Subject|12|||
144402299|NCT00617851|520683003|FG003|Overall Study|Withdrawal by Subject|4|||
144402300|NCT00617851|520683000|FG000|Overall Study|Lost to Follow-up|27|||
144402301|NCT00617851|520683001|FG001|Overall Study|Lost to Follow-up|29|||
144402302|NCT00617851|520683002|FG002|Overall Study|Lost to Follow-up|31|||
144402303|NCT00617851|520683003|FG003|Overall Study|Lost to Follow-up|19|||
144402304|NCT00617851|520683000|FG000|Overall Study|Inappropriate Enrollment|5|||
144402305|NCT00617851|520683001|FG001|Overall Study|Inappropriate Enrollment|4|||
144402306|NCT00617851|520683002|FG002|Overall Study|Inappropriate Enrollment|1|||
144402307|NCT00617851|520683003|FG003|Overall Study|Inappropriate Enrollment|1|||
144402308|NCT00617851|520683000|FG000|Overall Study|Unable to classify|1|||
144598683|NCT04796896|521392494|FG008|Overall Study|Death|1|||
144402309|NCT00617851|520683001|FG001|Overall Study|Unable to classify|0|||
144598684|NCT04796896|521392495|FG009|Overall Study|Death|0|||
144598685|NCT04796896|521392496|FG010|Overall Study|Death|0|||
144402310|NCT00617851|520683002|FG002|Overall Study|Unable to classify|1|||
144402311|NCT00617851|520683003|FG003|Overall Study|Unable to classify|0|||
144402312|NCT00491764|520683007|FG000|Overall Study|Adverse Event|1|||
144402313|NCT00491764|520683008|FG001|Overall Study|Adverse Event|2|||
144402314|NCT00491764|520683009|FG002|Overall Study|Adverse Event|4|||
144402315|NCT00491764|520683010|FG003|Overall Study|Adverse Event|4|||
144402316|NCT00491764|520683011|FG004|Overall Study|Adverse Event|0|||
144402317|NCT00491764|520683012|FG005|Overall Study|Adverse Event|1|||
144402318|NCT00491764|520683007|FG000|Overall Study|Lost to Follow-up|0|||
144402319|NCT00491764|520683008|FG001|Overall Study|Lost to Follow-up|1|||
144402320|NCT00491764|520683009|FG002|Overall Study|Lost to Follow-up|0|||
144402321|NCT00491764|520683010|FG003|Overall Study|Lost to Follow-up|1|||
144402322|NCT00491764|520683011|FG004|Overall Study|Lost to Follow-up|0|||
144402323|NCT00491764|520683012|FG005|Overall Study|Lost to Follow-up|3|||
144402324|NCT00491764|520683007|FG000|Overall Study|Withdrawal by Subject|2|||
144402325|NCT00491764|520683008|FG001|Overall Study|Withdrawal by Subject|3|||
144402326|NCT00491764|520683009|FG002|Overall Study|Withdrawal by Subject|1|||
144402327|NCT00491764|520683010|FG003|Overall Study|Withdrawal by Subject|2|||
144402328|NCT00491764|520683011|FG004|Overall Study|Withdrawal by Subject|2|||
144402329|NCT00491764|520683012|FG005|Overall Study|Withdrawal by Subject|4|||
144402330|NCT00491764|520683007|FG000|Overall Study|Non Compliance with the Protocol|1|||
144402331|NCT00491764|520683008|FG001|Overall Study|Non Compliance with the Protocol|0|||
144402332|NCT00491764|520683009|FG002|Overall Study|Non Compliance with the Protocol|0|||
144402333|NCT00491764|520683010|FG003|Overall Study|Non Compliance with the Protocol|0|||
144402334|NCT00491764|520683011|FG004|Overall Study|Non Compliance with the Protocol|0|||
144402335|NCT00491764|520683012|FG005|Overall Study|Non Compliance with the Protocol|0|||
144402336|NCT00491764|520683007|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
144402337|NCT00491764|520683008|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
144402338|NCT00491764|520683009|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
144402339|NCT00491764|520683010|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
144402340|NCT00491764|520683011|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
144402341|NCT00491764|520683012|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
144402342|NCT00491764|520683007|FG000|Overall Study|Administrative|1|||
144402343|NCT00491764|520683008|FG001|Overall Study|Administrative|0|||
144402344|NCT00491764|520683009|FG002|Overall Study|Administrative|2|||
144402345|NCT00491764|520683010|FG003|Overall Study|Administrative|1|||
144402346|NCT00491764|520683011|FG004|Overall Study|Administrative|0|||
144402347|NCT00491764|520683012|FG005|Overall Study|Administrative|0|||
144402348|NCT02110238|520683013|FG000|12 Week Pivotal Phase|Adverse Event|3|||
144402349|NCT02110238|520683014|FG001|12 Week Pivotal Phase|Adverse Event|0|||
144402350|NCT02110238|520683013|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
144402351|NCT02110238|520683014|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
144402352|NCT02110238|520683013|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
144402353|NCT02110238|520683014|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
144402354|NCT02110238|520683013|FG000|12 Week Pivotal Phase|Physician Decision|0|||
144402355|NCT02110238|520683014|FG001|12 Week Pivotal Phase|Physician Decision|2|||
144402356|NCT02110238|520683013|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
144402357|NCT02110238|520683014|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
144402358|NCT02110238|520683013|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
144402359|NCT02110238|520683014|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
144402360|NCT02110238|520683013|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
144402361|NCT02110238|520683014|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
144402362|NCT02110238|520683013|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
144402363|NCT02110238|520683014|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
144402364|NCT02110238|520683013|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
144402365|NCT02110238|520683014|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
144402366|NCT02110238|520683013|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
144402367|NCT02110238|520683014|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
144402368|NCT02110238|520683013|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
144402369|NCT02110238|520683014|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
144402370|NCT01365052|520683024|FG000|Overall Study|Adverse Event|4|||
144402371|NCT01365052|520683025|FG001|Overall Study|Adverse Event|4|||
144402372|NCT00850070|520683026|FG000|Overall Study|Lack of Efficacy|1|||
144402373|NCT00850070|520683027|FG001|Overall Study|Lack of Efficacy|1|||
144402374|NCT00850070|520683026|FG000|Overall Study|Adverse Event|2|||
144402375|NCT00850070|520683027|FG001|Overall Study|Adverse Event|0|||
144402376|NCT00074984|520683028|FG000|Overall Study|Death|1|||
144402377|NCT00074984|520683029|FG001|Overall Study|Death|2|||
144402378|NCT00074984|520683028|FG000|Overall Study|Withdrawal by Subject|2|||
144402379|NCT00074984|520683029|FG001|Overall Study|Withdrawal by Subject|3|||
144402380|NCT00074984|520683028|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
144402381|NCT00074984|520683029|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
144402382|NCT02202980|520683030|FG000|Overall Study|Lack of Efficacy|1|||
144402383|NCT02202980|520683031|FG001|Overall Study|Lack of Efficacy|0|||
144402384|NCT02202980|520683032|FG002|Overall Study|Lack of Efficacy|7|||
144402385|NCT02202980|520683033|FG003|Overall Study|Lack of Efficacy|0|||
144402386|NCT02202980|520683034|FG004|Overall Study|Lack of Efficacy|3|||
144402387|NCT02202980|520683035|FG005|Overall Study|Lack of Efficacy|1|||
144402388|NCT02202980|520683036|FG006|Overall Study|Lack of Efficacy|11|||
144402389|NCT02202980|520683037|FG007|Overall Study|Lack of Efficacy|2|||
144402390|NCT02202980|520683038|FG008|Overall Study|Lack of Efficacy|2|||
144402391|NCT02202980|520683039|FG009|Overall Study|Lack of Efficacy|0|||
144402392|NCT02202980|520683040|FG010|Overall Study|Lack of Efficacy|0|||
144402393|NCT02202980|520683041|FG011|Overall Study|Lack of Efficacy|3|||
144402394|NCT02202980|520683042|FG012|Overall Study|Lack of Efficacy|10|||
144402395|NCT02202980|520683043|FG013|Overall Study|Lack of Efficacy|0|||
144402396|NCT02202980|520683030|FG000|Overall Study|Protocol Violation|0|||
144402397|NCT02202980|520683031|FG001|Overall Study|Protocol Violation|0|||
144402398|NCT02202980|520683032|FG002|Overall Study|Protocol Violation|0|||
144402399|NCT02202980|520683033|FG003|Overall Study|Protocol Violation|3|||
144402400|NCT02202980|520683034|FG004|Overall Study|Protocol Violation|3|||
144402401|NCT02202980|520683035|FG005|Overall Study|Protocol Violation|0|||
144402402|NCT02202980|520683036|FG006|Overall Study|Protocol Violation|0|||
144402403|NCT02202980|520683037|FG007|Overall Study|Protocol Violation|0|||
144402404|NCT02202980|520683038|FG008|Overall Study|Protocol Violation|0|||
144402405|NCT02202980|520683039|FG009|Overall Study|Protocol Violation|0|||
144402406|NCT02202980|520683040|FG010|Overall Study|Protocol Violation|0|||
144402407|NCT02202980|520683041|FG011|Overall Study|Protocol Violation|0|||
144402408|NCT02202980|520683042|FG012|Overall Study|Protocol Violation|0|||
144402409|NCT02202980|520683043|FG013|Overall Study|Protocol Violation|0|||
144402410|NCT02202980|520683030|FG000|Overall Study|Lost to Follow-up|0|||
144402411|NCT02202980|520683031|FG001|Overall Study|Lost to Follow-up|1|||
144402412|NCT02202980|520683032|FG002|Overall Study|Lost to Follow-up|1|||
144402413|NCT02202980|520683033|FG003|Overall Study|Lost to Follow-up|1|||
144402414|NCT02202980|520683034|FG004|Overall Study|Lost to Follow-up|0|||
144402415|NCT02202980|520683035|FG005|Overall Study|Lost to Follow-up|0|||
144402416|NCT02202980|520683036|FG006|Overall Study|Lost to Follow-up|0|||
144402417|NCT02202980|520683037|FG007|Overall Study|Lost to Follow-up|1|||
144402418|NCT02202980|520683038|FG008|Overall Study|Lost to Follow-up|1|||
144402419|NCT02202980|520683039|FG009|Overall Study|Lost to Follow-up|0|||
144402420|NCT02202980|520683040|FG010|Overall Study|Lost to Follow-up|0|||
144402421|NCT02202980|520683041|FG011|Overall Study|Lost to Follow-up|0|||
144402422|NCT02202980|520683042|FG012|Overall Study|Lost to Follow-up|1|||
144402423|NCT02202980|520683043|FG013|Overall Study|Lost to Follow-up|0|||
144402424|NCT02202980|520683030|FG000|Overall Study|Withdrew Consent|0|||
144402425|NCT02202980|520683031|FG001|Overall Study|Withdrew Consent|1|||
144402426|NCT02202980|520683032|FG002|Overall Study|Withdrew Consent|2|||
144402427|NCT02202980|520683033|FG003|Overall Study|Withdrew Consent|0|||
144402428|NCT02202980|520683034|FG004|Overall Study|Withdrew Consent|0|||
144402429|NCT02202980|520683035|FG005|Overall Study|Withdrew Consent|0|||
144402430|NCT02202980|520683036|FG006|Overall Study|Withdrew Consent|0|||
144402431|NCT02202980|520683037|FG007|Overall Study|Withdrew Consent|0|||
144402432|NCT02202980|520683038|FG008|Overall Study|Withdrew Consent|1|||
144402433|NCT02202980|520683039|FG009|Overall Study|Withdrew Consent|0|||
144402434|NCT02202980|520683040|FG010|Overall Study|Withdrew Consent|0|||
144402435|NCT02202980|520683041|FG011|Overall Study|Withdrew Consent|0|||
144402436|NCT02202980|520683042|FG012|Overall Study|Withdrew Consent|0|||
144402437|NCT02202980|520683043|FG013|Overall Study|Withdrew Consent|0|||
144402438|NCT01522248|520683044|FG000|Overall Study|Lost to Follow-up|1|||
144402439|NCT01522248|520683045|FG001|Overall Study|Lost to Follow-up|0|||
144402440|NCT04138810|520683049|FG000|Overall Study|Withdrawal by Subject|0|||
144402441|NCT04138810|520683050|FG001|Overall Study|Withdrawal by Subject|1|||
144402442|NCT04138810|520683049|FG000|Overall Study|Subject cancelled surgery|1|||
144402443|NCT04138810|520683050|FG001|Overall Study|Subject cancelled surgery|0|||
144402444|NCT00591344|520683051|FG000|Overall Study|Transportation issues|1|||
144402445|NCT00591344|520683052|FG001|Overall Study|Transportation issues|0|||
144402446|NCT00591344|520683051|FG000|Overall Study|Moved out of state|1|||
144402447|NCT00591344|520683052|FG001|Overall Study|Moved out of state|0|||
144402448|NCT00591344|520683051|FG000|Overall Study|Medical complications|1|||
144402449|NCT00591344|520683052|FG001|Overall Study|Medical complications|3|||
144402450|NCT00591344|520683051|FG000|Overall Study|Underwent DBS|2|||
144402451|NCT00591344|520683052|FG001|Overall Study|Underwent DBS|2|||
144402452|NCT00591344|520683051|FG000|Overall Study|Death|0|||
144402453|NCT00591344|520683052|FG001|Overall Study|Death|1|||
144402454|NCT00591344|520683051|FG000|Overall Study|Lost to Follow-up|0|||
144402455|NCT00591344|520683052|FG001|Overall Study|Lost to Follow-up|1|||
144402456|NCT00591344|520683051|FG000|Overall Study|Did not want to come off medication|0|||
144402457|NCT00591344|520683052|FG001|Overall Study|Did not want to come off medication|1|||
144402458|NCT01696695|520683053|FG000|Overall Study|Disease progression|373|||
144402459|NCT01696695|520683053|FG000|Overall Study|Death|29|||
144402460|NCT01696695|520683053|FG000|Overall Study|Adverse Event|74|||
144402461|NCT01696695|520683053|FG000|Overall Study|Withdrawal by Subject|92|||
144402462|NCT01696695|520683053|FG000|Overall Study|Lost to Follow-up|48|||
144402463|NCT01696695|520683053|FG000|Overall Study|Other|74|||
144402464|NCT01696695|520683053|FG000|Overall Study|Major Protocol Violation|192|||
144402465|NCT05224141|520683056|FG000|Overall Study|Ongoing|75|||
144402466|NCT05224141|520683057|FG001|Overall Study|Ongoing|88|||
144402467|NCT05224141|520683056|FG000|Overall Study|Withdrawal by Subject|2|||
144402468|NCT05224141|520683057|FG001|Overall Study|Withdrawal by Subject|4|||
144402469|NCT05224141|520683056|FG000|Overall Study|Death|153|||
144402470|NCT05224141|520683057|FG001|Overall Study|Death|138|||
144402471|NCT02404220|520683069|FG000|Overall Study|Adverse Event|0|||
144402472|NCT02404220|520683070|FG001|Overall Study|Adverse Event|0|||
144402473|NCT02404220|520683071|FG002|Overall Study|Adverse Event|1|||
144402474|NCT02404220|520683072|FG003|Overall Study|Adverse Event|0|||
144402475|NCT02404220|520683069|FG000|Overall Study|Death|5|||
144402476|NCT02404220|520683070|FG001|Overall Study|Death|5|||
144402477|NCT02404220|520683071|FG002|Overall Study|Death|3|||
144402478|NCT02404220|520683072|FG003|Overall Study|Death|8|||
144402479|NCT02404220|520683069|FG000|Overall Study|Progressive Disease|0|||
144402480|NCT02404220|520683070|FG001|Overall Study|Progressive Disease|0|||
144402481|NCT02404220|520683071|FG002|Overall Study|Progressive Disease|1|||
144402482|NCT02404220|520683072|FG003|Overall Study|Progressive Disease|1|||
144402483|NCT02404220|520683069|FG000|Overall Study|Study Terminated by Sponsor|0|||
144402484|NCT02404220|520683070|FG001|Overall Study|Study Terminated by Sponsor|0|||
144524365|NCT02985957|521121914|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
144524366|NCT02985957|521121908|FG000|Treatment Period|Study drug toxicity|1|||
144524367|NCT02985957|521121909|FG001|Treatment Period|Study drug toxicity|23|||
144524368|NCT02985957|521121910|FG002|Treatment Period|Study drug toxicity|20|||
144524369|NCT02985957|521121911|FG003|Treatment Period|Study drug toxicity|11|||
144524370|NCT02985957|521121912|FG004|Treatment Period|Study drug toxicity|19|||
144524371|NCT02985957|521121913|FG005|Treatment Period|Study drug toxicity|3|||
144524372|NCT02985957|521121914|FG006|Treatment Period|Study drug toxicity|5|||
144524373|NCT02985957|521121908|FG000|Treatment Period|Disease progression|0|||
144524374|NCT02985957|521121909|FG001|Treatment Period|Disease progression|16|||
144524375|NCT02985957|521121910|FG002|Treatment Period|Disease progression|20|||
144524376|NCT02985957|521121911|FG003|Treatment Period|Disease progression|39|||
144524377|NCT02985957|521121912|FG004|Treatment Period|Disease progression|29|||
144524378|NCT02985957|521121913|FG005|Treatment Period|Disease progression|11|||
144524379|NCT02985957|521121914|FG006|Treatment Period|Disease progression|28|||
144524380|NCT02985957|521121908|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
144524381|NCT02985957|521121909|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
144524382|NCT02985957|521121910|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
144524383|NCT02985957|521121911|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
144524384|NCT02985957|521121912|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
144524385|NCT02985957|521121913|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
144524386|NCT02985957|521121914|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
144524387|NCT02985957|521121908|FG000|Treatment Period|Poor/Non-Compliance|0|||
144524388|NCT02985957|521121909|FG001|Treatment Period|Poor/Non-Compliance|0|||
144524389|NCT02985957|521121910|FG002|Treatment Period|Poor/Non-Compliance|0|||
144524390|NCT02985957|521121911|FG003|Treatment Period|Poor/Non-Compliance|0|||
144524391|NCT02985957|521121912|FG004|Treatment Period|Poor/Non-Compliance|1|||
144524392|NCT02985957|521121913|FG005|Treatment Period|Poor/Non-Compliance|1|||
144524393|NCT02985957|521121914|FG006|Treatment Period|Poor/Non-Compliance|0|||
144524394|NCT02985957|521121908|FG000|Treatment Period|Continuing in Treatment Period|0|||
144524395|NCT02985957|521121909|FG001|Treatment Period|Continuing in Treatment Period|1|||
144524396|NCT02985957|521121910|FG002|Treatment Period|Continuing in Treatment Period|0|||
144524397|NCT02985957|521121911|FG003|Treatment Period|Continuing in Treatment Period|4|||
144524398|NCT02985957|521121912|FG004|Treatment Period|Continuing in Treatment Period|4|||
144524399|NCT02985957|521121913|FG005|Treatment Period|Continuing in Treatment Period|0|||
144524400|NCT02985957|521121914|FG006|Treatment Period|Continuing in Treatment Period|0|||
144524401|NCT04342494|521121915|FG000|Overall Study|Questionnaire partially completed|1|||
144524402|NCT04342494|521121916|FG001|Overall Study|Questionnaire partially completed|0|||
144524403|NCT04342494|521121917|FG002|Overall Study|Questionnaire partially completed|2|||
144524404|NCT04342494|521121918|FG003|Overall Study|Questionnaire partially completed|0|||
144524405|NCT04342494|521121919|FG004|Overall Study|Questionnaire partially completed|1|||
144524406|NCT04342494|521121915|FG000|Overall Study|Lost to Follow-up|49|||
144524407|NCT04342494|521121916|FG001|Overall Study|Lost to Follow-up|38|||
144524408|NCT04342494|521121917|FG002|Overall Study|Lost to Follow-up|34|||
144524409|NCT04342494|521121918|FG003|Overall Study|Lost to Follow-up|34|||
144524410|NCT04342494|521121919|FG004|Overall Study|Lost to Follow-up|35|||
144524411|NCT05119023|521121920|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
144524412|NCT05119023|521121920|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
144524413|NCT05119023|521121920|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
144402485|NCT02404220|520683071|FG002|Overall Study|Study Terminated by Sponsor|2|||
144402486|NCT02404220|520683072|FG003|Overall Study|Study Terminated by Sponsor|1|||
144402487|NCT02404220|520683069|FG000|Overall Study|Withdrawal by Subject|0|||
144402488|NCT02404220|520683070|FG001|Overall Study|Withdrawal by Subject|1|||
144402489|NCT02404220|520683071|FG002|Overall Study|Withdrawal by Subject|0|||
144402490|NCT02404220|520683072|FG003|Overall Study|Withdrawal by Subject|0|||
144402491|NCT02404220|520683069|FG000|Overall Study|Enrolled but Never Treated|0|||
144402492|NCT02404220|520683070|FG001|Overall Study|Enrolled but Never Treated|2|||
144402493|NCT02404220|520683071|FG002|Overall Study|Enrolled but Never Treated|0|||
144402494|NCT02404220|520683072|FG003|Overall Study|Enrolled but Never Treated|0|||
144402495|NCT00116428|520683080|FG000|Overall Study|Withdrawal by Subject|2|||
144402496|NCT00116428|520683081|FG001|Overall Study|Withdrawal by Subject|5|||
144402497|NCT00116428|520683080|FG000|Overall Study|Did not meet inclusion criteria|1|||
144402498|NCT00116428|520683081|FG001|Overall Study|Did not meet inclusion criteria|0|||
144402499|NCT00113087|520683082|FG000|Overall Study|Death or Transplant|14|||
144402500|NCT00113087|520683083|FG001|Overall Study|Death or Transplant|16|||
144402501|NCT00113087|520683082|FG000|Overall Study|Family or MD withdrew subject|10|||
144402502|NCT00113087|520683083|FG001|Overall Study|Family or MD withdrew subject|5|||
144402503|NCT03452228|520683084|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
144402504|NCT03452228|520683085|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
144402505|NCT03452228|520683086|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
144402506|NCT03452228|520683084|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
144402507|NCT03452228|520683085|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
144402508|NCT03452228|520683086|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144402509|NCT03452228|520683084|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
144402510|NCT03452228|520683085|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
144402511|NCT03452228|520683086|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
144402512|NCT03452228|520683084|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144402513|NCT03452228|520683085|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144402514|NCT03452228|520683086|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
144402515|NCT00386607|520683087|FG000|Core|Adverse Event|40|||
144402516|NCT00386607|520683088|FG001|Core|Adverse Event|0|||
144402517|NCT00386607|520683087|FG000|Core|Abnormal laboratory value(s)|3|||
144402518|NCT00386607|520683088|FG001|Core|Abnormal laboratory value(s)|0|||
144402519|NCT00386607|520683087|FG000|Core|Unsatisfactory therapeutic effect|23|||
144402520|NCT00386607|520683088|FG001|Core|Unsatisfactory therapeutic effect|0|||
144402521|NCT00386607|520683087|FG000|Core|Condition no longer requires study drug|4|||
144402522|NCT00386607|520683088|FG001|Core|Condition no longer requires study drug|0|||
144402523|NCT00386607|520683087|FG000|Core|Patient withdrew consent|15|||
144402524|NCT00386607|520683088|FG001|Core|Patient withdrew consent|0|||
144402525|NCT00386607|520683087|FG000|Core|Lost to Follow-up|23|||
144402526|NCT00386607|520683088|FG001|Core|Lost to Follow-up|0|||
144402527|NCT00386607|520683087|FG000|Core|Administrative problems|1|||
144402528|NCT00386607|520683088|FG001|Core|Administrative problems|0|||
144402529|NCT00386607|520683087|FG000|Core|Protocol Deviation|6|||
144402530|NCT00386607|520683088|FG001|Core|Protocol Deviation|0|||
144402531|NCT00386607|520683087|FG000|Extension|Adverse Event|0|||
144402532|NCT00386607|520683088|FG001|Extension|Adverse Event|6|||
144402533|NCT00386607|520683087|FG000|Extension|Abnormal laboratory value(s)|0|||
144402534|NCT00386607|520683088|FG001|Extension|Abnormal laboratory value(s)|1|||
144402535|NCT00386607|520683087|FG000|Extension|Administrative problems|0|||
144402536|NCT00386607|520683088|FG001|Extension|Administrative problems|1|||
144598686|NCT04796896|521392497|FG011|Overall Study|Death|0|||
144598687|NCT02021292|521392498|FG000|Overall Study|Physician Decision|0|||
144598688|NCT02021292|521392499|FG001|Overall Study|Physician Decision|1|||
144598689|NCT02021292|521392498|FG000|Overall Study|Lost to Follow-up|0|||
144598690|NCT02021292|521392499|FG001|Overall Study|Lost to Follow-up|1|||
144598691|NCT02021292|521392498|FG000|Overall Study|Death|0|||
144598692|NCT02021292|521392499|FG001|Overall Study|Death|1|||
144598693|NCT05972733|521392502|FG000|Overall Study|Lost to Follow-up|2|||
144598694|NCT05972733|521392502|FG000|Overall Study|Withdrawal by Subject|1|||
144598695|NCT01177787|521392505|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
144598696|NCT01177787|521392505|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
144598697|NCT01177787|521392505|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
144598698|NCT00823901|521392510|FG000|Overall Study|Adverse Event|1|||
144598699|NCT00823901|521392511|FG001|Overall Study|Adverse Event|1|||
144598700|NCT00823901|521392510|FG000|Overall Study|Lack of Efficacy|1|||
144598701|NCT00823901|521392511|FG001|Overall Study|Lack of Efficacy|0|||
144598702|NCT00823901|521392510|FG000|Overall Study|Lost to Follow-up|2|||
144598703|NCT00823901|521392511|FG001|Overall Study|Lost to Follow-up|1|||
144598704|NCT01369511|521392512|FG000|Overall Study|Adverse Event|1|||
144598705|NCT01369511|521392513|FG001|Overall Study|Adverse Event|1|||
144598706|NCT01369511|521392514|FG002|Overall Study|Adverse Event|5|||
144598707|NCT01369511|521392515|FG003|Overall Study|Adverse Event|0|||
144598708|NCT01369511|521392512|FG000|Overall Study|Entry criteria not met|2|||
144402537|NCT00386607|520683087|FG000|Extension|Lost to Follow-up|0|||
144402538|NCT00386607|520683088|FG001|Extension|Lost to Follow-up|3|||
144402539|NCT00386607|520683087|FG000|Extension|Patient withdrew consent|0|||
144402540|NCT00386607|520683088|FG001|Extension|Patient withdrew consent|5|||
144598709|NCT01369511|521392513|FG001|Overall Study|Entry criteria not met|0|||
144402541|NCT00386607|520683087|FG000|Extension|Unsatisfactory therapeutic effect|0|||
144402542|NCT00386607|520683088|FG001|Extension|Unsatisfactory therapeutic effect|1|||
144402543|NCT03800173|520683090|FG000|Overall Study|Lost to Follow-up|0|||
144402544|NCT03800173|520683091|FG001|Overall Study|Lost to Follow-up|0|||
144402545|NCT03800173|520683092|FG002|Overall Study|Lost to Follow-up|0|||
144402546|NCT03800173|520683093|FG003|Overall Study|Lost to Follow-up|0|||
144402547|NCT03800173|520683094|FG004|Overall Study|Lost to Follow-up|1|||
144402548|NCT03540030|520683096|FG000|Overall Study|Withdrawal by Subject|2|||
144402549|NCT03540030|520683097|FG001|Overall Study|Withdrawal by Subject|1|||
144402550|NCT03540030|520683096|FG000|Overall Study|screen fail|7|||
144402551|NCT03540030|520683097|FG001|Overall Study|screen fail|1|||
144402552|NCT03540030|520683096|FG000|Overall Study|never had surgery after signing consent|9|||
144402553|NCT03540030|520683097|FG001|Overall Study|never had surgery after signing consent|1|||
144402554|NCT00423514|520683105|FG000|Overall Study|Ineligible|1|||
144402555|NCT00423514|520683106|FG001|Overall Study|Ineligible|0|||
144402556|NCT04729621|520683107|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
144402557|NCT04729621|520683108|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
144402558|NCT04729621|520683109|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
144402559|NCT04729621|520683110|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
144402560|NCT04729621|520683111|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
144402561|NCT04729621|520683107|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
144402562|NCT04729621|520683108|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
144402563|NCT04729621|520683109|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
144402564|NCT04729621|520683110|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
144402565|NCT04729621|520683111|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
144402566|NCT04729621|520683107|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
144402567|NCT04729621|520683108|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
144402568|NCT04729621|520683109|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
144402569|NCT04729621|520683110|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
144402570|NCT04729621|520683111|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
144402571|NCT04729621|520683107|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
144402572|NCT04729621|520683108|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
144402573|NCT04729621|520683109|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
144402574|NCT04729621|520683110|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
144402575|NCT04729621|520683111|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
144402576|NCT04729621|520683107|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
144402577|NCT04729621|520683108|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
144402578|NCT04729621|520683109|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
144402579|NCT04729621|520683110|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
144402580|NCT04729621|520683111|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
144402581|NCT04729621|520683107|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
144402582|NCT04729621|520683108|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
144402583|NCT04729621|520683109|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
144402584|NCT04729621|520683110|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
144402585|NCT04729621|520683111|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
144402586|NCT03308786|520683112|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
144402587|NCT02004522|520683113|FG000|Overall Study|Adverse Event|55|||
144402588|NCT02004522|520683114|FG001|Overall Study|Adverse Event|6|||
144402589|NCT02004522|520683113|FG000|Overall Study|Withdrawal by Subject|13|||
144402590|NCT02004522|520683114|FG001|Overall Study|Withdrawal by Subject|7|||
144524414|NCT02485938|521121924|FG000|Overall Study|Withdrawal of consent|2|||
144524415|NCT02485938|521121925|FG001|Overall Study|Withdrawal of consent|0|||
144524416|NCT04633122|521121926|FG000|Overall Study|Remained on treatment|19|||
144524417|NCT04633122|521121927|FG001|Overall Study|Remained on treatment|14|||
144524418|NCT04633122|521121926|FG000|Overall Study|Survival follow-up stopped|22|||
144402591|NCT02004522|520683113|FG000|Overall Study|Death|12|||
144402592|NCT02004522|520683114|FG001|Overall Study|Death|3|||
144402593|NCT02004522|520683113|FG000|Overall Study|Physician Decision|3|||
144402594|NCT02004522|520683114|FG001|Overall Study|Physician Decision|4|||
144402595|NCT02004522|520683113|FG000|Overall Study|Protocol Violation|1|||
144402596|NCT02004522|520683114|FG001|Overall Study|Protocol Violation|0|||
144402597|NCT02004522|520683113|FG000|Overall Study|Other is reason listed by PI|4|||
144402598|NCT02004522|520683114|FG001|Overall Study|Other is reason listed by PI|1|||
144402599|NCT02004522|520683113|FG000|Overall Study|Never Dosed|2|||
144402600|NCT02004522|520683114|FG001|Overall Study|Never Dosed|4|||
144402601|NCT02004522|520683113|FG000|Overall Study|Disease Progression|35|||
144524419|NCT04633122|521121927|FG001|Overall Study|Survival follow-up stopped|25|||
144402602|NCT02004522|520683114|FG001|Overall Study|Disease Progression|31|||
144524420|NCT04799899|521121928|FG000|Overall Study|Lost to Follow-up|2|||
144524421|NCT04799899|521121929|FG001|Overall Study|Lost to Follow-up|4|||
144524422|NCT03524118|521121931|FG000|Overall Study|Lost to Follow-up|0|||
144402603|NCT02004522|520683113|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
144402604|NCT02004522|520683114|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
144598710|NCT01369511|521392514|FG002|Overall Study|Entry criteria not met|0|||
144598711|NCT01369511|521392515|FG003|Overall Study|Entry criteria not met|1|||
144402605|NCT01787331|520683115|FG000|Overall Study|Physician Decision|1|||
144402606|NCT01787331|520683115|FG000|Overall Study|Withdrawal by Subject|1|||
144402607|NCT01402011|520683117|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
144598712|NCT01369511|521392512|FG000|Overall Study|Lost to Follow-up|0|||
144598713|NCT01369511|521392513|FG001|Overall Study|Lost to Follow-up|1|||
144598714|NCT01369511|521392514|FG002|Overall Study|Lost to Follow-up|1|||
144598715|NCT01369511|521392515|FG003|Overall Study|Lost to Follow-up|2|||
144598716|NCT01369511|521392512|FG000|Overall Study|Protocol Violation|0|||
144598717|NCT01369511|521392513|FG001|Overall Study|Protocol Violation|1|||
144598718|NCT01369511|521392514|FG002|Overall Study|Protocol Violation|0|||
144598719|NCT01369511|521392515|FG003|Overall Study|Protocol Violation|2|||
144598720|NCT01369511|521392512|FG000|Overall Study|Physician Decision|3|||
144598721|NCT01369511|521392513|FG001|Overall Study|Physician Decision|4|||
144598722|NCT01369511|521392514|FG002|Overall Study|Physician Decision|0|||
144598723|NCT01369511|521392515|FG003|Overall Study|Physician Decision|0|||
144402608|NCT01402011|520683118|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
144402609|NCT01402011|520683119|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
144402610|NCT01402011|520683117|FG000|Active Treatment Period|Withdrawal by Subject|1|||
144402611|NCT01402011|520683118|FG001|Active Treatment Period|Withdrawal by Subject|3|||
144402612|NCT01402011|520683119|FG002|Active Treatment Period|Withdrawal by Subject|0|||
144402613|NCT01402011|520683117|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
144402614|NCT01402011|520683118|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
144402615|NCT01402011|520683119|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
144402616|NCT00142298|520683120|FG000|Overall Study|Adverse Event|10|||
144402617|NCT00142298|520683121|FG001|Overall Study|Adverse Event|10|||
144402618|NCT00142298|520683122|FG002|Overall Study|Adverse Event|1|||
144402619|NCT00142298|520683123|FG003|Overall Study|Adverse Event|5|||
144402620|NCT00142298|520683124|FG004|Overall Study|Adverse Event|2|||
144402621|NCT00142298|520683125|FG005|Overall Study|Adverse Event|2|||
144402622|NCT00142298|520683126|FG006|Overall Study|Adverse Event|0|||
144598724|NCT01369511|521392512|FG000|Overall Study|Sponsor decision|2|||
144598725|NCT01369511|521392513|FG001|Overall Study|Sponsor decision|0|||
144598726|NCT01369511|521392514|FG002|Overall Study|Sponsor decision|1|||
144598727|NCT01369511|521392515|FG003|Overall Study|Sponsor decision|0|||
144598728|NCT01369511|521392512|FG000|Overall Study|Withdrawal by Subject|5|||
144598729|NCT01369511|521392513|FG001|Overall Study|Withdrawal by Subject|6|||
144598730|NCT01369511|521392514|FG002|Overall Study|Withdrawal by Subject|4|||
144598731|NCT01369511|521392515|FG003|Overall Study|Withdrawal by Subject|6|||
144598732|NCT01376349|521392516|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
144598733|NCT01376349|521392517|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
144402623|NCT00142298|520683127|FG007|Overall Study|Adverse Event|0|||
144402624|NCT00142298|520683128|FG008|Overall Study|Adverse Event|0|||
144402625|NCT00142298|520683129|FG009|Overall Study|Adverse Event|0|||
144402626|NCT00142298|520683120|FG000|Overall Study|Clinical disease progression|1|||
144402627|NCT00142298|520683121|FG001|Overall Study|Clinical disease progression|0|||
144402628|NCT00142298|520683122|FG002|Overall Study|Clinical disease progression|0|||
144402629|NCT00142298|520683123|FG003|Overall Study|Clinical disease progression|0|||
144402630|NCT00142298|520683124|FG004|Overall Study|Clinical disease progression|0|||
144402631|NCT00142298|520683125|FG005|Overall Study|Clinical disease progression|0|||
144402632|NCT00142298|520683126|FG006|Overall Study|Clinical disease progression|0|||
144402633|NCT00142298|520683127|FG007|Overall Study|Clinical disease progression|0|||
144402634|NCT00142298|520683128|FG008|Overall Study|Clinical disease progression|0|||
144402635|NCT00142298|520683129|FG009|Overall Study|Clinical disease progression|0|||
144402636|NCT00142298|520683120|FG000|Overall Study|Death|1|||
144402637|NCT00142298|520683121|FG001|Overall Study|Death|1|||
144402638|NCT00142298|520683122|FG002|Overall Study|Death|1|||
144402639|NCT00142298|520683123|FG003|Overall Study|Death|0|||
144402640|NCT00142298|520683124|FG004|Overall Study|Death|0|||
144402641|NCT00142298|520683125|FG005|Overall Study|Death|6|||
144598734|NCT01376349|521392518|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
144598735|NCT01376349|521392516|FG000|Raondomized Treatment|Adverse Event|13|||
144598736|NCT01376349|521392517|FG001|Raondomized Treatment|Adverse Event|17|||
144598737|NCT01376349|521392518|FG002|Raondomized Treatment|Adverse Event|14|||
144598738|NCT01376349|521392516|FG000|Raondomized Treatment|Unkown|1|||
144598739|NCT01376349|521392517|FG001|Raondomized Treatment|Unkown|2|||
144598740|NCT01376349|521392518|FG002|Raondomized Treatment|Unkown|1|||
144402642|NCT00142298|520683126|FG006|Overall Study|Death|0|||
144402643|NCT00142298|520683127|FG007|Overall Study|Death|0|||
144402644|NCT00142298|520683128|FG008|Overall Study|Death|0|||
144402645|NCT00142298|520683129|FG009|Overall Study|Death|0|||
144402646|NCT00142298|520683120|FG000|Overall Study|Lack of Efficacy|44|||
144402647|NCT00142298|520683121|FG001|Overall Study|Lack of Efficacy|62|||
144598741|NCT01376349|521392516|FG000|Raondomized Treatment|Alternative Treatment|0|||
144402648|NCT00142298|520683122|FG002|Overall Study|Lack of Efficacy|9|||
144402649|NCT00142298|520683123|FG003|Overall Study|Lack of Efficacy|12|||
144402650|NCT00142298|520683124|FG004|Overall Study|Lack of Efficacy|1|||
144402651|NCT00142298|520683125|FG005|Overall Study|Lack of Efficacy|0|||
144402652|NCT00142298|520683126|FG006|Overall Study|Lack of Efficacy|0|||
144402653|NCT00142298|520683127|FG007|Overall Study|Lack of Efficacy|1|||
144402654|NCT00142298|520683128|FG008|Overall Study|Lack of Efficacy|0|||
144402655|NCT00142298|520683129|FG009|Overall Study|Lack of Efficacy|0|||
144402656|NCT00142298|520683120|FG000|Overall Study|Non-compliance|15|||
144402657|NCT00142298|520683121|FG001|Overall Study|Non-compliance|13|||
144402658|NCT00142298|520683122|FG002|Overall Study|Non-compliance|0|||
144402659|NCT00142298|520683123|FG003|Overall Study|Non-compliance|6|||
144402660|NCT00142298|520683124|FG004|Overall Study|Non-compliance|1|||
144402661|NCT00142298|520683125|FG005|Overall Study|Non-compliance|0|||
144402662|NCT00142298|520683126|FG006|Overall Study|Non-compliance|0|||
144402663|NCT00142298|520683127|FG007|Overall Study|Non-compliance|3|||
144402664|NCT00142298|520683128|FG008|Overall Study|Non-compliance|3|||
144402665|NCT00142298|520683129|FG009|Overall Study|Non-compliance|0|||
144402666|NCT00142298|520683120|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
144402667|NCT00142298|520683121|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
144402668|NCT00142298|520683122|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
144402669|NCT00142298|520683123|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
144402670|NCT00142298|520683124|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
144402671|NCT00142298|520683125|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
144402672|NCT00142298|520683126|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
144402673|NCT00142298|520683127|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
144402674|NCT00142298|520683128|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
144402675|NCT00142298|520683129|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
144402676|NCT00142298|520683120|FG000|Overall Study|Pregnancy|4|||
144402677|NCT00142298|520683121|FG001|Overall Study|Pregnancy|4|||
144402678|NCT00142298|520683122|FG002|Overall Study|Pregnancy|2|||
144402679|NCT00142298|520683123|FG003|Overall Study|Pregnancy|3|||
144402680|NCT00142298|520683124|FG004|Overall Study|Pregnancy|0|||
144402681|NCT00142298|520683125|FG005|Overall Study|Pregnancy|0|||
144402682|NCT00142298|520683126|FG006|Overall Study|Pregnancy|0|||
144402683|NCT00142298|520683127|FG007|Overall Study|Pregnancy|0|||
144402684|NCT00142298|520683128|FG008|Overall Study|Pregnancy|1|||
144402685|NCT00142298|520683129|FG009|Overall Study|Pregnancy|0|||
144402686|NCT00142298|520683120|FG000|Overall Study|Virologic breakthrough|19|||
144402687|NCT00142298|520683121|FG001|Overall Study|Virologic breakthrough|23|||
144402688|NCT00142298|520683122|FG002|Overall Study|Virologic breakthrough|9|||
144402689|NCT00142298|520683123|FG003|Overall Study|Virologic breakthrough|7|||
144402690|NCT00142298|520683124|FG004|Overall Study|Virologic breakthrough|2|||
144402691|NCT00142298|520683125|FG005|Overall Study|Virologic breakthrough|3|||
144402692|NCT00142298|520683126|FG006|Overall Study|Virologic breakthrough|3|||
144402693|NCT00142298|520683127|FG007|Overall Study|Virologic breakthrough|0|||
144402694|NCT00142298|520683128|FG008|Overall Study|Virologic breakthrough|0|||
144402695|NCT00142298|520683129|FG009|Overall Study|Virologic breakthrough|0|||
144402696|NCT00142298|520683120|FG000|Overall Study|Other- not specified|0|||
144402697|NCT00142298|520683121|FG001|Overall Study|Other- not specified|3|||
144402698|NCT00142298|520683122|FG002|Overall Study|Other- not specified|0|||
144402699|NCT00142298|520683123|FG003|Overall Study|Other- not specified|1|||
144402700|NCT00142298|520683124|FG004|Overall Study|Other- not specified|0|||
144402701|NCT00142298|520683125|FG005|Overall Study|Other- not specified|0|||
144402702|NCT00142298|520683126|FG006|Overall Study|Other- not specified|0|||
144402703|NCT00142298|520683127|FG007|Overall Study|Other- not specified|0|||
144402704|NCT00142298|520683128|FG008|Overall Study|Other- not specified|0|||
144402705|NCT00142298|520683129|FG009|Overall Study|Other- not specified|0|||
144402706|NCT00142298|520683120|FG000|Overall Study|Lost to Follow-up|0|||
144402707|NCT00142298|520683121|FG001|Overall Study|Lost to Follow-up|0|||
144402708|NCT00142298|520683122|FG002|Overall Study|Lost to Follow-up|0|||
144402709|NCT00142298|520683123|FG003|Overall Study|Lost to Follow-up|0|||
144402710|NCT00142298|520683124|FG004|Overall Study|Lost to Follow-up|0|||
144402711|NCT00142298|520683125|FG005|Overall Study|Lost to Follow-up|0|||
144402712|NCT00142298|520683126|FG006|Overall Study|Lost to Follow-up|2|||
144402713|NCT00142298|520683127|FG007|Overall Study|Lost to Follow-up|0|||
144402714|NCT00142298|520683128|FG008|Overall Study|Lost to Follow-up|0|||
144402715|NCT00142298|520683129|FG009|Overall Study|Lost to Follow-up|0|||
144524423|NCT03524118|521121932|FG001|Overall Study|Lost to Follow-up|0|||
144402716|NCT00142298|520683120|FG000|Overall Study|Treatment Failure|0|||
144402717|NCT00142298|520683121|FG001|Overall Study|Treatment Failure|0|||
144402718|NCT00142298|520683122|FG002|Overall Study|Treatment Failure|0|||
144402719|NCT00142298|520683123|FG003|Overall Study|Treatment Failure|0|||
144402720|NCT00142298|520683124|FG004|Overall Study|Treatment Failure|0|||
144402721|NCT00142298|520683125|FG005|Overall Study|Treatment Failure|2|||
144402722|NCT00142298|520683126|FG006|Overall Study|Treatment Failure|2|||
144402723|NCT00142298|520683127|FG007|Overall Study|Treatment Failure|0|||
144402724|NCT00142298|520683128|FG008|Overall Study|Treatment Failure|0|||
144402725|NCT00142298|520683129|FG009|Overall Study|Treatment Failure|0|||
144402726|NCT02569671|520683130|FG000|Overall Study|Lost to Follow-up|2|||
144402727|NCT02569671|520683131|FG001|Overall Study|Lost to Follow-up|1|||
144402728|NCT02569671|520683130|FG000|Overall Study|Withdrawal by Subject|1|||
144402729|NCT02569671|520683131|FG001|Overall Study|Withdrawal by Subject|3|||
144402730|NCT01757535|520683132|FG000|Overall Study|Disease Relapse|151|||
144402731|NCT01757535|520683133|FG001|Overall Study|Disease Relapse|181|||
144402732|NCT01757535|520683132|FG000|Overall Study|Other Reasons|28|||
144402733|NCT01757535|520683133|FG001|Overall Study|Other Reasons|27|||
144402734|NCT01757535|520683132|FG000|Overall Study|Adverse Event|31|||
144402735|NCT01757535|520683133|FG001|Overall Study|Adverse Event|11|||
144402736|NCT01757535|520683132|FG000|Overall Study|Withdrew Consent|19|||
144402737|NCT01757535|520683133|FG001|Overall Study|Withdrew Consent|13|||
144402738|NCT01757535|520683132|FG000|Overall Study|Physician Decision|7|||
144402739|NCT01757535|520683133|FG001|Overall Study|Physician Decision|0|||
144402740|NCT01757535|520683132|FG000|Overall Study|Death|2|||
144402741|NCT01757535|520683133|FG001|Overall Study|Death|2|||
144402742|NCT00531934|520685115|FG000|Overall Study|Adverse Event|4|||
144402743|NCT00531934|520685116|FG001|Overall Study|Adverse Event|8|||
144402744|NCT00531934|520685115|FG000|Overall Study|Progression|52|||
144402745|NCT00531934|520685116|FG001|Overall Study|Progression|42|||
144402746|NCT00531934|520685115|FG000|Overall Study|Death|7|||
144524424|NCT03524118|521121933|FG002|Overall Study|Lost to Follow-up|0|||
144524425|NCT03524118|521121934|FG003|Overall Study|Lost to Follow-up|0|||
144524426|NCT03524118|521121935|FG004|Overall Study|Lost to Follow-up|1|||
144524427|NCT03524118|521121936|FG005|Overall Study|Lost to Follow-up|0|||
144524428|NCT03524118|521121931|FG000|Overall Study|Other|0|||
144524429|NCT03524118|521121932|FG001|Overall Study|Other|1|||
144524430|NCT03524118|521121933|FG002|Overall Study|Other|0|||
144524431|NCT03524118|521121934|FG003|Overall Study|Other|0|||
144524432|NCT03524118|521121935|FG004|Overall Study|Other|1|||
144524433|NCT03524118|521121936|FG005|Overall Study|Other|1|||
144402747|NCT00531934|520685116|FG001|Overall Study|Death|10|||
144402748|NCT00531934|520685115|FG000|Overall Study|Withdrawal by Subject|1|||
144402749|NCT00531934|520685116|FG001|Overall Study|Withdrawal by Subject|1|||
144402750|NCT00531934|520685115|FG000|Overall Study|Other|2|||
144402751|NCT00531934|520685116|FG001|Overall Study|Other|2|||
144402752|NCT00150709|520685117|FG000|Overall Study|Protocol Violation|7|||
144402753|NCT00150709|520685118|FG001|Overall Study|Protocol Violation|8|||
144402754|NCT00150709|520685119|FG002|Overall Study|Protocol Violation|3|||
144402755|NCT00150709|520685120|FG003|Overall Study|Protocol Violation|1|||
144402756|NCT00150709|520685117|FG000|Overall Study|Adverse Event|8|||
144402757|NCT00150709|520685118|FG001|Overall Study|Adverse Event|2|||
144402758|NCT00150709|520685119|FG002|Overall Study|Adverse Event|2|||
144402759|NCT00150709|520685120|FG003|Overall Study|Adverse Event|3|||
144402760|NCT00150709|520685117|FG000|Overall Study|Lack of Efficacy|6|||
144524434|NCT03524118|521121931|FG000|Overall Study|Physician Decision|0|||
144524435|NCT03524118|521121932|FG001|Overall Study|Physician Decision|0|||
144524436|NCT03524118|521121933|FG002|Overall Study|Physician Decision|0|||
144524437|NCT03524118|521121934|FG003|Overall Study|Physician Decision|0|||
144402761|NCT00150709|520685118|FG001|Overall Study|Lack of Efficacy|11|||
144402762|NCT00150709|520685119|FG002|Overall Study|Lack of Efficacy|9|||
144402763|NCT00150709|520685120|FG003|Overall Study|Lack of Efficacy|0|||
144402764|NCT00150709|520685117|FG000|Overall Study|Withdrawal by Subject|7|||
144402765|NCT00150709|520685118|FG001|Overall Study|Withdrawal by Subject|10|||
144524438|NCT03524118|521121935|FG004|Overall Study|Physician Decision|1|||
144524439|NCT03524118|521121936|FG005|Overall Study|Physician Decision|0|||
144524440|NCT03524118|521121931|FG000|Overall Study|Protocol Violation|0|||
144524441|NCT03524118|521121932|FG001|Overall Study|Protocol Violation|0|||
144524442|NCT03524118|521121933|FG002|Overall Study|Protocol Violation|1|||
144598742|NCT01376349|521392517|FG001|Raondomized Treatment|Alternative Treatment|0|||
144598743|NCT01376349|521392518|FG002|Raondomized Treatment|Alternative Treatment|1|||
144402766|NCT00150709|520685119|FG002|Overall Study|Withdrawal by Subject|5|||
144402767|NCT00150709|520685120|FG003|Overall Study|Withdrawal by Subject|0|||
144402768|NCT00150709|520685117|FG000|Overall Study|Lost to Follow-up|3|||
144402769|NCT00150709|520685118|FG001|Overall Study|Lost to Follow-up|2|||
144402770|NCT00150709|520685119|FG002|Overall Study|Lost to Follow-up|0|||
144402771|NCT00150709|520685120|FG003|Overall Study|Lost to Follow-up|0|||
144524443|NCT03524118|521121934|FG003|Overall Study|Protocol Violation|0|||
144524444|NCT03524118|521121935|FG004|Overall Study|Protocol Violation|1|||
144402772|NCT00150709|520685117|FG000|Overall Study|Sponsor decision|0|||
144402773|NCT00150709|520685118|FG001|Overall Study|Sponsor decision|0|||
144402774|NCT00150709|520685119|FG002|Overall Study|Sponsor decision|0|||
144402775|NCT00150709|520685120|FG003|Overall Study|Sponsor decision|1|||
144402776|NCT00150709|520685117|FG000|Overall Study|Site/Investigator discontinued the study|5|||
144402777|NCT00150709|520685118|FG001|Overall Study|Site/Investigator discontinued the study|5|||
144402778|NCT00150709|520685119|FG002|Overall Study|Site/Investigator discontinued the study|2|||
144524445|NCT03524118|521121936|FG005|Overall Study|Protocol Violation|0|||
144524446|NCT03524118|521121931|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144524447|NCT03524118|521121932|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144402779|NCT00150709|520685120|FG003|Overall Study|Site/Investigator discontinued the study|0|||
144402780|NCT00150709|520685117|FG000|Overall Study|Decision of parent(s)|1|||
144402781|NCT00150709|520685118|FG001|Overall Study|Decision of parent(s)|2|||
144402782|NCT00150709|520685119|FG002|Overall Study|Decision of parent(s)|0|||
144402783|NCT00150709|520685120|FG003|Overall Study|Decision of parent(s)|0|||
144402784|NCT00150709|520685117|FG000|Overall Study|Decision of parent(s) and investigator|3|||
144402785|NCT00150709|520685118|FG001|Overall Study|Decision of parent(s) and investigator|0|||
144402786|NCT00150709|520685119|FG002|Overall Study|Decision of parent(s) and investigator|0|||
144402787|NCT00150709|520685120|FG003|Overall Study|Decision of parent(s) and investigator|0|||
144402788|NCT00150709|520685117|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
144402789|NCT00150709|520685118|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
144402790|NCT00150709|520685119|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
144402791|NCT00150709|520685120|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
144402792|NCT00150709|520685117|FG000|Overall Study|Investigator decision|1|||
144402793|NCT00150709|520685118|FG001|Overall Study|Investigator decision|0|||
144402794|NCT00150709|520685119|FG002|Overall Study|Investigator decision|0|||
144402795|NCT00150709|520685120|FG003|Overall Study|Investigator decision|1|||
144402796|NCT00150709|520685117|FG000|Overall Study|Subject relocated|2|||
144402797|NCT00150709|520685118|FG001|Overall Study|Subject relocated|2|||
144402798|NCT00150709|520685119|FG002|Overall Study|Subject relocated|1|||
144402799|NCT00150709|520685120|FG003|Overall Study|Subject relocated|0|||
144402800|NCT00150709|520685117|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
144402801|NCT00150709|520685118|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
144402802|NCT00150709|520685119|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
144402803|NCT00150709|520685120|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
144402804|NCT00150709|520685117|FG000|Overall Study|Convenience|0|||
144402805|NCT00150709|520685118|FG001|Overall Study|Convenience|1|||
144402806|NCT00150709|520685119|FG002|Overall Study|Convenience|0|||
144402807|NCT00150709|520685120|FG003|Overall Study|Convenience|0|||
144402808|NCT00150709|520685117|FG000|Overall Study|Subject entered new drug study|0|||
144402809|NCT00150709|520685118|FG001|Overall Study|Subject entered new drug study|1|||
144402810|NCT00150709|520685119|FG002|Overall Study|Subject entered new drug study|0|||
144402811|NCT00150709|520685120|FG003|Overall Study|Subject entered new drug study|0|||
144402812|NCT00150709|520685117|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
144402813|NCT00150709|520685118|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
144402814|NCT00150709|520685119|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
144402815|NCT00150709|520685120|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
144402816|NCT00150709|520685117|FG000|Overall Study|Lack of ease of swallowing|0|||
144402817|NCT00150709|520685118|FG001|Overall Study|Lack of ease of swallowing|1|||
144402818|NCT00150709|520685119|FG002|Overall Study|Lack of ease of swallowing|0|||
144402819|NCT00150709|520685120|FG003|Overall Study|Lack of ease of swallowing|0|||
144402820|NCT02280304|520685121|FG000|Overall Study|Lost to Follow-up|7|||
144402821|NCT02280304|520685122|FG001|Overall Study|Lost to Follow-up|8|||
144402822|NCT00533897|520685128|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
144402823|NCT00533897|520685129|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
144402824|NCT00533897|520685130|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
144402825|NCT00533897|520685131|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
144402826|NCT00533897|520685132|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
144402827|NCT00533897|520685133|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
144402828|NCT00533897|520685134|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
144402829|NCT00533897|520685135|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
144402830|NCT00533897|520685128|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
144402831|NCT00533897|520685129|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144402832|NCT00533897|520685130|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144402833|NCT00533897|520685131|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144402834|NCT00533897|520685132|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144402835|NCT00533897|520685133|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144402836|NCT00533897|520685134|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144402837|NCT00533897|520685135|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
144524448|NCT03524118|521121933|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144402838|NCT00533897|520685128|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
144524449|NCT03524118|521121934|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
144524450|NCT03524118|521121935|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
144402839|NCT00533897|520685129|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144402840|NCT00533897|520685130|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144402841|NCT00533897|520685131|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144402842|NCT00533897|520685132|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144402843|NCT00533897|520685133|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144402844|NCT00533897|520685134|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144524451|NCT03524118|521121936|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144524452|NCT03339713|521121939|FG000|Overall Study|Lost to Follow-up|2|||
144524453|NCT03339713|521121940|FG001|Overall Study|Lost to Follow-up|1|||
144402845|NCT00533897|520685135|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
144402846|NCT00533897|520685128|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
144402847|NCT00533897|520685129|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402848|NCT00533897|520685130|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402849|NCT00533897|520685131|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402850|NCT00533897|520685132|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402851|NCT00533897|520685133|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402852|NCT00533897|520685134|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402853|NCT00533897|520685135|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
144402854|NCT00533897|520685128|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
144402855|NCT00533897|520685129|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402856|NCT00533897|520685130|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402857|NCT00533897|520685131|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402858|NCT00533897|520685132|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402859|NCT00533897|520685133|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402860|NCT00533897|520685134|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402861|NCT00533897|520685135|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
144402862|NCT00533897|520685128|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
144402863|NCT00533897|520685129|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402864|NCT00533897|520685130|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402865|NCT00533897|520685131|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402866|NCT00533897|520685132|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402867|NCT00533897|520685133|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402868|NCT00533897|520685134|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402869|NCT00533897|520685135|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
144402870|NCT00533897|520685128|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
144402871|NCT00533897|520685129|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
144402872|NCT00533897|520685130|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
144402873|NCT00533897|520685131|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
144402874|NCT00533897|520685132|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
144402875|NCT00533897|520685133|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
144402876|NCT00533897|520685134|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
144402877|NCT00533897|520685135|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
144402878|NCT00533897|520685128|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144402879|NCT00533897|520685129|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144402880|NCT00533897|520685130|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
144402881|NCT00533897|520685131|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144402882|NCT00533897|520685132|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144402883|NCT00533897|520685133|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144402884|NCT00533897|520685134|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144402885|NCT00533897|520685135|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
144524454|NCT03339713|521121939|FG000|Overall Study|Protocol Violation|1|||
144524455|NCT03339713|521121940|FG001|Overall Study|Protocol Violation|0|||
144524456|NCT03339713|521121939|FG000|Overall Study|Withdrawal by Subject|1|||
144598744|NCT01180998|521392519|FG000|Overall Study|Poor Vision|0|||
144598745|NCT01180998|521392520|FG001|Overall Study|Poor Vision|2|||
144598746|NCT01180998|521392521|FG002|Overall Study|Poor Vision|2|||
144598747|NCT01180998|521392519|FG000|Overall Study|Lost to Follow-up|0|||
144598748|NCT01180998|521392520|FG001|Overall Study|Lost to Follow-up|0|||
144524457|NCT03339713|521121940|FG001|Overall Study|Withdrawal by Subject|1|||
144524458|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
144524459|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
144524460|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
144524461|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
144524462|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
144524463|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
144524464|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
144524465|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
144524466|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
144524467|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
144524468|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
144524469|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
144524470|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
144524471|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
144524472|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
144524473|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
144598749|NCT01180998|521392521|FG002|Overall Study|Lost to Follow-up|1|||
144598750|NCT01180998|521392519|FG000|Overall Study|Protocol Violation|1|||
144402886|NCT00533897|520685128|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402887|NCT00533897|520685129|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402888|NCT00533897|520685130|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402889|NCT00533897|520685131|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402890|NCT00533897|520685132|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402891|NCT00533897|520685133|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
144402892|NCT00533897|520685134|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402893|NCT00533897|520685135|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
144402894|NCT00533897|520685128|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402895|NCT00533897|520685129|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402896|NCT00533897|520685130|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402897|NCT00533897|520685131|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402898|NCT00533897|520685132|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402899|NCT00533897|520685133|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
144402900|NCT00533897|520685134|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402901|NCT00533897|520685135|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
144402902|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
144402903|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
144402904|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
144402905|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
144402906|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
144402907|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
144402908|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
144402909|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
144402910|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Death|0|||
144402911|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Death|0|||
144402912|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Death|0|||
144402913|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Death|0|||
144402914|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Death|0|||
144402915|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Death|0|||
144402916|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Death|1|||
144402917|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Death|3|||
144402918|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
144402919|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
144402920|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
144402921|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
144402922|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
144402923|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
144402924|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
144402925|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
144402926|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402927|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402928|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402929|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402930|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402931|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402932|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
144402933|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
144402934|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Adverse Event|0|||
144402935|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Adverse Event|0|||
144402936|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Adverse Event|0|||
144402937|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Adverse Event|0|||
144402938|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Adverse Event|0|||
144402939|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Adverse Event|0|||
144402940|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Adverse Event|2|||
144402941|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Adverse Event|5|||
144402942|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Pregnancy|0|||
144402943|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Pregnancy|0|||
144402944|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Pregnancy|0|||
144524474|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
144524475|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
144524476|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
144524477|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
144524478|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
144402945|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Pregnancy|0|||
144524479|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
144402946|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Pregnancy|0|||
144402947|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Pregnancy|0|||
144402948|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Pregnancy|0|||
144402949|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Pregnancy|2|||
144402950|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
144402951|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
144402952|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
144402953|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
144402954|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
144402955|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
144402956|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
144402957|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
144402958|NCT00533897|520685128|FG000|Long Term Extension (LTE)|Other|0|||
144402959|NCT00533897|520685129|FG001|Long Term Extension (LTE)|Other|0|||
144402960|NCT00533897|520685130|FG002|Long Term Extension (LTE)|Other|0|||
144402961|NCT00533897|520685131|FG003|Long Term Extension (LTE)|Other|0|||
144402962|NCT00533897|520685132|FG004|Long Term Extension (LTE)|Other|0|||
144402963|NCT00533897|520685133|FG005|Long Term Extension (LTE)|Other|0|||
144402964|NCT00533897|520685134|FG006|Long Term Extension (LTE)|Other|1|||
144402965|NCT00533897|520685135|FG007|Long Term Extension (LTE)|Other|6|||
144402966|NCT01546207|520685149|FG000|Overall Study|Death|1|||
144402967|NCT00713323|520685150|FG000|Overall Study|Adverse Event|75|||
144402968|NCT00713323|520685150|FG000|Overall Study|Withdrawal by Subject|15|||
144402969|NCT00713323|520685150|FG000|Overall Study|Lost to Follow-up|11|||
144402970|NCT00713323|520685150|FG000|Overall Study|Lack of Efficacy|36|||
144402971|NCT00713323|520685150|FG000|Overall Study|Low creatine clearance at screening|1|||
144402972|NCT00713323|520685150|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
144402973|NCT00713323|520685150|FG000|Overall Study|Surgery cured allodynic pain|1|||
144402974|NCT00713323|520685150|FG000|Overall Study|Pain free|1|||
144402975|NCT00713323|520685150|FG000|Overall Study|Non-compliance|1|||
144402976|NCT00713323|520685150|FG000|Overall Study|Pain resolved|1|||
144402977|NCT00713323|520685150|FG000|Overall Study|Subject travelling to USA|1|||
144402978|NCT00713323|520685150|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
144402979|NCT00713323|520685150|FG000|Overall Study|Treatment that may interact with Sativex|1|||
144402980|NCT00506662|520685151|FG000|Overall Study|Adverse Event|0|||
144402981|NCT00506662|520685152|FG001|Overall Study|Adverse Event|2|||
144402982|NCT00506662|520685151|FG000|Overall Study|Lack of Efficacy|1|||
144402983|NCT00506662|520685152|FG001|Overall Study|Lack of Efficacy|0|||
144402984|NCT00506662|520685151|FG000|Overall Study|Protocol Violation|2|||
144402985|NCT00506662|520685152|FG001|Overall Study|Protocol Violation|4|||
144402986|NCT00506662|520685151|FG000|Overall Study|Trial terminated|10|||
144402987|NCT00506662|520685152|FG001|Overall Study|Trial terminated|16|||
144402988|NCT00506662|520685151|FG000|Overall Study|Not recorded|4|||
144402989|NCT00506662|520685152|FG001|Overall Study|Not recorded|6|||
144402990|NCT04015336|520685154|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
144402991|NCT00491075|520685155|FG000|Overall Study|Withdrawal by Subject|1|||
144402992|NCT00491075|520685155|FG000|Overall Study|Physician Decision|1|||
144402993|NCT01603355|520685156|FG000|Overall Study|Lack of Efficacy|2|||
144402994|NCT02764333|520685159|FG000|Overall Study|Ineligible|1|||
144524480|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
144524481|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
144524482|NCT01715285|521121941|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
144524483|NCT01715285|521121942|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
144524484|NCT01715285|521121943|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
144524485|NCT01715285|521121941|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
144524486|NCT01715285|521121942|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
144524487|NCT01715285|521121943|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
144524488|NCT01715285|521121941|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
144524489|NCT01715285|521121942|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
144524490|NCT01715285|521121943|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
144524491|NCT01715285|521121941|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
144524492|NCT01715285|521121942|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
144524493|NCT01715285|521121943|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
144524494|NCT01715285|521121941|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
144524495|NCT01715285|521121942|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
144524496|NCT01715285|521121943|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
144524497|NCT01715285|521121941|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
144524498|NCT01715285|521121942|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
144402995|NCT03355365|520685160|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
144402996|NCT03355365|520685161|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
144402997|NCT03355365|520685160|FG000|Year 1, First Intervention|Protocol Violation|1|||
144402998|NCT03355365|520685161|FG001|Year 1, First Intervention|Protocol Violation|0|||
144402999|NCT03355365|520685160|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
144403000|NCT03355365|520685161|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
144524499|NCT01715285|521121943|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
144524500|NCT04858321|521121945|FG000|Overall Study|Withdrawal by Subject|3|||
144403001|NCT03355365|520685160|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
144403002|NCT03355365|520685161|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
144403003|NCT03355365|520685160|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
144403004|NCT03355365|520685161|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
144403005|NCT03355365|520685160|FG000|Year 2, Crossover Intervention|severe COVID|0|||
144403006|NCT03355365|520685161|FG001|Year 2, Crossover Intervention|severe COVID|1|||
144403007|NCT03355365|520685160|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
144403008|NCT03355365|520685161|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
144403009|NCT04622306|520685162|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
144403010|NCT04622306|520685163|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
144403011|NCT04622306|520685164|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
144403012|NCT04622306|520685165|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
144403013|NCT04622306|520685166|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
144403014|NCT04622306|520685167|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
144403015|NCT04622306|520685162|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
144403016|NCT04622306|520685163|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
144403017|NCT04622306|520685164|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
144403018|NCT04622306|520685165|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
144403019|NCT04622306|520685166|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
144403020|NCT04622306|520685167|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
144403021|NCT01200524|520685168|FG000|Overall Study|Withdrawal by Subject|1|||
144403022|NCT01200524|520685169|FG001|Overall Study|Withdrawal by Subject|1|||
144403023|NCT01200524|520685170|FG002|Overall Study|Withdrawal by Subject|3|||
144403024|NCT01200524|520685168|FG000|Overall Study|Adverse Event|1|||
144403025|NCT01200524|520685169|FG001|Overall Study|Adverse Event|0|||
144403026|NCT01200524|520685170|FG002|Overall Study|Adverse Event|0|||
144403027|NCT01200524|520685168|FG000|Overall Study|Non availability of study nurse|0|||
144403028|NCT01200524|520685169|FG001|Overall Study|Non availability of study nurse|0|||
144403029|NCT01200524|520685170|FG002|Overall Study|Non availability of study nurse|1|||
144403030|NCT01601132|520685172|FG000|Overall Study|Patient withdrew consent|1|||
144403031|NCT01601132|520685172|FG000|Overall Study|Protocol deviation|1|||
144403032|NCT00697788|520685175|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403033|NCT00697788|520685176|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
144403034|NCT00697788|520685177|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403035|NCT00697788|520685178|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403036|NCT00697788|520685179|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403037|NCT00697788|520685180|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403038|NCT00697788|520685181|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403039|NCT00697788|520685182|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
144403040|NCT00697788|520685175|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403041|NCT00697788|520685176|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403042|NCT00697788|520685177|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403043|NCT00697788|520685178|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403044|NCT00697788|520685179|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
144403045|NCT00697788|520685180|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403046|NCT00697788|520685181|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403047|NCT00697788|520685182|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
144403048|NCT03228433|520685183|FG000|Overall Study|Lost to Follow-up|1|||
144403049|NCT03228433|520685184|FG001|Overall Study|Lost to Follow-up|0|||
144403050|NCT03228433|520685185|FG002|Overall Study|Lost to Follow-up|0|||
144403051|NCT03228433|520685186|FG003|Overall Study|Lost to Follow-up|0|||
144403052|NCT03228433|520685187|FG004|Overall Study|Lost to Follow-up|0|||
144403053|NCT03228433|520685188|FG005|Overall Study|Lost to Follow-up|0|||
144403054|NCT03228433|520685183|FG000|Overall Study|Positive alcohol test|0|||
144403055|NCT03228433|520685184|FG001|Overall Study|Positive alcohol test|0|||
144403056|NCT03228433|520685185|FG002|Overall Study|Positive alcohol test|0|||
144403057|NCT03228433|520685186|FG003|Overall Study|Positive alcohol test|1|||
144403058|NCT03228433|520685187|FG004|Overall Study|Positive alcohol test|0|||
144403059|NCT03228433|520685188|FG005|Overall Study|Positive alcohol test|0|||
144403060|NCT02980783|520685193|FG000|Overall Study|Lost to Follow-up|1|||
144403061|NCT03080454|520685194|FG000|Baseline|Adverse Event|2|||
144403062|NCT03080454|520685194|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
144403063|NCT03080454|520685194|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
144403064|NCT01058655|520685202|FG000|Overall Study|Withdrawal by Subject|1|||
144403065|NCT01058655|520685203|FG001|Overall Study|Withdrawal by Subject|0|||
144403066|NCT01058655|520685204|FG002|Overall Study|Withdrawal by Subject|3|||
144403067|NCT01058655|520685205|FG003|Overall Study|Withdrawal by Subject|4|||
144403068|NCT01058655|520685202|FG000|Overall Study|Prolonged Treatment Delay|0|||
144403069|NCT01058655|520685203|FG001|Overall Study|Prolonged Treatment Delay|0|||
144598751|NCT01180998|521392520|FG001|Overall Study|Protocol Violation|2|||
144598752|NCT01180998|521392521|FG002|Overall Study|Protocol Violation|0|||
144598753|NCT01180998|521392519|FG000|Overall Study|Withdrawal by Subject|0|||
144598754|NCT01180998|521392520|FG001|Overall Study|Withdrawal by Subject|0|||
144598755|NCT01180998|521392521|FG002|Overall Study|Withdrawal by Subject|1|||
144598756|NCT01180998|521392519|FG000|Overall Study|Poor comfort|3|||
144598757|NCT01180998|521392520|FG001|Overall Study|Poor comfort|0|||
144598758|NCT01180998|521392521|FG002|Overall Study|Poor comfort|4|||
144598759|NCT01180998|521392519|FG000|Overall Study|Poor lens handling|0|||
144598760|NCT01180998|521392520|FG001|Overall Study|Poor lens handling|0|||
144598761|NCT01180998|521392521|FG002|Overall Study|Poor lens handling|2|||
144598762|NCT00068588|521392524|FG000|Overall Study|Adverse Event|0|||
144598763|NCT00068588|521392525|FG001|Overall Study|Adverse Event|0|||
144598764|NCT00068588|521392526|FG002|Overall Study|Adverse Event|2|||
144598765|NCT00068588|521392524|FG000|Overall Study|Withdrawal by Subject|0|||
144598766|NCT00068588|521392525|FG001|Overall Study|Withdrawal by Subject|0|||
144598767|NCT00068588|521392526|FG002|Overall Study|Withdrawal by Subject|1|||
144598768|NCT00068588|521392524|FG000|Overall Study|Poor KPS|0|||
144598769|NCT00068588|521392525|FG001|Overall Study|Poor KPS|0|||
144598770|NCT00068588|521392526|FG002|Overall Study|Poor KPS|1|||
144598771|NCT04098068|521392527|FG000|Overall Study|Disease Progression|7|||
144598772|NCT04098068|521392527|FG000|Overall Study|Withdrawal by Subject|2|||
144598773|NCT04098068|521392527|FG000|Overall Study|New Cancer Diagnosis|1|||
144598774|NCT03871829|521392528|FG000|Overall Study|Lost to Follow-up|0|||
144598775|NCT03871829|521392529|FG001|Overall Study|Lost to Follow-up|1|||
144598776|NCT03871829|521392528|FG000|Overall Study|Withdrawal by Subject|1|||
144598777|NCT03871829|521392529|FG001|Overall Study|Withdrawal by Subject|1|||
144598778|NCT03871829|521392528|FG000|Overall Study|Death|12|||
144598779|NCT03871829|521392529|FG001|Overall Study|Death|8|||
144598780|NCT03871829|521392528|FG000|Overall Study|Study terminated by sponsor|31|||
144598781|NCT03871829|521392529|FG001|Overall Study|Study terminated by sponsor|34|||
144598782|NCT05458479|521392534|FG000|Overall Study|Lost to Follow-up|1|||
144598783|NCT02465463|521392541|FG000|Overall Study|Lost to Follow-up|2|||
144598784|NCT02465463|521392542|FG001|Overall Study|Lost to Follow-up|1|||
144598785|NCT02465463|521392541|FG000|Overall Study|Death|1|||
144598786|NCT02465463|521392542|FG001|Overall Study|Death|0|||
144598787|NCT02465463|521392541|FG000|Overall Study|Protocol Violation|1|||
144598788|NCT02465463|521392542|FG001|Overall Study|Protocol Violation|0|||
144598789|NCT01139658|521392548|FG000|Overall Study|Adverse Event|10|||
144598790|NCT01139658|521392549|FG001|Overall Study|Adverse Event|27|||
144598791|NCT01139658|521392548|FG000|Overall Study|Lack of Efficacy|15|||
144598792|NCT01139658|521392549|FG001|Overall Study|Lack of Efficacy|7|||
144598793|NCT01139658|521392548|FG000|Overall Study|Withdrawal by Subject|2|||
144598794|NCT01139658|521392549|FG001|Overall Study|Withdrawal by Subject|4|||
144598795|NCT01139658|521392548|FG000|Overall Study|No documentation of treatment|1|||
144598796|NCT01139658|521392549|FG001|Overall Study|No documentation of treatment|0|||
144598797|NCT01139658|521392548|FG000|Overall Study|Other|28|||
144598798|NCT01139658|521392549|FG001|Overall Study|Other|75|||
144598799|NCT02092220|521392550|FG000|Period 1|Unrelated Illness|0|||
144598800|NCT02092220|521392551|FG001|Period 1|Unrelated Illness|2|||
144598801|NCT02092220|521392550|FG000|Period 2|Severe Hypoglycaemia|1|||
144598802|NCT02092220|521392551|FG001|Period 2|Severe Hypoglycaemia|0|||
144598803|NCT02092220|521392550|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
144598804|NCT02092220|521392551|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
144598805|NCT00593957|521392553|FG000|Overall Study|Physician Decision|0|||
144598806|NCT00593957|521392554|FG001|Overall Study|Physician Decision|1|||
144598807|NCT00593957|521392555|FG002|Overall Study|Physician Decision|2|||
144598808|NCT02411578|521392558|FG000|Crossover Trial Phase|Pregnancy|0|||
144598809|NCT02411578|521392559|FG001|Crossover Trial Phase|Pregnancy|1|||
144598810|NCT02824263|521394490|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
144598811|NCT02824263|521394491|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
144722384|NCT02227862|521838695|FG000|Overall Study|Withdrawal by Subject|7|||
144722385|NCT02227862|521838696|FG001|Overall Study|Withdrawal by Subject|6|||
144598812|NCT02824263|521394490|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
144598813|NCT02824263|521394491|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
144598814|NCT00568321|521394492|FG000|Overall Study|Adverse Event|1|||
144598815|NCT00568321|521394493|FG001|Overall Study|Adverse Event|0|||
144598816|NCT00568321|521394494|FG002|Overall Study|Adverse Event|0|||
144598817|NCT00568321|521394492|FG000|Overall Study|Lack of Efficacy|8|||
144598818|NCT00568321|521394493|FG001|Overall Study|Lack of Efficacy|5|||
144598819|NCT00568321|521394494|FG002|Overall Study|Lack of Efficacy|6|||
144598820|NCT00568321|521394492|FG000|Overall Study|Lost to Follow-up|0|||
144598821|NCT00568321|521394493|FG001|Overall Study|Lost to Follow-up|0|||
144598822|NCT00568321|521394494|FG002|Overall Study|Lost to Follow-up|1|||
144598823|NCT00568321|521394492|FG000|Overall Study|Withdrawal by Subject|2|||
144598824|NCT00568321|521394493|FG001|Overall Study|Withdrawal by Subject|0|||
144598825|NCT00568321|521394494|FG002|Overall Study|Withdrawal by Subject|0|||
144598826|NCT00568321|521394492|FG000|Overall Study|Protocol Violation|0|||
144598827|NCT00568321|521394493|FG001|Overall Study|Protocol Violation|0|||
144403070|NCT01058655|520685204|FG002|Overall Study|Prolonged Treatment Delay|0|||
144403071|NCT01058655|520685205|FG003|Overall Study|Prolonged Treatment Delay|2|||
144403072|NCT01058655|520685202|FG000|Overall Study|Symptomatic Deterioration|0|||
144403073|NCT01058655|520685203|FG001|Overall Study|Symptomatic Deterioration|0|||
144403074|NCT01058655|520685204|FG002|Overall Study|Symptomatic Deterioration|0|||
144403075|NCT01058655|520685205|FG003|Overall Study|Symptomatic Deterioration|1|||
144403076|NCT01058655|520685202|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
144403077|NCT01058655|520685203|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
144403078|NCT01058655|520685204|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
144403079|NCT01058655|520685205|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
144403080|NCT01058655|520685202|FG000|Overall Study|Death|0|||
144403081|NCT01058655|520685203|FG001|Overall Study|Death|1|||
144403082|NCT01058655|520685204|FG002|Overall Study|Death|1|||
144403083|NCT01058655|520685205|FG003|Overall Study|Death|0|||
144403084|NCT01058655|520685202|FG000|Overall Study|Disease Progression|1|||
144403085|NCT01058655|520685203|FG001|Overall Study|Disease Progression|2|||
144403086|NCT01058655|520685204|FG002|Overall Study|Disease Progression|4|||
144403087|NCT01058655|520685205|FG003|Overall Study|Disease Progression|24|||
144403088|NCT01058655|520685202|FG000|Overall Study|Other|0|||
144403089|NCT01058655|520685203|FG001|Overall Study|Other|0|||
144403090|NCT01058655|520685204|FG002|Overall Study|Other|0|||
144403091|NCT01058655|520685205|FG003|Overall Study|Other|4|||
144403092|NCT00619177|520685208|FG000|Overall Study|Adverse Event|18|||
144403093|NCT00619177|520685208|FG000|Overall Study|Lost to Follow-up|2|||
144403094|NCT00619177|520685208|FG000|Overall Study|Lack of Efficacy|1|||
144403095|NCT00619177|520685208|FG000|Overall Study|Missing termination information|481|||
144403096|NCT00619177|520685208|FG000|Overall Study|Not specified reasons|6|||
144403097|NCT02435147|520685210|FG000|Overall Study|non-evaluable DXA scan|11|||
144403098|NCT02939079|520685211|FG000|Overall Study|Adverse Event|2|||
144403099|NCT02939079|520685212|FG001|Overall Study|Adverse Event|1|||
144403100|NCT02939079|520685211|FG000|Overall Study|Lost to Follow-up|0|||
144403101|NCT02939079|520685212|FG001|Overall Study|Lost to Follow-up|2|||
144403102|NCT02939079|520685211|FG000|Overall Study|Protocol Violation|1|||
144403103|NCT02939079|520685212|FG001|Overall Study|Protocol Violation|0|||
144403104|NCT02939079|520685211|FG000|Overall Study|Withdrawal by Subject|0|||
144403105|NCT02939079|520685212|FG001|Overall Study|Withdrawal by Subject|1|||
144403106|NCT02939079|520685211|FG000|Overall Study|relapse during the study|1|||
144403107|NCT02939079|520685212|FG001|Overall Study|relapse during the study|1|||
144403108|NCT04093414|520685213|FG000|3 Month Follow up|Physician Decision|0|||
144403109|NCT04093414|520685214|FG001|3 Month Follow up|Physician Decision|1|||
144403110|NCT04093414|520685213|FG000|6month Follow up|Physician Decision|1|||
144403111|NCT04093414|520685214|FG001|6month Follow up|Physician Decision|3|||
144403112|NCT04889222|520685215|FG000|Overall Study|Did not meet eligibility criteria|8|||
144403113|NCT04889222|520685215|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
144403114|NCT04889222|520685215|FG000|Overall Study|Did not proceed due to time constraints|5|||
144403115|NCT01180647|520685216|FG000|Overall Study|Lost to Follow-up|5|||
144403116|NCT01180647|520685217|FG001|Overall Study|Lost to Follow-up|6|||
144403117|NCT00338104|520685244|FG000|Overall Study|Protocol Violation|2|||
144403118|NCT00338104|520685245|FG001|Overall Study|Protocol Violation|1|||
144403119|NCT00338104|520685246|FG002|Overall Study|Protocol Violation|3|||
144403120|NCT00633750|520685247|FG000|Overall Study|Adverse Event|2|||
144403121|NCT00633750|520685247|FG000|Overall Study|Withdrawal by Subject|3|||
144524501|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
144524502|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
144524503|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
144524504|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
144524505|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
144524506|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
144524507|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Death|6|||
144524508|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Death|0|||
144524509|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Death|0|||
144598828|NCT00568321|521394494|FG002|Overall Study|Protocol Violation|1|||
144403122|NCT02362269|520685250|FG000|Overall Study|Moved|1|||
144403123|NCT02362269|520685251|FG001|Overall Study|Moved|0|||
144403124|NCT02362269|520685250|FG000|Overall Study|Lost to Follow-up|0|||
144403125|NCT02362269|520685251|FG001|Overall Study|Lost to Follow-up|6|||
144403126|NCT01903031|520685252|FG000|Overall Study|Not Able to Attend Clinic|1|||
144403127|NCT01903031|520685253|FG001|Overall Study|Not Able to Attend Clinic|1|||
144403128|NCT01903031|520685254|FG002|Overall Study|Not Able to Attend Clinic|0|||
144598829|NCT00568321|521394492|FG000|Overall Study|Randomized, not treated|2|||
144403129|NCT01903031|520685252|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
144403130|NCT01903031|520685253|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
144403131|NCT01903031|520685254|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
144403132|NCT01903031|520685252|FG000|Overall Study|Adverse Event|0|||
144403133|NCT01903031|520685253|FG001|Overall Study|Adverse Event|1|||
144403134|NCT01903031|520685254|FG002|Overall Study|Adverse Event|0|||
144403135|NCT01903031|520685252|FG000|Overall Study|Withdrawal by Subject|0|||
144403136|NCT01903031|520685253|FG001|Overall Study|Withdrawal by Subject|1|||
144403137|NCT01903031|520685254|FG002|Overall Study|Withdrawal by Subject|1|||
144403138|NCT01903031|520685252|FG000|Overall Study|Protocol Violation|0|||
144403139|NCT01903031|520685253|FG001|Overall Study|Protocol Violation|0|||
144403140|NCT01903031|520685254|FG002|Overall Study|Protocol Violation|2|||
144403141|NCT01903031|520685252|FG000|Overall Study|Lost to Follow-up|0|||
144403142|NCT01903031|520685253|FG001|Overall Study|Lost to Follow-up|0|||
144403143|NCT01903031|520685254|FG002|Overall Study|Lost to Follow-up|1|||
144403144|NCT01903031|520685252|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
144403145|NCT01903031|520685253|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
144403146|NCT01903031|520685254|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
144403147|NCT01811225|520685255|FG000|Treatment Period 1|Adverse Event|2|||
144403148|NCT01811225|520685256|FG001|Treatment Period 1|Adverse Event|3|||
144403149|NCT01811225|520685255|FG000|Treatment Period 1|Lost to Follow-up|12|||
144403150|NCT01811225|520685256|FG001|Treatment Period 1|Lost to Follow-up|8|||
144403151|NCT01811225|520685255|FG000|Treatment Period 1|transporation|1|||
144403152|NCT01811225|520685256|FG001|Treatment Period 1|transporation|0|||
144403153|NCT01811225|520685255|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
144403154|NCT01811225|520685256|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
144403155|NCT01811225|520685255|FG000|Treatment Period 2|Lost to Follow-up|1|||
144403156|NCT01811225|520685256|FG001|Treatment Period 2|Lost to Follow-up|2|||
144403157|NCT01811225|520685255|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
144403158|NCT01811225|520685256|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
144403159|NCT00287365|520685257|FG000|Overall Study|sample not acquired|13|||
144403160|NCT03000569|520685258|FG000|Overall Study|Withdrawal by Subject|1|||
144403161|NCT03000569|520685259|FG001|Overall Study|Withdrawal by Subject|0|||
144403162|NCT02298023|520685260|FG000|Overall Study|Withdrawal by Subject|1|||
144403163|NCT02298023|520685261|FG001|Overall Study|Withdrawal by Subject|0|||
144403164|NCT02298023|520685262|FG002|Overall Study|Withdrawal by Subject|0|||
144403165|NCT00569270|520685264|FG000|Period: First Intervention|Protocol Violation|0|||
144403166|NCT00569270|520685265|FG001|Period: First Intervention|Protocol Violation|1|||
144403167|NCT00447005|520685266|FG000|Overall Study|Adverse Event|1|||
144403168|NCT00447005|520685266|FG000|Overall Study|Lack of Efficacy|11|||
144403169|NCT00492531|520685267|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
144403170|NCT00492531|520685268|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
144403171|NCT00508755|520685272|FG000|Overall Study|Withdrawal by Subject|1|||
144403172|NCT01790932|520685275|FG000|Overall Study|Disease Progression|41|||
144403173|NCT01790932|520685275|FG000|Overall Study|Adverse Event|7|||
144403174|NCT01790932|520685275|FG000|Overall Study|Physician Decision|1|||
144403175|NCT01790932|520685275|FG000|Overall Study|Withdrawal by Subject|1|||
144403176|NCT04223973|520685278|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
144403177|NCT04223973|520685279|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
144403178|NCT04223973|520685278|FG000|Overall Study|Adverse Event|4|||
144403179|NCT04223973|520685279|FG001|Overall Study|Adverse Event|0|||
144403180|NCT04223973|520685278|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
144403181|NCT04223973|520685279|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
144403182|NCT04223973|520685278|FG000|Overall Study|Physician Decision|1|||
144403183|NCT04223973|520685279|FG001|Overall Study|Physician Decision|1|||
144403184|NCT04223973|520685278|FG000|Overall Study|Withdrawal by Subject|0|||
144403185|NCT04223973|520685279|FG001|Overall Study|Withdrawal by Subject|1|||
144524510|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
144403186|NCT03320057|520686583|FG000|Overall Study|Lost to Follow-up|4|||
144403187|NCT03320057|520686584|FG001|Overall Study|Lost to Follow-up|17|||
144524511|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
144524512|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
144524513|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
144524514|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
144524515|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
144403188|NCT03320057|520686583|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
144403189|NCT03320057|520686584|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
144403190|NCT04092582|520686586|FG000|Overall Study|Death|1|||
144403191|NCT04092582|520686587|FG001|Overall Study|Death|1|||
144403192|NCT04092582|520686586|FG000|Overall Study|Withdrawal by Subject|4|||
144403193|NCT04092582|520686587|FG001|Overall Study|Withdrawal by Subject|1|||
144524516|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
144524517|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
144524518|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
144403194|NCT04092582|520686586|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
144403195|NCT04092582|520686587|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
144524519|NCT01539083|521121946|FG000|Before Randomization (VCD Induction)|Other|5|||
144598830|NCT00568321|521394493|FG001|Overall Study|Randomized, not treated|0|||
144598831|NCT00568321|521394494|FG002|Overall Study|Randomized, not treated|1|||
144598832|NCT01676909|521394496|FG000|Overall Study|Withdrawal by Subject|3|||
144598833|NCT01676909|521394497|FG001|Overall Study|Withdrawal by Subject|5|||
144598834|NCT01676909|521394496|FG000|Overall Study|Lost to Follow-up|15|||
144598835|NCT01676909|521394497|FG001|Overall Study|Lost to Follow-up|9|||
144598836|NCT02076113|521394498|FG000|Overall Study|Lost to Follow-up|4|||
144598837|NCT02076113|521394499|FG001|Overall Study|Lost to Follow-up|1|||
144598838|NCT02076113|521394498|FG000|Overall Study|Withdrawal by Subject|2|||
144598839|NCT02076113|521394499|FG001|Overall Study|Withdrawal by Subject|3|||
144598840|NCT02076113|521394498|FG000|Overall Study|Death|1|||
144598841|NCT02076113|521394499|FG001|Overall Study|Death|3|||
144598842|NCT01176968|521394504|FG000|Overall Study|Adverse Event|10|||
144598843|NCT01176968|521394505|FG001|Overall Study|Adverse Event|11|||
144598844|NCT01176968|521394504|FG000|Overall Study|Death|2|||
144598845|NCT01176968|521394505|FG001|Overall Study|Death|3|||
144598846|NCT01176968|521394504|FG000|Overall Study|Lack of Efficacy|0|||
144598847|NCT01176968|521394505|FG001|Overall Study|Lack of Efficacy|1|||
144598848|NCT01176968|521394504|FG000|Overall Study|Lost to Follow-up|16|||
144598849|NCT01176968|521394505|FG001|Overall Study|Lost to Follow-up|14|||
144598850|NCT01176968|521394504|FG000|Overall Study|Withdrawal by Subject|48|||
144598851|NCT01176968|521394505|FG001|Overall Study|Withdrawal by Subject|48|||
144598852|NCT01176968|521394504|FG000|Overall Study|Protocol Violation|2|||
144598853|NCT01176968|521394505|FG001|Overall Study|Protocol Violation|1|||
144598854|NCT01176968|521394504|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
144598855|NCT01176968|521394505|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
144598856|NCT01176968|521394504|FG000|Overall Study|Study terminated by sponsor|0|||
144598857|NCT01176968|521394505|FG001|Overall Study|Study terminated by sponsor|1|||
144598858|NCT01176968|521394504|FG000|Overall Study|Reason not defined|5|||
144598859|NCT01176968|521394505|FG001|Overall Study|Reason not defined|3|||
144598860|NCT00718640|521394506|FG000|Overall Study|Adverse Event|4|||
144598861|NCT00718640|521394506|FG000|Overall Study|Death|1|||
144598862|NCT00718640|521394506|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
144403196|NCT00316719|520686588|FG000|Overall Study|Adverse Event|0|||
144403197|NCT00316719|520686589|FG001|Overall Study|Adverse Event|6|||
144403198|NCT00316719|520686588|FG000|Overall Study|Consent withdrawn|2|||
144403199|NCT00316719|520686589|FG001|Overall Study|Consent withdrawn|0|||
144403200|NCT02468674|520686592|FG000|Overall Study|Adverse Event|0|||
144403201|NCT02468674|520686593|FG001|Overall Study|Adverse Event|0|||
144403202|NCT02468674|520686594|FG002|Overall Study|Adverse Event|0|||
144403203|NCT02468674|520686595|FG003|Overall Study|Adverse Event|1|||
144403204|NCT02468674|520686596|FG004|Overall Study|Adverse Event|0|||
144403205|NCT02468674|520686597|FG005|Overall Study|Adverse Event|1|||
144403206|NCT02468674|520686598|FG006|Overall Study|Adverse Event|0|||
144403207|NCT02468674|520686599|FG007|Overall Study|Adverse Event|0|||
144403208|NCT02468674|520686600|FG008|Overall Study|Adverse Event|0|||
144403209|NCT02468674|520686592|FG000|Overall Study|Lost to Follow-up|1|||
144598863|NCT04485104|521394507|FG000|Overall Study|Physician Decision|2|||
144598864|NCT04485104|521394508|FG001|Overall Study|Physician Decision|0|||
144598865|NCT04485104|521394507|FG000|Overall Study|Decision by sponsor|0|||
144598866|NCT04485104|521394508|FG001|Overall Study|Decision by sponsor|1|||
144598867|NCT01386658|521394509|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
144598868|NCT01386658|521394510|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
144598869|NCT01386658|521394509|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
144598870|NCT01386658|521394510|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
144598871|NCT01067326|521394515|FG000|Overall Study|Adverse Event|0|||
144598872|NCT01067326|521394516|FG001|Overall Study|Adverse Event|2|||
144598873|NCT01067326|521394515|FG000|Overall Study|Withdrawal by Subject|1|||
144598874|NCT01067326|521394516|FG001|Overall Study|Withdrawal by Subject|0|||
144598875|NCT01067326|521394515|FG000|Overall Study|Early Study Termination|1|||
144403210|NCT02468674|520686593|FG001|Overall Study|Lost to Follow-up|0|||
144403211|NCT02468674|520686594|FG002|Overall Study|Lost to Follow-up|0|||
144403212|NCT02468674|520686595|FG003|Overall Study|Lost to Follow-up|0|||
144403213|NCT02468674|520686596|FG004|Overall Study|Lost to Follow-up|0|||
144403214|NCT02468674|520686597|FG005|Overall Study|Lost to Follow-up|0|||
144403215|NCT02468674|520686598|FG006|Overall Study|Lost to Follow-up|0|||
144403216|NCT02468674|520686599|FG007|Overall Study|Lost to Follow-up|1|||
144598876|NCT01067326|521394516|FG001|Overall Study|Early Study Termination|1|||
144598877|NCT00769860|521394517|FG000|Overall Study|Withdrawal by Subject|2|||
144598878|NCT00769860|521394518|FG001|Overall Study|Withdrawal by Subject|0|||
144598879|NCT03170154|521394524|FG000|Overall Study|Lost to Follow-up|4|||
144598880|NCT03170154|521394524|FG000|Overall Study|Death|2|||
144598881|NCT03170154|521394524|FG000|Overall Study|Withdrawal by Subject|2|||
144598882|NCT02279862|521394525|FG000|Overall Study|Study drug toxicity|3|||
144598883|NCT02279862|521394526|FG001|Overall Study|Study drug toxicity|6|||
144598884|NCT02279862|521394525|FG000|Overall Study|No longer meets criteria|0|||
144598885|NCT02279862|521394526|FG001|Overall Study|No longer meets criteria|1|||
144722386|NCT02227862|521838695|FG000|Overall Study|Lost to Follow-up|1|||
144403217|NCT02468674|520686600|FG008|Overall Study|Lost to Follow-up|1|||
144403218|NCT02468674|520686592|FG000|Overall Study|Physician Decision|0|||
144403219|NCT02468674|520686593|FG001|Overall Study|Physician Decision|0|||
144403220|NCT02468674|520686594|FG002|Overall Study|Physician Decision|0|||
144403221|NCT02468674|520686595|FG003|Overall Study|Physician Decision|0|||
144403222|NCT02468674|520686596|FG004|Overall Study|Physician Decision|0|||
144598886|NCT02279862|521394525|FG000|Overall Study|Administrative reason by sponsor|0|||
144598887|NCT02279862|521394526|FG001|Overall Study|Administrative reason by sponsor|1|||
144598888|NCT02279862|521394525|FG000|Overall Study|Disease progression|5|||
144598889|NCT02279862|521394526|FG001|Overall Study|Disease progression|2|||
144598890|NCT02279862|521394525|FG000|Overall Study|Study closed by sponsor|16|||
144598891|NCT02279862|521394526|FG001|Overall Study|Study closed by sponsor|13|||
144403223|NCT02468674|520686597|FG005|Overall Study|Physician Decision|0|||
144403224|NCT02468674|520686598|FG006|Overall Study|Physician Decision|1|||
144403225|NCT02468674|520686599|FG007|Overall Study|Physician Decision|0|||
144403226|NCT02468674|520686600|FG008|Overall Study|Physician Decision|0|||
144403227|NCT02468674|520686592|FG000|Overall Study|Patient/Guardian Decision|0|||
144403228|NCT02468674|520686593|FG001|Overall Study|Patient/Guardian Decision|0|||
144403229|NCT02468674|520686594|FG002|Overall Study|Patient/Guardian Decision|0|||
144403230|NCT02468674|520686595|FG003|Overall Study|Patient/Guardian Decision|0|||
144403231|NCT02468674|520686596|FG004|Overall Study|Patient/Guardian Decision|1|||
144403232|NCT02468674|520686597|FG005|Overall Study|Patient/Guardian Decision|0|||
144403233|NCT02468674|520686598|FG006|Overall Study|Patient/Guardian Decision|0|||
144403234|NCT02468674|520686599|FG007|Overall Study|Patient/Guardian Decision|2|||
144403235|NCT02468674|520686600|FG008|Overall Study|Patient/Guardian Decision|1|||
144403236|NCT02468674|520686592|FG000|Overall Study|Protocol Deviation|0|||
144403237|NCT02468674|520686593|FG001|Overall Study|Protocol Deviation|0|||
144403238|NCT02468674|520686594|FG002|Overall Study|Protocol Deviation|0|||
144403239|NCT02468674|520686595|FG003|Overall Study|Protocol Deviation|0|||
144403240|NCT02468674|520686596|FG004|Overall Study|Protocol Deviation|0|||
144403241|NCT02468674|520686597|FG005|Overall Study|Protocol Deviation|0|||
144403242|NCT02468674|520686598|FG006|Overall Study|Protocol Deviation|0|||
144403243|NCT02468674|520686599|FG007|Overall Study|Protocol Deviation|1|||
144403244|NCT02468674|520686600|FG008|Overall Study|Protocol Deviation|1|||
144403245|NCT01550289|520686602|FG000|Overall Study|Protocol Violation|1|||
144403246|NCT01550289|520686603|FG001|Overall Study|Protocol Violation|0|||
144403247|NCT01550289|520686602|FG000|Overall Study|Lost to Follow-up|1|||
144403248|NCT01550289|520686603|FG001|Overall Study|Lost to Follow-up|1|||
144403249|NCT01550289|520686602|FG000|Overall Study|Withdrawal by Subject|11|||
144403250|NCT01550289|520686603|FG001|Overall Study|Withdrawal by Subject|3|||
144403251|NCT02975336|520686604|FG000|DBPC (52 Weeks)|Adverse Event|16|||
144403252|NCT02975336|520686605|FG001|DBPC (52 Weeks)|Adverse Event|17|||
144403253|NCT02975336|520686606|FG002|DBPC (52 Weeks)|Adverse Event|13|||
144403254|NCT02975336|520686607|FG003|DBPC (52 Weeks)|Adverse Event|18|||
144524520|NCT01539083|521121947|FG001|Before Randomization (VCD Induction)|Other|0|||
144524521|NCT01539083|521121948|FG002|Before Randomization (VCD Induction)|Other|0|||
144524522|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
144524523|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
144524524|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
144524525|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Other|0|||
144524526|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Other|1|||
144524527|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Other|1|||
144524528|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
144524529|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
144598892|NCT02279862|521394525|FG000|Overall Study|Other|1|||
144598893|NCT02279862|521394526|FG001|Overall Study|Other|2|||
144403255|NCT02975336|520686608|FG004|DBPC (52 Weeks)|Adverse Event|0|||
144403256|NCT02975336|520686609|FG005|DBPC (52 Weeks)|Adverse Event|0|||
144403257|NCT02975336|520686610|FG006|DBPC (52 Weeks)|Adverse Event|0|||
144403258|NCT02975336|520686611|FG007|DBPC (52 Weeks)|Adverse Event|0|||
144403259|NCT02975336|520686604|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
144403260|NCT02975336|520686605|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
144403261|NCT02975336|520686606|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
144403262|NCT02975336|520686607|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
144403263|NCT02975336|520686608|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
144403264|NCT02975336|520686609|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
144403265|NCT02975336|520686610|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
144403266|NCT02975336|520686611|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
144403267|NCT02975336|520686604|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
144524530|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
144403268|NCT02975336|520686605|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
144403269|NCT02975336|520686606|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
144403270|NCT02975336|520686607|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
144524531|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
144598894|NCT02279862|521394525|FG000|Overall Study|Withdrawal by Subject|1|||
144403271|NCT02975336|520686608|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
144403272|NCT02975336|520686609|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
144403273|NCT02975336|520686610|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
144403274|NCT02975336|520686611|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
144403275|NCT02975336|520686604|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
144403276|NCT02975336|520686605|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
144403277|NCT02975336|520686606|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
144403278|NCT02975336|520686607|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
144403279|NCT02975336|520686608|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
144403280|NCT02975336|520686609|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
144403281|NCT02975336|520686610|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
144403282|NCT02975336|520686611|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
144403283|NCT02975336|520686604|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
144403284|NCT02975336|520686605|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
144403285|NCT02975336|520686606|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
144403286|NCT02975336|520686607|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
144403287|NCT02975336|520686608|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
144403288|NCT02975336|520686609|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
144403289|NCT02975336|520686610|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
144403290|NCT02975336|520686611|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
144403291|NCT02975336|520686604|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
144403292|NCT02975336|520686605|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
144403293|NCT02975336|520686606|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
144403294|NCT02975336|520686607|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
144403295|NCT02975336|520686608|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
144403296|NCT02975336|520686609|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
144403297|NCT02975336|520686610|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
144403298|NCT02975336|520686611|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
144403299|NCT02975336|520686604|FG000|LTE (104 Weeks)|Adverse Event|0|||
144403300|NCT02975336|520686605|FG001|LTE (104 Weeks)|Adverse Event|0|||
144403301|NCT02975336|520686606|FG002|LTE (104 Weeks)|Adverse Event|0|||
144403302|NCT02975336|520686607|FG003|LTE (104 Weeks)|Adverse Event|0|||
144403303|NCT02975336|520686608|FG004|LTE (104 Weeks)|Adverse Event|7|||
144403304|NCT02975336|520686609|FG005|LTE (104 Weeks)|Adverse Event|4|||
144403305|NCT02975336|520686610|FG006|LTE (104 Weeks)|Adverse Event|2|||
144403306|NCT02975336|520686611|FG007|LTE (104 Weeks)|Adverse Event|0|||
144403307|NCT02975336|520686604|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
144403308|NCT02975336|520686605|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
144403309|NCT02975336|520686606|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
144403310|NCT02975336|520686607|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
144403311|NCT02975336|520686608|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
144403312|NCT02975336|520686609|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
144403313|NCT02975336|520686610|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
144403314|NCT02975336|520686611|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
144403315|NCT02975336|520686604|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
144403316|NCT02975336|520686605|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
144403317|NCT02975336|520686606|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
144403318|NCT02975336|520686607|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
144403319|NCT02975336|520686608|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
144403320|NCT02975336|520686609|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
144403321|NCT02975336|520686610|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
144403322|NCT02975336|520686611|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
144403323|NCT02975336|520686604|FG000|LTE (104 Weeks)|Other|0|||
144403324|NCT02975336|520686605|FG001|LTE (104 Weeks)|Other|0|||
144403325|NCT02975336|520686606|FG002|LTE (104 Weeks)|Other|0|||
144403326|NCT02975336|520686607|FG003|LTE (104 Weeks)|Other|0|||
144403327|NCT02975336|520686608|FG004|LTE (104 Weeks)|Other|55|||
144403328|NCT02975336|520686609|FG005|LTE (104 Weeks)|Other|63|||
144403329|NCT02975336|520686610|FG006|LTE (104 Weeks)|Other|76|||
144403330|NCT02975336|520686611|FG007|LTE (104 Weeks)|Other|72|||
144403331|NCT01897454|520686612|FG000|Overall Study|Withdrawal by Subject|1|||
144403332|NCT05154578|520686614|FG000|Overall Study|Withdrawal by Subject|2|||
144403333|NCT05154578|520686615|FG001|Overall Study|Withdrawal by Subject|3|||
144403334|NCT05154578|520686616|FG002|Overall Study|Withdrawal by Subject|2|||
144403335|NCT05154578|520686617|FG003|Overall Study|Withdrawal by Subject|4|||
144403336|NCT05154578|520686618|FG004|Overall Study|Withdrawal by Subject|0|||
144403337|NCT05154578|520686614|FG000|Overall Study|Lost to Follow-up|0|||
144403338|NCT05154578|520686615|FG001|Overall Study|Lost to Follow-up|1|||
144403339|NCT05154578|520686616|FG002|Overall Study|Lost to Follow-up|0|||
144403340|NCT05154578|520686617|FG003|Overall Study|Lost to Follow-up|3|||
144403341|NCT05154578|520686618|FG004|Overall Study|Lost to Follow-up|0|||
144403342|NCT05154578|520686614|FG000|Overall Study|Adverse Event|0|||
144403343|NCT05154578|520686615|FG001|Overall Study|Adverse Event|0|||
144403344|NCT05154578|520686616|FG002|Overall Study|Adverse Event|0|||
144403345|NCT05154578|520686617|FG003|Overall Study|Adverse Event|1|||
144403346|NCT05154578|520686618|FG004|Overall Study|Adverse Event|0|||
144403347|NCT05154578|520686614|FG000|Overall Study|Relocated to another province|0|||
144403348|NCT05154578|520686615|FG001|Overall Study|Relocated to another province|0|||
144403349|NCT05154578|520686616|FG002|Overall Study|Relocated to another province|1|||
144403350|NCT05154578|520686617|FG003|Overall Study|Relocated to another province|0|||
144403351|NCT05154578|520686618|FG004|Overall Study|Relocated to another province|1|||
144403352|NCT05154578|520686614|FG000|Overall Study|Baby loss|0|||
144403353|NCT05154578|520686615|FG001|Overall Study|Baby loss|1|||
144403354|NCT05154578|520686616|FG002|Overall Study|Baby loss|0|||
144403355|NCT05154578|520686617|FG003|Overall Study|Baby loss|0|||
144403356|NCT05154578|520686618|FG004|Overall Study|Baby loss|0|||
144403357|NCT00142935|520686625|FG000|Overall Study|Other reason|1|||
144403358|NCT00142935|520686626|FG001|Overall Study|Other reason|1|||
144403359|NCT00142935|520686627|FG002|Overall Study|Other reason|1|||
144403360|NCT00142935|520686625|FG000|Overall Study|Lost to Follow-up|2|||
144403361|NCT00142935|520686626|FG001|Overall Study|Lost to Follow-up|5|||
144403362|NCT00142935|520686627|FG002|Overall Study|Lost to Follow-up|5|||
144403363|NCT00142935|520686625|FG000|Overall Study|Death|0|||
144403364|NCT00142935|520686626|FG001|Overall Study|Death|2|||
144403365|NCT00142935|520686627|FG002|Overall Study|Death|1|||
144403366|NCT00705289|520686628|FG000|Overall Study|Subject or treating physician's choice|131|||
144403367|NCT02601027|520686632|FG000|Registration to Surgery|Withdrawal by Subject|20|||
144403368|NCT02601027|520686633|FG001|Registration to Surgery|Withdrawal by Subject|10|||
144403369|NCT01146912|520686634|FG000|Overall Study|Already received influenza vaccination|817|||
144403370|NCT01146912|520686635|FG001|Overall Study|Already received influenza vaccination|822|||
144403371|NCT01146912|520686636|FG002|Overall Study|Already received influenza vaccination|13|||
144403372|NCT01146912|520686637|FG003|Overall Study|Already received influenza vaccination|15|||
144403373|NCT01146912|520686638|FG004|Overall Study|Already received influenza vaccination|41|||
144403374|NCT01146912|520686639|FG005|Overall Study|Already received influenza vaccination|61|||
144403375|NCT01146912|520686640|FG006|Overall Study|Already received influenza vaccination|56|||
144403376|NCT01146912|520686641|FG007|Overall Study|Already received influenza vaccination|0|||
144403377|NCT01146912|520686634|FG000|Overall Study|< 14 weeks gestational age|0|||
144403378|NCT01146912|520686635|FG001|Overall Study|< 14 weeks gestational age|0|||
144403379|NCT01146912|520686636|FG002|Overall Study|< 14 weeks gestational age|3|||
144403380|NCT01146912|520686637|FG003|Overall Study|< 14 weeks gestational age|2|||
144403381|NCT01146912|520686638|FG004|Overall Study|< 14 weeks gestational age|0|||
144403382|NCT01146912|520686639|FG005|Overall Study|< 14 weeks gestational age|0|||
144403383|NCT01146912|520686640|FG006|Overall Study|< 14 weeks gestational age|0|||
144403384|NCT01146912|520686641|FG007|Overall Study|< 14 weeks gestational age|0|||
144403385|NCT01146912|520686634|FG000|Overall Study|Duplicate patient|0|||
144403386|NCT01146912|520686635|FG001|Overall Study|Duplicate patient|0|||
144403387|NCT01146912|520686636|FG002|Overall Study|Duplicate patient|1|||
144403388|NCT01146912|520686637|FG003|Overall Study|Duplicate patient|0|||
144403389|NCT01146912|520686638|FG004|Overall Study|Duplicate patient|0|||
144403390|NCT01146912|520686639|FG005|Overall Study|Duplicate patient|0|||
144403391|NCT01146912|520686640|FG006|Overall Study|Duplicate patient|0|||
144403392|NCT01146912|520686641|FG007|Overall Study|Duplicate patient|0|||
144403393|NCT02248701|520686644|FG000|Overall Study|Withdrawal by Subject|2|||
144403394|NCT02248701|520686645|FG001|Overall Study|Withdrawal by Subject|1|||
144403395|NCT02248701|520686644|FG000|Overall Study|Physician Decision|0|||
144403396|NCT02248701|520686645|FG001|Overall Study|Physician Decision|1|||
144403397|NCT02248701|520686644|FG000|Overall Study|Adverse Event|1|||
144403398|NCT02248701|520686645|FG001|Overall Study|Adverse Event|0|||
144403399|NCT02248701|520686644|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
144403400|NCT02248701|520686645|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
144403401|NCT04289623|520686646|FG000|Wave 1 Emails|Email was not delivered|268|||
144403402|NCT04289623|520686647|FG001|Wave 1 Emails|Email was not delivered|257|||
144403403|NCT04289623|520686648|FG002|Wave 1 Emails|Email was not delivered|0|||
144403404|NCT04289623|520686649|FG003|Wave 1 Emails|Email was not delivered|0|||
144403405|NCT04289623|520686650|FG004|Wave 1 Emails|Email was not delivered|0|||
144403406|NCT04289623|520686651|FG005|Wave 1 Emails|Email was not delivered|0|||
144403407|NCT04515394|520686656|FG000|Overall Study|Participant did not receive treatment|1|||
144403408|NCT00413244|520686657|FG000|Overall Study|Withdrawal by Subject|10|||
144403409|NCT00413244|520686658|FG001|Overall Study|Withdrawal by Subject|1|||
144403410|NCT01609231|520686659|FG000|Overall Study|Adverse Event|1|||
144403411|NCT01609231|520686660|FG001|Overall Study|Adverse Event|3|||
144403412|NCT01609231|520686659|FG000|Overall Study|Physician Decision|1|||
144403413|NCT01609231|520686660|FG001|Overall Study|Physician Decision|0|||
144403414|NCT01609231|520686659|FG000|Overall Study|Withdrawal by Subject|1|||
144403415|NCT01609231|520686660|FG001|Overall Study|Withdrawal by Subject|0|||
144403416|NCT02761733|520686662|FG000|Overall Study|Death|3|||
144403417|NCT02761733|520686663|FG001|Overall Study|Death|5|||
144403418|NCT02761733|520686664|FG002|Overall Study|Death|1|||
144403419|NCT02761733|520686665|FG003|Overall Study|Death|1|||
144403420|NCT02761733|520686662|FG000|Overall Study|Lost to Follow-up|6|||
144403421|NCT02761733|520686663|FG001|Overall Study|Lost to Follow-up|7|||
144403422|NCT02761733|520686664|FG002|Overall Study|Lost to Follow-up|0|||
144403423|NCT02761733|520686665|FG003|Overall Study|Lost to Follow-up|3|||
144403424|NCT02761733|520686662|FG000|Overall Study|Physician Decision|4|||
144403425|NCT02761733|520686663|FG001|Overall Study|Physician Decision|0|||
144403426|NCT02761733|520686664|FG002|Overall Study|Physician Decision|0|||
144403427|NCT02761733|520686665|FG003|Overall Study|Physician Decision|0|||
144403428|NCT02761733|520686662|FG000|Overall Study|Withdrawal by Subject|2|||
144249893|NCT00207727|520111792|FG000|Overall Study|Withdrawal by Subject|0|||
144249894|NCT00207727|520111793|FG001|Overall Study|Withdrawal by Subject|0|||
144249895|NCT00207727|520111794|FG002|Overall Study|Withdrawal by Subject|0|||
144249896|NCT00207727|520111795|FG003|Overall Study|Withdrawal by Subject|0|||
144249897|NCT00207727|520111796|FG004|Overall Study|Withdrawal by Subject|1|||
144249898|NCT00207727|520111792|FG000|Overall Study|Lost to Follow-up|0|||
144249899|NCT00207727|520111793|FG001|Overall Study|Lost to Follow-up|1|||
144249900|NCT00207727|520111794|FG002|Overall Study|Lost to Follow-up|0|||
144249901|NCT00207727|520111795|FG003|Overall Study|Lost to Follow-up|0|||
144249902|NCT00207727|520111796|FG004|Overall Study|Lost to Follow-up|0|||
144249903|NCT00207727|520111792|FG000|Overall Study|Other|38|||
144249904|NCT00207727|520111793|FG001|Overall Study|Other|41|||
144249905|NCT00207727|520111794|FG002|Overall Study|Other|41|||
144249906|NCT00207727|520111795|FG003|Overall Study|Other|37|||
144249907|NCT00207727|520111796|FG004|Overall Study|Other|33|||
144249908|NCT00539032|520111800|FG000|Overall Study|Withdrawal by Subject|2|||
144249909|NCT00539032|520111801|FG001|Overall Study|Withdrawal by Subject|1|||
144249910|NCT02333383|520111802|FG000|Overall Study|Adalimumab discontinuation|21|||
144249911|NCT02333383|520111802|FG000|Overall Study|Lost to Follow-up|15|||
144249912|NCT02333383|520111802|FG000|Overall Study|Withdrawal by Subject|3|||
144249913|NCT02333383|520111802|FG000|Overall Study|Transfer to another hospital|2|||
144249914|NCT00463840|520111803|FG000|Overall Study|Disease progression|7|||
144249915|NCT00463840|520111803|FG000|Overall Study|Withdrawal by Subject|2|||
144249916|NCT00463840|520111803|FG000|Overall Study|Adverse Event|3|||
144249917|NCT01653327|520111804|FG000|Overall Study|Withdrawal by Subject|1|||
144249918|NCT05243563|520113398|FG000|Overall Study|Withdrawal by Subject|1|||
144249919|NCT05243563|520113399|FG001|Overall Study|Withdrawal by Subject|0|||
144249920|NCT05243563|520113398|FG000|Overall Study|Physician Decision|1|||
144249921|NCT05243563|520113399|FG001|Overall Study|Physician Decision|0|||
144249922|NCT00441363|520113400|FG000|Overall Study|Adverse Event|4|||
144403429|NCT02761733|520686663|FG001|Overall Study|Withdrawal by Subject|0|||
144403430|NCT02761733|520686664|FG002|Overall Study|Withdrawal by Subject|0|||
144524532|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
144524533|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
144524534|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
144524535|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
144524536|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
144524537|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
144524538|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
144524539|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
144524540|NCT01539083|521121946|FG000|After Randomization (TP and VTP)|Death|0|||
144524541|NCT01539083|521121947|FG001|After Randomization (TP and VTP)|Death|6|||
144524542|NCT01539083|521121948|FG002|After Randomization (TP and VTP)|Death|11|||
144524543|NCT04632992|521121955|FG000|Overall Study|Adverse Event|0|||
144524544|NCT04632992|521121956|FG001|Overall Study|Adverse Event|0|||
144524545|NCT04632992|521121957|FG002|Overall Study|Adverse Event|0|||
144524546|NCT04632992|521121958|FG003|Overall Study|Adverse Event|0|||
144524547|NCT04632992|521121959|FG004|Overall Study|Adverse Event|0|||
144524548|NCT04632992|521121960|FG005|Overall Study|Adverse Event|0|||
144524549|NCT04632992|521121961|FG006|Overall Study|Adverse Event|0|||
144524550|NCT04632992|521121962|FG007|Overall Study|Adverse Event|0|||
144524551|NCT04632992|521121963|FG008|Overall Study|Adverse Event|0|||
144524552|NCT04632992|521121964|FG009|Overall Study|Adverse Event|0|||
144524553|NCT04632992|521121965|FG010|Overall Study|Adverse Event|0|||
144524554|NCT04632992|521121966|FG011|Overall Study|Adverse Event|0|||
144524555|NCT04632992|521121967|FG012|Overall Study|Adverse Event|1|||
144524556|NCT04632992|521121968|FG013|Overall Study|Adverse Event|0|||
144524557|NCT04632992|521121955|FG000|Overall Study|Death|17|||
144524558|NCT04632992|521121956|FG001|Overall Study|Death|1|||
144524559|NCT04632992|521121957|FG002|Overall Study|Death|14|||
144524560|NCT04632992|521121958|FG003|Overall Study|Death|14|||
144524561|NCT04632992|521121959|FG004|Overall Study|Death|13|||
144249923|NCT00441363|520113401|FG001|Overall Study|Adverse Event|2|||
144249924|NCT00441363|520113400|FG000|Overall Study|Withdrawal by Subject|3|||
144249925|NCT00441363|520113401|FG001|Overall Study|Withdrawal by Subject|4|||
144249926|NCT00441363|520113400|FG000|Overall Study|Physician Decision|6|||
144249927|NCT00441363|520113401|FG001|Overall Study|Physician Decision|7|||
144249928|NCT00441363|520113400|FG000|Overall Study|Lost to Follow-up|2|||
144524562|NCT04632992|521121960|FG005|Overall Study|Death|6|||
144524563|NCT04632992|521121961|FG006|Overall Study|Death|7|||
144524564|NCT04632992|521121962|FG007|Overall Study|Death|12|||
144524565|NCT04632992|521121963|FG008|Overall Study|Death|15|||
144524566|NCT04632992|521121964|FG009|Overall Study|Death|20|||
144524567|NCT04632992|521121965|FG010|Overall Study|Death|8|||
144524568|NCT04632992|521121966|FG011|Overall Study|Death|2|||
144249929|NCT00441363|520113401|FG001|Overall Study|Lost to Follow-up|2|||
144403431|NCT02761733|520686665|FG003|Overall Study|Withdrawal by Subject|0|||
144403432|NCT02761733|520686662|FG000|Overall Study|Discharged from Study Site|10|||
144403433|NCT02761733|520686663|FG001|Overall Study|Discharged from Study Site|9|||
144403434|NCT02761733|520686664|FG002|Overall Study|Discharged from Study Site|25|||
144403435|NCT02761733|520686665|FG003|Overall Study|Discharged from Study Site|11|||
144403436|NCT02761733|520686662|FG000|Overall Study|Cognitive Impairment|5|||
144403437|NCT02761733|520686663|FG001|Overall Study|Cognitive Impairment|0|||
144403438|NCT02761733|520686664|FG002|Overall Study|Cognitive Impairment|1|||
144403439|NCT02761733|520686665|FG003|Overall Study|Cognitive Impairment|0|||
144403440|NCT03685123|520686666|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
144403441|NCT03685123|520686667|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
144403442|NCT03685123|520686668|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
144403443|NCT03685123|520686666|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
144403444|NCT03685123|520686667|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
144403445|NCT03685123|520686668|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
144403446|NCT03685123|520686666|FG000|Weight Loss Phase|Lost to Follow-up|1|||
144403447|NCT03685123|520686667|FG001|Weight Loss Phase|Lost to Follow-up|0|||
144403448|NCT03685123|520686668|FG002|Weight Loss Phase|Lost to Follow-up|0|||
144403449|NCT03685123|520686666|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
144403450|NCT03685123|520686667|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
144403451|NCT03685123|520686668|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
144403452|NCT03685123|520686666|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
144403453|NCT03685123|520686667|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
144403454|NCT03685123|520686668|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
144403455|NCT03685123|520686666|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
144403456|NCT03685123|520686667|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
144403457|NCT03685123|520686668|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
144403458|NCT00400764|520686670|FG000|Phase Ib|Adverse Event|1|||
144403459|NCT00400764|520686671|FG001|Phase Ib|Adverse Event|0|||
144403460|NCT00400764|520686672|FG002|Phase Ib|Adverse Event|0|||
144403461|NCT00400764|520686673|FG003|Phase Ib|Adverse Event|0|||
144403462|NCT00400764|520686674|FG004|Phase Ib|Adverse Event|0|||
144403463|NCT00400764|520686670|FG000|Phase Ib|Death|1|||
144403464|NCT00400764|520686671|FG001|Phase Ib|Death|0|||
144403465|NCT00400764|520686672|FG002|Phase Ib|Death|0|||
144403466|NCT00400764|520686673|FG003|Phase Ib|Death|0|||
144403467|NCT00400764|520686674|FG004|Phase Ib|Death|0|||
144403468|NCT00400764|520686670|FG000|Phase Ib|Disease Progression|4|||
144403469|NCT00400764|520686671|FG001|Phase Ib|Disease Progression|4|||
144403470|NCT00400764|520686672|FG002|Phase Ib|Disease Progression|0|||
144403471|NCT00400764|520686673|FG003|Phase Ib|Disease Progression|0|||
144403472|NCT00400764|520686674|FG004|Phase Ib|Disease Progression|0|||
144403473|NCT00400764|520686670|FG000|Phase II|Death|0|||
144403474|NCT00400764|520686671|FG001|Phase II|Death|0|||
144403475|NCT00400764|520686672|FG002|Phase II|Death|1|||
144403476|NCT00400764|520686673|FG003|Phase II|Death|2|||
144403477|NCT00400764|520686674|FG004|Phase II|Death|0|||
144403478|NCT00400764|520686670|FG000|Phase II|Lost to Follow-up|0|||
144403479|NCT00400764|520686671|FG001|Phase II|Lost to Follow-up|0|||
144403480|NCT00400764|520686672|FG002|Phase II|Lost to Follow-up|1|||
144403481|NCT00400764|520686673|FG003|Phase II|Lost to Follow-up|0|||
144403482|NCT00400764|520686674|FG004|Phase II|Lost to Follow-up|0|||
144403483|NCT00400764|520686670|FG000|Phase II|Physician Decision|0|||
144403484|NCT00400764|520686671|FG001|Phase II|Physician Decision|0|||
144598895|NCT02279862|521394526|FG001|Overall Study|Withdrawal by Subject|0|||
144598896|NCT03431857|521394529|FG000|Overall Study|Death|6|||
144598897|NCT03431857|521394529|FG000|Overall Study|Lost to Follow-up|41|||
144598898|NCT03431857|521394529|FG000|Overall Study|Adverse Event|6|||
144598899|NCT03431857|521394529|FG000|Overall Study|Withdrawal by Subject|1|||
144403485|NCT00400764|520686672|FG002|Phase II|Physician Decision|1|||
144403486|NCT00400764|520686673|FG003|Phase II|Physician Decision|1|||
144403487|NCT00400764|520686674|FG004|Phase II|Physician Decision|0|||
144403488|NCT00400764|520686670|FG000|Phase II|Sponsor's decision to terminate|0|||
144403489|NCT00400764|520686671|FG001|Phase II|Sponsor's decision to terminate|0|||
144403490|NCT00400764|520686672|FG002|Phase II|Sponsor's decision to terminate|18|||
144403491|NCT00400764|520686673|FG003|Phase II|Sponsor's decision to terminate|22|||
144403492|NCT00400764|520686674|FG004|Phase II|Sponsor's decision to terminate|11|||
144403493|NCT00400764|520686670|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
144403494|NCT00400764|520686671|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
144403495|NCT00400764|520686672|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
144403496|NCT00400764|520686673|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
144403497|NCT00400764|520686674|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
144403498|NCT00400764|520686670|FG000|Phase II|Withdrawal by Subject|0|||
144403499|NCT00400764|520686671|FG001|Phase II|Withdrawal by Subject|0|||
144403500|NCT00400764|520686672|FG002|Phase II|Withdrawal by Subject|1|||
144403501|NCT00400764|520686673|FG003|Phase II|Withdrawal by Subject|1|||
144598900|NCT01323621|521394530|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
144403502|NCT00400764|520686674|FG004|Phase II|Withdrawal by Subject|0|||
144403503|NCT02130297|520686677|FG000|Overall Study|Lost to Follow-up|4|||
144403504|NCT01387789|520686678|FG000|Overall Study|Adverse Event|5|||
144403505|NCT01387789|520686678|FG000|Overall Study|Lack of Efficacy|2|||
144403506|NCT01387789|520686678|FG000|Overall Study|Lost to Follow-up|1|||
144403507|NCT03113071|520686681|FG000|Overall Study|Withdrawal by Subject|1|||
144403508|NCT03113071|520686682|FG001|Overall Study|Withdrawal by Subject|0|||
144403509|NCT01187433|520686690|FG000|Overall Study|Protocol Violation|6|||
144403510|NCT01187433|520686691|FG001|Overall Study|Protocol Violation|2|||
144403511|NCT01187433|520686690|FG000|Overall Study|Withdrawal by Subject|5|||
144403512|NCT01187433|520686691|FG001|Overall Study|Withdrawal by Subject|2|||
144403513|NCT00302107|520686692|FG000|Overall Study|Lost to Follow-up|6|||
144403514|NCT00302107|520686693|FG001|Overall Study|Lost to Follow-up|5|||
144403515|NCT00302107|520686692|FG000|Overall Study|Protocol Violation|1|||
144403516|NCT00302107|520686693|FG001|Overall Study|Protocol Violation|0|||
144403517|NCT00302107|520686692|FG000|Overall Study|Relocation|0|||
144403518|NCT00302107|520686693|FG001|Overall Study|Relocation|1|||
144403519|NCT00302107|520686692|FG000|Overall Study|Withdrawal by Subject|0|||
144403520|NCT00302107|520686693|FG001|Overall Study|Withdrawal by Subject|3|||
144403521|NCT00302107|520686692|FG000|Overall Study|Adverse Event|1|||
144403522|NCT00302107|520686693|FG001|Overall Study|Adverse Event|0|||
144403523|NCT00437983|520686694|FG000|Overall Study|Adverse Event|6|||
144403524|NCT00437983|520686695|FG001|Overall Study|Adverse Event|6|||
144403525|NCT00437983|520686694|FG000|Overall Study|Protocol Violation|2|||
144403526|NCT00437983|520686695|FG001|Overall Study|Protocol Violation|1|||
144403527|NCT00437983|520686694|FG000|Overall Study|Withdrawal by Subject|5|||
144403528|NCT00437983|520686695|FG001|Overall Study|Withdrawal by Subject|6|||
144403529|NCT00594659|520686699|FG000|Overall Study|Lost to Follow-up|13|||
144403530|NCT00594659|520686700|FG001|Overall Study|Lost to Follow-up|9|||
144403531|NCT00594659|520686701|FG002|Overall Study|Lost to Follow-up|7|||
144403532|NCT00300274|520686702|FG000|Overall Study|Withdrawal by Subject|12|||
144403533|NCT00300274|520686703|FG001|Overall Study|Withdrawal by Subject|3|||
144403534|NCT00300274|520686704|FG002|Overall Study|Withdrawal by Subject|14|||
144403535|NCT00300274|520686702|FG000|Overall Study|Lost to Follow-up|3|||
144403536|NCT00300274|520686703|FG001|Overall Study|Lost to Follow-up|4|||
144403537|NCT00300274|520686704|FG002|Overall Study|Lost to Follow-up|5|||
144403538|NCT00300274|520686702|FG000|Overall Study|Death|31|||
144403539|NCT00300274|520686703|FG001|Overall Study|Death|20|||
144403540|NCT00300274|520686704|FG002|Overall Study|Death|25|||
144403541|NCT00300274|520686702|FG000|Overall Study|Re-transplant|0|||
144403542|NCT00300274|520686703|FG001|Overall Study|Re-transplant|0|||
144403543|NCT00300274|520686704|FG002|Overall Study|Re-transplant|1|||
144403544|NCT00242216|520686705|FG000|Overall Study|Lost to Follow-up|12|||
144403545|NCT00242216|520686706|FG001|Overall Study|Lost to Follow-up|17|||
144403546|NCT00242216|520686705|FG000|Overall Study|Death|4|||
144403547|NCT00242216|520686706|FG001|Overall Study|Death|2|||
144403548|NCT00242216|520686705|FG000|Overall Study|Lack of Efficacy|1|||
144403549|NCT00242216|520686706|FG001|Overall Study|Lack of Efficacy|2|||
144403550|NCT00242216|520686705|FG000|Overall Study|no medicaiton dispensed|1|||
144403551|NCT00242216|520686706|FG001|Overall Study|no medicaiton dispensed|1|||
144403552|NCT00678080|520686708|FG000|Overall Study|Physician Decision|2|||
144403553|NCT00678080|520686709|FG001|Overall Study|Physician Decision|0|||
144403554|NCT00678080|520686708|FG000|Overall Study|Lost to Follow-up|1|||
144403555|NCT00678080|520686709|FG001|Overall Study|Lost to Follow-up|0|||
144403556|NCT00678080|520686708|FG000|Overall Study|Withdrawal by Subject|0|||
144403557|NCT00678080|520686709|FG001|Overall Study|Withdrawal by Subject|1|||
144403558|NCT05136690|520686719|FG000|Period 1|Withdrawal by Subject|0|||
144403559|NCT05136690|520686720|FG001|Period 1|Withdrawal by Subject|1|||
144403560|NCT05136690|520686719|FG000|Period 2|Lost to Follow-up|0|||
144403561|NCT05136690|520686720|FG001|Period 2|Lost to Follow-up|3|||
144403562|NCT05136690|520686719|FG000|Period 2|Withdrawal by Subject|0|||
144403563|NCT05136690|520686720|FG001|Period 2|Withdrawal by Subject|1|||
144403564|NCT00894166|520688433|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
144403565|NCT00894166|520688434|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
144403566|NCT00894166|520688435|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
144403567|NCT00894166|520688436|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
144403568|NCT00894166|520688437|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
144403569|NCT00894166|520688438|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
144403570|NCT00894166|520688439|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
144403571|NCT00894166|520688440|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
144403572|NCT00894166|520688433|FG000|Overall Study|Death|0|||
144403573|NCT00894166|520688434|FG001|Overall Study|Death|0|||
144403574|NCT00894166|520688435|FG002|Overall Study|Death|0|||
144403575|NCT00894166|520688436|FG003|Overall Study|Death|1|||
144403576|NCT00894166|520688437|FG004|Overall Study|Death|0|||
144403577|NCT00894166|520688438|FG005|Overall Study|Death|0|||
144403578|NCT00894166|520688439|FG006|Overall Study|Death|0|||
144403579|NCT00894166|520688440|FG007|Overall Study|Death|0|||
144403580|NCT05350410|520688441|FG000|Overall Study|Withdrawal by Subject|1|||
144403581|NCT03750955|520688442|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
144403582|NCT03750955|520688443|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
144403583|NCT03750955|520688442|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
144403584|NCT03750955|520688443|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
144403585|NCT01773733|520688446|FG000|Overall Study|Adverse Event|3286|||
144403586|NCT01773733|520688447|FG001|Overall Study|Adverse Event|540|||
144403587|NCT01773733|520688446|FG000|Overall Study|Pregnancy|28|||
144403588|NCT01773733|520688447|FG001|Overall Study|Pregnancy|0|||
144403589|NCT01773733|520688446|FG000|Overall Study|Other different categories of not compl|55415|||
144598901|NCT01323621|521394531|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
144598902|NCT01323621|521394532|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
144598903|NCT01323621|521394530|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
144598904|NCT01323621|521394531|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
144598905|NCT01323621|521394532|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
144598906|NCT01323621|521394530|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
144598907|NCT01323621|521394531|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
144598908|NCT01323621|521394532|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
144598909|NCT01323621|521394530|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
144598910|NCT01323621|521394531|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
144598911|NCT01323621|521394532|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
144598912|NCT01323621|521394530|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
144598913|NCT01323621|521394531|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
144598914|NCT01323621|521394532|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
144598915|NCT01323621|521394530|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
144598916|NCT01323621|521394531|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
144249930|NCT00441363|520113400|FG000|Overall Study|Other|2|||
144403590|NCT01773733|520688447|FG001|Overall Study|Other different categories of not compl|7781|||
144403591|NCT01180985|520688448|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
144249931|NCT00441363|520113401|FG001|Overall Study|Other|0|||
144249932|NCT02437188|520113404|FG000|Overall Study|Randomized but did not receive surgery|4|||
144249933|NCT02437188|520113405|FG001|Overall Study|Randomized but did not receive surgery|8|||
144249934|NCT02437188|520113404|FG000|Overall Study|Adverse Event|0|||
144249935|NCT02437188|520113405|FG001|Overall Study|Adverse Event|1|||
144249936|NCT02661061|520113406|FG000|Overall Study|Lack of Efficacy|1|||
144249937|NCT02661061|520113407|FG001|Overall Study|Lack of Efficacy|1|||
144249938|NCT02661061|520113406|FG000|Overall Study|Withdrawal by Subject|1|||
144249939|NCT02661061|520113407|FG001|Overall Study|Withdrawal by Subject|1|||
144249940|NCT01980628|520113408|FG000|Overall Study|Adverse Event|12|||
144249941|NCT01980628|520113408|FG000|Overall Study|Physician Decision|5|||
144249942|NCT01980628|520113408|FG000|Overall Study|Withdrawal by Subject|4|||
144249943|NCT01980628|520113408|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
144249944|NCT01937715|520113412|FG000|Overall Study|Death|0|||
144249945|NCT01937715|520113413|FG001|Overall Study|Death|0|||
144249946|NCT01937715|520113414|FG002|Overall Study|Death|0|||
144249947|NCT01937715|520113415|FG003|Overall Study|Death|1|||
144249948|NCT01937715|520113416|FG004|Overall Study|Death|0|||
144249949|NCT01937715|520113412|FG000|Overall Study|Withdrawal by Subject|0|||
144249950|NCT01937715|520113413|FG001|Overall Study|Withdrawal by Subject|1|||
144249951|NCT01937715|520113414|FG002|Overall Study|Withdrawal by Subject|0|||
144249952|NCT01937715|520113415|FG003|Overall Study|Withdrawal by Subject|0|||
144249953|NCT01937715|520113416|FG004|Overall Study|Withdrawal by Subject|2|||
144403592|NCT01180985|520688449|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
144598917|NCT01323621|521394532|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
144598918|NCT01323621|521394530|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
144598919|NCT01323621|521394531|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
144598920|NCT01323621|521394532|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
144598921|NCT01323621|521394530|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
144598922|NCT01323621|521394531|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
144598923|NCT01323621|521394532|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
144598924|NCT01323621|521394530|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
144598925|NCT01323621|521394531|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
144598926|NCT01323621|521394532|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
144598927|NCT01323621|521394530|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144598928|NCT01323621|521394531|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
144598929|NCT01323621|521394532|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144598930|NCT01323621|521394530|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
144403593|NCT01030536|520688450|FG000|Overall Study|Withdrawal by Subject|0|||
144249954|NCT01937715|520113412|FG000|Overall Study|Other|0|||
144249955|NCT01937715|520113413|FG001|Overall Study|Other|0|||
144249956|NCT01937715|520113414|FG002|Overall Study|Other|0|||
144249957|NCT01937715|520113415|FG003|Overall Study|Other|3|||
144249958|NCT01937715|520113416|FG004|Overall Study|Other|0|||
144524569|NCT04632992|521121967|FG012|Overall Study|Death|10|||
144524570|NCT04632992|521121968|FG013|Overall Study|Death|1|||
144524571|NCT04632992|521121955|FG000|Overall Study|Lost to Follow-up|1|||
144524572|NCT04632992|521121956|FG001|Overall Study|Lost to Follow-up|0|||
144524573|NCT04632992|521121957|FG002|Overall Study|Lost to Follow-up|1|||
144524574|NCT04632992|521121958|FG003|Overall Study|Lost to Follow-up|0|||
144524575|NCT04632992|521121959|FG004|Overall Study|Lost to Follow-up|2|||
144524576|NCT04632992|521121960|FG005|Overall Study|Lost to Follow-up|0|||
144524577|NCT04632992|521121961|FG006|Overall Study|Lost to Follow-up|1|||
144524578|NCT04632992|521121962|FG007|Overall Study|Lost to Follow-up|1|||
144524579|NCT04632992|521121963|FG008|Overall Study|Lost to Follow-up|1|||
144524580|NCT04632992|521121964|FG009|Overall Study|Lost to Follow-up|1|||
144524581|NCT04632992|521121965|FG010|Overall Study|Lost to Follow-up|2|||
144524582|NCT04632992|521121966|FG011|Overall Study|Lost to Follow-up|0|||
144524583|NCT04632992|521121967|FG012|Overall Study|Lost to Follow-up|0|||
144524584|NCT04632992|521121968|FG013|Overall Study|Lost to Follow-up|0|||
144524585|NCT04632992|521121955|FG000|Overall Study|Reason not Specified|2|||
144524586|NCT04632992|521121956|FG001|Overall Study|Reason not Specified|0|||
144524587|NCT04632992|521121957|FG002|Overall Study|Reason not Specified|1|||
144524588|NCT04632992|521121958|FG003|Overall Study|Reason not Specified|1|||
144524589|NCT04632992|521121959|FG004|Overall Study|Reason not Specified|0|||
144524590|NCT04632992|521121960|FG005|Overall Study|Reason not Specified|0|||
144524591|NCT04632992|521121961|FG006|Overall Study|Reason not Specified|0|||
144524592|NCT04632992|521121962|FG007|Overall Study|Reason not Specified|0|||
144598931|NCT01323621|521394531|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
144403594|NCT01030536|520688451|FG001|Overall Study|Withdrawal by Subject|0|||
144403595|NCT01030536|520688452|FG002|Overall Study|Withdrawal by Subject|1|||
144403596|NCT01030536|520688453|FG003|Overall Study|Withdrawal by Subject|0|||
144403597|NCT01030536|520688454|FG004|Overall Study|Withdrawal by Subject|0|||
144403598|NCT01030536|520688450|FG000|Overall Study|undefined|1|||
144403599|NCT01030536|520688451|FG001|Overall Study|undefined|0|||
144403600|NCT01030536|520688452|FG002|Overall Study|undefined|1|||
144403601|NCT01030536|520688453|FG003|Overall Study|undefined|1|||
144403602|NCT01030536|520688454|FG004|Overall Study|undefined|0|||
144403603|NCT01030536|520688450|FG000|Overall Study|Adverse Event|0|||
144403604|NCT01030536|520688451|FG001|Overall Study|Adverse Event|3|||
144403605|NCT01030536|520688452|FG002|Overall Study|Adverse Event|1|||
144403606|NCT01030536|520688453|FG003|Overall Study|Adverse Event|0|||
144403607|NCT01030536|520688454|FG004|Overall Study|Adverse Event|1|||
144403608|NCT01030536|520688450|FG000|Overall Study|Progressive disease|6|||
144403609|NCT01030536|520688451|FG001|Overall Study|Progressive disease|2|||
144403610|NCT01030536|520688452|FG002|Overall Study|Progressive disease|3|||
144403611|NCT01030536|520688453|FG003|Overall Study|Progressive disease|2|||
144403612|NCT01030536|520688454|FG004|Overall Study|Progressive disease|0|||
144403613|NCT01030536|520688450|FG000|Overall Study|Death|0|||
144403614|NCT01030536|520688451|FG001|Overall Study|Death|1|||
144403615|NCT01030536|520688452|FG002|Overall Study|Death|0|||
144403616|NCT01030536|520688453|FG003|Overall Study|Death|0|||
144403617|NCT01030536|520688454|FG004|Overall Study|Death|0|||
144403618|NCT00129272|520688455|FG000|Overall Study|Lost to Follow-up|12|||
144403619|NCT00129272|520688456|FG001|Overall Study|Lost to Follow-up|11|||
144403620|NCT00129272|520688455|FG000|Overall Study|Withdrawal by Subject|5|||
144403621|NCT00129272|520688456|FG001|Overall Study|Withdrawal by Subject|11|||
144403622|NCT01419626|520688457|FG000|Overall Study|Protocol Violation|3|||
144598932|NCT01323621|521394532|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
144598933|NCT01323621|521394530|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144598934|NCT01323621|521394531|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
144598935|NCT01323621|521394532|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
144598936|NCT00651157|521394533|FG000|Overall Study|Death|1|||
144598937|NCT00651157|521394533|FG000|Overall Study|Protocol Violation|1|||
144403623|NCT01419626|520688458|FG001|Overall Study|Protocol Violation|2|||
144403624|NCT01419626|520688459|FG002|Overall Study|Protocol Violation|2|||
144403625|NCT01419626|520688457|FG000|Overall Study|Withdrawal by Subject|1|||
144403626|NCT01419626|520688458|FG001|Overall Study|Withdrawal by Subject|0|||
144403627|NCT01419626|520688459|FG002|Overall Study|Withdrawal by Subject|0|||
144403628|NCT01419626|520688457|FG000|Overall Study|Lost to Follow-up|0|||
144403629|NCT01419626|520688458|FG001|Overall Study|Lost to Follow-up|1|||
144524593|NCT04632992|521121963|FG008|Overall Study|Reason not Specified|0|||
144403630|NCT01419626|520688459|FG002|Overall Study|Lost to Follow-up|1|||
144524594|NCT04632992|521121964|FG009|Overall Study|Reason not Specified|0|||
144524595|NCT04632992|521121965|FG010|Overall Study|Reason not Specified|1|||
144524596|NCT04632992|521121966|FG011|Overall Study|Reason not Specified|0|||
144524597|NCT04632992|521121967|FG012|Overall Study|Reason not Specified|0|||
144524598|NCT04632992|521121968|FG013|Overall Study|Reason not Specified|0|||
144403631|NCT01145625|520688460|FG000|Overall Study|Lost to Follow-up|8|||
144403632|NCT01145625|520688461|FG001|Overall Study|Lost to Follow-up|9|||
144403633|NCT01145625|520688460|FG000|Overall Study|Adverse Event|6|||
144403634|NCT01145625|520688461|FG001|Overall Study|Adverse Event|4|||
144403635|NCT01145625|520688460|FG000|Overall Study|Protocol Violation|3|||
144403636|NCT01145625|520688461|FG001|Overall Study|Protocol Violation|1|||
144403637|NCT01145625|520688460|FG000|Overall Study|Withdrawal by Subject|7|||
144403638|NCT01145625|520688461|FG001|Overall Study|Withdrawal by Subject|16|||
144403639|NCT01145625|520688460|FG000|Overall Study|Pregnancy|0|||
144403640|NCT01145625|520688461|FG001|Overall Study|Pregnancy|1|||
144403641|NCT00885846|520688463|FG000|Overall Study|Withdrawal by Subject|2|||
144403642|NCT00885846|520688464|FG001|Overall Study|Withdrawal by Subject|5|||
144403643|NCT00885846|520688465|FG002|Overall Study|Withdrawal by Subject|2|||
144403644|NCT00880542|520688466|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
144403645|NCT00880542|520688466|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
144403646|NCT00880542|520688466|FG000|REP: Surgical Resection|progressive disease|1|||
144403647|NCT01952145|520688467|FG000|Overall Study|Protocol Violation|2|||
144403648|NCT01952145|520688468|FG001|Overall Study|Protocol Violation|1|||
144403649|NCT01952145|520688467|FG000|Overall Study|Death|0|||
144403650|NCT01952145|520688468|FG001|Overall Study|Death|1|||
144403651|NCT01952145|520688467|FG000|Overall Study|Adverse Event|9|||
144403652|NCT01952145|520688468|FG001|Overall Study|Adverse Event|0|||
144403653|NCT01952145|520688467|FG000|Overall Study|Withdrawal Criteria|16|||
144403654|NCT01952145|520688468|FG001|Overall Study|Withdrawal Criteria|11|||
144403655|NCT01952145|520688467|FG000|Overall Study|Unclassified|1|||
144403656|NCT01952145|520688468|FG001|Overall Study|Unclassified|1|||
144403657|NCT01540838|520688470|FG000|Overall Study|Open nasogastric tube|9|||
144403658|NCT01540838|520688471|FG001|Overall Study|Open nasogastric tube|7|||
144403659|NCT01540838|520688470|FG000|Overall Study|Treatment doses missing|8|||
144403660|NCT01540838|520688471|FG001|Overall Study|Treatment doses missing|12|||
144249959|NCT01698268|520113419|FG000|Overall Study|Physician Decision|2|||
144249960|NCT01698268|520113420|FG001|Overall Study|Physician Decision|1|||
144249961|NCT00298363|520113421|FG000|Overall Study|Lost to Follow-up|0|||
144249962|NCT00298363|520113422|FG001|Overall Study|Lost to Follow-up|0|||
144249963|NCT00298363|520113423|FG002|Overall Study|Lost to Follow-up|1|||
144249964|NCT00298363|520113421|FG000|Overall Study|Physician Decision|4|||
144249965|NCT00298363|520113422|FG001|Overall Study|Physician Decision|1|||
144249966|NCT00298363|520113423|FG002|Overall Study|Physician Decision|0|||
144249967|NCT00298363|520113421|FG000|Overall Study|Protocol Violation|1|||
144249968|NCT00298363|520113422|FG001|Overall Study|Protocol Violation|1|||
144249969|NCT00298363|520113423|FG002|Overall Study|Protocol Violation|0|||
144249970|NCT00298363|520113421|FG000|Overall Study|Withdrawal by Subject|5|||
144249971|NCT00298363|520113422|FG001|Overall Study|Withdrawal by Subject|1|||
144249972|NCT00298363|520113423|FG002|Overall Study|Withdrawal by Subject|3|||
144249973|NCT00298363|520113421|FG000|Overall Study|Adverse Event|5|||
144249974|NCT00298363|520113422|FG001|Overall Study|Adverse Event|2|||
144249975|NCT00298363|520113423|FG002|Overall Study|Adverse Event|2|||
144249976|NCT00298363|520113421|FG000|Overall Study|Lack of Efficacy|2|||
144249977|NCT00298363|520113422|FG001|Overall Study|Lack of Efficacy|3|||
144403661|NCT01540838|520688470|FG000|Overall Study|Additional antibiotic treatment|1|||
144403662|NCT01540838|520688471|FG001|Overall Study|Additional antibiotic treatment|2|||
144403663|NCT01540838|520688470|FG000|Overall Study|Died before treatment initiation|1|||
144403664|NCT01540838|520688471|FG001|Overall Study|Died before treatment initiation|1|||
144403665|NCT01540838|520688470|FG000|Overall Study|Not BM. Other treatment|3|||
144403666|NCT01540838|520688471|FG001|Overall Study|Not BM. Other treatment|1|||
144403667|NCT02130570|520688472|FG000|Overall Study|Death|3|||
144249978|NCT00298363|520113423|FG002|Overall Study|Lack of Efficacy|0|||
144403668|NCT02130570|520688473|FG001|Overall Study|Death|5|||
144524599|NCT04632992|521121955|FG000|Overall Study|Physician Decision|0|||
144524600|NCT04632992|521121956|FG001|Overall Study|Physician Decision|0|||
144524601|NCT04632992|521121957|FG002|Overall Study|Physician Decision|0|||
144524602|NCT04632992|521121958|FG003|Overall Study|Physician Decision|2|||
144524603|NCT04632992|521121959|FG004|Overall Study|Physician Decision|1|||
144524604|NCT04632992|521121960|FG005|Overall Study|Physician Decision|0|||
144524605|NCT04632992|521121961|FG006|Overall Study|Physician Decision|0|||
144524606|NCT04632992|521121962|FG007|Overall Study|Physician Decision|0|||
144249979|NCT00153816|520113424|FG000|Overall Study|Death|6|||
144249980|NCT00153816|520113425|FG001|Overall Study|Death|5|||
144249981|NCT00153816|520113426|FG002|Overall Study|Death|4|||
144249982|NCT00153816|520113427|FG003|Overall Study|Death|6|||
144403669|NCT02130570|520688472|FG000|Overall Study|Withdrawal by Subject|6|||
144403670|NCT02130570|520688473|FG001|Overall Study|Withdrawal by Subject|3|||
144403671|NCT02130570|520688472|FG000|Overall Study|Part of practice that discontinued study|0|||
144403672|NCT02130570|520688473|FG001|Overall Study|Part of practice that discontinued study|5|||
144403673|NCT00493025|520688476|FG000|Overall Study|Physician Decision|19|||
144403674|NCT03863197|520688477|FG000|Overall Study|Lost to Follow-up|2|||
144524607|NCT04632992|521121963|FG008|Overall Study|Physician Decision|0|||
144524608|NCT04632992|521121964|FG009|Overall Study|Physician Decision|0|||
144524609|NCT04632992|521121965|FG010|Overall Study|Physician Decision|0|||
144249983|NCT00153816|520113428|FG004|Overall Study|Death|0|||
144403675|NCT03863197|520688478|FG001|Overall Study|Lost to Follow-up|3|||
144249984|NCT00153816|520113429|FG005|Overall Study|Death|2|||
144403676|NCT03863197|520688477|FG000|Overall Study|Withdrawal by Subject|4|||
144403677|NCT03863197|520688478|FG001|Overall Study|Withdrawal by Subject|0|||
144403678|NCT03863197|520688477|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
144403679|NCT03863197|520688478|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
144403680|NCT01065597|520688479|FG000|Overall Study|Adverse Event|1|||
144403681|NCT01781975|520688480|FG000|Overall Study|Death|1|||
144403682|NCT01781975|520688481|FG001|Overall Study|Death|0|||
144403683|NCT01781975|520688480|FG000|Overall Study|Withdrawal by Subject|1|||
144403684|NCT01781975|520688481|FG001|Overall Study|Withdrawal by Subject|1|||
144403685|NCT01622231|520688482|FG000|Overall Study|Physician Decision|1|||
144403686|NCT01622231|520688482|FG000|Overall Study|Withdrawal by Subject|1|||
144403687|NCT02329080|520688484|FG000|Overall Study|Adverse Event|1|||
144403688|NCT02329080|520688484|FG000|Overall Study|Death|4|||
144403689|NCT02329080|520688484|FG000|Overall Study|Lack of Efficacy|22|||
144403690|NCT02329080|520688484|FG000|Overall Study|Lost to Follow-up|1|||
144403691|NCT02329080|520688484|FG000|Overall Study|Physician Decision|2|||
144403692|NCT02329080|520688484|FG000|Overall Study|Partial response|4|||
144403693|NCT02329080|520688484|FG000|Overall Study|Complete response|4|||
144403694|NCT01032174|520688485|FG000|Overall Study|Adverse Event|0|||
144403695|NCT01032174|520688486|FG001|Overall Study|Adverse Event|1|||
144403696|NCT02713204|520688489|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
144403697|NCT02713204|520688490|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
144403698|NCT02713204|520688491|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
144403699|NCT02713204|520688492|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
144403700|NCT02713204|520688493|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
144403701|NCT02713204|520688494|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
144403702|NCT02713204|520688495|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
144403703|NCT02713204|520688496|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
144403704|NCT02713204|520688489|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403705|NCT02713204|520688490|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403706|NCT02713204|520688491|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
144403707|NCT02713204|520688492|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403708|NCT02713204|520688493|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403709|NCT02713204|520688494|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403710|NCT02713204|520688495|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403711|NCT02713204|520688496|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144403712|NCT02713204|520688489|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403713|NCT02713204|520688490|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
144524610|NCT04632992|521121966|FG011|Overall Study|Physician Decision|0|||
144524611|NCT04632992|521121967|FG012|Overall Study|Physician Decision|3|||
144524612|NCT04632992|521121968|FG013|Overall Study|Physician Decision|0|||
144524613|NCT04632992|521121955|FG000|Overall Study|Progressive Disease|0|||
144524614|NCT04632992|521121956|FG001|Overall Study|Progressive Disease|0|||
144524615|NCT04632992|521121957|FG002|Overall Study|Progressive Disease|0|||
144524616|NCT04632992|521121958|FG003|Overall Study|Progressive Disease|0|||
144524617|NCT04632992|521121959|FG004|Overall Study|Progressive Disease|1|||
144524618|NCT04632992|521121960|FG005|Overall Study|Progressive Disease|0|||
144524619|NCT04632992|521121961|FG006|Overall Study|Progressive Disease|0|||
144524620|NCT04632992|521121962|FG007|Overall Study|Progressive Disease|0|||
144524621|NCT04632992|521121963|FG008|Overall Study|Progressive Disease|0|||
144403714|NCT02713204|520688491|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403715|NCT02713204|520688492|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403716|NCT02713204|520688493|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403717|NCT02713204|520688494|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403718|NCT02713204|520688495|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403719|NCT02713204|520688496|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144403720|NCT02713204|520688489|FG000|From Week 12 up to Week 36|Adverse Event|1|||
144403721|NCT02713204|520688490|FG001|From Week 12 up to Week 36|Adverse Event|0|||
144403722|NCT02713204|520688491|FG002|From Week 12 up to Week 36|Adverse Event|0|||
144403723|NCT02713204|520688492|FG003|From Week 12 up to Week 36|Adverse Event|1|||
144403724|NCT02713204|520688493|FG004|From Week 12 up to Week 36|Adverse Event|1|||
144403725|NCT02713204|520688494|FG005|From Week 12 up to Week 36|Adverse Event|0|||
144403726|NCT02713204|520688495|FG006|From Week 12 up to Week 36|Adverse Event|2|||
144403727|NCT02713204|520688496|FG007|From Week 12 up to Week 36|Adverse Event|1|||
144403728|NCT02713204|520688489|FG000|From Week 12 up to Week 36|Death|0|||
144403729|NCT02713204|520688490|FG001|From Week 12 up to Week 36|Death|0|||
144524622|NCT04632992|521121964|FG009|Overall Study|Progressive Disease|1|||
144524623|NCT04632992|521121965|FG010|Overall Study|Progressive Disease|1|||
144524624|NCT04632992|521121966|FG011|Overall Study|Progressive Disease|0|||
144524625|NCT04632992|521121967|FG012|Overall Study|Progressive Disease|2|||
144403730|NCT02713204|520688491|FG002|From Week 12 up to Week 36|Death|0|||
144403731|NCT02713204|520688492|FG003|From Week 12 up to Week 36|Death|1|||
144403732|NCT02713204|520688493|FG004|From Week 12 up to Week 36|Death|0|||
144403733|NCT02713204|520688494|FG005|From Week 12 up to Week 36|Death|1|||
144403734|NCT02713204|520688495|FG006|From Week 12 up to Week 36|Death|0|||
144403735|NCT02713204|520688496|FG007|From Week 12 up to Week 36|Death|3|||
144403736|NCT02713204|520688489|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403737|NCT02713204|520688490|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403738|NCT02713204|520688491|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403739|NCT02713204|520688492|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
144403740|NCT02713204|520688493|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403741|NCT02713204|520688494|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403742|NCT02713204|520688495|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403743|NCT02713204|520688496|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
144403744|NCT02713204|520688489|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
144403745|NCT02713204|520688490|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
144403746|NCT02713204|520688491|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
144403747|NCT02713204|520688492|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
144403748|NCT02713204|520688493|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
144403749|NCT02713204|520688494|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
144403750|NCT02713204|520688495|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
144403751|NCT02713204|520688496|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
144403752|NCT00467857|520688499|FG000|Overall Study|Adverse Event|1|||
144403753|NCT00467857|520688500|FG001|Overall Study|Adverse Event|0|||
144403754|NCT00467857|520688499|FG000|Overall Study|Withdrew consent|2|||
144403755|NCT00467857|520688500|FG001|Overall Study|Withdrew consent|0|||
144403756|NCT00467857|520688499|FG000|Overall Study|Death|0|||
144403757|NCT00467857|520688500|FG001|Overall Study|Death|1|||
144403758|NCT00467857|520688499|FG000|Overall Study|Discharged from court service|0|||
144403759|NCT00467857|520688500|FG001|Overall Study|Discharged from court service|1|||
144403760|NCT00467857|520688499|FG000|Overall Study|Emergency care required|0|||
144403761|NCT00467857|520688500|FG001|Overall Study|Emergency care required|1|||
144403762|NCT00467857|520688499|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
144403763|NCT00467857|520688500|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
144403764|NCT00467857|520688499|FG000|Overall Study|Discontinuation reason missing|0|||
144403765|NCT00467857|520688500|FG001|Overall Study|Discontinuation reason missing|3|||
144403766|NCT00660673|520688501|FG000|Overall Study|Adverse Event|84|||
144403767|NCT00660673|520688501|FG000|Overall Study|Lack of Efficacy|7|||
144403768|NCT00660673|520688501|FG000|Overall Study|Withdrawal by Subject|22|||
144403769|NCT00660673|520688501|FG000|Overall Study|Administrative|2|||
144403770|NCT00660673|520688501|FG000|Overall Study|Protocol Violation|2|||
144403771|NCT00516074|520688503|FG000|Overall Study|Adverse Event|0|||
144403772|NCT00516074|520688504|FG001|Overall Study|Adverse Event|1|||
144403773|NCT00516074|520688503|FG000|Overall Study|Subject Decision|4|||
144403774|NCT00516074|520688504|FG001|Overall Study|Subject Decision|2|||
144403775|NCT00516074|520688503|FG000|Overall Study|Loss of Glucose Control|2|||
144403776|NCT00516074|520688504|FG001|Overall Study|Loss of Glucose Control|0|||
144403777|NCT05213481|520688505|FG000|Overall Study|Adverse Event|3|||
144403778|NCT05213481|520688505|FG000|Overall Study|Lost to Follow-up|1|||
144403779|NCT03822182|520688509|FG000|Overall Study|Protocol Violation|0|||
144598938|NCT01117857|521394537|FG000|Overall Study|Lost to Follow-up|4|||
144598939|NCT01117857|521394537|FG000|Overall Study|Withdrawal by Subject|4|||
144598940|NCT01117857|521394537|FG000|Overall Study|Physician Decision|1|||
144598941|NCT01163721|521394539|FG000|Overall Study|Adverse Event|5|||
144403780|NCT03822182|520688510|FG001|Overall Study|Protocol Violation|1|||
144403781|NCT03822182|520688511|FG002|Overall Study|Protocol Violation|1|||
144403782|NCT00810355|520688512|FG000|Overall Study|Lost to Follow-up|13|||
144403783|NCT00810355|520688513|FG001|Overall Study|Lost to Follow-up|17|||
144403784|NCT00810355|520688514|FG002|Overall Study|Lost to Follow-up|11|||
144403785|NCT00810355|520688512|FG000|Overall Study|Withdrawal by Subject|1|||
144403786|NCT00810355|520688513|FG001|Overall Study|Withdrawal by Subject|0|||
144403787|NCT00810355|520688514|FG002|Overall Study|Withdrawal by Subject|0|||
144403788|NCT01612858|520688516|FG000|Overall Study|Withdrawal by Subject|5|||
144403789|NCT01612858|520688517|FG001|Overall Study|Withdrawal by Subject|1|||
144403790|NCT01484275|520688518|FG000|Overall Study|Study terminated by sponsor|28|||
144403791|NCT01484275|520688519|FG001|Overall Study|Study terminated by sponsor|32|||
144598942|NCT01163721|521394540|FG001|Overall Study|Adverse Event|6|||
144598943|NCT01163721|521394539|FG000|Overall Study|Withdrawal by Subject|3|||
144598944|NCT01163721|521394540|FG001|Overall Study|Withdrawal by Subject|4|||
144598945|NCT01163721|521394539|FG000|Overall Study|Lost to Follow-up|0|||
144598946|NCT01163721|521394540|FG001|Overall Study|Lost to Follow-up|1|||
144403792|NCT01484275|520688518|FG000|Overall Study|Other|10|||
144403793|NCT01484275|520688519|FG001|Overall Study|Other|0|||
144403794|NCT01484275|520688518|FG000|Overall Study|Death|3|||
144403795|NCT01484275|520688519|FG001|Overall Study|Death|4|||
144403796|NCT01484275|520688518|FG000|Overall Study|Withdrawal by Subject|1|||
144403797|NCT01484275|520688519|FG001|Overall Study|Withdrawal by Subject|5|||
144598947|NCT01163721|521394539|FG000|Overall Study|Physician Decision|0|||
144403798|NCT01484275|520688518|FG000|Overall Study|Lost to Follow-up|1|||
144403799|NCT01484275|520688519|FG001|Overall Study|Lost to Follow-up|1|||
144403800|NCT00003487|520688520|FG000|Overall Study|Not evaluable|2|||
144403801|NCT00657358|520688523|FG000|Overall Study|Lack of Efficacy|6|||
144403802|NCT02628938|520688527|FG000|Overall Study|Did not attend the follow up recall|2|||
144403803|NCT02628938|520688528|FG001|Overall Study|Did not attend the follow up recall|2|||
144403804|NCT02628938|520688529|FG002|Overall Study|Did not attend the follow up recall|1|||
144403805|NCT02628938|520688527|FG000|Overall Study|Failure to comply with the instructions|3|||
144403806|NCT02628938|520688528|FG001|Overall Study|Failure to comply with the instructions|0|||
144403807|NCT02628938|520688529|FG002|Overall Study|Failure to comply with the instructions|3|||
144403808|NCT02058693|520688530|FG000|Phase 1|Withdrawal by Subject|3|||
144403809|NCT02058693|520688531|FG001|Phase 1|Withdrawal by Subject|2|||
144403810|NCT02058693|520688530|FG000|Phase 1|Adverse Event|0|||
144403811|NCT02058693|520688531|FG001|Phase 1|Adverse Event|1|||
144524626|NCT04632992|521121968|FG013|Overall Study|Progressive Disease|0|||
144524627|NCT04632992|521121955|FG000|Overall Study|Withdrawal by Subject|4|||
144524628|NCT04632992|521121956|FG001|Overall Study|Withdrawal by Subject|1|||
144598948|NCT01163721|521394540|FG001|Overall Study|Physician Decision|1|||
144598949|NCT00688181|521394541|FG000|Overall Study|Lost to Follow-up|17|||
144598950|NCT00688181|521394541|FG000|Overall Study|Unknown Reason|4|||
144598951|NCT00688181|521394541|FG000|Overall Study|Non-clinical Reason|2|||
144598952|NCT01050205|521394542|FG000|Overall Study|Lost to Follow-up|7|||
144598953|NCT01050205|521394543|FG001|Overall Study|Lost to Follow-up|1|||
144598954|NCT01050205|521394542|FG000|Overall Study|Withdrawal by Subject|1|||
144598955|NCT01050205|521394543|FG001|Overall Study|Withdrawal by Subject|1|||
144598956|NCT01050205|521394542|FG000|Overall Study|Relocated from area|1|||
144598957|NCT01050205|521394543|FG001|Overall Study|Relocated from area|2|||
144598958|NCT01050205|521394542|FG000|Overall Study|Discontinued Intervention|2|||
144598959|NCT01050205|521394543|FG001|Overall Study|Discontinued Intervention|0|||
144598960|NCT01295281|521394546|FG000|First Intervention (7 Days)|Death|0|||
144598961|NCT01295281|521394547|FG001|First Intervention (7 Days)|Death|1|||
144598962|NCT00292461|521394548|FG000|Overall Study|Adverse Event|4|||
144598963|NCT00292461|521394549|FG001|Overall Study|Adverse Event|2|||
144598964|NCT00292461|521394548|FG000|Overall Study|Lack of Efficacy|1|||
144598965|NCT00292461|521394549|FG001|Overall Study|Lack of Efficacy|0|||
144598966|NCT00292461|521394548|FG000|Overall Study|Withdrawal by Subject|0|||
144598967|NCT00292461|521394549|FG001|Overall Study|Withdrawal by Subject|1|||
144598968|NCT00292461|521394548|FG000|Overall Study|Protocol Violation|4|||
144598969|NCT00292461|521394549|FG001|Overall Study|Protocol Violation|3|||
144598970|NCT00292461|521394548|FG000|Overall Study|Lost to Follow-up|1|||
144598971|NCT00292461|521394549|FG001|Overall Study|Lost to Follow-up|0|||
144598972|NCT01119001|521394550|FG000|Overall Study|Withdrawal by Subject|2|||
144598973|NCT00954421|521394551|FG000|Screening|screen failures|3|||
144598974|NCT00954421|521394551|FG000|6 Months of DBS|Withdrawal by Subject|1|||
144598975|NCT00954421|521394551|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
144598976|NCT01891721|521394552|FG000|Overall Study|Lost to Follow-up|10|||
144598977|NCT01891721|521394553|FG001|Overall Study|Lost to Follow-up|5|||
144598978|NCT01891721|521394554|FG002|Overall Study|Lost to Follow-up|1|||
144598979|NCT00633061|521394555|FG000|Overall Study|Study closed|86|||
144598980|NCT00633061|521394556|FG001|Overall Study|Study closed|0|||
144598981|NCT04343248|521394561|FG000|Overall Study|Withdrawal by Subject|5|||
144598982|NCT04343248|521394562|FG001|Overall Study|Withdrawal by Subject|6|||
144598983|NCT04343248|521394561|FG000|Overall Study|Death|1|||
144598984|NCT04343248|521394562|FG001|Overall Study|Death|2|||
144598985|NCT04343248|521394561|FG000|Overall Study|Lost to Follow-up|9|||
144598986|NCT04343248|521394562|FG001|Overall Study|Lost to Follow-up|6|||
144598987|NCT04343248|521394561|FG000|Overall Study|Physician Decision|0|||
144598988|NCT04343248|521394562|FG001|Overall Study|Physician Decision|1|||
144598989|NCT04343248|521394561|FG000|Overall Study|Adverse Event|1|||
144598990|NCT04343248|521394562|FG001|Overall Study|Adverse Event|0|||
144524629|NCT04632992|521121957|FG002|Overall Study|Withdrawal by Subject|5|||
144524630|NCT04632992|521121958|FG003|Overall Study|Withdrawal by Subject|4|||
144524631|NCT04632992|521121959|FG004|Overall Study|Withdrawal by Subject|3|||
144524632|NCT04632992|521121960|FG005|Overall Study|Withdrawal by Subject|3|||
144524633|NCT04632992|521121961|FG006|Overall Study|Withdrawal by Subject|0|||
144524634|NCT04632992|521121962|FG007|Overall Study|Withdrawal by Subject|5|||
144524635|NCT04632992|521121963|FG008|Overall Study|Withdrawal by Subject|0|||
144598991|NCT02708095|521394563|FG000|Overall Study|Adverse Event|4|||
144722387|NCT02227862|521838696|FG001|Overall Study|Lost to Follow-up|2|||
144403812|NCT02058693|520688530|FG000|Phase 1|Lack of Efficacy|1|||
144403813|NCT02058693|520688531|FG001|Phase 1|Lack of Efficacy|0|||
144524636|NCT04632992|521121964|FG009|Overall Study|Withdrawal by Subject|2|||
144524637|NCT04632992|521121965|FG010|Overall Study|Withdrawal by Subject|8|||
144598992|NCT02708095|521394564|FG001|Overall Study|Adverse Event|10|||
144598993|NCT02708095|521394565|FG002|Overall Study|Adverse Event|11|||
144598994|NCT02708095|521394563|FG000|Overall Study|Lack of Efficacy|9|||
144598995|NCT02708095|521394564|FG001|Overall Study|Lack of Efficacy|3|||
144598996|NCT02708095|521394565|FG002|Overall Study|Lack of Efficacy|0|||
144403814|NCT02058693|520688530|FG000|Phase 1|Physician Decision|1|||
144403815|NCT02058693|520688531|FG001|Phase 1|Physician Decision|1|||
144403816|NCT02058693|520688530|FG000|Phase 2|Withdrawal by Subject|0|||
144598997|NCT02708095|521394563|FG000|Overall Study|Lost to Follow-up|2|||
144403817|NCT02058693|520688531|FG001|Phase 2|Withdrawal by Subject|2|||
144403818|NCT00241358|520688533|FG000|Overall Study|Determined to be not ineligible|0|||
144403819|NCT00241358|520688534|FG001|Overall Study|Determined to be not ineligible|1|||
144403820|NCT00241358|520688535|FG002|Overall Study|Determined to be not ineligible|1|||
144403821|NCT00843856|520688536|FG000|Overall Study|Lost to Follow-up|1|||
144403822|NCT00843856|520688537|FG001|Overall Study|Lost to Follow-up|2|||
144403823|NCT03855228|520688538|FG000|Overall Study|Adverse Event|2|||
144403824|NCT03855228|520688539|FG001|Overall Study|Adverse Event|4|||
144403825|NCT03855228|520688540|FG002|Overall Study|Adverse Event|4|||
144403826|NCT03855228|520688541|FG003|Overall Study|Adverse Event|8|||
144403827|NCT03855228|520688538|FG000|Overall Study|Treatment Failure|1|||
144403828|NCT03855228|520688539|FG001|Overall Study|Treatment Failure|2|||
144403829|NCT03855228|520688540|FG002|Overall Study|Treatment Failure|1|||
144403830|NCT03855228|520688541|FG003|Overall Study|Treatment Failure|8|||
144403831|NCT03855228|520688538|FG000|Overall Study|Lost to Follow-up|0|||
144403832|NCT03855228|520688539|FG001|Overall Study|Lost to Follow-up|0|||
144403833|NCT03855228|520688540|FG002|Overall Study|Lost to Follow-up|0|||
144403834|NCT03855228|520688541|FG003|Overall Study|Lost to Follow-up|1|||
144403835|NCT03855228|520688538|FG000|Overall Study|Protocol Violation|0|||
144403836|NCT03855228|520688539|FG001|Overall Study|Protocol Violation|1|||
144403837|NCT03855228|520688540|FG002|Overall Study|Protocol Violation|2|||
144403838|NCT03855228|520688541|FG003|Overall Study|Protocol Violation|1|||
144403839|NCT03855228|520688538|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
144403840|NCT03855228|520688539|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
144403841|NCT03855228|520688540|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
144403842|NCT03855228|520688541|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
144403843|NCT00621959|520688543|FG000|Overall Study|Adverse Event|4|||
144403844|NCT00621959|520688544|FG001|Overall Study|Adverse Event|2|||
144403845|NCT00621959|520688543|FG000|Overall Study|Lack of Efficacy|1|||
144403846|NCT00621959|520688544|FG001|Overall Study|Lack of Efficacy|1|||
144403847|NCT00621959|520688543|FG000|Overall Study|Lost to Follow-up|0|||
144403848|NCT00621959|520688544|FG001|Overall Study|Lost to Follow-up|2|||
144403849|NCT00621959|520688543|FG000|Overall Study|Withdrawal by Subject|1|||
144403850|NCT00621959|520688544|FG001|Overall Study|Withdrawal by Subject|1|||
144403851|NCT00621959|520688543|FG000|Overall Study|Other|1|||
144403852|NCT00621959|520688544|FG001|Overall Study|Other|3|||
144403853|NCT01758523|520688545|FG000|Overall Study|Adverse Event|2|||
144403854|NCT01758523|520688546|FG001|Overall Study|Adverse Event|1|||
144403855|NCT01758523|520688545|FG000|Overall Study|Lack of Efficacy|4|||
144403856|NCT01758523|520688546|FG001|Overall Study|Lack of Efficacy|2|||
144403857|NCT01758523|520688545|FG000|Overall Study|Lost to Follow-up|3|||
144403858|NCT01758523|520688546|FG001|Overall Study|Lost to Follow-up|4|||
144403859|NCT01758523|520688545|FG000|Overall Study|Withdrawal by Subject|12|||
144403860|NCT01758523|520688546|FG001|Overall Study|Withdrawal by Subject|7|||
144403861|NCT01893203|520688547|FG000|Overall Study|Withdrawal by Subject|1|||
144403862|NCT00722800|520688548|FG000|Overall Study|Withdrawal by Subject|1|||
144403863|NCT00722800|520688549|FG001|Overall Study|Withdrawal by Subject|0|||
144403864|NCT00722800|520688548|FG000|Overall Study|Physician Decision|1|||
144403865|NCT00722800|520688549|FG001|Overall Study|Physician Decision|0|||
144403866|NCT02925117|520688553|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
144403867|NCT02925117|520688554|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
144524638|NCT04632992|521121966|FG011|Overall Study|Withdrawal by Subject|0|||
144524639|NCT04632992|521121967|FG012|Overall Study|Withdrawal by Subject|1|||
144524640|NCT04632992|521121968|FG013|Overall Study|Withdrawal by Subject|1|||
144524641|NCT02677805|521121969|FG000|Double Blind Phase|Lost to Follow-up|8|||
144524642|NCT02677805|521121970|FG001|Double Blind Phase|Lost to Follow-up|3|||
144524643|NCT02677805|521121971|FG002|Double Blind Phase|Lost to Follow-up|0|||
144524644|NCT02677805|521121969|FG000|Double Blind Phase|Withdrawal by Subject|5|||
144524645|NCT02677805|521121970|FG001|Double Blind Phase|Withdrawal by Subject|2|||
144524646|NCT02677805|521121971|FG002|Double Blind Phase|Withdrawal by Subject|0|||
144524647|NCT02677805|521121969|FG000|Open Label Phase|Lost to Follow-up|0|||
144524648|NCT02677805|521121970|FG001|Open Label Phase|Lost to Follow-up|0|||
144598998|NCT02708095|521394564|FG001|Overall Study|Lost to Follow-up|0|||
144722388|NCT00634907|521838700|FG000|Overall Study|Withdrawal by Subject|3|||
144524649|NCT02677805|521121971|FG002|Open Label Phase|Lost to Follow-up|10|||
144524650|NCT02677805|521121969|FG000|Open Label Phase|Withdrawal by Subject|0|||
144524651|NCT02677805|521121970|FG001|Open Label Phase|Withdrawal by Subject|0|||
144524652|NCT02677805|521121971|FG002|Open Label Phase|Withdrawal by Subject|6|||
144403868|NCT02925117|520688555|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
144403869|NCT02925117|520688556|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
144403870|NCT02925117|520688557|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403871|NCT02925117|520688558|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403872|NCT02925117|520688559|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403873|NCT02925117|520688560|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403874|NCT02925117|520688561|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403875|NCT02925117|520688562|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403876|NCT02925117|520688563|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403877|NCT02925117|520688564|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
144403878|NCT02925117|520688553|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
144403879|NCT02925117|520688554|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
144403880|NCT02925117|520688555|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
144403881|NCT02925117|520688556|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403882|NCT02925117|520688557|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403883|NCT02925117|520688558|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403884|NCT02925117|520688559|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403885|NCT02925117|520688560|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403886|NCT02925117|520688561|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403887|NCT02925117|520688562|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403888|NCT02925117|520688563|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403889|NCT02925117|520688564|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
144403890|NCT02925117|520688553|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
144403891|NCT02925117|520688554|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
144403892|NCT02925117|520688555|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403893|NCT02925117|520688556|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403894|NCT02925117|520688557|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403895|NCT02925117|520688558|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403896|NCT02925117|520688559|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403897|NCT02925117|520688560|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403898|NCT02925117|520688561|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403899|NCT02925117|520688562|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403900|NCT02925117|520688563|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403901|NCT02925117|520688564|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
144403902|NCT02925117|520688553|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
144403903|NCT02925117|520688554|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
144403904|NCT02925117|520688555|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
144403905|NCT02925117|520688556|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
144403906|NCT02925117|520688557|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
144403907|NCT02925117|520688558|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
144403908|NCT02925117|520688559|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
144403909|NCT02925117|520688560|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
144403910|NCT02925117|520688561|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
144403911|NCT02925117|520688562|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
144403912|NCT02925117|520688563|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
144403913|NCT02925117|520688564|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
144403914|NCT02925117|520688553|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403915|NCT02925117|520688554|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403916|NCT02925117|520688555|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403917|NCT02925117|520688556|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403918|NCT02925117|520688557|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403919|NCT02925117|520688558|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
144403920|NCT02925117|520688559|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403921|NCT02925117|520688560|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403922|NCT02925117|520688561|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403923|NCT02925117|520688562|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
144403924|NCT02925117|520688563|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
144403925|NCT02925117|520688564|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
144403926|NCT02925117|520688553|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
144403927|NCT02925117|520688554|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
144403928|NCT02925117|520688555|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
144403929|NCT02925117|520688556|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
144403930|NCT02925117|520688557|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
144403931|NCT02925117|520688558|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
144403932|NCT02925117|520688559|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
144403933|NCT02925117|520688560|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
144403934|NCT02925117|520688561|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
144403935|NCT02925117|520688562|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
144403936|NCT02925117|520688563|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
144403937|NCT02925117|520688564|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
144403938|NCT02925117|520688553|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
144403939|NCT02925117|520688554|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
144403940|NCT02925117|520688555|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
144403941|NCT02925117|520688556|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
144524653|NCT04350463|521121976|FG000|Overall Study|Other reason|0|||
144524654|NCT04350463|521121977|FG001|Overall Study|Other reason|0|||
144524655|NCT04350463|521121978|FG002|Overall Study|Other reason|0|||
144524656|NCT04350463|521121979|FG003|Overall Study|Other reason|1|||
144524657|NCT04350463|521121976|FG000|Overall Study|Lost to Follow-up|0|||
144524658|NCT04350463|521121977|FG001|Overall Study|Lost to Follow-up|0|||
144524659|NCT04350463|521121978|FG002|Overall Study|Lost to Follow-up|0|||
144524660|NCT04350463|521121979|FG003|Overall Study|Lost to Follow-up|2|||
144524661|NCT04350463|521121976|FG000|Overall Study|Withdrawal by Subject|4|||
144598999|NCT02708095|521394565|FG002|Overall Study|Lost to Follow-up|0|||
144599000|NCT02708095|521394563|FG000|Overall Study|Physician Decision|2|||
144599001|NCT02708095|521394564|FG001|Overall Study|Physician Decision|3|||
144599002|NCT02708095|521394565|FG002|Overall Study|Physician Decision|2|||
144599003|NCT02708095|521394563|FG000|Overall Study|Protocol Violation|0|||
144599004|NCT02708095|521394564|FG001|Overall Study|Protocol Violation|0|||
144599005|NCT02708095|521394565|FG002|Overall Study|Protocol Violation|1|||
144599006|NCT02708095|521394563|FG000|Overall Study|Withdrawal by Subject|5|||
144599007|NCT02708095|521394564|FG001|Overall Study|Withdrawal by Subject|3|||
144599008|NCT02708095|521394565|FG002|Overall Study|Withdrawal by Subject|4|||
144599009|NCT05125679|521394566|FG000|Overall Study|Study Terminated by Sponsor|2|||
144599010|NCT05125679|521394567|FG001|Overall Study|Study Terminated by Sponsor|5|||
144599011|NCT04908189|521394584|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
144599012|NCT04908189|521394585|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
144599013|NCT04908189|521394586|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
144599014|NCT04908189|521394584|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
144599015|NCT04908189|521394585|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
144599016|NCT04908189|521394586|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
144599017|NCT04908189|521394584|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
144599018|NCT04908189|521394585|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
144599019|NCT04908189|521394586|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
144599020|NCT04908189|521394584|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
144599021|NCT04908189|521394585|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
144599022|NCT04908189|521394586|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
144599023|NCT04908189|521394584|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
144599024|NCT04908189|521394585|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
144599025|NCT04908189|521394586|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
144599026|NCT04908189|521394584|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
144599027|NCT04908189|521394585|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
144599028|NCT04908189|521394586|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
144599029|NCT04908189|521394584|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
144599030|NCT04908189|521394585|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
144599031|NCT04908189|521394586|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
144599032|NCT04908189|521394584|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
144599033|NCT04908189|521394585|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
144599034|NCT04908189|521394586|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
144599035|NCT04908189|521394584|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
144599036|NCT04908189|521394585|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
144599037|NCT04908189|521394586|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
144599038|NCT04908189|521394584|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
144599039|NCT04908189|521394585|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
144599040|NCT04908189|521394586|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
144599041|NCT04908189|521394584|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
144599042|NCT04908189|521394585|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
144599043|NCT04908189|521394586|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
144599044|NCT04908189|521394584|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
144599045|NCT04908189|521394585|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
144599046|NCT04908189|521394586|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
144599047|NCT00607022|521394588|FG000|Overall Study|Withdrawal by Subject|1|||
144599048|NCT00607022|521394589|FG001|Overall Study|Withdrawal by Subject|0|||
144599049|NCT00607022|521394590|FG002|Overall Study|Withdrawal by Subject|0|||
144599050|NCT05461794|521394591|FG000|Overall Study|Withdrawal by Subject|1|||
144599051|NCT05461794|521394592|FG001|Overall Study|Withdrawal by Subject|1|||
144599052|NCT05461794|521394593|FG002|Overall Study|Withdrawal by Subject|3|||
144599053|NCT05461794|521394591|FG000|Overall Study|Study Terminated By Sponsor|18|||
144599054|NCT05461794|521394592|FG001|Overall Study|Study Terminated By Sponsor|13|||
144599055|NCT05461794|521394593|FG002|Overall Study|Study Terminated By Sponsor|16|||
144599056|NCT05461794|521394591|FG000|Overall Study|Death|20|||
144599057|NCT05461794|521394592|FG001|Overall Study|Death|5|||
144599058|NCT05461794|521394593|FG002|Overall Study|Death|19|||
144599059|NCT01210118|521394597|FG000|Overall Study|Lost to Follow-up|1|||
144599060|NCT01210118|521394598|FG001|Overall Study|Lost to Follow-up|1|||
144599061|NCT01210118|521394597|FG000|Overall Study|Protocol Violation|1|||
144599062|NCT01210118|521394598|FG001|Overall Study|Protocol Violation|1|||
144599063|NCT01210118|521394597|FG000|Overall Study|Spontaneous abortion|1|||
144599064|NCT01210118|521394598|FG001|Overall Study|Spontaneous abortion|3|||
144599065|NCT02958267|521394599|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
144599066|NCT02958267|521394600|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
144403942|NCT02925117|520688557|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
144403943|NCT02925117|520688558|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
144403944|NCT02925117|520688559|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
144403945|NCT02925117|520688560|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
144403946|NCT02925117|520688561|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
144403947|NCT02925117|520688562|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
144524662|NCT04350463|521121977|FG001|Overall Study|Withdrawal by Subject|0|||
144524663|NCT04350463|521121978|FG002|Overall Study|Withdrawal by Subject|1|||
144524664|NCT04350463|521121979|FG003|Overall Study|Withdrawal by Subject|4|||
144524665|NCT04350463|521121976|FG000|Overall Study|Adverse Event|0|||
144524666|NCT04350463|521121977|FG001|Overall Study|Adverse Event|0|||
144524667|NCT04350463|521121978|FG002|Overall Study|Adverse Event|0|||
144524668|NCT04350463|521121979|FG003|Overall Study|Adverse Event|2|||
144524669|NCT04350463|521121976|FG000|Overall Study|Death|27|||
144524670|NCT04350463|521121977|FG001|Overall Study|Death|2|||
144599067|NCT02958267|521394599|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
144403948|NCT02925117|520688563|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
144403949|NCT02925117|520688564|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
144403950|NCT02925117|520688553|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
144403951|NCT02925117|520688554|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
144403952|NCT02925117|520688555|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
144403953|NCT02925117|520688556|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
144403954|NCT02925117|520688557|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
144403955|NCT02925117|520688558|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
144403956|NCT02925117|520688559|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
144403957|NCT02925117|520688560|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
144403958|NCT02925117|520688561|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
144403959|NCT02925117|520688562|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
144403960|NCT02925117|520688563|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
144599068|NCT02958267|521394600|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
144599069|NCT02958267|521394599|FG000|Follow-up Visits|Additional treatment pursued|2|||
144599070|NCT02958267|521394600|FG001|Follow-up Visits|Additional treatment pursued|1|||
144599071|NCT00777946|521394601|FG000|Overall Study|Adverse Event|11|||
144599072|NCT00777946|521394602|FG001|Overall Study|Adverse Event|1|||
144599073|NCT00777946|521394603|FG002|Overall Study|Adverse Event|3|||
144599074|NCT00777946|521394601|FG000|Overall Study|Lack of Efficacy|0|||
144599075|NCT00777946|521394602|FG001|Overall Study|Lack of Efficacy|0|||
144599076|NCT00777946|521394603|FG002|Overall Study|Lack of Efficacy|9|||
144599077|NCT00777946|521394601|FG000|Overall Study|Condition no longer required study drug|1|||
144599078|NCT00777946|521394602|FG001|Overall Study|Condition no longer required study drug|0|||
144599079|NCT00777946|521394603|FG002|Overall Study|Condition no longer required study drug|0|||
144599080|NCT00777946|521394601|FG000|Overall Study|Patient withdrew consent|3|||
144599081|NCT00777946|521394602|FG001|Overall Study|Patient withdrew consent|2|||
144599082|NCT00777946|521394603|FG002|Overall Study|Patient withdrew consent|3|||
144599083|NCT00777946|521394601|FG000|Overall Study|Lost to Follow-up|3|||
144599084|NCT00777946|521394602|FG001|Overall Study|Lost to Follow-up|1|||
144599085|NCT00777946|521394603|FG002|Overall Study|Lost to Follow-up|0|||
144599086|NCT00777946|521394601|FG000|Overall Study|Protocol deviation|2|||
144599087|NCT00777946|521394602|FG001|Overall Study|Protocol deviation|1|||
144599088|NCT00777946|521394603|FG002|Overall Study|Protocol deviation|1|||
144599089|NCT00777946|521394601|FG000|Overall Study|Randomized in error|1|||
144599090|NCT00777946|521394602|FG001|Overall Study|Randomized in error|1|||
144599091|NCT00777946|521394603|FG002|Overall Study|Randomized in error|0|||
144599092|NCT05066724|521394607|FG000|Overall Study|Adverse Event|1|||
144599093|NCT05066724|521394607|FG000|Overall Study|Non-Compliance With Study Drug|5|||
144599094|NCT05066724|521394607|FG000|Overall Study|Withdrawal by Subject|6|||
144599095|NCT05066724|521394607|FG000|Overall Study|Physician Decision|2|||
144599096|NCT00475033|521394623|FG000|Infant Series|Failed to return|3|||
144599097|NCT00475033|521394624|FG001|Infant Series|Failed to return|4|||
144599098|NCT00475033|521394623|FG000|Infant Series|Parent or legal guardian request|1|||
144722389|NCT00634907|521838701|FG001|Overall Study|Withdrawal by Subject|0|||
144403961|NCT02925117|520688564|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
144524671|NCT04350463|521121978|FG002|Overall Study|Death|13|||
144403962|NCT00347360|520688578|FG000|Overall Study|Adverse Event|1|||
144524672|NCT04350463|521121979|FG003|Overall Study|Death|26|||
144722390|NCT00634907|521838700|FG000|Overall Study|Physician Decision|3|||
144403963|NCT00347360|520688579|FG001|Overall Study|Adverse Event|2|||
144403964|NCT00347360|520688580|FG002|Overall Study|Adverse Event|0|||
144403965|NCT00347360|520688581|FG003|Overall Study|Adverse Event|4|||
144524673|NCT04111536|521121980|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
144599099|NCT00475033|521394624|FG001|Infant Series|Parent or legal guardian request|5|||
144599100|NCT00475033|521394623|FG000|Infant Series|Protocol Violation|1|||
144599101|NCT00475033|521394624|FG001|Infant Series|Protocol Violation|2|||
144599102|NCT00475033|521394623|FG000|Infant Series|Lost to Follow-up|2|||
144599103|NCT00475033|521394624|FG001|Infant Series|Lost to Follow-up|0|||
144599104|NCT00475033|521394623|FG000|Infant Series|Adverse Event|0|||
144403966|NCT00347360|520688582|FG004|Overall Study|Adverse Event|1|||
144403967|NCT00347360|520688583|FG005|Overall Study|Adverse Event|2|||
144403968|NCT00347360|520688584|FG006|Overall Study|Adverse Event|2|||
144403969|NCT00347360|520688585|FG007|Overall Study|Adverse Event|0|||
144403970|NCT00347360|520688586|FG008|Overall Study|Adverse Event|2|||
144403971|NCT00347360|520688587|FG009|Overall Study|Adverse Event|3|||
144403972|NCT00347360|520688588|FG010|Overall Study|Adverse Event|3|||
144403973|NCT00347360|520688589|FG011|Overall Study|Adverse Event|1|||
144403974|NCT00347360|520688590|FG012|Overall Study|Adverse Event|3|||
144403975|NCT00347360|520688591|FG013|Overall Study|Adverse Event|2|||
144403976|NCT00347360|520688592|FG014|Overall Study|Adverse Event|2|||
144403977|NCT00347360|520688578|FG000|Overall Study|Lost to Follow-up|0|||
144403978|NCT00347360|520688579|FG001|Overall Study|Lost to Follow-up|0|||
144403979|NCT00347360|520688580|FG002|Overall Study|Lost to Follow-up|0|||
144403980|NCT00347360|520688581|FG003|Overall Study|Lost to Follow-up|2|||
144403981|NCT00347360|520688582|FG004|Overall Study|Lost to Follow-up|1|||
144403982|NCT00347360|520688583|FG005|Overall Study|Lost to Follow-up|1|||
144403983|NCT00347360|520688584|FG006|Overall Study|Lost to Follow-up|0|||
144403984|NCT00347360|520688585|FG007|Overall Study|Lost to Follow-up|1|||
144403985|NCT00347360|520688586|FG008|Overall Study|Lost to Follow-up|1|||
144403986|NCT00347360|520688587|FG009|Overall Study|Lost to Follow-up|2|||
144403987|NCT00347360|520688588|FG010|Overall Study|Lost to Follow-up|0|||
144403988|NCT00347360|520688589|FG011|Overall Study|Lost to Follow-up|0|||
144403989|NCT00347360|520688590|FG012|Overall Study|Lost to Follow-up|1|||
144403990|NCT00347360|520688591|FG013|Overall Study|Lost to Follow-up|0|||
144403991|NCT00347360|520688592|FG014|Overall Study|Lost to Follow-up|0|||
144403992|NCT00347360|520688578|FG000|Overall Study|Protocol Violation|2|||
144403993|NCT00347360|520688579|FG001|Overall Study|Protocol Violation|3|||
144403994|NCT00347360|520688580|FG002|Overall Study|Protocol Violation|1|||
144403995|NCT00347360|520688581|FG003|Overall Study|Protocol Violation|2|||
144403996|NCT00347360|520688582|FG004|Overall Study|Protocol Violation|1|||
144403997|NCT00347360|520688583|FG005|Overall Study|Protocol Violation|2|||
144403998|NCT00347360|520688584|FG006|Overall Study|Protocol Violation|0|||
144403999|NCT00347360|520688585|FG007|Overall Study|Protocol Violation|0|||
144404000|NCT00347360|520688586|FG008|Overall Study|Protocol Violation|1|||
144404001|NCT00347360|520688587|FG009|Overall Study|Protocol Violation|2|||
144404002|NCT00347360|520688588|FG010|Overall Study|Protocol Violation|0|||
144404003|NCT00347360|520688589|FG011|Overall Study|Protocol Violation|0|||
144404004|NCT00347360|520688590|FG012|Overall Study|Protocol Violation|0|||
144404005|NCT00347360|520688591|FG013|Overall Study|Protocol Violation|1|||
144404006|NCT00347360|520688592|FG014|Overall Study|Protocol Violation|0|||
144404007|NCT00347360|520688578|FG000|Overall Study|Withdrawal by Subject|0|||
144404008|NCT00347360|520688579|FG001|Overall Study|Withdrawal by Subject|1|||
144404009|NCT00347360|520688580|FG002|Overall Study|Withdrawal by Subject|2|||
144404010|NCT00347360|520688581|FG003|Overall Study|Withdrawal by Subject|4|||
144404011|NCT00347360|520688582|FG004|Overall Study|Withdrawal by Subject|1|||
144404012|NCT00347360|520688583|FG005|Overall Study|Withdrawal by Subject|2|||
144404013|NCT00347360|520688584|FG006|Overall Study|Withdrawal by Subject|1|||
144404014|NCT00347360|520688585|FG007|Overall Study|Withdrawal by Subject|1|||
144404015|NCT00347360|520688586|FG008|Overall Study|Withdrawal by Subject|1|||
144404016|NCT00347360|520688587|FG009|Overall Study|Withdrawal by Subject|1|||
144404017|NCT00347360|520688588|FG010|Overall Study|Withdrawal by Subject|0|||
144404018|NCT00347360|520688589|FG011|Overall Study|Withdrawal by Subject|3|||
144404019|NCT00347360|520688590|FG012|Overall Study|Withdrawal by Subject|4|||
144404020|NCT00347360|520688591|FG013|Overall Study|Withdrawal by Subject|2|||
144404021|NCT00347360|520688592|FG014|Overall Study|Withdrawal by Subject|1|||
144404022|NCT00347360|520688578|FG000|Overall Study|Lack of Efficacy|1|||
144404023|NCT00347360|520688579|FG001|Overall Study|Lack of Efficacy|1|||
144404024|NCT00347360|520688580|FG002|Overall Study|Lack of Efficacy|3|||
144404025|NCT00347360|520688581|FG003|Overall Study|Lack of Efficacy|1|||
144404026|NCT00347360|520688582|FG004|Overall Study|Lack of Efficacy|0|||
144404027|NCT00347360|520688583|FG005|Overall Study|Lack of Efficacy|1|||
144404028|NCT00347360|520688584|FG006|Overall Study|Lack of Efficacy|0|||
144404029|NCT00347360|520688585|FG007|Overall Study|Lack of Efficacy|1|||
144404030|NCT00347360|520688586|FG008|Overall Study|Lack of Efficacy|1|||
144404031|NCT00347360|520688587|FG009|Overall Study|Lack of Efficacy|0|||
144404032|NCT00347360|520688588|FG010|Overall Study|Lack of Efficacy|0|||
144404033|NCT00347360|520688589|FG011|Overall Study|Lack of Efficacy|0|||
144404034|NCT00347360|520688590|FG012|Overall Study|Lack of Efficacy|0|||
144404035|NCT00347360|520688591|FG013|Overall Study|Lack of Efficacy|0|||
144404036|NCT00347360|520688592|FG014|Overall Study|Lack of Efficacy|0|||
144404037|NCT00347360|520688578|FG000|Overall Study|Reason not listed/blank|1|||
144404038|NCT00347360|520688579|FG001|Overall Study|Reason not listed/blank|0|||
144404039|NCT00347360|520688580|FG002|Overall Study|Reason not listed/blank|0|||
144404040|NCT00347360|520688581|FG003|Overall Study|Reason not listed/blank|0|||
144404041|NCT00347360|520688582|FG004|Overall Study|Reason not listed/blank|0|||
144404042|NCT00347360|520688583|FG005|Overall Study|Reason not listed/blank|0|||
144404043|NCT00347360|520688584|FG006|Overall Study|Reason not listed/blank|1|||
144404044|NCT00347360|520688585|FG007|Overall Study|Reason not listed/blank|0|||
144524674|NCT04111536|521121981|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
144404045|NCT00347360|520688586|FG008|Overall Study|Reason not listed/blank|0|||
144404046|NCT00347360|520688587|FG009|Overall Study|Reason not listed/blank|0|||
144404047|NCT00347360|520688588|FG010|Overall Study|Reason not listed/blank|0|||
144404048|NCT00347360|520688589|FG011|Overall Study|Reason not listed/blank|0|||
144404049|NCT00347360|520688590|FG012|Overall Study|Reason not listed/blank|0|||
144404050|NCT00347360|520688591|FG013|Overall Study|Reason not listed/blank|1|||
144404051|NCT00347360|520688592|FG014|Overall Study|Reason not listed/blank|0|||
144404052|NCT00347360|520688578|FG000|Overall Study|Per sponsors instruction|0|||
144404053|NCT00347360|520688579|FG001|Overall Study|Per sponsors instruction|1|||
144404054|NCT00347360|520688580|FG002|Overall Study|Per sponsors instruction|0|||
144404055|NCT00347360|520688581|FG003|Overall Study|Per sponsors instruction|0|||
144404056|NCT00347360|520688582|FG004|Overall Study|Per sponsors instruction|0|||
144404057|NCT00347360|520688583|FG005|Overall Study|Per sponsors instruction|0|||
144404058|NCT00347360|520688584|FG006|Overall Study|Per sponsors instruction|0|||
144404059|NCT00347360|520688585|FG007|Overall Study|Per sponsors instruction|0|||
144404060|NCT00347360|520688586|FG008|Overall Study|Per sponsors instruction|0|||
144404061|NCT00347360|520688587|FG009|Overall Study|Per sponsors instruction|0|||
144404062|NCT00347360|520688588|FG010|Overall Study|Per sponsors instruction|0|||
144404063|NCT00347360|520688589|FG011|Overall Study|Per sponsors instruction|0|||
144404064|NCT00347360|520688590|FG012|Overall Study|Per sponsors instruction|0|||
144404065|NCT00347360|520688591|FG013|Overall Study|Per sponsors instruction|0|||
144404066|NCT00347360|520688592|FG014|Overall Study|Per sponsors instruction|0|||
144404067|NCT00347360|520688578|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
144404068|NCT00347360|520688579|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
144404069|NCT00347360|520688580|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
144404070|NCT00347360|520688581|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
144404071|NCT00347360|520688582|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
144404072|NCT00347360|520688583|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
144404073|NCT00347360|520688584|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
144404074|NCT00347360|520688585|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
144404075|NCT00347360|520688586|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
144404076|NCT00347360|520688587|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
144404077|NCT00347360|520688588|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
144404078|NCT00347360|520688589|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
144404079|NCT00347360|520688590|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
144404080|NCT00347360|520688591|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
144404081|NCT00347360|520688592|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
144404082|NCT00347360|520688578|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
144404083|NCT00347360|520688579|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
144404084|NCT00347360|520688580|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
144404085|NCT00347360|520688581|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
144404086|NCT00347360|520688582|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
144404087|NCT00347360|520688583|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
144404088|NCT00347360|520688584|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
144404089|NCT00347360|520688585|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
144404090|NCT00347360|520688586|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
144404091|NCT00347360|520688587|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
144404092|NCT00347360|520688588|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
144404093|NCT00347360|520688589|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
144404094|NCT00347360|520688590|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
144404095|NCT00347360|520688591|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
144404096|NCT00347360|520688592|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
144404097|NCT00347360|520688578|FG000|Overall Study|Abnormal lab values|0|||
144404098|NCT00347360|520688579|FG001|Overall Study|Abnormal lab values|0|||
144404099|NCT00347360|520688580|FG002|Overall Study|Abnormal lab values|0|||
144404100|NCT00347360|520688581|FG003|Overall Study|Abnormal lab values|0|||
144404101|NCT00347360|520688582|FG004|Overall Study|Abnormal lab values|0|||
144404102|NCT00347360|520688583|FG005|Overall Study|Abnormal lab values|0|||
144404103|NCT00347360|520688584|FG006|Overall Study|Abnormal lab values|1|||
144404104|NCT00347360|520688585|FG007|Overall Study|Abnormal lab values|0|||
144404105|NCT00347360|520688586|FG008|Overall Study|Abnormal lab values|0|||
144404106|NCT00347360|520688587|FG009|Overall Study|Abnormal lab values|0|||
144404107|NCT00347360|520688588|FG010|Overall Study|Abnormal lab values|0|||
144404108|NCT00347360|520688589|FG011|Overall Study|Abnormal lab values|0|||
144404109|NCT00347360|520688590|FG012|Overall Study|Abnormal lab values|0|||
144404110|NCT00347360|520688591|FG013|Overall Study|Abnormal lab values|0|||
144404111|NCT00347360|520688592|FG014|Overall Study|Abnormal lab values|0|||
144404112|NCT00347360|520688578|FG000|Overall Study|PI recommended early withdrawal|0|||
144404113|NCT00347360|520688579|FG001|Overall Study|PI recommended early withdrawal|0|||
144404114|NCT00347360|520688580|FG002|Overall Study|PI recommended early withdrawal|0|||
144404115|NCT00347360|520688581|FG003|Overall Study|PI recommended early withdrawal|0|||
144599105|NCT00475033|521394624|FG001|Infant Series|Adverse Event|2|||
144599106|NCT00475033|521394623|FG000|After the Infant Series|Adverse Event|0|||
144599107|NCT00475033|521394624|FG001|After the Infant Series|Adverse Event|4|||
144599108|NCT00475033|521394623|FG000|After the Infant Series|Parent or legal guardian request|2|||
144599109|NCT00475033|521394624|FG001|After the Infant Series|Parent or legal guardian request|2|||
144599110|NCT00475033|521394623|FG000|After the Infant Series|Failed to return|2|||
144599111|NCT00475033|521394624|FG001|After the Infant Series|Failed to return|1|||
144599112|NCT00475033|521394623|FG000|After the Infant Series|Protocol Violation|1|||
144599113|NCT00475033|521394624|FG001|After the Infant Series|Protocol Violation|0|||
144599114|NCT00475033|521394623|FG000|After the Infant Series|Lost to Follow-up|1|||
144599115|NCT00475033|521394624|FG001|After the Infant Series|Lost to Follow-up|0|||
144599116|NCT00475033|521394623|FG000|After the Infant Series|Other|0|||
144599117|NCT00475033|521394624|FG001|After the Infant Series|Other|1|||
144599118|NCT00475033|521394623|FG000|Toddler Dose|Parent or legal guardian request|2|||
144599119|NCT00475033|521394624|FG001|Toddler Dose|Parent or legal guardian request|0|||
144599120|NCT00475033|521394623|FG000|Toddler Dose|Failed to return|1|||
144599121|NCT00475033|521394624|FG001|Toddler Dose|Failed to return|0|||
144599122|NCT00475033|521394623|FG000|Toddler Dose|Lost to Follow-up|1|||
144599123|NCT00475033|521394624|FG001|Toddler Dose|Lost to Follow-up|0|||
144599124|NCT01696942|521394625|FG000|Overall Study|Withdrawal by Subject|1|||
144599125|NCT01696942|521394626|FG001|Overall Study|Withdrawal by Subject|0|||
144599126|NCT01696942|521394625|FG000|Overall Study|Protocol Violation|1|||
144599127|NCT01696942|521394626|FG001|Overall Study|Protocol Violation|2|||
144599128|NCT01696942|521394625|FG000|Overall Study|screen failure|0|||
144599129|NCT01696942|521394626|FG001|Overall Study|screen failure|1|||
144599130|NCT03231943|521394628|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599131|NCT03231943|521394629|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
144599132|NCT03231943|521394630|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
144599133|NCT03231943|521394631|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599134|NCT03231943|521394632|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599135|NCT03231943|521394633|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599136|NCT03231943|521394634|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599137|NCT03231943|521394635|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599138|NCT03231943|521394636|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599139|NCT03231943|521394637|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599140|NCT03231943|521394638|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599141|NCT03231943|521394639|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599142|NCT03231943|521394640|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
144599143|NCT03231943|521394628|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599144|NCT03231943|521394629|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
144599145|NCT03231943|521394630|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599146|NCT03231943|521394631|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599147|NCT03231943|521394632|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599148|NCT03231943|521394633|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599149|NCT03231943|521394634|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599150|NCT03231943|521394635|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599151|NCT03231943|521394636|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599152|NCT03231943|521394637|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599153|NCT03231943|521394638|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599154|NCT03231943|521394639|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599155|NCT03231943|521394640|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
144599156|NCT03231943|521394628|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
144599157|NCT03231943|521394629|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599158|NCT03231943|521394630|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599159|NCT03231943|521394631|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599160|NCT03231943|521394632|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599161|NCT03231943|521394633|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599162|NCT03231943|521394634|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599163|NCT03231943|521394635|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599164|NCT03231943|521394636|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599165|NCT03231943|521394637|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599166|NCT03231943|521394638|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599167|NCT03231943|521394639|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599168|NCT03231943|521394640|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
144599169|NCT03231943|521394628|FG000|Part 2|Adverse Event|0|||
144599170|NCT03231943|521394629|FG001|Part 2|Adverse Event|0|||
144599171|NCT03231943|521394630|FG002|Part 2|Adverse Event|0|||
144599172|NCT03231943|521394631|FG003|Part 2|Adverse Event|0|||
144599173|NCT03231943|521394632|FG004|Part 2|Adverse Event|0|||
144599174|NCT03231943|521394633|FG005|Part 2|Adverse Event|0|||
144599175|NCT03231943|521394634|FG006|Part 2|Adverse Event|0|||
144599176|NCT03231943|521394635|FG007|Part 2|Adverse Event|0|||
144599177|NCT03231943|521394636|FG008|Part 2|Adverse Event|0|||
144599178|NCT03231943|521394637|FG009|Part 2|Adverse Event|0|||
144404116|NCT00347360|520688582|FG004|Overall Study|PI recommended early withdrawal|0|||
144404117|NCT00347360|520688583|FG005|Overall Study|PI recommended early withdrawal|0|||
144404118|NCT00347360|520688584|FG006|Overall Study|PI recommended early withdrawal|0|||
144599179|NCT03231943|521394638|FG010|Part 2|Adverse Event|1|||
144599180|NCT03231943|521394639|FG011|Part 2|Adverse Event|0|||
144404119|NCT00347360|520688585|FG007|Overall Study|PI recommended early withdrawal|0|||
144599181|NCT03231943|521394640|FG012|Part 2|Adverse Event|0|||
144404120|NCT00347360|520688586|FG008|Overall Study|PI recommended early withdrawal|0|||
144404121|NCT00347360|520688587|FG009|Overall Study|PI recommended early withdrawal|1|||
144404122|NCT00347360|520688588|FG010|Overall Study|PI recommended early withdrawal|0|||
144404123|NCT00347360|520688589|FG011|Overall Study|PI recommended early withdrawal|0|||
144404124|NCT00347360|520688590|FG012|Overall Study|PI recommended early withdrawal|0|||
144404125|NCT00347360|520688591|FG013|Overall Study|PI recommended early withdrawal|0|||
144404126|NCT00347360|520688592|FG014|Overall Study|PI recommended early withdrawal|0|||
144524675|NCT04111536|521121980|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
144524676|NCT04111536|521121981|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
144524677|NCT04111536|521121980|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
144524678|NCT04111536|521121981|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
144524679|NCT04111536|521121980|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
144524680|NCT04111536|521121981|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
144524681|NCT04171999|521121982|FG000|Overall Study|deemed ineligible after randomization|2|||
144524682|NCT04171999|521121983|FG001|Overall Study|deemed ineligible after randomization|1|||
144524683|NCT05170009|521121986|FG000|Overall Study|Physician Decision|0|||
144524684|NCT05170009|521121987|FG001|Overall Study|Physician Decision|1|||
144524685|NCT04925986|521121988|FG000|Overall Study|Death|0|||
144524686|NCT04925986|521121989|FG001|Overall Study|Death|0|||
144524687|NCT04925986|521121990|FG002|Overall Study|Death|2|||
144524688|NCT04925986|521121991|FG003|Overall Study|Death|0|||
144524689|NCT04925986|521121988|FG000|Overall Study|Lack of Efficacy|1|||
144524690|NCT04925986|521121989|FG001|Overall Study|Lack of Efficacy|2|||
144524691|NCT04925986|521121990|FG002|Overall Study|Lack of Efficacy|0|||
144524692|NCT04925986|521121991|FG003|Overall Study|Lack of Efficacy|1|||
144524693|NCT04925986|521121988|FG000|Overall Study|Withdrawal by Subject|0|||
144524694|NCT04925986|521121989|FG001|Overall Study|Withdrawal by Subject|0|||
144524695|NCT04925986|521121990|FG002|Overall Study|Withdrawal by Subject|1|||
144524696|NCT04925986|521121991|FG003|Overall Study|Withdrawal by Subject|2|||
144524697|NCT04770532|521121993|FG000|Overall Study|Withdrawal by Subject|0|||
144524698|NCT04770532|521121994|FG001|Overall Study|Withdrawal by Subject|3|||
144524699|NCT04770532|521121993|FG000|Overall Study|Physician Decision|1|||
144524700|NCT04770532|521121994|FG001|Overall Study|Physician Decision|0|||
144524701|NCT04770532|521121993|FG000|Overall Study|Death|2|||
144524702|NCT04770532|521121994|FG001|Overall Study|Death|2|||
144524703|NCT05457647|521121996|FG000|Overall Study|Lost to Follow-up|3|||
144524704|NCT02683447|521121997|FG000|Overall Study|Lost to Follow-up|2|||
144524705|NCT04623671|521121999|FG000|Overall Study|Adverse Event|0|||
144524706|NCT04623671|521122000|FG001|Overall Study|Adverse Event|1|||
144524707|NCT04623671|521121999|FG000|Overall Study|Lost to Follow-up|2|||
144524708|NCT04623671|521122000|FG001|Overall Study|Lost to Follow-up|1|||
144524709|NCT04623671|521121999|FG000|Overall Study|Death|5|||
144524710|NCT04623671|521122000|FG001|Overall Study|Death|5|||
144524711|NCT03448107|521122001|FG000|Overall Study|Lost to Follow-up|229|||
144524712|NCT03448107|521122002|FG001|Overall Study|Lost to Follow-up|258|||
144524713|NCT03865498|521122003|FG000|Overall Study|Lack of Efficacy|12|||
144524714|NCT03865498|521122004|FG001|Overall Study|Lack of Efficacy|11|||
144524715|NCT03865498|521122003|FG000|Overall Study|Lost to Follow-up|125|||
144524716|NCT03865498|521122004|FG001|Overall Study|Lost to Follow-up|133|||
144524717|NCT03865498|521122003|FG000|Overall Study|Withdrawal by Subject|2|||
144524718|NCT03865498|521122004|FG001|Overall Study|Withdrawal by Subject|4|||
144524719|NCT01648023|521122005|FG000|Overall Study|Screen Fail Post Randomization|1|||
144524720|NCT01648023|521122006|FG001|Overall Study|Screen Fail Post Randomization|2|||
144524721|NCT05296525|521122011|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
144524722|NCT05296525|521122012|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
144599182|NCT03231943|521394628|FG000|Part 2|Withdrawal by Subject|0|||
144524723|NCT05296525|521122013|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
144524724|NCT05296525|521122014|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
144524725|NCT04137289|521122021|FG000|Overall Study|Death|0|||
144524726|NCT04137289|521122022|FG001|Overall Study|Death|0|||
144524727|NCT04137289|521122023|FG002|Overall Study|Death|0|||
144524728|NCT04137289|521122024|FG003|Overall Study|Death|0|||
144524729|NCT04137289|521122025|FG004|Overall Study|Death|0|||
144524730|NCT04137289|521122026|FG005|Overall Study|Death|0|||
144524731|NCT04137289|521122027|FG006|Overall Study|Death|1|||
144524732|NCT04137289|521122028|FG007|Overall Study|Death|0|||
144599183|NCT03231943|521394629|FG001|Part 2|Withdrawal by Subject|0|||
144404127|NCT00347360|520688578|FG000|Overall Study|Did not meet criteria before ABPM|0|||
144524733|NCT04137289|521122029|FG008|Overall Study|Death|0|||
144599184|NCT03231943|521394630|FG002|Part 2|Withdrawal by Subject|0|||
144599185|NCT03231943|521394631|FG003|Part 2|Withdrawal by Subject|0|||
144599186|NCT03231943|521394632|FG004|Part 2|Withdrawal by Subject|0|||
144599187|NCT03231943|521394633|FG005|Part 2|Withdrawal by Subject|0|||
144599188|NCT03231943|521394634|FG006|Part 2|Withdrawal by Subject|0|||
144599189|NCT03231943|521394635|FG007|Part 2|Withdrawal by Subject|0|||
144599190|NCT03231943|521394636|FG008|Part 2|Withdrawal by Subject|0|||
144599191|NCT03231943|521394637|FG009|Part 2|Withdrawal by Subject|0|||
144599192|NCT03231943|521394638|FG010|Part 2|Withdrawal by Subject|0|||
144599193|NCT03231943|521394639|FG011|Part 2|Withdrawal by Subject|1|||
144599194|NCT03231943|521394640|FG012|Part 2|Withdrawal by Subject|0|||
144599195|NCT02673619|521394641|FG000|Overall Study|Lost to Follow-up|1|||
144599196|NCT02673619|521394642|FG001|Overall Study|Lost to Follow-up|0|||
144599197|NCT02673619|521394643|FG002|Overall Study|Lost to Follow-up|0|||
144599198|NCT02673619|521394644|FG003|Overall Study|Lost to Follow-up|0|||
144599199|NCT02673619|521394641|FG000|Overall Study|Withdrawal by Subject|1|||
144599200|NCT02673619|521394642|FG001|Overall Study|Withdrawal by Subject|1|||
144599201|NCT02673619|521394643|FG002|Overall Study|Withdrawal by Subject|1|||
144599202|NCT02673619|521394644|FG003|Overall Study|Withdrawal by Subject|0|||
144599203|NCT02673619|521394641|FG000|Overall Study|Adverse Event|0|||
144404128|NCT00347360|520688579|FG001|Overall Study|Did not meet criteria before ABPM|0|||
144404129|NCT00347360|520688580|FG002|Overall Study|Did not meet criteria before ABPM|0|||
144404130|NCT00347360|520688581|FG003|Overall Study|Did not meet criteria before ABPM|0|||
144404131|NCT00347360|520688582|FG004|Overall Study|Did not meet criteria before ABPM|0|||
144404132|NCT00347360|520688583|FG005|Overall Study|Did not meet criteria before ABPM|0|||
144404133|NCT00347360|520688584|FG006|Overall Study|Did not meet criteria before ABPM|0|||
144404134|NCT00347360|520688585|FG007|Overall Study|Did not meet criteria before ABPM|0|||
144404135|NCT00347360|520688586|FG008|Overall Study|Did not meet criteria before ABPM|0|||
144404136|NCT00347360|520688587|FG009|Overall Study|Did not meet criteria before ABPM|0|||
144404137|NCT00347360|520688588|FG010|Overall Study|Did not meet criteria before ABPM|1|||
144404138|NCT00347360|520688589|FG011|Overall Study|Did not meet criteria before ABPM|0|||
144404139|NCT00347360|520688590|FG012|Overall Study|Did not meet criteria before ABPM|0|||
144404140|NCT00347360|520688591|FG013|Overall Study|Did not meet criteria before ABPM|0|||
144404141|NCT00347360|520688592|FG014|Overall Study|Did not meet criteria before ABPM|0|||
144404142|NCT00347360|520688578|FG000|Overall Study|Randomized in error|0|||
144404143|NCT00347360|520688579|FG001|Overall Study|Randomized in error|0|||
144404144|NCT00347360|520688580|FG002|Overall Study|Randomized in error|0|||
144404145|NCT00347360|520688581|FG003|Overall Study|Randomized in error|0|||
144404146|NCT00347360|520688582|FG004|Overall Study|Randomized in error|0|||
144404147|NCT00347360|520688583|FG005|Overall Study|Randomized in error|0|||
144404148|NCT00347360|520688584|FG006|Overall Study|Randomized in error|0|||
144404149|NCT00347360|520688585|FG007|Overall Study|Randomized in error|0|||
144599204|NCT02673619|521394642|FG001|Overall Study|Adverse Event|0|||
144599205|NCT02673619|521394643|FG002|Overall Study|Adverse Event|1|||
144599206|NCT02673619|521394644|FG003|Overall Study|Adverse Event|0|||
144599207|NCT02673619|521394641|FG000|Overall Study|Lack of Efficacy|0|||
144599208|NCT02673619|521394642|FG001|Overall Study|Lack of Efficacy|0|||
144599209|NCT02673619|521394643|FG002|Overall Study|Lack of Efficacy|1|||
144599210|NCT02673619|521394644|FG003|Overall Study|Lack of Efficacy|0|||
144599211|NCT03144804|521394646|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
144599212|NCT03602261|521394651|FG000|Overall Study|Adverse Event|5|||
144599213|NCT03602261|521394652|FG001|Overall Study|Adverse Event|1|||
144599214|NCT03602261|521394651|FG000|Overall Study|Physician Decision|1|||
144599215|NCT03602261|521394652|FG001|Overall Study|Physician Decision|0|||
144599216|NCT03602261|521394651|FG000|Overall Study|Withdrawal by Subject|1|||
144599217|NCT03602261|521394652|FG001|Overall Study|Withdrawal by Subject|1|||
144599218|NCT03602261|521394651|FG000|Overall Study|Lack of Efficacy|0|||
144599219|NCT03602261|521394652|FG001|Overall Study|Lack of Efficacy|1|||
144599220|NCT03602261|521394651|FG000|Overall Study|Subject moving out of state|1|||
144599221|NCT03602261|521394652|FG001|Overall Study|Subject moving out of state|0|||
144599222|NCT03769181|521396118|FG000|Overall Study|Adverse Event|1|||
144599223|NCT03769181|521396119|FG001|Overall Study|Adverse Event|0|||
144599224|NCT03769181|521396120|FG002|Overall Study|Adverse Event|2|||
144599225|NCT03769181|521396121|FG003|Overall Study|Adverse Event|4|||
144599226|NCT03769181|521396118|FG000|Overall Study|Withdrawal by Subject|1|||
144599227|NCT03769181|521396119|FG001|Overall Study|Withdrawal by Subject|0|||
144599228|NCT03769181|521396120|FG002|Overall Study|Withdrawal by Subject|2|||
144599229|NCT03769181|521396121|FG003|Overall Study|Withdrawal by Subject|1|||
144722391|NCT00634907|521838701|FG001|Overall Study|Physician Decision|9|||
144404150|NCT00347360|520688586|FG008|Overall Study|Randomized in error|0|||
144404151|NCT00347360|520688587|FG009|Overall Study|Randomized in error|0|||
144404152|NCT00347360|520688588|FG010|Overall Study|Randomized in error|0|||
144599230|NCT03769181|521396118|FG000|Overall Study|Progressive disease|9|||
144599231|NCT03769181|521396119|FG001|Overall Study|Progressive disease|7|||
144599232|NCT03769181|521396120|FG002|Overall Study|Progressive disease|13|||
144599233|NCT03769181|521396121|FG003|Overall Study|Progressive disease|6|||
144599234|NCT03769181|521396118|FG000|Overall Study|Other - Unspecified|2|||
144599235|NCT03769181|521396119|FG001|Overall Study|Other - Unspecified|1|||
144404153|NCT00347360|520688589|FG011|Overall Study|Randomized in error|1|||
144404154|NCT00347360|520688590|FG012|Overall Study|Randomized in error|0|||
144404155|NCT00347360|520688591|FG013|Overall Study|Randomized in error|0|||
144404156|NCT00347360|520688592|FG014|Overall Study|Randomized in error|0|||
144404157|NCT00347360|520688578|FG000|Overall Study|Failed inclusion criteria #4|0|||
144404158|NCT00347360|520688579|FG001|Overall Study|Failed inclusion criteria #4|0|||
144404159|NCT00347360|520688580|FG002|Overall Study|Failed inclusion criteria #4|0|||
144404160|NCT00347360|520688581|FG003|Overall Study|Failed inclusion criteria #4|0|||
144404161|NCT00347360|520688582|FG004|Overall Study|Failed inclusion criteria #4|0|||
144524734|NCT04137289|521122021|FG000|Overall Study|Clinical disease progression|0|||
144524735|NCT04137289|521122022|FG001|Overall Study|Clinical disease progression|0|||
144524736|NCT04137289|521122023|FG002|Overall Study|Clinical disease progression|0|||
144524737|NCT04137289|521122024|FG003|Overall Study|Clinical disease progression|4|||
144524738|NCT04137289|521122025|FG004|Overall Study|Clinical disease progression|4|||
144524739|NCT04137289|521122026|FG005|Overall Study|Clinical disease progression|2|||
144524740|NCT04137289|521122027|FG006|Overall Study|Clinical disease progression|5|||
144524741|NCT04137289|521122028|FG007|Overall Study|Clinical disease progression|1|||
144524742|NCT04137289|521122029|FG008|Overall Study|Clinical disease progression|0|||
144524743|NCT04137289|521122021|FG000|Overall Study|Lost to Follow-up|0|||
144524744|NCT04137289|521122022|FG001|Overall Study|Lost to Follow-up|0|||
144404162|NCT00347360|520688583|FG005|Overall Study|Failed inclusion criteria #4|0|||
144404163|NCT00347360|520688584|FG006|Overall Study|Failed inclusion criteria #4|0|||
144404164|NCT00347360|520688585|FG007|Overall Study|Failed inclusion criteria #4|0|||
144404165|NCT00347360|520688586|FG008|Overall Study|Failed inclusion criteria #4|0|||
144404166|NCT00347360|520688587|FG009|Overall Study|Failed inclusion criteria #4|0|||
144404167|NCT00347360|520688588|FG010|Overall Study|Failed inclusion criteria #4|0|||
144404168|NCT00347360|520688589|FG011|Overall Study|Failed inclusion criteria #4|1|||
144404169|NCT00347360|520688590|FG012|Overall Study|Failed inclusion criteria #4|0|||
144404170|NCT00347360|520688591|FG013|Overall Study|Failed inclusion criteria #4|0|||
144404171|NCT00347360|520688592|FG014|Overall Study|Failed inclusion criteria #4|0|||
144404172|NCT00347360|520688578|FG000|Overall Study|Prolonged duration between visits|0|||
144404173|NCT00347360|520688579|FG001|Overall Study|Prolonged duration between visits|0|||
144404174|NCT00347360|520688580|FG002|Overall Study|Prolonged duration between visits|0|||
144404175|NCT00347360|520688581|FG003|Overall Study|Prolonged duration between visits|0|||
144404176|NCT00347360|520688582|FG004|Overall Study|Prolonged duration between visits|0|||
144404177|NCT00347360|520688583|FG005|Overall Study|Prolonged duration between visits|0|||
144404178|NCT00347360|520688584|FG006|Overall Study|Prolonged duration between visits|0|||
144404179|NCT00347360|520688585|FG007|Overall Study|Prolonged duration between visits|0|||
144404180|NCT00347360|520688586|FG008|Overall Study|Prolonged duration between visits|0|||
144404181|NCT00347360|520688587|FG009|Overall Study|Prolonged duration between visits|0|||
144404182|NCT00347360|520688588|FG010|Overall Study|Prolonged duration between visits|0|||
144404183|NCT00347360|520688589|FG011|Overall Study|Prolonged duration between visits|0|||
144404184|NCT00347360|520688590|FG012|Overall Study|Prolonged duration between visits|1|||
144404185|NCT00347360|520688591|FG013|Overall Study|Prolonged duration between visits|0|||
144404186|NCT00347360|520688592|FG014|Overall Study|Prolonged duration between visits|0|||
144404187|NCT00347360|520688578|FG000|Overall Study|Subject left town, ran out of study drug|0|||
144404188|NCT00347360|520688579|FG001|Overall Study|Subject left town, ran out of study drug|0|||
144404189|NCT00347360|520688580|FG002|Overall Study|Subject left town, ran out of study drug|0|||
144404190|NCT00347360|520688581|FG003|Overall Study|Subject left town, ran out of study drug|0|||
144404191|NCT00347360|520688582|FG004|Overall Study|Subject left town, ran out of study drug|0|||
144404192|NCT00347360|520688583|FG005|Overall Study|Subject left town, ran out of study drug|0|||
144404193|NCT00347360|520688584|FG006|Overall Study|Subject left town, ran out of study drug|0|||
144404194|NCT00347360|520688585|FG007|Overall Study|Subject left town, ran out of study drug|0|||
144404195|NCT00347360|520688586|FG008|Overall Study|Subject left town, ran out of study drug|0|||
144404196|NCT00347360|520688587|FG009|Overall Study|Subject left town, ran out of study drug|0|||
144404197|NCT00347360|520688588|FG010|Overall Study|Subject left town, ran out of study drug|0|||
144404198|NCT00347360|520688589|FG011|Overall Study|Subject left town, ran out of study drug|0|||
144404199|NCT00347360|520688590|FG012|Overall Study|Subject left town, ran out of study drug|0|||
144404200|NCT00347360|520688591|FG013|Overall Study|Subject left town, ran out of study drug|1|||
144404201|NCT00347360|520688592|FG014|Overall Study|Subject left town, ran out of study drug|0|||
144404202|NCT00347360|520688578|FG000|Overall Study|Subject refuse to sign updated consent|0|||
144404203|NCT00347360|520688579|FG001|Overall Study|Subject refuse to sign updated consent|0|||
144404204|NCT00347360|520688580|FG002|Overall Study|Subject refuse to sign updated consent|0|||
144404205|NCT00347360|520688581|FG003|Overall Study|Subject refuse to sign updated consent|0|||
144404206|NCT00347360|520688582|FG004|Overall Study|Subject refuse to sign updated consent|0|||
144524745|NCT04137289|521122023|FG002|Overall Study|Lost to Follow-up|0|||
144599236|NCT03769181|521396120|FG002|Overall Study|Other - Unspecified|0|||
144599237|NCT03769181|521396121|FG003|Overall Study|Other - Unspecified|0|||
144404207|NCT00347360|520688583|FG005|Overall Study|Subject refuse to sign updated consent|0|||
144404208|NCT00347360|520688584|FG006|Overall Study|Subject refuse to sign updated consent|0|||
144404209|NCT00347360|520688585|FG007|Overall Study|Subject refuse to sign updated consent|0|||
144404210|NCT00347360|520688586|FG008|Overall Study|Subject refuse to sign updated consent|0|||
144404211|NCT00347360|520688587|FG009|Overall Study|Subject refuse to sign updated consent|0|||
144404212|NCT00347360|520688588|FG010|Overall Study|Subject refuse to sign updated consent|0|||
144404213|NCT00347360|520688589|FG011|Overall Study|Subject refuse to sign updated consent|0|||
144404214|NCT00347360|520688590|FG012|Overall Study|Subject refuse to sign updated consent|0|||
144404215|NCT00347360|520688591|FG013|Overall Study|Subject refuse to sign updated consent|0|||
144404216|NCT00347360|520688592|FG014|Overall Study|Subject refuse to sign updated consent|1|||
144404217|NCT00347360|520688578|FG000|Overall Study|Visits conflicted with new job|0|||
144404218|NCT00347360|520688579|FG001|Overall Study|Visits conflicted with new job|0|||
144404219|NCT00347360|520688580|FG002|Overall Study|Visits conflicted with new job|0|||
144404220|NCT00347360|520688581|FG003|Overall Study|Visits conflicted with new job|0|||
144404221|NCT00347360|520688582|FG004|Overall Study|Visits conflicted with new job|0|||
144404222|NCT00347360|520688583|FG005|Overall Study|Visits conflicted with new job|0|||
144404223|NCT00347360|520688584|FG006|Overall Study|Visits conflicted with new job|1|||
144404224|NCT00347360|520688585|FG007|Overall Study|Visits conflicted with new job|0|||
144404225|NCT00347360|520688586|FG008|Overall Study|Visits conflicted with new job|0|||
144404226|NCT00347360|520688587|FG009|Overall Study|Visits conflicted with new job|0|||
144404227|NCT00347360|520688588|FG010|Overall Study|Visits conflicted with new job|0|||
144404228|NCT00347360|520688589|FG011|Overall Study|Visits conflicted with new job|0|||
144404229|NCT00347360|520688590|FG012|Overall Study|Visits conflicted with new job|0|||
144404230|NCT00347360|520688591|FG013|Overall Study|Visits conflicted with new job|0|||
144404231|NCT00347360|520688592|FG014|Overall Study|Visits conflicted with new job|0|||
144404232|NCT00806351|520688598|FG000|Overall Study|Death|5|||
144404233|NCT00806351|520688599|FG001|Overall Study|Death|4|||
144404234|NCT00913380|520688602|FG000|Clinical Outcomes|Lost to Follow-up|6|||
144404235|NCT00913380|520688603|FG001|Clinical Outcomes|Lost to Follow-up|6|||
144404236|NCT02187744|520688604|FG000|Study|Participant refused further follow-up|1|||
144404237|NCT02187744|520688605|FG001|Study|Participant refused further follow-up|0|||
144404238|NCT02187744|520688604|FG000|Study|Other|2|||
144404239|NCT02187744|520688605|FG001|Study|Other|1|||
144404240|NCT02187744|520688604|FG000|Study|Lost to Follow-up|0|||
144404241|NCT02187744|520688605|FG001|Study|Lost to Follow-up|2|||
144404242|NCT02187744|520688604|FG000|Study|Related adverse event, not serious|0|||
144404243|NCT02187744|520688605|FG001|Study|Related adverse event, not serious|2|||
144404244|NCT02187744|520688604|FG000|Study|Death|1|||
144404245|NCT02187744|520688605|FG001|Study|Death|0|||
144404246|NCT02187744|520688604|FG000|Study|Related adverse event, serious non-fatal|0|||
144404247|NCT02187744|520688605|FG001|Study|Related adverse event, serious non-fatal|1|||
144404248|NCT02187744|520688604|FG000|Treatment|Death|1|||
144404249|NCT02187744|520688605|FG001|Treatment|Death|0|||
144404250|NCT02187744|520688604|FG000|Treatment|Related adverse event, serious non-fatal|0|||
144404251|NCT02187744|520688605|FG001|Treatment|Related adverse event, serious non-fatal|1|||
144404252|NCT02187744|520688604|FG000|Treatment|Related adverse event, not serious|0|||
144404253|NCT02187744|520688605|FG001|Treatment|Related adverse event, not serious|2|||
144404254|NCT02187744|520688604|FG000|Treatment|Lost to Follow-up|0|||
144404255|NCT02187744|520688605|FG001|Treatment|Lost to Follow-up|1|||
144404256|NCT02187744|520688604|FG000|Treatment|Other|2|||
144404257|NCT02187744|520688605|FG001|Treatment|Other|0|||
144404258|NCT02187744|520688604|FG000|Treatment|Participant refused continued treatment|1|||
144404259|NCT02187744|520688605|FG001|Treatment|Participant refused continued treatment|1|||
144404260|NCT01788228|520688606|FG000|Overall Study|Migrated/moved from study area|1|||
144404261|NCT01788228|520688607|FG001|Overall Study|Migrated/moved from study area|0|||
144404262|NCT00945893|520688611|FG000|Overall Study|Lost to Follow-up|2|||
144404263|NCT00945893|520688612|FG001|Overall Study|Lost to Follow-up|8|||
144404264|NCT00945893|520688611|FG000|Overall Study|Withdrawal of consent|1|||
144404265|NCT00945893|520688612|FG001|Overall Study|Withdrawal of consent|2|||
144404266|NCT01602120|520688613|FG000|Overall Study|Adverse Event|3|||
144404267|NCT01602120|520688614|FG001|Overall Study|Adverse Event|6|||
144404268|NCT01602120|520688615|FG002|Overall Study|Adverse Event|0|||
144404269|NCT01602120|520688616|FG003|Overall Study|Adverse Event|2|||
144404270|NCT01602120|520688613|FG000|Overall Study|Death|0|||
144404271|NCT01602120|520688614|FG001|Overall Study|Death|4|||
144599238|NCT03971422|521396122|FG000|Overall Study|Lost to Follow-up|0|||
144404272|NCT01602120|520688615|FG002|Overall Study|Death|0|||
144404273|NCT01602120|520688616|FG003|Overall Study|Death|0|||
144599239|NCT03971422|521396123|FG001|Overall Study|Lost to Follow-up|1|||
144599240|NCT03971422|521396124|FG002|Overall Study|Lost to Follow-up|0|||
144404274|NCT01602120|520688613|FG000|Overall Study|Lost to Follow-up|0|||
144404275|NCT01602120|520688614|FG001|Overall Study|Lost to Follow-up|1|||
144404276|NCT01602120|520688615|FG002|Overall Study|Lost to Follow-up|0|||
144404277|NCT01602120|520688616|FG003|Overall Study|Lost to Follow-up|1|||
144404278|NCT01602120|520688613|FG000|Overall Study|Protocol Violation|1|||
144599241|NCT03971422|521396122|FG000|Overall Study|Lack of Efficacy|5|||
144404279|NCT01602120|520688614|FG001|Overall Study|Protocol Violation|1|||
144404280|NCT01602120|520688615|FG002|Overall Study|Protocol Violation|0|||
144404281|NCT01602120|520688616|FG003|Overall Study|Protocol Violation|0|||
144404282|NCT01602120|520688613|FG000|Overall Study|Non-compliance|0|||
144404283|NCT01602120|520688614|FG001|Overall Study|Non-compliance|3|||
144404284|NCT01602120|520688615|FG002|Overall Study|Non-compliance|0|||
144404285|NCT01602120|520688616|FG003|Overall Study|Non-compliance|1|||
144404286|NCT01602120|520688613|FG000|Overall Study|Withdrawal by Subject|8|||
144404287|NCT01602120|520688614|FG001|Overall Study|Withdrawal by Subject|17|||
144404288|NCT01602120|520688615|FG002|Overall Study|Withdrawal by Subject|0|||
144404289|NCT01602120|520688616|FG003|Overall Study|Withdrawal by Subject|3|||
144404290|NCT01602120|520688613|FG000|Overall Study|Study Terminated by Sponsor|12|||
144404291|NCT01602120|520688614|FG001|Overall Study|Study Terminated by Sponsor|24|||
144404292|NCT01602120|520688615|FG002|Overall Study|Study Terminated by Sponsor|17|||
144524746|NCT04137289|521122024|FG003|Overall Study|Lost to Follow-up|1|||
144524747|NCT04137289|521122025|FG004|Overall Study|Lost to Follow-up|0|||
144524748|NCT04137289|521122026|FG005|Overall Study|Lost to Follow-up|0|||
144524749|NCT04137289|521122027|FG006|Overall Study|Lost to Follow-up|0|||
144524750|NCT04137289|521122028|FG007|Overall Study|Lost to Follow-up|0|||
144524751|NCT04137289|521122029|FG008|Overall Study|Lost to Follow-up|0|||
144524752|NCT04137289|521122021|FG000|Overall Study|Adverse Event|0|||
144524753|NCT04137289|521122022|FG001|Overall Study|Adverse Event|0|||
144524754|NCT04137289|521122023|FG002|Overall Study|Adverse Event|1|||
144524755|NCT04137289|521122024|FG003|Overall Study|Adverse Event|0|||
144524756|NCT04137289|521122025|FG004|Overall Study|Adverse Event|0|||
144524757|NCT04137289|521122026|FG005|Overall Study|Adverse Event|1|||
144524758|NCT04137289|521122027|FG006|Overall Study|Adverse Event|0|||
144524759|NCT04137289|521122028|FG007|Overall Study|Adverse Event|0|||
144524760|NCT04137289|521122029|FG008|Overall Study|Adverse Event|0|||
144524761|NCT04137289|521122021|FG000|Overall Study|Lack of clinical benefit|0|||
144524762|NCT04137289|521122022|FG001|Overall Study|Lack of clinical benefit|0|||
144524763|NCT04137289|521122023|FG002|Overall Study|Lack of clinical benefit|0|||
144524764|NCT04137289|521122024|FG003|Overall Study|Lack of clinical benefit|0|||
144524765|NCT04137289|521122025|FG004|Overall Study|Lack of clinical benefit|0|||
144524766|NCT04137289|521122026|FG005|Overall Study|Lack of clinical benefit|0|||
144524767|NCT04137289|521122027|FG006|Overall Study|Lack of clinical benefit|0|||
144524768|NCT04137289|521122028|FG007|Overall Study|Lack of clinical benefit|0|||
144524769|NCT04137289|521122029|FG008|Overall Study|Lack of clinical benefit|1|||
144524770|NCT04137289|521122021|FG000|Overall Study|Objective disease progression|1|||
144524771|NCT04137289|521122022|FG001|Overall Study|Objective disease progression|1|||
144524772|NCT04137289|521122023|FG002|Overall Study|Objective disease progression|6|||
144524773|NCT04137289|521122024|FG003|Overall Study|Objective disease progression|18|||
144524774|NCT04137289|521122025|FG004|Overall Study|Objective disease progression|12|||
144524775|NCT04137289|521122026|FG005|Overall Study|Objective disease progression|20|||
144524776|NCT04137289|521122027|FG006|Overall Study|Objective disease progression|18|||
144524777|NCT04137289|521122028|FG007|Overall Study|Objective disease progression|7|||
144524778|NCT04137289|521122029|FG008|Overall Study|Objective disease progression|6|||
144524779|NCT04307355|521122030|FG000|Overall Study|Non-Compliance|3|||
144524780|NCT04307355|521122031|FG001|Overall Study|Non-Compliance|3|||
144524781|NCT04307355|521122032|FG002|Overall Study|Non-Compliance|0|||
144524782|NCT02547363|521122037|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
144524783|NCT02547363|521122038|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
144524784|NCT02547363|521122037|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
144524785|NCT02547363|521122038|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
144524786|NCT02547363|521122037|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
144524787|NCT02547363|521122038|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
144524788|NCT02547363|521122037|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
144524789|NCT02547363|521122038|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
144524790|NCT02547363|521122037|FG000|12-month Follow-up|Withdrawal by Subject|4|||
144524791|NCT02547363|521122038|FG001|12-month Follow-up|Withdrawal by Subject|3|||
144524792|NCT02547363|521122037|FG000|12-month Follow-up|Lost to Follow-up|4|||
144524793|NCT02547363|521122038|FG001|12-month Follow-up|Lost to Follow-up|1|||
144524794|NCT02547363|521122037|FG000|12-month Follow-up|Lack of Efficacy|1|||
144524795|NCT02547363|521122038|FG001|12-month Follow-up|Lack of Efficacy|1|||
144524796|NCT02547363|521122037|FG000|12-month Follow-up|Other|1|||
144524797|NCT02547363|521122038|FG001|12-month Follow-up|Other|0|||
144524798|NCT04436276|521122039|FG000|Overall Study|Adverse Event|0|||
144524799|NCT04436276|521122040|FG001|Overall Study|Adverse Event|0|||
144524800|NCT04436276|521122041|FG002|Overall Study|Adverse Event|0|||
144524801|NCT04436276|521122042|FG003|Overall Study|Adverse Event|0|||
144524802|NCT04436276|521122043|FG004|Overall Study|Adverse Event|0|||
144524803|NCT04436276|521122044|FG005|Overall Study|Adverse Event|0|||
144524804|NCT04436276|521122045|FG006|Overall Study|Adverse Event|0|||
144524805|NCT04436276|521122046|FG007|Overall Study|Adverse Event|0|||
144524806|NCT04436276|521122047|FG008|Overall Study|Adverse Event|0|||
144524807|NCT04436276|521122048|FG009|Overall Study|Adverse Event|0|||
144404293|NCT01602120|520688616|FG003|Overall Study|Study Terminated by Sponsor|44|||
144404294|NCT01602120|520688613|FG000|Overall Study|Physician Decision|2|||
144404295|NCT01602120|520688614|FG001|Overall Study|Physician Decision|3|||
144404296|NCT01602120|520688615|FG002|Overall Study|Physician Decision|0|||
144404297|NCT01602120|520688616|FG003|Overall Study|Physician Decision|0|||
144404298|NCT01602120|520688613|FG000|Overall Study|Unspecified Reason|3|||
144404299|NCT01602120|520688614|FG001|Overall Study|Unspecified Reason|1|||
144404300|NCT01602120|520688615|FG002|Overall Study|Unspecified Reason|0|||
144404301|NCT01602120|520688616|FG003|Overall Study|Unspecified Reason|2|||
144404302|NCT04439201|520688621|FG000|Overall Study|Ineligible|2|||
144404303|NCT04439201|520688621|FG000|Overall Study|Never start protocol therapy|1|||
144404304|NCT04439201|520688621|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
144404305|NCT04439201|520688621|FG000|Overall Study|Mutation status not confirmed|4|||
144404306|NCT04439201|520688621|FG000|Overall Study|Adverse Event|1|||
144404307|NCT04439201|520688621|FG000|Overall Study|Death|7|||
144404308|NCT04439201|520688621|FG000|Overall Study|Withdrawal by Subject|2|||
144404309|NCT04439201|520688621|FG000|Overall Study|Disease progression|20|||
144404310|NCT04439201|520688621|FG000|Overall Study|Alternative therapy|1|||
144404311|NCT04439201|520688621|FG000|Overall Study|Physician Decision|1|||
144404312|NCT03730012|520688622|FG000|Overall Study|Adverse Event|0|||
144404313|NCT03730012|520688623|FG001|Overall Study|Adverse Event|1|||
144404314|NCT03730012|520688622|FG000|Overall Study|Lack of Efficacy|1|||
144404315|NCT03730012|520688623|FG001|Overall Study|Lack of Efficacy|5|||
144404316|NCT03730012|520688622|FG000|Overall Study|Withdrawal by Subject|0|||
144404317|NCT03730012|520688623|FG001|Overall Study|Withdrawal by Subject|1|||
144404318|NCT03730012|520688622|FG000|Overall Study|Miscellaneous|2|||
144404319|NCT03730012|520688623|FG001|Overall Study|Miscellaneous|1|||
144404320|NCT04680052|520690346|FG000|Overall Study|Ongoing|244|||
144404321|NCT04680052|520690347|FG001|Overall Study|Ongoing|229|||
144404322|NCT04680052|520690348|FG002|Overall Study|Ongoing|39|||
144404323|NCT04680052|520690349|FG003|Overall Study|Ongoing|46|||
144404324|NCT04680052|520690346|FG000|Overall Study|Death|15|||
144404325|NCT04680052|520690347|FG001|Overall Study|Death|22|||
144404326|NCT04680052|520690348|FG002|Overall Study|Death|7|||
144404327|NCT04680052|520690349|FG003|Overall Study|Death|1|||
144404328|NCT04680052|520690346|FG000|Overall Study|Lost to Follow-up|3|||
144404329|NCT04680052|520690347|FG001|Overall Study|Lost to Follow-up|2|||
144404330|NCT04680052|520690348|FG002|Overall Study|Lost to Follow-up|0|||
144404331|NCT04680052|520690349|FG003|Overall Study|Lost to Follow-up|1|||
144404332|NCT04680052|520690346|FG000|Overall Study|Withdrawal by Subject|11|||
144404333|NCT04680052|520690347|FG001|Overall Study|Withdrawal by Subject|19|||
144404334|NCT04680052|520690348|FG002|Overall Study|Withdrawal by Subject|7|||
144404335|NCT04680052|520690349|FG003|Overall Study|Withdrawal by Subject|5|||
144404336|NCT04680052|520690346|FG000|Overall Study|Missing|0|||
144404337|NCT04680052|520690347|FG001|Overall Study|Missing|1|||
144404338|NCT04680052|520690348|FG002|Overall Study|Missing|0|||
144404339|NCT04680052|520690349|FG003|Overall Study|Missing|0|||
144404340|NCT04680052|520690346|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
144404341|NCT04680052|520690347|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
144404342|NCT04680052|520690348|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
144404343|NCT04680052|520690349|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
144404344|NCT04680052|520690346|FG000|Overall Study|Physician Decision|0|||
144404345|NCT04680052|520690347|FG001|Overall Study|Physician Decision|1|||
144404346|NCT04680052|520690348|FG002|Overall Study|Physician Decision|0|||
144404347|NCT04680052|520690349|FG003|Overall Study|Physician Decision|0|||
144404348|NCT01367002|520690350|FG000|Overall Study|Withdrawal by Subject|1|||
144404349|NCT01367002|520690351|FG001|Overall Study|Withdrawal by Subject|0|||
144404350|NCT01367002|520690350|FG000|Overall Study|Physician Decision|0|||
144404351|NCT01367002|520690351|FG001|Overall Study|Physician Decision|2|||
144404352|NCT06956170|520690352|FG000|Overall Study|Death|2|||
144404353|NCT06956170|520690353|FG001|Overall Study|Death|1|||
144404354|NCT06956170|520690352|FG000|Overall Study|Withdrawal by Subject|1|||
144404355|NCT06956170|520690353|FG001|Overall Study|Withdrawal by Subject|0|||
144404356|NCT06956170|520690352|FG000|Overall Study|Ongoing|7|||
144404357|NCT06956170|520690353|FG001|Overall Study|Ongoing|10|||
144404358|NCT03281577|520690356|FG000|Overall Study|Adverse Event|0|||
144404359|NCT03281577|520690357|FG001|Overall Study|Adverse Event|0|||
144404360|NCT03281577|520690358|FG002|Overall Study|Adverse Event|0|||
144404361|NCT03281577|520690359|FG003|Overall Study|Adverse Event|1|||
144404362|NCT03281577|520690356|FG000|Overall Study|Withdrawal by Subject|1|||
144404363|NCT03281577|520690357|FG001|Overall Study|Withdrawal by Subject|0|||
144404364|NCT03281577|520690358|FG002|Overall Study|Withdrawal by Subject|0|||
144249985|NCT00153816|520113424|FG000|Overall Study|Lost to Follow-up|7|||
144404365|NCT03281577|520690359|FG003|Overall Study|Withdrawal by Subject|0|||
144404366|NCT00403234|520690360|FG000|Overall Study|Withdrawal by Subject|0|||
144404367|NCT00403234|520690361|FG001|Overall Study|Withdrawal by Subject|1|||
144404368|NCT00403234|520690362|FG002|Overall Study|Withdrawal by Subject|0|||
144404369|NCT00403234|520690363|FG003|Overall Study|Withdrawal by Subject|0|||
144404370|NCT00403234|520690360|FG000|Overall Study|Adverse Event|1|||
144599242|NCT03971422|521396123|FG001|Overall Study|Lack of Efficacy|1|||
144599243|NCT03971422|521396124|FG002|Overall Study|Lack of Efficacy|1|||
144599244|NCT03971422|521396122|FG000|Overall Study|Adverse event, not fatal|2|||
144404371|NCT00403234|520690361|FG001|Overall Study|Adverse Event|0|||
144404372|NCT00403234|520690362|FG002|Overall Study|Adverse Event|1|||
144404373|NCT00403234|520690363|FG003|Overall Study|Adverse Event|0|||
144404374|NCT02323113|520690364|FG000|Overall Study|Adverse Event|3|||
144404375|NCT02323113|520690365|FG001|Overall Study|Adverse Event|3|||
144404376|NCT02323113|520690366|FG002|Overall Study|Adverse Event|2|||
144404377|NCT02323113|520690367|FG003|Overall Study|Adverse Event|5|||
144404378|NCT02323113|520690368|FG004|Overall Study|Adverse Event|8|||
144404379|NCT02323113|520690369|FG005|Overall Study|Adverse Event|3|||
144404380|NCT02323113|520690370|FG006|Overall Study|Adverse Event|6|||
144404381|NCT02323113|520690371|FG007|Overall Study|Adverse Event|0|||
144404382|NCT02323113|520690364|FG000|Overall Study|Progressive Disease|0|||
144404383|NCT02323113|520690365|FG001|Overall Study|Progressive Disease|1|||
144404384|NCT02323113|520690366|FG002|Overall Study|Progressive Disease|1|||
144404385|NCT02323113|520690367|FG003|Overall Study|Progressive Disease|0|||
144404386|NCT02323113|520690368|FG004|Overall Study|Progressive Disease|0|||
144404387|NCT02323113|520690369|FG005|Overall Study|Progressive Disease|3|||
144404388|NCT02323113|520690370|FG006|Overall Study|Progressive Disease|0|||
144404389|NCT02323113|520690371|FG007|Overall Study|Progressive Disease|0|||
144404390|NCT02323113|520690364|FG000|Overall Study|Symptomatic Deterioration|0|||
144404391|NCT02323113|520690365|FG001|Overall Study|Symptomatic Deterioration|0|||
144404392|NCT02323113|520690366|FG002|Overall Study|Symptomatic Deterioration|1|||
144404393|NCT02323113|520690367|FG003|Overall Study|Symptomatic Deterioration|0|||
144404394|NCT02323113|520690368|FG004|Overall Study|Symptomatic Deterioration|1|||
144404395|NCT02323113|520690369|FG005|Overall Study|Symptomatic Deterioration|0|||
144404396|NCT02323113|520690370|FG006|Overall Study|Symptomatic Deterioration|0|||
144524808|NCT04436276|521122049|FG010|Overall Study|Adverse Event|0|||
144524809|NCT04436276|521122050|FG011|Overall Study|Adverse Event|0|||
144524810|NCT04436276|521122051|FG012|Overall Study|Adverse Event|0|||
144599245|NCT03971422|521396123|FG001|Overall Study|Adverse event, not fatal|2|||
144599246|NCT03971422|521396124|FG002|Overall Study|Adverse event, not fatal|5|||
144599247|NCT03971422|521396122|FG000|Overall Study|Worsening of MG Symptoms|1|||
144599248|NCT03971422|521396123|FG001|Overall Study|Worsening of MG Symptoms|4|||
144599249|NCT03971422|521396124|FG002|Overall Study|Worsening of MG Symptoms|2|||
144599250|NCT03971422|521396122|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
144599251|NCT03971422|521396123|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
144599252|NCT03971422|521396124|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
144599253|NCT03971422|521396122|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
144599254|NCT03971422|521396123|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
144599255|NCT03971422|521396124|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
144599256|NCT03971422|521396122|FG000|Overall Study|Due to COVID-19 pandemic|0|||
144599257|NCT03971422|521396123|FG001|Overall Study|Due to COVID-19 pandemic|1|||
144599258|NCT03971422|521396124|FG002|Overall Study|Due to COVID-19 pandemic|1|||
144599259|NCT01444651|521396128|FG000|Overall Study|Adverse Event|3|||
144599260|NCT01444651|521396129|FG001|Overall Study|Adverse Event|2|||
144599261|NCT01444651|521396128|FG000|Overall Study|Lost to Follow-up|5|||
144599262|NCT01444651|521396129|FG001|Overall Study|Lost to Follow-up|5|||
144599263|NCT01444651|521396128|FG000|Overall Study|Non-fasting|2|||
144599264|NCT01444651|521396129|FG001|Overall Study|Non-fasting|1|||
144599265|NCT01444651|521396128|FG000|Overall Study|Missing data|1|||
144599266|NCT01444651|521396129|FG001|Overall Study|Missing data|1|||
144599267|NCT01955122|521396130|FG000|Overall Study|Physician Decision|5|||
144599268|NCT01955122|521396131|FG001|Overall Study|Physician Decision|5|||
144599269|NCT01672788|521396132|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
144404397|NCT02323113|520690371|FG007|Overall Study|Symptomatic Deterioration|0|||
144524811|NCT04436276|521122052|FG013|Overall Study|Adverse Event|0|||
144524812|NCT04436276|521122053|FG014|Overall Study|Adverse Event|0|||
144524813|NCT04436276|521122054|FG015|Overall Study|Adverse Event|0|||
144524814|NCT04436276|521122055|FG016|Overall Study|Adverse Event|1|||
144524815|NCT04436276|521122056|FG017|Overall Study|Adverse Event|0|||
144524816|NCT04436276|521122057|FG018|Overall Study|Adverse Event|0|||
144524817|NCT04436276|521122058|FG019|Overall Study|Adverse Event|0|||
144524818|NCT04436276|521122059|FG020|Overall Study|Adverse Event|0|||
144599270|NCT01672788|521396133|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
144599271|NCT01672788|521396134|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
144249986|NCT00153816|520113425|FG001|Overall Study|Lost to Follow-up|8|||
144404398|NCT02323113|520690364|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
144404399|NCT02323113|520690365|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
144404400|NCT02323113|520690366|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
144524819|NCT04436276|521122060|FG021|Overall Study|Adverse Event|0|||
144524820|NCT04436276|521122061|FG022|Overall Study|Adverse Event|0|||
144524821|NCT04436276|521122039|FG000|Overall Study|Death|0|||
144524822|NCT04436276|521122040|FG001|Overall Study|Death|0|||
144599272|NCT01672788|521396135|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
144599273|NCT03338192|521396136|FG000|Year One to Year Two|High Blood Pressure|7|||
144599274|NCT03338192|521396137|FG001|Year One to Year Two|High Blood Pressure|1|||
144599275|NCT03338192|521396136|FG000|Year One to Year Two|HIV +|1|||
144599276|NCT03338192|521396137|FG001|Year One to Year Two|HIV +|0|||
144404401|NCT02323113|520690367|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
144404402|NCT02323113|520690368|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
144404403|NCT02323113|520690369|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
144404404|NCT02323113|520690370|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
144404405|NCT02323113|520690371|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
144404406|NCT02323113|520690364|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404407|NCT02323113|520690365|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
144404408|NCT02323113|520690366|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404409|NCT02323113|520690367|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404410|NCT02323113|520690368|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404411|NCT02323113|520690369|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404412|NCT02323113|520690370|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404413|NCT02323113|520690371|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
144404414|NCT00825682|520690372|FG000|Overall Study|personal reasons/ inconvenience|13|||
144404415|NCT00825682|520690373|FG001|Overall Study|personal reasons/ inconvenience|5|||
144404416|NCT02478632|520690379|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
144404417|NCT02478632|520690380|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
144404418|NCT02478632|520690379|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
144404419|NCT02478632|520690380|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
144404420|NCT02478632|520690379|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
144404421|NCT02478632|520690380|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
144404422|NCT00002651|520690381|FG000|Induction|Adverse Event|44|||
144404423|NCT00002651|520690382|FG001|Induction|Adverse Event|0|||
144404424|NCT00002651|520690383|FG002|Induction|Adverse Event|0|||
144404425|NCT00002651|520690381|FG000|Induction|Refusal unrelated to adverse event|50|||
144404426|NCT00002651|520690382|FG001|Induction|Refusal unrelated to adverse event|0|||
144404427|NCT00002651|520690383|FG002|Induction|Refusal unrelated to adverse event|0|||
144404428|NCT00002651|520690381|FG000|Induction|Progression/relapse|274|||
144404429|NCT00002651|520690382|FG001|Induction|Progression/relapse|0|||
144404430|NCT00002651|520690383|FG002|Induction|Progression/relapse|0|||
144404431|NCT00002651|520690381|FG000|Induction|Death|62|||
144404432|NCT00002651|520690382|FG001|Induction|Death|0|||
144404433|NCT00002651|520690383|FG002|Induction|Death|0|||
144404434|NCT00002651|520690381|FG000|Induction|Other|823|||
144404435|NCT00002651|520690382|FG001|Induction|Other|0|||
144404436|NCT00002651|520690383|FG002|Induction|Other|0|||
144404437|NCT00002651|520690381|FG000|Induction|not eligible|90|||
144404438|NCT00002651|520690382|FG001|Induction|not eligible|0|||
144404439|NCT00002651|520690383|FG002|Induction|not eligible|0|||
144404440|NCT00002651|520690381|FG000|Consolidation and Randomization|Adverse Event|0|||
144404441|NCT00002651|520690382|FG001|Consolidation and Randomization|Adverse Event|36|||
144404442|NCT00002651|520690383|FG002|Consolidation and Randomization|Adverse Event|14|||
144404443|NCT00002651|520690381|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
144404444|NCT00002651|520690382|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
144404445|NCT00002651|520690383|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
144404446|NCT00002651|520690381|FG000|Consolidation and Randomization|Progression/relapse|0|||
144404447|NCT00002651|520690382|FG001|Consolidation and Randomization|Progression/relapse|295|||
144404448|NCT00002651|520690383|FG002|Consolidation and Randomization|Progression/relapse|298|||
144404449|NCT00002651|520690381|FG000|Consolidation and Randomization|Death|0|||
144404450|NCT00002651|520690382|FG001|Consolidation and Randomization|Death|38|||
144404451|NCT00002651|520690383|FG002|Consolidation and Randomization|Death|48|||
144404452|NCT00002651|520690381|FG000|Consolidation and Randomization|Other|0|||
144404453|NCT00002651|520690382|FG001|Consolidation and Randomization|Other|314|||
144404454|NCT00002651|520690383|FG002|Consolidation and Randomization|Other|313|||
144404455|NCT00002651|520690381|FG000|Consolidation and Randomization|not eligible|0|||
144404456|NCT00002651|520690382|FG001|Consolidation and Randomization|not eligible|102|||
144599277|NCT03338192|521396136|FG000|Year Two to Year Four|High Blood Pressure|1|||
144404457|NCT00002651|520690383|FG002|Consolidation and Randomization|not eligible|112|||
144404458|NCT01705730|520690384|FG000|Overall Study|Lack of Efficacy|1|||
144404459|NCT01705730|520690384|FG000|Overall Study|Adverse Event|3|||
144404460|NCT01705730|520690384|FG000|Overall Study|Lost to Follow-up|1|||
144599278|NCT03338192|521396137|FG001|Year Two to Year Four|High Blood Pressure|0|||
144599279|NCT03338192|521396136|FG000|Year Two to Year Four|HIV +|2|||
144599280|NCT03338192|521396137|FG001|Year Two to Year Four|HIV +|0|||
144404461|NCT01705730|520690384|FG000|Overall Study|Reason not Specified|4|||
144404462|NCT00762385|520690388|FG000|First Intervention|Lens Issue|1|||
144404463|NCT00762385|520690389|FG001|First Intervention|Lens Issue|1|||
144404464|NCT00762385|520690388|FG000|First Intervention|Lost to Follow-up|0|||
144404465|NCT00762385|520690389|FG001|First Intervention|Lost to Follow-up|2|||
144404466|NCT00762385|520690388|FG000|First Intervention|Ineligible|1|||
144404467|NCT00762385|520690389|FG001|First Intervention|Ineligible|0|||
144404468|NCT00762385|520690388|FG000|First Intervention|Protocol Violation|0|||
144524823|NCT04436276|521122041|FG002|Overall Study|Death|0|||
144524824|NCT04436276|521122042|FG003|Overall Study|Death|0|||
144524825|NCT04436276|521122043|FG004|Overall Study|Death|0|||
144524826|NCT04436276|521122044|FG005|Overall Study|Death|0|||
144524827|NCT04436276|521122045|FG006|Overall Study|Death|0|||
144524828|NCT04436276|521122046|FG007|Overall Study|Death|0|||
144524829|NCT04436276|521122047|FG008|Overall Study|Death|0|||
144524830|NCT04436276|521122048|FG009|Overall Study|Death|0|||
144524831|NCT04436276|521122049|FG010|Overall Study|Death|0|||
144524832|NCT04436276|521122050|FG011|Overall Study|Death|0|||
144524833|NCT04436276|521122051|FG012|Overall Study|Death|1|||
144524834|NCT04436276|521122052|FG013|Overall Study|Death|0|||
144524835|NCT04436276|521122053|FG014|Overall Study|Death|1|||
144524836|NCT04436276|521122054|FG015|Overall Study|Death|0|||
144524837|NCT04436276|521122055|FG016|Overall Study|Death|0|||
144524838|NCT04436276|521122056|FG017|Overall Study|Death|0|||
144524839|NCT04436276|521122057|FG018|Overall Study|Death|0|||
144524840|NCT04436276|521122058|FG019|Overall Study|Death|2|||
144524841|NCT04436276|521122059|FG020|Overall Study|Death|0|||
144524842|NCT04436276|521122060|FG021|Overall Study|Death|1|||
144524843|NCT04436276|521122061|FG022|Overall Study|Death|0|||
144524844|NCT04436276|521122039|FG000|Overall Study|Lost to Follow-up|0|||
144524845|NCT04436276|521122040|FG001|Overall Study|Lost to Follow-up|2|||
144524846|NCT04436276|521122041|FG002|Overall Study|Lost to Follow-up|2|||
144524847|NCT04436276|521122042|FG003|Overall Study|Lost to Follow-up|1|||
144524848|NCT04436276|521122043|FG004|Overall Study|Lost to Follow-up|4|||
144524849|NCT04436276|521122044|FG005|Overall Study|Lost to Follow-up|1|||
144524850|NCT04436276|521122045|FG006|Overall Study|Lost to Follow-up|0|||
144524851|NCT04436276|521122046|FG007|Overall Study|Lost to Follow-up|0|||
144524852|NCT04436276|521122047|FG008|Overall Study|Lost to Follow-up|1|||
144524853|NCT04436276|521122048|FG009|Overall Study|Lost to Follow-up|0|||
144524854|NCT04436276|521122049|FG010|Overall Study|Lost to Follow-up|5|||
144524855|NCT04436276|521122050|FG011|Overall Study|Lost to Follow-up|5|||
144524856|NCT04436276|521122051|FG012|Overall Study|Lost to Follow-up|4|||
144524857|NCT04436276|521122052|FG013|Overall Study|Lost to Follow-up|1|||
144524858|NCT04436276|521122053|FG014|Overall Study|Lost to Follow-up|7|||
144524859|NCT04436276|521122054|FG015|Overall Study|Lost to Follow-up|7|||
144524860|NCT04436276|521122055|FG016|Overall Study|Lost to Follow-up|1|||
144524861|NCT04436276|521122056|FG017|Overall Study|Lost to Follow-up|0|||
144524862|NCT04436276|521122057|FG018|Overall Study|Lost to Follow-up|1|||
144524863|NCT04436276|521122058|FG019|Overall Study|Lost to Follow-up|1|||
144524864|NCT04436276|521122059|FG020|Overall Study|Lost to Follow-up|2|||
144524865|NCT04436276|521122060|FG021|Overall Study|Lost to Follow-up|1|||
144524866|NCT04436276|521122061|FG022|Overall Study|Lost to Follow-up|1|||
144524867|NCT04436276|521122039|FG000|Overall Study|Physician Decision|1|||
144524868|NCT04436276|521122040|FG001|Overall Study|Physician Decision|0|||
144524869|NCT04436276|521122041|FG002|Overall Study|Physician Decision|2|||
144524870|NCT04436276|521122042|FG003|Overall Study|Physician Decision|1|||
144524871|NCT04436276|521122043|FG004|Overall Study|Physician Decision|0|||
144524872|NCT04436276|521122044|FG005|Overall Study|Physician Decision|0|||
144524873|NCT04436276|521122045|FG006|Overall Study|Physician Decision|0|||
144524874|NCT04436276|521122046|FG007|Overall Study|Physician Decision|0|||
144524875|NCT04436276|521122047|FG008|Overall Study|Physician Decision|0|||
144524876|NCT04436276|521122048|FG009|Overall Study|Physician Decision|0|||
144524877|NCT04436276|521122049|FG010|Overall Study|Physician Decision|0|||
144524878|NCT04436276|521122050|FG011|Overall Study|Physician Decision|1|||
144524879|NCT04436276|521122051|FG012|Overall Study|Physician Decision|2|||
144404469|NCT00762385|520690389|FG001|First Intervention|Protocol Violation|1|||
144404470|NCT00762385|520690388|FG000|Second Intervention|Protocol Violation|3|||
144404471|NCT00762385|520690389|FG001|Second Intervention|Protocol Violation|3|||
144524880|NCT04436276|521122052|FG013|Overall Study|Physician Decision|0|||
144524881|NCT04436276|521122053|FG014|Overall Study|Physician Decision|0|||
144524882|NCT04436276|521122054|FG015|Overall Study|Physician Decision|0|||
144524883|NCT04436276|521122055|FG016|Overall Study|Physician Decision|0|||
144524884|NCT04436276|521122056|FG017|Overall Study|Physician Decision|0|||
144524885|NCT04436276|521122057|FG018|Overall Study|Physician Decision|0|||
144524886|NCT04436276|521122058|FG019|Overall Study|Physician Decision|0|||
144524887|NCT04436276|521122059|FG020|Overall Study|Physician Decision|1|||
144524888|NCT04436276|521122060|FG021|Overall Study|Physician Decision|2|||
144524889|NCT04436276|521122061|FG022|Overall Study|Physician Decision|0|||
144524890|NCT04436276|521122039|FG000|Overall Study|Protocol Violation|0|||
144404472|NCT04545060|520690391|FG000|Overall Study|Adverse Event|0|||
144404473|NCT04545060|520690392|FG001|Overall Study|Adverse Event|1|||
144404474|NCT04545060|520690391|FG000|Overall Study|Death|0|||
144404475|NCT04545060|520690392|FG001|Overall Study|Death|5|||
144404476|NCT04545060|520690391|FG000|Overall Study|Lost to Follow-up|10|||
144404477|NCT04545060|520690392|FG001|Overall Study|Lost to Follow-up|13|||
144404478|NCT04545060|520690391|FG000|Overall Study|Physician Decision|3|||
144404479|NCT04545060|520690392|FG001|Overall Study|Physician Decision|0|||
144404480|NCT04545060|520690391|FG000|Overall Study|Withdrawal by Subject|17|||
144404481|NCT04545060|520690392|FG001|Overall Study|Withdrawal by Subject|22|||
144404482|NCT00973674|520690395|FG000|Overall Study|Protocol Violation|2|||
144404483|NCT00973674|520690396|FG001|Overall Study|Protocol Violation|0|||
144404484|NCT00071396|520690397|FG000|Overall Study|Withdrawal by Subject|1|||
144404485|NCT00071396|520690397|FG000|Overall Study|Physician Decision|2|||
144404486|NCT03082261|520690398|FG000|Overall Study|Death|4|||
144404487|NCT03082261|520690398|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
144404488|NCT03082261|520690398|FG000|Overall Study|Insurance denial|1|||
144404489|NCT03082261|520690398|FG000|Overall Study|Peripheral lead added|1|||
144404490|NCT03082261|520690398|FG000|Overall Study|Withdrawal by Subject|40|||
144404491|NCT03082261|520690398|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
144404492|NCT03082261|520690398|FG000|Overall Study|Subject implanted with device other than study device|1|||
144404493|NCT03082261|520690398|FG000|Overall Study|Lost to Follow-up|14|||
144404494|NCT03082261|520690398|FG000|Overall Study|Subject moved to a different state|1|||
144404495|NCT03082261|520690398|FG000|Overall Study|Subject non-compliance|2|||
144404496|NCT03082261|520690398|FG000|Overall Study|Subject participation terminated by investigator|9|||
144404497|NCT03082261|520690398|FG000|Overall Study|Subject participation terminated by sponsor|4|||
144404498|NCT03082261|520690398|FG000|Overall Study|System explant|19|||
144404499|NCT03082261|520690398|FG000|Overall Study|Unable to place lead(s)|2|||
144404500|NCT03082261|520690398|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
144404501|NCT00839852|520690399|FG000|Overall Study|Adverse Event|10|||
144404502|NCT00839852|520690399|FG000|Overall Study|Insufficient Therapeutic Response|3|||
144404503|NCT00839852|520690399|FG000|Overall Study|Protocol Violation|9|||
144404504|NCT00839852|520690399|FG000|Overall Study|Withdrawal of Consent|16|||
144404505|NCT00839852|520690399|FG000|Overall Study|Lost to Follow-up|7|||
144404506|NCT00839852|520690399|FG000|Overall Study|Lack of Compliance While in Jail|1|||
144404507|NCT00839852|520690399|FG000|Overall Study|Pregnancy|1|||
144404508|NCT01986907|520690402|FG000|Overall Study|Adverse Event|11|||
144404509|NCT01986907|520690402|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
144404510|NCT01986907|520690402|FG000|Overall Study|Protocol Violation|4|||
144404511|NCT01986907|520690402|FG000|Overall Study|Withdrawal by Subject|76|||
144404512|NCT01986907|520690402|FG000|Overall Study|Lost to Follow-up|38|||
144404513|NCT01986907|520690402|FG000|Overall Study|Death|9|||
144404514|NCT02846324|520690404|FG000|Overall Study|Other|1|||
144404515|NCT02846324|520690405|FG001|Overall Study|Other|0|||
144404516|NCT02846324|520690406|FG002|Overall Study|Other|0|||
144404517|NCT02846324|520690407|FG003|Overall Study|Other|0|||
144404518|NCT02846324|520690404|FG000|Overall Study|Withdrawal by Subject|1|||
144404519|NCT02846324|520690405|FG001|Overall Study|Withdrawal by Subject|0|||
144404520|NCT02846324|520690406|FG002|Overall Study|Withdrawal by Subject|4|||
144404521|NCT02846324|520690407|FG003|Overall Study|Withdrawal by Subject|0|||
144404522|NCT03576495|520690425|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
144404523|NCT03576495|520690426|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
144404524|NCT02635776|520690428|FG000|Overall Study|Physician Decision|1|||
144404525|NCT02635776|520690429|FG001|Overall Study|Physician Decision|0|||
144404526|NCT02635776|520690428|FG000|Overall Study|Adverse Event|51|||
144404527|NCT02635776|520690429|FG001|Overall Study|Adverse Event|3|||
144404528|NCT02635776|520690428|FG000|Overall Study|Withdrawal by Subject|41|||
144404529|NCT02635776|520690429|FG001|Overall Study|Withdrawal by Subject|7|||
144404530|NCT02635776|520690428|FG000|Overall Study|Lost to Follow-up|4|||
144404531|NCT02635776|520690429|FG001|Overall Study|Lost to Follow-up|0|||
144404532|NCT02635776|520690428|FG000|Overall Study|Other reasons|5|||
144404533|NCT02635776|520690429|FG001|Overall Study|Other reasons|1|||
144404534|NCT00788073|520690430|FG000|STX209 Then Placebo|Adverse Event|1|||
144404535|NCT00788073|520690431|FG001|STX209 Then Placebo|Adverse Event|0|||
144404536|NCT00788073|520690430|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
144404537|NCT00788073|520690431|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
144249987|NCT00153816|520113426|FG002|Overall Study|Lost to Follow-up|5|||
144404538|NCT00788073|520690430|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
144404539|NCT00788073|520690431|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
144404540|NCT00788073|520690430|FG000|STX209 Then Placebo|unable to return due to travel|0|||
144404541|NCT00788073|520690431|FG001|STX209 Then Placebo|unable to return due to travel|1|||
144404542|NCT00788073|520690430|FG000|Placebo Then STX209|Adverse Event|2|||
144404543|NCT00788073|520690431|FG001|Placebo Then STX209|Adverse Event|0|||
144404544|NCT00788073|520690430|FG000|Placebo Then STX209|Protocol Violation|0|||
144404545|NCT00788073|520690431|FG001|Placebo Then STX209|Protocol Violation|1|||
144404546|NCT03608254|520690432|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
144524891|NCT04436276|521122040|FG001|Overall Study|Protocol Violation|0|||
144404547|NCT03608254|520690432|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
144722392|NCT00634907|521838700|FG000|Overall Study|Withdrawal by Subject|11|||
144722393|NCT00634907|521838701|FG001|Overall Study|Withdrawal by Subject|8|||
144404548|NCT04203797|520690433|FG000|Overall Study|Adverse Event|1|||
144404549|NCT04203797|520690434|FG001|Overall Study|Adverse Event|0|||
144404550|NCT04203797|520690433|FG000|Overall Study|Did not complete End of Study follow-up|1|||
144404551|NCT04203797|520690434|FG001|Overall Study|Did not complete End of Study follow-up|0|||
144404552|NCT03208127|520690436|FG000|Overall Study|Death|1|||
144404553|NCT04154930|520690441|FG000|Overall Study|Withdrawal by Subject|15|||
144404554|NCT04154930|520690442|FG001|Overall Study|Withdrawal by Subject|6|||
144404555|NCT04154930|520690441|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
144404556|NCT04154930|520690442|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
144404557|NCT04154930|520690441|FG000|Overall Study|Lost to Follow-up|14|||
144404558|NCT04154930|520690442|FG001|Overall Study|Lost to Follow-up|6|||
144404559|NCT04154930|520690441|FG000|Overall Study|Other|6|||
144404560|NCT04154930|520690442|FG001|Overall Study|Other|0|||
144404561|NCT00590135|520690443|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
144404562|NCT01449539|520690448|FG000|Overall Study|Withdrawal by Subject|3|||
144404563|NCT01449539|520690448|FG000|Overall Study|Toxicity not study related|1|||
144404564|NCT01972568|520690453|FG000|Overall Study|Other events|3|||
144404565|NCT01972568|520690454|FG001|Overall Study|Other events|0|||
144404566|NCT01972568|520690455|FG002|Overall Study|Other events|0|||
144404567|NCT01972568|520690453|FG000|Overall Study|Lack of Efficacy|0|||
144404568|NCT01972568|520690454|FG001|Overall Study|Lack of Efficacy|1|||
144404569|NCT01972568|520690455|FG002|Overall Study|Lack of Efficacy|2|||
144404570|NCT01972568|520690453|FG000|Overall Study|Protocol Violation|1|||
144404571|NCT01972568|520690454|FG001|Overall Study|Protocol Violation|2|||
144404572|NCT01972568|520690455|FG002|Overall Study|Protocol Violation|2|||
144404573|NCT01972568|520690453|FG000|Overall Study|Withdrawal by Subject|6|||
144404574|NCT01972568|520690454|FG001|Overall Study|Withdrawal by Subject|3|||
144404575|NCT01972568|520690455|FG002|Overall Study|Withdrawal by Subject|7|||
144404576|NCT01972568|520690453|FG000|Overall Study|Lost to Follow-up|1|||
144404577|NCT01972568|520690454|FG001|Overall Study|Lost to Follow-up|0|||
144404578|NCT01972568|520690455|FG002|Overall Study|Lost to Follow-up|0|||
144404579|NCT01972568|520690453|FG000|Overall Study|Adverse Event|5|||
144404580|NCT01972568|520690454|FG001|Overall Study|Adverse Event|6|||
144404581|NCT01972568|520690455|FG002|Overall Study|Adverse Event|5|||
144404582|NCT00306189|520690456|FG000|Overall Study|Physician Decision|0|||
144404583|NCT00306189|520690457|FG001|Overall Study|Physician Decision|0|||
144404584|NCT00306189|520690458|FG002|Overall Study|Physician Decision|0|||
144404585|NCT00306189|520690459|FG003|Overall Study|Physician Decision|1|||
144404586|NCT00306189|520690456|FG000|Overall Study|Adverse Event|3|||
144404587|NCT00306189|520690457|FG001|Overall Study|Adverse Event|3|||
144404588|NCT00306189|520690458|FG002|Overall Study|Adverse Event|2|||
144404589|NCT00306189|520690459|FG003|Overall Study|Adverse Event|2|||
144404590|NCT00306189|520690456|FG000|Overall Study|Withdrawal by Subject|4|||
144404591|NCT00306189|520690457|FG001|Overall Study|Withdrawal by Subject|2|||
144404592|NCT00306189|520690458|FG002|Overall Study|Withdrawal by Subject|8|||
144404593|NCT00306189|520690459|FG003|Overall Study|Withdrawal by Subject|1|||
144404594|NCT00306189|520690456|FG000|Overall Study|Ineligibility determined|1|||
144404595|NCT00306189|520690457|FG001|Overall Study|Ineligibility determined|1|||
144404596|NCT00306189|520690458|FG002|Overall Study|Ineligibility determined|1|||
144404597|NCT00306189|520690459|FG003|Overall Study|Ineligibility determined|1|||
144404598|NCT00306189|520690456|FG000|Overall Study|Other|1|||
144404599|NCT00306189|520690457|FG001|Overall Study|Other|0|||
144404600|NCT00306189|520690458|FG002|Overall Study|Other|0|||
144404601|NCT00306189|520690459|FG003|Overall Study|Other|0|||
144404602|NCT02059408|520690460|FG000|Overall Study|Did not get tested|0|||
144404603|NCT02059408|520690461|FG001|Overall Study|Did not get tested|330|||
144404604|NCT02059408|520690462|FG002|Overall Study|Did not get tested|358|||
144404605|NCT02993757|520690463|FG000|Overall Study|Non compliance with the protocol|155|||
144404606|NCT02993757|520690464|FG001|Overall Study|Non compliance with the protocol|170|||
144524892|NCT04436276|521122041|FG002|Overall Study|Protocol Violation|0|||
144524893|NCT04436276|521122042|FG003|Overall Study|Protocol Violation|0|||
144524894|NCT04436276|521122043|FG004|Overall Study|Protocol Violation|0|||
144524895|NCT04436276|521122044|FG005|Overall Study|Protocol Violation|0|||
144524896|NCT04436276|521122045|FG006|Overall Study|Protocol Violation|0|||
144524897|NCT04436276|521122046|FG007|Overall Study|Protocol Violation|0|||
144524898|NCT04436276|521122047|FG008|Overall Study|Protocol Violation|0|||
144524899|NCT04436276|521122048|FG009|Overall Study|Protocol Violation|0|||
144524900|NCT04436276|521122049|FG010|Overall Study|Protocol Violation|0|||
144524901|NCT04436276|521122050|FG011|Overall Study|Protocol Violation|0|||
144524902|NCT04436276|521122051|FG012|Overall Study|Protocol Violation|0|||
144524903|NCT04436276|521122052|FG013|Overall Study|Protocol Violation|1|||
144249988|NCT00153816|520113427|FG003|Overall Study|Lost to Follow-up|8|||
144404607|NCT02993757|520690463|FG000|Overall Study|Lost to Follow-up|1|||
144404608|NCT02993757|520690464|FG001|Overall Study|Lost to Follow-up|0|||
144404609|NCT02993757|520690463|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
144404610|NCT02993757|520690464|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
144404611|NCT00957580|520690465|FG000|Overall Study|Ongoing at data cut-off|0|||
144404612|NCT00957580|520690466|FG001|Overall Study|Ongoing at data cut-off|1|||
144404613|NCT00957580|520690467|FG002|Overall Study|Ongoing at data cut-off|0|||
144404614|NCT00957580|520690465|FG000|Overall Study|Enrolled but not treated|0|||
144404615|NCT00957580|520690466|FG001|Overall Study|Enrolled but not treated|1|||
144404616|NCT00957580|520690467|FG002|Overall Study|Enrolled but not treated|0|||
144404617|NCT02699593|520690473|FG000|Period 1|Unsatisfactory Visual Response|0|||
144404618|NCT02699593|520690474|FG001|Period 1|Unsatisfactory Visual Response|1|||
144404619|NCT02699593|520690473|FG000|Period 1|Torn Contact Len|4|||
144404620|NCT02699593|520690474|FG001|Period 1|Torn Contact Len|3|||
144404621|NCT02699593|520690473|FG000|Period 1|Protocol Violation|0|||
144404622|NCT02699593|520690474|FG001|Period 1|Protocol Violation|1|||
144404623|NCT02699593|520690473|FG000|Period 1|Withdrawal by Subject|0|||
144404624|NCT02699593|520690474|FG001|Period 1|Withdrawal by Subject|1|||
144404625|NCT02699593|520690473|FG000|Period 1|Adverse Event|1|||
144404626|NCT02699593|520690474|FG001|Period 1|Adverse Event|1|||
144404627|NCT02699593|520690473|FG000|Period 2|Adverse Event|1|||
144404628|NCT02699593|520690474|FG001|Period 2|Adverse Event|1|||
144404629|NCT02699593|520690473|FG000|Period 2|Lost Contact Lens|0|||
144404630|NCT02699593|520690474|FG001|Period 2|Lost Contact Lens|1|||
144404631|NCT02699593|520690473|FG000|Period 2|Torn Contact Lens|1|||
144404632|NCT02699593|520690474|FG001|Period 2|Torn Contact Lens|0|||
144404633|NCT01681472|520690475|FG000|Overall Study|Adverse Event|0|||
144404634|NCT01681472|520690476|FG001|Overall Study|Adverse Event|1|||
144404635|NCT01681472|520690477|FG002|Overall Study|Adverse Event|0|||
144404636|NCT01681472|520690478|FG003|Overall Study|Adverse Event|0|||
144404637|NCT01696071|520690491|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
144404638|NCT01696071|520690492|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
144404639|NCT02764697|520690493|FG000|Overall Study|Lack of Efficacy|3|||
144404640|NCT00672646|520690494|FG000|Overall Study|Lost to Follow-up|0|||
144404641|NCT00672646|520690495|FG001|Overall Study|Lost to Follow-up|1|||
144404642|NCT00672646|520690496|FG002|Overall Study|Lost to Follow-up|2|||
144404643|NCT00672646|520690494|FG000|Overall Study|Withdrawal by Subject|0|||
144404644|NCT00672646|520690495|FG001|Overall Study|Withdrawal by Subject|0|||
144404645|NCT00672646|520690496|FG002|Overall Study|Withdrawal by Subject|1|||
144404646|NCT01999179|520690497|FG000|Overall Study|Adverse Event|1|||
144404647|NCT01999179|520690497|FG000|Overall Study|Lost to Follow-up|1|||
144404648|NCT01999179|520690497|FG000|Overall Study|Change in Therapy|3|||
144404649|NCT01999179|520690497|FG000|Overall Study|New catheter|2|||
144404650|NCT03298867|520690505|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
144404651|NCT03298867|520690506|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
144404652|NCT03298867|520690505|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
144404653|NCT03298867|520690506|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
144404654|NCT03298867|520690505|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
144404655|NCT03298867|520690506|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
144404656|NCT03298867|520690505|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
144404657|NCT03298867|520690506|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
144404658|NCT03298867|520690505|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
144249989|NCT00153816|520113428|FG004|Overall Study|Lost to Follow-up|7|||
144249990|NCT00153816|520113429|FG005|Overall Study|Lost to Follow-up|9|||
144524904|NCT04436276|521122053|FG014|Overall Study|Protocol Violation|0|||
144524905|NCT04436276|521122054|FG015|Overall Study|Protocol Violation|1|||
144524906|NCT04436276|521122055|FG016|Overall Study|Protocol Violation|0|||
144524907|NCT04436276|521122056|FG017|Overall Study|Protocol Violation|0|||
144524908|NCT04436276|521122057|FG018|Overall Study|Protocol Violation|0|||
144524909|NCT04436276|521122058|FG019|Overall Study|Protocol Violation|0|||
144524910|NCT04436276|521122059|FG020|Overall Study|Protocol Violation|0|||
144524911|NCT04436276|521122060|FG021|Overall Study|Protocol Violation|0|||
144599281|NCT03338192|521396136|FG000|Year Four to Year Six|High Blood Pressure|2|||
144599282|NCT03338192|521396137|FG001|Year Four to Year Six|High Blood Pressure|1|||
144599283|NCT03329196|521396138|FG000|Overall Study|Adverse Event|10|||
144599284|NCT03329196|521396139|FG001|Overall Study|Adverse Event|5|||
144404659|NCT03298867|520690506|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
144404660|NCT03298867|520690505|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
144404661|NCT03298867|520690506|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
144404662|NCT03298867|520690505|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
144404663|NCT03298867|520690506|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
144404664|NCT03298867|520690505|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
144524912|NCT04436276|521122061|FG022|Overall Study|Protocol Violation|0|||
144524913|NCT04436276|521122039|FG000|Overall Study|Withdrawal by Subject|25|||
144524914|NCT04436276|521122040|FG001|Overall Study|Withdrawal by Subject|22|||
144599285|NCT03329196|521396138|FG000|Overall Study|Physician Decision|2|||
144599286|NCT03329196|521396139|FG001|Overall Study|Physician Decision|2|||
144599287|NCT03329196|521396138|FG000|Overall Study|Withdrawal by Subject|11|||
144404665|NCT03298867|520690506|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
144404666|NCT03298867|520690505|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
144404667|NCT03298867|520690506|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
144404668|NCT01752985|520690509|FG000|Treatment Period|Subject request to discontinue treatment|1|||
144404669|NCT01752985|520690510|FG001|Treatment Period|Subject request to discontinue treatment|0|||
144404670|NCT01752985|520690511|FG002|Treatment Period|Subject request to discontinue treatment|1|||
144404671|NCT01752985|520690509|FG000|Treatment Period|Subject no longer meets study criteria|0|||
144404672|NCT01752985|520690510|FG001|Treatment Period|Subject no longer meets study criteria|1|||
144404673|NCT01752985|520690511|FG002|Treatment Period|Subject no longer meets study criteria|1|||
144404674|NCT01752985|520690509|FG000|Treatment Period|Adverse Event|2|||
144404675|NCT01752985|520690510|FG001|Treatment Period|Adverse Event|1|||
144404676|NCT01752985|520690511|FG002|Treatment Period|Adverse Event|2|||
144404677|NCT01752985|520690509|FG000|Treatment Period|Withdrawal by Subject|1|||
144404678|NCT01752985|520690510|FG001|Treatment Period|Withdrawal by Subject|1|||
144404679|NCT01752985|520690511|FG002|Treatment Period|Withdrawal by Subject|0|||
144404680|NCT01752985|520690509|FG000|Treatment Period|Lost to Follow-up|0|||
144404681|NCT01752985|520690510|FG001|Treatment Period|Lost to Follow-up|0|||
144404682|NCT01752985|520690511|FG002|Treatment Period|Lost to Follow-up|1|||
144404683|NCT05147428|520690512|FG000|Overall Study|Removed prior to mailing|289|||
144404684|NCT05147428|520690513|FG001|Overall Study|Removed prior to mailing|306|||
144404685|NCT05147428|520690514|FG002|Overall Study|Removed prior to mailing|270|||
144404686|NCT05147428|520690512|FG000|Overall Study|Died or disenrolled during blackout period|239|||
144404687|NCT05147428|520690513|FG001|Overall Study|Died or disenrolled during blackout period|278|||
144404688|NCT05147428|520690514|FG002|Overall Study|Died or disenrolled during blackout period|273|||
144404689|NCT00094172|520692254|FG000|Overall Study|Adverse Event|0|||
144404690|NCT00094172|520692255|FG001|Overall Study|Adverse Event|1|||
144404691|NCT00094172|520692254|FG000|Overall Study|Lost to Follow-up|2|||
144404692|NCT00094172|520692255|FG001|Overall Study|Lost to Follow-up|0|||
144404693|NCT00094172|520692254|FG000|Overall Study|Protocol Violation|0|||
144404694|NCT00094172|520692255|FG001|Overall Study|Protocol Violation|1|||
144404695|NCT00094172|520692254|FG000|Overall Study|Withdrawal by Subject|10|||
144404696|NCT00094172|520692255|FG001|Overall Study|Withdrawal by Subject|5|||
144404697|NCT00094172|520692254|FG000|Overall Study|Primary endpoint met.|1|||
144404698|NCT00094172|520692255|FG001|Overall Study|Primary endpoint met.|0|||
144404699|NCT00094172|520692254|FG000|Overall Study|Started other MS therapy due to disease|1|||
144404700|NCT00094172|520692255|FG001|Overall Study|Started other MS therapy due to disease|0|||
144404701|NCT01020981|520692256|FG000|Overall Study|Did not return mailed survey|74|||
144404702|NCT01020981|520692257|FG001|Overall Study|Did not return mailed survey|58|||
144404703|NCT01020981|520692256|FG000|Overall Study|Survey returned undeliverable|8|||
144404704|NCT01020981|520692257|FG001|Overall Study|Survey returned undeliverable|32|||
144404705|NCT01020981|520692256|FG000|Overall Study|Participant declined to complete survey|2|||
144404706|NCT01020981|520692257|FG001|Overall Study|Participant declined to complete survey|0|||
144404707|NCT00289133|520692262|FG000|Overall Study|Non-study device implanted|12|||
144404708|NCT00289133|520692263|FG001|Overall Study|Non-study device implanted|0|||
144404709|NCT00289133|520692262|FG000|Overall Study|Protocol Violation|32|||
144404710|NCT00289133|520692263|FG001|Overall Study|Protocol Violation|38|||
144404711|NCT00289133|520692262|FG000|Overall Study|Withdrawal by Subject|9|||
144404712|NCT00289133|520692263|FG001|Overall Study|Withdrawal by Subject|10|||
144404713|NCT00289133|520692262|FG000|Overall Study|Death|5|||
144404714|NCT00289133|520692263|FG001|Overall Study|Death|10|||
144404715|NCT00289133|520692262|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
144404716|NCT00289133|520692263|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
144404717|NCT00289133|520692262|FG000|Overall Study|Physician Decision|41|||
144404718|NCT00289133|520692263|FG001|Overall Study|Physician Decision|45|||
144404719|NCT00289133|520692262|FG000|Overall Study|Revision|8|||
144404720|NCT00289133|520692263|FG001|Overall Study|Revision|6|||
144404721|NCT00289133|520692262|FG000|Overall Study|Lost to Follow-up|92|||
144404722|NCT00289133|520692263|FG001|Overall Study|Lost to Follow-up|115|||
144404723|NCT03372096|520692268|FG000|Overall Study|Study Closed|8|||
144599288|NCT03329196|521396139|FG001|Overall Study|Withdrawal by Subject|3|||
144599289|NCT03329196|521396138|FG000|Overall Study|Hepatic function abnormalities|0|||
144599290|NCT03329196|521396139|FG001|Overall Study|Hepatic function abnormalities|1|||
144599291|NCT03329196|521396138|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
144599292|NCT03329196|521396139|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
144599293|NCT03329196|521396138|FG000|Overall Study|Difficult to control Hb|2|||
144404724|NCT00541931|520692269|FG000|Overall Study|Adverse Event|1|||
144404725|NCT00541931|520692270|FG001|Overall Study|Adverse Event|0|||
144404726|NCT00541931|520692269|FG000|Overall Study|Lost to Follow-up|3|||
144404727|NCT00541931|520692270|FG001|Overall Study|Lost to Follow-up|3|||
144404728|NCT00541931|520692269|FG000|Overall Study|Withdrawal by Subject|1|||
144599294|NCT03329196|521396139|FG001|Overall Study|Difficult to control Hb|3|||
144599295|NCT03329196|521396138|FG000|Overall Study|Dialysis or renal transplant|13|||
144599296|NCT03329196|521396139|FG001|Overall Study|Dialysis or renal transplant|15|||
144599297|NCT01128361|521396142|FG000|Overall Study|Lost to Follow-up|0|||
144404729|NCT00541931|520692270|FG001|Overall Study|Withdrawal by Subject|0|||
144404730|NCT00541931|520692269|FG000|Overall Study|Transportation Issue|0|||
144404731|NCT00541931|520692270|FG001|Overall Study|Transportation Issue|1|||
144404732|NCT01947582|520692274|FG000|Overall Study|Withdrawal by Subject|1|||
144404733|NCT00064337|520692275|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
144404734|NCT00064337|520692275|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
144404735|NCT00064337|520692275|FG000|PBSCC or Induction/PBSCC|Progression|3|||
144404736|NCT00064337|520692275|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
144404737|NCT00064337|520692275|FG000|PBSCC or Induction/PBSCC|Death|2|||
144404738|NCT00064337|520692275|FG000|Transplant|Adverse Event|9|||
144404739|NCT00064337|520692275|FG000|Transplant|Not protocol-specified|5|||
144404740|NCT00064337|520692275|FG000|Transplant|Death|3|||
144404741|NCT00064337|520692275|FG000|Transplant|Patient Refusal|2|||
144404742|NCT00064337|520692275|FG000|Transplant|Progression|2|||
144404743|NCT00064337|520692275|FG000|Maintenance|Adverse Event|3|||
144404744|NCT00064337|520692275|FG000|Maintenance|Progression|2|||
144404745|NCT00064337|520692275|FG000|Maintenance|On treatment at time of analysis|2|||
144404746|NCT00064337|520692275|FG000|Maintenance|Not protocol-specified|2|||
144404747|NCT00064337|520692275|FG000|Maintenance|Death|1|||
144404748|NCT00612040|520692276|FG000|Overall Study|Adverse Event|0|||
144404749|NCT00612040|520692277|FG001|Overall Study|Adverse Event|2|||
144404750|NCT00612040|520692278|FG002|Overall Study|Adverse Event|1|||
144404751|NCT00612040|520692276|FG000|Overall Study|Protocol Violation|1|||
144404752|NCT00612040|520692277|FG001|Overall Study|Protocol Violation|2|||
144404753|NCT00612040|520692278|FG002|Overall Study|Protocol Violation|1|||
144404754|NCT00612040|520692276|FG000|Overall Study|Lack of Efficacy|2|||
144404755|NCT00612040|520692277|FG001|Overall Study|Lack of Efficacy|1|||
144404756|NCT00612040|520692278|FG002|Overall Study|Lack of Efficacy|0|||
144404757|NCT00612040|520692276|FG000|Overall Study|Unclassified|2|||
144404758|NCT00612040|520692277|FG001|Overall Study|Unclassified|2|||
144404759|NCT00612040|520692278|FG002|Overall Study|Unclassified|5|||
144404760|NCT00827502|520692279|FG000|Overall Study|randomized but not treated|11|||
144404761|NCT00827502|520692279|FG000|Overall Study|Adverse Event|1|||
144404762|NCT00827502|520692279|FG000|Overall Study|Lost to Follow-up|4|||
144404763|NCT00827502|520692279|FG000|Overall Study|Withdrawal by Subject|5|||
144404764|NCT01397890|520692284|FG000|Overall Study|Withdrawal by Subject|7|||
144404765|NCT01397890|520692285|FG001|Overall Study|Withdrawal by Subject|11|||
144404766|NCT01397890|520692284|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
144404767|NCT01397890|520692285|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
144404768|NCT01397890|520692284|FG000|Overall Study|Death|2|||
144404769|NCT01397890|520692285|FG001|Overall Study|Death|3|||
144404770|NCT01397890|520692284|FG000|Overall Study|Lost to Follow-up|1|||
144404771|NCT01397890|520692285|FG001|Overall Study|Lost to Follow-up|4|||
144404772|NCT01397890|520692284|FG000|Overall Study|Condition under Investigation Worsened|1|||
144404773|NCT01397890|520692285|FG001|Overall Study|Condition under Investigation Worsened|3|||
144404774|NCT01397890|520692284|FG000|Overall Study|Adverse Event|1|||
144404775|NCT01397890|520692285|FG001|Overall Study|Adverse Event|2|||
144404776|NCT01397890|520692284|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
144404777|NCT01397890|520692285|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
144404778|NCT01397890|520692284|FG000|Overall Study|Others|2|||
144404779|NCT01397890|520692285|FG001|Overall Study|Others|1|||
144404780|NCT02924571|520692286|FG000|Overall Study|Lost to Follow-up|1|||
144404781|NCT02924571|520692287|FG001|Overall Study|Lost to Follow-up|1|||
144404782|NCT02924571|520692288|FG002|Overall Study|Lost to Follow-up|0|||
144404783|NCT00434954|520692292|FG000|Overall Study|Adverse Event|17|||
144404784|NCT00434954|520692293|FG001|Overall Study|Adverse Event|2|||
144404785|NCT00434954|520692292|FG000|Overall Study|Entry criteria not met|14|||
144404786|NCT00434954|520692293|FG001|Overall Study|Entry criteria not met|16|||
144404787|NCT00434954|520692292|FG000|Overall Study|Lost to Follow-up|0|||
144404788|NCT00434954|520692293|FG001|Overall Study|Lost to Follow-up|1|||
144404789|NCT00434954|520692292|FG000|Overall Study|Physician Decision|6|||
144404790|NCT00434954|520692293|FG001|Overall Study|Physician Decision|3|||
144404791|NCT00434954|520692292|FG000|Overall Study|Protocol Violation|36|||
144404792|NCT00434954|520692293|FG001|Overall Study|Protocol Violation|27|||
144404793|NCT00434954|520692292|FG000|Overall Study|Sponsor decision|1|||
144404794|NCT00434954|520692293|FG001|Overall Study|Sponsor decision|0|||
144404795|NCT00434954|520692292|FG000|Overall Study|Subject decision|8|||
144404796|NCT00434954|520692293|FG001|Overall Study|Subject decision|22|||
144404797|NCT03417219|520692302|FG000|Overall Study|Lost to Follow-up|0|||
144404798|NCT03417219|520692303|FG001|Overall Study|Lost to Follow-up|3|||
144404799|NCT03345914|520692304|FG000|Overall Study|Transition to another study at week 16|80|||
144404800|NCT03345914|520692305|FG001|Overall Study|Transition to another study at week 16|86|||
144404801|NCT03345914|520692306|FG002|Overall Study|Transition to another study at week 16|78|||
144404802|NCT03345914|520692304|FG000|Overall Study|Transition to OLE during follow-up|37|||
144404803|NCT03345914|520692305|FG001|Overall Study|Transition to OLE during follow-up|33|||
144404804|NCT03345914|520692306|FG002|Overall Study|Transition to OLE during follow-up|39|||
144404805|NCT03345914|520692304|FG000|Overall Study|Physician Decision|0|||
144404806|NCT03345914|520692305|FG001|Overall Study|Physician Decision|1|||
144404807|NCT03345914|520692306|FG002|Overall Study|Physician Decision|1|||
144404808|NCT03345914|520692304|FG000|Overall Study|Withdrawal by Subject|5|||
144404809|NCT03345914|520692305|FG001|Overall Study|Withdrawal by Subject|1|||
144404810|NCT03345914|520692306|FG002|Overall Study|Withdrawal by Subject|2|||
144404811|NCT03345914|520692304|FG000|Overall Study|Other|1|||
144404812|NCT03345914|520692305|FG001|Overall Study|Other|1|||
144404813|NCT03345914|520692306|FG002|Overall Study|Other|1|||
144404814|NCT03345914|520692304|FG000|Overall Study|Ongoing|0|||
144404815|NCT03345914|520692305|FG001|Overall Study|Ongoing|0|||
144404816|NCT03345914|520692306|FG002|Overall Study|Ongoing|1|||
144404817|NCT02609828|520692307|FG000|Overall Study|Adverse Event|8|||
144404818|NCT02609828|520692308|FG001|Overall Study|Adverse Event|1|||
144404819|NCT02609828|520692309|FG002|Overall Study|Adverse Event|0|||
144404820|NCT02609828|520692310|FG003|Overall Study|Adverse Event|6|||
144404821|NCT02609828|520692307|FG000|Overall Study|Death|15|||
144404822|NCT02609828|520692308|FG001|Overall Study|Death|1|||
144404823|NCT02609828|520692309|FG002|Overall Study|Death|1|||
144404824|NCT02609828|520692310|FG003|Overall Study|Death|19|||
144404825|NCT02609828|520692307|FG000|Overall Study|Insufficient clinical response|2|||
144404826|NCT02609828|520692308|FG001|Overall Study|Insufficient clinical response|1|||
144404827|NCT02609828|520692309|FG002|Overall Study|Insufficient clinical response|0|||
144404828|NCT02609828|520692310|FG003|Overall Study|Insufficient clinical response|0|||
144404829|NCT02609828|520692307|FG000|Overall Study|Lost to Follow-up|0|||
144404830|NCT02609828|520692308|FG001|Overall Study|Lost to Follow-up|0|||
144404831|NCT02609828|520692309|FG002|Overall Study|Lost to Follow-up|0|||
144404832|NCT02609828|520692310|FG003|Overall Study|Lost to Follow-up|1|||
144404833|NCT02609828|520692307|FG000|Overall Study|Protocol Violation|2|||
144404834|NCT02609828|520692308|FG001|Overall Study|Protocol Violation|0|||
144404835|NCT02609828|520692309|FG002|Overall Study|Protocol Violation|0|||
144404836|NCT02609828|520692310|FG003|Overall Study|Protocol Violation|1|||
144404837|NCT02609828|520692307|FG000|Overall Study|Withdrawal by Subject|12|||
144404838|NCT02609828|520692308|FG001|Overall Study|Withdrawal by Subject|1|||
144404839|NCT02609828|520692309|FG002|Overall Study|Withdrawal by Subject|0|||
144404840|NCT02609828|520692310|FG003|Overall Study|Withdrawal by Subject|10|||
144404841|NCT02609828|520692307|FG000|Overall Study|Other|3|||
144404842|NCT02609828|520692308|FG001|Overall Study|Other|0|||
144404843|NCT02609828|520692309|FG002|Overall Study|Other|0|||
144404844|NCT02609828|520692310|FG003|Overall Study|Other|6|||
144404845|NCT02609828|520692307|FG000|Overall Study|Randomized but not treated|1|||
144404846|NCT02609828|520692308|FG001|Overall Study|Randomized but not treated|0|||
144404847|NCT02609828|520692309|FG002|Overall Study|Randomized but not treated|0|||
144404848|NCT02609828|520692310|FG003|Overall Study|Randomized but not treated|0|||
144404849|NCT00319553|520692311|FG000|Overall Study|Protocol Violation|1|||
144404850|NCT00319553|520692312|FG001|Overall Study|Protocol Violation|2|||
144404851|NCT00319553|520692311|FG000|Overall Study|Lost to Follow-up|2|||
144404852|NCT00319553|520692312|FG001|Overall Study|Lost to Follow-up|1|||
144404853|NCT00319553|520692311|FG000|Overall Study|Withdrawal by Subject|1|||
144404854|NCT00319553|520692312|FG001|Overall Study|Withdrawal by Subject|1|||
144404855|NCT00446251|520692316|FG000|Overall Study|On-study Transplants|2|||
144404856|NCT00446251|520692316|FG000|Overall Study|Rituximab Infusion Reaction|2|||
144404857|NCT00446251|520692316|FG000|Overall Study|Lost to Follow-up|1|||
144404858|NCT02319837|520692318|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
144404859|NCT02319837|520692319|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
144404860|NCT02319837|520692320|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
144404861|NCT02319837|520692318|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
144404862|NCT02319837|520692319|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
144404863|NCT02319837|520692320|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
144404864|NCT02319837|520692318|FG000|Study Treatment Phase|Adverse Event|73|||
144404865|NCT02319837|520692319|FG001|Study Treatment Phase|Adverse Event|36|||
144404866|NCT02319837|520692320|FG002|Study Treatment Phase|Adverse Event|63|||
144404867|NCT02319837|520692318|FG000|Study Treatment Phase|Development of castration resistance|0|||
144404868|NCT02319837|520692319|FG001|Study Treatment Phase|Development of castration resistance|2|||
144404869|NCT02319837|520692320|FG002|Study Treatment Phase|Development of castration resistance|0|||
144404870|NCT02319837|520692318|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
144404871|NCT02319837|520692319|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
144404872|NCT02319837|520692320|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
144404873|NCT02319837|520692318|FG000|Study Treatment Phase|Protocol Violation|2|||
144404874|NCT02319837|520692319|FG001|Study Treatment Phase|Protocol Violation|2|||
144404875|NCT02319837|520692320|FG002|Study Treatment Phase|Protocol Violation|1|||
144404876|NCT02319837|520692318|FG000|Study Treatment Phase|Lost to Follow-up|0|||
144404877|NCT02319837|520692319|FG001|Study Treatment Phase|Lost to Follow-up|1|||
144404878|NCT02319837|520692320|FG002|Study Treatment Phase|Lost to Follow-up|0|||
144404879|NCT02319837|520692318|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
144404880|NCT02319837|520692319|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
144404881|NCT02319837|520692320|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
144404882|NCT02319837|520692318|FG000|Study Treatment Phase|Other|0|||
144404883|NCT02319837|520692319|FG001|Study Treatment Phase|Other|1|||
144404884|NCT02319837|520692320|FG002|Study Treatment Phase|Other|0|||
144404885|NCT02319837|520692318|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
144404886|NCT02319837|520692319|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
144404887|NCT02319837|520692320|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
144404888|NCT02319837|520692318|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
144404889|NCT02319837|520692319|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
144404890|NCT02319837|520692320|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
144404891|NCT02319837|520692318|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
144404892|NCT02319837|520692319|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
144404893|NCT02319837|520692320|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
144404894|NCT02319837|520692318|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
144404895|NCT02319837|520692319|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
144404896|NCT02319837|520692320|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
144404897|NCT02319837|520692318|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
144404898|NCT02319837|520692319|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
144404899|NCT02319837|520692320|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
144404900|NCT02319837|520692318|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
144404901|NCT02319837|520692319|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
144404902|NCT02319837|520692320|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
144404903|NCT02319837|520692318|FG000|Long-Term Follow-Up Phase|Death|33|||
144404904|NCT02319837|520692319|FG001|Long-Term Follow-Up Phase|Death|54|||
144404905|NCT02319837|520692320|FG002|Long-Term Follow-Up Phase|Death|42|||
144404906|NCT00753766|520692323|FG000|Overall Study|Physician Decision|1|||
144404907|NCT00753766|520692324|FG001|Overall Study|Physician Decision|0|||
144404908|NCT04545554|520692329|FG000|Overall Study|Withdrawal by Subject|0|||
144404909|NCT04545554|520692330|FG001|Overall Study|Withdrawal by Subject|0|||
144404910|NCT04545554|520692331|FG002|Overall Study|Withdrawal by Subject|0|||
144404911|NCT04545554|520692332|FG003|Overall Study|Withdrawal by Subject|1|||
144404912|NCT04545554|520692333|FG004|Overall Study|Withdrawal by Subject|0|||
144404913|NCT04545554|520692334|FG005|Overall Study|Withdrawal by Subject|0|||
144404914|NCT00494299|520692337|FG000|Overall Study|Adverse Event|93|||
144404915|NCT00494299|520692338|FG001|Overall Study|Adverse Event|13|||
144404916|NCT00494299|520692337|FG000|Overall Study|Lost to Follow-up|1|||
144404917|NCT00494299|520692338|FG001|Overall Study|Lost to Follow-up|0|||
144404918|NCT00494299|520692337|FG000|Overall Study|Physician Decision|0|||
144404919|NCT00494299|520692338|FG001|Overall Study|Physician Decision|2|||
144404920|NCT00494299|520692337|FG000|Overall Study|Protocol Violation|1|||
144404921|NCT00494299|520692338|FG001|Overall Study|Protocol Violation|2|||
144404922|NCT00494299|520692337|FG000|Overall Study|Withdrawal by Subject|8|||
144404923|NCT00494299|520692338|FG001|Overall Study|Withdrawal by Subject|3|||
144404924|NCT00494299|520692337|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
144404925|NCT00494299|520692338|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
144404926|NCT00494299|520692337|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
144404927|NCT00494299|520692338|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
144404928|NCT00494299|520692337|FG000|Overall Study|Site Closed by Sponsor|6|||
144404929|NCT00494299|520692338|FG001|Overall Study|Site Closed by Sponsor|0|||
144404930|NCT00494299|520692337|FG000|Overall Study|Protocol Driven Decision Point|11|||
144404931|NCT00494299|520692338|FG001|Overall Study|Protocol Driven Decision Point|22|||
144404932|NCT01281137|520692339|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
144404933|NCT01281137|520692340|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
144404934|NCT01281137|520692339|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
144404935|NCT01281137|520692340|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
144404936|NCT01281137|520692339|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
144404937|NCT01281137|520692340|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
144524915|NCT04436276|521122041|FG002|Overall Study|Withdrawal by Subject|24|||
144524916|NCT04436276|521122042|FG003|Overall Study|Withdrawal by Subject|23|||
144524917|NCT04436276|521122043|FG004|Overall Study|Withdrawal by Subject|14|||
144524918|NCT04436276|521122044|FG005|Overall Study|Withdrawal by Subject|0|||
144524919|NCT04436276|521122045|FG006|Overall Study|Withdrawal by Subject|0|||
144524920|NCT04436276|521122046|FG007|Overall Study|Withdrawal by Subject|1|||
144404938|NCT01281137|520692339|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
144404939|NCT01281137|520692340|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
144404940|NCT01281137|520692339|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
144404941|NCT01281137|520692340|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
144599298|NCT01128361|521396143|FG001|Overall Study|Lost to Follow-up|1|||
144599299|NCT01128361|521396142|FG000|Overall Study|Withdrawal by Subject|5|||
144404942|NCT01313312|520692345|FG000|Overall Study|Adverse Event|5|||
144404943|NCT01313312|520692345|FG000|Overall Study|Withdrawal by Subject|18|||
144404944|NCT01313312|520692345|FG000|Overall Study|Lack of Efficacy|3|||
144404945|NCT01313312|520692345|FG000|Overall Study|Investigator Decision|1|||
144404946|NCT01313312|520692345|FG000|Overall Study|Observational Phase|1|||
144404947|NCT01313312|520692345|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
144404948|NCT01313312|520692345|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
144404949|NCT04295772|520692346|FG000|Overall Study|Protocol Violation|1|||
144404950|NCT04295772|520692347|FG001|Overall Study|Protocol Violation|0|||
144404951|NCT04295772|520692346|FG000|Overall Study|Ongoing for safety monitoring|14|||
144404952|NCT04295772|520692347|FG001|Overall Study|Ongoing for safety monitoring|1|||
144404953|NCT04295772|520692346|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
144404954|NCT04295772|520692347|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
144404955|NCT01206166|520692348|FG000|Overall Study|No evaluable data|2|||
144404956|NCT01206166|520692349|FG001|Overall Study|No evaluable data|3|||
144404957|NCT02716805|520692350|FG000|Overall Study|Progressive disease|2|||
144404958|NCT02716805|520692351|FG001|Overall Study|Progressive disease|0|||
144404959|NCT02716805|520692352|FG002|Overall Study|Progressive disease|0|||
144404960|NCT02716805|520692353|FG003|Overall Study|Progressive disease|0|||
144404961|NCT00932126|520692354|FG000|Overall Study|Adverse Event|0|||
144404962|NCT00932126|520692355|FG001|Overall Study|Adverse Event|0|||
144599300|NCT01128361|521396143|FG001|Overall Study|Withdrawal by Subject|2|||
144599301|NCT01929980|521396144|FG000|Overall Study|Physician Decision|1|||
144404963|NCT00932126|520692356|FG002|Overall Study|Adverse Event|0|||
144404964|NCT00932126|520692357|FG003|Overall Study|Adverse Event|0|||
144404965|NCT00932126|520692358|FG004|Overall Study|Adverse Event|0|||
144404966|NCT00932126|520692359|FG005|Overall Study|Adverse Event|0|||
144404967|NCT00932126|520692360|FG006|Overall Study|Adverse Event|1|||
144404968|NCT00932126|520692361|FG007|Overall Study|Adverse Event|2|||
144404969|NCT00932126|520692354|FG000|Overall Study|Protocol Violation|0|||
144404970|NCT00932126|520692355|FG001|Overall Study|Protocol Violation|0|||
144404971|NCT00932126|520692356|FG002|Overall Study|Protocol Violation|0|||
144404972|NCT00932126|520692357|FG003|Overall Study|Protocol Violation|0|||
144404973|NCT00932126|520692358|FG004|Overall Study|Protocol Violation|1|||
144599302|NCT04082429|521396145|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
144599303|NCT04082429|521396146|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
144404974|NCT00932126|520692359|FG005|Overall Study|Protocol Violation|0|||
144404975|NCT00932126|520692360|FG006|Overall Study|Protocol Violation|0|||
144404976|NCT00932126|520692361|FG007|Overall Study|Protocol Violation|0|||
144404977|NCT00932126|520692354|FG000|Overall Study|Withdrawal by Subject|0|||
144404978|NCT00932126|520692355|FG001|Overall Study|Withdrawal by Subject|0|||
144404979|NCT00932126|520692356|FG002|Overall Study|Withdrawal by Subject|1|||
144404980|NCT00932126|520692357|FG003|Overall Study|Withdrawal by Subject|0|||
144404981|NCT00932126|520692358|FG004|Overall Study|Withdrawal by Subject|0|||
144404982|NCT00932126|520692359|FG005|Overall Study|Withdrawal by Subject|0|||
144404983|NCT00932126|520692360|FG006|Overall Study|Withdrawal by Subject|0|||
144404984|NCT00932126|520692361|FG007|Overall Study|Withdrawal by Subject|1|||
144404985|NCT00932126|520692354|FG000|Overall Study|Objective progression or relapse|3|||
144404986|NCT00932126|520692355|FG001|Overall Study|Objective progression or relapse|3|||
144404987|NCT00932126|520692356|FG002|Overall Study|Objective progression or relapse|2|||
144404988|NCT00932126|520692357|FG003|Overall Study|Objective progression or relapse|3|||
144404989|NCT00932126|520692358|FG004|Overall Study|Objective progression or relapse|3|||
144404990|NCT00932126|520692359|FG005|Overall Study|Objective progression or relapse|3|||
144404991|NCT00932126|520692360|FG006|Overall Study|Objective progression or relapse|3|||
144404992|NCT00932126|520692361|FG007|Overall Study|Objective progression or relapse|5|||
144404993|NCT00932126|520692354|FG000|Overall Study|Other|0|||
144404994|NCT00932126|520692355|FG001|Overall Study|Other|0|||
144404995|NCT00932126|520692356|FG002|Overall Study|Other|0|||
144404996|NCT00932126|520692357|FG003|Overall Study|Other|0|||
144404997|NCT00932126|520692358|FG004|Overall Study|Other|1|||
144404998|NCT00932126|520692359|FG005|Overall Study|Other|0|||
144599304|NCT04082429|521396147|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
144599305|NCT04082429|521396148|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
144599306|NCT04082429|521396149|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
144599307|NCT04082429|521396150|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
144404999|NCT00932126|520692360|FG006|Overall Study|Other|1|||
144405000|NCT00932126|520692361|FG007|Overall Study|Other|2|||
144405001|NCT00066365|520692362|FG000|Overall Study|Adverse Event|1|||
144405002|NCT00066365|520692363|FG001|Overall Study|Adverse Event|0|||
144405003|NCT00066365|520692362|FG000|Overall Study|Lack of Efficacy|15|||
144405004|NCT00066365|520692363|FG001|Overall Study|Lack of Efficacy|12|||
144405005|NCT00066365|520692362|FG000|Overall Study|Physician Decision|1|||
144405006|NCT00066365|520692363|FG001|Overall Study|Physician Decision|0|||
144405007|NCT00066365|520692362|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
144405008|NCT00066365|520692363|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
144405009|NCT00066365|520692362|FG000|Overall Study|Ineligible|4|||
144405010|NCT00066365|520692363|FG001|Overall Study|Ineligible|2|||
144405011|NCT00939640|520692364|FG000|Overall Study|Physician Decision|1|||
144405012|NCT00239590|520692365|FG000|Randomized|Lost to Follow-up|0|||
144599308|NCT04082429|521396151|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
144599309|NCT04082429|521396152|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
144599310|NCT04082429|521396153|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
144599311|NCT04082429|521396145|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599312|NCT04082429|521396146|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599313|NCT04082429|521396147|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599314|NCT04082429|521396148|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599315|NCT04082429|521396149|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
144599316|NCT04082429|521396150|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599317|NCT04082429|521396151|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599318|NCT04082429|521396152|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599319|NCT04082429|521396153|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
144599320|NCT04082429|521396145|FG000|Main Part (After the Treatment Pause)|Death|0|||
144599321|NCT04082429|521396146|FG001|Main Part (After the Treatment Pause)|Death|0|||
144599322|NCT04082429|521396147|FG002|Main Part (After the Treatment Pause)|Death|0|||
144599323|NCT04082429|521396148|FG003|Main Part (After the Treatment Pause)|Death|0|||
144599324|NCT04082429|521396149|FG004|Main Part (After the Treatment Pause)|Death|1|||
144599325|NCT04082429|521396150|FG005|Main Part (After the Treatment Pause)|Death|0|||
144599326|NCT04082429|521396151|FG006|Main Part (After the Treatment Pause)|Death|0|||
144599327|NCT04082429|521396152|FG007|Main Part (After the Treatment Pause)|Death|0|||
144599328|NCT04082429|521396153|FG008|Main Part (After the Treatment Pause)|Death|0|||
144599329|NCT04082429|521396145|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599330|NCT04082429|521396146|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599331|NCT04082429|521396147|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599332|NCT04082429|521396148|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
144405013|NCT00239590|520692366|FG001|Randomized|Lost to Follow-up|1|||
144405014|NCT00239590|520692365|FG000|Randomized|Withdrawal by Subject|0|||
144405015|NCT00239590|520692366|FG001|Randomized|Withdrawal by Subject|1|||
144599333|NCT04082429|521396149|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599334|NCT04082429|521396150|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
144599335|NCT04082429|521396151|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599336|NCT04082429|521396152|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599337|NCT04082429|521396153|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
144599338|NCT04082429|521396145|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
144599339|NCT04082429|521396146|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
144599340|NCT04082429|521396147|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
144405016|NCT00239590|520692365|FG000|Completed Study Protocol|Adverse Event|1|||
144405017|NCT00239590|520692366|FG001|Completed Study Protocol|Adverse Event|1|||
144405018|NCT00239590|520692365|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
144405019|NCT00239590|520692366|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
144405020|NCT00579098|520692367|FG000|Overall Study|Lost to Follow-up|2|||
144599341|NCT04082429|521396148|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
144405021|NCT00579098|520692368|FG001|Overall Study|Lost to Follow-up|0|||
144405022|NCT00579098|520692367|FG000|Overall Study|Adverse Event|2|||
144405023|NCT00579098|520692368|FG001|Overall Study|Adverse Event|3|||
144405024|NCT00579098|520692367|FG000|Overall Study|Withdrawal by Subject|2|||
144405025|NCT00579098|520692368|FG001|Overall Study|Withdrawal by Subject|3|||
144405026|NCT00579098|520692367|FG000|Overall Study|AF returned after ablation|3|||
144405027|NCT00579098|520692368|FG001|Overall Study|AF returned after ablation|2|||
144405028|NCT01254331|520692370|FG000|Initial Phase|Adverse Event|3|||
144405029|NCT01254331|520692370|FG000|Initial Phase|Withdrawal by Subject|1|||
144405030|NCT01254331|520692370|FG000|Initial Phase|Pregnancy|1|||
144405031|NCT01254331|520692370|FG000|Extension Phase|Lack of Efficacy|1|||
144405032|NCT01254331|520692370|FG000|Extension Phase|Lost to Follow-up|3|||
144405033|NCT00289783|520692376|FG000|Primary Phase|Adverse Event|10|||
144405034|NCT00289783|520692377|FG001|Primary Phase|Adverse Event|1|||
144405035|NCT00289783|520692376|FG000|Primary Phase|Protocol Violation|27|||
144405036|NCT00289783|520692377|FG001|Primary Phase|Protocol Violation|6|||
144405037|NCT00289783|520692376|FG000|Primary Phase|Withdrawal by Subject|93|||
144405038|NCT00289783|520692377|FG001|Primary Phase|Withdrawal by Subject|40|||
144405039|NCT00289783|520692376|FG000|Primary Phase|Lost to Follow-up|60|||
144405040|NCT00289783|520692377|FG001|Primary Phase|Lost to Follow-up|14|||
144405041|NCT00289783|520692376|FG000|Primary Phase|Migration from the study area|26|||
144405042|NCT00289783|520692377|FG001|Primary Phase|Migration from the study area|10|||
144405043|NCT00289783|520692376|FG000|Primary Phase|Other|32|||
144405044|NCT00289783|520692377|FG001|Primary Phase|Other|12|||
144405045|NCT00289783|520692376|FG000|Fourth Dose Phase|Adverse Event|1|||
144405046|NCT00289783|520692377|FG001|Fourth Dose Phase|Adverse Event|0|||
144405047|NCT00289783|520692376|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
144405048|NCT00289783|520692377|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
144405049|NCT00289783|520692376|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
144405050|NCT00289783|520692377|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
144405051|NCT00289783|520692376|FG000|Fourth Dose Phase|Migration from the study area|1|||
144405052|NCT00289783|520692377|FG001|Fourth Dose Phase|Migration from the study area|1|||
144405053|NCT00289783|520692376|FG000|Fourth Dose Phase|Other|22|||
144405054|NCT00289783|520692377|FG001|Fourth Dose Phase|Other|10|||
144405055|NCT01453361|520692378|FG000|Overall Study|Disease Progression|6|||
144405056|NCT01453361|520692378|FG000|Overall Study|Screen-Failures|10|||
144405057|NCT03128047|520692379|FG000|Overall Study|Withdrawal by Subject|1|||
144405058|NCT01995825|520693697|FG000|Overall Study|Withdrawal by Subject|1|||
144405059|NCT01995825|520693698|FG001|Overall Study|Withdrawal by Subject|0|||
144405060|NCT01798004|520693699|FG000|Overall Study|Death|2|||
144405061|NCT01798004|520693699|FG000|Overall Study|Lack of Efficacy|8|||
144405062|NCT01798004|520693699|FG000|Overall Study|Physician Decision|25|||
144405063|NCT01798004|520693699|FG000|Overall Study|Withdrawal by Subject|4|||
144405064|NCT01798004|520693699|FG000|Overall Study|Ineligible|4|||
144405065|NCT01798004|520693699|FG000|Overall Study|Patient/parent refusal|7|||
144405066|NCT01798004|520693699|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
144405067|NCT01798004|520693699|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
144405068|NCT01516437|520693700|FG000|Overall Study|Reason not specified|0|||
144405069|NCT01516437|520693701|FG001|Overall Study|Reason not specified|0|||
144599342|NCT04082429|521396149|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
144599343|NCT04082429|521396150|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
144599344|NCT04082429|521396151|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
144599345|NCT04082429|521396152|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
144599346|NCT04082429|521396153|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
144599347|NCT04082429|521396145|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
144599348|NCT04082429|521396146|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599349|NCT04082429|521396147|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599350|NCT04082429|521396148|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599351|NCT04082429|521396149|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599352|NCT04082429|521396150|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
144599353|NCT04082429|521396151|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599354|NCT04082429|521396152|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599355|NCT04082429|521396153|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
144599356|NCT04082429|521396145|FG000|Extension Part|Ongoing|0|||
144599357|NCT04082429|521396146|FG001|Extension Part|Ongoing|7|||
144405070|NCT01516437|520693702|FG002|Overall Study|Reason not specified|1|||
144405071|NCT01516437|520693703|FG003|Overall Study|Reason not specified|1|||
144405072|NCT01385566|520693707|FG000|Overall Study|Lost to Follow-up|1|||
144405073|NCT01385566|520693708|FG001|Overall Study|Lost to Follow-up|0|||
144405074|NCT01385566|520693709|FG002|Overall Study|Lost to Follow-up|0|||
144405075|NCT01385566|520693710|FG003|Overall Study|Lost to Follow-up|0|||
144405076|NCT01385566|520693711|FG004|Overall Study|Lost to Follow-up|0|||
144405077|NCT01385566|520693712|FG005|Overall Study|Lost to Follow-up|0|||
144405078|NCT01385566|520693707|FG000|Overall Study|Withdrawal by Subject|0|||
144405079|NCT01385566|520693708|FG001|Overall Study|Withdrawal by Subject|0|||
144405080|NCT01385566|520693709|FG002|Overall Study|Withdrawal by Subject|0|||
144405081|NCT01385566|520693710|FG003|Overall Study|Withdrawal by Subject|1|||
144405082|NCT01385566|520693711|FG004|Overall Study|Withdrawal by Subject|0|||
144405083|NCT01385566|520693712|FG005|Overall Study|Withdrawal by Subject|0|||
144405084|NCT00560105|520693721|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
144405085|NCT00560105|520693722|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
144405086|NCT02400333|520693723|FG000|Overall Study|Withdrawal by Subject|0|||
144405087|NCT02400333|520693724|FG001|Overall Study|Withdrawal by Subject|1|||
144405088|NCT02400333|520693725|FG002|Overall Study|Withdrawal by Subject|0|||
144405089|NCT02400333|520693726|FG003|Overall Study|Withdrawal by Subject|1|||
144405090|NCT02400333|520693723|FG000|Overall Study|Protocol Violation|1|||
144405091|NCT02400333|520693724|FG001|Overall Study|Protocol Violation|0|||
144405092|NCT02400333|520693725|FG002|Overall Study|Protocol Violation|2|||
144405093|NCT02400333|520693726|FG003|Overall Study|Protocol Violation|1|||
144405094|NCT00443261|520693727|FG000|Overall Study|Death|1|||
144405095|NCT01663532|520693728|FG000|Overall Study|Lost to Follow-up|9|||
144405096|NCT01663532|520693729|FG001|Overall Study|Lost to Follow-up|10|||
144405097|NCT01663532|520693728|FG000|Overall Study|Adverse Event|7|||
144405098|NCT01663532|520693729|FG001|Overall Study|Adverse Event|13|||
144405099|NCT01663532|520693728|FG000|Overall Study|Met Withdrawal Criteria|7|||
144599358|NCT04082429|521396147|FG002|Extension Part|Ongoing|17|||
144405100|NCT01663532|520693729|FG001|Overall Study|Met Withdrawal Criteria|6|||
144405101|NCT01663532|520693728|FG000|Overall Study|Physician Decision|1|||
144405102|NCT01663532|520693729|FG001|Overall Study|Physician Decision|1|||
144405103|NCT01663532|520693728|FG000|Overall Study|Withdrawal by Subject|35|||
144405104|NCT01663532|520693729|FG001|Overall Study|Withdrawal by Subject|17|||
144405105|NCT01663532|520693728|FG000|Overall Study|Lack of Efficacy|15|||
144405106|NCT01663532|520693729|FG001|Overall Study|Lack of Efficacy|60|||
144405107|NCT03539081|520693734|FG000|Overall Study|Withdrawal by Subject|2|||
144405108|NCT03539081|520693735|FG001|Overall Study|Withdrawal by Subject|3|||
144405109|NCT03539081|520693736|FG002|Overall Study|Withdrawal by Subject|0|||
144405110|NCT03539081|520693734|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
144405111|NCT03539081|520693735|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
144405112|NCT03539081|520693736|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
144405113|NCT02025621|520693737|FG000|Overall Study|Withdrawal by Subject|1|||
144405114|NCT02025621|520693738|FG001|Overall Study|Withdrawal by Subject|0|||
144405115|NCT02025621|520693737|FG000|Overall Study|Death|0|||
144405116|NCT02025621|520693738|FG001|Overall Study|Death|1|||
144405117|NCT02025621|520693737|FG000|Overall Study|No longer eligible|10|||
144405118|NCT02025621|520693738|FG001|Overall Study|No longer eligible|15|||
144405119|NCT02025621|520693737|FG000|Overall Study|Surgery initiated before infusion|3|||
144405120|NCT02025621|520693738|FG001|Overall Study|Surgery initiated before infusion|3|||
144405121|NCT00739674|520693739|FG000|Overall Study|Screening failures|19|||
144405122|NCT00739674|520693740|FG001|Overall Study|Screening failures|17|||
144405123|NCT00739674|520693739|FG000|Overall Study|Site 212 removal|19|||
144405124|NCT00739674|520693740|FG001|Overall Study|Site 212 removal|13|||
144405125|NCT00739674|520693739|FG000|Overall Study|No follow-up data|33|||
144405126|NCT00739674|520693740|FG001|Overall Study|No follow-up data|18|||
144405127|NCT00739674|520693739|FG000|Overall Study|Dietician consultation >30 days|1|||
144405128|NCT00739674|520693740|FG001|Overall Study|Dietician consultation >30 days|9|||
144405129|NCT00739674|520693739|FG000|Overall Study|Adverse Event|22|||
144405130|NCT00739674|520693740|FG001|Overall Study|Adverse Event|13|||
144405131|NCT00739674|520693739|FG000|Overall Study|Death|1|||
144405132|NCT00739674|520693740|FG001|Overall Study|Death|0|||
144405133|NCT00739674|520693739|FG000|Overall Study|Lack of Efficacy|1|||
144405134|NCT00739674|520693740|FG001|Overall Study|Lack of Efficacy|0|||
144405135|NCT00739674|520693739|FG000|Overall Study|Lost to Follow-up|52|||
144405136|NCT00739674|520693740|FG001|Overall Study|Lost to Follow-up|30|||
144405137|NCT00739674|520693739|FG000|Overall Study|Protocol Violation|5|||
144599359|NCT04082429|521396148|FG003|Extension Part|Ongoing|6|||
144599360|NCT04082429|521396149|FG004|Extension Part|Ongoing|45|||
144599361|NCT04082429|521396150|FG005|Extension Part|Ongoing|0|||
144599362|NCT04082429|521396151|FG006|Extension Part|Ongoing|10|||
144599363|NCT04082429|521396152|FG007|Extension Part|Ongoing|23|||
144599364|NCT04082429|521396153|FG008|Extension Part|Ongoing|25|||
144599365|NCT02993523|521396159|FG000|Overall Study|Withdrew Consent|0|||
144405138|NCT00739674|520693740|FG001|Overall Study|Protocol Violation|5|||
144405139|NCT00739674|520693739|FG000|Overall Study|Withdrawal by Subject|9|||
144405140|NCT00739674|520693740|FG001|Overall Study|Withdrawal by Subject|9|||
144405141|NCT00739674|520693739|FG000|Overall Study|Reason missing|2|||
144405142|NCT00739674|520693740|FG001|Overall Study|Reason missing|0|||
144405143|NCT00739674|520693739|FG000|Overall Study|Clinic closed|6|||
144405144|NCT00739674|520693740|FG001|Overall Study|Clinic closed|4|||
144405145|NCT00739674|520693739|FG000|Overall Study|Patient moved|3|||
144405146|NCT00739674|520693740|FG001|Overall Study|Patient moved|2|||
144405147|NCT00739674|520693739|FG000|Overall Study|Non compliant|4|||
144405148|NCT00739674|520693740|FG001|Overall Study|Non compliant|0|||
144599366|NCT02993523|521396160|FG001|Overall Study|Withdrew Consent|0|||
144599367|NCT02993523|521396161|FG002|Overall Study|Withdrew Consent|2|||
144599368|NCT02993523|521396162|FG003|Overall Study|Withdrew Consent|9|||
144599369|NCT02993523|521396163|FG004|Overall Study|Withdrew Consent|0|||
144599370|NCT02993523|521396159|FG000|Overall Study|Lost to Follow-up|0|||
144599371|NCT02993523|521396160|FG001|Overall Study|Lost to Follow-up|0|||
144599372|NCT02993523|521396161|FG002|Overall Study|Lost to Follow-up|3|||
144405149|NCT00739674|520693739|FG000|Overall Study|Unable to attend visit|3|||
144405150|NCT00739674|520693740|FG001|Overall Study|Unable to attend visit|1|||
144405151|NCT00739674|520693739|FG000|Overall Study|Home monitoring off meds|1|||
144405152|NCT00739674|520693740|FG001|Overall Study|Home monitoring off meds|0|||
144405153|NCT00739674|520693739|FG000|Overall Study|Erectile dysfunction|0|||
144405154|NCT00739674|520693740|FG001|Overall Study|Erectile dysfunction|1|||
144405155|NCT04805541|520693742|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
144405156|NCT00283400|520693745|FG000|Overall Study|Withdrawal by Subject|1|||
144405157|NCT00283400|520693746|FG001|Overall Study|Withdrawal by Subject|1|||
144405158|NCT00283400|520693747|FG002|Overall Study|Withdrawal by Subject|0|||
144405159|NCT00283400|520693748|FG003|Overall Study|Withdrawal by Subject|0|||
144405160|NCT00283400|520693745|FG000|Overall Study|Death|1|||
144405161|NCT00283400|520693746|FG001|Overall Study|Death|0|||
144405162|NCT00283400|520693747|FG002|Overall Study|Death|1|||
144405163|NCT00283400|520693748|FG003|Overall Study|Death|0|||
144405164|NCT02195583|520693753|FG000|Overall Study|Lost to Follow-up|1|||
144405165|NCT02195583|520693753|FG000|Overall Study|Withdrawal by Subject|4|||
144405166|NCT02195583|520693753|FG000|Overall Study|Adverse Event|2|||
144405167|NCT02195583|520693753|FG000|Overall Study|Other Reason|2|||
144405168|NCT00983437|520693754|FG000|Overall Study|Adverse Event|9|||
144405169|NCT00983437|520693754|FG000|Overall Study|Lack of Efficacy|1|||
144405170|NCT00983437|520693754|FG000|Overall Study|Withdrawal by Subject|8|||
144405171|NCT00983437|520693754|FG000|Overall Study|Noncompliance to Study Procedures|1|||
144405172|NCT00983437|520693754|FG000|Overall Study|Lost to Follow-up|2|||
144405173|NCT00983437|520693754|FG000|Overall Study|Other Reason|26|||
144405174|NCT03094169|520693757|FG000|Overall Study|Lack of Efficacy|0|||
144405175|NCT03094169|520693758|FG001|Overall Study|Lack of Efficacy|0|||
144405176|NCT03094169|520693759|FG002|Overall Study|Lack of Efficacy|0|||
144405177|NCT03094169|520693760|FG003|Overall Study|Lack of Efficacy|0|||
144405178|NCT03094169|520693761|FG004|Overall Study|Lack of Efficacy|0|||
144405179|NCT03094169|520693762|FG005|Overall Study|Lack of Efficacy|0|||
144599373|NCT02993523|521396162|FG003|Overall Study|Lost to Follow-up|6|||
144599374|NCT02993523|521396163|FG004|Overall Study|Lost to Follow-up|0|||
144599375|NCT02993523|521396159|FG000|Overall Study|Death|1|||
144599376|NCT02993523|521396160|FG001|Overall Study|Death|1|||
144599377|NCT02993523|521396161|FG002|Overall Study|Death|138|||
144599378|NCT02993523|521396162|FG003|Overall Study|Death|222|||
144599379|NCT02993523|521396163|FG004|Overall Study|Death|6|||
144599380|NCT02993523|521396159|FG000|Overall Study|Reason not Specified|0|||
144599381|NCT02993523|521396160|FG001|Overall Study|Reason not Specified|0|||
144599382|NCT02993523|521396161|FG002|Overall Study|Reason not Specified|1|||
144599383|NCT02993523|521396162|FG003|Overall Study|Reason not Specified|1|||
144599384|NCT02993523|521396163|FG004|Overall Study|Reason not Specified|0|||
144599385|NCT03694418|521396164|FG000|Overall Study|Lost to Follow-up|115|||
144599386|NCT03694418|521396165|FG001|Overall Study|Lost to Follow-up|23|||
144599387|NCT03694418|521396166|FG002|Overall Study|Lost to Follow-up|12|||
144599388|NCT03694418|521396167|FG003|Overall Study|Lost to Follow-up|12|||
144599389|NCT03694418|521396168|FG004|Overall Study|Lost to Follow-up|13|||
144599390|NCT04288778|521396183|FG000|Overall Study|Withdrawal by Subject|2|||
144599391|NCT04288778|521396183|FG000|Overall Study|Adverse Event|5|||
144599392|NCT04288778|521396183|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144599393|NCT04288778|521396183|FG000|Overall Study|Other|1|||
144599394|NCT04288778|521396183|FG000|Overall Study|Started but not treated|2|||
144599395|NCT05057247|521396184|FG000|Overall Study|Death|4|||
144599396|NCT05057247|521396184|FG000|Overall Study|Physician Decision|3|||
144249991|NCT00153816|520113424|FG000|Overall Study|Withdrawal by Subject|9|||
144405180|NCT03094169|520693763|FG006|Overall Study|Lack of Efficacy|0|||
144405181|NCT03094169|520693764|FG007|Overall Study|Lack of Efficacy|21|||
144405182|NCT03094169|520693757|FG000|Overall Study|Adverse Event|0|||
144405183|NCT03094169|520693758|FG001|Overall Study|Adverse Event|0|||
144405184|NCT03094169|520693759|FG002|Overall Study|Adverse Event|0|||
144405185|NCT03094169|520693760|FG003|Overall Study|Adverse Event|0|||
144405186|NCT03094169|520693761|FG004|Overall Study|Adverse Event|0|||
144405187|NCT03094169|520693762|FG005|Overall Study|Adverse Event|0|||
144405188|NCT03094169|520693763|FG006|Overall Study|Adverse Event|0|||
144599397|NCT05057247|521396184|FG000|Overall Study|Progressive Disease|7|||
144599398|NCT05057247|521396184|FG000|Overall Study|Withdrawal by Subject|3|||
144599399|NCT05057247|521396184|FG000|Overall Study|Adverse Event|6|||
144599400|NCT05057247|521396184|FG000|Overall Study|Subject Non-Compliance|1|||
144599401|NCT05057247|521396184|FG000|Overall Study|On treatment|2|||
144405189|NCT03094169|520693764|FG007|Overall Study|Adverse Event|2|||
144599402|NCT00784693|521396185|FG000|Overall Study|Lost to Follow-up|0|||
144599403|NCT00784693|521396186|FG001|Overall Study|Lost to Follow-up|1|||
144722394|NCT00620763|521838707|FG000|Period: First Intervention|Withdrawal by Subject|0|||
144405190|NCT03094169|520693757|FG000|Overall Study|Withdrawal by Subject|0|||
144405191|NCT03094169|520693758|FG001|Overall Study|Withdrawal by Subject|0|||
144405192|NCT03094169|520693759|FG002|Overall Study|Withdrawal by Subject|0|||
144405193|NCT03094169|520693760|FG003|Overall Study|Withdrawal by Subject|0|||
144405194|NCT03094169|520693761|FG004|Overall Study|Withdrawal by Subject|0|||
144405195|NCT03094169|520693762|FG005|Overall Study|Withdrawal by Subject|0|||
144405196|NCT03094169|520693763|FG006|Overall Study|Withdrawal by Subject|1|||
144405197|NCT03094169|520693764|FG007|Overall Study|Withdrawal by Subject|1|||
144405198|NCT03094169|520693757|FG000|Overall Study|Trial Termination|0|||
144405199|NCT03094169|520693758|FG001|Overall Study|Trial Termination|0|||
144405200|NCT03094169|520693759|FG002|Overall Study|Trial Termination|0|||
144405201|NCT03094169|520693760|FG003|Overall Study|Trial Termination|0|||
144405202|NCT03094169|520693761|FG004|Overall Study|Trial Termination|0|||
144405203|NCT03094169|520693762|FG005|Overall Study|Trial Termination|0|||
144405204|NCT03094169|520693763|FG006|Overall Study|Trial Termination|0|||
144405205|NCT03094169|520693764|FG007|Overall Study|Trial Termination|1|||
144405206|NCT00675948|520693765|FG000|Overall Study|Adverse Event|23|||
144405207|NCT00675948|520693766|FG001|Overall Study|Adverse Event|1|||
144405208|NCT00675948|520693765|FG000|Overall Study|Lack of Efficacy|3|||
144405209|NCT00675948|520693766|FG001|Overall Study|Lack of Efficacy|0|||
144722395|NCT00620763|521838708|FG001|Period: First Intervention|Withdrawal by Subject|2|||
144722396|NCT00620763|521838707|FG000|Period: First Intervention|Protocol Violation|0|||
144722397|NCT00620763|521838708|FG001|Period: First Intervention|Protocol Violation|3|||
144722398|NCT00620763|521838707|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
144722399|NCT00620763|521838708|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
144722400|NCT00729859|521838709|FG000|Overall Study|Adverse Event|0|||
144722401|NCT00729859|521838710|FG001|Overall Study|Adverse Event|1|||
144722402|NCT00729859|521838711|FG002|Overall Study|Adverse Event|0|||
144722403|NCT00729859|521838709|FG000|Overall Study|Withdrawal by Subject|0|||
144722404|NCT00729859|521838710|FG001|Overall Study|Withdrawal by Subject|1|||
144722405|NCT00729859|521838711|FG002|Overall Study|Withdrawal by Subject|0|||
144722406|NCT02623829|521838714|FG000|Overall Study|Lost to Follow-up|1|||
144722407|NCT02623829|521838715|FG001|Overall Study|Lost to Follow-up|1|||
144722408|NCT00662025|521838716|FG000|Overall Study|Objective progression or relapse|51|||
144722409|NCT00662025|521838716|FG000|Overall Study|Adverse Event|7|||
144722410|NCT00662025|521838716|FG000|Overall Study|Withdrawal by Subject|1|||
144722411|NCT00662025|521838716|FG000|Overall Study|Results of other clinical study|2|||
144722412|NCT00662025|521838716|FG000|Overall Study|Target lesion cannot be evaluated|1|||
144405210|NCT00675948|520693765|FG000|Overall Study|Withdrawal by Subject|7|||
144405211|NCT00675948|520693766|FG001|Overall Study|Withdrawal by Subject|0|||
144405212|NCT00675948|520693765|FG000|Overall Study|Lost to Follow-up|2|||
144405213|NCT00675948|520693766|FG001|Overall Study|Lost to Follow-up|0|||
144405214|NCT00675948|520693765|FG000|Overall Study|Protocol Violation|1|||
144405215|NCT00675948|520693766|FG001|Overall Study|Protocol Violation|0|||
144405216|NCT00675948|520693765|FG000|Overall Study|Pain under control|1|||
144722413|NCT00662025|521838716|FG000|Overall Study|Domestic circumstances|1|||
144722414|NCT01700621|521838717|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
144722415|NCT01700621|521838718|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
144722416|NCT01700621|521838717|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
144405217|NCT00675948|520693766|FG001|Overall Study|Pain under control|0|||
144405218|NCT00675948|520693765|FG000|Overall Study|Sponsor decision|0|||
144405219|NCT00675948|520693766|FG001|Overall Study|Sponsor decision|1|||
144405220|NCT00675948|520693765|FG000|Overall Study|Patient died|1|||
144405221|NCT00675948|520693766|FG001|Overall Study|Patient died|0|||
144405222|NCT00675948|520693765|FG000|Overall Study|Patient unable to comply with diaries|1|||
144405223|NCT00675948|520693766|FG001|Overall Study|Patient unable to comply with diaries|0|||
144405224|NCT00675948|520693765|FG000|Overall Study|Patient feels unable to take medication|0|||
144405225|NCT00675948|520693766|FG001|Overall Study|Patient feels unable to take medication|1|||
144405226|NCT00762229|520693767|FG000|Overall Study|Lost to Follow-up|1|||
144405227|NCT00762229|520693768|FG001|Overall Study|Lost to Follow-up|1|||
144405228|NCT00762229|520693767|FG000|Overall Study|did not recveive intervention|0|||
144405229|NCT00762229|520693768|FG001|Overall Study|did not recveive intervention|1|||
144405230|NCT01896102|520693769|FG000|Overall Study|Death|1|||
144405231|NCT01896102|520693769|FG000|Overall Study|Participant to receive allogenic transplant|2|||
144405232|NCT01751178|520693770|FG000|Overall Study|Adverse Event|2|||
144405233|NCT01751178|520693771|FG001|Overall Study|Adverse Event|0|||
144405234|NCT01751178|520693772|FG002|Overall Study|Adverse Event|0|||
144524921|NCT04436276|521122047|FG008|Overall Study|Withdrawal by Subject|0|||
144524922|NCT04436276|521122048|FG009|Overall Study|Withdrawal by Subject|1|||
144524923|NCT04436276|521122049|FG010|Overall Study|Withdrawal by Subject|17|||
144524924|NCT04436276|521122050|FG011|Overall Study|Withdrawal by Subject|7|||
144524925|NCT04436276|521122051|FG012|Overall Study|Withdrawal by Subject|10|||
144524926|NCT04436276|521122052|FG013|Overall Study|Withdrawal by Subject|6|||
144524927|NCT04436276|521122053|FG014|Overall Study|Withdrawal by Subject|20|||
144524928|NCT04436276|521122054|FG015|Overall Study|Withdrawal by Subject|6|||
144524929|NCT04436276|521122055|FG016|Overall Study|Withdrawal by Subject|11|||
144524930|NCT04436276|521122056|FG017|Overall Study|Withdrawal by Subject|4|||
144524931|NCT04436276|521122057|FG018|Overall Study|Withdrawal by Subject|14|||
144524932|NCT04436276|521122058|FG019|Overall Study|Withdrawal by Subject|24|||
144524933|NCT04436276|521122059|FG020|Overall Study|Withdrawal by Subject|24|||
144524934|NCT04436276|521122060|FG021|Overall Study|Withdrawal by Subject|16|||
144524935|NCT04436276|521122061|FG022|Overall Study|Withdrawal by Subject|14|||
144524936|NCT04436276|521122039|FG000|Overall Study|Other|3|||
144524937|NCT04436276|521122040|FG001|Overall Study|Other|2|||
144524938|NCT04436276|521122041|FG002|Overall Study|Other|5|||
144524939|NCT04436276|521122042|FG003|Overall Study|Other|9|||
144524940|NCT04436276|521122043|FG004|Overall Study|Other|23|||
144524941|NCT04436276|521122044|FG005|Overall Study|Other|1|||
144524942|NCT04436276|521122045|FG006|Overall Study|Other|0|||
144524943|NCT04436276|521122046|FG007|Overall Study|Other|0|||
144524944|NCT04436276|521122047|FG008|Overall Study|Other|0|||
144524945|NCT04436276|521122048|FG009|Overall Study|Other|0|||
144524946|NCT04436276|521122049|FG010|Overall Study|Other|3|||
144524947|NCT04436276|521122050|FG011|Overall Study|Other|1|||
144524948|NCT04436276|521122051|FG012|Overall Study|Other|1|||
144524949|NCT04436276|521122052|FG013|Overall Study|Other|2|||
144524950|NCT04436276|521122053|FG014|Overall Study|Other|3|||
144524951|NCT04436276|521122054|FG015|Overall Study|Other|0|||
144524952|NCT04436276|521122055|FG016|Overall Study|Other|0|||
144524953|NCT04436276|521122056|FG017|Overall Study|Other|6|||
144524954|NCT04436276|521122057|FG018|Overall Study|Other|1|||
144524955|NCT04436276|521122058|FG019|Overall Study|Other|0|||
144524956|NCT04436276|521122059|FG020|Overall Study|Other|2|||
144524957|NCT04436276|521122060|FG021|Overall Study|Other|2|||
144524958|NCT04436276|521122061|FG022|Overall Study|Other|60|||
144524959|NCT00324805|521122062|FG000|Overall Study|Adverse Event|62|||
144524960|NCT00324805|521122063|FG001|Overall Study|Adverse Event|203|||
144524961|NCT00324805|521122062|FG000|Overall Study|Progression|7|||
144524962|NCT00324805|521122063|FG001|Overall Study|Progression|35|||
144524963|NCT00324805|521122062|FG000|Overall Study|Withdrawal by Subject|51|||
144524964|NCT00324805|521122063|FG001|Overall Study|Withdrawal by Subject|174|||
144524965|NCT00324805|521122062|FG000|Overall Study|Death|6|||
144524966|NCT00324805|521122063|FG001|Overall Study|Death|9|||
144524967|NCT00324805|521122062|FG000|Overall Study|Alternative therapy|4|||
144524968|NCT00324805|521122063|FG001|Overall Study|Alternative therapy|8|||
144524969|NCT00324805|521122062|FG000|Overall Study|Other complicating disease|1|||
144524970|NCT00324805|521122063|FG001|Overall Study|Other complicating disease|9|||
144524971|NCT00324805|521122062|FG000|Overall Study|Other reasons|7|||
144405235|NCT01751178|520693770|FG000|Overall Study|Other Reason (unknown)|1|||
144405236|NCT01751178|520693771|FG001|Overall Study|Other Reason (unknown)|0|||
144405237|NCT01751178|520693772|FG002|Overall Study|Other Reason (unknown)|2|||
144524972|NCT00324805|521122063|FG001|Overall Study|Other reasons|26|||
144524973|NCT00324805|521122062|FG000|Overall Study|Other|0|||
144524974|NCT00324805|521122063|FG001|Overall Study|Other|2|||
144524975|NCT00324805|521122062|FG000|Overall Study|Did not start therapy|12|||
144524976|NCT00324805|521122063|FG001|Overall Study|Did not start therapy|17|||
144524977|NCT03931174|521122065|FG000|Providers|Staff left organization|26|||
144524978|NCT03931174|521122066|FG001|Providers|Staff left organization|25|||
144524979|NCT03931174|521122065|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
144599404|NCT00784693|521396185|FG000|Overall Study|Lack of Efficacy|1|||
144599405|NCT00784693|521396186|FG001|Overall Study|Lack of Efficacy|1|||
144599406|NCT00784693|521396185|FG000|Overall Study|Withdrawal by Subject|0|||
144599407|NCT00784693|521396186|FG001|Overall Study|Withdrawal by Subject|4|||
144599408|NCT00784693|521396185|FG000|Overall Study|Randomized but not Treated|1|||
144599409|NCT00784693|521396186|FG001|Overall Study|Randomized but not Treated|0|||
144249992|NCT00153816|520113425|FG001|Overall Study|Withdrawal by Subject|9|||
144405238|NCT04891978|520693778|FG000|Baseline|Protocol Violation|2|||
144405239|NCT04891978|520693779|FG001|Baseline|Protocol Violation|1|||
144405240|NCT04891978|520693780|FG002|Baseline|Protocol Violation|0|||
144405241|NCT04891978|520693778|FG000|Baseline|Missing AIRQ|1|||
144405242|NCT04891978|520693779|FG001|Baseline|Missing AIRQ|0|||
144405243|NCT04891978|520693780|FG002|Baseline|Missing AIRQ|0|||
144405244|NCT04891978|520693778|FG000|Baseline|Did not attend a baseline visit|0|||
144405245|NCT04891978|520693779|FG001|Baseline|Did not attend a baseline visit|0|||
144405246|NCT04891978|520693780|FG002|Baseline|Did not attend a baseline visit|9|||
144405247|NCT01776840|520693781|FG000|Overall Study|Lost to Follow-up|12|||
144405248|NCT01776840|520693782|FG001|Overall Study|Lost to Follow-up|7|||
144405249|NCT01776840|520693781|FG000|Overall Study|Withdrawal by Subject|32|||
144405250|NCT01776840|520693782|FG001|Overall Study|Withdrawal by Subject|48|||
144405251|NCT01776840|520693781|FG000|Overall Study|Sponsor decision|89|||
144405252|NCT01776840|520693782|FG001|Overall Study|Sponsor decision|87|||
144405253|NCT03641339|520693783|FG000|Overall Study|Physician Decision|1|||
144405254|NCT03641339|520693784|FG001|Overall Study|Physician Decision|0|||
144405255|NCT03641339|520693785|FG002|Overall Study|Physician Decision|0|||
144405256|NCT03641339|520693786|FG003|Overall Study|Physician Decision|0|||
144405257|NCT03641339|520693787|FG004|Overall Study|Physician Decision|0|||
144405258|NCT03641339|520693788|FG005|Overall Study|Physician Decision|0|||
144405259|NCT03641339|520693783|FG000|Overall Study|Withdrawal by Subject|0|||
144405260|NCT03641339|520693784|FG001|Overall Study|Withdrawal by Subject|2|||
144405261|NCT03641339|520693785|FG002|Overall Study|Withdrawal by Subject|0|||
144599410|NCT00784693|521396185|FG000|Overall Study|Other|1|||
144599411|NCT00784693|521396186|FG001|Overall Study|Other|0|||
144599412|NCT00528866|521396187|FG000|Overall Study|Protocol Violation|6|||
144599413|NCT00993915|521396188|FG000|Overall Study|Insufficient clinical response|3|||
144249993|NCT00153816|520113426|FG002|Overall Study|Withdrawal by Subject|9|||
144249994|NCT00153816|520113427|FG003|Overall Study|Withdrawal by Subject|4|||
144405262|NCT03641339|520693786|FG003|Overall Study|Withdrawal by Subject|2|||
144405263|NCT03641339|520693787|FG004|Overall Study|Withdrawal by Subject|0|||
144405264|NCT03641339|520693788|FG005|Overall Study|Withdrawal by Subject|1|||
144405265|NCT02589405|520693791|FG000|Overall Study|Adverse Event|3|||
144405266|NCT02589405|520693791|FG000|Overall Study|Withdrawal by Subject|1|||
144599414|NCT00993915|521396188|FG000|Overall Study|Withdrawal by Subject|2|||
144599415|NCT00993915|521396188|FG000|Overall Study|Other|1|||
144599416|NCT00993915|521396188|FG000|Overall Study|Ongoing|3|||
144599417|NCT02030405|521396193|FG000|Overall Study|Withdrawal by Subject|1|||
144599418|NCT02030405|521396193|FG000|Overall Study|Lost to Follow-up|1|||
144599419|NCT00132496|521396194|FG000|Overall Study|Withdrawal by Subject|1|||
144599420|NCT00132496|521396195|FG001|Overall Study|Withdrawal by Subject|2|||
144599421|NCT00132496|521396194|FG000|Overall Study|Physician Decision|1|||
144599422|NCT00132496|521396195|FG001|Overall Study|Physician Decision|0|||
144599423|NCT02973048|521396196|FG000|Overall Study|Epidural catheter insertion failure|1|||
144599424|NCT02973048|521396197|FG001|Overall Study|Epidural catheter insertion failure|0|||
144599425|NCT02973048|521396196|FG000|Overall Study|Withdrawal by Subject|0|||
144599426|NCT02973048|521396197|FG001|Overall Study|Withdrawal by Subject|3|||
144599427|NCT01906346|521396201|FG000|Overall Study|AEs|1|||
144599428|NCT00364156|521396204|FG000|Overall Study|Withdrawal by Subject|73|||
144599429|NCT00364156|521396205|FG001|Overall Study|Withdrawal by Subject|80|||
144599430|NCT00364156|521396204|FG000|Overall Study|Protocol Violation|6|||
144599431|NCT00364156|521396205|FG001|Overall Study|Protocol Violation|1|||
144599432|NCT02511678|521396206|FG000|Overall Study|Withdrawal by Subject|2|||
144599433|NCT02511678|521396206|FG000|Overall Study|Lost to Follow-up|4|||
144599434|NCT02511678|521396206|FG000|Overall Study|Death|19|||
144249995|NCT00153816|520113428|FG004|Overall Study|Withdrawal by Subject|1|||
144249996|NCT00153816|520113429|FG005|Overall Study|Withdrawal by Subject|5|||
144249997|NCT00153816|520113424|FG000|Overall Study|Follow-up exam not done|8|||
144249998|NCT00153816|520113425|FG001|Overall Study|Follow-up exam not done|7|||
144249999|NCT00153816|520113426|FG002|Overall Study|Follow-up exam not done|11|||
144405267|NCT02264639|520693795|FG000|Overall Study|Death (after completing single-dose phase)|1|||
144405268|NCT02264639|520693796|FG001|Overall Study|Death (after completing single-dose phase)|0|||
144405269|NCT02264639|520693797|FG002|Overall Study|Death (after completing single-dose phase)|0|||
144405270|NCT02264639|520693798|FG003|Overall Study|Death (after completing single-dose phase)|0|||
144405271|NCT02264639|520693799|FG004|Overall Study|Death (after completing single-dose phase)|0|||
144405272|NCT02264639|520693795|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
144599435|NCT02511678|521396206|FG000|Overall Study|Adverse Event|1|||
144599436|NCT02511678|521396206|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
144599437|NCT02511678|521396206|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
144405273|NCT02264639|520693796|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
144405274|NCT02264639|520693797|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
144405275|NCT02264639|520693798|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
144405276|NCT02264639|520693799|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
144405277|NCT02264639|520693795|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
144405278|NCT02264639|520693796|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
144405279|NCT02264639|520693797|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
144405280|NCT02264639|520693798|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
144405281|NCT02264639|520693799|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
144405282|NCT02264639|520693795|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
144405283|NCT02264639|520693796|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
144405284|NCT02264639|520693797|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
144405285|NCT02264639|520693798|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
144405286|NCT02264639|520693799|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
144405287|NCT01416272|520693807|FG000|Overall Study|Unacceptable distance visual acuity|2|||
144405288|NCT01416272|520693807|FG000|Overall Study|Lost to Follow-up|1|||
144405289|NCT01416272|520693807|FG000|Overall Study|Study related complaints|1|||
144405290|NCT02693119|520693808|FG000|Open-Label Period|Withdrawal by Subject|0|||
144524980|NCT03931174|521122066|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
144524981|NCT03931174|521122065|FG000|Providers|Lost to Follow-up|4|||
144524982|NCT03931174|521122066|FG001|Providers|Lost to Follow-up|4|||
144524983|NCT03931174|521122065|FG000|Patients|Post-consent screening failure|1|||
144524984|NCT03931174|521122066|FG001|Patients|Post-consent screening failure|1|||
144524985|NCT03931174|521122065|FG000|Patients|Death|1|||
144524986|NCT03931174|521122066|FG001|Patients|Death|1|||
144524987|NCT03931174|521122065|FG000|Patients|Lost to Follow-up|60|||
144524988|NCT03931174|521122066|FG001|Patients|Lost to Follow-up|89|||
144524989|NCT05386030|521122069|FG000|Overall Study|Death|1|||
144524990|NCT05386030|521122070|FG001|Overall Study|Death|0|||
144524991|NCT05386030|521122069|FG000|Overall Study|Physician Decision|2|||
144524992|NCT05386030|521122070|FG001|Overall Study|Physician Decision|1|||
144524993|NCT05386030|521122069|FG000|Overall Study|Lost to Follow-up|19|||
144524994|NCT05386030|521122070|FG001|Overall Study|Lost to Follow-up|7|||
144524995|NCT05386030|521122069|FG000|Overall Study|Withdrawal by Subject|20|||
144524996|NCT05386030|521122070|FG001|Overall Study|Withdrawal by Subject|10|||
144524997|NCT05386030|521122069|FG000|Overall Study|Eligibility criteria violation|1|||
144524998|NCT05386030|521122070|FG001|Overall Study|Eligibility criteria violation|1|||
144524999|NCT05386030|521122069|FG000|Overall Study|Personal Reasons|1|||
144525000|NCT05386030|521122070|FG001|Overall Study|Personal Reasons|0|||
144525001|NCT03213691|521122071|FG000|Overall Study|Adverse Event|2|||
144525002|NCT03213691|521122071|FG000|Overall Study|Death|3|||
144525003|NCT03213691|521122071|FG000|Overall Study|Physician Decision|1|||
144525004|NCT03213691|521122071|FG000|Overall Study|Progressive Disease|14|||
144525005|NCT03213691|521122071|FG000|Overall Study|Ineligible|1|||
144525006|NCT03161028|521122072|FG000|Overall Study|Withdrawal by Subject|6|||
144525007|NCT03161028|521122073|FG001|Overall Study|Withdrawal by Subject|4|||
144525008|NCT03161028|521122072|FG000|Overall Study|Adverse Event|5|||
144525009|NCT03161028|521122073|FG001|Overall Study|Adverse Event|1|||
144525010|NCT03161028|521122072|FG000|Overall Study|Study drug side effects|2|||
144525011|NCT03161028|521122073|FG001|Overall Study|Study drug side effects|2|||
144525012|NCT03161028|521122072|FG000|Overall Study|Administrative PD/UP|4|||
144525013|NCT03161028|521122073|FG001|Overall Study|Administrative PD/UP|2|||
144525014|NCT03161028|521122072|FG000|Overall Study|Lost to Follow-up|2|||
144525015|NCT03161028|521122073|FG001|Overall Study|Lost to Follow-up|0|||
144525016|NCT03161028|521122072|FG000|Overall Study|Unable to comply with procedures|1|||
144525017|NCT03161028|521122073|FG001|Overall Study|Unable to comply with procedures|1|||
144525018|NCT00736723|521122074|FG000|Overall Study|Withdrawal by Subject|4|||
144525019|NCT00736723|521122075|FG001|Overall Study|Withdrawal by Subject|3|||
144525020|NCT04797897|521122078|FG000|Overall Study|Study Termination by Sponsor|1|||
144525021|NCT04797897|521122079|FG001|Overall Study|Study Termination by Sponsor|1|||
144525022|NCT01799265|521122081|FG000|Overall Study|Lost to Follow-up|1|||
144525023|NCT01799265|521122082|FG001|Overall Study|Lost to Follow-up|0|||
144525024|NCT01799265|521122081|FG000|Overall Study|Protocol Violation|2|||
144525025|NCT01799265|521122082|FG001|Overall Study|Protocol Violation|1|||
144525026|NCT01799265|521122081|FG000|Overall Study|inadequate sleep study|0|||
144405291|NCT02693119|520693809|FG001|Open-Label Period|Withdrawal by Subject|1|||
144525027|NCT01799265|521122082|FG001|Overall Study|inadequate sleep study|2|||
144525028|NCT04049643|521122086|FG000|Overall Study|Lack of Efficacy|1|||
144525029|NCT04049643|521122087|FG001|Overall Study|Lack of Efficacy|1|||
144525030|NCT04049643|521122088|FG002|Overall Study|Lack of Efficacy|0|||
144525031|NCT04049643|521122086|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
144525032|NCT04049643|521122087|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
144525033|NCT04049643|521122088|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
144405292|NCT02121522|520693815|FG000|Overall Study|Adverse Event|1|||
144405293|NCT00892047|520693820|FG000|Overall Study|Adverse Event|2|||
144405294|NCT00892047|520693821|FG001|Overall Study|Adverse Event|2|||
144405295|NCT00892047|520693820|FG000|Overall Study|subject burden|2|||
144405296|NCT00892047|520693821|FG001|Overall Study|subject burden|3|||
144405297|NCT00892047|520693820|FG000|Overall Study|Lack of Efficacy|0|||
144405298|NCT00892047|520693821|FG001|Overall Study|Lack of Efficacy|2|||
144405299|NCT05306977|520693822|FG000|Overall Study|Withdrawal by Subject|1|||
144405300|NCT01443078|520693823|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
144405301|NCT01443078|520693823|FG000|Overall Study|Withdrawal by Subject|1|||
144405302|NCT01443078|520693823|FG000|Overall Study|Patient had brain mets|1|||
144525034|NCT05028634|521123582|FG000|Overall Study|Withdrawal by Subject|0|||
144599438|NCT02511678|521396206|FG000|Overall Study|Required Radiofrequency Ablation|1|||
144599439|NCT02511678|521396206|FG000|Overall Study|Biopsy was Negative|1|||
144599440|NCT02511678|521396206|FG000|Overall Study|Protocol Violation|1|||
144599441|NCT02511678|521396206|FG000|Overall Study|Received Radiation Treatment|1|||
144599442|NCT00458341|521396210|FG000|Cycle 1|Adverse Event|1|||
144599443|NCT00458341|521396211|FG001|Cycle 1|Adverse Event|0|||
144599444|NCT04540133|521396212|FG000|Overall Study|Lost to Follow-up|1|||
144599445|NCT04540133|521396213|FG001|Overall Study|Lost to Follow-up|0|||
144599446|NCT02730598|521396214|FG000|Overall Study|Withdrawal by Subject|3|||
144599447|NCT02730598|521396215|FG001|Overall Study|Withdrawal by Subject|3|||
144599448|NCT02730598|521396214|FG000|Overall Study|Protocol Violation|0|||
144599449|NCT02730598|521396215|FG001|Overall Study|Protocol Violation|1|||
144599450|NCT02730598|521396214|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
144599451|NCT02730598|521396215|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
144599452|NCT02146326|521396216|FG000|Overall Study|Lost to Follow-up|3|||
144599453|NCT02146326|521396217|FG001|Overall Study|Lost to Follow-up|3|||
144599454|NCT02146326|521396218|FG002|Overall Study|Lost to Follow-up|11|||
144599455|NCT02146326|521396219|FG003|Overall Study|Lost to Follow-up|19|||
144599456|NCT02146326|521396216|FG000|Overall Study|Withdrawal by Subject|2|||
144599457|NCT02146326|521396217|FG001|Overall Study|Withdrawal by Subject|1|||
144599458|NCT02146326|521396218|FG002|Overall Study|Withdrawal by Subject|15|||
144599459|NCT02146326|521396219|FG003|Overall Study|Withdrawal by Subject|11|||
144599460|NCT02146326|521396216|FG000|Overall Study|Separated from mental health center|23|||
144525035|NCT05028634|521123583|FG001|Overall Study|Withdrawal by Subject|1|||
144525036|NCT04728347|521123584|FG000|Overall Study|Sponsor decision|0|||
144525037|NCT04728347|521123585|FG001|Overall Study|Sponsor decision|0|||
144525038|NCT04728347|521123586|FG002|Overall Study|Sponsor decision|1|||
144525039|NCT04728347|521123587|FG003|Overall Study|Sponsor decision|0|||
144525040|NCT03867500|521123589|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
144525041|NCT00753545|521123593|FG000|Overall Study|Death|98|||
144525042|NCT00753545|521123594|FG001|Overall Study|Death|112|||
144525043|NCT00753545|521123593|FG000|Overall Study|Lost to Follow-up|2|||
144525044|NCT00753545|521123594|FG001|Overall Study|Lost to Follow-up|3|||
144525045|NCT00753545|521123593|FG000|Overall Study|Protocol Violation|1|||
144525046|NCT00753545|521123594|FG001|Overall Study|Protocol Violation|0|||
144525047|NCT00753545|521123593|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
144525048|NCT00753545|521123594|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
144525049|NCT03474679|521123595|FG000|Overall Study|Death|7|||
144525050|NCT03474679|521123595|FG000|Overall Study|Withdrawal by Subject|1|||
144525051|NCT05499377|521123609|FG000|Overall Study|Withdrawal by Subject|2|||
144525052|NCT05499377|521123610|FG001|Overall Study|Withdrawal by Subject|0|||
144525053|NCT05499377|521123609|FG000|Overall Study|Physician Decision|1|||
144525054|NCT05499377|521123610|FG001|Overall Study|Physician Decision|0|||
144525055|NCT04149704|521123613|FG000|Three Month Follow-up|Death|2|||
144525056|NCT04149704|521123614|FG001|Three Month Follow-up|Death|0|||
144525057|NCT04149704|521123615|FG002|Three Month Follow-up|Death|0|||
144525058|NCT04149704|521123616|FG003|Three Month Follow-up|Death|0|||
144525059|NCT04149704|521123613|FG000|Three Month Follow-up|Lost to Follow-up|1|||
144599461|NCT02146326|521396217|FG001|Overall Study|Separated from mental health center|33|||
144525060|NCT04149704|521123614|FG001|Three Month Follow-up|Lost to Follow-up|4|||
144599462|NCT02146326|521396218|FG002|Overall Study|Separated from mental health center|0|||
144599463|NCT02146326|521396219|FG003|Overall Study|Separated from mental health center|0|||
144599464|NCT02146326|521396216|FG000|Overall Study|Incarcerated|0|||
144599465|NCT02146326|521396217|FG001|Overall Study|Incarcerated|0|||
144599466|NCT02146326|521396218|FG002|Overall Study|Incarcerated|3|||
144405303|NCT00087607|520693824|FG000|Overall Study|Adverse Event|14|||
144525061|NCT04149704|521123615|FG002|Three Month Follow-up|Lost to Follow-up|5|||
144525062|NCT04149704|521123616|FG003|Three Month Follow-up|Lost to Follow-up|5|||
144525063|NCT04149704|521123613|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
144525064|NCT04149704|521123614|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
144599467|NCT02146326|521396219|FG003|Overall Study|Incarcerated|8|||
144599468|NCT02146326|521396216|FG000|Overall Study|Death|0|||
144405304|NCT00087607|520693825|FG001|Overall Study|Adverse Event|24|||
144405305|NCT00087607|520693824|FG000|Overall Study|Death|0|||
144405306|NCT00087607|520693825|FG001|Overall Study|Death|1|||
144405307|NCT00087607|520693824|FG000|Overall Study|Insufficient Therapeutic Response|53|||
144405308|NCT00087607|520693825|FG001|Overall Study|Insufficient Therapeutic Response|42|||
144405309|NCT00087607|520693824|FG000|Overall Study|Failure to return|21|||
144405310|NCT00087607|520693825|FG001|Overall Study|Failure to return|17|||
144405311|NCT00087607|520693824|FG000|Overall Study|Withdrew Consent|12|||
144405312|NCT00087607|520693825|FG001|Overall Study|Withdrew Consent|16|||
144405313|NCT00087607|520693824|FG000|Overall Study|Administrative|12|||
144405314|NCT00087607|520693825|FG001|Overall Study|Administrative|12|||
144405315|NCT00087607|520693824|FG000|Overall Study|Refused Treatment|5|||
144405316|NCT00087607|520693825|FG001|Overall Study|Refused Treatment|7|||
144405317|NCT00087607|520693824|FG000|Overall Study|Other Protocol Violation|5|||
144405318|NCT00087607|520693825|FG001|Overall Study|Other Protocol Violation|2|||
144405319|NCT00087607|520693824|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
144405320|NCT00087607|520693825|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
144405321|NCT00190671|520693826|FG000|Overall Study|Satisfactory Response|4|||
144405322|NCT00190671|520693827|FG001|Overall Study|Satisfactory Response|7|||
144405323|NCT00190671|520693826|FG000|Overall Study|Lack of Efficacy|19|||
144405324|NCT00190671|520693827|FG001|Overall Study|Lack of Efficacy|24|||
144405325|NCT00190671|520693826|FG000|Overall Study|Death from Study Disease|1|||
144405326|NCT00190671|520693827|FG001|Overall Study|Death from Study Disease|1|||
144405327|NCT00190671|520693826|FG000|Overall Study|Adverse Event|3|||
144405328|NCT00190671|520693827|FG001|Overall Study|Adverse Event|2|||
144405329|NCT00190671|520693826|FG000|Overall Study|Clinical Relapse|0|||
144405330|NCT00190671|520693827|FG001|Overall Study|Clinical Relapse|1|||
144405331|NCT00190671|520693826|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
144405332|NCT00190671|520693827|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
144405333|NCT00190671|520693826|FG000|Overall Study|Death from Other Causes|0|||
144405334|NCT00190671|520693827|FG001|Overall Study|Death from Other Causes|2|||
144405335|NCT00190671|520693826|FG000|Overall Study|Protocol Violation|0|||
144405336|NCT00190671|520693827|FG001|Overall Study|Protocol Violation|1|||
144405337|NCT00190671|520693826|FG000|Overall Study|Withdrawal by Subject|0|||
144405338|NCT00190671|520693827|FG001|Overall Study|Withdrawal by Subject|2|||
144405339|NCT04502433|520693828|FG000|Overall Study|Death|2|||
144405340|NCT04502433|520693829|FG001|Overall Study|Death|4|||
144405341|NCT04502433|520693828|FG000|Overall Study|Lost to Follow-up|1|||
144405342|NCT04502433|520693829|FG001|Overall Study|Lost to Follow-up|0|||
144405343|NCT04502433|520693828|FG000|Overall Study|Physician Decision|0|||
144405344|NCT04502433|520693829|FG001|Overall Study|Physician Decision|1|||
144405345|NCT00660699|520693830|FG000|Overall Study|Withdrawal by Subject|2|||
144405346|NCT06934993|520693831|FG000|Overall Study|Withdrawal by Subject|29|||
144405347|NCT06934993|520693831|FG000|Overall Study|elevated postoperative creatinine level|11|||
144405348|NCT06934993|520693831|FG000|Overall Study|Death|3|||
144405349|NCT01594281|520695350|FG000|Interventional Core Phase|Protocol Deviation|1|||
144405350|NCT01594281|520695351|FG001|Interventional Core Phase|Protocol Deviation|0|||
144525065|NCT04149704|521123615|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
144525066|NCT04149704|521123616|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
144525067|NCT04149704|521123613|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
144525068|NCT04149704|521123614|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
144405351|NCT01594281|520695352|FG002|Interventional Core Phase|Protocol Deviation|0|||
144405352|NCT01594281|520695350|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
144405353|NCT01594281|520695351|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
144405354|NCT01594281|520695352|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
144405355|NCT01594281|520695350|FG000|Interventional Core Phase|Death|1|||
144405356|NCT01594281|520695351|FG001|Interventional Core Phase|Death|1|||
144405357|NCT01594281|520695352|FG002|Interventional Core Phase|Death|2|||
144405358|NCT01594281|520695350|FG000|Interventional Core Phase|Lost to Follow-up|1|||
144405359|NCT01594281|520695351|FG001|Interventional Core Phase|Lost to Follow-up|4|||
144405360|NCT01594281|520695352|FG002|Interventional Core Phase|Lost to Follow-up|1|||
144405361|NCT01594281|520695350|FG000|Interventional Core Phase|Adverse Event|4|||
144405362|NCT01594281|520695351|FG001|Interventional Core Phase|Adverse Event|4|||
144405363|NCT01594281|520695352|FG002|Interventional Core Phase|Adverse Event|4|||
144405364|NCT01594281|520695350|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
144405365|NCT01594281|520695351|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
144405366|NCT01594281|520695352|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
144525069|NCT04149704|521123615|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
144525070|NCT04149704|521123616|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
144405367|NCT01594281|520695350|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
144405368|NCT01594281|520695351|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
144405369|NCT01594281|520695352|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
144722417|NCT01700621|521838718|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
144722418|NCT01700621|521838717|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
144722419|NCT01700621|521838718|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
144722420|NCT02985151|521838721|FG000|Original Randomization|Withdrawal by Subject|0|||
144722421|NCT02985151|521838722|FG001|Original Randomization|Withdrawal by Subject|1|||
144722422|NCT02162758|521838726|FG000|Overall Study|Study termination|0|||
144722423|NCT02162758|521838727|FG001|Overall Study|Study termination|1|||
144722424|NCT04471935|521838728|FG000|Overall Study|Withdrawal by Subject|1|||
144722425|NCT04471935|521838728|FG000|Overall Study|Deemed ineligible to participate|1|||
144722426|NCT01766921|521838731|FG000|Overall Study|Administrative Reason|5|||
144722427|NCT01766921|521838732|FG001|Overall Study|Administrative Reason|5|||
144722428|NCT01766921|521838731|FG000|Overall Study|Death|1|||
144722429|NCT01766921|521838732|FG001|Overall Study|Death|1|||
144722430|NCT01766921|521838731|FG000|Overall Study|Lost to Follow-up|1|||
144722431|NCT01766921|521838732|FG001|Overall Study|Lost to Follow-up|3|||
144722432|NCT01766921|521838731|FG000|Overall Study|Unclassified|2|||
144722433|NCT01766921|521838732|FG001|Overall Study|Unclassified|2|||
144722434|NCT01766921|521838731|FG000|Overall Study|Protocol Violation|1|||
144722435|NCT01766921|521838732|FG001|Overall Study|Protocol Violation|1|||
144722436|NCT01766921|521838731|FG000|Overall Study|Withdrawal by Subject|14|||
144722437|NCT01766921|521838732|FG001|Overall Study|Withdrawal by Subject|5|||
144722438|NCT01659567|521838737|FG000|Overall Study|Lack of Efficacy|22|||
144722439|NCT01659567|521838737|FG000|Overall Study|Switched to Pegferon|6|||
144722440|NCT01659567|521838737|FG000|Overall Study|Adverse Event|12|||
144722441|NCT01659567|521838737|FG000|Overall Study|Good result at early stage of treatment|5|||
144722442|NCT01659567|521838737|FG000|Overall Study|Withdrawal by Subject|64|||
144722443|NCT01659567|521838737|FG000|Overall Study|Progression of the main disease|1|||
144722444|NCT01659567|521838737|FG000|Overall Study|Other|13|||
144722445|NCT01254409|521838745|FG000|Overall Study|Adverse Event|0|||
144722446|NCT01254409|521838746|FG001|Overall Study|Adverse Event|1|||
144722447|NCT01254409|521838747|FG002|Overall Study|Adverse Event|0|||
144722448|NCT01254409|521838748|FG003|Overall Study|Adverse Event|0|||
144722449|NCT01862328|521838753|FG000|Overall Study|Progressive Disease|3|||
144722450|NCT01862328|521838754|FG001|Overall Study|Progressive Disease|11|||
144722451|NCT01862328|521838755|FG002|Overall Study|Progressive Disease|5|||
144722452|NCT01862328|521838756|FG003|Overall Study|Progressive Disease|6|||
144722453|NCT01862328|521838757|FG004|Overall Study|Progressive Disease|7|||
144722454|NCT01862328|521838758|FG005|Overall Study|Progressive Disease|4|||
144722455|NCT01862328|521838759|FG006|Overall Study|Progressive Disease|3|||
144722456|NCT01862328|521838753|FG000|Overall Study|Adverse Event|0|||
144722457|NCT01862328|521838754|FG001|Overall Study|Adverse Event|4|||
144722458|NCT01862328|521838755|FG002|Overall Study|Adverse Event|0|||
144722459|NCT01862328|521838756|FG003|Overall Study|Adverse Event|1|||
144722460|NCT01862328|521838757|FG004|Overall Study|Adverse Event|0|||
144722461|NCT01862328|521838758|FG005|Overall Study|Adverse Event|2|||
144722462|NCT01862328|521838759|FG006|Overall Study|Adverse Event|4|||
144722463|NCT01862328|521838753|FG000|Overall Study|Other|0|||
144722464|NCT01862328|521838754|FG001|Overall Study|Other|2|||
144722465|NCT01862328|521838755|FG002|Overall Study|Other|1|||
144722466|NCT01862328|521838756|FG003|Overall Study|Other|0|||
144722467|NCT01862328|521838757|FG004|Overall Study|Other|4|||
144722468|NCT01862328|521838758|FG005|Overall Study|Other|0|||
144722469|NCT01862328|521838759|FG006|Overall Study|Other|1|||
144722470|NCT01862328|521838753|FG000|Overall Study|Withdrawal by Subject|1|||
144722471|NCT01862328|521838754|FG001|Overall Study|Withdrawal by Subject|1|||
144722472|NCT01862328|521838755|FG002|Overall Study|Withdrawal by Subject|0|||
144722473|NCT01862328|521838756|FG003|Overall Study|Withdrawal by Subject|0|||
144722474|NCT01862328|521838757|FG004|Overall Study|Withdrawal by Subject|1|||
144722475|NCT01862328|521838758|FG005|Overall Study|Withdrawal by Subject|1|||
144722476|NCT01862328|521838759|FG006|Overall Study|Withdrawal by Subject|1|||
144722477|NCT01862328|521838753|FG000|Overall Study|Symptomatic Deterioration|0|||
144722478|NCT01862328|521838754|FG001|Overall Study|Symptomatic Deterioration|0|||
144722479|NCT01862328|521838755|FG002|Overall Study|Symptomatic Deterioration|0|||
144722480|NCT01862328|521838756|FG003|Overall Study|Symptomatic Deterioration|0|||
144722481|NCT01862328|521838757|FG004|Overall Study|Symptomatic Deterioration|0|||
144722482|NCT01862328|521838758|FG005|Overall Study|Symptomatic Deterioration|0|||
144722483|NCT01862328|521838759|FG006|Overall Study|Symptomatic Deterioration|1|||
144722484|NCT00936975|521838760|FG000|Overall Study|Withdrawal by Subject|1|||
144722485|NCT00936975|521838760|FG000|Overall Study|Disease progression|3|||
144722486|NCT00936975|521838760|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
144722487|NCT02482571|521838761|FG000|Overall Study|Adverse Event|1|||
144722488|NCT02482571|521838761|FG000|Overall Study|Scanner or Respiract failure|3|||
144722489|NCT02482571|521838761|FG000|Overall Study|Withdrawal by Subject|4|||
144722490|NCT01498484|521838762|FG000|Overall Study|Death|6|||
144722491|NCT01498484|521838763|FG001|Overall Study|Death|3|||
144722492|NCT01498484|521838764|FG002|Overall Study|Death|1|||
144722493|NCT01498484|521838765|FG003|Overall Study|Death|1|||
144722494|NCT01498484|521838766|FG004|Overall Study|Death|0|||
144722495|NCT01498484|521838767|FG005|Overall Study|Death|0|||
144722496|NCT01498484|521838768|FG006|Overall Study|Death|10|||
144722497|NCT01498484|521838769|FG007|Overall Study|Death|1|||
144722498|NCT01498484|521838770|FG008|Overall Study|Death|0|||
144722499|NCT01498484|521838762|FG000|Overall Study|Physician Decision|3|||
144722500|NCT01498484|521838763|FG001|Overall Study|Physician Decision|2|||
144722501|NCT01498484|521838764|FG002|Overall Study|Physician Decision|1|||
144722502|NCT01498484|521838765|FG003|Overall Study|Physician Decision|1|||
144722503|NCT01498484|521838766|FG004|Overall Study|Physician Decision|0|||
144722504|NCT01498484|521838767|FG005|Overall Study|Physician Decision|0|||
144722505|NCT01498484|521838768|FG006|Overall Study|Physician Decision|8|||
144722506|NCT01498484|521838769|FG007|Overall Study|Physician Decision|13|||
144722507|NCT01498484|521838770|FG008|Overall Study|Physician Decision|1|||
144722508|NCT01498484|521838762|FG000|Overall Study|Adverse Event|0|||
144722509|NCT01498484|521838763|FG001|Overall Study|Adverse Event|0|||
144722510|NCT01498484|521838764|FG002|Overall Study|Adverse Event|0|||
144722511|NCT01498484|521838765|FG003|Overall Study|Adverse Event|0|||
144722512|NCT01498484|521838766|FG004|Overall Study|Adverse Event|0|||
144722513|NCT01498484|521838767|FG005|Overall Study|Adverse Event|1|||
144722514|NCT01498484|521838768|FG006|Overall Study|Adverse Event|0|||
144722515|NCT01498484|521838769|FG007|Overall Study|Adverse Event|0|||
144722516|NCT01498484|521838770|FG008|Overall Study|Adverse Event|0|||
144722517|NCT01498484|521838762|FG000|Overall Study|Withdrawal by Subject|0|||
144722518|NCT01498484|521838763|FG001|Overall Study|Withdrawal by Subject|0|||
144722519|NCT01498484|521838764|FG002|Overall Study|Withdrawal by Subject|0|||
144722520|NCT01498484|521838765|FG003|Overall Study|Withdrawal by Subject|1|||
144722521|NCT01498484|521838766|FG004|Overall Study|Withdrawal by Subject|0|||
144722522|NCT01498484|521838767|FG005|Overall Study|Withdrawal by Subject|0|||
144405370|NCT01594281|520695350|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
144405371|NCT01594281|520695351|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
144405372|NCT01594281|520695352|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
144405373|NCT01034631|520695354|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
144405374|NCT01034631|520695355|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
144405375|NCT01034631|520695356|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
144405376|NCT01034631|520695354|FG000|Phase II|Not Evaluable per protocol|0|||
144405377|NCT01034631|520695355|FG001|Phase II|Not Evaluable per protocol|0|||
144405378|NCT01034631|520695356|FG002|Phase II|Not Evaluable per protocol|2|||
144405379|NCT01034631|520695354|FG000|Phase II|Determined Ineligible per protocol|0|||
144405380|NCT01034631|520695355|FG001|Phase II|Determined Ineligible per protocol|1|||
144599469|NCT02146326|521396217|FG001|Overall Study|Death|0|||
144599470|NCT02146326|521396218|FG002|Overall Study|Death|4|||
144599471|NCT02146326|521396219|FG003|Overall Study|Death|4|||
144599472|NCT02146326|521396216|FG000|Overall Study|Unable to complete interview|0|||
144599473|NCT02146326|521396217|FG001|Overall Study|Unable to complete interview|0|||
144599474|NCT02146326|521396218|FG002|Overall Study|Unable to complete interview|10|||
144599475|NCT02146326|521396219|FG003|Overall Study|Unable to complete interview|6|||
144599476|NCT01079130|521396222|FG000|Overall Study|Adverse Event|1|||
144722523|NCT01498484|521838768|FG006|Overall Study|Withdrawal by Subject|1|||
144722524|NCT01498484|521838769|FG007|Overall Study|Withdrawal by Subject|0|||
144405381|NCT01034631|520695356|FG002|Phase II|Determined Ineligible per protocol|0|||
144405382|NCT01560403|520695357|FG000|Overall Study|Lost to Follow-up|0|||
144405383|NCT01560403|520695358|FG001|Overall Study|Lost to Follow-up|1|||
144405384|NCT04218695|520695361|FG000|Overall Study|Adverse Event|1|||
144405385|NCT04218695|520695362|FG001|Overall Study|Adverse Event|0|||
144405386|NCT01890473|520695363|FG000|Overall Study|Lost to Follow-up|1|||
144405387|NCT01890473|520695364|FG001|Overall Study|Lost to Follow-up|0|||
144405388|NCT01890473|520695363|FG000|Overall Study|Poor/non-compliance|1|||
144405389|NCT01890473|520695364|FG001|Overall Study|Poor/non-compliance|0|||
144722525|NCT01498484|521838770|FG008|Overall Study|Withdrawal by Subject|0|||
144722526|NCT01498484|521838762|FG000|Overall Study|Other|5|||
144722527|NCT01498484|521838763|FG001|Overall Study|Other|2|||
144722528|NCT01498484|521838764|FG002|Overall Study|Other|0|||
144405390|NCT04019288|520695365|FG000|Overall Study|Death|1|||
144405391|NCT04019288|520695366|FG001|Overall Study|Death|0|||
144405392|NCT04019288|520695367|FG002|Overall Study|Death|0|||
144405393|NCT01543958|520695368|FG000|Overall Study|Loss to follow-up|3|||
144599477|NCT01079130|521396223|FG001|Overall Study|Adverse Event|1|||
144722529|NCT01498484|521838765|FG003|Overall Study|Other|0|||
144722530|NCT01498484|521838766|FG004|Overall Study|Other|1|||
144722531|NCT01498484|521838767|FG005|Overall Study|Other|0|||
144405394|NCT01543958|520695368|FG000|Overall Study|ART initiation|1|||
144405395|NCT01945281|520695369|FG000|Overall Study|Adverse Event|1|||
144405396|NCT01945281|520695370|FG001|Overall Study|Adverse Event|0|||
144405397|NCT01945281|520695369|FG000|Overall Study|Death|3|||
144405398|NCT01945281|520695370|FG001|Overall Study|Death|3|||
144722532|NCT01498484|521838768|FG006|Overall Study|Other|3|||
144722533|NCT01498484|521838769|FG007|Overall Study|Other|0|||
144722534|NCT01498484|521838770|FG008|Overall Study|Other|1|||
144722535|NCT01199601|521838771|FG000|Overall Study|Lost to Follow-up|47|||
144722536|NCT01199601|521838772|FG001|Overall Study|Lost to Follow-up|66|||
144599478|NCT01079130|521396224|FG002|Overall Study|Adverse Event|0|||
144599479|NCT01079130|521396225|FG003|Overall Study|Adverse Event|1|||
144599480|NCT01079130|521396226|FG004|Overall Study|Adverse Event|5|||
144599481|NCT01079130|521396227|FG005|Overall Study|Adverse Event|1|||
144599482|NCT01079130|521396222|FG000|Overall Study|Administrative problems|1|||
144599483|NCT01079130|521396223|FG001|Overall Study|Administrative problems|3|||
144599484|NCT01079130|521396224|FG002|Overall Study|Administrative problems|0|||
144599485|NCT01079130|521396225|FG003|Overall Study|Administrative problems|0|||
144599486|NCT01079130|521396226|FG004|Overall Study|Administrative problems|0|||
144599487|NCT01079130|521396227|FG005|Overall Study|Administrative problems|1|||
144599488|NCT01079130|521396222|FG000|Overall Study|Withdrawal by Subject|0|||
144599489|NCT01079130|521396223|FG001|Overall Study|Withdrawal by Subject|1|||
144599490|NCT01079130|521396224|FG002|Overall Study|Withdrawal by Subject|0|||
144599491|NCT01079130|521396225|FG003|Overall Study|Withdrawal by Subject|0|||
144599492|NCT01079130|521396226|FG004|Overall Study|Withdrawal by Subject|1|||
144599493|NCT01079130|521396227|FG005|Overall Study|Withdrawal by Subject|3|||
144599494|NCT01079130|521396222|FG000|Overall Study|Protocol deviation|0|||
144599495|NCT01079130|521396223|FG001|Overall Study|Protocol deviation|2|||
144599496|NCT01079130|521396224|FG002|Overall Study|Protocol deviation|1|||
144599497|NCT01079130|521396225|FG003|Overall Study|Protocol deviation|2|||
144599498|NCT01079130|521396226|FG004|Overall Study|Protocol deviation|0|||
144599499|NCT01079130|521396227|FG005|Overall Study|Protocol deviation|0|||
144599500|NCT01079130|521396222|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144599501|NCT01079130|521396223|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144599502|NCT01079130|521396224|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144599503|NCT01079130|521396225|FG003|Overall Study|Abnormal test procedure result(s)|0|||
144599504|NCT01079130|521396226|FG004|Overall Study|Abnormal test procedure result(s)|1|||
144599505|NCT01079130|521396227|FG005|Overall Study|Abnormal test procedure result(s)|0|||
144599506|NCT01079130|521396222|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144599507|NCT01079130|521396223|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144599508|NCT01079130|521396224|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144599509|NCT01079130|521396225|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
144599510|NCT01079130|521396226|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
144599511|NCT01079130|521396227|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
144599512|NCT01079130|521396222|FG000|Overall Study|Lost to Follow-up|0|||
144599513|NCT01079130|521396223|FG001|Overall Study|Lost to Follow-up|0|||
144599514|NCT01079130|521396224|FG002|Overall Study|Lost to Follow-up|0|||
144599515|NCT01079130|521396225|FG003|Overall Study|Lost to Follow-up|0|||
144599516|NCT01079130|521396226|FG004|Overall Study|Lost to Follow-up|1|||
144599517|NCT01079130|521396227|FG005|Overall Study|Lost to Follow-up|0|||
144599518|NCT01853982|521396228|FG000|Overall Study|Withdrawal by Subject|1|||
144599519|NCT01853982|521396229|FG001|Overall Study|Withdrawal by Subject|0|||
144599520|NCT01853982|521396228|FG000|Overall Study|Death|1|||
144599521|NCT01853982|521396229|FG001|Overall Study|Death|0|||
144599522|NCT01853982|521396228|FG000|Overall Study|Lost to Follow-up|0|||
144599523|NCT01853982|521396229|FG001|Overall Study|Lost to Follow-up|1|||
144599524|NCT00390910|521396230|FG000|Overall Study|Adverse Event|1|||
144599525|NCT00390910|521396231|FG001|Overall Study|Adverse Event|0|||
144405399|NCT01945281|520695369|FG000|Overall Study|Physician Decision|1|||
144405400|NCT01945281|520695370|FG001|Overall Study|Physician Decision|1|||
144405401|NCT01945281|520695369|FG000|Overall Study|Technical Problems|1|||
144405402|NCT01945281|520695370|FG001|Overall Study|Technical Problems|0|||
144405403|NCT00934089|520695372|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
144405404|NCT00934089|520695373|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
144405405|NCT00934089|520695372|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
144405406|NCT00934089|520695373|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
144405407|NCT00003473|520695374|FG000|Overall Study|Three patients were not evaluable.|3|||
144405408|NCT04401423|520695375|FG000|Overall Study|Withdrawal by Subject|3|||
144405409|NCT04401423|520695376|FG001|Overall Study|Withdrawal by Subject|1|||
144599526|NCT00390910|521396232|FG002|Overall Study|Adverse Event|0|||
144599527|NCT00390910|521396230|FG000|Overall Study|Lost to Follow-up|0|||
144722537|NCT01199601|521838771|FG000|Overall Study|Withdrawal by Subject|15|||
144722538|NCT01199601|521838772|FG001|Overall Study|Withdrawal by Subject|3|||
144722539|NCT01199601|521838771|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
144405410|NCT04401423|520695375|FG000|Overall Study|Physician Decision|2|||
144405411|NCT04401423|520695376|FG001|Overall Study|Physician Decision|1|||
144405412|NCT00799383|520695379|FG000|Overall Study|Protocol Violation|1|||
144599528|NCT00390910|521396231|FG001|Overall Study|Lost to Follow-up|1|||
144599529|NCT00390910|521396232|FG002|Overall Study|Lost to Follow-up|5|||
144599530|NCT00390910|521396230|FG000|Overall Study|Withdrawal by Subject|1|||
144599531|NCT00390910|521396231|FG001|Overall Study|Withdrawal by Subject|3|||
144599532|NCT00390910|521396232|FG002|Overall Study|Withdrawal by Subject|2|||
144599533|NCT00390910|521396230|FG000|Overall Study|Migrated/moved from study area|0|||
144599534|NCT00390910|521396231|FG001|Overall Study|Migrated/moved from study area|0|||
144599535|NCT00390910|521396232|FG002|Overall Study|Migrated/moved from study area|3|||
144405413|NCT00799383|520695380|FG001|Overall Study|Protocol Violation|1|||
144405414|NCT00799383|520695379|FG000|Overall Study|Adverse Event|0|||
144405415|NCT00799383|520695380|FG001|Overall Study|Adverse Event|1|||
144405416|NCT00799383|520695379|FG000|Overall Study|Lost to Follow-up|1|||
144405417|NCT00799383|520695380|FG001|Overall Study|Lost to Follow-up|2|||
144405418|NCT00799383|520695379|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
144405419|NCT00799383|520695380|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
144405420|NCT00799383|520695379|FG000|Overall Study|Withdrawal by Subject|0|||
144405421|NCT00799383|520695380|FG001|Overall Study|Withdrawal by Subject|1|||
144405422|NCT00040365|520695386|FG000|Overall Study|Death|1|||
144405423|NCT00040365|520695386|FG000|Overall Study|Progressive disease|7|||
144405424|NCT00040365|520695386|FG000|Overall Study|Lost to Follow-up|3|||
144405425|NCT00680017|520695387|FG000|Overall Study|Adverse Event|13|||
144405426|NCT00680017|520695388|FG001|Overall Study|Adverse Event|7|||
144405427|NCT00680017|520695387|FG000|Overall Study|Withdrawal by Subject|2|||
144405428|NCT00680017|520695388|FG001|Overall Study|Withdrawal by Subject|5|||
144405429|NCT00680017|520695387|FG000|Overall Study|Lost to Follow-up|2|||
144405430|NCT00680017|520695388|FG001|Overall Study|Lost to Follow-up|0|||
144405431|NCT02555683|520695389|FG000|Overall Study|Physician Decision|1|||
144405432|NCT02555683|520695390|FG001|Overall Study|Physician Decision|0|||
144599536|NCT01839487|521396233|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
144405433|NCT02555683|520695391|FG002|Overall Study|Physician Decision|2|||
144405434|NCT02555683|520695389|FG000|Overall Study|Lost to Follow-up|2|||
144405435|NCT02555683|520695390|FG001|Overall Study|Lost to Follow-up|1|||
144405436|NCT02555683|520695391|FG002|Overall Study|Lost to Follow-up|2|||
144405437|NCT02555683|520695389|FG000|Overall Study|Technical Problems|1|||
144405438|NCT02555683|520695390|FG001|Overall Study|Technical Problems|1|||
144405439|NCT02555683|520695391|FG002|Overall Study|Technical Problems|0|||
144405440|NCT02555683|520695389|FG000|Overall Study|Protocol deviation|0|||
144405441|NCT02555683|520695390|FG001|Overall Study|Protocol deviation|1|||
144405442|NCT02555683|520695391|FG002|Overall Study|Protocol deviation|0|||
144405443|NCT02555683|520695389|FG000|Overall Study|Lack of Efficacy|2|||
144405444|NCT02555683|520695390|FG001|Overall Study|Lack of Efficacy|0|||
144405445|NCT02555683|520695391|FG002|Overall Study|Lack of Efficacy|0|||
144405446|NCT02555683|520695389|FG000|Overall Study|Death|0|||
144405447|NCT02555683|520695390|FG001|Overall Study|Death|1|||
144405448|NCT02555683|520695391|FG002|Overall Study|Death|2|||
144405449|NCT02555683|520695389|FG000|Overall Study|Adverse Event|1|||
144405450|NCT02555683|520695390|FG001|Overall Study|Adverse Event|0|||
144405451|NCT02555683|520695391|FG002|Overall Study|Adverse Event|1|||
144405452|NCT02555683|520695389|FG000|Overall Study|Subject/guardian decision|12|||
144405453|NCT02555683|520695390|FG001|Overall Study|Subject/guardian decision|12|||
144405454|NCT02555683|520695391|FG002|Overall Study|Subject/guardian decision|22|||
144405455|NCT02555683|520695389|FG000|Overall Study|Death post Treatment/safety period|0|||
144405456|NCT02555683|520695390|FG001|Overall Study|Death post Treatment/safety period|1|||
144405457|NCT02555683|520695391|FG002|Overall Study|Death post Treatment/safety period|0|||
144525071|NCT02268253|521123619|FG000|Stage 1|Withdrawal by Subject|1|||
144525072|NCT02268253|521123620|FG001|Stage 1|Withdrawal by Subject|0|||
144525073|NCT02268253|521123621|FG002|Stage 1|Withdrawal by Subject|0|||
144525074|NCT02268253|521123622|FG003|Stage 1|Withdrawal by Subject|0|||
144525075|NCT02268253|521123623|FG004|Stage 1|Withdrawal by Subject|0|||
144525076|NCT02268253|521123624|FG005|Stage 1|Withdrawal by Subject|0|||
144525077|NCT02268253|521123625|FG006|Stage 1|Withdrawal by Subject|0|||
144525078|NCT02268253|521123619|FG000|Stage 1|Death|0|||
144525079|NCT02268253|521123620|FG001|Stage 1|Death|2|||
144525080|NCT02268253|521123621|FG002|Stage 1|Death|2|||
144525081|NCT02268253|521123622|FG003|Stage 1|Death|2|||
144525082|NCT02268253|521123623|FG004|Stage 1|Death|1|||
144525083|NCT02268253|521123624|FG005|Stage 1|Death|1|||
144599537|NCT01839487|521396234|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
144599538|NCT01839487|521396235|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
144599539|NCT01839487|521396236|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
144405458|NCT01153347|520695392|FG000|Overall Study|Withdrawal by Subject|7|||
144405459|NCT01153347|520695393|FG001|Overall Study|Withdrawal by Subject|7|||
144405460|NCT01153347|520695394|FG002|Overall Study|Withdrawal by Subject|7|||
144405461|NCT01153347|520695395|FG003|Overall Study|Withdrawal by Subject|7|||
144405462|NCT01153347|520695392|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144405463|NCT01153347|520695393|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144405464|NCT01153347|520695394|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
144405465|NCT01153347|520695395|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
144405466|NCT01153347|520695392|FG000|Overall Study|Adverse Event|3|||
144405467|NCT01153347|520695393|FG001|Overall Study|Adverse Event|9|||
144405468|NCT01153347|520695394|FG002|Overall Study|Adverse Event|21|||
144405469|NCT01153347|520695395|FG003|Overall Study|Adverse Event|7|||
144525084|NCT02268253|521123625|FG006|Stage 1|Death|0|||
144525085|NCT02268253|521123619|FG000|Stage 2|Disease Recurrence/ Progression|0|||
144405470|NCT01153347|520695392|FG000|Overall Study|Severe non-compliance to protocol|6|||
144525086|NCT02268253|521123620|FG001|Stage 2|Disease Recurrence/ Progression|0|||
144405471|NCT01153347|520695393|FG001|Overall Study|Severe non-compliance to protocol|7|||
144405472|NCT01153347|520695394|FG002|Overall Study|Severe non-compliance to protocol|4|||
144405473|NCT01153347|520695395|FG003|Overall Study|Severe non-compliance to protocol|3|||
144405474|NCT01153347|520695392|FG000|Overall Study|Condition under investigation worsened|1|||
144405475|NCT01153347|520695393|FG001|Overall Study|Condition under investigation worsened|1|||
144405476|NCT01153347|520695394|FG002|Overall Study|Condition under investigation worsened|0|||
144405477|NCT01153347|520695395|FG003|Overall Study|Condition under investigation worsened|0|||
144405478|NCT01153347|520695392|FG000|Overall Study|Lack of Efficacy|2|||
144405479|NCT01153347|520695393|FG001|Overall Study|Lack of Efficacy|2|||
144405480|NCT01153347|520695394|FG002|Overall Study|Lack of Efficacy|0|||
144405481|NCT01153347|520695395|FG003|Overall Study|Lack of Efficacy|4|||
144405482|NCT01153347|520695392|FG000|Overall Study|Study-specific withdrawal criteria|4|||
144405483|NCT01153347|520695393|FG001|Overall Study|Study-specific withdrawal criteria|3|||
144405484|NCT01153347|520695394|FG002|Overall Study|Study-specific withdrawal criteria|1|||
144405485|NCT01153347|520695395|FG003|Overall Study|Study-specific withdrawal criteria|2|||
144405486|NCT01153347|520695392|FG000|Overall Study|Lost to Follow-up|4|||
144405487|NCT01153347|520695393|FG001|Overall Study|Lost to Follow-up|9|||
144405488|NCT01153347|520695394|FG002|Overall Study|Lost to Follow-up|11|||
144405489|NCT01153347|520695395|FG003|Overall Study|Lost to Follow-up|8|||
144405490|NCT01153347|520695392|FG000|Overall Study|Other|5|||
144405491|NCT01153347|520695393|FG001|Overall Study|Other|5|||
144405492|NCT01153347|520695394|FG002|Overall Study|Other|4|||
144405493|NCT01153347|520695395|FG003|Overall Study|Other|0|||
144405494|NCT01153347|520695392|FG000|Overall Study|Death|1|||
144405495|NCT01153347|520695393|FG001|Overall Study|Death|0|||
144405496|NCT01153347|520695394|FG002|Overall Study|Death|0|||
144405497|NCT01153347|520695395|FG003|Overall Study|Death|0|||
144405498|NCT05096221|520695398|FG000|Part 2|Physician Decision|0|||
144405499|NCT05096221|520695399|FG001|Part 2|Physician Decision|1|||
144405500|NCT04678661|520695400|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
144405501|NCT04678661|520695401|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
144405502|NCT04678661|520695400|FG000|Overall Study|Protocol Violation|2|||
144405503|NCT04678661|520695401|FG001|Overall Study|Protocol Violation|0|||
144405504|NCT04678661|520695400|FG000|Overall Study|Withdrawal by Subject|1|||
144405505|NCT04678661|520695401|FG001|Overall Study|Withdrawal by Subject|0|||
144405506|NCT04678661|520695400|FG000|Overall Study|Lost to Follow-up|2|||
144405507|NCT04678661|520695401|FG001|Overall Study|Lost to Follow-up|0|||
144405508|NCT04678661|520695400|FG000|Overall Study|Death|2|||
144405509|NCT04678661|520695401|FG001|Overall Study|Death|0|||
144405510|NCT01086033|520695402|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
144405511|NCT01086033|520695402|FG000|Overall Study|Lost to Follow-up|86|||
144405512|NCT01086033|520695402|FG000|Overall Study|Adverse Event|42|||
144405513|NCT01086033|520695402|FG000|Overall Study|Withdrawal by Subject|41|||
144405514|NCT01086033|520695402|FG000|Overall Study|Other|14|||
144599540|NCT01839487|521396237|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
144599541|NCT01839487|521396238|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
144599542|NCT01839487|521396233|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
144599543|NCT01839487|521396234|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
144599544|NCT01839487|521396235|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
144599545|NCT01839487|521396236|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
144599546|NCT01839487|521396237|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
144599547|NCT01839487|521396238|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
144599548|NCT01839487|521396233|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
144599549|NCT01839487|521396234|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
144599550|NCT01839487|521396235|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
144599551|NCT01839487|521396236|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
144599552|NCT01839487|521396237|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
144599553|NCT01839487|521396238|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
144599554|NCT01839487|521396233|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
144599555|NCT01839487|521396234|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
144599556|NCT01839487|521396235|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
144405515|NCT01086033|520695402|FG000|Overall Study|Other|13|||
144405516|NCT01086033|520695402|FG000|Overall Study|AE and Withdrew Consent|5|||
144405517|NCT01086033|520695402|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
144405518|NCT01086033|520695402|FG000|Overall Study|Withdrew consent and Other Reason|4|||
144405519|NCT01086033|520695402|FG000|Overall Study|AE and Lack of Efficacy|4|||
144405520|NCT01086033|520695402|FG000|Overall Study|Death|1|||
144405521|NCT01086033|520695402|FG000|Overall Study|AE and Lost to Follow-up|1|||
144405522|NCT01086033|520695402|FG000|Overall Study|AE and Other Reason|1|||
144599557|NCT01839487|521396236|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
144405523|NCT01086033|520695402|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
144405524|NCT04645953|520695403|FG000|Overall Study|Lost to Follow-up|2|||
144405525|NCT04645953|520695404|FG001|Overall Study|Lost to Follow-up|1|||
144405526|NCT04645953|520695405|FG002|Overall Study|Lost to Follow-up|1|||
144405527|NCT04645953|520695403|FG000|Overall Study|Withdrawal by Subject|0|||
144405528|NCT04645953|520695404|FG001|Overall Study|Withdrawal by Subject|1|||
144405529|NCT04645953|520695405|FG002|Overall Study|Withdrawal by Subject|0|||
144405530|NCT04645953|520695403|FG000|Overall Study|Physician Decision|0|||
144405531|NCT04645953|520695404|FG001|Overall Study|Physician Decision|1|||
144405532|NCT04645953|520695405|FG002|Overall Study|Physician Decision|0|||
144405533|NCT04645953|520695403|FG000|Overall Study|Discontinued Prior to Dosing|0|||
144405534|NCT04645953|520695404|FG001|Overall Study|Discontinued Prior to Dosing|0|||
144405535|NCT04645953|520695405|FG002|Overall Study|Discontinued Prior to Dosing|2|||
144405536|NCT00864721|520695406|FG000|Overall Study|Patient request|11|||
144405537|NCT00864721|520695406|FG000|Overall Study|Hospitalized|1|||
144525087|NCT02268253|521123621|FG002|Stage 2|Disease Recurrence/ Progression|1|||
144525088|NCT02268253|521123622|FG003|Stage 2|Disease Recurrence/ Progression|0|||
144405538|NCT00864721|520695406|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
144405539|NCT00864721|520695406|FG000|Overall Study|Adverse Event|21|||
144405540|NCT01921387|520695409|FG000|Overall Study|Adverse Event|1|||
144525089|NCT02268253|521123623|FG004|Stage 2|Disease Recurrence/ Progression|0|||
144525090|NCT02268253|521123624|FG005|Stage 2|Disease Recurrence/ Progression|0|||
144525091|NCT02268253|521123625|FG006|Stage 2|Disease Recurrence/ Progression|0|||
144525092|NCT02268253|521123619|FG000|Stage 2|Withdrawal by Subject|0|||
144525093|NCT02268253|521123620|FG001|Stage 2|Withdrawal by Subject|0|||
144525094|NCT02268253|521123621|FG002|Stage 2|Withdrawal by Subject|2|||
144525095|NCT02268253|521123622|FG003|Stage 2|Withdrawal by Subject|0|||
144525096|NCT02268253|521123623|FG004|Stage 2|Withdrawal by Subject|0|||
144525097|NCT02268253|521123624|FG005|Stage 2|Withdrawal by Subject|2|||
144525098|NCT02268253|521123625|FG006|Stage 2|Withdrawal by Subject|0|||
144525099|NCT02268253|521123619|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
144525100|NCT02268253|521123620|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
144525101|NCT02268253|521123621|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
144525102|NCT02268253|521123622|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
144525103|NCT02268253|521123623|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
144525104|NCT02268253|521123624|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
144525105|NCT02268253|521123625|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
144525106|NCT02268253|521123619|FG000|Stage 2|Death|0|||
144525107|NCT02268253|521123620|FG001|Stage 2|Death|0|||
144525108|NCT02268253|521123621|FG002|Stage 2|Death|19|||
144525109|NCT02268253|521123622|FG003|Stage 2|Death|0|||
144525110|NCT02268253|521123623|FG004|Stage 2|Death|0|||
144525111|NCT02268253|521123624|FG005|Stage 2|Death|20|||
144525112|NCT02268253|521123625|FG006|Stage 2|Death|1|||
144525113|NCT02268253|521123619|FG000|Stage 2|Lost to Follow-up|0|||
144525114|NCT02268253|521123620|FG001|Stage 2|Lost to Follow-up|0|||
144525115|NCT02268253|521123621|FG002|Stage 2|Lost to Follow-up|0|||
144525116|NCT02268253|521123622|FG003|Stage 2|Lost to Follow-up|0|||
144525117|NCT02268253|521123623|FG004|Stage 2|Lost to Follow-up|0|||
144525118|NCT02268253|521123624|FG005|Stage 2|Lost to Follow-up|4|||
144525119|NCT02268253|521123625|FG006|Stage 2|Lost to Follow-up|0|||
144525120|NCT02268253|521123619|FG000|Stage 2|Transferred to Hospice|0|||
144525121|NCT02268253|521123620|FG001|Stage 2|Transferred to Hospice|0|||
144525122|NCT02268253|521123621|FG002|Stage 2|Transferred to Hospice|0|||
144525123|NCT02268253|521123622|FG003|Stage 2|Transferred to Hospice|0|||
144525124|NCT02268253|521123623|FG004|Stage 2|Transferred to Hospice|0|||
144525125|NCT02268253|521123624|FG005|Stage 2|Transferred to Hospice|2|||
144525126|NCT02268253|521123625|FG006|Stage 2|Transferred to Hospice|0|||
144405541|NCT03741062|520695410|FG000|Overall Study|Protocol Violation|1|||
144525127|NCT02268253|521123619|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
144525128|NCT02268253|521123620|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
144525129|NCT02268253|521123621|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
144525130|NCT02268253|521123622|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
144525131|NCT02268253|521123623|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
144525132|NCT02268253|521123624|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
144525133|NCT02268253|521123625|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
144525134|NCT02268253|521123619|FG000|Stage 3A|Withdrawal by Subject|0|||
144525135|NCT02268253|521123620|FG001|Stage 3A|Withdrawal by Subject|0|||
144525136|NCT02268253|521123621|FG002|Stage 3A|Withdrawal by Subject|2|||
144525137|NCT02268253|521123622|FG003|Stage 3A|Withdrawal by Subject|0|||
144525138|NCT02268253|521123623|FG004|Stage 3A|Withdrawal by Subject|0|||
144525139|NCT02268253|521123624|FG005|Stage 3A|Withdrawal by Subject|0|||
144525140|NCT02268253|521123625|FG006|Stage 3A|Withdrawal by Subject|0|||
144525141|NCT02268253|521123619|FG000|Stage 3A|Physician Decision|0|||
144525142|NCT02268253|521123620|FG001|Stage 3A|Physician Decision|0|||
144405542|NCT03741062|520695411|FG001|Overall Study|Protocol Violation|0|||
144405543|NCT02763462|520695414|FG000|Overall Study|Protocol Violation|6|||
144405544|NCT00261807|520695415|FG000|Overall Study|Lost to Follow-up|2|||
144405545|NCT00261807|520695415|FG000|Overall Study|Adverse Event|2|||
144405546|NCT00261807|520695415|FG000|Overall Study|Death|1|||
144405547|NCT00261807|520695415|FG000|Overall Study|Protocol Violation|2|||
144405548|NCT01706146|520695416|FG000|Overall Study|Withdrawal by Subject|1|||
144405549|NCT01706146|520695416|FG000|Overall Study|Adverse Event|3|||
144405550|NCT01706146|520695416|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
144405551|NCT02527161|520695417|FG000|Overall Study|Failed MRI|52|||
144405552|NCT02527161|520695417|FG000|Overall Study|Withdrawal by Subject|19|||
144405553|NCT02527161|520695417|FG000|Overall Study|Delay in or unfit for surgery|16|||
144405554|NCT02527161|520695417|FG000|Overall Study|MRI contraindication|6|||
144405555|NCT02527161|520695417|FG000|Overall Study|Consent violation|4|||
144405556|NCT02527161|520695417|FG000|Overall Study|Only Recruited to Part A|27|||
144405557|NCT02527161|520695417|FG000|Overall Study|Physician Decision|1|||
144405558|NCT02527161|520695417|FG000|Overall Study|Adverse Event|1|||
144405559|NCT02527161|520695417|FG000|Overall Study|Lost to Follow-up|6|||
144405560|NCT02100514|520695418|FG000|Treatment Period|Adverse Event|0|||
144405561|NCT02100514|520695419|FG001|Treatment Period|Adverse Event|5|||
144405562|NCT02100514|520695420|FG002|Treatment Period|Adverse Event|0|||
144405563|NCT02100514|520695421|FG003|Treatment Period|Adverse Event|0|||
144405564|NCT02100514|520695422|FG004|Treatment Period|Adverse Event|0|||
144405565|NCT02100514|520695418|FG000|Treatment Period|Death|2|||
144405566|NCT02100514|520695419|FG001|Treatment Period|Death|2|||
144405567|NCT02100514|520695420|FG002|Treatment Period|Death|0|||
144405568|NCT02100514|520695421|FG003|Treatment Period|Death|0|||
144405569|NCT02100514|520695422|FG004|Treatment Period|Death|0|||
144405570|NCT02100514|520695418|FG000|Treatment Period|Lost to Follow-up|5|||
144405571|NCT02100514|520695419|FG001|Treatment Period|Lost to Follow-up|17|||
144405572|NCT02100514|520695420|FG002|Treatment Period|Lost to Follow-up|0|||
144405573|NCT02100514|520695421|FG003|Treatment Period|Lost to Follow-up|0|||
144405574|NCT02100514|520695422|FG004|Treatment Period|Lost to Follow-up|0|||
144405575|NCT02100514|520695418|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
144405576|NCT02100514|520695419|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
144405577|NCT02100514|520695420|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
144405578|NCT02100514|520695421|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
144405579|NCT02100514|520695422|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
144525143|NCT02268253|521123621|FG002|Stage 3A|Physician Decision|2|||
144525144|NCT02268253|521123622|FG003|Stage 3A|Physician Decision|0|||
144525145|NCT02268253|521123623|FG004|Stage 3A|Physician Decision|0|||
144525146|NCT02268253|521123624|FG005|Stage 3A|Physician Decision|0|||
144525147|NCT02268253|521123625|FG006|Stage 3A|Physician Decision|0|||
144525148|NCT02268253|521123619|FG000|Stage 3A|Study Terminated by Sponsor|0|||
144525149|NCT02268253|521123620|FG001|Stage 3A|Study Terminated by Sponsor|0|||
144525150|NCT02268253|521123621|FG002|Stage 3A|Study Terminated by Sponsor|2|||
144525151|NCT02268253|521123622|FG003|Stage 3A|Study Terminated by Sponsor|0|||
144525152|NCT02268253|521123623|FG004|Stage 3A|Study Terminated by Sponsor|0|||
144525153|NCT02268253|521123624|FG005|Stage 3A|Study Terminated by Sponsor|0|||
144525154|NCT02268253|521123625|FG006|Stage 3A|Study Terminated by Sponsor|0|||
144525155|NCT02268253|521123619|FG000|Stage 3A|Lost to Follow-up|0|||
144525156|NCT02268253|521123620|FG001|Stage 3A|Lost to Follow-up|0|||
144525157|NCT02268253|521123621|FG002|Stage 3A|Lost to Follow-up|1|||
144525158|NCT02268253|521123622|FG003|Stage 3A|Lost to Follow-up|0|||
144525159|NCT02268253|521123623|FG004|Stage 3A|Lost to Follow-up|0|||
144525160|NCT02268253|521123624|FG005|Stage 3A|Lost to Follow-up|0|||
144525161|NCT02268253|521123625|FG006|Stage 3A|Lost to Follow-up|0|||
144525162|NCT02268253|521123619|FG000|Stage 3A|Death|0|||
144525163|NCT02268253|521123620|FG001|Stage 3A|Death|0|||
144525164|NCT02268253|521123621|FG002|Stage 3A|Death|5|||
144525165|NCT02268253|521123622|FG003|Stage 3A|Death|0|||
144525166|NCT02268253|521123623|FG004|Stage 3A|Death|0|||
144525167|NCT02268253|521123624|FG005|Stage 3A|Death|0|||
144405580|NCT02100514|520695418|FG000|Treatment Period|Protocol Violation|1|||
144405581|NCT02100514|520695419|FG001|Treatment Period|Protocol Violation|1|||
144405582|NCT02100514|520695420|FG002|Treatment Period|Protocol Violation|0|||
144405583|NCT02100514|520695421|FG003|Treatment Period|Protocol Violation|0|||
144405584|NCT02100514|520695422|FG004|Treatment Period|Protocol Violation|0|||
144525168|NCT02268253|521123625|FG006|Stage 3A|Death|0|||
144525169|NCT05714761|521123626|FG000|Overall Study|Lost to Follow-up|3|||
144525170|NCT05714761|521123626|FG000|Overall Study|Withdrawal by Subject|3|||
144525171|NCT05714761|521123626|FG000|Overall Study|unblinding of sensor data|1|||
144525172|NCT05714761|521123626|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
144525173|NCT05714761|521123626|FG000|Overall Study|did not return second CGM sensor|4|||
144405585|NCT02100514|520695418|FG000|Treatment Period|Withdrawal by Subject|12|||
144405586|NCT02100514|520695419|FG001|Treatment Period|Withdrawal by Subject|37|||
144405587|NCT02100514|520695420|FG002|Treatment Period|Withdrawal by Subject|0|||
144525174|NCT03092518|521123628|FG000|Overall Study|Ineligible|2|||
144525175|NCT02547987|521123629|FG000|Overall Study|Withdrawal by Subject|1|||
144405588|NCT02100514|520695421|FG003|Treatment Period|Withdrawal by Subject|0|||
144405589|NCT02100514|520695422|FG004|Treatment Period|Withdrawal by Subject|0|||
144405590|NCT02100514|520695418|FG000|Treatment Period|Other|9|||
144405591|NCT02100514|520695419|FG001|Treatment Period|Other|11|||
144405592|NCT02100514|520695420|FG002|Treatment Period|Other|0|||
144405593|NCT02100514|520695421|FG003|Treatment Period|Other|0|||
144405594|NCT02100514|520695422|FG004|Treatment Period|Other|0|||
144405595|NCT02100514|520695418|FG000|Extension Period|Withdrew consent|0|||
144405596|NCT02100514|520695419|FG001|Extension Period|Withdrew consent|0|||
144405597|NCT02100514|520695420|FG002|Extension Period|Withdrew consent|2|||
144405598|NCT02100514|520695421|FG003|Extension Period|Withdrew consent|0|||
144405599|NCT02100514|520695422|FG004|Extension Period|Withdrew consent|0|||
144405600|NCT02747875|520695435|FG000|Overall Study|Physician Decision|1|||
144405601|NCT02747875|520695436|FG001|Overall Study|Physician Decision|0|||
144405602|NCT02747875|520695435|FG000|Overall Study|Adverse Event|0|||
144405603|NCT02747875|520695436|FG001|Overall Study|Adverse Event|1|||
144405604|NCT03570697|520695437|FG000|Overall Study|Lost to Follow-up|0|||
144405605|NCT03570697|520695438|FG001|Overall Study|Lost to Follow-up|1|||
144405606|NCT03570697|520695437|FG000|Overall Study|Death|2|||
144405607|NCT03570697|520695438|FG001|Overall Study|Death|0|||
144405608|NCT03570697|520695437|FG000|Overall Study|Withdrawal by Subject|4|||
144405609|NCT03570697|520695438|FG001|Overall Study|Withdrawal by Subject|2|||
144405610|NCT01876420|520695440|FG000|Overall Study|Missed 30 day visit|1|||
144405611|NCT03173313|520695441|FG000|Overall Study|Lost to Follow-up|2|||
144405612|NCT03173313|520695442|FG001|Overall Study|Lost to Follow-up|3|||
144405613|NCT03173313|520695441|FG000|Overall Study|Withdrawal by Subject|0|||
144405614|NCT03173313|520695442|FG001|Overall Study|Withdrawal by Subject|1|||
144405615|NCT03173313|520695441|FG000|Overall Study|Death|5|||
144405616|NCT03173313|520695442|FG001|Overall Study|Death|0|||
144405617|NCT03173313|520695441|FG000|Overall Study|Physician Decision|1|||
144405618|NCT03173313|520695442|FG001|Overall Study|Physician Decision|0|||
144405619|NCT03173313|520695441|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
144405620|NCT03173313|520695442|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
144405621|NCT03173313|520695441|FG000|Overall Study|Bone Fracture|1|||
144405622|NCT03173313|520695442|FG001|Overall Study|Bone Fracture|0|||
144405623|NCT05338216|520695445|FG000|Overall Study|Withdrawal by Subject|1|||
144405624|NCT05338216|520695446|FG001|Overall Study|Withdrawal by Subject|1|||
144405625|NCT04457336|520695447|FG000|Period 2: Part A|Withdrawal by Subject|0|||
144405626|NCT04457336|520695448|FG001|Period 2: Part A|Withdrawal by Subject|1|||
144405627|NCT04457336|520695449|FG002|Period 2: Part A|Withdrawal by Subject|1|||
144405628|NCT04457336|520695450|FG003|Period 2: Part A|Withdrawal by Subject|1|||
144405629|NCT04457336|520695451|FG004|Period 2: Part A|Withdrawal by Subject|0|||
144405630|NCT04457336|520695452|FG005|Period 2: Part A|Withdrawal by Subject|0|||
144405631|NCT04457336|520695453|FG006|Period 2: Part A|Withdrawal by Subject|0|||
144405632|NCT04457336|520695454|FG007|Period 2: Part A|Withdrawal by Subject|0|||
144405633|NCT04457336|520695447|FG000|Period 2: Part A|Adverse Event|0|||
144405634|NCT04457336|520695448|FG001|Period 2: Part A|Adverse Event|0|||
144405635|NCT04457336|520695449|FG002|Period 2: Part A|Adverse Event|1|||
144405636|NCT04457336|520695450|FG003|Period 2: Part A|Adverse Event|1|||
144405637|NCT04457336|520695451|FG004|Period 2: Part A|Adverse Event|0|||
144405638|NCT04457336|520695452|FG005|Period 2: Part A|Adverse Event|0|||
144405639|NCT04457336|520695453|FG006|Period 2: Part A|Adverse Event|0|||
144405640|NCT04457336|520695454|FG007|Period 2: Part A|Adverse Event|0|||
144525176|NCT02547987|521123629|FG000|Overall Study|Adverse Event|2|||
144525177|NCT05362487|521123630|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
144525178|NCT02146378|521123631|FG000|Overall Study|No information of administration|2|||
144525179|NCT04096040|521123641|FG000|Overall Study|Protocol Violation|12|||
144525180|NCT04096040|521123641|FG000|Overall Study|Non-compliant site|4|||
144525181|NCT03603600|521123644|FG000|Overall Study|Withdrawal by Subject|5|||
144525182|NCT03603600|521123645|FG001|Overall Study|Withdrawal by Subject|7|||
144525183|NCT03603600|521123644|FG000|Overall Study|Lost to Follow-up|2|||
144405641|NCT04457336|520695447|FG000|Period 2: Part A|Study Terminated|0|||
144405642|NCT04457336|520695448|FG001|Period 2: Part A|Study Terminated|0|||
144405643|NCT04457336|520695449|FG002|Period 2: Part A|Study Terminated|1|||
144405644|NCT04457336|520695450|FG003|Period 2: Part A|Study Terminated|0|||
144405645|NCT04457336|520695451|FG004|Period 2: Part A|Study Terminated|0|||
144405646|NCT04457336|520695452|FG005|Period 2: Part A|Study Terminated|0|||
144525184|NCT03603600|521123645|FG001|Overall Study|Lost to Follow-up|3|||
144405647|NCT04457336|520695453|FG006|Period 2: Part A|Study Terminated|0|||
144405648|NCT04457336|520695454|FG007|Period 2: Part A|Study Terminated|0|||
144405649|NCT04457336|520695447|FG000|Period 2: Part A|Protocol Violation|0|||
144405650|NCT04457336|520695448|FG001|Period 2: Part A|Protocol Violation|1|||
144405651|NCT04457336|520695449|FG002|Period 2: Part A|Protocol Violation|0|||
144405652|NCT04457336|520695450|FG003|Period 2: Part A|Protocol Violation|0|||
144405653|NCT04457336|520695451|FG004|Period 2: Part A|Protocol Violation|0|||
144405654|NCT04457336|520695452|FG005|Period 2: Part A|Protocol Violation|0|||
144405655|NCT04457336|520695453|FG006|Period 2: Part A|Protocol Violation|0|||
144405656|NCT04457336|520695454|FG007|Period 2: Part A|Protocol Violation|0|||
144525185|NCT03603600|521123644|FG000|Overall Study|Death|3|||
144405657|NCT04457336|520695447|FG000|Period 2: Part A|Lost to Follow-up|0|||
144405658|NCT04457336|520695448|FG001|Period 2: Part A|Lost to Follow-up|1|||
144405659|NCT04457336|520695449|FG002|Period 2: Part A|Lost to Follow-up|0|||
144405660|NCT04457336|520695450|FG003|Period 2: Part A|Lost to Follow-up|0|||
144405661|NCT04457336|520695451|FG004|Period 2: Part A|Lost to Follow-up|0|||
144405662|NCT04457336|520695452|FG005|Period 2: Part A|Lost to Follow-up|0|||
144405663|NCT04457336|520695453|FG006|Period 2: Part A|Lost to Follow-up|0|||
144405664|NCT04457336|520695454|FG007|Period 2: Part A|Lost to Follow-up|0|||
144405665|NCT04457336|520695447|FG000|Period 2: Part A|Other|0|||
144405666|NCT04457336|520695448|FG001|Period 2: Part A|Other|1|||
144405667|NCT04457336|520695449|FG002|Period 2: Part A|Other|0|||
144405668|NCT04457336|520695450|FG003|Period 2: Part A|Other|0|||
144405669|NCT04457336|520695451|FG004|Period 2: Part A|Other|0|||
144405670|NCT04457336|520695452|FG005|Period 2: Part A|Other|0|||
144405671|NCT04457336|520695453|FG006|Period 2: Part A|Other|0|||
144405672|NCT04457336|520695454|FG007|Period 2: Part A|Other|0|||
144405673|NCT04457336|520695447|FG000|Period 2: Part A|Physician Decision|0|||
144405674|NCT04457336|520695448|FG001|Period 2: Part A|Physician Decision|0|||
144405675|NCT04457336|520695449|FG002|Period 2: Part A|Physician Decision|0|||
144405676|NCT04457336|520695450|FG003|Period 2: Part A|Physician Decision|1|||
144405677|NCT04457336|520695451|FG004|Period 2: Part A|Physician Decision|0|||
144405678|NCT04457336|520695452|FG005|Period 2: Part A|Physician Decision|0|||
144405679|NCT04457336|520695453|FG006|Period 2: Part A|Physician Decision|0|||
144405680|NCT04457336|520695454|FG007|Period 2: Part A|Physician Decision|0|||
144405681|NCT04457336|520695447|FG000|Period 3: Part B|Study Terminated|0|||
144405682|NCT04457336|520695448|FG001|Period 3: Part B|Study Terminated|0|||
144405683|NCT04457336|520695449|FG002|Period 3: Part B|Study Terminated|0|||
144405684|NCT04457336|520695450|FG003|Period 3: Part B|Study Terminated|0|||
144405685|NCT04457336|520695451|FG004|Period 3: Part B|Study Terminated|1|||
144405686|NCT04457336|520695452|FG005|Period 3: Part B|Study Terminated|10|||
144405687|NCT04457336|520695453|FG006|Period 3: Part B|Study Terminated|13|||
144405688|NCT04457336|520695454|FG007|Period 3: Part B|Study Terminated|0|||
144405689|NCT04457336|520695447|FG000|Period 3: Part B|Withdrawal by Subject|0|||
144405690|NCT04457336|520695448|FG001|Period 3: Part B|Withdrawal by Subject|0|||
144405691|NCT04457336|520695449|FG002|Period 3: Part B|Withdrawal by Subject|0|||
144405692|NCT04457336|520695450|FG003|Period 3: Part B|Withdrawal by Subject|0|||
144405693|NCT04457336|520695451|FG004|Period 3: Part B|Withdrawal by Subject|0|||
144405694|NCT04457336|520695452|FG005|Period 3: Part B|Withdrawal by Subject|1|||
144405695|NCT04457336|520695453|FG006|Period 3: Part B|Withdrawal by Subject|2|||
144405696|NCT04457336|520695454|FG007|Period 3: Part B|Withdrawal by Subject|0|||
144405697|NCT04457336|520695447|FG000|Period 4: Part C|Study Terminated|0|||
144405698|NCT04457336|520695448|FG001|Period 4: Part C|Study Terminated|0|||
144405699|NCT04457336|520695449|FG002|Period 4: Part C|Study Terminated|0|||
144405700|NCT04457336|520695450|FG003|Period 4: Part C|Study Terminated|0|||
144405701|NCT04457336|520695451|FG004|Period 4: Part C|Study Terminated|0|||
144405702|NCT04457336|520695452|FG005|Period 4: Part C|Study Terminated|0|||
144405703|NCT04457336|520695453|FG006|Period 4: Part C|Study Terminated|0|||
144405704|NCT04457336|520695454|FG007|Period 4: Part C|Study Terminated|30|||
144405705|NCT04457336|520695447|FG000|Period 4: Part C|Adverse Event|0|||
144405706|NCT04457336|520695448|FG001|Period 4: Part C|Adverse Event|0|||
144405707|NCT04457336|520695449|FG002|Period 4: Part C|Adverse Event|0|||
144405708|NCT04457336|520695450|FG003|Period 4: Part C|Adverse Event|0|||
144405709|NCT04457336|520695451|FG004|Period 4: Part C|Adverse Event|0|||
144525186|NCT03603600|521123645|FG001|Overall Study|Death|1|||
144525187|NCT03603600|521123644|FG000|Overall Study|Physician Decision|2|||
144525188|NCT03603600|521123645|FG001|Overall Study|Physician Decision|1|||
144525189|NCT03603600|521123644|FG000|Overall Study|Other reason|1|||
144525190|NCT03603600|521123645|FG001|Overall Study|Other reason|0|||
144525191|NCT04973254|521123646|FG000|Overall Study|Not adherent|0|||
144525192|NCT04973254|521123647|FG001|Overall Study|Not adherent|1|||
144525193|NCT04973254|521123648|FG002|Overall Study|Not adherent|0|||
144525194|NCT04044768|521123649|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
144405710|NCT04457336|520695452|FG005|Period 4: Part C|Adverse Event|0|||
144405711|NCT04457336|520695453|FG006|Period 4: Part C|Adverse Event|0|||
144405712|NCT04457336|520695454|FG007|Period 4: Part C|Adverse Event|2|||
144405713|NCT04457336|520695447|FG000|Period 4: Part C|Site Terminated|0|||
144405714|NCT04457336|520695448|FG001|Period 4: Part C|Site Terminated|0|||
144405715|NCT04457336|520695449|FG002|Period 4: Part C|Site Terminated|0|||
144405716|NCT04457336|520695450|FG003|Period 4: Part C|Site Terminated|0|||
144405717|NCT04457336|520695451|FG004|Period 4: Part C|Site Terminated|0|||
144405718|NCT04457336|520695452|FG005|Period 4: Part C|Site Terminated|0|||
144405719|NCT04457336|520695453|FG006|Period 4: Part C|Site Terminated|0|||
144525195|NCT04044768|521123650|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
144525196|NCT05089019|521123654|FG000|Period 1|Withdrawal by Subject|0|||
144405720|NCT04457336|520695454|FG007|Period 4: Part C|Site Terminated|1|||
144405721|NCT04457336|520695447|FG000|Period 4: Part C|Other|0|||
144405722|NCT04457336|520695448|FG001|Period 4: Part C|Other|0|||
144525197|NCT05089019|521123655|FG001|Period 1|Withdrawal by Subject|1|||
144405723|NCT04457336|520695449|FG002|Period 4: Part C|Other|0|||
144405724|NCT04457336|520695450|FG003|Period 4: Part C|Other|0|||
144405725|NCT04457336|520695451|FG004|Period 4: Part C|Other|0|||
144405726|NCT04457336|520695452|FG005|Period 4: Part C|Other|0|||
144405727|NCT04457336|520695453|FG006|Period 4: Part C|Other|0|||
144405728|NCT04457336|520695454|FG007|Period 4: Part C|Other|2|||
144405729|NCT04457336|520695447|FG000|Period 4: Part C|Withdrawal by Subject|0|||
144405730|NCT04457336|520695448|FG001|Period 4: Part C|Withdrawal by Subject|0|||
144405731|NCT04457336|520695449|FG002|Period 4: Part C|Withdrawal by Subject|0|||
144405732|NCT04457336|520695450|FG003|Period 4: Part C|Withdrawal by Subject|0|||
144405733|NCT04457336|520695451|FG004|Period 4: Part C|Withdrawal by Subject|0|||
144405734|NCT04457336|520695452|FG005|Period 4: Part C|Withdrawal by Subject|0|||
144405735|NCT04457336|520695453|FG006|Period 4: Part C|Withdrawal by Subject|0|||
144405736|NCT04457336|520695454|FG007|Period 4: Part C|Withdrawal by Subject|3|||
144405737|NCT03330288|520695461|FG000|Overall Study|Other reason|1|||
144405738|NCT03330288|520695462|FG001|Overall Study|Other reason|1|||
144405739|NCT03330288|520695461|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
144405740|NCT03330288|520695462|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
144405741|NCT03330288|520695461|FG000|Overall Study|Adverse Event|1|||
144405742|NCT03330288|520695462|FG001|Overall Study|Adverse Event|0|||
144405743|NCT03330288|520695461|FG000|Overall Study|Withdrawal by Subject|1|||
144405744|NCT03330288|520695462|FG001|Overall Study|Withdrawal by Subject|0|||
144405745|NCT03330288|520695461|FG000|Overall Study|Lost to Follow-up|26|||
144405746|NCT03330288|520695462|FG001|Overall Study|Lost to Follow-up|7|||
144405747|NCT01042678|520695463|FG000|Overall Study|Physician Decision|1|||
144405748|NCT01042678|520695464|FG001|Overall Study|Physician Decision|0|||
144405749|NCT01042678|520695465|FG002|Overall Study|Physician Decision|0|||
144405750|NCT01042678|520695466|FG003|Overall Study|Physician Decision|0|||
144405751|NCT01042678|520695467|FG004|Overall Study|Physician Decision|0|||
144405752|NCT01042678|520695468|FG005|Overall Study|Physician Decision|0|||
144250000|NCT00153816|520113427|FG003|Overall Study|Follow-up exam not done|10|||
144250001|NCT00153816|520113428|FG004|Overall Study|Follow-up exam not done|8|||
144250002|NCT00153816|520113429|FG005|Overall Study|Follow-up exam not done|9|||
144250003|NCT00153816|520113424|FG000|Overall Study|Follow-up exam done, histology missing|2|||
144405753|NCT01719783|520695471|FG000|Dose 2|Physician Decision|1|||
144250004|NCT00153816|520113425|FG001|Overall Study|Follow-up exam done, histology missing|3|||
144250005|NCT00153816|520113426|FG002|Overall Study|Follow-up exam done, histology missing|3|||
144250006|NCT00153816|520113427|FG003|Overall Study|Follow-up exam done, histology missing|3|||
144250007|NCT00153816|520113428|FG004|Overall Study|Follow-up exam done, histology missing|1|||
144250008|NCT00153816|520113429|FG005|Overall Study|Follow-up exam done, histology missing|2|||
144405754|NCT01719783|520695472|FG001|Dose 2|Physician Decision|0|||
144405755|NCT01350492|520695473|FG000|Intervention|Lost to Follow-up|2|||
144405756|NCT01350492|520695474|FG001|Intervention|Lost to Follow-up|5|||
144405757|NCT01350492|520695473|FG000|Intervention|Withdrawal by Subject|3|||
144405758|NCT01350492|520695474|FG001|Intervention|Withdrawal by Subject|1|||
144405759|NCT01350492|520695473|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
144405760|NCT01350492|520695474|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
144405761|NCT01350492|520695473|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
144405762|NCT01350492|520695474|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
144405763|NCT00205881|520695475|FG000|Overall Study|Withdrawal by Subject|16|||
144405764|NCT00702689|520695476|FG000|Overall Study|Withdrawal by Subject|4|||
144405765|NCT00702689|520695476|FG000|Overall Study|Recurrent malignancy|1|||
144405766|NCT00702689|520695476|FG000|Overall Study|Adverse Event|1|||
144405767|NCT02805972|520695479|FG000|Washout Period|Lost to Follow-up|3|||
144405768|NCT02805972|520695480|FG001|Washout Period|Lost to Follow-up|0|||
144405769|NCT00369824|520695483|FG000|Overall Study|Adverse Event|0|||
144405770|NCT00369824|520695484|FG001|Overall Study|Adverse Event|2|||
144405771|NCT00369824|520695485|FG002|Overall Study|Adverse Event|0|||
144599558|NCT01839487|521396237|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
144599559|NCT01839487|521396238|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
144599560|NCT01839487|521396233|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
144599561|NCT01839487|521396234|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
144599562|NCT01839487|521396235|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
144599563|NCT01839487|521396236|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
144599564|NCT01839487|521396237|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
144599565|NCT01839487|521396238|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
144599566|NCT01839487|521396233|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
144599567|NCT01839487|521396234|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
144599568|NCT01839487|521396235|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
144599569|NCT01839487|521396236|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
144599570|NCT01839487|521396237|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
144599571|NCT01839487|521396238|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
144599572|NCT01839487|521396233|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
144405772|NCT00369824|520695486|FG003|Overall Study|Adverse Event|0|||
144405773|NCT00369824|520695487|FG004|Overall Study|Adverse Event|1|||
144405774|NCT00369824|520695488|FG005|Overall Study|Adverse Event|0|||
144599573|NCT01839487|521396234|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
144599574|NCT01839487|521396235|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
144599575|NCT01839487|521396236|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
144599576|NCT01839487|521396237|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
144599577|NCT01839487|521396238|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
144599578|NCT01839487|521396233|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
144599579|NCT01839487|521396234|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
144599580|NCT01839487|521396235|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
144525198|NCT05089019|521123654|FG000|Washout Period|Adverse Event|3|||
144525199|NCT05089019|521123655|FG001|Washout Period|Adverse Event|4|||
144525200|NCT05089019|521123654|FG000|Washout Period|Lost to Follow-up|1|||
144525201|NCT05089019|521123655|FG001|Washout Period|Lost to Follow-up|0|||
144525202|NCT05089019|521123654|FG000|Washout Period|Physician Decision|2|||
144525203|NCT05089019|521123655|FG001|Washout Period|Physician Decision|0|||
144525204|NCT05089019|521123654|FG000|Washout Period|Withdrawal by Subject|6|||
144525205|NCT05089019|521123655|FG001|Washout Period|Withdrawal by Subject|3|||
144525206|NCT05089019|521123654|FG000|Period 2|Adverse Event|4|||
144525207|NCT05089019|521123655|FG001|Period 2|Adverse Event|2|||
144525208|NCT05089019|521123654|FG000|Period 2|Lost to Follow-up|1|||
144525209|NCT05089019|521123655|FG001|Period 2|Lost to Follow-up|0|||
144525210|NCT05089019|521123654|FG000|Period 2|Withdrawal by Subject|0|||
144525211|NCT05089019|521123655|FG001|Period 2|Withdrawal by Subject|1|||
144525212|NCT04629716|521123656|FG000|Overall Study|Lost to Follow-up|7|||
144525213|NCT04629716|521123657|FG001|Overall Study|Lost to Follow-up|3|||
144525214|NCT01943409|521123661|FG000|Overall Study|resumed oral/entral|24|||
144525215|NCT01943409|521123662|FG001|Overall Study|resumed oral/entral|20|||
144525216|NCT01943409|521123661|FG000|Overall Study|Protocol Violation|14|||
144525217|NCT01943409|521123662|FG001|Overall Study|Protocol Violation|24|||
144525218|NCT01943409|521123661|FG000|Overall Study|Death|3|||
144525219|NCT01943409|521123662|FG001|Overall Study|Death|1|||
144525220|NCT01943409|521123661|FG000|Overall Study|Withdrawal by Subject|4|||
144525221|NCT01943409|521123662|FG001|Overall Study|Withdrawal by Subject|3|||
144525222|NCT02489903|521123663|FG000|Screening|Screen Failure|24|||
144525223|NCT02489903|521123664|FG001|Screening|Screen Failure|0|||
144525224|NCT02489903|521123665|FG002|Screening|Screen Failure|0|||
144525225|NCT02489903|521123666|FG003|Screening|Screen Failure|8|||
144525226|NCT02489903|521123663|FG000|Randomized and Received Treatment|Protocol Violation|0|||
144525227|NCT02489903|521123664|FG001|Randomized and Received Treatment|Protocol Violation|1|||
144525228|NCT02489903|521123665|FG002|Randomized and Received Treatment|Protocol Violation|0|||
144525229|NCT02489903|521123666|FG003|Randomized and Received Treatment|Protocol Violation|0|||
144525230|NCT02489903|521123663|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
144525231|NCT02489903|521123664|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
144525232|NCT02489903|521123665|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
144525233|NCT02489903|521123666|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
144525234|NCT02489903|521123663|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
144525235|NCT02489903|521123664|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
144525236|NCT02489903|521123665|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
144525237|NCT02489903|521123666|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
144525238|NCT02489903|521123663|FG000|Randomized and Received Treatment|Death|10|||
144525239|NCT02489903|521123664|FG001|Randomized and Received Treatment|Death|1|||
144525240|NCT02489903|521123665|FG002|Randomized and Received Treatment|Death|0|||
144525241|NCT02489903|521123666|FG003|Randomized and Received Treatment|Death|0|||
144525242|NCT04542317|521123667|FG000|Overall Study|Care recipients passed away|18|||
144525243|NCT04542317|521123668|FG001|Overall Study|Care recipients passed away|13|||
144525244|NCT04542317|521123667|FG000|Overall Study|No longer a primary caregiver|5|||
144525245|NCT04542317|521123668|FG001|Overall Study|No longer a primary caregiver|1|||
144525246|NCT04542317|521123667|FG000|Overall Study|Withdrawal by Subject|4|||
144525247|NCT04542317|521123668|FG001|Overall Study|Withdrawal by Subject|2|||
144525248|NCT04542317|521123667|FG000|Overall Study|Caregivers passed away|0|||
144599581|NCT01839487|521396236|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
144599582|NCT01839487|521396237|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
144599583|NCT01839487|521396238|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
144599584|NCT01839487|521396233|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
144599585|NCT01839487|521396234|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
144405775|NCT00369824|520695483|FG000|Overall Study|Protocol Violation|0|||
144525249|NCT04542317|521123668|FG001|Overall Study|Caregivers passed away|2|||
144525250|NCT02310646|521123669|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
144525251|NCT02310646|521123670|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
144525252|NCT02310646|521123669|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
144525253|NCT02310646|521123670|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
144525254|NCT03021096|521123673|FG000|Overall Study|Lost to Follow-up|4|||
144525255|NCT03021096|521123673|FG000|Overall Study|Protocol Violation|2|||
144525256|NCT04700163|521123674|FG000|Overall Study|Lost to Follow-up|0|||
144722540|NCT01199601|521838772|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
144722541|NCT00278512|521838774|FG000|Overall Study|Death|1|||
144722542|NCT00278512|521838775|FG001|Overall Study|Death|0|||
144722543|NCT01620177|521838776|FG000|Overall Study|Failure at Screening Visit|43|||
144722544|NCT01620177|521838776|FG000|Overall Study|Withdrawal by Subject|26|||
144722545|NCT01620177|521838776|FG000|Overall Study|Lost to Follow-up|7|||
144405776|NCT00369824|520695484|FG001|Overall Study|Protocol Violation|1|||
144405777|NCT00369824|520695485|FG002|Overall Study|Protocol Violation|0|||
144405778|NCT00369824|520695486|FG003|Overall Study|Protocol Violation|1|||
144405779|NCT00369824|520695487|FG004|Overall Study|Protocol Violation|1|||
144405780|NCT00369824|520695488|FG005|Overall Study|Protocol Violation|0|||
144405781|NCT00369824|520695483|FG000|Overall Study|Withdrawal by Subject|9|||
144405782|NCT00369824|520695484|FG001|Overall Study|Withdrawal by Subject|5|||
144405783|NCT00369824|520695485|FG002|Overall Study|Withdrawal by Subject|5|||
144405784|NCT00369824|520695486|FG003|Overall Study|Withdrawal by Subject|4|||
144405785|NCT00369824|520695487|FG004|Overall Study|Withdrawal by Subject|6|||
144405786|NCT00369824|520695488|FG005|Overall Study|Withdrawal by Subject|2|||
144405787|NCT00369824|520695483|FG000|Overall Study|Lost to Follow-up|6|||
144405788|NCT00369824|520695484|FG001|Overall Study|Lost to Follow-up|11|||
144405789|NCT00369824|520695485|FG002|Overall Study|Lost to Follow-up|7|||
144405790|NCT00369824|520695486|FG003|Overall Study|Lost to Follow-up|8|||
144405791|NCT00369824|520695487|FG004|Overall Study|Lost to Follow-up|9|||
144405792|NCT00369824|520695488|FG005|Overall Study|Lost to Follow-up|6|||
144405793|NCT00369824|520695483|FG000|Overall Study|Other|0|||
144405794|NCT00369824|520695484|FG001|Overall Study|Other|0|||
144405795|NCT00369824|520695485|FG002|Overall Study|Other|0|||
144405796|NCT00369824|520695486|FG003|Overall Study|Other|2|||
144405797|NCT00369824|520695487|FG004|Overall Study|Other|1|||
144405798|NCT00369824|520695488|FG005|Overall Study|Other|3|||
144405799|NCT02572401|520695489|FG000|Overall Study|Lost to Follow-up|5|||
144405800|NCT02572401|520695490|FG001|Overall Study|Lost to Follow-up|8|||
144405801|NCT02572401|520695491|FG002|Overall Study|Lost to Follow-up|9|||
144405802|NCT02572401|520695492|FG003|Overall Study|Lost to Follow-up|9|||
144405803|NCT02572401|520695489|FG000|Overall Study|Death|0|||
144405804|NCT02572401|520695490|FG001|Overall Study|Death|0|||
144405805|NCT02572401|520695491|FG002|Overall Study|Death|0|||
144405806|NCT02572401|520695492|FG003|Overall Study|Death|1|||
144405807|NCT00259610|520695494|FG000|Overall Study|Withdrawal by Subject|33|||
144405808|NCT00259610|520695495|FG001|Overall Study|Withdrawal by Subject|25|||
144405809|NCT00259610|520695496|FG002|Overall Study|Withdrawal by Subject|29|||
144405810|NCT00259610|520695497|FG003|Overall Study|Withdrawal by Subject|19|||
144405811|NCT00259610|520695494|FG000|Overall Study|Lost to Follow-up|19|||
144405812|NCT00259610|520695495|FG001|Overall Study|Lost to Follow-up|8|||
144405813|NCT00259610|520695496|FG002|Overall Study|Lost to Follow-up|18|||
144405814|NCT00259610|520695497|FG003|Overall Study|Lost to Follow-up|15|||
144405815|NCT00259610|520695494|FG000|Overall Study|Physician Decision|6|||
144405816|NCT00259610|520695495|FG001|Overall Study|Physician Decision|4|||
144405817|NCT00259610|520695496|FG002|Overall Study|Physician Decision|7|||
144405818|NCT00259610|520695497|FG003|Overall Study|Physician Decision|2|||
144405819|NCT00259610|520695494|FG000|Overall Study|Death|1|||
144405820|NCT00259610|520695495|FG001|Overall Study|Death|1|||
144405821|NCT00259610|520695496|FG002|Overall Study|Death|2|||
144405822|NCT00259610|520695497|FG003|Overall Study|Death|0|||
144405823|NCT00259610|520695494|FG000|Overall Study|non medical reason|6|||
144405824|NCT00259610|520695495|FG001|Overall Study|non medical reason|2|||
144405825|NCT00259610|520695496|FG002|Overall Study|non medical reason|10|||
144405826|NCT00259610|520695497|FG003|Overall Study|non medical reason|3|||
144405827|NCT00259610|520695494|FG000|Overall Study|Adverse Event|3|||
144405828|NCT00259610|520695495|FG001|Overall Study|Adverse Event|4|||
144405829|NCT00259610|520695496|FG002|Overall Study|Adverse Event|5|||
144405830|NCT00259610|520695497|FG003|Overall Study|Adverse Event|2|||
144405831|NCT00259610|520695494|FG000|Overall Study|Serious Adverse Event|8|||
144405832|NCT00259610|520695495|FG001|Overall Study|Serious Adverse Event|2|||
144405833|NCT00259610|520695496|FG002|Overall Study|Serious Adverse Event|2|||
144405834|NCT00259610|520695497|FG003|Overall Study|Serious Adverse Event|2|||
144405835|NCT01611155|520695498|FG000|Overall Study|Adverse Event|1|||
144405836|NCT01611155|520695499|FG001|Overall Study|Adverse Event|1|||
144405837|NCT01611155|520695498|FG000|Overall Study|Refused further treatment|6|||
144405838|NCT01611155|520695499|FG001|Overall Study|Refused further treatment|4|||
144405839|NCT01611155|520695498|FG000|Overall Study|Disease progression|1|||
144405840|NCT01611155|520695499|FG001|Overall Study|Disease progression|0|||
144405841|NCT01611155|520695498|FG000|Overall Study|Withdrawal by Subject|1|||
144405842|NCT01611155|520695499|FG001|Overall Study|Withdrawal by Subject|0|||
144405843|NCT01611155|520695498|FG000|Overall Study|Alternative treatment|0|||
144405844|NCT01611155|520695499|FG001|Overall Study|Alternative treatment|1|||
144405845|NCT01611155|520695498|FG000|Overall Study|Ineligible patient|0|||
144405846|NCT01611155|520695499|FG001|Overall Study|Ineligible patient|1|||
144405847|NCT02229383|520695501|FG000|Overall Study|Adverse Event|7|||
144405848|NCT02229383|520695502|FG001|Overall Study|Adverse Event|4|||
144405849|NCT02229383|520695501|FG000|Overall Study|Death|0|||
144722546|NCT01620177|521838776|FG000|Overall Study|Physician Decision|2|||
144405850|NCT02229383|520695502|FG001|Overall Study|Death|1|||
144405851|NCT02229383|520695501|FG000|Overall Study|Lost to Follow-up|5|||
144405852|NCT02229383|520695502|FG001|Overall Study|Lost to Follow-up|3|||
144405853|NCT02229383|520695501|FG000|Overall Study|Withdrawal by Subject|4|||
144525257|NCT04700163|521123675|FG001|Overall Study|Lost to Follow-up|0|||
144525258|NCT04700163|521123676|FG002|Overall Study|Lost to Follow-up|0|||
144722547|NCT01620177|521838776|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
144525259|NCT04700163|521123677|FG003|Overall Study|Lost to Follow-up|0|||
144525260|NCT04700163|521123678|FG004|Overall Study|Lost to Follow-up|0|||
144525261|NCT04700163|521123679|FG005|Overall Study|Lost to Follow-up|1|||
144525262|NCT05126433|521123692|FG000|Overall Study|Withdrawal by Subject|3|||
144525263|NCT05126433|521123693|FG001|Overall Study|Withdrawal by Subject|0|||
144525264|NCT05126433|521123694|FG002|Overall Study|Withdrawal by Subject|4|||
144525265|NCT05126433|521123692|FG000|Overall Study|Death|9|||
144525266|NCT05126433|521123693|FG001|Overall Study|Death|3|||
144525267|NCT05126433|521123694|FG002|Overall Study|Death|5|||
144525268|NCT05126433|521123692|FG000|Overall Study|Study Terminated by sponsor|0|||
144525269|NCT05126433|521123693|FG001|Overall Study|Study Terminated by sponsor|1|||
144525270|NCT05126433|521123694|FG002|Overall Study|Study Terminated by sponsor|2|||
144525271|NCT05126433|521123692|FG000|Overall Study|Progressive Disease|1|||
144525272|NCT05126433|521123693|FG001|Overall Study|Progressive Disease|4|||
144525273|NCT05126433|521123694|FG002|Overall Study|Progressive Disease|3|||
144525274|NCT05126433|521123692|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
144525275|NCT05126433|521123693|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
144525276|NCT05126433|521123694|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
144525277|NCT00764751|521123695|FG000|Overall Study|Adverse Event|1|||
144525278|NCT00764751|521123696|FG001|Overall Study|Adverse Event|1|||
144525279|NCT00764751|521123695|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
144525280|NCT00764751|521123696|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
144525281|NCT04065841|521123708|FG000|Overall Study|Adverse Event|4|||
144525282|NCT04065841|521123709|FG001|Overall Study|Adverse Event|2|||
144525283|NCT04065841|521123710|FG002|Overall Study|Adverse Event|10|||
144525284|NCT04065841|521123711|FG003|Overall Study|Adverse Event|1|||
144525285|NCT04065841|521123708|FG000|Overall Study|Lost to Follow-up|1|||
144525286|NCT04065841|521123709|FG001|Overall Study|Lost to Follow-up|2|||
144525287|NCT04065841|521123710|FG002|Overall Study|Lost to Follow-up|2|||
144525288|NCT04065841|521123711|FG003|Overall Study|Lost to Follow-up|2|||
144525289|NCT04065841|521123708|FG000|Overall Study|Physician Decision|1|||
144525290|NCT04065841|521123709|FG001|Overall Study|Physician Decision|0|||
144525291|NCT04065841|521123710|FG002|Overall Study|Physician Decision|0|||
144525292|NCT04065841|521123711|FG003|Overall Study|Physician Decision|0|||
144525293|NCT04065841|521123708|FG000|Overall Study|Protocol Violation|0|||
144525294|NCT04065841|521123709|FG001|Overall Study|Protocol Violation|1|||
144525295|NCT04065841|521123710|FG002|Overall Study|Protocol Violation|0|||
144525296|NCT04065841|521123711|FG003|Overall Study|Protocol Violation|0|||
144525297|NCT04065841|521123708|FG000|Overall Study|Study terminated by Sponsor|22|||
144525298|NCT04065841|521123709|FG001|Overall Study|Study terminated by Sponsor|16|||
144525299|NCT04065841|521123710|FG002|Overall Study|Study terminated by Sponsor|28|||
144525300|NCT04065841|521123711|FG003|Overall Study|Study terminated by Sponsor|17|||
144525301|NCT04065841|521123708|FG000|Overall Study|Withdrawal by Subject|1|||
144525302|NCT04065841|521123709|FG001|Overall Study|Withdrawal by Subject|1|||
144525303|NCT04065841|521123710|FG002|Overall Study|Withdrawal by Subject|2|||
144525304|NCT04065841|521123711|FG003|Overall Study|Withdrawal by Subject|0|||
144525305|NCT03322267|521123713|FG000|Overall Study|Lack of Efficacy|11|||
144525306|NCT03322267|521123713|FG000|Overall Study|Adverse Event|1|||
144525307|NCT03322267|521123713|FG000|Overall Study|Withdrawal by Subject|2|||
144525308|NCT05792085|521123714|FG000|Overall Study|Death|0|||
144525309|NCT05792085|521123715|FG001|Overall Study|Death|0|||
144525310|NCT05792085|521123716|FG002|Overall Study|Death|0|||
144525311|NCT05792085|521123717|FG003|Overall Study|Death|0|||
144525312|NCT05792085|521123718|FG004|Overall Study|Death|1|||
144525313|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
144525314|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
144525315|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
144525316|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
144599586|NCT01839487|521396235|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
144405854|NCT02229383|520695502|FG001|Overall Study|Withdrawal by Subject|6|||
144405855|NCT02229383|520695501|FG000|Overall Study|Did not receive treatment|1|||
144405856|NCT02229383|520695502|FG001|Overall Study|Did not receive treatment|0|||
144525317|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
144525318|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
144525319|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
144525320|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
144525321|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
144525322|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
144405857|NCT02229383|520695501|FG000|Overall Study|Other|3|||
144405858|NCT02229383|520695502|FG001|Overall Study|Other|8|||
144405859|NCT01687998|520697624|FG000|Overall Study|Withdrawal by Subject|49|||
144405860|NCT01687998|520697625|FG001|Overall Study|Withdrawal by Subject|51|||
144405861|NCT01687998|520697624|FG000|Overall Study|Known to be Alive at Study End|54|||
144405862|NCT01687998|520697625|FG001|Overall Study|Known to be Alive at Study End|62|||
144405863|NCT01687998|520697624|FG000|Overall Study|Lost to Follow-up|9|||
144599587|NCT01839487|521396236|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
144599588|NCT01839487|521396237|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
144599589|NCT01839487|521396238|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
144599590|NCT01422850|521396247|FG000|Overall Study|Physician Decision|3|||
144599591|NCT04484831|521396248|FG000|Overall Study|Withdrawal by Subject|1|||
144599592|NCT04484831|521396249|FG001|Overall Study|Withdrawal by Subject|0|||
144599593|NCT02244996|521396250|FG000|Overall Study|Lack of Efficacy|2|||
144599594|NCT02244996|521396251|FG001|Overall Study|Lack of Efficacy|6|||
144599595|NCT00174265|521396252|FG000|Overall Study|Adverse Event|7|||
144599596|NCT00174265|521396253|FG001|Overall Study|Adverse Event|4|||
144599597|NCT00174265|521396252|FG000|Overall Study|Lack of Efficacy|2|||
144599598|NCT00174265|521396253|FG001|Overall Study|Lack of Efficacy|2|||
144599599|NCT00174265|521396252|FG000|Overall Study|Withdrawal by Subject|3|||
144599600|NCT00174265|521396253|FG001|Overall Study|Withdrawal by Subject|5|||
144599601|NCT00174265|521396252|FG000|Overall Study|Lost to Follow-up|1|||
144599602|NCT00174265|521396253|FG001|Overall Study|Lost to Follow-up|0|||
144599603|NCT00174265|521396252|FG000|Overall Study|Other (Not specified)|16|||
144599604|NCT00174265|521396253|FG001|Overall Study|Other (Not specified)|10|||
144599605|NCT03471871|521396255|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
144599606|NCT03471871|521396256|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
144599607|NCT03471871|521396257|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
144599608|NCT03471871|521396258|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
144599609|NCT03471871|521396259|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
144599610|NCT03471871|521396255|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
144599611|NCT03471871|521396256|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
144599612|NCT03471871|521396257|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
144599613|NCT03471871|521396258|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
144599614|NCT03471871|521396259|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
144599615|NCT03471871|521396255|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
144599616|NCT03471871|521396256|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
144599617|NCT03471871|521396257|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
144599618|NCT03471871|521396258|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
144599619|NCT03471871|521396259|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
144599620|NCT03471871|521396255|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
144599621|NCT03471871|521396256|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
144599622|NCT03471871|521396257|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
144599623|NCT03471871|521396258|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
144599624|NCT03471871|521396259|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
144599625|NCT03471871|521396255|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
144599626|NCT03471871|521396256|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
144599627|NCT03471871|521396257|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
144599628|NCT03471871|521396258|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
144599629|NCT03471871|521396259|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
144599630|NCT03040622|521396261|FG000|Overall Study|unable to implant device|3|||
144405864|NCT01687998|520697625|FG001|Overall Study|Lost to Follow-up|7|||
144405865|NCT01871532|520697627|FG000|Overall Study|Withdrawal by Subject|1|||
144405866|NCT01871532|520697628|FG001|Overall Study|Withdrawal by Subject|2|||
144405867|NCT02550106|520697629|FG000|Overall Study|Adverse Event|1|||
144405868|NCT02550106|520697629|FG000|Overall Study|Lack of Efficacy|3|||
144405869|NCT02550106|520697629|FG000|Overall Study|Protocol Violation|6|||
144405870|NCT02550106|520697629|FG000|Overall Study|Withdrawal by Subject|2|||
144405871|NCT01709513|520697630|FG000|Overall Study|Randomized but not treated|0|||
144599631|NCT01313117|521396264|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
144599632|NCT01313117|521396264|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
144599633|NCT00909792|521397453|FG000|Period 1|Did not meet inclusion criteria|0|||
144599634|NCT00909792|521397454|FG001|Period 1|Did not meet inclusion criteria|1|||
144599635|NCT00909792|521397453|FG000|Period 2|Biomicroscopy|1|||
144405872|NCT01709513|520697631|FG001|Overall Study|Randomized but not treated|1|||
144405873|NCT01709513|520697632|FG002|Overall Study|Randomized but not treated|0|||
144405874|NCT01709513|520697630|FG000|Overall Study|Adverse Event|16|||
144405875|NCT01709513|520697631|FG001|Overall Study|Adverse Event|31|||
144405876|NCT01709513|520697632|FG002|Overall Study|Adverse Event|23|||
144405877|NCT01709513|520697630|FG000|Overall Study|Poor compliance to protocol|2|||
144405878|NCT01709513|520697631|FG001|Overall Study|Poor compliance to protocol|0|||
144599636|NCT00909792|521397454|FG001|Period 2|Biomicroscopy|0|||
144405879|NCT01709513|520697632|FG002|Overall Study|Poor compliance to protocol|0|||
144405880|NCT01709513|520697630|FG000|Overall Study|Other|3|||
144405881|NCT01709513|520697631|FG001|Overall Study|Other|11|||
144405882|NCT01709513|520697632|FG002|Overall Study|Other|7|||
144405883|NCT00354744|520697633|FG000|Overall Study|Adverse Event|2|||
144405884|NCT00354744|520697633|FG000|Overall Study|Death|2|||
144405885|NCT00354744|520697633|FG000|Overall Study|Lack of Efficacy|11|||
144405886|NCT00354744|520697633|FG000|Overall Study|Lost to Follow-up|2|||
144405887|NCT00354744|520697633|FG000|Overall Study|Physician Decision|11|||
144405888|NCT00354744|520697633|FG000|Overall Study|Withdrawal by Subject|14|||
144405889|NCT01193530|520697634|FG000|Overall Study|Withdrawal by Subject|2|||
144405890|NCT01193530|520697635|FG001|Overall Study|Withdrawal by Subject|2|||
144405891|NCT01193530|520697634|FG000|Overall Study|Began Contraindicated Therapy|1|||
144405892|NCT01193530|520697635|FG001|Overall Study|Began Contraindicated Therapy|0|||
144405893|NCT01193530|520697634|FG000|Overall Study|Lost Light Box|0|||
144405894|NCT01193530|520697635|FG001|Overall Study|Lost Light Box|1|||
144405895|NCT01193530|520697634|FG000|Overall Study|Returned home - out of state|0|||
144405896|NCT01193530|520697635|FG001|Overall Study|Returned home - out of state|1|||
144405897|NCT01193530|520697634|FG000|Overall Study|Non-Compliance|0|||
144405898|NCT01193530|520697635|FG001|Overall Study|Non-Compliance|1|||
144405899|NCT03166735|520697636|FG000|Overall Study|Not Treated|1|||
144405900|NCT03166735|520697637|FG001|Overall Study|Not Treated|0|||
144405901|NCT03166735|520697638|FG002|Overall Study|Not Treated|0|||
144405902|NCT03166735|520697639|FG003|Overall Study|Not Treated|0|||
144525323|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
144525324|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
144525325|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
144525326|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
144525327|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
144525328|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
144525329|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
144525330|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
144525331|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
144525332|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
144525333|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
144525334|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
144525335|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
144525336|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
144525337|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
144525338|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
144525339|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
144525340|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
144525341|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
144525342|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
144525343|NCT03852472|521123725|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
144525344|NCT03852472|521123726|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
144525345|NCT03852472|521123727|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
144525346|NCT03852472|521123728|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
144525347|NCT03852472|521123729|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
144525348|NCT03852472|521123725|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
144525349|NCT03852472|521123726|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
144525350|NCT03852472|521123727|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
144525351|NCT03852472|521123728|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
144525352|NCT03852472|521123729|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
144525353|NCT03852472|521123725|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
144525354|NCT03852472|521123726|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
144525355|NCT03852472|521123727|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
144525356|NCT03852472|521123728|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
144525357|NCT03852472|521123729|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
144525358|NCT03852472|521123725|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
144525359|NCT03852472|521123726|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
144525360|NCT03852472|521123727|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
144722548|NCT01789320|521838780|FG000|Overall Study|Re-enrolled into study|1|||
144405903|NCT03166735|520697640|FG004|Overall Study|Not Treated|0|||
144405904|NCT03166735|520697636|FG000|Overall Study|follow-up not completed as planned|0|||
144405905|NCT03166735|520697637|FG001|Overall Study|follow-up not completed as planned|1|||
144405906|NCT03166735|520697638|FG002|Overall Study|follow-up not completed as planned|1|||
144525361|NCT03852472|521123728|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
144525362|NCT03852472|521123729|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
144405907|NCT03166735|520697639|FG003|Overall Study|follow-up not completed as planned|0|||
144405908|NCT03166735|520697640|FG004|Overall Study|follow-up not completed as planned|1|||
144405909|NCT03166735|520697636|FG000|Overall Study|Withdrawal by Subject|0|||
144405910|NCT03166735|520697637|FG001|Overall Study|Withdrawal by Subject|0|||
144405911|NCT03166735|520697638|FG002|Overall Study|Withdrawal by Subject|1|||
144405912|NCT03166735|520697639|FG003|Overall Study|Withdrawal by Subject|1|||
144405913|NCT03166735|520697640|FG004|Overall Study|Withdrawal by Subject|2|||
144405914|NCT03166735|520697636|FG000|Overall Study|Lost to Follow-up|0|||
144405915|NCT03166735|520697637|FG001|Overall Study|Lost to Follow-up|2|||
144405916|NCT03166735|520697638|FG002|Overall Study|Lost to Follow-up|1|||
144405917|NCT03166735|520697639|FG003|Overall Study|Lost to Follow-up|0|||
144405918|NCT03166735|520697640|FG004|Overall Study|Lost to Follow-up|1|||
144405919|NCT00926328|520697641|FG000|Overall Study|Lost to Follow-up|12|||
144405920|NCT00926328|520697642|FG001|Overall Study|Lost to Follow-up|14|||
144405921|NCT00726986|520697643|FG000|Induction Phase|Adverse Event|4|||
144405922|NCT00726986|520697643|FG000|Induction Phase|Withdrawal by Subject|2|||
144405923|NCT00726986|520697643|FG000|Induction Phase|Death|2|||
144405924|NCT00726986|520697643|FG000|Induction Phase|Lack of Efficacy|5|||
144405925|NCT00726986|520697643|FG000|Induction Phase|Secondary Disease|2|||
144405926|NCT00726986|520697643|FG000|Maintenance Phase|Adverse Event|1|||
144405927|NCT00726986|520697643|FG000|Maintenance Phase|Lack of Efficacy|2|||
144405928|NCT01434667|520697649|FG000|Overall Study|Lost to Follow-up|5|||
144405929|NCT01434667|520697650|FG001|Overall Study|Lost to Follow-up|10|||
144405930|NCT02165215|520697651|FG000|Induction Phase|Adverse Event|1|||
144525363|NCT03852472|521123725|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
144525364|NCT03852472|521123726|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
144525365|NCT03852472|521123727|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
144525366|NCT03852472|521123728|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
144525367|NCT03852472|521123729|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
144525368|NCT03852472|521123725|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
144525369|NCT03852472|521123726|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
144525370|NCT03852472|521123727|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
144525371|NCT03852472|521123728|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
144525372|NCT03852472|521123729|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
144525373|NCT03852472|521123725|FG000|Period 2 - Week 44|Adverse Event|0|||
144525374|NCT03852472|521123726|FG001|Period 2 - Week 44|Adverse Event|3|||
144525375|NCT03852472|521123727|FG002|Period 2 - Week 44|Adverse Event|1|||
144525376|NCT03852472|521123728|FG003|Period 2 - Week 44|Adverse Event|2|||
144525377|NCT03852472|521123729|FG004|Period 2 - Week 44|Adverse Event|2|||
144525378|NCT03852472|521123725|FG000|Period 2 - Week 44|COVID-19 Related|0|||
144525379|NCT03852472|521123726|FG001|Period 2 - Week 44|COVID-19 Related|0|||
144525380|NCT03852472|521123727|FG002|Period 2 - Week 44|COVID-19 Related|0|||
144525381|NCT03852472|521123728|FG003|Period 2 - Week 44|COVID-19 Related|1|||
144525382|NCT03852472|521123729|FG004|Period 2 - Week 44|COVID-19 Related|0|||
144525383|NCT03852472|521123725|FG000|Period 2 - Week 44|Reason not stated|0|||
144525384|NCT03852472|521123726|FG001|Period 2 - Week 44|Reason not stated|0|||
144525385|NCT03852472|521123727|FG002|Period 2 - Week 44|Reason not stated|0|||
144525386|NCT03852472|521123728|FG003|Period 2 - Week 44|Reason not stated|0|||
144525387|NCT03852472|521123729|FG004|Period 2 - Week 44|Reason not stated|1|||
144525388|NCT01919554|521123730|FG000|Overall Study|Withdrawal by Subject|0|||
144525389|NCT01919554|521123731|FG001|Overall Study|Withdrawal by Subject|0|||
144525390|NCT01919554|521123732|FG002|Overall Study|Withdrawal by Subject|1|||
144525391|NCT01919554|521123733|FG003|Overall Study|Withdrawal by Subject|1|||
144525392|NCT05977530|521123734|FG000|Overall Study|Withdrawal by Subject|1|||
144525393|NCT05977530|521123734|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
144525394|NCT04719832|521123737|FG000|Overall Study|Adverse Event|2|||
144525395|NCT04719832|521123738|FG001|Overall Study|Adverse Event|0|||
144525396|NCT04719832|521123737|FG000|Overall Study|Lack of Efficacy|2|||
144405931|NCT02165215|520697652|FG001|Induction Phase|Adverse Event|0|||
144405932|NCT02165215|520697653|FG002|Induction Phase|Adverse Event|0|||
144405933|NCT02165215|520697651|FG000|Induction Phase|Withdrawal by Subject|10|||
144405934|NCT02165215|520697652|FG001|Induction Phase|Withdrawal by Subject|0|||
144405935|NCT02165215|520697653|FG002|Induction Phase|Withdrawal by Subject|0|||
144405936|NCT02165215|520697651|FG000|Induction Phase|Protocol Violation|1|||
144405937|NCT02165215|520697652|FG001|Induction Phase|Protocol Violation|0|||
144405938|NCT02165215|520697653|FG002|Induction Phase|Protocol Violation|0|||
144405939|NCT02165215|520697651|FG000|Induction Phase|Physician Decision|1|||
144405940|NCT02165215|520697652|FG001|Induction Phase|Physician Decision|0|||
144405941|NCT02165215|520697653|FG002|Induction Phase|Physician Decision|0|||
144525397|NCT04719832|521123738|FG001|Overall Study|Lack of Efficacy|4|||
144525398|NCT04719832|521123737|FG000|Overall Study|Lost to Follow-up|0|||
144525399|NCT04719832|521123738|FG001|Overall Study|Lost to Follow-up|2|||
144405942|NCT02165215|520697651|FG000|Induction Phase|Lack of Efficacy|2|||
144405943|NCT02165215|520697652|FG001|Induction Phase|Lack of Efficacy|0|||
144525400|NCT04719832|521123737|FG000|Overall Study|Physician Decision|0|||
144405944|NCT02165215|520697653|FG002|Induction Phase|Lack of Efficacy|0|||
144405945|NCT02165215|520697651|FG000|Induction Phase|Non-Compliance|2|||
144722549|NCT01789320|521838780|FG000|Overall Study|Lost to Follow-up|1|||
144722550|NCT00306384|521838784|FG000|Overall Study|Adverse Event|103|||
144722551|NCT00306384|521838785|FG001|Overall Study|Adverse Event|87|||
144722552|NCT00306384|521838786|FG002|Overall Study|Adverse Event|40|||
144405946|NCT02165215|520697652|FG001|Induction Phase|Non-Compliance|0|||
144405947|NCT02165215|520697653|FG002|Induction Phase|Non-Compliance|0|||
144405948|NCT02165215|520697651|FG000|Induction Phase|Lost to Follow-up|6|||
144405949|NCT02165215|520697652|FG001|Induction Phase|Lost to Follow-up|0|||
144405950|NCT02165215|520697653|FG002|Induction Phase|Lost to Follow-up|0|||
144405951|NCT02165215|520697651|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144722553|NCT00306384|521838784|FG000|Overall Study|Major protocol deviation|43|||
144722554|NCT00306384|521838785|FG001|Overall Study|Major protocol deviation|51|||
144722555|NCT00306384|521838786|FG002|Overall Study|Major protocol deviation|18|||
144722556|NCT00306384|521838784|FG000|Overall Study|Lost to Follow-up|57|||
144722557|NCT00306384|521838785|FG001|Overall Study|Lost to Follow-up|41|||
144722558|NCT00306384|521838786|FG002|Overall Study|Lost to Follow-up|35|||
144722559|NCT00306384|521838784|FG000|Overall Study|Voluntary withdrawal|199|||
144722560|NCT00306384|521838785|FG001|Overall Study|Voluntary withdrawal|187|||
144722561|NCT00306384|521838786|FG002|Overall Study|Voluntary withdrawal|91|||
144722562|NCT00306384|521838784|FG000|Overall Study|Study termination|1|||
144722563|NCT00306384|521838785|FG001|Overall Study|Study termination|0|||
144722564|NCT00306384|521838786|FG002|Overall Study|Study termination|1|||
144722565|NCT00306384|521838784|FG000|Overall Study|Pregnancy|3|||
144722566|NCT00306384|521838785|FG001|Overall Study|Pregnancy|1|||
144722567|NCT00306384|521838786|FG002|Overall Study|Pregnancy|1|||
144722568|NCT00306384|521838784|FG000|Overall Study|Lack of Efficacy|26|||
144722569|NCT00306384|521838785|FG001|Overall Study|Lack of Efficacy|40|||
144722570|NCT00306384|521838786|FG002|Overall Study|Lack of Efficacy|38|||
144722571|NCT00306384|521838784|FG000|Overall Study|Investigator discretion|28|||
144722572|NCT00306384|521838785|FG001|Overall Study|Investigator discretion|31|||
144722573|NCT00306384|521838786|FG002|Overall Study|Investigator discretion|21|||
144722574|NCT00306384|521838784|FG000|Overall Study|Other|80|||
144722575|NCT00306384|521838785|FG001|Overall Study|Other|70|||
144722576|NCT00306384|521838786|FG002|Overall Study|Other|32|||
144722577|NCT00306384|521838784|FG000|Overall Study|Site closure|2|||
144722578|NCT00306384|521838785|FG001|Overall Study|Site closure|0|||
144722579|NCT00306384|521838786|FG002|Overall Study|Site closure|0|||
144722580|NCT00673790|521838787|FG000|Overall Study|Adverse Event|23|||
144722581|NCT00673790|521838788|FG001|Overall Study|Adverse Event|14|||
144722582|NCT00673790|521838789|FG002|Overall Study|Adverse Event|2|||
144722583|NCT00673790|521838787|FG000|Overall Study|Lack of Efficacy|2|||
144722584|NCT00673790|521838788|FG001|Overall Study|Lack of Efficacy|2|||
144722585|NCT00673790|521838789|FG002|Overall Study|Lack of Efficacy|2|||
144722586|NCT00673790|521838787|FG000|Overall Study|Protocol Violation|6|||
144722587|NCT00673790|521838788|FG001|Overall Study|Protocol Violation|9|||
144722588|NCT00673790|521838789|FG002|Overall Study|Protocol Violation|1|||
144722589|NCT00673790|521838787|FG000|Overall Study|Withdrawal by Subject|7|||
144722590|NCT00673790|521838788|FG001|Overall Study|Withdrawal by Subject|4|||
144722591|NCT00673790|521838789|FG002|Overall Study|Withdrawal by Subject|1|||
144722592|NCT00673790|521838787|FG000|Overall Study|Lost to Follow-up|6|||
144405952|NCT02165215|520697652|FG001|Maintenance Phase|Withdrawal by Subject|7|||
144405953|NCT02165215|520697653|FG002|Maintenance Phase|Withdrawal by Subject|3|||
144405954|NCT02165215|520697651|FG000|Maintenance Phase|Multiple reasons|0|||
144405955|NCT02165215|520697652|FG001|Maintenance Phase|Multiple reasons|2|||
144405956|NCT02165215|520697653|FG002|Maintenance Phase|Multiple reasons|1|||
144405957|NCT02165215|520697651|FG000|Maintenance Phase|Lost to Follow-up|0|||
144405958|NCT02165215|520697652|FG001|Maintenance Phase|Lost to Follow-up|2|||
144405959|NCT02165215|520697653|FG002|Maintenance Phase|Lost to Follow-up|0|||
144405960|NCT02165215|520697651|FG000|Maintenance Phase|Adverse Event|0|||
144525401|NCT04719832|521123738|FG001|Overall Study|Physician Decision|1|||
144722593|NCT00673790|521838788|FG001|Overall Study|Lost to Follow-up|6|||
144722594|NCT00673790|521838789|FG002|Overall Study|Lost to Follow-up|5|||
144722595|NCT00673790|521838787|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
144722596|NCT00673790|521838788|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
144722597|NCT00673790|521838789|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
144722598|NCT00673790|521838787|FG000|Overall Study|Poor compliance|1|||
144405961|NCT02165215|520697652|FG001|Maintenance Phase|Adverse Event|1|||
144405962|NCT02165215|520697653|FG002|Maintenance Phase|Adverse Event|1|||
144722599|NCT00673790|521838788|FG001|Overall Study|Poor compliance|0|||
144722600|NCT00673790|521838789|FG002|Overall Study|Poor compliance|0|||
144722601|NCT00673790|521838787|FG000|Overall Study|Participated in two Nebivolol studies|0|||
144722602|NCT00673790|521838788|FG001|Overall Study|Participated in two Nebivolol studies|0|||
144405963|NCT05074667|520697654|FG000|Overall Study|Death|1|||
144405964|NCT05074667|520697654|FG000|Overall Study|Withdrawal by Subject|4|||
144405965|NCT05074667|520697654|FG000|Overall Study|Lost to Follow-up|10|||
144405966|NCT02279420|520697655|FG000|Overall Study|Lost to Follow-up|23|||
144405967|NCT03535844|520697658|FG000|Overall Study|Withdrawal by Subject|0|||
144405968|NCT03535844|520697659|FG001|Overall Study|Withdrawal by Subject|1|||
144405969|NCT00297830|520697662|FG000|6 Month Visit|Death|1|||
144405970|NCT00297830|520697663|FG001|6 Month Visit|Death|0|||
144405971|NCT00297830|520697664|FG002|6 Month Visit|Death|2|||
144405972|NCT00297830|520697662|FG000|6 Month Visit|Withdrawal by Subject|2|||
144405973|NCT00297830|520697663|FG001|6 Month Visit|Withdrawal by Subject|1|||
144405974|NCT00297830|520697664|FG002|6 Month Visit|Withdrawal by Subject|1|||
144405975|NCT00297830|520697662|FG000|6 Month Visit|Adverse Event|0|||
144405976|NCT00297830|520697663|FG001|6 Month Visit|Adverse Event|1|||
144405977|NCT00297830|520697664|FG002|6 Month Visit|Adverse Event|0|||
144405978|NCT00297830|520697662|FG000|12 Month Visit|Lost to Follow-up|1|||
144405979|NCT00297830|520697663|FG001|12 Month Visit|Lost to Follow-up|0|||
144405980|NCT00297830|520697664|FG002|12 Month Visit|Lost to Follow-up|0|||
144405981|NCT00297830|520697662|FG000|12 Month Visit|Adverse Event|0|||
144405982|NCT00297830|520697663|FG001|12 Month Visit|Adverse Event|3|||
144405983|NCT00297830|520697664|FG002|12 Month Visit|Adverse Event|0|||
144405984|NCT00297830|520697662|FG000|12 Month Visit|Withdrawal by Subject|0|||
144405985|NCT00297830|520697663|FG001|12 Month Visit|Withdrawal by Subject|3|||
144405986|NCT00297830|520697664|FG002|12 Month Visit|Withdrawal by Subject|0|||
144405987|NCT02835820|520697665|FG000|Overall Study|Baseline Screen Failure|0|||
144405988|NCT02835820|520697666|FG001|Overall Study|Baseline Screen Failure|3|||
144405989|NCT01867424|520697670|FG000|Overall Study|Patient noncompliance|2|||
144405990|NCT01867424|520697671|FG001|Overall Study|Patient noncompliance|1|||
144405991|NCT04613375|520697672|FG000|Overall Study|Death|198|||
144405992|NCT04613375|520697672|FG000|Overall Study|Withdrawal by Subject|3|||
144405993|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
144405994|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
144405995|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
144405996|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
144405997|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144405998|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144405999|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144406000|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144406001|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144406002|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144406003|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
144406004|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
144406005|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
144406006|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
144406007|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
144406008|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406009|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406010|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406011|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406012|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406013|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406014|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
144406015|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
144406016|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
144406017|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
144406018|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
144406019|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406020|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406021|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406022|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406023|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406024|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406025|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
144406026|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406027|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406028|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406029|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
144599637|NCT00909792|521397453|FG000|Period 2|Lost to Follow-up|0|||
144599638|NCT00909792|521397454|FG001|Period 2|Lost to Follow-up|1|||
144406030|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406031|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406032|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406033|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406034|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406035|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406036|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
144406037|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
144406038|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
144406039|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
144406040|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
144406041|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406042|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406043|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406044|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406045|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406046|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406047|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
144406048|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
144406049|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
144406050|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
144406051|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
144406052|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406053|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406054|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406055|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406056|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406057|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406058|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
144406059|NCT01847274|520697673|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
144406060|NCT01847274|520697674|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
144406061|NCT01847274|520697675|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
144406062|NCT01847274|520697676|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
144406063|NCT01847274|520697677|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406064|NCT01847274|520697678|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406065|NCT01847274|520697679|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406066|NCT01847274|520697680|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406067|NCT01847274|520697681|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406068|NCT01847274|520697682|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406069|NCT01847274|520697683|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
144406070|NCT01847274|520697673|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406071|NCT01847274|520697674|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406072|NCT01847274|520697675|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406073|NCT01847274|520697676|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406074|NCT01847274|520697677|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406075|NCT01847274|520697678|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
144406076|NCT01847274|520697679|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144525402|NCT04719832|521123737|FG000|Overall Study|Pregnancy|1|||
144525403|NCT04719832|521123738|FG001|Overall Study|Pregnancy|1|||
144722603|NCT00673790|521838789|FG002|Overall Study|Participated in two Nebivolol studies|1|||
144722604|NCT00673790|521838787|FG000|Overall Study|Unconfirmed pregnancy|0|||
144406077|NCT01847274|520697680|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406078|NCT01847274|520697681|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406079|NCT01847274|520697682|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406080|NCT01847274|520697683|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
144406081|NCT01847274|520697673|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406082|NCT01847274|520697674|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406083|NCT01847274|520697675|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406084|NCT01847274|520697676|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406085|NCT01847274|520697677|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
144406086|NCT01847274|520697678|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406087|NCT01847274|520697679|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144525404|NCT04719832|521123737|FG000|Overall Study|Withdrawal by Subject|5|||
144525405|NCT04719832|521123738|FG001|Overall Study|Withdrawal by Subject|5|||
144722605|NCT00673790|521838788|FG001|Overall Study|Unconfirmed pregnancy|1|||
144406088|NCT01847274|520697680|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406089|NCT01847274|520697681|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406090|NCT01847274|520697682|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406091|NCT01847274|520697683|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
144406092|NCT01847274|520697673|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406093|NCT01847274|520697674|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406094|NCT01847274|520697675|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406095|NCT01847274|520697676|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406096|NCT01847274|520697677|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406097|NCT01847274|520697678|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406098|NCT01847274|520697679|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
144406099|NCT01847274|520697680|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406100|NCT01847274|520697681|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406101|NCT01847274|520697682|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406102|NCT01847274|520697683|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
144406103|NCT01847274|520697673|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406104|NCT01847274|520697674|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406105|NCT01847274|520697675|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406106|NCT01847274|520697676|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406107|NCT01847274|520697677|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406108|NCT01847274|520697678|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406109|NCT01847274|520697679|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
144406110|NCT01847274|520697680|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406111|NCT01847274|520697681|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406112|NCT01847274|520697682|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406113|NCT01847274|520697683|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
144406114|NCT01847274|520697673|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406115|NCT01847274|520697674|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406116|NCT01847274|520697675|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406117|NCT01847274|520697676|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406118|NCT01847274|520697677|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406119|NCT01847274|520697678|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406120|NCT01847274|520697679|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
144406121|NCT01847274|520697680|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406122|NCT01847274|520697681|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406123|NCT01847274|520697682|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406124|NCT01847274|520697683|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
144406125|NCT01847274|520697673|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406126|NCT01847274|520697674|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406127|NCT01847274|520697675|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406128|NCT01847274|520697676|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406129|NCT01847274|520697677|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406130|NCT01847274|520697678|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406131|NCT01847274|520697679|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
144406132|NCT01847274|520697680|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
144525406|NCT04719832|521123737|FG000|Overall Study|Randomized, not treated|0|||
144525407|NCT04719832|521123738|FG001|Overall Study|Randomized, not treated|2|||
144525408|NCT04719832|521123737|FG000|Overall Study|GCP violations|4|||
144525409|NCT04719832|521123738|FG001|Overall Study|GCP violations|7|||
144525410|NCT05228457|521123739|FG000|Overall Study|Withdrawal by Subject|1|||
144525411|NCT05228457|521123740|FG001|Overall Study|Withdrawal by Subject|1|||
144525412|NCT03492216|521123747|FG000|Overall Study|Death|1|||
144525413|NCT03492216|521123748|FG001|Overall Study|Death|0|||
144525414|NCT03492216|521123749|FG002|Overall Study|Death|4|||
144525415|NCT03492216|521123750|FG003|Overall Study|Death|0|||
144525416|NCT03492216|521123747|FG000|Overall Study|Withdrawal by Subject|5|||
144525417|NCT03492216|521123748|FG001|Overall Study|Withdrawal by Subject|3|||
144525418|NCT03492216|521123749|FG002|Overall Study|Withdrawal by Subject|1|||
144525419|NCT03492216|521123750|FG003|Overall Study|Withdrawal by Subject|1|||
144525420|NCT03492216|521123747|FG000|Overall Study|Lost to Follow-up|9|||
144525421|NCT03492216|521123748|FG001|Overall Study|Lost to Follow-up|2|||
144525422|NCT03492216|521123749|FG002|Overall Study|Lost to Follow-up|7|||
144525423|NCT03492216|521123750|FG003|Overall Study|Lost to Follow-up|8|||
144525424|NCT03492216|521123747|FG000|Overall Study|Moved|5|||
144525425|NCT03492216|521123748|FG001|Overall Study|Moved|3|||
144525426|NCT03492216|521123749|FG002|Overall Study|Moved|3|||
144525427|NCT03492216|521123750|FG003|Overall Study|Moved|5|||
144525428|NCT03492216|521123747|FG000|Overall Study|Too ill|0|||
144525429|NCT03492216|521123748|FG001|Overall Study|Too ill|1|||
144406133|NCT01847274|520697681|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
144406134|NCT01847274|520697682|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
144406135|NCT01847274|520697683|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
144406136|NCT01847274|520697673|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406137|NCT01847274|520697674|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406138|NCT01847274|520697675|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406139|NCT01847274|520697676|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406140|NCT01847274|520697677|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406141|NCT01847274|520697678|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406142|NCT01847274|520697679|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406143|NCT01847274|520697680|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
144406144|NCT01847274|520697681|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406145|NCT01847274|520697682|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
144406146|NCT01847274|520697683|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
144406147|NCT01847274|520697673|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406148|NCT01847274|520697674|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406149|NCT01847274|520697675|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406150|NCT01847274|520697676|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406151|NCT01847274|520697677|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406152|NCT01847274|520697678|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406153|NCT01847274|520697679|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406154|NCT01847274|520697680|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
144406155|NCT01847274|520697681|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
144406156|NCT01847274|520697682|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
144406157|NCT01847274|520697683|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
144406158|NCT01847274|520697673|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406159|NCT01847274|520697674|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406160|NCT01847274|520697675|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406161|NCT01847274|520697676|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406162|NCT01847274|520697677|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406163|NCT01847274|520697678|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406164|NCT01847274|520697679|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406165|NCT01847274|520697680|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406166|NCT01847274|520697681|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406167|NCT01847274|520697682|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
144525430|NCT03492216|521123749|FG002|Overall Study|Too ill|0|||
144525431|NCT03492216|521123750|FG003|Overall Study|Too ill|0|||
144525432|NCT03492216|521123747|FG000|Overall Study|Incarcerated|0|||
144525433|NCT03492216|521123748|FG001|Overall Study|Incarcerated|0|||
144525434|NCT03492216|521123749|FG002|Overall Study|Incarcerated|2|||
144525435|NCT03492216|521123750|FG003|Overall Study|Incarcerated|0|||
144525436|NCT03774082|521123757|FG000|Overall Study|Death|6|||
144525437|NCT03774082|521123758|FG001|Overall Study|Death|3|||
144525438|NCT03774082|521123759|FG002|Overall Study|Death|2|||
144525439|NCT03774082|521123757|FG000|Overall Study|Subject decision|0|||
144525440|NCT03774082|521123758|FG001|Overall Study|Subject decision|3|||
144525441|NCT03774082|521123759|FG002|Overall Study|Subject decision|0|||
144525442|NCT03774082|521123757|FG000|Overall Study|Lost to Follow-up|2|||
144525443|NCT03774082|521123758|FG001|Overall Study|Lost to Follow-up|0|||
144250009|NCT03959488|520113434|FG000|Season 1|Other|6|||
144406168|NCT01847274|520697683|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
144406169|NCT02582983|520697685|FG000|Overall Study|Death|3|||
144406170|NCT02582983|520697685|FG000|Overall Study|Withdrawal by Subject|2|||
144406171|NCT02582983|520697685|FG000|Overall Study|Adverse Event|1|||
144406172|NCT05209360|520697686|FG000|Overall Study|Withdrawal by Subject|0|||
144406173|NCT05209360|520697687|FG001|Overall Study|Withdrawal by Subject|0|||
144406174|NCT05209360|520697688|FG002|Overall Study|Withdrawal by Subject|1|||
144406175|NCT05209360|520697689|FG003|Overall Study|Withdrawal by Subject|0|||
144406176|NCT05209360|520697690|FG004|Overall Study|Withdrawal by Subject|0|||
144406177|NCT05209360|520697691|FG005|Overall Study|Withdrawal by Subject|0|||
144406178|NCT00724932|520697694|FG000|Overall Study|Lost to Follow-up|1|||
144406179|NCT00724932|520697695|FG001|Overall Study|Lost to Follow-up|0|||
144525444|NCT03774082|521123759|FG002|Overall Study|Lost to Follow-up|0|||
144525445|NCT03774082|521123757|FG000|Overall Study|Guardian decision|0|||
144525446|NCT03774082|521123758|FG001|Overall Study|Guardian decision|0|||
144525447|NCT03774082|521123759|FG002|Overall Study|Guardian decision|1|||
144525448|NCT03774082|521123757|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
144525449|NCT03774082|521123758|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
144406180|NCT00724932|520697694|FG000|Overall Study|Not treated|4|||
144406181|NCT00724932|520697695|FG001|Overall Study|Not treated|3|||
144406182|NCT02021331|520697696|FG000|Overall Study|Adverse Event|0|||
144406183|NCT02021331|520697697|FG001|Overall Study|Adverse Event|2|||
144406184|NCT01081678|520697700|FG000|Overall Study|Ineligibility Determined|0|||
144406185|NCT01081678|520697701|FG001|Overall Study|Ineligibility Determined|0|||
144406186|NCT01081678|520697702|FG002|Overall Study|Ineligibility Determined|1|||
144406187|NCT01081678|520697703|FG003|Overall Study|Ineligibility Determined|1|||
144406188|NCT01081678|520697700|FG000|Overall Study|Noncompliance|3|||
144406189|NCT01081678|520697701|FG001|Overall Study|Noncompliance|4|||
144406190|NCT01081678|520697702|FG002|Overall Study|Noncompliance|5|||
144406191|NCT01081678|520697703|FG003|Overall Study|Noncompliance|2|||
144406192|NCT01081678|520697700|FG000|Overall Study|Adverse Event|2|||
144406193|NCT01081678|520697701|FG001|Overall Study|Adverse Event|1|||
144406194|NCT01081678|520697702|FG002|Overall Study|Adverse Event|2|||
144406195|NCT01081678|520697703|FG003|Overall Study|Adverse Event|2|||
144406196|NCT01081678|520697700|FG000|Overall Study|Withdrawal by Subject|15|||
144406197|NCT01081678|520697701|FG001|Overall Study|Withdrawal by Subject|7|||
144406198|NCT01081678|520697702|FG002|Overall Study|Withdrawal by Subject|17|||
144406199|NCT01081678|520697703|FG003|Overall Study|Withdrawal by Subject|14|||
144406200|NCT01081678|520697700|FG000|Overall Study|Administrative Decision|1|||
144406201|NCT01081678|520697701|FG001|Overall Study|Administrative Decision|0|||
144406202|NCT01081678|520697702|FG002|Overall Study|Administrative Decision|0|||
144406203|NCT01081678|520697703|FG003|Overall Study|Administrative Decision|1|||
144406204|NCT01081678|520697700|FG000|Overall Study|Lost to Follow-up|4|||
144406205|NCT01081678|520697701|FG001|Overall Study|Lost to Follow-up|1|||
144406206|NCT01081678|520697702|FG002|Overall Study|Lost to Follow-up|4|||
144406207|NCT01081678|520697703|FG003|Overall Study|Lost to Follow-up|3|||
144406208|NCT01081678|520697700|FG000|Overall Study|Death|2|||
144406209|NCT01081678|520697701|FG001|Overall Study|Death|2|||
144406210|NCT01081678|520697702|FG002|Overall Study|Death|2|||
144406211|NCT01081678|520697703|FG003|Overall Study|Death|6|||
144406212|NCT01081678|520697700|FG000|Overall Study|Other|0|||
144406213|NCT01081678|520697701|FG001|Overall Study|Other|1|||
144406214|NCT01081678|520697702|FG002|Overall Study|Other|0|||
144406215|NCT01081678|520697703|FG003|Overall Study|Other|0|||
144406216|NCT01281865|520697706|FG000|Overall Study|Adverse Event|1|||
144406217|NCT01281865|520697707|FG001|Overall Study|Adverse Event|1|||
144406218|NCT01281865|520697706|FG000|Overall Study|Withdrawal by Subject|1|||
144406219|NCT01281865|520697707|FG001|Overall Study|Withdrawal by Subject|0|||
144406220|NCT01281865|520697706|FG000|Overall Study|Lack of Efficacy|1|||
144406221|NCT01281865|520697707|FG001|Overall Study|Lack of Efficacy|0|||
144406222|NCT03758066|520697708|FG000|Overall Study|Lost to Follow-up|14|||
144406223|NCT03478657|520697709|FG000|Overall Study|Withdrawal by Subject|0|||
144406224|NCT03478657|520697710|FG001|Overall Study|Withdrawal by Subject|1|||
144406225|NCT02590003|520697711|FG000|Overall Study|Death|1|||
144406226|NCT02590003|520697712|FG001|Overall Study|Death|2|||
144406227|NCT01786668|520697713|FG000|Overall Study|Adverse Event|0|||
144406228|NCT01786668|520697714|FG001|Overall Study|Adverse Event|1|||
144406229|NCT01786668|520697715|FG002|Overall Study|Adverse Event|1|||
144406230|NCT01786668|520697716|FG003|Overall Study|Adverse Event|2|||
144406231|NCT01786668|520697713|FG000|Overall Study|Withdrawal by Subject|0|||
144406232|NCT01786668|520697714|FG001|Overall Study|Withdrawal by Subject|0|||
144406233|NCT01786668|520697715|FG002|Overall Study|Withdrawal by Subject|3|||
144406234|NCT01786668|520697716|FG003|Overall Study|Withdrawal by Subject|1|||
144599639|NCT02464228|521397455|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
144599640|NCT02464228|521397456|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
144599641|NCT02464228|521397457|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
144599642|NCT02464228|521397458|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
144599643|NCT02464228|521397455|FG000|Overall Study|Physician Decision|2|||
144406235|NCT01786668|520697713|FG000|Overall Study|Pregnancy|0|||
144406236|NCT01786668|520697714|FG001|Overall Study|Pregnancy|0|||
144406237|NCT01786668|520697715|FG002|Overall Study|Pregnancy|0|||
144406238|NCT01786668|520697716|FG003|Overall Study|Pregnancy|1|||
144406239|NCT01786668|520697713|FG000|Overall Study|Lost to Follow-up|1|||
144406240|NCT01786668|520697714|FG001|Overall Study|Lost to Follow-up|0|||
144406241|NCT01786668|520697715|FG002|Overall Study|Lost to Follow-up|1|||
144406242|NCT01786668|520697716|FG003|Overall Study|Lost to Follow-up|0|||
144406243|NCT01849783|520697717|FG000|Overall Study|Adverse Event|5|||
144406244|NCT01849783|520697717|FG000|Overall Study|Death|2|||
144406245|NCT01849783|520697717|FG000|Overall Study|Physician Decision|1|||
144406246|NCT01849783|520697717|FG000|Overall Study|Withdrawal by Subject|1|||
144406247|NCT01849783|520697717|FG000|Overall Study|Unable to comply|2|||
144406248|NCT01849783|520697717|FG000|Overall Study|Disease progression|11|||
144406249|NCT03948581|520697718|FG000|Overall Study|Lost to Follow-up|0|||
144406250|NCT03948581|520697719|FG001|Overall Study|Lost to Follow-up|1|||
144406251|NCT03068455|520697720|FG000|Pre-treatment Period|Disease progression|0|||
144599644|NCT02464228|521397456|FG001|Overall Study|Physician Decision|0|||
144406252|NCT03068455|520697721|FG001|Pre-treatment Period|Disease progression|1|||
144406253|NCT03068455|520697720|FG000|Pre-treatment Period|Participant withdrew consent|1|||
144525450|NCT03774082|521123759|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
144525451|NCT05030233|521123760|FG000|Overall Study|withdrawn for transfer|1|||
144722606|NCT00673790|521838789|FG002|Overall Study|Unconfirmed pregnancy|0|||
144722607|NCT00673790|521838787|FG000|Overall Study|Randomization criteria not met|0|||
144722608|NCT00673790|521838788|FG001|Overall Study|Randomization criteria not met|1|||
144722609|NCT00673790|521838789|FG002|Overall Study|Randomization criteria not met|0|||
144722610|NCT01118728|521838790|FG000|Overall Study|Adverse Event|17|||
144722611|NCT01118728|521838790|FG000|Overall Study|Lack of Efficacy|27|||
144722612|NCT01118728|521838790|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
144722613|NCT01118728|521838790|FG000|Overall Study|Withdrawal by Subject|3|||
144722614|NCT01118728|521838790|FG000|Overall Study|Lost to Follow-up|4|||
144722615|NCT01052116|521840505|FG000|Overall Study|Lost to Follow-up|11|||
144525452|NCT05030233|521123761|FG001|Overall Study|withdrawn for transfer|0|||
144525453|NCT04437615|521123762|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
144525454|NCT04828005|521123763|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
144525455|NCT04828005|521123764|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
144525456|NCT04828005|521123765|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
144525457|NCT04828005|521123766|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
144525458|NCT04828005|521123763|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
144525459|NCT04828005|521123764|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
144525460|NCT04828005|521123765|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
144722616|NCT01052116|521840506|FG001|Overall Study|Lost to Follow-up|17|||
144722617|NCT01052116|521840505|FG000|Overall Study|Withdrawal by Subject|3|||
144525461|NCT04828005|521123766|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
144599645|NCT02464228|521397457|FG002|Overall Study|Physician Decision|1|||
144599646|NCT02464228|521397458|FG003|Overall Study|Physician Decision|0|||
144722618|NCT01052116|521840506|FG001|Overall Study|Withdrawal by Subject|6|||
144599647|NCT02464228|521397455|FG000|Overall Study|Miscellaneous|1|||
144599648|NCT02464228|521397456|FG001|Overall Study|Miscellaneous|0|||
144599649|NCT02464228|521397457|FG002|Overall Study|Miscellaneous|1|||
144722619|NCT01052116|521840505|FG000|Overall Study|Spirometry not performed|0|||
144722620|NCT01052116|521840506|FG001|Overall Study|Spirometry not performed|4|||
144722621|NCT00275002|521840507|FG000|Overall Study|Death|1|||
144722622|NCT00275002|521840508|FG001|Overall Study|Death|0|||
144722623|NCT00275002|521840507|FG000|Overall Study|Disease progression|21|||
144722624|NCT00275002|521840508|FG001|Overall Study|Disease progression|15|||
144722625|NCT00275002|521840507|FG000|Overall Study|Adverse Event|0|||
144722626|NCT00275002|521840508|FG001|Overall Study|Adverse Event|1|||
144722627|NCT05456529|521840509|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
144525462|NCT04828005|521123763|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
144599650|NCT02464228|521397458|FG003|Overall Study|Miscellaneous|0|||
144599651|NCT02464228|521397455|FG000|Overall Study|Adverse Event|9|||
144599652|NCT02464228|521397456|FG001|Overall Study|Adverse Event|0|||
144599653|NCT02464228|521397457|FG002|Overall Study|Adverse Event|3|||
144599654|NCT02464228|521397458|FG003|Overall Study|Adverse Event|0|||
144599655|NCT02464228|521397455|FG000|Overall Study|Withdrawal by Subject|1|||
144599656|NCT02464228|521397456|FG001|Overall Study|Withdrawal by Subject|1|||
144599657|NCT02464228|521397457|FG002|Overall Study|Withdrawal by Subject|1|||
144599658|NCT02464228|521397458|FG003|Overall Study|Withdrawal by Subject|0|||
144599659|NCT02464228|521397455|FG000|Overall Study|Disease Progression|22|||
144599660|NCT02464228|521397456|FG001|Overall Study|Disease Progression|12|||
144599661|NCT02464228|521397457|FG002|Overall Study|Disease Progression|5|||
144599662|NCT02464228|521397458|FG003|Overall Study|Disease Progression|2|||
144599663|NCT01117454|521397461|FG000|Overall Study|Pregnancy|0|||
144599664|NCT01117454|521397462|FG001|Overall Study|Pregnancy|1|||
144599665|NCT02194062|521397472|FG000|Overall Study|Lost to Follow-up|2|||
144599666|NCT02194062|521397473|FG001|Overall Study|Lost to Follow-up|2|||
144599667|NCT02194062|521397474|FG002|Overall Study|Lost to Follow-up|5|||
144599668|NCT02502266|521397475|FG000|Overall Study|Adverse Event|0|||
144722628|NCT05456529|521840509|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
144722629|NCT05456529|521840509|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
144525463|NCT04828005|521123764|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
144525464|NCT04828005|521123765|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
144599669|NCT02502266|521397476|FG001|Overall Study|Adverse Event|0|||
144722630|NCT05456529|521840509|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
144722631|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
144599670|NCT02502266|521397477|FG002|Overall Study|Adverse Event|0|||
144599671|NCT02502266|521397478|FG003|Overall Study|Adverse Event|0|||
144599672|NCT02502266|521397479|FG004|Overall Study|Adverse Event|1|||
144599673|NCT02502266|521397480|FG005|Overall Study|Adverse Event|1|||
144722632|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
144722633|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Physician Decision|2|||
144525465|NCT04828005|521123766|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
144525466|NCT04828005|521123763|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
144525467|NCT04828005|521123764|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
144525468|NCT04828005|521123765|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
144525469|NCT04828005|521123766|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
144525470|NCT04828005|521123763|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
144525471|NCT04828005|521123764|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
144525472|NCT04828005|521123765|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
144525473|NCT04828005|521123766|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
144525474|NCT04828005|521123763|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
144525475|NCT04828005|521123764|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
144525476|NCT04828005|521123765|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
144525477|NCT04828005|521123766|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
144525478|NCT04828005|521123763|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
144525479|NCT04828005|521123764|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
144525480|NCT04828005|521123765|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
144525481|NCT04828005|521123766|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
144525482|NCT04828005|521123763|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
144525483|NCT04828005|521123764|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
144525484|NCT04828005|521123765|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
144525485|NCT04828005|521123766|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
144525486|NCT04828005|521123763|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
144525487|NCT04828005|521123764|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
144525488|NCT04828005|521123765|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
144525489|NCT04828005|521123766|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
144525490|NCT06516705|521125580|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
144525491|NCT06516705|521125581|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
144525492|NCT06516705|521125580|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
144525493|NCT06516705|521125581|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
144525494|NCT06516705|521125580|FG000|T3 ( 3 Month After Education)|covid-19|1|||
144525495|NCT06516705|521125581|FG001|T3 ( 3 Month After Education)|covid-19|2|||
144525496|NCT06516705|521125580|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
144525497|NCT06516705|521125581|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
144525498|NCT06516705|521125580|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
144525499|NCT06516705|521125581|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
144525500|NCT06516705|521125580|FG000|T4 ( 6 Month After Education)|covid-19|3|||
144525501|NCT06516705|521125581|FG001|T4 ( 6 Month After Education)|covid-19|2|||
144525502|NCT06516705|521125580|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
144525503|NCT06516705|521125581|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
144599674|NCT02502266|521397481|FG006|Overall Study|Adverse Event|1|||
144599675|NCT02502266|521397475|FG000|Overall Study|Withdrawal by Subject|30|||
144599676|NCT02502266|521397476|FG001|Overall Study|Withdrawal by Subject|15|||
144599677|NCT02502266|521397477|FG002|Overall Study|Withdrawal by Subject|16|||
144599678|NCT02502266|521397478|FG003|Overall Study|Withdrawal by Subject|0|||
144525504|NCT05579899|521125582|FG000|Overall Study|Lost to Follow-up|3|||
144525505|NCT05579899|521125583|FG001|Overall Study|Lost to Follow-up|1|||
144525506|NCT05579899|521125582|FG000|Overall Study|Adverse Event|0|||
144525507|NCT05579899|521125583|FG001|Overall Study|Adverse Event|3|||
144525508|NCT05579899|521125582|FG000|Overall Study|Pregnancy|0|||
144525509|NCT05579899|521125583|FG001|Overall Study|Pregnancy|1|||
144525510|NCT05579899|521125582|FG000|Overall Study|Withdrawal by Subject|0|||
144525511|NCT05579899|521125583|FG001|Overall Study|Withdrawal by Subject|3|||
144525512|NCT05453773|521125584|FG000|Overall Study|Withdrawal by Subject|3|||
144525513|NCT05453773|521125584|FG000|Overall Study|Lost to Follow-up|3|||
144525514|NCT05453773|521125584|FG000|Overall Study|Difficult Blood Draw|3|||
144525515|NCT03023410|521125587|FG000|Overall Study|study termination|0|||
144525516|NCT03023410|521125588|FG001|Overall Study|study termination|1|||
144525517|NCT04963270|521125590|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
144525518|NCT04963270|521125591|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
144525519|NCT04963270|521125592|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
144525520|NCT04963270|521125593|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
144525521|NCT04963270|521125590|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144599679|NCT02502266|521397479|FG004|Overall Study|Withdrawal by Subject|0|||
144525522|NCT04963270|521125591|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
144525523|NCT04963270|521125592|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144525524|NCT04963270|521125593|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144525525|NCT04963270|521125590|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
144525526|NCT04963270|521125591|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144599680|NCT02502266|521397480|FG005|Overall Study|Withdrawal by Subject|0|||
144406254|NCT03068455|520697721|FG001|Pre-treatment Period|Participant withdrew consent|1|||
144406255|NCT03068455|520697720|FG000|Pre-treatment Period|Poor/non-compliance|0|||
144406256|NCT03068455|520697721|FG001|Pre-treatment Period|Poor/non-compliance|1|||
144406257|NCT03068455|520697720|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
144406258|NCT03068455|520697721|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
144406259|NCT03068455|520697720|FG000|Pre-treatment Period|Not reported|2|||
144406260|NCT03068455|520697721|FG001|Pre-treatment Period|Not reported|1|||
144406261|NCT03068455|520697720|FG000|Treatment Period|Disease progression|166|||
144406262|NCT03068455|520697721|FG001|Treatment Period|Disease progression|208|||
144406263|NCT03068455|520697720|FG000|Treatment Period|Study drug toxicity|317|||
144406264|NCT03068455|520697721|FG001|Treatment Period|Study drug toxicity|104|||
144406265|NCT03068455|520697720|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
144406266|NCT03068455|520697721|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
144406267|NCT03068455|520697720|FG000|Treatment Period|Participant request to stop therapy|33|||
144406268|NCT03068455|520697721|FG001|Treatment Period|Participant request to stop therapy|20|||
144406269|NCT03068455|520697720|FG000|Treatment Period|Participant withdrew consent|5|||
144406270|NCT03068455|520697721|FG001|Treatment Period|Participant withdrew consent|10|||
144406271|NCT03068455|520697720|FG000|Treatment Period|Poor/non-compliance|3|||
144406272|NCT03068455|520697721|FG001|Treatment Period|Poor/non-compliance|0|||
144406273|NCT03068455|520697720|FG000|Treatment Period|Participant no longer meets study criteria|1|||
144406274|NCT03068455|520697721|FG001|Treatment Period|Participant no longer meets study criteria|3|||
144406275|NCT03068455|520697720|FG000|Treatment Period|Other reasons|12|||
144406276|NCT03068455|520697721|FG001|Treatment Period|Other reasons|4|||
144406277|NCT00415168|520697726|FG000|Overall Study|Death|26|||
144406278|NCT00415168|520697726|FG000|Overall Study|Lost to Follow-up|3|||
144406279|NCT00415168|520697726|FG000|Overall Study|Physician Decision|13|||
144406280|NCT00415168|520697726|FG000|Overall Study|Sponsor Decision|4|||
144406281|NCT00415168|520697726|FG000|Overall Study|Withdrawal by Subject|6|||
144406282|NCT01548287|520697729|FG000|Screening|No reason provided|0|||
144406283|NCT01548287|520697730|FG001|Screening|No reason provided|0|||
144406284|NCT01548287|520697731|FG002|Screening|No reason provided|0|||
144406285|NCT01548287|520697732|FG003|Screening|No reason provided|0|||
144406286|NCT01548287|520697733|FG004|Screening|No reason provided|9|||
144406287|NCT01548287|520697729|FG000|Screening|Did not meet eligibility criteria|0|||
144406288|NCT01548287|520697730|FG001|Screening|Did not meet eligibility criteria|0|||
144406289|NCT01548287|520697731|FG002|Screening|Did not meet eligibility criteria|0|||
144406290|NCT01548287|520697732|FG003|Screening|Did not meet eligibility criteria|0|||
144406291|NCT01548287|520697733|FG004|Screening|Did not meet eligibility criteria|74|||
144406292|NCT01548287|520697729|FG000|Randomized Period|Did not meet inclusion criteria|0|||
144406293|NCT01548287|520697730|FG001|Randomized Period|Did not meet inclusion criteria|0|||
144406294|NCT01548287|520697731|FG002|Randomized Period|Did not meet inclusion criteria|2|||
144406295|NCT01548287|520697732|FG003|Randomized Period|Did not meet inclusion criteria|0|||
144406296|NCT01548287|520697733|FG004|Randomized Period|Did not meet inclusion criteria|0|||
144406297|NCT01548287|520697729|FG000|Randomized Period|Adverse Event|0|||
144406298|NCT01548287|520697730|FG001|Randomized Period|Adverse Event|2|||
144406299|NCT01548287|520697731|FG002|Randomized Period|Adverse Event|5|||
144406300|NCT01548287|520697732|FG003|Randomized Period|Adverse Event|0|||
144406301|NCT01548287|520697733|FG004|Randomized Period|Adverse Event|0|||
144406302|NCT02762578|520697734|FG000|Overall Study|Adverse Event|1|||
144406303|NCT02762578|520697735|FG001|Overall Study|Adverse Event|6|||
144406304|NCT02762578|520697734|FG000|Overall Study|Protocol Violation|4|||
144406305|NCT02762578|520697735|FG001|Overall Study|Protocol Violation|2|||
144599681|NCT02502266|521397481|FG006|Overall Study|Withdrawal by Subject|0|||
144599682|NCT02502266|521397475|FG000|Overall Study|Still on Treatment|0|||
144599683|NCT02502266|521397476|FG001|Overall Study|Still on Treatment|0|||
144599684|NCT02502266|521397477|FG002|Overall Study|Still on Treatment|1|||
144599685|NCT02502266|521397478|FG003|Overall Study|Still on Treatment|0|||
144599686|NCT02502266|521397479|FG004|Overall Study|Still on Treatment|0|||
144599687|NCT02502266|521397480|FG005|Overall Study|Still on Treatment|0|||
144599688|NCT02502266|521397481|FG006|Overall Study|Still on Treatment|0|||
144599689|NCT02502266|521397475|FG000|Overall Study|Other Reasons|19|||
144406306|NCT02762578|520697734|FG000|Overall Study|Withdrawal by Subject|4|||
144406307|NCT02762578|520697735|FG001|Overall Study|Withdrawal by Subject|2|||
144406308|NCT02762578|520697734|FG000|Overall Study|Unclassified|6|||
144406309|NCT02762578|520697735|FG001|Overall Study|Unclassified|0|||
144406310|NCT01090492|520697738|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
144406311|NCT01090492|520697739|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
144406312|NCT01090492|520697740|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
144406313|NCT01090492|520697741|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
144406314|NCT01090492|520697742|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
144406315|NCT01090492|520697743|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
144599690|NCT02502266|521397476|FG001|Overall Study|Other Reasons|6|||
144599691|NCT02502266|521397477|FG002|Overall Study|Other Reasons|14|||
144525527|NCT04963270|521125592|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144525528|NCT04963270|521125593|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144525529|NCT04963270|521125590|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
144525530|NCT04963270|521125591|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
144525531|NCT04963270|521125592|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
144525532|NCT04963270|521125593|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
144525533|NCT04963270|521125590|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
144525534|NCT04963270|521125591|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
144525535|NCT04963270|521125592|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
144525536|NCT04963270|521125593|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
144525537|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
144525538|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
144525539|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
144525540|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
144525541|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
144525542|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
144525543|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
144525544|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
144525545|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
144525546|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
144525547|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
144525548|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
144525549|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
144525550|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
144525551|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
144525552|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
144525553|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
144525554|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
144525555|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
144525556|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
144525557|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
144525558|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
144525559|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
144525560|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
144525561|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
144525562|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
144525563|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
144525564|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
144525565|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
144525566|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
144525567|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
144599692|NCT02502266|521397478|FG003|Overall Study|Other Reasons|0|||
144599693|NCT02502266|521397479|FG004|Overall Study|Other Reasons|1|||
144599694|NCT02502266|521397480|FG005|Overall Study|Other Reasons|1|||
144599695|NCT02502266|521397481|FG006|Overall Study|Other Reasons|0|||
144599696|NCT02502266|521397475|FG000|Overall Study|Arm 4 Discontinued|0|||
144599697|NCT02502266|521397476|FG001|Overall Study|Arm 4 Discontinued|0|||
144599698|NCT02502266|521397477|FG002|Overall Study|Arm 4 Discontinued|0|||
144599699|NCT02502266|521397478|FG003|Overall Study|Arm 4 Discontinued|52|||
144599700|NCT02502266|521397479|FG004|Overall Study|Arm 4 Discontinued|0|||
144599701|NCT02502266|521397480|FG005|Overall Study|Arm 4 Discontinued|0|||
144599702|NCT02502266|521397481|FG006|Overall Study|Arm 4 Discontinued|0|||
144599703|NCT02502266|521397475|FG000|Overall Study|Never treated|0|||
144599704|NCT02502266|521397476|FG001|Overall Study|Never treated|0|||
144599705|NCT02502266|521397477|FG002|Overall Study|Never treated|0|||
144599706|NCT02502266|521397478|FG003|Overall Study|Never treated|0|||
144599707|NCT02502266|521397479|FG004|Overall Study|Never treated|0|||
144525568|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
144599708|NCT02502266|521397480|FG005|Overall Study|Never treated|1|||
144599709|NCT02502266|521397481|FG006|Overall Study|Never treated|0|||
144250010|NCT03959488|520113435|FG001|Season 1|Other|7|||
144250011|NCT03959488|520113436|FG002|Season 1|Other|0|||
144525569|NCT04963270|521125590|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
144599710|NCT01637623|521397482|FG000|Overall Study|Lost to Follow-up|0|||
144599711|NCT01637623|521397483|FG001|Overall Study|Lost to Follow-up|0|||
144599712|NCT01637623|521397484|FG002|Overall Study|Lost to Follow-up|2|||
144599713|NCT01637623|521397482|FG000|Overall Study|Physician Decision|1|||
144599714|NCT01637623|521397483|FG001|Overall Study|Physician Decision|0|||
144599715|NCT01637623|521397484|FG002|Overall Study|Physician Decision|1|||
144599716|NCT02634346|521397487|FG000|Overall Study|Withdrawal by Subject|8|||
144406316|NCT01090492|520697744|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
144406317|NCT01090492|520697745|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
144406318|NCT01090492|520697738|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
144406319|NCT01090492|520697739|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
144406320|NCT01090492|520697740|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
144406321|NCT01090492|520697741|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
144406322|NCT01090492|520697742|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
144406323|NCT01090492|520697743|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
144406324|NCT01090492|520697744|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
144406325|NCT01090492|520697745|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
144406326|NCT01090492|520697738|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406327|NCT01090492|520697739|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406328|NCT01090492|520697740|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
144406329|NCT01090492|520697741|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406330|NCT01090492|520697742|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406331|NCT01090492|520697743|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406332|NCT01090492|520697744|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406333|NCT01090492|520697745|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406334|NCT01090492|520697738|FG000|First Intervention Period (4 Weeks)|Other|0|||
144406335|NCT01090492|520697739|FG001|First Intervention Period (4 Weeks)|Other|0|||
144406336|NCT01090492|520697740|FG002|First Intervention Period (4 Weeks)|Other|1|||
144406337|NCT01090492|520697741|FG003|First Intervention Period (4 Weeks)|Other|1|||
144406338|NCT01090492|520697742|FG004|First Intervention Period (4 Weeks)|Other|2|||
144406339|NCT01090492|520697743|FG005|First Intervention Period (4 Weeks)|Other|0|||
144406340|NCT01090492|520697744|FG006|First Intervention Period (4 Weeks)|Other|0|||
144406341|NCT01090492|520697745|FG007|First Intervention Period (4 Weeks)|Other|0|||
144406342|NCT01090492|520697738|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406343|NCT01090492|520697739|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406344|NCT01090492|520697740|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406345|NCT01090492|520697741|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406346|NCT01090492|520697742|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
144406347|NCT01090492|520697743|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406348|NCT01090492|520697744|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406349|NCT01090492|520697745|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
144406350|NCT01090492|520697738|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
144406351|NCT01090492|520697739|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
144406352|NCT01090492|520697740|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
144406353|NCT01090492|520697741|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
144406354|NCT01090492|520697742|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
144406355|NCT01090492|520697743|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
144406356|NCT01090492|520697744|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
144406357|NCT01090492|520697745|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
144406358|NCT01090492|520697738|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
144406359|NCT01090492|520697739|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
144406360|NCT01090492|520697740|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
144406361|NCT01090492|520697741|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
144406362|NCT01090492|520697742|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
144406363|NCT01090492|520697743|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
144406364|NCT01090492|520697744|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
144406365|NCT01090492|520697745|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
144406366|NCT01090492|520697738|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406367|NCT01090492|520697739|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
144406368|NCT01090492|520697740|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406369|NCT01090492|520697741|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406370|NCT01090492|520697742|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406371|NCT01090492|520697743|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406372|NCT01090492|520697744|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406373|NCT01090492|520697745|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
144406374|NCT01090492|520697738|FG000|Second Intervention Period (4 Weeks)|Other|0|||
144406375|NCT01090492|520697739|FG001|Second Intervention Period (4 Weeks)|Other|1|||
144406376|NCT01090492|520697740|FG002|Second Intervention Period (4 Weeks)|Other|1|||
144406377|NCT01090492|520697741|FG003|Second Intervention Period (4 Weeks)|Other|0|||
144406378|NCT01090492|520697742|FG004|Second Intervention Period (4 Weeks)|Other|0|||
144406379|NCT01090492|520697743|FG005|Second Intervention Period (4 Weeks)|Other|0|||
144406380|NCT01090492|520697744|FG006|Second Intervention Period (4 Weeks)|Other|0|||
144406381|NCT01090492|520697745|FG007|Second Intervention Period (4 Weeks)|Other|0|||
144525570|NCT04963270|521125591|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
144406382|NCT01090492|520697738|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
144406383|NCT01090492|520697739|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
144406384|NCT01090492|520697740|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
144406385|NCT01090492|520697741|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
144406386|NCT01090492|520697742|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
144406387|NCT01090492|520697743|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
144406388|NCT01090492|520697744|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
144406389|NCT01090492|520697745|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
144406390|NCT01090492|520697738|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406391|NCT01090492|520697739|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406392|NCT01090492|520697740|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406393|NCT01090492|520697741|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406394|NCT01090492|520697742|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406395|NCT01090492|520697743|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406396|NCT01090492|520697744|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
144406397|NCT01090492|520697745|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
144406398|NCT01768286|520697746|FG000|Overall Study|Randomized But Not Treated|0|||
144406399|NCT01768286|520697747|FG001|Overall Study|Randomized But Not Treated|0|||
144406400|NCT01768286|520697748|FG002|Overall Study|Randomized But Not Treated|1|||
144406401|NCT01768286|520697749|FG003|Overall Study|Randomized But Not Treated|0|||
144406402|NCT01768286|520697746|FG000|Overall Study|Lack of Efficacy|7|||
144406403|NCT01768286|520697747|FG001|Overall Study|Lack of Efficacy|4|||
144406404|NCT01768286|520697748|FG002|Overall Study|Lack of Efficacy|0|||
144406405|NCT01768286|520697749|FG003|Overall Study|Lack of Efficacy|1|||
144406406|NCT01768286|520697746|FG000|Overall Study|Withdrew Consent|0|||
144406407|NCT01768286|520697747|FG001|Overall Study|Withdrew Consent|0|||
144406408|NCT01768286|520697748|FG002|Overall Study|Withdrew Consent|1|||
144406409|NCT01768286|520697749|FG003|Overall Study|Withdrew Consent|0|||
144406410|NCT02083965|520697750|FG000|Treatment Period|Other|1|||
144406411|NCT02083965|520697751|FG001|Treatment Period|Other|0|||
144406412|NCT01201785|520697753|FG000|Overall Study|Lost to Follow-up|16|||
144406413|NCT02151110|520697754|FG000|Overall Study|Withdrawal by Subject|0|||
144406414|NCT02151110|520697755|FG001|Overall Study|Withdrawal by Subject|0|||
144406415|NCT02151110|520697756|FG002|Overall Study|Withdrawal by Subject|0|||
144406416|NCT02151110|520697757|FG003|Overall Study|Withdrawal by Subject|0|||
144406417|NCT02151110|520697758|FG004|Overall Study|Withdrawal by Subject|0|||
144406418|NCT02151110|520697759|FG005|Overall Study|Withdrawal by Subject|0|||
144406419|NCT02151110|520697760|FG006|Overall Study|Withdrawal by Subject|0|||
144406420|NCT02151110|520697761|FG007|Overall Study|Withdrawal by Subject|1|||
144406421|NCT02151110|520697754|FG000|Overall Study|Lost to Follow-up|0|||
144406422|NCT02151110|520697755|FG001|Overall Study|Lost to Follow-up|0|||
144406423|NCT02151110|520697756|FG002|Overall Study|Lost to Follow-up|0|||
144406424|NCT02151110|520697757|FG003|Overall Study|Lost to Follow-up|0|||
144722634|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
144722635|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
144406425|NCT02151110|520697758|FG004|Overall Study|Lost to Follow-up|0|||
144406426|NCT02151110|520697759|FG005|Overall Study|Lost to Follow-up|0|||
144406427|NCT02151110|520697760|FG006|Overall Study|Lost to Follow-up|0|||
144406428|NCT02151110|520697761|FG007|Overall Study|Lost to Follow-up|2|||
144406429|NCT02015754|520697762|FG000|Overall Study|Disease progression|5|||
144406430|NCT02015754|520697762|FG000|Overall Study|Change in treatment modality|5|||
144406431|NCT02015754|520697762|FG000|Overall Study|Lost to Follow-up|1|||
144406432|NCT02369016|520697763|FG000|Overall Study|AE associated with clinical disease progression|2|||
144525571|NCT04963270|521125592|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
144525572|NCT04963270|521125593|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
144525573|NCT04802967|521125594|FG000|Part B|Withdrawal by Subject|0|||
144525574|NCT04802967|521125595|FG001|Part B|Withdrawal by Subject|0|||
144525575|NCT04802967|521125596|FG002|Part B|Withdrawal by Subject|0|||
144525576|NCT04802967|521125597|FG003|Part B|Withdrawal by Subject|0|||
144525577|NCT04802967|521125598|FG004|Part B|Withdrawal by Subject|0|||
144525578|NCT04802967|521125599|FG005|Part B|Withdrawal by Subject|1|||
144525579|NCT04802967|521125600|FG006|Part B|Withdrawal by Subject|0|||
144525580|NCT04802967|521125601|FG007|Part B|Withdrawal by Subject|0|||
144525581|NCT04802967|521125602|FG008|Part B|Withdrawal by Subject|0|||
144525582|NCT04802967|521125603|FG009|Part B|Withdrawal by Subject|0|||
144525583|NCT04195698|521125610|FG000|Overall Study|Adverse Event|4|||
144525584|NCT04195698|521125611|FG001|Overall Study|Adverse Event|11|||
144525585|NCT04195698|521125610|FG000|Overall Study|Withdrawal by Subject|9|||
144525586|NCT04195698|521125611|FG001|Overall Study|Withdrawal by Subject|10|||
144525587|NCT04195698|521125610|FG000|Overall Study|Lost to Follow-up|5|||
144525588|NCT04195698|521125611|FG001|Overall Study|Lost to Follow-up|4|||
144525589|NCT04195698|521125610|FG000|Overall Study|Lack of Efficacy|2|||
144525590|NCT04195698|521125611|FG001|Overall Study|Lack of Efficacy|10|||
144406433|NCT02369016|520697764|FG001|Overall Study|AE associated with clinical disease progression|1|||
144406434|NCT02369016|520697763|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
144406435|NCT02369016|520697764|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
144406436|NCT02369016|520697763|FG000|Overall Study|Progressive disease - clinical progression|1|||
144406437|NCT02369016|520697764|FG001|Overall Study|Progressive disease - clinical progression|4|||
144406438|NCT02369016|520697763|FG000|Overall Study|withdrawal by patient|4|||
144406439|NCT02369016|520697764|FG001|Overall Study|withdrawal by patient|0|||
144406440|NCT02369016|520697763|FG000|Overall Study|Progressive disease - radiological progression|6|||
144406441|NCT02369016|520697764|FG001|Overall Study|Progressive disease - radiological progression|2|||
144599717|NCT02634346|521397488|FG001|Overall Study|Withdrawal by Subject|9|||
144406442|NCT00939770|520697767|FG000|Overall Study|Adverse Event|1|||
144406443|NCT00939770|520697768|FG001|Overall Study|Adverse Event|1|||
144406444|NCT00939770|520697769|FG002|Overall Study|Adverse Event|0|||
144406445|NCT00939770|520697770|FG003|Overall Study|Adverse Event|0|||
144406446|NCT00939770|520697771|FG004|Overall Study|Adverse Event|6|||
144406447|NCT00939770|520697772|FG005|Overall Study|Adverse Event|2|||
144406448|NCT00939770|520697773|FG006|Overall Study|Adverse Event|1|||
144406449|NCT00939770|520697774|FG007|Overall Study|Adverse Event|1|||
144406450|NCT00939770|520697767|FG000|Overall Study|Lack of Efficacy|4|||
144406451|NCT00939770|520697768|FG001|Overall Study|Lack of Efficacy|6|||
144406452|NCT00939770|520697769|FG002|Overall Study|Lack of Efficacy|13|||
144406453|NCT00939770|520697770|FG003|Overall Study|Lack of Efficacy|9|||
144406454|NCT00939770|520697771|FG004|Overall Study|Lack of Efficacy|16|||
144406455|NCT00939770|520697772|FG005|Overall Study|Lack of Efficacy|8|||
144406456|NCT00939770|520697773|FG006|Overall Study|Lack of Efficacy|11|||
144406457|NCT00939770|520697774|FG007|Overall Study|Lack of Efficacy|1|||
144406458|NCT00939770|520697767|FG000|Overall Study|Lost to Follow-up|0|||
144406459|NCT00939770|520697768|FG001|Overall Study|Lost to Follow-up|0|||
144406460|NCT00939770|520697769|FG002|Overall Study|Lost to Follow-up|0|||
144406461|NCT00939770|520697770|FG003|Overall Study|Lost to Follow-up|0|||
144406462|NCT00939770|520697771|FG004|Overall Study|Lost to Follow-up|1|||
144406463|NCT00939770|520697772|FG005|Overall Study|Lost to Follow-up|0|||
144406464|NCT00939770|520697773|FG006|Overall Study|Lost to Follow-up|0|||
144406465|NCT00939770|520697774|FG007|Overall Study|Lost to Follow-up|0|||
144406466|NCT00939770|520697767|FG000|Overall Study|Physician Decision|0|||
144406467|NCT00939770|520697768|FG001|Overall Study|Physician Decision|0|||
144406468|NCT00939770|520697769|FG002|Overall Study|Physician Decision|2|||
144406469|NCT00939770|520697770|FG003|Overall Study|Physician Decision|0|||
144406470|NCT00939770|520697771|FG004|Overall Study|Physician Decision|7|||
144406471|NCT00939770|520697772|FG005|Overall Study|Physician Decision|1|||
144406472|NCT00939770|520697773|FG006|Overall Study|Physician Decision|0|||
144406473|NCT00939770|520697774|FG007|Overall Study|Physician Decision|6|||
144406474|NCT00939770|520697767|FG000|Overall Study|Protocol Violation|0|||
144525591|NCT04195698|521125610|FG000|Overall Study|Other|5|||
144525592|NCT04195698|521125611|FG001|Overall Study|Other|4|||
144525593|NCT01098812|521125612|FG000|Overall Study|Death|2|||
144525594|NCT01098812|521125613|FG001|Overall Study|Death|0|||
144525595|NCT01098812|521125614|FG002|Overall Study|Death|1|||
144525596|NCT01098812|521125612|FG000|Overall Study|Lost to Follow-up|0|||
144525597|NCT01098812|521125613|FG001|Overall Study|Lost to Follow-up|1|||
144525598|NCT01098812|521125614|FG002|Overall Study|Lost to Follow-up|0|||
144525599|NCT05459688|521125615|FG000|Overall Study|Lost to Follow-up|6|||
144525600|NCT05459688|521125615|FG000|Overall Study|Physician Decision|1|||
144525601|NCT05459688|521125615|FG000|Overall Study|Withdrawal by Subject|19|||
144525602|NCT05459688|521125615|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
144525603|NCT01129102|521125616|FG000|Overall Study|No study drug treatment|2|||
144525604|NCT01129102|521125617|FG001|Overall Study|No study drug treatment|3|||
144525605|NCT01129102|521125618|FG002|Overall Study|No study drug treatment|1|||
144525606|NCT01129102|521125616|FG000|Overall Study|Withdrawal by Subject|2|||
144525607|NCT01129102|521125617|FG001|Overall Study|Withdrawal by Subject|0|||
144525608|NCT01129102|521125618|FG002|Overall Study|Withdrawal by Subject|3|||
144525609|NCT01129102|521125616|FG000|Overall Study|Protocol Violation|0|||
144525610|NCT01129102|521125617|FG001|Overall Study|Protocol Violation|1|||
144722636|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
144250012|NCT03959488|520113437|FG003|Season 1|Other|0|||
144525611|NCT01129102|521125618|FG002|Overall Study|Protocol Violation|1|||
144525612|NCT01129102|521125616|FG000|Overall Study|Pregnancy|0|||
144722637|NCT05456529|521840509|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
144406475|NCT00939770|520697768|FG001|Overall Study|Protocol Violation|0|||
144406476|NCT00939770|520697769|FG002|Overall Study|Protocol Violation|0|||
144406477|NCT00939770|520697770|FG003|Overall Study|Protocol Violation|0|||
144406478|NCT00939770|520697771|FG004|Overall Study|Protocol Violation|1|||
144406479|NCT00939770|520697772|FG005|Overall Study|Protocol Violation|0|||
144406480|NCT00939770|520697773|FG006|Overall Study|Protocol Violation|0|||
144599718|NCT02634346|521397489|FG002|Overall Study|Withdrawal by Subject|8|||
144406481|NCT00939770|520697774|FG007|Overall Study|Protocol Violation|0|||
144525613|NCT01129102|521125617|FG001|Overall Study|Pregnancy|0|||
144525614|NCT01129102|521125618|FG002|Overall Study|Pregnancy|1|||
144406482|NCT00939770|520697767|FG000|Overall Study|Withdrawal by Subject|0|||
144406483|NCT00939770|520697768|FG001|Overall Study|Withdrawal by Subject|1|||
144406484|NCT00939770|520697769|FG002|Overall Study|Withdrawal by Subject|5|||
144406485|NCT00939770|520697770|FG003|Overall Study|Withdrawal by Subject|2|||
144406486|NCT00939770|520697771|FG004|Overall Study|Withdrawal by Subject|6|||
144406487|NCT00939770|520697772|FG005|Overall Study|Withdrawal by Subject|0|||
144406488|NCT00939770|520697773|FG006|Overall Study|Withdrawal by Subject|2|||
144406489|NCT00939770|520697774|FG007|Overall Study|Withdrawal by Subject|2|||
144406490|NCT01146665|520697775|FG000|Overall Study|Withdrawal by Subject|10|||
144406491|NCT01146665|520697776|FG001|Overall Study|Withdrawal by Subject|16|||
144406492|NCT05248867|520697777|FG000|Double-blind Period|Lost to Follow-up|0|||
144406493|NCT05248867|520697778|FG001|Double-blind Period|Lost to Follow-up|3|||
144406494|NCT05248867|520697779|FG002|Double-blind Period|Lost to Follow-up|0|||
144406495|NCT05248867|520697780|FG003|Double-blind Period|Lost to Follow-up|0|||
144406496|NCT05248867|520697781|FG004|Double-blind Period|Lost to Follow-up|0|||
144406497|NCT05248867|520697782|FG005|Double-blind Period|Lost to Follow-up|0|||
144406498|NCT05248867|520697777|FG000|Double-blind Period|Withdrawal by Subject|5|||
144525615|NCT01129102|521125616|FG000|Overall Study|Adverse Event|2|||
144525616|NCT01129102|521125617|FG001|Overall Study|Adverse Event|2|||
144525617|NCT01129102|521125618|FG002|Overall Study|Adverse Event|1|||
144525618|NCT01129102|521125616|FG000|Overall Study|Lost to Follow-up|2|||
144525619|NCT01129102|521125617|FG001|Overall Study|Lost to Follow-up|0|||
144525620|NCT01129102|521125618|FG002|Overall Study|Lost to Follow-up|0|||
144525621|NCT03379675|521125626|FG000|Overall Study|Lost to Follow-up|0|||
144525622|NCT03379675|521125627|FG001|Overall Study|Lost to Follow-up|1|||
144525623|NCT03379675|521125628|FG002|Overall Study|Lost to Follow-up|0|||
144525624|NCT03379675|521125626|FG000|Overall Study|Adverse Event|2|||
144525625|NCT03379675|521125627|FG001|Overall Study|Adverse Event|0|||
144525626|NCT03379675|521125628|FG002|Overall Study|Adverse Event|0|||
144525627|NCT03379675|521125626|FG000|Overall Study|Withdrawal by Subject|2|||
144525628|NCT03379675|521125627|FG001|Overall Study|Withdrawal by Subject|1|||
144599719|NCT02634346|521397487|FG000|Overall Study|Adverse Event|2|||
144599720|NCT02634346|521397488|FG001|Overall Study|Adverse Event|2|||
144599721|NCT02634346|521397489|FG002|Overall Study|Adverse Event|7|||
144599722|NCT02634346|521397487|FG000|Overall Study|Lack of Efficacy|1|||
144599723|NCT02634346|521397488|FG001|Overall Study|Lack of Efficacy|2|||
144599724|NCT02634346|521397489|FG002|Overall Study|Lack of Efficacy|8|||
144599725|NCT02634346|521397487|FG000|Overall Study|Lost to Follow-up|1|||
144599726|NCT02634346|521397488|FG001|Overall Study|Lost to Follow-up|0|||
144599727|NCT02634346|521397489|FG002|Overall Study|Lost to Follow-up|0|||
144599728|NCT02634346|521397487|FG000|Overall Study|Protocol Violation|0|||
144599729|NCT02634346|521397488|FG001|Overall Study|Protocol Violation|1|||
144599730|NCT02634346|521397489|FG002|Overall Study|Protocol Violation|0|||
144599731|NCT04615247|521397490|FG000|Overall Study|Adverse Event|0|||
144599732|NCT04615247|521397491|FG001|Overall Study|Adverse Event|2|||
144599733|NCT04615247|521397490|FG000|Overall Study|Withdrawal by Subject|1|||
144599734|NCT04615247|521397491|FG001|Overall Study|Withdrawal by Subject|1|||
144599735|NCT00221195|521397496|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
144599736|NCT00221195|521397497|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
144599737|NCT00221195|521397496|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
144599738|NCT00221195|521397497|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
144599739|NCT00221195|521397496|FG000|Washout Period (Months 7-9)|Death|0|||
144599740|NCT00221195|521397497|FG001|Washout Period (Months 7-9)|Death|1|||
144599741|NCT00221195|521397496|FG000|Therapy 2 (Months 10-15)|Death|1|||
144599742|NCT00221195|521397497|FG001|Therapy 2 (Months 10-15)|Death|0|||
144406499|NCT05248867|520697778|FG001|Double-blind Period|Withdrawal by Subject|14|||
144406500|NCT05248867|520697779|FG002|Double-blind Period|Withdrawal by Subject|0|||
144406501|NCT05248867|520697780|FG003|Double-blind Period|Withdrawal by Subject|0|||
144406502|NCT05248867|520697781|FG004|Double-blind Period|Withdrawal by Subject|0|||
144406503|NCT05248867|520697782|FG005|Double-blind Period|Withdrawal by Subject|0|||
144406504|NCT05248867|520697777|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
144406505|NCT05248867|520697778|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
144406506|NCT05248867|520697779|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
144406507|NCT05248867|520697780|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
144406508|NCT05248867|520697781|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
144406509|NCT05248867|520697782|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
144406510|NCT05248867|520697777|FG000|Double-blind Period|Other, not specified|3|||
144525629|NCT03379675|521125628|FG002|Overall Study|Withdrawal by Subject|2|||
144525630|NCT04332926|521125647|FG000|Overall Study|Withdrawal by Subject|6|||
144599743|NCT00221195|521397496|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
144599744|NCT00221195|521397497|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
144599745|NCT00216203|521397499|FG000|Overall Study|Withdrawal by Subject|2|||
144599746|NCT02596620|521397500|FG000|Overall Study|Lost to Follow-up|1|||
144599747|NCT02596620|521397501|FG001|Overall Study|Lost to Follow-up|1|||
144525631|NCT04332926|521125647|FG000|Overall Study|Physician Decision|6|||
144250013|NCT03959488|520113438|FG004|Season 1|Other|0|||
144406511|NCT05248867|520697778|FG001|Double-blind Period|Other, not specified|8|||
144406512|NCT05248867|520697779|FG002|Double-blind Period|Other, not specified|0|||
144406513|NCT05248867|520697780|FG003|Double-blind Period|Other, not specified|0|||
144406514|NCT05248867|520697781|FG004|Double-blind Period|Other, not specified|0|||
144406515|NCT05248867|520697782|FG005|Double-blind Period|Other, not specified|0|||
144406516|NCT05248867|520697777|FG000|Open-label Period|Withdrawal by Subject|0|||
144406517|NCT05248867|520697778|FG001|Open-label Period|Withdrawal by Subject|0|||
144406518|NCT05248867|520697779|FG002|Open-label Period|Withdrawal by Subject|3|||
144406519|NCT05248867|520697780|FG003|Open-label Period|Withdrawal by Subject|1|||
144406520|NCT05248867|520697781|FG004|Open-label Period|Withdrawal by Subject|7|||
144406521|NCT05248867|520697782|FG005|Open-label Period|Withdrawal by Subject|9|||
144406522|NCT05248867|520697777|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
144406523|NCT05248867|520697778|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
144406524|NCT05248867|520697779|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
144406525|NCT05248867|520697780|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
144406526|NCT05248867|520697781|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
144406527|NCT05248867|520697782|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
144406528|NCT05248867|520697777|FG000|Open-label Period|Lost to Follow-up|0|||
144406529|NCT05248867|520697778|FG001|Open-label Period|Lost to Follow-up|0|||
144406530|NCT05248867|520697779|FG002|Open-label Period|Lost to Follow-up|0|||
144406531|NCT05248867|520697780|FG003|Open-label Period|Lost to Follow-up|0|||
144406532|NCT05248867|520697781|FG004|Open-label Period|Lost to Follow-up|5|||
144406533|NCT05248867|520697782|FG005|Open-label Period|Lost to Follow-up|2|||
144406534|NCT05248867|520697777|FG000|Open-label Period|COVID-19 Infection|0|||
144406535|NCT05248867|520697778|FG001|Open-label Period|COVID-19 Infection|0|||
144406536|NCT05248867|520697779|FG002|Open-label Period|COVID-19 Infection|0|||
144406537|NCT05248867|520697780|FG003|Open-label Period|COVID-19 Infection|0|||
144406538|NCT05248867|520697781|FG004|Open-label Period|COVID-19 Infection|1|||
144406539|NCT05248867|520697782|FG005|Open-label Period|COVID-19 Infection|0|||
144406540|NCT05248867|520697777|FG000|Open-label Period|Other, not specified|0|||
144406541|NCT05248867|520697778|FG001|Open-label Period|Other, not specified|0|||
144406542|NCT05248867|520697779|FG002|Open-label Period|Other, not specified|0|||
144406543|NCT05248867|520697780|FG003|Open-label Period|Other, not specified|0|||
144406544|NCT05248867|520697781|FG004|Open-label Period|Other, not specified|4|||
144406545|NCT05248867|520697782|FG005|Open-label Period|Other, not specified|0|||
144406546|NCT01064310|520697783|FG000|Period 1|Adverse Event|7|||
144406547|NCT01064310|520697784|FG001|Period 1|Adverse Event|10|||
144406548|NCT01064310|520697785|FG002|Period 1|Adverse Event|0|||
144406549|NCT01064310|520697783|FG000|Period 1|Physician Decision|1|||
144406550|NCT01064310|520697784|FG001|Period 1|Physician Decision|0|||
144406551|NCT01064310|520697785|FG002|Period 1|Physician Decision|0|||
144406552|NCT01064310|520697783|FG000|Period 1|Withdrawal by Subject|2|||
144406553|NCT01064310|520697784|FG001|Period 1|Withdrawal by Subject|2|||
144406554|NCT01064310|520697785|FG002|Period 1|Withdrawal by Subject|0|||
144406555|NCT01064310|520697783|FG000|Period 1|Lack of Efficacy|3|||
144406556|NCT01064310|520697784|FG001|Period 1|Lack of Efficacy|5|||
144406557|NCT01064310|520697785|FG002|Period 1|Lack of Efficacy|0|||
144406558|NCT01064310|520697783|FG000|Period 1|Entered Open-label Period|1|||
144406559|NCT01064310|520697784|FG001|Period 1|Entered Open-label Period|1|||
144406560|NCT01064310|520697785|FG002|Period 1|Entered Open-label Period|0|||
144406561|NCT01064310|520697783|FG000|Period 2|Adverse Event|2|||
144406562|NCT01064310|520697784|FG001|Period 2|Adverse Event|1|||
144406563|NCT01064310|520697785|FG002|Period 2|Adverse Event|0|||
144406564|NCT01064310|520697783|FG000|Period 2|Physician Decision|0|||
144406565|NCT01064310|520697784|FG001|Period 2|Physician Decision|1|||
144406566|NCT01064310|520697785|FG002|Period 2|Physician Decision|0|||
144406567|NCT01064310|520697783|FG000|Period 2|Entered Open-label Period|1|||
144406568|NCT01064310|520697784|FG001|Period 2|Entered Open-label Period|0|||
144406569|NCT01064310|520697785|FG002|Period 2|Entered Open-label Period|0|||
144406570|NCT01064310|520697783|FG000|Period 2|Lack of Efficacy|1|||
144599748|NCT04658186|521397502|FG000|Overall Study|Adverse Event|4|||
144599749|NCT04658186|521397503|FG001|Overall Study|Adverse Event|18|||
144599750|NCT04658186|521397504|FG002|Overall Study|Adverse Event|15|||
144599751|NCT04658186|521397502|FG000|Overall Study|Lack of Efficacy|1|||
144599752|NCT04658186|521397503|FG001|Overall Study|Lack of Efficacy|1|||
144599753|NCT04658186|521397504|FG002|Overall Study|Lack of Efficacy|0|||
144599754|NCT04658186|521397502|FG000|Overall Study|Protocol Violation|0|||
144599755|NCT04658186|521397503|FG001|Overall Study|Protocol Violation|0|||
144599756|NCT04658186|521397504|FG002|Overall Study|Protocol Violation|1|||
144599757|NCT04658186|521397502|FG000|Overall Study|Lost to Follow-up|0|||
144406571|NCT01064310|520697784|FG001|Period 2|Lack of Efficacy|4|||
144599758|NCT04658186|521397503|FG001|Overall Study|Lost to Follow-up|0|||
144406572|NCT01064310|520697785|FG002|Period 2|Lack of Efficacy|0|||
144406573|NCT01064310|520697783|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
144406574|NCT01064310|520697784|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
144599759|NCT04658186|521397504|FG002|Overall Study|Lost to Follow-up|2|||
144599760|NCT04658186|521397502|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
144406575|NCT01064310|520697785|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
144406576|NCT01064310|520697783|FG000|Open Label Pazopinib|Adverse Event|0|||
144406577|NCT01064310|520697784|FG001|Open Label Pazopinib|Adverse Event|0|||
144406578|NCT01064310|520697785|FG002|Open Label Pazopinib|Adverse Event|12|||
144406579|NCT01064310|520697783|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
144406580|NCT01064310|520697784|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
144406581|NCT01064310|520697785|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
144406582|NCT01064310|520697783|FG000|Open Label Pazopinib|Physician Decision|0|||
144406583|NCT01064310|520697784|FG001|Open Label Pazopinib|Physician Decision|0|||
144406584|NCT01064310|520697785|FG002|Open Label Pazopinib|Physician Decision|20|||
144406585|NCT03128411|520697789|FG000|Treatment Phase|Adverse Event|21|||
144406586|NCT03128411|520697789|FG000|Treatment Phase|Physician Decision|1|||
144406587|NCT03128411|520697789|FG000|Treatment Phase|Other|2|||
144406588|NCT03128411|520697789|FG000|Long Term Follow-up Phase|Death|2|||
144406589|NCT00873015|520697790|FG000|Overall Study|Withdrawal by Subject|0|||
144406590|NCT00873015|520697791|FG001|Overall Study|Withdrawal by Subject|1|||
144406591|NCT00873015|520697792|FG002|Overall Study|Withdrawal by Subject|0|||
144406592|NCT00873015|520697793|FG003|Overall Study|Withdrawal by Subject|0|||
144406593|NCT00345839|520697794|FG000|Overall Study|Withdrawal by Subject|91|||
144406594|NCT00345839|520697795|FG001|Overall Study|Withdrawal by Subject|98|||
144406595|NCT00345839|520697794|FG000|Overall Study|Lost to Follow-up|58|||
144406596|NCT00345839|520697795|FG001|Overall Study|Lost to Follow-up|61|||
144406597|NCT01218113|520699281|FG000|Overall Study|Withdrawal by Subject|1|||
144406598|NCT01218113|520699282|FG001|Overall Study|Withdrawal by Subject|0|||
144406599|NCT01218113|520699283|FG002|Overall Study|Withdrawal by Subject|1|||
144406600|NCT01218113|520699281|FG000|Overall Study|Lost to Follow-up|4|||
144406601|NCT01218113|520699282|FG001|Overall Study|Lost to Follow-up|1|||
144406602|NCT01218113|520699283|FG002|Overall Study|Lost to Follow-up|4|||
144406603|NCT01218113|520699281|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
144406604|NCT01218113|520699282|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
144406605|NCT01218113|520699283|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
144406606|NCT01433991|520699288|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
144406607|NCT01433991|520699289|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
144406608|NCT01433991|520699290|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
144406609|NCT01433991|520699291|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
144406610|NCT01433991|520699288|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
144406611|NCT01433991|520699289|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
144406612|NCT01433991|520699290|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
144406613|NCT01433991|520699291|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
144406614|NCT01433991|520699288|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
144406615|NCT01433991|520699289|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
144406616|NCT01433991|520699290|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
144406617|NCT01433991|520699291|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
144406618|NCT01433991|520699288|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
144406619|NCT01433991|520699289|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
144406620|NCT01433991|520699290|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
144406621|NCT01433991|520699291|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
144406622|NCT01433991|520699288|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
144406623|NCT01433991|520699289|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
144406624|NCT01433991|520699290|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
144406625|NCT01433991|520699291|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
144406626|NCT01433991|520699288|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
144406627|NCT01433991|520699289|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
144406628|NCT01433991|520699290|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
144406629|NCT01433991|520699291|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
144406630|NCT01433991|520699288|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
144406631|NCT01433991|520699289|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
144406632|NCT01433991|520699290|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
144406633|NCT01433991|520699291|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
144406634|NCT00787891|520699294|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
144525632|NCT06019559|521125652|FG000|Overall Study|Withdrawal by Subject|7|||
144525633|NCT06019559|521125653|FG001|Overall Study|Withdrawal by Subject|6|||
144406635|NCT00787891|520699295|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
144406636|NCT00787891|520699294|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
144525634|NCT06019559|521125654|FG002|Overall Study|Withdrawal by Subject|5|||
144406637|NCT00787891|520699295|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
144406638|NCT00787891|520699294|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
144406639|NCT00787891|520699295|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
144525635|NCT06019559|521125652|FG000|Overall Study|Lost to Follow-up|2|||
144406640|NCT00787891|520699294|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
144406641|NCT00787891|520699295|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
144406642|NCT00787891|520699294|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
144406643|NCT00787891|520699295|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
144406644|NCT00787891|520699294|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
144406645|NCT00787891|520699295|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
144406646|NCT00787891|520699294|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
144406647|NCT00787891|520699295|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
144406648|NCT00787891|520699294|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
144406649|NCT00787891|520699295|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
144406650|NCT00787891|520699294|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
144406651|NCT00787891|520699295|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
144406652|NCT00787891|520699294|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
144406653|NCT00787891|520699295|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
144406654|NCT03486223|520699303|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
144406655|NCT03486223|520699304|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
144406656|NCT01513343|520699307|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
144406657|NCT01513343|520699308|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
144406658|NCT01513343|520699307|FG000|Post Data Collection|Dropped/withdrew from study|7|||
144406659|NCT01513343|520699308|FG001|Post Data Collection|Dropped/withdrew from study|1|||
144406660|NCT01513343|520699307|FG000|Post Data Collection|Lost to Follow-up|10|||
144406661|NCT01513343|520699308|FG001|Post Data Collection|Lost to Follow-up|23|||
144406662|NCT01513343|520699307|FG000|6-month Follow-up|Lost to Follow-up|28|||
144406663|NCT01513343|520699308|FG001|6-month Follow-up|Lost to Follow-up|17|||
144406664|NCT01513343|520699307|FG000|12-month Follow-up|Lost to Follow-up|10|||
144406665|NCT01513343|520699308|FG001|12-month Follow-up|Lost to Follow-up|3|||
144406666|NCT02034110|520699321|FG000|Overall Study|Physician Decision|0|||
144406667|NCT02034110|520699322|FG001|Overall Study|Physician Decision|0|||
144406668|NCT02034110|520699323|FG002|Overall Study|Physician Decision|0|||
144406669|NCT02034110|520699324|FG003|Overall Study|Physician Decision|0|||
144406670|NCT02034110|520699325|FG004|Overall Study|Physician Decision|2|||
144406671|NCT02034110|520699326|FG005|Overall Study|Physician Decision|0|||
144406672|NCT02034110|520699327|FG006|Overall Study|Physician Decision|1|||
144406673|NCT02034110|520699328|FG007|Overall Study|Physician Decision|0|||
144406674|NCT02034110|520699321|FG000|Overall Study|Lost to Follow-up|1|||
144406675|NCT02034110|520699322|FG001|Overall Study|Lost to Follow-up|0|||
144406676|NCT02034110|520699323|FG002|Overall Study|Lost to Follow-up|0|||
144406677|NCT02034110|520699324|FG003|Overall Study|Lost to Follow-up|0|||
144406678|NCT02034110|520699325|FG004|Overall Study|Lost to Follow-up|1|||
144406679|NCT02034110|520699326|FG005|Overall Study|Lost to Follow-up|0|||
144406680|NCT02034110|520699327|FG006|Overall Study|Lost to Follow-up|1|||
144406681|NCT02034110|520699328|FG007|Overall Study|Lost to Follow-up|0|||
144406682|NCT02034110|520699321|FG000|Overall Study|Withdrawal by Subject|5|||
144406683|NCT02034110|520699322|FG001|Overall Study|Withdrawal by Subject|7|||
144406684|NCT02034110|520699323|FG002|Overall Study|Withdrawal by Subject|0|||
144406685|NCT02034110|520699324|FG003|Overall Study|Withdrawal by Subject|3|||
144406686|NCT02034110|520699325|FG004|Overall Study|Withdrawal by Subject|7|||
144406687|NCT02034110|520699326|FG005|Overall Study|Withdrawal by Subject|0|||
144406688|NCT02034110|520699327|FG006|Overall Study|Withdrawal by Subject|3|||
144406689|NCT02034110|520699328|FG007|Overall Study|Withdrawal by Subject|1|||
144406690|NCT02034110|520699321|FG000|Overall Study|Study closed by sponsor|6|||
144406691|NCT02034110|520699322|FG001|Overall Study|Study closed by sponsor|2|||
144406692|NCT02034110|520699323|FG002|Overall Study|Study closed by sponsor|0|||
144406693|NCT02034110|520699324|FG003|Overall Study|Study closed by sponsor|6|||
144406694|NCT02034110|520699325|FG004|Overall Study|Study closed by sponsor|7|||
144406695|NCT02034110|520699326|FG005|Overall Study|Study closed by sponsor|0|||
144406696|NCT02034110|520699327|FG006|Overall Study|Study closed by sponsor|42|||
144406697|NCT02034110|520699328|FG007|Overall Study|Study closed by sponsor|0|||
144406698|NCT02587234|520699329|FG000|Overall Study|Withdrawal by Subject|1|||
144406699|NCT02587234|520699330|FG001|Overall Study|Withdrawal by Subject|1|||
144525636|NCT06019559|521125653|FG001|Overall Study|Lost to Follow-up|0|||
144525637|NCT06019559|521125654|FG002|Overall Study|Lost to Follow-up|3|||
144525638|NCT05949788|521125655|FG000|Overall Study|severe birth deformity|2|||
144406700|NCT02587234|520699329|FG000|Overall Study|Lost to Follow-up|0|||
144406701|NCT02587234|520699330|FG001|Overall Study|Lost to Follow-up|2|||
144406702|NCT01877265|520699331|FG000|Treatment Period 1|Sponsor Decision|0|||
144406703|NCT01877265|520699332|FG001|Treatment Period 1|Sponsor Decision|0|||
144406704|NCT01877265|520699333|FG002|Treatment Period 1|Sponsor Decision|1|||
144406705|NCT01877265|520699334|FG003|Treatment Period 1|Sponsor Decision|0|||
144406706|NCT01877265|520699335|FG004|Treatment Period 1|Sponsor Decision|0|||
144406707|NCT01877265|520699336|FG005|Treatment Period 1|Sponsor Decision|0|||
144525639|NCT05949788|521125656|FG001|Overall Study|severe birth deformity|7|||
144250014|NCT03959488|520113434|FG000|Season 1|Withdrawal by parent/guardian|43|||
144250015|NCT03959488|520113435|FG001|Season 1|Withdrawal by parent/guardian|28|||
144250016|NCT03959488|520113436|FG002|Season 1|Withdrawal by parent/guardian|0|||
144250017|NCT03959488|520113437|FG003|Season 1|Withdrawal by parent/guardian|0|||
144250018|NCT03959488|520113438|FG004|Season 1|Withdrawal by parent/guardian|0|||
144250019|NCT03959488|520113434|FG000|Season 1|Due to COVID-19 pandemic|2|||
144250020|NCT03959488|520113435|FG001|Season 1|Due to COVID-19 pandemic|3|||
144250021|NCT03959488|520113436|FG002|Season 1|Due to COVID-19 pandemic|0|||
144406708|NCT01877265|520699331|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
144406709|NCT01877265|520699332|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
144406710|NCT01877265|520699333|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
144406711|NCT01877265|520699334|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
144406712|NCT01877265|520699335|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
144406713|NCT01877265|520699336|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
144406714|NCT01877265|520699331|FG000|Treatment Period 3|Lost to Follow-up|1|||
144406715|NCT01877265|520699332|FG001|Treatment Period 3|Lost to Follow-up|0|||
144406716|NCT01877265|520699333|FG002|Treatment Period 3|Lost to Follow-up|0|||
144406717|NCT01877265|520699334|FG003|Treatment Period 3|Lost to Follow-up|0|||
144406718|NCT01877265|520699335|FG004|Treatment Period 3|Lost to Follow-up|0|||
144406719|NCT01877265|520699336|FG005|Treatment Period 3|Lost to Follow-up|0|||
144406720|NCT02732119|520699342|FG000|Phase I|Adverse Event|1|||
144250022|NCT03959488|520113437|FG003|Season 1|Due to COVID-19 pandemic|0|||
144250023|NCT03959488|520113438|FG004|Season 1|Due to COVID-19 pandemic|0|||
144406721|NCT02732119|520699343|FG001|Phase I|Adverse Event|3|||
144406722|NCT02732119|520699344|FG002|Phase I|Adverse Event|1|||
144406723|NCT02732119|520699345|FG003|Phase I|Adverse Event|0|||
144406724|NCT02732119|520699346|FG004|Phase I|Adverse Event|0|||
144406725|NCT02732119|520699342|FG000|Phase I|Progressive disease|7|||
144406726|NCT02732119|520699343|FG001|Phase I|Progressive disease|3|||
144250024|NCT03959488|520113434|FG000|Season 1|Lost to Follow-up|17|||
144250025|NCT03959488|520113435|FG001|Season 1|Lost to Follow-up|7|||
144250026|NCT03959488|520113436|FG002|Season 1|Lost to Follow-up|0|||
144406727|NCT02732119|520699344|FG002|Phase I|Progressive disease|2|||
144250027|NCT03959488|520113437|FG003|Season 1|Lost to Follow-up|0|||
144250028|NCT03959488|520113438|FG004|Season 1|Lost to Follow-up|0|||
144250029|NCT03959488|520113434|FG000|Season 1|Death|5|||
144250030|NCT03959488|520113435|FG001|Season 1|Death|1|||
144406728|NCT02732119|520699345|FG003|Phase I|Progressive disease|0|||
144406729|NCT02732119|520699346|FG004|Phase I|Progressive disease|0|||
144406730|NCT02732119|520699342|FG000|Phase I|Protocol deviation|0|||
144406731|NCT02732119|520699343|FG001|Phase I|Protocol deviation|1|||
144406732|NCT02732119|520699344|FG002|Phase I|Protocol deviation|0|||
144406733|NCT02732119|520699345|FG003|Phase I|Protocol deviation|0|||
144525640|NCT05949788|521125655|FG000|Overall Study|twin-twin transfusion syndrome|2|||
144525641|NCT05949788|521125656|FG001|Overall Study|twin-twin transfusion syndrome|7|||
144525642|NCT05949788|521125655|FG000|Overall Study|neonatal hemolytic disease|3|||
144250031|NCT03959488|520113436|FG002|Season 1|Death|0|||
144250032|NCT03959488|520113437|FG003|Season 1|Death|0|||
144250033|NCT03959488|520113438|FG004|Season 1|Death|0|||
144250034|NCT03959488|520113434|FG000|Season 2|Other|0|||
144250035|NCT03959488|520113435|FG001|Season 2|Other|0|||
144250036|NCT03959488|520113436|FG002|Season 2|Other|2|||
144250037|NCT03959488|520113437|FG003|Season 2|Other|0|||
144250038|NCT03959488|520113438|FG004|Season 2|Other|0|||
144250039|NCT03959488|520113434|FG000|Season 2|Withdrawal by parent/guardian|0|||
144250040|NCT03959488|520113435|FG001|Season 2|Withdrawal by parent/guardian|0|||
144250041|NCT03959488|520113436|FG002|Season 2|Withdrawal by parent/guardian|3|||
144250042|NCT03959488|520113437|FG003|Season 2|Withdrawal by parent/guardian|1|||
144250043|NCT03959488|520113438|FG004|Season 2|Withdrawal by parent/guardian|1|||
144250044|NCT03959488|520113434|FG000|Season 2|Lost to Follow-up|0|||
144250045|NCT03959488|520113435|FG001|Season 2|Lost to Follow-up|0|||
144250046|NCT03959488|520113436|FG002|Season 2|Lost to Follow-up|1|||
144250047|NCT03959488|520113437|FG003|Season 2|Lost to Follow-up|0|||
144250048|NCT03959488|520113438|FG004|Season 2|Lost to Follow-up|1|||
144250049|NCT01760447|520113439|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
144250050|NCT01760447|520113440|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
144250051|NCT01760447|520113441|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
144406734|NCT02732119|520699346|FG004|Phase I|Protocol deviation|0|||
144406735|NCT02732119|520699342|FG000|Phase I|Physician Decision|0|||
144525643|NCT05949788|521125656|FG001|Overall Study|neonatal hemolytic disease|8|||
144250052|NCT01760447|520113442|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
144250053|NCT01760447|520113439|FG000|Weeks 0-20|Withdrawal by Subject|2|||
144250054|NCT01760447|520113440|FG001|Weeks 0-20|Withdrawal by Subject|0|||
144250055|NCT01760447|520113441|FG002|Weeks 0-20|Withdrawal by Subject|1|||
144406736|NCT02732119|520699343|FG001|Phase I|Physician Decision|3|||
144406737|NCT02732119|520699344|FG002|Phase I|Physician Decision|4|||
144406738|NCT02732119|520699345|FG003|Phase I|Physician Decision|0|||
144406739|NCT02732119|520699346|FG004|Phase I|Physician Decision|0|||
144406740|NCT02732119|520699342|FG000|Phase II|Adverse Event|0|||
144406741|NCT02732119|520699343|FG001|Phase II|Adverse Event|0|||
144406742|NCT02732119|520699344|FG002|Phase II|Adverse Event|0|||
144406743|NCT02732119|520699345|FG003|Phase II|Adverse Event|3|||
144406744|NCT02732119|520699346|FG004|Phase II|Adverse Event|3|||
144406745|NCT02732119|520699342|FG000|Phase II|Death|0|||
144406746|NCT02732119|520699343|FG001|Phase II|Death|0|||
144406747|NCT02732119|520699344|FG002|Phase II|Death|0|||
144406748|NCT02732119|520699345|FG003|Phase II|Death|1|||
144406749|NCT02732119|520699346|FG004|Phase II|Death|0|||
144406750|NCT02732119|520699342|FG000|Phase II|Progressive dissease|0|||
144406751|NCT02732119|520699343|FG001|Phase II|Progressive dissease|0|||
144406752|NCT02732119|520699344|FG002|Phase II|Progressive dissease|0|||
144406753|NCT02732119|520699345|FG003|Phase II|Progressive dissease|30|||
144406754|NCT02732119|520699346|FG004|Phase II|Progressive dissease|23|||
144406755|NCT02732119|520699342|FG000|Phase II|Study terminated by sponsor|0|||
144406756|NCT02732119|520699343|FG001|Phase II|Study terminated by sponsor|0|||
144406757|NCT02732119|520699344|FG002|Phase II|Study terminated by sponsor|0|||
144406758|NCT02732119|520699345|FG003|Phase II|Study terminated by sponsor|2|||
144406759|NCT02732119|520699346|FG004|Phase II|Study terminated by sponsor|2|||
144406760|NCT02732119|520699342|FG000|Phase II|Other|0|||
144406761|NCT02732119|520699343|FG001|Phase II|Other|0|||
144406762|NCT02732119|520699344|FG002|Phase II|Other|0|||
144406763|NCT02732119|520699345|FG003|Phase II|Other|2|||
144406764|NCT02732119|520699346|FG004|Phase II|Other|0|||
144406765|NCT02732119|520699342|FG000|Phase II|Physician Decision|0|||
144406766|NCT02732119|520699343|FG001|Phase II|Physician Decision|0|||
144406767|NCT02732119|520699344|FG002|Phase II|Physician Decision|0|||
144525644|NCT05949788|521125655|FG000|Overall Study|death within 14 days after birth|2|||
144525645|NCT05949788|521125656|FG001|Overall Study|death within 14 days after birth|6|||
144525646|NCT05949788|521125655|FG000|Overall Study|transfer to another hospital|2|||
144525647|NCT05949788|521125656|FG001|Overall Study|transfer to another hospital|6|||
144525648|NCT05213390|521125657|FG000|Overall Study|Withdrawal by Subject|2|||
144525649|NCT05213390|521125657|FG000|Overall Study|Lost to Follow-up|12|||
144525650|NCT05213390|521125657|FG000|Overall Study|Protocol Violation|9|||
144525651|NCT01824537|521125658|FG000|Overall Study|Lost to Follow-up|78|||
144525652|NCT01824537|521125659|FG001|Overall Study|Lost to Follow-up|87|||
144525653|NCT03808818|521125664|FG000|Overall Study|Death|6|||
144525654|NCT03808818|521125665|FG001|Overall Study|Death|6|||
144525655|NCT03808818|521125664|FG000|Overall Study|Withdrawal by Subject|7|||
144525656|NCT03808818|521125665|FG001|Overall Study|Withdrawal by Subject|18|||
144525657|NCT03808818|521125664|FG000|Overall Study|Lost to Follow-up|31|||
144525658|NCT03808818|521125665|FG001|Overall Study|Lost to Follow-up|33|||
144525659|NCT05415722|521125666|FG000|Overall Study|Lost to Follow-up|0|||
144525660|NCT05415722|521125667|FG001|Overall Study|Lost to Follow-up|2|||
144525661|NCT05415722|521125668|FG002|Overall Study|Lost to Follow-up|0|||
144525662|NCT05415722|521125669|FG003|Overall Study|Lost to Follow-up|1|||
144525663|NCT05415722|521125670|FG004|Overall Study|Lost to Follow-up|0|||
144525664|NCT05415722|521125671|FG005|Overall Study|Lost to Follow-up|0|||
144525665|NCT05415722|521125672|FG006|Overall Study|Lost to Follow-up|1|||
144525666|NCT05415722|521125666|FG000|Overall Study|Physician Decision|0|||
144525667|NCT05415722|521125667|FG001|Overall Study|Physician Decision|0|||
144525668|NCT05415722|521125668|FG002|Overall Study|Physician Decision|0|||
144525669|NCT05415722|521125669|FG003|Overall Study|Physician Decision|1|||
144525670|NCT05415722|521125670|FG004|Overall Study|Physician Decision|0|||
144525671|NCT05415722|521125671|FG005|Overall Study|Physician Decision|0|||
144406768|NCT02732119|520699345|FG003|Phase II|Physician Decision|8|||
144406769|NCT02732119|520699346|FG004|Phase II|Physician Decision|5|||
144525672|NCT05415722|521125672|FG006|Overall Study|Physician Decision|1|||
144525673|NCT05415722|521125666|FG000|Overall Study|Protocol Violation|0|||
144525674|NCT05415722|521125667|FG001|Overall Study|Protocol Violation|0|||
144525675|NCT05415722|521125668|FG002|Overall Study|Protocol Violation|0|||
144525676|NCT05415722|521125669|FG003|Overall Study|Protocol Violation|1|||
144406770|NCT02193867|520699347|FG000|Overall Study|Death|2|||
144406771|NCT02193867|520699347|FG000|Overall Study|Sponsor Study Termination|2|||
144406772|NCT01056653|520699348|FG000|Overall Study|Lost to Follow-up|0|||
144406773|NCT01056653|520699349|FG001|Overall Study|Lost to Follow-up|0|||
144406774|NCT01056653|520699350|FG002|Overall Study|Lost to Follow-up|2|||
144406775|NCT01619423|520699351|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
144525677|NCT05415722|521125670|FG004|Overall Study|Protocol Violation|0|||
144406776|NCT01619423|520699352|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
144406777|NCT01619423|520699353|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
144406778|NCT01619423|520699354|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
144406779|NCT03733470|520699355|FG000|Overall Study|PI Decision|1|||
144406780|NCT03733470|520699356|FG001|Overall Study|PI Decision|1|||
144525678|NCT05415722|521125671|FG005|Overall Study|Protocol Violation|0|||
144525679|NCT05415722|521125672|FG006|Overall Study|Protocol Violation|0|||
144250056|NCT01760447|520113442|FG003|Weeks 0-20|Withdrawal by Subject|0|||
144406781|NCT04203498|520699366|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
144406782|NCT04203498|520699367|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
144406783|NCT04203498|520699366|FG000|Overall Study|Withdrawal of patient consent|7|||
144406784|NCT04203498|520699367|FG001|Overall Study|Withdrawal of patient consent|2|||
144406785|NCT04203498|520699366|FG000|Overall Study|Adverse Event|4|||
144406786|NCT04203498|520699367|FG001|Overall Study|Adverse Event|1|||
144406787|NCT04203498|520699366|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
144406788|NCT04203498|520699367|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
144406789|NCT04203498|520699366|FG000|Overall Study|Did not receive IMP|2|||
144406790|NCT04203498|520699367|FG001|Overall Study|Did not receive IMP|0|||
144406791|NCT02217878|520699368|FG000|Overall Study|required morphine due to chest pain|1|||
144406792|NCT02217878|520699369|FG001|Overall Study|required morphine due to chest pain|2|||
144406793|NCT02217878|520699368|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
144406794|NCT02217878|520699369|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
144406795|NCT02106975|520699370|FG000|Overall Study|Death|25|||
144406796|NCT02106975|520699371|FG001|Overall Study|Death|39|||
144406797|NCT00005044|520699372|FG000|Overall Study|Protocol Violation|37|||
144406798|NCT00005044|520699373|FG001|Overall Study|Protocol Violation|46|||
144406799|NCT00005044|520699372|FG000|Overall Study|Withdrawal by Subject|1|||
144406800|NCT00005044|520699373|FG001|Overall Study|Withdrawal by Subject|5|||
144406801|NCT00005044|520699372|FG000|Overall Study|No protocol treatment|0|||
144406802|NCT00005044|520699373|FG001|Overall Study|No protocol treatment|1|||
144406803|NCT03546062|520699374|FG000|Overall Study|Adverse Event|6|||
144406804|NCT03546062|520699375|FG001|Overall Study|Adverse Event|5|||
144406805|NCT03546062|520699376|FG002|Overall Study|Adverse Event|8|||
144406806|NCT00781274|520699377|FG000|Overall Study|Withdrawal by Subject|2|||
144406807|NCT00181155|520699378|FG000|Overall Study|Physician Decision|1|||
144406808|NCT00181155|520699379|FG001|Overall Study|Physician Decision|0|||
144406809|NCT00181155|520699378|FG000|Overall Study|Withdrawal by Subject|1|||
144406810|NCT00181155|520699379|FG001|Overall Study|Withdrawal by Subject|0|||
144406811|NCT00868608|520699383|FG000|Overall Study|Withdrawal by Subject|3|||
144406812|NCT00868608|520699384|FG001|Overall Study|Withdrawal by Subject|1|||
144406813|NCT00868608|520699385|FG002|Overall Study|Withdrawal by Subject|0|||
144406814|NCT00868608|520699383|FG000|Overall Study|Lost to Follow-up|3|||
144406815|NCT00868608|520699384|FG001|Overall Study|Lost to Follow-up|0|||
144406816|NCT00868608|520699385|FG002|Overall Study|Lost to Follow-up|1|||
144406817|NCT00868608|520699383|FG000|Overall Study|Death|16|||
144406818|NCT00868608|520699384|FG001|Overall Study|Death|2|||
144406819|NCT00868608|520699385|FG002|Overall Study|Death|4|||
144406820|NCT00868608|520699383|FG000|Overall Study|Other - Unspecified|1|||
144406821|NCT00868608|520699384|FG001|Overall Study|Other - Unspecified|0|||
144406822|NCT00868608|520699385|FG002|Overall Study|Other - Unspecified|0|||
144406823|NCT02935842|520699386|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
144406824|NCT02935842|520699387|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
144406825|NCT02935842|520699388|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
144406826|NCT02935842|520699389|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
144406827|NCT02935842|520699386|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
144406828|NCT02935842|520699387|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
144406829|NCT02935842|520699388|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
144406830|NCT02935842|520699389|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
144406831|NCT02935842|520699386|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
144406832|NCT02935842|520699387|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
144406833|NCT02935842|520699388|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
144406834|NCT02935842|520699389|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
144406835|NCT02935842|520699386|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
144406836|NCT02935842|520699387|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
144406837|NCT02935842|520699388|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
144406838|NCT02935842|520699389|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
144406839|NCT02935842|520699386|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
144406840|NCT02935842|520699387|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
144406841|NCT02935842|520699388|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
144406842|NCT02935842|520699389|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
144406843|NCT00911547|520699390|FG000|Overall Study|Adverse Event|8|||
144406844|NCT00911547|520699391|FG001|Overall Study|Adverse Event|27|||
144406845|NCT00911547|520699392|FG002|Overall Study|Adverse Event|11|||
144406846|NCT00911547|520699393|FG003|Overall Study|Adverse Event|6|||
144406847|NCT00911547|520699390|FG000|Overall Study|Lost to Follow-up|0|||
144406848|NCT00911547|520699391|FG001|Overall Study|Lost to Follow-up|0|||
144406849|NCT00911547|520699392|FG002|Overall Study|Lost to Follow-up|2|||
144406850|NCT00911547|520699393|FG003|Overall Study|Lost to Follow-up|1|||
144406851|NCT00911547|520699390|FG000|Overall Study|Protocol Violation|0|||
144406852|NCT00911547|520699391|FG001|Overall Study|Protocol Violation|5|||
144406853|NCT00911547|520699392|FG002|Overall Study|Protocol Violation|5|||
144406854|NCT00911547|520699393|FG003|Overall Study|Protocol Violation|1|||
144406855|NCT00911547|520699390|FG000|Overall Study|Withdrawal by Subject|3|||
144406856|NCT00911547|520699391|FG001|Overall Study|Withdrawal by Subject|10|||
144406857|NCT00911547|520699392|FG002|Overall Study|Withdrawal by Subject|4|||
144406858|NCT00911547|520699393|FG003|Overall Study|Withdrawal by Subject|8|||
144406859|NCT01980940|520699397|FG000|Overall Study|Protocol Violation|0|||
144406860|NCT01980940|520699398|FG001|Overall Study|Protocol Violation|0|||
144406861|NCT01980940|520699399|FG002|Overall Study|Protocol Violation|0|||
144406862|NCT01980940|520699400|FG003|Overall Study|Protocol Violation|0|||
144406863|NCT01980940|520699401|FG004|Overall Study|Protocol Violation|0|||
144406864|NCT01980940|520699402|FG005|Overall Study|Protocol Violation|2|||
144406865|NCT01980940|520699403|FG006|Overall Study|Protocol Violation|0|||
144406866|NCT01980940|520699404|FG007|Overall Study|Protocol Violation|0|||
144406867|NCT05695209|520699409|FG000|3-months|Withdrawal by Subject|2|||
144406868|NCT05695209|520699410|FG001|3-months|Withdrawal by Subject|0|||
144406869|NCT05695209|520699409|FG000|3-months|Unable to contact for 3-month data collection|0|||
144406870|NCT05695209|520699410|FG001|3-months|Unable to contact for 3-month data collection|1|||
144406871|NCT05695209|520699409|FG000|6-months|Lost to Follow-up|1|||
144406872|NCT05695209|520699410|FG001|6-months|Lost to Follow-up|1|||
144406873|NCT05358444|520699411|FG000|Overall Study|Withdrawal by Subject|0|||
144406874|NCT05358444|520699412|FG001|Overall Study|Withdrawal by Subject|1|||
144406875|NCT05358444|520699411|FG000|Overall Study|Lost to Follow-up|0|||
144406876|NCT05358444|520699412|FG001|Overall Study|Lost to Follow-up|3|||
144406877|NCT05372419|520699416|FG000|Overall Study|Protocol Deviation|1|||
144406878|NCT05372419|520699416|FG000|Overall Study|Withdrawal by Subject|5|||
144406879|NCT05372419|520699416|FG000|Overall Study|Lost to Follow-up|7|||
144406880|NCT04362072|520699417|FG000|Treatment|Adverse Event|1|||
144406881|NCT04362072|520699417|FG000|Treatment|Death|9|||
144406882|NCT04362072|520699417|FG000|Treatment|Physician Decision|2|||
144406883|NCT04362072|520699417|FG000|Treatment|Progressive disease|27|||
144406884|NCT04362072|520699417|FG000|Treatment|Withdrawal by Subject|4|||
144406885|NCT04362072|520699417|FG000|Treatment|Global deterioration of health status|1|||
144406886|NCT04362072|520699417|FG000|Treatment|Switched to commercial Lorlatinib|13|||
144406887|NCT04362072|520699417|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
144406888|NCT04362072|520699417|FG000|Treatment|Other|3|||
144406889|NCT04362072|520699417|FG000|Follow up|Death|2|||
144406890|NCT04362072|520699417|FG000|Follow up|Other|2|||
144406891|NCT04731363|520699418|FG000|Overall Study|Could not obtain samples|0|||
144406892|NCT04731363|520699419|FG001|Overall Study|Could not obtain samples|1|||
144406893|NCT04731363|520699420|FG002|Overall Study|Could not obtain samples|0|||
144406894|NCT04731363|520699421|FG003|Overall Study|Could not obtain samples|0|||
144406895|NCT04731363|520699418|FG000|Overall Study|Physician Decision|0|||
144406896|NCT04731363|520699419|FG001|Overall Study|Physician Decision|1|||
144525680|NCT05415722|521125666|FG000|Overall Study|Sponsor Discretion|0|||
144525681|NCT05415722|521125667|FG001|Overall Study|Sponsor Discretion|0|||
144525682|NCT05415722|521125668|FG002|Overall Study|Sponsor Discretion|0|||
144525683|NCT05415722|521125669|FG003|Overall Study|Sponsor Discretion|0|||
144525684|NCT05415722|521125670|FG004|Overall Study|Sponsor Discretion|1|||
144525685|NCT05415722|521125671|FG005|Overall Study|Sponsor Discretion|1|||
144525686|NCT05415722|521125672|FG006|Overall Study|Sponsor Discretion|0|||
144525687|NCT05415722|521125666|FG000|Overall Study|Withdrawal by Subject|0|||
144722638|NCT03349333|521840511|FG000|Overall Study|Progression of Disease|36|||
144406897|NCT04731363|520699420|FG002|Overall Study|Physician Decision|0|||
144406898|NCT04731363|520699421|FG003|Overall Study|Physician Decision|0|||
144406899|NCT03749447|520700713|FG000|Overall Study|Adverse Event|11|||
144406900|NCT03749447|520700714|FG001|Overall Study|Adverse Event|3|||
144406901|NCT03749447|520700713|FG000|Overall Study|Death|1|||
144406902|NCT03749447|520700714|FG001|Overall Study|Death|1|||
144406903|NCT03749447|520700713|FG000|Overall Study|Lost to Follow-up|2|||
144406904|NCT03749447|520700714|FG001|Overall Study|Lost to Follow-up|2|||
144406905|NCT03749447|520700713|FG000|Overall Study|Reason Not Specified|0|||
144406906|NCT03749447|520700714|FG001|Overall Study|Reason Not Specified|3|||
144406907|NCT03749447|520700713|FG000|Overall Study|Physician Decision|4|||
144406908|NCT03749447|520700714|FG001|Overall Study|Physician Decision|3|||
144525688|NCT05415722|521125667|FG001|Overall Study|Withdrawal by Subject|1|||
144406909|NCT03749447|520700713|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
144406910|NCT03749447|520700714|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
144406911|NCT03749447|520700713|FG000|Overall Study|Study Terminated By Sponsor|112|||
144406912|NCT03749447|520700714|FG001|Overall Study|Study Terminated By Sponsor|105|||
144406913|NCT03749447|520700713|FG000|Overall Study|Withdrawal by Subject|12|||
144406914|NCT03749447|520700714|FG001|Overall Study|Withdrawal by Subject|6|||
144406915|NCT03749447|520700713|FG000|Overall Study|Non-compliance With Study Drug|0|||
144406916|NCT03749447|520700714|FG001|Overall Study|Non-compliance With Study Drug|1|||
144406917|NCT00967668|520700715|FG000|Overall Study|Withdrawal by Subject|13|||
144406918|NCT00967668|520700716|FG001|Overall Study|Withdrawal by Subject|8|||
144406919|NCT00967668|520700717|FG002|Overall Study|Withdrawal by Subject|8|||
144406920|NCT00967668|520700715|FG000|Overall Study|Death|0|||
144406921|NCT00967668|520700716|FG001|Overall Study|Death|2|||
144406922|NCT00967668|520700717|FG002|Overall Study|Death|4|||
144406923|NCT00967668|520700715|FG000|Overall Study|Removed due to behavior|1|||
144406924|NCT00967668|520700716|FG001|Overall Study|Removed due to behavior|1|||
144406925|NCT00967668|520700717|FG002|Overall Study|Removed due to behavior|2|||
144406926|NCT00967668|520700715|FG000|Overall Study|Refused Year 2|11|||
144406927|NCT00967668|520700716|FG001|Overall Study|Refused Year 2|6|||
144406928|NCT00967668|520700717|FG002|Overall Study|Refused Year 2|4|||
144406929|NCT00967668|520700715|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
144406930|NCT00967668|520700716|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
144406931|NCT00967668|520700717|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
144406932|NCT00967668|520700715|FG000|Overall Study|Lost to Follow-up|15|||
144406933|NCT00967668|520700716|FG001|Overall Study|Lost to Follow-up|9|||
144406934|NCT00967668|520700717|FG002|Overall Study|Lost to Follow-up|16|||
144406935|NCT00967668|520700715|FG000|Overall Study|Refused 12-mo assessment|3|||
144406936|NCT00967668|520700716|FG001|Overall Study|Refused 12-mo assessment|1|||
144406937|NCT00967668|520700717|FG002|Overall Study|Refused 12-mo assessment|9|||
144406938|NCT00967668|520700715|FG000|Overall Study|Pregnancy|1|||
144406939|NCT00967668|520700716|FG001|Overall Study|Pregnancy|0|||
144406940|NCT00967668|520700717|FG002|Overall Study|Pregnancy|0|||
144406941|NCT00115739|520700719|FG000|Overall Study|Lost to Follow-up|3|||
144406942|NCT00259649|520700720|FG000|Overall Study|Lost to Follow-up|7|||
144406943|NCT00259649|520700720|FG000|Overall Study|irregular menses|3|||
144406944|NCT00745823|520700723|FG000|Overall Study|Adverse Event|5|||
144406945|NCT00745823|520700724|FG001|Overall Study|Adverse Event|3|||
144406946|NCT00745823|520700723|FG000|Overall Study|Lack of Efficacy|20|||
144406947|NCT00745823|520700724|FG001|Overall Study|Lack of Efficacy|6|||
144406948|NCT00745823|520700723|FG000|Overall Study|Lost to Follow-up|10|||
144406949|NCT00745823|520700724|FG001|Overall Study|Lost to Follow-up|11|||
144406950|NCT00745823|520700723|FG000|Overall Study|Physician Decision|10|||
144406951|NCT00745823|520700724|FG001|Overall Study|Physician Decision|5|||
144406952|NCT00745823|520700723|FG000|Overall Study|Pregnancy|0|||
144406953|NCT00745823|520700724|FG001|Overall Study|Pregnancy|4|||
144406954|NCT00745823|520700723|FG000|Overall Study|Withdrawal by Subject|14|||
144406955|NCT00745823|520700724|FG001|Overall Study|Withdrawal by Subject|8|||
144406956|NCT00745823|520700723|FG000|Overall Study|Study Terminated by Sponsor|326|||
144406957|NCT00745823|520700724|FG001|Overall Study|Study Terminated by Sponsor|349|||
144406958|NCT01673867|520700730|FG000|Randomization|Adverse event unrelated to study drug|1|||
144406959|NCT01673867|520700731|FG001|Randomization|Adverse event unrelated to study drug|0|||
144406960|NCT01673867|520700730|FG000|Randomization|Participant request to discontinue study treatment|0|||
144406961|NCT01673867|520700731|FG001|Randomization|Participant request to discontinue study treatment|4|||
144406962|NCT01673867|520700730|FG000|Randomization|Withdrawal by participant|0|||
144406963|NCT01673867|520700731|FG001|Randomization|Withdrawal by participant|12|||
144406964|NCT01673867|520700730|FG000|Randomization|Lost to Follow-up|0|||
144525689|NCT05415722|521125668|FG002|Overall Study|Withdrawal by Subject|0|||
144525690|NCT05415722|521125669|FG003|Overall Study|Withdrawal by Subject|1|||
144525691|NCT05415722|521125670|FG004|Overall Study|Withdrawal by Subject|1|||
144525692|NCT05415722|521125671|FG005|Overall Study|Withdrawal by Subject|0|||
144525693|NCT05415722|521125672|FG006|Overall Study|Withdrawal by Subject|1|||
144525694|NCT04537715|521125678|FG000|Overall Study|Death|3|||
144525695|NCT04537715|521125679|FG001|Overall Study|Death|1|||
144525696|NCT04537715|521125678|FG000|Overall Study|Withdrawal by Subject|3|||
144525697|NCT04537715|521125679|FG001|Overall Study|Withdrawal by Subject|1|||
144525698|NCT04537715|521125678|FG000|Overall Study|Other|4|||
144250057|NCT01760447|520113439|FG000|Weeks 0-20|Lost to Follow-up|1|||
144250058|NCT01760447|520113440|FG001|Weeks 0-20|Lost to Follow-up|0|||
144406965|NCT01673867|520700731|FG001|Randomization|Lost to Follow-up|1|||
144406966|NCT01673867|520700730|FG000|Randomization|Participant no longer meets study criteria|4|||
144406967|NCT01673867|520700731|FG001|Randomization|Participant no longer meets study criteria|5|||
144406968|NCT01673867|520700730|FG000|Treatment|Disease Progression|208|||
144406969|NCT01673867|520700731|FG001|Treatment|Disease Progression|178|||
144406970|NCT01673867|520700730|FG000|Treatment|Study Drug Toxicity|23|||
144406971|NCT01673867|520700731|FG001|Treatment|Study Drug Toxicity|43|||
144599761|NCT04658186|521397503|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
144525699|NCT04537715|521125679|FG001|Overall Study|Other|3|||
144406972|NCT01673867|520700730|FG000|Treatment|Death|2|||
144406973|NCT01673867|520700731|FG001|Treatment|Death|3|||
144406974|NCT01673867|520700730|FG000|Treatment|Adverse event unrelated to study drug|23|||
144406975|NCT01673867|520700731|FG001|Treatment|Adverse event unrelated to study drug|10|||
144406976|NCT01673867|520700730|FG000|Treatment|Participant request to discontinue study treatment|7|||
144406977|NCT01673867|520700731|FG001|Treatment|Participant request to discontinue study treatment|17|||
144406978|NCT01673867|520700730|FG000|Treatment|Withdrawal by participant|5|||
144406979|NCT01673867|520700731|FG001|Treatment|Withdrawal by participant|5|||
144406980|NCT01673867|520700730|FG000|Treatment|Maximum clinical benefit|1|||
144525700|NCT04537715|521125678|FG000|Overall Study|Progressive disease|1|||
144599762|NCT04658186|521397504|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
144599763|NCT04658186|521397502|FG000|Overall Study|Participant is Moving in Another Province|0|||
144599764|NCT04658186|521397503|FG001|Overall Study|Participant is Moving in Another Province|1|||
144599765|NCT04658186|521397504|FG002|Overall Study|Participant is Moving in Another Province|0|||
144599766|NCT04658186|521397502|FG000|Overall Study|Non-Compliance|0|||
144406981|NCT01673867|520700731|FG001|Treatment|Maximum clinical benefit|10|||
144406982|NCT01673867|520700730|FG000|Treatment|Participant no longer meets study criteria|2|||
144406983|NCT01673867|520700731|FG001|Treatment|Participant no longer meets study criteria|0|||
144406984|NCT01673867|520700730|FG000|Treatment|Administrative reason by sponsor|3|||
144406985|NCT01673867|520700731|FG001|Treatment|Administrative reason by sponsor|0|||
144406986|NCT01673867|520700730|FG000|Treatment|Other reason|11|||
144406987|NCT01673867|520700731|FG001|Treatment|Other reason|2|||
144406988|NCT01819831|520700736|FG000|Overall Study|Withdrawal by Subject|1|||
144406989|NCT00590720|520700737|FG000|Overall Study|Lost to Follow-up|1|||
144406990|NCT00590720|520700738|FG001|Overall Study|Lost to Follow-up|0|||
144406991|NCT00590720|520700737|FG000|Overall Study|Withdrawal by Subject|0|||
144406992|NCT00590720|520700738|FG001|Overall Study|Withdrawal by Subject|1|||
144406993|NCT01001377|520700740|FG000|Overall Study|Ineligibility determined|2|||
144406994|NCT01001377|520700741|FG001|Overall Study|Ineligibility determined|0|||
144406995|NCT01001377|520700740|FG000|Overall Study|Withdrawal by Subject|19|||
144406996|NCT01001377|520700741|FG001|Overall Study|Withdrawal by Subject|20|||
144406997|NCT01001377|520700740|FG000|Overall Study|Lost to Follow-up|14|||
144406998|NCT01001377|520700741|FG001|Overall Study|Lost to Follow-up|17|||
144406999|NCT01001377|520700740|FG000|Overall Study|Death|391|||
144407000|NCT01001377|520700741|FG001|Overall Study|Death|384|||
144407001|NCT00867568|520700745|FG000|Overall Study|Lack of Efficacy|10|||
144407002|NCT00867568|520700745|FG000|Overall Study|Adverse Event|4|||
144407003|NCT00867568|520700745|FG000|Overall Study|Withdrawal by Subject|1|||
144407004|NCT03639935|520700746|FG000|Overall Study|Death|3|||
144599767|NCT04658186|521397503|FG001|Overall Study|Non-Compliance|1|||
144599768|NCT04658186|521397504|FG002|Overall Study|Non-Compliance|1|||
144599769|NCT04658186|521397502|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
144599770|NCT04658186|521397503|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
144722639|NCT03349333|521840511|FG000|Overall Study|Adverse Event|11|||
144407005|NCT03639935|520700746|FG000|Overall Study|Adverse Event|1|||
144407006|NCT03727230|520700748|FG000|Overall Study|Lost to Follow-up|12|||
144407007|NCT02059395|520700749|FG000|Overall Study|Lost to Follow-up|2|||
144525701|NCT04537715|521125679|FG001|Overall Study|Progressive disease|0|||
144525702|NCT02191618|521125680|FG000|Overall Study|Withdrawal by Subject|3|||
144525703|NCT02191618|521125680|FG000|Overall Study|Missed Visit|4|||
144525704|NCT03031470|521125682|FG000|Overall Study|Adverse Event|3|||
144525705|NCT03031470|521125683|FG001|Overall Study|Adverse Event|0|||
144525706|NCT03031470|521125682|FG000|Overall Study|Death|3|||
144525707|NCT03031470|521125683|FG001|Overall Study|Death|1|||
144525708|NCT03031470|521125682|FG000|Overall Study|Lost to Follow-up|1|||
144525709|NCT03031470|521125683|FG001|Overall Study|Lost to Follow-up|1|||
144525710|NCT03031470|521125682|FG000|Overall Study|Withdrawal by Subject|1|||
144525711|NCT03031470|521125683|FG001|Overall Study|Withdrawal by Subject|0|||
144525712|NCT03031470|521125682|FG000|Overall Study|Protocol entry criteria not met|0|||
144525713|NCT03031470|521125683|FG001|Overall Study|Protocol entry criteria not met|1|||
144525714|NCT03031470|521125682|FG000|Overall Study|Cancel the operation|0|||
144525715|NCT03031470|521125683|FG001|Overall Study|Cancel the operation|1|||
144525716|NCT03848065|521125684|FG000|Overall Study|Death|0|||
144525717|NCT03848065|521125685|FG001|Overall Study|Death|1|||
144525718|NCT03848065|521125686|FG002|Overall Study|Death|0|||
144525719|NCT03848065|521125684|FG000|Overall Study|Lost to Follow-up|0|||
144525720|NCT03848065|521125685|FG001|Overall Study|Lost to Follow-up|0|||
144525721|NCT03848065|521125686|FG002|Overall Study|Lost to Follow-up|1|||
144525722|NCT03848065|521125684|FG000|Overall Study|Physician Decision|0|||
144525723|NCT03848065|521125685|FG001|Overall Study|Physician Decision|0|||
144525724|NCT03848065|521125686|FG002|Overall Study|Physician Decision|1|||
144525725|NCT03496168|521125687|FG000|Overall Study|Other Reasons|1|||
144525726|NCT03496168|521125687|FG000|Overall Study|Adverse Event|1|||
144525727|NCT05543629|521125692|FG000|Overall Study|Death|1|||
144525728|NCT05543629|521125693|FG001|Overall Study|Death|0|||
144525729|NCT05543629|521125694|FG002|Overall Study|Death|1|||
144407008|NCT02059395|520700750|FG001|Overall Study|Lost to Follow-up|4|||
144407009|NCT01606007|520700752|FG000|Overall Study|Reason 'Other' in the protocol|0|||
144407010|NCT01606007|520700753|FG001|Overall Study|Reason 'Other' in the protocol|1|||
144407011|NCT01606007|520700754|FG002|Overall Study|Reason 'Other' in the protocol|1|||
144407012|NCT01606007|520700752|FG000|Overall Study|Pregnancy|0|||
144407013|NCT01606007|520700753|FG001|Overall Study|Pregnancy|1|||
144407014|NCT01606007|520700754|FG002|Overall Study|Pregnancy|1|||
144525730|NCT05543629|521125695|FG003|Overall Study|Death|0|||
144525731|NCT05543629|521125696|FG004|Overall Study|Death|0|||
144525732|NCT05543629|521125697|FG005|Overall Study|Death|1|||
144525733|NCT05543629|521125698|FG006|Overall Study|Death|2|||
144525734|NCT05543629|521125699|FG007|Overall Study|Death|2|||
144525735|NCT05543629|521125692|FG000|Overall Study|Other Reasons|0|||
144407015|NCT01606007|520700752|FG000|Overall Study|Withdrawal by Subject|8|||
144407016|NCT01606007|520700753|FG001|Overall Study|Withdrawal by Subject|6|||
144407017|NCT01606007|520700754|FG002|Overall Study|Withdrawal by Subject|1|||
144407018|NCT01606007|520700752|FG000|Overall Study|Adverse Event|0|||
144407019|NCT01606007|520700753|FG001|Overall Study|Adverse Event|1|||
144407020|NCT01606007|520700754|FG002|Overall Study|Adverse Event|1|||
144407021|NCT01606007|520700752|FG000|Overall Study|discontinue study treatment|0|||
144407022|NCT01606007|520700753|FG001|Overall Study|discontinue study treatment|2|||
144407023|NCT01606007|520700754|FG002|Overall Study|discontinue study treatment|1|||
144407024|NCT01606007|520700752|FG000|Overall Study|Lost to Follow-up|6|||
144407025|NCT01606007|520700753|FG001|Overall Study|Lost to Follow-up|8|||
144525736|NCT05543629|521125693|FG001|Overall Study|Other Reasons|0|||
144525737|NCT05543629|521125694|FG002|Overall Study|Other Reasons|0|||
144525738|NCT05543629|521125695|FG003|Overall Study|Other Reasons|0|||
144407026|NCT01606007|520700754|FG002|Overall Study|Lost to Follow-up|5|||
144407027|NCT01606007|520700752|FG000|Overall Study|Poor/Non-compliance|1|||
144407028|NCT01606007|520700753|FG001|Overall Study|Poor/Non-compliance|0|||
144407029|NCT01606007|520700754|FG002|Overall Study|Poor/Non-compliance|0|||
144407030|NCT03095612|520700758|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
144407031|NCT03095612|520700759|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
144407032|NCT03095612|520700760|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
144407033|NCT03095612|520700761|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
144407034|NCT03095612|520700762|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
144407035|NCT03095612|520700763|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
144407036|NCT03095612|520700764|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
144407037|NCT04447794|520700765|FG000|Overall Study|Lost to Follow-up|2|||
144407038|NCT04447794|520700766|FG001|Overall Study|Lost to Follow-up|3|||
144407039|NCT04447794|520700767|FG002|Overall Study|Lost to Follow-up|8|||
144407040|NCT04447794|520700765|FG000|Overall Study|Withdrawal by Subject|1|||
144407041|NCT04447794|520700766|FG001|Overall Study|Withdrawal by Subject|1|||
144407042|NCT04447794|520700767|FG002|Overall Study|Withdrawal by Subject|0|||
144407043|NCT01235689|520700769|FG000|Overall Study|Adverse Event|12|||
144407044|NCT01235689|520700770|FG001|Overall Study|Adverse Event|16|||
144407045|NCT01235689|520700769|FG000|Overall Study|Lack of Efficacy|12|||
144407046|NCT01235689|520700770|FG001|Overall Study|Lack of Efficacy|5|||
144407047|NCT01235689|520700769|FG000|Overall Study|Withdrawal by Subject|3|||
144407048|NCT01235689|520700770|FG001|Overall Study|Withdrawal by Subject|4|||
144407049|NCT01235689|520700769|FG000|Overall Study|Lost to Follow-up|1|||
144407050|NCT01235689|520700770|FG001|Overall Study|Lost to Follow-up|2|||
144407051|NCT01235689|520700769|FG000|Overall Study|Miscellaneous|1|||
144407052|NCT01235689|520700770|FG001|Overall Study|Miscellaneous|5|||
144407053|NCT01390649|520700771|FG000|Overall Study|Physician Decision|1|||
144407054|NCT00389597|520700776|FG000|Overall Study|Lost to Follow-up|8|||
144407055|NCT00389597|520700777|FG001|Overall Study|Lost to Follow-up|6|||
144407056|NCT00389597|520700778|FG002|Overall Study|Lost to Follow-up|4|||
144407057|NCT00389597|520700779|FG003|Overall Study|Lost to Follow-up|6|||
144407058|NCT03988088|520700780|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
144407059|NCT03988088|520700781|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
144407060|NCT03988088|520700782|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
144407061|NCT03988088|520700783|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
144407062|NCT03988088|520700780|FG000|Open-Label Addendum|Lost to Follow-up|0|||
144407063|NCT03988088|520700781|FG001|Open-Label Addendum|Lost to Follow-up|0|||
144407064|NCT03988088|520700782|FG002|Open-Label Addendum|Lost to Follow-up|1|||
144407065|NCT03988088|520700783|FG003|Open-Label Addendum|Lost to Follow-up|0|||
144407066|NCT04431453|520700784|FG000|Overall Study|Withdrew Consent|0|||
144407067|NCT04431453|520700785|FG001|Overall Study|Withdrew Consent|1|||
144407068|NCT04431453|520700786|FG002|Overall Study|Withdrew Consent|0|||
144407069|NCT04431453|520700787|FG003|Overall Study|Withdrew Consent|2|||
144407070|NCT04431453|520700788|FG004|Overall Study|Withdrew Consent|0|||
144407071|NCT04431453|520700789|FG005|Overall Study|Withdrew Consent|0|||
144407072|NCT04431453|520700790|FG006|Overall Study|Withdrew Consent|0|||
144407073|NCT04431453|520700791|FG007|Overall Study|Withdrew Consent|0|||
144407074|NCT04431453|520700784|FG000|Overall Study|Death|1|||
144407075|NCT04431453|520700785|FG001|Overall Study|Death|0|||
144407076|NCT04431453|520700786|FG002|Overall Study|Death|0|||
144407077|NCT04431453|520700787|FG003|Overall Study|Death|0|||
144407078|NCT04431453|520700788|FG004|Overall Study|Death|0|||
144407079|NCT04431453|520700789|FG005|Overall Study|Death|0|||
144407080|NCT04431453|520700790|FG006|Overall Study|Death|0|||
144407081|NCT04431453|520700791|FG007|Overall Study|Death|1|||
144407082|NCT04431453|520700784|FG000|Overall Study|Lost to Follow-up|0|||
144407083|NCT04431453|520700785|FG001|Overall Study|Lost to Follow-up|0|||
144407084|NCT04431453|520700786|FG002|Overall Study|Lost to Follow-up|1|||
144407085|NCT04431453|520700787|FG003|Overall Study|Lost to Follow-up|1|||
144407086|NCT04431453|520700788|FG004|Overall Study|Lost to Follow-up|0|||
144407087|NCT04431453|520700789|FG005|Overall Study|Lost to Follow-up|0|||
144525739|NCT05543629|521125696|FG004|Overall Study|Other Reasons|1|||
144407088|NCT04431453|520700790|FG006|Overall Study|Lost to Follow-up|0|||
144407089|NCT04431453|520700791|FG007|Overall Study|Lost to Follow-up|0|||
144407090|NCT04431453|520700784|FG000|Overall Study|Enrolled but Never Treated|0|||
144407091|NCT04431453|520700785|FG001|Overall Study|Enrolled but Never Treated|0|||
144407092|NCT04431453|520700786|FG002|Overall Study|Enrolled but Never Treated|0|||
144407093|NCT04431453|520700787|FG003|Overall Study|Enrolled but Never Treated|0|||
144407094|NCT04431453|520700788|FG004|Overall Study|Enrolled but Never Treated|1|||
144407095|NCT04431453|520700789|FG005|Overall Study|Enrolled but Never Treated|0|||
144407096|NCT04431453|520700790|FG006|Overall Study|Enrolled but Never Treated|0|||
144407097|NCT04431453|520700791|FG007|Overall Study|Enrolled but Never Treated|0|||
144407098|NCT00622401|520700792|FG000|Overall Study|Disease progression prior to treatment|3|||
144407099|NCT00622401|520700793|FG001|Overall Study|Disease progression prior to treatment|2|||
144407100|NCT00622401|520700794|FG002|Overall Study|Disease progression prior to treatment|0|||
144407101|NCT03344796|520700798|FG000|Overall Study|Lost to Follow-up|0|||
144407102|NCT03344796|520700799|FG001|Overall Study|Lost to Follow-up|0|||
144407103|NCT03344796|520700800|FG002|Overall Study|Lost to Follow-up|0|||
144407104|NCT03344796|520700801|FG003|Overall Study|Lost to Follow-up|0|||
144407105|NCT03344796|520700802|FG004|Overall Study|Lost to Follow-up|0|||
144407106|NCT03344796|520700803|FG005|Overall Study|Lost to Follow-up|2|||
144407107|NCT01201850|520700804|FG000|Overall Study|Tumor progression|4|||
144407108|NCT00816595|520700809|FG000|Overall Study|Withdrawal by Subject|2|||
144407109|NCT00816595|520700810|FG001|Overall Study|Withdrawal by Subject|0|||
144407110|NCT00566995|520700815|FG000|Overall Study|Toxicity|4|||
144407111|NCT00566995|520700815|FG000|Overall Study|Withdrew consent|3|||
144407112|NCT00404235|520700816|FG000|Overall Study|Withdrawal by Subject|1|||
144407113|NCT00404235|520700817|FG001|Overall Study|Withdrawal by Subject|2|||
144407114|NCT00001880|520700818|FG000|Overall Study|Death|14|||
144407115|NCT00679432|520700819|FG000|Overall Study|Adverse Event|5|||
144407116|NCT00679432|520700820|FG001|Overall Study|Adverse Event|6|||
144407117|NCT00679432|520700821|FG002|Overall Study|Adverse Event|10|||
144407118|NCT00679432|520700822|FG003|Overall Study|Adverse Event|7|||
144407119|NCT00679432|520700819|FG000|Overall Study|Protocol Violation|1|||
144407120|NCT00679432|520700820|FG001|Overall Study|Protocol Violation|1|||
144407121|NCT00679432|520700821|FG002|Overall Study|Protocol Violation|2|||
144407122|NCT00679432|520700822|FG003|Overall Study|Protocol Violation|1|||
144407123|NCT00679432|520700819|FG000|Overall Study|Withdrawal by Subject|8|||
144407124|NCT00679432|520700820|FG001|Overall Study|Withdrawal by Subject|11|||
144407125|NCT00679432|520700821|FG002|Overall Study|Withdrawal by Subject|10|||
144407126|NCT00679432|520700822|FG003|Overall Study|Withdrawal by Subject|9|||
144407127|NCT00679432|520700819|FG000|Overall Study|Lost to Follow-up|1|||
144407128|NCT00679432|520700820|FG001|Overall Study|Lost to Follow-up|5|||
144407129|NCT00679432|520700821|FG002|Overall Study|Lost to Follow-up|4|||
144407130|NCT00679432|520700822|FG003|Overall Study|Lost to Follow-up|2|||
144407131|NCT00679432|520700819|FG000|Overall Study|Physician Decision|3|||
144407132|NCT00679432|520700820|FG001|Overall Study|Physician Decision|2|||
144407133|NCT00679432|520700821|FG002|Overall Study|Physician Decision|2|||
144407134|NCT00679432|520700822|FG003|Overall Study|Physician Decision|2|||
144407135|NCT00679432|520700819|FG000|Overall Study|Sponsor decision|1|||
144407136|NCT00679432|520700820|FG001|Overall Study|Sponsor decision|0|||
144407137|NCT00679432|520700821|FG002|Overall Study|Sponsor decision|0|||
144407138|NCT00679432|520700822|FG003|Overall Study|Sponsor decision|0|||
144407139|NCT00679432|520700819|FG000|Overall Study|Lack of Efficacy|13|||
144407140|NCT00679432|520700820|FG001|Overall Study|Lack of Efficacy|9|||
144407141|NCT00679432|520700821|FG002|Overall Study|Lack of Efficacy|14|||
144407142|NCT00679432|520700822|FG003|Overall Study|Lack of Efficacy|8|||
144407143|NCT00679432|520700819|FG000|Overall Study|Infectious colitis, normal histology|5|||
144599771|NCT04658186|521397504|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
144599772|NCT04658186|521397502|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
144599773|NCT04658186|521397503|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
144599774|NCT04658186|521397504|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
144599775|NCT04658186|521397502|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
144599776|NCT04658186|521397503|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
144599777|NCT04658186|521397504|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
144407144|NCT00679432|520700820|FG001|Overall Study|Infectious colitis, normal histology|4|||
144407145|NCT00679432|520700821|FG002|Overall Study|Infectious colitis, normal histology|8|||
144407146|NCT00679432|520700822|FG003|Overall Study|Infectious colitis, normal histology|3|||
144407147|NCT00679432|520700819|FG000|Overall Study|Randomization error, return to prior Rx|0|||
144407148|NCT00679432|520700820|FG001|Overall Study|Randomization error, return to prior Rx|0|||
144407149|NCT00679432|520700821|FG002|Overall Study|Randomization error, return to prior Rx|3|||
144407150|NCT00679432|520700822|FG003|Overall Study|Randomization error, return to prior Rx|0|||
144407151|NCT02639065|520700823|FG000|Study Treatment|Disease Progression|13|||
144407152|NCT02639065|520700823|FG000|Study Treatment|Adverse Event|9|||
144407153|NCT02639065|520700823|FG000|Study Treatment|Withdrawal by Subject|1|||
144407154|NCT02639065|520700823|FG000|Follow up|Subject refused to follow up|1|||
144407155|NCT02639065|520700823|FG000|Follow up|Symptomatic Deterioration|2|||
144407156|NCT02639065|520700823|FG000|Follow up|Death|2|||
144407157|NCT02639065|520700823|FG000|Follow up|Study Terminated|1|||
144407158|NCT02639065|520700823|FG000|Follow up|Disease Progression|3|||
144407159|NCT00824720|520700824|FG000|Overall Study|failed plug insertion|3|||
144407160|NCT00824720|520700825|FG001|Overall Study|failed plug insertion|1|||
144407161|NCT00824720|520700826|FG002|Overall Study|failed plug insertion|0|||
144407162|NCT00824720|520700824|FG000|Overall Study|Protocol Violation|0|||
144407163|NCT00824720|520700825|FG001|Overall Study|Protocol Violation|0|||
144407164|NCT00824720|520700826|FG002|Overall Study|Protocol Violation|1|||
144407165|NCT00481078|520700827|FG000|Overall Study|Progression of disease|11|||
144407166|NCT00481078|520700828|FG001|Overall Study|Progression of disease|11|||
144407167|NCT00481078|520700827|FG000|Overall Study|Adverse Event|15|||
144407168|NCT00481078|520700828|FG001|Overall Study|Adverse Event|3|||
144407169|NCT00481078|520700827|FG000|Overall Study|Death|5|||
144407170|NCT00481078|520700828|FG001|Overall Study|Death|3|||
144407171|NCT00481078|520700827|FG000|Overall Study|Intercurrent illness|1|||
144407172|NCT00481078|520700828|FG001|Overall Study|Intercurrent illness|0|||
144407173|NCT00481078|520700827|FG000|Overall Study|Withdrawal by Subject|7|||
144407174|NCT00481078|520700828|FG001|Overall Study|Withdrawal by Subject|1|||
144407175|NCT00481078|520700827|FG000|Overall Study|Information not available|1|||
144407176|NCT00481078|520700828|FG001|Overall Study|Information not available|0|||
144407177|NCT00481078|520700827|FG000|Overall Study|Received other treatment|2|||
144407178|NCT00481078|520700828|FG001|Overall Study|Received other treatment|1|||
144407179|NCT00481078|520700827|FG000|Overall Study|Brain metastasis|0|||
144407180|NCT00481078|520700828|FG001|Overall Study|Brain metastasis|1|||
144407181|NCT01558271|520700829|FG000|Overall Study|Adverse Event|6|||
144407182|NCT01558271|520700830|FG001|Overall Study|Adverse Event|3|||
144407183|NCT01558271|520700831|FG002|Overall Study|Adverse Event|4|||
144407184|NCT01558271|520700829|FG000|Overall Study|Lost to Follow-up|1|||
144407185|NCT01558271|520700830|FG001|Overall Study|Lost to Follow-up|0|||
144407186|NCT01558271|520700831|FG002|Overall Study|Lost to Follow-up|0|||
144407187|NCT01558271|520700829|FG000|Overall Study|Protocol Violation|1|||
144407188|NCT01558271|520700830|FG001|Overall Study|Protocol Violation|0|||
144407189|NCT01558271|520700831|FG002|Overall Study|Protocol Violation|0|||
144407190|NCT01558271|520700829|FG000|Overall Study|Withdrawal by Subject|10|||
144407191|NCT01558271|520700830|FG001|Overall Study|Withdrawal by Subject|6|||
144407192|NCT01558271|520700831|FG002|Overall Study|Withdrawal by Subject|12|||
144407193|NCT01558271|520700829|FG000|Overall Study|Physician Decision|0|||
144407194|NCT01558271|520700830|FG001|Overall Study|Physician Decision|2|||
144407195|NCT01558271|520700831|FG002|Overall Study|Physician Decision|1|||
144407196|NCT00743483|520700832|FG000|Baseline Period|Physician Decision|1|||
144407197|NCT00743483|520700832|FG000|Treatment Period|Adverse Event|1|||
144407198|NCT01084083|520700833|FG000|Overall Study|Adverse Event|5|||
144407199|NCT01084083|520700833|FG000|Overall Study|Death|1|||
144407200|NCT01084083|520700833|FG000|Overall Study|Withdrawal by Subject|2|||
144407201|NCT01084083|520700833|FG000|Overall Study|Complicating disease|1|||
144407202|NCT01084083|520700833|FG000|Overall Study|Other|2|||
144407203|NCT01084083|520700833|FG000|Overall Study|Never started assigned therapy|1|||
144407204|NCT00228384|520700834|FG000|Overall Study|Death|9|||
144407205|NCT00228384|520700835|FG001|Overall Study|Death|3|||
144407206|NCT00228384|520700834|FG000|Overall Study|Lost to Follow-up|6|||
144407207|NCT00228384|520700835|FG001|Overall Study|Lost to Follow-up|10|||
144407208|NCT00228384|520700834|FG000|Overall Study|Surgical Intervention (bypass)|5|||
144407209|NCT00228384|520700835|FG001|Overall Study|Surgical Intervention (bypass)|5|||
144407210|NCT00228384|520700834|FG000|Overall Study|Withdrawal by Subject|9|||
144407211|NCT00228384|520700835|FG001|Overall Study|Withdrawal by Subject|10|||
144407212|NCT00228384|520700834|FG000|Overall Study|Physician Decision|0|||
144407213|NCT00228384|520700835|FG001|Overall Study|Physician Decision|1|||
144407214|NCT01273597|520700836|FG000|Overall Study|Adverse Event|5|||
144407215|NCT01273597|520700836|FG000|Overall Study|Underwent Kidney Transplantation|2|||
144407216|NCT01273597|520700836|FG000|Overall Study|Reason Not Reported|1|||
144407217|NCT00873912|520700838|FG000|Overall Study|Withdrawal by Subject|1|||
144407218|NCT00873912|520700839|FG001|Overall Study|Withdrawal by Subject|0|||
144525740|NCT05543629|521125697|FG005|Overall Study|Other Reasons|0|||
144525741|NCT05543629|521125698|FG006|Overall Study|Other Reasons|0|||
144525742|NCT05543629|521125699|FG007|Overall Study|Other Reasons|0|||
144525743|NCT05543629|521125692|FG000|Overall Study|Physician Decision|0|||
144525744|NCT05543629|521125693|FG001|Overall Study|Physician Decision|0|||
144525745|NCT05543629|521125694|FG002|Overall Study|Physician Decision|3|||
144525746|NCT05543629|521125695|FG003|Overall Study|Physician Decision|0|||
144525747|NCT05543629|521125696|FG004|Overall Study|Physician Decision|0|||
144525748|NCT05543629|521125697|FG005|Overall Study|Physician Decision|0|||
144525749|NCT05543629|521125698|FG006|Overall Study|Physician Decision|1|||
144407219|NCT00873912|520700838|FG000|Overall Study|Lost to Follow-up|2|||
144407220|NCT00873912|520700839|FG001|Overall Study|Lost to Follow-up|0|||
144407221|NCT01466153|520700842|FG000|Overall Study|Disease Progression|2|||
144407222|NCT01466153|520700843|FG001|Overall Study|Disease Progression|2|||
144407223|NCT01466153|520700844|FG002|Overall Study|Disease Progression|0|||
144407224|NCT01466153|520700842|FG000|Overall Study|Adverse Event|14|||
144407225|NCT01466153|520700843|FG001|Overall Study|Adverse Event|13|||
144599778|NCT04658186|521397502|FG000|Overall Study|PI Decision due to Participant Safety|0|||
144599779|NCT04658186|521397503|FG001|Overall Study|PI Decision due to Participant Safety|0|||
144599780|NCT04658186|521397504|FG002|Overall Study|PI Decision due to Participant Safety|1|||
144599781|NCT04658186|521397502|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
144599782|NCT04658186|521397503|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
144407226|NCT01466153|520700844|FG002|Overall Study|Adverse Event|17|||
144407227|NCT01466153|520700842|FG000|Overall Study|Withdrawal of Consent|2|||
144407228|NCT01466153|520700843|FG001|Overall Study|Withdrawal of Consent|0|||
144407229|NCT01466153|520700844|FG002|Overall Study|Withdrawal of Consent|0|||
144407230|NCT01466153|520700842|FG000|Overall Study|Investigator Discretion|3|||
144407231|NCT01466153|520700843|FG001|Overall Study|Investigator Discretion|2|||
144599783|NCT04658186|521397504|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
144407232|NCT01466153|520700844|FG002|Overall Study|Investigator Discretion|2|||
144407233|NCT01466153|520700842|FG000|Overall Study|Randomized-Not Treated|2|||
144407234|NCT01466153|520700843|FG001|Overall Study|Randomized-Not Treated|3|||
144407235|NCT01466153|520700844|FG002|Overall Study|Randomized-Not Treated|4|||
144407236|NCT01466153|520700842|FG000|Overall Study|Other-Unspecified|6|||
144407237|NCT01466153|520700843|FG001|Overall Study|Other-Unspecified|4|||
144407238|NCT01466153|520700844|FG002|Overall Study|Other-Unspecified|2|||
144407239|NCT01785069|520700848|FG000|Overall Study|Implanted with nonstudy device|1|||
144407240|NCT01785069|520700849|FG001|Overall Study|Implanted with nonstudy device|2|||
144407241|NCT01785069|520700850|FG002|Overall Study|Implanted with nonstudy device|1|||
144407242|NCT01785069|520700851|FG003|Overall Study|Implanted with nonstudy device|0|||
144407243|NCT01785069|520700848|FG000|Overall Study|Death|0|||
144407244|NCT01785069|520700849|FG001|Overall Study|Death|0|||
144407245|NCT01785069|520700850|FG002|Overall Study|Death|2|||
144407246|NCT01785069|520700851|FG003|Overall Study|Death|0|||
144407247|NCT01785069|520700848|FG000|Overall Study|Subject choice|2|||
144407248|NCT01785069|520700849|FG001|Overall Study|Subject choice|2|||
144407249|NCT01785069|520700850|FG002|Overall Study|Subject choice|0|||
144407250|NCT01785069|520700851|FG003|Overall Study|Subject choice|1|||
144407251|NCT01785069|520700848|FG000|Overall Study|Lost to Follow-up|1|||
144407252|NCT01785069|520700849|FG001|Overall Study|Lost to Follow-up|2|||
144407253|NCT01785069|520700850|FG002|Overall Study|Lost to Follow-up|4|||
144407254|NCT01785069|520700851|FG003|Overall Study|Lost to Follow-up|1|||
144407255|NCT01785069|520700848|FG000|Overall Study|Reason not Specified|1|||
144407256|NCT01785069|520700849|FG001|Overall Study|Reason not Specified|2|||
144407257|NCT01785069|520700850|FG002|Overall Study|Reason not Specified|1|||
144407258|NCT01785069|520700851|FG003|Overall Study|Reason not Specified|4|||
144407259|NCT01785069|520700848|FG000|Overall Study|Not evaluable|7|||
144407260|NCT01785069|520700849|FG001|Overall Study|Not evaluable|4|||
144525750|NCT05543629|521125699|FG007|Overall Study|Physician Decision|0|||
144525751|NCT05543629|521125692|FG000|Overall Study|Study terminated by Sponsor|1|||
144525752|NCT05543629|521125693|FG001|Overall Study|Study terminated by Sponsor|0|||
144525753|NCT05543629|521125694|FG002|Overall Study|Study terminated by Sponsor|0|||
144525754|NCT05543629|521125695|FG003|Overall Study|Study terminated by Sponsor|1|||
144525755|NCT05543629|521125696|FG004|Overall Study|Study terminated by Sponsor|0|||
144525756|NCT05543629|521125697|FG005|Overall Study|Study terminated by Sponsor|4|||
144599784|NCT03801902|521397505|FG000|Overall Study|Did not receive protocol treatment.|1|||
144599785|NCT03801902|521397506|FG001|Overall Study|Did not receive protocol treatment.|0|||
144599786|NCT03801902|521397507|FG002|Overall Study|Did not receive protocol treatment.|0|||
144599787|NCT03801902|521397508|FG003|Overall Study|Did not receive protocol treatment.|0|||
144599788|NCT00908232|521397509|FG000|Cycle 1 to 4|Death|5|||
144599789|NCT00908232|521397510|FG001|Cycle 1 to 4|Death|0|||
144599790|NCT00908232|521397511|FG002|Cycle 1 to 4|Death|0|||
144599791|NCT00908232|521397512|FG003|Cycle 1 to 4|Death|0|||
144599792|NCT00908232|521397509|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
144599793|NCT00908232|521397510|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
144599794|NCT00908232|521397511|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
144599795|NCT00908232|521397512|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
144599796|NCT00908232|521397509|FG000|Cycle 1 to 4|Progressive Disease|6|||
144599797|NCT00908232|521397510|FG001|Cycle 1 to 4|Progressive Disease|0|||
144599798|NCT00908232|521397511|FG002|Cycle 1 to 4|Progressive Disease|0|||
144407261|NCT01785069|520700850|FG002|Overall Study|Not evaluable|5|||
144407262|NCT01785069|520700851|FG003|Overall Study|Not evaluable|8|||
144407263|NCT01088997|520700856|FG000|Overall Study|Physician Decision|1|||
144525757|NCT05543629|521125698|FG006|Overall Study|Study terminated by Sponsor|1|||
144525758|NCT05543629|521125699|FG007|Overall Study|Study terminated by Sponsor|0|||
144599799|NCT00908232|521397512|FG003|Cycle 1 to 4|Progressive Disease|0|||
144599800|NCT00908232|521397509|FG000|Cycle 1 to 4|Adverse Event|12|||
144407264|NCT01088997|520700857|FG001|Overall Study|Physician Decision|1|||
144407265|NCT01088997|520700856|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
144525759|NCT05543629|521125692|FG000|Overall Study|Withdrawal by Subject|1|||
144525760|NCT05543629|521125693|FG001|Overall Study|Withdrawal by Subject|1|||
144525761|NCT05543629|521125694|FG002|Overall Study|Withdrawal by Subject|0|||
144599801|NCT00908232|521397510|FG001|Cycle 1 to 4|Adverse Event|0|||
144599802|NCT00908232|521397511|FG002|Cycle 1 to 4|Adverse Event|0|||
144599803|NCT00908232|521397512|FG003|Cycle 1 to 4|Adverse Event|0|||
144599804|NCT00908232|521397509|FG000|Cycle 1 to 4|Other|1|||
144599805|NCT00908232|521397510|FG001|Cycle 1 to 4|Other|0|||
144599806|NCT00908232|521397511|FG002|Cycle 1 to 4|Other|0|||
144599807|NCT00908232|521397512|FG003|Cycle 1 to 4|Other|0|||
144250059|NCT01760447|520113441|FG002|Weeks 0-20|Lost to Follow-up|1|||
144599808|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
144599809|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
144599810|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
144407266|NCT01088997|520700857|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
144407267|NCT01088997|520700856|FG000|Overall Study|Excluded prior to receiving drug|1|||
144407268|NCT01088997|520700857|FG001|Overall Study|Excluded prior to receiving drug|1|||
144407269|NCT05570500|520700862|FG000|Overall Study|Lost to Follow-up|7|||
144407270|NCT05570500|520700863|FG001|Overall Study|Lost to Follow-up|5|||
144407271|NCT04997304|520700864|FG000|Overall Study|Lost to Follow-up|11|||
144407272|NCT04997304|520700864|FG000|Overall Study|Death|1|||
144407273|NCT04997304|520700864|FG000|Overall Study|Withdrawal by Subject|14|||
144407274|NCT04560998|520700865|FG000|Overall Study|Withdrawal by Subject|18|||
144407275|NCT04560998|520700866|FG001|Overall Study|Withdrawal by Subject|12|||
144407276|NCT04560998|520700865|FG000|Overall Study|Lost to Follow-up|8|||
144407277|NCT04560998|520700866|FG001|Overall Study|Lost to Follow-up|5|||
144407278|NCT04560998|520700865|FG000|Overall Study|Physician Decision|4|||
144407279|NCT04560998|520700866|FG001|Overall Study|Physician Decision|0|||
144407280|NCT02955602|520702613|FG000|Overall Study|Adverse Event|0|||
144407281|NCT02955602|520702614|FG001|Overall Study|Adverse Event|3|||
144407282|NCT02955602|520702615|FG002|Overall Study|Adverse Event|0|||
144407283|NCT02955602|520702613|FG000|Overall Study|Withdrawal of informed consent|1|||
144407284|NCT02955602|520702614|FG001|Overall Study|Withdrawal of informed consent|3|||
144407285|NCT02955602|520702615|FG002|Overall Study|Withdrawal of informed consent|2|||
144407286|NCT02955602|520702613|FG000|Overall Study|Lost to Follow-up|0|||
144407287|NCT02955602|520702614|FG001|Overall Study|Lost to Follow-up|0|||
144407288|NCT02955602|520702615|FG002|Overall Study|Lost to Follow-up|1|||
144407289|NCT02955602|520702613|FG000|Overall Study|Other|0|||
144407290|NCT02955602|520702614|FG001|Overall Study|Other|1|||
144407291|NCT02955602|520702615|FG002|Overall Study|Other|3|||
144407292|NCT00290888|520702616|FG000|Overall Study|Physician Decision|3|||
144407293|NCT00290888|520702617|FG001|Overall Study|Physician Decision|1|||
144407294|NCT04160195|520702622|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
144407295|NCT04160195|520702623|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
144407296|NCT03068130|520702628|FG000|Overall Study|Adverse Event|19|||
144407297|NCT03068130|520702628|FG000|Overall Study|Death|14|||
144407298|NCT03068130|520702628|FG000|Overall Study|Lost to Follow-up|4|||
144407299|NCT03068130|520702628|FG000|Overall Study|Withdrawal by Subject|26|||
144407300|NCT03068130|520702628|FG000|Overall Study|Administrative Reasons|3|||
144407301|NCT03068130|520702628|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
144407302|NCT03068130|520702628|FG000|Overall Study|Study terminated by sponsor|194|||
144407303|NCT03039283|520702631|FG000|Overall Study|Protocol Violation|2|||
144407304|NCT00964860|520702632|FG000|Overall Study|Withdrawal by Subject|0|||
144407305|NCT00964860|520702633|FG001|Overall Study|Withdrawal by Subject|1|||
144407306|NCT02585960|520702634|FG000|PK/Safety Assessment Period|Physician Decision|0|||
144407307|NCT02585960|520702635|FG001|PK/Safety Assessment Period|Physician Decision|1|||
144407308|NCT02585960|520702636|FG002|PK/Safety Assessment Period|Physician Decision|0|||
144407309|NCT02585960|520702634|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
144407310|NCT02585960|520702635|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
144407311|NCT02585960|520702636|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
144407312|NCT02585960|520702634|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
144407313|NCT02585960|520702635|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
144407314|NCT02585960|520702636|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
144407315|NCT02585960|520702634|FG000|PK/Safety Assessment Period|Other|4|||
144407316|NCT02585960|520702635|FG001|PK/Safety Assessment Period|Other|4|||
144407317|NCT02585960|520702636|FG002|PK/Safety Assessment Period|Other|0|||
144407318|NCT02585960|520702634|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
144407319|NCT02585960|520702635|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
144407320|NCT02585960|520702636|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
144407321|NCT02585960|520702634|FG000|PK/Safety Assessment Period|Screen Failure|0|||
144407322|NCT02585960|520702635|FG001|PK/Safety Assessment Period|Screen Failure|0|||
144407323|NCT02585960|520702636|FG002|PK/Safety Assessment Period|Screen Failure|1|||
144407324|NCT02585960|520702634|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
144407325|NCT02585960|520702635|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
144407326|NCT02585960|520702636|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
144407327|NCT02585960|520702634|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
144407328|NCT02585960|520702635|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
144407329|NCT02585960|520702636|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
144407330|NCT06333613|520702637|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
144599811|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
144407331|NCT04930965|520702643|FG000|Overall Study|Lost to Follow-up|7|||
144407332|NCT04930965|520702644|FG001|Overall Study|Lost to Follow-up|5|||
144407333|NCT04377620|520702645|FG000|Overall Study|Death|42|||
144407334|NCT04377620|520702646|FG001|Overall Study|Death|48|||
144407335|NCT04377620|520702647|FG002|Overall Study|Death|36|||
144407336|NCT04377620|520702645|FG000|Overall Study|Withdrawal by Subject|0|||
144407337|NCT04377620|520702646|FG001|Overall Study|Withdrawal by Subject|2|||
144407338|NCT04377620|520702647|FG002|Overall Study|Withdrawal by Subject|0|||
144407339|NCT05587296|520702648|FG000|Overall Study|Adverse Event|15|||
144407340|NCT05587296|520702649|FG001|Overall Study|Adverse Event|7|||
144407341|NCT05587296|520702648|FG000|Overall Study|Lack of Efficacy|2|||
144407342|NCT05587296|520702649|FG001|Overall Study|Lack of Efficacy|0|||
144407343|NCT05587296|520702648|FG000|Overall Study|Lost to Follow-up|1|||
144407344|NCT05587296|520702649|FG001|Overall Study|Lost to Follow-up|0|||
144407345|NCT05587296|520702648|FG000|Overall Study|Withdrawal by Subject|14|||
144407346|NCT05587296|520702649|FG001|Overall Study|Withdrawal by Subject|4|||
144407347|NCT05587296|520702648|FG000|Overall Study|miscellaneous|3|||
144407348|NCT05587296|520702649|FG001|Overall Study|miscellaneous|6|||
144407349|NCT05587296|520702648|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
144407350|NCT05587296|520702649|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
144407351|NCT00134082|520702650|FG000|Overall Study|Adverse Event|2|||
144407352|NCT00134082|520702650|FG000|Overall Study|Death|1|||
144407353|NCT02849678|520702653|FG000|Overall Study|Protocol Violation|3|||
144407354|NCT02849678|520702654|FG001|Overall Study|Protocol Violation|6|||
144407355|NCT00444912|520702661|FG000|Overall Study|Death|1|||
144407356|NCT00444912|520702662|FG001|Overall Study|Death|2|||
144407357|NCT00444912|520702661|FG000|Overall Study|Lost to Follow-up|1|||
144407358|NCT00444912|520702662|FG001|Overall Study|Lost to Follow-up|0|||
144407359|NCT00444912|520702661|FG000|Overall Study|Participant Failed Mobilization|1|||
144407360|NCT00444912|520702662|FG001|Overall Study|Participant Failed Mobilization|0|||
144407361|NCT00555971|520702664|FG000|Overall Study|Adverse Event|1|||
144407362|NCT00555971|520702665|FG001|Overall Study|Adverse Event|1|||
144407363|NCT00518284|520702670|FG000|Overall Study|Adverse Event|0|||
144407364|NCT00518284|520702671|FG001|Overall Study|Adverse Event|1|||
144407365|NCT00518284|520702672|FG002|Overall Study|Adverse Event|0|||
144407366|NCT00518284|520702673|FG003|Overall Study|Adverse Event|0|||
144407367|NCT00518284|520702670|FG000|Overall Study|Study Termination|0|||
144407368|NCT00518284|520702671|FG001|Overall Study|Study Termination|2|||
144407369|NCT00518284|520702672|FG002|Overall Study|Study Termination|1|||
144407370|NCT00518284|520702673|FG003|Overall Study|Study Termination|2|||
144407371|NCT03768414|520702674|FG000|Overall Study|Adverse Event or side effects|72|||
144407372|NCT03768414|520702675|FG001|Overall Study|Adverse Event or side effects|28|||
144407373|NCT03768414|520702674|FG000|Overall Study|Refusal unrelated to adverse event|33|||
144407374|NCT03768414|520702675|FG001|Overall Study|Refusal unrelated to adverse event|33|||
144407375|NCT03768414|520702674|FG000|Overall Study|Progression/relapse|132|||
144407376|NCT03768414|520702675|FG001|Overall Study|Progression/relapse|60|||
144407377|NCT03768414|520702674|FG000|Overall Study|Death|9|||
144407378|NCT03768414|520702675|FG001|Overall Study|Death|6|||
144407379|NCT03768414|520702674|FG000|Overall Study|Other - not protocol specified|45|||
144407380|NCT03768414|520702675|FG001|Overall Study|Other - not protocol specified|18|||
144407381|NCT03768414|520702674|FG000|Overall Study|Reason under review|3|||
144407382|NCT03768414|520702675|FG001|Overall Study|Reason under review|2|||
144407383|NCT00801632|520702677|FG000|Overall Study|Re-transplant|1|||
144407384|NCT05379231|520702678|FG000|Home Visit|Withdrawal by Subject|2|||
144407385|NCT05379231|520702678|FG000|In-lab Visit|Withdrawal by Subject|2|||
144525762|NCT05543629|521125695|FG003|Overall Study|Withdrawal by Subject|2|||
144525763|NCT05543629|521125696|FG004|Overall Study|Withdrawal by Subject|1|||
144525764|NCT05543629|521125697|FG005|Overall Study|Withdrawal by Subject|1|||
144525765|NCT05543629|521125698|FG006|Overall Study|Withdrawal by Subject|1|||
144525766|NCT05543629|521125699|FG007|Overall Study|Withdrawal by Subject|1|||
144525767|NCT05543629|521125692|FG000|Overall Study|Not Reported|2|||
144525768|NCT05543629|521125693|FG001|Overall Study|Not Reported|2|||
144525769|NCT05543629|521125694|FG002|Overall Study|Not Reported|0|||
144525770|NCT05543629|521125695|FG003|Overall Study|Not Reported|0|||
144525771|NCT05543629|521125696|FG004|Overall Study|Not Reported|1|||
144525772|NCT05543629|521125697|FG005|Overall Study|Not Reported|1|||
144525773|NCT05543629|521125698|FG006|Overall Study|Not Reported|3|||
144525774|NCT05543629|521125699|FG007|Overall Study|Not Reported|0|||
144525775|NCT04564742|521125700|FG000|Overall Study|Lost to Follow-up|1|||
144407386|NCT01496807|520702686|FG000|Overall Study|Progressive Disease|21|||
144407387|NCT01496807|520702686|FG000|Overall Study|Participant preference/toxicity|8|||
144407388|NCT01496807|520702686|FG000|Overall Study|Change in diagnosis|1|||
144407389|NCT02197520|520702693|FG000|Period 1|Withdrawal by Subject|1|||
144407390|NCT02197520|520702694|FG001|Period 1|Withdrawal by Subject|0|||
144525776|NCT04564742|521125701|FG001|Overall Study|Lost to Follow-up|0|||
144525777|NCT04564742|521125700|FG000|Overall Study|Consent Withdrawal|4|||
144407391|NCT02197520|520702693|FG000|Period 2|Adverse Event|0|||
144407392|NCT02197520|520702694|FG001|Period 2|Adverse Event|2|||
144525778|NCT04564742|521125701|FG001|Overall Study|Consent Withdrawal|4|||
144407393|NCT02197520|520702693|FG000|Period 2|Withdrawal by Subject|1|||
144407394|NCT02197520|520702694|FG001|Period 2|Withdrawal by Subject|0|||
144407395|NCT00334958|520702695|FG000|Overall Study|Medication Noncompliance|0|||
144407396|NCT00334958|520702696|FG001|Overall Study|Medication Noncompliance|3|||
144525779|NCT03313076|521125705|FG000|Overall Study|Withdrawal by Subject|2|||
144407397|NCT00334958|520702695|FG000|Overall Study|Protocol Violation|2|||
144407398|NCT00334958|520702696|FG001|Overall Study|Protocol Violation|2|||
144407399|NCT00334958|520702695|FG000|Overall Study|Request of the investigator or sponsor|0|||
144407400|NCT00334958|520702696|FG001|Overall Study|Request of the investigator or sponsor|1|||
144407401|NCT00334958|520702695|FG000|Overall Study|Withdrawal by Subject|7|||
144407402|NCT00334958|520702696|FG001|Overall Study|Withdrawal by Subject|4|||
144407403|NCT00334958|520702695|FG000|Overall Study|Adverse Event|27|||
144407404|NCT00334958|520702696|FG001|Overall Study|Adverse Event|12|||
144407405|NCT00334958|520702695|FG000|Overall Study|Other|1|||
144407406|NCT00334958|520702696|FG001|Overall Study|Other|2|||
144407407|NCT02021773|520702700|FG000|Overall Study|Adverse Event|1|||
144407408|NCT02021773|520702701|FG001|Overall Study|Adverse Event|4|||
144407409|NCT02021773|520702702|FG002|Overall Study|Adverse Event|3|||
144407410|NCT02021773|520702700|FG000|Overall Study|Lack of Efficacy|2|||
144407411|NCT02021773|520702701|FG001|Overall Study|Lack of Efficacy|2|||
144407412|NCT02021773|520702702|FG002|Overall Study|Lack of Efficacy|2|||
144407413|NCT02021773|520702700|FG000|Overall Study|Protocol Violation|2|||
144407414|NCT02021773|520702701|FG001|Overall Study|Protocol Violation|3|||
144407415|NCT02021773|520702702|FG002|Overall Study|Protocol Violation|1|||
144407416|NCT02021773|520702700|FG000|Overall Study|Withdrawal by Subject|3|||
144407417|NCT02021773|520702701|FG001|Overall Study|Withdrawal by Subject|4|||
144407418|NCT02021773|520702702|FG002|Overall Study|Withdrawal by Subject|5|||
144407419|NCT02021773|520702700|FG000|Overall Study|Lost to Follow-up|1|||
144407420|NCT02021773|520702701|FG001|Overall Study|Lost to Follow-up|3|||
144407421|NCT02021773|520702702|FG002|Overall Study|Lost to Follow-up|0|||
144407422|NCT02021773|520702700|FG000|Overall Study|Reason not specified|3|||
144407423|NCT02021773|520702701|FG001|Overall Study|Reason not specified|0|||
144407424|NCT02021773|520702702|FG002|Overall Study|Reason not specified|0|||
144407425|NCT01534962|520702703|FG000|Overall Study|Randomized but did not start treatment|2|||
144407426|NCT01534962|520702704|FG001|Overall Study|Randomized but did not start treatment|0|||
144407427|NCT01534962|520702705|FG002|Overall Study|Randomized but did not start treatment|0|||
144407428|NCT01534962|520702706|FG003|Overall Study|Randomized but did not start treatment|1|||
144407429|NCT01534962|520702703|FG000|Overall Study|Discontinued at AF recurrence|35|||
144407430|NCT01534962|520702704|FG001|Overall Study|Discontinued at AF recurrence|26|||
144407431|NCT01534962|520702705|FG002|Overall Study|Discontinued at AF recurrence|24|||
144407432|NCT01534962|520702706|FG003|Overall Study|Discontinued at AF recurrence|31|||
144407433|NCT02243696|520702707|FG000|Overall Study|Death|282|||
144407434|NCT02243696|520702707|FG000|Overall Study|Withdrawal by Subject|79|||
144407435|NCT02243696|520702707|FG000|Overall Study|Lost to Follow-up|57|||
144407436|NCT02243696|520702707|FG000|Overall Study|Subject No Longer has Study System|42|||
144407437|NCT02243696|520702707|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
144407438|NCT02243696|520702707|FG000|Overall Study|Study Terminated for EP PASSION|961|||
144407439|NCT00282984|520702708|FG000|Overall Study|Death|2|||
144407440|NCT00282984|520702709|FG001|Overall Study|Death|5|||
144407441|NCT00282984|520702708|FG000|Overall Study|Adverse Event|8|||
144407442|NCT00282984|520702709|FG001|Overall Study|Adverse Event|5|||
144407443|NCT00282984|520702708|FG000|Overall Study|Lack of Efficacy|0|||
144407444|NCT00282984|520702709|FG001|Overall Study|Lack of Efficacy|2|||
144407445|NCT00282984|520702708|FG000|Overall Study|Lost to Follow-up|14|||
144407446|NCT00282984|520702709|FG001|Overall Study|Lost to Follow-up|10|||
144407447|NCT00282984|520702708|FG000|Overall Study|Withdrawal by Participant|22|||
144407448|NCT00282984|520702709|FG001|Overall Study|Withdrawal by Participant|34|||
144407449|NCT00282984|520702708|FG000|Overall Study|Participant stopped study medication|2|||
144407450|NCT00282984|520702709|FG001|Overall Study|Participant stopped study medication|2|||
144525780|NCT03313076|521125706|FG001|Overall Study|Withdrawal by Subject|0|||
144525781|NCT03313076|521125707|FG002|Overall Study|Withdrawal by Subject|0|||
144525782|NCT03313076|521125708|FG003|Overall Study|Withdrawal by Subject|0|||
144407451|NCT00282984|520702708|FG000|Overall Study|Participant only allowed phone follow-up|0|||
144407452|NCT00282984|520702709|FG001|Overall Study|Participant only allowed phone follow-up|1|||
144525783|NCT03313076|521125705|FG000|Overall Study|Lost to Follow-up|0|||
144525784|NCT03313076|521125706|FG001|Overall Study|Lost to Follow-up|2|||
144525785|NCT03313076|521125707|FG002|Overall Study|Lost to Follow-up|2|||
144525786|NCT03313076|521125708|FG003|Overall Study|Lost to Follow-up|2|||
144525787|NCT05869383|521125709|FG000|Overall Study|Withdrawal by Subject|2|||
144525788|NCT05869383|521125710|FG001|Overall Study|Withdrawal by Subject|0|||
144525789|NCT04137367|521125713|FG000|Overall Study|Lost to Follow-up|8|||
144525790|NCT04137367|521125714|FG001|Overall Study|Lost to Follow-up|6|||
144525791|NCT04137367|521125715|FG002|Overall Study|Lost to Follow-up|4|||
144525792|NCT03270501|521125716|FG000|Overall Study|Screen failure|6|||
144525793|NCT03270501|521125716|FG000|Overall Study|Lost to Follow-up|2|||
144407453|NCT00282984|520702708|FG000|Overall Study|Participant used antipsychosis meds|0|||
144407454|NCT00282984|520702709|FG001|Overall Study|Participant used antipsychosis meds|1|||
144407455|NCT00282984|520702708|FG000|Overall Study|lack of motivation|1|||
144407456|NCT00282984|520702709|FG001|Overall Study|lack of motivation|0|||
144407457|NCT00282984|520702708|FG000|Overall Study|in prison|0|||
144407458|NCT00282984|520702709|FG001|Overall Study|in prison|1|||
144525794|NCT03270501|521125716|FG000|Overall Study|Adverse Event|1|||
144407459|NCT00282984|520702708|FG000|Overall Study|Protocol Violation|2|||
144407460|NCT00282984|520702709|FG001|Overall Study|Protocol Violation|0|||
144407461|NCT00191269|520702710|FG000|Overall Study|Protocol Violation|0|||
144407462|NCT00191269|520702711|FG001|Overall Study|Protocol Violation|2|||
144407463|NCT00191269|520702710|FG000|Overall Study|Adverse Event|1|||
144407464|NCT00191269|520702711|FG001|Overall Study|Adverse Event|4|||
144407465|NCT00191269|520702710|FG000|Overall Study|Progression of Disease|4|||
144407466|NCT00191269|520702711|FG001|Overall Study|Progression of Disease|42|||
144407467|NCT00191269|520702710|FG000|Overall Study|Lack of Efficacy|1|||
144407468|NCT00191269|520702711|FG001|Overall Study|Lack of Efficacy|5|||
144407469|NCT00191269|520702710|FG000|Overall Study|Withdrawal by Subject|0|||
144407470|NCT00191269|520702711|FG001|Overall Study|Withdrawal by Subject|1|||
144407471|NCT00191269|520702710|FG000|Overall Study|Pathologic Aggrevation|0|||
144407472|NCT00191269|520702711|FG001|Overall Study|Pathologic Aggrevation|1|||
144407473|NCT00191269|520702710|FG000|Overall Study|Physician Decision|0|||
144407474|NCT00191269|520702711|FG001|Overall Study|Physician Decision|3|||
144407475|NCT00915278|520702719|FG000|Overall Study|Death|1|||
144407476|NCT00915278|520702720|FG001|Overall Study|Death|0|||
144407477|NCT00915278|520702721|FG002|Overall Study|Death|0|||
144407478|NCT00915278|520702722|FG003|Overall Study|Death|0|||
144407479|NCT00915278|520702723|FG004|Overall Study|Death|0|||
144407480|NCT00915278|520702724|FG005|Overall Study|Death|0|||
144407481|NCT00915278|520702719|FG000|Overall Study|Lost to Follow-up|0|||
144407482|NCT00915278|520702720|FG001|Overall Study|Lost to Follow-up|1|||
144407483|NCT00915278|520702721|FG002|Overall Study|Lost to Follow-up|0|||
144407484|NCT00915278|520702722|FG003|Overall Study|Lost to Follow-up|0|||
144407485|NCT00915278|520702723|FG004|Overall Study|Lost to Follow-up|0|||
144407486|NCT00915278|520702724|FG005|Overall Study|Lost to Follow-up|0|||
144407487|NCT00915278|520702719|FG000|Overall Study|Withdrawal by Subject|0|||
144407488|NCT00915278|520702720|FG001|Overall Study|Withdrawal by Subject|1|||
144407489|NCT00915278|520702721|FG002|Overall Study|Withdrawal by Subject|0|||
144407490|NCT00915278|520702722|FG003|Overall Study|Withdrawal by Subject|0|||
144407491|NCT00915278|520702723|FG004|Overall Study|Withdrawal by Subject|1|||
144407492|NCT00915278|520702724|FG005|Overall Study|Withdrawal by Subject|4|||
144407493|NCT00915278|520702719|FG000|Overall Study|Adverse Event|4|||
144407494|NCT00915278|520702720|FG001|Overall Study|Adverse Event|1|||
144407495|NCT00915278|520702721|FG002|Overall Study|Adverse Event|0|||
144407496|NCT00915278|520702722|FG003|Overall Study|Adverse Event|0|||
144407497|NCT00915278|520702723|FG004|Overall Study|Adverse Event|0|||
144407498|NCT00915278|520702724|FG005|Overall Study|Adverse Event|0|||
144407499|NCT00915278|520702719|FG000|Overall Study|Progressive disease/clinical progression|0|||
144407500|NCT00915278|520702720|FG001|Overall Study|Progressive disease/clinical progression|0|||
144407501|NCT00915278|520702721|FG002|Overall Study|Progressive disease/clinical progression|0|||
144407502|NCT00915278|520702722|FG003|Overall Study|Progressive disease/clinical progression|3|||
144407503|NCT00915278|520702723|FG004|Overall Study|Progressive disease/clinical progression|1|||
144407504|NCT00915278|520702724|FG005|Overall Study|Progressive disease/clinical progression|2|||
144407505|NCT00915278|520702719|FG000|Overall Study|Infusion related AEs|0|||
144407506|NCT00915278|520702720|FG001|Overall Study|Infusion related AEs|0|||
144407507|NCT00915278|520702721|FG002|Overall Study|Infusion related AEs|0|||
144407508|NCT00915278|520702722|FG003|Overall Study|Infusion related AEs|0|||
144407509|NCT00915278|520702723|FG004|Overall Study|Infusion related AEs|0|||
144407510|NCT00915278|520702724|FG005|Overall Study|Infusion related AEs|2|||
144407511|NCT00915278|520702719|FG000|Overall Study|Admission to hospice|0|||
144407512|NCT00915278|520702720|FG001|Overall Study|Admission to hospice|0|||
144407513|NCT00915278|520702721|FG002|Overall Study|Admission to hospice|1|||
144407514|NCT00915278|520702722|FG003|Overall Study|Admission to hospice|0|||
144407515|NCT00915278|520702723|FG004|Overall Study|Admission to hospice|0|||
144407516|NCT00915278|520702724|FG005|Overall Study|Admission to hospice|0|||
144407517|NCT03137537|520702732|FG000|Overall Study|Adverse Event|0|||
144407518|NCT03137537|520702733|FG001|Overall Study|Adverse Event|1|||
144407519|NCT04066023|520702734|FG000|Overall Study|Adverse Event|0|||
144407520|NCT04066023|520702735|FG001|Overall Study|Adverse Event|0|||
144407521|NCT04066023|520702736|FG002|Overall Study|Adverse Event|1|||
144407522|NCT04066023|520702734|FG000|Overall Study|Sponsor decision|3|||
144407523|NCT04066023|520702735|FG001|Overall Study|Sponsor decision|6|||
144407524|NCT04066023|520702736|FG002|Overall Study|Sponsor decision|2|||
144407525|NCT04066023|520702734|FG000|Overall Study|Physician Decision|0|||
144407526|NCT04066023|520702735|FG001|Overall Study|Physician Decision|0|||
144407527|NCT04066023|520702736|FG002|Overall Study|Physician Decision|1|||
144407528|NCT04066023|520702734|FG000|Overall Study|Lost to Follow-up|0|||
144407529|NCT04066023|520702735|FG001|Overall Study|Lost to Follow-up|1|||
144407530|NCT04066023|520702736|FG002|Overall Study|Lost to Follow-up|1|||
144407531|NCT04066023|520702734|FG000|Overall Study|Noncompliance|0|||
144407532|NCT04066023|520702735|FG001|Overall Study|Noncompliance|1|||
144407533|NCT04066023|520702736|FG002|Overall Study|Noncompliance|1|||
144407534|NCT01552694|520702737|FG000|Overall Study|Lost to Follow-up|0|||
144407535|NCT01552694|520702738|FG001|Overall Study|Lost to Follow-up|1|||
144407536|NCT01552694|520702737|FG000|Overall Study|Protocol Violation|0|||
144407537|NCT01552694|520702738|FG001|Overall Study|Protocol Violation|1|||
144407538|NCT00191139|520702739|FG000|Overall Study|Adverse Event|2|||
144407539|NCT00191139|520702740|FG001|Overall Study|Adverse Event|6|||
144407540|NCT00191139|520702739|FG000|Overall Study|Death|2|||
144407541|NCT00191139|520702740|FG001|Overall Study|Death|0|||
144407542|NCT00191139|520702739|FG000|Overall Study|Withdrawal by Subject|0|||
144407543|NCT00191139|520702740|FG001|Overall Study|Withdrawal by Subject|3|||
144407544|NCT00191139|520702739|FG000|Overall Study|Disease Progression|0|||
144407545|NCT00191139|520702740|FG001|Overall Study|Disease Progression|1|||
144407546|NCT00191139|520702739|FG000|Overall Study|Other|1|||
144407547|NCT00191139|520702740|FG001|Overall Study|Other|2|||
144407548|NCT02465515|520702744|FG000|Overall Study|Investigator site closed|4|||
144407549|NCT02465515|520702745|FG001|Overall Study|Investigator site closed|5|||
144407550|NCT02465515|520702744|FG000|Overall Study|Withdrawal by Subject|74|||
144407551|NCT02465515|520702745|FG001|Overall Study|Withdrawal by Subject|43|||
144407552|NCT02465515|520702744|FG000|Overall Study|Physician Decision|8|||
144407553|NCT02465515|520702745|FG001|Overall Study|Physician Decision|12|||
144407554|NCT02465515|520702744|FG000|Overall Study|Lost to Follow-up|68|||
144407555|NCT02465515|520702745|FG001|Overall Study|Lost to Follow-up|51|||
144407556|NCT02564796|520702746|FG000|Overall Study|Physician Decision|2|||
144407557|NCT02564796|520702747|FG001|Overall Study|Physician Decision|2|||
144407558|NCT00293033|520702748|FG000|Open-label Titration Period|Adverse Event|10|||
144407559|NCT00293033|520702748|FG000|Open-label Titration Period|Death|3|||
144407560|NCT00293033|520702748|FG000|Open-label Titration Period|Lack of Efficacy|5|||
144407561|NCT00293033|520702748|FG000|Open-label Titration Period|Protocol Violation|2|||
144407562|NCT00293033|520702748|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
144407563|NCT00293033|520702748|FG000|Open-label Titration Period|Noncompliance and other|27|||
144407564|NCT00293033|520702748|FG000|Double-blind Treatment Period|Adverse Event|3|||
144407565|NCT00293033|520702748|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
144407566|NCT00293033|520702748|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
144407567|NCT00293033|520702748|FG000|Double-blind Treatment Period|Noncompliance|4|||
144407568|NCT00453063|520702749|FG000|Overall Study|Adverse Event|1|||
144407569|NCT00453063|520702750|FG001|Overall Study|Adverse Event|2|||
144407570|NCT00453063|520702749|FG000|Overall Study|Withdrawal by Subject|1|||
144407571|NCT00453063|520702750|FG001|Overall Study|Withdrawal by Subject|1|||
144407572|NCT00453063|520702749|FG000|Overall Study|Protocol Violation|1|||
144407573|NCT00453063|520702750|FG001|Overall Study|Protocol Violation|0|||
144407574|NCT00114530|520702751|FG000|Overall Study|Death|3|||
144407575|NCT00114530|520702752|FG001|Overall Study|Death|11|||
144407576|NCT00114530|520702751|FG000|Overall Study|Lost to Follow-up|1|||
144407577|NCT00114530|520702752|FG001|Overall Study|Lost to Follow-up|1|||
144407578|NCT00114530|520702751|FG000|Overall Study|Physician Decision|1|||
144407579|NCT00114530|520702752|FG001|Overall Study|Physician Decision|1|||
144407580|NCT00114530|520702751|FG000|Overall Study|Withdrawal by Subject|2|||
144407581|NCT00114530|520702752|FG001|Overall Study|Withdrawal by Subject|6|||
144407582|NCT00114530|520702751|FG000|Overall Study|Breast Cancer|1|||
144407583|NCT00114530|520702752|FG001|Overall Study|Breast Cancer|0|||
144407584|NCT00114530|520702751|FG000|Overall Study|Subject decision after endpoint failure|0|||
144407585|NCT00114530|520702752|FG001|Overall Study|Subject decision after endpoint failure|1|||
144407586|NCT00114530|520702751|FG000|Overall Study|Ineligible|1|||
144407587|NCT00114530|520702752|FG001|Overall Study|Ineligible|0|||
144407588|NCT00365508|520702754|FG000|Overall Study|Lost to Follow-up|139|||
144407589|NCT00365508|520702755|FG001|Overall Study|Lost to Follow-up|154|||
144407590|NCT00751933|520702758|FG000|Overall Study|Withdrawal by Subject|0|||
144407591|NCT00751933|520702759|FG001|Overall Study|Withdrawal by Subject|1|||
144407592|NCT00751933|520702760|FG002|Overall Study|Withdrawal by Subject|0|||
144407593|NCT00751933|520702761|FG003|Overall Study|Withdrawal by Subject|0|||
144407594|NCT00751933|520702758|FG000|Overall Study|Physician Decision|0|||
144407595|NCT00751933|520702759|FG001|Overall Study|Physician Decision|0|||
144407596|NCT00751933|520702760|FG002|Overall Study|Physician Decision|1|||
144407597|NCT00751933|520702761|FG003|Overall Study|Physician Decision|1|||
144407598|NCT01817530|520702763|FG000|Overall Study|Exclusionary Medication Received|0|||
144407599|NCT01817530|520702764|FG001|Overall Study|Exclusionary Medication Received|0|||
144407600|NCT01817530|520702765|FG002|Overall Study|Exclusionary Medication Received|0|||
144407601|NCT01817530|520702766|FG003|Overall Study|Exclusionary Medication Received|0|||
144407602|NCT01817530|520702767|FG004|Overall Study|Exclusionary Medication Received|1|||
144407603|NCT01817530|520702768|FG005|Overall Study|Exclusionary Medication Received|0|||
144407604|NCT01817530|520702769|FG006|Overall Study|Exclusionary Medication Received|0|||
144407605|NCT01817530|520702770|FG007|Overall Study|Exclusionary Medication Received|0|||
144407606|NCT01817530|520702763|FG000|Overall Study|Adverse Event|6|||
144407607|NCT01817530|520702764|FG001|Overall Study|Adverse Event|3|||
144407608|NCT01817530|520702765|FG002|Overall Study|Adverse Event|2|||
144407609|NCT01817530|520702766|FG003|Overall Study|Adverse Event|5|||
144407610|NCT01817530|520702767|FG004|Overall Study|Adverse Event|0|||
144407611|NCT01817530|520702768|FG005|Overall Study|Adverse Event|10|||
144407612|NCT01817530|520702769|FG006|Overall Study|Adverse Event|5|||
144407613|NCT01817530|520702770|FG007|Overall Study|Adverse Event|8|||
144407614|NCT01817530|520702763|FG000|Overall Study|Subject Noncompliant|3|||
144407615|NCT01817530|520702764|FG001|Overall Study|Subject Noncompliant|1|||
144407616|NCT01817530|520702765|FG002|Overall Study|Subject Noncompliant|0|||
144407617|NCT01817530|520702766|FG003|Overall Study|Subject Noncompliant|4|||
144407618|NCT01817530|520702767|FG004|Overall Study|Subject Noncompliant|0|||
144407619|NCT01817530|520702768|FG005|Overall Study|Subject Noncompliant|1|||
144407620|NCT01817530|520702769|FG006|Overall Study|Subject Noncompliant|1|||
144407621|NCT01817530|520702770|FG007|Overall Study|Subject Noncompliant|1|||
144407622|NCT01817530|520702763|FG000|Overall Study|Lack of Efficacy|1|||
144407623|NCT01817530|520702764|FG001|Overall Study|Lack of Efficacy|0|||
144407624|NCT01817530|520702765|FG002|Overall Study|Lack of Efficacy|0|||
144407625|NCT01817530|520702766|FG003|Overall Study|Lack of Efficacy|0|||
144407626|NCT01817530|520702767|FG004|Overall Study|Lack of Efficacy|0|||
144407627|NCT01817530|520702768|FG005|Overall Study|Lack of Efficacy|1|||
144407628|NCT01817530|520702769|FG006|Overall Study|Lack of Efficacy|0|||
144407629|NCT01817530|520702770|FG007|Overall Study|Lack of Efficacy|1|||
144407630|NCT01817530|520702763|FG000|Overall Study|Pregnancy|0|||
144407631|NCT01817530|520702764|FG001|Overall Study|Pregnancy|0|||
144407632|NCT01817530|520702765|FG002|Overall Study|Pregnancy|0|||
144407633|NCT01817530|520702766|FG003|Overall Study|Pregnancy|0|||
144407634|NCT01817530|520702767|FG004|Overall Study|Pregnancy|0|||
144407635|NCT01817530|520702768|FG005|Overall Study|Pregnancy|1|||
144407636|NCT01817530|520702769|FG006|Overall Study|Pregnancy|0|||
144407637|NCT01817530|520702770|FG007|Overall Study|Pregnancy|0|||
144407638|NCT01817530|520702763|FG000|Overall Study|Other|0|||
144407639|NCT01817530|520702764|FG001|Overall Study|Other|1|||
144407640|NCT01817530|520702765|FG002|Overall Study|Other|0|||
144407641|NCT01817530|520702766|FG003|Overall Study|Other|0|||
144407642|NCT01817530|520702767|FG004|Overall Study|Other|1|||
144407643|NCT01817530|520702768|FG005|Overall Study|Other|0|||
144407644|NCT01817530|520702769|FG006|Overall Study|Other|5|||
144407645|NCT01817530|520702770|FG007|Overall Study|Other|0|||
144407646|NCT01817530|520702763|FG000|Overall Study|Surgery or Invasive Intervention|1|||
144407647|NCT01817530|520702764|FG001|Overall Study|Surgery or Invasive Intervention|0|||
144407648|NCT01817530|520702765|FG002|Overall Study|Surgery or Invasive Intervention|0|||
144407649|NCT01817530|520702766|FG003|Overall Study|Surgery or Invasive Intervention|0|||
144407650|NCT01817530|520702767|FG004|Overall Study|Surgery or Invasive Intervention|1|||
144407651|NCT01817530|520702768|FG005|Overall Study|Surgery or Invasive Intervention|1|||
144407652|NCT01817530|520702769|FG006|Overall Study|Surgery or Invasive Intervention|1|||
144407653|NCT01817530|520702770|FG007|Overall Study|Surgery or Invasive Intervention|0|||
144407654|NCT01817530|520702763|FG000|Overall Study|Consent Withdrawn by Subject|3|||
144407655|NCT01817530|520702764|FG001|Overall Study|Consent Withdrawn by Subject|4|||
144407656|NCT01817530|520702765|FG002|Overall Study|Consent Withdrawn by Subject|7|||
144407657|NCT01817530|520702766|FG003|Overall Study|Consent Withdrawn by Subject|3|||
144407658|NCT01817530|520702767|FG004|Overall Study|Consent Withdrawn by Subject|5|||
144407659|NCT01817530|520702768|FG005|Overall Study|Consent Withdrawn by Subject|3|||
144407660|NCT01817530|520702769|FG006|Overall Study|Consent Withdrawn by Subject|3|||
144407661|NCT01817530|520702770|FG007|Overall Study|Consent Withdrawn by Subject|10|||
144407662|NCT01817530|520702763|FG000|Overall Study|Lost to Follow-up|1|||
144407663|NCT01817530|520702764|FG001|Overall Study|Lost to Follow-up|4|||
144407664|NCT01817530|520702765|FG002|Overall Study|Lost to Follow-up|2|||
144407665|NCT01817530|520702766|FG003|Overall Study|Lost to Follow-up|1|||
144407666|NCT01817530|520702767|FG004|Overall Study|Lost to Follow-up|3|||
144407667|NCT01817530|520702768|FG005|Overall Study|Lost to Follow-up|2|||
144407668|NCT01817530|520702769|FG006|Overall Study|Lost to Follow-up|8|||
144407669|NCT01817530|520702770|FG007|Overall Study|Lost to Follow-up|4|||
144599812|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
144250060|NCT01760447|520113442|FG003|Weeks 0-20|Lost to Follow-up|1|||
144250061|NCT01760447|520113439|FG000|Weeks 0-20|Randomized but not treated|0|||
144250062|NCT01760447|520113440|FG001|Weeks 0-20|Randomized but not treated|0|||
144407670|NCT03846804|520702771|FG000|Overall Study|Refused blood draw|1|||
144407671|NCT03846804|520702771|FG000|Overall Study|Protocol Violation|1|||
144407672|NCT02538029|520702772|FG000|Overall Study|unable to complete cognitive assessments|1|||
144407673|NCT02538029|520702773|FG001|Overall Study|unable to complete cognitive assessments|0|||
144407674|NCT02538029|520702774|FG002|Overall Study|unable to complete cognitive assessments|1|||
144407675|NCT00709761|520705461|FG000|Overall Study|Withdrawal by Subject|8|||
144407676|NCT00709761|520705461|FG000|Overall Study|study closed/terminated|17|||
144407677|NCT00709761|520705461|FG000|Overall Study|Lost to Follow-up|2|||
144250063|NCT01760447|520113441|FG002|Weeks 0-20|Randomized but not treated|2|||
144407678|NCT02200211|520705463|FG000|Overall Study|Lost to Follow-up|7|||
144407679|NCT02200211|520705464|FG001|Overall Study|Lost to Follow-up|7|||
144407680|NCT02200211|520705465|FG002|Overall Study|Lost to Follow-up|1|||
144407681|NCT02200211|520705466|FG003|Overall Study|Lost to Follow-up|2|||
144407682|NCT02200211|520705463|FG000|Overall Study|Withdrawal by Subject|1|||
144407683|NCT02200211|520705464|FG001|Overall Study|Withdrawal by Subject|0|||
144407684|NCT02200211|520705465|FG002|Overall Study|Withdrawal by Subject|0|||
144407685|NCT02200211|520705466|FG003|Overall Study|Withdrawal by Subject|0|||
144407686|NCT00381485|520705467|FG000|Open-Label Run-In Period|Adverse Event|9|||
144407687|NCT00381485|520705468|FG001|Open-Label Run-In Period|Adverse Event|0|||
144407688|NCT00381485|520705469|FG002|Open-Label Run-In Period|Adverse Event|0|||
144407689|NCT00381485|520705470|FG003|Open-Label Run-In Period|Adverse Event|0|||
144407690|NCT00381485|520705467|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
144407691|NCT00381485|520705468|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
144407692|NCT00381485|520705469|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
144407693|NCT00381485|520705470|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
144407694|NCT00381485|520705467|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
144407695|NCT00381485|520705468|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
144407696|NCT00381485|520705469|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
144407697|NCT00381485|520705470|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
144407698|NCT00381485|520705467|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
144407699|NCT00381485|520705468|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
144407700|NCT00381485|520705469|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
144407701|NCT00381485|520705470|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
144407702|NCT00381485|520705467|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
144407703|NCT00381485|520705468|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
144407704|NCT00381485|520705469|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
144407705|NCT00381485|520705470|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
144407706|NCT00381485|520705467|FG000|Open-Label Run-In Period|Treatment failure|1|||
144407707|NCT00381485|520705468|FG001|Open-Label Run-In Period|Treatment failure|0|||
144407708|NCT00381485|520705469|FG002|Open-Label Run-In Period|Treatment failure|0|||
144407709|NCT00381485|520705470|FG003|Open-Label Run-In Period|Treatment failure|0|||
144407710|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144407711|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Adverse Event|2|||
144407712|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Adverse Event|2|||
144407713|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Adverse Event|5|||
144407714|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
144407715|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
144407716|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
144407717|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
144407718|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144407719|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
144407720|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
144407721|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
144407722|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
144407723|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
144407724|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
144407725|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
144407726|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
144407727|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
144407728|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
144407729|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
144407730|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
144407731|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
144407732|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
144407733|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
144525795|NCT04948697|521125723|FG000|Overall Study|Progressive disease|27|||
144525796|NCT04948697|521125724|FG001|Overall Study|Progressive disease|18|||
144525797|NCT04948697|521125723|FG000|Overall Study|Adverse Event|14|||
144525798|NCT04948697|521125724|FG001|Overall Study|Adverse Event|4|||
144525799|NCT04948697|521125723|FG000|Overall Study|Participant moved to long term extension study|7|||
144525800|NCT04948697|521125724|FG001|Overall Study|Participant moved to long term extension study|4|||
144525801|NCT04948697|521125723|FG000|Overall Study|Withdrawal by Subject|10|||
144525802|NCT04948697|521125724|FG001|Overall Study|Withdrawal by Subject|0|||
144525803|NCT04948697|521125723|FG000|Overall Study|Closed by Sponsor|3|||
144525804|NCT04948697|521125724|FG001|Overall Study|Closed by Sponsor|2|||
144525805|NCT04948697|521125723|FG000|Overall Study|Physician Decision|0|||
144525806|NCT04948697|521125724|FG001|Overall Study|Physician Decision|2|||
144407734|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
144407735|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
144407736|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
144525807|NCT04948697|521125723|FG000|Overall Study|Lost to Follow-up|0|||
144525808|NCT04948697|521125724|FG001|Overall Study|Lost to Follow-up|1|||
144525809|NCT04948697|521125723|FG000|Overall Study|Other-Miscellaneous|1|||
144525810|NCT04948697|521125724|FG001|Overall Study|Other-Miscellaneous|0|||
144407737|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
144407738|NCT00381485|520705467|FG000|Double-Blind Treatment Period|Administrative|0|||
144407739|NCT00381485|520705468|FG001|Double-Blind Treatment Period|Administrative|1|||
144407740|NCT00381485|520705469|FG002|Double-Blind Treatment Period|Administrative|0|||
144407741|NCT00381485|520705470|FG003|Double-Blind Treatment Period|Administrative|1|||
144407742|NCT01235351|520705471|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
144407743|NCT01235351|520705472|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
144407744|NCT01918774|520705473|FG000|Overall Study|Lost prior to first CBTw session|4|||
144407745|NCT01918774|520705473|FG000|Overall Study|Lost to Follow-up|1|||
144407746|NCT01606800|520705474|FG000|Overall Study|Adverse Event|3|||
144407747|NCT01606800|520705475|FG001|Overall Study|Adverse Event|1|||
144407748|NCT01606800|520705474|FG000|Overall Study|Participant withdrew consent|0|||
144407749|NCT01606800|520705475|FG001|Overall Study|Participant withdrew consent|1|||
144407750|NCT01606800|520705474|FG000|Overall Study|Missing completion status|2|||
144407751|NCT01606800|520705475|FG001|Overall Study|Missing completion status|0|||
144407752|NCT00042289|520705476|FG000|Overall Study|Lost to Follow-up|3|||
144407753|NCT00042289|520705477|FG001|Overall Study|Lost to Follow-up|0|||
144407754|NCT00042289|520705478|FG002|Overall Study|Lost to Follow-up|0|||
144407755|NCT00042289|520705479|FG003|Overall Study|Lost to Follow-up|1|||
144407756|NCT00042289|520705480|FG004|Overall Study|Lost to Follow-up|3|||
144407757|NCT00042289|520705481|FG005|Overall Study|Lost to Follow-up|3|||
144407758|NCT00042289|520705482|FG006|Overall Study|Lost to Follow-up|6|||
144407759|NCT00042289|520705483|FG007|Overall Study|Lost to Follow-up|1|||
144407760|NCT00042289|520705484|FG008|Overall Study|Lost to Follow-up|1|||
144407761|NCT00042289|520705485|FG009|Overall Study|Lost to Follow-up|0|||
144407762|NCT00042289|520705486|FG010|Overall Study|Lost to Follow-up|0|||
144407763|NCT00042289|520705487|FG011|Overall Study|Lost to Follow-up|0|||
144407764|NCT00042289|520705488|FG012|Overall Study|Lost to Follow-up|0|||
144407765|NCT00042289|520705489|FG013|Overall Study|Lost to Follow-up|0|||
144407766|NCT00042289|520705490|FG014|Overall Study|Lost to Follow-up|0|||
144407767|NCT00042289|520705491|FG015|Overall Study|Lost to Follow-up|1|||
144407768|NCT00042289|520705492|FG016|Overall Study|Lost to Follow-up|1|||
144407769|NCT00042289|520705493|FG017|Overall Study|Lost to Follow-up|0|||
144407770|NCT00042289|520705494|FG018|Overall Study|Lost to Follow-up|3|||
144407771|NCT00042289|520705495|FG019|Overall Study|Lost to Follow-up|2|||
144407772|NCT00042289|520705496|FG020|Overall Study|Lost to Follow-up|0|||
144407773|NCT00042289|520705497|FG021|Overall Study|Lost to Follow-up|0|||
144407774|NCT00042289|520705498|FG022|Overall Study|Lost to Follow-up|0|||
144407775|NCT00042289|520705499|FG023|Overall Study|Lost to Follow-up|0|||
144407776|NCT00042289|520705500|FG024|Overall Study|Lost to Follow-up|0|||
144599813|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
144599814|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
144599815|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
144599816|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
144599817|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
144599818|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
144599819|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
144599820|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
144599821|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
144599822|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
144599823|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
144599824|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
144599825|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
144599826|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
144599827|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
144599828|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
144599829|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
144599830|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
144599831|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
144599832|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
144407777|NCT00042289|520705501|FG025|Overall Study|Lost to Follow-up|0|||
144407778|NCT00042289|520705502|FG026|Overall Study|Lost to Follow-up|2|||
144407779|NCT00042289|520705503|FG027|Overall Study|Lost to Follow-up|2|||
144407780|NCT00042289|520705504|FG028|Overall Study|Lost to Follow-up|2|||
144407781|NCT00042289|520705505|FG029|Overall Study|Lost to Follow-up|0|||
144407782|NCT00042289|520705506|FG030|Overall Study|Lost to Follow-up|0|||
144599833|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
144250064|NCT01760447|520113442|FG003|Weeks 0-20|Randomized but not treated|0|||
144250065|NCT01760447|520113439|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
144407783|NCT00042289|520705507|FG031|Overall Study|Lost to Follow-up|2|||
144407784|NCT00042289|520705508|FG032|Overall Study|Lost to Follow-up|1|||
144407785|NCT00042289|520705509|FG033|Overall Study|Lost to Follow-up|1|||
144407786|NCT00042289|520705510|FG034|Overall Study|Lost to Follow-up|1|||
144599834|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
144599835|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
144407787|NCT00042289|520705511|FG035|Overall Study|Lost to Follow-up|2|||
144407788|NCT00042289|520705512|FG036|Overall Study|Lost to Follow-up|1|||
144407789|NCT00042289|520705513|FG037|Overall Study|Lost to Follow-up|1|||
144407790|NCT00042289|520705514|FG038|Overall Study|Lost to Follow-up|0|||
144407791|NCT00042289|520705515|FG039|Overall Study|Lost to Follow-up|5|||
144407792|NCT00042289|520705516|FG040|Overall Study|Lost to Follow-up|0|||
144407793|NCT00042289|520705517|FG041|Overall Study|Lost to Follow-up|2|||
144407794|NCT00042289|520705518|FG042|Overall Study|Lost to Follow-up|2|||
144407795|NCT00042289|520705519|FG043|Overall Study|Lost to Follow-up|0|||
144407796|NCT00042289|520705520|FG044|Overall Study|Lost to Follow-up|0|||
144407797|NCT00042289|520705521|FG045|Overall Study|Lost to Follow-up|1|||
144407798|NCT00042289|520705522|FG046|Overall Study|Lost to Follow-up|0|||
144407799|NCT00042289|520705476|FG000|Overall Study|Other reason|0|||
144407800|NCT00042289|520705477|FG001|Overall Study|Other reason|0|||
144407801|NCT00042289|520705478|FG002|Overall Study|Other reason|0|||
144407802|NCT00042289|520705479|FG003|Overall Study|Other reason|2|||
144407803|NCT00042289|520705480|FG004|Overall Study|Other reason|0|||
144407804|NCT00042289|520705481|FG005|Overall Study|Other reason|0|||
144407805|NCT00042289|520705482|FG006|Overall Study|Other reason|0|||
144407806|NCT00042289|520705483|FG007|Overall Study|Other reason|0|||
144599836|NCT00908232|521397509|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
144599837|NCT00908232|521397510|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
144599838|NCT00908232|521397511|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
144599839|NCT00908232|521397512|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
144599840|NCT02260882|521397513|FG000|Overall Study|Protocol Violation|0|||
144599841|NCT02260882|521397514|FG001|Overall Study|Protocol Violation|1|||
144599842|NCT02119325|521397515|FG000|Washout Period 1|Adverse Event|0|||
144599843|NCT02119325|521397516|FG001|Washout Period 1|Adverse Event|1|||
144599844|NCT01601847|521397517|FG000|Overall Study|Death|1|||
144599845|NCT01601847|521397518|FG001|Overall Study|Death|0|||
144599846|NCT01601847|521397517|FG000|Overall Study|Withdrawal by Subject|11|||
144599847|NCT01601847|521397518|FG001|Overall Study|Withdrawal by Subject|7|||
144599848|NCT01601847|521397517|FG000|Overall Study|Lost to Follow-up|1|||
144599849|NCT01601847|521397518|FG001|Overall Study|Lost to Follow-up|3|||
144407807|NCT00042289|520705484|FG008|Overall Study|Other reason|0|||
144407808|NCT00042289|520705485|FG009|Overall Study|Other reason|0|||
144407809|NCT00042289|520705486|FG010|Overall Study|Other reason|0|||
144407810|NCT00042289|520705487|FG011|Overall Study|Other reason|0|||
144407811|NCT00042289|520705488|FG012|Overall Study|Other reason|0|||
144407812|NCT00042289|520705489|FG013|Overall Study|Other reason|0|||
144407813|NCT00042289|520705490|FG014|Overall Study|Other reason|0|||
144407814|NCT00042289|520705491|FG015|Overall Study|Other reason|0|||
144407815|NCT00042289|520705492|FG016|Overall Study|Other reason|0|||
144407816|NCT00042289|520705493|FG017|Overall Study|Other reason|0|||
144407817|NCT00042289|520705494|FG018|Overall Study|Other reason|1|||
144407818|NCT00042289|520705495|FG019|Overall Study|Other reason|0|||
144407819|NCT00042289|520705496|FG020|Overall Study|Other reason|0|||
144407820|NCT00042289|520705497|FG021|Overall Study|Other reason|0|||
144407821|NCT00042289|520705498|FG022|Overall Study|Other reason|0|||
144407822|NCT00042289|520705499|FG023|Overall Study|Other reason|1|||
144407823|NCT00042289|520705500|FG024|Overall Study|Other reason|0|||
144407824|NCT00042289|520705501|FG025|Overall Study|Other reason|0|||
144407825|NCT00042289|520705502|FG026|Overall Study|Other reason|1|||
144407826|NCT00042289|520705503|FG027|Overall Study|Other reason|0|||
144407827|NCT00042289|520705504|FG028|Overall Study|Other reason|3|||
144407828|NCT00042289|520705505|FG029|Overall Study|Other reason|0|||
144407829|NCT00042289|520705506|FG030|Overall Study|Other reason|0|||
144407830|NCT00042289|520705507|FG031|Overall Study|Other reason|1|||
144407831|NCT00042289|520705508|FG032|Overall Study|Other reason|0|||
144407832|NCT00042289|520705509|FG033|Overall Study|Other reason|1|||
144407833|NCT00042289|520705510|FG034|Overall Study|Other reason|0|||
144599850|NCT00954174|521397524|FG000|Overall Study|Adverse Event|28|||
144407834|NCT00042289|520705511|FG035|Overall Study|Other reason|2|||
144407835|NCT00042289|520705512|FG036|Overall Study|Other reason|0|||
144407836|NCT00042289|520705513|FG037|Overall Study|Other reason|0|||
144407837|NCT00042289|520705514|FG038|Overall Study|Other reason|0|||
144407838|NCT00042289|520705515|FG039|Overall Study|Other reason|0|||
144407839|NCT00042289|520705516|FG040|Overall Study|Other reason|0|||
144407840|NCT00042289|520705517|FG041|Overall Study|Other reason|0|||
144407841|NCT00042289|520705518|FG042|Overall Study|Other reason|0|||
144599851|NCT00954174|521397525|FG001|Overall Study|Adverse Event|23|||
144599852|NCT00954174|521397526|FG002|Overall Study|Adverse Event|4|||
144599853|NCT00954174|521397527|FG003|Overall Study|Adverse Event|9|||
144407842|NCT00042289|520705519|FG043|Overall Study|Other reason|1|||
144407843|NCT00042289|520705520|FG044|Overall Study|Other reason|0|||
144407844|NCT00042289|520705521|FG045|Overall Study|Other reason|0|||
144407845|NCT00042289|520705522|FG046|Overall Study|Other reason|0|||
144407846|NCT00042289|520705476|FG000|Overall Study|Severe debilitation, unable to continue|0|||
144599854|NCT00954174|521397524|FG000|Overall Study|Death|4|||
144599855|NCT00954174|521397525|FG001|Overall Study|Death|2|||
144407847|NCT00042289|520705477|FG001|Overall Study|Severe debilitation, unable to continue|0|||
144407848|NCT00042289|520705478|FG002|Overall Study|Severe debilitation, unable to continue|0|||
144407849|NCT00042289|520705479|FG003|Overall Study|Severe debilitation, unable to continue|0|||
144407850|NCT00042289|520705480|FG004|Overall Study|Severe debilitation, unable to continue|0|||
144407851|NCT00042289|520705481|FG005|Overall Study|Severe debilitation, unable to continue|0|||
144407852|NCT00042289|520705482|FG006|Overall Study|Severe debilitation, unable to continue|0|||
144407853|NCT00042289|520705483|FG007|Overall Study|Severe debilitation, unable to continue|0|||
144407854|NCT00042289|520705484|FG008|Overall Study|Severe debilitation, unable to continue|0|||
144407855|NCT00042289|520705485|FG009|Overall Study|Severe debilitation, unable to continue|0|||
144407856|NCT00042289|520705486|FG010|Overall Study|Severe debilitation, unable to continue|0|||
144407857|NCT00042289|520705487|FG011|Overall Study|Severe debilitation, unable to continue|0|||
144407858|NCT00042289|520705488|FG012|Overall Study|Severe debilitation, unable to continue|0|||
144407859|NCT00042289|520705489|FG013|Overall Study|Severe debilitation, unable to continue|0|||
144407860|NCT00042289|520705490|FG014|Overall Study|Severe debilitation, unable to continue|0|||
144407861|NCT00042289|520705491|FG015|Overall Study|Severe debilitation, unable to continue|0|||
144407862|NCT00042289|520705492|FG016|Overall Study|Severe debilitation, unable to continue|0|||
144407863|NCT00042289|520705493|FG017|Overall Study|Severe debilitation, unable to continue|0|||
144407864|NCT00042289|520705494|FG018|Overall Study|Severe debilitation, unable to continue|0|||
144407865|NCT00042289|520705495|FG019|Overall Study|Severe debilitation, unable to continue|0|||
144407866|NCT00042289|520705496|FG020|Overall Study|Severe debilitation, unable to continue|0|||
144407867|NCT00042289|520705497|FG021|Overall Study|Severe debilitation, unable to continue|1|||
144407868|NCT00042289|520705498|FG022|Overall Study|Severe debilitation, unable to continue|0|||
144407869|NCT00042289|520705499|FG023|Overall Study|Severe debilitation, unable to continue|1|||
144407870|NCT00042289|520705500|FG024|Overall Study|Severe debilitation, unable to continue|0|||
144407871|NCT00042289|520705501|FG025|Overall Study|Severe debilitation, unable to continue|0|||
144407872|NCT00042289|520705502|FG026|Overall Study|Severe debilitation, unable to continue|0|||
144407873|NCT00042289|520705503|FG027|Overall Study|Severe debilitation, unable to continue|1|||
144407874|NCT00042289|520705504|FG028|Overall Study|Severe debilitation, unable to continue|0|||
144407875|NCT00042289|520705505|FG029|Overall Study|Severe debilitation, unable to continue|0|||
144407876|NCT00042289|520705506|FG030|Overall Study|Severe debilitation, unable to continue|0|||
144407877|NCT00042289|520705507|FG031|Overall Study|Severe debilitation, unable to continue|1|||
144407878|NCT00042289|520705508|FG032|Overall Study|Severe debilitation, unable to continue|1|||
144407879|NCT00042289|520705509|FG033|Overall Study|Severe debilitation, unable to continue|0|||
144407880|NCT00042289|520705510|FG034|Overall Study|Severe debilitation, unable to continue|0|||
144407881|NCT00042289|520705511|FG035|Overall Study|Severe debilitation, unable to continue|0|||
144407882|NCT00042289|520705512|FG036|Overall Study|Severe debilitation, unable to continue|0|||
144407883|NCT00042289|520705513|FG037|Overall Study|Severe debilitation, unable to continue|0|||
144407884|NCT00042289|520705514|FG038|Overall Study|Severe debilitation, unable to continue|0|||
144407885|NCT00042289|520705515|FG039|Overall Study|Severe debilitation, unable to continue|0|||
144407886|NCT00042289|520705516|FG040|Overall Study|Severe debilitation, unable to continue|0|||
144407887|NCT00042289|520705517|FG041|Overall Study|Severe debilitation, unable to continue|0|||
144407888|NCT00042289|520705518|FG042|Overall Study|Severe debilitation, unable to continue|0|||
144407889|NCT00042289|520705519|FG043|Overall Study|Severe debilitation, unable to continue|0|||
144407890|NCT00042289|520705520|FG044|Overall Study|Severe debilitation, unable to continue|0|||
144407891|NCT00042289|520705521|FG045|Overall Study|Severe debilitation, unable to continue|0|||
144407892|NCT00042289|520705522|FG046|Overall Study|Severe debilitation, unable to continue|0|||
144407893|NCT00042289|520705476|FG000|Overall Study|Site closed|0|||
144407894|NCT00042289|520705477|FG001|Overall Study|Site closed|0|||
144407895|NCT00042289|520705478|FG002|Overall Study|Site closed|0|||
144407896|NCT00042289|520705479|FG003|Overall Study|Site closed|0|||
144407897|NCT00042289|520705480|FG004|Overall Study|Site closed|0|||
144599856|NCT00954174|521397526|FG002|Overall Study|Death|0|||
144599857|NCT00954174|521397527|FG003|Overall Study|Death|0|||
144599858|NCT00954174|521397524|FG000|Overall Study|Lack of Efficacy|32|||
144407898|NCT00042289|520705481|FG005|Overall Study|Site closed|0|||
144407899|NCT00042289|520705482|FG006|Overall Study|Site closed|0|||
144407900|NCT00042289|520705483|FG007|Overall Study|Site closed|0|||
144407901|NCT00042289|520705484|FG008|Overall Study|Site closed|0|||
144407902|NCT00042289|520705485|FG009|Overall Study|Site closed|0|||
144407903|NCT00042289|520705486|FG010|Overall Study|Site closed|0|||
144407904|NCT00042289|520705487|FG011|Overall Study|Site closed|0|||
144407905|NCT00042289|520705488|FG012|Overall Study|Site closed|0|||
144407906|NCT00042289|520705489|FG013|Overall Study|Site closed|0|||
144599859|NCT00954174|521397525|FG001|Overall Study|Lack of Efficacy|22|||
144599860|NCT00954174|521397526|FG002|Overall Study|Lack of Efficacy|8|||
144407907|NCT00042289|520705490|FG014|Overall Study|Site closed|0|||
144407908|NCT00042289|520705491|FG015|Overall Study|Site closed|0|||
144407909|NCT00042289|520705492|FG016|Overall Study|Site closed|0|||
144407910|NCT00042289|520705493|FG017|Overall Study|Site closed|0|||
144407911|NCT00042289|520705494|FG018|Overall Study|Site closed|0|||
144407912|NCT00042289|520705495|FG019|Overall Study|Site closed|0|||
144407913|NCT00042289|520705496|FG020|Overall Study|Site closed|0|||
144407914|NCT00042289|520705497|FG021|Overall Study|Site closed|0|||
144407915|NCT00042289|520705498|FG022|Overall Study|Site closed|0|||
144407916|NCT00042289|520705499|FG023|Overall Study|Site closed|0|||
144407917|NCT00042289|520705500|FG024|Overall Study|Site closed|0|||
144407918|NCT00042289|520705501|FG025|Overall Study|Site closed|0|||
144407919|NCT00042289|520705502|FG026|Overall Study|Site closed|0|||
144407920|NCT00042289|520705503|FG027|Overall Study|Site closed|0|||
144407921|NCT00042289|520705504|FG028|Overall Study|Site closed|0|||
144407922|NCT00042289|520705505|FG029|Overall Study|Site closed|0|||
144407923|NCT00042289|520705506|FG030|Overall Study|Site closed|0|||
144407924|NCT00042289|520705507|FG031|Overall Study|Site closed|3|||
144407925|NCT00042289|520705508|FG032|Overall Study|Site closed|0|||
144407926|NCT00042289|520705509|FG033|Overall Study|Site closed|0|||
144407927|NCT00042289|520705510|FG034|Overall Study|Site closed|0|||
144407928|NCT00042289|520705511|FG035|Overall Study|Site closed|0|||
144407929|NCT00042289|520705512|FG036|Overall Study|Site closed|1|||
144407930|NCT00042289|520705513|FG037|Overall Study|Site closed|0|||
144407931|NCT00042289|520705514|FG038|Overall Study|Site closed|0|||
144407932|NCT00042289|520705515|FG039|Overall Study|Site closed|0|||
144407933|NCT00042289|520705516|FG040|Overall Study|Site closed|0|||
144407934|NCT00042289|520705517|FG041|Overall Study|Site closed|0|||
144407935|NCT00042289|520705518|FG042|Overall Study|Site closed|1|||
144407936|NCT00042289|520705519|FG043|Overall Study|Site closed|0|||
144407937|NCT00042289|520705520|FG044|Overall Study|Site closed|0|||
144407938|NCT00042289|520705521|FG045|Overall Study|Site closed|0|||
144407939|NCT00042289|520705522|FG046|Overall Study|Site closed|0|||
144407940|NCT00042289|520705476|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
144407941|NCT00042289|520705477|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
144407942|NCT00042289|520705478|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
144407943|NCT00042289|520705479|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
144407944|NCT00042289|520705480|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
144407945|NCT00042289|520705481|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
144407946|NCT00042289|520705482|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
144407947|NCT00042289|520705483|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
144407948|NCT00042289|520705484|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
144407949|NCT00042289|520705485|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
144407950|NCT00042289|520705486|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
144407951|NCT00042289|520705487|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
144407952|NCT00042289|520705488|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
144407953|NCT00042289|520705489|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
144407954|NCT00042289|520705490|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
144407955|NCT00042289|520705491|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
144407956|NCT00042289|520705492|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
144525811|NCT04948697|521125723|FG000|Overall Study|Randomized but not treated|0|||
144525812|NCT04948697|521125724|FG001|Overall Study|Randomized but not treated|1|||
144525813|NCT04599062|521125726|FG000|Overall Study|Physician Decision|1|||
144525814|NCT04599062|521125727|FG001|Overall Study|Physician Decision|0|||
144525815|NCT01175356|521125733|FG000|Overall Study|Death|1|||
144525816|NCT01175356|521125733|FG000|Overall Study|Lack of Efficacy|12|||
144525817|NCT01175356|521125733|FG000|Overall Study|Lost to Follow-up|1|||
144525818|NCT01175356|521125733|FG000|Overall Study|Physician Decision|23|||
144525819|NCT01175356|521125733|FG000|Overall Study|Ineligible|1|||
144525820|NCT01175356|521125733|FG000|Overall Study|Treatment Slot Not Available|18|||
144525821|NCT01175356|521125733|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
144525822|NCT01175356|521125733|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
144525823|NCT01175356|521125733|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
144407957|NCT00042289|520705493|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
144407958|NCT00042289|520705494|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
144407959|NCT00042289|520705495|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
144407960|NCT00042289|520705496|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
144407961|NCT00042289|520705497|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
144407962|NCT00042289|520705498|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
144407963|NCT00042289|520705499|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
144407964|NCT00042289|520705500|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
144407965|NCT00042289|520705501|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
144407966|NCT00042289|520705502|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
144525824|NCT01175356|521125733|FG000|Overall Study|Inadequate stem cell for transplant|1|||
144407967|NCT00042289|520705503|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
144407968|NCT00042289|520705504|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
144407969|NCT00042289|520705505|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
144407970|NCT00042289|520705506|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
144407971|NCT00042289|520705507|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
144407972|NCT00042289|520705508|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
144407973|NCT00042289|520705509|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
144407974|NCT00042289|520705510|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
144407975|NCT00042289|520705511|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
144407976|NCT00042289|520705512|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
144407977|NCT00042289|520705513|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
144407978|NCT00042289|520705514|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
144407979|NCT00042289|520705515|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
144407980|NCT00042289|520705516|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
144407981|NCT00042289|520705517|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
144407982|NCT00042289|520705518|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
144407983|NCT00042289|520705519|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
144407984|NCT00042289|520705520|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
144407985|NCT00042289|520705521|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
144407986|NCT00042289|520705522|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
144407987|NCT00042289|520705476|FG000|Overall Study|Protocol Violation|0|||
144407988|NCT00042289|520705477|FG001|Overall Study|Protocol Violation|0|||
144407989|NCT00042289|520705478|FG002|Overall Study|Protocol Violation|0|||
144407990|NCT00042289|520705479|FG003|Overall Study|Protocol Violation|0|||
144407991|NCT00042289|520705480|FG004|Overall Study|Protocol Violation|0|||
144407992|NCT00042289|520705481|FG005|Overall Study|Protocol Violation|1|||
144407993|NCT00042289|520705482|FG006|Overall Study|Protocol Violation|0|||
144407994|NCT00042289|520705483|FG007|Overall Study|Protocol Violation|1|||
144407995|NCT00042289|520705484|FG008|Overall Study|Protocol Violation|0|||
144407996|NCT00042289|520705485|FG009|Overall Study|Protocol Violation|0|||
144407997|NCT00042289|520705486|FG010|Overall Study|Protocol Violation|0|||
144407998|NCT00042289|520705487|FG011|Overall Study|Protocol Violation|0|||
144407999|NCT00042289|520705488|FG012|Overall Study|Protocol Violation|0|||
144408000|NCT00042289|520705489|FG013|Overall Study|Protocol Violation|0|||
144408001|NCT00042289|520705490|FG014|Overall Study|Protocol Violation|0|||
144408002|NCT00042289|520705491|FG015|Overall Study|Protocol Violation|0|||
144408003|NCT00042289|520705492|FG016|Overall Study|Protocol Violation|0|||
144408004|NCT00042289|520705493|FG017|Overall Study|Protocol Violation|0|||
144408005|NCT00042289|520705494|FG018|Overall Study|Protocol Violation|0|||
144408006|NCT00042289|520705495|FG019|Overall Study|Protocol Violation|0|||
144408007|NCT00042289|520705496|FG020|Overall Study|Protocol Violation|0|||
144408008|NCT00042289|520705497|FG021|Overall Study|Protocol Violation|0|||
144408009|NCT00042289|520705498|FG022|Overall Study|Protocol Violation|0|||
144408010|NCT00042289|520705499|FG023|Overall Study|Protocol Violation|1|||
144408011|NCT00042289|520705500|FG024|Overall Study|Protocol Violation|1|||
144408012|NCT00042289|520705501|FG025|Overall Study|Protocol Violation|0|||
144408013|NCT00042289|520705502|FG026|Overall Study|Protocol Violation|2|||
144408014|NCT00042289|520705503|FG027|Overall Study|Protocol Violation|0|||
144408015|NCT00042289|520705504|FG028|Overall Study|Protocol Violation|0|||
144408016|NCT00042289|520705505|FG029|Overall Study|Protocol Violation|0|||
144408017|NCT00042289|520705506|FG030|Overall Study|Protocol Violation|1|||
144408018|NCT00042289|520705507|FG031|Overall Study|Protocol Violation|0|||
144408019|NCT00042289|520705508|FG032|Overall Study|Protocol Violation|0|||
144408020|NCT00042289|520705509|FG033|Overall Study|Protocol Violation|0|||
144408021|NCT00042289|520705510|FG034|Overall Study|Protocol Violation|0|||
144408022|NCT00042289|520705511|FG035|Overall Study|Protocol Violation|0|||
144408023|NCT00042289|520705512|FG036|Overall Study|Protocol Violation|0|||
144408024|NCT00042289|520705513|FG037|Overall Study|Protocol Violation|0|||
144408025|NCT00042289|520705514|FG038|Overall Study|Protocol Violation|0|||
144408026|NCT00042289|520705515|FG039|Overall Study|Protocol Violation|0|||
144408027|NCT00042289|520705516|FG040|Overall Study|Protocol Violation|0|||
144408028|NCT00042289|520705517|FG041|Overall Study|Protocol Violation|1|||
144408029|NCT00042289|520705518|FG042|Overall Study|Protocol Violation|1|||
144408030|NCT00042289|520705519|FG043|Overall Study|Protocol Violation|1|||
144408031|NCT00042289|520705520|FG044|Overall Study|Protocol Violation|0|||
144408032|NCT00042289|520705521|FG045|Overall Study|Protocol Violation|0|||
144408033|NCT00042289|520705522|FG046|Overall Study|Protocol Violation|0|||
144408034|NCT00042289|520705476|FG000|Overall Study|Withdrawal by Subject|4|||
144408035|NCT00042289|520705477|FG001|Overall Study|Withdrawal by Subject|1|||
144408036|NCT00042289|520705478|FG002|Overall Study|Withdrawal by Subject|0|||
144408037|NCT00042289|520705479|FG003|Overall Study|Withdrawal by Subject|2|||
144408038|NCT00042289|520705480|FG004|Overall Study|Withdrawal by Subject|0|||
144408039|NCT00042289|520705481|FG005|Overall Study|Withdrawal by Subject|2|||
144408040|NCT00042289|520705482|FG006|Overall Study|Withdrawal by Subject|0|||
144408041|NCT00042289|520705483|FG007|Overall Study|Withdrawal by Subject|0|||
144408042|NCT00042289|520705484|FG008|Overall Study|Withdrawal by Subject|0|||
144408043|NCT00042289|520705485|FG009|Overall Study|Withdrawal by Subject|1|||
144408044|NCT00042289|520705486|FG010|Overall Study|Withdrawal by Subject|0|||
144408045|NCT00042289|520705487|FG011|Overall Study|Withdrawal by Subject|0|||
144408046|NCT00042289|520705488|FG012|Overall Study|Withdrawal by Subject|2|||
144408047|NCT00042289|520705489|FG013|Overall Study|Withdrawal by Subject|0|||
144408048|NCT00042289|520705490|FG014|Overall Study|Withdrawal by Subject|0|||
144408049|NCT00042289|520705491|FG015|Overall Study|Withdrawal by Subject|0|||
144408050|NCT00042289|520705492|FG016|Overall Study|Withdrawal by Subject|0|||
144408051|NCT00042289|520705493|FG017|Overall Study|Withdrawal by Subject|0|||
144408052|NCT00042289|520705494|FG018|Overall Study|Withdrawal by Subject|0|||
144408053|NCT00042289|520705495|FG019|Overall Study|Withdrawal by Subject|0|||
144408054|NCT00042289|520705496|FG020|Overall Study|Withdrawal by Subject|0|||
144408055|NCT00042289|520705497|FG021|Overall Study|Withdrawal by Subject|1|||
144408056|NCT00042289|520705498|FG022|Overall Study|Withdrawal by Subject|1|||
144408057|NCT00042289|520705499|FG023|Overall Study|Withdrawal by Subject|1|||
144408058|NCT00042289|520705500|FG024|Overall Study|Withdrawal by Subject|0|||
144408059|NCT00042289|520705501|FG025|Overall Study|Withdrawal by Subject|0|||
144408060|NCT00042289|520705502|FG026|Overall Study|Withdrawal by Subject|1|||
144408061|NCT00042289|520705503|FG027|Overall Study|Withdrawal by Subject|0|||
144408062|NCT00042289|520705504|FG028|Overall Study|Withdrawal by Subject|2|||
144408063|NCT00042289|520705505|FG029|Overall Study|Withdrawal by Subject|0|||
144408064|NCT00042289|520705506|FG030|Overall Study|Withdrawal by Subject|0|||
144408065|NCT00042289|520705507|FG031|Overall Study|Withdrawal by Subject|1|||
144408066|NCT00042289|520705508|FG032|Overall Study|Withdrawal by Subject|2|||
144408067|NCT00042289|520705509|FG033|Overall Study|Withdrawal by Subject|1|||
144408068|NCT00042289|520705510|FG034|Overall Study|Withdrawal by Subject|0|||
144408069|NCT00042289|520705511|FG035|Overall Study|Withdrawal by Subject|0|||
144408070|NCT00042289|520705512|FG036|Overall Study|Withdrawal by Subject|0|||
144408071|NCT00042289|520705513|FG037|Overall Study|Withdrawal by Subject|1|||
144408072|NCT00042289|520705514|FG038|Overall Study|Withdrawal by Subject|0|||
144408073|NCT00042289|520705515|FG039|Overall Study|Withdrawal by Subject|0|||
144408074|NCT00042289|520705516|FG040|Overall Study|Withdrawal by Subject|0|||
144408075|NCT00042289|520705517|FG041|Overall Study|Withdrawal by Subject|0|||
144408076|NCT00042289|520705518|FG042|Overall Study|Withdrawal by Subject|1|||
144408077|NCT00042289|520705519|FG043|Overall Study|Withdrawal by Subject|0|||
144408078|NCT00042289|520705520|FG044|Overall Study|Withdrawal by Subject|0|||
144408079|NCT00042289|520705521|FG045|Overall Study|Withdrawal by Subject|0|||
144408080|NCT00042289|520705522|FG046|Overall Study|Withdrawal by Subject|0|||
144408081|NCT00717197|520705527|FG000|Overall Study|Unable to purchase study drug|5|||
144408082|NCT00717197|520705527|FG000|Overall Study|Tumor Progression|1|||
144408083|NCT00717197|520705527|FG000|Overall Study|Physician Decision|1|||
144408084|NCT00982137|520705528|FG000|Overall Study|Lost to Follow-up|0|||
144408085|NCT00982137|520705529|FG001|Overall Study|Lost to Follow-up|0|||
144408086|NCT00982137|520705530|FG002|Overall Study|Lost to Follow-up|0|||
144408087|NCT00982137|520705531|FG003|Overall Study|Lost to Follow-up|1|||
144408088|NCT00982137|520705528|FG000|Overall Study|Withdrawal by Subject|0|||
144408089|NCT00982137|520705529|FG001|Overall Study|Withdrawal by Subject|1|||
144408090|NCT00982137|520705530|FG002|Overall Study|Withdrawal by Subject|0|||
144408091|NCT00982137|520705531|FG003|Overall Study|Withdrawal by Subject|0|||
144525825|NCT01175356|521125733|FG000|Overall Study|Initiation other tx prior to completion|9|||
144525826|NCT03058289|521125736|FG000|Overall Study|Radiographic Deterioration|0|||
144525827|NCT03058289|521125737|FG001|Overall Study|Radiographic Deterioration|3|||
144525828|NCT03058289|521125738|FG002|Overall Study|Radiographic Deterioration|1|||
144525829|NCT03058289|521125739|FG003|Overall Study|Radiographic Deterioration|2|||
144525830|NCT03058289|521125740|FG004|Overall Study|Radiographic Deterioration|6|||
144525831|NCT03058289|521125741|FG005|Overall Study|Radiographic Deterioration|3|||
144525832|NCT03058289|521125742|FG006|Overall Study|Radiographic Deterioration|0|||
144525833|NCT03058289|521125743|FG007|Overall Study|Radiographic Deterioration|4|||
144525834|NCT03058289|521125744|FG008|Overall Study|Radiographic Deterioration|2|||
144525835|NCT03058289|521125736|FG000|Overall Study|Adverse Event|2|||
144525836|NCT03058289|521125737|FG001|Overall Study|Adverse Event|0|||
144599861|NCT00954174|521397527|FG003|Overall Study|Lack of Efficacy|6|||
144408092|NCT00126191|520705536|FG000|Overall Study|Physician Decision|0|||
144408093|NCT00126191|520705537|FG001|Overall Study|Physician Decision|1|||
144408094|NCT00126191|520705536|FG000|Overall Study|Death|0|||
144408095|NCT00126191|520705537|FG001|Overall Study|Death|1|||
144408096|NCT01648101|520705538|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
144408097|NCT01648101|520705539|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
144408098|NCT01648101|520705540|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
144408099|NCT01648101|520705538|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
144408100|NCT01648101|520705539|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
144525837|NCT03058289|521125738|FG002|Overall Study|Adverse Event|1|||
144599862|NCT00954174|521397524|FG000|Overall Study|Withdrawal by Subject|14|||
144599863|NCT00954174|521397525|FG001|Overall Study|Withdrawal by Subject|10|||
144599864|NCT00954174|521397526|FG002|Overall Study|Withdrawal by Subject|4|||
144599865|NCT00954174|521397527|FG003|Overall Study|Withdrawal by Subject|3|||
144599866|NCT00954174|521397524|FG000|Overall Study|Medical Reason|4|||
144599867|NCT00954174|521397525|FG001|Overall Study|Medical Reason|2|||
144599868|NCT00954174|521397526|FG002|Overall Study|Medical Reason|1|||
144599869|NCT00954174|521397527|FG003|Overall Study|Medical Reason|0|||
144599870|NCT00954174|521397524|FG000|Overall Study|Ineligible|40|||
144599871|NCT00954174|521397525|FG001|Overall Study|Ineligible|47|||
144599872|NCT00954174|521397526|FG002|Overall Study|Ineligible|7|||
144599873|NCT00954174|521397527|FG003|Overall Study|Ineligible|4|||
144599874|NCT00954174|521397524|FG000|Overall Study|Never Treated|4|||
144599875|NCT00954174|521397525|FG001|Overall Study|Never Treated|17|||
144599876|NCT00954174|521397526|FG002|Overall Study|Never Treated|0|||
144599877|NCT00954174|521397527|FG003|Overall Study|Never Treated|3|||
144599878|NCT02234323|521397528|FG000|All Enrolled|Not Treated: Completed study in database|2|||
144599879|NCT02234323|521397528|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
144599880|NCT02234323|521397528|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
144599881|NCT02234323|521397528|FG000|All Treated|Death|1|||
144599882|NCT02234323|521397528|FG000|All Treated|Physician Decision|5|||
144599883|NCT02234323|521397528|FG000|All Treated|Lack of Efficacy|3|||
144599884|NCT02234323|521397528|FG000|All Treated|Exceeded lab value limit|2|||
144599885|NCT02234323|521397528|FG000|All Treated|Other|7|||
144599886|NCT04209621|521397529|FG000|Overall Study|Death|1|||
144599887|NCT04209621|521397529|FG000|Overall Study|Study Terminated Early|2|||
144599888|NCT02249767|521397530|FG000|Overall Study|Did not use medication|8|||
144599889|NCT02249767|521397531|FG001|Overall Study|Did not use medication|9|||
144599890|NCT02249767|521397532|FG002|Overall Study|Did not use medication|8|||
144599891|NCT01372410|521397533|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
144599892|NCT01372410|521397534|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
144599893|NCT01372410|521397535|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
144599894|NCT01372410|521397536|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
144599895|NCT01372410|521397537|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
144599896|NCT01372410|521397538|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
144599897|NCT01372410|521397539|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
144599898|NCT01372410|521397540|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
144599899|NCT01372410|521397533|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
144599900|NCT01372410|521397534|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
144599901|NCT01372410|521397535|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
144599902|NCT01372410|521397536|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
144599903|NCT01372410|521397537|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
144599904|NCT01372410|521397538|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
144599905|NCT01372410|521397539|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
144599906|NCT01372410|521397540|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
144599907|NCT01372410|521397533|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144599908|NCT01372410|521397534|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144599909|NCT01372410|521397535|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144599910|NCT01372410|521397536|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144599911|NCT01372410|521397537|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
144599912|NCT01372410|521397538|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144599913|NCT01372410|521397539|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144408101|NCT01648101|520705540|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
144408102|NCT01648101|520705538|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
144408103|NCT01648101|520705539|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
144408104|NCT01648101|520705540|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
144408105|NCT01648101|520705538|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
144408106|NCT01648101|520705539|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
144408107|NCT01648101|520705540|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
144408108|NCT01648101|520705538|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
144599914|NCT01372410|521397540|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144599915|NCT01372410|521397533|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144599916|NCT01372410|521397534|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144599917|NCT01372410|521397535|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144599918|NCT01372410|521397536|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144599919|NCT01372410|521397537|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144599920|NCT01372410|521397538|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144599921|NCT01372410|521397539|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
144599922|NCT01372410|521397540|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
144408109|NCT01648101|520705539|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
144599923|NCT01372410|521397533|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
144408110|NCT01648101|520705540|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
144408111|NCT01648101|520705538|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
144408112|NCT01648101|520705539|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
144408113|NCT01648101|520705540|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
144408114|NCT01648101|520705538|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
144599924|NCT01372410|521397534|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
144722640|NCT03349333|521840511|FG000|Overall Study|Other|6|||
144408115|NCT01648101|520705539|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
144408116|NCT01648101|520705540|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
144408117|NCT01648101|520705538|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
144408118|NCT01648101|520705539|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
144408119|NCT01648101|520705540|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
144408120|NCT01648101|520705538|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
144408121|NCT01648101|520705539|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
144408122|NCT01648101|520705540|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
144408123|NCT01648101|520705538|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
144408124|NCT01648101|520705539|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
144408125|NCT01648101|520705540|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
144408126|NCT01648101|520705538|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
144408127|NCT01648101|520705539|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
144408128|NCT01648101|520705540|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
144408129|NCT02469298|520705556|FG000|Overall Study|Protocol Violation|0|||
144408130|NCT02469298|520705557|FG001|Overall Study|Protocol Violation|1|||
144408131|NCT02469298|520705558|FG002|Overall Study|Protocol Violation|1|||
144408132|NCT02469298|520705559|FG003|Overall Study|Protocol Violation|0|||
144408133|NCT02469298|520705556|FG000|Overall Study|Lost to Follow-up|1|||
144408134|NCT02469298|520705557|FG001|Overall Study|Lost to Follow-up|0|||
144408135|NCT02469298|520705558|FG002|Overall Study|Lost to Follow-up|1|||
144408136|NCT02469298|520705559|FG003|Overall Study|Lost to Follow-up|0|||
144408137|NCT02469298|520705556|FG000|Overall Study|Physician Decision|0|||
144408138|NCT02469298|520705557|FG001|Overall Study|Physician Decision|0|||
144408139|NCT02469298|520705558|FG002|Overall Study|Physician Decision|0|||
144408140|NCT02469298|520705559|FG003|Overall Study|Physician Decision|1|||
144408141|NCT02469298|520705556|FG000|Overall Study|Withdrawal by Subject|0|||
144408142|NCT02469298|520705557|FG001|Overall Study|Withdrawal by Subject|0|||
144408143|NCT02469298|520705558|FG002|Overall Study|Withdrawal by Subject|0|||
144408144|NCT02469298|520705559|FG003|Overall Study|Withdrawal by Subject|1|||
144408145|NCT00307294|520705560|FG000|Overall Study|Withdrawal by Subject|1|||
144408146|NCT03311724|520705563|FG000|Overall Study|Physician Decision|0|||
144408147|NCT03311724|520705564|FG001|Overall Study|Physician Decision|0|||
144408148|NCT03311724|520705565|FG002|Overall Study|Physician Decision|0|||
144408149|NCT03311724|520705566|FG003|Overall Study|Physician Decision|1|||
144408150|NCT03311724|520705563|FG000|Overall Study|Protocol Violation|1|||
144408151|NCT03311724|520705564|FG001|Overall Study|Protocol Violation|0|||
144408152|NCT03311724|520705565|FG002|Overall Study|Protocol Violation|1|||
144408153|NCT03311724|520705566|FG003|Overall Study|Protocol Violation|0|||
144408154|NCT03311724|520705563|FG000|Overall Study|Withdrawal by Subject|1|||
144408155|NCT03311724|520705564|FG001|Overall Study|Withdrawal by Subject|1|||
144408156|NCT03311724|520705565|FG002|Overall Study|Withdrawal by Subject|0|||
144408157|NCT03311724|520705566|FG003|Overall Study|Withdrawal by Subject|0|||
144408158|NCT03311724|520705563|FG000|Overall Study|Lost to Follow-up|1|||
144408159|NCT03311724|520705564|FG001|Overall Study|Lost to Follow-up|0|||
144408160|NCT03311724|520705565|FG002|Overall Study|Lost to Follow-up|0|||
144408161|NCT03311724|520705566|FG003|Overall Study|Lost to Follow-up|0|||
144525838|NCT03058289|521125739|FG003|Overall Study|Adverse Event|3|||
144525839|NCT03058289|521125740|FG004|Overall Study|Adverse Event|1|||
144525840|NCT03058289|521125741|FG005|Overall Study|Adverse Event|0|||
144525841|NCT03058289|521125742|FG006|Overall Study|Adverse Event|1|||
144525842|NCT03058289|521125743|FG007|Overall Study|Adverse Event|3|||
144525843|NCT03058289|521125744|FG008|Overall Study|Adverse Event|0|||
144525844|NCT03058289|521125736|FG000|Overall Study|Withdrawal by Subject|0|||
144525845|NCT03058289|521125737|FG001|Overall Study|Withdrawal by Subject|0|||
144525846|NCT03058289|521125738|FG002|Overall Study|Withdrawal by Subject|0|||
144525847|NCT03058289|521125739|FG003|Overall Study|Withdrawal by Subject|2|||
144525848|NCT03058289|521125740|FG004|Overall Study|Withdrawal by Subject|0|||
144525849|NCT03058289|521125741|FG005|Overall Study|Withdrawal by Subject|2|||
144525850|NCT03058289|521125742|FG006|Overall Study|Withdrawal by Subject|0|||
144525851|NCT03058289|521125743|FG007|Overall Study|Withdrawal by Subject|4|||
144525852|NCT03058289|521125744|FG008|Overall Study|Withdrawal by Subject|1|||
144525853|NCT03058289|521125736|FG000|Overall Study|Physician Decision|1|||
144525854|NCT03058289|521125737|FG001|Overall Study|Physician Decision|0|||
144525855|NCT03058289|521125738|FG002|Overall Study|Physician Decision|0|||
144525856|NCT03058289|521125739|FG003|Overall Study|Physician Decision|2|||
144525857|NCT03058289|521125740|FG004|Overall Study|Physician Decision|1|||
144525858|NCT03058289|521125741|FG005|Overall Study|Physician Decision|0|||
144525859|NCT03058289|521125742|FG006|Overall Study|Physician Decision|2|||
144525860|NCT03058289|521125743|FG007|Overall Study|Physician Decision|3|||
144408162|NCT03311724|520705563|FG000|Overall Study|Sponsor Decision|0|||
144408163|NCT03311724|520705564|FG001|Overall Study|Sponsor Decision|0|||
144408164|NCT03311724|520705565|FG002|Overall Study|Sponsor Decision|1|||
144408165|NCT03311724|520705566|FG003|Overall Study|Sponsor Decision|0|||
144408166|NCT01575769|520705567|FG000|Overall Study|Adverse Event|1|||
144408167|NCT01575769|520705567|FG000|Overall Study|Study terminated by sponsor|40|||
144408168|NCT03000439|520705570|FG000|Open Label Part 1|Adverse Event|6|||
144408169|NCT03000439|520705571|FG001|Open Label Part 1|Adverse Event|0|||
144408170|NCT03000439|520705572|FG002|Open Label Part 1|Adverse Event|0|||
144408171|NCT03000439|520705573|FG003|Open Label Part 1|Adverse Event|0|||
144408172|NCT03000439|520705570|FG000|Open Label Part 1|Other|2|||
144408173|NCT03000439|520705571|FG001|Open Label Part 1|Other|0|||
144408174|NCT03000439|520705572|FG002|Open Label Part 1|Other|0|||
144408175|NCT03000439|520705573|FG003|Open Label Part 1|Other|0|||
144408176|NCT03000439|520705570|FG000|Open Label Part 1|Insufficient clinical response|16|||
144408177|NCT03000439|520705571|FG001|Open Label Part 1|Insufficient clinical response|0|||
144408178|NCT03000439|520705572|FG002|Open Label Part 1|Insufficient clinical response|0|||
144408179|NCT03000439|520705573|FG003|Open Label Part 1|Insufficient clinical response|0|||
144408180|NCT03000439|520705570|FG000|Open Label Part 2|Other|0|||
144408181|NCT03000439|520705571|FG001|Open Label Part 2|Other|5|||
144408182|NCT03000439|520705572|FG002|Open Label Part 2|Other|0|||
144408183|NCT03000439|520705573|FG003|Open Label Part 2|Other|0|||
144408184|NCT03000439|520705570|FG000|Open Label Part 2|Insufficient clinical response|0|||
144408185|NCT03000439|520705571|FG001|Open Label Part 2|Insufficient clinical response|12|||
144408186|NCT03000439|520705572|FG002|Open Label Part 2|Insufficient clinical response|0|||
144408187|NCT03000439|520705573|FG003|Open Label Part 2|Insufficient clinical response|0|||
144408188|NCT03000439|520705570|FG000|Double Blind Phase|Adverse Event|0|||
144408189|NCT03000439|520705571|FG001|Double Blind Phase|Adverse Event|0|||
144408190|NCT03000439|520705572|FG002|Double Blind Phase|Adverse Event|2|||
144408191|NCT03000439|520705573|FG003|Double Blind Phase|Adverse Event|1|||
144408192|NCT03000439|520705570|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
144408193|NCT03000439|520705571|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
144408194|NCT03000439|520705572|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
144408195|NCT03000439|520705573|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
144525861|NCT03058289|521125744|FG008|Overall Study|Physician Decision|0|||
144408196|NCT03000439|520705570|FG000|Double Blind Phase|Other|0|||
144408197|NCT03000439|520705571|FG001|Double Blind Phase|Other|0|||
144525862|NCT03058289|521125736|FG000|Overall Study|Clinical Deterioration|2|||
144525863|NCT03058289|521125737|FG001|Overall Study|Clinical Deterioration|0|||
144525864|NCT03058289|521125738|FG002|Overall Study|Clinical Deterioration|0|||
144525865|NCT03058289|521125739|FG003|Overall Study|Clinical Deterioration|2|||
144525866|NCT03058289|521125740|FG004|Overall Study|Clinical Deterioration|1|||
144525867|NCT03058289|521125741|FG005|Overall Study|Clinical Deterioration|1|||
144525868|NCT03058289|521125742|FG006|Overall Study|Clinical Deterioration|0|||
144525869|NCT03058289|521125743|FG007|Overall Study|Clinical Deterioration|3|||
144525870|NCT03058289|521125744|FG008|Overall Study|Clinical Deterioration|2|||
144525871|NCT03058289|521125736|FG000|Overall Study|Lost to Follow-up|0|||
144525872|NCT03058289|521125737|FG001|Overall Study|Lost to Follow-up|0|||
144525873|NCT03058289|521125738|FG002|Overall Study|Lost to Follow-up|0|||
144599925|NCT01372410|521397535|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
144599926|NCT01372410|521397536|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
144599927|NCT01372410|521397537|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
144599928|NCT01372410|521397538|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
144599929|NCT01372410|521397539|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
144599930|NCT01372410|521397540|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
144599931|NCT01372410|521397533|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144599932|NCT01372410|521397534|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144599933|NCT01372410|521397535|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144599934|NCT01372410|521397536|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144599935|NCT01372410|521397537|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
144599936|NCT01372410|521397538|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144599937|NCT01372410|521397539|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144599938|NCT01372410|521397540|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
144408198|NCT03000439|520705572|FG002|Double Blind Phase|Other|10|||
144408199|NCT03000439|520705573|FG003|Double Blind Phase|Other|11|||
144525874|NCT03058289|521125739|FG003|Overall Study|Lost to Follow-up|0|||
144408200|NCT03000439|520705570|FG000|Double Blind Phase|Insufficient clinical response|0|||
144408201|NCT03000439|520705571|FG001|Double Blind Phase|Insufficient clinical response|0|||
144408202|NCT03000439|520705572|FG002|Double Blind Phase|Insufficient clinical response|0|||
144408203|NCT03000439|520705573|FG003|Double Blind Phase|Insufficient clinical response|2|||
144408204|NCT02370160|520705576|FG000|Overall Study|Death|3|||
144408205|NCT02370160|520705577|FG001|Overall Study|Death|4|||
144408206|NCT02370160|520705578|FG002|Overall Study|Death|1|||
144408207|NCT02501473|520705583|FG000|Overall Study|Study Terminated|2|||
144525875|NCT03058289|521125740|FG004|Overall Study|Lost to Follow-up|1|||
144525876|NCT03058289|521125741|FG005|Overall Study|Lost to Follow-up|0|||
144408208|NCT02501473|520705584|FG001|Overall Study|Study Terminated|3|||
144408209|NCT02501473|520705585|FG002|Overall Study|Study Terminated|7|||
144408210|NCT02501473|520705586|FG003|Overall Study|Study Terminated|9|||
144408211|NCT02501473|520705587|FG004|Overall Study|Study Terminated|2|||
144408212|NCT02501473|520705588|FG005|Overall Study|Study Terminated|10|||
144408213|NCT02501473|520705589|FG006|Overall Study|Study Terminated|1|||
144408214|NCT02501473|520705590|FG007|Overall Study|Study Terminated|0|||
144408215|NCT02501473|520705583|FG000|Overall Study|Withdrawal by Subject|0|||
144408216|NCT02501473|520705584|FG001|Overall Study|Withdrawal by Subject|0|||
144408217|NCT02501473|520705585|FG002|Overall Study|Withdrawal by Subject|3|||
144408218|NCT02501473|520705586|FG003|Overall Study|Withdrawal by Subject|3|||
144408219|NCT02501473|520705587|FG004|Overall Study|Withdrawal by Subject|2|||
144408220|NCT02501473|520705588|FG005|Overall Study|Withdrawal by Subject|2|||
144408221|NCT02501473|520705589|FG006|Overall Study|Withdrawal by Subject|0|||
144408222|NCT02501473|520705590|FG007|Overall Study|Withdrawal by Subject|0|||
144408223|NCT02501473|520705583|FG000|Overall Study|Death|0|||
144408224|NCT02501473|520705584|FG001|Overall Study|Death|0|||
144408225|NCT02501473|520705585|FG002|Overall Study|Death|1|||
144408226|NCT02501473|520705586|FG003|Overall Study|Death|1|||
144408227|NCT02501473|520705587|FG004|Overall Study|Death|0|||
144408228|NCT02501473|520705588|FG005|Overall Study|Death|1|||
144408229|NCT02501473|520705589|FG006|Overall Study|Death|0|||
144408230|NCT02501473|520705590|FG007|Overall Study|Death|0|||
144408231|NCT02501473|520705583|FG000|Overall Study|Lost to Follow-up|1|||
144408232|NCT02501473|520705584|FG001|Overall Study|Lost to Follow-up|0|||
144408233|NCT02501473|520705585|FG002|Overall Study|Lost to Follow-up|1|||
144408234|NCT02501473|520705586|FG003|Overall Study|Lost to Follow-up|0|||
144408235|NCT02501473|520705587|FG004|Overall Study|Lost to Follow-up|0|||
144408236|NCT02501473|520705588|FG005|Overall Study|Lost to Follow-up|1|||
144408237|NCT02501473|520705589|FG006|Overall Study|Lost to Follow-up|0|||
144408238|NCT02501473|520705590|FG007|Overall Study|Lost to Follow-up|0|||
144408239|NCT02501473|520705583|FG000|Overall Study|Reason not specified|0|||
144408240|NCT02501473|520705584|FG001|Overall Study|Reason not specified|0|||
144408241|NCT02501473|520705585|FG002|Overall Study|Reason not specified|1|||
144408242|NCT02501473|520705586|FG003|Overall Study|Reason not specified|1|||
144408243|NCT02501473|520705587|FG004|Overall Study|Reason not specified|0|||
144408244|NCT02501473|520705588|FG005|Overall Study|Reason not specified|0|||
144408245|NCT02501473|520705589|FG006|Overall Study|Reason not specified|0|||
144408246|NCT02501473|520705590|FG007|Overall Study|Reason not specified|0|||
144408247|NCT01581931|520705591|FG000|Washout|Adverse Event|0|||
144525877|NCT03058289|521125742|FG006|Overall Study|Lost to Follow-up|0|||
144525878|NCT03058289|521125743|FG007|Overall Study|Lost to Follow-up|0|||
144525879|NCT03058289|521125744|FG008|Overall Study|Lost to Follow-up|0|||
144525880|NCT03058289|521125736|FG000|Overall Study|Refused Further Treatment|0|||
144525881|NCT03058289|521125737|FG001|Overall Study|Refused Further Treatment|0|||
144408248|NCT01581931|520705592|FG001|Washout|Adverse Event|1|||
144525882|NCT03058289|521125738|FG002|Overall Study|Refused Further Treatment|1|||
144525883|NCT03058289|521125739|FG003|Overall Study|Refused Further Treatment|0|||
144525884|NCT03058289|521125740|FG004|Overall Study|Refused Further Treatment|1|||
144525885|NCT03058289|521125741|FG005|Overall Study|Refused Further Treatment|0|||
144525886|NCT03058289|521125742|FG006|Overall Study|Refused Further Treatment|0|||
144525887|NCT03058289|521125743|FG007|Overall Study|Refused Further Treatment|0|||
144525888|NCT03058289|521125744|FG008|Overall Study|Refused Further Treatment|0|||
144525889|NCT03058289|521125736|FG000|Overall Study|Rapid Progression of Disease|0|||
144525890|NCT03058289|521125737|FG001|Overall Study|Rapid Progression of Disease|0|||
144525891|NCT03058289|521125738|FG002|Overall Study|Rapid Progression of Disease|0|||
144525892|NCT03058289|521125739|FG003|Overall Study|Rapid Progression of Disease|1|||
144525893|NCT03058289|521125740|FG004|Overall Study|Rapid Progression of Disease|0|||
144408249|NCT05275400|520705597|FG000|Treatment Period|Adverse Event|7|||
144525894|NCT03058289|521125741|FG005|Overall Study|Rapid Progression of Disease|0|||
144525895|NCT03058289|521125742|FG006|Overall Study|Rapid Progression of Disease|0|||
144525896|NCT03058289|521125743|FG007|Overall Study|Rapid Progression of Disease|0|||
144408250|NCT05275400|520705598|FG001|Treatment Period|Adverse Event|1|||
144408251|NCT05275400|520705597|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
144408252|NCT05275400|520705598|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
144408253|NCT05275400|520705597|FG000|Treatment Period|Death|5|||
144408254|NCT05275400|520705598|FG001|Treatment Period|Death|2|||
144408255|NCT05275400|520705597|FG000|Treatment Period|Protocol Violation|1|||
144408256|NCT05275400|520705598|FG001|Treatment Period|Protocol Violation|0|||
144408257|NCT05275400|520705597|FG000|Treatment Period|Physician Decision|5|||
144408258|NCT05275400|520705598|FG001|Treatment Period|Physician Decision|4|||
144408259|NCT05275400|520705597|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
144408260|NCT05275400|520705598|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
144408261|NCT05275400|520705597|FG000|Treatment Period|Withdrawal by Subject|30|||
144408262|NCT05275400|520705598|FG001|Treatment Period|Withdrawal by Subject|12|||
144408263|NCT05275400|520705597|FG000|Treatment Period|Lost to Follow-up|1|||
144408264|NCT05275400|520705598|FG001|Treatment Period|Lost to Follow-up|5|||
144408265|NCT05275400|520705597|FG000|Treatment Period|Lack of Efficacy|1|||
144408266|NCT05275400|520705598|FG001|Treatment Period|Lack of Efficacy|0|||
144408267|NCT05275400|520705597|FG000|Treatment Period|Sponsor Decision|1|||
144408268|NCT05275400|520705598|FG001|Treatment Period|Sponsor Decision|0|||
144408269|NCT05275400|520705597|FG000|Follow-Up Period|Death|2|||
144408270|NCT05275400|520705598|FG001|Follow-Up Period|Death|0|||
144408271|NCT05275400|520705597|FG000|Follow-Up Period|Protocol Violation|1|||
144408272|NCT05275400|520705598|FG001|Follow-Up Period|Protocol Violation|0|||
144408273|NCT05275400|520705597|FG000|Follow-Up Period|Withdrawal by Subject|3|||
144408274|NCT05275400|520705598|FG001|Follow-Up Period|Withdrawal by Subject|0|||
144408275|NCT03478930|520705600|FG000|Overall Study|Adverse Event|0|||
144408276|NCT03478930|520705601|FG001|Overall Study|Adverse Event|1|||
144408277|NCT03478930|520705600|FG000|Overall Study|Lack of Efficacy|3|||
144408278|NCT03478930|520705601|FG001|Overall Study|Lack of Efficacy|3|||
144408279|NCT03478930|520705600|FG000|Overall Study|Withdrawal by Subject|6|||
144408280|NCT03478930|520705601|FG001|Overall Study|Withdrawal by Subject|5|||
144408281|NCT04189081|520705602|FG000|Overall Study|Lost to Follow-up|1|||
144408282|NCT04189081|520705603|FG001|Overall Study|Lost to Follow-up|0|||
144408283|NCT04189081|520705604|FG002|Overall Study|Lost to Follow-up|0|||
144408284|NCT04189081|520705602|FG000|Overall Study|Withdrawal by Subject|0|||
144408285|NCT04189081|520705603|FG001|Overall Study|Withdrawal by Subject|0|||
144408286|NCT04189081|520705604|FG002|Overall Study|Withdrawal by Subject|1|||
144408287|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
144408288|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
144408289|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
144408290|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
144408291|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
144408292|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
144408293|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
144408294|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
144408295|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
144408296|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
144408297|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
144408298|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
144408299|NCT00044083|520705605|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
144408300|NCT00044083|520705606|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
144408301|NCT00044083|520705605|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
144408302|NCT00044083|520705606|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
144408303|NCT00044083|520705605|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
144408304|NCT00044083|520705606|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
144408305|NCT00044083|520705605|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
144408306|NCT00044083|520705606|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
144408307|NCT00288054|520705607|FG000|Overall Study|Protocol Violation|2|||
144408308|NCT00288054|520705607|FG000|Overall Study|Lack of Efficacy|16|||
144408309|NCT00288054|520705607|FG000|Overall Study|Adverse Event|3|||
144408310|NCT00288054|520705607|FG000|Overall Study|Withdrawal by Subject|1|||
144408311|NCT00288054|520705607|FG000|Overall Study|Not protocol specified|2|||
144408312|NCT00289991|520705608|FG000|Overall Study|Death|35|||
144408313|NCT00289991|520705609|FG001|Overall Study|Death|38|||
144408314|NCT00289991|520705608|FG000|Overall Study|Adverse Event|15|||
144408315|NCT00289991|520705609|FG001|Overall Study|Adverse Event|13|||
144408316|NCT00289991|520705608|FG000|Overall Study|Failure of prophylaxis|1|||
144408317|NCT00289991|520705609|FG001|Overall Study|Failure of prophylaxis|1|||
144408318|NCT00289991|520705608|FG000|Overall Study|Fungal breakthrough infection|0|||
144408319|NCT00289991|520705609|FG001|Overall Study|Fungal breakthrough infection|1|||
144408320|NCT00289991|520705608|FG000|Overall Study|Lost to Follow-up|0|||
144408321|NCT00289991|520705609|FG001|Overall Study|Lost to Follow-up|1|||
144408322|NCT00289991|520705608|FG000|Overall Study|Withdrawal by Subject|2|||
144408323|NCT00289991|520705609|FG001|Overall Study|Withdrawal by Subject|12|||
144408324|NCT00289991|520705608|FG000|Overall Study|Other|5|||
144408325|NCT00289991|520705609|FG001|Overall Study|Other|14|||
144408326|NCT00851747|520705625|FG000|Overall Study|Physician Decision|6|||
144408327|NCT00851747|520705626|FG001|Overall Study|Physician Decision|6|||
144408328|NCT00851747|520705627|FG002|Overall Study|Physician Decision|6|||
144408329|NCT02340975|520705628|FG000|Overall Study|Death|6|||
144408330|NCT02340975|520705629|FG001|Overall Study|Death|23|||
144408331|NCT02340975|520705630|FG002|Overall Study|Death|21|||
144408332|NCT02340975|520705631|FG003|Overall Study|Death|7|||
144408333|NCT02340975|520705632|FG004|Overall Study|Death|21|||
144250066|NCT01760447|520113440|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
144250067|NCT01760447|520113441|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
144408334|NCT02340975|520705633|FG005|Overall Study|Death|13|||
144408335|NCT02340975|520705628|FG000|Overall Study|Lost to Follow-up|0|||
144408336|NCT02340975|520705629|FG001|Overall Study|Lost to Follow-up|0|||
144408337|NCT02340975|520705630|FG002|Overall Study|Lost to Follow-up|0|||
144408338|NCT02340975|520705631|FG003|Overall Study|Lost to Follow-up|0|||
144408339|NCT02340975|520705632|FG004|Overall Study|Lost to Follow-up|2|||
144408340|NCT02340975|520705633|FG005|Overall Study|Lost to Follow-up|0|||
144250068|NCT01760447|520113442|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
144250069|NCT01760447|520113439|FG000|Weeks 20-54|Withdrawal by Subject|2|||
144250070|NCT01760447|520113440|FG001|Weeks 20-54|Withdrawal by Subject|1|||
144525897|NCT03058289|521125744|FG008|Overall Study|Rapid Progression of Disease|0|||
144525898|NCT03800654|521125745|FG000|Overall Study|Time constraints|3|||
144525899|NCT03800654|521125746|FG001|Overall Study|Time constraints|3|||
144525900|NCT03800654|521125747|FG002|Overall Study|Time constraints|3|||
144525901|NCT03800654|521125745|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
144525902|NCT03800654|521125746|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
144525903|NCT03800654|521125747|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
144525904|NCT03800654|521125745|FG000|Overall Study|Lost to Follow-up|2|||
144525905|NCT03800654|521125746|FG001|Overall Study|Lost to Follow-up|1|||
144525906|NCT03800654|521125747|FG002|Overall Study|Lost to Follow-up|6|||
144525907|NCT03800654|521125745|FG000|Overall Study|Medical Health Issue|0|||
144525908|NCT03800654|521125746|FG001|Overall Study|Medical Health Issue|0|||
144525909|NCT03800654|521125747|FG002|Overall Study|Medical Health Issue|1|||
144525910|NCT03800654|521125745|FG000|Overall Study|Personal Issues|0|||
144525911|NCT03800654|521125746|FG001|Overall Study|Personal Issues|2|||
144525912|NCT03800654|521125747|FG002|Overall Study|Personal Issues|0|||
144525913|NCT03800654|521125745|FG000|Overall Study|Protocol Violation|0|||
144525914|NCT03800654|521125746|FG001|Overall Study|Protocol Violation|1|||
144525915|NCT03800654|521125747|FG002|Overall Study|Protocol Violation|0|||
144525916|NCT04081103|521125749|FG000|Overall Study|Adverse Event|1|||
144525917|NCT04081103|521125750|FG001|Overall Study|Adverse Event|1|||
144525918|NCT04081103|521125751|FG002|Overall Study|Adverse Event|1|||
144525919|NCT04081103|521125749|FG000|Overall Study|Physician Decision|0|||
144525920|NCT04081103|521125750|FG001|Overall Study|Physician Decision|0|||
144525921|NCT04081103|521125751|FG002|Overall Study|Physician Decision|1|||
144525922|NCT03365882|521125754|FG000|Randomization|Still Receiving Protocol Treatment|2|||
144525923|NCT03365882|521125755|FG001|Randomization|Still Receiving Protocol Treatment|0|||
144525924|NCT03365882|521125754|FG000|Randomization|Adverse Event|1|||
144525925|NCT03365882|521125755|FG001|Randomization|Adverse Event|2|||
144250071|NCT01760447|520113441|FG002|Weeks 20-54|Withdrawal by Subject|1|||
144525926|NCT03365882|521125754|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
144408341|NCT02340975|520705628|FG000|Overall Study|Withdrawal by Subject|0|||
144408342|NCT02340975|520705629|FG001|Overall Study|Withdrawal by Subject|0|||
144408343|NCT02340975|520705630|FG002|Overall Study|Withdrawal by Subject|3|||
144408344|NCT02340975|520705631|FG003|Overall Study|Withdrawal by Subject|3|||
144408345|NCT02340975|520705632|FG004|Overall Study|Withdrawal by Subject|2|||
144408346|NCT02340975|520705633|FG005|Overall Study|Withdrawal by Subject|0|||
144408347|NCT02340975|520705628|FG000|Overall Study|Other|0|||
144408348|NCT02340975|520705629|FG001|Overall Study|Other|4|||
144408349|NCT02340975|520705630|FG002|Overall Study|Other|0|||
144408350|NCT02340975|520705631|FG003|Overall Study|Other|2|||
144408351|NCT02340975|520705632|FG004|Overall Study|Other|0|||
144408352|NCT02340975|520705633|FG005|Overall Study|Other|6|||
144408353|NCT01007812|520705636|FG000|Period 1, One Week|Lost to Follow-up|0|||
144408354|NCT01007812|520705637|FG001|Period 1, One Week|Lost to Follow-up|1|||
144408355|NCT01007812|520705636|FG000|Period 1, One Week|Discomfort|1|||
144408356|NCT01007812|520705637|FG001|Period 1, One Week|Discomfort|0|||
144408357|NCT01091974|520705640|FG000|Overall Study|Did not start intervention|3|||
144408358|NCT01091974|520705641|FG001|Overall Study|Did not start intervention|1|||
144408359|NCT01091974|520705642|FG002|Overall Study|Did not start intervention|3|||
144408360|NCT01091974|520705643|FG003|Overall Study|Did not start intervention|1|||
144408361|NCT01091974|520705640|FG000|Overall Study|resumed sleep medication|0|||
144408362|NCT01091974|520705641|FG001|Overall Study|resumed sleep medication|0|||
144408363|NCT01091974|520705642|FG002|Overall Study|resumed sleep medication|1|||
144408364|NCT01091974|520705643|FG003|Overall Study|resumed sleep medication|2|||
144408365|NCT01091974|520705640|FG000|Overall Study|Withdrawal by Subject|1|||
144408366|NCT01091974|520705641|FG001|Overall Study|Withdrawal by Subject|3|||
144408367|NCT01091974|520705642|FG002|Overall Study|Withdrawal by Subject|2|||
144408368|NCT01091974|520705643|FG003|Overall Study|Withdrawal by Subject|2|||
144408369|NCT01091974|520705640|FG000|Overall Study|side-effects|1|||
144599939|NCT01372410|521397533|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
144408370|NCT01091974|520705641|FG001|Overall Study|side-effects|1|||
144408371|NCT01091974|520705642|FG002|Overall Study|side-effects|0|||
144408372|NCT01091974|520705643|FG003|Overall Study|side-effects|2|||
144408373|NCT02499783|520705644|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
144408374|NCT02499783|520705645|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
144408375|NCT02499783|520705646|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
144408376|NCT02499783|520705644|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
144408377|NCT02499783|520705645|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
144408378|NCT02499783|520705646|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
144408379|NCT02499783|520705644|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
144408380|NCT02499783|520705645|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
144408381|NCT02499783|520705646|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
144408382|NCT02499783|520705644|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
144408383|NCT02499783|520705645|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
144408384|NCT02499783|520705646|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
144408385|NCT02499783|520705644|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
144408386|NCT02499783|520705645|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
144408387|NCT02499783|520705646|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
144408388|NCT02499783|520705644|FG000|DB Period: Weeks 0-8|Other|1|||
144408389|NCT02499783|520705645|FG001|DB Period: Weeks 0-8|Other|1|||
144408390|NCT02499783|520705646|FG002|DB Period: Weeks 0-8|Other|0|||
144408391|NCT02499783|520705644|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
144408392|NCT02499783|520705645|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
144408393|NCT02499783|520705646|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
144408394|NCT02499783|520705644|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
144408395|NCT02499783|520705645|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
144408396|NCT02499783|520705646|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
144408397|NCT02499783|520705644|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
144408398|NCT02499783|520705645|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
144408399|NCT02499783|520705646|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
144408400|NCT02499783|520705644|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
144408401|NCT02499783|520705645|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
144408402|NCT02499783|520705646|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
144408403|NCT02228460|520705647|FG000|Overall Study|Adverse Event|1|||
144408404|NCT02228460|520705647|FG000|Overall Study|Lost to Follow-up|1|||
144408405|NCT01243892|520705648|FG000|Overall Study|Did not meet eligibility criteria|2|||
144408406|NCT01243892|520705649|FG001|Overall Study|Did not meet eligibility criteria|0|||
144408407|NCT01866293|520705654|FG000|Overall Study|Adverse Event|2|||
144408408|NCT03066804|520705655|FG000|Overall Study|Physician Decision|0|||
144408409|NCT03066804|520705656|FG001|Overall Study|Physician Decision|4|||
144408410|NCT03066804|520705655|FG000|Overall Study|Death|23|||
144408411|NCT03066804|520705656|FG001|Overall Study|Death|17|||
144408412|NCT03066804|520705655|FG000|Overall Study|Withdrawal by Subject|19|||
144408413|NCT03066804|520705656|FG001|Overall Study|Withdrawal by Subject|25|||
144408414|NCT03066804|520705655|FG000|Overall Study|Lost to Follow-up|2|||
144408415|NCT03066804|520705656|FG001|Overall Study|Lost to Follow-up|0|||
144408416|NCT03066804|520705655|FG000|Overall Study|Adverse Event|2|||
144408417|NCT03066804|520705656|FG001|Overall Study|Adverse Event|3|||
144408418|NCT03066804|520705655|FG000|Overall Study|Technical problems|5|||
144408419|NCT03066804|520705656|FG001|Overall Study|Technical problems|1|||
144408420|NCT03982368|520705657|FG000|Overall Study|Adverse Event|6|||
144408421|NCT03982368|520705658|FG001|Overall Study|Adverse Event|4|||
144408422|NCT03982368|520705659|FG002|Overall Study|Adverse Event|3|||
144408423|NCT03982368|520705657|FG000|Overall Study|Lost to Follow-up|2|||
144408424|NCT03982368|520705658|FG001|Overall Study|Lost to Follow-up|1|||
144408425|NCT03982368|520705659|FG002|Overall Study|Lost to Follow-up|0|||
144408426|NCT03982368|520705657|FG000|Overall Study|Withdrawal by Subject|1|||
144408427|NCT03982368|520705658|FG001|Overall Study|Withdrawal by Subject|2|||
144408428|NCT03982368|520705659|FG002|Overall Study|Withdrawal by Subject|0|||
144408429|NCT03982368|520705657|FG000|Overall Study|unknow|4|||
144599940|NCT01372410|521397534|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
144408430|NCT03982368|520705658|FG001|Overall Study|unknow|0|||
144408431|NCT03982368|520705659|FG002|Overall Study|unknow|2|||
144408432|NCT02571777|520705660|FG000|Overall Study|Subject/guardian decision|34|||
144408433|NCT02571777|520705661|FG001|Overall Study|Subject/guardian decision|26|||
144408434|NCT02571777|520705662|FG002|Overall Study|Subject/guardian decision|26|||
144408435|NCT02571777|520705663|FG003|Overall Study|Subject/guardian decision|25|||
144408436|NCT02571777|520705664|FG004|Overall Study|Subject/guardian decision|27|||
144408437|NCT02571777|520705660|FG000|Overall Study|Protocol Deviation|2|||
144408438|NCT02571777|520705661|FG001|Overall Study|Protocol Deviation|3|||
144408439|NCT02571777|520705662|FG002|Overall Study|Protocol Deviation|4|||
144408440|NCT02571777|520705663|FG003|Overall Study|Protocol Deviation|8|||
144408441|NCT02571777|520705664|FG004|Overall Study|Protocol Deviation|4|||
144408442|NCT02571777|520705660|FG000|Overall Study|Death|1|||
144408443|NCT02571777|520705661|FG001|Overall Study|Death|1|||
144408444|NCT02571777|520705662|FG002|Overall Study|Death|4|||
144408445|NCT02571777|520705663|FG003|Overall Study|Death|0|||
144408446|NCT02571777|520705664|FG004|Overall Study|Death|0|||
144408447|NCT02571777|520705660|FG000|Overall Study|Lost to Follow-up|1|||
144408448|NCT02571777|520705661|FG001|Overall Study|Lost to Follow-up|1|||
144408449|NCT02571777|520705662|FG002|Overall Study|Lost to Follow-up|2|||
144408450|NCT02571777|520705663|FG003|Overall Study|Lost to Follow-up|0|||
144408451|NCT02571777|520705664|FG004|Overall Study|Lost to Follow-up|1|||
144408452|NCT02571777|520705660|FG000|Overall Study|Physician Decision|1|||
144408453|NCT02571777|520705661|FG001|Overall Study|Physician Decision|7|||
144408454|NCT02571777|520705662|FG002|Overall Study|Physician Decision|5|||
144408455|NCT02571777|520705663|FG003|Overall Study|Physician Decision|2|||
144408456|NCT02571777|520705664|FG004|Overall Study|Physician Decision|4|||
144408457|NCT02571777|520705660|FG000|Overall Study|Pregnancy|0|||
144408458|NCT02571777|520705661|FG001|Overall Study|Pregnancy|0|||
144408459|NCT02571777|520705662|FG002|Overall Study|Pregnancy|0|||
144408460|NCT02571777|520705663|FG003|Overall Study|Pregnancy|2|||
144408461|NCT02571777|520705664|FG004|Overall Study|Pregnancy|0|||
144408462|NCT03706079|520705665|FG000|Predecessor Study|Death|0|||
144408463|NCT03706079|520705666|FG001|Predecessor Study|Death|2|||
144408464|NCT03706079|520705667|FG002|Predecessor Study|Death|0|||
144408465|NCT03706079|520705668|FG003|Predecessor Study|Death|1|||
144408466|NCT03706079|520705669|FG004|Predecessor Study|Death|0|||
144408467|NCT03706079|520705670|FG005|Predecessor Study|Death|0|||
144599941|NCT01372410|521397535|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
144599942|NCT01372410|521397536|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
144599943|NCT01372410|521397537|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
144599944|NCT01372410|521397538|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
144599945|NCT01372410|521397539|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
144599946|NCT01372410|521397540|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
144599947|NCT01372410|521397533|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144599948|NCT01372410|521397534|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144599949|NCT01372410|521397535|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144599950|NCT01372410|521397536|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144599951|NCT01372410|521397537|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144408468|NCT03706079|520705665|FG000|Predecessor Study|Lost to Follow-up|5|||
144408469|NCT03706079|520705666|FG001|Predecessor Study|Lost to Follow-up|2|||
144408470|NCT03706079|520705667|FG002|Predecessor Study|Lost to Follow-up|0|||
144408471|NCT03706079|520705668|FG003|Predecessor Study|Lost to Follow-up|0|||
144408472|NCT03706079|520705669|FG004|Predecessor Study|Lost to Follow-up|1|||
144408473|NCT03706079|520705670|FG005|Predecessor Study|Lost to Follow-up|0|||
144408474|NCT03706079|520705665|FG000|Predecessor Study|Withdrawal by Subject|8|||
144408475|NCT03706079|520705666|FG001|Predecessor Study|Withdrawal by Subject|15|||
144408476|NCT03706079|520705667|FG002|Predecessor Study|Withdrawal by Subject|0|||
144408477|NCT03706079|520705668|FG003|Predecessor Study|Withdrawal by Subject|5|||
144408478|NCT03706079|520705669|FG004|Predecessor Study|Withdrawal by Subject|2|||
144408479|NCT03706079|520705670|FG005|Predecessor Study|Withdrawal by Subject|0|||
144408480|NCT03706079|520705665|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
144408481|NCT03706079|520705666|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
144408482|NCT03706079|520705667|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
144408483|NCT03706079|520705668|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
144408484|NCT03706079|520705669|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
144408485|NCT03706079|520705670|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
144408486|NCT03706079|520705665|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
144408487|NCT03706079|520705666|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
144408488|NCT03706079|520705667|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
144408489|NCT03706079|520705668|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
144408490|NCT03706079|520705669|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
144408491|NCT03706079|520705670|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
144408492|NCT03706079|520705665|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
144408493|NCT03706079|520705666|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
144408494|NCT03706079|520705667|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
144408495|NCT03706079|520705668|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
144408496|NCT03706079|520705669|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
144408497|NCT03706079|520705670|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
144408498|NCT03706079|520705665|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
144408499|NCT03706079|520705666|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
144408500|NCT03706079|520705667|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
144408501|NCT03706079|520705668|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
144408502|NCT03706079|520705669|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
144408503|NCT03706079|520705670|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
144408504|NCT03706079|520705665|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
144408505|NCT03706079|520705666|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
144408506|NCT03706079|520705667|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
144408507|NCT03706079|520705668|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
144408508|NCT03706079|520705669|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
144408509|NCT03706079|520705670|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
144408510|NCT03706079|520705665|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
144408511|NCT03706079|520705666|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
144408512|NCT03706079|520705667|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
144408513|NCT03706079|520705668|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
144408514|NCT03706079|520705669|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
144408515|NCT03706079|520705670|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
144408516|NCT03706079|520705665|FG000|Long Term Extension (DESTINATION)|Death|8|||
144408517|NCT03706079|520705666|FG001|Long Term Extension (DESTINATION)|Death|2|||
144408518|NCT03706079|520705667|FG002|Long Term Extension (DESTINATION)|Death|2|||
144408519|NCT03706079|520705668|FG003|Long Term Extension (DESTINATION)|Death|1|||
144408520|NCT03706079|520705669|FG004|Long Term Extension (DESTINATION)|Death|0|||
144408521|NCT03706079|520705670|FG005|Long Term Extension (DESTINATION)|Death|0|||
144408522|NCT00329238|520705671|FG000|Overall Study|Adverse Event|147|||
144408523|NCT00329238|520705672|FG001|Overall Study|Adverse Event|129|||
144408524|NCT00329238|520705671|FG000|Overall Study|Protocol Violation|23|||
144408525|NCT00329238|520705672|FG001|Overall Study|Protocol Violation|34|||
144408526|NCT00329238|520705671|FG000|Overall Study|Lost to Follow-up|2|||
144408527|NCT00329238|520705672|FG001|Overall Study|Lost to Follow-up|6|||
144408528|NCT00329238|520705671|FG000|Overall Study|Withdrawal by Subject|64|||
144408529|NCT00329238|520705672|FG001|Overall Study|Withdrawal by Subject|58|||
144408530|NCT00329238|520705671|FG000|Overall Study|Other reason (not specified)|40|||
144408531|NCT00329238|520705672|FG001|Overall Study|Other reason (not specified)|54|||
144408532|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
144408533|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
144408534|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
144408535|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
144408536|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
144408537|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
144408538|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
144599952|NCT01372410|521397538|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144599953|NCT01372410|521397539|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
144599954|NCT01372410|521397540|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
144599955|NCT01372410|521397533|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599956|NCT01372410|521397534|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599957|NCT01372410|521397535|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
144599958|NCT01372410|521397536|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599959|NCT01372410|521397537|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599960|NCT01372410|521397538|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599961|NCT01372410|521397539|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599962|NCT01372410|521397540|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
144599963|NCT01372410|521397533|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144722641|NCT03349333|521840511|FG000|Overall Study|Withdrawal by Subject|5|||
144722642|NCT03349333|521840511|FG000|Overall Study|Conditions interfere with participation|2|||
144408539|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
144408540|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
144408541|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
144408542|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
144408543|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
144599964|NCT01372410|521397534|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144599965|NCT01372410|521397535|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144408544|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
144408545|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
144408546|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
144408547|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
144408548|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
144408549|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
144408550|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
144408551|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
144408552|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
144408553|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
144408554|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
144408555|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
144408556|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
144408557|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
144408558|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
144408559|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
144408560|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
144408561|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
144408562|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
144408563|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
144408564|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
144408565|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
144408566|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
144408567|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
144408568|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
144408569|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
144408570|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
144408571|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
144408572|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
144408573|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
144408574|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
144408575|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
144408576|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
144408577|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
144408578|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
144408579|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
144408580|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
144408581|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
144408582|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
144408583|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
144408584|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
144408585|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
144408586|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
144408587|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
144408588|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
144408589|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
144408590|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
144408591|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
144408592|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
144408593|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
144408594|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
144408595|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
144408596|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
144408597|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
144408598|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
144408599|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
144408600|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
144408601|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
144408602|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Change of location|0|||
144250072|NCT01760447|520113442|FG003|Weeks 20-54|Withdrawal by Subject|2|||
144408603|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Change of location|0|||
144408604|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Change of location|0|||
144408605|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Change of location|1|||
144408606|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Change of location|0|||
144408607|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
144408608|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
144408609|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
144408610|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
144408611|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
144408612|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
144408613|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
144408614|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
144408615|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
144408616|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
144408617|NCT00730405|520705675|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
144408618|NCT00730405|520705676|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
144408619|NCT00730405|520705677|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
144408620|NCT00730405|520705678|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
144408621|NCT00730405|520705679|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
144408622|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
144408623|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
144408624|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
144408625|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
144408626|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
144408627|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
144408628|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
144408629|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
144408630|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
144408631|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
144408632|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
144408633|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
144408634|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
144408635|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
144408636|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
144408637|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Death|0|||
144408638|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Death|1|||
144408639|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Death|0|||
144408640|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Death|1|||
144408641|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Death|0|||
144408642|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Change of location|1|||
144408643|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Change of location|1|||
144408644|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Change of location|0|||
144408645|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Change of location|1|||
144408646|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Change of location|0|||
144408647|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
144408648|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
144408649|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
144408650|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
144408651|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
144408652|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
144408653|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
144408654|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
144408655|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
144408656|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
144408657|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
144525927|NCT03365882|521125755|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
144525928|NCT03365882|521125754|FG000|Randomization|Progression/Relapse|21|||
144525929|NCT03365882|521125755|FG001|Randomization|Progression/Relapse|3|||
144525930|NCT03365882|521125754|FG000|Randomization|Death|1|||
144525931|NCT03365882|521125755|FG001|Randomization|Death|0|||
144525932|NCT03365882|521125754|FG000|Randomization|Other - Not Protocol Specified|1|||
144525933|NCT03365882|521125755|FG001|Randomization|Other - Not Protocol Specified|1|||
144525934|NCT03365882|521125754|FG000|Randomization|Major Protocol Deviation|0|||
144525935|NCT03365882|521125755|FG001|Randomization|Major Protocol Deviation|1|||
144408658|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
144408659|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
144525936|NCT03365882|521125754|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
144525937|NCT03365882|521125755|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
144408660|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
144408661|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
144408662|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
144408663|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
144408664|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
144408665|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
144408666|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
144408667|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
144408668|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
144408669|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
144408670|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
144408671|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
144408672|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
144408673|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
144408674|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
144408675|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
144408676|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
144408677|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
144408678|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
144408679|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
144408680|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
144408681|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
144408682|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
144408683|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
144408684|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
144408685|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
144408686|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
144408687|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
144408688|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
144408689|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
144408690|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
144408691|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
144408692|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
144408693|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
144408694|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
144408695|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
144408696|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
144408697|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Missing|0|||
144408698|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Missing|0|||
144599966|NCT01372410|521397536|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144599967|NCT01372410|521397537|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144599968|NCT01372410|521397538|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
144599969|NCT01372410|521397539|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144599970|NCT01372410|521397540|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
144599971|NCT00867113|521397541|FG000|Treatment Period|Adverse Event|15|||
144599972|NCT00867113|521397541|FG000|Treatment Period|Death|2|||
144599973|NCT00867113|521397541|FG000|Treatment Period|Withdrawal by Subject|19|||
144599974|NCT00867113|521397541|FG000|Treatment Period|Lost to Follow-up|3|||
144599975|NCT00867113|521397541|FG000|Treatment Period|Administrative problems|1|||
144599976|NCT00867113|521397541|FG000|Treatment Period|Disease progression/relapse|1|||
144599977|NCT00867113|521397541|FG000|Treatment Period|Protocol Violation|4|||
144599978|NCT00867113|521397541|FG000|Post Treatment After Survival Follow-up|Death|1|||
144599979|NCT00867113|521397541|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
144599980|NCT00867113|521397541|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
144599981|NCT00867113|521397541|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
144599982|NCT04585646|521397542|FG000|First Intervention|Physician Decision|1|||
144599983|NCT04585646|521397543|FG001|First Intervention|Physician Decision|0|||
144599984|NCT04585646|521397542|FG000|First Intervention|Lost to Follow-up|0|||
144599985|NCT04585646|521397543|FG001|First Intervention|Lost to Follow-up|3|||
144599986|NCT04585646|521397542|FG000|First Intervention|Withdrawal by Subject|0|||
144599987|NCT04585646|521397543|FG001|First Intervention|Withdrawal by Subject|1|||
144599988|NCT01886313|521397544|FG000|Overall Study|Adverse Event|1|||
144599989|NCT01886313|521397545|FG001|Overall Study|Adverse Event|1|||
144599990|NCT04614662|521397546|FG000|Overall Study|Withdrawal by Subject|0|||
144599991|NCT04614662|521397547|FG001|Overall Study|Withdrawal by Subject|1|||
144408699|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Missing|2|||
144408700|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Missing|0|||
144408701|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Missing|0|||
144408702|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
144408703|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
144408704|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
144408705|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
144408706|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
144408707|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
144408708|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
144408709|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
144408710|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
144408711|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
144408712|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
144408713|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
144408714|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
144408715|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
144408716|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
144408717|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
144408718|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
144408719|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
144408720|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
144408721|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
144408722|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
144408723|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
144408724|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
144250073|NCT01760447|520113439|FG000|Weeks 20-54|Lost to Follow-up|0|||
144408725|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
144408726|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
144408727|NCT00730405|520705675|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
144408728|NCT00730405|520705676|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
144408729|NCT00730405|520705677|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
144408730|NCT00730405|520705678|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
144408731|NCT00730405|520705679|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
144408732|NCT00913497|520705682|FG000|Overall Study|Adverse Event|1|||
144408733|NCT00913497|520705682|FG000|Overall Study|Withdrawal by Subject|2|||
144408734|NCT01427972|520705683|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408735|NCT01427972|520705684|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408736|NCT01427972|520705685|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408737|NCT01427972|520705686|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408738|NCT01427972|520705687|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408739|NCT01427972|520705688|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408740|NCT01427972|520705689|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408741|NCT01427972|520705690|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
144408742|NCT01427972|520705691|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408743|NCT01427972|520705692|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408744|NCT01427972|520705693|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408745|NCT01427972|520705694|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
144408746|NCT01427972|520705683|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408747|NCT01427972|520705684|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408748|NCT01427972|520705685|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408749|NCT01427972|520705686|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408750|NCT01427972|520705687|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408751|NCT01427972|520705688|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
144408752|NCT01427972|520705689|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408753|NCT01427972|520705690|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408754|NCT01427972|520705691|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408755|NCT01427972|520705692|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408756|NCT01427972|520705693|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408757|NCT01427972|520705694|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
144408758|NCT01427972|520705683|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408759|NCT01427972|520705684|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
144408760|NCT01427972|520705685|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408761|NCT01427972|520705686|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144599992|NCT01230788|521397554|FG000|Overall Study|Prescribed exclusion drug|1|||
144408762|NCT01427972|520705687|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408763|NCT01427972|520705688|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408764|NCT01427972|520705689|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408765|NCT01427972|520705690|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408766|NCT01427972|520705691|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408767|NCT01427972|520705692|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408768|NCT01427972|520705693|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408769|NCT01427972|520705694|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
144408770|NCT00530946|520705695|FG000|Overall Study|Adverse Event|1|||
144408771|NCT00530946|520705696|FG001|Overall Study|Adverse Event|2|||
144408772|NCT00530946|520705697|FG002|Overall Study|Adverse Event|1|||
144408773|NCT00530946|520705698|FG003|Overall Study|Adverse Event|1|||
144408774|NCT00530946|520705695|FG000|Overall Study|Protocol Violation|0|||
144408775|NCT00530946|520705696|FG001|Overall Study|Protocol Violation|0|||
144408776|NCT00530946|520705697|FG002|Overall Study|Protocol Violation|0|||
144408777|NCT00530946|520705698|FG003|Overall Study|Protocol Violation|1|||
144408778|NCT00530946|520705695|FG000|Overall Study|Noncompliance|1|||
144408779|NCT00530946|520705696|FG001|Overall Study|Noncompliance|0|||
144408780|NCT00530946|520705697|FG002|Overall Study|Noncompliance|0|||
144408781|NCT00530946|520705698|FG003|Overall Study|Noncompliance|0|||
144408782|NCT00457301|520705699|FG000|Overall Study|Withdrawal by Subject|3|||
144408783|NCT00457301|520705700|FG001|Overall Study|Withdrawal by Subject|3|||
144408784|NCT00457301|520705699|FG000|Overall Study|Censored out of the study|15|||
144408785|NCT00457301|520705700|FG001|Overall Study|Censored out of the study|14|||
144408786|NCT00457301|520705699|FG000|Overall Study|Death|5|||
144408787|NCT00457301|520705700|FG001|Overall Study|Death|7|||
144408788|NCT02094677|520705701|FG000|Overall Study|Screening|3|||
144408789|NCT02094677|520705702|FG001|Overall Study|Screening|1|||
144408790|NCT03408483|520705703|FG000|Overall Study|Physician Decision|3|||
144408791|NCT03408483|520705704|FG001|Overall Study|Physician Decision|3|||
144408792|NCT03408483|520705703|FG000|Overall Study|Lost to Follow-up|3|||
144408793|NCT03408483|520705704|FG001|Overall Study|Lost to Follow-up|0|||
144408794|NCT05399641|520705705|FG000|Overall Study|Adverse Event|0|||
144408795|NCT05399641|520705706|FG001|Overall Study|Adverse Event|1|||
144408796|NCT05399641|520705707|FG002|Overall Study|Adverse Event|1|||
144408797|NCT05399641|520705705|FG000|Overall Study|Lost to Follow-up|1|||
144408798|NCT05399641|520705706|FG001|Overall Study|Lost to Follow-up|2|||
144408799|NCT05399641|520705707|FG002|Overall Study|Lost to Follow-up|2|||
144408800|NCT05399641|520705705|FG000|Overall Study|Physician Decision|1|||
144408801|NCT05399641|520705706|FG001|Overall Study|Physician Decision|3|||
144408802|NCT05399641|520705707|FG002|Overall Study|Physician Decision|3|||
144408803|NCT05399641|520705705|FG000|Overall Study|Withdrawal by Subject|4|||
144408804|NCT05399641|520705706|FG001|Overall Study|Withdrawal by Subject|11|||
144408805|NCT05399641|520705707|FG002|Overall Study|Withdrawal by Subject|7|||
144599993|NCT01717768|521397556|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144599994|NCT01717768|521397557|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
144408806|NCT05399641|520705705|FG000|Overall Study|Reason not defined|3|||
144408807|NCT05399641|520705706|FG001|Overall Study|Reason not defined|5|||
144408808|NCT05399641|520705707|FG002|Overall Study|Reason not defined|6|||
144408809|NCT00478231|520705708|FG000|Overall Study|Death|7|||
144408810|NCT00478231|520705708|FG000|Overall Study|Lack of Efficacy|47|||
144408811|NCT00478231|520705708|FG000|Overall Study|Lost to Follow-up|7|||
144599995|NCT01717768|521397558|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144599996|NCT01717768|521397559|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144599997|NCT01717768|521397560|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144599998|NCT01717768|521397561|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144599999|NCT01717768|521397562|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144600000|NCT01717768|521397563|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144600001|NCT01717768|521397564|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144600002|NCT01717768|521397565|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144600003|NCT01717768|521397566|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144408812|NCT00478231|520705708|FG000|Overall Study|Withdrawal by Subject|6|||
144408813|NCT00478231|520705708|FG000|Overall Study|Other|9|||
144408814|NCT00478231|520705708|FG000|Overall Study|Adverse Event|5|||
144408815|NCT00478231|520705708|FG000|Overall Study|Randomized, not treated|3|||
144250074|NCT01760447|520113440|FG001|Weeks 20-54|Lost to Follow-up|0|||
144408816|NCT01300650|520705709|FG000|Overall Study|Adverse Event|1|||
144408817|NCT01702961|520705710|FG000|Overall Study|Additional treatment|3|||
144408818|NCT01702961|520705710|FG000|Overall Study|Progressive disease|5|||
144408819|NCT01702961|520705710|FG000|Overall Study|Relapse|20|||
144600004|NCT01717768|521397567|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
144600005|NCT01717768|521397556|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144408820|NCT01702961|520705710|FG000|Overall Study|Death|6|||
144408821|NCT01702961|520705710|FG000|Overall Study|Lost to Follow-up|2|||
144408822|NCT01702961|520705710|FG000|Overall Study|Ongoing|11|||
144408823|NCT00674362|520705715|FG000|Double Blind|Adverse Event|6|||
144408824|NCT00674362|520705716|FG001|Double Blind|Adverse Event|6|||
144408825|NCT00674362|520705715|FG000|Double Blind|Lack of Efficacy|2|||
144408826|NCT00674362|520705716|FG001|Double Blind|Lack of Efficacy|6|||
144408827|NCT00674362|520705715|FG000|Double Blind|Loss of efficacy|0|||
144408828|NCT00674362|520705716|FG001|Double Blind|Loss of efficacy|1|||
144408829|NCT00674362|520705715|FG000|Double Blind|Withdrawal by Subject|4|||
144408830|NCT00674362|520705716|FG001|Double Blind|Withdrawal by Subject|3|||
144408831|NCT00674362|520705715|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
144408832|NCT00674362|520705716|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
144408833|NCT00674362|520705715|FG000|Double Blind|Other: Surgery|0|||
144408834|NCT00674362|520705716|FG001|Double Blind|Other: Surgery|1|||
144408835|NCT00674362|520705715|FG000|Open Label|Adverse Event|1|||
144408836|NCT00674362|520705716|FG001|Open Label|Adverse Event|0|||
144408837|NCT00674362|520705715|FG000|Open Label|Other: Subject moved to extension study|1|||
144408838|NCT00674362|520705716|FG001|Open Label|Other: Subject moved to extension study|0|||
144408839|NCT00923156|520705717|FG000|Overall Study|Adverse Event|0|||
144408840|NCT00923156|520705718|FG001|Overall Study|Adverse Event|2|||
144408841|NCT00923156|520705719|FG002|Overall Study|Adverse Event|1|||
144408842|NCT00923156|520705717|FG000|Overall Study|Abnormal laboratory values|0|||
144408843|NCT00923156|520705718|FG001|Overall Study|Abnormal laboratory values|0|||
144408844|NCT00923156|520705719|FG002|Overall Study|Abnormal laboratory values|1|||
144408845|NCT00923156|520705717|FG000|Overall Study|Withdrawal by Subject|0|||
144408846|NCT00923156|520705718|FG001|Overall Study|Withdrawal by Subject|1|||
144408847|NCT00923156|520705719|FG002|Overall Study|Withdrawal by Subject|0|||
144408848|NCT00923156|520705717|FG000|Overall Study|Death|0|||
144408849|NCT00923156|520705718|FG001|Overall Study|Death|1|||
144408850|NCT00923156|520705719|FG002|Overall Study|Death|0|||
144408851|NCT00923156|520705717|FG000|Overall Study|Lack of Efficacy|0|||
144408852|NCT00923156|520705718|FG001|Overall Study|Lack of Efficacy|0|||
144408853|NCT00923156|520705719|FG002|Overall Study|Lack of Efficacy|1|||
144408854|NCT04665856|520705720|FG000|Overall Study|Site Terminated by Sponsor|1|||
144408855|NCT04665856|520705721|FG001|Overall Study|Site Terminated by Sponsor|0|||
144408856|NCT04665856|520705720|FG000|Overall Study|Withdrawal by Subject|2|||
144408857|NCT04665856|520705721|FG001|Overall Study|Withdrawal by Subject|0|||
144408858|NCT04665856|520705720|FG000|Overall Study|Lost to Follow-up|3|||
144408859|NCT04665856|520705721|FG001|Overall Study|Lost to Follow-up|2|||
144408860|NCT04665856|520705720|FG000|Overall Study|Death|39|||
144408861|NCT04665856|520705721|FG001|Overall Study|Death|44|||
144408862|NCT04665856|520705720|FG000|Overall Study|Ongoing in study|17|||
144408863|NCT04665856|520705721|FG001|Overall Study|Ongoing in study|15|||
144408864|NCT03386448|520705722|FG000|Overall Study|Adverse Event|0|||
144408865|NCT03386448|520705723|FG001|Overall Study|Adverse Event|2|||
144408866|NCT03338010|520705724|FG000|Overall Study|Withdrawal by Subject|14|||
144408867|NCT03338010|520705725|FG001|Overall Study|Withdrawal by Subject|8|||
144408868|NCT03338010|520705724|FG000|Overall Study|Lost to Follow-up|4|||
144408869|NCT03338010|520705725|FG001|Overall Study|Lost to Follow-up|2|||
144408870|NCT03338010|520705724|FG000|Overall Study|Adverse Event|3|||
144408871|NCT03338010|520705725|FG001|Overall Study|Adverse Event|2|||
144408872|NCT03338010|520705724|FG000|Overall Study|Physician Decision|2|||
144408873|NCT03338010|520705725|FG001|Overall Study|Physician Decision|2|||
144408874|NCT03338010|520705724|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144408875|NCT03338010|520705725|FG001|Overall Study|Non-Compliance with Study Drug|3|||
144408876|NCT03338010|520705724|FG000|Overall Study|Protocol Violation|0|||
144408877|NCT03338010|520705725|FG001|Overall Study|Protocol Violation|1|||
144408878|NCT03583697|520705726|FG000|Overall Study|Withdrawal by Subject|0|||
144408879|NCT03583697|520705727|FG001|Overall Study|Withdrawal by Subject|0|||
144408880|NCT03583697|520705728|FG002|Overall Study|Withdrawal by Subject|1|||
144408881|NCT03583697|520705726|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
144408882|NCT03583697|520705727|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
144408883|NCT03583697|520705728|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
144408884|NCT03724032|520705729|FG000|Overall Study|Physician Decision|1|||
144408885|NCT03724032|520705730|FG001|Overall Study|Physician Decision|0|||
144408886|NCT03724032|520705731|FG002|Overall Study|Physician Decision|0|||
144408887|NCT03724032|520705729|FG000|Overall Study|Protocol Violation|2|||
144408888|NCT03724032|520705730|FG001|Overall Study|Protocol Violation|2|||
144408889|NCT03724032|520705731|FG002|Overall Study|Protocol Violation|1|||
144408890|NCT02339584|520705732|FG000|Overall Study|Adverse Event|11|||
144408891|NCT02339584|520705733|FG001|Overall Study|Adverse Event|7|||
144408892|NCT02339584|520705732|FG000|Overall Study|Lack of Efficacy|0|||
144408893|NCT02339584|520705733|FG001|Overall Study|Lack of Efficacy|1|||
144408894|NCT02339584|520705732|FG000|Overall Study|Physician Decision|1|||
144408895|NCT02339584|520705733|FG001|Overall Study|Physician Decision|2|||
144408896|NCT02339584|520705732|FG000|Overall Study|Protocol Violation|1|||
144408897|NCT02339584|520705733|FG001|Overall Study|Protocol Violation|1|||
144408898|NCT02339584|520705732|FG000|Overall Study|Withdrawal by Subject|2|||
144408899|NCT02339584|520705733|FG001|Overall Study|Withdrawal by Subject|4|||
144408900|NCT02610725|520705734|FG000|Overall Study|Lost to Follow-up|197|||
144408901|NCT02610725|520705734|FG000|Overall Study|self-reported contraindication|9|||
144408902|NCT04094883|520705735|FG000|Overall Study|Withdrawal by Subject|1|||
144408903|NCT03192462|520707248|FG000|Overall Study|Death|13|||
144408904|NCT03192462|520707249|FG001|Overall Study|Death|11|||
144408905|NCT03192462|520707250|FG002|Overall Study|Death|10|||
144408906|NCT03192462|520707248|FG000|Overall Study|Lost to Follow-up|0|||
144408907|NCT03192462|520707249|FG001|Overall Study|Lost to Follow-up|1|||
144408908|NCT03192462|520707250|FG002|Overall Study|Lost to Follow-up|0|||
144408909|NCT05996718|520707251|FG000|Overall Study|Lost to Follow-up|3|||
144408910|NCT03945773|520707252|FG000|Overall Study|Consent Withdrawn|1|||
144408911|NCT03945773|520707253|FG001|Overall Study|Consent Withdrawn|1|||
144408912|NCT03945773|520707252|FG000|Overall Study|Lost to Follow-up|1|||
144408913|NCT03945773|520707253|FG001|Overall Study|Lost to Follow-up|0|||
144408914|NCT03945773|520707252|FG000|Overall Study|Death|46|||
144408915|NCT03945773|520707253|FG001|Overall Study|Death|22|||
144408916|NCT03945773|520707252|FG000|Overall Study|Physician Decision|1|||
144408917|NCT03945773|520707253|FG001|Overall Study|Physician Decision|0|||
144408918|NCT03945773|520707252|FG000|Overall Study|Other|1|||
144408919|NCT03945773|520707253|FG001|Overall Study|Other|0|||
144408920|NCT03945773|520707252|FG000|Overall Study|Ongoing at the time of DCO|4|||
144408921|NCT03945773|520707253|FG001|Overall Study|Ongoing at the time of DCO|3|||
144408922|NCT01713686|520707254|FG000|Overall Study|Lost to Follow-up|9|||
144408923|NCT01713686|520707254|FG000|Overall Study|Withdrawal by Subject|6|||
144408924|NCT03187197|520707258|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
144408925|NCT03187197|520707259|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
144408926|NCT03187197|520707260|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
144408927|NCT03187197|520707258|FG000|Overall Study|Withdrawal by Subject|8|||
144408928|NCT03187197|520707259|FG001|Overall Study|Withdrawal by Subject|63|||
144408929|NCT03187197|520707260|FG002|Overall Study|Withdrawal by Subject|4|||
144408930|NCT03187197|520707258|FG000|Overall Study|Lost to Follow-up|1|||
144408931|NCT03187197|520707259|FG001|Overall Study|Lost to Follow-up|60|||
144408932|NCT03187197|520707260|FG002|Overall Study|Lost to Follow-up|7|||
144408933|NCT03187197|520707258|FG000|Overall Study|Adverse Event|6|||
144408934|NCT03187197|520707259|FG001|Overall Study|Adverse Event|29|||
144408935|NCT03187197|520707260|FG002|Overall Study|Adverse Event|0|||
144408936|NCT03187197|520707258|FG000|Overall Study|Death|0|||
144408937|NCT03187197|520707259|FG001|Overall Study|Death|11|||
144408938|NCT03187197|520707260|FG002|Overall Study|Death|0|||
144408939|NCT03187197|520707258|FG000|Overall Study|Administrative problem|1|||
144408940|NCT03187197|520707259|FG001|Overall Study|Administrative problem|1|||
144408941|NCT03187197|520707260|FG002|Overall Study|Administrative problem|0|||
144408942|NCT03187197|520707258|FG000|Overall Study|Reason not listed|2|||
144408943|NCT03187197|520707259|FG001|Overall Study|Reason not listed|54|||
144408944|NCT03187197|520707260|FG002|Overall Study|Reason not listed|1|||
144408945|NCT03187197|520707258|FG000|Overall Study|Missing|1|||
144408946|NCT03187197|520707259|FG001|Overall Study|Missing|32|||
144408947|NCT03187197|520707260|FG002|Overall Study|Missing|3|||
144408948|NCT03187197|520707258|FG000|Overall Study|Status missing|2|||
144408949|NCT03187197|520707259|FG001|Overall Study|Status missing|33|||
144408950|NCT03187197|520707260|FG002|Overall Study|Status missing|3|||
144408951|NCT03187197|520707258|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
144408952|NCT03187197|520707259|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
144408953|NCT03187197|520707260|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
144408954|NCT02385045|520707261|FG000|Overall Study|Endoscopy could not be completed|4|||
144525938|NCT03365882|521125754|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
144525939|NCT03365882|521125755|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
144525940|NCT03365882|521125754|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
144408955|NCT04840615|520707262|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
144408956|NCT04840615|520707263|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
144408957|NCT04840615|520707264|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
144408958|NCT01898806|520707268|FG000|Overall Study|Withdrawal by Subject|2|||
144408959|NCT01898806|520707268|FG000|Overall Study|Physician Decision|1|||
144408960|NCT03003390|520707269|FG000|Overall Study|Physician Decision|2|||
144408961|NCT03003390|520707270|FG001|Overall Study|Physician Decision|0|||
144408962|NCT03003390|520707269|FG000|Overall Study|Parent refused intervention|2|||
144408963|NCT03003390|520707270|FG001|Overall Study|Parent refused intervention|0|||
144408964|NCT02980601|520707279|FG000|Overall Study|Lost to Follow-up|2|||
144408965|NCT02980601|520707280|FG001|Overall Study|Lost to Follow-up|2|||
144525941|NCT03365882|521125755|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
144408966|NCT02980601|520707279|FG000|Overall Study|Death|0|||
144408967|NCT02980601|520707280|FG001|Overall Study|Death|1|||
144408968|NCT02980601|520707279|FG000|Overall Study|Graft loss|1|||
144408969|NCT02980601|520707280|FG001|Overall Study|Graft loss|0|||
144408970|NCT02980601|520707279|FG000|Overall Study|Failed to sign consent|2|||
144408971|NCT02980601|520707280|FG001|Overall Study|Failed to sign consent|0|||
144408972|NCT03156543|520707281|FG000|Overall Study|Withdrawal by Subject|1|||
144408973|NCT03156543|520707282|FG001|Overall Study|Withdrawal by Subject|0|||
144408974|NCT01473836|520707283|FG000|Overall Study|Adverse Event|4|||
144408975|NCT01473836|520707283|FG000|Overall Study|Lack of Efficacy|1|||
144525942|NCT03365882|521125754|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
144525943|NCT03365882|521125755|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
144525944|NCT02696707|521127087|FG000|Per Protocol Population|Physician Decision|2|||
144525945|NCT02696707|521127088|FG001|Per Protocol Population|Physician Decision|1|||
144525946|NCT02696707|521127087|FG000|Per Protocol Population|Participant Decision|0|||
144525947|NCT02696707|521127088|FG001|Per Protocol Population|Participant Decision|2|||
144525948|NCT02696707|521127087|FG000|Completed Study as Planned|Reason = LVEF|2|||
144525949|NCT02696707|521127088|FG001|Completed Study as Planned|Reason = LVEF|2|||
144525950|NCT02696707|521127087|FG000|Completed Study as Planned|Protocol Violation|2|||
144525951|NCT02696707|521127088|FG001|Completed Study as Planned|Protocol Violation|6|||
144525952|NCT02696707|521127087|FG000|Completed Study as Planned|Metastatic disease|3|||
144525953|NCT02696707|521127088|FG001|Completed Study as Planned|Metastatic disease|0|||
144525954|NCT02696707|521127087|FG000|Completed Study as Planned|Location|1|||
144525955|NCT02696707|521127088|FG001|Completed Study as Planned|Location|1|||
144525956|NCT03869866|521127093|FG000|Overall Study|Protocol Violation|1|||
144525957|NCT03869866|521127093|FG000|Overall Study|Withdrawal by Subject|3|||
144525958|NCT01186367|521127094|FG000|Overall Study|Lost to Follow-up|7|||
144525959|NCT01186367|521127095|FG001|Overall Study|Lost to Follow-up|4|||
144525960|NCT01186367|521127096|FG002|Overall Study|Lost to Follow-up|7|||
144525961|NCT01186367|521127094|FG000|Overall Study|Did not receive study treatment|0|||
144525962|NCT01186367|521127095|FG001|Overall Study|Did not receive study treatment|1|||
144525963|NCT01186367|521127096|FG002|Overall Study|Did not receive study treatment|0|||
144525964|NCT00470704|521127097|FG000|Overall Study|Withdrawal by Subject|4|||
144525965|NCT00470704|521127098|FG001|Overall Study|Withdrawal by Subject|3|||
144525966|NCT00470704|521127097|FG000|Overall Study|Relapse/Progression|37|||
144525967|NCT00470704|521127098|FG001|Overall Study|Relapse/Progression|42|||
144525968|NCT00470704|521127097|FG000|Overall Study|toxicity|0|||
144525969|NCT00470704|521127098|FG001|Overall Study|toxicity|1|||
144525970|NCT04987320|521127104|FG000|Overall Study|Withdrawal by Subject|0|||
144525971|NCT04987320|521127105|FG001|Overall Study|Withdrawal by Subject|1|||
144525972|NCT00085735|521127106|FG000|Overall Study|Adverse Event|1|||
144525973|NCT00085735|521127107|FG001|Overall Study|Adverse Event|0|||
144525974|NCT00085735|521127108|FG002|Overall Study|Adverse Event|0|||
144525975|NCT00085735|521127109|FG003|Overall Study|Adverse Event|0|||
144525976|NCT00085735|521127110|FG004|Overall Study|Adverse Event|0|||
144525977|NCT00085735|521127111|FG005|Overall Study|Adverse Event|0|||
144525978|NCT00085735|521127106|FG000|Overall Study|Lack of Efficacy|2|||
144525979|NCT00085735|521127107|FG001|Overall Study|Lack of Efficacy|4|||
144525980|NCT00085735|521127108|FG002|Overall Study|Lack of Efficacy|6|||
144525981|NCT00085735|521127109|FG003|Overall Study|Lack of Efficacy|3|||
144525982|NCT00085735|521127110|FG004|Overall Study|Lack of Efficacy|4|||
144525983|NCT00085735|521127111|FG005|Overall Study|Lack of Efficacy|3|||
144525984|NCT00085735|521127106|FG000|Overall Study|Lost to Follow-up|0|||
144250075|NCT01760447|520113441|FG002|Weeks 20-54|Lost to Follow-up|1|||
144408976|NCT01473836|520707283|FG000|Overall Study|Does not meet entrance criteria|1|||
144408977|NCT00674700|520707291|FG000|Year 1|Adverse Event|17|||
144408978|NCT00674700|520707292|FG001|Year 1|Adverse Event|20|||
144408979|NCT00674700|520707293|FG002|Year 1|Adverse Event|5|||
144408980|NCT00674700|520707291|FG000|Year 1|Withdrawal by Subject|7|||
144408981|NCT00674700|520707292|FG001|Year 1|Withdrawal by Subject|7|||
144408982|NCT00674700|520707293|FG002|Year 1|Withdrawal by Subject|6|||
144408983|NCT00674700|520707291|FG000|Year 1|Any other reason not above-mentioned|7|||
144408984|NCT00674700|520707292|FG001|Year 1|Any other reason not above-mentioned|7|||
144408985|NCT00674700|520707293|FG002|Year 1|Any other reason not above-mentioned|6|||
144408986|NCT00674700|520707291|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
144408987|NCT00674700|520707292|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
144408988|NCT00674700|520707293|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
144408989|NCT00674700|520707291|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
144408990|NCT00674700|520707292|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
144408991|NCT00674700|520707293|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
144408992|NCT00674700|520707291|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
144408993|NCT00674700|520707292|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
144408994|NCT00674700|520707293|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
144408995|NCT02954237|520707294|FG000|Overall Study|Withdrawal by Subject|25|||
144408996|NCT02954237|520707294|FG000|Overall Study|Missed visit|16|||
144408997|NCT02954237|520707294|FG000|Overall Study|Death|2|||
144408998|NCT02966028|520707295|FG000|Overall Study|Adverse Event|7|||
144408999|NCT02966028|520707296|FG001|Overall Study|Adverse Event|13|||
144409000|NCT02966028|520707297|FG002|Overall Study|Adverse Event|10|||
144409001|NCT02966028|520707295|FG000|Overall Study|Physician Decision|1|||
144409002|NCT02966028|520707296|FG001|Overall Study|Physician Decision|0|||
144409003|NCT02966028|520707297|FG002|Overall Study|Physician Decision|2|||
144409004|NCT02966028|520707295|FG000|Overall Study|Withdrawal by Subject|7|||
144409005|NCT02966028|520707296|FG001|Overall Study|Withdrawal by Subject|5|||
144409006|NCT02966028|520707297|FG002|Overall Study|Withdrawal by Subject|5|||
144409007|NCT02966028|520707295|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
144409008|NCT02966028|520707296|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
144409009|NCT02966028|520707297|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
144409010|NCT00119106|520707299|FG000|Overall Study|HIV infected at baseline|179|||
144409011|NCT00119106|520707300|FG001|Overall Study|HIV infected at baseline|178|||
144409012|NCT01010061|520707301|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
144409013|NCT01010061|520707302|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
144409014|NCT01010061|520707301|FG000|Overall Study|Disease Progression|2|||
144409015|NCT01010061|520707302|FG001|Overall Study|Disease Progression|8|||
144409016|NCT01010061|520707301|FG000|Overall Study|Withdrew Consent|5|||
144409017|NCT01010061|520707302|FG001|Overall Study|Withdrew Consent|1|||
144409018|NCT01010061|520707301|FG000|Overall Study|Death|3|||
144409019|NCT01010061|520707302|FG001|Overall Study|Death|6|||
144409020|NCT01010061|520707301|FG000|Overall Study|Administrative/Other|0|||
144409021|NCT01010061|520707302|FG001|Overall Study|Administrative/Other|1|||
144409022|NCT01010061|520707301|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
144409023|NCT01010061|520707302|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
144409024|NCT01010061|520707301|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144409025|NCT01010061|520707302|FG001|Overall Study|Insufficient Therapeutic Response|5|||
144409026|NCT01010061|520707301|FG000|Overall Study|Violation of Selection Criteria|0|||
144409027|NCT01010061|520707302|FG001|Overall Study|Violation of Selection Criteria|1|||
144409028|NCT01010061|520707301|FG000|Overall Study|Did Not Receive Treatment|2|||
144409029|NCT01010061|520707302|FG001|Overall Study|Did Not Receive Treatment|2|||
144409030|NCT00968513|520707305|FG000|Overall Study|Death|4|||
144409031|NCT00968513|520707306|FG001|Overall Study|Death|10|||
144409032|NCT00968513|520707307|FG002|Overall Study|Death|15|||
144409033|NCT01203098|520707308|FG000|Overall Study|Adverse Event|3|||
144409034|NCT01203098|520707309|FG001|Overall Study|Adverse Event|1|||
144409035|NCT01203098|520707310|FG002|Overall Study|Adverse Event|7|||
144409036|NCT01203098|520707308|FG000|Overall Study|Lost to Follow-up|0|||
144409037|NCT01203098|520707309|FG001|Overall Study|Lost to Follow-up|0|||
144409038|NCT01203098|520707310|FG002|Overall Study|Lost to Follow-up|1|||
144409039|NCT01203098|520707308|FG000|Overall Study|Physician Decision|2|||
144409040|NCT01203098|520707309|FG001|Overall Study|Physician Decision|2|||
144250076|NCT01760447|520113442|FG003|Weeks 20-54|Lost to Follow-up|2|||
144409041|NCT01203098|520707310|FG002|Overall Study|Physician Decision|0|||
144409042|NCT01203098|520707308|FG000|Overall Study|Withdrawal by Subject|1|||
144409043|NCT01203098|520707309|FG001|Overall Study|Withdrawal by Subject|1|||
144409044|NCT01203098|520707310|FG002|Overall Study|Withdrawal by Subject|3|||
144409045|NCT03851705|520707315|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
144409046|NCT03851705|520707316|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
144409047|NCT03851705|520707317|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
144409048|NCT03851705|520707318|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
144409049|NCT03851705|520707315|FG000|Part 1: Double-Blind Period|Other reason|1|||
144409050|NCT03851705|520707316|FG001|Part 1: Double-Blind Period|Other reason|0|||
144409051|NCT03851705|520707317|FG002|Part 1: Double-Blind Period|Other reason|0|||
144722643|NCT03349333|521840511|FG000|Overall Study|Physician Decision|2|||
144722644|NCT03349333|521840511|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
144722645|NCT03349333|521840511|FG000|Overall Study|Patients in treatment less than 24 month|8|||
144722646|NCT01816477|521840514|FG000|Overall Study|Withdrawal by Subject|13|||
144722647|NCT01816477|521840515|FG001|Overall Study|Withdrawal by Subject|1|||
144722648|NCT01816477|521840514|FG000|Overall Study|Unable to tolerate catheter placement|3|||
144722649|NCT01816477|521840515|FG001|Overall Study|Unable to tolerate catheter placement|0|||
144722650|NCT00108732|521840516|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
144722651|NCT00108732|521840516|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
144722652|NCT00108732|521840516|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
144722653|NCT00108732|521840516|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
144722654|NCT00108732|521840516|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
144722655|NCT00108732|521840516|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
144722656|NCT00108732|521840516|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
144722657|NCT02116803|521840518|FG000|Overall Study|Adverse Event|2|||
144722658|NCT02116803|521840519|FG001|Overall Study|Adverse Event|1|||
144722659|NCT02116803|521840518|FG000|Overall Study|Physician Decision|1|||
144722660|NCT02116803|521840519|FG001|Overall Study|Physician Decision|0|||
144722661|NCT02116803|521840518|FG000|Overall Study|Progressive disease|4|||
144722662|NCT02116803|521840519|FG001|Overall Study|Progressive disease|0|||
144722663|NCT02116803|521840518|FG000|Overall Study|Study terminated by sponsor|2|||
144722664|NCT02116803|521840519|FG001|Overall Study|Study terminated by sponsor|1|||
144722665|NCT02116803|521840518|FG000|Overall Study|Death|1|||
144722666|NCT02116803|521840519|FG001|Overall Study|Death|0|||
144722667|NCT01901055|521840520|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
144722668|NCT01901055|521840521|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
144722669|NCT01901055|521840520|FG000|Randomization But Not Titrated|Physician Decision|0|||
144722670|NCT01901055|521840521|FG001|Randomization But Not Titrated|Physician Decision|1|||
144722671|NCT01901055|521840520|FG000|Started Protocol to Week 6|Physician Decision|2|||
144722672|NCT01901055|521840521|FG001|Started Protocol to Week 6|Physician Decision|1|||
144722673|NCT01901055|521840520|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
144722674|NCT01901055|521840521|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
144722675|NCT01901055|521840520|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
144722676|NCT01901055|521840521|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
144722677|NCT01901055|521840520|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
144722678|NCT01901055|521840521|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
144722679|NCT01901055|521840520|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
144722680|NCT01901055|521840521|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
144722681|NCT01901055|521840520|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
144722682|NCT01901055|521840521|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
144722683|NCT01901055|521840520|FG000|Week 24|Withdrawal by Subject|13|||
144722684|NCT01901055|521840521|FG001|Week 24|Withdrawal by Subject|19|||
144722685|NCT01901055|521840520|FG000|Week 24|Physician Decision|1|||
144722686|NCT01901055|521840521|FG001|Week 24|Physician Decision|0|||
144722687|NCT01901055|521840520|FG000|Week 36|Withdrawal by Subject|0|||
144722688|NCT01901055|521840521|FG001|Week 36|Withdrawal by Subject|5|||
144722689|NCT03019965|521840522|FG000|Overall Study|Withdrawal by Subject|1|||
144722690|NCT03019965|521840523|FG001|Overall Study|Withdrawal by Subject|0|||
144722691|NCT03019965|521840522|FG000|Overall Study|Protocol Violation|1|||
144722692|NCT03019965|521840523|FG001|Overall Study|Protocol Violation|3|||
144722693|NCT03019965|521840522|FG000|Overall Study|viral or fungal infection|3|||
144722694|NCT03019965|521840523|FG001|Overall Study|viral or fungal infection|4|||
144409052|NCT03851705|520707318|FG003|Part 1: Double-Blind Period|Other reason|0|||
144409053|NCT03851705|520707315|FG000|Part 2: Open-Label Period|Other reason|0|||
144600006|NCT01717768|521397557|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600007|NCT01717768|521397558|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600008|NCT01717768|521397559|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600009|NCT01717768|521397560|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600010|NCT01717768|521397561|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600011|NCT01717768|521397562|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600012|NCT01717768|521397563|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600013|NCT01717768|521397564|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600014|NCT01717768|521397565|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600015|NCT01717768|521397566|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
144600016|NCT01717768|521397567|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
144600017|NCT01717768|521397556|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600018|NCT01717768|521397557|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144409054|NCT03851705|520707316|FG001|Part 2: Open-Label Period|Other reason|0|||
144409055|NCT03851705|520707317|FG002|Part 2: Open-Label Period|Other reason|0|||
144409056|NCT03851705|520707318|FG003|Part 2: Open-Label Period|Other reason|1|||
144409057|NCT03851705|520707315|FG000|Part 2: Open-Label Period|Death|0|||
144409058|NCT03851705|520707316|FG001|Part 2: Open-Label Period|Death|0|||
144409059|NCT03851705|520707317|FG002|Part 2: Open-Label Period|Death|3|||
144409060|NCT03851705|520707318|FG003|Part 2: Open-Label Period|Death|0|||
144722695|NCT03019965|521840522|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
144722696|NCT03019965|521840523|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
144722697|NCT03019965|521840522|FG000|Overall Study|Physician Decision|1|||
144722698|NCT03019965|521840523|FG001|Overall Study|Physician Decision|1|||
144722699|NCT01915732|521840524|FG000|Overall Study|Withdrawal by Subject|18|||
144722700|NCT01915732|521840525|FG001|Overall Study|Withdrawal by Subject|18|||
144722701|NCT01915732|521840524|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
144722702|NCT01915732|521840525|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
144722703|NCT01915732|521840524|FG000|Overall Study|Adverse Event|12|||
144722704|NCT01915732|521840525|FG001|Overall Study|Adverse Event|4|||
144722705|NCT01915732|521840524|FG000|Overall Study|Protocol Violation|5|||
144722706|NCT01915732|521840525|FG001|Overall Study|Protocol Violation|5|||
144722707|NCT01915732|521840524|FG000|Overall Study|Lack of Efficacy|6|||
144722708|NCT01915732|521840525|FG001|Overall Study|Lack of Efficacy|11|||
144722709|NCT01915732|521840524|FG000|Overall Study|Lost to Follow-up|22|||
144722710|NCT01915732|521840525|FG001|Overall Study|Lost to Follow-up|26|||
144722711|NCT01915732|521840524|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
144722712|NCT01915732|521840525|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
144722713|NCT01915732|521840524|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
144722714|NCT01915732|521840525|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
144722715|NCT01915732|521840524|FG000|Overall Study|Drug Release Error|1|||
144722716|NCT01915732|521840525|FG001|Overall Study|Drug Release Error|0|||
144722717|NCT01915732|521840524|FG000|Overall Study|Recovered|1|||
144722718|NCT01915732|521840525|FG001|Overall Study|Recovered|0|||
144722719|NCT01915732|521840524|FG000|Overall Study|Pregnancy|1|||
144722720|NCT01915732|521840525|FG001|Overall Study|Pregnancy|0|||
144722721|NCT01915732|521840524|FG000|Overall Study|Poor Perceived Efficacy|1|||
144722722|NCT01915732|521840525|FG001|Overall Study|Poor Perceived Efficacy|0|||
144722723|NCT01915732|521840524|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
144722724|NCT01915732|521840525|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
144722725|NCT01915732|521840524|FG000|Overall Study|Got Well|0|||
144722726|NCT01915732|521840525|FG001|Overall Study|Got Well|1|||
144722727|NCT01915732|521840524|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
144722728|NCT01915732|521840525|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
144722729|NCT01915732|521840524|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
144722730|NCT01915732|521840525|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
144722731|NCT01915732|521840524|FG000|Overall Study|Job Transfer|0|||
144722732|NCT01915732|521840525|FG001|Overall Study|Job Transfer|1|||
144722733|NCT01915732|521840524|FG000|Overall Study|Improper Facial Procedure|0|||
144722734|NCT01915732|521840525|FG001|Overall Study|Improper Facial Procedure|1|||
144722735|NCT01915732|521840524|FG000|Overall Study|Poor Conscious Effect|0|||
144722736|NCT01915732|521840525|FG001|Overall Study|Poor Conscious Effect|1|||
144722737|NCT01325207|521840526|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
144409061|NCT03851705|520707315|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
144409062|NCT03851705|520707316|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
144409063|NCT03851705|520707317|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
144409064|NCT03851705|520707318|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
144409065|NCT00621582|520707322|FG000|Overall Study|Adverse Event|7|||
144722738|NCT01325207|521840527|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
144722739|NCT01325207|521840528|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
144722740|NCT01325207|521840529|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
144722741|NCT01325207|521840530|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
144722742|NCT01325207|521840531|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
144722743|NCT01325207|521840526|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
144250077|NCT04767529|520113449|FG000|Overall Study|Adverse Event|0|||
144409066|NCT00621582|520707322|FG000|Overall Study|Protocol Violation|57|||
144409067|NCT00621582|520707322|FG000|Overall Study|Lost to Follow-up|24|||
144409068|NCT00621582|520707322|FG000|Overall Study|issues not identified by investigators|18|||
144409069|NCT01387932|520707324|FG000|Randomized and Treated|Physician Decision|3|||
144409070|NCT01387932|520707325|FG001|Randomized and Treated|Physician Decision|2|||
144409071|NCT01387932|520707324|FG000|Randomized and Treated|Withdrawal by Subject|4|||
144409072|NCT01387932|520707325|FG001|Randomized and Treated|Withdrawal by Subject|2|||
144409073|NCT01387932|520707324|FG000|Survival Follow-up|Liver Transplant|24|||
144409074|NCT01387932|520707325|FG001|Survival Follow-up|Liver Transplant|28|||
144409075|NCT01387932|520707324|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
144409076|NCT01387932|520707325|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
144409077|NCT01387932|520707324|FG000|Survival Follow-up|Withdrawal by Subject|2|||
144409078|NCT01387932|520707325|FG001|Survival Follow-up|Withdrawal by Subject|4|||
144409079|NCT01387932|520707324|FG000|Survival Follow-up|Lost to Follow-up|6|||
144409080|NCT01387932|520707325|FG001|Survival Follow-up|Lost to Follow-up|5|||
144409081|NCT02591290|520707326|FG000|Overall Study|Withdrawal by Subject|2|||
144409082|NCT02571075|520707327|FG000|Overall Study|Lost to Follow-up|20|||
144409083|NCT02571075|520707328|FG001|Overall Study|Lost to Follow-up|24|||
144409084|NCT00963937|520707331|FG000|Overall Study|Protocol Violation|1|||
144409085|NCT00963937|520707332|FG001|Overall Study|Protocol Violation|1|||
144409086|NCT00963937|520707333|FG002|Overall Study|Protocol Violation|0|||
144409087|NCT00963937|520707331|FG000|Overall Study|Physician Decision|18|||
144409088|NCT00963937|520707332|FG001|Overall Study|Physician Decision|10|||
144409089|NCT00963937|520707333|FG002|Overall Study|Physician Decision|4|||
144409090|NCT01306942|520707337|FG000|Phase I|Adverse Event|2|||
144409091|NCT01306942|520707338|FG001|Phase I|Adverse Event|2|||
144409092|NCT01306942|520707339|FG002|Phase I|Adverse Event|0|||
144409093|NCT01306942|520707340|FG003|Phase I|Adverse Event|0|||
144409094|NCT01306942|520707337|FG000|Phase I|Physician Decision|3|||
144409095|NCT01306942|520707338|FG001|Phase I|Physician Decision|1|||
144409096|NCT01306942|520707339|FG002|Phase I|Physician Decision|0|||
144409097|NCT01306942|520707340|FG003|Phase I|Physician Decision|0|||
144409098|NCT01306942|520707337|FG000|Phase II|Adverse Event|0|||
144409099|NCT01306942|520707338|FG001|Phase II|Adverse Event|0|||
144409100|NCT01306942|520707339|FG002|Phase II|Adverse Event|0|||
144409101|NCT01306942|520707340|FG003|Phase II|Adverse Event|6|||
144409102|NCT01306942|520707337|FG000|Phase II|Physician Decision|2|||
144409103|NCT01306942|520707338|FG001|Phase II|Physician Decision|0|||
144409104|NCT01306942|520707339|FG002|Phase II|Physician Decision|0|||
144409105|NCT01306942|520707340|FG003|Phase II|Physician Decision|5|||
144409106|NCT01306942|520707337|FG000|Phase II|Withdrawal by Subject|0|||
144409107|NCT01306942|520707338|FG001|Phase II|Withdrawal by Subject|0|||
144409108|NCT01306942|520707339|FG002|Phase II|Withdrawal by Subject|0|||
144409109|NCT01306942|520707340|FG003|Phase II|Withdrawal by Subject|2|||
144409110|NCT01306942|520707337|FG000|Phase II|Death|0|||
144409111|NCT01306942|520707338|FG001|Phase II|Death|0|||
144409112|NCT01306942|520707339|FG002|Phase II|Death|0|||
144409113|NCT01306942|520707340|FG003|Phase II|Death|1|||
144409114|NCT01306942|520707337|FG000|Phase II|Not finished treatment|0|||
144409115|NCT01306942|520707338|FG001|Phase II|Not finished treatment|0|||
144409116|NCT01306942|520707339|FG002|Phase II|Not finished treatment|0|||
144409117|NCT01306942|520707340|FG003|Phase II|Not finished treatment|1|||
144409118|NCT01306942|520707337|FG000|Phase II|Protocol Violation|0|||
144409119|NCT01306942|520707338|FG001|Phase II|Protocol Violation|0|||
144409120|NCT01306942|520707339|FG002|Phase II|Protocol Violation|0|||
144409121|NCT01306942|520707340|FG003|Phase II|Protocol Violation|1|||
144409122|NCT03190915|520707347|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
144409123|NCT03190915|520707347|FG000|Overall Study|Progressive Disease|3|||
144409124|NCT03385564|520707348|FG000|Overall Study|Adverse Event|0|||
144409125|NCT03385564|520707349|FG001|Overall Study|Adverse Event|0|||
144409126|NCT03385564|520707350|FG002|Overall Study|Adverse Event|3|||
144600019|NCT01717768|521397558|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144409127|NCT03385564|520707351|FG003|Overall Study|Adverse Event|3|||
144409128|NCT03385564|520707348|FG000|Overall Study|Other than listed|0|||
144409129|NCT03385564|520707349|FG001|Overall Study|Other than listed|0|||
144409130|NCT03385564|520707350|FG002|Overall Study|Other than listed|0|||
144409131|NCT03385564|520707351|FG003|Overall Study|Other than listed|5|||
144409132|NCT03385564|520707348|FG000|Overall Study|Withdrawal by Subject|0|||
144409133|NCT03385564|520707349|FG001|Overall Study|Withdrawal by Subject|1|||
144409134|NCT03385564|520707350|FG002|Overall Study|Withdrawal by Subject|1|||
144409135|NCT03385564|520707351|FG003|Overall Study|Withdrawal by Subject|0|||
144409136|NCT03385564|520707348|FG000|Overall Study|Lack of Efficacy|0|||
144409137|NCT03385564|520707349|FG001|Overall Study|Lack of Efficacy|0|||
144409138|NCT03385564|520707350|FG002|Overall Study|Lack of Efficacy|0|||
144409139|NCT03385564|520707351|FG003|Overall Study|Lack of Efficacy|1|||
144409140|NCT03385564|520707348|FG000|Overall Study|Death|0|||
144409141|NCT03385564|520707349|FG001|Overall Study|Death|0|||
144409142|NCT03385564|520707350|FG002|Overall Study|Death|1|||
144409143|NCT03385564|520707351|FG003|Overall Study|Death|0|||
144409144|NCT03087643|520707356|FG000|Overall Study|Withdrawal by Subject|2|||
144409145|NCT03087643|520707357|FG001|Overall Study|Withdrawal by Subject|4|||
144409146|NCT03087643|520707356|FG000|Overall Study|Death|2|||
144409147|NCT03087643|520707357|FG001|Overall Study|Death|2|||
144409148|NCT01546883|520707361|FG000|Overall Study|Withdrawal by Subject|3|||
144409149|NCT01546883|520707361|FG000|Overall Study|Adverse Event|4|||
144409150|NCT01546883|520707361|FG000|Overall Study|Lost to Follow-up|2|||
144409151|NCT01546883|520707361|FG000|Overall Study|early closure of study|2|||
144409152|NCT01546883|520707361|FG000|Overall Study|other unrelated illness|1|||
144409153|NCT04545385|520707365|FG000|Overall Study|Withdrawal by Subject|2|||
144409154|NCT04545385|520707366|FG001|Overall Study|Withdrawal by Subject|0|||
144409155|NCT04545385|520707365|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
144409156|NCT04545385|520707366|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
144409157|NCT04545385|520707365|FG000|Overall Study|Study termination|10|||
144409158|NCT04545385|520707366|FG001|Overall Study|Study termination|10|||
144409159|NCT04545385|520707365|FG000|Overall Study|Sponsor decision|2|||
144409160|NCT04545385|520707366|FG001|Overall Study|Sponsor decision|2|||
144409161|NCT04545385|520707365|FG000|Overall Study|Other than specified|1|||
144409162|NCT04545385|520707366|FG001|Overall Study|Other than specified|0|||
144409163|NCT01128842|520707369|FG000|Overall Study|Adverse Event|1|||
144409164|NCT01128842|520707369|FG000|Overall Study|Disease Progression|6|||
144409165|NCT04528732|520707370|FG000|Overall Study|Death|1|||
144409166|NCT04528732|520707371|FG001|Overall Study|Death|0|||
144409167|NCT04528732|520707372|FG002|Overall Study|Death|1|||
144409168|NCT04528732|520707370|FG000|Overall Study|Lost to Follow-up|0|||
144409169|NCT04528732|520707371|FG001|Overall Study|Lost to Follow-up|1|||
144409170|NCT04528732|520707372|FG002|Overall Study|Lost to Follow-up|2|||
144409171|NCT00668707|520707379|FG000|Overall Study|Cancer Recurrence|58|||
144409172|NCT00668707|520707380|FG001|Overall Study|Cancer Recurrence|58|||
144409173|NCT00668707|520707379|FG000|Overall Study|Withdrawal by Subject|117|||
144409174|NCT00668707|520707380|FG001|Overall Study|Withdrawal by Subject|100|||
144409175|NCT00668707|520707379|FG000|Overall Study|Lost to Follow-up|3|||
144409176|NCT00668707|520707380|FG001|Overall Study|Lost to Follow-up|6|||
144409177|NCT00668707|520707379|FG000|Overall Study|Protocol Violation|10|||
144409178|NCT00668707|520707380|FG001|Overall Study|Protocol Violation|12|||
144409179|NCT00668707|520707379|FG000|Overall Study|Death|11|||
144409180|NCT00668707|520707380|FG001|Overall Study|Death|4|||
144409181|NCT00826943|520707381|FG000|Overall Study|Withdrawal by Subject|0|||
144409182|NCT00826943|520707382|FG001|Overall Study|Withdrawal by Subject|0|||
144409183|NCT00826943|520707383|FG002|Overall Study|Withdrawal by Subject|0|||
144409184|NCT00826943|520707384|FG003|Overall Study|Withdrawal by Subject|0|||
144409185|NCT00826943|520707385|FG004|Overall Study|Withdrawal by Subject|1|||
144409186|NCT00826943|520707386|FG005|Overall Study|Withdrawal by Subject|0|||
144409187|NCT01382212|520707387|FG000|Overall Study|Kidney transplant|1|||
144409188|NCT01382212|520707387|FG000|Overall Study|Withdrew consent|1|||
144409189|NCT01133522|520707391|FG000|Overall Study|Withdrawal by Subject|0|||
144409190|NCT01133522|520707392|FG001|Overall Study|Withdrawal by Subject|1|||
144409191|NCT01133522|520707393|FG002|Overall Study|Withdrawal by Subject|0|||
144409192|NCT01133522|520707394|FG003|Overall Study|Withdrawal by Subject|1|||
144409193|NCT01133522|520707395|FG004|Overall Study|Withdrawal by Subject|0|||
144409194|NCT01133522|520707396|FG005|Overall Study|Withdrawal by Subject|0|||
144409195|NCT01133522|520707397|FG006|Overall Study|Withdrawal by Subject|0|||
144409196|NCT01133522|520707398|FG007|Overall Study|Withdrawal by Subject|0|||
144409197|NCT01133522|520707399|FG008|Overall Study|Withdrawal by Subject|0|||
144409198|NCT01133522|520707400|FG009|Overall Study|Withdrawal by Subject|0|||
144409199|NCT01133522|520707391|FG000|Overall Study|Physician Decision|0|||
144409200|NCT01133522|520707392|FG001|Overall Study|Physician Decision|0|||
144409201|NCT01133522|520707393|FG002|Overall Study|Physician Decision|0|||
144409202|NCT01133522|520707394|FG003|Overall Study|Physician Decision|0|||
144409203|NCT01133522|520707395|FG004|Overall Study|Physician Decision|1|||
144409204|NCT01133522|520707396|FG005|Overall Study|Physician Decision|0|||
144409205|NCT01133522|520707397|FG006|Overall Study|Physician Decision|0|||
144409206|NCT01133522|520707398|FG007|Overall Study|Physician Decision|0|||
144409207|NCT01133522|520707399|FG008|Overall Study|Physician Decision|0|||
144409208|NCT01133522|520707400|FG009|Overall Study|Physician Decision|0|||
144409209|NCT02513394|520707408|FG000|Overall Study|Withdrawal by Subject|11|||
144409210|NCT02513394|520707409|FG001|Overall Study|Withdrawal by Subject|23|||
144722744|NCT01325207|521840527|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
144722745|NCT01325207|521840528|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
144722746|NCT01325207|521840529|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
144722747|NCT01325207|521840530|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
144722748|NCT01325207|521840531|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
144722749|NCT01325207|521840526|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
144722750|NCT01325207|521840527|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
144722751|NCT01325207|521840528|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
144722752|NCT01325207|521840529|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
144722753|NCT01325207|521840530|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
144722754|NCT01325207|521840531|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
144722755|NCT01325207|521840526|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
144722756|NCT01325207|521840527|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
144722757|NCT01325207|521840528|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
144722758|NCT01325207|521840529|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
144722759|NCT01325207|521840530|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
144722760|NCT01325207|521840531|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
144722761|NCT01325207|521840526|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
144722762|NCT01325207|521840527|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
144722763|NCT01325207|521840528|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
144722764|NCT01325207|521840529|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
144722765|NCT01325207|521840530|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
144722766|NCT01325207|521840531|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
144409211|NCT02513394|520707408|FG000|Overall Study|Ineligible|1|||
144409212|NCT02513394|520707409|FG001|Overall Study|Ineligible|0|||
144409213|NCT00688753|520709387|FG000|Overall Study|Disease progression|55|||
144409214|NCT00688753|520709387|FG000|Overall Study|Missing|1|||
144409215|NCT00688753|520709387|FG000|Overall Study|Death|9|||
144409216|NCT00688753|520709387|FG000|Overall Study|Withdrawal by Subject|3|||
144409217|NCT00688753|520709387|FG000|Overall Study|Adverse Event|20|||
144409218|NCT00688753|520709387|FG000|Overall Study|Protocol Violation|1|||
144409219|NCT00688753|520709387|FG000|Overall Study|Lost to Follow-up|3|||
144409220|NCT00395304|520709393|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144409221|NCT00395304|520709394|FG001|Treatment Period 1|Withdrawal by Subject|3|||
144409222|NCT00395304|520709395|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144409223|NCT00395304|520709396|FG003|Treatment Period 1|Withdrawal by Subject|2|||
144409224|NCT00395304|520709397|FG004|Treatment Period 1|Withdrawal by Subject|1|||
144409225|NCT00395304|520709398|FG005|Treatment Period 1|Withdrawal by Subject|1|||
144409226|NCT00395304|520709393|FG000|Treatment Period 1|Lost to Follow-up|1|||
144409227|NCT00395304|520709394|FG001|Treatment Period 1|Lost to Follow-up|0|||
144409228|NCT00395304|520709395|FG002|Treatment Period 1|Lost to Follow-up|0|||
144409229|NCT00395304|520709396|FG003|Treatment Period 1|Lost to Follow-up|1|||
144409230|NCT00395304|520709397|FG004|Treatment Period 1|Lost to Follow-up|0|||
144409231|NCT00395304|520709398|FG005|Treatment Period 1|Lost to Follow-up|1|||
144409232|NCT00395304|520709393|FG000|Treatment Period 1|Physician Decision|0|||
144409233|NCT00395304|520709394|FG001|Treatment Period 1|Physician Decision|1|||
144409234|NCT00395304|520709395|FG002|Treatment Period 1|Physician Decision|0|||
144409235|NCT00395304|520709396|FG003|Treatment Period 1|Physician Decision|0|||
144409236|NCT00395304|520709397|FG004|Treatment Period 1|Physician Decision|0|||
144409237|NCT00395304|520709398|FG005|Treatment Period 1|Physician Decision|0|||
144409238|NCT00395304|520709393|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144409239|NCT00395304|520709394|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144409240|NCT00395304|520709395|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144409241|NCT00395304|520709396|FG003|Treatment Period 2|Withdrawal by Subject|1|||
144409242|NCT00395304|520709397|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144409243|NCT00395304|520709398|FG005|Treatment Period 2|Withdrawal by Subject|2|||
144409244|NCT00395304|520709393|FG000|Treatment Period 2|Lost to Follow-up|0|||
144409245|NCT00395304|520709394|FG001|Treatment Period 2|Lost to Follow-up|3|||
144409246|NCT00395304|520709395|FG002|Treatment Period 2|Lost to Follow-up|0|||
144409247|NCT00395304|520709396|FG003|Treatment Period 2|Lost to Follow-up|0|||
144409248|NCT00395304|520709397|FG004|Treatment Period 2|Lost to Follow-up|0|||
144409249|NCT00395304|520709398|FG005|Treatment Period 2|Lost to Follow-up|0|||
144409250|NCT00395304|520709393|FG000|Treatment Period 2|Physician Decision|0|||
144409251|NCT00395304|520709394|FG001|Treatment Period 2|Physician Decision|0|||
144409252|NCT00395304|520709395|FG002|Treatment Period 2|Physician Decision|1|||
144409253|NCT00395304|520709396|FG003|Treatment Period 2|Physician Decision|0|||
144409254|NCT00395304|520709397|FG004|Treatment Period 2|Physician Decision|0|||
144409255|NCT00395304|520709398|FG005|Treatment Period 2|Physician Decision|0|||
144409256|NCT00395304|520709393|FG000|Treatment Period 2|Other|0|||
144409257|NCT00395304|520709394|FG001|Treatment Period 2|Other|1|||
144409258|NCT00395304|520709395|FG002|Treatment Period 2|Other|0|||
144409259|NCT00395304|520709396|FG003|Treatment Period 2|Other|0|||
144409260|NCT00395304|520709397|FG004|Treatment Period 2|Other|0|||
144409261|NCT00395304|520709398|FG005|Treatment Period 2|Other|0|||
144409262|NCT00395304|520709393|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144409263|NCT00395304|520709394|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144409264|NCT00395304|520709395|FG002|Treatment Period 3|Withdrawal by Subject|0|||
144409265|NCT00395304|520709396|FG003|Treatment Period 3|Withdrawal by Subject|1|||
144409266|NCT00395304|520709397|FG004|Treatment Period 3|Withdrawal by Subject|0|||
144409267|NCT00395304|520709398|FG005|Treatment Period 3|Withdrawal by Subject|1|||
144409268|NCT00395304|520709393|FG000|Treatment Period 3|Lost to Follow-up|1|||
144409269|NCT00395304|520709394|FG001|Treatment Period 3|Lost to Follow-up|1|||
144409270|NCT00395304|520709395|FG002|Treatment Period 3|Lost to Follow-up|0|||
144409271|NCT00395304|520709396|FG003|Treatment Period 3|Lost to Follow-up|0|||
144409272|NCT00395304|520709397|FG004|Treatment Period 3|Lost to Follow-up|0|||
144409273|NCT00395304|520709398|FG005|Treatment Period 3|Lost to Follow-up|0|||
144409274|NCT00395304|520709393|FG000|Treatment Period 3|Physician Decision|0|||
144409275|NCT00395304|520709394|FG001|Treatment Period 3|Physician Decision|1|||
144409276|NCT00395304|520709395|FG002|Treatment Period 3|Physician Decision|0|||
144409277|NCT00395304|520709396|FG003|Treatment Period 3|Physician Decision|0|||
144409278|NCT00395304|520709397|FG004|Treatment Period 3|Physician Decision|0|||
144409279|NCT00395304|520709398|FG005|Treatment Period 3|Physician Decision|0|||
144409280|NCT00395304|520709393|FG000|Treatment Period 3|Other|0|||
144409281|NCT00395304|520709394|FG001|Treatment Period 3|Other|0|||
144409282|NCT00395304|520709395|FG002|Treatment Period 3|Other|0|||
144409283|NCT00395304|520709396|FG003|Treatment Period 3|Other|1|||
144409284|NCT00395304|520709397|FG004|Treatment Period 3|Other|0|||
144409285|NCT00395304|520709398|FG005|Treatment Period 3|Other|0|||
144409286|NCT03797014|520709400|FG000|Overall Study|Withdrawal by Subject|1|||
144409287|NCT03797014|520709400|FG000|Overall Study|Lost to Follow-up|1|||
144409288|NCT03797014|520709400|FG000|Overall Study|Protocol Violation|1|||
144409289|NCT01970397|520709401|FG000|Overall Study|Adverse Event|0|||
144409290|NCT01970397|520709402|FG001|Overall Study|Adverse Event|1|||
144409291|NCT01970397|520709401|FG000|Overall Study|Lost to Follow-up|0|||
144409292|NCT01970397|520709402|FG001|Overall Study|Lost to Follow-up|1|||
144409293|NCT01970397|520709401|FG000|Overall Study|Personal Reasons|1|||
144409294|NCT01970397|520709402|FG001|Overall Study|Personal Reasons|2|||
144409295|NCT01970397|520709401|FG000|Overall Study|Protocol Violation|1|||
144409296|NCT01970397|520709402|FG001|Overall Study|Protocol Violation|1|||
144409297|NCT03305575|520709411|FG000|Overall Study|Physician Decision|1|||
144409298|NCT03305575|520709412|FG001|Overall Study|Physician Decision|0|||
144409299|NCT01389817|520709413|FG000|Overall Study|Physician Decision|1|||
144409300|NCT01389817|520709414|FG001|Overall Study|Physician Decision|0|||
144409301|NCT01389817|520709413|FG000|Overall Study|Lost to Follow-up|1|||
144409302|NCT01389817|520709414|FG001|Overall Study|Lost to Follow-up|0|||
144409303|NCT01389817|520709413|FG000|Overall Study|Withdrawal by Subject|2|||
144409304|NCT01389817|520709414|FG001|Overall Study|Withdrawal by Subject|0|||
144409305|NCT00105469|520709415|FG000|Overall Study|Adverse Event|9|||
144409306|NCT00105469|520709416|FG001|Overall Study|Adverse Event|8|||
144409307|NCT00105469|520709415|FG000|Overall Study|Protocol Violation|4|||
144409308|NCT00105469|520709416|FG001|Overall Study|Protocol Violation|0|||
144409309|NCT00105469|520709415|FG000|Overall Study|Withdrawal by Subject|2|||
144409310|NCT00105469|520709416|FG001|Overall Study|Withdrawal by Subject|3|||
144409311|NCT00105469|520709415|FG000|Overall Study|Lost to Follow-up|1|||
144409312|NCT00105469|520709416|FG001|Overall Study|Lost to Follow-up|0|||
144409313|NCT00105469|520709415|FG000|Overall Study|Lack of Efficacy|2|||
144409314|NCT00105469|520709416|FG001|Overall Study|Lack of Efficacy|0|||
144409315|NCT00105469|520709415|FG000|Overall Study|Other Reason|4|||
144409316|NCT00105469|520709416|FG001|Overall Study|Other Reason|0|||
144409317|NCT01749137|520709417|FG000|Overall Study|Adverse Event|4|||
144409318|NCT01749137|520709418|FG001|Overall Study|Adverse Event|4|||
144409319|NCT01749137|520709417|FG000|Overall Study|Lost to Follow-up|2|||
144409320|NCT01749137|520709418|FG001|Overall Study|Lost to Follow-up|3|||
144409321|NCT01749137|520709417|FG000|Overall Study|Physician Decision|1|||
144409322|NCT01749137|520709418|FG001|Overall Study|Physician Decision|0|||
144409323|NCT01749137|520709417|FG000|Overall Study|Withdrawal by Subject|8|||
144409324|NCT01749137|520709418|FG001|Overall Study|Withdrawal by Subject|4|||
144409325|NCT02871297|520709427|FG000|Overall Study|Adverse Event|34|||
144409326|NCT02871297|520709427|FG000|Overall Study|Lack of Efficacy|10|||
144409327|NCT02871297|520709427|FG000|Overall Study|Non-compliance with study drug|15|||
144409328|NCT02871297|520709427|FG000|Overall Study|Protocol Violation|3|||
144409329|NCT02871297|520709427|FG000|Overall Study|Withdrawal by Subject|20|||
144409330|NCT02871297|520709427|FG000|Overall Study|Lost to Follow-up|13|||
144409331|NCT02871297|520709427|FG000|Overall Study|Rolled over to 13546A|2|||
144409332|NCT02871297|520709427|FG000|Overall Study|Other than specified|39|||
144409333|NCT00599924|520709428|FG000|Overall Study|Lack of Efficacy|3|||
144409334|NCT00599924|520709429|FG001|Overall Study|Lack of Efficacy|5|||
144409335|NCT00599924|520709430|FG002|Overall Study|Lack of Efficacy|1|||
144409336|NCT00599924|520709431|FG003|Overall Study|Lack of Efficacy|2|||
144409337|NCT00599924|520709432|FG004|Overall Study|Lack of Efficacy|3|||
144409338|NCT00599924|520709433|FG005|Overall Study|Lack of Efficacy|2|||
144409339|NCT00599924|520709434|FG006|Overall Study|Lack of Efficacy|0|||
144409340|NCT00599924|520709428|FG000|Overall Study|Adverse Event|0|||
144409341|NCT00599924|520709429|FG001|Overall Study|Adverse Event|0|||
144409342|NCT00599924|520709430|FG002|Overall Study|Adverse Event|0|||
144409343|NCT00599924|520709431|FG003|Overall Study|Adverse Event|2|||
144409344|NCT00599924|520709432|FG004|Overall Study|Adverse Event|0|||
144409345|NCT00599924|520709433|FG005|Overall Study|Adverse Event|0|||
144409346|NCT00599924|520709434|FG006|Overall Study|Adverse Event|2|||
144409347|NCT00599924|520709428|FG000|Overall Study|Death|0|||
144409348|NCT00599924|520709429|FG001|Overall Study|Death|0|||
144409349|NCT00599924|520709430|FG002|Overall Study|Death|0|||
144409350|NCT00599924|520709431|FG003|Overall Study|Death|2|||
144409351|NCT00599924|520709432|FG004|Overall Study|Death|0|||
144409352|NCT00599924|520709433|FG005|Overall Study|Death|2|||
144409353|NCT00599924|520709434|FG006|Overall Study|Death|1|||
144525985|NCT00085735|521127107|FG001|Overall Study|Lost to Follow-up|1|||
144525986|NCT00085735|521127108|FG002|Overall Study|Lost to Follow-up|0|||
144409354|NCT00599924|520709428|FG000|Overall Study|Protocol Violation|0|||
144525987|NCT00085735|521127109|FG003|Overall Study|Lost to Follow-up|0|||
144409355|NCT00599924|520709429|FG001|Overall Study|Protocol Violation|0|||
144409356|NCT00599924|520709430|FG002|Overall Study|Protocol Violation|0|||
144409357|NCT00599924|520709431|FG003|Overall Study|Protocol Violation|1|||
144409358|NCT00599924|520709432|FG004|Overall Study|Protocol Violation|0|||
144409359|NCT00599924|520709433|FG005|Overall Study|Protocol Violation|0|||
144409360|NCT00599924|520709434|FG006|Overall Study|Protocol Violation|0|||
144409361|NCT00599924|520709428|FG000|Overall Study|Withdrawal by Subject|0|||
144409362|NCT00599924|520709429|FG001|Overall Study|Withdrawal by Subject|0|||
144409363|NCT00599924|520709430|FG002|Overall Study|Withdrawal by Subject|1|||
144409364|NCT00599924|520709431|FG003|Overall Study|Withdrawal by Subject|0|||
144409365|NCT00599924|520709432|FG004|Overall Study|Withdrawal by Subject|1|||
144525988|NCT00085735|521127110|FG004|Overall Study|Lost to Follow-up|1|||
144409366|NCT00599924|520709433|FG005|Overall Study|Withdrawal by Subject|0|||
144409367|NCT00599924|520709434|FG006|Overall Study|Withdrawal by Subject|0|||
144409368|NCT00599924|520709428|FG000|Overall Study|Other|0|||
144409369|NCT00599924|520709429|FG001|Overall Study|Other|0|||
144409370|NCT00599924|520709430|FG002|Overall Study|Other|0|||
144409371|NCT00599924|520709431|FG003|Overall Study|Other|1|||
144409372|NCT00599924|520709432|FG004|Overall Study|Other|2|||
144409373|NCT00599924|520709433|FG005|Overall Study|Other|0|||
144409374|NCT00599924|520709434|FG006|Overall Study|Other|2|||
144409375|NCT01806298|520709435|FG000|Overall Study|Adverse Event|3|||
144409376|NCT01806298|520709435|FG000|Overall Study|Protocol Non-compliance|1|||
144409377|NCT01806298|520709435|FG000|Overall Study|Withdrawal by Subject|1|||
144409378|NCT01806298|520709435|FG000|Overall Study|Other|5|||
144409379|NCT00980057|520709436|FG000|Overall Study|Death|13|||
144409380|NCT00980057|520709437|FG001|Overall Study|Death|3|||
144409381|NCT00980057|520709436|FG000|Overall Study|Adverse Event|0|||
144409382|NCT00980057|520709437|FG001|Overall Study|Adverse Event|1|||
144409383|NCT00980057|520709436|FG000|Overall Study|Physician Decision|4|||
144409384|NCT00980057|520709437|FG001|Overall Study|Physician Decision|0|||
144409385|NCT00980057|520709436|FG000|Overall Study|Lost to Follow-up|1|||
144409386|NCT00980057|520709437|FG001|Overall Study|Lost to Follow-up|0|||
144409387|NCT00980057|520709436|FG000|Overall Study|Withdrawal by Subject|1|||
144409388|NCT00980057|520709437|FG001|Overall Study|Withdrawal by Subject|1|||
144409389|NCT04980040|520709438|FG000|Overall Study|Violated the Inclusion Criteria|260|||
144409390|NCT04980040|520709438|FG000|Overall Study|Violated the Administration & Dosage|225|||
144409391|NCT04980040|520709438|FG000|Overall Study|Lost to Safety-Follow-up|4|||
144409392|NCT04980040|520709438|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
144409393|NCT00691015|520709442|FG000|Overall Study|Refused further treatment|1|||
144409394|NCT01397084|520709443|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
144409395|NCT01397084|520709443|FG000|Overall Study|Protocol Violation|2|||
144409396|NCT01397084|520709443|FG000|Overall Study|Adverse Event|2|||
144409397|NCT01397084|520709443|FG000|Overall Study|Withdrawal by Subject|1|||
144409398|NCT01397084|520709443|FG000|Overall Study|Lost to Follow-up|1|||
144409399|NCT01397084|520709443|FG000|Overall Study|Used other proton pump inhibitor|1|||
144409400|NCT00592384|520709448|FG000|Overall Study|Withdrawal by Subject|5|||
144409401|NCT00592384|520709449|FG001|Overall Study|Withdrawal by Subject|6|||
144409402|NCT01976338|520709450|FG000|Overall Study|Physician Decision|0|||
144409403|NCT01976338|520709451|FG001|Overall Study|Physician Decision|1|||
144409404|NCT01976338|520709450|FG000|Overall Study|Lost to Follow-up|3|||
144409405|NCT01976338|520709451|FG001|Overall Study|Lost to Follow-up|0|||
144409406|NCT01976338|520709450|FG000|Overall Study|Withdrawal by Subject|5|||
144409407|NCT01976338|520709451|FG001|Overall Study|Withdrawal by Subject|2|||
144409408|NCT01976338|520709450|FG000|Overall Study|Adverse Event|5|||
144409409|NCT01976338|520709451|FG001|Overall Study|Adverse Event|1|||
144409410|NCT02853604|520709452|FG000|Overall Study|Withdrawal by Subject|12|||
144409411|NCT02853604|520709453|FG001|Overall Study|Withdrawal by Subject|35|||
144409412|NCT02853604|520709452|FG000|Overall Study|Lost to Follow-up|4|||
144409413|NCT02853604|520709453|FG001|Overall Study|Lost to Follow-up|8|||
144409414|NCT02853604|520709452|FG000|Overall Study|Death|1|||
144409415|NCT02853604|520709453|FG001|Overall Study|Death|5|||
144409416|NCT02853604|520709452|FG000|Overall Study|Miscellaneous|11|||
144409417|NCT02853604|520709453|FG001|Overall Study|Miscellaneous|2|||
144409418|NCT02853604|520709452|FG000|Overall Study|Progressive Disease|0|||
144409419|NCT02853604|520709453|FG001|Overall Study|Progressive Disease|2|||
144409420|NCT03766581|520709455|FG000|Randomization|Other reasons|2|||
144409421|NCT03766581|520709456|FG001|Randomization|Other reasons|1|||
144409422|NCT03766581|520709457|FG002|Randomization|Other reasons|0|||
144409423|NCT03766581|520709458|FG003|Randomization|Other reasons|1|||
144409424|NCT03766581|520709459|FG004|Randomization|Other reasons|0|||
144409425|NCT03766581|520709460|FG005|Randomization|Other reasons|0|||
144409426|NCT03766581|520709461|FG006|Randomization|Other reasons|0|||
144409427|NCT03766581|520709462|FG007|Randomization|Other reasons|0|||
144409428|NCT03766581|520709455|FG000|Randomization|Participant no longer meets study criteria|5|||
144409429|NCT03766581|520709456|FG001|Randomization|Participant no longer meets study criteria|3|||
144409430|NCT03766581|520709457|FG002|Randomization|Participant no longer meets study criteria|4|||
144409431|NCT03766581|520709458|FG003|Randomization|Participant no longer meets study criteria|0|||
144409432|NCT03766581|520709459|FG004|Randomization|Participant no longer meets study criteria|2|||
144409433|NCT03766581|520709460|FG005|Randomization|Participant no longer meets study criteria|3|||
144409434|NCT03766581|520709461|FG006|Randomization|Participant no longer meets study criteria|0|||
144409435|NCT03766581|520709462|FG007|Randomization|Participant no longer meets study criteria|1|||
144409436|NCT03766581|520709455|FG000|Randomization|Participant request to discontinue study treatment|1|||
144409437|NCT03766581|520709456|FG001|Randomization|Participant request to discontinue study treatment|0|||
144409438|NCT03766581|520709457|FG002|Randomization|Participant request to discontinue study treatment|0|||
144409439|NCT03766581|520709458|FG003|Randomization|Participant request to discontinue study treatment|0|||
144409440|NCT03766581|520709459|FG004|Randomization|Participant request to discontinue study treatment|1|||
144409441|NCT03766581|520709460|FG005|Randomization|Participant request to discontinue study treatment|2|||
144409442|NCT03766581|520709461|FG006|Randomization|Participant request to discontinue study treatment|0|||
144409443|NCT03766581|520709462|FG007|Randomization|Participant request to discontinue study treatment|0|||
144250078|NCT04767529|520113450|FG001|Overall Study|Adverse Event|4|||
144250079|NCT04767529|520113451|FG002|Overall Study|Adverse Event|3|||
144250080|NCT04767529|520113449|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
144409444|NCT03766581|520709455|FG000|Randomization|Participant withdrew consent|1|||
144409445|NCT03766581|520709456|FG001|Randomization|Participant withdrew consent|0|||
144409446|NCT03766581|520709457|FG002|Randomization|Participant withdrew consent|1|||
144409447|NCT03766581|520709458|FG003|Randomization|Participant withdrew consent|2|||
144409448|NCT03766581|520709459|FG004|Randomization|Participant withdrew consent|1|||
144409449|NCT03766581|520709460|FG005|Randomization|Participant withdrew consent|1|||
144409450|NCT03766581|520709461|FG006|Randomization|Participant withdrew consent|0|||
144409451|NCT03766581|520709462|FG007|Randomization|Participant withdrew consent|0|||
144409452|NCT03766581|520709455|FG000|Treatment|Adverse Event|82|||
144409453|NCT03766581|520709456|FG001|Treatment|Adverse Event|44|||
144409454|NCT03766581|520709457|FG002|Treatment|Adverse Event|47|||
144409455|NCT03766581|520709458|FG003|Treatment|Adverse Event|46|||
144409456|NCT03766581|520709459|FG004|Treatment|Adverse Event|50|||
144409457|NCT03766581|520709460|FG005|Treatment|Adverse Event|77|||
144409458|NCT03766581|520709461|FG006|Treatment|Adverse Event|5|||
144409459|NCT03766581|520709462|FG007|Treatment|Adverse Event|2|||
144409460|NCT03766581|520709455|FG000|Treatment|Participant request to discontinue treatment|34|||
144409461|NCT03766581|520709456|FG001|Treatment|Participant request to discontinue treatment|6|||
144409462|NCT03766581|520709457|FG002|Treatment|Participant request to discontinue treatment|10|||
144409463|NCT03766581|520709458|FG003|Treatment|Participant request to discontinue treatment|10|||
144525989|NCT00085735|521127111|FG005|Overall Study|Lost to Follow-up|0|||
144525990|NCT00085735|521127106|FG000|Overall Study|Physician Decision|2|||
144525991|NCT00085735|521127107|FG001|Overall Study|Physician Decision|3|||
144525992|NCT00085735|521127108|FG002|Overall Study|Physician Decision|2|||
144525993|NCT00085735|521127109|FG003|Overall Study|Physician Decision|3|||
144525994|NCT00085735|521127110|FG004|Overall Study|Physician Decision|11|||
144525995|NCT00085735|521127111|FG005|Overall Study|Physician Decision|8|||
144525996|NCT00085735|521127106|FG000|Overall Study|Protocol Violation|1|||
144525997|NCT00085735|521127107|FG001|Overall Study|Protocol Violation|0|||
144525998|NCT00085735|521127108|FG002|Overall Study|Protocol Violation|0|||
144525999|NCT00085735|521127109|FG003|Overall Study|Protocol Violation|0|||
144526000|NCT00085735|521127110|FG004|Overall Study|Protocol Violation|0|||
144526001|NCT00085735|521127111|FG005|Overall Study|Protocol Violation|0|||
144526002|NCT00085735|521127106|FG000|Overall Study|Withdrawal by Subject|1|||
144526003|NCT00085735|521127107|FG001|Overall Study|Withdrawal by Subject|0|||
144526004|NCT00085735|521127108|FG002|Overall Study|Withdrawal by Subject|4|||
144526005|NCT00085735|521127109|FG003|Overall Study|Withdrawal by Subject|5|||
144526006|NCT00085735|521127110|FG004|Overall Study|Withdrawal by Subject|7|||
144526007|NCT00085735|521127111|FG005|Overall Study|Withdrawal by Subject|8|||
144526008|NCT00085735|521127106|FG000|Overall Study|Patient ineligible|1|||
144526009|NCT00085735|521127107|FG001|Overall Study|Patient ineligible|0|||
144526010|NCT00085735|521127108|FG002|Overall Study|Patient ineligible|3|||
144409464|NCT03766581|520709459|FG004|Treatment|Participant request to discontinue treatment|14|||
144409465|NCT03766581|520709460|FG005|Treatment|Participant request to discontinue treatment|15|||
144409466|NCT03766581|520709461|FG006|Treatment|Participant request to discontinue treatment|0|||
144409467|NCT03766581|520709462|FG007|Treatment|Participant request to discontinue treatment|1|||
144409468|NCT03766581|520709455|FG000|Treatment|Participant withdrew consent|11|||
144409469|NCT03766581|520709456|FG001|Treatment|Participant withdrew consent|4|||
144409470|NCT03766581|520709457|FG002|Treatment|Participant withdrew consent|5|||
144409471|NCT03766581|520709458|FG003|Treatment|Participant withdrew consent|5|||
144409472|NCT03766581|520709459|FG004|Treatment|Participant withdrew consent|4|||
144409473|NCT03766581|520709460|FG005|Treatment|Participant withdrew consent|4|||
144409474|NCT03766581|520709461|FG006|Treatment|Participant withdrew consent|0|||
144409475|NCT03766581|520709462|FG007|Treatment|Participant withdrew consent|0|||
144409476|NCT03766581|520709455|FG000|Treatment|Death|1|||
144409477|NCT03766581|520709456|FG001|Treatment|Death|0|||
144409478|NCT03766581|520709457|FG002|Treatment|Death|0|||
144409479|NCT03766581|520709458|FG003|Treatment|Death|0|||
144409480|NCT03766581|520709459|FG004|Treatment|Death|0|||
144409481|NCT03766581|520709460|FG005|Treatment|Death|0|||
144409482|NCT03766581|520709461|FG006|Treatment|Death|0|||
144409483|NCT03766581|520709462|FG007|Treatment|Death|0|||
144409484|NCT03766581|520709455|FG000|Treatment|Lost to Follow-up|1|||
144409485|NCT03766581|520709456|FG001|Treatment|Lost to Follow-up|0|||
144409486|NCT03766581|520709457|FG002|Treatment|Lost to Follow-up|0|||
144409487|NCT03766581|520709458|FG003|Treatment|Lost to Follow-up|1|||
144409488|NCT03766581|520709459|FG004|Treatment|Lost to Follow-up|0|||
144409489|NCT03766581|520709460|FG005|Treatment|Lost to Follow-up|0|||
144409490|NCT03766581|520709461|FG006|Treatment|Lost to Follow-up|0|||
144409491|NCT03766581|520709462|FG007|Treatment|Lost to Follow-up|0|||
144409492|NCT03766581|520709455|FG000|Treatment|Poor/Non compliance|2|||
144409493|NCT03766581|520709456|FG001|Treatment|Poor/Non compliance|2|||
144409494|NCT03766581|520709457|FG002|Treatment|Poor/Non compliance|1|||
144409495|NCT03766581|520709458|FG003|Treatment|Poor/Non compliance|1|||
144409496|NCT03766581|520709459|FG004|Treatment|Poor/Non compliance|1|||
144409497|NCT03766581|520709460|FG005|Treatment|Poor/Non compliance|1|||
144409498|NCT03766581|520709461|FG006|Treatment|Poor/Non compliance|0|||
144409499|NCT03766581|520709462|FG007|Treatment|Poor/Non compliance|0|||
144409500|NCT03766581|520709455|FG000|Treatment|Participant no longer meets study criteria|9|||
144409501|NCT03766581|520709456|FG001|Treatment|Participant no longer meets study criteria|1|||
144409502|NCT03766581|520709457|FG002|Treatment|Participant no longer meets study criteria|5|||
144409503|NCT03766581|520709458|FG003|Treatment|Participant no longer meets study criteria|4|||
144409504|NCT03766581|520709459|FG004|Treatment|Participant no longer meets study criteria|4|||
144409505|NCT03766581|520709460|FG005|Treatment|Participant no longer meets study criteria|4|||
144409506|NCT03766581|520709461|FG006|Treatment|Participant no longer meets study criteria|2|||
144409507|NCT03766581|520709462|FG007|Treatment|Participant no longer meets study criteria|0|||
144409508|NCT03766581|520709455|FG000|Treatment|Other reasons|13|||
144409509|NCT03766581|520709456|FG001|Treatment|Other reasons|8|||
144409510|NCT03766581|520709457|FG002|Treatment|Other reasons|3|||
144409511|NCT03766581|520709458|FG003|Treatment|Other reasons|7|||
144409512|NCT03766581|520709459|FG004|Treatment|Other reasons|3|||
144409513|NCT03766581|520709460|FG005|Treatment|Other reasons|3|||
144409514|NCT03766581|520709461|FG006|Treatment|Other reasons|0|||
144409515|NCT03766581|520709462|FG007|Treatment|Other reasons|0|||
144409516|NCT03716024|520709463|FG000|Overall Study|Randomized, not Treated|7|||
144409517|NCT03716024|520709464|FG001|Overall Study|Randomized, not Treated|8|||
144409518|NCT03716024|520709463|FG000|Overall Study|Adverse Event|1|||
144409519|NCT03716024|520709464|FG001|Overall Study|Adverse Event|2|||
144409520|NCT03716024|520709463|FG000|Overall Study|Treatment Failure|1|||
144409521|NCT03716024|520709464|FG001|Overall Study|Treatment Failure|0|||
144409522|NCT03716024|520709463|FG000|Overall Study|Lost to Follow-up|2|||
144409523|NCT03716024|520709464|FG001|Overall Study|Lost to Follow-up|6|||
144409524|NCT03716024|520709463|FG000|Overall Study|Withdrawal by Subject|0|||
144409525|NCT03716024|520709464|FG001|Overall Study|Withdrawal by Subject|1|||
144409526|NCT03716024|520709463|FG000|Overall Study|Missing Reason|0|||
144409527|NCT03716024|520709464|FG001|Overall Study|Missing Reason|1|||
144409528|NCT04182763|520709475|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
144409529|NCT04182763|520709476|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
144409530|NCT04182763|520709477|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
144409531|NCT04182763|520709478|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
144409532|NCT04182763|520709479|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
144409533|NCT04182763|520709475|FG000|Double-Blind Period, initial 6 months|Death|0|||
144409534|NCT04182763|520709476|FG001|Double-Blind Period, initial 6 months|Death|1|||
144409535|NCT04182763|520709477|FG002|Double-Blind Period, initial 6 months|Death|0|||
144409536|NCT04182763|520709478|FG003|Double-Blind Period, initial 6 months|Death|0|||
144409537|NCT04182763|520709479|FG004|Double-Blind Period, initial 6 months|Death|0|||
144409538|NCT04182763|520709475|FG000|Open-Label Period, subsequent 18 months|Death|3|||
144409539|NCT04182763|520709476|FG001|Open-Label Period, subsequent 18 months|Death|2|||
144409540|NCT04182763|520709477|FG002|Open-Label Period, subsequent 18 months|Death|2|||
144409541|NCT04182763|520709478|FG003|Open-Label Period, subsequent 18 months|Death|0|||
144409542|NCT04182763|520709479|FG004|Open-Label Period, subsequent 18 months|Death|1|||
144409543|NCT04182763|520709475|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
144409544|NCT04182763|520709476|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
144409545|NCT04182763|520709477|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
144409546|NCT04182763|520709478|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
144409547|NCT04182763|520709479|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
144409548|NCT04182763|520709475|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
144409549|NCT04182763|520709476|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
144409550|NCT04182763|520709477|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
144409551|NCT04182763|520709478|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
144409552|NCT04182763|520709479|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
144409553|NCT05988619|520709481|FG000|Overall Study|Lost to Follow-up|1|||
144409554|NCT05988619|520709482|FG001|Overall Study|Lost to Follow-up|4|||
144409555|NCT05988619|520709481|FG000|Overall Study|Withdrawal by Subject|2|||
144409556|NCT05988619|520709482|FG001|Overall Study|Withdrawal by Subject|9|||
144409557|NCT00587054|520709485|FG000|Overall Study|Patient not treated|9|||
144409558|NCT03010176|520709487|FG000|Overall Study|Death|21|||
144409559|NCT03010176|520709488|FG001|Overall Study|Death|35|||
144409560|NCT03010176|520709489|FG002|Overall Study|Death|19|||
144409561|NCT03010176|520709490|FG003|Overall Study|Death|19|||
144409562|NCT03010176|520709491|FG004|Overall Study|Death|14|||
144409563|NCT03010176|520709492|FG005|Overall Study|Death|0|||
144409564|NCT03010176|520709487|FG000|Overall Study|Lost to Follow-up|0|||
144409565|NCT03010176|520709488|FG001|Overall Study|Lost to Follow-up|0|||
144409566|NCT03010176|520709489|FG002|Overall Study|Lost to Follow-up|0|||
144409567|NCT03010176|520709490|FG003|Overall Study|Lost to Follow-up|0|||
144409568|NCT03010176|520709491|FG004|Overall Study|Lost to Follow-up|1|||
144409569|NCT03010176|520709492|FG005|Overall Study|Lost to Follow-up|0|||
144409570|NCT03010176|520709487|FG000|Overall Study|Physician Decision|0|||
144409571|NCT03010176|520709488|FG001|Overall Study|Physician Decision|4|||
144409572|NCT03010176|520709489|FG002|Overall Study|Physician Decision|0|||
144409573|NCT03010176|520709490|FG003|Overall Study|Physician Decision|1|||
144409574|NCT03010176|520709491|FG004|Overall Study|Physician Decision|0|||
144409575|NCT03010176|520709492|FG005|Overall Study|Physician Decision|0|||
144409576|NCT03010176|520709487|FG000|Overall Study|Sponsor Decision|0|||
144409577|NCT03010176|520709488|FG001|Overall Study|Sponsor Decision|4|||
144409578|NCT03010176|520709489|FG002|Overall Study|Sponsor Decision|4|||
144409579|NCT03010176|520709490|FG003|Overall Study|Sponsor Decision|1|||
144409580|NCT03010176|520709491|FG004|Overall Study|Sponsor Decision|6|||
144409581|NCT03010176|520709492|FG005|Overall Study|Sponsor Decision|0|||
144409582|NCT03010176|520709487|FG000|Overall Study|Withdrawal by Subject|11|||
144409583|NCT03010176|520709488|FG001|Overall Study|Withdrawal by Subject|9|||
144409584|NCT03010176|520709489|FG002|Overall Study|Withdrawal by Subject|3|||
144409585|NCT03010176|520709490|FG003|Overall Study|Withdrawal by Subject|0|||
144409586|NCT03010176|520709491|FG004|Overall Study|Withdrawal by Subject|4|||
144409587|NCT03010176|520709492|FG005|Overall Study|Withdrawal by Subject|0|||
144409588|NCT01651039|520709495|FG000|Overall Study|Non-evaluables|5|||
144409589|NCT01651039|520709495|FG000|Overall Study|Physician Decision|2|||
144409590|NCT01651039|520709495|FG000|Overall Study|Withdrawal by Subject|1|||
144409591|NCT01651039|520709495|FG000|Overall Study|Progressive Disease|22|||
144409592|NCT03600818|520709496|FG000|Overall Study|Adverse Event|4|||
144409593|NCT03600818|520709497|FG001|Overall Study|Adverse Event|7|||
144409594|NCT03600818|520709496|FG000|Overall Study|Lack of Efficacy|9|||
144409595|NCT03600818|520709497|FG001|Overall Study|Lack of Efficacy|4|||
144409596|NCT03600818|520709496|FG000|Overall Study|Withdrawal by Subject|4|||
144409597|NCT03600818|520709497|FG001|Overall Study|Withdrawal by Subject|3|||
144409598|NCT03600818|520709496|FG000|Overall Study|Other-unspecified|5|||
144409599|NCT03600818|520709497|FG001|Overall Study|Other-unspecified|3|||
144409600|NCT03600818|520709496|FG000|Overall Study|Randomized and not treated|0|||
144409601|NCT03600818|520709497|FG001|Overall Study|Randomized and not treated|1|||
144409602|NCT01488370|520709498|FG000|Overall Study|Protocol Violation|0|||
144409603|NCT01488370|520709499|FG001|Overall Study|Protocol Violation|1|||
144409604|NCT01488370|520709500|FG002|Overall Study|Protocol Violation|1|||
144409605|NCT01471171|520709501|FG000|Treatment Period 1|Adverse Event|4|||
144409606|NCT01471171|520709502|FG001|Treatment Period 1|Adverse Event|1|||
144409607|NCT01471171|520709501|FG000|Treatment Period 2|Adverse Event|1|||
144409608|NCT01471171|520709502|FG001|Treatment Period 2|Adverse Event|0|||
144409609|NCT00553644|520709507|FG000|Overall Study|Adverse Event|17|||
144409610|NCT00553644|520709507|FG000|Overall Study|Withdrawal by Subject|4|||
144409611|NCT00553644|520709507|FG000|Overall Study|Physician Decision|1|||
144409612|NCT00553644|520709507|FG000|Overall Study|Alternative therapy|6|||
144409613|NCT00705484|520709508|FG000|Overall Study|Adverse Event|28|||
144409614|NCT00705484|520709509|FG001|Overall Study|Adverse Event|27|||
144409615|NCT00705484|520709508|FG000|Overall Study|Lost to Follow-up|169|||
144409616|NCT00705484|520709509|FG001|Overall Study|Lost to Follow-up|250|||
144409617|NCT00705484|520709508|FG000|Overall Study|Withdrawal by Subject|96|||
144409618|NCT00705484|520709509|FG001|Overall Study|Withdrawal by Subject|72|||
144409619|NCT00705484|520709508|FG000|Overall Study|Administrative|89|||
144409620|NCT00705484|520709509|FG001|Overall Study|Administrative|59|||
144409621|NCT03470441|520709514|FG000|Overall Study|Death|0|||
144409622|NCT03470441|520709515|FG001|Overall Study|Death|1|||
144409623|NCT03470441|520709516|FG002|Overall Study|Death|1|||
144409624|NCT03470441|520709517|FG003|Overall Study|Death|0|||
144409625|NCT03470441|520709514|FG000|Overall Study|Adverse Event|0|||
144409626|NCT03470441|520709515|FG001|Overall Study|Adverse Event|0|||
144409627|NCT03470441|520709516|FG002|Overall Study|Adverse Event|0|||
144409628|NCT03470441|520709517|FG003|Overall Study|Adverse Event|1|||
144409629|NCT03470441|520709514|FG000|Overall Study|Withdrawal by Subject|1|||
144409630|NCT03470441|520709515|FG001|Overall Study|Withdrawal by Subject|4|||
144409631|NCT03470441|520709516|FG002|Overall Study|Withdrawal by Subject|1|||
144409632|NCT03470441|520709517|FG003|Overall Study|Withdrawal by Subject|3|||
144526011|NCT00085735|521127109|FG003|Overall Study|Patient ineligible|7|||
144526012|NCT00085735|521127110|FG004|Overall Study|Patient ineligible|17|||
144526013|NCT00085735|521127111|FG005|Overall Study|Patient ineligible|8|||
144526014|NCT00085735|521127106|FG000|Overall Study|Excess residual disease|2|||
144526015|NCT00085735|521127107|FG001|Overall Study|Excess residual disease|2|||
144526016|NCT00085735|521127108|FG002|Overall Study|Excess residual disease|1|||
144526017|NCT00085735|521127109|FG003|Overall Study|Excess residual disease|1|||
144526018|NCT00085735|521127110|FG004|Overall Study|Excess residual disease|1|||
144526019|NCT00085735|521127111|FG005|Overall Study|Excess residual disease|4|||
144526020|NCT00085735|521127106|FG000|Overall Study|Reason not documented|1|||
144526021|NCT00085735|521127107|FG001|Overall Study|Reason not documented|0|||
144526022|NCT00085735|521127108|FG002|Overall Study|Reason not documented|1|||
144526023|NCT00085735|521127109|FG003|Overall Study|Reason not documented|0|||
144526024|NCT00085735|521127110|FG004|Overall Study|Reason not documented|1|||
144526025|NCT00085735|521127111|FG005|Overall Study|Reason not documented|0|||
144526026|NCT00085735|521127106|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
144526027|NCT00085735|521127107|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
144526028|NCT00085735|521127108|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
144526029|NCT00085735|521127109|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
144526030|NCT00085735|521127110|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
144526031|NCT00085735|521127111|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
144526032|NCT01824875|521127112|FG000|Overall Study|Disease progression|22|||
144526033|NCT01824875|521127113|FG001|Overall Study|Disease progression|15|||
144526034|NCT01824875|521127112|FG000|Overall Study|Withdrawal by Subject|5|||
144526035|NCT01824875|521127113|FG001|Overall Study|Withdrawal by Subject|4|||
144526036|NCT01824875|521127112|FG000|Overall Study|Adverse Event|4|||
144526037|NCT01824875|521127113|FG001|Overall Study|Adverse Event|10|||
144526038|NCT01824875|521127112|FG000|Overall Study|Alternative therapy|3|||
144526039|NCT01824875|521127113|FG001|Overall Study|Alternative therapy|0|||
144526040|NCT01824875|521127112|FG000|Overall Study|Complicating disease|1|||
144526041|NCT01824875|521127113|FG001|Overall Study|Complicating disease|0|||
144526042|NCT01824875|521127112|FG000|Overall Study|Physician Decision|0|||
144526043|NCT01824875|521127113|FG001|Overall Study|Physician Decision|1|||
144526044|NCT01824875|521127112|FG000|Overall Study|Non-compliance|1|||
144526045|NCT01824875|521127113|FG001|Overall Study|Non-compliance|1|||
144526046|NCT01824875|521127112|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
144526047|NCT01824875|521127113|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
144526048|NCT01824875|521127112|FG000|Overall Study|Administrative issues|0|||
144526049|NCT01824875|521127113|FG001|Overall Study|Administrative issues|2|||
144526050|NCT01824875|521127112|FG000|Overall Study|Ineligible or never started treatment|9|||
144526051|NCT01824875|521127113|FG001|Overall Study|Ineligible or never started treatment|5|||
144526052|NCT01824875|521127112|FG000|Overall Study|Other|0|||
144250081|NCT04767529|520113450|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
144526053|NCT01824875|521127113|FG001|Overall Study|Other|2|||
144526054|NCT02817776|521127114|FG000|Overall Study|Excluded|33|||
144526055|NCT02817776|521127114|FG000|Overall Study|Lost to Follow-up|20|||
144526056|NCT02817776|521127114|FG000|Overall Study|Withdrawal by Subject|33|||
144526057|NCT02817776|521127114|FG000|Overall Study|Death|2|||
144526058|NCT05540665|521127115|FG000|Overall Study|Study terminated by sponsor|6|||
144526059|NCT05540665|521127116|FG001|Overall Study|Study terminated by sponsor|6|||
144526060|NCT05540665|521127117|FG002|Overall Study|Study terminated by sponsor|7|||
144526061|NCT03371381|521127118|FG000|Overall Study|Death|5|||
144526062|NCT03371381|521127118|FG000|Overall Study|Study terminated by sponsor|3|||
144526063|NCT03371381|521127118|FG000|Overall Study|Other|4|||
144526064|NCT02979327|521127119|FG000|First Intervention|Protocol Violation|1|||
144526065|NCT02979327|521127120|FG001|First Intervention|Protocol Violation|0|||
144526066|NCT04376502|521127122|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
144526067|NCT02547233|521127123|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
144526068|NCT02547233|521127124|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
144526069|NCT02547233|521127123|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
144526070|NCT02547233|521127124|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
144526071|NCT02547233|521127123|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
144526072|NCT02547233|521127124|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
144526073|NCT02547233|521127123|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
144526074|NCT02547233|521127124|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
144526075|NCT02547233|521127123|FG000|12-month Follow-up|Withdrawal by Subject|10|||
144526076|NCT02547233|521127124|FG001|12-month Follow-up|Withdrawal by Subject|10|||
144526077|NCT02547233|521127123|FG000|12-month Follow-up|Lost to Follow-up|3|||
144526078|NCT02547233|521127124|FG001|12-month Follow-up|Lost to Follow-up|3|||
144526079|NCT02547233|521127123|FG000|12-month Follow-up|Lack of Efficacy|1|||
144526080|NCT02547233|521127124|FG001|12-month Follow-up|Lack of Efficacy|2|||
144526081|NCT02547233|521127123|FG000|12-month Follow-up|Protocol Violation|0|||
144526082|NCT02547233|521127124|FG001|12-month Follow-up|Protocol Violation|1|||
144526083|NCT02547233|521127123|FG000|12-month Follow-up|Other|0|||
144526084|NCT02547233|521127124|FG001|12-month Follow-up|Other|1|||
144526085|NCT06215521|521127125|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
144526086|NCT06215521|521127126|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
144526087|NCT06215521|521127127|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
144526088|NCT06215521|521127128|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
144526089|NCT06215521|521127129|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
144526090|NCT06215521|521127130|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
144526091|NCT02998268|521127132|FG000|Overall Study|Adverse Event|0|||
144526092|NCT02998268|521127133|FG001|Overall Study|Adverse Event|2|||
144526093|NCT02998268|521127132|FG000|Overall Study|Withdrawal by Subject|0|||
144526094|NCT02998268|521127133|FG001|Overall Study|Withdrawal by Subject|1|||
144526095|NCT04225273|521127134|FG000|Overall Study|Lost to Follow-up|3|||
144526096|NCT05269667|521127135|FG000|Overall Study|Study Terminated by Sponsor|4|||
144526097|NCT05270408|521127136|FG000|Started Treatment|Withdrawal by Subject|0|||
144526098|NCT05270408|521127137|FG001|Started Treatment|Withdrawal by Subject|0|||
144526099|NCT05270408|521127138|FG002|Started Treatment|Withdrawal by Subject|3|||
144526100|NCT05270408|521127136|FG000|Started Treatment|Adverse Event|0|||
144526101|NCT05270408|521127137|FG001|Started Treatment|Adverse Event|0|||
144526102|NCT05270408|521127138|FG002|Started Treatment|Adverse Event|1|||
144526103|NCT05270408|521127136|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
144526104|NCT05270408|521127137|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
144526105|NCT05270408|521127138|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
144526106|NCT03768505|521127139|FG000|Overall Study|sponsor decision|76|||
144526107|NCT03768505|521127139|FG000|Overall Study|Death|35|||
144526108|NCT03768505|521127139|FG000|Overall Study|Other -Various|30|||
144526109|NCT03768505|521127139|FG000|Overall Study|Withdrawal by Subject|22|||
144526110|NCT03768505|521127139|FG000|Overall Study|Lost to Follow-up|6|||
144526111|NCT02861300|521127140|FG000|Overall Study|Death|0|||
144526112|NCT02861300|521127141|FG001|Overall Study|Death|0|||
144526113|NCT02861300|521127142|FG002|Overall Study|Death|0|||
144526114|NCT02861300|521127143|FG003|Overall Study|Death|0|||
144526115|NCT02861300|521127144|FG004|Overall Study|Death|0|||
144526116|NCT02861300|521127145|FG005|Overall Study|Death|0|||
144526117|NCT02861300|521127146|FG006|Overall Study|Death|24|||
144526118|NCT02861300|521127140|FG000|Overall Study|Delay in treatment|0|||
144526119|NCT02861300|521127141|FG001|Overall Study|Delay in treatment|0|||
144526120|NCT02861300|521127142|FG002|Overall Study|Delay in treatment|0|||
144526121|NCT02861300|521127143|FG003|Overall Study|Delay in treatment|0|||
144526122|NCT02861300|521127144|FG004|Overall Study|Delay in treatment|0|||
144526123|NCT02861300|521127145|FG005|Overall Study|Delay in treatment|1|||
144526124|NCT02861300|521127146|FG006|Overall Study|Delay in treatment|0|||
144526125|NCT02861300|521127140|FG000|Overall Study|Disease Progression|0|||
144526126|NCT02861300|521127141|FG001|Overall Study|Disease Progression|1|||
144526127|NCT02861300|521127142|FG002|Overall Study|Disease Progression|0|||
144526128|NCT02861300|521127143|FG003|Overall Study|Disease Progression|0|||
144526129|NCT02861300|521127144|FG004|Overall Study|Disease Progression|0|||
144526130|NCT02861300|521127145|FG005|Overall Study|Disease Progression|0|||
144526131|NCT02861300|521127146|FG006|Overall Study|Disease Progression|2|||
144526132|NCT02861300|521127140|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
144526133|NCT02861300|521127141|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
144526134|NCT02861300|521127142|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
144526135|NCT02861300|521127143|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
144526136|NCT02861300|521127144|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
144526137|NCT02861300|521127145|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
144526138|NCT02861300|521127146|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
144526139|NCT02861300|521127140|FG000|Overall Study|Clinical Complications|0|||
144526140|NCT02861300|521127141|FG001|Overall Study|Clinical Complications|0|||
144526141|NCT02861300|521127142|FG002|Overall Study|Clinical Complications|0|||
144600020|NCT01717768|521397559|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600021|NCT01717768|521397560|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600022|NCT01717768|521397561|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600023|NCT01717768|521397562|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600024|NCT01717768|521397563|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
144600025|NCT01717768|521397564|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600026|NCT01717768|521397565|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600027|NCT01717768|521397566|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600028|NCT01717768|521397567|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
144600029|NCT01717768|521397556|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600030|NCT01717768|521397557|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600031|NCT01717768|521397558|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600032|NCT01717768|521397559|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600033|NCT01717768|521397560|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600034|NCT01717768|521397561|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600035|NCT01717768|521397562|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600036|NCT01717768|521397563|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600037|NCT01717768|521397564|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600038|NCT01717768|521397565|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
144600039|NCT01717768|521397566|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600040|NCT01717768|521397567|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
144600041|NCT01774084|521397568|FG000|Overall Study|Personal reasons|1|||
144600042|NCT01774084|521397569|FG001|Overall Study|Personal reasons|0|||
144600043|NCT02430051|521397572|FG000|Overall Study|Withdrawal by Subject|6|||
144600044|NCT02430051|521397573|FG001|Overall Study|Withdrawal by Subject|3|||
144600045|NCT02430051|521397572|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
144600046|NCT02430051|521397573|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
144600047|NCT02430051|521397572|FG000|Overall Study|Protocol Violation|1|||
144600048|NCT02430051|521397573|FG001|Overall Study|Protocol Violation|0|||
144600049|NCT04526197|521397574|FG000|Period 1|Adverse Event|0|||
144600050|NCT04526197|521397575|FG001|Period 1|Adverse Event|1|||
144600051|NCT04526197|521397574|FG000|Period 1|Withdrawal by Subject|1|||
144600052|NCT04526197|521397575|FG001|Period 1|Withdrawal by Subject|0|||
144600053|NCT04526197|521397574|FG000|Period 2|Adverse Event|0|||
144600054|NCT04526197|521397575|FG001|Period 2|Adverse Event|1|||
144600055|NCT04526197|521397574|FG000|Period 2|Withdrawal by Subject|0|||
144600056|NCT04526197|521397575|FG001|Period 2|Withdrawal by Subject|1|||
144600057|NCT01136811|521397576|FG000|Overall Study|Physician Decision|11|||
144600058|NCT00372385|521397577|FG000|Overall Study|Adverse Event|6|||
144600059|NCT00372385|521397578|FG001|Overall Study|Adverse Event|11|||
144600060|NCT00372385|521397579|FG002|Overall Study|Adverse Event|9|||
144600061|NCT00372385|521397580|FG003|Overall Study|Adverse Event|7|||
144600062|NCT00372385|521397577|FG000|Overall Study|Noncompliance|0|||
144600063|NCT00372385|521397578|FG001|Overall Study|Noncompliance|1|||
144600064|NCT00372385|521397579|FG002|Overall Study|Noncompliance|1|||
144600065|NCT00372385|521397580|FG003|Overall Study|Noncompliance|1|||
144600066|NCT00372385|521397577|FG000|Overall Study|Physician Decision|1|||
144600067|NCT00372385|521397578|FG001|Overall Study|Physician Decision|0|||
144600068|NCT00372385|521397579|FG002|Overall Study|Physician Decision|0|||
144600069|NCT00372385|521397580|FG003|Overall Study|Physician Decision|0|||
144600070|NCT00372385|521397577|FG000|Overall Study|Lost to Follow-up|2|||
144600071|NCT00372385|521397578|FG001|Overall Study|Lost to Follow-up|0|||
144600072|NCT00372385|521397579|FG002|Overall Study|Lost to Follow-up|0|||
144600073|NCT00372385|521397580|FG003|Overall Study|Lost to Follow-up|0|||
144600074|NCT00372385|521397577|FG000|Overall Study|Withdrawal by Subject|2|||
144600075|NCT00372385|521397578|FG001|Overall Study|Withdrawal by Subject|1|||
144600076|NCT00372385|521397579|FG002|Overall Study|Withdrawal by Subject|0|||
144600077|NCT00372385|521397580|FG003|Overall Study|Withdrawal by Subject|0|||
144600078|NCT00372385|521397577|FG000|Overall Study|Refusal of Treatment|3|||
144600079|NCT00372385|521397578|FG001|Overall Study|Refusal of Treatment|6|||
144600080|NCT00372385|521397579|FG002|Overall Study|Refusal of Treatment|0|||
144600081|NCT00372385|521397580|FG003|Overall Study|Refusal of Treatment|0|||
144600082|NCT00372385|521397577|FG000|Overall Study|No Response|1|||
144600083|NCT00372385|521397578|FG001|Overall Study|No Response|1|||
144600084|NCT00372385|521397579|FG002|Overall Study|No Response|0|||
144600085|NCT00372385|521397580|FG003|Overall Study|No Response|0|||
144600086|NCT00372385|521397577|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
144600087|NCT00372385|521397578|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
144600088|NCT00372385|521397579|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
144600089|NCT00372385|521397580|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
144600090|NCT00372385|521397577|FG000|Overall Study|Virologic Stopping Rule|17|||
144600091|NCT00372385|521397578|FG001|Overall Study|Virologic Stopping Rule|0|||
144526142|NCT02861300|521127143|FG003|Overall Study|Clinical Complications|0|||
144526143|NCT02861300|521127144|FG004|Overall Study|Clinical Complications|0|||
144526144|NCT02861300|521127145|FG005|Overall Study|Clinical Complications|0|||
144526145|NCT02861300|521127146|FG006|Overall Study|Clinical Complications|1|||
144526146|NCT05399459|521127149|FG000|Overall Study|Randomized but not treated|29|||
144526147|NCT05399459|521127150|FG001|Overall Study|Randomized but not treated|30|||
144526148|NCT05399459|521127151|FG002|Overall Study|Randomized but not treated|38|||
144526149|NCT05399459|521127149|FG000|Overall Study|Lost to Follow-up|1|||
144526150|NCT05399459|521127150|FG001|Overall Study|Lost to Follow-up|0|||
144526151|NCT05399459|521127151|FG002|Overall Study|Lost to Follow-up|0|||
144526152|NCT04992520|521127152|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
144526153|NCT04992520|521127153|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
144526154|NCT04992520|521127154|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
144526155|NCT04992520|521127155|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
144526156|NCT04992520|521127156|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
144526157|NCT04992520|521127157|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
144526158|NCT04992520|521127152|FG000|Part A: First Challenge|Non-compliance|0|||
144526159|NCT04992520|521127153|FG001|Part A: First Challenge|Non-compliance|0|||
144526160|NCT04992520|521127154|FG002|Part A: First Challenge|Non-compliance|0|||
144526161|NCT04992520|521127155|FG003|Part A: First Challenge|Non-compliance|1|||
144526162|NCT04992520|521127156|FG004|Part A: First Challenge|Non-compliance|0|||
144526163|NCT04992520|521127157|FG005|Part A: First Challenge|Non-compliance|0|||
144526164|NCT04992520|521127152|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
144526165|NCT04992520|521127153|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
144526166|NCT04992520|521127154|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
144526167|NCT04992520|521127155|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
144526168|NCT04992520|521127156|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
144526169|NCT04992520|521127157|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
144526170|NCT04992520|521127152|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
144526171|NCT04992520|521127153|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
144526172|NCT04992520|521127154|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
144526173|NCT04992520|521127155|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
144526174|NCT04992520|521127156|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
144526175|NCT04992520|521127157|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
144526176|NCT03625167|521127159|FG000|Overall Study|Protocol Violation|5|||
144526177|NCT02231164|521127160|FG000|Overall Study|Adverse Event|1|||
144526178|NCT02231164|521127161|FG001|Overall Study|Adverse Event|1|||
144526179|NCT02231164|521127160|FG000|Overall Study|Lack of Efficacy|4|||
144526180|NCT02231164|521127161|FG001|Overall Study|Lack of Efficacy|3|||
144526181|NCT02231164|521127160|FG000|Overall Study|Withdrawal by Subject|1|||
144526182|NCT02231164|521127161|FG001|Overall Study|Withdrawal by Subject|2|||
144526183|NCT06103188|521127163|FG000|Overall Study|Lost to Follow-up|1|||
144526184|NCT06103188|521127164|FG001|Overall Study|Lost to Follow-up|6|||
144526185|NCT06103188|521127165|FG002|Overall Study|Lost to Follow-up|4|||
144526186|NCT05201079|521127170|FG000|Overall Study|Adverse Event|7|||
144526187|NCT05201079|521127171|FG001|Overall Study|Adverse Event|11|||
144526188|NCT05201079|521127170|FG000|Overall Study|Death|1|||
144526189|NCT05201079|521127171|FG001|Overall Study|Death|1|||
144526190|NCT05201079|521127170|FG000|Overall Study|Lack of Efficacy|0|||
144526191|NCT05201079|521127171|FG001|Overall Study|Lack of Efficacy|2|||
144526192|NCT05201079|521127170|FG000|Overall Study|Lost to Follow-up|0|||
144526193|NCT05201079|521127171|FG001|Overall Study|Lost to Follow-up|1|||
144526194|NCT05201079|521127170|FG000|Overall Study|Physician Decision|1|||
144526195|NCT05201079|521127171|FG001|Overall Study|Physician Decision|1|||
144526196|NCT05201079|521127170|FG000|Overall Study|Protocol Violation|1|||
144526197|NCT05201079|521127171|FG001|Overall Study|Protocol Violation|0|||
144526198|NCT05201079|521127170|FG000|Overall Study|Withdrawal by Subject|1|||
144526199|NCT05201079|521127171|FG001|Overall Study|Withdrawal by Subject|0|||
144526200|NCT05201079|521127170|FG000|Overall Study|Forbidden medication|9|||
144526201|NCT05201079|521127171|FG001|Overall Study|Forbidden medication|5|||
144526202|NCT05201079|521127170|FG000|Overall Study|Transfer to another hospital|0|||
144526203|NCT05201079|521127171|FG001|Overall Study|Transfer to another hospital|1|||
144526204|NCT05201079|521127170|FG000|Overall Study|Clinical condition|1|||
144526205|NCT05201079|521127171|FG001|Overall Study|Clinical condition|0|||
144526206|NCT05201079|521127170|FG000|Overall Study|SAE and sepsis|1|||
144526207|NCT05201079|521127171|FG001|Overall Study|SAE and sepsis|0|||
144526208|NCT04145440|521127172|FG000|Overall Study|Physician Decision|3|||
144526209|NCT04145440|521127173|FG001|Overall Study|Physician Decision|0|||
144526210|NCT04145440|521127172|FG000|Overall Study|Use of prohibited therapy|2|||
144526211|NCT04145440|521127173|FG001|Overall Study|Use of prohibited therapy|3|||
144526212|NCT05281562|521127174|FG000|Overall Study|Ineligible patient|1|||
144526213|NCT05281562|521127175|FG001|Overall Study|Ineligible patient|0|||
144526214|NCT06457802|521127178|FG000|Overall Study|Early termination of study prior to participant completion|2|||
144526215|NCT06457802|521127179|FG001|Overall Study|Early termination of study prior to participant completion|2|||
144526216|NCT04524442|521127181|FG000|Overall Study|Subject Decision|1|||
144526217|NCT04880863|521127189|FG000|Overall Study|Adverse Event|1|||
144526218|NCT04880863|521127189|FG000|Overall Study|Patient decision|2|||
144526219|NCT04880863|521127189|FG000|Overall Study|Confirmed Disease Progression|15|||
144526220|NCT04880863|521127189|FG000|Overall Study|Death|3|||
144526221|NCT04880863|521127189|FG000|Overall Study|Physician Decision|4|||
144526222|NCT04880863|521127189|FG000|Overall Study|Unconfirmed Disease Progression|4|||
144526223|NCT04880863|521127189|FG000|Overall Study|Withdrawal by Subject|2|||
144526224|NCT04880863|521127189|FG000|Overall Study|Study discontinuation by the sponsor|4|||
144526225|NCT04880863|521127189|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
144526226|NCT04880863|521127189|FG000|Overall Study|Not received study drug NAP|2|||
144526227|NCT04898673|521127190|FG000|Overall Study|Screenfail|1|||
144526228|NCT04898673|521127191|FG001|Overall Study|Screenfail|0|||
144526229|NCT01152450|521127192|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
144526230|NCT01152450|521127193|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
144526231|NCT01152450|521127194|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
144526232|NCT01152450|521127195|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
144526233|NCT01152450|521127196|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
144526234|NCT01152450|521127197|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
144526235|NCT01152450|521127192|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
144526236|NCT01152450|521127193|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
144526237|NCT01152450|521127194|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
144526238|NCT01152450|521127195|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
144526239|NCT01152450|521127196|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
144526240|NCT01152450|521127197|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
144526241|NCT01152450|521127192|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144526242|NCT01152450|521127193|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
144526243|NCT01152450|521127194|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
144526244|NCT01152450|521127195|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144526245|NCT01152450|521127196|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144526246|NCT01152450|521127197|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
144526247|NCT05239455|521127198|FG000|Overall Study|Adverse Event|1|||
144526248|NCT05239455|521127198|FG000|Overall Study|Sponsor Decision|5|||
144526249|NCT05239455|521127198|FG000|Overall Study|Incomplete Blood Collection|1|||
144526250|NCT03084536|521127199|FG000|Overall Study|Determined to be ineligible|0|||
144526251|NCT03084536|521127200|FG001|Overall Study|Determined to be ineligible|0|||
144526252|NCT03084536|521127201|FG002|Overall Study|Determined to be ineligible|16|||
144526253|NCT03084536|521127199|FG000|Overall Study|Withdrawal by Subject|0|||
144526254|NCT03084536|521127200|FG001|Overall Study|Withdrawal by Subject|0|||
144526255|NCT03084536|521127201|FG002|Overall Study|Withdrawal by Subject|4|||
144526256|NCT03084536|521127199|FG000|Overall Study|Physician Decision|0|||
144526257|NCT03084536|521127200|FG001|Overall Study|Physician Decision|0|||
144526258|NCT03084536|521127201|FG002|Overall Study|Physician Decision|3|||
144526259|NCT03084536|521127199|FG000|Overall Study|Death|0|||
144526260|NCT03084536|521127200|FG001|Overall Study|Death|0|||
144526261|NCT03084536|521127201|FG002|Overall Study|Death|1|||
144526262|NCT03084536|521127199|FG000|Overall Study|Lost to Follow-up|0|||
144526263|NCT03084536|521127200|FG001|Overall Study|Lost to Follow-up|0|||
144526264|NCT03084536|521127201|FG002|Overall Study|Lost to Follow-up|1|||
144526265|NCT03084536|521127199|FG000|Overall Study|Protocol Violation|0|||
144526266|NCT03084536|521127200|FG001|Overall Study|Protocol Violation|0|||
144526267|NCT03084536|521127201|FG002|Overall Study|Protocol Violation|1|||
144526268|NCT03084536|521127199|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
144526269|NCT03084536|521127200|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
144526270|NCT03084536|521127201|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
144526271|NCT02151981|521127204|FG000|Overall Study|Death|184|||
144526272|NCT02151981|521127205|FG001|Overall Study|Death|88|||
144526273|NCT02151981|521127204|FG000|Overall Study|Lost to Follow-up|7|||
144526274|NCT02151981|521127205|FG001|Overall Study|Lost to Follow-up|1|||
144526275|NCT02151981|521127204|FG000|Overall Study|Withdrawal by Subject|27|||
144600092|NCT00372385|521397579|FG002|Overall Study|Virologic Stopping Rule|0|||
144526276|NCT02151981|521127205|FG001|Overall Study|Withdrawal by Subject|21|||
144526277|NCT02151981|521127204|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144526278|NCT02151981|521127205|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144526279|NCT02151981|521127204|FG000|Overall Study|Other reasons|1|||
144526280|NCT02151981|521127205|FG001|Overall Study|Other reasons|2|||
144526281|NCT05192109|521127215|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
144526282|NCT05192109|521127216|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
144526283|NCT05192109|521127217|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144526284|NCT05192109|521127218|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144526285|NCT05192109|521127215|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
144526286|NCT05192109|521127216|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
144526287|NCT05192109|521127217|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144526288|NCT05192109|521127218|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144526289|NCT05576155|521127219|FG000|Overall Study|Withdrawal by Subject|1|||
144526290|NCT05576155|521127220|FG001|Overall Study|Withdrawal by Subject|1|||
144526291|NCT04515849|521127221|FG000|Overall Study|Adverse Event|0|||
144526292|NCT04515849|521127222|FG001|Overall Study|Adverse Event|0|||
144526293|NCT04515849|521127223|FG002|Overall Study|Adverse Event|0|||
144526294|NCT04515849|521127224|FG003|Overall Study|Adverse Event|1|||
144526295|NCT04515849|521127225|FG004|Overall Study|Adverse Event|2|||
144526296|NCT04515849|521127221|FG000|Overall Study|Death|2|||
144526297|NCT04515849|521127222|FG001|Overall Study|Death|0|||
144526298|NCT04515849|521127223|FG002|Overall Study|Death|0|||
144526299|NCT04515849|521127224|FG003|Overall Study|Death|0|||
144526300|NCT04515849|521127225|FG004|Overall Study|Death|0|||
144526301|NCT04515849|521127221|FG000|Overall Study|Other:family emergency|0|||
144526302|NCT04515849|521127222|FG001|Overall Study|Other:family emergency|0|||
144526303|NCT04515849|521127223|FG002|Overall Study|Other:family emergency|0|||
144526304|NCT04515849|521127224|FG003|Overall Study|Other:family emergency|1|||
144526305|NCT04515849|521127225|FG004|Overall Study|Other:family emergency|0|||
144526306|NCT04515849|521127221|FG000|Overall Study|Other:randomised by error|0|||
144526307|NCT04515849|521127222|FG001|Overall Study|Other:randomised by error|1|||
144526308|NCT04515849|521127223|FG002|Overall Study|Other:randomised by error|0|||
144526309|NCT04515849|521127224|FG003|Overall Study|Other:randomised by error|0|||
144526310|NCT04515849|521127225|FG004|Overall Study|Other:randomised by error|0|||
144526311|NCT04515849|521127221|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
144526312|NCT04515849|521127222|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
144526313|NCT04515849|521127223|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
144526314|NCT04515849|521127224|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
144526315|NCT04515849|521127225|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
144526316|NCT04515849|521127221|FG000|Overall Study|Physician Decision|0|||
144526317|NCT04515849|521127222|FG001|Overall Study|Physician Decision|1|||
144526318|NCT04515849|521127223|FG002|Overall Study|Physician Decision|0|||
144526319|NCT04515849|521127224|FG003|Overall Study|Physician Decision|0|||
144526320|NCT04515849|521127225|FG004|Overall Study|Physician Decision|0|||
144526321|NCT04515849|521127221|FG000|Overall Study|Withdrawal by Subject|1|||
144250082|NCT04767529|520113451|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
144250083|NCT04767529|520113449|FG000|Overall Study|Required use of a prohibited medication|0|||
144250084|NCT04767529|520113450|FG001|Overall Study|Required use of a prohibited medication|1|||
144250085|NCT04767529|520113451|FG002|Overall Study|Required use of a prohibited medication|0|||
144250086|NCT04767529|520113449|FG000|Overall Study|Withdrawal by Subject|7|||
144250087|NCT04767529|520113450|FG001|Overall Study|Withdrawal by Subject|5|||
144250088|NCT04767529|520113451|FG002|Overall Study|Withdrawal by Subject|4|||
144250089|NCT04767529|520113449|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
144526322|NCT04515849|521127222|FG001|Overall Study|Withdrawal by Subject|2|||
144526323|NCT04515849|521127223|FG002|Overall Study|Withdrawal by Subject|1|||
144526324|NCT04515849|521127224|FG003|Overall Study|Withdrawal by Subject|0|||
144526325|NCT04515849|521127225|FG004|Overall Study|Withdrawal by Subject|0|||
144526326|NCT03287817|521129130|FG000|Overall Study|Progressive disease|4|||
144526327|NCT03287817|521129131|FG001|Overall Study|Progressive disease|2|||
144526328|NCT03287817|521129132|FG002|Overall Study|Progressive disease|3|||
144526329|NCT03287817|521129133|FG003|Overall Study|Progressive disease|10|||
144526330|NCT03287817|521129134|FG004|Overall Study|Progressive disease|8|||
144526331|NCT03287817|521129130|FG000|Overall Study|Death|0|||
144526332|NCT03287817|521129131|FG001|Overall Study|Death|0|||
144526333|NCT03287817|521129132|FG002|Overall Study|Death|2|||
144526334|NCT03287817|521129133|FG003|Overall Study|Death|3|||
144526335|NCT03287817|521129134|FG004|Overall Study|Death|4|||
144600093|NCT00372385|521397580|FG003|Overall Study|Virologic Stopping Rule|0|||
144600094|NCT03049735|521397588|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
144250090|NCT04767529|520113450|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
144526336|NCT03287817|521129130|FG000|Overall Study|Physician Decision|0|||
144526337|NCT03287817|521129131|FG001|Overall Study|Physician Decision|0|||
144526338|NCT03287817|521129132|FG002|Overall Study|Physician Decision|0|||
144526339|NCT03287817|521129133|FG003|Overall Study|Physician Decision|1|||
144526340|NCT03287817|521129134|FG004|Overall Study|Physician Decision|0|||
144526341|NCT03287817|521129130|FG000|Overall Study|Withdrawal by Subject|0|||
144600095|NCT03049735|521397589|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
144526342|NCT03287817|521129131|FG001|Overall Study|Withdrawal by Subject|0|||
144526343|NCT03287817|521129132|FG002|Overall Study|Withdrawal by Subject|0|||
144526344|NCT03287817|521129133|FG003|Overall Study|Withdrawal by Subject|0|||
144526345|NCT03287817|521129134|FG004|Overall Study|Withdrawal by Subject|4|||
144526346|NCT05251909|521129135|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
144526347|NCT05251909|521129136|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
144526348|NCT06181227|521129137|FG000|Overall Study|Study terminated by sponsor|7|||
144526349|NCT06181227|521129138|FG001|Overall Study|Study terminated by sponsor|9|||
144526350|NCT05543915|521129139|FG000|Overall Study|Lost to Follow-up|0|||
144526351|NCT05543915|521129140|FG001|Overall Study|Lost to Follow-up|1|||
144526352|NCT02561247|521129143|FG000|Overall Study|Protocol Violation|1|||
144526353|NCT02561247|521129143|FG000|Overall Study|Withdrawal by Subject|1|||
144526354|NCT02561247|521129143|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
144526355|NCT03462030|521129148|FG000|Overall Study|Withdrawal by Subject|1|||
144526356|NCT03462030|521129149|FG001|Overall Study|Withdrawal by Subject|1|||
144526357|NCT02675751|521129150|FG000|Overall Study|Lost to Follow-up|16|||
144526358|NCT02598388|521129151|FG000|Overall Study|Lost to Follow-up|1|||
144526359|NCT02598388|521129152|FG001|Overall Study|Lost to Follow-up|0|||
144526360|NCT02598388|521129153|FG002|Overall Study|Lost to Follow-up|1|||
144526361|NCT02598388|521129154|FG003|Overall Study|Lost to Follow-up|0|||
144526362|NCT02598388|521129155|FG004|Overall Study|Lost to Follow-up|5|||
144526363|NCT02598388|521129156|FG005|Overall Study|Lost to Follow-up|1|||
144526364|NCT02598388|521129157|FG006|Overall Study|Lost to Follow-up|2|||
144526365|NCT02598388|521129158|FG007|Overall Study|Lost to Follow-up|1|||
144526366|NCT02598388|521129159|FG008|Overall Study|Lost to Follow-up|0|||
144526367|NCT02598388|521129160|FG009|Overall Study|Lost to Follow-up|0|||
144526368|NCT02598388|521129161|FG010|Overall Study|Lost to Follow-up|1|||
144526369|NCT02598388|521129162|FG011|Overall Study|Lost to Follow-up|0|||
144526370|NCT02598388|521129151|FG000|Overall Study|Withdrawal by Subject|0|||
144526371|NCT02598388|521129152|FG001|Overall Study|Withdrawal by Subject|0|||
144526372|NCT02598388|521129153|FG002|Overall Study|Withdrawal by Subject|0|||
144526373|NCT02598388|521129154|FG003|Overall Study|Withdrawal by Subject|0|||
144526374|NCT02598388|521129155|FG004|Overall Study|Withdrawal by Subject|2|||
144526375|NCT02598388|521129156|FG005|Overall Study|Withdrawal by Subject|0|||
144526376|NCT02598388|521129157|FG006|Overall Study|Withdrawal by Subject|2|||
144526377|NCT02598388|521129158|FG007|Overall Study|Withdrawal by Subject|0|||
144526378|NCT02598388|521129159|FG008|Overall Study|Withdrawal by Subject|0|||
144526379|NCT02598388|521129160|FG009|Overall Study|Withdrawal by Subject|1|||
144526380|NCT02598388|521129161|FG010|Overall Study|Withdrawal by Subject|0|||
144526381|NCT02598388|521129162|FG011|Overall Study|Withdrawal by Subject|0|||
144526382|NCT02598388|521129151|FG000|Overall Study|Other|0|||
144526383|NCT02598388|521129152|FG001|Overall Study|Other|0|||
144526384|NCT02598388|521129153|FG002|Overall Study|Other|1|||
144526385|NCT02598388|521129154|FG003|Overall Study|Other|0|||
144526386|NCT02598388|521129155|FG004|Overall Study|Other|3|||
144526387|NCT02598388|521129156|FG005|Overall Study|Other|0|||
144526388|NCT02598388|521129157|FG006|Overall Study|Other|1|||
144526389|NCT02598388|521129158|FG007|Overall Study|Other|0|||
144526390|NCT02598388|521129159|FG008|Overall Study|Other|0|||
144526391|NCT02598388|521129160|FG009|Overall Study|Other|0|||
144526392|NCT02598388|521129161|FG010|Overall Study|Other|0|||
144526393|NCT02598388|521129162|FG011|Overall Study|Other|0|||
144526394|NCT02359890|521129163|FG000|Overall Study|Not meeting eligibility|4|||
144526395|NCT02359890|521129163|FG000|Overall Study|Never treated with study catheter|6|||
144526396|NCT05256017|521129164|FG000|Treatment Period|Withdrawal by Subject|1|||
144526397|NCT05256017|521129165|FG001|Treatment Period|Withdrawal by Subject|1|||
144526398|NCT05256017|521129164|FG000|Follow-up|Lost to Follow-up|7|||
144526399|NCT05256017|521129165|FG001|Follow-up|Lost to Follow-up|1|||
144526400|NCT05256017|521129164|FG000|Follow-up|Withdrawal by Subject|1|||
144526401|NCT05256017|521129165|FG001|Follow-up|Withdrawal by Subject|0|||
144526402|NCT05256017|521129164|FG000|Follow-up|Death|0|||
144526403|NCT05256017|521129165|FG001|Follow-up|Death|1|||
144526404|NCT01073566|521129166|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
144526405|NCT01073566|521129167|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
144526406|NCT05672069|521129168|FG000|Overall Study|Implant removal|1|||
144526407|NCT05672069|521129168|FG000|Overall Study|Lost to Follow-up|2|||
144526408|NCT04663737|521129173|FG000|Overall Study|Withdrawal by Subject|2|||
144526409|NCT04663737|521129174|FG001|Overall Study|Withdrawal by Subject|0|||
144526410|NCT04016662|521129175|FG000|Run-In Phase|Death|1|||
144526411|NCT04016662|521129175|FG000|Run-In Phase|Withdrawal by Subject|11|||
144526412|NCT04016662|521129175|FG000|Run-In Phase|Not meeting screening eligibility|9|||
144526413|NCT04016662|521129175|FG000|Run-In Phase|Physician Decision|3|||
144526414|NCT04016662|521129175|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
144526415|NCT04016662|521129175|FG000|PLGS (12 Weeks)|Death|1|||
144526416|NCT04016662|521129175|FG000|SAP (12 Weeks)|Death|1|||
144526417|NCT01802788|521129176|FG000|Overall Study|Withdrawal by Subject|102|||
144526418|NCT01802788|521129177|FG001|Overall Study|Withdrawal by Subject|5|||
144526419|NCT01802788|521129176|FG000|Overall Study|Death|382|||
144526420|NCT01802788|521129177|FG001|Overall Study|Death|18|||
144526421|NCT01802788|521129176|FG000|Overall Study|Lost to Follow-up|31|||
144526422|NCT01802788|521129177|FG001|Overall Study|Lost to Follow-up|2|||
144526423|NCT01802788|521129176|FG000|Overall Study|Physician Decision|3|||
144526424|NCT01802788|521129177|FG001|Overall Study|Physician Decision|0|||
144526425|NCT01802788|521129176|FG000|Overall Study|Patient Non-Compliance|1|||
144526426|NCT01802788|521129177|FG001|Overall Study|Patient Non-Compliance|0|||
144526427|NCT01802788|521129176|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
144526428|NCT01802788|521129177|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
144526429|NCT01802788|521129176|FG000|Overall Study|Other Reasons|19|||
144526430|NCT01802788|521129177|FG001|Overall Study|Other Reasons|0|||
144526431|NCT02043678|521129178|FG000|Overall Study|Never treated|11|||
144526432|NCT02043678|521129179|FG001|Overall Study|Never treated|9|||
144526433|NCT02043678|521129178|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
144526434|NCT02043678|521129179|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
144526435|NCT02043678|521129178|FG000|Overall Study|AE without clinical PD|54|||
144526436|NCT02043678|521129179|FG001|Overall Study|AE without clinical PD|36|||
144526437|NCT02043678|521129178|FG000|Overall Study|Lost to Follow-up|1|||
144526438|NCT02043678|521129179|FG001|Overall Study|Lost to Follow-up|1|||
144526439|NCT02043678|521129178|FG000|Overall Study|Other|10|||
144526440|NCT02043678|521129179|FG001|Overall Study|Other|14|||
144526441|NCT02043678|521129178|FG000|Overall Study|Clinical PD|114|||
144526442|NCT02043678|521129179|FG001|Overall Study|Clinical PD|148|||
144526443|NCT02043678|521129178|FG000|Overall Study|Radiological PD|100|||
144526444|NCT02043678|521129179|FG001|Overall Study|Radiological PD|90|||
144526445|NCT02043678|521129178|FG000|Overall Study|Protocol-driven decision point|59|||
144526446|NCT02043678|521129179|FG001|Overall Study|Protocol-driven decision point|58|||
144526447|NCT02043678|521129178|FG000|Overall Study|Withdrawal by Subject|16|||
144526448|NCT02043678|521129179|FG001|Overall Study|Withdrawal by Subject|20|||
144526449|NCT02043678|521129178|FG000|Overall Study|Protocol Violation|1|||
144526450|NCT02043678|521129179|FG001|Overall Study|Protocol Violation|0|||
144526451|NCT02043678|521129178|FG000|Overall Study|Deterioration of general conditions|1|||
144526452|NCT02043678|521129179|FG001|Overall Study|Deterioration of general conditions|1|||
144526453|NCT02043678|521129178|FG000|Overall Study|Logistical difficulties|2|||
144526454|NCT02043678|521129179|FG001|Overall Study|Logistical difficulties|0|||
144526455|NCT02043678|521129178|FG000|Overall Study|Non-compliance with study drug|3|||
144526456|NCT02043678|521129179|FG001|Overall Study|Non-compliance with study drug|1|||
144526457|NCT02043678|521129178|FG000|Overall Study|Physician Decision|4|||
144526458|NCT02043678|521129179|FG001|Overall Study|Physician Decision|3|||
144526459|NCT02043678|521129178|FG000|Overall Study|Subject decision|0|||
144526460|NCT02043678|521129179|FG001|Overall Study|Subject decision|1|||
144526461|NCT02043678|521129178|FG000|Overall Study|Switching to other therapy|3|||
144526462|NCT02043678|521129179|FG001|Overall Study|Switching to other therapy|2|||
144526463|NCT02043678|521129178|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
144526464|NCT02043678|521129179|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
144526465|NCT02043678|521129178|FG000|Overall Study|Missing|1|||
144526466|NCT02043678|521129179|FG001|Overall Study|Missing|0|||
144526467|NCT02043678|521129178|FG000|Overall Study|Adverse Event|0|||
144526468|NCT02043678|521129179|FG001|Overall Study|Adverse Event|1|||
144526469|NCT03216057|521129180|FG000|Overall Study|Lost to Follow-up|2|||
144526470|NCT03216057|521129181|FG001|Overall Study|Lost to Follow-up|2|||
144526471|NCT04568603|521129182|FG000|Overall Study|Physician Decision|1|||
144526472|NCT03907878|521129183|FG000|Treatment Period|Withdrawal by Subject|5|||
144526473|NCT03907878|521129183|FG000|Treatment Period|Adverse Event|4|||
144600096|NCT03049735|521397590|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
144600097|NCT03049735|521397588|FG000|Overall Study|Other|5|||
144526474|NCT03907878|521129183|FG000|Treatment Period|Lack of Efficacy|1|||
144526475|NCT03907878|521129183|FG000|Treatment Period|Protocol Violation|1|||
144600098|NCT03049735|521397589|FG001|Overall Study|Other|3|||
144600099|NCT03049735|521397590|FG002|Overall Study|Other|1|||
144600100|NCT03049735|521397588|FG000|Overall Study|Lack of Efficacy|4|||
144526476|NCT03907878|521129183|FG000|Follow-up Period|Adverse Event|3|||
144600101|NCT03049735|521397589|FG001|Overall Study|Lack of Efficacy|0|||
144600102|NCT03049735|521397590|FG002|Overall Study|Lack of Efficacy|3|||
144526477|NCT03907878|521129183|FG000|Follow-up Period|Withdrawal by Subject|3|||
144526478|NCT05144009|521129184|FG000|Overall Study|Lost to Follow-up|0|||
144526479|NCT05144009|521129185|FG001|Overall Study|Lost to Follow-up|1|||
144526480|NCT05144009|521129184|FG000|Overall Study|Study Termination by the Sponsor|11|||
144526481|NCT05144009|521129185|FG001|Overall Study|Study Termination by the Sponsor|11|||
144526482|NCT05144009|521129184|FG000|Overall Study|Disease Progression|1|||
144526483|NCT05144009|521129185|FG001|Overall Study|Disease Progression|0|||
144526484|NCT05144009|521129184|FG000|Overall Study|Participant Decision|0|||
144526485|NCT05144009|521129185|FG001|Overall Study|Participant Decision|2|||
144526486|NCT05144009|521129184|FG000|Overall Study|Death|5|||
144526487|NCT05144009|521129185|FG001|Overall Study|Death|10|||
144600103|NCT03049735|521397588|FG000|Overall Study|Protocol deviation|1|||
144526488|NCT04499924|521129186|FG000|Overall Study|Study termination by sponsor|4|||
144526489|NCT04499924|521129187|FG001|Overall Study|Study termination by sponsor|6|||
144526490|NCT04499924|521129186|FG000|Overall Study|Withdrawal by Subject|1|||
144526491|NCT04499924|521129187|FG001|Overall Study|Withdrawal by Subject|3|||
144526492|NCT03904147|521129192|FG000|Overall Study|Death|15|||
144526493|NCT03904147|521129193|FG001|Overall Study|Death|13|||
144526494|NCT03904147|521129194|FG002|Overall Study|Death|15|||
144526495|NCT03904147|521129192|FG000|Overall Study|Withdrawal by Subject|7|||
144526496|NCT03904147|521129193|FG001|Overall Study|Withdrawal by Subject|12|||
144526497|NCT03904147|521129194|FG002|Overall Study|Withdrawal by Subject|1|||
144526498|NCT03904147|521129192|FG000|Overall Study|1Y visit completed after 365 days|1|||
144526499|NCT03904147|521129193|FG001|Overall Study|1Y visit completed after 365 days|1|||
144526500|NCT03904147|521129194|FG002|Overall Study|1Y visit completed after 365 days|0|||
144526501|NCT03011333|521129204|FG000|Overall Study|Lost to Follow-up|0|||
144526502|NCT03011333|521129205|FG001|Overall Study|Lost to Follow-up|1|||
144526503|NCT03011333|521129206|FG002|Overall Study|Lost to Follow-up|0|||
144526504|NCT03011333|521129207|FG003|Overall Study|Lost to Follow-up|1|||
144526505|NCT03011333|521129208|FG004|Overall Study|Lost to Follow-up|4|||
144526506|NCT03011333|521129209|FG005|Overall Study|Lost to Follow-up|4|||
144526507|NCT03011333|521129210|FG006|Overall Study|Lost to Follow-up|5|||
144526508|NCT04413708|521129211|FG000|Overall Study|Lost to Follow-up|1|||
144526509|NCT04413708|521129212|FG001|Overall Study|Lost to Follow-up|2|||
144526510|NCT02815566|521129216|FG000|Overall Study|Adverse Event|1|||
144526511|NCT02815566|521129217|FG001|Overall Study|Adverse Event|1|||
144526512|NCT02815566|521129216|FG000|Overall Study|Withdrawal by Subject|1|||
144526513|NCT02815566|521129217|FG001|Overall Study|Withdrawal by Subject|0|||
144526514|NCT02815566|521129216|FG000|Overall Study|Lost to Follow-up|0|||
144526515|NCT02815566|521129217|FG001|Overall Study|Lost to Follow-up|1|||
144526516|NCT04032704|521129218|FG000|Part A|Withdrawal by Subject|0|||
144526517|NCT04032704|521129219|FG001|Part A|Withdrawal by Subject|0|||
144526518|NCT04032704|521129220|FG002|Part A|Withdrawal by Subject|3|||
144526519|NCT04032704|521129221|FG003|Part A|Withdrawal by Subject|0|||
144526520|NCT04032704|521129222|FG004|Part A|Withdrawal by Subject|1|||
144526521|NCT04032704|521129223|FG005|Part A|Withdrawal by Subject|7|||
144526522|NCT04032704|521129224|FG006|Part A|Withdrawal by Subject|0|||
144526523|NCT04032704|521129225|FG007|Part A|Withdrawal by Subject|0|||
144526524|NCT04032704|521129226|FG008|Part A|Withdrawal by Subject|0|||
144526525|NCT04032704|521129227|FG009|Part A|Withdrawal by Subject|0|||
144526526|NCT04032704|521129228|FG010|Part A|Withdrawal by Subject|0|||
144526527|NCT04032704|521129229|FG011|Part A|Withdrawal by Subject|0|||
144526528|NCT04032704|521129230|FG012|Part A|Withdrawal by Subject|0|||
144526529|NCT04032704|521129231|FG013|Part A|Withdrawal by Subject|0|||
144526530|NCT04032704|521129232|FG014|Part A|Withdrawal by Subject|0|||
144526531|NCT04032704|521129233|FG015|Part A|Withdrawal by Subject|0|||
144526532|NCT04032704|521129234|FG016|Part A|Withdrawal by Subject|0|||
144526533|NCT04032704|521129235|FG017|Part A|Withdrawal by Subject|0|||
144526534|NCT04032704|521129218|FG000|Part A|Lost to Follow-up|1|||
144526535|NCT04032704|521129219|FG001|Part A|Lost to Follow-up|0|||
144526536|NCT04032704|521129220|FG002|Part A|Lost to Follow-up|0|||
144526537|NCT04032704|521129221|FG003|Part A|Lost to Follow-up|0|||
144526538|NCT04032704|521129222|FG004|Part A|Lost to Follow-up|0|||
144526539|NCT04032704|521129223|FG005|Part A|Lost to Follow-up|0|||
144526540|NCT04032704|521129224|FG006|Part A|Lost to Follow-up|0|||
144526541|NCT04032704|521129225|FG007|Part A|Lost to Follow-up|0|||
144526542|NCT04032704|521129226|FG008|Part A|Lost to Follow-up|0|||
144526543|NCT04032704|521129227|FG009|Part A|Lost to Follow-up|0|||
144526544|NCT04032704|521129228|FG010|Part A|Lost to Follow-up|0|||
144526545|NCT04032704|521129229|FG011|Part A|Lost to Follow-up|0|||
144526546|NCT04032704|521129230|FG012|Part A|Lost to Follow-up|0|||
144526547|NCT04032704|521129231|FG013|Part A|Lost to Follow-up|0|||
144526548|NCT04032704|521129232|FG014|Part A|Lost to Follow-up|0|||
144526549|NCT04032704|521129233|FG015|Part A|Lost to Follow-up|0|||
144526550|NCT04032704|521129234|FG016|Part A|Lost to Follow-up|0|||
144526551|NCT04032704|521129235|FG017|Part A|Lost to Follow-up|0|||
144526552|NCT04032704|521129218|FG000|Part A|Death|9|||
144526553|NCT04032704|521129219|FG001|Part A|Death|2|||
144526554|NCT04032704|521129220|FG002|Part A|Death|10|||
144526555|NCT04032704|521129221|FG003|Part A|Death|7|||
144526556|NCT04032704|521129222|FG004|Part A|Death|4|||
144526557|NCT04032704|521129223|FG005|Part A|Death|5|||
144526558|NCT04032704|521129224|FG006|Part A|Death|0|||
144526559|NCT04032704|521129225|FG007|Part A|Death|0|||
144526560|NCT04032704|521129226|FG008|Part A|Death|0|||
144526561|NCT04032704|521129227|FG009|Part A|Death|0|||
144526562|NCT04032704|521129228|FG010|Part A|Death|0|||
144526563|NCT04032704|521129229|FG011|Part A|Death|0|||
144526564|NCT04032704|521129230|FG012|Part A|Death|0|||
144526565|NCT04032704|521129231|FG013|Part A|Death|0|||
144526566|NCT04032704|521129232|FG014|Part A|Death|0|||
144526567|NCT04032704|521129233|FG015|Part A|Death|0|||
144526568|NCT04032704|521129234|FG016|Part A|Death|0|||
144526569|NCT04032704|521129235|FG017|Part A|Death|0|||
144526570|NCT04032704|521129218|FG000|Part B|Other|0|||
144526571|NCT04032704|521129219|FG001|Part B|Other|0|||
144526572|NCT04032704|521129220|FG002|Part B|Other|0|||
144600104|NCT03049735|521397589|FG001|Overall Study|Protocol deviation|0|||
144600105|NCT03049735|521397590|FG002|Overall Study|Protocol deviation|0|||
144600106|NCT03049735|521397588|FG000|Overall Study|Pregnancy|0|||
144600107|NCT03049735|521397589|FG001|Overall Study|Pregnancy|0|||
144600108|NCT03049735|521397590|FG002|Overall Study|Pregnancy|1|||
144600109|NCT03049735|521397588|FG000|Overall Study|Adverse Event|7|||
144526573|NCT04032704|521129221|FG003|Part B|Other|0|||
144526574|NCT04032704|521129222|FG004|Part B|Other|0|||
144600110|NCT03049735|521397589|FG001|Overall Study|Adverse Event|18|||
144600111|NCT03049735|521397590|FG002|Overall Study|Adverse Event|5|||
144600112|NCT03049735|521397588|FG000|Overall Study|Withdrawal by Subject|10|||
144600113|NCT03049735|521397589|FG001|Overall Study|Withdrawal by Subject|3|||
144600114|NCT03049735|521397590|FG002|Overall Study|Withdrawal by Subject|7|||
144526575|NCT04032704|521129223|FG005|Part B|Other|0|||
144526576|NCT04032704|521129224|FG006|Part B|Other|0|||
144526577|NCT04032704|521129225|FG007|Part B|Other|1|||
144526578|NCT04032704|521129226|FG008|Part B|Other|2|||
144526579|NCT04032704|521129227|FG009|Part B|Other|1|||
144526580|NCT04032704|521129228|FG010|Part B|Other|1|||
144526581|NCT04032704|521129229|FG011|Part B|Other|1|||
144526582|NCT04032704|521129230|FG012|Part B|Other|5|||
144526583|NCT04032704|521129231|FG013|Part B|Other|13|||
144526584|NCT04032704|521129232|FG014|Part B|Other|0|||
144526585|NCT04032704|521129233|FG015|Part B|Other|0|||
144526586|NCT04032704|521129234|FG016|Part B|Other|0|||
144526587|NCT04032704|521129235|FG017|Part B|Other|0|||
144526588|NCT04032704|521129218|FG000|Part B|Study termination by Sponsor|0|||
144526589|NCT04032704|521129219|FG001|Part B|Study termination by Sponsor|0|||
144526590|NCT04032704|521129220|FG002|Part B|Study termination by Sponsor|0|||
144526591|NCT04032704|521129221|FG003|Part B|Study termination by Sponsor|0|||
144526592|NCT04032704|521129222|FG004|Part B|Study termination by Sponsor|0|||
144526593|NCT04032704|521129223|FG005|Part B|Study termination by Sponsor|0|||
144526594|NCT04032704|521129224|FG006|Part B|Study termination by Sponsor|0|||
144526595|NCT04032704|521129225|FG007|Part B|Study termination by Sponsor|0|||
144526596|NCT04032704|521129226|FG008|Part B|Study termination by Sponsor|1|||
144526597|NCT04032704|521129227|FG009|Part B|Study termination by Sponsor|0|||
144526598|NCT04032704|521129228|FG010|Part B|Study termination by Sponsor|0|||
144526599|NCT04032704|521129229|FG011|Part B|Study termination by Sponsor|0|||
144526600|NCT04032704|521129230|FG012|Part B|Study termination by Sponsor|0|||
144526601|NCT04032704|521129231|FG013|Part B|Study termination by Sponsor|0|||
144526602|NCT04032704|521129232|FG014|Part B|Study termination by Sponsor|0|||
144526603|NCT04032704|521129233|FG015|Part B|Study termination by Sponsor|0|||
144526604|NCT04032704|521129234|FG016|Part B|Study termination by Sponsor|0|||
144526605|NCT04032704|521129235|FG017|Part B|Study termination by Sponsor|0|||
144526606|NCT04032704|521129218|FG000|Part B|Withdrawal by Subject|0|||
144526607|NCT04032704|521129219|FG001|Part B|Withdrawal by Subject|0|||
144526608|NCT04032704|521129220|FG002|Part B|Withdrawal by Subject|0|||
144526609|NCT04032704|521129221|FG003|Part B|Withdrawal by Subject|0|||
144526610|NCT04032704|521129222|FG004|Part B|Withdrawal by Subject|0|||
144526611|NCT04032704|521129223|FG005|Part B|Withdrawal by Subject|0|||
144526612|NCT04032704|521129224|FG006|Part B|Withdrawal by Subject|3|||
144526613|NCT04032704|521129225|FG007|Part B|Withdrawal by Subject|2|||
144526614|NCT04032704|521129226|FG008|Part B|Withdrawal by Subject|2|||
144526615|NCT04032704|521129227|FG009|Part B|Withdrawal by Subject|1|||
144526616|NCT04032704|521129228|FG010|Part B|Withdrawal by Subject|4|||
144526617|NCT04032704|521129229|FG011|Part B|Withdrawal by Subject|6|||
144722767|NCT01325207|521840526|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
144722768|NCT01325207|521840527|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
144722769|NCT01325207|521840528|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
144722770|NCT01325207|521840529|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
144526618|NCT04032704|521129230|FG012|Part B|Withdrawal by Subject|2|||
144526619|NCT04032704|521129231|FG013|Part B|Withdrawal by Subject|1|||
144526620|NCT04032704|521129232|FG014|Part B|Withdrawal by Subject|0|||
144526621|NCT04032704|521129233|FG015|Part B|Withdrawal by Subject|1|||
144526622|NCT04032704|521129234|FG016|Part B|Withdrawal by Subject|0|||
144526623|NCT04032704|521129235|FG017|Part B|Withdrawal by Subject|0|||
144526624|NCT04032704|521129218|FG000|Part B|Lost to Follow-up|0|||
144526625|NCT04032704|521129219|FG001|Part B|Lost to Follow-up|0|||
144526626|NCT04032704|521129220|FG002|Part B|Lost to Follow-up|0|||
144526627|NCT04032704|521129221|FG003|Part B|Lost to Follow-up|0|||
144526628|NCT04032704|521129222|FG004|Part B|Lost to Follow-up|0|||
144526629|NCT04032704|521129223|FG005|Part B|Lost to Follow-up|0|||
144526630|NCT04032704|521129224|FG006|Part B|Lost to Follow-up|0|||
144526631|NCT04032704|521129225|FG007|Part B|Lost to Follow-up|0|||
144526632|NCT04032704|521129226|FG008|Part B|Lost to Follow-up|0|||
144526633|NCT04032704|521129227|FG009|Part B|Lost to Follow-up|0|||
144600115|NCT03049735|521397588|FG000|Overall Study|Lost to Follow-up|1|||
144526634|NCT04032704|521129228|FG010|Part B|Lost to Follow-up|0|||
144526635|NCT04032704|521129229|FG011|Part B|Lost to Follow-up|1|||
144526636|NCT04032704|521129230|FG012|Part B|Lost to Follow-up|0|||
144526637|NCT04032704|521129231|FG013|Part B|Lost to Follow-up|0|||
144526638|NCT04032704|521129232|FG014|Part B|Lost to Follow-up|0|||
144526639|NCT04032704|521129233|FG015|Part B|Lost to Follow-up|0|||
144526640|NCT04032704|521129234|FG016|Part B|Lost to Follow-up|0|||
144526641|NCT04032704|521129235|FG017|Part B|Lost to Follow-up|0|||
144526642|NCT04032704|521129218|FG000|Part B|Death|0|||
144526643|NCT04032704|521129219|FG001|Part B|Death|0|||
144526644|NCT04032704|521129220|FG002|Part B|Death|0|||
144526645|NCT04032704|521129221|FG003|Part B|Death|0|||
144526646|NCT04032704|521129222|FG004|Part B|Death|0|||
144526647|NCT04032704|521129223|FG005|Part B|Death|0|||
144526648|NCT04032704|521129224|FG006|Part B|Death|13|||
144526649|NCT04032704|521129225|FG007|Part B|Death|13|||
144526650|NCT04032704|521129226|FG008|Part B|Death|14|||
144526651|NCT04032704|521129227|FG009|Part B|Death|12|||
144526652|NCT04032704|521129228|FG010|Part B|Death|12|||
144526653|NCT04032704|521129229|FG011|Part B|Death|13|||
144526654|NCT04032704|521129230|FG012|Part B|Death|7|||
144526655|NCT04032704|521129231|FG013|Part B|Death|17|||
144526656|NCT04032704|521129232|FG014|Part B|Death|2|||
144526657|NCT04032704|521129233|FG015|Part B|Death|1|||
144600116|NCT03049735|521397589|FG001|Overall Study|Lost to Follow-up|5|||
144600117|NCT03049735|521397590|FG002|Overall Study|Lost to Follow-up|5|||
144600118|NCT03153111|521397591|FG000|Overall Study|Death|2|||
144600119|NCT03153111|521397592|FG001|Overall Study|Death|5|||
144600120|NCT03153111|521397591|FG000|Overall Study|Lost to Follow-up|1|||
144600121|NCT03153111|521397592|FG001|Overall Study|Lost to Follow-up|0|||
144600122|NCT03153111|521397591|FG000|Overall Study|Physician Decision|5|||
144600123|NCT03153111|521397592|FG001|Overall Study|Physician Decision|1|||
144600124|NCT03153111|521397591|FG000|Overall Study|Withdrawal by Subject|3|||
144600125|NCT03153111|521397592|FG001|Overall Study|Withdrawal by Subject|3|||
144600126|NCT01658826|521397593|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
144600127|NCT01658826|521397594|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
144526658|NCT04032704|521129234|FG016|Part B|Death|2|||
144526659|NCT04032704|521129235|FG017|Part B|Death|2|||
144526660|NCT03133546|521129241|FG000|Overall Study|Death|46|||
144526661|NCT03133546|521129242|FG001|Overall Study|Death|43|||
144526662|NCT03133546|521129241|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
144526663|NCT03133546|521129242|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
144526664|NCT01501955|521129246|FG000|Overall Study|Withdrawal by Subject|1|||
144526665|NCT01501955|521129247|FG001|Overall Study|Withdrawal by Subject|0|||
144526666|NCT01501955|521129246|FG000|Overall Study|Adverse Event|1|||
144526667|NCT01501955|521129247|FG001|Overall Study|Adverse Event|3|||
144526668|NCT02993159|521129248|FG000|Overall Study|Withdrawal by Subject|1|||
144410193|NCT05393895|520709535|FG000|Overall Study|Adverse Event|2|||
144410194|NCT05393895|520709536|FG001|Overall Study|Adverse Event|3|||
144600128|NCT01658826|521397593|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
144600129|NCT01658826|521397594|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
144600130|NCT01658826|521397593|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
144600131|NCT01658826|521397594|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
144600132|NCT01658826|521397593|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
144600133|NCT01658826|521397594|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
144600134|NCT01658826|521397593|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
144600135|NCT01658826|521397594|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
144600136|NCT01658826|521397593|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
144600137|NCT01658826|521397594|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
144600138|NCT01658826|521397593|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
144410195|NCT05393895|520709535|FG000|Overall Study|Lost to Follow-up|4|||
144410196|NCT05393895|520709536|FG001|Overall Study|Lost to Follow-up|3|||
144410197|NCT05393895|520709535|FG000|Overall Study|Protocol Violation|1|||
144410198|NCT05393895|520709536|FG001|Overall Study|Protocol Violation|0|||
144410199|NCT05393895|520709535|FG000|Overall Study|Withdrawal by Subject|1|||
144410200|NCT05393895|520709536|FG001|Overall Study|Withdrawal by Subject|4|||
144410201|NCT02002091|520709541|FG000|Screening|Lost to Follow-up|10|||
144410202|NCT02002091|520709542|FG001|Screening|Lost to Follow-up|12|||
144410203|NCT02002091|520709541|FG000|Screening|Death|3|||
144410204|NCT02002091|520709542|FG001|Screening|Death|2|||
144410205|NCT02083783|520709551|FG000|Overall Study|Withdrawal by Subject|1|||
144410206|NCT02083783|520709552|FG001|Overall Study|Withdrawal by Subject|0|||
144410207|NCT02256631|520709555|FG000|Overall Study|Lost to Follow-up|1|||
144410208|NCT02256631|520709556|FG001|Overall Study|Lost to Follow-up|1|||
144410209|NCT02256631|520709557|FG002|Overall Study|Lost to Follow-up|0|||
144526669|NCT02993159|521129249|FG001|Overall Study|Withdrawal by Subject|3|||
144526670|NCT02993159|521129248|FG000|Overall Study|Protocol Violation|1|||
144526671|NCT02993159|521129249|FG001|Overall Study|Protocol Violation|0|||
144410210|NCT02256631|520709558|FG003|Overall Study|Lost to Follow-up|2|||
144410211|NCT02256631|520709559|FG004|Overall Study|Lost to Follow-up|0|||
144410212|NCT02256631|520709560|FG005|Overall Study|Lost to Follow-up|4|||
144410213|NCT02256631|520709561|FG006|Overall Study|Lost to Follow-up|1|||
144410214|NCT02256631|520709555|FG000|Overall Study|Withdrawal by Subject|0|||
144410215|NCT02256631|520709556|FG001|Overall Study|Withdrawal by Subject|0|||
144410216|NCT02256631|520709557|FG002|Overall Study|Withdrawal by Subject|0|||
144410217|NCT02256631|520709558|FG003|Overall Study|Withdrawal by Subject|1|||
144410218|NCT02256631|520709559|FG004|Overall Study|Withdrawal by Subject|1|||
144410219|NCT02256631|520709560|FG005|Overall Study|Withdrawal by Subject|0|||
144410220|NCT02256631|520709561|FG006|Overall Study|Withdrawal by Subject|1|||
144410221|NCT02256631|520709555|FG000|Overall Study|Unable to get to clinic|0|||
144410222|NCT02256631|520709556|FG001|Overall Study|Unable to get to clinic|2|||
144410223|NCT02256631|520709557|FG002|Overall Study|Unable to get to clinic|0|||
144600139|NCT01658826|521397594|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
144410224|NCT02256631|520709558|FG003|Overall Study|Unable to get to clinic|1|||
144410225|NCT02256631|520709559|FG004|Overall Study|Unable to get to clinic|0|||
144410226|NCT02256631|520709560|FG005|Overall Study|Unable to get to clinic|1|||
144600140|NCT01658826|521397593|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
144600141|NCT01658826|521397594|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
144600142|NCT01658826|521397593|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
144410227|NCT02256631|520709561|FG006|Overall Study|Unable to get to clinic|2|||
144410228|NCT00622284|520709562|FG000|Overall Study|Lack of Efficacy|45|||
144410229|NCT00622284|520709563|FG001|Overall Study|Lack of Efficacy|15|||
144410230|NCT00622284|520709562|FG000|Overall Study|Adverse Event|61|||
144410231|NCT00622284|520709563|FG001|Overall Study|Adverse Event|90|||
144410232|NCT00622284|520709562|FG000|Overall Study|Protocol Violation|12|||
144410233|NCT00622284|520709563|FG001|Overall Study|Protocol Violation|5|||
144410234|NCT00622284|520709562|FG000|Overall Study|Lost to Follow-up|11|||
144410235|NCT00622284|520709563|FG001|Overall Study|Lost to Follow-up|13|||
144410236|NCT00622284|520709562|FG000|Overall Study|Withdrawal by Subject|27|||
144410237|NCT00622284|520709563|FG001|Overall Study|Withdrawal by Subject|24|||
144410238|NCT00622284|520709562|FG000|Overall Study|Other reason (not specified)|33|||
144410239|NCT00622284|520709563|FG001|Overall Study|Other reason (not specified)|24|||
144410240|NCT03943147|520709564|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
144410241|NCT03943147|520709565|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
144410242|NCT03943147|520709564|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
144410243|NCT03943147|520709565|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
144410244|NCT03943147|520709564|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
144410245|NCT03943147|520709565|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
144410246|NCT03943147|520709564|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
144410247|NCT03943147|520709565|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
144410248|NCT03943147|520709564|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
144410249|NCT03943147|520709565|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
144410250|NCT03943147|520709564|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
144410251|NCT03943147|520709565|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
144410252|NCT00629707|520709568|FG000|Overall Study|Withdrawal by Subject|0|||
144410253|NCT00629707|520709569|FG001|Overall Study|Withdrawal by Subject|1|||
144410254|NCT00629707|520709568|FG000|Overall Study|Physician Decision|0|||
144410255|NCT00629707|520709569|FG001|Overall Study|Physician Decision|1|||
144410256|NCT00968201|520709571|FG000|Base Study - (Period II)|Adverse Event|8|||
144410257|NCT00968201|520709572|FG001|Base Study - (Period II)|Adverse Event|0|||
144410258|NCT00968201|520709573|FG002|Base Study - (Period II)|Adverse Event|16|||
144410259|NCT00968201|520709571|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
144410260|NCT00968201|520709572|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
144410261|NCT00968201|520709573|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
144410262|NCT00968201|520709571|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
144410263|NCT00968201|520709572|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
144410264|NCT00968201|520709573|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
144410265|NCT00968201|520709571|FG000|Base Study - (Period II)|Protocol Violation|12|||
144410266|NCT00968201|520709572|FG001|Base Study - (Period II)|Protocol Violation|0|||
144410267|NCT00968201|520709573|FG002|Base Study - (Period II)|Protocol Violation|12|||
144410268|NCT00968201|520709571|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
144410269|NCT00968201|520709572|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
144410270|NCT00968201|520709573|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
144410271|NCT00968201|520709571|FG000|Base Study - (Period II)|Site Error|0|||
144410272|NCT00968201|520709572|FG001|Base Study - (Period II)|Site Error|0|||
144410273|NCT00968201|520709573|FG002|Base Study - (Period II)|Site Error|1|||
144410274|NCT00968201|520709571|FG000|Extension Study - (Period III)|Adverse Event|0|||
144410275|NCT00968201|520709572|FG001|Extension Study - (Period III)|Adverse Event|5|||
144410276|NCT00968201|520709573|FG002|Extension Study - (Period III)|Adverse Event|22|||
144410277|NCT00968201|520709571|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
144410278|NCT00968201|520709572|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
144410279|NCT00968201|520709573|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
144410280|NCT00968201|520709571|FG000|Extension Study - (Period III)|Protocol Violation|0|||
144410281|NCT00968201|520709572|FG001|Extension Study - (Period III)|Protocol Violation|17|||
144410282|NCT00968201|520709573|FG002|Extension Study - (Period III)|Protocol Violation|14|||
144410283|NCT00968201|520709571|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
144410284|NCT00968201|520709572|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
144410285|NCT00968201|520709573|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
144410286|NCT00968201|520709571|FG000|Extension Study - (Period III)|Patient Relocated|0|||
144410287|NCT00968201|520709572|FG001|Extension Study - (Period III)|Patient Relocated|1|||
144410288|NCT00968201|520709573|FG002|Extension Study - (Period III)|Patient Relocated|1|||
144410289|NCT00968201|520709571|FG000|Extension Study - (Period III)|Noncompliance|0|||
144410290|NCT00968201|520709572|FG001|Extension Study - (Period III)|Noncompliance|0|||
144410291|NCT00968201|520709573|FG002|Extension Study - (Period III)|Noncompliance|3|||
144410292|NCT00968201|520709571|FG000|Extension Study - (Period III)|Other|0|||
144410293|NCT00968201|520709572|FG001|Extension Study - (Period III)|Other|0|||
144410294|NCT00968201|520709573|FG002|Extension Study - (Period III)|Other|2|||
144410295|NCT00968201|520709571|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
144410296|NCT00968201|520709572|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
144410297|NCT00968201|520709573|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
144410298|NCT02619175|520709574|FG000|Overall Study|Withdrawal by Subject|1|||
144410299|NCT02619175|520709575|FG001|Overall Study|Withdrawal by Subject|0|||
144410300|NCT02619175|520709574|FG000|Overall Study|foot pain|1|||
144410301|NCT02619175|520709575|FG001|Overall Study|foot pain|0|||
144410302|NCT02302807|520709578|FG000|Overall Study|Withdrawal by Subject|28|||
144410303|NCT02302807|520709579|FG001|Overall Study|Withdrawal by Subject|11|||
144410304|NCT02302807|520709578|FG000|Overall Study|Lost to Follow-up|4|||
144410305|NCT02302807|520709579|FG001|Overall Study|Lost to Follow-up|6|||
144410306|NCT02302807|520709578|FG000|Overall Study|Death|397|||
144410307|NCT02302807|520709579|FG001|Overall Study|Death|385|||
144410308|NCT02302807|520709578|FG000|Overall Study|Study Terminated By Sponsor|35|||
144410309|NCT02302807|520709579|FG001|Overall Study|Study Terminated By Sponsor|64|||
144410310|NCT02302807|520709578|FG000|Overall Study|Physician Decision|0|||
144410311|NCT02302807|520709579|FG001|Overall Study|Physician Decision|1|||
144410312|NCT03307967|520709582|FG000|Overall Study|Lost to Follow-up|4|||
144410313|NCT03268954|520709583|FG000|Overall Study|Withdrawal by Subject|27|||
144410314|NCT03268954|520709584|FG001|Overall Study|Withdrawal by Subject|17|||
144410315|NCT03268954|520709583|FG000|Overall Study|Lost to Follow-up|2|||
144410316|NCT03268954|520709584|FG001|Overall Study|Lost to Follow-up|3|||
144410317|NCT03268954|520709583|FG000|Overall Study|Reason Not Specified|3|||
144410318|NCT03268954|520709584|FG001|Overall Study|Reason Not Specified|8|||
144410319|NCT00621985|520711476|FG000|Dexamethasone Admission|Adverse Event|1|||
144410320|NCT01408485|520711481|FG000|Overall Study|Withdrawal by Subject|21|||
144410321|NCT01338792|520711482|FG000|Overall Study|Adverse Event|2|||
144410322|NCT01338792|520711482|FG000|Overall Study|Death|1|||
144410323|NCT01338792|520711482|FG000|Overall Study|Withdrawal by Subject|1|||
144410324|NCT00618072|520711483|FG000|Overall Study|Lost to Follow-up|2|||
144410325|NCT00618072|520711484|FG001|Overall Study|Lost to Follow-up|0|||
144410326|NCT00618072|520711485|FG002|Overall Study|Lost to Follow-up|3|||
144410327|NCT00618072|520711483|FG000|Overall Study|Physician Decision|0|||
144410328|NCT00618072|520711484|FG001|Overall Study|Physician Decision|1|||
144526672|NCT02993159|521129248|FG000|Overall Study|Opted out of surgery|2|||
144410329|NCT00618072|520711485|FG002|Overall Study|Physician Decision|1|||
144410330|NCT00573469|520711486|FG000|Overall Study|Adverse Event|1|||
144410331|NCT00573469|520711487|FG001|Overall Study|Adverse Event|1|||
144410332|NCT00573469|520711488|FG002|Overall Study|Adverse Event|1|||
144410333|NCT00573469|520711486|FG000|Overall Study|Withdrawal by Subject|0|||
144410334|NCT00573469|520711487|FG001|Overall Study|Withdrawal by Subject|2|||
144410335|NCT00573469|520711488|FG002|Overall Study|Withdrawal by Subject|0|||
144410336|NCT00573469|520711486|FG000|Overall Study|Other|5|||
144410337|NCT00573469|520711487|FG001|Overall Study|Other|1|||
144410338|NCT00573469|520711488|FG002|Overall Study|Other|3|||
144410339|NCT02151591|520711490|FG000|Overall Study|Lost to Follow-up|6|||
144410340|NCT02151591|520711491|FG001|Overall Study|Lost to Follow-up|3|||
144410341|NCT03555591|520711494|FG000|Overall Study|Protocol Violation|77|||
144410342|NCT03633695|520711495|FG000|Overall Study|Lost to Follow-up|4|||
144410343|NCT03633695|520711496|FG001|Overall Study|Lost to Follow-up|5|||
144410344|NCT03633695|520711495|FG000|Overall Study|Discontinued|8|||
144410345|NCT03633695|520711496|FG001|Overall Study|Discontinued|4|||
144410346|NCT00684593|520711497|FG000|Overall Study|Adverse Event|0|||
144410347|NCT00684593|520711498|FG001|Overall Study|Adverse Event|2|||
144410348|NCT00617773|520711506|FG000|Overall Study|Physician Decision|1|||
144410349|NCT00617773|520711506|FG000|Overall Study|Lack of compliance with the protocol|1|||
144410350|NCT00617773|520711506|FG000|Overall Study|Withdrawal by Subject|1|||
144410351|NCT00617773|520711506|FG000|Overall Study|Death|1|||
144410352|NCT00617773|520711506|FG000|Overall Study|Progressive disease|19|||
144410353|NCT00617773|520711506|FG000|Overall Study|Protocol Violation|1|||
144410354|NCT03130257|520711510|FG000|Overall Study|Withdrawal by Subject|1|||
144410355|NCT03130257|520711511|FG001|Overall Study|Withdrawal by Subject|0|||
144410356|NCT03130257|520711512|FG002|Overall Study|Withdrawal by Subject|2|||
144410357|NCT05526716|520711513|FG000|Overall Study|Death|1|||
144410358|NCT05526716|520711514|FG001|Overall Study|Death|2|||
144410359|NCT05526716|520711513|FG000|Overall Study|Lost to Follow-up|17|||
144410360|NCT05526716|520711514|FG001|Overall Study|Lost to Follow-up|15|||
144410361|NCT05526716|520711513|FG000|Overall Study|Physician Decision|0|||
144410362|NCT05526716|520711514|FG001|Overall Study|Physician Decision|1|||
144410363|NCT05526716|520711513|FG000|Overall Study|Randomized by mistake without study treatment|0|||
144410364|NCT05526716|520711514|FG001|Overall Study|Randomized by mistake without study treatment|1|||
144410365|NCT05526716|520711513|FG000|Overall Study|Withdrawal by Subject|12|||
144410366|NCT05526716|520711514|FG001|Overall Study|Withdrawal by Subject|12|||
144410367|NCT05526716|520711513|FG000|Overall Study|Not reported|0|||
144410368|NCT05526716|520711514|FG001|Overall Study|Not reported|2|||
144410369|NCT01751867|520711515|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
144410370|NCT01751867|520711516|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
144410371|NCT01751867|520711515|FG000|Overall Study|Diease Progression|4|||
144410372|NCT01751867|520711516|FG001|Overall Study|Diease Progression|18|||
144410373|NCT01751867|520711515|FG000|Overall Study|Adverse Event|8|||
144410374|NCT01751867|520711516|FG001|Overall Study|Adverse Event|15|||
144410375|NCT01751867|520711515|FG000|Overall Study|Poor Compliance|0|||
144410376|NCT01751867|520711516|FG001|Overall Study|Poor Compliance|5|||
144410377|NCT01751867|520711515|FG000|Overall Study|Withdrawal by Subject|3|||
144410378|NCT01751867|520711516|FG001|Overall Study|Withdrawal by Subject|1|||
144410379|NCT01751867|520711515|FG000|Overall Study|Physician Decision|4|||
144410380|NCT01751867|520711516|FG001|Overall Study|Physician Decision|7|||
144410381|NCT01751867|520711515|FG000|Overall Study|Protocol Violation|0|||
144410382|NCT01751867|520711516|FG001|Overall Study|Protocol Violation|2|||
144410383|NCT01751867|520711515|FG000|Overall Study|Death|0|||
144410384|NCT01751867|520711516|FG001|Overall Study|Death|5|||
144410385|NCT01751867|520711515|FG000|Overall Study|Other|11|||
144410386|NCT01751867|520711516|FG001|Overall Study|Other|37|||
144410387|NCT01751867|520711515|FG000|Overall Study|Randomized but not treated.|2|||
144410388|NCT01751867|520711516|FG001|Overall Study|Randomized but not treated.|1|||
144410389|NCT04932096|520711517|FG000|Overall Study|Withdrawal by Subject|1|||
144410390|NCT04932096|520711518|FG001|Overall Study|Withdrawal by Subject|1|||
144410391|NCT04932096|520711517|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
144410392|NCT04932096|520711518|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
144410393|NCT01508650|520711519|FG000|Overall Study|Lost to Follow-up|0|||
144410394|NCT01508650|520711520|FG001|Overall Study|Lost to Follow-up|3|||
144250091|NCT04767529|520113451|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
144250092|NCT04767529|520113449|FG000|Overall Study|Lost to Follow-up|0|||
144410395|NCT02064894|520711521|FG000|Overall Study|Withdrawal by Subject|43|||
144410396|NCT02064894|520711522|FG001|Overall Study|Withdrawal by Subject|102|||
144410397|NCT02064894|520711523|FG002|Overall Study|Withdrawal by Subject|115|||
144410398|NCT01438957|520711524|FG000|Overall Study|Physician Decision|1|||
144410399|NCT01438957|520711525|FG001|Overall Study|Physician Decision|1|||
144410400|NCT01438957|520711526|FG002|Overall Study|Physician Decision|0|||
144410401|NCT01438957|520711527|FG003|Overall Study|Physician Decision|1|||
144410402|NCT01438957|520711528|FG004|Overall Study|Physician Decision|0|||
144410403|NCT01396148|520711529|FG000|Overall Study|Patient Decision|1|||
144410404|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
144410405|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
144410406|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
144410407|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
144410408|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
144410409|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
144410410|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
144410411|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
144410412|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
144410413|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
144410414|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
144410415|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
144410416|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
144410417|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
144410418|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
144410419|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
144410420|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
144410421|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
144410422|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
144410423|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
144410424|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
144410425|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
144410426|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
144410427|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
144410428|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410429|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
144410430|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410431|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410432|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410433|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410434|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410435|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
144410436|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
144410437|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
144410438|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
144410439|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
144410440|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
144410441|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
144410442|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
144410443|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
144410444|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
144410445|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410446|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410447|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410448|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410449|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410450|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410451|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
144410452|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
144410453|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
144410454|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
144410455|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
144410456|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
144410457|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
144410458|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
144410459|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
144410460|NCT03095066|520711538|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
144410461|NCT03095066|520711539|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
144410462|NCT03095066|520711540|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
144410463|NCT03095066|520711541|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
144410464|NCT03095066|520711542|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
144410465|NCT03095066|520711543|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
144410466|NCT03095066|520711544|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
144410467|NCT03095066|520711545|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
144410468|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
144410469|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
144410470|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
144410471|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
144250093|NCT04767529|520113450|FG001|Overall Study|Lost to Follow-up|2|||
144250094|NCT04767529|520113451|FG002|Overall Study|Lost to Follow-up|3|||
144250095|NCT02290925|520113457|FG000|First Period of Three Months|Lost to Follow-up|2|||
144410472|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
144410473|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
144250096|NCT02290925|520113458|FG001|First Period of Three Months|Lost to Follow-up|1|||
144410474|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
144410475|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
144410476|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
144410477|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
144410478|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
144410479|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
144410480|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
144410481|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
144410482|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
144410483|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
144410484|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
144410485|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
144410486|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
144410487|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
144410488|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
144410489|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
144410490|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
144410491|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
144410492|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
144410493|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
144410494|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
144410495|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
144410496|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
144410497|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
144410498|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
144410499|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
144410500|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410501|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410502|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
144410503|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410504|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410505|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410506|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410507|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
144410508|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
144410509|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
144410510|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
144410511|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
144410512|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
144410513|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
144526673|NCT02993159|521129249|FG001|Overall Study|Opted out of surgery|0|||
144526674|NCT02993159|521129248|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
144526675|NCT02993159|521129249|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
144526676|NCT02993159|521129248|FG000|Overall Study|Physician Decision|0|||
144526677|NCT02993159|521129249|FG001|Overall Study|Physician Decision|1|||
144526678|NCT05034328|521129250|FG000|Overall Study|Protocol Violation|1|||
144526679|NCT05034328|521129251|FG001|Overall Study|Protocol Violation|0|||
144526680|NCT05034328|521129250|FG000|Overall Study|Lost to Follow-up|0|||
144526681|NCT05034328|521129251|FG001|Overall Study|Lost to Follow-up|10|||
144526682|NCT02969707|521129252|FG000|Overall Study|Withdrawal by Subject|6|||
144526683|NCT02969707|521129253|FG001|Overall Study|Withdrawal by Subject|5|||
144526684|NCT02969707|521129252|FG000|Overall Study|Severe anxiety|0|||
144526685|NCT02969707|521129253|FG001|Overall Study|Severe anxiety|1|||
144526686|NCT02969707|521129252|FG000|Overall Study|Positive toxicology screen|0|||
144526687|NCT02969707|521129253|FG001|Overall Study|Positive toxicology screen|2|||
144526688|NCT02969707|521129252|FG000|Overall Study|Claustrophobia|2|||
144526689|NCT02969707|521129253|FG001|Overall Study|Claustrophobia|2|||
144526690|NCT02969707|521129252|FG000|Overall Study|Non-compliance|1|||
144526691|NCT02969707|521129253|FG001|Overall Study|Non-compliance|2|||
144526692|NCT04313972|521129254|FG000|Overall Study|Withdrawal by Subject|0|||
144526693|NCT04313972|521129255|FG001|Overall Study|Withdrawal by Subject|1|||
144526694|NCT04314713|521129256|FG000|Overall Study|Lost to Follow-up|0|||
144526695|NCT04314713|521129257|FG001|Overall Study|Lost to Follow-up|0|||
144526696|NCT04314713|521129258|FG002|Overall Study|Lost to Follow-up|0|||
144526697|NCT04314713|521129259|FG003|Overall Study|Lost to Follow-up|1|||
144526698|NCT04314713|521129260|FG004|Overall Study|Lost to Follow-up|0|||
144526699|NCT04314713|521129261|FG005|Overall Study|Lost to Follow-up|0|||
144526700|NCT01544114|521129287|FG000|Overall Study|Withdrawal by Subject|0|||
144526701|NCT01544114|521129288|FG001|Overall Study|Withdrawal by Subject|0|||
144526702|NCT01544114|521129289|FG002|Overall Study|Withdrawal by Subject|3|||
144410514|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
144410515|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
144410516|NCT03095066|520711538|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410517|NCT03095066|520711539|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410518|NCT03095066|520711540|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410519|NCT03095066|520711541|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410520|NCT03095066|520711542|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410521|NCT03095066|520711543|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410522|NCT03095066|520711544|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
144410523|NCT03095066|520711545|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
144410524|NCT03095066|520711538|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410525|NCT03095066|520711539|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410526|NCT03095066|520711540|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410527|NCT03095066|520711541|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410528|NCT03095066|520711542|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410529|NCT03095066|520711543|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
144410530|NCT03095066|520711544|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410531|NCT03095066|520711545|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
144410532|NCT03095066|520711538|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
144410533|NCT03095066|520711539|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
144410534|NCT03095066|520711540|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
144410535|NCT03095066|520711541|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
144410536|NCT03095066|520711542|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
144410537|NCT03095066|520711543|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
144410538|NCT03095066|520711544|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
144410539|NCT03095066|520711545|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
144410540|NCT03095066|520711538|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
144410541|NCT03095066|520711539|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
144410542|NCT03095066|520711540|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
144410543|NCT03095066|520711541|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
144410544|NCT03095066|520711542|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
144410545|NCT03095066|520711543|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
144410546|NCT03095066|520711544|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
144410547|NCT03095066|520711545|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
144410548|NCT03095066|520711538|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
144410549|NCT03095066|520711539|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
144410550|NCT03095066|520711540|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
144410551|NCT03095066|520711541|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
144410552|NCT03095066|520711542|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
144410553|NCT03095066|520711543|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
144410554|NCT03095066|520711544|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
144410555|NCT03095066|520711545|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
144526703|NCT01544114|521129287|FG000|Overall Study|Lost to Follow-up|0|||
144526704|NCT01544114|521129288|FG001|Overall Study|Lost to Follow-up|2|||
144526705|NCT01544114|521129289|FG002|Overall Study|Lost to Follow-up|0|||
144526706|NCT01544114|521129287|FG000|Overall Study|Adverse Event|1|||
144526707|NCT01544114|521129288|FG001|Overall Study|Adverse Event|1|||
144526708|NCT01544114|521129289|FG002|Overall Study|Adverse Event|2|||
144526709|NCT01544114|521129287|FG000|Overall Study|Protocol Violation|0|||
144526710|NCT01544114|521129288|FG001|Overall Study|Protocol Violation|1|||
144526711|NCT01544114|521129289|FG002|Overall Study|Protocol Violation|0|||
144526712|NCT01733316|521129292|FG000|RP103 Phase|Non-compliance|1|||
144526713|NCT01733316|521129292|FG000|Long Term Extension Phase|Adverse Event|1|||
144526714|NCT01733316|521129292|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
144526715|NCT01733316|521129292|FG000|Long Term Extension Phase|Sponsor Decision|2|||
144526716|NCT05526430|521129293|FG000|Overall Study|Withdrawal by Subject|0|||
144526717|NCT05526430|521129294|FG001|Overall Study|Withdrawal by Subject|2|||
144526718|NCT05526430|521129295|FG002|Overall Study|Withdrawal by Subject|0|||
144526719|NCT05526430|521129296|FG003|Overall Study|Withdrawal by Subject|0|||
144526720|NCT03024437|521129305|FG000|Overall Study|Adverse Event|0|||
144526721|NCT03024437|521129306|FG001|Overall Study|Adverse Event|1|||
144526722|NCT03024437|521129307|FG002|Overall Study|Adverse Event|3|||
144526723|NCT03024437|521129308|FG003|Overall Study|Adverse Event|5|||
144410556|NCT03095066|520711538|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
144410557|NCT03095066|520711539|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
144410558|NCT03095066|520711540|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
144526724|NCT03024437|521129309|FG004|Overall Study|Adverse Event|0|||
144526725|NCT03024437|521129305|FG000|Overall Study|Physician Decision|1|||
144526726|NCT03024437|521129306|FG001|Overall Study|Physician Decision|0|||
144526727|NCT03024437|521129307|FG002|Overall Study|Physician Decision|0|||
144526728|NCT03024437|521129308|FG003|Overall Study|Physician Decision|1|||
144526729|NCT03024437|521129309|FG004|Overall Study|Physician Decision|0|||
144526730|NCT03024437|521129305|FG000|Overall Study|Disease progression, relapse|1|||
144410559|NCT03095066|520711541|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
144410560|NCT03095066|520711542|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
144410561|NCT03095066|520711543|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
144410562|NCT03095066|520711544|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
144410563|NCT03095066|520711545|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
144410564|NCT00160693|520711546|FG000|Overall Study|Adverse Event|97|||
144410565|NCT00160693|520711546|FG000|Overall Study|Lack of Efficacy|30|||
144410566|NCT00160693|520711546|FG000|Overall Study|Protocol Violation|24|||
144410567|NCT00160693|520711546|FG000|Overall Study|Lost to Follow-up|15|||
144410568|NCT00160693|520711546|FG000|Overall Study|Withdrawal by Subject|54|||
144410569|NCT00160693|520711546|FG000|Overall Study|Study terminated by sponsor|15|||
144410570|NCT02170298|520711551|FG000|Overall Study|Withdrawal by Subject|0|||
144410571|NCT02170298|520711552|FG001|Overall Study|Withdrawal by Subject|1|||
144410572|NCT02170298|520711551|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
144410573|NCT02170298|520711552|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
144410574|NCT00777608|520711554|FG000|Overall Study|Lost to Follow-up|1|||
144410575|NCT00777608|520711555|FG001|Overall Study|Lost to Follow-up|1|||
144410576|NCT00777608|520711554|FG000|Overall Study|Withdrawal by Subject|1|||
144410577|NCT00777608|520711555|FG001|Overall Study|Withdrawal by Subject|3|||
144410578|NCT00777608|520711554|FG000|Overall Study|Protocol Violation|1|||
144410579|NCT00777608|520711555|FG001|Overall Study|Protocol Violation|0|||
144410580|NCT00777608|520711554|FG000|Overall Study|Investigator Decision|1|||
144410581|NCT00777608|520711555|FG001|Overall Study|Investigator Decision|2|||
144410582|NCT04213079|520711556|FG000|Overall Study|Lost to Follow-up|0|||
144410583|NCT04213079|520711557|FG001|Overall Study|Lost to Follow-up|2|||
144410584|NCT00520936|520711558|FG000|Overall Study|Physician Decision|0|||
144410585|NCT00520936|520711559|FG001|Overall Study|Physician Decision|2|||
144410586|NCT00520936|520711560|FG002|Overall Study|Physician Decision|1|||
144410587|NCT00520936|520711561|FG003|Overall Study|Physician Decision|0|||
144410588|NCT00520936|520711562|FG004|Overall Study|Physician Decision|0|||
144410589|NCT00520936|520711563|FG005|Overall Study|Physician Decision|0|||
144410590|NCT00520936|520711564|FG006|Overall Study|Physician Decision|0|||
144410591|NCT00520936|520711565|FG007|Overall Study|Physician Decision|0|||
144410592|NCT00520936|520711558|FG000|Overall Study|Withdrawal by Subject|0|||
144410593|NCT00520936|520711559|FG001|Overall Study|Withdrawal by Subject|0|||
144410594|NCT00520936|520711560|FG002|Overall Study|Withdrawal by Subject|0|||
144410595|NCT00520936|520711561|FG003|Overall Study|Withdrawal by Subject|0|||
144410596|NCT00520936|520711562|FG004|Overall Study|Withdrawal by Subject|0|||
144410597|NCT00520936|520711563|FG005|Overall Study|Withdrawal by Subject|0|||
144410598|NCT00520936|520711564|FG006|Overall Study|Withdrawal by Subject|0|||
144410599|NCT00520936|520711565|FG007|Overall Study|Withdrawal by Subject|1|||
144410600|NCT00520936|520711558|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
144410601|NCT00520936|520711559|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
144410602|NCT00520936|520711560|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
144410603|NCT00520936|520711561|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
144410604|NCT00520936|520711562|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
144410605|NCT00520936|520711563|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
144410606|NCT00520936|520711564|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
144410607|NCT00520936|520711565|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
144410608|NCT00520936|520711558|FG000|Overall Study|Death|0|||
144410609|NCT00520936|520711559|FG001|Overall Study|Death|0|||
144410610|NCT00520936|520711560|FG002|Overall Study|Death|0|||
144410611|NCT00520936|520711561|FG003|Overall Study|Death|0|||
144410612|NCT00520936|520711562|FG004|Overall Study|Death|0|||
144410613|NCT00520936|520711563|FG005|Overall Study|Death|0|||
144410614|NCT00520936|520711564|FG006|Overall Study|Death|1|||
144410615|NCT00520936|520711565|FG007|Overall Study|Death|0|||
144410616|NCT00520936|520711558|FG000|Overall Study|Protocol Violation|0|||
144410617|NCT00520936|520711559|FG001|Overall Study|Protocol Violation|1|||
144410618|NCT00520936|520711560|FG002|Overall Study|Protocol Violation|1|||
144410619|NCT00520936|520711561|FG003|Overall Study|Protocol Violation|0|||
144526731|NCT03024437|521129306|FG001|Overall Study|Disease progression, relapse|0|||
144250097|NCT02290925|520113457|FG000|First Period of Three Months|Death|1|||
144250098|NCT02290925|520113458|FG001|First Period of Three Months|Death|0|||
144410620|NCT00520936|520711562|FG004|Overall Study|Protocol Violation|1|||
144410621|NCT00520936|520711563|FG005|Overall Study|Protocol Violation|0|||
144410622|NCT00520936|520711564|FG006|Overall Study|Protocol Violation|1|||
144410623|NCT00520936|520711565|FG007|Overall Study|Protocol Violation|0|||
144410624|NCT04343261|520711566|FG000|Overall Study|Adverse Event|1|||
144410625|NCT04343261|520711566|FG000|Overall Study|received inadequate amount of antibodies|7|||
144410626|NCT03616600|520711567|FG000|Overall Study|Withdrawal by Subject|1|||
144410627|NCT03616600|520711568|FG001|Overall Study|Withdrawal by Subject|0|||
144410628|NCT03984994|520711569|FG000|Overall Study|Withdrawal by Subject|2|||
144410629|NCT03984994|520711570|FG001|Overall Study|Withdrawal by Subject|1|||
144410630|NCT04220866|520711571|FG000|Overall Study|Death|4|||
144410631|NCT04220866|520711572|FG001|Overall Study|Death|5|||
144410632|NCT04220866|520711571|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
144410633|NCT04220866|520711572|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
144410634|NCT04220866|520711571|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
144410635|NCT04220866|520711572|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
144410636|NCT04220866|520711571|FG000|Overall Study|Withdrawal by Subject|0|||
144410637|NCT04220866|520711572|FG001|Overall Study|Withdrawal by Subject|1|||
144410638|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Death|0|||
144410639|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Death|0|||
144410640|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Death|0|||
144410641|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Death|0|||
144410642|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Death|1|||
144410643|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Death|0|||
144410644|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Death|0|||
144410645|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Death|0|||
144410646|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
144410647|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
144410648|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
144410649|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
144410650|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
144410651|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
144410652|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
144410653|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
144410654|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
144410655|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
144410656|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
144410657|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
144410658|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
144410659|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
144410660|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
144410661|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
144410662|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
144410663|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
144410664|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
144410665|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
144410666|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
144410667|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
144410668|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
144410669|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
144410670|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
144410671|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
144410672|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
144410673|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
144410674|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
144410675|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
144410676|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
144410677|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
144410678|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
144410679|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
144410680|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
144410681|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
144410682|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
144410683|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
144410684|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
144410685|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
144410686|NCT00726232|520711573|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
144410687|NCT00726232|520711574|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410688|NCT00726232|520711575|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410689|NCT00726232|520711576|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410690|NCT00726232|520711577|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410691|NCT00726232|520711578|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410692|NCT00726232|520711579|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410693|NCT00726232|520711580|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
144410694|NCT00726232|520711573|FG000|Expansion Phase|Death|0|||
144410695|NCT00726232|520711574|FG001|Expansion Phase|Death|0|||
144410696|NCT00726232|520711575|FG002|Expansion Phase|Death|0|||
144410697|NCT00726232|520711576|FG003|Expansion Phase|Death|0|||
144526732|NCT03024437|521129307|FG002|Overall Study|Disease progression, relapse|0|||
144526733|NCT03024437|521129308|FG003|Overall Study|Disease progression, relapse|3|||
144410698|NCT00726232|520711577|FG004|Expansion Phase|Death|0|||
144410699|NCT00726232|520711578|FG005|Expansion Phase|Death|0|||
144410700|NCT00726232|520711579|FG006|Expansion Phase|Death|0|||
144410701|NCT00726232|520711580|FG007|Expansion Phase|Death|1|||
144410702|NCT00726232|520711573|FG000|Expansion Phase|Adverse Event|0|||
144410703|NCT00726232|520711574|FG001|Expansion Phase|Adverse Event|0|||
144410704|NCT00726232|520711575|FG002|Expansion Phase|Adverse Event|0|||
144410705|NCT00726232|520711576|FG003|Expansion Phase|Adverse Event|0|||
144410706|NCT00726232|520711577|FG004|Expansion Phase|Adverse Event|0|||
144410707|NCT00726232|520711578|FG005|Expansion Phase|Adverse Event|0|||
144410708|NCT00726232|520711579|FG006|Expansion Phase|Adverse Event|6|||
144410709|NCT00726232|520711580|FG007|Expansion Phase|Adverse Event|11|||
144410710|NCT00726232|520711573|FG000|Expansion Phase|Withdrawal by Subject|0|||
144410711|NCT00726232|520711574|FG001|Expansion Phase|Withdrawal by Subject|0|||
144410712|NCT00726232|520711575|FG002|Expansion Phase|Withdrawal by Subject|0|||
144410713|NCT00726232|520711576|FG003|Expansion Phase|Withdrawal by Subject|0|||
144410714|NCT00726232|520711577|FG004|Expansion Phase|Withdrawal by Subject|0|||
144410715|NCT00726232|520711578|FG005|Expansion Phase|Withdrawal by Subject|0|||
144410716|NCT00726232|520711579|FG006|Expansion Phase|Withdrawal by Subject|2|||
144410717|NCT00726232|520711580|FG007|Expansion Phase|Withdrawal by Subject|3|||
144410718|NCT00726232|520711573|FG000|Expansion Phase|Disease progression|0|||
144410719|NCT00726232|520711574|FG001|Expansion Phase|Disease progression|0|||
144410720|NCT00726232|520711575|FG002|Expansion Phase|Disease progression|0|||
144410721|NCT00726232|520711576|FG003|Expansion Phase|Disease progression|0|||
144410722|NCT00726232|520711577|FG004|Expansion Phase|Disease progression|0|||
144410723|NCT00726232|520711578|FG005|Expansion Phase|Disease progression|0|||
144410724|NCT00726232|520711579|FG006|Expansion Phase|Disease progression|4|||
144410725|NCT00726232|520711580|FG007|Expansion Phase|Disease progression|0|||
144410726|NCT00726232|520711573|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
144410727|NCT00726232|520711574|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
144410728|NCT00726232|520711575|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
144410729|NCT00726232|520711576|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
144410730|NCT00726232|520711577|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
144410731|NCT00726232|520711578|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
144410732|NCT00726232|520711579|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
144410733|NCT00726232|520711580|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
144410734|NCT00726232|520711573|FG000|Expansion Phase|Per Investigator: lack of response|0|||
144410735|NCT00726232|520711574|FG001|Expansion Phase|Per Investigator: lack of response|0|||
144410736|NCT00726232|520711575|FG002|Expansion Phase|Per Investigator: lack of response|0|||
144410737|NCT00726232|520711576|FG003|Expansion Phase|Per Investigator: lack of response|0|||
144410738|NCT00726232|520711577|FG004|Expansion Phase|Per Investigator: lack of response|0|||
144410739|NCT00726232|520711578|FG005|Expansion Phase|Per Investigator: lack of response|0|||
144410740|NCT00726232|520711579|FG006|Expansion Phase|Per Investigator: lack of response|1|||
144410741|NCT00726232|520711580|FG007|Expansion Phase|Per Investigator: lack of response|7|||
144410742|NCT00726232|520711573|FG000|Expansion Phase|Unspecified reason|0|||
144410743|NCT00726232|520711574|FG001|Expansion Phase|Unspecified reason|0|||
144410744|NCT00726232|520711575|FG002|Expansion Phase|Unspecified reason|0|||
144410745|NCT00726232|520711576|FG003|Expansion Phase|Unspecified reason|0|||
144410746|NCT00726232|520711577|FG004|Expansion Phase|Unspecified reason|0|||
144410747|NCT00726232|520711578|FG005|Expansion Phase|Unspecified reason|0|||
144410748|NCT00726232|520711579|FG006|Expansion Phase|Unspecified reason|1|||
144410749|NCT00726232|520711580|FG007|Expansion Phase|Unspecified reason|0|||
144410750|NCT03858309|520711581|FG000|Overall Study|Withdrawal by Subject|2|||
144410751|NCT03858309|520711582|FG001|Overall Study|Withdrawal by Subject|3|||
144410752|NCT03897465|520711591|FG000|Overall Study|Lost to Follow-up|2|||
144410753|NCT03897465|520711592|FG001|Overall Study|Lost to Follow-up|1|||
144410754|NCT03897465|520711591|FG000|Overall Study|Adverse Event|2|||
144410755|NCT03897465|520711592|FG001|Overall Study|Adverse Event|0|||
144410756|NCT03897465|520711591|FG000|Overall Study|complete healing by V2|1|||
144410757|NCT03897465|520711592|FG001|Overall Study|complete healing by V2|0|||
144410758|NCT03897465|520711591|FG000|Overall Study|occurence of exclusion criterion|1|||
144410759|NCT03897465|520711592|FG001|Overall Study|occurence of exclusion criterion|1|||
144410760|NCT03897465|520711591|FG000|Overall Study|Other|1|||
144410761|NCT03897465|520711592|FG001|Overall Study|Other|0|||
144410762|NCT02197247|520711593|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
144410763|NCT02197247|520711593|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
144722771|NCT01325207|521840530|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
144722772|NCT01325207|521840531|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
144410764|NCT02197247|520711593|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
144410765|NCT02197247|520711593|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
144410766|NCT02197247|520711593|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
144410767|NCT02197247|520711593|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
144410768|NCT02197247|520711593|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
144410769|NCT02197247|520711593|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
144410770|NCT04967443|520711603|FG000|Open Label Treatment|Death|1|||
144410771|NCT04967443|520711604|FG001|Open Label Treatment|Death|0|||
144410772|NCT04967443|520711605|FG002|Open Label Treatment|Death|0|||
144410773|NCT04967443|520711606|FG003|Open Label Treatment|Death|0|||
144410774|NCT04967443|520711607|FG004|Open Label Treatment|Death|0|||
144410775|NCT04967443|520711608|FG005|Open Label Treatment|Death|0|||
144410776|NCT04967443|520711609|FG006|Open Label Treatment|Death|0|||
144410777|NCT04967443|520711610|FG007|Open Label Treatment|Death|0|||
144410778|NCT04967443|520711603|FG000|Open Label Treatment|Lost to Follow-up|0|||
144410779|NCT04967443|520711604|FG001|Open Label Treatment|Lost to Follow-up|0|||
144410780|NCT04967443|520711605|FG002|Open Label Treatment|Lost to Follow-up|1|||
144410781|NCT04967443|520711606|FG003|Open Label Treatment|Lost to Follow-up|0|||
144410782|NCT04967443|520711607|FG004|Open Label Treatment|Lost to Follow-up|0|||
144410783|NCT04967443|520711608|FG005|Open Label Treatment|Lost to Follow-up|0|||
144410784|NCT04967443|520711609|FG006|Open Label Treatment|Lost to Follow-up|0|||
144410785|NCT04967443|520711610|FG007|Open Label Treatment|Lost to Follow-up|0|||
144410786|NCT04967443|520711603|FG000|Open Label Treatment|Withdrawal by Subject|0|||
144410787|NCT04967443|520711604|FG001|Open Label Treatment|Withdrawal by Subject|1|||
144410788|NCT04967443|520711605|FG002|Open Label Treatment|Withdrawal by Subject|0|||
144410789|NCT04967443|520711606|FG003|Open Label Treatment|Withdrawal by Subject|1|||
144410790|NCT04967443|520711607|FG004|Open Label Treatment|Withdrawal by Subject|0|||
144410791|NCT04967443|520711608|FG005|Open Label Treatment|Withdrawal by Subject|1|||
144410792|NCT04967443|520711609|FG006|Open Label Treatment|Withdrawal by Subject|2|||
144410793|NCT04967443|520711610|FG007|Open Label Treatment|Withdrawal by Subject|3|||
144410794|NCT04967443|520711603|FG000|Follow-Up|Death|1|||
144410795|NCT04967443|520711604|FG001|Follow-Up|Death|0|||
144410796|NCT04967443|520711605|FG002|Follow-Up|Death|0|||
144410797|NCT04967443|520711606|FG003|Follow-Up|Death|0|||
144410798|NCT04967443|520711607|FG004|Follow-Up|Death|0|||
144410799|NCT04967443|520711608|FG005|Follow-Up|Death|0|||
144410800|NCT04967443|520711609|FG006|Follow-Up|Death|0|||
144410801|NCT04967443|520711610|FG007|Follow-Up|Death|0|||
144410802|NCT04967443|520711603|FG000|Follow-Up|Lost to Follow-up|0|||
144410803|NCT04967443|520711604|FG001|Follow-Up|Lost to Follow-up|0|||
144410804|NCT04967443|520711605|FG002|Follow-Up|Lost to Follow-up|1|||
144410805|NCT04967443|520711606|FG003|Follow-Up|Lost to Follow-up|1|||
144410806|NCT04967443|520711607|FG004|Follow-Up|Lost to Follow-up|0|||
144410807|NCT04967443|520711608|FG005|Follow-Up|Lost to Follow-up|0|||
144410808|NCT04967443|520711609|FG006|Follow-Up|Lost to Follow-up|0|||
144410809|NCT04967443|520711610|FG007|Follow-Up|Lost to Follow-up|0|||
144410810|NCT04967443|520711603|FG000|Follow-Up|Withdrawal by Subject|0|||
144410811|NCT04967443|520711604|FG001|Follow-Up|Withdrawal by Subject|1|||
144410812|NCT04967443|520711605|FG002|Follow-Up|Withdrawal by Subject|0|||
144410813|NCT04967443|520711606|FG003|Follow-Up|Withdrawal by Subject|1|||
144410814|NCT04967443|520711607|FG004|Follow-Up|Withdrawal by Subject|0|||
144410815|NCT04967443|520711608|FG005|Follow-Up|Withdrawal by Subject|1|||
144410816|NCT04967443|520711609|FG006|Follow-Up|Withdrawal by Subject|2|||
144410817|NCT04967443|520711610|FG007|Follow-Up|Withdrawal by Subject|3|||
144410818|NCT02405780|520711612|FG000|Period I|Adverse Event|8|||
144410819|NCT02405780|520711613|FG001|Period I|Adverse Event|0|||
144410820|NCT02405780|520711614|FG002|Period I|Adverse Event|3|||
144410821|NCT02405780|520711615|FG003|Period I|Adverse Event|7|||
144410822|NCT02405780|520711612|FG000|Period I|Medical reasons|1|||
144410823|NCT02405780|520711613|FG001|Period I|Medical reasons|1|||
144410824|NCT02405780|520711614|FG002|Period I|Medical reasons|0|||
144722773|NCT01325207|521840526|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
144722774|NCT01325207|521840527|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
144410825|NCT02405780|520711615|FG003|Period I|Medical reasons|1|||
144410826|NCT02405780|520711612|FG000|Period I|Screening Failure|1|||
144722775|NCT01325207|521840528|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
144410827|NCT02405780|520711613|FG001|Period I|Screening Failure|0|||
144410828|NCT02405780|520711614|FG002|Period I|Screening Failure|1|||
144410829|NCT02405780|520711615|FG003|Period I|Screening Failure|0|||
144410830|NCT02405780|520711612|FG000|Period I|Withdrawal by Subject|9|||
144410831|NCT02405780|520711613|FG001|Period I|Withdrawal by Subject|1|||
144410832|NCT02405780|520711614|FG002|Period I|Withdrawal by Subject|3|||
144410833|NCT02405780|520711615|FG003|Period I|Withdrawal by Subject|4|||
144410834|NCT02405780|520711612|FG000|Period I|Non-compliance with study procedures|8|||
144410835|NCT02405780|520711613|FG001|Period I|Non-compliance with study procedures|6|||
144410836|NCT02405780|520711614|FG002|Period I|Non-compliance with study procedures|8|||
144410837|NCT02405780|520711615|FG003|Period I|Non-compliance with study procedures|11|||
144410838|NCT02405780|520711612|FG000|Period II|Adverse Event|3|||
144410839|NCT02405780|520711613|FG001|Period II|Adverse Event|5|||
144410840|NCT02405780|520711614|FG002|Period II|Adverse Event|4|||
144410841|NCT02405780|520711615|FG003|Period II|Adverse Event|11|||
144410842|NCT02405780|520711612|FG000|Period II|Medical reason|0|||
144410843|NCT02405780|520711613|FG001|Period II|Medical reason|1|||
144410844|NCT02405780|520711614|FG002|Period II|Medical reason|0|||
144410845|NCT02405780|520711615|FG003|Period II|Medical reason|0|||
144410846|NCT02405780|520711612|FG000|Period II|Pregnancy|0|||
144410847|NCT02405780|520711613|FG001|Period II|Pregnancy|0|||
144410848|NCT02405780|520711614|FG002|Period II|Pregnancy|1|||
144410849|NCT02405780|520711615|FG003|Period II|Pregnancy|0|||
144410850|NCT02405780|520711612|FG000|Period II|Withdrawal by Subject|7|||
144410851|NCT02405780|520711613|FG001|Period II|Withdrawal by Subject|4|||
144410852|NCT02405780|520711614|FG002|Period II|Withdrawal by Subject|0|||
144410853|NCT02405780|520711615|FG003|Period II|Withdrawal by Subject|3|||
144410854|NCT02405780|520711612|FG000|Period II|Non-compliance with study procedures|5|||
144410855|NCT02405780|520711613|FG001|Period II|Non-compliance with study procedures|2|||
144410856|NCT02405780|520711614|FG002|Period II|Non-compliance with study procedures|7|||
144410857|NCT02405780|520711615|FG003|Period II|Non-compliance with study procedures|4|||
144410858|NCT01654536|520711616|FG000|Overall Study|Lost to Follow-up|5|||
144410859|NCT01654536|520711617|FG001|Overall Study|Lost to Follow-up|5|||
144410860|NCT01654536|520711616|FG000|Overall Study|Physician Decision|12|||
144410861|NCT01654536|520711617|FG001|Overall Study|Physician Decision|8|||
144410862|NCT01654536|520711616|FG000|Overall Study|Withdrawal by Subject|27|||
144410863|NCT01654536|520711617|FG001|Overall Study|Withdrawal by Subject|25|||
144410864|NCT04502693|520711619|FG000|Overall Study|Adverse Event|7|||
144410865|NCT04502693|520711620|FG001|Overall Study|Adverse Event|6|||
144410866|NCT04502693|520711621|FG002|Overall Study|Adverse Event|11|||
144410867|NCT04502693|520711622|FG003|Overall Study|Adverse Event|1|||
144410868|NCT04502693|520711619|FG000|Overall Study|Lost to Follow-up|32|||
144410869|NCT04502693|520711620|FG001|Overall Study|Lost to Follow-up|36|||
144410870|NCT04502693|520711621|FG002|Overall Study|Lost to Follow-up|69|||
144410871|NCT04502693|520711622|FG003|Overall Study|Lost to Follow-up|4|||
144722776|NCT01325207|521840529|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
144722777|NCT01325207|521840530|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
144722778|NCT01325207|521840531|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
144722779|NCT01974895|521840532|FG000|Overall Study|Protocol Violation|1|||
144722780|NCT01974895|521840533|FG001|Overall Study|Protocol Violation|0|||
144722781|NCT01974895|521840532|FG000|Overall Study|Lost to Follow-up|4|||
144410872|NCT04502693|520711619|FG000|Overall Study|Protocol Violation|8|||
144410873|NCT04502693|520711620|FG001|Overall Study|Protocol Violation|8|||
144410874|NCT04502693|520711621|FG002|Overall Study|Protocol Violation|16|||
144410875|NCT04502693|520711622|FG003|Overall Study|Protocol Violation|1|||
144410876|NCT04502693|520711619|FG000|Overall Study|Withdrawal by Subject|46|||
144410877|NCT04502693|520711620|FG001|Overall Study|Withdrawal by Subject|38|||
144410878|NCT04502693|520711621|FG002|Overall Study|Withdrawal by Subject|54|||
144410879|NCT04502693|520711622|FG003|Overall Study|Withdrawal by Subject|7|||
144410880|NCT04502693|520711619|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
144410881|NCT04502693|520711620|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
144410882|NCT04502693|520711621|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
144410883|NCT04502693|520711622|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144410884|NCT04502693|520711619|FG000|Overall Study|Other|1|||
144410885|NCT04502693|520711620|FG001|Overall Study|Other|0|||
144410886|NCT04502693|520711621|FG002|Overall Study|Other|1|||
144410887|NCT04502693|520711622|FG003|Overall Study|Other|1|||
144410888|NCT00602797|520711623|FG000|Overall Study|Adverse Event|1|||
144410889|NCT03736447|520711627|FG000|Overall Study|Adverse Event|5|||
144410890|NCT03736447|520711628|FG001|Overall Study|Adverse Event|1|||
144410891|NCT03736447|520711627|FG000|Overall Study|Withdrawal by Subject|5|||
144722782|NCT01974895|521840533|FG001|Overall Study|Lost to Follow-up|6|||
144410892|NCT03736447|520711628|FG001|Overall Study|Withdrawal by Subject|1|||
144410893|NCT03736447|520711627|FG000|Overall Study|Lost to Follow-up|1|||
144410894|NCT03736447|520711628|FG001|Overall Study|Lost to Follow-up|0|||
144410895|NCT03736447|520711627|FG000|Overall Study|Physician Decision|1|||
144410896|NCT03736447|520711628|FG001|Overall Study|Physician Decision|0|||
144410897|NCT03736447|520711627|FG000|Overall Study|Continued commitment to study treatment|3|||
144410898|NCT03736447|520711628|FG001|Overall Study|Continued commitment to study treatment|0|||
144410899|NCT03736447|520711627|FG000|Overall Study|Taste aversion to study product|0|||
144410900|NCT03736447|520711628|FG001|Overall Study|Taste aversion to study product|1|||
144410901|NCT02784431|520711629|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
144410902|NCT02784431|520711629|FG000|Overall Study|Early Study Termination|19|||
144410903|NCT02657369|520711630|FG000|Overall Study|Death|27|||
144410904|NCT02657369|520711630|FG000|Overall Study|Study terminated by sponsor|7|||
144410905|NCT00361569|520711631|FG000|Overall Study|Protocol Violation|3|||
144410906|NCT00361569|520711632|FG001|Overall Study|Protocol Violation|2|||
144410907|NCT00361569|520711633|FG002|Overall Study|Protocol Violation|4|||
144410908|NCT00361569|520711634|FG003|Overall Study|Protocol Violation|2|||
144410909|NCT00361569|520711631|FG000|Overall Study|Withdrawal by Subject|2|||
144410910|NCT00361569|520711632|FG001|Overall Study|Withdrawal by Subject|1|||
144410911|NCT00361569|520711633|FG002|Overall Study|Withdrawal by Subject|9|||
144410912|NCT00361569|520711634|FG003|Overall Study|Withdrawal by Subject|14|||
144410913|NCT00361569|520711631|FG000|Overall Study|Adverse Event|3|||
144410914|NCT00361569|520711632|FG001|Overall Study|Adverse Event|5|||
144410915|NCT00361569|520711633|FG002|Overall Study|Adverse Event|2|||
144410916|NCT00361569|520711634|FG003|Overall Study|Adverse Event|2|||
144410917|NCT00361569|520711631|FG000|Overall Study|Lost to Follow-up|2|||
144410918|NCT00361569|520711632|FG001|Overall Study|Lost to Follow-up|3|||
144410919|NCT00361569|520711633|FG002|Overall Study|Lost to Follow-up|3|||
144410920|NCT00361569|520711634|FG003|Overall Study|Lost to Follow-up|2|||
144410921|NCT00361569|520711631|FG000|Overall Study|Not specified by investigator|2|||
144410922|NCT00361569|520711632|FG001|Overall Study|Not specified by investigator|0|||
144410923|NCT00361569|520711633|FG002|Overall Study|Not specified by investigator|0|||
144410924|NCT00361569|520711634|FG003|Overall Study|Not specified by investigator|1|||
144410925|NCT02605824|520711635|FG000|Overall Study|Physician Decision|1|||
144410926|NCT02605824|520711636|FG001|Overall Study|Physician Decision|0|||
144410927|NCT04875195|520711637|FG000|Overall Study|Death|9|||
144410928|NCT04875195|520711638|FG001|Overall Study|Death|3|||
144410929|NCT04875195|520711637|FG000|Overall Study|Withdrawal by Subject|2|||
144410930|NCT04875195|520711638|FG001|Overall Study|Withdrawal by Subject|1|||
144410931|NCT04875195|520711637|FG000|Overall Study|Ongoing in study|49|||
144410932|NCT04875195|520711638|FG001|Overall Study|Ongoing in study|2|||
144410933|NCT00074152|520711639|FG000|Overall Study|Death|21|||
144410934|NCT00074152|520711640|FG001|Overall Study|Death|9|||
144410935|NCT00074152|520711639|FG000|Overall Study|Lack of Efficacy|34|||
144410936|NCT00074152|520711640|FG001|Overall Study|Lack of Efficacy|24|||
144410937|NCT02612727|520711641|FG000|Overall Study|Parent request|4|||
144410938|NCT02612727|520711642|FG001|Overall Study|Parent request|1|||
144410939|NCT02612727|520711641|FG000|Overall Study|Needed treatment incompatible with PT|1|||
144410940|NCT02612727|520711642|FG001|Overall Study|Needed treatment incompatible with PT|1|||
144410941|NCT02612727|520711641|FG000|Overall Study|Direct hyperbilirubinemia|0|||
144410942|NCT02612727|520711642|FG001|Overall Study|Direct hyperbilirubinemia|2|||
144410943|NCT01095731|520711643|FG000|Overall Study|Protocol Violation|1|||
144410944|NCT01095731|520711644|FG001|Overall Study|Protocol Violation|1|||
144410945|NCT01095731|520711643|FG000|Overall Study|Withdrawal by Subject|0|||
144410946|NCT01095731|520711644|FG001|Overall Study|Withdrawal by Subject|1|||
144410947|NCT01446289|520711645|FG000|Overall Study|Withdrawal by Subject|1|||
144410948|NCT01446289|520711646|FG001|Overall Study|Withdrawal by Subject|0|||
144410949|NCT01446289|520711647|FG002|Overall Study|Withdrawal by Subject|1|||
144410950|NCT01446289|520711648|FG003|Overall Study|Withdrawal by Subject|0|||
144410951|NCT03329573|520711649|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
144410952|NCT03329573|520711650|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
144410953|NCT03329573|520711651|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
144410954|NCT03329573|520711652|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
144410955|NCT03329573|520711649|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
144410956|NCT03329573|520711650|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
144410957|NCT03329573|520711651|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144410958|NCT03329573|520711652|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144410959|NCT03329573|520711649|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
144410960|NCT03329573|520711650|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
144410961|NCT03329573|520711651|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
144410962|NCT03329573|520711652|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
144410963|NCT03329573|520711649|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
144410964|NCT03329573|520711650|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
144410965|NCT03329573|520711651|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
144410966|NCT03329573|520711652|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
144410967|NCT02777333|520711653|FG000|Overall Study|Withdrawal by Subject|0|||
144410968|NCT02777333|520711654|FG001|Overall Study|Withdrawal by Subject|1|||
144410969|NCT02777333|520711653|FG000|Overall Study|Lost to Follow-up|0|||
144410970|NCT02777333|520711654|FG001|Overall Study|Lost to Follow-up|1|||
144410971|NCT00837811|520711655|FG000|Overall Study|Adverse Event|4|||
144410972|NCT00837811|520711656|FG001|Overall Study|Adverse Event|6|||
144410973|NCT00837811|520711657|FG002|Overall Study|Adverse Event|0|||
144410974|NCT00837811|520711655|FG000|Overall Study|Death|1|||
144410975|NCT00837811|520711656|FG001|Overall Study|Death|1|||
144410976|NCT00837811|520711657|FG002|Overall Study|Death|0|||
144410977|NCT00837811|520711655|FG000|Overall Study|Lack of Efficacy|0|||
144410978|NCT00837811|520711656|FG001|Overall Study|Lack of Efficacy|11|||
144410979|NCT00837811|520711657|FG002|Overall Study|Lack of Efficacy|0|||
144410980|NCT00837811|520711655|FG000|Overall Study|Lost to Follow-up|1|||
144410981|NCT00837811|520711656|FG001|Overall Study|Lost to Follow-up|3|||
144410982|NCT00837811|520711657|FG002|Overall Study|Lost to Follow-up|0|||
144410983|NCT00837811|520711655|FG000|Overall Study|Physician Decision|0|||
144410984|NCT00837811|520711656|FG001|Overall Study|Physician Decision|2|||
144410985|NCT00837811|520711657|FG002|Overall Study|Physician Decision|1|||
144410986|NCT00837811|520711655|FG000|Overall Study|Withdrawal by Subject|1|||
144410987|NCT00837811|520711656|FG001|Overall Study|Withdrawal by Subject|9|||
144410988|NCT00837811|520711657|FG002|Overall Study|Withdrawal by Subject|0|||
144410989|NCT00837811|520711655|FG000|Overall Study|Sponsor Decision|0|||
144410990|NCT00837811|520711656|FG001|Overall Study|Sponsor Decision|2|||
144410991|NCT00837811|520711657|FG002|Overall Study|Sponsor Decision|0|||
144410992|NCT02578316|520711658|FG000|Extension Phase|Progression of disease|6|||
144410993|NCT05243641|520711662|FG000|Overall Study|Adverse Event|3|||
144410994|NCT05243641|520711663|FG001|Overall Study|Adverse Event|0|||
144410995|NCT05243641|520711664|FG002|Overall Study|Adverse Event|0|||
144410996|NCT05243641|520711665|FG003|Overall Study|Adverse Event|1|||
144410997|NCT05243641|520711666|FG004|Overall Study|Adverse Event|0|||
144410998|NCT05243641|520711667|FG005|Overall Study|Adverse Event|0|||
144410999|NCT05243641|520711662|FG000|Overall Study|Disease progression|4|||
144411000|NCT05243641|520711663|FG001|Overall Study|Disease progression|0|||
144411001|NCT05243641|520711664|FG002|Overall Study|Disease progression|0|||
144411002|NCT05243641|520711665|FG003|Overall Study|Disease progression|2|||
144411003|NCT05243641|520711666|FG004|Overall Study|Disease progression|0|||
144411004|NCT05243641|520711667|FG005|Overall Study|Disease progression|0|||
144411005|NCT04698187|520711669|FG000|Overall Study|Withdrawal by Subject|7|||
144411006|NCT04698187|520711669|FG000|Overall Study|Death|21|||
144411007|NCT04698187|520711669|FG000|Overall Study|Sponsor Decision|15|||
144411008|NCT04698187|520711669|FG000|Overall Study|In-transit Disease|1|||
144411009|NCT03820986|520711670|FG000|Overall Study|Death|201|||
144411010|NCT03820986|520711671|FG001|Overall Study|Death|175|||
144411011|NCT03820986|520711670|FG000|Overall Study|Lost to Follow-up|1|||
144411012|NCT03820986|520711671|FG001|Overall Study|Lost to Follow-up|1|||
144411013|NCT03820986|520711670|FG000|Overall Study|Physician Decision|1|||
144411014|NCT03820986|520711671|FG001|Overall Study|Physician Decision|0|||
144411015|NCT03820986|520711670|FG000|Overall Study|Sponsor Decision|122|||
144411016|NCT03820986|520711671|FG001|Overall Study|Sponsor Decision|160|||
144411017|NCT03820986|520711670|FG000|Overall Study|Withdrawal by Subject|9|||
144411018|NCT03820986|520711671|FG001|Overall Study|Withdrawal by Subject|4|||
144411019|NCT02993146|520711672|FG000|Overall Study|Withdrawal by Subject|0|||
144411020|NCT02993146|520711673|FG001|Overall Study|Withdrawal by Subject|0|||
144411021|NCT02993146|520711674|FG002|Overall Study|Withdrawal by Subject|1|||
144411022|NCT02993146|520711675|FG003|Overall Study|Withdrawal by Subject|1|||
144411023|NCT04524689|520711678|FG000|Overall Study|Withdrawal by Subject|1|||
144411024|NCT04524689|520711679|FG001|Overall Study|Withdrawal by Subject|1|||
144411025|NCT04524689|520711680|FG002|Overall Study|Withdrawal by Subject|0|||
144411026|NCT04524689|520711681|FG003|Overall Study|Withdrawal by Subject|0|||
144411027|NCT04524689|520711682|FG004|Overall Study|Withdrawal by Subject|2|||
144411028|NCT04524689|520711683|FG005|Overall Study|Withdrawal by Subject|0|||
144411029|NCT04524689|520711678|FG000|Overall Study|Study terminated by Sponsor|6|||
144411030|NCT04524689|520711679|FG001|Overall Study|Study terminated by Sponsor|0|||
144411031|NCT04524689|520711680|FG002|Overall Study|Study terminated by Sponsor|1|||
144411032|NCT04524689|520711681|FG003|Overall Study|Study terminated by Sponsor|0|||
144411033|NCT04524689|520711682|FG004|Overall Study|Study terminated by Sponsor|4|||
144411034|NCT04524689|520711683|FG005|Overall Study|Study terminated by Sponsor|0|||
144411035|NCT04524689|520711678|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
144411036|NCT04524689|520711679|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
144411037|NCT04524689|520711680|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
144411038|NCT04524689|520711681|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
144411039|NCT04524689|520711682|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
144411040|NCT04524689|520711683|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
144411041|NCT05766423|520711684|FG000|Overall Study|Withdrawal by Subject|1|||
144411042|NCT05766423|520711685|FG001|Overall Study|Withdrawal by Subject|0|||
144722783|NCT01974895|521840532|FG000|Overall Study|Withdrawal by Subject|0|||
144411043|NCT05766423|520711684|FG000|Overall Study|Consented, not scheduled|3|||
144411044|NCT05766423|520711685|FG001|Overall Study|Consented, not scheduled|5|||
144411045|NCT00612690|520713799|FG000|Overall Study|Lost to Follow-up|72|||
144411046|NCT00612690|520713800|FG001|Overall Study|Lost to Follow-up|98|||
144411047|NCT00612690|520713799|FG000|Overall Study|Withdrawal by Subject|32|||
144411048|NCT00612690|520713800|FG001|Overall Study|Withdrawal by Subject|20|||
144411049|NCT00612690|520713799|FG000|Overall Study|Withdrawal by Site|11|||
144411050|NCT00612690|520713800|FG001|Overall Study|Withdrawal by Site|0|||
144411051|NCT01664533|520713801|FG000|Overall Study|Death|42|||
144411052|NCT01664533|520713801|FG000|Overall Study|Lost to Follow-up|3|||
144411053|NCT01664533|520713801|FG000|Overall Study|Study termination|9|||
144411054|NCT01664533|520713801|FG000|Overall Study|Protocol Violation|3|||
144411055|NCT00844831|520713803|FG000|Overall Study|Withdrawal by Subject|4|||
144411056|NCT00844831|520713803|FG000|Overall Study|Adverse Event|1|||
144411057|NCT00844831|520713803|FG000|Overall Study|Physician Decision|1|||
144411058|NCT05255068|520713804|FG000|Overall Study|Lost to Follow-up|0|||
144411059|NCT05255068|520713805|FG001|Overall Study|Lost to Follow-up|1|||
144411060|NCT00540514|520713807|FG000|Overall Study|Still on treatment|3|||
144411061|NCT00540514|520713808|FG001|Overall Study|Still on treatment|0|||
144411062|NCT00540514|520713807|FG000|Overall Study|Unacceptable Toxicity|61|||
144411063|NCT00540514|520713808|FG001|Overall Study|Unacceptable Toxicity|62|||
144411064|NCT00540514|520713807|FG000|Overall Study|Adverse Event|20|||
144411065|NCT00540514|520713808|FG001|Overall Study|Adverse Event|24|||
144411066|NCT00540514|520713807|FG000|Overall Study|Physician Decision|86|||
144411067|NCT00540514|520713808|FG001|Overall Study|Physician Decision|99|||
144411068|NCT00540514|520713807|FG000|Overall Study|Protocol Deviation|3|||
144411069|NCT00540514|520713808|FG001|Overall Study|Protocol Deviation|4|||
144411070|NCT00540514|520713807|FG000|Overall Study|Lost to Follow-up|1|||
144411071|NCT00540514|520713808|FG001|Overall Study|Lost to Follow-up|1|||
144411072|NCT00540514|520713807|FG000|Overall Study|Withdrawal by Subject|65|||
144411073|NCT00540514|520713808|FG001|Overall Study|Withdrawal by Subject|67|||
144411074|NCT00540514|520713807|FG000|Overall Study|Excluded prior to treatment|7|||
144411075|NCT00540514|520713808|FG001|Overall Study|Excluded prior to treatment|7|||
144411076|NCT00540514|520713807|FG000|Overall Study|Paclitaxel not available|0|||
144411077|NCT00540514|520713808|FG001|Overall Study|Paclitaxel not available|2|||
144411078|NCT04487730|520713809|FG000|Overall Study|Withdrawal by Subject|3|||
144411079|NCT04487730|520713810|FG001|Overall Study|Withdrawal by Subject|1|||
144411080|NCT04487730|520713809|FG000|Overall Study|Lost to Follow-up|0|||
144411081|NCT04487730|520713810|FG001|Overall Study|Lost to Follow-up|1|||
144411082|NCT04487730|520713809|FG000|Overall Study|Physician Decision|0|||
144411083|NCT04487730|520713810|FG001|Overall Study|Physician Decision|1|||
144411084|NCT00907777|520713811|FG000|Overall Study|Withdrawal by Subject|0|||
144411085|NCT00907777|520713812|FG001|Overall Study|Withdrawal by Subject|1|||
144411086|NCT03364023|520713815|FG000|Overall Study|Lost to Follow-up|3|||
144411087|NCT03364023|520713815|FG000|Overall Study|Death|14|||
144411088|NCT04115839|520713821|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
144411089|NCT04115839|520713822|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
144411090|NCT04115839|520713823|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
144411091|NCT04115839|520713824|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
144411092|NCT04115839|520713825|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
144411093|NCT04115839|520713826|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
144411094|NCT04115839|520713827|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
144411095|NCT04115839|520713821|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
144411096|NCT04115839|520713822|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
144411097|NCT04115839|520713823|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
144411098|NCT04115839|520713824|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
144411099|NCT04115839|520713825|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
144411100|NCT04115839|520713826|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
144411101|NCT04115839|520713827|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
144411102|NCT04115839|520713821|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
144411103|NCT04115839|520713822|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
144411104|NCT04115839|520713823|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
144411105|NCT04115839|520713824|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
144411106|NCT04115839|520713825|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
144411107|NCT04115839|520713826|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
144411108|NCT04115839|520713827|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
144411109|NCT04115839|520713821|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
144526734|NCT03024437|521129309|FG004|Overall Study|Disease progression, relapse|0|||
144526735|NCT03024437|521129305|FG000|Overall Study|Disease progression, refractory disease|4|||
144411110|NCT04115839|520713822|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
144411111|NCT04115839|520713823|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
144411112|NCT04115839|520713824|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
144411113|NCT04115839|520713825|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
144411114|NCT04115839|520713826|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
144411115|NCT04115839|520713827|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
144411116|NCT04115839|520713821|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
144411117|NCT04115839|520713822|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
144411118|NCT04115839|520713823|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
144411119|NCT04115839|520713824|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
144411120|NCT04115839|520713825|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
144411121|NCT04115839|520713826|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
144411122|NCT04115839|520713827|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
144411123|NCT04115839|520713821|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
144411124|NCT04115839|520713822|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
144411125|NCT04115839|520713823|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
144526736|NCT03024437|521129306|FG001|Overall Study|Disease progression, refractory disease|4|||
144526737|NCT03024437|521129307|FG002|Overall Study|Disease progression, refractory disease|2|||
144526738|NCT03024437|521129308|FG003|Overall Study|Disease progression, refractory disease|2|||
144411126|NCT04115839|520713824|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
144411127|NCT04115839|520713825|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
144411128|NCT04115839|520713826|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
144411129|NCT04115839|520713827|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
144411130|NCT03808545|520713830|FG000|Overall Study|Withdrawal by Subject|1|||
144411131|NCT03808545|520713831|FG001|Overall Study|Withdrawal by Subject|1|||
144411132|NCT00601458|520713834|FG000|Overall Study|Dosing Error|1|||
144411133|NCT00601458|520713835|FG001|Overall Study|Dosing Error|0|||
144411134|NCT00601458|520713836|FG002|Overall Study|Dosing Error|0|||
144411135|NCT00601458|520713834|FG000|Overall Study|Incomplete Data|0|||
144411136|NCT00601458|520713835|FG001|Overall Study|Incomplete Data|2|||
144411137|NCT00601458|520713836|FG002|Overall Study|Incomplete Data|0|||
144411138|NCT00601458|520713834|FG000|Overall Study|Protocol Violation|3|||
144411139|NCT00601458|520713835|FG001|Overall Study|Protocol Violation|2|||
144411140|NCT00601458|520713836|FG002|Overall Study|Protocol Violation|1|||
144411141|NCT00601458|520713834|FG000|Overall Study|Early Termination|0|||
144411142|NCT00601458|520713835|FG001|Overall Study|Early Termination|1|||
144411143|NCT00601458|520713836|FG002|Overall Study|Early Termination|1|||
144411144|NCT00370032|520713837|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
144411145|NCT00370032|520713838|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
144411146|NCT00370032|520713837|FG000|Washout Period|Withdrawal by Subject|0|||
144411147|NCT00370032|520713838|FG001|Washout Period|Withdrawal by Subject|1|||
144411148|NCT00370032|520713837|FG000|Washout Period|Lost to Follow-up|0|||
144411149|NCT00370032|520713838|FG001|Washout Period|Lost to Follow-up|1|||
144411150|NCT00370032|520713837|FG000|Washout Period|Adverse Event|1|||
144411151|NCT00370032|520713838|FG001|Washout Period|Adverse Event|0|||
144411152|NCT00370032|520713837|FG000|Follow-up Period|Withdrawal by Subject|1|||
144411153|NCT00370032|520713838|FG001|Follow-up Period|Withdrawal by Subject|0|||
144411154|NCT00518986|520713839|FG000|Overall Study|Adverse Event|12|||
144411155|NCT00518986|520713840|FG001|Overall Study|Adverse Event|7|||
144411156|NCT00518986|520713839|FG000|Overall Study|Lack of Efficacy|0|||
144411157|NCT00518986|520713840|FG001|Overall Study|Lack of Efficacy|2|||
144411158|NCT00518986|520713839|FG000|Overall Study|Lost to Follow-up|3|||
144411159|NCT00518986|520713840|FG001|Overall Study|Lost to Follow-up|2|||
144411160|NCT00518986|520713839|FG000|Overall Study|Physician Decision|0|||
144411161|NCT00518986|520713840|FG001|Overall Study|Physician Decision|3|||
144411162|NCT00518986|520713839|FG000|Overall Study|Protocol Violation|5|||
144411163|NCT00518986|520713840|FG001|Overall Study|Protocol Violation|7|||
144411164|NCT00518986|520713839|FG000|Overall Study|Withdrawal by Subject|4|||
144411165|NCT00518986|520713840|FG001|Overall Study|Withdrawal by Subject|4|||
144411166|NCT00518986|520713839|FG000|Overall Study|Non-Specific|2|||
144411167|NCT00518986|520713840|FG001|Overall Study|Non-Specific|1|||
144411168|NCT02166463|520713841|FG000|Overall Study|Lost to Follow-up|0|||
144411169|NCT02166463|520713842|FG001|Overall Study|Lost to Follow-up|1|||
144411170|NCT02166463|520713841|FG000|Overall Study|Physician Decision|10|||
144411171|NCT02166463|520713842|FG001|Overall Study|Physician Decision|10|||
144411172|NCT02166463|520713841|FG000|Overall Study|Ineligible|11|||
144411173|NCT02166463|520713842|FG001|Overall Study|Ineligible|2|||
144411174|NCT02166463|520713841|FG000|Overall Study|Progressive Disease|9|||
144411175|NCT02166463|520713842|FG001|Overall Study|Progressive Disease|6|||
144411176|NCT02166463|520713841|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
144411177|NCT02166463|520713842|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
144411178|NCT02166463|520713841|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
144411179|NCT02166463|520713842|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
144411180|NCT02166463|520713841|FG000|Overall Study|Refusal of further protocol therapy|5|||
144411181|NCT02166463|520713842|FG001|Overall Study|Refusal of further protocol therapy|6|||
144411182|NCT05683249|520713843|FG000|Overall Study|Adverse Event|3|||
144411183|NCT05683249|520713844|FG001|Overall Study|Adverse Event|1|||
144411184|NCT05683249|520713843|FG000|Overall Study|Lack of Efficacy|0|||
144411185|NCT05683249|520713844|FG001|Overall Study|Lack of Efficacy|2|||
144411186|NCT05683249|520713843|FG000|Overall Study|Lost to Follow-up|6|||
144526739|NCT03024437|521129309|FG004|Overall Study|Disease progression, refractory disease|1|||
144526740|NCT03024437|521129305|FG000|Overall Study|Newly diagnosed cancer|0|||
144526741|NCT03024437|521129306|FG001|Overall Study|Newly diagnosed cancer|0|||
144526742|NCT03024437|521129307|FG002|Overall Study|Newly diagnosed cancer|0|||
144526743|NCT03024437|521129308|FG003|Overall Study|Newly diagnosed cancer|1|||
144411187|NCT05683249|520713844|FG001|Overall Study|Lost to Follow-up|5|||
144411188|NCT05683249|520713843|FG000|Overall Study|Non-compliance with Study Drug|2|||
144411189|NCT05683249|520713844|FG001|Overall Study|Non-compliance with Study Drug|0|||
144411190|NCT05683249|520713843|FG000|Overall Study|Protocol Violation|6|||
144526744|NCT03024437|521129309|FG004|Overall Study|Newly diagnosed cancer|0|||
144722784|NCT01974895|521840533|FG001|Overall Study|Withdrawal by Subject|1|||
144411191|NCT05683249|520713844|FG001|Overall Study|Protocol Violation|3|||
144411192|NCT05683249|520713843|FG000|Overall Study|Withdrawal by Subject|9|||
144411193|NCT05683249|520713844|FG001|Overall Study|Withdrawal by Subject|8|||
144250099|NCT02290925|520113457|FG000|First Period of Three Months|Insulin Started|1|||
144250100|NCT02290925|520113458|FG001|First Period of Three Months|Insulin Started|1|||
144250101|NCT02290925|520113457|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
144250102|NCT02290925|520113458|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
144250103|NCT02290925|520113457|FG000|Second Period of 3 Months|insulin started|0|||
144250104|NCT02290925|520113458|FG001|Second Period of 3 Months|insulin started|1|||
144250105|NCT00981058|520113460|FG000|Overall Study|Progressive Disease|38|||
144250106|NCT00981058|520113461|FG001|Overall Study|Progressive Disease|31|||
144250107|NCT00981058|520113460|FG000|Overall Study|Lost to Follow-up|3|||
144250108|NCT00981058|520113461|FG001|Overall Study|Lost to Follow-up|2|||
144250109|NCT00981058|520113460|FG000|Overall Study|Physician Decision|4|||
144250110|NCT00981058|520113461|FG001|Overall Study|Physician Decision|5|||
144250111|NCT00981058|520113460|FG000|Overall Study|Randomization Error|0|||
144250112|NCT00981058|520113461|FG001|Overall Study|Randomization Error|1|||
144250113|NCT00981058|520113460|FG000|Overall Study|Withdrawal by Subject|24|||
144250114|NCT00981058|520113461|FG001|Overall Study|Withdrawal by Subject|22|||
144250115|NCT02719353|520113468|FG000|First Intervention|Physician Decision|0|||
144250116|NCT02719353|520113469|FG001|First Intervention|Physician Decision|1|||
144250117|NCT01955109|520113474|FG000|Overall Study|Adverse Event|2|||
144250118|NCT01955109|520113475|FG001|Overall Study|Adverse Event|0|||
144250119|NCT01955109|520113474|FG000|Overall Study|Participant unwilling to continue|35|||
144250120|NCT01955109|520113475|FG001|Overall Study|Participant unwilling to continue|7|||
144250121|NCT01955109|520113474|FG000|Overall Study|Physician Decision|2|||
144250122|NCT01955109|520113475|FG001|Overall Study|Physician Decision|0|||
144250123|NCT01955109|520113474|FG000|Overall Study|Lost to Follow-up|3|||
144250124|NCT01955109|520113475|FG001|Overall Study|Lost to Follow-up|1|||
144250125|NCT01955109|520113474|FG000|Overall Study|Non-compliance|3|||
144250126|NCT01955109|520113475|FG001|Overall Study|Non-compliance|1|||
144250127|NCT00904839|520113477|FG000|Overall Study|Adverse Event|0|||
144250128|NCT00904839|520113478|FG001|Overall Study|Adverse Event|5|||
144250129|NCT00904839|520113479|FG002|Overall Study|Adverse Event|4|||
144411194|NCT05683249|520713843|FG000|Overall Study|Other|0|||
144411195|NCT05683249|520713844|FG001|Overall Study|Other|2|||
144411196|NCT05469178|520713845|FG000|Overall Study|Death|1|||
144411197|NCT05469178|520713846|FG001|Overall Study|Death|1|||
144411198|NCT05469178|520713847|FG002|Overall Study|Death|3|||
144411199|NCT05469178|520713848|FG003|Overall Study|Death|6|||
144411200|NCT05469178|520713845|FG000|Overall Study|Lack of Efficacy|2|||
144411201|NCT05469178|520713846|FG001|Overall Study|Lack of Efficacy|2|||
144411202|NCT05469178|520713847|FG002|Overall Study|Lack of Efficacy|1|||
144411203|NCT05469178|520713848|FG003|Overall Study|Lack of Efficacy|10|||
144411204|NCT01328431|520713849|FG000|Baseline|Protocol Violation|0|||
144411205|NCT01328431|520713850|FG001|Baseline|Protocol Violation|2|||
144411206|NCT01328431|520713849|FG000|1 Month (1M)|Lost to Follow-up|55|||
144411207|NCT01328431|520713850|FG001|1 Month (1M)|Lost to Follow-up|58|||
144411208|NCT01328431|520713849|FG000|3 Month (3M)|Death|2|||
144411209|NCT01328431|520713850|FG001|3 Month (3M)|Death|2|||
144411210|NCT01328431|520713849|FG000|3 Month (3M)|Lost to Follow-up|75|||
144411211|NCT01328431|520713850|FG001|3 Month (3M)|Lost to Follow-up|70|||
144411212|NCT01328431|520713849|FG000|12 Month (12M)|Death|2|||
144411213|NCT01328431|520713850|FG001|12 Month (12M)|Death|6|||
144411214|NCT01328431|520713849|FG000|12 Month (12M)|Lost to Follow-up|82|||
144411215|NCT01328431|520713850|FG001|12 Month (12M)|Lost to Follow-up|91|||
144411216|NCT03617185|520713856|FG000|Baseline|Lost to Follow-up|0|||
144411217|NCT03617185|520713857|FG001|Baseline|Lost to Follow-up|2|||
144411218|NCT03617185|520713858|FG002|Baseline|Lost to Follow-up|1|||
144411219|NCT03617185|520713859|FG003|Baseline|Lost to Follow-up|1|||
144411220|NCT03617185|520713856|FG000|Baseline|Withdrawal by Subject|0|||
144411221|NCT03617185|520713857|FG001|Baseline|Withdrawal by Subject|1|||
144411222|NCT03617185|520713858|FG002|Baseline|Withdrawal by Subject|0|||
144411223|NCT03617185|520713859|FG003|Baseline|Withdrawal by Subject|1|||
144411224|NCT03617185|520713856|FG000|Baseline|Driving Distance/Travel|0|||
144411225|NCT03617185|520713857|FG001|Baseline|Driving Distance/Travel|0|||
144411226|NCT03617185|520713858|FG002|Baseline|Driving Distance/Travel|2|||
144411227|NCT03617185|520713859|FG003|Baseline|Driving Distance/Travel|0|||
144250130|NCT00904839|520113477|FG000|Overall Study|Protocol Violation|0|||
144250131|NCT00904839|520113478|FG001|Overall Study|Protocol Violation|1|||
144250132|NCT00904839|520113479|FG002|Overall Study|Protocol Violation|1|||
144250133|NCT00904839|520113477|FG000|Overall Study|Lost to Follow-up|0|||
144250134|NCT00904839|520113478|FG001|Overall Study|Lost to Follow-up|1|||
144250135|NCT00904839|520113479|FG002|Overall Study|Lost to Follow-up|2|||
144250136|NCT00904839|520113477|FG000|Overall Study|Withdrawal by Subject|0|||
144250137|NCT00904839|520113478|FG001|Overall Study|Withdrawal by Subject|2|||
144411228|NCT03617185|520713856|FG000|Baseline|Family Obligations|0|||
144411229|NCT03617185|520713857|FG001|Baseline|Family Obligations|0|||
144411230|NCT03617185|520713858|FG002|Baseline|Family Obligations|0|||
144411231|NCT03617185|520713859|FG003|Baseline|Family Obligations|1|||
144411232|NCT03617185|520713856|FG000|3 Months|Lost to Follow-up|4|||
144411233|NCT03617185|520713857|FG001|3 Months|Lost to Follow-up|1|||
144411234|NCT03617185|520713858|FG002|3 Months|Lost to Follow-up|0|||
144600143|NCT01658826|521397594|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
144600144|NCT00047320|521397595|FG000|Overall Study|Lack of Efficacy|8|||
144600145|NCT00047320|521397595|FG000|Overall Study|Lost to Follow-up|1|||
144600146|NCT00047320|521397595|FG000|Overall Study|Physician Decision|8|||
144600147|NCT00047320|521397595|FG000|Overall Study|Withdrawal by Subject|9|||
144600148|NCT00047320|521397595|FG000|Overall Study|Ineligible|2|||
144600149|NCT06071754|521397596|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
144600150|NCT05028517|521397597|FG000|Overall Study|Lost to Follow-up|13|||
144600151|NCT05028517|521397598|FG001|Overall Study|Lost to Follow-up|20|||
144600152|NCT05028517|521397599|FG002|Overall Study|Lost to Follow-up|12|||
144600153|NCT05028517|521397597|FG000|Overall Study|Withdrawal by Subject|0|||
144600154|NCT05028517|521397598|FG001|Overall Study|Withdrawal by Subject|0|||
144600155|NCT05028517|521397599|FG002|Overall Study|Withdrawal by Subject|1|||
144600156|NCT03078907|521399259|FG000|Overall Study|Adverse Event|2|||
144600157|NCT03078907|521399260|FG001|Overall Study|Adverse Event|0|||
144600158|NCT03078907|521399259|FG000|Overall Study|Other|1|||
144600159|NCT03078907|521399260|FG001|Overall Study|Other|0|||
144600160|NCT03078907|521399259|FG000|Overall Study|Protocol Violation|0|||
144600161|NCT03078907|521399260|FG001|Overall Study|Protocol Violation|1|||
144600162|NCT00985166|521399261|FG000|Overall Study|Lost to Follow-up|3|||
144600163|NCT00985166|521399262|FG001|Overall Study|Lost to Follow-up|2|||
144600164|NCT00985166|521399263|FG002|Overall Study|Lost to Follow-up|2|||
144600165|NCT00985166|521399261|FG000|Overall Study|Withdrawal by Subject|3|||
144600166|NCT00985166|521399262|FG001|Overall Study|Withdrawal by Subject|2|||
144600167|NCT00985166|521399263|FG002|Overall Study|Withdrawal by Subject|0|||
144600168|NCT00985166|521399261|FG000|Overall Study|Test not done|2|||
144600169|NCT00985166|521399262|FG001|Overall Study|Test not done|0|||
144600170|NCT00985166|521399263|FG002|Overall Study|Test not done|4|||
144600171|NCT00985166|521399261|FG000|Overall Study|Other|1|||
144600172|NCT00985166|521399262|FG001|Overall Study|Other|0|||
144600173|NCT00985166|521399263|FG002|Overall Study|Other|1|||
144600174|NCT03434353|521399267|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
144600175|NCT03434353|521399268|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
144600176|NCT03434353|521399269|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
144600177|NCT03434353|521399270|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
144600178|NCT03434353|521399271|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
144600179|NCT03434353|521399267|FG000|Overall Study|Withdrew consent|1|||
144600180|NCT03434353|521399268|FG001|Overall Study|Withdrew consent|0|||
144600181|NCT03434353|521399269|FG002|Overall Study|Withdrew consent|3|||
144600182|NCT03434353|521399270|FG003|Overall Study|Withdrew consent|0|||
144600183|NCT03434353|521399271|FG004|Overall Study|Withdrew consent|0|||
144600184|NCT03434353|521399267|FG000|Overall Study|Adverse Event|1|||
144600185|NCT03434353|521399268|FG001|Overall Study|Adverse Event|0|||
144600186|NCT03434353|521399269|FG002|Overall Study|Adverse Event|0|||
144411235|NCT03617185|520713859|FG003|3 Months|Lost to Follow-up|2|||
144411236|NCT03617185|520713856|FG000|3 Months|Withdrawal by Subject|1|||
144411237|NCT03617185|520713857|FG001|3 Months|Withdrawal by Subject|3|||
144411238|NCT03617185|520713858|FG002|3 Months|Withdrawal by Subject|0|||
144411239|NCT03617185|520713859|FG003|3 Months|Withdrawal by Subject|0|||
144600187|NCT03434353|521399270|FG003|Overall Study|Adverse Event|0|||
144600188|NCT03434353|521399271|FG004|Overall Study|Adverse Event|1|||
144600189|NCT03434353|521399267|FG000|Overall Study|Lost to Follow-up|2|||
144600190|NCT03434353|521399268|FG001|Overall Study|Lost to Follow-up|0|||
144600191|NCT03434353|521399269|FG002|Overall Study|Lost to Follow-up|0|||
144600192|NCT03434353|521399270|FG003|Overall Study|Lost to Follow-up|0|||
144600193|NCT03434353|521399271|FG004|Overall Study|Lost to Follow-up|0|||
144600194|NCT01990534|521399272|FG000|Overall Study|Death|22|||
144600195|NCT01990534|521399272|FG000|Overall Study|Progressive disease|3|||
144600196|NCT01990534|521399272|FG000|Overall Study|Protocol Violation|1|||
144600197|NCT01990534|521399272|FG000|Overall Study|Withdrawal of Informed Consent|2|||
144600198|NCT01990534|521399272|FG000|Overall Study|Symptomatic Deterioration|1|||
144600199|NCT01990534|521399272|FG000|Overall Study|Withdrawal by Subject|3|||
144600200|NCT01990534|521399272|FG000|Overall Study|Reason not Specified|2|||
144600201|NCT01990534|521399272|FG000|Overall Study|Lost to Follow-up|1|||
144600202|NCT00234494|521399273|FG000|Overall Study|Protocol Violation|2|||
144600203|NCT01831544|521399276|FG000|Overall Study|Death|1|||
144600204|NCT01831544|521399276|FG000|Overall Study|Still on original MVAD device|2|||
144600205|NCT01681628|521399279|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
144600206|NCT01681628|521399280|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
144600207|NCT01681628|521399279|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
144600208|NCT01681628|521399280|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
144600209|NCT01681628|521399279|FG000|19 Months Follow-up|Death|1|||
144600210|NCT01681628|521399280|FG001|19 Months Follow-up|Death|0|||
144600211|NCT01681628|521399279|FG000|19 Months Follow-up|Lost to Follow-up|61|||
144722785|NCT01974895|521840532|FG000|Overall Study|Other (Missed Visit)|1|||
144411240|NCT03617185|520713856|FG000|3 Months|Driving Distance/Travel|1|||
144411241|NCT03617185|520713857|FG001|3 Months|Driving Distance/Travel|0|||
144411242|NCT03617185|520713858|FG002|3 Months|Driving Distance/Travel|0|||
144411243|NCT03617185|520713859|FG003|3 Months|Driving Distance/Travel|0|||
144411244|NCT03617185|520713856|FG000|3 Months|Family Obligations|0|||
144411245|NCT03617185|520713857|FG001|3 Months|Family Obligations|0|||
144411246|NCT03617185|520713858|FG002|3 Months|Family Obligations|0|||
144411247|NCT03617185|520713859|FG003|3 Months|Family Obligations|1|||
144411248|NCT03617185|520713856|FG000|12 Months|Lost to Follow-up|3|||
144411249|NCT03617185|520713857|FG001|12 Months|Lost to Follow-up|1|||
144411250|NCT03617185|520713858|FG002|12 Months|Lost to Follow-up|3|||
144411251|NCT03617185|520713859|FG003|12 Months|Lost to Follow-up|0|||
144411252|NCT03617185|520713856|FG000|12 Months|Withdrawal by Subject|0|||
144411253|NCT03617185|520713857|FG001|12 Months|Withdrawal by Subject|0|||
144411254|NCT03617185|520713858|FG002|12 Months|Withdrawal by Subject|0|||
144411255|NCT03617185|520713859|FG003|12 Months|Withdrawal by Subject|1|||
144411256|NCT03617185|520713856|FG000|12 Months|Driving Distance/Travel|0|||
144411257|NCT03617185|520713857|FG001|12 Months|Driving Distance/Travel|0|||
144411258|NCT03617185|520713858|FG002|12 Months|Driving Distance/Travel|1|||
144411259|NCT03617185|520713859|FG003|12 Months|Driving Distance/Travel|0|||
144411260|NCT01964430|520713860|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
144411261|NCT01964430|520713861|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
144411262|NCT01964430|520713860|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
144411263|NCT01964430|520713861|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
144411264|NCT01964430|520713860|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
144411265|NCT01964430|520713861|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
144411266|NCT01964430|520713860|FG000|Treatment Period|Adverse Event|71|||
144411267|NCT01964430|520713861|FG001|Treatment Period|Adverse Event|37|||
144411268|NCT01964430|520713860|FG000|Treatment Period|Withdrawal by Subject|36|||
144411269|NCT01964430|520713861|FG001|Treatment Period|Withdrawal by Subject|27|||
144411270|NCT01964430|520713860|FG000|Treatment Period|Death|1|||
144411271|NCT01964430|520713861|FG001|Treatment Period|Death|3|||
144411272|NCT01964430|520713860|FG000|Treatment Period|Protocol Deviation|0|||
144411273|NCT01964430|520713861|FG001|Treatment Period|Protocol Deviation|1|||
144411274|NCT01964430|520713860|FG000|Treatment Period|Physician Decision|5|||
144411275|NCT01964430|520713861|FG001|Treatment Period|Physician Decision|4|||
144411276|NCT01964430|520713860|FG000|Treatment Period|Disease Relapse|28|||
144411277|NCT01964430|520713861|FG001|Treatment Period|Disease Relapse|38|||
144411278|NCT01964430|520713860|FG000|Treatment Period|Other reasons|1|||
144411279|NCT01964430|520713861|FG001|Treatment Period|Other reasons|3|||
144411280|NCT02801396|520713862|FG000|Period 1|Withdrawal by Subject|0|||
144411281|NCT02801396|520713863|FG001|Period 1|Withdrawal by Subject|0|||
144411282|NCT02801396|520713864|FG002|Period 1|Withdrawal by Subject|0|||
144411283|NCT02801396|520713865|FG003|Period 1|Withdrawal by Subject|0|||
144411284|NCT02801396|520713866|FG004|Period 1|Withdrawal by Subject|1|||
144411285|NCT02801396|520713867|FG005|Period 1|Withdrawal by Subject|0|||
144411286|NCT03322631|520713873|FG000|Overall Study|Withdrawal by Subject|0|||
144411287|NCT03322631|520713874|FG001|Overall Study|Withdrawal by Subject|1|||
144411288|NCT03322631|520713875|FG002|Overall Study|Withdrawal by Subject|0|||
144411289|NCT03322631|520713876|FG003|Overall Study|Withdrawal by Subject|0|||
144411290|NCT03322631|520713873|FG000|Overall Study|Adverse Event|0|||
144411291|NCT03322631|520713874|FG001|Overall Study|Adverse Event|0|||
144411292|NCT03322631|520713875|FG002|Overall Study|Adverse Event|1|||
144411293|NCT03322631|520713876|FG003|Overall Study|Adverse Event|0|||
144411294|NCT02378961|520713877|FG000|Overall Study|Lack of Efficacy|4|||
144411295|NCT02378961|520713878|FG001|Overall Study|Lack of Efficacy|2|||
144411296|NCT02378961|520713879|FG002|Overall Study|Lack of Efficacy|0|||
144411297|NCT02378961|520713880|FG003|Overall Study|Lack of Efficacy|1|||
144411298|NCT02378961|520713877|FG000|Overall Study|Death|0|||
144411299|NCT02378961|520713878|FG001|Overall Study|Death|0|||
144411300|NCT02378961|520713879|FG002|Overall Study|Death|1|||
144411301|NCT02378961|520713880|FG003|Overall Study|Death|0|||
144411302|NCT02412618|520713881|FG000|Overall Study|Withdrawal by Subject|1|||
144411303|NCT02412618|520713882|FG001|Overall Study|Withdrawal by Subject|1|||
144411304|NCT02412618|520713881|FG000|Overall Study|Expulsion|1|||
144411305|NCT02412618|520713882|FG001|Overall Study|Expulsion|1|||
144411306|NCT01253408|520713884|FG000|Overall Study|Adverse Event|0|||
144411307|NCT01253408|520713885|FG001|Overall Study|Adverse Event|1|||
144411308|NCT01253408|520713886|FG002|Overall Study|Adverse Event|0|||
144411309|NCT00393029|520713893|FG000|Overall Study|Not treated|0|||
144411310|NCT00393029|520713894|FG001|Overall Study|Not treated|1|||
144411311|NCT03715530|520713895|FG000|Overall Study|Lost to Follow-up|3|||
144411312|NCT03715530|520713896|FG001|Overall Study|Lost to Follow-up|1|||
144411313|NCT03715530|520713897|FG002|Overall Study|Lost to Follow-up|2|||
144411314|NCT01594762|520713901|FG000|Overall Study|Withdrawal by Subject|1|||
144411315|NCT01594762|520713902|FG001|Overall Study|Withdrawal by Subject|0|||
144411316|NCT01594762|520713901|FG000|Overall Study|Lost to Follow-up|10|||
144411317|NCT01594762|520713902|FG001|Overall Study|Lost to Follow-up|10|||
144411318|NCT00382252|520713903|FG000|Overall Study|Death|4|||
144411319|NCT00382252|520713903|FG000|Overall Study|Protocol Violation|8|||
144250138|NCT00904839|520113479|FG002|Overall Study|Withdrawal by Subject|0|||
144411320|NCT00382252|520713903|FG000|Overall Study|Not treated by RFA|1|||
144411321|NCT03338998|520713905|FG000|Treatment Period|Withdrawal by Subject|1|||
144411322|NCT03338998|520713906|FG001|Treatment Period|Withdrawal by Subject|1|||
144250139|NCT00904839|520113477|FG000|Overall Study|Not treated|1|||
144250140|NCT00904839|520113478|FG001|Overall Study|Not treated|0|||
144411323|NCT03338998|520713905|FG000|Treatment Period|Adverse Event|0|||
144411324|NCT03338998|520713906|FG001|Treatment Period|Adverse Event|2|||
144411325|NCT03338998|520713905|FG000|Treatment Period|Protocol deviation|1|||
144411326|NCT03338998|520713906|FG001|Treatment Period|Protocol deviation|0|||
144411327|NCT03338998|520713905|FG000|Treatment Period|Physician Decision|2|||
144411328|NCT03338998|520713906|FG001|Treatment Period|Physician Decision|0|||
144411329|NCT03338998|520713905|FG000|Treatment Period|Subject failed swallow test|4|||
144411330|NCT03338998|520713906|FG001|Treatment Period|Subject failed swallow test|0|||
144411331|NCT03338998|520713905|FG000|Safety Follow-Up Period|Adverse Event|0|||
144411332|NCT03338998|520713906|FG001|Safety Follow-Up Period|Adverse Event|1|||
144411333|NCT03338998|520713905|FG000|Safety Follow-Up Period|Protocol deviation|1|||
144411334|NCT03338998|520713906|FG001|Safety Follow-Up Period|Protocol deviation|0|||
144411335|NCT03338998|520713905|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
144411336|NCT03338998|520713906|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
144411337|NCT00039130|520713907|FG000|Overall Study|Adverse Event|11|||
144411338|NCT00039130|520713907|FG000|Overall Study|Death|9|||
144411339|NCT00039130|520713907|FG000|Overall Study|Withdrawal by Subject|3|||
144411340|NCT00039130|520713907|FG000|Overall Study|Progression|2|||
144411341|NCT00039130|520713907|FG000|Overall Study|Subsequent treatment|2|||
144411342|NCT00039130|520713907|FG000|Overall Study|Physician Decision|3|||
144411343|NCT03288129|520713908|FG000|Overall Study|Adverse Event|10|||
144600212|NCT01681628|521399280|FG001|19 Months Follow-up|Lost to Follow-up|43|||
144600213|NCT01521897|521399281|FG000|Overall Study|Protocol Violation|18|||
144600214|NCT01521897|521399281|FG000|Overall Study|Lost to Follow-up|5|||
144600215|NCT03055013|521399282|FG000|Overall Study|Adverse Event|78|||
144600216|NCT03055013|521399283|FG001|Overall Study|Adverse Event|0|||
144600217|NCT03055013|521399282|FG000|Overall Study|Death|6|||
144600218|NCT03055013|521399283|FG001|Overall Study|Death|0|||
144600219|NCT03055013|521399282|FG000|Overall Study|Disease relapse|33|||
144600220|NCT03055013|521399283|FG001|Overall Study|Disease relapse|0|||
144600221|NCT03055013|521399282|FG000|Overall Study|Withdrawal by Subject|28|||
144600222|NCT03055013|521399283|FG001|Overall Study|Withdrawal by Subject|0|||
144600223|NCT03055013|521399282|FG000|Overall Study|Other complicating disease|5|||
144600224|NCT03055013|521399283|FG001|Overall Study|Other complicating disease|0|||
144600225|NCT03055013|521399282|FG000|Overall Study|Physician Decision|1|||
144600226|NCT03055013|521399283|FG001|Overall Study|Physician Decision|0|||
144600227|NCT03055013|521399282|FG000|Overall Study|Benign mass/non-RCC|4|||
144600228|NCT03055013|521399283|FG001|Overall Study|Benign mass/non-RCC|0|||
144600229|NCT03055013|521399282|FG000|Overall Study|Enrolled in another trial|1|||
144600230|NCT03055013|521399283|FG001|Overall Study|Enrolled in another trial|0|||
144600231|NCT03055013|521399282|FG000|Overall Study|Non-protocol therapy|1|||
144600232|NCT03055013|521399283|FG001|Overall Study|Non-protocol therapy|0|||
144600233|NCT03055013|521399282|FG000|Overall Study|Incompliance|1|||
144600234|NCT03055013|521399283|FG001|Overall Study|Incompliance|0|||
144600235|NCT03055013|521399282|FG000|Overall Study|Insurance issues|1|||
144600236|NCT03055013|521399283|FG001|Overall Study|Insurance issues|0|||
144600237|NCT03055013|521399282|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
144250141|NCT00904839|520113479|FG002|Overall Study|Not treated|1|||
144250142|NCT00904839|520113477|FG000|Overall Study|Other than above|0|||
144411344|NCT03288129|520713908|FG000|Overall Study|Lost to Follow-up|3|||
144411345|NCT03288129|520713908|FG000|Overall Study|Withdrawal by Subject|3|||
144411346|NCT03288129|520713908|FG000|Overall Study|Withdrawal of consent/assent|1|||
144411347|NCT03288129|520713908|FG000|Overall Study|Other|5|||
144411348|NCT01744197|520713916|FG000|Overall Study|Received 1 patch|2|||
144600238|NCT03055013|521399283|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
144600239|NCT03055013|521399282|FG000|Overall Study|Did not receive nivolumab|10|||
144600240|NCT03055013|521399283|FG001|Overall Study|Did not receive nivolumab|0|||
144600241|NCT03055013|521399282|FG000|Overall Study|Did not receive surgery|0|||
144600242|NCT03055013|521399283|FG001|Overall Study|Did not receive surgery|28|||
144600243|NCT03422172|521399287|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
144600244|NCT03422172|521399287|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
144600245|NCT03422172|521399287|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
144600246|NCT05736211|521399289|FG000|Overall Study|Lost to Follow-up|6|||
144600247|NCT05736211|521399290|FG001|Overall Study|Lost to Follow-up|0|||
144600248|NCT00293722|521399291|FG000|Overall Study|Other|427|||
144600249|NCT04982588|521399292|FG000|Overall Study|Withdrawal by Subject|2|||
144250143|NCT00904839|520113478|FG001|Overall Study|Other than above|9|||
144411349|NCT01744197|520713917|FG001|Overall Study|Received 1 patch|1|||
144411350|NCT01744197|520713916|FG000|Overall Study|No patch received|2|||
144411351|NCT01744197|520713917|FG001|Overall Study|No patch received|2|||
144411352|NCT04706091|520713918|FG000|Treatment 2|Withdrawal by Subject|1|||
144411353|NCT04706091|520713919|FG001|Treatment 2|Withdrawal by Subject|0|||
144250144|NCT00904839|520113479|FG002|Overall Study|Other than above|7|||
144250145|NCT04521114|520113484|FG000|Overall Study|Lost to Follow-up|1|||
144250146|NCT04521114|520113485|FG001|Overall Study|Lost to Follow-up|2|||
144250147|NCT04521114|520113486|FG002|Overall Study|Lost to Follow-up|0|||
144250148|NCT04521114|520113484|FG000|Overall Study|Withdrawal by Subject|1|||
144250149|NCT04521114|520113485|FG001|Overall Study|Withdrawal by Subject|2|||
144250150|NCT04521114|520113486|FG002|Overall Study|Withdrawal by Subject|2|||
144250151|NCT04521114|520113484|FG000|Overall Study|Adverse Event|1|||
144250152|NCT04521114|520113485|FG001|Overall Study|Adverse Event|0|||
144250153|NCT04521114|520113486|FG002|Overall Study|Adverse Event|0|||
144250154|NCT04521114|520113484|FG000|Overall Study|Sponsor Wish|1|||
144250155|NCT04521114|520113485|FG001|Overall Study|Sponsor Wish|0|||
144250156|NCT04521114|520113486|FG002|Overall Study|Sponsor Wish|0|||
144250157|NCT04521114|520113484|FG000|Overall Study|Withdrawal of Consent|2|||
144250158|NCT04521114|520113485|FG001|Overall Study|Withdrawal of Consent|2|||
144250159|NCT04521114|520113486|FG002|Overall Study|Withdrawal of Consent|0|||
144411354|NCT01063868|520713920|FG000|Overall Study|Adverse Event|9|||
144411355|NCT01063868|520713921|FG001|Overall Study|Adverse Event|7|||
144411356|NCT01063868|520713920|FG000|Overall Study|Withdrawal by Subject|3|||
144411357|NCT01063868|520713921|FG001|Overall Study|Withdrawal by Subject|1|||
144411358|NCT01063868|520713920|FG000|Overall Study|Study Terminated By Sponsor|23|||
144411359|NCT01063868|520713921|FG001|Overall Study|Study Terminated By Sponsor|4|||
144411360|NCT01949506|520713922|FG000|Overall Study|Physician Decision|1|||
144411361|NCT02915016|520713923|FG000|Overall Study|Lost to Follow-up|4|||
144411362|NCT02915016|520713924|FG001|Overall Study|Lost to Follow-up|2|||
144411363|NCT02915016|520713925|FG002|Overall Study|Lost to Follow-up|5|||
144411364|NCT02915016|520713926|FG003|Overall Study|Lost to Follow-up|3|||
144411365|NCT02915016|520713927|FG004|Overall Study|Lost to Follow-up|5|||
144411366|NCT02915016|520713928|FG005|Overall Study|Lost to Follow-up|2|||
144411367|NCT02915016|520713929|FG006|Overall Study|Lost to Follow-up|8|||
144411368|NCT02915016|520713930|FG007|Overall Study|Lost to Follow-up|2|||
144411369|NCT02915016|520713923|FG000|Overall Study|Physician Decision|0|||
144411370|NCT02915016|520713924|FG001|Overall Study|Physician Decision|0|||
144411371|NCT02915016|520713925|FG002|Overall Study|Physician Decision|1|||
144411372|NCT02915016|520713926|FG003|Overall Study|Physician Decision|0|||
144411373|NCT02915016|520713927|FG004|Overall Study|Physician Decision|0|||
144411374|NCT02915016|520713928|FG005|Overall Study|Physician Decision|1|||
144411375|NCT02915016|520713929|FG006|Overall Study|Physician Decision|2|||
144411376|NCT02915016|520713930|FG007|Overall Study|Physician Decision|0|||
144411377|NCT02915016|520713923|FG000|Overall Study|Withdrawal by Subject|2|||
144411378|NCT02915016|520713924|FG001|Overall Study|Withdrawal by Subject|0|||
144411379|NCT02915016|520713925|FG002|Overall Study|Withdrawal by Subject|1|||
144411380|NCT02915016|520713926|FG003|Overall Study|Withdrawal by Subject|0|||
144411381|NCT02915016|520713927|FG004|Overall Study|Withdrawal by Subject|1|||
144411382|NCT02915016|520713928|FG005|Overall Study|Withdrawal by Subject|3|||
144411383|NCT02915016|520713929|FG006|Overall Study|Withdrawal by Subject|1|||
144411384|NCT02915016|520713930|FG007|Overall Study|Withdrawal by Subject|1|||
144411385|NCT02915016|520713923|FG000|Overall Study|Elected not to continue|0|||
144411386|NCT02915016|520713924|FG001|Overall Study|Elected not to continue|0|||
144411387|NCT02915016|520713925|FG002|Overall Study|Elected not to continue|0|||
144250160|NCT01167634|520113487|FG000|Overall Study|Lost to Follow-up|1|||
144250161|NCT01167634|520113488|FG001|Overall Study|Lost to Follow-up|3|||
144250162|NCT01167634|520113489|FG002|Overall Study|Lost to Follow-up|3|||
144250163|NCT01167634|520113490|FG003|Overall Study|Lost to Follow-up|4|||
144250164|NCT01167634|520113487|FG000|Overall Study|Withdrawal by Subject|1|||
144250165|NCT01167634|520113488|FG001|Overall Study|Withdrawal by Subject|1|||
144250166|NCT01167634|520113489|FG002|Overall Study|Withdrawal by Subject|0|||
144250167|NCT01167634|520113490|FG003|Overall Study|Withdrawal by Subject|0|||
144250168|NCT02614131|520113491|FG000|Overall Study|Withdrawal by Subject|1|||
144250169|NCT02614131|520113492|FG001|Overall Study|Withdrawal by Subject|0|||
144250170|NCT02614131|520113493|FG002|Overall Study|Withdrawal by Subject|0|||
144411388|NCT02915016|520713926|FG003|Overall Study|Elected not to continue|1|||
144411389|NCT02915016|520713927|FG004|Overall Study|Elected not to continue|0|||
144411390|NCT02915016|520713928|FG005|Overall Study|Elected not to continue|0|||
144411391|NCT02915016|520713929|FG006|Overall Study|Elected not to continue|1|||
144411392|NCT02915016|520713930|FG007|Overall Study|Elected not to continue|0|||
144411393|NCT02915016|520713923|FG000|Overall Study|HIV infection|1|||
144411394|NCT02915016|520713924|FG001|Overall Study|HIV infection|1|||
144600250|NCT01008696|521399293|FG000|Overall Study|Participant's evasion of hospital visit|5|||
144600251|NCT01008696|521399294|FG001|Overall Study|Participant's evasion of hospital visit|4|||
144600252|NCT01008696|521399293|FG000|Overall Study|Withdrawal by Subject|2|||
144250171|NCT02614131|520113494|FG003|Overall Study|Withdrawal by Subject|0|||
144250172|NCT02614131|520113495|FG004|Overall Study|Withdrawal by Subject|0|||
144411395|NCT02915016|520713925|FG002|Overall Study|HIV infection|1|||
144411396|NCT02915016|520713926|FG003|Overall Study|HIV infection|0|||
144411397|NCT02915016|520713927|FG004|Overall Study|HIV infection|1|||
144411398|NCT02915016|520713928|FG005|Overall Study|HIV infection|0|||
144411399|NCT02915016|520713929|FG006|Overall Study|HIV infection|0|||
144411400|NCT02915016|520713930|FG007|Overall Study|HIV infection|0|||
144411401|NCT02915016|520713923|FG000|Overall Study|Participant unable to adhere|0|||
144411402|NCT02915016|520713924|FG001|Overall Study|Participant unable to adhere|0|||
144411403|NCT02915016|520713925|FG002|Overall Study|Participant unable to adhere|0|||
144411404|NCT02915016|520713926|FG003|Overall Study|Participant unable to adhere|0|||
144411405|NCT02915016|520713927|FG004|Overall Study|Participant unable to adhere|0|||
144411406|NCT02915016|520713928|FG005|Overall Study|Participant unable to adhere|0|||
144411407|NCT02915016|520713929|FG006|Overall Study|Participant unable to adhere|0|||
144411408|NCT02915016|520713930|FG007|Overall Study|Participant unable to adhere|1|||
144411409|NCT02166905|520713931|FG000|Overall Study|Withdrawal by Subject|1|||
144411410|NCT02166905|520713932|FG001|Overall Study|Withdrawal by Subject|0|||
144411411|NCT02166905|520713933|FG002|Overall Study|Withdrawal by Subject|0|||
144411412|NCT02166905|520713934|FG003|Overall Study|Withdrawal by Subject|0|||
144411413|NCT02617628|520713935|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
144411414|NCT02617628|520713936|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
144411415|NCT03278873|520713937|FG000|Overall Study|Withdrawal by Subject|0|||
144411416|NCT03278873|520713938|FG001|Overall Study|Withdrawal by Subject|1|||
144411417|NCT03278873|520713939|FG002|Overall Study|Withdrawal by Subject|0|||
144411418|NCT03278873|520713940|FG003|Overall Study|Withdrawal by Subject|0|||
144411419|NCT03278873|520713937|FG000|Overall Study|Sponsor's decision|0|||
144411420|NCT03278873|520713938|FG001|Overall Study|Sponsor's decision|1|||
144411421|NCT03278873|520713939|FG002|Overall Study|Sponsor's decision|0|||
144411422|NCT03278873|520713940|FG003|Overall Study|Sponsor's decision|0|||
144411423|NCT03278873|520713937|FG000|Overall Study|Early Termination|2|||
144411424|NCT03278873|520713938|FG001|Overall Study|Early Termination|6|||
144411425|NCT03278873|520713939|FG002|Overall Study|Early Termination|0|||
144411426|NCT03278873|520713940|FG003|Overall Study|Early Termination|4|||
144411427|NCT03278873|520713937|FG000|Overall Study|Lost to Follow-up|0|||
144411428|NCT03278873|520713938|FG001|Overall Study|Lost to Follow-up|0|||
144411429|NCT03278873|520713939|FG002|Overall Study|Lost to Follow-up|2|||
144411430|NCT03278873|520713940|FG003|Overall Study|Lost to Follow-up|0|||
144411431|NCT03278873|520713937|FG000|Overall Study|The patient decided to withdraw via email|1|||
144411432|NCT03278873|520713938|FG001|Overall Study|The patient decided to withdraw via email|0|||
144411433|NCT03278873|520713939|FG002|Overall Study|The patient decided to withdraw via email|0|||
144411434|NCT03278873|520713940|FG003|Overall Study|The patient decided to withdraw via email|0|||
144411435|NCT03278873|520713937|FG000|Overall Study|The patient was unresponsive to contact|0|||
144411436|NCT03278873|520713938|FG001|Overall Study|The patient was unresponsive to contact|0|||
144411437|NCT03278873|520713939|FG002|Overall Study|The patient was unresponsive to contact|0|||
144411438|NCT03278873|520713940|FG003|Overall Study|The patient was unresponsive to contact|4|||
144411439|NCT03278873|520713937|FG000|Overall Study|The patient wished to participate no longer|0|||
144411440|NCT03278873|520713938|FG001|Overall Study|The patient wished to participate no longer|1|||
144411441|NCT03278873|520713939|FG002|Overall Study|The patient wished to participate no longer|0|||
144411442|NCT03278873|520713940|FG003|Overall Study|The patient wished to participate no longer|0|||
144411443|NCT03278873|520713937|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
144411444|NCT03278873|520713938|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
144411445|NCT03278873|520713939|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
144411446|NCT03278873|520713940|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
144411447|NCT02801331|520713953|FG000|Overall Study|Transferred to another hospital|8|||
144411448|NCT02801331|520713954|FG001|Overall Study|Transferred to another hospital|7|||
144411449|NCT02801331|520713953|FG000|Overall Study|Withdrawal by Subject|0|||
144411450|NCT02801331|520713954|FG001|Overall Study|Withdrawal by Subject|4|||
144411451|NCT02801331|520713953|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
144411452|NCT02801331|520713954|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
144411453|NCT02443987|520713955|FG000|Overall Study|Bladder injury|1|||
144411454|NCT02443987|520713956|FG001|Overall Study|Bladder injury|1|||
144411455|NCT02443987|520713955|FG000|Overall Study|Other|0|||
144411456|NCT02443987|520713956|FG001|Overall Study|Other|1|||
144411457|NCT01397708|520713960|FG000|Overall Study|Withdrawal by Subject|0|||
144411458|NCT01397708|520713961|FG001|Overall Study|Withdrawal by Subject|0|||
144411459|NCT01397708|520713962|FG002|Overall Study|Withdrawal by Subject|1|||
144411460|NCT01397708|520713963|FG003|Overall Study|Withdrawal by Subject|0|||
144411461|NCT01397708|520713964|FG004|Overall Study|Withdrawal by Subject|0|||
144411462|NCT01397708|520713965|FG005|Overall Study|Withdrawal by Subject|0|||
144411463|NCT01397708|520713966|FG006|Overall Study|Withdrawal by Subject|0|||
144411464|NCT01397708|520713967|FG007|Overall Study|Withdrawal by Subject|1|||
144411465|NCT01397708|520713960|FG000|Overall Study|Death|0|||
144411466|NCT01397708|520713961|FG001|Overall Study|Death|0|||
144411467|NCT01397708|520713962|FG002|Overall Study|Death|1|||
144411468|NCT01397708|520713963|FG003|Overall Study|Death|1|||
144411469|NCT01397708|520713964|FG004|Overall Study|Death|0|||
144411470|NCT01397708|520713965|FG005|Overall Study|Death|0|||
144411471|NCT01397708|520713966|FG006|Overall Study|Death|0|||
144411472|NCT01397708|520713967|FG007|Overall Study|Death|0|||
144411473|NCT01397708|520713960|FG000|Overall Study|Lost to Follow-up|0|||
144411474|NCT01397708|520713961|FG001|Overall Study|Lost to Follow-up|0|||
144411475|NCT01397708|520713962|FG002|Overall Study|Lost to Follow-up|0|||
144411476|NCT01397708|520713963|FG003|Overall Study|Lost to Follow-up|0|||
144411477|NCT01397708|520713964|FG004|Overall Study|Lost to Follow-up|1|||
144411478|NCT01397708|520713965|FG005|Overall Study|Lost to Follow-up|0|||
144411479|NCT01397708|520713966|FG006|Overall Study|Lost to Follow-up|0|||
144411480|NCT01397708|520713967|FG007|Overall Study|Lost to Follow-up|0|||
144411481|NCT01397708|520713960|FG000|Overall Study|Other|0|||
144411482|NCT01397708|520713961|FG001|Overall Study|Other|0|||
144411483|NCT01397708|520713962|FG002|Overall Study|Other|0|||
144411484|NCT01397708|520713963|FG003|Overall Study|Other|0|||
144411485|NCT01397708|520713964|FG004|Overall Study|Other|0|||
144411486|NCT01397708|520713965|FG005|Overall Study|Other|0|||
144411487|NCT01397708|520713966|FG006|Overall Study|Other|1|||
144411488|NCT01397708|520713967|FG007|Overall Study|Other|0|||
144411489|NCT01638546|520713978|FG000|Overall Study|Adverse Event|1|||
144411490|NCT01638546|520713979|FG001|Overall Study|Adverse Event|3|||
144411491|NCT04526665|520713980|FG000|Overall Study|Withdrawal by Subject|6|||
144600253|NCT01008696|521399294|FG001|Overall Study|Withdrawal by Subject|4|||
144600254|NCT01008696|521399293|FG000|Overall Study|Physician Decision|5|||
144600255|NCT01008696|521399294|FG001|Overall Study|Physician Decision|1|||
144600256|NCT01008696|521399293|FG000|Overall Study|Adverse Event|1|||
144600257|NCT01008696|521399294|FG001|Overall Study|Adverse Event|0|||
144600258|NCT01008696|521399293|FG000|Overall Study|Participants' non-cooperation|2|||
144411492|NCT04526665|520713981|FG001|Overall Study|Withdrawal by Subject|3|||
144411493|NCT04526665|520713980|FG000|Overall Study|Adverse Event|4|||
144411494|NCT04526665|520713981|FG001|Overall Study|Adverse Event|1|||
144411495|NCT04526665|520713980|FG000|Overall Study|Physician Decision|2|||
144411496|NCT04526665|520713981|FG001|Overall Study|Physician Decision|2|||
144411497|NCT04526665|520713980|FG000|Overall Study|Death|2|||
144411498|NCT04526665|520713981|FG001|Overall Study|Death|0|||
144411499|NCT04526665|520713980|FG000|Overall Study|Other|0|||
144411500|NCT04526665|520713981|FG001|Overall Study|Other|1|||
144411501|NCT04292743|520713984|FG000|Overall Study|Physician Decision|1|||
144411502|NCT04292743|520713985|FG001|Overall Study|Physician Decision|3|||
144411503|NCT04292743|520713986|FG002|Overall Study|Physician Decision|0|||
144411504|NCT04292743|520713987|FG003|Overall Study|Physician Decision|0|||
144411505|NCT04292743|520713984|FG000|Overall Study|Withdrawal by Subject|0|||
144411506|NCT04292743|520713985|FG001|Overall Study|Withdrawal by Subject|5|||
144411507|NCT04292743|520713986|FG002|Overall Study|Withdrawal by Subject|0|||
144411508|NCT04292743|520713987|FG003|Overall Study|Withdrawal by Subject|0|||
144411509|NCT04292743|520713984|FG000|Overall Study|Death|0|||
144411510|NCT04292743|520713985|FG001|Overall Study|Death|1|||
144600259|NCT01008696|521399294|FG001|Overall Study|Participants' non-cooperation|3|||
144600260|NCT01008696|521399293|FG000|Overall Study|Other|2|||
144411511|NCT04292743|520713986|FG002|Overall Study|Death|0|||
144411512|NCT04292743|520713987|FG003|Overall Study|Death|0|||
144411513|NCT04292743|520713984|FG000|Overall Study|Progression of Disease|2|||
144411514|NCT04292743|520713985|FG001|Overall Study|Progression of Disease|5|||
144411515|NCT04292743|520713986|FG002|Overall Study|Progression of Disease|0|||
144411516|NCT04292743|520713987|FG003|Overall Study|Progression of Disease|0|||
144411517|NCT04292743|520713984|FG000|Overall Study|No Treatment per protocol|0|||
144411518|NCT04292743|520713985|FG001|Overall Study|No Treatment per protocol|2|||
144411519|NCT04292743|520713986|FG002|Overall Study|No Treatment per protocol|0|||
144411520|NCT04292743|520713987|FG003|Overall Study|No Treatment per protocol|0|||
144411521|NCT05330702|520713988|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
144411522|NCT05330702|520713989|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
144411523|NCT05330702|520713990|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
144411524|NCT00790023|520715615|FG000|Overall Study|Adverse Event|2|||
144411525|NCT00790023|520715616|FG001|Overall Study|Adverse Event|1|||
144411526|NCT00790023|520715617|FG002|Overall Study|Adverse Event|4|||
144411527|NCT00790023|520715615|FG000|Overall Study|Protocol Violation|2|||
144411528|NCT00790023|520715616|FG001|Overall Study|Protocol Violation|4|||
144411529|NCT00790023|520715617|FG002|Overall Study|Protocol Violation|2|||
144411530|NCT00790023|520715615|FG000|Overall Study|Withdrawal by Subject|2|||
144411531|NCT00790023|520715616|FG001|Overall Study|Withdrawal by Subject|0|||
144411532|NCT00790023|520715617|FG002|Overall Study|Withdrawal by Subject|6|||
144411533|NCT00790023|520715615|FG000|Overall Study|Lost to Follow-up|0|||
144411534|NCT00790023|520715616|FG001|Overall Study|Lost to Follow-up|0|||
144411535|NCT00790023|520715617|FG002|Overall Study|Lost to Follow-up|1|||
144411536|NCT00790023|520715615|FG000|Overall Study|Other|5|||
144411537|NCT00790023|520715616|FG001|Overall Study|Other|5|||
144411538|NCT00790023|520715617|FG002|Overall Study|Other|8|||
144411539|NCT02468414|520715618|FG000|Overall Study|Early Study Termination by Sponsor|1|||
144411540|NCT02468414|520715619|FG001|Overall Study|Early Study Termination by Sponsor|0|||
144411541|NCT02468414|520715618|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
144411542|NCT02468414|520715619|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
144411543|NCT02468414|520715618|FG000|Overall Study|Screen Failure|1|||
144411544|NCT02468414|520715619|FG001|Overall Study|Screen Failure|0|||
144411545|NCT00187486|520715620|FG000|Overall Study|Protocol Violation|1|||
144411546|NCT02599129|520715621|FG000|Overall Study|Lack of Efficacy|2|||
144722786|NCT01974895|521840533|FG001|Overall Study|Other (Missed Visit)|0|||
144600261|NCT01008696|521399294|FG001|Overall Study|Other|3|||
144600262|NCT01008696|521399293|FG000|Overall Study|Other|0|||
144600263|NCT01008696|521399294|FG001|Overall Study|Other|2|||
144600264|NCT00992511|521399295|FG000|Overall Study|Migrated/moved from study area|1|||
144600265|NCT00992511|521399296|FG001|Overall Study|Migrated/moved from study area|0|||
144600266|NCT00992511|521399297|FG002|Overall Study|Migrated/moved from study area|1|||
144600267|NCT00992511|521399298|FG003|Overall Study|Migrated/moved from study area|2|||
144600268|NCT00992511|521399295|FG000|Overall Study|Lost to Follow-up|1|||
144600269|NCT00992511|521399296|FG001|Overall Study|Lost to Follow-up|0|||
144600270|NCT00992511|521399297|FG002|Overall Study|Lost to Follow-up|0|||
144600271|NCT00992511|521399298|FG003|Overall Study|Lost to Follow-up|2|||
144600272|NCT00992511|521399295|FG000|Overall Study|Withdrawal by Subject|0|||
144600273|NCT00992511|521399296|FG001|Overall Study|Withdrawal by Subject|0|||
144600274|NCT00992511|521399297|FG002|Overall Study|Withdrawal by Subject|1|||
144600275|NCT00992511|521399298|FG003|Overall Study|Withdrawal by Subject|1|||
144600276|NCT04498169|521399299|FG000|Study Completion|Adverse Event|1|||
144600277|NCT04498169|521399300|FG001|Study Completion|Adverse Event|1|||
144600278|NCT02960854|521399301|FG000|Overall Study|Not Disclosed|2|||
144600279|NCT02960854|521399302|FG001|Overall Study|Not Disclosed|2|||
144600280|NCT02960854|521399301|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
144600281|NCT02960854|521399302|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
144600282|NCT02960854|521399301|FG000|Overall Study|Subject Withdrew Consent|0|||
144600283|NCT02960854|521399302|FG001|Overall Study|Subject Withdrew Consent|1|||
144600284|NCT02960854|521399301|FG000|Overall Study|Death|4|||
144600285|NCT02960854|521399302|FG001|Overall Study|Death|6|||
144600286|NCT00833911|521399303|FG000|Titration|Adverse Event|18|||
144600287|NCT00833911|521399303|FG000|Titration|Withdrawal by Subject|3|||
144250173|NCT02614131|520113496|FG005|Overall Study|Withdrawal by Subject|0|||
144411547|NCT02599129|520715622|FG001|Overall Study|Lack of Efficacy|2|||
144411548|NCT02599129|520715621|FG000|Overall Study|Lost to Follow-up|1|||
144411549|NCT02599129|520715622|FG001|Overall Study|Lost to Follow-up|0|||
144411550|NCT02599129|520715621|FG000|Overall Study|Withdrawal by Subject|2|||
144411551|NCT02599129|520715622|FG001|Overall Study|Withdrawal by Subject|1|||
144411552|NCT01029795|520715627|FG000|Overall Study|Entry Criteria Not Met|2|||
144600288|NCT00833911|521399303|FG000|Maintenance Phase I|Adverse Event|73|||
144411553|NCT01029795|520715628|FG001|Overall Study|Entry Criteria Not Met|1|||
144411554|NCT01029795|520715627|FG000|Overall Study|Physician Decision|2|||
144411555|NCT01029795|520715628|FG001|Overall Study|Physician Decision|1|||
144411556|NCT01029795|520715627|FG000|Overall Study|Sponsor Decision|11|||
144600289|NCT00833911|521399303|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
144600290|NCT00833911|521399303|FG000|Maintenance Phase I|Physician Decision|10|||
144600291|NCT00833911|521399303|FG000|Maintenance Phase I|Lack of Efficacy|4|||
144411557|NCT01029795|520715628|FG001|Overall Study|Sponsor Decision|17|||
144411558|NCT01029795|520715627|FG000|Overall Study|Withdrawal by Subject|1|||
144411559|NCT01029795|520715628|FG001|Overall Study|Withdrawal by Subject|3|||
144411560|NCT03217175|520715629|FG000|Overall Study|Physician Decision|4|||
144411561|NCT03217175|520715630|FG001|Overall Study|Physician Decision|1|||
144411562|NCT05035550|520715641|FG000|Overall Study|Withdrawal by Subject|3|||
144411563|NCT05035550|520715642|FG001|Overall Study|Withdrawal by Subject|0|||
144411564|NCT01806545|520715643|FG000|Overall Study|Adverse Event|2|||
144411565|NCT01806545|520715644|FG001|Overall Study|Adverse Event|3|||
144411566|NCT01806545|520715643|FG000|Overall Study|Lost to Follow-up|1|||
144411567|NCT01806545|520715644|FG001|Overall Study|Lost to Follow-up|0|||
144411568|NCT01806545|520715643|FG000|Overall Study|Withdrawal by Subject|3|||
144411569|NCT01806545|520715644|FG001|Overall Study|Withdrawal by Subject|2|||
144411570|NCT00429273|520715645|FG000|Overall Study|Lost to Follow-up|1|||
144411571|NCT00429273|520715646|FG001|Overall Study|Lost to Follow-up|2|||
144411572|NCT00429273|520715647|FG002|Overall Study|Lost to Follow-up|2|||
144411573|NCT00429273|520715645|FG000|Overall Study|Physician Decision|6|||
144411574|NCT00429273|520715646|FG001|Overall Study|Physician Decision|5|||
144411575|NCT00429273|520715647|FG002|Overall Study|Physician Decision|5|||
144411576|NCT00429273|520715645|FG000|Overall Study|Adverse Event|1|||
144411577|NCT00429273|520715646|FG001|Overall Study|Adverse Event|1|||
144411578|NCT00429273|520715647|FG002|Overall Study|Adverse Event|2|||
144411579|NCT00884312|520715649|FG000|Overall Study|Non-fatal Progressive Disease|0|||
144411580|NCT00884312|520715650|FG001|Overall Study|Non-fatal Progressive Disease|8|||
144411581|NCT00884312|520715649|FG000|Overall Study|Fatal Progressive Disease|0|||
144411582|NCT00884312|520715650|FG001|Overall Study|Fatal Progressive Disease|1|||
144411583|NCT00884312|520715649|FG000|Overall Study|Non-fatal Adverse Event|1|||
144411584|NCT00884312|520715650|FG001|Overall Study|Non-fatal Adverse Event|0|||
144411585|NCT00884312|520715649|FG000|Overall Study|Fatal Adverse Event|1|||
144411586|NCT00884312|520715650|FG001|Overall Study|Fatal Adverse Event|4|||
144411587|NCT00884312|520715649|FG000|Overall Study|Withdrawal by Subject|0|||
144411588|NCT00884312|520715650|FG001|Overall Study|Withdrawal by Subject|6|||
144411589|NCT00884312|520715649|FG000|Overall Study|Physician Decision|0|||
144411590|NCT00884312|520715650|FG001|Overall Study|Physician Decision|1|||
144600292|NCT00833911|521399303|FG000|Maintenance Phase II|Adverse Event|6|||
144600293|NCT00833911|521399303|FG000|Maintenance Phase II|Physician Decision|2|||
144411591|NCT00884312|520715649|FG000|Overall Study|Other|0|||
144411592|NCT00884312|520715650|FG001|Overall Study|Other|4|||
144411593|NCT00884312|520715649|FG000|Overall Study|Did Not Receive Study Drug|0|||
144411594|NCT00884312|520715650|FG001|Overall Study|Did Not Receive Study Drug|1|||
144411595|NCT00224042|520715651|FG000|Overall Study|Adverse Event|2|||
144411596|NCT00224042|520715652|FG001|Overall Study|Adverse Event|1|||
144411597|NCT00224042|520715651|FG000|Overall Study|Protocol Violation|0|||
144411598|NCT00224042|520715652|FG001|Overall Study|Protocol Violation|1|||
144411599|NCT00224042|520715651|FG000|Overall Study|Physician Decision|0|||
144600294|NCT00833911|521399303|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
144600295|NCT00833911|521399303|FG000|Maintenance Phase II|Lack of Efficacy|1|||
144411600|NCT00224042|520715652|FG001|Overall Study|Physician Decision|1|||
144411601|NCT00224042|520715651|FG000|Overall Study|Did not meet lab incusion criteria|2|||
144411602|NCT00224042|520715652|FG001|Overall Study|Did not meet lab incusion criteria|3|||
144411603|NCT00224042|520715651|FG000|Overall Study|Other|2|||
144411604|NCT00224042|520715652|FG001|Overall Study|Other|0|||
144411605|NCT01854710|520715661|FG000|Overall Study|Withdrawal by Subject|2|||
144411606|NCT01854710|520715662|FG001|Overall Study|Withdrawal by Subject|1|||
144411607|NCT01854710|520715663|FG002|Overall Study|Withdrawal by Subject|0|||
144411608|NCT01854710|520715664|FG003|Overall Study|Withdrawal by Subject|0|||
144411609|NCT01854710|520715665|FG004|Overall Study|Withdrawal by Subject|0|||
144411610|NCT01854710|520715666|FG005|Overall Study|Withdrawal by Subject|0|||
144600296|NCT01207596|521399306|FG000|Overall Study|Physician Decision|4|||
144600297|NCT01207596|521399306|FG000|Overall Study|Lack of Efficacy|1|||
144411611|NCT01854710|520715661|FG000|Overall Study|CRI procedural error|2|||
144411612|NCT01854710|520715662|FG001|Overall Study|CRI procedural error|2|||
144411613|NCT01854710|520715663|FG002|Overall Study|CRI procedural error|2|||
144411614|NCT01854710|520715664|FG003|Overall Study|CRI procedural error|2|||
144411615|NCT01854710|520715665|FG004|Overall Study|CRI procedural error|2|||
144411616|NCT01854710|520715666|FG005|Overall Study|CRI procedural error|2|||
144411617|NCT03132220|520715667|FG000|Overall Study|Lost to Follow-up|17|||
144411618|NCT03132220|520715668|FG001|Overall Study|Lost to Follow-up|8|||
144411619|NCT03132220|520715667|FG000|Overall Study|Withdrawal by Subject|1|||
144411620|NCT03132220|520715668|FG001|Overall Study|Withdrawal by Subject|4|||
144411621|NCT00730132|520715669|FG000|Overall Study|Protocol Violation|154|||
144411622|NCT00730132|520715669|FG000|Overall Study|Death|1|||
144411623|NCT02296320|520715670|FG000|Overall Study|Withdrawal by Subject|4|||
144411624|NCT02296320|520715671|FG001|Overall Study|Withdrawal by Subject|0|||
144411625|NCT02296320|520715672|FG002|Overall Study|Withdrawal by Subject|2|||
144411626|NCT02296320|520715670|FG000|Overall Study|Death|24|||
144411627|NCT02296320|520715671|FG001|Overall Study|Death|3|||
144411628|NCT02296320|520715672|FG002|Overall Study|Death|27|||
144411629|NCT02296320|520715670|FG000|Overall Study|Lost to Follow-up|5|||
144411630|NCT02296320|520715671|FG001|Overall Study|Lost to Follow-up|2|||
144411631|NCT02296320|520715672|FG002|Overall Study|Lost to Follow-up|7|||
144411632|NCT02296320|520715670|FG000|Overall Study|Not treated|2|||
144411633|NCT02296320|520715671|FG001|Overall Study|Not treated|0|||
144411634|NCT02296320|520715672|FG002|Overall Study|Not treated|0|||
144411635|NCT02296320|520715670|FG000|Overall Study|Not - specified|0|||
144411636|NCT02296320|520715671|FG001|Overall Study|Not - specified|0|||
144411637|NCT02296320|520715672|FG002|Overall Study|Not - specified|1|||
144411638|NCT02099708|520715673|FG000|Overall Study|Data Not Available|30|||
144411639|NCT02099708|520715673|FG000|Overall Study|Lost to Follow-up|141|||
144411640|NCT02099708|520715673|FG000|Overall Study|Other|29|||
144411641|NCT05466682|520715677|FG000|Overall Study|Withdrawal by Subject|0|||
144411642|NCT05466682|520715678|FG001|Overall Study|Withdrawal by Subject|2|||
144411643|NCT05466682|520715677|FG000|Overall Study|Lost to Follow-up|2|||
144411644|NCT05466682|520715678|FG001|Overall Study|Lost to Follow-up|1|||
144411645|NCT01930123|520715679|FG000|Overall Study|Adverse Event|1|||
144411646|NCT01930123|520715680|FG001|Overall Study|Adverse Event|0|||
144411647|NCT01930123|520715679|FG000|Overall Study|Physician Decision|21|||
144411648|NCT01930123|520715680|FG001|Overall Study|Physician Decision|8|||
144411649|NCT01930123|520715679|FG000|Overall Study|Withdrawal by Subject|1|||
144411650|NCT01930123|520715680|FG001|Overall Study|Withdrawal by Subject|0|||
144411651|NCT03208244|520715683|FG000|Overall Study|Death|1|||
144411652|NCT03310021|520715686|FG000|Overall Study|Withdrawal by Subject|0|||
144411653|NCT03310021|520715687|FG001|Overall Study|Withdrawal by Subject|0|||
144411654|NCT03310021|520715688|FG002|Overall Study|Withdrawal by Subject|0|||
144411655|NCT03310021|520715689|FG003|Overall Study|Withdrawal by Subject|0|||
144411656|NCT03310021|520715690|FG004|Overall Study|Withdrawal by Subject|0|||
144411657|NCT03310021|520715691|FG005|Overall Study|Withdrawal by Subject|0|||
144411658|NCT03310021|520715692|FG006|Overall Study|Withdrawal by Subject|1|||
144411659|NCT03310021|520715693|FG007|Overall Study|Withdrawal by Subject|0|||
144411660|NCT03310021|520715694|FG008|Overall Study|Withdrawal by Subject|0|||
144411661|NCT03310021|520715695|FG009|Overall Study|Withdrawal by Subject|0|||
144411662|NCT03310021|520715696|FG010|Overall Study|Withdrawal by Subject|0|||
144411663|NCT03310021|520715697|FG011|Overall Study|Withdrawal by Subject|0|||
144411664|NCT03310021|520715698|FG012|Overall Study|Withdrawal by Subject|0|||
144411665|NCT03310021|520715699|FG013|Overall Study|Withdrawal by Subject|0|||
144411666|NCT03310021|520715700|FG014|Overall Study|Withdrawal by Subject|0|||
144411667|NCT03310021|520715701|FG015|Overall Study|Withdrawal by Subject|0|||
144411668|NCT03310021|520715702|FG016|Overall Study|Withdrawal by Subject|0|||
144411669|NCT03310021|520715703|FG017|Overall Study|Withdrawal by Subject|0|||
144411670|NCT03310021|520715704|FG018|Overall Study|Withdrawal by Subject|0|||
144411671|NCT03310021|520715705|FG019|Overall Study|Withdrawal by Subject|0|||
144411672|NCT03310021|520715686|FG000|Overall Study|Lost to Follow-up|0|||
144411673|NCT03310021|520715687|FG001|Overall Study|Lost to Follow-up|0|||
144411674|NCT03310021|520715688|FG002|Overall Study|Lost to Follow-up|0|||
144411675|NCT03310021|520715689|FG003|Overall Study|Lost to Follow-up|0|||
144411676|NCT03310021|520715690|FG004|Overall Study|Lost to Follow-up|0|||
144411677|NCT03310021|520715691|FG005|Overall Study|Lost to Follow-up|0|||
144411678|NCT03310021|520715692|FG006|Overall Study|Lost to Follow-up|0|||
144411679|NCT03310021|520715693|FG007|Overall Study|Lost to Follow-up|0|||
144411680|NCT03310021|520715694|FG008|Overall Study|Lost to Follow-up|0|||
144411681|NCT03310021|520715695|FG009|Overall Study|Lost to Follow-up|0|||
144411682|NCT03310021|520715696|FG010|Overall Study|Lost to Follow-up|1|||
144411683|NCT03310021|520715697|FG011|Overall Study|Lost to Follow-up|0|||
144411684|NCT03310021|520715698|FG012|Overall Study|Lost to Follow-up|0|||
144411685|NCT03310021|520715699|FG013|Overall Study|Lost to Follow-up|0|||
144411686|NCT03310021|520715700|FG014|Overall Study|Lost to Follow-up|0|||
144411687|NCT03310021|520715701|FG015|Overall Study|Lost to Follow-up|0|||
144411688|NCT03310021|520715702|FG016|Overall Study|Lost to Follow-up|0|||
144411689|NCT03310021|520715703|FG017|Overall Study|Lost to Follow-up|0|||
144411690|NCT03310021|520715704|FG018|Overall Study|Lost to Follow-up|0|||
144411691|NCT03310021|520715705|FG019|Overall Study|Lost to Follow-up|0|||
144411692|NCT00702923|520715708|FG000|Overall Study|Adverse Event|1|||
144411693|NCT03953820|520715710|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
144411694|NCT03953820|520715711|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
144411695|NCT03953820|520715712|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
144411696|NCT03953820|520715710|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
144411697|NCT03953820|520715711|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
144411698|NCT03953820|520715712|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
144411699|NCT01049308|520715717|FG000|Pill Counts|Withdrawal by Subject|83|||
144411700|NCT01318993|520715718|FG000|Overall Study|Adverse Event|53|||
144411701|NCT01318993|520715718|FG000|Overall Study|Lack of Efficacy|121|||
144411702|NCT01318993|520715718|FG000|Overall Study|Protocol Violation|3|||
144411703|NCT01318993|520715718|FG000|Overall Study|Protocol based stopping criteria|6|||
144411704|NCT01318993|520715718|FG000|Overall Study|Study closed or terminated|174|||
144411705|NCT01318993|520715718|FG000|Overall Study|Lost to Follow-up|4|||
144411706|NCT01318993|520715718|FG000|Overall Study|Physician Decision|13|||
144411707|NCT01318993|520715718|FG000|Overall Study|Withdrawal by Subject|24|||
144411708|NCT03334539|520715719|FG000|Overall Study|Adverse Event|3|||
144411709|NCT03334539|520715720|FG001|Overall Study|Adverse Event|5|||
144411710|NCT03334539|520715721|FG002|Overall Study|Adverse Event|0|||
144411711|NCT03334539|520715719|FG000|Overall Study|Withdrawal by Subject|0|||
144411712|NCT03334539|520715720|FG001|Overall Study|Withdrawal by Subject|1|||
144411713|NCT03334539|520715721|FG002|Overall Study|Withdrawal by Subject|1|||
144411714|NCT03334539|520715719|FG000|Overall Study|Administrative Reasons|1|||
144411715|NCT03334539|520715720|FG001|Overall Study|Administrative Reasons|0|||
144411716|NCT03334539|520715721|FG002|Overall Study|Administrative Reasons|0|||
144411717|NCT03334539|520715719|FG000|Overall Study|Hypertension Not Controlled|0|||
144411718|NCT03334539|520715720|FG001|Overall Study|Hypertension Not Controlled|1|||
144411719|NCT03334539|520715721|FG002|Overall Study|Hypertension Not Controlled|0|||
144411720|NCT04974697|520715722|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
144411721|NCT04974697|520715722|FG000|Overall Study|Lens discomfort|1|||
144411722|NCT03706456|520715723|FG000|Overall Study|Adverse Event|1|||
144411723|NCT03706456|520715723|FG000|Overall Study|Lack of Efficacy|2|||
144411724|NCT03302234|520715724|FG000|Overall Study|Death|191|||
144411725|NCT03302234|520715725|FG001|Overall Study|Death|192|||
144411726|NCT03302234|520715724|FG000|Overall Study|Withdrawal by Subject|2|||
144411727|NCT03302234|520715725|FG001|Overall Study|Withdrawal by Subject|2|||
144411728|NCT03302234|520715724|FG000|Overall Study|Sponsor Decision|90|||
144411729|NCT03302234|520715725|FG001|Overall Study|Sponsor Decision|89|||
144411730|NCT03302234|520715724|FG000|Overall Study|Laryngeal carcinoma|0|||
144411731|NCT03302234|520715725|FG001|Overall Study|Laryngeal carcinoma|1|||
144411732|NCT03302234|520715724|FG000|Overall Study|Not Reported|1|||
144411733|NCT03302234|520715725|FG001|Overall Study|Not Reported|0|||
144250174|NCT02614131|520113497|FG006|Overall Study|Withdrawal by Subject|0|||
144250175|NCT02614131|520113491|FG000|Overall Study|Adverse Event|0|||
144411734|NCT02795832|520715729|FG000|Overall Study|Adverse Event|0|||
144411735|NCT02795832|520715730|FG001|Overall Study|Adverse Event|0|||
144411736|NCT02795832|520715731|FG002|Overall Study|Adverse Event|0|||
144411737|NCT02795832|520715732|FG003|Overall Study|Adverse Event|0|||
144411738|NCT02795832|520715733|FG004|Overall Study|Adverse Event|0|||
144411739|NCT02795832|520715734|FG005|Overall Study|Adverse Event|3|||
144411740|NCT01845831|520715735|FG000|Inpatient Phase|Withdrawal by Subject|1|||
144411741|NCT01845831|520715736|FG001|Inpatient Phase|Withdrawal by Subject|1|||
144411742|NCT01845831|520715737|FG002|Inpatient Phase|Withdrawal by Subject|0|||
144411743|NCT01845831|520715738|FG003|Inpatient Phase|Withdrawal by Subject|0|||
144411744|NCT01845831|520715739|FG004|Inpatient Phase|Withdrawal by Subject|0|||
144411745|NCT00221403|520715740|FG000|Overall Study|Protocol Violation|1|||
144411746|NCT00221403|520715741|FG001|Overall Study|Protocol Violation|0|||
144411747|NCT00221403|520715742|FG002|Overall Study|Protocol Violation|0|||
144411748|NCT00221403|520715740|FG000|Overall Study|Physician Decision|1|||
144411749|NCT00221403|520715741|FG001|Overall Study|Physician Decision|0|||
144411750|NCT00221403|520715742|FG002|Overall Study|Physician Decision|0|||
144411751|NCT00221403|520715740|FG000|Overall Study|Withdrawal by Subject|0|||
144722787|NCT01974895|521840532|FG000|Overall Study|Other (Reason unknown)|9|||
144411752|NCT00221403|520715741|FG001|Overall Study|Withdrawal by Subject|3|||
144411753|NCT00221403|520715742|FG002|Overall Study|Withdrawal by Subject|0|||
144411754|NCT00221403|520715740|FG000|Overall Study|Lack of Efficacy|0|||
144411755|NCT00221403|520715741|FG001|Overall Study|Lack of Efficacy|1|||
144411756|NCT00221403|520715742|FG002|Overall Study|Lack of Efficacy|0|||
144411757|NCT00221403|520715740|FG000|Overall Study|Adverse Event|0|||
144411758|NCT00221403|520715741|FG001|Overall Study|Adverse Event|1|||
144411759|NCT00221403|520715742|FG002|Overall Study|Adverse Event|0|||
144411760|NCT02695329|520715746|FG000|Overall Study|Adverse Event|1|||
144411761|NCT02695329|520715747|FG001|Overall Study|Adverse Event|0|||
144411762|NCT02695329|520715746|FG000|Overall Study|Poor X-ray quality for measurement|4|||
144411763|NCT02695329|520715747|FG001|Overall Study|Poor X-ray quality for measurement|5|||
144411764|NCT01348165|520715748|FG000|Overall Study|Adverse Event|0|||
144411765|NCT01348165|520715749|FG001|Overall Study|Adverse Event|0|||
144411766|NCT01348165|520715750|FG002|Overall Study|Adverse Event|0|||
144411767|NCT01348165|520715751|FG003|Overall Study|Adverse Event|0|||
144411768|NCT01348165|520715752|FG004|Overall Study|Adverse Event|0|||
144411769|NCT01348165|520715753|FG005|Overall Study|Adverse Event|0|||
144411770|NCT01348165|520715754|FG006|Overall Study|Adverse Event|1|||
144411771|NCT03547583|520715755|FG000|Overall Study|Adverse Event|16|||
144600298|NCT01207596|521399306|FG000|Overall Study|Adverse Event|3|||
144600299|NCT01207596|521399306|FG000|Overall Study|Withdrawal by Subject|1|||
144600300|NCT01862640|521399313|FG000|Overall Study|Adverse Event|4|||
144600301|NCT01862640|521399314|FG001|Overall Study|Adverse Event|10|||
144600302|NCT01862640|521399315|FG002|Overall Study|Adverse Event|6|||
144600303|NCT01862640|521399316|FG003|Overall Study|Adverse Event|8|||
144600304|NCT01862640|521399313|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
144600305|NCT01862640|521399314|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
144600306|NCT01862640|521399315|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
144600307|NCT01862640|521399316|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
144600308|NCT01862640|521399313|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
144600309|NCT01862640|521399314|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
144600310|NCT01862640|521399315|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
144600311|NCT01862640|521399316|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
144600312|NCT01862640|521399313|FG000|Overall Study|Withdrawal by Subject|2|||
144600313|NCT01862640|521399314|FG001|Overall Study|Withdrawal by Subject|4|||
144600314|NCT01862640|521399315|FG002|Overall Study|Withdrawal by Subject|8|||
144600315|NCT01862640|521399316|FG003|Overall Study|Withdrawal by Subject|5|||
144600316|NCT01862640|521399313|FG000|Overall Study|Protocol Deviation|0|||
144600317|NCT01862640|521399314|FG001|Overall Study|Protocol Deviation|0|||
144600318|NCT01862640|521399315|FG002|Overall Study|Protocol Deviation|1|||
144600319|NCT01862640|521399316|FG003|Overall Study|Protocol Deviation|0|||
144600320|NCT01019317|521399319|FG000|Overall Study|Not Eligible|4|||
144600321|NCT02178553|521399320|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
144600322|NCT02178553|521399321|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
144600323|NCT02178553|521399320|FG000|Overall Study|Physician Decision|0|||
144411772|NCT03547583|520715756|FG001|Overall Study|Adverse Event|11|||
144411773|NCT03547583|520715757|FG002|Overall Study|Adverse Event|10|||
144411774|NCT03547583|520715755|FG000|Overall Study|Death|11|||
144411775|NCT03547583|520715756|FG001|Overall Study|Death|7|||
144411776|NCT03547583|520715757|FG002|Overall Study|Death|4|||
144411777|NCT03547583|520715755|FG000|Overall Study|Lost to Follow-up|1|||
144411778|NCT03547583|520715756|FG001|Overall Study|Lost to Follow-up|0|||
144411779|NCT03547583|520715757|FG002|Overall Study|Lost to Follow-up|0|||
144411780|NCT03547583|520715755|FG000|Overall Study|Non-compliance with study drug|0|||
144411781|NCT03547583|520715756|FG001|Overall Study|Non-compliance with study drug|0|||
144411782|NCT03547583|520715757|FG002|Overall Study|Non-compliance with study drug|1|||
144411783|NCT03547583|520715755|FG000|Overall Study|Physician Decision|1|||
144411784|NCT03547583|520715756|FG001|Overall Study|Physician Decision|0|||
144411785|NCT03547583|520715757|FG002|Overall Study|Physician Decision|3|||
144411786|NCT03547583|520715755|FG000|Overall Study|Protocol Violation|2|||
144411787|NCT03547583|520715756|FG001|Overall Study|Protocol Violation|1|||
144411788|NCT03547583|520715757|FG002|Overall Study|Protocol Violation|1|||
144411789|NCT03547583|520715755|FG000|Overall Study|Withdrawal by Subject|12|||
144411790|NCT03547583|520715756|FG001|Overall Study|Withdrawal by Subject|19|||
144411791|NCT03547583|520715757|FG002|Overall Study|Withdrawal by Subject|10|||
144411792|NCT03547583|520715755|FG000|Overall Study|Other|2|||
144411793|NCT03547583|520715756|FG001|Overall Study|Other|2|||
144411794|NCT03547583|520715757|FG002|Overall Study|Other|3|||
144411795|NCT04518306|520715760|FG000|Double-Blind Period|Run in failure|0|||
144411796|NCT04518306|520715761|FG001|Double-Blind Period|Run in failure|0|||
144411797|NCT04518306|520715762|FG002|Double-Blind Period|Run in failure|1|||
144411798|NCT04518306|520715760|FG000|Double-Blind Period|Adverse Event|0|||
144411799|NCT04518306|520715761|FG001|Double-Blind Period|Adverse Event|2|||
144411800|NCT04518306|520715762|FG002|Double-Blind Period|Adverse Event|2|||
144411801|NCT04518306|520715760|FG000|Double-Blind Period|Lost to Follow-up|1|||
144411802|NCT04518306|520715761|FG001|Double-Blind Period|Lost to Follow-up|2|||
144411803|NCT04518306|520715762|FG002|Double-Blind Period|Lost to Follow-up|2|||
144411804|NCT04518306|520715760|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
144411805|NCT04518306|520715761|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
144411806|NCT04518306|520715762|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
144411807|NCT04518306|520715760|FG000|Double-Blind Period|Other|0|||
144411808|NCT04518306|520715761|FG001|Double-Blind Period|Other|2|||
144722788|NCT01974895|521840533|FG001|Overall Study|Other (Reason unknown)|8|||
144722789|NCT00635154|521840534|FG000|Overall Study|Alternative Treatment|8|||
144722790|NCT00635154|521840534|FG000|Overall Study|Other|4|||
144722791|NCT00635154|521840534|FG000|Overall Study|Still on treatment|21|||
144411809|NCT04518306|520715762|FG002|Double-Blind Period|Other|0|||
144722792|NCT01513148|521840535|FG000|Overall Study|Protocol Violation|2|||
144411810|NCT04518306|520715760|FG000|Double-Blind Period|Missing|0|||
144411811|NCT04518306|520715761|FG001|Double-Blind Period|Missing|1|||
144411812|NCT04518306|520715762|FG002|Double-Blind Period|Missing|0|||
144411813|NCT03069378|520715763|FG000|Overall Study|Withdrawal by Subject|1|||
144411814|NCT02881554|520715764|FG000|Overall Study|Withdrawal by Subject|2|||
144411815|NCT02881554|520715765|FG001|Overall Study|Withdrawal by Subject|0|||
144411816|NCT03291808|520717036|FG000|Overall Study|Lost to Follow-up|6|||
144411817|NCT03291808|520717036|FG000|Overall Study|Research burden|4|||
144411818|NCT02674529|520717037|FG000|Overall Study|Lost to Follow-up|1|||
144411819|NCT02674529|520717038|FG001|Overall Study|Lost to Follow-up|2|||
144722793|NCT01513148|521840536|FG001|Overall Study|Protocol Violation|2|||
144722794|NCT03500484|521840537|FG000|Overall Study|Adverse Event|2|||
144722795|NCT03500484|521840538|FG001|Overall Study|Adverse Event|0|||
144722796|NCT03500484|521840537|FG000|Overall Study|Physician Decision|1|||
144722797|NCT03500484|521840538|FG001|Overall Study|Physician Decision|0|||
144722798|NCT03500484|521840537|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
144722799|NCT03500484|521840538|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
144722800|NCT02795104|521840539|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
144722801|NCT02795104|521840540|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
144722802|NCT02795104|521840541|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
144722803|NCT02795104|521840539|FG000|Overall Study|Withdrawal by Subject|0|||
144722804|NCT02795104|521840540|FG001|Overall Study|Withdrawal by Subject|2|||
144722805|NCT02795104|521840541|FG002|Overall Study|Withdrawal by Subject|0|||
144722806|NCT02795104|521840539|FG000|Overall Study|Lost to Follow-up|0|||
144722807|NCT02795104|521840540|FG001|Overall Study|Lost to Follow-up|0|||
144722808|NCT02795104|521840541|FG002|Overall Study|Lost to Follow-up|1|||
144722809|NCT01654380|521840542|FG000|Part B, Period 1|Physician Decision|0|||
144722810|NCT01654380|521840543|FG001|Part B, Period 1|Physician Decision|0|||
144411820|NCT02674529|520717037|FG000|Overall Study|Withdrawal by Subject|2|||
144411821|NCT02674529|520717038|FG001|Overall Study|Withdrawal by Subject|1|||
144411822|NCT02674529|520717037|FG000|Overall Study|Physician Decision|0|||
144411823|NCT02674529|520717038|FG001|Overall Study|Physician Decision|1|||
144411824|NCT02674529|520717037|FG000|Overall Study|Protocol Violation|0|||
144411825|NCT02674529|520717038|FG001|Overall Study|Protocol Violation|1|||
144411826|NCT02891850|520717039|FG000|Overall Study|Adverse Event|3|||
144411827|NCT02891850|520717040|FG001|Overall Study|Adverse Event|0|||
144411828|NCT02891850|520717039|FG000|Overall Study|Death|0|||
144722811|NCT01654380|521840544|FG002|Part B, Period 1|Physician Decision|1|||
144722812|NCT01654380|521840545|FG003|Part B, Period 1|Physician Decision|0|||
144722813|NCT04652453|521840548|FG000|Overall Study|Death|8|||
144722814|NCT04652453|521840549|FG001|Overall Study|Death|2|||
144411829|NCT02891850|520717040|FG001|Overall Study|Death|4|||
144411830|NCT02891850|520717039|FG000|Overall Study|Physician Decision|1|||
144722815|NCT04652453|521840550|FG002|Overall Study|Death|0|||
144722816|NCT04652453|521840548|FG000|Overall Study|Hospice|5|||
144722817|NCT04652453|521840549|FG001|Overall Study|Hospice|5|||
144722818|NCT04652453|521840550|FG002|Overall Study|Hospice|0|||
144722819|NCT04652453|521840548|FG000|Overall Study|Withdrawal by Subject|2|||
144722820|NCT04652453|521840549|FG001|Overall Study|Withdrawal by Subject|0|||
144722821|NCT04652453|521840550|FG002|Overall Study|Withdrawal by Subject|0|||
144722822|NCT04543136|521840551|FG000|Overall Study|Withdrawal by Subject|0|||
144722823|NCT04543136|521840552|FG001|Overall Study|Withdrawal by Subject|1|||
144411831|NCT02891850|520717040|FG001|Overall Study|Physician Decision|0|||
144526745|NCT03024437|521129305|FG000|Overall Study|Moved out of state|0|||
144526746|NCT03024437|521129306|FG001|Overall Study|Moved out of state|1|||
144722824|NCT04543136|521840553|FG002|Overall Study|Withdrawal by Subject|0|||
144722825|NCT04543136|521840554|FG003|Overall Study|Withdrawal by Subject|1|||
144411832|NCT02891850|520717039|FG000|Overall Study|Pregnancy|1|||
144411833|NCT02891850|520717040|FG001|Overall Study|Pregnancy|0|||
144411834|NCT02891850|520717039|FG000|Overall Study|Withdrawal by Subject|2|||
144411835|NCT02891850|520717040|FG001|Overall Study|Withdrawal by Subject|3|||
144411836|NCT02397278|520717051|FG000|Overall Study|Withdrawal by Subject|0|||
144411837|NCT02397278|520717052|FG001|Overall Study|Withdrawal by Subject|2|||
144722826|NCT04543136|521840555|FG004|Overall Study|Withdrawal by Subject|0|||
144722827|NCT04543136|521840556|FG005|Overall Study|Withdrawal by Subject|0|||
144411838|NCT02397278|520717051|FG000|Overall Study|Deemed ineligible following surgery|1|||
144411839|NCT02397278|520717052|FG001|Overall Study|Deemed ineligible following surgery|1|||
144411840|NCT00331682|520717057|FG000|Overall Study|Adverse Event|1|||
144411841|NCT03292588|520717058|FG000|Overall Study|Death|1|||
144411842|NCT03292588|520717059|FG001|Overall Study|Death|0|||
144411843|NCT03292588|520717058|FG000|Overall Study|Lost to Follow-up|12|||
144411844|NCT03292588|520717059|FG001|Overall Study|Lost to Follow-up|16|||
144411845|NCT03292588|520717058|FG000|Overall Study|Physician Decision|0|||
144411846|NCT03292588|520717059|FG001|Overall Study|Physician Decision|1|||
144411847|NCT03292588|520717058|FG000|Overall Study|Withdrawal by Subject|4|||
144411848|NCT03292588|520717059|FG001|Overall Study|Withdrawal by Subject|4|||
144411849|NCT03292588|520717058|FG000|Overall Study|Move out of town|1|||
144411850|NCT03292588|520717059|FG001|Overall Study|Move out of town|0|||
144411851|NCT03292588|520717058|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
144411852|NCT03292588|520717059|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
144411853|NCT00004978|520717060|FG000|Overall Study|Death|107|||
144411854|NCT00004978|520717061|FG001|Overall Study|Death|116|||
144411855|NCT00004978|520717060|FG000|Overall Study|Lost to Follow-up|101|||
144411856|NCT00004978|520717061|FG001|Overall Study|Lost to Follow-up|108|||
144411857|NCT00004978|520717060|FG000|Overall Study|Withdrawal by Subject|17|||
144411858|NCT00004978|520717061|FG001|Overall Study|Withdrawal by Subject|26|||
144411859|NCT00004978|520717060|FG000|Overall Study|site closure - not in analysis cohort|19|||
144411860|NCT00004978|520717061|FG001|Overall Study|site closure - not in analysis cohort|20|||
144411861|NCT01652703|520717062|FG000|Overall Study|Withdrawal by Subject|0|||
144411862|NCT01652703|520717063|FG001|Overall Study|Withdrawal by Subject|1|||
144411863|NCT01652703|520717064|FG002|Overall Study|Withdrawal by Subject|3|||
144411864|NCT01652703|520717065|FG003|Overall Study|Withdrawal by Subject|1|||
144411865|NCT01652703|520717066|FG004|Overall Study|Withdrawal by Subject|0|||
144411866|NCT01652703|520717067|FG005|Overall Study|Withdrawal by Subject|1|||
144411867|NCT01652703|520717062|FG000|Overall Study|Other|0|||
144411868|NCT01652703|520717063|FG001|Overall Study|Other|0|||
144411869|NCT01652703|520717064|FG002|Overall Study|Other|0|||
144411870|NCT01652703|520717065|FG003|Overall Study|Other|1|||
144411871|NCT01652703|520717066|FG004|Overall Study|Other|1|||
144411872|NCT01652703|520717067|FG005|Overall Study|Other|1|||
144411873|NCT00062374|520717071|FG000|Overall Study|Not treated|12|||
144411874|NCT02155608|520717072|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
144411875|NCT02155608|520717073|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
144411876|NCT02155608|520717072|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
144411877|NCT02155608|520717073|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
144411878|NCT01532414|520717074|FG000|Overall Study|Lost to Follow-up|3|||
144411879|NCT01532414|520717075|FG001|Overall Study|Lost to Follow-up|0|||
144411880|NCT01532414|520717076|FG002|Overall Study|Lost to Follow-up|1|||
144411881|NCT01532414|520717074|FG000|Overall Study|Withdrawal by Subject|3|||
144411882|NCT01532414|520717075|FG001|Overall Study|Withdrawal by Subject|0|||
144411883|NCT01532414|520717076|FG002|Overall Study|Withdrawal by Subject|0|||
144411884|NCT01532414|520717074|FG000|Overall Study|No V6 semen sample|0|||
144411885|NCT01532414|520717075|FG001|Overall Study|No V6 semen sample|1|||
144411886|NCT01532414|520717076|FG002|Overall Study|No V6 semen sample|0|||
144411887|NCT01532414|520717074|FG000|Overall Study|Adverse Event|0|||
144411888|NCT01532414|520717075|FG001|Overall Study|Adverse Event|1|||
144411889|NCT01532414|520717076|FG002|Overall Study|Adverse Event|1|||
144411890|NCT01532414|520717074|FG000|Overall Study|Unable to complete 24 hour PK|0|||
144411891|NCT01532414|520717075|FG001|Overall Study|Unable to complete 24 hour PK|0|||
144411892|NCT01532414|520717076|FG002|Overall Study|Unable to complete 24 hour PK|1|||
144411893|NCT01532414|520717074|FG000|Overall Study|Withdrawn by sponsor|1|||
144411894|NCT01532414|520717075|FG001|Overall Study|Withdrawn by sponsor|0|||
144411895|NCT01532414|520717076|FG002|Overall Study|Withdrawn by sponsor|0|||
144411896|NCT02380677|520717079|FG000|Overall Study|Adverse Event|0|||
144411897|NCT02380677|520717080|FG001|Overall Study|Adverse Event|0|||
144411898|NCT02380677|520717081|FG002|Overall Study|Adverse Event|0|||
144411899|NCT02380677|520717082|FG003|Overall Study|Adverse Event|1|||
144411900|NCT02380677|520717083|FG004|Overall Study|Adverse Event|1|||
144411901|NCT02380677|520717084|FG005|Overall Study|Adverse Event|4|||
144411902|NCT02380677|520717085|FG006|Overall Study|Adverse Event|2|||
144411903|NCT02380677|520717086|FG007|Overall Study|Adverse Event|2|||
144411904|NCT02380677|520717087|FG008|Overall Study|Adverse Event|2|||
144411905|NCT02380677|520717088|FG009|Overall Study|Adverse Event|1|||
144411906|NCT02380677|520717089|FG010|Overall Study|Adverse Event|2|||
144411907|NCT02380677|520717090|FG011|Overall Study|Adverse Event|1|||
144411908|NCT02380677|520717079|FG000|Overall Study|Physician Decision|1|||
144411909|NCT02380677|520717080|FG001|Overall Study|Physician Decision|0|||
144411910|NCT02380677|520717081|FG002|Overall Study|Physician Decision|1|||
144411911|NCT02380677|520717082|FG003|Overall Study|Physician Decision|1|||
144411912|NCT02380677|520717083|FG004|Overall Study|Physician Decision|0|||
144526747|NCT03024437|521129307|FG002|Overall Study|Moved out of state|0|||
144411913|NCT02380677|520717084|FG005|Overall Study|Physician Decision|0|||
144411914|NCT02380677|520717085|FG006|Overall Study|Physician Decision|0|||
144411915|NCT02380677|520717086|FG007|Overall Study|Physician Decision|0|||
144411916|NCT02380677|520717087|FG008|Overall Study|Physician Decision|0|||
144411917|NCT02380677|520717088|FG009|Overall Study|Physician Decision|0|||
144411918|NCT02380677|520717089|FG010|Overall Study|Physician Decision|0|||
144411919|NCT02380677|520717090|FG011|Overall Study|Physician Decision|0|||
144411920|NCT02380677|520717079|FG000|Overall Study|Lack of Efficacy|0|||
144411921|NCT02380677|520717080|FG001|Overall Study|Lack of Efficacy|1|||
144411922|NCT02380677|520717081|FG002|Overall Study|Lack of Efficacy|2|||
144411923|NCT02380677|520717082|FG003|Overall Study|Lack of Efficacy|0|||
144411924|NCT02380677|520717083|FG004|Overall Study|Lack of Efficacy|4|||
144411925|NCT02380677|520717084|FG005|Overall Study|Lack of Efficacy|1|||
144411926|NCT02380677|520717085|FG006|Overall Study|Lack of Efficacy|1|||
144411927|NCT02380677|520717086|FG007|Overall Study|Lack of Efficacy|2|||
144411928|NCT02380677|520717087|FG008|Overall Study|Lack of Efficacy|2|||
144411929|NCT02380677|520717088|FG009|Overall Study|Lack of Efficacy|0|||
144411930|NCT02380677|520717089|FG010|Overall Study|Lack of Efficacy|2|||
144411931|NCT02380677|520717090|FG011|Overall Study|Lack of Efficacy|1|||
144411932|NCT02380677|520717079|FG000|Overall Study|Withdrawal by Subject|0|||
144411933|NCT02380677|520717080|FG001|Overall Study|Withdrawal by Subject|0|||
144411934|NCT02380677|520717081|FG002|Overall Study|Withdrawal by Subject|0|||
144411935|NCT02380677|520717082|FG003|Overall Study|Withdrawal by Subject|0|||
144411936|NCT02380677|520717083|FG004|Overall Study|Withdrawal by Subject|0|||
144411937|NCT02380677|520717084|FG005|Overall Study|Withdrawal by Subject|0|||
144411938|NCT02380677|520717085|FG006|Overall Study|Withdrawal by Subject|0|||
144411939|NCT02380677|520717086|FG007|Overall Study|Withdrawal by Subject|0|||
144411940|NCT02380677|520717087|FG008|Overall Study|Withdrawal by Subject|0|||
144411941|NCT02380677|520717088|FG009|Overall Study|Withdrawal by Subject|1|||
144411942|NCT02380677|520717089|FG010|Overall Study|Withdrawal by Subject|0|||
144411943|NCT02380677|520717090|FG011|Overall Study|Withdrawal by Subject|3|||
144411944|NCT02380677|520717079|FG000|Overall Study|Other|0|||
144411945|NCT02380677|520717080|FG001|Overall Study|Other|0|||
144411946|NCT02380677|520717081|FG002|Overall Study|Other|0|||
144411947|NCT02380677|520717082|FG003|Overall Study|Other|1|||
144411948|NCT02380677|520717083|FG004|Overall Study|Other|1|||
144411949|NCT02380677|520717084|FG005|Overall Study|Other|1|||
144411950|NCT02380677|520717085|FG006|Overall Study|Other|0|||
144411951|NCT02380677|520717086|FG007|Overall Study|Other|0|||
144411952|NCT02380677|520717087|FG008|Overall Study|Other|0|||
144411953|NCT02380677|520717088|FG009|Overall Study|Other|0|||
144411954|NCT02380677|520717089|FG010|Overall Study|Other|0|||
144411955|NCT02380677|520717090|FG011|Overall Study|Other|0|||
144411956|NCT00840450|520717096|FG000|Overall Study|Adverse Event|1|||
144411957|NCT00840450|520717096|FG000|Overall Study|Lack of Efficacy|2|||
144411958|NCT00617123|520717097|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
144411959|NCT00617123|520717098|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
144411960|NCT00617123|520717097|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
144411961|NCT00617123|520717098|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
144411962|NCT00617123|520717097|FG000|Referral Screening Period|Adverse Event|0|||
144411963|NCT00617123|520717098|FG001|Referral Screening Period|Adverse Event|1|||
144411964|NCT00617123|520717097|FG000|Study Treatment Period|Withdrawal by Subject|8|||
144411965|NCT00617123|520717098|FG001|Study Treatment Period|Withdrawal by Subject|12|||
144411966|NCT00617123|520717097|FG000|Study Treatment Period|Adverse Event|7|||
144411967|NCT00617123|520717098|FG001|Study Treatment Period|Adverse Event|3|||
144411968|NCT00617123|520717097|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
144411969|NCT00617123|520717098|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
144411970|NCT00617123|520717097|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
144411971|NCT00617123|520717098|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
144411972|NCT00133952|520717100|FG000|Overall Study|Adverse Event|1|||
144411973|NCT00133952|520717101|FG001|Overall Study|Adverse Event|2|||
144411974|NCT00133952|520717100|FG000|Overall Study|Death|3|||
144411975|NCT00133952|520717101|FG001|Overall Study|Death|2|||
144411976|NCT00133952|520717100|FG000|Overall Study|Lost to Follow-up|9|||
144411977|NCT00133952|520717101|FG001|Overall Study|Lost to Follow-up|14|||
144411978|NCT00133952|520717100|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
144411979|NCT00133952|520717101|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
144411980|NCT00133952|520717100|FG000|Overall Study|Protocol Violation|1|||
144411981|NCT00133952|520717101|FG001|Overall Study|Protocol Violation|1|||
144411982|NCT00133952|520717100|FG000|Overall Study|Withdrawal by Subject|20|||
144411983|NCT00133952|520717101|FG001|Overall Study|Withdrawal by Subject|4|||
144411984|NCT00133952|520717100|FG000|Overall Study|Physician Decision|4|||
144411985|NCT00133952|520717101|FG001|Overall Study|Physician Decision|3|||
144411986|NCT00133952|520717100|FG000|Overall Study|Sponsor Decision|0|||
144411987|NCT00133952|520717101|FG001|Overall Study|Sponsor Decision|1|||
144411988|NCT03052725|520717102|FG000|Overall Study|Adverse Event|2|||
144411989|NCT03052725|520717103|FG001|Overall Study|Adverse Event|0|||
144411990|NCT03052725|520717102|FG000|Overall Study|Withdrawal by Subject|3|||
144411991|NCT03052725|520717103|FG001|Overall Study|Withdrawal by Subject|4|||
144411992|NCT03052725|520717102|FG000|Overall Study|Pregnancy|0|||
144411993|NCT03052725|520717103|FG001|Overall Study|Pregnancy|1|||
144411994|NCT03052725|520717102|FG000|Overall Study|Site closure|0|||
144411995|NCT03052725|520717103|FG001|Overall Study|Site closure|1|||
144411996|NCT03052725|520717102|FG000|Overall Study|Study terminated by sponsor|143|||
144411997|NCT03052725|520717103|FG001|Overall Study|Study terminated by sponsor|144|||
144411998|NCT03462082|520717107|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
144411999|NCT03462082|520717108|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
144412000|NCT03462082|520717109|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
144412001|NCT03462082|520717110|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
144412002|NCT03462082|520717111|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
144412003|NCT03462082|520717112|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
144412004|NCT03462082|520717113|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
144412005|NCT03462082|520717114|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
144412006|NCT02548650|520717127|FG000|Triple Therapy|Adverse Event|1|||
144412007|NCT02548650|520717128|FG001|Triple Therapy|Adverse Event|0|||
144412008|NCT02548650|520717127|FG000|Triple Therapy|Withdrawal by Subject|0|||
144412009|NCT02548650|520717128|FG001|Triple Therapy|Withdrawal by Subject|4|||
144412010|NCT02548650|520717127|FG000|Double Therapy|Adverse Event|1|||
144412011|NCT02548650|520717128|FG001|Double Therapy|Adverse Event|1|||
144412012|NCT02548650|520717127|FG000|Double Therapy|Withdrawal by Subject|0|||
144412013|NCT02548650|520717128|FG001|Double Therapy|Withdrawal by Subject|1|||
144412014|NCT02128113|520717129|FG000|Overall Study|Withdrawal by Subject|3|||
144412015|NCT02128113|520717130|FG001|Overall Study|Withdrawal by Subject|1|||
144412016|NCT02128113|520717131|FG002|Overall Study|Withdrawal by Subject|0|||
144412017|NCT02128113|520717129|FG000|Overall Study|Protocol Violation|0|||
144412018|NCT02128113|520717130|FG001|Overall Study|Protocol Violation|1|||
144412019|NCT02128113|520717131|FG002|Overall Study|Protocol Violation|0|||
144412020|NCT02128113|520717129|FG000|Overall Study|Surgery cancelled|0|||
144412021|NCT02128113|520717130|FG001|Overall Study|Surgery cancelled|1|||
144412022|NCT02128113|520717131|FG002|Overall Study|Surgery cancelled|0|||
144412023|NCT02128113|520717129|FG000|Overall Study|Adverse Event|0|||
144412024|NCT02128113|520717130|FG001|Overall Study|Adverse Event|0|||
144412025|NCT02128113|520717131|FG002|Overall Study|Adverse Event|1|||
144412026|NCT01061177|520717132|FG000|Overall Study|Adverse Event|117|||
144412027|NCT01061177|520717132|FG000|Overall Study|Withdrawal by Subject|27|||
144412028|NCT01061177|520717132|FG000|Overall Study|Disease progression|17|||
144412029|NCT01061177|520717132|FG000|Overall Study|Protocol Violation|11|||
144412030|NCT01061177|520717132|FG000|Overall Study|Lost to Follow-up|9|||
144526748|NCT03024437|521129308|FG003|Overall Study|Moved out of state|0|||
144526749|NCT03024437|521129309|FG004|Overall Study|Moved out of state|0|||
144526750|NCT03024437|521129305|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
144412031|NCT01061177|520717132|FG000|Overall Study|New cancer therapy|9|||
144412032|NCT01061177|520717132|FG000|Overall Study|Abnormal laboratory values|6|||
144412033|NCT01061177|520717132|FG000|Overall Study|Abnormal test procedure results|4|||
144412034|NCT01061177|520717132|FG000|Overall Study|Administratie problems|4|||
144412035|NCT01061177|520717132|FG000|Overall Study|Death|4|||
144412036|NCT05147350|520717136|FG000|Overall Study|Death|2|||
144412037|NCT05147350|520717137|FG001|Overall Study|Death|3|||
144412038|NCT05147350|520717138|FG002|Overall Study|Death|3|||
144412039|NCT05147350|520717139|FG003|Overall Study|Death|2|||
144412040|NCT05147350|520717140|FG004|Overall Study|Death|2|||
144412041|NCT05147350|520717141|FG005|Overall Study|Death|1|||
144412042|NCT05147350|520717142|FG006|Overall Study|Death|1|||
144412043|NCT05147350|520717143|FG007|Overall Study|Death|3|||
144412044|NCT05147350|520717136|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
144412045|NCT05147350|520717137|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
144412046|NCT05147350|520717138|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
144600324|NCT02178553|521399321|FG001|Overall Study|Physician Decision|4|||
144412047|NCT05147350|520717139|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
144412048|NCT05147350|520717140|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
144412049|NCT05147350|520717141|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
144412050|NCT05147350|520717142|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
144412051|NCT05147350|520717143|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
144412052|NCT05147350|520717136|FG000|Overall Study|Withdrawal by Subject|0|||
144412053|NCT05147350|520717137|FG001|Overall Study|Withdrawal by Subject|0|||
144412054|NCT05147350|520717138|FG002|Overall Study|Withdrawal by Subject|3|||
144412055|NCT05147350|520717139|FG003|Overall Study|Withdrawal by Subject|1|||
144412056|NCT05147350|520717140|FG004|Overall Study|Withdrawal by Subject|1|||
144412057|NCT05147350|520717141|FG005|Overall Study|Withdrawal by Subject|0|||
144412058|NCT05147350|520717142|FG006|Overall Study|Withdrawal by Subject|1|||
144412059|NCT05147350|520717143|FG007|Overall Study|Withdrawal by Subject|0|||
144412060|NCT05147350|520717136|FG000|Overall Study|Other Reasons|0|||
144412061|NCT05147350|520717137|FG001|Overall Study|Other Reasons|0|||
144412062|NCT05147350|520717138|FG002|Overall Study|Other Reasons|2|||
144412063|NCT05147350|520717139|FG003|Overall Study|Other Reasons|0|||
144412064|NCT05147350|520717140|FG004|Overall Study|Other Reasons|0|||
144412065|NCT05147350|520717141|FG005|Overall Study|Other Reasons|2|||
144412066|NCT05147350|520717142|FG006|Overall Study|Other Reasons|1|||
144412067|NCT05147350|520717143|FG007|Overall Study|Other Reasons|1|||
144412068|NCT01539538|520717144|FG000|Overall Study|Adverse Event|13|||
144412069|NCT01539538|520717145|FG001|Overall Study|Adverse Event|18|||
144412070|NCT01539538|520717144|FG000|Overall Study|Lack of Efficacy|13|||
144412071|NCT01539538|520717145|FG001|Overall Study|Lack of Efficacy|16|||
144412072|NCT01539538|520717144|FG000|Overall Study|Withdrawal by Subject|2|||
144412073|NCT01539538|520717145|FG001|Overall Study|Withdrawal by Subject|3|||
144412074|NCT01539538|520717144|FG000|Overall Study|PCA no longer required or PCA problem|3|||
144412075|NCT01539538|520717145|FG001|Overall Study|PCA no longer required or PCA problem|7|||
144412076|NCT00847379|520717146|FG000|Overall Study|Study terminated by Sponsor|59|||
144412077|NCT00847379|520717147|FG001|Overall Study|Study terminated by Sponsor|57|||
144412078|NCT00847379|520717148|FG002|Overall Study|Study terminated by Sponsor|57|||
144250176|NCT02614131|520113492|FG001|Overall Study|Adverse Event|0|||
144250177|NCT02614131|520113493|FG002|Overall Study|Adverse Event|0|||
144250178|NCT02614131|520113494|FG003|Overall Study|Adverse Event|0|||
144250179|NCT02614131|520113495|FG004|Overall Study|Adverse Event|0|||
144250180|NCT02614131|520113496|FG005|Overall Study|Adverse Event|0|||
144250181|NCT02614131|520113497|FG006|Overall Study|Adverse Event|1|||
144250182|NCT02117713|520113505|FG000|Week 48|Adverse Event|4|||
144250183|NCT02117713|520113505|FG000|Week 48|Withdrawal by caregiver|2|||
144250184|NCT02117713|520113505|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
144250185|NCT02117713|520113505|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
144250186|NCT02117713|520113505|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
144250187|NCT02117713|520113505|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
144250188|NCT01094782|520113506|FG000|Overall Study|Withdrawal by Subject|5|||
144250189|NCT01094782|520113507|FG001|Overall Study|Withdrawal by Subject|5|||
144250190|NCT01094782|520113508|FG002|Overall Study|Withdrawal by Subject|1|||
144250191|NCT01094782|520113509|FG003|Overall Study|Withdrawal by Subject|5|||
144250192|NCT01094782|520113510|FG004|Overall Study|Withdrawal by Subject|5|||
144250193|NCT01094782|520113511|FG005|Overall Study|Withdrawal by Subject|0|||
144250194|NCT01094782|520113506|FG000|Overall Study|Lost to Follow-up|1|||
144250195|NCT01094782|520113507|FG001|Overall Study|Lost to Follow-up|0|||
144250196|NCT01094782|520113508|FG002|Overall Study|Lost to Follow-up|0|||
144250197|NCT01094782|520113509|FG003|Overall Study|Lost to Follow-up|2|||
144250198|NCT01094782|520113510|FG004|Overall Study|Lost to Follow-up|1|||
144250199|NCT01094782|520113511|FG005|Overall Study|Lost to Follow-up|4|||
144412079|NCT00521014|520717149|FG000|Overall Study|Inevaluable, not treated|1|||
144412080|NCT03978832|520717150|FG000|Overall Study|Adverse Event|1|||
144412081|NCT03978832|520717150|FG000|Overall Study|Lost to Follow-up|1|||
144412082|NCT03978832|520717150|FG000|Overall Study|Withdrawal by Subject|6|||
144250200|NCT01094782|520113506|FG000|Overall Study|Positive Drug Screen|2|||
144250201|NCT01094782|520113507|FG001|Overall Study|Positive Drug Screen|2|||
144412083|NCT03978832|520717150|FG000|Overall Study|Physician Decision|2|||
144412084|NCT03978832|520717150|FG000|Overall Study|did not pass screening criteria|44|||
144250202|NCT01094782|520113508|FG002|Overall Study|Positive Drug Screen|1|||
144412085|NCT02864498|520717155|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
144412086|NCT02864498|520717156|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
144412087|NCT02864498|520717157|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
144412088|NCT02864498|520717155|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
144412089|NCT02864498|520717156|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
144412090|NCT02864498|520717157|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
144412091|NCT02864498|520717155|FG000|Overall Study|Investigator Discretion|0|||
144412092|NCT02864498|520717156|FG001|Overall Study|Investigator Discretion|2|||
144412093|NCT02864498|520717157|FG002|Overall Study|Investigator Discretion|1|||
144250203|NCT01094782|520113509|FG003|Overall Study|Positive Drug Screen|1|||
144412094|NCT02864498|520717155|FG000|Overall Study|Lost to Follow-up|8|||
144412095|NCT02864498|520717156|FG001|Overall Study|Lost to Follow-up|6|||
144412096|NCT02864498|520717157|FG002|Overall Study|Lost to Follow-up|3|||
144412097|NCT02864498|520717155|FG000|Overall Study|Lack of Efficacy|5|||
144412098|NCT02864498|520717156|FG001|Overall Study|Lack of Efficacy|3|||
144412099|NCT02864498|520717157|FG002|Overall Study|Lack of Efficacy|3|||
144412100|NCT02864498|520717155|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
144412101|NCT02864498|520717156|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
144412102|NCT02864498|520717157|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
144412103|NCT02864498|520717155|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
144412104|NCT02864498|520717156|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
144412105|NCT02864498|520717157|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
144412106|NCT02864498|520717155|FG000|Overall Study|Subject moved out of the country.|0|||
144412107|NCT02864498|520717156|FG001|Overall Study|Subject moved out of the country.|0|||
144412108|NCT02864498|520717157|FG002|Overall Study|Subject moved out of the country.|1|||
144412109|NCT01256008|520717158|FG000|Overall Study|Lost to Follow-up|6|||
144412110|NCT01256008|520717159|FG001|Overall Study|Lost to Follow-up|4|||
144412111|NCT01256008|520717160|FG002|Overall Study|Lost to Follow-up|11|||
144412112|NCT01256008|520717158|FG000|Overall Study|Withdrawal by Subject|2|||
144412113|NCT01256008|520717159|FG001|Overall Study|Withdrawal by Subject|3|||
144412114|NCT01256008|520717160|FG002|Overall Study|Withdrawal by Subject|10|||
144412115|NCT02244606|520717161|FG000|Overall Study|Adverse Event|0|||
144412116|NCT02244606|520717162|FG001|Overall Study|Adverse Event|1|||
144412117|NCT02244606|520717163|FG002|Overall Study|Adverse Event|1|||
144412118|NCT02244606|520717164|FG003|Overall Study|Adverse Event|0|||
144412119|NCT02244606|520717161|FG000|Overall Study|Lost to Follow-up|2|||
144412120|NCT02244606|520717162|FG001|Overall Study|Lost to Follow-up|2|||
144412121|NCT02244606|520717163|FG002|Overall Study|Lost to Follow-up|1|||
144412122|NCT02244606|520717164|FG003|Overall Study|Lost to Follow-up|0|||
144412123|NCT02244606|520717161|FG000|Overall Study|Protocol Violation|0|||
144412124|NCT02244606|520717162|FG001|Overall Study|Protocol Violation|0|||
144412125|NCT02244606|520717163|FG002|Overall Study|Protocol Violation|0|||
144412126|NCT02244606|520717164|FG003|Overall Study|Protocol Violation|1|||
144412127|NCT02244606|520717161|FG000|Overall Study|Withdrawal by Subject|1|||
144412128|NCT02244606|520717162|FG001|Overall Study|Withdrawal by Subject|1|||
144412129|NCT02244606|520717163|FG002|Overall Study|Withdrawal by Subject|0|||
144412130|NCT02244606|520717164|FG003|Overall Study|Withdrawal by Subject|0|||
144412131|NCT02244606|520717161|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
144412132|NCT02244606|520717162|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
144412133|NCT02244606|520717163|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
144412134|NCT02244606|520717164|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
144412135|NCT00378378|520717167|FG000|Overall Study|Withdrawal by Subject|0|||
144412136|NCT00378378|520717168|FG001|Overall Study|Withdrawal by Subject|1|||
144412137|NCT00378378|520717169|FG002|Overall Study|Withdrawal by Subject|0|||
144412138|NCT00378378|520717167|FG000|Overall Study|Treatment Failure|0|||
144412139|NCT00378378|520717168|FG001|Overall Study|Treatment Failure|0|||
144412140|NCT00378378|520717169|FG002|Overall Study|Treatment Failure|1|||
144412141|NCT00378378|520717167|FG000|Overall Study|Non-compliance with protocol|0|||
144412142|NCT00378378|520717168|FG001|Overall Study|Non-compliance with protocol|0|||
144412143|NCT00378378|520717169|FG002|Overall Study|Non-compliance with protocol|1|||
144412144|NCT00407797|520717170|FG000|Overall Study|Lost to Follow-up|2|||
144412145|NCT00407797|520717170|FG000|Overall Study|Adverse Event|6|||
144412146|NCT00407797|520717170|FG000|Overall Study|Other|7|||
144412147|NCT00407797|520717170|FG000|Overall Study|Withdrawal by Subject|3|||
144412148|NCT01812174|520717171|FG000|Overall Study|Death|1|||
144412149|NCT01812174|520717172|FG001|Overall Study|Death|0|||
144412150|NCT01812174|520717171|FG000|Overall Study|Protocol Violation|2|||
144412151|NCT01812174|520717172|FG001|Overall Study|Protocol Violation|0|||
144412152|NCT01336764|520717177|FG000|Overall Study|Withdrawal by Subject|5|||
144412153|NCT01336764|520717178|FG001|Overall Study|Withdrawal by Subject|5|||
144412154|NCT05537883|520717179|FG000|Overall Study|revisional surgery|4|||
144412155|NCT05537883|520717180|FG001|Overall Study|revisional surgery|2|||
144412156|NCT05537883|520717179|FG000|Overall Study|surgeries were cancelled|0|||
144412157|NCT05537883|520717180|FG001|Overall Study|surgeries were cancelled|2|||
144412158|NCT05537883|520717179|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
144412159|NCT05537883|520717180|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
144412160|NCT05229406|520717181|FG000|Overall Study|Withdrawal by Subject|1|||
144412161|NCT05229406|520717182|FG001|Overall Study|Withdrawal by Subject|2|||
144412162|NCT00799422|520717183|FG000|First Week of Wear|Lost to Follow-up|0|||
144412163|NCT00799422|520717184|FG001|First Week of Wear|Lost to Follow-up|0|||
144526751|NCT03024437|521129306|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
144412164|NCT00799422|520717185|FG002|First Week of Wear|Lost to Follow-up|1|||
144412165|NCT00799422|520717186|FG003|First Week of Wear|Lost to Follow-up|0|||
144412166|NCT00799422|520717187|FG004|First Week of Wear|Lost to Follow-up|0|||
144412167|NCT00799422|520717188|FG005|First Week of Wear|Lost to Follow-up|0|||
144412168|NCT00799422|520717183|FG000|First Week of Wear|Adverse Event|0|||
144412169|NCT00799422|520717184|FG001|First Week of Wear|Adverse Event|0|||
144412170|NCT00799422|520717185|FG002|First Week of Wear|Adverse Event|0|||
144412171|NCT00799422|520717186|FG003|First Week of Wear|Adverse Event|1|||
144412172|NCT00799422|520717187|FG004|First Week of Wear|Adverse Event|0|||
144412173|NCT00799422|520717188|FG005|First Week of Wear|Adverse Event|0|||
144412174|NCT04659161|520717189|FG000|Overall Study|Adverse Event|10|||
144412175|NCT04659161|520717190|FG001|Overall Study|Adverse Event|6|||
144412176|NCT04659161|520717189|FG000|Overall Study|Withdrawal by Subject|13|||
144412177|NCT04659161|520717190|FG001|Overall Study|Withdrawal by Subject|12|||
144412178|NCT04659161|520717189|FG000|Overall Study|Other|9|||
144412179|NCT04659161|520717190|FG001|Overall Study|Other|8|||
144412180|NCT01269463|520717191|FG000|First Intervention|Withdrawal by Subject|1|||
144412181|NCT01269463|520717192|FG001|First Intervention|Withdrawal by Subject|0|||
144412182|NCT01269463|520717191|FG000|First Intervention|Adverse Event|1|||
144412183|NCT01269463|520717192|FG001|First Intervention|Adverse Event|0|||
144412184|NCT01269463|520717191|FG000|First Intervention|Lack of Efficacy|0|||
144412185|NCT01269463|520717192|FG001|First Intervention|Lack of Efficacy|1|||
144412186|NCT01269463|520717191|FG000|First Intervention|Physician Decision|0|||
144412187|NCT01269463|520717192|FG001|First Intervention|Physician Decision|1|||
144412188|NCT03199274|520717193|FG000|Overall Study|Withdrawal by Subject|4|||
144412189|NCT03199274|520717194|FG001|Overall Study|Withdrawal by Subject|0|||
144412190|NCT03199274|520717193|FG000|Overall Study|Lost to Follow-up|0|||
144412191|NCT03199274|520717194|FG001|Overall Study|Lost to Follow-up|1|||
144412192|NCT03199274|520717193|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
144412193|NCT03199274|520717194|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
144412194|NCT05980182|520717195|FG000|Overall Study|Lost to Follow-up|10|||
144412195|NCT01892293|520718469|FG000|Overall Study|Apheresed but not treated|4|||
144412196|NCT03602482|520718470|FG000|Overall Study|Withdrawal by Subject|6|||
144412197|NCT03602482|520718471|FG001|Overall Study|Withdrawal by Subject|7|||
144412198|NCT03602482|520718472|FG002|Overall Study|Withdrawal by Subject|0|||
144412199|NCT03602482|520718473|FG003|Overall Study|Withdrawal by Subject|0|||
144250204|NCT01094782|520113510|FG004|Overall Study|Positive Drug Screen|3|||
144250205|NCT01094782|520113511|FG005|Overall Study|Positive Drug Screen|2|||
144250206|NCT01094782|520113506|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
144250207|NCT01094782|520113507|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
144250208|NCT01094782|520113508|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
144250209|NCT01094782|520113509|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
144250210|NCT01094782|520113510|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
144250211|NCT01094782|520113511|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
144250212|NCT01094782|520113506|FG000|Overall Study|Unable to Complete Questionnaires|0|||
144250213|NCT01094782|520113507|FG001|Overall Study|Unable to Complete Questionnaires|1|||
144250214|NCT01094782|520113508|FG002|Overall Study|Unable to Complete Questionnaires|0|||
144250215|NCT01094782|520113509|FG003|Overall Study|Unable to Complete Questionnaires|0|||
144250216|NCT01094782|520113510|FG004|Overall Study|Unable to Complete Questionnaires|0|||
144250217|NCT01094782|520113511|FG005|Overall Study|Unable to Complete Questionnaires|0|||
144250218|NCT01094782|520113506|FG000|Overall Study|Healthy Subject Had Pain|0|||
144250219|NCT01094782|520113507|FG001|Overall Study|Healthy Subject Had Pain|1|||
144250220|NCT01094782|520113508|FG002|Overall Study|Healthy Subject Had Pain|0|||
144250221|NCT01094782|520113509|FG003|Overall Study|Healthy Subject Had Pain|0|||
144250222|NCT01094782|520113510|FG004|Overall Study|Healthy Subject Had Pain|0|||
144250223|NCT01094782|520113511|FG005|Overall Study|Healthy Subject Had Pain|0|||
144250224|NCT01094782|520113506|FG000|Overall Study|Hypertension|0|||
144250225|NCT01094782|520113507|FG001|Overall Study|Hypertension|0|||
144250226|NCT01094782|520113508|FG002|Overall Study|Hypertension|1|||
144412200|NCT02601469|520718476|FG000|Overall Study|Enrolled in Error|1|||
144412201|NCT02601469|520718477|FG001|Overall Study|Enrolled in Error|0|||
144412202|NCT01411774|520718482|FG000|Overall Study|Withdrawal by Subject|0|||
144412203|NCT01411774|520718483|FG001|Overall Study|Withdrawal by Subject|3|||
144412204|NCT00056316|520718484|FG000|Overall Study|Withdrawal by Subject|2|||
144412205|NCT00056316|520718485|FG001|Overall Study|Withdrawal by Subject|2|||
144412206|NCT00056316|520718484|FG000|Overall Study|Death/NH placement of pt|1|||
144412207|NCT00056316|520718485|FG001|Overall Study|Death/NH placement of pt|1|||
144412208|NCT02820753|520718486|FG000|2 Month|Withdrawal by Subject|3|||
144250227|NCT01094782|520113509|FG003|Overall Study|Hypertension|0|||
144250228|NCT01094782|520113510|FG004|Overall Study|Hypertension|0|||
144250229|NCT01094782|520113511|FG005|Overall Study|Hypertension|0|||
144412209|NCT02820753|520718487|FG001|2 Month|Withdrawal by Subject|3|||
144412210|NCT02820753|520718486|FG000|2 Month|Lost to Follow-up|24|||
144412211|NCT02820753|520718487|FG001|2 Month|Lost to Follow-up|26|||
144412212|NCT02820753|520718486|FG000|2 Month|Stopped per NIH Hold|51|||
144412213|NCT02820753|520718487|FG001|2 Month|Stopped per NIH Hold|13|||
144412214|NCT02820753|520718486|FG000|6 Month|Withdrawal by Subject|2|||
144412215|NCT02820753|520718487|FG001|6 Month|Withdrawal by Subject|2|||
144412216|NCT02820753|520718486|FG000|6 Month|Lost to Follow-up|20|||
144412217|NCT02820753|520718487|FG001|6 Month|Lost to Follow-up|27|||
144412218|NCT02820753|520718486|FG000|6 Month|Stopped per NIH Hold|81|||
144412219|NCT02820753|520718487|FG001|6 Month|Stopped per NIH Hold|81|||
144412220|NCT02820753|520718486|FG000|6 Month|Death|0|||
144412221|NCT02820753|520718487|FG001|6 Month|Death|1|||
144412222|NCT02161731|520718488|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
144412223|NCT02161731|520718489|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
144412224|NCT02161731|520718488|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
144412225|NCT02161731|520718489|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
144412226|NCT01315678|520718494|FG000|Overall Study|Withdrawal by Subject|7|||
144412227|NCT01315678|520718495|FG001|Overall Study|Withdrawal by Subject|3|||
144412228|NCT01315678|520718494|FG000|Overall Study|Adverse Event|3|||
144412229|NCT01315678|520718495|FG001|Overall Study|Adverse Event|1|||
144412230|NCT01315678|520718494|FG000|Overall Study|Lost to Follow-up|1|||
144412231|NCT01315678|520718495|FG001|Overall Study|Lost to Follow-up|0|||
144412232|NCT01315678|520718494|FG000|Overall Study|similar reason to those listed above|3|||
144412233|NCT01315678|520718495|FG001|Overall Study|similar reason to those listed above|2|||
144412234|NCT05048784|520718503|FG000|Period 1|Adverse Event|3|||
144412235|NCT05048784|520718504|FG001|Period 1|Adverse Event|1|||
144412236|NCT05048784|520718505|FG002|Period 1|Adverse Event|0|||
144412237|NCT05048784|520718506|FG003|Period 1|Adverse Event|0|||
144412238|NCT05048784|520718503|FG000|Period 2|Lost to Follow-up|0|||
144412239|NCT05048784|520718504|FG001|Period 2|Lost to Follow-up|1|||
144412240|NCT05048784|520718505|FG002|Period 2|Lost to Follow-up|0|||
144412241|NCT05048784|520718506|FG003|Period 2|Lost to Follow-up|0|||
144412242|NCT02269241|520718509|FG000|Overall Study|Lost to Follow-up|269|||
144412243|NCT02269241|520718509|FG000|Overall Study|Withdrawal by Subject|155|||
144412244|NCT02269241|520718509|FG000|Overall Study|Protocol Violation|1|||
144412245|NCT02269241|520718509|FG000|Overall Study|Physician Decision|7|||
144412246|NCT02269241|520718509|FG000|Overall Study|Pregnancy|15|||
144412247|NCT02269241|520718509|FG000|Overall Study|Wish for pregnancy|5|||
144412248|NCT02269241|520718509|FG000|Overall Study|Development of an exclusion criteria|16|||
144412249|NCT02269241|520718509|FG000|Overall Study|Adverse Event|113|||
144412250|NCT02269241|520718509|FG000|Overall Study|At the specific request of the sponsor|20|||
144412251|NCT02269241|520718509|FG000|Overall Study|Several reasons not classified|53|||
144412252|NCT02269241|520718509|FG000|Overall Study|Screening failures|546|||
144412253|NCT03020160|520718510|FG000|Overall Study|Withdrawal by Subject|1|||
144412254|NCT03020160|520718511|FG001|Overall Study|Withdrawal by Subject|0|||
144412255|NCT02270957|520718512|FG000|Overall Study|Lack of Efficacy|2|||
144412256|NCT02270957|520718513|FG001|Overall Study|Lack of Efficacy|4|||
144412257|NCT02270957|520718512|FG000|Overall Study|Adverse Event|2|||
144412258|NCT02270957|520718513|FG001|Overall Study|Adverse Event|0|||
144412259|NCT01513473|520718514|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
144412260|NCT01513473|520718515|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
144412261|NCT01513473|520718514|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
144412262|NCT01513473|520718515|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
144412263|NCT01513473|520718514|FG000|Main Trial (26 Weeks)|Unclassified|0|||
144412264|NCT01513473|520718515|FG001|Main Trial (26 Weeks)|Unclassified|2|||
144412265|NCT01513473|520718514|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
144412266|NCT01513473|520718515|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
144412267|NCT01513473|520718514|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
144412268|NCT01513473|520718515|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
144412269|NCT00166114|520718519|FG000|Overall Study|Protocol Violation|2|||
144412270|NCT00166114|520718520|FG001|Overall Study|Protocol Violation|1|||
144412271|NCT00166114|520718519|FG000|Overall Study|Withdrawal by Subject|10|||
144412272|NCT00166114|520718520|FG001|Overall Study|Withdrawal by Subject|4|||
144412273|NCT00166114|520718519|FG000|Overall Study|Adverse Event|2|||
144412274|NCT00166114|520718520|FG001|Overall Study|Adverse Event|1|||
144412275|NCT00545168|520718527|FG000|Overall Study|Lost to Follow-up|5|||
144412276|NCT00545168|520718528|FG001|Overall Study|Lost to Follow-up|5|||
144412277|NCT00545168|520718529|FG002|Overall Study|Lost to Follow-up|5|||
144412278|NCT00545168|520718527|FG000|Overall Study|Withdrawal by Subject|9|||
144526752|NCT03024437|521129307|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
144526753|NCT03024437|521129308|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
144412279|NCT00545168|520718528|FG001|Overall Study|Withdrawal by Subject|0|||
144412280|NCT00545168|520718529|FG002|Overall Study|Withdrawal by Subject|13|||
144412281|NCT00545168|520718527|FG000|Overall Study|Protocol Violation|1|||
144526754|NCT03024437|521129309|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
144412282|NCT00545168|520718528|FG001|Overall Study|Protocol Violation|0|||
144412283|NCT00545168|520718529|FG002|Overall Study|Protocol Violation|1|||
144412284|NCT00545168|520718527|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
144412285|NCT00545168|520718528|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
144526755|NCT02601313|521129310|FG000|Overall Study|Death|2|||
144412286|NCT00545168|520718529|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
144412287|NCT00489541|520718532|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
144412288|NCT00489541|520718533|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
144412289|NCT00489541|520718532|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
144412290|NCT00489541|520718533|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
144412291|NCT00489541|520718532|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
144412292|NCT00489541|520718533|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
144412293|NCT00489541|520718532|FG000|12-Month Clinical Follow-up|Death|3|||
144412294|NCT00489541|520718533|FG001|12-Month Clinical Follow-up|Death|2|||
144412295|NCT00489541|520718532|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
144412296|NCT00489541|520718533|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
144412297|NCT00489541|520718532|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
144412298|NCT00489541|520718533|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
144412299|NCT00003479|520718534|FG000|Overall Study|Not evaluable|3|||
144412300|NCT00299104|520718535|FG000|Treatment Period|Adverse Event|14|||
144412301|NCT00299104|520718536|FG001|Treatment Period|Adverse Event|9|||
144412302|NCT00299104|520718537|FG002|Treatment Period|Adverse Event|7|||
144412303|NCT00299104|520718535|FG000|Treatment Period|Death|1|||
144412304|NCT00299104|520718536|FG001|Treatment Period|Death|1|||
144412305|NCT00299104|520718537|FG002|Treatment Period|Death|1|||
144412306|NCT00299104|520718535|FG000|Treatment Period|Insufficient therapeutic response|34|||
144412307|NCT00299104|520718536|FG001|Treatment Period|Insufficient therapeutic response|13|||
144412308|NCT00299104|520718537|FG002|Treatment Period|Insufficient therapeutic response|8|||
144412309|NCT00299104|520718535|FG000|Treatment Period|Failure to return|9|||
144412310|NCT00299104|520718536|FG001|Treatment Period|Failure to return|8|||
144412311|NCT00299104|520718537|FG002|Treatment Period|Failure to return|8|||
144412312|NCT00299104|520718535|FG000|Treatment Period|Violation of selection criteria|1|||
144412313|NCT00299104|520718536|FG001|Treatment Period|Violation of selection criteria|2|||
144412314|NCT00299104|520718537|FG002|Treatment Period|Violation of selection criteria|0|||
144412315|NCT00299104|520718535|FG000|Treatment Period|Protocol Violation|1|||
144412316|NCT00299104|520718536|FG001|Treatment Period|Protocol Violation|1|||
144412317|NCT00299104|520718537|FG002|Treatment Period|Protocol Violation|0|||
144412318|NCT00299104|520718535|FG000|Treatment Period|Refused treatment|9|||
144412319|NCT00299104|520718536|FG001|Treatment Period|Refused treatment|2|||
144412320|NCT00299104|520718537|FG002|Treatment Period|Refused treatment|2|||
144412321|NCT00299104|520718535|FG000|Treatment Period|Withdrew consent|14|||
144412322|NCT00299104|520718536|FG001|Treatment Period|Withdrew consent|19|||
144412323|NCT00299104|520718537|FG002|Treatment Period|Withdrew consent|9|||
144412324|NCT00299104|520718535|FG000|Treatment Period|Administrative reasons|106|||
144412325|NCT00299104|520718536|FG001|Treatment Period|Administrative reasons|120|||
144412326|NCT00299104|520718537|FG002|Treatment Period|Administrative reasons|137|||
144412327|NCT00299104|520718535|FG000|Safety Follow-Up (SFU) Period|Death|3|||
144412328|NCT00299104|520718536|FG001|Safety Follow-Up (SFU) Period|Death|2|||
144412329|NCT00299104|520718537|FG002|Safety Follow-Up (SFU) Period|Death|1|||
144412330|NCT00299104|520718535|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
144412331|NCT00299104|520718536|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
144412332|NCT00299104|520718537|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
144412333|NCT00299104|520718535|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
144412334|NCT00299104|520718536|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
144412335|NCT00299104|520718537|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
144412336|NCT00299104|520718535|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
144412337|NCT00299104|520718536|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
144412338|NCT00299104|520718537|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
144412339|NCT00299104|520718535|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
144412340|NCT00299104|520718536|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
144412341|NCT00299104|520718537|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
144412342|NCT00299104|520718535|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
144526756|NCT02601313|521129311|FG001|Overall Study|Death|41|||
144526757|NCT02601313|521129312|FG002|Overall Study|Death|6|||
144526758|NCT02601313|521129310|FG000|Overall Study|Enrolled but never treated|0|||
144526759|NCT02601313|521129311|FG001|Overall Study|Enrolled but never treated|6|||
144526760|NCT02601313|521129312|FG002|Overall Study|Enrolled but never treated|3|||
144526761|NCT02601313|521129310|FG000|Overall Study|Enrolled, did not initiate AC|4|||
144526762|NCT02601313|521129311|FG001|Overall Study|Enrolled, did not initiate AC|0|||
144412343|NCT00299104|520718536|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
144412344|NCT00299104|520718537|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
144412345|NCT00299104|520718535|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
144526763|NCT02601313|521129312|FG002|Overall Study|Enrolled, did not initiate AC|0|||
144412346|NCT00299104|520718536|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
144412347|NCT00299104|520718537|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
144412348|NCT00299104|520718535|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
144412349|NCT00299104|520718536|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
144412350|NCT00299104|520718537|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
144526764|NCT02601313|521129310|FG000|Overall Study|Full consent withdrawal|0|||
144412351|NCT04390191|520718547|FG000|Overall Study|Withdrawal by Subject|1|||
144412352|NCT04390191|520718548|FG001|Overall Study|Withdrawal by Subject|0|||
144412353|NCT00003499|520718549|FG000|Overall Study|Not evaluable|8|||
144412354|NCT01402492|520718552|FG000|Overall Study|Withdrawal by Subject|17|||
144412355|NCT01402492|520718553|FG001|Overall Study|Withdrawal by Subject|11|||
144412356|NCT01402492|520718554|FG002|Overall Study|Withdrawal by Subject|11|||
144412357|NCT01402492|520718552|FG000|Overall Study|Adverse Event|2|||
144412358|NCT01402492|520718553|FG001|Overall Study|Adverse Event|3|||
144412359|NCT01402492|520718554|FG002|Overall Study|Adverse Event|4|||
144412360|NCT01402492|520718552|FG000|Overall Study|Physician Decision|0|||
144412361|NCT01402492|520718553|FG001|Overall Study|Physician Decision|3|||
144412362|NCT01402492|520718554|FG002|Overall Study|Physician Decision|0|||
144412363|NCT01402492|520718552|FG000|Overall Study|Incarcerated (N=3)|2|||
144412364|NCT01402492|520718553|FG001|Overall Study|Incarcerated (N=3)|0|||
144412365|NCT01402492|520718554|FG002|Overall Study|Incarcerated (N=3)|1|||
144412366|NCT02321800|520718555|FG000|Overall Study|Withdrawal by Subject|3|||
144412367|NCT02321800|520718556|FG001|Overall Study|Withdrawal by Subject|3|||
144412368|NCT02321800|520718555|FG000|Overall Study|Death|1|||
144412369|NCT02321800|520718556|FG001|Overall Study|Death|0|||
144412370|NCT02321800|520718555|FG000|Overall Study|Protocol Violation|1|||
144412371|NCT02321800|520718556|FG001|Overall Study|Protocol Violation|0|||
144412372|NCT02321800|520718555|FG000|Overall Study|Lost to Follow-up|10|||
144412373|NCT02321800|520718556|FG001|Overall Study|Lost to Follow-up|4|||
144412374|NCT02321800|520718555|FG000|Overall Study|Adverse Event|2|||
144412375|NCT02321800|520718556|FG001|Overall Study|Adverse Event|3|||
144412376|NCT02321800|520718555|FG000|Overall Study|Other, Miscellaneous|3|||
144412377|NCT02321800|520718556|FG001|Overall Study|Other, Miscellaneous|1|||
144412378|NCT00982878|520718557|FG000|Overall Study|Physician Decision|1|||
144412379|NCT01051323|520718562|FG000|Overall Study|Discontinuation of treatment|103|||
144412380|NCT01051323|520718562|FG000|Overall Study|Transplantation|28|||
144412381|NCT01051323|520718562|FG000|Overall Study|Dialysis dependency|22|||
144412382|NCT01051323|520718562|FG000|Overall Study|Withdrawal by Subject|13|||
144412383|NCT01051323|520718562|FG000|Overall Study|Lost to Follow-up|31|||
144412384|NCT01051323|520718562|FG000|Overall Study|Death|129|||
144412385|NCT01051323|520718562|FG000|Overall Study|Hospitalization|28|||
144412386|NCT01051323|520718562|FG000|Overall Study|Other|148|||
144412387|NCT01051323|520718562|FG000|Overall Study|Missing|37|||
144412388|NCT01626391|520718563|FG000|Overall Study|Physician Decision|1|||
144412389|NCT01626391|520718564|FG001|Overall Study|Physician Decision|0|||
144412390|NCT01626391|520718563|FG000|Overall Study|Withdrawal by Subject|1|||
144412391|NCT01626391|520718564|FG001|Overall Study|Withdrawal by Subject|0|||
144412392|NCT00036270|520718568|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
144412393|NCT00036270|520718569|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
144412394|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
144412395|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
144412396|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
144412397|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
144412398|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
144412399|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
144412400|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Other|277|||
144412401|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Other|288|||
144412402|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
144412403|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
144412404|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
144412405|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
144412406|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
144412407|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
144412408|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
144412409|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
144412410|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
144600325|NCT02178553|521399320|FG000|Overall Study|Technical problem with injection|1|||
144600326|NCT02178553|521399321|FG001|Overall Study|Technical problem with injection|3|||
144600327|NCT01699789|521399323|FG000|Overall Study|Withdrawal by Subject|18|||
144600328|NCT01699789|521399324|FG001|Overall Study|Withdrawal by Subject|23|||
144600329|NCT01699789|521399323|FG000|Overall Study|Death|1|||
144412411|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
144412412|NCT00036270|520718568|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
144600330|NCT01699789|521399324|FG001|Overall Study|Death|2|||
144600331|NCT01699789|521399323|FG000|Overall Study|Lost to Follow-up|83|||
144412413|NCT00036270|520718569|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
144412414|NCT02516163|520718570|FG000|Overall Study|Withdrawal by Subject|1|||
144600332|NCT01699789|521399324|FG001|Overall Study|Lost to Follow-up|101|||
144600333|NCT02554903|521399325|FG000|Overall Study|Death|1|||
144600334|NCT02554903|521399326|FG001|Overall Study|Death|1|||
144600335|NCT02554903|521399325|FG000|Overall Study|Physician Decision|2|||
144412415|NCT02516163|520718570|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
144412416|NCT02516163|520718570|FG000|Overall Study|Unfit/delay in surgery|3|||
144412417|NCT02516163|520718570|FG000|Overall Study|Use of incorrect measurement technique|5|||
144412418|NCT02516163|520718570|FG000|Overall Study|Data not recorded|2|||
144412419|NCT02516163|520718570|FG000|Overall Study|MRI contraindication exclusion|6|||
144412420|NCT01658072|520718571|FG000|Overall Study|Protocol Violation|4|||
144412421|NCT01658072|520718572|FG001|Overall Study|Protocol Violation|2|||
144412422|NCT00040664|520718573|FG000|Overall Study|Adverse Event|12|||
144412423|NCT00040664|520718574|FG001|Overall Study|Adverse Event|3|||
144412424|NCT00040664|520718575|FG002|Overall Study|Adverse Event|2|||
144412425|NCT00040664|520718576|FG003|Overall Study|Adverse Event|7|||
144412426|NCT00040664|520718573|FG000|Overall Study|Lack of Efficacy|9|||
144412427|NCT00040664|520718574|FG001|Overall Study|Lack of Efficacy|2|||
144412428|NCT00040664|520718575|FG002|Overall Study|Lack of Efficacy|3|||
144412429|NCT00040664|520718576|FG003|Overall Study|Lack of Efficacy|4|||
144412430|NCT00040664|520718573|FG000|Overall Study|Insufficient CD4 response|1|||
144412431|NCT00040664|520718574|FG001|Overall Study|Insufficient CD4 response|0|||
144412432|NCT00040664|520718575|FG002|Overall Study|Insufficient CD4 response|1|||
144412433|NCT00040664|520718576|FG003|Overall Study|Insufficient CD4 response|0|||
144412434|NCT00040664|520718573|FG000|Overall Study|Lost to Follow-up|4|||
144412435|NCT00040664|520718574|FG001|Overall Study|Lost to Follow-up|2|||
144412436|NCT00040664|520718575|FG002|Overall Study|Lost to Follow-up|0|||
144412437|NCT00040664|520718576|FG003|Overall Study|Lost to Follow-up|2|||
144412438|NCT00040664|520718573|FG000|Overall Study|Protocol Violation|2|||
144412439|NCT00040664|520718574|FG001|Overall Study|Protocol Violation|1|||
144412440|NCT00040664|520718575|FG002|Overall Study|Protocol Violation|0|||
144412441|NCT00040664|520718576|FG003|Overall Study|Protocol Violation|1|||
144412442|NCT00040664|520718573|FG000|Overall Study|Withdrawal by Subject|7|||
144412443|NCT00040664|520718574|FG001|Overall Study|Withdrawal by Subject|0|||
144412444|NCT00040664|520718575|FG002|Overall Study|Withdrawal by Subject|3|||
144412445|NCT00040664|520718576|FG003|Overall Study|Withdrawal by Subject|4|||
144412446|NCT00040664|520718573|FG000|Overall Study|Pregnancy|3|||
144412447|NCT00040664|520718574|FG001|Overall Study|Pregnancy|0|||
144412448|NCT00040664|520718575|FG002|Overall Study|Pregnancy|0|||
144412449|NCT00040664|520718576|FG003|Overall Study|Pregnancy|3|||
144412450|NCT00040664|520718573|FG000|Overall Study|Medication adherence/compliance problems|8|||
144412451|NCT00040664|520718574|FG001|Overall Study|Medication adherence/compliance problems|2|||
144412452|NCT00040664|520718575|FG002|Overall Study|Medication adherence/compliance problems|1|||
144412453|NCT00040664|520718576|FG003|Overall Study|Medication adherence/compliance problems|5|||
144412454|NCT00040664|520718573|FG000|Overall Study|Poor taste|2|||
144412455|NCT00040664|520718574|FG001|Overall Study|Poor taste|0|||
144412456|NCT00040664|520718575|FG002|Overall Study|Poor taste|2|||
144412457|NCT00040664|520718576|FG003|Overall Study|Poor taste|0|||
144412458|NCT00040664|520718573|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
144412459|NCT00040664|520718574|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
144412460|NCT00040664|520718575|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
144412461|NCT00040664|520718576|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
144412462|NCT00040664|520718573|FG000|Overall Study|Change of formulation|2|||
144412463|NCT00040664|520718574|FG001|Overall Study|Change of formulation|2|||
144412464|NCT00040664|520718575|FG002|Overall Study|Change of formulation|0|||
144412465|NCT00040664|520718576|FG003|Overall Study|Change of formulation|0|||
144412466|NCT00040664|520718573|FG000|Overall Study|Non-viability of oral suspension|1|||
144412467|NCT00040664|520718574|FG001|Overall Study|Non-viability of oral suspension|0|||
144412468|NCT00040664|520718575|FG002|Overall Study|Non-viability of oral suspension|1|||
144412469|NCT00040664|520718576|FG003|Overall Study|Non-viability of oral suspension|0|||
144412470|NCT01874054|520718577|FG000|Overall Study|Withdrawal by Subject|3|||
144412471|NCT01874054|520718577|FG000|Overall Study|Study Termination by Sponsor|42|||
144412472|NCT01874054|520718577|FG000|Overall Study|Lost to Follow-up|5|||
144412473|NCT01874054|520718577|FG000|Overall Study|Death|5|||
144412474|NCT00880009|520718582|FG000|Overall Study|Study terminated by sponsor|14|||
144412475|NCT00880009|520718582|FG000|Overall Study|Withdrawal by Subject|1|||
144412476|NCT00880009|520718582|FG000|Overall Study|Protocol Violation|1|||
144412477|NCT03845985|520718583|FG000|Overall Study|Lost to Follow-up|2|||
144412478|NCT03845985|520718584|FG001|Overall Study|Lost to Follow-up|1|||
144412479|NCT03845985|520718583|FG000|Overall Study|Physician Decision|1|||
144412480|NCT03845985|520718584|FG001|Overall Study|Physician Decision|0|||
144412481|NCT03845985|520718583|FG000|Overall Study|Withdrawal by Subject|4|||
144412482|NCT03845985|520718584|FG001|Overall Study|Withdrawal by Subject|1|||
144412483|NCT02010775|520718589|FG000|Overall Study|Adverse Event|0|||
144412484|NCT02010775|520718590|FG001|Overall Study|Adverse Event|0|||
144412485|NCT02010775|520718591|FG002|Overall Study|Adverse Event|0|||
144412486|NCT02010775|520718592|FG003|Overall Study|Adverse Event|0|||
144412487|NCT02010775|520718593|FG004|Overall Study|Adverse Event|1|||
144412488|NCT02010775|520718589|FG000|Overall Study|Pregnancy|0|||
144412489|NCT02010775|520718590|FG001|Overall Study|Pregnancy|0|||
144412490|NCT02010775|520718591|FG002|Overall Study|Pregnancy|2|||
144412491|NCT02010775|520718592|FG003|Overall Study|Pregnancy|0|||
144412492|NCT02010775|520718593|FG004|Overall Study|Pregnancy|0|||
144412493|NCT02010775|520718589|FG000|Overall Study|Lost to Follow-up|2|||
144412494|NCT02010775|520718590|FG001|Overall Study|Lost to Follow-up|0|||
144412495|NCT02010775|520718591|FG002|Overall Study|Lost to Follow-up|0|||
144412496|NCT02010775|520718592|FG003|Overall Study|Lost to Follow-up|1|||
144412497|NCT02010775|520718593|FG004|Overall Study|Lost to Follow-up|1|||
144412498|NCT02010775|520718589|FG000|Overall Study|Personal Reasons|3|||
144412499|NCT02010775|520718590|FG001|Overall Study|Personal Reasons|3|||
144412500|NCT02010775|520718591|FG002|Overall Study|Personal Reasons|1|||
144412501|NCT02010775|520718592|FG003|Overall Study|Personal Reasons|2|||
144412502|NCT02010775|520718593|FG004|Overall Study|Personal Reasons|4|||
144412503|NCT01929343|520718595|FG000|Overall Study|Physician Decision|0|||
144412504|NCT01929343|520718596|FG001|Overall Study|Physician Decision|2|||
144412505|NCT01929343|520718597|FG002|Overall Study|Physician Decision|0|||
144412506|NCT01929343|520718595|FG000|Overall Study|Withdrawal by Subject|1|||
144722828|NCT02192099|521840557|FG000|Overall Study|Adverse Event|1|||
144722829|NCT02192099|521840557|FG000|Overall Study|Lost to Follow-up|2|||
144722830|NCT02192099|521840557|FG000|Overall Study|Physician Decision|1|||
144722831|NCT02192099|521840557|FG000|Overall Study|Pregnancy|1|||
144412507|NCT01929343|520718596|FG001|Overall Study|Withdrawal by Subject|0|||
144412508|NCT01929343|520718597|FG002|Overall Study|Withdrawal by Subject|0|||
144412509|NCT02197130|520718600|FG000|Overall Study|Adverse Event|13|||
144412510|NCT02197130|520718601|FG001|Overall Study|Adverse Event|4|||
144722832|NCT02192099|521840557|FG000|Overall Study|Protocol Violation|8|||
144722833|NCT02192099|521840557|FG000|Overall Study|Study Terminated by Sponsor|32|||
144722834|NCT02192099|521840557|FG000|Overall Study|Withdrawal by Subject|11|||
144722835|NCT02192099|521840557|FG000|Overall Study|Miscellaneous Reasons|5|||
144722836|NCT04128007|521840563|FG000|Overall Study|Withdrawal by Subject|9|||
144722837|NCT04128007|521840564|FG001|Overall Study|Withdrawal by Subject|6|||
144722838|NCT04128007|521840563|FG000|Overall Study|Protocol Violation|1|||
144722839|NCT04128007|521840564|FG001|Overall Study|Protocol Violation|0|||
144722840|NCT04128007|521840563|FG000|Overall Study|Lost to Follow-up|8|||
144722841|NCT04128007|521840564|FG001|Overall Study|Lost to Follow-up|7|||
144722842|NCT04128007|521840563|FG000|Overall Study|Adverse Event|5|||
144722843|NCT04128007|521840564|FG001|Overall Study|Adverse Event|2|||
144722844|NCT04128007|521840563|FG000|Overall Study|Not reported|0|||
144722845|NCT04128007|521840564|FG001|Overall Study|Not reported|2|||
144722846|NCT00429923|521840567|FG000|Overall Study|Adverse Event|0|||
144722847|NCT00429923|521840568|FG001|Overall Study|Adverse Event|2|||
144722848|NCT00429923|521840569|FG002|Overall Study|Adverse Event|3|||
144722849|NCT00429923|521840567|FG000|Overall Study|Lack of Efficacy|4|||
144722850|NCT00429923|521840568|FG001|Overall Study|Lack of Efficacy|1|||
144722851|NCT00429923|521840569|FG002|Overall Study|Lack of Efficacy|33|||
144722852|NCT00429923|521840567|FG000|Overall Study|Lost to Follow-up|0|||
144722853|NCT00429923|521840568|FG001|Overall Study|Lost to Follow-up|0|||
144722854|NCT00429923|521840569|FG002|Overall Study|Lost to Follow-up|2|||
144722855|NCT00429923|521840567|FG000|Overall Study|Withdrew Consent|1|||
144722856|NCT00429923|521840568|FG001|Overall Study|Withdrew Consent|0|||
144722857|NCT00429923|521840569|FG002|Overall Study|Withdrew Consent|1|||
144722858|NCT00429923|521840567|FG000|Overall Study|Early Termination|0|||
144722859|NCT00429923|521840568|FG001|Overall Study|Early Termination|1|||
144722860|NCT00429923|521840569|FG002|Overall Study|Early Termination|0|||
144722861|NCT01937364|521840570|FG000|Overall Study|Adverse Event|2|||
144722862|NCT01937364|521840571|FG001|Overall Study|Adverse Event|1|||
144722863|NCT04799158|521840572|FG000|Run-In Period|Adverse Event|6|||
144722864|NCT04799158|521840573|FG001|Run-In Period|Adverse Event|0|||
144722865|NCT04799158|521840574|FG002|Run-In Period|Adverse Event|0|||
144722866|NCT04799158|521840575|FG003|Run-In Period|Adverse Event|0|||
144722867|NCT04799158|521840576|FG004|Run-In Period|Adverse Event|0|||
144722868|NCT04799158|521840572|FG000|Run-In Period|Lost to Follow-up|4|||
144722869|NCT04799158|521840573|FG001|Run-In Period|Lost to Follow-up|0|||
144412511|NCT02197130|520718602|FG002|Overall Study|Adverse Event|23|||
144412512|NCT02197130|520718600|FG000|Overall Study|Death|0|||
144412513|NCT02197130|520718601|FG001|Overall Study|Death|1|||
144412514|NCT02197130|520718602|FG002|Overall Study|Death|0|||
144412515|NCT02197130|520718600|FG000|Overall Study|Lost to Follow-up|2|||
144412516|NCT02197130|520718601|FG001|Overall Study|Lost to Follow-up|0|||
144412517|NCT02197130|520718602|FG002|Overall Study|Lost to Follow-up|1|||
144412518|NCT02197130|520718600|FG000|Overall Study|Does not meet entrance criteria|0|||
144722870|NCT04799158|521840574|FG002|Run-In Period|Lost to Follow-up|0|||
144722871|NCT04799158|521840575|FG003|Run-In Period|Lost to Follow-up|0|||
144722872|NCT04799158|521840576|FG004|Run-In Period|Lost to Follow-up|0|||
144722873|NCT04799158|521840572|FG000|Run-In Period|Significant Protocol Deviation|1|||
144722874|NCT04799158|521840573|FG001|Run-In Period|Significant Protocol Deviation|0|||
144412519|NCT02197130|520718601|FG001|Overall Study|Does not meet entrance criteria|0|||
144412520|NCT02197130|520718602|FG002|Overall Study|Does not meet entrance criteria|1|||
144722875|NCT04799158|521840574|FG002|Run-In Period|Significant Protocol Deviation|0|||
144722876|NCT04799158|521840575|FG003|Run-In Period|Significant Protocol Deviation|0|||
144722877|NCT04799158|521840576|FG004|Run-In Period|Significant Protocol Deviation|0|||
144722878|NCT04799158|521840572|FG000|Run-In Period|Withdrawal by Subject|11|||
144412521|NCT02197130|520718600|FG000|Overall Study|Withdrawal by Subject|0|||
144412522|NCT02197130|520718601|FG001|Overall Study|Withdrawal by Subject|3|||
144412523|NCT02197130|520718602|FG002|Overall Study|Withdrawal by Subject|4|||
144412524|NCT02197130|520718600|FG000|Overall Study|Other|1|||
144412525|NCT02197130|520718601|FG001|Overall Study|Other|0|||
144412526|NCT02197130|520718602|FG002|Overall Study|Other|3|||
144412527|NCT00317356|520718615|FG000|Overall Study|Adverse Event|0|||
144412528|NCT00317356|520718616|FG001|Overall Study|Adverse Event|0|||
144412529|NCT00317356|520718617|FG002|Overall Study|Adverse Event|1|||
144412530|NCT00317356|520718618|FG003|Overall Study|Adverse Event|0|||
144412531|NCT00317356|520718615|FG000|Overall Study|Lack of Efficacy|1|||
144412532|NCT00317356|520718616|FG001|Overall Study|Lack of Efficacy|1|||
144412533|NCT00317356|520718617|FG002|Overall Study|Lack of Efficacy|0|||
144412534|NCT00317356|520718618|FG003|Overall Study|Lack of Efficacy|3|||
144412535|NCT00317356|520718615|FG000|Overall Study|Physician Decision|0|||
144412536|NCT00317356|520718616|FG001|Overall Study|Physician Decision|1|||
144412537|NCT00317356|520718617|FG002|Overall Study|Physician Decision|0|||
144412538|NCT00317356|520718618|FG003|Overall Study|Physician Decision|0|||
144412539|NCT00684307|520720616|FG000|Overall Study|Adverse Event|11|||
144600336|NCT02554903|521399326|FG001|Overall Study|Physician Decision|2|||
144600337|NCT02554903|521399325|FG000|Overall Study|Heart Transplant|1|||
144600338|NCT02554903|521399326|FG001|Overall Study|Heart Transplant|2|||
144600339|NCT00639223|521399331|FG000|Overall Study|Lost to Follow-up|0|||
144600340|NCT00639223|521399332|FG001|Overall Study|Lost to Follow-up|2|||
144412540|NCT00684307|520720617|FG001|Overall Study|Adverse Event|6|||
144412541|NCT00684307|520720618|FG002|Overall Study|Adverse Event|15|||
144412542|NCT00684307|520720619|FG003|Overall Study|Adverse Event|16|||
144600341|NCT04226833|521399335|FG000|Overall Study|Death|0|||
144600342|NCT04226833|521399336|FG001|Overall Study|Death|0|||
144600343|NCT04226833|521399337|FG002|Overall Study|Death|1|||
144600344|NCT04226833|521399338|FG003|Overall Study|Death|0|||
144600345|NCT02540538|521399339|FG000|Overall Study|Pregnancy|0|||
144600346|NCT02540538|521399340|FG001|Overall Study|Pregnancy|1|||
144600347|NCT02540538|521399341|FG002|Overall Study|Pregnancy|0|||
144600348|NCT01472380|521399345|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
144600349|NCT01472380|521399345|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
144600350|NCT01557348|521399346|FG000|Overall Study|Adverse Event|6|||
144600351|NCT01557348|521399347|FG001|Overall Study|Adverse Event|16|||
144600352|NCT01557348|521399346|FG000|Overall Study|Infusion reaction event|5|||
144600353|NCT01557348|521399347|FG001|Overall Study|Infusion reaction event|5|||
144600354|NCT01557348|521399346|FG000|Overall Study|Death|7|||
144600355|NCT01557348|521399347|FG001|Overall Study|Death|4|||
144600356|NCT01557348|521399346|FG000|Overall Study|Insufficient Therapeutic Response|13|||
144600357|NCT01557348|521399347|FG001|Overall Study|Insufficient Therapeutic Response|28|||
144600358|NCT01557348|521399346|FG000|Overall Study|Withdrawal by Subject|5|||
144600359|NCT01557348|521399347|FG001|Overall Study|Withdrawal by Subject|4|||
144600360|NCT01557348|521399346|FG000|Overall Study|Lost to Follow-up|26|||
144600361|NCT01557348|521399347|FG001|Overall Study|Lost to Follow-up|22|||
144412543|NCT00684307|520720620|FG004|Overall Study|Adverse Event|8|||
144412544|NCT00684307|520720616|FG000|Overall Study|Development of increasing Liver Function|0|||
144600362|NCT01557348|521399346|FG000|Overall Study|Administrative|18|||
144600363|NCT01557348|521399347|FG001|Overall Study|Administrative|11|||
144600364|NCT00403754|521399348|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
144600365|NCT00403754|521399349|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
144600366|NCT00403754|521399350|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
144600367|NCT00403754|521399351|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
144600368|NCT00403754|521399348|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
144600369|NCT00403754|521399349|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
144600370|NCT00403754|521399350|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
144600371|NCT00403754|521399351|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
144600372|NCT02000427|521399356|FG000|Overall Study|Death|22|||
144600373|NCT03829319|521399357|FG000|Overall Study|Sponsor's Decision|4|||
144600374|NCT03829319|521399358|FG001|Overall Study|Sponsor's Decision|90|||
144600375|NCT03829319|521399359|FG002|Overall Study|Sponsor's Decision|102|||
144412545|NCT00684307|520720617|FG001|Overall Study|Development of increasing Liver Function|2|||
144412546|NCT00684307|520720618|FG002|Overall Study|Development of increasing Liver Function|0|||
144412547|NCT00684307|520720619|FG003|Overall Study|Development of increasing Liver Function|1|||
144412548|NCT00684307|520720620|FG004|Overall Study|Development of increasing Liver Function|0|||
144412549|NCT00684307|520720616|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
144600376|NCT03829319|521399357|FG000|Overall Study|Withdrawal by Subject|1|||
144600377|NCT03829319|521399358|FG001|Overall Study|Withdrawal by Subject|5|||
144600378|NCT03829319|521399359|FG002|Overall Study|Withdrawal by Subject|4|||
144600379|NCT03829319|521399357|FG000|Overall Study|Physician Decision|0|||
144722879|NCT04799158|521840573|FG001|Run-In Period|Withdrawal by Subject|0|||
144722880|NCT04799158|521840574|FG002|Run-In Period|Withdrawal by Subject|0|||
144722881|NCT04799158|521840575|FG003|Run-In Period|Withdrawal by Subject|0|||
144722882|NCT04799158|521840576|FG004|Run-In Period|Withdrawal by Subject|0|||
144722883|NCT04799158|521840572|FG000|Run-In Period|Miscellaneous|3|||
144722884|NCT04799158|521840573|FG001|Run-In Period|Miscellaneous|0|||
144722885|NCT04799158|521840574|FG002|Run-In Period|Miscellaneous|0|||
144722886|NCT04799158|521840575|FG003|Run-In Period|Miscellaneous|0|||
144722887|NCT04799158|521840576|FG004|Run-In Period|Miscellaneous|0|||
144722888|NCT04799158|521840572|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
144412550|NCT00684307|520720617|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
144412551|NCT00684307|520720618|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
144412552|NCT00684307|520720619|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
144412553|NCT00684307|520720620|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
144412554|NCT00684307|520720616|FG000|Overall Study|Incorrect enrolment or randomization|4|||
144412555|NCT00684307|520720617|FG001|Overall Study|Incorrect enrolment or randomization|0|||
144412556|NCT00684307|520720618|FG002|Overall Study|Incorrect enrolment or randomization|0|||
144412557|NCT00684307|520720619|FG003|Overall Study|Incorrect enrolment or randomization|0|||
144412558|NCT00684307|520720620|FG004|Overall Study|Incorrect enrolment or randomization|0|||
144412559|NCT00684307|520720616|FG000|Overall Study|Interupted IP for more than 7 days|0|||
144412560|NCT00684307|520720617|FG001|Overall Study|Interupted IP for more than 7 days|4|||
144412561|NCT00684307|520720618|FG002|Overall Study|Interupted IP for more than 7 days|1|||
144412562|NCT00684307|520720619|FG003|Overall Study|Interupted IP for more than 7 days|3|||
144412563|NCT00684307|520720620|FG004|Overall Study|Interupted IP for more than 7 days|3|||
144412564|NCT00684307|520720616|FG000|Overall Study|Severe non compliance to protocol|1|||
144412565|NCT00684307|520720617|FG001|Overall Study|Severe non compliance to protocol|0|||
144412566|NCT00684307|520720618|FG002|Overall Study|Severe non compliance to protocol|0|||
144412567|NCT00684307|520720619|FG003|Overall Study|Severe non compliance to protocol|1|||
144412568|NCT00684307|520720620|FG004|Overall Study|Severe non compliance to protocol|2|||
144412569|NCT00684307|520720616|FG000|Overall Study|Participant not willing to continue|7|||
144412570|NCT00684307|520720617|FG001|Overall Study|Participant not willing to continue|10|||
144412571|NCT00684307|520720618|FG002|Overall Study|Participant not willing to continue|11|||
144412572|NCT00684307|520720619|FG003|Overall Study|Participant not willing to continue|5|||
144412573|NCT00684307|520720620|FG004|Overall Study|Participant not willing to continue|8|||
144412574|NCT00684307|520720616|FG000|Overall Study|Criteria from the CSR|0|||
144412575|NCT00684307|520720617|FG001|Overall Study|Criteria from the CSR|0|||
144412576|NCT00684307|520720618|FG002|Overall Study|Criteria from the CSR|1|||
144412577|NCT00684307|520720619|FG003|Overall Study|Criteria from the CSR|3|||
144412578|NCT00684307|520720620|FG004|Overall Study|Criteria from the CSR|3|||
144412579|NCT00543140|520720621|FG000|Overall Study|Lost to Follow-up|33|||
144412580|NCT00543140|520720621|FG000|Overall Study|Withdrawal by Subject|13|||
144412581|NCT00543140|520720621|FG000|Overall Study|Protocol Violation|10|||
144412582|NCT00543140|520720621|FG000|Overall Study|Insufficient weight loss|10|||
144412583|NCT00543140|520720621|FG000|Overall Study|SAE leading to explant of SAGB|3|||
144412584|NCT00543140|520720621|FG000|Overall Study|Death|1|||
144412585|NCT00543140|520720621|FG000|Overall Study|Subject moved|1|||
144412586|NCT00543140|520720621|FG000|Overall Study|Conversion to different procedure|1|||
144412587|NCT02483520|520720622|FG000|Overall Study|Lost to Follow-up|3|||
144412588|NCT02483520|520720623|FG001|Overall Study|Lost to Follow-up|4|||
144412589|NCT02483520|520720622|FG000|Overall Study|Withdrawal by Subject|4|||
144412590|NCT02483520|520720623|FG001|Overall Study|Withdrawal by Subject|14|||
144412591|NCT02483520|520720622|FG000|Overall Study|Hospitalized|2|||
144412592|NCT02483520|520720623|FG001|Overall Study|Hospitalized|3|||
144412593|NCT02483520|520720622|FG000|Overall Study|Moved to LTC|2|||
144412594|NCT02483520|520720623|FG001|Overall Study|Moved to LTC|3|||
144412595|NCT02573311|520720626|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
144412596|NCT02573311|520720627|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
144412597|NCT02573311|520720626|FG000|Disposition for Part 2|Physician Decision|25|||
144412598|NCT02573311|520720627|FG001|Disposition for Part 2|Physician Decision|7|||
144412599|NCT02573311|520720626|FG000|Disposition for Part 2|Adverse Event|36|||
144412600|NCT02573311|520720627|FG001|Disposition for Part 2|Adverse Event|5|||
144412601|NCT02573311|520720626|FG000|Disposition for Part 2|Lost to Follow-up|76|||
144412602|NCT02573311|520720627|FG001|Disposition for Part 2|Lost to Follow-up|7|||
144412603|NCT02573311|520720626|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
144199336|NCT03107026|519928872|FG002|Overall Study|Withdrawal by Subject|17|||
144412604|NCT02573311|520720627|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
144412605|NCT02573311|520720626|FG000|Disposition for Part 2|Investigator decision|0|||
144722889|NCT04799158|521840573|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
144722890|NCT04799158|521840574|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
144412606|NCT02573311|520720627|FG001|Disposition for Part 2|Investigator decision|1|||
144412607|NCT02573311|520720626|FG000|Disposition for Part 2|Other than specified above|13|||
144412608|NCT02573311|520720627|FG001|Disposition for Part 2|Other than specified above|3|||
144412609|NCT04171531|520720629|FG000|Overall Study|Lost to Follow-up|4|||
144412610|NCT04171531|520720630|FG001|Overall Study|Lost to Follow-up|5|||
144412611|NCT04171531|520720629|FG000|Overall Study|Consent only through 6 months|1|||
144412612|NCT04171531|520720630|FG001|Overall Study|Consent only through 6 months|1|||
144412613|NCT04171531|520720629|FG000|Overall Study|Insurance did not cover procedure|0|||
144412614|NCT04171531|520720630|FG001|Overall Study|Insurance did not cover procedure|1|||
144412615|NCT04171531|520720629|FG000|Overall Study|Physician Decision|0|||
144412616|NCT04171531|520720630|FG001|Overall Study|Physician Decision|3|||
144412617|NCT04171531|520720629|FG000|Overall Study|Withdrawal by Subject|1|||
144412618|NCT04171531|520720630|FG001|Overall Study|Withdrawal by Subject|5|||
144412619|NCT04862585|520720634|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
144412620|NCT04862585|520720635|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
144412621|NCT04862585|520720634|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
144412622|NCT04862585|520720635|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
144412623|NCT04862585|520720634|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
144412624|NCT04862585|520720635|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
144412625|NCT04862585|520720634|FG000|Overall Study|one withdrew without providing a reason|0|||
144412626|NCT04862585|520720635|FG001|Overall Study|one withdrew without providing a reason|1|||
144412627|NCT03366337|520720638|FG000|Overall Study|Lost to Follow-up|1|||
144412628|NCT03366337|520720639|FG001|Overall Study|Lost to Follow-up|0|||
144412629|NCT03366337|520720640|FG002|Overall Study|Lost to Follow-up|1|||
144412630|NCT03366337|520720641|FG003|Overall Study|Lost to Follow-up|0|||
144412631|NCT03366337|520720638|FG000|Overall Study|Withdrawal by Subject|2|||
144412632|NCT03366337|520720639|FG001|Overall Study|Withdrawal by Subject|0|||
144412633|NCT03366337|520720640|FG002|Overall Study|Withdrawal by Subject|1|||
144412634|NCT03366337|520720641|FG003|Overall Study|Withdrawal by Subject|1|||
144412635|NCT05288062|520720642|FG000|Overall Study|Ineligible|0|||
144412636|NCT05288062|520720643|FG001|Overall Study|Ineligible|0|||
144412637|NCT05288062|520720644|FG002|Overall Study|Ineligible|1|||
144412638|NCT05288062|520720645|FG003|Overall Study|Ineligible|0|||
144412639|NCT05288062|520720642|FG000|Overall Study|Withdrawal by Subject|0|||
144412640|NCT05288062|520720643|FG001|Overall Study|Withdrawal by Subject|0|||
144412641|NCT05288062|520720644|FG002|Overall Study|Withdrawal by Subject|1|||
144412642|NCT05288062|520720645|FG003|Overall Study|Withdrawal by Subject|0|||
144412643|NCT01025752|520720649|FG000|Overall Study|Lost to Follow-up|7|||
144412644|NCT01025752|520720650|FG001|Overall Study|Lost to Follow-up|10|||
144412645|NCT01025752|520720649|FG000|Overall Study|Physician Decision|1|||
144412646|NCT01025752|520720650|FG001|Overall Study|Physician Decision|3|||
144412647|NCT01537393|520720653|FG000|Overall Study|Exclude prior to study|32|||
144412648|NCT01537393|520720654|FG001|Overall Study|Exclude prior to study|44|||
144412649|NCT01537393|520720653|FG000|Overall Study|Death|20|||
144412650|NCT01537393|520720654|FG001|Overall Study|Death|32|||
144412651|NCT01537393|520720653|FG000|Overall Study|Withdrawal by Subject|18|||
144412652|NCT01537393|520720654|FG001|Overall Study|Withdrawal by Subject|17|||
144412653|NCT01537393|520720653|FG000|Overall Study|Lost to Follow-up|53|||
144412654|NCT01537393|520720654|FG001|Overall Study|Lost to Follow-up|48|||
144412655|NCT01537393|520720653|FG000|Overall Study|Failure - Regrafted|28|||
144412656|NCT01537393|520720654|FG001|Overall Study|Failure - Regrafted|43|||
144412657|NCT01537393|520720653|FG000|Overall Study|Failure - Not regrafted|2|||
144412658|NCT01537393|520720654|FG001|Overall Study|Failure - Not regrafted|6|||
144412659|NCT01537393|520720653|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
144412660|NCT01537393|520720654|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
144412661|NCT01697566|520720655|FG000|Overall Study|Withdrawal by Subject|0|||
144412662|NCT01697566|520720656|FG001|Overall Study|Withdrawal by Subject|0|||
144412663|NCT01697566|520720657|FG002|Overall Study|Withdrawal by Subject|1|||
144412664|NCT01697566|520720658|FG003|Overall Study|Withdrawal by Subject|1|||
144412665|NCT01697566|520720655|FG000|Overall Study|Final biopsy not obtained|0|||
144412666|NCT01697566|520720656|FG001|Overall Study|Final biopsy not obtained|0|||
144412667|NCT01697566|520720657|FG002|Overall Study|Final biopsy not obtained|1|||
144412668|NCT01697566|520720658|FG003|Overall Study|Final biopsy not obtained|0|||
144412669|NCT00459953|520720659|FG000|Overall Study|not analyzed-household member in study|1|||
144412670|NCT00459953|520720660|FG001|Overall Study|not analyzed-household member in study|1|||
144412671|NCT01447433|520720661|FG000|Overall Study|Lost to Follow-up|0|||
144412672|NCT01447433|520720662|FG001|Overall Study|Lost to Follow-up|2|||
144412673|NCT01447433|520720661|FG000|Overall Study|Withdrawal by Subject|3|||
144412674|NCT01447433|520720662|FG001|Overall Study|Withdrawal by Subject|3|||
144412675|NCT01447433|520720661|FG000|Overall Study|Protocol Violation|1|||
144412676|NCT01447433|520720662|FG001|Overall Study|Protocol Violation|1|||
144412677|NCT01578187|520720663|FG000|Usability Phase|Withdrawal by Subject|1|||
144412678|NCT01370356|520720668|FG000|Overall Study|Death|1|||
144412679|NCT01370356|520720669|FG001|Overall Study|Death|0|||
144412680|NCT01370356|520720668|FG000|Overall Study|Lack of Efficacy|6|||
144412681|NCT01370356|520720669|FG001|Overall Study|Lack of Efficacy|28|||
144412682|NCT01370356|520720668|FG000|Overall Study|Lost to Follow-up|76|||
144412683|NCT01370356|520720669|FG001|Overall Study|Lost to Follow-up|81|||
144412684|NCT01370356|520720668|FG000|Overall Study|Withdrawal by Subject|54|||
144412685|NCT01370356|520720669|FG001|Overall Study|Withdrawal by Subject|59|||
144412686|NCT01370356|520720668|FG000|Overall Study|Reason not specified|39|||
144412687|NCT01370356|520720669|FG001|Overall Study|Reason not specified|43|||
144412688|NCT01370356|520720668|FG000|Overall Study|Protocol Violation|3|||
144412689|NCT01370356|520720669|FG001|Overall Study|Protocol Violation|3|||
144600380|NCT03829319|521399358|FG001|Overall Study|Physician Decision|3|||
144412690|NCT01370356|520720668|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
144412691|NCT01370356|520720669|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
144600381|NCT03829319|521399359|FG002|Overall Study|Physician Decision|0|||
144600382|NCT03829319|521399357|FG000|Overall Study|Lost to Follow-up|0|||
144600383|NCT03829319|521399358|FG001|Overall Study|Lost to Follow-up|0|||
144600384|NCT03829319|521399359|FG002|Overall Study|Lost to Follow-up|1|||
144600385|NCT03829319|521399357|FG000|Overall Study|Death|8|||
144600386|NCT03829319|521399358|FG001|Overall Study|Death|277|||
144600387|NCT03829319|521399359|FG002|Overall Study|Death|266|||
144600388|NCT02846532|521399360|FG000|Overall Study|Lost to Follow-up|0|||
144600389|NCT02846532|521399361|FG001|Overall Study|Lost to Follow-up|1|||
144600390|NCT02846532|521399362|FG002|Overall Study|Lost to Follow-up|1|||
144600391|NCT02846532|521399360|FG000|Overall Study|Withdrawal by Subject|1|||
144600392|NCT02846532|521399361|FG001|Overall Study|Withdrawal by Subject|2|||
144600393|NCT02846532|521399362|FG002|Overall Study|Withdrawal by Subject|0|||
144600394|NCT04484259|521399363|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
144600395|NCT04484259|521399364|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
144600396|NCT04484259|521399365|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
144600397|NCT04484259|521399366|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
144600398|NCT04484259|521399367|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
144600399|NCT04484259|521399363|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
144600400|NCT04484259|521399364|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
144600401|NCT04484259|521399365|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
144600402|NCT04484259|521399366|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
144600403|NCT04484259|521399367|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
144600404|NCT04484259|521399363|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
144600405|NCT04484259|521399364|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
144600406|NCT04484259|521399365|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
144600407|NCT04484259|521399366|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
144600408|NCT04484259|521399367|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
144600409|NCT04484259|521399363|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
144412692|NCT01370356|520720668|FG000|Overall Study|AE Not Related to Study Drug|1|||
144412693|NCT01370356|520720669|FG001|Overall Study|AE Not Related to Study Drug|4|||
144412694|NCT01709162|520720672|FG000|Overall Study|Disease progression|3|||
144526765|NCT02601313|521129311|FG001|Overall Study|Full consent withdrawal|3|||
144526766|NCT02601313|521129312|FG002|Overall Study|Full consent withdrawal|2|||
144526767|NCT02601313|521129310|FG000|Overall Study|Lost to Follow-up|0|||
144526768|NCT02601313|521129311|FG001|Overall Study|Lost to Follow-up|1|||
144526769|NCT02601313|521129312|FG002|Overall Study|Lost to Follow-up|1|||
144526770|NCT03459729|521129313|FG000|Overall Study|Physician Decision|2|||
144526771|NCT06182033|521129314|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
144526772|NCT06182033|521129315|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
144526773|NCT06182033|521129314|FG000|Overall Study|Target child relocation|1|||
144526774|NCT06182033|521129315|FG001|Overall Study|Target child relocation|1|||
144526775|NCT06182033|521129314|FG000|Overall Study|Withdrawal by Subject|1|||
144526776|NCT06182033|521129315|FG001|Overall Study|Withdrawal by Subject|0|||
144526777|NCT05704543|521129316|FG000|Overall Study|Withdrawal by Subject|1|||
144526778|NCT05704543|521129317|FG001|Overall Study|Withdrawal by Subject|1|||
144526779|NCT05704543|521129318|FG002|Overall Study|Withdrawal by Subject|0|||
144526780|NCT05704543|521129319|FG003|Overall Study|Withdrawal by Subject|2|||
144250230|NCT01094782|520113506|FG000|Overall Study|Wrong Pain Condition|0|||
144526781|NCT05704543|521129316|FG000|Overall Study|Lost to Follow-up|1|||
144526782|NCT05704543|521129317|FG001|Overall Study|Lost to Follow-up|2|||
144250231|NCT01094782|520113507|FG001|Overall Study|Wrong Pain Condition|0|||
144526783|NCT05704543|521129318|FG002|Overall Study|Lost to Follow-up|0|||
144526784|NCT05704543|521129319|FG003|Overall Study|Lost to Follow-up|0|||
144526785|NCT03257410|521131762|FG000|Overall Study|Adverse Event|2|||
144526786|NCT03257410|521131763|FG001|Overall Study|Adverse Event|3|||
144526787|NCT03257410|521131762|FG000|Overall Study|Protocol Violation|1|||
144526788|NCT03257410|521131763|FG001|Overall Study|Protocol Violation|2|||
144526789|NCT03257410|521131762|FG000|Overall Study|Lost to Follow-up|1|||
144250232|NCT01094782|520113508|FG002|Overall Study|Wrong Pain Condition|0|||
144526790|NCT03257410|521131763|FG001|Overall Study|Lost to Follow-up|0|||
144526791|NCT03257410|521131762|FG000|Overall Study|Withdrawal by Subject|1|||
144412695|NCT01709162|520720673|FG001|Overall Study|Disease progression|3|||
144412696|NCT01709162|520720672|FG000|Overall Study|Study drug toxicity|2|||
144412697|NCT01709162|520720673|FG001|Overall Study|Study drug toxicity|0|||
144412698|NCT01709162|520720672|FG000|Overall Study|Administrative reason by sponsor|0|||
144412699|NCT01709162|520720673|FG001|Overall Study|Administrative reason by sponsor|1|||
144412700|NCT01709162|520720672|FG000|Overall Study|Other|1|||
144412701|NCT01709162|520720673|FG001|Overall Study|Other|0|||
144412702|NCT01709162|520720672|FG000|Overall Study|Withdrawal by Subject|0|||
144412703|NCT01709162|520720673|FG001|Overall Study|Withdrawal by Subject|1|||
144412704|NCT01233258|520720675|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
144600410|NCT04484259|521399364|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
144600411|NCT04484259|521399365|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
144600412|NCT04484259|521399366|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
144600413|NCT04484259|521399367|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
144600414|NCT04484259|521399363|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
144600415|NCT04484259|521399364|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
144600416|NCT04484259|521399365|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
144600417|NCT04484259|521399366|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
144600418|NCT04484259|521399367|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
144600419|NCT04484259|521399363|FG000|Randomized Treatment|Withdrawal by Subject|1|||
144600420|NCT04484259|521399364|FG001|Randomized Treatment|Withdrawal by Subject|0|||
144722891|NCT04799158|521840575|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
144722892|NCT04799158|521840576|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
144722893|NCT04799158|521840572|FG000|On-Demand Treatment Period|Adverse Event|0|||
144600421|NCT04484259|521399365|FG002|Randomized Treatment|Withdrawal by Subject|0|||
144600422|NCT04484259|521399366|FG003|Randomized Treatment|Withdrawal by Subject|0|||
144600423|NCT04484259|521399367|FG004|Randomized Treatment|Withdrawal by Subject|0|||
144250233|NCT01094782|520113509|FG003|Overall Study|Wrong Pain Condition|2|||
144412705|NCT01233258|520720676|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
144412706|NCT01233258|520720677|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
144412707|NCT01233258|520720678|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
144600424|NCT03951220|521399368|FG000|Overall Study|Withdrawal by Subject|9|||
144722894|NCT04799158|521840573|FG001|On-Demand Treatment Period|Adverse Event|1|||
144250234|NCT01094782|520113510|FG004|Overall Study|Wrong Pain Condition|1|||
144412708|NCT01233258|520720679|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
144412709|NCT01233258|520720680|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
144412710|NCT01233258|520720675|FG000|First Intervention (6 Months)|Protocol Violation|0|||
144412711|NCT01233258|520720676|FG001|First Intervention (6 Months)|Protocol Violation|0|||
144412712|NCT01233258|520720677|FG002|First Intervention (6 Months)|Protocol Violation|1|||
144412713|NCT01233258|520720678|FG003|First Intervention (6 Months)|Protocol Violation|0|||
144412714|NCT01233258|520720679|FG004|First Intervention (6 Months)|Protocol Violation|0|||
144412715|NCT01233258|520720680|FG005|First Intervention (6 Months)|Protocol Violation|0|||
144526792|NCT03257410|521131763|FG001|Overall Study|Withdrawal by Subject|2|||
144526793|NCT03257410|521131762|FG000|Overall Study|Physician Decision|1|||
144526794|NCT03257410|521131763|FG001|Overall Study|Physician Decision|1|||
144526795|NCT03257410|521131762|FG000|Overall Study|Renal transplantation|2|||
144526796|NCT03257410|521131763|FG001|Overall Study|Renal transplantation|0|||
144526797|NCT03257410|521131762|FG000|Overall Study|Switch to peritoneal dialysis|1|||
144526798|NCT03257410|521131763|FG001|Overall Study|Switch to peritoneal dialysis|0|||
144526799|NCT03257410|521131762|FG000|Overall Study|Death|3|||
144526800|NCT03257410|521131763|FG001|Overall Study|Death|2|||
144526801|NCT03257410|521131762|FG000|Overall Study|Change to another dialysis center|2|||
144526802|NCT03257410|521131763|FG001|Overall Study|Change to another dialysis center|2|||
144526803|NCT03257410|521131762|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
144526804|NCT03257410|521131763|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
144526805|NCT03257410|521131762|FG000|Overall Study|Miscellaneous|2|||
144526806|NCT03257410|521131763|FG001|Overall Study|Miscellaneous|2|||
144526807|NCT03257410|521131762|FG000|Overall Study|Other|0|||
144526808|NCT03257410|521131763|FG001|Overall Study|Other|1|||
144526809|NCT00433329|521131764|FG000|Overall Study|Adverse Event|9|||
144526810|NCT00433329|521131764|FG000|Overall Study|Death|4|||
144526811|NCT00433329|521131764|FG000|Overall Study|Withdrew consent|3|||
144526812|NCT00433329|521131764|FG000|Overall Study|Discontinued sildenafil|2|||
144526813|NCT00433329|521131764|FG000|Overall Study|Moved out of state|1|||
144526814|NCT00433329|521131764|FG000|Overall Study|Lost to Follow-up|1|||
144526815|NCT00433329|521131764|FG000|Overall Study|Physician Decision|1|||
144526816|NCT03381196|521131765|FG000|Overall Study|Withdrawal by Subject|7|||
144526817|NCT03381196|521131766|FG001|Overall Study|Withdrawal by Subject|7|||
144526818|NCT03381196|521131765|FG000|Overall Study|Other|0|||
144526819|NCT03381196|521131766|FG001|Overall Study|Other|1|||
144526820|NCT03381196|521131765|FG000|Overall Study|Lost to Follow-up|5|||
144526821|NCT03381196|521131766|FG001|Overall Study|Lost to Follow-up|4|||
144526822|NCT03381196|521131765|FG000|Overall Study|Death|0|||
144526823|NCT03381196|521131766|FG001|Overall Study|Death|1|||
144526824|NCT03381196|521131765|FG000|Overall Study|Adverse Event|1|||
144526825|NCT03381196|521131766|FG001|Overall Study|Adverse Event|0|||
144526826|NCT03381196|521131765|FG000|Overall Study|Randomized, not treated|3|||
144526827|NCT03381196|521131766|FG001|Overall Study|Randomized, not treated|6|||
144526828|NCT03628924|521131770|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
144526829|NCT03628924|521131771|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
144526830|NCT03628924|521131772|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
144526831|NCT03628924|521131773|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
144526832|NCT03628924|521131774|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
144526833|NCT03628924|521131775|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
144526834|NCT03628924|521131776|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
144526835|NCT03628924|521131770|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144526836|NCT03628924|521131771|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144526837|NCT03628924|521131772|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
144526838|NCT03628924|521131773|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144526839|NCT03628924|521131774|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144526840|NCT03628924|521131775|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144526841|NCT03628924|521131776|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144526842|NCT03628924|521131770|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
144526843|NCT03628924|521131771|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
144526844|NCT03628924|521131772|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
144526845|NCT03628924|521131773|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
144526846|NCT03628924|521131774|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
144526847|NCT03628924|521131775|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
144526848|NCT03628924|521131776|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
144526849|NCT03628924|521131770|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144412716|NCT01233258|520720675|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
144412717|NCT01233258|520720676|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
144412718|NCT01233258|520720677|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
144526850|NCT03628924|521131771|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
144526851|NCT03628924|521131772|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144526852|NCT03628924|521131773|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144526853|NCT03628924|521131774|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144250235|NCT01094782|520113511|FG005|Overall Study|Wrong Pain Condition|1|||
144250236|NCT01094782|520113506|FG000|Overall Study|Recent Interventional Injection|0|||
144250237|NCT01094782|520113507|FG001|Overall Study|Recent Interventional Injection|0|||
144250238|NCT01094782|520113508|FG002|Overall Study|Recent Interventional Injection|0|||
144250239|NCT01094782|520113509|FG003|Overall Study|Recent Interventional Injection|0|||
144250240|NCT01094782|520113510|FG004|Overall Study|Recent Interventional Injection|0|||
144250241|NCT01094782|520113511|FG005|Overall Study|Recent Interventional Injection|1|||
144250242|NCT01094782|520113506|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
144250243|NCT01094782|520113507|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
144250244|NCT01094782|520113508|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
144250245|NCT01094782|520113509|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
144250246|NCT01094782|520113510|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
144250247|NCT01094782|520113511|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
144250248|NCT01094782|520113506|FG000|Overall Study|Noncompliance With Study Schedule|0|||
144250249|NCT01094782|520113507|FG001|Overall Study|Noncompliance With Study Schedule|0|||
144250250|NCT01094782|520113508|FG002|Overall Study|Noncompliance With Study Schedule|0|||
144250251|NCT01094782|520113509|FG003|Overall Study|Noncompliance With Study Schedule|1|||
144250252|NCT01094782|520113510|FG004|Overall Study|Noncompliance With Study Schedule|0|||
144250253|NCT01094782|520113511|FG005|Overall Study|Noncompliance With Study Schedule|0|||
144250254|NCT00957905|520113513|FG000|Part B|Not Treated|0|||
144250255|NCT00957905|520113514|FG001|Part B|Not Treated|1|||
144250256|NCT00957905|520113513|FG000|Part B|Physician Decision|0|||
144250257|NCT00957905|520113514|FG001|Part B|Physician Decision|1|||
144250258|NCT00957905|520113513|FG000|Part B|Death|0|||
144250259|NCT00957905|520113514|FG001|Part B|Death|1|||
144250260|NCT00957905|520113513|FG000|Part B|Protocol Violation|0|||
144250261|NCT00957905|520113514|FG001|Part B|Protocol Violation|1|||
144250262|NCT02073656|520113515|FG000|Primary Study|Lost to Follow-up|6|||
144250263|NCT02073656|520113515|FG000|Primary Study|Death|1|||
144250264|NCT02073656|520113515|FG000|Primary Study|Withdrew Consent|1|||
144250265|NCT01987232|520113516|FG000|Overall Study|Ongoing in Study|0|||
144250266|NCT01987232|520113517|FG001|Overall Study|Ongoing in Study|0|||
144250267|NCT01987232|520113518|FG002|Overall Study|Ongoing in Study|0|||
144250268|NCT01987232|520113519|FG003|Overall Study|Ongoing in Study|1|||
144250269|NCT01987232|520113520|FG004|Overall Study|Ongoing in Study|0|||
144250270|NCT01952080|520113521|FG000|Overall Study|Withdrawal by Subject|0|||
144250271|NCT01952080|520113522|FG001|Overall Study|Withdrawal by Subject|0|||
144250272|NCT01952080|520113523|FG002|Overall Study|Withdrawal by Subject|0|||
144250273|NCT01952080|520113524|FG003|Overall Study|Withdrawal by Subject|1|||
144250274|NCT01952080|520113521|FG000|Overall Study|Protocol Non-compliance|0|||
144250275|NCT01952080|520113522|FG001|Overall Study|Protocol Non-compliance|1|||
144250276|NCT01952080|520113523|FG002|Overall Study|Protocol Non-compliance|0|||
144250277|NCT01952080|520113524|FG003|Overall Study|Protocol Non-compliance|0|||
144250278|NCT02028169|520113525|FG000|Overall Study|Lost to Follow-up|21|||
144250279|NCT02028169|520113525|FG000|Overall Study|Lack of Efficacy|2|||
144250280|NCT02028169|520113525|FG000|Overall Study|Withdrawal by Subject|2|||
144250281|NCT02028169|520113525|FG000|Overall Study|Adverse Event|1|||
144250282|NCT02028169|520113525|FG000|Overall Study|Cessation of Drug|1|||
144250283|NCT02028169|520113525|FG000|Overall Study|Concomitant Medication Usage|1|||
144250284|NCT02258334|520113528|FG000|Overall Study|Adverse Event|1|||
144250285|NCT02258334|520113529|FG001|Overall Study|Adverse Event|0|||
144250286|NCT02258334|520113530|FG002|Overall Study|Adverse Event|0|||
144250287|NCT02258334|520113531|FG003|Overall Study|Adverse Event|0|||
144250288|NCT01969084|520113532|FG000|Overall Study|Adverse Event|0|||
144250289|NCT01969084|520113533|FG001|Overall Study|Adverse Event|1|||
144412719|NCT01233258|520720678|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
144412720|NCT01233258|520720679|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
144412721|NCT01233258|520720680|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
144412722|NCT04584645|520720681|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
144412723|NCT04584645|520720682|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
144412724|NCT00390468|520720683|FG000|Overall Study|Protocol Violation|2|||
144412725|NCT00390468|520720683|FG000|Overall Study|Lack of Efficacy|1|||
144412726|NCT03926169|520720690|FG000|Period A|Adverse Event|2|||
144250290|NCT03723070|520113538|FG000|Overall Study|Lost to Follow-up|2|||
144250291|NCT03723070|520113538|FG000|Overall Study|Physician Decision|1|||
144412727|NCT03926169|520720691|FG001|Period A|Adverse Event|2|||
144250292|NCT03723070|520113538|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
144250293|NCT02208050|520113539|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
144250294|NCT02208050|520113540|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
144526854|NCT03628924|521131775|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144250295|NCT00477607|520113541|FG000|Overall Study|Lost to Follow-up|7|||
144250296|NCT00477607|520113542|FG001|Overall Study|Lost to Follow-up|7|||
144250297|NCT01732471|520113543|FG000|Overall Study|Withdrawal by Subject|1|||
144250298|NCT02892513|520113546|FG000|Overall Study|Withdrawal by Subject|0|||
144412728|NCT03926169|520720692|FG002|Period A|Adverse Event|1|||
144412729|NCT03926169|520720690|FG000|Period A|Withdrawal by Subject|2|||
144412730|NCT03926169|520720691|FG001|Period A|Withdrawal by Subject|2|||
144412731|NCT03926169|520720692|FG002|Period A|Withdrawal by Subject|2|||
144412732|NCT03926169|520720690|FG000|Period A|Lost to Follow-up|3|||
144412733|NCT03926169|520720691|FG001|Period A|Lost to Follow-up|1|||
144412734|NCT03926169|520720692|FG002|Period A|Lost to Follow-up|0|||
144412735|NCT03926169|520720690|FG000|Period A|Lack of Efficacy|0|||
144412736|NCT03926169|520720691|FG001|Period A|Lack of Efficacy|2|||
144412737|NCT03926169|520720692|FG002|Period A|Lack of Efficacy|2|||
144412738|NCT03926169|520720690|FG000|Period A|COVID-19 Infection|0|||
144412739|NCT03926169|520720691|FG001|Period A|COVID-19 Infection|1|||
144412740|NCT03926169|520720692|FG002|Period A|COVID-19 Infection|0|||
144412741|NCT03926169|520720690|FG000|Period A|COVID-19 Logistical Restrictions|0|||
144412742|NCT03926169|520720691|FG001|Period A|COVID-19 Logistical Restrictions|2|||
144412743|NCT03926169|520720692|FG002|Period A|COVID-19 Logistical Restrictions|1|||
144412744|NCT03926169|520720690|FG000|Period A|Other, Not Specified|1|||
144412745|NCT03926169|520720691|FG001|Period A|Other, Not Specified|0|||
144412746|NCT03926169|520720692|FG002|Period A|Other, Not Specified|0|||
144412747|NCT03926169|520720690|FG000|Period B|Adverse Event|3|||
144412748|NCT03926169|520720691|FG001|Period B|Adverse Event|1|||
144412749|NCT03926169|520720692|FG002|Period B|Adverse Event|1|||
144412750|NCT03926169|520720690|FG000|Period B|Withdrawal by Subject|1|||
144412751|NCT03926169|520720691|FG001|Period B|Withdrawal by Subject|3|||
144412752|NCT03926169|520720692|FG002|Period B|Withdrawal by Subject|0|||
144412753|NCT03926169|520720690|FG000|Period B|Lack of Efficacy|3|||
144412754|NCT03926169|520720691|FG001|Period B|Lack of Efficacy|1|||
144412755|NCT03926169|520720692|FG002|Period B|Lack of Efficacy|1|||
144412756|NCT03926169|520720690|FG000|Period B|Lost to Follow-up|1|||
144412757|NCT03926169|520720691|FG001|Period B|Lost to Follow-up|1|||
144412758|NCT03926169|520720692|FG002|Period B|Lost to Follow-up|4|||
144412759|NCT03926169|520720690|FG000|Period B|Other, Not Specified|62|||
144412760|NCT03926169|520720691|FG001|Period B|Other, Not Specified|57|||
144412761|NCT03926169|520720692|FG002|Period B|Other, Not Specified|65|||
144412762|NCT03708328|520720695|FG000|Overall Study|Death|3|||
144412763|NCT03708328|520720696|FG001|Overall Study|Death|3|||
144412764|NCT03708328|520720697|FG002|Overall Study|Death|4|||
144412765|NCT03708328|520720698|FG003|Overall Study|Death|2|||
144412766|NCT03708328|520720699|FG004|Overall Study|Death|2|||
144412767|NCT03708328|520720700|FG005|Overall Study|Death|13|||
144412768|NCT03708328|520720701|FG006|Overall Study|Death|26|||
144412769|NCT03708328|520720702|FG007|Overall Study|Death|18|||
144412770|NCT03708328|520720703|FG008|Overall Study|Death|13|||
144412771|NCT03708328|520720704|FG009|Overall Study|Death|8|||
144412772|NCT03708328|520720695|FG000|Overall Study|Lost to Follow-up|0|||
144412773|NCT03708328|520720696|FG001|Overall Study|Lost to Follow-up|1|||
144412774|NCT03708328|520720697|FG002|Overall Study|Lost to Follow-up|0|||
144412775|NCT03708328|520720698|FG003|Overall Study|Lost to Follow-up|1|||
144412776|NCT03708328|520720699|FG004|Overall Study|Lost to Follow-up|0|||
144412777|NCT03708328|520720700|FG005|Overall Study|Lost to Follow-up|3|||
144412778|NCT03708328|520720701|FG006|Overall Study|Lost to Follow-up|3|||
144412779|NCT03708328|520720702|FG007|Overall Study|Lost to Follow-up|0|||
144412780|NCT03708328|520720703|FG008|Overall Study|Lost to Follow-up|0|||
144412781|NCT03708328|520720704|FG009|Overall Study|Lost to Follow-up|1|||
144412782|NCT03708328|520720695|FG000|Overall Study|Physician Decision|0|||
144412783|NCT03708328|520720696|FG001|Overall Study|Physician Decision|0|||
144412784|NCT03708328|520720697|FG002|Overall Study|Physician Decision|0|||
144412785|NCT03708328|520720698|FG003|Overall Study|Physician Decision|0|||
144412786|NCT03708328|520720699|FG004|Overall Study|Physician Decision|0|||
144412787|NCT03708328|520720700|FG005|Overall Study|Physician Decision|1|||
144412788|NCT03708328|520720701|FG006|Overall Study|Physician Decision|0|||
144412789|NCT03708328|520720702|FG007|Overall Study|Physician Decision|0|||
144412790|NCT03708328|520720703|FG008|Overall Study|Physician Decision|0|||
144412791|NCT03708328|520720704|FG009|Overall Study|Physician Decision|0|||
144412792|NCT03708328|520720695|FG000|Overall Study|Withdrawal by Subject|0|||
144412793|NCT03708328|520720696|FG001|Overall Study|Withdrawal by Subject|0|||
144412794|NCT03708328|520720697|FG002|Overall Study|Withdrawal by Subject|0|||
144412795|NCT03708328|520720698|FG003|Overall Study|Withdrawal by Subject|0|||
144412796|NCT03708328|520720699|FG004|Overall Study|Withdrawal by Subject|1|||
144412797|NCT03708328|520720700|FG005|Overall Study|Withdrawal by Subject|0|||
144412798|NCT03708328|520720701|FG006|Overall Study|Withdrawal by Subject|2|||
144412799|NCT03708328|520720702|FG007|Overall Study|Withdrawal by Subject|4|||
144412800|NCT03708328|520720703|FG008|Overall Study|Withdrawal by Subject|1|||
144412801|NCT03708328|520720704|FG009|Overall Study|Withdrawal by Subject|5|||
144412802|NCT03708328|520720695|FG000|Overall Study|Study Closed Locally|0|||
144412803|NCT03708328|520720696|FG001|Overall Study|Study Closed Locally|0|||
144412804|NCT03708328|520720697|FG002|Overall Study|Study Closed Locally|0|||
144412805|NCT03708328|520720698|FG003|Overall Study|Study Closed Locally|0|||
144412806|NCT03708328|520720699|FG004|Overall Study|Study Closed Locally|0|||
144412807|NCT03708328|520720700|FG005|Overall Study|Study Closed Locally|0|||
144412808|NCT03708328|520720701|FG006|Overall Study|Study Closed Locally|0|||
144412809|NCT03708328|520720702|FG007|Overall Study|Study Closed Locally|1|||
144412810|NCT03708328|520720703|FG008|Overall Study|Study Closed Locally|0|||
144250299|NCT02892513|520113547|FG001|Overall Study|Withdrawal by Subject|1|||
144250300|NCT00432276|520113548|FG000|Overall Study|Hyperglycemic Rescue|44|||
144250301|NCT00432276|520113549|FG001|Overall Study|Hyperglycemic Rescue|87|||
144250302|NCT00432276|520113548|FG000|Overall Study|Adverse Event|13|||
144250303|NCT00432276|520113549|FG001|Overall Study|Adverse Event|16|||
144250304|NCT00432276|520113548|FG000|Overall Study|Protocol Violation|25|||
144412811|NCT03708328|520720704|FG009|Overall Study|Study Closed Locally|0|||
144412812|NCT03708328|520720695|FG000|Overall Study|Study Ended By Sponsor|0|||
144412813|NCT03708328|520720696|FG001|Overall Study|Study Ended By Sponsor|0|||
144412814|NCT03708328|520720697|FG002|Overall Study|Study Ended By Sponsor|0|||
144600425|NCT03951220|521399369|FG001|Overall Study|Withdrawal by Subject|2|||
144600426|NCT03951220|521399370|FG002|Overall Study|Withdrawal by Subject|0|||
144600427|NCT04498832|521399371|FG000|Overall Study|Adverse Event|1|||
144600428|NCT04498832|521399372|FG001|Overall Study|Adverse Event|3|||
144600429|NCT04498832|521399371|FG000|Overall Study|Withdrawal by Subject|0|||
144600430|NCT04498832|521399372|FG001|Overall Study|Withdrawal by Subject|1|||
144600431|NCT05359003|521399373|FG000|Overall Study|Withdrawal by Subject|1|||
144600432|NCT05359003|521399374|FG001|Overall Study|Withdrawal by Subject|3|||
144600433|NCT01313650|521399377|FG000|Overall Study|Adverse Event|9|||
144600434|NCT01313650|521399378|FG001|Overall Study|Adverse Event|34|||
144600435|NCT01313650|521399379|FG002|Overall Study|Adverse Event|24|||
144600436|NCT01313650|521399380|FG003|Overall Study|Adverse Event|23|||
144600437|NCT01313650|521399377|FG000|Overall Study|Lack of Efficacy|37|||
144600438|NCT01313650|521399378|FG001|Overall Study|Lack of Efficacy|20|||
144600439|NCT01313650|521399379|FG002|Overall Study|Lack of Efficacy|32|||
144600440|NCT01313650|521399380|FG003|Overall Study|Lack of Efficacy|20|||
144600441|NCT01313650|521399377|FG000|Overall Study|Lost to Follow-up|1|||
144600442|NCT01313650|521399378|FG001|Overall Study|Lost to Follow-up|0|||
144600443|NCT01313650|521399379|FG002|Overall Study|Lost to Follow-up|3|||
144600444|NCT01313650|521399380|FG003|Overall Study|Lost to Follow-up|2|||
144600445|NCT01313650|521399377|FG000|Overall Study|Withdrawal by Subject|16|||
144600446|NCT01313650|521399378|FG001|Overall Study|Withdrawal by Subject|20|||
144600447|NCT01313650|521399379|FG002|Overall Study|Withdrawal by Subject|15|||
144600448|NCT01313650|521399380|FG003|Overall Study|Withdrawal by Subject|15|||
144600449|NCT01313650|521399377|FG000|Overall Study|Protocol Violation|4|||
144600450|NCT01313650|521399378|FG001|Overall Study|Protocol Violation|7|||
144600451|NCT01313650|521399379|FG002|Overall Study|Protocol Violation|5|||
144600452|NCT01313650|521399380|FG003|Overall Study|Protocol Violation|6|||
144600453|NCT01313650|521399377|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
144600454|NCT01313650|521399378|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
144600455|NCT01313650|521399379|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
144600456|NCT01313650|521399380|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
144600457|NCT05393037|521399383|FG000|Part A|Death|1|||
144600458|NCT05393037|521399384|FG001|Part A|Death|0|||
144600459|NCT05393037|521399383|FG000|Part A|Lost to Follow-up|1|||
144600460|NCT05393037|521399384|FG001|Part A|Lost to Follow-up|1|||
144600461|NCT05393037|521399383|FG000|Part A|Withdrawal by Subject|2|||
144600462|NCT05393037|521399384|FG001|Part A|Withdrawal by Subject|4|||
144600463|NCT05393037|521399383|FG000|Part B|Lost to Follow-up|1|||
144600464|NCT05393037|521399384|FG001|Part B|Lost to Follow-up|0|||
144600465|NCT01012739|521399385|FG000|Treatment Period 1|Adverse Event|0|||
144600466|NCT01012739|521399386|FG001|Treatment Period 1|Adverse Event|0|||
144600467|NCT01012739|521399387|FG002|Treatment Period 1|Adverse Event|0|||
144600468|NCT01012739|521399388|FG003|Treatment Period 1|Adverse Event|1|||
144600469|NCT01012739|521399385|FG000|Treatment Period 2|Abnormal test procedure results|0|||
144600470|NCT01012739|521399386|FG001|Treatment Period 2|Abnormal test procedure results|0|||
144600471|NCT01012739|521399387|FG002|Treatment Period 2|Abnormal test procedure results|0|||
144600472|NCT01012739|521399388|FG003|Treatment Period 2|Abnormal test procedure results|1|||
144600473|NCT02684357|521399393|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
144600474|NCT02684357|521399394|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
144600475|NCT02684357|521399395|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
144600476|NCT02684357|521399396|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
144600477|NCT02684357|521399397|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
144526855|NCT03628924|521131776|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144526856|NCT03628924|521131770|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
144526857|NCT03628924|521131771|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
144526858|NCT03628924|521131772|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
144526859|NCT03628924|521131773|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
144526860|NCT03628924|521131774|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
144526861|NCT03628924|521131775|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
144526862|NCT03628924|521131776|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
144526863|NCT03628924|521131770|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
144526864|NCT03628924|521131771|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
144600478|NCT02684357|521399398|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
144600479|NCT02684357|521399393|FG000|Part A|Lost to Follow-up|0|||
144600480|NCT02684357|521399394|FG001|Part A|Lost to Follow-up|2|||
144600481|NCT02684357|521399395|FG002|Part A|Lost to Follow-up|2|||
144600482|NCT02684357|521399396|FG003|Part A|Lost to Follow-up|0|||
144600483|NCT02684357|521399397|FG004|Part A|Lost to Follow-up|0|||
144600484|NCT02684357|521399398|FG005|Part A|Lost to Follow-up|0|||
144600485|NCT02684357|521399393|FG000|Part A|Withdrawal by Subject|3|||
144412815|NCT03708328|520720698|FG003|Overall Study|Study Ended By Sponsor|0|||
144412816|NCT03708328|520720699|FG004|Overall Study|Study Ended By Sponsor|0|||
144412817|NCT03708328|520720700|FG005|Overall Study|Study Ended By Sponsor|1|||
144412818|NCT03708328|520720701|FG006|Overall Study|Study Ended By Sponsor|0|||
144412819|NCT03708328|520720702|FG007|Overall Study|Study Ended By Sponsor|1|||
144412820|NCT03708328|520720703|FG008|Overall Study|Study Ended By Sponsor|0|||
144412821|NCT03708328|520720704|FG009|Overall Study|Study Ended By Sponsor|0|||
144412822|NCT03708328|520720695|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412823|NCT03708328|520720696|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412824|NCT03708328|520720697|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412825|NCT03708328|520720698|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412826|NCT03708328|520720699|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412827|NCT03708328|520720700|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412828|NCT03708328|520720701|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412829|NCT03708328|520720702|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412830|NCT03708328|520720703|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
144412831|NCT03708328|520720704|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
144412832|NCT04523220|520720705|FG000|Main Treatment Period|Physician Decision|1|||
144412833|NCT04523220|520720706|FG001|Main Treatment Period|Physician Decision|1|||
144412834|NCT04523220|520720707|FG002|Main Treatment Period|Physician Decision|0|||
144412835|NCT04523220|520720705|FG000|Main Treatment Period|Other|5|||
144412836|NCT04523220|520720706|FG001|Main Treatment Period|Other|2|||
144412837|NCT04523220|520720707|FG002|Main Treatment Period|Other|4|||
144412838|NCT04523220|520720705|FG000|Main Treatment Period|Subject Decision|5|||
144412839|NCT04523220|520720706|FG001|Main Treatment Period|Subject Decision|7|||
144412840|NCT04523220|520720707|FG002|Main Treatment Period|Subject Decision|3|||
144412841|NCT04523220|520720705|FG000|Main Treatment Period|Death|5|||
144412842|NCT04523220|520720706|FG001|Main Treatment Period|Death|11|||
144412843|NCT04523220|520720707|FG002|Main Treatment Period|Death|4|||
144412844|NCT04523220|520720705|FG000|Main Treatment Period|Adverse Event|11|||
144412845|NCT04523220|520720706|FG001|Main Treatment Period|Adverse Event|9|||
144412846|NCT04523220|520720707|FG002|Main Treatment Period|Adverse Event|9|||
144412847|NCT04523220|520720705|FG000|Main Treatment Period|Withdrawal by Subject|3|||
144412848|NCT04523220|520720706|FG001|Main Treatment Period|Withdrawal by Subject|3|||
144412849|NCT04523220|520720707|FG002|Main Treatment Period|Withdrawal by Subject|4|||
144412850|NCT04523220|520720705|FG000|Main Treatment Period|Study drug never adminstered|10|||
144412851|NCT04523220|520720706|FG001|Main Treatment Period|Study drug never adminstered|3|||
144412852|NCT04523220|520720707|FG002|Main Treatment Period|Study drug never adminstered|5|||
144412853|NCT04523220|520720705|FG000|Extension Treatment Period|Physician Decision|1|||
144412854|NCT04523220|520720706|FG001|Extension Treatment Period|Physician Decision|0|||
144412855|NCT04523220|520720707|FG002|Extension Treatment Period|Physician Decision|3|||
144412856|NCT04523220|520720705|FG000|Extension Treatment Period|Other|2|||
144412857|NCT04523220|520720706|FG001|Extension Treatment Period|Other|6|||
144412858|NCT04523220|520720707|FG002|Extension Treatment Period|Other|6|||
144412859|NCT04523220|520720705|FG000|Extension Treatment Period|Subject Decision|5|||
144412860|NCT04523220|520720706|FG001|Extension Treatment Period|Subject Decision|2|||
144412861|NCT04523220|520720707|FG002|Extension Treatment Period|Subject Decision|4|||
144412862|NCT04523220|520720705|FG000|Extension Treatment Period|Death|6|||
144412863|NCT04523220|520720706|FG001|Extension Treatment Period|Death|4|||
144412864|NCT04523220|520720707|FG002|Extension Treatment Period|Death|7|||
144412865|NCT04523220|520720705|FG000|Extension Treatment Period|Adverse Event|6|||
144412866|NCT04523220|520720706|FG001|Extension Treatment Period|Adverse Event|7|||
144412867|NCT04523220|520720707|FG002|Extension Treatment Period|Adverse Event|9|||
144412868|NCT04523220|520720705|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
144412869|NCT04523220|520720706|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
144412870|NCT04523220|520720707|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
144412871|NCT04523220|520720705|FG000|Extension Treatment Period|Study drug never administered|0|||
144412872|NCT04523220|520720706|FG001|Extension Treatment Period|Study drug never administered|1|||
144412873|NCT04523220|520720707|FG002|Extension Treatment Period|Study drug never administered|0|||
144412874|NCT00571948|520720708|FG000|Overall Study|Lost to Follow-up|2|||
144412875|NCT00571948|520720709|FG001|Overall Study|Lost to Follow-up|0|||
144412876|NCT00571948|520720708|FG000|Overall Study|Withdrawal by Subject|1|||
144412877|NCT00571948|520720709|FG001|Overall Study|Withdrawal by Subject|2|||
144250305|NCT00432276|520113549|FG001|Overall Study|Protocol Violation|20|||
144412878|NCT00571948|520720708|FG000|Overall Study|Protocol Violation|3|||
144412879|NCT00571948|520720709|FG001|Overall Study|Protocol Violation|3|||
144412880|NCT00571948|520720708|FG000|Overall Study|infant refused study meal|3|||
144412881|NCT00571948|520720709|FG001|Overall Study|infant refused study meal|4|||
144412882|NCT00571948|520720708|FG000|Overall Study|Parent were afraid of blood colection|2|||
144600486|NCT02684357|521399394|FG001|Part A|Withdrawal by Subject|0|||
144412883|NCT00571948|520720709|FG001|Overall Study|Parent were afraid of blood colection|5|||
144412884|NCT04112784|520720710|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
144412885|NCT04112784|520720710|FG000|Overall Study|Screen Failures|4|||
144412886|NCT00256750|520720711|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
144412887|NCT00256750|520720712|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
144412888|NCT00256750|520720713|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
144412889|NCT00256750|520720711|FG000|Transplanted Pre-Treatment|Other|2|||
144412890|NCT00256750|520720712|FG001|Transplanted Pre-Treatment|Other|0|||
144412891|NCT00256750|520720713|FG002|Transplanted Pre-Treatment|Other|0|||
144412892|NCT00256750|520720711|FG000|Transplanted Pre-Treatment|Death|1|||
144412893|NCT00256750|520720712|FG001|Transplanted Pre-Treatment|Death|0|||
144412894|NCT00256750|520720713|FG002|Transplanted Pre-Treatment|Death|0|||
144412895|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
144412896|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
144412897|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
144412898|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Death|3|||
144412899|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Death|2|||
144412900|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Death|4|||
144412901|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
144412902|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
144412903|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
144412904|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
144412905|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
144412906|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
144412907|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Other|5|||
144412908|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Other|4|||
144412909|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Other|2|||
144412910|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
144412911|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
144412912|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
144412913|NCT00256750|520720711|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
144412914|NCT00256750|520720712|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
144412915|NCT00256750|520720713|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
144412916|NCT00256750|520720711|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
144412917|NCT00256750|520720712|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
144412918|NCT00256750|520720713|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
144412919|NCT00256750|520720711|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
144412920|NCT00256750|520720712|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
144412921|NCT00256750|520720713|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
144526865|NCT03628924|521131772|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
144526866|NCT03628924|521131773|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
144526867|NCT03628924|521131774|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
144526868|NCT03628924|521131775|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
144526869|NCT03628924|521131776|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
144526870|NCT03628924|521131770|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
144526871|NCT03628924|521131771|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
144526872|NCT03628924|521131772|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
144526873|NCT03628924|521131773|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
144526874|NCT03628924|521131774|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
144526875|NCT03628924|521131775|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
144526876|NCT03628924|521131776|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
144526877|NCT03628924|521131770|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
144600487|NCT02684357|521399395|FG002|Part A|Withdrawal by Subject|0|||
144600488|NCT02684357|521399396|FG003|Part A|Withdrawal by Subject|0|||
144600489|NCT02684357|521399397|FG004|Part A|Withdrawal by Subject|0|||
144412922|NCT00256750|520720711|FG000|Post-Transplant Treated (24 Months)|Death|3|||
144412923|NCT00256750|520720712|FG001|Post-Transplant Treated (24 Months)|Death|0|||
144600490|NCT02684357|521399398|FG005|Part A|Withdrawal by Subject|0|||
144722895|NCT04799158|521840574|FG002|On-Demand Treatment Period|Adverse Event|0|||
144722896|NCT04799158|521840575|FG003|On-Demand Treatment Period|Adverse Event|0|||
144722897|NCT04799158|521840576|FG004|On-Demand Treatment Period|Adverse Event|1|||
144722898|NCT04799158|521840572|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
144722899|NCT04799158|521840573|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
144722900|NCT04799158|521840574|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
144722901|NCT04799158|521840575|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
144722902|NCT04799158|521840576|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
144722903|NCT04799158|521840572|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
144722904|NCT04799158|521840573|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
144722905|NCT04799158|521840574|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
144722906|NCT04799158|521840575|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
144722907|NCT04799158|521840576|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
144722908|NCT04799158|521840572|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
144600491|NCT02684357|521399393|FG000|Part A|Other|0|||
144600492|NCT02684357|521399394|FG001|Part A|Other|1|||
144600493|NCT02684357|521399395|FG002|Part A|Other|0|||
144600494|NCT02684357|521399396|FG003|Part A|Other|0|||
144600495|NCT02684357|521399397|FG004|Part A|Other|0|||
144600496|NCT02684357|521399398|FG005|Part A|Other|0|||
144600497|NCT02684357|521399393|FG000|Part B|Adverse Event (Other)|0|||
144600498|NCT02684357|521399394|FG001|Part B|Adverse Event (Other)|0|||
144600499|NCT02684357|521399395|FG002|Part B|Adverse Event (Other)|0|||
144600500|NCT02684357|521399396|FG003|Part B|Adverse Event (Other)|1|||
144600501|NCT02684357|521399397|FG004|Part B|Adverse Event (Other)|1|||
144600502|NCT02684357|521399398|FG005|Part B|Adverse Event (Other)|1|||
144600503|NCT02684357|521399393|FG000|Part B|Lost to Follow-up|0|||
144600504|NCT02684357|521399394|FG001|Part B|Lost to Follow-up|0|||
144600505|NCT02684357|521399395|FG002|Part B|Lost to Follow-up|0|||
144600506|NCT02684357|521399396|FG003|Part B|Lost to Follow-up|1|||
144600507|NCT02684357|521399397|FG004|Part B|Lost to Follow-up|1|||
144600508|NCT02684357|521399398|FG005|Part B|Lost to Follow-up|7|||
144600509|NCT02684357|521399393|FG000|Part B|Withdrawal by Subject|0|||
144600510|NCT02684357|521399394|FG001|Part B|Withdrawal by Subject|0|||
144600511|NCT02684357|521399395|FG002|Part B|Withdrawal by Subject|0|||
144600512|NCT02684357|521399396|FG003|Part B|Withdrawal by Subject|0|||
144600513|NCT02684357|521399397|FG004|Part B|Withdrawal by Subject|2|||
144600514|NCT02684357|521399398|FG005|Part B|Withdrawal by Subject|4|||
144600515|NCT02684357|521399393|FG000|Part B|Other|0|||
144600516|NCT02684357|521399394|FG001|Part B|Other|0|||
144600517|NCT02684357|521399395|FG002|Part B|Other|0|||
144600518|NCT02684357|521399396|FG003|Part B|Other|1|||
144600519|NCT02684357|521399397|FG004|Part B|Other|0|||
144600520|NCT02684357|521399398|FG005|Part B|Other|1|||
144250306|NCT00432276|520113548|FG000|Overall Study|Lost to Follow-up|6|||
144250307|NCT00432276|520113549|FG001|Overall Study|Lost to Follow-up|2|||
144412924|NCT00256750|520720713|FG002|Post-Transplant Treated (24 Months)|Death|0|||
144412925|NCT00256750|520720711|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
144412926|NCT00256750|520720712|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
144412927|NCT00256750|520720713|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
144412928|NCT00256750|520720711|FG000|Post-Transplant Treated (24 Months)|Other|2|||
144412929|NCT00256750|520720712|FG001|Post-Transplant Treated (24 Months)|Other|0|||
144412930|NCT00256750|520720713|FG002|Post-Transplant Treated (24 Months)|Other|1|||
144412931|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
144412932|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
144412933|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
144412934|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
144412935|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
144412936|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
144412937|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Death|0|||
144412938|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Death|2|||
144412939|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Death|1|||
144412940|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
144471969|NCT03217747|520925355|FG002|Overall Study|Withdrawal by Subject|1|||
144600521|NCT04567615|521399399|FG000|Randomization|Participant withdrew consent|1|||
144600522|NCT04567615|521399400|FG001|Randomization|Participant withdrew consent|0|||
144600523|NCT04567615|521399401|FG002|Randomization|Participant withdrew consent|0|||
144600524|NCT04567615|521399399|FG000|Randomization|Adverse event unrelated to study drug|0|||
144600525|NCT04567615|521399400|FG001|Randomization|Adverse event unrelated to study drug|1|||
144600526|NCT04567615|521399401|FG002|Randomization|Adverse event unrelated to study drug|0|||
144600527|NCT04567615|521399399|FG000|Treatment Period|Participant Withdrew Consent|2|||
144600528|NCT04567615|521399400|FG001|Treatment Period|Participant Withdrew Consent|5|||
144600529|NCT04567615|521399401|FG002|Treatment Period|Participant Withdrew Consent|1|||
144600530|NCT04567615|521399399|FG000|Treatment Period|Death|1|||
144722909|NCT04799158|521840573|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
144722910|NCT04799158|521840574|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
144600531|NCT04567615|521399400|FG001|Treatment Period|Death|2|||
144600532|NCT04567615|521399401|FG002|Treatment Period|Death|0|||
144600533|NCT04567615|521399399|FG000|Treatment Period|Lost to Follow-up|0|||
144600534|NCT04567615|521399400|FG001|Treatment Period|Lost to Follow-up|1|||
144600535|NCT04567615|521399401|FG002|Treatment Period|Lost to Follow-up|0|||
144600536|NCT04567615|521399399|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
144600537|NCT04567615|521399400|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
144600538|NCT04567615|521399401|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
144600539|NCT04567615|521399399|FG000|Treatment Period|Disease Progression|85|||
144412941|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
144600540|NCT04567615|521399400|FG001|Treatment Period|Disease Progression|63|||
144600541|NCT04567615|521399401|FG002|Treatment Period|Disease Progression|16|||
144600542|NCT04567615|521399399|FG000|Treatment Period|Study Drug Toxicity|3|||
144600543|NCT04567615|521399400|FG001|Treatment Period|Study Drug Toxicity|10|||
144600544|NCT04567615|521399401|FG002|Treatment Period|Study Drug Toxicity|4|||
144600545|NCT04567615|521399399|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
144600546|NCT04567615|521399400|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
144600547|NCT04567615|521399401|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
144600548|NCT04567615|521399399|FG000|Treatment Period|Other Reasons|1|||
144600549|NCT04567615|521399400|FG001|Treatment Period|Other Reasons|2|||
144600550|NCT04567615|521399401|FG002|Treatment Period|Other Reasons|0|||
144600551|NCT04567615|521399399|FG000|Treatment Period|Still On-going Treatment|21|||
144600552|NCT04567615|521399400|FG001|Treatment Period|Still On-going Treatment|22|||
144600553|NCT04567615|521399401|FG002|Treatment Period|Still On-going Treatment|2|||
144600554|NCT01306890|521401559|FG000|Overall Study|Adverse Event|2|||
144600555|NCT01306890|521401559|FG000|Overall Study|Death|1223|||
144600556|NCT01306890|521401559|FG000|Overall Study|Lost to Follow-up|58|||
144600557|NCT01306890|521401559|FG000|Overall Study|Withdrawal by Subject|88|||
144600558|NCT01306890|521401559|FG000|Overall Study|Unspecified reasons|104|||
144600559|NCT01306890|521401559|FG000|Overall Study|Study Termination|3|||
144600560|NCT01306890|521401559|FG000|Overall Study|No discontinuation documentation|41|||
144600561|NCT02217436|521401560|FG000|Overall Study|Protocol Violation|1|||
144600562|NCT02217436|521401561|FG001|Overall Study|Protocol Violation|1|||
144600563|NCT02217436|521401560|FG000|Overall Study|Incomplete data|0|||
144600564|NCT02217436|521401561|FG001|Overall Study|Incomplete data|1|||
144600565|NCT01890148|521401562|FG000|Overall Study|Adverse Event|1|||
144600566|NCT01215175|521401563|FG000|Overall Study|Lost to Follow-up|0|||
144600567|NCT01215175|521401564|FG001|Overall Study|Lost to Follow-up|1|||
144600568|NCT01215175|521401565|FG002|Overall Study|Lost to Follow-up|0|||
144600569|NCT01215175|521401566|FG003|Overall Study|Lost to Follow-up|1|||
144600570|NCT01215175|521401567|FG004|Overall Study|Lost to Follow-up|0|||
144600571|NCT01678209|521401568|FG000|Overall Study|could not scan twice|1|||
144600572|NCT01678209|521401569|FG001|Overall Study|could not scan twice|1|||
144600573|NCT01678209|521401570|FG002|Overall Study|could not scan twice|1|||
144600574|NCT01678209|521401568|FG000|Overall Study|scheduling conflicts|0|||
144600575|NCT01678209|521401569|FG001|Overall Study|scheduling conflicts|0|||
144412942|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
144412943|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
144412944|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
144412945|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
144412946|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
144412947|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
144412948|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
144412949|NCT00256750|520720711|FG000|Post-Transplant Treated (36 Months)|Other|0|||
144412950|NCT00256750|520720712|FG001|Post-Transplant Treated (36 Months)|Other|1|||
144412951|NCT00256750|520720713|FG002|Post-Transplant Treated (36 Months)|Other|1|||
144600576|NCT01678209|521401570|FG002|Overall Study|scheduling conflicts|1|||
144250308|NCT00432276|520113548|FG000|Overall Study|Withdrawal by Subject|25|||
144412952|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
144600577|NCT01678209|521401568|FG000|Overall Study|screen fail|16|||
144600578|NCT01678209|521401569|FG001|Overall Study|screen fail|17|||
144600579|NCT01678209|521401570|FG002|Overall Study|screen fail|16|||
144600580|NCT03739762|521401571|FG000|Overall Study|Lost to Follow-up|1|||
144600581|NCT03739762|521401572|FG001|Overall Study|Lost to Follow-up|1|||
144600582|NCT03739762|521401571|FG000|Overall Study|Withdrawal by Subject|2|||
144600583|NCT03739762|521401572|FG001|Overall Study|Withdrawal by Subject|6|||
144600584|NCT00607880|521401573|FG000|Overall Study|Unable to place port due to occlusion|1|||
144600585|NCT00607880|521401574|FG001|Overall Study|Unable to place port due to occlusion|0|||
144600586|NCT02170389|521401578|FG000|Overall Study|Study terminated prior to start of treat|1|||
144250309|NCT00432276|520113549|FG001|Overall Study|Withdrawal by Subject|20|||
144600587|NCT02366728|521401580|FG000|Overall Study|Death|0|||
144600588|NCT02366728|521401581|FG001|Overall Study|Death|0|||
144600589|NCT02366728|521401582|FG002|Overall Study|Death|1|||
144600590|NCT02366728|521401580|FG000|Overall Study|Adverse Event|1|||
144600591|NCT02366728|521401581|FG001|Overall Study|Adverse Event|0|||
144600592|NCT02366728|521401582|FG002|Overall Study|Adverse Event|0|||
144600593|NCT02366728|521401580|FG000|Overall Study|Screen Failure|2|||
144600594|NCT02366728|521401581|FG001|Overall Study|Screen Failure|1|||
144600595|NCT02366728|521401582|FG002|Overall Study|Screen Failure|0|||
144600596|NCT02366728|521401580|FG000|Overall Study|Only yielded 2 vaccines|1|||
144600597|NCT02366728|521401581|FG001|Overall Study|Only yielded 2 vaccines|0|||
144600598|NCT02366728|521401582|FG002|Overall Study|Only yielded 2 vaccines|0|||
144600599|NCT01383161|521401583|FG000|Overall Study|Adverse Event|5|||
144600600|NCT01383161|521401584|FG001|Overall Study|Adverse Event|1|||
144600601|NCT01383161|521401583|FG000|Overall Study|Withdrawal by Subject|0|||
144600602|NCT01383161|521401584|FG001|Overall Study|Withdrawal by Subject|2|||
144600603|NCT01383161|521401583|FG000|Overall Study|Lack of Efficacy|0|||
144600604|NCT01383161|521401584|FG001|Overall Study|Lack of Efficacy|1|||
144600605|NCT03942406|521401591|FG000|Overall Study|Lost to Follow-up|4|||
144600606|NCT03942406|521401592|FG001|Overall Study|Lost to Follow-up|5|||
144600607|NCT03942406|521401593|FG002|Overall Study|Lost to Follow-up|3|||
144600608|NCT03942406|521401594|FG003|Overall Study|Lost to Follow-up|7|||
144600609|NCT03942406|521401595|FG004|Overall Study|Lost to Follow-up|1|||
144600610|NCT03942406|521401596|FG005|Overall Study|Lost to Follow-up|0|||
144600611|NCT03942406|521401597|FG006|Overall Study|Lost to Follow-up|0|||
144600612|NCT03942406|521401591|FG000|Overall Study|Withdrawal by Subject|3|||
144600613|NCT03942406|521401592|FG001|Overall Study|Withdrawal by Subject|1|||
144600614|NCT03942406|521401593|FG002|Overall Study|Withdrawal by Subject|1|||
144600615|NCT03942406|521401594|FG003|Overall Study|Withdrawal by Subject|3|||
144600616|NCT03942406|521401595|FG004|Overall Study|Withdrawal by Subject|0|||
144600617|NCT03942406|521401596|FG005|Overall Study|Withdrawal by Subject|0|||
144600618|NCT03942406|521401597|FG006|Overall Study|Withdrawal by Subject|0|||
144600619|NCT03942406|521401591|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
144600620|NCT03942406|521401592|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
144412953|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
144412954|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
144412955|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
144412956|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
144412957|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
144412958|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
144412959|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
144412960|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
144412961|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
144412962|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
144412963|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
144412964|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
144412965|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
144412966|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
144412967|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
144412968|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
144412969|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
144600621|NCT03942406|521401593|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
144600622|NCT03942406|521401594|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
144600623|NCT03942406|521401595|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
144600624|NCT03942406|521401596|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
144600625|NCT03942406|521401597|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
144600626|NCT01054144|521401600|FG000|Overall Study|Death|2|||
144600627|NCT02748018|521401601|FG000|Study Period|Adverse Event|1|||
144600628|NCT02748018|521401602|FG001|Study Period|Adverse Event|3|||
144412970|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
144412971|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
144412972|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
144412973|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
144600629|NCT02748018|521401603|FG002|Study Period|Adverse Event|4|||
144600630|NCT02748018|521401604|FG003|Study Period|Adverse Event|0|||
144600631|NCT02748018|521401605|FG004|Study Period|Adverse Event|3|||
144600632|NCT02748018|521401606|FG005|Study Period|Adverse Event|3|||
144600633|NCT02748018|521401601|FG000|Study Period|Withdrawal by Subject|7|||
144600634|NCT02748018|521401602|FG001|Study Period|Withdrawal by Subject|4|||
144600635|NCT02748018|521401603|FG002|Study Period|Withdrawal by Subject|4|||
144412974|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
144412975|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
144412976|NCT00256750|520720711|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
144412977|NCT00256750|520720712|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
144412978|NCT00256750|520720713|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
144412979|NCT02030041|520720715|FG000|Overall Study|Withdrawal by Subject|2|||
144412980|NCT02030041|520720716|FG001|Overall Study|Withdrawal by Subject|2|||
144412981|NCT02030041|520720717|FG002|Overall Study|Withdrawal by Subject|1|||
144412982|NCT01032837|520720718|FG000|Overall Study|Adverse event/internal illness|0|||
144412983|NCT01032837|520720719|FG001|Overall Study|Adverse event/internal illness|1|||
144412984|NCT01032837|520720720|FG002|Overall Study|Adverse event/internal illness|0|||
144412985|NCT01032837|520720721|FG003|Overall Study|Adverse event/internal illness|1|||
144412986|NCT01032837|520720718|FG000|Overall Study|Withdrew consent|0|||
144412987|NCT01032837|520720719|FG001|Overall Study|Withdrew consent|2|||
144412988|NCT01032837|520720720|FG002|Overall Study|Withdrew consent|0|||
144412989|NCT01032837|520720721|FG003|Overall Study|Withdrew consent|1|||
144412990|NCT01032837|520720718|FG000|Overall Study|Failed to return|0|||
144412991|NCT01032837|520720719|FG001|Overall Study|Failed to return|0|||
144412992|NCT01032837|520720720|FG002|Overall Study|Failed to return|1|||
144412993|NCT01032837|520720721|FG003|Overall Study|Failed to return|0|||
144412994|NCT01032837|520720718|FG000|Overall Study|Refused treatment|0|||
144412995|NCT01032837|520720719|FG001|Overall Study|Refused treatment|0|||
144412996|NCT01032837|520720720|FG002|Overall Study|Refused treatment|0|||
144412997|NCT01032837|520720721|FG003|Overall Study|Refused treatment|1|||
144412998|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
144412999|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
144413000|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
144413001|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
144413002|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
144413003|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
144413004|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
144413005|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
144413006|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
144413007|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
144413008|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
144413009|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
144413010|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
144413011|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
144413012|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
144413013|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
144413014|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
144413015|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
144413016|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
144413017|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
144413018|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
144413019|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
144413020|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
144413021|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
144413022|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
144413023|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
144413024|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
144413025|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
144600636|NCT02748018|521401604|FG003|Study Period|Withdrawal by Subject|11|||
144413026|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
144413027|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
144413028|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
144413029|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
144413030|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
144413031|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
144413032|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
144413033|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
144413034|NCT00843024|520720722|FG000|Single-blind Placebo Run-In Phase|Other|0|||
144413035|NCT00843024|520720723|FG001|Single-blind Placebo Run-In Phase|Other|1|||
144250310|NCT00432276|520113548|FG000|Overall Study|Physician Decision|6|||
144250311|NCT00432276|520113549|FG001|Overall Study|Physician Decision|8|||
144250312|NCT00432276|520113548|FG000|Overall Study|Other|2|||
144413036|NCT00843024|520720724|FG002|Single-blind Placebo Run-In Phase|Other|0|||
144413037|NCT00843024|520720725|FG003|Single-blind Placebo Run-In Phase|Other|0|||
144413038|NCT00843024|520720726|FG004|Single-blind Placebo Run-In Phase|Other|0|||
144413039|NCT00843024|520720727|FG005|Single-blind Placebo Run-In Phase|Other|0|||
144413040|NCT00843024|520720722|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
144413041|NCT00843024|520720723|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
144413042|NCT00843024|520720724|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
144413043|NCT00843024|520720725|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
144413044|NCT00843024|520720726|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
144413045|NCT00843024|520720727|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
144413046|NCT00843024|520720722|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
144413047|NCT00843024|520720723|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
144413048|NCT00843024|520720724|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
144413049|NCT00843024|520720725|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
144413050|NCT00843024|520720726|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
144413051|NCT00843024|520720727|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
144413052|NCT00843024|520720722|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144413053|NCT00843024|520720723|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144413054|NCT00843024|520720724|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144413055|NCT00843024|520720725|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
144413056|NCT00843024|520720726|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144413057|NCT00843024|520720727|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
144413058|NCT00843024|520720722|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
144413059|NCT00843024|520720723|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
144413060|NCT00843024|520720724|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
144413061|NCT00843024|520720725|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
144413062|NCT00843024|520720726|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
144413063|NCT00843024|520720727|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
144413064|NCT00843024|520720722|FG000|Double-blind Treatment Phase|Physician Decision|0|||
144413065|NCT00843024|520720723|FG001|Double-blind Treatment Phase|Physician Decision|0|||
144413066|NCT00843024|520720724|FG002|Double-blind Treatment Phase|Physician Decision|0|||
144413067|NCT00843024|520720725|FG003|Double-blind Treatment Phase|Physician Decision|3|||
144413068|NCT00843024|520720726|FG004|Double-blind Treatment Phase|Physician Decision|1|||
144413069|NCT00843024|520720727|FG005|Double-blind Treatment Phase|Physician Decision|1|||
144413070|NCT00843024|520720722|FG000|Double-blind Treatment Phase|Adverse Event|0|||
144413071|NCT00843024|520720723|FG001|Double-blind Treatment Phase|Adverse Event|0|||
144413072|NCT00843024|520720724|FG002|Double-blind Treatment Phase|Adverse Event|0|||
144413073|NCT00843024|520720725|FG003|Double-blind Treatment Phase|Adverse Event|0|||
144413074|NCT00843024|520720726|FG004|Double-blind Treatment Phase|Adverse Event|1|||
144413075|NCT00843024|520720727|FG005|Double-blind Treatment Phase|Adverse Event|1|||
144413076|NCT00843024|520720722|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
144526878|NCT03628924|521131771|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
144526879|NCT03628924|521131772|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
144526880|NCT03628924|521131773|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
144526881|NCT03628924|521131774|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
144526882|NCT03628924|521131775|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
144526883|NCT03628924|521131776|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
144526884|NCT03628924|521131770|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
144526885|NCT03628924|521131771|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
144526886|NCT03628924|521131772|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
144526887|NCT03628924|521131773|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
144526888|NCT03628924|521131774|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
144526889|NCT03628924|521131775|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
144526890|NCT03628924|521131776|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
144722911|NCT04799158|521840575|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
144413077|NCT00843024|520720723|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
144413078|NCT00843024|520720724|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
144600637|NCT02748018|521401605|FG004|Study Period|Withdrawal by Subject|12|||
144600638|NCT02748018|521401606|FG005|Study Period|Withdrawal by Subject|10|||
144600639|NCT02748018|521401601|FG000|Study Period|Pregnancy|0|||
144722912|NCT04799158|521840576|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
144722913|NCT04799158|521840572|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
144722914|NCT04799158|521840573|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
144722915|NCT04799158|521840574|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
144722916|NCT04799158|521840575|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
144722917|NCT04799158|521840576|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
144722918|NCT04799158|521840572|FG000|On-Demand Treatment Period|Miscellaneous|0|||
144722919|NCT04799158|521840573|FG001|On-Demand Treatment Period|Miscellaneous|0|||
144722920|NCT04799158|521840574|FG002|On-Demand Treatment Period|Miscellaneous|0|||
144722921|NCT04799158|521840575|FG003|On-Demand Treatment Period|Miscellaneous|0|||
144722922|NCT04799158|521840576|FG004|On-Demand Treatment Period|Miscellaneous|1|||
144722923|NCT03922477|521840579|FG000|Overall Study|Death|9|||
144722924|NCT03922477|521840579|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
144722925|NCT03922477|521840579|FG000|Overall Study|Physician Decision|1|||
144722926|NCT03922477|521840579|FG000|Overall Study|Withdrawal by Subject|2|||
144722927|NCT04104646|521840581|FG000|Overall Study|Withdrawal by Subject|1|||
144722928|NCT04104646|521840582|FG001|Overall Study|Withdrawal by Subject|1|||
144722929|NCT04104646|521840581|FG000|Overall Study|Lost to Follow-up|1|||
144722930|NCT04104646|521840582|FG001|Overall Study|Lost to Follow-up|0|||
144722931|NCT04104646|521840581|FG000|Overall Study|Physician Decision|2|||
144722932|NCT04104646|521840582|FG001|Overall Study|Physician Decision|0|||
144722933|NCT02607800|521840583|FG000|Overall Study|Lost to Follow-up|7|||
144722934|NCT02607800|521840584|FG001|Overall Study|Lost to Follow-up|10|||
144722935|NCT02607800|521840583|FG000|Overall Study|Withdrew Consent|2|||
144600640|NCT02748018|521401602|FG001|Study Period|Pregnancy|1|||
144600641|NCT02748018|521401603|FG002|Study Period|Pregnancy|0|||
144600642|NCT02748018|521401604|FG003|Study Period|Pregnancy|0|||
144600643|NCT02748018|521401605|FG004|Study Period|Pregnancy|1|||
144600644|NCT02748018|521401606|FG005|Study Period|Pregnancy|0|||
144600645|NCT02748018|521401601|FG000|Study Period|Physician Decision|2|||
144600646|NCT02748018|521401602|FG001|Study Period|Physician Decision|2|||
144600647|NCT02748018|521401603|FG002|Study Period|Physician Decision|1|||
144600648|NCT02748018|521401604|FG003|Study Period|Physician Decision|0|||
144600649|NCT02748018|521401605|FG004|Study Period|Physician Decision|2|||
144600650|NCT02748018|521401606|FG005|Study Period|Physician Decision|0|||
144600651|NCT02748018|521401601|FG000|Study Period|Lost to Follow-up|0|||
144600652|NCT02748018|521401602|FG001|Study Period|Lost to Follow-up|0|||
144600653|NCT02748018|521401603|FG002|Study Period|Lost to Follow-up|0|||
144600654|NCT02748018|521401604|FG003|Study Period|Lost to Follow-up|2|||
144600655|NCT02748018|521401605|FG004|Study Period|Lost to Follow-up|0|||
144600656|NCT02748018|521401606|FG005|Study Period|Lost to Follow-up|1|||
144600657|NCT02748018|521401601|FG000|Continuation Period|Adverse Event|2|||
144600658|NCT02748018|521401602|FG001|Continuation Period|Adverse Event|0|||
144600659|NCT02748018|521401603|FG002|Continuation Period|Adverse Event|1|||
144600660|NCT02748018|521401604|FG003|Continuation Period|Adverse Event|1|||
144600661|NCT02748018|521401605|FG004|Continuation Period|Adverse Event|1|||
144600662|NCT02748018|521401606|FG005|Continuation Period|Adverse Event|4|||
144600663|NCT02748018|521401601|FG000|Continuation Period|Withdrawal by Subject|3|||
144600664|NCT02748018|521401602|FG001|Continuation Period|Withdrawal by Subject|5|||
144600665|NCT02748018|521401603|FG002|Continuation Period|Withdrawal by Subject|3|||
144600666|NCT02748018|521401604|FG003|Continuation Period|Withdrawal by Subject|9|||
144600667|NCT02748018|521401605|FG004|Continuation Period|Withdrawal by Subject|11|||
144600668|NCT02748018|521401606|FG005|Continuation Period|Withdrawal by Subject|1|||
144600669|NCT02748018|521401601|FG000|Continuation Period|Lost to Follow-up|0|||
144600670|NCT02748018|521401602|FG001|Continuation Period|Lost to Follow-up|2|||
144600671|NCT02748018|521401603|FG002|Continuation Period|Lost to Follow-up|1|||
144600672|NCT02748018|521401604|FG003|Continuation Period|Lost to Follow-up|0|||
144600673|NCT02748018|521401605|FG004|Continuation Period|Lost to Follow-up|1|||
144722936|NCT02607800|521840584|FG001|Overall Study|Withdrew Consent|0|||
144722937|NCT02607800|521840583|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
144722938|NCT02607800|521840584|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
144722939|NCT01656889|521840585|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
144600674|NCT02748018|521401606|FG005|Continuation Period|Lost to Follow-up|0|||
144600675|NCT02748018|521401601|FG000|Continuation Period|Pregnancy|1|||
144600676|NCT02748018|521401602|FG001|Continuation Period|Pregnancy|2|||
144600677|NCT02748018|521401603|FG002|Continuation Period|Pregnancy|0|||
144600678|NCT02748018|521401604|FG003|Continuation Period|Pregnancy|0|||
144600679|NCT02748018|521401605|FG004|Continuation Period|Pregnancy|0|||
144600680|NCT02748018|521401606|FG005|Continuation Period|Pregnancy|0|||
144413079|NCT00843024|520720725|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
144413080|NCT00843024|520720726|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
144413081|NCT00843024|520720727|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
144413082|NCT05201703|520720728|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
144413083|NCT05201703|520720729|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
144413084|NCT05201703|520720728|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
144413085|NCT05201703|520720729|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
144413086|NCT02006719|520720730|FG000|Overall Study|Withdrawal by Subject|10|||
144413087|NCT02006719|520720731|FG001|Overall Study|Withdrawal by Subject|2|||
144413088|NCT02006719|520720730|FG000|Overall Study|Lost to Follow-up|5|||
144413089|NCT02006719|520720731|FG001|Overall Study|Lost to Follow-up|1|||
144413090|NCT02006719|520720730|FG000|Overall Study|Protocol Violation|2|||
144413091|NCT02006719|520720731|FG001|Overall Study|Protocol Violation|0|||
144413092|NCT02006719|520720730|FG000|Overall Study|Adverse Event|1|||
144413093|NCT02006719|520720731|FG001|Overall Study|Adverse Event|1|||
144413094|NCT02006719|520720730|FG000|Overall Study|Other/Unknown|0|||
144413095|NCT02006719|520720731|FG001|Overall Study|Other/Unknown|1|||
144413096|NCT02439138|520720733|FG000|Overall Study|Adverse Event|1|||
144413097|NCT02439138|520720733|FG000|Overall Study|PI decision to terminate the study|2|||
144413098|NCT02615145|520720738|FG000|Overall Study|Did Not Start Treatment|0|||
144413099|NCT02615145|520720739|FG001|Overall Study|Did Not Start Treatment|0|||
144413100|NCT02615145|520720740|FG002|Overall Study|Did Not Start Treatment|1|||
144413101|NCT02615145|520720741|FG003|Overall Study|Did Not Start Treatment|1|||
144413102|NCT02615145|520720738|FG000|Overall Study|Failure to Return|20|||
144413103|NCT02615145|520720739|FG001|Overall Study|Failure to Return|10|||
144413104|NCT02615145|520720740|FG002|Overall Study|Failure to Return|7|||
144413105|NCT02615145|520720741|FG003|Overall Study|Failure to Return|0|||
144413106|NCT02615145|520720738|FG000|Overall Study|Death|2|||
144413107|NCT02615145|520720739|FG001|Overall Study|Death|3|||
144413108|NCT02615145|520720740|FG002|Overall Study|Death|0|||
144413109|NCT02615145|520720741|FG003|Overall Study|Death|0|||
144413110|NCT02615145|520720738|FG000|Overall Study|Other, Not Specified|5|||
144413111|NCT02615145|520720739|FG001|Overall Study|Other, Not Specified|2|||
144413112|NCT02615145|520720740|FG002|Overall Study|Other, Not Specified|0|||
144413113|NCT02615145|520720741|FG003|Overall Study|Other, Not Specified|0|||
144413114|NCT01737697|520720742|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413115|NCT01737697|520720743|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
144413116|NCT01737697|520720744|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413117|NCT01737697|520720745|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
144413118|NCT01737697|520720746|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
144413119|NCT01737697|520720747|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413120|NCT01737697|520720748|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413121|NCT01737697|520720749|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413122|NCT01737697|520720750|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144526891|NCT03628924|521131770|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
144526892|NCT03628924|521131771|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
144526893|NCT03628924|521131772|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
144526894|NCT03628924|521131773|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
144526895|NCT03628924|521131774|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
144526896|NCT03628924|521131775|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
144526897|NCT03628924|521131776|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
144526898|NCT03854227|521131781|FG000|Overall Study|Adverse Event|0|||
144526899|NCT03854227|521131782|FG001|Overall Study|Adverse Event|0|||
144526900|NCT03854227|521131783|FG002|Overall Study|Adverse Event|0|||
144526901|NCT03854227|521131784|FG003|Overall Study|Adverse Event|1|||
144526902|NCT03854227|521131785|FG004|Overall Study|Adverse Event|0|||
144526903|NCT03854227|521131786|FG005|Overall Study|Adverse Event|0|||
144526904|NCT03854227|521131787|FG006|Overall Study|Adverse Event|1|||
144526905|NCT03854227|521131788|FG007|Overall Study|Adverse Event|0|||
144526906|NCT03854227|521131789|FG008|Overall Study|Adverse Event|0|||
144526907|NCT03854227|521131790|FG009|Overall Study|Adverse Event|3|||
144526908|NCT03854227|521131791|FG010|Overall Study|Adverse Event|0|||
144526909|NCT03854227|521131792|FG011|Overall Study|Adverse Event|1|||
144526910|NCT03854227|521131781|FG000|Overall Study|Death|0|||
144526911|NCT03854227|521131782|FG001|Overall Study|Death|0|||
144526912|NCT03854227|521131783|FG002|Overall Study|Death|0|||
144526913|NCT03854227|521131784|FG003|Overall Study|Death|0|||
144526914|NCT03854227|521131785|FG004|Overall Study|Death|0|||
144526915|NCT03854227|521131786|FG005|Overall Study|Death|1|||
144526916|NCT03854227|521131787|FG006|Overall Study|Death|0|||
144413123|NCT01737697|520720751|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413124|NCT01737697|520720752|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413125|NCT01737697|520720753|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413126|NCT01737697|520720754|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413127|NCT01737697|520720755|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413128|NCT01737697|520720756|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
144413129|NCT01737697|520720742|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
144413130|NCT01737697|520720743|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
144413131|NCT01737697|520720744|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
144526917|NCT03854227|521131788|FG007|Overall Study|Death|0|||
144526918|NCT03854227|521131789|FG008|Overall Study|Death|0|||
144526919|NCT03854227|521131790|FG009|Overall Study|Death|1|||
144600681|NCT02748018|521401601|FG000|Continuation Period|Physician Decision|0|||
144600682|NCT02748018|521401602|FG001|Continuation Period|Physician Decision|1|||
144600683|NCT02748018|521401603|FG002|Continuation Period|Physician Decision|2|||
144600684|NCT02748018|521401604|FG003|Continuation Period|Physician Decision|0|||
144600685|NCT02748018|521401605|FG004|Continuation Period|Physician Decision|2|||
144600686|NCT02748018|521401606|FG005|Continuation Period|Physician Decision|1|||
144600687|NCT02748018|521401601|FG000|Continuation Period|Protocol Violation|0|||
144600688|NCT02748018|521401602|FG001|Continuation Period|Protocol Violation|1|||
144600689|NCT02748018|521401603|FG002|Continuation Period|Protocol Violation|0|||
144600690|NCT02748018|521401604|FG003|Continuation Period|Protocol Violation|0|||
144600691|NCT02748018|521401605|FG004|Continuation Period|Protocol Violation|0|||
144600692|NCT02748018|521401606|FG005|Continuation Period|Protocol Violation|0|||
144600693|NCT05628285|521401607|FG000|Overall Study|Lost to Follow-up|1|||
144600694|NCT06069778|521401608|FG000|Overall Study|Withdrawal by Subject|1|||
144600695|NCT02856893|521401609|FG000|Overall Study|Lack of Efficacy|27|||
144600696|NCT02856893|521401610|FG001|Overall Study|Lack of Efficacy|15|||
144600697|NCT02856893|521401611|FG002|Overall Study|Lack of Efficacy|19|||
144600698|NCT02856893|521401609|FG000|Overall Study|Death|1|||
144600699|NCT02856893|521401610|FG001|Overall Study|Death|0|||
144600700|NCT02856893|521401611|FG002|Overall Study|Death|0|||
144600701|NCT02856893|521401609|FG000|Overall Study|Adverse Event|2|||
144600702|NCT02856893|521401610|FG001|Overall Study|Adverse Event|0|||
144413132|NCT01737697|520720745|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413133|NCT01737697|520720746|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413134|NCT01737697|520720747|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413135|NCT01737697|520720748|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413136|NCT01737697|520720749|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413137|NCT01737697|520720750|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413138|NCT01737697|520720751|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413139|NCT01737697|520720752|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413140|NCT01737697|520720753|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413141|NCT01737697|520720754|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413142|NCT01737697|520720755|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413143|NCT01737697|520720756|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
144413144|NCT01737697|520720742|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413145|NCT01737697|520720743|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413146|NCT01737697|520720744|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413147|NCT01737697|520720745|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
144413148|NCT01737697|520720746|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413149|NCT01737697|520720747|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413150|NCT01737697|520720748|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413151|NCT01737697|520720749|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413152|NCT01737697|520720750|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413153|NCT01737697|520720751|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413154|NCT01737697|520720752|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
144600703|NCT02856893|521401611|FG002|Overall Study|Adverse Event|0|||
144600704|NCT02856893|521401609|FG000|Overall Study|Physician Decision|0|||
144600705|NCT02856893|521401610|FG001|Overall Study|Physician Decision|2|||
144600706|NCT02856893|521401611|FG002|Overall Study|Physician Decision|3|||
144600707|NCT02856893|521401609|FG000|Overall Study|Withdrawal by Subject|1|||
144600708|NCT02856893|521401610|FG001|Overall Study|Withdrawal by Subject|1|||
144600709|NCT02856893|521401611|FG002|Overall Study|Withdrawal by Subject|0|||
144600710|NCT02856893|521401609|FG000|Overall Study|Other reasons|2|||
144413155|NCT01737697|520720753|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413156|NCT01737697|520720754|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
144600711|NCT02856893|521401610|FG001|Overall Study|Other reasons|1|||
144600712|NCT02856893|521401611|FG002|Overall Study|Other reasons|2|||
144600713|NCT02310672|521401612|FG000|Overall Study|Death|1|||
144600714|NCT02310672|521401612|FG000|Overall Study|Lost to Follow-up|1|||
144600715|NCT02310672|521401612|FG000|Overall Study|Withdrawal by Subject|1|||
144600716|NCT02310672|521401612|FG000|Overall Study|Sponsor's decision|12|||
144600717|NCT04704336|521401616|FG000|Overall Study|Death|2|||
144600718|NCT04704336|521401617|FG001|Overall Study|Death|2|||
144600719|NCT04704336|521401616|FG000|Overall Study|Lost to Follow-up|33|||
144600720|NCT04704336|521401617|FG001|Overall Study|Lost to Follow-up|40|||
144600721|NCT03118674|521401621|FG000|Overall Study|Lost to Follow-up|2|||
144413157|NCT01737697|520720755|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413158|NCT01737697|520720756|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
144413159|NCT01737697|520720742|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413160|NCT01737697|520720743|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
144413161|NCT01737697|520720744|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413162|NCT01737697|520720745|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144526920|NCT03854227|521131791|FG010|Overall Study|Death|0|||
144526921|NCT03854227|521131792|FG011|Overall Study|Death|1|||
144526922|NCT03854227|521131781|FG000|Overall Study|Physician Decision|0|||
144526923|NCT03854227|521131782|FG001|Overall Study|Physician Decision|0|||
144413163|NCT01737697|520720746|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144526924|NCT03854227|521131783|FG002|Overall Study|Physician Decision|0|||
144526925|NCT03854227|521131784|FG003|Overall Study|Physician Decision|0|||
144526926|NCT03854227|521131785|FG004|Overall Study|Physician Decision|0|||
144413164|NCT01737697|520720747|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413165|NCT01737697|520720748|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413166|NCT01737697|520720749|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413167|NCT01737697|520720750|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413168|NCT01737697|520720751|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413169|NCT01737697|520720752|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413170|NCT01737697|520720753|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413171|NCT01737697|520720754|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413172|NCT01737697|520720755|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413173|NCT01737697|520720756|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
144413174|NCT01737697|520720742|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413175|NCT01737697|520720743|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413176|NCT01737697|520720744|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413177|NCT01737697|520720745|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413178|NCT01737697|520720746|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
144413179|NCT01737697|520720747|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413180|NCT01737697|520720748|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144600722|NCT03118674|521401621|FG000|Overall Study|Screen Faliure|8|||
144600723|NCT03118674|521401621|FG000|Overall Study|Withdrawal by Subject|5|||
144600724|NCT01324323|521401622|FG000|Overall Study|Withdrawal by Subject|1|||
144600725|NCT00537485|521401623|FG000|Overall Study|Adverse Event|10|||
144600726|NCT00537485|521401624|FG001|Overall Study|Adverse Event|5|||
144600727|NCT00537485|521401623|FG000|Overall Study|Withdrawal by Subject|3|||
144600728|NCT00537485|521401624|FG001|Overall Study|Withdrawal by Subject|2|||
144600729|NCT00537485|521401623|FG000|Overall Study|Withdrawal by Subject|1|||
144600730|NCT00537485|521401624|FG001|Overall Study|Withdrawal by Subject|3|||
144600731|NCT00537485|521401623|FG000|Overall Study|Physician Decision|1|||
144600732|NCT00537485|521401624|FG001|Overall Study|Physician Decision|0|||
144600733|NCT03153137|521401625|FG000|Overall Study|Lost to Follow-up|1|||
144600734|NCT03153137|521401626|FG001|Overall Study|Lost to Follow-up|0|||
144600735|NCT03153137|521401625|FG000|Overall Study|Withdrawal by Subject|2|||
144600736|NCT03153137|521401626|FG001|Overall Study|Withdrawal by Subject|1|||
144600737|NCT03153137|521401625|FG000|Overall Study|Physician Decision|0|||
144600738|NCT03153137|521401626|FG001|Overall Study|Physician Decision|3|||
144600739|NCT01284062|521401636|FG000|Overall Study|Adverse Event|4|||
144600740|NCT01284062|521401637|FG001|Overall Study|Adverse Event|5|||
144600741|NCT01284062|521401638|FG002|Overall Study|Adverse Event|0|||
144600742|NCT01284062|521401639|FG003|Overall Study|Adverse Event|5|||
144600743|NCT01284062|521401636|FG000|Overall Study|Lack of Efficacy|3|||
144600744|NCT01284062|521401637|FG001|Overall Study|Lack of Efficacy|2|||
144600745|NCT01284062|521401638|FG002|Overall Study|Lack of Efficacy|2|||
144600746|NCT01284062|521401639|FG003|Overall Study|Lack of Efficacy|1|||
144600747|NCT01284062|521401636|FG000|Overall Study|Medication error without adverse event|0|||
144600748|NCT01284062|521401637|FG001|Overall Study|Medication error without adverse event|0|||
144600749|NCT01284062|521401638|FG002|Overall Study|Medication error without adverse event|1|||
144600750|NCT01284062|521401639|FG003|Overall Study|Medication error without adverse event|0|||
144526927|NCT03854227|521131786|FG005|Overall Study|Physician Decision|1|||
144526928|NCT03854227|521131787|FG006|Overall Study|Physician Decision|0|||
144526929|NCT03854227|521131788|FG007|Overall Study|Physician Decision|0|||
144600751|NCT01284062|521401636|FG000|Overall Study|Protocol Violation|1|||
144250313|NCT00432276|520113549|FG001|Overall Study|Other|3|||
144413181|NCT01737697|520720749|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144526930|NCT03854227|521131789|FG008|Overall Study|Physician Decision|1|||
144526931|NCT03854227|521131790|FG009|Overall Study|Physician Decision|1|||
144526932|NCT03854227|521131791|FG010|Overall Study|Physician Decision|0|||
144526933|NCT03854227|521131792|FG011|Overall Study|Physician Decision|1|||
144600752|NCT01284062|521401637|FG001|Overall Study|Protocol Violation|0|||
144600753|NCT01284062|521401638|FG002|Overall Study|Protocol Violation|0|||
144600754|NCT01284062|521401639|FG003|Overall Study|Protocol Violation|2|||
144600755|NCT01284062|521401636|FG000|Overall Study|Withdrawal by Subject|3|||
144600756|NCT01284062|521401637|FG001|Overall Study|Withdrawal by Subject|1|||
144600757|NCT01284062|521401638|FG002|Overall Study|Withdrawal by Subject|2|||
144413182|NCT01737697|520720750|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413183|NCT01737697|520720751|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413184|NCT01737697|520720752|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413185|NCT01737697|520720753|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413186|NCT01737697|520720754|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413187|NCT01737697|520720755|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413188|NCT01737697|520720756|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
144413189|NCT01737697|520720742|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413190|NCT01737697|520720743|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
144413191|NCT01737697|520720744|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
144413192|NCT01737697|520720745|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
144413193|NCT01737697|520720746|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
144413194|NCT01737697|520720747|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413195|NCT01737697|520720748|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413196|NCT01737697|520720749|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413197|NCT01737697|520720750|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413198|NCT01737697|520720751|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413199|NCT01737697|520720752|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413200|NCT01737697|520720753|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413201|NCT01737697|520720754|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413202|NCT01737697|520720755|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413203|NCT01737697|520720756|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
144413204|NCT01737697|520720742|FG000|Subacute Phase|Adverse Event|0|||
144413205|NCT01737697|520720743|FG001|Subacute Phase|Adverse Event|0|||
144413206|NCT01737697|520720744|FG002|Subacute Phase|Adverse Event|0|||
144413207|NCT01737697|520720745|FG003|Subacute Phase|Adverse Event|0|||
144413208|NCT01737697|520720746|FG004|Subacute Phase|Adverse Event|0|||
144413209|NCT01737697|520720747|FG005|Subacute Phase|Adverse Event|1|||
144413210|NCT01737697|520720748|FG006|Subacute Phase|Adverse Event|1|||
144413211|NCT01737697|520720749|FG007|Subacute Phase|Adverse Event|1|||
144413212|NCT01737697|520720750|FG008|Subacute Phase|Adverse Event|1|||
144413213|NCT01737697|520720751|FG009|Subacute Phase|Adverse Event|1|||
144413214|NCT01737697|520720752|FG010|Subacute Phase|Adverse Event|4|||
144413215|NCT01737697|520720753|FG011|Subacute Phase|Adverse Event|1|||
144413216|NCT01737697|520720754|FG012|Subacute Phase|Adverse Event|1|||
144413217|NCT01737697|520720755|FG013|Subacute Phase|Adverse Event|0|||
144413218|NCT01737697|520720756|FG014|Subacute Phase|Adverse Event|0|||
144413219|NCT01737697|520720742|FG000|Subacute Phase|Withdrawal by Subject|0|||
144413220|NCT01737697|520720743|FG001|Subacute Phase|Withdrawal by Subject|0|||
144413221|NCT01737697|520720744|FG002|Subacute Phase|Withdrawal by Subject|0|||
144413222|NCT01737697|520720745|FG003|Subacute Phase|Withdrawal by Subject|0|||
144413223|NCT01737697|520720746|FG004|Subacute Phase|Withdrawal by Subject|0|||
144413224|NCT01737697|520720747|FG005|Subacute Phase|Withdrawal by Subject|1|||
144413225|NCT01737697|520720748|FG006|Subacute Phase|Withdrawal by Subject|0|||
144413226|NCT01737697|520720749|FG007|Subacute Phase|Withdrawal by Subject|2|||
144413227|NCT01737697|520720750|FG008|Subacute Phase|Withdrawal by Subject|0|||
144413228|NCT01737697|520720751|FG009|Subacute Phase|Withdrawal by Subject|1|||
144413229|NCT01737697|520720752|FG010|Subacute Phase|Withdrawal by Subject|0|||
144413230|NCT01737697|520720753|FG011|Subacute Phase|Withdrawal by Subject|1|||
144413231|NCT01737697|520720754|FG012|Subacute Phase|Withdrawal by Subject|1|||
144413232|NCT01737697|520720755|FG013|Subacute Phase|Withdrawal by Subject|1|||
144413233|NCT01737697|520720756|FG014|Subacute Phase|Withdrawal by Subject|0|||
144413234|NCT01737697|520720742|FG000|Subacute Phase|Lost to Follow-up|0|||
144413235|NCT01737697|520720743|FG001|Subacute Phase|Lost to Follow-up|0|||
144413236|NCT01737697|520720744|FG002|Subacute Phase|Lost to Follow-up|0|||
144413237|NCT01737697|520720745|FG003|Subacute Phase|Lost to Follow-up|0|||
144413238|NCT01737697|520720746|FG004|Subacute Phase|Lost to Follow-up|0|||
144413239|NCT01737697|520720747|FG005|Subacute Phase|Lost to Follow-up|0|||
144413240|NCT01737697|520720748|FG006|Subacute Phase|Lost to Follow-up|0|||
144413241|NCT01737697|520720749|FG007|Subacute Phase|Lost to Follow-up|0|||
144413242|NCT01737697|520720750|FG008|Subacute Phase|Lost to Follow-up|0|||
144413243|NCT01737697|520720751|FG009|Subacute Phase|Lost to Follow-up|0|||
144413244|NCT01737697|520720752|FG010|Subacute Phase|Lost to Follow-up|0|||
144413245|NCT01737697|520720753|FG011|Subacute Phase|Lost to Follow-up|0|||
144413246|NCT01737697|520720754|FG012|Subacute Phase|Lost to Follow-up|0|||
144413247|NCT01737697|520720755|FG013|Subacute Phase|Lost to Follow-up|0|||
144413248|NCT01737697|520720756|FG014|Subacute Phase|Lost to Follow-up|1|||
144413249|NCT01737697|520720742|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
144413250|NCT01737697|520720743|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
144413251|NCT01737697|520720744|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
144413252|NCT01737697|520720745|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
144413253|NCT01737697|520720746|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
144413254|NCT01737697|520720747|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
144413255|NCT01737697|520720748|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
144413256|NCT01737697|520720749|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
144413257|NCT01737697|520720750|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
144413258|NCT01737697|520720751|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
144413259|NCT01737697|520720752|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
144413260|NCT01737697|520720753|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
144413261|NCT01737697|520720754|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
144413262|NCT01737697|520720755|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
144413263|NCT01737697|520720756|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
144413264|NCT01737697|520720742|FG000|Subacute Phase|Protocol Violation|0|||
144413265|NCT01737697|520720743|FG001|Subacute Phase|Protocol Violation|0|||
144413266|NCT01737697|520720744|FG002|Subacute Phase|Protocol Violation|0|||
144413267|NCT01737697|520720745|FG003|Subacute Phase|Protocol Violation|0|||
144413268|NCT01737697|520720746|FG004|Subacute Phase|Protocol Violation|0|||
144413269|NCT01737697|520720747|FG005|Subacute Phase|Protocol Violation|1|||
144413270|NCT01737697|520720748|FG006|Subacute Phase|Protocol Violation|0|||
144413271|NCT01737697|520720749|FG007|Subacute Phase|Protocol Violation|0|||
144413272|NCT01737697|520720750|FG008|Subacute Phase|Protocol Violation|0|||
144413273|NCT01737697|520720751|FG009|Subacute Phase|Protocol Violation|0|||
144413274|NCT01737697|520720752|FG010|Subacute Phase|Protocol Violation|1|||
144413275|NCT01737697|520720753|FG011|Subacute Phase|Protocol Violation|0|||
144413276|NCT01737697|520720754|FG012|Subacute Phase|Protocol Violation|0|||
144413277|NCT01737697|520720755|FG013|Subacute Phase|Protocol Violation|0|||
144413278|NCT01737697|520720756|FG014|Subacute Phase|Protocol Violation|0|||
144413279|NCT01737697|520720742|FG000|Subacute Phase|Physician Decision|0|||
144413280|NCT01737697|520720743|FG001|Subacute Phase|Physician Decision|0|||
144413281|NCT01737697|520720744|FG002|Subacute Phase|Physician Decision|0|||
144413282|NCT01737697|520720745|FG003|Subacute Phase|Physician Decision|0|||
144413283|NCT01737697|520720746|FG004|Subacute Phase|Physician Decision|0|||
144413284|NCT01737697|520720747|FG005|Subacute Phase|Physician Decision|0|||
144413285|NCT01737697|520720748|FG006|Subacute Phase|Physician Decision|0|||
144413286|NCT01737697|520720749|FG007|Subacute Phase|Physician Decision|0|||
144413287|NCT01737697|520720750|FG008|Subacute Phase|Physician Decision|1|||
144413288|NCT01737697|520720751|FG009|Subacute Phase|Physician Decision|0|||
144413289|NCT01737697|520720752|FG010|Subacute Phase|Physician Decision|0|||
144413290|NCT01737697|520720753|FG011|Subacute Phase|Physician Decision|0|||
144413291|NCT01737697|520720754|FG012|Subacute Phase|Physician Decision|0|||
144413292|NCT01737697|520720755|FG013|Subacute Phase|Physician Decision|0|||
144413293|NCT01737697|520720756|FG014|Subacute Phase|Physician Decision|0|||
144413294|NCT01737697|520720742|FG000|Subacute Phase|Death|0|||
144413295|NCT01737697|520720743|FG001|Subacute Phase|Death|0|||
144413296|NCT01737697|520720744|FG002|Subacute Phase|Death|0|||
144413297|NCT01737697|520720745|FG003|Subacute Phase|Death|0|||
144413298|NCT01737697|520720746|FG004|Subacute Phase|Death|0|||
144413299|NCT01737697|520720747|FG005|Subacute Phase|Death|0|||
144413300|NCT01737697|520720748|FG006|Subacute Phase|Death|0|||
144413301|NCT01737697|520720749|FG007|Subacute Phase|Death|0|||
144413302|NCT01737697|520720750|FG008|Subacute Phase|Death|0|||
144413303|NCT01737697|520720751|FG009|Subacute Phase|Death|0|||
144413304|NCT01737697|520720752|FG010|Subacute Phase|Death|1|||
144413305|NCT01737697|520720753|FG011|Subacute Phase|Death|0|||
144413306|NCT01737697|520720754|FG012|Subacute Phase|Death|0|||
144413307|NCT01737697|520720755|FG013|Subacute Phase|Death|0|||
144413308|NCT01737697|520720756|FG014|Subacute Phase|Death|0|||
144413309|NCT01866930|520720758|FG000|Treatment Period|Other|1|||
144413310|NCT01866930|520720759|FG001|Treatment Period|Other|0|||
144413311|NCT01866930|520720758|FG000|Treatment Period|Death|0|||
144413312|NCT01866930|520720759|FG001|Treatment Period|Death|2|||
144413313|NCT01866930|520720758|FG000|Treatment Period|Poor/non compliance|0|||
144413314|NCT01866930|520720759|FG001|Treatment Period|Poor/non compliance|2|||
144413315|NCT01866930|520720758|FG000|Treatment Period|No longer meets study criteria|0|||
144413316|NCT01866930|520720759|FG001|Treatment Period|No longer meets study criteria|1|||
144526934|NCT03854227|521131781|FG000|Overall Study|Progressive disease|1|||
144526935|NCT03854227|521131782|FG001|Overall Study|Progressive disease|1|||
144526936|NCT03854227|521131783|FG002|Overall Study|Progressive disease|1|||
144526937|NCT03854227|521131784|FG003|Overall Study|Progressive disease|2|||
144413317|NCT01866930|520720758|FG000|Treatment Period|Withdrawal by Subject|2|||
144413318|NCT01866930|520720759|FG001|Treatment Period|Withdrawal by Subject|8|||
144413319|NCT01866930|520720758|FG000|Treatment Period|Lack of Efficacy|1|||
144413320|NCT01866930|520720759|FG001|Treatment Period|Lack of Efficacy|9|||
144413321|NCT01866930|520720758|FG000|Treatment Period|Adverse Event|4|||
144413322|NCT01866930|520720759|FG001|Treatment Period|Adverse Event|12|||
144413323|NCT01866930|520720758|FG000|Treatment Period|Lost to Follow-up|1|||
144413324|NCT01866930|520720759|FG001|Treatment Period|Lost to Follow-up|1|||
144413325|NCT01866930|520720758|FG000|Follow-up Period|Lost to Follow-up|1|||
144413326|NCT01866930|520720759|FG001|Follow-up Period|Lost to Follow-up|1|||
144413327|NCT01866930|520720758|FG000|Follow-up Period|Other|1|||
144413328|NCT01866930|520720759|FG001|Follow-up Period|Other|5|||
144413329|NCT01866930|520720758|FG000|Follow-up Period|No longer required per protocol|1|||
144413330|NCT01866930|520720759|FG001|Follow-up Period|No longer required per protocol|0|||
144413331|NCT01866930|520720758|FG000|Follow-up Period|Withdrawal by Subject|3|||
144413332|NCT01866930|520720759|FG001|Follow-up Period|Withdrawal by Subject|3|||
144526938|NCT03854227|521131785|FG004|Overall Study|Progressive disease|3|||
144413333|NCT03648983|520720760|FG000|Overall Study|Study was terminated due to PI departure|95|||
144413334|NCT02521870|520720763|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413335|NCT02521870|520720764|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
144413336|NCT02521870|520720765|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144250314|NCT00655681|520113550|FG000|Overall Study|Lost to Follow-up|1|||
144250315|NCT00655681|520113551|FG001|Overall Study|Lost to Follow-up|1|||
144250316|NCT00467961|520113553|FG000|Overall Study|Technical Failures|5|||
144250317|NCT00467961|520113553|FG000|Overall Study|Disease Progression|2|||
144250318|NCT02429310|520113555|FG000|Overall Study|Lost to Follow-up|1|||
144250319|NCT02429310|520113556|FG001|Overall Study|Lost to Follow-up|2|||
144250320|NCT02429310|520113555|FG000|Overall Study|Protocol Violation|1|||
144250321|NCT02429310|520113556|FG001|Overall Study|Protocol Violation|1|||
144250322|NCT02227368|520115459|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
144250323|NCT02227368|520115460|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
144250324|NCT02227368|520115459|FG000|Overall Study|Lost to Follow-up|1|||
144250325|NCT02227368|520115460|FG001|Overall Study|Lost to Follow-up|0|||
144250326|NCT02227368|520115459|FG000|Overall Study|Adverse Event|1|||
144250327|NCT02227368|520115460|FG001|Overall Study|Adverse Event|0|||
144250328|NCT02510820|520115464|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
144250329|NCT02510820|520115465|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144250330|NCT02510820|520115464|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144413337|NCT02521870|520720766|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413338|NCT02521870|520720767|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413339|NCT02521870|520720768|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413340|NCT02521870|520720769|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413341|NCT02521870|520720770|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413342|NCT02521870|520720771|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413343|NCT02521870|520720772|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413344|NCT02521870|520720773|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144526939|NCT03854227|521131786|FG005|Overall Study|Progressive disease|1|||
144526940|NCT03854227|521131787|FG006|Overall Study|Progressive disease|2|||
144526941|NCT03854227|521131788|FG007|Overall Study|Progressive disease|5|||
144526942|NCT03854227|521131789|FG008|Overall Study|Progressive disease|2|||
144526943|NCT03854227|521131790|FG009|Overall Study|Progressive disease|5|||
144526944|NCT03854227|521131791|FG010|Overall Study|Progressive disease|1|||
144526945|NCT03854227|521131792|FG011|Overall Study|Progressive disease|6|||
144526946|NCT03854227|521131781|FG000|Overall Study|Study terminated by sponsor|0|||
144526947|NCT03854227|521131782|FG001|Overall Study|Study terminated by sponsor|0|||
144526948|NCT03854227|521131783|FG002|Overall Study|Study terminated by sponsor|0|||
144526949|NCT03854227|521131784|FG003|Overall Study|Study terminated by sponsor|0|||
144526950|NCT03854227|521131785|FG004|Overall Study|Study terminated by sponsor|0|||
144526951|NCT03854227|521131786|FG005|Overall Study|Study terminated by sponsor|0|||
144526952|NCT03854227|521131787|FG006|Overall Study|Study terminated by sponsor|0|||
144526953|NCT03854227|521131788|FG007|Overall Study|Study terminated by sponsor|0|||
144526954|NCT03854227|521131789|FG008|Overall Study|Study terminated by sponsor|0|||
144526955|NCT03854227|521131790|FG009|Overall Study|Study terminated by sponsor|1|||
144526956|NCT03854227|521131791|FG010|Overall Study|Study terminated by sponsor|0|||
144526957|NCT03854227|521131792|FG011|Overall Study|Study terminated by sponsor|0|||
144526958|NCT03854227|521131781|FG000|Overall Study|Withdrawal by Subject|0|||
144526959|NCT03854227|521131782|FG001|Overall Study|Withdrawal by Subject|0|||
144526960|NCT03854227|521131783|FG002|Overall Study|Withdrawal by Subject|1|||
144526961|NCT03854227|521131784|FG003|Overall Study|Withdrawal by Subject|0|||
144526962|NCT03854227|521131785|FG004|Overall Study|Withdrawal by Subject|0|||
144526963|NCT03854227|521131786|FG005|Overall Study|Withdrawal by Subject|0|||
144526964|NCT03854227|521131787|FG006|Overall Study|Withdrawal by Subject|0|||
144526965|NCT03854227|521131788|FG007|Overall Study|Withdrawal by Subject|0|||
144526966|NCT03854227|521131789|FG008|Overall Study|Withdrawal by Subject|0|||
144526967|NCT03854227|521131790|FG009|Overall Study|Withdrawal by Subject|1|||
144526968|NCT03854227|521131791|FG010|Overall Study|Withdrawal by Subject|1|||
144526969|NCT03854227|521131792|FG011|Overall Study|Withdrawal by Subject|0|||
144526970|NCT03854227|521131781|FG000|Overall Study|Disease relapse|0|||
144526971|NCT03854227|521131782|FG001|Overall Study|Disease relapse|0|||
144526972|NCT03854227|521131783|FG002|Overall Study|Disease relapse|0|||
144526973|NCT03854227|521131784|FG003|Overall Study|Disease relapse|0|||
144526974|NCT03854227|521131785|FG004|Overall Study|Disease relapse|0|||
144526975|NCT03854227|521131786|FG005|Overall Study|Disease relapse|0|||
144526976|NCT03854227|521131787|FG006|Overall Study|Disease relapse|0|||
144526977|NCT03854227|521131788|FG007|Overall Study|Disease relapse|0|||
144526978|NCT03854227|521131789|FG008|Overall Study|Disease relapse|1|||
144526979|NCT03854227|521131790|FG009|Overall Study|Disease relapse|0|||
144526980|NCT03854227|521131791|FG010|Overall Study|Disease relapse|0|||
144526981|NCT03854227|521131792|FG011|Overall Study|Disease relapse|0|||
144526982|NCT03854227|521131781|FG000|Overall Study|Global deterioration of health status|0|||
144526983|NCT03854227|521131782|FG001|Overall Study|Global deterioration of health status|0|||
144526984|NCT03854227|521131783|FG002|Overall Study|Global deterioration of health status|0|||
144250331|NCT02510820|520115465|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
144250332|NCT03046056|520115466|FG000|Overall Study|Non-responder at Week 10|6|||
144250333|NCT03046056|520115467|FG001|Overall Study|Non-responder at Week 10|6|||
144250334|NCT03046056|520115468|FG002|Overall Study|Non-responder at Week 10|4|||
144250335|NCT03046056|520115466|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
144250336|NCT03046056|520115467|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
144250337|NCT03046056|520115468|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
144250338|NCT03046056|520115466|FG000|Overall Study|Adverse Event|1|||
144250339|NCT03046056|520115467|FG001|Overall Study|Adverse Event|5|||
144250340|NCT03046056|520115468|FG002|Overall Study|Adverse Event|0|||
144250341|NCT03046056|520115466|FG000|Overall Study|Non-compliance With Study Drug|0|||
144250342|NCT03046056|520115467|FG001|Overall Study|Non-compliance With Study Drug|0|||
144250343|NCT03046056|520115468|FG002|Overall Study|Non-compliance With Study Drug|2|||
144250344|NCT03046056|520115466|FG000|Overall Study|Protocol Violation|1|||
144250345|NCT03046056|520115467|FG001|Overall Study|Protocol Violation|1|||
144250346|NCT03046056|520115468|FG002|Overall Study|Protocol Violation|0|||
144250347|NCT03046056|520115466|FG000|Overall Study|Investigator's Discretion|0|||
144250348|NCT03046056|520115467|FG001|Overall Study|Investigator's Discretion|1|||
144413345|NCT02521870|520720774|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144413346|NCT02521870|520720763|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
144413347|NCT02521870|520720764|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
144413348|NCT02521870|520720765|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
144413349|NCT02521870|520720766|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
144413350|NCT02521870|520720767|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
144413351|NCT02521870|520720768|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
144413352|NCT02521870|520720769|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
144413353|NCT02521870|520720770|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
144413354|NCT02521870|520720771|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
144413355|NCT02521870|520720772|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
144413356|NCT02521870|520720773|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
144413357|NCT02521870|520720774|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
144413358|NCT02521870|520720763|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
144413359|NCT02521870|520720764|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
144413360|NCT02521870|520720765|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
144413361|NCT02521870|520720766|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
144413362|NCT02521870|520720767|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
144413363|NCT02521870|520720768|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
144413364|NCT02521870|520720769|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
144413365|NCT02521870|520720770|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
144413366|NCT02521870|520720771|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
144413367|NCT02521870|520720772|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
144413368|NCT02521870|520720773|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
144413369|NCT02521870|520720774|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
144413370|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144413371|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144413372|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144413373|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144413374|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
144413375|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
144413376|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
144413377|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144413378|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
144413379|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
144413380|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
144413381|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144413382|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
144413383|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
144413384|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
144413385|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
144413386|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
144413387|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
144413388|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
144722940|NCT01656889|521840586|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
144413389|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
144413390|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
144413391|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
144413392|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
144413393|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
144413394|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
144413395|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
144413396|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
144722941|NCT01656889|521840585|FG000|Treatment Period, 12 Weeks|Death|0|||
144250349|NCT03046056|520115468|FG002|Overall Study|Investigator's Discretion|0|||
144250350|NCT03046056|520115466|FG000|Overall Study|Withdrew Consent|1|||
144250351|NCT03046056|520115467|FG001|Overall Study|Withdrew Consent|0|||
144250352|NCT03046056|520115468|FG002|Overall Study|Withdrew Consent|0|||
144250353|NCT02913105|520115469|FG000|Overall Study|Adverse Event|11|||
144250354|NCT02913105|520115470|FG001|Overall Study|Adverse Event|0|||
144250355|NCT02913105|520115471|FG002|Overall Study|Adverse Event|4|||
144250356|NCT02913105|520115469|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144250357|NCT02913105|520115470|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144250358|NCT02913105|520115471|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144250359|NCT02913105|520115469|FG000|Overall Study|Reason Not Specified|3|||
144250360|NCT02913105|520115470|FG001|Overall Study|Reason Not Specified|1|||
144250361|NCT02913105|520115471|FG002|Overall Study|Reason Not Specified|1|||
144250362|NCT02913105|520115469|FG000|Overall Study|Physician Decision|1|||
144250363|NCT02913105|520115470|FG001|Overall Study|Physician Decision|1|||
144250364|NCT02913105|520115471|FG002|Overall Study|Physician Decision|0|||
144250365|NCT02913105|520115469|FG000|Overall Study|Withdrawal by Subject|0|||
144250366|NCT02913105|520115470|FG001|Overall Study|Withdrawal by Subject|3|||
144250367|NCT02913105|520115471|FG002|Overall Study|Withdrawal by Subject|1|||
144250368|NCT01317004|520115472|FG000|Overall Study|Withdrawal by Subject|1|||
144250369|NCT01317004|520115473|FG001|Overall Study|Withdrawal by Subject|4|||
144250370|NCT01317004|520115472|FG000|Overall Study|Protocol Violation|0|||
144250371|NCT01317004|520115473|FG001|Overall Study|Protocol Violation|2|||
144413397|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
144413398|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
144413399|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
144413400|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
144413401|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
144413402|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
144413403|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
144413404|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
144413405|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
144413406|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Death|0|||
144413407|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Death|0|||
144413408|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Death|0|||
144413409|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Death|0|||
144413410|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Death|1|||
144413411|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Death|1|||
144413412|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Death|3|||
144413413|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Death|1|||
144413414|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Death|1|||
144413415|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Death|5|||
144413416|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Death|2|||
144413417|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Death|2|||
144413418|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Other|0|||
144413419|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Other|0|||
144413420|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Other|0|||
144413421|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Other|0|||
144413422|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Other|10|||
144413423|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Other|3|||
144413424|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Other|2|||
144413425|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Other|0|||
144413426|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Other|10|||
144413427|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Other|5|||
144413428|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Other|1|||
144413429|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Other|7|||
144413430|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413431|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413432|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413433|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413434|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
144413435|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144250372|NCT01317004|520115472|FG000|Overall Study|Adverse Event|3|||
144250373|NCT01317004|520115473|FG001|Overall Study|Adverse Event|3|||
144413436|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413437|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413438|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413439|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144722942|NCT01656889|521840586|FG001|Treatment Period, 12 Weeks|Death|1|||
144250374|NCT04114656|520115474|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
144413440|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413441|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144413442|NCT02521870|520720763|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413443|NCT02521870|520720764|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413444|NCT02521870|520720765|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144250375|NCT04114656|520115475|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
144413445|NCT02521870|520720766|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413446|NCT02521870|520720767|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
144413447|NCT02521870|520720768|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413448|NCT02521870|520720769|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413449|NCT02521870|520720770|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413450|NCT02521870|520720771|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413451|NCT02521870|520720772|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413452|NCT02521870|520720773|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413453|NCT02521870|520720774|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
144413454|NCT00279305|520720775|FG000|Overall Study|Pregnancy|1|||
144413455|NCT00279305|520720776|FG001|Overall Study|Pregnancy|0|||
144413456|NCT00279305|520720775|FG000|Overall Study|Withdrawal by Subject|2|||
144413457|NCT00279305|520720776|FG001|Overall Study|Withdrawal by Subject|0|||
144413458|NCT00279305|520720775|FG000|Overall Study|Dificulting establishing IV|1|||
144413459|NCT00279305|520720776|FG001|Overall Study|Dificulting establishing IV|0|||
144413460|NCT00279305|520720775|FG000|Overall Study|FDA Safety Alert|4|||
144413461|NCT00279305|520720776|FG001|Overall Study|FDA Safety Alert|1|||
144413462|NCT04404361|520720778|FG000|Overall Study|Death|12|||
144413463|NCT04404361|520720779|FG001|Overall Study|Death|12|||
144413464|NCT04404361|520720778|FG000|Overall Study|Withdrawal by Subject|13|||
144413465|NCT04404361|520720779|FG001|Overall Study|Withdrawal by Subject|5|||
144413466|NCT04404361|520720778|FG000|Overall Study|Lost to Follow-up|6|||
144413467|NCT04404361|520720779|FG001|Overall Study|Lost to Follow-up|3|||
144413468|NCT04404361|520720778|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
144413469|NCT04404361|520720779|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
144413470|NCT02862171|520720780|FG000|Overall Study|Death|1|||
144413471|NCT02862171|520720780|FG000|Overall Study|Lost to Follow-up|13|||
144413472|NCT02862171|520720780|FG000|Overall Study|Withdrawal by Subject|57|||
144413473|NCT02862171|520720780|FG000|Overall Study|Non-compliance|4|||
144413474|NCT02862171|520720780|FG000|Overall Study|HIV-1 seroconversion|18|||
144413475|NCT00558558|520720781|FG000|Overall Study|Unable to swallow|1|||
144413476|NCT00558558|520720781|FG000|Overall Study|Withdrawal by Subject|1|||
144413477|NCT00558558|520720781|FG000|Overall Study|Lack of Efficacy|4|||
144413478|NCT02549937|520720783|FG000|Overall Study|Death|0|||
144413479|NCT02549937|520720784|FG001|Overall Study|Death|1|||
144413480|NCT02549937|520720785|FG002|Overall Study|Death|0|||
144526985|NCT03854227|521131784|FG003|Overall Study|Global deterioration of health status|0|||
144526986|NCT03854227|521131785|FG004|Overall Study|Global deterioration of health status|0|||
144526987|NCT03854227|521131786|FG005|Overall Study|Global deterioration of health status|1|||
144526988|NCT03854227|521131787|FG006|Overall Study|Global deterioration of health status|0|||
144526989|NCT03854227|521131788|FG007|Overall Study|Global deterioration of health status|1|||
144526990|NCT03854227|521131789|FG008|Overall Study|Global deterioration of health status|0|||
144526991|NCT03854227|521131790|FG009|Overall Study|Global deterioration of health status|0|||
144526992|NCT03854227|521131791|FG010|Overall Study|Global deterioration of health status|0|||
144526993|NCT03854227|521131792|FG011|Overall Study|Global deterioration of health status|0|||
144526994|NCT03854227|521131781|FG000|Overall Study|Refused further treatment|0|||
144526995|NCT03854227|521131782|FG001|Overall Study|Refused further treatment|0|||
144526996|NCT03854227|521131783|FG002|Overall Study|Refused further treatment|0|||
144526997|NCT03854227|521131784|FG003|Overall Study|Refused further treatment|0|||
144526998|NCT03854227|521131785|FG004|Overall Study|Refused further treatment|0|||
144526999|NCT03854227|521131786|FG005|Overall Study|Refused further treatment|0|||
144527000|NCT03854227|521131787|FG006|Overall Study|Refused further treatment|0|||
144527001|NCT03854227|521131788|FG007|Overall Study|Refused further treatment|0|||
144527002|NCT03854227|521131789|FG008|Overall Study|Refused further treatment|0|||
144527003|NCT03854227|521131790|FG009|Overall Study|Refused further treatment|1|||
144527004|NCT03854227|521131791|FG010|Overall Study|Refused further treatment|0|||
144527005|NCT03854227|521131792|FG011|Overall Study|Refused further treatment|1|||
144527006|NCT03854227|521131781|FG000|Overall Study|Other|0|||
144527007|NCT03854227|521131782|FG001|Overall Study|Other|0|||
144527008|NCT03854227|521131783|FG002|Overall Study|Other|0|||
144527009|NCT03854227|521131784|FG003|Overall Study|Other|0|||
144527010|NCT03854227|521131785|FG004|Overall Study|Other|0|||
144527011|NCT03854227|521131786|FG005|Overall Study|Other|0|||
144527012|NCT03854227|521131787|FG006|Overall Study|Other|0|||
144527013|NCT03854227|521131788|FG007|Overall Study|Other|0|||
144527014|NCT03854227|521131789|FG008|Overall Study|Other|1|||
144527015|NCT03854227|521131790|FG009|Overall Study|Other|1|||
144527016|NCT03854227|521131791|FG010|Overall Study|Other|0|||
144527017|NCT03854227|521131792|FG011|Overall Study|Other|0|||
144527018|NCT03668236|521131793|FG000|90-day Follow-up|Withdrawal by Subject|3|||
144527019|NCT03668236|521131794|FG001|90-day Follow-up|Withdrawal by Subject|2|||
144527020|NCT03668236|521131793|FG000|90-day Follow-up|Lost to Follow-up|3|||
144527021|NCT03668236|521131794|FG001|90-day Follow-up|Lost to Follow-up|1|||
144527022|NCT03668236|521131793|FG000|Baseline Characteristics|Lost to Follow-up|9|||
144527023|NCT03668236|521131794|FG001|Baseline Characteristics|Lost to Follow-up|5|||
144413481|NCT02549937|520720786|FG003|Overall Study|Death|1|||
144413482|NCT02549937|520720787|FG004|Overall Study|Death|0|||
144413483|NCT02549937|520720788|FG005|Overall Study|Death|8|||
144413484|NCT02549937|520720789|FG006|Overall Study|Death|0|||
144413485|NCT02549937|520720790|FG007|Overall Study|Death|0|||
144413486|NCT02549937|520720791|FG008|Overall Study|Death|19|||
144413487|NCT02549937|520720783|FG000|Overall Study|No follow up required|3|||
144413488|NCT02549937|520720784|FG001|Overall Study|No follow up required|6|||
144413489|NCT02549937|520720785|FG002|Overall Study|No follow up required|3|||
144413490|NCT02549937|520720786|FG003|Overall Study|No follow up required|8|||
144527024|NCT03668236|521131793|FG000|1-year Follow-up|Withdrawal by Subject|17|||
144527025|NCT03668236|521131794|FG001|1-year Follow-up|Withdrawal by Subject|15|||
144527026|NCT06132282|521131795|FG000|Overall Study|Lost to Follow-up|31|||
144527027|NCT03748953|521131796|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
144527028|NCT03748953|521131797|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
144527029|NCT03748953|521131796|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
144527030|NCT03748953|521131797|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
144527031|NCT03748953|521131796|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
144527032|NCT03748953|521131797|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
144527033|NCT03748953|521131796|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
144527034|NCT03748953|521131797|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
144527035|NCT03748953|521131796|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
144527036|NCT03748953|521131797|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
144527037|NCT02276885|521131798|FG000|Overall Study|Withdrawal by Subject|2|||
144527038|NCT02276885|521131799|FG001|Overall Study|Withdrawal by Subject|0|||
144527039|NCT02276885|521131798|FG000|Overall Study|Lost to Follow-up|5|||
144527040|NCT02276885|521131799|FG001|Overall Study|Lost to Follow-up|2|||
144527041|NCT03858634|521131801|FG000|Overall Study|Withdrawal by Subject|1|||
144527042|NCT03858634|521131802|FG001|Overall Study|Withdrawal by Subject|0|||
144527043|NCT03858634|521131801|FG000|Overall Study|Adverse Event|1|||
144527044|NCT03858634|521131802|FG001|Overall Study|Adverse Event|0|||
144527045|NCT03858634|521131801|FG000|Overall Study|Lost to Follow-up|0|||
144527046|NCT03858634|521131802|FG001|Overall Study|Lost to Follow-up|1|||
144527047|NCT03858634|521131801|FG000|Overall Study|Other, Not Specified|1|||
144527048|NCT03858634|521131802|FG001|Overall Study|Other, Not Specified|1|||
144527049|NCT03150173|521131803|FG000|Overall Study|Lost to Follow-up|13|||
144527050|NCT03150173|521131804|FG001|Overall Study|Lost to Follow-up|5|||
144527051|NCT03461276|521131811|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
144527052|NCT03461276|521131812|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
144527053|NCT03461276|521131811|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
144527054|NCT03461276|521131812|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
144527055|NCT03461276|521131811|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
144527056|NCT03461276|521131812|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
144527057|NCT03461276|521131811|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
144527058|NCT03461276|521131812|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
144527059|NCT03461276|521131811|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
144527060|NCT03461276|521131812|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
144527061|NCT03461276|521131811|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
144527062|NCT03461276|521131812|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
144527063|NCT03461276|521131811|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
144527064|NCT03461276|521131812|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
144527065|NCT03461276|521131811|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
144527066|NCT03461276|521131812|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
144527067|NCT03461276|521131811|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
144527068|NCT03461276|521131812|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
144527069|NCT03461276|521131811|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
144527070|NCT03461276|521131812|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
144527071|NCT01593917|521131813|FG000|Overall Study|Death|67|||
144527072|NCT01593917|521131813|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
144527073|NCT01593917|521131813|FG000|Overall Study|Withdrawal by Subject|23|||
144527074|NCT01593917|521131813|FG000|Overall Study|Lost to Follow-up|12|||
144250376|NCT04114656|520115474|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
144413491|NCT02549937|520720787|FG004|Overall Study|No follow up required|12|||
144413492|NCT02549937|520720788|FG005|Overall Study|No follow up required|21|||
144527075|NCT01593917|521131813|FG000|Overall Study|Protocol Violation|5|||
144527076|NCT01593917|521131813|FG000|Overall Study|Physician Decision|3|||
144527077|NCT02841579|521131814|FG000|Overall Study|Death|1|||
144527078|NCT02841579|521131814|FG000|Overall Study|Adverse Event|1|||
144413493|NCT02549937|520720789|FG006|Overall Study|No follow up required|9|||
144527079|NCT02841579|521131814|FG000|Overall Study|Lack of Efficacy|9|||
144527080|NCT03652389|521131815|FG000|Overall Study|Lost to Follow-up|1|||
144527081|NCT03652389|521131816|FG001|Overall Study|Lost to Follow-up|5|||
144527082|NCT03652389|521131815|FG000|Overall Study|Withdrawal by Subject|5|||
144250377|NCT04114656|520115475|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
144250378|NCT04114656|520115474|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
144250379|NCT04114656|520115475|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
144250380|NCT04114656|520115474|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
144250381|NCT04114656|520115475|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
144250382|NCT04114656|520115474|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
144250383|NCT04114656|520115475|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
144250384|NCT02474355|520115479|FG000|Overall Study|Other|43|||
144250385|NCT02474355|520115479|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
144413494|NCT02549937|520720790|FG007|Overall Study|No follow up required|11|||
144413495|NCT02549937|520720791|FG008|Overall Study|No follow up required|0|||
144413496|NCT02549937|520720783|FG000|Overall Study|Other|0|||
144413497|NCT02549937|520720784|FG001|Overall Study|Other|0|||
144413498|NCT02549937|520720785|FG002|Overall Study|Other|0|||
144413499|NCT02549937|520720786|FG003|Overall Study|Other|0|||
144413500|NCT02549937|520720787|FG004|Overall Study|Other|1|||
144413501|NCT02549937|520720788|FG005|Overall Study|Other|0|||
144413502|NCT02549937|520720789|FG006|Overall Study|Other|3|||
144413503|NCT02549937|520720790|FG007|Overall Study|Other|2|||
144413504|NCT02549937|520720791|FG008|Overall Study|Other|3|||
144413505|NCT02549937|520720783|FG000|Overall Study|Lost to Follow-up|0|||
144413506|NCT02549937|520720784|FG001|Overall Study|Lost to Follow-up|0|||
144413507|NCT02549937|520720785|FG002|Overall Study|Lost to Follow-up|0|||
144413508|NCT02549937|520720786|FG003|Overall Study|Lost to Follow-up|0|||
144413509|NCT02549937|520720787|FG004|Overall Study|Lost to Follow-up|0|||
144413510|NCT02549937|520720788|FG005|Overall Study|Lost to Follow-up|0|||
144413511|NCT02549937|520720789|FG006|Overall Study|Lost to Follow-up|0|||
144413512|NCT02549937|520720790|FG007|Overall Study|Lost to Follow-up|0|||
144413513|NCT02549937|520720791|FG008|Overall Study|Lost to Follow-up|3|||
144722943|NCT01656889|521840585|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
144722944|NCT01656889|521840586|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
144722945|NCT01656889|521840585|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
144722946|NCT01656889|521840586|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
144722947|NCT01656889|521840585|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
144722948|NCT01656889|521840586|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
144722949|NCT01656889|521840585|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
144722950|NCT01656889|521840586|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
144722951|NCT01656889|521840585|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
144722952|NCT01656889|521840586|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
144722953|NCT01656889|521840585|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
144722954|NCT01656889|521840586|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
144722955|NCT01656889|521840585|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
144722956|NCT01656889|521840586|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
144722957|NCT01656889|521840585|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
144722958|NCT01656889|521840586|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
144722959|NCT03387098|521840587|FG000|Overall Study|progressive disease|1|||
144250386|NCT02474355|520115479|FG000|Overall Study|Lost to Follow-up|98|||
144250387|NCT02474355|520115479|FG000|Overall Study|Withdrawal by Subject|124|||
144250388|NCT02474355|520115479|FG000|Overall Study|Death|1361|||
144250389|NCT02469168|520115486|FG000|Overall Study|Trial closed|1|||
144250390|NCT02469168|520115487|FG001|Overall Study|Trial closed|0|||
144250391|NCT00135356|520115488|FG000|Overall Study|Adverse Event|6|||
144250392|NCT00135356|520115489|FG001|Overall Study|Adverse Event|2|||
144250393|NCT00135356|520115488|FG000|Overall Study|Lack of Efficacy|2|||
144250394|NCT00135356|520115489|FG001|Overall Study|Lack of Efficacy|0|||
144250395|NCT00135356|520115488|FG000|Overall Study|Lost to Follow-up|3|||
144413514|NCT02549937|520720783|FG000|Overall Study|Withdrawal by Subject|0|||
144413515|NCT02549937|520720784|FG001|Overall Study|Withdrawal by Subject|0|||
144413516|NCT02549937|520720785|FG002|Overall Study|Withdrawal by Subject|0|||
144722960|NCT03387098|521840587|FG000|Overall Study|Withdrawal by Subject|2|||
144250396|NCT00135356|520115489|FG001|Overall Study|Lost to Follow-up|1|||
144250397|NCT00135356|520115488|FG000|Overall Study|Surgery for abdominal fat|1|||
144413517|NCT02549937|520720786|FG003|Overall Study|Withdrawal by Subject|0|||
144413518|NCT02549937|520720787|FG004|Overall Study|Withdrawal by Subject|0|||
144413519|NCT02549937|520720788|FG005|Overall Study|Withdrawal by Subject|1|||
144413520|NCT02549937|520720789|FG006|Overall Study|Withdrawal by Subject|4|||
144413521|NCT02549937|520720790|FG007|Overall Study|Withdrawal by Subject|3|||
144413522|NCT02549937|520720791|FG008|Overall Study|Withdrawal by Subject|2|||
144722961|NCT03387098|521840587|FG000|Overall Study|study terminated by sponsor|1|||
144722962|NCT02486796|521840588|FG000|Overall Study|Withdrawal by Subject|1|||
144722963|NCT02486796|521840589|FG001|Overall Study|Withdrawal by Subject|1|||
144722964|NCT02486796|521840588|FG000|Overall Study|Physician Decision|1|||
144413523|NCT02549937|520720783|FG000|Overall Study|Sponsor Decision|0|||
144722965|NCT02486796|521840589|FG001|Overall Study|Physician Decision|0|||
144413524|NCT02549937|520720784|FG001|Overall Study|Sponsor Decision|0|||
144413525|NCT02549937|520720785|FG002|Overall Study|Sponsor Decision|0|||
144413526|NCT02549937|520720786|FG003|Overall Study|Sponsor Decision|0|||
144413527|NCT02549937|520720787|FG004|Overall Study|Sponsor Decision|0|||
144413528|NCT02549937|520720788|FG005|Overall Study|Sponsor Decision|0|||
144413529|NCT02549937|520720789|FG006|Overall Study|Sponsor Decision|0|||
144413530|NCT02549937|520720790|FG007|Overall Study|Sponsor Decision|0|||
144413531|NCT02549937|520720791|FG008|Overall Study|Sponsor Decision|6|||
144413532|NCT03930797|520720792|FG000|Overall Study|Lost to Follow-up|3|||
144413533|NCT03930797|520720793|FG001|Overall Study|Lost to Follow-up|10|||
144413534|NCT00662012|520720794|FG000|Overall Study|Lost to Follow-up|85|||
144413535|NCT00662012|520720794|FG000|Overall Study|Death|1|||
144413536|NCT00662012|520720794|FG000|Overall Study|Withdrawal by Subject|1|||
144413537|NCT02144012|520720798|FG000|Overall Study|Adverse Event|1|||
144413538|NCT02144012|520720799|FG001|Overall Study|Adverse Event|0|||
144413539|NCT02144012|520720798|FG000|Overall Study|Death|1|||
144413540|NCT02144012|520720799|FG001|Overall Study|Death|0|||
144413541|NCT02144012|520720798|FG000|Overall Study|Withdrawal by Subject|11|||
144413542|NCT02144012|520720799|FG001|Overall Study|Withdrawal by Subject|3|||
144413543|NCT02144012|520720798|FG000|Overall Study|Study Terminated by Sponsor|18|||
144413544|NCT02144012|520720799|FG001|Overall Study|Study Terminated by Sponsor|12|||
144413545|NCT02144012|520720798|FG000|Overall Study|Other|3|||
144413546|NCT02144012|520720799|FG001|Overall Study|Other|0|||
144413547|NCT04656691|520720802|FG000|Overall Study|Adverse Event|1|||
144413548|NCT04023526|520722642|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
144413549|NCT04023526|520722643|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
144413550|NCT04023526|520722642|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
144413551|NCT04023526|520722643|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
144413552|NCT02324569|520722648|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
144413553|NCT02324569|520722649|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
144413554|NCT02324569|520722648|FG000|Overall Study|Voluntary Withdrawal|3|||
144413555|NCT02324569|520722649|FG001|Overall Study|Voluntary Withdrawal|6|||
144413556|NCT02324569|520722648|FG000|Overall Study|Lack of Efficacy|2|||
144413557|NCT02324569|520722649|FG001|Overall Study|Lack of Efficacy|3|||
144413558|NCT02324569|520722648|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
144413559|NCT02324569|520722649|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
144413560|NCT02324569|520722648|FG000|Overall Study|Inconvenient Schedule|2|||
144413561|NCT02324569|520722649|FG001|Overall Study|Inconvenient Schedule|0|||
144413562|NCT01943292|520722650|FG000|Overall Study|Withdrawal by Subject|1|||
144413563|NCT01943292|520722651|FG001|Overall Study|Withdrawal by Subject|0|||
144413564|NCT01943292|520722652|FG002|Overall Study|Withdrawal by Subject|0|||
144600758|NCT01284062|521401639|FG003|Overall Study|Withdrawal by Subject|5|||
144600759|NCT01284062|521401636|FG000|Overall Study|Other|0|||
144600760|NCT01284062|521401637|FG001|Overall Study|Other|0|||
144600761|NCT01284062|521401638|FG002|Overall Study|Other|0|||
144600762|NCT01284062|521401639|FG003|Overall Study|Other|1|||
144600763|NCT01284062|521401636|FG000|Overall Study|Site Closed|0|||
144600764|NCT01284062|521401637|FG001|Overall Study|Site Closed|0|||
144600765|NCT01284062|521401638|FG002|Overall Study|Site Closed|1|||
144413565|NCT00638378|520722653|FG000|Overall Study|Death|2|||
144413566|NCT00638378|520722653|FG000|Overall Study|Adverse Event|1|||
144413567|NCT00638378|520722653|FG000|Overall Study|Disease progression|15|||
144413568|NCT00638378|520722653|FG000|Overall Study|Physician Decision|4|||
144413569|NCT00996216|520722654|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
144413570|NCT00996216|520722654|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
144413571|NCT00996216|520722654|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
144413572|NCT03761277|520722667|FG000|Enrollment to Implant|Screen Failure|17|||
144413573|NCT03761277|520722667|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
144413574|NCT03761277|520722667|FG000|Enrollment to Implant|Physician Decision|2|||
144413575|NCT03761277|520722667|FG000|Enrollment to Implant|Site Closure|3|||
144413576|NCT03761277|520722667|FG000|Enrollment to Implant|Sponsor Request|2|||
144413577|NCT03761277|520722667|FG000|Post-Implant to 6 Months|Adverse Event|2|||
144413578|NCT03761277|520722667|FG000|Post-Implant to 6 Months|Death|1|||
144413579|NCT03761277|520722667|FG000|Post-Implant to 6 Months|Site Closure|2|||
144600766|NCT01284062|521401639|FG003|Overall Study|Site Closed|0|||
144413580|NCT03761277|520722667|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
144413581|NCT03761277|520722667|FG000|6 Months to 12 Months|Physician Decision|2|||
144413582|NCT03761277|520722667|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
144413583|NCT00903695|520722668|FG000|Overall Study|medical exclusion after 1st testing|1|||
144413584|NCT00903695|520722669|FG001|Overall Study|medical exclusion after 1st testing|0|||
144413585|NCT00903695|520722668|FG000|Overall Study|lung cancer|1|||
144413586|NCT00903695|520722669|FG001|Overall Study|lung cancer|0|||
144413587|NCT00578812|520722671|FG000|Overall Study|Not treated|6|||
144413588|NCT00578812|520722672|FG001|Overall Study|Not treated|7|||
144413589|NCT04532164|520722674|FG000|Overall Study|Adverse Event|1|||
144600767|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
144600768|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
144250398|NCT00135356|520115489|FG001|Overall Study|Surgery for abdominal fat|0|||
144413590|NCT04532164|520722674|FG000|Overall Study|Protocol Violation|5|||
144413591|NCT04532164|520722674|FG000|Overall Study|Lost to Follow-up|1|||
144413592|NCT04532164|520722674|FG000|Overall Study|Found to be Ineligible|3|||
144413593|NCT04532164|520722674|FG000|Overall Study|Withdrawal by Subject|14|||
144413594|NCT01104493|520722675|FG000|Overall Study|Lost to Follow-up|0|||
144413595|NCT01104493|520722676|FG001|Overall Study|Lost to Follow-up|2|||
144413596|NCT00727025|520722689|FG000|Overall Study|Physician Decision|23|||
144413597|NCT01218204|520722690|FG000|Part B Washout|Adverse Event|0|||
144413598|NCT01218204|520722691|FG001|Part B Washout|Adverse Event|1|||
144413599|NCT01218204|520722692|FG002|Part B Washout|Adverse Event|0|||
144413600|NCT01218204|520722693|FG003|Part B Washout|Adverse Event|0|||
144250399|NCT00135356|520115488|FG000|Overall Study|Change in antiviral regimen|0|||
144413601|NCT01218204|520722690|FG000|Part B Washout|Lost to Follow-up|0|||
144413602|NCT01218204|520722691|FG001|Part B Washout|Lost to Follow-up|2|||
144413603|NCT01218204|520722692|FG002|Part B Washout|Lost to Follow-up|0|||
144413604|NCT01218204|520722693|FG003|Part B Washout|Lost to Follow-up|0|||
144413605|NCT01218204|520722690|FG000|Part B Washout|Physician Decision|0|||
144413606|NCT01218204|520722691|FG001|Part B Washout|Physician Decision|14|||
144413607|NCT01218204|520722692|FG002|Part B Washout|Physician Decision|0|||
144250400|NCT00135356|520115489|FG001|Overall Study|Change in antiviral regimen|1|||
144413608|NCT01218204|520722693|FG003|Part B Washout|Physician Decision|0|||
144413609|NCT01218204|520722690|FG000|Part B Washout|Withdrawal by Subject|0|||
144413610|NCT01218204|520722691|FG001|Part B Washout|Withdrawal by Subject|14|||
144413611|NCT01218204|520722692|FG002|Part B Washout|Withdrawal by Subject|0|||
144413612|NCT01218204|520722693|FG003|Part B Washout|Withdrawal by Subject|0|||
144413613|NCT01218204|520722690|FG000|Part B Washout|Reached defined stopping criteria|0|||
144413614|NCT01218204|520722691|FG001|Part B Washout|Reached defined stopping criteria|2|||
144413615|NCT01218204|520722692|FG002|Part B Washout|Reached defined stopping criteria|0|||
144413616|NCT01218204|520722693|FG003|Part B Washout|Reached defined stopping criteria|0|||
144413617|NCT01218204|520722690|FG000|Part B Washout|Did not meet continuation criteria|0|||
144413618|NCT01218204|520722691|FG001|Part B Washout|Did not meet continuation criteria|112|||
144413619|NCT01218204|520722692|FG002|Part B Washout|Did not meet continuation criteria|0|||
144413620|NCT01218204|520722693|FG003|Part B Washout|Did not meet continuation criteria|0|||
144413621|NCT01218204|520722690|FG000|Part B Run-in|Adverse Event|0|||
144413622|NCT01218204|520722691|FG001|Part B Run-in|Adverse Event|0|||
144413623|NCT01218204|520722692|FG002|Part B Run-in|Adverse Event|1|||
144413624|NCT01218204|520722693|FG003|Part B Run-in|Adverse Event|0|||
144413625|NCT01218204|520722690|FG000|Part B Run-in|Protocol Violation|0|||
144413626|NCT01218204|520722691|FG001|Part B Run-in|Protocol Violation|0|||
144413627|NCT01218204|520722692|FG002|Part B Run-in|Protocol Violation|2|||
144413628|NCT01218204|520722693|FG003|Part B Run-in|Protocol Violation|0|||
144413629|NCT01218204|520722690|FG000|Part B Run-in|Withdrawal by Subject|0|||
144413630|NCT01218204|520722691|FG001|Part B Run-in|Withdrawal by Subject|0|||
144250401|NCT00135356|520115488|FG000|Overall Study|Poor/noncompliance|1|||
144250402|NCT00135356|520115489|FG001|Overall Study|Poor/noncompliance|1|||
144527083|NCT03652389|521131816|FG001|Overall Study|Withdrawal by Subject|1|||
144527084|NCT03652389|521131815|FG000|Overall Study|New diagnosis|2|||
144527085|NCT03652389|521131816|FG001|Overall Study|New diagnosis|0|||
144527086|NCT03020199|521131821|FG000|Treatment Period|Adverse Event|0|||
144527087|NCT03020199|521131822|FG001|Treatment Period|Adverse Event|2|||
144527088|NCT03020199|521131821|FG000|Treatment Period|Lack of Efficacy|1|||
144527089|NCT03020199|521131822|FG001|Treatment Period|Lack of Efficacy|6|||
144527090|NCT03020199|521131821|FG000|Treatment Period|Lost to Follow-up|1|||
144527091|NCT03020199|521131822|FG001|Treatment Period|Lost to Follow-up|6|||
144722966|NCT02974153|521840590|FG000|Overall Study|Adverse Event|6|||
144722967|NCT02974153|521840591|FG001|Overall Study|Adverse Event|0|||
144413631|NCT01218204|520722692|FG002|Part B Run-in|Withdrawal by Subject|3|||
144413632|NCT01218204|520722693|FG003|Part B Run-in|Withdrawal by Subject|0|||
144413633|NCT01218204|520722690|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
144413634|NCT01218204|520722691|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
144413635|NCT01218204|520722692|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
144413636|NCT01218204|520722693|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
144413637|NCT01218204|520722690|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
144527092|NCT03020199|521131821|FG000|Treatment Period|Physician Decision|0|||
144722968|NCT02974153|521840592|FG002|Overall Study|Adverse Event|1|||
144722969|NCT02974153|521840590|FG000|Overall Study|Lack of Efficacy|6|||
144527093|NCT03020199|521131822|FG001|Treatment Period|Physician Decision|1|||
144722970|NCT02974153|521840591|FG001|Overall Study|Lack of Efficacy|5|||
144413638|NCT01218204|520722691|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
144413639|NCT01218204|520722692|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
144413640|NCT01218204|520722693|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
144413641|NCT00743340|520722694|FG000|Overall Study|Study medication non-compliance|1|||
144413642|NCT00743340|520722694|FG000|Overall Study|Lost to Follow-up|1|||
144413643|NCT00743340|520722694|FG000|Overall Study|Withdrawal from the Study|5|||
144413644|NCT00743340|520722694|FG000|Overall Study|Protocol Violation|1|||
144413645|NCT00743340|520722694|FG000|Overall Study|Virologic failure|8|||
144413646|NCT00743340|520722694|FG000|Overall Study|Pregnancy|1|||
144413647|NCT00743340|520722694|FG000|Overall Study|Rolled over to other Gilead Study|23|||
144413648|NCT00743340|520722694|FG000|Overall Study|Participant Relocated|1|||
144413649|NCT00127660|520722695|FG000|Overall Study|Protocol Violation|3|||
144413650|NCT00127660|520722696|FG001|Overall Study|Protocol Violation|3|||
144413651|NCT00127660|520722697|FG002|Overall Study|Protocol Violation|5|||
144413652|NCT00127660|520722698|FG003|Overall Study|Protocol Violation|0|||
144413653|NCT05131646|520722699|FG000|Overall Study|Withdrawal by Subject|1|||
144413654|NCT05131646|520722700|FG001|Overall Study|Withdrawal by Subject|0|||
144413655|NCT05131646|520722701|FG002|Overall Study|Withdrawal by Subject|0|||
144413656|NCT03454997|520722702|FG000|Overall Study|Staff Coach - Left Oranization|1|||
144413657|NCT03454997|520722703|FG001|Overall Study|Staff Coach - Left Oranization|1|||
144413658|NCT03454997|520722702|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
144413659|NCT03454997|520722703|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
144413660|NCT03454997|520722702|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
144413661|NCT03454997|520722703|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
144413662|NCT03454997|520722702|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
144413663|NCT03454997|520722703|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
144413664|NCT03454997|520722702|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
144413665|NCT03454997|520722703|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
144413666|NCT03454997|520722702|FG000|Overall Study|Client with SMI - Left organization|0|||
144413667|NCT03454997|520722703|FG001|Overall Study|Client with SMI - Left organization|1|||
144413668|NCT03454997|520722702|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
144413669|NCT03454997|520722703|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
144413670|NCT01191801|520722704|FG000|Overall Study|Death|36|||
144413671|NCT01191801|520722705|FG001|Overall Study|Death|12|||
144413672|NCT01191801|520722704|FG000|Overall Study|Lack of Efficacy|176|||
144413673|NCT01191801|520722705|FG001|Overall Study|Lack of Efficacy|258|||
144413674|NCT01191801|520722704|FG000|Overall Study|Adverse Event|9|||
144413675|NCT01191801|520722705|FG001|Overall Study|Adverse Event|8|||
144722971|NCT02974153|521840592|FG002|Overall Study|Lack of Efficacy|10|||
144722972|NCT02974153|521840590|FG000|Overall Study|Lost to Follow-up|9|||
144722973|NCT02974153|521840591|FG001|Overall Study|Lost to Follow-up|10|||
144722974|NCT02974153|521840592|FG002|Overall Study|Lost to Follow-up|17|||
144722975|NCT02974153|521840590|FG000|Overall Study|Physician Decision|0|||
144413676|NCT01191801|520722704|FG000|Overall Study|Protocol Violation|2|||
144413677|NCT01191801|520722705|FG001|Overall Study|Protocol Violation|4|||
144413678|NCT01191801|520722704|FG000|Overall Study|Physician Decision|47|||
144413679|NCT01191801|520722705|FG001|Overall Study|Physician Decision|24|||
144413680|NCT01191801|520722704|FG000|Overall Study|Withdrawal by Subject|1|||
144413681|NCT01191801|520722705|FG001|Overall Study|Withdrawal by Subject|4|||
144413682|NCT01191801|520722704|FG000|Overall Study|Not Provided|45|||
144413683|NCT01191801|520722705|FG001|Overall Study|Not Provided|27|||
144413684|NCT02794883|520722707|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
144413685|NCT02794883|520722708|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
144413686|NCT02794883|520722709|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
144413687|NCT02794883|520722707|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
144413688|NCT02794883|520722708|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
144413689|NCT02794883|520722709|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
144413690|NCT02794883|520722707|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
144413691|NCT02794883|520722708|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
144413692|NCT02794883|520722709|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
144413693|NCT02794883|520722707|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
144413694|NCT02794883|520722708|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
144413695|NCT02794883|520722709|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
144413696|NCT02794883|520722707|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
144413697|NCT02794883|520722708|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
144413698|NCT02794883|520722709|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
144413699|NCT02794883|520722707|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
144722976|NCT02974153|521840591|FG001|Overall Study|Physician Decision|2|||
144722977|NCT02974153|521840592|FG002|Overall Study|Physician Decision|1|||
144722978|NCT02974153|521840590|FG000|Overall Study|Withdrawal by Subject|9|||
144722979|NCT02974153|521840591|FG001|Overall Study|Withdrawal by Subject|16|||
144722980|NCT02974153|521840592|FG002|Overall Study|Withdrawal by Subject|11|||
144413700|NCT02794883|520722708|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
144413701|NCT02794883|520722709|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
144413702|NCT02794883|520722707|FG000|Follow-up Period (up to 2 Years)|Death|12|||
144413703|NCT02794883|520722708|FG001|Follow-up Period (up to 2 Years)|Death|10|||
144413704|NCT02794883|520722709|FG002|Follow-up Period (up to 2 Years)|Death|10|||
144413705|NCT02042183|520722712|FG000|Overall Study|Physician Decision|7|||
144413706|NCT02042183|520722713|FG001|Overall Study|Physician Decision|2|||
144413707|NCT02042183|520722712|FG000|Overall Study|Lack of Efficacy|4|||
144413708|NCT02042183|520722713|FG001|Overall Study|Lack of Efficacy|3|||
144413709|NCT02042183|520722712|FG000|Overall Study|Non-compliance with Study Drug|2|||
144413710|NCT02042183|520722713|FG001|Overall Study|Non-compliance with Study Drug|3|||
144413711|NCT02042183|520722712|FG000|Overall Study|Adverse Event|17|||
144413712|NCT02042183|520722713|FG001|Overall Study|Adverse Event|6|||
144413713|NCT02042183|520722712|FG000|Overall Study|Other|3|||
144413714|NCT02042183|520722713|FG001|Overall Study|Other|3|||
144413715|NCT02042183|520722712|FG000|Overall Study|Withdrawal by Subject|21|||
144413716|NCT02042183|520722713|FG001|Overall Study|Withdrawal by Subject|16|||
144413717|NCT02042183|520722712|FG000|Overall Study|Site Terminated by Sponsor|2|||
144413718|NCT02042183|520722713|FG001|Overall Study|Site Terminated by Sponsor|1|||
144413719|NCT02042183|520722712|FG000|Overall Study|Lost to Follow-up|9|||
144413720|NCT02042183|520722713|FG001|Overall Study|Lost to Follow-up|2|||
144413721|NCT01727297|520722714|FG000|Overall Study|Death|13|||
144413722|NCT01727297|520722715|FG001|Overall Study|Death|0|||
144413723|NCT01727297|520722714|FG000|Overall Study|Protocol Violation|1|||
144413724|NCT01727297|520722715|FG001|Overall Study|Protocol Violation|10|||
144413725|NCT01727297|520722714|FG000|Overall Study|Adverse Event|3|||
144413726|NCT01727297|520722715|FG001|Overall Study|Adverse Event|1|||
144413727|NCT01727297|520722714|FG000|Overall Study|Lost to Follow-up|11|||
144413728|NCT01727297|520722715|FG001|Overall Study|Lost to Follow-up|0|||
144413729|NCT01727297|520722714|FG000|Overall Study|Withdrawal by Subject|26|||
144413730|NCT01727297|520722715|FG001|Overall Study|Withdrawal by Subject|27|||
144413731|NCT01727297|520722714|FG000|Overall Study|Physician Decision|19|||
144413732|NCT01727297|520722715|FG001|Overall Study|Physician Decision|5|||
144413733|NCT01727297|520722714|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
144413734|NCT01727297|520722715|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
144413735|NCT01192516|520722718|FG000|Overall Study|Lost to Follow-up|7|||
144413736|NCT01192516|520722719|FG001|Overall Study|Lost to Follow-up|10|||
144413737|NCT01192516|520722720|FG002|Overall Study|Lost to Follow-up|7|||
144413738|NCT01192516|520722718|FG000|Overall Study|Withdrawal by Subject|4|||
144413739|NCT01192516|520722719|FG001|Overall Study|Withdrawal by Subject|4|||
144413740|NCT01192516|520722720|FG002|Overall Study|Withdrawal by Subject|1|||
144413741|NCT01192516|520722718|FG000|Overall Study|started new treatment|5|||
144413742|NCT01192516|520722719|FG001|Overall Study|started new treatment|1|||
144413743|NCT01192516|520722720|FG002|Overall Study|started new treatment|0|||
144413744|NCT01192516|520722718|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
144413745|NCT01192516|520722719|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
144413746|NCT01192516|520722720|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
144413747|NCT02266225|520722733|FG000|Overall Study|Lost to Follow-up|2|||
144413748|NCT02266225|520722733|FG000|Overall Study|Death|1|||
144413749|NCT02266225|520722733|FG000|Overall Study|Withdrawal by Subject|13|||
144413750|NCT03018704|520722734|FG000|Overall Study|Lost to Follow-up|1|||
144413751|NCT03018704|520722735|FG001|Overall Study|Lost to Follow-up|1|||
144413752|NCT00320411|520722736|FG000|Overall Study|No investigational product admin.|4|||
144413753|NCT04448171|520722737|FG000|Overall Study|Procedure Cancelled|1|||
144413754|NCT04448171|520722738|FG001|Overall Study|Procedure Cancelled|0|||
144413755|NCT04448171|520722737|FG000|Overall Study|Protocol Violation|1|||
144413756|NCT04448171|520722738|FG001|Overall Study|Protocol Violation|0|||
144413757|NCT04605484|520722741|FG000|Overall Study|Lost to Follow-up|0|||
144413758|NCT04605484|520722742|FG001|Overall Study|Lost to Follow-up|1|||
144413759|NCT04605484|520722743|FG002|Overall Study|Lost to Follow-up|1|||
144413760|NCT04605484|520722741|FG000|Overall Study|Other|0|||
144413761|NCT04605484|520722742|FG001|Overall Study|Other|1|||
144413762|NCT04605484|520722743|FG002|Overall Study|Other|0|||
144413763|NCT00660309|520722746|FG000|Overall Study|Adverse Event|2|||
144250403|NCT00135356|520115488|FG000|Overall Study|No longer meets study criteria|2|||
144413764|NCT00660309|520722747|FG001|Overall Study|Adverse Event|0|||
144413765|NCT00660309|520722746|FG000|Overall Study|Withdrawal by Subject|0|||
144722981|NCT02974153|521840590|FG000|Overall Study|Study Burden|8|||
144722982|NCT02974153|521840591|FG001|Overall Study|Study Burden|7|||
144722983|NCT02974153|521840592|FG002|Overall Study|Study Burden|3|||
144722984|NCT02974153|521840590|FG000|Overall Study|Other|14|||
144413766|NCT00660309|520722747|FG001|Overall Study|Withdrawal by Subject|3|||
144413767|NCT00211809|520722750|FG000|Overall Study|Lack of Efficacy|1|||
144413768|NCT00211809|520722750|FG000|Overall Study|Lost to Follow-up|2|||
144722985|NCT02974153|521840591|FG001|Overall Study|Other|8|||
144722986|NCT02974153|521840592|FG002|Overall Study|Other|7|||
144722987|NCT02521948|521840593|FG000|Overall Study|Adverse Event|2|||
144722988|NCT02521948|521840593|FG000|Overall Study|Death|4|||
144722989|NCT02521948|521840593|FG000|Overall Study|Lost to Follow-up|1|||
144722990|NCT02521948|521840593|FG000|Overall Study|Did not attend one or both follow-ups|6|||
144722991|NCT00423800|521840594|FG000|Overall Study|Protocol Violation|0|||
144722992|NCT00423800|521840595|FG001|Overall Study|Protocol Violation|1|||
144722993|NCT00679783|521840597|FG000|Overall Study|Adverse Event|0|||
144722994|NCT00679783|521840598|FG001|Overall Study|Adverse Event|0|||
144722995|NCT00679783|521840599|FG002|Overall Study|Adverse Event|0|||
144722996|NCT00679783|521840600|FG003|Overall Study|Adverse Event|3|||
144722997|NCT00679783|521840601|FG004|Overall Study|Adverse Event|0|||
144722998|NCT00679783|521840602|FG005|Overall Study|Adverse Event|0|||
144722999|NCT00679783|521840603|FG006|Overall Study|Adverse Event|1|||
144723000|NCT00679783|521840597|FG000|Overall Study|Lack of Efficacy|0|||
144723001|NCT00679783|521840598|FG001|Overall Study|Lack of Efficacy|1|||
144413769|NCT00211809|520722750|FG000|Overall Study|Pregnancy|1|||
144413770|NCT00211809|520722750|FG000|Overall Study|side effects|2|||
144413771|NCT01417234|520722751|FG000|Overall Study|Subject non-compliant|3|||
144413772|NCT00023764|520722752|FG000|Overall Study|Other|1|||
144723002|NCT00679783|521840599|FG002|Overall Study|Lack of Efficacy|0|||
144723003|NCT00679783|521840600|FG003|Overall Study|Lack of Efficacy|2|||
144723004|NCT00679783|521840601|FG004|Overall Study|Lack of Efficacy|0|||
144723005|NCT00679783|521840602|FG005|Overall Study|Lack of Efficacy|0|||
144723006|NCT00679783|521840603|FG006|Overall Study|Lack of Efficacy|0|||
144413773|NCT00023764|520722752|FG000|Overall Study|Adverse Event|4|||
144413774|NCT00023764|520722752|FG000|Overall Study|Withdrawal by Subject|1|||
144413775|NCT00023764|520722752|FG000|Overall Study|Progression of disease|6|||
144413776|NCT00023764|520722752|FG000|Overall Study|patient received other treatment|1|||
144413777|NCT00023764|520722752|FG000|Overall Study|delay in obtaining staging images|1|||
144413778|NCT01217801|520722755|FG000|Period 1|Protocol Violation|1|||
144413779|NCT01217801|520722756|FG001|Period 1|Protocol Violation|1|||
144250404|NCT00135356|520115489|FG001|Overall Study|No longer meets study criteria|0|||
144250405|NCT00135356|520115488|FG000|Overall Study|Withdrawal by Subject|2|||
144413780|NCT01217801|520722755|FG000|Period 1|Withdrawal by Subject|0|||
144600769|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
144723007|NCT00679783|521840597|FG000|Overall Study|Withdrawal by Subject|0|||
144250406|NCT00135356|520115489|FG001|Overall Study|Withdrawal by Subject|4|||
144413781|NCT01217801|520722756|FG001|Period 1|Withdrawal by Subject|1|||
144413782|NCT03129100|520722757|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
144413783|NCT03129100|520722758|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
144413784|NCT03129100|520722759|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
144413785|NCT03129100|520722760|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
144413786|NCT03129100|520722761|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
144413787|NCT03129100|520722762|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
144413788|NCT03129100|520722763|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
144413789|NCT03129100|520722764|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
144413790|NCT03129100|520722765|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
144723008|NCT00679783|521840598|FG001|Overall Study|Withdrawal by Subject|0|||
144723009|NCT00679783|521840599|FG002|Overall Study|Withdrawal by Subject|1|||
144723010|NCT00679783|521840600|FG003|Overall Study|Withdrawal by Subject|1|||
144723011|NCT00679783|521840601|FG004|Overall Study|Withdrawal by Subject|0|||
144413791|NCT03129100|520722766|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
144413792|NCT03129100|520722767|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
144413793|NCT03129100|520722768|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
144413794|NCT03129100|520722769|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
144413795|NCT03129100|520722770|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
144413796|NCT03129100|520722771|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
144413797|NCT03129100|520722772|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
144413798|NCT03129100|520722773|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
144723012|NCT00679783|521840602|FG005|Overall Study|Withdrawal by Subject|0|||
144723013|NCT00679783|521840603|FG006|Overall Study|Withdrawal by Subject|0|||
144723014|NCT00679783|521840597|FG000|Overall Study|Not Captured|0|||
144723015|NCT00679783|521840598|FG001|Overall Study|Not Captured|0|||
144413799|NCT03129100|520722774|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
144413800|NCT03129100|520722775|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
144413801|NCT03129100|520722776|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
144413802|NCT03129100|520722777|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
144413803|NCT03129100|520722778|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
144413804|NCT03129100|520722779|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
144413805|NCT03129100|520722780|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
144413806|NCT03129100|520722781|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
144413807|NCT03129100|520722782|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
144413808|NCT03129100|520722757|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
144413809|NCT03129100|520722758|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413810|NCT03129100|520722759|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413811|NCT03129100|520722760|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413812|NCT03129100|520722761|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413813|NCT03129100|520722762|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413814|NCT03129100|520722763|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413815|NCT03129100|520722764|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413816|NCT03129100|520722765|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413817|NCT03129100|520722766|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413818|NCT03129100|520722767|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413819|NCT03129100|520722768|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413820|NCT03129100|520722769|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413821|NCT03129100|520722770|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413822|NCT03129100|520722771|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413823|NCT03129100|520722772|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413824|NCT03129100|520722773|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144723016|NCT00679783|521840599|FG002|Overall Study|Not Captured|0|||
144723017|NCT00679783|521840600|FG003|Overall Study|Not Captured|5|||
144413825|NCT03129100|520722774|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144723018|NCT00679783|521840601|FG004|Overall Study|Not Captured|0|||
144413826|NCT03129100|520722775|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413827|NCT03129100|520722776|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413828|NCT03129100|520722777|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413829|NCT03129100|520722778|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144723019|NCT00679783|521840602|FG005|Overall Study|Not Captured|0|||
144723020|NCT00679783|521840603|FG006|Overall Study|Not Captured|0|||
144413830|NCT03129100|520722779|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413831|NCT03129100|520722780|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413832|NCT03129100|520722781|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413833|NCT03129100|520722782|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
144413834|NCT03129100|520722757|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
144413835|NCT03129100|520722758|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
144413836|NCT03129100|520722759|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413837|NCT03129100|520722760|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413838|NCT03129100|520722761|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413839|NCT03129100|520722762|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413840|NCT03129100|520722763|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413841|NCT03129100|520722764|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413842|NCT03129100|520722765|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413843|NCT03129100|520722766|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413844|NCT03129100|520722767|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413845|NCT03129100|520722768|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413846|NCT03129100|520722769|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413847|NCT03129100|520722770|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413848|NCT03129100|520722771|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413849|NCT03129100|520722772|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144527094|NCT03020199|521131821|FG000|Treatment Period|Subject/guardian decision|8|||
144527095|NCT03020199|521131822|FG001|Treatment Period|Subject/guardian decision|15|||
144527096|NCT03020199|521131821|FG000|Treatment Period|Subjects not treated|3|||
144527097|NCT03020199|521131822|FG001|Treatment Period|Subjects not treated|4|||
144527098|NCT03020199|521131821|FG000|Follow-up Period|Disease relapse|32|||
144527099|NCT03020199|521131822|FG001|Follow-up Period|Disease relapse|7|||
144527100|NCT03020199|521131821|FG000|Follow-up Period|Lack of Efficacy|1|||
144527101|NCT03020199|521131822|FG001|Follow-up Period|Lack of Efficacy|2|||
144527102|NCT03020199|521131821|FG000|Follow-up Period|Lost to Follow-up|4|||
144527103|NCT03020199|521131822|FG001|Follow-up Period|Lost to Follow-up|6|||
144527104|NCT03020199|521131821|FG000|Follow-up Period|Physician Decision|2|||
144527105|NCT03020199|521131822|FG001|Follow-up Period|Physician Decision|2|||
144527106|NCT03020199|521131821|FG000|Follow-up Period|Protocol Violation|1|||
144527107|NCT03020199|521131822|FG001|Follow-up Period|Protocol Violation|2|||
144527108|NCT03020199|521131821|FG000|Follow-up Period|Study terminated by Sponsor|6|||
144527109|NCT03020199|521131822|FG001|Follow-up Period|Study terminated by Sponsor|3|||
144527110|NCT03020199|521131821|FG000|Follow-up Period|Subject/guardian decision|14|||
144527111|NCT03020199|521131822|FG001|Follow-up Period|Subject/guardian decision|9|||
144527112|NCT05583578|521131823|FG000|Overall Study|Withdrawal by Subject|2|||
144527113|NCT05583578|521131824|FG001|Overall Study|Withdrawal by Subject|0|||
144527114|NCT00248287|521131826|FG000|Overall Study|Adverse Event|11|||
144527115|NCT00248287|521131827|FG001|Overall Study|Adverse Event|10|||
144527116|NCT00248287|521131826|FG000|Overall Study|Death|1|||
144527117|NCT00248287|521131827|FG001|Overall Study|Death|0|||
144527118|NCT00248287|521131826|FG000|Overall Study|Lost to Follow-up|0|||
144527119|NCT00248287|521131827|FG001|Overall Study|Lost to Follow-up|1|||
144527120|NCT00248287|521131826|FG000|Overall Study|Investigator Request|4|||
144527121|NCT00248287|521131827|FG001|Overall Study|Investigator Request|3|||
144250407|NCT02263729|520115490|FG000|Overall Study|Lost to Follow-up|1|||
144413850|NCT03129100|520722773|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144527122|NCT00248287|521131826|FG000|Overall Study|Patient Request|5|||
144527123|NCT00248287|521131827|FG001|Overall Study|Patient Request|3|||
144413851|NCT03129100|520722774|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413852|NCT03129100|520722775|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413853|NCT03129100|520722776|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413854|NCT03129100|520722777|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413855|NCT03129100|520722778|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413856|NCT03129100|520722779|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413857|NCT03129100|520722780|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413858|NCT03129100|520722781|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413859|NCT03129100|520722782|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
144413860|NCT03129100|520722757|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
144413861|NCT03129100|520722758|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
144413862|NCT03129100|520722759|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413863|NCT03129100|520722760|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413864|NCT03129100|520722761|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413865|NCT03129100|520722762|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413866|NCT03129100|520722763|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413867|NCT03129100|520722764|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413868|NCT03129100|520722765|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413869|NCT03129100|520722766|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413870|NCT03129100|520722767|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413871|NCT03129100|520722768|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413872|NCT03129100|520722769|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413873|NCT03129100|520722770|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413874|NCT03129100|520722771|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413875|NCT03129100|520722772|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413876|NCT03129100|520722773|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413877|NCT03129100|520722774|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144527124|NCT00248287|521131826|FG000|Overall Study|Other|3|||
144527125|NCT00248287|521131827|FG001|Overall Study|Other|2|||
144527126|NCT02714257|521131828|FG000|Overall Study|Withdrawal by Subject|6|||
144527127|NCT02714257|521131829|FG001|Overall Study|Withdrawal by Subject|11|||
144527128|NCT02714257|521131828|FG000|Overall Study|Death|3|||
144527129|NCT02714257|521131829|FG001|Overall Study|Death|4|||
144527130|NCT02714257|521131828|FG000|Overall Study|Lost to Follow-up|1|||
144527131|NCT02714257|521131829|FG001|Overall Study|Lost to Follow-up|6|||
144527132|NCT04103580|521131832|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
144527133|NCT04103580|521131833|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
144527134|NCT04103580|521131832|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
144527135|NCT04103580|521131833|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
144527136|NCT04103580|521131832|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
144527137|NCT04103580|521131833|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
144527138|NCT04103580|521131832|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
144527139|NCT04103580|521131833|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
144527140|NCT04103580|521131832|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
144527141|NCT04103580|521131833|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
144527142|NCT04103580|521131832|FG000|Phase 1 Active Caregiving|Other|3|||
144250408|NCT02263729|520115491|FG001|Overall Study|Lost to Follow-up|1|||
144250409|NCT04591015|520115492|FG000|Overall Study|Death|6|||
144527143|NCT04103580|521131833|FG001|Phase 1 Active Caregiving|Other|3|||
144527144|NCT04103580|521131832|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
144527145|NCT04103580|521131833|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
144413878|NCT03129100|520722775|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413879|NCT03129100|520722776|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413880|NCT03129100|520722777|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413881|NCT03129100|520722778|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413882|NCT03129100|520722779|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413883|NCT03129100|520722780|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413884|NCT03129100|520722781|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413885|NCT03129100|520722782|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
144413886|NCT03129100|520722757|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413887|NCT03129100|520722758|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
144527146|NCT04103580|521131832|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
144413888|NCT03129100|520722759|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413889|NCT03129100|520722760|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413890|NCT03129100|520722761|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413891|NCT03129100|520722762|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413892|NCT03129100|520722763|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413893|NCT03129100|520722764|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413894|NCT03129100|520722765|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413895|NCT03129100|520722766|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413896|NCT03129100|520722767|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413897|NCT03129100|520722768|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413898|NCT03129100|520722769|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413899|NCT03129100|520722770|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413900|NCT03129100|520722771|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413901|NCT03129100|520722772|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413902|NCT03129100|520722773|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413903|NCT03129100|520722774|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413904|NCT03129100|520722775|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413905|NCT03129100|520722776|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413906|NCT03129100|520722777|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413907|NCT03129100|520722778|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413908|NCT03129100|520722779|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413909|NCT03129100|520722780|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413910|NCT03129100|520722781|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413911|NCT03129100|520722782|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
144413912|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413913|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413914|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
144413915|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
144413916|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413917|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
144413918|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413919|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413920|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413921|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413922|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413923|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413924|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413925|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413926|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413927|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413928|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413929|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413930|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413931|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413932|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413933|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413934|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413935|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413936|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413937|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
144413938|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Death|0|||
144413939|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Death|0|||
144413940|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Death|1|||
144413941|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Death|0|||
144413942|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Death|0|||
144413943|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Death|0|||
144413944|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Death|0|||
144413945|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Death|0|||
144413946|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Death|0|||
144413947|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Death|0|||
144413948|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Death|0|||
144413949|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Death|0|||
144413950|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Death|0|||
144413951|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Death|0|||
144413952|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Death|0|||
144413953|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Death|0|||
144413954|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Death|0|||
144413955|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Death|0|||
144413956|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Death|0|||
144413957|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Death|0|||
144413958|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Death|0|||
144413959|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Death|0|||
144413960|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Death|0|||
144413961|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Death|0|||
144413962|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Death|0|||
144413963|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Death|0|||
144413964|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413965|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413966|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
144413967|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
144413968|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
144413969|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
144413970|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
144413971|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413972|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413973|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413974|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413975|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413976|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413977|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413978|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413979|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413980|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413981|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413982|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413983|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413984|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413985|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413986|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413987|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413988|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413989|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
144413990|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413991|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413992|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
144413993|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413994|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413995|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413996|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413997|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413998|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144413999|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414000|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144250410|NCT04591015|520115493|FG001|Overall Study|Death|4|||
144250411|NCT04591015|520115492|FG000|Overall Study|Withdrawal by Subject|6|||
144250412|NCT04591015|520115493|FG001|Overall Study|Withdrawal by Subject|3|||
144250413|NCT04591015|520115492|FG000|Overall Study|Lost to Follow-up|16|||
144250414|NCT04591015|520115493|FG001|Overall Study|Lost to Follow-up|11|||
144250415|NCT02686814|520115494|FG000|Overall Study|Physician Decision|14|||
144414001|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414002|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414003|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414004|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414005|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414006|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414007|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414008|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414009|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414010|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414011|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414012|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414013|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414014|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414015|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
144414016|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414017|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414018|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
144414019|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414020|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414021|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414022|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414023|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414024|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414025|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414026|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144600770|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
144600771|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
144600772|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
144600773|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
144600774|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
144600775|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Death|1|||
144600776|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Death|1|||
144600777|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
144600778|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
144600779|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
144600780|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
144414027|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414028|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414029|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414030|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414031|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414032|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414033|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414034|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414035|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414036|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414037|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414038|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414039|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414040|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414041|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
144414042|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414043|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414044|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
144414045|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414046|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414047|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414048|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414049|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414050|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414051|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414052|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414053|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414054|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414055|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414056|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414057|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414058|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414059|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414060|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414061|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414062|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414063|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414064|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414065|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414066|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414067|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
144414068|NCT03129100|520722757|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414069|NCT03129100|520722758|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414070|NCT03129100|520722759|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414071|NCT03129100|520722760|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414072|NCT03129100|520722761|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
144414073|NCT03129100|520722762|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
144414074|NCT03129100|520722763|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
144414075|NCT03129100|520722764|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414076|NCT03129100|520722765|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414077|NCT03129100|520722766|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414078|NCT03129100|520722767|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414079|NCT03129100|520722768|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414080|NCT03129100|520722769|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414081|NCT03129100|520722770|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414082|NCT03129100|520722771|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414083|NCT03129100|520722772|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414084|NCT03129100|520722773|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414085|NCT03129100|520722774|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414086|NCT03129100|520722775|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414087|NCT03129100|520722776|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414088|NCT03129100|520722777|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414089|NCT03129100|520722778|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414090|NCT03129100|520722779|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414091|NCT03129100|520722780|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414092|NCT03129100|520722781|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414093|NCT03129100|520722782|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
144414094|NCT03129100|520722757|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414095|NCT03129100|520722758|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414096|NCT03129100|520722759|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414097|NCT03129100|520722760|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414098|NCT03129100|520722761|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414099|NCT03129100|520722762|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414100|NCT03129100|520722763|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414101|NCT03129100|520722764|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144250416|NCT02686814|520115494|FG000|Overall Study|Withdrawal by Subject|4|||
144250417|NCT02686814|520115494|FG000|Overall Study|Death|1|||
144250418|NCT00631163|520115500|FG000|Number of Participants in Year 1|Adverse Event|12|||
144414102|NCT03129100|520722765|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414103|NCT03129100|520722766|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
144414104|NCT03129100|520722767|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414105|NCT03129100|520722768|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414106|NCT03129100|520722769|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414107|NCT03129100|520722770|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414108|NCT03129100|520722771|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414109|NCT03129100|520722772|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414110|NCT03129100|520722773|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414111|NCT03129100|520722774|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414112|NCT03129100|520722775|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414113|NCT03129100|520722776|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144723021|NCT00679783|521840597|FG000|Overall Study|Ongoing at data cut-off|2|||
144414114|NCT03129100|520722777|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414115|NCT03129100|520722778|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414116|NCT03129100|520722779|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414117|NCT03129100|520722780|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414118|NCT03129100|520722781|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414119|NCT03129100|520722782|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
144414120|NCT03129100|520722757|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414121|NCT03129100|520722758|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414122|NCT03129100|520722759|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414123|NCT03129100|520722760|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414124|NCT03129100|520722761|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414125|NCT03129100|520722762|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414126|NCT03129100|520722763|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414127|NCT03129100|520722764|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414128|NCT03129100|520722765|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414129|NCT03129100|520722766|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414130|NCT03129100|520722767|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414131|NCT03129100|520722768|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
144414132|NCT03129100|520722769|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414133|NCT03129100|520722770|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414134|NCT03129100|520722771|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414135|NCT03129100|520722772|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414136|NCT03129100|520722773|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414137|NCT03129100|520722774|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414138|NCT03129100|520722775|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414139|NCT03129100|520722776|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414140|NCT03129100|520722777|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414141|NCT03129100|520722778|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414142|NCT03129100|520722779|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414143|NCT03129100|520722780|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414144|NCT03129100|520722781|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414145|NCT03129100|520722782|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
144414146|NCT03129100|520722757|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414147|NCT03129100|520722758|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414148|NCT03129100|520722759|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414149|NCT03129100|520722760|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414150|NCT03129100|520722761|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414151|NCT03129100|520722762|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414152|NCT03129100|520722763|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414153|NCT03129100|520722764|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414154|NCT03129100|520722765|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414155|NCT03129100|520722766|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414156|NCT03129100|520722767|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414157|NCT03129100|520722768|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
144414158|NCT03129100|520722769|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
144414159|NCT03129100|520722770|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
144414160|NCT03129100|520722771|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
144414161|NCT03129100|520722772|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414162|NCT03129100|520722773|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414163|NCT03129100|520722774|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414164|NCT03129100|520722775|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414165|NCT03129100|520722776|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414166|NCT03129100|520722777|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414167|NCT03129100|520722778|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144723022|NCT00679783|521840598|FG001|Overall Study|Ongoing at data cut-off|2|||
144414168|NCT03129100|520722779|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414169|NCT03129100|520722780|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414170|NCT03129100|520722781|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414171|NCT03129100|520722782|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
144414172|NCT03129100|520722757|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414173|NCT03129100|520722758|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414174|NCT03129100|520722759|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414175|NCT03129100|520722760|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414176|NCT03129100|520722761|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414177|NCT03129100|520722762|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414178|NCT03129100|520722763|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414179|NCT03129100|520722764|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414180|NCT03129100|520722765|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414181|NCT03129100|520722766|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414182|NCT03129100|520722767|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414183|NCT03129100|520722768|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
144414184|NCT03129100|520722769|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414185|NCT03129100|520722770|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
144414186|NCT03129100|520722771|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
144414187|NCT03129100|520722772|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414188|NCT03129100|520722773|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414189|NCT03129100|520722774|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414190|NCT03129100|520722775|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414191|NCT03129100|520722776|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414192|NCT03129100|520722777|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414193|NCT03129100|520722778|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414194|NCT03129100|520722779|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414195|NCT03129100|520722780|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414196|NCT03129100|520722781|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414197|NCT03129100|520722782|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
144414198|NCT03129100|520722757|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414199|NCT03129100|520722758|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414200|NCT03129100|520722759|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414201|NCT03129100|520722760|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414202|NCT03129100|520722761|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414203|NCT03129100|520722762|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414204|NCT03129100|520722763|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414205|NCT03129100|520722764|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414206|NCT03129100|520722765|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414207|NCT03129100|520722766|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414208|NCT03129100|520722767|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414209|NCT03129100|520722768|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414210|NCT03129100|520722769|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414211|NCT03129100|520722770|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414212|NCT03129100|520722771|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414213|NCT03129100|520722772|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
144414214|NCT03129100|520722773|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414215|NCT03129100|520722774|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414216|NCT03129100|520722775|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414217|NCT03129100|520722776|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414218|NCT03129100|520722777|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414219|NCT03129100|520722778|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414220|NCT03129100|520722779|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414221|NCT03129100|520722780|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414222|NCT03129100|520722781|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414223|NCT03129100|520722782|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
144414224|NCT03129100|520722757|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414225|NCT03129100|520722758|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414226|NCT03129100|520722759|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414227|NCT03129100|520722760|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414228|NCT03129100|520722761|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414229|NCT03129100|520722762|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414230|NCT03129100|520722763|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414231|NCT03129100|520722764|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414232|NCT03129100|520722765|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414233|NCT03129100|520722766|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414234|NCT03129100|520722767|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414235|NCT03129100|520722768|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414236|NCT03129100|520722769|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
144414237|NCT03129100|520722770|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414238|NCT03129100|520722771|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
144414239|NCT03129100|520722772|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
144414240|NCT03129100|520722773|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414241|NCT03129100|520722774|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414242|NCT03129100|520722775|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414243|NCT03129100|520722776|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144527147|NCT04103580|521131833|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
144527148|NCT04103580|521131832|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
144527149|NCT04103580|521131833|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
144527150|NCT04103580|521131832|FG000|Phase 2 Bereavement|Other|8|||
144527151|NCT04103580|521131833|FG001|Phase 2 Bereavement|Other|6|||
144527152|NCT04568486|521131834|FG000|Overall Study|Withdrawal by Subject|26|||
144527153|NCT04568486|521131834|FG000|Overall Study|Lost to Follow-up|7|||
144527154|NCT04248725|521131835|FG000|Post-Treatment|Lost to Follow-up|6|||
144527155|NCT04248725|521131836|FG001|Post-Treatment|Lost to Follow-up|5|||
144527156|NCT04248725|521131835|FG000|6-Month Follow Up|Lost to Follow-up|9|||
144527157|NCT04248725|521131836|FG001|6-Month Follow Up|Lost to Follow-up|8|||
144527158|NCT01210807|521131839|FG000|Overall Study|Lost to Follow-up|1|||
144527159|NCT01210807|521131840|FG001|Overall Study|Lost to Follow-up|2|||
144527160|NCT01210807|521131839|FG000|Overall Study|Not implanted bilaterally|2|||
144527161|NCT01210807|521131840|FG001|Overall Study|Not implanted bilaterally|1|||
144527162|NCT05477186|521131845|FG000|Overall Study|Vaccine not administered|0|||
144527163|NCT05477186|521131846|FG001|Overall Study|Vaccine not administered|2|||
144527164|NCT05477186|521131847|FG002|Overall Study|Vaccine not administered|1|||
144527165|NCT05477186|521131848|FG003|Overall Study|Vaccine not administered|0|||
144527166|NCT05477186|521131849|FG004|Overall Study|Vaccine not administered|1|||
144527167|NCT05477186|521131850|FG005|Overall Study|Vaccine not administered|0|||
144527168|NCT05477186|521131851|FG006|Overall Study|Vaccine not administered|0|||
144527169|NCT05477186|521131845|FG000|Overall Study|Withdrawal by Subject|1|||
144527170|NCT05477186|521131846|FG001|Overall Study|Withdrawal by Subject|0|||
144723023|NCT00679783|521840599|FG002|Overall Study|Ongoing at data cut-off|0|||
144723024|NCT00679783|521840600|FG003|Overall Study|Ongoing at data cut-off|9|||
144414244|NCT03129100|520722777|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414245|NCT03129100|520722778|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414246|NCT03129100|520722779|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414247|NCT03129100|520722780|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414248|NCT03129100|520722781|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414249|NCT03129100|520722782|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
144414250|NCT03129100|520722757|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414251|NCT03129100|520722758|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414252|NCT03129100|520722759|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414253|NCT03129100|520722760|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414254|NCT03129100|520722761|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414255|NCT03129100|520722762|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414256|NCT03129100|520722763|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414257|NCT03129100|520722764|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414258|NCT03129100|520722765|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414259|NCT03129100|520722766|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414260|NCT03129100|520722767|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414261|NCT03129100|520722768|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414262|NCT03129100|520722769|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414263|NCT03129100|520722770|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414264|NCT03129100|520722771|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414265|NCT03129100|520722772|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414266|NCT03129100|520722773|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414267|NCT03129100|520722774|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
144414268|NCT03129100|520722775|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414269|NCT03129100|520722776|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
144414270|NCT03129100|520722777|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414271|NCT03129100|520722778|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144527171|NCT05477186|521131847|FG002|Overall Study|Withdrawal by Subject|0|||
144414272|NCT03129100|520722779|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414273|NCT03129100|520722780|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144527172|NCT05477186|521131848|FG003|Overall Study|Withdrawal by Subject|0|||
144527173|NCT05477186|521131849|FG004|Overall Study|Withdrawal by Subject|0|||
144527174|NCT05477186|521131850|FG005|Overall Study|Withdrawal by Subject|1|||
144527175|NCT05477186|521131851|FG006|Overall Study|Withdrawal by Subject|0|||
144527176|NCT05477186|521131845|FG000|Overall Study|Lost to Follow-up|1|||
144527177|NCT05477186|521131846|FG001|Overall Study|Lost to Follow-up|0|||
144527178|NCT05477186|521131847|FG002|Overall Study|Lost to Follow-up|2|||
144527179|NCT05477186|521131848|FG003|Overall Study|Lost to Follow-up|1|||
144527180|NCT05477186|521131849|FG004|Overall Study|Lost to Follow-up|1|||
144527181|NCT05477186|521131850|FG005|Overall Study|Lost to Follow-up|0|||
144527182|NCT05477186|521131851|FG006|Overall Study|Lost to Follow-up|2|||
144527183|NCT05566639|521131872|FG000|Overall Study|Adverse Event|1|||
144527184|NCT05566639|521131873|FG001|Overall Study|Adverse Event|1|||
144527185|NCT05566639|521131872|FG000|Overall Study|Serious Adverse Event|1|||
144527186|NCT05566639|521131873|FG001|Overall Study|Serious Adverse Event|3|||
144527187|NCT05566639|521131872|FG000|Overall Study|Death|44|||
144527188|NCT05566639|521131873|FG001|Overall Study|Death|45|||
144527189|NCT05566639|521131872|FG000|Overall Study|Lost to Follow-up|467|||
144527190|NCT05566639|521131873|FG001|Overall Study|Lost to Follow-up|461|||
144527191|NCT05566639|521131872|FG000|Overall Study|Physician Decision|45|||
144527192|NCT05566639|521131873|FG001|Overall Study|Physician Decision|44|||
144527193|NCT05566639|521131872|FG000|Overall Study|Protocol Deviation|4|||
144527194|NCT05566639|521131873|FG001|Overall Study|Protocol Deviation|4|||
144527195|NCT05566639|521131872|FG000|Overall Study|Withdrawal by Subject|277|||
144527196|NCT05566639|521131873|FG001|Overall Study|Withdrawal by Subject|271|||
144527197|NCT05566639|521131872|FG000|Overall Study|Other Than Specified|52|||
144527198|NCT05566639|521131873|FG001|Overall Study|Other Than Specified|64|||
144527199|NCT04054193|521131881|FG000|Cycle 1|Physician Decision|1|||
144414274|NCT03129100|520722781|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144527200|NCT04054193|521131881|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
144527201|NCT04054193|521131881|FG000|Cycle 1|Allocated but not treated|3|||
144527202|NCT04054193|521131881|FG000|Cycles 2-3|Physician Decision|2|||
144414275|NCT03129100|520722782|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
144414276|NCT03129100|520722757|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414277|NCT03129100|520722758|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414278|NCT03129100|520722759|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414279|NCT03129100|520722760|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144527203|NCT04054193|521131881|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
144527204|NCT04054193|521131881|FG000|Cycles 2-3|Various reasons|17|||
144527205|NCT04830800|521131887|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
144527206|NCT04830800|521131888|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
144538356|NCT00609869|521174169|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
144414280|NCT03129100|520722761|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414281|NCT03129100|520722762|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414282|NCT03129100|520722763|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414283|NCT03129100|520722764|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414284|NCT03129100|520722765|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414285|NCT03129100|520722766|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414286|NCT03129100|520722767|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414287|NCT03129100|520722768|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414288|NCT03129100|520722769|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414289|NCT03129100|520722770|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414290|NCT03129100|520722771|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414291|NCT03129100|520722772|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414292|NCT03129100|520722773|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414293|NCT03129100|520722774|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414294|NCT03129100|520722775|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414295|NCT03129100|520722776|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414296|NCT03129100|520722777|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
144414297|NCT03129100|520722778|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414298|NCT03129100|520722779|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414299|NCT03129100|520722780|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414300|NCT03129100|520722781|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414301|NCT03129100|520722782|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
144414302|NCT03129100|520722757|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
144414303|NCT03129100|520722758|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
144414304|NCT03129100|520722759|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
144414305|NCT03129100|520722760|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
144414306|NCT03129100|520722761|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
144414307|NCT03129100|520722762|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
144414308|NCT03129100|520722763|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
144414309|NCT03129100|520722764|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
144414310|NCT03129100|520722765|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
144414311|NCT03129100|520722766|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
144414312|NCT03129100|520722767|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
144414313|NCT03129100|520722768|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
144414314|NCT03129100|520722769|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
144414315|NCT03129100|520722770|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
144414316|NCT03129100|520722771|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
144414317|NCT03129100|520722772|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
144414318|NCT03129100|520722773|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
144414319|NCT03129100|520722774|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
144414320|NCT03129100|520722775|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
144414321|NCT03129100|520722776|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
144414322|NCT03129100|520722777|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
144414323|NCT03129100|520722778|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
144414324|NCT03129100|520722779|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
144414325|NCT03129100|520722780|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
144414326|NCT03129100|520722781|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
144414327|NCT03129100|520722782|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
144414328|NCT03129100|520722757|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414329|NCT03129100|520722758|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414330|NCT03129100|520722759|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414331|NCT03129100|520722760|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414332|NCT03129100|520722761|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414333|NCT03129100|520722762|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414334|NCT03129100|520722763|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414335|NCT03129100|520722764|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414336|NCT03129100|520722765|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144723025|NCT00679783|521840601|FG004|Overall Study|Ongoing at data cut-off|1|||
144414337|NCT03129100|520722766|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414338|NCT03129100|520722767|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414339|NCT03129100|520722768|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414340|NCT03129100|520722769|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414341|NCT03129100|520722770|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144538357|NCT00609869|521174169|FG000|Overall Study|Severe hematologic toxicity|1|||
144723026|NCT00679783|521840602|FG005|Overall Study|Ongoing at data cut-off|0|||
144414342|NCT03129100|520722771|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414343|NCT03129100|520722772|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414344|NCT03129100|520722773|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414345|NCT03129100|520722774|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414346|NCT03129100|520722775|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414347|NCT03129100|520722776|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414348|NCT03129100|520722777|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
144414349|NCT03129100|520722778|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414350|NCT03129100|520722779|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414351|NCT03129100|520722780|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414352|NCT03129100|520722781|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414353|NCT03129100|520722782|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
144414354|NCT03129100|520722757|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
144414355|NCT03129100|520722758|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
144414356|NCT03129100|520722759|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
144414357|NCT03129100|520722760|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
144414358|NCT03129100|520722761|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
144414359|NCT03129100|520722762|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
144414360|NCT03129100|520722763|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
144414361|NCT03129100|520722764|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
144414362|NCT03129100|520722765|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
144414363|NCT03129100|520722766|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
144414364|NCT03129100|520722767|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
144414365|NCT03129100|520722768|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
144414366|NCT03129100|520722769|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
144414367|NCT03129100|520722770|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
144414368|NCT03129100|520722771|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
144414369|NCT03129100|520722772|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
144414370|NCT03129100|520722773|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
144414371|NCT03129100|520722774|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
144250419|NCT00631163|520115500|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
144414372|NCT03129100|520722775|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
144414373|NCT03129100|520722776|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
144414374|NCT03129100|520722777|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
144723027|NCT00679783|521840603|FG006|Overall Study|Ongoing at data cut-off|0|||
144723028|NCT00814320|521840604|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
144723029|NCT00814320|521840605|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
144723030|NCT00814320|521840604|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
144723031|NCT00814320|521840605|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
144723032|NCT00814320|521840604|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
144723033|NCT00814320|521840605|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
144723034|NCT00814320|521840604|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
144723035|NCT00814320|521840605|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
144723036|NCT00814320|521840604|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
144723037|NCT00814320|521840605|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
144723038|NCT00814320|521840604|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
144723039|NCT00814320|521840605|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
144723040|NCT00814320|521840604|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
144723041|NCT00814320|521840605|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
144723042|NCT00814320|521840604|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
144723043|NCT00814320|521840605|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
144723044|NCT00814320|521840604|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
144723045|NCT00814320|521840605|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
144723046|NCT00814320|521840604|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
144723047|NCT00814320|521840605|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
144723048|NCT00491504|521840606|FG000|Overall Study|Adverse Event|0|||
144723049|NCT00491504|521840607|FG001|Overall Study|Adverse Event|1|||
144723050|NCT00491504|521840608|FG002|Overall Study|Adverse Event|0|||
144723051|NCT00491504|521840609|FG003|Overall Study|Adverse Event|0|||
144723052|NCT00491504|521840606|FG000|Overall Study|Withdrawal by Subject|0|||
144723053|NCT00491504|521840607|FG001|Overall Study|Withdrawal by Subject|0|||
144723054|NCT00491504|521840608|FG002|Overall Study|Withdrawal by Subject|1|||
144723055|NCT00491504|521840609|FG003|Overall Study|Withdrawal by Subject|2|||
144723056|NCT00491504|521840606|FG000|Overall Study|Protocol Violation|0|||
144723057|NCT00491504|521840607|FG001|Overall Study|Protocol Violation|0|||
144723058|NCT00491504|521840608|FG002|Overall Study|Protocol Violation|3|||
144723059|NCT00491504|521840609|FG003|Overall Study|Protocol Violation|2|||
144723060|NCT02568384|521840612|FG000|Overall Study|Mobile devices incompatible with App|2|||
144723061|NCT01485536|521840614|FG000|Overall Study|Withdrawal by Subject|3|||
144723062|NCT01485536|521840614|FG000|Overall Study|Adverse Event|1|||
144723063|NCT02799602|521840615|FG000|Overall Study|Protocol Violation|1|||
144723064|NCT02799602|521840616|FG001|Overall Study|Protocol Violation|0|||
144723065|NCT02799602|521840615|FG000|Overall Study|Physician Decision|5|||
144723066|NCT02799602|521840616|FG001|Overall Study|Physician Decision|6|||
144723067|NCT02799602|521840615|FG000|Overall Study|Lost to Follow-up|4|||
144723068|NCT02799602|521840616|FG001|Overall Study|Lost to Follow-up|2|||
144723069|NCT02799602|521840615|FG000|Overall Study|Additional primary malignancy|11|||
144723070|NCT02799602|521840616|FG001|Overall Study|Additional primary malignancy|6|||
144723071|NCT02799602|521840615|FG000|Overall Study|Non-compliance with study drug|14|||
144723072|NCT02799602|521840616|FG001|Overall Study|Non-compliance with study drug|12|||
144723073|NCT02799602|521840615|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
144723074|NCT02799602|521840616|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
144723075|NCT02799602|521840615|FG000|Overall Study|Withdrawal by Subject|26|||
144723076|NCT02799602|521840616|FG001|Overall Study|Withdrawal by Subject|40|||
144723077|NCT02799602|521840615|FG000|Overall Study|Progressive disease - clinical progression|131|||
144723078|NCT02799602|521840616|FG001|Overall Study|Progressive disease - clinical progression|276|||
144723079|NCT02799602|521840615|FG000|Overall Study|Progressive disease - radiological progression|90|||
144723080|NCT02799602|521840616|FG001|Overall Study|Progressive disease - radiological progression|133|||
144527207|NCT04830800|521131889|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
144527208|NCT04830800|521131890|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
144527209|NCT04830800|521131891|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
144527210|NCT02626533|521131892|FG000|Overall Study|Protocol Violation|14|||
144527211|NCT02626533|521131892|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
144527212|NCT02626533|521131892|FG000|Overall Study|Withdrawal by Subject|1|||
144527213|NCT04753697|521131893|FG000|Induction Phase|Withdrawal by Subject|12|||
144527214|NCT04753697|521131894|FG001|Induction Phase|Withdrawal by Subject|5|||
144723081|NCT02799602|521840615|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
144723082|NCT02799602|521840616|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
144723083|NCT02799602|521840615|FG000|Overall Study|Death|9|||
144723084|NCT02799602|521840616|FG001|Overall Study|Death|5|||
144414375|NCT03129100|520722778|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
144414376|NCT03129100|520722779|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
144414377|NCT03129100|520722780|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
144414378|NCT03129100|520722781|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
144414379|NCT03129100|520722782|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
144414380|NCT03129100|520722757|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414381|NCT03129100|520722758|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414382|NCT03129100|520722759|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414383|NCT03129100|520722760|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414384|NCT03129100|520722761|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414385|NCT03129100|520722762|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414386|NCT03129100|520722763|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414387|NCT03129100|520722764|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414388|NCT03129100|520722765|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414389|NCT03129100|520722766|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414390|NCT03129100|520722767|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414391|NCT03129100|520722768|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414392|NCT03129100|520722769|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414393|NCT03129100|520722770|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414394|NCT03129100|520722771|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414395|NCT03129100|520722772|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414396|NCT03129100|520722773|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414397|NCT03129100|520722774|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414398|NCT03129100|520722775|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414399|NCT03129100|520722776|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414400|NCT03129100|520722777|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414401|NCT03129100|520722778|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414402|NCT03129100|520722779|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414403|NCT03129100|520722780|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
144414404|NCT03129100|520722781|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
144414405|NCT03129100|520722782|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
144414406|NCT03129100|520722757|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414407|NCT03129100|520722758|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414408|NCT03129100|520722759|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414409|NCT03129100|520722760|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414410|NCT03129100|520722761|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414411|NCT03129100|520722762|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414412|NCT03129100|520722763|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414413|NCT03129100|520722764|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414414|NCT03129100|520722765|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414415|NCT03129100|520722766|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414416|NCT03129100|520722767|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414417|NCT03129100|520722768|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414418|NCT03129100|520722769|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414419|NCT03129100|520722770|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414420|NCT03129100|520722771|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414421|NCT03129100|520722772|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414422|NCT03129100|520722773|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414423|NCT03129100|520722774|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414424|NCT03129100|520722775|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414425|NCT03129100|520722776|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414426|NCT03129100|520722777|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414427|NCT03129100|520722778|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414428|NCT03129100|520722779|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
144414429|NCT03129100|520722780|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
144414430|NCT03129100|520722781|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
144414431|NCT03129100|520722782|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
144414432|NCT03129100|520722757|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414433|NCT03129100|520722758|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414434|NCT03129100|520722759|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414435|NCT03129100|520722760|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414436|NCT03129100|520722761|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414437|NCT03129100|520722762|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414438|NCT03129100|520722763|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414439|NCT03129100|520722764|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414440|NCT03129100|520722765|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414441|NCT03129100|520722766|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414442|NCT03129100|520722767|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414443|NCT03129100|520722768|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414444|NCT03129100|520722769|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144723085|NCT02799602|521840615|FG000|Overall Study|Other|287|||
144723086|NCT02799602|521840616|FG001|Overall Study|Other|118|||
144723087|NCT02799602|521840615|FG000|Overall Study|Study drug never administered|0|||
144723088|NCT02799602|521840616|FG001|Overall Study|Study drug never administered|3|||
144723089|NCT01734772|521840617|FG000|Overall Study|Adverse Event|1|||
144723090|NCT01734772|521840618|FG001|Overall Study|Adverse Event|2|||
144723091|NCT01734772|521840617|FG000|Overall Study|Withdrawal by Subject|0|||
144723092|NCT01734772|521840618|FG001|Overall Study|Withdrawal by Subject|1|||
144723093|NCT03730103|521840619|FG000|Overall Study|Did not meet inclusion criteria|0|||
144723094|NCT03730103|521840620|FG001|Overall Study|Did not meet inclusion criteria|5|||
144723095|NCT02626949|521840621|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
144723096|NCT02626949|521840622|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
144723097|NCT02626949|521840621|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
144723098|NCT02626949|521840622|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
144723099|NCT02626949|521840621|FG000|Enrolled|Lost to Follow-up|7|||
144723100|NCT02626949|521840622|FG001|Enrolled|Lost to Follow-up|6|||
144723101|NCT02626949|521840621|FG000|Enrolled|Withdrawal by Subject|3|||
144723102|NCT02626949|521840622|FG001|Enrolled|Withdrawal by Subject|2|||
144723103|NCT01488578|521840623|FG000|Overall Study|Protocol Violation|1836|||
144723104|NCT02308111|521840624|FG000|Overall Study|Adverse Event|31|||
144723105|NCT02308111|521840625|FG001|Overall Study|Adverse Event|19|||
144723106|NCT02308111|521840624|FG000|Overall Study|Death|9|||
144723107|NCT02308111|521840625|FG001|Overall Study|Death|6|||
144723108|NCT02308111|521840624|FG000|Overall Study|Lost to Follow-up|2|||
144723109|NCT02308111|521840625|FG001|Overall Study|Lost to Follow-up|7|||
144723110|NCT02308111|521840624|FG000|Overall Study|Physician Decision|6|||
144723111|NCT02308111|521840625|FG001|Overall Study|Physician Decision|17|||
144723112|NCT02308111|521840624|FG000|Overall Study|Protocol Violation|0|||
144723113|NCT02308111|521840625|FG001|Overall Study|Protocol Violation|1|||
144414445|NCT03129100|520722770|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414446|NCT03129100|520722771|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414447|NCT03129100|520722772|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414448|NCT03129100|520722773|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144723114|NCT02308111|521840624|FG000|Overall Study|Withdrawal by Subject|28|||
144723115|NCT02308111|521840625|FG001|Overall Study|Withdrawal by Subject|38|||
144723116|NCT02308111|521840624|FG000|Overall Study|Study Terminated by Sponsor|72|||
144414449|NCT03129100|520722774|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144723117|NCT02308111|521840625|FG001|Overall Study|Study Terminated by Sponsor|61|||
144723118|NCT02308111|521840624|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
144723119|NCT02308111|521840625|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
144723120|NCT02308111|521840624|FG000|Overall Study|Site Closure|3|||
144723121|NCT02308111|521840625|FG001|Overall Study|Site Closure|3|||
144414450|NCT03129100|520722775|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414451|NCT03129100|520722776|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414452|NCT03129100|520722777|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414453|NCT03129100|520722778|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414454|NCT03129100|520722779|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414455|NCT03129100|520722780|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414456|NCT03129100|520722781|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
144414457|NCT03129100|520722782|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
144414458|NCT03129100|520722757|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414459|NCT03129100|520722758|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414460|NCT03129100|520722759|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414461|NCT03129100|520722760|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414462|NCT03129100|520722761|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414463|NCT03129100|520722762|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414464|NCT03129100|520722763|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414465|NCT03129100|520722764|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414466|NCT03129100|520722765|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414467|NCT03129100|520722766|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414468|NCT03129100|520722767|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414469|NCT03129100|520722768|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414470|NCT03129100|520722769|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414471|NCT03129100|520722770|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414472|NCT03129100|520722771|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414473|NCT03129100|520722772|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414474|NCT03129100|520722773|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414475|NCT03129100|520722774|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414476|NCT03129100|520722775|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414477|NCT03129100|520722776|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414478|NCT03129100|520722777|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414479|NCT03129100|520722778|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414480|NCT03129100|520722779|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414481|NCT03129100|520722780|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414482|NCT03129100|520722781|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
144414483|NCT03129100|520722782|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
144414484|NCT03129100|520722757|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
144414485|NCT03129100|520722758|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
144414486|NCT03129100|520722759|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
144414487|NCT03129100|520722760|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
144414488|NCT03129100|520722761|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
144414489|NCT03129100|520722762|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
144414490|NCT03129100|520722763|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
144414491|NCT03129100|520722764|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
144414492|NCT03129100|520722765|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
144414493|NCT03129100|520722766|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
144414494|NCT03129100|520722767|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
144414495|NCT03129100|520722768|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
144414496|NCT03129100|520722769|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
144414497|NCT03129100|520722770|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
144414498|NCT03129100|520722771|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
144414499|NCT03129100|520722772|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
144414500|NCT03129100|520722773|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
144414501|NCT03129100|520722774|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
144414502|NCT03129100|520722775|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
144414503|NCT03129100|520722776|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
144414504|NCT03129100|520722777|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
144414505|NCT03129100|520722778|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
144414506|NCT03129100|520722779|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
144414507|NCT03129100|520722780|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
144414508|NCT03129100|520722781|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
144414509|NCT03129100|520722782|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
144414510|NCT02756013|520722783|FG000|Overall Study|Adverse Event|1|||
144414511|NCT02756013|520722783|FG000|Overall Study|Hypersensitivity|1|||
144527215|NCT04753697|521131895|FG002|Induction Phase|Withdrawal by Subject|6|||
144414512|NCT01197560|520722784|FG000|Overall Study|Adverse Event|6|||
144414513|NCT01197560|520722785|FG001|Overall Study|Adverse Event|8|||
144414514|NCT01197560|520722784|FG000|Overall Study|Death|3|||
144414515|NCT01197560|520722785|FG001|Overall Study|Death|5|||
144414516|NCT01197560|520722784|FG000|Overall Study|Withdrawal by Subject|1|||
144414517|NCT01197560|520722785|FG001|Overall Study|Withdrawal by Subject|1|||
144414518|NCT01197560|520722784|FG000|Overall Study|Disease progression|40|||
144414519|NCT01197560|520722785|FG001|Overall Study|Disease progression|35|||
144414520|NCT01197560|520722784|FG000|Overall Study|Miscellaneous|4|||
144414521|NCT01197560|520722785|FG001|Overall Study|Miscellaneous|3|||
144414522|NCT01197560|520722784|FG000|Overall Study|Missing|0|||
144414523|NCT01197560|520722785|FG001|Overall Study|Missing|1|||
144414524|NCT00006237|520722786|FG000|Overall Study|Adverse Event|39|||
144414525|NCT00006237|520722787|FG001|Overall Study|Adverse Event|29|||
144414526|NCT00006237|520722786|FG000|Overall Study|Death|1|||
144414527|NCT00006237|520722787|FG001|Overall Study|Death|0|||
144414528|NCT00006237|520722786|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
144414529|NCT00006237|520722787|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
144414530|NCT00006237|520722786|FG000|Overall Study|Progression/relapse|54|||
144414531|NCT00006237|520722787|FG001|Overall Study|Progression/relapse|2|||
144414532|NCT00006237|520722786|FG000|Overall Study|Not eligible|9|||
144414533|NCT00006237|520722787|FG001|Overall Study|Not eligible|20|||
144414534|NCT00006237|520722786|FG000|Overall Study|Withdrawal by Subject|0|||
144414535|NCT00006237|520722787|FG001|Overall Study|Withdrawal by Subject|1|||
144414536|NCT00006237|520722786|FG000|Overall Study|Not protocol specified|14|||
144414537|NCT00006237|520722787|FG001|Overall Study|Not protocol specified|5|||
144414538|NCT03727347|520722788|FG000|Overall Study|Withdrawal by Subject|2|||
144414539|NCT03727347|520722788|FG000|Overall Study|Lost to Follow-up|1|||
144414540|NCT01846416|520722791|FG000|Treatment Phase|Death|2|||
144414541|NCT01846416|520722792|FG001|Treatment Phase|Death|9|||
144414542|NCT01846416|520722793|FG002|Treatment Phase|Death|1|||
144414543|NCT01846416|520722791|FG000|Treatment Phase|Withdrawal by Subject|2|||
144414544|NCT01846416|520722792|FG001|Treatment Phase|Withdrawal by Subject|4|||
144414545|NCT01846416|520722793|FG002|Treatment Phase|Withdrawal by Subject|2|||
144414546|NCT01846416|520722791|FG000|Treatment Phase|Other|1|||
144414547|NCT01846416|520722792|FG001|Treatment Phase|Other|5|||
144414548|NCT01846416|520722793|FG002|Treatment Phase|Other|1|||
144414549|NCT01846416|520722791|FG000|Treatment Phase|Physician Decision|1|||
144414550|NCT01846416|520722792|FG001|Treatment Phase|Physician Decision|2|||
144414551|NCT01846416|520722793|FG002|Treatment Phase|Physician Decision|0|||
144414552|NCT01846416|520722791|FG000|Treatment Phase|Adverse Event|3|||
144414553|NCT01846416|520722792|FG001|Treatment Phase|Adverse Event|4|||
144414554|NCT01846416|520722793|FG002|Treatment Phase|Adverse Event|0|||
144414555|NCT01846416|520722791|FG000|Treatment Phase|Non-compliance|0|||
144414556|NCT01846416|520722792|FG001|Treatment Phase|Non-compliance|2|||
144414557|NCT01846416|520722793|FG002|Treatment Phase|Non-compliance|0|||
144414558|NCT01846416|520722791|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
144414559|NCT01846416|520722792|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
144414560|NCT01846416|520722793|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
144414561|NCT01846416|520722791|FG000|Treatment Phase|Progressive Disease|21|||
144414562|NCT01846416|520722792|FG001|Treatment Phase|Progressive Disease|63|||
144414563|NCT01846416|520722793|FG002|Treatment Phase|Progressive Disease|9|||
144414564|NCT01846416|520722791|FG000|Survival Follow-up|Death|21|||
144414565|NCT01846416|520722792|FG001|Survival Follow-up|Death|62|||
144414566|NCT01846416|520722793|FG002|Survival Follow-up|Death|9|||
144414567|NCT01846416|520722791|FG000|Survival Follow-up|Lost to Follow-up|0|||
144414568|NCT01846416|520722792|FG001|Survival Follow-up|Lost to Follow-up|2|||
144414569|NCT01846416|520722793|FG002|Survival Follow-up|Lost to Follow-up|2|||
144414570|NCT01846416|520722791|FG000|Survival Follow-up|Withdrawal by Subject|2|||
144414571|NCT01846416|520722792|FG001|Survival Follow-up|Withdrawal by Subject|7|||
144414572|NCT01846416|520722793|FG002|Survival Follow-up|Withdrawal by Subject|0|||
144414573|NCT01846416|520722791|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
144414574|NCT01846416|520722792|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
144414575|NCT01846416|520722793|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
144414576|NCT01846416|520722791|FG000|Survival Follow-up|Other|3|||
144723122|NCT02308111|521840624|FG000|Overall Study|Non-compliance with Study Drug|3|||
144723123|NCT02308111|521840625|FG001|Overall Study|Non-compliance with Study Drug|1|||
144414577|NCT01846416|520722792|FG001|Survival Follow-up|Other|1|||
144414578|NCT01846416|520722793|FG002|Survival Follow-up|Other|1|||
144414579|NCT00211510|520722796|FG000|Overall Study|Physician Decision|3|||
144414580|NCT00211510|520722797|FG001|Overall Study|Physician Decision|1|||
144414581|NCT00211510|520722796|FG000|Overall Study|Withdrawal by Subject|3|||
144414582|NCT00211510|520722797|FG001|Overall Study|Withdrawal by Subject|1|||
144414583|NCT01962896|520722798|FG000|Overall Study|Lack of Efficacy|4|||
144414584|NCT01487200|520722799|FG000|Overall Study|Withdrawal by Subject|0|||
144414585|NCT01487200|520722800|FG001|Overall Study|Withdrawal by Subject|1|||
144414586|NCT01487200|520722801|FG002|Overall Study|Withdrawal by Subject|0|||
144414587|NCT01487200|520722802|FG003|Overall Study|Withdrawal by Subject|0|||
144414588|NCT02837783|520722803|FG000|Overall Study|Adverse Event|1|||
144414589|NCT02837783|520722804|FG001|Overall Study|Adverse Event|0|||
144527216|NCT04753697|521131893|FG000|Induction Phase|Physician Decision|1|||
144414590|NCT02837783|520722803|FG000|Overall Study|Other, Not Specified|1|||
144414591|NCT02837783|520722804|FG001|Overall Study|Other, Not Specified|2|||
144414592|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
144414593|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
144414594|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
144414595|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414596|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414597|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414598|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414599|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414600|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414601|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414602|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
144414603|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
144414604|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414605|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
144414606|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414607|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414608|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414609|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414610|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414611|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414612|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414613|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
144414614|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
144414615|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
144414616|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
144414617|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414618|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414619|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414620|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414621|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414622|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414623|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414624|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
144414625|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
144414626|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
144414627|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414628|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414629|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414630|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414631|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414632|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414633|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414634|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414635|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
144414636|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
144414637|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
144414638|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
144414639|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144527217|NCT04753697|521131894|FG001|Induction Phase|Physician Decision|0|||
144414640|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414641|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414642|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414643|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414644|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414645|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414646|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
144414647|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414648|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
144414649|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
144414650|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414651|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414652|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414653|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414654|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414655|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414656|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414657|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
144414658|NCT02207244|520722807|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414659|NCT02207244|520722808|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
144414660|NCT02207244|520722809|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414661|NCT02207244|520722810|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414662|NCT02207244|520722811|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414663|NCT02207244|520722812|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414664|NCT02207244|520722813|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414665|NCT02207244|520722814|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414666|NCT02207244|520722815|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414667|NCT02207244|520722816|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414668|NCT02207244|520722817|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
144414669|NCT02207244|520722807|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414670|NCT02207244|520722808|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414671|NCT02207244|520722809|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414672|NCT02207244|520722810|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414673|NCT02207244|520722811|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
144414674|NCT02207244|520722812|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
144414675|NCT02207244|520722813|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414676|NCT02207244|520722814|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414677|NCT02207244|520722815|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414678|NCT02207244|520722816|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414679|NCT02207244|520722817|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
144414680|NCT02207244|520722807|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414681|NCT02207244|520722808|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414682|NCT02207244|520722809|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414683|NCT02207244|520722810|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414684|NCT02207244|520722811|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414685|NCT02207244|520722812|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
144414686|NCT02207244|520722813|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414687|NCT02207244|520722814|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414688|NCT02207244|520722815|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414689|NCT02207244|520722816|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414690|NCT02207244|520722817|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
144414691|NCT02207244|520722807|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414692|NCT02207244|520722808|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414693|NCT02207244|520722809|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414694|NCT02207244|520722810|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
144414695|NCT02207244|520722811|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
144414696|NCT02207244|520722812|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
144414697|NCT02207244|520722813|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414698|NCT02207244|520722814|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414699|NCT02207244|520722815|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414700|NCT02207244|520722816|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414701|NCT02207244|520722817|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
144414702|NCT02207244|520722807|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414703|NCT02207244|520722808|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414704|NCT02207244|520722809|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414705|NCT02207244|520722810|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
144414706|NCT02207244|520722811|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
144414707|NCT02207244|520722812|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
144414708|NCT02207244|520722813|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414709|NCT02207244|520722814|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414710|NCT02207244|520722815|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414711|NCT02207244|520722816|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414712|NCT02207244|520722817|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
144414713|NCT02207244|520722807|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414714|NCT02207244|520722808|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414715|NCT02207244|520722809|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414716|NCT02207244|520722810|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
144414717|NCT02207244|520722811|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414718|NCT02207244|520722812|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
144414719|NCT02207244|520722813|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414720|NCT02207244|520722814|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414721|NCT02207244|520722815|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414722|NCT02207244|520722816|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414723|NCT02207244|520722817|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
144414724|NCT02207244|520722807|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414725|NCT02207244|520722808|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414726|NCT02207244|520722809|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414727|NCT02207244|520722810|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
144414728|NCT02207244|520722811|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414729|NCT02207244|520722812|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414730|NCT02207244|520722813|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414731|NCT02207244|520722814|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414732|NCT02207244|520722815|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414733|NCT02207244|520722816|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414734|NCT02207244|520722817|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
144414735|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144414736|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144414737|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144414738|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144414739|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144414740|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144414741|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
144414742|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
144414743|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
144414744|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
144414745|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
144723124|NCT02308111|521840624|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
144723125|NCT02308111|521840625|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
144723126|NCT02308111|521840624|FG000|Overall Study|Liver Transplant|3|||
144414746|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414747|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414748|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414749|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414750|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414751|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414752|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414753|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
144414754|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414755|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414756|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
144414757|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414758|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414759|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414760|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414761|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414762|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414763|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
144414764|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
144414765|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
144414766|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
144414767|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
144414768|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414769|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414770|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414771|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414772|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414773|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414774|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
144414775|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
144414776|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414777|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
144414778|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
144414779|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144414780|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144414781|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144527218|NCT04753697|521131895|FG002|Induction Phase|Physician Decision|0|||
144723127|NCT02308111|521840625|FG001|Overall Study|Liver Transplant|3|||
144414782|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144414783|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144414784|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144414785|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
144414786|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
144414787|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
144414788|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
144414789|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
144414790|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414791|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414792|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414793|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414794|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414795|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414796|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414797|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
144414798|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
144414799|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414800|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
144414801|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414802|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414803|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414804|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414805|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414806|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414807|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414808|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414809|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
144414810|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414811|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
144414812|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414813|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414814|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414815|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414816|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414817|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414818|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414819|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
144414820|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414821|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414822|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
144414823|NCT02207244|520722807|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414824|NCT02207244|520722808|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144527219|NCT04753697|521131893|FG000|Induction Phase|Lost to Follow-up|2|||
144527220|NCT04753697|521131894|FG001|Induction Phase|Lost to Follow-up|2|||
144414825|NCT02207244|520722809|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414826|NCT02207244|520722810|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414827|NCT02207244|520722811|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414828|NCT02207244|520722812|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414829|NCT02207244|520722813|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
144414830|NCT02207244|520722814|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414831|NCT02207244|520722815|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414832|NCT02207244|520722816|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414833|NCT02207244|520722817|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
144414834|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414835|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414836|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414837|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414838|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414839|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414840|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414841|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414842|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
144414843|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
144414844|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
144414845|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414846|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414847|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414848|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414849|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414850|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414851|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414852|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414853|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
144414854|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
144414855|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
144414856|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414857|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414858|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414859|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414860|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414861|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414862|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414863|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414864|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
144414865|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
144414866|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
144414867|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414868|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414869|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414870|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414871|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414872|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414873|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414874|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414875|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
144414876|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
144414877|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
144414878|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
144414879|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
144414880|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
144414881|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
144414882|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
144414883|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
144414884|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
144414885|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
144414886|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
144414887|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
144414888|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
144414889|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
144527221|NCT04753697|521131895|FG002|Induction Phase|Lost to Follow-up|1|||
144414890|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
144414891|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
144414892|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
144414893|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
144414894|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
144414895|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
144414896|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
144414897|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
144723128|NCT02308111|521840624|FG000|Overall Study|Liver Transplant Waitlist|2|||
144723129|NCT02308111|521840625|FG001|Overall Study|Liver Transplant Waitlist|2|||
144727088|NCT05097989|521854424|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
144414898|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
144414899|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
144414900|NCT02207244|520722807|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414901|NCT02207244|520722808|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414902|NCT02207244|520722809|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414903|NCT02207244|520722810|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414904|NCT02207244|520722811|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414905|NCT02207244|520722812|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414906|NCT02207244|520722813|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414907|NCT02207244|520722814|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414908|NCT02207244|520722815|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414909|NCT02207244|520722816|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
144414910|NCT02207244|520722817|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
144414911|NCT02216591|520722818|FG000|Overall Study|Lost to Follow-up|0|||
144414912|NCT02216591|520722819|FG001|Overall Study|Lost to Follow-up|1|||
144414913|NCT02846779|520722822|FG000|Overall Study|Lost Enrollment|83|||
144250420|NCT00631163|520115500|FG000|Number of Participants in Year 1|Death|6|||
144414914|NCT02846779|520722823|FG001|Overall Study|Lost Enrollment|82|||
144414915|NCT02846779|520722824|FG002|Overall Study|Lost Enrollment|86|||
144414916|NCT02846779|520722822|FG000|Overall Study|Less than 31 days of follow-up|56|||
144414917|NCT02846779|520722823|FG001|Overall Study|Less than 31 days of follow-up|45|||
144414918|NCT02846779|520722824|FG002|Overall Study|Less than 31 days of follow-up|52|||
144414919|NCT00911820|520724445|FG000|Overall Study|RECIST progression|12|||
144414920|NCT00911820|520724446|FG001|Overall Study|RECIST progression|8|||
144414921|NCT00911820|520724445|FG000|Overall Study|Adverse Event|8|||
144414922|NCT00911820|520724446|FG001|Overall Study|Adverse Event|8|||
144414923|NCT00911820|520724445|FG000|Overall Study|Clinical Progression|7|||
144414924|NCT00911820|520724446|FG001|Overall Study|Clinical Progression|5|||
144414925|NCT00911820|520724445|FG000|Overall Study|Physician Decision|5|||
144414926|NCT00911820|520724446|FG001|Overall Study|Physician Decision|9|||
144414927|NCT00911820|520724445|FG000|Overall Study|Decline in Performance Status|4|||
144414928|NCT00911820|520724446|FG001|Overall Study|Decline in Performance Status|2|||
144414929|NCT00911820|520724445|FG000|Overall Study|Withdrawal by Subject|3|||
144414930|NCT00911820|520724446|FG001|Overall Study|Withdrawal by Subject|4|||
144414931|NCT00911820|520724445|FG000|Overall Study|Death|1|||
144414932|NCT00911820|520724446|FG001|Overall Study|Death|2|||
144414933|NCT00911820|520724445|FG000|Overall Study|Pursue surgery|1|||
144414934|NCT00911820|520724446|FG001|Overall Study|Pursue surgery|1|||
144414935|NCT00911820|520724445|FG000|Overall Study|Pursue Radiation|1|||
144414936|NCT00911820|520724446|FG001|Overall Study|Pursue Radiation|0|||
144414937|NCT00911820|520724445|FG000|Overall Study|Still on Therapy|2|||
144414938|NCT00911820|520724446|FG001|Overall Study|Still on Therapy|2|||
144414939|NCT00911820|520724445|FG000|Overall Study|Pathology Not Confirmed|1|||
144414940|NCT00911820|520724446|FG001|Overall Study|Pathology Not Confirmed|0|||
144414941|NCT00911820|520724445|FG000|Overall Study|Withdraw before Receive Treatment|0|||
144414942|NCT00911820|520724446|FG001|Overall Study|Withdraw before Receive Treatment|2|||
144527222|NCT04753697|521131893|FG000|Induction Phase|Lack of Efficacy|1|||
144527223|NCT04753697|521131894|FG001|Induction Phase|Lack of Efficacy|0|||
144527224|NCT04753697|521131895|FG002|Induction Phase|Lack of Efficacy|0|||
144527225|NCT04753697|521131893|FG000|Maintenance Phase|Physician Decision|0|||
144250421|NCT00631163|520115500|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
144414943|NCT00309387|520724447|FG000|Overall Study|Death|72|||
144414944|NCT00309387|520724448|FG001|Overall Study|Death|73|||
144414945|NCT00309387|520724447|FG000|Overall Study|Lost to Follow-up|70|||
144414946|NCT00309387|520724448|FG001|Overall Study|Lost to Follow-up|86|||
144414947|NCT01342796|520724449|FG000|Overall Study|Withdrawal by Subject|2|||
144414948|NCT01342796|520724450|FG001|Overall Study|Withdrawal by Subject|0|||
144414949|NCT01342796|520724449|FG000|Overall Study|Lost to Follow-up|0|||
144414950|NCT01342796|520724450|FG001|Overall Study|Lost to Follow-up|3|||
144414951|NCT01342796|520724449|FG000|Overall Study|Inappropriate enrollment|1|||
144414952|NCT01342796|520724450|FG001|Overall Study|Inappropriate enrollment|0|||
144414953|NCT01599234|520724459|FG000|Overall Study|Adverse Event|9|||
144414954|NCT01599234|520724460|FG001|Overall Study|Adverse Event|5|||
144414955|NCT01599234|520724459|FG000|Overall Study|Withdrawal by Subject|2|||
144527226|NCT04753697|521131894|FG001|Maintenance Phase|Physician Decision|0|||
144527227|NCT04753697|521131895|FG002|Maintenance Phase|Physician Decision|1|||
144527228|NCT04753697|521131893|FG000|Maintenance Phase|Withdrawal by Subject|3|||
144414956|NCT01599234|520724460|FG001|Overall Study|Withdrawal by Subject|1|||
144414957|NCT01599234|520724459|FG000|Overall Study|Lost to Follow-up|1|||
144414958|NCT01599234|520724460|FG001|Overall Study|Lost to Follow-up|2|||
144414959|NCT01599234|520724459|FG000|Overall Study|Lack of Efficacy|2|||
144414960|NCT01599234|520724460|FG001|Overall Study|Lack of Efficacy|4|||
144414961|NCT01599234|520724459|FG000|Overall Study|Unable to operate spray|1|||
144414962|NCT01599234|520724460|FG001|Overall Study|Unable to operate spray|0|||
144414963|NCT01599234|520724459|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
144414964|NCT01599234|520724460|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
144414965|NCT01599234|520724459|FG000|Overall Study|Death|1|||
144414966|NCT01599234|520724460|FG001|Overall Study|Death|0|||
144414967|NCT01599234|520724459|FG000|Overall Study|Patient would not stop driving|1|||
144414968|NCT01599234|520724460|FG001|Overall Study|Patient would not stop driving|0|||
144414969|NCT01599234|520724459|FG000|Overall Study|Contra-indication discovered|0|||
144414970|NCT01599234|520724460|FG001|Overall Study|Contra-indication discovered|1|||
144414971|NCT01599234|520724459|FG000|Overall Study|Pregnancy|0|||
144414972|NCT01599234|520724460|FG001|Overall Study|Pregnancy|1|||
144414973|NCT03902574|520724461|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
144414974|NCT03902574|520724462|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
144414975|NCT03902574|520724463|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
144414976|NCT04492618|520724466|FG000|Overall Study|Withdrawal by Subject|1|||
144414977|NCT03489720|520724467|FG000|Overall Study|Withdrawal by Subject|2|||
144414978|NCT03489720|520724468|FG001|Overall Study|Withdrawal by Subject|0|||
144414979|NCT00085631|520724471|FG000|Overall Study|Missing Data|4|||
144414980|NCT00085631|520724472|FG001|Overall Study|Missing Data|11|||
144414981|NCT00085631|520724473|FG002|Overall Study|Missing Data|7|||
144414982|NCT02495168|520724474|FG000|Overall Study|Other than Specified|18|||
144414983|NCT02495168|520724475|FG001|Overall Study|Other than Specified|22|||
144414984|NCT02495168|520724476|FG002|Overall Study|Other than Specified|5|||
144414985|NCT02495168|520724474|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
144414986|NCT02495168|520724475|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
144414987|NCT02495168|520724476|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
144414988|NCT02495168|520724474|FG000|Overall Study|Physician Decision|1|||
144414989|NCT02495168|520724475|FG001|Overall Study|Physician Decision|1|||
144414990|NCT02495168|520724476|FG002|Overall Study|Physician Decision|0|||
144414991|NCT02495168|520724474|FG000|Overall Study|Lost to Follow-up|10|||
144414992|NCT02495168|520724475|FG001|Overall Study|Lost to Follow-up|6|||
144414993|NCT02495168|520724476|FG002|Overall Study|Lost to Follow-up|1|||
144414994|NCT02495168|520724474|FG000|Overall Study|Withdrawal by Subject|1|||
144414995|NCT02495168|520724475|FG001|Overall Study|Withdrawal by Subject|4|||
144414996|NCT02495168|520724476|FG002|Overall Study|Withdrawal by Subject|2|||
144414997|NCT02495168|520724474|FG000|Overall Study|Protocol Violation|0|||
144414998|NCT02495168|520724475|FG001|Overall Study|Protocol Violation|10|||
144414999|NCT02495168|520724476|FG002|Overall Study|Protocol Violation|1|||
144415000|NCT02495168|520724474|FG000|Overall Study|Adverse Event|4|||
144727089|NCT05097989|521854425|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
144415001|NCT02495168|520724475|FG001|Overall Study|Adverse Event|8|||
144415002|NCT02495168|520724476|FG002|Overall Study|Adverse Event|3|||
144415003|NCT02495168|520724474|FG000|Overall Study|Lack of Efficacy|0|||
144415004|NCT02495168|520724475|FG001|Overall Study|Lack of Efficacy|0|||
144415005|NCT02495168|520724476|FG002|Overall Study|Lack of Efficacy|3|||
144415006|NCT03521934|520724485|FG000|Overall Study|Death|65|||
144415007|NCT03521934|520724486|FG001|Overall Study|Death|73|||
144415008|NCT03521934|520724485|FG000|Overall Study|Withdrawal by Subject|18|||
144415009|NCT03521934|520724486|FG001|Overall Study|Withdrawal by Subject|23|||
144415010|NCT03521934|520724485|FG000|Overall Study|Site Terminated by Sponsor|39|||
144415011|NCT03521934|520724486|FG001|Overall Study|Site Terminated by Sponsor|35|||
144415012|NCT03521934|520724485|FG000|Overall Study|Study Terminated by Sponsor|483|||
144415013|NCT03521934|520724486|FG001|Overall Study|Study Terminated by Sponsor|477|||
144415014|NCT03521934|520724485|FG000|Overall Study|Reason not Specified|3|||
144415015|NCT03521934|520724486|FG001|Overall Study|Reason not Specified|6|||
144415016|NCT02101060|520724487|FG000|Overall Study|Adverse Event|1|||
144415017|NCT02101060|520724488|FG001|Overall Study|Adverse Event|0|||
144415018|NCT02101060|520724487|FG000|Overall Study|Withdrawal by Subject|1|||
144415019|NCT02101060|520724488|FG001|Overall Study|Withdrawal by Subject|1|||
144415020|NCT02101060|520724487|FG000|Overall Study|Lost to Follow-up|3|||
144415021|NCT02101060|520724488|FG001|Overall Study|Lost to Follow-up|3|||
144415022|NCT04166435|520724489|FG000|Overall Study|2 patients ineligible for response|2|||
144415023|NCT01425281|520724497|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
144415024|NCT01425281|520724498|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
144415025|NCT01425281|520724497|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
144415026|NCT01425281|520724498|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
144415027|NCT01425281|520724497|FG000|At 180-day Clinical Follow-up|Death|0|||
144415028|NCT01425281|520724498|FG001|At 180-day Clinical Follow-up|Death|1|||
144415029|NCT01425281|520724497|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
144415030|NCT01425281|520724498|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
144415031|NCT01425281|520724497|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
144415032|NCT01425281|520724498|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
144415033|NCT01425281|520724497|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
144415034|NCT01425281|520724498|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
144415035|NCT01425281|520724497|FG000|At 2-year Clinical Follow-up|Death|2|||
144415036|NCT01425281|520724498|FG001|At 2-year Clinical Follow-up|Death|0|||
144415037|NCT01425281|520724497|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
144415038|NCT01425281|520724498|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
144415039|NCT01425281|520724497|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
144415040|NCT01425281|520724498|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
144415041|NCT01425281|520724497|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
144415042|NCT01425281|520724498|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
144415043|NCT01425281|520724497|FG000|At 3-year Clinical Follow-up|Death|2|||
144415044|NCT01425281|520724498|FG001|At 3-year Clinical Follow-up|Death|3|||
144415045|NCT01425281|520724497|FG000|At 4-year Clinical Follow-up|Death|7|||
144415046|NCT01425281|520724498|FG001|At 4-year Clinical Follow-up|Death|3|||
144415047|NCT01425281|520724497|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
144415048|NCT01425281|520724498|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
144415049|NCT01425281|520724497|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
144415050|NCT01425281|520724498|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
144415051|NCT01425281|520724497|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
144415052|NCT01425281|520724498|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
144415053|NCT01425281|520724497|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
144415054|NCT01425281|520724498|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
144415055|NCT01425281|520724497|FG000|At 5-year Clinical Follow-up|Death|2|||
144415056|NCT01425281|520724498|FG001|At 5-year Clinical Follow-up|Death|0|||
144415057|NCT01425281|520724497|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
144415058|NCT01425281|520724498|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
144723130|NCT02308111|521840624|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
144723131|NCT02308111|521840625|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
144723132|NCT01873859|521840630|FG000|Overall Study|Withdrawal by Subject|0|||
144415059|NCT01425281|520724497|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
144415060|NCT01425281|520724498|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
144723133|NCT01873859|521840631|FG001|Overall Study|Withdrawal by Subject|4|||
144723134|NCT00601484|521840633|FG000|Overall Study|Adverse Event|0|||
144415061|NCT01425281|520724497|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
144415062|NCT01425281|520724498|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
144415063|NCT01987505|520724499|FG000|Overall Study|Other|9|||
144415064|NCT01987505|520724499|FG000|Overall Study|Withdrawal by Subject|2|||
144415065|NCT01987505|520724499|FG000|Overall Study|Other Reason|2|||
144415066|NCT01987505|520724499|FG000|Overall Study|Lost to Follow-up|15|||
144415067|NCT01987505|520724499|FG000|Overall Study|Investigator Decision|2|||
144415068|NCT01987505|520724499|FG000|Overall Study|Death|4|||
144415069|NCT01833520|520724500|FG000|Overall Study|Lack of Efficacy|3|||
144415070|NCT01833520|520724501|FG001|Overall Study|Lack of Efficacy|3|||
144415071|NCT01833520|520724502|FG002|Overall Study|Lack of Efficacy|8|||
144415072|NCT01833520|520724503|FG003|Overall Study|Lack of Efficacy|3|||
144415073|NCT03266107|520724504|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
144415074|NCT03266107|520724504|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
144415075|NCT03266107|520724504|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
144415076|NCT03266107|520724504|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
144415077|NCT01111149|520724508|FG000|Overall Study|Protocol Violation|1|||
144415078|NCT01111149|520724509|FG001|Overall Study|Protocol Violation|1|||
144415079|NCT01111149|520724510|FG002|Overall Study|Protocol Violation|2|||
144415080|NCT01111149|520724508|FG000|Overall Study|Withdrawal by Subject|1|||
144415081|NCT01111149|520724509|FG001|Overall Study|Withdrawal by Subject|0|||
144527229|NCT04753697|521131894|FG001|Maintenance Phase|Withdrawal by Subject|4|||
144250422|NCT00631163|520115500|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
144250423|NCT00631163|520115500|FG000|Number of Participants in Year 1|Administrative problems|6|||
144250424|NCT00631163|520115500|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
144250425|NCT00631163|520115500|FG000|Number of Participants in Year 2|Adverse Event|1|||
144250426|NCT00631163|520115500|FG000|Number of Participants in Year 2|Protocol Violation|1|||
144250427|NCT00631163|520115500|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
144250428|NCT00715520|520115501|FG000|Overall Study|Screen failure|8|||
144250429|NCT00715520|520115502|FG001|Overall Study|Screen failure|1|||
144250430|NCT00715520|520115503|FG002|Overall Study|Screen failure|1|||
144250431|NCT00715520|520115501|FG000|Overall Study|Withdrawal by Subject|2|||
144250432|NCT00715520|520115502|FG001|Overall Study|Withdrawal by Subject|0|||
144250433|NCT00715520|520115503|FG002|Overall Study|Withdrawal by Subject|1|||
144250434|NCT04122625|520115504|FG000|Part A (up to 2.92 Years)|Death|2|||
144250435|NCT04122625|520115505|FG001|Part A (up to 2.92 Years)|Death|4|||
144527230|NCT04753697|521131895|FG002|Maintenance Phase|Withdrawal by Subject|6|||
144250436|NCT04122625|520115506|FG002|Part A (up to 2.92 Years)|Death|0|||
144250437|NCT04122625|520115507|FG003|Part A (up to 2.92 Years)|Death|0|||
144250438|NCT04122625|520115508|FG004|Part A (up to 2.92 Years)|Death|0|||
144250439|NCT04122625|520115509|FG005|Part A (up to 2.92 Years)|Death|0|||
144415082|NCT01111149|520724510|FG002|Overall Study|Withdrawal by Subject|2|||
144415083|NCT00496470|520724518|FG000|Overall Study|Adverse Event|8|||
144415084|NCT00496470|520724519|FG001|Overall Study|Adverse Event|10|||
144415085|NCT00496470|520724518|FG000|Overall Study|Withdrawal by Subject|5|||
144527231|NCT04753697|521131893|FG000|Maintenance Phase|Lost to Follow-up|2|||
144250440|NCT04122625|520115504|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
144250441|NCT04122625|520115505|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
144250442|NCT04122625|520115506|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
144250443|NCT04122625|520115507|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
144250444|NCT04122625|520115508|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
144250445|NCT04122625|520115509|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
144250446|NCT04122625|520115504|FG000|Part B (up to 2.33 Years)|Death|0|||
144250447|NCT04122625|520115505|FG001|Part B (up to 2.33 Years)|Death|0|||
144250448|NCT04122625|520115506|FG002|Part B (up to 2.33 Years)|Death|5|||
144250449|NCT04122625|520115507|FG003|Part B (up to 2.33 Years)|Death|7|||
144250450|NCT04122625|520115508|FG004|Part B (up to 2.33 Years)|Death|6|||
144250451|NCT04122625|520115509|FG005|Part B (up to 2.33 Years)|Death|7|||
144250452|NCT02697591|520115510|FG000|Overall Study|Lost to Follow-up|0|||
144250453|NCT02697591|520115511|FG001|Overall Study|Lost to Follow-up|0|||
144250454|NCT02697591|520115512|FG002|Overall Study|Lost to Follow-up|0|||
144250455|NCT02697591|520115513|FG003|Overall Study|Lost to Follow-up|0|||
144250456|NCT02697591|520115514|FG004|Overall Study|Lost to Follow-up|0|||
144250457|NCT02697591|520115515|FG005|Overall Study|Lost to Follow-up|1|||
144250458|NCT02697591|520115516|FG006|Overall Study|Lost to Follow-up|1|||
144250459|NCT02697591|520115517|FG007|Overall Study|Lost to Follow-up|0|||
144250460|NCT02697591|520115518|FG008|Overall Study|Lost to Follow-up|0|||
144250461|NCT02697591|520115519|FG009|Overall Study|Lost to Follow-up|1|||
144250462|NCT02697591|520115510|FG000|Overall Study|Withdrawal by Subject|1|||
144250463|NCT02697591|520115511|FG001|Overall Study|Withdrawal by Subject|1|||
144250464|NCT02697591|520115512|FG002|Overall Study|Withdrawal by Subject|2|||
144250465|NCT02697591|520115513|FG003|Overall Study|Withdrawal by Subject|1|||
144250466|NCT02697591|520115514|FG004|Overall Study|Withdrawal by Subject|7|||
144250467|NCT02697591|520115515|FG005|Overall Study|Withdrawal by Subject|6|||
144250468|NCT02697591|520115516|FG006|Overall Study|Withdrawal by Subject|9|||
144250469|NCT02697591|520115517|FG007|Overall Study|Withdrawal by Subject|1|||
144250470|NCT02697591|520115518|FG008|Overall Study|Withdrawal by Subject|6|||
144250471|NCT02697591|520115519|FG009|Overall Study|Withdrawal by Subject|10|||
144250472|NCT02697591|520115510|FG000|Overall Study|Physician Decision|1|||
144250473|NCT02697591|520115511|FG001|Overall Study|Physician Decision|0|||
144250474|NCT02697591|520115512|FG002|Overall Study|Physician Decision|0|||
144250475|NCT02697591|520115513|FG003|Overall Study|Physician Decision|0|||
144250476|NCT02697591|520115514|FG004|Overall Study|Physician Decision|1|||
144250477|NCT02697591|520115515|FG005|Overall Study|Physician Decision|2|||
144250478|NCT02697591|520115516|FG006|Overall Study|Physician Decision|0|||
144250479|NCT02697591|520115517|FG007|Overall Study|Physician Decision|0|||
144250480|NCT02697591|520115518|FG008|Overall Study|Physician Decision|1|||
144250481|NCT02697591|520115519|FG009|Overall Study|Physician Decision|1|||
144250482|NCT02697591|520115510|FG000|Overall Study|Death|2|||
144250483|NCT02697591|520115511|FG001|Overall Study|Death|3|||
144250484|NCT02697591|520115512|FG002|Overall Study|Death|1|||
144250485|NCT02697591|520115513|FG003|Overall Study|Death|1|||
144250486|NCT02697591|520115514|FG004|Overall Study|Death|4|||
144250487|NCT02697591|520115515|FG005|Overall Study|Death|5|||
144250488|NCT02697591|520115516|FG006|Overall Study|Death|3|||
144250489|NCT02697591|520115517|FG007|Overall Study|Death|1|||
144250490|NCT02697591|520115518|FG008|Overall Study|Death|1|||
144250491|NCT02697591|520115519|FG009|Overall Study|Death|5|||
144250492|NCT02697591|520115510|FG000|Overall Study|Reason not Specified|0|||
144250493|NCT02697591|520115511|FG001|Overall Study|Reason not Specified|0|||
144250494|NCT02697591|520115512|FG002|Overall Study|Reason not Specified|0|||
144250495|NCT02697591|520115513|FG003|Overall Study|Reason not Specified|1|||
144250496|NCT02697591|520115514|FG004|Overall Study|Reason not Specified|1|||
144250497|NCT02697591|520115515|FG005|Overall Study|Reason not Specified|2|||
144250498|NCT02697591|520115516|FG006|Overall Study|Reason not Specified|3|||
144250499|NCT02697591|520115517|FG007|Overall Study|Reason not Specified|1|||
144250500|NCT02697591|520115518|FG008|Overall Study|Reason not Specified|1|||
144250501|NCT02697591|520115519|FG009|Overall Study|Reason not Specified|3|||
144250502|NCT01937884|520115520|FG000|Overall Study|Withdrawal by Subject|1|||
144250503|NCT01937884|520115521|FG001|Overall Study|Withdrawal by Subject|0|||
144250504|NCT02147067|520115522|FG000|Overall Study|Withdrawal by Subject|2|||
144250505|NCT02147067|520115523|FG001|Overall Study|Withdrawal by Subject|2|||
144250506|NCT00419159|520115525|FG000|Overall Study|Adverse Event|7|||
144250507|NCT00419159|520115526|FG001|Overall Study|Adverse Event|15|||
144723135|NCT00601484|521840634|FG001|Overall Study|Adverse Event|1|||
144250508|NCT00419159|520115525|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144250509|NCT00419159|520115526|FG001|Overall Study|Abnormal laboratory value(s)|2|||
144250510|NCT00419159|520115525|FG000|Overall Study|Subject's no longer requires study drug|0|||
144250511|NCT00419159|520115526|FG001|Overall Study|Subject's no longer requires study drug|1|||
144250512|NCT00419159|520115525|FG000|Overall Study|Protocol Violation|1|||
144250513|NCT00419159|520115526|FG001|Overall Study|Protocol Violation|0|||
144250514|NCT00419159|520115525|FG000|Overall Study|Withdrawal by Subject|10|||
144250515|NCT00419159|520115526|FG001|Overall Study|Withdrawal by Subject|3|||
144250516|NCT00419159|520115525|FG000|Overall Study|Lost to Follow-up|0|||
144250517|NCT00419159|520115526|FG001|Overall Study|Lost to Follow-up|1|||
144250518|NCT00419159|520115525|FG000|Overall Study|Death|2|||
144250519|NCT00419159|520115526|FG001|Overall Study|Death|2|||
144250520|NCT00419159|520115525|FG000|Overall Study|Disease progression|79|||
144250521|NCT00419159|520115526|FG001|Overall Study|Disease progression|76|||
144250522|NCT01017601|520115527|FG000|Overall Study|Disease Progression|12|||
144250523|NCT01017601|520115528|FG001|Overall Study|Disease Progression|12|||
144250524|NCT01017601|520115527|FG000|Overall Study|Withdrawal by Subject|0|||
144250525|NCT01017601|520115528|FG001|Overall Study|Withdrawal by Subject|1|||
144250526|NCT02735096|520115529|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
144250527|NCT00379808|520115530|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
144250528|NCT00379808|520115531|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
144250529|NCT02083653|520115534|FG000|Overall Study|Randomized but not Treated|0|||
144250530|NCT02083653|520115535|FG001|Overall Study|Randomized but not Treated|2|||
144250531|NCT02083653|520115536|FG002|Overall Study|Randomized but not Treated|7|||
144250532|NCT02083653|520115534|FG000|Overall Study|Adverse Event|12|||
144250533|NCT02083653|520115535|FG001|Overall Study|Adverse Event|5|||
144250534|NCT02083653|520115536|FG002|Overall Study|Adverse Event|4|||
144250535|NCT02083653|520115534|FG000|Overall Study|Lost to Follow-up|1|||
144250536|NCT02083653|520115535|FG001|Overall Study|Lost to Follow-up|0|||
144250537|NCT02083653|520115536|FG002|Overall Study|Lost to Follow-up|0|||
144250538|NCT02083653|520115534|FG000|Overall Study|Death|2|||
144250539|NCT02083653|520115535|FG001|Overall Study|Death|2|||
144250540|NCT02083653|520115536|FG002|Overall Study|Death|2|||
144250541|NCT02083653|520115534|FG000|Overall Study|Progressive Disease|65|||
144250542|NCT02083653|520115535|FG001|Overall Study|Progressive Disease|73|||
144250543|NCT02083653|520115536|FG002|Overall Study|Progressive Disease|63|||
144250544|NCT02083653|520115534|FG000|Overall Study|Withdrawal by Subject|2|||
144250545|NCT02083653|520115535|FG001|Overall Study|Withdrawal by Subject|1|||
144250546|NCT02083653|520115536|FG002|Overall Study|Withdrawal by Subject|2|||
144250547|NCT02083653|520115534|FG000|Overall Study|Other Events|0|||
144250548|NCT02083653|520115535|FG001|Overall Study|Other Events|2|||
144250549|NCT02083653|520115536|FG002|Overall Study|Other Events|2|||
144250550|NCT02083653|520115534|FG000|Overall Study|Reason Missing|0|||
144250551|NCT02083653|520115535|FG001|Overall Study|Reason Missing|0|||
144250552|NCT02083653|520115536|FG002|Overall Study|Reason Missing|4|||
144250553|NCT01380691|520115540|FG000|Washout (7 Days)|Protocol Violation|0|||
144250554|NCT01380691|520115541|FG001|Washout (7 Days)|Protocol Violation|0|||
144250555|NCT01380691|520115542|FG002|Washout (7 Days)|Protocol Violation|0|||
144250556|NCT01380691|520115543|FG003|Washout (7 Days)|Protocol Violation|1|||
144250557|NCT01380691|520115540|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
144250558|NCT01380691|520115541|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
144250559|NCT01380691|520115542|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
144250560|NCT01380691|520115543|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
144250561|NCT02536781|520115545|FG000|Overall Study|Lost to Follow-up|2|||
144250562|NCT02536781|520115546|FG001|Overall Study|Lost to Follow-up|0|||
144250563|NCT03423147|520115547|FG000|Overall Study|Lost to Follow-up|5|||
144250564|NCT03423147|520115548|FG001|Overall Study|Lost to Follow-up|8|||
144250565|NCT03423147|520115547|FG000|Overall Study|Withdrawal by Subject|1|||
144250566|NCT03423147|520115548|FG001|Overall Study|Withdrawal by Subject|0|||
144250567|NCT03423147|520115547|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
144250568|NCT03423147|520115548|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
144250569|NCT03423147|520115547|FG000|Overall Study|Age < 18|1|||
144250570|NCT03423147|520115548|FG001|Overall Study|Age < 18|0|||
144250571|NCT03423147|520115547|FG000|Overall Study|No Trial of Labor|0|||
144250572|NCT03423147|520115548|FG001|Overall Study|No Trial of Labor|1|||
144250573|NCT01048099|520115549|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
144250574|NCT01048099|520115549|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
144250575|NCT00508157|520115550|FG000|Overall Study|Adverse Event|0|||
144250576|NCT00508157|520115551|FG001|Overall Study|Adverse Event|1|||
144250577|NCT00508157|520115550|FG000|Overall Study|Subject Withdrew Consent|1|||
144527232|NCT04753697|521131894|FG001|Maintenance Phase|Lost to Follow-up|2|||
144527233|NCT04753697|521131895|FG002|Maintenance Phase|Lost to Follow-up|0|||
144723136|NCT00601484|521840633|FG000|Overall Study|Lost to Follow-up|4|||
144250578|NCT00508157|520115551|FG001|Overall Study|Subject Withdrew Consent|0|||
144250579|NCT00508157|520115550|FG000|Overall Study|Lost to Follow-up|1|||
144250580|NCT00508157|520115551|FG001|Overall Study|Lost to Follow-up|0|||
144250581|NCT00508157|520115550|FG000|Overall Study|Subject no longer met study criteria|0|||
144250582|NCT00508157|520115551|FG001|Overall Study|Subject no longer met study criteria|1|||
144250583|NCT00508157|520115550|FG000|Overall Study|Other known cause|0|||
144250584|NCT00508157|520115551|FG001|Overall Study|Other known cause|1|||
144250585|NCT01731470|520115553|FG000|Overall Study|Withdrawal by Subject|1|||
144250586|NCT01731470|520115553|FG000|Overall Study|Did not meet study criteria|1|||
144250587|NCT00862459|520115556|FG000|Overall Study|Lost to Follow-up|1|||
144250588|NCT00862459|520115557|FG001|Overall Study|Lost to Follow-up|2|||
144250589|NCT00862459|520115558|FG002|Overall Study|Lost to Follow-up|2|||
144250590|NCT00862459|520115556|FG000|Overall Study|Protocol Violation|1|||
144250591|NCT00862459|520115557|FG001|Overall Study|Protocol Violation|0|||
144415086|NCT00496470|520724519|FG001|Overall Study|Withdrawal by Subject|12|||
144415087|NCT00496470|520724518|FG000|Overall Study|Incorrectly enrolled|13|||
144415088|NCT00496470|520724519|FG001|Overall Study|Incorrectly enrolled|5|||
144415089|NCT00496470|520724518|FG000|Overall Study|Other reason|0|||
144415090|NCT00496470|520724519|FG001|Overall Study|Other reason|2|||
144415091|NCT01844518|520724520|FG000|Overall Study|Adverse Event|7|||
144415092|NCT01844518|520724521|FG001|Overall Study|Adverse Event|1|||
144415093|NCT01844518|520724520|FG000|Overall Study|Lack of Efficacy|17|||
144415094|NCT01844518|520724521|FG001|Overall Study|Lack of Efficacy|5|||
144415095|NCT01844518|520724520|FG000|Overall Study|Participant's request to discontinue|4|||
144415096|NCT01844518|520724521|FG001|Overall Study|Participant's request to discontinue|1|||
144415097|NCT01844518|520724520|FG000|Overall Study|Poor/Non-compliance|1|||
144415098|NCT01844518|520724521|FG001|Overall Study|Poor/Non-compliance|0|||
144415099|NCT01844518|520724520|FG000|Overall Study|No Longer Met Study Criteria|2|||
144415100|NCT01844518|520724521|FG001|Overall Study|No Longer Met Study Criteria|0|||
144415101|NCT01844518|520724520|FG000|Overall Study|Withdrawal by Subject|9|||
144415102|NCT01844518|520724521|FG001|Overall Study|Withdrawal by Subject|0|||
144415103|NCT01844518|520724520|FG000|Overall Study|Pregnancy|1|||
144415104|NCT01844518|520724521|FG001|Overall Study|Pregnancy|0|||
144415105|NCT00291577|520724522|FG000|Overall Study|Adverse Event|1|||
144415106|NCT00291577|520724522|FG000|Overall Study|Other|4|||
144415107|NCT00291577|520724522|FG000|Overall Study|Withdrawal by Subject|2|||
144415108|NCT00291577|520724522|FG000|Overall Study|Lack of Efficacy|14|||
144415109|NCT01587001|520724529|FG000|Overall Study|Lost to Follow-up|2|||
144415110|NCT01587001|520724530|FG001|Overall Study|Lost to Follow-up|0|||
144415111|NCT01587001|520724529|FG000|Overall Study|Insufficient samples to complete testing|4|||
144415112|NCT01587001|520724530|FG001|Overall Study|Insufficient samples to complete testing|1|||
144415113|NCT02854631|520724533|FG000|Overall Study|Adverse Event|1|||
144415114|NCT02854631|520724534|FG001|Overall Study|Adverse Event|2|||
144415115|NCT02854631|520724533|FG000|Overall Study|Withdrew Consent|3|||
144415116|NCT02854631|520724534|FG001|Overall Study|Withdrew Consent|2|||
144415117|NCT02854631|520724533|FG000|Overall Study|Investigator's Discretion|2|||
144415118|NCT02854631|520724534|FG001|Overall Study|Investigator's Discretion|0|||
144415119|NCT02854631|520724533|FG000|Overall Study|Death|12|||
144415120|NCT02854631|520724534|FG001|Overall Study|Death|8|||
144415121|NCT02854631|520724533|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
144415122|NCT02854631|520724534|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
144415123|NCT02854631|520724533|FG000|Overall Study|Protocol Violation|0|||
144415124|NCT02854631|520724534|FG001|Overall Study|Protocol Violation|1|||
144415125|NCT02854631|520724533|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
144415126|NCT02854631|520724534|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
144415127|NCT02854631|520724533|FG000|Overall Study|Lost to Follow-up|4|||
144723137|NCT00601484|521840634|FG001|Overall Study|Lost to Follow-up|3|||
144415128|NCT02854631|520724534|FG001|Overall Study|Lost to Follow-up|2|||
144415129|NCT04051008|520724535|FG000|Overall Study|Withdrawal by Subject|2|||
144415130|NCT04051008|520724536|FG001|Overall Study|Withdrawal by Subject|0|||
144415131|NCT04051008|520724537|FG002|Overall Study|Withdrawal by Subject|1|||
144415132|NCT03200860|520724538|FG000|Overall Study|Withdrawal by Subject|1|||
144415133|NCT03200860|520724539|FG001|Overall Study|Withdrawal by Subject|0|||
144415134|NCT00844896|520724540|FG000|Overall Study|Lost to Follow-up|12|||
144415135|NCT00844896|520724541|FG001|Overall Study|Lost to Follow-up|16|||
144415136|NCT00844896|520724540|FG000|Overall Study|Parents did not have time to complete|0|||
144527234|NCT04753697|521131893|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
144527235|NCT04753697|521131894|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
144527236|NCT04753697|521131895|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
144527237|NCT04753697|521131893|FG000|Maintenance Phase|Adverse Event|0|||
144250592|NCT00862459|520115558|FG002|Overall Study|Protocol Violation|0|||
144250593|NCT00862459|520115556|FG000|Overall Study|Withdrawal by Subject|1|||
144415137|NCT00844896|520724541|FG001|Overall Study|Parents did not have time to complete|1|||
144415138|NCT02233647|520724542|FG000|Overall Study|Adverse Event|1|||
144415139|NCT00621153|520724544|FG000|Overall Study|Safety Reason|8|||
144415140|NCT00621153|520724545|FG001|Overall Study|Safety Reason|7|||
144415141|NCT00621153|520724544|FG000|Overall Study|Adverse Event|3|||
144415142|NCT00621153|520724545|FG001|Overall Study|Adverse Event|2|||
144415143|NCT00621153|520724544|FG000|Overall Study|Lost to Follow-up|5|||
144415144|NCT00621153|520724545|FG001|Overall Study|Lost to Follow-up|1|||
144415145|NCT00621153|520724544|FG000|Overall Study|Withdrawal by Subject|4|||
144415146|NCT00621153|520724545|FG001|Overall Study|Withdrawal by Subject|5|||
144415147|NCT00753415|520724546|FG000|Part A|Disease progression|1|||
144415148|NCT00753415|520724547|FG001|Part A|Disease progression|0|||
144415149|NCT00753415|520724548|FG002|Part A|Disease progression|1|||
144415150|NCT00753415|520724549|FG003|Part A|Disease progression|2|||
144250594|NCT00862459|520115557|FG001|Overall Study|Withdrawal by Subject|1|||
144250595|NCT00862459|520115558|FG002|Overall Study|Withdrawal by Subject|3|||
144250596|NCT00862459|520115556|FG000|Overall Study|Adverse Event|0|||
144415151|NCT00753415|520724550|FG004|Part A|Disease progression|0|||
144415152|NCT00753415|520724551|FG005|Part A|Disease progression|0|||
144415153|NCT00753415|520724552|FG006|Part A|Disease progression|0|||
144415154|NCT00753415|520724553|FG007|Part A|Disease progression|0|||
144415155|NCT00753415|520724554|FG008|Part A|Disease progression|0|||
144250597|NCT00862459|520115557|FG001|Overall Study|Adverse Event|1|||
144415156|NCT00753415|520724555|FG009|Part A|Disease progression|0|||
144415157|NCT00753415|520724546|FG000|Part A|Withdrawal by Subject|0|||
144415158|NCT00753415|520724547|FG001|Part A|Withdrawal by Subject|0|||
144415159|NCT00753415|520724548|FG002|Part A|Withdrawal by Subject|1|||
144415160|NCT00753415|520724549|FG003|Part A|Withdrawal by Subject|0|||
144415161|NCT00753415|520724550|FG004|Part A|Withdrawal by Subject|0|||
144415162|NCT00753415|520724551|FG005|Part A|Withdrawal by Subject|0|||
144415163|NCT00753415|520724552|FG006|Part A|Withdrawal by Subject|0|||
144415164|NCT00753415|520724553|FG007|Part A|Withdrawal by Subject|0|||
144415165|NCT00753415|520724554|FG008|Part A|Withdrawal by Subject|0|||
144415166|NCT00753415|520724555|FG009|Part A|Withdrawal by Subject|0|||
144415167|NCT00753415|520724546|FG000|Part B|Lost to Follow-up|0|||
144415168|NCT00753415|520724547|FG001|Part B|Lost to Follow-up|0|||
144415169|NCT00753415|520724548|FG002|Part B|Lost to Follow-up|0|||
144415170|NCT00753415|520724549|FG003|Part B|Lost to Follow-up|0|||
144415171|NCT00753415|520724550|FG004|Part B|Lost to Follow-up|0|||
144415172|NCT00753415|520724551|FG005|Part B|Lost to Follow-up|0|||
144415173|NCT00753415|520724552|FG006|Part B|Lost to Follow-up|0|||
144415174|NCT00753415|520724553|FG007|Part B|Lost to Follow-up|1|||
144415175|NCT00753415|520724554|FG008|Part B|Lost to Follow-up|1|||
144415176|NCT00753415|520724555|FG009|Part B|Lost to Follow-up|0|||
144415177|NCT00753415|520724546|FG000|Part B|Disease progression|0|||
144415178|NCT00753415|520724547|FG001|Part B|Disease progression|0|||
144415179|NCT00753415|520724548|FG002|Part B|Disease progression|0|||
144415180|NCT00753415|520724549|FG003|Part B|Disease progression|0|||
144415181|NCT00753415|520724550|FG004|Part B|Disease progression|0|||
144415182|NCT00753415|520724551|FG005|Part B|Disease progression|0|||
144415183|NCT00753415|520724552|FG006|Part B|Disease progression|0|||
144415184|NCT00753415|520724553|FG007|Part B|Disease progression|0|||
144415185|NCT00753415|520724554|FG008|Part B|Disease progression|2|||
144415186|NCT00753415|520724555|FG009|Part B|Disease progression|1|||
144415187|NCT04212650|520724556|FG000|Overall Study|Withdrawal by Subject|1|||
144415188|NCT04212650|520724557|FG001|Overall Study|Withdrawal by Subject|0|||
144415189|NCT00887978|520724563|FG000|Overall Study|Adverse Event|18|||
144415190|NCT00887978|520724564|FG001|Overall Study|Adverse Event|5|||
144415191|NCT00887978|520724563|FG000|Overall Study|Clinical Worsening|4|||
144415192|NCT00887978|520724564|FG001|Overall Study|Clinical Worsening|4|||
144415193|NCT00887978|520724563|FG000|Overall Study|Death|2|||
144415194|NCT00887978|520724564|FG001|Overall Study|Death|3|||
144415195|NCT00887978|520724563|FG000|Overall Study|Withdrawal by Subject|1|||
144415196|NCT00887978|520724564|FG001|Overall Study|Withdrawal by Subject|2|||
144415197|NCT00887978|520724563|FG000|Overall Study|Lost to Follow-up|0|||
144415198|NCT00887978|520724564|FG001|Overall Study|Lost to Follow-up|1|||
144415199|NCT05425745|520724574|FG000|Overall Study|Withdrawal of Consent|3|||
144415200|NCT05425745|520724575|FG001|Overall Study|Withdrawal of Consent|3|||
144415201|NCT05425745|520724574|FG000|Overall Study|Death|2|||
144415202|NCT05425745|520724575|FG001|Overall Study|Death|3|||
144415203|NCT05425745|520724574|FG000|Overall Study|Lost to Follow-up|1|||
144415204|NCT05425745|520724575|FG001|Overall Study|Lost to Follow-up|2|||
144415205|NCT05425745|520724574|FG000|Overall Study|Adverse Event|0|||
144415206|NCT05425745|520724575|FG001|Overall Study|Adverse Event|1|||
144415207|NCT05425745|520724574|FG000|Overall Study|Did not return for end of study visit|0|||
144415208|NCT05425745|520724575|FG001|Overall Study|Did not return for end of study visit|1|||
144415209|NCT05425745|520724574|FG000|Overall Study|End of study visit completed by phone|1|||
144415210|NCT05425745|520724575|FG001|Overall Study|End of study visit completed by phone|0|||
144415211|NCT05425745|520724574|FG000|Overall Study|Subject decision|1|||
144415212|NCT05425745|520724575|FG001|Overall Study|Subject decision|0|||
144415213|NCT02700815|520726455|FG000|Overall Study|Adverse Event|0|||
144415214|NCT02700815|520726456|FG001|Overall Study|Adverse Event|6|||
144415215|NCT02700815|520726457|FG002|Overall Study|Adverse Event|2|||
144415216|NCT02700815|520726458|FG003|Overall Study|Adverse Event|3|||
144415217|NCT02700815|520726455|FG000|Overall Study|Lack of Efficacy|0|||
144415218|NCT02700815|520726456|FG001|Overall Study|Lack of Efficacy|0|||
144415219|NCT02700815|520726457|FG002|Overall Study|Lack of Efficacy|1|||
144723138|NCT00601484|521840633|FG000|Overall Study|Lack of Efficacy|0|||
144723139|NCT00601484|521840634|FG001|Overall Study|Lack of Efficacy|2|||
144723140|NCT00601484|521840633|FG000|Overall Study|Withdrawal by Subject|1|||
144415220|NCT02700815|520726458|FG003|Overall Study|Lack of Efficacy|2|||
144415221|NCT02700815|520726455|FG000|Overall Study|Lost to Follow-up|1|||
144415222|NCT02700815|520726456|FG001|Overall Study|Lost to Follow-up|0|||
144415223|NCT02700815|520726457|FG002|Overall Study|Lost to Follow-up|0|||
144415224|NCT02700815|520726458|FG003|Overall Study|Lost to Follow-up|1|||
144415225|NCT02700815|520726455|FG000|Overall Study|Refusal to continue medication|0|||
144600781|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
144415226|NCT02700815|520726456|FG001|Overall Study|Refusal to continue medication|1|||
144415227|NCT02700815|520726457|FG002|Overall Study|Refusal to continue medication|0|||
144415228|NCT02700815|520726458|FG003|Overall Study|Refusal to continue medication|1|||
144415229|NCT02700815|520726455|FG000|Overall Study|Withdrawal by Subject|0|||
144415230|NCT02700815|520726456|FG001|Overall Study|Withdrawal by Subject|0|||
144415231|NCT02700815|520726457|FG002|Overall Study|Withdrawal by Subject|1|||
144723141|NCT00601484|521840634|FG001|Overall Study|Withdrawal by Subject|1|||
144415232|NCT02700815|520726458|FG003|Overall Study|Withdrawal by Subject|0|||
144415233|NCT02239978|520726462|FG000|Overall Study|Withdrawal by Subject|2|||
144415234|NCT02239978|520726463|FG001|Overall Study|Withdrawal by Subject|0|||
144415235|NCT01852110|520726475|FG000|Overall Study|Adverse Event|12|||
144415236|NCT01852110|520726476|FG001|Overall Study|Adverse Event|5|||
144415237|NCT01852110|520726477|FG002|Overall Study|Adverse Event|0|||
144415238|NCT01852110|520726478|FG003|Overall Study|Adverse Event|0|||
144415239|NCT01852110|520726479|FG004|Overall Study|Adverse Event|0|||
144415240|NCT01852110|520726480|FG005|Overall Study|Adverse Event|0|||
144415241|NCT01852110|520726475|FG000|Overall Study|Lost to Follow-up|1|||
144415242|NCT01852110|520726476|FG001|Overall Study|Lost to Follow-up|3|||
144415243|NCT01852110|520726477|FG002|Overall Study|Lost to Follow-up|0|||
144415244|NCT01852110|520726478|FG003|Overall Study|Lost to Follow-up|0|||
144415245|NCT01852110|520726479|FG004|Overall Study|Lost to Follow-up|0|||
144415246|NCT01852110|520726480|FG005|Overall Study|Lost to Follow-up|0|||
144415247|NCT01852110|520726475|FG000|Overall Study|Non-compliance with Study Drug|2|||
144415248|NCT01852110|520726476|FG001|Overall Study|Non-compliance with Study Drug|1|||
144415249|NCT01852110|520726477|FG002|Overall Study|Non-compliance with Study Drug|0|||
144415250|NCT01852110|520726478|FG003|Overall Study|Non-compliance with Study Drug|0|||
144415251|NCT01852110|520726479|FG004|Overall Study|Non-compliance with Study Drug|0|||
144415252|NCT01852110|520726480|FG005|Overall Study|Non-compliance with Study Drug|0|||
144415253|NCT01852110|520726475|FG000|Overall Study|Physician Decision|1|||
144415254|NCT01852110|520726476|FG001|Overall Study|Physician Decision|0|||
144415255|NCT01852110|520726477|FG002|Overall Study|Physician Decision|0|||
144415256|NCT01852110|520726478|FG003|Overall Study|Physician Decision|0|||
144415257|NCT01852110|520726479|FG004|Overall Study|Physician Decision|0|||
144415258|NCT01852110|520726480|FG005|Overall Study|Physician Decision|0|||
144415259|NCT01852110|520726475|FG000|Overall Study|Protocol Violation|0|||
144415260|NCT01852110|520726476|FG001|Overall Study|Protocol Violation|1|||
144415261|NCT01852110|520726477|FG002|Overall Study|Protocol Violation|0|||
144415262|NCT01852110|520726478|FG003|Overall Study|Protocol Violation|0|||
144415263|NCT01852110|520726479|FG004|Overall Study|Protocol Violation|0|||
144415264|NCT01852110|520726480|FG005|Overall Study|Protocol Violation|0|||
144415265|NCT01852110|520726475|FG000|Overall Study|Study Terminated by Sponsor|30|||
144415266|NCT01852110|520726476|FG001|Overall Study|Study Terminated by Sponsor|32|||
144415267|NCT01852110|520726477|FG002|Overall Study|Study Terminated by Sponsor|0|||
144527238|NCT04753697|521131894|FG001|Maintenance Phase|Adverse Event|1|||
144527239|NCT04753697|521131895|FG002|Maintenance Phase|Adverse Event|1|||
144527240|NCT04753697|521131893|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
144527241|NCT04753697|521131894|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
144527242|NCT04753697|521131895|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
144527243|NCT03701763|521131898|FG000|Placebo-controlled Phase|Adverse Event|1|||
144527244|NCT03701763|521131899|FG001|Placebo-controlled Phase|Adverse Event|5|||
144527245|NCT03701763|521131900|FG002|Placebo-controlled Phase|Adverse Event|0|||
144527246|NCT03701763|521131901|FG003|Placebo-controlled Phase|Adverse Event|0|||
144527247|NCT03701763|521131898|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
144527248|NCT03701763|521131899|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
144527249|NCT03701763|521131900|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
144527250|NCT03701763|521131901|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
144527251|NCT03701763|521131898|FG000|Placebo-controlled Phase|Miscellaneous|2|||
144527252|NCT03701763|521131899|FG001|Placebo-controlled Phase|Miscellaneous|0|||
144527253|NCT03701763|521131900|FG002|Placebo-controlled Phase|Miscellaneous|0|||
144527254|NCT03701763|521131901|FG003|Placebo-controlled Phase|Miscellaneous|0|||
144527255|NCT03701763|521131898|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
144527256|NCT03701763|521131899|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
144527257|NCT03701763|521131900|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
144527258|NCT03701763|521131901|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
144527259|NCT03701763|521131898|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
144527260|NCT03701763|521131899|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
144527261|NCT03701763|521131900|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
144527262|NCT03701763|521131901|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
144415268|NCT01852110|520726478|FG003|Overall Study|Study Terminated by Sponsor|0|||
144250598|NCT00862459|520115558|FG002|Overall Study|Adverse Event|0|||
144415269|NCT01852110|520726479|FG004|Overall Study|Study Terminated by Sponsor|0|||
144415270|NCT01852110|520726480|FG005|Overall Study|Study Terminated by Sponsor|0|||
144415271|NCT01852110|520726475|FG000|Overall Study|Withdrawal by Subject|4|||
144415272|NCT01852110|520726476|FG001|Overall Study|Withdrawal by Subject|4|||
144415273|NCT01852110|520726477|FG002|Overall Study|Withdrawal by Subject|0|||
144415274|NCT01852110|520726478|FG003|Overall Study|Withdrawal by Subject|0|||
144415275|NCT01852110|520726479|FG004|Overall Study|Withdrawal by Subject|0|||
144527263|NCT03701763|521131898|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
144415276|NCT01852110|520726480|FG005|Overall Study|Withdrawal by Subject|0|||
144250599|NCT00862459|520115556|FG000|Overall Study|Personal reasons|1|||
144415277|NCT00793403|520726481|FG000|Overall Study|Other|73|||
144415278|NCT02141282|520726482|FG000|Overall Study|Adverse event, not related to progression|8|||
144723142|NCT00601484|521840633|FG000|Overall Study|Randomized, but not treated|0|||
144723143|NCT00601484|521840634|FG001|Overall Study|Randomized, but not treated|1|||
144723144|NCT03977584|521840635|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
144600782|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
144600783|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
144415279|NCT02141282|520726483|FG001|Overall Study|Adverse event, not related to progression|1|||
144415280|NCT02141282|520726484|FG002|Overall Study|Adverse event, not related to progression|3|||
144415281|NCT02141282|520726485|FG003|Overall Study|Adverse event, not related to progression|1|||
144415282|NCT02141282|520726482|FG000|Overall Study|Adverse event, related to progression|1|||
144415283|NCT02141282|520726483|FG001|Overall Study|Adverse event, related to progression|0|||
144415284|NCT02141282|520726484|FG002|Overall Study|Adverse event, related to progression|2|||
144415285|NCT02141282|520726485|FG003|Overall Study|Adverse event, related to progression|0|||
144415286|NCT02141282|520726482|FG000|Overall Study|COVID-19 infection|1|||
144415287|NCT02141282|520726483|FG001|Overall Study|COVID-19 infection|0|||
144415288|NCT02141282|520726484|FG002|Overall Study|COVID-19 infection|0|||
144415289|NCT02141282|520726485|FG003|Overall Study|COVID-19 infection|0|||
144415290|NCT02141282|520726482|FG000|Overall Study|Lost to Follow-up|0|||
144415291|NCT02141282|520726483|FG001|Overall Study|Lost to Follow-up|0|||
144415292|NCT02141282|520726484|FG002|Overall Study|Lost to Follow-up|4|||
144415293|NCT02141282|520726485|FG003|Overall Study|Lost to Follow-up|2|||
144415294|NCT02141282|520726482|FG000|Overall Study|Other, not specified|14|||
144415295|NCT02141282|520726483|FG001|Overall Study|Other, not specified|11|||
144415296|NCT02141282|520726484|FG002|Overall Study|Other, not specified|23|||
144415297|NCT02141282|520726485|FG003|Overall Study|Other, not specified|9|||
144415298|NCT02141282|520726482|FG000|Overall Study|Progressive disease, Richter's|4|||
144415299|NCT02141282|520726483|FG001|Overall Study|Progressive disease, Richter's|1|||
144415300|NCT02141282|520726484|FG002|Overall Study|Progressive disease, Richter's|1|||
144415301|NCT02141282|520726485|FG003|Overall Study|Progressive disease, Richter's|1|||
144415302|NCT02141282|520726482|FG000|Overall Study|Progressive disease per protocol|12|||
144415303|NCT02141282|520726483|FG001|Overall Study|Progressive disease per protocol|7|||
144415304|NCT02141282|520726484|FG002|Overall Study|Progressive disease per protocol|9|||
144415305|NCT02141282|520726485|FG003|Overall Study|Progressive disease per protocol|2|||
144415306|NCT02141282|520726482|FG000|Overall Study|Stem cell transplant|1|||
144415307|NCT02141282|520726483|FG001|Overall Study|Stem cell transplant|0|||
144415308|NCT02141282|520726484|FG002|Overall Study|Stem cell transplant|1|||
144415309|NCT02141282|520726485|FG003|Overall Study|Stem cell transplant|0|||
144415310|NCT02141282|520726482|FG000|Overall Study|Study terminated by Sponsor|0|||
144415311|NCT02141282|520726483|FG001|Overall Study|Study terminated by Sponsor|1|||
144415312|NCT02141282|520726484|FG002|Overall Study|Study terminated by Sponsor|0|||
144415313|NCT02141282|520726485|FG003|Overall Study|Study terminated by Sponsor|0|||
144415314|NCT02141282|520726482|FG000|Overall Study|Subject non-compliance|0|||
144415315|NCT02141282|520726483|FG001|Overall Study|Subject non-compliance|0|||
144415316|NCT02141282|520726484|FG002|Overall Study|Subject non-compliance|1|||
144415317|NCT02141282|520726485|FG003|Overall Study|Subject non-compliance|0|||
144415318|NCT02141282|520726482|FG000|Overall Study|Withdrew consent|2|||
144415319|NCT02141282|520726483|FG001|Overall Study|Withdrew consent|0|||
144415320|NCT02141282|520726484|FG002|Overall Study|Withdrew consent|4|||
144415321|NCT02141282|520726485|FG003|Overall Study|Withdrew consent|0|||
144415322|NCT00963547|520726494|FG000|Overall Study|Adverse Event|0|||
144415323|NCT00963547|520726495|FG001|Overall Study|Adverse Event|1|||
144415324|NCT00963547|520726496|FG002|Overall Study|Adverse Event|0|||
144250600|NCT00862459|520115557|FG001|Overall Study|Personal reasons|0|||
144250601|NCT00862459|520115558|FG002|Overall Study|Personal reasons|0|||
144250602|NCT00862459|520115556|FG000|Overall Study|Operation|1|||
144250603|NCT00862459|520115557|FG001|Overall Study|Operation|1|||
144723145|NCT03977584|521840636|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
144250604|NCT00862459|520115558|FG002|Overall Study|Operation|0|||
144415325|NCT00963547|520726497|FG003|Overall Study|Adverse Event|1|||
144250605|NCT00862459|520115556|FG000|Overall Study|Intravenous (IV) site problems|1|||
144415326|NCT00963547|520726498|FG004|Overall Study|Adverse Event|0|||
144415327|NCT00963547|520726499|FG005|Overall Study|Adverse Event|0|||
144415328|NCT00963547|520726500|FG006|Overall Study|Adverse Event|0|||
144415329|NCT00963547|520726494|FG000|Overall Study|Physician Decision|1|||
144415330|NCT00963547|520726495|FG001|Overall Study|Physician Decision|1|||
144250606|NCT00862459|520115557|FG001|Overall Study|Intravenous (IV) site problems|0|||
144250607|NCT00862459|520115558|FG002|Overall Study|Intravenous (IV) site problems|1|||
144415331|NCT00963547|520726496|FG002|Overall Study|Physician Decision|0|||
144415332|NCT00963547|520726497|FG003|Overall Study|Physician Decision|0|||
144415333|NCT00963547|520726498|FG004|Overall Study|Physician Decision|0|||
144415334|NCT00963547|520726499|FG005|Overall Study|Physician Decision|0|||
144415335|NCT00963547|520726500|FG006|Overall Study|Physician Decision|0|||
144415336|NCT00963547|520726494|FG000|Overall Study|Progressive Disease|3|||
144415337|NCT00963547|520726495|FG001|Overall Study|Progressive Disease|8|||
144415338|NCT00963547|520726496|FG002|Overall Study|Progressive Disease|9|||
144415339|NCT00963547|520726497|FG003|Overall Study|Progressive Disease|5|||
144415340|NCT00963547|520726498|FG004|Overall Study|Progressive Disease|0|||
144415341|NCT00963547|520726499|FG005|Overall Study|Progressive Disease|0|||
144415342|NCT00963547|520726500|FG006|Overall Study|Progressive Disease|0|||
144415343|NCT00963547|520726494|FG000|Overall Study|Withdrawal by Subject|0|||
144415344|NCT00963547|520726495|FG001|Overall Study|Withdrawal by Subject|0|||
144415345|NCT00963547|520726496|FG002|Overall Study|Withdrawal by Subject|3|||
144415346|NCT00963547|520726497|FG003|Overall Study|Withdrawal by Subject|0|||
144415347|NCT00963547|520726498|FG004|Overall Study|Withdrawal by Subject|0|||
144415348|NCT00963547|520726499|FG005|Overall Study|Withdrawal by Subject|0|||
144415349|NCT00963547|520726500|FG006|Overall Study|Withdrawal by Subject|0|||
144415350|NCT00963547|520726494|FG000|Overall Study|Reason Unknown|0|||
144415351|NCT00963547|520726495|FG001|Overall Study|Reason Unknown|1|||
144415352|NCT00963547|520726496|FG002|Overall Study|Reason Unknown|0|||
144415353|NCT00963547|520726497|FG003|Overall Study|Reason Unknown|0|||
144415354|NCT00963547|520726498|FG004|Overall Study|Reason Unknown|0|||
144415355|NCT00963547|520726499|FG005|Overall Study|Reason Unknown|0|||
144415356|NCT00963547|520726500|FG006|Overall Study|Reason Unknown|0|||
144415357|NCT00630396|520726501|FG000|Overall Study|Death|4|||
144415358|NCT00630396|520726501|FG000|Overall Study|Lost to Follow-up|3|||
144415359|NCT02430311|520726504|FG000|Part A|Adverse Event|0|||
144415360|NCT02430311|520726505|FG001|Part A|Adverse Event|1|||
144415361|NCT02430311|520726504|FG000|Part A|Withdrawal by Subject|1|||
144415362|NCT02430311|520726505|FG001|Part A|Withdrawal by Subject|0|||
144415363|NCT02430311|520726504|FG000|Part B|Meet study-specific withdrawal criteria|6|||
144415364|NCT02430311|520726505|FG001|Part B|Meet study-specific withdrawal criteria|6|||
144415365|NCT02430311|520726504|FG000|Part B|Withdrawal by Subject|2|||
144415366|NCT02430311|520726505|FG001|Part B|Withdrawal by Subject|2|||
144415367|NCT02430311|520726504|FG000|Part B|Adverse Event|1|||
144415368|NCT02430311|520726505|FG001|Part B|Adverse Event|0|||
144415369|NCT02430311|520726504|FG000|Part B|Death|1|||
144415370|NCT02430311|520726505|FG001|Part B|Death|0|||
144415371|NCT04160091|520726508|FG000|Overall Study|Terminated by Sponsor|7|||
144415372|NCT04160091|520726509|FG001|Overall Study|Terminated by Sponsor|3|||
144415373|NCT04160091|520726510|FG002|Overall Study|Terminated by Sponsor|5|||
144415374|NCT04160091|520726511|FG003|Overall Study|Terminated by Sponsor|2|||
144415375|NCT04160091|520726508|FG000|Overall Study|Noncompliance|0|||
144415376|NCT04160091|520726509|FG001|Overall Study|Noncompliance|0|||
144415377|NCT04160091|520726510|FG002|Overall Study|Noncompliance|0|||
144415378|NCT04160091|520726511|FG003|Overall Study|Noncompliance|1|||
144415379|NCT04160091|520726508|FG000|Overall Study|Withdrawal by Subject|0|||
144415380|NCT04160091|520726509|FG001|Overall Study|Withdrawal by Subject|0|||
144415381|NCT04160091|520726510|FG002|Overall Study|Withdrawal by Subject|0|||
144415382|NCT04160091|520726511|FG003|Overall Study|Withdrawal by Subject|1|||
144415383|NCT00381095|520726517|FG000|Overall Study|Death|3|||
144415384|NCT00381095|520726518|FG001|Overall Study|Death|4|||
144415385|NCT00381095|520726517|FG000|Overall Study|Lack of Efficacy|2|||
144415386|NCT00381095|520726518|FG001|Overall Study|Lack of Efficacy|4|||
144415387|NCT00381095|520726517|FG000|Overall Study|Other|2|||
144415388|NCT00381095|520726518|FG001|Overall Study|Other|2|||
144415389|NCT00381095|520726517|FG000|Overall Study|Protocol Violation|1|||
144415390|NCT00381095|520726518|FG001|Overall Study|Protocol Violation|1|||
144415391|NCT00381095|520726517|FG000|Overall Study|Withdrawal by Subject|3|||
144415392|NCT00381095|520726518|FG001|Overall Study|Withdrawal by Subject|3|||
144415393|NCT00381095|520726517|FG000|Overall Study|Adverse Event|2|||
144415394|NCT00381095|520726518|FG001|Overall Study|Adverse Event|7|||
144415395|NCT02485301|520726519|FG000|Overall Study|Serious Adverse Events|2|||
144415396|NCT02485301|520726520|FG001|Overall Study|Serious Adverse Events|1|||
144415397|NCT02485301|520726519|FG000|Overall Study|Protocol Violation|0|||
144415398|NCT02485301|520726520|FG001|Overall Study|Protocol Violation|1|||
144415399|NCT02485301|520726519|FG000|Overall Study|Withdrawal by Subject|6|||
144415400|NCT02485301|520726520|FG001|Overall Study|Withdrawal by Subject|7|||
144415401|NCT02485301|520726519|FG000|Overall Study|Migrated/moved from study area|10|||
144415402|NCT02485301|520726520|FG001|Overall Study|Migrated/moved from study area|19|||
144415403|NCT02485301|520726519|FG000|Overall Study|Lost to Follow-up|17|||
144415404|NCT02485301|520726520|FG001|Overall Study|Lost to Follow-up|17|||
144415405|NCT02485301|520726519|FG000|Overall Study|Other|3|||
144415406|NCT02485301|520726520|FG001|Overall Study|Other|4|||
144415407|NCT00411645|520726525|FG000|Overall Study|Consent Withdrawn|13|||
144415408|NCT00411645|520726526|FG001|Overall Study|Consent Withdrawn|22|||
144415409|NCT00411645|520726525|FG000|Overall Study|Death|56|||
144415410|NCT00411645|520726526|FG001|Overall Study|Death|135|||
144415411|NCT00411645|520726525|FG000|Overall Study|Investigator/Sponsor Decision|10|||
144415412|NCT00411645|520726526|FG001|Overall Study|Investigator/Sponsor Decision|7|||
144415413|NCT00411645|520726525|FG000|Overall Study|Lost to Follow-up|2|||
144415414|NCT00411645|520726526|FG001|Overall Study|Lost to Follow-up|0|||
144415415|NCT02573350|520726529|FG000|Overall Study|Lost to Follow-up|2|||
144415416|NCT02573350|520726530|FG001|Overall Study|Lost to Follow-up|1|||
144415417|NCT02573350|520726529|FG000|Overall Study|Adverse Event|3|||
144415418|NCT02573350|520726530|FG001|Overall Study|Adverse Event|4|||
144415419|NCT02573350|520726529|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
144415420|NCT02573350|520726530|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
144415421|NCT02573350|520726529|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
144415422|NCT02573350|520726530|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
144415423|NCT02573350|520726529|FG000|Overall Study|Subject withdrew consent to participate|6|||
144415424|NCT02573350|520726530|FG001|Overall Study|Subject withdrew consent to participate|1|||
144600784|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
144600785|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
144600786|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
144600787|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
144600788|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
144600789|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
144600790|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
144600791|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
144415425|NCT02573350|520726529|FG000|Overall Study|Protocol Deviation|1|||
144415426|NCT02573350|520726530|FG001|Overall Study|Protocol Deviation|1|||
144415427|NCT02708121|520726531|FG000|Overall Study|Withdrawn by Study Team|1|||
144415428|NCT02708121|520726532|FG001|Overall Study|Withdrawn by Study Team|1|||
144415429|NCT02708121|520726531|FG000|Overall Study|Withdrawal by Subject|0|||
144415430|NCT02708121|520726532|FG001|Overall Study|Withdrawal by Subject|4|||
144415431|NCT02969369|520726535|FG000|Study|Adverse Event|1|||
144415432|NCT02969369|520726536|FG001|Study|Adverse Event|6|||
144415433|NCT02969369|520726535|FG000|Study|Lack of Efficacy|0|||
144415434|NCT02969369|520726536|FG001|Study|Lack of Efficacy|1|||
144415435|NCT02969369|520726535|FG000|Study|Lost to Follow-up|0|||
144415436|NCT02969369|520726536|FG001|Study|Lost to Follow-up|1|||
144415437|NCT02969369|520726535|FG000|Study|Withdrawal by Subject|3|||
144415438|NCT02969369|520726536|FG001|Study|Withdrawal by Subject|5|||
144415439|NCT02969369|520726535|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
144415440|NCT02969369|520726536|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
144415441|NCT02969369|520726535|FG000|Double-blind Period|Adverse Event|1|||
144415442|NCT02969369|520726536|FG001|Double-blind Period|Adverse Event|5|||
144415443|NCT02969369|520726535|FG000|Double-blind Period|Lost to Follow-up|0|||
144415444|NCT02969369|520726536|FG001|Double-blind Period|Lost to Follow-up|1|||
144415445|NCT02969369|520726535|FG000|Double-blind Period|Withdrawal by Subject|2|||
144415446|NCT02969369|520726536|FG001|Double-blind Period|Withdrawal by Subject|3|||
144415447|NCT02969369|520726535|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
144415448|NCT02969369|520726536|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
144415449|NCT02969369|520726535|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
144415450|NCT02969369|520726536|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
144415451|NCT02969369|520726535|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
144415452|NCT02969369|520726536|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
144415453|NCT02969369|520726535|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
144415454|NCT02969369|520726536|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
144415455|NCT01484197|520726540|FG000|Treatment Period 1|Adverse Event|1|||
144415456|NCT01484197|520726541|FG001|Treatment Period 1|Adverse Event|0|||
144415457|NCT01484197|520726542|FG002|Treatment Period 1|Adverse Event|0|||
144415458|NCT01484197|520726543|FG003|Treatment Period 1|Adverse Event|0|||
144415459|NCT01484197|520726540|FG000|Treatment Period 2|Subject withdrew consent|0|||
144415460|NCT01484197|520726541|FG001|Treatment Period 2|Subject withdrew consent|0|||
144415461|NCT01484197|520726542|FG002|Treatment Period 2|Subject withdrew consent|0|||
144415462|NCT01484197|520726543|FG003|Treatment Period 2|Subject withdrew consent|1|||
144415463|NCT00814164|520726544|FG000|Overall Study|Progression|7|||
144415464|NCT00814164|520726544|FG000|Overall Study|not stated|7|||
144415465|NCT00814164|520726544|FG000|Overall Study|Death|5|||
144415466|NCT01980992|520726545|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
144415467|NCT01980992|520726546|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
144415468|NCT01980992|520726545|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
144415469|NCT01980992|520726546|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
144415470|NCT01980992|520726545|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
144415471|NCT01980992|520726546|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
144415472|NCT01980992|520726545|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
144415473|NCT01980992|520726546|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
144415474|NCT01980992|520726545|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
144415475|NCT01980992|520726546|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
144415476|NCT01980992|520726545|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
144415477|NCT01980992|520726546|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
144415478|NCT00299975|520726547|FG000|Overall Study|Adverse Event|1|||
144415479|NCT00299975|520726548|FG001|Overall Study|Adverse Event|0|||
144415480|NCT00299975|520726549|FG002|Overall Study|Adverse Event|2|||
144600792|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
144600793|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
144600794|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
144600795|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
144600796|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
144600797|NCT00559585|521401642|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
144600798|NCT00559585|521401643|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
144600799|NCT00559585|521401642|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
144600800|NCT00559585|521401643|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
144600801|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
144600802|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
144600803|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
144600804|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
144600805|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
144600806|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
144600807|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
144600808|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
144600809|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
144600810|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
144600811|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
144600812|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
144600813|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
144600814|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
144600815|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
144600816|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
144600817|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
144600818|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
144600819|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
144600820|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
144600821|NCT00559585|521401642|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
144600822|NCT00559585|521401643|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
144600823|NCT02644941|521401644|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
144600824|NCT02644941|521401645|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
144600825|NCT01145495|521401646|FG000|Overall Study|Adverse Event|6|||
144600826|NCT01145495|521401646|FG000|Overall Study|Withdrawal by Subject|6|||
144600827|NCT01145495|521401646|FG000|Overall Study|Disease progression after respone|2|||
144600828|NCT00323297|521401653|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
144600829|NCT00323297|521401654|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
144600830|NCT00323297|521401653|FG000|Part A (Double Blind Randomized)|Death|0|||
144600831|NCT00323297|521401654|FG001|Part A (Double Blind Randomized)|Death|1|||
144600832|NCT00323297|521401653|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
144600833|NCT00323297|521401654|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
144250608|NCT00862459|520115556|FG000|Overall Study|Unable to hold still for imaging|0|||
144250609|NCT00862459|520115557|FG001|Overall Study|Unable to hold still for imaging|1|||
144250610|NCT00862459|520115558|FG002|Overall Study|Unable to hold still for imaging|0|||
144600834|NCT00323297|521401653|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
144600835|NCT00323297|521401654|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
144600836|NCT00323297|521401653|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
144250611|NCT00862459|520115556|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
144600837|NCT00323297|521401654|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
144600838|NCT00323297|521401653|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
144600839|NCT00323297|521401654|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
144600840|NCT00323297|521401653|FG000|Part B (Open-label)|Death|0|||
144600841|NCT00323297|521401654|FG001|Part B (Open-label)|Death|1|||
144600842|NCT00323297|521401653|FG000|Part B (Open-label)|Reason unspecified|0|||
144600843|NCT00323297|521401654|FG001|Part B (Open-label)|Reason unspecified|1|||
144600844|NCT00323297|521401653|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
144600845|NCT00323297|521401654|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
144600846|NCT00323297|521401653|FG000|Part B (Open-label)|Lack of Efficacy|3|||
144600847|NCT00323297|521401654|FG001|Part B (Open-label)|Lack of Efficacy|1|||
144600848|NCT00323297|521401653|FG000|Part B (Open-label)|Adverse Event|5|||
144600849|NCT00323297|521401654|FG001|Part B (Open-label)|Adverse Event|5|||
144600850|NCT00323297|521401653|FG000|Part B (Open-label)|Protocol Violation|0|||
144600851|NCT00323297|521401654|FG001|Part B (Open-label)|Protocol Violation|1|||
144600852|NCT01603082|521401656|FG000|Overall Study|Adverse Event|0|||
144600853|NCT01603082|521401657|FG001|Overall Study|Adverse Event|1|||
144600854|NCT01603082|521401656|FG000|Overall Study|Withdrawal by Subject|1|||
144600855|NCT01603082|521401657|FG001|Overall Study|Withdrawal by Subject|0|||
144600856|NCT01603082|521401656|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
144600857|NCT01603082|521401657|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
144600858|NCT00634010|521401660|FG000|Overall Study|Adverse Event|2|||
144600859|NCT00634010|521401661|FG001|Overall Study|Adverse Event|5|||
144600860|NCT00634010|521401660|FG000|Overall Study|Withdrawal by Subject|5|||
144600861|NCT00634010|521401661|FG001|Overall Study|Withdrawal by Subject|6|||
144600862|NCT00634010|521401660|FG000|Overall Study|Physician Decision|1|||
144600863|NCT00634010|521401661|FG001|Overall Study|Physician Decision|1|||
144600864|NCT00634010|521401660|FG000|Overall Study|Disease Progression|1|||
144600865|NCT00634010|521401661|FG001|Overall Study|Disease Progression|1|||
144600866|NCT00634010|521401660|FG000|Overall Study|Non-Compliant|1|||
144600867|NCT00634010|521401661|FG001|Overall Study|Non-Compliant|1|||
144600868|NCT01026142|521401662|FG000|Overall Study|Death|136|||
144600869|NCT01026142|521401663|FG001|Overall Study|Death|134|||
144600870|NCT01026142|521401662|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
144600871|NCT01026142|521401663|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
144600872|NCT05085665|521401668|FG000|Overall Study|Physician Decision|2|||
144600873|NCT01641809|521401669|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
144600874|NCT01641809|521401670|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
144600875|NCT01641809|521401671|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
144600876|NCT01641809|521401672|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
144600877|NCT01641809|521401669|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
144600878|NCT01641809|521401670|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
144600879|NCT01641809|521401671|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
144600880|NCT01641809|521401672|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
144600881|NCT01641809|521401669|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
144600882|NCT01641809|521401670|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
144600883|NCT01641809|521401671|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
144600884|NCT01641809|521401672|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
144600885|NCT01641809|521401669|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
144600886|NCT01641809|521401670|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
144600887|NCT01641809|521401671|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
144600888|NCT01641809|521401672|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
144600889|NCT01641809|521401669|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
144600890|NCT01641809|521401670|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
144600891|NCT01641809|521401671|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
144600892|NCT01641809|521401672|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
144600893|NCT01641809|521401669|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
144600894|NCT01641809|521401670|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
144600895|NCT01641809|521401671|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
144600896|NCT01641809|521401672|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
144600897|NCT01641809|521401669|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
144600898|NCT01641809|521401670|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
144600899|NCT01641809|521401671|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
144600900|NCT01641809|521401672|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
144600901|NCT01641809|521401669|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
144600902|NCT01641809|521401670|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
144600903|NCT01641809|521401671|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
144600904|NCT01641809|521401672|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
144600905|NCT01641809|521401669|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
144600906|NCT01641809|521401670|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
144600907|NCT01641809|521401671|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
144600908|NCT01641809|521401672|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
144600909|NCT01641809|521401669|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
144600910|NCT01641809|521401670|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
144600911|NCT01641809|521401671|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
144600912|NCT01641809|521401672|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
144600913|NCT01641809|521401669|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
144600914|NCT01641809|521401670|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
144600915|NCT01641809|521401671|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
144600916|NCT01641809|521401672|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
144600917|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
144600918|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
144600919|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
144600920|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
144600921|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
144600922|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
144600923|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
144600924|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
144600925|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
144600926|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
144600927|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
144600928|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
144600929|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
144600930|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
144600931|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
144600932|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
144600933|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
144600934|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
144600935|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
144600936|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
144600937|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
144600938|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
144600939|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
144600940|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
144600941|NCT01641809|521401669|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
144600942|NCT01641809|521401670|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
144600943|NCT01641809|521401671|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
144600944|NCT01641809|521401672|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
144600945|NCT03294109|521401673|FG000|Overall Study|Withdrawal by Subject|6|||
144600946|NCT03294109|521401674|FG001|Overall Study|Withdrawal by Subject|5|||
144600947|NCT03690141|521401677|FG000|Overall Study|Adverse Event|5|||
144600948|NCT03690141|521401677|FG000|Overall Study|Withdrawal by Subject|3|||
144600949|NCT03690141|521401677|FG000|Overall Study|Physician Decision|4|||
144600950|NCT03690141|521401677|FG000|Overall Study|Disease progression|4|||
144600951|NCT04744285|521401678|FG000|Overall Study|Withdrawal by Subject|1|||
144600952|NCT04744285|521401679|FG001|Overall Study|Withdrawal by Subject|1|||
144600953|NCT04744285|521401680|FG002|Overall Study|Withdrawal by Subject|2|||
144415481|NCT00299975|520726547|FG000|Overall Study|Pregnancy|0|||
144415482|NCT00299975|520726548|FG001|Overall Study|Pregnancy|0|||
144415483|NCT00299975|520726549|FG002|Overall Study|Pregnancy|1|||
144415484|NCT00299975|520726547|FG000|Overall Study|Lack of Efficacy|1|||
144415485|NCT00299975|520726548|FG001|Overall Study|Lack of Efficacy|0|||
144415486|NCT00299975|520726549|FG002|Overall Study|Lack of Efficacy|1|||
144415487|NCT00299975|520726547|FG000|Overall Study|Lost to Follow-up|1|||
144415488|NCT00299975|520726548|FG001|Overall Study|Lost to Follow-up|0|||
144415489|NCT00299975|520726549|FG002|Overall Study|Lost to Follow-up|0|||
144415490|NCT00299975|520726547|FG000|Overall Study|Withdrawal by Subject|0|||
144415491|NCT00299975|520726548|FG001|Overall Study|Withdrawal by Subject|1|||
144415492|NCT00299975|520726549|FG002|Overall Study|Withdrawal by Subject|3|||
144415493|NCT00299975|520726547|FG000|Overall Study|Physician Decision|0|||
144415494|NCT00299975|520726548|FG001|Overall Study|Physician Decision|0|||
144415495|NCT00299975|520726549|FG002|Overall Study|Physician Decision|1|||
144415496|NCT05228132|520726555|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
144415497|NCT05228132|520726555|FG000|Overall Study|Adverse Event|3|||
144415498|NCT05228132|520726555|FG000|Overall Study|Lost to Follow-up|1|||
144415499|NCT05228132|520726555|FG000|Overall Study|Arteriovenous-fistula mature|1|||
144415500|NCT02627144|520726556|FG000|Overall Study|Serious adverse event|32|||
144415501|NCT02627144|520726556|FG000|Overall Study|Cancer progression|171|||
144415502|NCT02627144|520726556|FG000|Overall Study|Death from cancer|20|||
144415503|NCT02627144|520726556|FG000|Overall Study|Death from other cause|8|||
144415504|NCT02627144|520726556|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
144415505|NCT02627144|520726556|FG000|Overall Study|Administrative reasons|65|||
144415506|NCT02627144|520726556|FG000|Overall Study|Lost to Follow-up|8|||
144415507|NCT02627144|520726556|FG000|Overall Study|Enrolled, not treated|6|||
144415508|NCT02627144|520726556|FG000|Overall Study|Other|17|||
144415509|NCT00420927|520726557|FG000|Period 1|Adverse Event|19|||
144415510|NCT00420927|520726558|FG001|Period 1|Adverse Event|15|||
144415511|NCT00420927|520726559|FG002|Period 1|Adverse Event|0|||
144415512|NCT00420927|520726560|FG003|Period 1|Adverse Event|0|||
144415513|NCT00420927|520726561|FG004|Period 1|Adverse Event|0|||
144415514|NCT00420927|520726562|FG005|Period 1|Adverse Event|0|||
144415515|NCT00420927|520726563|FG006|Period 1|Adverse Event|0|||
144415516|NCT00420927|520726557|FG000|Period 1|Withdrawal by Subject|7|||
144415517|NCT00420927|520726558|FG001|Period 1|Withdrawal by Subject|12|||
144415518|NCT00420927|520726559|FG002|Period 1|Withdrawal by Subject|0|||
144415519|NCT00420927|520726560|FG003|Period 1|Withdrawal by Subject|0|||
144415520|NCT00420927|520726561|FG004|Period 1|Withdrawal by Subject|0|||
144415521|NCT00420927|520726562|FG005|Period 1|Withdrawal by Subject|0|||
144415522|NCT00420927|520726563|FG006|Period 1|Withdrawal by Subject|0|||
144415523|NCT00420927|520726557|FG000|Period 1|Lost to Follow-up|8|||
144415524|NCT00420927|520726558|FG001|Period 1|Lost to Follow-up|6|||
144415525|NCT00420927|520726559|FG002|Period 1|Lost to Follow-up|0|||
144415526|NCT00420927|520726560|FG003|Period 1|Lost to Follow-up|0|||
144415527|NCT00420927|520726561|FG004|Period 1|Lost to Follow-up|0|||
144527264|NCT03701763|521131899|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
144527265|NCT03701763|521131900|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
144527266|NCT03701763|521131901|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
144527267|NCT03701763|521131898|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
144527268|NCT03701763|521131899|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
144527269|NCT03701763|521131900|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
144527270|NCT03701763|521131901|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
144527271|NCT03701763|521131898|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
144527272|NCT03701763|521131899|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
144527273|NCT03701763|521131900|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
144527274|NCT03701763|521131901|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
144527275|NCT03701763|521131898|FG000|Apremilast Extension Phase|Adverse Event|0|||
144527276|NCT03701763|521131899|FG001|Apremilast Extension Phase|Adverse Event|0|||
144527277|NCT03701763|521131900|FG002|Apremilast Extension Phase|Adverse Event|3|||
144527278|NCT03701763|521131901|FG003|Apremilast Extension Phase|Adverse Event|1|||
144527279|NCT03701763|521131898|FG000|Apremilast Extension Phase|Miscellaneous|0|||
144527280|NCT03701763|521131899|FG001|Apremilast Extension Phase|Miscellaneous|0|||
144527281|NCT03701763|521131900|FG002|Apremilast Extension Phase|Miscellaneous|2|||
144527282|NCT03701763|521131901|FG003|Apremilast Extension Phase|Miscellaneous|1|||
144527283|NCT03701763|521131898|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
144527284|NCT03701763|521131899|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
144527285|NCT03701763|521131900|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
144527286|NCT03701763|521131901|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
144527287|NCT03701763|521131898|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
144527288|NCT03701763|521131899|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
144527289|NCT03701763|521131900|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
144527290|NCT03701763|521131901|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
144600954|NCT04744285|521401681|FG003|Overall Study|Withdrawal by Subject|1|||
144415528|NCT00420927|520726562|FG005|Period 1|Lost to Follow-up|0|||
144415529|NCT00420927|520726563|FG006|Period 1|Lost to Follow-up|0|||
144415530|NCT00420927|520726557|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
144415531|NCT00420927|520726558|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
144415532|NCT00420927|520726559|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
144415533|NCT00420927|520726560|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
144415534|NCT00420927|520726561|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
144415535|NCT00420927|520726562|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
144415536|NCT00420927|520726563|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
144415537|NCT00420927|520726557|FG000|Period 1|Death|2|||
144415538|NCT00420927|520726558|FG001|Period 1|Death|0|||
144415539|NCT00420927|520726559|FG002|Period 1|Death|0|||
144415540|NCT00420927|520726560|FG003|Period 1|Death|0|||
144415541|NCT00420927|520726561|FG004|Period 1|Death|0|||
144415542|NCT00420927|520726562|FG005|Period 1|Death|0|||
144415543|NCT00420927|520726563|FG006|Period 1|Death|0|||
144415544|NCT00420927|520726557|FG000|Period 1|Subject moved/relocated|0|||
144415545|NCT00420927|520726558|FG001|Period 1|Subject moved/relocated|2|||
144415546|NCT00420927|520726559|FG002|Period 1|Subject moved/relocated|0|||
144415547|NCT00420927|520726560|FG003|Period 1|Subject moved/relocated|0|||
144415548|NCT00420927|520726561|FG004|Period 1|Subject moved/relocated|0|||
144415549|NCT00420927|520726562|FG005|Period 1|Subject moved/relocated|0|||
144415550|NCT00420927|520726563|FG006|Period 1|Subject moved/relocated|0|||
144415551|NCT00420927|520726557|FG000|Period 1|Noncompliant with study drug|1|||
144415552|NCT00420927|520726558|FG001|Period 1|Noncompliant with study drug|1|||
144415553|NCT00420927|520726559|FG002|Period 1|Noncompliant with study drug|0|||
144415554|NCT00420927|520726560|FG003|Period 1|Noncompliant with study drug|0|||
144415555|NCT00420927|520726561|FG004|Period 1|Noncompliant with study drug|0|||
144415556|NCT00420927|520726562|FG005|Period 1|Noncompliant with study drug|0|||
144415557|NCT00420927|520726563|FG006|Period 1|Noncompliant with study drug|0|||
144415558|NCT00420927|520726557|FG000|Period 1|Randomization error|1|||
144415559|NCT00420927|520726558|FG001|Period 1|Randomization error|0|||
144415560|NCT00420927|520726559|FG002|Period 1|Randomization error|0|||
144415561|NCT00420927|520726560|FG003|Period 1|Randomization error|0|||
144415562|NCT00420927|520726561|FG004|Period 1|Randomization error|0|||
144415563|NCT00420927|520726562|FG005|Period 1|Randomization error|0|||
144415564|NCT00420927|520726563|FG006|Period 1|Randomization error|0|||
144415565|NCT00420927|520726557|FG000|Period 1|Suspected tuberculosis/positive test|1|||
144415566|NCT00420927|520726558|FG001|Period 1|Suspected tuberculosis/positive test|1|||
144415567|NCT00420927|520726559|FG002|Period 1|Suspected tuberculosis/positive test|0|||
144415568|NCT00420927|520726560|FG003|Period 1|Suspected tuberculosis/positive test|0|||
144415569|NCT00420927|520726561|FG004|Period 1|Suspected tuberculosis/positive test|0|||
144415570|NCT00420927|520726562|FG005|Period 1|Suspected tuberculosis/positive test|0|||
144415571|NCT00420927|520726563|FG006|Period 1|Suspected tuberculosis/positive test|0|||
144415572|NCT00420927|520726557|FG000|Period 1|Study site closure|0|||
144415573|NCT00420927|520726558|FG001|Period 1|Study site closure|1|||
144415574|NCT00420927|520726559|FG002|Period 1|Study site closure|0|||
144415575|NCT00420927|520726560|FG003|Period 1|Study site closure|0|||
144415576|NCT00420927|520726561|FG004|Period 1|Study site closure|0|||
144415577|NCT00420927|520726562|FG005|Period 1|Study site closure|0|||
144415578|NCT00420927|520726563|FG006|Period 1|Study site closure|0|||
144415579|NCT00420927|520726557|FG000|Period 1|Subject received new diagnosis|0|||
144415580|NCT00420927|520726558|FG001|Period 1|Subject received new diagnosis|2|||
144415581|NCT00420927|520726559|FG002|Period 1|Subject received new diagnosis|0|||
144415582|NCT00420927|520726560|FG003|Period 1|Subject received new diagnosis|0|||
144415583|NCT00420927|520726561|FG004|Period 1|Subject received new diagnosis|0|||
144415584|NCT00420927|520726562|FG005|Period 1|Subject received new diagnosis|0|||
144415585|NCT00420927|520726563|FG006|Period 1|Subject received new diagnosis|0|||
144415586|NCT00420927|520726557|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
144415587|NCT00420927|520726558|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
144415588|NCT00420927|520726559|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
144415589|NCT00420927|520726560|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
144415590|NCT00420927|520726561|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
144415591|NCT00420927|520726562|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
144415592|NCT00420927|520726563|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
144415593|NCT00420927|520726557|FG000|Period 1|Failed to meet entry criteria|8|||
144415594|NCT00420927|520726558|FG001|Period 1|Failed to meet entry criteria|7|||
144415595|NCT00420927|520726559|FG002|Period 1|Failed to meet entry criteria|0|||
144415596|NCT00420927|520726560|FG003|Period 1|Failed to meet entry criteria|0|||
144415597|NCT00420927|520726561|FG004|Period 1|Failed to meet entry criteria|0|||
144527291|NCT03701763|521131898|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
144415598|NCT00420927|520726562|FG005|Period 1|Failed to meet entry criteria|0|||
144415599|NCT00420927|520726563|FG006|Period 1|Failed to meet entry criteria|0|||
144415600|NCT00420927|520726557|FG000|Period 1|Took prohibited medication|1|||
144415601|NCT00420927|520726558|FG001|Period 1|Took prohibited medication|3|||
144415602|NCT00420927|520726559|FG002|Period 1|Took prohibited medication|0|||
144415603|NCT00420927|520726560|FG003|Period 1|Took prohibited medication|0|||
144415604|NCT00420927|520726561|FG004|Period 1|Took prohibited medication|0|||
144415605|NCT00420927|520726562|FG005|Period 1|Took prohibited medication|0|||
144415606|NCT00420927|520726563|FG006|Period 1|Took prohibited medication|0|||
144415607|NCT00420927|520726557|FG000|Period 2|Adverse Event|0|||
144415608|NCT00420927|520726558|FG001|Period 2|Adverse Event|0|||
144415609|NCT00420927|520726559|FG002|Period 2|Adverse Event|7|||
144415610|NCT00420927|520726560|FG003|Period 2|Adverse Event|3|||
144415611|NCT00420927|520726561|FG004|Period 2|Adverse Event|17|||
144415612|NCT00420927|520726562|FG005|Period 2|Adverse Event|6|||
144415613|NCT00420927|520726563|FG006|Period 2|Adverse Event|20|||
144415614|NCT00420927|520726557|FG000|Period 2|Withdrawal by Subject|0|||
144415615|NCT00420927|520726558|FG001|Period 2|Withdrawal by Subject|0|||
144415616|NCT00420927|520726559|FG002|Period 2|Withdrawal by Subject|1|||
144415617|NCT00420927|520726560|FG003|Period 2|Withdrawal by Subject|3|||
144415618|NCT00420927|520726561|FG004|Period 2|Withdrawal by Subject|11|||
144415619|NCT00420927|520726562|FG005|Period 2|Withdrawal by Subject|2|||
144415620|NCT00420927|520726563|FG006|Period 2|Withdrawal by Subject|12|||
144415621|NCT00420927|520726557|FG000|Period 2|Lost to Follow-up|0|||
144415622|NCT00420927|520726558|FG001|Period 2|Lost to Follow-up|0|||
144415623|NCT00420927|520726559|FG002|Period 2|Lost to Follow-up|2|||
144415624|NCT00420927|520726560|FG003|Period 2|Lost to Follow-up|2|||
144415625|NCT00420927|520726561|FG004|Period 2|Lost to Follow-up|6|||
144415626|NCT00420927|520726562|FG005|Period 2|Lost to Follow-up|3|||
144415627|NCT00420927|520726563|FG006|Period 2|Lost to Follow-up|9|||
144415628|NCT00420927|520726557|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
144415629|NCT00420927|520726558|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
144415630|NCT00420927|520726559|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
144415631|NCT00420927|520726560|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
144415632|NCT00420927|520726561|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
144415633|NCT00420927|520726562|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
144415634|NCT00420927|520726563|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
144415635|NCT00420927|520726557|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
144415636|NCT00420927|520726558|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
144415637|NCT00420927|520726559|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
144415638|NCT00420927|520726560|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
144415639|NCT00420927|520726561|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
144415640|NCT00420927|520726562|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
144415641|NCT00420927|520726563|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
144415642|NCT00420927|520726557|FG000|Period 2|Subject unable to find transportation|0|||
144415643|NCT00420927|520726558|FG001|Period 2|Subject unable to find transportation|0|||
144415644|NCT00420927|520726559|FG002|Period 2|Subject unable to find transportation|0|||
144415645|NCT00420927|520726560|FG003|Period 2|Subject unable to find transportation|0|||
144415646|NCT00420927|520726561|FG004|Period 2|Subject unable to find transportation|0|||
144415647|NCT00420927|520726562|FG005|Period 2|Subject unable to find transportation|0|||
144415648|NCT00420927|520726563|FG006|Period 2|Subject unable to find transportation|1|||
144415649|NCT00420927|520726557|FG000|Period 2|Physician Decision|0|||
144415650|NCT00420927|520726558|FG001|Period 2|Physician Decision|0|||
144415651|NCT00420927|520726559|FG002|Period 2|Physician Decision|0|||
144415652|NCT00420927|520726560|FG003|Period 2|Physician Decision|0|||
144415653|NCT00420927|520726561|FG004|Period 2|Physician Decision|1|||
144415654|NCT00420927|520726562|FG005|Period 2|Physician Decision|1|||
144415655|NCT00420927|520726563|FG006|Period 2|Physician Decision|0|||
144415656|NCT00420927|520726557|FG000|Period 2|Sponsor decision|0|||
144415657|NCT00420927|520726558|FG001|Period 2|Sponsor decision|0|||
144415658|NCT00420927|520726559|FG002|Period 2|Sponsor decision|1|||
144415659|NCT00420927|520726560|FG003|Period 2|Sponsor decision|0|||
144415660|NCT00420927|520726561|FG004|Period 2|Sponsor decision|0|||
144415661|NCT00420927|520726562|FG005|Period 2|Sponsor decision|0|||
144415662|NCT00420927|520726563|FG006|Period 2|Sponsor decision|1|||
144415663|NCT00420927|520726557|FG000|Period 2|Randomization error|0|||
144415664|NCT00420927|520726558|FG001|Period 2|Randomization error|0|||
144415665|NCT00420927|520726559|FG002|Period 2|Randomization error|0|||
144415666|NCT00420927|520726560|FG003|Period 2|Randomization error|0|||
144415667|NCT00420927|520726561|FG004|Period 2|Randomization error|1|||
144415668|NCT00420927|520726562|FG005|Period 2|Randomization error|1|||
144415669|NCT00420927|520726563|FG006|Period 2|Randomization error|0|||
144415670|NCT00420927|520726557|FG000|Period 2|Noncompliant with study drug|0|||
144415671|NCT00420927|520726558|FG001|Period 2|Noncompliant with study drug|0|||
144415672|NCT00420927|520726559|FG002|Period 2|Noncompliant with study drug|0|||
144415673|NCT00420927|520726560|FG003|Period 2|Noncompliant with study drug|1|||
144415674|NCT00420927|520726561|FG004|Period 2|Noncompliant with study drug|0|||
144415675|NCT00420927|520726562|FG005|Period 2|Noncompliant with study drug|0|||
144415676|NCT00420927|520726563|FG006|Period 2|Noncompliant with study drug|2|||
144415677|NCT00420927|520726557|FG000|Period 2|Methotrexate intolerance|0|||
144415678|NCT00420927|520726558|FG001|Period 2|Methotrexate intolerance|0|||
144415679|NCT00420927|520726559|FG002|Period 2|Methotrexate intolerance|0|||
144415680|NCT00420927|520726560|FG003|Period 2|Methotrexate intolerance|0|||
144415681|NCT00420927|520726561|FG004|Period 2|Methotrexate intolerance|0|||
144415682|NCT00420927|520726562|FG005|Period 2|Methotrexate intolerance|0|||
144415683|NCT00420927|520726563|FG006|Period 2|Methotrexate intolerance|1|||
144415684|NCT00420927|520726557|FG000|Period 2|Took prohibited medication|0|||
144415685|NCT00420927|520726558|FG001|Period 2|Took prohibited medication|0|||
144415686|NCT00420927|520726559|FG002|Period 2|Took prohibited medication|0|||
144415687|NCT00420927|520726560|FG003|Period 2|Took prohibited medication|0|||
144415688|NCT00420927|520726561|FG004|Period 2|Took prohibited medication|1|||
144415689|NCT00420927|520726562|FG005|Period 2|Took prohibited medication|0|||
144415690|NCT00420927|520726563|FG006|Period 2|Took prohibited medication|0|||
144415691|NCT00642460|520726564|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
144415692|NCT00642460|520726565|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
144415693|NCT00642460|520726566|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
144415694|NCT00642460|520726567|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
144415695|NCT00642460|520726568|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
144415696|NCT00642460|520726569|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
144415697|NCT00642460|520726564|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
144415698|NCT00642460|520726565|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
144415699|NCT00642460|520726566|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
144415700|NCT00642460|520726567|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
144415701|NCT00642460|520726568|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
144415702|NCT00642460|520726569|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
144415703|NCT00642460|520726564|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
144415704|NCT00642460|520726565|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
144415705|NCT00642460|520726566|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
144415706|NCT00642460|520726567|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
144415707|NCT00642460|520726568|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
144415708|NCT00642460|520726569|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
144415709|NCT00642460|520726564|FG000|Part II: Open-Label Up to Week 92|Death|0|||
144415710|NCT00642460|520726565|FG001|Part II: Open-Label Up to Week 92|Death|1|||
144415711|NCT00642460|520726566|FG002|Part II: Open-Label Up to Week 92|Death|0|||
144415712|NCT00642460|520726567|FG003|Part II: Open-Label Up to Week 92|Death|2|||
144415713|NCT00642460|520726568|FG004|Part II: Open-Label Up to Week 92|Death|0|||
144415714|NCT00642460|520726569|FG005|Part II: Open-Label Up to Week 92|Death|0|||
144415715|NCT00642460|520726564|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
144415716|NCT00642460|520726565|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
144415717|NCT00642460|520726566|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
144415718|NCT00642460|520726567|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
144415719|NCT00642460|520726568|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
144415720|NCT00642460|520726569|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
144415721|NCT00642460|520726564|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
144415722|NCT00642460|520726565|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
144415723|NCT00642460|520726566|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
144415724|NCT00642460|520726567|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
144415725|NCT00642460|520726568|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
144415726|NCT00642460|520726569|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
144415727|NCT00642460|520726564|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
144415728|NCT00642460|520726565|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
144415729|NCT00642460|520726566|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
144415730|NCT00642460|520726567|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
144415731|NCT00642460|520726568|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
144415732|NCT00642460|520726569|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
144415733|NCT00642460|520726564|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
144415734|NCT00642460|520726565|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
144415735|NCT00642460|520726566|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
144415736|NCT00642460|520726567|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
144415737|NCT00642460|520726568|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
144527292|NCT03701763|521131899|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
144527293|NCT03701763|521131900|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
144527294|NCT03701763|521131901|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
144415738|NCT00642460|520726569|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
144415739|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
144415740|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
144415741|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
144415742|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
144415743|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
144415744|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
144415745|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
144415746|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
144415747|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
144415748|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
144415749|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
144415750|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
144415751|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
144415752|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
144415753|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
144415754|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
144415755|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
144415756|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
144415757|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
144415758|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
144415759|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
144415760|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
144415761|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
144415762|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
144415763|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Other|0|||
144415764|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Other|0|||
144415765|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Other|0|||
144415766|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Other|0|||
144415767|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Other|2|||
144415768|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Other|2|||
144415769|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Death|0|||
144415770|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Death|0|||
144415771|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Death|0|||
144415772|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Death|0|||
144415773|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Death|0|||
144415774|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Death|3|||
144415775|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
144415776|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
144415777|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
144415778|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
144415779|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
144415780|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
144415781|NCT00642460|520726564|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
144415782|NCT00642460|520726565|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
144415783|NCT00642460|520726566|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
144415784|NCT00642460|520726567|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
144415785|NCT00642460|520726568|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
144415786|NCT00642460|520726569|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
144415787|NCT02088047|520726574|FG000|Overall Study|Withdrawal by Subject|1|||
144415788|NCT02088047|520726575|FG001|Overall Study|Withdrawal by Subject|0|||
144415789|NCT00729651|520726579|FG000|Overall Study|Withdrawal by Subject|5|||
144415790|NCT00729651|520726580|FG001|Overall Study|Withdrawal by Subject|6|||
144415791|NCT00729651|520726579|FG000|Overall Study|Lost to Follow-up|5|||
144415792|NCT00729651|520726580|FG001|Overall Study|Lost to Follow-up|4|||
144415793|NCT00729651|520726579|FG000|Overall Study|Protocol Violation|0|||
144415794|NCT00729651|520726580|FG001|Overall Study|Protocol Violation|1|||
144415795|NCT00729651|520726579|FG000|Overall Study|Adverse Event|7|||
144415796|NCT00729651|520726580|FG001|Overall Study|Adverse Event|3|||
144415797|NCT00729651|520726579|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
144415798|NCT00729651|520726580|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
144415799|NCT00729651|520726579|FG000|Overall Study|Subject's private reason|2|||
144415800|NCT00729651|520726580|FG001|Overall Study|Subject's private reason|0|||
144415801|NCT01218243|520726581|FG000|Overall Study|Lack of Efficacy|1|||
144415802|NCT01218243|520726582|FG001|Overall Study|Lack of Efficacy|1|||
144415803|NCT01218243|520726581|FG000|Overall Study|Lost to Follow-up|3|||
144415804|NCT01218243|520726582|FG001|Overall Study|Lost to Follow-up|3|||
144527295|NCT03701763|521131898|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
144723146|NCT03977584|521840637|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
144415805|NCT01218243|520726581|FG000|Overall Study|Protocol Violation|5|||
144415806|NCT01218243|520726582|FG001|Overall Study|Protocol Violation|10|||
144415807|NCT01637272|520726585|FG000|Overall Study|Adverse Event|6|||
144415808|NCT01637272|520726585|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144415809|NCT01637272|520726585|FG000|Overall Study|Withdrawal by Subject|3|||
144415810|NCT01637272|520726585|FG000|Overall Study|Lost to Follow-up|2|||
144415811|NCT01637272|520726585|FG000|Overall Study|completed core, did not enter ext. phase|4|||
144415812|NCT01637272|520726585|FG000|Overall Study|Administrative problems|1|||
144415813|NCT01637272|520726585|FG000|Overall Study|Protocol Violation|2|||
144415814|NCT01496612|520726586|FG000|1st Intervention|Adverse Event|1|||
144415815|NCT01496612|520726587|FG001|1st Intervention|Adverse Event|0|||
144415816|NCT01496612|520726586|FG000|1st Intervention|Withdrawal by Subject|1|||
144415817|NCT01496612|520726587|FG001|1st Intervention|Withdrawal by Subject|0|||
144415818|NCT00833794|520726588|FG000|Open-label Phase|Adverse Event|225|||
144415819|NCT00833794|520726589|FG001|Open-label Phase|Adverse Event|0|||
144415820|NCT00833794|520726588|FG000|Open-label Phase|Lack of Efficacy|28|||
144415821|NCT00833794|520726589|FG001|Open-label Phase|Lack of Efficacy|0|||
144415822|NCT00833794|520726588|FG000|Open-label Phase|Withdrawal by Subject|48|||
144415823|NCT00833794|520726589|FG001|Open-label Phase|Withdrawal by Subject|0|||
144415824|NCT00833794|520726588|FG000|Open-label Phase|Physician Decision|20|||
144415825|NCT00833794|520726589|FG001|Open-label Phase|Physician Decision|0|||
144415826|NCT00833794|520726588|FG000|Open-label Phase|Administrative reason|1|||
144415827|NCT00833794|520726589|FG001|Open-label Phase|Administrative reason|0|||
144415828|NCT00833794|520726588|FG000|Open-label Phase|Protocol Violation|47|||
144415829|NCT00833794|520726589|FG001|Open-label Phase|Protocol Violation|0|||
144415830|NCT00833794|520726588|FG000|Open-label Phase|Did not complete wash-out period|12|||
144415831|NCT00833794|520726589|FG001|Open-label Phase|Did not complete wash-out period|0|||
144415832|NCT00833794|520726588|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
144415833|NCT00833794|520726589|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
144415834|NCT00833794|520726588|FG000|Double-blind Phase|Adverse Event|44|||
144415835|NCT00833794|520726589|FG001|Double-blind Phase|Adverse Event|11|||
144415836|NCT00833794|520726588|FG000|Double-blind Phase|Lack of Efficacy|34|||
144415837|NCT00833794|520726589|FG001|Double-blind Phase|Lack of Efficacy|22|||
144415838|NCT00833794|520726588|FG000|Double-blind Phase|Withdrawal by Subject|23|||
144415839|NCT00833794|520726589|FG001|Double-blind Phase|Withdrawal by Subject|6|||
144415840|NCT00833794|520726588|FG000|Double-blind Phase|Physician Decision|4|||
144415841|NCT00833794|520726589|FG001|Double-blind Phase|Physician Decision|7|||
144415842|NCT00833794|520726588|FG000|Double-blind Phase|Administrative reason|1|||
144415843|NCT00833794|520726589|FG001|Double-blind Phase|Administrative reason|3|||
144415844|NCT00496054|520726594|FG000|Overall Study|Adverse Event|1|||
144415845|NCT00496054|520726594|FG000|Overall Study|Lost to Follow-up|7|||
144415846|NCT01950741|520726599|FG000|Overall Study|Lost to Follow-up|1|||
144415847|NCT01950741|520726599|FG000|Overall Study|Death|1|||
144415848|NCT01950741|520726599|FG000|Overall Study|Withdrawal by Subject|1|||
144415849|NCT00471328|520726602|FG000|Core Phase|Adverse Event|18|||
144415850|NCT00471328|520726603|FG001|Core Phase|Adverse Event|6|||
144415851|NCT00471328|520726602|FG000|Core Phase|Death|8|||
144415852|NCT00471328|520726603|FG001|Core Phase|Death|4|||
144415853|NCT00471328|520726602|FG000|Core Phase|Withdrawal by Subject|2|||
144415854|NCT00471328|520726603|FG001|Core Phase|Withdrawal by Subject|2|||
144415855|NCT00471328|520726602|FG000|Core Phase|Abnormal laboratory value|1|||
144415856|NCT00471328|520726603|FG001|Core Phase|Abnormal laboratory value|0|||
144415857|NCT00471328|520726602|FG000|Core Phase|Disease Progression|78|||
144415858|NCT00471328|520726603|FG001|Core Phase|Disease Progression|53|||
144415859|NCT00471328|520726602|FG000|Core Phase|Administrative Problem|0|||
144415860|NCT00471328|520726603|FG001|Core Phase|Administrative Problem|1|||
144415861|NCT00471328|520726602|FG000|Core Phase|Protocol Deviation|0|||
144415862|NCT00471328|520726603|FG001|Core Phase|Protocol Deviation|1|||
144415863|NCT00471328|520726602|FG000|Extension Phase|Adverse Event|3|||
144415864|NCT00471328|520726603|FG001|Extension Phase|Adverse Event|12|||
144415865|NCT00471328|520726602|FG000|Extension Phase|Withdrawal by Subject|0|||
144415866|NCT00471328|520726603|FG001|Extension Phase|Withdrawal by Subject|2|||
144415867|NCT00471328|520726602|FG000|Extension Phase|Death|1|||
144415868|NCT00471328|520726603|FG001|Extension Phase|Death|7|||
144415869|NCT00471328|520726602|FG000|Extension Phase|Protocol Deviation|3|||
144415870|NCT00471328|520726603|FG001|Extension Phase|Protocol Deviation|1|||
144415871|NCT00471328|520726602|FG000|Extension Phase|Treatment duration as per protocol|0|||
144415872|NCT00471328|520726603|FG001|Extension Phase|Treatment duration as per protocol|1|||
144415873|NCT00471328|520726602|FG000|Extension Phase|Disease Progression|32|||
144415874|NCT00471328|520726603|FG001|Extension Phase|Disease Progression|44|||
144415875|NCT00471328|520726602|FG000|Extension Phase|New cancer Therapy|1|||
144415876|NCT00471328|520726603|FG001|Extension Phase|New cancer Therapy|0|||
144415877|NCT00471328|520726602|FG000|Extension Phase|Administrative Problem|1|||
144415878|NCT00471328|520726603|FG001|Extension Phase|Administrative Problem|0|||
144415879|NCT00519831|520726604|FG000|Overall Study|Adverse Event|3|||
144415880|NCT00458211|520726608|FG000|Overall Study|Lack of Efficacy|12|||
144415881|NCT00458211|520726608|FG000|Overall Study|Withdrawal by Subject|2|||
144415882|NCT00458211|520726608|FG000|Overall Study|Protocol Violation|2|||
144415883|NCT04342897|520726609|FG000|Overall Study|Death|7|||
144415884|NCT04342897|520726610|FG001|Overall Study|Death|4|||
144415885|NCT04342897|520726609|FG000|Overall Study|Lost to Follow-up|6|||
144415886|NCT04342897|520726610|FG001|Overall Study|Lost to Follow-up|6|||
144415887|NCT04342897|520726609|FG000|Overall Study|Withdrawal by Subject|1|||
144415888|NCT04342897|520726610|FG001|Overall Study|Withdrawal by Subject|2|||
144415889|NCT02634320|520726617|FG000|Overall Study|Adverse Event|2|||
144415890|NCT02634320|520726617|FG000|Overall Study|Lost to Follow-up|3|||
144415891|NCT02634320|520726617|FG000|Overall Study|Moved out of area|2|||
144415892|NCT02634320|520726617|FG000|Overall Study|Out of window for study visits|1|||
144415893|NCT02634320|520726617|FG000|Overall Study|Protocol Violation|1|||
144415894|NCT02634320|520726617|FG000|Overall Study|Withdrawal by Subject|5|||
144415895|NCT02634320|520726617|FG000|Overall Study|Lack of Efficacy|2|||
144415896|NCT00838578|520726622|FG000|Overall Study|Protocol Violation|2|||
144415897|NCT00598832|520726623|FG000|Overall Study|Lack of Efficacy|3|||
144415898|NCT00598832|520726624|FG001|Overall Study|Lack of Efficacy|7|||
144415899|NCT00598832|520726623|FG000|Overall Study|Adverse Event|6|||
144415900|NCT00598832|520726624|FG001|Overall Study|Adverse Event|2|||
144415901|NCT00598832|520726623|FG000|Overall Study|Withdrawal by Subject|25|||
144415902|NCT00598832|520726624|FG001|Overall Study|Withdrawal by Subject|36|||
144415903|NCT00598832|520726623|FG000|Overall Study|Protocol Violation|0|||
144415904|NCT00598832|520726624|FG001|Overall Study|Protocol Violation|2|||
144415905|NCT00598832|520726623|FG000|Overall Study|Lost to Follow-up|24|||
144415906|NCT00598832|520726624|FG001|Overall Study|Lost to Follow-up|29|||
144415907|NCT00598832|520726623|FG000|Overall Study|Pregnancy|2|||
144415908|NCT00598832|520726624|FG001|Overall Study|Pregnancy|2|||
144415909|NCT00598832|520726623|FG000|Overall Study|Physician Decision|1|||
144415910|NCT00598832|520726624|FG001|Overall Study|Physician Decision|4|||
144415911|NCT00598832|520726623|FG000|Overall Study|Non compliance|1|||
144415912|NCT00598832|520726624|FG001|Overall Study|Non compliance|0|||
144415913|NCT00357968|520726629|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
144415914|NCT00357968|520726630|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
144415915|NCT00357968|520726629|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
144415916|NCT00357968|520726630|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
144415917|NCT03919799|520726631|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
144415918|NCT03919799|520726632|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
144415919|NCT03919799|520726633|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
144415920|NCT03919799|520726634|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
144415921|NCT03919799|520726635|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
144415922|NCT03919799|520726631|FG000|DB Period (28 Weeks)|Adverse Event|1|||
144415923|NCT03919799|520726632|FG001|DB Period (28 Weeks)|Adverse Event|1|||
144415924|NCT03919799|520726633|FG002|DB Period (28 Weeks)|Adverse Event|1|||
144415925|NCT03919799|520726634|FG003|DB Period (28 Weeks)|Adverse Event|0|||
144415926|NCT03919799|520726635|FG004|DB Period (28 Weeks)|Adverse Event|0|||
144415927|NCT03919799|520726631|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
144415928|NCT03919799|520726632|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
144415929|NCT03919799|520726633|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
144415930|NCT03919799|520726634|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
144415931|NCT03919799|520726635|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
144415932|NCT03919799|520726631|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
144415933|NCT03919799|520726632|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
144415934|NCT03919799|520726633|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
144415935|NCT03919799|520726634|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
144415936|NCT03919799|520726635|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
144415937|NCT03919799|520726631|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
144415938|NCT03919799|520726632|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
144415939|NCT03919799|520726633|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
144415940|NCT03919799|520726634|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
144415941|NCT03919799|520726635|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
144527296|NCT03701763|521131899|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
144527297|NCT03701763|521131900|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
144415942|NCT02142959|520726636|FG000|Overall Study|Adverse Event|1|||
144415943|NCT02142959|520726637|FG001|Overall Study|Adverse Event|0|||
144415944|NCT02142959|520726638|FG002|Overall Study|Adverse Event|0|||
144415945|NCT02142959|520726636|FG000|Overall Study|Death|0|||
144415946|NCT02142959|520726637|FG001|Overall Study|Death|1|||
144415947|NCT02142959|520726638|FG002|Overall Study|Death|0|||
144415948|NCT02142959|520726636|FG000|Overall Study|Withdrawal by Subject|3|||
144415949|NCT02142959|520726637|FG001|Overall Study|Withdrawal by Subject|1|||
144415950|NCT02142959|520726638|FG002|Overall Study|Withdrawal by Subject|3|||
144415951|NCT02142959|520726636|FG000|Overall Study|Administrative Reasons|1|||
144415952|NCT02142959|520726637|FG001|Overall Study|Administrative Reasons|0|||
144415953|NCT02142959|520726638|FG002|Overall Study|Administrative Reasons|1|||
144415954|NCT02142959|520726636|FG000|Overall Study|Missing|0|||
144415955|NCT02142959|520726637|FG001|Overall Study|Missing|1|||
144415956|NCT02142959|520726638|FG002|Overall Study|Missing|0|||
144415957|NCT02142959|520726636|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
144415958|NCT02142959|520726637|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
144415959|NCT02142959|520726638|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
144415960|NCT02142959|520726636|FG000|Overall Study|Patient didn't complete end of study visit|0|||
144415961|NCT02142959|520726637|FG001|Overall Study|Patient didn't complete end of study visit|0|||
144415962|NCT02142959|520726638|FG002|Overall Study|Patient didn't complete end of study visit|1|||
144415963|NCT03547687|520726639|FG000|Overall Study|Withdrawal by Subject|1|||
144415964|NCT03547687|520726639|FG000|Overall Study|Death|1|||
144415965|NCT00679302|520726640|FG000|Overall Study|Lost to Follow-up|8|||
144415966|NCT00679302|520726641|FG001|Overall Study|Lost to Follow-up|4|||
144415967|NCT00842712|520728021|FG000|Safety Run-in Part|Adverse Event|0|||
144415968|NCT00842712|520728022|FG001|Safety Run-in Part|Adverse Event|1|||
144415969|NCT00842712|520728023|FG002|Safety Run-in Part|Adverse Event|0|||
144415970|NCT00842712|520728024|FG003|Safety Run-in Part|Adverse Event|0|||
144415971|NCT00842712|520728025|FG004|Safety Run-in Part|Adverse Event|0|||
144415972|NCT00842712|520728026|FG005|Safety Run-in Part|Adverse Event|0|||
144415973|NCT00842712|520728027|FG006|Safety Run-in Part|Adverse Event|0|||
144415974|NCT00842712|520728021|FG000|Safety Run-in Part|Progressive disease|3|||
144415975|NCT00842712|520728022|FG001|Safety Run-in Part|Progressive disease|1|||
144415976|NCT00842712|520728023|FG002|Safety Run-in Part|Progressive disease|0|||
144415977|NCT00842712|520728024|FG003|Safety Run-in Part|Progressive disease|1|||
144415978|NCT00842712|520728025|FG004|Safety Run-in Part|Progressive disease|0|||
144415979|NCT00842712|520728026|FG005|Safety Run-in Part|Progressive disease|0|||
144415980|NCT00842712|520728027|FG006|Safety Run-in Part|Progressive disease|0|||
144415981|NCT00842712|520728021|FG000|Randomized Part|Randomized but not treated|0|||
144415982|NCT00842712|520728022|FG001|Randomized Part|Randomized but not treated|0|||
144415983|NCT00842712|520728023|FG002|Randomized Part|Randomized but not treated|0|||
144415984|NCT00842712|520728024|FG003|Randomized Part|Randomized but not treated|0|||
144415985|NCT00842712|520728025|FG004|Randomized Part|Randomized but not treated|0|||
144415986|NCT00842712|520728026|FG005|Randomized Part|Randomized but not treated|1|||
144415987|NCT00842712|520728027|FG006|Randomized Part|Randomized but not treated|4|||
144415988|NCT00842712|520728021|FG000|Randomized Part|Ongoing at cut-off date|0|||
144415989|NCT00842712|520728022|FG001|Randomized Part|Ongoing at cut-off date|0|||
144415990|NCT00842712|520728023|FG002|Randomized Part|Ongoing at cut-off date|0|||
144415991|NCT00842712|520728024|FG003|Randomized Part|Ongoing at cut-off date|0|||
144415992|NCT00842712|520728025|FG004|Randomized Part|Ongoing at cut-off date|0|||
144415993|NCT00842712|520728026|FG005|Randomized Part|Ongoing at cut-off date|0|||
144415994|NCT00842712|520728027|FG006|Randomized Part|Ongoing at cut-off date|2|||
144415995|NCT00410046|520728028|FG000|Overall Study|Adverse Event|3|||
144415996|NCT00410046|520728028|FG000|Overall Study|Withdrawal by Subject|1|||
144415997|NCT00410046|520728028|FG000|Overall Study|Lost to Follow-up|1|||
144415998|NCT01752907|520728029|FG000|Overall Study|Withdrawal by Subject|4|||
144415999|NCT01752907|520728030|FG001|Overall Study|Withdrawal by Subject|10|||
144416000|NCT01752907|520728029|FG000|Overall Study|Lost to Follow-up|2|||
144416001|NCT01752907|520728030|FG001|Overall Study|Lost to Follow-up|1|||
144416002|NCT01752907|520728029|FG000|Overall Study|Decision by Sponsor|6|||
144416003|NCT01752907|520728030|FG001|Overall Study|Decision by Sponsor|9|||
144416004|NCT03098550|520728031|FG000|Overall Study|Disease Progression|30|||
144600955|NCT00448435|521401682|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
144600956|NCT00448435|521401683|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
144600957|NCT04195581|521401686|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
144600958|NCT04195581|521401686|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
144600959|NCT04195581|521401686|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
144600960|NCT04195581|521401686|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
144416005|NCT03098550|520728032|FG001|Overall Study|Disease Progression|19|||
144416006|NCT03098550|520728033|FG002|Overall Study|Disease Progression|41|||
144416007|NCT03098550|520728031|FG000|Overall Study|Study Drug Toxicity|2|||
144416008|NCT03098550|520728032|FG001|Overall Study|Study Drug Toxicity|1|||
144416009|NCT03098550|520728033|FG002|Overall Study|Study Drug Toxicity|0|||
144416010|NCT03098550|520728031|FG000|Overall Study|Death|1|||
144416011|NCT03098550|520728032|FG001|Overall Study|Death|0|||
144416012|NCT03098550|520728033|FG002|Overall Study|Death|0|||
144416013|NCT03098550|520728031|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
144600961|NCT04195581|521401686|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
144416014|NCT03098550|520728032|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
144416015|NCT03098550|520728033|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
144416016|NCT03098550|520728031|FG000|Overall Study|Administrative reason by sponsor|0|||
144416017|NCT03098550|520728032|FG001|Overall Study|Administrative reason by sponsor|0|||
144416018|NCT03098550|520728033|FG002|Overall Study|Administrative reason by sponsor|1|||
144416019|NCT03098550|520728031|FG000|Overall Study|Other reasons|2|||
144416020|NCT03098550|520728032|FG001|Overall Study|Other reasons|0|||
144416021|NCT03098550|520728033|FG002|Overall Study|Other reasons|0|||
144416022|NCT01384760|520728034|FG000|Overall Study|Lost to Follow-up|0|||
144416023|NCT01384760|520728035|FG001|Overall Study|Lost to Follow-up|6|||
144416024|NCT01384760|520728034|FG000|Overall Study|Protocol Violation|16|||
144416025|NCT01384760|520728035|FG001|Overall Study|Protocol Violation|0|||
144416026|NCT00759031|520728044|FG000|First Intervention (1 Day)|Physician Decision|1|||
144416027|NCT00759031|520728045|FG001|First Intervention (1 Day)|Physician Decision|0|||
144250612|NCT00862459|520115557|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
144416028|NCT00759031|520728044|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
144416029|NCT00759031|520728045|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
144416030|NCT00759031|520728044|FG000|First Intervention (1 Day)|Screening failure|1|||
144416031|NCT00759031|520728045|FG001|First Intervention (1 Day)|Screening failure|0|||
144416032|NCT04180488|520728046|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
144416033|NCT04180488|520728047|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
144416034|NCT04180488|520728048|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
144416035|NCT04180488|520728049|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
144416036|NCT04180488|520728050|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
144416037|NCT04180488|520728051|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
144416038|NCT04180488|520728046|FG000|Overall Study|Withdrawal by Subject|8|||
144416039|NCT04180488|520728047|FG001|Overall Study|Withdrawal by Subject|4|||
144416040|NCT04180488|520728048|FG002|Overall Study|Withdrawal by Subject|5|||
144416041|NCT04180488|520728049|FG003|Overall Study|Withdrawal by Subject|2|||
144416042|NCT04180488|520728050|FG004|Overall Study|Withdrawal by Subject|8|||
144416043|NCT04180488|520728051|FG005|Overall Study|Withdrawal by Subject|6|||
144416044|NCT04180488|520728046|FG000|Overall Study|Adverse Event|3|||
144416045|NCT04180488|520728047|FG001|Overall Study|Adverse Event|2|||
144416046|NCT04180488|520728048|FG002|Overall Study|Adverse Event|0|||
144416047|NCT04180488|520728049|FG003|Overall Study|Adverse Event|0|||
144416048|NCT04180488|520728050|FG004|Overall Study|Adverse Event|0|||
144416049|NCT04180488|520728051|FG005|Overall Study|Adverse Event|0|||
144416050|NCT04180488|520728046|FG000|Overall Study|Poor compliance to protocol|0|||
144416051|NCT04180488|520728047|FG001|Overall Study|Poor compliance to protocol|0|||
144416052|NCT04180488|520728048|FG002|Overall Study|Poor compliance to protocol|1|||
144416053|NCT04180488|520728049|FG003|Overall Study|Poor compliance to protocol|0|||
144416054|NCT04180488|520728050|FG004|Overall Study|Poor compliance to protocol|0|||
144416055|NCT04180488|520728051|FG005|Overall Study|Poor compliance to protocol|0|||
144416056|NCT03506815|520728052|FG000|Overall Study|Adverse Event|8|||
144416057|NCT03506815|520728053|FG001|Overall Study|Adverse Event|0|||
144416058|NCT03506815|520728052|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
144416059|NCT03506815|520728053|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
144416060|NCT03506815|520728052|FG000|Overall Study|Protocol Violation|1|||
144416061|NCT03506815|520728053|FG001|Overall Study|Protocol Violation|0|||
144416062|NCT03506815|520728052|FG000|Overall Study|Elective Surgery|1|||
144416063|NCT03506815|520728053|FG001|Overall Study|Elective Surgery|0|||
144416064|NCT02692716|520728054|FG000|Overall Study|Lost to Follow-up|2|||
144416065|NCT02692716|520728055|FG001|Overall Study|Lost to Follow-up|5|||
144416066|NCT02692716|520728054|FG000|Overall Study|Withdrawal by Subject|3|||
144416067|NCT02692716|520728055|FG001|Overall Study|Withdrawal by Subject|1|||
144416068|NCT01327885|520728056|FG000|Overall Study|Disease progression-according to RECIST|173|||
144416069|NCT01327885|520728057|FG001|Overall Study|Disease progression-according to RECIST|165|||
144416070|NCT01327885|520728056|FG000|Overall Study|Clinical progression|24|||
144416071|NCT01327885|520728057|FG001|Overall Study|Clinical progression|27|||
144416072|NCT01327885|520728056|FG000|Overall Study|Adverse Event|14|||
144416073|NCT01327885|520728057|FG001|Overall Study|Adverse Event|10|||
144250613|NCT00862459|520115558|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
144416074|NCT01327885|520728056|FG000|Overall Study|Subject choice|5|||
144416075|NCT01327885|520728057|FG001|Overall Study|Subject choice|10|||
144416076|NCT01327885|520728056|FG000|Overall Study|Other|8|||
144416077|NCT01327885|520728057|FG001|Overall Study|Other|6|||
144250614|NCT00862459|520115556|FG000|Overall Study|Administrative problems|0|||
144250615|NCT00862459|520115557|FG001|Overall Study|Administrative problems|1|||
144416078|NCT01327885|520728056|FG000|Overall Study|Withdrawal of consent from study|3|||
144600962|NCT04195581|521401686|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
144416079|NCT01327885|520728057|FG001|Overall Study|Withdrawal of consent from study|4|||
144416080|NCT01327885|520728056|FG000|Overall Study|Not treated|1|||
144416081|NCT01327885|520728057|FG001|Overall Study|Not treated|1|||
144416082|NCT01327885|520728056|FG000|Overall Study|Administrative decision|0|||
144416083|NCT01327885|520728057|FG001|Overall Study|Administrative decision|1|||
144416084|NCT02511184|520728061|FG000|Overall Study|Death|1|||
144416085|NCT02511184|520728062|FG001|Overall Study|Death|0|||
144416086|NCT02511184|520728061|FG000|Overall Study|Lost to Follow-up|0|||
144416087|NCT02511184|520728062|FG001|Overall Study|Lost to Follow-up|1|||
144416088|NCT02511184|520728061|FG000|Overall Study|Study terminated by sponsor|1|||
144416089|NCT02511184|520728062|FG001|Overall Study|Study terminated by sponsor|5|||
144416090|NCT02511184|520728061|FG000|Overall Study|Withdrawal by Subject|0|||
144416091|NCT02511184|520728062|FG001|Overall Study|Withdrawal by Subject|1|||
144416092|NCT03138889|520728063|FG000|Overall Study|Withdrawal by Subject|5|||
144416093|NCT03138889|520728064|FG001|Overall Study|Withdrawal by Subject|5|||
144416094|NCT03138889|520728065|FG002|Overall Study|Withdrawal by Subject|0|||
144416095|NCT03138889|520728066|FG003|Overall Study|Withdrawal by Subject|2|||
144416096|NCT03138889|520728067|FG004|Overall Study|Withdrawal by Subject|1|||
144416097|NCT03138889|520728068|FG005|Overall Study|Withdrawal by Subject|3|||
144416098|NCT03138889|520728069|FG006|Overall Study|Withdrawal by Subject|0|||
144416099|NCT03138889|520728070|FG007|Overall Study|Withdrawal by Subject|1|||
144416100|NCT00105482|520728071|FG000|Overall Study|Adverse Event|1|||
144416101|NCT00105482|520728072|FG001|Overall Study|Adverse Event|1|||
144416102|NCT00105482|520728071|FG000|Overall Study|Lost to Follow-up|26|||
144416103|NCT00105482|520728072|FG001|Overall Study|Lost to Follow-up|17|||
144416104|NCT00105482|520728071|FG000|Overall Study|Withdrawal by Subject|0|||
144416105|NCT00105482|520728072|FG001|Overall Study|Withdrawal by Subject|1|||
144416106|NCT00105482|520728071|FG000|Overall Study|Lost Interest|29|||
144416107|NCT00105482|520728072|FG001|Overall Study|Lost Interest|32|||
144416108|NCT00105482|520728071|FG000|Overall Study|Scheduling Conflict|2|||
144416109|NCT00105482|520728072|FG001|Overall Study|Scheduling Conflict|3|||
144416110|NCT00105482|520728071|FG000|Overall Study|Withdrawn by PI|1|||
144416111|NCT00105482|520728072|FG001|Overall Study|Withdrawn by PI|1|||
144416112|NCT01349790|520728073|FG000|Overall Study|Investigator Judgement|3|||
144416113|NCT01349790|520728073|FG000|Overall Study|Death|2|||
144416114|NCT01349790|520728073|FG000|Overall Study|Withdrawal by Patient|2|||
144416115|NCT01349790|520728073|FG000|Overall Study|Adverse Event|1|||
144250616|NCT00862459|520115558|FG002|Overall Study|Administrative problems|0|||
144250617|NCT03564795|520115559|FG000|Overall Study|Withdrawal by Subject|3|||
144416116|NCT01349790|520728073|FG000|Overall Study|Lost to Follow-up|1|||
144416117|NCT04016285|520728074|FG000|Overall Study|Did not progress to surgery|2|||
144416118|NCT04016285|520728075|FG001|Overall Study|Did not progress to surgery|5|||
144416119|NCT04016285|520728074|FG000|Overall Study|Failed to collect outcome data|5|||
144416120|NCT04016285|520728075|FG001|Overall Study|Failed to collect outcome data|3|||
144416121|NCT00284050|520728076|FG000|Overall Study|Adverse Event|1|||
144416122|NCT00284050|520728077|FG001|Overall Study|Adverse Event|1|||
144416123|NCT00284050|520728078|FG002|Overall Study|Adverse Event|1|||
144416124|NCT00284050|520728076|FG000|Overall Study|Lack of Efficacy|0|||
144416125|NCT00284050|520728077|FG001|Overall Study|Lack of Efficacy|1|||
144527298|NCT03701763|521131901|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
144527299|NCT03701763|521131898|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
144527300|NCT03701763|521131899|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
144527301|NCT03701763|521131900|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
144527302|NCT03701763|521131901|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
144527303|NCT03701763|521131898|FG000|14-Week Observational Follow-up Phase|Other|0|||
144527304|NCT03701763|521131899|FG001|14-Week Observational Follow-up Phase|Other|0|||
144527305|NCT03701763|521131900|FG002|14-Week Observational Follow-up Phase|Other|1|||
144527306|NCT03701763|521131901|FG003|14-Week Observational Follow-up Phase|Other|0|||
144527307|NCT03701763|521131898|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
144527308|NCT03701763|521131899|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
144527309|NCT03701763|521131900|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
144527310|NCT03701763|521131901|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
144527311|NCT03701763|521131898|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
144527312|NCT03701763|521131899|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
144527313|NCT03701763|521131900|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
144527314|NCT03701763|521131901|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
144416126|NCT00284050|520728078|FG002|Overall Study|Lack of Efficacy|3|||
144416127|NCT00284050|520728076|FG000|Overall Study|Protocol Violation|0|||
144416128|NCT00284050|520728077|FG001|Overall Study|Protocol Violation|1|||
144416129|NCT00284050|520728078|FG002|Overall Study|Protocol Violation|2|||
144416130|NCT00284050|520728076|FG000|Overall Study|Withdrawal by Subject|2|||
144527315|NCT04200456|521131902|FG000|Overall Study|Physician Decision|0|||
144527316|NCT04200456|521131903|FG001|Overall Study|Physician Decision|1|||
144416131|NCT00284050|520728077|FG001|Overall Study|Withdrawal by Subject|2|||
144416132|NCT00284050|520728078|FG002|Overall Study|Withdrawal by Subject|2|||
144416133|NCT00284050|520728076|FG000|Overall Study|Lost to Follow-up|1|||
144416134|NCT00284050|520728077|FG001|Overall Study|Lost to Follow-up|0|||
144416135|NCT00284050|520728078|FG002|Overall Study|Lost to Follow-up|1|||
144416136|NCT00284050|520728076|FG000|Overall Study|Death|1|||
144416137|NCT00284050|520728077|FG001|Overall Study|Death|0|||
144416138|NCT00284050|520728078|FG002|Overall Study|Death|0|||
144416139|NCT02547649|520728081|FG000|Overall Study|Lost to Follow-up|3|||
144416140|NCT02547649|520728082|FG001|Overall Study|Lost to Follow-up|1|||
144416141|NCT02547649|520728083|FG002|Overall Study|Lost to Follow-up|1|||
144416142|NCT02547649|520728081|FG000|Overall Study|Not vaccinated|0|||
144527317|NCT04200456|521131902|FG000|Overall Study|Withdrawal by Subject|2|||
144527318|NCT04200456|521131903|FG001|Overall Study|Withdrawal by Subject|2|||
144527319|NCT04200456|521131902|FG000|Overall Study|Lack of Efficacy|1|||
144527320|NCT04200456|521131903|FG001|Overall Study|Lack of Efficacy|1|||
144527321|NCT04200456|521131902|FG000|Overall Study|Adverse event, non-fatal|0|||
144527322|NCT04200456|521131903|FG001|Overall Study|Adverse event, non-fatal|1|||
144527323|NCT04200456|521131902|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
144527324|NCT04200456|521131903|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
144527325|NCT04068181|521131905|FG000|Overall Study|Death|17|||
144527326|NCT04068181|521131906|FG001|Overall Study|Death|12|||
144527327|NCT04068181|521131907|FG002|Overall Study|Death|4|||
144527328|NCT04068181|521131908|FG003|Overall Study|Death|7|||
144527329|NCT04068181|521131905|FG000|Overall Study|Lost to Follow-up|1|||
144527330|NCT04068181|521131906|FG001|Overall Study|Lost to Follow-up|0|||
144527331|NCT04068181|521131907|FG002|Overall Study|Lost to Follow-up|0|||
144527332|NCT04068181|521131908|FG003|Overall Study|Lost to Follow-up|0|||
144527333|NCT04068181|521131905|FG000|Overall Study|Withdrawal of consent from study|3|||
144527334|NCT04068181|521131906|FG001|Overall Study|Withdrawal of consent from study|0|||
144527335|NCT04068181|521131907|FG002|Overall Study|Withdrawal of consent from study|0|||
144527336|NCT04068181|521131908|FG003|Overall Study|Withdrawal of consent from study|0|||
144527337|NCT03785964|521131911|FG000|Overall Study|Adverse Event|14|||
144527338|NCT03785964|521131912|FG001|Overall Study|Adverse Event|1|||
144527339|NCT03785964|521131911|FG000|Overall Study|Unqualified Clinical Progression|1|||
144527340|NCT03785964|521131912|FG001|Overall Study|Unqualified Clinical Progression|1|||
144527341|NCT03785964|521131911|FG000|Overall Study|Participant non-compliance|1|||
144527342|NCT03785964|521131912|FG001|Overall Study|Participant non-compliance|1|||
144527343|NCT03785964|521131911|FG000|Overall Study|Not treated|1|||
144527344|NCT03785964|521131912|FG001|Overall Study|Not treated|0|||
144527345|NCT03785964|521131911|FG000|Overall Study|Other reason|5|||
144527346|NCT03785964|521131912|FG001|Overall Study|Other reason|11|||
144527347|NCT03785964|521131911|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
144527348|NCT03785964|521131912|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
144527349|NCT02723591|521131913|FG000|Overall Study|Adverse Event|48|||
144527350|NCT02723591|521131914|FG001|Overall Study|Adverse Event|40|||
144723147|NCT03504852|521840641|FG000|Overall Study|Withdrawal of informed consent|2|||
144723148|NCT03504852|521840642|FG001|Overall Study|Withdrawal of informed consent|1|||
144416143|NCT02547649|520728082|FG001|Overall Study|Not vaccinated|0|||
144416144|NCT02547649|520728083|FG002|Overall Study|Not vaccinated|1|||
144416145|NCT02547649|520728081|FG000|Overall Study|Withdrawal by Subject|0|||
144416146|NCT02547649|520728082|FG001|Overall Study|Withdrawal by Subject|4|||
144527351|NCT02723591|521131913|FG000|Overall Study|Death|2|||
144527352|NCT02723591|521131914|FG001|Overall Study|Death|2|||
144527353|NCT02723591|521131913|FG000|Overall Study|Lack of Efficacy|4|||
144527354|NCT02723591|521131914|FG001|Overall Study|Lack of Efficacy|3|||
144527355|NCT02723591|521131913|FG000|Overall Study|Lost to Follow-up|1|||
144527356|NCT02723591|521131914|FG001|Overall Study|Lost to Follow-up|7|||
144527357|NCT02723591|521131913|FG000|Overall Study|Protocol Violation|20|||
144527358|NCT02723591|521131914|FG001|Overall Study|Protocol Violation|23|||
144527359|NCT02723591|521131913|FG000|Overall Study|Withdrawal by Subject|4|||
144527360|NCT02723591|521131914|FG001|Overall Study|Withdrawal by Subject|8|||
144527361|NCT02723591|521131913|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
144527362|NCT02723591|521131914|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
144527363|NCT02723591|521131913|FG000|Overall Study|Miscellaneous|5|||
144416147|NCT02547649|520728083|FG002|Overall Study|Withdrawal by Subject|2|||
144416148|NCT01750242|520728086|FG000|Overall Study|Unreadable Images|3|||
144416149|NCT03765918|520728087|FG000|Overall Study|Death|109|||
144416150|NCT03765918|520728088|FG001|Overall Study|Death|127|||
144416151|NCT03765918|520728087|FG000|Overall Study|Lost to Follow-up|2|||
144416152|NCT03765918|520728088|FG001|Overall Study|Lost to Follow-up|3|||
144416153|NCT03765918|520728087|FG000|Overall Study|Withdrawal by Subject|12|||
144416154|NCT03765918|520728088|FG001|Overall Study|Withdrawal by Subject|16|||
144416155|NCT03765918|520728087|FG000|Overall Study|Participants Ongoing|240|||
144416156|NCT03765918|520728088|FG001|Overall Study|Participants Ongoing|205|||
144416157|NCT04202965|520728089|FG000|Overall Study|Adverse Event|3|||
144416158|NCT04202965|520728089|FG000|Overall Study|Did not meet inclusion criteria|1|||
144416159|NCT00006903|520728090|FG000|Overall Study|Still receiving treatment|0|||
144416160|NCT00006903|520728091|FG001|Overall Study|Still receiving treatment|0|||
144416161|NCT00006903|520728092|FG002|Overall Study|Still receiving treatment|1|||
144416162|NCT00006903|520728090|FG000|Overall Study|Refused further treatment|0|||
144416163|NCT00006903|520728091|FG001|Overall Study|Refused further treatment|2|||
144416164|NCT00006903|520728092|FG002|Overall Study|Refused further treatment|1|||
144416165|NCT00006903|520728090|FG000|Overall Study|Adverse Event|0|||
144416166|NCT00006903|520728091|FG001|Overall Study|Adverse Event|0|||
144416167|NCT00006903|520728092|FG002|Overall Study|Adverse Event|1|||
144416168|NCT00006903|520728090|FG000|Overall Study|Death|0|||
144416169|NCT00006903|520728091|FG001|Overall Study|Death|1|||
144416170|NCT00006903|520728092|FG002|Overall Study|Death|0|||
144416171|NCT00006903|520728090|FG000|Overall Study|Patient never treated|0|||
144416172|NCT00006903|520728091|FG001|Overall Study|Patient never treated|0|||
144416173|NCT00006903|520728092|FG002|Overall Study|Patient never treated|1|||
144416174|NCT00006903|520728090|FG000|Overall Study|Ineligible|10|||
144416175|NCT00006903|520728091|FG001|Overall Study|Ineligible|1|||
144416176|NCT00006903|520728092|FG002|Overall Study|Ineligible|2|||
144416177|NCT01909674|520728093|FG000|Overall Study|Withdrawal by Subject|5|||
144416178|NCT01909674|520728094|FG001|Overall Study|Withdrawal by Subject|2|||
144416179|NCT01169493|520728100|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
144416180|NCT01169493|520728101|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
144416181|NCT01169493|520728102|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
144416182|NCT01169493|520728103|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
144416183|NCT01169493|520728104|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
144416184|NCT01169493|520728105|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
144416185|NCT01169493|520728100|FG000|Period 3 (6 Months)|Adverse Event|0|||
144416186|NCT01169493|520728101|FG001|Period 3 (6 Months)|Adverse Event|1|||
144416187|NCT01169493|520728102|FG002|Period 3 (6 Months)|Adverse Event|0|||
144416188|NCT01169493|520728103|FG003|Period 3 (6 Months)|Adverse Event|0|||
144416189|NCT01169493|520728104|FG004|Period 3 (6 Months)|Adverse Event|0|||
144416190|NCT01169493|520728105|FG005|Period 3 (6 Months)|Adverse Event|0|||
144416191|NCT01169493|520728100|FG000|Period 3 (6 Months)|Physician Decision|0|||
144416192|NCT01169493|520728101|FG001|Period 3 (6 Months)|Physician Decision|1|||
144416193|NCT01169493|520728102|FG002|Period 3 (6 Months)|Physician Decision|1|||
144416194|NCT01169493|520728103|FG003|Period 3 (6 Months)|Physician Decision|0|||
144416195|NCT01169493|520728104|FG004|Period 3 (6 Months)|Physician Decision|0|||
144416196|NCT01169493|520728105|FG005|Period 3 (6 Months)|Physician Decision|0|||
144416197|NCT03167411|520728106|FG000|Overall Study|Adverse Event|0|||
144416198|NCT03167411|520728107|FG001|Overall Study|Adverse Event|1|||
144416199|NCT02651922|520728114|FG000|Overall Study|due to exclusion criteria|2|||
144416200|NCT02557646|520728115|FG000|Overall Study|Adverse Event|40|||
144416201|NCT02557646|520728115|FG000|Overall Study|Death|1|||
144416202|NCT02557646|520728115|FG000|Overall Study|Lack of Efficacy|186|||
144416203|NCT02557646|520728115|FG000|Overall Study|Withdrawal by Subject|18|||
144416204|NCT02557646|520728115|FG000|Overall Study|Lost to Follow-up|17|||
144416205|NCT02557646|520728115|FG000|Overall Study|Other|14|||
144416206|NCT01217814|520728116|FG000|Overall Study|Adverse Event|1|||
144416207|NCT01217814|520728117|FG001|Overall Study|Adverse Event|1|||
144416208|NCT01217814|520728118|FG002|Overall Study|Adverse Event|0|||
144416209|NCT01217814|520728116|FG000|Overall Study|Lack of Efficacy|0|||
144416210|NCT01217814|520728117|FG001|Overall Study|Lack of Efficacy|0|||
144416211|NCT01217814|520728118|FG002|Overall Study|Lack of Efficacy|1|||
144416212|NCT01482884|520728125|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
144416213|NCT01482884|520728126|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
144416214|NCT01482884|520728125|FG000|Overall Study|Protocol Violation|1|||
144416215|NCT01482884|520728126|FG001|Overall Study|Protocol Violation|0|||
144416216|NCT01482884|520728125|FG000|Overall Study|Lost to Follow-up|2|||
144416217|NCT01482884|520728126|FG001|Overall Study|Lost to Follow-up|2|||
144416218|NCT01482884|520728125|FG000|Overall Study|Lack of Efficacy|0|||
144416219|NCT01482884|520728126|FG001|Overall Study|Lack of Efficacy|1|||
144416220|NCT01482884|520728125|FG000|Overall Study|Adverse Event|2|||
144416221|NCT01482884|520728126|FG001|Overall Study|Adverse Event|1|||
144416222|NCT01482884|520728125|FG000|Overall Study|Withdrawal by Subject|8|||
144416223|NCT01482884|520728126|FG001|Overall Study|Withdrawal by Subject|13|||
144416224|NCT00439244|520728129|FG000|Overall Study|Adverse Event|5|||
144416225|NCT00439244|520728130|FG001|Overall Study|Adverse Event|2|||
144416226|NCT00439244|520728131|FG002|Overall Study|Adverse Event|3|||
144416227|NCT00439244|520728129|FG000|Overall Study|Withdrawal by Subject|3|||
144416228|NCT00439244|520728130|FG001|Overall Study|Withdrawal by Subject|1|||
144416229|NCT00439244|520728131|FG002|Overall Study|Withdrawal by Subject|2|||
144416230|NCT00439244|520728129|FG000|Overall Study|Lost to Follow-up|2|||
144416231|NCT00439244|520728130|FG001|Overall Study|Lost to Follow-up|1|||
144416232|NCT00439244|520728131|FG002|Overall Study|Lost to Follow-up|2|||
144416233|NCT00439244|520728129|FG000|Overall Study|Death|0|||
144416234|NCT00439244|520728130|FG001|Overall Study|Death|1|||
144416235|NCT00439244|520728131|FG002|Overall Study|Death|0|||
144416236|NCT00439244|520728129|FG000|Overall Study|Protocol Violation|0|||
144416237|NCT00439244|520728130|FG001|Overall Study|Protocol Violation|1|||
144416238|NCT00439244|520728131|FG002|Overall Study|Protocol Violation|0|||
144416239|NCT00439244|520728129|FG000|Overall Study|Administrative problems|1|||
144416240|NCT00439244|520728130|FG001|Overall Study|Administrative problems|0|||
144416241|NCT00439244|520728131|FG002|Overall Study|Administrative problems|0|||
144416242|NCT01753856|520728132|FG000|Overall Study|Adverse Event|1|||
144416243|NCT01753856|520728133|FG001|Overall Study|Adverse Event|0|||
144416244|NCT01753856|520728132|FG000|Overall Study|Withdrawal by Subject|0|||
144416245|NCT01753856|520728133|FG001|Overall Study|Withdrawal by Subject|2|||
144416246|NCT01753856|520728132|FG000|Overall Study|Sponsor Decision|2|||
144416247|NCT01753856|520728133|FG001|Overall Study|Sponsor Decision|0|||
144416248|NCT01774968|520728136|FG000|Overall Study|Adverse Event|4|||
144416249|NCT01774968|520728137|FG001|Overall Study|Adverse Event|4|||
144416250|NCT01774968|520728136|FG000|Overall Study|Death|0|||
144416251|NCT01774968|520728137|FG001|Overall Study|Death|1|||
144416252|NCT01774968|520728136|FG000|Overall Study|Lost to Follow-up|1|||
144416253|NCT01774968|520728137|FG001|Overall Study|Lost to Follow-up|3|||
144416254|NCT01774968|520728136|FG000|Overall Study|Physician Decision|5|||
144416255|NCT01774968|520728137|FG001|Overall Study|Physician Decision|1|||
144416256|NCT01774968|520728136|FG000|Overall Study|Protocol Violation|14|||
144416257|NCT01774968|520728137|FG001|Overall Study|Protocol Violation|13|||
144416258|NCT01774968|520728136|FG000|Overall Study|Sponsor Decision|0|||
144416259|NCT01774968|520728137|FG001|Overall Study|Sponsor Decision|2|||
144416260|NCT01774968|520728136|FG000|Overall Study|Withdrawal by Subject|6|||
144416261|NCT01774968|520728137|FG001|Overall Study|Withdrawal by Subject|11|||
144416262|NCT04600921|520728140|FG000|Overall Study|Withdrawal by Subject|3|||
144416263|NCT04600921|520728141|FG001|Overall Study|Withdrawal by Subject|5|||
144416264|NCT04600921|520728140|FG000|Overall Study|Death|0|||
144416265|NCT04600921|520728141|FG001|Overall Study|Death|1|||
144416266|NCT04847557|520728142|FG000|Overall Study|Adverse Event|1|||
144416267|NCT04847557|520728143|FG001|Overall Study|Adverse Event|0|||
144416268|NCT04847557|520728142|FG000|Overall Study|Death|19|||
144416269|NCT04847557|520728143|FG001|Overall Study|Death|15|||
144416270|NCT04847557|520728142|FG000|Overall Study|Lost to Follow-up|3|||
144416271|NCT04847557|520728143|FG001|Overall Study|Lost to Follow-up|6|||
144416272|NCT04847557|520728142|FG000|Overall Study|Physician Decision|1|||
144416273|NCT04847557|520728143|FG001|Overall Study|Physician Decision|0|||
144416274|NCT04847557|520728142|FG000|Overall Study|Protocol Violation|0|||
144416275|NCT04847557|520728143|FG001|Overall Study|Protocol Violation|1|||
144416276|NCT04847557|520728142|FG000|Overall Study|Withdrawal by Subject|8|||
144416277|NCT04847557|520728143|FG001|Overall Study|Withdrawal by Subject|14|||
144416278|NCT00793598|520730167|FG000|Overall Study|Patient Request|0|||
144416279|NCT00793598|520730168|FG001|Overall Study|Patient Request|1|||
144416280|NCT00793598|520730169|FG002|Overall Study|Patient Request|0|||
144416281|NCT00793598|520730170|FG003|Overall Study|Patient Request|0|||
144416282|NCT00793598|520730171|FG004|Overall Study|Patient Request|0|||
144416283|NCT00793598|520730172|FG005|Overall Study|Patient Request|0|||
144416284|NCT00793598|520730173|FG006|Overall Study|Patient Request|0|||
144416285|NCT00793598|520730174|FG007|Overall Study|Patient Request|0|||
144416286|NCT00793598|520730167|FG000|Overall Study|Protocol Violation|0|||
144416287|NCT00793598|520730168|FG001|Overall Study|Protocol Violation|0|||
144416288|NCT00793598|520730169|FG002|Overall Study|Protocol Violation|0|||
144416289|NCT00793598|520730170|FG003|Overall Study|Protocol Violation|0|||
144416290|NCT00793598|520730171|FG004|Overall Study|Protocol Violation|0|||
144416291|NCT00793598|520730172|FG005|Overall Study|Protocol Violation|0|||
144416292|NCT00793598|520730173|FG006|Overall Study|Protocol Violation|0|||
144416293|NCT00793598|520730174|FG007|Overall Study|Protocol Violation|1|||
144416294|NCT00793598|520730167|FG000|Overall Study|Subject not dosed|0|||
144416295|NCT00793598|520730168|FG001|Overall Study|Subject not dosed|0|||
144416296|NCT00793598|520730169|FG002|Overall Study|Subject not dosed|0|||
144416297|NCT00793598|520730170|FG003|Overall Study|Subject not dosed|0|||
144416298|NCT00793598|520730171|FG004|Overall Study|Subject not dosed|0|||
144416299|NCT00793598|520730172|FG005|Overall Study|Subject not dosed|1|||
144416300|NCT00793598|520730173|FG006|Overall Study|Subject not dosed|0|||
144416301|NCT00793598|520730174|FG007|Overall Study|Subject not dosed|0|||
144416302|NCT02762266|520730175|FG000|Overall Study|Physician Decision|2|||
144416303|NCT02762266|520730176|FG001|Overall Study|Physician Decision|0|||
144416304|NCT02961751|520730181|FG000|Overall Study|Lost to Follow-up|11|||
144416305|NCT02961751|520730181|FG000|Overall Study|Physician Decision|2|||
144416306|NCT02961751|520730181|FG000|Overall Study|Not Eligible at Enrollment|1|||
144416307|NCT02961751|520730181|FG000|Overall Study|Protocol Violation|1|||
144416308|NCT03909295|520730182|FG000|Overall Study|Adverse Event|2|||
144416309|NCT03909295|520730182|FG000|Overall Study|Study terminated by sponsor|50|||
144416310|NCT03312933|520730189|FG000|Overall Study|Protocol Violation|15|||
144416311|NCT03312933|520730189|FG000|Overall Study|Lost to Follow-up|36|||
144416312|NCT03312933|520730189|FG000|Overall Study|Withdrawal by Subject|3|||
144416313|NCT02310568|520730190|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
144416314|NCT02310568|520730191|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
144416315|NCT02310568|520730192|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
144416316|NCT02310568|520730193|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
144416317|NCT02310568|520730194|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
144416318|NCT02310568|520730190|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
144416319|NCT02310568|520730191|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
144416320|NCT02310568|520730192|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
144416321|NCT02310568|520730193|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
144416322|NCT02310568|520730194|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
144416323|NCT02310568|520730190|FG000|Stage 1 ( 4 Weeks)|Other|1|||
144416324|NCT02310568|520730191|FG001|Stage 1 ( 4 Weeks)|Other|1|||
144416325|NCT02310568|520730192|FG002|Stage 1 ( 4 Weeks)|Other|0|||
144416326|NCT02310568|520730193|FG003|Stage 1 ( 4 Weeks)|Other|0|||
144416327|NCT02310568|520730194|FG004|Stage 1 ( 4 Weeks)|Other|0|||
144416328|NCT02310568|520730190|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
144416329|NCT02310568|520730191|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
144416330|NCT02310568|520730192|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
144416331|NCT02310568|520730193|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
144416332|NCT02310568|520730194|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
144416333|NCT02310568|520730190|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
144416334|NCT02310568|520730191|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
144416335|NCT02310568|520730192|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
144416336|NCT02310568|520730193|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
144416337|NCT02310568|520730194|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
144416338|NCT02310568|520730190|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
144416339|NCT02310568|520730191|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
144416340|NCT02310568|520730192|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
144416341|NCT02310568|520730193|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
144416342|NCT02310568|520730194|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
144416343|NCT02310568|520730190|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
144416344|NCT02310568|520730191|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
144416345|NCT02310568|520730192|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
144416346|NCT02310568|520730193|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
144416347|NCT02310568|520730194|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
144416348|NCT02310568|520730190|FG000|Stage 2 (4 Weeks)|Other|0|||
144416349|NCT02310568|520730191|FG001|Stage 2 (4 Weeks)|Other|1|||
144416350|NCT02310568|520730192|FG002|Stage 2 (4 Weeks)|Other|1|||
144416351|NCT02310568|520730193|FG003|Stage 2 (4 Weeks)|Other|0|||
144416352|NCT02310568|520730194|FG004|Stage 2 (4 Weeks)|Other|0|||
144416353|NCT02310568|520730190|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
144416354|NCT02310568|520730191|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
144416355|NCT02310568|520730192|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
144416356|NCT02310568|520730193|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
144416357|NCT02310568|520730194|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
144416358|NCT02310568|520730190|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
144416359|NCT02310568|520730191|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
144416360|NCT02310568|520730192|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
144416361|NCT02310568|520730193|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
144416362|NCT02310568|520730194|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
144416363|NCT02310568|520730190|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
144416364|NCT02310568|520730191|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
144416365|NCT02310568|520730192|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
144416366|NCT02310568|520730193|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
144416367|NCT02310568|520730194|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
144416368|NCT02990910|520730197|FG000|Overall Study|Lack of Efficacy|6|||
144416369|NCT02990910|520730198|FG001|Overall Study|Lack of Efficacy|10|||
144416370|NCT02989194|520730204|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
144527364|NCT02723591|521131914|FG001|Overall Study|Miscellaneous|6|||
144723149|NCT03504852|521840643|FG002|Overall Study|Withdrawal of informed consent|0|||
144416371|NCT02989194|520730205|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
144416372|NCT02989194|520730206|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
144416373|NCT02989194|520730204|FG000|Overall Study|Lost to Follow-up|0|||
144416374|NCT02989194|520730205|FG001|Overall Study|Lost to Follow-up|1|||
144416375|NCT02989194|520730206|FG002|Overall Study|Lost to Follow-up|0|||
144416376|NCT02989194|520730204|FG000|Overall Study|Withdrawal by Subject|0|||
144416377|NCT02989194|520730205|FG001|Overall Study|Withdrawal by Subject|1|||
144416378|NCT02989194|520730206|FG002|Overall Study|Withdrawal by Subject|0|||
144416379|NCT01549860|520730208|FG000|Overall Study|Withdrawal by Subject|1|||
144416380|NCT01549860|520730209|FG001|Overall Study|Withdrawal by Subject|0|||
144416381|NCT01549860|520730208|FG000|Overall Study|Physician Decision|1|||
144416382|NCT01549860|520730209|FG001|Overall Study|Physician Decision|1|||
144416383|NCT01366521|520730210|FG000|Overall Study|Adverse Event|1|||
144416384|NCT01366521|520730211|FG001|Overall Study|Adverse Event|0|||
144416385|NCT01366521|520730212|FG002|Overall Study|Adverse Event|0|||
144416386|NCT01366521|520730213|FG003|Overall Study|Adverse Event|0|||
144416387|NCT01366521|520730210|FG000|Overall Study|Protocol Violation|0|||
144416388|NCT01366521|520730211|FG001|Overall Study|Protocol Violation|0|||
144416389|NCT01366521|520730212|FG002|Overall Study|Protocol Violation|1|||
144723150|NCT03504852|521840641|FG000|Overall Study|Withdrawal by Subject|5|||
144723151|NCT03504852|521840642|FG001|Overall Study|Withdrawal by Subject|5|||
144723152|NCT03504852|521840643|FG002|Overall Study|Withdrawal by Subject|1|||
144723153|NCT03504852|521840641|FG000|Overall Study|Lost to Follow-up|4|||
144416390|NCT01366521|520730213|FG003|Overall Study|Protocol Violation|0|||
144416391|NCT01366521|520730210|FG000|Overall Study|Physician Decision|0|||
144416392|NCT01366521|520730211|FG001|Overall Study|Physician Decision|0|||
144416393|NCT01366521|520730212|FG002|Overall Study|Physician Decision|1|||
144416394|NCT01366521|520730213|FG003|Overall Study|Physician Decision|0|||
144416395|NCT01366521|520730210|FG000|Overall Study|Withdrawal by Subject|0|||
144416396|NCT01366521|520730211|FG001|Overall Study|Withdrawal by Subject|1|||
144416397|NCT01366521|520730212|FG002|Overall Study|Withdrawal by Subject|0|||
144416398|NCT01366521|520730213|FG003|Overall Study|Withdrawal by Subject|0|||
144416399|NCT00660023|520730214|FG000|Overall Study|Adverse Event|2|||
144723154|NCT03504852|521840642|FG001|Overall Study|Lost to Follow-up|1|||
144723155|NCT03504852|521840643|FG002|Overall Study|Lost to Follow-up|0|||
144723156|NCT03504852|521840641|FG000|Overall Study|New therapy for study indication|1|||
144723157|NCT03504852|521840642|FG001|Overall Study|New therapy for study indication|0|||
144416400|NCT00660023|520730214|FG000|Overall Study|Death|8|||
144416401|NCT00660023|520730214|FG000|Overall Study|Blood Transfusion|5|||
144416402|NCT00660023|520730214|FG000|Overall Study|Renal Transplantation|3|||
144416403|NCT00660023|520730214|FG000|Overall Study|Withdrawal by Subject|1|||
144600963|NCT00821431|521401687|FG000|Overall Study|Adverse Event|6|||
144416404|NCT00660023|520730214|FG000|Overall Study|Missed Pregnancy Test|1|||
144416405|NCT00660023|520730214|FG000|Overall Study|Other Screening Failure|9|||
144416406|NCT02899988|520730219|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
144416407|NCT02899988|520730220|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
144416408|NCT02899988|520730221|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416409|NCT02899988|520730222|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416410|NCT02899988|520730223|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416411|NCT02899988|520730224|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416412|NCT02899988|520730225|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416413|NCT02899988|520730226|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416414|NCT02899988|520730227|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416415|NCT02899988|520730228|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416416|NCT02899988|520730229|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144416417|NCT02899988|520730219|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
144416418|NCT02899988|520730220|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
144416419|NCT02899988|520730221|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
144416420|NCT02899988|520730222|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
144416421|NCT02899988|520730223|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
144416422|NCT02899988|520730224|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
144416423|NCT02899988|520730225|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
144416424|NCT02899988|520730226|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
144416425|NCT02899988|520730227|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
144416426|NCT02899988|520730228|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
144416427|NCT02899988|520730229|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
144416428|NCT02899988|520730219|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
144416429|NCT02899988|520730220|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
144416430|NCT02899988|520730221|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
144416431|NCT02899988|520730222|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
144416432|NCT02899988|520730223|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
144416433|NCT02899988|520730224|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
144416434|NCT02899988|520730225|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
144416435|NCT02899988|520730226|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
144416436|NCT02899988|520730227|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
144416437|NCT02899988|520730228|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
144416438|NCT02899988|520730229|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
144416439|NCT02899988|520730219|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
144416440|NCT02899988|520730220|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
144416441|NCT02899988|520730221|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
144416442|NCT02899988|520730222|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
144416443|NCT02899988|520730223|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
144416444|NCT02899988|520730224|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
144416445|NCT02899988|520730225|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
144416446|NCT02899988|520730226|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
144416447|NCT02899988|520730227|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
144416448|NCT02899988|520730228|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
144416449|NCT02899988|520730229|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
144416450|NCT02899988|520730219|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416451|NCT02899988|520730220|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416452|NCT02899988|520730221|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416453|NCT02899988|520730222|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416454|NCT02899988|520730223|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416455|NCT02899988|520730224|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
144416456|NCT02899988|520730225|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416457|NCT02899988|520730226|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
144416458|NCT02899988|520730227|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416459|NCT02899988|520730228|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416460|NCT02899988|520730229|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
144416461|NCT02899988|520730219|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
144416462|NCT02899988|520730220|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
144416463|NCT02899988|520730221|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
144416464|NCT02899988|520730222|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
144416465|NCT02899988|520730223|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
144416466|NCT02899988|520730224|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
144416467|NCT02899988|520730225|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
144416468|NCT02899988|520730226|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
144416469|NCT02899988|520730227|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
144416470|NCT02899988|520730228|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
144416471|NCT02899988|520730229|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
144600964|NCT00821431|521401688|FG001|Overall Study|Adverse Event|3|||
144600965|NCT00821431|521401687|FG000|Overall Study|Withdrawal by Subject|5|||
144416472|NCT00856284|520730234|FG000|Overall Study|Hyperglycemic rescue|231|||
144416473|NCT00856284|520730235|FG001|Overall Study|Hyperglycemic rescue|201|||
144416474|NCT00856284|520730236|FG002|Overall Study|Hyperglycemic rescue|235|||
144416475|NCT00856284|520730234|FG000|Overall Study|Adverse Event|60|||
144416476|NCT00856284|520730235|FG001|Overall Study|Adverse Event|74|||
144416477|NCT00856284|520730236|FG002|Overall Study|Adverse Event|82|||
144416478|NCT00856284|520730234|FG000|Overall Study|Major protocol deviation|24|||
144416479|NCT00856284|520730235|FG001|Overall Study|Major protocol deviation|16|||
144416480|NCT00856284|520730236|FG002|Overall Study|Major protocol deviation|15|||
144416481|NCT00856284|520730234|FG000|Overall Study|Lost to Follow-up|20|||
144416482|NCT00856284|520730235|FG001|Overall Study|Lost to Follow-up|22|||
144416483|NCT00856284|520730236|FG002|Overall Study|Lost to Follow-up|28|||
144416484|NCT00856284|520730234|FG000|Overall Study|Voluntary withdrawal|48|||
144416485|NCT00856284|520730235|FG001|Overall Study|Voluntary withdrawal|52|||
144416486|NCT00856284|520730236|FG002|Overall Study|Voluntary withdrawal|62|||
144416487|NCT00856284|520730234|FG000|Overall Study|Pregnancy|1|||
144416488|NCT00856284|520730235|FG001|Overall Study|Pregnancy|2|||
144416489|NCT00856284|520730236|FG002|Overall Study|Pregnancy|0|||
144416490|NCT00856284|520730234|FG000|Overall Study|Investigator discretion|9|||
144416491|NCT00856284|520730235|FG001|Overall Study|Investigator discretion|8|||
144416492|NCT00856284|520730236|FG002|Overall Study|Investigator discretion|10|||
144416493|NCT00856284|520730234|FG000|Overall Study|Other|15|||
144416494|NCT00856284|520730235|FG001|Overall Study|Other|17|||
144416495|NCT00856284|520730236|FG002|Overall Study|Other|14|||
144416496|NCT00856284|520730234|FG000|Overall Study|Randomized in error|0|||
144416497|NCT00856284|520730235|FG001|Overall Study|Randomized in error|0|||
144416498|NCT00856284|520730236|FG002|Overall Study|Randomized in error|1|||
144416499|NCT03824912|520730243|FG000|Overall Study|Lost to Follow-up|18|||
144416500|NCT03824912|520730244|FG001|Overall Study|Lost to Follow-up|15|||
144416501|NCT03824912|520730245|FG002|Overall Study|Lost to Follow-up|8|||
144416502|NCT03824912|520730243|FG000|Overall Study|Negative Baseline Culture Result|118|||
144416503|NCT03824912|520730244|FG001|Overall Study|Negative Baseline Culture Result|112|||
144416504|NCT03824912|520730245|FG002|Overall Study|Negative Baseline Culture Result|57|||
144416505|NCT03824912|520730243|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144416506|NCT03824912|520730244|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144416507|NCT03824912|520730245|FG002|Overall Study|Non-Compliance with Study Drug|1|||
144416508|NCT03824912|520730243|FG000|Overall Study|Protocol Violation|1|||
144416509|NCT03824912|520730244|FG001|Overall Study|Protocol Violation|4|||
144416510|NCT03824912|520730245|FG002|Overall Study|Protocol Violation|1|||
144416511|NCT03824912|520730243|FG000|Overall Study|Withdrawal by Subject|3|||
144416512|NCT03824912|520730244|FG001|Overall Study|Withdrawal by Subject|2|||
144416513|NCT03824912|520730245|FG002|Overall Study|Withdrawal by Subject|1|||
144416514|NCT03824912|520730243|FG000|Overall Study|Participation in another study|0|||
144416515|NCT03824912|520730244|FG001|Overall Study|Participation in another study|1|||
144416516|NCT03824912|520730245|FG002|Overall Study|Participation in another study|0|||
144416517|NCT04271605|520730246|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
144416518|NCT01059825|520730250|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
144416519|NCT01059825|520730251|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
144416520|NCT01059825|520730252|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
144416521|NCT01059825|520730253|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
144416522|NCT01059825|520730254|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
144416523|NCT01059825|520730255|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
144416524|NCT01059825|520730256|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
144416525|NCT01059825|520730250|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
144416526|NCT01059825|520730251|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
144250618|NCT03564795|520115559|FG000|Overall Study|Lost to Follow-up|6|||
144250619|NCT03564795|520115559|FG000|Overall Study|Physician Decision|2|||
144250620|NCT01333956|520115564|FG000|Overall Study|Lost to Follow-up|1|||
144250621|NCT01333956|520115565|FG001|Overall Study|Lost to Follow-up|2|||
144250622|NCT01333956|520115566|FG002|Overall Study|Lost to Follow-up|0|||
144250623|NCT01333956|520115567|FG003|Overall Study|Lost to Follow-up|1|||
144250624|NCT01333956|520115564|FG000|Overall Study|Unable to complete study procedure|1|||
144416527|NCT01059825|520730252|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
144416528|NCT01059825|520730253|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
144416529|NCT01059825|520730254|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
144416530|NCT01059825|520730255|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
144416531|NCT01059825|520730256|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
144416532|NCT01059825|520730250|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
144416533|NCT01059825|520730251|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
144416534|NCT01059825|520730252|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
144416535|NCT01059825|520730253|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
144250625|NCT01333956|520115565|FG001|Overall Study|Unable to complete study procedure|0|||
144250626|NCT01333956|520115566|FG002|Overall Study|Unable to complete study procedure|0|||
144416536|NCT01059825|520730254|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
144416537|NCT01059825|520730255|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
144416538|NCT01059825|520730256|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
144416539|NCT01059825|520730250|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
144416540|NCT01059825|520730251|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
144416541|NCT01059825|520730252|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
144416542|NCT01059825|520730253|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
144416543|NCT01059825|520730254|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
144250627|NCT01333956|520115567|FG003|Overall Study|Unable to complete study procedure|1|||
144416544|NCT01059825|520730255|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
144416545|NCT01059825|520730256|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
144416546|NCT01059825|520730250|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
144416547|NCT01059825|520730251|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
144416548|NCT01059825|520730252|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
144416549|NCT01059825|520730253|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
144416550|NCT01059825|520730254|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
144416551|NCT01059825|520730255|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
144416552|NCT01059825|520730256|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
144416553|NCT01059825|520730250|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
144416554|NCT01059825|520730251|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
144416555|NCT01059825|520730252|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
144416556|NCT01059825|520730253|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
144416557|NCT01059825|520730254|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
144416558|NCT01059825|520730255|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
144416559|NCT01059825|520730256|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
144416560|NCT01059825|520730250|FG000|Treatment Period|Lost to Follow-up|2|||
144416561|NCT01059825|520730251|FG001|Treatment Period|Lost to Follow-up|1|||
144416562|NCT01059825|520730252|FG002|Treatment Period|Lost to Follow-up|0|||
144416563|NCT01059825|520730253|FG003|Treatment Period|Lost to Follow-up|1|||
144416564|NCT01059825|520730254|FG004|Treatment Period|Lost to Follow-up|2|||
144416565|NCT01059825|520730255|FG005|Treatment Period|Lost to Follow-up|0|||
144416566|NCT01059825|520730256|FG006|Treatment Period|Lost to Follow-up|0|||
144416567|NCT01059825|520730250|FG000|Treatment Period|Withdrawal by Subject|3|||
144416568|NCT01059825|520730251|FG001|Treatment Period|Withdrawal by Subject|0|||
144416569|NCT01059825|520730252|FG002|Treatment Period|Withdrawal by Subject|1|||
144416570|NCT01059825|520730253|FG003|Treatment Period|Withdrawal by Subject|5|||
144416571|NCT01059825|520730254|FG004|Treatment Period|Withdrawal by Subject|4|||
144416572|NCT01059825|520730255|FG005|Treatment Period|Withdrawal by Subject|1|||
144416573|NCT01059825|520730256|FG006|Treatment Period|Withdrawal by Subject|0|||
144416574|NCT01059825|520730250|FG000|Treatment Period|Other reason not specified|1|||
144416575|NCT01059825|520730251|FG001|Treatment Period|Other reason not specified|2|||
144416576|NCT01059825|520730252|FG002|Treatment Period|Other reason not specified|1|||
144416577|NCT01059825|520730253|FG003|Treatment Period|Other reason not specified|2|||
144416578|NCT01059825|520730254|FG004|Treatment Period|Other reason not specified|0|||
144416579|NCT01059825|520730255|FG005|Treatment Period|Other reason not specified|0|||
144416580|NCT01059825|520730256|FG006|Treatment Period|Other reason not specified|0|||
144416581|NCT01059825|520730250|FG000|Treatment Period|Protocol Violation|0|||
144416582|NCT01059825|520730251|FG001|Treatment Period|Protocol Violation|0|||
144416583|NCT01059825|520730252|FG002|Treatment Period|Protocol Violation|1|||
144416584|NCT01059825|520730253|FG003|Treatment Period|Protocol Violation|1|||
144416585|NCT01059825|520730254|FG004|Treatment Period|Protocol Violation|1|||
144416586|NCT01059825|520730255|FG005|Treatment Period|Protocol Violation|1|||
144416587|NCT01059825|520730256|FG006|Treatment Period|Protocol Violation|0|||
144416588|NCT01059825|520730250|FG000|Treatment Period|Adverse event related to study drug|1|||
144416589|NCT01059825|520730251|FG001|Treatment Period|Adverse event related to study drug|0|||
144416590|NCT01059825|520730252|FG002|Treatment Period|Adverse event related to study drug|1|||
144416591|NCT01059825|520730253|FG003|Treatment Period|Adverse event related to study drug|1|||
144416592|NCT01059825|520730254|FG004|Treatment Period|Adverse event related to study drug|0|||
144416593|NCT01059825|520730255|FG005|Treatment Period|Adverse event related to study drug|0|||
144416594|NCT01059825|520730256|FG006|Treatment Period|Adverse event related to study drug|0|||
144416595|NCT01059825|520730250|FG000|Treatment Period|Insufficient clinical response|3|||
144416596|NCT01059825|520730251|FG001|Treatment Period|Insufficient clinical response|0|||
144416597|NCT01059825|520730252|FG002|Treatment Period|Insufficient clinical response|0|||
144416598|NCT01059825|520730253|FG003|Treatment Period|Insufficient clinical response|0|||
144416599|NCT01059825|520730254|FG004|Treatment Period|Insufficient clinical response|0|||
144416600|NCT01059825|520730255|FG005|Treatment Period|Insufficient clinical response|0|||
144416601|NCT01059825|520730256|FG006|Treatment Period|Insufficient clinical response|0|||
144416602|NCT01059825|520730250|FG000|Treatment Period|Adverse event not related to study drug|0|||
144416603|NCT01059825|520730251|FG001|Treatment Period|Adverse event not related to study drug|1|||
144416604|NCT01059825|520730252|FG002|Treatment Period|Adverse event not related to study drug|2|||
144250628|NCT01333956|520115564|FG000|Overall Study|Withdrawal by Subject|0|||
144250629|NCT01333956|520115565|FG001|Overall Study|Withdrawal by Subject|2|||
144250630|NCT01333956|520115566|FG002|Overall Study|Withdrawal by Subject|1|||
144250631|NCT01333956|520115567|FG003|Overall Study|Withdrawal by Subject|0|||
144250632|NCT01210144|520115568|FG000|Overall Study|Lack of ovarian response|1|||
144250633|NCT01210144|520115569|FG001|Overall Study|Lack of ovarian response|0|||
144250634|NCT01210144|520115568|FG000|Overall Study|No fertilization|1|||
144250635|NCT01210144|520115569|FG001|Overall Study|No fertilization|0|||
144250636|NCT01210144|520115568|FG000|Overall Study|No transfer|1|||
144250637|NCT01210144|520115569|FG001|Overall Study|No transfer|0|||
144250638|NCT02678000|520115573|FG000|PART 2|Adverse Event|0|||
144250639|NCT02678000|520115574|FG001|PART 2|Adverse Event|0|||
144250640|NCT02678000|520115575|FG002|PART 2|Adverse Event|2|||
144250641|NCT02678000|520115576|FG003|PART 2|Adverse Event|1|||
144250642|NCT02678000|520115577|FG004|PART 2|Adverse Event|0|||
144250643|NCT02678000|520115573|FG000|PART 2|Withdrawal by Subject|0|||
144250644|NCT02678000|520115574|FG001|PART 2|Withdrawal by Subject|0|||
144250645|NCT02678000|520115575|FG002|PART 2|Withdrawal by Subject|1|||
144250646|NCT02678000|520115576|FG003|PART 2|Withdrawal by Subject|0|||
144250647|NCT02678000|520115577|FG004|PART 2|Withdrawal by Subject|0|||
144250648|NCT02360475|520115578|FG000|Overall Study|Lost to Follow-up|4|||
144250649|NCT02360475|520115579|FG001|Overall Study|Lost to Follow-up|12|||
144250650|NCT02360475|520115580|FG002|Overall Study|Lost to Follow-up|6|||
144250651|NCT02360475|520115581|FG003|Overall Study|Lost to Follow-up|4|||
144416605|NCT01059825|520730253|FG003|Treatment Period|Adverse event not related to study drug|1|||
144416606|NCT01059825|520730254|FG004|Treatment Period|Adverse event not related to study drug|1|||
144416607|NCT01059825|520730255|FG005|Treatment Period|Adverse event not related to study drug|1|||
144416608|NCT01059825|520730256|FG006|Treatment Period|Adverse event not related to study drug|0|||
144416609|NCT02041286|520730257|FG000|Overall Study|Adverse Event|1|||
144416610|NCT03342690|520730266|FG000|Overall Study|Missing Information|9|||
144416611|NCT03342690|520730266|FG000|Overall Study|Protocol Violation|16|||
144416612|NCT01906008|520730277|FG000|Overall Study|Lost to Follow-up|2|||
144416613|NCT01906008|520730278|FG001|Overall Study|Lost to Follow-up|0|||
144416614|NCT01906008|520730277|FG000|Overall Study|Oxaliplatin toxicity|2|||
144416615|NCT01906008|520730278|FG001|Overall Study|Oxaliplatin toxicity|0|||
144416616|NCT01906008|520730277|FG000|Overall Study|Protocol Violation|0|||
144416617|NCT01906008|520730278|FG001|Overall Study|Protocol Violation|1|||
144416618|NCT01906008|520730277|FG000|Overall Study|Withdrawal by Subject|1|||
144416619|NCT01906008|520730278|FG001|Overall Study|Withdrawal by Subject|5|||
144416620|NCT01906008|520730277|FG000|Overall Study|Did not start study med|3|||
144416621|NCT01906008|520730278|FG001|Overall Study|Did not start study med|4|||
144416622|NCT01906008|520730277|FG000|Overall Study|Oxaliplatin stops|10|||
144416623|NCT01906008|520730278|FG001|Overall Study|Oxaliplatin stops|8|||
144416624|NCT01906008|520730277|FG000|Overall Study|Hospice|1|||
144416625|NCT01906008|520730278|FG001|Overall Study|Hospice|0|||
144416626|NCT01906008|520730277|FG000|Overall Study|Physician Decision|3|||
144416627|NCT01906008|520730278|FG001|Overall Study|Physician Decision|3|||
144416628|NCT01906008|520730277|FG000|Overall Study|Lack of compliance of study med|5|||
144416629|NCT01906008|520730278|FG001|Overall Study|Lack of compliance of study med|3|||
144416630|NCT01906008|520730277|FG000|Overall Study|Adverse Event|0|||
144416631|NCT01906008|520730278|FG001|Overall Study|Adverse Event|3|||
144416632|NCT02117648|520730279|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
144416633|NCT02117648|520730279|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
144416634|NCT02117648|520730279|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
144416635|NCT02117648|520730279|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
144250652|NCT02360475|520115578|FG000|Overall Study|Withdrawal by Subject|0|||
144416636|NCT02117648|520730279|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
144416637|NCT02117648|520730279|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
144527365|NCT05070728|521131915|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
144527366|NCT05070728|521131916|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
144250653|NCT02360475|520115579|FG001|Overall Study|Withdrawal by Subject|1|||
144250654|NCT02360475|520115580|FG002|Overall Study|Withdrawal by Subject|2|||
144416638|NCT02117648|520730279|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
144416639|NCT02117648|520730279|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
144527367|NCT05446168|521131917|FG000|Overall Study|Physician Decision|0|||
144250655|NCT02360475|520115581|FG003|Overall Study|Withdrawal by Subject|0|||
144250656|NCT02360475|520115578|FG000|Overall Study|Migrated/moved from study area|0|||
144416640|NCT02117648|520730279|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
144416641|NCT02117648|520730279|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
144416642|NCT02117648|520730279|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
144416643|NCT00171730|520730281|FG000|Overall Study|Adverse Event|3|||
144416644|NCT00171730|520730281|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
144416645|NCT00171730|520730281|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
144416646|NCT00171730|520730281|FG000|Overall Study|Withdrawal by Subject|3|||
144416647|NCT05025241|520730282|FG000|Screening|Failed Screening|5|||
144416648|NCT05025241|520730282|FG000|Treatment and Follow Up|Adverse Event|3|||
144416649|NCT01366209|520730283|FG000|Overall Study|Adverse Event|6|||
144416650|NCT01366209|520730284|FG001|Overall Study|Adverse Event|7|||
144416651|NCT01366209|520730283|FG000|Overall Study|Withdrawal by Subject|4|||
144416652|NCT01366209|520730284|FG001|Overall Study|Withdrawal by Subject|4|||
144416653|NCT01366209|520730283|FG000|Overall Study|Death|12|||
144416654|NCT01366209|520730284|FG001|Overall Study|Death|19|||
144416655|NCT01366209|520730283|FG000|Overall Study|Lung transplantation|6|||
144416656|NCT01366209|520730284|FG001|Overall Study|Lung transplantation|1|||
144416657|NCT01366209|520730283|FG000|Overall Study|Lost to Follow-up|2|||
144416658|NCT01366209|520730284|FG001|Overall Study|Lost to Follow-up|1|||
144416659|NCT01366209|520730283|FG000|Overall Study|Physician Decision|1|||
144416660|NCT01366209|520730284|FG001|Overall Study|Physician Decision|0|||
144416661|NCT01366209|520730283|FG000|Overall Study|Sponsors decision|0|||
144416662|NCT01366209|520730284|FG001|Overall Study|Sponsors decision|1|||
144416663|NCT01366209|520730283|FG000|Overall Study|Withdrew consent|4|||
144416664|NCT01366209|520730284|FG001|Overall Study|Withdrew consent|3|||
144416665|NCT01053221|520730285|FG000|Overall Study|The study was closed prematurely|5|||
144416666|NCT01053221|520730286|FG001|Overall Study|The study was closed prematurely|9|||
144416667|NCT02220205|520730287|FG000|Overall Study|Withdrawal by Subject|1|||
144416668|NCT02220205|520730288|FG001|Overall Study|Withdrawal by Subject|0|||
144416669|NCT01465997|520730289|FG000|Overall Study|Adverse Event|12|||
144416670|NCT01465997|520730290|FG001|Overall Study|Adverse Event|22|||
144416671|NCT01465997|520730289|FG000|Overall Study|Lack of Efficacy|13|||
144416672|NCT01465997|520730290|FG001|Overall Study|Lack of Efficacy|1|||
144416673|NCT01465997|520730289|FG000|Overall Study|Protocol Violation|1|||
144416674|NCT01465997|520730290|FG001|Overall Study|Protocol Violation|4|||
144416675|NCT01465997|520730289|FG000|Overall Study|Lost to Follow-up|6|||
144416676|NCT01465997|520730290|FG001|Overall Study|Lost to Follow-up|9|||
144416677|NCT01465997|520730289|FG000|Overall Study|Withdrawal by Subject|32|||
144416678|NCT01465997|520730290|FG001|Overall Study|Withdrawal by Subject|35|||
144416679|NCT01465997|520730289|FG000|Overall Study|investigator's decision|1|||
144416680|NCT01465997|520730290|FG001|Overall Study|investigator's decision|1|||
144416681|NCT01465997|520730289|FG000|Overall Study|Death|0|||
144416682|NCT01465997|520730290|FG001|Overall Study|Death|1|||
144416683|NCT01465997|520730289|FG000|Overall Study|sponsor's decision|1|||
144416684|NCT01465997|520730290|FG001|Overall Study|sponsor's decision|1|||
144416685|NCT01465997|520730289|FG000|Overall Study|subject withdrew consent|1|||
144416686|NCT01465997|520730290|FG001|Overall Study|subject withdrew consent|0|||
144416687|NCT01465997|520730289|FG000|Overall Study|local lab unblinded site|1|||
144416688|NCT01465997|520730290|FG001|Overall Study|local lab unblinded site|0|||
144416689|NCT01465997|520730289|FG000|Overall Study|withdrew before follow-up|0|||
144416690|NCT01465997|520730290|FG001|Overall Study|withdrew before follow-up|13|||
144416691|NCT01465997|520730289|FG000|Overall Study|decision by site staff|0|||
144416692|NCT01465997|520730290|FG001|Overall Study|decision by site staff|1|||
144416693|NCT01465997|520730289|FG000|Overall Study|subject left participation SP0993|0|||
144416694|NCT01465997|520730290|FG001|Overall Study|subject left participation SP0993|1|||
144416695|NCT02246660|520730291|FG000|Overall Study|Withdrawal by Subject|0|||
144416696|NCT02246660|520730292|FG001|Overall Study|Withdrawal by Subject|1|||
144416697|NCT02246660|520730293|FG002|Overall Study|Withdrawal by Subject|0|||
144416698|NCT02246660|520730291|FG000|Overall Study|Death|0|||
144416699|NCT02246660|520730292|FG001|Overall Study|Death|0|||
144416700|NCT02246660|520730293|FG002|Overall Study|Death|1|||
144416701|NCT05227027|520730294|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
144416702|NCT05227027|520730295|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
144416703|NCT03552198|520730296|FG000|Overall Study|Lost to Follow-up|42|||
144416704|NCT03552198|520730297|FG001|Overall Study|Lost to Follow-up|48|||
144416705|NCT03552198|520730298|FG002|Overall Study|Lost to Follow-up|15|||
144416706|NCT03552198|520730299|FG003|Overall Study|Lost to Follow-up|19|||
144416707|NCT03552198|520730296|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
144416708|NCT03552198|520730297|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
144416709|NCT03552198|520730298|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
144416710|NCT03552198|520730299|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
144416711|NCT03552198|520730296|FG000|Overall Study|Did not receive air alerts|1|||
144416712|NCT03552198|520730297|FG001|Overall Study|Did not receive air alerts|0|||
144416713|NCT03552198|520730298|FG002|Overall Study|Did not receive air alerts|0|||
144416714|NCT03552198|520730299|FG003|Overall Study|Did not receive air alerts|1|||
144416715|NCT06149247|520730300|FG000|Overall Study|Adverse Event|0|||
144416716|NCT06149247|520730301|FG001|Overall Study|Adverse Event|1|||
144416717|NCT00855920|520730302|FG000|Overall Study|Protocol Violation|0|||
144416718|NCT00855920|520730303|FG001|Overall Study|Protocol Violation|0|||
144416719|NCT00855920|520730304|FG002|Overall Study|Protocol Violation|2|||
144416720|NCT00855920|520730302|FG000|Overall Study|Adverse Event|2|||
144416721|NCT00855920|520730303|FG001|Overall Study|Adverse Event|1|||
144416722|NCT00855920|520730304|FG002|Overall Study|Adverse Event|1|||
144416723|NCT00855920|520730302|FG000|Overall Study|Lack of Efficacy|2|||
144416724|NCT00855920|520730303|FG001|Overall Study|Lack of Efficacy|2|||
144416725|NCT00855920|520730304|FG002|Overall Study|Lack of Efficacy|2|||
144416726|NCT00855920|520730302|FG000|Overall Study|Withdrawal by Subject|2|||
144416727|NCT00855920|520730303|FG001|Overall Study|Withdrawal by Subject|3|||
144416728|NCT00855920|520730304|FG002|Overall Study|Withdrawal by Subject|2|||
144416729|NCT00855920|520730302|FG000|Overall Study|Lost to Follow-up|1|||
144416730|NCT00855920|520730303|FG001|Overall Study|Lost to Follow-up|0|||
144416731|NCT00855920|520730304|FG002|Overall Study|Lost to Follow-up|2|||
144416732|NCT00855920|520730302|FG000|Overall Study|Death|0|||
144416733|NCT00855920|520730303|FG001|Overall Study|Death|1|||
144416734|NCT00855920|520730304|FG002|Overall Study|Death|0|||
144416735|NCT00855920|520730302|FG000|Overall Study|Decision by the sponsor|0|||
144416736|NCT00855920|520730303|FG001|Overall Study|Decision by the sponsor|1|||
144416737|NCT00855920|520730304|FG002|Overall Study|Decision by the sponsor|1|||
144416738|NCT00855920|520730302|FG000|Overall Study|Other than specified above|1|||
144416739|NCT00855920|520730303|FG001|Overall Study|Other than specified above|1|||
144416740|NCT00855920|520730304|FG002|Overall Study|Other than specified above|1|||
144416741|NCT01666782|520730305|FG000|Overall Study|Received 2 doses of vaccine|0|||
144416742|NCT01666782|520730306|FG001|Overall Study|Received 2 doses of vaccine|1|||
144416743|NCT01666782|520730305|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
144416744|NCT01666782|520730306|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
144416745|NCT01756898|520730320|FG000|Overall Study|Adverse Event|7|||
144416746|NCT01756898|520730321|FG001|Overall Study|Adverse Event|1|||
144416747|NCT01756898|520730322|FG002|Overall Study|Adverse Event|0|||
144416748|NCT01756898|520730323|FG003|Overall Study|Adverse Event|0|||
144416749|NCT01756898|520730320|FG000|Overall Study|Lack of Efficacy|4|||
144416750|NCT01756898|520730321|FG001|Overall Study|Lack of Efficacy|7|||
144416751|NCT01756898|520730322|FG002|Overall Study|Lack of Efficacy|6|||
144416752|NCT01756898|520730323|FG003|Overall Study|Lack of Efficacy|6|||
144416753|NCT01756898|520730320|FG000|Overall Study|Lost to Follow-up|2|||
144416754|NCT01756898|520730321|FG001|Overall Study|Lost to Follow-up|4|||
144416755|NCT01756898|520730322|FG002|Overall Study|Lost to Follow-up|2|||
144416756|NCT01756898|520730323|FG003|Overall Study|Lost to Follow-up|3|||
144416757|NCT01756898|520730320|FG000|Overall Study|Protocol Violation|1|||
144416758|NCT01756898|520730321|FG001|Overall Study|Protocol Violation|2|||
144416759|NCT01756898|520730322|FG002|Overall Study|Protocol Violation|2|||
144416760|NCT01756898|520730323|FG003|Overall Study|Protocol Violation|1|||
144416761|NCT01756898|520730320|FG000|Overall Study|Withdrew Consent|5|||
144416762|NCT01756898|520730321|FG001|Overall Study|Withdrew Consent|3|||
144416763|NCT01756898|520730322|FG002|Overall Study|Withdrew Consent|5|||
144416764|NCT01756898|520730323|FG003|Overall Study|Withdrew Consent|6|||
144416765|NCT01756898|520730320|FG000|Overall Study|Other|0|||
144416766|NCT01756898|520730321|FG001|Overall Study|Other|2|||
144416767|NCT01756898|520730322|FG002|Overall Study|Other|2|||
144416768|NCT01756898|520730323|FG003|Overall Study|Other|0|||
144416769|NCT01500694|520730324|FG000|Overall Study|Adverse Event|4|||
144416770|NCT01500694|520730325|FG001|Overall Study|Adverse Event|3|||
144723158|NCT03504852|521840643|FG002|Overall Study|New therapy for study indication|0|||
144723159|NCT03504852|521840641|FG000|Overall Study|Lack of Efficacy|1|||
144723160|NCT03504852|521840642|FG001|Overall Study|Lack of Efficacy|2|||
144250657|NCT02360475|520115579|FG001|Overall Study|Migrated/moved from study area|0|||
144416771|NCT01500694|520730324|FG000|Overall Study|Protocol Violation|0|||
144416772|NCT01500694|520730325|FG001|Overall Study|Protocol Violation|1|||
144416773|NCT01500694|520730324|FG000|Overall Study|Withdrawal by Subject|23|||
144416774|NCT01500694|520730325|FG001|Overall Study|Withdrawal by Subject|14|||
144416775|NCT01500694|520730324|FG000|Overall Study|Lost to Follow-up|2|||
144416776|NCT01500694|520730325|FG001|Overall Study|Lost to Follow-up|3|||
144416777|NCT01500694|520730324|FG000|Overall Study|Lack of Efficacy|14|||
144416778|NCT01500694|520730325|FG001|Overall Study|Lack of Efficacy|5|||
144416779|NCT01500694|520730324|FG000|Overall Study|Other|9|||
144416780|NCT01500694|520730325|FG001|Overall Study|Other|3|||
144416781|NCT03572062|520730326|FG000|Overall Study|Adverse Event|0|||
144416782|NCT03572062|520730327|FG001|Overall Study|Adverse Event|0|||
144416783|NCT03572062|520730328|FG002|Overall Study|Adverse Event|0|||
144416784|NCT03572062|520730329|FG003|Overall Study|Adverse Event|0|||
144416785|NCT03572062|520730330|FG004|Overall Study|Adverse Event|0|||
144416786|NCT03572062|520730331|FG005|Overall Study|Adverse Event|0|||
144416787|NCT03572062|520730332|FG006|Overall Study|Adverse Event|0|||
144416788|NCT03572062|520730333|FG007|Overall Study|Adverse Event|0|||
144416789|NCT03572062|520730334|FG008|Overall Study|Adverse Event|1|||
144416790|NCT03572062|520730335|FG009|Overall Study|Adverse Event|3|||
144250658|NCT02360475|520115580|FG002|Overall Study|Migrated/moved from study area|0|||
144250659|NCT02360475|520115581|FG003|Overall Study|Migrated/moved from study area|1|||
144250660|NCT03759366|520115583|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
144250661|NCT03759366|520115583|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
144250662|NCT03759366|520115583|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
144250663|NCT03759366|520115583|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
144250664|NCT03759366|520115583|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
144250665|NCT03759366|520115583|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
144250666|NCT03759366|520115583|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
144250667|NCT04226495|520115584|FG000|Overall Study|Withdrawal by Subject|3|||
144250668|NCT04226495|520115585|FG001|Overall Study|Withdrawal by Subject|3|||
144250669|NCT04226495|520115584|FG000|Overall Study|PI discretion|3|||
144250670|NCT04226495|520115585|FG001|Overall Study|PI discretion|4|||
144250671|NCT00435019|520115586|FG000|Overall Study|Adverse Event|1|||
144250672|NCT00435019|520115587|FG001|Overall Study|Adverse Event|0|||
144250673|NCT00435019|520115586|FG000|Overall Study|Lack of Efficacy|1|||
144250674|NCT00435019|520115587|FG001|Overall Study|Lack of Efficacy|2|||
144250675|NCT00435019|520115586|FG000|Overall Study|Protocol Violation|3|||
144250676|NCT00435019|520115587|FG001|Overall Study|Protocol Violation|1|||
144250677|NCT00435019|520115586|FG000|Overall Study|Personal reasons for withdrawal|8|||
144250678|NCT00435019|520115587|FG001|Overall Study|Personal reasons for withdrawal|7|||
144250679|NCT00505661|520115592|FG000|Overall Study|Not Eligible|4|||
144250680|NCT04459598|520115593|FG000|Overall Study|Adverse Event|1|||
144250681|NCT04459598|520115594|FG001|Overall Study|Adverse Event|1|||
144250682|NCT00866333|520115601|FG000|Overall Study|Withdrawal of consent|0|||
144250683|NCT00866333|520115602|FG001|Overall Study|Withdrawal of consent|1|||
144250684|NCT00866333|520115603|FG002|Overall Study|Withdrawal of consent|2|||
144250685|NCT00866333|520115601|FG000|Overall Study|Reason not Specified|3|||
144250686|NCT00866333|520115602|FG001|Overall Study|Reason not Specified|1|||
144250687|NCT00866333|520115603|FG002|Overall Study|Reason not Specified|1|||
144250688|NCT00866333|520115601|FG000|Overall Study|Study Terminated by Sponsor|2|||
144250689|NCT00866333|520115602|FG001|Overall Study|Study Terminated by Sponsor|5|||
144250690|NCT00866333|520115603|FG002|Overall Study|Study Terminated by Sponsor|9|||
144250691|NCT01764659|520115604|FG000|Overall Study|Death|1|||
144250692|NCT01764659|520115604|FG000|Overall Study|Physician Decision|1|||
144250693|NCT01210352|520115605|FG000|Overall Study|Adverse Event|0|||
144250694|NCT01210352|520115606|FG001|Overall Study|Adverse Event|0|||
144250695|NCT01210352|520115607|FG002|Overall Study|Adverse Event|0|||
144250696|NCT01210352|520115608|FG003|Overall Study|Adverse Event|0|||
144250697|NCT01210352|520115609|FG004|Overall Study|Adverse Event|0|||
144250698|NCT01210352|520115610|FG005|Overall Study|Adverse Event|0|||
144250699|NCT01210352|520115611|FG006|Overall Study|Adverse Event|0|||
144250700|NCT01210352|520115612|FG007|Overall Study|Adverse Event|2|||
144250701|NCT01210352|520115613|FG008|Overall Study|Adverse Event|1|||
144416791|NCT03572062|520730326|FG000|Overall Study|Death|0|||
144416792|NCT03572062|520730327|FG001|Overall Study|Death|0|||
144527368|NCT05446168|521131918|FG001|Overall Study|Physician Decision|1|||
144250702|NCT01210352|520115605|FG000|Overall Study|Lack of Efficacy|0|||
144250703|NCT01210352|520115606|FG001|Overall Study|Lack of Efficacy|0|||
144250704|NCT01210352|520115607|FG002|Overall Study|Lack of Efficacy|0|||
144250705|NCT01210352|520115608|FG003|Overall Study|Lack of Efficacy|0|||
144250706|NCT01210352|520115609|FG004|Overall Study|Lack of Efficacy|0|||
144250707|NCT01210352|520115610|FG005|Overall Study|Lack of Efficacy|0|||
144250708|NCT01210352|520115611|FG006|Overall Study|Lack of Efficacy|1|||
144250709|NCT01210352|520115612|FG007|Overall Study|Lack of Efficacy|0|||
144250710|NCT01210352|520115613|FG008|Overall Study|Lack of Efficacy|0|||
144416793|NCT03572062|520730328|FG002|Overall Study|Death|0|||
144416794|NCT03572062|520730329|FG003|Overall Study|Death|0|||
144416795|NCT03572062|520730330|FG004|Overall Study|Death|0|||
144416796|NCT03572062|520730331|FG005|Overall Study|Death|1|||
144416797|NCT03572062|520730332|FG006|Overall Study|Death|0|||
144416798|NCT03572062|520730333|FG007|Overall Study|Death|0|||
144250711|NCT01210352|520115605|FG000|Overall Study|Physician Decision|0|||
144250712|NCT01210352|520115606|FG001|Overall Study|Physician Decision|0|||
144250713|NCT01210352|520115607|FG002|Overall Study|Physician Decision|0|||
144250714|NCT01210352|520115608|FG003|Overall Study|Physician Decision|0|||
144250715|NCT01210352|520115609|FG004|Overall Study|Physician Decision|0|||
144250716|NCT01210352|520115610|FG005|Overall Study|Physician Decision|0|||
144250717|NCT01210352|520115611|FG006|Overall Study|Physician Decision|0|||
144250718|NCT01210352|520115612|FG007|Overall Study|Physician Decision|1|||
144250719|NCT01210352|520115613|FG008|Overall Study|Physician Decision|2|||
144250720|NCT01210352|520115605|FG000|Overall Study|Withdrawal by Subject|0|||
144250721|NCT01210352|520115606|FG001|Overall Study|Withdrawal by Subject|0|||
144250722|NCT01210352|520115607|FG002|Overall Study|Withdrawal by Subject|1|||
144250723|NCT01210352|520115608|FG003|Overall Study|Withdrawal by Subject|0|||
144250724|NCT01210352|520115609|FG004|Overall Study|Withdrawal by Subject|0|||
144250725|NCT01210352|520115610|FG005|Overall Study|Withdrawal by Subject|0|||
144250726|NCT01210352|520115611|FG006|Overall Study|Withdrawal by Subject|1|||
144250727|NCT01210352|520115612|FG007|Overall Study|Withdrawal by Subject|0|||
144250728|NCT01210352|520115613|FG008|Overall Study|Withdrawal by Subject|1|||
144250729|NCT01210352|520115605|FG000|Overall Study|Patient Discharged Early|0|||
144250730|NCT01210352|520115606|FG001|Overall Study|Patient Discharged Early|0|||
144250731|NCT01210352|520115607|FG002|Overall Study|Patient Discharged Early|1|||
144250732|NCT01210352|520115608|FG003|Overall Study|Patient Discharged Early|0|||
144250733|NCT01210352|520115609|FG004|Overall Study|Patient Discharged Early|0|||
144250734|NCT01210352|520115610|FG005|Overall Study|Patient Discharged Early|0|||
144250735|NCT01210352|520115611|FG006|Overall Study|Patient Discharged Early|0|||
144250736|NCT01210352|520115612|FG007|Overall Study|Patient Discharged Early|0|||
144250737|NCT01210352|520115613|FG008|Overall Study|Patient Discharged Early|0|||
144250738|NCT04918355|520115614|FG000|Overall Study|no qualifying health encounter|497|||
144250739|NCT04918355|520115615|FG001|Overall Study|no qualifying health encounter|192|||
144250740|NCT04918355|520115616|FG002|Overall Study|no qualifying health encounter|438|||
144250741|NCT04918355|520115617|FG003|Overall Study|no qualifying health encounter|424|||
144250742|NCT04852276|520115618|FG000|Overall Study|Death|2|||
144250743|NCT04852276|520115619|FG001|Overall Study|Death|0|||
144250744|NCT04852276|520115618|FG000|Overall Study|Lost to Follow-up|15|||
144250745|NCT04852276|520115619|FG001|Overall Study|Lost to Follow-up|9|||
144250746|NCT04852276|520115618|FG000|Overall Study|Withdrawal by Subject|26|||
144250747|NCT04852276|520115619|FG001|Overall Study|Withdrawal by Subject|6|||
144250748|NCT01890759|520117339|FG000|Overall Study|Protocol Violation|0|||
144250749|NCT01890759|520117340|FG001|Overall Study|Protocol Violation|2|||
144250750|NCT01890759|520117339|FG000|Overall Study|Lost to Follow-up|0|||
144250751|NCT01890759|520117340|FG001|Overall Study|Lost to Follow-up|2|||
144250752|NCT01890759|520117339|FG000|Overall Study|Withdrawal by Subject|2|||
144416799|NCT03572062|520730334|FG008|Overall Study|Death|0|||
144416800|NCT03572062|520730335|FG009|Overall Study|Death|0|||
144416801|NCT03572062|520730326|FG000|Overall Study|Lost to Follow-up|0|||
144416802|NCT03572062|520730327|FG001|Overall Study|Lost to Follow-up|0|||
144416803|NCT03572062|520730328|FG002|Overall Study|Lost to Follow-up|0|||
144416804|NCT03572062|520730329|FG003|Overall Study|Lost to Follow-up|0|||
144416805|NCT03572062|520730330|FG004|Overall Study|Lost to Follow-up|0|||
144416806|NCT03572062|520730331|FG005|Overall Study|Lost to Follow-up|1|||
144416807|NCT03572062|520730332|FG006|Overall Study|Lost to Follow-up|1|||
144416808|NCT03572062|520730333|FG007|Overall Study|Lost to Follow-up|0|||
144416809|NCT03572062|520730334|FG008|Overall Study|Lost to Follow-up|0|||
144416810|NCT03572062|520730335|FG009|Overall Study|Lost to Follow-up|0|||
144416811|NCT03572062|520730326|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416812|NCT03572062|520730327|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416813|NCT03572062|520730328|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416814|NCT03572062|520730329|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416815|NCT03572062|520730330|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416816|NCT03572062|520730331|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416817|NCT03572062|520730332|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416818|NCT03572062|520730333|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
144416819|NCT03572062|520730334|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
144416820|NCT03572062|520730335|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
144250753|NCT01890759|520117340|FG001|Overall Study|Withdrawal by Subject|8|||
144250754|NCT04003623|520117345|FG000|Overall Study|Withdrawal by Subject|1|||
144250755|NCT04003623|520117346|FG001|Overall Study|Withdrawal by Subject|0|||
144250756|NCT04228965|520117347|FG000|Overall Study|Lost to Follow-up|26|||
144250757|NCT04228965|520117348|FG001|Overall Study|Lost to Follow-up|11|||
144250758|NCT04228965|520117347|FG000|Overall Study|Withdrawal by Subject|18|||
144250759|NCT04228965|520117348|FG001|Overall Study|Withdrawal by Subject|5|||
144250760|NCT03214679|520117349|FG000|Overall Study|Lost to Follow-up|12|||
144250761|NCT03214679|520117350|FG001|Overall Study|Lost to Follow-up|14|||
144250762|NCT03214679|520117349|FG000|Overall Study|not eligible|2|||
144416821|NCT03572062|520730326|FG000|Overall Study|Study Terminated By Sponsor|0|||
144416822|NCT03572062|520730327|FG001|Overall Study|Study Terminated By Sponsor|0|||
144416823|NCT03572062|520730328|FG002|Overall Study|Study Terminated By Sponsor|0|||
144416824|NCT03572062|520730329|FG003|Overall Study|Study Terminated By Sponsor|0|||
144416825|NCT03572062|520730330|FG004|Overall Study|Study Terminated By Sponsor|0|||
144416826|NCT03572062|520730331|FG005|Overall Study|Study Terminated By Sponsor|0|||
144416827|NCT03572062|520730332|FG006|Overall Study|Study Terminated By Sponsor|0|||
144416828|NCT03572062|520730333|FG007|Overall Study|Study Terminated By Sponsor|0|||
144416829|NCT03572062|520730334|FG008|Overall Study|Study Terminated By Sponsor|29|||
144416830|NCT03572062|520730335|FG009|Overall Study|Study Terminated By Sponsor|27|||
144416831|NCT03572062|520730326|FG000|Overall Study|Physician Decision|0|||
144416832|NCT03572062|520730327|FG001|Overall Study|Physician Decision|0|||
144416833|NCT03572062|520730328|FG002|Overall Study|Physician Decision|0|||
144416834|NCT03572062|520730329|FG003|Overall Study|Physician Decision|0|||
144416835|NCT03572062|520730330|FG004|Overall Study|Physician Decision|0|||
144416836|NCT03572062|520730331|FG005|Overall Study|Physician Decision|0|||
144416837|NCT03572062|520730332|FG006|Overall Study|Physician Decision|0|||
144416838|NCT03572062|520730333|FG007|Overall Study|Physician Decision|0|||
144416839|NCT03572062|520730334|FG008|Overall Study|Physician Decision|1|||
144416840|NCT03572062|520730335|FG009|Overall Study|Physician Decision|0|||
144416841|NCT03572062|520730326|FG000|Overall Study|Withdrawal by Subject|0|||
144416842|NCT03572062|520730327|FG001|Overall Study|Withdrawal by Subject|0|||
144416843|NCT03572062|520730328|FG002|Overall Study|Withdrawal by Subject|0|||
144416844|NCT03572062|520730329|FG003|Overall Study|Withdrawal by Subject|0|||
144416845|NCT03572062|520730330|FG004|Overall Study|Withdrawal by Subject|0|||
144416846|NCT03572062|520730331|FG005|Overall Study|Withdrawal by Subject|0|||
144416847|NCT03572062|520730332|FG006|Overall Study|Withdrawal by Subject|0|||
144416848|NCT03572062|520730333|FG007|Overall Study|Withdrawal by Subject|0|||
144416849|NCT03572062|520730334|FG008|Overall Study|Withdrawal by Subject|0|||
144416850|NCT03572062|520730335|FG009|Overall Study|Withdrawal by Subject|1|||
144723161|NCT03504852|521840643|FG002|Overall Study|Lack of Efficacy|0|||
144416851|NCT03572062|520730326|FG000|Overall Study|Randomized But Not Treated|0|||
144416852|NCT03572062|520730327|FG001|Overall Study|Randomized But Not Treated|0|||
144416853|NCT03572062|520730328|FG002|Overall Study|Randomized But Not Treated|0|||
144416854|NCT03572062|520730329|FG003|Overall Study|Randomized But Not Treated|0|||
144416855|NCT03572062|520730330|FG004|Overall Study|Randomized But Not Treated|1|||
144416856|NCT03572062|520730331|FG005|Overall Study|Randomized But Not Treated|2|||
144416857|NCT03572062|520730332|FG006|Overall Study|Randomized But Not Treated|0|||
144416858|NCT03572062|520730333|FG007|Overall Study|Randomized But Not Treated|1|||
144416859|NCT03572062|520730334|FG008|Overall Study|Randomized But Not Treated|0|||
144416860|NCT03572062|520730335|FG009|Overall Study|Randomized But Not Treated|0|||
144416861|NCT01691781|520730336|FG000|Overall Study|Withdrawal by Subject|4|||
144416862|NCT01691781|520730337|FG001|Overall Study|Withdrawal by Subject|3|||
144416863|NCT01691781|520730336|FG000|Overall Study|Physician Decision|1|||
144416864|NCT01691781|520730337|FG001|Overall Study|Physician Decision|1|||
144416865|NCT01691781|520730336|FG000|Overall Study|Protocol Violation|2|||
144416866|NCT01691781|520730337|FG001|Overall Study|Protocol Violation|2|||
144416867|NCT01691781|520730336|FG000|Overall Study|Adverse Event|0|||
144416868|NCT01691781|520730337|FG001|Overall Study|Adverse Event|1|||
144416869|NCT01918085|520730338|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
144416870|NCT01918085|520730339|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
144416871|NCT02132130|520730340|FG000|Overall Study|Lost to Follow-up|0|||
144416872|NCT02132130|520730341|FG001|Overall Study|Lost to Follow-up|2|||
144416873|NCT02132130|520730342|FG002|Overall Study|Lost to Follow-up|0|||
144416874|NCT02132130|520730343|FG003|Overall Study|Lost to Follow-up|0|||
144416875|NCT02132130|520730340|FG000|Overall Study|Withdrawal by Subject|0|||
144416876|NCT02132130|520730341|FG001|Overall Study|Withdrawal by Subject|0|||
144416877|NCT02132130|520730342|FG002|Overall Study|Withdrawal by Subject|0|||
144416878|NCT02132130|520730343|FG003|Overall Study|Withdrawal by Subject|1|||
144416879|NCT02760069|520730346|FG000|Overall Study|Withdrawal by Subject|0|||
144416880|NCT02760069|520730347|FG001|Overall Study|Withdrawal by Subject|1|||
144416881|NCT02760069|520730348|FG002|Overall Study|Withdrawal by Subject|1|||
144416882|NCT00646776|520730358|FG000|Overall Study|Adverse Event|1|||
144416883|NCT00646776|520730359|FG001|Overall Study|Adverse Event|9|||
144416884|NCT00646776|520730358|FG000|Overall Study|Investigator discretion|0|||
144416885|NCT00646776|520730359|FG001|Overall Study|Investigator discretion|4|||
144416886|NCT00600483|520730363|FG000|Overall Study|Lost to Follow-up|26|||
144416887|NCT00600483|520730364|FG001|Overall Study|Lost to Follow-up|47|||
144416888|NCT00600483|520730363|FG000|Overall Study|Randomized but not treated|10|||
144416889|NCT00600483|520730364|FG001|Overall Study|Randomized but not treated|0|||
144416890|NCT02547454|520730379|FG000|Overall Study|Due to hemodialysis|53|||
144416891|NCT02547454|520730379|FG000|Overall Study|Due to transplantation|1|||
144527369|NCT03905798|521131922|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
144416892|NCT02547454|520730379|FG000|Overall Study|Due to no further need to treat|4|||
144416893|NCT02547454|520730379|FG000|Overall Study|Death|38|||
144250763|NCT03214679|520117350|FG001|Overall Study|not eligible|0|||
144416894|NCT02547454|520730379|FG000|Overall Study|Lost to Follow-up|26|||
144416895|NCT02547454|520730379|FG000|Overall Study|Other|39|||
144416896|NCT02547454|520730379|FG000|Overall Study|No data|11|||
144416897|NCT00580606|520730380|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
144416898|NCT00580606|520730381|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
144416899|NCT00580606|520730380|FG000|Open Label (OL)|Withdrawal by Subject|4|||
144416900|NCT00580606|520730381|FG001|Open Label (OL)|Withdrawal by Subject|6|||
144416901|NCT00580606|520730380|FG000|Open Label (OL)|Dosing Symptoms|0|||
144416902|NCT00580606|520730381|FG001|Open Label (OL)|Dosing Symptoms|1|||
144416903|NCT00580606|520730380|FG000|Open Label (OL)|Lost to Follow-up|0|||
144416904|NCT00580606|520730381|FG001|Open Label (OL)|Lost to Follow-up|1|||
144416905|NCT00580606|520730380|FG000|Open Label (OL)|Pregnancy|0|||
144416906|NCT00580606|520730381|FG001|Open Label (OL)|Pregnancy|1|||
144416907|NCT00580606|520730380|FG000|Open Label (OL)|Non-compliance|2|||
144416908|NCT00580606|520730381|FG001|Open Label (OL)|Non-compliance|0|||
144416909|NCT00580606|520730380|FG000|Open Label (OL)|Physician Decision|1|||
144416910|NCT00580606|520730381|FG001|Open Label (OL)|Physician Decision|1|||
144416911|NCT00580606|520730380|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
144416912|NCT00580606|520730381|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
144416913|NCT03031678|520730382|FG000|Overall Study|Study closed prior to completion|1|||
144416914|NCT03694821|520730383|FG000|Overall Study|Study terminated|4|||
144416915|NCT03694821|520730384|FG001|Overall Study|Study terminated|8|||
144416916|NCT03694821|520730385|FG002|Overall Study|Study terminated|4|||
144416917|NCT01405456|520730386|FG000|Overall Study|Lost to Follow-up|2|||
144416918|NCT01405456|520730387|FG001|Overall Study|Lost to Follow-up|1|||
144416919|NCT01405456|520730386|FG000|Overall Study|Physician Decision|1|||
144416920|NCT01405456|520730387|FG001|Overall Study|Physician Decision|0|||
144416921|NCT05475236|520730389|FG000|Overall Study|Withdrawal by Subject|0|||
144416922|NCT05475236|520730390|FG001|Overall Study|Withdrawal by Subject|1|||
144416923|NCT00477971|520730391|FG000|Overall Study|Disease progression|6|||
144416924|NCT00477971|520730392|FG001|Overall Study|Disease progression|0|||
144416925|NCT00477971|520730391|FG000|Overall Study|Withdrawal by Subject|3|||
144416926|NCT00477971|520730392|FG001|Overall Study|Withdrawal by Subject|1|||
144416927|NCT00477971|520730391|FG000|Overall Study|Adverse Event|3|||
144416928|NCT00477971|520730392|FG001|Overall Study|Adverse Event|0|||
144416929|NCT00477971|520730391|FG000|Overall Study|Death|2|||
144416930|NCT00477971|520730392|FG001|Overall Study|Death|4|||
144416931|NCT00477971|520730391|FG000|Overall Study|Alternative treatment|3|||
144416932|NCT00477971|520730392|FG001|Overall Study|Alternative treatment|1|||
144416933|NCT04419714|520730393|FG000|Overall Study|Technical Fault|5|||
144416934|NCT04419714|520730393|FG000|Overall Study|Protocol Deviation|2|||
144416935|NCT04419714|520730393|FG000|Overall Study|Withdrawal by Subject|1|||
144416936|NCT01325584|520730394|FG000|Overall Study|Death|1|||
144416937|NCT00524368|520732431|FG000|Overall Study|Adverse Event|10|||
144416938|NCT00524368|520732432|FG001|Overall Study|Adverse Event|12|||
144416939|NCT00524368|520732431|FG000|Overall Study|Lost to Follow-up|9|||
144416940|NCT00524368|520732432|FG001|Overall Study|Lost to Follow-up|13|||
144416941|NCT00524368|520732431|FG000|Overall Study|Withdrawal by Subject|4|||
144416942|NCT00524368|520732432|FG001|Overall Study|Withdrawal by Subject|5|||
144416943|NCT00524368|520732431|FG000|Overall Study|Non-compliant|8|||
144416944|NCT00524368|520732432|FG001|Overall Study|Non-compliant|9|||
144416945|NCT00524368|520732431|FG000|Overall Study|Reached a Virologic Endpoint|3|||
144416946|NCT00524368|520732432|FG001|Overall Study|Reached a Virologic Endpoint|2|||
144416947|NCT00524368|520732431|FG000|Overall Study|Sponsor's Decision|2|||
144416948|NCT00524368|520732432|FG001|Overall Study|Sponsor's Decision|0|||
144416949|NCT00524368|520732431|FG000|Overall Study|Ineligible to Continue the study|2|||
144416950|NCT00524368|520732432|FG001|Overall Study|Ineligible to Continue the study|5|||
144416951|NCT00524368|520732431|FG000|Overall Study|Other|3|||
144416952|NCT00524368|520732432|FG001|Overall Study|Other|2|||
144416953|NCT01955733|520732433|FG000|Period 1|Lost to Follow-up|1|||
144723162|NCT03504852|521840641|FG000|Overall Study|Death|0|||
144723163|NCT03504852|521840642|FG001|Overall Study|Death|1|||
144723164|NCT03504852|521840643|FG002|Overall Study|Death|0|||
144723165|NCT03504852|521840641|FG000|Overall Study|Adverse Event|4|||
144416954|NCT01955733|520732434|FG001|Period 1|Lost to Follow-up|0|||
144416955|NCT01955733|520732435|FG002|Period 1|Lost to Follow-up|0|||
144416956|NCT01955733|520732433|FG000|Period 2|Adverse Event|1|||
144416957|NCT01955733|520732434|FG001|Period 2|Adverse Event|0|||
144416958|NCT01955733|520732435|FG002|Period 2|Adverse Event|0|||
144250764|NCT05025332|520117355|FG000|Screening|Screen failure|12|||
144416959|NCT01955733|520732433|FG000|Period 2|Physician Decision|0|||
144416960|NCT01955733|520732434|FG001|Period 2|Physician Decision|0|||
144416961|NCT01955733|520732435|FG002|Period 2|Physician Decision|1|||
144416962|NCT01955733|520732433|FG000|Period 2|Withdrawal by Subject|1|||
144416963|NCT01955733|520732434|FG001|Period 2|Withdrawal by Subject|3|||
144723166|NCT03504852|521840642|FG001|Overall Study|Adverse Event|8|||
144416964|NCT01955733|520732435|FG002|Period 2|Withdrawal by Subject|2|||
144416965|NCT01955733|520732433|FG000|Period 2|Study terminated by sponsor|8|||
144723167|NCT03504852|521840643|FG002|Overall Study|Adverse Event|2|||
144416966|NCT01955733|520732434|FG001|Period 2|Study terminated by sponsor|14|||
144416967|NCT01955733|520732435|FG002|Period 2|Study terminated by sponsor|16|||
144723168|NCT01200394|521840644|FG000|Overall Study|Adverse Event|0|||
144416968|NCT01955733|520732433|FG000|Period 2|Lost to Follow-up|2|||
144416969|NCT01955733|520732434|FG001|Period 2|Lost to Follow-up|0|||
144416970|NCT01955733|520732435|FG002|Period 2|Lost to Follow-up|0|||
144416971|NCT01955733|520732433|FG000|Period 2|Other not defined above|0|||
144416972|NCT01955733|520732434|FG001|Period 2|Other not defined above|2|||
144416973|NCT01955733|520732435|FG002|Period 2|Other not defined above|2|||
144416974|NCT02154490|520732436|FG000|Overall Study|No tissue submitted|23|||
144416975|NCT02154490|520732436|FG000|Overall Study|No biomarker results|167|||
144416976|NCT02154490|520732436|FG000|Overall Study|Not assigned to a sub-study|270|||
144416977|NCT02154490|520732436|FG000|Overall Study|Did not register to a sub-study|749|||
144416978|NCT02289690|520732449|FG000|Overall Study|Adverse Event Related to Progression|0|||
144416979|NCT02289690|520732450|FG001|Overall Study|Adverse Event Related to Progression|1|||
144416980|NCT02289690|520732451|FG002|Overall Study|Adverse Event Related to Progression|1|||
144416981|NCT02289690|520732452|FG003|Overall Study|Adverse Event Related to Progression|0|||
144416982|NCT02289690|520732453|FG004|Overall Study|Adverse Event Related to Progression|1|||
144416983|NCT02289690|520732454|FG005|Overall Study|Adverse Event Related to Progression|0|||
144416984|NCT02289690|520732455|FG006|Overall Study|Adverse Event Related to Progression|1|||
144416985|NCT02289690|520732456|FG007|Overall Study|Adverse Event Related to Progression|0|||
144416986|NCT02289690|520732457|FG008|Overall Study|Adverse Event Related to Progression|0|||
144416987|NCT02289690|520732458|FG009|Overall Study|Adverse Event Related to Progression|0|||
144416988|NCT02289690|520732449|FG000|Overall Study|Withdrawal by Subject|1|||
144416989|NCT02289690|520732450|FG001|Overall Study|Withdrawal by Subject|0|||
144416990|NCT02289690|520732451|FG002|Overall Study|Withdrawal by Subject|0|||
144416991|NCT02289690|520732452|FG003|Overall Study|Withdrawal by Subject|0|||
144416992|NCT02289690|520732453|FG004|Overall Study|Withdrawal by Subject|1|||
144416993|NCT02289690|520732454|FG005|Overall Study|Withdrawal by Subject|1|||
144179689|NCT04573309|519852401|FG000|Overall Study|Protocol Violation|1|||
144179690|NCT04573309|519852402|FG001|Overall Study|Protocol Violation|0|||
144179691|NCT01691430|519852405|FG000|Overall Study|Death|17|||
144179692|NCT01691430|519852406|FG001|Overall Study|Death|16|||
144179693|NCT01691430|519852405|FG000|Overall Study|Withdrawal by Subject|5|||
144416994|NCT02289690|520732455|FG006|Overall Study|Withdrawal by Subject|0|||
144416995|NCT02289690|520732456|FG007|Overall Study|Withdrawal by Subject|0|||
144416996|NCT02289690|520732457|FG008|Overall Study|Withdrawal by Subject|4|||
144416997|NCT02289690|520732458|FG009|Overall Study|Withdrawal by Subject|2|||
144416998|NCT02289690|520732449|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
144600966|NCT00821431|521401688|FG001|Overall Study|Withdrawal by Subject|0|||
144600967|NCT00821431|521401687|FG000|Overall Study|Lost to Follow-up|1|||
144600968|NCT00821431|521401688|FG001|Overall Study|Lost to Follow-up|0|||
144600969|NCT00821431|521401687|FG000|Overall Study|Protocol Violation|3|||
144600970|NCT00821431|521401688|FG001|Overall Study|Protocol Violation|1|||
144600971|NCT00821431|521401687|FG000|Overall Study|Physician Decision|0|||
144600972|NCT00821431|521401688|FG001|Overall Study|Physician Decision|1|||
144600973|NCT01387230|521401689|FG000|Overall Study|Adverse Event|0|||
144723169|NCT01200394|521840645|FG001|Overall Study|Adverse Event|14|||
144179694|NCT01691430|519852406|FG001|Overall Study|Withdrawal by Subject|1|||
144416999|NCT02289690|520732450|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
144417000|NCT02289690|520732451|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
144417001|NCT02289690|520732452|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
144417002|NCT02289690|520732453|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
144600974|NCT01387230|521401690|FG001|Overall Study|Adverse Event|1|||
144600975|NCT01387230|521401691|FG002|Overall Study|Adverse Event|3|||
144723170|NCT01200394|521840644|FG000|Overall Study|Death|1|||
144179695|NCT01691430|519852405|FG000|Overall Study|Lost to Follow-up|0|||
144179696|NCT01691430|519852406|FG001|Overall Study|Lost to Follow-up|3|||
144179697|NCT02583048|519852407|FG000|Overall Study|Withdrawal by Subject|0|||
144417003|NCT02289690|520732454|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
144417004|NCT02289690|520732455|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
144179698|NCT02583048|519852408|FG001|Overall Study|Withdrawal by Subject|1|||
144179699|NCT02583048|519852409|FG002|Overall Study|Withdrawal by Subject|0|||
144179700|NCT02583048|519852407|FG000|Overall Study|Failed to meet eligibility criterion|0|||
144179701|NCT02583048|519852408|FG001|Overall Study|Failed to meet eligibility criterion|0|||
144179702|NCT02583048|519852409|FG002|Overall Study|Failed to meet eligibility criterion|1|||
144417005|NCT02289690|520732456|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
144417006|NCT02289690|520732457|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
144417007|NCT02289690|520732458|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
144417008|NCT02289690|520732449|FG000|Overall Study|Lost to Follow-up|0|||
144417009|NCT02289690|520732450|FG001|Overall Study|Lost to Follow-up|0|||
144417010|NCT02289690|520732451|FG002|Overall Study|Lost to Follow-up|0|||
144600976|NCT01387230|521401689|FG000|Overall Study|Lack of Efficacy|8|||
144250765|NCT05025332|520117355|FG000|Treatment & Follow Up|Protocol Violation|1|||
144250766|NCT05025332|520117355|FG000|Treatment & Follow Up|Adverse Event|4|||
144250767|NCT01306214|520117356|FG000|Overall Study|Death|0|||
144250768|NCT01306214|520117357|FG001|Overall Study|Death|0|||
144250769|NCT01306214|520117358|FG002|Overall Study|Death|1|||
144250770|NCT01306214|520117356|FG000|Overall Study|Lost to Follow-up|3|||
144250771|NCT01306214|520117357|FG001|Overall Study|Lost to Follow-up|5|||
144250772|NCT01306214|520117358|FG002|Overall Study|Lost to Follow-up|4|||
144250773|NCT01306214|520117356|FG000|Overall Study|Withdrawal by Subject|24|||
144250774|NCT01306214|520117357|FG001|Overall Study|Withdrawal by Subject|22|||
144250775|NCT01306214|520117358|FG002|Overall Study|Withdrawal by Subject|16|||
144250776|NCT01306214|520117356|FG000|Overall Study|Not treated|1|||
144250777|NCT01306214|520117357|FG001|Overall Study|Not treated|1|||
144250778|NCT01306214|520117358|FG002|Overall Study|Not treated|1|||
144250779|NCT02907619|520117359|FG000|Overall Study|Study terminated by sponsor|18|||
144250780|NCT02907619|520117360|FG001|Overall Study|Study terminated by sponsor|18|||
144250781|NCT02907619|520117361|FG002|Overall Study|Study terminated by sponsor|19|||
144250782|NCT02907619|520117359|FG000|Overall Study|Death|0|||
144250783|NCT02907619|520117360|FG001|Overall Study|Death|0|||
144250784|NCT02907619|520117361|FG002|Overall Study|Death|1|||
144250785|NCT02907619|520117359|FG000|Overall Study|Withdrawal by Subject|1|||
144250786|NCT02907619|520117360|FG001|Overall Study|Withdrawal by Subject|1|||
144250787|NCT02907619|520117361|FG002|Overall Study|Withdrawal by Subject|0|||
144250788|NCT02907619|520117359|FG000|Overall Study|Other|0|||
144250789|NCT02907619|520117360|FG001|Overall Study|Other|1|||
144250790|NCT02907619|520117361|FG002|Overall Study|Other|0|||
144250791|NCT01375374|520117362|FG000|Overall Study|Adverse Event|1|||
144250792|NCT01908582|520117363|FG000|Period 2|Physician Decision|1|||
144250793|NCT01908582|520117363|FG000|Period 2|Withdrawal by Subject|1|||
144250794|NCT02065518|520117365|FG000|Overall Study|Lost to Follow-up|3|||
144250795|NCT02065518|520117366|FG001|Overall Study|Lost to Follow-up|4|||
144250796|NCT02065518|520117367|FG002|Overall Study|Lost to Follow-up|0|||
144250797|NCT02065518|520117368|FG003|Overall Study|Lost to Follow-up|3|||
144250798|NCT02065518|520117365|FG000|Overall Study|Withdrawal by Subject|3|||
144250799|NCT02065518|520117366|FG001|Overall Study|Withdrawal by Subject|4|||
144250800|NCT02065518|520117367|FG002|Overall Study|Withdrawal by Subject|9|||
144250801|NCT02065518|520117368|FG003|Overall Study|Withdrawal by Subject|2|||
144250802|NCT00564278|520117369|FG000|Overall Study|Lost to Follow-up|35|||
144250803|NCT00564278|520117370|FG001|Overall Study|Lost to Follow-up|33|||
144250804|NCT00564278|520117369|FG000|Overall Study|Physician Decision|1|||
144250805|NCT00564278|520117370|FG001|Overall Study|Physician Decision|2|||
144250806|NCT00564278|520117369|FG000|Overall Study|Withdrawal by Subject|11|||
144250807|NCT00564278|520117370|FG001|Overall Study|Withdrawal by Subject|7|||
144250808|NCT06439095|520117371|FG000|Overall Study|Lost to Follow-up|2|||
144250809|NCT03341936|520117372|FG000|Overall Study|Ineligible|1|||
144250810|NCT03341936|520117372|FG000|Overall Study|Disease Progression|2|||
144250811|NCT03341936|520117372|FG000|Overall Study|Withdrew Consent|4|||
144250812|NCT03341936|520117372|FG000|Overall Study|Non-Compliance|1|||
144250813|NCT03341936|520117372|FG000|Overall Study|Physician Decision|1|||
144250814|NCT03341936|520117372|FG000|Overall Study|Withdrawal by Subject|1|||
144250815|NCT03341936|520117372|FG000|Overall Study|Other|1|||
144250816|NCT02368886|520117373|FG000|Overall Study|Cancel|1|||
144250817|NCT02368886|520117374|FG001|Overall Study|Cancel|1|||
144250818|NCT02368886|520117375|FG002|Overall Study|Cancel|1|||
144250819|NCT02368886|520117376|FG003|Overall Study|Cancel|3|||
144250820|NCT02368886|520117373|FG000|Overall Study|Ineligible|0|||
144250821|NCT02368886|520117374|FG001|Overall Study|Ineligible|0|||
144250822|NCT02368886|520117375|FG002|Overall Study|Ineligible|0|||
144250823|NCT02368886|520117376|FG003|Overall Study|Ineligible|1|||
144250824|NCT02131636|520117381|FG000|Overall Study|Personal Reasons|4|||
144250825|NCT02131636|520117382|FG001|Overall Study|Personal Reasons|4|||
144250826|NCT02131636|520117381|FG000|Overall Study|Lost to Follow-up|4|||
144417011|NCT02289690|520732452|FG003|Overall Study|Lost to Follow-up|0|||
144417012|NCT02289690|520732453|FG004|Overall Study|Lost to Follow-up|0|||
144600977|NCT01387230|521401690|FG001|Overall Study|Lack of Efficacy|5|||
144250827|NCT02131636|520117382|FG001|Overall Study|Lost to Follow-up|0|||
144250828|NCT02131636|520117381|FG000|Overall Study|Adverse Event|4|||
144250829|NCT02131636|520117382|FG001|Overall Study|Adverse Event|1|||
144250830|NCT03484403|520117383|FG000|Overall Study|Withdrawal by Subject|6|||
144250831|NCT03484403|520117384|FG001|Overall Study|Withdrawal by Subject|4|||
144250832|NCT02173379|520117385|FG000|Overall Study|Lost to Follow-up|89|||
144250833|NCT02173379|520117386|FG001|Overall Study|Lost to Follow-up|81|||
144250834|NCT02173379|520117385|FG000|Overall Study|Withdrawal by Subject|24|||
144417013|NCT02289690|520732454|FG005|Overall Study|Lost to Follow-up|0|||
144417014|NCT02289690|520732455|FG006|Overall Study|Lost to Follow-up|0|||
144417015|NCT02289690|520732456|FG007|Overall Study|Lost to Follow-up|1|||
144417016|NCT02289690|520732457|FG008|Overall Study|Lost to Follow-up|0|||
144417017|NCT02289690|520732458|FG009|Overall Study|Lost to Follow-up|2|||
144417018|NCT02289690|520732449|FG000|Overall Study|Death|0|||
144417019|NCT02289690|520732450|FG001|Overall Study|Death|0|||
144417020|NCT02289690|520732451|FG002|Overall Study|Death|0|||
144179703|NCT00659815|519852416|FG000|Overall Study|Study related symptoms and complaints|2|||
144179704|NCT00659815|519852417|FG001|Overall Study|Study related symptoms and complaints|1|||
144179705|NCT00659815|519852416|FG000|Overall Study|Inability to maintain wearing schedule|1|||
144179706|NCT00659815|519852417|FG001|Overall Study|Inability to maintain wearing schedule|2|||
144179707|NCT00659815|519852416|FG000|Overall Study|Withdrawal by Subject|1|||
144179708|NCT00659815|519852417|FG001|Overall Study|Withdrawal by Subject|1|||
144179709|NCT02651987|519852418|FG000|Overall Study|Adverse Event|2|||
144179710|NCT02651987|519852419|FG001|Overall Study|Adverse Event|2|||
144179711|NCT02651987|519852418|FG000|Overall Study|Consent Withdrawn|2|||
144179712|NCT02651987|519852419|FG001|Overall Study|Consent Withdrawn|0|||
144179713|NCT02651987|519852418|FG000|Overall Study|Local PD|0|||
144179714|NCT02651987|519852419|FG001|Overall Study|Local PD|2|||
144179715|NCT02651987|519852418|FG000|Overall Study|Investigator Decision|1|||
144179716|NCT02651987|519852419|FG001|Overall Study|Investigator Decision|1|||
144179717|NCT04408924|519852420|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
144179718|NCT04408924|519852420|FG000|Overall Study|Lost to Follow-up|3|||
144179719|NCT04408924|519852420|FG000|Overall Study|Withdrawal by Subject|5|||
144179720|NCT04408924|519852420|FG000|Overall Study|Sponsor Decision|2|||
144179721|NCT04661202|519852421|FG000|Overall Study|Withdrawal by Subject|1|||
144179722|NCT04661202|519852422|FG001|Overall Study|Withdrawal by Subject|1|||
144179723|NCT04661202|519852421|FG000|Overall Study|Lack of Efficacy|2|||
144179724|NCT04661202|519852422|FG001|Overall Study|Lack of Efficacy|0|||
144417021|NCT02289690|520732452|FG003|Overall Study|Death|0|||
144417022|NCT02289690|520732453|FG004|Overall Study|Death|0|||
144179725|NCT02694536|519852428|FG000|Overall Study|Progressive Disease|40|||
144179726|NCT02694536|519852428|FG000|Overall Study|Lost to Follow-up|1|||
144179727|NCT02694536|519852428|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
144179728|NCT02694536|519852428|FG000|Overall Study|Withdrawal by Subject|8|||
144179729|NCT02694536|519852428|FG000|Overall Study|Death|8|||
144179730|NCT02694536|519852428|FG000|Overall Study|Other|22|||
144179731|NCT01911429|519852429|FG000|Overall Study|Adverse Event|5|||
144179732|NCT01911429|519852430|FG001|Overall Study|Adverse Event|3|||
144179733|NCT01911429|519852431|FG002|Overall Study|Adverse Event|9|||
144179734|NCT01911429|519852429|FG000|Overall Study|Lack of Efficacy|1|||
144417023|NCT02289690|520732454|FG005|Overall Study|Death|0|||
144417024|NCT02289690|520732455|FG006|Overall Study|Death|0|||
144417025|NCT02289690|520732456|FG007|Overall Study|Death|49|||
144417026|NCT02289690|520732457|FG008|Overall Study|Death|45|||
144417027|NCT02289690|520732458|FG009|Overall Study|Death|41|||
144417028|NCT02289690|520732449|FG000|Overall Study|Sponsor Discontinued Study|0|||
144417029|NCT02289690|520732450|FG001|Overall Study|Sponsor Discontinued Study|0|||
144417030|NCT02289690|520732451|FG002|Overall Study|Sponsor Discontinued Study|0|||
144417031|NCT02289690|520732452|FG003|Overall Study|Sponsor Discontinued Study|0|||
144417032|NCT02289690|520732453|FG004|Overall Study|Sponsor Discontinued Study|0|||
144417033|NCT02289690|520732454|FG005|Overall Study|Sponsor Discontinued Study|0|||
144417034|NCT02289690|520732455|FG006|Overall Study|Sponsor Discontinued Study|0|||
144417035|NCT02289690|520732456|FG007|Overall Study|Sponsor Discontinued Study|9|||
144417036|NCT02289690|520732457|FG008|Overall Study|Sponsor Discontinued Study|7|||
144417037|NCT02289690|520732458|FG009|Overall Study|Sponsor Discontinued Study|15|||
144417038|NCT02289690|520732449|FG000|Overall Study|Other|0|||
144417039|NCT02289690|520732450|FG001|Overall Study|Other|0|||
144417040|NCT02289690|520732451|FG002|Overall Study|Other|0|||
144417041|NCT02289690|520732452|FG003|Overall Study|Other|1|||
144417042|NCT02289690|520732453|FG004|Overall Study|Other|1|||
144417043|NCT02289690|520732454|FG005|Overall Study|Other|0|||
144417044|NCT02289690|520732455|FG006|Overall Study|Other|1|||
144417045|NCT02289690|520732456|FG007|Overall Study|Other|2|||
144417046|NCT02289690|520732457|FG008|Overall Study|Other|3|||
144417047|NCT02289690|520732458|FG009|Overall Study|Other|1|||
144417048|NCT02085785|520732461|FG000|Overall Study|Withdrawal by Subject|2|||
144417049|NCT02085785|520732462|FG001|Overall Study|Withdrawal by Subject|1|||
144417050|NCT02085785|520732461|FG000|Overall Study|Lost to Follow-up|0|||
144417051|NCT02085785|520732462|FG001|Overall Study|Lost to Follow-up|1|||
144417052|NCT00779467|520732463|FG000|Overall Study|Lack of Efficacy|11|||
144417053|NCT00779467|520732464|FG001|Overall Study|Lack of Efficacy|2|||
144417054|NCT00779467|520732465|FG002|Overall Study|Lack of Efficacy|6|||
144417055|NCT00779467|520732466|FG003|Overall Study|Lack of Efficacy|11|||
144179735|NCT01911429|519852430|FG001|Overall Study|Lack of Efficacy|2|||
144179736|NCT01911429|519852431|FG002|Overall Study|Lack of Efficacy|4|||
144179737|NCT01911429|519852429|FG000|Overall Study|Lost to Follow-up|0|||
144179738|NCT01911429|519852430|FG001|Overall Study|Lost to Follow-up|0|||
144179739|NCT01911429|519852431|FG002|Overall Study|Lost to Follow-up|1|||
144417056|NCT00779467|520732463|FG000|Overall Study|failed inclusion criteria|3|||
144179740|NCT01911429|519852429|FG000|Overall Study|Protocol Violation|0|||
144179741|NCT01911429|519852430|FG001|Overall Study|Protocol Violation|0|||
144179742|NCT01911429|519852431|FG002|Overall Study|Protocol Violation|1|||
144179743|NCT01911429|519852429|FG000|Overall Study|Withdrawal by Subject|5|||
144179744|NCT01911429|519852430|FG001|Overall Study|Withdrawal by Subject|5|||
144179745|NCT01911429|519852431|FG002|Overall Study|Withdrawal by Subject|4|||
144179746|NCT01911429|519852429|FG000|Overall Study|Accidental randomization|0|||
144179747|NCT01911429|519852430|FG001|Overall Study|Accidental randomization|0|||
144179748|NCT01911429|519852431|FG002|Overall Study|Accidental randomization|1|||
144179749|NCT01911429|519852429|FG000|Overall Study|subject left study|1|||
144179750|NCT01911429|519852430|FG001|Overall Study|subject left study|0|||
144179751|NCT01911429|519852431|FG002|Overall Study|subject left study|0|||
144417057|NCT00779467|520732464|FG001|Overall Study|failed inclusion criteria|3|||
144417058|NCT00779467|520732465|FG002|Overall Study|failed inclusion criteria|1|||
144417059|NCT00779467|520732466|FG003|Overall Study|failed inclusion criteria|2|||
144417060|NCT00779467|520732463|FG000|Overall Study|missing data|1|||
144417061|NCT00779467|520732464|FG001|Overall Study|missing data|0|||
144417062|NCT00779467|520732465|FG002|Overall Study|missing data|1|||
144417063|NCT00779467|520732466|FG003|Overall Study|missing data|4|||
144417064|NCT00779467|520732463|FG000|Overall Study|technical issue|0|||
144417065|NCT00779467|520732464|FG001|Overall Study|technical issue|0|||
144417066|NCT00779467|520732465|FG002|Overall Study|technical issue|2|||
144417067|NCT00779467|520732466|FG003|Overall Study|technical issue|1|||
144417068|NCT00779467|520732463|FG000|Overall Study|unavailable research staff|0|||
144417069|NCT00779467|520732464|FG001|Overall Study|unavailable research staff|0|||
144417070|NCT00779467|520732465|FG002|Overall Study|unavailable research staff|0|||
144417071|NCT00779467|520732466|FG003|Overall Study|unavailable research staff|1|||
144417072|NCT04626297|520732467|FG000|Overall Study|Adverse Event|5|||
144417073|NCT04626297|520732468|FG001|Overall Study|Adverse Event|3|||
144417074|NCT04626297|520732467|FG000|Overall Study|Lost to Follow-up|7|||
144417075|NCT04626297|520732468|FG001|Overall Study|Lost to Follow-up|3|||
144417076|NCT04626297|520732467|FG000|Overall Study|Protocol Violation|5|||
144417077|NCT04626297|520732468|FG001|Overall Study|Protocol Violation|1|||
144417078|NCT04626297|520732467|FG000|Overall Study|Withdrawal by Subject|20|||
144417079|NCT04626297|520732468|FG001|Overall Study|Withdrawal by Subject|6|||
144417080|NCT04626297|520732467|FG000|Overall Study|Sponsor decision|2|||
144417081|NCT04626297|520732468|FG001|Overall Study|Sponsor decision|1|||
144417082|NCT04118166|520732469|FG000|Overall Study|Adverse Event|1|||
144417083|NCT02254486|520732472|FG000|Overall Study|Adverse Event|1|||
144417084|NCT02254486|520732473|FG001|Overall Study|Adverse Event|1|||
144417085|NCT02254486|520732472|FG000|Overall Study|Lack of Efficacy|1|||
144417086|NCT02254486|520732473|FG001|Overall Study|Lack of Efficacy|0|||
144417087|NCT02254486|520732472|FG000|Overall Study|Lost to Follow-up|2|||
144417088|NCT02254486|520732473|FG001|Overall Study|Lost to Follow-up|4|||
144417089|NCT02254486|520732472|FG000|Overall Study|Protocol Violation|1|||
144417090|NCT02254486|520732473|FG001|Overall Study|Protocol Violation|2|||
144417091|NCT02254486|520732472|FG000|Overall Study|Withdrawal by Subject|17|||
144417092|NCT02254486|520732473|FG001|Overall Study|Withdrawal by Subject|15|||
144417093|NCT02254486|520732472|FG000|Overall Study|GFR<60mL/min|16|||
144417094|NCT02254486|520732473|FG001|Overall Study|GFR<60mL/min|21|||
144417095|NCT02254486|520732472|FG000|Overall Study|Various|12|||
144179752|NCT03540160|519852432|FG000|Overall Study|Protocol Violation|1|||
144179753|NCT03540160|519852432|FG000|Overall Study|Physician Decision|8|||
144179754|NCT03540160|519852432|FG000|Overall Study|Lack of Efficacy|60|||
144179755|NCT03540160|519852432|FG000|Overall Study|Pregnancy|1|||
144179756|NCT03540160|519852432|FG000|Overall Study|Adverse Event|20|||
144417096|NCT02254486|520732473|FG001|Overall Study|Various|12|||
144417097|NCT01350414|520732480|FG000|Overall Study|Lost to Follow-up|13|||
144417098|NCT01350414|520732480|FG000|Overall Study|Withdrawal by Subject|4|||
144179757|NCT03540160|519852432|FG000|Overall Study|Withdrawal by Subject|68|||
144179758|NCT03540160|519852432|FG000|Overall Study|COVID-19|2|||
144179759|NCT03540160|519852432|FG000|Overall Study|Study Closure|10|||
144179760|NCT03540160|519852432|FG000|Overall Study|Lost to Follow-up|18|||
144179761|NCT03540160|519852432|FG000|Overall Study|Sponsor decision|191|||
144417099|NCT01350414|520732480|FG000|Overall Study|Physician Decision|2|||
144417100|NCT02743520|520732481|FG000|Overall Study|Withdrawal by Subject|1|||
144417101|NCT01749514|520732482|FG000|Overall Study|Lost to Follow-up|0|||
144417102|NCT01749514|520732483|FG001|Overall Study|Lost to Follow-up|0|||
144417103|NCT01749514|520732484|FG002|Overall Study|Lost to Follow-up|0|||
144417104|NCT01749514|520732485|FG003|Overall Study|Lost to Follow-up|0|||
144417105|NCT01749514|520732486|FG004|Overall Study|Lost to Follow-up|0|||
144417106|NCT01749514|520732487|FG005|Overall Study|Lost to Follow-up|0|||
144417107|NCT01749514|520732488|FG006|Overall Study|Lost to Follow-up|0|||
144179762|NCT02704091|519852434|FG000|Overall Study|Adverse Event|4|||
144179763|NCT02704091|519852435|FG001|Overall Study|Adverse Event|3|||
144179764|NCT02704091|519852434|FG000|Overall Study|Protocol Violation|5|||
144179765|NCT02704091|519852435|FG001|Overall Study|Protocol Violation|3|||
144179766|NCT02704091|519852434|FG000|Overall Study|Consent withdrawn|4|||
144179767|NCT02704091|519852435|FG001|Overall Study|Consent withdrawn|4|||
144417108|NCT01749514|520732489|FG007|Overall Study|Lost to Follow-up|1|||
144417109|NCT01749514|520732482|FG000|Overall Study|Withdrawal by Subject|0|||
144417110|NCT01749514|520732483|FG001|Overall Study|Withdrawal by Subject|0|||
144417111|NCT01749514|520732484|FG002|Overall Study|Withdrawal by Subject|0|||
144417112|NCT01749514|520732485|FG003|Overall Study|Withdrawal by Subject|0|||
144417113|NCT01749514|520732486|FG004|Overall Study|Withdrawal by Subject|0|||
144417114|NCT01749514|520732487|FG005|Overall Study|Withdrawal by Subject|1|||
144417115|NCT01749514|520732488|FG006|Overall Study|Withdrawal by Subject|0|||
144179768|NCT02704091|519852434|FG000|Overall Study|Lost to Follow-up|13|||
144417116|NCT01749514|520732489|FG007|Overall Study|Withdrawal by Subject|1|||
144417117|NCT01749514|520732482|FG000|Overall Study|Not Reported|0|||
144417118|NCT01749514|520732483|FG001|Overall Study|Not Reported|0|||
144417119|NCT01749514|520732484|FG002|Overall Study|Not Reported|0|||
144417120|NCT01749514|520732485|FG003|Overall Study|Not Reported|0|||
144417121|NCT01749514|520732486|FG004|Overall Study|Not Reported|0|||
144417122|NCT01749514|520732487|FG005|Overall Study|Not Reported|0|||
144417123|NCT01749514|520732488|FG006|Overall Study|Not Reported|0|||
144417124|NCT01749514|520732489|FG007|Overall Study|Not Reported|5|||
144417125|NCT02509156|520732490|FG000|Randomized Phase|Death|1|||
144417126|NCT02509156|520732491|FG001|Randomized Phase|Death|0|||
144417127|NCT02509156|520732490|FG000|Randomized Phase|Withdrawal by Subject|1|||
144527370|NCT06473662|521131923|FG000|Overall Study|Withdrawal by Subject|1|||
144179769|NCT02704091|519852435|FG001|Overall Study|Lost to Follow-up|5|||
144179770|NCT02704091|519852434|FG000|Overall Study|Other|2|||
144179771|NCT02704091|519852435|FG001|Overall Study|Other|8|||
144179772|NCT01634139|519852436|FG000|Overall Study|Non compliant with protocol|1|||
144179773|NCT01634139|519852437|FG001|Overall Study|Non compliant with protocol|0|||
144179774|NCT01634139|519852438|FG002|Overall Study|Non compliant with protocol|0|||
144179775|NCT01634139|519852436|FG000|Overall Study|Consent withdrawn not due to AE|4|||
144179776|NCT01634139|519852437|FG001|Overall Study|Consent withdrawn not due to AE|3|||
144179777|NCT01634139|519852438|FG002|Overall Study|Consent withdrawn not due to AE|2|||
144179778|NCT01634139|519852436|FG000|Overall Study|Other|4|||
144179779|NCT01634139|519852437|FG001|Overall Study|Other|0|||
144179780|NCT01634139|519852438|FG002|Overall Study|Other|3|||
144179781|NCT01634139|519852436|FG000|Overall Study|Lost to Follow-up|0|||
144179782|NCT01634139|519852437|FG001|Overall Study|Lost to Follow-up|2|||
144179783|NCT01634139|519852438|FG002|Overall Study|Lost to Follow-up|0|||
144179784|NCT01634139|519852436|FG000|Overall Study|Not treated|1|||
144179785|NCT01634139|519852437|FG001|Overall Study|Not treated|1|||
144179786|NCT01634139|519852438|FG002|Overall Study|Not treated|0|||
144179787|NCT00425308|519852439|FG000|Overall Study|Adverse Event|2|||
144179788|NCT00425308|519852440|FG001|Overall Study|Adverse Event|1|||
144179789|NCT00425308|519852439|FG000|Overall Study|Withdrawal by Subject|1|||
144179790|NCT00425308|519852440|FG001|Overall Study|Withdrawal by Subject|0|||
144179791|NCT00425308|519852439|FG000|Overall Study|Death|1|||
144179792|NCT00425308|519852440|FG001|Overall Study|Death|0|||
144179793|NCT01266902|519852444|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
144179794|NCT01266902|519852445|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
144179795|NCT01266902|519852446|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
144179796|NCT01266902|519852444|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
144179797|NCT01266902|519852445|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
144179798|NCT01266902|519852446|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
144179799|NCT01266902|519852444|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
144179800|NCT01266902|519852445|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
144179801|NCT01266902|519852446|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
144179802|NCT01266902|519852444|FG000|Period 1 (Main Study)|Adverse Event|3|||
144179803|NCT01266902|519852445|FG001|Period 1 (Main Study)|Adverse Event|11|||
144179804|NCT01266902|519852446|FG002|Period 1 (Main Study)|Adverse Event|0|||
144527371|NCT06473662|521131924|FG001|Overall Study|Withdrawal by Subject|6|||
144527372|NCT06473662|521131925|FG002|Overall Study|Withdrawal by Subject|5|||
144527373|NCT06473662|521131923|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
144527374|NCT06473662|521131924|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
144527375|NCT06473662|521131925|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
144527376|NCT06473662|521131923|FG000|Overall Study|Starting HbA1c below 7%|0|||
144527377|NCT06473662|521131924|FG001|Overall Study|Starting HbA1c below 7%|1|||
144527378|NCT06473662|521131925|FG002|Overall Study|Starting HbA1c below 7%|1|||
144527379|NCT06473662|521131923|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
144179805|NCT01266902|519852444|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
144417128|NCT02509156|520732491|FG001|Randomized Phase|Withdrawal by Subject|1|||
144417129|NCT03042533|520732492|FG000|Overall Study|MD left program|1|||
144417130|NCT03042533|520732493|FG001|Overall Study|MD left program|4|||
144417131|NCT03042533|520732494|FG002|Overall Study|MD left program|1|||
144600978|NCT01387230|521401691|FG002|Overall Study|Lack of Efficacy|4|||
144179806|NCT01266902|519852445|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
144179807|NCT01266902|519852446|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
144179808|NCT01266902|519852444|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
144179809|NCT01266902|519852445|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
144417132|NCT02551731|520732495|FG000|Overall Study|Withdrawal by Subject|2|||
144417133|NCT00010374|520732496|FG000|Overall Study|False positive phrenic nerve test|1|||
144417134|NCT00372112|520732497|FG000|Overall Study|Adverse Event|0|||
144417135|NCT00372112|520732498|FG001|Overall Study|Adverse Event|1|||
144417136|NCT00372112|520732499|FG002|Overall Study|Adverse Event|1|||
144417137|NCT00372112|520732500|FG003|Overall Study|Adverse Event|1|||
144417138|NCT00372112|520732497|FG000|Overall Study|Withdrawal by Subject|0|||
144417139|NCT00372112|520732498|FG001|Overall Study|Withdrawal by Subject|0|||
144417140|NCT00372112|520732499|FG002|Overall Study|Withdrawal by Subject|2|||
144417141|NCT00372112|520732500|FG003|Overall Study|Withdrawal by Subject|1|||
144417142|NCT00372112|520732497|FG000|Overall Study|Exacerbation|0|||
144417143|NCT00372112|520732498|FG001|Overall Study|Exacerbation|0|||
144417144|NCT00372112|520732499|FG002|Overall Study|Exacerbation|0|||
144417145|NCT00372112|520732500|FG003|Overall Study|Exacerbation|1|||
144417146|NCT00372112|520732497|FG000|Overall Study|PR >240 at Visit 3|0|||
144417147|NCT00372112|520732498|FG001|Overall Study|PR >240 at Visit 3|0|||
144417148|NCT00372112|520732499|FG002|Overall Study|PR >240 at Visit 3|0|||
144417149|NCT00372112|520732500|FG003|Overall Study|PR >240 at Visit 3|1|||
144417150|NCT00372112|520732497|FG000|Overall Study|Hepatitis B|1|||
144417151|NCT00372112|520732498|FG001|Overall Study|Hepatitis B|0|||
144417152|NCT00372112|520732499|FG002|Overall Study|Hepatitis B|0|||
144417153|NCT00372112|520732500|FG003|Overall Study|Hepatitis B|0|||
144417154|NCT00372112|520732497|FG000|Overall Study|Other-protocol violation|0|||
144417155|NCT00372112|520732498|FG001|Overall Study|Other-protocol violation|0|||
144417156|NCT00372112|520732499|FG002|Overall Study|Other-protocol violation|1|||
144417157|NCT00372112|520732500|FG003|Overall Study|Other-protocol violation|0|||
144417158|NCT01678911|520732501|FG000|Second Intervention|Lost to Follow-up|2|||
144417159|NCT01678911|520732502|FG001|Second Intervention|Lost to Follow-up|0|||
144417160|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
144417161|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
144417162|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
144179810|NCT01266902|519852446|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
144179811|NCT01266902|519852444|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
144179812|NCT01266902|519852445|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
144179813|NCT01266902|519852446|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
144179814|NCT01266902|519852444|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
144179815|NCT01266902|519852445|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
144179816|NCT01266902|519852446|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
144179817|NCT01266902|519852444|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
144179818|NCT01266902|519852445|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
144179819|NCT01266902|519852446|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
144179820|NCT01266902|519852444|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
144179821|NCT01266902|519852445|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
144179822|NCT01266902|519852446|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
144179823|NCT05562011|519852447|FG000|Overall Study|Withdrawal by Subject|3|||
144179824|NCT05562011|519852447|FG000|Overall Study|Lost to Follow-up|1|||
144179825|NCT05562011|519852447|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
144179826|NCT05562011|519852447|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
144179827|NCT05562011|519852447|FG000|Overall Study|Device malfunction|13|||
144179828|NCT04567329|519852450|FG000|Overall Study|Withdrawal by Subject|5|||
144179829|NCT04567329|519852451|FG001|Overall Study|Withdrawal by Subject|6|||
144179830|NCT04567329|519852450|FG000|Overall Study|Protocol Violation|2|||
144179831|NCT04567329|519852451|FG001|Overall Study|Protocol Violation|3|||
144417163|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
144417164|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
144417165|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
144417166|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
144417167|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
144417168|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Patient Request|1|||
144417169|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Patient Request|0|||
144417170|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
144417171|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
144179832|NCT04567329|519852450|FG000|Overall Study|Discontinued|2|||
144179833|NCT04567329|519852451|FG001|Overall Study|Discontinued|2|||
144417172|NCT04649060|520732503|FG000|Arm A/Arm B Treatment|Other|1|||
144417173|NCT04649060|520732504|FG001|Arm A/Arm B Treatment|Other|0|||
144417174|NCT04649060|520732503|FG000|Crossover (Arm B)|Adverse Event|0|||
144417175|NCT04649060|520732504|FG001|Crossover (Arm B)|Adverse Event|1|||
144527380|NCT06473662|521131924|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
144527381|NCT06473662|521131925|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
144417176|NCT04649060|520732503|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
144417177|NCT04649060|520732504|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
144417178|NCT02706691|520732505|FG000|Overall Study|Adverse Event|1|||
144179834|NCT04567329|519852450|FG000|Overall Study|Lost to Follow-up|0|||
144417179|NCT00356369|520732506|FG000|Active Phase|Withdrawal by Subject|2|||
144417180|NCT00356369|520732507|FG001|Active Phase|Withdrawal by Subject|1|||
144417181|NCT00137046|520732508|FG000|Overall Study|Death|2|||
144417182|NCT00137046|520732509|FG001|Overall Study|Death|1|||
144417183|NCT00137046|520732508|FG000|Overall Study|Adverse Event|16|||
144417184|NCT00137046|520732509|FG001|Overall Study|Adverse Event|5|||
144417185|NCT00137046|520732508|FG000|Overall Study|Laboratory Abnormality|2|||
144417186|NCT00137046|520732509|FG001|Overall Study|Laboratory Abnormality|0|||
144417187|NCT00137046|520732508|FG000|Overall Study|Lack of Efficacy|13|||
144417188|NCT00137046|520732509|FG001|Overall Study|Lack of Efficacy|1|||
144417189|NCT00137046|520732508|FG000|Overall Study|Lost to Follow-up|8|||
144417190|NCT00137046|520732509|FG001|Overall Study|Lost to Follow-up|24|||
144417191|NCT00137046|520732508|FG000|Overall Study|Other|23|||
144417192|NCT00137046|520732509|FG001|Overall Study|Other|19|||
144417193|NCT00137046|520732508|FG000|Overall Study|Withdrawal by Subject|33|||
144417194|NCT00137046|520732509|FG001|Overall Study|Withdrawal by Subject|42|||
144417195|NCT00137046|520732508|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
144417196|NCT00137046|520732509|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
144417197|NCT00137046|520732508|FG000|Overall Study|Withdrew prior to study treatment|1|||
144417198|NCT00137046|520732509|FG001|Overall Study|Withdrew prior to study treatment|1|||
144417199|NCT02532972|520732511|FG000|Overall Study|Withdrawal by Subject|1|||
144417200|NCT02859454|520732512|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
144417201|NCT04294472|520732513|FG000|Overall Study|Adverse Event|0|||
144417202|NCT04294472|520732514|FG001|Overall Study|Adverse Event|1|||
144417203|NCT04294472|520732515|FG002|Overall Study|Adverse Event|1|||
144417204|NCT04294472|520732513|FG000|Overall Study|Randomized but not treated|0|||
144417205|NCT04294472|520732514|FG001|Overall Study|Randomized but not treated|1|||
144417206|NCT04294472|520732515|FG002|Overall Study|Randomized but not treated|1|||
144417207|NCT03944954|520732516|FG000|Overall Study|Withdrawal by Subject|22|||
144417208|NCT03944954|520732517|FG001|Overall Study|Withdrawal by Subject|4|||
144417209|NCT03944954|520732516|FG000|Overall Study|Lost to Follow-up|18|||
144417210|NCT03944954|520732517|FG001|Overall Study|Lost to Follow-up|0|||
144417211|NCT03944954|520732516|FG000|Overall Study|Failed Medical Screening|7|||
144417212|NCT03944954|520732517|FG001|Overall Study|Failed Medical Screening|0|||
144417213|NCT02268084|520732520|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
144417214|NCT02268084|520732521|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
144417215|NCT02268084|520732520|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
144417216|NCT02268084|520732521|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
144417217|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
144417218|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
144417219|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
144417220|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
144417221|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
144417222|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
144417223|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
144417224|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
144417225|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
144417226|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
144417227|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
144417228|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
144417229|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
144417230|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
144417231|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
144417232|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
144417233|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
144417234|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
144417235|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
144417236|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
144417237|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
144417238|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
144417239|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
144417240|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
144417241|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
144417242|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
144417243|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
144417244|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
144471970|NCT03217747|520925356|FG003|Overall Study|Withdrawal by Subject|1|||
144723171|NCT01200394|521840645|FG001|Overall Study|Death|0|||
144417245|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
144417246|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
144417247|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
144417248|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
144417249|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
144417250|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
144417251|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
144417252|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
144417253|NCT02603419|520732522|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
144417254|NCT02603419|520732523|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
144417255|NCT02603419|520732524|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
144417256|NCT02603419|520732525|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
144417257|NCT02603419|520732526|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
144417258|NCT02603419|520732527|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
144179835|NCT04567329|519852451|FG001|Overall Study|Lost to Follow-up|1|||
144179836|NCT04567329|519852450|FG000|Overall Study|Lack of Efficacy|0|||
144179837|NCT04567329|519852451|FG001|Overall Study|Lack of Efficacy|1|||
144179838|NCT04411680|519852452|FG000|Treatment Period|Adverse Event|3|||
144179839|NCT04411680|519852453|FG001|Treatment Period|Adverse Event|0|||
144179840|NCT04411680|519852452|FG000|Treatment Period|Discharged from hospital|18|||
144179841|NCT04411680|519852453|FG001|Treatment Period|Discharged from hospital|7|||
144179842|NCT04411680|519852452|FG000|Treatment Period|Missed 1 or more doses|8|||
144179843|NCT04411680|519852453|FG001|Treatment Period|Missed 1 or more doses|0|||
144179844|NCT04411680|519852452|FG000|Treatment Period|Transferred to another hospital|0|||
144179845|NCT04411680|519852453|FG001|Treatment Period|Transferred to another hospital|1|||
144179846|NCT04411680|519852452|FG000|Follow up Period|Withdrawal by Subject|2|||
144179847|NCT04411680|519852453|FG001|Follow up Period|Withdrawal by Subject|0|||
144179848|NCT04411680|519852452|FG000|Follow up Period|Lost to Follow-up|5|||
144179849|NCT04411680|519852453|FG001|Follow up Period|Lost to Follow-up|6|||
144179850|NCT04411680|519852452|FG000|Follow up Period|Death|11|||
144179851|NCT04411680|519852453|FG001|Follow up Period|Death|8|||
144179852|NCT00841659|519852458|FG000|Washout: 2 Weeks|Protocol Violation|1|||
144179853|NCT00841659|519852459|FG001|Washout: 2 Weeks|Protocol Violation|0|||
144179854|NCT01149057|519852460|FG000|Overall Study|Lack of Efficacy|16|||
144179855|NCT01149057|519852460|FG000|Overall Study|Adverse Event|13|||
144179856|NCT01149057|519852460|FG000|Overall Study|Withdrawal by Subject|9|||
144179857|NCT01149057|519852460|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
144179858|NCT01149057|519852460|FG000|Overall Study|B Cell Depletion|4|||
144417259|NCT02603419|520732522|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
144417260|NCT02603419|520732523|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
144417261|NCT02603419|520732524|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
144417262|NCT02603419|520732525|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
144417263|NCT02603419|520732526|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
144417264|NCT02603419|520732527|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
144417265|NCT02603419|520732522|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
144417266|NCT02603419|520732523|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
144417267|NCT02603419|520732524|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
144417268|NCT02603419|520732525|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
144417269|NCT02603419|520732526|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
144417270|NCT02603419|520732527|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
144417271|NCT02603419|520732522|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
144417272|NCT02603419|520732523|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
144417273|NCT02603419|520732524|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
144417274|NCT02603419|520732525|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
144417275|NCT02603419|520732526|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
144417276|NCT02603419|520732527|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
144417277|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
144417278|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
144417279|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
144417280|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
144417281|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
144723172|NCT01200394|521840644|FG000|Overall Study|Lost to Follow-up|0|||
144179859|NCT01149057|519852460|FG000|Overall Study|Participant Non-Compliance|2|||
144179860|NCT01149057|519852460|FG000|Overall Study|Lost to Follow-up|1|||
144179861|NCT01149057|519852460|FG000|Overall Study|High Parathyroid Hormone Value|1|||
144179862|NCT01149057|519852460|FG000|Overall Study|Other|6|||
144179863|NCT04608448|519852461|FG000|Overall Study|Withdrawal by Subject|1|||
144179864|NCT04608448|519852461|FG000|Overall Study|Adverse Event|1|||
144179865|NCT02436200|519852477|FG000|Overall Study|Significant outlier|1|||
144179866|NCT00672984|519852478|FG000|First Intervention|Adverse Event|5|||
144417282|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
144417283|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
144417284|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
144417285|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Other|1|||
144600979|NCT01387230|521401689|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
144600980|NCT01387230|521401690|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
144600981|NCT01387230|521401691|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
144600982|NCT01387230|521401689|FG000|Overall Study|Lost to Follow-up|0|||
144179867|NCT00672984|519852479|FG001|First Intervention|Adverse Event|0|||
144179868|NCT00672984|519852480|FG002|First Intervention|Adverse Event|0|||
144179869|NCT00672984|519852478|FG000|First Intervention|Withdrawal by Subject|1|||
144179870|NCT00672984|519852479|FG001|First Intervention|Withdrawal by Subject|2|||
144179871|NCT00672984|519852480|FG002|First Intervention|Withdrawal by Subject|2|||
144179872|NCT00672984|519852478|FG000|First Intervention|Sponsor decision|3|||
144179873|NCT00672984|519852479|FG001|First Intervention|Sponsor decision|0|||
144179874|NCT00672984|519852480|FG002|First Intervention|Sponsor decision|0|||
144179875|NCT00672984|519852478|FG000|Second Intervention|Non-compliance with facility policies|0|||
144179876|NCT00672984|519852479|FG001|Second Intervention|Non-compliance with facility policies|2|||
144179877|NCT00672984|519852480|FG002|Second Intervention|Non-compliance with facility policies|0|||
144179878|NCT00672984|519852478|FG000|Second Intervention|Withdrawal by Subject|0|||
144179879|NCT00672984|519852479|FG001|Second Intervention|Withdrawal by Subject|3|||
144179880|NCT00672984|519852480|FG002|Second Intervention|Withdrawal by Subject|0|||
144179881|NCT00672984|519852478|FG000|Second Intervention|Protocol Violation|0|||
144179882|NCT00672984|519852479|FG001|Second Intervention|Protocol Violation|1|||
144179883|NCT00672984|519852480|FG002|Second Intervention|Protocol Violation|1|||
144179884|NCT00672984|519852478|FG000|Third Intervention|Adverse Event|1|||
144179885|NCT00672984|519852479|FG001|Third Intervention|Adverse Event|0|||
144179886|NCT00672984|519852480|FG002|Third Intervention|Adverse Event|1|||
144179887|NCT01968551|519852481|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
144179888|NCT01968551|519852482|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
144179889|NCT01968551|519852483|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
144179890|NCT01968551|519852481|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
144179891|NCT01968551|519852482|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
144179892|NCT01968551|519852483|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
144417286|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Other|4|||
144417287|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Other|3|||
144600983|NCT01387230|521401690|FG001|Overall Study|Lost to Follow-up|0|||
144600984|NCT01387230|521401691|FG002|Overall Study|Lost to Follow-up|1|||
144600985|NCT01387230|521401689|FG000|Overall Study|Withdrawal by Subject|4|||
144600986|NCT01387230|521401690|FG001|Overall Study|Withdrawal by Subject|1|||
144600987|NCT01387230|521401691|FG002|Overall Study|Withdrawal by Subject|0|||
144600988|NCT03026127|521401694|FG000|CRISP R61|Adverse Event|5|||
144600989|NCT03026127|521401695|FG001|CRISP R61|Adverse Event|0|||
144600990|NCT03026127|521401696|FG002|CRISP R61|Adverse Event|0|||
144600991|NCT03026127|521401694|FG000|CRISP R61|Lost to Follow-up|2|||
144600992|NCT03026127|521401695|FG001|CRISP R61|Lost to Follow-up|0|||
144600993|NCT03026127|521401696|FG002|CRISP R61|Lost to Follow-up|0|||
144600994|NCT03026127|521401694|FG000|CRISP R61|Dropped before therapy|5|||
144600995|NCT03026127|521401695|FG001|CRISP R61|Dropped before therapy|0|||
144600996|NCT03026127|521401696|FG002|CRISP R61|Dropped before therapy|0|||
144600997|NCT03026127|521401694|FG000|CRISP R33|Lost to Follow-up|0|||
144600998|NCT03026127|521401695|FG001|CRISP R33|Lost to Follow-up|5|||
144600999|NCT03026127|521401696|FG002|CRISP R33|Lost to Follow-up|4|||
144601000|NCT03026127|521401694|FG000|CRISP R33|Adverse Event|0|||
144417288|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Other|6|||
144417289|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
144601001|NCT03026127|521401695|FG001|CRISP R33|Adverse Event|9|||
144601002|NCT03026127|521401696|FG002|CRISP R33|Adverse Event|5|||
144601003|NCT03026127|521401694|FG000|CRISP R33|Withdrawal by Subject|0|||
144601004|NCT03026127|521401695|FG001|CRISP R33|Withdrawal by Subject|9|||
144601005|NCT03026127|521401696|FG002|CRISP R33|Withdrawal by Subject|1|||
144601006|NCT03026127|521401694|FG000|CRISP R33|Lack of Efficacy|0|||
144601007|NCT03026127|521401695|FG001|CRISP R33|Lack of Efficacy|3|||
144601008|NCT03026127|521401696|FG002|CRISP R33|Lack of Efficacy|2|||
144601009|NCT03026127|521401694|FG000|CRISP R33|Physician Decision|0|||
144601010|NCT03026127|521401695|FG001|CRISP R33|Physician Decision|3|||
144179893|NCT01968551|519852481|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
144179894|NCT01968551|519852482|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
144179895|NCT01968551|519852483|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
144179896|NCT01968551|519852481|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
144179897|NCT01968551|519852482|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
144179898|NCT01968551|519852483|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
144179899|NCT01968551|519852481|FG000|Extension Phase|Adverse Event|0|||
144179900|NCT01968551|519852482|FG001|Extension Phase|Adverse Event|0|||
144179901|NCT01968551|519852483|FG002|Extension Phase|Adverse Event|2|||
144601011|NCT03026127|521401696|FG002|CRISP R33|Physician Decision|1|||
144417290|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
144417291|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
144417292|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
144417293|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
144417294|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
144417295|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
144179902|NCT01968551|519852481|FG000|Extension Phase|Death|0|||
144179903|NCT01968551|519852482|FG001|Extension Phase|Death|1|||
144417296|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
144417297|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
144417298|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
144417299|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
144417300|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
144417301|NCT02925494|520732528|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
144417302|NCT02925494|520732529|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
144417303|NCT02925494|520732530|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
144417304|NCT02925494|520732531|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
144417305|NCT03334448|520732535|FG000|Washout|Personal Reason|0|||
144417306|NCT03334448|520732536|FG001|Washout|Personal Reason|1|||
144417307|NCT03334448|520732537|FG002|Washout|Personal Reason|0|||
144417308|NCT03334448|520732538|FG003|Washout|Personal Reason|0|||
144417309|NCT03334448|520732535|FG000|Washout|Protocol Violation|0|||
144417310|NCT03334448|520732536|FG001|Washout|Protocol Violation|0|||
144723173|NCT01200394|521840645|FG001|Overall Study|Lost to Follow-up|1|||
144723174|NCT01200394|521840644|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
144723175|NCT01200394|521840645|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
144723176|NCT01200394|521840644|FG000|Overall Study|Protocol Violation|0|||
144723177|NCT01200394|521840645|FG001|Overall Study|Protocol Violation|3|||
144723178|NCT01200394|521840644|FG000|Overall Study|Withdrawal by Subject|0|||
144723179|NCT01200394|521840645|FG001|Overall Study|Withdrawal by Subject|5|||
144723180|NCT01200394|521840644|FG000|Overall Study|Other|0|||
144723181|NCT01200394|521840645|FG001|Overall Study|Other|1|||
144723182|NCT02729896|521840648|FG000|Overall Study|Death|0|||
144723183|NCT02729896|521840649|FG001|Overall Study|Death|2|||
144723184|NCT02729896|521840650|FG002|Overall Study|Death|13|||
144723185|NCT02729896|521840648|FG000|Overall Study|Lost to Follow-up|0|||
144723186|NCT02729896|521840649|FG001|Overall Study|Lost to Follow-up|2|||
144723187|NCT02729896|521840650|FG002|Overall Study|Lost to Follow-up|3|||
144723188|NCT02729896|521840648|FG000|Overall Study|Other|0|||
144723189|NCT02729896|521840649|FG001|Overall Study|Other|2|||
144723190|NCT02729896|521840650|FG002|Overall Study|Other|0|||
144723191|NCT02729896|521840648|FG000|Overall Study|Physician Decision|1|||
144723192|NCT02729896|521840649|FG001|Overall Study|Physician Decision|2|||
144179904|NCT01968551|519852483|FG002|Extension Phase|Death|0|||
144179905|NCT01968551|519852481|FG000|Extension Phase|Withdrew Consent|0|||
144179906|NCT01968551|519852482|FG001|Extension Phase|Withdrew Consent|0|||
144179907|NCT01968551|519852483|FG002|Extension Phase|Withdrew Consent|1|||
144417311|NCT03334448|520732537|FG002|Washout|Protocol Violation|0|||
144417312|NCT03334448|520732538|FG003|Washout|Protocol Violation|1|||
144417313|NCT00371137|520732543|FG000|Overall Study|Adverse Event|20|||
144417314|NCT00371137|520732544|FG001|Overall Study|Adverse Event|35|||
144417315|NCT00371137|520732545|FG002|Overall Study|Adverse Event|42|||
144417316|NCT00371137|520732543|FG000|Overall Study|Withdrawal by Subject|11|||
144417317|NCT00371137|520732544|FG001|Overall Study|Withdrawal by Subject|10|||
144417318|NCT00371137|520732545|FG002|Overall Study|Withdrawal by Subject|15|||
144417319|NCT00371137|520732543|FG000|Overall Study|Lost to Follow-up|6|||
144417320|NCT00371137|520732544|FG001|Overall Study|Lost to Follow-up|3|||
144417321|NCT00371137|520732545|FG002|Overall Study|Lost to Follow-up|5|||
144417322|NCT00371137|520732543|FG000|Overall Study|Lack of Efficacy|30|||
144417323|NCT00371137|520732544|FG001|Overall Study|Lack of Efficacy|12|||
144417324|NCT00371137|520732545|FG002|Overall Study|Lack of Efficacy|13|||
144179908|NCT01968551|519852481|FG000|Extension Phase|Lost to Follow-up|1|||
144179909|NCT01968551|519852482|FG001|Extension Phase|Lost to Follow-up|0|||
144417325|NCT00371137|520732543|FG000|Overall Study|Sponsor Decision|2|||
144417326|NCT00371137|520732544|FG001|Overall Study|Sponsor Decision|1|||
144417327|NCT00371137|520732545|FG002|Overall Study|Sponsor Decision|2|||
144601012|NCT03026127|521401694|FG000|CRISP R33|Transportation|0|||
144417328|NCT00371137|520732543|FG000|Overall Study|Physician Decision|1|||
144417329|NCT00371137|520732544|FG001|Overall Study|Physician Decision|1|||
144417330|NCT00371137|520732545|FG002|Overall Study|Physician Decision|1|||
144723193|NCT02729896|521840650|FG002|Overall Study|Physician Decision|3|||
144723194|NCT02729896|521840648|FG000|Overall Study|Progressive Disease|0|||
144723195|NCT02729896|521840649|FG001|Overall Study|Progressive Disease|1|||
144723196|NCT02729896|521840650|FG002|Overall Study|Progressive Disease|0|||
144723197|NCT02729896|521840648|FG000|Overall Study|Withdrawal by Subject|1|||
144723198|NCT02729896|521840649|FG001|Overall Study|Withdrawal by Subject|0|||
144723199|NCT02729896|521840650|FG002|Overall Study|Withdrawal by Subject|3|||
144179910|NCT01968551|519852483|FG002|Extension Phase|Lost to Follow-up|1|||
144179911|NCT00406393|519852484|FG000|Overall Study|Did not undergo transplantation|2|||
144417331|NCT00371137|520732543|FG000|Overall Study|Protocol Violation|2|||
144417332|NCT00371137|520732544|FG001|Overall Study|Protocol Violation|1|||
144417333|NCT00371137|520732545|FG002|Overall Study|Protocol Violation|1|||
144417334|NCT02013791|520732546|FG000|Period 1|Lost to Follow-up|0|||
144417335|NCT02013791|520732547|FG001|Period 1|Lost to Follow-up|0|||
144417336|NCT02013791|520732548|FG002|Period 1|Lost to Follow-up|0|||
144417337|NCT02013791|520732549|FG003|Period 1|Lost to Follow-up|1|||
144417338|NCT02013791|520732550|FG004|Period 1|Lost to Follow-up|0|||
144417339|NCT02013791|520732551|FG005|Period 1|Lost to Follow-up|0|||
144417340|NCT02013791|520732552|FG006|Period 1|Lost to Follow-up|1|||
144417341|NCT02013791|520732553|FG007|Period 1|Lost to Follow-up|1|||
144417342|NCT02013791|520732554|FG008|Period 1|Lost to Follow-up|0|||
144417343|NCT02013791|520732546|FG000|Period 1|Other Miscellaneous Reasons|0|||
144417344|NCT02013791|520732547|FG001|Period 1|Other Miscellaneous Reasons|2|||
144417345|NCT02013791|520732548|FG002|Period 1|Other Miscellaneous Reasons|0|||
144417346|NCT02013791|520732549|FG003|Period 1|Other Miscellaneous Reasons|0|||
144417347|NCT02013791|520732550|FG004|Period 1|Other Miscellaneous Reasons|0|||
144417348|NCT02013791|520732551|FG005|Period 1|Other Miscellaneous Reasons|0|||
144417349|NCT02013791|520732552|FG006|Period 1|Other Miscellaneous Reasons|0|||
144417350|NCT02013791|520732553|FG007|Period 1|Other Miscellaneous Reasons|0|||
144417351|NCT02013791|520732554|FG008|Period 1|Other Miscellaneous Reasons|0|||
144417352|NCT02170051|520732555|FG000|Overall Study|Withdrawal by Subject|10|||
144417353|NCT02170051|520732556|FG001|Overall Study|Withdrawal by Subject|10|||
144417354|NCT02170051|520732555|FG000|Overall Study|Lost to Follow-up|1|||
144417355|NCT02170051|520732556|FG001|Overall Study|Lost to Follow-up|3|||
144417356|NCT03798483|520732557|FG000|Overall Study|Lost to Follow-up|2|||
144417357|NCT02289417|520732558|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
144417358|NCT02289417|520732559|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417359|NCT02289417|520732560|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
144417360|NCT02289417|520732561|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417361|NCT02289417|520732562|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417362|NCT02289417|520732563|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417363|NCT02289417|520732564|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417364|NCT02289417|520732565|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417365|NCT02289417|520732566|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
144417366|NCT02289417|520732558|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
144417367|NCT02289417|520732559|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
144417368|NCT02289417|520732560|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
144417369|NCT02289417|520732561|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
144417370|NCT02289417|520732562|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
144417371|NCT02289417|520732563|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
144417372|NCT02289417|520732564|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
144417373|NCT02289417|520732565|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
144417374|NCT02289417|520732566|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
144417375|NCT02289417|520732558|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417376|NCT02289417|520732559|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
144417377|NCT02289417|520732560|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417378|NCT02289417|520732561|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417379|NCT02289417|520732562|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417380|NCT02289417|520732563|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417381|NCT02289417|520732564|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417382|NCT02289417|520732565|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417383|NCT02289417|520732566|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
144417384|NCT02289417|520732558|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
144417385|NCT02289417|520732559|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417386|NCT02289417|520732560|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417387|NCT02289417|520732561|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417388|NCT02289417|520732562|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417389|NCT02289417|520732563|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417390|NCT02289417|520732564|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417391|NCT02289417|520732565|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144527382|NCT06473662|521131923|FG000|Overall Study|Did not take medication|2|||
144179912|NCT00406393|519852485|FG001|Overall Study|Did not undergo transplantation|1|||
144179913|NCT04060251|519852486|FG000|Overall Study|Study terminated due to low enrollment.|7|||
144179914|NCT04060251|519852487|FG001|Overall Study|Study terminated due to low enrollment.|5|||
144179915|NCT04060251|519852488|FG002|Overall Study|Study terminated due to low enrollment.|7|||
144179916|NCT04060251|519852486|FG000|Overall Study|Adverse Event|1|||
144179917|NCT04060251|519852487|FG001|Overall Study|Adverse Event|1|||
144179918|NCT04060251|519852488|FG002|Overall Study|Adverse Event|0|||
144527383|NCT06473662|521131924|FG001|Overall Study|Did not take medication|3|||
144527384|NCT06473662|521131925|FG002|Overall Study|Did not take medication|2|||
144527385|NCT03463044|521131928|FG000|Overall Study|Lost to Follow-up|0|||
144417392|NCT02289417|520732566|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
144417393|NCT02289417|520732558|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
144417394|NCT02289417|520732559|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
144417395|NCT02289417|520732560|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
144417396|NCT02289417|520732561|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
144417397|NCT02289417|520732562|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
144417398|NCT02289417|520732563|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
144417399|NCT02289417|520732564|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
144417400|NCT02289417|520732565|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
144417401|NCT02289417|520732566|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
144417402|NCT02289417|520732558|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417403|NCT02289417|520732559|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417404|NCT02289417|520732560|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
144417405|NCT02289417|520732561|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417406|NCT02289417|520732562|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417407|NCT02289417|520732563|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417408|NCT02289417|520732564|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417409|NCT02289417|520732565|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417410|NCT02289417|520732566|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
144417411|NCT02289417|520732558|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
144417412|NCT02289417|520732559|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
144417413|NCT02289417|520732560|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
144417414|NCT02289417|520732561|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
144417415|NCT02289417|520732562|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
144417416|NCT02289417|520732563|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
144417417|NCT02289417|520732564|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
144417418|NCT02289417|520732565|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
144417419|NCT02289417|520732566|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
144417420|NCT02289417|520732558|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
144601013|NCT03026127|521401695|FG001|CRISP R33|Transportation|2|||
144601014|NCT03026127|521401696|FG002|CRISP R33|Transportation|1|||
144601015|NCT01182766|521401700|FG000|Overall Study|Lost to Follow-up|32|||
144601016|NCT01182766|521401701|FG001|Overall Study|Lost to Follow-up|36|||
144417421|NCT02289417|520732559|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
144417422|NCT02289417|520732560|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
144417423|NCT02289417|520732561|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
144417424|NCT02289417|520732562|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
144417425|NCT02289417|520732563|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
144417426|NCT02289417|520732564|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
144417427|NCT02289417|520732565|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
144417428|NCT02289417|520732566|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
144417429|NCT02289417|520732558|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417430|NCT02289417|520732559|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417431|NCT02289417|520732560|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417432|NCT02289417|520732561|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417433|NCT02289417|520732562|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417434|NCT02289417|520732563|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417435|NCT02289417|520732564|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
144417436|NCT02289417|520732565|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417437|NCT02289417|520732566|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
144417438|NCT02289417|520732558|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417439|NCT02289417|520732559|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417440|NCT02289417|520732560|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417441|NCT02289417|520732561|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
144417442|NCT02289417|520732562|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417443|NCT02289417|520732563|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417444|NCT02289417|520732564|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
144417445|NCT02289417|520732565|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417446|NCT02289417|520732566|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
144417447|NCT02289417|520732558|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
144417448|NCT02289417|520732559|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
144417449|NCT02289417|520732560|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
144417450|NCT02289417|520732561|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
144417451|NCT02289417|520732562|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
144417452|NCT02289417|520732563|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
144417453|NCT02289417|520732564|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
144417454|NCT02289417|520732565|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
144417455|NCT02289417|520732566|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
144417456|NCT02289417|520732558|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417457|NCT02289417|520732559|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417458|NCT02289417|520732560|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417459|NCT02289417|520732561|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417460|NCT02289417|520732562|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417461|NCT02289417|520732563|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417462|NCT02289417|520732564|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
144417463|NCT02289417|520732565|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
144417464|NCT02289417|520732566|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
144417465|NCT02289417|520732558|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417466|NCT02289417|520732559|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417467|NCT02289417|520732560|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417468|NCT02289417|520732561|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417469|NCT02289417|520732562|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417470|NCT02289417|520732563|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417471|NCT02289417|520732564|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
144417472|NCT02289417|520732565|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
144527386|NCT03463044|521131929|FG001|Overall Study|Lost to Follow-up|0|||
144527387|NCT03463044|521131930|FG002|Overall Study|Lost to Follow-up|0|||
144527388|NCT03463044|521131931|FG003|Overall Study|Lost to Follow-up|0|||
144527389|NCT03463044|521131932|FG004|Overall Study|Lost to Follow-up|0|||
144527390|NCT03463044|521131933|FG005|Overall Study|Lost to Follow-up|0|||
144527391|NCT03463044|521131934|FG006|Overall Study|Lost to Follow-up|0|||
144527392|NCT03463044|521131935|FG007|Overall Study|Lost to Follow-up|1|||
144527393|NCT03463044|521131936|FG008|Overall Study|Lost to Follow-up|0|||
144527394|NCT01574274|521133255|FG000|Overall Study|Ineligible|0|||
144527395|NCT01574274|521133256|FG001|Overall Study|Ineligible|1|||
144527396|NCT01574274|521133255|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
144527397|NCT01574274|521133256|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
144527398|NCT01574274|521133255|FG000|Overall Study|Ph+ B-ALL|3|||
144527399|NCT01574274|521133256|FG001|Overall Study|Ph+ B-ALL|4|||
144417473|NCT02289417|520732566|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
144527400|NCT01574274|521133255|FG000|Overall Study|Induction Death|2|||
144527401|NCT01574274|521133256|FG001|Overall Study|Induction Death|0|||
144527402|NCT01574274|521133255|FG000|Overall Study|Induction Failure|4|||
144527403|NCT01574274|521133256|FG001|Overall Study|Induction Failure|1|||
144527404|NCT01574274|521133255|FG000|Overall Study|Adverse Event|16|||
144417474|NCT02289417|520732558|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417475|NCT02289417|520732559|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417476|NCT02289417|520732560|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417477|NCT02289417|520732561|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417478|NCT02289417|520732562|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417479|NCT02289417|520732563|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417480|NCT02289417|520732564|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417481|NCT02289417|520732565|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
144417482|NCT02289417|520732566|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
144417483|NCT02007109|520732567|FG000|Overall Study|Diary not returned or excluded|102|||
144417484|NCT02007109|520732567|FG000|Overall Study|Excluded - Age<7yo|9|||
144417485|NCT00687323|520732568|FG000|Overall Study|Death|25|||
144417486|NCT00687323|520732568|FG000|Overall Study|Withdrawal by Subject|1|||
144417487|NCT00687323|520732568|FG000|Overall Study|Excluded from efficacy evaluations|6|||
144417488|NCT00687323|520732568|FG000|Overall Study|Screen failure|148|||
144417489|NCT03655691|520732570|FG000|Overall Study|Adverse Event|0|||
144417490|NCT03655691|520732571|FG001|Overall Study|Adverse Event|0|||
144417491|NCT03655691|520732572|FG002|Overall Study|Adverse Event|1|||
144417492|NCT03655691|520732570|FG000|Overall Study|Lost to Follow-up|1|||
144601017|NCT01182766|521401702|FG002|Overall Study|Lost to Follow-up|29|||
144601018|NCT01182766|521401700|FG000|Overall Study|Withdrawal by Subject|14|||
144601019|NCT01182766|521401701|FG001|Overall Study|Withdrawal by Subject|3|||
144601020|NCT01182766|521401702|FG002|Overall Study|Withdrawal by Subject|6|||
144601021|NCT01182766|521401700|FG000|Overall Study|Physician Decision|1|||
144601022|NCT01182766|521401701|FG001|Overall Study|Physician Decision|0|||
144601023|NCT01182766|521401702|FG002|Overall Study|Physician Decision|0|||
144601024|NCT01182766|521401700|FG000|Overall Study|Non-compliance|1|||
144601025|NCT01182766|521401701|FG001|Overall Study|Non-compliance|1|||
144601026|NCT01182766|521401702|FG002|Overall Study|Non-compliance|1|||
144601027|NCT03027557|521401703|FG000|Overall Study|Adverse Event|1|||
144601028|NCT03027557|521401704|FG001|Overall Study|Adverse Event|0|||
144601029|NCT03027557|521401705|FG002|Overall Study|Adverse Event|0|||
144601030|NCT02510560|521401706|FG000|Overall Study|Discontinued from Treatment|27|||
144601031|NCT02510560|521401707|FG001|Overall Study|Discontinued from Treatment|18|||
144601032|NCT02510560|521401708|FG002|Overall Study|Discontinued from Treatment|19|||
144601033|NCT02510560|521401706|FG000|Overall Study|Other|4|||
144601034|NCT02510560|521401707|FG001|Overall Study|Other|4|||
144601035|NCT02510560|521401708|FG002|Overall Study|Other|3|||
144601036|NCT04936841|521401709|FG000|Overall Study|Death|1|||
144601037|NCT04598477|521401710|FG000|Overall Study|Adverse Event|2|||
144601038|NCT04598477|521401711|FG001|Overall Study|Adverse Event|0|||
144601039|NCT04598477|521401710|FG000|Overall Study|Death|0|||
144601040|NCT04598477|521401711|FG001|Overall Study|Death|1|||
144723200|NCT00582309|521840651|FG000|Overall Study|Protocol Violation|0|||
144723201|NCT00582309|521840652|FG001|Overall Study|Protocol Violation|0|||
144723202|NCT00582309|521840653|FG002|Overall Study|Protocol Violation|2|||
144417493|NCT03655691|520732571|FG001|Overall Study|Lost to Follow-up|1|||
144417494|NCT03655691|520732572|FG002|Overall Study|Lost to Follow-up|2|||
144417495|NCT03655691|520732570|FG000|Overall Study|Protocol Violation|0|||
144527405|NCT01574274|521133256|FG001|Overall Study|Adverse Event|13|||
144527406|NCT01574274|521133255|FG000|Overall Study|Remission Death|1|||
144527407|NCT01574274|521133256|FG001|Overall Study|Remission Death|0|||
144527408|NCT01574274|521133255|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
144527409|NCT01574274|521133256|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
144527410|NCT01574274|521133255|FG000|Overall Study|Other, unknown|3|||
144527411|NCT01574274|521133256|FG001|Overall Study|Other, unknown|2|||
144527412|NCT04676763|521133257|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
144527413|NCT04676763|521133258|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
144527414|NCT04676763|521133259|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
144527415|NCT04676763|521133257|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
144527416|NCT04676763|521133258|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
144527417|NCT04676763|521133259|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
144527418|NCT04676763|521133257|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
144527419|NCT04676763|521133258|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
144527420|NCT04676763|521133259|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
144527421|NCT05808257|521133269|FG000|Overall Study|Lost to Follow-up|8|||
144527422|NCT05808257|521133270|FG001|Overall Study|Lost to Follow-up|8|||
144527423|NCT05496231|521133276|FG000|Overall Study|Adverse Event|1|||
144527424|NCT05496231|521133277|FG001|Overall Study|Adverse Event|1|||
144527425|NCT05496231|521133278|FG002|Overall Study|Adverse Event|0|||
144527426|NCT05496231|521133279|FG003|Overall Study|Adverse Event|4|||
144527427|NCT05496231|521133276|FG000|Overall Study|Withdrawal by Subject|5|||
144527428|NCT05496231|521133277|FG001|Overall Study|Withdrawal by Subject|5|||
144527429|NCT05496231|521133278|FG002|Overall Study|Withdrawal by Subject|4|||
144601041|NCT04598477|521401710|FG000|Overall Study|Lost to Follow-up|1|||
144417496|NCT03655691|520732571|FG001|Overall Study|Protocol Violation|1|||
144417497|NCT03655691|520732572|FG002|Overall Study|Protocol Violation|0|||
144417498|NCT03655691|520732570|FG000|Overall Study|Withdrawal by Subject|1|||
144417499|NCT03655691|520732571|FG001|Overall Study|Withdrawal by Subject|1|||
144417500|NCT03655691|520732572|FG002|Overall Study|Withdrawal by Subject|0|||
144417501|NCT04557371|520732577|FG000|Overall Study|Covid-19-related|0|||
144417502|NCT04557371|520732578|FG001|Overall Study|Covid-19-related|1|||
144417503|NCT04557371|520732579|FG002|Overall Study|Covid-19-related|0|||
144417504|NCT04557371|520732577|FG000|Overall Study|Withdrawal by Subject|0|||
144417505|NCT04557371|520732578|FG001|Overall Study|Withdrawal by Subject|1|||
144417506|NCT04557371|520732579|FG002|Overall Study|Withdrawal by Subject|0|||
144417507|NCT04557371|520732577|FG000|Overall Study|Adverse Event|1|||
144417508|NCT04557371|520732578|FG001|Overall Study|Adverse Event|0|||
144417509|NCT04557371|520732579|FG002|Overall Study|Adverse Event|0|||
144417510|NCT04102020|520732582|FG000|Overall Study|Adverse Event|1|||
144417511|NCT04102020|520732583|FG001|Overall Study|Adverse Event|0|||
144417512|NCT04102020|520732584|FG002|Overall Study|Adverse Event|0|||
144417513|NCT04102020|520732585|FG003|Overall Study|Adverse Event|1|||
144417514|NCT04102020|520732586|FG004|Overall Study|Adverse Event|0|||
144417515|NCT04102020|520732582|FG000|Overall Study|Withdrawal by Subject|0|||
144417516|NCT04102020|520732583|FG001|Overall Study|Withdrawal by Subject|1|||
144417517|NCT04102020|520732584|FG002|Overall Study|Withdrawal by Subject|1|||
144417518|NCT04102020|520732585|FG003|Overall Study|Withdrawal by Subject|1|||
144417519|NCT04102020|520732586|FG004|Overall Study|Withdrawal by Subject|1|||
144417520|NCT04102020|520732582|FG000|Overall Study|Death|1|||
144417521|NCT04102020|520732583|FG001|Overall Study|Death|4|||
144417522|NCT04102020|520732584|FG002|Overall Study|Death|1|||
144417523|NCT04102020|520732585|FG003|Overall Study|Death|1|||
144417524|NCT04102020|520732586|FG004|Overall Study|Death|0|||
144601042|NCT04598477|521401711|FG001|Overall Study|Lost to Follow-up|0|||
144417525|NCT04102020|520732582|FG000|Overall Study|Physician Decision|1|||
144417526|NCT04102020|520732583|FG001|Overall Study|Physician Decision|2|||
144417527|NCT04102020|520732584|FG002|Overall Study|Physician Decision|2|||
144417528|NCT04102020|520732585|FG003|Overall Study|Physician Decision|0|||
144417529|NCT04102020|520732586|FG004|Overall Study|Physician Decision|1|||
144417530|NCT04102020|520732582|FG000|Overall Study|COVID-19 Infection|1|||
144417531|NCT04102020|520732583|FG001|Overall Study|COVID-19 Infection|0|||
144417532|NCT04102020|520732584|FG002|Overall Study|COVID-19 Infection|0|||
144417533|NCT04102020|520732585|FG003|Overall Study|COVID-19 Infection|0|||
144417534|NCT04102020|520732586|FG004|Overall Study|COVID-19 Infection|0|||
144417535|NCT04102020|520732582|FG000|Overall Study|Not disclosed|5|||
144417536|NCT04102020|520732583|FG001|Overall Study|Not disclosed|3|||
144417537|NCT04102020|520732584|FG002|Overall Study|Not disclosed|8|||
144417538|NCT04102020|520732585|FG003|Overall Study|Not disclosed|0|||
144417539|NCT04102020|520732586|FG004|Overall Study|Not disclosed|1|||
144417540|NCT04102020|520732582|FG000|Overall Study|MIssing|1|||
144417541|NCT04102020|520732583|FG001|Overall Study|MIssing|0|||
144417542|NCT04102020|520732584|FG002|Overall Study|MIssing|1|||
144417543|NCT04102020|520732585|FG003|Overall Study|MIssing|1|||
144417544|NCT04102020|520732586|FG004|Overall Study|MIssing|1|||
144417545|NCT04102020|520732582|FG000|Overall Study|Continuing in ongoing study|13|||
144417546|NCT04102020|520732583|FG001|Overall Study|Continuing in ongoing study|13|||
144417547|NCT04102020|520732584|FG002|Overall Study|Continuing in ongoing study|7|||
144417548|NCT04102020|520732585|FG003|Overall Study|Continuing in ongoing study|26|||
144417549|NCT04102020|520732586|FG004|Overall Study|Continuing in ongoing study|12|||
144417550|NCT05109442|520732587|FG000|Overall Study|Withdrawal by Subject|0|||
144417551|NCT05109442|520732588|FG001|Overall Study|Withdrawal by Subject|0|||
144417552|NCT05109442|520732589|FG002|Overall Study|Withdrawal by Subject|1|||
144417553|NCT05109442|520732590|FG003|Overall Study|Withdrawal by Subject|0|||
144417554|NCT05109442|520732591|FG004|Overall Study|Withdrawal by Subject|0|||
144417555|NCT05109442|520732592|FG005|Overall Study|Withdrawal by Subject|0|||
144417556|NCT05109442|520732587|FG000|Overall Study|Adverse Event|0|||
144417557|NCT05109442|520732588|FG001|Overall Study|Adverse Event|1|||
144417558|NCT05109442|520732589|FG002|Overall Study|Adverse Event|5|||
144417559|NCT05109442|520732590|FG003|Overall Study|Adverse Event|0|||
144417560|NCT05109442|520732591|FG004|Overall Study|Adverse Event|0|||
144417561|NCT05109442|520732592|FG005|Overall Study|Adverse Event|2|||
144417562|NCT05109442|520732587|FG000|Overall Study|Death|0|||
144417563|NCT05109442|520732588|FG001|Overall Study|Death|0|||
144417564|NCT05109442|520732589|FG002|Overall Study|Death|4|||
144417565|NCT05109442|520732590|FG003|Overall Study|Death|0|||
144417566|NCT05109442|520732591|FG004|Overall Study|Death|0|||
144417567|NCT05109442|520732592|FG005|Overall Study|Death|1|||
144417568|NCT05109442|520732587|FG000|Overall Study|Physician Decision|1|||
144417569|NCT05109442|520732588|FG001|Overall Study|Physician Decision|0|||
144417570|NCT05109442|520732589|FG002|Overall Study|Physician Decision|1|||
144417571|NCT05109442|520732590|FG003|Overall Study|Physician Decision|0|||
144417572|NCT05109442|520732591|FG004|Overall Study|Physician Decision|0|||
144417573|NCT05109442|520732592|FG005|Overall Study|Physician Decision|2|||
144417574|NCT05109442|520732587|FG000|Overall Study|Other than listed|0|||
144417575|NCT05109442|520732588|FG001|Overall Study|Other than listed|0|||
144417576|NCT05109442|520732589|FG002|Overall Study|Other than listed|9|||
144417577|NCT05109442|520732590|FG003|Overall Study|Other than listed|2|||
144417578|NCT05109442|520732591|FG004|Overall Study|Other than listed|0|||
144417579|NCT05109442|520732592|FG005|Overall Study|Other than listed|8|||
144417580|NCT05109442|520732587|FG000|Overall Study|Lack of Efficacy|3|||
144417581|NCT05109442|520732588|FG001|Overall Study|Lack of Efficacy|5|||
144417582|NCT05109442|520732589|FG002|Overall Study|Lack of Efficacy|29|||
144417583|NCT05109442|520732590|FG003|Overall Study|Lack of Efficacy|10|||
144417584|NCT05109442|520732591|FG004|Overall Study|Lack of Efficacy|11|||
144417585|NCT05109442|520732592|FG005|Overall Study|Lack of Efficacy|17|||
144417586|NCT03918447|520732597|FG000|Overall Study|Death|1|||
144417587|NCT03918447|520732598|FG001|Overall Study|Death|0|||
144417588|NCT03918447|520732597|FG000|Overall Study|Lost to Follow-up|13|||
144417589|NCT03918447|520732598|FG001|Overall Study|Lost to Follow-up|6|||
144417590|NCT03918447|520732597|FG000|Overall Study|Withdrawal by Subject|19|||
144417591|NCT03918447|520732598|FG001|Overall Study|Withdrawal by Subject|17|||
144417592|NCT03918447|520732597|FG000|Overall Study|Study Terminated by Sponsor|195|||
144417593|NCT03918447|520732598|FG001|Overall Study|Study Terminated by Sponsor|197|||
144417594|NCT03918447|520732597|FG000|Overall Study|Reason not Specified|0|||
144417595|NCT03918447|520732598|FG001|Overall Study|Reason not Specified|1|||
144417596|NCT03278613|520732599|FG000|Overall Study|Lost to Follow-up|3|||
144417597|NCT03278613|520732600|FG001|Overall Study|Lost to Follow-up|1|||
144417598|NCT05355805|520732601|FG000|Overall Study|Lost to Follow-up|6|||
144417599|NCT05355805|520732602|FG001|Overall Study|Lost to Follow-up|11|||
144417600|NCT05355805|520732603|FG002|Overall Study|Lost to Follow-up|10|||
144417601|NCT05355805|520732604|FG003|Overall Study|Lost to Follow-up|6|||
144417602|NCT05355805|520732601|FG000|Overall Study|Decision by Sponsor|0|||
144417603|NCT05355805|520732602|FG001|Overall Study|Decision by Sponsor|0|||
144417604|NCT05355805|520732603|FG002|Overall Study|Decision by Sponsor|1|||
144417605|NCT05355805|520732604|FG003|Overall Study|Decision by Sponsor|0|||
144417606|NCT05355805|520732601|FG000|Overall Study|Withdrawal by Subject|7|||
144417607|NCT05355805|520732602|FG001|Overall Study|Withdrawal by Subject|14|||
144417608|NCT05355805|520732603|FG002|Overall Study|Withdrawal by Subject|15|||
144417609|NCT05355805|520732604|FG003|Overall Study|Withdrawal by Subject|13|||
144417610|NCT05353985|520732605|FG000|Overall Study|Adverse Event|5|||
144417611|NCT05353985|520732606|FG001|Overall Study|Adverse Event|7|||
144417612|NCT05353985|520732605|FG000|Overall Study|Lost to Follow-up|1|||
144417613|NCT05353985|520732606|FG001|Overall Study|Lost to Follow-up|1|||
144417614|NCT05353985|520732605|FG000|Overall Study|Protocol Violation|1|||
144417615|NCT05353985|520732606|FG001|Overall Study|Protocol Violation|0|||
144417616|NCT05353985|520732605|FG000|Overall Study|Withdrawal by Subject|13|||
144417617|NCT05353985|520732606|FG001|Overall Study|Withdrawal by Subject|17|||
144417618|NCT05353985|520732605|FG000|Overall Study|Reason Not Specified|1|||
144417619|NCT05353985|520732606|FG001|Overall Study|Reason Not Specified|0|||
144417620|NCT05353985|520732605|FG000|Overall Study|Randomized in Error & Not Treated|0|||
144417621|NCT05353985|520732606|FG001|Overall Study|Randomized in Error & Not Treated|1|||
144417622|NCT04221009|520733762|FG000|Overall Study|Withdrawal by Subject|4|||
144417623|NCT00482612|520733777|FG000|In-treatment Period|No study medication administered|0|||
144417624|NCT00482612|520733778|FG001|In-treatment Period|No study medication administered|0|||
144417625|NCT00482612|520733779|FG002|In-treatment Period|No study medication administered|1|||
144417626|NCT00482612|520733780|FG003|In-treatment Period|No study medication administered|0|||
144417627|NCT00482612|520733777|FG000|Follow-up Period|Other|4|||
144417628|NCT00482612|520733778|FG001|Follow-up Period|Other|2|||
144417629|NCT00482612|520733779|FG002|Follow-up Period|Other|1|||
144417630|NCT00482612|520733780|FG003|Follow-up Period|Other|2|||
144417631|NCT00482612|520733777|FG000|Follow-up Period|Lack of compliance|0|||
144417632|NCT00482612|520733778|FG001|Follow-up Period|Lack of compliance|0|||
144417633|NCT00482612|520733779|FG002|Follow-up Period|Lack of compliance|1|||
144417634|NCT00482612|520733780|FG003|Follow-up Period|Lack of compliance|0|||
144417635|NCT00482612|520733777|FG000|Follow-up Period|Lost to Follow-up|0|||
144417636|NCT00482612|520733778|FG001|Follow-up Period|Lost to Follow-up|4|||
144417637|NCT00482612|520733779|FG002|Follow-up Period|Lost to Follow-up|2|||
144417638|NCT00482612|520733780|FG003|Follow-up Period|Lost to Follow-up|1|||
144417639|NCT00482612|520733777|FG000|Follow-up Period|Adverse Event|4|||
144417640|NCT00482612|520733778|FG001|Follow-up Period|Adverse Event|7|||
144417641|NCT00482612|520733779|FG002|Follow-up Period|Adverse Event|9|||
144417642|NCT00482612|520733780|FG003|Follow-up Period|Adverse Event|0|||
144417643|NCT00482612|520733777|FG000|Follow-up Period|Lack of Efficacy|2|||
144417644|NCT00482612|520733778|FG001|Follow-up Period|Lack of Efficacy|0|||
144417645|NCT00482612|520733779|FG002|Follow-up Period|Lack of Efficacy|1|||
144417646|NCT00482612|520733780|FG003|Follow-up Period|Lack of Efficacy|0|||
144417647|NCT00482612|520733777|FG000|Follow-up Period|Withdrawal by Subject|3|||
144417648|NCT00482612|520733778|FG001|Follow-up Period|Withdrawal by Subject|5|||
144417649|NCT00482612|520733779|FG002|Follow-up Period|Withdrawal by Subject|7|||
144417650|NCT00482612|520733780|FG003|Follow-up Period|Withdrawal by Subject|2|||
144417651|NCT00482612|520733777|FG000|Follow-up Period|Reasons not related to trial|1|||
144417652|NCT00482612|520733778|FG001|Follow-up Period|Reasons not related to trial|0|||
144417653|NCT00482612|520733779|FG002|Follow-up Period|Reasons not related to trial|1|||
144417654|NCT00482612|520733780|FG003|Follow-up Period|Reasons not related to trial|3|||
144417655|NCT00464087|520733784|FG000|Overall Study|No PCI per inclusion criteria|0|||
144417656|NCT00464087|520733785|FG001|Overall Study|No PCI per inclusion criteria|0|||
144417657|NCT00464087|520733786|FG002|Overall Study|No PCI per inclusion criteria|29|||
144417658|NCT00418314|520733788|FG000|Overall Study|Withdrawal by Subject|1|||
144417659|NCT00418314|520733789|FG001|Overall Study|Withdrawal by Subject|2|||
144417660|NCT02057406|520733790|FG000|Overall Study|Physician Decision|0|||
144417661|NCT02057406|520733791|FG001|Overall Study|Physician Decision|0|||
144417662|NCT02057406|520733792|FG002|Overall Study|Physician Decision|2|||
144417663|NCT02057406|520733790|FG000|Overall Study|Withdrawal by Subject|0|||
144417664|NCT02057406|520733791|FG001|Overall Study|Withdrawal by Subject|2|||
144417665|NCT02057406|520733792|FG002|Overall Study|Withdrawal by Subject|0|||
144417666|NCT02057406|520733790|FG000|Overall Study|Lost to Follow-up|0|||
144417667|NCT02057406|520733791|FG001|Overall Study|Lost to Follow-up|0|||
144417668|NCT02057406|520733792|FG002|Overall Study|Lost to Follow-up|1|||
144417669|NCT02057406|520733790|FG000|Overall Study|Death|1|||
144417670|NCT02057406|520733791|FG001|Overall Study|Death|0|||
144417671|NCT02057406|520733792|FG002|Overall Study|Death|0|||
144417672|NCT02057406|520733790|FG000|Overall Study|Protocol Violation|0|||
144417673|NCT02057406|520733791|FG001|Overall Study|Protocol Violation|1|||
144417674|NCT02057406|520733792|FG002|Overall Study|Protocol Violation|0|||
144417675|NCT02057406|520733790|FG000|Overall Study|Patient transportation issues|0|||
144417676|NCT02057406|520733791|FG001|Overall Study|Patient transportation issues|0|||
144417677|NCT02057406|520733792|FG002|Overall Study|Patient transportation issues|1|||
144417678|NCT01224431|520733793|FG000|Overall Study|not randomized|0|||
144417679|NCT01224431|520733794|FG001|Overall Study|not randomized|4|||
144417680|NCT01224431|520733793|FG000|Overall Study|no video record|0|||
144417681|NCT01224431|520733794|FG001|Overall Study|no video record|1|||
144417682|NCT03654651|520733796|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
144417683|NCT03654651|520733797|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
144417684|NCT01401283|520733798|FG000|Overall Study|surgery cancelled|5|||
144417685|NCT01401283|520733799|FG001|Overall Study|surgery cancelled|8|||
144417686|NCT01401283|520733798|FG000|Overall Study|preoperative arrhythmia|5|||
144417687|NCT01401283|520733799|FG001|Overall Study|preoperative arrhythmia|0|||
144417688|NCT01401283|520733798|FG000|Overall Study|no central venous access|0|||
144417689|NCT01401283|520733799|FG001|Overall Study|no central venous access|1|||
144417690|NCT01401283|520733798|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
144417691|NCT01401283|520733799|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
144417692|NCT02433483|520733800|FG000|Overall Study|Unacceptable toxicity|1|||
144417693|NCT02433483|520733800|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
144417694|NCT01963403|520733801|FG000|Overall Study|Lost to Follow-up|2|||
144417695|NCT01963403|520733802|FG001|Overall Study|Lost to Follow-up|3|||
144417696|NCT01963403|520733801|FG000|Overall Study|Implant removal|0|||
144417697|NCT01963403|520733802|FG001|Overall Study|Implant removal|1|||
144417698|NCT03585504|520733803|FG000|Overall Study|Lost to Follow-up|26|||
144417699|NCT03585504|520733804|FG001|Overall Study|Lost to Follow-up|29|||
144417700|NCT01414114|520733805|FG000|Overall Study|Adverse Event|2|||
144417701|NCT01414114|520733805|FG000|Overall Study|Withdrawal by Subject|1|||
144417702|NCT01414114|520733805|FG000|Overall Study|Other|2|||
144417703|NCT05620563|520733806|FG000|Overall Study|Adverse Event|3|||
144417704|NCT05620563|520733807|FG001|Overall Study|Adverse Event|1|||
144417705|NCT05620563|520733806|FG000|Overall Study|Lost to Follow-up|0|||
144417706|NCT05620563|520733807|FG001|Overall Study|Lost to Follow-up|2|||
144417707|NCT05620563|520733806|FG000|Overall Study|Protocol Deviation|1|||
144417708|NCT05620563|520733807|FG001|Overall Study|Protocol Deviation|2|||
144417709|NCT05620563|520733806|FG000|Overall Study|Withdrawal by Subject|3|||
144417710|NCT05620563|520733807|FG001|Overall Study|Withdrawal by Subject|3|||
144417711|NCT05620563|520733806|FG000|Overall Study|Physician Decision|0|||
144417712|NCT05620563|520733807|FG001|Overall Study|Physician Decision|1|||
144417713|NCT02692703|520733808|FG000|Overall Study|Lost to Follow-up|1|||
144417714|NCT02692703|520733808|FG000|Overall Study|Other|1|||
144417715|NCT03247530|520733811|FG000|Overall Study|Withdrawal by caregiver|19|||
144417716|NCT03247530|520733812|FG001|Overall Study|Withdrawal by caregiver|8|||
144417717|NCT03247530|520733813|FG002|Overall Study|Withdrawal by caregiver|10|||
144417718|NCT03247530|520733811|FG000|Overall Study|Lost to Follow-up|3|||
144417719|NCT03247530|520733812|FG001|Overall Study|Lost to Follow-up|9|||
144417720|NCT03247530|520733813|FG002|Overall Study|Lost to Follow-up|6|||
144417721|NCT03247530|520733811|FG000|Overall Study|Adverse Event|2|||
144417722|NCT03247530|520733812|FG001|Overall Study|Adverse Event|5|||
144417723|NCT03247530|520733813|FG002|Overall Study|Adverse Event|2|||
144417724|NCT03247530|520733811|FG000|Overall Study|Failure to follow procedure|1|||
144417725|NCT03247530|520733812|FG001|Overall Study|Failure to follow procedure|1|||
144417726|NCT03247530|520733813|FG002|Overall Study|Failure to follow procedure|1|||
144417727|NCT03247530|520733811|FG000|Overall Study|Withdrawal by Subject|1|||
144417728|NCT03247530|520733812|FG001|Overall Study|Withdrawal by Subject|1|||
144417729|NCT03247530|520733813|FG002|Overall Study|Withdrawal by Subject|0|||
144417730|NCT03247530|520733811|FG000|Overall Study|Study medication misuse|0|||
144417731|NCT03247530|520733812|FG001|Overall Study|Study medication misuse|1|||
144417732|NCT03247530|520733813|FG002|Overall Study|Study medication misuse|0|||
144417733|NCT03247530|520733811|FG000|Overall Study|Other, multiple categories|1|||
144417734|NCT03247530|520733812|FG001|Overall Study|Other, multiple categories|3|||
144417735|NCT03247530|520733813|FG002|Overall Study|Other, multiple categories|1|||
144417736|NCT04326231|520733817|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
144417737|NCT01985867|520733820|FG000|Overall Study|Lost to Follow-up|3|||
144417738|NCT01985867|520733821|FG001|Overall Study|Lost to Follow-up|4|||
144417739|NCT01985867|520733820|FG000|Overall Study|Adverse Event|3|||
144417740|NCT01985867|520733821|FG001|Overall Study|Adverse Event|2|||
144417741|NCT01985867|520733820|FG000|Overall Study|Lack of Efficacy|1|||
144417742|NCT01985867|520733821|FG001|Overall Study|Lack of Efficacy|0|||
144417743|NCT02670837|520733822|FG000|Overall Study|Death|2|||
144417744|NCT02670837|520733823|FG001|Overall Study|Death|0|||
144417745|NCT02670837|520733824|FG002|Overall Study|Death|0|||
144417746|NCT01919723|520733830|FG000|Overall Study|Blood Samples Hemolyzed|2|||
144417747|NCT01919723|520733831|FG001|Overall Study|Blood Samples Hemolyzed|2|||
144417748|NCT04502589|520733832|FG000|Overall Study|Physician Decision|1|||
144417749|NCT04502589|520733833|FG001|Overall Study|Physician Decision|0|||
144417750|NCT01922089|520733842|FG000|Overall Study|Adverse Event|18|||
144417751|NCT01922089|520733843|FG001|Overall Study|Adverse Event|13|||
144417752|NCT01922089|520733842|FG000|Overall Study|Protocol Deviation|10|||
144417753|NCT01922089|520733843|FG001|Overall Study|Protocol Deviation|7|||
144417754|NCT01922089|520733842|FG000|Overall Study|Withdrawal by Subject|3|||
144417755|NCT01922089|520733843|FG001|Overall Study|Withdrawal by Subject|4|||
144417756|NCT01922089|520733842|FG000|Overall Study|administrative problems|4|||
144417757|NCT01922089|520733843|FG001|Overall Study|administrative problems|1|||
144417758|NCT01922089|520733842|FG000|Overall Study|Physician Decision|2|||
144417759|NCT01922089|520733843|FG001|Overall Study|Physician Decision|3|||
144417760|NCT01922089|520733842|FG000|Overall Study|Death|2|||
144417761|NCT01922089|520733843|FG001|Overall Study|Death|1|||
144417762|NCT01922089|520733842|FG000|Overall Study|Lost to Follow-up|0|||
144417763|NCT01922089|520733843|FG001|Overall Study|Lost to Follow-up|1|||
144417764|NCT02496611|520733847|FG000|Overall Study|Lost to Follow-up|2|||
144417765|NCT02496611|520733848|FG001|Overall Study|Lost to Follow-up|1|||
144417766|NCT02496611|520733847|FG000|Overall Study|Withdrawal by Subject|5|||
144417767|NCT02496611|520733848|FG001|Overall Study|Withdrawal by Subject|2|||
144417768|NCT02850965|520733849|FG000|Overall Study|Other than listed|3|||
144417769|NCT02850965|520733850|FG001|Overall Study|Other than listed|4|||
144417770|NCT02850965|520733849|FG000|Overall Study|Protocol Violation|0|||
144417771|NCT02850965|520733850|FG001|Overall Study|Protocol Violation|2|||
144417772|NCT02850965|520733849|FG000|Overall Study|Lost to Follow-up|5|||
144417773|NCT02850965|520733850|FG001|Overall Study|Lost to Follow-up|3|||
144417774|NCT02850965|520733849|FG000|Overall Study|Lack of Efficacy|4|||
144417775|NCT02850965|520733850|FG001|Overall Study|Lack of Efficacy|8|||
144417776|NCT02850965|520733849|FG000|Overall Study|Adverse Event|3|||
144417777|NCT02850965|520733850|FG001|Overall Study|Adverse Event|2|||
144417778|NCT02850965|520733849|FG000|Overall Study|Withdrawal by Subject|3|||
144417779|NCT02850965|520733850|FG001|Overall Study|Withdrawal by Subject|4|||
144417780|NCT02850965|520733849|FG000|Overall Study|Physician Decision|0|||
144417781|NCT02850965|520733850|FG001|Overall Study|Physician Decision|1|||
144417782|NCT02850965|520733849|FG000|Overall Study|Randomized but not treated|0|||
144417783|NCT02850965|520733850|FG001|Overall Study|Randomized but not treated|1|||
144417784|NCT02788357|520733854|FG000|Overall Study|Lost to Follow-up|3|||
144417785|NCT02788357|520733855|FG001|Overall Study|Lost to Follow-up|0|||
144417786|NCT01365910|520733856|FG000|Overall Study|Withdrawal by Subject|7|||
144417787|NCT01365910|520733856|FG000|Overall Study|disease progression|18|||
144417788|NCT01365910|520733856|FG000|Overall Study|Adverse Event|3|||
144417789|NCT01365910|520733856|FG000|Overall Study|other complicating disease|1|||
144417790|NCT01365910|520733856|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
144417791|NCT00276744|520733857|FG000|PART A|Reason unknown|98|||
144417792|NCT02725710|520733858|FG000|Overall Study|Lost to Follow-up|1|||
144417793|NCT02725710|520733859|FG001|Overall Study|Lost to Follow-up|0|||
144417794|NCT04786990|520733866|FG000|Overall Study|Withdrawal by Subject|1|||
144417795|NCT04786990|520733866|FG000|Overall Study|Adverse Event|1|||
144417796|NCT04786990|520733866|FG000|Overall Study|Lost to Follow-up|1|||
144417797|NCT04786990|520733866|FG000|Overall Study|Noncompliance|1|||
144417798|NCT04786990|520733866|FG000|Overall Study|Unable to complete site visits|1|||
144417799|NCT04786990|520733866|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
144417800|NCT01782222|520733867|FG000|Overall Study|Adverse Event|4|||
144417801|NCT01782222|520733868|FG001|Overall Study|Adverse Event|5|||
144417802|NCT01782222|520733869|FG002|Overall Study|Adverse Event|3|||
144417803|NCT01782222|520733867|FG000|Overall Study|Lack of Efficacy|2|||
144417804|NCT01782222|520733868|FG001|Overall Study|Lack of Efficacy|1|||
144417805|NCT01782222|520733869|FG002|Overall Study|Lack of Efficacy|0|||
144417806|NCT01782222|520733867|FG000|Overall Study|Protocol Violation|1|||
144417807|NCT01782222|520733868|FG001|Overall Study|Protocol Violation|0|||
144417808|NCT01782222|520733869|FG002|Overall Study|Protocol Violation|0|||
144417809|NCT01782222|520733867|FG000|Overall Study|Withdrawal by Subject|1|||
144180014|NCT04236596|519852534|FG000|Overall Study|Withdrawal by Subject|1|||
144180015|NCT04236596|519852534|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
144180016|NCT04236596|519852534|FG000|Overall Study|Participants did not receive implant at all|4|||
144180017|NCT01894230|519853862|FG000|Overall Study|Lost to Follow-up|2|||
144417810|NCT01782222|520733868|FG001|Overall Study|Withdrawal by Subject|4|||
144180018|NCT01894230|519853863|FG001|Overall Study|Lost to Follow-up|2|||
144417811|NCT01782222|520733869|FG002|Overall Study|Withdrawal by Subject|1|||
144417812|NCT01782222|520733867|FG000|Overall Study|Moved to other state|0|||
144417813|NCT01782222|520733868|FG001|Overall Study|Moved to other state|1|||
144417814|NCT01782222|520733869|FG002|Overall Study|Moved to other state|0|||
144417815|NCT01858389|520733874|FG000|Overall Study|Death|1|||
144417816|NCT01858389|520733875|FG001|Overall Study|Death|3|||
144417817|NCT01858389|520733874|FG000|Overall Study|Study terminated by sponsor|0|||
144180019|NCT01894230|519853862|FG000|Overall Study|Withdrawal by Subject|4|||
144180020|NCT01894230|519853863|FG001|Overall Study|Withdrawal by Subject|4|||
144417818|NCT01858389|520733875|FG001|Overall Study|Study terminated by sponsor|2|||
144417819|NCT01858389|520733874|FG000|Overall Study|Withdrawal by Subject|0|||
144417820|NCT01858389|520733875|FG001|Overall Study|Withdrawal by Subject|1|||
144527430|NCT05496231|521133279|FG003|Overall Study|Withdrawal by Subject|11|||
144417821|NCT01858389|520733874|FG000|Overall Study|Progressive disease|10|||
144250835|NCT02173379|520117386|FG001|Overall Study|Withdrawal by Subject|29|||
144250836|NCT02173379|520117385|FG000|Overall Study|Physician Decision|8|||
144250837|NCT02173379|520117386|FG001|Overall Study|Physician Decision|8|||
144250838|NCT02173379|520117385|FG000|Overall Study|Death|75|||
144250839|NCT02173379|520117386|FG001|Overall Study|Death|72|||
144250840|NCT02173379|520117385|FG000|Overall Study|Other Reason|1|||
144250841|NCT02173379|520117386|FG001|Overall Study|Other Reason|0|||
144250842|NCT02636699|520117387|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
144250843|NCT02636699|520117388|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
144250844|NCT02636699|520117389|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
144250845|NCT02636699|520117387|FG000|Screening Period|Withdrawal by Subject|0|||
144250846|NCT02636699|520117388|FG001|Screening Period|Withdrawal by Subject|0|||
144250847|NCT02636699|520117389|FG002|Screening Period|Withdrawal by Subject|23|||
144250848|NCT02636699|520117387|FG000|Screening Period|Adverse Event|0|||
144250849|NCT02636699|520117388|FG001|Screening Period|Adverse Event|0|||
144250850|NCT02636699|520117389|FG002|Screening Period|Adverse Event|1|||
144250851|NCT02636699|520117387|FG000|Screening Period|Other not specified|0|||
144250852|NCT02636699|520117388|FG001|Screening Period|Other not specified|0|||
144250853|NCT02636699|520117389|FG002|Screening Period|Other not specified|3|||
144250854|NCT02636699|520117387|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
144250855|NCT02636699|520117388|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
144250856|NCT02636699|520117389|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
144250857|NCT02636699|520117387|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
144250858|NCT02636699|520117388|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
144250859|NCT02636699|520117389|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
144250860|NCT02636699|520117387|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
144250861|NCT02636699|520117388|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
144250862|NCT02636699|520117389|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
144250863|NCT02636699|520117387|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
144250864|NCT02636699|520117388|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
144250865|NCT02636699|520117389|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
144250866|NCT02636699|520117387|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
144250867|NCT02636699|520117388|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
144180021|NCT01894230|519853862|FG000|Overall Study|Non-adherent|0|||
144417822|NCT01858389|520733875|FG001|Overall Study|Progressive disease|11|||
144417823|NCT01858389|520733874|FG000|Overall Study|Other|2|||
144417824|NCT01858389|520733875|FG001|Overall Study|Other|4|||
144417825|NCT01858389|520733874|FG000|Overall Study|Adverse Event|3|||
144417826|NCT01858389|520733875|FG001|Overall Study|Adverse Event|1|||
144417827|NCT01858389|520733874|FG000|Overall Study|Did not receive treatment|0|||
144417828|NCT01858389|520733875|FG001|Overall Study|Did not receive treatment|3|||
144417829|NCT03978520|520733876|FG000|Overall Study|Adverse Event|2|||
144417830|NCT03978520|520733877|FG001|Overall Study|Adverse Event|5|||
144417831|NCT03978520|520733878|FG002|Overall Study|Adverse Event|3|||
144417832|NCT03978520|520733879|FG003|Overall Study|Adverse Event|5|||
144180022|NCT01894230|519853863|FG001|Overall Study|Non-adherent|1|||
144180023|NCT01894230|519853862|FG000|Overall Study|Death|1|||
144180024|NCT01894230|519853863|FG001|Overall Study|Death|0|||
144180025|NCT02219009|519853866|FG000|Overall Study|Withdrawal by Subject|5|||
144180026|NCT02219009|519853867|FG001|Overall Study|Withdrawal by Subject|1|||
144180027|NCT02219009|519853866|FG000|Overall Study|Adverse Event|2|||
144180028|NCT02219009|519853867|FG001|Overall Study|Adverse Event|4|||
144180029|NCT02219009|519853866|FG000|Overall Study|Lost to Follow-up|2|||
144180030|NCT02219009|519853867|FG001|Overall Study|Lost to Follow-up|2|||
144180031|NCT02219009|519853866|FG000|Overall Study|Protocol deviation|1|||
144180032|NCT02219009|519853867|FG001|Overall Study|Protocol deviation|0|||
144180033|NCT02219009|519853866|FG000|Overall Study|Physician Decision|0|||
144180034|NCT02219009|519853867|FG001|Overall Study|Physician Decision|1|||
144250868|NCT02636699|520117389|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
144250869|NCT02636699|520117387|FG000|Treatment and Follow-up Periods|Other|3|||
144250870|NCT02636699|520117388|FG001|Treatment and Follow-up Periods|Other|1|||
144250871|NCT02636699|520117389|FG002|Treatment and Follow-up Periods|Other|0|||
144180035|NCT00660387|519853868|FG000|Overall Study|Adverse Event|1|||
144250872|NCT00530790|520117390|FG000|Overall Study|Adverse Event|2|||
144250873|NCT00530790|520117390|FG000|Overall Study|Withdrawal by Subject|2|||
144250874|NCT00530790|520117390|FG000|Overall Study|Physician Decision|1|||
144250875|NCT00438256|520117393|FG000|Overall Study|Ineligible for Resection|2|||
144250876|NCT00438256|520117394|FG001|Overall Study|Ineligible for Resection|1|||
144250877|NCT00438256|520117395|FG002|Overall Study|Ineligible for Resection|1|||
144417833|NCT03978520|520733880|FG004|Overall Study|Adverse Event|6|||
144180036|NCT00660387|519853869|FG001|Overall Study|Adverse Event|2|||
144250878|NCT00438256|520117396|FG003|Overall Study|Ineligible for Resection|7|||
144250879|NCT00438256|520117393|FG000|Overall Study|Excluded final Diagnosis|0|||
144417834|NCT03978520|520733876|FG000|Overall Study|Withdrawal by Subject|10|||
144180037|NCT00660387|519853868|FG000|Overall Study|Lack of Efficacy|0|||
144180038|NCT00660387|519853869|FG001|Overall Study|Lack of Efficacy|1|||
144180039|NCT00660387|519853868|FG000|Overall Study|Protocol Violation|1|||
144180040|NCT00660387|519853869|FG001|Overall Study|Protocol Violation|0|||
144180041|NCT02966340|519853870|FG000|Overall Study|Adverse Event|0|||
144180042|NCT02966340|519853871|FG001|Overall Study|Adverse Event|1|||
144180043|NCT02966340|519853870|FG000|Overall Study|Lost to Follow-up|0|||
144180044|NCT02966340|519853871|FG001|Overall Study|Lost to Follow-up|1|||
144180045|NCT02966340|519853870|FG000|Overall Study|Withdrawal by Subject|1|||
144180046|NCT02966340|519853871|FG001|Overall Study|Withdrawal by Subject|0|||
144180047|NCT02966340|519853870|FG000|Overall Study|data acquisition error|1|||
144180048|NCT02966340|519853871|FG001|Overall Study|data acquisition error|0|||
144180049|NCT02966340|519853870|FG000|Overall Study|startle non-responder|1|||
144180050|NCT02966340|519853871|FG001|Overall Study|startle non-responder|1|||
144180051|NCT02485158|519853879|FG000|Overall Study|Withdrawal by Subject|3|||
144180052|NCT02485158|519853879|FG000|Overall Study|expected drug side effect|1|||
144180053|NCT00202839|519853880|FG000|Overall Study|Adverse Event|1|||
144180054|NCT00202839|519853881|FG001|Overall Study|Adverse Event|5|||
144180055|NCT00202839|519853880|FG000|Overall Study|Physician Decision|12|||
144180056|NCT00202839|519853881|FG001|Overall Study|Physician Decision|0|||
144180057|NCT00202839|519853880|FG000|Overall Study|Withdrawal by Subject|6|||
144180058|NCT00202839|519853881|FG001|Overall Study|Withdrawal by Subject|2|||
144180059|NCT00202839|519853880|FG000|Overall Study|Protocol Violation|2|||
144180060|NCT00202839|519853881|FG001|Overall Study|Protocol Violation|1|||
144180061|NCT00202839|519853880|FG000|Overall Study|Lost to Follow-up|3|||
144180062|NCT00202839|519853881|FG001|Overall Study|Lost to Follow-up|2|||
144180063|NCT01098851|519853882|FG000|Overall Study|Equipment failure|1|||
144180064|NCT01098851|519853883|FG001|Overall Study|Equipment failure|0|||
144180065|NCT03087786|519853884|FG000|Overall Study|Withdrawal by Subject|2|||
144180066|NCT03087786|519853885|FG001|Overall Study|Withdrawal by Subject|0|||
144180067|NCT00642993|519853888|FG000|Overall Study|Adverse Event|85|||
144180068|NCT00642993|519853889|FG001|Overall Study|Adverse Event|4|||
144180069|NCT00642993|519853888|FG000|Overall Study|Lost to Follow-up|8|||
144180070|NCT00642993|519853889|FG001|Overall Study|Lost to Follow-up|4|||
144180071|NCT00642993|519853888|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
144180072|NCT00642993|519853889|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
144180073|NCT00642993|519853888|FG000|Overall Study|Protocol Violation|1|||
144180074|NCT00642993|519853889|FG001|Overall Study|Protocol Violation|4|||
144180075|NCT00642993|519853888|FG000|Overall Study|Did not meet protocol eligibility|0|||
144180076|NCT00642993|519853889|FG001|Overall Study|Did not meet protocol eligibility|1|||
144180077|NCT00642993|519853888|FG000|Overall Study|Administrative|1|||
144180078|NCT00642993|519853889|FG001|Overall Study|Administrative|0|||
144180079|NCT02664415|519853890|FG000|Overall Study|Adverse Event|1|||
144180080|NCT02664415|519853891|FG001|Overall Study|Adverse Event|0|||
144180081|NCT01151280|519853894|FG000|Overall Study|Adverse Event|1|||
144180082|NCT01151280|519853894|FG000|Overall Study|Lack of Efficacy|3|||
144180083|NCT00960154|519853895|FG000|Overall Study|Study termination|25|||
144180084|NCT00960154|519853896|FG001|Overall Study|Study termination|25|||
144180085|NCT03119662|519853897|FG000|Overall Study|Withdrawal by Subject|0|||
144180086|NCT03119662|519853898|FG001|Overall Study|Withdrawal by Subject|1|||
144180087|NCT00757705|519853899|FG000|Overall Study|Adverse Event|19|||
144180088|NCT00757705|519853899|FG000|Overall Study|Lost to Follow-up|16|||
144180089|NCT00757705|519853899|FG000|Overall Study|Withdrawal by Subject|25|||
144180090|NCT00757705|519853899|FG000|Overall Study|Insufficient Response|26|||
144180091|NCT00757705|519853899|FG000|Overall Study|Ineligible to continue|8|||
144417835|NCT03978520|520733877|FG001|Overall Study|Withdrawal by Subject|4|||
144417836|NCT03978520|520733878|FG002|Overall Study|Withdrawal by Subject|5|||
144417837|NCT03978520|520733879|FG003|Overall Study|Withdrawal by Subject|6|||
144417838|NCT03978520|520733880|FG004|Overall Study|Withdrawal by Subject|5|||
144417839|NCT03978520|520733876|FG000|Overall Study|Lost to Follow-up|2|||
144417840|NCT03978520|520733877|FG001|Overall Study|Lost to Follow-up|2|||
144723203|NCT02708277|521840658|FG000|Overall Study|Lost to Follow-up|7|||
144723204|NCT02708277|521840659|FG001|Overall Study|Lost to Follow-up|4|||
144180092|NCT00757705|519853899|FG000|Overall Study|Non-compliant|9|||
144180093|NCT00757705|519853899|FG000|Overall Study|Other|18|||
144180094|NCT02817828|519853900|FG000|Overall Study|Lost to Follow-up|41|||
144180095|NCT02817828|519853900|FG000|Overall Study|Adverse event not related to bleeding|104|||
144180096|NCT02817828|519853900|FG000|Overall Study|Adverse event related to bleeding|53|||
144417841|NCT03978520|520733878|FG002|Overall Study|Lost to Follow-up|2|||
144417842|NCT03978520|520733879|FG003|Overall Study|Lost to Follow-up|0|||
144723205|NCT01058421|521840660|FG000|1 Month Outcomes|Death|10|||
144180097|NCT02817828|519853900|FG000|Overall Study|Protocol Violation|11|||
144180098|NCT02817828|519853900|FG000|Overall Study|Pregnancy|7|||
144180099|NCT02817828|519853900|FG000|Overall Study|Pregnancy wish|15|||
144180100|NCT02817828|519853900|FG000|Overall Study|Withdrawal by Subject|78|||
144180101|NCT02817828|519853900|FG000|Overall Study|Other|26|||
144180102|NCT00660660|519853904|FG000|Overall Study|Adverse Event|1|||
144180103|NCT00660660|519853905|FG001|Overall Study|Adverse Event|0|||
144180104|NCT00660660|519853904|FG000|Overall Study|Lost to Follow-up|0|||
144723206|NCT01058421|521840661|FG001|1 Month Outcomes|Death|6|||
144417843|NCT03978520|520733880|FG004|Overall Study|Lost to Follow-up|1|||
144417844|NCT03978520|520733876|FG000|Overall Study|COVID-19 infection|0|||
144417845|NCT03978520|520733877|FG001|Overall Study|COVID-19 infection|1|||
144417846|NCT03978520|520733878|FG002|Overall Study|COVID-19 infection|0|||
144417847|NCT03978520|520733879|FG003|Overall Study|COVID-19 infection|0|||
144417848|NCT03978520|520733880|FG004|Overall Study|COVID-19 infection|0|||
144417849|NCT03978520|520733876|FG000|Overall Study|Other, not specified|9|||
144417850|NCT03978520|520733877|FG001|Overall Study|Other, not specified|4|||
144417851|NCT03978520|520733878|FG002|Overall Study|Other, not specified|1|||
144417852|NCT03978520|520733879|FG003|Overall Study|Other, not specified|1|||
144417853|NCT03978520|520733880|FG004|Overall Study|Other, not specified|2|||
144180105|NCT00660660|519853905|FG001|Overall Study|Lost to Follow-up|6|||
144180106|NCT00660660|519853904|FG000|Overall Study|Lack of Efficacy|0|||
144180107|NCT00660660|519853905|FG001|Overall Study|Lack of Efficacy|2|||
144180108|NCT00660660|519853904|FG000|Overall Study|Withdrawal by Subject|3|||
144417854|NCT03978520|520733876|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
144417855|NCT03978520|520733877|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
144417856|NCT03978520|520733878|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
144417857|NCT03978520|520733879|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
144417858|NCT03978520|520733880|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
144417859|NCT01605877|520733881|FG000|Overall Study|Withdrawal by Subject|1|||
144417860|NCT01835587|520733884|FG000|Overall Study|Disease Recurrence or Relapse|0|||
144417861|NCT01835587|520733885|FG001|Overall Study|Disease Recurrence or Relapse|3|||
144417862|NCT01835587|520733886|FG002|Overall Study|Disease Recurrence or Relapse|0|||
144417863|NCT01835587|520733887|FG003|Overall Study|Disease Recurrence or Relapse|3|||
144417864|NCT01835587|520733884|FG000|Overall Study|Withdrawal by Subject|2|||
144417865|NCT01835587|520733885|FG001|Overall Study|Withdrawal by Subject|0|||
144417866|NCT01835587|520733886|FG002|Overall Study|Withdrawal by Subject|0|||
144417867|NCT01835587|520733887|FG003|Overall Study|Withdrawal by Subject|3|||
144417868|NCT01835587|520733884|FG000|Overall Study|Adverse Event|0|||
144417869|NCT01835587|520733885|FG001|Overall Study|Adverse Event|0|||
144417870|NCT01835587|520733886|FG002|Overall Study|Adverse Event|2|||
144417871|NCT01835587|520733887|FG003|Overall Study|Adverse Event|2|||
144417872|NCT01835587|520733884|FG000|Overall Study|Death|0|||
144417873|NCT01835587|520733885|FG001|Overall Study|Death|0|||
144417874|NCT01835587|520733886|FG002|Overall Study|Death|0|||
144417875|NCT01835587|520733887|FG003|Overall Study|Death|1|||
144417876|NCT01835587|520733884|FG000|Overall Study|Miscellaneous|0|||
144417877|NCT01835587|520733885|FG001|Overall Study|Miscellaneous|1|||
144417878|NCT01835587|520733886|FG002|Overall Study|Miscellaneous|0|||
144417879|NCT01835587|520733887|FG003|Overall Study|Miscellaneous|0|||
144417880|NCT03310775|520733893|FG000|Overall Study|Lost to Follow-up|2|||
144417881|NCT03310775|520733894|FG001|Overall Study|Lost to Follow-up|3|||
144417882|NCT03310775|520733893|FG000|Overall Study|aggravation of depression|0|||
144417883|NCT03310775|520733894|FG001|Overall Study|aggravation of depression|1|||
144417884|NCT00126568|520733895|FG000|Overall Study|Death|2|||
144180109|NCT00660660|519853905|FG001|Overall Study|Withdrawal by Subject|0|||
144180110|NCT00660660|519853904|FG000|Overall Study|Incorrect enrollment and other|0|||
144417885|NCT03064451|520733896|FG000|Overall Study|Lost to Follow-up|1|||
144417886|NCT03064451|520733896|FG000|Overall Study|Mapping Failure|4|||
144417887|NCT03064451|520733896|FG000|Overall Study|Exited prior to procedure|8|||
144417888|NCT03064451|520733896|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
144417889|NCT00750204|520733897|FG000|Overall Study|study halted prematurely|1|||
144417890|NCT00750204|520733898|FG001|Overall Study|study halted prematurely|1|||
144417891|NCT02373202|520735646|FG000|Overall Study|Adverse Event|2|||
144417892|NCT02373202|520735647|FG001|Overall Study|Adverse Event|5|||
144417893|NCT02373202|520735648|FG002|Overall Study|Adverse Event|2|||
144417894|NCT02373202|520735649|FG003|Overall Study|Adverse Event|1|||
144417895|NCT02373202|520735646|FG000|Overall Study|Lack of Efficacy|0|||
144417896|NCT02373202|520735647|FG001|Overall Study|Lack of Efficacy|0|||
144417897|NCT02373202|520735648|FG002|Overall Study|Lack of Efficacy|1|||
144417898|NCT02373202|520735649|FG003|Overall Study|Lack of Efficacy|0|||
144417899|NCT02373202|520735646|FG000|Overall Study|Other|0|||
144180111|NCT00660660|519853905|FG001|Overall Study|Incorrect enrollment and other|1|||
144527431|NCT05496231|521133276|FG000|Overall Study|Migrated/moved from the study area|3|||
144527432|NCT05496231|521133277|FG001|Overall Study|Migrated/moved from the study area|5|||
144527433|NCT05496231|521133278|FG002|Overall Study|Migrated/moved from the study area|3|||
144180112|NCT00660660|519853904|FG000|Overall Study|New medication after randomization|1|||
144417900|NCT02373202|520735647|FG001|Overall Study|Other|1|||
144417901|NCT02373202|520735648|FG002|Overall Study|Other|0|||
144417902|NCT02373202|520735649|FG003|Overall Study|Other|0|||
144417903|NCT03010254|520735650|FG000|Overall Study|Adverse Event|0|||
144417904|NCT03010254|520735651|FG001|Overall Study|Adverse Event|1|||
144417905|NCT03010254|520735650|FG000|Overall Study|Lost to Follow-up|4|||
144417906|NCT03010254|520735651|FG001|Overall Study|Lost to Follow-up|0|||
144417907|NCT03010254|520735650|FG000|Overall Study|Withdrawal by Subject|1|||
144527434|NCT05496231|521133279|FG003|Overall Study|Migrated/moved from the study area|3|||
144417908|NCT03010254|520735651|FG001|Overall Study|Withdrawal by Subject|1|||
144417909|NCT03010254|520735650|FG000|Overall Study|Other|2|||
144417910|NCT03010254|520735651|FG001|Overall Study|Other|3|||
144417911|NCT01404325|520735652|FG000|Overall Study|Lost to Follow-up|1|||
144417912|NCT01404325|520735653|FG001|Overall Study|Lost to Follow-up|0|||
144417913|NCT01404325|520735652|FG000|Overall Study|Death|2|||
144417914|NCT01404325|520735653|FG001|Overall Study|Death|0|||
144417915|NCT01404325|520735652|FG000|Overall Study|Graft loss/Retransplantation|1|||
144417916|NCT01404325|520735653|FG001|Overall Study|Graft loss/Retransplantation|0|||
144417917|NCT01404325|520735652|FG000|Overall Study|non-specified reason|0|||
144417918|NCT01404325|520735653|FG001|Overall Study|non-specified reason|2|||
144417919|NCT01411228|520735654|FG000|Overall Study|Lost to Follow-up|0|||
144250880|NCT00438256|520117394|FG001|Overall Study|Excluded final Diagnosis|0|||
144250881|NCT00438256|520117395|FG002|Overall Study|Excluded final Diagnosis|0|||
144250882|NCT00438256|520117396|FG003|Overall Study|Excluded final Diagnosis|2|||
144250883|NCT01490697|520117400|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
144250884|NCT01490697|520117401|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
144250885|NCT03742258|520117407|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
144250886|NCT03742258|520117408|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
144250887|NCT03742258|520117409|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
144250888|NCT03742258|520117407|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
144250889|NCT03742258|520117408|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
144250890|NCT03742258|520117409|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
144250891|NCT03742258|520117407|FG000|Survival Follow-Up|Still in Follow-up|0|||
144250892|NCT03742258|520117408|FG001|Survival Follow-Up|Still in Follow-up|0|||
144250893|NCT03742258|520117409|FG002|Survival Follow-Up|Still in Follow-up|2|||
144250894|NCT00564395|520117416|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
144250895|NCT00564395|520117417|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
144250896|NCT00564395|520117416|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
144250897|NCT00564395|520117417|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
144250898|NCT01625689|520117420|FG000|Overall Study|Migration|2|||
144250899|NCT01625689|520117421|FG001|Overall Study|Migration|1|||
144417920|NCT01411228|520735655|FG001|Overall Study|Lost to Follow-up|0|||
144417921|NCT01411228|520735656|FG002|Overall Study|Lost to Follow-up|1|||
144417922|NCT01411228|520735654|FG000|Overall Study|Withdrawal by Subject|1|||
144417923|NCT01411228|520735655|FG001|Overall Study|Withdrawal by Subject|0|||
144417924|NCT01411228|520735656|FG002|Overall Study|Withdrawal by Subject|0|||
144417925|NCT01986855|520735657|FG000|Overall Study|Adverse Event|1|||
144417926|NCT01986855|520735658|FG001|Overall Study|Adverse Event|0|||
144417927|NCT01986855|520735659|FG002|Overall Study|Adverse Event|0|||
144417928|NCT01986855|520735657|FG000|Overall Study|Death|3|||
144417929|NCT01986855|520735658|FG001|Overall Study|Death|4|||
144417930|NCT01986855|520735659|FG002|Overall Study|Death|4|||
144417931|NCT01986855|520735657|FG000|Overall Study|Lost to Follow-up|2|||
144417932|NCT01986855|520735658|FG001|Overall Study|Lost to Follow-up|1|||
144417933|NCT01986855|520735659|FG002|Overall Study|Lost to Follow-up|0|||
144417934|NCT01986855|520735657|FG000|Overall Study|Screen Failure|0|||
144417935|NCT01986855|520735658|FG001|Overall Study|Screen Failure|1|||
144417936|NCT01986855|520735659|FG002|Overall Study|Screen Failure|0|||
144417937|NCT01986855|520735657|FG000|Overall Study|Participant Moved|0|||
144417938|NCT01986855|520735658|FG001|Overall Study|Participant Moved|0|||
144417939|NCT01986855|520735659|FG002|Overall Study|Participant Moved|2|||
144417940|NCT01986855|520735657|FG000|Overall Study|Withdrawal by Subject|7|||
144417941|NCT01986855|520735658|FG001|Overall Study|Withdrawal by Subject|8|||
144417942|NCT01986855|520735659|FG002|Overall Study|Withdrawal by Subject|5|||
144417943|NCT02064868|520735660|FG000|Overall Study|Lost to Follow-up|14|||
144417944|NCT02064868|520735661|FG001|Overall Study|Lost to Follow-up|8|||
144417945|NCT02064868|520735660|FG000|Overall Study|Physician Decision|1|||
144417946|NCT02064868|520735661|FG001|Overall Study|Physician Decision|0|||
144417947|NCT02064868|520735660|FG000|Overall Study|Withdrawal by Subject|14|||
144417948|NCT02064868|520735661|FG001|Overall Study|Withdrawal by Subject|3|||
144417949|NCT02064868|520735660|FG000|Overall Study|Technical Problems or Missing|5|||
144417950|NCT02064868|520735661|FG001|Overall Study|Technical Problems or Missing|2|||
144417951|NCT02670083|520735665|FG000|Overall Study|Adverse Event|16|||
144417952|NCT02670083|520735666|FG001|Overall Study|Adverse Event|13|||
144250900|NCT02134353|520117428|FG000|Overall Study|Adverse Event|10|||
144250901|NCT02134353|520117429|FG001|Overall Study|Adverse Event|6|||
144417953|NCT02670083|520735665|FG000|Overall Study|Death|4|||
144417954|NCT02670083|520735666|FG001|Overall Study|Death|6|||
144417955|NCT02670083|520735665|FG000|Overall Study|Lost to Follow-up|2|||
144417956|NCT02670083|520735666|FG001|Overall Study|Lost to Follow-up|2|||
144417957|NCT02670083|520735665|FG000|Overall Study|Multiple Reasons|9|||
144601043|NCT04598477|521401710|FG000|Overall Study|Physician Decision|7|||
144417958|NCT02670083|520735666|FG001|Overall Study|Multiple Reasons|9|||
144417959|NCT02670083|520735665|FG000|Overall Study|Physician Decision|0|||
144417960|NCT02670083|520735666|FG001|Overall Study|Physician Decision|2|||
144417961|NCT02670083|520735665|FG000|Overall Study|Study Terminated By Sponsor|257|||
144180113|NCT00660660|519853905|FG001|Overall Study|New medication after randomization|0|||
144180114|NCT02308241|519853906|FG000|Overall Study|Withdrawal by Subject|3|||
144180115|NCT01741545|519853907|FG000|Treatment Period|Lack of Efficacy|0|||
144180116|NCT01741545|519853908|FG001|Treatment Period|Lack of Efficacy|1|||
144180117|NCT01741545|519853907|FG000|Treatment Period|Adverse event, non-fatal|1|||
144180118|NCT01741545|519853908|FG001|Treatment Period|Adverse event, non-fatal|3|||
144180119|NCT01741545|519853907|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
144180120|NCT01741545|519853908|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
144180121|NCT01741545|519853907|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
144180122|NCT01741545|519853908|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
144180123|NCT01853176|519853909|FG000|Overall Study|Study terminated|4|||
144180124|NCT01853176|519853910|FG001|Overall Study|Study terminated|0|||
144180125|NCT03599362|519853911|FG000|Overall Study|Screen Failure|3|||
144180126|NCT01370083|519853913|FG000|Overall Study|Lost to Follow-up|2|||
144180127|NCT01370083|519853914|FG001|Overall Study|Lost to Follow-up|0|||
144180128|NCT01370083|519853913|FG000|Overall Study|Adverse Event|0|||
144180129|NCT01370083|519853914|FG001|Overall Study|Adverse Event|1|||
144180130|NCT01945580|519853916|FG000|Overall Study|Withdrawal by Subject|13|||
144180131|NCT01945580|519853917|FG001|Overall Study|Withdrawal by Subject|35|||
144180132|NCT01945580|519853916|FG000|Overall Study|Physician Decision|3|||
144180133|NCT01945580|519853917|FG001|Overall Study|Physician Decision|2|||
144180134|NCT01945580|519853916|FG000|Overall Study|Lost to Follow-up|26|||
144180135|NCT01945580|519853917|FG001|Overall Study|Lost to Follow-up|39|||
144180136|NCT01945580|519853916|FG000|Overall Study|Death|7|||
144180137|NCT01945580|519853917|FG001|Overall Study|Death|2|||
144417962|NCT02670083|520735666|FG001|Overall Study|Study Terminated By Sponsor|254|||
144417963|NCT02670083|520735665|FG000|Overall Study|Symptomatic Deterioration|0|||
144417964|NCT02670083|520735666|FG001|Overall Study|Symptomatic Deterioration|2|||
144417965|NCT02670083|520735665|FG000|Overall Study|Withdrawal by Subject|32|||
144417966|NCT02670083|520735666|FG001|Overall Study|Withdrawal by Subject|31|||
144417967|NCT02670083|520735665|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144417968|NCT02670083|520735666|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144417969|NCT02425046|520735671|FG000|Overall Study|Lost to Follow-up|52|||
144417970|NCT02425046|520735672|FG001|Overall Study|Lost to Follow-up|50|||
144417971|NCT02425046|520735673|FG002|Overall Study|Lost to Follow-up|56|||
144527435|NCT05496231|521133276|FG000|Overall Study|Lost to Follow-up|13|||
144417972|NCT02425046|520735671|FG000|Overall Study|Withdrawal by Subject|16|||
144417973|NCT02425046|520735672|FG001|Overall Study|Withdrawal by Subject|12|||
144417974|NCT02425046|520735673|FG002|Overall Study|Withdrawal by Subject|0|||
144417975|NCT03562481|520735674|FG000|First Intervention|Lost to Follow-up|1|||
144417976|NCT03562481|520735675|FG001|First Intervention|Lost to Follow-up|0|||
144417977|NCT02904512|520735679|FG000|Overall Study|Withdrawal by Subject|1|||
144417978|NCT02904512|520735680|FG001|Overall Study|Withdrawal by Subject|0|||
144417979|NCT02904512|520735679|FG000|Overall Study|Transferred to ICU|1|||
144417980|NCT02904512|520735680|FG001|Overall Study|Transferred to ICU|0|||
144417981|NCT02904512|520735679|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
144417982|NCT02904512|520735680|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
144417983|NCT00549302|520735697|FG000|Double-Blind|Death|2|||
144417984|NCT00549302|520735698|FG001|Double-Blind|Death|9|||
144417985|NCT00549302|520735699|FG002|Double-Blind|Death|0|||
144417986|NCT00549302|520735697|FG000|Double-Blind|Adverse Event|3|||
144180138|NCT01945580|519853916|FG000|Overall Study|Patient moved out of state|0|||
144180139|NCT01945580|519853917|FG001|Overall Study|Patient moved out of state|1|||
144180140|NCT01945580|519853916|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
144180141|NCT01945580|519853917|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
144180142|NCT01945580|519853916|FG000|Overall Study|Family illness - unable to return|0|||
144180143|NCT01945580|519853917|FG001|Overall Study|Family illness - unable to return|1|||
144180144|NCT01945580|519853916|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
144180145|NCT01945580|519853917|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
144180146|NCT01945580|519853916|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
144180147|NCT01945580|519853917|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
144180148|NCT01945580|519853916|FG000|Overall Study|Noncompliance with 36 month visit|1|||
144180149|NCT01945580|519853917|FG001|Overall Study|Noncompliance with 36 month visit|0|||
144180150|NCT01945580|519853916|FG000|Overall Study|The patient moved.|1|||
144180151|NCT01945580|519853917|FG001|Overall Study|The patient moved.|0|||
144417987|NCT00549302|520735698|FG001|Double-Blind|Adverse Event|16|||
144417988|NCT00549302|520735699|FG002|Double-Blind|Adverse Event|0|||
144417989|NCT00549302|520735697|FG000|Double-Blind|Withdrawal by Subject|3|||
144417990|NCT00549302|520735698|FG001|Double-Blind|Withdrawal by Subject|8|||
144417991|NCT00549302|520735699|FG002|Double-Blind|Withdrawal by Subject|0|||
144417992|NCT00549302|520735697|FG000|Double-Blind|Investigator Decision|1|||
144417993|NCT00549302|520735698|FG001|Double-Blind|Investigator Decision|5|||
144527436|NCT05496231|521133277|FG001|Overall Study|Lost to Follow-up|6|||
144417994|NCT00549302|520735699|FG002|Double-Blind|Investigator Decision|0|||
144417995|NCT00549302|520735697|FG000|Double-Blind|Sponsor Decision|0|||
144417996|NCT00549302|520735698|FG001|Double-Blind|Sponsor Decision|1|||
144180152|NCT01945580|519853916|FG000|Overall Study|No data available|0|||
144180153|NCT01945580|519853917|FG001|Overall Study|No data available|2|||
144180154|NCT02933060|519853920|FG000|Overall Study|Withdrawal by Subject|0|||
144417997|NCT00549302|520735699|FG002|Double-Blind|Sponsor Decision|0|||
144417998|NCT00549302|520735697|FG000|Double-Blind|Lost to Follow-up|1|||
144417999|NCT00549302|520735698|FG001|Double-Blind|Lost to Follow-up|2|||
144418000|NCT00549302|520735699|FG002|Double-Blind|Lost to Follow-up|0|||
144418001|NCT00549302|520735697|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
144418002|NCT00549302|520735698|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
144418003|NCT00549302|520735699|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
144180155|NCT02933060|519853921|FG001|Overall Study|Withdrawal by Subject|1|||
144180156|NCT05034874|519853922|FG000|Overall Study|Withdrawal by Subject|6|||
144180157|NCT05034874|519853923|FG001|Overall Study|Withdrawal by Subject|6|||
144180158|NCT05034874|519853922|FG000|Overall Study|Lost to Follow-up|18|||
144180159|NCT05034874|519853923|FG001|Overall Study|Lost to Follow-up|8|||
144418004|NCT00549302|520735697|FG000|Double-Blind|New condition or starts new therapy|0|||
144180160|NCT05034874|519853922|FG000|Overall Study|Physician Decision|0|||
144180161|NCT05034874|519853923|FG001|Overall Study|Physician Decision|1|||
144180162|NCT05034874|519853922|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
144418005|NCT00549302|520735698|FG001|Double-Blind|New condition or starts new therapy|2|||
144418006|NCT00549302|520735699|FG002|Double-Blind|New condition or starts new therapy|0|||
144418007|NCT00549302|520735697|FG000|Open-Label|Adverse Event|0|||
144418008|NCT00549302|520735698|FG001|Open-Label|Adverse Event|0|||
144418009|NCT00549302|520735699|FG002|Open-Label|Adverse Event|11|||
144418010|NCT00549302|520735697|FG000|Open-Label|Death|0|||
144418011|NCT00549302|520735698|FG001|Open-Label|Death|0|||
144418012|NCT00549302|520735699|FG002|Open-Label|Death|40|||
144418013|NCT00549302|520735697|FG000|Open-Label|Investigator Decision|0|||
144418014|NCT00549302|520735698|FG001|Open-Label|Investigator Decision|0|||
144418015|NCT00549302|520735699|FG002|Open-Label|Investigator Decision|5|||
144418016|NCT00549302|520735697|FG000|Open-Label|Lost to Follow-up|0|||
144418017|NCT00549302|520735698|FG001|Open-Label|Lost to Follow-up|0|||
144418018|NCT00549302|520735699|FG002|Open-Label|Lost to Follow-up|2|||
144418019|NCT00549302|520735697|FG000|Open-Label|Other|0|||
144418020|NCT00549302|520735698|FG001|Open-Label|Other|0|||
144418021|NCT00549302|520735699|FG002|Open-Label|Other|3|||
144418022|NCT00549302|520735697|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
144527437|NCT05496231|521133278|FG002|Overall Study|Lost to Follow-up|11|||
144527438|NCT05496231|521133279|FG003|Overall Study|Lost to Follow-up|6|||
144527439|NCT05496231|521133276|FG000|Overall Study|Other|9|||
144527440|NCT05496231|521133277|FG001|Overall Study|Other|7|||
144527441|NCT05496231|521133278|FG002|Overall Study|Other|7|||
144527442|NCT05496231|521133279|FG003|Overall Study|Other|8|||
144527443|NCT03974178|521133280|FG000|Overall Study|Death|0|||
144527444|NCT03974178|521133281|FG001|Overall Study|Death|1|||
144527445|NCT05670587|521133284|FG000|Overall Study|Withdrawal by Subject|3|||
144527446|NCT04508309|521133287|FG000|Overall Study|Death|0|||
144601044|NCT04598477|521401711|FG001|Overall Study|Physician Decision|2|||
144601045|NCT04598477|521401710|FG000|Overall Study|Pregnancy|0|||
144180163|NCT05034874|519853923|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
144180164|NCT05616728|519853928|FG000|Overall Study|Lost to Follow-up|0|||
144180165|NCT05616728|519853929|FG001|Overall Study|Lost to Follow-up|0|||
144180166|NCT05616728|519853930|FG002|Overall Study|Lost to Follow-up|1|||
144180167|NCT05616728|519853928|FG000|Overall Study|Withdrawal by Subject|1|||
144180168|NCT05616728|519853929|FG001|Overall Study|Withdrawal by Subject|1|||
144180169|NCT05616728|519853930|FG002|Overall Study|Withdrawal by Subject|0|||
144180170|NCT05616728|519853928|FG000|Overall Study|Physician Decision|1|||
144180171|NCT05616728|519853929|FG001|Overall Study|Physician Decision|1|||
144180172|NCT05616728|519853930|FG002|Overall Study|Physician Decision|1|||
144180173|NCT05616728|519853928|FG000|Overall Study|Other|0|||
144180174|NCT05616728|519853929|FG001|Overall Study|Other|2|||
144180175|NCT05616728|519853930|FG002|Overall Study|Other|0|||
144418023|NCT00549302|520735698|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
144418024|NCT00549302|520735699|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
144418025|NCT00549302|520735697|FG000|Open-Label|Withdrawal by Subject|0|||
144418026|NCT00549302|520735698|FG001|Open-Label|Withdrawal by Subject|0|||
144418027|NCT00549302|520735699|FG002|Open-Label|Withdrawal by Subject|6|||
144418028|NCT03590041|520735703|FG000|Overall Study|Protocol Violation|4|||
144418029|NCT03590041|520735704|FG001|Overall Study|Protocol Violation|3|||
144418030|NCT03590041|520735703|FG000|Overall Study|No session data recorded|14|||
144418031|NCT03590041|520735704|FG001|Overall Study|No session data recorded|2|||
144527447|NCT04508309|521133288|FG001|Overall Study|Death|0|||
144180176|NCT00577655|519853931|FG000|Overall Study|Patient Request|0|||
144527448|NCT04508309|521133289|FG002|Overall Study|Death|0|||
144180177|NCT00577655|519853932|FG001|Overall Study|Patient Request|2|||
144418032|NCT00865124|520735705|FG000|Overall Study|Physician Decision|2|||
144527449|NCT04508309|521133290|FG003|Overall Study|Death|0|||
144601046|NCT04598477|521401711|FG001|Overall Study|Pregnancy|1|||
144250902|NCT02134353|520117428|FG000|Overall Study|Lost to Follow-up|1|||
144527450|NCT04508309|521133291|FG004|Overall Study|Death|1|||
144527451|NCT04508309|521133287|FG000|Overall Study|Lost to Follow-up|0|||
144180178|NCT00577655|519853931|FG000|Overall Study|Protocol Violation|0|||
144180179|NCT00577655|519853932|FG001|Overall Study|Protocol Violation|1|||
144180180|NCT00577655|519853931|FG000|Overall Study|Lost to Follow-up|1|||
144180181|NCT00577655|519853932|FG001|Overall Study|Lost to Follow-up|1|||
144180182|NCT00875524|519853934|FG000|Overall Study|Serious adverse event|0|||
144180183|NCT00875524|519853935|FG001|Overall Study|Serious adverse event|1|||
144180184|NCT00875524|519853934|FG000|Overall Study|Protocol Violation|4|||
144180185|NCT00875524|519853935|FG001|Overall Study|Protocol Violation|0|||
144180186|NCT00875524|519853934|FG000|Overall Study|Lost to Follow-up|1|||
144180187|NCT00875524|519853935|FG001|Overall Study|Lost to Follow-up|0|||
144180188|NCT00875524|519853934|FG000|Overall Study|Withdrawal by Subject|3|||
144180189|NCT00875524|519853935|FG001|Overall Study|Withdrawal by Subject|5|||
144180190|NCT01370863|519853936|FG000|Overall Study|Adverse Event|1|||
144180191|NCT01370863|519853937|FG001|Overall Study|Adverse Event|1|||
144180192|NCT01370863|519853936|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
144180193|NCT01370863|519853937|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
144180194|NCT01370863|519853936|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
144180195|NCT01370863|519853937|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
144180196|NCT00881751|519853940|FG000|Overall Study|Physician Decision|0|||
144180197|NCT00881751|519853941|FG001|Overall Study|Physician Decision|1|||
144180198|NCT00881751|519853940|FG000|Overall Study|Adverse Event|0|||
144180199|NCT00881751|519853941|FG001|Overall Study|Adverse Event|2|||
144180200|NCT00881751|519853940|FG000|Overall Study|Withdrawal by Subject|0|||
144180201|NCT00881751|519853941|FG001|Overall Study|Withdrawal by Subject|2|||
144180202|NCT00819169|519853942|FG000|Overall Study|Withdrawal by Subject|2|||
144180203|NCT00819169|519853943|FG001|Overall Study|Withdrawal by Subject|0|||
144180204|NCT00819169|519853944|FG002|Overall Study|Withdrawal by Subject|0|||
144180205|NCT00819169|519853945|FG003|Overall Study|Withdrawal by Subject|1|||
144180206|NCT00819169|519853946|FG004|Overall Study|Withdrawal by Subject|1|||
144180207|NCT00819169|519853947|FG005|Overall Study|Withdrawal by Subject|1|||
144180208|NCT00819169|519853948|FG006|Overall Study|Withdrawal by Subject|5|||
144180209|NCT00819169|519853949|FG007|Overall Study|Withdrawal by Subject|1|||
144180210|NCT00819169|519853950|FG008|Overall Study|Withdrawal by Subject|4|||
144180211|NCT00819169|519853942|FG000|Overall Study|Lost to Follow-up|0|||
144180212|NCT00819169|519853943|FG001|Overall Study|Lost to Follow-up|2|||
144180213|NCT00819169|519853944|FG002|Overall Study|Lost to Follow-up|0|||
144180214|NCT00819169|519853945|FG003|Overall Study|Lost to Follow-up|1|||
144180215|NCT00819169|519853946|FG004|Overall Study|Lost to Follow-up|0|||
144180216|NCT00819169|519853947|FG005|Overall Study|Lost to Follow-up|6|||
144180217|NCT00819169|519853948|FG006|Overall Study|Lost to Follow-up|2|||
144180218|NCT00819169|519853949|FG007|Overall Study|Lost to Follow-up|2|||
144180219|NCT00819169|519853950|FG008|Overall Study|Lost to Follow-up|1|||
144180220|NCT00819169|519853942|FG000|Overall Study|Death|1|||
144180221|NCT00819169|519853943|FG001|Overall Study|Death|1|||
144180222|NCT00819169|519853944|FG002|Overall Study|Death|3|||
144250903|NCT02134353|520117429|FG001|Overall Study|Lost to Follow-up|1|||
144250904|NCT02134353|520117428|FG000|Overall Study|Lack of Efficacy|2|||
144250905|NCT02134353|520117429|FG001|Overall Study|Lack of Efficacy|1|||
144180223|NCT00819169|519853945|FG003|Overall Study|Death|8|||
144180224|NCT00819169|519853946|FG004|Overall Study|Death|5|||
144180225|NCT00819169|519853947|FG005|Overall Study|Death|7|||
144180226|NCT00819169|519853948|FG006|Overall Study|Death|9|||
144180227|NCT00819169|519853949|FG007|Overall Study|Death|4|||
144180228|NCT00819169|519853950|FG008|Overall Study|Death|7|||
144180229|NCT00819169|519853942|FG000|Overall Study|Ineligibility determined|0|||
144180230|NCT00819169|519853943|FG001|Overall Study|Ineligibility determined|0|||
144180231|NCT00819169|519853944|FG002|Overall Study|Ineligibility determined|0|||
144250906|NCT02134353|520117428|FG000|Overall Study|Withdrawal by Subject|12|||
144180232|NCT00819169|519853945|FG003|Overall Study|Ineligibility determined|2|||
144180233|NCT00819169|519853946|FG004|Overall Study|Ineligibility determined|0|||
144180234|NCT00819169|519853947|FG005|Overall Study|Ineligibility determined|0|||
144180235|NCT00819169|519853948|FG006|Overall Study|Ineligibility determined|0|||
144418033|NCT00865124|520735706|FG001|Overall Study|Physician Decision|1|||
144418034|NCT00865124|520735707|FG002|Overall Study|Physician Decision|0|||
144418035|NCT00865124|520735705|FG000|Overall Study|Withdrawn consent|2|||
144418036|NCT00865124|520735706|FG001|Overall Study|Withdrawn consent|0|||
144418037|NCT00865124|520735707|FG002|Overall Study|Withdrawn consent|0|||
144418038|NCT01979016|520735709|FG000|Overall Study|Withdrawal by Subject|2|||
144418039|NCT01979016|520735710|FG001|Overall Study|Withdrawal by Subject|0|||
144418040|NCT01979016|520735709|FG000|Overall Study|Adverse Event|0|||
144418041|NCT01979016|520735710|FG001|Overall Study|Adverse Event|1|||
144418042|NCT04983264|520735711|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
144418043|NCT04983264|520735712|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
144418044|NCT04983264|520735713|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
144418045|NCT04983264|520735711|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
144180236|NCT00819169|519853949|FG007|Overall Study|Ineligibility determined|0|||
144180237|NCT00819169|519853950|FG008|Overall Study|Ineligibility determined|1|||
144180238|NCT00819169|519853942|FG000|Overall Study|Adverse Event|0|||
144180239|NCT00819169|519853943|FG001|Overall Study|Adverse Event|0|||
144180240|NCT00819169|519853944|FG002|Overall Study|Adverse Event|0|||
144180241|NCT00819169|519853945|FG003|Overall Study|Adverse Event|0|||
144180242|NCT00819169|519853946|FG004|Overall Study|Adverse Event|1|||
144180243|NCT00819169|519853947|FG005|Overall Study|Adverse Event|0|||
144180244|NCT00819169|519853948|FG006|Overall Study|Adverse Event|0|||
144180245|NCT00819169|519853949|FG007|Overall Study|Adverse Event|0|||
144180246|NCT00819169|519853950|FG008|Overall Study|Adverse Event|0|||
144180247|NCT00819169|519853942|FG000|Overall Study|Administrative Decision|0|||
144180248|NCT00819169|519853943|FG001|Overall Study|Administrative Decision|0|||
144180249|NCT00819169|519853944|FG002|Overall Study|Administrative Decision|0|||
144180250|NCT00819169|519853945|FG003|Overall Study|Administrative Decision|0|||
144180251|NCT00819169|519853946|FG004|Overall Study|Administrative Decision|1|||
144180252|NCT00819169|519853947|FG005|Overall Study|Administrative Decision|2|||
144180253|NCT00819169|519853948|FG006|Overall Study|Administrative Decision|0|||
144180254|NCT00819169|519853949|FG007|Overall Study|Administrative Decision|2|||
144180255|NCT00819169|519853950|FG008|Overall Study|Administrative Decision|0|||
144180256|NCT01971645|519853952|FG000|Overall Study|Adverse Event|1|||
144418046|NCT04983264|520735712|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
144418047|NCT04983264|520735713|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
144418048|NCT01124422|520735714|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
144418049|NCT01124422|520735715|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
144418050|NCT01124422|520735716|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
144418051|NCT01124422|520735714|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
144418052|NCT01124422|520735715|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
144418053|NCT01124422|520735716|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
144418054|NCT01124422|520735714|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
144418055|NCT01124422|520735715|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
144418056|NCT01124422|520735716|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
144418057|NCT01124422|520735714|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
144418058|NCT01124422|520735715|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
144418059|NCT01124422|520735716|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
144418060|NCT01124422|520735714|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
144418061|NCT01124422|520735715|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
144418062|NCT01124422|520735716|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
144418063|NCT01124422|520735714|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
144418064|NCT01124422|520735715|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
144418065|NCT01124422|520735716|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
144418066|NCT01124422|520735714|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
144418067|NCT01124422|520735715|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
144418068|NCT01124422|520735716|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
144418069|NCT01124422|520735714|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
144418070|NCT01124422|520735715|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
144418071|NCT01124422|520735716|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
144418072|NCT01124422|520735714|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
144418073|NCT01124422|520735715|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
144418074|NCT01124422|520735716|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
144418075|NCT01124422|520735714|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
144418076|NCT01124422|520735715|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
144418077|NCT01124422|520735716|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
144418078|NCT00938639|520735717|FG000|Overall Study|Moved away from study area|0|||
144418079|NCT00938639|520735718|FG001|Overall Study|Moved away from study area|1|||
144418080|NCT00938639|520735717|FG000|Overall Study|Lost to Follow-up|1|||
144418081|NCT00938639|520735718|FG001|Overall Study|Lost to Follow-up|2|||
144418082|NCT00938639|520735717|FG000|Overall Study|Family issues|1|||
144418083|NCT00938639|520735718|FG001|Overall Study|Family issues|1|||
144418084|NCT00938639|520735717|FG000|Overall Study|Participant noncompliance|1|||
144527452|NCT04508309|521133288|FG001|Overall Study|Lost to Follow-up|0|||
144180257|NCT01971645|519853953|FG001|Overall Study|Adverse Event|0|||
144180258|NCT01971645|519853954|FG002|Overall Study|Adverse Event|0|||
144418085|NCT00938639|520735718|FG001|Overall Study|Participant noncompliance|0|||
144180259|NCT01971645|519853952|FG000|Overall Study|Lost to Follow-up|1|||
144180260|NCT01971645|519853953|FG001|Overall Study|Lost to Follow-up|0|||
144180261|NCT01971645|519853954|FG002|Overall Study|Lost to Follow-up|1|||
144418086|NCT03303079|520735723|FG000|Overall Study|Adverse Event|0|||
144527453|NCT04508309|521133289|FG002|Overall Study|Lost to Follow-up|1|||
144527454|NCT04508309|521133290|FG003|Overall Study|Lost to Follow-up|1|||
144180262|NCT01971645|519853952|FG000|Overall Study|Protocol Violation|0|||
144418087|NCT03303079|520735724|FG001|Overall Study|Adverse Event|1|||
144418088|NCT03303079|520735725|FG002|Overall Study|Adverse Event|3|||
144418089|NCT03303079|520735723|FG000|Overall Study|Protocol Violation|5|||
144418090|NCT03303079|520735724|FG001|Overall Study|Protocol Violation|4|||
144418091|NCT03303079|520735725|FG002|Overall Study|Protocol Violation|7|||
144418092|NCT03303079|520735723|FG000|Overall Study|Withdrawal by Subject|2|||
144418093|NCT03303079|520735724|FG001|Overall Study|Withdrawal by Subject|4|||
144418094|NCT03303079|520735725|FG002|Overall Study|Withdrawal by Subject|2|||
144418095|NCT03303079|520735723|FG000|Overall Study|Other than specified|0|||
144418096|NCT03303079|520735724|FG001|Overall Study|Other than specified|2|||
144418097|NCT03303079|520735725|FG002|Overall Study|Other than specified|0|||
144418098|NCT02205814|520735742|FG000|Overall Study|Lost to Follow-up|0|||
144418099|NCT02205814|520735743|FG001|Overall Study|Lost to Follow-up|0|||
144418100|NCT02205814|520735744|FG002|Overall Study|Lost to Follow-up|0|||
144418101|NCT02205814|520735745|FG003|Overall Study|Lost to Follow-up|1|||
144418102|NCT02205814|520735742|FG000|Overall Study|Lack of Efficacy|1|||
144418103|NCT02205814|520735743|FG001|Overall Study|Lack of Efficacy|0|||
144418104|NCT02205814|520735744|FG002|Overall Study|Lack of Efficacy|1|||
144418105|NCT02205814|520735745|FG003|Overall Study|Lack of Efficacy|1|||
144418106|NCT02205814|520735742|FG000|Overall Study|Physician Decision|0|||
144418107|NCT02205814|520735743|FG001|Overall Study|Physician Decision|0|||
144418108|NCT02205814|520735744|FG002|Overall Study|Physician Decision|1|||
144418109|NCT02205814|520735745|FG003|Overall Study|Physician Decision|0|||
144418110|NCT02205814|520735742|FG000|Overall Study|Protocol Violation|1|||
144418111|NCT02205814|520735743|FG001|Overall Study|Protocol Violation|0|||
144418112|NCT02205814|520735744|FG002|Overall Study|Protocol Violation|0|||
144418113|NCT02205814|520735745|FG003|Overall Study|Protocol Violation|1|||
144418114|NCT02205814|520735742|FG000|Overall Study|Withdrawal by Subject|0|||
144418115|NCT02205814|520735743|FG001|Overall Study|Withdrawal by Subject|1|||
144418116|NCT02205814|520735744|FG002|Overall Study|Withdrawal by Subject|2|||
144418117|NCT02205814|520735745|FG003|Overall Study|Withdrawal by Subject|1|||
144418118|NCT02205814|520735742|FG000|Overall Study|not compliant with study procedures|0|||
144418119|NCT02205814|520735743|FG001|Overall Study|not compliant with study procedures|0|||
144418120|NCT02205814|520735744|FG002|Overall Study|not compliant with study procedures|1|||
144418121|NCT02205814|520735745|FG003|Overall Study|not compliant with study procedures|0|||
144418122|NCT01426373|520735746|FG000|Overall Study|Adverse Event|6|||
144418123|NCT01426373|520735746|FG000|Overall Study|Lost to Follow-up|14|||
144418124|NCT01426373|520735746|FG000|Overall Study|Participant Convenience|10|||
144418125|NCT01426373|520735746|FG000|Overall Study|Miscellaneous Reasons|4|||
144418126|NCT00143403|520735747|FG000|Overall Study|Adverse Event|3|||
144418127|NCT00143403|520735748|FG001|Overall Study|Adverse Event|8|||
144418128|NCT00143403|520735747|FG000|Overall Study|Death|1|||
144418129|NCT00143403|520735748|FG001|Overall Study|Death|0|||
144418130|NCT00143403|520735747|FG000|Overall Study|Withdrawal by Subject|3|||
144418131|NCT00143403|520735748|FG001|Overall Study|Withdrawal by Subject|12|||
144418132|NCT00143403|520735747|FG000|Overall Study|Relapse|15|||
144418133|NCT00143403|520735748|FG001|Overall Study|Relapse|7|||
144418134|NCT00143403|520735747|FG000|Overall Study|Protocol Violation|2|||
144418135|NCT00143403|520735748|FG001|Overall Study|Protocol Violation|2|||
144418136|NCT00143403|520735747|FG000|Overall Study|specified by site|4|||
144418137|NCT00143403|520735748|FG001|Overall Study|specified by site|9|||
144418138|NCT00143403|520735747|FG000|Overall Study|Randomized Not Treated|7|||
144527455|NCT04508309|521133291|FG004|Overall Study|Lost to Follow-up|0|||
144250907|NCT02134353|520117429|FG001|Overall Study|Withdrawal by Subject|13|||
144250908|NCT02134353|520117428|FG000|Overall Study|Death|0|||
144250909|NCT02134353|520117429|FG001|Overall Study|Death|1|||
144250910|NCT02134353|520117428|FG000|Overall Study|Pregnancy|0|||
144250911|NCT02134353|520117429|FG001|Overall Study|Pregnancy|1|||
144250912|NCT02134353|520117428|FG000|Overall Study|Relocation|1|||
144250913|NCT02134353|520117429|FG001|Overall Study|Relocation|0|||
144250914|NCT02134353|520117428|FG000|Overall Study|Other - Patient's Choice|0|||
144250915|NCT02134353|520117429|FG001|Overall Study|Other - Patient's Choice|1|||
144250916|NCT00474786|520117430|FG000|Overall Study|Not Meeting Study Criteria|0|||
144250917|NCT00474786|520117431|FG001|Overall Study|Not Meeting Study Criteria|1|||
144418139|NCT00143403|520735748|FG001|Overall Study|Randomized Not Treated|8|||
144418140|NCT01574326|520735749|FG000|Overall Study|Randomized but not treated|0|||
144418141|NCT01574326|520735750|FG001|Overall Study|Randomized but not treated|1|||
144418142|NCT01574326|520735749|FG000|Overall Study|Withdrawal by Participant|2|||
144418143|NCT01574326|520735750|FG001|Overall Study|Withdrawal by Participant|4|||
144418144|NCT01574326|520735749|FG000|Overall Study|Physician Decision|5|||
144418145|NCT01574326|520735750|FG001|Overall Study|Physician Decision|3|||
144527456|NCT04508309|521133287|FG000|Overall Study|Withdrawal by Subject|0|||
144418146|NCT01574326|520735749|FG000|Overall Study|Adverse Event|1|||
144418147|NCT01574326|520735750|FG001|Overall Study|Adverse Event|3|||
144418148|NCT01574326|520735749|FG000|Overall Study|Other: Mainly kidney transplant|8|||
144250918|NCT00474786|520117430|FG000|Overall Study|Investigator Request|2|||
144250919|NCT00474786|520117431|FG001|Overall Study|Investigator Request|1|||
144250920|NCT00474786|520117430|FG000|Overall Study|Death|189|||
144418149|NCT01574326|520735750|FG001|Overall Study|Other: Mainly kidney transplant|8|||
144418150|NCT01574612|520735753|FG000|Overall Study|Adverse Event|3|||
144418151|NCT01574612|520735753|FG000|Overall Study|non compliant with drug|2|||
144180263|NCT01971645|519853953|FG001|Overall Study|Protocol Violation|0|||
144418152|NCT01574612|520735753|FG000|Overall Study|Withdrawal by Subject|1|||
144418153|NCT01574612|520735753|FG000|Overall Study|Lost to Follow-up|2|||
144418154|NCT00582166|520735754|FG000|Overall Study|Death|1|||
144418155|NCT00582166|520735754|FG000|Overall Study|Ineligible pathology|1|||
144418156|NCT01606436|520735755|FG000|Overall Study|Withdrawal by Subject|0|||
144418157|NCT01606436|520735756|FG001|Overall Study|Withdrawal by Subject|0|||
144418158|NCT01606436|520735757|FG002|Overall Study|Withdrawal by Subject|1|||
144418159|NCT01606436|520735758|FG003|Overall Study|Withdrawal by Subject|1|||
144418160|NCT01606436|520735759|FG004|Overall Study|Withdrawal by Subject|1|||
144418161|NCT01606436|520735760|FG005|Overall Study|Withdrawal by Subject|0|||
144418162|NCT01606436|520735755|FG000|Overall Study|Adverse Event|0|||
144418163|NCT01606436|520735756|FG001|Overall Study|Adverse Event|0|||
144418164|NCT01606436|520735757|FG002|Overall Study|Adverse Event|1|||
144418165|NCT01606436|520735758|FG003|Overall Study|Adverse Event|0|||
144418166|NCT01606436|520735759|FG004|Overall Study|Adverse Event|0|||
144418167|NCT01606436|520735760|FG005|Overall Study|Adverse Event|0|||
144418168|NCT01606436|520735755|FG000|Overall Study|Sponsor Decision|0|||
144418169|NCT01606436|520735756|FG001|Overall Study|Sponsor Decision|0|||
144418170|NCT01606436|520735757|FG002|Overall Study|Sponsor Decision|0|||
144418171|NCT01606436|520735758|FG003|Overall Study|Sponsor Decision|1|||
144418172|NCT01606436|520735759|FG004|Overall Study|Sponsor Decision|0|||
144418173|NCT01606436|520735760|FG005|Overall Study|Sponsor Decision|0|||
144418174|NCT00110149|520735761|FG000|Overall Study|Physician Decision|3|||
144418175|NCT03235154|520735764|FG000|Overall Study|Withdrawal by Subject|1|||
144418176|NCT03235154|520735764|FG000|Overall Study|Adverse Event|1|||
144418177|NCT03235154|520735764|FG000|Overall Study|Lost to Follow-up|2|||
144418178|NCT01683383|520735765|FG000|Overall Study|Infant was not transported|1|||
144418179|NCT01683383|520735766|FG001|Overall Study|Infant was not transported|0|||
144418180|NCT00996307|520735767|FG000|Overall Study|Adverse Event|0|||
144418181|NCT00996307|520735768|FG001|Overall Study|Adverse Event|1|||
144418182|NCT00996307|520735769|FG002|Overall Study|Adverse Event|0|||
144418183|NCT00996307|520735770|FG003|Overall Study|Adverse Event|0|||
144418184|NCT00996307|520735767|FG000|Overall Study|Withdrawal by Subject|3|||
144418185|NCT00996307|520735768|FG001|Overall Study|Withdrawal by Subject|2|||
144418186|NCT00996307|520735769|FG002|Overall Study|Withdrawal by Subject|5|||
144418187|NCT00996307|520735770|FG003|Overall Study|Withdrawal by Subject|5|||
144418188|NCT00996307|520735767|FG000|Overall Study|Lost to Follow-up|13|||
144418189|NCT00996307|520735768|FG001|Overall Study|Lost to Follow-up|13|||
144418190|NCT00996307|520735769|FG002|Overall Study|Lost to Follow-up|7|||
144418191|NCT00996307|520735770|FG003|Overall Study|Lost to Follow-up|15|||
144418192|NCT00996307|520735767|FG000|Overall Study|Administrative reason|0|||
144418193|NCT00996307|520735768|FG001|Overall Study|Administrative reason|1|||
144418194|NCT00996307|520735769|FG002|Overall Study|Administrative reason|0|||
144418195|NCT00996307|520735770|FG003|Overall Study|Administrative reason|0|||
144418196|NCT00996307|520735767|FG000|Overall Study|Unable to classify|4|||
144418197|NCT00996307|520735768|FG001|Overall Study|Unable to classify|0|||
144418198|NCT00996307|520735769|FG002|Overall Study|Unable to classify|2|||
144418199|NCT00996307|520735770|FG003|Overall Study|Unable to classify|1|||
144418200|NCT02326025|520735771|FG000|Overall Study|Adverse Event|3|||
144418201|NCT02326025|520735772|FG001|Overall Study|Adverse Event|0|||
144418202|NCT02326025|520735771|FG000|Overall Study|Physician Decision|1|||
144418203|NCT02326025|520735772|FG001|Overall Study|Physician Decision|2|||
144601047|NCT04598477|521401710|FG000|Overall Study|Requires Prohibited Medication|0|||
144601048|NCT04598477|521401711|FG001|Overall Study|Requires Prohibited Medication|1|||
144418204|NCT02326025|520735771|FG000|Overall Study|Physician and Participant Decision|1|||
144418205|NCT02326025|520735772|FG001|Overall Study|Physician and Participant Decision|0|||
144418206|NCT02326025|520735771|FG000|Overall Study|Withdrawal by Subject|0|||
144418207|NCT02326025|520735772|FG001|Overall Study|Withdrawal by Subject|2|||
144418208|NCT02326025|520735771|FG000|Overall Study|Protocol Violation|0|||
144418209|NCT02326025|520735772|FG001|Overall Study|Protocol Violation|1|||
144418210|NCT00897104|520735773|FG000|Overall Study|Lost to Follow-up|12|||
144418211|NCT00897104|520735774|FG001|Overall Study|Lost to Follow-up|17|||
144418212|NCT00897104|520735775|FG002|Overall Study|Lost to Follow-up|2|||
144418213|NCT00897104|520735773|FG000|Overall Study|Pregnancy|0|||
144418214|NCT00897104|520735774|FG001|Overall Study|Pregnancy|1|||
144418215|NCT00897104|520735775|FG002|Overall Study|Pregnancy|0|||
144418216|NCT00897104|520735773|FG000|Overall Study|Protocol Violation|0|||
144418217|NCT00897104|520735774|FG001|Overall Study|Protocol Violation|1|||
144418218|NCT00897104|520735775|FG002|Overall Study|Protocol Violation|0|||
144418219|NCT00897104|520735773|FG000|Overall Study|Withdrawal by Subject|23|||
144418220|NCT00897104|520735774|FG001|Overall Study|Withdrawal by Subject|27|||
144418221|NCT00897104|520735775|FG002|Overall Study|Withdrawal by Subject|3|||
144418222|NCT00897104|520735773|FG000|Overall Study|Abnormal Prestudy Labs|2|||
144418223|NCT00897104|520735774|FG001|Overall Study|Abnormal Prestudy Labs|0|||
144418224|NCT00897104|520735775|FG002|Overall Study|Abnormal Prestudy Labs|0|||
144418225|NCT00897104|520735773|FG000|Overall Study|Abnormal Baseline ECG|2|||
144418226|NCT00897104|520735774|FG001|Overall Study|Abnormal Baseline ECG|2|||
144250921|NCT00474786|520117431|FG001|Overall Study|Death|170|||
144250922|NCT00474786|520117430|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
144250923|NCT00474786|520117431|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
144250924|NCT00474786|520117430|FG000|Overall Study|Lost to Follow-up|4|||
144250925|NCT00474786|520117431|FG001|Overall Study|Lost to Follow-up|7|||
144250926|NCT00474786|520117430|FG000|Overall Study|Protocol Violation|2|||
144250927|NCT00474786|520117431|FG001|Overall Study|Protocol Violation|0|||
144250928|NCT00474786|520117430|FG000|Overall Study|Withdrawal by Subject|15|||
144250929|NCT00474786|520117431|FG001|Overall Study|Withdrawal by Subject|15|||
144250930|NCT00474786|520117430|FG000|Overall Study|Other|5|||
144250931|NCT00474786|520117431|FG001|Overall Study|Other|0|||
144250932|NCT03426436|520117432|FG000|Overall Study|Incorrect lead placement|12|||
144250933|NCT03426436|520117432|FG000|Overall Study|Withdrawal by Subject|2|||
144250934|NCT03426436|520117432|FG000|Overall Study|Consent issue|1|||
144250935|NCT03426436|520117432|FG000|Overall Study|ECGs not saved|4|||
144250936|NCT00358956|520117433|FG000|Overall Study|Adverse Event|3|||
144250937|NCT00358956|520117433|FG000|Overall Study|condition under investigation worsened|4|||
144250938|NCT00358956|520117433|FG000|Overall Study|Withdrawal by Subject|1|||
144250939|NCT04776018|520117434|FG000|Overall Study|Death|0|||
144250940|NCT04776018|520117435|FG001|Overall Study|Death|1|||
144250941|NCT04776018|520117436|FG002|Overall Study|Death|4|||
144250942|NCT04776018|520117437|FG003|Overall Study|Death|1|||
144250943|NCT04776018|520117438|FG004|Overall Study|Death|4|||
144250944|NCT04776018|520117439|FG005|Overall Study|Death|0|||
144527457|NCT04508309|521133288|FG001|Overall Study|Withdrawal by Subject|0|||
144527458|NCT04508309|521133289|FG002|Overall Study|Withdrawal by Subject|0|||
144527459|NCT04508309|521133290|FG003|Overall Study|Withdrawal by Subject|0|||
144250945|NCT04776018|520117440|FG006|Overall Study|Death|0|||
144250946|NCT04776018|520117434|FG000|Overall Study|Study terminated by sponsor|2|||
144250947|NCT04776018|520117435|FG001|Overall Study|Study terminated by sponsor|1|||
144250948|NCT04776018|520117436|FG002|Overall Study|Study terminated by sponsor|4|||
144250949|NCT04776018|520117437|FG003|Overall Study|Study terminated by sponsor|0|||
144250950|NCT04776018|520117438|FG004|Overall Study|Study terminated by sponsor|3|||
144250951|NCT04776018|520117439|FG005|Overall Study|Study terminated by sponsor|0|||
144250952|NCT04776018|520117440|FG006|Overall Study|Study terminated by sponsor|0|||
144250953|NCT04776018|520117434|FG000|Overall Study|Withdrawal by Subject|1|||
144250954|NCT04776018|520117435|FG001|Overall Study|Withdrawal by Subject|0|||
144250955|NCT04776018|520117436|FG002|Overall Study|Withdrawal by Subject|0|||
144527460|NCT04508309|521133291|FG004|Overall Study|Withdrawal by Subject|1|||
144527461|NCT02305888|521133292|FG000|Overall Study|Lost to Follow-up|0|||
144527462|NCT02305888|521133293|FG001|Overall Study|Lost to Follow-up|0|||
144527463|NCT02305888|521133294|FG002|Overall Study|Lost to Follow-up|1|||
144527464|NCT02305888|521133292|FG000|Overall Study|Adverse Event|0|||
144527465|NCT02305888|521133293|FG001|Overall Study|Adverse Event|1|||
144527466|NCT02305888|521133294|FG002|Overall Study|Adverse Event|0|||
144527467|NCT05940194|521133295|FG000|Overall Study|Adverse Event|0|||
144527468|NCT05940194|521133296|FG001|Overall Study|Adverse Event|1|||
144527469|NCT05940194|521133297|FG002|Overall Study|Adverse Event|0|||
144527470|NCT05940194|521133295|FG000|Overall Study|Migrated/Moved from the study area|2|||
144527471|NCT05940194|521133296|FG001|Overall Study|Migrated/Moved from the study area|2|||
144527472|NCT05940194|521133297|FG002|Overall Study|Migrated/Moved from the study area|4|||
144527473|NCT04914676|521133298|FG000|Overall Study|Study termination|3|||
144527474|NCT04914676|521133299|FG001|Overall Study|Study termination|0|||
144527475|NCT03085810|521133300|FG000|Main Study|Withdrawal by Subject|77|||
144527476|NCT03085810|521133301|FG001|Main Study|Withdrawal by Subject|0|||
144527477|NCT03085810|521133302|FG002|Main Study|Withdrawal by Subject|0|||
144527478|NCT03085810|521133300|FG000|Main Study|Terminated By Sponsor|14|||
144527479|NCT03085810|521133301|FG001|Main Study|Terminated By Sponsor|0|||
144601049|NCT04598477|521401710|FG000|Overall Study|Study Terminated by Sponsor|18|||
144601050|NCT04598477|521401711|FG001|Overall Study|Study Terminated by Sponsor|12|||
144601051|NCT04598477|521401710|FG000|Overall Study|Withdrawal by Subject|16|||
144601052|NCT04598477|521401711|FG001|Overall Study|Withdrawal by Subject|12|||
144250956|NCT04776018|520117437|FG003|Overall Study|Withdrawal by Subject|2|||
144527480|NCT03085810|521133302|FG002|Main Study|Terminated By Sponsor|0|||
144527481|NCT03085810|521133300|FG000|Main Study|Protocol Violation|15|||
144250957|NCT04776018|520117438|FG004|Overall Study|Withdrawal by Subject|1|||
144250958|NCT04776018|520117439|FG005|Overall Study|Withdrawal by Subject|0|||
144250959|NCT04776018|520117440|FG006|Overall Study|Withdrawal by Subject|0|||
144250960|NCT04776018|520117434|FG000|Overall Study|Other|0|||
144250961|NCT04776018|520117435|FG001|Overall Study|Other|1|||
144527482|NCT03085810|521133301|FG001|Main Study|Protocol Violation|0|||
144527483|NCT03085810|521133302|FG002|Main Study|Protocol Violation|0|||
144527484|NCT03085810|521133300|FG000|Main Study|Physician Decision|13|||
144527485|NCT03085810|521133301|FG001|Main Study|Physician Decision|0|||
144527486|NCT03085810|521133302|FG002|Main Study|Physician Decision|0|||
144250962|NCT04776018|520117436|FG002|Overall Study|Other|1|||
144250963|NCT04776018|520117437|FG003|Overall Study|Other|0|||
144527487|NCT03085810|521133300|FG000|Main Study|Lost to Follow-up|17|||
144601053|NCT04598477|521401710|FG000|Overall Study|Other|15|||
144180264|NCT01971645|519853954|FG002|Overall Study|Protocol Violation|1|||
144180265|NCT00566722|519853955|FG000|Overall Study|Adverse Event|0|||
144180266|NCT00566722|519853956|FG001|Overall Study|Adverse Event|1|||
144180267|NCT00566722|519853957|FG002|Overall Study|Adverse Event|0|||
144180268|NCT00566722|519853955|FG000|Overall Study|Withdrawal by Subject|0|||
144180269|NCT00566722|519853956|FG001|Overall Study|Withdrawal by Subject|0|||
144250964|NCT04776018|520117438|FG004|Overall Study|Other|0|||
144250965|NCT04776018|520117439|FG005|Overall Study|Other|0|||
144250966|NCT04776018|520117440|FG006|Overall Study|Other|0|||
144250967|NCT04776018|520117434|FG000|Overall Study|Lost to Follow-up|0|||
144250968|NCT04776018|520117435|FG001|Overall Study|Lost to Follow-up|0|||
144250969|NCT04776018|520117436|FG002|Overall Study|Lost to Follow-up|1|||
144250970|NCT04776018|520117437|FG003|Overall Study|Lost to Follow-up|0|||
144250971|NCT04776018|520117438|FG004|Overall Study|Lost to Follow-up|0|||
144250972|NCT04776018|520117439|FG005|Overall Study|Lost to Follow-up|0|||
144250973|NCT04776018|520117440|FG006|Overall Study|Lost to Follow-up|0|||
144250974|NCT00394433|520117441|FG000|Overall Study|Adverse Event|2|||
144250975|NCT00394433|520117441|FG000|Overall Study|Alternative Therapy|1|||
144250976|NCT00594386|520117444|FG000|Overall Study|Major protocol violation|2|||
144250977|NCT00594386|520117444|FG000|Overall Study|Lack of Efficacy|12|||
144250978|NCT00594386|520117444|FG000|Overall Study|Adverse Event|68|||
144250979|NCT00594386|520117444|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
144250980|NCT00594386|520117444|FG000|Overall Study|Subject withdrew consent|35|||
144250981|NCT00594386|520117444|FG000|Overall Study|Study ended per sponsor|115|||
144250982|NCT00594386|520117444|FG000|Overall Study|Lost to Follow-up|6|||
144250983|NCT00594386|520117444|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
144250984|NCT00594386|520117444|FG000|Overall Study|Other: Subject moved to Seattle|1|||
144180270|NCT00566722|519853957|FG002|Overall Study|Withdrawal by Subject|1|||
144180271|NCT00566722|519853955|FG000|Overall Study|Lost to Follow-up|1|||
144180272|NCT00566722|519853956|FG001|Overall Study|Lost to Follow-up|1|||
144180273|NCT00566722|519853957|FG002|Overall Study|Lost to Follow-up|1|||
144180274|NCT00566722|519853955|FG000|Overall Study|Lack of Efficacy|1|||
144180275|NCT00566722|519853956|FG001|Overall Study|Lack of Efficacy|2|||
144180276|NCT00566722|519853957|FG002|Overall Study|Lack of Efficacy|4|||
144180277|NCT00566722|519853955|FG000|Overall Study|Did not meet exclusion criteria|0|||
144180278|NCT00566722|519853956|FG001|Overall Study|Did not meet exclusion criteria|0|||
144180279|NCT00566722|519853957|FG002|Overall Study|Did not meet exclusion criteria|2|||
144180280|NCT00566722|519853955|FG000|Overall Study|Serious adverse event|0|||
144180281|NCT00566722|519853956|FG001|Overall Study|Serious adverse event|1|||
144180282|NCT00566722|519853957|FG002|Overall Study|Serious adverse event|0|||
144180283|NCT00566722|519853955|FG000|Overall Study|Noncompliant with drug administration|0|||
144180284|NCT00566722|519853956|FG001|Overall Study|Noncompliant with drug administration|0|||
144180285|NCT00566722|519853957|FG002|Overall Study|Noncompliant with drug administration|1|||
144180286|NCT02119936|519853958|FG000|Overall Study|Lost to Follow-up|10|||
144180287|NCT01390948|519853959|FG000|Overall Study|End of Study|1|||
144180288|NCT01390948|519853960|FG001|Overall Study|End of Study|0|||
144180289|NCT01390948|519853961|FG002|Overall Study|End of Study|0|||
144180290|NCT01390948|519853959|FG000|Overall Study|Withdrew consent|2|||
144180291|NCT01390948|519853960|FG001|Overall Study|Withdrew consent|2|||
144180292|NCT01390948|519853961|FG002|Overall Study|Withdrew consent|0|||
144180293|NCT01390948|519853959|FG000|Overall Study|Progressive Disease|2|||
144250985|NCT00594386|520117444|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
144250986|NCT00594386|520117444|FG000|Overall Study|Other: Study terminated per investigator|2|||
144250987|NCT00594386|520117444|FG000|Overall Study|Other: Sponsor closure of study|1|||
144250988|NCT00594386|520117444|FG000|Overall Study|Other: Site terminated participation|1|||
144250989|NCT00594386|520117444|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
144250990|NCT00594386|520117444|FG000|Overall Study|Other: Loss of drivers license|1|||
144180294|NCT01390948|519853960|FG001|Overall Study|Progressive Disease|5|||
144180295|NCT01390948|519853961|FG002|Overall Study|Progressive Disease|0|||
144180296|NCT01390948|519853959|FG000|Overall Study|Death during follow-up|10|||
144180297|NCT01390948|519853960|FG001|Overall Study|Death during follow-up|11|||
144180298|NCT01390948|519853961|FG002|Overall Study|Death during follow-up|1|||
144250991|NCT03168919|520117445|FG000|Overall Study|Withdrawal by Subject|2|||
144418227|NCT00897104|520735775|FG002|Overall Study|Abnormal Baseline ECG|0|||
144418228|NCT00897104|520735773|FG000|Overall Study|Need for Concom. Med.|0|||
144418229|NCT00897104|520735774|FG001|Overall Study|Need for Concom. Med.|1|||
144180299|NCT05315713|519853962|FG000|Overall Study|Death|5|||
144180300|NCT05315713|519853962|FG000|Overall Study|Progressive disease|1|||
144180301|NCT05315713|519853962|FG000|Overall Study|Withdrawal by Subject|1|||
144180302|NCT05315713|519853962|FG000|Overall Study|Study terminated by sponsor|1|||
144180303|NCT02218216|519853965|FG000|Overall Study|Study terminated before completed|6|||
144180304|NCT02218216|519853966|FG001|Overall Study|Study terminated before completed|0|||
144180305|NCT02218216|519853967|FG002|Overall Study|Study terminated before completed|0|||
144250992|NCT01085136|520117446|FG000|Part A|Other Adverse event|223|||
144250993|NCT01085136|520117447|FG001|Part A|Other Adverse event|0|||
144418230|NCT00897104|520735775|FG002|Overall Study|Need for Concom. Med.|1|||
144250994|NCT01085136|520117448|FG002|Part A|Other Adverse event|0|||
144250995|NCT01085136|520117446|FG000|Part A|Protocol Violation|3|||
144250996|NCT01085136|520117447|FG001|Part A|Protocol Violation|0|||
144250997|NCT01085136|520117448|FG002|Part A|Protocol Violation|0|||
144250998|NCT01085136|520117446|FG000|Part A|Lost to Follow-up|3|||
144250999|NCT01085136|520117447|FG001|Part A|Lost to Follow-up|0|||
144251000|NCT01085136|520117448|FG002|Part A|Lost to Follow-up|0|||
144251001|NCT01085136|520117446|FG000|Part A|Refusal to continue trial medication|64|||
144251002|NCT01085136|520117447|FG001|Part A|Refusal to continue trial medication|0|||
144251003|NCT01085136|520117448|FG002|Part A|Refusal to continue trial medication|0|||
144251004|NCT01085136|520117446|FG000|Part A|Other reason not defined above|30|||
144251005|NCT01085136|520117447|FG001|Part A|Other reason not defined above|0|||
144251006|NCT01085136|520117448|FG002|Part A|Other reason not defined above|0|||
144251007|NCT01085136|520117446|FG000|Part B|Other AE|0|||
144251008|NCT01085136|520117447|FG001|Part B|Other AE|29|||
144251009|NCT01085136|520117448|FG002|Part B|Other AE|8|||
144251010|NCT01085136|520117446|FG000|Part B|Refusal to continue trial medication|0|||
144251011|NCT01085136|520117447|FG001|Part B|Refusal to continue trial medication|12|||
144251012|NCT01085136|520117448|FG002|Part B|Refusal to continue trial medication|7|||
144251013|NCT01085136|520117446|FG000|Part B|Not treated|0|||
144251014|NCT01085136|520117447|FG001|Part B|Not treated|4|||
144251015|NCT01085136|520117448|FG002|Part B|Not treated|8|||
144251016|NCT01085136|520117446|FG000|Part B|Other reason not defined above|0|||
144251017|NCT01085136|520117447|FG001|Part B|Other reason not defined above|6|||
144251018|NCT01085136|520117448|FG002|Part B|Other reason not defined above|3|||
144251019|NCT02195427|520117449|FG000|Overall Study|Did not consent to study extension|13|||
144251020|NCT02195427|520117450|FG001|Overall Study|Did not consent to study extension|9|||
144251021|NCT02195427|520117449|FG000|Overall Study|Withdrawal by Subject|4|||
144251022|NCT02195427|520117450|FG001|Overall Study|Withdrawal by Subject|2|||
144251023|NCT02195427|520117449|FG000|Overall Study|Lost to Follow-up|0|||
144251024|NCT02195427|520117450|FG001|Overall Study|Lost to Follow-up|1|||
144418231|NCT00897104|520735773|FG000|Overall Study|Lack of Migraine Attack|20|||
144418232|NCT00897104|520735774|FG001|Overall Study|Lack of Migraine Attack|22|||
144418233|NCT00897104|520735775|FG002|Overall Study|Lack of Migraine Attack|1|||
144418234|NCT00897104|520735773|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
144418235|NCT00897104|520735774|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144418236|NCT00897104|520735775|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144418237|NCT00897104|520735773|FG000|Overall Study|Other|3|||
144418238|NCT00897104|520735774|FG001|Overall Study|Other|0|||
144418239|NCT00897104|520735775|FG002|Overall Study|Other|0|||
144418240|NCT00897104|520735773|FG000|Overall Study|Protocol Violation|1|||
144418241|NCT00897104|520735774|FG001|Overall Study|Protocol Violation|0|||
144418242|NCT00897104|520735775|FG002|Overall Study|Protocol Violation|0|||
144418243|NCT00897104|520735773|FG000|Overall Study|Withdrawal by Subject|0|||
144418244|NCT00897104|520735774|FG001|Overall Study|Withdrawal by Subject|0|||
144418245|NCT00897104|520735775|FG002|Overall Study|Withdrawal by Subject|1|||
144418246|NCT00434330|520735776|FG000|Overall Study|Adverse Event|0|||
144418247|NCT00434330|520735777|FG001|Overall Study|Adverse Event|0|||
144418248|NCT00434330|520735778|FG002|Overall Study|Adverse Event|1|||
144418249|NCT00434330|520735779|FG003|Overall Study|Adverse Event|0|||
144418250|NCT00434330|520735780|FG004|Overall Study|Adverse Event|0|||
144418251|NCT00434330|520735781|FG005|Overall Study|Adverse Event|0|||
144418252|NCT00434330|520735776|FG000|Overall Study|Death|1|||
144418253|NCT00434330|520735777|FG001|Overall Study|Death|0|||
144418254|NCT00434330|520735778|FG002|Overall Study|Death|0|||
144418255|NCT00434330|520735779|FG003|Overall Study|Death|0|||
144418256|NCT00434330|520735780|FG004|Overall Study|Death|1|||
144418257|NCT00434330|520735781|FG005|Overall Study|Death|1|||
144418258|NCT00434330|520735776|FG000|Overall Study|Withdrawal by Subject|0|||
144418259|NCT00434330|520735777|FG001|Overall Study|Withdrawal by Subject|0|||
144418260|NCT00434330|520735778|FG002|Overall Study|Withdrawal by Subject|1|||
144251025|NCT02195427|520117449|FG000|Overall Study|Protocol Violation|7|||
144251026|NCT02195427|520117450|FG001|Overall Study|Protocol Violation|14|||
144251027|NCT02195427|520117449|FG000|Overall Study|Conditional re-treatment at W52|2|||
144251028|NCT02195427|520117450|FG001|Overall Study|Conditional re-treatment at W52|1|||
144251029|NCT03611582|520117453|FG000|Overall Study|Adverse Event|26|||
144251030|NCT03611582|520117454|FG001|Overall Study|Adverse Event|6|||
144251031|NCT03611582|520117453|FG000|Overall Study|Protocol Violation|0|||
144418261|NCT00434330|520735779|FG003|Overall Study|Withdrawal by Subject|1|||
144418262|NCT00434330|520735780|FG004|Overall Study|Withdrawal by Subject|0|||
144418263|NCT00434330|520735781|FG005|Overall Study|Withdrawal by Subject|0|||
144418264|NCT00434330|520735776|FG000|Overall Study|Renal transplant|0|||
144251032|NCT03611582|520117454|FG001|Overall Study|Protocol Violation|1|||
144251033|NCT03611582|520117453|FG000|Overall Study|Pregnancy|1|||
144251034|NCT03611582|520117454|FG001|Overall Study|Pregnancy|2|||
144251035|NCT03611582|520117453|FG000|Overall Study|Lack of Efficacy|0|||
144418265|NCT00434330|520735777|FG001|Overall Study|Renal transplant|0|||
144251036|NCT03611582|520117454|FG001|Overall Study|Lack of Efficacy|1|||
144418266|NCT00434330|520735778|FG002|Overall Study|Renal transplant|0|||
144418267|NCT00434330|520735779|FG003|Overall Study|Renal transplant|1|||
144251037|NCT03611582|520117453|FG000|Overall Study|At the discretion of the investigator|1|||
144251038|NCT03611582|520117454|FG001|Overall Study|At the discretion of the investigator|0|||
144251039|NCT03611582|520117453|FG000|Overall Study|Safety concern as judged by the investigator|1|||
144251040|NCT03611582|520117454|FG001|Overall Study|Safety concern as judged by the investigator|2|||
144251041|NCT03611582|520117453|FG000|Overall Study|Withdrawal by Subject|4|||
144251042|NCT03611582|520117454|FG001|Overall Study|Withdrawal by Subject|3|||
144251043|NCT03611582|520117453|FG000|Overall Study|Lost to Follow-up|18|||
144251044|NCT03611582|520117454|FG001|Overall Study|Lost to Follow-up|7|||
144251045|NCT03611582|520117453|FG000|Overall Study|other|17|||
144418268|NCT00434330|520735780|FG004|Overall Study|Renal transplant|0|||
144418269|NCT00434330|520735781|FG005|Overall Study|Renal transplant|0|||
144418270|NCT00434330|520735776|FG000|Overall Study|Subject Not Compliant With Study|0|||
144418271|NCT00434330|520735777|FG001|Overall Study|Subject Not Compliant With Study|0|||
144418272|NCT00434330|520735778|FG002|Overall Study|Subject Not Compliant With Study|1|||
144418273|NCT00434330|520735779|FG003|Overall Study|Subject Not Compliant With Study|0|||
144251046|NCT03611582|520117454|FG001|Overall Study|other|16|||
144251047|NCT01783821|520117455|FG000|Overall Study|Screen Failure|1|||
144251048|NCT01783821|520117456|FG001|Overall Study|Screen Failure|1|||
144418274|NCT00434330|520735780|FG004|Overall Study|Subject Not Compliant With Study|0|||
144418275|NCT00434330|520735781|FG005|Overall Study|Subject Not Compliant With Study|0|||
144418276|NCT04853225|520735782|FG000|Overall Study|Withdrawal by Subject|81|||
144418277|NCT04853225|520735783|FG001|Overall Study|Withdrawal by Subject|4|||
144418278|NCT04853225|520735784|FG002|Overall Study|Withdrawal by Subject|1|||
144418279|NCT04853225|520735782|FG000|Overall Study|Physician Decision|12|||
144418280|NCT04853225|520735783|FG001|Overall Study|Physician Decision|4|||
144418281|NCT04853225|520735784|FG002|Overall Study|Physician Decision|1|||
144418282|NCT04853225|520735782|FG000|Overall Study|Lost to Follow-up|50|||
144418283|NCT04853225|520735783|FG001|Overall Study|Lost to Follow-up|0|||
144418284|NCT04853225|520735784|FG002|Overall Study|Lost to Follow-up|0|||
144418285|NCT04853225|520735782|FG000|Overall Study|Other|102|||
144418286|NCT04853225|520735783|FG001|Overall Study|Other|11|||
144418287|NCT04853225|520735784|FG002|Overall Study|Other|5|||
144418288|NCT04853225|520735782|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
144418289|NCT04853225|520735783|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
144418290|NCT04853225|520735784|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
144418291|NCT04853225|520735782|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
144418292|NCT04853225|520735783|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
144418293|NCT04853225|520735784|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
144418294|NCT01937559|520735785|FG000|Overall Study|Physician Decision|3|||
144418295|NCT01937559|520735786|FG001|Overall Study|Physician Decision|3|||
144418296|NCT01937559|520735787|FG002|Overall Study|Physician Decision|0|||
144418297|NCT01937559|520735785|FG000|Overall Study|Withdrawal by Subject|6|||
144418298|NCT01937559|520735786|FG001|Overall Study|Withdrawal by Subject|4|||
144418299|NCT01937559|520735787|FG002|Overall Study|Withdrawal by Subject|0|||
144418300|NCT01937559|520735785|FG000|Overall Study|screen fail|2|||
144418301|NCT01937559|520735786|FG001|Overall Study|screen fail|4|||
144418302|NCT01937559|520735787|FG002|Overall Study|screen fail|0|||
144418303|NCT02167893|520735788|FG000|Overall Study|Investigator transferred|85|||
144418304|NCT02167893|520735788|FG000|Overall Study|Investigator health reasons|10|||
144418305|NCT02167893|520735788|FG000|Overall Study|Case report forms not collected|68|||
144418306|NCT00848081|520737743|FG000|Overall Study|Adverse Event|6|||
144251049|NCT01907217|520117457|FG000|Overall Study|Withdrawal by Subject|0|||
144251050|NCT01907217|520117458|FG001|Overall Study|Withdrawal by Subject|2|||
144251051|NCT00422292|520117459|FG000|Overall Study|Serious adverse events|1|||
144251052|NCT00422292|520117460|FG001|Overall Study|Serious adverse events|4|||
144251053|NCT00422292|520117461|FG002|Overall Study|Serious adverse events|0|||
144251054|NCT00422292|520117462|FG003|Overall Study|Serious adverse events|0|||
144251055|NCT00422292|520117459|FG000|Overall Study|Adverse Event|1|||
144251056|NCT00422292|520117460|FG001|Overall Study|Adverse Event|0|||
144418307|NCT00848081|520737744|FG001|Overall Study|Adverse Event|7|||
144251057|NCT00422292|520117461|FG002|Overall Study|Adverse Event|1|||
144251058|NCT00422292|520117462|FG003|Overall Study|Adverse Event|0|||
144251059|NCT00422292|520117459|FG000|Overall Study|Protocol Violation|4|||
144418308|NCT00848081|520737743|FG000|Overall Study|Protocol Violation|8|||
144418309|NCT00848081|520737744|FG001|Overall Study|Protocol Violation|5|||
144251060|NCT00422292|520117460|FG001|Overall Study|Protocol Violation|25|||
144251061|NCT00422292|520117461|FG002|Overall Study|Protocol Violation|8|||
144418310|NCT00848081|520737743|FG000|Overall Study|Lost to Follow-up|1|||
144418311|NCT00848081|520737744|FG001|Overall Study|Lost to Follow-up|0|||
144418312|NCT00848081|520737743|FG000|Overall Study|Physician Decision|0|||
144418313|NCT00848081|520737744|FG001|Overall Study|Physician Decision|3|||
144418314|NCT00848081|520737743|FG000|Overall Study|Withdrawal by Subject|5|||
144418315|NCT00848081|520737744|FG001|Overall Study|Withdrawal by Subject|3|||
144418316|NCT00609492|520737745|FG000|Overall Study|Withdrawal by Subject|0|||
144418317|NCT00609492|520737746|FG001|Overall Study|Withdrawal by Subject|2|||
144180306|NCT05740098|519853972|FG000|Overall Study|Lost to Follow-up|26|||
144180307|NCT05740098|519853973|FG001|Overall Study|Lost to Follow-up|17|||
144180308|NCT05740098|519853974|FG002|Overall Study|Lost to Follow-up|21|||
144180309|NCT03867760|519853975|FG000|Overall Study|Lost to Follow-up|2|||
144180310|NCT03867760|519853976|FG001|Overall Study|Lost to Follow-up|3|||
144180311|NCT03867760|519853975|FG000|Overall Study|Withdrawal by Subject|1|||
144180312|NCT03867760|519853976|FG001|Overall Study|Withdrawal by Subject|2|||
144180313|NCT03867760|519853975|FG000|Overall Study|subject could not meet study logistics|3|||
144180314|NCT03867760|519853976|FG001|Overall Study|subject could not meet study logistics|3|||
144180315|NCT01073631|519853977|FG000|Overall Study|Death|82|||
144180316|NCT01073631|519853977|FG000|Overall Study|Adverse Event|24|||
144418318|NCT00609492|520737747|FG002|Overall Study|Withdrawal by Subject|3|||
144418319|NCT00609492|520737745|FG000|Overall Study|Lost to Follow-up|1|||
144418320|NCT00609492|520737746|FG001|Overall Study|Lost to Follow-up|1|||
144418321|NCT00609492|520737747|FG002|Overall Study|Lost to Follow-up|4|||
144418322|NCT00720434|520737748|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
144418323|NCT00720434|520737749|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
144418324|NCT00720434|520737750|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
144418325|NCT00720434|520737751|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
144418326|NCT00720434|520737748|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
144418327|NCT00720434|520737749|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
144418328|NCT00720434|520737750|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
144418329|NCT00720434|520737751|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
144418330|NCT00720434|520737748|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
144180317|NCT01073631|519853977|FG000|Overall Study|Other|63|||
144180318|NCT01566435|519853978|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
144251062|NCT00422292|520117462|FG003|Overall Study|Protocol Violation|5|||
144251063|NCT00422292|520117459|FG000|Overall Study|Lost to Follow-up|6|||
144418331|NCT00720434|520737749|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
144418332|NCT00720434|520737750|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
144418333|NCT00720434|520737751|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
144418334|NCT00720434|520737748|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
144418335|NCT00720434|520737749|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
144418336|NCT00720434|520737750|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
144418337|NCT00720434|520737751|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
144418338|NCT00720434|520737748|FG000|Open-Label Period (Week 5-72)|Other|4|||
144418339|NCT00720434|520737749|FG001|Open-Label Period (Week 5-72)|Other|3|||
144418340|NCT00720434|520737750|FG002|Open-Label Period (Week 5-72)|Other|3|||
144418341|NCT00720434|520737751|FG003|Open-Label Period (Week 5-72)|Other|2|||
144418342|NCT02782780|520737752|FG000|Overall Study|dropped out after randomization.|7|||
144418343|NCT02782780|520737753|FG001|Overall Study|dropped out after randomization.|5|||
144418344|NCT02782780|520737752|FG000|Overall Study|Protocol Violation|0|||
144418345|NCT02782780|520737753|FG001|Overall Study|Protocol Violation|2|||
144418346|NCT01413191|520737754|FG000|Overall Study|Lost to Follow-up|5|||
144418347|NCT01413191|520737754|FG000|Overall Study|Disease Progression|5|||
144418348|NCT01413191|520737754|FG000|Overall Study|Death|1|||
144418349|NCT03519932|520737758|FG000|First Intervention|Adverse Event|1|||
144418350|NCT03519932|520737759|FG001|First Intervention|Adverse Event|3|||
144418351|NCT00644995|520737760|FG000|Overall Study|Lost to Follow-up|1|||
144418352|NCT00644995|520737761|FG001|Overall Study|Lost to Follow-up|4|||
144418353|NCT00644995|520737760|FG000|Overall Study|Refused|1|||
144418354|NCT00644995|520737761|FG001|Overall Study|Refused|0|||
144418355|NCT00267046|520737762|FG000|Overall Study|Disease progression|4|||
144418356|NCT00267046|520737763|FG001|Overall Study|Disease progression|2|||
144418357|NCT00267046|520737762|FG000|Overall Study|Chemotoxicity|2|||
144418358|NCT00267046|520737763|FG001|Overall Study|Chemotoxicity|0|||
144418359|NCT00267046|520737762|FG000|Overall Study|Open-label palifermin|2|||
144418360|NCT00267046|520737763|FG001|Overall Study|Open-label palifermin|7|||
144418361|NCT00267046|520737762|FG000|Overall Study|Surgery|3|||
144418362|NCT00267046|520737763|FG001|Overall Study|Surgery|1|||
144418363|NCT00267046|520737762|FG000|Overall Study|Withdrawal by Subject|1|||
144418364|NCT00267046|520737763|FG001|Overall Study|Withdrawal by Subject|0|||
144418365|NCT00267046|520737762|FG000|Overall Study|Radiation|0|||
144418366|NCT00267046|520737763|FG001|Overall Study|Radiation|1|||
144418367|NCT00460408|520737764|FG000|Overall Study|Adverse Event|1|||
144180319|NCT02957331|519853979|FG000|Overall Study|Protocol Violation|1|||
144251064|NCT00422292|520117460|FG001|Overall Study|Lost to Follow-up|12|||
144251065|NCT00422292|520117461|FG002|Overall Study|Lost to Follow-up|6|||
144251066|NCT00422292|520117462|FG003|Overall Study|Lost to Follow-up|6|||
144418368|NCT00460408|520737765|FG001|Overall Study|Adverse Event|0|||
144418369|NCT00460408|520737766|FG002|Overall Study|Adverse Event|0|||
144418370|NCT00460408|520737767|FG003|Overall Study|Adverse Event|0|||
144418371|NCT00460408|520737764|FG000|Overall Study|Death|7|||
144418372|NCT00460408|520737765|FG001|Overall Study|Death|0|||
144180320|NCT02957331|519853980|FG001|Overall Study|Protocol Violation|0|||
144418373|NCT00460408|520737766|FG002|Overall Study|Death|0|||
144418374|NCT00460408|520737767|FG003|Overall Study|Death|0|||
144418375|NCT00460408|520737764|FG000|Overall Study|Lost to Follow-up|11|||
144418376|NCT00460408|520737765|FG001|Overall Study|Lost to Follow-up|0|||
144418377|NCT00460408|520737766|FG002|Overall Study|Lost to Follow-up|1|||
144418378|NCT00460408|520737767|FG003|Overall Study|Lost to Follow-up|0|||
144418379|NCT00460408|520737764|FG000|Overall Study|Withdrawal by Subject|31|||
144418380|NCT00460408|520737765|FG001|Overall Study|Withdrawal by Subject|0|||
144418381|NCT00460408|520737766|FG002|Overall Study|Withdrawal by Subject|0|||
144418382|NCT00460408|520737767|FG003|Overall Study|Withdrawal by Subject|0|||
144418383|NCT00460408|520737764|FG000|Overall Study|Insufficient clinical response|5|||
144418384|NCT00460408|520737765|FG001|Overall Study|Insufficient clinical response|1|||
144418385|NCT00460408|520737766|FG002|Overall Study|Insufficient clinical response|5|||
144418386|NCT00460408|520737767|FG003|Overall Study|Insufficient clinical response|0|||
144418387|NCT00460408|520737764|FG000|Overall Study|Other|12|||
144418388|NCT00460408|520737765|FG001|Overall Study|Other|2|||
144418389|NCT00460408|520737766|FG002|Overall Study|Other|0|||
144418390|NCT00460408|520737767|FG003|Overall Study|Other|0|||
144418391|NCT00142584|520737768|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
144418392|NCT00142584|520737769|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
144418393|NCT00142584|520737768|FG000|Overall Study|Withdrawal by Subject|30|||
144418394|NCT00142584|520737769|FG001|Overall Study|Withdrawal by Subject|16|||
144418395|NCT00142584|520737768|FG000|Overall Study|Lost to Follow-up|22|||
144418396|NCT00142584|520737769|FG001|Overall Study|Lost to Follow-up|12|||
144418397|NCT00142584|520737768|FG000|Overall Study|Adverse Event|14|||
144418398|NCT00142584|520737769|FG001|Overall Study|Adverse Event|5|||
144418399|NCT00142584|520737768|FG000|Overall Study|Protocol Violation|4|||
144418400|NCT00142584|520737769|FG001|Overall Study|Protocol Violation|7|||
144418401|NCT00142584|520737768|FG000|Overall Study|Treatment Failure|2|||
144418402|NCT00142584|520737769|FG001|Overall Study|Treatment Failure|0|||
144418403|NCT03315208|520737773|FG000|Overall Study|Lost to Follow-up|11|||
144418404|NCT03315208|520737774|FG001|Overall Study|Lost to Follow-up|6|||
144418405|NCT03315208|520737773|FG000|Overall Study|Withdrawal by Subject|2|||
144418406|NCT03315208|520737774|FG001|Overall Study|Withdrawal by Subject|0|||
144418407|NCT02875860|520737777|FG000|Overall Study|Withdrawal by Subject|0|||
144418408|NCT02875860|520737778|FG001|Overall Study|Withdrawal by Subject|1|||
144418409|NCT01156311|520737788|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
144418410|NCT01156311|520737789|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
144418411|NCT01156311|520737790|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
144418412|NCT01156311|520737791|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
144418413|NCT01156311|520737788|FG000|2-Month Monotherapy Period|Physician Decision|0|||
144418414|NCT01156311|520737789|FG001|2-Month Monotherapy Period|Physician Decision|1|||
144418415|NCT01156311|520737790|FG002|2-Month Monotherapy Period|Physician Decision|0|||
144418416|NCT01156311|520737791|FG003|2-Month Monotherapy Period|Physician Decision|0|||
144418417|NCT01156311|520737788|FG000|2-Month Monotherapy Period|Other|1|||
144418418|NCT01156311|520737789|FG001|2-Month Monotherapy Period|Other|0|||
144418419|NCT01156311|520737790|FG002|2-Month Monotherapy Period|Other|0|||
144418420|NCT01156311|520737791|FG003|2-Month Monotherapy Period|Other|0|||
144418421|NCT01156311|520737788|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
144418422|NCT01156311|520737789|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
144418423|NCT01156311|520737790|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
144418424|NCT01156311|520737791|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
144418425|NCT01156311|520737788|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
144418426|NCT01156311|520737789|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
144418427|NCT01156311|520737790|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
144527488|NCT03085810|521133301|FG001|Main Study|Lost to Follow-up|0|||
144180321|NCT02588339|519853982|FG000|Overall Study|Withdrawal by Subject|1|||
144180322|NCT02588339|519853982|FG000|Overall Study|GVHD Progression prior to treatment|2|||
144180323|NCT00486434|519855423|FG000|Overall Study|Withdrawal by Subject|34|||
144180324|NCT00486434|519855424|FG001|Overall Study|Withdrawal by Subject|39|||
144180325|NCT00486434|519855423|FG000|Overall Study|Adverse Event|118|||
144180326|NCT00486434|519855424|FG001|Overall Study|Adverse Event|44|||
144180327|NCT00486434|519855423|FG000|Overall Study|Protocol Violation|22|||
144180328|NCT00486434|519855424|FG001|Overall Study|Protocol Violation|21|||
144418428|NCT01156311|520737791|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
144527489|NCT03085810|521133302|FG002|Main Study|Lost to Follow-up|0|||
144418429|NCT01156311|520737788|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
144527490|NCT03085810|521133300|FG000|Main Study|Adverse Event|25|||
144180329|NCT00486434|519855423|FG000|Overall Study|Lack of Efficacy|12|||
144180330|NCT00486434|519855424|FG001|Overall Study|Lack of Efficacy|19|||
144180331|NCT00486434|519855423|FG000|Overall Study|Lost to Follow-up|2|||
144180332|NCT00486434|519855424|FG001|Overall Study|Lost to Follow-up|3|||
144180333|NCT00486434|519855423|FG000|Overall Study|Death|1|||
144418430|NCT01156311|520737789|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
144418431|NCT01156311|520737790|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
144418432|NCT01156311|520737791|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
144418433|NCT01156311|520737788|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
144527491|NCT03085810|521133301|FG001|Main Study|Adverse Event|0|||
144180334|NCT00486434|519855424|FG001|Overall Study|Death|2|||
144180335|NCT00486434|519855423|FG000|Overall Study|Personal reasons|5|||
144180336|NCT00486434|519855424|FG001|Overall Study|Personal reasons|6|||
144180337|NCT02218541|519855425|FG000|Overall Study|Lost to Follow-up|2|||
144180338|NCT02218541|519855426|FG001|Overall Study|Lost to Follow-up|1|||
144180339|NCT02218541|519855425|FG000|Overall Study|Implant Failure|4|||
144180340|NCT02218541|519855426|FG001|Overall Study|Implant Failure|1|||
144180341|NCT00856349|519855427|FG000|Overall Study|Death|418|||
144180342|NCT00856349|519855427|FG000|Overall Study|Withdrawal by Subject|116|||
144180343|NCT00856349|519855427|FG000|Overall Study|Lost to Follow-up|91|||
144180344|NCT00856349|519855427|FG000|Overall Study|Protocol Violation|38|||
144180345|NCT00856349|519855427|FG000|Overall Study|Physician Decision|13|||
144180346|NCT00856349|519855427|FG000|Overall Study|Subject relocation|104|||
144180347|NCT00856349|519855427|FG000|Overall Study|Device explant|33|||
144180348|NCT00856349|519855427|FG000|Overall Study|Site closure|78|||
144180349|NCT00856349|519855427|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
144180350|NCT02998541|519855438|FG000|Overall Study|Adverse Event|4|||
144180351|NCT02998541|519855439|FG001|Overall Study|Adverse Event|5|||
144180352|NCT02998541|519855440|FG002|Overall Study|Adverse Event|1|||
144180353|NCT02998541|519855438|FG000|Overall Study|Protocol Violation|1|||
144180354|NCT02998541|519855439|FG001|Overall Study|Protocol Violation|0|||
144180355|NCT02998541|519855440|FG002|Overall Study|Protocol Violation|0|||
144180356|NCT02998541|519855438|FG000|Overall Study|Withdrawal by Subject|3|||
144180357|NCT02998541|519855439|FG001|Overall Study|Withdrawal by Subject|1|||
144180358|NCT02998541|519855440|FG002|Overall Study|Withdrawal by Subject|0|||
144180359|NCT02998541|519855438|FG000|Overall Study|Lost to Follow-up|0|||
144180360|NCT02998541|519855439|FG001|Overall Study|Lost to Follow-up|3|||
144180361|NCT02998541|519855440|FG002|Overall Study|Lost to Follow-up|1|||
144180362|NCT02998541|519855438|FG000|Overall Study|Physician Decision|0|||
144180363|NCT02998541|519855439|FG001|Overall Study|Physician Decision|0|||
144180364|NCT02998541|519855440|FG002|Overall Study|Physician Decision|3|||
144180365|NCT02998541|519855438|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144180366|NCT02998541|519855439|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144180367|NCT02998541|519855440|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
144180368|NCT00183196|519855441|FG000|Overall Study|Withdrawal by Subject|18|||
144180369|NCT00183196|519855442|FG001|Overall Study|Withdrawal by Subject|11|||
144180370|NCT00183196|519855443|FG002|Overall Study|Withdrawal by Subject|13|||
144180371|NCT00183196|519855441|FG000|Overall Study|Adverse Event|1|||
144180372|NCT00183196|519855442|FG001|Overall Study|Adverse Event|2|||
144251067|NCT00422292|520117459|FG000|Overall Study|Withdrawal by Subject|6|||
144251068|NCT00422292|520117460|FG001|Overall Study|Withdrawal by Subject|25|||
144418434|NCT01156311|520737789|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
144418435|NCT01156311|520737790|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
144418436|NCT01156311|520737791|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
144418437|NCT01156311|520737788|FG000|6-month Add-on Therapy Period|Other|0|||
144418438|NCT01156311|520737789|FG001|6-month Add-on Therapy Period|Other|0|||
144418439|NCT01156311|520737790|FG002|6-month Add-on Therapy Period|Other|1|||
144418440|NCT01156311|520737791|FG003|6-month Add-on Therapy Period|Other|2|||
144418441|NCT01741701|520737794|FG000|Overall Study|Adverse Event|5|||
144418442|NCT01741701|520737795|FG001|Overall Study|Adverse Event|1|||
144418443|NCT01741701|520737794|FG000|Overall Study|Withdrawal by Subject|0|||
144418444|NCT01741701|520737795|FG001|Overall Study|Withdrawal by Subject|1|||
144418445|NCT03033394|520737802|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
144418446|NCT03033394|520737802|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
144418447|NCT03033394|520737802|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
144418448|NCT03033394|520737802|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
144418449|NCT03033394|520737802|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
144418450|NCT01830972|520737804|FG000|Part II|Withdrawal by Subject|2|||
144418451|NCT01830972|520737805|FG001|Part II|Withdrawal by Subject|2|||
144418452|NCT01830972|520737804|FG000|Part III|Withdrawal by Subject|1|||
144418453|NCT01830972|520737805|FG001|Part III|Withdrawal by Subject|0|||
144601054|NCT04598477|521401711|FG001|Overall Study|Other|8|||
144601055|NCT05579990|521401717|FG000|Overall Study|Lost to Follow-up|3|||
144601056|NCT05118204|521401718|FG000|Overall Study|Lost to Follow-up|3|||
144180373|NCT00183196|519855443|FG002|Overall Study|Adverse Event|2|||
144180374|NCT00183196|519855441|FG000|Overall Study|Legal event|1|||
144180375|NCT00183196|519855442|FG001|Overall Study|Legal event|1|||
144180376|NCT00183196|519855443|FG002|Overall Study|Legal event|1|||
144180377|NCT00183196|519855441|FG000|Overall Study|Required more intensive care|0|||
144180378|NCT00183196|519855442|FG001|Overall Study|Required more intensive care|1|||
144180379|NCT00183196|519855443|FG002|Overall Study|Required more intensive care|2|||
144180380|NCT01513239|519855449|FG000|Period 1: Main Phase|Adverse Event|1|||
144180381|NCT01513239|519855450|FG001|Period 1: Main Phase|Adverse Event|1|||
144180382|NCT01513239|519855451|FG002|Period 1: Main Phase|Adverse Event|2|||
144418454|NCT01830972|520737804|FG000|Part III|Noncompliance|1|||
144601057|NCT05118204|521401719|FG001|Overall Study|Lost to Follow-up|2|||
144418455|NCT01830972|520737805|FG001|Part III|Noncompliance|0|||
144418456|NCT01830972|520737804|FG000|Part IV|Withdrawal by Subject|2|||
144418457|NCT01830972|520737805|FG001|Part IV|Withdrawal by Subject|1|||
144418458|NCT01830972|520737804|FG000|Part IV|Non-Compliance|1|||
144418459|NCT01830972|520737805|FG001|Part IV|Non-Compliance|0|||
144418460|NCT01276353|520737806|FG000|Double-blind|Adverse Event|2|||
144418461|NCT01276353|520737807|FG001|Double-blind|Adverse Event|0|||
144418462|NCT01276353|520737806|FG000|Double-blind|Withdrawal by Subject|1|||
144418463|NCT01276353|520737807|FG001|Double-blind|Withdrawal by Subject|0|||
144418464|NCT01276353|520737806|FG000|Extension|Adverse Event|2|||
144418465|NCT01276353|520737807|FG001|Extension|Adverse Event|5|||
144418466|NCT01276353|520737806|FG000|Extension|Withdrawal by Subject|1|||
144418467|NCT01276353|520737807|FG001|Extension|Withdrawal by Subject|2|||
144418468|NCT01276353|520737806|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
144418469|NCT01276353|520737807|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
144418470|NCT01276353|520737806|FG000|Extension|Physician Decision|1|||
144418471|NCT01276353|520737807|FG001|Extension|Physician Decision|0|||
144418472|NCT01276353|520737806|FG000|Extension|Prohibited concomitant medications|0|||
144418473|NCT01276353|520737807|FG001|Extension|Prohibited concomitant medications|1|||
144418474|NCT04952402|520737808|FG000|Overall Study|Lost to Follow-up|1|||
144418475|NCT04952402|520737809|FG001|Overall Study|Lost to Follow-up|3|||
144418476|NCT04952402|520737808|FG000|Overall Study|Lack Of Venous Access|0|||
144418477|NCT04952402|520737809|FG001|Overall Study|Lack Of Venous Access|1|||
144418478|NCT00514540|520737810|FG000|First-Line Chemo|Withdrawal by Subject|1|||
144418479|NCT00514540|520737810|FG000|First-Line Chemo|Protocol Violation|7|||
144418480|NCT00514540|520737810|FG000|Second-Line|Physician/Patient Decision|31|||
144418481|NCT00587639|520737811|FG000|Overall Study|Withdrawal by Subject|1|||
144418482|NCT01996982|520737816|FG000|Overall Study|PI/team left institution|7|||
144418483|NCT00533845|520737837|FG000|Overall Study|Physician Decision|1|||
144418484|NCT00533845|520737838|FG001|Overall Study|Physician Decision|0|||
144418485|NCT00160251|520737850|FG000|Prior to Amendment 2|Adverse Event|2|||
144418486|NCT00160251|520737851|FG001|Prior to Amendment 2|Adverse Event|1|||
144418487|NCT00160251|520737852|FG002|Prior to Amendment 2|Adverse Event|3|||
144418488|NCT00160251|520737853|FG003|Prior to Amendment 2|Adverse Event|1|||
144418489|NCT00160251|520737854|FG004|Prior to Amendment 2|Adverse Event|1|||
144418490|NCT00160251|520737855|FG005|Prior to Amendment 2|Adverse Event|1|||
144418491|NCT00160251|520737856|FG006|Prior to Amendment 2|Adverse Event|1|||
144418492|NCT00160251|520737857|FG007|Prior to Amendment 2|Adverse Event|0|||
144418493|NCT00160251|520737850|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
144418494|NCT00160251|520737851|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
144418495|NCT00160251|520737852|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
144418496|NCT00160251|520737853|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
144418497|NCT00160251|520737854|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
144418498|NCT00160251|520737855|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
144418499|NCT00160251|520737856|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
144418500|NCT00160251|520737857|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
144418501|NCT00160251|520737850|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
144418502|NCT00160251|520737851|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
144418503|NCT00160251|520737852|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
144418504|NCT00160251|520737853|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
144418505|NCT00160251|520737854|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
144418506|NCT00160251|520737855|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
144418507|NCT00160251|520737856|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
144418508|NCT00160251|520737857|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
144418509|NCT00160251|520737850|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
144418510|NCT00160251|520737851|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
144418511|NCT00160251|520737852|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
144418512|NCT00160251|520737853|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
144418513|NCT00160251|520737854|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
144418514|NCT00160251|520737855|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
144418515|NCT00160251|520737856|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
144418516|NCT00160251|520737857|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
144527492|NCT03085810|521133302|FG002|Main Study|Adverse Event|0|||
144527493|NCT03085810|521133300|FG000|Main Study|Pregnancy|7|||
144527494|NCT03085810|521133301|FG001|Main Study|Pregnancy|0|||
144527495|NCT03085810|521133302|FG002|Main Study|Pregnancy|0|||
144418517|NCT00160251|520737850|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
144418518|NCT00160251|520737851|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
144418519|NCT00160251|520737852|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
144418520|NCT00160251|520737853|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
144418521|NCT00160251|520737854|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
144418522|NCT00160251|520737855|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
144418523|NCT00160251|520737856|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
144418524|NCT00160251|520737857|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
144527496|NCT03085810|521133300|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
144527497|NCT03085810|521133301|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
144418525|NCT00160251|520737850|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
144418526|NCT00160251|520737851|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
144418527|NCT00160251|520737852|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
144418528|NCT00160251|520737853|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
144418529|NCT00160251|520737854|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
144418530|NCT00160251|520737855|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
144418531|NCT00160251|520737856|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
144418532|NCT00160251|520737857|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
144418533|NCT00160251|520737850|FG000|Post-amendment 2|Adverse Event|0|||
144418534|NCT00160251|520737851|FG001|Post-amendment 2|Adverse Event|0|||
144418535|NCT00160251|520737852|FG002|Post-amendment 2|Adverse Event|0|||
144418536|NCT00160251|520737853|FG003|Post-amendment 2|Adverse Event|0|||
144418537|NCT00160251|520737854|FG004|Post-amendment 2|Adverse Event|0|||
144418538|NCT00160251|520737855|FG005|Post-amendment 2|Adverse Event|0|||
144418539|NCT00160251|520737856|FG006|Post-amendment 2|Adverse Event|0|||
144418540|NCT00160251|520737857|FG007|Post-amendment 2|Adverse Event|20|||
144418541|NCT00160251|520737850|FG000|Post-amendment 2|Lack of Efficacy|0|||
144418542|NCT00160251|520737851|FG001|Post-amendment 2|Lack of Efficacy|0|||
144418543|NCT00160251|520737852|FG002|Post-amendment 2|Lack of Efficacy|0|||
144418544|NCT00160251|520737853|FG003|Post-amendment 2|Lack of Efficacy|0|||
144418545|NCT00160251|520737854|FG004|Post-amendment 2|Lack of Efficacy|0|||
144418546|NCT00160251|520737855|FG005|Post-amendment 2|Lack of Efficacy|0|||
144418547|NCT00160251|520737856|FG006|Post-amendment 2|Lack of Efficacy|0|||
144418548|NCT00160251|520737857|FG007|Post-amendment 2|Lack of Efficacy|24|||
144418549|NCT00160251|520737850|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418550|NCT00160251|520737851|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418551|NCT00160251|520737852|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418552|NCT00160251|520737853|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418553|NCT00160251|520737854|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418554|NCT00160251|520737855|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418555|NCT00160251|520737856|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
144418556|NCT00160251|520737857|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
144418557|NCT00563381|520737858|FG000|Overall Study|Adverse Event|264|||
144418558|NCT00563381|520737859|FG001|Overall Study|Adverse Event|292|||
144418559|NCT00563381|520737858|FG000|Overall Study|Protocol Violation|66|||
144418560|NCT00563381|520737859|FG001|Overall Study|Protocol Violation|74|||
144418561|NCT00563381|520737858|FG000|Overall Study|Lost to Follow-up|7|||
144418562|NCT00563381|520737859|FG001|Overall Study|Lost to Follow-up|15|||
144418563|NCT00563381|520737858|FG000|Overall Study|Withdrawal by Subject|192|||
144418564|NCT00563381|520737859|FG001|Overall Study|Withdrawal by Subject|209|||
144418565|NCT00563381|520737858|FG000|Overall Study|Lack of Efficacy|32|||
144418566|NCT00563381|520737859|FG001|Overall Study|Lack of Efficacy|24|||
144418567|NCT00563381|520737858|FG000|Overall Study|Individual different reasons|24|||
144418568|NCT00563381|520737859|FG001|Overall Study|Individual different reasons|34|||
144418569|NCT02452398|520737862|FG000|Overall Study|Adverse Event|1|||
144418570|NCT02452398|520737862|FG000|Overall Study|Lost to Follow-up|28|||
144418571|NCT02452398|520737862|FG000|Overall Study|Physician Decision|2|||
144418572|NCT02452398|520737862|FG000|Overall Study|Withdrawal by Subject|6|||
144418573|NCT02452398|520737862|FG000|Overall Study|Moved away|4|||
144418574|NCT02407704|520737863|FG000|Overall Study|Lost to Follow-up|0|||
144418575|NCT02407704|520737864|FG001|Overall Study|Lost to Follow-up|0|||
144418576|NCT02407704|520737865|FG002|Overall Study|Lost to Follow-up|0|||
144418577|NCT02407704|520737866|FG003|Overall Study|Lost to Follow-up|2|||
144418578|NCT02407704|520737863|FG000|Overall Study|Protocol Violation|0|||
144418579|NCT02407704|520737864|FG001|Overall Study|Protocol Violation|0|||
144418580|NCT02407704|520737865|FG002|Overall Study|Protocol Violation|0|||
144418581|NCT02407704|520737866|FG003|Overall Study|Protocol Violation|1|||
144418582|NCT02407704|520737863|FG000|Overall Study|Withdrawal by Subject|0|||
144418583|NCT02407704|520737864|FG001|Overall Study|Withdrawal by Subject|0|||
144418584|NCT02407704|520737865|FG002|Overall Study|Withdrawal by Subject|1|||
144418585|NCT02407704|520737866|FG003|Overall Study|Withdrawal by Subject|0|||
144418586|NCT02730455|520737867|FG000|Overall Study|Death|5|||
144418587|NCT02730455|520737868|FG001|Overall Study|Death|6|||
144418588|NCT02730455|520737869|FG002|Overall Study|Death|4|||
144418589|NCT02730455|520737867|FG000|Overall Study|Consent withdrawn|2|||
144418590|NCT02730455|520737868|FG001|Overall Study|Consent withdrawn|4|||
144601058|NCT05118204|521401718|FG000|Overall Study|Withdrawal by Subject|0|||
144601059|NCT05118204|521401719|FG001|Overall Study|Withdrawal by Subject|2|||
144418591|NCT02730455|520737869|FG002|Overall Study|Consent withdrawn|1|||
144418592|NCT02730455|520737867|FG000|Overall Study|Lost to Follow-up|3|||
144418593|NCT02730455|520737868|FG001|Overall Study|Lost to Follow-up|1|||
144418594|NCT02730455|520737869|FG002|Overall Study|Lost to Follow-up|4|||
144418595|NCT02730455|520737867|FG000|Overall Study|Other|1|||
144418596|NCT02730455|520737868|FG001|Overall Study|Other|1|||
144418597|NCT02730455|520737869|FG002|Overall Study|Other|2|||
144418598|NCT02730455|520737867|FG000|Overall Study|Other|2|||
144418599|NCT02730455|520737868|FG001|Overall Study|Other|2|||
144601060|NCT02466971|521401721|FG000|Overall Study|eligible and never treated|14|||
144418600|NCT02730455|520737869|FG002|Overall Study|Other|0|||
144418601|NCT00748033|520737873|FG000|Overall Study|Adverse Event|0|||
144418602|NCT00748033|520737874|FG001|Overall Study|Adverse Event|1|||
144418603|NCT01018186|520737875|FG000|2-week Run-in Period|Protocol Violation|1|||
144418604|NCT01018186|520737876|FG001|2-week Run-in Period|Protocol Violation|0|||
144418605|NCT01018186|520737877|FG002|2-week Run-in Period|Protocol Violation|0|||
144418606|NCT01018186|520737878|FG003|2-week Run-in Period|Protocol Violation|0|||
144418607|NCT01018186|520737875|FG000|2-week Run-in Period|Lost to Follow-up|2|||
144418608|NCT01018186|520737876|FG001|2-week Run-in Period|Lost to Follow-up|0|||
144418609|NCT01018186|520737877|FG002|2-week Run-in Period|Lost to Follow-up|0|||
144418610|NCT01018186|520737878|FG003|2-week Run-in Period|Lost to Follow-up|0|||
144418611|NCT01018186|520737875|FG000|2-week Run-in Period|Physician Decision|3|||
144418612|NCT01018186|520737876|FG001|2-week Run-in Period|Physician Decision|0|||
144418613|NCT01018186|520737877|FG002|2-week Run-in Period|Physician Decision|0|||
144418614|NCT01018186|520737878|FG003|2-week Run-in Period|Physician Decision|0|||
144418615|NCT01018186|520737875|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
144418616|NCT01018186|520737876|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144418617|NCT01018186|520737877|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144418618|NCT01018186|520737878|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
144418619|NCT01018186|520737875|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
144418620|NCT01018186|520737876|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
144418621|NCT01018186|520737877|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
144418622|NCT01018186|520737878|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
144418623|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
144418624|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
144418625|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
144418626|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
144418627|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
144418628|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
144418629|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
144418630|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
144418631|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
144418632|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
144418633|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
144418634|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
144418635|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
144418636|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
144418637|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
144418638|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
144418639|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
144418640|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
144418641|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
144418642|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
144418643|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
144418644|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
144418645|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
144418646|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
144418647|NCT01018186|520737875|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144418648|NCT01018186|520737876|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
144418649|NCT01018186|520737877|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
144418650|NCT01018186|520737878|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
144418651|NCT00536198|520737879|FG000|Overall Study|Lost to Follow-up|15|||
144418652|NCT00536198|520737880|FG001|Overall Study|Lost to Follow-up|14|||
144418653|NCT00536198|520737879|FG000|Overall Study|Withdrawal by Subject|16|||
144418654|NCT00536198|520737880|FG001|Overall Study|Withdrawal by Subject|12|||
144180383|NCT01513239|519855452|FG003|Period 1: Main Phase|Adverse Event|0|||
144180384|NCT01513239|519855453|FG004|Period 1: Main Phase|Adverse Event|0|||
144180385|NCT01513239|519855454|FG005|Period 1: Main Phase|Adverse Event|0|||
144180386|NCT01513239|519855449|FG000|Period 1: Main Phase|Death|29|||
144180387|NCT01513239|519855450|FG001|Period 1: Main Phase|Death|22|||
144180388|NCT01513239|519855451|FG002|Period 1: Main Phase|Death|32|||
144418655|NCT00536198|520737879|FG000|Overall Study|Adverse Event|2|||
144418656|NCT00536198|520737880|FG001|Overall Study|Adverse Event|2|||
144418657|NCT00536198|520737879|FG000|Overall Study|Rescue|3|||
144418658|NCT00536198|520737880|FG001|Overall Study|Rescue|9|||
144418659|NCT00536198|520737879|FG000|Overall Study|Pregnancy|1|||
144418660|NCT00536198|520737880|FG001|Overall Study|Pregnancy|1|||
144418661|NCT00536198|520737879|FG000|Overall Study|Protocol Violation|0|||
144418662|NCT00536198|520737880|FG001|Overall Study|Protocol Violation|1|||
144180389|NCT01513239|519855452|FG003|Period 1: Main Phase|Death|0|||
144180390|NCT01513239|519855453|FG004|Period 1: Main Phase|Death|0|||
144418663|NCT00640601|520737881|FG000|Overall Study|Adverse Event|43|||
144418664|NCT00640601|520737881|FG000|Overall Study|Withdrawal by Subject|20|||
144418665|NCT00640601|520737881|FG000|Overall Study|Protocol Violation|6|||
144418666|NCT00640601|520737881|FG000|Overall Study|Lack of Efficacy|16|||
144418667|NCT00640601|520737881|FG000|Overall Study|Lost to Follow-up|9|||
144418668|NCT00640601|520737881|FG000|Overall Study|Physician Decision|8|||
144418669|NCT00640601|520737881|FG000|Overall Study|treatment naive, combination therapy|10|||
144418670|NCT00230607|520737884|FG000|Overall Study|Other|3|||
144418671|NCT00165776|520737885|FG000|Overall Study|Lack of Efficacy|0|||
144418672|NCT00165776|520737886|FG001|Overall Study|Lack of Efficacy|0|||
144418673|NCT00165776|520737887|FG002|Overall Study|Lack of Efficacy|0|||
144418674|NCT00165776|520737888|FG003|Overall Study|Lack of Efficacy|1|||
144418675|NCT00165776|520737885|FG000|Overall Study|Withdrawal by Subject|4|||
144418676|NCT00165776|520737886|FG001|Overall Study|Withdrawal by Subject|1|||
144418677|NCT00165776|520737887|FG002|Overall Study|Withdrawal by Subject|2|||
144418678|NCT00165776|520737888|FG003|Overall Study|Withdrawal by Subject|0|||
144418679|NCT00165776|520737885|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
144418680|NCT00165776|520737886|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
144418681|NCT00165776|520737887|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
144418682|NCT00165776|520737888|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
144418683|NCT01648205|520737896|FG000|Placebo|Pregnancy|1|||
144418684|NCT01648205|520737896|FG000|Placebo|Withdrawal by Subject|1|||
144418685|NCT01648205|520737896|FG000|Placebo|Protocol Violation|2|||
144418686|NCT01648205|520737896|FG000|Ranolazine|Death|1|||
144418687|NCT01648205|520737896|FG000|Ranolazine|Withdrawal by Subject|1|||
144418688|NCT01648205|520737896|FG000|Ranolazine|Protocol Violation|3|||
144418689|NCT00203996|520737897|FG000|Overall Study|Lost to Follow-up|0|||
144418690|NCT00203996|520737898|FG001|Overall Study|Lost to Follow-up|0|||
144418691|NCT00203996|520737899|FG002|Overall Study|Lost to Follow-up|0|||
144418692|NCT00203996|520737900|FG003|Overall Study|Lost to Follow-up|1|||
144418693|NCT00203996|520737901|FG004|Overall Study|Lost to Follow-up|0|||
144418694|NCT00203996|520737902|FG005|Overall Study|Lost to Follow-up|0|||
144418695|NCT00203996|520737903|FG006|Overall Study|Lost to Follow-up|0|||
144418696|NCT00203996|520737904|FG007|Overall Study|Lost to Follow-up|0|||
144418697|NCT00203996|520737905|FG008|Overall Study|Lost to Follow-up|0|||
144418698|NCT00203996|520737906|FG009|Overall Study|Lost to Follow-up|0|||
144418699|NCT00203996|520737897|FG000|Overall Study|Protocol Violation|0|||
144418700|NCT00203996|520737898|FG001|Overall Study|Protocol Violation|0|||
144418701|NCT00203996|520737899|FG002|Overall Study|Protocol Violation|0|||
144418702|NCT00203996|520737900|FG003|Overall Study|Protocol Violation|6|||
144418703|NCT00203996|520737901|FG004|Overall Study|Protocol Violation|1|||
144418704|NCT00203996|520737902|FG005|Overall Study|Protocol Violation|0|||
144418705|NCT00203996|520737903|FG006|Overall Study|Protocol Violation|0|||
144418706|NCT00203996|520737904|FG007|Overall Study|Protocol Violation|0|||
144418707|NCT00203996|520737905|FG008|Overall Study|Protocol Violation|0|||
144418708|NCT00203996|520737906|FG009|Overall Study|Protocol Violation|0|||
144418709|NCT00203996|520737897|FG000|Overall Study|Physician Decision|0|||
144418710|NCT00203996|520737898|FG001|Overall Study|Physician Decision|0|||
144418711|NCT00203996|520737899|FG002|Overall Study|Physician Decision|0|||
144418712|NCT00203996|520737900|FG003|Overall Study|Physician Decision|2|||
144418713|NCT00203996|520737901|FG004|Overall Study|Physician Decision|0|||
144418714|NCT00203996|520737902|FG005|Overall Study|Physician Decision|0|||
144418715|NCT00203996|520737903|FG006|Overall Study|Physician Decision|0|||
144418716|NCT00203996|520737904|FG007|Overall Study|Physician Decision|0|||
144418717|NCT00203996|520737905|FG008|Overall Study|Physician Decision|0|||
144418718|NCT00203996|520737906|FG009|Overall Study|Physician Decision|1|||
144527498|NCT03085810|521133302|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
144527499|NCT03085810|521133300|FG000|Main Study|Lack of Efficacy|10|||
144527500|NCT03085810|521133301|FG001|Main Study|Lack of Efficacy|0|||
144527501|NCT03085810|521133302|FG002|Main Study|Lack of Efficacy|0|||
144527502|NCT03085810|521133300|FG000|Main Study|Death|12|||
144527503|NCT03085810|521133301|FG001|Main Study|Death|0|||
144723207|NCT01058421|521840660|FG000|1 Month Outcomes|Lost to Follow-up|8|||
144418719|NCT00203996|520737897|FG000|Overall Study|CPAP machine malfunction|0|||
144418720|NCT00203996|520737898|FG001|Overall Study|CPAP machine malfunction|0|||
144418721|NCT00203996|520737899|FG002|Overall Study|CPAP machine malfunction|0|||
144723208|NCT01058421|521840661|FG001|1 Month Outcomes|Lost to Follow-up|7|||
144418722|NCT00203996|520737900|FG003|Overall Study|CPAP machine malfunction|1|||
144418723|NCT00203996|520737901|FG004|Overall Study|CPAP machine malfunction|0|||
144418724|NCT00203996|520737902|FG005|Overall Study|CPAP machine malfunction|0|||
144418725|NCT00203996|520737903|FG006|Overall Study|CPAP machine malfunction|0|||
144418726|NCT00203996|520737904|FG007|Overall Study|CPAP machine malfunction|0|||
144723209|NCT01058421|521840660|FG000|1 Month Outcomes|Remained in Hospital|5|||
144418727|NCT00203996|520737905|FG008|Overall Study|CPAP machine malfunction|0|||
144418728|NCT00203996|520737906|FG009|Overall Study|CPAP machine malfunction|0|||
144418729|NCT00203996|520737897|FG000|Overall Study|Scheduling issue|0|||
144418730|NCT00203996|520737898|FG001|Overall Study|Scheduling issue|0|||
144527504|NCT03085810|521133302|FG002|Main Study|Death|0|||
144527505|NCT03085810|521133300|FG000|Main Study|Disease progression|1|||
144723210|NCT01058421|521840661|FG001|1 Month Outcomes|Remained in Hospital|12|||
144418731|NCT00203996|520737899|FG002|Overall Study|Scheduling issue|0|||
144418732|NCT00203996|520737900|FG003|Overall Study|Scheduling issue|0|||
144418733|NCT00203996|520737901|FG004|Overall Study|Scheduling issue|0|||
144418734|NCT00203996|520737902|FG005|Overall Study|Scheduling issue|0|||
144418735|NCT00203996|520737903|FG006|Overall Study|Scheduling issue|0|||
144418736|NCT00203996|520737904|FG007|Overall Study|Scheduling issue|2|||
144180391|NCT01513239|519855454|FG005|Period 1: Main Phase|Death|0|||
144180392|NCT01513239|519855449|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
144418737|NCT00203996|520737905|FG008|Overall Study|Scheduling issue|0|||
144418738|NCT00203996|520737906|FG009|Overall Study|Scheduling issue|0|||
144418739|NCT01428453|520737911|FG000|Overall Study|Adverse Event|2|||
144418740|NCT01428453|520737912|FG001|Overall Study|Adverse Event|7|||
144418741|NCT01428453|520737911|FG000|Overall Study|Protocol Violation|1|||
144418742|NCT01428453|520737912|FG001|Overall Study|Protocol Violation|0|||
144418743|NCT01428453|520737911|FG000|Overall Study|Lost to Follow-up|0|||
144418744|NCT01428453|520737912|FG001|Overall Study|Lost to Follow-up|1|||
144180393|NCT01513239|519855450|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
144180394|NCT01513239|519855451|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
144180395|NCT01513239|519855452|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
144180396|NCT01513239|519855453|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
144418745|NCT01428453|520737911|FG000|Overall Study|Withdrawal by Subject|3|||
144418746|NCT01428453|520737912|FG001|Overall Study|Withdrawal by Subject|1|||
144418747|NCT01996709|520737913|FG000|Overall Study|Withdrawal by Subject|1|||
144418748|NCT01996709|520737914|FG001|Overall Study|Withdrawal by Subject|0|||
144418749|NCT01996709|520737913|FG000|Overall Study|Lost to Follow-up|3|||
144418750|NCT01996709|520737914|FG001|Overall Study|Lost to Follow-up|0|||
144418751|NCT01996709|520737913|FG000|Overall Study|Subject Non-Compliant|1|||
144418752|NCT01996709|520737914|FG001|Overall Study|Subject Non-Compliant|0|||
144418753|NCT01996709|520737913|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
144418754|NCT01996709|520737914|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
144418755|NCT00850564|520737917|FG000|Overall Study|Withdrawal by Subject|2|||
144418756|NCT04818840|520737918|FG000|Overall Study|Lost to Follow-up|0|||
144418757|NCT04818840|520737919|FG001|Overall Study|Lost to Follow-up|5|||
144418758|NCT04818840|520737918|FG000|Overall Study|Physician Decision|1|||
144418759|NCT04818840|520737919|FG001|Overall Study|Physician Decision|0|||
144418760|NCT04818840|520737918|FG000|Overall Study|Site Terminated by Sponsor|0|||
144418761|NCT04818840|520737919|FG001|Overall Study|Site Terminated by Sponsor|3|||
144418762|NCT04818840|520737918|FG000|Overall Study|Study Terminated by Sponsor|43|||
144418763|NCT04818840|520737919|FG001|Overall Study|Study Terminated by Sponsor|7|||
144418764|NCT04818840|520737918|FG000|Overall Study|Withdrawal by Subject|0|||
144418765|NCT04818840|520737919|FG001|Overall Study|Withdrawal by Subject|1|||
144418766|NCT00733408|520739940|FG000|Overall Study|Adverse Event|4|||
144418767|NCT00531232|520739941|FG000|Overall Study|Investigator decision|0|||
144418768|NCT00531232|520739942|FG001|Overall Study|Investigator decision|0|||
144418769|NCT00531232|520739943|FG002|Overall Study|Investigator decision|4|||
144418770|NCT00531232|520739941|FG000|Overall Study|Participants refused further treatment|0|||
144418771|NCT00531232|520739942|FG001|Overall Study|Participants refused further treatment|1|||
144180397|NCT01513239|519855454|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
144180398|NCT01513239|519855449|FG000|Period 1: Main Phase|Physician Decision|4|||
144180399|NCT01513239|519855450|FG001|Period 1: Main Phase|Physician Decision|4|||
144418772|NCT00531232|520739943|FG002|Overall Study|Participants refused further treatment|2|||
144418773|NCT00531232|520739941|FG000|Overall Study|Adverse events (AEs)|1|||
144418774|NCT00531232|520739942|FG001|Overall Study|Adverse events (AEs)|2|||
144418775|NCT00531232|520739943|FG002|Overall Study|Adverse events (AEs)|2|||
144418776|NCT00531232|520739941|FG000|Overall Study|Treatment failure|1|||
144418777|NCT00531232|520739942|FG001|Overall Study|Treatment failure|3|||
144527506|NCT03085810|521133301|FG001|Main Study|Disease progression|0|||
144180400|NCT01513239|519855451|FG002|Period 1: Main Phase|Physician Decision|4|||
144180401|NCT01513239|519855452|FG003|Period 1: Main Phase|Physician Decision|0|||
144180402|NCT01513239|519855453|FG004|Period 1: Main Phase|Physician Decision|0|||
144180403|NCT01513239|519855454|FG005|Period 1: Main Phase|Physician Decision|0|||
144418778|NCT00531232|520739943|FG002|Overall Study|Treatment failure|7|||
144418779|NCT00531232|520739941|FG000|Overall Study|Disease recurrence|0|||
144418780|NCT00531232|520739942|FG001|Overall Study|Disease recurrence|0|||
144418781|NCT00531232|520739943|FG002|Overall Study|Disease recurrence|1|||
144418782|NCT00531232|520739941|FG000|Overall Study|Deceased|2|||
144527507|NCT03085810|521133302|FG002|Main Study|Disease progression|0|||
144527508|NCT03085810|521133300|FG000|Main Study|Site Closure|3|||
144180404|NCT01513239|519855449|FG000|Period 1: Main Phase|Protocol Violation|2|||
144180405|NCT01513239|519855450|FG001|Period 1: Main Phase|Protocol Violation|2|||
144180406|NCT01513239|519855451|FG002|Period 1: Main Phase|Protocol Violation|2|||
144180407|NCT01513239|519855452|FG003|Period 1: Main Phase|Protocol Violation|0|||
144527509|NCT03085810|521133301|FG001|Main Study|Site Closure|0|||
144418783|NCT00531232|520739942|FG001|Overall Study|Deceased|2|||
144418784|NCT00531232|520739943|FG002|Overall Study|Deceased|2|||
144418785|NCT00531232|520739941|FG000|Overall Study|Withdrawal by Subject|0|||
144418786|NCT00531232|520739942|FG001|Overall Study|Withdrawal by Subject|1|||
144527510|NCT03085810|521133302|FG002|Main Study|Site Closure|0|||
144418787|NCT00531232|520739943|FG002|Overall Study|Withdrawal by Subject|2|||
144418788|NCT00531232|520739941|FG000|Overall Study|Other|0|||
144418789|NCT00531232|520739942|FG001|Overall Study|Other|0|||
144418790|NCT00531232|520739943|FG002|Overall Study|Other|5|||
144418791|NCT01438424|520739944|FG000|Overall Study|Continuing treatment|29|||
144418792|NCT01438424|520739944|FG000|Overall Study|Minimal virologic response|95|||
144418793|NCT01438424|520739944|FG000|Overall Study|Not identified|55|||
144418794|NCT01438424|520739944|FG000|Overall Study|Withdrawal by Subject|104|||
144418795|NCT01438424|520739944|FG000|Overall Study|Progression of chronic hepatitis B|22|||
144418796|NCT01438424|520739944|FG000|Overall Study|Death|22|||
144418797|NCT01438424|520739944|FG000|Overall Study|Adverse Event|17|||
144418798|NCT01438424|520739944|FG000|Overall Study|Lost to Follow-up|17|||
144418799|NCT01438424|520739944|FG000|Overall Study|Abnormal laboratory test result|14|||
144418800|NCT01438424|520739944|FG000|Overall Study|Need for drug prohibited by protocol|14|||
144418801|NCT01438424|520739944|FG000|Overall Study|Pregnancy|7|||
144418802|NCT01438424|520739944|FG000|Overall Study|No longer met inclusion criteria|1|||
144418803|NCT01438424|520739944|FG000|Overall Study|Participant noncompliance|20|||
144418804|NCT04232124|520739945|FG000|Overall Study|Lost to Follow-up|3|||
144418805|NCT02279173|520739952|FG000|Overall Study|Protocol-specified Criteria|67|||
144418806|NCT02279173|520739952|FG000|Overall Study|Withdrawal by Subject|20|||
144418807|NCT02279173|520739952|FG000|Overall Study|Decision by Sponsor|4|||
144418808|NCT02279173|520739952|FG000|Overall Study|Lost to Follow-up|3|||
144418809|NCT01164956|520739953|FG000|Overall Study|Side Effects|1|||
144418810|NCT01164956|520739954|FG001|Overall Study|Side Effects|0|||
144418811|NCT01164956|520739955|FG002|Overall Study|Side Effects|1|||
144418812|NCT00931762|520739956|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
144418813|NCT00931762|520739956|FG000|Overall Study|Administrative Problems|5|||
144418814|NCT00931762|520739956|FG000|Overall Study|Death|1|||
144418815|NCT00931762|520739956|FG000|Overall Study|Disease Progression|3|||
144418816|NCT00931762|520739956|FG000|Overall Study|Adverse Event (s)|11|||
144418817|NCT00931762|520739956|FG000|Overall Study|Subject withdrew consent|13|||
144418818|NCT01320085|520739957|FG000|Overall Study|Disease Progression|26|||
144418819|NCT01320085|520739958|FG001|Overall Study|Disease Progression|93|||
144418820|NCT01320085|520739959|FG002|Overall Study|Disease Progression|17|||
144418821|NCT01320085|520739957|FG000|Overall Study|Adverse Event|12|||
144418822|NCT01320085|520739958|FG001|Overall Study|Adverse Event|20|||
144418823|NCT01320085|520739959|FG002|Overall Study|Adverse Event|5|||
144418824|NCT01320085|520739957|FG000|Overall Study|Withdrawal by Subject|2|||
144418825|NCT01320085|520739958|FG001|Overall Study|Withdrawal by Subject|4|||
144418826|NCT01320085|520739959|FG002|Overall Study|Withdrawal by Subject|1|||
144418827|NCT01320085|520739957|FG000|Overall Study|Protocol Deviation|1|||
144418828|NCT01320085|520739958|FG001|Overall Study|Protocol Deviation|0|||
144418829|NCT01320085|520739959|FG002|Overall Study|Protocol Deviation|1|||
144418830|NCT01320085|520739957|FG000|Overall Study|Administrative problems|0|||
144418831|NCT01320085|520739958|FG001|Overall Study|Administrative problems|0|||
144418832|NCT01320085|520739959|FG002|Overall Study|Administrative problems|1|||
144418833|NCT01702454|520739960|FG000|Overall Study|Consent withdrawal|0|||
144418834|NCT01702454|520739961|FG001|Overall Study|Consent withdrawal|1|||
144418835|NCT01702454|520739960|FG000|Overall Study|Migrated/moved from study area|0|||
144418836|NCT01702454|520739961|FG001|Overall Study|Migrated/moved from study area|1|||
144418837|NCT01702454|520739960|FG000|Overall Study|Lost to Follow-up|3|||
144418838|NCT01702454|520739961|FG001|Overall Study|Lost to Follow-up|6|||
144418839|NCT00710710|520739962|FG000|Overall Study|Consent withdrawn|2|||
144418840|NCT00710710|520739963|FG001|Overall Study|Consent withdrawn|2|||
144418841|NCT00710710|520739962|FG000|Overall Study|Protocol Violation|0|||
144180408|NCT01513239|519855453|FG004|Period 1: Main Phase|Protocol Violation|0|||
144180409|NCT01513239|519855454|FG005|Period 1: Main Phase|Protocol Violation|0|||
144180410|NCT01513239|519855449|FG000|Period 1: Main Phase|Technical Problems|1|||
144180411|NCT01513239|519855450|FG001|Period 1: Main Phase|Technical Problems|2|||
144180412|NCT01513239|519855451|FG002|Period 1: Main Phase|Technical Problems|0|||
144180413|NCT01513239|519855452|FG003|Period 1: Main Phase|Technical Problems|0|||
144180414|NCT01513239|519855453|FG004|Period 1: Main Phase|Technical Problems|0|||
144418842|NCT00710710|520739963|FG001|Overall Study|Protocol Violation|1|||
144418843|NCT00710710|520739962|FG000|Overall Study|Adverse Event|3|||
144418844|NCT00710710|520739963|FG001|Overall Study|Adverse Event|3|||
144418845|NCT00710710|520739962|FG000|Overall Study|Progressive disease|40|||
144418846|NCT00710710|520739963|FG001|Overall Study|Progressive disease|38|||
144180415|NCT01513239|519855454|FG005|Period 1: Main Phase|Technical Problems|0|||
144418847|NCT03510884|520739964|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
144418848|NCT03510884|520739965|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
144418849|NCT03510884|520739966|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
144418850|NCT03510884|520739967|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
144418851|NCT03510884|520739964|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
144418852|NCT03510884|520739965|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
144418853|NCT03510884|520739966|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
144418854|NCT03510884|520739967|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
144418855|NCT03510884|520739964|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
144418856|NCT03510884|520739965|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
144418857|NCT03510884|520739966|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
144418858|NCT03510884|520739967|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
144418859|NCT03510884|520739964|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
144418860|NCT03510884|520739965|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
144418861|NCT03510884|520739966|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
144418862|NCT03510884|520739967|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
144418863|NCT03510884|520739964|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
144418864|NCT03510884|520739965|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
144418865|NCT03510884|520739966|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
144418866|NCT03510884|520739967|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
144418867|NCT03510884|520739964|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
144418868|NCT03510884|520739965|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
144418869|NCT03510884|520739966|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
144418870|NCT03510884|520739967|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
144418871|NCT03510884|520739964|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
144418872|NCT03510884|520739965|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
144418873|NCT03510884|520739966|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
144418874|NCT03510884|520739967|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
144418875|NCT03510884|520739964|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
144418876|NCT03510884|520739965|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
144418877|NCT03510884|520739966|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
144418878|NCT03510884|520739967|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
144418879|NCT03510884|520739964|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
144418880|NCT03510884|520739965|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
144418881|NCT03510884|520739966|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
144418882|NCT03510884|520739967|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
144418883|NCT03510884|520739964|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
144418884|NCT03510884|520739965|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
144418885|NCT03510884|520739966|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
144418886|NCT03510884|520739967|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
144418887|NCT00589914|520739968|FG000|Overall Study|Adverse Event|19|||
144418888|NCT00589914|520739969|FG001|Overall Study|Adverse Event|10|||
144418889|NCT00589914|520739968|FG000|Overall Study|Death|2|||
144418890|NCT00589914|520739969|FG001|Overall Study|Death|0|||
144418891|NCT00589914|520739968|FG000|Overall Study|Lack of Efficacy|40|||
144418892|NCT00589914|520739969|FG001|Overall Study|Lack of Efficacy|43|||
144418893|NCT00589914|520739968|FG000|Overall Study|Lost to Follow-up|11|||
144418894|NCT00589914|520739969|FG001|Overall Study|Lost to Follow-up|18|||
144418895|NCT00589914|520739968|FG000|Overall Study|Pregnancy|1|||
144418896|NCT00589914|520739969|FG001|Overall Study|Pregnancy|0|||
144418897|NCT00589914|520739968|FG000|Overall Study|Withdrawal by Subject|55|||
144418898|NCT00589914|520739969|FG001|Overall Study|Withdrawal by Subject|49|||
144418899|NCT00589914|520739968|FG000|Overall Study|Other|22|||
144418900|NCT00589914|520739969|FG001|Overall Study|Other|17|||
144418901|NCT02564042|520739975|FG000|Overall Study|Adverse Event|4|||
144418902|NCT02564042|520739976|FG001|Overall Study|Adverse Event|4|||
144418903|NCT02564042|520739977|FG002|Overall Study|Adverse Event|3|||
144418904|NCT02564042|520739978|FG003|Overall Study|Adverse Event|0|||
144418905|NCT02564042|520739979|FG004|Overall Study|Adverse Event|0|||
144418906|NCT02564042|520739980|FG005|Overall Study|Adverse Event|1|||
144418907|NCT02564042|520739975|FG000|Overall Study|Lost to Follow-up|1|||
144418908|NCT02564042|520739976|FG001|Overall Study|Lost to Follow-up|1|||
144418909|NCT02564042|520739977|FG002|Overall Study|Lost to Follow-up|1|||
144418910|NCT02564042|520739978|FG003|Overall Study|Lost to Follow-up|0|||
144418911|NCT02564042|520739979|FG004|Overall Study|Lost to Follow-up|1|||
144418912|NCT02564042|520739980|FG005|Overall Study|Lost to Follow-up|1|||
144418913|NCT02564042|520739975|FG000|Overall Study|Physician Decision|1|||
144418914|NCT02564042|520739976|FG001|Overall Study|Physician Decision|0|||
144418915|NCT02564042|520739977|FG002|Overall Study|Physician Decision|0|||
144418916|NCT02564042|520739978|FG003|Overall Study|Physician Decision|1|||
144418917|NCT02564042|520739979|FG004|Overall Study|Physician Decision|0|||
144418918|NCT02564042|520739980|FG005|Overall Study|Physician Decision|0|||
144418919|NCT02564042|520739975|FG000|Overall Study|Withdrawal by Subject|5|||
144601061|NCT02466971|521401722|FG001|Overall Study|eligible and never treated|20|||
144418920|NCT02564042|520739976|FG001|Overall Study|Withdrawal by Subject|3|||
144418921|NCT02564042|520739977|FG002|Overall Study|Withdrawal by Subject|2|||
144418922|NCT02564042|520739978|FG003|Overall Study|Withdrawal by Subject|2|||
144601062|NCT02466971|521401721|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
144418923|NCT02564042|520739979|FG004|Overall Study|Withdrawal by Subject|10|||
144418924|NCT02564042|520739980|FG005|Overall Study|Withdrawal by Subject|12|||
144418925|NCT02289898|520739987|FG000|Overall Study|Death|5|||
144418926|NCT02289898|520739988|FG001|Overall Study|Death|4|||
144418927|NCT02289898|520739989|FG002|Overall Study|Death|3|||
144418928|NCT02289898|520739987|FG000|Overall Study|Physician Decision|2|||
144418929|NCT02289898|520739988|FG001|Overall Study|Physician Decision|5|||
144418930|NCT02289898|520739989|FG002|Overall Study|Physician Decision|2|||
144418931|NCT02289898|520739987|FG000|Overall Study|Withdrawal by Subject|0|||
144418932|NCT02289898|520739988|FG001|Overall Study|Withdrawal by Subject|4|||
144418933|NCT02289898|520739989|FG002|Overall Study|Withdrawal by Subject|1|||
144418934|NCT02289898|520739987|FG000|Overall Study|Adverse Event|3|||
144418935|NCT02289898|520739988|FG001|Overall Study|Adverse Event|5|||
144418936|NCT02289898|520739989|FG002|Overall Study|Adverse Event|5|||
144418937|NCT02289898|520739987|FG000|Overall Study|Disease progression|34|||
144418938|NCT02289898|520739988|FG001|Overall Study|Disease progression|28|||
144418939|NCT02289898|520739989|FG002|Overall Study|Disease progression|34|||
144418940|NCT02289898|520739987|FG000|Overall Study|Use of another anticancer therapy|0|||
144418941|NCT02289898|520739988|FG001|Overall Study|Use of another anticancer therapy|0|||
144418942|NCT02289898|520739989|FG002|Overall Study|Use of another anticancer therapy|1|||
144418943|NCT02289898|520739987|FG000|Overall Study|Other|8|||
144418944|NCT02289898|520739988|FG001|Overall Study|Other|7|||
144418945|NCT02289898|520739989|FG002|Overall Study|Other|10|||
144418946|NCT00885105|520739990|FG000|Overall Study|Withdrawal by Subject|0|||
144418947|NCT00885105|520739991|FG001|Overall Study|Withdrawal by Subject|8|||
144418948|NCT00885105|520739990|FG000|Overall Study|Adverse Event|1|||
144418949|NCT00885105|520739991|FG001|Overall Study|Adverse Event|0|||
144418950|NCT00885105|520739990|FG000|Overall Study|Protocol Violation|0|||
144418951|NCT00885105|520739991|FG001|Overall Study|Protocol Violation|2|||
144418952|NCT01402544|520739992|FG000|Overall Study|Withdrawal by Subject|6|||
144418953|NCT01828281|520739993|FG000|Overall Study|Withdrawal by Subject|1|||
144418954|NCT01828281|520739994|FG001|Overall Study|Withdrawal by Subject|0|||
144418955|NCT01442493|520739995|FG000|Overall Study|withdrawn from study|3|||
144418956|NCT01442493|520739996|FG001|Overall Study|withdrawn from study|2|||
144418957|NCT00759954|520739997|FG000|Overall Study|Personal reason|1|||
144418958|NCT00759954|520739998|FG001|Overall Study|Personal reason|0|||
144418959|NCT00759954|520739997|FG000|Overall Study|Adverse Event|1|||
144418960|NCT00759954|520739998|FG001|Overall Study|Adverse Event|2|||
144418961|NCT01829191|520739999|FG000|Overall Study|Relocation|0|||
144418962|NCT01829191|520740000|FG001|Overall Study|Relocation|1|||
144418963|NCT01829191|520739999|FG000|Overall Study|Lens discomfort|0|||
144418964|NCT01829191|520740000|FG001|Overall Study|Lens discomfort|3|||
144418965|NCT01829191|520739999|FG000|Overall Study|Lens handling difficulty|1|||
144418966|NCT01829191|520740000|FG001|Overall Study|Lens handling difficulty|4|||
144418967|NCT01829191|520739999|FG000|Overall Study|Protocol Violation|4|||
144418968|NCT01829191|520740000|FG001|Overall Study|Protocol Violation|1|||
144418969|NCT01829191|520739999|FG000|Overall Study|Withdrawal by Subject|2|||
144418970|NCT01829191|520740000|FG001|Overall Study|Withdrawal by Subject|3|||
144418971|NCT01829191|520739999|FG000|Overall Study|Lost to Follow-up|0|||
144418972|NCT01829191|520740000|FG001|Overall Study|Lost to Follow-up|1|||
144418973|NCT01829191|520739999|FG000|Overall Study|Subject was fit for ortho - k|0|||
144418974|NCT01829191|520740000|FG001|Overall Study|Subject was fit for ortho - k|1|||
144418975|NCT00553514|520740001|FG000|Overall Study|Protocol deviation|0|||
144418976|NCT00553514|520740002|FG001|Overall Study|Protocol deviation|0|||
144418977|NCT00553514|520740003|FG002|Overall Study|Protocol deviation|0|||
144418978|NCT00553514|520740004|FG003|Overall Study|Protocol deviation|1|||
144418979|NCT00553514|520740005|FG004|Overall Study|Protocol deviation|0|||
144418980|NCT00553514|520740001|FG000|Overall Study|Lack of ovarian response|4|||
144418981|NCT00553514|520740002|FG001|Overall Study|Lack of ovarian response|5|||
144418982|NCT00553514|520740003|FG002|Overall Study|Lack of ovarian response|5|||
144418983|NCT00553514|520740004|FG003|Overall Study|Lack of ovarian response|5|||
144418984|NCT00553514|520740005|FG004|Overall Study|Lack of ovarian response|6|||
144418985|NCT00553514|520740001|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
144601063|NCT02466971|521401722|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
144418986|NCT00553514|520740002|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
144418987|NCT00553514|520740003|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
144418988|NCT00553514|520740004|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
144418989|NCT00553514|520740005|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
144418990|NCT00553514|520740001|FG000|Overall Study|Risk of multiple pregnancy|0|||
144418991|NCT00553514|520740002|FG001|Overall Study|Risk of multiple pregnancy|2|||
144418992|NCT00553514|520740003|FG002|Overall Study|Risk of multiple pregnancy|0|||
144418993|NCT00553514|520740004|FG003|Overall Study|Risk of multiple pregnancy|1|||
144418994|NCT00553514|520740005|FG004|Overall Study|Risk of multiple pregnancy|0|||
144418995|NCT00553514|520740001|FG000|Overall Study|Other|1|||
144418996|NCT00553514|520740002|FG001|Overall Study|Other|1|||
144418997|NCT00553514|520740003|FG002|Overall Study|Other|0|||
144418998|NCT00553514|520740004|FG003|Overall Study|Other|0|||
144418999|NCT00553514|520740005|FG004|Overall Study|Other|1|||
144419000|NCT00726661|520740006|FG000|Overall Study|Lost to Follow-up|36|||
144419001|NCT00726661|520740007|FG001|Overall Study|Lost to Follow-up|11|||
144419002|NCT00726661|520740006|FG000|Overall Study|Withdrawal by Subject|17|||
144419003|NCT00726661|520740007|FG001|Overall Study|Withdrawal by Subject|13|||
144419004|NCT00726661|520740006|FG000|Overall Study|Trial terminated by sponsor|214|||
144419005|NCT00726661|520740007|FG001|Overall Study|Trial terminated by sponsor|187|||
144419006|NCT00726661|520740006|FG000|Overall Study|Death|475|||
144419007|NCT00726661|520740007|FG001|Overall Study|Death|159|||
144180416|NCT01513239|519855449|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
144419008|NCT00726661|520740006|FG000|Overall Study|Physician Decision|25|||
144419009|NCT00726661|520740007|FG001|Overall Study|Physician Decision|13|||
144419010|NCT00726661|520740006|FG000|Overall Study|Other|47|||
144419011|NCT00726661|520740007|FG001|Overall Study|Other|35|||
144419012|NCT01285310|520740010|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
144180417|NCT01513239|519855450|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
144180418|NCT01513239|519855451|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
144180419|NCT01513239|519855452|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
144180420|NCT01513239|519855453|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
144180421|NCT01513239|519855454|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
144180422|NCT01513239|519855449|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
144180423|NCT01513239|519855450|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
144180424|NCT01513239|519855451|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
144180425|NCT01513239|519855452|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
144180426|NCT01513239|519855453|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
144180427|NCT01513239|519855454|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
144180428|NCT01513239|519855449|FG000|Period 2: 9 Month Extension Phase|Death|0|||
144180429|NCT01513239|519855450|FG001|Period 2: 9 Month Extension Phase|Death|0|||
144180430|NCT01513239|519855451|FG002|Period 2: 9 Month Extension Phase|Death|0|||
144180431|NCT01513239|519855452|FG003|Period 2: 9 Month Extension Phase|Death|2|||
144180432|NCT01513239|519855453|FG004|Period 2: 9 Month Extension Phase|Death|5|||
144180433|NCT01513239|519855454|FG005|Period 2: 9 Month Extension Phase|Death|2|||
144180434|NCT01513239|519855449|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
144180435|NCT01513239|519855450|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
144180436|NCT01513239|519855451|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
144180437|NCT01513239|519855452|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
144180438|NCT01513239|519855453|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
144419013|NCT01285310|520740011|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
144419014|NCT01285310|520740012|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
144419015|NCT01285310|520740013|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
144419016|NCT01285310|520740014|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
144419017|NCT01285310|520740010|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
144419018|NCT01285310|520740011|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
144419019|NCT01285310|520740012|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
144419020|NCT01285310|520740013|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
144419021|NCT01285310|520740014|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
144419022|NCT01285310|520740010|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
144419023|NCT01285310|520740011|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
144419024|NCT01285310|520740012|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
144419025|NCT01285310|520740013|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
144419026|NCT01285310|520740014|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
144419027|NCT01285310|520740010|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
144419028|NCT01285310|520740011|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
144419029|NCT01285310|520740012|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
144419030|NCT01285310|520740013|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
144419031|NCT01285310|520740014|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
144419032|NCT01285310|520740010|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
144419033|NCT01285310|520740011|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
144419034|NCT01285310|520740012|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
144527511|NCT03085810|521133300|FG000|Main Study|Planned pregnancy|17|||
144723211|NCT01058421|521840660|FG000|1 Month Outcomes|Remained in Other Facility|16|||
144180439|NCT01513239|519855454|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
144180440|NCT01513239|519855449|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
144180441|NCT01513239|519855450|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
144180442|NCT01513239|519855451|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
144180443|NCT01513239|519855452|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
144251069|NCT00422292|520117461|FG002|Overall Study|Withdrawal by Subject|7|||
144251070|NCT00422292|520117462|FG003|Overall Study|Withdrawal by Subject|13|||
144419035|NCT01285310|520740013|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
144419036|NCT01285310|520740014|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
144251071|NCT02440854|520117463|FG000|Overall Study|Relocation of patient|1|||
144251072|NCT02440854|520117463|FG000|Overall Study|Death|6|||
144251073|NCT02440854|520117463|FG000|Overall Study|Lost to Follow-up|10|||
144251074|NCT02440854|520117463|FG000|Overall Study|Afatinib discontinuation|46|||
144251075|NCT02440854|520117463|FG000|Overall Study|stopped study at earlier timepoint|14|||
144251076|NCT02440854|520117463|FG000|Overall Study|Study medication not received|1|||
144251077|NCT02440854|520117463|FG000|Overall Study|Violation of inclusion criteria|2|||
144251078|NCT03338569|520117464|FG000|Overall Study|Physician Decision|8|||
144251079|NCT03338569|520117465|FG001|Overall Study|Physician Decision|3|||
144251080|NCT03338569|520117464|FG000|Overall Study|Withdrawal by Subject|0|||
144251081|NCT03338569|520117465|FG001|Overall Study|Withdrawal by Subject|1|||
144251082|NCT03338569|520117464|FG000|Overall Study|Lost to Follow-up|0|||
144251083|NCT03338569|520117465|FG001|Overall Study|Lost to Follow-up|1|||
144251084|NCT02669082|520117466|FG000|Overall Study|Adverse Event|1|||
144251085|NCT01854879|520117467|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
144251086|NCT01854879|520117467|FG000|Overall Study|screen fail|3|||
144251087|NCT01854879|520117467|FG000|Overall Study|incomplete data set|1|||
144251088|NCT04494425|520119233|FG000|Overall Study|Death|160|||
144251089|NCT04494425|520119234|FG001|Overall Study|Death|166|||
144251090|NCT04494425|520119233|FG000|Overall Study|Withdrawal by Subject|10|||
144251091|NCT04494425|520119234|FG001|Overall Study|Withdrawal by Subject|40|||
144180444|NCT01513239|519855453|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
144180445|NCT01513239|519855454|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
144180446|NCT01513239|519855449|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
144180447|NCT01513239|519855450|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
144180448|NCT01513239|519855451|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
144180449|NCT01513239|519855452|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
144180450|NCT01513239|519855453|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
144180451|NCT01513239|519855454|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
144180452|NCT00396162|519855455|FG000|Overall Study|Withdrawal by Subject|2|||
144180453|NCT00396162|519855456|FG001|Overall Study|Withdrawal by Subject|3|||
144180454|NCT03387462|519855459|FG000|Overall Study|Lost to Follow-up|1|||
144180455|NCT01460628|519855460|FG000|Overall Study|Adverse Event|3|||
144180456|NCT01460628|519855460|FG000|Overall Study|Withdrawal by Subject|2|||
144180457|NCT01664039|519855464|FG000|Overall Study|Adverse Event|3|||
144180458|NCT01664039|519855465|FG001|Overall Study|Adverse Event|4|||
144180459|NCT01664039|519855464|FG000|Overall Study|Lost to Follow-up|1|||
144180460|NCT01664039|519855465|FG001|Overall Study|Lost to Follow-up|1|||
144180461|NCT01664039|519855464|FG000|Overall Study|Withdrawal by Subject|1|||
144180462|NCT01664039|519855465|FG001|Overall Study|Withdrawal by Subject|3|||
144180463|NCT01664039|519855464|FG000|Overall Study|Noncompliance|1|||
144180464|NCT01664039|519855465|FG001|Overall Study|Noncompliance|1|||
144180465|NCT01944722|519855468|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
144180466|NCT01944722|519855468|FG000|Overall Study|Specimen Shipping Issues|34|||
144180467|NCT01944722|519855468|FG000|Overall Study|Improper Storage/Transport|5|||
144180468|NCT01944722|519855468|FG000|Overall Study|Insufficient Volume for Test|1|||
144180469|NCT01944722|519855468|FG000|Overall Study|Missing Specimens|3|||
144180470|NCT01944722|519855468|FG000|Overall Study|Specimens Mislabeled|2|||
144180471|NCT01944722|519855468|FG000|Overall Study|Withdrawal by Subject|8|||
144180472|NCT01944722|519855468|FG000|Overall Study|NILM Subjects <30 years old|8106|||
144180473|NCT01944722|519855468|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
144180474|NCT01944722|519855468|FG000|Overall Study|>ASCUS Cytology|1122|||
144180475|NCT02906917|519855472|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
144180476|NCT02906917|519855473|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
144180477|NCT02906917|519855472|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
144180478|NCT02906917|519855473|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
144180479|NCT02906917|519855472|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
144251092|NCT04494425|520119233|FG000|Overall Study|Other|1|||
144251093|NCT04494425|520119234|FG001|Overall Study|Other|1|||
144180480|NCT02906917|519855473|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
144180481|NCT02906917|519855472|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
144180482|NCT02906917|519855473|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
144180483|NCT02906917|519855472|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
144180484|NCT02906917|519855473|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
144251094|NCT04494425|520119233|FG000|Overall Study|Ongoing at the time of PCD|265|||
144251095|NCT04494425|520119234|FG001|Overall Study|Ongoing at the time of PCD|223|||
144419037|NCT01285310|520740010|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
144419038|NCT01285310|520740011|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
144419039|NCT01285310|520740012|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
144251096|NCT01270321|520119235|FG000|Overall Study|Death|3|||
144419040|NCT01285310|520740013|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
144180485|NCT02906917|519855472|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
144251097|NCT01270321|520119236|FG001|Overall Study|Death|1|||
144251098|NCT01270321|520119237|FG002|Overall Study|Death|4|||
144527512|NCT03085810|521133301|FG001|Main Study|Planned pregnancy|0|||
144419041|NCT01285310|520740014|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
144419042|NCT01285310|520740010|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
144419043|NCT01285310|520740011|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
144419044|NCT01285310|520740012|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
144419045|NCT01285310|520740013|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
144419046|NCT01285310|520740014|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
144419047|NCT01285310|520740010|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
144419048|NCT01285310|520740011|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
144419049|NCT01285310|520740012|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
144419050|NCT01285310|520740013|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
144419051|NCT01285310|520740014|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
144419052|NCT01285310|520740010|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
144419053|NCT01285310|520740011|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
144419054|NCT01285310|520740012|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
144419055|NCT01285310|520740013|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
144419056|NCT01285310|520740014|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
144419057|NCT01285310|520740010|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
144419058|NCT01285310|520740011|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
144419059|NCT01285310|520740012|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
144419060|NCT01285310|520740013|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
144180486|NCT02906917|519855473|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
144180487|NCT02906917|519855472|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
144180488|NCT02906917|519855473|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
144180489|NCT02906917|519855472|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
144180490|NCT02906917|519855473|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
144419061|NCT01285310|520740014|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
144180491|NCT05387408|519855474|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
144180492|NCT03358147|519855478|FG000|Overall Study|Withdrawal by Subject|13|||
144180493|NCT03358147|519855479|FG001|Overall Study|Withdrawal by Subject|19|||
144180494|NCT03358147|519855480|FG002|Overall Study|Withdrawal by Subject|16|||
144180495|NCT03358147|519855481|FG003|Overall Study|Withdrawal by Subject|10|||
144180496|NCT03358147|519855482|FG004|Overall Study|Withdrawal by Subject|5|||
144180497|NCT03358147|519855478|FG000|Overall Study|Adverse Event|3|||
144180498|NCT03358147|519855479|FG001|Overall Study|Adverse Event|9|||
144180499|NCT03358147|519855480|FG002|Overall Study|Adverse Event|7|||
144180500|NCT03358147|519855481|FG003|Overall Study|Adverse Event|5|||
144180501|NCT03358147|519855482|FG004|Overall Study|Adverse Event|2|||
144180502|NCT03358147|519855478|FG000|Overall Study|Lost to Follow-up|4|||
144180503|NCT03358147|519855479|FG001|Overall Study|Lost to Follow-up|3|||
144180504|NCT03358147|519855480|FG002|Overall Study|Lost to Follow-up|7|||
144180505|NCT03358147|519855481|FG003|Overall Study|Lost to Follow-up|6|||
144180506|NCT03358147|519855482|FG004|Overall Study|Lost to Follow-up|4|||
144180507|NCT03358147|519855478|FG000|Overall Study|Major Protocol Deviation|11|||
144180508|NCT03358147|519855479|FG001|Overall Study|Major Protocol Deviation|3|||
144180509|NCT03358147|519855480|FG002|Overall Study|Major Protocol Deviation|2|||
144180510|NCT03358147|519855481|FG003|Overall Study|Major Protocol Deviation|3|||
144180511|NCT03358147|519855482|FG004|Overall Study|Major Protocol Deviation|1|||
144180512|NCT03358147|519855478|FG000|Overall Study|Protocol specified criteria|2|||
144180513|NCT03358147|519855479|FG001|Overall Study|Protocol specified criteria|3|||
144180514|NCT03358147|519855480|FG002|Overall Study|Protocol specified criteria|0|||
144180515|NCT03358147|519855481|FG003|Overall Study|Protocol specified criteria|3|||
144180516|NCT03358147|519855482|FG004|Overall Study|Protocol specified criteria|1|||
144180517|NCT03358147|519855478|FG000|Overall Study|Physician Decision|1|||
144180518|NCT03358147|519855479|FG001|Overall Study|Physician Decision|0|||
144180519|NCT03358147|519855480|FG002|Overall Study|Physician Decision|1|||
144180520|NCT03358147|519855481|FG003|Overall Study|Physician Decision|6|||
144419062|NCT01285310|520740010|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
144180521|NCT03358147|519855482|FG004|Overall Study|Physician Decision|1|||
144180522|NCT03358147|519855478|FG000|Overall Study|Administrative reasons|0|||
144180523|NCT03358147|519855479|FG001|Overall Study|Administrative reasons|1|||
144180524|NCT03358147|519855480|FG002|Overall Study|Administrative reasons|0|||
144180525|NCT03358147|519855481|FG003|Overall Study|Administrative reasons|3|||
144180526|NCT03358147|519855482|FG004|Overall Study|Administrative reasons|0|||
144180527|NCT03358147|519855478|FG000|Overall Study|Lack of Efficacy|0|||
144180528|NCT03358147|519855479|FG001|Overall Study|Lack of Efficacy|1|||
144180529|NCT03358147|519855480|FG002|Overall Study|Lack of Efficacy|1|||
144180530|NCT03358147|519855481|FG003|Overall Study|Lack of Efficacy|0|||
144180531|NCT03358147|519855482|FG004|Overall Study|Lack of Efficacy|0|||
144180532|NCT02072096|519855483|FG000|Overall Study|Lack of Efficacy|18|||
144251099|NCT01270321|520119235|FG000|Overall Study|Adverse Event|7|||
144419063|NCT01285310|520740011|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
144419064|NCT01285310|520740012|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
144180533|NCT02072096|519855484|FG001|Overall Study|Lack of Efficacy|29|||
144180534|NCT02072096|519855483|FG000|Overall Study|Protocol Violation|7|||
144419065|NCT01285310|520740013|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
144419066|NCT01285310|520740014|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
144419067|NCT01285310|520740010|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
144419068|NCT01285310|520740011|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
144419069|NCT01285310|520740012|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
144419070|NCT01285310|520740013|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
144419071|NCT01285310|520740014|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
144419072|NCT04997161|520740019|FG000|Overall Study|Study terminated by sponsor|3|||
144419073|NCT01442675|520740020|FG000|Overall Study|Protocol Violation|6|||
144419074|NCT01442675|520740020|FG000|Overall Study|Lost to Follow-up|2|||
144419075|NCT01442675|520740020|FG000|Overall Study|Withdrawal by Subject|4|||
144419076|NCT00752232|520740021|FG000|Overall Study|Protocol Violation|0|||
144419077|NCT00752232|520740022|FG001|Overall Study|Protocol Violation|0|||
144419078|NCT00752232|520740023|FG002|Overall Study|Protocol Violation|0|||
144419079|NCT00752232|520740024|FG003|Overall Study|Protocol Violation|0|||
144419080|NCT00752232|520740025|FG004|Overall Study|Protocol Violation|0|||
144419081|NCT00752232|520740026|FG005|Overall Study|Protocol Violation|1|||
144419082|NCT00752232|520740027|FG006|Overall Study|Protocol Violation|0|||
144419083|NCT00752232|520740021|FG000|Overall Study|Caregiver request|2|||
144419084|NCT00752232|520740022|FG001|Overall Study|Caregiver request|0|||
144419085|NCT00752232|520740023|FG002|Overall Study|Caregiver request|0|||
144419086|NCT00752232|520740024|FG003|Overall Study|Caregiver request|0|||
144419087|NCT00752232|520740025|FG004|Overall Study|Caregiver request|1|||
144419088|NCT00752232|520740026|FG005|Overall Study|Caregiver request|0|||
144419089|NCT00752232|520740027|FG006|Overall Study|Caregiver request|0|||
144419090|NCT00752232|520740021|FG000|Overall Study|Investigator request|0|||
144419091|NCT00752232|520740022|FG001|Overall Study|Investigator request|0|||
144419092|NCT00752232|520740023|FG002|Overall Study|Investigator request|0|||
144419093|NCT00752232|520740024|FG003|Overall Study|Investigator request|0|||
144419094|NCT00752232|520740025|FG004|Overall Study|Investigator request|1|||
144419095|NCT00752232|520740026|FG005|Overall Study|Investigator request|0|||
144419096|NCT00752232|520740027|FG006|Overall Study|Investigator request|0|||
144419097|NCT00752232|520740021|FG000|Overall Study|Subject request|0|||
144419098|NCT00752232|520740022|FG001|Overall Study|Subject request|0|||
144419099|NCT00752232|520740023|FG002|Overall Study|Subject request|1|||
144419100|NCT00752232|520740024|FG003|Overall Study|Subject request|0|||
144419101|NCT00752232|520740025|FG004|Overall Study|Subject request|0|||
144419102|NCT00752232|520740026|FG005|Overall Study|Subject request|0|||
144419103|NCT00752232|520740027|FG006|Overall Study|Subject request|0|||
144419104|NCT00752232|520740021|FG000|Overall Study|Group home admission|0|||
144419105|NCT00752232|520740022|FG001|Overall Study|Group home admission|0|||
144419106|NCT00752232|520740023|FG002|Overall Study|Group home admission|0|||
144419107|NCT00752232|520740024|FG003|Overall Study|Group home admission|1|||
144419108|NCT00752232|520740025|FG004|Overall Study|Group home admission|0|||
144419109|NCT00752232|520740026|FG005|Overall Study|Group home admission|0|||
144419110|NCT00752232|520740027|FG006|Overall Study|Group home admission|0|||
144419111|NCT00752232|520740021|FG000|Overall Study|Caregiver could not attend the subject|0|||
144419112|NCT00752232|520740022|FG001|Overall Study|Caregiver could not attend the subject|0|||
144419113|NCT00752232|520740023|FG002|Overall Study|Caregiver could not attend the subject|0|||
144419114|NCT00752232|520740024|FG003|Overall Study|Caregiver could not attend the subject|0|||
144419115|NCT00752232|520740025|FG004|Overall Study|Caregiver could not attend the subject|1|||
144419116|NCT00752232|520740026|FG005|Overall Study|Caregiver could not attend the subject|0|||
144419117|NCT00752232|520740027|FG006|Overall Study|Caregiver could not attend the subject|0|||
144419118|NCT00555321|520740030|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
144419119|NCT00555321|520740031|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
144419120|NCT00555321|520740032|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
144419121|NCT00555321|520740033|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
144419122|NCT00555321|520740034|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
144419123|NCT00555321|520740030|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
144419124|NCT00555321|520740031|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
144180535|NCT02072096|519855484|FG001|Overall Study|Protocol Violation|7|||
144180536|NCT02072096|519855483|FG000|Overall Study|Withdrawal by Subject|5|||
144180537|NCT02072096|519855484|FG001|Overall Study|Withdrawal by Subject|7|||
144419125|NCT00555321|520740032|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
144419126|NCT00555321|520740033|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
144419127|NCT00555321|520740034|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
144419128|NCT00555321|520740030|FG000|Treatment Phase up to 12-months|Death|2|||
144180538|NCT02072096|519855483|FG000|Overall Study|Adverse Event|5|||
144180539|NCT02072096|519855484|FG001|Overall Study|Adverse Event|2|||
144723212|NCT01058421|521840661|FG001|1 Month Outcomes|Remained in Other Facility|17|||
144180540|NCT02072096|519855483|FG000|Overall Study|No Reason Provided|4|||
144180541|NCT02072096|519855484|FG001|Overall Study|No Reason Provided|2|||
144419129|NCT00555321|520740031|FG001|Treatment Phase up to 12-months|Death|1|||
144419130|NCT00555321|520740032|FG002|Treatment Phase up to 12-months|Death|4|||
144419131|NCT00555321|520740033|FG003|Treatment Phase up to 12-months|Death|0|||
144419132|NCT00555321|520740034|FG004|Treatment Phase up to 12-months|Death|0|||
144419133|NCT00555321|520740030|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
144419134|NCT00555321|520740031|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
144419135|NCT00555321|520740032|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
144419136|NCT00555321|520740033|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
144419137|NCT00555321|520740034|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
144419138|NCT00555321|520740030|FG000|Treatment Phase up to 12-months|Other Reason|1|||
144419139|NCT00555321|520740031|FG001|Treatment Phase up to 12-months|Other Reason|3|||
144419140|NCT00555321|520740032|FG002|Treatment Phase up to 12-months|Other Reason|2|||
144419141|NCT00555321|520740033|FG003|Treatment Phase up to 12-months|Other Reason|0|||
144419142|NCT00555321|520740034|FG004|Treatment Phase up to 12-months|Other Reason|0|||
144419143|NCT00555321|520740030|FG000|Treatment Phase up to 12-months|Never treated|2|||
144419144|NCT00555321|520740031|FG001|Treatment Phase up to 12-months|Never treated|3|||
144419145|NCT00555321|520740032|FG002|Treatment Phase up to 12-months|Never treated|1|||
144419146|NCT00555321|520740033|FG003|Treatment Phase up to 12-months|Never treated|0|||
144419147|NCT00555321|520740034|FG004|Treatment Phase up to 12-months|Never treated|4|||
144419148|NCT00555321|520740030|FG000|Long-term Extension Phase|Adverse Event|2|||
144419149|NCT00555321|520740031|FG001|Long-term Extension Phase|Adverse Event|5|||
144419150|NCT00555321|520740032|FG002|Long-term Extension Phase|Adverse Event|2|||
144419151|NCT00555321|520740033|FG003|Long-term Extension Phase|Adverse Event|1|||
144419152|NCT00555321|520740034|FG004|Long-term Extension Phase|Adverse Event|0|||
144419153|NCT00555321|520740030|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
144419154|NCT00555321|520740031|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
144419155|NCT00555321|520740032|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
144419156|NCT00555321|520740033|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
144419157|NCT00555321|520740034|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
144419158|NCT00555321|520740030|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
144419159|NCT00555321|520740031|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
144419160|NCT00555321|520740032|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
144419161|NCT00555321|520740033|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
144419162|NCT00555321|520740034|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
144419163|NCT00555321|520740030|FG000|Long-term Extension Phase|Death|2|||
144419164|NCT00555321|520740031|FG001|Long-term Extension Phase|Death|0|||
144419165|NCT00555321|520740032|FG002|Long-term Extension Phase|Death|0|||
144419166|NCT00555321|520740033|FG003|Long-term Extension Phase|Death|3|||
144419167|NCT00555321|520740034|FG004|Long-term Extension Phase|Death|0|||
144419168|NCT00555321|520740030|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
144419169|NCT00555321|520740031|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
144419170|NCT00555321|520740032|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
144419171|NCT00555321|520740033|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
144419172|NCT00555321|520740034|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
144419173|NCT00555321|520740030|FG000|Long-term Extension Phase|Other Reason|1|||
144419174|NCT00555321|520740031|FG001|Long-term Extension Phase|Other Reason|0|||
144180542|NCT02072096|519855483|FG000|Overall Study|Death|2|||
144180543|NCT02072096|519855484|FG001|Overall Study|Death|0|||
144180544|NCT02072096|519855483|FG000|Overall Study|Physician Decision|0|||
144180545|NCT02072096|519855484|FG001|Overall Study|Physician Decision|1|||
144180546|NCT02072096|519855483|FG000|Overall Study|Study Terminated by Sponsor|43|||
144180547|NCT02072096|519855484|FG001|Overall Study|Study Terminated by Sponsor|30|||
144180548|NCT02072096|519855483|FG000|Overall Study|Lost to Follow-up|1|||
144180549|NCT02072096|519855484|FG001|Overall Study|Lost to Follow-up|0|||
144180550|NCT01168856|519855487|FG000|Overall Study|Lost to Follow-up|4|||
144180551|NCT01168856|519855488|FG001|Overall Study|Lost to Follow-up|34|||
144180552|NCT01168856|519855487|FG000|Overall Study|Withdrawal by Subject|6|||
144180553|NCT01168856|519855488|FG001|Overall Study|Withdrawal by Subject|8|||
144180554|NCT01168856|519855487|FG000|Overall Study|Physician Decision|2|||
144180555|NCT01168856|519855488|FG001|Overall Study|Physician Decision|1|||
144180556|NCT01168856|519855487|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
144419175|NCT00555321|520740032|FG002|Long-term Extension Phase|Other Reason|2|||
144419176|NCT00555321|520740033|FG003|Long-term Extension Phase|Other Reason|0|||
144419177|NCT00555321|520740034|FG004|Long-term Extension Phase|Other Reason|0|||
144419178|NCT00005937|520740035|FG000|Overall Study|Lack of Efficacy|5|||
144419179|NCT01288469|520740036|FG000|Overall Study|Adverse Event|4|||
144419180|NCT01288469|520740037|FG001|Overall Study|Adverse Event|1|||
144419181|NCT01288469|520740038|FG002|Overall Study|Adverse Event|1|||
144419182|NCT01288469|520740036|FG000|Overall Study|Poor compliance to protocol|0|||
144180557|NCT01168856|519855488|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
144180558|NCT01168856|519855487|FG000|Overall Study|Participant received anti-HCV treatment|1|||
144251100|NCT01270321|520119236|FG001|Overall Study|Adverse Event|9|||
144419183|NCT01288469|520740037|FG001|Overall Study|Poor compliance to protocol|1|||
144419184|NCT01288469|520740038|FG002|Overall Study|Poor compliance to protocol|0|||
144419185|NCT01288469|520740036|FG000|Overall Study|Participant Moved|1|||
144419186|NCT01288469|520740037|FG001|Overall Study|Participant Moved|0|||
144419187|NCT01288469|520740038|FG002|Overall Study|Participant Moved|0|||
144419188|NCT01288469|520740036|FG000|Overall Study|Consent withdrawn by subject|1|||
144419189|NCT01288469|520740037|FG001|Overall Study|Consent withdrawn by subject|1|||
144419190|NCT01288469|520740038|FG002|Overall Study|Consent withdrawn by subject|1|||
144419191|NCT01288469|520740036|FG000|Overall Study|Exclusion criteria finally met|1|||
144419192|NCT01288469|520740037|FG001|Overall Study|Exclusion criteria finally met|0|||
144419193|NCT01288469|520740038|FG002|Overall Study|Exclusion criteria finally met|0|||
144419194|NCT01957644|520740042|FG000|Overall Study|Adverse Event|4|||
144419195|NCT01957644|520740043|FG001|Overall Study|Adverse Event|2|||
144419196|NCT01957644|520740044|FG002|Overall Study|Adverse Event|0|||
144419197|NCT01957644|520740045|FG003|Overall Study|Adverse Event|0|||
144419198|NCT01957644|520740046|FG004|Overall Study|Adverse Event|1|||
144419199|NCT01957644|520740042|FG000|Overall Study|Progressive disease / relapse|0|||
144419200|NCT01957644|520740043|FG001|Overall Study|Progressive disease / relapse|1|||
144419201|NCT01957644|520740044|FG002|Overall Study|Progressive disease / relapse|0|||
144419202|NCT01957644|520740045|FG003|Overall Study|Progressive disease / relapse|1|||
144419203|NCT01957644|520740046|FG004|Overall Study|Progressive disease / relapse|0|||
144419204|NCT01957644|520740042|FG000|Overall Study|Other reason|1|||
144419205|NCT01957644|520740043|FG001|Overall Study|Other reason|2|||
144419206|NCT01957644|520740044|FG002|Overall Study|Other reason|1|||
144419207|NCT01957644|520740045|FG003|Overall Study|Other reason|1|||
144419208|NCT01957644|520740046|FG004|Overall Study|Other reason|0|||
144419209|NCT01957644|520740042|FG000|Overall Study|Withdrawal by Subject|1|||
144419210|NCT01957644|520740043|FG001|Overall Study|Withdrawal by Subject|0|||
144419211|NCT01957644|520740044|FG002|Overall Study|Withdrawal by Subject|0|||
144419212|NCT01957644|520740045|FG003|Overall Study|Withdrawal by Subject|0|||
144419213|NCT01957644|520740046|FG004|Overall Study|Withdrawal by Subject|0|||
144419214|NCT01957644|520740042|FG000|Overall Study|Protocol Violation|0|||
144419215|NCT01957644|520740043|FG001|Overall Study|Protocol Violation|1|||
144419216|NCT01957644|520740044|FG002|Overall Study|Protocol Violation|0|||
144419217|NCT01957644|520740045|FG003|Overall Study|Protocol Violation|0|||
144419218|NCT01957644|520740046|FG004|Overall Study|Protocol Violation|0|||
144419219|NCT03049280|520740050|FG000|Overall Study|Physician Decision|1|||
144419220|NCT00001723|520740053|FG000|Overall Study|Lack of Efficacy|6|||
144419221|NCT00001723|520740054|FG001|Overall Study|Lack of Efficacy|7|||
144419222|NCT00001723|520740053|FG000|Overall Study|Lack of family interest|4|||
144419223|NCT00001723|520740054|FG001|Overall Study|Lack of family interest|5|||
144419224|NCT00001723|520740053|FG000|Overall Study|Lost to Follow-up|2|||
144419225|NCT00001723|520740054|FG001|Overall Study|Lost to Follow-up|2|||
144419226|NCT00001723|520740053|FG000|Overall Study|medication intolerance|1|||
144419227|NCT00001723|520740054|FG001|Overall Study|medication intolerance|2|||
144419228|NCT02643082|520740055|FG000|Period 1|Adverse Event|1|||
144419229|NCT02643082|520740056|FG001|Period 1|Adverse Event|0|||
144419230|NCT01867021|520740057|FG000|Overall Study|Adverse Event|0|||
144419231|NCT01867021|520740058|FG001|Overall Study|Adverse Event|1|||
144419232|NCT01867021|520740057|FG000|Overall Study|Not Eligible|0|||
144419233|NCT01867021|520740058|FG001|Overall Study|Not Eligible|1|||
144419234|NCT01867021|520740057|FG000|Overall Study|Death|1|||
144419235|NCT01867021|520740058|FG001|Overall Study|Death|0|||
144419236|NCT01867021|520740057|FG000|Overall Study|Lost to Follow-up|0|||
144419237|NCT01867021|520740058|FG001|Overall Study|Lost to Follow-up|2|||
144419238|NCT01867021|520740057|FG000|Overall Study|Withdrawal by Subject|1|||
144419239|NCT01867021|520740058|FG001|Overall Study|Withdrawal by Subject|6|||
144419240|NCT00881712|520740059|FG000|Overall Study|Death|1|||
144419241|NCT00881712|520740060|FG001|Overall Study|Death|0|||
144419242|NCT00881712|520740061|FG002|Overall Study|Death|0|||
144419243|NCT00881712|520740059|FG000|Overall Study|Withdrawal by Subject|1|||
144419244|NCT00881712|520740060|FG001|Overall Study|Withdrawal by Subject|0|||
144419245|NCT00881712|520740061|FG002|Overall Study|Withdrawal by Subject|0|||
144419246|NCT01324999|520740062|FG000|Overall Study|Adverse Event|3|||
144419247|NCT01324999|520740062|FG000|Overall Study|Withdrawal by Subject|2|||
144419248|NCT02505867|520740064|FG000|Overall Study|Lack of Efficacy|6|||
144419249|NCT02505867|520740065|FG001|Overall Study|Lack of Efficacy|6|||
144419250|NCT03681405|520740066|FG000|Overall Study|Found to be ineligible after randomized|1|||
144419251|NCT03681405|520740067|FG001|Overall Study|Found to be ineligible after randomized|0|||
144419252|NCT02860169|520740072|FG000|Part A|Withdrawal by Subject|1|||
144419253|NCT02860169|520740072|FG000|Part A|Other (Screening failure)|6|||
144419254|NCT02860169|520740072|FG000|Part A|Other (Survey not completed)|3|||
144419255|NCT02860169|520740072|FG000|Part A|Other (did not completed consent)|1|||
144419256|NCT02860169|520740072|FG000|Part B|Other (Screening failure)|10|||
144419257|NCT02860169|520740072|FG000|Part B|Withdrawal by Subject|1|||
144419258|NCT02860169|520740072|FG000|Part C|Other (Screening failure)|1|||
144419259|NCT03789318|520740073|FG000|Overall Study|Adverse Event|0|||
144419260|NCT03789318|520740074|FG001|Overall Study|Adverse Event|0|||
144419261|NCT03789318|520740075|FG002|Overall Study|Adverse Event|1|||
144419262|NCT03789318|520740076|FG003|Overall Study|Adverse Event|1|||
144419263|NCT03789318|520740077|FG004|Overall Study|Adverse Event|0|||
144419264|NCT03789318|520740073|FG000|Overall Study|Lost to Follow-up|0|||
144419265|NCT03789318|520740074|FG001|Overall Study|Lost to Follow-up|0|||
144419266|NCT03789318|520740075|FG002|Overall Study|Lost to Follow-up|1|||
144419267|NCT03789318|520740076|FG003|Overall Study|Lost to Follow-up|0|||
144419268|NCT03789318|520740077|FG004|Overall Study|Lost to Follow-up|0|||
144419269|NCT03789318|520740073|FG000|Overall Study|Withdrawal by Subject|0|||
144419270|NCT03789318|520740074|FG001|Overall Study|Withdrawal by Subject|0|||
144419271|NCT03789318|520740075|FG002|Overall Study|Withdrawal by Subject|1|||
144419272|NCT03789318|520740076|FG003|Overall Study|Withdrawal by Subject|0|||
144419273|NCT03789318|520740077|FG004|Overall Study|Withdrawal by Subject|0|||
144471971|NCT03217747|520925357|FG004|Overall Study|Withdrawal by Subject|1|||
144471972|NCT03217747|520925358|FG005|Overall Study|Withdrawal by Subject|2|||
144471973|NCT03217747|520925359|FG006|Overall Study|Withdrawal by Subject|1|||
144471974|NCT03217747|520925360|FG007|Overall Study|Withdrawal by Subject|0|||
144471975|NCT03217747|520925361|FG008|Overall Study|Withdrawal by Subject|0|||
144471976|NCT03217747|520925362|FG009|Overall Study|Withdrawal by Subject|0|||
144471977|NCT03217747|520925363|FG010|Overall Study|Withdrawal by Subject|0|||
144471978|NCT03217747|520925364|FG011|Overall Study|Withdrawal by Subject|1|||
144471979|NCT03217747|520925365|FG012|Overall Study|Withdrawal by Subject|0|||
144471980|NCT03217747|520925366|FG013|Overall Study|Withdrawal by Subject|1|||
144471981|NCT03217747|520925353|FG000|Overall Study|Toxicity and progression|1|||
144471982|NCT03217747|520925354|FG001|Overall Study|Toxicity and progression|0|||
144471983|NCT03217747|520925355|FG002|Overall Study|Toxicity and progression|0|||
144471984|NCT03217747|520925356|FG003|Overall Study|Toxicity and progression|0|||
144471985|NCT03217747|520925357|FG004|Overall Study|Toxicity and progression|0|||
144471986|NCT03217747|520925358|FG005|Overall Study|Toxicity and progression|0|||
144471987|NCT03217747|520925359|FG006|Overall Study|Toxicity and progression|0|||
144471988|NCT03217747|520925360|FG007|Overall Study|Toxicity and progression|0|||
144471989|NCT03217747|520925361|FG008|Overall Study|Toxicity and progression|0|||
144471990|NCT03217747|520925362|FG009|Overall Study|Toxicity and progression|0|||
144471991|NCT03217747|520925363|FG010|Overall Study|Toxicity and progression|0|||
144471992|NCT03217747|520925364|FG011|Overall Study|Toxicity and progression|0|||
144471993|NCT03217747|520925365|FG012|Overall Study|Toxicity and progression|0|||
144471994|NCT03217747|520925366|FG013|Overall Study|Toxicity and progression|0|||
144471995|NCT03217747|520925353|FG000|Overall Study|Removal of sole target lesion|1|||
144471996|NCT03217747|520925354|FG001|Overall Study|Removal of sole target lesion|0|||
144471997|NCT03217747|520925355|FG002|Overall Study|Removal of sole target lesion|0|||
144471998|NCT03217747|520925356|FG003|Overall Study|Removal of sole target lesion|0|||
144471999|NCT03217747|520925357|FG004|Overall Study|Removal of sole target lesion|0|||
144472000|NCT03217747|520925358|FG005|Overall Study|Removal of sole target lesion|0|||
144472001|NCT03217747|520925359|FG006|Overall Study|Removal of sole target lesion|0|||
144472002|NCT03217747|520925360|FG007|Overall Study|Removal of sole target lesion|0|||
144472003|NCT03217747|520925361|FG008|Overall Study|Removal of sole target lesion|0|||
144472004|NCT03217747|520925362|FG009|Overall Study|Removal of sole target lesion|0|||
144472005|NCT03217747|520925363|FG010|Overall Study|Removal of sole target lesion|0|||
144472006|NCT03217747|520925364|FG011|Overall Study|Removal of sole target lesion|0|||
144472007|NCT03217747|520925365|FG012|Overall Study|Removal of sole target lesion|0|||
144472008|NCT03217747|520925366|FG013|Overall Study|Removal of sole target lesion|0|||
144472009|NCT03217747|520925353|FG000|Overall Study|Stroke|0|||
144472010|NCT03217747|520925354|FG001|Overall Study|Stroke|0|||
144472011|NCT03217747|520925355|FG002|Overall Study|Stroke|0|||
144472012|NCT03217747|520925356|FG003|Overall Study|Stroke|0|||
144472013|NCT03217747|520925357|FG004|Overall Study|Stroke|0|||
144472014|NCT03217747|520925358|FG005|Overall Study|Stroke|1|||
144472015|NCT03217747|520925359|FG006|Overall Study|Stroke|0|||
144472016|NCT03217747|520925360|FG007|Overall Study|Stroke|0|||
144472017|NCT03217747|520925361|FG008|Overall Study|Stroke|0|||
144472018|NCT03217747|520925362|FG009|Overall Study|Stroke|0|||
144472019|NCT03217747|520925363|FG010|Overall Study|Stroke|0|||
144472020|NCT03217747|520925364|FG011|Overall Study|Stroke|1|||
144472021|NCT03217747|520925365|FG012|Overall Study|Stroke|0|||
144723213|NCT01058421|521840660|FG000|3 Month Outcomes|Death|3|||
144723214|NCT01058421|521840661|FG001|3 Month Outcomes|Death|5|||
144472022|NCT03217747|520925366|FG013|Overall Study|Stroke|0|||
144472023|NCT03996291|520925367|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
144472024|NCT03996291|520925368|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
144472025|NCT03996291|520925369|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
144472026|NCT03996291|520925370|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
144472027|NCT03996291|520925371|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
144472028|NCT03996291|520925372|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
144472029|NCT03996291|520925373|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
144472030|NCT03996291|520925374|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
144472031|NCT03996291|520925367|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
144472032|NCT03996291|520925368|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
144419274|NCT02329730|520742220|FG000|Overall Study|Protocol Violation|0|||
144419275|NCT02329730|520742221|FG001|Overall Study|Protocol Violation|0|||
144419276|NCT02329730|520742222|FG002|Overall Study|Protocol Violation|0|||
144419277|NCT02329730|520742223|FG003|Overall Study|Protocol Violation|0|||
144419278|NCT02329730|520742224|FG004|Overall Study|Protocol Violation|2|||
144419279|NCT02329730|520742225|FG005|Overall Study|Protocol Violation|2|||
144419280|NCT02329730|520742226|FG006|Overall Study|Protocol Violation|0|||
144419281|NCT02329730|520742227|FG007|Overall Study|Protocol Violation|0|||
144419282|NCT02329730|520742228|FG008|Overall Study|Protocol Violation|0|||
144419283|NCT02329730|520742229|FG009|Overall Study|Protocol Violation|0|||
144419284|NCT02329730|520742230|FG010|Overall Study|Protocol Violation|0|||
144419285|NCT02329730|520742231|FG011|Overall Study|Protocol Violation|0|||
144419286|NCT02329730|520742220|FG000|Overall Study|Withdrawal by Subject|0|||
144419287|NCT02329730|520742221|FG001|Overall Study|Withdrawal by Subject|0|||
144419288|NCT02329730|520742222|FG002|Overall Study|Withdrawal by Subject|0|||
144419289|NCT02329730|520742223|FG003|Overall Study|Withdrawal by Subject|0|||
144419290|NCT02329730|520742224|FG004|Overall Study|Withdrawal by Subject|1|||
144419291|NCT02329730|520742225|FG005|Overall Study|Withdrawal by Subject|0|||
144419292|NCT02329730|520742226|FG006|Overall Study|Withdrawal by Subject|1|||
144419293|NCT02329730|520742227|FG007|Overall Study|Withdrawal by Subject|1|||
144419294|NCT02329730|520742228|FG008|Overall Study|Withdrawal by Subject|1|||
144419295|NCT02329730|520742229|FG009|Overall Study|Withdrawal by Subject|1|||
144419296|NCT02329730|520742230|FG010|Overall Study|Withdrawal by Subject|0|||
144419297|NCT02329730|520742231|FG011|Overall Study|Withdrawal by Subject|0|||
144419298|NCT02345850|520742234|FG000|Overall Study|Not transplanted|10|||
144419299|NCT02345850|520742235|FG001|Overall Study|Not transplanted|5|||
144419300|NCT02345850|520742236|FG002|Overall Study|Not transplanted|4|||
144419301|NCT02345850|520742234|FG000|Overall Study|Lost to Follow-up|2|||
144419302|NCT02345850|520742235|FG001|Overall Study|Lost to Follow-up|3|||
144419303|NCT02345850|520742236|FG002|Overall Study|Lost to Follow-up|2|||
144419304|NCT02345850|520742234|FG000|Overall Study|Withdrawal by Subject|1|||
144419305|NCT02345850|520742235|FG001|Overall Study|Withdrawal by Subject|0|||
144180559|NCT01168856|519855488|FG001|Overall Study|Participant received anti-HCV treatment|0|||
144180560|NCT01168856|519855487|FG000|Overall Study|Death|0|||
144180561|NCT01168856|519855488|FG001|Overall Study|Death|2|||
144180562|NCT01168856|519855487|FG000|Overall Study|Other|1|||
144180563|NCT01168856|519855488|FG001|Overall Study|Other|291|||
144180564|NCT01168856|519855487|FG000|Overall Study|Protocol Violation|4|||
144180565|NCT01168856|519855488|FG001|Overall Study|Protocol Violation|6|||
144180566|NCT04442503|519855489|FG000|Overall Study|Adverse Event|1|||
144180567|NCT04442503|519855490|FG001|Overall Study|Adverse Event|1|||
144180568|NCT04442503|519855489|FG000|Overall Study|Lost to Follow-up|8|||
144180569|NCT04442503|519855490|FG001|Overall Study|Lost to Follow-up|6|||
144180570|NCT04442503|519855489|FG000|Overall Study|Physician Decision|0|||
144180571|NCT04442503|519855490|FG001|Overall Study|Physician Decision|2|||
144180572|NCT04442503|519855489|FG000|Overall Study|Withdrawal by Subject|3|||
144180573|NCT04442503|519855490|FG001|Overall Study|Withdrawal by Subject|4|||
144180574|NCT04442503|519855489|FG000|Overall Study|Reason not Specified|0|||
144180575|NCT04442503|519855490|FG001|Overall Study|Reason not Specified|1|||
144180576|NCT04442503|519855489|FG000|Overall Study|Randomized but not Treated|3|||
144419306|NCT02345850|520742236|FG002|Overall Study|Withdrawal by Subject|0|||
144419307|NCT02392247|520742237|FG000|Overall Study|Withdrawal by Subject|1|||
144527513|NCT03085810|521133302|FG002|Main Study|Planned pregnancy|0|||
144527514|NCT03085810|521133300|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
144527515|NCT03085810|521133301|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
144527516|NCT03085810|521133302|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
144527517|NCT03085810|521133300|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
144527518|NCT03085810|521133301|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
144527519|NCT03085810|521133302|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
144527520|NCT03085810|521133300|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
144527521|NCT03085810|521133301|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
144527522|NCT03085810|521133302|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
144527523|NCT03085810|521133300|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
144527524|NCT03085810|521133301|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
144527525|NCT03085810|521133302|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
144527526|NCT02606422|521133305|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
144527527|NCT02606422|521133306|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
144527528|NCT02606422|521133305|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
144527529|NCT02606422|521133306|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
144527530|NCT02606422|521133305|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
144180577|NCT04442503|519855490|FG001|Overall Study|Randomized but not Treated|1|||
144419308|NCT02392247|520742237|FG000|Overall Study|Surgery cancelled; no data|1|||
144419309|NCT01991067|520742239|FG000|Overall Study|Lost to Follow-up|6|||
144419310|NCT01991067|520742240|FG001|Overall Study|Lost to Follow-up|5|||
144601064|NCT02466971|521401721|FG000|Overall Study|ineligible and treated|1|||
144601065|NCT02466971|521401722|FG001|Overall Study|ineligible and treated|0|||
144601066|NCT02466971|521401721|FG000|Overall Study|ineligible and never treated|0|||
144601067|NCT02466971|521401722|FG001|Overall Study|ineligible and never treated|1|||
144601068|NCT04029480|521401723|FG000|Overall Study|Physician Decision|0|||
144601069|NCT04029480|521401724|FG001|Overall Study|Physician Decision|0|||
144601070|NCT04029480|521401725|FG002|Overall Study|Physician Decision|2|||
144601071|NCT04029480|521401726|FG003|Overall Study|Physician Decision|1|||
144601072|NCT04029480|521401723|FG000|Overall Study|Withdrawal by Subject|2|||
144601073|NCT04029480|521401724|FG001|Overall Study|Withdrawal by Subject|0|||
144601074|NCT04029480|521401725|FG002|Overall Study|Withdrawal by Subject|1|||
144419311|NCT02068443|520742243|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144419312|NCT02068443|520742244|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
144419313|NCT02068443|520742245|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
144419314|NCT02068443|520742243|FG000|Overall Study|Voluntary Withdrawal|4|||
144419315|NCT02068443|520742244|FG001|Overall Study|Voluntary Withdrawal|0|||
144419316|NCT02068443|520742245|FG002|Overall Study|Voluntary Withdrawal|1|||
144419317|NCT02068443|520742243|FG000|Overall Study|Lack of Efficacy|2|||
144419318|NCT02068443|520742244|FG001|Overall Study|Lack of Efficacy|1|||
144419319|NCT02068443|520742245|FG002|Overall Study|Lack of Efficacy|0|||
144419320|NCT02068443|520742243|FG000|Overall Study|Other Reason Not Specified|1|||
144419321|NCT02068443|520742244|FG001|Overall Study|Other Reason Not Specified|0|||
144419322|NCT02068443|520742245|FG002|Overall Study|Other Reason Not Specified|0|||
144419323|NCT00664742|520742246|FG000|Overall Study|Withdrawn due to adverse events|3|||
144419324|NCT00664742|520742246|FG000|Overall Study|Withdrawal by Subject|31|||
144419325|NCT00664742|520742246|FG000|Overall Study|Lost to Follow-up|92|||
144419326|NCT04317066|520742247|FG000|Overall Study|Sponsor decision|5|||
144419327|NCT04317066|520742247|FG000|Overall Study|Death|2|||
144419328|NCT02014597|520742250|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
144419329|NCT02014597|520742251|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
144419330|NCT02825992|520742252|FG000|Overall Study|Withdrawal by Subject|4|||
144419331|NCT02825992|520742252|FG000|Overall Study|Lost to Follow-up|2|||
144419332|NCT02825992|520742252|FG000|Overall Study|Procedure terminated|2|||
144419333|NCT02618434|520742253|FG000|Overall Study|Withdrawal by Subject|0|||
144419334|NCT02618434|520742254|FG001|Overall Study|Withdrawal by Subject|2|||
144419335|NCT02618434|520742255|FG002|Overall Study|Withdrawal by Subject|3|||
144419336|NCT02618434|520742253|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
144419337|NCT02618434|520742254|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
144419338|NCT02618434|520742255|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
144419339|NCT02618434|520742253|FG000|Overall Study|Lost to Follow-up|3|||
144419340|NCT02618434|520742254|FG001|Overall Study|Lost to Follow-up|1|||
144419341|NCT02618434|520742255|FG002|Overall Study|Lost to Follow-up|3|||
144419342|NCT02618434|520742253|FG000|Overall Study|Adverse Event|1|||
144419343|NCT02618434|520742254|FG001|Overall Study|Adverse Event|0|||
144419344|NCT02618434|520742255|FG002|Overall Study|Adverse Event|12|||
144419345|NCT02618434|520742253|FG000|Overall Study|Physician Decision|0|||
144419346|NCT02618434|520742254|FG001|Overall Study|Physician Decision|1|||
144419347|NCT02618434|520742255|FG002|Overall Study|Physician Decision|0|||
144419348|NCT02618434|520742253|FG000|Overall Study|Protocol Violation|0|||
144419349|NCT02618434|520742254|FG001|Overall Study|Protocol Violation|0|||
144419350|NCT02618434|520742255|FG002|Overall Study|Protocol Violation|1|||
144419351|NCT02618434|520742253|FG000|Overall Study|Other, Multiple categories|1|||
144419352|NCT02618434|520742254|FG001|Overall Study|Other, Multiple categories|1|||
144419353|NCT02618434|520742255|FG002|Overall Study|Other, Multiple categories|1|||
144419354|NCT02066233|520742256|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
144419355|NCT02066233|520742257|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
144419356|NCT00103142|520742258|FG000|Overall Study|Adverse Event|1|||
144419357|NCT00103142|520742259|FG001|Overall Study|Adverse Event|0|||
144419358|NCT00103142|520742258|FG000|Overall Study|Progression of disease|2|||
144419359|NCT00103142|520742259|FG001|Overall Study|Progression of disease|1|||
144419360|NCT02772081|520742260|FG000|Overall Study|Physician Decision|1|||
144419361|NCT02772081|520742261|FG001|Overall Study|Physician Decision|1|||
144419362|NCT02772081|520742260|FG000|Overall Study|Death|1|||
144419363|NCT02772081|520742261|FG001|Overall Study|Death|1|||
144419364|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Death|3|||
144419365|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Death|3|||
144601075|NCT04029480|521401726|FG003|Overall Study|Withdrawal by Subject|1|||
144419366|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Death|0|||
144419367|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Death|0|||
144419368|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
144419369|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
144419370|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
144419371|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
144419372|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
144601076|NCT04786119|521401727|FG000|Overall Study|Withdrawal by Subject|4|||
144601077|NCT04786119|521401728|FG001|Overall Study|Withdrawal by Subject|5|||
144419373|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
144419374|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
144419375|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
144419376|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
144419377|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
144419378|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
144419379|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
144419380|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
144419381|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
144419382|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
144419383|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
144419384|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
144419385|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
144419386|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
144419387|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
144419388|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
144419389|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
144419390|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
144419391|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
144419392|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Other|6|||
144419393|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Other|3|||
144419394|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Other|0|||
144419395|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Other|0|||
144419396|NCT02051608|520742268|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
144419397|NCT02051608|520742269|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
144419398|NCT02051608|520742270|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
144419399|NCT02051608|520742271|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
144419400|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Adverse Event|0|||
144419401|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Adverse Event|0|||
144419402|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Adverse Event|6|||
144419403|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Adverse Event|8|||
144419404|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Death|0|||
144419405|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Death|0|||
144419406|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Death|7|||
144419407|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Death|4|||
144419408|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
144419409|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
144419410|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
144419411|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
144419412|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
144419413|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
144419414|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
144419415|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
144419416|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
144419417|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
144419418|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
144419419|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
144419420|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
144419421|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
144419422|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
144419423|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
144419424|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Physician Decision|0|||
144419425|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Physician Decision|0|||
144419426|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Physician Decision|8|||
144419427|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Physician Decision|5|||
144419428|NCT02051608|520742268|FG000|Part 2: Open-label Extension|Other|0|||
144419429|NCT02051608|520742269|FG001|Part 2: Open-label Extension|Other|0|||
144419430|NCT02051608|520742270|FG002|Part 2: Open-label Extension|Other|9|||
144180578|NCT00387153|519855491|FG000|Overall Study|Adverse Event|1|||
144601078|NCT04786119|521401727|FG000|Overall Study|Lost to Follow-up|5|||
144601079|NCT04786119|521401728|FG001|Overall Study|Lost to Follow-up|5|||
144180579|NCT00387153|519855491|FG000|Overall Study|Disease Progression|3|||
144601080|NCT04786119|521401727|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
144601081|NCT04786119|521401728|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
144180580|NCT00387153|519855491|FG000|Overall Study|Lack of Response|4|||
144601082|NCT06268288|521401729|FG000|Overall Study|Withdrawal by Subject|1|||
144180581|NCT00474058|519855492|FG000|Overall Study|Adverse Event|11|||
144180582|NCT00474058|519855493|FG001|Overall Study|Adverse Event|6|||
144180583|NCT00474058|519855492|FG000|Overall Study|Lack of Efficacy|0|||
144180584|NCT00474058|519855493|FG001|Overall Study|Lack of Efficacy|4|||
144419431|NCT02051608|520742271|FG003|Part 2: Open-label Extension|Other|9|||
144419432|NCT01083576|520742274|FG000|Overall Study|Treatment Failure|6|||
144419433|NCT01083576|520742275|FG001|Overall Study|Treatment Failure|1|||
144419434|NCT01986985|520742276|FG000|Overall Study|Withdrawal by Subject|4|||
144419435|NCT01986985|520742276|FG000|Overall Study|Scan not completed due to malfunction|3|||
144419436|NCT02005445|520742277|FG000|Overall Study|Dual study enrollment|0|||
144419437|NCT02005445|520742278|FG001|Overall Study|Dual study enrollment|1|||
144419438|NCT02709785|520742282|FG000|Overall Study|Withdrawal by Subject|1|||
144419439|NCT02709785|520742283|FG001|Overall Study|Withdrawal by Subject|2|||
144419440|NCT02709785|520742284|FG002|Overall Study|Withdrawal by Subject|1|||
144419441|NCT01961323|520742285|FG000|Overall Study|Withdrawal by Subject|7|||
144419442|NCT01961323|520742285|FG000|Overall Study|Lost to Follow-up|8|||
144419443|NCT01961323|520742285|FG000|Overall Study|screen failure|34|||
144419444|NCT01881776|520742287|FG000|Overall Study|Lost to Follow-up|1|||
144419445|NCT01881776|520742288|FG001|Overall Study|Lost to Follow-up|2|||
144419446|NCT01881776|520742289|FG002|Overall Study|Lost to Follow-up|1|||
144419447|NCT01881776|520742287|FG000|Overall Study|Protocol Violation|0|||
144419448|NCT01881776|520742288|FG001|Overall Study|Protocol Violation|2|||
144419449|NCT01881776|520742289|FG002|Overall Study|Protocol Violation|1|||
144419450|NCT02320149|520742290|FG000|Overall Study|Adverse Event|3|||
144419451|NCT02320149|520742291|FG001|Overall Study|Adverse Event|7|||
144419452|NCT02320149|520742290|FG000|Overall Study|Withdrawal of Consent|28|||
144180585|NCT00474058|519855492|FG000|Overall Study|Withdrawal by Subject|11|||
144180586|NCT00474058|519855493|FG001|Overall Study|Withdrawal by Subject|7|||
144180587|NCT00474058|519855492|FG000|Overall Study|Other|2|||
144180588|NCT00474058|519855493|FG001|Overall Study|Other|0|||
144180589|NCT02640235|519855494|FG000|Overall Study|Withdrawal by Subject|7|||
144180590|NCT02640235|519855495|FG001|Overall Study|Withdrawal by Subject|6|||
144180591|NCT02640235|519855494|FG000|Overall Study|Lost to Follow-up|4|||
144180592|NCT02640235|519855495|FG001|Overall Study|Lost to Follow-up|3|||
144180593|NCT02640235|519855494|FG000|Overall Study|Death|2|||
144180594|NCT02640235|519855495|FG001|Overall Study|Death|3|||
144180595|NCT02640235|519855494|FG000|Overall Study|Other|1|||
144180596|NCT02640235|519855495|FG001|Overall Study|Other|2|||
144180597|NCT00503867|519855498|FG000|Overall Study|Lost to Follow-up|1|||
144180598|NCT00503867|519855498|FG000|Overall Study|Adverse Event|1|||
144180599|NCT00301964|519855502|FG000|Overall Study|Second primary|2|||
144180600|NCT00301964|519855502|FG000|Overall Study|Wrong primary|1|||
144180601|NCT00301964|519855502|FG000|Overall Study|Inadequate pathology|1|||
144180602|NCT02385708|519855503|FG000|Overall Study|Withdrawal by Subject|0|||
144180603|NCT02385708|519855504|FG001|Overall Study|Withdrawal by Subject|2|||
144180604|NCT02385708|519855503|FG000|Overall Study|Withdrawn - surgery canceled|2|||
144180605|NCT02385708|519855504|FG001|Overall Study|Withdrawn - surgery canceled|5|||
144180606|NCT02385708|519855503|FG000|Overall Study|Investigator decision|5|||
144180607|NCT02385708|519855504|FG001|Overall Study|Investigator decision|7|||
144180608|NCT02385708|519855503|FG000|Overall Study|Protocol Violation|1|||
144180609|NCT02385708|519855504|FG001|Overall Study|Protocol Violation|1|||
144180610|NCT03504085|519855506|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
144180611|NCT03504085|519855507|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
144180612|NCT03504085|519855506|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
144180613|NCT03504085|519855507|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
144180614|NCT02761915|519855508|FG000|Overall Study|Death|3|||
144180615|NCT02761915|519855509|FG001|Overall Study|Death|1|||
144180616|NCT02761915|519855510|FG002|Overall Study|Death|1|||
144180617|NCT02761915|519855511|FG003|Overall Study|Death|1|||
144180618|NCT02761915|519855512|FG004|Overall Study|Death|0|||
144180619|NCT02761915|519855513|FG005|Overall Study|Death|1|||
144180620|NCT02761915|519855508|FG000|Overall Study|Withdrawal by Subject|1|||
144419453|NCT02320149|520742291|FG001|Overall Study|Withdrawal of Consent|32|||
144419454|NCT02320149|520742290|FG000|Overall Study|Lost to Follow-up|21|||
144419455|NCT02320149|520742291|FG001|Overall Study|Lost to Follow-up|34|||
144419456|NCT02320149|520742290|FG000|Overall Study|Protocol Violation|2|||
144180621|NCT02761915|519855509|FG001|Overall Study|Withdrawal by Subject|0|||
144180622|NCT02761915|519855510|FG002|Overall Study|Withdrawal by Subject|0|||
144180623|NCT02761915|519855511|FG003|Overall Study|Withdrawal by Subject|0|||
144180624|NCT02761915|519855512|FG004|Overall Study|Withdrawal by Subject|1|||
144180625|NCT02761915|519855513|FG005|Overall Study|Withdrawal by Subject|2|||
144180626|NCT02761915|519855508|FG000|Overall Study|Disease Progression|0|||
144180627|NCT02761915|519855509|FG001|Overall Study|Disease Progression|0|||
144419457|NCT02320149|520742291|FG001|Overall Study|Protocol Violation|1|||
144419458|NCT02320149|520742290|FG000|Overall Study|Noncompliance with Study Treatment|7|||
144419459|NCT02320149|520742291|FG001|Overall Study|Noncompliance with Study Treatment|2|||
144527531|NCT02606422|521133306|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
144527532|NCT02606422|521133305|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
144180628|NCT02761915|519855510|FG002|Overall Study|Disease Progression|0|||
144180629|NCT02761915|519855511|FG003|Overall Study|Disease Progression|2|||
144180630|NCT02761915|519855512|FG004|Overall Study|Disease Progression|2|||
144180631|NCT02761915|519855513|FG005|Overall Study|Disease Progression|2|||
144419460|NCT02320149|520742290|FG000|Overall Study|Lack of Efficacy|0|||
144419461|NCT02320149|520742291|FG001|Overall Study|Lack of Efficacy|1|||
144419462|NCT02320149|520742290|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144419463|NCT02320149|520742291|FG001|Overall Study|Other Miscellaneous Reasons|3|||
144419464|NCT00022633|520742292|FG000|Overall Study|Adverse Event|11|||
144419465|NCT00022633|520742293|FG001|Overall Study|Adverse Event|1|||
144419466|NCT00022633|520742292|FG000|Overall Study|Refusal unrelated to adverse event|1|||
144419467|NCT00022633|520742293|FG001|Overall Study|Refusal unrelated to adverse event|0|||
144419468|NCT00022633|520742292|FG000|Overall Study|Progression/relapse|9|||
144419469|NCT00022633|520742293|FG001|Overall Study|Progression/relapse|2|||
144419470|NCT00022633|520742292|FG000|Overall Study|Death|4|||
144419471|NCT00022633|520742293|FG001|Overall Study|Death|0|||
144527533|NCT02606422|521133306|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
144527534|NCT04625465|521133307|FG000|Overall Study|Lost to Follow-up|2|||
144527535|NCT04625465|521133308|FG001|Overall Study|Lost to Follow-up|2|||
144180632|NCT01143337|519855514|FG000|Overall Study|Adverse Event|3|||
144180633|NCT01143337|519855515|FG001|Overall Study|Adverse Event|9|||
144419472|NCT00022633|520742292|FG000|Overall Study|Other - not protocol specified|3|||
144180634|NCT01143337|519855516|FG002|Overall Study|Adverse Event|5|||
144180635|NCT01143337|519855514|FG000|Overall Study|Lack of Efficacy|6|||
144419473|NCT00022633|520742293|FG001|Overall Study|Other - not protocol specified|2|||
144419474|NCT00022633|520742292|FG000|Overall Study|Ineligible|4|||
144419475|NCT00022633|520742293|FG001|Overall Study|Ineligible|0|||
144419476|NCT06133348|520742294|FG000|Overall Study|Death|3|||
144419477|NCT06133348|520742294|FG000|Overall Study|Lost to Follow-up|1|||
144419478|NCT06133348|520742294|FG000|Overall Study|Physician Decision|1|||
144419479|NCT06133348|520742294|FG000|Overall Study|Withdrawal by Subject|5|||
144419480|NCT00487747|520742295|FG000|Overall Study|Adverse Event|1|||
144419481|NCT00487747|520742295|FG000|Overall Study|Lost to Follow-up|9|||
144419482|NCT00487747|520742295|FG000|Overall Study|Lack of Efficacy|1|||
144419483|NCT01359449|520742296|FG000|Overall Study|Lost to Follow-up|1|||
144419484|NCT01359449|520742297|FG001|Overall Study|Lost to Follow-up|0|||
144419485|NCT01359449|520742296|FG000|Overall Study|Protocol Violation|0|||
144419486|NCT01359449|520742297|FG001|Overall Study|Protocol Violation|2|||
144419487|NCT01359449|520742296|FG000|Overall Study|Withdrawal by Subject|3|||
144419488|NCT01359449|520742297|FG001|Overall Study|Withdrawal by Subject|2|||
144419489|NCT02036294|520742298|FG000|Overall Study|Death|7|||
144180636|NCT01143337|519855515|FG001|Overall Study|Lack of Efficacy|2|||
144180637|NCT01143337|519855516|FG002|Overall Study|Lack of Efficacy|1|||
144180638|NCT01143337|519855514|FG000|Overall Study|Protocol Violation|1|||
144180639|NCT01143337|519855515|FG001|Overall Study|Protocol Violation|0|||
144180640|NCT01143337|519855516|FG002|Overall Study|Protocol Violation|0|||
144180641|NCT01143337|519855514|FG000|Overall Study|Withdrawal by Subject|0|||
144419490|NCT02036294|520742299|FG001|Overall Study|Death|8|||
144527536|NCT04625465|521133309|FG002|Overall Study|Lost to Follow-up|1|||
144527537|NCT04625465|521133310|FG003|Overall Study|Lost to Follow-up|0|||
144527538|NCT04625465|521133311|FG004|Overall Study|Lost to Follow-up|0|||
144527539|NCT04625465|521133312|FG005|Overall Study|Lost to Follow-up|2|||
144527540|NCT04625465|521133313|FG006|Overall Study|Lost to Follow-up|0|||
144527541|NCT04625465|521133314|FG007|Overall Study|Lost to Follow-up|0|||
144527542|NCT04625465|521133307|FG000|Overall Study|Death|1|||
144527543|NCT04625465|521133308|FG001|Overall Study|Death|0|||
144527544|NCT04625465|521133309|FG002|Overall Study|Death|0|||
144527545|NCT04625465|521133310|FG003|Overall Study|Death|0|||
144527546|NCT04625465|521133311|FG004|Overall Study|Death|0|||
144527547|NCT04625465|521133312|FG005|Overall Study|Death|0|||
144527548|NCT04625465|521133313|FG006|Overall Study|Death|0|||
144527549|NCT04625465|521133314|FG007|Overall Study|Death|0|||
144527550|NCT04625465|521133307|FG000|Overall Study|Withdrawal by Subject|1|||
144527551|NCT04625465|521133308|FG001|Overall Study|Withdrawal by Subject|0|||
144527552|NCT04625465|521133309|FG002|Overall Study|Withdrawal by Subject|4|||
144723215|NCT01058421|521840660|FG000|3 Month Outcomes|Lost to Follow-up|12|||
144180642|NCT01143337|519855515|FG001|Overall Study|Withdrawal by Subject|0|||
144180643|NCT01143337|519855516|FG002|Overall Study|Withdrawal by Subject|1|||
144180644|NCT01143337|519855514|FG000|Overall Study|Other reason|0|||
144180645|NCT01143337|519855515|FG001|Overall Study|Other reason|0|||
144180646|NCT01143337|519855516|FG002|Overall Study|Other reason|5|||
144419491|NCT02036294|520742298|FG000|Overall Study|Withdrawal by Subject|2|||
144419492|NCT02036294|520742299|FG001|Overall Study|Withdrawal by Subject|3|||
144419493|NCT02927431|520742300|FG000|Overall Study|Withdrawal by Subject|0|||
144527553|NCT04625465|521133310|FG003|Overall Study|Withdrawal by Subject|4|||
144180647|NCT01926119|519855530|FG000|Overall Study|Withdrawal by Subject|1|||
144527554|NCT04625465|521133311|FG004|Overall Study|Withdrawal by Subject|4|||
144527555|NCT04625465|521133312|FG005|Overall Study|Withdrawal by Subject|0|||
144723216|NCT01058421|521840661|FG001|3 Month Outcomes|Lost to Follow-up|11|||
144419494|NCT02927431|520742301|FG001|Overall Study|Withdrawal by Subject|0|||
144419495|NCT02927431|520742302|FG002|Overall Study|Withdrawal by Subject|1|||
144419496|NCT00673465|520742305|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
144527556|NCT04625465|521133313|FG006|Overall Study|Withdrawal by Subject|0|||
144419497|NCT00673465|520742306|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419498|NCT00673465|520742307|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419499|NCT00673465|520742308|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419500|NCT00673465|520742309|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
144419501|NCT00673465|520742310|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
144419502|NCT00673465|520742311|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419503|NCT00673465|520742312|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419504|NCT00673465|520742313|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419505|NCT00673465|520742314|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419506|NCT00673465|520742315|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419507|NCT00673465|520742316|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
144419508|NCT00673465|520742305|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419509|NCT00673465|520742306|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419510|NCT00673465|520742307|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419511|NCT00673465|520742308|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419512|NCT00673465|520742309|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
144419513|NCT00673465|520742310|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419514|NCT00673465|520742311|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419515|NCT00673465|520742312|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419516|NCT00673465|520742313|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419517|NCT00673465|520742314|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419518|NCT00673465|520742315|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419519|NCT00673465|520742316|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
144419520|NCT00429104|520742317|FG000|Overall Study|Protocol Violation|1|||
144419521|NCT01907815|520742318|FG000|Overall Study|Withdrawal by Subject|1|||
144419522|NCT01907815|520742319|FG001|Overall Study|Withdrawal by Subject|0|||
144419523|NCT01195415|520742320|FG000|Overall Study|No repeat biopsy due to progression|2|||
144419524|NCT02485574|520742331|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
144419525|NCT01408914|520742333|FG000|Overall Study|Could not complete tx in protocol period|5|||
144419526|NCT01408914|520742334|FG001|Overall Study|Could not complete tx in protocol period|5|||
144419527|NCT01408914|520742335|FG002|Overall Study|Could not complete tx in protocol period|6|||
144419528|NCT01408914|520742333|FG000|Overall Study|Lost to Follow-up|4|||
144419529|NCT01408914|520742334|FG001|Overall Study|Lost to Follow-up|1|||
144419530|NCT01408914|520742335|FG002|Overall Study|Lost to Follow-up|2|||
144419531|NCT01408914|520742333|FG000|Overall Study|Physician Decision|1|||
144419532|NCT01408914|520742334|FG001|Overall Study|Physician Decision|1|||
144419533|NCT01408914|520742335|FG002|Overall Study|Physician Decision|0|||
144419534|NCT01408914|520742333|FG000|Overall Study|Withdrawal by Subject|1|||
144419535|NCT01408914|520742334|FG001|Overall Study|Withdrawal by Subject|0|||
144419536|NCT01408914|520742335|FG002|Overall Study|Withdrawal by Subject|1|||
144419537|NCT01408914|520742333|FG000|Overall Study|Moved out of study jurisdiction|1|||
144419538|NCT01408914|520742334|FG001|Overall Study|Moved out of study jurisdiction|1|||
144419539|NCT01408914|520742335|FG002|Overall Study|Moved out of study jurisdiction|0|||
144419540|NCT01408914|520742333|FG000|Overall Study|Late exclusion|0|||
144419541|NCT01408914|520742334|FG001|Overall Study|Late exclusion|3|||
144419542|NCT01408914|520742335|FG002|Overall Study|Late exclusion|3|||
144419543|NCT01408914|520742333|FG000|Overall Study|Change in local TB/HIV norms|0|||
144419544|NCT01408914|520742334|FG001|Overall Study|Change in local TB/HIV norms|1|||
144419545|NCT01408914|520742335|FG002|Overall Study|Change in local TB/HIV norms|1|||
144419546|NCT01957553|520742340|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
144419547|NCT01957553|520742341|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
144419548|NCT01957553|520742340|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
144419549|NCT01957553|520742341|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
144419550|NCT01957553|520742340|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
144419551|NCT01957553|520742341|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
144419552|NCT01957553|520742340|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
144419553|NCT01957553|520742341|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
144419554|NCT01957553|520742340|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
144419555|NCT01957553|520742341|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
144419556|NCT01957553|520742340|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
144419557|NCT01957553|520742341|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
144419558|NCT01957553|520742340|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
144419559|NCT01957553|520742341|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
144419560|NCT01957553|520742340|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
144419561|NCT01957553|520742341|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
144419562|NCT01957553|520742340|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
144419563|NCT01957553|520742341|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
144419564|NCT04044716|520742342|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
144180648|NCT02654145|519855533|FG000|Overall Study|Lack of Efficacy|1|||
144419565|NCT04044716|520742343|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
144419566|NCT04044716|520742344|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
144419567|NCT04044716|520742342|FG000|Overall Study|Lost to Follow-up|2|||
144419568|NCT04044716|520742343|FG001|Overall Study|Lost to Follow-up|3|||
144419569|NCT04044716|520742344|FG002|Overall Study|Lost to Follow-up|0|||
144419570|NCT02733367|520742345|FG000|Overall Study|Withdrawal by Subject|6|||
144419571|NCT00191789|520742348|FG000|Overall Study|Adverse Event|5|||
144419572|NCT00191789|520742348|FG000|Overall Study|Patient: Satisfactory Response|5|||
144419573|NCT00191789|520742348|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
144419574|NCT00191789|520742348|FG000|Overall Study|Withdrawal by Subject|4|||
144419575|NCT00191789|520742348|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
144419576|NCT00191789|520742348|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
144419577|NCT00191789|520742348|FG000|Overall Study|Death - Not Study-Drug Related|1|||
144419578|NCT03060629|520742357|FG000|Overall Study|Death|4|||
144419579|NCT03060629|520742358|FG001|Overall Study|Death|5|||
144419580|NCT03060629|520742357|FG000|Overall Study|Withdrawal by Subject|50|||
144419581|NCT03060629|520742358|FG001|Overall Study|Withdrawal by Subject|35|||
144419582|NCT03060629|520742357|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
144419583|NCT03060629|520742358|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
144419584|NCT03060629|520742357|FG000|Overall Study|Participant Relocate|15|||
144419585|NCT03060629|520742358|FG001|Overall Study|Participant Relocate|15|||
144419586|NCT03060629|520742357|FG000|Overall Study|Unable to Contact Participant|34|||
144419587|NCT03060629|520742358|FG001|Overall Study|Unable to Contact Participant|23|||
144419588|NCT03060629|520742357|FG000|Overall Study|Investigator Decision|7|||
144419589|NCT03060629|520742358|FG001|Overall Study|Investigator Decision|7|||
144419590|NCT03060629|520742357|FG000|Overall Study|Study Terminated by Sponsor|1100|||
144419591|NCT03060629|520742358|FG001|Overall Study|Study Terminated by Sponsor|1123|||
144419592|NCT03060629|520742357|FG000|Overall Study|Other|4|||
144527557|NCT04625465|521133314|FG007|Overall Study|Withdrawal by Subject|0|||
144180649|NCT02654145|519855533|FG000|Overall Study|Protocol Violation|1|||
144180650|NCT02654145|519855533|FG000|Overall Study|Withdrawal by Subject|5|||
144180651|NCT00009945|519855534|FG000|Overall Study|no follow up data|7|||
144180652|NCT00009945|519855535|FG001|Overall Study|no follow up data|5|||
144180653|NCT00354835|519855536|FG000|Overall Study|Death|1|||
144180654|NCT00354835|519855537|FG001|Overall Study|Death|1|||
144527558|NCT02966873|521133317|FG000|Overall Study|Lost to Follow-up|16|||
144180655|NCT00354835|519855536|FG000|Overall Study|Physician Decision|8|||
144180656|NCT00354835|519855537|FG001|Overall Study|Physician Decision|13|||
144180657|NCT00354835|519855536|FG000|Overall Study|Withdrawal by Subject|2|||
144180658|NCT00354835|519855537|FG001|Overall Study|Withdrawal by Subject|1|||
144180659|NCT00354835|519855536|FG000|Overall Study|Ineligible|17|||
144180660|NCT00354835|519855537|FG001|Overall Study|Ineligible|16|||
144180661|NCT00354835|519855536|FG000|Overall Study|Disease progression or relapse|15|||
144180662|NCT00354835|519855537|FG001|Overall Study|Disease progression or relapse|22|||
144180663|NCT00354835|519855536|FG000|Overall Study|Adverse Event|6|||
144180664|NCT00354835|519855537|FG001|Overall Study|Adverse Event|0|||
144180665|NCT00354835|519855536|FG000|Overall Study|Refusal of further therapy|3|||
144180666|NCT00354835|519855537|FG001|Overall Study|Refusal of further therapy|8|||
144180667|NCT00645853|519855538|FG000|Overall Study|Adverse Event|18|||
144180668|NCT00645853|519855539|FG001|Overall Study|Adverse Event|7|||
144180669|NCT00645853|519855538|FG000|Overall Study|AZ study closure in Hungary|60|||
144180670|NCT00645853|519855539|FG001|Overall Study|AZ study closure in Hungary|40|||
144180671|NCT00645853|519855538|FG000|Overall Study|Withdrawal by Subject|5|||
144180672|NCT00645853|519855539|FG001|Overall Study|Withdrawal by Subject|2|||
144180673|NCT00645853|519855538|FG000|Overall Study|Protocol Violation|0|||
144180674|NCT00645853|519855539|FG001|Overall Study|Protocol Violation|2|||
144180675|NCT00645853|519855538|FG000|Overall Study|Discontinuation criteria|2|||
144180676|NCT00645853|519855539|FG001|Overall Study|Discontinuation criteria|2|||
144180677|NCT00645853|519855538|FG000|Overall Study|recall of ICF, planned operation, death|7|||
144180678|NCT00645853|519855539|FG001|Overall Study|recall of ICF, planned operation, death|4|||
144180679|NCT02637141|519855542|FG000|Overall Study|Adverse Event|1|||
144419593|NCT03060629|520742358|FG001|Overall Study|Other|4|||
144419594|NCT01862874|520742359|FG000|Overall Study|Randomized not treated|1|||
144419595|NCT01862874|520742360|FG001|Overall Study|Randomized not treated|0|||
144527559|NCT02966873|521133318|FG001|Overall Study|Lost to Follow-up|15|||
144527560|NCT01456949|521133319|FG000|Enrollment|PI death- incomplete data|6|||
144180680|NCT02637141|519855543|FG001|Overall Study|Adverse Event|1|||
144180681|NCT02637141|519855544|FG002|Overall Study|Adverse Event|0|||
144180682|NCT02637141|519855542|FG000|Overall Study|Withdrawal by Subject|1|||
144180683|NCT02637141|519855543|FG001|Overall Study|Withdrawal by Subject|1|||
144419596|NCT01862874|520742359|FG000|Overall Study|Adverse Event|0|||
144419597|NCT01862874|520742360|FG001|Overall Study|Adverse Event|3|||
144419598|NCT01862874|520742359|FG000|Overall Study|Lost to Follow-up|26|||
144419599|NCT01862874|520742360|FG001|Overall Study|Lost to Follow-up|29|||
144419600|NCT01862874|520742359|FG000|Overall Study|Physician Decision|5|||
144180684|NCT02637141|519855544|FG002|Overall Study|Withdrawal by Subject|1|||
144419601|NCT01862874|520742360|FG001|Overall Study|Physician Decision|3|||
144419602|NCT01862874|520742359|FG000|Overall Study|Withdrawn by parent/guardian|1|||
144419603|NCT01862874|520742360|FG001|Overall Study|Withdrawn by parent/guardian|1|||
144419604|NCT01862874|520742359|FG000|Overall Study|Withdrawal by Subject|46|||
144419605|NCT01862874|520742360|FG001|Overall Study|Withdrawal by Subject|40|||
144419606|NCT01862874|520742359|FG000|Overall Study|Death|0|||
144419607|NCT01862874|520742360|FG001|Overall Study|Death|1|||
144419608|NCT00071513|520742366|FG000|Intervention Component|Withdrawal by Subject|2|||
144419609|NCT00071513|520742367|FG001|Intervention Component|Withdrawal by Subject|3|||
144419610|NCT00071513|520742366|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
144419611|NCT00071513|520742367|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
144419612|NCT01958008|520742370|FG000|Overall Study|Worsening of disease under study|0|||
144419613|NCT01958008|520742371|FG001|Overall Study|Worsening of disease under study|0|||
144419614|NCT01958008|520742372|FG002|Overall Study|Worsening of disease under study|1|||
144419615|NCT01958008|520742373|FG003|Overall Study|Worsening of disease under study|0|||
144419616|NCT01958008|520742370|FG000|Overall Study|Other adverse event|1|||
144419617|NCT01958008|520742371|FG001|Overall Study|Other adverse event|0|||
144419618|NCT01958008|520742372|FG002|Overall Study|Other adverse event|0|||
144419619|NCT01958008|520742373|FG003|Overall Study|Other adverse event|0|||
144419620|NCT01634360|520742374|FG000|Overall Study|Adverse Event|10|||
144419621|NCT01634360|520742375|FG001|Overall Study|Adverse Event|34|||
144419622|NCT01634360|520742374|FG000|Overall Study|subject withdrew consent|13|||
144419623|NCT01634360|520742375|FG001|Overall Study|subject withdrew consent|23|||
144419624|NCT01634360|520742374|FG000|Overall Study|Protocol Violation|1|||
144419625|NCT01634360|520742375|FG001|Overall Study|Protocol Violation|1|||
144419626|NCT01634360|520742374|FG000|Overall Study|Lack of Efficacy|4|||
144419627|NCT01634360|520742375|FG001|Overall Study|Lack of Efficacy|14|||
144419628|NCT01634360|520742374|FG000|Overall Study|Other|3|||
144419629|NCT01634360|520742375|FG001|Overall Study|Other|20|||
144419630|NCT01634360|520742374|FG000|Overall Study|Study termination by sponsor|18|||
144419631|NCT01634360|520742375|FG001|Overall Study|Study termination by sponsor|44|||
144419632|NCT03667924|520742376|FG000|Baseline Completed|Lost to Follow-up|0|||
144419633|NCT03667924|520742377|FG001|Baseline Completed|Lost to Follow-up|2|||
144419634|NCT03667924|520742378|FG002|Baseline Completed|Lost to Follow-up|0|||
144419635|NCT03667924|520742376|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
144419636|NCT03667924|520742377|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
144419637|NCT03667924|520742378|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
144419638|NCT03667924|520742376|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
144419639|NCT03667924|520742377|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
144419640|NCT03667924|520742378|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
144419641|NCT03667924|520742376|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
144419642|NCT03667924|520742377|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
144419643|NCT03667924|520742378|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
144419644|NCT03667924|520742376|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
144419645|NCT03667924|520742377|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
144419646|NCT03667924|520742378|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
144419647|NCT03667924|520742376|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
144419648|NCT03667924|520742377|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
144419649|NCT03667924|520742378|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
144419650|NCT03667924|520742376|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
144419651|NCT03667924|520742377|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
144419652|NCT03667924|520742378|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
144419653|NCT02743871|520742379|FG000|Overall Study|Lost to Follow-up|0|||
144419654|NCT02743871|520742380|FG001|Overall Study|Lost to Follow-up|0|||
144419655|NCT02743871|520742381|FG002|Overall Study|Lost to Follow-up|0|||
144419656|NCT02743871|520742382|FG003|Overall Study|Lost to Follow-up|1|||
144419657|NCT02743871|520742383|FG004|Overall Study|Lost to Follow-up|0|||
144419658|NCT02743871|520742384|FG005|Overall Study|Lost to Follow-up|0|||
144419659|NCT02743871|520742385|FG006|Overall Study|Lost to Follow-up|1|||
144419660|NCT02743871|520742386|FG007|Overall Study|Lost to Follow-up|0|||
144419661|NCT02743871|520742387|FG008|Overall Study|Lost to Follow-up|0|||
144419662|NCT02743871|520742388|FG009|Overall Study|Lost to Follow-up|0|||
144419663|NCT02743871|520742389|FG010|Overall Study|Lost to Follow-up|0|||
144419664|NCT02743871|520742390|FG011|Overall Study|Lost to Follow-up|2|||
144419665|NCT02743871|520742391|FG012|Overall Study|Lost to Follow-up|0|||
144419666|NCT02743871|520742392|FG013|Overall Study|Lost to Follow-up|0|||
144419667|NCT02743871|520742379|FG000|Overall Study|Withdrawal by Subject|0|||
144419668|NCT02743871|520742380|FG001|Overall Study|Withdrawal by Subject|0|||
144419669|NCT02743871|520742381|FG002|Overall Study|Withdrawal by Subject|0|||
144419670|NCT02743871|520742382|FG003|Overall Study|Withdrawal by Subject|0|||
144419671|NCT02743871|520742383|FG004|Overall Study|Withdrawal by Subject|0|||
144419672|NCT02743871|520742384|FG005|Overall Study|Withdrawal by Subject|0|||
144419673|NCT02743871|520742385|FG006|Overall Study|Withdrawal by Subject|0|||
144419674|NCT02743871|520742386|FG007|Overall Study|Withdrawal by Subject|0|||
144419675|NCT02743871|520742387|FG008|Overall Study|Withdrawal by Subject|0|||
144419676|NCT02743871|520742388|FG009|Overall Study|Withdrawal by Subject|0|||
144419677|NCT02743871|520742389|FG010|Overall Study|Withdrawal by Subject|1|||
144419678|NCT02743871|520742390|FG011|Overall Study|Withdrawal by Subject|0|||
144419679|NCT02743871|520742391|FG012|Overall Study|Withdrawal by Subject|12|||
144419680|NCT02743871|520742392|FG013|Overall Study|Withdrawal by Subject|6|||
144419681|NCT02743871|520742379|FG000|Overall Study|Adverse Event|1|||
144419682|NCT02743871|520742380|FG001|Overall Study|Adverse Event|0|||
144419683|NCT02743871|520742381|FG002|Overall Study|Adverse Event|0|||
144419684|NCT02743871|520742382|FG003|Overall Study|Adverse Event|0|||
144419685|NCT02743871|520742383|FG004|Overall Study|Adverse Event|0|||
144419686|NCT02743871|520742384|FG005|Overall Study|Adverse Event|0|||
144419687|NCT02743871|520742385|FG006|Overall Study|Adverse Event|0|||
144419688|NCT02743871|520742386|FG007|Overall Study|Adverse Event|0|||
144419689|NCT02743871|520742387|FG008|Overall Study|Adverse Event|0|||
144419690|NCT02743871|520742388|FG009|Overall Study|Adverse Event|0|||
144419691|NCT02743871|520742389|FG010|Overall Study|Adverse Event|0|||
144419692|NCT02743871|520742390|FG011|Overall Study|Adverse Event|0|||
144419693|NCT02743871|520742391|FG012|Overall Study|Adverse Event|0|||
144419694|NCT02743871|520742392|FG013|Overall Study|Adverse Event|0|||
144419695|NCT02743871|520742379|FG000|Overall Study|Other|0|||
144419696|NCT02743871|520742380|FG001|Overall Study|Other|0|||
144419697|NCT02743871|520742381|FG002|Overall Study|Other|0|||
144419698|NCT02743871|520742382|FG003|Overall Study|Other|0|||
144419699|NCT02743871|520742383|FG004|Overall Study|Other|0|||
144419700|NCT02743871|520742384|FG005|Overall Study|Other|0|||
144419701|NCT02743871|520742385|FG006|Overall Study|Other|0|||
144419702|NCT02743871|520742386|FG007|Overall Study|Other|0|||
144419703|NCT02743871|520742387|FG008|Overall Study|Other|0|||
144419704|NCT02743871|520742388|FG009|Overall Study|Other|0|||
144419705|NCT02743871|520742389|FG010|Overall Study|Other|0|||
144419706|NCT02743871|520742390|FG011|Overall Study|Other|1|||
144419707|NCT02743871|520742391|FG012|Overall Study|Other|1|||
144419708|NCT02743871|520742392|FG013|Overall Study|Other|1|||
144419709|NCT02743871|520742379|FG000|Overall Study|Protocol Violation|0|||
144419710|NCT02743871|520742380|FG001|Overall Study|Protocol Violation|0|||
144419711|NCT02743871|520742381|FG002|Overall Study|Protocol Violation|0|||
144419712|NCT02743871|520742382|FG003|Overall Study|Protocol Violation|0|||
144419713|NCT02743871|520742383|FG004|Overall Study|Protocol Violation|0|||
144419714|NCT02743871|520742384|FG005|Overall Study|Protocol Violation|0|||
144419715|NCT02743871|520742385|FG006|Overall Study|Protocol Violation|0|||
144419716|NCT02743871|520742386|FG007|Overall Study|Protocol Violation|0|||
144419717|NCT02743871|520742387|FG008|Overall Study|Protocol Violation|0|||
144419718|NCT02743871|520742388|FG009|Overall Study|Protocol Violation|0|||
144419719|NCT02743871|520742389|FG010|Overall Study|Protocol Violation|0|||
144419720|NCT02743871|520742390|FG011|Overall Study|Protocol Violation|0|||
144419721|NCT02743871|520742391|FG012|Overall Study|Protocol Violation|2|||
144419722|NCT02743871|520742392|FG013|Overall Study|Protocol Violation|0|||
144419723|NCT02480114|520742393|FG000|Overall Study|Not completing surveys|3|||
144419724|NCT02480114|520742394|FG001|Overall Study|Not completing surveys|2|||
144419725|NCT02480114|520742393|FG000|Overall Study|Withdrawal by Subject|2|||
144419726|NCT02480114|520742394|FG001|Overall Study|Withdrawal by Subject|4|||
144419727|NCT02480114|520742393|FG000|Overall Study|Disease progression|3|||
144419728|NCT02480114|520742394|FG001|Overall Study|Disease progression|0|||
144419729|NCT02480114|520742393|FG000|Overall Study|Improper completion of survey|1|||
144419730|NCT02480114|520742394|FG001|Overall Study|Improper completion of survey|1|||
144419731|NCT02480114|520742393|FG000|Overall Study|Not eligible|0|||
144419732|NCT02480114|520742394|FG001|Overall Study|Not eligible|1|||
144419733|NCT00512707|520742395|FG000|Overall Study|Lost to Follow-up|5|||
144180685|NCT01597791|519855545|FG000|Overall Study|Physician Decision|2|||
144180686|NCT01597791|519855546|FG001|Overall Study|Physician Decision|1|||
144180687|NCT01597791|519855545|FG000|Overall Study|Cesarean Section|6|||
144180688|NCT01597791|519855546|FG001|Overall Study|Cesarean Section|7|||
144180689|NCT01597791|519855545|FG000|Overall Study|Subject withdrawal|0|||
144180690|NCT01597791|519855546|FG001|Overall Study|Subject withdrawal|1|||
144180691|NCT01597791|519855545|FG000|Overall Study|Protocol Violation|0|||
144180692|NCT01597791|519855546|FG001|Overall Study|Protocol Violation|1|||
144419734|NCT00512707|520742396|FG001|Overall Study|Lost to Follow-up|11|||
144419735|NCT00512707|520742395|FG000|Overall Study|Developed skin irritation|2|||
144419736|NCT00512707|520742396|FG001|Overall Study|Developed skin irritation|1|||
144419737|NCT00512707|520742395|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
144419738|NCT00512707|520742396|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
144419739|NCT00512707|520742395|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
144419740|NCT00512707|520742396|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
144419741|NCT01317160|520742397|FG000|Overall Study|Incorrect inclusion|1|||
144419742|NCT01317160|520742398|FG001|Overall Study|Incorrect inclusion|1|||
144419743|NCT01317160|520742397|FG000|Overall Study|Lost to Follow-up|3|||
144419744|NCT01317160|520742398|FG001|Overall Study|Lost to Follow-up|3|||
144419745|NCT01317160|520742397|FG000|Overall Study|Withdrawal by Subject|0|||
144419746|NCT01317160|520742398|FG001|Overall Study|Withdrawal by Subject|2|||
144419747|NCT00224055|520743810|FG000|Overall Study|Adverse Event|9|||
144419748|NCT00224055|520743811|FG001|Overall Study|Adverse Event|3|||
144419749|NCT00224055|520743810|FG000|Overall Study|Lost to Follow-up|1|||
144419750|NCT00224055|520743811|FG001|Overall Study|Lost to Follow-up|2|||
144419751|NCT00224055|520743810|FG000|Overall Study|Protocol Violation|1|||
144419752|NCT00224055|520743811|FG001|Overall Study|Protocol Violation|1|||
144419753|NCT00224055|520743810|FG000|Overall Study|Inclusion Violation|3|||
144419754|NCT00224055|520743811|FG001|Overall Study|Inclusion Violation|6|||
144419755|NCT00224055|520743810|FG000|Overall Study|Withdrawal by Subject|0|||
144419756|NCT00224055|520743811|FG001|Overall Study|Withdrawal by Subject|2|||
144419757|NCT00224055|520743810|FG000|Overall Study|Other|1|||
144419758|NCT00224055|520743811|FG001|Overall Study|Other|0|||
144419759|NCT05126901|520743812|FG000|Overall Study|Withdrawal by Subject|1|||
144419760|NCT05126901|520743813|FG001|Overall Study|Withdrawal by Subject|1|||
144419761|NCT05126901|520743814|FG002|Overall Study|Withdrawal by Subject|4|||
144419762|NCT05126901|520743812|FG000|Overall Study|Adverse Event|0|||
144419763|NCT05126901|520743813|FG001|Overall Study|Adverse Event|0|||
144419764|NCT05126901|520743814|FG002|Overall Study|Adverse Event|1|||
144419765|NCT05126901|520743812|FG000|Overall Study|Lost to Follow-up|0|||
144419766|NCT05126901|520743813|FG001|Overall Study|Lost to Follow-up|2|||
144419767|NCT05126901|520743814|FG002|Overall Study|Lost to Follow-up|0|||
144419768|NCT00754624|520743815|FG000|Overall Study|Adverse Event|16|||
144419769|NCT00754624|520743815|FG000|Overall Study|Death|1|||
144419770|NCT00754624|520743815|FG000|Overall Study|Physician Decision|8|||
144419771|NCT00754624|520743815|FG000|Overall Study|Protocol Violation|1|||
144419772|NCT00754624|520743815|FG000|Overall Study|Withdrawal by Subject|28|||
144419773|NCT00754624|520743815|FG000|Overall Study|Various|12|||
144419774|NCT00754624|520743815|FG000|Overall Study|Lost to Follow-up|3|||
144419775|NCT04067544|520743816|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
144419776|NCT01529346|520743819|FG000|Overall Study|Lost to Follow-up|2|||
144419777|NCT01529346|520743820|FG001|Overall Study|Lost to Follow-up|0|||
144419778|NCT01529346|520743821|FG002|Overall Study|Lost to Follow-up|1|||
144419779|NCT01529346|520743822|FG003|Overall Study|Lost to Follow-up|0|||
144419780|NCT01529346|520743823|FG004|Overall Study|Lost to Follow-up|0|||
144419781|NCT01529346|520743819|FG000|Overall Study|Other|0|||
144419782|NCT01529346|520743820|FG001|Overall Study|Other|1|||
144419783|NCT01529346|520743821|FG002|Overall Study|Other|1|||
144419784|NCT01529346|520743822|FG003|Overall Study|Other|0|||
144419785|NCT01529346|520743823|FG004|Overall Study|Other|0|||
144419786|NCT02282020|520743824|FG000|Overall Study|Objective Disease Progression|128|||
144419787|NCT02282020|520743825|FG001|Overall Study|Objective Disease Progression|30|||
144419788|NCT02282020|520743824|FG000|Overall Study|Adverse Event|18|||
144419789|NCT02282020|520743825|FG001|Overall Study|Adverse Event|15|||
144419790|NCT02282020|520743824|FG000|Overall Study|Withdrawal by Subject|7|||
144419791|NCT02282020|520743825|FG001|Overall Study|Withdrawal by Subject|10|||
144419792|NCT02282020|520743824|FG000|Overall Study|Miscellaneous|5|||
144419793|NCT02282020|520743825|FG001|Overall Study|Miscellaneous|19|||
144419794|NCT02282020|520743824|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
144419795|NCT02282020|520743825|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
144601083|NCT06268288|521401730|FG001|Overall Study|Withdrawal by Subject|2|||
144601084|NCT02593786|521401731|FG000|Overall Study|Disease progression|12|||
144601085|NCT02593786|521401732|FG001|Overall Study|Disease progression|16|||
144601086|NCT02593786|521401733|FG002|Overall Study|Disease progression|10|||
144601087|NCT02593786|521401734|FG003|Overall Study|Disease progression|7|||
144601088|NCT02593786|521401731|FG000|Overall Study|Study drug toxicity|1|||
144601089|NCT02593786|521401732|FG001|Overall Study|Study drug toxicity|0|||
144601090|NCT02593786|521401733|FG002|Overall Study|Study drug toxicity|0|||
144419796|NCT02282020|520743824|FG000|Overall Study|Developed Discontinuation Criteria|0|||
144419797|NCT02282020|520743825|FG001|Overall Study|Developed Discontinuation Criteria|2|||
144419798|NCT02282020|520743824|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
144419799|NCT02282020|520743825|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
144419800|NCT01500629|520743826|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
144419801|NCT01500629|520743827|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
144419802|NCT01499667|520743828|FG000|Overall Study|administrative problems|4|||
144419803|NCT01499667|520743829|FG001|Overall Study|administrative problems|5|||
144601091|NCT02593786|521401734|FG003|Overall Study|Study drug toxicity|0|||
144251101|NCT01270321|520119237|FG002|Overall Study|Adverse Event|5|||
144419804|NCT01499667|520743830|FG002|Overall Study|administrative problems|5|||
144419805|NCT01499667|520743828|FG000|Overall Study|Protocol Violation|1|||
144419806|NCT01499667|520743829|FG001|Overall Study|Protocol Violation|3|||
144419807|NCT01499667|520743830|FG002|Overall Study|Protocol Violation|2|||
144419808|NCT01499667|520743828|FG000|Overall Study|Adverse Event|0|||
144419809|NCT01499667|520743829|FG001|Overall Study|Adverse Event|2|||
144419810|NCT01499667|520743830|FG002|Overall Study|Adverse Event|2|||
144601092|NCT02593786|521401731|FG000|Overall Study|Adverse event unrelated to study drug|1|||
144419811|NCT01499667|520743828|FG000|Overall Study|Withdrawal by Subject|2|||
144419812|NCT01499667|520743829|FG001|Overall Study|Withdrawal by Subject|1|||
144419813|NCT01499667|520743830|FG002|Overall Study|Withdrawal by Subject|1|||
144419814|NCT01499667|520743828|FG000|Overall Study|Lack of Efficacy|2|||
144419815|NCT01499667|520743829|FG001|Overall Study|Lack of Efficacy|0|||
144419816|NCT01499667|520743830|FG002|Overall Study|Lack of Efficacy|0|||
144419817|NCT01356966|520743831|FG000|Overall Study|Withdrawal by Subject|1|||
144419818|NCT01356966|520743832|FG001|Overall Study|Withdrawal by Subject|2|||
144419819|NCT01356966|520743831|FG000|Overall Study|Physician Decision|1|||
144419820|NCT01356966|520743832|FG001|Overall Study|Physician Decision|0|||
144601093|NCT02593786|521401732|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144601094|NCT02593786|521401733|FG002|Overall Study|Adverse event unrelated to study drug|1|||
144419821|NCT00849381|520743833|FG000|Overall Study|Adverse Event|1|||
144419822|NCT00849381|520743833|FG000|Overall Study|Lost to Follow-up|129|||
144419823|NCT00849381|520743833|FG000|Overall Study|Protocol Violation|5|||
144419824|NCT00849381|520743833|FG000|Overall Study|Withdrawal by Subject|6|||
144419825|NCT00849381|520743833|FG000|Overall Study|Other|4|||
144419826|NCT00460031|520743839|FG000|Overall Study|Adverse Event|5|||
144419827|NCT00460031|520743839|FG000|Overall Study|Withdrawal by Subject|5|||
144419828|NCT00460031|520743839|FG000|Overall Study|Death|1|||
144419829|NCT04429061|520743840|FG000|Overall Study|Lost to Follow-up|62|||
144419830|NCT04429061|520743841|FG001|Overall Study|Lost to Follow-up|87|||
144419831|NCT04429061|520743840|FG000|Overall Study|Withdrawal by Subject|3|||
144419832|NCT04429061|520743841|FG001|Overall Study|Withdrawal by Subject|4|||
144419833|NCT02506153|520743846|FG000|Overall Study|Adverse Event|359|||
144419834|NCT02506153|520743847|FG001|Overall Study|Adverse Event|114|||
144419835|NCT02506153|520743846|FG000|Overall Study|Refused unrelated to adverse event|127|||
144419836|NCT02506153|520743847|FG001|Overall Study|Refused unrelated to adverse event|18|||
144419837|NCT02506153|520743846|FG000|Overall Study|Progression/relapse|91|||
144419838|NCT02506153|520743847|FG001|Overall Study|Progression/relapse|136|||
144419839|NCT02506153|520743846|FG000|Overall Study|Death|2|||
144419840|NCT02506153|520743847|FG001|Overall Study|Death|1|||
144419841|NCT02506153|520743846|FG000|Overall Study|Other - not protocol specified|23|||
144419842|NCT02506153|520743847|FG001|Overall Study|Other - not protocol specified|12|||
144419843|NCT00311623|520743855|FG000|Overall Study|Physician Decision|0|||
144419844|NCT00311623|520743856|FG001|Overall Study|Physician Decision|0|||
144419845|NCT00311623|520743857|FG002|Overall Study|Physician Decision|2|||
144419846|NCT05682326|520743858|FG000|Overall Study|Withdrawal by Subject|1|||
144419847|NCT05682326|520743859|FG001|Overall Study|Withdrawal by Subject|0|||
144419848|NCT03070782|520743861|FG000|Overall Study|Adverse Event|3|||
144419849|NCT03070782|520743862|FG001|Overall Study|Adverse Event|0|||
144419850|NCT03070782|520743863|FG002|Overall Study|Adverse Event|3|||
144419851|NCT03070782|520743864|FG003|Overall Study|Adverse Event|1|||
144419852|NCT03070782|520743865|FG004|Overall Study|Adverse Event|6|||
144419853|NCT03070782|520743866|FG005|Overall Study|Adverse Event|2|||
144419854|NCT03070782|520743861|FG000|Overall Study|Withdrawal by Subject|2|||
144419855|NCT03070782|520743862|FG001|Overall Study|Withdrawal by Subject|1|||
144419856|NCT03070782|520743863|FG002|Overall Study|Withdrawal by Subject|1|||
144419857|NCT03070782|520743864|FG003|Overall Study|Withdrawal by Subject|0|||
144419858|NCT03070782|520743865|FG004|Overall Study|Withdrawal by Subject|4|||
144419859|NCT03070782|520743866|FG005|Overall Study|Withdrawal by Subject|3|||
144419860|NCT03070782|520743861|FG000|Overall Study|Reason Not Specified|2|||
144419861|NCT03070782|520743862|FG001|Overall Study|Reason Not Specified|0|||
144419862|NCT03070782|520743863|FG002|Overall Study|Reason Not Specified|0|||
144419863|NCT03070782|520743864|FG003|Overall Study|Reason Not Specified|1|||
144419864|NCT03070782|520743865|FG004|Overall Study|Reason Not Specified|2|||
144419865|NCT03070782|520743866|FG005|Overall Study|Reason Not Specified|1|||
144419866|NCT03070782|520743861|FG000|Overall Study|Ineligibility|0|||
144419867|NCT03070782|520743862|FG001|Overall Study|Ineligibility|0|||
144419868|NCT03070782|520743863|FG002|Overall Study|Ineligibility|0|||
144419869|NCT03070782|520743864|FG003|Overall Study|Ineligibility|1|||
144419870|NCT03070782|520743865|FG004|Overall Study|Ineligibility|0|||
144419871|NCT03070782|520743866|FG005|Overall Study|Ineligibility|1|||
144419872|NCT03070782|520743861|FG000|Overall Study|Pregnancy|0|||
144419873|NCT03070782|520743862|FG001|Overall Study|Pregnancy|0|||
144419874|NCT03070782|520743863|FG002|Overall Study|Pregnancy|0|||
144419875|NCT03070782|520743864|FG003|Overall Study|Pregnancy|1|||
144419876|NCT03070782|520743865|FG004|Overall Study|Pregnancy|0|||
144419877|NCT03070782|520743866|FG005|Overall Study|Pregnancy|0|||
144419878|NCT03070782|520743861|FG000|Overall Study|Investigator Judgement|0|||
144419879|NCT03070782|520743862|FG001|Overall Study|Investigator Judgement|0|||
144419880|NCT03070782|520743863|FG002|Overall Study|Investigator Judgement|0|||
144419881|NCT03070782|520743864|FG003|Overall Study|Investigator Judgement|1|||
144419882|NCT03070782|520743865|FG004|Overall Study|Investigator Judgement|0|||
144419883|NCT03070782|520743866|FG005|Overall Study|Investigator Judgement|0|||
144419884|NCT01314443|520743867|FG000|Overall Study|Withdrawal by Subject|2|||
144419885|NCT01314443|520743868|FG001|Overall Study|Withdrawal by Subject|1|||
144419886|NCT01314443|520743869|FG002|Overall Study|Withdrawal by Subject|1|||
144419887|NCT01314443|520743870|FG003|Overall Study|Withdrawal by Subject|1|||
144419888|NCT01314443|520743867|FG000|Overall Study|Protocol Violation|2|||
144419889|NCT01314443|520743868|FG001|Overall Study|Protocol Violation|2|||
144419890|NCT01314443|520743869|FG002|Overall Study|Protocol Violation|1|||
144180693|NCT01728116|519855549|FG000|Overall Study|Sponsor Terminated Study|106|||
144180694|NCT01728116|519855550|FG001|Overall Study|Sponsor Terminated Study|35|||
144180695|NCT01728116|519855549|FG000|Overall Study|Withdrawal by Subject|16|||
144180696|NCT01728116|519855550|FG001|Overall Study|Withdrawal by Subject|9|||
144419891|NCT01314443|520743870|FG003|Overall Study|Protocol Violation|1|||
144419892|NCT02567435|520743874|FG000|Overall Study|Death|1|||
144419893|NCT02567435|520743875|FG001|Overall Study|Death|1|||
144419894|NCT02567435|520743876|FG002|Overall Study|Death|0|||
144419895|NCT02567435|520743877|FG003|Overall Study|Death|0|||
144419896|NCT02567435|520743874|FG000|Overall Study|Ineligible|1|||
144419897|NCT02567435|520743875|FG001|Overall Study|Ineligible|3|||
144419898|NCT02567435|520743876|FG002|Overall Study|Ineligible|0|||
144419899|NCT02567435|520743877|FG003|Overall Study|Ineligible|0|||
144419900|NCT02567435|520743874|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
144419901|NCT02567435|520743875|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
144419902|NCT02567435|520743876|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
144419903|NCT02567435|520743877|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
144419904|NCT01348347|520743881|FG000|Overall Study|Withdrawal by Subject|1|||
144419905|NCT01348347|520743882|FG001|Overall Study|Withdrawal by Subject|1|||
144419906|NCT01348347|520743883|FG002|Overall Study|Withdrawal by Subject|1|||
144419907|NCT01348347|520743881|FG000|Overall Study|Progressive disease|2|||
144419908|NCT01348347|520743882|FG001|Overall Study|Progressive disease|5|||
144419909|NCT01348347|520743883|FG002|Overall Study|Progressive disease|5|||
144419910|NCT01714635|520743884|FG000|Overall Study|Discontinued|1|||
144419911|NCT01714635|520743885|FG001|Overall Study|Discontinued|0|||
144419912|NCT01714635|520743886|FG002|Overall Study|Discontinued|2|||
144419913|NCT01714635|520743884|FG000|Overall Study|Missed 6-month exam|1|||
144419914|NCT01714635|520743885|FG001|Overall Study|Missed 6-month exam|0|||
144419915|NCT01714635|520743886|FG002|Overall Study|Missed 6-month exam|0|||
144419916|NCT03672747|520743887|FG000|Overall Study|Lost to Follow-up|1|||
144419917|NCT03672747|520743888|FG001|Overall Study|Lost to Follow-up|1|||
144419918|NCT03672747|520743889|FG002|Overall Study|Lost to Follow-up|2|||
144419919|NCT03672747|520743890|FG003|Overall Study|Lost to Follow-up|2|||
144419920|NCT03672747|520743891|FG004|Overall Study|Lost to Follow-up|2|||
144419921|NCT03672747|520743892|FG005|Overall Study|Lost to Follow-up|1|||
144419922|NCT04285879|520743893|FG000|Overall Study|Lost to Follow-up|1|||
144419923|NCT04285879|520743894|FG001|Overall Study|Lost to Follow-up|8|||
144419924|NCT04285879|520743893|FG000|Overall Study|medical/surgical exclusion|16|||
144419925|NCT04285879|520743894|FG001|Overall Study|medical/surgical exclusion|0|||
144419926|NCT01782495|520743901|FG000|Overall Study|Adverse Event|0|||
144419927|NCT01782495|520743902|FG001|Overall Study|Adverse Event|0|||
144419928|NCT01782495|520743903|FG002|Overall Study|Adverse Event|0|||
144419929|NCT01782495|520743904|FG003|Overall Study|Adverse Event|0|||
144419930|NCT01782495|520743905|FG004|Overall Study|Adverse Event|0|||
144419931|NCT01782495|520743906|FG005|Overall Study|Adverse Event|0|||
144419932|NCT01782495|520743907|FG006|Overall Study|Adverse Event|0|||
144419933|NCT01782495|520743908|FG007|Overall Study|Adverse Event|2|||
144419934|NCT01782495|520743909|FG008|Overall Study|Adverse Event|0|||
144419935|NCT01782495|520743910|FG009|Overall Study|Adverse Event|0|||
144419936|NCT01782495|520743911|FG010|Overall Study|Adverse Event|0|||
144419937|NCT01782495|520743901|FG000|Overall Study|Withdrew Consent|0|||
144419938|NCT01782495|520743902|FG001|Overall Study|Withdrew Consent|1|||
144419939|NCT01782495|520743903|FG002|Overall Study|Withdrew Consent|0|||
144419940|NCT01782495|520743904|FG003|Overall Study|Withdrew Consent|0|||
144419941|NCT01782495|520743905|FG004|Overall Study|Withdrew Consent|0|||
144419942|NCT01782495|520743906|FG005|Overall Study|Withdrew Consent|0|||
144527561|NCT01456949|521133319|FG000|Enrollment|Death|1|||
144527562|NCT01456949|521133319|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
144527563|NCT01456949|521133319|FG000|Enrollment|Physician Decision|10|||
144180697|NCT01728116|519855549|FG000|Overall Study|Adverse Event|13|||
144419943|NCT01782495|520743907|FG006|Overall Study|Withdrew Consent|0|||
144419944|NCT01782495|520743908|FG007|Overall Study|Withdrew Consent|1|||
144419945|NCT01782495|520743909|FG008|Overall Study|Withdrew Consent|0|||
144419946|NCT01782495|520743910|FG009|Overall Study|Withdrew Consent|0|||
144419947|NCT01782495|520743911|FG010|Overall Study|Withdrew Consent|0|||
144419948|NCT01927367|520743912|FG000|Overall Study|Withdrawal by Subject|7|||
144419949|NCT01927367|520743913|FG001|Overall Study|Withdrawal by Subject|4|||
144419950|NCT01927367|520743912|FG000|Overall Study|No baseline data|0|||
144180698|NCT01728116|519855550|FG001|Overall Study|Adverse Event|0|||
144419951|NCT01927367|520743913|FG001|Overall Study|No baseline data|1|||
144419952|NCT00241280|520743916|FG000|Overall Study|Adverse Event|2|||
144419953|NCT00241280|520743917|FG001|Overall Study|Adverse Event|6|||
144419954|NCT00241280|520743916|FG000|Overall Study|Discomfort|11|||
144419955|NCT00241280|520743917|FG001|Overall Study|Discomfort|16|||
144419956|NCT00241280|520743916|FG000|Overall Study|Pregnancy|1|||
144419957|NCT00241280|520743917|FG001|Overall Study|Pregnancy|5|||
144419958|NCT00241280|520743916|FG000|Overall Study|Lost to Follow-up|5|||
144419959|NCT00241280|520743917|FG001|Overall Study|Lost to Follow-up|8|||
144419960|NCT00241280|520743916|FG000|Overall Study|Withdrawal by Subject|7|||
144419961|NCT00241280|520743917|FG001|Overall Study|Withdrawal by Subject|4|||
144419962|NCT00241280|520743916|FG000|Overall Study|Protocol Violation|4|||
144419963|NCT00241280|520743917|FG001|Overall Study|Protocol Violation|10|||
144419964|NCT00241280|520743916|FG000|Overall Study|Relocation|4|||
144419965|NCT00241280|520743917|FG001|Overall Study|Relocation|4|||
144419966|NCT00241280|520743916|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
144419967|NCT00241280|520743917|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
144419968|NCT00241280|520743916|FG000|Overall Study|Unsatisfactory Visual Response|1|||
144419969|NCT00241280|520743917|FG001|Overall Study|Unsatisfactory Visual Response|1|||
144419970|NCT00241280|520743916|FG000|Overall Study|Diabetic|1|||
144419971|NCT00241280|520743917|FG001|Overall Study|Diabetic|0|||
144419972|NCT00241280|520743916|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
144419973|NCT00241280|520743917|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
144419974|NCT00241280|520743916|FG000|Overall Study|Dispensed incorrect test article|1|||
144419975|NCT00241280|520743917|FG001|Overall Study|Dispensed incorrect test article|2|||
144419976|NCT00241280|520743916|FG000|Overall Study|Unacceptable Fit|0|||
144419977|NCT00241280|520743917|FG001|Overall Study|Unacceptable Fit|1|||
144419978|NCT00241280|520743916|FG000|Overall Study|Scheduling Conflict|0|||
144419979|NCT00241280|520743917|FG001|Overall Study|Scheduling Conflict|2|||
144419980|NCT00241280|520743916|FG000|Overall Study|History of Ocular Surgery|0|||
144419981|NCT00241280|520743917|FG001|Overall Study|History of Ocular Surgery|1|||
144419982|NCT00241280|520743916|FG000|Overall Study|Coating on Lens|1|||
144180699|NCT01728116|519855549|FG000|Overall Study|Procedure/device failure|7|||
144419983|NCT00241280|520743917|FG001|Overall Study|Coating on Lens|0|||
144419984|NCT00241280|520743916|FG000|Overall Study|Excessive Dryness|0|||
144419985|NCT00241280|520743917|FG001|Overall Study|Excessive Dryness|1|||
144419986|NCT03358290|520743918|FG000|Overall Study|Study discontinued by Sponsor|0|||
144419987|NCT03358290|520743919|FG001|Overall Study|Study discontinued by Sponsor|1|||
144419988|NCT03358290|520743920|FG002|Overall Study|Study discontinued by Sponsor|1|||
144419989|NCT03358290|520743921|FG003|Overall Study|Study discontinued by Sponsor|0|||
144419990|NCT03358290|520743922|FG004|Overall Study|Study discontinued by Sponsor|0|||
144419991|NCT03358290|520743918|FG000|Overall Study|Adverse Event|0|||
144180700|NCT01728116|519855550|FG001|Overall Study|Procedure/device failure|0|||
144180701|NCT01728116|519855549|FG000|Overall Study|Lost to Follow-up|9|||
144180702|NCT01728116|519855550|FG001|Overall Study|Lost to Follow-up|2|||
144180703|NCT01728116|519855549|FG000|Overall Study|Physician Decision|2|||
144180704|NCT01728116|519855550|FG001|Overall Study|Physician Decision|0|||
144180705|NCT01728116|519855549|FG000|Overall Study|Subject Non-Compliance|2|||
144180706|NCT01728116|519855550|FG001|Overall Study|Subject Non-Compliance|0|||
144180707|NCT01728116|519855549|FG000|Overall Study|Inter-current finding at procedure|1|||
144180708|NCT01728116|519855550|FG001|Overall Study|Inter-current finding at procedure|0|||
144180709|NCT01728116|519855549|FG000|Overall Study|Incorrectly enrolled in Study|0|||
144180710|NCT01728116|519855550|FG001|Overall Study|Incorrectly enrolled in Study|1|||
144180711|NCT01728116|519855549|FG000|Overall Study|various not noted previously|5|||
144180712|NCT01728116|519855550|FG001|Overall Study|various not noted previously|0|||
144180713|NCT01868243|519855551|FG000|Overall Study|Death|0|||
144180714|NCT01868243|519855552|FG001|Overall Study|Death|1|||
144180715|NCT00467597|519855553|FG000|Overall Study|Withdrawal by Subject|2|||
144419992|NCT03358290|520743919|FG001|Overall Study|Adverse Event|0|||
144419993|NCT03358290|520743920|FG002|Overall Study|Adverse Event|1|||
144180716|NCT00467597|519855554|FG001|Overall Study|Withdrawal by Subject|0|||
144419994|NCT03358290|520743921|FG003|Overall Study|Adverse Event|2|||
144419995|NCT03358290|520743922|FG004|Overall Study|Adverse Event|0|||
144527564|NCT01456949|521133319|FG000|Enrollment|Withdrawal by Subject|7|||
144527565|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
144527566|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
144527567|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
144527568|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
144527569|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
144527570|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
144419996|NCT03358290|520743918|FG000|Overall Study|Withdrawal by Subject|0|||
144419997|NCT03358290|520743919|FG001|Overall Study|Withdrawal by Subject|0|||
144419998|NCT03358290|520743920|FG002|Overall Study|Withdrawal by Subject|0|||
144180717|NCT02096705|519855555|FG000|Treatment|Adverse Event|6|||
144180718|NCT02096705|519855556|FG001|Treatment|Adverse Event|3|||
144180719|NCT02096705|519855555|FG000|Treatment|Subject request to discontinue treatment|1|||
144419999|NCT03358290|520743921|FG003|Overall Study|Withdrawal by Subject|0|||
144420000|NCT03358290|520743922|FG004|Overall Study|Withdrawal by Subject|1|||
144420001|NCT02999854|520743924|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
144180720|NCT02096705|519855556|FG001|Treatment|Subject request to discontinue treatment|1|||
144180721|NCT02096705|519855555|FG000|Treatment|Withdrawal by Subject|1|||
144180722|NCT02096705|519855556|FG001|Treatment|Withdrawal by Subject|0|||
144180723|NCT02096705|519855555|FG000|Treatment|Other|1|||
144180724|NCT02096705|519855556|FG001|Treatment|Other|1|||
144180725|NCT02096705|519855555|FG000|Follow-up|Withdrawal by Subject|1|||
144420002|NCT02999854|520743925|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
144420003|NCT02999854|520743924|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
144180726|NCT02096705|519855556|FG001|Follow-up|Withdrawal by Subject|0|||
144180727|NCT02096705|519855555|FG000|Follow-up|Adverse Event|2|||
144180728|NCT02096705|519855556|FG001|Follow-up|Adverse Event|2|||
144180729|NCT02096705|519855555|FG000|Follow-up|Subjects not reporting status|1|||
144180730|NCT02096705|519855556|FG001|Follow-up|Subjects not reporting status|2|||
144180731|NCT00379353|519855557|FG000|Overall Study|Hospitalization|3|||
144180732|NCT00379353|519855558|FG001|Overall Study|Hospitalization|3|||
144180733|NCT00379353|519855557|FG000|Overall Study|Withdrawal by Subject|5|||
144180734|NCT00379353|519855558|FG001|Overall Study|Withdrawal by Subject|2|||
144180735|NCT00379353|519855557|FG000|Overall Study|Death|1|||
144420004|NCT02999854|520743925|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
144420005|NCT02999854|520743924|FG000|Active Study Phase (up to 18 Months)|Death|7|||
144420006|NCT02999854|520743925|FG001|Active Study Phase (up to 18 Months)|Death|5|||
144420007|NCT02999854|520743924|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
144420008|NCT02999854|520743925|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
144420009|NCT02999854|520743924|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
144420010|NCT02999854|520743925|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
144420011|NCT02999854|520743924|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
144420012|NCT02999854|520743925|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
144420013|NCT02999854|520743924|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
144420014|NCT02999854|520743925|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
144420015|NCT02999854|520743924|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
144420016|NCT02999854|520743925|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
144420017|NCT02848651|520743926|FG000|Overall Study|Death|85|||
144420018|NCT02848651|520743926|FG000|Overall Study|Lost to Follow-up|1|||
144420019|NCT02848651|520743926|FG000|Overall Study|Non-Compliance|1|||
144420020|NCT02848651|520743926|FG000|Overall Study|Symptomatic Deterioration|1|||
144420021|NCT02848651|520743926|FG000|Overall Study|Physician Decision|4|||
144420022|NCT02848651|520743926|FG000|Overall Study|Withdrawal by Subject|14|||
144420023|NCT04140292|520743927|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
144420024|NCT04140292|520743928|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
144420025|NCT00662363|520743931|FG000|Overall Study|Withdrawal by Subject|6|||
144420026|NCT00662363|520743932|FG001|Overall Study|Withdrawal by Subject|5|||
144420027|NCT00662363|520743931|FG000|Overall Study|Adverse Event|0|||
144420028|NCT00662363|520743932|FG001|Overall Study|Adverse Event|3|||
144251102|NCT00703326|520119242|FG000|Overall Study|Lost to Follow-up|47|||
144251103|NCT00703326|520119243|FG001|Overall Study|Lost to Follow-up|18|||
144251104|NCT00703326|520119242|FG000|Overall Study|Withdrawal by Subject|54|||
144420029|NCT00662363|520743931|FG000|Overall Study|Discharged early from rehab|4|||
144420030|NCT00662363|520743932|FG001|Overall Study|Discharged early from rehab|1|||
144420031|NCT00662363|520743931|FG000|Overall Study|Protocol Violation|1|||
144251105|NCT00703326|520119243|FG001|Overall Study|Withdrawal by Subject|20|||
144251106|NCT00703326|520119242|FG000|Overall Study|Adverse Event|1|||
144251107|NCT00703326|520119243|FG001|Overall Study|Adverse Event|0|||
144420032|NCT00662363|520743932|FG001|Overall Study|Protocol Violation|1|||
144420033|NCT03700671|520743936|FG000|Overall Study|Lack of Efficacy|1|||
144420034|NCT03700671|520743937|FG001|Overall Study|Lack of Efficacy|2|||
144420035|NCT04405037|520743938|FG000|Overall Study|Withdrawal by Subject|1|||
144420036|NCT04405037|520743939|FG001|Overall Study|Withdrawal by Subject|0|||
144420037|NCT04405037|520743938|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
144420038|NCT04405037|520743939|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
144420039|NCT02180867|520743940|FG000|Overall Study|Adverse Event|3|||
144420040|NCT02180867|520743941|FG001|Overall Study|Adverse Event|4|||
144420041|NCT02180867|520743942|FG002|Overall Study|Adverse Event|1|||
144420042|NCT02180867|520743943|FG003|Overall Study|Adverse Event|5|||
144420043|NCT02180867|520743944|FG004|Overall Study|Adverse Event|0|||
144420044|NCT02180867|520743945|FG005|Overall Study|Adverse Event|0|||
144180736|NCT00379353|519855558|FG001|Overall Study|Death|0|||
144180737|NCT00379353|519855557|FG000|Overall Study|Cardiac Tamponade|1|||
144251108|NCT01393106|520119249|FG000|Overall Study|Adverse Event|3|||
144601095|NCT02593786|521401734|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144180738|NCT00379353|519855558|FG001|Overall Study|Cardiac Tamponade|0|||
144180739|NCT00379353|519855557|FG000|Overall Study|Non-compliance|1|||
144180740|NCT00379353|519855558|FG001|Overall Study|Non-compliance|0|||
144420045|NCT02180867|520743946|FG006|Overall Study|Adverse Event|0|||
144420046|NCT02180867|520743940|FG000|Overall Study|Death|0|||
144420047|NCT02180867|520743941|FG001|Overall Study|Death|0|||
144180741|NCT00379353|519855557|FG000|Overall Study|Conflicting drug treatment|0|||
144420048|NCT02180867|520743942|FG002|Overall Study|Death|0|||
144180742|NCT00379353|519855558|FG001|Overall Study|Conflicting drug treatment|1|||
144420049|NCT02180867|520743943|FG003|Overall Study|Death|0|||
144420050|NCT02180867|520743944|FG004|Overall Study|Death|1|||
144420051|NCT02180867|520743945|FG005|Overall Study|Death|0|||
144420052|NCT02180867|520743946|FG006|Overall Study|Death|0|||
144420053|NCT02180867|520743940|FG000|Overall Study|Lack of Efficacy|0|||
144420054|NCT02180867|520743941|FG001|Overall Study|Lack of Efficacy|2|||
144420055|NCT02180867|520743942|FG002|Overall Study|Lack of Efficacy|0|||
144420056|NCT02180867|520743943|FG003|Overall Study|Lack of Efficacy|1|||
144420057|NCT02180867|520743944|FG004|Overall Study|Lack of Efficacy|6|||
144420058|NCT02180867|520743945|FG005|Overall Study|Lack of Efficacy|0|||
144420059|NCT02180867|520743946|FG006|Overall Study|Lack of Efficacy|1|||
144420060|NCT02180867|520743940|FG000|Overall Study|Physician Decision|1|||
144420061|NCT02180867|520743941|FG001|Overall Study|Physician Decision|3|||
144420062|NCT02180867|520743942|FG002|Overall Study|Physician Decision|1|||
144420063|NCT02180867|520743943|FG003|Overall Study|Physician Decision|10|||
144420064|NCT02180867|520743944|FG004|Overall Study|Physician Decision|9|||
144420065|NCT02180867|520743945|FG005|Overall Study|Physician Decision|3|||
144420066|NCT02180867|520743946|FG006|Overall Study|Physician Decision|4|||
144420067|NCT02180867|520743940|FG000|Overall Study|Withdrawal by Subject|0|||
144420068|NCT02180867|520743941|FG001|Overall Study|Withdrawal by Subject|0|||
144420069|NCT02180867|520743942|FG002|Overall Study|Withdrawal by Subject|0|||
144420070|NCT02180867|520743943|FG003|Overall Study|Withdrawal by Subject|1|||
144420071|NCT02180867|520743944|FG004|Overall Study|Withdrawal by Subject|1|||
144420072|NCT02180867|520743945|FG005|Overall Study|Withdrawal by Subject|0|||
144180743|NCT01958476|519855559|FG000|Overall Study|Parent requested exclusion from analysis|1|||
144180744|NCT01958476|519855560|FG001|Overall Study|Parent requested exclusion from analysis|0|||
144180745|NCT05412121|519855563|FG000|Overall Study|Withdrawal by Subject|4|||
144420073|NCT02180867|520743946|FG006|Overall Study|Withdrawal by Subject|0|||
144420074|NCT02180867|520743940|FG000|Overall Study|Ineligible|1|||
144420075|NCT02180867|520743941|FG001|Overall Study|Ineligible|2|||
144420076|NCT02180867|520743942|FG002|Overall Study|Ineligible|0|||
144420077|NCT02180867|520743943|FG003|Overall Study|Ineligible|3|||
144420078|NCT02180867|520743944|FG004|Overall Study|Ineligible|5|||
144420079|NCT02180867|520743945|FG005|Overall Study|Ineligible|0|||
144420080|NCT02180867|520743946|FG006|Overall Study|Ineligible|0|||
144420081|NCT02180867|520743940|FG000|Overall Study|Repeat Eligibility Studies|0|||
144420082|NCT02180867|520743941|FG001|Overall Study|Repeat Eligibility Studies|0|||
144420083|NCT02180867|520743942|FG002|Overall Study|Repeat Eligibility Studies|0|||
144420084|NCT02180867|520743943|FG003|Overall Study|Repeat Eligibility Studies|0|||
144420085|NCT02180867|520743944|FG004|Overall Study|Repeat Eligibility Studies|1|||
144420086|NCT02180867|520743945|FG005|Overall Study|Repeat Eligibility Studies|0|||
144420087|NCT02180867|520743946|FG006|Overall Study|Repeat Eligibility Studies|0|||
144420088|NCT02180867|520743940|FG000|Overall Study|Refusal of further protocol therapy|1|||
144420089|NCT02180867|520743941|FG001|Overall Study|Refusal of further protocol therapy|0|||
144420090|NCT02180867|520743942|FG002|Overall Study|Refusal of further protocol therapy|2|||
144420091|NCT02180867|520743943|FG003|Overall Study|Refusal of further protocol therapy|6|||
144420092|NCT02180867|520743944|FG004|Overall Study|Refusal of further protocol therapy|4|||
144420093|NCT02180867|520743945|FG005|Overall Study|Refusal of further protocol therapy|0|||
144420094|NCT02180867|520743946|FG006|Overall Study|Refusal of further protocol therapy|0|||
144420095|NCT03578367|520743947|FG000|Overall Study|Adverse Event|0|||
144420096|NCT03578367|520743948|FG001|Overall Study|Adverse Event|3|||
144420097|NCT03578367|520743949|FG002|Overall Study|Adverse Event|0|||
144420098|NCT03578367|520743950|FG003|Overall Study|Adverse Event|5|||
144420099|NCT03578367|520743947|FG000|Overall Study|Withdrawal by Subject|2|||
144601096|NCT02593786|521401731|FG000|Overall Study|Participant request to discontinue study therapy|0|||
144601097|NCT02593786|521401732|FG001|Overall Study|Participant request to discontinue study therapy|2|||
144180746|NCT05412121|519855563|FG000|Overall Study|Physician Decision|1|||
144180747|NCT05412121|519855563|FG000|Overall Study|Lost to Follow-up|5|||
144180748|NCT02670551|519855564|FG000|Overall Study|Adverse Event|4|||
144420100|NCT03578367|520743948|FG001|Overall Study|Withdrawal by Subject|2|||
144420101|NCT03578367|520743949|FG002|Overall Study|Withdrawal by Subject|1|||
144420102|NCT03578367|520743950|FG003|Overall Study|Withdrawal by Subject|3|||
144420103|NCT03578367|520743947|FG000|Overall Study|Physician Decision|0|||
144420104|NCT03578367|520743948|FG001|Overall Study|Physician Decision|0|||
144420105|NCT03578367|520743949|FG002|Overall Study|Physician Decision|14|||
144420106|NCT03578367|520743950|FG003|Overall Study|Physician Decision|0|||
144420107|NCT03578367|520743947|FG000|Overall Study|Death|1|||
144420108|NCT03578367|520743948|FG001|Overall Study|Death|0|||
144420109|NCT03578367|520743949|FG002|Overall Study|Death|0|||
144420110|NCT03578367|520743950|FG003|Overall Study|Death|0|||
144420111|NCT03578367|520743947|FG000|Overall Study|Not treated|0|||
144420112|NCT03578367|520743948|FG001|Overall Study|Not treated|0|||
144420113|NCT03578367|520743949|FG002|Overall Study|Not treated|1|||
144420114|NCT03578367|520743950|FG003|Overall Study|Not treated|0|||
144420115|NCT01853826|520745824|FG000|Overall Study|Patients who switched to commercial drug|11|||
144420116|NCT01853826|520745824|FG000|Overall Study|Patient refused to continue medication|21|||
144420117|NCT01853826|520745824|FG000|Overall Study|Lost to Follow-up|2|||
144420118|NCT01853826|520745824|FG000|Overall Study|Non-compliant with protocol|4|||
144420119|NCT01853826|520745824|FG000|Overall Study|Other adverse events (AE)|62|||
144420120|NCT01853826|520745824|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
144420121|NCT01853826|520745824|FG000|Overall Study|Progressive disease|342|||
144420122|NCT01853826|520745824|FG000|Overall Study|Other than listed|13|||
144420123|NCT01853826|520745824|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
144420124|NCT03653637|520745825|FG000|Overall Study|Death|1|||
144420125|NCT03653637|520745826|FG001|Overall Study|Death|3|||
144420126|NCT03653637|520745825|FG000|Overall Study|Lost to Follow-up|29|||
144420127|NCT03653637|520745826|FG001|Overall Study|Lost to Follow-up|30|||
144420128|NCT03653637|520745825|FG000|Overall Study|Physician Decision|1|||
144420129|NCT03653637|520745826|FG001|Overall Study|Physician Decision|1|||
144420130|NCT03653637|520745825|FG000|Overall Study|Withdrawal by Subject|7|||
144420131|NCT03653637|520745826|FG001|Overall Study|Withdrawal by Subject|4|||
144420132|NCT05661942|520745828|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
144420133|NCT05661942|520745829|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
144420134|NCT02927080|520745830|FG000|Overall Study|Withdrawal by Subject|0|||
144420135|NCT02927080|520745831|FG001|Overall Study|Withdrawal by Subject|0|||
144420136|NCT02927080|520745832|FG002|Overall Study|Withdrawal by Subject|0|||
144420137|NCT02927080|520745833|FG003|Overall Study|Withdrawal by Subject|0|||
144420138|NCT02927080|520745834|FG004|Overall Study|Withdrawal by Subject|1|||
144420139|NCT02927080|520745835|FG005|Overall Study|Withdrawal by Subject|0|||
144420140|NCT02927080|520745836|FG006|Overall Study|Withdrawal by Subject|1|||
144420141|NCT02927080|520745837|FG007|Overall Study|Withdrawal by Subject|1|||
144420142|NCT02927080|520745838|FG008|Overall Study|Withdrawal by Subject|0|||
144420143|NCT02927080|520745839|FG009|Overall Study|Withdrawal by Subject|2|||
144420144|NCT02927080|520745830|FG000|Overall Study|Willingness to comply with protocol|0|||
144420145|NCT02927080|520745831|FG001|Overall Study|Willingness to comply with protocol|0|||
144420146|NCT02927080|520745832|FG002|Overall Study|Willingness to comply with protocol|0|||
144420147|NCT02927080|520745833|FG003|Overall Study|Willingness to comply with protocol|0|||
144420148|NCT02927080|520745834|FG004|Overall Study|Willingness to comply with protocol|0|||
144420149|NCT02927080|520745835|FG005|Overall Study|Willingness to comply with protocol|0|||
144420150|NCT02927080|520745836|FG006|Overall Study|Willingness to comply with protocol|0|||
144420151|NCT02927080|520745837|FG007|Overall Study|Willingness to comply with protocol|0|||
144420152|NCT02927080|520745838|FG008|Overall Study|Willingness to comply with protocol|0|||
144420153|NCT02927080|520745839|FG009|Overall Study|Willingness to comply with protocol|1|||
144420154|NCT02927080|520745830|FG000|Overall Study|Study terminated by Sponsor|0|||
144420155|NCT02927080|520745831|FG001|Overall Study|Study terminated by Sponsor|0|||
144420156|NCT02927080|520745832|FG002|Overall Study|Study terminated by Sponsor|0|||
144420157|NCT02927080|520745833|FG003|Overall Study|Study terminated by Sponsor|0|||
144420158|NCT02927080|520745834|FG004|Overall Study|Study terminated by Sponsor|0|||
144420159|NCT02927080|520745835|FG005|Overall Study|Study terminated by Sponsor|0|||
144420160|NCT02927080|520745836|FG006|Overall Study|Study terminated by Sponsor|6|||
144420161|NCT02927080|520745837|FG007|Overall Study|Study terminated by Sponsor|7|||
144420162|NCT02927080|520745838|FG008|Overall Study|Study terminated by Sponsor|2|||
144420163|NCT02927080|520745839|FG009|Overall Study|Study terminated by Sponsor|3|||
144420164|NCT02927080|520745830|FG000|Overall Study|Adverse Event|0|||
144420165|NCT02927080|520745831|FG001|Overall Study|Adverse Event|1|||
144420166|NCT02927080|520745832|FG002|Overall Study|Adverse Event|0|||
144420167|NCT02927080|520745833|FG003|Overall Study|Adverse Event|0|||
144420168|NCT02927080|520745834|FG004|Overall Study|Adverse Event|0|||
144420169|NCT02927080|520745835|FG005|Overall Study|Adverse Event|0|||
144420170|NCT02927080|520745836|FG006|Overall Study|Adverse Event|0|||
144420171|NCT02927080|520745837|FG007|Overall Study|Adverse Event|1|||
144420172|NCT02927080|520745838|FG008|Overall Study|Adverse Event|0|||
144420173|NCT02927080|520745839|FG009|Overall Study|Adverse Event|1|||
144180749|NCT02670551|519855565|FG001|Overall Study|Adverse Event|7|||
144180750|NCT02670551|519855566|FG002|Overall Study|Adverse Event|9|||
144180751|NCT02670551|519855564|FG000|Overall Study|Lack of Efficacy|2|||
144180752|NCT02670551|519855565|FG001|Overall Study|Lack of Efficacy|0|||
144180753|NCT02670551|519855566|FG002|Overall Study|Lack of Efficacy|3|||
144180754|NCT02670551|519855564|FG000|Overall Study|Withdrawal of Consent|6|||
144420174|NCT02927080|520745830|FG000|Overall Study|Other|0|||
144420175|NCT02927080|520745831|FG001|Overall Study|Other|0|||
144420176|NCT02927080|520745832|FG002|Overall Study|Other|0|||
144420177|NCT02927080|520745833|FG003|Overall Study|Other|0|||
144420178|NCT02927080|520745834|FG004|Overall Study|Other|0|||
144420179|NCT02927080|520745835|FG005|Overall Study|Other|0|||
144420180|NCT02927080|520745836|FG006|Overall Study|Other|1|||
144420181|NCT02927080|520745837|FG007|Overall Study|Other|0|||
144420182|NCT02927080|520745838|FG008|Overall Study|Other|1|||
144420183|NCT02927080|520745839|FG009|Overall Study|Other|0|||
144420184|NCT02664441|520745840|FG000|Randomization|Withdrawal by Subject|0|||
144420185|NCT02664441|520745841|FG001|Randomization|Withdrawal by Subject|1|||
144420186|NCT02664441|520745840|FG000|36-week Randomized Trial|Adverse Event|2|||
144420187|NCT02664441|520745841|FG001|36-week Randomized Trial|Adverse Event|0|||
144420188|NCT02664441|520745840|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
144420189|NCT02664441|520745841|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
144420190|NCT02664441|520745840|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
144420191|NCT02664441|520745841|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
144420192|NCT02664441|520745840|FG000|18-week Open Label Extension|Adverse Event|1|||
144420193|NCT02664441|520745841|FG001|18-week Open Label Extension|Adverse Event|0|||
144420194|NCT02664441|520745840|FG000|18-week Open Label Extension|Physician Decision|1|||
144420195|NCT02664441|520745841|FG001|18-week Open Label Extension|Physician Decision|0|||
144420196|NCT02664441|520745840|FG000|18-week Open Label Extension|Death|1|||
144420197|NCT02664441|520745841|FG001|18-week Open Label Extension|Death|0|||
144420198|NCT02664441|520745840|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
144420199|NCT02664441|520745841|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
144420200|NCT05040386|520745842|FG000|Overall Study|Withdrawal by Subject|1|||
144420201|NCT05040386|520745843|FG001|Overall Study|Withdrawal by Subject|0|||
144420202|NCT05040386|520745844|FG002|Overall Study|Withdrawal by Subject|1|||
144420203|NCT05040386|520745845|FG003|Overall Study|Withdrawal by Subject|0|||
144420204|NCT05040386|520745842|FG000|Overall Study|Lost to Follow-up|0|||
144420205|NCT05040386|520745843|FG001|Overall Study|Lost to Follow-up|0|||
144420206|NCT05040386|520745844|FG002|Overall Study|Lost to Follow-up|1|||
144420207|NCT05040386|520745845|FG003|Overall Study|Lost to Follow-up|0|||
144420208|NCT00082355|520745846|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
144420209|NCT00082355|520745846|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
144420210|NCT00082355|520745846|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
144420211|NCT01084174|520745847|FG000|Overall Study|gastrointestinal symptoms|1|||
144420212|NCT01084174|520745848|FG001|Overall Study|gastrointestinal symptoms|1|||
144420213|NCT01084174|520745847|FG000|Overall Study|Eosinophilic esophagitis|0|||
144420214|NCT01084174|520745848|FG001|Overall Study|Eosinophilic esophagitis|1|||
144420215|NCT01084174|520745847|FG000|Overall Study|Anaphylaxis|0|||
144420216|NCT01084174|520745848|FG001|Overall Study|Anaphylaxis|1|||
144420217|NCT01084174|520745847|FG000|Overall Study|Participant noncompliance|0|||
144420218|NCT01084174|520745848|FG001|Overall Study|Participant noncompliance|1|||
144420219|NCT01594125|520745849|FG000|Overall Study|Withdrawal by Subject|1|||
144420220|NCT01594125|520745850|FG001|Overall Study|Withdrawal by Subject|0|||
144420221|NCT01594125|520745851|FG002|Overall Study|Withdrawal by Subject|0|||
144420222|NCT01594125|520745852|FG003|Overall Study|Withdrawal by Subject|1|||
144420223|NCT01594125|520745853|FG004|Overall Study|Withdrawal by Subject|0|||
144420224|NCT01594125|520745849|FG000|Overall Study|Progressive Disease|3|||
144420225|NCT01594125|520745850|FG001|Overall Study|Progressive Disease|12|||
144420226|NCT01594125|520745851|FG002|Overall Study|Progressive Disease|3|||
144420227|NCT01594125|520745852|FG003|Overall Study|Progressive Disease|3|||
144420228|NCT01594125|520745853|FG004|Overall Study|Progressive Disease|7|||
144420229|NCT01484873|520745854|FG000|Overall Study|Withdrawal by Subject|2|||
144420230|NCT01549392|520745855|FG000|Overall Study|Withdrawal by Subject|1|||
144723217|NCT01058421|521840660|FG000|3 Month Outcomes|Remained in Hospital|0|||
144723218|NCT01058421|521840661|FG001|3 Month Outcomes|Remained in Hospital|2|||
144180755|NCT02670551|519855565|FG001|Overall Study|Withdrawal of Consent|3|||
144180756|NCT02670551|519855566|FG002|Overall Study|Withdrawal of Consent|8|||
144180757|NCT02670551|519855564|FG000|Overall Study|Lost to Follow-up|5|||
144180758|NCT02670551|519855565|FG001|Overall Study|Lost to Follow-up|7|||
144180759|NCT02670551|519855566|FG002|Overall Study|Lost to Follow-up|6|||
144180760|NCT02670551|519855564|FG000|Overall Study|Protocol Violation|1|||
144180761|NCT02670551|519855565|FG001|Overall Study|Protocol Violation|0|||
144180762|NCT02670551|519855566|FG002|Overall Study|Protocol Violation|0|||
144180763|NCT02670551|519855564|FG000|Overall Study|Noncompliance with study drug|3|||
144180764|NCT02670551|519855565|FG001|Overall Study|Noncompliance with study drug|3|||
144180765|NCT02670551|519855566|FG002|Overall Study|Noncompliance with study drug|2|||
144180766|NCT02670551|519855564|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144180767|NCT02670551|519855565|FG001|Overall Study|Other Miscellaneous Reasons|3|||
144180768|NCT02670551|519855566|FG002|Overall Study|Other Miscellaneous Reasons|3|||
144180769|NCT02670551|519855564|FG000|Overall Study|Did Not Receive Treatment|5|||
144180770|NCT02670551|519855565|FG001|Overall Study|Did Not Receive Treatment|3|||
144180771|NCT02670551|519855566|FG002|Overall Study|Did Not Receive Treatment|0|||
144180772|NCT00537095|519855568|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
144180773|NCT00537095|519855569|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
144180774|NCT00537095|519855568|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
144180775|NCT00537095|519855569|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
144180776|NCT00537095|519855568|FG000|Randomized Treatment Period (433 Days)|Death|3|||
144180777|NCT00537095|519855569|FG001|Randomized Treatment Period (433 Days)|Death|1|||
144180778|NCT00537095|519855568|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
144180779|NCT00537095|519855569|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
144420231|NCT01549392|520745856|FG001|Overall Study|Withdrawal by Subject|0|||
144723219|NCT01058421|521840660|FG000|3 Month Outcomes|Remained in Other Facility|5|||
144420232|NCT02743806|520745857|FG000|Overall Study|Adverse Event|9|||
144420233|NCT02743806|520745857|FG000|Overall Study|Lost to Follow-up|8|||
144420234|NCT02743806|520745857|FG000|Overall Study|Voluntary Withdrawal|54|||
144420235|NCT02743806|520745857|FG000|Overall Study|Study Termination|65|||
144420236|NCT02743806|520745857|FG000|Overall Study|Pregnancy|6|||
144420237|NCT02743806|520745857|FG000|Overall Study|No Longer Clinically Benefiting|27|||
144420238|NCT02743806|520745857|FG000|Overall Study|Reason Not Specified|12|||
144420239|NCT01988103|520745858|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
144420240|NCT01988103|520745859|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
144420241|NCT01988103|520745860|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
144420242|NCT01988103|520745861|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
144420243|NCT01988103|520745862|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
144420244|NCT01988103|520745858|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
144420245|NCT01988103|520745859|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
144420246|NCT01988103|520745860|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
144420247|NCT01988103|520745861|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
144420248|NCT01988103|520745862|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
144420249|NCT01988103|520745858|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
144420250|NCT01988103|520745859|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
144420251|NCT01988103|520745860|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
144420252|NCT01988103|520745861|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
144420253|NCT01988103|520745862|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
144420254|NCT01988103|520745858|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
144420255|NCT01988103|520745859|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
144420256|NCT01988103|520745860|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
144420257|NCT01988103|520745861|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
144420258|NCT01988103|520745862|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
144420259|NCT01988103|520745858|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
144420260|NCT01988103|520745859|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
144420261|NCT01988103|520745860|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
144420262|NCT01988103|520745861|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
144420263|NCT01988103|520745862|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
144420264|NCT01988103|520745858|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
144420265|NCT01988103|520745859|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
144420266|NCT01988103|520745860|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
144420267|NCT01988103|520745861|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
144420268|NCT01988103|520745862|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
144420269|NCT01988103|520745858|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
144420270|NCT01988103|520745859|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
144420271|NCT01988103|520745860|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
144420272|NCT01988103|520745861|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
144420273|NCT01988103|520745862|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
144420274|NCT05492942|520745863|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
144420275|NCT05492942|520745864|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
144420276|NCT05492942|520745865|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
144420277|NCT05492942|520745866|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
144420278|NCT02598076|520745869|FG000|Overall Study|Lost to Follow-up|2|||
144420279|NCT02598076|520745870|FG001|Overall Study|Lost to Follow-up|3|||
144180780|NCT00537095|519855568|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
144420280|NCT01946425|520745872|FG000|Overall Study|Protocol Violation|1|||
144420281|NCT01946425|520745873|FG001|Overall Study|Protocol Violation|0|||
144420282|NCT01946425|520745872|FG000|Overall Study|Withdrawal by Subject|1|||
144420283|NCT01946425|520745873|FG001|Overall Study|Withdrawal by Subject|0|||
144420284|NCT03103919|520745876|FG000|Overall Study|Adverse Event|2|||
144420285|NCT03103919|520745877|FG001|Overall Study|Adverse Event|2|||
144420286|NCT03998189|520745878|FG000|Overall Study|Lack of Efficacy|0|||
144420287|NCT03998189|520745879|FG001|Overall Study|Lack of Efficacy|1|||
144420288|NCT03454893|520745882|FG000|Overall Study|Study Terminated by the Sponsor|5|||
144420289|NCT03454893|520745882|FG000|Overall Study|Did not pass screening|4|||
144420290|NCT04876274|520745883|FG000|Overall Study|Lost to Follow-up|9|||
144420291|NCT04876274|520745884|FG001|Overall Study|Lost to Follow-up|12|||
144420292|NCT03414424|520745885|FG000|Overall Study|Screened out after consent|0|||
144420293|NCT03414424|520745886|FG001|Overall Study|Screened out after consent|2|||
144420294|NCT03414424|520745885|FG000|Overall Study|Lost to Follow-up|0|||
144601098|NCT02593786|521401733|FG002|Overall Study|Participant request to discontinue study therapy|0|||
144199337|NCT03107026|519928870|FG000|Overall Study|non compliance with study visits|1|||
144180781|NCT00537095|519855569|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
144180782|NCT00537095|519855568|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
144180783|NCT00537095|519855569|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
144180784|NCT00537095|519855568|FG000|Open-label Period (590 Days)|Adverse Event|2|||
144180785|NCT00537095|519855569|FG001|Open-label Period (590 Days)|Adverse Event|11|||
144180786|NCT00537095|519855568|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
144180787|NCT00537095|519855569|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
144180788|NCT00537095|519855568|FG000|Open-label Period (590 Days)|Death|2|||
144180789|NCT00537095|519855569|FG001|Open-label Period (590 Days)|Death|2|||
144180790|NCT00537095|519855568|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
144180791|NCT00537095|519855569|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
144180792|NCT00537095|519855568|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
144180793|NCT00537095|519855569|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
144180794|NCT00714051|519855571|FG000|Overall Study|Withdrawal by Subject|1|||
144180795|NCT00714051|519855572|FG001|Overall Study|Withdrawal by Subject|0|||
144180796|NCT00714051|519855571|FG000|Overall Study|Death|0|||
144180797|NCT00714051|519855572|FG001|Overall Study|Death|1|||
144420295|NCT03414424|520745886|FG001|Overall Study|Lost to Follow-up|1|||
144420296|NCT03527966|520745887|FG000|Overall Study|Lost to Follow-up|3|||
144420297|NCT03527966|520745888|FG001|Overall Study|Lost to Follow-up|0|||
144420298|NCT01948050|520745889|FG000|Overall Study|Withdrawal by Subject|0|||
144420299|NCT01948050|520745890|FG001|Overall Study|Withdrawal by Subject|1|||
144420300|NCT00558025|520745891|FG000|Overall Study|Adverse Event|1|||
144180798|NCT01929681|519855573|FG000|Overall Study|Withdrawal by Subject|1|||
144420301|NCT00558025|520745892|FG001|Overall Study|Adverse Event|1|||
144420302|NCT00558025|520745891|FG000|Overall Study|Withdrawal by Subject|2|||
144420303|NCT00558025|520745892|FG001|Overall Study|Withdrawal by Subject|2|||
144420304|NCT00558025|520745891|FG000|Overall Study|Protocol Violation|1|||
144420305|NCT00558025|520745892|FG001|Overall Study|Protocol Violation|0|||
144420306|NCT02288559|520745893|FG000|Overall Study|Adverse Event|1|||
144420307|NCT02288559|520745894|FG001|Overall Study|Adverse Event|1|||
144420308|NCT02288559|520745895|FG002|Overall Study|Adverse Event|5|||
144420309|NCT02288559|520745896|FG003|Overall Study|Adverse Event|0|||
144420310|NCT02288559|520745893|FG000|Overall Study|Death|0|||
144420311|NCT02288559|520745894|FG001|Overall Study|Death|0|||
144420312|NCT02288559|520745895|FG002|Overall Study|Death|1|||
144420313|NCT02288559|520745896|FG003|Overall Study|Death|0|||
144420314|NCT02288559|520745893|FG000|Overall Study|Lost to Follow-up|0|||
144420315|NCT02288559|520745894|FG001|Overall Study|Lost to Follow-up|0|||
144420316|NCT02288559|520745895|FG002|Overall Study|Lost to Follow-up|0|||
144420317|NCT02288559|520745896|FG003|Overall Study|Lost to Follow-up|1|||
144420318|NCT02288559|520745893|FG000|Overall Study|Withdrawal by Subject|0|||
144420319|NCT02288559|520745894|FG001|Overall Study|Withdrawal by Subject|0|||
144420320|NCT02288559|520745895|FG002|Overall Study|Withdrawal by Subject|2|||
144420321|NCT02288559|520745896|FG003|Overall Study|Withdrawal by Subject|1|||
144420322|NCT02288559|520745893|FG000|Overall Study|Reason Not Specified|0|||
144420323|NCT02288559|520745894|FG001|Overall Study|Reason Not Specified|0|||
144420324|NCT02288559|520745895|FG002|Overall Study|Reason Not Specified|3|||
144420325|NCT02288559|520745896|FG003|Overall Study|Reason Not Specified|0|||
144420326|NCT00449540|520745898|FG000|Pretreatment Phase|No migraine experienced|66|||
144420327|NCT00449540|520745899|FG001|Pretreatment Phase|No migraine experienced|0|||
144420328|NCT00449540|520745900|FG002|Pretreatment Phase|No migraine experienced|0|||
144420329|NCT00449540|520745898|FG000|Treatment Phase|did not experience or treat migraine|0|||
144420330|NCT00449540|520745899|FG001|Treatment Phase|did not experience or treat migraine|20|||
144420331|NCT00449540|520745900|FG002|Treatment Phase|did not experience or treat migraine|17|||
144420332|NCT04545866|520745901|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
144420333|NCT04545866|520745902|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
144420334|NCT04545866|520745901|FG000|Overall Study|Withdrawal by Physician|1|||
144420335|NCT04545866|520745902|FG001|Overall Study|Withdrawal by Physician|0|||
144420336|NCT05247866|520745903|FG000|Overall Study|Adverse Event|2|||
144420337|NCT05247866|520745903|FG000|Overall Study|Lack of Efficacy|1|||
144420338|NCT05247866|520745903|FG000|Overall Study|Protocol Violation|1|||
144180799|NCT01929681|519855574|FG001|Overall Study|Withdrawal by Subject|0|||
144180800|NCT01929681|519855573|FG000|Overall Study|Physician Decision|1|||
144601099|NCT02593786|521401734|FG003|Overall Study|Participant request to discontinue study therapy|0|||
144723220|NCT01058421|521840661|FG001|3 Month Outcomes|Remained in Other Facility|8|||
144180801|NCT01929681|519855574|FG001|Overall Study|Physician Decision|1|||
144180802|NCT02535923|519855581|FG000|Overall Study|Lost to Follow-up|5|||
144180803|NCT02535923|519855582|FG001|Overall Study|Lost to Follow-up|5|||
144180804|NCT02535923|519855581|FG000|Overall Study|Withdrawal by Subject|4|||
144180805|NCT02535923|519855582|FG001|Overall Study|Withdrawal by Subject|3|||
144420339|NCT05247866|520745903|FG000|Overall Study|Withdrawal by Subject|3|||
144420340|NCT04463719|520745906|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
144420341|NCT04463719|520745907|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
144420342|NCT04463719|520745908|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
144420343|NCT00333866|520745911|FG000|Overall Study|Adverse Event|23|||
144420344|NCT00333866|520745912|FG001|Overall Study|Adverse Event|37|||
144420345|NCT00333866|520745913|FG002|Overall Study|Adverse Event|38|||
144420346|NCT00333866|520745914|FG003|Overall Study|Adverse Event|47|||
144420347|NCT00333866|520745911|FG000|Overall Study|Other|3|||
144420348|NCT00333866|520745912|FG001|Overall Study|Other|2|||
144420349|NCT00333866|520745913|FG002|Overall Study|Other|2|||
144420350|NCT00333866|520745914|FG003|Overall Study|Other|2|||
144420351|NCT00333866|520745911|FG000|Overall Study|Lack of Efficacy|8|||
144420352|NCT00333866|520745912|FG001|Overall Study|Lack of Efficacy|6|||
144420353|NCT00333866|520745913|FG002|Overall Study|Lack of Efficacy|3|||
144420354|NCT00333866|520745914|FG003|Overall Study|Lack of Efficacy|5|||
144420355|NCT00333866|520745911|FG000|Overall Study|Lost to Follow-up|1|||
144420356|NCT00333866|520745912|FG001|Overall Study|Lost to Follow-up|2|||
144420357|NCT00333866|520745913|FG002|Overall Study|Lost to Follow-up|2|||
144420358|NCT00333866|520745914|FG003|Overall Study|Lost to Follow-up|2|||
144420359|NCT00333866|520745911|FG000|Overall Study|Withdrawal by Subject|8|||
144420360|NCT00333866|520745912|FG001|Overall Study|Withdrawal by Subject|14|||
144420361|NCT00333866|520745913|FG002|Overall Study|Withdrawal by Subject|4|||
144420362|NCT00333866|520745914|FG003|Overall Study|Withdrawal by Subject|9|||
144420363|NCT00333866|520745911|FG000|Overall Study|Randomized but not Treated|5|||
144420364|NCT00333866|520745912|FG001|Overall Study|Randomized but not Treated|3|||
144420365|NCT00333866|520745913|FG002|Overall Study|Randomized but not Treated|2|||
144420366|NCT00333866|520745914|FG003|Overall Study|Randomized but not Treated|1|||
144420367|NCT06073119|520745915|FG000|Overall Study|Adverse Event|1|||
144420368|NCT06073119|520745916|FG001|Overall Study|Adverse Event|3|||
144420369|NCT06073119|520745917|FG002|Overall Study|Adverse Event|0|||
144420370|NCT06073119|520745918|FG003|Overall Study|Adverse Event|0|||
144420371|NCT06073119|520745919|FG004|Overall Study|Adverse Event|1|||
144420372|NCT06073119|520745920|FG005|Overall Study|Adverse Event|0|||
144420373|NCT06073119|520745915|FG000|Overall Study|Non-compliance with study schedule|1|||
144420374|NCT06073119|520745916|FG001|Overall Study|Non-compliance with study schedule|0|||
144420375|NCT06073119|520745917|FG002|Overall Study|Non-compliance with study schedule|0|||
144420376|NCT06073119|520745918|FG003|Overall Study|Non-compliance with study schedule|0|||
144420377|NCT06073119|520745919|FG004|Overall Study|Non-compliance with study schedule|1|||
144420378|NCT06073119|520745920|FG005|Overall Study|Non-compliance with study schedule|0|||
144420379|NCT06073119|520745915|FG000|Overall Study|Withdrawal by Subject|4|||
144420380|NCT06073119|520745916|FG001|Overall Study|Withdrawal by Subject|4|||
144420381|NCT06073119|520745917|FG002|Overall Study|Withdrawal by Subject|3|||
144420382|NCT06073119|520745918|FG003|Overall Study|Withdrawal by Subject|5|||
144420383|NCT06073119|520745919|FG004|Overall Study|Withdrawal by Subject|3|||
144420384|NCT06073119|520745920|FG005|Overall Study|Withdrawal by Subject|1|||
144420385|NCT06073119|520745915|FG000|Overall Study|Other|2|||
144420386|NCT06073119|520745916|FG001|Overall Study|Other|4|||
144420387|NCT06073119|520745917|FG002|Overall Study|Other|1|||
144420388|NCT06073119|520745918|FG003|Overall Study|Other|0|||
144420389|NCT06073119|520745919|FG004|Overall Study|Other|1|||
144420390|NCT06073119|520745920|FG005|Overall Study|Other|0|||
144420391|NCT02393547|520745923|FG000|Overall Study|Adverse Event|2|||
144420392|NCT02393547|520745923|FG000|Overall Study|Withdrawal by Subject|3|||
144420393|NCT02393547|520745923|FG000|Overall Study|Lost to Follow-up|1|||
144420394|NCT02979522|520745924|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
144420395|NCT02979522|520745925|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
144601100|NCT02593786|521401731|FG000|Overall Study|Other reasons|1|||
144601101|NCT02593786|521401732|FG001|Overall Study|Other reasons|1|||
144601102|NCT02593786|521401733|FG002|Overall Study|Other reasons|0|||
144601103|NCT02593786|521401734|FG003|Overall Study|Other reasons|5|||
144601104|NCT01019980|521401735|FG000|Overall Study|Drug not available.|2|||
144180806|NCT00685334|519855583|FG000|Overall Study|Withdrawal by Subject|5|||
144420396|NCT02979522|520745924|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
144420397|NCT02979522|520745925|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
144420398|NCT05185089|520745926|FG000|First Intervention (4 weeks)|Adverse Event|0|||
144420399|NCT05185089|520745927|FG001|First Intervention (4 weeks)|Adverse Event|0|||
144420400|NCT05185089|520745928|FG002|First Intervention (4 weeks)|Adverse Event|0|||
144420401|NCT05185089|520745929|FG003|First Intervention (4 weeks)|Adverse Event|1|||
144420402|NCT05185089|520745926|FG000|Second Intervention (4 weeks)|Death|0|||
144420403|NCT05185089|520745927|FG001|Second Intervention (4 weeks)|Death|1|||
144420404|NCT05185089|520745928|FG002|Second Intervention (4 weeks)|Death|0|||
144420405|NCT05185089|520745929|FG003|Second Intervention (4 weeks)|Death|0|||
144420406|NCT05185089|520745926|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
144420407|NCT05185089|520745927|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
144420408|NCT05185089|520745928|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
144420409|NCT05185089|520745929|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
144601105|NCT01019980|521401736|FG001|Overall Study|Drug not available.|0|||
144420410|NCT00667368|520745930|FG000|Overall Study|Lost to Follow-up|176|||
144420411|NCT00667368|520745931|FG001|Overall Study|Lost to Follow-up|155|||
144420412|NCT00667368|520745930|FG000|Overall Study|Discontinued early|24|||
144420413|NCT00667368|520745931|FG001|Overall Study|Discontinued early|17|||
144420414|NCT05582889|520745933|FG000|Overall Study|Health event|3|||
144420415|NCT05582889|520745934|FG001|Overall Study|Health event|2|||
144420416|NCT05582889|520745933|FG000|Overall Study|Lost to Follow-up|2|||
144420417|NCT05582889|520745934|FG001|Overall Study|Lost to Follow-up|4|||
144420418|NCT06112756|520745935|FG000|Overall Study|Withdrawal by Subject|0|||
144420419|NCT06112756|520745936|FG001|Overall Study|Withdrawal by Subject|2|||
144420420|NCT06112756|520745935|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
144420421|NCT06112756|520745936|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
144420422|NCT06112756|520745935|FG000|Overall Study|Adverse Event|2|||
144420423|NCT06112756|520745936|FG001|Overall Study|Adverse Event|2|||
144420424|NCT04551092|520745937|FG000|Overall Study|Lost to Follow-up|7|||
144420425|NCT04551092|520745937|FG000|Overall Study|Withdrawal by Subject|4|||
144420426|NCT01712490|520745938|FG000|Overall Study|Ongoing|601|||
144420427|NCT01712490|520745939|FG001|Overall Study|Ongoing|586|||
144420428|NCT01712490|520745938|FG000|Overall Study|Other|11|||
144420429|NCT01712490|520745939|FG001|Overall Study|Other|11|||
144420430|NCT01712490|520745938|FG000|Overall Study|Withdrawal by Subject|36|||
144420431|NCT01712490|520745939|FG001|Overall Study|Withdrawal by Subject|44|||
144420432|NCT01712490|520745938|FG000|Overall Study|Lost to Follow-up|16|||
144420433|NCT01712490|520745939|FG001|Overall Study|Lost to Follow-up|29|||
144420434|NCT06079320|520745940|FG000|Follow up Phase|Lost to Follow-up|1|||
144420435|NCT06079320|520745941|FG001|Follow up Phase|Lost to Follow-up|0|||
144420436|NCT01129960|520745942|FG000|Overall Study|Withdrawal by Subject|3|||
144420437|NCT01129960|520745943|FG001|Overall Study|Withdrawal by Subject|0|||
144420438|NCT01129960|520745944|FG002|Overall Study|Withdrawal by Subject|3|||
144420439|NCT01129960|520745945|FG003|Overall Study|Withdrawal by Subject|2|||
144420440|NCT01129960|520745942|FG000|Overall Study|Lack of Efficacy|1|||
144420441|NCT01129960|520745943|FG001|Overall Study|Lack of Efficacy|1|||
144420442|NCT01129960|520745944|FG002|Overall Study|Lack of Efficacy|1|||
144420443|NCT01129960|520745945|FG003|Overall Study|Lack of Efficacy|1|||
144420444|NCT01129960|520745942|FG000|Overall Study|Adverse Event|23|||
144420445|NCT01129960|520745943|FG001|Overall Study|Adverse Event|16|||
144420446|NCT01129960|520745944|FG002|Overall Study|Adverse Event|16|||
144420447|NCT01129960|520745945|FG003|Overall Study|Adverse Event|7|||
144420448|NCT01129960|520745942|FG000|Overall Study|Protocol Violation|1|||
144420449|NCT01129960|520745943|FG001|Overall Study|Protocol Violation|2|||
144420450|NCT01129960|520745944|FG002|Overall Study|Protocol Violation|3|||
144420451|NCT01129960|520745945|FG003|Overall Study|Protocol Violation|0|||
144420452|NCT01129960|520745942|FG000|Overall Study|Lost to Follow-up|0|||
144420453|NCT01129960|520745943|FG001|Overall Study|Lost to Follow-up|2|||
144420454|NCT01129960|520745944|FG002|Overall Study|Lost to Follow-up|3|||
144420455|NCT01129960|520745945|FG003|Overall Study|Lost to Follow-up|3|||
144420456|NCT01129960|520745942|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
144420457|NCT01129960|520745943|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
144420458|NCT01129960|520745944|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
144420459|NCT01129960|520745945|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
144420460|NCT01129960|520745942|FG000|Overall Study|Physician Decision|1|||
144420461|NCT01129960|520745943|FG001|Overall Study|Physician Decision|0|||
144420462|NCT01129960|520745944|FG002|Overall Study|Physician Decision|0|||
144420463|NCT01129960|520745945|FG003|Overall Study|Physician Decision|0|||
144420464|NCT01129960|520745942|FG000|Overall Study|Pregnancy|1|||
144420465|NCT01129960|520745943|FG001|Overall Study|Pregnancy|0|||
144420466|NCT01129960|520745944|FG002|Overall Study|Pregnancy|0|||
144180807|NCT00685334|519855584|FG001|Overall Study|Withdrawal by Subject|6|||
144180808|NCT00685334|519855583|FG000|Overall Study|Lost to Follow-up|4|||
144420467|NCT01129960|520745945|FG003|Overall Study|Pregnancy|0|||
144527571|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
144527572|NCT01456949|521133319|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
144180809|NCT00685334|519855584|FG001|Overall Study|Lost to Follow-up|0|||
144180810|NCT00685334|519855583|FG000|Overall Study|Chose to enter hospital|1|||
144180811|NCT00685334|519855584|FG001|Overall Study|Chose to enter hospital|1|||
144180812|NCT02300987|519857238|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
144180813|NCT02300987|519857239|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
144180814|NCT02300987|519857238|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
144180815|NCT02300987|519857239|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
144420468|NCT03428360|520745946|FG000|Overall Study|Informed consent withdrawn|5|||
144420469|NCT03428360|520745946|FG000|Overall Study|Withdrawal by Subject|4|||
144420470|NCT03428360|520745946|FG000|Overall Study|Lost to Follow-up|5|||
144420471|NCT03428360|520745946|FG000|Overall Study|Physician Decision|2|||
144180816|NCT02300987|519857238|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
144420472|NCT03428360|520745946|FG000|Overall Study|Informed consent withdrawn|5|||
144420473|NCT03428360|520745946|FG000|Overall Study|Study terminated by sponsor|10|||
144420474|NCT03428360|520745946|FG000|Overall Study|Non-compliant with study|1|||
144251109|NCT01393106|520119249|FG000|Overall Study|Withdrawal by Subject|1|||
144251110|NCT01393106|520119249|FG000|Overall Study|Lack of Efficacy|1|||
144251111|NCT01744483|520119250|FG000|Overall Study|Death|9|||
144723221|NCT01058421|521840660|FG000|6 Month Outcomes|Death|2|||
144251112|NCT01744483|520119251|FG001|Overall Study|Death|4|||
144251113|NCT01744483|520119252|FG002|Overall Study|Death|11|||
144251114|NCT01744483|520119250|FG000|Overall Study|Lost to Follow-up|8|||
144251115|NCT01744483|520119251|FG001|Overall Study|Lost to Follow-up|9|||
144251116|NCT01744483|520119252|FG002|Overall Study|Lost to Follow-up|11|||
144251117|NCT01744483|520119250|FG000|Overall Study|Protocol Violation|1|||
144251118|NCT01744483|520119251|FG001|Overall Study|Protocol Violation|2|||
144251119|NCT01744483|520119252|FG002|Overall Study|Protocol Violation|1|||
144251120|NCT01744483|520119250|FG000|Overall Study|Withdrawal by Subject|4|||
144251121|NCT01744483|520119251|FG001|Overall Study|Withdrawal by Subject|6|||
144251122|NCT01744483|520119252|FG002|Overall Study|Withdrawal by Subject|2|||
144251123|NCT01744483|520119250|FG000|Overall Study|No ICU Admit|5|||
144420475|NCT03428360|520745946|FG000|Overall Study|Non-compliant with study drug|3|||
144420476|NCT03428360|520745946|FG000|Overall Study|Death|3|||
144420477|NCT03428360|520745946|FG000|Overall Study|Adverse Event|1|||
144420478|NCT03428360|520745946|FG000|Overall Study|Not on antiepileptic drug|1|||
144420479|NCT01244425|520745947|FG000|Overall Study|Withdrawal by Subject|2|||
144420480|NCT01244425|520745948|FG001|Overall Study|Withdrawal by Subject|2|||
144420481|NCT01244425|520745947|FG000|Overall Study|Adverse Event|1|||
144420482|NCT01244425|520745948|FG001|Overall Study|Adverse Event|1|||
144420483|NCT00368355|520745949|FG000|Overall Study|Adverse Event|1|||
144420484|NCT00368355|520745950|FG001|Overall Study|Adverse Event|0|||
144420485|NCT00368355|520745949|FG000|Overall Study|Death|2|||
144420486|NCT00368355|520745950|FG001|Overall Study|Death|4|||
144420487|NCT00368355|520745949|FG000|Overall Study|Relapse|6|||
144420488|NCT00368355|520745950|FG001|Overall Study|Relapse|10|||
144420489|NCT00368355|520745949|FG000|Overall Study|Subsequent transplant|0|||
144420490|NCT00368355|520745950|FG001|Overall Study|Subsequent transplant|3|||
144420491|NCT00368355|520745949|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
144420492|NCT00368355|520745950|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
144420493|NCT01013701|520745961|FG000|Overall Study|study prematurely terminated|7|||
144420494|NCT03241342|520745963|FG000|Overall Study|Adverse Event|5|||
144420495|NCT03241342|520745964|FG001|Overall Study|Adverse Event|8|||
144420496|NCT03241342|520745965|FG002|Overall Study|Adverse Event|4|||
144420497|NCT03241342|520745963|FG000|Overall Study|Lack of Efficacy|0|||
144420498|NCT03241342|520745964|FG001|Overall Study|Lack of Efficacy|0|||
144420499|NCT03241342|520745965|FG002|Overall Study|Lack of Efficacy|1|||
144420500|NCT03241342|520745963|FG000|Overall Study|noncompliance with study drug|2|||
144420501|NCT03241342|520745964|FG001|Overall Study|noncompliance with study drug|1|||
144420502|NCT03241342|520745965|FG002|Overall Study|noncompliance with study drug|1|||
144420503|NCT03241342|520745963|FG000|Overall Study|sponsor decision|0|||
144420504|NCT03241342|520745964|FG001|Overall Study|sponsor decision|1|||
144420505|NCT03241342|520745965|FG002|Overall Study|sponsor decision|2|||
144420506|NCT03241342|520745963|FG000|Overall Study|not reported|15|||
144420507|NCT03241342|520745964|FG001|Overall Study|not reported|21|||
144420508|NCT03241342|520745965|FG002|Overall Study|not reported|19|||
144420509|NCT00556712|520745966|FG000|Overall Study|Adverse Event|7|||
144420510|NCT00556712|520745967|FG001|Overall Study|Adverse Event|19|||
144420511|NCT00556712|520745966|FG000|Overall Study|Death|5|||
144420512|NCT00556712|520745967|FG001|Overall Study|Death|10|||
144420513|NCT00556712|520745966|FG000|Overall Study|Progressive Disease|383|||
144420514|NCT00556712|520745967|FG001|Overall Study|Progressive Disease|320|||
144420515|NCT00556712|520745966|FG000|Overall Study|Protocol Violation|3|||
144420516|NCT00556712|520745967|FG001|Overall Study|Protocol Violation|2|||
144420517|NCT00556712|520745966|FG000|Overall Study|Refused Treatment|17|||
144420518|NCT00556712|520745967|FG001|Overall Study|Refused Treatment|16|||
144420519|NCT00556712|520745966|FG000|Overall Study|Failure to Return|2|||
144420520|NCT00556712|520745967|FG001|Overall Study|Failure to Return|3|||
144420521|NCT00556712|520745966|FG000|Overall Study|Other|2|||
144420522|NCT00556712|520745967|FG001|Overall Study|Other|2|||
144420523|NCT00556712|520745966|FG000|Overall Study|Ongoing at Data Cutoff|32|||
144420524|NCT00556712|520745967|FG001|Overall Study|Ongoing at Data Cutoff|66|||
144420525|NCT01059799|520745970|FG000|Overall Study|Adverse Event|2|||
144420526|NCT01059799|520745971|FG001|Overall Study|Adverse Event|3|||
144420527|NCT01059799|520745970|FG000|Overall Study|Lack of Efficacy|1|||
144420528|NCT01059799|520745971|FG001|Overall Study|Lack of Efficacy|0|||
144420529|NCT01059799|520745970|FG000|Overall Study|Protocol Violation|3|||
144420530|NCT01059799|520745971|FG001|Overall Study|Protocol Violation|2|||
144420531|NCT01059799|520745970|FG000|Overall Study|Withdrawal criteria|13|||
144420532|NCT01059799|520745971|FG001|Overall Study|Withdrawal criteria|2|||
144420533|NCT01059799|520745970|FG000|Overall Study|Other|12|||
144251124|NCT01744483|520119251|FG001|Overall Study|No ICU Admit|1|||
144420534|NCT01059799|520745971|FG001|Overall Study|Other|3|||
144420535|NCT04772755|520745973|FG000|Overall Study|Withdrawal by Subject|1|||
144420536|NCT04772755|520745974|FG001|Overall Study|Withdrawal by Subject|0|||
144527573|NCT03710603|521133320|FG000|Overall Study|Adverse Event|1|||
144420537|NCT04772755|520745973|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
144420538|NCT04772755|520745974|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
144420539|NCT01905657|520745975|FG000|Overall Study|Adverse Event|23|||
144420540|NCT01905657|520745976|FG001|Overall Study|Adverse Event|17|||
144420541|NCT01905657|520745977|FG002|Overall Study|Adverse Event|18|||
144420542|NCT01905657|520745975|FG000|Overall Study|Clinical Progression|103|||
144420543|NCT01905657|520745976|FG001|Overall Study|Clinical Progression|78|||
144420544|NCT01905657|520745977|FG002|Overall Study|Clinical Progression|59|||
144723222|NCT01058421|521840661|FG001|6 Month Outcomes|Death|2|||
144420545|NCT01905657|520745975|FG000|Overall Study|Death|40|||
144420546|NCT01905657|520745976|FG001|Overall Study|Death|43|||
144420547|NCT01905657|520745977|FG002|Overall Study|Death|47|||
144420548|NCT01905657|520745975|FG000|Overall Study|Excluded Medication|13|||
144420549|NCT01905657|520745976|FG001|Overall Study|Excluded Medication|16|||
144420550|NCT01905657|520745977|FG002|Overall Study|Excluded Medication|9|||
144420551|NCT01905657|520745975|FG000|Overall Study|Lost to Follow-up|1|||
144420552|NCT01905657|520745976|FG001|Overall Study|Lost to Follow-up|2|||
144420553|NCT01905657|520745977|FG002|Overall Study|Lost to Follow-up|1|||
144420554|NCT01905657|520745975|FG000|Overall Study|Physician Decision|5|||
144420555|NCT01905657|520745976|FG001|Overall Study|Physician Decision|8|||
144420556|NCT01905657|520745977|FG002|Overall Study|Physician Decision|12|||
144420557|NCT01905657|520745975|FG000|Overall Study|Protocol Violation|2|||
144420558|NCT01905657|520745976|FG001|Overall Study|Protocol Violation|1|||
144420559|NCT01905657|520745977|FG002|Overall Study|Protocol Violation|1|||
144420560|NCT01905657|520745975|FG000|Overall Study|Screen Failure|0|||
144420561|NCT01905657|520745976|FG001|Overall Study|Screen Failure|1|||
144420562|NCT01905657|520745977|FG002|Overall Study|Screen Failure|0|||
144420563|NCT01905657|520745975|FG000|Overall Study|Withdrawal by Subject|15|||
144420564|NCT01905657|520745976|FG001|Overall Study|Withdrawal by Subject|21|||
144420565|NCT01905657|520745977|FG002|Overall Study|Withdrawal by Subject|53|||
144420566|NCT01905657|520745975|FG000|Overall Study|Sponsor Decision|1|||
144420567|NCT01905657|520745976|FG001|Overall Study|Sponsor Decision|0|||
144420568|NCT01905657|520745977|FG002|Overall Study|Sponsor Decision|0|||
144420569|NCT02744391|520745978|FG000|Overall Study|Lost to Follow-up|9|||
144420570|NCT02744391|520745978|FG000|Overall Study|Physician Decision|2|||
144420571|NCT02744391|520745978|FG000|Overall Study|Withdrawal by Subject|3|||
144420572|NCT05838742|520745979|FG000|Overall Study|Adverse Event|2|||
144420573|NCT05838742|520745980|FG001|Overall Study|Adverse Event|0|||
144420574|NCT05838742|520745981|FG002|Overall Study|Adverse Event|1|||
144420575|NCT05838742|520745982|FG003|Overall Study|Adverse Event|0|||
144420576|NCT05838742|520745983|FG004|Overall Study|Adverse Event|1|||
144420577|NCT05838742|520745979|FG000|Overall Study|Lost to Follow-up|1|||
144420578|NCT05838742|520745980|FG001|Overall Study|Lost to Follow-up|1|||
144420579|NCT05838742|520745981|FG002|Overall Study|Lost to Follow-up|1|||
144420580|NCT05838742|520745982|FG003|Overall Study|Lost to Follow-up|0|||
144420581|NCT05838742|520745983|FG004|Overall Study|Lost to Follow-up|0|||
144420582|NCT05838742|520745979|FG000|Overall Study|Physician Decision|0|||
144420583|NCT05838742|520745980|FG001|Overall Study|Physician Decision|0|||
144420584|NCT05838742|520745981|FG002|Overall Study|Physician Decision|0|||
144420585|NCT05838742|520745982|FG003|Overall Study|Physician Decision|0|||
144420586|NCT05838742|520745983|FG004|Overall Study|Physician Decision|1|||
144420587|NCT05838742|520745979|FG000|Overall Study|Withdrawal by Subject|8|||
144420588|NCT05838742|520745980|FG001|Overall Study|Withdrawal by Subject|3|||
144420589|NCT05838742|520745981|FG002|Overall Study|Withdrawal by Subject|3|||
144420590|NCT05838742|520745982|FG003|Overall Study|Withdrawal by Subject|1|||
144420591|NCT05838742|520745983|FG004|Overall Study|Withdrawal by Subject|4|||
144420592|NCT05838742|520745979|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
144420593|NCT05838742|520745980|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
144420594|NCT05838742|520745981|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
144420595|NCT05838742|520745982|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
144723223|NCT01058421|521840660|FG000|6 Month Outcomes|Lost to Follow-up|16|||
144420596|NCT05838742|520745983|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
144420597|NCT05838742|520745979|FG000|Overall Study|Lack of Efficacy|0|||
144420598|NCT05838742|520745980|FG001|Overall Study|Lack of Efficacy|0|||
144420599|NCT05838742|520745981|FG002|Overall Study|Lack of Efficacy|0|||
144420600|NCT05838742|520745982|FG003|Overall Study|Lack of Efficacy|1|||
144420601|NCT05838742|520745983|FG004|Overall Study|Lack of Efficacy|0|||
144420602|NCT05838742|520745979|FG000|Overall Study|Randomized, not treated|2|||
144420603|NCT05838742|520745980|FG001|Overall Study|Randomized, not treated|1|||
144420604|NCT05838742|520745981|FG002|Overall Study|Randomized, not treated|0|||
144420605|NCT05838742|520745982|FG003|Overall Study|Randomized, not treated|1|||
144420606|NCT05838742|520745983|FG004|Overall Study|Randomized, not treated|0|||
144527574|NCT03710603|521133321|FG001|Overall Study|Adverse Event|0|||
144420607|NCT01535053|520745988|FG000|Overall Study|Ineligible|1|||
144420608|NCT01535053|520745989|FG001|Overall Study|Ineligible|2|||
144420609|NCT01031069|520745990|FG000|Overall Study|Serious Adverse Event|0|||
144420610|NCT01031069|520745991|FG001|Overall Study|Serious Adverse Event|1|||
144420611|NCT01031069|520745992|FG002|Overall Study|Serious Adverse Event|0|||
144723224|NCT01058421|521840661|FG001|6 Month Outcomes|Lost to Follow-up|21|||
144420612|NCT01031069|520745993|FG003|Overall Study|Serious Adverse Event|0|||
144420613|NCT01031069|520745990|FG000|Overall Study|Withdrawal by Subject|2|||
144420614|NCT01031069|520745991|FG001|Overall Study|Withdrawal by Subject|3|||
144420615|NCT01031069|520745992|FG002|Overall Study|Withdrawal by Subject|18|||
144420616|NCT01031069|520745993|FG003|Overall Study|Withdrawal by Subject|18|||
144420617|NCT01031069|520745990|FG000|Overall Study|Migrated/moved from study area|1|||
144420618|NCT01031069|520745991|FG001|Overall Study|Migrated/moved from study area|2|||
144420619|NCT01031069|520745992|FG002|Overall Study|Migrated/moved from study area|1|||
144420620|NCT01031069|520745993|FG003|Overall Study|Migrated/moved from study area|1|||
144420621|NCT01031069|520745990|FG000|Overall Study|Lost to Follow-up|9|||
144420622|NCT01031069|520745991|FG001|Overall Study|Lost to Follow-up|5|||
144420623|NCT01031069|520745992|FG002|Overall Study|Lost to Follow-up|21|||
144420624|NCT01031069|520745993|FG003|Overall Study|Lost to Follow-up|15|||
144420625|NCT01031069|520745990|FG000|Overall Study|Other|0|||
144420626|NCT01031069|520745991|FG001|Overall Study|Other|0|||
144420627|NCT01031069|520745992|FG002|Overall Study|Other|1|||
144420628|NCT01031069|520745993|FG003|Overall Study|Other|0|||
144420629|NCT03032705|520745995|FG000|Overall Study|Lost to Follow-up|16|||
144420630|NCT03032705|520745996|FG001|Overall Study|Lost to Follow-up|17|||
144420631|NCT03032705|520745995|FG000|Overall Study|did not quality|6|||
144420632|NCT03032705|520745996|FG001|Overall Study|did not quality|6|||
144420633|NCT02081690|520747530|FG000|Overall Study|Death|3|||
144420634|NCT02081690|520747530|FG000|Overall Study|Physician Decision|3|||
144420635|NCT02081690|520747530|FG000|Overall Study|Withdrawal by Subject|1|||
144420636|NCT00982488|520747534|FG000|Overall Study|Administrative reason by sponsor|81|||
144420637|NCT00982488|520747535|FG001|Overall Study|Administrative reason by sponsor|3|||
144420638|NCT00982488|520747536|FG002|Overall Study|Administrative reason by sponsor|11|||
144420639|NCT00982488|520747537|FG003|Overall Study|Administrative reason by sponsor|0|||
144420640|NCT00982488|520747538|FG004|Overall Study|Administrative reason by sponsor|0|||
144420641|NCT00982488|520747534|FG000|Overall Study|Adverse event unrelated to study drug|5|||
144420642|NCT00982488|520747535|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144420643|NCT00982488|520747536|FG002|Overall Study|Adverse event unrelated to study drug|0|||
144420644|NCT00982488|520747537|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144420645|NCT00982488|520747538|FG004|Overall Study|Adverse event unrelated to study drug|0|||
144420646|NCT00982488|520747534|FG000|Overall Study|Death|11|||
144420647|NCT00982488|520747535|FG001|Overall Study|Death|0|||
144420648|NCT00982488|520747536|FG002|Overall Study|Death|2|||
144420649|NCT00982488|520747537|FG003|Overall Study|Death|0|||
144420650|NCT00982488|520747538|FG004|Overall Study|Death|0|||
144420651|NCT00982488|520747534|FG000|Overall Study|Disease progression|30|||
144420652|NCT00982488|520747535|FG001|Overall Study|Disease progression|5|||
144420653|NCT00982488|520747536|FG002|Overall Study|Disease progression|10|||
144420654|NCT00982488|520747537|FG003|Overall Study|Disease progression|1|||
144420655|NCT00982488|520747538|FG004|Overall Study|Disease progression|1|||
144420656|NCT00982488|520747534|FG000|Overall Study|Lost to Follow-up|1|||
144420657|NCT00982488|520747535|FG001|Overall Study|Lost to Follow-up|0|||
144420658|NCT00982488|520747536|FG002|Overall Study|Lost to Follow-up|0|||
144420659|NCT00982488|520747537|FG003|Overall Study|Lost to Follow-up|0|||
144420660|NCT00982488|520747538|FG004|Overall Study|Lost to Follow-up|0|||
144420661|NCT00982488|520747534|FG000|Overall Study|Maximum clinical benefit|1|||
144420662|NCT00982488|520747535|FG001|Overall Study|Maximum clinical benefit|1|||
144420663|NCT00982488|520747536|FG002|Overall Study|Maximum clinical benefit|1|||
144420664|NCT00982488|520747537|FG003|Overall Study|Maximum clinical benefit|0|||
144420665|NCT00982488|520747538|FG004|Overall Study|Maximum clinical benefit|0|||
144420666|NCT00982488|520747534|FG000|Overall Study|Other|15|||
144527575|NCT03710603|521133320|FG000|Overall Study|Death|44|||
144527576|NCT03710603|521133321|FG001|Overall Study|Death|34|||
144527577|NCT03710603|521133320|FG000|Overall Study|Lost to Follow-up|3|||
144527578|NCT03710603|521133321|FG001|Overall Study|Lost to Follow-up|5|||
144420667|NCT00982488|520747535|FG001|Overall Study|Other|1|||
144420668|NCT00982488|520747536|FG002|Overall Study|Other|3|||
144420669|NCT00982488|520747537|FG003|Overall Study|Other|1|||
144420670|NCT00982488|520747538|FG004|Overall Study|Other|0|||
144527579|NCT03710603|521133320|FG000|Overall Study|Withdrawal by Subject|11|||
144420671|NCT00982488|520747534|FG000|Overall Study|Poor compliance/noncompliance|0|||
144420672|NCT00982488|520747535|FG001|Overall Study|Poor compliance/noncompliance|1|||
144420673|NCT00982488|520747536|FG002|Overall Study|Poor compliance/noncompliance|0|||
144420674|NCT00982488|520747537|FG003|Overall Study|Poor compliance/noncompliance|0|||
144527580|NCT03710603|521133321|FG001|Overall Study|Withdrawal by Subject|10|||
144420675|NCT00982488|520747538|FG004|Overall Study|Poor compliance/noncompliance|0|||
144420676|NCT00982488|520747534|FG000|Overall Study|Stem cell transplant|2|||
144420677|NCT00982488|520747535|FG001|Overall Study|Stem cell transplant|0|||
144420678|NCT00982488|520747536|FG002|Overall Study|Stem cell transplant|0|||
144420679|NCT00982488|520747537|FG003|Overall Study|Stem cell transplant|1|||
144420680|NCT00982488|520747538|FG004|Overall Study|Stem cell transplant|0|||
144420681|NCT00982488|520747534|FG000|Overall Study|Study drug toxicity|34|||
144420682|NCT00982488|520747535|FG001|Overall Study|Study drug toxicity|1|||
144420683|NCT00982488|520747536|FG002|Overall Study|Study drug toxicity|6|||
144420684|NCT00982488|520747537|FG003|Overall Study|Study drug toxicity|0|||
144420685|NCT00982488|520747538|FG004|Overall Study|Study drug toxicity|0|||
144420686|NCT00982488|520747534|FG000|Overall Study|Withdrawal by Subject|5|||
144420687|NCT00982488|520747535|FG001|Overall Study|Withdrawal by Subject|1|||
144420688|NCT00982488|520747536|FG002|Overall Study|Withdrawal by Subject|1|||
144420689|NCT00982488|520747537|FG003|Overall Study|Withdrawal by Subject|0|||
144420690|NCT00982488|520747538|FG004|Overall Study|Withdrawal by Subject|0|||
144420691|NCT04203238|520747539|FG000|Overall Study|Withdrawal by Subject|1|||
144420692|NCT04203238|520747540|FG001|Overall Study|Withdrawal by Subject|1|||
144420693|NCT04203238|520747539|FG000|Overall Study|Covid-19|3|||
144420694|NCT04203238|520747540|FG001|Overall Study|Covid-19|0|||
144420695|NCT01134783|520747542|FG000|Overall Study|Pregnancy|16|||
144420696|NCT01134783|520747543|FG001|Overall Study|Pregnancy|8|||
144420697|NCT01134783|520747542|FG000|Overall Study|Withdrawal by Subject|15|||
144420698|NCT01134783|520747543|FG001|Overall Study|Withdrawal by Subject|9|||
144420699|NCT01134783|520747542|FG000|Overall Study|Lost to Follow-up|5|||
144420700|NCT01134783|520747543|FG001|Overall Study|Lost to Follow-up|20|||
144420701|NCT00001596|520747544|FG000|Overall Study|Death|1|||
144420702|NCT00001596|520747545|FG001|Overall Study|Death|0|||
144420703|NCT00001596|520747544|FG000|Overall Study|Withdrawal by Subject|3|||
144420704|NCT00001596|520747545|FG001|Overall Study|Withdrawal by Subject|1|||
144420705|NCT00001596|520747544|FG000|Overall Study|Study Termination|12|||
144420706|NCT00001596|520747545|FG001|Overall Study|Study Termination|9|||
144420707|NCT00001596|520747544|FG000|Overall Study|Adverse Event|1|||
144420708|NCT00001596|520747545|FG001|Overall Study|Adverse Event|0|||
144420709|NCT00180414|520747554|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
144420710|NCT00180414|520747555|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
144420711|NCT00463346|520747557|FG000|Overall Study|Withdrawal by Subject|3|||
144420712|NCT00463346|520747558|FG001|Overall Study|Withdrawal by Subject|3|||
144420713|NCT01572909|520747559|FG000|Overall Study|Adverse Event|7|||
144420714|NCT01572909|520747560|FG001|Overall Study|Adverse Event|2|||
144420715|NCT01572909|520747559|FG000|Overall Study|Death|3|||
144420716|NCT01572909|520747560|FG001|Overall Study|Death|1|||
144420717|NCT01572909|520747559|FG000|Overall Study|Lost to Follow-up|8|||
144420718|NCT01572909|520747560|FG001|Overall Study|Lost to Follow-up|7|||
144420719|NCT01572909|520747559|FG000|Overall Study|Physician Decision|1|||
144420720|NCT01572909|520747560|FG001|Overall Study|Physician Decision|1|||
144420721|NCT01572909|520747559|FG000|Overall Study|Technical Issues|1|||
144420722|NCT01572909|520747560|FG001|Overall Study|Technical Issues|0|||
144420723|NCT01572909|520747559|FG000|Overall Study|Withdrawal by Subject|12|||
144420724|NCT01572909|520747560|FG001|Overall Study|Withdrawal by Subject|11|||
144420725|NCT01572909|520747559|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
144420726|NCT01572909|520747560|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
144420727|NCT03641651|520747565|FG000|Overall Study|organizational issues at one study site|1|||
144420728|NCT00951665|520747566|FG000|Phase 1b|Adverse Event|2|||
144420729|NCT00951665|520747567|FG001|Phase 1b|Adverse Event|1|||
144420730|NCT00951665|520747568|FG002|Phase 1b|Adverse Event|0|||
144420731|NCT00951665|520747569|FG003|Phase 1b|Adverse Event|1|||
144420732|NCT00951665|520747570|FG004|Phase 1b|Adverse Event|0|||
144420733|NCT00951665|520747571|FG005|Phase 1b|Adverse Event|0|||
144420734|NCT00951665|520747566|FG000|Phase 1b|Death|1|||
144420735|NCT00951665|520747567|FG001|Phase 1b|Death|0|||
144420736|NCT00951665|520747568|FG002|Phase 1b|Death|2|||
144420737|NCT00951665|520747569|FG003|Phase 1b|Death|0|||
144420738|NCT00951665|520747570|FG004|Phase 1b|Death|0|||
144420739|NCT00951665|520747571|FG005|Phase 1b|Death|0|||
144420740|NCT00951665|520747566|FG000|Phase 1b|Physician Decision|4|||
144420741|NCT00951665|520747567|FG001|Phase 1b|Physician Decision|0|||
144420742|NCT00951665|520747568|FG002|Phase 1b|Physician Decision|1|||
144601106|NCT03808688|521403322|FG000|Overall Study|Adverse Event|13|||
144420743|NCT00951665|520747569|FG003|Phase 1b|Physician Decision|0|||
144420744|NCT00951665|520747570|FG004|Phase 1b|Physician Decision|0|||
144420745|NCT00951665|520747571|FG005|Phase 1b|Physician Decision|0|||
144420746|NCT00951665|520747566|FG000|Phase 1b|Withdrawal by Subject|0|||
144420747|NCT00951665|520747567|FG001|Phase 1b|Withdrawal by Subject|1|||
144601107|NCT03808688|521403323|FG001|Overall Study|Adverse Event|17|||
144601108|NCT03808688|521403322|FG000|Overall Study|Lack of Efficacy|2|||
144420748|NCT00951665|520747568|FG002|Phase 1b|Withdrawal by Subject|0|||
144420749|NCT00951665|520747569|FG003|Phase 1b|Withdrawal by Subject|0|||
144251125|NCT01744483|520119252|FG002|Overall Study|No ICU Admit|2|||
144251126|NCT01744483|520119250|FG000|Overall Study|Routed to OSH|2|||
144420750|NCT00951665|520747570|FG004|Phase 1b|Withdrawal by Subject|0|||
144420751|NCT00951665|520747571|FG005|Phase 1b|Withdrawal by Subject|0|||
144420752|NCT00951665|520747566|FG000|Phase 1b|Disease Progression|13|||
144420753|NCT00951665|520747567|FG001|Phase 1b|Disease Progression|2|||
144420754|NCT00951665|520747568|FG002|Phase 1b|Disease Progression|14|||
144420755|NCT00951665|520747569|FG003|Phase 1b|Disease Progression|0|||
144420756|NCT00951665|520747570|FG004|Phase 1b|Disease Progression|0|||
144420757|NCT00951665|520747571|FG005|Phase 1b|Disease Progression|0|||
144420758|NCT00951665|520747566|FG000|Phase 1b|Protocol Violation|2|||
144601109|NCT03808688|521403323|FG001|Overall Study|Lack of Efficacy|0|||
144420759|NCT00951665|520747567|FG001|Phase 1b|Protocol Violation|0|||
144420760|NCT00951665|520747568|FG002|Phase 1b|Protocol Violation|0|||
144420761|NCT00951665|520747569|FG003|Phase 1b|Protocol Violation|0|||
144420762|NCT00951665|520747570|FG004|Phase 1b|Protocol Violation|0|||
144420763|NCT00951665|520747571|FG005|Phase 1b|Protocol Violation|0|||
144420764|NCT00951665|520747566|FG000|Phase 2a|Adverse Event|0|||
144420765|NCT00951665|520747567|FG001|Phase 2a|Adverse Event|0|||
144420766|NCT00951665|520747568|FG002|Phase 2a|Adverse Event|0|||
144420767|NCT00951665|520747569|FG003|Phase 2a|Adverse Event|0|||
144420768|NCT00951665|520747570|FG004|Phase 2a|Adverse Event|2|||
144420769|NCT00951665|520747571|FG005|Phase 2a|Adverse Event|0|||
144420770|NCT00951665|520747566|FG000|Phase 2a|Death|0|||
144420771|NCT00951665|520747567|FG001|Phase 2a|Death|0|||
144420772|NCT00951665|520747568|FG002|Phase 2a|Death|0|||
144420773|NCT00951665|520747569|FG003|Phase 2a|Death|0|||
144420774|NCT00951665|520747570|FG004|Phase 2a|Death|1|||
144420775|NCT00951665|520747571|FG005|Phase 2a|Death|1|||
144420776|NCT00951665|520747566|FG000|Phase 2a|Lost to Follow-up|0|||
144420777|NCT00951665|520747567|FG001|Phase 2a|Lost to Follow-up|0|||
144420778|NCT00951665|520747568|FG002|Phase 2a|Lost to Follow-up|0|||
144420779|NCT00951665|520747569|FG003|Phase 2a|Lost to Follow-up|0|||
144420780|NCT00951665|520747570|FG004|Phase 2a|Lost to Follow-up|1|||
144420781|NCT00951665|520747571|FG005|Phase 2a|Lost to Follow-up|0|||
144420782|NCT00951665|520747566|FG000|Phase 2a|Physician Decision|0|||
144420783|NCT00951665|520747567|FG001|Phase 2a|Physician Decision|0|||
144420784|NCT00951665|520747568|FG002|Phase 2a|Physician Decision|0|||
144420785|NCT00951665|520747569|FG003|Phase 2a|Physician Decision|0|||
144420786|NCT00951665|520747570|FG004|Phase 2a|Physician Decision|0|||
144420787|NCT00951665|520747571|FG005|Phase 2a|Physician Decision|1|||
144420788|NCT00951665|520747566|FG000|Phase 2a|Withdrawal by Subject|0|||
144420789|NCT00951665|520747567|FG001|Phase 2a|Withdrawal by Subject|0|||
144420790|NCT00951665|520747568|FG002|Phase 2a|Withdrawal by Subject|0|||
144420791|NCT00951665|520747569|FG003|Phase 2a|Withdrawal by Subject|0|||
144420792|NCT00951665|520747570|FG004|Phase 2a|Withdrawal by Subject|2|||
144420793|NCT00951665|520747571|FG005|Phase 2a|Withdrawal by Subject|0|||
144420794|NCT00951665|520747566|FG000|Phase 2a|Disease Progression|0|||
144420795|NCT00951665|520747567|FG001|Phase 2a|Disease Progression|0|||
144420796|NCT00951665|520747568|FG002|Phase 2a|Disease Progression|0|||
144420797|NCT00951665|520747569|FG003|Phase 2a|Disease Progression|0|||
144420798|NCT00951665|520747570|FG004|Phase 2a|Disease Progression|6|||
144420799|NCT00951665|520747571|FG005|Phase 2a|Disease Progression|5|||
144420800|NCT02723084|520747572|FG000|Overall Study|Withdrawal by Subject|1|||
144420801|NCT02723084|520747573|FG001|Overall Study|Withdrawal by Subject|1|||
144420802|NCT02723084|520747572|FG000|Overall Study|Lost to Follow-up|3|||
144420803|NCT02723084|520747573|FG001|Overall Study|Lost to Follow-up|0|||
144420804|NCT05024058|520747574|FG000|Treatment|Study terminated by sponsor|5|||
144420805|NCT05024058|520747575|FG001|Treatment|Study terminated by sponsor|6|||
144420806|NCT05024058|520747576|FG002|Treatment|Study terminated by sponsor|4|||
144420807|NCT05024058|520747577|FG003|Treatment|Study terminated by sponsor|2|||
144420808|NCT05024058|520747578|FG004|Treatment|Study terminated by sponsor|3|||
144420809|NCT05024058|520747579|FG005|Treatment|Study terminated by sponsor|3|||
144420810|NCT05024058|520747580|FG006|Treatment|Study terminated by sponsor|1|||
144420811|NCT05024058|520747581|FG007|Treatment|Study terminated by sponsor|3|||
144420812|NCT05024058|520747582|FG008|Treatment|Study terminated by sponsor|6|||
144420813|NCT05024058|520747583|FG009|Treatment|Study terminated by sponsor|6|||
144420814|NCT05024058|520747574|FG000|Follow-up|Withdrawal by Subject|1|||
144420815|NCT05024058|520747575|FG001|Follow-up|Withdrawal by Subject|0|||
144420816|NCT05024058|520747576|FG002|Follow-up|Withdrawal by Subject|1|||
144420817|NCT05024058|520747577|FG003|Follow-up|Withdrawal by Subject|0|||
144420818|NCT05024058|520747578|FG004|Follow-up|Withdrawal by Subject|0|||
144420819|NCT05024058|520747579|FG005|Follow-up|Withdrawal by Subject|0|||
144420820|NCT05024058|520747580|FG006|Follow-up|Withdrawal by Subject|0|||
144420821|NCT05024058|520747581|FG007|Follow-up|Withdrawal by Subject|1|||
144420822|NCT05024058|520747582|FG008|Follow-up|Withdrawal by Subject|0|||
144420823|NCT05024058|520747583|FG009|Follow-up|Withdrawal by Subject|1|||
144420824|NCT02734810|520747587|FG000|Overall Study|Adverse Event|1|||
144420825|NCT02734810|520747588|FG001|Overall Study|Adverse Event|0|||
144420826|NCT02734810|520747587|FG000|Overall Study|Lack of Efficacy|1|||
144420827|NCT02734810|520747588|FG001|Overall Study|Lack of Efficacy|0|||
144420828|NCT00127712|520747590|FG000|Overall Study|Adverse Event|3|||
144251127|NCT01744483|520119251|FG001|Overall Study|Routed to OSH|0|||
144420829|NCT00127712|520747591|FG001|Overall Study|Adverse Event|0|||
144420830|NCT00127712|520747590|FG000|Overall Study|Lack of GI access to continue|2|||
144420831|NCT00127712|520747591|FG001|Overall Study|Lack of GI access to continue|0|||
144420832|NCT00715078|520747594|FG000|Overall Study|Death|29|||
144420833|NCT00715078|520747595|FG001|Overall Study|Death|36|||
144420834|NCT00715078|520747596|FG002|Overall Study|Death|36|||
144420835|NCT00715078|520747594|FG000|Overall Study|Withdrawal by Subject|1|||
144420836|NCT00715078|520747595|FG001|Overall Study|Withdrawal by Subject|0|||
144420837|NCT00715078|520747596|FG002|Overall Study|Withdrawal by Subject|1|||
144420838|NCT00715078|520747594|FG000|Overall Study|Unable to start due to disease prog.|0|||
144420839|NCT00715078|520747595|FG001|Overall Study|Unable to start due to disease prog.|0|||
144527581|NCT05002088|521133322|FG000|Overall Study|Withdrawal by Subject|9|||
144420840|NCT00715078|520747596|FG002|Overall Study|Unable to start due to disease prog.|1|||
144420841|NCT00386776|520747597|FG000|Overall Study|Withdrawal by Subject|8|||
144420842|NCT02259582|520747598|FG000|Overall Study|Physician Decision|0|||
144420843|NCT02259582|520747599|FG001|Overall Study|Physician Decision|1|||
144723225|NCT01058421|521840660|FG000|6 Month Outcomes|Remained in Other Facility|1|||
144723226|NCT01058421|521840661|FG001|6 Month Outcomes|Remained in Other Facility|3|||
144420844|NCT02259582|520747600|FG002|Overall Study|Physician Decision|0|||
144420845|NCT02259582|520747598|FG000|Overall Study|Death|0|||
144420846|NCT02259582|520747599|FG001|Overall Study|Death|0|||
144420847|NCT02259582|520747600|FG002|Overall Study|Death|1|||
144420848|NCT02259582|520747598|FG000|Overall Study|Adverse Event|1|||
144420849|NCT02259582|520747599|FG001|Overall Study|Adverse Event|0|||
144420850|NCT02259582|520747600|FG002|Overall Study|Adverse Event|1|||
144420851|NCT02259582|520747598|FG000|Overall Study|Withdrawal by Subject|0|||
144420852|NCT02259582|520747599|FG001|Overall Study|Withdrawal by Subject|0|||
144420853|NCT02259582|520747600|FG002|Overall Study|Withdrawal by Subject|1|||
144420854|NCT02259582|520747598|FG000|Overall Study|Disease progression|14|||
144420855|NCT02259582|520747599|FG001|Overall Study|Disease progression|15|||
144420856|NCT02259582|520747600|FG002|Overall Study|Disease progression|17|||
144420857|NCT02259582|520747598|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
144420858|NCT02259582|520747599|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
144420859|NCT02259582|520747600|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
144420860|NCT00503308|520747601|FG000|Overall Study|Protocol Violation|2|||
144420861|NCT00503308|520747602|FG001|Overall Study|Protocol Violation|1|||
144420862|NCT02233309|520747603|FG000|Overall Study|Physician Decision|5|||
144420863|NCT03263442|520747604|FG000|Inpatient Phase|Death|1|||
144420864|NCT03263442|520747605|FG001|Inpatient Phase|Death|0|||
144420865|NCT03263442|520747604|FG000|Inpatient Phase|Withdrawal by Subject|1|||
144420866|NCT03263442|520747605|FG001|Inpatient Phase|Withdrawal by Subject|0|||
144420867|NCT03263442|520747604|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
144420868|NCT03263442|520747605|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
144420869|NCT03263442|520747604|FG000|1-month Follow-Up|Lost to Follow-up|1|||
144420870|NCT03263442|520747605|FG001|1-month Follow-Up|Lost to Follow-up|0|||
144420871|NCT03263442|520747604|FG000|3-month Follow-Up|Lost to Follow-up|1|||
144420872|NCT03263442|520747605|FG001|3-month Follow-Up|Lost to Follow-up|3|||
144420873|NCT03263442|520747604|FG000|6-month Follow-Up|Lost to Follow-up|2|||
144420874|NCT03263442|520747605|FG001|6-month Follow-Up|Lost to Follow-up|2|||
144420875|NCT03804879|520747606|FG000|Overall Study|Adverse Event|3|||
144420876|NCT03804879|520747607|FG001|Overall Study|Adverse Event|0|||
144420877|NCT03804879|520747606|FG000|Overall Study|Study Terminated By Sponsor|10|||
144420878|NCT03804879|520747607|FG001|Overall Study|Study Terminated By Sponsor|12|||
144420879|NCT03804879|520747606|FG000|Overall Study|Withdrawal by Subject|3|||
144527582|NCT05002088|521133323|FG001|Overall Study|Withdrawal by Subject|0|||
144420880|NCT03804879|520747607|FG001|Overall Study|Withdrawal by Subject|1|||
144420881|NCT03198234|520747608|FG000|Overall Study|Relapse of primary disease|0|||
144420882|NCT03198234|520747609|FG001|Overall Study|Relapse of primary disease|1|||
144420883|NCT03198234|520747610|FG002|Overall Study|Relapse of primary disease|0|||
144420884|NCT03228537|520747611|FG000|Neoadjuvant|Adverse Event|2|||
144420885|NCT03228537|520747611|FG000|Neoadjuvant|Progression/Relapse|4|||
144420886|NCT03228537|520747611|FG000|Neoadjuvant|Death|1|||
144420887|NCT03228537|520747611|FG000|Surgery|Death|1|||
144420888|NCT03228537|520747611|FG000|Surgery|Other - Not Protocol Specified|2|||
144420889|NCT03228537|520747611|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
144420890|NCT03228537|520747611|FG000|Maintenance|Progression/Relapse|10|||
144420891|NCT04900220|520747612|FG000|Overall Study|Lost to Follow-up|1|||
144420892|NCT04900220|520747613|FG001|Overall Study|Lost to Follow-up|1|||
144420893|NCT02622321|520747614|FG000|Overall Study|Withdrawal by Subject|2|||
144420894|NCT02622321|520747615|FG001|Overall Study|Withdrawal by Subject|0|||
144420895|NCT02622321|520747616|FG002|Overall Study|Withdrawal by Subject|0|||
144420896|NCT02622321|520747617|FG003|Overall Study|Withdrawal by Subject|0|||
144527583|NCT05002088|521133322|FG000|Overall Study|Lost to Follow-up|0|||
144723227|NCT02260492|521840664|FG000|Overall Study|Adverse Event|6|||
144527584|NCT05002088|521133323|FG001|Overall Study|Lost to Follow-up|1|||
144180817|NCT02300987|519857239|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
144180818|NCT02300987|519857238|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
144180819|NCT02300987|519857239|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
144420897|NCT02622321|520747614|FG000|Overall Study|Death|0|||
144420898|NCT02622321|520747615|FG001|Overall Study|Death|0|||
144420899|NCT02622321|520747616|FG002|Overall Study|Death|1|||
144420900|NCT02622321|520747617|FG003|Overall Study|Death|0|||
144420901|NCT02622321|520747614|FG000|Overall Study|Physician Decision|1|||
144527585|NCT05002088|521133322|FG000|Overall Study|Death|16|||
144527586|NCT05002088|521133323|FG001|Overall Study|Death|2|||
144420902|NCT02622321|520747615|FG001|Overall Study|Physician Decision|0|||
144420903|NCT02622321|520747616|FG002|Overall Study|Physician Decision|0|||
144527587|NCT05002088|521133322|FG000|Overall Study|Protocol Violation|25|||
144420904|NCT02622321|520747617|FG003|Overall Study|Physician Decision|0|||
144420905|NCT00965718|520747619|FG000|Overall Study|Withdrawal by Subject|4|||
144420906|NCT02028065|520747620|FG000|Randomization Through Start Treatment|Not treated|1|||
144420907|NCT02028065|520747621|FG001|Randomization Through Start Treatment|Not treated|3|||
144420908|NCT02028065|520747622|FG002|Randomization Through Start Treatment|Not treated|3|||
144420909|NCT02028065|520747620|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
144420910|NCT02028065|520747621|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
144420911|NCT02028065|520747622|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
144420912|NCT02028065|520747620|FG000|Treatment Through Study Completion|Physician Decision|1|||
144420913|NCT02028065|520747621|FG001|Treatment Through Study Completion|Physician Decision|0|||
144420914|NCT02028065|520747622|FG002|Treatment Through Study Completion|Physician Decision|0|||
144420915|NCT02028065|520747620|FG000|Treatment Through Study Completion|Protocol Violation|1|||
144420916|NCT02028065|520747621|FG001|Treatment Through Study Completion|Protocol Violation|4|||
144251128|NCT01744483|520119252|FG002|Overall Study|Routed to OSH|1|||
144251129|NCT03041467|520119253|FG000|Overall Study|Death|46|||
144420917|NCT02028065|520747622|FG002|Treatment Through Study Completion|Protocol Violation|0|||
144420918|NCT02028065|520747620|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
144420919|NCT02028065|520747621|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
144420920|NCT02028065|520747622|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
144420921|NCT02028065|520747620|FG000|Treatment Through Study Completion|Adverse Event|3|||
144420922|NCT02028065|520747621|FG001|Treatment Through Study Completion|Adverse Event|3|||
144420923|NCT02028065|520747622|FG002|Treatment Through Study Completion|Adverse Event|5|||
144420924|NCT01414855|520747625|FG000|Overall Study|Death|17|||
144420925|NCT01414855|520747625|FG000|Overall Study|Lost to Follow-up|5|||
144420926|NCT01414855|520747625|FG000|Overall Study|Withdrawal by Subject|7|||
144420927|NCT04851314|520747629|FG000|Overall Study|Unable to complete research set-up procedures|0|||
144420928|NCT04851314|520747630|FG001|Overall Study|Unable to complete research set-up procedures|2|||
144420929|NCT04851314|520747629|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
144420930|NCT04851314|520747630|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
144420931|NCT02260921|520747637|FG000|Overall Study|Adverse Event|1|||
144420932|NCT02260921|520747638|FG001|Overall Study|Adverse Event|0|||
144420933|NCT02260921|520747637|FG000|Overall Study|Lost to Follow-up|4|||
144420934|NCT02260921|520747638|FG001|Overall Study|Lost to Follow-up|3|||
144420935|NCT02260921|520747637|FG000|Overall Study|Withdraw Consent|4|||
144420936|NCT02260921|520747638|FG001|Overall Study|Withdraw Consent|1|||
144420937|NCT02260921|520747637|FG000|Overall Study|Death|1|||
144420938|NCT02260921|520747638|FG001|Overall Study|Death|0|||
144420939|NCT02260921|520747637|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
144420940|NCT02260921|520747638|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
144420941|NCT00867009|520747639|FG000|Induction Period|Nonserious Adverse Event|5|||
144420942|NCT00867009|520747639|FG000|Induction Period|Serious Adverse Event|10|||
144420943|NCT00867009|520747639|FG000|Induction Period|Death due to serious adverse event|6|||
144420944|NCT00867009|520747639|FG000|Induction Period|Death due to Study Disease|4|||
144420945|NCT00867009|520747639|FG000|Induction Period|Protocol Violation|1|||
144420946|NCT00867009|520747639|FG000|Induction Period|Withdrawal by Subject|8|||
144420947|NCT00867009|520747639|FG000|Induction Period|Physician Decision|3|||
144420948|NCT00867009|520747639|FG000|Induction Period|Progressive Disease (PD)|25|||
144420949|NCT00867009|520747639|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
144420950|NCT03266094|520747640|FG000|Overall Study|Lost to Follow-up|1|||
144420951|NCT03266094|520747640|FG000|Overall Study|Withdrawal by Subject|1|||
144420952|NCT04059094|520747647|FG000|Overall Study|Adverse Event|0|||
144420953|NCT04059094|520747648|FG001|Overall Study|Adverse Event|0|||
144420954|NCT04059094|520747649|FG002|Overall Study|Adverse Event|0|||
144420955|NCT04059094|520747650|FG003|Overall Study|Adverse Event|0|||
144420956|NCT04059094|520747651|FG004|Overall Study|Adverse Event|1|||
144420957|NCT04059094|520747647|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
144420958|NCT04059094|520747648|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
144420959|NCT04059094|520747649|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
144420960|NCT04059094|520747650|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
144420961|NCT04059094|520747651|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
144420962|NCT01339429|520747652|FG000|Overall Study|Withdrawal by Subject|1|||
144420963|NCT01339429|520747652|FG000|Overall Study|Physician Decision|3|||
144420964|NCT00459667|520747655|FG000|Overall Study|Adverse Event|9|||
144420965|NCT00459667|520747656|FG001|Overall Study|Adverse Event|12|||
144420966|NCT00459667|520747657|FG002|Overall Study|Adverse Event|8|||
144420967|NCT00459667|520747655|FG000|Overall Study|Lost to Follow-up|5|||
144420968|NCT00459667|520747656|FG001|Overall Study|Lost to Follow-up|9|||
144420969|NCT00459667|520747657|FG002|Overall Study|Lost to Follow-up|3|||
144420970|NCT00459667|520747655|FG000|Overall Study|Pregnancy|1|||
144420971|NCT00459667|520747656|FG001|Overall Study|Pregnancy|1|||
144601110|NCT03808688|521403322|FG000|Overall Study|Lost to Follow-up|0|||
144601111|NCT03808688|521403323|FG001|Overall Study|Lost to Follow-up|2|||
144251130|NCT03041467|520119254|FG001|Overall Study|Death|39|||
144251131|NCT03041467|520119253|FG000|Overall Study|Withdrawal by Subject|36|||
144251132|NCT03041467|520119254|FG001|Overall Study|Withdrawal by Subject|37|||
144251133|NCT03041467|520119253|FG000|Overall Study|Lost to Follow-up|6|||
144251134|NCT03041467|520119254|FG001|Overall Study|Lost to Follow-up|8|||
144251135|NCT03041467|520119253|FG000|Overall Study|Declined consent for study extension|21|||
144251136|NCT03041467|520119254|FG001|Overall Study|Declined consent for study extension|33|||
144251137|NCT03041467|520119253|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
144251138|NCT03041467|520119254|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
144251139|NCT01190189|520119255|FG000|Overall Study|Lost to Follow-up|4|||
144251140|NCT01190189|520119255|FG000|Overall Study|Withdrawal by Subject|1|||
144251141|NCT01190189|520119255|FG000|Overall Study|Migrated/moved from study area|1|||
144251142|NCT02732015|520119256|FG000|Overall Study|Lost to Follow-up|0|||
144251143|NCT02732015|520119257|FG001|Overall Study|Lost to Follow-up|1|||
144251144|NCT05437640|520119260|FG000|Washout (1 Week)|Adverse Event|1|||
144251145|NCT05437640|520119261|FG001|Washout (1 Week)|Adverse Event|0|||
144251146|NCT00734656|520119266|FG000|Lab Session 1|Withdrawal by Subject|2|||
144251147|NCT00734656|520119267|FG001|Lab Session 1|Withdrawal by Subject|0|||
144251148|NCT00734656|520119268|FG002|Lab Session 1|Withdrawal by Subject|0|||
144251149|NCT00734656|520119269|FG003|Lab Session 1|Withdrawal by Subject|0|||
144251150|NCT00734656|520119266|FG000|Washout 1|Withdrawal by Subject|1|||
144251151|NCT00734656|520119267|FG001|Washout 1|Withdrawal by Subject|5|||
144251152|NCT00734656|520119268|FG002|Washout 1|Withdrawal by Subject|2|||
144251153|NCT00734656|520119269|FG003|Washout 1|Withdrawal by Subject|3|||
144251154|NCT00734656|520119266|FG000|Lab Session 2|Withdrawal by Subject|1|||
144251155|NCT00734656|520119267|FG001|Lab Session 2|Withdrawal by Subject|0|||
144251156|NCT00734656|520119268|FG002|Lab Session 2|Withdrawal by Subject|0|||
144251157|NCT00734656|520119269|FG003|Lab Session 2|Withdrawal by Subject|1|||
144251158|NCT00734656|520119266|FG000|Washout 2|Withdrawal by Subject|1|||
144251159|NCT00734656|520119267|FG001|Washout 2|Withdrawal by Subject|1|||
144251160|NCT00734656|520119268|FG002|Washout 2|Withdrawal by Subject|1|||
144251161|NCT00734656|520119269|FG003|Washout 2|Withdrawal by Subject|0|||
144251162|NCT00734656|520119266|FG000|Washout 3|Withdrawal by Subject|1|||
144251163|NCT00734656|520119267|FG001|Washout 3|Withdrawal by Subject|0|||
144251164|NCT00734656|520119268|FG002|Washout 3|Withdrawal by Subject|0|||
144251165|NCT00734656|520119269|FG003|Washout 3|Withdrawal by Subject|1|||
144251166|NCT00734656|520119266|FG000|Lab Session 4|Withdrawal by Subject|0|||
144251167|NCT00734656|520119267|FG001|Lab Session 4|Withdrawal by Subject|0|||
144251168|NCT00734656|520119268|FG002|Lab Session 4|Withdrawal by Subject|0|||
144251169|NCT00734656|520119269|FG003|Lab Session 4|Withdrawal by Subject|1|||
144251170|NCT03915626|520119271|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
144251171|NCT03015194|520119272|FG000|Overall Study|Death|10|||
144251172|NCT03015194|520119272|FG000|Overall Study|Withdrawal by Subject|2|||
144251173|NCT01754766|520119277|FG000|Overall Study|Personal reasons|1|||
144251174|NCT01754766|520119278|FG001|Overall Study|Personal reasons|1|||
144251175|NCT01754766|520119279|FG002|Overall Study|Personal reasons|0|||
144251176|NCT00433017|520119280|FG000|Overall Study|Adverse Event|5|||
144251177|NCT00433017|520119281|FG001|Overall Study|Adverse Event|3|||
144420972|NCT00459667|520747657|FG002|Overall Study|Pregnancy|1|||
144420973|NCT00459667|520747655|FG000|Overall Study|Protocol Violation|1|||
144420974|NCT00459667|520747656|FG001|Overall Study|Protocol Violation|0|||
144420975|NCT00459667|520747657|FG002|Overall Study|Protocol Violation|0|||
144420976|NCT00459667|520747655|FG000|Overall Study|Withdrawal by Subject|3|||
144420977|NCT00459667|520747656|FG001|Overall Study|Withdrawal by Subject|5|||
144420978|NCT00459667|520747657|FG002|Overall Study|Withdrawal by Subject|5|||
144420979|NCT00459667|520747655|FG000|Overall Study|Other disease modifying treatment|1|||
144420980|NCT00459667|520747656|FG001|Overall Study|Other disease modifying treatment|2|||
144420981|NCT00459667|520747657|FG002|Overall Study|Other disease modifying treatment|1|||
144420982|NCT00459667|520747655|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
144420983|NCT00459667|520747656|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
144527588|NCT05002088|521133323|FG001|Overall Study|Protocol Violation|7|||
144527589|NCT03691935|521133324|FG000|Overall Study|Physician Decision|2|||
144527590|NCT03691935|521133325|FG001|Overall Study|Physician Decision|1|||
144251178|NCT00433017|520119280|FG000|Overall Study|Withdrawal by Subject|4|||
144251179|NCT00433017|520119281|FG001|Overall Study|Withdrawal by Subject|5|||
144251180|NCT00433017|520119280|FG000|Overall Study|Lost to Follow-up|3|||
144420984|NCT00459667|520747657|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
144420985|NCT00459667|520747655|FG000|Overall Study|No treatment administered|6|||
144420986|NCT00459667|520747656|FG001|Overall Study|No treatment administered|3|||
144251181|NCT00433017|520119281|FG001|Overall Study|Lost to Follow-up|4|||
144251182|NCT00433017|520119280|FG000|Overall Study|Administrative problems|80|||
144251183|NCT00433017|520119281|FG001|Overall Study|Administrative problems|86|||
144251184|NCT00433017|520119280|FG000|Overall Study|Protocol Violation|1|||
144251185|NCT00433017|520119281|FG001|Overall Study|Protocol Violation|0|||
144420987|NCT00459667|520747657|FG002|Overall Study|No treatment administered|1|||
144527591|NCT03691935|521133324|FG000|Overall Study|Adverse Event|3|||
144420988|NCT00396591|520747658|FG000|Overall Study|Disease Progression|13|||
144420989|NCT00396591|520747658|FG000|Overall Study|Adverse Event|2|||
144420990|NCT00396591|520747658|FG000|Overall Study|Participant request|1|||
144420991|NCT01962207|520747662|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
144420992|NCT01962207|520747663|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
144420993|NCT01962207|520747664|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
144420994|NCT01962207|520747665|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
144420995|NCT01962207|520747662|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
144420996|NCT01962207|520747663|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
144420997|NCT01962207|520747664|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
144420998|NCT01962207|520747665|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
144527592|NCT03691935|521133325|FG001|Overall Study|Adverse Event|0|||
144527593|NCT01275677|521133333|FG000|Overall Study|Not at risk for recurrence.|1|||
144527594|NCT01275677|521133334|FG001|Overall Study|Not at risk for recurrence.|1|||
144527595|NCT01275677|521133333|FG000|Overall Study|No follow-up|26|||
144527596|NCT01275677|521133334|FG001|Overall Study|No follow-up|37|||
144527597|NCT01275677|521133333|FG000|Overall Study|No clinical follow up.|1|||
144527598|NCT01275677|521133334|FG001|Overall Study|No clinical follow up.|4|||
144527599|NCT03478956|521133338|FG000|Randomized Treatment Period|Adverse Event|1|||
144527600|NCT03478956|521133339|FG001|Randomized Treatment Period|Adverse Event|0|||
144527601|NCT03478956|521133340|FG002|Randomized Treatment Period|Adverse Event|0|||
144527602|NCT03478956|521133341|FG003|Randomized Treatment Period|Adverse Event|0|||
144527603|NCT03478956|521133338|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
144527604|NCT03478956|521133339|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
144527605|NCT03478956|521133340|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
144527606|NCT03478956|521133341|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
144601112|NCT03808688|521403322|FG000|Overall Study|Withdrawal by Subject|1|||
144601113|NCT03808688|521403323|FG001|Overall Study|Withdrawal by Subject|0|||
144601114|NCT03808688|521403322|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
144601115|NCT03808688|521403323|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
144601116|NCT03808688|521403322|FG000|Overall Study|IOP Too High|1|||
144601117|NCT03808688|521403323|FG001|Overall Study|IOP Too High|1|||
144601118|NCT03808688|521403322|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
144601119|NCT03808688|521403323|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
144601120|NCT03808688|521403322|FG000|Overall Study|Visit Out of Window|0|||
144601121|NCT03808688|521403323|FG001|Overall Study|Visit Out of Window|1|||
144601122|NCT03808688|521403322|FG000|Overall Study|Medication Non-Compliance|0|||
144601123|NCT03808688|521403323|FG001|Overall Study|Medication Non-Compliance|1|||
144180820|NCT02300987|519857238|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
144420999|NCT01962207|520747662|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
144421000|NCT01962207|520747663|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
144421001|NCT01962207|520747664|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
144421002|NCT01962207|520747665|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
144421003|NCT01962207|520747662|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
144421004|NCT01962207|520747663|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
144421005|NCT01962207|520747664|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
144421006|NCT01962207|520747665|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
144421007|NCT01962207|520747662|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
144421008|NCT01962207|520747663|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
144421009|NCT01962207|520747664|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
144421010|NCT01962207|520747665|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
144421011|NCT01962207|520747662|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
144421012|NCT01962207|520747663|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
144421013|NCT01962207|520747664|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
144421014|NCT01962207|520747665|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
144421015|NCT02289079|520747669|FG000|Overall Study|Physician Decision|2|||
144421016|NCT02289079|520747670|FG001|Overall Study|Physician Decision|0|||
144421017|NCT02289079|520747669|FG000|Overall Study|Lost to Follow-up|0|||
144421018|NCT02289079|520747670|FG001|Overall Study|Lost to Follow-up|1|||
144421019|NCT02671422|520747671|FG000|Overall Study|Lost to Follow-up|1|||
144421020|NCT02671422|520747671|FG000|Overall Study|Adverse Event|68|||
144421021|NCT02671422|520747671|FG000|Overall Study|Lack of Efficacy|1|||
144421022|NCT02671422|520747671|FG000|Overall Study|Lost to Follow-up|4|||
144421023|NCT02671422|520747671|FG000|Overall Study|Withdrawal by Subject|7|||
144421024|NCT02671422|520747671|FG000|Overall Study|Progressive Disease|156|||
144421025|NCT02671422|520747671|FG000|Overall Study|Worsening of Disease|4|||
144421026|NCT02671422|520747671|FG000|Overall Study|Sponsor decision|5|||
144421027|NCT02671422|520747671|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
144527607|NCT03478956|521133338|FG000|Open Label Extension Period|Adverse Event|0|||
144527608|NCT03478956|521133339|FG001|Open Label Extension Period|Adverse Event|0|||
144527609|NCT03478956|521133340|FG002|Open Label Extension Period|Adverse Event|4|||
144527610|NCT03478956|521133341|FG003|Open Label Extension Period|Adverse Event|0|||
144527611|NCT03478956|521133338|FG000|Open Label Extension Period|Lack of Efficacy|0|||
144421028|NCT02671422|520747671|FG000|Overall Study|Not treated with Vargatef®|3|||
144421029|NCT02671422|520747671|FG000|Overall Study|Other not defined above|3|||
144421030|NCT03036072|520747672|FG000|Overall Study|Death|0|||
144421031|NCT03036072|520747673|FG001|Overall Study|Death|1|||
144421032|NCT03036072|520747672|FG000|Overall Study|Withdrawal by Subject|0|||
144421033|NCT03036072|520747673|FG001|Overall Study|Withdrawal by Subject|1|||
144421034|NCT03036072|520747672|FG000|Overall Study|Physician Decision|0|||
144421035|NCT03036072|520747673|FG001|Overall Study|Physician Decision|1|||
144421036|NCT02484729|520747674|FG000|Overall Study|Failure of IntelliCap Error|0|||
144421037|NCT02484729|520747675|FG001|Overall Study|Failure of IntelliCap Error|0|||
144421038|NCT02484729|520747676|FG002|Overall Study|Failure of IntelliCap Error|0|||
144421039|NCT02484729|520747677|FG003|Overall Study|Failure of IntelliCap Error|0|||
144421040|NCT02484729|520747678|FG004|Overall Study|Failure of IntelliCap Error|0|||
144421041|NCT02484729|520747679|FG005|Overall Study|Failure of IntelliCap Error|0|||
144421042|NCT02484729|520747680|FG006|Overall Study|Failure of IntelliCap Error|0|||
144421043|NCT02484729|520747681|FG007|Overall Study|Failure of IntelliCap Error|0|||
144421044|NCT02484729|520747682|FG008|Overall Study|Failure of IntelliCap Error|0|||
144421045|NCT02484729|520747683|FG009|Overall Study|Failure of IntelliCap Error|1|||
144421046|NCT04080297|520747684|FG000|Overall Study|Adverse Event|1|||
144421047|NCT04080297|520747685|FG001|Overall Study|Adverse Event|3|||
144421048|NCT04080297|520747684|FG000|Overall Study|concurrent illness|1|||
144421049|NCT04080297|520747685|FG001|Overall Study|concurrent illness|0|||
144421050|NCT02623439|520747688|FG000|Overall Study|Withdrawal by Subject|1|||
144421051|NCT02623439|520747688|FG000|Overall Study|Screen Failure|1|||
144421052|NCT04484142|520747689|FG000|Overall Study|Adverse Event|13|||
144421053|NCT04484142|520747689|FG000|Overall Study|Progressive Disease|87|||
144421054|NCT04484142|520747689|FG000|Overall Study|Clinical Progression|10|||
144421055|NCT04484142|520747689|FG000|Overall Study|Withdrawal by Subject|6|||
144421056|NCT04484142|520747689|FG000|Overall Study|Physician Decision|1|||
144421057|NCT05371509|520747690|FG000|Overall Study|Physician Decision|1|||
144421058|NCT05371509|520747691|FG001|Overall Study|Physician Decision|0|||
144421059|NCT03851302|520747694|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
144421060|NCT03851302|520747695|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
144421061|NCT03851302|520747696|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
144421062|NCT03851302|520747697|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
144421063|NCT03851302|520747698|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
144421064|NCT03851302|520747699|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
144421065|NCT03851302|520747694|FG000|Screening (1 Day)|Screened out|0|||
144421066|NCT03851302|520747695|FG001|Screening (1 Day)|Screened out|0|||
144421067|NCT03851302|520747696|FG002|Screening (1 Day)|Screened out|1|||
144421068|NCT03851302|520747697|FG003|Screening (1 Day)|Screened out|1|||
144421069|NCT03851302|520747698|FG004|Screening (1 Day)|Screened out|0|||
144421070|NCT03851302|520747699|FG005|Screening (1 Day)|Screened out|0|||
144421071|NCT03851302|520747694|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
144421072|NCT03851302|520747695|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
144421073|NCT03851302|520747696|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
144421074|NCT03851302|520747697|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
144421075|NCT03851302|520747698|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
144421076|NCT03851302|520747699|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
144421077|NCT04434092|520747700|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
144421078|NCT04434092|520747701|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
144421079|NCT04434092|520747702|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
144421080|NCT04434092|520747700|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
144421081|NCT04434092|520747701|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
144421082|NCT04434092|520747702|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
144421083|NCT04434092|520747700|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
144527612|NCT03478956|521133339|FG001|Open Label Extension Period|Lack of Efficacy|0|||
144527613|NCT03478956|521133340|FG002|Open Label Extension Period|Lack of Efficacy|8|||
144527614|NCT03478956|521133341|FG003|Open Label Extension Period|Lack of Efficacy|0|||
144527615|NCT03478956|521133338|FG000|Open Label Extension Period|Reason Not Provided|0|||
144527616|NCT03478956|521133339|FG001|Open Label Extension Period|Reason Not Provided|0|||
144527617|NCT03478956|521133340|FG002|Open Label Extension Period|Reason Not Provided|1|||
144527618|NCT03478956|521133341|FG003|Open Label Extension Period|Reason Not Provided|0|||
144527619|NCT03478956|521133338|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
144527620|NCT03478956|521133339|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
144527621|NCT03478956|521133340|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
144527622|NCT03478956|521133341|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
144421084|NCT04434092|520747701|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
144421085|NCT04434092|520747702|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
144421086|NCT04434092|520747700|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
144421087|NCT04434092|520747701|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
144421088|NCT04434092|520747702|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
144421089|NCT04434092|520747700|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
144421090|NCT04434092|520747701|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
144421091|NCT04434092|520747702|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
144421092|NCT04434092|520747700|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
144421093|NCT04434092|520747701|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
144421094|NCT04434092|520747702|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
144421095|NCT04434092|520747700|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
144421096|NCT04434092|520747701|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
144421097|NCT04434092|520747702|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
144421098|NCT04779489|520749526|FG000|Overall Study|Physician Decision|1|||
144421099|NCT00415909|520749531|FG000|Overall Study|Withdrawal by Subject|2|||
144421100|NCT00415909|520749531|FG000|Overall Study|Death|1|||
144421101|NCT00407563|520749534|FG000|Overall Study|Patient continues on treatment|1|||
144421102|NCT02450903|520749535|FG000|Overall Study|Adverse Event|3|||
144421103|NCT02450903|520749535|FG000|Overall Study|Progressive disease|15|||
144421104|NCT02450903|520749535|FG000|Overall Study|Switched to commercial drug|1|||
144421105|NCT02450903|520749535|FG000|Overall Study|Subject/guardian decision|1|||
144421106|NCT00157950|520749542|FG000|Overall Study|Death|1|||
144421107|NCT00157950|520749543|FG001|Overall Study|Death|0|||
144421108|NCT02892760|520749547|FG000|Overall Study|Withdrawal by Subject|3|||
144421109|NCT00588848|520749554|FG000|Overall Study|Physician Decision|0|||
144421110|NCT00588848|520749555|FG001|Overall Study|Physician Decision|3|||
144421111|NCT00249444|520749556|FG000|Overall Study|Lost to Follow-up|2|||
144421112|NCT00249444|520749557|FG001|Overall Study|Lost to Follow-up|2|||
144421113|NCT00249444|520749556|FG000|Overall Study|non-compliant|9|||
144421114|NCT00249444|520749557|FG001|Overall Study|non-compliant|11|||
144421115|NCT00249444|520749556|FG000|Overall Study|Adverse Event|1|||
144421116|NCT00249444|520749557|FG001|Overall Study|Adverse Event|1|||
144421117|NCT00249444|520749556|FG000|Overall Study|life event|0|||
144421118|NCT00249444|520749557|FG001|Overall Study|life event|1|||
144421119|NCT02902965|520749558|FG000|Overall Study|Withdrawal by Subject|10|||
144421120|NCT02673489|520749559|FG000|Treatment Period|Lost to Follow-up|3|||
144421121|NCT02673489|520749560|FG001|Treatment Period|Lost to Follow-up|0|||
144421122|NCT02673489|520749559|FG000|Treatment Period|Participant request to discontinue|1|||
144421123|NCT02673489|520749560|FG001|Treatment Period|Participant request to discontinue|1|||
144251186|NCT00433017|520119280|FG000|Overall Study|Death|2|||
144251187|NCT00433017|520119281|FG001|Overall Study|Death|2|||
144251188|NCT00433017|520119280|FG000|Overall Study|Subject no longer requires study drug|1|||
144251189|NCT00433017|520119281|FG001|Overall Study|Subject no longer requires study drug|1|||
144251190|NCT01026818|520119282|FG000|Screening Period|Entry Criteria Not Met|105|||
144251191|NCT01026818|520119283|FG001|Screening Period|Entry Criteria Not Met|0|||
144251192|NCT01026818|520119284|FG002|Screening Period|Entry Criteria Not Met|0|||
144251193|NCT01026818|520119285|FG003|Screening Period|Entry Criteria Not Met|0|||
144251194|NCT01026818|520119282|FG000|Screening Period|Withdrawal by Subject|49|||
144251195|NCT01026818|520119283|FG001|Screening Period|Withdrawal by Subject|0|||
144251196|NCT01026818|520119284|FG002|Screening Period|Withdrawal by Subject|0|||
144251197|NCT01026818|520119285|FG003|Screening Period|Withdrawal by Subject|0|||
144251198|NCT01026818|520119282|FG000|Screening Period|Protocol Deviation|3|||
144251199|NCT01026818|520119283|FG001|Screening Period|Protocol Deviation|0|||
144251200|NCT01026818|520119284|FG002|Screening Period|Protocol Deviation|0|||
144251201|NCT01026818|520119285|FG003|Screening Period|Protocol Deviation|0|||
144251202|NCT01026818|520119282|FG000|Screening Period|Adverse Event|2|||
144251203|NCT01026818|520119283|FG001|Screening Period|Adverse Event|0|||
144251204|NCT01026818|520119284|FG002|Screening Period|Adverse Event|0|||
144421124|NCT02673489|520749559|FG000|Treatment Period|Participant moved to another province|1|||
144421125|NCT02673489|520749560|FG001|Treatment Period|Participant moved to another province|0|||
144527623|NCT03478956|521133338|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
144527624|NCT03478956|521133339|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
144527625|NCT03478956|521133340|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
144723228|NCT02260492|521840665|FG001|Overall Study|Adverse Event|1|||
144421126|NCT02673489|520749559|FG000|Treatment Period|Participant was incarcerated|0|||
144421127|NCT02673489|520749560|FG001|Treatment Period|Participant was incarcerated|1|||
144421128|NCT02673489|520749559|FG000|Treatment Period|Adverse Event|0|||
144421129|NCT02673489|520749560|FG001|Treatment Period|Adverse Event|1|||
144421130|NCT02673489|520749559|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
144421131|NCT02673489|520749560|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
144421132|NCT02673489|520749559|FG000|Follow Up Period|Unable to return for follow-up|0|||
144421133|NCT02673489|520749560|FG001|Follow Up Period|Unable to return for follow-up|1|||
144421134|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
144421135|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
144421136|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
144421137|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
144527626|NCT03478956|521133341|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
144723229|NCT02260492|521840666|FG002|Overall Study|Adverse Event|2|||
144723230|NCT02260492|521840664|FG000|Overall Study|Death|0|||
144421138|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
144421139|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
144421140|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
144421141|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
144421142|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
144421143|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
144421144|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
144421145|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
144421146|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
144421147|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
144421148|NCT00293254|520749561|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
144421149|NCT00293254|520749562|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
144421150|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
144421151|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
144421152|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Death|4|||
144421153|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Death|1|||
144421154|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
144421155|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
144421156|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
144421157|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
144421158|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
144421159|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
144421160|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
144421161|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
144421162|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
144421163|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
144421164|NCT00293254|520749561|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
144421165|NCT00293254|520749562|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
144421166|NCT00293254|520749561|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
144421167|NCT00293254|520749562|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
144421168|NCT00293254|520749561|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
144421169|NCT00293254|520749562|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
144421170|NCT00293254|520749561|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
144421171|NCT00293254|520749562|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
144421172|NCT00293254|520749561|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
144421173|NCT00293254|520749562|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
144421174|NCT00293254|520749561|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
144421175|NCT00293254|520749562|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
144421176|NCT00293254|520749561|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
144421177|NCT00293254|520749562|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
144421178|NCT00293254|520749561|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
144421179|NCT00293254|520749562|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
144421180|NCT00293254|520749561|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
144421181|NCT00293254|520749562|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
144421182|NCT00293254|520749561|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
144421183|NCT00293254|520749562|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
144421184|NCT00293254|520749561|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
144421185|NCT00293254|520749562|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
144421186|NCT00293254|520749561|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
144421187|NCT00293254|520749562|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
144421188|NCT02335489|520749563|FG000|Overall Study|Sponsor terminated study|4|||
144421189|NCT02335489|520749563|FG000|Overall Study|Lost to Follow-up|1|||
144421190|NCT02335489|520749563|FG000|Overall Study|Withdrawal by Subject|2|||
144421191|NCT02335489|520749563|FG000|Overall Study|Physician Decision|2|||
144421192|NCT02335489|520749563|FG000|Overall Study|Lack of Efficacy|1|||
144421193|NCT00759863|520749567|FG000|Overall Study|Death, moved, or lost contact|20|||
144421194|NCT00759863|520749568|FG001|Overall Study|Death, moved, or lost contact|18|||
144421195|NCT00412854|520749572|FG000|Overall Study|Withdrawn due to adverse events|1|||
144421196|NCT00412854|520749573|FG001|Overall Study|Withdrawn due to adverse events|5|||
144421197|NCT00412854|520749572|FG000|Overall Study|Withdrawn for other reasons|13|||
144421198|NCT00412854|520749573|FG001|Overall Study|Withdrawn for other reasons|11|||
144421199|NCT00531050|520749574|FG000|Part 1: Period 1|Adverse Event|0|||
144421200|NCT00531050|520749575|FG001|Part 1: Period 1|Adverse Event|1|||
144421201|NCT00531050|520749576|FG002|Part 1: Period 1|Adverse Event|0|||
144421202|NCT00531050|520749577|FG003|Part 1: Period 1|Adverse Event|0|||
144421203|NCT00531050|520749578|FG004|Part 1: Period 1|Adverse Event|0|||
144251205|NCT01026818|520119285|FG003|Screening Period|Adverse Event|0|||
144421204|NCT00531050|520749579|FG005|Part 1: Period 1|Adverse Event|0|||
144421205|NCT00531050|520749574|FG000|Part 1: Period 1|Protocol Deviation|0|||
144421206|NCT00531050|520749575|FG001|Part 1: Period 1|Protocol Deviation|0|||
144421207|NCT00531050|520749576|FG002|Part 1: Period 1|Protocol Deviation|0|||
144421208|NCT00531050|520749577|FG003|Part 1: Period 1|Protocol Deviation|1|||
144421209|NCT00531050|520749578|FG004|Part 1: Period 1|Protocol Deviation|0|||
144421210|NCT00531050|520749579|FG005|Part 1: Period 1|Protocol Deviation|0|||
144421211|NCT00531050|520749574|FG000|Part 1: Period 3|Adverse Event|1|||
144421212|NCT00531050|520749575|FG001|Part 1: Period 3|Adverse Event|0|||
144421213|NCT00531050|520749576|FG002|Part 1: Period 3|Adverse Event|0|||
144421214|NCT00531050|520749577|FG003|Part 1: Period 3|Adverse Event|0|||
144421215|NCT00531050|520749578|FG004|Part 1: Period 3|Adverse Event|0|||
144421216|NCT00531050|520749579|FG005|Part 1: Period 3|Adverse Event|0|||
144421217|NCT00531050|520749574|FG000|Part 2: Period 1|Adverse Event|0|||
144421218|NCT00531050|520749575|FG001|Part 2: Period 1|Adverse Event|0|||
144421219|NCT00531050|520749576|FG002|Part 2: Period 1|Adverse Event|0|||
144421220|NCT00531050|520749577|FG003|Part 2: Period 1|Adverse Event|0|||
144421221|NCT00531050|520749578|FG004|Part 2: Period 1|Adverse Event|0|||
144421222|NCT00531050|520749579|FG005|Part 2: Period 1|Adverse Event|1|||
144251206|NCT01026818|520119282|FG000|Screening Period|Physician Decision|1|||
144421223|NCT00531050|520749574|FG000|Part 2: Period 3|Abnormal test procedure|1|||
144421224|NCT00531050|520749575|FG001|Part 2: Period 3|Abnormal test procedure|0|||
144421225|NCT00531050|520749576|FG002|Part 2: Period 3|Abnormal test procedure|0|||
144421226|NCT00531050|520749577|FG003|Part 2: Period 3|Abnormal test procedure|0|||
144421227|NCT00531050|520749578|FG004|Part 2: Period 3|Abnormal test procedure|0|||
144421228|NCT00531050|520749579|FG005|Part 2: Period 3|Abnormal test procedure|1|||
144421229|NCT00799487|520749581|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
144421230|NCT00799487|520749582|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
144421231|NCT00799487|520749583|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
144421232|NCT00799487|520749581|FG000|Dose Adjustment Period|Adverse Event|2|||
144421233|NCT00799487|520749582|FG001|Dose Adjustment Period|Adverse Event|0|||
144421234|NCT00799487|520749583|FG002|Dose Adjustment Period|Adverse Event|0|||
144421235|NCT00799487|520749581|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
144421236|NCT00799487|520749582|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
144421237|NCT00799487|520749583|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
144421238|NCT00799487|520749581|FG000|Dose Adjustment Period|Investigator Discretion|2|||
144421239|NCT00799487|520749582|FG001|Dose Adjustment Period|Investigator Discretion|0|||
144421240|NCT00799487|520749583|FG002|Dose Adjustment Period|Investigator Discretion|0|||
144421241|NCT00799487|520749581|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
144421242|NCT00799487|520749582|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
144421243|NCT00799487|520749583|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
144251207|NCT01026818|520119283|FG001|Screening Period|Physician Decision|0|||
144251208|NCT01026818|520119284|FG002|Screening Period|Physician Decision|0|||
144251209|NCT01026818|520119285|FG003|Screening Period|Physician Decision|0|||
144421244|NCT00799487|520749581|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
144421245|NCT00799487|520749582|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
144527627|NCT03478956|521133338|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
144527628|NCT03478956|521133339|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
144527629|NCT03478956|521133340|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
144527630|NCT03478956|521133341|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
144527631|NCT04865289|521133342|FG000|Overall Study|Participant ongoing in study|47|||
144527632|NCT04865289|521133343|FG001|Overall Study|Participant ongoing in study|35|||
144527633|NCT04865289|521133342|FG000|Overall Study|Death|27|||
144527634|NCT04865289|521133343|FG001|Overall Study|Death|21|||
144527635|NCT02733159|521133345|FG000|Overall Study|Adverse Event|1|||
144527636|NCT02733159|521133345|FG000|Overall Study|Lack of disease progression|1|||
144527637|NCT04171141|521135226|FG000|Overall Study|Adverse Event|0|||
144723231|NCT02260492|521840665|FG001|Overall Study|Death|1|||
144251210|NCT01026818|520119282|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
144421246|NCT00799487|520749583|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
144421247|NCT00799487|520749581|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
144421248|NCT00799487|520749582|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
144527638|NCT04171141|521135227|FG001|Overall Study|Adverse Event|0|||
144723232|NCT02260492|521840666|FG002|Overall Study|Death|0|||
144421249|NCT00799487|520749583|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
144421250|NCT00799487|520749581|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
144421251|NCT00799487|520749582|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
144421252|NCT00799487|520749583|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
144421253|NCT00799487|520749581|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
144421254|NCT00799487|520749582|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
144421255|NCT00799487|520749583|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
144527639|NCT04171141|521135228|FG002|Overall Study|Adverse Event|2|||
144527640|NCT04171141|521135229|FG003|Overall Study|Adverse Event|0|||
144723233|NCT02260492|521840664|FG000|Overall Study|Lost to Follow-up|12|||
144421256|NCT00799487|520749581|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
144421257|NCT00799487|520749582|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
144421258|NCT00799487|520749583|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
144421259|NCT00799487|520749581|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
144421260|NCT00799487|520749582|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
144421261|NCT00799487|520749583|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
144421262|NCT00799487|520749581|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
144421263|NCT00799487|520749582|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
144421264|NCT00799487|520749583|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
144421265|NCT00232817|520749584|FG000|Overall Study|Protocol Violation|2|||
144421266|NCT00232817|520749585|FG001|Overall Study|Protocol Violation|1|||
144421267|NCT04481750|520749586|FG000|Period 1 (Fasted)|Adverse Event|0|||
144421268|NCT04481750|520749587|FG001|Period 1 (Fasted)|Adverse Event|0|||
144421269|NCT04481750|520749588|FG002|Period 1 (Fasted)|Adverse Event|1|||
144421270|NCT04481750|520749589|FG003|Period 1 (Fasted)|Adverse Event|0|||
144421271|NCT04481750|520749590|FG004|Period 1 (Fasted)|Adverse Event|0|||
144421272|NCT04481750|520749591|FG005|Period 1 (Fasted)|Adverse Event|0|||
144421273|NCT04481750|520749592|FG006|Period 1 (Fasted)|Adverse Event|0|||
144421274|NCT04481750|520749593|FG007|Period 1 (Fasted)|Adverse Event|0|||
144421275|NCT04481750|520749594|FG008|Period 1 (Fasted)|Adverse Event|0|||
144421276|NCT04481750|520749595|FG009|Period 1 (Fasted)|Adverse Event|0|||
144421277|NCT04481750|520749596|FG010|Period 1 (Fasted)|Adverse Event|0|||
144421278|NCT01463878|520749597|FG000|Overall Study|no longer met criteria for tube feed|2|||
144421279|NCT01463878|520749598|FG001|Overall Study|no longer met criteria for tube feed|2|||
144421280|NCT02436889|520749599|FG000|Overall Study|No improvement in symptoms|1|||
144421281|NCT02436889|520749600|FG001|Overall Study|No improvement in symptoms|0|||
144421282|NCT02436889|520749599|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
144421283|NCT02436889|520749600|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
144421284|NCT01034462|520749601|FG000|Overall Study|Adverse Event|7|||
144421285|NCT01034462|520749602|FG001|Overall Study|Adverse Event|17|||
144421286|NCT01034462|520749601|FG000|Overall Study|Lack of Efficacy|4|||
144421287|NCT01034462|520749602|FG001|Overall Study|Lack of Efficacy|4|||
144421288|NCT01034462|520749601|FG000|Overall Study|Protocol Violation|10|||
144421289|NCT01034462|520749602|FG001|Overall Study|Protocol Violation|7|||
144421290|NCT01034462|520749601|FG000|Overall Study|Withdrawal by Subject|9|||
144421291|NCT01034462|520749602|FG001|Overall Study|Withdrawal by Subject|8|||
144421292|NCT01034462|520749601|FG000|Overall Study|Lost to Follow-up|14|||
144421293|NCT01034462|520749602|FG001|Overall Study|Lost to Follow-up|16|||
144421294|NCT01034462|520749601|FG000|Overall Study|Other reasons|1|||
144421295|NCT01034462|520749602|FG001|Overall Study|Other reasons|2|||
144421296|NCT00708643|520749603|FG000|Overall Study|Adverse Event|0|||
144421297|NCT00708643|520749604|FG001|Overall Study|Adverse Event|1|||
144421298|NCT04273217|520749605|FG000|Overall Study|Lost to Follow-up|0|||
144421299|NCT04273217|520749606|FG001|Overall Study|Lost to Follow-up|0|||
144421300|NCT04273217|520749607|FG002|Overall Study|Lost to Follow-up|0|||
144421301|NCT04273217|520749608|FG003|Overall Study|Lost to Follow-up|0|||
144421302|NCT04273217|520749609|FG004|Overall Study|Lost to Follow-up|0|||
144421303|NCT04273217|520749610|FG005|Overall Study|Lost to Follow-up|1|||
144421304|NCT04273217|520749605|FG000|Overall Study|Participant non-compliance|0|||
144421305|NCT04273217|520749606|FG001|Overall Study|Participant non-compliance|0|||
144421306|NCT04273217|520749607|FG002|Overall Study|Participant non-compliance|0|||
144421307|NCT04273217|520749608|FG003|Overall Study|Participant non-compliance|0|||
144421308|NCT04273217|520749609|FG004|Overall Study|Participant non-compliance|1|||
144421309|NCT04273217|520749610|FG005|Overall Study|Participant non-compliance|0|||
144421310|NCT04273217|520749605|FG000|Overall Study|Positive urine drug screen|1|||
144421311|NCT04273217|520749606|FG001|Overall Study|Positive urine drug screen|0|||
144421312|NCT04273217|520749607|FG002|Overall Study|Positive urine drug screen|1|||
144421313|NCT04273217|520749608|FG003|Overall Study|Positive urine drug screen|0|||
144421314|NCT04273217|520749609|FG004|Overall Study|Positive urine drug screen|0|||
144421315|NCT04273217|520749610|FG005|Overall Study|Positive urine drug screen|1|||
144421316|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
144421317|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
144527641|NCT04171141|521135230|FG004|Overall Study|Adverse Event|0|||
144421318|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
144421319|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
144421320|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
144421321|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
144421322|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
144421323|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
144421324|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
144421325|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
144421326|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
144421327|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
144527642|NCT04171141|521135231|FG005|Overall Study|Adverse Event|0|||
144421328|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
144421329|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
144421330|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
144421331|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
144421332|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
144421333|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
144421334|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
144421335|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
144421336|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
144421337|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
144421338|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
144421339|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
144421340|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
144421341|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
144421342|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
144421343|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
144421344|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
144421345|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
144421346|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
144421347|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
144421348|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
144421349|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
144421350|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
144421351|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
144421352|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
144421353|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
144421354|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
144421355|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
144421356|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
144421357|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
144421358|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
144421359|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
144421360|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
144421361|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
144421362|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
144421363|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
144421364|NCT03720470|520749611|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
144421365|NCT03720470|520749612|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
144421366|NCT03720470|520749613|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
144421367|NCT03720470|520749614|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
144421368|NCT03720470|520749615|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
144421369|NCT03720470|520749616|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
144421370|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
144421371|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
144421372|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
144421373|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
144421374|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
144421375|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
144421376|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
144421377|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
144421378|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
144421379|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
144421380|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
144421381|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
144421382|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
144421383|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
144421384|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
144421385|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
144421386|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
144527643|NCT04171141|521135232|FG006|Overall Study|Adverse Event|0|||
144527644|NCT04171141|521135233|FG007|Overall Study|Adverse Event|0|||
144723234|NCT02260492|521840665|FG001|Overall Study|Lost to Follow-up|9|||
144723235|NCT02260492|521840666|FG002|Overall Study|Lost to Follow-up|0|||
144723236|NCT02260492|521840664|FG000|Overall Study|Physician Decision|2|||
144527645|NCT04171141|521135234|FG008|Overall Study|Adverse Event|0|||
144723237|NCT02260492|521840665|FG001|Overall Study|Physician Decision|0|||
144421387|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
144421388|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
144421389|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
144421390|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
144421391|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
144421392|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
144421393|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
144421394|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
144421395|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
144421396|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
144421397|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
144421398|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
144421399|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
144421400|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
144421401|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
144421402|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
144421403|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
144421404|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
144421405|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
144421406|NCT03720470|520749611|FG000|Treatment Period: Final 4 Weeks|Other|0|||
144421407|NCT03720470|520749612|FG001|Treatment Period: Final 4 Weeks|Other|1|||
144421408|NCT03720470|520749613|FG002|Treatment Period: Final 4 Weeks|Other|0|||
144421409|NCT03720470|520749614|FG003|Treatment Period: Final 4 Weeks|Other|2|||
144421410|NCT03720470|520749615|FG004|Treatment Period: Final 4 Weeks|Other|1|||
144421411|NCT03720470|520749616|FG005|Treatment Period: Final 4 Weeks|Other|0|||
144421412|NCT04532099|520749617|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
144421413|NCT04532099|520749618|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
144421414|NCT04532099|520749619|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
144421415|NCT00498602|520749624|FG000|Overall Study|Death|0|||
144421416|NCT00498602|520749625|FG001|Overall Study|Death|0|||
144421417|NCT00498602|520749626|FG002|Overall Study|Death|0|||
144421418|NCT00498602|520749627|FG003|Overall Study|Death|0|||
144421419|NCT00498602|520749628|FG004|Overall Study|Death|0|||
144421420|NCT00498602|520749629|FG005|Overall Study|Death|1|||
144421421|NCT00498602|520749630|FG006|Overall Study|Death|0|||
144421422|NCT00498602|520749624|FG000|Overall Study|Lack of Efficacy|1|||
144421423|NCT00498602|520749625|FG001|Overall Study|Lack of Efficacy|0|||
144421424|NCT00498602|520749626|FG002|Overall Study|Lack of Efficacy|0|||
144421425|NCT00498602|520749627|FG003|Overall Study|Lack of Efficacy|0|||
144421426|NCT00498602|520749628|FG004|Overall Study|Lack of Efficacy|0|||
144421427|NCT00498602|520749629|FG005|Overall Study|Lack of Efficacy|0|||
144421428|NCT00498602|520749630|FG006|Overall Study|Lack of Efficacy|0|||
144421429|NCT00498602|520749624|FG000|Overall Study|Lost to Follow-up|0|||
144421430|NCT00498602|520749625|FG001|Overall Study|Lost to Follow-up|2|||
144421431|NCT00498602|520749626|FG002|Overall Study|Lost to Follow-up|0|||
144421432|NCT00498602|520749627|FG003|Overall Study|Lost to Follow-up|2|||
144421433|NCT00498602|520749628|FG004|Overall Study|Lost to Follow-up|0|||
144421434|NCT00498602|520749629|FG005|Overall Study|Lost to Follow-up|0|||
144421435|NCT00498602|520749630|FG006|Overall Study|Lost to Follow-up|0|||
144421436|NCT00498602|520749624|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
144421437|NCT00498602|520749625|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
144421438|NCT00498602|520749626|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
144421439|NCT00498602|520749627|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
144421440|NCT00498602|520749628|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
144421441|NCT00498602|520749629|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
144421442|NCT00498602|520749630|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
144421443|NCT00498602|520749624|FG000|Overall Study|AE not related to Study Drug|1|||
144421444|NCT00498602|520749625|FG001|Overall Study|AE not related to Study Drug|3|||
144421445|NCT00498602|520749626|FG002|Overall Study|AE not related to Study Drug|0|||
144421446|NCT00498602|520749627|FG003|Overall Study|AE not related to Study Drug|0|||
144421447|NCT00498602|520749628|FG004|Overall Study|AE not related to Study Drug|2|||
144421448|NCT00498602|520749629|FG005|Overall Study|AE not related to Study Drug|2|||
144421449|NCT00498602|520749630|FG006|Overall Study|AE not related to Study Drug|1|||
144527646|NCT04171141|521135235|FG009|Overall Study|Adverse Event|0|||
144527647|NCT04171141|521135236|FG010|Overall Study|Adverse Event|0|||
144527648|NCT04171141|521135237|FG011|Overall Study|Adverse Event|0|||
144421450|NCT00498602|520749624|FG000|Overall Study|Caregiver Request|2|||
144421451|NCT00498602|520749625|FG001|Overall Study|Caregiver Request|2|||
144421452|NCT00498602|520749626|FG002|Overall Study|Caregiver Request|2|||
144421453|NCT00498602|520749627|FG003|Overall Study|Caregiver Request|0|||
144421454|NCT00498602|520749628|FG004|Overall Study|Caregiver Request|1|||
144421455|NCT00498602|520749629|FG005|Overall Study|Caregiver Request|2|||
144527649|NCT04171141|521135238|FG012|Overall Study|Adverse Event|0|||
144421456|NCT00498602|520749630|FG006|Overall Study|Caregiver Request|0|||
144421457|NCT00498602|520749624|FG000|Overall Study|Investigator Request|0|||
144421458|NCT00498602|520749625|FG001|Overall Study|Investigator Request|0|||
144421459|NCT00498602|520749626|FG002|Overall Study|Investigator Request|1|||
144421460|NCT00498602|520749627|FG003|Overall Study|Investigator Request|0|||
144421461|NCT00498602|520749628|FG004|Overall Study|Investigator Request|0|||
144421462|NCT00498602|520749629|FG005|Overall Study|Investigator Request|0|||
144421463|NCT00498602|520749630|FG006|Overall Study|Investigator Request|0|||
144421464|NCT00498602|520749624|FG000|Overall Study|Subject Request|3|||
144421465|NCT00498602|520749625|FG001|Overall Study|Subject Request|0|||
144421466|NCT00498602|520749626|FG002|Overall Study|Subject Request|1|||
144421467|NCT00498602|520749627|FG003|Overall Study|Subject Request|1|||
144421468|NCT00498602|520749628|FG004|Overall Study|Subject Request|1|||
144421469|NCT00498602|520749629|FG005|Overall Study|Subject Request|4|||
144421470|NCT00498602|520749630|FG006|Overall Study|Subject Request|1|||
144421471|NCT00498602|520749624|FG000|Overall Study|Other|2|||
144421472|NCT00498602|520749625|FG001|Overall Study|Other|3|||
144421473|NCT00498602|520749626|FG002|Overall Study|Other|1|||
144421474|NCT00498602|520749627|FG003|Overall Study|Other|0|||
144421475|NCT00498602|520749628|FG004|Overall Study|Other|0|||
144421476|NCT00498602|520749629|FG005|Overall Study|Other|3|||
144421477|NCT00498602|520749630|FG006|Overall Study|Other|0|||
144421478|NCT01506479|520749631|FG000|Overall Study|Lost to Follow-up|1|||
144421479|NCT01506479|520749632|FG001|Overall Study|Lost to Follow-up|2|||
144421480|NCT01506479|520749633|FG002|Overall Study|Lost to Follow-up|2|||
144421481|NCT01506479|520749631|FG000|Overall Study|Withdrawal by Subject|1|||
144421482|NCT01506479|520749632|FG001|Overall Study|Withdrawal by Subject|2|||
144527650|NCT04171141|521135239|FG013|Overall Study|Adverse Event|2|||
144527651|NCT04171141|521135240|FG014|Overall Study|Adverse Event|0|||
144527652|NCT04171141|521135241|FG015|Overall Study|Adverse Event|0|||
144527653|NCT04171141|521135226|FG000|Overall Study|Physician Decision|0|||
144527654|NCT04171141|521135227|FG001|Overall Study|Physician Decision|0|||
144527655|NCT04171141|521135228|FG002|Overall Study|Physician Decision|0|||
144527656|NCT04171141|521135229|FG003|Overall Study|Physician Decision|0|||
144527657|NCT04171141|521135230|FG004|Overall Study|Physician Decision|1|||
144527658|NCT04171141|521135231|FG005|Overall Study|Physician Decision|0|||
144180821|NCT02300987|519857239|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
144180822|NCT03086135|519857240|FG000|Overall Study|Adverse Event|1|||
144180823|NCT03086135|519857240|FG000|Overall Study|Lost to Follow-up|2|||
144180824|NCT01622660|519857241|FG000|Overall Study|Adverse Event|1|||
144180825|NCT02259348|519857242|FG000|Overall Study|Donors|6|||
144180826|NCT02259348|519857242|FG000|Overall Study|Death|4|||
144180827|NCT04211766|519857243|FG000|Overall Study|Withdrawal by Subject|5|||
144180828|NCT04211766|519857244|FG001|Overall Study|Withdrawal by Subject|1|||
144180829|NCT00820599|519857248|FG000|Overall Study|Death|129|||
144180830|NCT00820599|519857248|FG000|Overall Study|Withdrawal by Subject|2|||
144180831|NCT01120899|519857249|FG000|Overall Study|Withdrawal by Subject|3|||
144180832|NCT03686215|519857250|FG000|Overall Study|Adverse Event|0|||
144180833|NCT03686215|519857251|FG001|Overall Study|Adverse Event|0|||
144180834|NCT03686215|519857252|FG002|Overall Study|Adverse Event|7|||
144180835|NCT03686215|519857250|FG000|Overall Study|Physician Decision|0|||
144180836|NCT03686215|519857251|FG001|Overall Study|Physician Decision|0|||
144180837|NCT03686215|519857252|FG002|Overall Study|Physician Decision|1|||
144180838|NCT03686215|519857250|FG000|Overall Study|Protocol Violation|0|||
144180839|NCT03686215|519857251|FG001|Overall Study|Protocol Violation|0|||
144180840|NCT03686215|519857252|FG002|Overall Study|Protocol Violation|4|||
144180841|NCT03686215|519857250|FG000|Overall Study|Device issue|1|||
144180842|NCT03686215|519857251|FG001|Overall Study|Device issue|0|||
144180843|NCT03686215|519857252|FG002|Overall Study|Device issue|2|||
144180844|NCT00522041|519857253|FG000|Overall Study|Adverse Event|9|||
144180845|NCT00522041|519857254|FG001|Overall Study|Adverse Event|3|||
144180846|NCT00522041|519857253|FG000|Overall Study|Protocol Violation|2|||
144180847|NCT00522041|519857254|FG001|Overall Study|Protocol Violation|0|||
144180848|NCT00522041|519857253|FG000|Overall Study|Lost to Follow-up|1|||
144180849|NCT00522041|519857254|FG001|Overall Study|Lost to Follow-up|4|||
144180850|NCT00522041|519857253|FG000|Overall Study|Voluntary withdrawal|5|||
144180851|NCT00522041|519857254|FG001|Overall Study|Voluntary withdrawal|4|||
144421483|NCT01506479|520749633|FG002|Overall Study|Withdrawal by Subject|1|||
144527659|NCT04171141|521135232|FG006|Overall Study|Physician Decision|0|||
144527660|NCT04171141|521135233|FG007|Overall Study|Physician Decision|0|||
144180852|NCT00522041|519857253|FG000|Overall Study|Did not receive treatment|0|||
144527661|NCT04171141|521135234|FG008|Overall Study|Physician Decision|0|||
144180853|NCT00522041|519857254|FG001|Overall Study|Did not receive treatment|1|||
144180854|NCT02725515|519857255|FG000|Overall Study|Refused infusion (no study treatment)|1|||
144180855|NCT02725515|519857256|FG001|Overall Study|Refused infusion (no study treatment)|0|||
144421484|NCT01506479|520749631|FG000|Overall Study|Missing assessment|1|||
144421485|NCT01506479|520749632|FG001|Overall Study|Missing assessment|0|||
144421486|NCT01506479|520749633|FG002|Overall Study|Missing assessment|0|||
144421487|NCT01506479|520749631|FG000|Overall Study|Adverse Event|0|||
144421488|NCT01506479|520749632|FG001|Overall Study|Adverse Event|1|||
144421489|NCT01506479|520749633|FG002|Overall Study|Adverse Event|0|||
144421490|NCT00330616|520749636|FG000|Overall Study|Adverse Event|13|||
144421491|NCT00330616|520749636|FG000|Overall Study|Lack of Efficacy|1|||
144421492|NCT00330616|520749636|FG000|Overall Study|Lost to Follow-up|2|||
144421493|NCT00330616|520749636|FG000|Overall Study|Withdrawal by Subject|4|||
144421494|NCT00330616|520749636|FG000|Overall Study|Other|1|||
144421495|NCT02642042|520749639|FG000|Overall Study|Adverse Event|22|||
144421496|NCT02642042|520749639|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
144421497|NCT02642042|520749639|FG000|Overall Study|Progression/Relapse|28|||
144421498|NCT02642042|520749639|FG000|Overall Study|Death|1|||
144421499|NCT02642042|520749639|FG000|Overall Study|Not Protocol Specified|2|||
144421500|NCT01333059|520749640|FG000|Overall Study|Physician Decision|3|||
144421501|NCT01333059|520749641|FG001|Overall Study|Physician Decision|3|||
144421502|NCT01333059|520749640|FG000|Overall Study|Protocol Violation|3|||
144421503|NCT01333059|520749641|FG001|Overall Study|Protocol Violation|0|||
144421504|NCT04903626|520749643|FG000|Overall Study|Lost to Follow-up|6|||
144421505|NCT04903626|520749643|FG000|Overall Study|Withdrawal by Subject|1|||
144421506|NCT04903626|520749643|FG000|Overall Study|Other, Not Specified|1|||
144421507|NCT03035409|520749644|FG000|Overall Study|Adverse Event|5|||
144421508|NCT03035409|520749644|FG000|Overall Study|Death|2|||
144421509|NCT03035409|520749644|FG000|Overall Study|Withdrawal by Subject|2|||
144421510|NCT03035409|520749644|FG000|Overall Study|Non compliance|4|||
144421511|NCT03035409|520749644|FG000|Overall Study|Patient was jittery|1|||
144421512|NCT03035409|520749644|FG000|Overall Study|Did not like Questionnaire|1|||
144421513|NCT03035409|520749644|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
144421514|NCT03035409|520749644|FG000|Overall Study|Did not like taking drugs|1|||
144421515|NCT00927784|520749645|FG000|Overall Study|Death|1|||
144421516|NCT00927784|520749646|FG001|Overall Study|Death|0|||
144421517|NCT00927784|520749645|FG000|Overall Study|Withdrawal by Subject|1|||
144421518|NCT00927784|520749646|FG001|Overall Study|Withdrawal by Subject|0|||
144421519|NCT01405742|520749647|FG000|Overall Study|Lost to Follow-up|1|||
144421520|NCT01405742|520749648|FG001|Overall Study|Lost to Follow-up|0|||
144421521|NCT02056340|520749649|FG000|Overall Study|Lost to Follow-up|5|||
144421522|NCT02056340|520749650|FG001|Overall Study|Lost to Follow-up|5|||
144421523|NCT02056340|520749649|FG000|Overall Study|Withdrawal by Subject|2|||
144421524|NCT02056340|520749650|FG001|Overall Study|Withdrawal by Subject|6|||
144421525|NCT03473808|520749654|FG000|Overall Study|Withdrawal by Subject|1|||
144421526|NCT03171415|520749655|FG000|Overall Study|Lost to Follow-up|0|||
144421527|NCT03171415|520749656|FG001|Overall Study|Lost to Follow-up|0|||
144421528|NCT03171415|520749657|FG002|Overall Study|Lost to Follow-up|0|||
144421529|NCT03171415|520749658|FG003|Overall Study|Lost to Follow-up|0|||
144421530|NCT03171415|520749659|FG004|Overall Study|Lost to Follow-up|2|||
144421531|NCT01085591|520749660|FG000|Overall Study|Adverse Event|0|||
144421532|NCT01085591|520749661|FG001|Overall Study|Adverse Event|1|||
144421533|NCT01085591|520749662|FG002|Overall Study|Adverse Event|3|||
144421534|NCT01085591|520749660|FG000|Overall Study|Physician Decision|1|||
144421535|NCT01085591|520749661|FG001|Overall Study|Physician Decision|0|||
144421536|NCT01085591|520749662|FG002|Overall Study|Physician Decision|1|||
144421537|NCT01085591|520749660|FG000|Overall Study|Withdrawal by Subject|0|||
144421538|NCT01085591|520749661|FG001|Overall Study|Withdrawal by Subject|2|||
144421539|NCT01085591|520749662|FG002|Overall Study|Withdrawal by Subject|1|||
144421540|NCT01085591|520749660|FG000|Overall Study|Lost to Follow-up|0|||
144421541|NCT01085591|520749661|FG001|Overall Study|Lost to Follow-up|1|||
144421542|NCT01085591|520749662|FG002|Overall Study|Lost to Follow-up|1|||
144421543|NCT01085591|520749660|FG000|Overall Study|Protocol Violation|1|||
144421544|NCT01085591|520749661|FG001|Overall Study|Protocol Violation|1|||
144421545|NCT01085591|520749662|FG002|Overall Study|Protocol Violation|1|||
144421546|NCT01085591|520749660|FG000|Overall Study|Other|0|||
144421547|NCT01085591|520749661|FG001|Overall Study|Other|1|||
144421548|NCT01085591|520749662|FG002|Overall Study|Other|0|||
144421549|NCT01085591|520749660|FG000|Overall Study|Not Properly Consented|1|||
144421550|NCT01085591|520749661|FG001|Overall Study|Not Properly Consented|0|||
144421551|NCT01085591|520749662|FG002|Overall Study|Not Properly Consented|0|||
144421552|NCT01846611|520749666|FG000|Overall Study|Lost to Follow-up|4|||
144527662|NCT04171141|521135235|FG009|Overall Study|Physician Decision|0|||
144527663|NCT04171141|521135236|FG010|Overall Study|Physician Decision|0|||
144421553|NCT01846611|520749667|FG001|Overall Study|Lost to Follow-up|6|||
144421554|NCT01846611|520749666|FG000|Overall Study|Withdrawal by Subject|15|||
144421555|NCT01846611|520749667|FG001|Overall Study|Withdrawal by Subject|19|||
144421556|NCT01846611|520749666|FG000|Overall Study|Other|19|||
144421557|NCT01846611|520749667|FG001|Overall Study|Other|18|||
144527664|NCT04171141|521135237|FG011|Overall Study|Physician Decision|0|||
144421558|NCT00847704|520749668|FG000|Overall Study|Withdrawal by Subject|1|||
144421559|NCT02111850|520749669|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421560|NCT02111850|520749670|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421561|NCT02111850|520749671|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421562|NCT02111850|520749672|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421563|NCT02111850|520749673|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
144527665|NCT04171141|521135238|FG012|Overall Study|Physician Decision|0|||
144421564|NCT02111850|520749674|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421565|NCT02111850|520749675|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421566|NCT02111850|520749676|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421567|NCT02111850|520749677|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421568|NCT02111850|520749678|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421569|NCT02111850|520749679|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
144421570|NCT05119569|520749680|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
144421571|NCT05119569|520749681|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
144421572|NCT05119569|520749682|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
144421573|NCT05119569|520749683|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
144421574|NCT05119569|520749680|FG000|Double Blind Treatment Phase|Adverse Event|6|||
144421575|NCT05119569|520749681|FG001|Double Blind Treatment Phase|Adverse Event|0|||
144421576|NCT05119569|520749682|FG002|Double Blind Treatment Phase|Adverse Event|0|||
144421577|NCT05119569|520749683|FG003|Double Blind Treatment Phase|Adverse Event|0|||
144421578|NCT05119569|520749680|FG000|Open Label Extension Phase|Ongoing in the study|0|||
144421579|NCT05119569|520749681|FG001|Open Label Extension Phase|Ongoing in the study|0|||
144421580|NCT05119569|520749682|FG002|Open Label Extension Phase|Ongoing in the study|65|||
144421581|NCT05119569|520749683|FG003|Open Label Extension Phase|Ongoing in the study|34|||
144421582|NCT02839707|520749684|FG000|Phase I|Not eligible for analysis|9|||
144421583|NCT02839707|520749685|FG001|Phase I|Not eligible for analysis|0|||
144421584|NCT02839707|520749686|FG002|Phase I|Not eligible for analysis|0|||
144421585|NCT02839707|520749684|FG000|Phase II|Not treated according to protocol|4|||
144421586|NCT02839707|520749685|FG001|Phase II|Not treated according to protocol|0|||
144421587|NCT02839707|520749686|FG002|Phase II|Not treated according to protocol|2|||
144421588|NCT02839707|520749684|FG000|Phase III|Not treated according to protocol|0|||
144421589|NCT02839707|520749685|FG001|Phase III|Not treated according to protocol|0|||
144421590|NCT02839707|520749686|FG002|Phase III|Not treated according to protocol|4|||
144421591|NCT02890355|520749687|FG000|Overall Study|Adverse Event|5|||
144421592|NCT02890355|520749688|FG001|Overall Study|Adverse Event|5|||
144421593|NCT02890355|520749687|FG000|Overall Study|Refusal unrelated to adverse event|5|||
144421594|NCT02890355|520749688|FG001|Overall Study|Refusal unrelated to adverse event|10|||
144421595|NCT02890355|520749687|FG000|Overall Study|Progression/relapse|46|||
144421596|NCT02890355|520749688|FG001|Overall Study|Progression/relapse|39|||
144421597|NCT02890355|520749687|FG000|Overall Study|Not protocol specified|3|||
144251211|NCT01026818|520119283|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
144251212|NCT01026818|520119284|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
144421598|NCT02890355|520749688|FG001|Overall Study|Not protocol specified|4|||
144421599|NCT01409564|520751117|FG000|Overall Study|low medication compliance|4|||
144421600|NCT01409564|520751118|FG001|Overall Study|low medication compliance|3|||
144421601|NCT01409564|520751117|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
144421602|NCT01409564|520751118|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
144421603|NCT00225251|520751119|FG000|Overall Study|Withdrawal by Subject|1|||
144421604|NCT00225251|520751120|FG001|Overall Study|Withdrawal by Subject|1|||
144421605|NCT03045328|520751121|FG000|Overall Study|Withdrawal by Subject|2|||
144421606|NCT00592839|520751124|FG000|Overall Study|Withdrawal by Subject|1|||
144421607|NCT00592839|520751125|FG001|Overall Study|Withdrawal by Subject|1|||
144421608|NCT00592839|520751126|FG002|Overall Study|Withdrawal by Subject|3|||
144421609|NCT00592839|520751124|FG000|Overall Study|Protocol Violation|1|||
144421610|NCT00592839|520751125|FG001|Overall Study|Protocol Violation|1|||
144421611|NCT00592839|520751126|FG002|Overall Study|Protocol Violation|2|||
144421612|NCT00592839|520751124|FG000|Overall Study|Adverse Event|0|||
144421613|NCT00592839|520751125|FG001|Overall Study|Adverse Event|1|||
144421614|NCT00592839|520751126|FG002|Overall Study|Adverse Event|0|||
144421615|NCT00592839|520751124|FG000|Overall Study|Lost to Follow-up|0|||
144421616|NCT00592839|520751125|FG001|Overall Study|Lost to Follow-up|1|||
144421617|NCT00592839|520751126|FG002|Overall Study|Lost to Follow-up|1|||
144421618|NCT01313767|520751127|FG000|Overall Study|Adverse Event|1|||
144421619|NCT01313767|520751128|FG001|Overall Study|Adverse Event|0|||
144421620|NCT01313767|520751127|FG000|Overall Study|Lost to Follow-up|1|||
144421621|NCT01313767|520751128|FG001|Overall Study|Lost to Follow-up|0|||
144421622|NCT01313767|520751127|FG000|Overall Study|Withdrawal by Subject|2|||
144421623|NCT01313767|520751128|FG001|Overall Study|Withdrawal by Subject|1|||
144723238|NCT02260492|521840666|FG002|Overall Study|Physician Decision|1|||
144251213|NCT01026818|520119285|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
144421624|NCT01313767|520751127|FG000|Overall Study|Protocol Violation|3|||
144421625|NCT01313767|520751128|FG001|Overall Study|Protocol Violation|1|||
144421626|NCT01287897|520751129|FG000|Overall Study|Adverse Event|5|||
144421627|NCT01287897|520751130|FG001|Overall Study|Adverse Event|3|||
144421628|NCT01287897|520751131|FG002|Overall Study|Adverse Event|6|||
144421629|NCT01287897|520751132|FG003|Overall Study|Adverse Event|4|||
144421630|NCT01287897|520751129|FG000|Overall Study|Lack of Efficacy|2|||
144421631|NCT01287897|520751130|FG001|Overall Study|Lack of Efficacy|0|||
144421632|NCT01287897|520751131|FG002|Overall Study|Lack of Efficacy|0|||
144251214|NCT01026818|520119282|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
144251215|NCT01026818|520119283|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
144251216|NCT01026818|520119284|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
144251217|NCT01026818|520119285|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
144251218|NCT01026818|520119282|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
144251219|NCT01026818|520119283|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
144251220|NCT01026818|520119284|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
144527666|NCT04171141|521135239|FG013|Overall Study|Physician Decision|0|||
144527667|NCT04171141|521135240|FG014|Overall Study|Physician Decision|0|||
144527668|NCT04171141|521135241|FG015|Overall Study|Physician Decision|1|||
144251221|NCT01026818|520119285|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
144251222|NCT01026818|520119282|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
144251223|NCT01026818|520119283|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
144251224|NCT01026818|520119284|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
144251225|NCT01026818|520119285|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
144251226|NCT01026818|520119282|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
144251227|NCT01026818|520119283|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
144251228|NCT01026818|520119284|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
144421633|NCT01287897|520751132|FG003|Overall Study|Lack of Efficacy|0|||
144421634|NCT01287897|520751129|FG000|Overall Study|Protocol Violation|1|||
144421635|NCT01287897|520751130|FG001|Overall Study|Protocol Violation|1|||
144421636|NCT01287897|520751131|FG002|Overall Study|Protocol Violation|0|||
144421637|NCT01287897|520751132|FG003|Overall Study|Protocol Violation|1|||
144421638|NCT01287897|520751129|FG000|Overall Study|Lost to Follow-up|0|||
144421639|NCT01287897|520751130|FG001|Overall Study|Lost to Follow-up|0|||
144421640|NCT01287897|520751131|FG002|Overall Study|Lost to Follow-up|2|||
144421641|NCT01287897|520751132|FG003|Overall Study|Lost to Follow-up|0|||
144421642|NCT01287897|520751129|FG000|Overall Study|Withdrawal by Subject|1|||
144421643|NCT01287897|520751130|FG001|Overall Study|Withdrawal by Subject|5|||
144421644|NCT01287897|520751131|FG002|Overall Study|Withdrawal by Subject|3|||
144421645|NCT01287897|520751132|FG003|Overall Study|Withdrawal by Subject|2|||
144421646|NCT01287897|520751129|FG000|Overall Study|Not consented properly|0|||
144421647|NCT01287897|520751130|FG001|Overall Study|Not consented properly|1|||
144421648|NCT01287897|520751131|FG002|Overall Study|Not consented properly|0|||
144421649|NCT01287897|520751132|FG003|Overall Study|Not consented properly|0|||
144421650|NCT01287897|520751129|FG000|Overall Study|Not meeting entrance criteria|1|||
144421651|NCT01287897|520751130|FG001|Overall Study|Not meeting entrance criteria|1|||
144421652|NCT01287897|520751131|FG002|Overall Study|Not meeting entrance criteria|0|||
144421653|NCT01287897|520751132|FG003|Overall Study|Not meeting entrance criteria|0|||
144421654|NCT01287897|520751129|FG000|Overall Study|Other|1|||
144421655|NCT01287897|520751130|FG001|Overall Study|Other|0|||
144421656|NCT01287897|520751131|FG002|Overall Study|Other|1|||
144421657|NCT01287897|520751132|FG003|Overall Study|Other|0|||
144421658|NCT03045081|520751133|FG000|Overall Study|Withdrawal by Subject|6|||
144421659|NCT03045081|520751134|FG001|Overall Study|Withdrawal by Subject|11|||
144251229|NCT01026818|520119285|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
144251230|NCT01026818|520119282|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
144421660|NCT00065507|520751137|FG000|Overall Study|Death|16|||
144421661|NCT00065507|520751138|FG001|Overall Study|Death|17|||
144421662|NCT00065507|520751137|FG000|Overall Study|Adverse Event|4|||
144421663|NCT00065507|520751138|FG001|Overall Study|Adverse Event|3|||
144421664|NCT00065507|520751137|FG000|Overall Study|Lack of Efficacy|0|||
144421665|NCT00065507|520751138|FG001|Overall Study|Lack of Efficacy|6|||
144421666|NCT00065507|520751137|FG000|Overall Study|Poor/Non-compliance|3|||
144421667|NCT00065507|520751138|FG001|Overall Study|Poor/Non-compliance|2|||
144421668|NCT00065507|520751137|FG000|Overall Study|Lost to Follow-up|3|||
144421669|NCT00065507|520751138|FG001|Overall Study|Lost to Follow-up|0|||
144421670|NCT00065507|520751137|FG000|Overall Study|Subject Withdrew Consent|2|||
144527669|NCT04171141|521135226|FG000|Overall Study|Progressive disease|2|||
144527670|NCT04171141|521135227|FG001|Overall Study|Progressive disease|3|||
144527671|NCT04171141|521135228|FG002|Overall Study|Progressive disease|4|||
144251231|NCT01026818|520119283|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
144251232|NCT01026818|520119284|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
144251233|NCT01026818|520119285|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
144421671|NCT00065507|520751138|FG001|Overall Study|Subject Withdrew Consent|1|||
144421672|NCT00065507|520751137|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
144421673|NCT00065507|520751138|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
144421674|NCT00100815|520751139|FG000|Overall Study|Progression|24|||
144421675|NCT00100815|520751139|FG000|Overall Study|Adverse Event|18|||
144421676|NCT00100815|520751139|FG000|Overall Study|Death|4|||
144421677|NCT00100815|520751139|FG000|Overall Study|Other|3|||
144421678|NCT00227903|520751140|FG000|Overall Study|Withdrawal by Subject|2|||
144421679|NCT00227903|520751141|FG001|Overall Study|Withdrawal by Subject|5|||
144527672|NCT04171141|521135229|FG003|Overall Study|Progressive disease|7|||
144527673|NCT04171141|521135230|FG004|Overall Study|Progressive disease|1|||
144421680|NCT00227903|520751140|FG000|Overall Study|Subject moved out of area|1|||
144421681|NCT00227903|520751141|FG001|Overall Study|Subject moved out of area|2|||
144421682|NCT00227903|520751140|FG000|Overall Study|Lost to Follow-up|1|||
144421683|NCT00227903|520751141|FG001|Overall Study|Lost to Follow-up|3|||
144421684|NCT00227903|520751140|FG000|Overall Study|Miscarriage|1|||
144421685|NCT00227903|520751141|FG001|Overall Study|Miscarriage|0|||
144421686|NCT00723892|520751144|FG000|Overall Study|Participant not tracked|33|||
144421687|NCT00723892|520751145|FG001|Overall Study|Participant not tracked|35|||
144421688|NCT00723892|520751144|FG000|Overall Study|Virological criterion|24|||
144421689|NCT00723892|520751145|FG001|Overall Study|Virological criterion|9|||
144421690|NCT00723892|520751144|FG000|Overall Study|Withdrawal by Subject|6|||
144421691|NCT00723892|520751145|FG001|Overall Study|Withdrawal by Subject|9|||
144421692|NCT00723892|520751144|FG000|Overall Study|End planned|11|||
144421693|NCT00723892|520751145|FG001|Overall Study|End planned|7|||
144421694|NCT00723892|520751144|FG000|Overall Study|Bad tolerance|5|||
144421695|NCT00723892|520751145|FG001|Overall Study|Bad tolerance|5|||
144421696|NCT00723892|520751144|FG000|Overall Study|Multiple reasons|17|||
144421697|NCT00723892|520751145|FG001|Overall Study|Multiple reasons|12|||
144421698|NCT00723892|520751144|FG000|Overall Study|Other|6|||
144421699|NCT00723892|520751145|FG001|Overall Study|Other|3|||
144421700|NCT00723892|520751144|FG000|Overall Study|Study end|1|||
144421701|NCT00723892|520751145|FG001|Overall Study|Study end|3|||
144421702|NCT00723892|520751144|FG000|Overall Study|Weight loss|1|||
144421703|NCT00723892|520751145|FG001|Overall Study|Weight loss|3|||
144421704|NCT00723892|520751144|FG000|Overall Study|Alcohol abuse|0|||
144421705|NCT00723892|520751145|FG001|Overall Study|Alcohol abuse|1|||
144421706|NCT00723892|520751144|FG000|Overall Study|Intercurrent infection|2|||
144421707|NCT00723892|520751145|FG001|Overall Study|Intercurrent infection|0|||
144421708|NCT00723892|520751144|FG000|Overall Study|Drug addiction|1|||
144421709|NCT00723892|520751145|FG001|Overall Study|Drug addiction|0|||
144421710|NCT01113801|520751149|FG000|Overall Study|Adverse Event|4|||
144421711|NCT01113801|520751150|FG001|Overall Study|Adverse Event|0|||
144421712|NCT01113801|520751151|FG002|Overall Study|Adverse Event|2|||
144421713|NCT01113801|520751152|FG003|Overall Study|Adverse Event|6|||
144421714|NCT01113801|520751149|FG000|Overall Study|Death|4|||
144421715|NCT01113801|520751150|FG001|Overall Study|Death|5|||
144527674|NCT04171141|521135231|FG005|Overall Study|Progressive disease|8|||
144527675|NCT04171141|521135232|FG006|Overall Study|Progressive disease|4|||
144527676|NCT04171141|521135233|FG007|Overall Study|Progressive disease|6|||
144527677|NCT04171141|521135234|FG008|Overall Study|Progressive disease|7|||
144180856|NCT02725515|519857255|FG000|Overall Study|Loss of Improvement per Protocol|14|||
144180857|NCT02725515|519857256|FG001|Overall Study|Loss of Improvement per Protocol|25|||
144180858|NCT02725515|519857255|FG000|Overall Study|Withdrawal by Subject|2|||
144180859|NCT02725515|519857256|FG001|Overall Study|Withdrawal by Subject|1|||
144180860|NCT02725515|519857255|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144180861|NCT02725515|519857256|FG001|Overall Study|Non-Compliance With Study Drug|3|||
144180862|NCT02725515|519857255|FG000|Overall Study|Lost to Follow-up|1|||
144180863|NCT02725515|519857256|FG001|Overall Study|Lost to Follow-up|1|||
144180864|NCT02725515|519857255|FG000|Overall Study|Adverse Event|7|||
144180865|NCT02725515|519857256|FG001|Overall Study|Adverse Event|2|||
144180866|NCT02725515|519857255|FG000|Overall Study|No Documented Disease Improvement|0|||
144180867|NCT02725515|519857256|FG001|Overall Study|No Documented Disease Improvement|1|||
144180868|NCT02725515|519857255|FG000|Overall Study|Completed Study Under Original Protocol|0|||
144180869|NCT02725515|519857256|FG001|Overall Study|Completed Study Under Original Protocol|1|||
144180870|NCT02725515|519857255|FG000|Overall Study|Lack of Response|0|||
144180871|NCT02725515|519857256|FG001|Overall Study|Lack of Response|1|||
144180872|NCT00874549|519857257|FG000|Overall Study|Adverse Event|0|||
144180873|NCT00874549|519857258|FG001|Overall Study|Adverse Event|0|||
144180874|NCT00874549|519857259|FG002|Overall Study|Adverse Event|1|||
144180875|NCT00874549|519857260|FG003|Overall Study|Adverse Event|0|||
144180876|NCT00874549|519857257|FG000|Overall Study|Protocol Violation|1|||
144180877|NCT00874549|519857258|FG001|Overall Study|Protocol Violation|0|||
144180878|NCT00874549|519857259|FG002|Overall Study|Protocol Violation|2|||
144180879|NCT00874549|519857260|FG003|Overall Study|Protocol Violation|1|||
144180880|NCT00874549|519857257|FG000|Overall Study|Lost to Follow-up|0|||
144180881|NCT00874549|519857258|FG001|Overall Study|Lost to Follow-up|0|||
144180882|NCT00874549|519857259|FG002|Overall Study|Lost to Follow-up|1|||
144180883|NCT00874549|519857260|FG003|Overall Study|Lost to Follow-up|0|||
144180884|NCT00874549|519857257|FG000|Overall Study|Withdrawal by Subject|0|||
144180885|NCT00874549|519857258|FG001|Overall Study|Withdrawal by Subject|1|||
144180886|NCT00874549|519857259|FG002|Overall Study|Withdrawal by Subject|0|||
144180887|NCT00874549|519857260|FG003|Overall Study|Withdrawal by Subject|1|||
144180888|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
144180889|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
144180890|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
144180891|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
144421716|NCT01113801|520751151|FG002|Overall Study|Death|3|||
144421717|NCT01113801|520751152|FG003|Overall Study|Death|4|||
144527678|NCT04171141|521135235|FG009|Overall Study|Progressive disease|3|||
144421718|NCT01113801|520751149|FG000|Overall Study|Protocol Violation|0|||
144180892|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
144180893|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
144180894|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
144180895|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
144180896|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
144180897|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
144180898|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
144180899|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
144180900|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
144180901|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
144180902|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
144180903|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
144180904|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
144180905|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
144180906|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
144180907|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
144180908|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
144180909|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
144180910|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
144180911|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
144180912|NCT01710358|519857261|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
144180913|NCT01710358|519857262|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
144180914|NCT01710358|519857263|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
144180915|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
144180916|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
144180917|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
144180918|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
144180919|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
144180920|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
144180921|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
144180922|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
144180923|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
144180924|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
144180925|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
144180926|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
144180927|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
144180928|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
144180929|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
144180930|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
144180931|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
144180932|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
144180933|NCT01710358|519857261|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
144180934|NCT01710358|519857262|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
144180935|NCT01710358|519857263|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
144180936|NCT01710358|519857261|FG000|Rescue Period|Adverse Event|0|||
144180937|NCT01710358|519857262|FG001|Rescue Period|Adverse Event|15|||
144180938|NCT01710358|519857263|FG002|Rescue Period|Adverse Event|0|||
144180939|NCT01710358|519857261|FG000|Rescue Period|Death|0|||
144180940|NCT01710358|519857262|FG001|Rescue Period|Death|1|||
144180941|NCT01710358|519857263|FG002|Rescue Period|Death|0|||
144180942|NCT01710358|519857261|FG000|Rescue Period|Lack of Efficacy|0|||
144180943|NCT01710358|519857262|FG001|Rescue Period|Lack of Efficacy|7|||
144180944|NCT01710358|519857263|FG002|Rescue Period|Lack of Efficacy|0|||
144180945|NCT01710358|519857261|FG000|Rescue Period|Withdrawal by Subject|0|||
144180946|NCT01710358|519857262|FG001|Rescue Period|Withdrawal by Subject|8|||
144180947|NCT01710358|519857263|FG002|Rescue Period|Withdrawal by Subject|0|||
144180948|NCT00084864|519857264|FG000|Overall Study|Adverse Event|1|||
144180949|NCT00084864|519857265|FG001|Overall Study|Adverse Event|0|||
144180950|NCT00084864|519857266|FG002|Overall Study|Adverse Event|0|||
144180951|NCT00084864|519857267|FG003|Overall Study|Adverse Event|0|||
144180952|NCT01456962|519857272|FG000|Overall Study|Lost to Follow-up|2|||
144180953|NCT01456962|519857273|FG001|Overall Study|Lost to Follow-up|1|||
144180954|NCT02377349|519857281|FG000|Overall Study|Serious Adverse Event|1|||
144180955|NCT02377349|519857282|FG001|Overall Study|Serious Adverse Event|0|||
144180956|NCT02377349|519857281|FG000|Overall Study|Protocol Violation|3|||
144421719|NCT01113801|520751150|FG001|Overall Study|Protocol Violation|1|||
144180957|NCT02377349|519857282|FG001|Overall Study|Protocol Violation|2|||
144180958|NCT02377349|519857281|FG000|Overall Study|Withdrawal by Subject|5|||
144421720|NCT01113801|520751151|FG002|Overall Study|Protocol Violation|0|||
144421721|NCT01113801|520751152|FG003|Overall Study|Protocol Violation|0|||
144421722|NCT01113801|520751149|FG000|Overall Study|Withdrawal by Subject|9|||
144421723|NCT01113801|520751150|FG001|Overall Study|Withdrawal by Subject|7|||
144421724|NCT01113801|520751151|FG002|Overall Study|Withdrawal by Subject|7|||
144421725|NCT01113801|520751152|FG003|Overall Study|Withdrawal by Subject|8|||
144421726|NCT01113801|520751149|FG000|Overall Study|Physician Decision|2|||
144421727|NCT01113801|520751150|FG001|Overall Study|Physician Decision|2|||
144421728|NCT01113801|520751151|FG002|Overall Study|Physician Decision|3|||
144421729|NCT01113801|520751152|FG003|Overall Study|Physician Decision|3|||
144421730|NCT01113801|520751149|FG000|Overall Study|Sponsor Decision|15|||
144421731|NCT01113801|520751150|FG001|Overall Study|Sponsor Decision|21|||
144421732|NCT01113801|520751151|FG002|Overall Study|Sponsor Decision|20|||
144421733|NCT01113801|520751152|FG003|Overall Study|Sponsor Decision|15|||
144421734|NCT01113801|520751149|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
144421735|NCT01113801|520751150|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
144421736|NCT01113801|520751151|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
144421737|NCT01113801|520751152|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
144421738|NCT01949051|520751155|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
144421739|NCT01949051|520751156|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
144421740|NCT01949051|520751157|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
144421741|NCT01949051|520751158|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
144421742|NCT01949051|520751159|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
144421743|NCT01949051|520751160|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
144421744|NCT01949051|520751155|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
144421745|NCT01949051|520751156|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144421746|NCT01949051|520751157|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144421747|NCT01949051|520751158|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144421748|NCT01949051|520751159|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144421749|NCT01949051|520751160|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
144421750|NCT01949051|520751155|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
144421751|NCT01949051|520751156|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
144421752|NCT01949051|520751157|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
144421753|NCT01949051|520751158|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
144421754|NCT01949051|520751159|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
144421755|NCT01949051|520751160|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
144421756|NCT01949051|520751155|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
144421757|NCT01949051|520751156|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
144421758|NCT01949051|520751157|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
144421759|NCT01949051|520751158|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
144421760|NCT01949051|520751159|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
144421761|NCT01949051|520751160|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
144421762|NCT01949051|520751155|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
144421763|NCT01949051|520751156|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
144421764|NCT01949051|520751157|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
144421765|NCT01949051|520751158|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
144421766|NCT01949051|520751159|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
144421767|NCT01949051|520751160|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
144421768|NCT01846507|520751162|FG000|Overall Study|Lost to Follow-up|4|||
144421769|NCT01846507|520751162|FG000|Overall Study|Protocol Violation|1|||
144421770|NCT01846507|520751162|FG000|Overall Study|Missing data|2|||
144421771|NCT01782859|520751163|FG000|Overall Study|Protocol Violation|6|||
144421772|NCT01782859|520751164|FG001|Overall Study|Protocol Violation|6|||
144251234|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
144421773|NCT01782859|520751163|FG000|Overall Study|Withdrawal by Subject|0|||
144421774|NCT01782859|520751164|FG001|Overall Study|Withdrawal by Subject|1|||
144527679|NCT04171141|521135236|FG010|Overall Study|Progressive disease|4|||
144527680|NCT04171141|521135237|FG011|Overall Study|Progressive disease|3|||
144527681|NCT04171141|521135238|FG012|Overall Study|Progressive disease|4|||
144527682|NCT04171141|521135239|FG013|Overall Study|Progressive disease|2|||
144527683|NCT04171141|521135240|FG014|Overall Study|Progressive disease|4|||
144527684|NCT04171141|521135241|FG015|Overall Study|Progressive disease|1|||
144527685|NCT04171141|521135226|FG000|Overall Study|Withdrawal by Subject|0|||
144527686|NCT04171141|521135227|FG001|Overall Study|Withdrawal by Subject|0|||
144527687|NCT04171141|521135228|FG002|Overall Study|Withdrawal by Subject|0|||
144421775|NCT03402386|520751170|FG000|Overall Study|Adverse Event|3|||
144421776|NCT03402386|520751170|FG000|Overall Study|Physician Decision|1|||
144421777|NCT03402386|520751170|FG000|Overall Study|Difficult to control Hb|2|||
144421778|NCT01896531|520751171|FG000|Overall Study|Death|57|||
144421779|NCT01896531|520751172|FG001|Overall Study|Death|59|||
144421780|NCT01896531|520751171|FG000|Overall Study|Lost to Follow-up|3|||
144421781|NCT01896531|520751172|FG001|Overall Study|Lost to Follow-up|0|||
144527688|NCT04171141|521135229|FG003|Overall Study|Withdrawal by Subject|1|||
144527689|NCT04171141|521135230|FG004|Overall Study|Withdrawal by Subject|0|||
144527690|NCT04171141|521135231|FG005|Overall Study|Withdrawal by Subject|0|||
144180959|NCT02377349|519857282|FG001|Overall Study|Withdrawal by Subject|3|||
144180960|NCT02377349|519857281|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
144180961|NCT02377349|519857282|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
144180962|NCT02377349|519857281|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
144180963|NCT02377349|519857282|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
144421782|NCT01896531|520751171|FG000|Overall Study|Non-compliance|0|||
144421783|NCT01896531|520751172|FG001|Overall Study|Non-compliance|1|||
144421784|NCT01896531|520751171|FG000|Overall Study|Study Ended by Sponsor|7|||
144421785|NCT01896531|520751172|FG001|Overall Study|Study Ended by Sponsor|20|||
144421786|NCT01896531|520751171|FG000|Overall Study|Withdrawal by Subject|3|||
144421787|NCT01896531|520751172|FG001|Overall Study|Withdrawal by Subject|2|||
144421788|NCT01896531|520751171|FG000|Overall Study|Death Prior to Treatment|1|||
144421789|NCT01896531|520751172|FG001|Overall Study|Death Prior to Treatment|0|||
144421790|NCT00268996|520751173|FG000|Overall Study|Adverse Event|11|||
144421791|NCT00268996|520751174|FG001|Overall Study|Adverse Event|7|||
144421792|NCT00268996|520751173|FG000|Overall Study|Lost to Follow-up|3|||
144421793|NCT00268996|520751174|FG001|Overall Study|Lost to Follow-up|1|||
144421794|NCT00268996|520751173|FG000|Overall Study|Withdrawal by Subject|5|||
144421795|NCT00268996|520751174|FG001|Overall Study|Withdrawal by Subject|11|||
144421796|NCT00268996|520751173|FG000|Overall Study|Non-compliance|1|||
144421797|NCT00268996|520751174|FG001|Overall Study|Non-compliance|0|||
144421798|NCT00268996|520751173|FG000|Overall Study|Other|1|||
144421799|NCT00268996|520751174|FG001|Overall Study|Other|1|||
144421800|NCT02956486|520751175|FG000|Core Phase|Adverse Event|51|||
144421801|NCT02956486|520751176|FG001|Core Phase|Adverse Event|88|||
144421802|NCT02956486|520751177|FG002|Core Phase|Adverse Event|0|||
144421803|NCT02956486|520751175|FG000|Core Phase|Lost to Follow-up|8|||
144421804|NCT02956486|520751176|FG001|Core Phase|Lost to Follow-up|6|||
144421805|NCT02956486|520751177|FG002|Core Phase|Lost to Follow-up|0|||
144421806|NCT02956486|520751175|FG000|Core Phase|Inadequate therapeutic effect|4|||
144421807|NCT02956486|520751176|FG001|Core Phase|Inadequate therapeutic effect|5|||
144421808|NCT02956486|520751177|FG002|Core Phase|Inadequate therapeutic effect|0|||
144421809|NCT02956486|520751175|FG000|Core Phase|Withdrawal by Subject|101|||
144421810|NCT02956486|520751176|FG001|Core Phase|Withdrawal by Subject|104|||
144421811|NCT02956486|520751177|FG002|Core Phase|Withdrawal by Subject|0|||
144421812|NCT02956486|520751175|FG000|Core Phase|Study terminated by sponsor|888|||
144421813|NCT02956486|520751176|FG001|Core Phase|Study terminated by sponsor|848|||
144421814|NCT02956486|520751177|FG002|Core Phase|Study terminated by sponsor|0|||
144421815|NCT02956486|520751175|FG000|Core Phase|Other|27|||
144421816|NCT02956486|520751176|FG001|Core Phase|Other|18|||
144421817|NCT02956486|520751177|FG002|Core Phase|Other|0|||
144421818|NCT02956486|520751175|FG000|Core Phase|Not treated|0|||
144421819|NCT02956486|520751176|FG001|Core Phase|Not treated|3|||
144421820|NCT02956486|520751177|FG002|Core Phase|Not treated|0|||
144421821|NCT02956486|520751175|FG000|Extension Phase|Adverse Event|0|||
144421822|NCT02956486|520751176|FG001|Extension Phase|Adverse Event|0|||
144421823|NCT02956486|520751177|FG002|Extension Phase|Adverse Event|2|||
144421824|NCT02956486|520751175|FG000|Extension Phase|Study terminated by sponsor|0|||
144421825|NCT02956486|520751176|FG001|Extension Phase|Study terminated by sponsor|0|||
144421826|NCT02956486|520751177|FG002|Extension Phase|Study terminated by sponsor|16|||
144421827|NCT02956486|520751175|FG000|Extension Phase|Not Treated|0|||
144421828|NCT02956486|520751176|FG001|Extension Phase|Not Treated|0|||
144421829|NCT02956486|520751177|FG002|Extension Phase|Not Treated|1|||
144421830|NCT03325075|520751180|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
144421831|NCT03325075|520751181|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
144421832|NCT03325075|520751182|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
144421833|NCT03325075|520751183|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
144421834|NCT03325075|520751180|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
144421835|NCT03325075|520751181|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
144180964|NCT02377349|519857281|FG000|Overall Study|Other|0|||
144421836|NCT03325075|520751182|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
144421837|NCT03325075|520751183|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
144421838|NCT03325075|520751180|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
144421839|NCT03325075|520751181|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
144421840|NCT03325075|520751182|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
144421841|NCT03325075|520751183|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
144421842|NCT00422591|520751184|FG000|Overall Study|Physician Decision|4|||
144180965|NCT02377349|519857282|FG001|Overall Study|Other|1|||
144421843|NCT00422591|520751184|FG000|Overall Study|Withdrawal by Subject|2|||
144421844|NCT02377466|520751185|FG000|Overall Study|Other: Randomized and not treated|0|||
144421845|NCT02377466|520751186|FG001|Overall Study|Other: Randomized and not treated|2|||
144421846|NCT04210310|520751187|FG000|Overall Study|Lost to Follow-up|32|||
144421847|NCT04210310|520751188|FG001|Overall Study|Lost to Follow-up|1|||
144421848|NCT01585194|520751189|FG000|Overall Study|Withdrawal by Subject|1|||
144421849|NCT01585194|520751189|FG000|Overall Study|Physician Decision|2|||
144180966|NCT03277248|519857285|FG000|Overall Study|Adverse Event|3|||
144421850|NCT01585194|520751189|FG000|Overall Study|Lack of insurance|1|||
144421851|NCT01187043|520751201|FG000|Overall Study|Adverse Event|0|||
144421852|NCT01187043|520751202|FG001|Overall Study|Adverse Event|0|||
144421853|NCT01187043|520751203|FG002|Overall Study|Adverse Event|0|||
144421854|NCT01187043|520751204|FG003|Overall Study|Adverse Event|0|||
144421855|NCT01187043|520751205|FG004|Overall Study|Adverse Event|1|||
144421856|NCT01187043|520751201|FG000|Overall Study|Unable to make scheduled visits|1|||
144421857|NCT01187043|520751202|FG001|Overall Study|Unable to make scheduled visits|0|||
144421858|NCT01187043|520751203|FG002|Overall Study|Unable to make scheduled visits|4|||
144421859|NCT01187043|520751204|FG003|Overall Study|Unable to make scheduled visits|0|||
144421860|NCT01187043|520751205|FG004|Overall Study|Unable to make scheduled visits|1|||
144421861|NCT00573534|520751206|FG000|Overall Study|oppositional behavior|3|||
144421862|NCT02457910|520751211|FG000|Overall Study|Withdrawal by Subject|0|||
144421863|NCT02457910|520751212|FG001|Overall Study|Withdrawal by Subject|0|||
144421864|NCT02457910|520751213|FG002|Overall Study|Withdrawal by Subject|0|||
144421865|NCT02457910|520751214|FG003|Overall Study|Withdrawal by Subject|0|||
144421866|NCT02457910|520751215|FG004|Overall Study|Withdrawal by Subject|0|||
144421867|NCT02457910|520751216|FG005|Overall Study|Withdrawal by Subject|1|||
144421868|NCT02457910|520751211|FG000|Overall Study|Adverse Event|0|||
144421869|NCT02457910|520751212|FG001|Overall Study|Adverse Event|2|||
144421870|NCT02457910|520751213|FG002|Overall Study|Adverse Event|1|||
144421871|NCT02457910|520751214|FG003|Overall Study|Adverse Event|1|||
144421872|NCT02457910|520751215|FG004|Overall Study|Adverse Event|1|||
144421873|NCT02457910|520751216|FG005|Overall Study|Adverse Event|3|||
144421874|NCT02457910|520751211|FG000|Overall Study|Disease progression|3|||
144421875|NCT02457910|520751212|FG001|Overall Study|Disease progression|3|||
144421876|NCT02457910|520751213|FG002|Overall Study|Disease progression|1|||
144421877|NCT02457910|520751214|FG003|Overall Study|Disease progression|1|||
144421878|NCT02457910|520751215|FG004|Overall Study|Disease progression|4|||
144421879|NCT02457910|520751216|FG005|Overall Study|Disease progression|6|||
144421880|NCT02457910|520751211|FG000|Overall Study|Other complicating illness|0|||
144421881|NCT02457910|520751212|FG001|Overall Study|Other complicating illness|0|||
144421882|NCT02457910|520751213|FG002|Overall Study|Other complicating illness|0|||
144421883|NCT02457910|520751214|FG003|Overall Study|Other complicating illness|0|||
144421884|NCT02457910|520751215|FG004|Overall Study|Other complicating illness|0|||
144421885|NCT02457910|520751216|FG005|Overall Study|Other complicating illness|1|||
144421886|NCT02457910|520751211|FG000|Overall Study|Death|0|||
144421887|NCT02457910|520751212|FG001|Overall Study|Death|0|||
144421888|NCT02457910|520751213|FG002|Overall Study|Death|1|||
144421889|NCT02457910|520751214|FG003|Overall Study|Death|0|||
144421890|NCT02457910|520751215|FG004|Overall Study|Death|0|||
144421891|NCT02457910|520751216|FG005|Overall Study|Death|0|||
144421892|NCT00467259|520751217|FG000|Overall Study|Adverse Event|24|||
144421893|NCT00467259|520751218|FG001|Overall Study|Adverse Event|90|||
144421894|NCT00467259|520751217|FG000|Overall Study|Protocol Violation|1|||
144421895|NCT00467259|520751218|FG001|Overall Study|Protocol Violation|7|||
144527691|NCT04171141|521135232|FG006|Overall Study|Withdrawal by Subject|1|||
144527692|NCT04171141|521135233|FG007|Overall Study|Withdrawal by Subject|0|||
144421896|NCT00467259|520751217|FG000|Overall Study|Withdrawal by Subject|34|||
144421897|NCT00467259|520751218|FG001|Overall Study|Withdrawal by Subject|108|||
144421898|NCT00467259|520751217|FG000|Overall Study|Physician Decision|0|||
144421899|NCT00467259|520751218|FG001|Overall Study|Physician Decision|2|||
144421900|NCT00467259|520751217|FG000|Overall Study|Lost to Follow-up|14|||
144421901|NCT00467259|520751218|FG001|Overall Study|Lost to Follow-up|34|||
144421902|NCT00467259|520751217|FG000|Overall Study|Site Closed|2|||
144421903|NCT00467259|520751218|FG001|Overall Study|Site Closed|1|||
144421904|NCT02196558|520751219|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
144421905|NCT02196558|520751220|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
144421906|NCT02196558|520751221|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
144421907|NCT02196558|520751219|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
144421908|NCT02196558|520751220|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
144421909|NCT02196558|520751221|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
144421910|NCT02196558|520751219|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
144180967|NCT03277248|519857286|FG001|Overall Study|Adverse Event|1|||
144421911|NCT02196558|520751220|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
144421912|NCT02196558|520751221|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
144421913|NCT02196558|520751219|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
144421914|NCT02196558|520751220|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
144421915|NCT02196558|520751221|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
144421916|NCT02196558|520751219|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
144421917|NCT02196558|520751220|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
144421918|NCT02196558|520751221|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
144421919|NCT02107482|520751222|FG000|Overall Study|inconveinence|2|||
144421920|NCT02107482|520751222|FG000|Overall Study|Lost to Follow-up|1|||
144421921|NCT02107482|520751222|FG000|Overall Study|Lack of Efficacy|1|||
144421922|NCT03128892|520751225|FG000|Overall Study|Withdrawal by Subject|2|||
144421923|NCT03128892|520751225|FG000|Overall Study|Physician Decision|1|||
144421924|NCT01850524|520751226|FG000|Overall Study|Lost to Follow-up|5|||
144421925|NCT01850524|520751227|FG001|Overall Study|Lost to Follow-up|10|||
144421926|NCT01850524|520751226|FG000|Overall Study|Withdrawal by Subject|24|||
144421927|NCT01850524|520751227|FG001|Overall Study|Withdrawal by Subject|22|||
144421928|NCT01850524|520751226|FG000|Overall Study|Reason not Specified|142|||
144421929|NCT01850524|520751227|FG001|Overall Study|Reason not Specified|141|||
144421930|NCT00883116|520751237|FG000|Overall Study|Adverse event unrelated to study drug|5|||
144421931|NCT00883116|520751238|FG001|Overall Study|Adverse event unrelated to study drug|10|||
144421932|NCT00883116|520751237|FG000|Overall Study|Death|6|||
144421933|NCT00883116|520751238|FG001|Overall Study|Death|2|||
144421934|NCT00883116|520751237|FG000|Overall Study|Disease progression|130|||
144421935|NCT00883116|520751238|FG001|Overall Study|Disease progression|128|||
144421936|NCT00883116|520751237|FG000|Overall Study|Lost to Follow-up|0|||
144421937|NCT00883116|520751238|FG001|Overall Study|Lost to Follow-up|1|||
144421938|NCT00883116|520751237|FG000|Overall Study|Maximum clinical benefit|13|||
144421939|NCT00883116|520751238|FG001|Overall Study|Maximum clinical benefit|46|||
144421940|NCT00883116|520751237|FG000|Overall Study|Not identified|3|||
144421941|NCT00883116|520751238|FG001|Overall Study|Not identified|6|||
144421942|NCT00883116|520751237|FG000|Overall Study|Study drug toxicity|36|||
144421943|NCT00883116|520751238|FG001|Overall Study|Study drug toxicity|16|||
144421944|NCT00883116|520751237|FG000|Overall Study|Withdrawal by Subject|14|||
144421945|NCT00883116|520751238|FG001|Overall Study|Withdrawal by Subject|8|||
144421946|NCT00883116|520751237|FG000|Overall Study|No longer meets study criteria|2|||
144421947|NCT00883116|520751238|FG001|Overall Study|No longer meets study criteria|2|||
144421948|NCT01106898|520751239|FG000|Overall Study|Adverse Event|6|||
144421949|NCT03021265|520751240|FG000|Overall Study|Adverse Event|29|||
144421950|NCT03021265|520751240|FG000|Overall Study|Lack of Efficacy|3|||
144421951|NCT03021265|520751240|FG000|Overall Study|Improved|17|||
144421952|NCT03021265|520751240|FG000|Overall Study|Lost to Follow-up|67|||
144421953|NCT03021265|520751240|FG000|Overall Study|No reason given|2|||
144421954|NCT03021265|520751240|FG000|Overall Study|No visit since the first visit|4|||
144421955|NCT01698801|520751241|FG000|Treatment Phase|Adverse Event|4|||
144421956|NCT01698801|520751241|FG000|Treatment Phase|Protocol Violation|1|||
144421957|NCT01698801|520751241|FG000|Treatment Phase|Other|4|||
144421958|NCT01698801|520751241|FG000|Treatment Phase|Withdrawal by Subject|1|||
144421959|NCT01698801|520751241|FG000|Treatment Phase|Disease progression|1|||
144421960|NCT01698801|520751241|FG000|Follow Up Phase|Withdrawal by Subject|1|||
144421961|NCT01698801|520751241|FG000|Follow Up Phase|Death|4|||
144421962|NCT03061331|520751244|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
144421963|NCT03061331|520751245|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
144421964|NCT01980875|520751246|FG000|Overall Study|Withdrew Consent|1|||
144421965|NCT01980875|520751247|FG001|Overall Study|Withdrew Consent|1|||
144421966|NCT01980875|520751248|FG002|Overall Study|Withdrew Consent|1|||
144421967|NCT01980875|520751246|FG000|Overall Study|Study Terminated by Sponsor|7|||
144421968|NCT01980875|520751247|FG001|Overall Study|Study Terminated by Sponsor|24|||
144421969|NCT01980875|520751248|FG002|Overall Study|Study Terminated by Sponsor|22|||
144421970|NCT01980875|520751246|FG000|Overall Study|Lost to Follow-up|0|||
144421971|NCT01980875|520751247|FG001|Overall Study|Lost to Follow-up|0|||
144421972|NCT01980875|520751248|FG002|Overall Study|Lost to Follow-up|1|||
144421973|NCT00665847|520751249|FG000|Overall Study|Adverse Event|8|||
144421974|NCT00665847|520751249|FG000|Overall Study|Withdrawal by Subject|2|||
144421975|NCT00665847|520751249|FG000|Overall Study|Subject non-compliant|8|||
144421976|NCT00665847|520751249|FG000|Overall Study|Subject reached a virologic endpoint|4|||
144421977|NCT00665847|520751249|FG000|Overall Study|Resistance to TMC125|1|||
144421978|NCT00665847|520751249|FG000|Overall Study|Subject ineligible to continue the trial|1|||
144421979|NCT00665847|520751249|FG000|Overall Study|Switch to Commercial Medication|1|||
144180968|NCT03277248|519857285|FG000|Overall Study|Subject Withdrawal of Consent|6|||
144421980|NCT01189812|520751255|FG000|Overall Study|Withdrawal by Subject|2|||
144421981|NCT01189812|520751256|FG001|Overall Study|Withdrawal by Subject|3|||
144527693|NCT04171141|521135234|FG008|Overall Study|Withdrawal by Subject|0|||
144527694|NCT04171141|521135235|FG009|Overall Study|Withdrawal by Subject|1|||
144527695|NCT04171141|521135236|FG010|Overall Study|Withdrawal by Subject|0|||
144180969|NCT03277248|519857286|FG001|Overall Study|Subject Withdrawal of Consent|23|||
144180970|NCT03277248|519857285|FG000|Overall Study|Investigator/Sponsor Decision|2|||
144527696|NCT04171141|521135237|FG011|Overall Study|Withdrawal by Subject|0|||
144180971|NCT03277248|519857286|FG001|Overall Study|Investigator/Sponsor Decision|2|||
144180972|NCT03277248|519857285|FG000|Overall Study|Pregnancy|4|||
144180973|NCT03277248|519857286|FG001|Overall Study|Pregnancy|1|||
144421982|NCT01189812|520751255|FG000|Overall Study|Adverse Event|1|||
144421983|NCT01189812|520751256|FG001|Overall Study|Adverse Event|0|||
144421984|NCT01189812|520751255|FG000|Overall Study|Out of Window|4|||
144421985|NCT01189812|520751256|FG001|Overall Study|Out of Window|3|||
144421986|NCT01189812|520751255|FG000|Overall Study|Moved out of State|1|||
144421987|NCT01189812|520751256|FG001|Overall Study|Moved out of State|2|||
144421988|NCT02200445|520751258|FG000|Overall Study|Lack of Efficacy|1|||
144421989|NCT02200445|520751259|FG001|Overall Study|Lack of Efficacy|2|||
144527697|NCT04171141|521135238|FG012|Overall Study|Withdrawal by Subject|0|||
144421990|NCT02200445|520751260|FG002|Overall Study|Lack of Efficacy|2|||
144421991|NCT02200445|520751258|FG000|Overall Study|Adverse Event|0|||
144421992|NCT02200445|520751259|FG001|Overall Study|Adverse Event|2|||
144421993|NCT02200445|520751260|FG002|Overall Study|Adverse Event|0|||
144421994|NCT03334903|520751261|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
144421995|NCT03334903|520751262|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
144421996|NCT03334903|520751261|FG000|Overall Study|Protocol Violation|1|||
144421997|NCT03334903|520751262|FG001|Overall Study|Protocol Violation|3|||
144421998|NCT03334903|520751261|FG000|Overall Study|Surgery postponed|1|||
144421999|NCT03334903|520751262|FG001|Overall Study|Surgery postponed|0|||
144422000|NCT03334903|520751261|FG000|Overall Study|Adverse Event|1|||
144422001|NCT03334903|520751262|FG001|Overall Study|Adverse Event|1|||
144422002|NCT03334903|520751261|FG000|Overall Study|Withdrawal by Subject|0|||
144422003|NCT03334903|520751262|FG001|Overall Study|Withdrawal by Subject|1|||
144422004|NCT02879305|520751263|FG000|Overall Study|Investigator Site Closed|55|||
144422005|NCT02879305|520751264|FG001|Overall Study|Investigator Site Closed|57|||
144422006|NCT02879305|520751263|FG000|Overall Study|Withdrawal by Subject|44|||
144422007|NCT02879305|520751264|FG001|Overall Study|Withdrawal by Subject|42|||
144422008|NCT02879305|520751263|FG000|Overall Study|Lost to Follow-up|17|||
144422009|NCT02879305|520751264|FG001|Overall Study|Lost to Follow-up|12|||
144422010|NCT02879305|520751263|FG000|Overall Study|Other|1|||
144422011|NCT02879305|520751264|FG001|Overall Study|Other|0|||
144422012|NCT00397982|520753321|FG000|Overall Study|Withdrawal by Subject|1|||
144422013|NCT00397982|520753321|FG000|Overall Study|Adverse Event|1|||
144422014|NCT00397982|520753321|FG000|Overall Study|noncompliance|1|||
144422015|NCT00397982|520753321|FG000|Overall Study|Unrelated health issues|1|||
144422016|NCT01199289|520753322|FG000|Overall Study|Ineligibility determined|2|||
144422017|NCT01199289|520753323|FG001|Overall Study|Ineligibility determined|1|||
144422018|NCT01199289|520753324|FG002|Overall Study|Ineligibility determined|0|||
144422019|NCT01199289|520753325|FG003|Overall Study|Ineligibility determined|0|||
144422020|NCT01199289|520753322|FG000|Overall Study|Protocol Violation|1|||
144422021|NCT01199289|520753323|FG001|Overall Study|Protocol Violation|0|||
144422022|NCT01199289|520753324|FG002|Overall Study|Protocol Violation|0|||
144422023|NCT01199289|520753325|FG003|Overall Study|Protocol Violation|1|||
144422024|NCT01199289|520753322|FG000|Overall Study|Noncompliance|1|||
144422025|NCT01199289|520753323|FG001|Overall Study|Noncompliance|0|||
144422026|NCT01199289|520753324|FG002|Overall Study|Noncompliance|2|||
144422027|NCT01199289|520753325|FG003|Overall Study|Noncompliance|0|||
144422028|NCT01199289|520753322|FG000|Overall Study|Adverse Event|0|||
144422029|NCT01199289|520753323|FG001|Overall Study|Adverse Event|3|||
144422030|NCT01199289|520753324|FG002|Overall Study|Adverse Event|1|||
144422031|NCT01199289|520753325|FG003|Overall Study|Adverse Event|4|||
144422032|NCT01199289|520753322|FG000|Overall Study|Full consent withdrawn|2|||
144422033|NCT01199289|520753323|FG001|Overall Study|Full consent withdrawn|2|||
144180974|NCT03277248|519857285|FG000|Overall Study|Lost to Follow-up|0|||
144180975|NCT03277248|519857286|FG001|Overall Study|Lost to Follow-up|2|||
144180976|NCT03277248|519857285|FG000|Overall Study|Lack of Efficacy|0|||
144180977|NCT03277248|519857286|FG001|Overall Study|Lack of Efficacy|2|||
144180978|NCT03277248|519857285|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
144180979|NCT03277248|519857286|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
144180980|NCT01451541|519857293|FG000|Overall Study|Adverse Event|4|||
144180981|NCT01451541|519857294|FG001|Overall Study|Adverse Event|3|||
144180982|NCT01451541|519857295|FG002|Overall Study|Adverse Event|6|||
144180983|NCT01451541|519857293|FG000|Overall Study|Lack of Efficacy|2|||
144422034|NCT01199289|520753324|FG002|Overall Study|Full consent withdrawn|2|||
144422035|NCT01199289|520753325|FG003|Overall Study|Full consent withdrawn|3|||
144422036|NCT01199289|520753322|FG000|Overall Study|Administrative decision|0|||
144422037|NCT01199289|520753323|FG001|Overall Study|Administrative decision|0|||
144422038|NCT01199289|520753324|FG002|Overall Study|Administrative decision|0|||
144422039|NCT01199289|520753325|FG003|Overall Study|Administrative decision|1|||
144422040|NCT01199289|520753322|FG000|Overall Study|Lost to Follow-up|0|||
144422041|NCT01199289|520753323|FG001|Overall Study|Lost to Follow-up|0|||
144422042|NCT01199289|520753324|FG002|Overall Study|Lost to Follow-up|0|||
144422043|NCT01199289|520753325|FG003|Overall Study|Lost to Follow-up|1|||
144422044|NCT01199289|520753322|FG000|Overall Study|Protocol-specified criteria|3|||
144422045|NCT01199289|520753323|FG001|Overall Study|Protocol-specified criteria|0|||
144422046|NCT01199289|520753324|FG002|Overall Study|Protocol-specified criteria|0|||
144180984|NCT01451541|519857294|FG001|Overall Study|Lack of Efficacy|0|||
144422047|NCT01199289|520753325|FG003|Overall Study|Protocol-specified criteria|1|||
144422048|NCT01199289|520753322|FG000|Overall Study|Pregnancy|0|||
144422049|NCT01199289|520753323|FG001|Overall Study|Pregnancy|1|||
144422050|NCT01199289|520753324|FG002|Overall Study|Pregnancy|0|||
144422051|NCT01199289|520753325|FG003|Overall Study|Pregnancy|1|||
144422052|NCT02636868|520753326|FG000|Overall Study|Death|0|||
144422053|NCT02636868|520753327|FG001|Overall Study|Death|1|||
144422054|NCT02636868|520753328|FG002|Overall Study|Death|2|||
144180985|NCT01451541|519857295|FG002|Overall Study|Lack of Efficacy|0|||
144180986|NCT01451541|519857293|FG000|Overall Study|Lost to Follow-up|4|||
144180987|NCT01451541|519857294|FG001|Overall Study|Lost to Follow-up|4|||
144180988|NCT01451541|519857295|FG002|Overall Study|Lost to Follow-up|7|||
144180989|NCT01451541|519857293|FG000|Overall Study|Withdrawal by Subject|15|||
144180990|NCT01451541|519857294|FG001|Overall Study|Withdrawal by Subject|8|||
144180991|NCT01451541|519857295|FG002|Overall Study|Withdrawal by Subject|6|||
144180992|NCT01451541|519857293|FG000|Overall Study|randomization error, noncompliance|11|||
144180993|NCT01451541|519857294|FG001|Overall Study|randomization error, noncompliance|10|||
144180994|NCT01451541|519857295|FG002|Overall Study|randomization error, noncompliance|8|||
144180995|NCT03366428|519857298|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
144180996|NCT03366428|519857298|FG000|Overall Study|Adverse Event|12|||
144180997|NCT03366428|519857298|FG000|Overall Study|Clinical progression|2|||
144180998|NCT03366428|519857298|FG000|Overall Study|Withdrawal by Subject|4|||
144180999|NCT02166606|519857299|FG000|Overall Study|Adverse Event|3|||
144181000|NCT02166606|519857299|FG000|Overall Study|Death|31|||
144181001|NCT02166606|519857299|FG000|Overall Study|Protocol Violation|7|||
144181002|NCT02166606|519857299|FG000|Overall Study|Lost to Follow-up|30|||
144181003|NCT02166606|519857299|FG000|Overall Study|Withdrawal by Subject|1|||
144181004|NCT02166606|519857299|FG000|Overall Study|Physician Decision|1|||
144181005|NCT02166606|519857299|FG000|Overall Study|Device upgrade|1|||
144181006|NCT02166606|519857299|FG000|Overall Study|Enrolled after End of Enrollment|4|||
144181007|NCT00533507|519857300|FG000|Overall Study|Withdrawal by Subject|1|||
144181008|NCT02943096|519857301|FG000|Overall Study|Lack of Efficacy|0|||
144181009|NCT02943096|519857302|FG001|Overall Study|Lack of Efficacy|1|||
144181010|NCT05065619|519857303|FG000|Up to Day 42|Lost to Follow-up|1|||
144181011|NCT05065619|519857304|FG001|Up to Day 42|Lost to Follow-up|0|||
144422055|NCT03220217|520753329|FG000|Overall Study|Withdrawal by Subject|0|||
144422056|NCT03220217|520753330|FG001|Overall Study|Withdrawal by Subject|1|||
144422057|NCT03220217|520753331|FG002|Overall Study|Withdrawal by Subject|0|||
144422058|NCT03220217|520753329|FG000|Overall Study|Subject Missed Procedure|0|||
144422059|NCT03220217|520753330|FG001|Overall Study|Subject Missed Procedure|0|||
144422060|NCT03220217|520753331|FG002|Overall Study|Subject Missed Procedure|1|||
144422061|NCT03025542|520753332|FG000|Overall Study|Adverse Event|0|||
144422062|NCT03025542|520753333|FG001|Overall Study|Adverse Event|2|||
144422063|NCT03025542|520753332|FG000|Overall Study|Lost to Follow-up|1|||
144422064|NCT03025542|520753333|FG001|Overall Study|Lost to Follow-up|0|||
144422065|NCT03025542|520753332|FG000|Overall Study|Withdrawal by Subject|1|||
144422066|NCT03025542|520753333|FG001|Overall Study|Withdrawal by Subject|0|||
144422067|NCT00903617|520753335|FG000|Overall Study|Adverse Event|0|||
144422068|NCT00903617|520753336|FG001|Overall Study|Adverse Event|1|||
144422069|NCT00903617|520753337|FG002|Overall Study|Adverse Event|1|||
144422070|NCT00903617|520753338|FG003|Overall Study|Adverse Event|0|||
144422071|NCT00903617|520753335|FG000|Overall Study|Protocol-defined stopping criteria|0|||
144422072|NCT00903617|520753336|FG001|Overall Study|Protocol-defined stopping criteria|2|||
144422073|NCT00903617|520753337|FG002|Overall Study|Protocol-defined stopping criteria|0|||
144422074|NCT00903617|520753338|FG003|Overall Study|Protocol-defined stopping criteria|0|||
144422075|NCT00903617|520753335|FG000|Overall Study|Lost to Follow-up|2|||
144422076|NCT00903617|520753336|FG001|Overall Study|Lost to Follow-up|0|||
144422077|NCT00903617|520753337|FG002|Overall Study|Lost to Follow-up|1|||
144422078|NCT00903617|520753338|FG003|Overall Study|Lost to Follow-up|1|||
144422079|NCT00903617|520753335|FG000|Overall Study|Withdrawal by Subject|1|||
144422080|NCT00903617|520753336|FG001|Overall Study|Withdrawal by Subject|2|||
144422081|NCT00903617|520753337|FG002|Overall Study|Withdrawal by Subject|3|||
144422082|NCT00903617|520753338|FG003|Overall Study|Withdrawal by Subject|0|||
144422083|NCT01104636|520753339|FG000|Overall Study|Lack of Efficacy|43|||
144422084|NCT01104636|520753339|FG000|Overall Study|Lost to Follow-up|24|||
144422085|NCT01104636|520753339|FG000|Overall Study|Withdrawal by Subject|4|||
144422086|NCT01104636|520753339|FG000|Overall Study|Other|43|||
144181012|NCT05065619|519857303|FG000|Up to Day 42|Withdrawal by Subject|1|||
144422087|NCT01104636|520753339|FG000|Overall Study|Study terminated by sponsor|1|||
144422088|NCT01104636|520753339|FG000|Overall Study|Pregnancy|2|||
144422089|NCT01104636|520753339|FG000|Overall Study|Adverse Event|40|||
144422090|NCT01104636|520753339|FG000|Overall Study|Ongoing|21|||
144422091|NCT03055260|520753340|FG000|Overall Study|Withdrawal by Subject|1|||
144422092|NCT03055260|520753341|FG001|Overall Study|Withdrawal by Subject|0|||
144527698|NCT04171141|521135239|FG013|Overall Study|Withdrawal by Subject|0|||
144527699|NCT04171141|521135240|FG014|Overall Study|Withdrawal by Subject|0|||
144527700|NCT04171141|521135241|FG015|Overall Study|Withdrawal by Subject|0|||
144422093|NCT02507505|520753342|FG000|Overall Study|Withdrawal by Subject|13|||
144422094|NCT02507505|520753343|FG001|Overall Study|Withdrawal by Subject|11|||
144181013|NCT05065619|519857304|FG001|Up to Day 42|Withdrawal by Subject|0|||
144181014|NCT05065619|519857303|FG000|After Day 43|Lost to Follow-up|1|||
144181015|NCT05065619|519857304|FG001|After Day 43|Lost to Follow-up|0|||
144181016|NCT05065619|519857303|FG000|After Day 43|Physician Decision|3|||
144181017|NCT05065619|519857304|FG001|After Day 43|Physician Decision|0|||
144181018|NCT05065619|519857303|FG000|After Day 43|Withdrawal by Subject|1|||
144181019|NCT05065619|519857304|FG001|After Day 43|Withdrawal by Subject|2|||
144181020|NCT05065619|519857303|FG000|After Day 43|Public vaccination|6|||
144422095|NCT02507505|520753342|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
144422096|NCT02507505|520753343|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
144422097|NCT02507505|520753342|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
144422098|NCT02507505|520753343|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
144422099|NCT02507505|520753342|FG000|Overall Study|Death before receipt of anesthesia|0|||
144422100|NCT02507505|520753343|FG001|Overall Study|Death before receipt of anesthesia|1|||
144422101|NCT00967798|520753344|FG000|Overall Study|Withdrawal by Subject|5|||
144422102|NCT00967798|520753345|FG001|Overall Study|Withdrawal by Subject|2|||
144422103|NCT00967798|520753344|FG000|Overall Study|Lost to Follow-up|4|||
144422104|NCT00967798|520753345|FG001|Overall Study|Lost to Follow-up|1|||
144422105|NCT00254540|520753346|FG000|Overall Study|Adverse Event|6|||
144422106|NCT00254540|520753347|FG001|Overall Study|Adverse Event|7|||
144422107|NCT00254540|520753346|FG000|Overall Study|Lack of Efficacy|13|||
144422108|NCT00254540|520753347|FG001|Overall Study|Lack of Efficacy|13|||
144422109|NCT00254540|520753346|FG000|Overall Study|Death|0|||
144422110|NCT00254540|520753347|FG001|Overall Study|Death|1|||
144422111|NCT00254540|520753346|FG000|Overall Study|Laboratory Test Abnormality|0|||
144422112|NCT00254540|520753347|FG001|Overall Study|Laboratory Test Abnormality|1|||
144422113|NCT04483011|520753357|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
144422114|NCT04483011|520753358|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
144422115|NCT03518073|520753359|FG000|Overall Study|Adverse Event|2|||
144422116|NCT03518073|520753360|FG001|Overall Study|Adverse Event|4|||
144422117|NCT03518073|520753361|FG002|Overall Study|Adverse Event|2|||
144422118|NCT03518073|520753359|FG000|Overall Study|Death|2|||
144422119|NCT03518073|520753360|FG001|Overall Study|Death|1|||
144422120|NCT03518073|520753361|FG002|Overall Study|Death|3|||
144422121|NCT03518073|520753359|FG000|Overall Study|Lost to Follow-up|1|||
144422122|NCT03518073|520753360|FG001|Overall Study|Lost to Follow-up|0|||
144422123|NCT03518073|520753361|FG002|Overall Study|Lost to Follow-up|1|||
144422124|NCT03518073|520753359|FG000|Overall Study|Physician Decision|5|||
144422125|NCT03518073|520753360|FG001|Overall Study|Physician Decision|0|||
144422126|NCT03518073|520753361|FG002|Overall Study|Physician Decision|2|||
144422127|NCT03518073|520753359|FG000|Overall Study|Progressive disease|1|||
144422128|NCT03518073|520753360|FG001|Overall Study|Progressive disease|1|||
144422129|NCT03518073|520753361|FG002|Overall Study|Progressive disease|1|||
144422130|NCT03518073|520753359|FG000|Overall Study|Protocol Violation|1|||
144422131|NCT03518073|520753360|FG001|Overall Study|Protocol Violation|0|||
144422132|NCT03518073|520753361|FG002|Overall Study|Protocol Violation|0|||
144422133|NCT03518073|520753359|FG000|Overall Study|Withdrawal by Subject|30|||
144422134|NCT03518073|520753360|FG001|Overall Study|Withdrawal by Subject|34|||
144422135|NCT03518073|520753361|FG002|Overall Study|Withdrawal by Subject|29|||
144422136|NCT03518073|520753359|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
144422137|NCT03518073|520753360|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
144422138|NCT03518073|520753361|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
144422139|NCT03518073|520753359|FG000|Overall Study|Covid-19|1|||
144422140|NCT03518073|520753360|FG001|Overall Study|Covid-19|2|||
144422141|NCT03518073|520753361|FG002|Overall Study|Covid-19|1|||
144422142|NCT00475176|520753362|FG000|Overall Study|Adverse Event|2|||
144422143|NCT00475176|520753362|FG000|Overall Study|Withdrawal by Subject|1|||
144422144|NCT00475176|520753362|FG000|Overall Study|Protocol Violation|1|||
144422145|NCT01853046|520753363|FG000|Overall Study|Withdrawal by Subject|1|||
144422146|NCT01853046|520753364|FG001|Overall Study|Withdrawal by Subject|1|||
144422147|NCT01853046|520753363|FG000|Overall Study|Adverse Event|4|||
144422148|NCT01853046|520753364|FG001|Overall Study|Adverse Event|2|||
144422149|NCT01853046|520753363|FG000|Overall Study|Disease progression|13|||
144422150|NCT01853046|520753364|FG001|Overall Study|Disease progression|3|||
144422151|NCT00708162|520753368|FG000|Randomized Phase|Randomized but Not Treated|7|||
144181021|NCT05065619|519857304|FG001|After Day 43|Public vaccination|8|||
144422152|NCT00708162|520753369|FG001|Randomized Phase|Randomized but Not Treated|5|||
144422153|NCT00708162|520753368|FG000|Randomized Phase|Participant Noncompliance|40|||
144422154|NCT00708162|520753369|FG001|Randomized Phase|Participant Noncompliance|32|||
144422155|NCT00708162|520753368|FG000|Randomized Phase|Lost to Follow-up|34|||
144422156|NCT00708162|520753369|FG001|Randomized Phase|Lost to Follow-up|34|||
144422157|NCT00708162|520753368|FG000|Randomized Phase|Withdrew Consent|31|||
144422158|NCT00708162|520753369|FG001|Randomized Phase|Withdrew Consent|22|||
144422159|NCT00708162|520753368|FG000|Randomized Phase|Lack of Efficacy|14|||
144181022|NCT05065619|519857303|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
144181023|NCT05065619|519857304|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
144181024|NCT05065619|519857303|FG000|After Day 43|Study Terminated by Sponsor|88|||
144181025|NCT05065619|519857304|FG001|After Day 43|Study Terminated by Sponsor|16|||
144422160|NCT00708162|520753369|FG001|Randomized Phase|Lack of Efficacy|19|||
144422161|NCT00708162|520753368|FG000|Randomized Phase|Protocol Violation|10|||
144422162|NCT00708162|520753369|FG001|Randomized Phase|Protocol Violation|11|||
144422163|NCT00708162|520753368|FG000|Randomized Phase|Adverse Event|8|||
144422164|NCT00708162|520753369|FG001|Randomized Phase|Adverse Event|12|||
144181026|NCT00556673|519857306|FG000|Overall Study|Protocol deviation|3|||
144422165|NCT00708162|520753368|FG000|Randomized Phase|Investigator's Discretion|7|||
144422166|NCT00708162|520753369|FG001|Randomized Phase|Investigator's Discretion|10|||
144422167|NCT00708162|520753368|FG000|Randomized Phase|Death|2|||
144422168|NCT00708162|520753369|FG001|Randomized Phase|Death|9|||
144422169|NCT00708162|520753368|FG000|Randomized Phase|Pregnancy|3|||
144422170|NCT00708162|520753369|FG001|Randomized Phase|Pregnancy|0|||
144422171|NCT00708162|520753368|FG000|Open-Label Phase|Lost to Follow-up|10|||
144422172|NCT00708162|520753369|FG001|Open-Label Phase|Lost to Follow-up|8|||
144422173|NCT00708162|520753368|FG000|Open-Label Phase|Withdrew Consent|12|||
144422174|NCT00708162|520753369|FG001|Open-Label Phase|Withdrew Consent|6|||
144422175|NCT00708162|520753368|FG000|Open-Label Phase|Participant Noncompliance|7|||
144422176|NCT00708162|520753369|FG001|Open-Label Phase|Participant Noncompliance|7|||
144422177|NCT00708162|520753368|FG000|Open-Label Phase|Lack of Efficacy|7|||
144422178|NCT00708162|520753369|FG001|Open-Label Phase|Lack of Efficacy|4|||
144422179|NCT00708162|520753368|FG000|Open-Label Phase|Investigator's Discretion|3|||
144422180|NCT00708162|520753369|FG001|Open-Label Phase|Investigator's Discretion|2|||
144422181|NCT00708162|520753368|FG000|Open-Label Phase|Death|3|||
144422182|NCT00708162|520753369|FG001|Open-Label Phase|Death|1|||
144422183|NCT00708162|520753368|FG000|Open-Label Phase|Adverse Event|1|||
144422184|NCT00708162|520753369|FG001|Open-Label Phase|Adverse Event|2|||
144422185|NCT00708162|520753368|FG000|Open-Label Phase|Other|1|||
144422186|NCT00708162|520753369|FG001|Open-Label Phase|Other|0|||
144422187|NCT01475331|520753371|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
144422188|NCT01475331|520753372|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
144422189|NCT01475331|520753371|FG000|Overall Study|excessive main duct communication|1|||
144422190|NCT01475331|520753372|FG001|Overall Study|excessive main duct communication|1|||
144422191|NCT01475331|520753371|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
144422192|NCT01475331|520753372|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
144422193|NCT01475331|520753371|FG000|Overall Study|Sign of malignancy during the procedure|2|||
144422194|NCT01475331|520753372|FG001|Overall Study|Sign of malignancy during the procedure|0|||
144422195|NCT01475331|520753371|FG000|Overall Study|cyst found to be prohibitively small|0|||
144422196|NCT01475331|520753372|FG001|Overall Study|cyst found to be prohibitively small|1|||
144422197|NCT01525550|520753373|FG000|Overall Study|Lost to Follow-up|8|||
144422198|NCT01525550|520753374|FG001|Overall Study|Lost to Follow-up|2|||
144422199|NCT01525550|520753373|FG000|Overall Study|Death|19|||
144422200|NCT01525550|520753374|FG001|Overall Study|Death|28|||
144422201|NCT01525550|520753373|FG000|Overall Study|Other|0|||
144422202|NCT01525550|520753374|FG001|Overall Study|Other|4|||
144422203|NCT01525550|520753373|FG000|Overall Study|Sponsor's Decision|30|||
144422204|NCT01525550|520753374|FG001|Overall Study|Sponsor's Decision|11|||
144422205|NCT01525550|520753373|FG000|Overall Study|Withdrawal by Subject|4|||
144422206|NCT01525550|520753374|FG001|Overall Study|Withdrawal by Subject|0|||
144422207|NCT00462761|520753375|FG000|Overall Study|Adverse Event|6|||
144422208|NCT00462761|520753375|FG000|Overall Study|Withdrawal by Subject|9|||
144422209|NCT00462761|520753375|FG000|Overall Study|Physician Decision|5|||
144422210|NCT00462761|520753375|FG000|Overall Study|Disease progression|43|||
144422211|NCT00462761|520753375|FG000|Overall Study|Death|12|||
144422212|NCT00462761|520753375|FG000|Overall Study|Other|1|||
144422213|NCT01244906|520753376|FG000|Overall Study|Death|2|||
144422214|NCT01244906|520753376|FG000|Overall Study|Progression of disease post treatment|6|||
144422215|NCT02877082|520753377|FG000|Overall Study|Trial was closed early|5|||
144422216|NCT03480750|520753378|FG000|Overall Study|Withdrawal by Subject|0|||
144422217|NCT03480750|520753379|FG001|Overall Study|Withdrawal by Subject|1|||
144422218|NCT03480750|520753380|FG002|Overall Study|Withdrawal by Subject|0|||
144422219|NCT03480750|520753381|FG003|Overall Study|Withdrawal by Subject|0|||
144181027|NCT00556673|519857307|FG001|Overall Study|Protocol deviation|2|||
144181028|NCT01528735|519857308|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
144422220|NCT03480750|520753382|FG004|Overall Study|Withdrawal by Subject|0|||
144422221|NCT03480750|520753383|FG005|Overall Study|Withdrawal by Subject|0|||
144181029|NCT01528735|519857309|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
144422222|NCT03480750|520753378|FG000|Overall Study|The interruption in Trientine shippment|0|||
144422223|NCT03480750|520753379|FG001|Overall Study|The interruption in Trientine shippment|0|||
144422224|NCT03480750|520753380|FG002|Overall Study|The interruption in Trientine shippment|0|||
144422225|NCT03480750|520753381|FG003|Overall Study|The interruption in Trientine shippment|0|||
144422226|NCT03480750|520753382|FG004|Overall Study|The interruption in Trientine shippment|0|||
144422227|NCT03480750|520753383|FG005|Overall Study|The interruption in Trientine shippment|1|||
144422228|NCT03318315|520753384|FG000|Overall Study|Lost to Follow-up|3|||
144422229|NCT03318315|520753385|FG001|Overall Study|Lost to Follow-up|2|||
144422230|NCT03318315|520753386|FG002|Overall Study|Lost to Follow-up|1|||
144422231|NCT03318315|520753384|FG000|Overall Study|Protocol Violation|1|||
144422232|NCT03318315|520753385|FG001|Overall Study|Protocol Violation|1|||
144422233|NCT03318315|520753386|FG002|Overall Study|Protocol Violation|1|||
144422234|NCT03318315|520753384|FG000|Overall Study|Withdrawal by Subject|0|||
144422235|NCT03318315|520753385|FG001|Overall Study|Withdrawal by Subject|0|||
144422236|NCT03318315|520753386|FG002|Overall Study|Withdrawal by Subject|2|||
144422237|NCT02611778|520753387|FG000|Overall Study|Withdrawal by Subject|2|||
144422238|NCT02611778|520753388|FG001|Overall Study|Withdrawal by Subject|8|||
144422239|NCT02611778|520753387|FG000|Overall Study|Adverse Event|1|||
144422240|NCT02611778|520753388|FG001|Overall Study|Adverse Event|2|||
144422241|NCT02611778|520753387|FG000|Overall Study|Death|2|||
144422242|NCT02611778|520753388|FG001|Overall Study|Death|1|||
144422243|NCT02611778|520753387|FG000|Overall Study|Protocol Violation|1|||
144422244|NCT02611778|520753388|FG001|Overall Study|Protocol Violation|0|||
144422245|NCT02611778|520753387|FG000|Overall Study|Lost to Follow-up|3|||
144422246|NCT02611778|520753388|FG001|Overall Study|Lost to Follow-up|1|||
144422247|NCT02611778|520753387|FG000|Overall Study|Need for alternative treatment|1|||
144422248|NCT02611778|520753388|FG001|Overall Study|Need for alternative treatment|0|||
144422249|NCT02611778|520753387|FG000|Overall Study|Other Reason|2|||
144422250|NCT02611778|520753388|FG001|Overall Study|Other Reason|1|||
144422251|NCT02746874|520753389|FG000|Overall Study|Withdrawal by Subject|0|||
144422252|NCT02746874|520753390|FG001|Overall Study|Withdrawal by Subject|1|||
144422253|NCT02746874|520753389|FG000|Overall Study|Surgery Date Changed|0|||
144422254|NCT02746874|520753390|FG001|Overall Study|Surgery Date Changed|2|||
144422255|NCT00276159|520753393|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
144422256|NCT01382446|520753402|FG000|Overall Study|Withdrawal by Subject|0|||
144422257|NCT01382446|520753403|FG001|Overall Study|Withdrawal by Subject|1|||
144422258|NCT01382446|520753402|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
144422259|NCT01382446|520753403|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
144422260|NCT00495170|520753408|FG000|Overall Study|Lost to Follow-up|9|||
144422261|NCT00495170|520753408|FG000|Overall Study|Withdrawal by Subject|3|||
144422262|NCT00495170|520753408|FG000|Overall Study|Inappropriate staging|8|||
144422263|NCT00255047|520753415|FG000|Overall Study|Serious Adverse Events|2|||
144422264|NCT00255047|520753416|FG001|Overall Study|Serious Adverse Events|1|||
144422265|NCT00255047|520753417|FG002|Overall Study|Serious Adverse Events|2|||
144422266|NCT00255047|520753418|FG003|Overall Study|Serious Adverse Events|1|||
144422267|NCT00255047|520753415|FG000|Overall Study|Adverse Event|0|||
144422268|NCT00255047|520753416|FG001|Overall Study|Adverse Event|3|||
144422269|NCT00255047|520753417|FG002|Overall Study|Adverse Event|2|||
144422270|NCT00255047|520753418|FG003|Overall Study|Adverse Event|1|||
144422271|NCT00255047|520753415|FG000|Overall Study|Protocol Violation|13|||
144422272|NCT00255047|520753416|FG001|Overall Study|Protocol Violation|13|||
144422273|NCT00255047|520753417|FG002|Overall Study|Protocol Violation|16|||
144422274|NCT00255047|520753418|FG003|Overall Study|Protocol Violation|20|||
144422275|NCT00255047|520753415|FG000|Overall Study|Lost to Follow-up|9|||
144422276|NCT00255047|520753416|FG001|Overall Study|Lost to Follow-up|8|||
144422277|NCT00255047|520753417|FG002|Overall Study|Lost to Follow-up|5|||
144422278|NCT00255047|520753418|FG003|Overall Study|Lost to Follow-up|6|||
144422279|NCT00255047|520753415|FG000|Overall Study|Withdrawal by Subject|24|||
144422280|NCT00255047|520753416|FG001|Overall Study|Withdrawal by Subject|23|||
144422281|NCT00255047|520753417|FG002|Overall Study|Withdrawal by Subject|25|||
144422282|NCT00255047|520753418|FG003|Overall Study|Withdrawal by Subject|18|||
144422283|NCT00811473|520753419|FG000|Overall Study|Adverse Event|3|||
144422284|NCT00811473|520753420|FG001|Overall Study|Adverse Event|12|||
144422285|NCT00811473|520753419|FG000|Overall Study|Lost to Follow-up|5|||
144422286|NCT00811473|520753420|FG001|Overall Study|Lost to Follow-up|1|||
144422287|NCT00811473|520753419|FG000|Overall Study|Withdrawal by Subject|2|||
144422288|NCT00811473|520753420|FG001|Overall Study|Withdrawal by Subject|4|||
144422289|NCT00811473|520753419|FG000|Overall Study|Severe non-compliance to protocol|2|||
144422290|NCT00811473|520753420|FG001|Overall Study|Severe non-compliance to protocol|4|||
144422291|NCT00811473|520753419|FG000|Overall Study|Lack of therapeutic response|4|||
144422292|NCT00811473|520753420|FG001|Overall Study|Lack of therapeutic response|1|||
144422293|NCT00811473|520753419|FG000|Overall Study|Condition under investigation worsened|1|||
144422294|NCT00811473|520753420|FG001|Overall Study|Condition under investigation worsened|3|||
144422295|NCT00811473|520753419|FG000|Overall Study|Other 2|4|||
144422296|NCT00811473|520753420|FG001|Overall Study|Other 2|1|||
144422297|NCT00811473|520753419|FG000|Overall Study|Incorrect Enrollment|1|||
144422298|NCT00811473|520753420|FG001|Overall Study|Incorrect Enrollment|0|||
144422299|NCT00811473|520753419|FG000|Overall Study|Safety Reasons|1|||
144422300|NCT00811473|520753420|FG001|Overall Study|Safety Reasons|0|||
144527701|NCT04171141|521135226|FG000|Overall Study|Global deterioration of health status|0|||
144527702|NCT04171141|521135227|FG001|Overall Study|Global deterioration of health status|0|||
144422301|NCT01119131|520753430|FG000|Overall Study|Adverse Event|1|||
144422302|NCT01119131|520753431|FG001|Overall Study|Adverse Event|1|||
144422303|NCT01119131|520753432|FG002|Overall Study|Adverse Event|1|||
144422304|NCT01119131|520753430|FG000|Overall Study|Non-Compliance|1|||
144422305|NCT01119131|520753431|FG001|Overall Study|Non-Compliance|0|||
144422306|NCT01119131|520753432|FG002|Overall Study|Non-Compliance|4|||
144422307|NCT01119131|520753430|FG000|Overall Study|Physician Decision|0|||
144422308|NCT01119131|520753431|FG001|Overall Study|Physician Decision|0|||
144422309|NCT01119131|520753432|FG002|Overall Study|Physician Decision|1|||
144422310|NCT00732615|520753433|FG000|Overall Study|Withdrawal by Subject|3|||
144422311|NCT00732615|520753434|FG001|Overall Study|Withdrawal by Subject|1|||
144422312|NCT00732615|520753433|FG000|Overall Study|Lost to Follow-up|0|||
144251235|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
144251236|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
144251237|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
144251238|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
144251239|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
144251240|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
144251241|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
144251242|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
144422313|NCT00732615|520753434|FG001|Overall Study|Lost to Follow-up|1|||
144422314|NCT00732615|520753433|FG000|Overall Study|Adverse Event|0|||
144422315|NCT00732615|520753434|FG001|Overall Study|Adverse Event|2|||
144251243|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
144422316|NCT00732615|520753433|FG000|Overall Study|Physician Decision|3|||
144422317|NCT00732615|520753434|FG001|Overall Study|Physician Decision|0|||
144422318|NCT00732615|520753433|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
144422319|NCT00732615|520753434|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
144422320|NCT00993291|520753435|FG000|Overall Study|Withdrawal by Subject|1|||
144422321|NCT00003492|520753436|FG000|Overall Study|Not evaluable|6|||
144422322|NCT03566823|520753437|FG000|Overall Study|Lack of Efficacy|0|||
144422323|NCT03566823|520753438|FG001|Overall Study|Lack of Efficacy|1|||
144422324|NCT03566823|520753439|FG002|Overall Study|Lack of Efficacy|0|||
144422325|NCT03566823|520753437|FG000|Overall Study|Withdrawal by Subject|1|||
144422326|NCT03566823|520753438|FG001|Overall Study|Withdrawal by Subject|2|||
144422327|NCT03566823|520753439|FG002|Overall Study|Withdrawal by Subject|0|||
144422328|NCT03566823|520753437|FG000|Overall Study|Adverse Event|1|||
144422329|NCT03566823|520753438|FG001|Overall Study|Adverse Event|0|||
144422330|NCT03566823|520753439|FG002|Overall Study|Adverse Event|2|||
144422331|NCT01528254|520753440|FG000|Overall Study|Administrative problems|96|||
144422332|NCT01528254|520753441|FG001|Overall Study|Administrative problems|94|||
144422333|NCT01528254|520753440|FG000|Overall Study|Adverse Event|28|||
144422334|NCT01528254|520753441|FG001|Overall Study|Adverse Event|44|||
144422335|NCT01528254|520753440|FG000|Overall Study|Lost to Follow-up|17|||
144422336|NCT01528254|520753441|FG001|Overall Study|Lost to Follow-up|24|||
144422337|NCT01528254|520753440|FG000|Overall Study|Death|13|||
144422338|NCT01528254|520753441|FG001|Overall Study|Death|9|||
144422339|NCT01528254|520753440|FG000|Overall Study|Protocol deviation|9|||
144422340|NCT01528254|520753441|FG001|Overall Study|Protocol deviation|19|||
144422341|NCT01528254|520753440|FG000|Overall Study|New therapy for study indication|8|||
144422342|NCT01528254|520753441|FG001|Overall Study|New therapy for study indication|6|||
144422343|NCT01528254|520753440|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
144422344|NCT01528254|520753441|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
144422345|NCT01528254|520753440|FG000|Overall Study|Withdrawal by Subject|5|||
144422346|NCT01528254|520753441|FG001|Overall Study|Withdrawal by Subject|4|||
144422347|NCT01528254|520753440|FG000|Overall Study|Abnormal laboratory value(s)|3|||
144422348|NCT01528254|520753441|FG001|Overall Study|Abnormal laboratory value(s)|7|||
144422349|NCT01528254|520753440|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144422350|NCT01528254|520753441|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144422351|NCT01528254|520753440|FG000|Overall Study|No longer requires study drug|1|||
144422352|NCT01528254|520753441|FG001|Overall Study|No longer requires study drug|1|||
144422353|NCT04446377|520753442|FG000|Overall Study|Withdrawal by Subject|6|||
144422354|NCT04446377|520753443|FG001|Overall Study|Withdrawal by Subject|1|||
144422355|NCT04446377|520753442|FG000|Overall Study|Physician Decision|1|||
144422356|NCT04446377|520753443|FG001|Overall Study|Physician Decision|1|||
144422357|NCT04446377|520753442|FG000|Overall Study|Lost to Follow-up|0|||
144422358|NCT04446377|520753443|FG001|Overall Study|Lost to Follow-up|2|||
144422359|NCT04446377|520753442|FG000|Overall Study|Not eligible|0|||
144422360|NCT04446377|520753443|FG001|Overall Study|Not eligible|1|||
144422361|NCT00737282|520753444|FG000|Overall Study|Study prematurely terminated|175|||
144422362|NCT02763189|520753445|FG000|Overall Study|Device failure|0|||
144422363|NCT02763189|520753446|FG001|Overall Study|Device failure|2|||
144422364|NCT02049957|520753447|FG000|Overall Study|Progressive Disease|5|||
144422365|NCT02049957|520753448|FG001|Overall Study|Progressive Disease|4|||
144251244|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
144422366|NCT02049957|520753449|FG002|Overall Study|Progressive Disease|2|||
144422367|NCT02049957|520753450|FG003|Overall Study|Progressive Disease|2|||
144422368|NCT02049957|520753451|FG004|Overall Study|Progressive Disease|6|||
144422369|NCT02049957|520753452|FG005|Overall Study|Progressive Disease|35|||
144422370|NCT02049957|520753453|FG006|Overall Study|Progressive Disease|7|||
144527703|NCT04171141|521135228|FG002|Overall Study|Global deterioration of health status|0|||
144422371|NCT02049957|520753454|FG007|Overall Study|Progressive Disease|26|||
144422372|NCT02049957|520753455|FG008|Overall Study|Progressive Disease|6|||
144422373|NCT02049957|520753447|FG000|Overall Study|Adverse Event|1|||
144422374|NCT02049957|520753448|FG001|Overall Study|Adverse Event|1|||
144422375|NCT02049957|520753449|FG002|Overall Study|Adverse Event|1|||
144422376|NCT02049957|520753450|FG003|Overall Study|Adverse Event|0|||
144527704|NCT04171141|521135229|FG003|Overall Study|Global deterioration of health status|1|||
144723239|NCT02260492|521840664|FG000|Overall Study|Withdrawal by Subject|3|||
144723240|NCT02260492|521840665|FG001|Overall Study|Withdrawal by Subject|2|||
144181030|NCT01528735|519857308|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
144181031|NCT01528735|519857309|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
144422377|NCT02049957|520753451|FG004|Overall Study|Adverse Event|0|||
144422378|NCT02049957|520753452|FG005|Overall Study|Adverse Event|5|||
144422379|NCT02049957|520753453|FG006|Overall Study|Adverse Event|0|||
144422380|NCT02049957|520753454|FG007|Overall Study|Adverse Event|6|||
144422381|NCT02049957|520753455|FG008|Overall Study|Adverse Event|1|||
144422382|NCT02049957|520753447|FG000|Overall Study|Study Terminated by Sponsor|0|||
144422383|NCT02049957|520753448|FG001|Overall Study|Study Terminated by Sponsor|1|||
144422384|NCT02049957|520753449|FG002|Overall Study|Study Terminated by Sponsor|0|||
144422385|NCT02049957|520753450|FG003|Overall Study|Study Terminated by Sponsor|0|||
144422386|NCT02049957|520753451|FG004|Overall Study|Study Terminated by Sponsor|0|||
144422387|NCT02049957|520753452|FG005|Overall Study|Study Terminated by Sponsor|0|||
144422388|NCT02049957|520753453|FG006|Overall Study|Study Terminated by Sponsor|1|||
144422389|NCT02049957|520753454|FG007|Overall Study|Study Terminated by Sponsor|0|||
144422390|NCT02049957|520753455|FG008|Overall Study|Study Terminated by Sponsor|0|||
144422391|NCT02049957|520753447|FG000|Overall Study|Withdrawal by Subject|0|||
144422392|NCT02049957|520753448|FG001|Overall Study|Withdrawal by Subject|0|||
144422393|NCT02049957|520753449|FG002|Overall Study|Withdrawal by Subject|0|||
144422394|NCT02049957|520753450|FG003|Overall Study|Withdrawal by Subject|1|||
144422395|NCT02049957|520753451|FG004|Overall Study|Withdrawal by Subject|0|||
144422396|NCT02049957|520753452|FG005|Overall Study|Withdrawal by Subject|2|||
144422397|NCT02049957|520753453|FG006|Overall Study|Withdrawal by Subject|0|||
144422398|NCT02049957|520753454|FG007|Overall Study|Withdrawal by Subject|3|||
144422399|NCT02049957|520753455|FG008|Overall Study|Withdrawal by Subject|1|||
144422400|NCT02049957|520753447|FG000|Overall Study|Physician Decision|0|||
144422401|NCT02049957|520753448|FG001|Overall Study|Physician Decision|0|||
144422402|NCT02049957|520753449|FG002|Overall Study|Physician Decision|0|||
144422403|NCT02049957|520753450|FG003|Overall Study|Physician Decision|0|||
144422404|NCT02049957|520753451|FG004|Overall Study|Physician Decision|0|||
144422405|NCT02049957|520753452|FG005|Overall Study|Physician Decision|1|||
144422406|NCT02049957|520753453|FG006|Overall Study|Physician Decision|0|||
144422407|NCT02049957|520753454|FG007|Overall Study|Physician Decision|0|||
144422408|NCT02049957|520753455|FG008|Overall Study|Physician Decision|0|||
144422409|NCT03557151|520753456|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
144422410|NCT03557151|520753457|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
144422411|NCT03557151|520753456|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
144422412|NCT03557151|520753457|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
144422413|NCT03557151|520753456|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
144422414|NCT03557151|520753457|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
144422415|NCT01414075|520753458|FG000|Overall Study|Adverse Event|1|||
144422416|NCT01414075|520753459|FG001|Overall Study|Adverse Event|0|||
144422417|NCT01414075|520753460|FG002|Overall Study|Adverse Event|1|||
144422418|NCT01414075|520753461|FG003|Overall Study|Adverse Event|0|||
144422419|NCT01414075|520753458|FG000|Overall Study|Death|1|||
144422420|NCT01414075|520753459|FG001|Overall Study|Death|0|||
144422421|NCT01414075|520753460|FG002|Overall Study|Death|0|||
144422422|NCT01414075|520753461|FG003|Overall Study|Death|1|||
144422423|NCT01414075|520753458|FG000|Overall Study|Withdrawal by Subject|0|||
144422424|NCT01414075|520753459|FG001|Overall Study|Withdrawal by Subject|0|||
144422425|NCT01414075|520753460|FG002|Overall Study|Withdrawal by Subject|0|||
144422426|NCT01414075|520753461|FG003|Overall Study|Withdrawal by Subject|1|||
144422427|NCT01414075|520753458|FG000|Overall Study|Other than specified|1|||
144422428|NCT01414075|520753459|FG001|Overall Study|Other than specified|0|||
144422429|NCT01414075|520753460|FG002|Overall Study|Other than specified|1|||
144422430|NCT01414075|520753461|FG003|Overall Study|Other than specified|0|||
144422431|NCT02810392|520753463|FG000|Overall Study|Subject too ill to continue|1|||
144422432|NCT02810392|520753464|FG001|Overall Study|Subject too ill to continue|0|||
144422433|NCT02810392|520753463|FG000|Overall Study|COVID 19 research restrictions|0|||
144422434|NCT02810392|520753464|FG001|Overall Study|COVID 19 research restrictions|1|||
144422435|NCT00840294|520753465|FG000|Overall Study|Withdrawal by Subject|2|||
144422436|NCT00840294|520753466|FG001|Overall Study|Withdrawal by Subject|1|||
144422437|NCT00840294|520753465|FG000|Overall Study|Protocol Violation|1|||
144422438|NCT00840294|520753466|FG001|Overall Study|Protocol Violation|3|||
144422439|NCT00840294|520753465|FG000|Overall Study|Illness|0|||
144422440|NCT00840294|520753466|FG001|Overall Study|Illness|1|||
144422441|NCT04868890|520753467|FG000|Overall Study|Death|2|||
144422442|NCT04868890|520753468|FG001|Overall Study|Death|1|||
144422443|NCT04868890|520753467|FG000|Overall Study|Withdrawal by Subject|1|||
144422444|NCT04868890|520753468|FG001|Overall Study|Withdrawal by Subject|5|||
144723241|NCT02260492|521840666|FG002|Overall Study|Withdrawal by Subject|2|||
144422445|NCT02669433|520753471|FG000|Overall Study|Protocol Violation|0|||
144422446|NCT02669433|520753472|FG001|Overall Study|Protocol Violation|4|||
144422447|NCT02669433|520753473|FG002|Overall Study|Protocol Violation|1|||
144422448|NCT02669433|520753471|FG000|Overall Study|Disease Progression|1|||
144422449|NCT02669433|520753472|FG001|Overall Study|Disease Progression|0|||
144422450|NCT02669433|520753473|FG002|Overall Study|Disease Progression|0|||
144422451|NCT02669433|520753471|FG000|Overall Study|Physician Decision|1|||
144422452|NCT02669433|520753472|FG001|Overall Study|Physician Decision|1|||
144422453|NCT02669433|520753473|FG002|Overall Study|Physician Decision|0|||
144422454|NCT02669433|520753471|FG000|Overall Study|Adverse Event|6|||
144422455|NCT02669433|520753472|FG001|Overall Study|Adverse Event|7|||
144422456|NCT02669433|520753473|FG002|Overall Study|Adverse Event|10|||
144422457|NCT02669433|520753471|FG000|Overall Study|Sponsor Termination|1|||
144422458|NCT02669433|520753472|FG001|Overall Study|Sponsor Termination|0|||
144422459|NCT02669433|520753473|FG002|Overall Study|Sponsor Termination|1|||
144422460|NCT02669433|520753471|FG000|Overall Study|Withdrawal by Subject|5|||
144422461|NCT02669433|520753472|FG001|Overall Study|Withdrawal by Subject|1|||
144422462|NCT02669433|520753473|FG002|Overall Study|Withdrawal by Subject|0|||
144422463|NCT02669433|520753471|FG000|Overall Study|Withdrawal by Caregiver|1|||
144422464|NCT02669433|520753472|FG001|Overall Study|Withdrawal by Caregiver|0|||
144422465|NCT02669433|520753473|FG002|Overall Study|Withdrawal by Caregiver|2|||
144422466|NCT02669433|520753471|FG000|Overall Study|Death|0|||
144422467|NCT02669433|520753472|FG001|Overall Study|Death|1|||
144422468|NCT02669433|520753473|FG002|Overall Study|Death|1|||
144422469|NCT00576927|520753474|FG000|Clinical Assessment|Lack of Efficacy|24|||
144422470|NCT00576927|520753474|FG000|Clinical Assessment|Death|1|||
144422471|NCT00576927|520753474|FG000|Clinical Assessment|Withdrawal by Subject|10|||
144422472|NCT00576927|520753474|FG000|Clinical Assessment|Physician Decision|1|||
144422473|NCT00576927|520753474|FG000|Baseline|Physician Decision|9|||
144422474|NCT00576927|520753474|FG000|Baseline|Medication Change by PCP of subject|1|||
144422475|NCT00576927|520753474|FG000|Baseline|Withdrawal by Subject|3|||
144422476|NCT00576927|520753474|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
144422477|NCT00576927|520753474|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
144422478|NCT00576927|520753474|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
144422479|NCT00576927|520753474|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
144422480|NCT00576927|520753474|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
144422481|NCT03715764|520753476|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
144422482|NCT03715764|520753477|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
144422483|NCT03715764|520753476|FG000|3 Month Follow-up|Lost to Follow-up|2|||
144422484|NCT03715764|520753477|FG001|3 Month Follow-up|Lost to Follow-up|2|||
144422485|NCT03715764|520753476|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
144422486|NCT03715764|520753477|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
144422487|NCT03715764|520753476|FG000|6 Month Follow-up|Lost to Follow-up|3|||
144422488|NCT03715764|520753477|FG001|6 Month Follow-up|Lost to Follow-up|0|||
144422489|NCT03715764|520753476|FG000|12 Month Follow-up|Lost to Follow-up|2|||
144422490|NCT03715764|520753477|FG001|12 Month Follow-up|Lost to Follow-up|3|||
144422491|NCT03715764|520753476|FG000|12 Month Follow-up|Pregnancy|0|||
144422492|NCT03715764|520753477|FG001|12 Month Follow-up|Pregnancy|1|||
144422493|NCT03715764|520753476|FG000|12 Month Follow-up|Surgery|2|||
144422494|NCT03715764|520753477|FG001|12 Month Follow-up|Surgery|0|||
144422495|NCT03715764|520753476|FG000|12 Month Follow-up|Wrong address|1|||
144422496|NCT03715764|520753477|FG001|12 Month Follow-up|Wrong address|0|||
144422497|NCT03715764|520753476|FG000|12 Month Follow-up|No symptoms|1|||
144422498|NCT03715764|520753477|FG001|12 Month Follow-up|No symptoms|0|||
144422499|NCT03715764|520753476|FG000|12 Month Follow-up|Changed primary care centre|0|||
144422500|NCT03715764|520753477|FG001|12 Month Follow-up|Changed primary care centre|1|||
144422501|NCT01361464|520753480|FG000|Overall Study|Death|1|||
144422502|NCT01361464|520753480|FG000|Overall Study|Withdrawal by Subject|2|||
144422503|NCT00818662|520753481|FG000|Overall Study|Adverse Event|5|||
144422504|NCT00818662|520753482|FG001|Overall Study|Adverse Event|14|||
144181032|NCT00757172|519857312|FG000|Overall Study|Withdrawal by Subject|4|||
144181033|NCT00757172|519857312|FG000|Overall Study|Physician Decision|3|||
144181034|NCT00757172|519857312|FG000|Overall Study|Progression|4|||
144181035|NCT01426854|519857313|FG000|Overall Study|Adverse Event|1|||
144181036|NCT01426854|519857314|FG001|Overall Study|Adverse Event|5|||
144422505|NCT00818662|520753483|FG002|Overall Study|Adverse Event|4|||
144422506|NCT00818662|520753484|FG003|Overall Study|Adverse Event|3|||
144422507|NCT00818662|520753481|FG000|Overall Study|Withdrawal by Subject|5|||
144422508|NCT00818662|520753482|FG001|Overall Study|Withdrawal by Subject|4|||
144422509|NCT00818662|520753483|FG002|Overall Study|Withdrawal by Subject|2|||
144422510|NCT00818662|520753484|FG003|Overall Study|Withdrawal by Subject|2|||
144422511|NCT00818662|520753481|FG000|Overall Study|Death|1|||
144422512|NCT00818662|520753482|FG001|Overall Study|Death|3|||
144181037|NCT01426854|519857313|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
144181038|NCT01426854|519857314|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
144422513|NCT00818662|520753483|FG002|Overall Study|Death|0|||
144422514|NCT00818662|520753484|FG003|Overall Study|Death|0|||
144422515|NCT00818662|520753481|FG000|Overall Study|Physician Decision|1|||
144422516|NCT00818662|520753482|FG001|Overall Study|Physician Decision|0|||
144422517|NCT00818662|520753483|FG002|Overall Study|Physician Decision|0|||
144422518|NCT00818662|520753484|FG003|Overall Study|Physician Decision|0|||
144422519|NCT00818662|520753481|FG000|Overall Study|Lost to Follow-up|0|||
144422520|NCT00818662|520753482|FG001|Overall Study|Lost to Follow-up|0|||
144422521|NCT00818662|520753483|FG002|Overall Study|Lost to Follow-up|0|||
144422522|NCT00818662|520753484|FG003|Overall Study|Lost to Follow-up|1|||
144422523|NCT00818662|520753481|FG000|Overall Study|Unwilling or Unable to Participate|4|||
144422524|NCT00818662|520753482|FG001|Overall Study|Unwilling or Unable to Participate|6|||
144422525|NCT00818662|520753483|FG002|Overall Study|Unwilling or Unable to Participate|2|||
144422526|NCT00818662|520753484|FG003|Overall Study|Unwilling or Unable to Participate|4|||
144422527|NCT00818662|520753481|FG000|Overall Study|Protocol Violation|1|||
144422528|NCT00818662|520753482|FG001|Overall Study|Protocol Violation|1|||
144422529|NCT00818662|520753483|FG002|Overall Study|Protocol Violation|0|||
144422530|NCT00818662|520753484|FG003|Overall Study|Protocol Violation|0|||
144422531|NCT00818662|520753481|FG000|Overall Study|Requires a Prohibited Medication|1|||
144422532|NCT00818662|520753482|FG001|Overall Study|Requires a Prohibited Medication|0|||
144422533|NCT00818662|520753483|FG002|Overall Study|Requires a Prohibited Medication|0|||
144422534|NCT00818662|520753484|FG003|Overall Study|Requires a Prohibited Medication|0|||
144422535|NCT00818662|520753481|FG000|Overall Study|Safety Risk|1|||
144422536|NCT00818662|520753482|FG001|Overall Study|Safety Risk|1|||
144422537|NCT00818662|520753483|FG002|Overall Study|Safety Risk|0|||
144422538|NCT00818662|520753484|FG003|Overall Study|Safety Risk|1|||
144422539|NCT00818662|520753481|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
144422540|NCT00818662|520753482|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
144422541|NCT00818662|520753483|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
144422542|NCT00818662|520753484|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
144422543|NCT00818662|520753481|FG000|Overall Study|Participant's health declined|0|||
144422544|NCT00818662|520753482|FG001|Overall Study|Participant's health declined|0|||
144422545|NCT00818662|520753483|FG002|Overall Study|Participant's health declined|0|||
144422546|NCT00818662|520753484|FG003|Overall Study|Participant's health declined|1|||
144422547|NCT00818662|520753481|FG000|Overall Study|Caregiver to pursue other treatment|0|||
144422548|NCT00818662|520753482|FG001|Overall Study|Caregiver to pursue other treatment|1|||
144422549|NCT00818662|520753483|FG002|Overall Study|Caregiver to pursue other treatment|0|||
144422550|NCT00818662|520753484|FG003|Overall Study|Caregiver to pursue other treatment|0|||
144422551|NCT00818662|520753481|FG000|Overall Study|Moving out of state|0|||
144422552|NCT00818662|520753482|FG001|Overall Study|Moving out of state|0|||
144422553|NCT00818662|520753483|FG002|Overall Study|Moving out of state|0|||
144422554|NCT00818662|520753484|FG003|Overall Study|Moving out of state|1|||
144422555|NCT00818662|520753481|FG000|Overall Study|Declined move to another study site|1|||
144422556|NCT00818662|520753482|FG001|Overall Study|Declined move to another study site|0|||
144422557|NCT00818662|520753483|FG002|Overall Study|Declined move to another study site|0|||
144422558|NCT00818662|520753484|FG003|Overall Study|Declined move to another study site|0|||
144422559|NCT00818662|520753481|FG000|Overall Study|Change in living situation|0|||
144422560|NCT00818662|520753482|FG001|Overall Study|Change in living situation|0|||
144422561|NCT00818662|520753483|FG002|Overall Study|Change in living situation|0|||
144422562|NCT00818662|520753484|FG003|Overall Study|Change in living situation|1|||
144422563|NCT00818662|520753481|FG000|Overall Study|Study partner decision|0|||
144422564|NCT00818662|520753482|FG001|Overall Study|Study partner decision|0|||
144422565|NCT00818662|520753483|FG002|Overall Study|Study partner decision|0|||
144422566|NCT00818662|520753484|FG003|Overall Study|Study partner decision|1|||
144422567|NCT00818662|520753481|FG000|Overall Study|Admitted to long term nursing care|0|||
144422568|NCT00818662|520753482|FG001|Overall Study|Admitted to long term nursing care|1|||
144422569|NCT00818662|520753483|FG002|Overall Study|Admitted to long term nursing care|0|||
144422570|NCT00818662|520753484|FG003|Overall Study|Admitted to long term nursing care|0|||
144422571|NCT01472081|520753485|FG000|Overall Study|Continuing treatment at time of analysis|1|||
144422572|NCT01472081|520753486|FG001|Overall Study|Continuing treatment at time of analysis|4|||
144422573|NCT01472081|520753487|FG002|Overall Study|Continuing treatment at time of analysis|1|||
144422574|NCT01472081|520753488|FG003|Overall Study|Continuing treatment at time of analysis|8|||
144422575|NCT01472081|520753489|FG004|Overall Study|Continuing treatment at time of analysis|9|||
144422576|NCT01472081|520753490|FG005|Overall Study|Continuing treatment at time of analysis|0|||
144422577|NCT01472081|520753485|FG000|Overall Study|Disease Progression|4|||
144422578|NCT01472081|520753486|FG001|Overall Study|Disease Progression|10|||
144422579|NCT01472081|520753487|FG002|Overall Study|Disease Progression|12|||
144422580|NCT01472081|520753488|FG003|Overall Study|Disease Progression|31|||
144422581|NCT01472081|520753489|FG004|Overall Study|Disease Progression|22|||
144422582|NCT01472081|520753490|FG005|Overall Study|Disease Progression|3|||
144422583|NCT01472081|520753485|FG000|Overall Study|Study drug toxicity|2|||
144422584|NCT01472081|520753486|FG001|Overall Study|Study drug toxicity|9|||
144422585|NCT01472081|520753487|FG002|Overall Study|Study drug toxicity|4|||
144422586|NCT01472081|520753488|FG003|Overall Study|Study drug toxicity|6|||
144422587|NCT01472081|520753489|FG004|Overall Study|Study drug toxicity|13|||
144422588|NCT01472081|520753490|FG005|Overall Study|Study drug toxicity|2|||
144422589|NCT01472081|520753485|FG000|Overall Study|Death|0|||
144422590|NCT01472081|520753486|FG001|Overall Study|Death|0|||
144422591|NCT01472081|520753487|FG002|Overall Study|Death|0|||
144422592|NCT01472081|520753488|FG003|Overall Study|Death|0|||
144422593|NCT01472081|520753489|FG004|Overall Study|Death|1|||
144422594|NCT01472081|520753490|FG005|Overall Study|Death|0|||
144422595|NCT01472081|520753485|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
144422596|NCT01472081|520753486|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
144527705|NCT04171141|521135230|FG004|Overall Study|Global deterioration of health status|0|||
144527706|NCT04171141|521135231|FG005|Overall Study|Global deterioration of health status|2|||
144527707|NCT04171141|521135232|FG006|Overall Study|Global deterioration of health status|1|||
144527708|NCT04171141|521135233|FG007|Overall Study|Global deterioration of health status|0|||
144527709|NCT04171141|521135234|FG008|Overall Study|Global deterioration of health status|1|||
144527710|NCT04171141|521135235|FG009|Overall Study|Global deterioration of health status|0|||
144527711|NCT04171141|521135236|FG010|Overall Study|Global deterioration of health status|0|||
144527712|NCT04171141|521135237|FG011|Overall Study|Global deterioration of health status|0|||
144527713|NCT04171141|521135238|FG012|Overall Study|Global deterioration of health status|0|||
144527714|NCT04171141|521135239|FG013|Overall Study|Global deterioration of health status|0|||
144527715|NCT04171141|521135240|FG014|Overall Study|Global deterioration of health status|1|||
144181039|NCT01426854|519857313|FG000|Overall Study|Lost to Follow-up|3|||
144181040|NCT01426854|519857314|FG001|Overall Study|Lost to Follow-up|0|||
144422597|NCT01472081|520753487|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
144422598|NCT01472081|520753488|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
144422599|NCT01472081|520753489|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
144422600|NCT01472081|520753490|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
144422601|NCT01472081|520753485|FG000|Overall Study|Withdrawal by Subject|0|||
144422602|NCT01472081|520753486|FG001|Overall Study|Withdrawal by Subject|0|||
144422603|NCT01472081|520753487|FG002|Overall Study|Withdrawal by Subject|0|||
144422604|NCT01472081|520753488|FG003|Overall Study|Withdrawal by Subject|0|||
144422605|NCT01472081|520753489|FG004|Overall Study|Withdrawal by Subject|0|||
144422606|NCT01472081|520753490|FG005|Overall Study|Withdrawal by Subject|1|||
144422607|NCT01472081|520753485|FG000|Overall Study|Poor/non-compliance|0|||
144422608|NCT01472081|520753486|FG001|Overall Study|Poor/non-compliance|0|||
144422609|NCT01472081|520753487|FG002|Overall Study|Poor/non-compliance|1|||
144422610|NCT01472081|520753488|FG003|Overall Study|Poor/non-compliance|0|||
144422611|NCT01472081|520753489|FG004|Overall Study|Poor/non-compliance|1|||
144422612|NCT01472081|520753490|FG005|Overall Study|Poor/non-compliance|0|||
144422613|NCT01472081|520753485|FG000|Overall Study|No longer meets study criteria|0|||
144422614|NCT01472081|520753486|FG001|Overall Study|No longer meets study criteria|0|||
144422615|NCT01472081|520753487|FG002|Overall Study|No longer meets study criteria|1|||
144422616|NCT01472081|520753488|FG003|Overall Study|No longer meets study criteria|0|||
144422617|NCT01472081|520753489|FG004|Overall Study|No longer meets study criteria|0|||
144422618|NCT01472081|520753490|FG005|Overall Study|No longer meets study criteria|0|||
144422619|NCT01472081|520753485|FG000|Overall Study|Subject request to discontinue treatment|0|||
144422620|NCT01472081|520753486|FG001|Overall Study|Subject request to discontinue treatment|3|||
144422621|NCT01472081|520753487|FG002|Overall Study|Subject request to discontinue treatment|1|||
144422622|NCT01472081|520753488|FG003|Overall Study|Subject request to discontinue treatment|1|||
144422623|NCT01472081|520753489|FG004|Overall Study|Subject request to discontinue treatment|0|||
144422624|NCT01472081|520753490|FG005|Overall Study|Subject request to discontinue treatment|0|||
144422625|NCT01705652|520753492|FG000|Overall Study|Adverse Event|1|||
144422626|NCT01705652|520753493|FG001|Overall Study|Adverse Event|0|||
144422627|NCT01705652|520753492|FG000|Overall Study|Withdrawal by Subject|1|||
144422628|NCT01705652|520753493|FG001|Overall Study|Withdrawal by Subject|2|||
144422629|NCT01705652|520753492|FG000|Overall Study|non-compliance|1|||
144422630|NCT01705652|520753493|FG001|Overall Study|non-compliance|1|||
144422631|NCT00541034|520753494|FG000|Overall Study|Non-Compliance|3|||
144422632|NCT01614067|520753496|FG000|Overall Study|Pregnancy|1|||
144422633|NCT01614067|520753497|FG001|Overall Study|Pregnancy|0|||
144422634|NCT01614067|520753496|FG000|Overall Study|Physician Decision|6|||
144422635|NCT01614067|520753497|FG001|Overall Study|Physician Decision|5|||
144422636|NCT01614067|520753496|FG000|Overall Study|Withdrawal by Subject|0|||
144422637|NCT01614067|520753497|FG001|Overall Study|Withdrawal by Subject|1|||
144422638|NCT01614067|520753496|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
144422639|NCT01614067|520753497|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
144422640|NCT01505868|520753498|FG000|Overall Study|Withdrawal by Subject|1|||
144422641|NCT01505868|520753499|FG001|Overall Study|Withdrawal by Subject|0|||
144181041|NCT01426854|519857313|FG000|Overall Study|Noncompliance|0|||
144422642|NCT01505868|520753500|FG002|Overall Study|Withdrawal by Subject|0|||
144422643|NCT01505868|520753501|FG003|Overall Study|Withdrawal by Subject|0|||
144422644|NCT01505868|520753502|FG004|Overall Study|Withdrawal by Subject|0|||
144422645|NCT00680043|520753503|FG000|Overall Study|Withdrawal by Subject|1|||
144422646|NCT00680043|520753504|FG001|Overall Study|Withdrawal by Subject|0|||
144422647|NCT00680043|520753505|FG002|Overall Study|Withdrawal by Subject|0|||
144422648|NCT00680043|520753503|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
144422649|NCT00680043|520753504|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
144181042|NCT01426854|519857314|FG001|Overall Study|Noncompliance|1|||
144422650|NCT00680043|520753505|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
144422651|NCT00680043|520753503|FG000|Overall Study|Renal Transplant|1|||
144422652|NCT00680043|520753504|FG001|Overall Study|Renal Transplant|0|||
144422653|NCT00680043|520753505|FG002|Overall Study|Renal Transplant|4|||
144422654|NCT02625259|520753506|FG000|First Intervention (Day 1)|Other|0|||
144422655|NCT02625259|520753507|FG001|First Intervention (Day 1)|Other|0|||
144422656|NCT02625259|520753508|FG002|First Intervention (Day 1)|Other|1|||
144422657|NCT02625259|520753509|FG003|First Intervention (Day 1)|Other|0|||
144422658|NCT02625259|520753510|FG004|First Intervention (Day 1)|Other|0|||
144422659|NCT02625259|520753506|FG000|First Intervention (Day 1)|Adverse Event|2|||
144422660|NCT02625259|520753507|FG001|First Intervention (Day 1)|Adverse Event|1|||
144422661|NCT02625259|520753508|FG002|First Intervention (Day 1)|Adverse Event|0|||
144422662|NCT02625259|520753509|FG003|First Intervention (Day 1)|Adverse Event|0|||
144422663|NCT02625259|520753510|FG004|First Intervention (Day 1)|Adverse Event|0|||
144422664|NCT02625259|520753506|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
144422665|NCT02625259|520753507|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
144422666|NCT02625259|520753508|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
144422667|NCT02625259|520753509|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
144422668|NCT02625259|520753510|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
144422669|NCT02998840|520753511|FG000|Overall Study|Lost to Follow-up|1|||
144422670|NCT02998840|520753512|FG001|Overall Study|Lost to Follow-up|1|||
144422671|NCT02998840|520753513|FG002|Overall Study|Lost to Follow-up|2|||
144422672|NCT02998840|520753514|FG003|Overall Study|Lost to Follow-up|3|||
144422673|NCT02998840|520753511|FG000|Overall Study|Withdrawal by Subject|1|||
144422674|NCT02998840|520753512|FG001|Overall Study|Withdrawal by Subject|1|||
144422675|NCT02998840|520753513|FG002|Overall Study|Withdrawal by Subject|0|||
144422676|NCT02998840|520753514|FG003|Overall Study|Withdrawal by Subject|1|||
144422677|NCT02998840|520753511|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
144422678|NCT02998840|520753512|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
144422679|NCT02998840|520753513|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
144422680|NCT02998840|520753514|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
144422681|NCT00513474|520753518|FG000|Overall Study|Death|6|||
144422682|NCT00513474|520753519|FG001|Overall Study|Death|9|||
144422683|NCT00513474|520753518|FG000|Overall Study|Participant Withdrew Consent|1|||
144422684|NCT00513474|520753519|FG001|Overall Study|Participant Withdrew Consent|0|||
144422685|NCT01686633|520753520|FG000|Overall Study|Lack of Efficacy|33|||
144422686|NCT01686633|520753521|FG001|Overall Study|Lack of Efficacy|13|||
144422687|NCT01686633|520753522|FG002|Overall Study|Lack of Efficacy|11|||
144422688|NCT01686633|520753520|FG000|Overall Study|Withdrawal by Subject|8|||
144422689|NCT01686633|520753521|FG001|Overall Study|Withdrawal by Subject|8|||
144422690|NCT01686633|520753522|FG002|Overall Study|Withdrawal by Subject|5|||
144422691|NCT01686633|520753520|FG000|Overall Study|Physician Decision|3|||
144422692|NCT01686633|520753521|FG001|Overall Study|Physician Decision|4|||
144422693|NCT01686633|520753522|FG002|Overall Study|Physician Decision|4|||
144422694|NCT01686633|520753520|FG000|Overall Study|Adverse Event|4|||
144422695|NCT01686633|520753521|FG001|Overall Study|Adverse Event|3|||
144422696|NCT01686633|520753522|FG002|Overall Study|Adverse Event|3|||
144422697|NCT01686633|520753520|FG000|Overall Study|Protocol Violation|2|||
144422698|NCT01686633|520753521|FG001|Overall Study|Protocol Violation|3|||
144422699|NCT01686633|520753522|FG002|Overall Study|Protocol Violation|0|||
144422700|NCT01686633|520753520|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
144422701|NCT01686633|520753521|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
144422702|NCT01686633|520753522|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
144422703|NCT01686633|520753520|FG000|Overall Study|Lost to Follow-up|0|||
144422704|NCT01686633|520753521|FG001|Overall Study|Lost to Follow-up|1|||
144422705|NCT01686633|520753522|FG002|Overall Study|Lost to Follow-up|1|||
144422706|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Adverse Event|82|||
144422707|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Death|6|||
144422708|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
144422709|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
144422710|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
144422711|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
144422712|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
144422713|NCT00195676|520753523|FG000|Period O - Open-label Treatment|Other reasons|68|||
144527716|NCT04171141|521135241|FG015|Overall Study|Global deterioration of health status|1|||
144422714|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
144422715|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
144422716|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
144422717|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
144422718|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
144422719|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
144527717|NCT04858451|521135246|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
144527718|NCT04858451|521135247|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144181043|NCT01426854|519857313|FG000|Overall Study|Treatment Failure|0|||
144181044|NCT01426854|519857314|FG001|Overall Study|Treatment Failure|16|||
144422720|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
144422721|NCT00195676|520753523|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
144422722|NCT00195676|520753523|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
144422723|NCT00195676|520753523|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
144422724|NCT00195676|520753523|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
144422725|NCT00195676|520753523|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
144422726|NCT00195676|520753523|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
144422727|NCT00312494|520755812|FG000|Overall Study|Randomized; not treated with study drug|9|||
144422728|NCT00312494|520755813|FG001|Overall Study|Randomized; not treated with study drug|10|||
144422729|NCT00312494|520755814|FG002|Overall Study|Randomized; not treated with study drug|5|||
144422730|NCT00312494|520755812|FG000|Overall Study|Adverse Event|33|||
144422731|NCT00312494|520755813|FG001|Overall Study|Adverse Event|15|||
144422732|NCT00312494|520755814|FG002|Overall Study|Adverse Event|11|||
144422733|NCT00312494|520755812|FG000|Overall Study|Lack of Efficacy|4|||
144422734|NCT00312494|520755813|FG001|Overall Study|Lack of Efficacy|6|||
144422735|NCT00312494|520755814|FG002|Overall Study|Lack of Efficacy|8|||
144422736|NCT00312494|520755812|FG000|Overall Study|Laboratory abnormality|1|||
144422737|NCT00312494|520755813|FG001|Overall Study|Laboratory abnormality|0|||
144422738|NCT00312494|520755814|FG002|Overall Study|Laboratory abnormality|0|||
144422739|NCT00312494|520755812|FG000|Overall Study|Lost to Follow-up|8|||
144422740|NCT00312494|520755813|FG001|Overall Study|Lost to Follow-up|8|||
144422741|NCT00312494|520755814|FG002|Overall Study|Lost to Follow-up|8|||
144422742|NCT00312494|520755812|FG000|Overall Study|Withdrawal by Subject|6|||
144422743|NCT00312494|520755813|FG001|Overall Study|Withdrawal by Subject|9|||
144422744|NCT00312494|520755814|FG002|Overall Study|Withdrawal by Subject|10|||
144422745|NCT00312494|520755812|FG000|Overall Study|Other|10|||
144422746|NCT00312494|520755813|FG001|Overall Study|Other|10|||
144422747|NCT00312494|520755814|FG002|Overall Study|Other|1|||
144422748|NCT00501293|520755815|FG000|Optimization Period|Enrolled in error|1|||
144422749|NCT00501293|520755816|FG001|Optimization Period|Enrolled in error|0|||
144422750|NCT00501293|520755815|FG000|Maintenance Period|Withdrawal by Subject|14|||
144422751|NCT00501293|520755816|FG001|Maintenance Period|Withdrawal by Subject|13|||
144422752|NCT00501293|520755815|FG000|Maintenance Period|Lost to Follow-up|12|||
144422753|NCT00501293|520755816|FG001|Maintenance Period|Lost to Follow-up|7|||
144422754|NCT00501293|520755815|FG000|Maintenance Period|Adverse Event|6|||
144422755|NCT00501293|520755816|FG001|Maintenance Period|Adverse Event|6|||
144422756|NCT00501293|520755815|FG000|Maintenance Period|Protocol Violation|2|||
144422757|NCT00501293|520755816|FG001|Maintenance Period|Protocol Violation|1|||
144422758|NCT00501293|520755815|FG000|Maintenance Period|Lack of Efficacy|4|||
144422759|NCT00501293|520755816|FG001|Maintenance Period|Lack of Efficacy|1|||
144422760|NCT00501293|520755815|FG000|Maintenance Period|Noncompliant with study medication|5|||
144422761|NCT00501293|520755816|FG001|Maintenance Period|Noncompliant with study medication|0|||
144422762|NCT00501293|520755815|FG000|Maintenance Period|Went into rehabilitation|1|||
144422763|NCT00501293|520755816|FG001|Maintenance Period|Went into rehabilitation|0|||
144422764|NCT00501293|520755815|FG000|Maintenance Period|Would not wear patch|1|||
144422765|NCT00501293|520755816|FG001|Maintenance Period|Would not wear patch|0|||
144422766|NCT00501293|520755815|FG000|Maintenance Period|Application site reaction|1|||
144422767|NCT00501293|520755816|FG001|Maintenance Period|Application site reaction|0|||
144422768|NCT00488345|520755817|FG000|Overall Study|Adverse Event|0|||
144422769|NCT00488345|520755818|FG001|Overall Study|Adverse Event|1|||
144422770|NCT00488345|520755819|FG002|Overall Study|Adverse Event|1|||
144422771|NCT00488345|520755817|FG000|Overall Study|Unable to administer antibiotics at home|0|||
144422772|NCT00488345|520755818|FG001|Overall Study|Unable to administer antibiotics at home|1|||
144422773|NCT00488345|520755819|FG002|Overall Study|Unable to administer antibiotics at home|0|||
144422774|NCT00488345|520755817|FG000|Overall Study|Institutional Review Board review|0|||
144422775|NCT00488345|520755818|FG001|Overall Study|Institutional Review Board review|0|||
144422776|NCT00488345|520755819|FG002|Overall Study|Institutional Review Board review|1|||
144422777|NCT00488345|520755817|FG000|Overall Study|Surgical team recommendation|0|||
144422778|NCT00488345|520755818|FG001|Overall Study|Surgical team recommendation|1|||
144422779|NCT00488345|520755819|FG002|Overall Study|Surgical team recommendation|0|||
144422780|NCT00488345|520755817|FG000|Overall Study|Parent/legal guardian request|0|||
144181045|NCT01426854|519857313|FG000|Overall Study|Protocol Deviation|0|||
144422781|NCT00488345|520755818|FG001|Overall Study|Parent/legal guardian request|1|||
144422782|NCT00488345|520755819|FG002|Overall Study|Parent/legal guardian request|1|||
144422783|NCT03020407|520755821|FG000|Overall Study|Withdrawal by Subject|2|||
144422784|NCT03020407|520755822|FG001|Overall Study|Withdrawal by Subject|1|||
144422785|NCT03020407|520755821|FG000|Overall Study|Lost to Follow-up|2|||
144422786|NCT03020407|520755822|FG001|Overall Study|Lost to Follow-up|3|||
144422787|NCT03020407|520755821|FG000|Overall Study|Protocol Violation|0|||
144422788|NCT03020407|520755822|FG001|Overall Study|Protocol Violation|1|||
144422789|NCT02699554|520755823|FG000|Overall Study|Lost to Follow-up|9|||
144181046|NCT01426854|519857314|FG001|Overall Study|Protocol Deviation|1|||
144422790|NCT00788151|520755824|FG000|Overall Study|Other adverse event|0|||
144422791|NCT00788151|520755825|FG001|Overall Study|Other adverse event|2|||
144422792|NCT00788151|520755824|FG000|Overall Study|Protocol Violation|0|||
144422793|NCT00788151|520755825|FG001|Overall Study|Protocol Violation|1|||
144422794|NCT00788151|520755824|FG000|Overall Study|Withdrawal by Subject|13|||
144422795|NCT00788151|520755825|FG001|Overall Study|Withdrawal by Subject|6|||
144422796|NCT00788151|520755824|FG000|Overall Study|Enrolled but not treated|1|||
144422797|NCT00788151|520755825|FG001|Overall Study|Enrolled but not treated|1|||
144422798|NCT00503009|520755826|FG000|Overall Study|Protocol Violation|1|||
144422799|NCT00503009|520755827|FG001|Overall Study|Protocol Violation|0|||
144422800|NCT00503009|520755828|FG002|Overall Study|Protocol Violation|1|||
144422801|NCT00503009|520755826|FG000|Overall Study|Withdrawal by Subject|0|||
144422802|NCT00503009|520755827|FG001|Overall Study|Withdrawal by Subject|1|||
144422803|NCT00503009|520755828|FG002|Overall Study|Withdrawal by Subject|1|||
144422804|NCT00503009|520755826|FG000|Overall Study|Physician Decision|0|||
144422805|NCT00503009|520755827|FG001|Overall Study|Physician Decision|1|||
144422806|NCT00503009|520755828|FG002|Overall Study|Physician Decision|1|||
144422807|NCT01349803|520755830|FG000|Overall Study|Adverse Event|0|||
144422808|NCT01349803|520755831|FG001|Overall Study|Adverse Event|0|||
144422809|NCT01349803|520755832|FG002|Overall Study|Adverse Event|0|||
144422810|NCT01349803|520755833|FG003|Overall Study|Adverse Event|2|||
144422811|NCT01349803|520755830|FG000|Overall Study|Withdrawal by Subject|1|||
144422812|NCT01349803|520755831|FG001|Overall Study|Withdrawal by Subject|0|||
144422813|NCT01349803|520755832|FG002|Overall Study|Withdrawal by Subject|0|||
144422814|NCT01349803|520755833|FG003|Overall Study|Withdrawal by Subject|0|||
144422815|NCT01349803|520755830|FG000|Overall Study|Protocol-specified criteria|0|||
144422816|NCT01349803|520755831|FG001|Overall Study|Protocol-specified criteria|1|||
144422817|NCT01349803|520755832|FG002|Overall Study|Protocol-specified criteria|3|||
144422818|NCT01349803|520755833|FG003|Overall Study|Protocol-specified criteria|0|||
144422819|NCT02169739|520755834|FG000|Overall Study|Lost to Follow-up|0|||
144422820|NCT02169739|520755835|FG001|Overall Study|Lost to Follow-up|4|||
144422821|NCT03635957|520755836|FG000|Run-In Period|Lost to Follow-up|1|||
144422822|NCT03635957|520755836|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
144422823|NCT00350636|520755837|FG000|Overall Study|Adverse Event|19|||
144422824|NCT00350636|520755838|FG001|Overall Study|Adverse Event|13|||
144422825|NCT00350636|520755837|FG000|Overall Study|Protocol Violation|1|||
144422826|NCT00350636|520755838|FG001|Overall Study|Protocol Violation|3|||
144422827|NCT00350636|520755837|FG000|Overall Study|Withdrawal by Subject|13|||
144422828|NCT00350636|520755838|FG001|Overall Study|Withdrawal by Subject|17|||
144422829|NCT00350636|520755837|FG000|Overall Study|Lost to Follow-up|9|||
144422830|NCT00350636|520755838|FG001|Overall Study|Lost to Follow-up|8|||
144422831|NCT00350636|520755837|FG000|Overall Study|Physician Decision|0|||
144422832|NCT00350636|520755838|FG001|Overall Study|Physician Decision|2|||
144422833|NCT00350636|520755837|FG000|Overall Study|Other|1|||
144422834|NCT00350636|520755838|FG001|Overall Study|Other|2|||
144422835|NCT01710033|520755839|FG000|Stage 2|Adverse Event|0|||
144422836|NCT01710033|520755840|FG001|Stage 2|Adverse Event|0|||
144422837|NCT01710033|520755841|FG002|Stage 2|Adverse Event|0|||
144422838|NCT01710033|520755842|FG003|Stage 2|Adverse Event|0|||
144422839|NCT01710033|520755843|FG004|Stage 2|Adverse Event|1|||
144422840|NCT01647282|520755849|FG000|Overall Study|Physician Decision|7|||
144422841|NCT01647282|520755850|FG001|Overall Study|Physician Decision|5|||
144422842|NCT01042236|520755851|FG000|Treatment Period 1|Adverse Event|0|||
144422843|NCT01042236|520755852|FG001|Treatment Period 1|Adverse Event|1|||
144422844|NCT01042236|520755853|FG002|Treatment Period 1|Adverse Event|0|||
144422845|NCT01042236|520755854|FG003|Treatment Period 1|Adverse Event|0|||
144422846|NCT01042236|520755855|FG004|Treatment Period 1|Adverse Event|1|||
144422847|NCT01042236|520755856|FG005|Treatment Period 1|Adverse Event|0|||
144422848|NCT01042236|520755851|FG000|Treatment Period 3|Adverse Event|0|||
144422849|NCT01042236|520755852|FG001|Treatment Period 3|Adverse Event|0|||
144723242|NCT03131999|521840667|FG000|Overall Study|Withdrawal by Subject|0|||
144723243|NCT03131999|521840668|FG001|Overall Study|Withdrawal by Subject|1|||
144422850|NCT01042236|520755853|FG002|Treatment Period 3|Adverse Event|0|||
144422851|NCT01042236|520755854|FG003|Treatment Period 3|Adverse Event|1|||
144422852|NCT01042236|520755855|FG004|Treatment Period 3|Adverse Event|0|||
144422853|NCT01042236|520755856|FG005|Treatment Period 3|Adverse Event|0|||
144422854|NCT01042236|520755851|FG000|Treatment Period 3|Protocol Violation|0|||
144422855|NCT01042236|520755852|FG001|Treatment Period 3|Protocol Violation|0|||
144422856|NCT01042236|520755853|FG002|Treatment Period 3|Protocol Violation|0|||
144422857|NCT01042236|520755854|FG003|Treatment Period 3|Protocol Violation|1|||
144422858|NCT01042236|520755855|FG004|Treatment Period 3|Protocol Violation|0|||
144422859|NCT01042236|520755856|FG005|Treatment Period 3|Protocol Violation|0|||
144422860|NCT01163279|520755863|FG000|Overall Study|Withdrawal by Subject|2|||
144422861|NCT01163279|520755864|FG001|Overall Study|Withdrawal by Subject|0|||
144422862|NCT02232425|520755865|FG000|Overall Study|Lost to Follow-up|6|||
144422863|NCT02232425|520755866|FG001|Overall Study|Lost to Follow-up|2|||
144422864|NCT02232425|520755865|FG000|Overall Study|Adverse Event|2|||
144422865|NCT02232425|520755866|FG001|Overall Study|Adverse Event|0|||
144422866|NCT02232425|520755865|FG000|Overall Study|Withdrawal by Subject|5|||
144422867|NCT02232425|520755866|FG001|Overall Study|Withdrawal by Subject|6|||
144422868|NCT02232425|520755865|FG000|Overall Study|Lack of Efficacy|1|||
144422869|NCT02232425|520755866|FG001|Overall Study|Lack of Efficacy|0|||
144422870|NCT00665353|520755867|FG000|Study Step 1|Adverse Event|1|||
144422871|NCT00665353|520755867|FG000|Study Step 1|Withdrawal by Subject|2|||
144422872|NCT00665353|520755867|FG000|Study Step 2|Lost to Follow-up|2|||
144422873|NCT00665353|520755867|FG000|Study Step 2|Lack of Efficacy|12|||
144422874|NCT01601626|520755868|FG000|Overall Study|Death|1|||
144422875|NCT01601626|520755869|FG001|Overall Study|Death|1|||
144422876|NCT01601626|520755870|FG002|Overall Study|Death|1|||
144422877|NCT01601626|520755868|FG000|Overall Study|Lost to Follow-up|1|||
144422878|NCT01601626|520755869|FG001|Overall Study|Lost to Follow-up|2|||
144422879|NCT01601626|520755870|FG002|Overall Study|Lost to Follow-up|0|||
144422880|NCT01601626|520755868|FG000|Overall Study|Unable to Get to Clinic|0|||
144422881|NCT01601626|520755869|FG001|Overall Study|Unable to Get to Clinic|1|||
144422882|NCT01601626|520755870|FG002|Overall Study|Unable to Get to Clinic|0|||
144422883|NCT01601626|520755868|FG000|Overall Study|Withdrawal by Subject|0|||
144422884|NCT01601626|520755869|FG001|Overall Study|Withdrawal by Subject|1|||
144422885|NCT01601626|520755870|FG002|Overall Study|Withdrawal by Subject|1|||
144422886|NCT01601626|520755868|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
144422887|NCT01601626|520755869|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
144422888|NCT01601626|520755870|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
144422889|NCT02632552|520755872|FG000|Overall Study|Lost to Follow-up|14|||
144422890|NCT02632552|520755873|FG001|Overall Study|Lost to Follow-up|8|||
144422891|NCT02632552|520755872|FG000|Overall Study|Withdrawal by Subject|2|||
144422892|NCT02632552|520755873|FG001|Overall Study|Withdrawal by Subject|0|||
144422893|NCT02632552|520755872|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
144422894|NCT02632552|520755873|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
144422895|NCT02436356|520755877|FG000|Overall Study|Excluded by MRI Screening|0|||
144422896|NCT02436356|520755878|FG001|Overall Study|Excluded by MRI Screening|0|||
144422897|NCT02436356|520755879|FG002|Overall Study|Excluded by MRI Screening|2|||
144422898|NCT02436356|520755877|FG000|Overall Study|Lost to Follow-up|0|||
144422899|NCT02436356|520755878|FG001|Overall Study|Lost to Follow-up|1|||
144422900|NCT02436356|520755879|FG002|Overall Study|Lost to Follow-up|0|||
144422901|NCT02436356|520755877|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
144422902|NCT02436356|520755878|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
144422903|NCT02436356|520755879|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
144422904|NCT02436356|520755877|FG000|Overall Study|Excluded due to other medical conditions|3|||
144422905|NCT02436356|520755878|FG001|Overall Study|Excluded due to other medical conditions|0|||
144422906|NCT02436356|520755879|FG002|Overall Study|Excluded due to other medical conditions|0|||
144422907|NCT02436356|520755877|FG000|Overall Study|Withdrawal by Subject|1|||
144422908|NCT02436356|520755878|FG001|Overall Study|Withdrawal by Subject|0|||
144422909|NCT02436356|520755879|FG002|Overall Study|Withdrawal by Subject|0|||
144422910|NCT04577118|520755884|FG000|Overall Study|Withdrawal by Subject|4|||
144422911|NCT00810407|520755885|FG000|Overall Study|Protocol Violation|3|||
144422912|NCT00810407|520755885|FG000|Overall Study|No Visit After First Day of Treatment|3|||
144422913|NCT02968563|520755886|FG000|Overall Study|Adverse Event|0|||
144422914|NCT02968563|520755887|FG001|Overall Study|Adverse Event|6|||
144422915|NCT02968563|520755886|FG000|Overall Study|Death|1|||
144422916|NCT02968563|520755887|FG001|Overall Study|Death|1|||
144422917|NCT02968563|520755886|FG000|Overall Study|Lost to Follow-up|0|||
144422918|NCT02968563|520755887|FG001|Overall Study|Lost to Follow-up|1|||
144422919|NCT03287804|520755891|FG000|Overall Study|Death|1|||
144422920|NCT03287804|520755891|FG000|Overall Study|Physician Decision|2|||
144422921|NCT03287804|520755891|FG000|Overall Study|Progressive disease|8|||
144422922|NCT04008030|520755894|FG000|Pre-Treatment|Withdrawal by Subject|0|||
144422923|NCT04008030|520755895|FG001|Pre-Treatment|Withdrawal by Subject|0|||
144422924|NCT04008030|520755896|FG002|Pre-Treatment|Withdrawal by Subject|9|||
144422925|NCT04008030|520755894|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
144422926|NCT04008030|520755895|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
144422927|NCT04008030|520755896|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
144422928|NCT04008030|520755894|FG000|Pre-Treatment|Other reasons|0|||
144422929|NCT04008030|520755895|FG001|Pre-Treatment|Other reasons|1|||
144422930|NCT04008030|520755896|FG002|Pre-Treatment|Other reasons|6|||
144422931|NCT04008030|520755894|FG000|Treatment|Withdrawal by Subject|1|||
144251245|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
144251246|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
144422932|NCT04008030|520755895|FG001|Treatment|Withdrawal by Subject|1|||
144422933|NCT04008030|520755896|FG002|Treatment|Withdrawal by Subject|1|||
144422934|NCT04008030|520755894|FG000|Treatment|Death|2|||
144422935|NCT04008030|520755895|FG001|Treatment|Death|4|||
144422936|NCT04008030|520755896|FG002|Treatment|Death|0|||
144422937|NCT04008030|520755894|FG000|Treatment|Pregnancy|0|||
144422938|NCT04008030|520755895|FG001|Treatment|Pregnancy|1|||
144422939|NCT04008030|520755896|FG002|Treatment|Pregnancy|0|||
144422940|NCT04008030|520755894|FG000|Treatment|Participant no longer meets study criteria|0|||
144527719|NCT04858451|521135248|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527720|NCT04858451|521135249|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527721|NCT04858451|521135250|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527722|NCT04858451|521135251|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527723|NCT04858451|521135252|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527724|NCT04858451|521135253|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527725|NCT04858451|521135254|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
144527726|NCT04858451|521135246|FG000|Part 2|Discontinued|0|||
144527727|NCT04858451|521135247|FG001|Part 2|Discontinued|0|||
144527728|NCT04858451|521135248|FG002|Part 2|Discontinued|0|||
144527729|NCT04858451|521135249|FG003|Part 2|Discontinued|0|||
144527730|NCT04858451|521135250|FG004|Part 2|Discontinued|0|||
144527731|NCT04858451|521135251|FG005|Part 2|Discontinued|0|||
144527732|NCT04858451|521135252|FG006|Part 2|Discontinued|0|||
144181047|NCT01426854|519857313|FG000|Overall Study|Other|3|||
144181048|NCT01426854|519857314|FG001|Overall Study|Other|2|||
144181049|NCT03555695|519857315|FG000|Overall Study|Withdrawal by Subject|1|||
144422941|NCT04008030|520755895|FG001|Treatment|Participant no longer meets study criteria|1|||
144422942|NCT04008030|520755896|FG002|Treatment|Participant no longer meets study criteria|0|||
144422943|NCT04008030|520755894|FG000|Treatment|Other reasons|5|||
144422944|NCT04008030|520755895|FG001|Treatment|Other reasons|13|||
144422945|NCT04008030|520755896|FG002|Treatment|Other reasons|6|||
144422946|NCT04008030|520755894|FG000|Treatment|Disease Progression|137|||
144422947|NCT04008030|520755895|FG001|Treatment|Disease Progression|82|||
144422948|NCT04008030|520755896|FG002|Treatment|Disease Progression|85|||
144422949|NCT04008030|520755894|FG000|Treatment|Study drug toxicity|28|||
144422950|NCT04008030|520755895|FG001|Treatment|Study drug toxicity|48|||
144422951|NCT04008030|520755896|FG002|Treatment|Study drug toxicity|8|||
144422952|NCT04008030|520755894|FG000|Treatment|Adverse Event unrelated to study drug|28|||
144422953|NCT04008030|520755895|FG001|Treatment|Adverse Event unrelated to study drug|22|||
144422954|NCT04008030|520755896|FG002|Treatment|Adverse Event unrelated to study drug|6|||
144422955|NCT04008030|520755894|FG000|Treatment|Maximum Clinical Benefit|0|||
144422956|NCT04008030|520755895|FG001|Treatment|Maximum Clinical Benefit|1|||
144422957|NCT04008030|520755896|FG002|Treatment|Maximum Clinical Benefit|9|||
144422958|NCT04008030|520755894|FG000|Treatment|On-going treatment|13|||
144422959|NCT04008030|520755895|FG001|Treatment|On-going treatment|20|||
144422960|NCT04008030|520755896|FG002|Treatment|On-going treatment|0|||
144422961|NCT03108027|520755903|FG000|Period 1|Subject/Guardian Decision|0|||
144422962|NCT03108027|520755904|FG001|Period 1|Subject/Guardian Decision|0|||
144422963|NCT03108027|520755905|FG002|Period 1|Subject/Guardian Decision|0|||
144422964|NCT03108027|520755906|FG003|Period 1|Subject/Guardian Decision|2|||
144422965|NCT03108027|520755907|FG004|Period 1|Subject/Guardian Decision|0|||
144422966|NCT03108027|520755908|FG005|Period 1|Subject/Guardian Decision|0|||
144422967|NCT03108027|520755903|FG000|Period 3|Adverse Event|0|||
144422968|NCT03108027|520755904|FG001|Period 3|Adverse Event|1|||
144422969|NCT03108027|520755905|FG002|Period 3|Adverse Event|0|||
144422970|NCT03108027|520755906|FG003|Period 3|Adverse Event|0|||
144422971|NCT03108027|520755907|FG004|Period 3|Adverse Event|0|||
144422972|NCT03108027|520755908|FG005|Period 3|Adverse Event|0|||
144422973|NCT02426892|520755909|FG000|Overall Study|Adverse Event|2|||
144422974|NCT02426892|520755909|FG000|Overall Study|Lack of Efficacy|17|||
144422975|NCT02426892|520755909|FG000|Overall Study|Withdrawal by Subject|1|||
144422976|NCT02574247|520755910|FG000|Overall Study|Withdrawal by Subject|1|||
144422977|NCT02574247|520755911|FG001|Overall Study|Withdrawal by Subject|0|||
144422978|NCT02574247|520755912|FG002|Overall Study|Withdrawal by Subject|0|||
144422979|NCT02574247|520755910|FG000|Overall Study|Did not meet inclusion criteria|4|||
144422980|NCT02574247|520755911|FG001|Overall Study|Did not meet inclusion criteria|3|||
144422981|NCT02574247|520755912|FG002|Overall Study|Did not meet inclusion criteria|5|||
144422982|NCT03178773|520755913|FG000|Overall Study|Death|0|||
144422983|NCT03178773|520755914|FG001|Overall Study|Death|1|||
144422984|NCT03178773|520755913|FG000|Overall Study|Lost to Follow-up|29|||
144422985|NCT03178773|520755914|FG001|Overall Study|Lost to Follow-up|25|||
144422986|NCT03178773|520755913|FG000|Overall Study|Withdrawal by Subject|10|||
144422987|NCT03178773|520755914|FG001|Overall Study|Withdrawal by Subject|14|||
144422988|NCT00770289|520755918|FG000|Overall Study|Other|6|||
144422989|NCT02733991|520755919|FG000|Overall Study|Adverse Event|1|||
144527733|NCT04858451|521135253|FG007|Part 2|Discontinued|0|||
144527734|NCT04858451|521135254|FG008|Part 2|Discontinued|63|||
144527735|NCT03314454|521135255|FG000|Overall Study|Protocol Violation|1|||
144527736|NCT04119843|521135256|FG000|Overall Study|Adverse Event|3|||
144527737|NCT04119843|521135256|FG000|Overall Study|Death|1|||
144527738|NCT04233216|521135258|FG000|Overall Study|Lost to Follow-up|1|||
144527739|NCT04233216|521135259|FG001|Overall Study|Lost to Follow-up|0|||
144422990|NCT02733991|520755920|FG001|Overall Study|Adverse Event|0|||
144422991|NCT02733991|520755919|FG000|Overall Study|Withdrawal by Subject|0|||
144527740|NCT04233216|521135260|FG002|Overall Study|Lost to Follow-up|2|||
144527741|NCT04233216|521135261|FG003|Overall Study|Lost to Follow-up|0|||
144723244|NCT05328375|521842265|FG000|Overall Study|Withdrawal by Subject|0|||
144181050|NCT03555695|519857315|FG000|Overall Study|Lost to Follow-up|1|||
144422992|NCT02733991|520755920|FG001|Overall Study|Withdrawal by Subject|5|||
144422993|NCT02659631|520755923|FG000|Overall Study|Lost to Follow-up|0|||
144422994|NCT02659631|520755924|FG001|Overall Study|Lost to Follow-up|0|||
144422995|NCT02659631|520755925|FG002|Overall Study|Lost to Follow-up|2|||
144422996|NCT02659631|520755926|FG003|Overall Study|Lost to Follow-up|0|||
144422997|NCT02659631|520755927|FG004|Overall Study|Lost to Follow-up|0|||
144422998|NCT02659631|520755928|FG005|Overall Study|Lost to Follow-up|1|||
144422999|NCT02659631|520755929|FG006|Overall Study|Lost to Follow-up|0|||
144423000|NCT02659631|520755930|FG007|Overall Study|Lost to Follow-up|0|||
144423001|NCT02659631|520755931|FG008|Overall Study|Lost to Follow-up|0|||
144423002|NCT02659631|520755932|FG009|Overall Study|Lost to Follow-up|0|||
144423003|NCT02659631|520755923|FG000|Overall Study|Withdrawal prior to treatment|0|||
144423004|NCT02659631|520755924|FG001|Overall Study|Withdrawal prior to treatment|0|||
144423005|NCT02659631|520755925|FG002|Overall Study|Withdrawal prior to treatment|0|||
144423006|NCT02659631|520755926|FG003|Overall Study|Withdrawal prior to treatment|0|||
144423007|NCT02659631|520755927|FG004|Overall Study|Withdrawal prior to treatment|1|||
144423008|NCT02659631|520755928|FG005|Overall Study|Withdrawal prior to treatment|0|||
144423009|NCT02659631|520755929|FG006|Overall Study|Withdrawal prior to treatment|0|||
144423010|NCT02659631|520755930|FG007|Overall Study|Withdrawal prior to treatment|0|||
144423011|NCT02659631|520755931|FG008|Overall Study|Withdrawal prior to treatment|0|||
144423012|NCT02659631|520755932|FG009|Overall Study|Withdrawal prior to treatment|0|||
144423013|NCT02659631|520755923|FG000|Overall Study|Participant refused further follow-up|0|||
144423014|NCT02659631|520755924|FG001|Overall Study|Participant refused further follow-up|0|||
144423015|NCT02659631|520755925|FG002|Overall Study|Participant refused further follow-up|0|||
144423016|NCT02659631|520755926|FG003|Overall Study|Participant refused further follow-up|1|||
144423017|NCT02659631|520755927|FG004|Overall Study|Participant refused further follow-up|0|||
144423018|NCT02659631|520755928|FG005|Overall Study|Participant refused further follow-up|0|||
144423019|NCT02659631|520755929|FG006|Overall Study|Participant refused further follow-up|0|||
144423020|NCT02659631|520755930|FG007|Overall Study|Participant refused further follow-up|0|||
144423021|NCT02659631|520755931|FG008|Overall Study|Participant refused further follow-up|1|||
144423022|NCT02659631|520755932|FG009|Overall Study|Participant refused further follow-up|0|||
144423023|NCT02659631|520755923|FG000|Overall Study|Death (follow-up phase)|1|||
144423024|NCT02659631|520755924|FG001|Overall Study|Death (follow-up phase)|2|||
144423025|NCT02659631|520755925|FG002|Overall Study|Death (follow-up phase)|1|||
144423026|NCT02659631|520755926|FG003|Overall Study|Death (follow-up phase)|1|||
144423027|NCT02659631|520755927|FG004|Overall Study|Death (follow-up phase)|3|||
144423028|NCT02659631|520755928|FG005|Overall Study|Death (follow-up phase)|2|||
144423029|NCT02659631|520755929|FG006|Overall Study|Death (follow-up phase)|0|||
144423030|NCT02659631|520755930|FG007|Overall Study|Death (follow-up phase)|3|||
144423031|NCT02659631|520755931|FG008|Overall Study|Death (follow-up phase)|1|||
144423032|NCT02659631|520755932|FG009|Overall Study|Death (follow-up phase)|0|||
144423033|NCT02659631|520755923|FG000|Overall Study|Death (treatment phase)|0|||
144423034|NCT02659631|520755924|FG001|Overall Study|Death (treatment phase)|0|||
144423035|NCT02659631|520755925|FG002|Overall Study|Death (treatment phase)|0|||
144423036|NCT02659631|520755926|FG003|Overall Study|Death (treatment phase)|0|||
144423037|NCT02659631|520755927|FG004|Overall Study|Death (treatment phase)|1|||
144423038|NCT02659631|520755928|FG005|Overall Study|Death (treatment phase)|0|||
144423039|NCT02659631|520755929|FG006|Overall Study|Death (treatment phase)|1|||
144423040|NCT02659631|520755930|FG007|Overall Study|Death (treatment phase)|0|||
144423041|NCT02659631|520755931|FG008|Overall Study|Death (treatment phase)|0|||
144423042|NCT02659631|520755932|FG009|Overall Study|Death (treatment phase)|0|||
144423043|NCT04191499|520755933|FG000|Overall Study|Adverse Event|1|||
144423044|NCT04191499|520755934|FG001|Overall Study|Adverse Event|0|||
144423045|NCT04191499|520755933|FG000|Overall Study|Death|42|||
144423046|NCT04191499|520755934|FG001|Overall Study|Death|55|||
144423047|NCT04191499|520755933|FG000|Overall Study|Lost to Follow-up|4|||
144423048|NCT04191499|520755934|FG001|Overall Study|Lost to Follow-up|1|||
144423049|NCT04191499|520755933|FG000|Overall Study|Physician Decision|1|||
144423050|NCT04191499|520755934|FG001|Overall Study|Physician Decision|0|||
144423051|NCT04191499|520755933|FG000|Overall Study|Progressive Disease|1|||
144423052|NCT04191499|520755934|FG001|Overall Study|Progressive Disease|0|||
144423053|NCT04191499|520755933|FG000|Overall Study|Symptomatic Deterioration|1|||
144527742|NCT04233216|521135258|FG000|Overall Study|Physician Decision|0|||
144527743|NCT04233216|521135259|FG001|Overall Study|Physician Decision|3|||
144527744|NCT04233216|521135260|FG002|Overall Study|Physician Decision|0|||
144527745|NCT04233216|521135261|FG003|Overall Study|Physician Decision|2|||
144527746|NCT04233216|521135258|FG000|Overall Study|Withdrawal by Subject|0|||
144527747|NCT04233216|521135259|FG001|Overall Study|Withdrawal by Subject|2|||
144527748|NCT04233216|521135260|FG002|Overall Study|Withdrawal by Subject|1|||
144423054|NCT04191499|520755934|FG001|Overall Study|Symptomatic Deterioration|0|||
144423055|NCT04191499|520755933|FG000|Overall Study|Withdrawal by Subject|7|||
144423056|NCT04191499|520755934|FG001|Overall Study|Withdrawal by Subject|11|||
144423057|NCT04191499|520755933|FG000|Overall Study|Ongoing in the study|104|||
144527749|NCT04233216|521135261|FG003|Overall Study|Withdrawal by Subject|0|||
144527750|NCT03663569|521135262|FG000|Overall Study|Discontinuation of study|11|||
144423058|NCT04191499|520755934|FG001|Overall Study|Ongoing in the study|97|||
144423059|NCT00680745|520755935|FG000|Overall Study|Withdrawal by Subject|8|||
144423060|NCT00680745|520755936|FG001|Overall Study|Withdrawal by Subject|3|||
144423061|NCT00680745|520755937|FG002|Overall Study|Withdrawal by Subject|2|||
144423062|NCT00680745|520755938|FG003|Overall Study|Withdrawal by Subject|8|||
144423063|NCT00680745|520755935|FG000|Overall Study|Lost to Follow-up|0|||
144423064|NCT00680745|520755936|FG001|Overall Study|Lost to Follow-up|1|||
144423065|NCT00680745|520755937|FG002|Overall Study|Lost to Follow-up|1|||
144423066|NCT00680745|520755938|FG003|Overall Study|Lost to Follow-up|0|||
144423067|NCT00680745|520755935|FG000|Overall Study|Death|1|||
144423068|NCT00680745|520755936|FG001|Overall Study|Death|0|||
144423069|NCT00680745|520755937|FG002|Overall Study|Death|1|||
144423070|NCT00680745|520755938|FG003|Overall Study|Death|0|||
144423071|NCT00680745|520755935|FG000|Overall Study|Adverse Event|5|||
144423072|NCT00680745|520755936|FG001|Overall Study|Adverse Event|3|||
144423073|NCT00680745|520755937|FG002|Overall Study|Adverse Event|3|||
144423074|NCT00680745|520755938|FG003|Overall Study|Adverse Event|3|||
144423075|NCT00680745|520755935|FG000|Overall Study|Poor/Non-compliance|0|||
144423076|NCT00680745|520755936|FG001|Overall Study|Poor/Non-compliance|3|||
144423077|NCT00680745|520755937|FG002|Overall Study|Poor/Non-compliance|0|||
144423078|NCT00680745|520755938|FG003|Overall Study|Poor/Non-compliance|0|||
144423079|NCT00680745|520755935|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
144423080|NCT00680745|520755936|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
144423081|NCT00680745|520755937|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
144423082|NCT00680745|520755938|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
144423083|NCT00680745|520755935|FG000|Overall Study|False Treatment|0|||
144423084|NCT00680745|520755936|FG001|Overall Study|False Treatment|1|||
144423085|NCT00680745|520755937|FG002|Overall Study|False Treatment|3|||
144423086|NCT00680745|520755938|FG003|Overall Study|False Treatment|0|||
144423087|NCT01928329|520755941|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
144423088|NCT01928329|520755942|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
144423089|NCT01928329|520755941|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
144423090|NCT01928329|520755942|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
144423091|NCT01928329|520755941|FG000|Overall Study|Adverse Event|5|||
144423092|NCT01928329|520755942|FG001|Overall Study|Adverse Event|3|||
144423093|NCT01928329|520755941|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
144423094|NCT01928329|520755942|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
144423095|NCT01928329|520755941|FG000|Overall Study|Withdrawal by Subject|1|||
144423096|NCT01928329|520755942|FG001|Overall Study|Withdrawal by Subject|5|||
144423097|NCT01928329|520755941|FG000|Overall Study|Physician Decision|1|||
144423098|NCT01928329|520755942|FG001|Overall Study|Physician Decision|1|||
144423099|NCT02617511|520755944|FG000|Overall Study|Withdrawal by Subject|1|||
144423100|NCT02617511|520755945|FG001|Overall Study|Withdrawal by Subject|0|||
144423101|NCT02141997|520755946|FG000|Overall Study|Adverse Event|0|||
144423102|NCT02141997|520755947|FG001|Overall Study|Adverse Event|2|||
144423103|NCT02141997|520755948|FG002|Overall Study|Adverse Event|0|||
144423104|NCT02141997|520755949|FG003|Overall Study|Adverse Event|1|||
144423105|NCT02141997|520755946|FG000|Overall Study|Participant noncompliance|1|||
144423106|NCT02141997|520755947|FG001|Overall Study|Participant noncompliance|0|||
144423107|NCT02141997|520755948|FG002|Overall Study|Participant noncompliance|0|||
144423108|NCT02141997|520755949|FG003|Overall Study|Participant noncompliance|0|||
144423109|NCT02141997|520755946|FG000|Overall Study|Withdrew consent|1|||
144423110|NCT02141997|520755947|FG001|Overall Study|Withdrew consent|0|||
144423111|NCT02141997|520755948|FG002|Overall Study|Withdrew consent|3|||
144423112|NCT02141997|520755949|FG003|Overall Study|Withdrew consent|0|||
144423113|NCT02141997|520755946|FG000|Overall Study|Other|1|||
144423114|NCT02141997|520755947|FG001|Overall Study|Other|4|||
144423115|NCT02141997|520755948|FG002|Overall Study|Other|0|||
144423116|NCT02141997|520755949|FG003|Overall Study|Other|0|||
144423117|NCT03564145|520755952|FG000|Overall Study|Adverse Event|4|||
144423118|NCT03564145|520755952|FG000|Overall Study|Lost to Follow-up|21|||
144423119|NCT03564145|520755952|FG000|Overall Study|Protocol Violation|2|||
144423120|NCT03564145|520755952|FG000|Overall Study|Withdrawal by Subject|48|||
144423121|NCT03564145|520755952|FG000|Overall Study|Study Terminated by Sponsor|146|||
144423122|NCT03564145|520755952|FG000|Overall Study|Physician Decision|1|||
144423123|NCT03564145|520755952|FG000|Overall Study|Other Than Specified|1|||
144423124|NCT03564145|520755952|FG000|Overall Study|Pregnancy|1|||
144423125|NCT04702997|520755953|FG000|Overall Study|Withdrawal by Subject|1|||
144423126|NCT04702997|520755954|FG001|Overall Study|Withdrawal by Subject|1|||
144423127|NCT01386554|520755960|FG000|Overall Study|Lost to Follow-up|0|||
144423128|NCT01386554|520755961|FG001|Overall Study|Lost to Follow-up|0|||
144423129|NCT01386554|520755962|FG002|Overall Study|Lost to Follow-up|1|||
144423130|NCT01386554|520755960|FG000|Overall Study|Adverse Event|2|||
144423131|NCT01386554|520755961|FG001|Overall Study|Adverse Event|5|||
144423132|NCT01386554|520755962|FG002|Overall Study|Adverse Event|2|||
144423133|NCT01386554|520755960|FG000|Overall Study|Progressive disease|1|||
144423134|NCT01386554|520755961|FG001|Overall Study|Progressive disease|2|||
144423135|NCT01386554|520755962|FG002|Overall Study|Progressive disease|2|||
144423136|NCT01386554|520755960|FG000|Overall Study|Administration of live vaccines|0|||
144423137|NCT01386554|520755961|FG001|Overall Study|Administration of live vaccines|1|||
144423138|NCT01386554|520755962|FG002|Overall Study|Administration of live vaccines|0|||
144423139|NCT01386554|520755960|FG000|Overall Study|Investigator discretion|0|||
144423140|NCT01386554|520755961|FG001|Overall Study|Investigator discretion|0|||
144423141|NCT01386554|520755962|FG002|Overall Study|Investigator discretion|1|||
144423142|NCT01386554|520755960|FG000|Overall Study|Reason not collected|0|||
144423143|NCT01386554|520755961|FG001|Overall Study|Reason not collected|1|||
144423144|NCT01386554|520755962|FG002|Overall Study|Reason not collected|0|||
144423145|NCT02759471|520755963|FG000|Overall Study|discomfort|2|||
144423146|NCT02554812|520755964|FG000|Overall Study|Adverse Event|2|||
144423147|NCT02554812|520755965|FG001|Overall Study|Adverse Event|5|||
144423148|NCT02554812|520755966|FG002|Overall Study|Adverse Event|3|||
144423149|NCT02554812|520755967|FG003|Overall Study|Adverse Event|0|||
144423150|NCT02554812|520755968|FG004|Overall Study|Adverse Event|5|||
144423151|NCT02554812|520755969|FG005|Overall Study|Adverse Event|0|||
144423152|NCT02554812|520755970|FG006|Overall Study|Adverse Event|1|||
144423153|NCT02554812|520755971|FG007|Overall Study|Adverse Event|6|||
144423154|NCT02554812|520755972|FG008|Overall Study|Adverse Event|2|||
144423155|NCT02554812|520755973|FG009|Overall Study|Adverse Event|2|||
144423156|NCT02554812|520755974|FG010|Overall Study|Adverse Event|1|||
144423157|NCT02554812|520755975|FG011|Overall Study|Adverse Event|2|||
144423158|NCT02554812|520755976|FG012|Overall Study|Adverse Event|0|||
144423159|NCT02554812|520755977|FG013|Overall Study|Adverse Event|3|||
144423160|NCT02554812|520755978|FG014|Overall Study|Adverse Event|2|||
144423161|NCT02554812|520755979|FG015|Overall Study|Adverse Event|1|||
144423162|NCT02554812|520755980|FG016|Overall Study|Adverse Event|0|||
144423163|NCT02554812|520755981|FG017|Overall Study|Adverse Event|1|||
144423164|NCT02554812|520755982|FG018|Overall Study|Adverse Event|0|||
144423165|NCT02554812|520755983|FG019|Overall Study|Adverse Event|0|||
144423166|NCT02554812|520755984|FG020|Overall Study|Adverse Event|0|||
144423167|NCT02554812|520755985|FG021|Overall Study|Adverse Event|2|||
144423168|NCT02554812|520755986|FG022|Overall Study|Adverse Event|1|||
144423169|NCT02554812|520755987|FG023|Overall Study|Adverse Event|1|||
144423170|NCT02554812|520755988|FG024|Overall Study|Adverse Event|1|||
144423171|NCT02554812|520755989|FG025|Overall Study|Adverse Event|2|||
144423172|NCT02554812|520755990|FG026|Overall Study|Adverse Event|1|||
144423173|NCT02554812|520755964|FG000|Overall Study|Death|1|||
144423174|NCT02554812|520755965|FG001|Overall Study|Death|2|||
144423175|NCT02554812|520755966|FG002|Overall Study|Death|2|||
144423176|NCT02554812|520755967|FG003|Overall Study|Death|2|||
144423177|NCT02554812|520755968|FG004|Overall Study|Death|0|||
144423178|NCT02554812|520755969|FG005|Overall Study|Death|1|||
144423179|NCT02554812|520755970|FG006|Overall Study|Death|1|||
144423180|NCT02554812|520755971|FG007|Overall Study|Death|1|||
144423181|NCT02554812|520755972|FG008|Overall Study|Death|0|||
144423182|NCT02554812|520755973|FG009|Overall Study|Death|0|||
144423183|NCT02554812|520755974|FG010|Overall Study|Death|0|||
144423184|NCT02554812|520755975|FG011|Overall Study|Death|0|||
144181051|NCT03555695|519857315|FG000|Overall Study|appendicitis (unrelated)|1|||
144181052|NCT03555695|519857315|FG000|Overall Study|pre-existing sciatica|1|||
144423185|NCT02554812|520755976|FG012|Overall Study|Death|0|||
144423186|NCT02554812|520755977|FG013|Overall Study|Death|0|||
144423187|NCT02554812|520755978|FG014|Overall Study|Death|1|||
144423188|NCT02554812|520755979|FG015|Overall Study|Death|1|||
144423189|NCT02554812|520755980|FG016|Overall Study|Death|1|||
144423190|NCT02554812|520755981|FG017|Overall Study|Death|0|||
144423191|NCT02554812|520755982|FG018|Overall Study|Death|1|||
144423192|NCT02554812|520755983|FG019|Overall Study|Death|2|||
144527751|NCT03663569|521135262|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
144527752|NCT03663569|521135262|FG000|Overall Study|Deceased patient|6|||
144527753|NCT03663569|521135262|FG000|Overall Study|Lost to Follow-up|18|||
144527754|NCT03663569|521135262|FG000|Overall Study|Withdrawal of consent|5|||
144527755|NCT03663569|521135262|FG000|Overall Study|Patient's request|11|||
144527756|NCT03663569|521135262|FG000|Overall Study|Adverse Event|4|||
144527757|NCT03663569|521135262|FG000|Overall Study|Not come to second visit|3|||
144527758|NCT03663569|521135262|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
144527759|NCT03663569|521135262|FG000|Overall Study|Serious adverse event|1|||
144527760|NCT04231149|521135263|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
144527761|NCT04231149|521135264|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
144527762|NCT04231149|521135265|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
144527763|NCT04231149|521135266|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
144527764|NCT04231149|521135267|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
144527765|NCT03252847|521135268|FG000|Overall Study|Withdrawal by Subject|0|||
144527766|NCT03252847|521135269|FG001|Overall Study|Withdrawal by Subject|0|||
144181053|NCT01971554|519857316|FG000|Overall Study|Lost to Follow-up|1|||
144423193|NCT02554812|520755984|FG020|Overall Study|Death|0|||
144423194|NCT02554812|520755985|FG021|Overall Study|Death|1|||
144423195|NCT02554812|520755986|FG022|Overall Study|Death|1|||
144423196|NCT02554812|520755987|FG023|Overall Study|Death|0|||
144181054|NCT01971554|519857317|FG001|Overall Study|Lost to Follow-up|0|||
144181055|NCT01971554|519857318|FG002|Overall Study|Lost to Follow-up|0|||
144181056|NCT01971554|519857319|FG003|Overall Study|Lost to Follow-up|0|||
144181057|NCT01942135|519857321|FG000|Overall Study|Adverse Event|21|||
144423197|NCT02554812|520755988|FG024|Overall Study|Death|0|||
144423198|NCT02554812|520755989|FG025|Overall Study|Death|0|||
144423199|NCT02554812|520755990|FG026|Overall Study|Death|0|||
144423200|NCT02554812|520755964|FG000|Overall Study|Lost to Follow-up|0|||
144423201|NCT02554812|520755965|FG001|Overall Study|Lost to Follow-up|1|||
144423202|NCT02554812|520755966|FG002|Overall Study|Lost to Follow-up|0|||
144423203|NCT02554812|520755967|FG003|Overall Study|Lost to Follow-up|0|||
144423204|NCT02554812|520755968|FG004|Overall Study|Lost to Follow-up|0|||
144423205|NCT02554812|520755969|FG005|Overall Study|Lost to Follow-up|0|||
144423206|NCT02554812|520755970|FG006|Overall Study|Lost to Follow-up|0|||
144423207|NCT02554812|520755971|FG007|Overall Study|Lost to Follow-up|0|||
144423208|NCT02554812|520755972|FG008|Overall Study|Lost to Follow-up|0|||
144423209|NCT02554812|520755973|FG009|Overall Study|Lost to Follow-up|0|||
144423210|NCT02554812|520755974|FG010|Overall Study|Lost to Follow-up|0|||
144423211|NCT02554812|520755975|FG011|Overall Study|Lost to Follow-up|0|||
144423212|NCT02554812|520755976|FG012|Overall Study|Lost to Follow-up|0|||
144423213|NCT02554812|520755977|FG013|Overall Study|Lost to Follow-up|0|||
144423214|NCT02554812|520755978|FG014|Overall Study|Lost to Follow-up|0|||
144423215|NCT02554812|520755979|FG015|Overall Study|Lost to Follow-up|0|||
144423216|NCT02554812|520755980|FG016|Overall Study|Lost to Follow-up|0|||
144423217|NCT02554812|520755981|FG017|Overall Study|Lost to Follow-up|0|||
144423218|NCT02554812|520755982|FG018|Overall Study|Lost to Follow-up|0|||
144423219|NCT02554812|520755983|FG019|Overall Study|Lost to Follow-up|0|||
144423220|NCT02554812|520755984|FG020|Overall Study|Lost to Follow-up|0|||
144423221|NCT02554812|520755985|FG021|Overall Study|Lost to Follow-up|0|||
144423222|NCT02554812|520755986|FG022|Overall Study|Lost to Follow-up|0|||
144423223|NCT02554812|520755987|FG023|Overall Study|Lost to Follow-up|0|||
144423224|NCT02554812|520755988|FG024|Overall Study|Lost to Follow-up|0|||
144423225|NCT02554812|520755989|FG025|Overall Study|Lost to Follow-up|0|||
144423226|NCT02554812|520755990|FG026|Overall Study|Lost to Follow-up|0|||
144423227|NCT02554812|520755964|FG000|Overall Study|Global deterioration of health status|4|||
144423228|NCT02554812|520755965|FG001|Overall Study|Global deterioration of health status|3|||
144423229|NCT02554812|520755966|FG002|Overall Study|Global deterioration of health status|3|||
144423230|NCT02554812|520755967|FG003|Overall Study|Global deterioration of health status|2|||
144423231|NCT02554812|520755968|FG004|Overall Study|Global deterioration of health status|5|||
144423232|NCT02554812|520755969|FG005|Overall Study|Global deterioration of health status|0|||
144423233|NCT02554812|520755970|FG006|Overall Study|Global deterioration of health status|2|||
144423234|NCT02554812|520755971|FG007|Overall Study|Global deterioration of health status|1|||
144423235|NCT02554812|520755972|FG008|Overall Study|Global deterioration of health status|1|||
144423236|NCT02554812|520755973|FG009|Overall Study|Global deterioration of health status|1|||
144423237|NCT02554812|520755974|FG010|Overall Study|Global deterioration of health status|2|||
144423238|NCT02554812|520755975|FG011|Overall Study|Global deterioration of health status|1|||
144423239|NCT02554812|520755976|FG012|Overall Study|Global deterioration of health status|0|||
144423240|NCT02554812|520755977|FG013|Overall Study|Global deterioration of health status|0|||
144423241|NCT02554812|520755978|FG014|Overall Study|Global deterioration of health status|0|||
144423242|NCT02554812|520755979|FG015|Overall Study|Global deterioration of health status|1|||
144423243|NCT02554812|520755980|FG016|Overall Study|Global deterioration of health status|0|||
144423244|NCT02554812|520755981|FG017|Overall Study|Global deterioration of health status|0|||
144423245|NCT02554812|520755982|FG018|Overall Study|Global deterioration of health status|0|||
144423246|NCT02554812|520755983|FG019|Overall Study|Global deterioration of health status|0|||
144423247|NCT02554812|520755984|FG020|Overall Study|Global deterioration of health status|0|||
144423248|NCT02554812|520755985|FG021|Overall Study|Global deterioration of health status|0|||
144423249|NCT02554812|520755986|FG022|Overall Study|Global deterioration of health status|0|||
144423250|NCT02554812|520755987|FG023|Overall Study|Global deterioration of health status|0|||
144423251|NCT02554812|520755988|FG024|Overall Study|Global deterioration of health status|0|||
144181058|NCT01942135|519857322|FG001|Overall Study|Adverse Event|7|||
144181059|NCT01942135|519857321|FG000|Overall Study|Global Deterioration of Health Status|9|||
144181060|NCT01942135|519857322|FG001|Overall Study|Global Deterioration of Health Status|6|||
144423252|NCT02554812|520755989|FG025|Overall Study|Global deterioration of health status|0|||
144423253|NCT02554812|520755990|FG026|Overall Study|Global deterioration of health status|0|||
144423254|NCT02554812|520755964|FG000|Overall Study|Progressive disease|20|||
144423255|NCT02554812|520755965|FG001|Overall Study|Progressive disease|16|||
144423256|NCT02554812|520755966|FG002|Overall Study|Progressive disease|19|||
144423257|NCT02554812|520755967|FG003|Overall Study|Progressive disease|18|||
144423258|NCT02554812|520755968|FG004|Overall Study|Progressive disease|21|||
144423259|NCT02554812|520755969|FG005|Overall Study|Progressive disease|15|||
144723245|NCT05328375|521842266|FG001|Overall Study|Withdrawal by Subject|1|||
144181061|NCT01942135|519857321|FG000|Overall Study|Randomized Not Treated|2|||
144423260|NCT02554812|520755970|FG006|Overall Study|Progressive disease|6|||
144423261|NCT02554812|520755971|FG007|Overall Study|Progressive disease|13|||
144423262|NCT02554812|520755972|FG008|Overall Study|Progressive disease|6|||
144423263|NCT02554812|520755973|FG009|Overall Study|Progressive disease|6|||
144423264|NCT02554812|520755974|FG010|Overall Study|Progressive disease|8|||
144423265|NCT02554812|520755975|FG011|Overall Study|Progressive disease|8|||
144423266|NCT02554812|520755976|FG012|Overall Study|Progressive disease|6|||
144423267|NCT02554812|520755977|FG013|Overall Study|Progressive disease|10|||
144423268|NCT02554812|520755978|FG014|Overall Study|Progressive disease|20|||
144423269|NCT02554812|520755979|FG015|Overall Study|Progressive disease|6|||
144423270|NCT02554812|520755980|FG016|Overall Study|Progressive disease|3|||
144423271|NCT02554812|520755981|FG017|Overall Study|Progressive disease|3|||
144423272|NCT02554812|520755982|FG018|Overall Study|Progressive disease|11|||
144423273|NCT02554812|520755983|FG019|Overall Study|Progressive disease|7|||
144423274|NCT02554812|520755984|FG020|Overall Study|Progressive disease|11|||
144423275|NCT02554812|520755985|FG021|Overall Study|Progressive disease|6|||
144423276|NCT02554812|520755986|FG022|Overall Study|Progressive disease|9|||
144423277|NCT02554812|520755987|FG023|Overall Study|Progressive disease|9|||
144423278|NCT02554812|520755988|FG024|Overall Study|Progressive disease|4|||
144423279|NCT02554812|520755989|FG025|Overall Study|Progressive disease|5|||
144423280|NCT02554812|520755990|FG026|Overall Study|Progressive disease|5|||
144423281|NCT02554812|520755964|FG000|Overall Study|Other|0|||
144423282|NCT02554812|520755965|FG001|Overall Study|Other|0|||
144423283|NCT02554812|520755966|FG002|Overall Study|Other|2|||
144423284|NCT02554812|520755967|FG003|Overall Study|Other|3|||
144423285|NCT02554812|520755968|FG004|Overall Study|Other|2|||
144423286|NCT02554812|520755969|FG005|Overall Study|Other|1|||
144423287|NCT02554812|520755970|FG006|Overall Study|Other|0|||
144423288|NCT02554812|520755971|FG007|Overall Study|Other|0|||
144423289|NCT02554812|520755972|FG008|Overall Study|Other|1|||
144423290|NCT02554812|520755973|FG009|Overall Study|Other|1|||
144423291|NCT02554812|520755974|FG010|Overall Study|Other|0|||
144423292|NCT02554812|520755975|FG011|Overall Study|Other|0|||
144423293|NCT02554812|520755976|FG012|Overall Study|Other|1|||
144423294|NCT02554812|520755977|FG013|Overall Study|Other|0|||
144423295|NCT02554812|520755978|FG014|Overall Study|Other|1|||
144527767|NCT03252847|521135270|FG002|Overall Study|Withdrawal by Subject|1|||
144527768|NCT03252847|521135271|FG003|Overall Study|Withdrawal by Subject|0|||
144527769|NCT03252847|521135272|FG004|Overall Study|Withdrawal by Subject|0|||
144423296|NCT02554812|520755979|FG015|Overall Study|Other|0|||
144423297|NCT02554812|520755980|FG016|Overall Study|Other|0|||
144423298|NCT02554812|520755981|FG017|Overall Study|Other|0|||
144423299|NCT02554812|520755982|FG018|Overall Study|Other|0|||
144423300|NCT02554812|520755983|FG019|Overall Study|Other|0|||
144423301|NCT02554812|520755984|FG020|Overall Study|Other|0|||
144423302|NCT02554812|520755985|FG021|Overall Study|Other|2|||
144423303|NCT02554812|520755986|FG022|Overall Study|Other|0|||
144423304|NCT02554812|520755987|FG023|Overall Study|Other|0|||
144423305|NCT02554812|520755988|FG024|Overall Study|Other|0|||
144423306|NCT02554812|520755989|FG025|Overall Study|Other|0|||
144423307|NCT02554812|520755990|FG026|Overall Study|Other|0|||
144423308|NCT02554812|520755964|FG000|Overall Study|Withdrawal by Subject|1|||
144423309|NCT02554812|520755965|FG001|Overall Study|Withdrawal by Subject|0|||
144423310|NCT02554812|520755966|FG002|Overall Study|Withdrawal by Subject|0|||
144423311|NCT02554812|520755967|FG003|Overall Study|Withdrawal by Subject|2|||
144423312|NCT02554812|520755968|FG004|Overall Study|Withdrawal by Subject|2|||
144423313|NCT02554812|520755969|FG005|Overall Study|Withdrawal by Subject|3|||
144423314|NCT02554812|520755970|FG006|Overall Study|Withdrawal by Subject|0|||
144423315|NCT02554812|520755971|FG007|Overall Study|Withdrawal by Subject|0|||
144423316|NCT02554812|520755972|FG008|Overall Study|Withdrawal by Subject|1|||
144423317|NCT02554812|520755973|FG009|Overall Study|Withdrawal by Subject|1|||
144527770|NCT03252847|521135273|FG005|Overall Study|Withdrawal by Subject|0|||
144527771|NCT03252847|521135274|FG006|Overall Study|Withdrawal by Subject|0|||
144527772|NCT03252847|521135268|FG000|Overall Study|Other: Patient decision|0|||
144527773|NCT03252847|521135269|FG001|Overall Study|Other: Patient decision|0|||
144527774|NCT03252847|521135270|FG002|Overall Study|Other: Patient decision|0|||
144423318|NCT02554812|520755974|FG010|Overall Study|Withdrawal by Subject|0|||
144423319|NCT02554812|520755975|FG011|Overall Study|Withdrawal by Subject|1|||
144423320|NCT02554812|520755976|FG012|Overall Study|Withdrawal by Subject|1|||
144423321|NCT02554812|520755977|FG013|Overall Study|Withdrawal by Subject|1|||
144423322|NCT02554812|520755978|FG014|Overall Study|Withdrawal by Subject|1|||
144423323|NCT02554812|520755979|FG015|Overall Study|Withdrawal by Subject|1|||
144423324|NCT02554812|520755980|FG016|Overall Study|Withdrawal by Subject|3|||
144423325|NCT02554812|520755981|FG017|Overall Study|Withdrawal by Subject|1|||
144423326|NCT02554812|520755982|FG018|Overall Study|Withdrawal by Subject|0|||
144527775|NCT03252847|521135271|FG003|Overall Study|Other: Patient decision|0|||
144423327|NCT02554812|520755983|FG019|Overall Study|Withdrawal by Subject|2|||
144723246|NCT00278200|521842267|FG000|Overall Study|Death|1|||
144423328|NCT02554812|520755984|FG020|Overall Study|Withdrawal by Subject|0|||
144423329|NCT02554812|520755985|FG021|Overall Study|Withdrawal by Subject|1|||
144423330|NCT02554812|520755986|FG022|Overall Study|Withdrawal by Subject|0|||
144423331|NCT02554812|520755987|FG023|Overall Study|Withdrawal by Subject|1|||
144527776|NCT03252847|521135272|FG004|Overall Study|Other: Patient decision|1|||
144181062|NCT01942135|519857322|FG001|Overall Study|Randomized Not Treated|2|||
144181063|NCT01942135|519857321|FG000|Overall Study|Death|2|||
144181064|NCT01942135|519857322|FG001|Overall Study|Death|1|||
144181065|NCT01942135|519857321|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
144181066|NCT01942135|519857322|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
144181067|NCT01942135|519857321|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
144423332|NCT02554812|520755988|FG024|Overall Study|Withdrawal by Subject|0|||
144423333|NCT02554812|520755989|FG025|Overall Study|Withdrawal by Subject|0|||
144423334|NCT02554812|520755990|FG026|Overall Study|Withdrawal by Subject|1|||
144423335|NCT02554812|520755964|FG000|Overall Study|Physician Decision|1|||
144423336|NCT02554812|520755965|FG001|Overall Study|Physician Decision|0|||
144423337|NCT02554812|520755966|FG002|Overall Study|Physician Decision|0|||
144423338|NCT02554812|520755967|FG003|Overall Study|Physician Decision|1|||
144423339|NCT02554812|520755968|FG004|Overall Study|Physician Decision|0|||
144423340|NCT02554812|520755969|FG005|Overall Study|Physician Decision|1|||
144423341|NCT02554812|520755970|FG006|Overall Study|Physician Decision|0|||
144423342|NCT02554812|520755971|FG007|Overall Study|Physician Decision|0|||
144423343|NCT02554812|520755972|FG008|Overall Study|Physician Decision|0|||
144423344|NCT02554812|520755973|FG009|Overall Study|Physician Decision|0|||
144423345|NCT02554812|520755974|FG010|Overall Study|Physician Decision|1|||
144423346|NCT02554812|520755975|FG011|Overall Study|Physician Decision|0|||
144423347|NCT02554812|520755976|FG012|Overall Study|Physician Decision|0|||
144423348|NCT02554812|520755977|FG013|Overall Study|Physician Decision|0|||
144423349|NCT02554812|520755978|FG014|Overall Study|Physician Decision|0|||
144423350|NCT02554812|520755979|FG015|Overall Study|Physician Decision|0|||
144423351|NCT02554812|520755980|FG016|Overall Study|Physician Decision|1|||
144423352|NCT02554812|520755981|FG017|Overall Study|Physician Decision|1|||
144423353|NCT02554812|520755982|FG018|Overall Study|Physician Decision|0|||
144423354|NCT02554812|520755983|FG019|Overall Study|Physician Decision|1|||
144423355|NCT02554812|520755984|FG020|Overall Study|Physician Decision|1|||
144423356|NCT02554812|520755985|FG021|Overall Study|Physician Decision|0|||
144423357|NCT02554812|520755986|FG022|Overall Study|Physician Decision|1|||
144423358|NCT02554812|520755987|FG023|Overall Study|Physician Decision|0|||
144423359|NCT02554812|520755988|FG024|Overall Study|Physician Decision|0|||
144423360|NCT02554812|520755989|FG025|Overall Study|Physician Decision|0|||
144423361|NCT02554812|520755990|FG026|Overall Study|Physician Decision|0|||
144423362|NCT02554812|520755964|FG000|Overall Study|Study terminated by sponsor|0|||
144423363|NCT02554812|520755965|FG001|Overall Study|Study terminated by sponsor|0|||
144423364|NCT02554812|520755966|FG002|Overall Study|Study terminated by sponsor|0|||
144423365|NCT02554812|520755967|FG003|Overall Study|Study terminated by sponsor|0|||
144423366|NCT02554812|520755968|FG004|Overall Study|Study terminated by sponsor|0|||
144423367|NCT02554812|520755969|FG005|Overall Study|Study terminated by sponsor|0|||
144423368|NCT02554812|520755970|FG006|Overall Study|Study terminated by sponsor|0|||
144423369|NCT02554812|520755971|FG007|Overall Study|Study terminated by sponsor|0|||
144423370|NCT02554812|520755972|FG008|Overall Study|Study terminated by sponsor|0|||
144423371|NCT02554812|520755973|FG009|Overall Study|Study terminated by sponsor|0|||
144423372|NCT02554812|520755974|FG010|Overall Study|Study terminated by sponsor|0|||
144423373|NCT02554812|520755975|FG011|Overall Study|Study terminated by sponsor|0|||
144423374|NCT02554812|520755976|FG012|Overall Study|Study terminated by sponsor|0|||
144423375|NCT02554812|520755977|FG013|Overall Study|Study terminated by sponsor|0|||
144423376|NCT02554812|520755978|FG014|Overall Study|Study terminated by sponsor|0|||
144423377|NCT02554812|520755979|FG015|Overall Study|Study terminated by sponsor|0|||
144423378|NCT02554812|520755980|FG016|Overall Study|Study terminated by sponsor|0|||
144423379|NCT02554812|520755981|FG017|Overall Study|Study terminated by sponsor|0|||
144423380|NCT02554812|520755982|FG018|Overall Study|Study terminated by sponsor|0|||
144423381|NCT02554812|520755983|FG019|Overall Study|Study terminated by sponsor|0|||
144423382|NCT02554812|520755984|FG020|Overall Study|Study terminated by sponsor|0|||
144423383|NCT02554812|520755985|FG021|Overall Study|Study terminated by sponsor|0|||
144423384|NCT02554812|520755986|FG022|Overall Study|Study terminated by sponsor|0|||
144423385|NCT02554812|520755987|FG023|Overall Study|Study terminated by sponsor|0|||
144423386|NCT02554812|520755988|FG024|Overall Study|Study terminated by sponsor|1|||
144423387|NCT02554812|520755989|FG025|Overall Study|Study terminated by sponsor|0|||
144423388|NCT02554812|520755990|FG026|Overall Study|Study terminated by sponsor|0|||
144723247|NCT00278200|521842268|FG001|Overall Study|Death|3|||
144723248|NCT00278200|521842267|FG000|Overall Study|Physician Decision|0|||
144181068|NCT01942135|519857322|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
144423389|NCT02554812|520755964|FG000|Overall Study|No longer meets eligibility criteria|0|||
144423390|NCT02554812|520755965|FG001|Overall Study|No longer meets eligibility criteria|1|||
144423391|NCT02554812|520755966|FG002|Overall Study|No longer meets eligibility criteria|0|||
144423392|NCT02554812|520755967|FG003|Overall Study|No longer meets eligibility criteria|0|||
144423393|NCT02554812|520755968|FG004|Overall Study|No longer meets eligibility criteria|0|||
144423394|NCT02554812|520755969|FG005|Overall Study|No longer meets eligibility criteria|0|||
144423395|NCT02554812|520755970|FG006|Overall Study|No longer meets eligibility criteria|0|||
144423396|NCT02554812|520755971|FG007|Overall Study|No longer meets eligibility criteria|0|||
144423397|NCT02554812|520755972|FG008|Overall Study|No longer meets eligibility criteria|0|||
144423398|NCT02554812|520755973|FG009|Overall Study|No longer meets eligibility criteria|0|||
144423399|NCT02554812|520755974|FG010|Overall Study|No longer meets eligibility criteria|0|||
144423400|NCT02554812|520755975|FG011|Overall Study|No longer meets eligibility criteria|0|||
144423401|NCT02554812|520755976|FG012|Overall Study|No longer meets eligibility criteria|0|||
144423402|NCT02554812|520755977|FG013|Overall Study|No longer meets eligibility criteria|0|||
144423403|NCT02554812|520755978|FG014|Overall Study|No longer meets eligibility criteria|0|||
144423404|NCT02554812|520755979|FG015|Overall Study|No longer meets eligibility criteria|0|||
144423405|NCT02554812|520755980|FG016|Overall Study|No longer meets eligibility criteria|0|||
144423406|NCT02554812|520755981|FG017|Overall Study|No longer meets eligibility criteria|0|||
144423407|NCT02554812|520755982|FG018|Overall Study|No longer meets eligibility criteria|0|||
144423408|NCT02554812|520755983|FG019|Overall Study|No longer meets eligibility criteria|0|||
144423409|NCT02554812|520755984|FG020|Overall Study|No longer meets eligibility criteria|0|||
144423410|NCT02554812|520755985|FG021|Overall Study|No longer meets eligibility criteria|0|||
144423411|NCT02554812|520755986|FG022|Overall Study|No longer meets eligibility criteria|0|||
144423412|NCT02554812|520755987|FG023|Overall Study|No longer meets eligibility criteria|0|||
144423413|NCT02554812|520755988|FG024|Overall Study|No longer meets eligibility criteria|0|||
144423414|NCT02554812|520755989|FG025|Overall Study|No longer meets eligibility criteria|0|||
144423415|NCT02554812|520755990|FG026|Overall Study|No longer meets eligibility criteria|0|||
144423416|NCT00587561|520757944|FG000|Overall Study|Lost to Follow-up|6|||
144423417|NCT00587561|520757945|FG001|Overall Study|Lost to Follow-up|4|||
144423418|NCT03204981|520757947|FG000|Overall Study|Physician Decision|2|||
144423419|NCT03204981|520757947|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
144423420|NCT04244786|520757948|FG000|Overall Study|Adverse Event|0|||
144423421|NCT04244786|520757949|FG001|Overall Study|Adverse Event|0|||
144423422|NCT04244786|520757950|FG002|Overall Study|Adverse Event|2|||
144423423|NCT04244786|520757948|FG000|Overall Study|Withdrawal by Subject|0|||
144423424|NCT04244786|520757949|FG001|Overall Study|Withdrawal by Subject|0|||
144423425|NCT04244786|520757950|FG002|Overall Study|Withdrawal by Subject|5|||
144423426|NCT03274687|520757951|FG000|Overall Study|Protocol Violation|1|||
144423427|NCT03274687|520757952|FG001|Overall Study|Protocol Violation|1|||
144423428|NCT00613938|520757953|FG000|Overall Study|Withdrawal by Subject|2|||
144423429|NCT00613938|520757954|FG001|Overall Study|Withdrawal by Subject|4|||
144423430|NCT00613938|520757955|FG002|Overall Study|Withdrawal by Subject|9|||
144423431|NCT00613938|520757956|FG003|Overall Study|Withdrawal by Subject|9|||
144423432|NCT00613938|520757953|FG000|Overall Study|Adverse Event|1|||
144423433|NCT00613938|520757954|FG001|Overall Study|Adverse Event|4|||
144423434|NCT00613938|520757955|FG002|Overall Study|Adverse Event|8|||
144423435|NCT00613938|520757956|FG003|Overall Study|Adverse Event|5|||
144423436|NCT00613938|520757953|FG000|Overall Study|Lack of Efficacy|16|||
144423437|NCT00613938|520757954|FG001|Overall Study|Lack of Efficacy|18|||
144423438|NCT00613938|520757955|FG002|Overall Study|Lack of Efficacy|5|||
144423439|NCT00613938|520757956|FG003|Overall Study|Lack of Efficacy|9|||
144423440|NCT00613938|520757953|FG000|Overall Study|Other|1|||
144423441|NCT00613938|520757954|FG001|Overall Study|Other|2|||
144423442|NCT00613938|520757955|FG002|Overall Study|Other|1|||
144423443|NCT00613938|520757956|FG003|Overall Study|Other|3|||
144423444|NCT00623727|520757957|FG000|Double Blind (DB)|Adverse Event|1|||
144423445|NCT00623727|520757958|FG001|Double Blind (DB)|Adverse Event|3|||
144423446|NCT00623727|520757957|FG000|Double Blind (DB)|Physician Decision|0|||
144423447|NCT00623727|520757958|FG001|Double Blind (DB)|Physician Decision|1|||
144423448|NCT00623727|520757957|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
144423449|NCT00623727|520757958|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
144423450|NCT00623727|520757957|FG000|Double Blind (DB)|Lack of Efficacy|2|||
144423451|NCT00623727|520757958|FG001|Double Blind (DB)|Lack of Efficacy|2|||
144423452|NCT00623727|520757957|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
144423453|NCT00623727|520757958|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
144423454|NCT00623727|520757957|FG000|Double Blind (DB)|Lost to Follow-up|1|||
144423455|NCT00623727|520757958|FG001|Double Blind (DB)|Lost to Follow-up|1|||
144423456|NCT00623727|520757957|FG000|Double Blind (DB)|Protocol Violation|2|||
144423457|NCT00623727|520757958|FG001|Double Blind (DB)|Protocol Violation|2|||
144423458|NCT00623727|520757957|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
144423459|NCT00623727|520757958|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
144423460|NCT00623727|520757957|FG000|Open Label Follow-up|Study termination|0|||
144423461|NCT00623727|520757958|FG001|Open Label Follow-up|Study termination|6|||
144423462|NCT00623727|520757957|FG000|Open Label Follow-up|Participant convenience|0|||
144423463|NCT00623727|520757958|FG001|Open Label Follow-up|Participant convenience|1|||
144423464|NCT03745937|520757959|FG000|Overall Study|Withdrawal by Subject|0|||
144423465|NCT03745937|520757960|FG001|Overall Study|Withdrawal by Subject|0|||
144423466|NCT03745937|520757961|FG002|Overall Study|Withdrawal by Subject|0|||
144423467|NCT03745937|520757962|FG003|Overall Study|Withdrawal by Subject|1|||
144423468|NCT03745937|520757959|FG000|Overall Study|Not-specifed|0|||
144423469|NCT03745937|520757960|FG001|Overall Study|Not-specifed|1|||
144423470|NCT03745937|520757961|FG002|Overall Study|Not-specifed|0|||
144423471|NCT03745937|520757962|FG003|Overall Study|Not-specifed|1|||
144423472|NCT01706003|520757968|FG000|Overall Study|Withdrawal by Subject|2|||
144423473|NCT01706003|520757969|FG001|Overall Study|Withdrawal by Subject|0|||
144423474|NCT01706003|520757968|FG000|Overall Study|Not scheduled|3|||
144423475|NCT01706003|520757969|FG001|Overall Study|Not scheduled|0|||
144423476|NCT01706003|520757968|FG000|Overall Study|Lost to Follow-up|6|||
144423477|NCT01706003|520757969|FG001|Overall Study|Lost to Follow-up|4|||
144423478|NCT00696696|520757972|FG000|Overall Study|Adverse Event|5|||
144423479|NCT00696696|520757972|FG000|Overall Study|Withdrawal by Subject|8|||
144423480|NCT00696696|520757972|FG000|Overall Study|Physician Decision|2|||
144423481|NCT00696696|520757972|FG000|Overall Study|Death|3|||
144423482|NCT02642614|520757973|FG000|Overall Study|Adverse Event|1|||
144423483|NCT02642614|520757974|FG001|Overall Study|Adverse Event|1|||
144423484|NCT02642614|520757975|FG002|Overall Study|Adverse Event|2|||
144423485|NCT02642614|520757976|FG003|Overall Study|Adverse Event|2|||
144423486|NCT02642614|520757973|FG000|Overall Study|Lost to Follow-up|1|||
144423487|NCT02642614|520757974|FG001|Overall Study|Lost to Follow-up|0|||
144423488|NCT02642614|520757975|FG002|Overall Study|Lost to Follow-up|0|||
144423489|NCT02642614|520757976|FG003|Overall Study|Lost to Follow-up|0|||
144423490|NCT02642614|520757973|FG000|Overall Study|Withdrawal by Subject|1|||
144423491|NCT02642614|520757974|FG001|Overall Study|Withdrawal by Subject|1|||
144423492|NCT02642614|520757975|FG002|Overall Study|Withdrawal by Subject|0|||
144423493|NCT02642614|520757976|FG003|Overall Study|Withdrawal by Subject|0|||
144423494|NCT03182829|520757977|FG000|Overall Study|Protocol Violation|12|||
144423495|NCT03182829|520757978|FG001|Overall Study|Protocol Violation|12|||
144423496|NCT03182829|520757977|FG000|Overall Study|Other|4|||
144423497|NCT03182829|520757978|FG001|Overall Study|Other|3|||
144423498|NCT03316131|520757979|FG000|Treatment Period 2|Protocol deviation|1|||
144423499|NCT03316131|520757980|FG001|Treatment Period 2|Protocol deviation|0|||
144423500|NCT05608005|520757982|FG000|Overall Study|Adverse Event|2|||
144423501|NCT05608005|520757983|FG001|Overall Study|Adverse Event|1|||
144423502|NCT05608005|520757984|FG002|Overall Study|Adverse Event|3|||
144423503|NCT05608005|520757982|FG000|Overall Study|Protocol Violation|2|||
144423504|NCT05608005|520757983|FG001|Overall Study|Protocol Violation|3|||
144423505|NCT05608005|520757984|FG002|Overall Study|Protocol Violation|0|||
144423506|NCT05608005|520757982|FG000|Overall Study|Withdrawal by Subject|10|||
144423507|NCT05608005|520757983|FG001|Overall Study|Withdrawal by Subject|12|||
144423508|NCT05608005|520757984|FG002|Overall Study|Withdrawal by Subject|4|||
144423509|NCT05608005|520757982|FG000|Overall Study|Lost to Follow-up|25|||
144423510|NCT05608005|520757983|FG001|Overall Study|Lost to Follow-up|27|||
144423511|NCT05608005|520757984|FG002|Overall Study|Lost to Follow-up|15|||
144423512|NCT05608005|520757982|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
144423513|NCT05608005|520757983|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
144423514|NCT05608005|520757984|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
144423515|NCT00936910|520757987|FG000|Overall Study|Lack of Efficacy|3|||
144423516|NCT01485640|520757988|FG000|Overall Study|Adverse Event|10|||
144423517|NCT01485640|520757988|FG000|Overall Study|Lack of Efficacy|2|||
144423518|NCT01485640|520757988|FG000|Overall Study|Protocol Violation|1|||
144423519|NCT01485640|520757988|FG000|Overall Study|Withdrawal by Subject|14|||
144423520|NCT01485640|520757988|FG000|Overall Study|Terminated by Sponsor|95|||
144423521|NCT01585428|520757992|FG000|Overall Study|Death during treatment|1|||
144423522|NCT01585428|520757993|FG001|Overall Study|Death during treatment|0|||
144423523|NCT02057198|520757994|FG000|Overall Study|Death|0|||
144423524|NCT02057198|520757995|FG001|Overall Study|Death|0|||
144423525|NCT02057198|520757996|FG002|Overall Study|Death|1|||
144423526|NCT02057198|520757994|FG000|Overall Study|Discharged early; lost to followup|0|||
144423527|NCT02057198|520757995|FG001|Overall Study|Discharged early; lost to followup|1|||
144423528|NCT02057198|520757996|FG002|Overall Study|Discharged early; lost to followup|0|||
144423529|NCT02355691|520757999|FG000|Overall Study|Loss of Research Personnel|7|||
144423530|NCT02355691|520758000|FG001|Overall Study|Loss of Research Personnel|9|||
144423531|NCT02345811|520758003|FG000|First Intervention|Withdrawal by Subject|1|||
144423532|NCT02345811|520758004|FG001|First Intervention|Withdrawal by Subject|1|||
144181069|NCT01942135|519857321|FG000|Overall Study|Withdrawal by Subject|4|||
144181070|NCT01942135|519857322|FG001|Overall Study|Withdrawal by Subject|3|||
144181071|NCT01942135|519857321|FG000|Overall Study|Protocol Violation|1|||
144181072|NCT01942135|519857322|FG001|Overall Study|Protocol Violation|0|||
144423533|NCT02522286|520758005|FG000|Overall Study|Withdrawal by Subject|3|||
144423534|NCT02522286|520758006|FG001|Overall Study|Withdrawal by Subject|0|||
144423535|NCT02522286|520758007|FG002|Overall Study|Withdrawal by Subject|0|||
144423536|NCT02522286|520758008|FG003|Overall Study|Withdrawal by Subject|3|||
144423537|NCT02489344|520758010|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
144423538|NCT02489344|520758010|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
144423539|NCT02489344|520758010|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
144423540|NCT02489344|520758010|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
144423541|NCT00605813|520758011|FG000|Overall Study|Protocol Violation|25|||
144423542|NCT03683758|520758014|FG000|Overall Study|Non-study commitment conflict|1|||
144423543|NCT03683758|520758015|FG001|Overall Study|Non-study commitment conflict|3|||
144423544|NCT03683758|520758014|FG000|Overall Study|Illness preventing participation|1|||
144423545|NCT03683758|520758015|FG001|Overall Study|Illness preventing participation|0|||
144423546|NCT03683758|520758014|FG000|Overall Study|Adverse Event|1|||
144423547|NCT03683758|520758015|FG001|Overall Study|Adverse Event|0|||
144423548|NCT01172847|520758018|FG000|Overall Study|Withdrawal by Subject|3|||
144423549|NCT02411292|520758020|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
144423550|NCT02411292|520758020|FG000|Overall Study|Death|2|||
144423551|NCT02411292|520758020|FG000|Overall Study|Lost to Follow-up|3|||
144423552|NCT00453921|520758021|FG000|Overall Study|Withdrawal by Subject|1|||
144423553|NCT00453921|520758022|FG001|Overall Study|Withdrawal by Subject|1|||
144423554|NCT00453921|520758023|FG002|Overall Study|Withdrawal by Subject|1|||
144423555|NCT00453921|520758024|FG003|Overall Study|Withdrawal by Subject|1|||
144423556|NCT00453921|520758021|FG000|Overall Study|Lost to Follow-up|0|||
144423557|NCT00453921|520758022|FG001|Overall Study|Lost to Follow-up|0|||
144181073|NCT01942135|519857321|FG000|Overall Study|Other|19|||
144181074|NCT01942135|519857322|FG001|Overall Study|Other|4|||
144527777|NCT03252847|521135273|FG005|Overall Study|Other: Patient decision|0|||
144527778|NCT03252847|521135274|FG006|Overall Study|Other: Patient decision|0|||
144527779|NCT04979442|521135277|FG000|Overall Study|Death|43|||
144527780|NCT04979442|521135278|FG001|Overall Study|Death|30|||
144527781|NCT04979442|521135277|FG000|Overall Study|Withdrawal by Subject|8|||
144527782|NCT04979442|521135278|FG001|Overall Study|Withdrawal by Subject|13|||
144527783|NCT04979442|521135277|FG000|Overall Study|Physician Decision|1|||
144527784|NCT04979442|521135278|FG001|Overall Study|Physician Decision|1|||
144527785|NCT04979442|521135277|FG000|Overall Study|Lost to Follow-up|0|||
144527786|NCT04979442|521135278|FG001|Overall Study|Lost to Follow-up|2|||
144527787|NCT04979442|521135277|FG000|Overall Study|do not want to continue|0|||
144527788|NCT04979442|521135278|FG001|Overall Study|do not want to continue|1|||
144527789|NCT04298983|521135283|FG000|Overall Study|Adverse Event|4|||
144527790|NCT04298983|521135283|FG000|Overall Study|Lack of Efficacy|3|||
144527791|NCT04005794|521135284|FG000|Overall Study|Lost to Follow-up|0|||
144527792|NCT04005794|521135285|FG001|Overall Study|Lost to Follow-up|4|||
144527793|NCT04005794|521135286|FG002|Overall Study|Lost to Follow-up|0|||
144527794|NCT05877976|521135287|FG000|Overall Study|Lost to Follow-up|31|||
144527795|NCT04042233|521135289|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
144527796|NCT04042233|521135290|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
144527797|NCT04042233|521135289|FG000|Overall Study|Protocol Violation|0|||
144527798|NCT04042233|521135290|FG001|Overall Study|Protocol Violation|2|||
144527799|NCT04907851|521135293|FG000|Overall Study|Consent withdrawn|1|||
144527800|NCT04907851|521135294|FG001|Overall Study|Consent withdrawn|2|||
144527801|NCT04907851|521135295|FG002|Overall Study|Consent withdrawn|0|||
144527802|NCT04907851|521135293|FG000|Overall Study|Death|5|||
144527803|NCT04907851|521135294|FG001|Overall Study|Death|15|||
144527804|NCT04907851|521135295|FG002|Overall Study|Death|10|||
144527805|NCT03656510|521135309|FG000|Overall Study|Lost to Follow-up|1|||
144527806|NCT03656510|521135310|FG001|Overall Study|Lost to Follow-up|0|||
144527807|NCT03656510|521135311|FG002|Overall Study|Lost to Follow-up|0|||
144527808|NCT03656510|521135312|FG003|Overall Study|Lost to Follow-up|0|||
144527809|NCT03656510|521135313|FG004|Overall Study|Lost to Follow-up|0|||
144527810|NCT03656510|521135314|FG005|Overall Study|Lost to Follow-up|0|||
144527811|NCT03656510|521135309|FG000|Overall Study|Withdrawal by Subject|1|||
144527812|NCT03656510|521135310|FG001|Overall Study|Withdrawal by Subject|1|||
144527813|NCT03656510|521135311|FG002|Overall Study|Withdrawal by Subject|0|||
144527814|NCT03656510|521135312|FG003|Overall Study|Withdrawal by Subject|1|||
144527815|NCT03656510|521135313|FG004|Overall Study|Withdrawal by Subject|0|||
144527816|NCT03656510|521135314|FG005|Overall Study|Withdrawal by Subject|0|||
144527817|NCT05297565|521135317|FG000|Overall Study|Other Reasons|0|||
144527818|NCT05297565|521135318|FG001|Overall Study|Other Reasons|1|||
144527819|NCT05297565|521135317|FG000|Overall Study|Physician Decision|0|||
144527820|NCT05297565|521135318|FG001|Overall Study|Physician Decision|1|||
144527821|NCT05297565|521135317|FG000|Overall Study|Disease recurrence|1|||
144527822|NCT05297565|521135318|FG001|Overall Study|Disease recurrence|0|||
144527823|NCT03819153|521135323|FG000|Overall Study|Withdrawal by Subject|20|||
144527824|NCT03819153|521135324|FG001|Overall Study|Withdrawal by Subject|28|||
144527825|NCT03819153|521135323|FG000|Overall Study|Lost to Follow-up|23|||
144527826|NCT03819153|521135324|FG001|Overall Study|Lost to Follow-up|30|||
144527827|NCT05546411|521135326|FG000|Overall Study|Progressive Disease|1|||
144527828|NCT05546411|521135327|FG001|Overall Study|Progressive Disease|0|||
144527829|NCT05546411|521135326|FG000|Overall Study|Adverse Event|0|||
144527830|NCT05546411|521135327|FG001|Overall Study|Adverse Event|1|||
144181075|NCT01717040|519857323|FG000|Overall Study|Lost to Follow-up|2|||
144423558|NCT00453921|520758023|FG002|Overall Study|Lost to Follow-up|1|||
144527831|NCT05546411|521135326|FG000|Overall Study|Metastatic disease|1|||
144527832|NCT05546411|521135327|FG001|Overall Study|Metastatic disease|0|||
144527833|NCT03235544|521135328|FG000|Overall Study|Death|11|||
144527834|NCT03235544|521135329|FG001|Overall Study|Death|31|||
144527835|NCT03235544|521135330|FG002|Overall Study|Death|19|||
144527836|NCT03235544|521135331|FG003|Overall Study|Death|34|||
144527837|NCT03235544|521135328|FG000|Overall Study|Lost to Follow-up|0|||
144423559|NCT00453921|520758024|FG003|Overall Study|Lost to Follow-up|0|||
144423560|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
144423561|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
144423562|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
144423563|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
144423564|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
144423565|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
144423566|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
144423567|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
144423568|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Other|4|||
144423569|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Other|1|||
144423570|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
144423571|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
144423572|NCT00303498|520758025|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
144423573|NCT00303498|520758026|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
144423574|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
144423575|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
144423576|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Death|1|||
144423577|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Death|0|||
144423578|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
144423579|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
144423580|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
144423581|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
144423582|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
144423583|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
144423584|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
144527838|NCT03235544|521135329|FG001|Overall Study|Lost to Follow-up|1|||
144527839|NCT03235544|521135330|FG002|Overall Study|Lost to Follow-up|1|||
144527840|NCT03235544|521135331|FG003|Overall Study|Lost to Follow-up|1|||
144527841|NCT03235544|521135328|FG000|Overall Study|Withdrawal by Subject|0|||
144527842|NCT03235544|521135329|FG001|Overall Study|Withdrawal by Subject|3|||
144527843|NCT03235544|521135330|FG002|Overall Study|Withdrawal by Subject|1|||
144527844|NCT03235544|521135331|FG003|Overall Study|Withdrawal by Subject|5|||
144527845|NCT03235544|521135328|FG000|Overall Study|Disease Progression|0|||
144527846|NCT03235544|521135329|FG001|Overall Study|Disease Progression|1|||
144527847|NCT03235544|521135330|FG002|Overall Study|Disease Progression|0|||
144527848|NCT03235544|521135331|FG003|Overall Study|Disease Progression|2|||
144527849|NCT03235544|521135328|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
144527850|NCT03235544|521135329|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
144723249|NCT00278200|521842268|FG001|Overall Study|Physician Decision|1|||
144723250|NCT01290263|521842269|FG000|Overall Study|Adverse Event|0|||
144723251|NCT01290263|521842270|FG001|Overall Study|Adverse Event|0|||
144423585|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
144423586|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Other|1|||
144527851|NCT03235544|521135330|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
144527852|NCT03235544|521135331|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
144527853|NCT03235544|521135328|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
144527854|NCT03235544|521135329|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
144527855|NCT03235544|521135330|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
144527856|NCT03235544|521135331|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
144527857|NCT00950742|521135332|FG000|Overall Study|Other Adverse Event|1|||
144527858|NCT00950742|521135333|FG001|Overall Study|Other Adverse Event|0|||
144527859|NCT00950742|521135332|FG000|Overall Study|Withdrawal by Subject|3|||
144527860|NCT00950742|521135333|FG001|Overall Study|Withdrawal by Subject|0|||
144527861|NCT00950742|521135332|FG000|Overall Study|Progressive Disease|6|||
144527862|NCT00950742|521135333|FG001|Overall Study|Progressive Disease|2|||
144527863|NCT00950742|521135332|FG000|Overall Study|Dose limiting toxicity|6|||
144527864|NCT00950742|521135333|FG001|Overall Study|Dose limiting toxicity|0|||
144527865|NCT05436262|521135334|FG000|Pre-Randomization|Withdrawal by Subject|1|||
144527866|NCT05436262|521135335|FG001|Pre-Randomization|Withdrawal by Subject|0|||
144527867|NCT05436262|521135336|FG002|Pre-Randomization|Withdrawal by Subject|0|||
144527868|NCT05436262|521135334|FG000|Randomization|Withdrawal by Subject|0|||
144527869|NCT05436262|521135335|FG001|Randomization|Withdrawal by Subject|1|||
144527870|NCT05436262|521135336|FG002|Randomization|Withdrawal by Subject|0|||
144527871|NCT03599661|521135338|FG000|Overall Study|Lost to Follow-up|9|||
144181076|NCT01717040|519857324|FG001|Overall Study|Lost to Follow-up|3|||
144181077|NCT01717040|519857323|FG000|Overall Study|Lack of Efficacy|1|||
144423587|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Other|0|||
144423588|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
144423589|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
144527872|NCT03511664|521135341|FG000|Overall Study|Death|457|||
144527873|NCT03511664|521135342|FG001|Overall Study|Death|201|||
144181078|NCT01717040|519857324|FG001|Overall Study|Lack of Efficacy|1|||
144181079|NCT01717040|519857323|FG000|Overall Study|Adverse Event|1|||
144181080|NCT01717040|519857324|FG001|Overall Study|Adverse Event|0|||
144181081|NCT01717040|519857323|FG000|Overall Study|Required Medication Change|0|||
144423590|NCT00303498|520758025|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
144423591|NCT00303498|520758026|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
144423592|NCT00174915|520758029|FG000|Overall Study|Lost to Follow-up|19|||
144423593|NCT00174915|520758030|FG001|Overall Study|Lost to Follow-up|17|||
144423594|NCT00174915|520758031|FG002|Overall Study|Lost to Follow-up|9|||
144423595|NCT00174915|520758032|FG003|Overall Study|Lost to Follow-up|17|||
144423596|NCT00174915|520758033|FG004|Overall Study|Lost to Follow-up|10|||
144423597|NCT00174915|520758029|FG000|Overall Study|Adverse Event|18|||
144423598|NCT00174915|520758030|FG001|Overall Study|Adverse Event|16|||
144423599|NCT00174915|520758031|FG002|Overall Study|Adverse Event|11|||
144423600|NCT00174915|520758032|FG003|Overall Study|Adverse Event|18|||
144527874|NCT03511664|521135343|FG002|Overall Study|Death|21|||
144527875|NCT03511664|521135341|FG000|Overall Study|Withdrew consent|40|||
144527876|NCT03511664|521135342|FG001|Overall Study|Withdrew consent|63|||
144527877|NCT03511664|521135343|FG002|Overall Study|Withdrew consent|3|||
144527878|NCT03511664|521135341|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
144527879|NCT03511664|521135342|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
144527880|NCT03511664|521135343|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
144527881|NCT03511664|521135341|FG000|Overall Study|Lost to Follow-up|8|||
144527882|NCT03511664|521135342|FG001|Overall Study|Lost to Follow-up|5|||
144527883|NCT03511664|521135343|FG002|Overall Study|Lost to Follow-up|0|||
144527884|NCT03511664|521135341|FG000|Overall Study|Physician Decision|2|||
144527885|NCT03511664|521135342|FG001|Overall Study|Physician Decision|1|||
144527886|NCT03511664|521135343|FG002|Overall Study|Physician Decision|0|||
144527887|NCT03511664|521135341|FG000|Overall Study|Patient non-compliance|1|||
144527888|NCT03511664|521135342|FG001|Overall Study|Patient non-compliance|0|||
144527889|NCT03511664|521135343|FG002|Overall Study|Patient non-compliance|0|||
144527890|NCT01946789|521135344|FG000|Overall Study|Death|0|||
144527891|NCT01946789|521135345|FG001|Overall Study|Death|2|||
144527892|NCT01946789|521135346|FG002|Overall Study|Death|1|||
144527893|NCT01946789|521135347|FG003|Overall Study|Death|1|||
144527894|NCT01946789|521135348|FG004|Overall Study|Death|1|||
144527895|NCT01946789|521135349|FG005|Overall Study|Death|1|||
144527896|NCT01946789|521135350|FG006|Overall Study|Death|3|||
144527897|NCT01946789|521135351|FG007|Overall Study|Death|1|||
144527898|NCT01946789|521135352|FG008|Overall Study|Death|2|||
144527899|NCT01946789|521135344|FG000|Overall Study|Progressive Disease|0|||
144527900|NCT01946789|521135345|FG001|Overall Study|Progressive Disease|0|||
144527901|NCT01946789|521135346|FG002|Overall Study|Progressive Disease|1|||
144527902|NCT01946789|521135347|FG003|Overall Study|Progressive Disease|0|||
144527903|NCT01946789|521135348|FG004|Overall Study|Progressive Disease|0|||
144527904|NCT01946789|521135349|FG005|Overall Study|Progressive Disease|2|||
144527905|NCT01946789|521135350|FG006|Overall Study|Progressive Disease|0|||
144527906|NCT01946789|521135351|FG007|Overall Study|Progressive Disease|0|||
144527907|NCT01946789|521135352|FG008|Overall Study|Progressive Disease|0|||
144527908|NCT01946789|521135344|FG000|Overall Study|Withdrawal by Subject|0|||
144527909|NCT01946789|521135345|FG001|Overall Study|Withdrawal by Subject|0|||
144527910|NCT01946789|521135346|FG002|Overall Study|Withdrawal by Subject|0|||
144527911|NCT01946789|521135347|FG003|Overall Study|Withdrawal by Subject|2|||
144527912|NCT01946789|521135348|FG004|Overall Study|Withdrawal by Subject|1|||
144527913|NCT01946789|521135349|FG005|Overall Study|Withdrawal by Subject|0|||
144527914|NCT01946789|521135350|FG006|Overall Study|Withdrawal by Subject|1|||
144527915|NCT01946789|521135351|FG007|Overall Study|Withdrawal by Subject|0|||
144527916|NCT01946789|521135352|FG008|Overall Study|Withdrawal by Subject|0|||
144527917|NCT05374798|521135371|FG000|Overall Study|Lost to Follow-up|2|||
144527918|NCT05374798|521135371|FG000|Overall Study|Withdrawal by Subject|2|||
144527919|NCT05374798|521135371|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
144527920|NCT04707625|521135372|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
144527921|NCT03334630|521135373|FG000|Overall Study|Withdrawal by Subject|7|||
144527922|NCT03334630|521135374|FG001|Overall Study|Withdrawal by Subject|7|||
144527923|NCT03334630|521135373|FG000|Overall Study|Lost to Follow-up|3|||
144181082|NCT01717040|519857324|FG001|Overall Study|Required Medication Change|1|||
144181083|NCT01717040|519857323|FG000|Overall Study|New Substance Use Disorder|1|||
144423601|NCT00174915|520758033|FG004|Overall Study|Adverse Event|5|||
144423602|NCT00174915|520758029|FG000|Overall Study|Personal Reason(s)|16|||
144423603|NCT00174915|520758030|FG001|Overall Study|Personal Reason(s)|16|||
144527924|NCT03334630|521135374|FG001|Overall Study|Lost to Follow-up|1|||
144527925|NCT03334630|521135373|FG000|Overall Study|Adverse Event|0|||
144527926|NCT03334630|521135374|FG001|Overall Study|Adverse Event|1|||
144527927|NCT03334630|521135373|FG000|Overall Study|Physician Decision|1|||
144527928|NCT03334630|521135374|FG001|Overall Study|Physician Decision|1|||
144527929|NCT03334630|521135373|FG000|Overall Study|Enrollment closed|2|||
144527930|NCT03334630|521135374|FG001|Overall Study|Enrollment closed|1|||
144538358|NCT00609869|521174169|FG000|Overall Study|Withdrawal by Subject|1|||
144527931|NCT03334630|521135373|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
144527932|NCT03334630|521135374|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
144527933|NCT03334630|521135373|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
144527934|NCT03334630|521135374|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
144527935|NCT04498390|521135377|FG000|Overall Study|Adverse Event|0|||
144181084|NCT01717040|519857324|FG001|Overall Study|New Substance Use Disorder|0|||
144181085|NCT00494013|519857325|FG000|Overall Study|Adverse Event|0|||
144181086|NCT00494013|519857326|FG001|Overall Study|Adverse Event|1|||
144181087|NCT00494013|519857325|FG000|Overall Study|Entry Criteria Not Met|1|||
144181088|NCT00494013|519857326|FG001|Overall Study|Entry Criteria Not Met|4|||
144181089|NCT00494013|519857325|FG000|Overall Study|Lost to Follow-up|5|||
144181090|NCT00494013|519857326|FG001|Overall Study|Lost to Follow-up|6|||
144181091|NCT00494013|519857325|FG000|Overall Study|Physician Decision|3|||
144181092|NCT00494013|519857326|FG001|Overall Study|Physician Decision|5|||
144181093|NCT00494013|519857325|FG000|Overall Study|Protocol Violation|8|||
144181094|NCT00494013|519857326|FG001|Overall Study|Protocol Violation|5|||
144181095|NCT00494013|519857325|FG000|Overall Study|Withdrawal by Subject|13|||
144423604|NCT00174915|520758031|FG002|Overall Study|Personal Reason(s)|9|||
144423605|NCT00174915|520758032|FG003|Overall Study|Personal Reason(s)|9|||
144423606|NCT00174915|520758033|FG004|Overall Study|Personal Reason(s)|9|||
144423607|NCT00174915|520758029|FG000|Overall Study|Other|15|||
144423608|NCT00174915|520758030|FG001|Overall Study|Other|8|||
144423609|NCT00174915|520758031|FG002|Overall Study|Other|6|||
144423610|NCT00174915|520758032|FG003|Overall Study|Other|5|||
144423611|NCT00174915|520758033|FG004|Overall Study|Other|3|||
144423612|NCT00174915|520758029|FG000|Overall Study|Gout Flare|13|||
144423613|NCT00174915|520758030|FG001|Overall Study|Gout Flare|6|||
144181096|NCT00494013|519857326|FG001|Overall Study|Withdrawal by Subject|14|||
144181097|NCT00494013|519857325|FG000|Overall Study|Sponsor Decision|0|||
144181098|NCT00494013|519857326|FG001|Overall Study|Sponsor Decision|1|||
144181099|NCT04194151|519857327|FG000|Overall Study|Physician Decision|1|||
144423614|NCT00174915|520758031|FG002|Overall Study|Gout Flare|8|||
144423615|NCT00174915|520758032|FG003|Overall Study|Gout Flare|1|||
144423616|NCT00174915|520758033|FG004|Overall Study|Gout Flare|0|||
144423617|NCT00174915|520758029|FG000|Overall Study|Protocol Violation|6|||
144423618|NCT00174915|520758030|FG001|Overall Study|Protocol Violation|3|||
144423619|NCT00174915|520758031|FG002|Overall Study|Protocol Violation|3|||
144423620|NCT00174915|520758032|FG003|Overall Study|Protocol Violation|6|||
144423621|NCT00174915|520758033|FG004|Overall Study|Protocol Violation|3|||
144423622|NCT00174915|520758029|FG000|Overall Study|Therapeutic Failure|6|||
144423623|NCT00174915|520758030|FG001|Overall Study|Therapeutic Failure|3|||
144423624|NCT00174915|520758031|FG002|Overall Study|Therapeutic Failure|2|||
144423625|NCT00174915|520758032|FG003|Overall Study|Therapeutic Failure|1|||
144423626|NCT00174915|520758033|FG004|Overall Study|Therapeutic Failure|3|||
144423627|NCT03060447|520758034|FG000|Overall Study|Withdrawal by Subject|2|||
144423628|NCT03060447|520758035|FG001|Overall Study|Withdrawal by Subject|0|||
144423629|NCT01870583|520758036|FG000|Overall Study|Protocol Violation|0|||
144423630|NCT01870583|520758037|FG001|Overall Study|Protocol Violation|5|||
144423631|NCT01870583|520758038|FG002|Overall Study|Protocol Violation|3|||
144423632|NCT01870583|520758036|FG000|Overall Study|Lost to Follow-up|11|||
144181100|NCT04194151|519857328|FG001|Overall Study|Physician Decision|1|||
144181101|NCT04194151|519857329|FG002|Overall Study|Physician Decision|1|||
144181102|NCT04194151|519857330|FG003|Overall Study|Physician Decision|1|||
144181103|NCT04194151|519857331|FG004|Overall Study|Physician Decision|0|||
144181104|NCT04194151|519857332|FG005|Overall Study|Physician Decision|1|||
144181105|NCT04194151|519857327|FG000|Overall Study|Monitorization problem|0|||
144181106|NCT04194151|519857328|FG001|Overall Study|Monitorization problem|1|||
144181107|NCT04194151|519857329|FG002|Overall Study|Monitorization problem|0|||
144181108|NCT04194151|519857330|FG003|Overall Study|Monitorization problem|0|||
144181109|NCT04194151|519857331|FG004|Overall Study|Monitorization problem|0|||
144423633|NCT01870583|520758037|FG001|Overall Study|Lost to Follow-up|13|||
144423634|NCT01870583|520758038|FG002|Overall Study|Lost to Follow-up|5|||
144527936|NCT04498390|521135378|FG001|Overall Study|Adverse Event|0|||
144527937|NCT04498390|521135379|FG002|Overall Study|Adverse Event|1|||
144527938|NCT04498390|521135380|FG003|Overall Study|Adverse Event|0|||
144181110|NCT04194151|519857332|FG005|Overall Study|Monitorization problem|0|||
144181111|NCT04203823|519857333|FG000|Overall Study|Withdrawal by Subject|2|||
144181112|NCT04203823|519857334|FG001|Overall Study|Withdrawal by Subject|2|||
144181113|NCT04203823|519857333|FG000|Overall Study|Adverse Event|1|||
144181114|NCT04203823|519857334|FG001|Overall Study|Adverse Event|1|||
144181115|NCT04203823|519857333|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144423635|NCT02132767|520758040|FG000|Overall Study|Death|3|||
144423636|NCT02132767|520758041|FG001|Overall Study|Death|2|||
144423637|NCT02132767|520758040|FG000|Overall Study|Withdrawal by Subject|10|||
144423638|NCT02132767|520758041|FG001|Overall Study|Withdrawal by Subject|9|||
144423639|NCT02132767|520758040|FG000|Overall Study|Lost to Follow-up|4|||
144423640|NCT02132767|520758041|FG001|Overall Study|Lost to Follow-up|4|||
144423641|NCT03914326|520758046|FG000|Overall Study|Withdrawal by Subject|27|||
144527939|NCT04498390|521135381|FG004|Overall Study|Adverse Event|0|||
144423642|NCT03914326|520758047|FG001|Overall Study|Withdrawal by Subject|34|||
144423643|NCT03914326|520758046|FG000|Overall Study|Lost to Follow-up|43|||
144423644|NCT03914326|520758047|FG001|Overall Study|Lost to Follow-up|51|||
144423645|NCT03914326|520758046|FG000|Overall Study|Randomised more than once|0|||
144423646|NCT03914326|520758047|FG001|Overall Study|Randomised more than once|1|||
144423647|NCT00546637|520758048|FG000|Overall Study|Adverse Event|46|||
144423648|NCT00546637|520758049|FG001|Overall Study|Adverse Event|20|||
144423649|NCT00546637|520758048|FG000|Overall Study|Lack of Efficacy|5|||
144423650|NCT00546637|520758049|FG001|Overall Study|Lack of Efficacy|5|||
144423651|NCT00546637|520758048|FG000|Overall Study|Lost to Follow-up|2|||
144423652|NCT00546637|520758049|FG001|Overall Study|Lost to Follow-up|2|||
144423653|NCT00546637|520758048|FG000|Overall Study|Other|10|||
144423654|NCT00546637|520758049|FG001|Overall Study|Other|12|||
144423655|NCT00546637|520758048|FG000|Overall Study|Withdrawal by Subject|7|||
144423656|NCT00546637|520758049|FG001|Overall Study|Withdrawal by Subject|9|||
144423657|NCT00546637|520758048|FG000|Overall Study|Randomized, but not treated|3|||
144423658|NCT00546637|520758049|FG001|Overall Study|Randomized, but not treated|1|||
144423659|NCT03274440|520758050|FG000|Overall Study|Time commitment too great|1|||
144423660|NCT03274440|520758051|FG001|Overall Study|Time commitment too great|0|||
144423661|NCT03274440|520758052|FG002|Overall Study|Time commitment too great|0|||
144423662|NCT03274440|520758053|FG003|Overall Study|Time commitment too great|1|||
144423663|NCT03274440|520758054|FG004|Overall Study|Time commitment too great|0|||
144423664|NCT03274440|520758055|FG005|Overall Study|Time commitment too great|0|||
144181116|NCT04203823|519857334|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
144181117|NCT01499043|519857335|FG000|Overall Study|Progressive disease (radiographic)|2|||
144181118|NCT01499043|519857335|FG000|Overall Study|Progressive disease (clinical)|1|||
144181119|NCT01499043|519857335|FG000|Overall Study|Withdrawal by Subject|2|||
144181120|NCT01499043|519857335|FG000|Overall Study|Adverse Event|1|||
144181121|NCT03193021|519857336|FG000|Overall Study|Lost to Follow-up|1|||
144181122|NCT03193021|519857337|FG001|Overall Study|Lost to Follow-up|1|||
144181123|NCT02286466|519857338|FG000|Overall Study|Death|1|||
144181124|NCT02286466|519857339|FG001|Overall Study|Death|3|||
144181125|NCT02286466|519857338|FG000|Overall Study|Withdrawal by Subject|5|||
144181126|NCT02286466|519857339|FG001|Overall Study|Withdrawal by Subject|2|||
144423665|NCT04984993|520758056|FG000|Overall Study|Withdrawal by Subject|8|||
144181127|NCT02286466|519857338|FG000|Overall Study|Lost to Follow-up|1|||
144181128|NCT02286466|519857339|FG001|Overall Study|Lost to Follow-up|4|||
144181129|NCT02286466|519857338|FG000|Overall Study|Declined Clinician Assessment|0|||
144181130|NCT02286466|519857339|FG001|Overall Study|Declined Clinician Assessment|1|||
144181131|NCT00835081|519857340|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144181132|NCT00835081|519857341|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144181133|NCT00421304|519857342|FG000|Overall Study|Lost to Follow-up|5|||
144181134|NCT00421304|519857343|FG001|Overall Study|Lost to Follow-up|2|||
144181135|NCT00421304|519857344|FG002|Overall Study|Lost to Follow-up|5|||
144181136|NCT00421304|519857342|FG000|Overall Study|Withdrawal by Subject|2|||
144181137|NCT00421304|519857343|FG001|Overall Study|Withdrawal by Subject|2|||
144181138|NCT00421304|519857344|FG002|Overall Study|Withdrawal by Subject|2|||
144181139|NCT00421304|519857342|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
144181140|NCT00421304|519857343|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
144181141|NCT00421304|519857344|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
144181142|NCT00421304|519857342|FG000|Overall Study|Did not attend Day 360 visit|0|||
144423666|NCT04984993|520758057|FG001|Overall Study|Withdrawal by Subject|2|||
144423667|NCT04984993|520758056|FG000|Overall Study|Lost to Follow-up|2|||
144423668|NCT04984993|520758057|FG001|Overall Study|Lost to Follow-up|2|||
144423669|NCT04984993|520758056|FG000|Overall Study|Both patients moved to another country|4|||
144423670|NCT04984993|520758057|FG001|Overall Study|Both patients moved to another country|0|||
144423671|NCT01496313|520758058|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
144423672|NCT01496313|520758059|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
144423673|NCT01496313|520758060|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
144423674|NCT01496313|520758061|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
144423675|NCT01496313|520758062|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
144181143|NCT00421304|519857343|FG001|Overall Study|Did not attend Day 360 visit|0|||
144423676|NCT01496313|520758063|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
144423677|NCT01496313|520758058|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
144423678|NCT01496313|520758059|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
144423679|NCT01496313|520758060|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
144423680|NCT01496313|520758061|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
144181144|NCT00421304|519857344|FG002|Overall Study|Did not attend Day 360 visit|1|||
144181145|NCT03196284|519857345|FG000|Main Part|Withdrawal by Subject|0|||
144181146|NCT03196284|519857346|FG001|Main Part|Withdrawal by Subject|1|||
144181147|NCT03196284|519857347|FG002|Main Part|Withdrawal by Subject|0|||
144181148|NCT03196284|519857345|FG000|Extension Part|Lack of Efficacy|0|||
144181149|NCT03196284|519857346|FG001|Extension Part|Lack of Efficacy|0|||
144472033|NCT03996291|520925369|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
144181150|NCT03196284|519857347|FG002|Extension Part|Lack of Efficacy|1|||
144423681|NCT01496313|520758062|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
144423682|NCT01496313|520758063|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
144423683|NCT01496313|520758058|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
144423684|NCT01496313|520758059|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
144423685|NCT01496313|520758060|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
144423686|NCT01496313|520758061|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
144423687|NCT01496313|520758062|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
144423688|NCT01496313|520758063|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
144423689|NCT01496313|520758058|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
144423690|NCT01496313|520758059|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
144423691|NCT01496313|520758060|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
144423692|NCT01496313|520758061|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
144423693|NCT01496313|520758062|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
144423694|NCT01496313|520758063|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
144423695|NCT01496313|520758058|FG000|Randomized Period (up to 14 Months)|Other|1|||
144423696|NCT01496313|520758059|FG001|Randomized Period (up to 14 Months)|Other|2|||
144423697|NCT01496313|520758060|FG002|Randomized Period (up to 14 Months)|Other|0|||
144423698|NCT01496313|520758061|FG003|Randomized Period (up to 14 Months)|Other|0|||
144423699|NCT01496313|520758062|FG004|Randomized Period (up to 14 Months)|Other|0|||
144423700|NCT01496313|520758063|FG005|Randomized Period (up to 14 Months)|Other|0|||
144423701|NCT01496313|520758058|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
144423702|NCT01496313|520758059|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
144423703|NCT01496313|520758060|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
144423704|NCT01496313|520758061|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
144423705|NCT01496313|520758062|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
144423706|NCT01496313|520758063|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
144423707|NCT01496313|520758058|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
144423708|NCT01496313|520758059|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
144423709|NCT01496313|520758060|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
144423710|NCT01496313|520758061|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
144423711|NCT01496313|520758062|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
144423712|NCT01496313|520758063|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
144181151|NCT03196284|519857345|FG000|Extension Part|Withdrawal by Subject|0|||
144538359|NCT00609869|521174169|FG000|Overall Study|Seizures|1|||
144538360|NCT00609869|521174169|FG000|Overall Study|Severe tumor flare reaction|1|||
144538361|NCT00609869|521174169|FG000|Overall Study|Hepatitis B infection|1|||
144538362|NCT00609869|521174169|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
144538363|NCT00609869|521174169|FG000|Overall Study|Mantle cell: not evaluable|4|||
144538364|NCT01627561|521174170|FG000|Overall Study|Lost to Follow-up|1|||
144538365|NCT01627561|521174171|FG001|Overall Study|Lost to Follow-up|0|||
144538366|NCT01627561|521174170|FG000|Overall Study|Withdrawal by Subject|0|||
144538367|NCT01627561|521174171|FG001|Overall Study|Withdrawal by Subject|1|||
144538368|NCT01627561|521174170|FG000|Overall Study|Migrated/moved from study area|0|||
144538369|NCT01627561|521174171|FG001|Overall Study|Migrated/moved from study area|2|||
144538370|NCT03478969|521174177|FG000|Overall Study|Withdrawal by Subject|4|||
144538371|NCT03478969|521174178|FG001|Overall Study|Withdrawal by Subject|7|||
144538372|NCT03478969|521174179|FG002|Overall Study|Withdrawal by Subject|6|||
144538373|NCT03478969|521174177|FG000|Overall Study|Adverse Event|2|||
144538374|NCT03478969|521174178|FG001|Overall Study|Adverse Event|0|||
144538375|NCT03478969|521174179|FG002|Overall Study|Adverse Event|1|||
144538376|NCT03478969|521174177|FG000|Overall Study|Pregnancy|1|||
144538377|NCT03478969|521174178|FG001|Overall Study|Pregnancy|0|||
144538378|NCT03478969|521174179|FG002|Overall Study|Pregnancy|0|||
144538379|NCT03478969|521174177|FG000|Overall Study|Personal Reasons|1|||
144538380|NCT03478969|521174178|FG001|Overall Study|Personal Reasons|0|||
144538381|NCT03478969|521174179|FG002|Overall Study|Personal Reasons|1|||
144538382|NCT03478969|521174177|FG000|Overall Study|Covid-19|1|||
144538383|NCT03478969|521174178|FG001|Overall Study|Covid-19|4|||
144538384|NCT03478969|521174179|FG002|Overall Study|Covid-19|3|||
144538385|NCT03478969|521174177|FG000|Overall Study|Multiple Reasons|0|||
144538386|NCT03478969|521174178|FG001|Overall Study|Multiple Reasons|1|||
144538387|NCT03478969|521174179|FG002|Overall Study|Multiple Reasons|1|||
144538388|NCT03478969|521174177|FG000|Overall Study|Eligibility Criteria|0|||
144538389|NCT03478969|521174178|FG001|Overall Study|Eligibility Criteria|0|||
144538390|NCT03478969|521174179|FG002|Overall Study|Eligibility Criteria|5|||
144538391|NCT03478969|521174177|FG000|Overall Study|Lost to Follow-up|0|||
144538392|NCT03478969|521174178|FG001|Overall Study|Lost to Follow-up|0|||
144423713|NCT01496313|520758058|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
144423714|NCT01496313|520758059|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
144423715|NCT01496313|520758060|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
144423716|NCT01496313|520758061|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
144423717|NCT01496313|520758062|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
144423718|NCT01496313|520758063|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
144423719|NCT00451321|520758069|FG000|Overall Study|Lost to Follow-up|3|||
144423720|NCT00451321|520758070|FG001|Overall Study|Lost to Follow-up|3|||
144423721|NCT00451321|520758071|FG002|Overall Study|Lost to Follow-up|1|||
144423722|NCT00451321|520758072|FG003|Overall Study|Lost to Follow-up|3|||
144423723|NCT00451321|520758073|FG004|Overall Study|Lost to Follow-up|0|||
144423724|NCT00451321|520758074|FG005|Overall Study|Lost to Follow-up|1|||
144423725|NCT00451321|520758075|FG006|Overall Study|Lost to Follow-up|0|||
144423726|NCT00451321|520758076|FG007|Overall Study|Lost to Follow-up|0|||
144423727|NCT00451321|520758069|FG000|Overall Study|Withdrawal by Subject|3|||
144423728|NCT00451321|520758070|FG001|Overall Study|Withdrawal by Subject|1|||
144423729|NCT00451321|520758071|FG002|Overall Study|Withdrawal by Subject|0|||
144423730|NCT00451321|520758072|FG003|Overall Study|Withdrawal by Subject|4|||
144423731|NCT00451321|520758073|FG004|Overall Study|Withdrawal by Subject|0|||
144423732|NCT00451321|520758074|FG005|Overall Study|Withdrawal by Subject|0|||
144423733|NCT00451321|520758075|FG006|Overall Study|Withdrawal by Subject|0|||
144423734|NCT00451321|520758076|FG007|Overall Study|Withdrawal by Subject|0|||
144423735|NCT00451321|520758069|FG000|Overall Study|Study closed/terminated|1|||
144423736|NCT00451321|520758070|FG001|Overall Study|Study closed/terminated|1|||
144423737|NCT00451321|520758071|FG002|Overall Study|Study closed/terminated|17|||
144423738|NCT00451321|520758072|FG003|Overall Study|Study closed/terminated|5|||
144423739|NCT00451321|520758073|FG004|Overall Study|Study closed/terminated|7|||
144423740|NCT00451321|520758074|FG005|Overall Study|Study closed/terminated|7|||
144423741|NCT00451321|520758075|FG006|Overall Study|Study closed/terminated|5|||
144423742|NCT00451321|520758076|FG007|Overall Study|Study closed/terminated|3|||
144423743|NCT00451321|520758069|FG000|Overall Study|Sponsor decision to amend protocol|0|||
144423744|NCT00451321|520758070|FG001|Overall Study|Sponsor decision to amend protocol|0|||
144423745|NCT00451321|520758071|FG002|Overall Study|Sponsor decision to amend protocol|0|||
144423746|NCT00451321|520758072|FG003|Overall Study|Sponsor decision to amend protocol|0|||
144423747|NCT00451321|520758073|FG004|Overall Study|Sponsor decision to amend protocol|0|||
144423748|NCT00451321|520758074|FG005|Overall Study|Sponsor decision to amend protocol|1|||
144423749|NCT00451321|520758075|FG006|Overall Study|Sponsor decision to amend protocol|1|||
144423750|NCT00451321|520758076|FG007|Overall Study|Sponsor decision to amend protocol|3|||
144423751|NCT02064166|520758077|FG000|Overall Study|Adverse Event|1|||
144423752|NCT02064166|520758078|FG001|Overall Study|Adverse Event|0|||
144423753|NCT00909389|520758084|FG000|Overall Study|Adverse Event|6|||
144423754|NCT00909389|520758084|FG000|Overall Study|Death|4|||
144423755|NCT00909389|520758084|FG000|Overall Study|Poor Compliance|16|||
144423756|NCT00909389|520758084|FG000|Overall Study|Lost to Follow-up|4|||
144423757|NCT00909389|520758084|FG000|Overall Study|No Information|103|||
144423758|NCT00877383|520758096|FG000|Overall Study|Adverse Event|13|||
144423759|NCT00877383|520758097|FG001|Overall Study|Adverse Event|14|||
144423760|NCT00877383|520758096|FG000|Overall Study|Lost to Follow-up|5|||
144423761|NCT00877383|520758097|FG001|Overall Study|Lost to Follow-up|3|||
144423762|NCT00877383|520758096|FG000|Overall Study|Subject withdrew consent|3|||
144423763|NCT00877383|520758097|FG001|Overall Study|Subject withdrew consent|12|||
144423764|NCT00877383|520758096|FG000|Overall Study|Subject no longer requires study drug|2|||
144423765|NCT00877383|520758097|FG001|Overall Study|Subject no longer requires study drug|0|||
144423766|NCT00877383|520758096|FG000|Overall Study|Administrative problems|2|||
144423767|NCT00877383|520758097|FG001|Overall Study|Administrative problems|0|||
144423768|NCT00877383|520758096|FG000|Overall Study|Protocol deviation|2|||
144423769|NCT00877383|520758097|FG001|Overall Study|Protocol deviation|6|||
144423770|NCT00877383|520758096|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144423771|NCT00877383|520758097|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144423772|NCT00877383|520758096|FG000|Overall Study|Death|1|||
144423773|NCT00877383|520758097|FG001|Overall Study|Death|2|||
144423774|NCT00459108|520758098|FG000|Overall Study|Withdrawal by Subject|5|||
144423775|NCT00459108|520758098|FG000|Overall Study|Adverse Event|3|||
144423776|NCT00459108|520758098|FG000|Overall Study|Death|2|||
144423777|NCT00459108|520758098|FG000|Overall Study|Progression|1|||
144423778|NCT02157298|520758101|FG000|Overall Study|Adverse Event|1|||
144423779|NCT02157298|520758102|FG001|Overall Study|Adverse Event|0|||
144423780|NCT02157298|520758101|FG000|Overall Study|Subject no longer meets study criteria|1|||
144423781|NCT02157298|520758102|FG001|Overall Study|Subject no longer meets study criteria|2|||
144423782|NCT02157298|520758101|FG000|Overall Study|Poor/Non-compliance|1|||
144423783|NCT02157298|520758102|FG001|Overall Study|Poor/Non-compliance|0|||
144423784|NCT02157298|520758101|FG000|Overall Study|Withdrawal by Subject|1|||
144423785|NCT02157298|520758102|FG001|Overall Study|Withdrawal by Subject|0|||
144423786|NCT01722071|520758103|FG000|Overall Study|Protocol Violation|1|||
144423787|NCT01722071|520758104|FG001|Overall Study|Protocol Violation|0|||
144423788|NCT01338493|520758105|FG000|Enrolled|Withdrawal by Subject|1|||
144423789|NCT01338493|520758105|FG000|Enrolled|Patient not implanted|4|||
144423790|NCT01338493|520758105|FG000|Discharge|Death|1|||
144423791|NCT01338493|520758105|FG000|Discharge|Missed visit|1|||
144423792|NCT01338493|520758105|FG000|6 Months Follow up|Lost to Follow-up|11|||
144423793|NCT01338493|520758105|FG000|6 Months Follow up|Missed visit|8|||
144423794|NCT01338493|520758105|FG000|12 Months Follow up|Lost to Follow-up|9|||
144423795|NCT00656474|520758106|FG000|Overall Study|Other Reason|1|||
144423796|NCT02062879|520758107|FG000|Overall Study|Withdrawal by Subject|4|||
144423797|NCT02062879|520758108|FG001|Overall Study|Withdrawal by Subject|1|||
144423798|NCT00353262|520758109|FG000|Overall Study|Adverse Event|8|||
144423799|NCT00353262|520758109|FG000|Overall Study|Withdrawal by Subject|2|||
144423800|NCT00353262|520758109|FG000|Overall Study|Insufficient Therapeutic Response|13|||
144423801|NCT00353262|520758109|FG000|Overall Study|Progression|1|||
144423802|NCT00353262|520758109|FG000|Overall Study|Surgery|4|||
144423803|NCT00353262|520758109|FG000|Overall Study|Break from Chemotherapy|1|||
144181152|NCT03196284|519857346|FG001|Extension Part|Withdrawal by Subject|0|||
144423804|NCT05286307|520758110|FG000|Overall Study|Incomplete outcome assessments|2|||
144423805|NCT05286307|520758111|FG001|Overall Study|Incomplete outcome assessments|1|||
144423806|NCT05286307|520758110|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
144423807|NCT05286307|520758111|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
144423808|NCT05286307|520758110|FG000|Overall Study|Lost to follow up at 6 months|25|||
144423809|NCT05286307|520758111|FG001|Overall Study|Lost to follow up at 6 months|35|||
144423810|NCT05286307|520758110|FG000|Overall Study|Study medication not available|1|||
144423811|NCT05286307|520758111|FG001|Overall Study|Study medication not available|1|||
144423812|NCT01103284|520758112|FG000|Overall Study|Death|2|||
144423813|NCT01103284|520758113|FG001|Overall Study|Death|0|||
144423814|NCT01103284|520758112|FG000|Overall Study|Lost to Follow-up|9|||
144423815|NCT01103284|520758113|FG001|Overall Study|Lost to Follow-up|10|||
144423816|NCT01103284|520758112|FG000|Overall Study|Pregnancy|3|||
144423817|NCT01103284|520758113|FG001|Overall Study|Pregnancy|1|||
144423818|NCT01103284|520758112|FG000|Overall Study|Protocol Violation|12|||
144423819|NCT01103284|520758113|FG001|Overall Study|Protocol Violation|5|||
144423820|NCT01103284|520758112|FG000|Overall Study|Adverse Event|0|||
144423821|NCT01103284|520758113|FG001|Overall Study|Adverse Event|5|||
144423822|NCT01103284|520758112|FG000|Overall Study|Withdrawal by Subject|14|||
144423823|NCT01103284|520758113|FG001|Overall Study|Withdrawal by Subject|18|||
144423824|NCT01103284|520758112|FG000|Overall Study|Dermal Hypersensitivity|0|||
144423825|NCT01103284|520758113|FG001|Overall Study|Dermal Hypersensitivity|1|||
144423826|NCT01103284|520758112|FG000|Overall Study|Termination by the Sponsor|0|||
144423827|NCT01103284|520758113|FG001|Overall Study|Termination by the Sponsor|1|||
144423828|NCT01103284|520758112|FG000|Overall Study|Not described|2|||
144423829|NCT01103284|520758113|FG001|Overall Study|Not described|1|||
144423830|NCT01103284|520758112|FG000|Overall Study|Missing CRF entries for study completion|0|||
144423831|NCT01103284|520758113|FG001|Overall Study|Missing CRF entries for study completion|2|||
144423832|NCT00573755|520759408|FG000|Overall Study|Still receiving treatment|1|||
144423833|NCT00573755|520759409|FG001|Overall Study|Still receiving treatment|0|||
144423834|NCT03045887|520759416|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
144423835|NCT03045887|520759417|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423836|NCT03045887|520759418|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423837|NCT03045887|520759419|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423838|NCT03045887|520759420|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423839|NCT03045887|520759421|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423840|NCT03045887|520759422|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423841|NCT03045887|520759423|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423842|NCT03045887|520759424|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423843|NCT03045887|520759425|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
144423844|NCT03045887|520759416|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144423845|NCT03045887|520759417|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144181153|NCT03196284|519857347|FG002|Extension Part|Withdrawal by Subject|1|||
144181154|NCT03196284|519857345|FG000|Extension Part|Physician Decision|0|||
144181155|NCT03196284|519857346|FG001|Extension Part|Physician Decision|0|||
144423846|NCT03045887|520759418|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144423847|NCT03045887|520759419|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
144423848|NCT03045887|520759420|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144423849|NCT03045887|520759421|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144601124|NCT01940354|521403334|FG000|Overall Study|Withdrawal by Subject|4|||
144423850|NCT03045887|520759422|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144423851|NCT03045887|520759423|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144423852|NCT03045887|520759424|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144601125|NCT01940354|521403335|FG001|Overall Study|Withdrawal by Subject|2|||
144423853|NCT03045887|520759425|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
144181156|NCT03196284|519857347|FG002|Extension Part|Physician Decision|1|||
144181157|NCT01675596|519857348|FG000|Overall Study|Death|6|||
144423854|NCT03045887|520759416|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
144423855|NCT03045887|520759417|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423856|NCT03045887|520759418|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423857|NCT03045887|520759419|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423858|NCT03045887|520759420|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423859|NCT03045887|520759421|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423860|NCT03045887|520759422|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423861|NCT03045887|520759423|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423862|NCT03045887|520759424|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423863|NCT03045887|520759425|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
144423864|NCT03045887|520759416|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423865|NCT03045887|520759417|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423866|NCT03045887|520759418|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
144423867|NCT03045887|520759419|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
144423868|NCT03045887|520759420|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423869|NCT03045887|520759421|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423870|NCT03045887|520759422|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423871|NCT03045887|520759423|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423872|NCT03045887|520759424|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423873|NCT03045887|520759425|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
144423874|NCT03045887|520759416|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423875|NCT03045887|520759417|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423876|NCT03045887|520759418|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423877|NCT03045887|520759419|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
144423878|NCT03045887|520759420|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423879|NCT03045887|520759421|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423880|NCT03045887|520759422|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423881|NCT03045887|520759423|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423882|NCT03045887|520759424|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423883|NCT03045887|520759425|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
144423884|NCT00778700|520759426|FG000|Overall Study|Adverse Event|6|||
144423885|NCT00778700|520759427|FG001|Overall Study|Adverse Event|1|||
144423886|NCT00778700|520759428|FG002|Overall Study|Adverse Event|3|||
144423887|NCT00778700|520759429|FG003|Overall Study|Adverse Event|5|||
144423888|NCT00778700|520759426|FG000|Overall Study|Protocol Violation|1|||
144423889|NCT00778700|520759427|FG001|Overall Study|Protocol Violation|1|||
144423890|NCT00778700|520759428|FG002|Overall Study|Protocol Violation|0|||
144423891|NCT00778700|520759429|FG003|Overall Study|Protocol Violation|0|||
144423892|NCT00778700|520759426|FG000|Overall Study|Subject Withdrew Consent|6|||
144423893|NCT00778700|520759427|FG001|Overall Study|Subject Withdrew Consent|4|||
144423894|NCT00778700|520759428|FG002|Overall Study|Subject Withdrew Consent|1|||
144423895|NCT00778700|520759429|FG003|Overall Study|Subject Withdrew Consent|4|||
144423896|NCT00778700|520759426|FG000|Overall Study|Lost to Follow-up|3|||
144423897|NCT00778700|520759427|FG001|Overall Study|Lost to Follow-up|1|||
144423898|NCT00778700|520759428|FG002|Overall Study|Lost to Follow-up|0|||
144423899|NCT00778700|520759429|FG003|Overall Study|Lost to Follow-up|1|||
144423900|NCT00778700|520759426|FG000|Overall Study|Reason not Specified|2|||
144423901|NCT00778700|520759427|FG001|Overall Study|Reason not Specified|0|||
144423902|NCT00778700|520759428|FG002|Overall Study|Reason not Specified|1|||
144423903|NCT00778700|520759429|FG003|Overall Study|Reason not Specified|3|||
144423904|NCT00778700|520759426|FG000|Overall Study|Other|0|||
144423905|NCT00778700|520759427|FG001|Overall Study|Other|0|||
144423906|NCT00778700|520759428|FG002|Overall Study|Other|1|||
144423907|NCT00778700|520759429|FG003|Overall Study|Other|0|||
144423908|NCT03227029|520759430|FG000|Overall Study|Child Wheezed (no treatment)|0|||
144423909|NCT03227029|520759431|FG001|Overall Study|Child Wheezed (no treatment)|1|||
144423910|NCT03227029|520759432|FG002|Overall Study|Child Wheezed (no treatment)|0|||
144423911|NCT03227029|520759430|FG000|Overall Study|No post RSV season visit due to COVID|3|||
144423912|NCT03227029|520759431|FG001|Overall Study|No post RSV season visit due to COVID|3|||
144423913|NCT03227029|520759432|FG002|Overall Study|No post RSV season visit due to COVID|2|||
144423914|NCT03227029|520759430|FG000|Overall Study|Not able to get to clinic|0|||
144423915|NCT03227029|520759431|FG001|Overall Study|Not able to get to clinic|0|||
144423916|NCT03227029|520759432|FG002|Overall Study|Not able to get to clinic|1|||
144423917|NCT03227029|520759430|FG000|Overall Study|Withdrawal by Subject|1|||
144423918|NCT03227029|520759431|FG001|Overall Study|Withdrawal by Subject|0|||
144423919|NCT03227029|520759432|FG002|Overall Study|Withdrawal by Subject|0|||
144423920|NCT03227029|520759430|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
144423921|NCT03227029|520759431|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
144423922|NCT03227029|520759432|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
144423923|NCT01291173|520759433|FG000|Overall Study|Adverse Event|0|||
144423924|NCT01291173|520759434|FG001|Overall Study|Adverse Event|3|||
144423925|NCT01291173|520759435|FG002|Overall Study|Adverse Event|1|||
144423926|NCT01291173|520759436|FG003|Overall Study|Adverse Event|3|||
144527940|NCT04498390|521135377|FG000|Overall Study|Withdrawal by Subject|0|||
144527941|NCT04498390|521135378|FG001|Overall Study|Withdrawal by Subject|0|||
144527942|NCT04498390|521135379|FG002|Overall Study|Withdrawal by Subject|0|||
144527943|NCT04498390|521135380|FG003|Overall Study|Withdrawal by Subject|1|||
144527944|NCT04498390|521135381|FG004|Overall Study|Withdrawal by Subject|0|||
144527945|NCT02052882|521135382|FG000|Overall Study|Not treated|11|||
144527946|NCT02052882|521135382|FG000|Overall Study|Protocol Violation|1|||
144527947|NCT02052882|521135382|FG000|Overall Study|Inadequate testing|1|||
144527948|NCT03362476|521135394|FG000|Overall Study|Withdrawal by Subject|0|||
144527949|NCT03362476|521135395|FG001|Overall Study|Withdrawal by Subject|1|||
144527950|NCT04690582|521135396|FG000|Overall Study|Withdrawal by Subject|6|||
144527951|NCT04690582|521135397|FG001|Overall Study|Withdrawal by Subject|4|||
144527952|NCT04577963|521135401|FG000|Part 2|Death|0|||
144527953|NCT04577963|521135402|FG001|Part 2|Death|1|||
144601126|NCT03756350|521403336|FG000|Overall Study|Lost to Follow-up|1|||
144601127|NCT01524133|521403339|FG000|Treatment Phase|Withdrawal by Subject|13|||
144601128|NCT01524133|521403340|FG001|Treatment Phase|Withdrawal by Subject|28|||
144601129|NCT01524133|521403341|FG002|Treatment Phase|Withdrawal by Subject|31|||
144601130|NCT01524133|521403339|FG000|Treatment Phase|Physician Decision|6|||
144601131|NCT01524133|521403340|FG001|Treatment Phase|Physician Decision|3|||
144601132|NCT01524133|521403341|FG002|Treatment Phase|Physician Decision|3|||
144601133|NCT01524133|521403339|FG000|Treatment Phase|Lost to Follow-up|0|||
144601134|NCT01524133|521403340|FG001|Treatment Phase|Lost to Follow-up|1|||
144601135|NCT01524133|521403341|FG002|Treatment Phase|Lost to Follow-up|2|||
144601136|NCT01524133|521403339|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
144601137|NCT01524133|521403340|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
144601138|NCT01524133|521403341|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
144601139|NCT01524133|521403339|FG000|Overall Study 52 Weeks|Physician Decision|1|||
144601140|NCT01524133|521403340|FG001|Overall Study 52 Weeks|Physician Decision|0|||
144601141|NCT01524133|521403341|FG002|Overall Study 52 Weeks|Physician Decision|2|||
144601142|NCT01524133|521403339|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
144601143|NCT01524133|521403340|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
144601144|NCT01524133|521403341|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
144601145|NCT04964960|521403342|FG000|Overall Study|Withdrawal by Subject|1|||
144601146|NCT04964960|521403342|FG000|Overall Study|Did not complete cycles|1|||
144601147|NCT01423812|521403343|FG000|Overall Study|Lost to Follow-up|2|||
144601148|NCT01423812|521403344|FG001|Overall Study|Lost to Follow-up|2|||
144601149|NCT01423812|521403343|FG000|Overall Study|Withdrawal by Subject|1|||
144601150|NCT01423812|521403344|FG001|Overall Study|Withdrawal by Subject|2|||
144601151|NCT02616614|521403345|FG000|Overall Study|Withdrawal by Subject|10|||
144601152|NCT02616614|521403346|FG001|Overall Study|Withdrawal by Subject|5|||
144423927|NCT01291173|520759433|FG000|Overall Study|Protocol Violation|7|||
144423928|NCT01291173|520759434|FG001|Overall Study|Protocol Violation|2|||
144423929|NCT01291173|520759435|FG002|Overall Study|Protocol Violation|2|||
144423930|NCT01291173|520759436|FG003|Overall Study|Protocol Violation|5|||
144423931|NCT01291173|520759433|FG000|Overall Study|Withdrawal by Subject|6|||
144423932|NCT01291173|520759434|FG001|Overall Study|Withdrawal by Subject|4|||
144423933|NCT01291173|520759435|FG002|Overall Study|Withdrawal by Subject|4|||
144423934|NCT01291173|520759436|FG003|Overall Study|Withdrawal by Subject|2|||
144423935|NCT01291173|520759433|FG000|Overall Study|Lost to Follow-up|4|||
144423936|NCT01291173|520759434|FG001|Overall Study|Lost to Follow-up|6|||
144423937|NCT01291173|520759435|FG002|Overall Study|Lost to Follow-up|3|||
144423938|NCT01291173|520759436|FG003|Overall Study|Lost to Follow-up|2|||
144423939|NCT01291173|520759433|FG000|Overall Study|Unable to meet visit schedule|0|||
144423940|NCT01291173|520759434|FG001|Overall Study|Unable to meet visit schedule|0|||
144423941|NCT01291173|520759435|FG002|Overall Study|Unable to meet visit schedule|1|||
144423942|NCT01291173|520759436|FG003|Overall Study|Unable to meet visit schedule|0|||
144423943|NCT01291173|520759433|FG000|Overall Study|Lack of compliance|0|||
144423944|NCT01291173|520759434|FG001|Overall Study|Lack of compliance|0|||
144423945|NCT01291173|520759435|FG002|Overall Study|Lack of compliance|0|||
144423946|NCT01291173|520759436|FG003|Overall Study|Lack of compliance|1|||
144601153|NCT02616614|521403347|FG002|Overall Study|Withdrawal by Subject|6|||
144601154|NCT02616614|521403345|FG000|Overall Study|Physician Decision|2|||
144601155|NCT02616614|521403346|FG001|Overall Study|Physician Decision|1|||
144601156|NCT02616614|521403347|FG002|Overall Study|Physician Decision|0|||
144601157|NCT02616614|521403345|FG000|Overall Study|Adverse Event|1|||
144601158|NCT02616614|521403346|FG001|Overall Study|Adverse Event|4|||
144423947|NCT01291173|520759433|FG000|Overall Study|Subject was unblinded|0|||
144423948|NCT01291173|520759434|FG001|Overall Study|Subject was unblinded|0|||
144423949|NCT01291173|520759435|FG002|Overall Study|Subject was unblinded|1|||
144423950|NCT01291173|520759436|FG003|Overall Study|Subject was unblinded|0|||
144423951|NCT01291173|520759433|FG000|Overall Study|Excluded therapy|0|||
144423952|NCT01291173|520759434|FG001|Overall Study|Excluded therapy|0|||
144527954|NCT04577963|521135403|FG002|Part 2|Death|8|||
144527955|NCT04577963|521135404|FG003|Part 2|Death|0|||
144527956|NCT04577963|521135405|FG004|Part 2|Death|20|||
144527957|NCT04577963|521135401|FG000|Part 2|Lost to Follow-up|0|||
144527958|NCT04577963|521135402|FG001|Part 2|Lost to Follow-up|0|||
144423953|NCT01291173|520759435|FG002|Overall Study|Excluded therapy|1|||
144423954|NCT01291173|520759436|FG003|Overall Study|Excluded therapy|0|||
144423955|NCT00390858|520759437|FG000|Overall Study|Adverse Event|6|||
144423956|NCT00390858|520759438|FG001|Overall Study|Adverse Event|2|||
144423957|NCT00390858|520759437|FG000|Overall Study|Lack of Efficacy|0|||
144423958|NCT00390858|520759438|FG001|Overall Study|Lack of Efficacy|1|||
144423959|NCT00390858|520759437|FG000|Overall Study|Withdrawal by Subject|3|||
144423960|NCT00390858|520759438|FG001|Overall Study|Withdrawal by Subject|4|||
144423961|NCT00450450|520759439|FG000|Overall Study|Death|1|||
144423962|NCT00450450|520759440|FG001|Overall Study|Death|3|||
144423963|NCT00450450|520759439|FG000|Overall Study|Relapse|2|||
144423964|NCT00450450|520759440|FG001|Overall Study|Relapse|0|||
144423965|NCT00450450|520759439|FG000|Overall Study|Missing Data|2|||
144423966|NCT00450450|520759440|FG001|Overall Study|Missing Data|0|||
144423967|NCT02024867|520759441|FG000|Overall Study|Protocol Violation|3|||
144423968|NCT02024867|520759442|FG001|Overall Study|Protocol Violation|3|||
144423969|NCT02024867|520759441|FG000|Overall Study|Lost to Follow-up|6|||
144423970|NCT02024867|520759442|FG001|Overall Study|Lost to Follow-up|4|||
144423971|NCT02865187|520759445|FG000|Overall Study|Lost to Follow-up|12|||
144423972|NCT02865187|520759446|FG001|Overall Study|Lost to Follow-up|7|||
144423973|NCT02865187|520759445|FG000|Overall Study|Adverse Event|1|||
144423974|NCT02865187|520759446|FG001|Overall Study|Adverse Event|0|||
144423975|NCT04267133|520759447|FG000|Overall Study|Withdrawal by Subject|1|||
144423976|NCT04267133|520759447|FG000|Overall Study|Adverse Event|4|||
144423977|NCT01110707|520759448|FG000|Overall Study|Protocol Violation|0|||
144423978|NCT01110707|520759449|FG001|Overall Study|Protocol Violation|3|||
144423979|NCT02369341|520759451|FG000|Overall Study|Migrated/moved from study area|1|||
144423980|NCT02369341|520759452|FG001|Overall Study|Migrated/moved from study area|0|||
144423981|NCT00674661|520759454|FG000|Overall Study|Other|5|||
144423982|NCT00674661|520759455|FG001|Overall Study|Other|7|||
144423983|NCT00674661|520759454|FG000|Overall Study|Lost to Follow-up|6|||
144423984|NCT00674661|520759455|FG001|Overall Study|Lost to Follow-up|3|||
144423985|NCT00674661|520759454|FG000|Overall Study|Withdrawal by Subject|0|||
144423986|NCT00674661|520759455|FG001|Overall Study|Withdrawal by Subject|5|||
144423987|NCT00003901|520759456|FG000|Overall Study|Adverse Event|1|||
144423988|NCT00003901|520759456|FG000|Overall Study|Withdrawal by Subject|1|||
144423989|NCT00003901|520759456|FG000|Overall Study|Ineligible|6|||
144423990|NCT00003901|520759456|FG000|Overall Study|CT Scan not within protocol requirement|2|||
144423991|NCT00003901|520759456|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
144423992|NCT00003901|520759456|FG000|Overall Study|Medical problems|6|||
144423993|NCT02707991|520759457|FG000|Overall Study|Protocol Violation|1|||
144423994|NCT02707991|520759458|FG001|Overall Study|Protocol Violation|0|||
144423995|NCT02707991|520759457|FG000|Overall Study|Became ineligible|0|||
144527959|NCT04577963|521135403|FG002|Part 2|Lost to Follow-up|0|||
144527960|NCT04577963|521135404|FG003|Part 2|Lost to Follow-up|0|||
144527961|NCT04577963|521135405|FG004|Part 2|Lost to Follow-up|2|||
144527962|NCT04577963|521135401|FG000|Part 2|Withdrawal by Subject|0|||
144527963|NCT04577963|521135402|FG001|Part 2|Withdrawal by Subject|0|||
144527964|NCT04577963|521135403|FG002|Part 2|Withdrawal by Subject|0|||
144527965|NCT04577963|521135404|FG003|Part 2|Withdrawal by Subject|0|||
144527966|NCT04577963|521135405|FG004|Part 2|Withdrawal by Subject|10|||
144527967|NCT04577963|521135401|FG000|Part 2|Progressive disease|0|||
144527968|NCT04577963|521135402|FG001|Part 2|Progressive disease|0|||
144527969|NCT04577963|521135403|FG002|Part 2|Progressive disease|0|||
144527970|NCT04577963|521135404|FG003|Part 2|Progressive disease|0|||
144527971|NCT04577963|521135405|FG004|Part 2|Progressive disease|2|||
144527972|NCT04577963|521135401|FG000|Part 2|Investigator decision|0|||
144527973|NCT04577963|521135402|FG001|Part 2|Investigator decision|0|||
144527974|NCT04577963|521135403|FG002|Part 2|Investigator decision|0|||
144527975|NCT04577963|521135404|FG003|Part 2|Investigator decision|0|||
144527976|NCT04577963|521135405|FG004|Part 2|Investigator decision|1|||
144527977|NCT04577963|521135401|FG000|Part 2|Sponsor terminated study|0|||
144181158|NCT01675596|519857348|FG000|Overall Study|Exit with other reason|1|||
144181159|NCT01675596|519857348|FG000|Overall Study|Missed Visit|1|||
144181160|NCT01139762|519857349|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
144423996|NCT02707991|520759458|FG001|Overall Study|Became ineligible|1|||
144423997|NCT02268864|520759459|FG000|Overall Study|Withdrawal by Subject|2|||
144423998|NCT02268864|520759460|FG001|Overall Study|Withdrawal by Subject|0|||
144423999|NCT02268864|520759461|FG002|Overall Study|Withdrawal by Subject|0|||
144424000|NCT02268864|520759459|FG000|Overall Study|Death|0|||
144424001|NCT02268864|520759460|FG001|Overall Study|Death|1|||
144424002|NCT02268864|520759461|FG002|Overall Study|Death|0|||
144424003|NCT00857220|520759462|FG000|Overall Study|Adverse Event|35|||
144424004|NCT00857220|520759462|FG000|Overall Study|Death|1|||
144527978|NCT04577963|521135402|FG001|Part 2|Sponsor terminated study|0|||
144527979|NCT04577963|521135403|FG002|Part 2|Sponsor terminated study|3|||
144527980|NCT04577963|521135404|FG003|Part 2|Sponsor terminated study|1|||
144527981|NCT04577963|521135405|FG004|Part 2|Sponsor terminated study|4|||
144527982|NCT02709161|521135406|FG000|Overall Study|Withdrawal by Subject|1|||
144527983|NCT02709161|521135407|FG001|Overall Study|Withdrawal by Subject|0|||
144424005|NCT00857220|520759462|FG000|Overall Study|Lack of Efficacy|11|||
144424006|NCT00857220|520759462|FG000|Overall Study|Lost to Follow-up|30|||
144424007|NCT00857220|520759462|FG000|Overall Study|Physician Decision|4|||
144424008|NCT00857220|520759462|FG000|Overall Study|Protocol Violation|16|||
144424009|NCT00857220|520759462|FG000|Overall Study|Withdrawal by Subject|67|||
144424010|NCT00857220|520759462|FG000|Overall Study|Clinical Hold|6|||
144424011|NCT00857220|520759462|FG000|Overall Study|Site Closed|5|||
144424012|NCT00857220|520759462|FG000|Overall Study|Miscellaneous|8|||
144424013|NCT03698994|520759463|FG000|Overall Study|Adverse Event|2|||
144424014|NCT03698994|520759463|FG000|Overall Study|Death|1|||
144424015|NCT03698994|520759463|FG000|Overall Study|Physician Decision|1|||
144424016|NCT03698994|520759463|FG000|Overall Study|Withdrawal by Subject|3|||
144424017|NCT03698994|520759463|FG000|Overall Study|Progressive Disease|12|||
144424018|NCT02612428|520759464|FG000|VTL-308|Death|14|||
144424019|NCT02612428|520759465|FG001|VTL-308|Death|16|||
144424020|NCT02612428|520759464|FG000|VTL-308|Withdrawal by Subject|0|||
144424021|NCT02612428|520759465|FG001|VTL-308|Withdrawal by Subject|1|||
144424022|NCT02612428|520759464|FG000|VTL-308E|Death|9|||
144424023|NCT02612428|520759465|FG001|VTL-308E|Death|7|||
144424024|NCT02612428|520759464|FG000|VTL-308E|Lost to Follow-up|2|||
144424025|NCT02612428|520759465|FG001|VTL-308E|Lost to Follow-up|0|||
144424026|NCT00742001|520759466|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
144424027|NCT00742001|520759467|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
144424028|NCT00742001|520759468|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
144424029|NCT00137423|520759469|FG000|Overall Study|Adverse Event|7|||
144424030|NCT00137423|520759470|FG001|Overall Study|Adverse Event|9|||
144424031|NCT00137423|520759469|FG000|Overall Study|consent withdrawn|1|||
144424032|NCT00137423|520759470|FG001|Overall Study|consent withdrawn|1|||
144424033|NCT00137423|520759469|FG000|Overall Study|Lack of Efficacy|31|||
144424034|NCT00137423|520759470|FG001|Overall Study|Lack of Efficacy|33|||
144424035|NCT00137423|520759469|FG000|Overall Study|Death|0|||
144424036|NCT00137423|520759470|FG001|Overall Study|Death|1|||
144424037|NCT03187262|520759471|FG000|Induction|Lack of Efficacy|2|||
144424038|NCT03187262|520759471|FG000|Induction|Progressive Disease|4|||
144424039|NCT03187262|520759471|FG000|Consolidation|Progressive Disease|5|||
144424040|NCT02604212|520759473|FG000|Overall Study|Study Terminated by Sponsor|2|||
144424041|NCT02604212|520759474|FG001|Overall Study|Study Terminated by Sponsor|1|||
144424042|NCT02604212|520759475|FG002|Overall Study|Study Terminated by Sponsor|3|||
144424043|NCT02604212|520759476|FG003|Overall Study|Study Terminated by Sponsor|3|||
144424044|NCT02604212|520759473|FG000|Overall Study|Withdrawal by Subject|0|||
144424045|NCT02604212|520759474|FG001|Overall Study|Withdrawal by Subject|0|||
144424046|NCT02604212|520759475|FG002|Overall Study|Withdrawal by Subject|1|||
144424047|NCT02604212|520759476|FG003|Overall Study|Withdrawal by Subject|0|||
144424048|NCT02580357|520759477|FG000|Overall Study|Lost to Follow-up|2|||
144424049|NCT02580357|520759478|FG001|Overall Study|Lost to Follow-up|0|||
144424050|NCT02580357|520759479|FG002|Overall Study|Lost to Follow-up|0|||
144424051|NCT02580357|520759477|FG000|Overall Study|Protocol Violation|1|||
144424052|NCT02580357|520759478|FG001|Overall Study|Protocol Violation|0|||
144424053|NCT02580357|520759479|FG002|Overall Study|Protocol Violation|0|||
144424054|NCT00597766|520759486|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
144424055|NCT00597766|520759487|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
144424056|NCT00597766|520759488|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
144424057|NCT00597766|520759486|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
144424058|NCT00597766|520759487|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
144424059|NCT00597766|520759488|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
144424060|NCT01166763|520759490|FG000|Overall Study|Withdrawal by Subject|3|||
144424061|NCT04339296|520759491|FG000|Overall Study|Refuse to participate after allocation|1|||
144424062|NCT04339296|520759492|FG001|Overall Study|Refuse to participate after allocation|1|||
144424063|NCT04339296|520759491|FG000|Overall Study|Withdrew after completion of baseline|2|||
144424064|NCT04339296|520759492|FG001|Overall Study|Withdrew after completion of baseline|1|||
144424065|NCT04339296|520759491|FG000|Overall Study|Lost to Follow-up|0|||
144424066|NCT04339296|520759492|FG001|Overall Study|Lost to Follow-up|4|||
144424067|NCT04339296|520759491|FG000|Overall Study|Discontinued intervention|5|||
144424068|NCT04339296|520759492|FG001|Overall Study|Discontinued intervention|3|||
144424069|NCT01909479|520759493|FG000|From Baseline to Week 26|Adverse Event|3|||
144424070|NCT01909479|520759494|FG001|From Baseline to Week 26|Adverse Event|2|||
144424071|NCT01909479|520759493|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
144424072|NCT01909479|520759494|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
144424073|NCT01909479|520759493|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
144424074|NCT01909479|520759494|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
144424075|NCT01909479|520759493|FG000|26 - 52 Weeks|Adverse Event|0|||
144424076|NCT01909479|520759494|FG001|26 - 52 Weeks|Adverse Event|1|||
144424077|NCT01909479|520759493|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
144424078|NCT01909479|520759494|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
144424079|NCT01909479|520759493|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
144424080|NCT01909479|520759494|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
144424081|NCT01909479|520759493|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
144424082|NCT01909479|520759494|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
144181161|NCT01139762|519857350|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
144181162|NCT01139762|519857351|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
144181163|NCT01139762|519857349|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
144181164|NCT01139762|519857350|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
144181165|NCT01139762|519857351|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
144181166|NCT01139762|519857349|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
144181167|NCT01139762|519857350|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
144181168|NCT01139762|519857351|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
144181169|NCT01139762|519857349|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
144181170|NCT01139762|519857350|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
144181171|NCT01139762|519857351|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
144181172|NCT01139762|519857349|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
144181173|NCT01139762|519857350|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
144181174|NCT01139762|519857351|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
144181175|NCT01139762|519857349|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
144181176|NCT01139762|519857350|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
144181177|NCT01139762|519857351|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
144181178|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
144181179|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
144181180|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
144181181|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Death|0|||
144181182|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Death|1|||
144181183|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Death|1|||
144181184|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
144181185|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
144181186|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
144181187|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
144181188|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
144181189|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
144181190|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
144181191|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
144181192|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
144181193|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
144181194|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
144181195|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
144181196|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
144181197|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
144181198|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
144181199|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
144181200|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
144181201|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
144181202|NCT01139762|519857349|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
144181203|NCT01139762|519857350|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
144181204|NCT01139762|519857351|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
144181205|NCT01912807|519857352|FG000|Overall Study|Did not meet elegibility criteria|6|||
144181206|NCT01912807|519857353|FG001|Overall Study|Did not meet elegibility criteria|4|||
144181207|NCT01912807|519857352|FG000|Overall Study|Lost to Follow-up|36|||
144424083|NCT01909479|520759493|FG000|52 Weeks to End of Study|Adverse Event|2|||
144424084|NCT01909479|520759494|FG001|52 Weeks to End of Study|Adverse Event|1|||
144424085|NCT01909479|520759493|FG000|52 Weeks to End of Study|Death|0|||
144424086|NCT01909479|520759494|FG001|52 Weeks to End of Study|Death|1|||
144424087|NCT01909479|520759493|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
144424088|NCT01909479|520759494|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
144424089|NCT01909479|520759493|FG000|52 Weeks to End of Study|Protocol Violation|1|||
144601159|NCT02616614|521403347|FG002|Overall Study|Adverse Event|1|||
144181208|NCT01912807|519857353|FG001|Overall Study|Lost to Follow-up|37|||
144181209|NCT04750239|519857354|FG000|Overall Study|Withdrawal by Subject|2|||
144181210|NCT04750239|519857354|FG000|Overall Study|Trial terminated by sponsor|1|||
144181211|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Adverse Event|8|||
144181212|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Adverse Event|5|||
144181213|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Adverse Event|9|||
144251247|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
144601160|NCT02616614|521403345|FG000|Overall Study|Protocol Violation|0|||
144601161|NCT02616614|521403346|FG001|Overall Study|Protocol Violation|3|||
144181214|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Adverse Event|0|||
144181215|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Adverse Event|0|||
144424090|NCT01909479|520759494|FG001|52 Weeks to End of Study|Protocol Violation|0|||
144601162|NCT02616614|521403347|FG002|Overall Study|Protocol Violation|1|||
144181216|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Adverse Event|0|||
144601163|NCT02616614|521403345|FG000|Overall Study|Prohibited Medication|12|||
144601164|NCT02616614|521403346|FG001|Overall Study|Prohibited Medication|9|||
144601165|NCT02616614|521403347|FG002|Overall Study|Prohibited Medication|5|||
144601166|NCT02616614|521403345|FG000|Overall Study|More than 3 applications missed|6|||
144601167|NCT02616614|521403346|FG001|Overall Study|More than 3 applications missed|8|||
144601168|NCT02616614|521403347|FG002|Overall Study|More than 3 applications missed|1|||
144601169|NCT02616614|521403345|FG000|Overall Study|Lost to Follow-up|31|||
144601170|NCT02616614|521403346|FG001|Overall Study|Lost to Follow-up|28|||
144601171|NCT02616614|521403347|FG002|Overall Study|Lost to Follow-up|13|||
144601172|NCT02616614|521403345|FG000|Overall Study|Pregnancy|2|||
144601173|NCT02616614|521403346|FG001|Overall Study|Pregnancy|0|||
144601174|NCT02616614|521403347|FG002|Overall Study|Pregnancy|1|||
144601175|NCT02616614|521403345|FG000|Overall Study|Other|1|||
144601176|NCT02616614|521403346|FG001|Overall Study|Other|2|||
144601177|NCT02616614|521403347|FG002|Overall Study|Other|1|||
144601178|NCT01214187|521403348|FG000|Overall Study|Adverse Event|6|||
144601179|NCT01214187|521403349|FG001|Overall Study|Adverse Event|2|||
144601180|NCT01214187|521403348|FG000|Overall Study|Death|1|||
144601181|NCT01214187|521403349|FG001|Overall Study|Death|1|||
144601182|NCT01214187|521403348|FG000|Overall Study|Withdrawal by Subject|0|||
144601183|NCT01214187|521403349|FG001|Overall Study|Withdrawal by Subject|3|||
144601184|NCT01233869|521403350|FG000|Initial Treatment Period (24 Months)|Death|1|||
144601185|NCT01233869|521403351|FG001|Initial Treatment Period (24 Months)|Death|0|||
144601186|NCT01233869|521403352|FG002|Initial Treatment Period (24 Months)|Death|0|||
144601187|NCT01233869|521403353|FG003|Initial Treatment Period (24 Months)|Death|0|||
144601188|NCT01233869|521403350|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
144601189|NCT01233869|521403351|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
144601190|NCT01233869|521403352|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
144601191|NCT01233869|521403353|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
144601192|NCT01233869|521403350|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
144601193|NCT01233869|521403351|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
144601194|NCT01233869|521403352|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
144601195|NCT01233869|521403353|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
144601196|NCT01233869|521403350|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
144601197|NCT01233869|521403351|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
144601198|NCT01233869|521403352|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
144601199|NCT01233869|521403353|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
144601200|NCT01233869|521403350|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
144601201|NCT01233869|521403351|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
144601202|NCT01233869|521403352|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
144601203|NCT01233869|521403353|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
144601204|NCT01233869|521403350|FG000|Extended Treatment Period (46 Months)|Other|3|||
144601205|NCT01233869|521403351|FG001|Extended Treatment Period (46 Months)|Other|0|||
144601206|NCT01233869|521403352|FG002|Extended Treatment Period (46 Months)|Other|0|||
144601207|NCT01233869|521403353|FG003|Extended Treatment Period (46 Months)|Other|3|||
144601208|NCT01233869|521403350|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
144601209|NCT01233869|521403351|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
144601210|NCT01233869|521403352|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
144601211|NCT01233869|521403353|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
144424091|NCT01909479|520759493|FG000|52 Weeks to End of Study|Progressive disease|1|||
144424092|NCT01909479|520759494|FG001|52 Weeks to End of Study|Progressive disease|1|||
144424093|NCT01909479|520759493|FG000|52 Weeks to End of Study|Personal reasons|2|||
144424094|NCT01909479|520759494|FG001|52 Weeks to End of Study|Personal reasons|1|||
144424095|NCT01909479|520759493|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
144424096|NCT01909479|520759494|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
144424097|NCT01909479|520759493|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
144424098|NCT01909479|520759494|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
144424099|NCT01909479|520759493|FG000|52 Weeks to End of Study|Lack of contact|1|||
144424100|NCT01909479|520759494|FG001|52 Weeks to End of Study|Lack of contact|0|||
144424101|NCT01909479|520759493|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
144424102|NCT01909479|520759494|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
144181217|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
144181218|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
144181219|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
144181220|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
144181221|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
144181222|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
144181223|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
144181224|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
144181225|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
144181226|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
144181227|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
144424103|NCT01909479|520759493|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
144424104|NCT01909479|520759494|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
144424105|NCT02375113|520759497|FG000|Overall Study|Undisclosed Reason(s).|1|||
144424106|NCT02375113|520759498|FG001|Overall Study|Undisclosed Reason(s).|1|||
144424107|NCT02375113|520759497|FG000|Overall Study|Poor adherence (<70%).|1|||
144424108|NCT02375113|520759498|FG001|Overall Study|Poor adherence (<70%).|0|||
144424109|NCT02375113|520759497|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
144424110|NCT02375113|520759498|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
144424111|NCT00511667|520759512|FG000|Overall Study|Adverse Event|1|||
144424112|NCT00511667|520759513|FG001|Overall Study|Adverse Event|0|||
144424113|NCT00511667|520759512|FG000|Overall Study|Protocol Violation|1|||
144424114|NCT00511667|520759513|FG001|Overall Study|Protocol Violation|1|||
144424115|NCT00511667|520759512|FG000|Overall Study|Withdrawal by Subject|2|||
144424116|NCT00511667|520759513|FG001|Overall Study|Withdrawal by Subject|0|||
144424117|NCT00511667|520759512|FG000|Overall Study|Site terminated|6|||
144424118|NCT00511667|520759513|FG001|Overall Study|Site terminated|1|||
144424119|NCT00511667|520759512|FG000|Overall Study|Other|2|||
144424120|NCT00511667|520759513|FG001|Overall Study|Other|1|||
144424121|NCT03605303|520759514|FG000|Period 1|Study Terminated|2|||
144424122|NCT03605303|520759515|FG001|Period 1|Study Terminated|1|||
144424123|NCT00309842|520759516|FG000|Overall Study|Lost to Follow-up|1|||
144424124|NCT02626520|520759517|FG000|Overall Study|Physician Decision|1|||
144424125|NCT02626520|520759518|FG001|Overall Study|Physician Decision|1|||
144424126|NCT02626520|520759517|FG000|Overall Study|Adverse Event|0|||
144181228|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
144424127|NCT02626520|520759518|FG001|Overall Study|Adverse Event|4|||
144424128|NCT02626520|520759517|FG000|Overall Study|Lack of Efficacy|0|||
144424129|NCT02626520|520759518|FG001|Overall Study|Lack of Efficacy|2|||
144424130|NCT02626520|520759517|FG000|Overall Study|Did not start protocol therapy|0|||
144424131|NCT02626520|520759518|FG001|Overall Study|Did not start protocol therapy|2|||
144424132|NCT02626520|520759517|FG000|Overall Study|Study terminated|0|||
144424133|NCT02626520|520759518|FG001|Overall Study|Study terminated|1|||
144424134|NCT02953314|520759519|FG000|Overall Study|Adverse Event|0|||
144424135|NCT02953314|520759520|FG001|Overall Study|Adverse Event|1|||
144424136|NCT02953314|520759519|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
144424137|NCT02953314|520759520|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
144424138|NCT00492115|520759521|FG000|Overall Study|Withdrawal by Subject|3|||
144424139|NCT00492115|520759522|FG001|Overall Study|Withdrawal by Subject|4|||
144424140|NCT02045797|520759525|FG000|Overall Study|Adverse Event|3|||
144424141|NCT02045797|520759526|FG001|Overall Study|Adverse Event|1|||
144424142|NCT02045797|520759527|FG002|Overall Study|Adverse Event|0|||
144424143|NCT02045797|520759525|FG000|Overall Study|Lack of Efficacy|1|||
144424144|NCT02045797|520759526|FG001|Overall Study|Lack of Efficacy|0|||
144424145|NCT02045797|520759527|FG002|Overall Study|Lack of Efficacy|0|||
144424146|NCT02045797|520759525|FG000|Overall Study|Lost to Follow-up|2|||
144424147|NCT02045797|520759526|FG001|Overall Study|Lost to Follow-up|3|||
144424148|NCT02045797|520759527|FG002|Overall Study|Lost to Follow-up|1|||
144424149|NCT02045797|520759525|FG000|Overall Study|Physician Decision|0|||
144424150|NCT02045797|520759526|FG001|Overall Study|Physician Decision|1|||
144424151|NCT02045797|520759527|FG002|Overall Study|Physician Decision|0|||
144424152|NCT02045797|520759525|FG000|Overall Study|Withdrawal by Subject|1|||
144424153|NCT02045797|520759526|FG001|Overall Study|Withdrawal by Subject|2|||
144424154|NCT02045797|520759527|FG002|Overall Study|Withdrawal by Subject|0|||
144424155|NCT03232281|520761209|FG000|Overall Study|Adverse Event|1|||
144424156|NCT03232281|520761210|FG001|Overall Study|Adverse Event|1|||
144424157|NCT03232281|520761209|FG000|Overall Study|Withdrawal by Subject|5|||
144424158|NCT03232281|520761210|FG001|Overall Study|Withdrawal by Subject|4|||
144424159|NCT03232281|520761209|FG000|Overall Study|Protocol Deviation|1|||
144424160|NCT03232281|520761210|FG001|Overall Study|Protocol Deviation|1|||
144424161|NCT05407675|520761215|FG000|Overall Study|Withdrawal by Subject|0|||
144424162|NCT05407675|520761216|FG001|Overall Study|Withdrawal by Subject|2|||
144424163|NCT05407675|520761217|FG002|Overall Study|Withdrawal by Subject|3|||
144181229|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Physician Decision|4|||
144424164|NCT05407675|520761218|FG003|Overall Study|Withdrawal by Subject|5|||
144424165|NCT05407675|520761219|FG004|Overall Study|Withdrawal by Subject|0|||
144424166|NCT05407675|520761220|FG005|Overall Study|Withdrawal by Subject|2|||
144424167|NCT05407675|520761221|FG006|Overall Study|Withdrawal by Subject|0|||
144424168|NCT05407675|520761222|FG007|Overall Study|Withdrawal by Subject|0|||
144424169|NCT05407675|520761223|FG008|Overall Study|Withdrawal by Subject|2|||
144424170|NCT05407675|520761224|FG009|Overall Study|Withdrawal by Subject|0|||
144424171|NCT05407675|520761225|FG010|Overall Study|Withdrawal by Subject|1|||
144424172|NCT05407675|520761226|FG011|Overall Study|Withdrawal by Subject|0|||
144424173|NCT05407675|520761227|FG012|Overall Study|Withdrawal by Subject|0|||
144424174|NCT05407675|520761215|FG000|Overall Study|Site terminated by sponsor|0|||
144424175|NCT05407675|520761216|FG001|Overall Study|Site terminated by sponsor|0|||
144181230|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Physician Decision|0|||
144181231|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Physician Decision|2|||
144424176|NCT05407675|520761217|FG002|Overall Study|Site terminated by sponsor|1|||
144251248|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
144251249|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
144251250|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
144251251|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
144251252|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
144251253|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
144251254|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
144251255|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
144251256|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
144251257|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
144251258|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
144251259|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
144251260|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
144251261|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
144251262|NCT01026818|520119282|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
144251263|NCT01026818|520119283|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
144251264|NCT01026818|520119284|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
144251265|NCT01026818|520119285|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
144251266|NCT01026818|520119282|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
144251267|NCT01026818|520119283|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
144251268|NCT01026818|520119284|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
144251269|NCT01026818|520119285|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
144251270|NCT01026818|520119282|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
144251271|NCT01026818|520119283|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
144251272|NCT01026818|520119284|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
144424177|NCT05407675|520761218|FG003|Overall Study|Site terminated by sponsor|0|||
144424178|NCT05407675|520761219|FG004|Overall Study|Site terminated by sponsor|2|||
144424179|NCT05407675|520761220|FG005|Overall Study|Site terminated by sponsor|0|||
144601212|NCT01237340|521403360|FG000|Overall Study|Adverse Event|3|||
144601213|NCT01237340|521403360|FG000|Overall Study|Withdrawal by Subject|1|||
144601214|NCT01237340|521403360|FG000|Overall Study|Early termination of the trial|36|||
144601215|NCT01610687|521403361|FG000|Overall Study|Lack of Efficacy|26|||
144601216|NCT01610687|521403361|FG000|Overall Study|Adverse Event|18|||
144601217|NCT01610687|521403361|FG000|Overall Study|Moved out of area|6|||
144601218|NCT01610687|521403361|FG000|Overall Study|Withdrawal by Subject|7|||
144601219|NCT01610687|521403361|FG000|Overall Study|Lost to Follow-up|4|||
144601220|NCT01610687|521403361|FG000|Overall Study|Symptom control without study medication|2|||
144601221|NCT01610687|521403361|FG000|Overall Study|Unable to make journey|1|||
144601222|NCT01610687|521403361|FG000|Overall Study|Death|1|||
144601223|NCT01610687|521403361|FG000|Overall Study|Cannabis affecting job|1|||
144723252|NCT01290263|521842271|FG002|Overall Study|Adverse Event|0|||
144723253|NCT01290263|521842272|FG003|Overall Study|Adverse Event|1|||
144181232|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Physician Decision|0|||
144181233|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Physician Decision|0|||
144181234|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Physician Decision|0|||
144181235|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Pregnancy|1|||
144181236|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Pregnancy|2|||
144181237|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Pregnancy|0|||
144181238|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Pregnancy|0|||
144424180|NCT05407675|520761221|FG006|Overall Study|Site terminated by sponsor|1|||
144424181|NCT05407675|520761222|FG007|Overall Study|Site terminated by sponsor|0|||
144424182|NCT05407675|520761223|FG008|Overall Study|Site terminated by sponsor|0|||
144424183|NCT05407675|520761224|FG009|Overall Study|Site terminated by sponsor|2|||
144601224|NCT01610687|521403361|FG000|Overall Study|Felt more alter without study medication|1|||
144601225|NCT03836807|521403362|FG000|Overall Study|Physician Decision|1|||
144601226|NCT03836807|521403363|FG001|Overall Study|Physician Decision|0|||
144181239|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Pregnancy|0|||
144181240|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Pregnancy|0|||
144181241|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
144181242|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
144601227|NCT01272947|521403364|FG000|Overall Study|Abnormal Laboratory Value|2|||
144601228|NCT01272947|521403365|FG001|Overall Study|Abnormal Laboratory Value|2|||
144601229|NCT02019420|521403368|FG000|Overall Study|Did not receive study drug|2|||
144601230|NCT02019420|521403369|FG001|Overall Study|Did not receive study drug|2|||
144601231|NCT02019420|521403368|FG000|Overall Study|Withdrawal by Subject|1|||
144601232|NCT02019420|521403369|FG001|Overall Study|Withdrawal by Subject|3|||
144723254|NCT01290263|521842273|FG004|Overall Study|Adverse Event|1|||
144181243|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
144527984|NCT05309291|521135408|FG000|Overall Study|Adverse Event|0|||
144527985|NCT05309291|521135409|FG001|Overall Study|Adverse Event|1|||
144527986|NCT05209152|521135410|FG000|Overall Study|Sponsor decision|1|||
144527987|NCT05209152|521135411|FG001|Overall Study|Sponsor decision|2|||
144527988|NCT05209152|521135410|FG000|Overall Study|Death|3|||
144527989|NCT05209152|521135411|FG001|Overall Study|Death|1|||
144527990|NCT04857723|521135413|FG000|Overall Study|Withdrawal by Subject|2|||
144527991|NCT03221426|521135414|FG000|Overall Study|Ongoing in study|212|||
144527992|NCT03221426|521135415|FG001|Overall Study|Ongoing in study|193|||
144527993|NCT03221426|521135416|FG002|Overall Study|Ongoing in study|61|||
144527994|NCT03221426|521135417|FG003|Overall Study|Ongoing in study|55|||
144527995|NCT03221426|521135414|FG000|Overall Study|Withdrawal by Subject|12|||
144527996|NCT03221426|521135415|FG001|Overall Study|Withdrawal by Subject|4|||
144527997|NCT03221426|521135416|FG002|Overall Study|Withdrawal by Subject|2|||
144527998|NCT03221426|521135417|FG003|Overall Study|Withdrawal by Subject|3|||
144527999|NCT03221426|521135414|FG000|Overall Study|Lost to Follow-up|4|||
144528000|NCT03221426|521135415|FG001|Overall Study|Lost to Follow-up|1|||
144528001|NCT03221426|521135416|FG002|Overall Study|Lost to Follow-up|1|||
144528002|NCT03221426|521135417|FG003|Overall Study|Lost to Follow-up|0|||
144528003|NCT03221426|521135414|FG000|Overall Study|Death|174|||
144528004|NCT03221426|521135415|FG001|Overall Study|Death|204|||
144528005|NCT03221426|521135416|FG002|Overall Study|Death|36|||
144528006|NCT03221426|521135417|FG003|Overall Study|Death|45|||
144528007|NCT05029622|521137055|FG000|Overall Study|Lost to Follow-up|1|||
144528008|NCT03899259|521137062|FG000|Overall Study|Adverse Event|5|||
144528009|NCT03899259|521137063|FG001|Overall Study|Adverse Event|4|||
144528010|NCT03899259|521137064|FG002|Overall Study|Adverse Event|6|||
144528011|NCT03899259|521137062|FG000|Overall Study|Lack of Efficacy|5|||
144528012|NCT03899259|521137063|FG001|Overall Study|Lack of Efficacy|0|||
144528013|NCT03899259|521137064|FG002|Overall Study|Lack of Efficacy|2|||
144528014|NCT03899259|521137062|FG000|Overall Study|Pregnancy|3|||
144528015|NCT03899259|521137063|FG001|Overall Study|Pregnancy|0|||
144528016|NCT03899259|521137064|FG002|Overall Study|Pregnancy|1|||
144528017|NCT03899259|521137062|FG000|Overall Study|Physician Decision|0|||
144528018|NCT03899259|521137063|FG001|Overall Study|Physician Decision|1|||
144528019|NCT03899259|521137064|FG002|Overall Study|Physician Decision|0|||
144528020|NCT03899259|521137062|FG000|Overall Study|Protocol Deviation|1|||
144528021|NCT03899259|521137063|FG001|Overall Study|Protocol Deviation|1|||
144528022|NCT03899259|521137064|FG002|Overall Study|Protocol Deviation|1|||
144528023|NCT03899259|521137062|FG000|Overall Study|Withdrawal by Subject|8|||
144528024|NCT03899259|521137063|FG001|Overall Study|Withdrawal by Subject|10|||
144528025|NCT03899259|521137064|FG002|Overall Study|Withdrawal by Subject|12|||
144528026|NCT03899259|521137062|FG000|Overall Study|Lost to Follow-up|5|||
144601233|NCT02019420|521403368|FG000|Overall Study|At request of sponsor or investigator|0|||
144601234|NCT02019420|521403369|FG001|Overall Study|At request of sponsor or investigator|1|||
144601235|NCT02019420|521403368|FG000|Overall Study|Death|104|||
144601236|NCT02019420|521403369|FG001|Overall Study|Death|99|||
144601237|NCT02019420|521403368|FG000|Overall Study|Transferred to other care facility|1|||
144601238|NCT02019420|521403369|FG001|Overall Study|Transferred to other care facility|1|||
144601239|NCT01093625|521403374|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
144601240|NCT01093625|521403375|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
144601241|NCT01093625|521403374|FG000|2-Week Visit|Withdrawal by Subject|1|||
144601242|NCT01093625|521403375|FG001|2-Week Visit|Withdrawal by Subject|0|||
144601243|NCT01093625|521403374|FG000|1-Month Visit|Lost to Follow-up|2|||
144601244|NCT01093625|521403375|FG001|1-Month Visit|Lost to Follow-up|0|||
144601245|NCT01093625|521403374|FG000|3-Month Visit|Lost to Follow-up|2|||
144601246|NCT01093625|521403375|FG001|3-Month Visit|Lost to Follow-up|0|||
144601247|NCT01093625|521403374|FG000|6-Month Visit|Withdrawal by Subject|6|||
144181244|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
144181245|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
144181246|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
144601248|NCT01093625|521403375|FG001|6-Month Visit|Withdrawal by Subject|7|||
144601249|NCT01093625|521403374|FG000|6-Month Visit|Lost to Follow-up|2|||
144601250|NCT01093625|521403375|FG001|6-Month Visit|Lost to Follow-up|2|||
144601251|NCT01093625|521403374|FG000|1-Year Visit|Lost to Follow-up|5|||
144601252|NCT01093625|521403375|FG001|1-Year Visit|Lost to Follow-up|3|||
144601253|NCT04233164|521403380|FG000|Overall Study|Unable to obtain specimen|0|||
144601254|NCT04233164|521403381|FG001|Overall Study|Unable to obtain specimen|1|||
144528027|NCT03899259|521137063|FG001|Overall Study|Lost to Follow-up|6|||
144528028|NCT03899259|521137064|FG002|Overall Study|Lost to Follow-up|2|||
144528029|NCT03899259|521137062|FG000|Overall Study|Lack of Adherence|1|||
144528030|NCT03899259|521137063|FG001|Overall Study|Lack of Adherence|0|||
144528031|NCT03899259|521137064|FG002|Overall Study|Lack of Adherence|0|||
144528032|NCT03899259|521137062|FG000|Overall Study|Screen Failure|1|||
144528033|NCT03899259|521137063|FG001|Overall Study|Screen Failure|0|||
144528034|NCT03899259|521137064|FG002|Overall Study|Screen Failure|0|||
144528035|NCT03899259|521137062|FG000|Overall Study|Ongoing Study Participation|127|||
144528036|NCT03899259|521137063|FG001|Overall Study|Ongoing Study Participation|134|||
144528037|NCT03899259|521137064|FG002|Overall Study|Ongoing Study Participation|210|||
144251273|NCT01026818|520119285|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
144251274|NCT01026818|520119282|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
144251275|NCT01026818|520119283|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
144251276|NCT01026818|520119284|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
144251277|NCT01026818|520119285|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
144251278|NCT01026818|520119282|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
144251279|NCT01026818|520119283|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
144251280|NCT01026818|520119284|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
144251281|NCT01026818|520119285|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
144601255|NCT01843218|521403382|FG000|Overall Study|Withdrawal by Subject|5|||
144601256|NCT01431534|521403383|FG000|Treatment Phase|Adverse Event|0|||
144601257|NCT01431534|521403384|FG001|Treatment Phase|Adverse Event|0|||
144601258|NCT01431534|521403385|FG002|Treatment Phase|Adverse Event|1|||
144601259|NCT01431534|521403383|FG000|Treatment Phase|Progressive Disease|4|||
144601260|NCT01431534|521403384|FG001|Treatment Phase|Progressive Disease|3|||
144601261|NCT01431534|521403385|FG002|Treatment Phase|Progressive Disease|10|||
144601262|NCT01009554|521403386|FG000|Overall Study|Adverse Event|1|||
144601263|NCT01009554|521403387|FG001|Overall Study|Adverse Event|1|||
144601264|NCT01009554|521403386|FG000|Overall Study|Withdrawal by Subject|1|||
144601265|NCT01009554|521403387|FG001|Overall Study|Withdrawal by Subject|3|||
144601266|NCT01009554|521403386|FG000|Overall Study|Noncompliant with Study Product|0|||
144601267|NCT01009554|521403387|FG001|Overall Study|Noncompliant with Study Product|3|||
144601268|NCT01605253|521403388|FG000|Overall Study|Physician Decision|3|||
144601269|NCT01605253|521403389|FG001|Overall Study|Physician Decision|2|||
144601270|NCT01605253|521403388|FG000|Overall Study|Lost to Follow-up|3|||
144601271|NCT01605253|521403389|FG001|Overall Study|Lost to Follow-up|1|||
144601272|NCT04427501|521403392|FG000|Overall Study|Death|0|||
144601273|NCT04427501|521403393|FG001|Overall Study|Death|0|||
144601274|NCT04427501|521403394|FG002|Overall Study|Death|0|||
144601275|NCT04427501|521403395|FG003|Overall Study|Death|0|||
144601276|NCT04427501|521403396|FG004|Overall Study|Death|0|||
144601277|NCT04427501|521403397|FG005|Overall Study|Death|15|||
144601278|NCT04427501|521403398|FG006|Overall Study|Death|0|||
144601279|NCT04427501|521403399|FG007|Overall Study|Death|0|||
144601280|NCT04427501|521403400|FG008|Overall Study|Death|0|||
144601281|NCT04427501|521403401|FG009|Overall Study|Death|0|||
144601282|NCT04427501|521403402|FG010|Overall Study|Death|0|||
144601283|NCT04427501|521403403|FG011|Overall Study|Death|0|||
144601284|NCT04427501|521403392|FG000|Overall Study|Lost to Follow-up|5|||
144601285|NCT04427501|521403393|FG001|Overall Study|Lost to Follow-up|1|||
144601286|NCT04427501|521403394|FG002|Overall Study|Lost to Follow-up|2|||
144601287|NCT04427501|521403395|FG003|Overall Study|Lost to Follow-up|0|||
144601288|NCT04427501|521403396|FG004|Overall Study|Lost to Follow-up|2|||
144601289|NCT04427501|521403397|FG005|Overall Study|Lost to Follow-up|11|||
144601290|NCT04427501|521403398|FG006|Overall Study|Lost to Follow-up|10|||
144601291|NCT04427501|521403399|FG007|Overall Study|Lost to Follow-up|10|||
144601292|NCT04427501|521403400|FG008|Overall Study|Lost to Follow-up|2|||
144601293|NCT04427501|521403401|FG009|Overall Study|Lost to Follow-up|5|||
144601294|NCT04427501|521403402|FG010|Overall Study|Lost to Follow-up|2|||
144601295|NCT04427501|521403403|FG011|Overall Study|Lost to Follow-up|0|||
144601296|NCT04427501|521403392|FG000|Overall Study|Physician Decision|0|||
144601297|NCT04427501|521403393|FG001|Overall Study|Physician Decision|3|||
144601298|NCT04427501|521403394|FG002|Overall Study|Physician Decision|0|||
144601299|NCT04427501|521403395|FG003|Overall Study|Physician Decision|0|||
144601300|NCT04427501|521403396|FG004|Overall Study|Physician Decision|0|||
144601301|NCT04427501|521403397|FG005|Overall Study|Physician Decision|0|||
144601302|NCT04427501|521403398|FG006|Overall Study|Physician Decision|2|||
144601303|NCT04427501|521403399|FG007|Overall Study|Physician Decision|0|||
144601304|NCT04427501|521403400|FG008|Overall Study|Physician Decision|0|||
144528038|NCT01197378|521137065|FG000|Overall Study|Adverse Event|3|||
144528039|NCT01197378|521137065|FG000|Overall Study|Withdrawal by Subject|1|||
144528040|NCT01197378|521137065|FG000|Overall Study|Physician Decision|1|||
144528041|NCT01197378|521137065|FG000|Overall Study|Other|2|||
144528042|NCT06232590|521137066|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
144528043|NCT06232590|521137067|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
144528044|NCT05139810|521137068|FG000|Overall Study|Voluntary Withdrawal|2|||
144528045|NCT05139810|521137069|FG001|Overall Study|Voluntary Withdrawal|1|||
144601305|NCT04427501|521403401|FG009|Overall Study|Physician Decision|0|||
144601306|NCT04427501|521403402|FG010|Overall Study|Physician Decision|0|||
144251282|NCT01026818|520119282|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
144251283|NCT01026818|520119283|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
144601307|NCT04427501|521403403|FG011|Overall Study|Physician Decision|0|||
144601308|NCT04427501|521403392|FG000|Overall Study|Withdrawal by Subject|9|||
144528046|NCT05139810|521137070|FG002|Overall Study|Voluntary Withdrawal|0|||
144601309|NCT04427501|521403393|FG001|Overall Study|Withdrawal by Subject|2|||
144601310|NCT04427501|521403394|FG002|Overall Study|Withdrawal by Subject|2|||
144601311|NCT04427501|521403395|FG003|Overall Study|Withdrawal by Subject|3|||
144601312|NCT04427501|521403396|FG004|Overall Study|Withdrawal by Subject|7|||
144723255|NCT01290263|521842269|FG000|Overall Study|Lack of Efficacy|8|||
144723256|NCT01290263|521842270|FG001|Overall Study|Lack of Efficacy|2|||
144723257|NCT01290263|521842271|FG002|Overall Study|Lack of Efficacy|7|||
144723258|NCT01290263|521842272|FG003|Overall Study|Lack of Efficacy|24|||
144723259|NCT01290263|521842273|FG004|Overall Study|Lack of Efficacy|33|||
144723260|NCT01290263|521842269|FG000|Overall Study|Withdrawal by Subject|3|||
144723261|NCT01290263|521842270|FG001|Overall Study|Withdrawal by Subject|1|||
144723262|NCT01290263|521842271|FG002|Overall Study|Withdrawal by Subject|0|||
144723263|NCT01290263|521842272|FG003|Overall Study|Withdrawal by Subject|1|||
144723264|NCT01290263|521842273|FG004|Overall Study|Withdrawal by Subject|2|||
144723265|NCT01290263|521842269|FG000|Overall Study|Participant Non-Compliance|0|||
144723266|NCT01290263|521842270|FG001|Overall Study|Participant Non-Compliance|0|||
144723267|NCT01290263|521842271|FG002|Overall Study|Participant Non-Compliance|0|||
144723268|NCT01290263|521842272|FG003|Overall Study|Participant Non-Compliance|1|||
144723269|NCT01290263|521842273|FG004|Overall Study|Participant Non-Compliance|1|||
144723270|NCT01521559|521842274|FG000|Overall Study|Adverse Event|0|||
144723271|NCT01521559|521842275|FG001|Overall Study|Adverse Event|4|||
144723272|NCT01521559|521842274|FG000|Overall Study|Death|1|||
144723273|NCT01521559|521842275|FG001|Overall Study|Death|0|||
144723274|NCT01521559|521842274|FG000|Overall Study|Withdrawal by Subject|9|||
144723275|NCT01521559|521842275|FG001|Overall Study|Withdrawal by Subject|11|||
144723276|NCT01521559|521842274|FG000|Overall Study|Lost to Follow-up|3|||
144723277|NCT01521559|521842275|FG001|Overall Study|Lost to Follow-up|1|||
144723278|NCT01521559|521842274|FG000|Overall Study|Protocol Violation|1|||
144723279|NCT01521559|521842275|FG001|Overall Study|Protocol Violation|0|||
144723280|NCT01521559|521842274|FG000|Overall Study|Other|1|||
144723281|NCT01521559|521842275|FG001|Overall Study|Other|2|||
144723282|NCT02918162|521842277|FG000|Overall Study|Withdrawal by Subject|1|||
144723283|NCT02918162|521842277|FG000|Overall Study|Omental Disease|1|||
144723284|NCT00395226|521842278|FG000|Overall Study|Adverse Event|4|||
144723285|NCT00395226|521842279|FG001|Overall Study|Adverse Event|3|||
144723286|NCT00395226|521842278|FG000|Overall Study|Withdrawal by Subject|0|||
144723287|NCT00395226|521842279|FG001|Overall Study|Withdrawal by Subject|1|||
144723288|NCT00395226|521842278|FG000|Overall Study|Lost to Follow-up|0|||
144723289|NCT00395226|521842279|FG001|Overall Study|Lost to Follow-up|1|||
144723290|NCT02374918|521842280|FG000|Overall Study|Protocol Violation|2|||
144723291|NCT02374918|521842281|FG001|Overall Study|Protocol Violation|0|||
144723292|NCT02374918|521842282|FG002|Overall Study|Protocol Violation|2|||
144723293|NCT02374918|521842283|FG003|Overall Study|Protocol Violation|1|||
144723294|NCT02374918|521842280|FG000|Overall Study|Withdrawal by Subject|1|||
144723295|NCT02374918|521842281|FG001|Overall Study|Withdrawal by Subject|1|||
144723296|NCT02374918|521842282|FG002|Overall Study|Withdrawal by Subject|1|||
144723297|NCT02374918|521842283|FG003|Overall Study|Withdrawal by Subject|0|||
144723298|NCT02374918|521842280|FG000|Overall Study|Lack of Efficacy|0|||
144424184|NCT05407675|520761225|FG010|Overall Study|Site terminated by sponsor|2|||
144424185|NCT05407675|520761226|FG011|Overall Study|Site terminated by sponsor|2|||
144424186|NCT05407675|520761227|FG012|Overall Study|Site terminated by sponsor|1|||
144424187|NCT05407675|520761215|FG000|Overall Study|Disease Progression|0|||
144424188|NCT05407675|520761216|FG001|Overall Study|Disease Progression|0|||
144424189|NCT05407675|520761217|FG002|Overall Study|Disease Progression|0|||
144424190|NCT05407675|520761218|FG003|Overall Study|Disease Progression|0|||
144424191|NCT05407675|520761219|FG004|Overall Study|Disease Progression|0|||
144424192|NCT05407675|520761220|FG005|Overall Study|Disease Progression|0|||
144424193|NCT05407675|520761221|FG006|Overall Study|Disease Progression|0|||
144723299|NCT02374918|521842281|FG001|Overall Study|Lack of Efficacy|0|||
144723300|NCT02374918|521842282|FG002|Overall Study|Lack of Efficacy|1|||
144723301|NCT02374918|521842283|FG003|Overall Study|Lack of Efficacy|1|||
144723302|NCT01506947|521842284|FG000|Overall Study|Lost to Follow-up|7|||
144723303|NCT01506947|521842284|FG000|Overall Study|Adverse Event|5|||
144723304|NCT01506947|521842284|FG000|Overall Study|Death|1|||
144723305|NCT01506947|521842284|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
144723306|NCT02752776|521842288|FG000|Overall Study|Adverse Event|15|||
144723307|NCT02752776|521842289|FG001|Overall Study|Adverse Event|23|||
144181247|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
144181248|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
144181249|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
144181250|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
144181251|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
144181252|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
144181253|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
144181254|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
144181255|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
144181256|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
144424194|NCT05407675|520761222|FG007|Overall Study|Disease Progression|0|||
144424195|NCT05407675|520761223|FG008|Overall Study|Disease Progression|0|||
144424196|NCT05407675|520761224|FG009|Overall Study|Disease Progression|0|||
144723308|NCT02752776|521842290|FG002|Overall Study|Adverse Event|11|||
144181257|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
144181258|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
144181259|NCT02614196|519857355|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
144181260|NCT02614196|519857356|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
144424197|NCT05407675|520761225|FG010|Overall Study|Disease Progression|1|||
144424198|NCT05407675|520761226|FG011|Overall Study|Disease Progression|0|||
144424199|NCT05407675|520761227|FG012|Overall Study|Disease Progression|0|||
144424200|NCT05407675|520761215|FG000|Overall Study|Physician Decision|0|||
144424201|NCT05407675|520761216|FG001|Overall Study|Physician Decision|0|||
144424202|NCT05407675|520761217|FG002|Overall Study|Physician Decision|0|||
144424203|NCT05407675|520761218|FG003|Overall Study|Physician Decision|0|||
144424204|NCT05407675|520761219|FG004|Overall Study|Physician Decision|0|||
144424205|NCT05407675|520761220|FG005|Overall Study|Physician Decision|0|||
144424206|NCT05407675|520761221|FG006|Overall Study|Physician Decision|0|||
144424207|NCT05407675|520761222|FG007|Overall Study|Physician Decision|0|||
144424208|NCT05407675|520761223|FG008|Overall Study|Physician Decision|0|||
144424209|NCT05407675|520761224|FG009|Overall Study|Physician Decision|0|||
144424210|NCT05407675|520761225|FG010|Overall Study|Physician Decision|1|||
144424211|NCT05407675|520761226|FG011|Overall Study|Physician Decision|0|||
144424212|NCT05407675|520761227|FG012|Overall Study|Physician Decision|0|||
144424213|NCT05407675|520761215|FG000|Overall Study|Other reasons|0|||
144424214|NCT05407675|520761216|FG001|Overall Study|Other reasons|0|||
144424215|NCT05407675|520761217|FG002|Overall Study|Other reasons|0|||
144424216|NCT05407675|520761218|FG003|Overall Study|Other reasons|0|||
144424217|NCT05407675|520761219|FG004|Overall Study|Other reasons|0|||
144424218|NCT05407675|520761220|FG005|Overall Study|Other reasons|0|||
144424219|NCT05407675|520761221|FG006|Overall Study|Other reasons|0|||
144424220|NCT05407675|520761222|FG007|Overall Study|Other reasons|0|||
144424221|NCT05407675|520761223|FG008|Overall Study|Other reasons|1|||
144424222|NCT05407675|520761224|FG009|Overall Study|Other reasons|1|||
144424223|NCT05407675|520761225|FG010|Overall Study|Other reasons|1|||
144424224|NCT05407675|520761226|FG011|Overall Study|Other reasons|1|||
144424225|NCT05407675|520761227|FG012|Overall Study|Other reasons|0|||
144424226|NCT05407675|520761215|FG000|Overall Study|Death|3|||
144424227|NCT05407675|520761216|FG001|Overall Study|Death|4|||
144424228|NCT05407675|520761217|FG002|Overall Study|Death|3|||
144424229|NCT05407675|520761218|FG003|Overall Study|Death|6|||
144424230|NCT05407675|520761219|FG004|Overall Study|Death|0|||
144424231|NCT05407675|520761220|FG005|Overall Study|Death|2|||
144424232|NCT05407675|520761221|FG006|Overall Study|Death|4|||
144424233|NCT05407675|520761222|FG007|Overall Study|Death|2|||
144424234|NCT05407675|520761223|FG008|Overall Study|Death|2|||
144424235|NCT05407675|520761224|FG009|Overall Study|Death|4|||
144424236|NCT05407675|520761225|FG010|Overall Study|Death|2|||
144424237|NCT05407675|520761226|FG011|Overall Study|Death|1|||
144424238|NCT05407675|520761227|FG012|Overall Study|Death|0|||
144424239|NCT05407675|520761215|FG000|Overall Study|Adverse Event|0|||
144424240|NCT05407675|520761216|FG001|Overall Study|Adverse Event|0|||
144424241|NCT05407675|520761217|FG002|Overall Study|Adverse Event|0|||
144424242|NCT05407675|520761218|FG003|Overall Study|Adverse Event|0|||
144424243|NCT05407675|520761219|FG004|Overall Study|Adverse Event|1|||
144424244|NCT05407675|520761220|FG005|Overall Study|Adverse Event|0|||
144424245|NCT05407675|520761221|FG006|Overall Study|Adverse Event|0|||
144424246|NCT05407675|520761222|FG007|Overall Study|Adverse Event|0|||
144424247|NCT05407675|520761223|FG008|Overall Study|Adverse Event|0|||
144424248|NCT05407675|520761224|FG009|Overall Study|Adverse Event|0|||
144424249|NCT05407675|520761225|FG010|Overall Study|Adverse Event|0|||
144424250|NCT05407675|520761226|FG011|Overall Study|Adverse Event|1|||
144424251|NCT05407675|520761227|FG012|Overall Study|Adverse Event|0|||
144424252|NCT05407675|520761215|FG000|Overall Study|Ongoing Treatment|0|||
144424253|NCT05407675|520761216|FG001|Overall Study|Ongoing Treatment|0|||
144424254|NCT05407675|520761217|FG002|Overall Study|Ongoing Treatment|0|||
144424255|NCT05407675|520761218|FG003|Overall Study|Ongoing Treatment|0|||
144424256|NCT05407675|520761219|FG004|Overall Study|Ongoing Treatment|0|||
144424257|NCT05407675|520761220|FG005|Overall Study|Ongoing Treatment|0|||
144424258|NCT05407675|520761221|FG006|Overall Study|Ongoing Treatment|0|||
144424259|NCT05407675|520761222|FG007|Overall Study|Ongoing Treatment|0|||
144424260|NCT05407675|520761223|FG008|Overall Study|Ongoing Treatment|1|||
144424261|NCT05407675|520761224|FG009|Overall Study|Ongoing Treatment|0|||
144424262|NCT05407675|520761225|FG010|Overall Study|Ongoing Treatment|0|||
144424263|NCT05407675|520761226|FG011|Overall Study|Ongoing Treatment|0|||
144181261|NCT02614196|519857357|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
144424264|NCT05407675|520761227|FG012|Overall Study|Ongoing Treatment|0|||
144424265|NCT04105998|520761228|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
144424266|NCT04105998|520761229|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
144424267|NCT01050257|520761230|FG000|Overall Study|Adverse Event|4|||
144424268|NCT01050257|520761231|FG001|Overall Study|Adverse Event|4|||
144424269|NCT01050257|520761232|FG002|Overall Study|Adverse Event|2|||
144424270|NCT01050257|520761230|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
144424271|NCT01050257|520761231|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
144424272|NCT01050257|520761232|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
144424273|NCT01050257|520761230|FG000|Overall Study|Withdrawal by Subject|0|||
144424274|NCT01050257|520761231|FG001|Overall Study|Withdrawal by Subject|3|||
144424275|NCT01050257|520761232|FG002|Overall Study|Withdrawal by Subject|0|||
144424276|NCT01050257|520761230|FG000|Overall Study|No reason specified|0|||
144424277|NCT01050257|520761231|FG001|Overall Study|No reason specified|0|||
144424278|NCT01050257|520761232|FG002|Overall Study|No reason specified|2|||
144424279|NCT01050257|520761230|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
144424280|NCT01050257|520761231|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
144424281|NCT01050257|520761232|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
144424282|NCT01050257|520761230|FG000|Overall Study|Violation criteria|0|||
144424283|NCT01050257|520761231|FG001|Overall Study|Violation criteria|1|||
144424284|NCT01050257|520761232|FG002|Overall Study|Violation criteria|0|||
144424285|NCT01050257|520761230|FG000|Overall Study|Failure to return|0|||
144424286|NCT01050257|520761231|FG001|Overall Study|Failure to return|2|||
144424287|NCT01050257|520761232|FG002|Overall Study|Failure to return|0|||
144424288|NCT01050257|520761230|FG000|Overall Study|Death|0|||
144424289|NCT01050257|520761231|FG001|Overall Study|Death|0|||
144424290|NCT01050257|520761232|FG002|Overall Study|Death|1|||
144424291|NCT00171223|520761233|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
144424292|NCT00171223|520761234|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
144424293|NCT00171223|520761235|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
144424294|NCT00171223|520761233|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
144424295|NCT00171223|520761234|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
144424296|NCT00171223|520761235|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
144424297|NCT00171223|520761233|FG000|Overall Study|Abnormal Procedure|1|||
144424298|NCT00171223|520761234|FG001|Overall Study|Abnormal Procedure|0|||
144424299|NCT00171223|520761235|FG002|Overall Study|Abnormal Procedure|0|||
144424300|NCT00171223|520761233|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
144424301|NCT00171223|520761234|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
144424302|NCT00171223|520761235|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
144424303|NCT00171223|520761233|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
144528047|NCT05139810|521137068|FG000|Overall Study|Pregnancy|1|||
144528048|NCT05139810|521137069|FG001|Overall Study|Pregnancy|0|||
144528049|NCT05139810|521137070|FG002|Overall Study|Pregnancy|0|||
144528050|NCT05139810|521137068|FG000|Overall Study|Roll Over to CS7|19|||
144528051|NCT05139810|521137069|FG001|Overall Study|Roll Over to CS7|44|||
144528052|NCT05139810|521137070|FG002|Overall Study|Roll Over to CS7|20|||
144528053|NCT03240016|521137071|FG000|Overall Study|Adverse Event|9|||
144528054|NCT03240016|521137071|FG000|Overall Study|Withdrawal by Subject|7|||
144528055|NCT03240016|521137071|FG000|Overall Study|Death|1|||
144528056|NCT03240016|521137071|FG000|Overall Study|Physician Decision|2|||
144528057|NCT05200403|521137072|FG000|Overall Study|Withdrawal by Subject|4|||
144528058|NCT05200403|521137073|FG001|Overall Study|Withdrawal by Subject|2|||
144528059|NCT05200403|521137074|FG002|Overall Study|Withdrawal by Subject|6|||
144538393|NCT03478969|521174179|FG002|Overall Study|Lost to Follow-up|1|||
144538394|NCT01185600|521174180|FG000|Overall Study|Adverse Event|1|||
144538395|NCT01185600|521174181|FG001|Overall Study|Adverse Event|1|||
144538396|NCT01185600|521174180|FG000|Overall Study|Death|0|||
144538397|NCT01185600|521174181|FG001|Overall Study|Death|1|||
144538398|NCT01185600|521174180|FG000|Overall Study|Lost to Follow-up|0|||
144538399|NCT01185600|521174181|FG001|Overall Study|Lost to Follow-up|5|||
144538400|NCT01185600|521174180|FG000|Overall Study|Physician Decision|29|||
144538401|NCT01185600|521174181|FG001|Overall Study|Physician Decision|35|||
144538402|NCT01185600|521174180|FG000|Overall Study|Withdrawal by Subject|1|||
144538403|NCT01185600|521174181|FG001|Overall Study|Withdrawal by Subject|1|||
144538404|NCT01185600|521174180|FG000|Overall Study|Hold by DSMB|1|||
144538405|NCT01185600|521174181|FG001|Overall Study|Hold by DSMB|2|||
144538406|NCT03418922|521174185|FG000|Overall Study|Withdrawal by Subject|0|||
144538407|NCT03418922|521174186|FG001|Overall Study|Withdrawal by Subject|2|||
144538408|NCT03418922|521174185|FG000|Overall Study|Adverse Event|2|||
144538409|NCT03418922|521174186|FG001|Overall Study|Adverse Event|2|||
144538410|NCT03418922|521174185|FG000|Overall Study|Death|0|||
144538411|NCT03418922|521174186|FG001|Overall Study|Death|1|||
144538412|NCT03418922|521174185|FG000|Overall Study|Physician Decision|0|||
144538413|NCT03418922|521174186|FG001|Overall Study|Physician Decision|1|||
144538414|NCT03577106|521174187|FG000|Overall Study|Withdrawal by Subject|3|||
144538415|NCT01579318|521174188|FG000|Overall Study|Disease Progression|1|||
144538416|NCT02347332|521174191|FG000|Overall Study|Not treated|5|||
144538417|NCT02347332|521174192|FG001|Overall Study|Not treated|2|||
144538418|NCT02347332|521174191|FG000|Overall Study|Progressive disease|141|||
144538419|NCT02347332|521174192|FG001|Overall Study|Progressive disease|159|||
144538420|NCT02347332|521174191|FG000|Overall Study|Adverse Event|50|||
144538421|NCT02347332|521174192|FG001|Overall Study|Adverse Event|41|||
144538422|NCT02347332|521174191|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
144538423|NCT02347332|521174192|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
144538424|NCT02347332|521174191|FG000|Overall Study|Protocol Violation|1|||
144424304|NCT00171223|520761234|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
144424305|NCT00171223|520761235|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
144424306|NCT00171223|520761233|FG000|Overall Study|Protocol Violation|2|||
144424307|NCT00171223|520761234|FG001|Overall Study|Protocol Violation|2|||
144424308|NCT00171223|520761235|FG002|Overall Study|Protocol Violation|3|||
144424309|NCT00171223|520761233|FG000|Overall Study|Participant Withdrew Consent|12|||
144424310|NCT00171223|520761234|FG001|Overall Study|Participant Withdrew Consent|21|||
144424311|NCT00171223|520761235|FG002|Overall Study|Participant Withdrew Consent|15|||
144424312|NCT00171223|520761233|FG000|Overall Study|Lost to Follow-up|5|||
144424313|NCT00171223|520761234|FG001|Overall Study|Lost to Follow-up|2|||
144424314|NCT00171223|520761235|FG002|Overall Study|Lost to Follow-up|3|||
144424315|NCT00171223|520761233|FG000|Overall Study|Administrative Problems|4|||
144424316|NCT00171223|520761234|FG001|Overall Study|Administrative Problems|7|||
144424317|NCT00171223|520761235|FG002|Overall Study|Administrative Problems|6|||
144424318|NCT00171223|520761233|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
144424319|NCT00171223|520761234|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
144424320|NCT00171223|520761235|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
144424321|NCT00171223|520761233|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
144424322|NCT00171223|520761234|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
144424323|NCT00171223|520761235|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
144424324|NCT00278109|520761237|FG000|Overall Study|Adverse Event|3|||
144424325|NCT00278109|520761237|FG000|Overall Study|social circumstances|1|||
144424326|NCT00383149|520761241|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
144424327|NCT00383149|520761241|FG000|Overall Study|Death|2|||
144424328|NCT00383149|520761241|FG000|Overall Study|Disease Progression|38|||
144424329|NCT00383149|520761241|FG000|Overall Study|Lost to Follow-up|1|||
144424330|NCT00383149|520761241|FG000|Overall Study|Other|1|||
144424331|NCT00383149|520761241|FG000|Overall Study|Study Drug Toxicity|4|||
144424332|NCT00383149|520761241|FG000|Overall Study|Request to Discontinue Treatment|4|||
144424333|NCT00383149|520761241|FG000|Overall Study|Participant Withdrew Consent|1|||
144424334|NCT00453544|520761250|FG000|Overall Study|Withdrawal by Subject|1|||
144424335|NCT00453544|520761251|FG001|Overall Study|Withdrawal by Subject|0|||
144424336|NCT00453544|520761252|FG002|Overall Study|Withdrawal by Subject|0|||
144424337|NCT00453544|520761253|FG003|Overall Study|Withdrawal by Subject|0|||
144424338|NCT00453544|520761250|FG000|Overall Study|Primary outcome measure not completed|1|||
144424339|NCT00453544|520761251|FG001|Overall Study|Primary outcome measure not completed|1|||
144424340|NCT00453544|520761252|FG002|Overall Study|Primary outcome measure not completed|0|||
144424341|NCT00453544|520761253|FG003|Overall Study|Primary outcome measure not completed|1|||
144424342|NCT03721276|520761256|FG000|Overall Study|Lost to Follow-up|5|||
144424343|NCT03721276|520761257|FG001|Overall Study|Lost to Follow-up|3|||
144424344|NCT03721276|520761256|FG000|Overall Study|Adverse Event|0|||
144601313|NCT04427501|521403397|FG005|Overall Study|Withdrawal by Subject|25|||
144601314|NCT04427501|521403398|FG006|Overall Study|Withdrawal by Subject|15|||
144601315|NCT04427501|521403399|FG007|Overall Study|Withdrawal by Subject|7|||
144601316|NCT04427501|521403400|FG008|Overall Study|Withdrawal by Subject|4|||
144601317|NCT04427501|521403401|FG009|Overall Study|Withdrawal by Subject|1|||
144601318|NCT04427501|521403402|FG010|Overall Study|Withdrawal by Subject|4|||
144601319|NCT04427501|521403403|FG011|Overall Study|Withdrawal by Subject|0|||
144601320|NCT04427501|521403392|FG000|Overall Study|Other - as reported by the investigator|1|||
144601321|NCT04427501|521403393|FG001|Overall Study|Other - as reported by the investigator|0|||
144601322|NCT04427501|521403394|FG002|Overall Study|Other - as reported by the investigator|0|||
144601323|NCT04427501|521403395|FG003|Overall Study|Other - as reported by the investigator|0|||
144601324|NCT04427501|521403396|FG004|Overall Study|Other - as reported by the investigator|0|||
144601325|NCT04427501|521403397|FG005|Overall Study|Other - as reported by the investigator|6|||
144601326|NCT04427501|521403398|FG006|Overall Study|Other - as reported by the investigator|6|||
144601327|NCT04427501|521403399|FG007|Overall Study|Other - as reported by the investigator|0|||
144601328|NCT04427501|521403400|FG008|Overall Study|Other - as reported by the investigator|0|||
144601329|NCT04427501|521403401|FG009|Overall Study|Other - as reported by the investigator|0|||
144601330|NCT04427501|521403402|FG010|Overall Study|Other - as reported by the investigator|0|||
144601331|NCT04427501|521403403|FG011|Overall Study|Other - as reported by the investigator|0|||
144601332|NCT04427501|521403392|FG000|Overall Study|Other|0|||
144601333|NCT04427501|521403393|FG001|Overall Study|Other|0|||
144424345|NCT03721276|520761257|FG001|Overall Study|Adverse Event|1|||
144601334|NCT04427501|521403394|FG002|Overall Study|Other|0|||
144601335|NCT04427501|521403395|FG003|Overall Study|Other|0|||
144601336|NCT04427501|521403396|FG004|Overall Study|Other|0|||
144601337|NCT04427501|521403397|FG005|Overall Study|Other|0|||
144424346|NCT00450333|520761258|FG000|Overall Study|Study terminated|47|||
144424347|NCT00450333|520761259|FG001|Overall Study|Study terminated|54|||
144424348|NCT00450333|520761260|FG002|Overall Study|Study terminated|16|||
144601338|NCT04427501|521403398|FG006|Overall Study|Other|0|||
144601339|NCT04427501|521403399|FG007|Overall Study|Other|0|||
144601340|NCT04427501|521403400|FG008|Overall Study|Other|0|||
144424349|NCT00450333|520761261|FG003|Overall Study|Study terminated|21|||
144528060|NCT05299723|521137075|FG000|Overall Study|Withdrawal by Subject|0|||
144528061|NCT05299723|521137076|FG001|Overall Study|Withdrawal by Subject|2|||
144528062|NCT05299723|521137077|FG002|Overall Study|Withdrawal by Subject|0|||
144528063|NCT03913442|521137078|FG000|Overall Study|Adverse Event|0|||
144528064|NCT03913442|521137079|FG001|Overall Study|Adverse Event|3|||
144528065|NCT03913442|521137078|FG000|Overall Study|Withdrawal by Subject|5|||
144528066|NCT03913442|521137079|FG001|Overall Study|Withdrawal by Subject|5|||
144528067|NCT03913442|521137078|FG000|Overall Study|Terminations|2|||
144528068|NCT03913442|521137079|FG001|Overall Study|Terminations|1|||
144528069|NCT03913442|521137078|FG000|Overall Study|Lost to Follow-up|2|||
144528070|NCT03913442|521137079|FG001|Overall Study|Lost to Follow-up|2|||
144528071|NCT02433379|521137084|FG000|Overall Study|Screen Failures|55|||
144528072|NCT02433379|521137084|FG000|Overall Study|Death|57|||
144528073|NCT02433379|521137084|FG000|Overall Study|Total Withdrawals|209|||
144528074|NCT04850898|521137085|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
144528075|NCT04850898|521137086|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
144528076|NCT00592852|521137087|FG000|Overall Study|Non-compliance|1|||
144528077|NCT00592852|521137087|FG000|Overall Study|Adverse Event|3|||
144528078|NCT00592852|521137087|FG000|Overall Study|Found ineligible|1|||
144528079|NCT00592852|521137087|FG000|Overall Study|Withdrawal by Subject|1|||
144528080|NCT04770402|521137096|FG000|Overall Study|Lost to Follow-up|1|||
144528081|NCT04770402|521137097|FG001|Overall Study|Lost to Follow-up|2|||
144528082|NCT04770402|521137096|FG000|Overall Study|Non-compliance|1|||
144528083|NCT04770402|521137097|FG001|Overall Study|Non-compliance|0|||
144601341|NCT04427501|521403401|FG009|Overall Study|Other|0|||
144601342|NCT04427501|521403402|FG010|Overall Study|Other|0|||
144601343|NCT04427501|521403403|FG011|Overall Study|Other|1|||
144601344|NCT00708175|521403410|FG000|Overall Study|Adverse Event|4|||
144601345|NCT00708175|521403411|FG001|Overall Study|Adverse Event|5|||
144601346|NCT00708175|521403410|FG000|Overall Study|Protocol Violation|2|||
144601347|NCT00708175|521403411|FG001|Overall Study|Protocol Violation|3|||
144601348|NCT00708175|521403410|FG000|Overall Study|Lost to Follow-up|5|||
144601349|NCT00708175|521403411|FG001|Overall Study|Lost to Follow-up|3|||
144601350|NCT00708175|521403410|FG000|Overall Study|Withdrawal by Subject|5|||
144601351|NCT00708175|521403411|FG001|Overall Study|Withdrawal by Subject|7|||
144601352|NCT00708175|521403410|FG000|Overall Study|BMD loss >7%|2|||
144601353|NCT00708175|521403411|FG001|Overall Study|BMD loss >7%|3|||
144601354|NCT02038920|521403412|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
144601355|NCT02038920|521403413|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
144601356|NCT02038920|521403414|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
144601357|NCT02038920|521403415|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
144601358|NCT02038920|521403416|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
144601359|NCT02038920|521403417|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
144601360|NCT02038920|521403412|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
144601361|NCT02038920|521403413|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
144601362|NCT02038920|521403414|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
144601363|NCT02038920|521403415|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
144601364|NCT02038920|521403416|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
144601365|NCT02038920|521403417|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
144601366|NCT02038920|521403412|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
144601367|NCT02038920|521403413|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
144601368|NCT02038920|521403414|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
144601369|NCT02038920|521403415|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
144601370|NCT02038920|521403416|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
144601371|NCT02038920|521403417|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
144601372|NCT02038920|521403412|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
144601373|NCT02038920|521403413|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
144601374|NCT02038920|521403414|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
144601375|NCT02038920|521403415|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
144601376|NCT02038920|521403416|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
144601377|NCT02038920|521403417|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
144601378|NCT02038920|521403412|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
144601379|NCT02038920|521403413|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
144601380|NCT02038920|521403414|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
144723309|NCT02752776|521842288|FG000|Overall Study|Lack of Efficacy|2|||
144181262|NCT02614196|519857358|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
144528084|NCT04770402|521137096|FG000|Overall Study|Withdrawal by Subject|0|||
144528085|NCT04770402|521137097|FG001|Overall Study|Withdrawal by Subject|1|||
144528086|NCT05764525|521137109|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
144528087|NCT05764525|521137110|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
144528088|NCT05764525|521137109|FG000|Overall Study|Withdrawal by Subject|4|||
144601381|NCT02038920|521403415|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
144601382|NCT02038920|521403416|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
144601383|NCT02038920|521403417|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
144601384|NCT02038920|521403412|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
144601385|NCT02038920|521403413|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
144723310|NCT02752776|521842289|FG001|Overall Study|Lack of Efficacy|6|||
144723311|NCT02752776|521842290|FG002|Overall Study|Lack of Efficacy|14|||
144723312|NCT02752776|521842288|FG000|Overall Study|Lost to Follow-up|11|||
144723313|NCT02752776|521842289|FG001|Overall Study|Lost to Follow-up|12|||
144723314|NCT02752776|521842290|FG002|Overall Study|Lost to Follow-up|4|||
144723315|NCT02752776|521842288|FG000|Overall Study|Non-compliance with study treatment|0|||
144723316|NCT02752776|521842289|FG001|Overall Study|Non-compliance with study treatment|0|||
144723317|NCT02752776|521842290|FG002|Overall Study|Non-compliance with study treatment|1|||
144723318|NCT02752776|521842288|FG000|Overall Study|Physician Decision|2|||
144723319|NCT02752776|521842289|FG001|Overall Study|Physician Decision|6|||
144723320|NCT02752776|521842290|FG002|Overall Study|Physician Decision|2|||
144723321|NCT02752776|521842288|FG000|Overall Study|Pregnancy|1|||
144723322|NCT02752776|521842289|FG001|Overall Study|Pregnancy|6|||
144723323|NCT02752776|521842290|FG002|Overall Study|Pregnancy|3|||
144723324|NCT02752776|521842288|FG000|Overall Study|Protocol Violation|10|||
144723325|NCT02752776|521842289|FG001|Overall Study|Protocol Violation|13|||
144723326|NCT02752776|521842290|FG002|Overall Study|Protocol Violation|6|||
144723327|NCT02752776|521842288|FG000|Overall Study|Subject/guardian decision|8|||
144723328|NCT02752776|521842289|FG001|Overall Study|Subject/guardian decision|6|||
144723329|NCT02752776|521842290|FG002|Overall Study|Subject/guardian decision|4|||
144723330|NCT02752776|521842288|FG000|Overall Study|Death|0|||
144723331|NCT02752776|521842289|FG001|Overall Study|Death|0|||
144723332|NCT02752776|521842290|FG002|Overall Study|Death|1|||
144723333|NCT02752776|521842288|FG000|Overall Study|Withdrawal by Subject|3|||
144723334|NCT02752776|521842289|FG001|Overall Study|Withdrawal by Subject|4|||
144723335|NCT02752776|521842290|FG002|Overall Study|Withdrawal by Subject|2|||
144723336|NCT01946165|521842291|FG000|Overall Study|Physician Decision|2|||
144723337|NCT01946165|521842292|FG001|Overall Study|Physician Decision|0|||
144723338|NCT01946165|521842291|FG000|Overall Study|Withdrawal by Subject|0|||
144723339|NCT01946165|521842292|FG001|Overall Study|Withdrawal by Subject|2|||
144723340|NCT01179919|521842293|FG000|Overall Study|Protocol Violation|1|||
144723341|NCT01179919|521842293|FG000|Overall Study|Adverse Event|1|||
144723342|NCT00698685|521842297|FG000|Overall Study|Sister withdrew as donor|1|||
144723343|NCT00698685|521842297|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
144424350|NCT00450333|520761258|FG000|Overall Study|Adverse Event|1|||
144424351|NCT00450333|520761259|FG001|Overall Study|Adverse Event|7|||
144424352|NCT00450333|520761260|FG002|Overall Study|Adverse Event|2|||
144424353|NCT00450333|520761261|FG003|Overall Study|Adverse Event|2|||
144601386|NCT02038920|521403414|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
144601387|NCT02038920|521403415|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
144601388|NCT02038920|521403416|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
144601389|NCT02038920|521403417|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
144601390|NCT02038920|521403412|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
144601391|NCT02038920|521403413|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
144601392|NCT02038920|521403414|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
144601393|NCT02038920|521403415|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
144601394|NCT02038920|521403416|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
144601395|NCT02038920|521403417|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
144601396|NCT02038920|521403412|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
144601397|NCT02038920|521403413|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
144601398|NCT02038920|521403414|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
144601399|NCT02038920|521403415|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
144601400|NCT02038920|521403416|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
144424354|NCT00450333|520761258|FG000|Overall Study|Protocol Violation|1|||
144424355|NCT00450333|520761259|FG001|Overall Study|Protocol Violation|0|||
144723344|NCT01399736|521842304|FG000|Overall Study|Withdrawal by Subject|4|||
144723345|NCT01399736|521842305|FG001|Overall Study|Withdrawal by Subject|2|||
144723346|NCT01399736|521842304|FG000|Overall Study|Lost to Follow-up|0|||
144723347|NCT01399736|521842305|FG001|Overall Study|Lost to Follow-up|2|||
144723348|NCT00386009|521842309|FG000|Overall Study|Adverse Event|0|||
144723349|NCT00386009|521842310|FG001|Overall Study|Adverse Event|2|||
144723350|NCT00386009|521842309|FG000|Overall Study|Death|1|||
144723351|NCT00386009|521842310|FG001|Overall Study|Death|0|||
144424356|NCT00450333|520761260|FG002|Overall Study|Protocol Violation|1|||
144723352|NCT00386009|521842309|FG000|Overall Study|Entry Criteria Not Met|0|||
144723353|NCT00386009|521842310|FG001|Overall Study|Entry Criteria Not Met|2|||
144723354|NCT00386009|521842309|FG000|Overall Study|Lost to Follow-up|1|||
144723355|NCT00386009|521842310|FG001|Overall Study|Lost to Follow-up|1|||
144424357|NCT00450333|520761261|FG003|Overall Study|Protocol Violation|0|||
144181263|NCT02614196|519857359|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
144181264|NCT02614196|519857360|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
144181265|NCT02614196|519857355|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
144181266|NCT02614196|519857356|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
144181267|NCT02614196|519857357|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
144181268|NCT02614196|519857358|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
144181269|NCT02614196|519857359|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
144181270|NCT02614196|519857360|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
144181271|NCT02614196|519857355|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
144424358|NCT00450333|520761258|FG000|Overall Study|Withdrawal by Subject|1|||
144424359|NCT00450333|520761259|FG001|Overall Study|Withdrawal by Subject|0|||
144424360|NCT00450333|520761260|FG002|Overall Study|Withdrawal by Subject|3|||
144424361|NCT00450333|520761261|FG003|Overall Study|Withdrawal by Subject|0|||
144424362|NCT00450333|520761258|FG000|Overall Study|Kidney transplant|1|||
144601401|NCT02038920|521403417|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
144601402|NCT02038920|521403412|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
144601403|NCT02038920|521403413|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
144601404|NCT02038920|521403414|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
144601405|NCT02038920|521403415|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
144601406|NCT02038920|521403416|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
144601407|NCT02038920|521403417|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
144601408|NCT02038920|521403412|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
144601409|NCT02038920|521403413|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
144601410|NCT02038920|521403414|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
144601411|NCT02038920|521403415|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
144601412|NCT02038920|521403416|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
144601413|NCT02038920|521403417|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
144601414|NCT02038920|521403412|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
144601415|NCT02038920|521403413|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
144601416|NCT02038920|521403414|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
144601417|NCT02038920|521403415|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
144601418|NCT02038920|521403416|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
144601419|NCT02038920|521403417|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
144601420|NCT02038920|521403412|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
144601421|NCT02038920|521403413|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
144601422|NCT02038920|521403414|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
144601423|NCT02038920|521403415|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
144601424|NCT02038920|521403416|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
144601425|NCT02038920|521403417|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
144601426|NCT02383589|521403419|FG000|Treatment Period|Adverse Event|1|||
144601427|NCT02383589|521403420|FG001|Treatment Period|Adverse Event|3|||
144601428|NCT02383589|521403419|FG000|Treatment Period|Lost to Follow-up|0|||
144601429|NCT02383589|521403420|FG001|Treatment Period|Lost to Follow-up|1|||
144601430|NCT02383589|521403419|FG000|Treatment Period|Withdrawal by Subject|0|||
144601431|NCT02383589|521403420|FG001|Treatment Period|Withdrawal by Subject|5|||
144601432|NCT02383589|521403419|FG000|Treatment Period|Non-compliance with study drug|0|||
144601433|NCT02383589|521403420|FG001|Treatment Period|Non-compliance with study drug|1|||
144601434|NCT02383589|521403419|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
144601435|NCT02383589|521403420|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
144601436|NCT02383589|521403419|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
144601437|NCT02383589|521403420|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
144601438|NCT02383589|521403419|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
144601439|NCT02383589|521403420|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
144251284|NCT01026818|520119284|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
144251285|NCT01026818|520119285|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
144251286|NCT04575584|520119286|FG000|Overall Study|Death|6|||
144251287|NCT04575584|520119287|FG001|Overall Study|Death|4|||
144251288|NCT04575584|520119288|FG002|Overall Study|Death|6|||
144251289|NCT04575584|520119289|FG003|Overall Study|Death|2|||
144251290|NCT04575584|520119290|FG004|Overall Study|Death|0|||
144251291|NCT04575584|520119291|FG005|Overall Study|Death|0|||
144251292|NCT04575584|520119286|FG000|Overall Study|Lost to Follow-up|1|||
144723356|NCT00386009|521842309|FG000|Overall Study|Protocol Violation|1|||
144424363|NCT00450333|520761259|FG001|Overall Study|Kidney transplant|0|||
144251293|NCT04575584|520119287|FG001|Overall Study|Lost to Follow-up|1|||
144251294|NCT04575584|520119288|FG002|Overall Study|Lost to Follow-up|1|||
144251295|NCT04575584|520119289|FG003|Overall Study|Lost to Follow-up|1|||
144251296|NCT04575584|520119290|FG004|Overall Study|Lost to Follow-up|0|||
144251297|NCT04575584|520119291|FG005|Overall Study|Lost to Follow-up|0|||
144251298|NCT04575584|520119286|FG000|Overall Study|Physician Decision|0|||
144251299|NCT04575584|520119287|FG001|Overall Study|Physician Decision|1|||
144251300|NCT04575584|520119288|FG002|Overall Study|Physician Decision|1|||
144528089|NCT05764525|521137110|FG001|Overall Study|Withdrawal by Subject|8|||
144528090|NCT05764525|521137109|FG000|Overall Study|Physician Decision|1|||
144528091|NCT05764525|521137110|FG001|Overall Study|Physician Decision|0|||
144528092|NCT04079218|521137115|FG000|Overall Study|Death|1|||
144528093|NCT04079218|521137116|FG001|Overall Study|Death|0|||
144528094|NCT04079218|521137115|FG000|Overall Study|Withdrawal by Subject|3|||
144528095|NCT04079218|521137116|FG001|Overall Study|Withdrawal by Subject|0|||
144528096|NCT04079218|521137115|FG000|Overall Study|Physician Decision|4|||
144528097|NCT04079218|521137116|FG001|Overall Study|Physician Decision|0|||
144528098|NCT04079218|521137115|FG000|Overall Study|Lost to Follow-up|0|||
144528099|NCT04079218|521137116|FG001|Overall Study|Lost to Follow-up|1|||
144528100|NCT05907174|521137120|FG000|3-Month Assessment|Withdrawal by Subject|0|||
144528101|NCT05907174|521137121|FG001|3-Month Assessment|Withdrawal by Subject|0|||
144528102|NCT05907174|521137122|FG002|3-Month Assessment|Withdrawal by Subject|0|||
144528103|NCT05907174|521137123|FG003|3-Month Assessment|Withdrawal by Subject|1|||
144528104|NCT05907174|521137120|FG000|3-Month Assessment|Lost to Follow-up|1|||
144528105|NCT05907174|521137121|FG001|3-Month Assessment|Lost to Follow-up|1|||
144528106|NCT05907174|521137122|FG002|3-Month Assessment|Lost to Follow-up|1|||
144528107|NCT05907174|521137123|FG003|3-Month Assessment|Lost to Follow-up|1|||
144528108|NCT05907174|521137120|FG000|6-Month Assessment|Death|0|||
144528109|NCT05907174|521137121|FG001|6-Month Assessment|Death|0|||
144528110|NCT05907174|521137122|FG002|6-Month Assessment|Death|3|||
144528111|NCT05907174|521137123|FG003|6-Month Assessment|Death|0|||
144528112|NCT05907174|521137120|FG000|6-Month Assessment|Withdrawal by Subject|0|||
144528113|NCT05907174|521137121|FG001|6-Month Assessment|Withdrawal by Subject|0|||
144528114|NCT05907174|521137122|FG002|6-Month Assessment|Withdrawal by Subject|1|||
144528115|NCT05907174|521137123|FG003|6-Month Assessment|Withdrawal by Subject|1|||
144528116|NCT05907174|521137120|FG000|6-Month Assessment|Lost to Follow-up|0|||
144528117|NCT05907174|521137121|FG001|6-Month Assessment|Lost to Follow-up|1|||
144528118|NCT05907174|521137122|FG002|6-Month Assessment|Lost to Follow-up|1|||
144528119|NCT05907174|521137123|FG003|6-Month Assessment|Lost to Follow-up|1|||
144528120|NCT05093842|521137126|FG000|Overall Study|Pregnancy loss|1|||
144528121|NCT05093842|521137127|FG001|Overall Study|Pregnancy loss|1|||
144528122|NCT05093842|521137126|FG000|Overall Study|Lost to Follow-up|6|||
144528123|NCT05093842|521137127|FG001|Overall Study|Lost to Follow-up|0|||
144528124|NCT05093842|521137126|FG000|Overall Study|Physician Decision|0|||
144528125|NCT05093842|521137127|FG001|Overall Study|Physician Decision|1|||
144528126|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
144528127|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
144528128|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
144528129|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
144528130|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
144528131|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
144528132|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
144528133|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
144723357|NCT00386009|521842310|FG001|Overall Study|Protocol Violation|0|||
144181272|NCT02614196|519857356|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
144181273|NCT02614196|519857357|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
144181274|NCT02614196|519857358|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
144181275|NCT02614196|519857359|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
144181276|NCT02614196|519857360|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
144181277|NCT02614196|519857355|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
144181278|NCT02614196|519857356|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
144181279|NCT02614196|519857357|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
144181280|NCT02614196|519857358|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
144181281|NCT02614196|519857359|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
144181282|NCT02614196|519857360|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
144181283|NCT02614196|519857355|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
144181284|NCT02614196|519857356|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
144181285|NCT02614196|519857357|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
144181286|NCT02614196|519857358|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
144181287|NCT02614196|519857359|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
144181288|NCT02614196|519857360|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
144181289|NCT00903877|519857361|FG000|Overall Study|Did not meet study criteria|33|||
144251301|NCT04575584|520119289|FG003|Overall Study|Physician Decision|1|||
144528134|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
144528135|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
144528136|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
144528137|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
144528138|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
144528139|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
144528140|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
144528141|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
144528142|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
144424364|NCT00450333|520761260|FG002|Overall Study|Kidney transplant|1|||
144424365|NCT00450333|520761261|FG003|Overall Study|Kidney transplant|3|||
144424366|NCT00450333|520761258|FG000|Overall Study|Death|3|||
144424367|NCT00450333|520761259|FG001|Overall Study|Death|2|||
144424368|NCT00450333|520761260|FG002|Overall Study|Death|2|||
144424369|NCT00450333|520761261|FG003|Overall Study|Death|2|||
144424370|NCT01340898|520761266|FG000|Primary Phase|Serious Adverse Events|0|||
144424371|NCT01340898|520761267|FG001|Primary Phase|Serious Adverse Events|0|||
144424372|NCT01340898|520761268|FG002|Primary Phase|Serious Adverse Events|1|||
144424373|NCT01340898|520761266|FG000|Primary Phase|Withdrawal by Subject|8|||
144424374|NCT01340898|520761267|FG001|Primary Phase|Withdrawal by Subject|7|||
144424375|NCT01340898|520761268|FG002|Primary Phase|Withdrawal by Subject|5|||
144424376|NCT01340898|520761266|FG000|Primary Phase|Migrated/moved from study area|4|||
144424377|NCT01340898|520761267|FG001|Primary Phase|Migrated/moved from study area|1|||
144424378|NCT01340898|520761268|FG002|Primary Phase|Migrated/moved from study area|0|||
144424379|NCT01340898|520761266|FG000|Primary Phase|Lost to Follow-up|4|||
144424380|NCT01340898|520761267|FG001|Primary Phase|Lost to Follow-up|1|||
144424381|NCT01340898|520761268|FG002|Primary Phase|Lost to Follow-up|0|||
144424382|NCT01340898|520761266|FG000|Booster Phase|Withdrawal by Subject|3|||
144424383|NCT01340898|520761267|FG001|Booster Phase|Withdrawal by Subject|0|||
144424384|NCT01340898|520761268|FG002|Booster Phase|Withdrawal by Subject|4|||
144424385|NCT01340898|520761266|FG000|Booster Phase|Migrated/moved from study area|3|||
144424386|NCT01340898|520761267|FG001|Booster Phase|Migrated/moved from study area|0|||
144424387|NCT01340898|520761268|FG002|Booster Phase|Migrated/moved from study area|0|||
144424388|NCT01340898|520761266|FG000|Booster Phase|Lost to Follow-up|4|||
144424389|NCT01340898|520761267|FG001|Booster Phase|Lost to Follow-up|2|||
144424390|NCT01340898|520761268|FG002|Booster Phase|Lost to Follow-up|3|||
144424391|NCT01214629|520761270|FG000|Overall Study|Progressive Disease|1|||
144424392|NCT01214629|520761271|FG001|Overall Study|Progressive Disease|1|||
144424393|NCT01214629|520761272|FG002|Overall Study|Progressive Disease|0|||
144424394|NCT01214629|520761273|FG003|Overall Study|Progressive Disease|1|||
144424395|NCT01214629|520761274|FG004|Overall Study|Progressive Disease|2|||
144424396|NCT01214629|520761275|FG005|Overall Study|Progressive Disease|3|||
144424397|NCT01214629|520761276|FG006|Overall Study|Progressive Disease|1|||
144424398|NCT01214629|520761277|FG007|Overall Study|Progressive Disease|1|||
144424399|NCT01214629|520761278|FG008|Overall Study|Progressive Disease|1|||
144424400|NCT01214629|520761279|FG009|Overall Study|Progressive Disease|5|||
144424401|NCT01214629|520761280|FG010|Overall Study|Progressive Disease|1|||
144424402|NCT01214629|520761270|FG000|Overall Study|Adverse Event|0|||
144424403|NCT01214629|520761271|FG001|Overall Study|Adverse Event|0|||
144424404|NCT01214629|520761272|FG002|Overall Study|Adverse Event|0|||
144424405|NCT01214629|520761273|FG003|Overall Study|Adverse Event|1|||
144424406|NCT01214629|520761274|FG004|Overall Study|Adverse Event|0|||
144424407|NCT01214629|520761275|FG005|Overall Study|Adverse Event|1|||
144424408|NCT01214629|520761276|FG006|Overall Study|Adverse Event|0|||
144424409|NCT01214629|520761277|FG007|Overall Study|Adverse Event|0|||
144424410|NCT01214629|520761278|FG008|Overall Study|Adverse Event|0|||
144424411|NCT01214629|520761279|FG009|Overall Study|Adverse Event|1|||
144424412|NCT01214629|520761280|FG010|Overall Study|Adverse Event|0|||
144424413|NCT01214629|520761270|FG000|Overall Study|Physician Decision|0|||
144424414|NCT01214629|520761271|FG001|Overall Study|Physician Decision|0|||
144424415|NCT01214629|520761272|FG002|Overall Study|Physician Decision|0|||
144424416|NCT01214629|520761273|FG003|Overall Study|Physician Decision|0|||
144424417|NCT01214629|520761274|FG004|Overall Study|Physician Decision|0|||
144424418|NCT01214629|520761275|FG005|Overall Study|Physician Decision|0|||
144424419|NCT01214629|520761276|FG006|Overall Study|Physician Decision|0|||
144424420|NCT01214629|520761277|FG007|Overall Study|Physician Decision|0|||
144424421|NCT01214629|520761278|FG008|Overall Study|Physician Decision|0|||
144424422|NCT01214629|520761279|FG009|Overall Study|Physician Decision|0|||
144424423|NCT01214629|520761280|FG010|Overall Study|Physician Decision|1|||
144424424|NCT01214629|520761270|FG000|Overall Study|Withdrawal by Subject|0|||
144424425|NCT01214629|520761271|FG001|Overall Study|Withdrawal by Subject|0|||
144181290|NCT00903877|519857361|FG000|Overall Study|Withdrawal by Subject|3|||
144181291|NCT00903877|519857361|FG000|Overall Study|Adverse Event|2|||
144424426|NCT01214629|520761272|FG002|Overall Study|Withdrawal by Subject|0|||
144424427|NCT01214629|520761273|FG003|Overall Study|Withdrawal by Subject|0|||
144424428|NCT01214629|520761274|FG004|Overall Study|Withdrawal by Subject|0|||
144424429|NCT01214629|520761275|FG005|Overall Study|Withdrawal by Subject|0|||
144424430|NCT01214629|520761276|FG006|Overall Study|Withdrawal by Subject|0|||
144424431|NCT01214629|520761277|FG007|Overall Study|Withdrawal by Subject|0|||
144424432|NCT01214629|520761278|FG008|Overall Study|Withdrawal by Subject|0|||
144424433|NCT01214629|520761279|FG009|Overall Study|Withdrawal by Subject|1|||
144424434|NCT01214629|520761280|FG010|Overall Study|Withdrawal by Subject|0|||
144424435|NCT00416078|520761286|FG000|Overall Study|Death|3|||
144424436|NCT00416078|520761287|FG001|Overall Study|Death|4|||
144424437|NCT00416078|520761286|FG000|Overall Study|Withdrawal by Subject|3|||
144424438|NCT00416078|520761287|FG001|Overall Study|Withdrawal by Subject|2|||
144424439|NCT00416078|520761286|FG000|Overall Study|Physician Decision|1|||
144424440|NCT00416078|520761287|FG001|Overall Study|Physician Decision|0|||
144181292|NCT00903877|519857361|FG000|Overall Study|Lost to Follow-up|1|||
144181293|NCT00903877|519857361|FG000|Overall Study|Participation put on hold|4|||
144601440|NCT00866697|521403421|FG000|Overall Study|Study closed/terminated|156|||
144601441|NCT00866697|521403422|FG001|Overall Study|Study closed/terminated|138|||
144601442|NCT00866697|521403421|FG000|Overall Study|Lost to Follow-up|22|||
144601443|NCT00866697|521403422|FG001|Overall Study|Lost to Follow-up|28|||
144601444|NCT00866697|521403421|FG000|Overall Study|Physician Decision|3|||
144601445|NCT00866697|521403422|FG001|Overall Study|Physician Decision|5|||
144601446|NCT00866697|521403421|FG000|Overall Study|Withdrawal by Subject|33|||
144601447|NCT00866697|521403422|FG001|Overall Study|Withdrawal by Subject|57|||
144601448|NCT02906787|521403425|FG000|Overall Study|Withdrawal by Subject|12|||
144601449|NCT02906787|521403426|FG001|Overall Study|Withdrawal by Subject|10|||
144601450|NCT02906787|521403425|FG000|Overall Study|Missed|24|||
144601451|NCT02906787|521403426|FG001|Overall Study|Missed|22|||
144601452|NCT04275297|521403427|FG000|Overall Study|Lost to Follow-up|1|||
144601453|NCT04275297|521403428|FG001|Overall Study|Lost to Follow-up|1|||
144601454|NCT00447382|521403429|FG000|Overall Study|Adverse Event|1|||
144601455|NCT00447382|521403430|FG001|Overall Study|Adverse Event|1|||
144601456|NCT00447382|521403429|FG000|Overall Study|Lack of Efficacy|1|||
144601457|NCT00447382|521403430|FG001|Overall Study|Lack of Efficacy|0|||
144601458|NCT00447382|521403429|FG000|Overall Study|Protocol Violation|2|||
144601459|NCT00447382|521403430|FG001|Overall Study|Protocol Violation|0|||
144601460|NCT00447382|521403429|FG000|Overall Study|Unclassified|2|||
144601461|NCT00447382|521403430|FG001|Overall Study|Unclassified|5|||
144601462|NCT03901053|521403435|FG000|Overall Study|Lost to Follow-up|6|||
144601463|NCT03901053|521403436|FG001|Overall Study|Lost to Follow-up|2|||
144601464|NCT03901053|521403435|FG000|Overall Study|Withdrawal by Subject|4|||
144601465|NCT03901053|521403436|FG001|Overall Study|Withdrawal by Subject|3|||
144601466|NCT03901053|521403435|FG000|Overall Study|Unsatisfactory Device|1|||
144601467|NCT03901053|521403436|FG001|Overall Study|Unsatisfactory Device|2|||
144601468|NCT03901053|521403435|FG000|Overall Study|No longer meets study criteria|1|||
144601469|NCT03901053|521403436|FG001|Overall Study|No longer meets study criteria|3|||
144601470|NCT03901053|521403435|FG000|Overall Study|Subject's Medical Status|0|||
144601471|NCT03901053|521403436|FG001|Overall Study|Subject's Medical Status|1|||
144601472|NCT03901053|521403435|FG000|Overall Study|Screening Failure|1|||
144601473|NCT03901053|521403436|FG001|Overall Study|Screening Failure|0|||
144601474|NCT04600336|521403437|FG000|Initial Treatment|Withdrawal by Subject|1|||
144601475|NCT04600336|521403438|FG001|Initial Treatment|Withdrawal by Subject|2|||
144601476|NCT04600336|521403439|FG002|Initial Treatment|Withdrawal by Subject|0|||
144601477|NCT04600336|521403440|FG003|Initial Treatment|Withdrawal by Subject|0|||
144601478|NCT04600336|521403437|FG000|Initial Treatment|Adverse Event|0|||
144601479|NCT04600336|521403438|FG001|Initial Treatment|Adverse Event|2|||
144601480|NCT04600336|521403439|FG002|Initial Treatment|Adverse Event|0|||
144601481|NCT04600336|521403440|FG003|Initial Treatment|Adverse Event|0|||
144601482|NCT04600336|521403437|FG000|Initial Treatment|Other complicating disease|0|||
144601483|NCT04600336|521403438|FG001|Initial Treatment|Other complicating disease|0|||
144601484|NCT04600336|521403439|FG002|Initial Treatment|Other complicating disease|1|||
144601485|NCT04600336|521403440|FG003|Initial Treatment|Other complicating disease|0|||
144601486|NCT04600336|521403437|FG000|Crossover Treatment|Withdrawal by Subject|0|||
144601487|NCT04600336|521403438|FG001|Crossover Treatment|Withdrawal by Subject|0|||
144601488|NCT04600336|521403439|FG002|Crossover Treatment|Withdrawal by Subject|2|||
144601489|NCT04600336|521403440|FG003|Crossover Treatment|Withdrawal by Subject|1|||
144601490|NCT04600336|521403437|FG000|Crossover Treatment|Adverse Event|0|||
144601491|NCT04600336|521403438|FG001|Crossover Treatment|Adverse Event|0|||
144601492|NCT04600336|521403439|FG002|Crossover Treatment|Adverse Event|1|||
144601493|NCT04600336|521403440|FG003|Crossover Treatment|Adverse Event|1|||
144601494|NCT04739800|521403441|FG000|Overall Study|Adverse Event|2|||
144601495|NCT04739800|521403442|FG001|Overall Study|Adverse Event|1|||
144601496|NCT04739800|521403443|FG002|Overall Study|Adverse Event|4|||
144601497|NCT04739800|521403444|FG003|Overall Study|Adverse Event|5|||
144601498|NCT04739800|521403441|FG000|Overall Study|Never Treated|2|||
144601499|NCT04739800|521403442|FG001|Overall Study|Never Treated|0|||
144601500|NCT04739800|521403443|FG002|Overall Study|Never Treated|1|||
144601501|NCT04739800|521403444|FG003|Overall Study|Never Treated|1|||
144601502|NCT04739800|521403441|FG000|Overall Study|On Treatment|5|||
144601503|NCT04739800|521403442|FG001|Overall Study|On Treatment|9|||
144181294|NCT00919711|519857362|FG000|Overall Study|Withdrawal by Subject|15|||
144601504|NCT04739800|521403443|FG002|Overall Study|On Treatment|9|||
144601505|NCT04739800|521403444|FG003|Overall Study|On Treatment|9|||
144181295|NCT00919711|519857363|FG001|Overall Study|Withdrawal by Subject|7|||
144601506|NCT04739800|521403441|FG000|Overall Study|Symptomatic Deterioration|1|||
144601507|NCT04739800|521403442|FG001|Overall Study|Symptomatic Deterioration|1|||
144181296|NCT00919711|519857362|FG000|Overall Study|Adverse Event|13|||
144181297|NCT00919711|519857363|FG001|Overall Study|Adverse Event|3|||
144601508|NCT04739800|521403443|FG002|Overall Study|Symptomatic Deterioration|3|||
144601509|NCT04739800|521403444|FG003|Overall Study|Symptomatic Deterioration|0|||
144181298|NCT00919711|519857362|FG000|Overall Study|Other|1|||
144601510|NCT04739800|521403441|FG000|Overall Study|Withdrawal by Subject|1|||
144181299|NCT00919711|519857363|FG001|Overall Study|Other|2|||
144181300|NCT00919711|519857362|FG000|Overall Study|Administrative Decision|0|||
144181301|NCT00919711|519857363|FG001|Overall Study|Administrative Decision|1|||
144181302|NCT00919711|519857362|FG000|Overall Study|Lost to Follow-up|2|||
144181303|NCT00919711|519857363|FG001|Overall Study|Lost to Follow-up|0|||
144181304|NCT00919711|519857362|FG000|Overall Study|Death|1|||
144181305|NCT00919711|519857363|FG001|Overall Study|Death|0|||
144181306|NCT00919711|519857362|FG000|Overall Study|Noncompliance|1|||
144181307|NCT00919711|519857363|FG001|Overall Study|Noncompliance|0|||
144181308|NCT00087529|519857365|FG000|Overall Study|Death|1|||
144181309|NCT00087529|519857366|FG001|Overall Study|Death|0|||
144181310|NCT00087529|519857365|FG000|Overall Study|Adverse Event|0|||
144181311|NCT00087529|519857366|FG001|Overall Study|Adverse Event|8|||
144181312|NCT00087529|519857365|FG000|Overall Study|Pregnancy|0|||
144181313|NCT00087529|519857366|FG001|Overall Study|Pregnancy|1|||
144181314|NCT00087529|519857365|FG000|Overall Study|Lost to Follow-up|2|||
144181315|NCT00087529|519857366|FG001|Overall Study|Lost to Follow-up|3|||
144181316|NCT00087529|519857365|FG000|Overall Study|Participant Decision|14|||
144181317|NCT00087529|519857366|FG001|Overall Study|Participant Decision|37|||
144181318|NCT00087529|519857365|FG000|Overall Study|Physician Decision|4|||
144181319|NCT00087529|519857366|FG001|Overall Study|Physician Decision|8|||
144181320|NCT00087529|519857365|FG000|Overall Study|Initiation of Excluded Therapy|0|||
144181321|NCT00087529|519857366|FG001|Overall Study|Initiation of Excluded Therapy|1|||
144181322|NCT00087529|519857365|FG000|Overall Study|Participant Noncompliance|0|||
144181323|NCT00087529|519857366|FG001|Overall Study|Participant Noncompliance|1|||
144181324|NCT00087529|519857365|FG000|Overall Study|Disease Progression|5|||
144181325|NCT00087529|519857366|FG001|Overall Study|Disease Progression|4|||
144181326|NCT00087529|519857365|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
144181327|NCT00087529|519857366|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
144181328|NCT01253564|519857376|FG000|Overall Study|Disease Progression|22|||
144181329|NCT01253564|519857376|FG000|Overall Study|Withdrawal by Subject|1|||
144181330|NCT01253564|519857376|FG000|Overall Study|Serious Adverse Event|1|||
144181331|NCT03694197|519857379|FG000|Overall Study|Adverse Event|9|||
144181332|NCT03694197|519857379|FG000|Overall Study|Protocol became inconvenient to participate|1|||
144181333|NCT03694197|519857379|FG000|Overall Study|Physician Decision|4|||
144181334|NCT03694197|519857379|FG000|Overall Study|Study terminated by sponsor|1350|||
144181335|NCT03694197|519857379|FG000|Overall Study|Participant moved|5|||
144181336|NCT03694197|519857379|FG000|Overall Study|Participant withdrew consent|10|||
144181337|NCT03694197|519857379|FG000|Overall Study|Related to IMP administration|1|||
144181338|NCT03694197|519857379|FG000|Overall Study|Not disclosed|5|||
144181339|NCT01023061|519858844|FG000|Overall Study|Withdrawal prior to treatment|2|||
144181340|NCT00927251|519858845|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
144181341|NCT01813435|519858846|FG000|Overall Study|did not finish experimental regimen|1902|||
144181342|NCT01813435|519858847|FG001|Overall Study|did not finish experimental regimen|770|||
144181343|NCT01813435|519858846|FG000|Overall Study|Lost to Follow-up|268|||
144181344|NCT01813435|519858847|FG001|Overall Study|Lost to Follow-up|237|||
144181345|NCT02435433|519858850|FG000|Overall Study|Withdrawal by Subject|2|||
144181346|NCT02435433|519858851|FG001|Overall Study|Withdrawal by Subject|3|||
144424441|NCT00416078|520761286|FG000|Overall Study|Lost to Follow-up|4|||
144424442|NCT00416078|520761287|FG001|Overall Study|Lost to Follow-up|2|||
144424443|NCT01829230|520761288|FG000|Overall Study|Protocol Violation|0|||
144424444|NCT01829230|520761289|FG001|Overall Study|Protocol Violation|2|||
144424445|NCT01829230|520761288|FG000|Overall Study|Withdrawal by Subject|0|||
144424446|NCT01829230|520761289|FG001|Overall Study|Withdrawal by Subject|1|||
144424447|NCT01829230|520761288|FG000|Overall Study|Lost to Follow-up|1|||
144424448|NCT01829230|520761289|FG001|Overall Study|Lost to Follow-up|1|||
144424449|NCT04128267|520761293|FG000|Overall Study|Withdrawal by Subject|6|||
144424450|NCT04128267|520761293|FG000|Overall Study|Death|2|||
144424451|NCT04128267|520761293|FG000|Overall Study|Disease progression|1|||
144424452|NCT04128267|520761293|FG000|Overall Study|Participant had other medical issues|4|||
144424453|NCT04128267|520761293|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
144424454|NCT04501666|520761294|FG000|Overall Study|Physician Decision|0|||
144424455|NCT04501666|520761295|FG001|Overall Study|Physician Decision|1|||
144424456|NCT04501666|520761294|FG000|Overall Study|Adverse Event|12|||
144181347|NCT02435433|519858852|FG002|Overall Study|Withdrawal by Subject|1|||
144181348|NCT02435433|519858853|FG003|Overall Study|Withdrawal by Subject|0|||
144181349|NCT02435433|519858854|FG004|Overall Study|Withdrawal by Subject|0|||
144181350|NCT02435433|519858850|FG000|Overall Study|Lost to Follow-up|2|||
144424457|NCT04501666|520761295|FG001|Overall Study|Adverse Event|4|||
144424458|NCT04501666|520761294|FG000|Overall Study|Subject's request|10|||
144424459|NCT04501666|520761295|FG001|Overall Study|Subject's request|6|||
144181351|NCT02435433|519858851|FG001|Overall Study|Lost to Follow-up|2|||
144181352|NCT02435433|519858852|FG002|Overall Study|Lost to Follow-up|4|||
144181353|NCT02435433|519858853|FG003|Overall Study|Lost to Follow-up|1|||
144424460|NCT04501666|520761294|FG000|Overall Study|Protocol Deviation|2|||
144181354|NCT02435433|519858854|FG004|Overall Study|Lost to Follow-up|0|||
144181355|NCT01243151|519858855|FG000|Overall Study|Adverse Event|0|||
144181356|NCT01243151|519858856|FG001|Overall Study|Adverse Event|1|||
144181357|NCT01243151|519858857|FG002|Overall Study|Adverse Event|0|||
144181358|NCT01243151|519858858|FG003|Overall Study|Adverse Event|0|||
144181359|NCT01243151|519858859|FG004|Overall Study|Adverse Event|0|||
144181360|NCT01243151|519858855|FG000|Overall Study|Protocol Violation|0|||
144181361|NCT01243151|519858856|FG001|Overall Study|Protocol Violation|0|||
144181362|NCT01243151|519858857|FG002|Overall Study|Protocol Violation|1|||
144181363|NCT01243151|519858858|FG003|Overall Study|Protocol Violation|0|||
144181364|NCT01243151|519858859|FG004|Overall Study|Protocol Violation|0|||
144181365|NCT01243151|519858855|FG000|Overall Study|Other|0|||
144181366|NCT01243151|519858856|FG001|Overall Study|Other|0|||
144181367|NCT01243151|519858857|FG002|Overall Study|Other|0|||
144181368|NCT01243151|519858858|FG003|Overall Study|Other|1|||
144181369|NCT01243151|519858859|FG004|Overall Study|Other|0|||
144181370|NCT01243151|519858855|FG000|Overall Study|Randomized but not treated|0|||
144181371|NCT01243151|519858856|FG001|Overall Study|Randomized but not treated|0|||
144181372|NCT01243151|519858857|FG002|Overall Study|Randomized but not treated|0|||
144181373|NCT01243151|519858858|FG003|Overall Study|Randomized but not treated|1|||
144181374|NCT01243151|519858859|FG004|Overall Study|Randomized but not treated|0|||
144181375|NCT01721772|519858865|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
144181376|NCT01721772|519858866|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
144181377|NCT01721772|519858865|FG000|Pre-Treatment|Poor/non-compliance|0|||
144181378|NCT01721772|519858866|FG001|Pre-Treatment|Poor/non-compliance|1|||
144181379|NCT01721772|519858865|FG000|Pre-Treatment|Participant withdrew consent|0|||
144181380|NCT01721772|519858866|FG001|Pre-Treatment|Participant withdrew consent|1|||
144181381|NCT01721772|519858865|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
144181382|NCT01721772|519858866|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
144181383|NCT01721772|519858865|FG000|Treatment|Disease progression|119|||
144181384|NCT01721772|519858866|FG001|Treatment|Disease progression|168|||
144181385|NCT01721772|519858865|FG000|Treatment|Study drug toxicity|19|||
144181386|NCT01721772|519858866|FG001|Treatment|Study drug toxicity|10|||
144181387|NCT01721772|519858865|FG000|Treatment|Adverse event unrelated to study drug|7|||
144181388|NCT01721772|519858866|FG001|Treatment|Adverse event unrelated to study drug|7|||
144181389|NCT01721772|519858865|FG000|Treatment|Maximum clinical benefit|16|||
144181390|NCT01721772|519858866|FG001|Treatment|Maximum clinical benefit|4|||
144181391|NCT01721772|519858865|FG000|Treatment|Other|19|||
144181392|NCT01721772|519858866|FG001|Treatment|Other|2|||
144181393|NCT01721772|519858865|FG000|Treatment|Participant withdrew consent|2|||
144181394|NCT01721772|519858866|FG001|Treatment|Participant withdrew consent|5|||
144181395|NCT01721772|519858865|FG000|Treatment|Participant request to discontinue study treatment|21|||
144181396|NCT01721772|519858866|FG001|Treatment|Participant request to discontinue study treatment|8|||
144181397|NCT01721772|519858865|FG000|Treatment|Death|1|||
144181398|NCT01721772|519858866|FG001|Treatment|Death|0|||
144181399|NCT01721772|519858865|FG000|Treatment|Not reported|1|||
144181400|NCT01721772|519858866|FG001|Treatment|Not reported|0|||
144181401|NCT01721772|519858865|FG000|Treatment|Poor/non-compliance|1|||
144181402|NCT01721772|519858866|FG001|Treatment|Poor/non-compliance|0|||
144181403|NCT01721772|519858865|FG000|Treatment|Lost to Follow-up|0|||
144181404|NCT01721772|519858866|FG001|Treatment|Lost to Follow-up|1|||
144181405|NCT04542694|519858868|FG000|Overall Study|The need for prohibited therapy|2|||
144181406|NCT04542694|519858869|FG001|Overall Study|The need for prohibited therapy|0|||
144181407|NCT04542694|519858868|FG000|Overall Study|Adverse Event|1|||
144181408|NCT04542694|519858869|FG001|Overall Study|Adverse Event|0|||
144181409|NCT04542694|519858868|FG000|Overall Study|Protocol Violation|1|||
144181410|NCT04542694|519858869|FG001|Overall Study|Protocol Violation|0|||
144181411|NCT00969124|519858870|FG000|Overall Study|Protocol Violation|2|||
144181412|NCT00969124|519858870|FG000|Overall Study|Inadequate bowel preparation|15|||
144181413|NCT00969124|519858870|FG000|Overall Study|Inability to reach cecum|9|||
144181414|NCT00969124|519858870|FG000|Overall Study|Previously unrecognized disease|3|||
144181415|NCT00969124|519858870|FG000|Overall Study|Technical error|1|||
144181416|NCT00687739|519858871|FG000|Overall Study|Lost to Follow-up|2|||
144181417|NCT00687739|519858872|FG001|Overall Study|Lost to Follow-up|2|||
144181418|NCT00687739|519858873|FG002|Overall Study|Lost to Follow-up|1|||
144251302|NCT04575584|520119290|FG004|Overall Study|Physician Decision|0|||
144723358|NCT00386009|521842309|FG000|Overall Study|Sponsor Decision|1|||
144181419|NCT00687739|519858874|FG003|Overall Study|Lost to Follow-up|2|||
144181420|NCT00687739|519858871|FG000|Overall Study|Adverse Event|0|||
144181421|NCT00687739|519858872|FG001|Overall Study|Adverse Event|1|||
144181422|NCT00687739|519858873|FG002|Overall Study|Adverse Event|1|||
144181423|NCT00687739|519858874|FG003|Overall Study|Adverse Event|0|||
144181424|NCT02786953|519858883|FG000|Overall Study|Withdrawal by Subject|3|||
144181425|NCT02786953|519858884|FG001|Overall Study|Withdrawal by Subject|0|||
144181426|NCT02786953|519858883|FG000|Overall Study|Physician Decision|0|||
144181427|NCT02786953|519858884|FG001|Overall Study|Physician Decision|1|||
144251303|NCT04575584|520119291|FG005|Overall Study|Physician Decision|0|||
144181428|NCT00874822|519858887|FG000|Overall Study|excluded by criteria|8|||
144181429|NCT00840658|519858889|FG000|Overall Study|Death|2|||
144181430|NCT00840658|519858890|FG001|Overall Study|Death|2|||
144181431|NCT00840658|519858891|FG002|Overall Study|Death|3|||
144181432|NCT00840658|519858892|FG003|Overall Study|Death|3|||
144601511|NCT04739800|521403442|FG001|Overall Study|Withdrawal by Subject|2|||
144601512|NCT04739800|521403443|FG002|Overall Study|Withdrawal by Subject|1|||
144601513|NCT04739800|521403444|FG003|Overall Study|Withdrawal by Subject|3|||
144601514|NCT04739800|521403441|FG000|Overall Study|Other Reason|1|||
144601515|NCT04739800|521403442|FG001|Overall Study|Other Reason|3|||
144601516|NCT04739800|521403443|FG002|Overall Study|Other Reason|5|||
144601517|NCT04739800|521403444|FG003|Overall Study|Other Reason|4|||
144601518|NCT04091451|521403447|FG000|Overall Study|Adverse Event|15|||
144601519|NCT04091451|521403448|FG001|Overall Study|Adverse Event|10|||
144601520|NCT04091451|521403447|FG000|Overall Study|Lost to Follow-up|8|||
144601521|NCT04091451|521403448|FG001|Overall Study|Lost to Follow-up|8|||
144601522|NCT04091451|521403447|FG000|Overall Study|Protocol Violation|5|||
144601523|NCT04091451|521403448|FG001|Overall Study|Protocol Violation|4|||
144601524|NCT04091451|521403447|FG000|Overall Study|Withdrawal by Subject|21|||
144601525|NCT04091451|521403448|FG001|Overall Study|Withdrawal by Subject|27|||
144601526|NCT04091451|521403447|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
144601527|NCT04091451|521403448|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
144601528|NCT04091451|521403447|FG000|Overall Study|Migrated/moved from the study area|3|||
144601529|NCT04091451|521403448|FG001|Overall Study|Migrated/moved from the study area|5|||
144601530|NCT04091451|521403447|FG000|Overall Study|Suspected HZ episode|1|||
144601531|NCT04091451|521403448|FG001|Overall Study|Suspected HZ episode|0|||
144601532|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
144601533|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
144601534|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
144601535|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
144601536|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
144601537|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
144601538|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
144601539|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
144601540|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
144601541|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
144601542|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
144601543|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
144601544|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
144601545|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
144601546|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
144601547|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
144601548|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
144601549|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
144601550|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
144601551|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
144601552|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
144601553|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
144601554|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
144601555|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
144601556|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
144601557|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
144601558|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
144601559|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
144601560|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
144601561|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
144601562|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
144601563|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
144601564|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
144601565|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
144601566|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
144601567|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
144601568|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
144601569|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
144601570|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
144601571|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
144601572|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
144601573|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
144601574|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
144601575|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
144723359|NCT00386009|521842310|FG001|Overall Study|Sponsor Decision|1|||
144601576|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
144424461|NCT04501666|520761295|FG001|Overall Study|Protocol Deviation|1|||
144424462|NCT04501666|520761294|FG000|Overall Study|Other-- site permanently closing|0|||
144424463|NCT04501666|520761295|FG001|Overall Study|Other-- site permanently closing|1|||
144424464|NCT00553150|520761296|FG000|Overall Study|Withdrawal by Subject|0|||
144424465|NCT00553150|520761297|FG001|Overall Study|Withdrawal by Subject|0|||
144424466|NCT00553150|520761298|FG002|Overall Study|Withdrawal by Subject|0|||
144181433|NCT00840658|519858889|FG000|Overall Study|Lost to Follow-up|3|||
144181434|NCT00840658|519858890|FG001|Overall Study|Lost to Follow-up|1|||
144181435|NCT00840658|519858891|FG002|Overall Study|Lost to Follow-up|2|||
144424467|NCT00553150|520761299|FG003|Overall Study|Withdrawal by Subject|2|||
144424468|NCT00553150|520761296|FG000|Overall Study|Protocol Violation|0|||
144424469|NCT00553150|520761297|FG001|Overall Study|Protocol Violation|0|||
144424470|NCT00553150|520761298|FG002|Overall Study|Protocol Violation|0|||
144424471|NCT00553150|520761299|FG003|Overall Study|Protocol Violation|1|||
144424472|NCT00553150|520761296|FG000|Overall Study|Ineligible|0|||
144424473|NCT00553150|520761297|FG001|Overall Study|Ineligible|0|||
144424474|NCT00553150|520761298|FG002|Overall Study|Ineligible|0|||
144424475|NCT00553150|520761299|FG003|Overall Study|Ineligible|1|||
144424476|NCT00056407|520761300|FG000|Overall Study|Adverse Event|282|||
144424477|NCT00056407|520761301|FG001|Overall Study|Adverse Event|364|||
144424478|NCT00056407|520761300|FG000|Overall Study|Withdrawal by Subject|377|||
144424479|NCT00056407|520761301|FG001|Overall Study|Withdrawal by Subject|361|||
144424480|NCT00056407|520761300|FG000|Overall Study|Lost to Follow-up|123|||
144424481|NCT00056407|520761301|FG001|Overall Study|Lost to Follow-up|113|||
144424482|NCT00056407|520761300|FG000|Overall Study|Protocol Violation|104|||
144528143|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
144528144|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
144528145|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
144528146|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
144528147|NCT04800211|521137136|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
144528148|NCT04800211|521137137|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
144528149|NCT04800211|521137138|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
144528150|NCT04800211|521137136|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
144528151|NCT04800211|521137137|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
144528152|NCT04800211|521137138|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
144528153|NCT04800211|521137136|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
144528154|NCT04800211|521137137|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
144528155|NCT04800211|521137138|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
144528156|NCT04800211|521137136|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
144528157|NCT04800211|521137137|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
144528158|NCT04800211|521137138|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
144528159|NCT05170841|521137141|FG000|Single Dose Phase|Adverse Event|1|||
144528160|NCT05170841|521137142|FG001|Single Dose Phase|Adverse Event|2|||
144528161|NCT05170841|521137143|FG002|Single Dose Phase|Adverse Event|0|||
144528162|NCT05170841|521137144|FG003|Single Dose Phase|Adverse Event|2|||
144528163|NCT05170841|521137141|FG000|Multiple Dose Phase|Adverse Event|1|||
144528164|NCT05170841|521137142|FG001|Multiple Dose Phase|Adverse Event|2|||
144528165|NCT05170841|521137143|FG002|Multiple Dose Phase|Adverse Event|1|||
144528166|NCT05170841|521137144|FG003|Multiple Dose Phase|Adverse Event|4|||
144528167|NCT05170841|521137141|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
144528168|NCT05170841|521137142|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
144528169|NCT05170841|521137143|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
144528170|NCT05170841|521137144|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
144528171|NCT05123586|521137147|FG000|Overall Study|Physician Decision|1|||
144528172|NCT05123586|521137148|FG001|Overall Study|Physician Decision|1|||
144528173|NCT05123586|521137147|FG000|Overall Study|Withdrawal by Subject|0|||
144528174|NCT05123586|521137148|FG001|Overall Study|Withdrawal by Subject|3|||
144528175|NCT03734679|521137149|FG000|Overall Study|Missed Visit|1|||
144528176|NCT01346540|521137174|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
144528177|NCT01346540|521137175|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
144528178|NCT01346540|521137174|FG000|Overall Study|Adverse Event|0|||
144528179|NCT01346540|521137175|FG001|Overall Study|Adverse Event|4|||
144601577|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
144181436|NCT00840658|519858892|FG003|Overall Study|Lost to Follow-up|1|||
144424483|NCT00056407|520761301|FG001|Overall Study|Protocol Violation|95|||
144424484|NCT00056407|520761300|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
144424485|NCT00056407|520761301|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
144424486|NCT00056407|520761300|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
144424487|NCT00056407|520761301|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
144424488|NCT00056407|520761300|FG000|Overall Study|Missing|25|||
144528180|NCT05216406|521137178|FG000|Overall Study|Lost to Follow-up|8|||
144528181|NCT05216406|521137179|FG001|Overall Study|Lost to Follow-up|9|||
144528182|NCT04270942|521137183|FG000|Overall Study|Death|1|||
144528183|NCT03672916|521137191|FG000|Overall Study|Death|6|||
144528184|NCT03672916|521137191|FG000|Overall Study|Lost to Follow-up|29|||
144528185|NCT03672916|521137191|FG000|Overall Study|Adverse Event|6|||
144601578|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
144601579|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
144601580|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
144601581|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
144601582|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
144601583|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
144601584|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
144601585|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
144601586|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
144181437|NCT05278858|519858893|FG000|Overall Study|Withdrawal by Subject|1|||
144181438|NCT04697173|519858894|FG000|Overall Study|Withdrawal by Subject|34|||
144181439|NCT04697173|519858895|FG001|Overall Study|Withdrawal by Subject|38|||
144181440|NCT05004649|519858897|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
144181441|NCT05004649|519858897|FG000|Overall Study|Lost to Follow-up|1|||
144181442|NCT05004649|519858897|FG000|Overall Study|Withdrawal by Subject|2|||
144181443|NCT05004649|519858897|FG000|Overall Study|COVID-19|1|||
144181444|NCT00728754|519858898|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
144181445|NCT00728754|519858899|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
144181446|NCT00728754|519858898|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
144181447|NCT00728754|519858899|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
144181448|NCT00728754|519858898|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
144181449|NCT00728754|519858899|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
144181450|NCT01859598|519858900|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
144181451|NCT00295490|519858901|FG000|Overall Study|Protocol Violation|0|||
144181452|NCT00295490|519858902|FG001|Overall Study|Protocol Violation|0|||
144181453|NCT00295490|519858903|FG002|Overall Study|Protocol Violation|3|||
144181454|NCT00295490|519858904|FG003|Overall Study|Protocol Violation|3|||
144181455|NCT00295490|519858901|FG000|Overall Study|Withdrawal by Subject|0|||
144181456|NCT00295490|519858902|FG001|Overall Study|Withdrawal by Subject|2|||
144181457|NCT00295490|519858903|FG002|Overall Study|Withdrawal by Subject|0|||
144181458|NCT00295490|519858904|FG003|Overall Study|Withdrawal by Subject|1|||
144181459|NCT00295490|519858901|FG000|Overall Study|Lost to Follow-up|0|||
144181460|NCT00295490|519858902|FG001|Overall Study|Lost to Follow-up|0|||
144181461|NCT00295490|519858903|FG002|Overall Study|Lost to Follow-up|1|||
144181462|NCT00295490|519858904|FG003|Overall Study|Lost to Follow-up|0|||
144181463|NCT00295490|519858901|FG000|Overall Study|Adverse Event|1|||
144181464|NCT00295490|519858902|FG001|Overall Study|Adverse Event|0|||
144181465|NCT00295490|519858903|FG002|Overall Study|Adverse Event|0|||
144181466|NCT00295490|519858904|FG003|Overall Study|Adverse Event|0|||
144181467|NCT00295490|519858901|FG000|Overall Study|Other|0|||
144181468|NCT00295490|519858902|FG001|Overall Study|Other|2|||
144181469|NCT00295490|519858903|FG002|Overall Study|Other|0|||
144181470|NCT00295490|519858904|FG003|Overall Study|Other|1|||
144181471|NCT03255980|519858905|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
144181472|NCT03255980|519858906|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
144181473|NCT03255980|519858907|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
144181474|NCT03255980|519858908|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
144181475|NCT03255980|519858905|FG000|Overall Study|Adverse Event|1|||
144181476|NCT03255980|519858906|FG001|Overall Study|Adverse Event|1|||
144181477|NCT03255980|519858907|FG002|Overall Study|Adverse Event|0|||
144181478|NCT03255980|519858908|FG003|Overall Study|Adverse Event|1|||
144181479|NCT03255980|519858905|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
144181480|NCT03255980|519858906|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
144181481|NCT03255980|519858907|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
144181482|NCT03255980|519858908|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
144181483|NCT03255980|519858905|FG000|Overall Study|Lost to Follow-up|1|||
144181484|NCT03255980|519858906|FG001|Overall Study|Lost to Follow-up|1|||
144181485|NCT03255980|519858907|FG002|Overall Study|Lost to Follow-up|0|||
144181486|NCT03255980|519858908|FG003|Overall Study|Lost to Follow-up|3|||
144251304|NCT04575584|520119286|FG000|Overall Study|Withdrawal by Subject|7|||
144424489|NCT00056407|520761301|FG001|Overall Study|Missing|34|||
144601587|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
144601588|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
144723360|NCT00386009|521842309|FG000|Overall Study|Withdrawal by Subject|5|||
144181487|NCT03255980|519858905|FG000|Overall Study|Withdrawal by Subject|0|||
144181488|NCT03255980|519858906|FG001|Overall Study|Withdrawal by Subject|1|||
144723361|NCT00386009|521842310|FG001|Overall Study|Withdrawal by Subject|4|||
144181489|NCT03255980|519858907|FG002|Overall Study|Withdrawal by Subject|0|||
144181490|NCT03255980|519858908|FG003|Overall Study|Withdrawal by Subject|3|||
144181491|NCT04473326|519858909|FG000|Overall Study|Death|0|||
144181492|NCT04473326|519858910|FG001|Overall Study|Death|1|||
144181493|NCT04473326|519858909|FG000|Overall Study|Withdrawal by Subject|1|||
144181494|NCT04473326|519858910|FG001|Overall Study|Withdrawal by Subject|2|||
144181495|NCT02611362|519858911|FG000|Overall Study|Withdrawal by Subject|7|||
144251305|NCT04575584|520119287|FG001|Overall Study|Withdrawal by Subject|9|||
144181496|NCT02611362|519858912|FG001|Overall Study|Withdrawal by Subject|2|||
144181497|NCT02611362|519858911|FG000|Overall Study|Lost to Follow-up|2|||
144181498|NCT02611362|519858912|FG001|Overall Study|Lost to Follow-up|4|||
144181499|NCT00354159|519858913|FG000|Randomized Study Period|Withdrawal by Subject|5|||
144181500|NCT00354159|519858914|FG001|Randomized Study Period|Withdrawal by Subject|3|||
144181501|NCT00354159|519858913|FG000|Randomized Study Period|Physician Decision|6|||
144181502|NCT00354159|519858914|FG001|Randomized Study Period|Physician Decision|10|||
144181503|NCT00354159|519858913|FG000|Randomized Study Period|Lost to Follow-up|4|||
144181504|NCT00354159|519858914|FG001|Randomized Study Period|Lost to Follow-up|0|||
144181505|NCT00354159|519858913|FG000|Randomized Study Period|Death|7|||
144181506|NCT00354159|519858914|FG001|Randomized Study Period|Death|9|||
144181507|NCT00354159|519858913|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
144251306|NCT04575584|520119288|FG002|Overall Study|Withdrawal by Subject|5|||
144251307|NCT04575584|520119289|FG003|Overall Study|Withdrawal by Subject|3|||
144424490|NCT00616655|520761302|FG000|Overall Study|Adverse Event|10|||
144424491|NCT00616655|520761303|FG001|Overall Study|Adverse Event|7|||
144424492|NCT00616655|520761304|FG002|Overall Study|Adverse Event|12|||
144424493|NCT00616655|520761302|FG000|Overall Study|Lack of Efficacy|5|||
144424494|NCT00616655|520761303|FG001|Overall Study|Lack of Efficacy|5|||
144424495|NCT00616655|520761304|FG002|Overall Study|Lack of Efficacy|5|||
144424496|NCT00616655|520761302|FG000|Overall Study|Lost to Follow-up|3|||
144424497|NCT00616655|520761303|FG001|Overall Study|Lost to Follow-up|12|||
144424498|NCT00616655|520761304|FG002|Overall Study|Lost to Follow-up|10|||
144424499|NCT00616655|520761302|FG000|Overall Study|Protocol Violation|2|||
144424500|NCT00616655|520761303|FG001|Overall Study|Protocol Violation|4|||
144424501|NCT00616655|520761304|FG002|Overall Study|Protocol Violation|3|||
144424502|NCT00616655|520761302|FG000|Overall Study|Withdrawal by Subject|9|||
144424503|NCT00616655|520761303|FG001|Overall Study|Withdrawal by Subject|7|||
144424504|NCT00616655|520761304|FG002|Overall Study|Withdrawal by Subject|11|||
144424505|NCT00616655|520761302|FG000|Overall Study|Does not meet in/ex criteria|0|||
144424506|NCT00616655|520761303|FG001|Overall Study|Does not meet in/ex criteria|0|||
144424507|NCT00616655|520761304|FG002|Overall Study|Does not meet in/ex criteria|2|||
144424508|NCT00616655|520761302|FG000|Overall Study|Other|6|||
144424509|NCT00616655|520761303|FG001|Overall Study|Other|6|||
144424510|NCT00616655|520761304|FG002|Overall Study|Other|5|||
144424511|NCT03761147|520761305|FG000|Overall Study|Withdrawal by Subject|6|||
144424512|NCT03761147|520761306|FG001|Overall Study|Withdrawal by Subject|1|||
144424513|NCT03761147|520761305|FG000|Overall Study|Adverse Event|1|||
144424514|NCT03761147|520761306|FG001|Overall Study|Adverse Event|3|||
144424515|NCT01026792|520761309|FG000|Overall Study|Protocol Violation|1|||
144424516|NCT03204305|520761310|FG000|Overall Study|Lost to Follow-up|6|||
144424517|NCT03204305|520761311|FG001|Overall Study|Lost to Follow-up|4|||
144424518|NCT03204305|520761312|FG002|Overall Study|Lost to Follow-up|0|||
144424519|NCT03204305|520761313|FG003|Overall Study|Lost to Follow-up|0|||
144424520|NCT03204305|520761310|FG000|Overall Study|Physician Decision|1|||
144424521|NCT03204305|520761311|FG001|Overall Study|Physician Decision|0|||
144601589|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
144601590|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
144601591|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
144601592|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
144601593|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
144601594|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
144601595|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
144601596|NCT00217737|521403449|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
144601597|NCT00217737|521403450|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
144601598|NCT00217737|521403451|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
144601599|NCT00217737|521403452|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
144601600|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
144601601|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
144601602|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
144601603|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
144601604|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
144601605|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
144601606|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
144601607|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
144601608|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Study suspension|0|||
144181508|NCT00354159|519858914|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
144601609|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Study suspension|45|||
144181509|NCT00354159|519858913|FG000|Long-term Follow-up|Physician Decision|127|||
144424522|NCT03204305|520761312|FG002|Overall Study|Physician Decision|0|||
144424523|NCT03204305|520761313|FG003|Overall Study|Physician Decision|0|||
144424524|NCT03204305|520761310|FG000|Overall Study|failure to place arterial line|2|||
144424525|NCT03204305|520761311|FG001|Overall Study|failure to place arterial line|1|||
144424526|NCT03204305|520761312|FG002|Overall Study|failure to place arterial line|0|||
144424527|NCT03204305|520761313|FG003|Overall Study|failure to place arterial line|0|||
144424528|NCT03204305|520761310|FG000|Overall Study|Withdrawal by Subject|2|||
144424529|NCT03204305|520761311|FG001|Overall Study|Withdrawal by Subject|0|||
144424530|NCT03204305|520761312|FG002|Overall Study|Withdrawal by Subject|0|||
144424531|NCT03204305|520761313|FG003|Overall Study|Withdrawal by Subject|0|||
144424532|NCT01165554|520761314|FG000|Overall Study|Withdrawal by Subject|23|||
144424533|NCT00535223|520761318|FG000|Overall Study|Withdrawal by Subject|4|||
144424534|NCT00535223|520761319|FG001|Overall Study|Withdrawal by Subject|1|||
144424535|NCT00101907|520761323|FG000|Overall Study|Adverse Event|1|||
144424536|NCT00101907|520761324|FG001|Overall Study|Adverse Event|0|||
144424537|NCT00101907|520761325|FG002|Overall Study|Adverse Event|0|||
144424538|NCT00101907|520761326|FG003|Overall Study|Adverse Event|0|||
144424539|NCT00101907|520761327|FG004|Overall Study|Adverse Event|0|||
144424540|NCT00101907|520761328|FG005|Overall Study|Adverse Event|0|||
144424541|NCT00101907|520761323|FG000|Overall Study|Death|0|||
144424542|NCT00101907|520761324|FG001|Overall Study|Death|1|||
144424543|NCT00101907|520761325|FG002|Overall Study|Death|0|||
144424544|NCT00101907|520761326|FG003|Overall Study|Death|0|||
144424545|NCT00101907|520761327|FG004|Overall Study|Death|3|||
144424546|NCT00101907|520761328|FG005|Overall Study|Death|0|||
144424547|NCT00101907|520761323|FG000|Overall Study|Physician Decision|0|||
144424548|NCT00101907|520761324|FG001|Overall Study|Physician Decision|0|||
144424549|NCT00101907|520761325|FG002|Overall Study|Physician Decision|0|||
144424550|NCT00101907|520761326|FG003|Overall Study|Physician Decision|1|||
144424551|NCT00101907|520761327|FG004|Overall Study|Physician Decision|1|||
144424552|NCT00101907|520761328|FG005|Overall Study|Physician Decision|0|||
144424553|NCT00101907|520761323|FG000|Overall Study|Withdrawal by Subject|1|||
144424554|NCT00101907|520761324|FG001|Overall Study|Withdrawal by Subject|0|||
144424555|NCT00101907|520761325|FG002|Overall Study|Withdrawal by Subject|1|||
144424556|NCT00101907|520761326|FG003|Overall Study|Withdrawal by Subject|0|||
144424557|NCT00101907|520761327|FG004|Overall Study|Withdrawal by Subject|1|||
144424558|NCT00101907|520761328|FG005|Overall Study|Withdrawal by Subject|0|||
144424559|NCT01765153|520761329|FG000|Training Phase 1|Format of intervention differed|1|||
144424560|NCT01765153|520761330|FG001|Training Phase 1|Format of intervention differed|0|||
144424561|NCT01765153|520761329|FG000|Training Phase 1|Poor participation in intervention|0|||
144424562|NCT01765153|520761330|FG001|Training Phase 1|Poor participation in intervention|1|||
144424563|NCT01765153|520761329|FG000|Rest Phase 1|Withdrawal by Subject|0|||
144424564|NCT01765153|520761330|FG001|Rest Phase 1|Withdrawal by Subject|1|||
144424565|NCT01765153|520761329|FG000|Training Phase 2|Withdrawal by Subject|0|||
144424566|NCT01765153|520761330|FG001|Training Phase 2|Withdrawal by Subject|1|||
144528186|NCT03672916|521137191|FG000|Overall Study|Withdrawal by Subject|11|||
144528187|NCT04797195|521137192|FG000|Overall Study|Death|8|||
144528188|NCT04797195|521137193|FG001|Overall Study|Death|15|||
144528189|NCT04797195|521137192|FG000|Overall Study|Change from PD|15|||
144528190|NCT04797195|521137193|FG001|Overall Study|Change from PD|15|||
144528191|NCT04797195|521137192|FG000|Overall Study|Withdrawal by Subject|3|||
144528192|NCT04797195|521137193|FG001|Overall Study|Withdrawal by Subject|2|||
144528193|NCT01236781|521137194|FG000|Overall Study|Ineligible|2|||
144528194|NCT01236781|521137195|FG001|Overall Study|Ineligible|1|||
144528195|NCT01236781|521137194|FG000|Overall Study|Did not complete study imaging|5|||
144528196|NCT01236781|521137195|FG001|Overall Study|Did not complete study imaging|0|||
144528197|NCT04059185|521137200|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
144528198|NCT04059185|521137201|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
144528199|NCT04059185|521137202|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
144528200|NCT04059185|521137200|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
144528201|NCT04059185|521137201|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
144528202|NCT04059185|521137202|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
144528203|NCT04059185|521137200|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
144528204|NCT04059185|521137201|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
144528205|NCT04059185|521137202|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
144528206|NCT04059185|521137200|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
144528207|NCT04059185|521137201|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
144528208|NCT04059185|521137202|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
144528209|NCT04059185|521137200|FG000|Longitudinal Assessment-Adults Only|Death|4|||
144424567|NCT01765153|520761329|FG000|Rest Phase 2|Lost to Follow-up|2|||
144424568|NCT01765153|520761330|FG001|Rest Phase 2|Lost to Follow-up|1|||
144424569|NCT03915496|520761333|FG000|Overall Study|Adverse Event|2|||
144424570|NCT03915496|520761334|FG001|Overall Study|Adverse Event|1|||
144424571|NCT03915496|520761335|FG002|Overall Study|Adverse Event|2|||
144424572|NCT02663674|520761336|FG000|Overall Study|Lost to Follow-up|5|||
144424573|NCT02663674|520761337|FG001|Overall Study|Lost to Follow-up|4|||
144424574|NCT02663674|520761336|FG000|Overall Study|Withdrawal by Subject|1|||
144528210|NCT04059185|521137201|FG001|Longitudinal Assessment-Adults Only|Death|4|||
144528211|NCT04059185|521137202|FG002|Longitudinal Assessment-Adults Only|Death|3|||
144528212|NCT04587453|521137207|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
144723362|NCT02978326|521842318|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
144723363|NCT02978326|521842319|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
144723364|NCT02978326|521842320|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
144723365|NCT02978326|521842318|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
144723366|NCT02978326|521842319|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
144723367|NCT02978326|521842320|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
144723368|NCT02978326|521842318|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
144723369|NCT02978326|521842319|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
144723370|NCT02978326|521842320|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
144723371|NCT02978326|521842318|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
144723372|NCT02978326|521842319|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
144723373|NCT02978326|521842320|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
144723374|NCT00865709|521842325|FG000|Treatment|Adverse Event|9|||
144723375|NCT00865709|521842326|FG001|Treatment|Adverse Event|6|||
144723376|NCT00865709|521842325|FG000|Treatment|Withdrawal by Subject|10|||
144723377|NCT00865709|521842326|FG001|Treatment|Withdrawal by Subject|7|||
144723378|NCT00865709|521842325|FG000|Treatment|Physician Decision|3|||
144723379|NCT00865709|521842326|FG001|Treatment|Physician Decision|2|||
144723380|NCT00865709|521842325|FG000|Treatment|Surgery|8|||
144723381|NCT00865709|521842326|FG001|Treatment|Surgery|3|||
144723382|NCT01265784|521842327|FG000|Overall Study|Lost to Follow-up|5|||
144723383|NCT01265784|521842328|FG001|Overall Study|Lost to Follow-up|3|||
144723384|NCT01265784|521842329|FG002|Overall Study|Lost to Follow-up|2|||
144723385|NCT01265784|521842327|FG000|Overall Study|Withdrawal by Subject|0|||
144723386|NCT01265784|521842328|FG001|Overall Study|Withdrawal by Subject|5|||
144181510|NCT00354159|519858914|FG001|Long-term Follow-up|Physician Decision|122|||
144181511|NCT00354159|519858913|FG000|Long-term Follow-up|Lost to Follow-up|1|||
144424575|NCT02663674|520761337|FG001|Overall Study|Withdrawal by Subject|4|||
144424576|NCT02663674|520761336|FG000|Overall Study|Physician Decision|1|||
144424577|NCT02663674|520761337|FG001|Overall Study|Physician Decision|1|||
144424578|NCT02663674|520761336|FG000|Overall Study|Other Event (Health Related)|0|||
144424579|NCT02663674|520761337|FG001|Overall Study|Other Event (Health Related)|1|||
144424580|NCT02472795|520761338|FG000|Overall Study|Adverse Event|0|||
144424581|NCT02472795|520761339|FG001|Overall Study|Adverse Event|1|||
144424582|NCT02472795|520761340|FG002|Overall Study|Adverse Event|0|||
144181512|NCT00354159|519858914|FG001|Long-term Follow-up|Lost to Follow-up|0|||
144424583|NCT02472795|520761341|FG003|Overall Study|Adverse Event|0|||
144424584|NCT02472795|520761342|FG004|Overall Study|Adverse Event|2|||
144424585|NCT02472795|520761338|FG000|Overall Study|Withdrawal by Subject|0|||
144424586|NCT02472795|520761339|FG001|Overall Study|Withdrawal by Subject|0|||
144424587|NCT02472795|520761340|FG002|Overall Study|Withdrawal by Subject|0|||
144424588|NCT02472795|520761341|FG003|Overall Study|Withdrawal by Subject|0|||
144424589|NCT02472795|520761342|FG004|Overall Study|Withdrawal by Subject|1|||
144424590|NCT04219891|520761344|FG000|Overall Study|Lost to Follow-up|3|||
144424591|NCT04219891|520761344|FG000|Overall Study|Withdrawal by Subject|2|||
144424592|NCT04708886|520762132|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
144424593|NCT04708886|520762132|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
144424594|NCT00202644|520762133|FG000|Overall Study|Adverse Event|12|||
144424595|NCT00202644|520762134|FG001|Overall Study|Adverse Event|13|||
144424596|NCT00202644|520762133|FG000|Overall Study|Withdrawal by Subject|8|||
144424597|NCT00202644|520762134|FG001|Overall Study|Withdrawal by Subject|6|||
144424598|NCT00202644|520762133|FG000|Overall Study|Lack of Efficacy|6|||
144424599|NCT00202644|520762134|FG001|Overall Study|Lack of Efficacy|6|||
144424600|NCT00202644|520762133|FG000|Overall Study|Lost to Follow-up|0|||
144424601|NCT00202644|520762134|FG001|Overall Study|Lost to Follow-up|1|||
144424602|NCT00202644|520762133|FG000|Overall Study|Other|9|||
144424603|NCT00202644|520762134|FG001|Overall Study|Other|1|||
144424604|NCT02750592|520762140|FG000|Overall Study|Adverse Event|3|||
144424605|NCT02750592|520762140|FG000|Overall Study|Lack of Efficacy|2|||
144424606|NCT02981342|520762143|FG000|Overall Study|Adverse Event|0|||
144424607|NCT02981342|520762144|FG001|Overall Study|Adverse Event|0|||
144424608|NCT02981342|520762145|FG002|Overall Study|Adverse Event|0|||
144424609|NCT02981342|520762146|FG003|Overall Study|Adverse Event|1|||
144424610|NCT02981342|520762143|FG000|Overall Study|Death|0|||
144424611|NCT02981342|520762144|FG001|Overall Study|Death|9|||
144424612|NCT02981342|520762145|FG002|Overall Study|Death|9|||
144424613|NCT02981342|520762146|FG003|Overall Study|Death|4|||
144723387|NCT01265784|521842329|FG002|Overall Study|Withdrawal by Subject|0|||
144723388|NCT01265784|521842327|FG000|Overall Study|Physician Decision|1|||
144723389|NCT01265784|521842328|FG001|Overall Study|Physician Decision|0|||
144723390|NCT01265784|521842329|FG002|Overall Study|Physician Decision|1|||
144181513|NCT00354159|519858913|FG000|Long-term Follow-up|Death|14|||
144424614|NCT02981342|520762143|FG000|Overall Study|Withdrawal by Subject|0|||
144424615|NCT02981342|520762144|FG001|Overall Study|Withdrawal by Subject|0|||
144424616|NCT02981342|520762145|FG002|Overall Study|Withdrawal by Subject|3|||
144424617|NCT02981342|520762146|FG003|Overall Study|Withdrawal by Subject|1|||
144424618|NCT02981342|520762143|FG000|Overall Study|Study closed by sponsor|0|||
144723391|NCT01265784|521842327|FG000|Overall Study|Adverse Event|1|||
144723392|NCT01265784|521842328|FG001|Overall Study|Adverse Event|0|||
144528213|NCT04587453|521137208|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
144528214|NCT05623228|521137211|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
144528215|NCT05623228|521137212|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528216|NCT05623228|521137213|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528217|NCT05623228|521137214|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528218|NCT05623228|521137215|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528219|NCT05623228|521137216|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528220|NCT05623228|521137217|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528221|NCT05623228|521137218|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
144528222|NCT05623228|521137211|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
144528223|NCT05623228|521137212|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
144528224|NCT05623228|521137213|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
144528225|NCT05623228|521137214|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
144528226|NCT05623228|521137215|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
144528227|NCT05623228|521137216|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
144528228|NCT05623228|521137217|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
144528229|NCT05623228|521137218|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
144528230|NCT03766685|521139032|FG000|Overall Study|Lost to Follow-up|1|||
144528231|NCT03766685|521139033|FG001|Overall Study|Lost to Follow-up|1|||
144528232|NCT03766685|521139034|FG002|Overall Study|Lost to Follow-up|0|||
144528233|NCT03766685|521139035|FG003|Overall Study|Lost to Follow-up|0|||
144528234|NCT03766685|521139032|FG000|Overall Study|Adverse Event, not fatal|0|||
144528235|NCT03766685|521139033|FG001|Overall Study|Adverse Event, not fatal|1|||
144528236|NCT03766685|521139034|FG002|Overall Study|Adverse Event, not fatal|0|||
144528237|NCT03766685|521139035|FG003|Overall Study|Adverse Event, not fatal|1|||
144528238|NCT03766685|521139032|FG000|Overall Study|Withdrawal by Subject|0|||
144528239|NCT03766685|521139033|FG001|Overall Study|Withdrawal by Subject|2|||
144528240|NCT03766685|521139034|FG002|Overall Study|Withdrawal by Subject|0|||
144528241|NCT03766685|521139035|FG003|Overall Study|Withdrawal by Subject|0|||
144528242|NCT03766685|521139032|FG000|Overall Study|Protocol Violation|0|||
144528243|NCT03766685|521139033|FG001|Overall Study|Protocol Violation|1|||
144528244|NCT03766685|521139034|FG002|Overall Study|Protocol Violation|0|||
144528245|NCT03766685|521139035|FG003|Overall Study|Protocol Violation|0|||
144528246|NCT03766685|521139032|FG000|Overall Study|Non-compliance|0|||
144528247|NCT03766685|521139033|FG001|Overall Study|Non-compliance|2|||
144528248|NCT03766685|521139034|FG002|Overall Study|Non-compliance|0|||
144528249|NCT03766685|521139035|FG003|Overall Study|Non-compliance|0|||
144528250|NCT02116530|521139036|FG000|Overall Study|Withdrawal by Subject|1|||
144528251|NCT02116530|521139037|FG001|Overall Study|Withdrawal by Subject|2|||
144528252|NCT02116530|521139036|FG000|Overall Study|Adverse Event|4|||
144528253|NCT02116530|521139037|FG001|Overall Study|Adverse Event|0|||
144528254|NCT02116530|521139036|FG000|Overall Study|Physician Decision|1|||
144528255|NCT02116530|521139037|FG001|Overall Study|Physician Decision|0|||
144528256|NCT02116530|521139036|FG000|Overall Study|Lost to Follow-up|1|||
144528257|NCT02116530|521139037|FG001|Overall Study|Lost to Follow-up|0|||
144528258|NCT02116530|521139036|FG000|Overall Study|Other Medical Problems|2|||
144528259|NCT02116530|521139037|FG001|Overall Study|Other Medical Problems|2|||
144528260|NCT02927236|521139040|FG000|Characterization Phase|Physician Decision|0|||
144528261|NCT02927236|521139041|FG001|Characterization Phase|Physician Decision|3|||
144528262|NCT02927236|521139042|FG002|Characterization Phase|Physician Decision|0|||
144528263|NCT02927236|521139043|FG003|Characterization Phase|Physician Decision|2|||
144528264|NCT02927236|521139040|FG000|Characterization Phase|Lost to Follow-up|0|||
144528265|NCT02927236|521139041|FG001|Characterization Phase|Lost to Follow-up|0|||
144528266|NCT02927236|521139042|FG002|Characterization Phase|Lost to Follow-up|0|||
144528267|NCT02927236|521139043|FG003|Characterization Phase|Lost to Follow-up|3|||
144528268|NCT02927236|521139040|FG000|Characterization Phase|Withdrawal by Subject|1|||
144528269|NCT02927236|521139041|FG001|Characterization Phase|Withdrawal by Subject|0|||
144528270|NCT02927236|521139042|FG002|Characterization Phase|Withdrawal by Subject|0|||
144528271|NCT02927236|521139043|FG003|Characterization Phase|Withdrawal by Subject|1|||
144528272|NCT02927236|521139040|FG000|Treatment Phase|Adverse Event|1|||
144528273|NCT02927236|521139041|FG001|Treatment Phase|Adverse Event|0|||
144528274|NCT02927236|521139042|FG002|Treatment Phase|Adverse Event|1|||
144528275|NCT02927236|521139043|FG003|Treatment Phase|Adverse Event|1|||
144528276|NCT02927236|521139040|FG000|Treatment Phase|Protocol Violation|3|||
144528277|NCT02927236|521139041|FG001|Treatment Phase|Protocol Violation|0|||
144528278|NCT02927236|521139042|FG002|Treatment Phase|Protocol Violation|0|||
144538425|NCT02347332|521174192|FG001|Overall Study|Protocol Violation|1|||
144538426|NCT02347332|521174191|FG000|Overall Study|Lost to Follow-up|2|||
144538427|NCT02347332|521174192|FG001|Overall Study|Lost to Follow-up|1|||
144538428|NCT02347332|521174191|FG000|Overall Study|Physician Decision|4|||
144538429|NCT02347332|521174192|FG001|Overall Study|Physician Decision|3|||
144538430|NCT02347332|521174191|FG000|Overall Study|Withdrawal by Subject|20|||
144538431|NCT02347332|521174192|FG001|Overall Study|Withdrawal by Subject|14|||
144538432|NCT02347332|521174191|FG000|Overall Study|Protocol requirement|1|||
144538433|NCT02347332|521174192|FG001|Overall Study|Protocol requirement|1|||
144601610|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Study suspension|0|||
144601611|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Study suspension|0|||
144181514|NCT00354159|519858914|FG001|Long-term Follow-up|Death|11|||
144424619|NCT02981342|520762144|FG001|Overall Study|Study closed by sponsor|0|||
144424620|NCT02981342|520762145|FG002|Overall Study|Study closed by sponsor|1|||
144424621|NCT02981342|520762146|FG003|Overall Study|Study closed by sponsor|1|||
144424622|NCT02981342|520762143|FG000|Overall Study|Randomized, Never Treated|0|||
144424623|NCT02981342|520762144|FG001|Overall Study|Randomized, Never Treated|1|||
144424624|NCT02981342|520762145|FG002|Overall Study|Randomized, Never Treated|0|||
144424625|NCT02981342|520762146|FG003|Overall Study|Randomized, Never Treated|7|||
144424626|NCT02981342|520762143|FG000|Overall Study|Lost to Follow-up|0|||
144424627|NCT02981342|520762144|FG001|Overall Study|Lost to Follow-up|1|||
144424628|NCT02981342|520762145|FG002|Overall Study|Lost to Follow-up|0|||
144424629|NCT02981342|520762146|FG003|Overall Study|Lost to Follow-up|0|||
144424630|NCT01372501|520762147|FG000|Overall Study|Adverse Event|4|||
144424631|NCT01372501|520762147|FG000|Overall Study|Device migration|1|||
144424632|NCT01132482|520762148|FG000|Overall Study|Adverse Event|1|||
144424633|NCT01132482|520762149|FG001|Overall Study|Adverse Event|0|||
144424634|NCT05333900|520762150|FG000|Overall Study|Protocol Violation|0|||
144424635|NCT05333900|520762151|FG001|Overall Study|Protocol Violation|1|||
144424636|NCT05333900|520762150|FG000|Overall Study|Withdrawal by Subject|0|||
144424637|NCT05333900|520762151|FG001|Overall Study|Withdrawal by Subject|1|||
144424638|NCT05333900|520762150|FG000|Overall Study|COVID-19 Pandemic|1|||
144424639|NCT05333900|520762151|FG001|Overall Study|COVID-19 Pandemic|1|||
144424640|NCT01277523|520762154|FG000|Overall Study|Adverse Event|1|||
144424641|NCT01277523|520762155|FG001|Overall Study|Adverse Event|0|||
144424642|NCT01277523|520762156|FG002|Overall Study|Adverse Event|0|||
144424643|NCT01277523|520762154|FG000|Overall Study|Protocol Violation|2|||
144424644|NCT01277523|520762155|FG001|Overall Study|Protocol Violation|0|||
144424645|NCT01277523|520762156|FG002|Overall Study|Protocol Violation|0|||
144424646|NCT01277523|520762154|FG000|Overall Study|Other Reason not Defined|0|||
144424647|NCT01277523|520762155|FG001|Overall Study|Other Reason not Defined|1|||
144424648|NCT01277523|520762156|FG002|Overall Study|Other Reason not Defined|0|||
144424649|NCT03724812|520762157|FG000|Overall Study|Missed Visit|1|||
144424650|NCT03724812|520762157|FG000|Overall Study|Death|2|||
144424651|NCT03724812|520762157|FG000|Overall Study|Withdrawal by Subject|1|||
144424652|NCT01851720|520762158|FG000|Overall Study|Lost to Follow-up|0|||
144424653|NCT01851720|520762159|FG001|Overall Study|Lost to Follow-up|1|||
144424654|NCT02389998|520762166|FG000|Overall Study|car accident|1|||
144424655|NCT02389998|520762167|FG001|Overall Study|car accident|0|||
144181515|NCT00354159|519858913|FG000|Long-term Follow-up|Study Closed|29|||
144181516|NCT00354159|519858914|FG001|Long-term Follow-up|Study Closed|34|||
144181517|NCT02229084|519858916|FG000|Overall Study|Adverse Event|1|||
144181518|NCT02229084|519858917|FG001|Overall Study|Adverse Event|0|||
144181519|NCT02229084|519858918|FG002|Overall Study|Adverse Event|0|||
144181520|NCT02229084|519858919|FG003|Overall Study|Adverse Event|0|||
144181521|NCT02229084|519858920|FG004|Overall Study|Adverse Event|0|||
144181522|NCT02229084|519858921|FG005|Overall Study|Adverse Event|0|||
144181523|NCT02229084|519858922|FG006|Overall Study|Adverse Event|0|||
144181524|NCT02229084|519858916|FG000|Overall Study|Lost to Follow-up|0|||
144181525|NCT02229084|519858917|FG001|Overall Study|Lost to Follow-up|0|||
144181526|NCT02229084|519858918|FG002|Overall Study|Lost to Follow-up|1|||
144181527|NCT02229084|519858919|FG003|Overall Study|Lost to Follow-up|1|||
144181528|NCT02229084|519858920|FG004|Overall Study|Lost to Follow-up|0|||
144181529|NCT02229084|519858921|FG005|Overall Study|Lost to Follow-up|0|||
144181530|NCT02229084|519858922|FG006|Overall Study|Lost to Follow-up|1|||
144181531|NCT02229084|519858916|FG000|Overall Study|Physician Decision|0|||
144181532|NCT02229084|519858917|FG001|Overall Study|Physician Decision|0|||
144181533|NCT02229084|519858918|FG002|Overall Study|Physician Decision|0|||
144181534|NCT02229084|519858919|FG003|Overall Study|Physician Decision|1|||
144181535|NCT02229084|519858920|FG004|Overall Study|Physician Decision|3|||
144181536|NCT02229084|519858921|FG005|Overall Study|Physician Decision|0|||
144181537|NCT02229084|519858922|FG006|Overall Study|Physician Decision|1|||
144181538|NCT02229084|519858916|FG000|Overall Study|Withdrawal by Subject|0|||
144181539|NCT02229084|519858917|FG001|Overall Study|Withdrawal by Subject|0|||
144181540|NCT02229084|519858918|FG002|Overall Study|Withdrawal by Subject|1|||
144181541|NCT02229084|519858919|FG003|Overall Study|Withdrawal by Subject|0|||
144181542|NCT02229084|519858920|FG004|Overall Study|Withdrawal by Subject|1|||
144181543|NCT02229084|519858921|FG005|Overall Study|Withdrawal by Subject|1|||
144181544|NCT02229084|519858922|FG006|Overall Study|Withdrawal by Subject|1|||
144181545|NCT02229084|519858916|FG000|Overall Study|Death|0|||
144181546|NCT02229084|519858917|FG001|Overall Study|Death|0|||
144181547|NCT02229084|519858918|FG002|Overall Study|Death|0|||
144181548|NCT02229084|519858919|FG003|Overall Study|Death|0|||
144181549|NCT02229084|519858920|FG004|Overall Study|Death|0|||
144181550|NCT02229084|519858921|FG005|Overall Study|Death|0|||
144181551|NCT02229084|519858922|FG006|Overall Study|Death|1|||
144181552|NCT01559116|519858937|FG000|Overall Study|Adverse Event|10|||
144181553|NCT01559116|519858937|FG000|Overall Study|Lack of Efficacy|1|||
144181554|NCT01559116|519858937|FG000|Overall Study|Lost to Follow-up|1|||
144181555|NCT01559116|519858937|FG000|Overall Study|Protocol Violation|1|||
144181556|NCT01559116|519858937|FG000|Overall Study|Withdrawal by Subject|4|||
144424656|NCT03525574|520762168|FG000|Overall Study|Adverse Event|15|||
144424657|NCT03525574|520762169|FG001|Overall Study|Adverse Event|0|||
144424658|NCT03525574|520762168|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
144424659|NCT03525574|520762169|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
144424660|NCT03525574|520762168|FG000|Overall Study|Lost to Follow-up|4|||
144424661|NCT03525574|520762169|FG001|Overall Study|Lost to Follow-up|0|||
144424662|NCT03525574|520762168|FG000|Overall Study|Commercial drug is Available for participant|48|||
144424663|NCT03525574|520762169|FG001|Overall Study|Commercial drug is Available for participant|0|||
144424664|NCT03525574|520762168|FG000|Overall Study|Death|1|||
144424665|NCT03525574|520762169|FG001|Overall Study|Death|0|||
144424666|NCT03525574|520762168|FG000|Overall Study|Other non-compliance|2|||
144424667|NCT03525574|520762169|FG001|Overall Study|Other non-compliance|0|||
144424668|NCT03525574|520762168|FG000|Overall Study|Physician Decision|6|||
144424669|NCT03525574|520762169|FG001|Overall Study|Physician Decision|0|||
144424670|NCT03525574|520762168|FG000|Overall Study|Other|58|||
144424671|NCT03525574|520762169|FG001|Overall Study|Other|0|||
144424672|NCT03525574|520762168|FG000|Overall Study|Enrolled but never dosed|1|||
144424673|NCT03525574|520762169|FG001|Overall Study|Enrolled but never dosed|0|||
144424674|NCT03525574|520762168|FG000|Overall Study|Not enrolled in 105 study|0|||
144424675|NCT03525574|520762169|FG001|Overall Study|Not enrolled in 105 study|3|||
144424676|NCT01770379|520762172|FG000|Overall Study|Technical issues|1|||
144424677|NCT01770379|520762173|FG001|Overall Study|Technical issues|0|||
144424678|NCT01770379|520762174|FG002|Overall Study|Technical issues|0|||
144424679|NCT01770379|520762172|FG000|Overall Study|Withdrawal by Subject|7|||
144424680|NCT01770379|520762173|FG001|Overall Study|Withdrawal by Subject|10|||
144424681|NCT01770379|520762174|FG002|Overall Study|Withdrawal by Subject|7|||
144424682|NCT01770379|520762172|FG000|Overall Study|study terminated by sponsor|22|||
144424683|NCT01770379|520762173|FG001|Overall Study|study terminated by sponsor|23|||
144424684|NCT01770379|520762174|FG002|Overall Study|study terminated by sponsor|22|||
144424685|NCT01770379|520762172|FG000|Overall Study|Protocol Violation|0|||
144424686|NCT01770379|520762173|FG001|Overall Study|Protocol Violation|1|||
144424687|NCT01770379|520762174|FG002|Overall Study|Protocol Violation|1|||
144424688|NCT01770379|520762172|FG000|Overall Study|Physician Decision|0|||
144424689|NCT01770379|520762173|FG001|Overall Study|Physician Decision|1|||
144424690|NCT01770379|520762174|FG002|Overall Study|Physician Decision|2|||
144424691|NCT01770379|520762172|FG000|Overall Study|Lost to Follow-up|0|||
144424692|NCT01770379|520762173|FG001|Overall Study|Lost to Follow-up|0|||
144601612|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
144601613|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
144601614|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
144601615|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
144601616|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Death|2|||
144601617|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Death|3|||
144601618|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Death|0|||
144601619|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Death|0|||
144424693|NCT01770379|520762174|FG002|Overall Study|Lost to Follow-up|2|||
144424694|NCT01770379|520762172|FG000|Overall Study|Lack of Efficacy|8|||
144181557|NCT01559116|519858937|FG000|Overall Study|other than stated above|9|||
144181558|NCT01532908|519858938|FG000|Overall Study|Not Transplanted|1|||
144424695|NCT01770379|520762173|FG001|Overall Study|Lack of Efficacy|6|||
144424696|NCT01770379|520762174|FG002|Overall Study|Lack of Efficacy|6|||
144424697|NCT01770379|520762172|FG000|Overall Study|Adverse Event|1|||
144424698|NCT01770379|520762173|FG001|Overall Study|Adverse Event|3|||
144424699|NCT01770379|520762174|FG002|Overall Study|Adverse Event|2|||
144424700|NCT01074450|520762183|FG000|First Intervention|Emesis in Dosing Interval|0|||
144601620|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
144601621|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
144181559|NCT01532908|519858939|FG001|Overall Study|Not Transplanted|0|||
144181560|NCT04610580|519858940|FG000|Two-way Crossover Period|Adverse Event|1|||
144424701|NCT01074450|520762184|FG001|First Intervention|Emesis in Dosing Interval|2|||
144424702|NCT01074450|520762183|FG000|Second Intervention|Protocol Violation|1|||
144424703|NCT01074450|520762184|FG001|Second Intervention|Protocol Violation|0|||
144424704|NCT01074450|520762183|FG000|Second Intervention|Physician Decision|0|||
144424705|NCT01074450|520762184|FG001|Second Intervention|Physician Decision|1|||
144601622|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
144424706|NCT02728895|520762185|FG000|Overall Study|Other|1|||
144424707|NCT02728895|520762186|FG001|Overall Study|Other|2|||
144424708|NCT02728895|520762185|FG000|Overall Study|Withdrawal by Subject|0|||
144424709|NCT02728895|520762186|FG001|Overall Study|Withdrawal by Subject|3|||
144424710|NCT02769247|520762187|FG000|Overall Study|Withdrawal by Subject|1|||
144424711|NCT02769247|520762188|FG001|Overall Study|Withdrawal by Subject|0|||
144424712|NCT02769247|520762189|FG002|Overall Study|Withdrawal by Subject|0|||
144424713|NCT02769247|520762190|FG003|Overall Study|Withdrawal by Subject|1|||
144424714|NCT02769247|520762187|FG000|Overall Study|Protocol Violation|0|||
144424715|NCT02769247|520762188|FG001|Overall Study|Protocol Violation|0|||
144424716|NCT02769247|520762189|FG002|Overall Study|Protocol Violation|1|||
144424717|NCT02769247|520762190|FG003|Overall Study|Protocol Violation|0|||
144424718|NCT02769247|520762187|FG000|Overall Study|Physician Decision|1|||
144424719|NCT02769247|520762188|FG001|Overall Study|Physician Decision|0|||
144424720|NCT02769247|520762189|FG002|Overall Study|Physician Decision|0|||
144424721|NCT02769247|520762190|FG003|Overall Study|Physician Decision|0|||
144424722|NCT03164928|520762200|FG000|Overall Study|Lost to Follow-up|1|||
144424723|NCT03164928|520762201|FG001|Overall Study|Lost to Follow-up|0|||
144424724|NCT01998737|520762202|FG000|Overall Study|Corrupted database|23|||
144424725|NCT01998737|520762203|FG001|Overall Study|Corrupted database|0|||
144424726|NCT00326950|520762204|FG000|Overall Study|Progressive Disease|1|||
144424727|NCT03855280|520762213|FG000|Treatment Phase|Adverse Event|1|||
144424728|NCT03855280|520762213|FG000|Treatment Phase|Withdrawal by Subject|1|||
144424729|NCT03855280|520762213|FG000|Continuation Phase|Protocol Violation|1|||
144424730|NCT03855280|520762213|FG000|Continuation Phase|Adverse Event|1|||
144424731|NCT03855280|520762213|FG000|Continuation Phase|Sponsor Concluded Study|1|||
144424732|NCT00969150|520762214|FG000|Overall Study|Adverse Event|4|||
144424733|NCT00969150|520762215|FG001|Overall Study|Adverse Event|14|||
144424734|NCT00969150|520762214|FG000|Overall Study|Lack of Efficacy|1|||
144424735|NCT00969150|520762215|FG001|Overall Study|Lack of Efficacy|1|||
144424736|NCT00969150|520762214|FG000|Overall Study|Protocol Violation|9|||
144424737|NCT00969150|520762215|FG001|Overall Study|Protocol Violation|12|||
144424738|NCT00969150|520762214|FG000|Overall Study|Withdrawal by Subject|13|||
144424739|NCT00969150|520762215|FG001|Overall Study|Withdrawal by Subject|9|||
144424740|NCT00969150|520762214|FG000|Overall Study|Lost to Follow-up|5|||
144424741|NCT00969150|520762215|FG001|Overall Study|Lost to Follow-up|4|||
144424742|NCT00969150|520762214|FG000|Overall Study|Other reasons|1|||
144424743|NCT00969150|520762215|FG001|Overall Study|Other reasons|0|||
144424744|NCT00461682|520762219|FG000|Overall Study|Protocol Violation|1|||
144424745|NCT04166513|520762222|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
144424746|NCT04166513|520762223|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
144424747|NCT04166513|520762224|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
144424748|NCT04166513|520762225|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
144424749|NCT04166513|520762222|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
144424750|NCT04166513|520762223|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
144424751|NCT04166513|520762224|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
144424752|NCT04166513|520762225|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
144424753|NCT04166513|520762222|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
144424754|NCT04166513|520762223|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
144424755|NCT04166513|520762224|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
144424756|NCT04166513|520762225|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
144424757|NCT04166513|520762222|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
144424758|NCT04166513|520762223|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
144424759|NCT04166513|520762224|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
144424760|NCT04166513|520762225|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
144424761|NCT04166513|520762222|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
144424762|NCT04166513|520762223|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
144424763|NCT04166513|520762224|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
144424764|NCT04166513|520762225|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
144424765|NCT00597012|520762226|FG000|Overall Study|Death|1|||
144424766|NCT00597012|520762227|FG001|Overall Study|Death|1|||
144424767|NCT00597012|520762226|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
144424768|NCT00597012|520762227|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
144424769|NCT00597012|520762226|FG000|Overall Study|Withdrawal by Subject|7|||
144424770|NCT00597012|520762227|FG001|Overall Study|Withdrawal by Subject|4|||
144424771|NCT00597012|520762226|FG000|Overall Study|Ineligible|2|||
144424772|NCT00597012|520762227|FG001|Overall Study|Ineligible|0|||
144424773|NCT00597012|520762226|FG000|Overall Study|Lost to Follow-up|0|||
144424774|NCT00597012|520762227|FG001|Overall Study|Lost to Follow-up|2|||
144424775|NCT00670800|520763239|FG000|Overall Study|2 controls were insulin resistant|0|||
144424776|NCT00670800|520763240|FG001|Overall Study|2 controls were insulin resistant|2|||
144424777|NCT01786629|520763241|FG000|Overall Study|Lack of Efficacy|0|||
144601623|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
144601624|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
144424778|NCT01786629|520763242|FG001|Overall Study|Lack of Efficacy|4|||
144424779|NCT01786629|520763241|FG000|Overall Study|Adverse Event|0|||
144424780|NCT01786629|520763242|FG001|Overall Study|Adverse Event|1|||
144424781|NCT04568590|520763246|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
144424782|NCT02710045|520763259|FG000|Overall Study|Death|1|||
144424783|NCT02710045|520763260|FG001|Overall Study|Death|2|||
144424784|NCT02710045|520763261|FG002|Overall Study|Death|0|||
144424785|NCT02710045|520763259|FG000|Overall Study|Withdrawal by Subject|6|||
144181561|NCT04610580|519858941|FG001|Two-way Crossover Period|Adverse Event|0|||
144424786|NCT02710045|520763260|FG001|Overall Study|Withdrawal by Subject|6|||
144424787|NCT02710045|520763261|FG002|Overall Study|Withdrawal by Subject|2|||
144424788|NCT02710045|520763259|FG000|Overall Study|Protocol Violation|1|||
144424789|NCT02710045|520763260|FG001|Overall Study|Protocol Violation|2|||
144424790|NCT02710045|520763261|FG002|Overall Study|Protocol Violation|3|||
144424791|NCT02710045|520763259|FG000|Overall Study|Lost to Follow-up|3|||
144424792|NCT02710045|520763260|FG001|Overall Study|Lost to Follow-up|6|||
144424793|NCT02710045|520763261|FG002|Overall Study|Lost to Follow-up|7|||
144424794|NCT02710045|520763259|FG000|Overall Study|Physician Decision|0|||
144424795|NCT02710045|520763260|FG001|Overall Study|Physician Decision|0|||
144424796|NCT02710045|520763261|FG002|Overall Study|Physician Decision|1|||
144601625|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
144601626|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
144601627|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
144601628|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
144601629|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
144601630|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
144601631|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
144601632|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
144601633|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
144601634|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
144601635|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
144601636|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
144601637|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
144601638|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
144601639|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
144601640|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
144601641|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
144601642|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
144601643|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
144601644|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
144601645|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
144601646|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
144601647|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
144601648|NCT00217737|521403449|FG000|Step 2 Randomization/Registration|Other|1|||
144601649|NCT00217737|521403450|FG001|Step 2 Randomization/Registration|Other|2|||
144601650|NCT00217737|521403451|FG002|Step 2 Randomization/Registration|Other|0|||
144601651|NCT00217737|521403452|FG003|Step 2 Randomization/Registration|Other|0|||
144601652|NCT03308942|521404754|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
144601653|NCT03308942|521404755|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
144601654|NCT03308942|521404756|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
144601655|NCT03308942|521404757|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
144601656|NCT03308942|521404758|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
144601657|NCT03308942|521404754|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
144424797|NCT02710045|520763259|FG000|Overall Study|Poor Attendance|0|||
144424798|NCT02710045|520763260|FG001|Overall Study|Poor Attendance|1|||
144424799|NCT02710045|520763261|FG002|Overall Study|Poor Attendance|0|||
144424800|NCT04499781|520763262|FG000|Overall Study|Lost to Follow-up|2|||
144424801|NCT04499781|520763263|FG001|Overall Study|Lost to Follow-up|3|||
144424802|NCT04499781|520763262|FG000|Overall Study|Withdrawal by Subject|2|||
144424803|NCT04499781|520763263|FG001|Overall Study|Withdrawal by Subject|0|||
144424804|NCT01275833|520763264|FG000|Overall Study|Study terminated|1|||
144424805|NCT01275833|520763265|FG001|Overall Study|Study terminated|1|||
144424806|NCT00227305|520763266|FG000|Overall Study|Adverse Event|40|||
144424807|NCT00227305|520763266|FG000|Overall Study|Withdrawal by Subject|42|||
144424808|NCT00227305|520763266|FG000|Overall Study|Lost to Follow-up|33|||
144424809|NCT00227305|520763266|FG000|Overall Study|Study specific discontinuation|13|||
144424810|NCT00227305|520763266|FG000|Overall Study|MOVED OUT OF AREA|3|||
144424811|NCT00227305|520763266|FG000|Overall Study|Lack of Efficacy|7|||
144424812|NCT00227305|520763266|FG000|Overall Study|Physician Decision|3|||
144424813|NCT00227305|520763266|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
144424814|NCT00227305|520763266|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
144424815|NCT00227305|520763266|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
144424816|NCT02118012|520763267|FG000|Overall Study|Adverse Event|0|||
144424817|NCT02118012|520763268|FG001|Overall Study|Adverse Event|1|||
144424818|NCT02118012|520763267|FG000|Overall Study|Physician Decision|0|||
144424819|NCT02118012|520763268|FG001|Overall Study|Physician Decision|1|||
144424820|NCT04519645|520763275|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
144424821|NCT04519645|520763276|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
144424822|NCT04519645|520763277|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
144424823|NCT04519645|520763275|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
144424824|NCT04519645|520763276|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
144601658|NCT03308942|521404755|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
144601659|NCT03308942|521404756|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
144601660|NCT03308942|521404757|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
144601661|NCT03308942|521404758|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
144601662|NCT03308942|521404754|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
144601663|NCT03308942|521404755|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
144601664|NCT03308942|521404756|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
144601665|NCT03308942|521404757|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
144601666|NCT03308942|521404758|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
144601667|NCT03308942|521404754|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
144601668|NCT03308942|521404755|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
144601669|NCT03308942|521404756|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
144601670|NCT03308942|521404757|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
144601671|NCT03308942|521404758|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
144601672|NCT03308942|521404754|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
144601673|NCT03308942|521404755|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
144601674|NCT03308942|521404756|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
144601675|NCT03308942|521404757|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
144601676|NCT03308942|521404758|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
144601677|NCT03308942|521404754|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
144601678|NCT03308942|521404755|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
144601679|NCT03308942|521404756|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
144601680|NCT03308942|521404757|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
144601681|NCT03308942|521404758|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
144601682|NCT03308942|521404754|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
144601683|NCT03308942|521404755|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
144601684|NCT03308942|521404756|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
144601685|NCT03308942|521404757|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
144601686|NCT03308942|521404758|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
144601687|NCT01131351|521404759|FG000|Overall Study|Adverse Event|0|||
144181562|NCT04610580|519858942|FG002|Two-way Crossover Period|Adverse Event|0|||
144424825|NCT04519645|520763277|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
144181563|NCT04610580|519858943|FG003|Two-way Crossover Period|Adverse Event|0|||
144181564|NCT04610580|519858944|FG004|Two-way Crossover Period|Adverse Event|0|||
144181565|NCT04610580|519858945|FG005|Two-way Crossover Period|Adverse Event|0|||
144181566|NCT04610580|519858940|FG000|Two-way Crossover Period|Physician Decision|1|||
144181567|NCT04610580|519858941|FG001|Two-way Crossover Period|Physician Decision|0|||
144181568|NCT04610580|519858942|FG002|Two-way Crossover Period|Physician Decision|0|||
144424826|NCT04519645|520763275|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
144424827|NCT04519645|520763276|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
144424828|NCT04519645|520763277|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
144424829|NCT04519645|520763275|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
144424830|NCT04519645|520763276|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
144424831|NCT04519645|520763277|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
144424832|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
144424833|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
144424834|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
144424835|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
144424836|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
144424837|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
144424838|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
144424839|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
144424840|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
144424841|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
144424842|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
144424843|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
144424844|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
144424845|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
144424846|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
144424847|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
144601688|NCT01131351|521404760|FG001|Overall Study|Adverse Event|2|||
144181569|NCT04610580|519858943|FG003|Two-way Crossover Period|Physician Decision|0|||
144181570|NCT04610580|519858944|FG004|Two-way Crossover Period|Physician Decision|0|||
144181571|NCT04610580|519858945|FG005|Two-way Crossover Period|Physician Decision|0|||
144181572|NCT04610580|519858940|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
144424848|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
144424849|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
144424850|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
144424851|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
144424852|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
144424853|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
144424854|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
144601689|NCT01131351|521404759|FG000|Overall Study|Protocol Deviation|0|||
144601690|NCT01131351|521404760|FG001|Overall Study|Protocol Deviation|1|||
144601691|NCT04147234|521404761|FG000|Overall Study|Clinical deterioration|0|||
144601692|NCT04147234|521404762|FG001|Overall Study|Clinical deterioration|0|||
144601693|NCT04147234|521404763|FG002|Overall Study|Clinical deterioration|1|||
144601694|NCT04147234|521404764|FG003|Overall Study|Clinical deterioration|0|||
144601695|NCT04147234|521404765|FG004|Overall Study|Clinical deterioration|0|||
144601696|NCT04147234|521404766|FG005|Overall Study|Clinical deterioration|0|||
144601697|NCT04147234|521404767|FG006|Overall Study|Clinical deterioration|0|||
144601698|NCT04147234|521404761|FG000|Overall Study|Withdrawal by Subject|0|||
144601699|NCT04147234|521404762|FG001|Overall Study|Withdrawal by Subject|1|||
144601700|NCT04147234|521404763|FG002|Overall Study|Withdrawal by Subject|1|||
144601701|NCT04147234|521404764|FG003|Overall Study|Withdrawal by Subject|0|||
144601702|NCT04147234|521404765|FG004|Overall Study|Withdrawal by Subject|0|||
144601703|NCT04147234|521404766|FG005|Overall Study|Withdrawal by Subject|0|||
144601704|NCT04147234|521404767|FG006|Overall Study|Withdrawal by Subject|0|||
144601705|NCT04147234|521404761|FG000|Overall Study|Clinical disease progression|1|||
144601706|NCT04147234|521404762|FG001|Overall Study|Clinical disease progression|3|||
144601707|NCT04147234|521404763|FG002|Overall Study|Clinical disease progression|1|||
144601708|NCT04147234|521404764|FG003|Overall Study|Clinical disease progression|1|||
144601709|NCT04147234|521404765|FG004|Overall Study|Clinical disease progression|0|||
144601710|NCT04147234|521404766|FG005|Overall Study|Clinical disease progression|1|||
144601711|NCT04147234|521404767|FG006|Overall Study|Clinical disease progression|0|||
144601712|NCT04147234|521404761|FG000|Overall Study|Objective disease progression|6|||
144601713|NCT04147234|521404762|FG001|Overall Study|Objective disease progression|4|||
144601714|NCT04147234|521404763|FG002|Overall Study|Objective disease progression|3|||
144601715|NCT04147234|521404764|FG003|Overall Study|Objective disease progression|3|||
144601716|NCT04147234|521404765|FG004|Overall Study|Objective disease progression|5|||
144601717|NCT04147234|521404766|FG005|Overall Study|Objective disease progression|2|||
144601718|NCT04147234|521404767|FG006|Overall Study|Objective disease progression|3|||
144601719|NCT04147234|521404761|FG000|Overall Study|Adverse Event|0|||
144601720|NCT04147234|521404762|FG001|Overall Study|Adverse Event|0|||
144601721|NCT04147234|521404763|FG002|Overall Study|Adverse Event|0|||
144601722|NCT04147234|521404764|FG003|Overall Study|Adverse Event|0|||
144601723|NCT04147234|521404765|FG004|Overall Study|Adverse Event|1|||
144601724|NCT04147234|521404766|FG005|Overall Study|Adverse Event|0|||
144601725|NCT04147234|521404767|FG006|Overall Study|Adverse Event|0|||
144601726|NCT05104476|521404770|FG000|Overall Study|Randomized But Not Treated|1|||
144601727|NCT05104476|521404771|FG001|Overall Study|Randomized But Not Treated|2|||
144601728|NCT05104476|521404770|FG000|Overall Study|Adverse Event|2|||
144601729|NCT05104476|521404771|FG001|Overall Study|Adverse Event|2|||
144601730|NCT05104476|521404770|FG000|Overall Study|Withdrawal by Subject|3|||
144601731|NCT05104476|521404771|FG001|Overall Study|Withdrawal by Subject|3|||
144601732|NCT05104476|521404770|FG000|Overall Study|Other Than Specified|0|||
144601733|NCT05104476|521404771|FG001|Overall Study|Other Than Specified|3|||
144601734|NCT04606771|521404772|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
144601735|NCT04606771|521404773|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
144601736|NCT04606771|521404772|FG000|Overall Study|Death|5|||
144601737|NCT04606771|521404773|FG001|Overall Study|Death|6|||
144601738|NCT04606771|521404772|FG000|Overall Study|Wrong randomisation|0|||
144601739|NCT04606771|521404773|FG001|Overall Study|Wrong randomisation|1|||
144601740|NCT03155373|521404777|FG000|Overall Study|No longer required surgery|1|||
144181573|NCT04610580|519858941|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
144181574|NCT04610580|519858942|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
144181575|NCT04610580|519858943|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
144181576|NCT04610580|519858944|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
144181577|NCT04610580|519858945|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
144181578|NCT04610580|519858940|FG000|Two-way Crossover Period|Other than specified|0|||
144181579|NCT04610580|519858941|FG001|Two-way Crossover Period|Other than specified|1|||
144181580|NCT04610580|519858942|FG002|Two-way Crossover Period|Other than specified|0|||
144601741|NCT03155373|521404777|FG000|Overall Study|Protocol Violation|1|||
144601742|NCT03155373|521404777|FG000|Overall Study|Death|2|||
144601743|NCT03155373|521404777|FG000|Overall Study|Withdrawal by Subject|3|||
144601744|NCT04464265|521404781|FG000|Overall Study|Physician Decision|2|||
144601745|NCT01438151|521404784|FG000|Overall Study|study terminated|8|||
144601746|NCT02459769|521404785|FG000|Overall Study|Withdrawal by Subject|7|||
144723393|NCT01265784|521842329|FG002|Overall Study|Adverse Event|0|||
144251308|NCT04575584|520119290|FG004|Overall Study|Withdrawal by Subject|0|||
144251309|NCT04575584|520119291|FG005|Overall Study|Withdrawal by Subject|0|||
144251310|NCT04575584|520119286|FG000|Overall Study|Not recorded|0|||
144251311|NCT04575584|520119287|FG001|Overall Study|Not recorded|0|||
144251312|NCT04575584|520119288|FG002|Overall Study|Not recorded|0|||
144251313|NCT04575584|520119289|FG003|Overall Study|Not recorded|1|||
144251314|NCT04575584|520119290|FG004|Overall Study|Not recorded|0|||
144601747|NCT02459769|521404786|FG001|Overall Study|Withdrawal by Subject|4|||
144601748|NCT02459769|521404787|FG002|Overall Study|Withdrawal by Subject|8|||
144601749|NCT02459769|521404788|FG003|Overall Study|Withdrawal by Subject|5|||
144601750|NCT02459769|521404785|FG000|Overall Study|Lost to Follow-up|1|||
144601751|NCT02459769|521404786|FG001|Overall Study|Lost to Follow-up|0|||
144601752|NCT02459769|521404787|FG002|Overall Study|Lost to Follow-up|1|||
144601753|NCT02459769|521404788|FG003|Overall Study|Lost to Follow-up|0|||
144601754|NCT00312221|521404789|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
144601755|NCT00312221|521404790|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
144601756|NCT00312221|521404791|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
144601757|NCT00312221|521404792|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
144601758|NCT00312221|521404789|FG000|Open-label Run-in Period|Adverse Event|74|||
144601759|NCT00312221|521404790|FG001|Open-label Run-in Period|Adverse Event|0|||
144601760|NCT00312221|521404791|FG002|Open-label Run-in Period|Adverse Event|0|||
144601761|NCT00312221|521404792|FG003|Open-label Run-in Period|Adverse Event|0|||
144601762|NCT00312221|521404789|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
144601763|NCT00312221|521404790|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
144601764|NCT00312221|521404791|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
144601765|NCT00312221|521404792|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
144601766|NCT00312221|521404789|FG000|Open-label Run-in Period|Administrative|42|||
144601767|NCT00312221|521404790|FG001|Open-label Run-in Period|Administrative|0|||
144601768|NCT00312221|521404791|FG002|Open-label Run-in Period|Administrative|0|||
144601769|NCT00312221|521404792|FG003|Open-label Run-in Period|Administrative|0|||
144601770|NCT00312221|521404789|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
144601771|NCT00312221|521404790|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
144601772|NCT00312221|521404791|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
144601773|NCT00312221|521404792|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
144601774|NCT00312221|521404789|FG000|Open-label Run-in Period|Did not qualify|5|||
144601775|NCT00312221|521404790|FG001|Open-label Run-in Period|Did not qualify|0|||
144601776|NCT00312221|521404791|FG002|Open-label Run-in Period|Did not qualify|0|||
144601777|NCT00312221|521404792|FG003|Open-label Run-in Period|Did not qualify|0|||
144601778|NCT00312221|521404789|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144601779|NCT00312221|521404790|FG001|Double-blind Phase|Withdrawal by Subject|6|||
144601780|NCT00312221|521404791|FG002|Double-blind Phase|Withdrawal by Subject|8|||
144601781|NCT00312221|521404792|FG003|Double-blind Phase|Withdrawal by Subject|7|||
144601782|NCT00312221|521404789|FG000|Double-blind Phase|Adverse Event|0|||
144601783|NCT00312221|521404790|FG001|Double-blind Phase|Adverse Event|10|||
144601784|NCT00312221|521404791|FG002|Double-blind Phase|Adverse Event|19|||
144723394|NCT01265784|521842327|FG000|Overall Study|Death|3|||
144181581|NCT04610580|519858943|FG003|Two-way Crossover Period|Other than specified|0|||
144181582|NCT04610580|519858944|FG004|Two-way Crossover Period|Other than specified|0|||
144181583|NCT04610580|519858945|FG005|Two-way Crossover Period|Other than specified|0|||
144181584|NCT04610580|519858940|FG000|Washout Before Extension Period|Other than specified|0|||
144181585|NCT04610580|519858941|FG001|Washout Before Extension Period|Other than specified|1|||
144181586|NCT04610580|519858942|FG002|Washout Before Extension Period|Other than specified|0|||
144181587|NCT04610580|519858943|FG003|Washout Before Extension Period|Other than specified|0|||
144181588|NCT04610580|519858944|FG004|Washout Before Extension Period|Other than specified|0|||
144181589|NCT04610580|519858945|FG005|Washout Before Extension Period|Other than specified|0|||
144181590|NCT04610580|519858940|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
144181591|NCT04610580|519858941|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
144181592|NCT04610580|519858942|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
144181593|NCT04610580|519858943|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
144181594|NCT04610580|519858944|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
144181595|NCT04610580|519858945|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
144181596|NCT04610580|519858940|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
144181597|NCT04610580|519858941|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
144181598|NCT04610580|519858942|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
144181599|NCT04610580|519858943|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
144181600|NCT04610580|519858944|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
144251315|NCT04575584|520119291|FG005|Overall Study|Not recorded|0|||
144601785|NCT00312221|521404792|FG003|Double-blind Phase|Adverse Event|18|||
144251316|NCT02634801|520119292|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
144251317|NCT02634801|520119293|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
144601786|NCT00312221|521404789|FG000|Double-blind Phase|Lost to Follow-up|0|||
144601787|NCT00312221|521404790|FG001|Double-blind Phase|Lost to Follow-up|0|||
144601788|NCT00312221|521404791|FG002|Double-blind Phase|Lost to Follow-up|2|||
144251318|NCT02634801|520119294|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
144251319|NCT02634801|520119292|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
144251320|NCT02634801|520119293|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
144251321|NCT02634801|520119294|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
144251322|NCT02634801|520119292|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
144251323|NCT02634801|520119293|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
144251324|NCT02634801|520119294|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
144251325|NCT02634801|520119292|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
144251326|NCT02634801|520119293|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
144251327|NCT02634801|520119294|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
144251328|NCT02634801|520119292|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
144251329|NCT02634801|520119293|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
144251330|NCT02634801|520119294|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
144251331|NCT02634801|520119292|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
144424855|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
144424856|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
144424857|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
144424858|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
144424859|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
144424860|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
144251332|NCT02634801|520119293|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
144251333|NCT02634801|520119294|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
144251334|NCT02634801|520119292|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
144251335|NCT02634801|520119293|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
144251336|NCT02634801|520119294|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
144251337|NCT02634801|520119292|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
144251338|NCT02634801|520119293|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
144251339|NCT02634801|520119294|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
144251340|NCT02634801|520119292|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
144251341|NCT02634801|520119293|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
144251342|NCT02634801|520119294|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
144251343|NCT02634801|520119292|FG000|Follow-up Period|Lost to Follow-up|3|||
144251344|NCT02634801|520119293|FG001|Follow-up Period|Lost to Follow-up|1|||
144251345|NCT02634801|520119294|FG002|Follow-up Period|Lost to Follow-up|2|||
144251346|NCT02634801|520119292|FG000|Follow-up Period|Physician Decision|0|||
144251347|NCT02634801|520119293|FG001|Follow-up Period|Physician Decision|0|||
144251348|NCT02634801|520119294|FG002|Follow-up Period|Physician Decision|1|||
144251349|NCT02634801|520119292|FG000|Follow-up Period|Withdrawal by Subject|1|||
144251350|NCT02634801|520119293|FG001|Follow-up Period|Withdrawal by Subject|2|||
144251351|NCT02634801|520119294|FG002|Follow-up Period|Withdrawal by Subject|5|||
144251352|NCT02634801|520119292|FG000|Follow-up Period|Adverse Event|1|||
144251353|NCT02634801|520119293|FG001|Follow-up Period|Adverse Event|5|||
144251354|NCT02634801|520119294|FG002|Follow-up Period|Adverse Event|0|||
144251355|NCT02335346|520119297|FG000|Overall Study|Adverse Event|11|||
144251356|NCT02335346|520119297|FG000|Overall Study|Withdrawal by Subject|1|||
144251357|NCT01548768|520119298|FG000|Overall Study|Withdrawal by Subject|0|||
144251358|NCT01548768|520119299|FG001|Overall Study|Withdrawal by Subject|2|||
144251359|NCT01548768|520119300|FG002|Overall Study|Withdrawal by Subject|1|||
144251360|NCT01548768|520119301|FG003|Overall Study|Withdrawal by Subject|0|||
144251361|NCT01548768|520119298|FG000|Overall Study|Physician Decision|1|||
144251362|NCT01548768|520119299|FG001|Overall Study|Physician Decision|0|||
144251363|NCT01548768|520119300|FG002|Overall Study|Physician Decision|0|||
144251364|NCT01548768|520119301|FG003|Overall Study|Physician Decision|0|||
144251365|NCT01548768|520119298|FG000|Overall Study|Adverse Event|0|||
144251366|NCT01548768|520119299|FG001|Overall Study|Adverse Event|0|||
144251367|NCT01548768|520119300|FG002|Overall Study|Adverse Event|0|||
144251368|NCT01548768|520119301|FG003|Overall Study|Adverse Event|1|||
144251369|NCT01548768|520119298|FG000|Overall Study|Non-Compliance|0|||
144251370|NCT01548768|520119299|FG001|Overall Study|Non-Compliance|0|||
144251371|NCT01548768|520119300|FG002|Overall Study|Non-Compliance|0|||
144251372|NCT01548768|520119301|FG003|Overall Study|Non-Compliance|3|||
144251373|NCT03594955|520119302|FG000|Overall Study|Adverse Event|1|||
144251374|NCT03594955|520119302|FG000|Overall Study|Progressive disease|5|||
144251375|NCT03594955|520119302|FG000|Overall Study|Sponsor's decision|1|||
144251376|NCT00560703|520119304|FG000|Overall Study|Adverse Event|0|||
144251377|NCT00560703|520119305|FG001|Overall Study|Adverse Event|2|||
144251378|NCT00560703|520119304|FG000|Overall Study|Protocol Violation|0|||
144424861|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
144251379|NCT00560703|520119305|FG001|Overall Study|Protocol Violation|2|||
144251380|NCT00560703|520119304|FG000|Overall Study|Withdrawal by Subject|0|||
144251381|NCT00560703|520119305|FG001|Overall Study|Withdrawal by Subject|1|||
144424862|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
144723395|NCT01265784|521842328|FG001|Overall Study|Death|0|||
144528279|NCT02927236|521139043|FG003|Treatment Phase|Protocol Violation|1|||
144528280|NCT02927236|521139040|FG000|Treatment Phase|Lost to Follow-up|1|||
144528281|NCT02927236|521139041|FG001|Treatment Phase|Lost to Follow-up|0|||
144528282|NCT02927236|521139042|FG002|Treatment Phase|Lost to Follow-up|0|||
144528283|NCT02927236|521139043|FG003|Treatment Phase|Lost to Follow-up|0|||
144528284|NCT02927236|521139040|FG000|Follow-up Phase|Lost to Follow-up|1|||
144528285|NCT02927236|521139041|FG001|Follow-up Phase|Lost to Follow-up|0|||
144528286|NCT02927236|521139042|FG002|Follow-up Phase|Lost to Follow-up|1|||
144528287|NCT02927236|521139043|FG003|Follow-up Phase|Lost to Follow-up|0|||
144528288|NCT02844465|521139044|FG000|Overall Study|Screen Failure|36|||
144601789|NCT00312221|521404792|FG003|Double-blind Phase|Lost to Follow-up|2|||
144601790|NCT00312221|521404789|FG000|Double-blind Phase|Administrative|0|||
144181601|NCT04610580|519858945|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
144181602|NCT03480022|519858950|FG000|Overall Study|Pregnancy|2|||
144181603|NCT03480022|519858951|FG001|Overall Study|Pregnancy|0|||
144181604|NCT03480022|519858950|FG000|Overall Study|Adverse Event|6|||
144181605|NCT03480022|519858951|FG001|Overall Study|Adverse Event|0|||
144181606|NCT03480022|519858950|FG000|Overall Study|Lack of Efficacy|0|||
144181607|NCT03480022|519858951|FG001|Overall Study|Lack of Efficacy|2|||
144181608|NCT03480022|519858950|FG000|Overall Study|Physician Decision|0|||
144181609|NCT03480022|519858951|FG001|Overall Study|Physician Decision|1|||
144181610|NCT03480022|519858950|FG000|Overall Study|Withdrawal by Subject|2|||
144181611|NCT03480022|519858951|FG001|Overall Study|Withdrawal by Subject|0|||
144181612|NCT03480022|519858950|FG000|Overall Study|Medication concerns|1|||
144181613|NCT03480022|519858951|FG001|Overall Study|Medication concerns|0|||
144181614|NCT03480022|519858950|FG000|Overall Study|Family member COVID exposure|0|||
144181615|NCT03480022|519858951|FG001|Overall Study|Family member COVID exposure|1|||
144181616|NCT00881569|519858952|FG000|Overall Study|Disease progression|1|||
144181617|NCT00881569|519858953|FG001|Overall Study|Disease progression|1|||
144181618|NCT04164758|519858958|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
144181619|NCT04164758|519858959|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
144181620|NCT04164758|519858960|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
144181621|NCT04164758|519858958|FG000|Overall Study|Adverse Event|0|||
144181622|NCT04164758|519858959|FG001|Overall Study|Adverse Event|1|||
144181623|NCT04164758|519858960|FG002|Overall Study|Adverse Event|0|||
144181624|NCT01949532|519858963|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
144181625|NCT01949532|519858964|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
144181626|NCT01824498|519858967|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
144181627|NCT01824498|519858968|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
144181628|NCT01824498|519858969|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
144181629|NCT01824498|519858970|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
144181630|NCT01824498|519858971|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
144181631|NCT01824498|519858972|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
144181632|NCT03980522|519858976|FG000|Treatment Period|Adverse Event|1|||
144181633|NCT03980522|519858977|FG001|Treatment Period|Adverse Event|0|||
144181634|NCT03980522|519858978|FG002|Treatment Period|Adverse Event|0|||
144181635|NCT03980522|519858979|FG003|Treatment Period|Adverse Event|0|||
144181636|NCT03980522|519858980|FG004|Treatment Period|Adverse Event|0|||
144181637|NCT01874535|519858983|FG000|Overall Study|Lost to Follow-up|10|||
144181638|NCT01874535|519858984|FG001|Overall Study|Lost to Follow-up|9|||
144181639|NCT01874535|519858983|FG000|Overall Study|incomplete symptom resolution|45|||
144181640|NCT01874535|519858984|FG001|Overall Study|incomplete symptom resolution|35|||
144181641|NCT01215721|519858985|FG000|Overall Study|Adverse Event|2|||
144181642|NCT00045162|519858986|FG000|Overall Study|Ineligible|12|||
144181643|NCT00045162|519858987|FG001|Overall Study|Ineligible|8|||
144181644|NCT00045162|519858986|FG000|Overall Study|Not treated|7|||
144181645|NCT00045162|519858987|FG001|Overall Study|Not treated|2|||
144181646|NCT00045162|519858986|FG000|Overall Study|Adverse Event|55|||
144181647|NCT00045162|519858987|FG001|Overall Study|Adverse Event|50|||
144181648|NCT00045162|519858986|FG000|Overall Study|Lack of Efficacy|32|||
144181649|NCT00045162|519858987|FG001|Overall Study|Lack of Efficacy|29|||
144181650|NCT00045162|519858986|FG000|Overall Study|Death|10|||
144181651|NCT00045162|519858987|FG001|Overall Study|Death|10|||
144528289|NCT02844465|521139044|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
144601791|NCT00312221|521404790|FG001|Double-blind Phase|Administrative|26|||
144181652|NCT00045162|519858986|FG000|Overall Study|Withdrawal by Subject|5|||
144181653|NCT00045162|519858987|FG001|Overall Study|Withdrawal by Subject|3|||
144181654|NCT00045162|519858986|FG000|Overall Study|Other|21|||
144181655|NCT00045162|519858987|FG001|Overall Study|Other|16|||
144181656|NCT01044433|519858988|FG000|Overall Study|Lost to Follow-up|3|||
144181657|NCT01044433|519858988|FG000|Overall Study|Withdrawal by Subject|3|||
144181658|NCT00939523|519858991|FG000|Overall Study|Lack of Efficacy|1|||
144181659|NCT00939523|519858991|FG000|Overall Study|Physician Decision|2|||
144181660|NCT00570128|519859004|FG000|Overall Study|Adverse Event|1|||
144181661|NCT00570128|519859005|FG001|Overall Study|Adverse Event|0|||
144181662|NCT00570128|519859004|FG000|Overall Study|Lost to Follow-up|1|||
144181663|NCT00570128|519859005|FG001|Overall Study|Lost to Follow-up|0|||
144181664|NCT00570128|519859004|FG000|Overall Study|Withdrawal by Subject|2|||
144528290|NCT02844465|521139044|FG000|Overall Study|Withdrawal by Subject|5|||
144251382|NCT00560703|520119304|FG000|Overall Study|non-compliance|0|||
144251383|NCT00560703|520119305|FG001|Overall Study|non-compliance|1|||
144251384|NCT04278924|520119306|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
144251385|NCT04278924|520119307|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
144251386|NCT04278924|520119308|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
144251387|NCT04278924|520119309|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
144251388|NCT04278924|520119310|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
144251389|NCT04278924|520119311|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
144251390|NCT04278924|520119312|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
144251391|NCT04278924|520119306|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
144424863|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
144424864|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
144424865|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
144424866|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
144424867|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
144424868|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
144424869|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
144601792|NCT00312221|521404791|FG002|Double-blind Phase|Administrative|37|||
144601793|NCT00312221|521404792|FG003|Double-blind Phase|Administrative|33|||
144601794|NCT00312221|521404789|FG000|Double-blind Phase|Lack of Efficacy|0|||
144601795|NCT00312221|521404790|FG001|Double-blind Phase|Lack of Efficacy|17|||
144601796|NCT00312221|521404791|FG002|Double-blind Phase|Lack of Efficacy|6|||
144601797|NCT00312221|521404792|FG003|Double-blind Phase|Lack of Efficacy|10|||
144601798|NCT02060721|521404793|FG000|Overall Study|Lost to Follow-up|1|||
144601799|NCT02060721|521404793|FG000|Overall Study|Physician Decision|2|||
144601800|NCT02060721|521404793|FG000|Overall Study|Death|14|||
144601801|NCT02060721|521404793|FG000|Overall Study|Withdrawal by Subject|2|||
144601802|NCT02060721|521404793|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
144601803|NCT00866723|521404794|FG000|Overall Study|Withdrawal by Subject|1|||
144601804|NCT00866723|521404794|FG000|Overall Study|Disease Progression|4|||
144251392|NCT04278924|520119307|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
144251393|NCT04278924|520119308|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
144251394|NCT04278924|520119309|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
144251395|NCT04278924|520119310|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
144251396|NCT04278924|520119311|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
144251397|NCT04278924|520119312|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
144251398|NCT06226649|520119313|FG000|Overall Study|Withdrawal by Subject|4|||
144424870|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
144251399|NCT06226649|520119314|FG001|Overall Study|Withdrawal by Subject|1|||
144251400|NCT04847232|520119315|FG000|Overall Study|Death|123|||
144251401|NCT04847232|520119316|FG001|Overall Study|Death|115|||
144251402|NCT04847232|520119315|FG000|Overall Study|Lost to Follow-up|3|||
144251403|NCT04847232|520119316|FG001|Overall Study|Lost to Follow-up|10|||
144251404|NCT04847232|520119315|FG000|Overall Study|Withdrawal by Subject|73|||
144251405|NCT04847232|520119316|FG001|Overall Study|Withdrawal by Subject|101|||
144251406|NCT04847232|520119315|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
144424871|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
144424872|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
144424873|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
144601805|NCT04178967|521404795|FG000|Induction Period|Adverse Event|4|||
144601806|NCT04178967|521404796|FG001|Induction Period|Adverse Event|6|||
144601807|NCT04178967|521404797|FG002|Induction Period|Adverse Event|0|||
144251407|NCT04847232|520119316|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
144251408|NCT02476916|520119321|FG000|Core Period|Adverse Event|2|||
144251409|NCT02476916|520119322|FG001|Core Period|Adverse Event|2|||
144251410|NCT02476916|520119321|FG000|Core Period|Investigator decision|1|||
144251411|NCT02476916|520119322|FG001|Core Period|Investigator decision|1|||
144251412|NCT02476916|520119321|FG000|Core Period|Withdrawal by Subject|3|||
144251413|NCT02476916|520119322|FG001|Core Period|Withdrawal by Subject|0|||
144251414|NCT02476916|520119321|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
144251415|NCT02476916|520119322|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
144251416|NCT02476916|520119321|FG000|Extension Period|On Treatment|12|||
144251417|NCT02476916|520119322|FG001|Extension Period|On Treatment|17|||
144251418|NCT05600036|520119323|FG000|Overall Study|Adverse Event|0|||
144251419|NCT05600036|520119324|FG001|Overall Study|Adverse Event|2|||
144251420|NCT05600036|520119325|FG002|Overall Study|Adverse Event|1|||
144251421|NCT05600036|520119326|FG003|Overall Study|Adverse Event|0|||
144251422|NCT05600036|520119327|FG004|Overall Study|Adverse Event|1|||
144251423|NCT05600036|520119328|FG005|Overall Study|Adverse Event|0|||
144251424|NCT05600036|520119323|FG000|Overall Study|Lost to Follow-up|0|||
144251425|NCT05600036|520119324|FG001|Overall Study|Lost to Follow-up|2|||
144181665|NCT00570128|519859005|FG001|Overall Study|Withdrawal by Subject|0|||
144181666|NCT03868631|519859006|FG000|Baseline to Week 6|Adverse Event|0|||
144251426|NCT05600036|520119325|FG002|Overall Study|Lost to Follow-up|1|||
144251427|NCT05600036|520119326|FG003|Overall Study|Lost to Follow-up|1|||
144251428|NCT05600036|520119327|FG004|Overall Study|Lost to Follow-up|0|||
144251429|NCT05600036|520119328|FG005|Overall Study|Lost to Follow-up|0|||
144251430|NCT05600036|520119323|FG000|Overall Study|Protocol Violation|0|||
144251431|NCT05600036|520119324|FG001|Overall Study|Protocol Violation|0|||
144251432|NCT05600036|520119325|FG002|Overall Study|Protocol Violation|2|||
144251433|NCT05600036|520119326|FG003|Overall Study|Protocol Violation|0|||
144251434|NCT05600036|520119327|FG004|Overall Study|Protocol Violation|0|||
144251435|NCT05600036|520119328|FG005|Overall Study|Protocol Violation|0|||
144424874|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
144424875|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
144424876|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
144424877|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
144424878|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
144424879|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
144424880|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
144424881|NCT03742037|520763285|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
144424882|NCT03742037|520763286|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
144424883|NCT03742037|520763287|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
144424884|NCT03742037|520763288|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
144424885|NCT03742037|520763289|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
144424886|NCT03742037|520763290|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
144424887|NCT03742037|520763291|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
144424888|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
144424889|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
144424890|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
144424891|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
144424892|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
144424893|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
144424894|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
144424895|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
144424896|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
144424897|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
144528291|NCT02844465|521139044|FG000|Overall Study|Lost to Follow-up|1|||
144181667|NCT03868631|519859007|FG001|Baseline to Week 6|Adverse Event|3|||
144181668|NCT03868631|519859006|FG000|Baseline to Week 6|Protocol Violation|1|||
144181669|NCT03868631|519859007|FG001|Baseline to Week 6|Protocol Violation|1|||
144181670|NCT03868631|519859006|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
144181671|NCT03868631|519859007|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
144181672|NCT03868631|519859006|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
144181673|NCT03868631|519859007|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
144181674|NCT03868631|519859006|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
144181675|NCT03868631|519859007|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
144181676|NCT03868631|519859006|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
144181677|NCT03868631|519859007|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
144181678|NCT02005562|519860528|FG000|Overall Study|Death|2|||
144181679|NCT02005562|519860529|FG001|Overall Study|Death|2|||
144181680|NCT02005562|519860528|FG000|Overall Study|Graft loss|7|||
144181681|NCT02005562|519860529|FG001|Overall Study|Graft loss|6|||
144181682|NCT02005562|519860528|FG000|Overall Study|Withdrawal by Subject|2|||
144181683|NCT02005562|519860529|FG001|Overall Study|Withdrawal by Subject|2|||
144181684|NCT02005562|519860528|FG000|Overall Study|No transplant|1|||
144181685|NCT02005562|519860529|FG001|Overall Study|No transplant|4|||
144181686|NCT02005562|519860528|FG000|Overall Study|Physician Decision|0|||
144181687|NCT02005562|519860529|FG001|Overall Study|Physician Decision|1|||
144181688|NCT04729101|519860530|FG000|Overall Study|Adverse Event|1|||
144181689|NCT04729101|519860531|FG001|Overall Study|Adverse Event|0|||
144181690|NCT04729101|519860530|FG000|Overall Study|Physician Decision|1|||
144181691|NCT04729101|519860531|FG001|Overall Study|Physician Decision|0|||
144181692|NCT04729101|519860530|FG000|Overall Study|Withdrawal by Subject|1|||
144181693|NCT04729101|519860531|FG001|Overall Study|Withdrawal by Subject|0|||
144181694|NCT00274625|519860532|FG000|Overall Study|Lost to Follow-up|46|||
144251436|NCT05600036|520119323|FG000|Overall Study|Withdrawal by Subject|0|||
144251437|NCT05600036|520119324|FG001|Overall Study|Withdrawal by Subject|1|||
144181695|NCT00274625|519860533|FG001|Overall Study|Lost to Follow-up|54|||
144181696|NCT00274625|519860532|FG000|Overall Study|Excluded from analysis|14|||
144181697|NCT00274625|519860533|FG001|Overall Study|Excluded from analysis|8|||
144181698|NCT02940522|519860534|FG000|Overall Study|Lost to Follow-up|1|||
144181699|NCT02940522|519860535|FG001|Overall Study|Lost to Follow-up|2|||
144251438|NCT05600036|520119325|FG002|Overall Study|Withdrawal by Subject|2|||
144181700|NCT02940522|519860534|FG000|Overall Study|Withdrawal by Subject|1|||
144181701|NCT02940522|519860535|FG001|Overall Study|Withdrawal by Subject|0|||
144181702|NCT00762411|519860538|FG000|Initial Treatment|Death|7|||
144181703|NCT00762411|519860539|FG001|Initial Treatment|Death|6|||
144181704|NCT00762411|519860538|FG000|Initial Treatment|Adverse Event|132|||
144181705|NCT00762411|519860539|FG001|Initial Treatment|Adverse Event|40|||
144181706|NCT00762411|519860538|FG000|Initial Treatment|Protocol Violation|4|||
144181707|NCT00762411|519860539|FG001|Initial Treatment|Protocol Violation|1|||
144181708|NCT00762411|519860538|FG000|Initial Treatment|Withdrawal by Subject|65|||
144181709|NCT00762411|519860539|FG001|Initial Treatment|Withdrawal by Subject|52|||
144181710|NCT00762411|519860538|FG000|Initial Treatment|Physician Decision|1|||
144181711|NCT00762411|519860539|FG001|Initial Treatment|Physician Decision|0|||
144181712|NCT00762411|519860538|FG000|Initial Treatment|Sponsor Decision|293|||
144251439|NCT05600036|520119326|FG003|Overall Study|Withdrawal by Subject|0|||
144251440|NCT05600036|520119327|FG004|Overall Study|Withdrawal by Subject|3|||
144251441|NCT05600036|520119328|FG005|Overall Study|Withdrawal by Subject|5|||
144251442|NCT05600036|520119323|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
144251443|NCT05600036|520119324|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
144251444|NCT05600036|520119325|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
144251445|NCT05600036|520119326|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
144251446|NCT05600036|520119327|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
144251447|NCT05600036|520119328|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
144181713|NCT00762411|519860539|FG001|Initial Treatment|Sponsor Decision|401|||
144181714|NCT00762411|519860538|FG000|Initial Treatment|Lost to Follow-up|5|||
144181715|NCT00762411|519860539|FG001|Initial Treatment|Lost to Follow-up|0|||
144181716|NCT00762411|519860538|FG000|Initial Treatment|Caregiver Decision|21|||
144181717|NCT00762411|519860539|FG001|Initial Treatment|Caregiver Decision|16|||
144181718|NCT00762411|519860538|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
144181719|NCT00762411|519860539|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
144181720|NCT00762411|519860538|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
144181721|NCT00762411|519860539|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
144181722|NCT00762411|519860538|FG000|Delayed Start|Adverse Event|0|||
144181723|NCT00762411|519860539|FG001|Delayed Start|Adverse Event|4|||
144181724|NCT00762411|519860538|FG000|Delayed Start|Protocol Violation|0|||
144181725|NCT00762411|519860539|FG001|Delayed Start|Protocol Violation|1|||
144181726|NCT00762411|519860538|FG000|Delayed Start|Sponsor Decision|16|||
144181727|NCT00762411|519860539|FG001|Delayed Start|Sponsor Decision|20|||
144251448|NCT05600036|520119323|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
144251449|NCT05600036|520119324|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
144251450|NCT05600036|520119325|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
144251451|NCT05600036|520119326|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
144251452|NCT05600036|520119327|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
144251453|NCT05600036|520119328|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
144528292|NCT02844465|521139044|FG000|Overall Study|Retreatment|1|||
144528293|NCT04117347|521139045|FG000|Overall Study|Adverse Event|0|||
144528294|NCT04117347|521139046|FG001|Overall Study|Adverse Event|0|||
144528295|NCT04117347|521139047|FG002|Overall Study|Adverse Event|1|||
144528296|NCT04117347|521139045|FG000|Overall Study|No time for study|0|||
144528297|NCT04117347|521139046|FG001|Overall Study|No time for study|2|||
144528298|NCT04117347|521139047|FG002|Overall Study|No time for study|0|||
144528299|NCT04117347|521139045|FG000|Overall Study|Family emergency|1|||
144528300|NCT04117347|521139046|FG001|Overall Study|Family emergency|0|||
144528301|NCT04117347|521139047|FG002|Overall Study|Family emergency|0|||
144528302|NCT03687086|521139048|FG000|Overall Study|Withdrawal by Subject|3|||
144528303|NCT03687086|521139049|FG001|Overall Study|Withdrawal by Subject|4|||
144528304|NCT03687086|521139048|FG000|Overall Study|Lost to Follow-up|1|||
144528305|NCT03687086|521139049|FG001|Overall Study|Lost to Follow-up|1|||
144528306|NCT03687086|521139048|FG000|Overall Study|Death|1|||
144528307|NCT03687086|521139049|FG001|Overall Study|Death|0|||
144528308|NCT03687086|521139048|FG000|Overall Study|Incomplete assessment|0|||
144528309|NCT03687086|521139049|FG001|Overall Study|Incomplete assessment|2|||
144528310|NCT05194956|521139050|FG000|Washout Period|Withdrawal by Subject|0|||
144528311|NCT05194956|521139051|FG001|Washout Period|Withdrawal by Subject|2|||
144528312|NCT02505984|521139052|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
144538434|NCT02347332|521174191|FG000|Overall Study|Switch Post-Trial program|0|||
144538435|NCT02347332|521174192|FG001|Overall Study|Switch Post-Trial program|1|||
144181728|NCT00762411|519860538|FG000|Delayed Start|Caregiver Decision|1|||
144181729|NCT00762411|519860539|FG001|Delayed Start|Caregiver Decision|1|||
144181730|NCT00762411|519860538|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
144181731|NCT00762411|519860539|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
144181732|NCT00762411|519860538|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
144538436|NCT01970007|521174194|FG000|Overall Study|Death|5|||
144538437|NCT01970007|521174194|FG000|Overall Study|Withdrawal by Subject|23|||
144538438|NCT01970007|521174194|FG000|Overall Study|Lost to Follow-up|24|||
144424898|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
144424899|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
144251454|NCT05600036|520119323|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
144251455|NCT05600036|520119324|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
144424900|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
144424901|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
144424902|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
144424903|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
144424904|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
144424905|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
144424906|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
144251456|NCT05600036|520119325|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
144251457|NCT05600036|520119326|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
144251458|NCT05600036|520119327|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
144251459|NCT05600036|520119328|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
144424907|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
144424908|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
144424909|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
144424910|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
144424911|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
144181733|NCT00762411|519860539|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
144181734|NCT00762411|519860538|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
144181735|NCT00762411|519860539|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
144181736|NCT00762411|519860538|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
144181737|NCT00762411|519860539|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
144181738|NCT00762411|519860538|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
144181739|NCT00762411|519860539|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
144181740|NCT00762411|519860538|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
144181741|NCT00762411|519860539|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
144181742|NCT04590781|519860543|FG000|Overall Study|Death|0|||
144181743|NCT04590781|519860544|FG001|Overall Study|Death|2|||
144181744|NCT04590781|519860543|FG000|Overall Study|Withdrawal by Subject|2|||
144181745|NCT04590781|519860544|FG001|Overall Study|Withdrawal by Subject|0|||
144181746|NCT01680016|519860545|FG000|Overall Study|Adverse Event|0|||
144181747|NCT01680016|519860546|FG001|Overall Study|Adverse Event|0|||
144181748|NCT01680016|519860547|FG002|Overall Study|Adverse Event|1|||
144181749|NCT01680016|519860548|FG003|Overall Study|Adverse Event|4|||
144181750|NCT01680016|519860545|FG000|Overall Study|The Subject went out of The Trial|1|||
144181751|NCT01680016|519860546|FG001|Overall Study|The Subject went out of The Trial|0|||
144181752|NCT01680016|519860547|FG002|Overall Study|The Subject went out of The Trial|3|||
144181753|NCT01680016|519860548|FG003|Overall Study|The Subject went out of The Trial|0|||
144181754|NCT01680016|519860545|FG000|Overall Study|Protocol Violation|0|||
144181755|NCT01680016|519860546|FG001|Overall Study|Protocol Violation|1|||
144181756|NCT01680016|519860547|FG002|Overall Study|Protocol Violation|0|||
144181757|NCT01680016|519860548|FG003|Overall Study|Protocol Violation|0|||
144181758|NCT01680016|519860545|FG000|Overall Study|Withdrawal by Subject|5|||
144181759|NCT01680016|519860546|FG001|Overall Study|Withdrawal by Subject|7|||
144181760|NCT01680016|519860547|FG002|Overall Study|Withdrawal by Subject|1|||
144181761|NCT01680016|519860548|FG003|Overall Study|Withdrawal by Subject|1|||
144181762|NCT01662024|519860553|FG000|Overall Study|Pregnancy|2|||
144181763|NCT01662024|519860553|FG000|Overall Study|Withdrawal by Subject|3|||
144181764|NCT00442351|519860554|FG000|Overall Study|Administrative|6|||
144181765|NCT00442351|519860555|FG001|Overall Study|Administrative|5|||
144181766|NCT00442351|519860554|FG000|Overall Study|Did not meet protocol eligibility|1|||
144181767|NCT00442351|519860555|FG001|Overall Study|Did not meet protocol eligibility|0|||
144181768|NCT00442351|519860554|FG000|Overall Study|Other|0|||
144181769|NCT00442351|519860555|FG001|Overall Study|Other|1|||
144181770|NCT01490190|519860557|FG000|Overall Study|Withdrawal by Subject|9|||
144181771|NCT01490190|519860557|FG000|Overall Study|Adverse Event|17|||
144181772|NCT01490190|519860557|FG000|Overall Study|Protocol Violation|5|||
144181773|NCT01490190|519860557|FG000|Overall Study|Lost to Follow-up|13|||
144251460|NCT04401202|520119329|FG000|Overall Study|Lost to Follow-up|2|||
144251461|NCT04401202|520119330|FG001|Overall Study|Lost to Follow-up|2|||
144181774|NCT01490190|519860557|FG000|Overall Study|Relocation|1|||
144181775|NCT01490190|519860557|FG000|Overall Study|Inconvenience|1|||
144181776|NCT01490190|519860557|FG000|Overall Study|Ring expulsion|2|||
144181777|NCT00544167|519860558|FG000|Overall Study|Adverse Event|21|||
144181778|NCT00544167|519860558|FG000|Overall Study|Physician Decision|8|||
144181779|NCT00735696|519860559|FG000|Overall Study|Withdrawal by Subject|1|||
144181780|NCT00735696|519860559|FG000|Overall Study|Enrolled but never Treated|1|||
144181781|NCT02655224|519860561|FG000|Overall Study|Adverse Event|1|||
144181782|NCT02655224|519860562|FG001|Overall Study|Adverse Event|1|||
144181783|NCT02733627|519860563|FG000|Overall Study|Adverse Event|0|||
144181784|NCT02733627|519860564|FG001|Overall Study|Adverse Event|1|||
144181785|NCT02733627|519860565|FG002|Overall Study|Adverse Event|1|||
144181786|NCT02733627|519860566|FG003|Overall Study|Adverse Event|0|||
144181787|NCT02733627|519860563|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
144181788|NCT02733627|519860564|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
144181789|NCT02733627|519860565|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
144181790|NCT02733627|519860566|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
144181791|NCT00059332|519860567|FG000|Overall Study|Withdrawal by Subject|2|||
144181792|NCT00059332|519860568|FG001|Overall Study|Withdrawal by Subject|1|||
144181793|NCT00059332|519860567|FG000|Overall Study|Lost to Follow-up|1|||
144181794|NCT00059332|519860568|FG001|Overall Study|Lost to Follow-up|1|||
144181795|NCT01119625|519860569|FG000|Overall Study|Lost to Follow-up|1|||
144181796|NCT01119625|519860570|FG001|Overall Study|Lost to Follow-up|2|||
144181797|NCT01119625|519860569|FG000|Overall Study|Withdrawal by Subject|2|||
144181798|NCT01119625|519860570|FG001|Overall Study|Withdrawal by Subject|1|||
144181799|NCT01119625|519860569|FG000|Overall Study|Other|0|||
144181800|NCT01119625|519860570|FG001|Overall Study|Other|1|||
144181801|NCT00210639|519860575|FG000|Overall Study|Lost to Follow-up|37|||
144181802|NCT00210639|519860576|FG001|Overall Study|Lost to Follow-up|29|||
144181803|NCT00210639|519860575|FG000|Overall Study|Withdrawal by Subject|8|||
144181804|NCT00210639|519860576|FG001|Overall Study|Withdrawal by Subject|1|||
144181805|NCT00210639|519860575|FG000|Overall Study|Other|18|||
144181806|NCT00210639|519860576|FG001|Overall Study|Other|12|||
144181807|NCT00397254|519860577|FG000|Overall Study|Lost to Follow-up|2|||
144181808|NCT00397254|519860578|FG001|Overall Study|Lost to Follow-up|2|||
144181809|NCT02854800|519860580|FG000|Overall Study|Protocol Violation|16|||
144181810|NCT02854800|519860581|FG001|Overall Study|Protocol Violation|11|||
144181811|NCT02854800|519860582|FG002|Overall Study|Protocol Violation|3|||
144181812|NCT02854800|519860580|FG000|Overall Study|Withdrawal by Subject|4|||
144181813|NCT02854800|519860581|FG001|Overall Study|Withdrawal by Subject|2|||
144181814|NCT02854800|519860582|FG002|Overall Study|Withdrawal by Subject|3|||
144181815|NCT02627963|519860588|FG000|Overall Study|Randomized but not treated|2|||
144181816|NCT02627963|519860589|FG001|Overall Study|Randomized but not treated|6|||
144181817|NCT03073798|519860590|FG000|Overall Study|Adverse Event|1|||
144181818|NCT03073798|519860590|FG000|Overall Study|Withdrawal by Subject|1|||
144181819|NCT01186458|519860594|FG000|Overall Study|Adverse Event|1|||
144181820|NCT04281472|519860595|FG000|Stage A|Lack of Efficacy|8|||
144181821|NCT04281472|519860596|FG001|Stage A|Lack of Efficacy|0|||
144181822|NCT04281472|519860597|FG002|Stage A|Lack of Efficacy|0|||
144181823|NCT04281472|519860595|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
144181824|NCT04281472|519860596|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
144181825|NCT04281472|519860597|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
144181826|NCT04281472|519860595|FG000|Stage A|Adverse Event|20|||
144181827|NCT04281472|519860596|FG001|Stage A|Adverse Event|0|||
144181828|NCT04281472|519860597|FG002|Stage A|Adverse Event|0|||
144181829|NCT04281472|519860595|FG000|Stage A|Death|1|||
144181830|NCT04281472|519860596|FG001|Stage A|Death|0|||
144181831|NCT04281472|519860597|FG002|Stage A|Death|0|||
144181832|NCT04281472|519860595|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
144181833|NCT04281472|519860596|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
144181834|NCT04281472|519860597|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
144528313|NCT02505984|521139053|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
144181835|NCT04281472|519860595|FG000|Stage A|Lost to Follow-up|2|||
144181836|NCT04281472|519860596|FG001|Stage A|Lost to Follow-up|0|||
144181837|NCT04281472|519860597|FG002|Stage A|Lost to Follow-up|0|||
144181838|NCT04281472|519860595|FG000|Stage A|Non-compliance with study drug|1|||
144181839|NCT04281472|519860596|FG001|Stage A|Non-compliance with study drug|0|||
144181840|NCT04281472|519860597|FG002|Stage A|Non-compliance with study drug|0|||
144181841|NCT04281472|519860595|FG000|Stage A|Physician Decision|1|||
144181842|NCT04281472|519860596|FG001|Stage A|Physician Decision|0|||
144181843|NCT04281472|519860597|FG002|Stage A|Physician Decision|0|||
144181844|NCT04281472|519860595|FG000|Stage A|Prohibited medications|2|||
144181845|NCT04281472|519860596|FG001|Stage A|Prohibited medications|0|||
144181846|NCT04281472|519860597|FG002|Stage A|Prohibited medications|0|||
144181847|NCT04281472|519860595|FG000|Stage A|Withdrawal by Subject|11|||
144181848|NCT04281472|519860596|FG001|Stage A|Withdrawal by Subject|0|||
144181849|NCT04281472|519860597|FG002|Stage A|Withdrawal by Subject|0|||
144181850|NCT04281472|519860595|FG000|Stage A|Other|5|||
144181851|NCT04281472|519860596|FG001|Stage A|Other|0|||
144181852|NCT04281472|519860597|FG002|Stage A|Other|0|||
144181853|NCT04281472|519860595|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
144181854|NCT04281472|519860596|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
144251462|NCT04401202|520119329|FG000|Overall Study|Adverse Event|0|||
144181855|NCT04281472|519860597|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
144181856|NCT04281472|519860595|FG000|Stage B|Adverse Event|0|||
144181857|NCT04281472|519860596|FG001|Stage B|Adverse Event|3|||
144181858|NCT04281472|519860597|FG002|Stage B|Adverse Event|0|||
144181859|NCT04281472|519860595|FG000|Stage B|Death|0|||
144181860|NCT04281472|519860596|FG001|Stage B|Death|0|||
144181861|NCT04281472|519860597|FG002|Stage B|Death|1|||
144251463|NCT04401202|520119330|FG001|Overall Study|Adverse Event|1|||
144251464|NCT04401202|520119329|FG000|Overall Study|Hospitalized|4|||
144251465|NCT04401202|520119330|FG001|Overall Study|Hospitalized|1|||
144251466|NCT01006590|520119331|FG000|Overall Study|Adverse Event|2|||
144251467|NCT01006590|520119332|FG001|Overall Study|Adverse Event|3|||
144251468|NCT01006590|520119331|FG000|Overall Study|Death|1|||
144251469|NCT01006590|520119332|FG001|Overall Study|Death|1|||
144251470|NCT01006590|520119331|FG000|Overall Study|Lost to Follow-up|1|||
144528314|NCT02505984|521139052|FG000|Overall Study|Unreliable self-report data|1|||
144528315|NCT02505984|521139053|FG001|Overall Study|Unreliable self-report data|0|||
144528316|NCT02505984|521139052|FG000|Overall Study|Study blind opened during assessment|0|||
144528317|NCT02505984|521139053|FG001|Overall Study|Study blind opened during assessment|1|||
144528318|NCT02505984|521139052|FG000|Overall Study|Noncompliance with study protocol|0|||
144528319|NCT02505984|521139053|FG001|Overall Study|Noncompliance with study protocol|1|||
144528320|NCT05934942|521139061|FG000|Run-in Period|Not treated|1|||
144528321|NCT05934942|521139061|FG000|Run-in Period|Withdrawal by Subject|1|||
144528322|NCT00539591|521139062|FG000|Overall Study|Toxicity|3|||
144528323|NCT00539591|521139063|FG001|Overall Study|Toxicity|0|||
144528324|NCT00539591|521139064|FG002|Overall Study|Toxicity|0|||
144528325|NCT00539591|521139062|FG000|Overall Study|Disease progression|2|||
144528326|NCT00539591|521139063|FG001|Overall Study|Disease progression|2|||
144528327|NCT00539591|521139064|FG002|Overall Study|Disease progression|3|||
144528328|NCT04362254|521139065|FG000|Overall Study|Adverse Event|1|||
144528329|NCT04362254|521139065|FG000|Overall Study|Protocol Violation|1|||
144528330|NCT04362254|521139065|FG000|Overall Study|Due to early termination of the trial|10|||
144528331|NCT04568434|521139066|FG000|Overall Study|Voluntary Withdrawal|0|||
144528332|NCT04568434|521139067|FG001|Overall Study|Voluntary Withdrawal|1|||
144528333|NCT04568434|521139068|FG002|Overall Study|Voluntary Withdrawal|1|||
144528334|NCT04568434|521139066|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
144528335|NCT04568434|521139067|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
144528336|NCT04568434|521139068|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
144528337|NCT04568434|521139066|FG000|Overall Study|Investigator Judgement|1|||
144528338|NCT04568434|521139067|FG001|Overall Study|Investigator Judgement|0|||
144528339|NCT04568434|521139068|FG002|Overall Study|Investigator Judgement|0|||
144528340|NCT05469464|521139069|FG000|Overall Study|Withdrawal by Subject|8|||
144528341|NCT05469464|521139070|FG001|Overall Study|Withdrawal by Subject|7|||
144528342|NCT05469464|521139071|FG002|Overall Study|Withdrawal by Subject|4|||
144528343|NCT05469464|521139072|FG003|Overall Study|Withdrawal by Subject|5|||
144528344|NCT05469464|521139069|FG000|Overall Study|Adverse Event|8|||
144528345|NCT05469464|521139070|FG001|Overall Study|Adverse Event|14|||
144528346|NCT05469464|521139071|FG002|Overall Study|Adverse Event|13|||
144528347|NCT05469464|521139072|FG003|Overall Study|Adverse Event|2|||
144528348|NCT05469464|521139069|FG000|Overall Study|Lost to Follow-up|2|||
144528349|NCT05469464|521139070|FG001|Overall Study|Lost to Follow-up|5|||
144528350|NCT05469464|521139071|FG002|Overall Study|Lost to Follow-up|3|||
144528351|NCT05469464|521139072|FG003|Overall Study|Lost to Follow-up|3|||
144528352|NCT05469464|521139069|FG000|Overall Study|Lack of Efficacy|4|||
144528353|NCT05469464|521139070|FG001|Overall Study|Lack of Efficacy|1|||
144528354|NCT05469464|521139071|FG002|Overall Study|Lack of Efficacy|2|||
144528355|NCT05469464|521139072|FG003|Overall Study|Lack of Efficacy|2|||
144528356|NCT05469464|521139069|FG000|Overall Study|Physician Decision|0|||
144528357|NCT05469464|521139070|FG001|Overall Study|Physician Decision|0|||
144528358|NCT05469464|521139071|FG002|Overall Study|Physician Decision|0|||
144528359|NCT05469464|521139072|FG003|Overall Study|Physician Decision|1|||
144528360|NCT01928394|521139073|FG000|Treatment Period|Disease progression|17|||
144528361|NCT01928394|521139074|FG001|Treatment Period|Disease progression|2|||
144528362|NCT01928394|521139075|FG002|Treatment Period|Disease progression|12|||
144528363|NCT01928394|521139076|FG003|Treatment Period|Disease progression|48|||
144528364|NCT01928394|521139077|FG004|Treatment Period|Disease progression|3|||
144528365|NCT01928394|521139078|FG005|Treatment Period|Disease progression|25|||
144528366|NCT01928394|521139079|FG006|Treatment Period|Disease progression|38|||
144528367|NCT01928394|521139080|FG007|Treatment Period|Disease progression|16|||
144181862|NCT04281472|519860595|FG000|Stage B|Lack of Efficacy|0|||
144181863|NCT04281472|519860596|FG001|Stage B|Lack of Efficacy|0|||
144251471|NCT01006590|520119332|FG001|Overall Study|Lost to Follow-up|1|||
144181864|NCT04281472|519860597|FG002|Stage B|Lack of Efficacy|1|||
144528368|NCT01928394|521139081|FG008|Treatment Period|Disease progression|3|||
144528369|NCT01928394|521139082|FG009|Treatment Period|Disease progression|11|||
144528370|NCT01928394|521139083|FG010|Treatment Period|Disease progression|22|||
144528371|NCT01928394|521139084|FG011|Treatment Period|Disease progression|73|||
144528372|NCT01928394|521139085|FG012|Treatment Period|Disease progression|38|||
144181865|NCT04281472|519860595|FG000|Stage B|Lost to Follow-up|0|||
144181866|NCT04281472|519860596|FG001|Stage B|Lost to Follow-up|0|||
144181867|NCT04281472|519860597|FG002|Stage B|Lost to Follow-up|2|||
144181868|NCT04281472|519860595|FG000|Stage B|Prohibited medications|0|||
144251472|NCT01006590|520119331|FG000|Overall Study|Protocol Violation|1|||
144251473|NCT01006590|520119332|FG001|Overall Study|Protocol Violation|0|||
144601808|NCT04178967|521404798|FG003|Induction Period|Adverse Event|0|||
144601809|NCT04178967|521404799|FG004|Induction Period|Adverse Event|0|||
144601810|NCT04178967|521404800|FG005|Induction Period|Adverse Event|0|||
144601811|NCT04178967|521404801|FG006|Induction Period|Adverse Event|0|||
144601812|NCT04178967|521404802|FG007|Induction Period|Adverse Event|0|||
144601813|NCT04178967|521404803|FG008|Induction Period|Adverse Event|0|||
144601814|NCT04178967|521404804|FG009|Induction Period|Adverse Event|0|||
144601815|NCT04178967|521404805|FG010|Induction Period|Adverse Event|0|||
144601816|NCT04178967|521404795|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
144601817|NCT04178967|521404796|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
144601818|NCT04178967|521404797|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
144601819|NCT04178967|521404798|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
144601820|NCT04178967|521404799|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
144601821|NCT04178967|521404800|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
144601822|NCT04178967|521404801|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
144601823|NCT04178967|521404802|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
144601824|NCT04178967|521404803|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
144601825|NCT04178967|521404804|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
144601826|NCT04178967|521404805|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
144601827|NCT04178967|521404795|FG000|Induction Period|Lack of Efficacy|4|||
144601828|NCT04178967|521404796|FG001|Induction Period|Lack of Efficacy|1|||
144601829|NCT04178967|521404797|FG002|Induction Period|Lack of Efficacy|0|||
144601830|NCT04178967|521404798|FG003|Induction Period|Lack of Efficacy|0|||
144601831|NCT04178967|521404799|FG004|Induction Period|Lack of Efficacy|0|||
144601832|NCT04178967|521404800|FG005|Induction Period|Lack of Efficacy|0|||
144601833|NCT04178967|521404801|FG006|Induction Period|Lack of Efficacy|0|||
144601834|NCT04178967|521404802|FG007|Induction Period|Lack of Efficacy|0|||
144601835|NCT04178967|521404803|FG008|Induction Period|Lack of Efficacy|0|||
144601836|NCT04178967|521404804|FG009|Induction Period|Lack of Efficacy|0|||
144601837|NCT04178967|521404805|FG010|Induction Period|Lack of Efficacy|0|||
144601838|NCT04178967|521404795|FG000|Induction Period|Protocol Violation|0|||
144601839|NCT04178967|521404796|FG001|Induction Period|Protocol Violation|6|||
144601840|NCT04178967|521404797|FG002|Induction Period|Protocol Violation|0|||
144601841|NCT04178967|521404798|FG003|Induction Period|Protocol Violation|0|||
144601842|NCT04178967|521404799|FG004|Induction Period|Protocol Violation|0|||
144601843|NCT04178967|521404800|FG005|Induction Period|Protocol Violation|0|||
144601844|NCT04178967|521404801|FG006|Induction Period|Protocol Violation|0|||
144601845|NCT04178967|521404802|FG007|Induction Period|Protocol Violation|0|||
144601846|NCT04178967|521404803|FG008|Induction Period|Protocol Violation|0|||
144601847|NCT04178967|521404804|FG009|Induction Period|Protocol Violation|0|||
144601848|NCT04178967|521404805|FG010|Induction Period|Protocol Violation|0|||
144601849|NCT04178967|521404795|FG000|Induction Period|Withdrawal by Subject|6|||
144601850|NCT04178967|521404796|FG001|Induction Period|Withdrawal by Subject|4|||
144601851|NCT04178967|521404797|FG002|Induction Period|Withdrawal by Subject|0|||
144601852|NCT04178967|521404798|FG003|Induction Period|Withdrawal by Subject|0|||
144601853|NCT04178967|521404799|FG004|Induction Period|Withdrawal by Subject|0|||
144601854|NCT04178967|521404800|FG005|Induction Period|Withdrawal by Subject|0|||
144601855|NCT04178967|521404801|FG006|Induction Period|Withdrawal by Subject|0|||
144601856|NCT04178967|521404802|FG007|Induction Period|Withdrawal by Subject|0|||
144601857|NCT04178967|521404803|FG008|Induction Period|Withdrawal by Subject|0|||
144601858|NCT04178967|521404804|FG009|Induction Period|Withdrawal by Subject|0|||
144181869|NCT04281472|519860596|FG001|Stage B|Prohibited medications|2|||
144181870|NCT04281472|519860597|FG002|Stage B|Prohibited medications|1|||
144181871|NCT04281472|519860595|FG000|Stage B|Protocol Violation|0|||
144601859|NCT04178967|521404805|FG010|Induction Period|Withdrawal by Subject|0|||
144601860|NCT04178967|521404795|FG000|Induction Period|Lost to Follow-up|2|||
144601861|NCT04178967|521404796|FG001|Induction Period|Lost to Follow-up|0|||
144601862|NCT04178967|521404797|FG002|Induction Period|Lost to Follow-up|0|||
144601863|NCT04178967|521404798|FG003|Induction Period|Lost to Follow-up|0|||
144601864|NCT04178967|521404799|FG004|Induction Period|Lost to Follow-up|0|||
144723396|NCT01265784|521842329|FG002|Overall Study|Death|0|||
144251474|NCT01006590|520119331|FG000|Overall Study|Withdrawal by Subject|4|||
144601865|NCT04178967|521404800|FG005|Induction Period|Lost to Follow-up|0|||
144601866|NCT04178967|521404801|FG006|Induction Period|Lost to Follow-up|0|||
144601867|NCT04178967|521404802|FG007|Induction Period|Lost to Follow-up|0|||
144601868|NCT04178967|521404803|FG008|Induction Period|Lost to Follow-up|0|||
144181872|NCT04281472|519860596|FG001|Stage B|Protocol Violation|1|||
144181873|NCT04281472|519860597|FG002|Stage B|Protocol Violation|1|||
144181874|NCT04281472|519860595|FG000|Stage B|Sponsor decision|0|||
144601869|NCT04178967|521404804|FG009|Induction Period|Lost to Follow-up|0|||
144601870|NCT04178967|521404805|FG010|Induction Period|Lost to Follow-up|0|||
144181875|NCT04281472|519860596|FG001|Stage B|Sponsor decision|0|||
144601871|NCT04178967|521404795|FG000|Induction Period|Participant Missed Study Visits|0|||
144601872|NCT04178967|521404796|FG001|Induction Period|Participant Missed Study Visits|1|||
144601873|NCT04178967|521404797|FG002|Induction Period|Participant Missed Study Visits|0|||
144601874|NCT04178967|521404798|FG003|Induction Period|Participant Missed Study Visits|0|||
144601875|NCT04178967|521404799|FG004|Induction Period|Participant Missed Study Visits|0|||
144601876|NCT04178967|521404800|FG005|Induction Period|Participant Missed Study Visits|0|||
144601877|NCT04178967|521404801|FG006|Induction Period|Participant Missed Study Visits|0|||
144601878|NCT04178967|521404802|FG007|Induction Period|Participant Missed Study Visits|0|||
144601879|NCT04178967|521404803|FG008|Induction Period|Participant Missed Study Visits|0|||
144601880|NCT04178967|521404804|FG009|Induction Period|Participant Missed Study Visits|0|||
144601881|NCT04178967|521404805|FG010|Induction Period|Participant Missed Study Visits|0|||
144723397|NCT01265784|521842327|FG000|Overall Study|Protocol Violation|2|||
144723398|NCT01265784|521842328|FG001|Overall Study|Protocol Violation|0|||
144723399|NCT01265784|521842329|FG002|Overall Study|Protocol Violation|0|||
144723400|NCT01265784|521842327|FG000|Overall Study|Incorrectly Randomized|0|||
144723401|NCT01265784|521842328|FG001|Overall Study|Incorrectly Randomized|0|||
144723402|NCT01265784|521842329|FG002|Overall Study|Incorrectly Randomized|1|||
144723403|NCT03072459|521842335|FG000|Overall Study|Device revised/removed|1|||
144723404|NCT03072459|521842335|FG000|Overall Study|Subject not able to return|1|||
144723405|NCT00329602|521842336|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
144723406|NCT00329602|521842337|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
144723407|NCT00329602|521842338|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
144723408|NCT00329602|521842336|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
144723409|NCT00329602|521842337|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
144723410|NCT00329602|521842338|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
144723411|NCT00329602|521842336|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
144723412|NCT00329602|521842337|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
144181876|NCT04281472|519860597|FG002|Stage B|Sponsor decision|1|||
144181877|NCT04281472|519860595|FG000|Stage B|Withdrawal by Subject|0|||
144181878|NCT04281472|519860596|FG001|Stage B|Withdrawal by Subject|3|||
144181879|NCT04281472|519860597|FG002|Stage B|Withdrawal by Subject|3|||
144181880|NCT04281472|519860595|FG000|Stage B|Other|0|||
144181881|NCT04281472|519860596|FG001|Stage B|Other|3|||
144181882|NCT04281472|519860597|FG002|Stage B|Other|0|||
144181883|NCT00152451|519860598|FG000|Overall Study|Adverse Event|4|||
144181884|NCT00323258|519860604|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
144181885|NCT00323258|519860605|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
144181886|NCT00323258|519860604|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
144181887|NCT00323258|519860605|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
144181888|NCT00323258|519860604|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
144181889|NCT00323258|519860605|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
144181890|NCT00323258|519860604|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
144181891|NCT00323258|519860605|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
144181892|NCT00323258|519860604|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
144181893|NCT00323258|519860605|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
144181894|NCT00323258|519860604|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
144181895|NCT00323258|519860605|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
144181896|NCT00323258|519860604|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
144181897|NCT00323258|519860605|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
144181898|NCT02372006|519860606|FG000|Overall Study|Progressive disease|8|||
144181899|NCT02372006|519860607|FG001|Overall Study|Progressive disease|7|||
144181900|NCT02372006|519860608|FG002|Overall Study|Progressive disease|34|||
144181901|NCT02372006|519860606|FG000|Overall Study|Dose limiting toxicity|0|||
144181902|NCT02372006|519860607|FG001|Overall Study|Dose limiting toxicity|1|||
144181903|NCT02372006|519860608|FG002|Overall Study|Dose limiting toxicity|0|||
144181904|NCT02372006|519860606|FG000|Overall Study|Adverse Event|0|||
144181905|NCT02372006|519860607|FG001|Overall Study|Adverse Event|0|||
144181906|NCT02372006|519860608|FG002|Overall Study|Adverse Event|3|||
144181907|NCT02372006|519860606|FG000|Overall Study|Withdrawal by Subject|0|||
144181908|NCT02372006|519860607|FG001|Overall Study|Withdrawal by Subject|1|||
144181909|NCT02372006|519860608|FG002|Overall Study|Withdrawal by Subject|1|||
144181910|NCT02372006|519860606|FG000|Overall Study|Other reason for not completing|0|||
144181911|NCT02372006|519860607|FG001|Overall Study|Other reason for not completing|0|||
144181912|NCT02372006|519860608|FG002|Overall Study|Other reason for not completing|1|||
144181913|NCT01055834|519860612|FG000|Treatment Period I|Adverse Event|1|||
144181914|NCT01055834|519860613|FG001|Treatment Period I|Adverse Event|0|||
144181915|NCT01717313|519860614|FG000|Phase A (Weeks 0 to 24)|Death|0|||
144181916|NCT01717313|519860615|FG001|Phase A (Weeks 0 to 24)|Death|1|||
144181917|NCT01717313|519860614|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
144181918|NCT01717313|519860615|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
144181919|NCT01717313|519860614|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
144181920|NCT01717313|519860615|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
144181921|NCT01717313|519860614|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
144181922|NCT01717313|519860615|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
144181923|NCT01717313|519860614|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
144181924|NCT01717313|519860615|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
144181925|NCT01717313|519860614|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
144181926|NCT01717313|519860615|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
144181927|NCT01717313|519860614|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
144181928|NCT01717313|519860615|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
144181929|NCT01717313|519860614|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
144251475|NCT01006590|520119332|FG001|Overall Study|Withdrawal by Subject|2|||
144251476|NCT01006590|520119331|FG000|Overall Study|Study specific discontinuation criteria|16|||
144251477|NCT01006590|520119332|FG001|Overall Study|Study specific discontinuation criteria|23|||
144251478|NCT01006590|520119331|FG000|Overall Study|Other|3|||
144251479|NCT01006590|520119332|FG001|Overall Study|Other|2|||
144251480|NCT03332095|520119333|FG000|Overall Study|Lost to Follow-up|1|||
144251481|NCT03332095|520119334|FG001|Overall Study|Lost to Follow-up|0|||
144251482|NCT03332095|520119333|FG000|Overall Study|Pregnancy|0|||
144251483|NCT03332095|520119334|FG001|Overall Study|Pregnancy|1|||
144251484|NCT02570750|520119340|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
144251485|NCT02570750|520119341|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
144251486|NCT02570750|520119340|FG000|Overall Study|Protocol deviation|4|||
144251487|NCT02570750|520119341|FG001|Overall Study|Protocol deviation|2|||
144251488|NCT02570750|520119340|FG000|Overall Study|Withdrawal by Subject|5|||
144251489|NCT02570750|520119341|FG001|Overall Study|Withdrawal by Subject|0|||
144251490|NCT02570750|520119340|FG000|Overall Study|Lost to Follow-up|2|||
144251491|NCT02570750|520119341|FG001|Overall Study|Lost to Follow-up|2|||
144251492|NCT02570750|520119340|FG000|Overall Study|Adverse Event|2|||
144251493|NCT02570750|520119341|FG001|Overall Study|Adverse Event|1|||
144251494|NCT01410240|520119342|FG000|Overall Study|Physician Decision|0|||
144251495|NCT01410240|520119343|FG001|Overall Study|Physician Decision|0|||
144251496|NCT01410240|520119344|FG002|Overall Study|Physician Decision|1|||
144251497|NCT01410240|520119342|FG000|Overall Study|Missed week 6 assessments|1|||
144251498|NCT01410240|520119343|FG001|Overall Study|Missed week 6 assessments|1|||
144251499|NCT01410240|520119344|FG002|Overall Study|Missed week 6 assessments|1|||
144251500|NCT04348500|520119345|FG000|Overall Study|Death|2|||
144251501|NCT04348500|520119346|FG001|Overall Study|Death|2|||
144251502|NCT04348500|520119345|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
144251503|NCT04348500|520119346|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
144251504|NCT02776670|520119347|FG000|Overall Study|Adverse Event|0|||
144251505|NCT02776670|520119348|FG001|Overall Study|Adverse Event|2|||
144251506|NCT02776670|520119347|FG000|Overall Study|Protocol Violation|0|||
144251507|NCT02776670|520119348|FG001|Overall Study|Protocol Violation|2|||
144251508|NCT02776670|520119347|FG000|Overall Study|Withdrawal by Subject|0|||
144251509|NCT02776670|520119348|FG001|Overall Study|Withdrawal by Subject|1|||
144251510|NCT02776670|520119347|FG000|Overall Study|Other - Reason not given|0|||
144251511|NCT02776670|520119348|FG001|Overall Study|Other - Reason not given|1|||
144251512|NCT03699540|520119349|FG000|Overall Study|Lost to Follow-up|1|||
144251513|NCT00624832|520119352|FG000|Overall Study|Adverse Event|0|||
144251514|NCT00624832|520119353|FG001|Overall Study|Adverse Event|1|||
144251515|NCT00624832|520119354|FG002|Overall Study|Adverse Event|0|||
144251516|NCT00624832|520119355|FG003|Overall Study|Adverse Event|1|||
144251517|NCT00624832|520119352|FG000|Overall Study|Abnormal Laboratory Value|2|||
144251518|NCT00624832|520119353|FG001|Overall Study|Abnormal Laboratory Value|0|||
144528373|NCT01928394|521139086|FG013|Treatment Period|Disease progression|118|||
144528374|NCT01928394|521139087|FG014|Treatment Period|Disease progression|59|||
144528375|NCT01928394|521139088|FG015|Treatment Period|Disease progression|1|||
144528376|NCT01928394|521139089|FG016|Treatment Period|Disease progression|43|||
144528377|NCT01928394|521139090|FG017|Treatment Period|Disease progression|56|||
144528378|NCT01928394|521139091|FG018|Treatment Period|Disease progression|50|||
144528379|NCT01928394|521139092|FG019|Treatment Period|Disease progression|71|||
144528380|NCT01928394|521139093|FG020|Treatment Period|Disease progression|30|||
144528381|NCT01928394|521139094|FG021|Treatment Period|Disease progression|31|||
144528382|NCT01928394|521139095|FG022|Treatment Period|Disease progression|31|||
144528383|NCT01928394|521139073|FG000|Treatment Period|Study drug toxicity|1|||
144528384|NCT01928394|521139074|FG001|Treatment Period|Study drug toxicity|1|||
144528385|NCT01928394|521139075|FG002|Treatment Period|Study drug toxicity|3|||
144528386|NCT01928394|521139076|FG003|Treatment Period|Study drug toxicity|3|||
144528387|NCT01928394|521139077|FG004|Treatment Period|Study drug toxicity|0|||
144528388|NCT01928394|521139078|FG005|Treatment Period|Study drug toxicity|9|||
144528389|NCT01928394|521139079|FG006|Treatment Period|Study drug toxicity|7|||
144528390|NCT01928394|521139080|FG007|Treatment Period|Study drug toxicity|1|||
144528391|NCT01928394|521139081|FG008|Treatment Period|Study drug toxicity|0|||
144528392|NCT01928394|521139082|FG009|Treatment Period|Study drug toxicity|5|||
144528393|NCT01928394|521139083|FG010|Treatment Period|Study drug toxicity|2|||
144601882|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601883|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601884|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601885|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601886|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601887|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
144601888|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
144601889|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
144601890|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601891|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601892|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
144601893|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601894|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601895|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601896|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601897|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601898|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
144601899|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601900|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601901|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601902|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601903|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144601904|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601905|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601906|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601907|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
144601908|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601909|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601910|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601911|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601912|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601913|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601914|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144601915|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601916|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601917|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601918|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601919|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601920|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601921|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
144601922|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601923|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601924|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601925|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
144601926|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601927|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601928|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601929|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601930|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
144601931|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
144601932|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601933|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
144601934|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601935|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601936|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144601937|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
144601938|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
144601939|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
144601940|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
144181930|NCT01717313|519860615|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
144181931|NCT01717313|519860614|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
144181932|NCT01717313|519860615|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
144181933|NCT04133311|519860617|FG000|Period 1 Double Masked Treatment Period|Death|1|||
144181934|NCT04133311|519860618|FG001|Period 1 Double Masked Treatment Period|Death|0|||
144181935|NCT04133311|519860619|FG002|Period 1 Double Masked Treatment Period|Death|0|||
144181936|NCT04133311|519860620|FG003|Period 1 Double Masked Treatment Period|Death|0|||
144181937|NCT04133311|519860617|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
144251519|NCT00624832|520119354|FG002|Overall Study|Abnormal Laboratory Value|0|||
144251520|NCT00624832|520119355|FG003|Overall Study|Abnormal Laboratory Value|0|||
144251521|NCT01939223|520119356|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
144181938|NCT04133311|519860618|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
144181939|NCT04133311|519860619|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
144181940|NCT04133311|519860620|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
144181941|NCT04133311|519860617|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
144181942|NCT04133311|519860618|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
144181943|NCT04133311|519860619|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
144181944|NCT04133311|519860620|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
144181945|NCT04133311|519860617|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
144181946|NCT04133311|519860618|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
144181947|NCT04133311|519860619|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
144181948|NCT04133311|519860620|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
144181949|NCT04133311|519860617|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
144181950|NCT04133311|519860618|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
144181951|NCT04133311|519860619|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
144181952|NCT04133311|519860620|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
144181953|NCT04133311|519860617|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
144181954|NCT04133311|519860618|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
144181955|NCT04133311|519860619|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
144181956|NCT04133311|519860620|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
144181957|NCT04133311|519860617|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
144181958|NCT04133311|519860618|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
144181959|NCT04133311|519860619|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
144181960|NCT04133311|519860620|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
144181961|NCT04133311|519860617|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
144181962|NCT04133311|519860618|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
144251522|NCT01939223|520119357|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
144251523|NCT01939223|520119356|FG000|Overall Study|Disease recurrence (radiological)|1|||
144251524|NCT01939223|520119357|FG001|Overall Study|Disease recurrence (radiological)|3|||
144251525|NCT01939223|520119356|FG000|Overall Study|Study stopped by Sponsor|5|||
144528394|NCT01928394|521139084|FG011|Treatment Period|Study drug toxicity|3|||
144528395|NCT01928394|521139085|FG012|Treatment Period|Study drug toxicity|7|||
144528396|NCT01928394|521139086|FG013|Treatment Period|Study drug toxicity|5|||
144528397|NCT01928394|521139087|FG014|Treatment Period|Study drug toxicity|12|||
144528398|NCT01928394|521139088|FG015|Treatment Period|Study drug toxicity|0|||
144528399|NCT01928394|521139089|FG016|Treatment Period|Study drug toxicity|3|||
144528400|NCT01928394|521139090|FG017|Treatment Period|Study drug toxicity|3|||
144528401|NCT01928394|521139091|FG018|Treatment Period|Study drug toxicity|12|||
144528402|NCT01928394|521139092|FG019|Treatment Period|Study drug toxicity|15|||
144528403|NCT01928394|521139093|FG020|Treatment Period|Study drug toxicity|4|||
144528404|NCT01928394|521139094|FG021|Treatment Period|Study drug toxicity|7|||
144528405|NCT01928394|521139095|FG022|Treatment Period|Study drug toxicity|4|||
144528406|NCT01928394|521139073|FG000|Treatment Period|AE unrelated to study drug|0|||
144528407|NCT01928394|521139074|FG001|Treatment Period|AE unrelated to study drug|0|||
144528408|NCT01928394|521139075|FG002|Treatment Period|AE unrelated to study drug|2|||
144528409|NCT01928394|521139076|FG003|Treatment Period|AE unrelated to study drug|3|||
144528410|NCT01928394|521139077|FG004|Treatment Period|AE unrelated to study drug|0|||
144528411|NCT01928394|521139078|FG005|Treatment Period|AE unrelated to study drug|5|||
144528412|NCT01928394|521139079|FG006|Treatment Period|AE unrelated to study drug|1|||
144528413|NCT01928394|521139080|FG007|Treatment Period|AE unrelated to study drug|0|||
144528414|NCT01928394|521139081|FG008|Treatment Period|AE unrelated to study drug|0|||
144528415|NCT01928394|521139082|FG009|Treatment Period|AE unrelated to study drug|2|||
144528416|NCT01928394|521139083|FG010|Treatment Period|AE unrelated to study drug|0|||
144528417|NCT01928394|521139084|FG011|Treatment Period|AE unrelated to study drug|12|||
144181963|NCT04133311|519860619|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
144181964|NCT04133311|519860620|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
144181965|NCT00573313|519860627|FG000|Overall Study|Protocol Violation|5|||
144251526|NCT01939223|520119357|FG001|Overall Study|Study stopped by Sponsor|7|||
144251527|NCT01939223|520119356|FG000|Overall Study|Withdrawal by Subject|6|||
144251528|NCT01939223|520119357|FG001|Overall Study|Withdrawal by Subject|0|||
144528418|NCT01928394|521139085|FG012|Treatment Period|AE unrelated to study drug|6|||
144528419|NCT01928394|521139086|FG013|Treatment Period|AE unrelated to study drug|13|||
144528420|NCT01928394|521139087|FG014|Treatment Period|AE unrelated to study drug|6|||
144528421|NCT01928394|521139088|FG015|Treatment Period|AE unrelated to study drug|1|||
144181966|NCT00573313|519860628|FG001|Overall Study|Protocol Violation|0|||
144528422|NCT01928394|521139089|FG016|Treatment Period|AE unrelated to study drug|1|||
144528423|NCT01928394|521139090|FG017|Treatment Period|AE unrelated to study drug|6|||
144528424|NCT01928394|521139091|FG018|Treatment Period|AE unrelated to study drug|3|||
144528425|NCT01928394|521139092|FG019|Treatment Period|AE unrelated to study drug|5|||
144528426|NCT01928394|521139093|FG020|Treatment Period|AE unrelated to study drug|1|||
144181967|NCT00573313|519860629|FG002|Overall Study|Protocol Violation|6|||
144181968|NCT00573313|519860630|FG003|Overall Study|Protocol Violation|0|||
144181969|NCT03885934|519860634|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
144181970|NCT03885934|519860635|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
144181971|NCT03885934|519860636|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
144181972|NCT03885934|519860637|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
144181973|NCT03885934|519860638|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
144181974|NCT03885934|519860639|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
144181975|NCT02179190|519860640|FG000|Enrollment|Exit Prior to Device Attempt|11|||
144181976|NCT02179190|519860640|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
144181977|NCT02179190|519860640|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
144181978|NCT02179190|519860640|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
144181979|NCT02179190|519860640|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
144181980|NCT02179190|519860640|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
144181981|NCT01993940|519860641|FG000|Overall Study|Adverse Event|16|||
144181982|NCT01993940|519860642|FG001|Overall Study|Adverse Event|11|||
144181983|NCT01993940|519860641|FG000|Overall Study|Withdrawal by Subject|15|||
144181984|NCT01993940|519860642|FG001|Overall Study|Withdrawal by Subject|19|||
144181985|NCT01993940|519860641|FG000|Overall Study|Lost to Follow-up|2|||
144181986|NCT01993940|519860642|FG001|Overall Study|Lost to Follow-up|5|||
144181987|NCT01993940|519860641|FG000|Overall Study|Protocol Violation|5|||
144181988|NCT01993940|519860642|FG001|Overall Study|Protocol Violation|8|||
144181989|NCT01993940|519860641|FG000|Overall Study|Death|1|||
144181990|NCT01993940|519860642|FG001|Overall Study|Death|0|||
144181991|NCT01993940|519860641|FG000|Overall Study|Other - Miscellaneous|1|||
144181992|NCT01993940|519860642|FG001|Overall Study|Other - Miscellaneous|1|||
144181993|NCT01670097|519860647|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
144181994|NCT01670097|519860648|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
144181995|NCT01670097|519860647|FG000|Overall Study|Study burden|1|||
144181996|NCT01670097|519860648|FG001|Overall Study|Study burden|0|||
144181997|NCT01670097|519860647|FG000|Overall Study|COPD exacerbation|0|||
144181998|NCT01670097|519860648|FG001|Overall Study|COPD exacerbation|1|||
144181999|NCT01670097|519860647|FG000|Overall Study|Neutropenia|0|||
144182000|NCT01670097|519860648|FG001|Overall Study|Neutropenia|1|||
144182001|NCT01670097|519860647|FG000|Overall Study|Clinical deterioration|0|||
144182002|NCT01670097|519860648|FG001|Overall Study|Clinical deterioration|1|||
144182003|NCT01670097|519860647|FG000|Overall Study|Disease progression|0|||
144182004|NCT01670097|519860648|FG001|Overall Study|Disease progression|1|||
144182005|NCT03259165|519860649|FG000|Overall Study|COVID 19 pandemic|1|||
144182006|NCT03259165|519860650|FG001|Overall Study|COVID 19 pandemic|1|||
144182007|NCT05665387|519860653|FG000|Overall Study|Withdrawal by Subject|1|||
144182008|NCT05665387|519860654|FG001|Overall Study|Withdrawal by Subject|0|||
144182009|NCT05665387|519860655|FG002|Overall Study|Withdrawal by Subject|1|||
144182010|NCT03732833|519860656|FG000|Overall Study|Adverse Event|0|||
144182011|NCT03732833|519860657|FG001|Overall Study|Adverse Event|3|||
144182012|NCT03732833|519860658|FG002|Overall Study|Adverse Event|1|||
144182013|NCT03732833|519860656|FG000|Overall Study|Withdrawal by Subject|11|||
144182014|NCT03732833|519860657|FG001|Overall Study|Withdrawal by Subject|13|||
144182015|NCT03732833|519860658|FG002|Overall Study|Withdrawal by Subject|8|||
144182016|NCT03732833|519860656|FG000|Overall Study|Lost to Follow-up|3|||
144182017|NCT03732833|519860657|FG001|Overall Study|Lost to Follow-up|5|||
144182018|NCT03732833|519860658|FG002|Overall Study|Lost to Follow-up|4|||
144182019|NCT03732833|519860656|FG000|Overall Study|Pregnancy|0|||
144182020|NCT03732833|519860657|FG001|Overall Study|Pregnancy|2|||
144182021|NCT03732833|519860658|FG002|Overall Study|Pregnancy|0|||
144182022|NCT03732833|519860656|FG000|Overall Study|Physician Decision|2|||
144182023|NCT03732833|519860657|FG001|Overall Study|Physician Decision|3|||
144182024|NCT03732833|519860658|FG002|Overall Study|Physician Decision|1|||
144182025|NCT03732833|519860656|FG000|Overall Study|Covid-19 related and other reasons|2|||
144182026|NCT03732833|519860657|FG001|Overall Study|Covid-19 related and other reasons|7|||
144182027|NCT03732833|519860658|FG002|Overall Study|Covid-19 related and other reasons|3|||
144182028|NCT02311894|519860659|FG000|Overall Study|Discontinued in error|1|||
144182029|NCT02311894|519860659|FG000|Overall Study|Lost to Follow-up|1|||
144182030|NCT02311894|519860659|FG000|Overall Study|Adverse Event|1|||
144528427|NCT01928394|521139094|FG021|Treatment Period|AE unrelated to study drug|1|||
144528428|NCT01928394|521139095|FG022|Treatment Period|AE unrelated to study drug|0|||
144182031|NCT02311894|519860659|FG000|Overall Study|Withdrawal by Subject|1|||
144182032|NCT00884390|519860660|FG000|Overall Study|Adverse Event|0|||
144182033|NCT00884390|519860661|FG001|Overall Study|Adverse Event|1|||
144528429|NCT01928394|521139073|FG000|Treatment Period|Participant request to stop therapy|0|||
144723413|NCT00329602|521842338|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
144723414|NCT00329602|521842336|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
144182034|NCT00884390|519860660|FG000|Overall Study|Lost to Follow-up|0|||
144424912|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
144182035|NCT00884390|519860661|FG001|Overall Study|Lost to Follow-up|1|||
144424913|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
144424914|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
144424915|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
144424916|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
144424917|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
144424918|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
144424919|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
144424920|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
144424921|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
144424922|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
144424923|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
144424924|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
144424925|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
144424926|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
144424927|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
144424928|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
144424929|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
144424930|NCT03742037|520763285|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
144424931|NCT03742037|520763286|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
144424932|NCT03742037|520763287|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
144424933|NCT03742037|520763288|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
144601941|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
144182036|NCT00884390|519860660|FG000|Overall Study|Physician Decision|2|||
144601942|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
144601943|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
144601944|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
144601945|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
144601946|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
144601947|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
144601948|NCT04178967|521404795|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144601949|NCT04178967|521404796|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144601950|NCT04178967|521404797|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144601951|NCT04178967|521404798|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
144601952|NCT04178967|521404799|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144182037|NCT00884390|519860661|FG001|Overall Study|Physician Decision|1|||
144182038|NCT00884390|519860660|FG000|Overall Study|Protocol Violation|4|||
144182039|NCT00884390|519860661|FG001|Overall Study|Protocol Violation|1|||
144182040|NCT00884390|519860660|FG000|Overall Study|Withdrawal by Subject|4|||
144182041|NCT00884390|519860661|FG001|Overall Study|Withdrawal by Subject|1|||
144182042|NCT00884390|519860660|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
144182043|NCT00884390|519860661|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
144601953|NCT04178967|521404800|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
144601954|NCT04178967|521404801|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
144601955|NCT04178967|521404802|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
144601956|NCT04178967|521404803|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144601957|NCT04178967|521404804|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144601958|NCT04178967|521404805|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144601959|NCT04178967|521404795|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601960|NCT04178967|521404796|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601961|NCT04178967|521404797|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
144182044|NCT00884390|519860660|FG000|Overall Study|Other|11|||
144182045|NCT00884390|519860661|FG001|Overall Study|Other|1|||
144182046|NCT02623218|519860662|FG000|Overall Study|Lost to Follow-up|0|||
144182047|NCT02623218|519860663|FG001|Overall Study|Lost to Follow-up|1|||
144182048|NCT02623218|519860664|FG002|Overall Study|Lost to Follow-up|0|||
144182049|NCT02623218|519860665|FG003|Overall Study|Lost to Follow-up|0|||
144251529|NCT00957424|520119364|FG000|Overall Study|Lost to Follow-up|19|||
144251530|NCT00957424|520119364|FG000|Overall Study|Protocol Violation|3|||
144601962|NCT04178967|521404798|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601963|NCT04178967|521404799|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
144182050|NCT02623218|519860666|FG004|Overall Study|Lost to Follow-up|0|||
144424934|NCT03742037|520763289|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
144182051|NCT01726803|519860667|FG000|Overall Study|Lost to Follow-up|6|||
144182052|NCT01726803|519860668|FG001|Overall Study|Lost to Follow-up|1|||
144182053|NCT01726803|519860667|FG000|Overall Study|Withdrawal by Subject|1|||
144182054|NCT01726803|519860668|FG001|Overall Study|Withdrawal by Subject|0|||
144424935|NCT03742037|520763290|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
144424936|NCT03742037|520763291|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
144424937|NCT04447755|520763292|FG000|Overall Study|Death|9|||
144424938|NCT04447755|520763293|FG001|Overall Study|Death|16|||
144424939|NCT04447755|520763294|FG002|Overall Study|Death|8|||
144424940|NCT04447755|520763295|FG003|Overall Study|Death|9|||
144424941|NCT04447755|520763296|FG004|Overall Study|Death|8|||
144424942|NCT04447755|520763297|FG005|Overall Study|Death|9|||
144182055|NCT00024258|519860670|FG000|Overall Study|Withdrawal by Subject|1|||
144182056|NCT00024258|519860670|FG000|Overall Study|Disease Progression|8|||
144182057|NCT01562613|519860675|FG000|Overall Study|Lost to Follow-up|2|||
144182058|NCT01562613|519860675|FG000|Overall Study|Withdrawal by Subject|2|||
144182059|NCT01520987|519862196|FG000|Overall Study|Withdrawal by Subject|1|||
144182060|NCT01520987|519862197|FG001|Overall Study|Withdrawal by Subject|0|||
144182061|NCT01520987|519862198|FG002|Overall Study|Withdrawal by Subject|0|||
144182062|NCT01520987|519862199|FG003|Overall Study|Withdrawal by Subject|0|||
144182063|NCT01520987|519862200|FG004|Overall Study|Withdrawal by Subject|0|||
144182064|NCT01520987|519862201|FG005|Overall Study|Withdrawal by Subject|1|||
144182065|NCT01520987|519862202|FG006|Overall Study|Withdrawal by Subject|0|||
144182066|NCT01520987|519862203|FG007|Overall Study|Withdrawal by Subject|0|||
144182067|NCT02710214|519862204|FG000|Overall Study|Lost to Follow-up|1|||
144182068|NCT02710214|519862205|FG001|Overall Study|Lost to Follow-up|0|||
144182069|NCT02710214|519862204|FG000|Overall Study|Lack of Efficacy|0|||
144182070|NCT02710214|519862205|FG001|Overall Study|Lack of Efficacy|1|||
144182071|NCT02710214|519862204|FG000|Overall Study|Death|0|||
144182072|NCT02710214|519862205|FG001|Overall Study|Death|1|||
144182073|NCT02832167|519862206|FG000|Treatment Period 1|Disease progression|90|||
144182074|NCT02832167|519862206|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
144182075|NCT02832167|519862206|FG000|Treatment Period 1|Death|2|||
144182076|NCT02832167|519862206|FG000|Treatment Period 1|Study Drug Toxicity|6|||
144182077|NCT02832167|519862206|FG000|Treatment Period 1|Participant request to discontinue|9|||
144182078|NCT02832167|519862206|FG000|Treatment Period 1|No longer meet study criteria|1|||
144182079|NCT02832167|519862206|FG000|Treatment Period 1|Participant withdrew consent|3|||
144424943|NCT04447755|520763298|FG006|Overall Study|Death|55|||
144601964|NCT04178967|521404800|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601965|NCT04178967|521404801|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601966|NCT04178967|521404802|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601967|NCT04178967|521404803|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
144601968|NCT04178967|521404804|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
144601969|NCT04178967|521404805|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
144601970|NCT04178967|521404795|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601971|NCT04178967|521404796|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601972|NCT04178967|521404797|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601973|NCT04178967|521404798|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601974|NCT04178967|521404799|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601975|NCT04178967|521404800|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601976|NCT04178967|521404801|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601977|NCT04178967|521404802|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144601978|NCT04178967|521404803|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
144601979|NCT04178967|521404804|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
144601980|NCT04178967|521404805|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
144601981|NCT04178967|521404795|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601982|NCT04178967|521404796|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601983|NCT04178967|521404797|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144424944|NCT04447755|520763292|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144601984|NCT04178967|521404798|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601985|NCT04178967|521404799|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601986|NCT04178967|521404800|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601987|NCT04178967|521404801|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601988|NCT04178967|521404802|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601989|NCT04178967|521404803|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601990|NCT04178967|521404804|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
144601991|NCT04178967|521404805|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144601992|NCT04178967|521404795|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601993|NCT04178967|521404796|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601994|NCT04178967|521404797|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601995|NCT04178967|521404798|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601996|NCT04178967|521404799|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601997|NCT04178967|521404800|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601998|NCT04178967|521404801|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144601999|NCT04178967|521404802|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144602000|NCT04178967|521404803|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
144602001|NCT04178967|521404804|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
144602002|NCT04178967|521404805|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
144602003|NCT04178967|521404795|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602004|NCT04178967|521404796|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602005|NCT04178967|521404797|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602006|NCT04178967|521404798|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602007|NCT04178967|521404799|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602008|NCT04178967|521404800|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602009|NCT04178967|521404801|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602010|NCT04178967|521404802|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602011|NCT04178967|521404803|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602012|NCT04178967|521404804|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
144602013|NCT04178967|521404805|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
144602014|NCT04178967|521404795|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602015|NCT04178967|521404796|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602016|NCT04178967|521404797|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602017|NCT04178967|521404798|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602018|NCT04178967|521404799|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602019|NCT04178967|521404800|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602020|NCT04178967|521404801|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602021|NCT04178967|521404802|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602022|NCT04178967|521404803|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602023|NCT04178967|521404804|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
144602024|NCT04178967|521404805|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
144602025|NCT00628251|521404806|FG000|Randomised Part|Withdrawal by Subject|0|||
144602026|NCT00628251|521404807|FG001|Randomised Part|Withdrawal by Subject|0|||
144602027|NCT00628251|521404808|FG002|Randomised Part|Withdrawal by Subject|1|||
144602028|NCT00628251|521404806|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
144602029|NCT00628251|521404807|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
144602030|NCT00628251|521404808|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
144602031|NCT00628251|521404806|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
144602032|NCT00628251|521404807|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
144602033|NCT00628251|521404808|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
144602034|NCT00628251|521404806|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
144602035|NCT00628251|521404807|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
144602036|NCT00628251|521404808|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
144602037|NCT00628251|521404806|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
144602038|NCT00628251|521404807|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
144602039|NCT00628251|521404808|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
144602040|NCT00628251|521404806|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
144602041|NCT00628251|521404807|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
144602042|NCT00628251|521404808|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
144602043|NCT01807923|521404810|FG000|Overall Study|Adverse Event|2|||
144602044|NCT01807923|521404811|FG001|Overall Study|Adverse Event|1|||
144602045|NCT01807923|521404812|FG002|Overall Study|Adverse Event|2|||
144602046|NCT01807923|521404810|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
144602047|NCT01807923|521404811|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
144602048|NCT01807923|521404812|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
144602049|NCT01807923|521404810|FG000|Overall Study|Physician Decision|0|||
144602050|NCT01807923|521404811|FG001|Overall Study|Physician Decision|0|||
144602051|NCT01807923|521404812|FG002|Overall Study|Physician Decision|1|||
144602052|NCT01807923|521404810|FG000|Overall Study|Not Eligible (Genotype)|0|||
144602053|NCT01807923|521404811|FG001|Overall Study|Not Eligible (Genotype)|0|||
144602054|NCT01807923|521404812|FG002|Overall Study|Not Eligible (Genotype)|1|||
144602055|NCT01807923|521404810|FG000|Overall Study|Randomized But Not Treated|3|||
144602056|NCT01807923|521404811|FG001|Overall Study|Randomized But Not Treated|2|||
144602057|NCT01807923|521404812|FG002|Overall Study|Randomized But Not Treated|5|||
144602058|NCT02558231|521404814|FG000|Overall Study|Death|4|||
144602059|NCT02558231|521404815|FG001|Overall Study|Death|12|||
144602060|NCT02558231|521404814|FG000|Overall Study|Lost to Follow-up|7|||
144251531|NCT00957424|520119364|FG000|Overall Study|Withdrawal by Subject|1|||
144251532|NCT02700698|520119365|FG000|Overall Study|Withdrawal by Subject|1|||
144251533|NCT02700698|520119366|FG001|Overall Study|Withdrawal by Subject|0|||
144251534|NCT00703118|520119367|FG000|Overall Study|Adverse Event|1|||
144251535|NCT00703118|520119368|FG001|Overall Study|Adverse Event|2|||
144251536|NCT00703118|520119369|FG002|Overall Study|Adverse Event|2|||
144251537|NCT00703118|520119367|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
144251538|NCT00703118|520119368|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
144251539|NCT00703118|520119369|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
144251540|NCT00703118|520119367|FG000|Overall Study|Lost to Follow-up|6|||
144251541|NCT00703118|520119368|FG001|Overall Study|Lost to Follow-up|4|||
144251542|NCT00703118|520119369|FG002|Overall Study|Lost to Follow-up|4|||
144251543|NCT00703118|520119367|FG000|Overall Study|Withdrawal by Subject|8|||
144251544|NCT00703118|520119368|FG001|Overall Study|Withdrawal by Subject|7|||
144251545|NCT00703118|520119369|FG002|Overall Study|Withdrawal by Subject|13|||
144251546|NCT00703118|520119367|FG000|Overall Study|Other|0|||
144251547|NCT00703118|520119368|FG001|Overall Study|Other|0|||
144251548|NCT00703118|520119369|FG002|Overall Study|Other|1|||
144251549|NCT04165135|520119370|FG000|Overall Study|Protocol Violation|10|||
144251550|NCT04165135|520119370|FG000|Overall Study|Participants withdrawal of consent|5|||
144251551|NCT05053035|520119375|FG000|Overall Study|Withdrawal by Subject|1|||
144251552|NCT05053035|520119376|FG001|Overall Study|Withdrawal by Subject|0|||
144251553|NCT02005627|520119380|FG000|Overall Study|Lost to Follow-up|1|||
144251554|NCT02005627|520119381|FG001|Overall Study|Lost to Follow-up|2|||
144602061|NCT02558231|521404815|FG001|Overall Study|Lost to Follow-up|4|||
144602062|NCT02558231|521404814|FG000|Overall Study|Withdrawal by Subject|7|||
144602063|NCT02558231|521404815|FG001|Overall Study|Withdrawal by Subject|4|||
144602064|NCT02558231|521404814|FG000|Overall Study|Physician Decision|7|||
144602065|NCT02558231|521404815|FG001|Overall Study|Physician Decision|5|||
144602066|NCT02558231|521404814|FG000|Overall Study|Sponsor Decision|0|||
144602067|NCT02558231|521404815|FG001|Overall Study|Sponsor Decision|1|||
144602068|NCT00995007|521404816|FG000|Overall Study|Withdrew consent|1|||
144602069|NCT00995007|521404817|FG001|Overall Study|Withdrew consent|0|||
144602070|NCT00995007|521404816|FG000|Overall Study|Refused further treatment|8|||
144602071|NCT00995007|521404817|FG001|Overall Study|Refused further treatment|2|||
144602072|NCT00995007|521404816|FG000|Overall Study|Toxicity|8|||
144602073|NCT00995007|521404817|FG001|Overall Study|Toxicity|0|||
144602074|NCT03933397|521404818|FG000|Overall Study|No emergency department visit|65|||
144602075|NCT03933397|521404819|FG001|Overall Study|No emergency department visit|71|||
144602076|NCT03933397|521404818|FG000|Overall Study|Missed emergency department visit|25|||
144602077|NCT03933397|521404819|FG001|Overall Study|Missed emergency department visit|30|||
144602078|NCT03933397|521404818|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
144602079|NCT03933397|521404819|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
144602080|NCT03933397|521404818|FG000|Overall Study|Withdrawal by Subject|1|||
144602081|NCT03933397|521404819|FG001|Overall Study|Withdrawal by Subject|0|||
144602082|NCT03933397|521404818|FG000|Overall Study|Physician Decision|1|||
144602083|NCT03933397|521404819|FG001|Overall Study|Physician Decision|1|||
144602084|NCT03933397|521404818|FG000|Overall Study|missing pain score|1|||
144602085|NCT03933397|521404819|FG001|Overall Study|missing pain score|1|||
144602086|NCT03933397|521404818|FG000|Overall Study|Confirmed COVID-19|1|||
144602087|NCT03933397|521404819|FG001|Overall Study|Confirmed COVID-19|2|||
144602088|NCT02066051|521404822|FG000|Overall Study|Subject developed active GVHD|1|||
144602089|NCT02401412|521404823|FG000|Overall Study|Lost to Follow-up|1|||
144602090|NCT02401412|521404824|FG001|Overall Study|Lost to Follow-up|0|||
144602091|NCT02401412|521404823|FG000|Overall Study|Discontinued Intervention|15|||
144602092|NCT02401412|521404824|FG001|Overall Study|Discontinued Intervention|21|||
144602093|NCT02401412|521404823|FG000|Overall Study|Withdrawal by Subject|4|||
144602094|NCT02401412|521404824|FG001|Overall Study|Withdrawal by Subject|4|||
144251555|NCT02005627|520119380|FG000|Overall Study|Withdrawal by Subject|1|||
144251556|NCT02005627|520119381|FG001|Overall Study|Withdrawal by Subject|2|||
144602095|NCT02401412|521404823|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
144602096|NCT02401412|521404824|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
144602097|NCT02401412|521404823|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
144602098|NCT02401412|521404824|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
144602099|NCT00882310|521404825|FG000|Overall Study|Screen Failure|10|||
144251557|NCT03003000|520119388|FG000|Overall Study|Adverse Event|1|||
144251558|NCT03003000|520119389|FG001|Overall Study|Adverse Event|2|||
144251559|NCT03003000|520119390|FG002|Overall Study|Adverse Event|3|||
144251560|NCT03003000|520119388|FG000|Overall Study|Lack of Efficacy|1|||
144251561|NCT03003000|520119389|FG001|Overall Study|Lack of Efficacy|0|||
144251562|NCT03003000|520119390|FG002|Overall Study|Lack of Efficacy|0|||
144251563|NCT03003000|520119388|FG000|Overall Study|Non-compliant with protocol|0|||
144251564|NCT03003000|520119389|FG001|Overall Study|Non-compliant with protocol|1|||
144251565|NCT03003000|520119390|FG002|Overall Study|Non-compliant with protocol|1|||
144602100|NCT00882310|521404825|FG000|Overall Study|Never received treatment|1|||
144602101|NCT00882310|521404825|FG000|Overall Study|Death|6|||
144251566|NCT03003000|520119388|FG000|Overall Study|Refused to continue medication|2|||
144251567|NCT03003000|520119389|FG001|Overall Study|Refused to continue medication|0|||
144251568|NCT03003000|520119390|FG002|Overall Study|Refused to continue medication|0|||
144251569|NCT03003000|520119388|FG000|Overall Study|Other than listed|1|||
144251570|NCT03003000|520119389|FG001|Overall Study|Other than listed|1|||
144251571|NCT03003000|520119390|FG002|Overall Study|Other than listed|1|||
144251572|NCT03913104|520119391|FG000|Overall Study|Lost to Follow-up|20|||
144251573|NCT03913104|520119391|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
144251574|NCT03913104|520119391|FG000|Overall Study|Withdrawal by Subject|2|||
144251575|NCT00048997|520119392|FG000|Overall Study|Protocol Violation|7|||
144251576|NCT00048997|520119393|FG001|Overall Study|Protocol Violation|2|||
144251577|NCT00048997|520119392|FG000|Overall Study|Withdrawal by Subject|6|||
144251578|NCT00048997|520119393|FG001|Overall Study|Withdrawal by Subject|1|||
144251579|NCT00048165|520119394|FG000|Completed 6 Months Study|Administration/Other|8|||
144251580|NCT00048165|520119395|FG001|Completed 6 Months Study|Administration/Other|8|||
144251581|NCT00048165|520119394|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
144251582|NCT00048165|520119395|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
144251583|NCT00048165|520119394|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
144251584|NCT00048165|520119395|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
144251585|NCT00048165|520119394|FG000|Completed 6 Months Study|Death|12|||
144251586|NCT00048165|520119395|FG001|Completed 6 Months Study|Death|6|||
144251587|NCT00048165|520119394|FG000|Completed 6 Months Study|Insufficient therapy|1|||
144251588|NCT00048165|520119395|FG001|Completed 6 Months Study|Insufficient therapy|4|||
144251589|NCT00048165|520119394|FG000|Completed 6 Months Study|Other violation|4|||
144251590|NCT00048165|520119395|FG001|Completed 6 Months Study|Other violation|6|||
144251591|NCT00048165|520119394|FG000|Completed 6 Months Study|Refused treatment|5|||
144251592|NCT00048165|520119395|FG001|Completed 6 Months Study|Refused treatment|5|||
144251593|NCT00048165|520119394|FG000|Completed 6 Months Study|Violation criteria|0|||
144251594|NCT00048165|520119395|FG001|Completed 6 Months Study|Violation criteria|2|||
144251595|NCT00048165|520119394|FG000|Completed 6 Months Study|Did not receive study drug|6|||
144251596|NCT00048165|520119395|FG001|Completed 6 Months Study|Did not receive study drug|6|||
144251597|NCT00048165|520119394|FG000|Completed 12 Months Study|Administration/Other|0|||
144251598|NCT00048165|520119395|FG001|Completed 12 Months Study|Administration/Other|2|||
144251599|NCT00048165|520119394|FG000|Completed 12 Months Study|Death|2|||
144251600|NCT00048165|520119395|FG001|Completed 12 Months Study|Death|1|||
144251601|NCT00048165|520119394|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
144251602|NCT00048165|520119395|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
144251603|NCT01370616|520119396|FG000|Overall Study|Adverse Event|11|||
144251604|NCT01370616|520119397|FG001|Overall Study|Adverse Event|16|||
144251605|NCT01370616|520119396|FG000|Overall Study|Death|1|||
144251606|NCT01370616|520119397|FG001|Overall Study|Death|0|||
144251607|NCT01370616|520119396|FG000|Overall Study|Lack of Efficacy|6|||
144251608|NCT01370616|520119397|FG001|Overall Study|Lack of Efficacy|2|||
144251609|NCT01370616|520119396|FG000|Overall Study|Lost to Follow-up|0|||
144251610|NCT01370616|520119397|FG001|Overall Study|Lost to Follow-up|3|||
144251611|NCT01370616|520119396|FG000|Overall Study|Physician Decision|6|||
144251612|NCT01370616|520119397|FG001|Overall Study|Physician Decision|6|||
144251613|NCT01370616|520119396|FG000|Overall Study|Progressive Disease|0|||
144251614|NCT01370616|520119397|FG001|Overall Study|Progressive Disease|1|||
144251615|NCT01370616|520119396|FG000|Overall Study|Recovery|1|||
144251616|NCT01370616|520119397|FG001|Overall Study|Recovery|0|||
144251617|NCT01370616|520119396|FG000|Overall Study|Technical Problems|3|||
144251618|NCT01370616|520119397|FG001|Overall Study|Technical Problems|5|||
144251619|NCT01370616|520119396|FG000|Overall Study|Withdrawal by Subject|34|||
144251620|NCT01370616|520119397|FG001|Overall Study|Withdrawal by Subject|34|||
144251621|NCT00803205|520119398|FG000|Overall Study|Adverse Event|7|||
144251622|NCT00803205|520119399|FG001|Overall Study|Adverse Event|2|||
144251623|NCT00803205|520119398|FG000|Overall Study|Lost to Follow-up|1|||
144251624|NCT00803205|520119399|FG001|Overall Study|Lost to Follow-up|0|||
144251625|NCT00803205|520119398|FG000|Overall Study|Withdrawal by Subject|9|||
144251626|NCT00803205|520119399|FG001|Overall Study|Withdrawal by Subject|9|||
144251627|NCT00803205|520119398|FG000|Overall Study|Physician Decision|1|||
144251628|NCT00803205|520119399|FG001|Overall Study|Physician Decision|0|||
144424945|NCT04447755|520763293|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144424946|NCT04447755|520763294|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144424947|NCT04447755|520763295|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144251629|NCT00803205|520119398|FG000|Overall Study|Protocol Violation|1|||
144251630|NCT00803205|520119399|FG001|Overall Study|Protocol Violation|1|||
144251631|NCT00803205|520119398|FG000|Overall Study|Medical Monitor Decision|1|||
144251632|NCT00803205|520119399|FG001|Overall Study|Medical Monitor Decision|0|||
144251633|NCT00803205|520119398|FG000|Overall Study|Acquired a Lung Infection|0|||
144251634|NCT00803205|520119399|FG001|Overall Study|Acquired a Lung Infection|1|||
144251635|NCT00803205|520119398|FG000|Overall Study|Sponsor Decision|0|||
144251636|NCT00803205|520119399|FG001|Overall Study|Sponsor Decision|1|||
144251637|NCT02243046|520119401|FG000|Overall Study|Lost to Follow-up|1|||
144251638|NCT02243046|520119402|FG001|Overall Study|Lost to Follow-up|1|||
144251639|NCT02243046|520119403|FG002|Overall Study|Lost to Follow-up|4|||
144251640|NCT04607980|520119404|FG000|Overall Study|Adverse Event|3|||
144251641|NCT04607980|520119405|FG001|Overall Study|Adverse Event|4|||
144251642|NCT04607980|520119404|FG000|Overall Study|Death|0|||
144251643|NCT04607980|520119405|FG001|Overall Study|Death|1|||
144251644|NCT04607980|520119404|FG000|Overall Study|Withdrawal by Subject|2|||
144251645|NCT04607980|520119405|FG001|Overall Study|Withdrawal by Subject|5|||
144251646|NCT04607980|520119404|FG000|Overall Study|Lost to Follow-up|4|||
144251647|NCT04607980|520119405|FG001|Overall Study|Lost to Follow-up|8|||
144251648|NCT04607980|520119404|FG000|Overall Study|Protocol Violation|0|||
144251649|NCT04607980|520119405|FG001|Overall Study|Protocol Violation|3|||
144251650|NCT04607980|520119404|FG000|Overall Study|Other|3|||
144251651|NCT04607980|520119405|FG001|Overall Study|Other|0|||
144251652|NCT02012959|520119406|FG000|Treatment Phase A|Adverse Event|2|||
144251653|NCT02012959|520119407|FG001|Treatment Phase A|Adverse Event|0|||
144251654|NCT02012959|520119408|FG002|Treatment Phase A|Adverse Event|0|||
144251655|NCT02012959|520119409|FG003|Treatment Phase A|Adverse Event|0|||
144251656|NCT02012959|520119410|FG004|Treatment Phase A|Adverse Event|0|||
144251657|NCT00410072|520120794|FG000|Day 1 to Week 48|Adverse Event|1|||
144251658|NCT00410072|520120795|FG001|Day 1 to Week 48|Adverse Event|2|||
144251659|NCT00410072|520120794|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
144251660|NCT00410072|520120795|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
144251661|NCT00410072|520120794|FG000|Day 1 to Week 48|Other|0|||
144251662|NCT00410072|520120795|FG001|Day 1 to Week 48|Other|1|||
144424948|NCT04447755|520763296|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144424949|NCT04447755|520763297|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144528430|NCT01928394|521139074|FG001|Treatment Period|Participant request to stop therapy|0|||
144528431|NCT01928394|521139075|FG002|Treatment Period|Participant request to stop therapy|0|||
144528432|NCT01928394|521139076|FG003|Treatment Period|Participant request to stop therapy|0|||
144528433|NCT01928394|521139077|FG004|Treatment Period|Participant request to stop therapy|0|||
144528434|NCT01928394|521139078|FG005|Treatment Period|Participant request to stop therapy|3|||
144528435|NCT01928394|521139079|FG006|Treatment Period|Participant request to stop therapy|3|||
144528436|NCT01928394|521139080|FG007|Treatment Period|Participant request to stop therapy|0|||
144528437|NCT01928394|521139081|FG008|Treatment Period|Participant request to stop therapy|0|||
144602102|NCT00882310|521404825|FG000|Overall Study|Progression of disease|4|||
144602103|NCT00882310|521404825|FG000|Overall Study|Adverse Event|1|||
144602104|NCT02014740|521404828|FG000|Overall Study|Lost to Follow-up|4|||
144602105|NCT02014740|521404829|FG001|Overall Study|Lost to Follow-up|4|||
144602106|NCT02014740|521404828|FG000|Overall Study|Withdrawal by Subject|2|||
144251663|NCT00410072|520120794|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
144251664|NCT00410072|520120795|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
144251665|NCT00410072|520120794|FG000|Day 1 to Week 48|Pregnancy|0|||
144251666|NCT00410072|520120795|FG001|Day 1 to Week 48|Pregnancy|2|||
144251667|NCT00410072|520120794|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
144424950|NCT04447755|520763298|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
144424951|NCT04447755|520763292|FG000|Overall Study|Sponsor Decision|0|||
144424952|NCT04447755|520763293|FG001|Overall Study|Sponsor Decision|0|||
144424953|NCT04447755|520763294|FG002|Overall Study|Sponsor Decision|0|||
144424954|NCT04447755|520763295|FG003|Overall Study|Sponsor Decision|0|||
144424955|NCT04447755|520763296|FG004|Overall Study|Sponsor Decision|1|||
144424956|NCT04447755|520763297|FG005|Overall Study|Sponsor Decision|0|||
144424957|NCT04447755|520763298|FG006|Overall Study|Sponsor Decision|10|||
144424958|NCT04447755|520763292|FG000|Overall Study|Lost to Follow-up|0|||
144424959|NCT04447755|520763293|FG001|Overall Study|Lost to Follow-up|0|||
144424960|NCT04447755|520763294|FG002|Overall Study|Lost to Follow-up|0|||
144424961|NCT04447755|520763295|FG003|Overall Study|Lost to Follow-up|0|||
144424962|NCT04447755|520763296|FG004|Overall Study|Lost to Follow-up|0|||
144424963|NCT04447755|520763297|FG005|Overall Study|Lost to Follow-up|0|||
144424964|NCT04447755|520763298|FG006|Overall Study|Lost to Follow-up|1|||
144424965|NCT00619801|520763301|FG000|Overall Study|Lack of Efficacy|0|||
144424966|NCT00619801|520763302|FG001|Overall Study|Lack of Efficacy|1|||
144424967|NCT00619801|520763301|FG000|Overall Study|Withdrawal by Subject|1|||
144424968|NCT00619801|520763302|FG001|Overall Study|Withdrawal by Subject|1|||
144528438|NCT01928394|521139082|FG009|Treatment Period|Participant request to stop therapy|0|||
144528439|NCT01928394|521139083|FG010|Treatment Period|Participant request to stop therapy|3|||
144602107|NCT02014740|521404829|FG001|Overall Study|Withdrawal by Subject|1|||
144251668|NCT00410072|520120795|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
144251669|NCT00410072|520120794|FG000|After Week 48 to Week 96|Adverse Event|1|||
144424969|NCT00619801|520763301|FG000|Overall Study|Loss of efficacy|0|||
144251670|NCT00410072|520120795|FG001|After Week 48 to Week 96|Adverse Event|2|||
144251671|NCT00410072|520120794|FG000|After Week 48 to Week 96|Death|0|||
144251672|NCT00410072|520120795|FG001|After Week 48 to Week 96|Death|1|||
144251673|NCT00410072|520120794|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
144251674|NCT00410072|520120795|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
144251675|NCT00410072|520120794|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
144424970|NCT00619801|520763302|FG001|Overall Study|Loss of efficacy|1|||
144602108|NCT02608879|521404830|FG000|Overall Study|Lost to Follow-up|1|||
144602109|NCT02608879|521404831|FG001|Overall Study|Lost to Follow-up|0|||
144602110|NCT02608879|521404832|FG002|Overall Study|Lost to Follow-up|0|||
144602111|NCT02608879|521404830|FG000|Overall Study|Did not meet continuation criteria|0|||
144602112|NCT02608879|521404831|FG001|Overall Study|Did not meet continuation criteria|0|||
144602113|NCT02608879|521404832|FG002|Overall Study|Did not meet continuation criteria|3|||
144602114|NCT00835120|521404841|FG000|Overall Study|Lack of Efficacy|1|||
144602115|NCT00835120|521404841|FG000|Overall Study|Lost to Follow-up|3|||
144602116|NCT00835120|521404841|FG000|Overall Study|Adverse Event|2|||
144602117|NCT00835120|521404841|FG000|Overall Study|Withdrawal by Subject|2|||
144602118|NCT02499770|521404842|FG000|Overall Study|Death|17|||
144602119|NCT02499770|521404843|FG001|Overall Study|Death|56|||
144602120|NCT02499770|521404842|FG000|Overall Study|Study completion|1|||
144602121|NCT02499770|521404843|FG001|Overall Study|Study completion|10|||
144602122|NCT02499770|521404842|FG000|Overall Study|Withdrawal by Subject|0|||
144602123|NCT02499770|521404843|FG001|Overall Study|Withdrawal by Subject|7|||
144602124|NCT02499770|521404842|FG000|Overall Study|Lost to Follow-up|0|||
144602125|NCT02499770|521404843|FG001|Overall Study|Lost to Follow-up|2|||
144602126|NCT02499770|521404842|FG000|Overall Study|Subject declined further treatment|1|||
144602127|NCT02499770|521404843|FG001|Overall Study|Subject declined further treatment|0|||
144602128|NCT02499770|521404842|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
144602129|NCT02499770|521404843|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
144602130|NCT02499770|521404842|FG000|Overall Study|Randomized but not enrolled|0|||
144602131|NCT02499770|521404843|FG001|Overall Study|Randomized but not enrolled|1|||
144602132|NCT00671554|521404852|FG000|Overall Study|Disease progression|3|||
144602133|NCT04376060|521404856|FG000|Overall Study|Physician Decision|1|||
144602134|NCT04225806|521404859|FG000|Overall Study|Trial termination|15|||
144602135|NCT02408861|521404860|FG000|Overall Study|Death|0|||
144602136|NCT02408861|521404861|FG001|Overall Study|Death|3|||
144602137|NCT02408861|521404862|FG002|Overall Study|Death|1|||
144602138|NCT02408861|521404863|FG003|Overall Study|Death|2|||
144602139|NCT02408861|521404864|FG004|Overall Study|Death|4|||
144602140|NCT02408861|521404865|FG005|Overall Study|Death|1|||
144602141|NCT02408861|521404866|FG006|Overall Study|Death|0|||
144602142|NCT02408861|521404860|FG000|Overall Study|Lost to Follow-up|0|||
144602143|NCT02408861|521404861|FG001|Overall Study|Lost to Follow-up|0|||
144602144|NCT02408861|521404862|FG002|Overall Study|Lost to Follow-up|1|||
144602145|NCT02408861|521404863|FG003|Overall Study|Lost to Follow-up|1|||
144602146|NCT02408861|521404864|FG004|Overall Study|Lost to Follow-up|4|||
144602147|NCT02408861|521404865|FG005|Overall Study|Lost to Follow-up|2|||
144602148|NCT02408861|521404866|FG006|Overall Study|Lost to Follow-up|1|||
144602149|NCT02408861|521404860|FG000|Overall Study|Disease Progression|0|||
144602150|NCT02408861|521404861|FG001|Overall Study|Disease Progression|0|||
144602151|NCT02408861|521404862|FG002|Overall Study|Disease Progression|1|||
144602152|NCT02408861|521404863|FG003|Overall Study|Disease Progression|0|||
144602153|NCT02408861|521404864|FG004|Overall Study|Disease Progression|3|||
144602154|NCT02408861|521404865|FG005|Overall Study|Disease Progression|1|||
144602155|NCT02408861|521404866|FG006|Overall Study|Disease Progression|1|||
144602156|NCT02408861|521404860|FG000|Overall Study|Adverse Event|1|||
144602157|NCT02408861|521404861|FG001|Overall Study|Adverse Event|0|||
144602158|NCT02408861|521404862|FG002|Overall Study|Adverse Event|1|||
144602159|NCT02408861|521404863|FG003|Overall Study|Adverse Event|0|||
144602160|NCT02408861|521404864|FG004|Overall Study|Adverse Event|2|||
144602161|NCT02408861|521404865|FG005|Overall Study|Adverse Event|0|||
144602162|NCT02408861|521404866|FG006|Overall Study|Adverse Event|0|||
144602163|NCT02408861|521404860|FG000|Overall Study|Physician Decision|1|||
144602164|NCT02408861|521404861|FG001|Overall Study|Physician Decision|1|||
144602165|NCT02408861|521404862|FG002|Overall Study|Physician Decision|1|||
144602166|NCT02408861|521404863|FG003|Overall Study|Physician Decision|0|||
144602167|NCT02408861|521404864|FG004|Overall Study|Physician Decision|0|||
144602168|NCT02408861|521404865|FG005|Overall Study|Physician Decision|1|||
144602169|NCT02408861|521404866|FG006|Overall Study|Physician Decision|0|||
144602170|NCT02408861|521404860|FG000|Overall Study|Protocol Violation|1|||
144424971|NCT00642941|520763309|FG000|Overall Study|Physician Decision|3|||
144424972|NCT00642941|520763310|FG001|Overall Study|Physician Decision|1|||
144602171|NCT02408861|521404861|FG001|Overall Study|Protocol Violation|0|||
144602172|NCT02408861|521404862|FG002|Overall Study|Protocol Violation|0|||
144602173|NCT02408861|521404863|FG003|Overall Study|Protocol Violation|0|||
144602174|NCT02408861|521404864|FG004|Overall Study|Protocol Violation|0|||
144602175|NCT02408861|521404865|FG005|Overall Study|Protocol Violation|0|||
144602176|NCT02408861|521404866|FG006|Overall Study|Protocol Violation|0|||
144602177|NCT02408861|521404860|FG000|Overall Study|Withdrawal by Subject|0|||
144602178|NCT02408861|521404861|FG001|Overall Study|Withdrawal by Subject|0|||
144602179|NCT02408861|521404862|FG002|Overall Study|Withdrawal by Subject|0|||
144602180|NCT02408861|521404863|FG003|Overall Study|Withdrawal by Subject|0|||
144602181|NCT02408861|521404864|FG004|Overall Study|Withdrawal by Subject|1|||
144602182|NCT02408861|521404865|FG005|Overall Study|Withdrawal by Subject|1|||
144602183|NCT02408861|521404866|FG006|Overall Study|Withdrawal by Subject|0|||
144602184|NCT02408861|521404860|FG000|Overall Study|Other Treatment|0|||
144602185|NCT02408861|521404861|FG001|Overall Study|Other Treatment|0|||
144602186|NCT02408861|521404862|FG002|Overall Study|Other Treatment|0|||
144528440|NCT01928394|521139084|FG011|Treatment Period|Participant request to stop therapy|2|||
144528441|NCT01928394|521139085|FG012|Treatment Period|Participant request to stop therapy|1|||
144528442|NCT01928394|521139086|FG013|Treatment Period|Participant request to stop therapy|2|||
144528443|NCT01928394|521139087|FG014|Treatment Period|Participant request to stop therapy|4|||
144528444|NCT01928394|521139088|FG015|Treatment Period|Participant request to stop therapy|0|||
144528445|NCT01928394|521139089|FG016|Treatment Period|Participant request to stop therapy|1|||
144528446|NCT01928394|521139090|FG017|Treatment Period|Participant request to stop therapy|3|||
144528447|NCT01928394|521139091|FG018|Treatment Period|Participant request to stop therapy|1|||
144528448|NCT01928394|521139092|FG019|Treatment Period|Participant request to stop therapy|1|||
144602187|NCT02408861|521404863|FG003|Overall Study|Other Treatment|0|||
144602188|NCT02408861|521404864|FG004|Overall Study|Other Treatment|0|||
144602189|NCT02408861|521404865|FG005|Overall Study|Other Treatment|1|||
144602190|NCT02408861|521404866|FG006|Overall Study|Other Treatment|1|||
144602191|NCT00977574|521404867|FG000|Overall Study|Never Treated|4|||
144602192|NCT00977574|521404868|FG001|Overall Study|Never Treated|2|||
144602193|NCT00977574|521404869|FG002|Overall Study|Never Treated|4|||
144602194|NCT07052682|521404870|FG000|Overall Study|Withdrawal by Subject|4|||
144602195|NCT04667247|521404875|FG000|Overall Study|Withdrawal by Subject|0|||
144602196|NCT04667247|521404876|FG001|Overall Study|Withdrawal by Subject|1|||
144602197|NCT05460273|521404877|FG000|Overall Study|Death|43|||
144602198|NCT05460273|521404878|FG001|Overall Study|Death|9|||
144602199|NCT05460273|521404877|FG000|Overall Study|Lost to Follow-up|7|||
144602200|NCT05460273|521404878|FG001|Overall Study|Lost to Follow-up|0|||
144602201|NCT05460273|521404877|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
144602202|NCT05460273|521404878|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
144602203|NCT04124614|521404879|FG000|Placebo Run-in Period|Not Randomized|34|||
144602204|NCT04124614|521404880|FG001|Placebo Run-in Period|Not Randomized|0|||
144602205|NCT04124614|521404881|FG002|Placebo Run-in Period|Not Randomized|0|||
144602206|NCT04124614|521404879|FG000|Double Blind Treatment Period|Adverse Event|0|||
144602207|NCT04124614|521404880|FG001|Double Blind Treatment Period|Adverse Event|7|||
144602208|NCT04124614|521404881|FG002|Double Blind Treatment Period|Adverse Event|22|||
144602209|NCT04124614|521404879|FG000|Double Blind Treatment Period|Death|0|||
144602210|NCT04124614|521404880|FG001|Double Blind Treatment Period|Death|0|||
144602211|NCT04124614|521404881|FG002|Double Blind Treatment Period|Death|1|||
144602212|NCT04124614|521404879|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
144602213|NCT04124614|521404880|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
144602214|NCT04124614|521404881|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
144602215|NCT04124614|521404879|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
144602216|NCT04124614|521404880|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
144602217|NCT04124614|521404881|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
144602218|NCT04124614|521404879|FG000|Double Blind Treatment Period|Physician Decision|0|||
144602219|NCT04124614|521404880|FG001|Double Blind Treatment Period|Physician Decision|0|||
144602220|NCT04124614|521404881|FG002|Double Blind Treatment Period|Physician Decision|3|||
144602221|NCT04124614|521404879|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
144602222|NCT04124614|521404880|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
144602223|NCT04124614|521404881|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
144182080|NCT02832167|519862206|FG000|Treatment Period 1|Other reasons|6|||
144182081|NCT02832167|519862206|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
144182082|NCT02832167|519862206|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
144182083|NCT02832167|519862206|FG000|Transition From Period 1 to Period 2|Death|2|||
144182084|NCT02832167|519862206|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
144182085|NCT02832167|519862206|FG000|Treatment Period 2|Disease progression|69|||
144182086|NCT02832167|519862206|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
144182087|NCT02832167|519862206|FG000|Treatment Period 2|Maximum clinical benefit|1|||
144182088|NCT02832167|519862206|FG000|Treatment Period 2|Study Drug Toxicity|5|||
144182089|NCT02832167|519862206|FG000|Treatment Period 2|Participant request to discontinue|2|||
144182090|NCT02832167|519862206|FG000|Treatment Period 2|Participant withdrew consent|3|||
144182091|NCT02832167|519862206|FG000|Treatment Period 2|Other reasons|3|||
144182092|NCT01754376|519862207|FG000|Overall Study|Adverse Event|1|||
144182093|NCT01754376|519862207|FG000|Overall Study|Lack of Efficacy|2|||
144182094|NCT04556734|519862208|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
144182095|NCT04556734|519862209|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
144182096|NCT04556734|519862210|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
144182097|NCT04556734|519862211|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144182098|NCT04556734|519862212|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144182099|NCT04556734|519862213|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144182100|NCT04556734|519862214|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144182101|NCT04556734|519862215|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144182102|NCT04556734|519862208|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
144182103|NCT04556734|519862209|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144424973|NCT00642941|520763311|FG002|Overall Study|Physician Decision|0|||
144424974|NCT00642941|520763312|FG003|Overall Study|Physician Decision|0|||
144424975|NCT00642941|520763313|FG004|Overall Study|Physician Decision|0|||
144424976|NCT00642941|520763314|FG005|Overall Study|Physician Decision|0|||
144424977|NCT00642941|520763315|FG006|Overall Study|Physician Decision|1|||
144424978|NCT00642941|520763316|FG007|Overall Study|Physician Decision|0|||
144424979|NCT00642941|520763317|FG008|Overall Study|Physician Decision|0|||
144424980|NCT00642941|520763318|FG009|Overall Study|Physician Decision|1|||
144424981|NCT00642941|520763319|FG010|Overall Study|Physician Decision|0|||
144424982|NCT00642941|520763320|FG011|Overall Study|Physician Decision|1|||
144424983|NCT00642941|520763309|FG000|Overall Study|Death|4|||
144424984|NCT00642941|520763310|FG001|Overall Study|Death|0|||
144424985|NCT00642941|520763311|FG002|Overall Study|Death|1|||
144424986|NCT00642941|520763312|FG003|Overall Study|Death|1|||
144424987|NCT00642941|520763313|FG004|Overall Study|Death|2|||
144424988|NCT00642941|520763314|FG005|Overall Study|Death|1|||
144424989|NCT00642941|520763315|FG006|Overall Study|Death|0|||
144251676|NCT00410072|520120795|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
144251677|NCT00410072|520120794|FG000|After Week 48 to Week 96|Other|2|||
144251678|NCT00410072|520120795|FG001|After Week 48 to Week 96|Other|0|||
144251679|NCT00410072|520120794|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
144251680|NCT00410072|520120795|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
144251681|NCT00410072|520120794|FG000|After Week 48 to Week 96|Pregnancy|0|||
144251682|NCT00410072|520120795|FG001|After Week 48 to Week 96|Pregnancy|2|||
144251683|NCT00410072|520120794|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
144251684|NCT00410072|520120795|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
144251685|NCT03326518|520120820|FG000|Overall Study|Protocol Violation|1|||
144251686|NCT03326518|520120821|FG001|Overall Study|Protocol Violation|0|||
144251687|NCT03326518|520120822|FG002|Overall Study|Protocol Violation|0|||
144251688|NCT03326518|520120820|FG000|Overall Study|Withdrawal by Subject|1|||
144251689|NCT03326518|520120821|FG001|Overall Study|Withdrawal by Subject|0|||
144251690|NCT03326518|520120822|FG002|Overall Study|Withdrawal by Subject|0|||
144251691|NCT03326518|520120820|FG000|Overall Study|Lost to Follow-up|1|||
144251692|NCT03326518|520120821|FG001|Overall Study|Lost to Follow-up|0|||
144251693|NCT03326518|520120822|FG002|Overall Study|Lost to Follow-up|1|||
144251694|NCT06010732|520120824|FG000|Crossover Period 1|Protocol Violation|0|||
144251695|NCT06010732|520120825|FG001|Crossover Period 1|Protocol Violation|0|||
144251696|NCT06010732|520120826|FG002|Crossover Period 1|Protocol Violation|1|||
144251697|NCT06010732|520120827|FG003|Crossover Period 1|Protocol Violation|0|||
144251698|NCT06010732|520120828|FG004|Crossover Period 1|Protocol Violation|1|||
144251699|NCT06010732|520120829|FG005|Crossover Period 1|Protocol Violation|0|||
144251700|NCT06010732|520120824|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
144251701|NCT06010732|520120825|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
144251702|NCT06010732|520120826|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
144251703|NCT06010732|520120827|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
144251704|NCT06010732|520120828|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
144251705|NCT06010732|520120829|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
144251706|NCT06010732|520120824|FG000|Crossover Period 2|Adverse Event|0|||
144251707|NCT06010732|520120825|FG001|Crossover Period 2|Adverse Event|1|||
144251708|NCT06010732|520120826|FG002|Crossover Period 2|Adverse Event|0|||
144251709|NCT06010732|520120827|FG003|Crossover Period 2|Adverse Event|0|||
144251710|NCT06010732|520120828|FG004|Crossover Period 2|Adverse Event|0|||
144251711|NCT06010732|520120829|FG005|Crossover Period 2|Adverse Event|0|||
144251712|NCT06010732|520120824|FG000|Crossover Period 2|broken denture|0|||
144251713|NCT06010732|520120825|FG001|Crossover Period 2|broken denture|0|||
144251714|NCT06010732|520120826|FG002|Crossover Period 2|broken denture|1|||
144251715|NCT06010732|520120827|FG003|Crossover Period 2|broken denture|0|||
144424990|NCT00642941|520763316|FG007|Overall Study|Death|0|||
144424991|NCT00642941|520763317|FG008|Overall Study|Death|0|||
144424992|NCT00642941|520763318|FG009|Overall Study|Death|0|||
144251716|NCT06010732|520120828|FG004|Crossover Period 2|broken denture|0|||
144251717|NCT06010732|520120829|FG005|Crossover Period 2|broken denture|0|||
144251718|NCT02714036|520120831|FG000|Overall Study|Adverse Event|9|||
144251719|NCT02714036|520120832|FG001|Overall Study|Adverse Event|2|||
144251720|NCT02714036|520120831|FG000|Overall Study|Withdrawal by Subject|3|||
144251721|NCT02714036|520120832|FG001|Overall Study|Withdrawal by Subject|2|||
144251722|NCT04942210|520120833|FG000|Overall Study|Adverse Event|0|||
144251723|NCT04942210|520120834|FG001|Overall Study|Adverse Event|1|||
144251724|NCT04942210|520120833|FG000|Overall Study|Protocol Deviation|4|||
144251725|NCT04942210|520120834|FG001|Overall Study|Protocol Deviation|1|||
144424993|NCT00642941|520763319|FG010|Overall Study|Death|0|||
144424994|NCT00642941|520763320|FG011|Overall Study|Death|1|||
144424995|NCT00642941|520763309|FG000|Overall Study|Study closed by Sponsor|0|||
144424996|NCT00642941|520763310|FG001|Overall Study|Study closed by Sponsor|1|||
144424997|NCT00642941|520763311|FG002|Overall Study|Study closed by Sponsor|0|||
144424998|NCT00642941|520763312|FG003|Overall Study|Study closed by Sponsor|0|||
144424999|NCT00642941|520763313|FG004|Overall Study|Study closed by Sponsor|0|||
144425000|NCT00642941|520763314|FG005|Overall Study|Study closed by Sponsor|0|||
144425001|NCT00642941|520763315|FG006|Overall Study|Study closed by Sponsor|0|||
144425002|NCT00642941|520763316|FG007|Overall Study|Study closed by Sponsor|0|||
144425003|NCT00642941|520763317|FG008|Overall Study|Study closed by Sponsor|0|||
144425004|NCT00642941|520763318|FG009|Overall Study|Study closed by Sponsor|0|||
144425005|NCT00642941|520763319|FG010|Overall Study|Study closed by Sponsor|0|||
144425006|NCT00642941|520763320|FG011|Overall Study|Study closed by Sponsor|0|||
144425007|NCT00642941|520763309|FG000|Overall Study|Withdrawal by Subject|1|||
144425008|NCT00642941|520763310|FG001|Overall Study|Withdrawal by Subject|0|||
144425009|NCT00642941|520763311|FG002|Overall Study|Withdrawal by Subject|0|||
144425010|NCT00642941|520763312|FG003|Overall Study|Withdrawal by Subject|2|||
144425011|NCT00642941|520763313|FG004|Overall Study|Withdrawal by Subject|0|||
144425012|NCT00642941|520763314|FG005|Overall Study|Withdrawal by Subject|0|||
144425013|NCT00642941|520763315|FG006|Overall Study|Withdrawal by Subject|2|||
144425014|NCT00642941|520763316|FG007|Overall Study|Withdrawal by Subject|0|||
144182104|NCT04556734|519862210|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144182105|NCT04556734|519862211|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144182106|NCT04556734|519862212|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144182107|NCT04556734|519862213|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144182108|NCT04556734|519862214|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144182109|NCT04556734|519862215|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144182110|NCT04556734|519862208|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144182111|NCT04556734|519862209|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144182112|NCT04556734|519862210|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144182113|NCT04556734|519862211|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144182114|NCT04556734|519862212|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144182115|NCT04556734|519862213|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144182116|NCT04556734|519862214|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144182117|NCT04556734|519862215|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144182118|NCT04556734|519862208|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
144182119|NCT04556734|519862209|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182120|NCT04556734|519862210|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182121|NCT04556734|519862211|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182122|NCT04556734|519862212|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182123|NCT04556734|519862213|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182124|NCT04556734|519862214|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182125|NCT04556734|519862215|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144182126|NCT04556734|519862208|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182127|NCT04556734|519862209|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182128|NCT04556734|519862210|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
144182129|NCT04556734|519862211|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182130|NCT04556734|519862212|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182131|NCT04556734|519862213|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182132|NCT04556734|519862214|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182133|NCT04556734|519862215|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
144182134|NCT04556734|519862208|FG000|OLE Period (28 Weeks)|Not reported|0|||
144425015|NCT00642941|520763317|FG008|Overall Study|Withdrawal by Subject|1|||
144425016|NCT00642941|520763318|FG009|Overall Study|Withdrawal by Subject|0|||
144425017|NCT00642941|520763319|FG010|Overall Study|Withdrawal by Subject|0|||
144425018|NCT00642941|520763320|FG011|Overall Study|Withdrawal by Subject|1|||
144425019|NCT00642941|520763309|FG000|Overall Study|Protocol Violation|0|||
144528449|NCT01928394|521139093|FG020|Treatment Period|Participant request to stop therapy|3|||
144528450|NCT01928394|521139094|FG021|Treatment Period|Participant request to stop therapy|1|||
144528451|NCT01928394|521139095|FG022|Treatment Period|Participant request to stop therapy|3|||
144528452|NCT01928394|521139073|FG000|Treatment Period|Participant withdrew consent|0|||
144528453|NCT01928394|521139074|FG001|Treatment Period|Participant withdrew consent|0|||
144528454|NCT01928394|521139075|FG002|Treatment Period|Participant withdrew consent|1|||
144528455|NCT01928394|521139076|FG003|Treatment Period|Participant withdrew consent|1|||
144528456|NCT01928394|521139077|FG004|Treatment Period|Participant withdrew consent|0|||
144528457|NCT01928394|521139078|FG005|Treatment Period|Participant withdrew consent|1|||
144528458|NCT01928394|521139079|FG006|Treatment Period|Participant withdrew consent|0|||
144528459|NCT01928394|521139080|FG007|Treatment Period|Participant withdrew consent|1|||
144528460|NCT01928394|521139081|FG008|Treatment Period|Participant withdrew consent|0|||
144528461|NCT01928394|521139082|FG009|Treatment Period|Participant withdrew consent|0|||
144528462|NCT01928394|521139083|FG010|Treatment Period|Participant withdrew consent|1|||
144528463|NCT01928394|521139084|FG011|Treatment Period|Participant withdrew consent|1|||
144528464|NCT01928394|521139085|FG012|Treatment Period|Participant withdrew consent|1|||
144528465|NCT01928394|521139086|FG013|Treatment Period|Participant withdrew consent|0|||
144528466|NCT01928394|521139087|FG014|Treatment Period|Participant withdrew consent|2|||
144528467|NCT01928394|521139088|FG015|Treatment Period|Participant withdrew consent|0|||
144528468|NCT01928394|521139089|FG016|Treatment Period|Participant withdrew consent|2|||
144425020|NCT00642941|520763310|FG001|Overall Study|Protocol Violation|0|||
144425021|NCT00642941|520763311|FG002|Overall Study|Protocol Violation|0|||
144425022|NCT00642941|520763312|FG003|Overall Study|Protocol Violation|0|||
144425023|NCT00642941|520763313|FG004|Overall Study|Protocol Violation|0|||
144425024|NCT00642941|520763314|FG005|Overall Study|Protocol Violation|0|||
144425025|NCT00642941|520763315|FG006|Overall Study|Protocol Violation|1|||
144425026|NCT00642941|520763316|FG007|Overall Study|Protocol Violation|0|||
144425027|NCT00642941|520763317|FG008|Overall Study|Protocol Violation|0|||
144182135|NCT04556734|519862209|FG001|OLE Period (28 Weeks)|Not reported|0|||
144182136|NCT04556734|519862210|FG002|OLE Period (28 Weeks)|Not reported|0|||
144182137|NCT04556734|519862211|FG003|OLE Period (28 Weeks)|Not reported|0|||
144182138|NCT04556734|519862212|FG004|OLE Period (28 Weeks)|Not reported|0|||
144182139|NCT04556734|519862213|FG005|OLE Period (28 Weeks)|Not reported|1|||
144182140|NCT04556734|519862214|FG006|OLE Period (28 Weeks)|Not reported|0|||
144182141|NCT04556734|519862215|FG007|OLE Period (28 Weeks)|Not reported|0|||
144182142|NCT04556734|519862208|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182143|NCT04556734|519862209|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182144|NCT04556734|519862210|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182145|NCT04556734|519862211|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182146|NCT04556734|519862212|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182147|NCT04556734|519862213|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182148|NCT04556734|519862214|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
144182149|NCT04556734|519862215|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
144182150|NCT04556734|519862208|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
144182151|NCT04556734|519862209|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
144182152|NCT04556734|519862210|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
144182153|NCT04556734|519862211|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
144182154|NCT04556734|519862212|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
144182155|NCT04556734|519862213|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
144182156|NCT04556734|519862214|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
144182157|NCT04556734|519862215|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
144182158|NCT04556734|519862208|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144182159|NCT04556734|519862209|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144182160|NCT04556734|519862210|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144182161|NCT04556734|519862211|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
144182162|NCT04556734|519862212|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
144182163|NCT04556734|519862213|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
144182164|NCT04556734|519862214|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
144182165|NCT04556734|519862215|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
144182166|NCT04768296|519862219|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
144182167|NCT04768296|519862220|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
144182168|NCT03035890|519862229|FG000|Overall Study|Death|1|||
144182169|NCT02274558|519862240|FG000|Overall Study|Adverse Event|2|||
144182170|NCT02274558|519862241|FG001|Overall Study|Adverse Event|4|||
144602224|NCT04124614|521404879|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
144602225|NCT04124614|521404880|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
144602226|NCT04124614|521404881|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
144602227|NCT04124614|521404879|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
144602228|NCT04124614|521404880|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
144602229|NCT04124614|521404881|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
144602230|NCT05749952|521404882|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
144602231|NCT06950879|521404883|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
144602232|NCT02113579|521406970|FG000|Overall Study|Adverse Event|1|||
144602233|NCT02113579|521406971|FG001|Overall Study|Adverse Event|0|||
144602234|NCT02113579|521406970|FG000|Overall Study|Withdrawal by Subject|3|||
144602235|NCT02113579|521406971|FG001|Overall Study|Withdrawal by Subject|2|||
144602236|NCT02113579|521406970|FG000|Overall Study|Lost to Follow-up|6|||
144602237|NCT02113579|521406971|FG001|Overall Study|Lost to Follow-up|2|||
144602238|NCT00726622|521406972|FG000|Overall Study|Withdrawal by Subject|16|||
144602239|NCT00726622|521406973|FG001|Overall Study|Withdrawal by Subject|2|||
144425028|NCT00642941|520763318|FG009|Overall Study|Protocol Violation|0|||
144425029|NCT00642941|520763319|FG010|Overall Study|Protocol Violation|0|||
144425030|NCT00642941|520763320|FG011|Overall Study|Protocol Violation|0|||
144425031|NCT00642941|520763309|FG000|Overall Study|Adverse Event|1|||
144602240|NCT00726622|521406972|FG000|Overall Study|Physician Decision|0|||
144602241|NCT00726622|521406973|FG001|Overall Study|Physician Decision|1|||
144182171|NCT02274558|519862242|FG002|Overall Study|Adverse Event|2|||
144425032|NCT00642941|520763310|FG001|Overall Study|Adverse Event|1|||
144182172|NCT02274558|519862240|FG000|Overall Study|Non-compliance|2|||
144182173|NCT02274558|519862241|FG001|Overall Study|Non-compliance|1|||
144182174|NCT02274558|519862242|FG002|Overall Study|Non-compliance|0|||
144182175|NCT02274558|519862240|FG000|Overall Study|Withdrawal by Subject|1|||
144182176|NCT02274558|519862241|FG001|Overall Study|Withdrawal by Subject|5|||
144182177|NCT02274558|519862242|FG002|Overall Study|Withdrawal by Subject|4|||
144182178|NCT02274558|519862240|FG000|Overall Study|Death|0|||
144602242|NCT00726622|521406972|FG000|Overall Study|Metastasis|2|||
144602243|NCT00726622|521406973|FG001|Overall Study|Metastasis|0|||
144602244|NCT01016964|521406977|FG000|Overall Study|Lost to Follow-up|3|||
144602245|NCT01016964|521406978|FG001|Overall Study|Lost to Follow-up|3|||
144602246|NCT03872453|521406979|FG000|Overall Study|Adverse Event|1|||
144602247|NCT03872453|521406980|FG001|Overall Study|Adverse Event|1|||
144602248|NCT03872453|521406981|FG002|Overall Study|Adverse Event|0|||
144602249|NCT03872453|521406982|FG003|Overall Study|Adverse Event|0|||
144602250|NCT03872453|521406979|FG000|Overall Study|Lost to Follow-up|8|||
144602251|NCT03872453|521406980|FG001|Overall Study|Lost to Follow-up|7|||
144602252|NCT03872453|521406981|FG002|Overall Study|Lost to Follow-up|4|||
144602253|NCT03872453|521406982|FG003|Overall Study|Lost to Follow-up|4|||
144602254|NCT03872453|521406979|FG000|Overall Study|Never Treated Migraine|19|||
144602255|NCT03872453|521406980|FG001|Overall Study|Never Treated Migraine|17|||
144602256|NCT03872453|521406981|FG002|Overall Study|Never Treated Migraine|13|||
144602257|NCT03872453|521406982|FG003|Overall Study|Never Treated Migraine|12|||
144602258|NCT03872453|521406979|FG000|Overall Study|Pregnancy|1|||
144602259|NCT03872453|521406980|FG001|Overall Study|Pregnancy|0|||
144602260|NCT03872453|521406981|FG002|Overall Study|Pregnancy|0|||
144602261|NCT03872453|521406982|FG003|Overall Study|Pregnancy|0|||
144602262|NCT03872453|521406979|FG000|Overall Study|Protocol Deviation|2|||
144602263|NCT03872453|521406980|FG001|Overall Study|Protocol Deviation|0|||
144602264|NCT03872453|521406981|FG002|Overall Study|Protocol Deviation|0|||
144602265|NCT03872453|521406982|FG003|Overall Study|Protocol Deviation|2|||
144602266|NCT03872453|521406979|FG000|Overall Study|Withdrawal by Subject|0|||
144602267|NCT03872453|521406980|FG001|Overall Study|Withdrawal by Subject|1|||
144602268|NCT03872453|521406981|FG002|Overall Study|Withdrawal by Subject|2|||
144602269|NCT03872453|521406982|FG003|Overall Study|Withdrawal by Subject|0|||
144602270|NCT03872453|521406979|FG000|Overall Study|Other Than Specified|1|||
144602271|NCT03872453|521406980|FG001|Overall Study|Other Than Specified|0|||
144602272|NCT03872453|521406981|FG002|Overall Study|Other Than Specified|0|||
144602273|NCT03872453|521406982|FG003|Overall Study|Other Than Specified|0|||
144602274|NCT00352885|521406983|FG000|Overall Study|Withdrawal by Subject|0|||
144602275|NCT00352885|521406984|FG001|Overall Study|Withdrawal by Subject|3|||
144602276|NCT00352885|521406983|FG000|Overall Study|Development of major depression|0|||
144602277|NCT00352885|521406984|FG001|Overall Study|Development of major depression|1|||
144602278|NCT00352885|521406983|FG000|Overall Study|Progression of metastatic melanoma|5|||
144602279|NCT00352885|521406984|FG001|Overall Study|Progression of metastatic melanoma|3|||
144602280|NCT00352885|521406983|FG000|Overall Study|Side effects of IL-2 administration|1|||
144602281|NCT00352885|521406984|FG001|Overall Study|Side effects of IL-2 administration|0|||
144602282|NCT03873493|521406985|FG000|Overall Study|Withdrawal by Subject|1|||
144602283|NCT03873493|521406985|FG000|Overall Study|Death|9|||
144602284|NCT03873493|521406985|FG000|Overall Study|Lost to Follow-up|1|||
144602285|NCT03873493|521406985|FG000|Overall Study|Study Terminated by Sponsor|1|||
144602286|NCT03873493|521406985|FG000|Overall Study|Other|2|||
144602287|NCT00440700|521406989|FG000|Overall Study|Withdrawal by Subject|8|||
144602288|NCT00440700|521406990|FG001|Overall Study|Withdrawal by Subject|8|||
144602289|NCT00440700|521406991|FG002|Overall Study|Withdrawal by Subject|4|||
144602290|NCT01096342|521406992|FG000|Overall Study|Protocol Violation|1|||
144602291|NCT04906616|521406993|FG000|Overall Study|Divorce|3|||
144602292|NCT04906616|521406994|FG001|Overall Study|Divorce|2|||
144602293|NCT00929656|521406995|FG000|Overall Study|Lost to Follow-up|0|||
144602294|NCT00929656|521406996|FG001|Overall Study|Lost to Follow-up|1|||
144602295|NCT00385203|521406999|FG000|Overall Study|Adverse Event|5|||
144602296|NCT00385203|521407000|FG001|Overall Study|Adverse Event|4|||
144602297|NCT00385203|521406999|FG000|Overall Study|Death|1|||
144602298|NCT00385203|521407000|FG001|Overall Study|Death|0|||
144602299|NCT00385203|521406999|FG000|Overall Study|Condition under investigation worsened|18|||
144602300|NCT00385203|521407000|FG001|Overall Study|Condition under investigation worsened|3|||
144602301|NCT00385203|521406999|FG000|Overall Study|Incorrect enrollment|2|||
144602302|NCT00385203|521407000|FG001|Overall Study|Incorrect enrollment|0|||
144602303|NCT00698451|521407011|FG000|Overall Study|Adverse Event|22|||
144602304|NCT00698451|521407011|FG000|Overall Study|Physician Decision|2|||
144602305|NCT00698451|521407011|FG000|Overall Study|Protocol Violation|6|||
144602306|NCT00698451|521407011|FG000|Overall Study|Withdrawal by Subject|6|||
144602307|NCT00698451|521407011|FG000|Overall Study|Disease progression|3|||
144602308|NCT01187550|521407014|FG000|Overall Study|Protocol Violation|3|||
144602309|NCT01187550|521407015|FG001|Overall Study|Protocol Violation|1|||
144723415|NCT00329602|521842337|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
144602310|NCT01187550|521407014|FG000|Overall Study|Other|3|||
144602311|NCT01187550|521407015|FG001|Overall Study|Other|0|||
144602312|NCT01187550|521407014|FG000|Overall Study|Randomized but not treated|8|||
144602313|NCT01187550|521407015|FG001|Overall Study|Randomized but not treated|0|||
144602314|NCT00733304|521407016|FG000|Overall Study|Adverse Event|3|||
144602315|NCT00733304|521407017|FG001|Overall Study|Adverse Event|0|||
144602316|NCT00733304|521407018|FG002|Overall Study|Adverse Event|0|||
144602317|NCT00733304|521407016|FG000|Overall Study|Lack of Efficacy|0|||
144602318|NCT00733304|521407017|FG001|Overall Study|Lack of Efficacy|0|||
144602319|NCT00733304|521407018|FG002|Overall Study|Lack of Efficacy|2|||
144602320|NCT00733304|521407016|FG000|Overall Study|Lost to Follow-up|0|||
144602321|NCT00733304|521407017|FG001|Overall Study|Lost to Follow-up|1|||
144602322|NCT00733304|521407018|FG002|Overall Study|Lost to Follow-up|0|||
144602323|NCT00733304|521407016|FG000|Overall Study|Physician Decision|3|||
144602324|NCT00733304|521407017|FG001|Overall Study|Physician Decision|1|||
144602325|NCT00733304|521407018|FG002|Overall Study|Physician Decision|3|||
144602326|NCT00733304|521407016|FG000|Overall Study|Withdrawal by Subject|1|||
144602327|NCT00733304|521407017|FG001|Overall Study|Withdrawal by Subject|1|||
144182179|NCT02274558|519862241|FG001|Overall Study|Death|0|||
144182180|NCT02274558|519862242|FG002|Overall Study|Death|1|||
144182181|NCT02274558|519862240|FG000|Overall Study|Lost to Follow-up|2|||
144182182|NCT02274558|519862241|FG001|Overall Study|Lost to Follow-up|1|||
144602328|NCT00733304|521407018|FG002|Overall Study|Withdrawal by Subject|0|||
144602329|NCT02445755|521407028|FG000|Overall Study|Withdrawal by Subject|2|||
144602330|NCT02445755|521407028|FG000|Overall Study|Protocol Violation|6|||
144602331|NCT02445755|521407028|FG000|Overall Study|Screen Failure|5|||
144602332|NCT05352048|521407029|FG000|Overall Study|Lost to Follow-up|1|||
144602333|NCT05352048|521407029|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
144602334|NCT02308007|521407039|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
144602335|NCT02308007|521407040|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
144602336|NCT02308007|521407041|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
144602337|NCT02308007|521407039|FG000|Overall Study|Positive for STD at Baseline|7|||
144602338|NCT02308007|521407040|FG001|Overall Study|Positive for STD at Baseline|11|||
144602339|NCT02308007|521407041|FG002|Overall Study|Positive for STD at Baseline|7|||
144602340|NCT02308007|521407039|FG000|Overall Study|Lost to Follow-up|3|||
144602341|NCT02308007|521407040|FG001|Overall Study|Lost to Follow-up|0|||
144602342|NCT02308007|521407041|FG002|Overall Study|Lost to Follow-up|1|||
144602343|NCT00528567|521407047|FG000|Overall Study|Death|4|||
144602344|NCT00528567|521407048|FG001|Overall Study|Death|5|||
144602345|NCT00528567|521407047|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
144602346|NCT00528567|521407048|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
144602347|NCT00528567|521407047|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
144602348|NCT00528567|521407048|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
144602349|NCT00528567|521407047|FG000|Overall Study|Violation Criteria at Entry|3|||
144602350|NCT00528567|521407048|FG001|Overall Study|Violation Criteria at Entry|17|||
144602351|NCT00528567|521407047|FG000|Overall Study|Withdrew Consent|59|||
144602352|NCT00528567|521407048|FG001|Overall Study|Withdrew Consent|55|||
144602353|NCT00528567|521407047|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
144602354|NCT00528567|521407048|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
144602355|NCT00528567|521407047|FG000|Overall Study|Failure to Return|1|||
144602356|NCT00528567|521407048|FG001|Overall Study|Failure to Return|4|||
144602357|NCT00528567|521407047|FG000|Overall Study|Other Protocol Violation|5|||
144602358|NCT00528567|521407048|FG001|Overall Study|Other Protocol Violation|21|||
144602359|NCT00528567|521407047|FG000|Overall Study|Administrative/Other|22|||
144602360|NCT00528567|521407048|FG001|Overall Study|Administrative/Other|75|||
144602361|NCT00631189|521407051|FG000|Initial Phase|Protocol Violation|347|||
144602362|NCT00631189|521407052|FG001|Initial Phase|Protocol Violation|0|||
144602363|NCT00631189|521407053|FG002|Initial Phase|Protocol Violation|0|||
144602364|NCT00631189|521407054|FG003|Initial Phase|Protocol Violation|0|||
144602365|NCT00631189|521407051|FG000|Initial Phase|Withdrawal by Subject|4|||
144602366|NCT00631189|521407052|FG001|Initial Phase|Withdrawal by Subject|0|||
144182183|NCT02274558|519862242|FG002|Overall Study|Lost to Follow-up|1|||
144602367|NCT00631189|521407053|FG002|Initial Phase|Withdrawal by Subject|0|||
144602368|NCT00631189|521407054|FG003|Initial Phase|Withdrawal by Subject|0|||
144602369|NCT00631189|521407051|FG000|Treatment Phase|Withdrawal by Subject|0|||
144602370|NCT00631189|521407052|FG001|Treatment Phase|Withdrawal by Subject|2|||
144602371|NCT00631189|521407053|FG002|Treatment Phase|Withdrawal by Subject|1|||
144602372|NCT00631189|521407054|FG003|Treatment Phase|Withdrawal by Subject|1|||
144602373|NCT00631189|521407051|FG000|Treatment Phase|Protocol Violation|0|||
144602374|NCT00631189|521407052|FG001|Treatment Phase|Protocol Violation|1|||
144602375|NCT00631189|521407053|FG002|Treatment Phase|Protocol Violation|6|||
144602376|NCT00631189|521407054|FG003|Treatment Phase|Protocol Violation|2|||
144602377|NCT00631189|521407051|FG000|Treatment Phase|Adverse Event|0|||
144602378|NCT00631189|521407052|FG001|Treatment Phase|Adverse Event|3|||
144602379|NCT00631189|521407053|FG002|Treatment Phase|Adverse Event|2|||
144602380|NCT00631189|521407054|FG003|Treatment Phase|Adverse Event|4|||
144602381|NCT00631189|521407051|FG000|Treatment Phase|Lost to Follow-up|0|||
144602382|NCT00631189|521407052|FG001|Treatment Phase|Lost to Follow-up|1|||
144602383|NCT00631189|521407053|FG002|Treatment Phase|Lost to Follow-up|0|||
144602384|NCT00631189|521407054|FG003|Treatment Phase|Lost to Follow-up|0|||
144182184|NCT02274558|519862240|FG000|Overall Study|Physician Decision|0|||
144182185|NCT02274558|519862241|FG001|Overall Study|Physician Decision|2|||
144182186|NCT02274558|519862242|FG002|Overall Study|Physician Decision|1|||
144182187|NCT02587143|519862249|FG000|Overall Study|Adverse Event|1|||
144182188|NCT02587143|519862250|FG001|Overall Study|Adverse Event|0|||
144182189|NCT02754492|519862251|FG000|Overall Study|Protocol Violation|2|||
144182190|NCT02754492|519862252|FG001|Overall Study|Protocol Violation|2|||
144528469|NCT01928394|521139090|FG017|Treatment Period|Participant withdrew consent|1|||
144602385|NCT00631189|521407051|FG000|Treatment Phase|Pregnancy|0|||
144602386|NCT00631189|521407052|FG001|Treatment Phase|Pregnancy|0|||
144602387|NCT00631189|521407053|FG002|Treatment Phase|Pregnancy|1|||
144602388|NCT00631189|521407054|FG003|Treatment Phase|Pregnancy|0|||
144602389|NCT00631189|521407051|FG000|Treatment Phase|patient did not take pravastatin|0|||
144602390|NCT00631189|521407052|FG001|Treatment Phase|patient did not take pravastatin|0|||
144602391|NCT00631189|521407053|FG002|Treatment Phase|patient did not take pravastatin|1|||
144602392|NCT00631189|521407054|FG003|Treatment Phase|patient did not take pravastatin|0|||
144602393|NCT00974090|521407055|FG000|Period 1: Double Blind Period|Adverse Event|2|||
144602394|NCT00974090|521407056|FG001|Period 1: Double Blind Period|Adverse Event|1|||
144602395|NCT00974090|521407055|FG000|Period 1: Double Blind Period|Physician Decision|1|||
144602396|NCT00974090|521407056|FG001|Period 1: Double Blind Period|Physician Decision|0|||
144602397|NCT00974090|521407055|FG000|Period 2: Open-label Period|Adverse Event|4|||
144602398|NCT00974090|521407056|FG001|Period 2: Open-label Period|Adverse Event|6|||
144602399|NCT00974090|521407055|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
144602400|NCT00974090|521407056|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
144602401|NCT00974090|521407055|FG000|Period 2: Open-label Period|Physician Decision|0|||
144602402|NCT00974090|521407056|FG001|Period 2: Open-label Period|Physician Decision|3|||
144602403|NCT00974090|521407055|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
144602404|NCT00974090|521407056|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
144602405|NCT03189862|521407057|FG000|Overall Study|Withdrawal by Subject|1|||
144602406|NCT03189862|521407058|FG001|Overall Study|Withdrawal by Subject|0|||
144602407|NCT03189862|521407057|FG000|Overall Study|Lost to Follow-up|54|||
144602408|NCT03189862|521407058|FG001|Overall Study|Lost to Follow-up|62|||
144182191|NCT02754492|519862253|FG002|Overall Study|Protocol Violation|0|||
144182192|NCT02754492|519862254|FG003|Overall Study|Protocol Violation|1|||
144182193|NCT02754492|519862251|FG000|Overall Study|Withdrawal by Subject|2|||
144182194|NCT02754492|519862252|FG001|Overall Study|Withdrawal by Subject|0|||
144182195|NCT02754492|519862253|FG002|Overall Study|Withdrawal by Subject|0|||
144602409|NCT01122576|521407059|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
144602410|NCT01122576|521407060|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
144602411|NCT01122576|521407061|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
144602412|NCT01122576|521407059|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
144602413|NCT01122576|521407060|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
144602414|NCT01122576|521407061|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
144602415|NCT01122576|521407059|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
144602416|NCT01122576|521407060|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
144602417|NCT01122576|521407061|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
144602418|NCT05696236|521407062|FG000|Overall Study|Lost to Follow-up|1|||
144602419|NCT05696236|521407063|FG001|Overall Study|Lost to Follow-up|0|||
144602420|NCT05696236|521407062|FG000|Overall Study|Later determined to not be eligible for participation|0|||
144528470|NCT01928394|521139091|FG018|Treatment Period|Participant withdrew consent|1|||
144528471|NCT01928394|521139092|FG019|Treatment Period|Participant withdrew consent|1|||
144528472|NCT01928394|521139093|FG020|Treatment Period|Participant withdrew consent|0|||
144528473|NCT01928394|521139094|FG021|Treatment Period|Participant withdrew consent|2|||
144528474|NCT01928394|521139095|FG022|Treatment Period|Participant withdrew consent|0|||
144528475|NCT01928394|521139073|FG000|Treatment Period|Poor/non-compliance|0|||
144528476|NCT01928394|521139074|FG001|Treatment Period|Poor/non-compliance|0|||
144528477|NCT01928394|521139075|FG002|Treatment Period|Poor/non-compliance|0|||
144528478|NCT01928394|521139076|FG003|Treatment Period|Poor/non-compliance|1|||
144528479|NCT01928394|521139077|FG004|Treatment Period|Poor/non-compliance|0|||
144528480|NCT01928394|521139078|FG005|Treatment Period|Poor/non-compliance|0|||
144528481|NCT01928394|521139079|FG006|Treatment Period|Poor/non-compliance|0|||
144528482|NCT01928394|521139080|FG007|Treatment Period|Poor/non-compliance|0|||
144528483|NCT01928394|521139081|FG008|Treatment Period|Poor/non-compliance|0|||
144528484|NCT01928394|521139082|FG009|Treatment Period|Poor/non-compliance|0|||
144528485|NCT01928394|521139083|FG010|Treatment Period|Poor/non-compliance|0|||
144528486|NCT01928394|521139084|FG011|Treatment Period|Poor/non-compliance|0|||
144528487|NCT01928394|521139085|FG012|Treatment Period|Poor/non-compliance|1|||
144528488|NCT01928394|521139086|FG013|Treatment Period|Poor/non-compliance|0|||
144528489|NCT01928394|521139087|FG014|Treatment Period|Poor/non-compliance|1|||
144528490|NCT01928394|521139088|FG015|Treatment Period|Poor/non-compliance|0|||
144528491|NCT01928394|521139089|FG016|Treatment Period|Poor/non-compliance|0|||
144528492|NCT01928394|521139090|FG017|Treatment Period|Poor/non-compliance|1|||
144528493|NCT01928394|521139091|FG018|Treatment Period|Poor/non-compliance|0|||
144528494|NCT01928394|521139092|FG019|Treatment Period|Poor/non-compliance|1|||
144528495|NCT01928394|521139093|FG020|Treatment Period|Poor/non-compliance|0|||
144528496|NCT01928394|521139094|FG021|Treatment Period|Poor/non-compliance|0|||
144528497|NCT01928394|521139095|FG022|Treatment Period|Poor/non-compliance|0|||
144182196|NCT02754492|519862254|FG003|Overall Study|Withdrawal by Subject|0|||
144528498|NCT01928394|521139073|FG000|Treatment Period|other reason|0|||
144528499|NCT01928394|521139074|FG001|Treatment Period|other reason|0|||
144528500|NCT01928394|521139075|FG002|Treatment Period|other reason|0|||
144602421|NCT05696236|521407063|FG001|Overall Study|Later determined to not be eligible for participation|1|||
144602422|NCT05696236|521407062|FG000|Overall Study|Withdrawal by Subject|2|||
144602423|NCT05696236|521407063|FG001|Overall Study|Withdrawal by Subject|2|||
144602424|NCT01829360|521407064|FG000|Overall Study|Protocol Violation|0|||
144602425|NCT01829360|521407065|FG001|Overall Study|Protocol Violation|0|||
144602426|NCT01829360|521407066|FG002|Overall Study|Protocol Violation|1|||
144602427|NCT01829360|521407067|FG003|Overall Study|Protocol Violation|0|||
144602428|NCT02378220|521407072|FG000|Overall Study|Death|6|||
144602429|NCT02378220|521407073|FG001|Overall Study|Death|1|||
144602430|NCT00578786|521407074|FG000|Overall Study|Adverse Event|27|||
144602431|NCT00578786|521407075|FG001|Overall Study|Adverse Event|37|||
144602432|NCT00578786|521407076|FG002|Overall Study|Adverse Event|17|||
144602433|NCT00578786|521407074|FG000|Overall Study|Lack of Efficacy|2|||
144602434|NCT00578786|521407075|FG001|Overall Study|Lack of Efficacy|5|||
144602435|NCT00578786|521407076|FG002|Overall Study|Lack of Efficacy|2|||
144182197|NCT02754492|519862251|FG000|Overall Study|Equipment malfuntion|0|||
144602436|NCT00578786|521407074|FG000|Overall Study|Early Escape from Prior Study|2|||
144602437|NCT00578786|521407075|FG001|Overall Study|Early Escape from Prior Study|1|||
144425033|NCT00642941|520763311|FG002|Overall Study|Adverse Event|0|||
144425034|NCT00642941|520763312|FG003|Overall Study|Adverse Event|0|||
144425035|NCT00642941|520763313|FG004|Overall Study|Adverse Event|0|||
144425036|NCT00642941|520763314|FG005|Overall Study|Adverse Event|0|||
144425037|NCT00642941|520763315|FG006|Overall Study|Adverse Event|1|||
144425038|NCT00642941|520763316|FG007|Overall Study|Adverse Event|1|||
144425039|NCT00642941|520763317|FG008|Overall Study|Adverse Event|0|||
144425040|NCT00642941|520763318|FG009|Overall Study|Adverse Event|1|||
144425041|NCT00642941|520763319|FG010|Overall Study|Adverse Event|0|||
144425042|NCT00642941|520763320|FG011|Overall Study|Adverse Event|0|||
144425043|NCT00642941|520763309|FG000|Overall Study|Other|1|||
144425044|NCT00642941|520763310|FG001|Overall Study|Other|1|||
144425045|NCT00642941|520763311|FG002|Overall Study|Other|1|||
144425046|NCT00642941|520763312|FG003|Overall Study|Other|1|||
144425047|NCT00642941|520763313|FG004|Overall Study|Other|0|||
144425048|NCT00642941|520763314|FG005|Overall Study|Other|1|||
144602438|NCT00578786|521407076|FG002|Overall Study|Early Escape from Prior Study|2|||
144602439|NCT00578786|521407074|FG000|Overall Study|Withdrawal by Subject|7|||
144602440|NCT00578786|521407075|FG001|Overall Study|Withdrawal by Subject|8|||
144602441|NCT00578786|521407076|FG002|Overall Study|Withdrawal by Subject|5|||
144602442|NCT00578786|521407074|FG000|Overall Study|Protocol Violation|0|||
144602443|NCT00578786|521407075|FG001|Overall Study|Protocol Violation|3|||
144182198|NCT02754492|519862252|FG001|Overall Study|Equipment malfuntion|0|||
144182199|NCT02754492|519862253|FG002|Overall Study|Equipment malfuntion|2|||
144182200|NCT02754492|519862254|FG003|Overall Study|Equipment malfuntion|5|||
144182201|NCT02754492|519862251|FG000|Overall Study|Adverse Event|0|||
144182202|NCT02754492|519862252|FG001|Overall Study|Adverse Event|0|||
144182203|NCT02754492|519862253|FG002|Overall Study|Adverse Event|0|||
144182204|NCT02754492|519862254|FG003|Overall Study|Adverse Event|13|||
144182205|NCT02754492|519862251|FG000|Overall Study|Venous access issues not resulting in AE|0|||
144182206|NCT02754492|519862252|FG001|Overall Study|Venous access issues not resulting in AE|0|||
144182207|NCT02754492|519862253|FG002|Overall Study|Venous access issues not resulting in AE|0|||
144182208|NCT02754492|519862254|FG003|Overall Study|Venous access issues not resulting in AE|4|||
144182209|NCT00487695|519862255|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
144182210|NCT00487695|519862256|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
144182211|NCT00487695|519862255|FG000|First Procedure|active wheezing (did not have procedure)|1|||
144182212|NCT00487695|519862256|FG001|First Procedure|active wheezing (did not have procedure)|0|||
144182213|NCT00487695|519862255|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
144182214|NCT00487695|519862256|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
144182215|NCT00487695|519862255|FG000|Second Procedure|active wheezing|0|||
144182216|NCT00487695|519862256|FG001|Second Procedure|active wheezing|1|||
144182217|NCT00487695|519862255|FG000|Second Procedure|Withdrawal by Subject|1|||
144182218|NCT00487695|519862256|FG001|Second Procedure|Withdrawal by Subject|2|||
144182219|NCT02167594|519862257|FG000|Overall Study|Withdrawal by Subject|2|||
144182220|NCT02167594|519862258|FG001|Overall Study|Withdrawal by Subject|0|||
144182221|NCT02167594|519862259|FG002|Overall Study|Withdrawal by Subject|0|||
144182222|NCT02167594|519862257|FG000|Overall Study|Death|0|||
144182223|NCT02167594|519862258|FG001|Overall Study|Death|1|||
144182224|NCT02167594|519862259|FG002|Overall Study|Death|0|||
144182225|NCT01943435|519862263|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
144182226|NCT01943435|519862264|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
144182227|NCT01943435|519862265|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
144182228|NCT01943435|519862263|FG000|Intervention Period|Withdrawal by Subject|3|||
144182229|NCT01943435|519862264|FG001|Intervention Period|Withdrawal by Subject|3|||
144182230|NCT01943435|519862265|FG002|Intervention Period|Withdrawal by Subject|4|||
144182231|NCT01943435|519862263|FG000|2 Month Follow up|Lost to Follow-up|2|||
144182232|NCT01943435|519862264|FG001|2 Month Follow up|Lost to Follow-up|3|||
144602444|NCT00578786|521407076|FG002|Overall Study|Protocol Violation|1|||
144602445|NCT00578786|521407074|FG000|Overall Study|Physician Decision|1|||
144602446|NCT00578786|521407075|FG001|Overall Study|Physician Decision|0|||
144602447|NCT00578786|521407076|FG002|Overall Study|Physician Decision|1|||
144602448|NCT00578786|521407074|FG000|Overall Study|Sponsor Decision|0|||
144182233|NCT01943435|519862265|FG002|2 Month Follow up|Lost to Follow-up|0|||
144182234|NCT01943435|519862263|FG000|6 Month Follow up|Lost to Follow-up|12|||
144182235|NCT01943435|519862264|FG001|6 Month Follow up|Lost to Follow-up|7|||
144182236|NCT01943435|519862265|FG002|6 Month Follow up|Lost to Follow-up|15|||
144182237|NCT00743145|519862273|FG000|Overall Study|Withdrawal by Subject|1|||
144182238|NCT00743145|519862273|FG000|Overall Study|Adverse Event|2|||
144602449|NCT00578786|521407075|FG001|Overall Study|Sponsor Decision|0|||
144602450|NCT00578786|521407076|FG002|Overall Study|Sponsor Decision|1|||
144602451|NCT00578786|521407074|FG000|Overall Study|Lost to Follow-up|0|||
144602452|NCT00578786|521407075|FG001|Overall Study|Lost to Follow-up|4|||
144602453|NCT00578786|521407076|FG002|Overall Study|Lost to Follow-up|0|||
144602454|NCT00578786|521407074|FG000|Overall Study|Pregnancy|0|||
144602455|NCT00578786|521407075|FG001|Overall Study|Pregnancy|1|||
144602456|NCT00578786|521407076|FG002|Overall Study|Pregnancy|0|||
144602457|NCT00578786|521407074|FG000|Overall Study|Not Otherwise Specified|0|||
144182239|NCT00743145|519862273|FG000|Overall Study|Pregnancy|1|||
144602458|NCT00578786|521407075|FG001|Overall Study|Not Otherwise Specified|4|||
144602459|NCT00578786|521407076|FG002|Overall Study|Not Otherwise Specified|1|||
144602460|NCT00578786|521407074|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
144602461|NCT00578786|521407075|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
144602462|NCT00578786|521407076|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
144602463|NCT05105789|521407077|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
144602464|NCT01975428|521407084|FG000|Overall Study|Lost to Follow-up|17|||
144602465|NCT01975428|521407085|FG001|Overall Study|Lost to Follow-up|4|||
144602466|NCT01975428|521407084|FG000|Overall Study|Withdrawal by Subject|3|||
144425049|NCT00642941|520763315|FG006|Overall Study|Other|0|||
144425050|NCT00642941|520763316|FG007|Overall Study|Other|1|||
144425051|NCT00642941|520763317|FG008|Overall Study|Other|0|||
144425052|NCT00642941|520763318|FG009|Overall Study|Other|0|||
144425053|NCT00642941|520763319|FG010|Overall Study|Other|0|||
144425054|NCT00642941|520763320|FG011|Overall Study|Other|1|||
144182240|NCT01567527|519862274|FG000|Conversion Phase.|Protocol deviation|3|||
144182241|NCT01567527|519862275|FG001|Conversion Phase.|Protocol deviation|0|||
144182242|NCT01567527|519862276|FG002|Conversion Phase.|Protocol deviation|0|||
144182243|NCT01567527|519862277|FG003|Conversion Phase.|Protocol deviation|0|||
144182244|NCT01567527|519862278|FG004|Conversion Phase.|Protocol deviation|0|||
144182245|NCT01567527|519862274|FG000|Conversion Phase.|Met withdrawal criteria|10|||
144182246|NCT01567527|519862275|FG001|Conversion Phase.|Met withdrawal criteria|0|||
144182247|NCT01567527|519862276|FG002|Conversion Phase.|Met withdrawal criteria|0|||
144182248|NCT01567527|519862277|FG003|Conversion Phase.|Met withdrawal criteria|0|||
144182249|NCT01567527|519862278|FG004|Conversion Phase.|Met withdrawal criteria|0|||
144182250|NCT01567527|519862274|FG000|Conversion Phase.|Withdrawal by Subject|32|||
144182251|NCT01567527|519862275|FG001|Conversion Phase.|Withdrawal by Subject|0|||
144182252|NCT01567527|519862276|FG002|Conversion Phase.|Withdrawal by Subject|0|||
144182253|NCT01567527|519862277|FG003|Conversion Phase.|Withdrawal by Subject|0|||
144182254|NCT01567527|519862278|FG004|Conversion Phase.|Withdrawal by Subject|0|||
144182255|NCT01567527|519862274|FG000|Conversion Phase.|Lost to Follow-up|16|||
144602467|NCT01975428|521407085|FG001|Overall Study|Withdrawal by Subject|10|||
144182256|NCT01567527|519862275|FG001|Conversion Phase.|Lost to Follow-up|0|||
144182257|NCT01567527|519862276|FG002|Conversion Phase.|Lost to Follow-up|0|||
144182258|NCT01567527|519862277|FG003|Conversion Phase.|Lost to Follow-up|0|||
144602468|NCT00041067|521407086|FG000|Overall Study|Adverse Event|20|||
144602469|NCT00041067|521407086|FG000|Overall Study|Progression|19|||
144602470|NCT00041067|521407086|FG000|Overall Study|Patient refusal|12|||
144602471|NCT00041067|521407086|FG000|Overall Study|Other reasons|23|||
144602472|NCT00041067|521407086|FG000|Overall Study|Ineligible|2|||
144182259|NCT01567527|519862278|FG004|Conversion Phase.|Lost to Follow-up|0|||
144182260|NCT01567527|519862274|FG000|Conversion Phase.|Lack of Efficacy|2|||
144182261|NCT01567527|519862275|FG001|Conversion Phase.|Lack of Efficacy|0|||
144182262|NCT01567527|519862276|FG002|Conversion Phase.|Lack of Efficacy|0|||
144182263|NCT01567527|519862277|FG003|Conversion Phase.|Lack of Efficacy|0|||
144182264|NCT01567527|519862278|FG004|Conversion Phase.|Lack of Efficacy|0|||
144602473|NCT01251120|521407087|FG000|Overall Study|Lack of Efficacy|0|||
144602474|NCT01251120|521407088|FG001|Overall Study|Lack of Efficacy|1|||
144602475|NCT01822522|521407089|FG000|Overall Study|Adverse Event|1|||
144602476|NCT01822522|521407090|FG001|Overall Study|Adverse Event|1|||
144602477|NCT01822522|521407091|FG002|Overall Study|Adverse Event|1|||
144602478|NCT01822522|521407092|FG003|Overall Study|Adverse Event|0|||
144425055|NCT00642941|520763309|FG000|Overall Study|Disease progression|60|||
144182265|NCT01567527|519862274|FG000|Conversion Phase.|Adverse Event|33|||
144425056|NCT00642941|520763310|FG001|Overall Study|Disease progression|50|||
144425057|NCT00642941|520763311|FG002|Overall Study|Disease progression|5|||
144602479|NCT01822522|521407093|FG004|Overall Study|Adverse Event|0|||
144602480|NCT01822522|521407094|FG005|Overall Study|Adverse Event|1|||
144602481|NCT01822522|521407089|FG000|Overall Study|Death|3|||
144602482|NCT01822522|521407090|FG001|Overall Study|Death|0|||
144602483|NCT01822522|521407091|FG002|Overall Study|Death|2|||
144602484|NCT01822522|521407092|FG003|Overall Study|Death|0|||
144602485|NCT01822522|521407093|FG004|Overall Study|Death|0|||
144602486|NCT01822522|521407094|FG005|Overall Study|Death|0|||
144602487|NCT01822522|521407089|FG000|Overall Study|Lost to Follow-up|0|||
144602488|NCT01822522|521407090|FG001|Overall Study|Lost to Follow-up|0|||
144602489|NCT01822522|521407091|FG002|Overall Study|Lost to Follow-up|1|||
144602490|NCT01822522|521407092|FG003|Overall Study|Lost to Follow-up|1|||
144602491|NCT01822522|521407093|FG004|Overall Study|Lost to Follow-up|0|||
144602492|NCT01822522|521407094|FG005|Overall Study|Lost to Follow-up|1|||
144602493|NCT01822522|521407089|FG000|Overall Study|Withdrawal by Subject|0|||
144602494|NCT01822522|521407090|FG001|Overall Study|Withdrawal by Subject|0|||
144602495|NCT01822522|521407091|FG002|Overall Study|Withdrawal by Subject|0|||
144602496|NCT01822522|521407092|FG003|Overall Study|Withdrawal by Subject|1|||
144602497|NCT01822522|521407093|FG004|Overall Study|Withdrawal by Subject|0|||
144602498|NCT01822522|521407094|FG005|Overall Study|Withdrawal by Subject|0|||
144602499|NCT01822522|521407089|FG000|Overall Study|Lack of Efficacy|0|||
144602500|NCT01822522|521407090|FG001|Overall Study|Lack of Efficacy|0|||
144602501|NCT01822522|521407091|FG002|Overall Study|Lack of Efficacy|0|||
144602502|NCT01822522|521407092|FG003|Overall Study|Lack of Efficacy|0|||
144602503|NCT01822522|521407093|FG004|Overall Study|Lack of Efficacy|0|||
144602504|NCT01822522|521407094|FG005|Overall Study|Lack of Efficacy|2|||
144602505|NCT00685685|521407095|FG000|Washout Period of 7 Days|Adverse Event|2|||
144602506|NCT00685685|521407096|FG001|Washout Period of 7 Days|Adverse Event|0|||
144602507|NCT00685685|521407095|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
144602508|NCT00685685|521407096|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144602509|NCT04029116|521407097|FG000|Overall Study|Adverse Event|0|||
144602510|NCT04029116|521407098|FG001|Overall Study|Adverse Event|2|||
144602511|NCT04029116|521407097|FG000|Overall Study|Lost to Follow-up|3|||
144602512|NCT04029116|521407098|FG001|Overall Study|Lost to Follow-up|5|||
144602513|NCT04029116|521407097|FG000|Overall Study|Physician Decision|2|||
144602514|NCT04029116|521407098|FG001|Overall Study|Physician Decision|0|||
144602515|NCT04029116|521407097|FG000|Overall Study|Pregnancy|1|||
144602516|NCT04029116|521407098|FG001|Overall Study|Pregnancy|2|||
144602517|NCT04029116|521407097|FG000|Overall Study|Withdrawal by Subject|4|||
144602518|NCT04029116|521407098|FG001|Overall Study|Withdrawal by Subject|6|||
144602519|NCT04029116|521407097|FG000|Overall Study|Other|2|||
144602520|NCT04029116|521407098|FG001|Overall Study|Other|1|||
144602521|NCT02469896|521407099|FG000|Overall Study|Withdrawal by Subject|2|||
144602522|NCT02469896|521407100|FG001|Overall Study|Withdrawal by Subject|0|||
144602523|NCT01294150|521407101|FG000|Overall Study|Physician Decision|2|||
144602524|NCT01294150|521407102|FG001|Overall Study|Physician Decision|2|||
144602525|NCT03675776|521407103|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
144602526|NCT03675776|521407104|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
144602527|NCT03675776|521407105|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
144602528|NCT03675776|521407103|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
144602529|NCT03675776|521407104|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
144602530|NCT03675776|521407105|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
144602531|NCT04513665|521407106|FG000|Overall Study|Adverse Event|2|||
144602532|NCT04513665|521407107|FG001|Overall Study|Adverse Event|0|||
144602533|NCT04513665|521407106|FG000|Overall Study|Lack of Efficacy|14|||
144602534|NCT04513665|521407107|FG001|Overall Study|Lack of Efficacy|0|||
144602535|NCT02742766|521407110|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602536|NCT02742766|521407111|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602537|NCT02742766|521407112|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602538|NCT02742766|521407113|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602539|NCT02742766|521407114|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602540|NCT02742766|521407115|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602541|NCT02742766|521407116|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602542|NCT02742766|521407117|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144723416|NCT00329602|521842338|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
144602543|NCT02742766|521407118|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602544|NCT02742766|521407119|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602545|NCT02742766|521407120|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602546|NCT02742766|521407121|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602547|NCT02742766|521407122|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144723417|NCT00329602|521842336|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
144602548|NCT02742766|521407123|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
144602549|NCT02742766|521407124|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602550|NCT02742766|521407125|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602551|NCT02742766|521407126|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602552|NCT02742766|521407127|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144602553|NCT02742766|521407128|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
144425058|NCT00642941|520763312|FG003|Overall Study|Disease progression|36|||
144425059|NCT00642941|520763313|FG004|Overall Study|Disease progression|23|||
144602554|NCT02742766|521407110|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602555|NCT02742766|521407111|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602556|NCT02742766|521407112|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602557|NCT02742766|521407113|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
144251726|NCT04942210|520120833|FG000|Overall Study|Withdrawal by Subject|5|||
144251727|NCT04942210|520120834|FG001|Overall Study|Withdrawal by Subject|2|||
144251728|NCT04942210|520120833|FG000|Overall Study|Lost to Follow-up|16|||
144251729|NCT04942210|520120834|FG001|Overall Study|Lost to Follow-up|7|||
144251730|NCT04942210|520120833|FG000|Overall Study|Ongoing at the time of DBL date|60|||
144251731|NCT04942210|520120834|FG001|Overall Study|Ongoing at the time of DBL date|25|||
144251732|NCT04942210|520120833|FG000|Overall Study|Randomized but did not receive vaccination|3|||
144251733|NCT04942210|520120834|FG001|Overall Study|Randomized but did not receive vaccination|0|||
144251734|NCT05697627|520120835|FG000|Overall Study|Adverse Event|1|||
144251735|NCT01038752|520120838|FG000|Overall Study|Tumor Progression|2|||
144251736|NCT01038752|520120839|FG001|Overall Study|Tumor Progression|2|||
144251737|NCT01038752|520120838|FG000|Overall Study|Lost to Follow-up|3|||
144251738|NCT01038752|520120839|FG001|Overall Study|Lost to Follow-up|3|||
144251739|NCT04933617|520120844|FG000|Dose Escalation|Early closure of study|0|||
144251740|NCT04933617|520120845|FG001|Dose Escalation|Early closure of study|3|||
144251741|NCT04933617|520120846|FG002|Dose Escalation|Early closure of study|0|||
144251742|NCT04933617|520120847|FG003|Dose Escalation|Early closure of study|0|||
144251743|NCT04933617|520120848|FG004|Dose Escalation|Early closure of study|0|||
144251744|NCT02191046|520120858|FG000|Overall Study|low compliance|5|||
144602558|NCT02742766|521407114|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602559|NCT02742766|521407115|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602560|NCT02742766|521407116|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602561|NCT02742766|521407117|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602562|NCT02742766|521407118|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602563|NCT02742766|521407119|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602564|NCT02742766|521407120|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602565|NCT02742766|521407121|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602566|NCT02742766|521407122|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
144602567|NCT02742766|521407123|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
144602568|NCT02742766|521407124|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602569|NCT02742766|521407125|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
144602570|NCT02742766|521407126|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602571|NCT02742766|521407127|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602572|NCT02742766|521407128|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
144602573|NCT03739437|521407131|FG000|Overall Study|Lost to Follow-up|2|||
144602574|NCT03739437|521407132|FG001|Overall Study|Lost to Follow-up|5|||
144602575|NCT01351623|521407133|FG000|Overall Study|Protocol Violation|2|||
144602576|NCT01351623|521407133|FG000|Overall Study|Adverse Event|4|||
144602577|NCT01351623|521407133|FG000|Overall Study|Withdrawal by Subject|1|||
144602578|NCT01351623|521407133|FG000|Overall Study|Death|2|||
144602579|NCT04201821|521407137|FG000|Overall Study|Withdrawal by Subject|2|||
144602580|NCT01130974|521407138|FG000|Overall Study|Protocol Violation|10|||
144602581|NCT01130974|521407139|FG001|Overall Study|Protocol Violation|10|||
144602582|NCT01130974|521407138|FG000|Overall Study|Withdrawal by Subject|0|||
144602583|NCT01130974|521407139|FG001|Overall Study|Withdrawal by Subject|1|||
144602584|NCT01130974|521407138|FG000|Overall Study|Ineligibility criteria|5|||
144602585|NCT01130974|521407139|FG001|Overall Study|Ineligibility criteria|2|||
144602586|NCT01395316|521407140|FG000|Overall Study|Lost to Follow-up|2|||
144602587|NCT01395316|521407140|FG000|Overall Study|poor MRI quality|1|||
144602588|NCT03359590|521407144|FG000|First Intervention|Withdrawal by Subject|1|||
144251745|NCT02191046|520120859|FG001|Overall Study|low compliance|1|||
144251746|NCT01964716|520120860|FG000|Overall Study|Withdrawal by Subject|2|||
144251747|NCT01964716|520120861|FG001|Overall Study|Withdrawal by Subject|3|||
144251748|NCT01964716|520120860|FG000|Overall Study|Lost to Follow-up|1|||
144251749|NCT01964716|520120861|FG001|Overall Study|Lost to Follow-up|2|||
144251750|NCT01964716|520120860|FG000|Overall Study|No longer met eligibility criteria|1|||
144251751|NCT01964716|520120861|FG001|Overall Study|No longer met eligibility criteria|1|||
144723418|NCT00329602|521842337|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
144723419|NCT00329602|521842338|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
144251752|NCT01964716|520120860|FG000|Overall Study|Death|1|||
144251753|NCT01964716|520120861|FG001|Overall Study|Death|0|||
144251754|NCT01119846|520120870|FG000|Overall Study|Adverse Event|1|||
144425060|NCT00642941|520763314|FG005|Overall Study|Disease progression|39|||
144602589|NCT03359590|521407145|FG001|First Intervention|Withdrawal by Subject|1|||
144602590|NCT03359590|521407144|FG000|First Intervention|Protocol Violation|0|||
144251755|NCT01119846|520120871|FG001|Overall Study|Adverse Event|0|||
144251756|NCT01119846|520120872|FG002|Overall Study|Adverse Event|6|||
144602591|NCT03359590|521407145|FG001|First Intervention|Protocol Violation|1|||
144602592|NCT06132425|521407147|FG000|Overall Study|Withdrawal by Subject|3|||
144602593|NCT06132425|521407148|FG001|Overall Study|Withdrawal by Subject|0|||
144425061|NCT00642941|520763315|FG006|Overall Study|Disease progression|18|||
144425062|NCT00642941|520763316|FG007|Overall Study|Disease progression|12|||
144425063|NCT00642941|520763317|FG008|Overall Study|Disease progression|10|||
144425064|NCT00642941|520763318|FG009|Overall Study|Disease progression|7|||
144425065|NCT00642941|520763319|FG010|Overall Study|Disease progression|12|||
144425066|NCT00642941|520763320|FG011|Overall Study|Disease progression|7|||
144425067|NCT03051607|520763321|FG000|Overall Study|Adverse Event|66|||
144528501|NCT01928394|521139076|FG003|Treatment Period|other reason|0|||
144528502|NCT01928394|521139077|FG004|Treatment Period|other reason|0|||
144602594|NCT06132425|521407147|FG000|Overall Study|Did not follow study instructions|0|||
144602595|NCT06132425|521407148|FG001|Overall Study|Did not follow study instructions|2|||
144602596|NCT06132425|521407147|FG000|Overall Study|Lost to Follow-up|3|||
144602597|NCT06132425|521407148|FG001|Overall Study|Lost to Follow-up|5|||
144602598|NCT02446600|521407151|FG000|Overall Study|Never treated|20|||
144602599|NCT02446600|521407152|FG001|Overall Study|Never treated|2|||
144602600|NCT02446600|521407153|FG002|Overall Study|Never treated|6|||
144602601|NCT02446600|521407154|FG003|Overall Study|Never treated|0|||
144602602|NCT02446600|521407151|FG000|Overall Study|Withdrawal by Subject|19|||
144602603|NCT02446600|521407152|FG001|Overall Study|Withdrawal by Subject|5|||
144528503|NCT01928394|521139078|FG005|Treatment Period|other reason|0|||
144528504|NCT01928394|521139079|FG006|Treatment Period|other reason|0|||
144528505|NCT01928394|521139080|FG007|Treatment Period|other reason|0|||
144528506|NCT01928394|521139081|FG008|Treatment Period|other reason|0|||
144528507|NCT01928394|521139082|FG009|Treatment Period|other reason|0|||
144528508|NCT01928394|521139083|FG010|Treatment Period|other reason|1|||
144528509|NCT01928394|521139084|FG011|Treatment Period|other reason|1|||
144528510|NCT01928394|521139085|FG012|Treatment Period|other reason|1|||
144528511|NCT01928394|521139086|FG013|Treatment Period|other reason|0|||
144528512|NCT01928394|521139087|FG014|Treatment Period|other reason|1|||
144528513|NCT01928394|521139088|FG015|Treatment Period|other reason|0|||
144602604|NCT02446600|521407153|FG002|Overall Study|Withdrawal by Subject|17|||
144602605|NCT02446600|521407154|FG003|Overall Study|Withdrawal by Subject|0|||
144602606|NCT02446600|521407151|FG000|Overall Study|Ineligible|1|||
144602607|NCT02446600|521407152|FG001|Overall Study|Ineligible|4|||
144602608|NCT02446600|521407153|FG002|Overall Study|Ineligible|4|||
144602609|NCT02446600|521407154|FG003|Overall Study|Ineligible|1|||
144528514|NCT01928394|521139089|FG016|Treatment Period|other reason|0|||
144602610|NCT02446600|521407151|FG000|Overall Study|Duplicate Enrollment|0|||
144602611|NCT02446600|521407152|FG001|Overall Study|Duplicate Enrollment|1|||
144602612|NCT02446600|521407153|FG002|Overall Study|Duplicate Enrollment|0|||
144602613|NCT02446600|521407154|FG003|Overall Study|Duplicate Enrollment|0|||
144602614|NCT04409353|521407155|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
144602615|NCT04409353|521407156|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
144602616|NCT04409353|521407157|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
144602617|NCT04409353|521407155|FG000|Overall Study|Lost to Follow-up|6|||
144602618|NCT04409353|521407156|FG001|Overall Study|Lost to Follow-up|8|||
144602619|NCT04409353|521407157|FG002|Overall Study|Lost to Follow-up|7|||
144602620|NCT04409353|521407155|FG000|Overall Study|Major surgery during participation window|4|||
144602621|NCT04409353|521407156|FG001|Overall Study|Major surgery during participation window|3|||
144602622|NCT04409353|521407157|FG002|Overall Study|Major surgery during participation window|3|||
144602623|NCT04409353|521407155|FG000|Overall Study|Life event occurred during participation window|3|||
144602624|NCT04409353|521407156|FG001|Overall Study|Life event occurred during participation window|2|||
144602625|NCT04409353|521407157|FG002|Overall Study|Life event occurred during participation window|4|||
144602626|NCT04409353|521407155|FG000|Overall Study|Lack of Efficacy|4|||
144602627|NCT04409353|521407156|FG001|Overall Study|Lack of Efficacy|1|||
144602628|NCT04409353|521407157|FG002|Overall Study|Lack of Efficacy|3|||
144602629|NCT04409353|521407155|FG000|Overall Study|Adverse Event|2|||
144602630|NCT04409353|521407156|FG001|Overall Study|Adverse Event|1|||
144602631|NCT04409353|521407157|FG002|Overall Study|Adverse Event|1|||
144602632|NCT04409353|521407155|FG000|Overall Study|Disease burden - unable to participate|0|||
144602633|NCT04409353|521407156|FG001|Overall Study|Disease burden - unable to participate|1|||
144425068|NCT03338855|520763323|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
144425069|NCT03338855|520763324|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
144425070|NCT00455429|520763325|FG000|Overall Study|Study Terminated by Sponsor|0|||
144425071|NCT00455429|520763326|FG001|Overall Study|Study Terminated by Sponsor|0|||
144528515|NCT01928394|521139090|FG017|Treatment Period|other reason|0|||
144528516|NCT01928394|521139091|FG018|Treatment Period|other reason|2|||
144528517|NCT01928394|521139092|FG019|Treatment Period|other reason|2|||
144602634|NCT04409353|521407157|FG002|Overall Study|Disease burden - unable to participate|1|||
144602635|NCT04409353|521407155|FG000|Overall Study|Intervention too complicated|1|||
144602636|NCT04409353|521407156|FG001|Overall Study|Intervention too complicated|0|||
144602637|NCT04409353|521407157|FG002|Overall Study|Intervention too complicated|1|||
144602638|NCT05390580|521407158|FG000|Overall Study|Physician Decision|3|||
144602639|NCT05390580|521407159|FG001|Overall Study|Physician Decision|2|||
144602640|NCT04014361|521407160|FG000|Period 2|Physician Decision|0|||
144602641|NCT04014361|521407161|FG001|Period 2|Physician Decision|0|||
144602642|NCT04014361|521407162|FG002|Period 2|Physician Decision|0|||
144602643|NCT04014361|521407163|FG003|Period 2|Physician Decision|1|||
144602644|NCT04014361|521407164|FG004|Period 2|Physician Decision|0|||
144602645|NCT04014361|521407165|FG005|Period 2|Physician Decision|0|||
144602646|NCT04014361|521407166|FG006|Period 2|Physician Decision|0|||
144602647|NCT04014361|521407167|FG007|Period 2|Physician Decision|0|||
144602648|NCT06308666|521407168|FG000|Overall Study|Withdrawal by Subject|1|||
144602649|NCT06308666|521407168|FG000|Overall Study|Protocol Violation|2|||
144602650|NCT01130051|521407170|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
144602651|NCT01130051|521407171|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
144602652|NCT01130051|521407170|FG000|Washout Period of 14 Days|Protocol Violation|1|||
144602653|NCT01130051|521407171|FG001|Washout Period of 14 Days|Protocol Violation|1|||
144602654|NCT01298518|521407174|FG000|Overall Study|Withdrawal by Subject|0|||
144602655|NCT01298518|521407175|FG001|Overall Study|Withdrawal by Subject|0|||
144602656|NCT01298518|521407176|FG002|Overall Study|Withdrawal by Subject|1|||
144602657|NCT03610165|521407177|FG000|Overall Study|Device didn't work|0|||
144602658|NCT03610165|521407178|FG001|Overall Study|Device didn't work|1|||
144602659|NCT02129205|521407179|FG000|Overall Study|Withdrawal by Subject|0|||
144602660|NCT02129205|521407180|FG001|Overall Study|Withdrawal by Subject|0|||
144602661|NCT02129205|521407181|FG002|Overall Study|Withdrawal by Subject|0|||
144602662|NCT02129205|521407182|FG003|Overall Study|Withdrawal by Subject|0|||
144602663|NCT02129205|521407183|FG004|Overall Study|Withdrawal by Subject|1|||
144602664|NCT02129205|521407184|FG005|Overall Study|Withdrawal by Subject|1|||
144602665|NCT02129205|521407185|FG006|Overall Study|Withdrawal by Subject|1|||
144602666|NCT02129205|521407186|FG007|Overall Study|Withdrawal by Subject|0|||
144602667|NCT02129205|521407187|FG008|Overall Study|Withdrawal by Subject|1|||
144602668|NCT02129205|521407188|FG009|Overall Study|Withdrawal by Subject|0|||
144602669|NCT02129205|521407179|FG000|Overall Study|Other|1|||
144602670|NCT02129205|521407180|FG001|Overall Study|Other|0|||
144602671|NCT02129205|521407181|FG002|Overall Study|Other|0|||
144602672|NCT02129205|521407182|FG003|Overall Study|Other|0|||
144602673|NCT02129205|521407183|FG004|Overall Study|Other|2|||
144602674|NCT02129205|521407184|FG005|Overall Study|Other|3|||
144602675|NCT02129205|521407185|FG006|Overall Study|Other|3|||
144602676|NCT02129205|521407186|FG007|Overall Study|Other|2|||
144602677|NCT02129205|521407187|FG008|Overall Study|Other|1|||
144602678|NCT02129205|521407188|FG009|Overall Study|Other|0|||
144602679|NCT04890054|521408470|FG000|Overall Study|Lost to Follow-up|202|||
144602680|NCT04890054|521408471|FG001|Overall Study|Lost to Follow-up|219|||
144602681|NCT00702845|521408479|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
144602682|NCT00702845|521408480|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
144602683|NCT00702845|521408479|FG000|Overall Study|Too high ovarian response|5|||
144602684|NCT00702845|521408480|FG001|Overall Study|Too high ovarian response|1|||
144602685|NCT00702845|521408479|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
144602686|NCT00702845|521408480|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
144602687|NCT00702845|521408479|FG000|Overall Study|Insufficient ovarian response|1|||
144602688|NCT00702845|521408480|FG001|Overall Study|Insufficient ovarian response|0|||
144602689|NCT00702845|521408479|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
144602690|NCT00702845|521408480|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
144602691|NCT00702845|521408479|FG000|Overall Study|No or abnormal fertilization|4|||
144602692|NCT00702845|521408480|FG001|Overall Study|No or abnormal fertilization|2|||
144602693|NCT00702845|521408479|FG000|Overall Study|Patient's decision|2|||
144602694|NCT00702845|521408480|FG001|Overall Study|Patient's decision|1|||
144425072|NCT00455429|520763327|FG002|Overall Study|Study Terminated by Sponsor|0|||
144425073|NCT00455429|520763328|FG003|Overall Study|Study Terminated by Sponsor|3|||
144425074|NCT00455429|520763325|FG000|Overall Study|Lost to Follow-up|1|||
144425075|NCT00455429|520763326|FG001|Overall Study|Lost to Follow-up|0|||
144425076|NCT00455429|520763327|FG002|Overall Study|Lost to Follow-up|0|||
144425077|NCT00455429|520763328|FG003|Overall Study|Lost to Follow-up|3|||
144425078|NCT00455429|520763325|FG000|Overall Study|Withdrawal by Subject|0|||
144425079|NCT00455429|520763326|FG001|Overall Study|Withdrawal by Subject|1|||
144425080|NCT00455429|520763327|FG002|Overall Study|Withdrawal by Subject|1|||
144425081|NCT00455429|520763328|FG003|Overall Study|Withdrawal by Subject|0|||
144602695|NCT00702845|521408479|FG000|Overall Study|Not randomized|0|||
144602696|NCT00702845|521408480|FG001|Overall Study|Not randomized|1|||
144602697|NCT00928564|521408484|FG000|Overall Study|Lost to Follow-up|6|||
144602698|NCT00928564|521408485|FG001|Overall Study|Lost to Follow-up|0|||
144425082|NCT00455429|520763325|FG000|Overall Study|Lack of Efficacy|0|||
144602699|NCT02973425|521408486|FG000|Overall Study|Lost to Follow-up|49|||
144602700|NCT02973425|521408487|FG001|Overall Study|Lost to Follow-up|53|||
144602701|NCT02012296|521408490|FG000|Overall Study|Lack of Efficacy|0|||
144602702|NCT02012296|521408491|FG001|Overall Study|Lack of Efficacy|0|||
144602703|NCT02012296|521408492|FG002|Overall Study|Lack of Efficacy|15|||
144602704|NCT02012296|521408490|FG000|Overall Study|Adverse Event|0|||
144602705|NCT02012296|521408491|FG001|Overall Study|Adverse Event|0|||
144425083|NCT00455429|520763326|FG001|Overall Study|Lack of Efficacy|1|||
144425084|NCT00455429|520763327|FG002|Overall Study|Lack of Efficacy|0|||
144602706|NCT02012296|521408492|FG002|Overall Study|Adverse Event|2|||
144602707|NCT02012296|521408490|FG000|Overall Study|Early study closure|0|||
144425085|NCT00455429|520763328|FG003|Overall Study|Lack of Efficacy|1|||
144425086|NCT00455429|520763325|FG000|Overall Study|Adverse Event|0|||
144425087|NCT00455429|520763326|FG001|Overall Study|Adverse Event|1|||
144425088|NCT00455429|520763327|FG002|Overall Study|Adverse Event|0|||
144425089|NCT00455429|520763328|FG003|Overall Study|Adverse Event|3|||
144425090|NCT00455429|520763325|FG000|Overall Study|Randomly assigned but not treated|0|||
144425091|NCT00455429|520763326|FG001|Overall Study|Randomly assigned but not treated|0|||
144425092|NCT00455429|520763327|FG002|Overall Study|Randomly assigned but not treated|0|||
144425093|NCT00455429|520763328|FG003|Overall Study|Randomly assigned but not treated|2|||
144425094|NCT00455429|520763325|FG000|Overall Study|Personal Reason|1|||
144425095|NCT00455429|520763326|FG001|Overall Study|Personal Reason|0|||
144425096|NCT00455429|520763327|FG002|Overall Study|Personal Reason|0|||
144425097|NCT00455429|520763328|FG003|Overall Study|Personal Reason|0|||
144425098|NCT00455429|520763325|FG000|Overall Study|Non-compliance|0|||
144425099|NCT00455429|520763326|FG001|Overall Study|Non-compliance|0|||
144425100|NCT00455429|520763327|FG002|Overall Study|Non-compliance|0|||
144425101|NCT00455429|520763328|FG003|Overall Study|Non-compliance|1|||
144425102|NCT00455429|520763325|FG000|Overall Study|Other|0|||
144425103|NCT00455429|520763326|FG001|Overall Study|Other|2|||
144425104|NCT00455429|520763327|FG002|Overall Study|Other|0|||
144425105|NCT00455429|520763328|FG003|Overall Study|Other|1|||
144425106|NCT02226003|520763333|FG000|Overall Study|Lost to Follow-up|2|||
144425107|NCT02226003|520763334|FG001|Overall Study|Lost to Follow-up|1|||
144425108|NCT02226003|520763335|FG002|Overall Study|Lost to Follow-up|3|||
144425109|NCT02226003|520763333|FG000|Overall Study|Withdrawal by Subject|0|||
144425110|NCT02226003|520763334|FG001|Overall Study|Withdrawal by Subject|0|||
144425111|NCT02226003|520763335|FG002|Overall Study|Withdrawal by Subject|3|||
144425112|NCT03658538|520763338|FG000|Overall Study|Death|2|||
144425113|NCT03658538|520763339|FG001|Overall Study|Death|1|||
144425114|NCT03658538|520763338|FG000|Overall Study|Cancer diagnosis|1|||
144425115|NCT03658538|520763339|FG001|Overall Study|Cancer diagnosis|0|||
144425116|NCT03658538|520763338|FG000|Overall Study|Change residence|1|||
144425117|NCT03658538|520763339|FG001|Overall Study|Change residence|2|||
144528518|NCT01928394|521139093|FG020|Treatment Period|other reason|0|||
144528519|NCT01928394|521139094|FG021|Treatment Period|other reason|0|||
144528520|NCT01928394|521139095|FG022|Treatment Period|other reason|0|||
144528521|NCT01928394|521139073|FG000|Treatment Period|Maximum clinical benefit|0|||
144528522|NCT01928394|521139074|FG001|Treatment Period|Maximum clinical benefit|0|||
144528523|NCT01928394|521139075|FG002|Treatment Period|Maximum clinical benefit|0|||
144528524|NCT01928394|521139076|FG003|Treatment Period|Maximum clinical benefit|0|||
144528525|NCT01928394|521139077|FG004|Treatment Period|Maximum clinical benefit|0|||
144528526|NCT01928394|521139078|FG005|Treatment Period|Maximum clinical benefit|0|||
144528527|NCT01928394|521139079|FG006|Treatment Period|Maximum clinical benefit|0|||
144528528|NCT01928394|521139080|FG007|Treatment Period|Maximum clinical benefit|0|||
144528529|NCT01928394|521139081|FG008|Treatment Period|Maximum clinical benefit|0|||
144528530|NCT01928394|521139082|FG009|Treatment Period|Maximum clinical benefit|0|||
144528531|NCT01928394|521139083|FG010|Treatment Period|Maximum clinical benefit|1|||
144528532|NCT01928394|521139084|FG011|Treatment Period|Maximum clinical benefit|1|||
144528533|NCT01928394|521139085|FG012|Treatment Period|Maximum clinical benefit|0|||
144528534|NCT01928394|521139086|FG013|Treatment Period|Maximum clinical benefit|0|||
144528535|NCT01928394|521139087|FG014|Treatment Period|Maximum clinical benefit|1|||
144528536|NCT01928394|521139088|FG015|Treatment Period|Maximum clinical benefit|0|||
144528537|NCT01928394|521139089|FG016|Treatment Period|Maximum clinical benefit|0|||
144528538|NCT01928394|521139090|FG017|Treatment Period|Maximum clinical benefit|1|||
144528539|NCT01928394|521139091|FG018|Treatment Period|Maximum clinical benefit|1|||
144528540|NCT01928394|521139092|FG019|Treatment Period|Maximum clinical benefit|0|||
144602708|NCT02012296|521408491|FG001|Overall Study|Early study closure|0|||
144602709|NCT02012296|521408492|FG002|Overall Study|Early study closure|5|||
144602710|NCT02012296|521408490|FG000|Overall Study|Protocol Violation|0|||
144602711|NCT02012296|521408491|FG001|Overall Study|Protocol Violation|1|||
144602712|NCT02012296|521408492|FG002|Overall Study|Protocol Violation|0|||
144602713|NCT01448213|521408493|FG000|Overall Study|Lost to Follow-up|12|||
144602714|NCT01448213|521408494|FG001|Overall Study|Lost to Follow-up|10|||
144602715|NCT01448213|521408493|FG000|Overall Study|Adverse Event|4|||
144602716|NCT01448213|521408494|FG001|Overall Study|Adverse Event|10|||
144602717|NCT01448213|521408493|FG000|Overall Study|Protocol Violation|1|||
144602718|NCT01448213|521408494|FG001|Overall Study|Protocol Violation|2|||
144602719|NCT01330914|521408495|FG000|Overall Study|Withdrawal by Subject|4|||
144602720|NCT01330914|521408495|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
144602721|NCT03503513|521408496|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
144425118|NCT03658538|520763338|FG000|Overall Study|Lost to Follow-up|3|||
144425119|NCT03658538|520763339|FG001|Overall Study|Lost to Follow-up|3|||
144425120|NCT03658538|520763338|FG000|Overall Study|Unblinded|2|||
144425121|NCT03658538|520763339|FG001|Overall Study|Unblinded|3|||
144425122|NCT03658538|520763338|FG000|Overall Study|Physician Decision|0|||
144528541|NCT01928394|521139093|FG020|Treatment Period|Maximum clinical benefit|2|||
144528542|NCT01928394|521139094|FG021|Treatment Period|Maximum clinical benefit|0|||
144602722|NCT03503513|521408496|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
144602723|NCT03503513|521408496|FG000|Overall Study|Physician Decision|3|||
144602724|NCT03503513|521408496|FG000|Overall Study|Withdrawal by Subject|2|||
144602725|NCT03503513|521408496|FG000|Overall Study|Lost to Follow-up|1|||
144602726|NCT02294682|521408499|FG000|Overall Study|Could not swallow pills|1|||
144602727|NCT02294682|521408500|FG001|Overall Study|Could not swallow pills|0|||
144602728|NCT01754857|521408501|FG000|Overall Study|Adverse Event|7|||
144602729|NCT01754857|521408501|FG000|Overall Study|Disease progression|3|||
144602730|NCT01754857|521408501|FG000|Overall Study|Physician Decision|2|||
144602731|NCT01754857|521408501|FG000|Overall Study|Withdrawal by Subject|3|||
144602732|NCT01754857|521408501|FG000|Overall Study|other complicating disease|1|||
144602733|NCT01754857|521408501|FG000|Overall Study|ineligible to continue onto maintenance|1|||
144602734|NCT01754857|521408501|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
144602735|NCT01754857|521408501|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
144602736|NCT00059839|521408504|FG000|Overall Study|Death|1|||
144602737|NCT00059839|521408505|FG001|Overall Study|Death|1|||
144602738|NCT00059839|521408504|FG000|Overall Study|Lack of Efficacy|6|||
144602739|NCT00059839|521408505|FG001|Overall Study|Lack of Efficacy|5|||
144602740|NCT00059839|521408504|FG000|Overall Study|Lost to Follow-up|2|||
144602741|NCT00059839|521408505|FG001|Overall Study|Lost to Follow-up|0|||
144602742|NCT00059839|521408504|FG000|Overall Study|Physician Decision|1|||
144602743|NCT00059839|521408505|FG001|Overall Study|Physician Decision|2|||
144602744|NCT00059839|521408504|FG000|Overall Study|Withdrawal by Subject|1|||
144602745|NCT00059839|521408505|FG001|Overall Study|Withdrawal by Subject|6|||
144602746|NCT00059839|521408504|FG000|Overall Study|Ineligible|1|||
144602747|NCT00059839|521408505|FG001|Overall Study|Ineligible|3|||
144425123|NCT03658538|520763339|FG001|Overall Study|Physician Decision|1|||
144425124|NCT03658538|520763338|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
144425125|NCT03658538|520763339|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
144425126|NCT03658538|520763338|FG000|Overall Study|Evicted from home|1|||
144425127|NCT03658538|520763339|FG001|Overall Study|Evicted from home|0|||
144425128|NCT00410761|520765234|FG000|Randomized Treatment Period|Adverse Event|34|||
144425129|NCT00410761|520765235|FG001|Randomized Treatment Period|Adverse Event|3|||
144425130|NCT00410761|520765234|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
144425131|NCT00410761|520765235|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
144425132|NCT00410761|520765234|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
144425133|NCT00410761|520765235|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
144425134|NCT00410761|520765234|FG000|Randomized Treatment Period|Other|69|||
144425135|NCT00410761|520765235|FG001|Randomized Treatment Period|Other|21|||
144425136|NCT00410761|520765234|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
144425137|NCT00410761|520765235|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
144425138|NCT00410761|520765234|FG000|Open-Label Treatment Period|Adverse Event|13|||
144425139|NCT00410761|520765235|FG001|Open-Label Treatment Period|Adverse Event|15|||
144425140|NCT00410761|520765234|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
144425141|NCT00410761|520765235|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
144425142|NCT00410761|520765234|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
144425143|NCT00410761|520765235|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
144425144|NCT00410761|520765234|FG000|Open-Label Treatment Period|Other|18|||
144425145|NCT00410761|520765235|FG001|Open-Label Treatment Period|Other|9|||
144425146|NCT03712904|520765237|FG000|Overall Study|Death|0|||
144425147|NCT03712904|520765238|FG001|Overall Study|Death|1|||
144425148|NCT03712904|520765237|FG000|Overall Study|Withdrawal by Subject|0|||
144425149|NCT03712904|520765238|FG001|Overall Study|Withdrawal by Subject|1|||
144425150|NCT03712904|520765237|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
144425151|NCT03712904|520765238|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
144425152|NCT00542919|520765244|FG000|Overall Study|Adverse Event|1|||
144425153|NCT00542919|520765245|FG001|Overall Study|Adverse Event|5|||
144425154|NCT00542919|520765246|FG002|Overall Study|Adverse Event|1|||
144425155|NCT00542919|520765244|FG000|Overall Study|Withdrawal by Subject|1|||
144425156|NCT00542919|520765245|FG001|Overall Study|Withdrawal by Subject|0|||
144425157|NCT00542919|520765246|FG002|Overall Study|Withdrawal by Subject|3|||
144425158|NCT00542919|520765244|FG000|Overall Study|Physician Decision|2|||
144425159|NCT00542919|520765245|FG001|Overall Study|Physician Decision|2|||
144425160|NCT00542919|520765246|FG002|Overall Study|Physician Decision|1|||
144602748|NCT03842163|521408506|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
144602749|NCT03842163|521408506|FG000|Overall Study|Scintigraphy was not performed|44|||
144602750|NCT03829241|521408507|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
144602751|NCT03829241|521408508|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
144182266|NCT01567527|519862275|FG001|Conversion Phase.|Adverse Event|0|||
144602752|NCT03829241|521408507|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
144602753|NCT03829241|521408508|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
144602754|NCT03829241|521408507|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
144425161|NCT00542919|520765244|FG000|Overall Study|Sponsor Decision|1|||
144425162|NCT00542919|520765245|FG001|Overall Study|Sponsor Decision|0|||
144425163|NCT00542919|520765246|FG002|Overall Study|Sponsor Decision|0|||
144425164|NCT00542919|520765244|FG000|Overall Study|Lost to Follow-up|2|||
144425165|NCT00542919|520765245|FG001|Overall Study|Lost to Follow-up|0|||
144425166|NCT00542919|520765246|FG002|Overall Study|Lost to Follow-up|1|||
144425167|NCT01394523|520765249|FG000|Overall Study|Unable to place block|1|||
144425168|NCT01394523|520765250|FG001|Overall Study|Unable to place block|0|||
144425169|NCT01394523|520765251|FG002|Overall Study|Unable to place block|0|||
144425170|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Death|3|||
144425171|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Death|2|||
144425172|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Death|4|||
144425173|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Death|3|||
144425174|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Death|0|||
144425175|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Death|0|||
144425176|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
144425177|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
144425178|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
144425179|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
144425180|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
144425181|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
144425182|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
144425183|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
144425184|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
144425185|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
144425186|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
144425187|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
144425188|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
144425189|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
144425190|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
144425191|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
144425192|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
144425193|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
144425194|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
144425195|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
144425196|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
144425197|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
144425198|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
144425199|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
144425200|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
144425201|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
144425202|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
144425203|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
144425204|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
144425205|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
144425206|NCT02432846|520765252|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
144425207|NCT02432846|520765253|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
144425208|NCT02432846|520765254|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
144425209|NCT02432846|520765255|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
144425210|NCT02432846|520765256|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
144425211|NCT02432846|520765257|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
144425212|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
144425213|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
144425214|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
144425215|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
144425216|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
144425217|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
144425218|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
144425219|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
144425220|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
144425221|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
144425222|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
144425223|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
144425224|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
144528543|NCT01928394|521139095|FG022|Treatment Period|Maximum clinical benefit|0|||
144425225|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
144425226|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
144528544|NCT01928394|521139073|FG000|Treatment Period|Lost to Follow-up|0|||
144528545|NCT01928394|521139074|FG001|Treatment Period|Lost to Follow-up|0|||
144528546|NCT01928394|521139075|FG002|Treatment Period|Lost to Follow-up|0|||
144425227|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
144425228|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
144425229|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
144425230|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
144425231|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
144425232|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
144425233|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
144425234|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
144425235|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
144425236|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
144425237|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
144425238|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
144425239|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
144425240|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
144425241|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
144425242|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
144425243|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
144425244|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
144425245|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
144425246|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
144425247|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
144425248|NCT02432846|520765252|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
144425249|NCT02432846|520765253|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
144425250|NCT02432846|520765254|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
144425251|NCT02432846|520765255|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
144425252|NCT02432846|520765256|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
144425253|NCT02432846|520765257|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
144425254|NCT01912287|520765258|FG000|Overall Study|Ineligible|1|||
144425255|NCT01912287|520765259|FG001|Overall Study|Ineligible|0|||
144425256|NCT01912287|520765260|FG002|Overall Study|Ineligible|1|||
144425257|NCT01912287|520765258|FG000|Overall Study|No-show|0|||
144425258|NCT01912287|520765259|FG001|Overall Study|No-show|0|||
144425259|NCT01912287|520765260|FG002|Overall Study|No-show|1|||
144425260|NCT01912287|520765258|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
144425261|NCT01912287|520765259|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
144425262|NCT01912287|520765260|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
144425263|NCT01912287|520765258|FG000|Overall Study|Felt treatment no longer needed|0|||
144425264|NCT01912287|520765259|FG001|Overall Study|Felt treatment no longer needed|1|||
144425265|NCT01912287|520765260|FG002|Overall Study|Felt treatment no longer needed|0|||
144425266|NCT01912287|520765258|FG000|Overall Study|Life circumstances|4|||
144425267|NCT01912287|520765259|FG001|Overall Study|Life circumstances|2|||
144425268|NCT01912287|520765260|FG002|Overall Study|Life circumstances|0|||
144425269|NCT01912287|520765258|FG000|Overall Study|Lost Interest|1|||
144425270|NCT01912287|520765259|FG001|Overall Study|Lost Interest|0|||
144425271|NCT01912287|520765260|FG002|Overall Study|Lost Interest|0|||
144425272|NCT01912287|520765258|FG000|Overall Study|Uknown reason - subject drop out|5|||
144425273|NCT01912287|520765259|FG001|Overall Study|Uknown reason - subject drop out|7|||
144425274|NCT01912287|520765260|FG002|Overall Study|Uknown reason - subject drop out|3|||
144425275|NCT01912287|520765258|FG000|Overall Study|Missed Assesment|1|||
144425276|NCT01912287|520765259|FG001|Overall Study|Missed Assesment|1|||
144425277|NCT01912287|520765260|FG002|Overall Study|Missed Assesment|1|||
144425278|NCT01912287|520765258|FG000|Overall Study|Scheduling/change in availability|17|||
144425279|NCT01912287|520765259|FG001|Overall Study|Scheduling/change in availability|10|||
144425280|NCT01912287|520765260|FG002|Overall Study|Scheduling/change in availability|8|||
144425281|NCT03226392|520765261|FG000|Overall Study|Protocol Deviation|1|||
144425282|NCT03226392|520765262|FG001|Overall Study|Protocol Deviation|0|||
144425283|NCT03226392|520765261|FG000|Overall Study|Physician Decision|1|||
144425284|NCT03226392|520765262|FG001|Overall Study|Physician Decision|0|||
144425285|NCT03226392|520765261|FG000|Overall Study|Lost to Follow-up|1|||
144425286|NCT03226392|520765262|FG001|Overall Study|Lost to Follow-up|0|||
144425287|NCT03226392|520765261|FG000|Overall Study|Adverse Event|1|||
144425288|NCT03226392|520765262|FG001|Overall Study|Adverse Event|0|||
144425289|NCT03226392|520765261|FG000|Overall Study|Technical Problems|0|||
144425290|NCT03226392|520765262|FG001|Overall Study|Technical Problems|2|||
144425291|NCT03226392|520765261|FG000|Overall Study|Subject/Guardian Decision|7|||
144425292|NCT03226392|520765262|FG001|Overall Study|Subject/Guardian Decision|6|||
144425293|NCT04788953|520765263|FG000|Overall Study|Adverse Event|1|||
144425294|NCT04788953|520765264|FG001|Overall Study|Adverse Event|1|||
144602755|NCT03829241|521408508|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
144602756|NCT03829241|521408507|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
144251757|NCT01119846|520120870|FG000|Overall Study|Physician Decision|1|||
144251758|NCT01119846|520120871|FG001|Overall Study|Physician Decision|0|||
144425295|NCT04788953|520765263|FG000|Overall Study|Withdrawal by Subject|1|||
144425296|NCT04788953|520765264|FG001|Overall Study|Withdrawal by Subject|0|||
144425297|NCT04788953|520765263|FG000|Overall Study|Protocol Violation|0|||
144425298|NCT04788953|520765264|FG001|Overall Study|Protocol Violation|1|||
144425299|NCT00937157|520765265|FG000|Overall Study|Pregnancy|1|||
144425300|NCT00937157|520765265|FG000|Overall Study|Lost to Follow-up|3|||
144425301|NCT00469092|520765266|FG000|Overall Study|Adverse Event|5|||
144425302|NCT00469092|520765267|FG001|Overall Study|Adverse Event|4|||
144425303|NCT00469092|520765266|FG000|Overall Study|Lack of Efficacy|1|||
144425304|NCT00469092|520765267|FG001|Overall Study|Lack of Efficacy|0|||
144425305|NCT00469092|520765266|FG000|Overall Study|Lost to Follow-up|1|||
144425306|NCT00469092|520765267|FG001|Overall Study|Lost to Follow-up|2|||
144425307|NCT00469092|520765266|FG000|Overall Study|Protocol Violation|3|||
144425308|NCT00469092|520765267|FG001|Overall Study|Protocol Violation|3|||
144425309|NCT00469092|520765266|FG000|Overall Study|Withdrawal by Subject|4|||
144425310|NCT00469092|520765267|FG001|Overall Study|Withdrawal by Subject|4|||
144425311|NCT00469092|520765266|FG000|Overall Study|Withdrawal Criteria|3|||
144425312|NCT00469092|520765267|FG001|Overall Study|Withdrawal Criteria|4|||
144425313|NCT00469092|520765266|FG000|Overall Study|Incorrectly Randomised|4|||
144425314|NCT00469092|520765267|FG001|Overall Study|Incorrectly Randomised|3|||
144425315|NCT00469092|520765266|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
144425316|NCT00469092|520765267|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
144425317|NCT00469092|520765266|FG000|Overall Study|Use of lipid lowering drug|1|||
144425318|NCT00469092|520765267|FG001|Overall Study|Use of lipid lowering drug|0|||
144425319|NCT00469092|520765266|FG000|Overall Study|Hypoglycaemic Episodes|1|||
144425320|NCT00469092|520765267|FG001|Overall Study|Hypoglycaemic Episodes|1|||
144528547|NCT01928394|521139076|FG003|Treatment Period|Lost to Follow-up|0|||
144528548|NCT01928394|521139077|FG004|Treatment Period|Lost to Follow-up|0|||
144528549|NCT01928394|521139078|FG005|Treatment Period|Lost to Follow-up|0|||
144528550|NCT01928394|521139079|FG006|Treatment Period|Lost to Follow-up|0|||
144528551|NCT01928394|521139080|FG007|Treatment Period|Lost to Follow-up|0|||
144528552|NCT01928394|521139081|FG008|Treatment Period|Lost to Follow-up|0|||
144528553|NCT01928394|521139082|FG009|Treatment Period|Lost to Follow-up|0|||
144528554|NCT01928394|521139083|FG010|Treatment Period|Lost to Follow-up|0|||
144528555|NCT01928394|521139084|FG011|Treatment Period|Lost to Follow-up|0|||
144528556|NCT01928394|521139085|FG012|Treatment Period|Lost to Follow-up|0|||
144528557|NCT01928394|521139086|FG013|Treatment Period|Lost to Follow-up|0|||
144528558|NCT01928394|521139087|FG014|Treatment Period|Lost to Follow-up|0|||
144528559|NCT01928394|521139088|FG015|Treatment Period|Lost to Follow-up|0|||
144528560|NCT01928394|521139089|FG016|Treatment Period|Lost to Follow-up|0|||
144528561|NCT01928394|521139090|FG017|Treatment Period|Lost to Follow-up|0|||
144528562|NCT01928394|521139091|FG018|Treatment Period|Lost to Follow-up|0|||
144528563|NCT01928394|521139092|FG019|Treatment Period|Lost to Follow-up|0|||
144528564|NCT01928394|521139093|FG020|Treatment Period|Lost to Follow-up|0|||
144528565|NCT01928394|521139094|FG021|Treatment Period|Lost to Follow-up|0|||
144528566|NCT01928394|521139095|FG022|Treatment Period|Lost to Follow-up|1|||
144528567|NCT01928394|521139073|FG000|Treatment Period|Death|0|||
144528568|NCT01928394|521139074|FG001|Treatment Period|Death|0|||
144528569|NCT01928394|521139075|FG002|Treatment Period|Death|0|||
144528570|NCT01928394|521139076|FG003|Treatment Period|Death|0|||
144528571|NCT01928394|521139077|FG004|Treatment Period|Death|0|||
144528572|NCT01928394|521139078|FG005|Treatment Period|Death|0|||
144528573|NCT01928394|521139079|FG006|Treatment Period|Death|0|||
144528574|NCT01928394|521139080|FG007|Treatment Period|Death|0|||
144528575|NCT01928394|521139081|FG008|Treatment Period|Death|0|||
144528576|NCT01928394|521139082|FG009|Treatment Period|Death|0|||
144528577|NCT01928394|521139083|FG010|Treatment Period|Death|0|||
144528578|NCT01928394|521139084|FG011|Treatment Period|Death|0|||
144528579|NCT01928394|521139085|FG012|Treatment Period|Death|0|||
144528580|NCT01928394|521139086|FG013|Treatment Period|Death|1|||
144528581|NCT01928394|521139087|FG014|Treatment Period|Death|2|||
144528582|NCT01928394|521139088|FG015|Treatment Period|Death|0|||
144528583|NCT01928394|521139089|FG016|Treatment Period|Death|0|||
144528584|NCT01928394|521139090|FG017|Treatment Period|Death|0|||
144602757|NCT03829241|521408508|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
144528585|NCT01928394|521139091|FG018|Treatment Period|Death|0|||
144528586|NCT01928394|521139092|FG019|Treatment Period|Death|0|||
144528587|NCT01928394|521139093|FG020|Treatment Period|Death|0|||
144528588|NCT01928394|521139094|FG021|Treatment Period|Death|0|||
144528589|NCT01928394|521139095|FG022|Treatment Period|Death|0|||
144528590|NCT01928394|521139073|FG000|Follow-up Period|Participant withdrew consent|3|||
144528591|NCT01928394|521139074|FG001|Follow-up Period|Participant withdrew consent|0|||
144425321|NCT00469092|520765266|FG000|Overall Study|Abnormal lab value|1|||
144425322|NCT00469092|520765267|FG001|Overall Study|Abnormal lab value|0|||
144528592|NCT01928394|521139075|FG002|Follow-up Period|Participant withdrew consent|1|||
144528593|NCT01928394|521139076|FG003|Follow-up Period|Participant withdrew consent|4|||
144528594|NCT01928394|521139077|FG004|Follow-up Period|Participant withdrew consent|0|||
144602758|NCT03829241|521408507|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
144602759|NCT03829241|521408508|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
144602760|NCT03829241|521408507|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
144602761|NCT03829241|521408508|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
144602762|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
144602763|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
144602764|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
144602765|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
144602766|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
144602767|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
144602768|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
144602769|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
144602770|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
144602771|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
144602772|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
144602773|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
144602774|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
144602775|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
144602776|NCT03829241|521408507|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
144602777|NCT03829241|521408508|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
144602778|NCT03083847|521408509|FG000|Main|Physician Decision|0|||
144602779|NCT03083847|521408510|FG001|Main|Physician Decision|0|||
144602780|NCT03083847|521408511|FG002|Main|Physician Decision|0|||
144602781|NCT03083847|521408512|FG003|Main|Physician Decision|0|||
144602782|NCT03083847|521408513|FG004|Main|Physician Decision|0|||
144602783|NCT03083847|521408514|FG005|Main|Physician Decision|1|||
144602784|NCT03083847|521408515|FG006|Main|Physician Decision|0|||
144602785|NCT03083847|521408516|FG007|Main|Physician Decision|0|||
144602786|NCT03083847|521408517|FG008|Main|Physician Decision|0|||
144602787|NCT03083847|521408518|FG009|Main|Physician Decision|0|||
144602788|NCT03083847|521408509|FG000|Main|Pregnancy|0|||
144602789|NCT03083847|521408510|FG001|Main|Pregnancy|0|||
144602790|NCT03083847|521408511|FG002|Main|Pregnancy|0|||
144602791|NCT03083847|521408512|FG003|Main|Pregnancy|0|||
144602792|NCT03083847|521408513|FG004|Main|Pregnancy|0|||
144602793|NCT03083847|521408514|FG005|Main|Pregnancy|0|||
144602794|NCT03083847|521408515|FG006|Main|Pregnancy|0|||
144602795|NCT03083847|521408516|FG007|Main|Pregnancy|1|||
144602796|NCT03083847|521408517|FG008|Main|Pregnancy|0|||
144602797|NCT03083847|521408518|FG009|Main|Pregnancy|0|||
144602798|NCT03083847|521408509|FG000|Main|Adverse Event|0|||
144602799|NCT03083847|521408510|FG001|Main|Adverse Event|0|||
144602800|NCT03083847|521408511|FG002|Main|Adverse Event|0|||
144602801|NCT03083847|521408512|FG003|Main|Adverse Event|0|||
144602802|NCT03083847|521408513|FG004|Main|Adverse Event|0|||
144602803|NCT03083847|521408514|FG005|Main|Adverse Event|0|||
144602804|NCT03083847|521408515|FG006|Main|Adverse Event|0|||
144602805|NCT03083847|521408516|FG007|Main|Adverse Event|2|||
144602806|NCT03083847|521408517|FG008|Main|Adverse Event|0|||
144425323|NCT00469092|520765266|FG000|Overall Study|Use of Corticosteroid|1|||
144425324|NCT00469092|520765267|FG001|Overall Study|Use of Corticosteroid|0|||
144425325|NCT02150954|520765268|FG000|Overall Study|Protocol Violation|1|||
144425326|NCT02150954|520765269|FG001|Overall Study|Protocol Violation|0|||
144425327|NCT01998633|520765270|FG000|Overall Study|Death|1|||
144425328|NCT02631850|520765271|FG000|Treatment Period|Lost to Follow-up|0|||
144425329|NCT02631850|520765272|FG001|Treatment Period|Lost to Follow-up|1|||
144425330|NCT02631850|520765273|FG002|Treatment Period|Lost to Follow-up|0|||
144425331|NCT02631850|520765274|FG003|Treatment Period|Lost to Follow-up|0|||
144425332|NCT02631850|520765271|FG000|Treatment Period|Protocol Violation|1|||
144425333|NCT02631850|520765272|FG001|Treatment Period|Protocol Violation|0|||
144425334|NCT02631850|520765273|FG002|Treatment Period|Protocol Violation|0|||
144425335|NCT02631850|520765274|FG003|Treatment Period|Protocol Violation|0|||
144425336|NCT02631850|520765271|FG000|Treatment Period|Withdrawal by Subject|0|||
144425337|NCT02631850|520765272|FG001|Treatment Period|Withdrawal by Subject|5|||
144425338|NCT02631850|520765273|FG002|Treatment Period|Withdrawal by Subject|2|||
144425339|NCT02631850|520765274|FG003|Treatment Period|Withdrawal by Subject|2|||
144425340|NCT02631850|520765271|FG000|Treatment Period|Adverse Event|1|||
144425341|NCT02631850|520765272|FG001|Treatment Period|Adverse Event|0|||
144425342|NCT02631850|520765273|FG002|Treatment Period|Adverse Event|2|||
144425343|NCT02631850|520765274|FG003|Treatment Period|Adverse Event|3|||
144425344|NCT02631850|520765271|FG000|Treatment Period|Family medical issue|1|||
144602807|NCT03083847|521408518|FG009|Main|Adverse Event|0|||
144602808|NCT03083847|521408509|FG000|Main|Withdrawal by Subject|0|||
144602809|NCT03083847|521408510|FG001|Main|Withdrawal by Subject|0|||
144602810|NCT03083847|521408511|FG002|Main|Withdrawal by Subject|0|||
144602811|NCT03083847|521408512|FG003|Main|Withdrawal by Subject|0|||
144602812|NCT03083847|521408513|FG004|Main|Withdrawal by Subject|0|||
144602813|NCT03083847|521408514|FG005|Main|Withdrawal by Subject|0|||
144425345|NCT02631850|520765272|FG001|Treatment Period|Family medical issue|0|||
144425346|NCT02631850|520765273|FG002|Treatment Period|Family medical issue|0|||
144425347|NCT02631850|520765274|FG003|Treatment Period|Family medical issue|0|||
144425348|NCT02631850|520765271|FG000|6 Month Follow up|Lost to Follow-up|5|||
144425349|NCT02631850|520765272|FG001|6 Month Follow up|Lost to Follow-up|8|||
144425350|NCT02631850|520765273|FG002|6 Month Follow up|Lost to Follow-up|3|||
144425351|NCT02631850|520765274|FG003|6 Month Follow up|Lost to Follow-up|5|||
144425352|NCT02631850|520765271|FG000|6 Month Follow up|Withdrawal by Subject|1|||
144425353|NCT02631850|520765272|FG001|6 Month Follow up|Withdrawal by Subject|0|||
144425354|NCT02631850|520765273|FG002|6 Month Follow up|Withdrawal by Subject|0|||
144425355|NCT02631850|520765274|FG003|6 Month Follow up|Withdrawal by Subject|2|||
144425356|NCT02631850|520765271|FG000|6 Month Follow up|Adverse Event|1|||
144425357|NCT02631850|520765272|FG001|6 Month Follow up|Adverse Event|4|||
144425358|NCT02631850|520765273|FG002|6 Month Follow up|Adverse Event|1|||
144425359|NCT02631850|520765274|FG003|6 Month Follow up|Adverse Event|3|||
144425360|NCT02631850|520765271|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
144425361|NCT02631850|520765272|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
144425362|NCT02631850|520765273|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
144425363|NCT02631850|520765274|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
144425364|NCT01462084|520765277|FG000|Overall Study|Withdrawal by Subject|1|||
144425365|NCT01462084|520765278|FG001|Overall Study|Withdrawal by Subject|0|||
144425366|NCT01462084|520765277|FG000|Overall Study|Protocol Violation|1|||
144425367|NCT01462084|520765278|FG001|Overall Study|Protocol Violation|1|||
144425368|NCT03992781|520765279|FG000|Overall Study|Lost to Follow-up|5|||
144425369|NCT03992781|520765279|FG000|Overall Study|Adverse Event|1|||
144425370|NCT03992781|520765279|FG000|Overall Study|Lack of Efficacy|5|||
144425371|NCT00518323|520765280|FG000|Overall Study|Lack of Efficacy|14|||
144425372|NCT00518323|520765281|FG001|Overall Study|Lack of Efficacy|2|||
144425373|NCT00518323|520765282|FG002|Overall Study|Lack of Efficacy|4|||
144425374|NCT00518323|520765283|FG003|Overall Study|Lack of Efficacy|20|||
144425375|NCT00518323|520765280|FG000|Overall Study|Withdrawal by Subject|1|||
144425376|NCT00518323|520765281|FG001|Overall Study|Withdrawal by Subject|2|||
144425377|NCT00518323|520765282|FG002|Overall Study|Withdrawal by Subject|4|||
144425378|NCT00518323|520765283|FG003|Overall Study|Withdrawal by Subject|2|||
144425379|NCT00518323|520765280|FG000|Overall Study|Lost to Follow-up|0|||
144425380|NCT00518323|520765281|FG001|Overall Study|Lost to Follow-up|2|||
144425381|NCT00518323|520765282|FG002|Overall Study|Lost to Follow-up|1|||
144425382|NCT00518323|520765283|FG003|Overall Study|Lost to Follow-up|3|||
144425383|NCT00518323|520765280|FG000|Overall Study|Adverse Event|1|||
144425384|NCT00518323|520765281|FG001|Overall Study|Adverse Event|1|||
144425385|NCT00518323|520765282|FG002|Overall Study|Adverse Event|1|||
144425386|NCT00518323|520765283|FG003|Overall Study|Adverse Event|0|||
144425387|NCT00518323|520765280|FG000|Overall Study|Prohibited medication and others|3|||
144425388|NCT00518323|520765281|FG001|Overall Study|Prohibited medication and others|1|||
144425389|NCT00518323|520765282|FG002|Overall Study|Prohibited medication and others|1|||
144425390|NCT00518323|520765283|FG003|Overall Study|Prohibited medication and others|0|||
144425391|NCT01086540|520765284|FG000|Overall Study|Death|3|||
144425392|NCT01086540|520765285|FG001|Overall Study|Death|1|||
144425393|NCT01086540|520765284|FG000|Overall Study|Physician Decision|2|||
144425394|NCT01086540|520765285|FG001|Overall Study|Physician Decision|1|||
144425395|NCT01086540|520765284|FG000|Overall Study|Addition of new therapy for PAH|1|||
144425396|NCT01086540|520765285|FG001|Overall Study|Addition of new therapy for PAH|0|||
144425397|NCT02278263|520765286|FG000|Overall Study|Protocol Violation|7|||
144425398|NCT02278263|520765287|FG001|Overall Study|Protocol Violation|0|||
144425399|NCT02278263|520765288|FG002|Overall Study|Protocol Violation|9|||
144425400|NCT03880019|520765290|FG000|Overall Study|Competing disease|1|||
144425401|NCT02092662|520765291|FG000|Overall Study|Lost to Follow-up|13|||
144425402|NCT02092662|520765292|FG001|Overall Study|Lost to Follow-up|0|||
144425403|NCT01132547|520765293|FG000|Overall Study|Withdrawal by Subject|3|||
144723420|NCT00329602|521842336|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
144723421|NCT00329602|521842337|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
144425404|NCT01132547|520765294|FG001|Overall Study|Withdrawal by Subject|1|||
144425405|NCT01132547|520765293|FG000|Overall Study|Death|1|||
144425406|NCT01132547|520765294|FG001|Overall Study|Death|0|||
144425407|NCT05811234|520765295|FG000|Overall Study|Loss of Effectiveness|2|||
144425408|NCT05811234|520765295|FG000|Overall Study|Adverse Event|4|||
144425409|NCT05811234|520765295|FG000|Overall Study|Pregnancy|1|||
144425410|NCT05811234|520765295|FG000|Overall Study|Disease progression|1|||
144723422|NCT00329602|521842338|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
144723423|NCT02275364|521842339|FG000|Period 1|Withdrawal by Subject|1|||
144602814|NCT03083847|521408515|FG006|Main|Withdrawal by Subject|1|||
144425411|NCT05811234|520765295|FG000|Overall Study|Withdrawal by Subject|4|||
144723424|NCT02275364|521842340|FG001|Period 1|Withdrawal by Subject|0|||
144723425|NCT02275364|521842339|FG000|Period 1|Other reason|1|||
144425412|NCT05811234|520765295|FG000|Overall Study|Lost to Follow-up|13|||
144425413|NCT05811234|520765295|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
144425414|NCT03424265|520765300|FG000|Overall Study|screening failure|1|||
144425415|NCT03424265|520765301|FG001|Overall Study|screening failure|0|||
144425416|NCT03424265|520765300|FG000|Overall Study|Withdrawal by Subject|0|||
144425417|NCT03424265|520765301|FG001|Overall Study|Withdrawal by Subject|2|||
144425418|NCT03447990|520765302|FG000|Overall Study|Withdrawal by Subject|0|||
144425419|NCT03447990|520765303|FG001|Overall Study|Withdrawal by Subject|0|||
144425420|NCT03447990|520765304|FG002|Overall Study|Withdrawal by Subject|0|||
144425421|NCT03447990|520765305|FG003|Overall Study|Withdrawal by Subject|0|||
144425422|NCT03447990|520765306|FG004|Overall Study|Withdrawal by Subject|0|||
144425423|NCT03447990|520765307|FG005|Overall Study|Withdrawal by Subject|0|||
144425424|NCT03447990|520765308|FG006|Overall Study|Withdrawal by Subject|1|||
144425425|NCT00238121|520765319|FG000|Overall Study|Withdrawal by Subject|1|||
144528595|NCT01928394|521139078|FG005|Follow-up Period|Participant withdrew consent|2|||
144528596|NCT01928394|521139079|FG006|Follow-up Period|Participant withdrew consent|5|||
144528597|NCT01928394|521139080|FG007|Follow-up Period|Participant withdrew consent|1|||
144528598|NCT01928394|521139081|FG008|Follow-up Period|Participant withdrew consent|0|||
144528599|NCT01928394|521139082|FG009|Follow-up Period|Participant withdrew consent|0|||
144528600|NCT01928394|521139083|FG010|Follow-up Period|Participant withdrew consent|5|||
144528601|NCT01928394|521139084|FG011|Follow-up Period|Participant withdrew consent|8|||
144528602|NCT01928394|521139085|FG012|Follow-up Period|Participant withdrew consent|2|||
144528603|NCT01928394|521139086|FG013|Follow-up Period|Participant withdrew consent|12|||
144528604|NCT01928394|521139087|FG014|Follow-up Period|Participant withdrew consent|7|||
144528605|NCT01928394|521139088|FG015|Follow-up Period|Participant withdrew consent|0|||
144528606|NCT01928394|521139089|FG016|Follow-up Period|Participant withdrew consent|5|||
144528607|NCT01928394|521139090|FG017|Follow-up Period|Participant withdrew consent|3|||
144528608|NCT01928394|521139091|FG018|Follow-up Period|Participant withdrew consent|2|||
144528609|NCT01928394|521139092|FG019|Follow-up Period|Participant withdrew consent|7|||
144528610|NCT01928394|521139093|FG020|Follow-up Period|Participant withdrew consent|4|||
144528611|NCT01928394|521139094|FG021|Follow-up Period|Participant withdrew consent|6|||
144528612|NCT01928394|521139095|FG022|Follow-up Period|Participant withdrew consent|2|||
144528613|NCT01928394|521139073|FG000|Follow-up Period|Death|0|||
144528614|NCT01928394|521139074|FG001|Follow-up Period|Death|0|||
144528615|NCT01928394|521139075|FG002|Follow-up Period|Death|2|||
144528616|NCT01928394|521139076|FG003|Follow-up Period|Death|6|||
144528617|NCT01928394|521139077|FG004|Follow-up Period|Death|0|||
144528618|NCT01928394|521139078|FG005|Follow-up Period|Death|6|||
144528619|NCT01928394|521139079|FG006|Follow-up Period|Death|6|||
144528620|NCT01928394|521139080|FG007|Follow-up Period|Death|2|||
144528621|NCT01928394|521139081|FG008|Follow-up Period|Death|1|||
144528622|NCT01928394|521139082|FG009|Follow-up Period|Death|2|||
144528623|NCT01928394|521139083|FG010|Follow-up Period|Death|4|||
144528624|NCT01928394|521139084|FG011|Follow-up Period|Death|12|||
144528625|NCT01928394|521139085|FG012|Follow-up Period|Death|11|||
144528626|NCT01928394|521139086|FG013|Follow-up Period|Death|25|||
144528627|NCT01928394|521139087|FG014|Follow-up Period|Death|18|||
144528628|NCT01928394|521139088|FG015|Follow-up Period|Death|0|||
144528629|NCT01928394|521139089|FG016|Follow-up Period|Death|6|||
144528630|NCT01928394|521139090|FG017|Follow-up Period|Death|5|||
144528631|NCT01928394|521139091|FG018|Follow-up Period|Death|13|||
144528632|NCT01928394|521139092|FG019|Follow-up Period|Death|13|||
144528633|NCT01928394|521139093|FG020|Follow-up Period|Death|5|||
144528634|NCT01928394|521139094|FG021|Follow-up Period|Death|3|||
144528635|NCT01928394|521139095|FG022|Follow-up Period|Death|2|||
144528636|NCT01928394|521139073|FG000|Follow-up Period|other reason|0|||
144528637|NCT01928394|521139074|FG001|Follow-up Period|other reason|0|||
144528638|NCT01928394|521139075|FG002|Follow-up Period|other reason|0|||
144528639|NCT01928394|521139076|FG003|Follow-up Period|other reason|0|||
144528640|NCT01928394|521139077|FG004|Follow-up Period|other reason|0|||
144528641|NCT01928394|521139078|FG005|Follow-up Period|other reason|0|||
144602815|NCT03083847|521408516|FG007|Main|Withdrawal by Subject|1|||
144182267|NCT01567527|519862276|FG002|Conversion Phase.|Adverse Event|0|||
144182268|NCT01567527|519862277|FG003|Conversion Phase.|Adverse Event|0|||
144182269|NCT01567527|519862278|FG004|Conversion Phase.|Adverse Event|0|||
144528642|NCT01928394|521139079|FG006|Follow-up Period|other reason|1|||
144528643|NCT01928394|521139080|FG007|Follow-up Period|other reason|3|||
144528644|NCT01928394|521139081|FG008|Follow-up Period|other reason|0|||
144528645|NCT01928394|521139082|FG009|Follow-up Period|other reason|0|||
144528646|NCT01928394|521139083|FG010|Follow-up Period|other reason|2|||
144528647|NCT01928394|521139084|FG011|Follow-up Period|other reason|1|||
144528648|NCT01928394|521139085|FG012|Follow-up Period|other reason|0|||
144528649|NCT01928394|521139086|FG013|Follow-up Period|other reason|1|||
144528650|NCT01928394|521139087|FG014|Follow-up Period|other reason|4|||
144528651|NCT01928394|521139088|FG015|Follow-up Period|other reason|0|||
144425426|NCT00238121|520765320|FG001|Overall Study|Withdrawal by Subject|1|||
144528652|NCT01928394|521139089|FG016|Follow-up Period|other reason|2|||
144528653|NCT01928394|521139090|FG017|Follow-up Period|other reason|0|||
144425427|NCT00238121|520765319|FG000|Overall Study|Adverse Event|2|||
144425428|NCT00238121|520765320|FG001|Overall Study|Adverse Event|1|||
144528654|NCT01928394|521139091|FG018|Follow-up Period|other reason|1|||
144425429|NCT00484939|520765321|FG000|Overall Study|Death|9|||
144425430|NCT00484939|520765322|FG001|Overall Study|Death|13|||
144425431|NCT00484939|520765321|FG000|Overall Study|Adverse Event|22|||
144425432|NCT00484939|520765322|FG001|Overall Study|Adverse Event|12|||
144425433|NCT00484939|520765321|FG000|Overall Study|Patient Withdrew Consent|19|||
144425434|NCT00484939|520765322|FG001|Overall Study|Patient Withdrew Consent|10|||
144602816|NCT03083847|521408517|FG008|Main|Withdrawal by Subject|0|||
144602817|NCT03083847|521408518|FG009|Main|Withdrawal by Subject|0|||
144602818|NCT02224599|521408519|FG000|Overall Study|Physician Decision|1|||
144602819|NCT02224599|521408519|FG000|Overall Study|Progression of Disease|1|||
144602820|NCT00129623|521408520|FG000|Overall Study|Adverse Event|3|||
144602821|NCT00129623|521408521|FG001|Overall Study|Adverse Event|7|||
144602822|NCT00129623|521408520|FG000|Overall Study|Refused Treatment|5|||
144602823|NCT00129623|521408521|FG001|Overall Study|Refused Treatment|3|||
144602824|NCT00129623|521408520|FG000|Overall Study|Failure to Return|1|||
144602825|NCT00129623|521408521|FG001|Overall Study|Failure to Return|1|||
144602826|NCT00129623|521408520|FG000|Overall Study|Relocated job out of state|1|||
144602827|NCT00129623|521408521|FG001|Overall Study|Relocated job out of state|0|||
144602828|NCT00129623|521408520|FG000|Overall Study|Uncertainty to return|0|||
144425435|NCT00484939|520765321|FG000|Overall Study|Protocol Violation|3|||
144425436|NCT00484939|520765322|FG001|Overall Study|Protocol Violation|3|||
144425437|NCT00484939|520765321|FG000|Overall Study|Lost to Follow-up|0|||
144425438|NCT00484939|520765322|FG001|Overall Study|Lost to Follow-up|3|||
144425439|NCT00484939|520765321|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
144425440|NCT00484939|520765322|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
144425441|NCT00484939|520765321|FG000|Overall Study|Disease progression|67|||
144425442|NCT00484939|520765322|FG001|Overall Study|Disease progression|88|||
144425443|NCT00484939|520765321|FG000|Overall Study|Screen Failure|2|||
144425444|NCT00484939|520765322|FG001|Overall Study|Screen Failure|2|||
144425445|NCT00484939|520765321|FG000|Overall Study|Reason Not Specified|11|||
144425446|NCT00484939|520765322|FG001|Overall Study|Reason Not Specified|6|||
144425447|NCT04948450|520765323|FG000|Overall Study|Return home|1|||
144425448|NCT04948450|520765324|FG001|Overall Study|Return home|3|||
144425449|NCT01474876|520765328|FG000|Overall Study|Adverse Event|11|||
144425450|NCT01474876|520765329|FG001|Overall Study|Adverse Event|5|||
144425451|NCT01474876|520765330|FG002|Overall Study|Adverse Event|0|||
144425452|NCT01474876|520765328|FG000|Overall Study|Serious Adverse Event|2|||
144425453|NCT01474876|520765329|FG001|Overall Study|Serious Adverse Event|3|||
144425454|NCT01474876|520765330|FG002|Overall Study|Serious Adverse Event|0|||
144425455|NCT01474876|520765328|FG000|Overall Study|Lost to Follow-up|5|||
144425456|NCT01474876|520765329|FG001|Overall Study|Lost to Follow-up|4|||
144425457|NCT01474876|520765330|FG002|Overall Study|Lost to Follow-up|0|||
144425458|NCT01474876|520765328|FG000|Overall Study|Investigator's decision|28|||
144425459|NCT01474876|520765329|FG001|Overall Study|Investigator's decision|6|||
144425460|NCT01474876|520765330|FG002|Overall Study|Investigator's decision|0|||
144425461|NCT01474876|520765328|FG000|Overall Study|Patient's request|19|||
144425462|NCT01474876|520765329|FG001|Overall Study|Patient's request|5|||
144425463|NCT01474876|520765330|FG002|Overall Study|Patient's request|0|||
144425464|NCT01474876|520765328|FG000|Overall Study|Investigator's decision and pt request|1|||
144425465|NCT01474876|520765329|FG001|Overall Study|Investigator's decision and pt request|0|||
144425466|NCT01474876|520765330|FG002|Overall Study|Investigator's decision and pt request|0|||
144425467|NCT01523886|520765334|FG000|Overall Study|surgery cancelled|0|||
144425468|NCT01523886|520765335|FG001|Overall Study|surgery cancelled|1|||
144425469|NCT01173718|520765344|FG000|Overall Study|Death|17|||
144425470|NCT01173718|520765344|FG000|Overall Study|Abandonment of study graft|27|||
144425471|NCT01367158|520765345|FG000|Overall Study|Withdrew consent|0|||
144425472|NCT01367158|520765346|FG001|Overall Study|Withdrew consent|2|||
144425473|NCT01367158|520765347|FG002|Overall Study|Withdrew consent|1|||
144425474|NCT01367158|520765348|FG003|Overall Study|Withdrew consent|0|||
144425475|NCT01367158|520765349|FG004|Overall Study|Withdrew consent|2|||
144425476|NCT01367158|520765350|FG005|Overall Study|Withdrew consent|0|||
144425477|NCT01367158|520765351|FG006|Overall Study|Withdrew consent|0|||
144425478|NCT01367158|520765352|FG007|Overall Study|Withdrew consent|1|||
144425479|NCT01367158|520765353|FG008|Overall Study|Withdrew consent|0|||
144425480|NCT01367158|520765354|FG009|Overall Study|Withdrew consent|0|||
144425481|NCT01367158|520765355|FG010|Overall Study|Withdrew consent|0|||
144425482|NCT01367158|520765345|FG000|Overall Study|Lost to Follow-up|0|||
144425483|NCT01367158|520765346|FG001|Overall Study|Lost to Follow-up|0|||
144425484|NCT01367158|520765347|FG002|Overall Study|Lost to Follow-up|0|||
144425485|NCT01367158|520765348|FG003|Overall Study|Lost to Follow-up|1|||
144602829|NCT00129623|521408521|FG001|Overall Study|Uncertainty to return|1|||
144602830|NCT00596934|521408522|FG000|Overall Study|Protocol Violation|1|||
144425486|NCT01367158|520765349|FG004|Overall Study|Lost to Follow-up|0|||
144425487|NCT01367158|520765350|FG005|Overall Study|Lost to Follow-up|2|||
144425488|NCT01367158|520765351|FG006|Overall Study|Lost to Follow-up|0|||
144425489|NCT01367158|520765352|FG007|Overall Study|Lost to Follow-up|1|||
144425490|NCT01367158|520765353|FG008|Overall Study|Lost to Follow-up|0|||
144425491|NCT01367158|520765354|FG009|Overall Study|Lost to Follow-up|0|||
144602831|NCT00596934|521408522|FG000|Overall Study|Withdrawal by Subject|1|||
144425492|NCT01367158|520765355|FG010|Overall Study|Lost to Follow-up|1|||
144425493|NCT01367158|520765345|FG000|Overall Study|Protocol Violation|0|||
144425494|NCT01367158|520765346|FG001|Overall Study|Protocol Violation|1|||
144425495|NCT01367158|520765347|FG002|Overall Study|Protocol Violation|0|||
144425496|NCT01367158|520765348|FG003|Overall Study|Protocol Violation|0|||
144425497|NCT01367158|520765349|FG004|Overall Study|Protocol Violation|0|||
144425498|NCT01367158|520765350|FG005|Overall Study|Protocol Violation|0|||
144425499|NCT01367158|520765351|FG006|Overall Study|Protocol Violation|0|||
144425500|NCT01367158|520765352|FG007|Overall Study|Protocol Violation|0|||
144425501|NCT01367158|520765353|FG008|Overall Study|Protocol Violation|0|||
144425502|NCT01367158|520765354|FG009|Overall Study|Protocol Violation|0|||
144425503|NCT01367158|520765355|FG010|Overall Study|Protocol Violation|0|||
144425504|NCT01499563|520765358|FG000|Overall Study|Withdrawal by Subject|10|||
144425505|NCT01499563|520765359|FG001|Overall Study|Withdrawal by Subject|11|||
144425506|NCT01499563|520765360|FG002|Overall Study|Withdrawal by Subject|7|||
144425507|NCT01499563|520765361|FG003|Overall Study|Withdrawal by Subject|8|||
144425508|NCT01499563|520765358|FG000|Overall Study|Physician Decision|2|||
144425509|NCT01499563|520765359|FG001|Overall Study|Physician Decision|1|||
144425510|NCT01499563|520765360|FG002|Overall Study|Physician Decision|3|||
144425511|NCT01499563|520765361|FG003|Overall Study|Physician Decision|0|||
144425512|NCT01499563|520765358|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
144425513|NCT01499563|520765359|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
144425514|NCT01499563|520765360|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
144425515|NCT01499563|520765361|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
144425516|NCT01499563|520765358|FG000|Overall Study|Adverse Event|2|||
144425517|NCT01499563|520765359|FG001|Overall Study|Adverse Event|0|||
144425518|NCT01499563|520765360|FG002|Overall Study|Adverse Event|1|||
144425519|NCT01499563|520765361|FG003|Overall Study|Adverse Event|3|||
144425520|NCT01499563|520765358|FG000|Overall Study|Lack of Efficacy|0|||
144425521|NCT01499563|520765359|FG001|Overall Study|Lack of Efficacy|1|||
144425522|NCT01499563|520765360|FG002|Overall Study|Lack of Efficacy|6|||
144425523|NCT01499563|520765361|FG003|Overall Study|Lack of Efficacy|3|||
144425524|NCT01499563|520765358|FG000|Overall Study|Other|8|||
144425525|NCT01499563|520765359|FG001|Overall Study|Other|6|||
144425526|NCT01499563|520765360|FG002|Overall Study|Other|6|||
144425527|NCT01499563|520765361|FG003|Overall Study|Other|4|||
144425528|NCT03279692|520765362|FG000|Overall Study|Withdrawal by Subject|1|||
144425529|NCT05198843|520765372|FG000|Overall Study|Lack of Efficacy|1|||
144425530|NCT02921776|520765374|FG000|Overall Study|patient deterioration, fatigue|2|||
144425531|NCT02921776|520765375|FG001|Overall Study|patient deterioration, fatigue|6|||
144425532|NCT02921776|520765376|FG002|Overall Study|patient deterioration, fatigue|0|||
144425533|NCT02921776|520765377|FG003|Overall Study|patient deterioration, fatigue|0|||
144425534|NCT02921776|520765378|FG004|Overall Study|patient deterioration, fatigue|0|||
144425535|NCT02921776|520765379|FG005|Overall Study|patient deterioration, fatigue|0|||
144425536|NCT02921776|520765380|FG006|Overall Study|patient deterioration, fatigue|0|||
144425537|NCT02921776|520765381|FG007|Overall Study|patient deterioration, fatigue|0|||
144425538|NCT02921776|520765374|FG000|Overall Study|Withdrawal by Subject|0|||
144425539|NCT02921776|520765375|FG001|Overall Study|Withdrawal by Subject|2|||
144425540|NCT02921776|520765376|FG002|Overall Study|Withdrawal by Subject|0|||
144425541|NCT02921776|520765377|FG003|Overall Study|Withdrawal by Subject|1|||
144425542|NCT02921776|520765378|FG004|Overall Study|Withdrawal by Subject|1|||
144425543|NCT02921776|520765379|FG005|Overall Study|Withdrawal by Subject|0|||
144425544|NCT02921776|520765380|FG006|Overall Study|Withdrawal by Subject|8|||
144425545|NCT02921776|520765381|FG007|Overall Study|Withdrawal by Subject|1|||
144425546|NCT02921776|520765374|FG000|Overall Study|Death|0|||
144425547|NCT02921776|520765375|FG001|Overall Study|Death|0|||
144425548|NCT02921776|520765376|FG002|Overall Study|Death|0|||
144425549|NCT02921776|520765377|FG003|Overall Study|Death|2|||
144425550|NCT02921776|520765378|FG004|Overall Study|Death|0|||
144425551|NCT02921776|520765379|FG005|Overall Study|Death|0|||
144425552|NCT02921776|520765380|FG006|Overall Study|Death|0|||
144425553|NCT02921776|520765381|FG007|Overall Study|Death|0|||
144425554|NCT02921776|520765374|FG000|Overall Study|extubation or early discharge|0|||
144425555|NCT02921776|520765375|FG001|Overall Study|extubation or early discharge|0|||
144425556|NCT02921776|520765376|FG002|Overall Study|extubation or early discharge|0|||
144425557|NCT02921776|520765377|FG003|Overall Study|extubation or early discharge|5|||
144425558|NCT02921776|520765378|FG004|Overall Study|extubation or early discharge|5|||
144425559|NCT02921776|520765379|FG005|Overall Study|extubation or early discharge|0|||
144425560|NCT02921776|520765380|FG006|Overall Study|extubation or early discharge|0|||
144425561|NCT02921776|520765381|FG007|Overall Study|extubation or early discharge|0|||
144425562|NCT02921776|520765374|FG000|Overall Study|Lost to Follow-up|0|||
144425563|NCT02921776|520765375|FG001|Overall Study|Lost to Follow-up|0|||
144425564|NCT02921776|520765376|FG002|Overall Study|Lost to Follow-up|0|||
144528655|NCT01928394|521139092|FG019|Follow-up Period|other reason|1|||
144425565|NCT02921776|520765377|FG003|Overall Study|Lost to Follow-up|0|||
144425566|NCT02921776|520765378|FG004|Overall Study|Lost to Follow-up|0|||
144528656|NCT01928394|521139093|FG020|Follow-up Period|other reason|0|||
144528657|NCT01928394|521139094|FG021|Follow-up Period|other reason|0|||
144251759|NCT01119846|520120872|FG002|Overall Study|Physician Decision|0|||
144602832|NCT02315898|521408525|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
144602833|NCT02315898|521408526|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
144602834|NCT02315898|521408527|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
144602835|NCT02315898|521408528|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
144602836|NCT03239483|521408529|FG000|Overall Study|Lost to Follow-up|1|||
144602837|NCT03239483|521408530|FG001|Overall Study|Lost to Follow-up|0|||
144602838|NCT03239483|521408529|FG000|Overall Study|Withdrawal by Subject|1|||
144602839|NCT03239483|521408530|FG001|Overall Study|Withdrawal by Subject|0|||
144602840|NCT00056862|521408533|FG000|Overall Study|Protocol Violation|1|||
144602841|NCT00056862|521408534|FG001|Overall Study|Protocol Violation|0|||
144425567|NCT02921776|520765379|FG005|Overall Study|Lost to Follow-up|2|||
144425568|NCT02921776|520765380|FG006|Overall Study|Lost to Follow-up|3|||
144425569|NCT02921776|520765381|FG007|Overall Study|Lost to Follow-up|6|||
144425570|NCT04537234|520765382|FG000|Overall Study|Withdrawal by Subject|2|||
144425571|NCT04537234|520765383|FG001|Overall Study|Withdrawal by Subject|0|||
144425572|NCT07114198|520765384|FG000|Overall Study|Protocol Violation|1|||
144425573|NCT07114198|520765385|FG001|Overall Study|Protocol Violation|1|||
144425574|NCT01721330|520765386|FG000|Overall Study|Withdrawal by Subject|0|||
144425575|NCT01721330|520765387|FG001|Overall Study|Withdrawal by Subject|1|||
144425576|NCT00296374|520765388|FG000|Overall Study|Adverse Event|14|||
144425577|NCT00296374|520765389|FG001|Overall Study|Adverse Event|10|||
144425578|NCT00296374|520765390|FG002|Overall Study|Adverse Event|7|||
144425579|NCT00296374|520765388|FG000|Overall Study|Withdrawal by Subject|3|||
144425580|NCT00296374|520765389|FG001|Overall Study|Withdrawal by Subject|5|||
144425581|NCT00296374|520765390|FG002|Overall Study|Withdrawal by Subject|11|||
144425582|NCT00296374|520765388|FG000|Overall Study|Incorrect enrollment|3|||
144425583|NCT00296374|520765389|FG001|Overall Study|Incorrect enrollment|3|||
144425584|NCT00296374|520765390|FG002|Overall Study|Incorrect enrollment|4|||
144425585|NCT00296374|520765388|FG000|Overall Study|Protocol Violation|1|||
144425586|NCT00296374|520765389|FG001|Overall Study|Protocol Violation|2|||
144425587|NCT00296374|520765390|FG002|Overall Study|Protocol Violation|3|||
144425588|NCT00296374|520765388|FG000|Overall Study|Lost to Follow-up|3|||
144425589|NCT00296374|520765389|FG001|Overall Study|Lost to Follow-up|1|||
144425590|NCT00296374|520765390|FG002|Overall Study|Lost to Follow-up|1|||
144425591|NCT00296374|520765388|FG000|Overall Study|Relocated to another state|1|||
144425592|NCT00296374|520765389|FG001|Overall Study|Relocated to another state|0|||
144425593|NCT00296374|520765390|FG002|Overall Study|Relocated to another state|0|||
144425594|NCT00296374|520765388|FG000|Overall Study|Stopped drug before end of study visit|0|||
144425595|NCT00296374|520765389|FG001|Overall Study|Stopped drug before end of study visit|1|||
144425596|NCT00296374|520765390|FG002|Overall Study|Stopped drug before end of study visit|0|||
144425597|NCT00296374|520765388|FG000|Overall Study|Nephrologist introduced ACE|0|||
144425598|NCT00296374|520765389|FG001|Overall Study|Nephrologist introduced ACE|1|||
144425599|NCT00296374|520765390|FG002|Overall Study|Nephrologist introduced ACE|0|||
144425600|NCT00296374|520765388|FG000|Overall Study|Pregnancy|0|||
144425601|NCT00296374|520765389|FG001|Overall Study|Pregnancy|0|||
144425602|NCT00296374|520765390|FG002|Overall Study|Pregnancy|2|||
144425603|NCT00296374|520765388|FG000|Overall Study|Other|0|||
144425604|NCT00296374|520765389|FG001|Overall Study|Other|0|||
144425605|NCT00296374|520765390|FG002|Overall Study|Other|1|||
144425606|NCT04318080|520767215|FG000|Overall Study|Study closed by sponsor|10|||
144425607|NCT04318080|520767216|FG001|Overall Study|Study closed by sponsor|22|||
144425608|NCT04318080|520767215|FG000|Overall Study|Death|3|||
144425609|NCT04318080|520767216|FG001|Overall Study|Death|9|||
144425610|NCT04318080|520767215|FG000|Overall Study|Withdrawal by Subject|1|||
144425611|NCT04318080|520767216|FG001|Overall Study|Withdrawal by Subject|0|||
144425612|NCT04318080|520767215|FG000|Overall Study|Protocol Deviation|1|||
144425613|NCT04318080|520767216|FG001|Overall Study|Protocol Deviation|0|||
144425614|NCT06308822|520767217|FG000|Overall Study|Mutation Status Not Confirmed|17|||
144425615|NCT06308822|520767217|FG000|Overall Study|Adverse Event|1|||
144425616|NCT06308822|520767217|FG000|Overall Study|Death|5|||
144425617|NCT06308822|520767217|FG000|Overall Study|Disease progression|8|||
144425618|NCT06308822|520767217|FG000|Overall Study|Withdrawal by Subject|1|||
144425619|NCT06308822|520767217|FG000|Overall Study|Physician Decision|3|||
144602842|NCT01271803|521408535|FG000|Overall Study|Progressive disease|0|||
144602843|NCT01271803|521408536|FG001|Overall Study|Progressive disease|0|||
144602844|NCT01271803|521408537|FG002|Overall Study|Progressive disease|2|||
144602845|NCT01271803|521408535|FG000|Overall Study|Death|53|||
144602846|NCT01271803|521408536|FG001|Overall Study|Death|34|||
144602847|NCT01271803|521408537|FG002|Overall Study|Death|0|||
144425620|NCT04734652|520767223|FG000|Overall Study|Withdrawal by Subject|2|||
144425621|NCT04734652|520767224|FG001|Overall Study|Withdrawal by Subject|0|||
144425622|NCT04734652|520767223|FG000|Overall Study|Death|0|||
144425623|NCT04734652|520767224|FG001|Overall Study|Death|1|||
144425624|NCT01852942|520767226|FG000|Overall Study|Physician Decision|1|||
144425625|NCT01852942|520767227|FG001|Overall Study|Physician Decision|0|||
144723426|NCT02275364|521842340|FG001|Period 1|Other reason|0|||
144602848|NCT01271803|521408535|FG000|Overall Study|Withdrawal by Subject|1|||
144602849|NCT01271803|521408536|FG001|Overall Study|Withdrawal by Subject|5|||
144602850|NCT01271803|521408537|FG002|Overall Study|Withdrawal by Subject|0|||
144602851|NCT01271803|521408535|FG000|Overall Study|Lost to Follow-up|1|||
144602852|NCT01271803|521408536|FG001|Overall Study|Lost to Follow-up|0|||
144602853|NCT01271803|521408537|FG002|Overall Study|Lost to Follow-up|0|||
144602854|NCT00728481|521408538|FG000|Overall Study|Withdrawal by Subject|0|||
144602855|NCT00728481|521408539|FG001|Overall Study|Withdrawal by Subject|1|||
144602856|NCT00728481|521408538|FG000|Overall Study|Adverse Event|0|||
144602857|NCT00728481|521408539|FG001|Overall Study|Adverse Event|1|||
144602858|NCT00728481|521408538|FG000|Overall Study|Study medication non-compliance|0|||
144602859|NCT00728481|521408539|FG001|Overall Study|Study medication non-compliance|2|||
144602860|NCT00728481|521408538|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
144602861|NCT00728481|521408539|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
144602862|NCT02545322|521408540|FG000|Overall Study|Withdrawal by Subject|3|||
144602863|NCT00778622|521408541|FG000|Overall Study|Adverse Event|5|||
144602864|NCT00778622|521408542|FG001|Overall Study|Adverse Event|4|||
144602865|NCT00778622|521408543|FG002|Overall Study|Adverse Event|7|||
144182270|NCT01567527|519862274|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
144182271|NCT01567527|519862275|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
144182272|NCT01567527|519862276|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
144182273|NCT01567527|519862277|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
144182274|NCT01567527|519862278|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
144182275|NCT01567527|519862274|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
144425626|NCT01852942|520767226|FG000|Overall Study|Death|1|||
144602866|NCT00778622|521408541|FG000|Overall Study|Withdrawal by Subject|4|||
144602867|NCT00778622|521408542|FG001|Overall Study|Withdrawal by Subject|5|||
144602868|NCT00778622|521408543|FG002|Overall Study|Withdrawal by Subject|5|||
144602869|NCT00778622|521408541|FG000|Overall Study|Lost to Follow-up|3|||
144602870|NCT00778622|521408542|FG001|Overall Study|Lost to Follow-up|3|||
144602871|NCT00778622|521408543|FG002|Overall Study|Lost to Follow-up|2|||
144602872|NCT00778622|521408541|FG000|Overall Study|Protocol Violation|0|||
144602873|NCT00778622|521408542|FG001|Overall Study|Protocol Violation|3|||
144602874|NCT00778622|521408543|FG002|Overall Study|Protocol Violation|0|||
144602875|NCT00778622|521408541|FG000|Overall Study|Lack of Efficacy|2|||
144602876|NCT00778622|521408542|FG001|Overall Study|Lack of Efficacy|0|||
144602877|NCT00778622|521408543|FG002|Overall Study|Lack of Efficacy|0|||
144602878|NCT00778622|521408541|FG000|Overall Study|immigration|1|||
144602879|NCT00778622|521408542|FG001|Overall Study|immigration|0|||
144602880|NCT00778622|521408543|FG002|Overall Study|immigration|0|||
144602881|NCT00778622|521408541|FG000|Overall Study|Other|1|||
144602882|NCT00778622|521408542|FG001|Overall Study|Other|0|||
144602883|NCT00778622|521408543|FG002|Overall Study|Other|1|||
144602884|NCT01968070|521408544|FG000|Period 1|Withdrawal by Subject|0|||
144602885|NCT01968070|521408545|FG001|Period 1|Withdrawal by Subject|1|||
144425627|NCT01852942|520767227|FG001|Overall Study|Death|1|||
144425628|NCT01852942|520767226|FG000|Overall Study|Withdrawal by Subject|2|||
144425629|NCT01852942|520767227|FG001|Overall Study|Withdrawal by Subject|3|||
144425630|NCT01852942|520767226|FG000|Overall Study|Lost to Follow-up|1|||
144425631|NCT01852942|520767227|FG001|Overall Study|Lost to Follow-up|2|||
144425632|NCT01921179|520767228|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
144425633|NCT01921179|520767229|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
144425634|NCT01921179|520767228|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
144425635|NCT01921179|520767229|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
144425636|NCT01190254|520767234|FG000|Overall Study|Adverse Event|3|||
144425637|NCT01190254|520767235|FG001|Overall Study|Adverse Event|6|||
144425638|NCT01190254|520767236|FG002|Overall Study|Adverse Event|8|||
144425639|NCT01190254|520767234|FG000|Overall Study|Lack of Efficacy|7|||
144425640|NCT01190254|520767235|FG001|Overall Study|Lack of Efficacy|4|||
144602886|NCT01968070|521408546|FG002|Period 1|Withdrawal by Subject|0|||
144602887|NCT01968070|521408547|FG003|Period 1|Withdrawal by Subject|0|||
144602888|NCT01968070|521408548|FG004|Period 1|Withdrawal by Subject|0|||
144602889|NCT01968070|521408549|FG005|Period 1|Withdrawal by Subject|0|||
144602890|NCT01968070|521408550|FG006|Period 1|Withdrawal by Subject|1|||
144602891|NCT01968070|521408551|FG007|Period 1|Withdrawal by Subject|0|||
144602892|NCT01968070|521408552|FG008|Period 1|Withdrawal by Subject|0|||
144602893|NCT01968070|521408553|FG009|Period 1|Withdrawal by Subject|0|||
144602894|NCT01968070|521408554|FG010|Period 1|Withdrawal by Subject|0|||
144602895|NCT01968070|521408555|FG011|Period 1|Withdrawal by Subject|0|||
144602896|NCT01968070|521408556|FG012|Period 1|Withdrawal by Subject|0|||
144602897|NCT01968070|521408557|FG013|Period 1|Withdrawal by Subject|0|||
144602898|NCT01968070|521408558|FG014|Period 1|Withdrawal by Subject|0|||
144602899|NCT01968070|521408559|FG015|Period 1|Withdrawal by Subject|1|||
144602900|NCT01968070|521408560|FG016|Period 1|Withdrawal by Subject|0|||
144602901|NCT01968070|521408561|FG017|Period 1|Withdrawal by Subject|0|||
144602902|NCT01968070|521408544|FG000|Period 1|Protocol Violation|0|||
144602903|NCT01968070|521408545|FG001|Period 1|Protocol Violation|0|||
144602904|NCT01968070|521408546|FG002|Period 1|Protocol Violation|0|||
144425641|NCT01190254|520767236|FG002|Overall Study|Lack of Efficacy|5|||
144425642|NCT01190254|520767234|FG000|Overall Study|Lost to Follow-up|4|||
144425643|NCT01190254|520767235|FG001|Overall Study|Lost to Follow-up|2|||
144425644|NCT01190254|520767236|FG002|Overall Study|Lost to Follow-up|0|||
144425645|NCT01190254|520767234|FG000|Overall Study|Withdrawal by Subject|4|||
144425646|NCT01190254|520767235|FG001|Overall Study|Withdrawal by Subject|5|||
144425647|NCT01190254|520767236|FG002|Overall Study|Withdrawal by Subject|7|||
144425648|NCT01190254|520767234|FG000|Overall Study|Protocol Violation|2|||
144425649|NCT01190254|520767235|FG001|Overall Study|Protocol Violation|0|||
144425650|NCT01190254|520767236|FG002|Overall Study|Protocol Violation|2|||
144425651|NCT01190254|520767234|FG000|Overall Study|Did not meet protocol eligibility|1|||
144425652|NCT01190254|520767235|FG001|Overall Study|Did not meet protocol eligibility|0|||
144425653|NCT01190254|520767236|FG002|Overall Study|Did not meet protocol eligibility|0|||
144425654|NCT04146545|520767237|FG000|Overall Study|deemed ineligible after randomization|1|||
144425655|NCT04146545|520767238|FG001|Overall Study|deemed ineligible after randomization|0|||
144425656|NCT01729754|520767239|FG000|Part 1|Adverse Event|2|||
144425657|NCT01729754|520767240|FG001|Part 1|Adverse Event|0|||
144425658|NCT01729754|520767241|FG002|Part 1|Adverse Event|0|||
144425659|NCT01729754|520767242|FG003|Part 1|Adverse Event|1|||
144425660|NCT01729754|520767243|FG004|Part 1|Adverse Event|0|||
144425661|NCT01729754|520767244|FG005|Part 1|Adverse Event|0|||
144425662|NCT01729754|520767245|FG006|Part 1|Adverse Event|2|||
144425663|NCT01729754|520767246|FG007|Part 1|Adverse Event|0|||
144602905|NCT01968070|521408547|FG003|Period 1|Protocol Violation|1|||
144602906|NCT01968070|521408548|FG004|Period 1|Protocol Violation|1|||
144602907|NCT01968070|521408549|FG005|Period 1|Protocol Violation|0|||
144602908|NCT01968070|521408550|FG006|Period 1|Protocol Violation|0|||
144602909|NCT01968070|521408551|FG007|Period 1|Protocol Violation|0|||
144602910|NCT01968070|521408552|FG008|Period 1|Protocol Violation|0|||
144602911|NCT01968070|521408553|FG009|Period 1|Protocol Violation|0|||
144602912|NCT01968070|521408554|FG010|Period 1|Protocol Violation|0|||
144602913|NCT01968070|521408555|FG011|Period 1|Protocol Violation|0|||
144602914|NCT01968070|521408556|FG012|Period 1|Protocol Violation|0|||
144602915|NCT01968070|521408557|FG013|Period 1|Protocol Violation|0|||
144602916|NCT01968070|521408558|FG014|Period 1|Protocol Violation|0|||
144602917|NCT01968070|521408559|FG015|Period 1|Protocol Violation|0|||
144182276|NCT01567527|519862275|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
144182277|NCT01567527|519862276|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
144182278|NCT01567527|519862277|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
144182279|NCT01567527|519862278|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
144182280|NCT01567527|519862274|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
144182281|NCT01567527|519862275|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
144182282|NCT01567527|519862276|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
144182283|NCT01567527|519862277|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
144182284|NCT01567527|519862278|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
144182285|NCT01567527|519862274|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
144182286|NCT01567527|519862275|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
144182287|NCT01567527|519862276|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
144182288|NCT01567527|519862277|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
144182289|NCT01567527|519862278|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
144182290|NCT01567527|519862274|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
144182291|NCT01567527|519862275|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
144182292|NCT01567527|519862276|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
144182293|NCT01567527|519862277|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
144182294|NCT01567527|519862278|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
144182295|NCT01567527|519862274|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
144602918|NCT01968070|521408560|FG016|Period 1|Protocol Violation|0|||
144602919|NCT01968070|521408561|FG017|Period 1|Protocol Violation|0|||
144182296|NCT01567527|519862275|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
144182297|NCT01567527|519862276|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
144182298|NCT01567527|519862277|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
144425664|NCT01729754|520767247|FG008|Part 1|Adverse Event|0|||
144425665|NCT01729754|520767248|FG009|Part 1|Adverse Event|5|||
144425666|NCT01729754|520767239|FG000|Part 1|Lack of Efficacy|1|||
144425667|NCT01729754|520767240|FG001|Part 1|Lack of Efficacy|0|||
144425668|NCT01729754|520767241|FG002|Part 1|Lack of Efficacy|0|||
144602920|NCT01968070|521408544|FG000|Period 1|Lost to Follow-up|0|||
144602921|NCT01968070|521408545|FG001|Period 1|Lost to Follow-up|0|||
144602922|NCT01968070|521408546|FG002|Period 1|Lost to Follow-up|0|||
144425669|NCT01729754|520767242|FG003|Part 1|Lack of Efficacy|0|||
144425670|NCT01729754|520767243|FG004|Part 1|Lack of Efficacy|0|||
144425671|NCT01729754|520767244|FG005|Part 1|Lack of Efficacy|0|||
144425672|NCT01729754|520767245|FG006|Part 1|Lack of Efficacy|2|||
144425673|NCT01729754|520767246|FG007|Part 1|Lack of Efficacy|0|||
144602923|NCT01968070|521408547|FG003|Period 1|Lost to Follow-up|1|||
144602924|NCT01968070|521408548|FG004|Period 1|Lost to Follow-up|0|||
144182299|NCT01567527|519862278|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
144182300|NCT01567527|519862274|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
144182301|NCT01567527|519862275|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
144182302|NCT01567527|519862276|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
144182303|NCT01567527|519862277|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
144182304|NCT01567527|519862278|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
144182305|NCT01567527|519862274|FG000|IM Depot Stabilization.|Protocol deviation|0|||
144425674|NCT01729754|520767247|FG008|Part 1|Lack of Efficacy|0|||
144602925|NCT01968070|521408549|FG005|Period 1|Lost to Follow-up|0|||
144602926|NCT01968070|521408550|FG006|Period 1|Lost to Follow-up|0|||
144602927|NCT01968070|521408551|FG007|Period 1|Lost to Follow-up|0|||
144602928|NCT01968070|521408552|FG008|Period 1|Lost to Follow-up|0|||
144602929|NCT01968070|521408553|FG009|Period 1|Lost to Follow-up|0|||
144602930|NCT01968070|521408554|FG010|Period 1|Lost to Follow-up|0|||
144602931|NCT01968070|521408555|FG011|Period 1|Lost to Follow-up|0|||
144602932|NCT01968070|521408556|FG012|Period 1|Lost to Follow-up|0|||
144602933|NCT01968070|521408557|FG013|Period 1|Lost to Follow-up|0|||
144602934|NCT01968070|521408558|FG014|Period 1|Lost to Follow-up|0|||
144602935|NCT01968070|521408559|FG015|Period 1|Lost to Follow-up|0|||
144602936|NCT01968070|521408560|FG016|Period 1|Lost to Follow-up|0|||
144602937|NCT01968070|521408561|FG017|Period 1|Lost to Follow-up|0|||
144602938|NCT01968070|521408544|FG000|Period 1|Adverse Event|0|||
144602939|NCT01968070|521408545|FG001|Period 1|Adverse Event|0|||
144602940|NCT01968070|521408546|FG002|Period 1|Adverse Event|0|||
144602941|NCT01968070|521408547|FG003|Period 1|Adverse Event|0|||
144602942|NCT01968070|521408548|FG004|Period 1|Adverse Event|0|||
144602943|NCT01968070|521408549|FG005|Period 1|Adverse Event|0|||
144602944|NCT01968070|521408550|FG006|Period 1|Adverse Event|1|||
144602945|NCT01968070|521408551|FG007|Period 1|Adverse Event|0|||
144602946|NCT01968070|521408552|FG008|Period 1|Adverse Event|0|||
144602947|NCT01968070|521408553|FG009|Period 1|Adverse Event|0|||
144602948|NCT01968070|521408554|FG010|Period 1|Adverse Event|0|||
144602949|NCT01968070|521408555|FG011|Period 1|Adverse Event|0|||
144602950|NCT01968070|521408556|FG012|Period 1|Adverse Event|0|||
144602951|NCT01968070|521408557|FG013|Period 1|Adverse Event|0|||
144602952|NCT01968070|521408558|FG014|Period 1|Adverse Event|0|||
144602953|NCT01968070|521408559|FG015|Period 1|Adverse Event|0|||
144602954|NCT01968070|521408560|FG016|Period 1|Adverse Event|0|||
144602955|NCT01968070|521408561|FG017|Period 1|Adverse Event|0|||
144602956|NCT01968070|521408544|FG000|Period 1|Physician Decision|0|||
144602957|NCT01968070|521408545|FG001|Period 1|Physician Decision|0|||
144602958|NCT01968070|521408546|FG002|Period 1|Physician Decision|0|||
144602959|NCT01968070|521408547|FG003|Period 1|Physician Decision|0|||
144602960|NCT01968070|521408548|FG004|Period 1|Physician Decision|0|||
144602961|NCT01968070|521408549|FG005|Period 1|Physician Decision|0|||
144602962|NCT01968070|521408550|FG006|Period 1|Physician Decision|0|||
144602963|NCT01968070|521408551|FG007|Period 1|Physician Decision|0|||
144602964|NCT01968070|521408552|FG008|Period 1|Physician Decision|0|||
144602965|NCT01968070|521408553|FG009|Period 1|Physician Decision|0|||
144602966|NCT01968070|521408554|FG010|Period 1|Physician Decision|0|||
144602967|NCT01968070|521408555|FG011|Period 1|Physician Decision|1|||
144602968|NCT01968070|521408556|FG012|Period 1|Physician Decision|0|||
144602969|NCT01968070|521408557|FG013|Period 1|Physician Decision|0|||
144602970|NCT01968070|521408558|FG014|Period 1|Physician Decision|0|||
144602971|NCT01968070|521408559|FG015|Period 1|Physician Decision|0|||
144602972|NCT01968070|521408560|FG016|Period 1|Physician Decision|0|||
144425675|NCT01729754|520767248|FG009|Part 1|Lack of Efficacy|0|||
144425676|NCT01729754|520767239|FG000|Part 1|Lost to Follow-up|1|||
144425677|NCT01729754|520767240|FG001|Part 1|Lost to Follow-up|0|||
144425678|NCT01729754|520767241|FG002|Part 1|Lost to Follow-up|0|||
144425679|NCT01729754|520767242|FG003|Part 1|Lost to Follow-up|2|||
144425680|NCT01729754|520767243|FG004|Part 1|Lost to Follow-up|0|||
144602973|NCT01968070|521408561|FG017|Period 1|Physician Decision|0|||
144602974|NCT01968070|521408544|FG000|Period 2|Withdrawal by Subject|0|||
144602975|NCT01968070|521408545|FG001|Period 2|Withdrawal by Subject|0|||
144602976|NCT01968070|521408546|FG002|Period 2|Withdrawal by Subject|0|||
144602977|NCT01968070|521408547|FG003|Period 2|Withdrawal by Subject|0|||
144602978|NCT01968070|521408548|FG004|Period 2|Withdrawal by Subject|1|||
144602979|NCT01968070|521408549|FG005|Period 2|Withdrawal by Subject|0|||
144602980|NCT01968070|521408550|FG006|Period 2|Withdrawal by Subject|0|||
144602981|NCT01968070|521408551|FG007|Period 2|Withdrawal by Subject|0|||
144425681|NCT01729754|520767244|FG005|Part 1|Lost to Follow-up|0|||
144602982|NCT01968070|521408552|FG008|Period 2|Withdrawal by Subject|0|||
144602983|NCT01968070|521408553|FG009|Period 2|Withdrawal by Subject|0|||
144602984|NCT01968070|521408554|FG010|Period 2|Withdrawal by Subject|0|||
144602985|NCT01968070|521408555|FG011|Period 2|Withdrawal by Subject|0|||
144602986|NCT01968070|521408556|FG012|Period 2|Withdrawal by Subject|0|||
144602987|NCT01968070|521408557|FG013|Period 2|Withdrawal by Subject|0|||
144602988|NCT01968070|521408558|FG014|Period 2|Withdrawal by Subject|0|||
144602989|NCT01968070|521408559|FG015|Period 2|Withdrawal by Subject|0|||
144602990|NCT01968070|521408560|FG016|Period 2|Withdrawal by Subject|0|||
144602991|NCT01968070|521408561|FG017|Period 2|Withdrawal by Subject|0|||
144602992|NCT00890929|521408564|FG000|Overall Study|Death before treatment|2|||
144602993|NCT00890929|521408564|FG000|Overall Study|Withdrawal by Subject|3|||
144602994|NCT00890929|521408564|FG000|Overall Study|Physician Decision|1|||
144602995|NCT00108069|521408565|FG000|Overall Study|Never rec'd study drug|0|||
144602996|NCT00108069|521408566|FG001|Overall Study|Never rec'd study drug|1|||
144602997|NCT00108069|521408565|FG000|Overall Study|Adverse Event|1|||
144602998|NCT00108069|521408566|FG001|Overall Study|Adverse Event|1|||
144602999|NCT00108069|521408565|FG000|Overall Study|Withdrawal by Subject|1|||
144603000|NCT00108069|521408566|FG001|Overall Study|Withdrawal by Subject|0|||
144182306|NCT01567527|519862275|FG001|IM Depot Stabilization.|Protocol deviation|0|||
144182307|NCT01567527|519862276|FG002|IM Depot Stabilization.|Protocol deviation|5|||
144182308|NCT01567527|519862277|FG003|IM Depot Stabilization.|Protocol deviation|0|||
144182309|NCT01567527|519862278|FG004|IM Depot Stabilization.|Protocol deviation|0|||
144182310|NCT01567527|519862274|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
144182311|NCT01567527|519862275|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
144182312|NCT01567527|519862276|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
144182313|NCT01567527|519862277|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
144603001|NCT00108069|521408565|FG000|Overall Study|Death|1|||
144603002|NCT00108069|521408566|FG001|Overall Study|Death|0|||
144603003|NCT00108069|521408565|FG000|Overall Study|Progessive disease|27|||
144603004|NCT00108069|521408566|FG001|Overall Study|Progessive disease|11|||
144182314|NCT01567527|519862278|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
144182315|NCT01567527|519862274|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
144182316|NCT01567527|519862275|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
144182317|NCT01567527|519862276|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
144425682|NCT01729754|520767245|FG006|Part 1|Lost to Follow-up|3|||
144603005|NCT03684642|521408569|FG000|Overall Study|Adverse Event|6|||
144603006|NCT03684642|521408570|FG001|Overall Study|Adverse Event|15|||
144603007|NCT03684642|521408571|FG002|Overall Study|Adverse Event|11|||
144603008|NCT03684642|521408569|FG000|Overall Study|Withdrawal by Subject|35|||
144603009|NCT03684642|521408570|FG001|Overall Study|Withdrawal by Subject|53|||
144603010|NCT03684642|521408571|FG002|Overall Study|Withdrawal by Subject|23|||
144723427|NCT03595657|521842341|FG000|Overall Study|Adverse Event|14|||
144723428|NCT03595657|521842341|FG000|Overall Study|Death|1|||
144425683|NCT01729754|520767246|FG007|Part 1|Lost to Follow-up|0|||
144425684|NCT01729754|520767247|FG008|Part 1|Lost to Follow-up|0|||
144723429|NCT03595657|521842341|FG000|Overall Study|Lack of Efficacy|40|||
144723430|NCT03595657|521842341|FG000|Overall Study|Withdrawal by Subject|10|||
144425685|NCT01729754|520767248|FG009|Part 1|Lost to Follow-up|3|||
144425686|NCT01729754|520767239|FG000|Part 1|Non-compliance with Study Drug|1|||
144425687|NCT01729754|520767240|FG001|Part 1|Non-compliance with Study Drug|0|||
144425688|NCT01729754|520767241|FG002|Part 1|Non-compliance with Study Drug|0|||
144425689|NCT01729754|520767242|FG003|Part 1|Non-compliance with Study Drug|0|||
144425690|NCT01729754|520767243|FG004|Part 1|Non-compliance with Study Drug|0|||
144425691|NCT01729754|520767244|FG005|Part 1|Non-compliance with Study Drug|0|||
144425692|NCT01729754|520767245|FG006|Part 1|Non-compliance with Study Drug|0|||
144425693|NCT01729754|520767246|FG007|Part 1|Non-compliance with Study Drug|0|||
144425694|NCT01729754|520767247|FG008|Part 1|Non-compliance with Study Drug|0|||
144425695|NCT01729754|520767248|FG009|Part 1|Non-compliance with Study Drug|0|||
144425696|NCT01729754|520767239|FG000|Part 1|Physician Decision|0|||
144425697|NCT01729754|520767240|FG001|Part 1|Physician Decision|0|||
144425698|NCT01729754|520767241|FG002|Part 1|Physician Decision|0|||
144425699|NCT01729754|520767242|FG003|Part 1|Physician Decision|0|||
144425700|NCT01729754|520767243|FG004|Part 1|Physician Decision|0|||
144425701|NCT01729754|520767244|FG005|Part 1|Physician Decision|0|||
144425702|NCT01729754|520767245|FG006|Part 1|Physician Decision|0|||
144425703|NCT01729754|520767246|FG007|Part 1|Physician Decision|0|||
144425704|NCT01729754|520767247|FG008|Part 1|Physician Decision|0|||
144425705|NCT01729754|520767248|FG009|Part 1|Physician Decision|4|||
144425706|NCT01729754|520767239|FG000|Part 1|Pregnancy|0|||
144425707|NCT01729754|520767240|FG001|Part 1|Pregnancy|0|||
144425708|NCT01729754|520767241|FG002|Part 1|Pregnancy|0|||
144425709|NCT01729754|520767242|FG003|Part 1|Pregnancy|1|||
144425710|NCT01729754|520767243|FG004|Part 1|Pregnancy|0|||
144425711|NCT01729754|520767244|FG005|Part 1|Pregnancy|0|||
144425712|NCT01729754|520767245|FG006|Part 1|Pregnancy|0|||
144603011|NCT03684642|521408569|FG000|Overall Study|Lack of Efficacy|0|||
144603012|NCT03684642|521408570|FG001|Overall Study|Lack of Efficacy|0|||
144425713|NCT01729754|520767246|FG007|Part 1|Pregnancy|0|||
144603013|NCT03684642|521408571|FG002|Overall Study|Lack of Efficacy|1|||
144603014|NCT03684642|521408569|FG000|Overall Study|Poor compliance to protocol|0|||
144603015|NCT03684642|521408570|FG001|Overall Study|Poor compliance to protocol|4|||
144603016|NCT03684642|521408571|FG002|Overall Study|Poor compliance to protocol|1|||
144603017|NCT03684642|521408569|FG000|Overall Study|Other than specified|62|||
144603018|NCT03684642|521408570|FG001|Overall Study|Other than specified|60|||
144425714|NCT01729754|520767247|FG008|Part 1|Pregnancy|0|||
144723431|NCT03595657|521842341|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
144723432|NCT03595657|521842341|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
144603019|NCT03684642|521408571|FG002|Overall Study|Other than specified|67|||
144603020|NCT03684642|521408569|FG000|Overall Study|Randomized and not treated|0|||
144603021|NCT03684642|521408570|FG001|Overall Study|Randomized and not treated|0|||
144603022|NCT03684642|521408571|FG002|Overall Study|Randomized and not treated|1|||
144603023|NCT03684642|521408569|FG000|Overall Study|Missing completion status but alive at last contact|0|||
144603024|NCT03684642|521408570|FG001|Overall Study|Missing completion status but alive at last contact|1|||
144603025|NCT03684642|521408571|FG002|Overall Study|Missing completion status but alive at last contact|2|||
144603026|NCT00999713|521408573|FG000|Overall Study|Physician Decision|2|||
144603027|NCT00999713|521408574|FG001|Overall Study|Physician Decision|0|||
144603028|NCT01840605|521408575|FG000|Overall Study|Adverse Event|0|||
144603029|NCT01840605|521408576|FG001|Overall Study|Adverse Event|1|||
144603030|NCT01840605|521408575|FG000|Overall Study|Physician Decision|2|||
144603031|NCT01840605|521408576|FG001|Overall Study|Physician Decision|1|||
144603032|NCT04435782|521408584|FG000|Overall Study|Study terminated by sponsor|4|||
144603033|NCT03672461|521408585|FG000|Overall Study|COVID Related|4|||
144603034|NCT03672461|521408586|FG001|Overall Study|COVID Related|2|||
144603035|NCT03672461|521408585|FG000|Overall Study|Adverse Event|2|||
144603036|NCT03672461|521408586|FG001|Overall Study|Adverse Event|0|||
144603037|NCT03672461|521408585|FG000|Overall Study|Serious Adverse Event|0|||
144603038|NCT03672461|521408586|FG001|Overall Study|Serious Adverse Event|1|||
144603039|NCT03672461|521408585|FG000|Overall Study|Too Busy|3|||
144603040|NCT03672461|521408586|FG001|Overall Study|Too Busy|1|||
144603041|NCT03672461|521408585|FG000|Overall Study|Lost to Follow-up|1|||
144603042|NCT03672461|521408586|FG001|Overall Study|Lost to Follow-up|2|||
144425715|NCT01729754|520767248|FG009|Part 1|Pregnancy|1|||
144425716|NCT01729754|520767239|FG000|Part 1|Progressive Disease|0|||
144425717|NCT01729754|520767240|FG001|Part 1|Progressive Disease|0|||
144603043|NCT03672461|521408585|FG000|Overall Study|Family|2|||
144603044|NCT03672461|521408586|FG001|Overall Study|Family|2|||
144603045|NCT03672461|521408585|FG000|Overall Study|No remote technology access|0|||
144603046|NCT03672461|521408586|FG001|Overall Study|No remote technology access|1|||
144603047|NCT03672461|521408585|FG000|Overall Study|Withdrawal by Subject|1|||
144603048|NCT03672461|521408586|FG001|Overall Study|Withdrawal by Subject|0|||
144425718|NCT01729754|520767241|FG002|Part 1|Progressive Disease|0|||
144425719|NCT01729754|520767242|FG003|Part 1|Progressive Disease|0|||
144425720|NCT01729754|520767243|FG004|Part 1|Progressive Disease|0|||
144603049|NCT03672461|521408585|FG000|Overall Study|Cannot tolerate intervention|1|||
144603050|NCT03672461|521408586|FG001|Overall Study|Cannot tolerate intervention|0|||
144603051|NCT03672461|521408585|FG000|Overall Study|Incomplete outcome data|6|||
144603052|NCT03672461|521408586|FG001|Overall Study|Incomplete outcome data|1|||
144603053|NCT04313153|521409951|FG000|Overall Study|Adverse Event (includes Death)|14|||
144603054|NCT04313153|521409952|FG001|Overall Study|Adverse Event (includes Death)|19|||
144603055|NCT04313153|521409953|FG002|Overall Study|Adverse Event (includes Death)|10|||
144603056|NCT04313153|521409951|FG000|Overall Study|Physician Decision|4|||
144603057|NCT04313153|521409952|FG001|Overall Study|Physician Decision|2|||
144603058|NCT04313153|521409953|FG002|Overall Study|Physician Decision|1|||
144603059|NCT04313153|521409951|FG000|Overall Study|Withdrawal by Subject|7|||
144603060|NCT04313153|521409952|FG001|Overall Study|Withdrawal by Subject|6|||
144603061|NCT04313153|521409953|FG002|Overall Study|Withdrawal by Subject|2|||
144603062|NCT04313153|521409951|FG000|Overall Study|Lack of Efficacy|3|||
144603063|NCT04313153|521409952|FG001|Overall Study|Lack of Efficacy|3|||
144603064|NCT04313153|521409953|FG002|Overall Study|Lack of Efficacy|0|||
144603065|NCT04313153|521409951|FG000|Overall Study|Lost to Follow-up|1|||
144603066|NCT04313153|521409952|FG001|Overall Study|Lost to Follow-up|0|||
144603067|NCT04313153|521409953|FG002|Overall Study|Lost to Follow-up|2|||
144603068|NCT04313153|521409951|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
144603069|NCT04313153|521409952|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
144425721|NCT01729754|520767244|FG005|Part 1|Progressive Disease|0|||
144425722|NCT01729754|520767245|FG006|Part 1|Progressive Disease|0|||
144425723|NCT01729754|520767246|FG007|Part 1|Progressive Disease|0|||
144425724|NCT01729754|520767247|FG008|Part 1|Progressive Disease|0|||
144425725|NCT01729754|520767248|FG009|Part 1|Progressive Disease|1|||
144425726|NCT01729754|520767239|FG000|Part 1|Protocol Violation|2|||
144425727|NCT01729754|520767240|FG001|Part 1|Protocol Violation|0|||
144723433|NCT01066052|521842342|FG000|Overall Study|Enrolled But Not Treated|3|||
144603070|NCT04313153|521409953|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
144603071|NCT04313153|521409951|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
144603072|NCT04313153|521409952|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
144603073|NCT04313153|521409953|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
144603074|NCT04313153|521409951|FG000|Overall Study|Change in Dialysis Modality|0|||
144425728|NCT01729754|520767241|FG002|Part 1|Protocol Violation|0|||
144425729|NCT01729754|520767242|FG003|Part 1|Protocol Violation|1|||
144425730|NCT01729754|520767243|FG004|Part 1|Protocol Violation|0|||
144723434|NCT01066052|521842343|FG001|Overall Study|Enrolled But Not Treated|0|||
144425731|NCT01729754|520767244|FG005|Part 1|Protocol Violation|0|||
144425732|NCT01729754|520767245|FG006|Part 1|Protocol Violation|1|||
144723435|NCT00663871|521842344|FG000|Overall Study|Lost to Follow-up|5|||
144425733|NCT01729754|520767246|FG007|Part 1|Protocol Violation|0|||
144425734|NCT01729754|520767247|FG008|Part 1|Protocol Violation|0|||
144425735|NCT01729754|520767248|FG009|Part 1|Protocol Violation|0|||
144425736|NCT01729754|520767239|FG000|Part 1|Withdrawal by Subject|5|||
144425737|NCT01729754|520767240|FG001|Part 1|Withdrawal by Subject|0|||
144425738|NCT01729754|520767241|FG002|Part 1|Withdrawal by Subject|0|||
144425739|NCT01729754|520767242|FG003|Part 1|Withdrawal by Subject|7|||
144425740|NCT01729754|520767243|FG004|Part 1|Withdrawal by Subject|0|||
144425741|NCT01729754|520767244|FG005|Part 1|Withdrawal by Subject|0|||
144425742|NCT01729754|520767245|FG006|Part 1|Withdrawal by Subject|5|||
144425743|NCT01729754|520767246|FG007|Part 1|Withdrawal by Subject|0|||
144425744|NCT01729754|520767247|FG008|Part 1|Withdrawal by Subject|0|||
144425745|NCT01729754|520767248|FG009|Part 1|Withdrawal by Subject|6|||
144425746|NCT01729754|520767239|FG000|Part 1|Other Protocol Specified Criteria|2|||
144425747|NCT01729754|520767240|FG001|Part 1|Other Protocol Specified Criteria|0|||
144425748|NCT01729754|520767241|FG002|Part 1|Other Protocol Specified Criteria|0|||
144425749|NCT01729754|520767242|FG003|Part 1|Other Protocol Specified Criteria|0|||
144425750|NCT01729754|520767243|FG004|Part 1|Other Protocol Specified Criteria|0|||
144425751|NCT01729754|520767244|FG005|Part 1|Other Protocol Specified Criteria|0|||
144425752|NCT01729754|520767245|FG006|Part 1|Other Protocol Specified Criteria|1|||
144425753|NCT01729754|520767246|FG007|Part 1|Other Protocol Specified Criteria|0|||
144425754|NCT01729754|520767247|FG008|Part 1|Other Protocol Specified Criteria|0|||
144425755|NCT01729754|520767248|FG009|Part 1|Other Protocol Specified Criteria|4|||
144425756|NCT01729754|520767239|FG000|Part 2|Adverse Event|2|||
144425757|NCT01729754|520767240|FG001|Part 2|Adverse Event|0|||
144425758|NCT01729754|520767241|FG002|Part 2|Adverse Event|0|||
144425759|NCT01729754|520767242|FG003|Part 2|Adverse Event|0|||
144425760|NCT01729754|520767243|FG004|Part 2|Adverse Event|0|||
144425761|NCT01729754|520767244|FG005|Part 2|Adverse Event|0|||
144425762|NCT01729754|520767245|FG006|Part 2|Adverse Event|0|||
144425763|NCT01729754|520767246|FG007|Part 2|Adverse Event|0|||
144425764|NCT01729754|520767247|FG008|Part 2|Adverse Event|1|||
144425765|NCT01729754|520767248|FG009|Part 2|Adverse Event|2|||
144425766|NCT01729754|520767239|FG000|Part 2|Lack of Efficacy|0|||
144425767|NCT01729754|520767240|FG001|Part 2|Lack of Efficacy|0|||
144425768|NCT01729754|520767241|FG002|Part 2|Lack of Efficacy|0|||
144425769|NCT01729754|520767242|FG003|Part 2|Lack of Efficacy|0|||
144425770|NCT01729754|520767243|FG004|Part 2|Lack of Efficacy|0|||
144425771|NCT01729754|520767244|FG005|Part 2|Lack of Efficacy|0|||
144425772|NCT01729754|520767245|FG006|Part 2|Lack of Efficacy|0|||
144425773|NCT01729754|520767246|FG007|Part 2|Lack of Efficacy|0|||
144425774|NCT01729754|520767247|FG008|Part 2|Lack of Efficacy|2|||
144425775|NCT01729754|520767248|FG009|Part 2|Lack of Efficacy|2|||
144425776|NCT01729754|520767239|FG000|Part 2|Lost to Follow-up|0|||
144425777|NCT01729754|520767240|FG001|Part 2|Lost to Follow-up|0|||
144425778|NCT01729754|520767241|FG002|Part 2|Lost to Follow-up|0|||
144425779|NCT01729754|520767242|FG003|Part 2|Lost to Follow-up|2|||
144425780|NCT01729754|520767243|FG004|Part 2|Lost to Follow-up|0|||
144425781|NCT01729754|520767244|FG005|Part 2|Lost to Follow-up|0|||
144425782|NCT01729754|520767245|FG006|Part 2|Lost to Follow-up|0|||
144425783|NCT01729754|520767246|FG007|Part 2|Lost to Follow-up|1|||
144425784|NCT01729754|520767247|FG008|Part 2|Lost to Follow-up|0|||
144425785|NCT01729754|520767248|FG009|Part 2|Lost to Follow-up|2|||
144425786|NCT01729754|520767239|FG000|Part 2|Non-Compliance with Study Drug|0|||
144425787|NCT01729754|520767240|FG001|Part 2|Non-Compliance with Study Drug|0|||
144425788|NCT01729754|520767241|FG002|Part 2|Non-Compliance with Study Drug|0|||
144425789|NCT01729754|520767242|FG003|Part 2|Non-Compliance with Study Drug|0|||
144425790|NCT01729754|520767243|FG004|Part 2|Non-Compliance with Study Drug|0|||
144425791|NCT01729754|520767244|FG005|Part 2|Non-Compliance with Study Drug|0|||
144425792|NCT01729754|520767245|FG006|Part 2|Non-Compliance with Study Drug|0|||
144425793|NCT01729754|520767246|FG007|Part 2|Non-Compliance with Study Drug|0|||
144425794|NCT01729754|520767247|FG008|Part 2|Non-Compliance with Study Drug|0|||
144425795|NCT01729754|520767248|FG009|Part 2|Non-Compliance with Study Drug|1|||
144425796|NCT01729754|520767239|FG000|Part 2|Pregnancy|0|||
144425797|NCT01729754|520767240|FG001|Part 2|Pregnancy|0|||
144425798|NCT01729754|520767241|FG002|Part 2|Pregnancy|0|||
144425799|NCT01729754|520767242|FG003|Part 2|Pregnancy|1|||
144425800|NCT01729754|520767243|FG004|Part 2|Pregnancy|0|||
144425801|NCT01729754|520767244|FG005|Part 2|Pregnancy|0|||
144723436|NCT00663871|521842345|FG001|Overall Study|Lost to Follow-up|5|||
144425802|NCT01729754|520767245|FG006|Part 2|Pregnancy|0|||
144425803|NCT01729754|520767246|FG007|Part 2|Pregnancy|0|||
144528658|NCT01928394|521139095|FG022|Follow-up Period|other reason|1|||
144425804|NCT01729754|520767247|FG008|Part 2|Pregnancy|0|||
144425805|NCT01729754|520767248|FG009|Part 2|Pregnancy|1|||
144425806|NCT01729754|520767239|FG000|Part 2|Withdrawal by Subject|3|||
144425807|NCT01729754|520767240|FG001|Part 2|Withdrawal by Subject|0|||
144425808|NCT01729754|520767241|FG002|Part 2|Withdrawal by Subject|0|||
144425809|NCT01729754|520767242|FG003|Part 2|Withdrawal by Subject|2|||
144425810|NCT01729754|520767243|FG004|Part 2|Withdrawal by Subject|0|||
144425811|NCT01729754|520767244|FG005|Part 2|Withdrawal by Subject|0|||
144425812|NCT01729754|520767245|FG006|Part 2|Withdrawal by Subject|0|||
144425813|NCT01729754|520767246|FG007|Part 2|Withdrawal by Subject|1|||
144603075|NCT04313153|521409952|FG001|Overall Study|Change in Dialysis Modality|1|||
144603076|NCT04313153|521409953|FG002|Overall Study|Change in Dialysis Modality|2|||
144603077|NCT04313153|521409951|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
144603078|NCT04313153|521409952|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
144603079|NCT04313153|521409953|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
144603080|NCT04313153|521409951|FG000|Overall Study|Other|5|||
144603081|NCT04313153|521409952|FG001|Overall Study|Other|3|||
144603082|NCT04313153|521409953|FG002|Overall Study|Other|2|||
144603083|NCT05586269|521409954|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
144603084|NCT05586269|521409955|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
144603085|NCT05586269|521409956|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
144603086|NCT05586269|521409957|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
144603087|NCT05586269|521409954|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
144603088|NCT05586269|521409955|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
144603089|NCT05586269|521409956|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
144603090|NCT05586269|521409957|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
144603091|NCT04752475|521409958|FG000|Overall Study|Withdrawal by Subject|1|||
144603092|NCT04752475|521409959|FG001|Overall Study|Withdrawal by Subject|1|||
144603093|NCT00523718|521409965|FG000|Overall Study|Withdrawal by Subject|1|||
144603094|NCT00523718|521409966|FG001|Overall Study|Withdrawal by Subject|0|||
144603095|NCT00523718|521409965|FG000|Overall Study|Protocol Violation|2|||
144603096|NCT00523718|521409966|FG001|Overall Study|Protocol Violation|0|||
144603097|NCT01310803|521409967|FG000|Overall Study|Subject terminated by Sponsor|1|||
144603098|NCT01310803|521409968|FG001|Overall Study|Subject terminated by Sponsor|0|||
144603099|NCT00332839|521409969|FG000|Core (Months 0 - 12)|Administrative problems|1|||
144603100|NCT00332839|521409970|FG001|Core (Months 0 - 12)|Administrative problems|1|||
144603101|NCT00332839|521409969|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
144603102|NCT00332839|521409970|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
144603103|NCT00332839|521409969|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
144603104|NCT00332839|521409970|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
144603105|NCT00332839|521409969|FG000|Core (Months 0 - 12)|Adverse Event|5|||
144603106|NCT00332839|521409970|FG001|Core (Months 0 - 12)|Adverse Event|15|||
144603107|NCT00332839|521409969|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
144603108|NCT00332839|521409970|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
144603109|NCT00332839|521409969|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
144603110|NCT00332839|521409970|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
144603111|NCT00332839|521409969|FG000|Follow-up (Months 12 - 60)|Death|1|||
144603112|NCT00332839|521409970|FG001|Follow-up (Months 12 - 60)|Death|1|||
144603113|NCT01436071|521409971|FG000|Overall Study|Adverse Event|1|||
144603114|NCT01436071|521409972|FG001|Overall Study|Adverse Event|0|||
144603115|NCT01436071|521409971|FG000|Overall Study|Lack of Efficacy|16|||
144603116|NCT01436071|521409972|FG001|Overall Study|Lack of Efficacy|7|||
144425814|NCT01729754|520767247|FG008|Part 2|Withdrawal by Subject|1|||
144425815|NCT01729754|520767248|FG009|Part 2|Withdrawal by Subject|4|||
144425816|NCT01729754|520767239|FG000|Part 2|Other Protocol Specified Criteria|1|||
144425817|NCT01729754|520767240|FG001|Part 2|Other Protocol Specified Criteria|0|||
144723437|NCT00663871|521842344|FG000|Overall Study|Withdrawal by Subject|5|||
144723438|NCT00663871|521842345|FG001|Overall Study|Withdrawal by Subject|2|||
144723439|NCT01835145|521842348|FG000|Overall Study|Ineligible prior to treatment|1|||
144723440|NCT01835145|521842349|FG001|Overall Study|Ineligible prior to treatment|0|||
144723441|NCT02984683|521842350|FG000|Overall Study|Adverse Event|3|||
144425818|NCT01729754|520767241|FG002|Part 2|Other Protocol Specified Criteria|0|||
144425819|NCT01729754|520767242|FG003|Part 2|Other Protocol Specified Criteria|0|||
144425820|NCT01729754|520767243|FG004|Part 2|Other Protocol Specified Criteria|0|||
144425821|NCT01729754|520767244|FG005|Part 2|Other Protocol Specified Criteria|0|||
144425822|NCT01729754|520767245|FG006|Part 2|Other Protocol Specified Criteria|0|||
144603117|NCT01436071|521409971|FG000|Overall Study|Protocol Violation|0|||
144603118|NCT01436071|521409972|FG001|Overall Study|Protocol Violation|1|||
144603119|NCT01436071|521409971|FG000|Overall Study|Lost to Follow-up|3|||
144723442|NCT02984683|521842351|FG001|Overall Study|Adverse Event|3|||
144723443|NCT02984683|521842350|FG000|Overall Study|Withdrawal by Subject|1|||
144723444|NCT02984683|521842351|FG001|Overall Study|Withdrawal by Subject|0|||
144723445|NCT02984683|521842350|FG000|Overall Study|Disease progression|7|||
144425823|NCT01729754|520767246|FG007|Part 2|Other Protocol Specified Criteria|1|||
144603120|NCT01436071|521409972|FG001|Overall Study|Lost to Follow-up|1|||
144603121|NCT01436071|521409971|FG000|Overall Study|Physician Decision|1|||
144603122|NCT01436071|521409972|FG001|Overall Study|Physician Decision|0|||
144603123|NCT01436071|521409971|FG000|Overall Study|Withdrawal by Subject|2|||
144603124|NCT01436071|521409972|FG001|Overall Study|Withdrawal by Subject|2|||
144603125|NCT01436071|521409971|FG000|Overall Study|Did Not Receive Trial Medication|3|||
144603126|NCT01436071|521409972|FG001|Overall Study|Did Not Receive Trial Medication|3|||
144425824|NCT01729754|520767247|FG008|Part 2|Other Protocol Specified Criteria|0|||
144603127|NCT03047551|521409975|FG000|Overall Study|Did not receive TAS|1|||
144723446|NCT02984683|521842351|FG001|Overall Study|Disease progression|9|||
144603128|NCT03047551|521409976|FG001|Overall Study|Did not receive TAS|0|||
144603129|NCT03047551|521409975|FG000|Overall Study|Physician Decision|1|||
144603130|NCT03047551|521409976|FG001|Overall Study|Physician Decision|0|||
144425825|NCT01729754|520767248|FG009|Part 2|Other Protocol Specified Criteria|0|||
144425826|NCT01729754|520767239|FG000|Part 3|Adverse Event|0|||
144425827|NCT01729754|520767240|FG001|Part 3|Adverse Event|0|||
144425828|NCT01729754|520767241|FG002|Part 3|Adverse Event|1|||
144425829|NCT01729754|520767242|FG003|Part 3|Adverse Event|0|||
144425830|NCT01729754|520767243|FG004|Part 3|Adverse Event|0|||
144425831|NCT01729754|520767244|FG005|Part 3|Adverse Event|5|||
144425832|NCT01729754|520767245|FG006|Part 3|Adverse Event|0|||
144425833|NCT01729754|520767246|FG007|Part 3|Adverse Event|0|||
144425834|NCT01729754|520767247|FG008|Part 3|Adverse Event|0|||
144425835|NCT01729754|520767248|FG009|Part 3|Adverse Event|3|||
144425836|NCT01729754|520767239|FG000|Part 3|Death|0|||
144425837|NCT01729754|520767240|FG001|Part 3|Death|0|||
144425838|NCT01729754|520767241|FG002|Part 3|Death|0|||
144425839|NCT01729754|520767242|FG003|Part 3|Death|0|||
144425840|NCT01729754|520767243|FG004|Part 3|Death|0|||
144425841|NCT01729754|520767244|FG005|Part 3|Death|2|||
144425842|NCT01729754|520767245|FG006|Part 3|Death|0|||
144425843|NCT01729754|520767246|FG007|Part 3|Death|0|||
144425844|NCT01729754|520767247|FG008|Part 3|Death|0|||
144528659|NCT01928394|521139073|FG000|Follow-up Period|Lost to Follow-up|0|||
144528660|NCT01928394|521139074|FG001|Follow-up Period|Lost to Follow-up|0|||
144528661|NCT01928394|521139075|FG002|Follow-up Period|Lost to Follow-up|0|||
144528662|NCT01928394|521139076|FG003|Follow-up Period|Lost to Follow-up|0|||
144528663|NCT01928394|521139077|FG004|Follow-up Period|Lost to Follow-up|0|||
144528664|NCT01928394|521139078|FG005|Follow-up Period|Lost to Follow-up|0|||
144528665|NCT01928394|521139079|FG006|Follow-up Period|Lost to Follow-up|0|||
144528666|NCT01928394|521139080|FG007|Follow-up Period|Lost to Follow-up|0|||
144528667|NCT01928394|521139081|FG008|Follow-up Period|Lost to Follow-up|0|||
144528668|NCT01928394|521139082|FG009|Follow-up Period|Lost to Follow-up|0|||
144528669|NCT01928394|521139083|FG010|Follow-up Period|Lost to Follow-up|0|||
144528670|NCT01928394|521139084|FG011|Follow-up Period|Lost to Follow-up|1|||
144528671|NCT01928394|521139085|FG012|Follow-up Period|Lost to Follow-up|1|||
144528672|NCT01928394|521139086|FG013|Follow-up Period|Lost to Follow-up|0|||
144528673|NCT01928394|521139087|FG014|Follow-up Period|Lost to Follow-up|1|||
144528674|NCT01928394|521139088|FG015|Follow-up Period|Lost to Follow-up|0|||
144528675|NCT01928394|521139089|FG016|Follow-up Period|Lost to Follow-up|1|||
144528676|NCT01928394|521139090|FG017|Follow-up Period|Lost to Follow-up|0|||
144528677|NCT01928394|521139091|FG018|Follow-up Period|Lost to Follow-up|0|||
144528678|NCT01928394|521139092|FG019|Follow-up Period|Lost to Follow-up|0|||
144528679|NCT01928394|521139093|FG020|Follow-up Period|Lost to Follow-up|0|||
144528680|NCT01928394|521139094|FG021|Follow-up Period|Lost to Follow-up|0|||
144528681|NCT01928394|521139095|FG022|Follow-up Period|Lost to Follow-up|1|||
144528682|NCT05485779|521139098|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528683|NCT05485779|521139099|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528684|NCT05485779|521139100|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528685|NCT05485779|521139101|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528686|NCT05485779|521139102|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528687|NCT05485779|521139103|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528688|NCT05485779|521139104|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528689|NCT05485779|521139105|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
144528690|NCT05485779|521139106|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
144528691|NCT05485779|521139107|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528692|NCT05485779|521139108|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
144528693|NCT05485779|521139098|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528694|NCT05485779|521139099|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528695|NCT05485779|521139100|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
144723447|NCT02415959|521842356|FG000|Overall Study|Adverse Event|0|||
144425845|NCT01729754|520767248|FG009|Part 3|Death|0|||
144425846|NCT01729754|520767239|FG000|Part 3|Lack of Efficacy|0|||
144425847|NCT01729754|520767240|FG001|Part 3|Lack of Efficacy|0|||
144528696|NCT05485779|521139101|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528697|NCT05485779|521139102|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
144603131|NCT03047551|521409975|FG000|Overall Study|Withdrawal by Subject|0|||
144603132|NCT03047551|521409976|FG001|Overall Study|Withdrawal by Subject|1|||
144723448|NCT02415959|521842357|FG001|Overall Study|Adverse Event|1|||
144425848|NCT01729754|520767241|FG002|Part 3|Lack of Efficacy|0|||
144425849|NCT01729754|520767242|FG003|Part 3|Lack of Efficacy|0|||
144425850|NCT01729754|520767243|FG004|Part 3|Lack of Efficacy|2|||
144425851|NCT01729754|520767244|FG005|Part 3|Lack of Efficacy|0|||
144425852|NCT01729754|520767245|FG006|Part 3|Lack of Efficacy|0|||
144425853|NCT01729754|520767246|FG007|Part 3|Lack of Efficacy|0|||
144528698|NCT05485779|521139103|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528699|NCT05485779|521139104|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528700|NCT05485779|521139105|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528701|NCT05485779|521139106|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
144603133|NCT03047551|521409975|FG000|Overall Study|Probe malfunction|0|||
144603134|NCT03047551|521409976|FG001|Overall Study|Probe malfunction|1|||
144603135|NCT03047551|521409975|FG000|Overall Study|Ineligible|0|||
144603136|NCT03047551|521409976|FG001|Overall Study|Ineligible|1|||
144603137|NCT00594516|521409977|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
144603138|NCT00594516|521409978|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
144603139|NCT00594516|521409979|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
144603140|NCT00594516|521409977|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
144603141|NCT00594516|521409978|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
144603142|NCT00594516|521409979|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
144603143|NCT00594516|521409977|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
144603144|NCT00594516|521409978|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
144603145|NCT00594516|521409979|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
144603146|NCT00594516|521409977|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
144603147|NCT00594516|521409978|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
144603148|NCT00594516|521409979|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
144603149|NCT00594516|521409977|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
144603150|NCT00594516|521409978|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
144603151|NCT00594516|521409979|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
144603152|NCT00594516|521409977|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
144603153|NCT00594516|521409978|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
144603154|NCT00594516|521409979|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
144603155|NCT00594516|521409977|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
144603156|NCT00594516|521409978|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
144603157|NCT00594516|521409979|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
144603158|NCT00594516|521409977|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
144603159|NCT00594516|521409978|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
144603160|NCT00594516|521409979|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
144603161|NCT00594516|521409977|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
144603162|NCT00594516|521409978|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
144603163|NCT00594516|521409979|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
144603164|NCT02462928|521409980|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
144603165|NCT02462928|521409981|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
144603166|NCT02462928|521409982|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
144182318|NCT01567527|519862277|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
144182319|NCT01567527|519862278|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
144182320|NCT01567527|519862274|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
144182321|NCT01567527|519862275|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
144182322|NCT01567527|519862276|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
144182323|NCT01567527|519862277|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
144182324|NCT01567527|519862278|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
144182325|NCT01567527|519862274|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
144425854|NCT01729754|520767247|FG008|Part 3|Lack of Efficacy|0|||
144603167|NCT02462928|521409980|FG000|Overall Study|Adverse Event|47|||
144603168|NCT02462928|521409981|FG001|Overall Study|Adverse Event|51|||
144603169|NCT02462928|521409982|FG002|Overall Study|Adverse Event|25|||
144603170|NCT02462928|521409980|FG000|Overall Study|Lack of Efficacy|3|||
144603171|NCT02462928|521409981|FG001|Overall Study|Lack of Efficacy|8|||
144603172|NCT02462928|521409982|FG002|Overall Study|Lack of Efficacy|3|||
144603173|NCT02462928|521409980|FG000|Overall Study|Lost to Follow-up|4|||
144603174|NCT02462928|521409981|FG001|Overall Study|Lost to Follow-up|4|||
144603175|NCT02462928|521409982|FG002|Overall Study|Lost to Follow-up|1|||
144603176|NCT02462928|521409980|FG000|Overall Study|Withdrawal by Patient|31|||
144603177|NCT02462928|521409981|FG001|Overall Study|Withdrawal by Patient|21|||
144603178|NCT02462928|521409982|FG002|Overall Study|Withdrawal by Patient|21|||
144425855|NCT01729754|520767248|FG009|Part 3|Lack of Efficacy|4|||
144425856|NCT01729754|520767239|FG000|Part 3|Lost to Follow-up|0|||
144425857|NCT01729754|520767240|FG001|Part 3|Lost to Follow-up|1|||
144603179|NCT02462928|521409980|FG000|Overall Study|Protocol Violation|0|||
144603180|NCT02462928|521409981|FG001|Overall Study|Protocol Violation|1|||
144603181|NCT02462928|521409982|FG002|Overall Study|Protocol Violation|0|||
144603182|NCT02462928|521409980|FG000|Overall Study|Reason not Specified|4|||
144603183|NCT02462928|521409981|FG001|Overall Study|Reason not Specified|6|||
144603184|NCT02462928|521409982|FG002|Overall Study|Reason not Specified|5|||
144603185|NCT04641299|521409983|FG000|Overall Study|Adverse Event|0|||
144603186|NCT04641299|521409984|FG001|Overall Study|Adverse Event|0|||
144603187|NCT04641299|521409985|FG002|Overall Study|Adverse Event|2|||
144603188|NCT04641299|521409986|FG003|Overall Study|Adverse Event|0|||
144425858|NCT01729754|520767241|FG002|Part 3|Lost to Follow-up|2|||
144603189|NCT04641299|521409983|FG000|Overall Study|Lost to Follow-up|0|||
144603190|NCT04641299|521409984|FG001|Overall Study|Lost to Follow-up|1|||
144603191|NCT04641299|521409985|FG002|Overall Study|Lost to Follow-up|0|||
144603192|NCT04641299|521409986|FG003|Overall Study|Lost to Follow-up|0|||
144603193|NCT04641299|521409983|FG000|Overall Study|Withdrawal by Subject|1|||
144425859|NCT01729754|520767242|FG003|Part 3|Lost to Follow-up|0|||
144425860|NCT01729754|520767243|FG004|Part 3|Lost to Follow-up|0|||
144425861|NCT01729754|520767244|FG005|Part 3|Lost to Follow-up|3|||
144425862|NCT01729754|520767245|FG006|Part 3|Lost to Follow-up|0|||
144425863|NCT01729754|520767246|FG007|Part 3|Lost to Follow-up|0|||
144425864|NCT01729754|520767247|FG008|Part 3|Lost to Follow-up|1|||
144425865|NCT01729754|520767248|FG009|Part 3|Lost to Follow-up|0|||
144425866|NCT01729754|520767239|FG000|Part 3|Physician Decision|0|||
144425867|NCT01729754|520767240|FG001|Part 3|Physician Decision|0|||
144425868|NCT01729754|520767241|FG002|Part 3|Physician Decision|1|||
144425869|NCT01729754|520767242|FG003|Part 3|Physician Decision|0|||
144425870|NCT01729754|520767243|FG004|Part 3|Physician Decision|0|||
144425871|NCT01729754|520767244|FG005|Part 3|Physician Decision|0|||
144425872|NCT01729754|520767245|FG006|Part 3|Physician Decision|0|||
144425873|NCT01729754|520767246|FG007|Part 3|Physician Decision|0|||
144425874|NCT01729754|520767247|FG008|Part 3|Physician Decision|0|||
144425875|NCT01729754|520767248|FG009|Part 3|Physician Decision|0|||
144425876|NCT01729754|520767239|FG000|Part 3|Withdrawal by Subject|0|||
144425877|NCT01729754|520767240|FG001|Part 3|Withdrawal by Subject|4|||
144425878|NCT01729754|520767241|FG002|Part 3|Withdrawal by Subject|1|||
144425879|NCT01729754|520767242|FG003|Part 3|Withdrawal by Subject|0|||
144425880|NCT01729754|520767243|FG004|Part 3|Withdrawal by Subject|2|||
144425881|NCT01729754|520767244|FG005|Part 3|Withdrawal by Subject|1|||
144425882|NCT01729754|520767245|FG006|Part 3|Withdrawal by Subject|0|||
144425883|NCT01729754|520767246|FG007|Part 3|Withdrawal by Subject|2|||
144425884|NCT01729754|520767247|FG008|Part 3|Withdrawal by Subject|0|||
144425885|NCT01729754|520767248|FG009|Part 3|Withdrawal by Subject|0|||
144425886|NCT01729754|520767239|FG000|Part 3|Other Protocol Specified Criteria|0|||
144425887|NCT01729754|520767240|FG001|Part 3|Other Protocol Specified Criteria|0|||
144425888|NCT01729754|520767241|FG002|Part 3|Other Protocol Specified Criteria|0|||
144425889|NCT01729754|520767242|FG003|Part 3|Other Protocol Specified Criteria|0|||
144425890|NCT01729754|520767243|FG004|Part 3|Other Protocol Specified Criteria|0|||
144425891|NCT01729754|520767244|FG005|Part 3|Other Protocol Specified Criteria|2|||
144425892|NCT01729754|520767245|FG006|Part 3|Other Protocol Specified Criteria|0|||
144425893|NCT01729754|520767246|FG007|Part 3|Other Protocol Specified Criteria|1|||
144425894|NCT01729754|520767247|FG008|Part 3|Other Protocol Specified Criteria|0|||
144425895|NCT01729754|520767248|FG009|Part 3|Other Protocol Specified Criteria|0|||
144425896|NCT01558752|520767252|FG000|Overall Study|Physician Decision|2|||
144425897|NCT01558752|520767253|FG001|Overall Study|Physician Decision|0|||
144425898|NCT00894322|520767265|FG000|Overall Study|Withdrawal by Subject|1|||
144425899|NCT00894322|520767266|FG001|Overall Study|Withdrawal by Subject|0|||
144425900|NCT00894322|520767267|FG002|Overall Study|Withdrawal by Subject|0|||
144425901|NCT02738450|520767275|FG000|Overall Study|Withdrawal by Subject|0|||
144425902|NCT02738450|520767276|FG001|Overall Study|Withdrawal by Subject|2|||
144425903|NCT02738450|520767277|FG002|Overall Study|Withdrawal by Subject|0|||
144425904|NCT03251079|520767278|FG000|Overall Study|Withdrawal by Subject|1|||
144425905|NCT01603459|520767284|FG000|Overall Study|Adverse Event|5|||
144425906|NCT01603459|520767284|FG000|Overall Study|Withdrawal by Subject|5|||
144425907|NCT01603459|520767284|FG000|Overall Study|Lost to Follow-up|3|||
144425908|NCT01603459|520767284|FG000|Overall Study|Predefined discontinuation criteria|3|||
144425909|NCT01603459|520767284|FG000|Overall Study|Non-compliance|1|||
144425910|NCT01603459|520767284|FG000|Overall Study|Administrative reason|1|||
144425911|NCT00399360|520767285|FG000|Overall Study|Lost to Follow-up|2|||
144425912|NCT00399360|520767286|FG001|Overall Study|Lost to Follow-up|1|||
144425913|NCT00399360|520767287|FG002|Overall Study|Lost to Follow-up|2|||
144425914|NCT00399360|520767288|FG003|Overall Study|Lost to Follow-up|4|||
144425915|NCT00399360|520767285|FG000|Overall Study|Adverse Event|0|||
144425916|NCT00399360|520767286|FG001|Overall Study|Adverse Event|0|||
144425917|NCT00399360|520767287|FG002|Overall Study|Adverse Event|1|||
144425918|NCT00399360|520767288|FG003|Overall Study|Adverse Event|0|||
144425919|NCT00399360|520767285|FG000|Overall Study|Withdrawal by Subject|0|||
144425920|NCT00399360|520767286|FG001|Overall Study|Withdrawal by Subject|2|||
144425921|NCT00399360|520767287|FG002|Overall Study|Withdrawal by Subject|0|||
144425922|NCT00399360|520767288|FG003|Overall Study|Withdrawal by Subject|2|||
144425923|NCT02335099|520767290|FG000|Treatment|Withdrawal by Subject|1|||
144425924|NCT02335099|520767291|FG001|Treatment|Withdrawal by Subject|3|||
144425925|NCT02335099|520767290|FG000|Treatment|Lost to Follow-up|2|||
144425926|NCT02335099|520767291|FG001|Treatment|Lost to Follow-up|0|||
144425927|NCT02335099|520767290|FG000|Treatment|Death|1|||
144425928|NCT02335099|520767291|FG001|Treatment|Death|0|||
144425929|NCT02335099|520767290|FG000|Treatment|Adverse Event|1|||
144723449|NCT02415959|521842358|FG002|Overall Study|Adverse Event|0|||
144425930|NCT02335099|520767291|FG001|Treatment|Adverse Event|2|||
144425931|NCT02335099|520767290|FG000|Follow-up|Death|0|||
144425932|NCT02335099|520767291|FG001|Follow-up|Death|1|||
144425933|NCT01288287|520767292|FG000|Overall Study|Lost to Follow-up|8|||
144425934|NCT01288287|520767292|FG000|Overall Study|Withdrawal by Subject|4|||
144425935|NCT01288287|520767292|FG000|Overall Study|Lack of Efficacy|13|||
144425936|NCT01288287|520767292|FG000|Overall Study|Other Reason|13|||
144425937|NCT01288287|520767292|FG000|Overall Study|Unknown Reason|1|||
144425938|NCT01288287|520767292|FG000|Overall Study|Unknown Status|7|||
144603194|NCT04641299|521409984|FG001|Overall Study|Withdrawal by Subject|0|||
144603195|NCT04641299|521409985|FG002|Overall Study|Withdrawal by Subject|0|||
144425939|NCT03519347|520767293|FG000|Interventional Crossover Period 1|Death|0|||
144425940|NCT03519347|520767294|FG001|Interventional Crossover Period 1|Death|0|||
144603196|NCT04641299|521409986|FG003|Overall Study|Withdrawal by Subject|0|||
144603197|NCT04641299|521409983|FG000|Overall Study|Reason not given|1|||
144603198|NCT04641299|521409984|FG001|Overall Study|Reason not given|0|||
144603199|NCT04641299|521409985|FG002|Overall Study|Reason not given|0|||
144603200|NCT04641299|521409986|FG003|Overall Study|Reason not given|0|||
144603201|NCT03876171|521409992|FG000|Overall Study|Withdrawal by Subject|3|||
144603202|NCT03876171|521409993|FG001|Overall Study|Withdrawal by Subject|3|||
144603203|NCT03876171|521409992|FG000|Overall Study|Re-arrest|0|||
144603204|NCT03876171|521409993|FG001|Overall Study|Re-arrest|4|||
144603205|NCT01170039|521409998|FG000|Overall Study|Withdrawal by Subject|5|||
144182326|NCT01567527|519862275|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
144182327|NCT01567527|519862276|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
144182328|NCT01567527|519862277|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
144182329|NCT01567527|519862278|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
144182330|NCT01567527|519862274|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
144425941|NCT03519347|520767295|FG002|Interventional Crossover Period 1|Death|0|||
144425942|NCT03519347|520767296|FG003|Interventional Crossover Period 1|Death|1|||
144425943|NCT01641692|520767302|FG000|Treatment Period 1|Adverse Event|1|||
144425944|NCT01641692|520767303|FG001|Treatment Period 1|Adverse Event|0|||
144425945|NCT01641692|520767304|FG002|Treatment Period 1|Adverse Event|0|||
144425946|NCT01641692|520767305|FG003|Treatment Period 1|Adverse Event|0|||
144425947|NCT01641692|520767306|FG004|Treatment Period 1|Adverse Event|0|||
144425948|NCT01641692|520767307|FG005|Treatment Period 1|Adverse Event|0|||
144425949|NCT01641692|520767308|FG006|Treatment Period 1|Adverse Event|0|||
144425950|NCT01641692|520767309|FG007|Treatment Period 1|Adverse Event|0|||
144425951|NCT01641692|520767302|FG000|Treatment Period 1|Lack of Efficacy|0|||
144425952|NCT01641692|520767303|FG001|Treatment Period 1|Lack of Efficacy|0|||
144425953|NCT01641692|520767304|FG002|Treatment Period 1|Lack of Efficacy|0|||
144425954|NCT01641692|520767305|FG003|Treatment Period 1|Lack of Efficacy|0|||
144425955|NCT01641692|520767306|FG004|Treatment Period 1|Lack of Efficacy|0|||
144425956|NCT01641692|520767307|FG005|Treatment Period 1|Lack of Efficacy|0|||
144425957|NCT01641692|520767308|FG006|Treatment Period 1|Lack of Efficacy|0|||
144425958|NCT01641692|520767309|FG007|Treatment Period 1|Lack of Efficacy|1|||
144425959|NCT01641692|520767302|FG000|Treatment Period 1|Protocol Violation|1|||
144425960|NCT01641692|520767303|FG001|Treatment Period 1|Protocol Violation|0|||
144425961|NCT01641692|520767304|FG002|Treatment Period 1|Protocol Violation|0|||
144425962|NCT01641692|520767305|FG003|Treatment Period 1|Protocol Violation|0|||
144425963|NCT01641692|520767306|FG004|Treatment Period 1|Protocol Violation|2|||
144425964|NCT01641692|520767307|FG005|Treatment Period 1|Protocol Violation|0|||
144425965|NCT01641692|520767308|FG006|Treatment Period 1|Protocol Violation|0|||
144425966|NCT01641692|520767309|FG007|Treatment Period 1|Protocol Violation|0|||
144425967|NCT01641692|520767302|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
144425968|NCT01641692|520767303|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
144425969|NCT01641692|520767304|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
144425970|NCT01641692|520767305|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
144182331|NCT01567527|519862275|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
144182332|NCT01567527|519862276|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
144182333|NCT01567527|519862277|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
144182334|NCT01567527|519862278|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
144182335|NCT01567527|519862274|FG000|IM Depot Stabilization.|Adverse Event|0|||
144425971|NCT01641692|520767306|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
144425972|NCT01641692|520767307|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
144603206|NCT01170039|521409999|FG001|Overall Study|Withdrawal by Subject|3|||
144603207|NCT01170039|521409998|FG000|Overall Study|Lack of funding, drug not available|3|||
144603208|NCT01170039|521409999|FG001|Overall Study|Lack of funding, drug not available|3|||
144603209|NCT00908583|521410000|FG000|Phase 1|Withdrawal by Subject|1|||
144603210|NCT00908583|521410000|FG000|Phase 1|Adverse Event|4|||
144603211|NCT00908583|521410000|FG000|Phase 2|Physician Decision|1|||
144425973|NCT01641692|520767308|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
144425974|NCT01641692|520767309|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
144425975|NCT01641692|520767302|FG000|Treatment Period 1|Lost to Follow-up|0|||
144425976|NCT01641692|520767303|FG001|Treatment Period 1|Lost to Follow-up|0|||
144425977|NCT01641692|520767304|FG002|Treatment Period 1|Lost to Follow-up|1|||
144603212|NCT00908583|521410000|FG000|Phase 2|Adverse Event|1|||
144182336|NCT01567527|519862275|FG001|IM Depot Stabilization.|Adverse Event|0|||
144425978|NCT01641692|520767305|FG003|Treatment Period 1|Lost to Follow-up|0|||
144603213|NCT00908583|521410000|FG000|Phase 3|Adverse Event|2|||
144603214|NCT00908583|521410000|FG000|Phase 4|Adverse Event|1|||
144182337|NCT01567527|519862276|FG002|IM Depot Stabilization.|Adverse Event|37|||
144182338|NCT01567527|519862277|FG003|IM Depot Stabilization.|Adverse Event|0|||
144182339|NCT01567527|519862278|FG004|IM Depot Stabilization.|Adverse Event|0|||
144251760|NCT01119846|520120870|FG000|Overall Study|Protocol Violation|0|||
144723450|NCT02415959|521842359|FG003|Overall Study|Adverse Event|0|||
144723451|NCT02415959|521842360|FG004|Overall Study|Adverse Event|0|||
144723452|NCT02415959|521842356|FG000|Overall Study|Protocol Violation|0|||
144723453|NCT02415959|521842357|FG001|Overall Study|Protocol Violation|0|||
144723454|NCT02415959|521842358|FG002|Overall Study|Protocol Violation|0|||
144723455|NCT02415959|521842359|FG003|Overall Study|Protocol Violation|1|||
144723456|NCT02415959|521842360|FG004|Overall Study|Protocol Violation|0|||
144723457|NCT01048333|521842361|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
144723458|NCT01048333|521842362|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
144723459|NCT01048333|521842363|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
144723460|NCT01048333|521842364|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
144723461|NCT01048333|521842365|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
144723462|NCT01048333|521842366|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
144723463|NCT03008460|521842371|FG000|Overall Study|Protocol deviation|0|||
144723464|NCT03008460|521842372|FG001|Overall Study|Protocol deviation|2|||
144723465|NCT03008460|521842371|FG000|Overall Study|Study drug not dispensed|0|||
144723466|NCT03008460|521842372|FG001|Overall Study|Study drug not dispensed|1|||
144723467|NCT03008460|521842371|FG000|Overall Study|Adverse Event|0|||
144723468|NCT03008460|521842372|FG001|Overall Study|Adverse Event|1|||
144723469|NCT03008460|521842371|FG000|Overall Study|Withdrawal by Subject|5|||
144723470|NCT03008460|521842372|FG001|Overall Study|Withdrawal by Subject|6|||
144723471|NCT03008460|521842371|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
144723472|NCT03008460|521842372|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
144182340|NCT01567527|519862274|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
144182341|NCT01567527|519862275|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
144182342|NCT01567527|519862276|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
144182343|NCT01567527|519862277|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
144182344|NCT01567527|519862278|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
144603215|NCT00908583|521410000|FG000|Phase 4|Physician Decision|1|||
144603216|NCT00908583|521410000|FG000|Phase 5|Adverse Event|3|||
144603217|NCT00993954|521410001|FG000|Overall Study|Protocol Violation|21|||
144603218|NCT00993954|521410002|FG001|Overall Study|Protocol Violation|2|||
144603219|NCT00860951|521410003|FG000|Overall Study|Withdrawal by Subject|2|||
144603220|NCT00860951|521410003|FG000|Overall Study|Lost to Follow-up|5|||
144603221|NCT00727649|521410004|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
144603222|NCT00727649|521410005|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
144603223|NCT00727649|521410004|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
144603224|NCT00727649|521410005|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
144603225|NCT00727649|521410004|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
144603226|NCT00727649|521410005|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
144603227|NCT00727649|521410004|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
144603228|NCT00727649|521410005|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
144603229|NCT00727649|521410004|FG000|Second Intervention (4-weeks)|Death|1|||
144603230|NCT00727649|521410005|FG001|Second Intervention (4-weeks)|Death|0|||
144603231|NCT00727649|521410004|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
144603232|NCT00727649|521410005|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
144603233|NCT00727649|521410004|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
144603234|NCT00727649|521410005|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
144603235|NCT01830855|521410008|FG000|Overall Study|Other|7|||
144603236|NCT01830855|521410009|FG001|Overall Study|Other|1|||
144603237|NCT01830855|521410010|FG002|Overall Study|Other|4|||
144603238|NCT01830855|521410011|FG003|Overall Study|Other|4|||
144603239|NCT01830855|521410008|FG000|Overall Study|Medication error without associated AE|1|||
144603240|NCT01830855|521410009|FG001|Overall Study|Medication error without associated AE|0|||
144603241|NCT01830855|521410010|FG002|Overall Study|Medication error without associated AE|0|||
144723473|NCT03008460|521842371|FG000|Overall Study|End of study visit outside permitted time window|0|||
144723474|NCT03008460|521842372|FG001|Overall Study|End of study visit outside permitted time window|1|||
144723475|NCT03008460|521842371|FG000|Overall Study|Lost to Follow-up|1|||
144723476|NCT03008460|521842372|FG001|Overall Study|Lost to Follow-up|3|||
144723477|NCT03495869|521842377|FG000|Overall Study|Lost to Follow-up|4|||
144723478|NCT03495869|521842378|FG001|Overall Study|Lost to Follow-up|17|||
144723479|NCT03495869|521842379|FG002|Overall Study|Lost to Follow-up|8|||
144723480|NCT03495869|521842380|FG003|Overall Study|Lost to Follow-up|14|||
144723481|NCT03495869|521842377|FG000|Overall Study|Withdrawal by Subject|0|||
144723482|NCT03495869|521842378|FG001|Overall Study|Withdrawal by Subject|3|||
144723483|NCT03495869|521842379|FG002|Overall Study|Withdrawal by Subject|0|||
144723484|NCT03495869|521842380|FG003|Overall Study|Withdrawal by Subject|3|||
144723485|NCT03495869|521842377|FG000|Overall Study|Dropped from study|0|||
144723486|NCT03495869|521842378|FG001|Overall Study|Dropped from study|7|||
144723487|NCT03495869|521842379|FG002|Overall Study|Dropped from study|2|||
144603242|NCT01830855|521410011|FG003|Overall Study|Medication error without associated AE|1|||
144603243|NCT01830855|521410008|FG000|Overall Study|Pregnancy|3|||
144603244|NCT01830855|521410009|FG001|Overall Study|Pregnancy|1|||
144603245|NCT01830855|521410010|FG002|Overall Study|Pregnancy|2|||
144603246|NCT01830855|521410011|FG003|Overall Study|Pregnancy|1|||
144251761|NCT01119846|520120871|FG001|Overall Study|Protocol Violation|0|||
144251762|NCT01119846|520120872|FG002|Overall Study|Protocol Violation|1|||
144251763|NCT01119846|520120870|FG000|Overall Study|Withdrawal by Subject|0|||
144251764|NCT01119846|520120871|FG001|Overall Study|Withdrawal by Subject|0|||
144251765|NCT01119846|520120872|FG002|Overall Study|Withdrawal by Subject|4|||
144251766|NCT01084538|520120873|FG000|Overall Study|Drug not available|30|||
144723488|NCT03495869|521842380|FG003|Overall Study|Dropped from study|4|||
144723489|NCT04634409|521842383|FG000|Overall Study|Death|0|||
144425979|NCT01641692|520767306|FG004|Treatment Period 1|Lost to Follow-up|0|||
144425980|NCT01641692|520767307|FG005|Treatment Period 1|Lost to Follow-up|0|||
144425981|NCT01641692|520767308|FG006|Treatment Period 1|Lost to Follow-up|0|||
144425982|NCT01641692|520767309|FG007|Treatment Period 1|Lost to Follow-up|0|||
144425983|NCT01641692|520767302|FG000|Treatment Period 1|Physician Decision|0|||
144425984|NCT01641692|520767303|FG001|Treatment Period 1|Physician Decision|0|||
144425985|NCT01641692|520767304|FG002|Treatment Period 1|Physician Decision|0|||
144425986|NCT01641692|520767305|FG003|Treatment Period 1|Physician Decision|0|||
144425987|NCT01641692|520767306|FG004|Treatment Period 1|Physician Decision|1|||
144425988|NCT01641692|520767307|FG005|Treatment Period 1|Physician Decision|0|||
144425989|NCT01641692|520767308|FG006|Treatment Period 1|Physician Decision|0|||
144425990|NCT01641692|520767309|FG007|Treatment Period 1|Physician Decision|0|||
144425991|NCT01641692|520767302|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144425992|NCT01641692|520767303|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144425993|NCT01641692|520767304|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144425994|NCT01641692|520767305|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144425995|NCT01641692|520767306|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144425996|NCT01641692|520767307|FG005|Treatment Period 1|Withdrawal by Subject|2|||
144425997|NCT01641692|520767308|FG006|Treatment Period 1|Withdrawal by Subject|0|||
144425998|NCT01641692|520767309|FG007|Treatment Period 1|Withdrawal by Subject|1|||
144425999|NCT01641692|520767302|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
144426000|NCT01641692|520767303|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426001|NCT01641692|520767304|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426002|NCT01641692|520767305|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426003|NCT01641692|520767306|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426004|NCT01641692|520767307|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426005|NCT01641692|520767308|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426006|NCT01641692|520767309|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
144426007|NCT01641692|520767302|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144426008|NCT01641692|520767303|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144426009|NCT01641692|520767304|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144426010|NCT01641692|520767305|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144426011|NCT01641692|520767306|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144426012|NCT01641692|520767307|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144426013|NCT01641692|520767308|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
144426014|NCT01641692|520767309|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144723490|NCT04634409|521842384|FG001|Overall Study|Death|0|||
144251767|NCT01084538|520120873|FG000|Overall Study|Adverse Event|9|||
144251768|NCT01084538|520120873|FG000|Overall Study|Kidney transplant|6|||
144251769|NCT01084538|520120873|FG000|Overall Study|Serious Adverse Event|3|||
144251770|NCT01084538|520120873|FG000|Overall Study|Lack of effectiveness|2|||
144251771|NCT01084538|520120873|FG000|Overall Study|Patient noncompliance|2|||
144426015|NCT01641692|520767302|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
144426016|NCT01641692|520767303|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426017|NCT01641692|520767304|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
144528702|NCT05485779|521139107|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
144528703|NCT05485779|521139108|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
144528704|NCT05485779|521139098|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528705|NCT05485779|521139099|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528706|NCT05485779|521139100|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528707|NCT05485779|521139101|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
144528708|NCT05485779|521139102|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144538439|NCT01970007|521174194|FG000|Overall Study|"Other endpoint"|3|||
144723491|NCT04634409|521842385|FG002|Overall Study|Death|0|||
144723492|NCT04634409|521842386|FG003|Overall Study|Death|0|||
144426018|NCT01641692|520767305|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
144426019|NCT01641692|520767306|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
144426020|NCT01641692|520767307|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426021|NCT01641692|520767308|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426022|NCT01641692|520767309|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
144426023|NCT01641692|520767302|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
144426024|NCT01641692|520767303|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
144426025|NCT01641692|520767304|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144426026|NCT01641692|520767305|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
144426027|NCT01641692|520767306|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
144426028|NCT01641692|520767307|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144426029|NCT01641692|520767308|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
144426030|NCT01641692|520767309|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144426031|NCT01641692|520767302|FG000|Treatment Period 2|Lack of Efficacy|1|||
144426032|NCT01641692|520767303|FG001|Treatment Period 2|Lack of Efficacy|0|||
144426033|NCT01641692|520767304|FG002|Treatment Period 2|Lack of Efficacy|0|||
144426034|NCT01641692|520767305|FG003|Treatment Period 2|Lack of Efficacy|0|||
144426035|NCT01641692|520767306|FG004|Treatment Period 2|Lack of Efficacy|0|||
144426036|NCT01641692|520767307|FG005|Treatment Period 2|Lack of Efficacy|0|||
144426037|NCT01641692|520767308|FG006|Treatment Period 2|Lack of Efficacy|0|||
144426038|NCT01641692|520767309|FG007|Treatment Period 2|Lack of Efficacy|0|||
144426039|NCT01641692|520767302|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
144426040|NCT01641692|520767303|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426041|NCT01641692|520767304|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426042|NCT01641692|520767305|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426043|NCT01641692|520767306|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426044|NCT01641692|520767307|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426045|NCT01641692|520767308|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426046|NCT01641692|520767309|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144426047|NCT01641692|520767302|FG000|Treatment Period 2|Lost to Follow-up|0|||
144426048|NCT01641692|520767303|FG001|Treatment Period 2|Lost to Follow-up|0|||
144603247|NCT01830855|521410008|FG000|Overall Study|No longer meets eligibility criteria|11|||
144603248|NCT01830855|521410009|FG001|Overall Study|No longer meets eligibility criteria|2|||
144603249|NCT01830855|521410010|FG002|Overall Study|No longer meets eligibility criteria|3|||
144603250|NCT01830855|521410011|FG003|Overall Study|No longer meets eligibility criteria|5|||
144603251|NCT01830855|521410008|FG000|Overall Study|Adverse Event|11|||
144603252|NCT01830855|521410009|FG001|Overall Study|Adverse Event|5|||
144603253|NCT01830855|521410010|FG002|Overall Study|Adverse Event|6|||
144603254|NCT01830855|521410011|FG003|Overall Study|Adverse Event|3|||
144603255|NCT01830855|521410008|FG000|Overall Study|Protocol deviation|10|||
144603256|NCT01830855|521410009|FG001|Overall Study|Protocol deviation|5|||
144603257|NCT01830855|521410010|FG002|Overall Study|Protocol deviation|6|||
144603258|NCT01830855|521410011|FG003|Overall Study|Protocol deviation|6|||
144603259|NCT01830855|521410008|FG000|Overall Study|Withdrawal by Subject|33|||
144603260|NCT01830855|521410009|FG001|Overall Study|Withdrawal by Subject|14|||
144603261|NCT01830855|521410010|FG002|Overall Study|Withdrawal by Subject|10|||
144603262|NCT01830855|521410011|FG003|Overall Study|Withdrawal by Subject|12|||
144603263|NCT01830855|521410008|FG000|Overall Study|No longer willing to participate|32|||
144603264|NCT01830855|521410009|FG001|Overall Study|No longer willing to participate|13|||
144603265|NCT01830855|521410010|FG002|Overall Study|No longer willing to participate|12|||
144603266|NCT01830855|521410011|FG003|Overall Study|No longer willing to participate|17|||
144603267|NCT01830855|521410008|FG000|Overall Study|Lost to Follow-up|47|||
144603268|NCT01830855|521410009|FG001|Overall Study|Lost to Follow-up|20|||
144603269|NCT01830855|521410010|FG002|Overall Study|Lost to Follow-up|23|||
144603270|NCT01830855|521410011|FG003|Overall Study|Lost to Follow-up|33|||
144603271|NCT01667081|521410012|FG000|Overall Study|Death|43|||
144603272|NCT01667081|521410013|FG001|Overall Study|Death|3|||
144603273|NCT01667081|521410012|FG000|Overall Study|Lost to Follow-up|99|||
144603274|NCT01667081|521410013|FG001|Overall Study|Lost to Follow-up|48|||
144603275|NCT01667081|521410012|FG000|Overall Study|Physician Decision|16|||
144603276|NCT01667081|521410013|FG001|Overall Study|Physician Decision|2|||
144603277|NCT01667081|521410012|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
144603278|NCT01667081|521410013|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
144603279|NCT01667081|521410012|FG000|Overall Study|Withdrawal by Subject|90|||
144603280|NCT01667081|521410013|FG001|Overall Study|Withdrawal by Subject|35|||
144603281|NCT03034460|521410014|FG000|Overall Study|Adverse Event|0|||
144603282|NCT03034460|521410015|FG001|Overall Study|Adverse Event|1|||
144603283|NCT03034460|521410014|FG000|Overall Study|Withdrawal by Subject|2|||
144603284|NCT03034460|521410015|FG001|Overall Study|Withdrawal by Subject|2|||
144603285|NCT03034460|521410014|FG000|Overall Study|Personal Reasons|1|||
144603286|NCT03034460|521410015|FG001|Overall Study|Personal Reasons|0|||
144603287|NCT00295633|521410018|FG000|Overall Study|Lack of Efficacy|19|||
144603288|NCT00295633|521410019|FG001|Overall Study|Lack of Efficacy|7|||
144603289|NCT00295633|521410020|FG002|Overall Study|Lack of Efficacy|16|||
144603290|NCT00295633|521410018|FG000|Overall Study|Withdrawal of consent by subject|16|||
144603291|NCT00295633|521410019|FG001|Overall Study|Withdrawal of consent by subject|16|||
144603292|NCT00295633|521410020|FG002|Overall Study|Withdrawal of consent by subject|26|||
144603293|NCT00295633|521410018|FG000|Overall Study|Adverse Event|9|||
144251772|NCT01084538|520120873|FG000|Overall Study|Hyperphosphatemia|2|||
144603294|NCT00295633|521410019|FG001|Overall Study|Adverse Event|17|||
144603295|NCT00295633|521410020|FG002|Overall Study|Adverse Event|9|||
144603296|NCT00295633|521410018|FG000|Overall Study|Lost to Follow-up|6|||
144603297|NCT00295633|521410019|FG001|Overall Study|Lost to Follow-up|11|||
144603298|NCT00295633|521410020|FG002|Overall Study|Lost to Follow-up|7|||
144603299|NCT00295633|521410018|FG000|Overall Study|Physician Decision|9|||
144603300|NCT00295633|521410019|FG001|Overall Study|Physician Decision|10|||
144603301|NCT00295633|521410020|FG002|Overall Study|Physician Decision|8|||
144603302|NCT00295633|521410018|FG000|Overall Study|Poor/Noncompliance|2|||
144603303|NCT00295633|521410019|FG001|Overall Study|Poor/Noncompliance|2|||
144603304|NCT00295633|521410020|FG002|Overall Study|Poor/Noncompliance|6|||
144603305|NCT00295633|521410018|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
144603306|NCT00295633|521410019|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
144603307|NCT00295633|521410020|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
144603308|NCT00295633|521410018|FG000|Overall Study|Death|1|||
144603309|NCT00295633|521410019|FG001|Overall Study|Death|1|||
144603310|NCT00295633|521410020|FG002|Overall Study|Death|0|||
144603311|NCT00295633|521410018|FG000|Overall Study|Administrative reason by sponsor|0|||
144603312|NCT00295633|521410019|FG001|Overall Study|Administrative reason by sponsor|0|||
144426049|NCT01641692|520767304|FG002|Treatment Period 2|Lost to Follow-up|0|||
144426050|NCT01641692|520767305|FG003|Treatment Period 2|Lost to Follow-up|0|||
144426051|NCT01641692|520767306|FG004|Treatment Period 2|Lost to Follow-up|0|||
144426052|NCT01641692|520767307|FG005|Treatment Period 2|Lost to Follow-up|1|||
144426053|NCT01641692|520767308|FG006|Treatment Period 2|Lost to Follow-up|0|||
144426054|NCT01641692|520767309|FG007|Treatment Period 2|Lost to Follow-up|0|||
144426055|NCT01641692|520767302|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144426056|NCT01641692|520767303|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144426057|NCT01641692|520767304|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144426058|NCT01641692|520767305|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144426059|NCT01641692|520767306|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144426060|NCT01641692|520767307|FG005|Treatment Period 2|Withdrawal by Subject|1|||
144426061|NCT01641692|520767308|FG006|Treatment Period 2|Withdrawal by Subject|0|||
144426062|NCT01641692|520767309|FG007|Treatment Period 2|Withdrawal by Subject|1|||
144426063|NCT01641692|520767302|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426064|NCT01641692|520767303|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426065|NCT01641692|520767304|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426066|NCT01641692|520767305|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426067|NCT01641692|520767306|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
144426068|NCT01641692|520767307|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426069|NCT01641692|520767308|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
144426070|NCT01641692|520767309|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
144426071|NCT01641692|520767302|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144426072|NCT01641692|520767303|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144426073|NCT01641692|520767304|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
144426074|NCT01641692|520767305|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144426075|NCT01641692|520767306|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144426076|NCT01641692|520767307|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
144426077|NCT01641692|520767308|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144426078|NCT01641692|520767309|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
144426079|NCT01641692|520767302|FG000|Treatment Period 3|Adverse Event|0|||
144426080|NCT01641692|520767303|FG001|Treatment Period 3|Adverse Event|0|||
144426081|NCT01641692|520767304|FG002|Treatment Period 3|Adverse Event|0|||
144426082|NCT01641692|520767305|FG003|Treatment Period 3|Adverse Event|0|||
144426083|NCT01641692|520767306|FG004|Treatment Period 3|Adverse Event|0|||
144426084|NCT01641692|520767307|FG005|Treatment Period 3|Adverse Event|0|||
144426085|NCT01641692|520767308|FG006|Treatment Period 3|Adverse Event|1|||
144426086|NCT01641692|520767309|FG007|Treatment Period 3|Adverse Event|0|||
144426087|NCT01641692|520767302|FG000|Treatment Period 3|Protocol Violation|0|||
144603313|NCT00295633|521410020|FG002|Overall Study|Administrative reason by sponsor|1|||
144603314|NCT00404066|521410023|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
144603315|NCT00404066|521410023|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
144603316|NCT01399190|521410024|FG000|Overall Study|Not Eligible for Final Analysis|5|||
144603317|NCT01399190|521410024|FG000|Overall Study|Adverse Event|8|||
144603318|NCT01399190|521410024|FG000|Overall Study|Participant's Request|5|||
144603319|NCT01399190|521410024|FG000|Overall Study|Physician Decision|2|||
144603320|NCT01296035|521410025|FG000|Overall Study|Withdrawal by Subject|1|||
144603321|NCT03085758|521410030|FG000|Overall Study|Death|26|||
144603322|NCT03085758|521410031|FG001|Overall Study|Death|24|||
144603323|NCT03085758|521410032|FG002|Overall Study|Death|53|||
144426088|NCT01641692|520767303|FG001|Treatment Period 3|Protocol Violation|0|||
144426089|NCT01641692|520767304|FG002|Treatment Period 3|Protocol Violation|1|||
144426090|NCT01641692|520767305|FG003|Treatment Period 3|Protocol Violation|0|||
144603324|NCT03085758|521410030|FG000|Overall Study|Lost to Follow-up|1|||
144603325|NCT03085758|521410031|FG001|Overall Study|Lost to Follow-up|1|||
144603326|NCT03085758|521410032|FG002|Overall Study|Lost to Follow-up|1|||
144603327|NCT03085758|521410030|FG000|Overall Study|Withdrawal by Subject|2|||
144603328|NCT03085758|521410031|FG001|Overall Study|Withdrawal by Subject|2|||
144603329|NCT03085758|521410032|FG002|Overall Study|Withdrawal by Subject|1|||
144603330|NCT03085758|521410030|FG000|Overall Study|Refusal to recall it up to day 90|0|||
144603331|NCT03085758|521410031|FG001|Overall Study|Refusal to recall it up to day 90|0|||
144603332|NCT03085758|521410032|FG002|Overall Study|Refusal to recall it up to day 90|1|||
144603333|NCT03085758|521410030|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
144603334|NCT03085758|521410031|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
144603335|NCT03085758|521410032|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
144603336|NCT05395104|521410039|FG000|Overall Study|Met Liver Stopping Criteria|1|||
144603337|NCT05395104|521410039|FG000|Overall Study|Withdrawal by Subject|1|||
144603338|NCT00381563|521410040|FG000|Overall Study|Withdrawal by Subject|5|||
144603339|NCT00381563|521410041|FG001|Overall Study|Withdrawal by Subject|5|||
144603340|NCT00381563|521410040|FG000|Overall Study|Lost to Follow-up|2|||
144603341|NCT00381563|521410041|FG001|Overall Study|Lost to Follow-up|0|||
144603342|NCT00381563|521410040|FG000|Overall Study|Protocol Violation|0|||
144603343|NCT00381563|521410041|FG001|Overall Study|Protocol Violation|1|||
144603344|NCT03974334|521410043|FG000|Overall Study|Lost to Follow-up|1|||
144426091|NCT01641692|520767306|FG004|Treatment Period 3|Protocol Violation|0|||
144426092|NCT01641692|520767307|FG005|Treatment Period 3|Protocol Violation|0|||
144426093|NCT01641692|520767308|FG006|Treatment Period 3|Protocol Violation|0|||
144426094|NCT01641692|520767309|FG007|Treatment Period 3|Protocol Violation|0|||
144426095|NCT01641692|520767302|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144426096|NCT01641692|520767303|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144426097|NCT01641692|520767304|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144426098|NCT01641692|520767305|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144426099|NCT01641692|520767306|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144603345|NCT00931944|521410044|FG000|Overall Study|Adverse Event|4|||
144603346|NCT00931944|521410044|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
144603347|NCT00931944|521410044|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
144603348|NCT00931944|521410044|FG000|Overall Study|Death|28|||
144603349|NCT00931944|521410044|FG000|Overall Study|Other|2|||
144603350|NCT01109173|521410045|FG000|Overall Study|Adverse Event|15|||
144603351|NCT01109173|521410046|FG001|Overall Study|Adverse Event|17|||
144603352|NCT01109173|521410047|FG002|Overall Study|Adverse Event|9|||
144603353|NCT01109173|521410048|FG003|Overall Study|Adverse Event|6|||
144603354|NCT01109173|521410045|FG000|Overall Study|Lost to Follow-up|0|||
144603355|NCT01109173|521410046|FG001|Overall Study|Lost to Follow-up|1|||
144603356|NCT01109173|521410047|FG002|Overall Study|Lost to Follow-up|0|||
144603357|NCT01109173|521410048|FG003|Overall Study|Lost to Follow-up|0|||
144603358|NCT01109173|521410045|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
144603359|NCT01109173|521410046|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
144603360|NCT01109173|521410047|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
144603361|NCT01109173|521410048|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
144603362|NCT01109173|521410045|FG000|Overall Study|Noncompliance|0|||
144603363|NCT01109173|521410046|FG001|Overall Study|Noncompliance|1|||
144603364|NCT01109173|521410047|FG002|Overall Study|Noncompliance|0|||
144603365|NCT01109173|521410048|FG003|Overall Study|Noncompliance|0|||
144603366|NCT01109173|521410045|FG000|Overall Study|Treatment Failure|25|||
144426100|NCT01641692|520767307|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144426101|NCT01641692|520767308|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
144426102|NCT01641692|520767309|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144603367|NCT01109173|521410046|FG001|Overall Study|Treatment Failure|32|||
144426103|NCT01641692|520767302|FG000|Treatment Period 3|Lost to Follow-up|0|||
144426104|NCT01641692|520767303|FG001|Treatment Period 3|Lost to Follow-up|1|||
144426105|NCT01641692|520767304|FG002|Treatment Period 3|Lost to Follow-up|0|||
144426106|NCT01641692|520767305|FG003|Treatment Period 3|Lost to Follow-up|0|||
144426107|NCT01641692|520767306|FG004|Treatment Period 3|Lost to Follow-up|0|||
144426108|NCT01641692|520767307|FG005|Treatment Period 3|Lost to Follow-up|0|||
144426109|NCT01641692|520767308|FG006|Treatment Period 3|Lost to Follow-up|0|||
144426110|NCT01641692|520767309|FG007|Treatment Period 3|Lost to Follow-up|0|||
144603368|NCT01109173|521410047|FG002|Overall Study|Treatment Failure|69|||
144603369|NCT01109173|521410048|FG003|Overall Study|Treatment Failure|64|||
144603370|NCT01109173|521410045|FG000|Overall Study|Protocol Violation|4|||
144603371|NCT01109173|521410046|FG001|Overall Study|Protocol Violation|5|||
144426111|NCT01641692|520767302|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
144603372|NCT01109173|521410047|FG002|Overall Study|Protocol Violation|1|||
144603373|NCT01109173|521410048|FG003|Overall Study|Protocol Violation|2|||
144603374|NCT01109173|521410045|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
144603375|NCT01109173|521410046|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
144426112|NCT01641692|520767303|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
144426113|NCT01641692|520767304|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
144603376|NCT01109173|521410047|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
144603377|NCT01109173|521410048|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
144603378|NCT01109173|521410045|FG000|Overall Study|Not Specifiied|5|||
144603379|NCT01109173|521410046|FG001|Overall Study|Not Specifiied|4|||
144603380|NCT01109173|521410047|FG002|Overall Study|Not Specifiied|9|||
144603381|NCT01109173|521410048|FG003|Overall Study|Not Specifiied|14|||
144603382|NCT01132612|521410049|FG000|Overall Study|Death|0|||
144603383|NCT01132612|521410050|FG001|Overall Study|Death|0|||
144603384|NCT01132612|521410051|FG002|Overall Study|Death|1|||
144603385|NCT01132612|521410049|FG000|Overall Study|Protocol deviation|0|||
144603386|NCT01132612|521410050|FG001|Overall Study|Protocol deviation|0|||
144603387|NCT01132612|521410051|FG002|Overall Study|Protocol deviation|3|||
144603388|NCT01132612|521410049|FG000|Overall Study|Lost to Follow-up|2|||
144603389|NCT01132612|521410050|FG001|Overall Study|Lost to Follow-up|2|||
144603390|NCT01132612|521410051|FG002|Overall Study|Lost to Follow-up|7|||
144603391|NCT01132612|521410049|FG000|Overall Study|Adverse Event|5|||
144603392|NCT01132612|521410050|FG001|Overall Study|Adverse Event|2|||
144603393|NCT01132612|521410051|FG002|Overall Study|Adverse Event|15|||
144603394|NCT01132612|521410049|FG000|Overall Study|Withdrawal by Subject|5|||
144603395|NCT01132612|521410050|FG001|Overall Study|Withdrawal by Subject|8|||
144603396|NCT01132612|521410051|FG002|Overall Study|Withdrawal by Subject|19|||
144603397|NCT01132612|521410049|FG000|Overall Study|Administrative problems|5|||
144603398|NCT01132612|521410050|FG001|Overall Study|Administrative problems|1|||
144603399|NCT01132612|521410051|FG002|Overall Study|Administrative problems|52|||
144603400|NCT01132612|521410049|FG000|Overall Study|Lack of Efficacy|23|||
144603401|NCT01132612|521410050|FG001|Overall Study|Lack of Efficacy|22|||
144603402|NCT01132612|521410051|FG002|Overall Study|Lack of Efficacy|73|||
144603403|NCT02252536|521410055|FG000|Overall Study|Lost to Follow-up|5|||
144603404|NCT02252536|521410056|FG001|Overall Study|Lost to Follow-up|3|||
144603405|NCT00006392|521410062|FG000|Overall Study|Ineligible|11|||
144603406|NCT00006392|521410063|FG001|Overall Study|Ineligible|3|||
144603407|NCT00006392|521410064|FG002|Overall Study|Ineligible|5|||
144603408|NCT00006392|521410065|FG003|Overall Study|Ineligible|5|||
144603409|NCT00006392|521410062|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
144603410|NCT00006392|521410063|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
144603411|NCT00006392|521410064|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
144603412|NCT00006392|521410065|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
144603413|NCT01186796|521410066|FG000|Overall Study|Adverse Event|3|||
144603414|NCT01186796|521410067|FG001|Overall Study|Adverse Event|0|||
144603415|NCT01186796|521410066|FG000|Overall Study|Withdrawal by Subject|1|||
144603416|NCT01186796|521410067|FG001|Overall Study|Withdrawal by Subject|1|||
144603417|NCT01186796|521410066|FG000|Overall Study|Protocol Violation|0|||
144603418|NCT01186796|521410067|FG001|Overall Study|Protocol Violation|1|||
144603419|NCT03838198|521410071|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
144603420|NCT03838198|521410072|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
144603421|NCT03838198|521410073|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
144603422|NCT03838198|521410074|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
144603423|NCT03838198|521410071|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
144603424|NCT03838198|521410072|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
144603425|NCT03838198|521410073|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
144603426|NCT03838198|521410074|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
144603427|NCT01287364|521410075|FG000|Overall Study|Adverse Event|0|||
144426114|NCT01641692|520767305|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
144426115|NCT01641692|520767306|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
144426116|NCT01641692|520767307|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
144426117|NCT01641692|520767308|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
144426118|NCT01641692|520767309|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
144426119|NCT01641692|520767302|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
144426120|NCT01641692|520767303|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
144426121|NCT01641692|520767304|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
144426122|NCT01641692|520767305|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
144426123|NCT01641692|520767306|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
144426124|NCT01641692|520767307|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
144603428|NCT01287364|521410076|FG001|Overall Study|Adverse Event|3|||
144603429|NCT01287364|521410075|FG000|Overall Study|Protocol Violation|5|||
144603430|NCT01287364|521410076|FG001|Overall Study|Protocol Violation|5|||
144603431|NCT01287364|521410075|FG000|Overall Study|Other Reason|4|||
144603432|NCT01287364|521410076|FG001|Overall Study|Other Reason|2|||
144603433|NCT00770770|521410089|FG000|Overall Study|Lost to Follow-up|1|||
144603434|NCT00770770|521410090|FG001|Overall Study|Lost to Follow-up|0|||
144603435|NCT00770770|521410089|FG000|Overall Study|Withdrawal by Subject|1|||
144723493|NCT04634409|521842387|FG004|Overall Study|Death|0|||
144603436|NCT00770770|521410090|FG001|Overall Study|Withdrawal by Subject|0|||
144603437|NCT00770770|521410089|FG000|Overall Study|Death|0|||
144426125|NCT01641692|520767308|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
144426126|NCT01641692|520767309|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
144426127|NCT02515045|520767313|FG000|Overall Study|Adverse Event|0|||
144426128|NCT02515045|520767314|FG001|Overall Study|Adverse Event|3|||
144426129|NCT02515045|520767315|FG002|Overall Study|Adverse Event|3|||
144426130|NCT02515045|520767313|FG000|Overall Study|Lost to Follow-up|0|||
144426131|NCT02515045|520767314|FG001|Overall Study|Lost to Follow-up|1|||
144426132|NCT02515045|520767315|FG002|Overall Study|Lost to Follow-up|1|||
144426133|NCT01412021|520767316|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
144426134|NCT01412021|520767316|FG000|Overall Study|Treatment Prior to Approval|3|||
144426135|NCT01412021|520767316|FG000|Overall Study|Transferred to Other Hospital|9|||
144426136|NCT00449644|520767321|FG000|Overall Study|Adverse Event|0|||
144426137|NCT00449644|520767322|FG001|Overall Study|Adverse Event|0|||
144426138|NCT00449644|520767323|FG002|Overall Study|Adverse Event|3|||
144426139|NCT00449644|520767324|FG003|Overall Study|Adverse Event|5|||
144426140|NCT00449644|520767321|FG000|Overall Study|Death|1|||
144426141|NCT00449644|520767322|FG001|Overall Study|Death|0|||
144426142|NCT00449644|520767323|FG002|Overall Study|Death|6|||
144426143|NCT00449644|520767324|FG003|Overall Study|Death|1|||
144426144|NCT00449644|520767321|FG000|Overall Study|Lost to Follow-up|1|||
144426145|NCT00449644|520767322|FG001|Overall Study|Lost to Follow-up|1|||
144426146|NCT00449644|520767323|FG002|Overall Study|Lost to Follow-up|5|||
144426147|NCT00449644|520767324|FG003|Overall Study|Lost to Follow-up|3|||
144426148|NCT00449644|520767321|FG000|Overall Study|Pregnancy|0|||
144426149|NCT00449644|520767322|FG001|Overall Study|Pregnancy|0|||
144426150|NCT00449644|520767323|FG002|Overall Study|Pregnancy|3|||
144426151|NCT00449644|520767324|FG003|Overall Study|Pregnancy|2|||
144426152|NCT00449644|520767321|FG000|Overall Study|Protocol Violation|4|||
144426153|NCT00449644|520767322|FG001|Overall Study|Protocol Violation|4|||
144426154|NCT00449644|520767323|FG002|Overall Study|Protocol Violation|3|||
144426155|NCT00449644|520767324|FG003|Overall Study|Protocol Violation|7|||
144426156|NCT00449644|520767321|FG000|Overall Study|Withdrawal by Subject|3|||
144426157|NCT00449644|520767322|FG001|Overall Study|Withdrawal by Subject|4|||
144426158|NCT00449644|520767323|FG002|Overall Study|Withdrawal by Subject|6|||
144426159|NCT00449644|520767324|FG003|Overall Study|Withdrawal by Subject|7|||
144426160|NCT00449644|520767321|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
144426161|NCT00449644|520767322|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
144426162|NCT00449644|520767323|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
144426163|NCT00449644|520767324|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
144426164|NCT00449644|520767321|FG000|Overall Study|Other|1|||
144426165|NCT00449644|520767322|FG001|Overall Study|Other|4|||
144426166|NCT00449644|520767323|FG002|Overall Study|Other|1|||
144426167|NCT00449644|520767324|FG003|Overall Study|Other|0|||
144426168|NCT00449644|520767321|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
144426169|NCT00449644|520767322|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
144426170|NCT00449644|520767323|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
144426171|NCT00449644|520767324|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
144426172|NCT00529542|520767325|FG000|Overall Study|Withdrawal by Subject|1|||
144426173|NCT00529542|520767326|FG001|Overall Study|Withdrawal by Subject|0|||
144426174|NCT00529542|520767325|FG000|Overall Study|Lost to Follow-up|0|||
144426175|NCT00529542|520767326|FG001|Overall Study|Lost to Follow-up|1|||
144426176|NCT02291055|520767331|FG000|Overall Study|Death|2|||
144426177|NCT02291055|520767332|FG001|Overall Study|Death|2|||
144603438|NCT00770770|521410090|FG001|Overall Study|Death|1|||
144603439|NCT00770770|521410089|FG000|Overall Study|Study Terminated|8|||
144603440|NCT00770770|521410090|FG001|Overall Study|Study Terminated|0|||
144426178|NCT02291055|520767333|FG002|Overall Study|Death|5|||
144426179|NCT02291055|520767334|FG003|Overall Study|Death|8|||
144426180|NCT02291055|520767335|FG004|Overall Study|Death|12|||
144603441|NCT05372653|521410091|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
144603442|NCT05372653|521410092|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
144426181|NCT02291055|520767331|FG000|Overall Study|Lost to Follow-up|0|||
144426182|NCT02291055|520767332|FG001|Overall Study|Lost to Follow-up|0|||
144426183|NCT02291055|520767333|FG002|Overall Study|Lost to Follow-up|0|||
144426184|NCT02291055|520767334|FG003|Overall Study|Lost to Follow-up|1|||
144426185|NCT02291055|520767335|FG004|Overall Study|Lost to Follow-up|2|||
144426186|NCT02291055|520767331|FG000|Overall Study|Withdrawal by Subject|3|||
144426187|NCT02291055|520767332|FG001|Overall Study|Withdrawal by Subject|1|||
144426188|NCT02291055|520767333|FG002|Overall Study|Withdrawal by Subject|1|||
144426189|NCT02291055|520767334|FG003|Overall Study|Withdrawal by Subject|5|||
144426190|NCT02291055|520767335|FG004|Overall Study|Withdrawal by Subject|10|||
144426191|NCT02291055|520767331|FG000|Overall Study|Progressive Disease|0|||
144426192|NCT02291055|520767332|FG001|Overall Study|Progressive Disease|0|||
144426193|NCT02291055|520767333|FG002|Overall Study|Progressive Disease|1|||
144426194|NCT02291055|520767334|FG003|Overall Study|Progressive Disease|4|||
144426195|NCT02291055|520767335|FG004|Overall Study|Progressive Disease|2|||
144603443|NCT05372653|521410091|FG000|Overall Study|Adverse Event|0|||
144426196|NCT02291055|520767331|FG000|Overall Study|Study Terminated by Sponsor|0|||
144603444|NCT05372653|521410092|FG001|Overall Study|Adverse Event|1|||
144603445|NCT00117507|521410093|FG000|Overall Study|Adverse Event|4|||
144603446|NCT00117507|521410093|FG000|Overall Study|Abnormal laboratory values|3|||
144603447|NCT00117507|521410093|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144426197|NCT02291055|520767332|FG001|Overall Study|Study Terminated by Sponsor|0|||
144426198|NCT02291055|520767333|FG002|Overall Study|Study Terminated by Sponsor|0|||
144426199|NCT02291055|520767334|FG003|Overall Study|Study Terminated by Sponsor|5|||
144426200|NCT02291055|520767335|FG004|Overall Study|Study Terminated by Sponsor|1|||
144426201|NCT02291055|520767331|FG000|Overall Study|Other|0|||
144426202|NCT02291055|520767332|FG001|Overall Study|Other|2|||
144426203|NCT02291055|520767333|FG002|Overall Study|Other|1|||
144426204|NCT02291055|520767334|FG003|Overall Study|Other|4|||
144426205|NCT02291055|520767335|FG004|Overall Study|Other|0|||
144426206|NCT00733746|520767340|FG000|Overall Study|Ineligible|5|||
144426207|NCT02113956|520767341|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
144426208|NCT02113956|520767342|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
144426209|NCT02113956|520767341|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
144426210|NCT02113956|520767342|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
144426211|NCT02113956|520767341|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
144426212|NCT02113956|520767342|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
144426213|NCT02446990|520767343|FG000|Overall Study|Death|485|||
144426214|NCT02446990|520767344|FG001|Overall Study|Death|458|||
144426215|NCT02446990|520767343|FG000|Overall Study|Lost to Follow-up|3|||
144426216|NCT02446990|520767344|FG001|Overall Study|Lost to Follow-up|1|||
144426217|NCT02446990|520767343|FG000|Overall Study|Physician Decision|1|||
144426218|NCT02446990|520767344|FG001|Overall Study|Physician Decision|0|||
144426219|NCT02446990|520767343|FG000|Overall Study|Withdrawal by Subject|231|||
144426220|NCT02446990|520767344|FG001|Overall Study|Withdrawal by Subject|199|||
144426221|NCT01064401|520767345|FG000|Overall Study|Adverse Event|47|||
144426222|NCT01064401|520767346|FG001|Overall Study|Adverse Event|56|||
144426223|NCT01064401|520767345|FG000|Overall Study|Lack of Efficacy|46|||
144426224|NCT01064401|520767346|FG001|Overall Study|Lack of Efficacy|23|||
144426225|NCT01064401|520767345|FG000|Overall Study|Lost to Follow-up|12|||
144426226|NCT01064401|520767346|FG001|Overall Study|Lost to Follow-up|9|||
144426227|NCT01064401|520767345|FG000|Overall Study|Consent Withdrawn|98|||
144426228|NCT01064401|520767346|FG001|Overall Study|Consent Withdrawn|80|||
144426229|NCT01064401|520767345|FG000|Overall Study|Investigator Decision|4|||
144426230|NCT01064401|520767346|FG001|Overall Study|Investigator Decision|6|||
144426231|NCT01064401|520767345|FG000|Overall Study|Death|4|||
144426232|NCT01064401|520767346|FG001|Overall Study|Death|0|||
144426233|NCT01064401|520767345|FG000|Overall Study|Pregnancy|4|||
144426234|NCT01064401|520767346|FG001|Overall Study|Pregnancy|7|||
144426235|NCT01064401|520767345|FG000|Overall Study|Noncompliance|7|||
144426236|NCT01064401|520767346|FG001|Overall Study|Noncompliance|8|||
144426237|NCT01064401|520767345|FG000|Overall Study|Site Closure|4|||
144723494|NCT04634409|521842388|FG005|Overall Study|Death|0|||
144723495|NCT04634409|521842389|FG006|Overall Study|Death|0|||
144723496|NCT04634409|521842390|FG007|Overall Study|Death|0|||
144723497|NCT04634409|521842391|FG008|Overall Study|Death|0|||
144723498|NCT04634409|521842392|FG009|Overall Study|Death|0|||
144723499|NCT04634409|521842393|FG010|Overall Study|Death|1|||
144723500|NCT04634409|521842394|FG011|Overall Study|Death|0|||
144723501|NCT04634409|521842395|FG012|Overall Study|Death|1|||
144723502|NCT04634409|521842396|FG013|Overall Study|Death|0|||
144603448|NCT00117507|521410093|FG000|Overall Study|Patient withdrew consent|4|||
144426238|NCT01064401|520767346|FG001|Overall Study|Site Closure|5|||
144426239|NCT01064401|520767345|FG000|Overall Study|Other|2|||
144426240|NCT01064401|520767346|FG001|Overall Study|Other|1|||
144426241|NCT03158051|520767347|FG000|Overall Study|Lost to Follow-up|41|||
144426242|NCT03158051|520767348|FG001|Overall Study|Lost to Follow-up|47|||
144426243|NCT03158051|520767347|FG000|Overall Study|Physician Decision|6|||
144603449|NCT00117507|521410093|FG000|Overall Study|Death|3|||
144603450|NCT00711529|521410094|FG000|Overall Study|Protocol Violation|2|||
144426244|NCT03158051|520767348|FG001|Overall Study|Physician Decision|7|||
144426245|NCT03158051|520767347|FG000|Overall Study|Withdrawal by Subject|24|||
144426246|NCT03158051|520767348|FG001|Overall Study|Withdrawal by Subject|15|||
144426247|NCT03158051|520767347|FG000|Overall Study|Death|0|||
144426248|NCT03158051|520767348|FG001|Overall Study|Death|1|||
144426249|NCT02588833|520767349|FG000|Part 1|Withdrawal by Subject|1|||
144426250|NCT02588833|520767350|FG001|Part 1|Withdrawal by Subject|0|||
144426251|NCT02588833|520767349|FG000|Part 2A|Physician Decision|0|||
144426252|NCT02588833|520767350|FG001|Part 2A|Physician Decision|1|||
144426253|NCT02588833|520767349|FG000|Part 2A|Withdrawal by Subject|0|||
144603451|NCT00711529|521410095|FG001|Overall Study|Protocol Violation|0|||
144603452|NCT00711529|521410094|FG000|Overall Study|Withdrawal by Subject|2|||
144723503|NCT04634409|521842397|FG014|Overall Study|Death|0|||
144723504|NCT04634409|521842398|FG015|Overall Study|Death|0|||
144723505|NCT04634409|521842399|FG016|Overall Study|Death|0|||
144426254|NCT02588833|520767350|FG001|Part 2A|Withdrawal by Subject|1|||
144426255|NCT02588833|520767349|FG000|Part 2B|Adverse Event|0|||
144723506|NCT04634409|521842400|FG017|Overall Study|Death|0|||
144603453|NCT00711529|521410095|FG001|Overall Study|Withdrawal by Subject|6|||
144426256|NCT02588833|520767350|FG001|Part 2B|Adverse Event|1|||
144426257|NCT02588833|520767349|FG000|Part 2C|Adverse Event|0|||
144426258|NCT02588833|520767350|FG001|Part 2C|Adverse Event|1|||
144426259|NCT02588833|520767349|FG000|Part 2C|Withdrawal by Subject|0|||
144426260|NCT02588833|520767350|FG001|Part 2C|Withdrawal by Subject|1|||
144426261|NCT02588833|520767349|FG000|Part 3 (Safety Follow-up)|Other|0|||
144426262|NCT02588833|520767350|FG001|Part 3 (Safety Follow-up)|Other|2|||
144426263|NCT02738151|520767351|FG000|Overall Study|Randomized but not treated|4|||
144426264|NCT02738151|520767352|FG001|Overall Study|Randomized but not treated|1|||
144426265|NCT02738151|520767351|FG000|Overall Study|Adverse Event|4|||
144426266|NCT02738151|520767352|FG001|Overall Study|Adverse Event|5|||
144426267|NCT02738151|520767351|FG000|Overall Study|Hypoglycemia|0|||
144426268|NCT02738151|520767352|FG001|Overall Study|Hypoglycemia|1|||
144426269|NCT02738151|520767351|FG000|Overall Study|Poor Compliance to Protocol|4|||
144426270|NCT02738151|520767352|FG001|Overall Study|Poor Compliance to Protocol|3|||
144426271|NCT02738151|520767351|FG000|Overall Study|Other than specified above|11|||
144426272|NCT02738151|520767352|FG001|Overall Study|Other than specified above|21|||
144426273|NCT03333044|520767356|FG000|Overall Study|Pregnancy|1|||
144426274|NCT03333044|520767357|FG001|Overall Study|Pregnancy|0|||
144426275|NCT03333044|520767358|FG002|Overall Study|Pregnancy|0|||
144426276|NCT03333044|520767356|FG000|Overall Study|Lost to Follow-up|0|||
144426277|NCT03333044|520767357|FG001|Overall Study|Lost to Follow-up|14|||
144426278|NCT03333044|520767358|FG002|Overall Study|Lost to Follow-up|6|||
144426279|NCT03649711|520767361|FG000|Overall Study|Adverse Event|0|||
144426280|NCT03649711|520767362|FG001|Overall Study|Adverse Event|1|||
144426281|NCT03649711|520767363|FG002|Overall Study|Adverse Event|0|||
144426282|NCT03649711|520767361|FG000|Overall Study|Kidney Transplant|1|||
144426283|NCT03649711|520767362|FG001|Overall Study|Kidney Transplant|0|||
144426284|NCT03649711|520767363|FG002|Overall Study|Kidney Transplant|0|||
144426285|NCT02926924|520769484|FG000|Overall Study|withdrawal - reason unknown|0|||
144426286|NCT02926924|520769485|FG001|Overall Study|withdrawal - reason unknown|1|||
144426287|NCT00773292|520769486|FG000|Treatment 48 Weeks|Adverse Event|1|||
144426288|NCT00773292|520769486|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
144426289|NCT04729127|520769487|FG000|Overall Study|Suspended/Terminated EI Services|4|||
144426290|NCT04729127|520769488|FG001|Overall Study|Suspended/Terminated EI Services|0|||
144426291|NCT04729127|520769489|FG002|Overall Study|Suspended/Terminated EI Services|4|||
144426292|NCT04729127|520769490|FG003|Overall Study|Suspended/Terminated EI Services|6|||
144426293|NCT04729127|520769491|FG004|Overall Study|Suspended/Terminated EI Services|0|||
144426294|NCT04729127|520769492|FG005|Overall Study|Suspended/Terminated EI Services|6|||
144426295|NCT04729127|520769493|FG006|Overall Study|Suspended/Terminated EI Services|2|||
144426296|NCT04729127|520769494|FG007|Overall Study|Suspended/Terminated EI Services|0|||
144426297|NCT04729127|520769495|FG008|Overall Study|Suspended/Terminated EI Services|2|||
144426298|NCT04729127|520769487|FG000|Overall Study|Withdrawal by Subject|1|||
144426299|NCT04729127|520769488|FG001|Overall Study|Withdrawal by Subject|0|||
144426300|NCT04729127|520769489|FG002|Overall Study|Withdrawal by Subject|1|||
144426301|NCT04729127|520769490|FG003|Overall Study|Withdrawal by Subject|0|||
144426302|NCT04729127|520769491|FG004|Overall Study|Withdrawal by Subject|0|||
144426303|NCT04729127|520769492|FG005|Overall Study|Withdrawal by Subject|0|||
144426304|NCT04729127|520769493|FG006|Overall Study|Withdrawal by Subject|0|||
144426305|NCT04729127|520769494|FG007|Overall Study|Withdrawal by Subject|0|||
144426306|NCT04729127|520769495|FG008|Overall Study|Withdrawal by Subject|0|||
144426307|NCT04729127|520769487|FG000|Overall Study|Switched Agency/Setting|1|||
144426308|NCT04729127|520769488|FG001|Overall Study|Switched Agency/Setting|0|||
144426309|NCT04729127|520769489|FG002|Overall Study|Switched Agency/Setting|1|||
144426310|NCT04729127|520769490|FG003|Overall Study|Switched Agency/Setting|1|||
144426311|NCT04729127|520769491|FG004|Overall Study|Switched Agency/Setting|0|||
144426312|NCT04729127|520769492|FG005|Overall Study|Switched Agency/Setting|1|||
144426313|NCT04729127|520769493|FG006|Overall Study|Switched Agency/Setting|1|||
144603454|NCT03740997|521410098|FG000|Overall Study|Withdrawal by Subject|1|||
144603455|NCT03740997|521410099|FG001|Overall Study|Withdrawal by Subject|0|||
144603456|NCT03740997|521410098|FG000|Overall Study|Participant was unable to complete study procedures|1|||
144426314|NCT04729127|520769494|FG007|Overall Study|Switched Agency/Setting|0|||
144426315|NCT04729127|520769495|FG008|Overall Study|Switched Agency/Setting|1|||
144426316|NCT02385266|520769498|FG000|Overall Study|Withdrawal by Subject|1|||
144426317|NCT02385266|520769499|FG001|Overall Study|Withdrawal by Subject|3|||
144603457|NCT03740997|521410099|FG001|Overall Study|Participant was unable to complete study procedures|0|||
144603458|NCT01003990|521410100|FG000|Overall Study|Adverse Event|8|||
144603459|NCT01003990|521410101|FG001|Overall Study|Adverse Event|5|||
144603460|NCT01003990|521410102|FG002|Overall Study|Adverse Event|11|||
144426318|NCT03388138|520769501|FG000|Overall Study|Protocol Violation|1|||
144426319|NCT03388138|520769502|FG001|Overall Study|Protocol Violation|0|||
144426320|NCT01528072|520769503|FG000|Overall Study|Withdrawal by Subject|5|||
144426321|NCT01528072|520769503|FG000|Overall Study|Physician Decision|1|||
144426322|NCT01528072|520769503|FG000|Overall Study|Determined not eligible by AEAC|1|||
144426323|NCT01528072|520769503|FG000|Overall Study|Missed Visit|2|||
144426324|NCT01528072|520769503|FG000|Overall Study|Lost to Follow-up|5|||
144603461|NCT01003990|521410100|FG000|Overall Study|Death|0|||
144603462|NCT01003990|521410101|FG001|Overall Study|Death|8|||
144603463|NCT01003990|521410102|FG002|Overall Study|Death|1|||
144603464|NCT01003990|521410100|FG000|Overall Study|Lack of Efficacy|10|||
144603465|NCT01003990|521410101|FG001|Overall Study|Lack of Efficacy|2|||
144603466|NCT01003990|521410102|FG002|Overall Study|Lack of Efficacy|3|||
144603467|NCT01003990|521410100|FG000|Overall Study|Lost to Follow-up|30|||
144603468|NCT01003990|521410101|FG001|Overall Study|Lost to Follow-up|12|||
144603469|NCT01003990|521410102|FG002|Overall Study|Lost to Follow-up|7|||
144603470|NCT01003990|521410100|FG000|Overall Study|Reasons Not Identified|14|||
144603471|NCT01003990|521410101|FG001|Overall Study|Reasons Not Identified|13|||
144603472|NCT01003990|521410102|FG002|Overall Study|Reasons Not Identified|8|||
144603473|NCT01003990|521410100|FG000|Overall Study|Poor/Non-compliance|4|||
144603474|NCT01003990|521410101|FG001|Overall Study|Poor/Non-compliance|3|||
144603475|NCT01003990|521410102|FG002|Overall Study|Poor/Non-compliance|2|||
144603476|NCT01003990|521410100|FG000|Overall Study|Pregnancy|10|||
144603477|NCT01003990|521410101|FG001|Overall Study|Pregnancy|2|||
144603478|NCT01003990|521410102|FG002|Overall Study|Pregnancy|4|||
144603479|NCT01003990|521410100|FG000|Overall Study|No Longer Met Study Criteria|4|||
144603480|NCT01003990|521410101|FG001|Overall Study|No Longer Met Study Criteria|1|||
144603481|NCT01003990|521410102|FG002|Overall Study|No Longer Met Study Criteria|0|||
144603482|NCT01003990|521410100|FG000|Overall Study|Subject Withdrew Consent|12|||
144603483|NCT01003990|521410101|FG001|Overall Study|Subject Withdrew Consent|5|||
144603484|NCT01003990|521410102|FG002|Overall Study|Subject Withdrew Consent|7|||
144603485|NCT03606980|521410105|FG000|Overall Study|Lost to Follow-up|3|||
144603486|NCT03606980|521410106|FG001|Overall Study|Lost to Follow-up|2|||
144603487|NCT03606980|521410107|FG002|Overall Study|Lost to Follow-up|3|||
144603488|NCT03606980|521410105|FG000|Overall Study|Withdrawal by Subject|1|||
144603489|NCT03606980|521410106|FG001|Overall Study|Withdrawal by Subject|0|||
144603490|NCT03606980|521410107|FG002|Overall Study|Withdrawal by Subject|4|||
144603491|NCT01102803|521410108|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
144426325|NCT01528072|520769503|FG000|Overall Study|Explanted|2|||
144426326|NCT01528072|520769503|FG000|Overall Study|Site Closure|4|||
144426327|NCT01528072|520769503|FG000|Overall Study|Death|2|||
144426328|NCT01528072|520769503|FG000|Overall Study|Early Termination of Study|52|||
144426329|NCT01859494|520769504|FG000|Overall Study|Adverse Event|1|||
144426330|NCT04741074|520769507|FG000|Overall Study|Withdrawal by Subject|1|||
144426331|NCT04741074|520769508|FG001|Overall Study|Withdrawal by Subject|1|||
144426332|NCT04741074|520769507|FG000|Overall Study|Study terminated prematurely|1|||
144426333|NCT04741074|520769508|FG001|Overall Study|Study terminated prematurely|0|||
144426334|NCT02357901|520769513|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
144426335|NCT02357901|520769514|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
144426336|NCT02357901|520769515|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
144426337|NCT02357901|520769516|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
144426338|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
144426339|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
144426340|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
144426341|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
144426342|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
144426343|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
144426344|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
144426345|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
144426346|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
144426347|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
144426348|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
144426349|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
144603492|NCT01102803|521410109|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
144603493|NCT01102803|521410108|FG000|Post to Follow-Up|Lost to Follow-up|1|||
144603494|NCT01102803|521410109|FG001|Post to Follow-Up|Lost to Follow-up|3|||
144603495|NCT03427125|521410110|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
144603496|NCT03427125|521410111|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
144603497|NCT03427125|521410112|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
144603498|NCT02684279|521410113|FG000|Overall Study|Adverse Event|87|||
144603499|NCT02684279|521410113|FG000|Overall Study|Lack of Efficacy|4|||
144603500|NCT02684279|521410113|FG000|Overall Study|Lost to Follow-up|61|||
144603501|NCT02684279|521410113|FG000|Overall Study|Protocol Violation|6|||
144603502|NCT02684279|521410113|FG000|Overall Study|Pregnancy|8|||
144603503|NCT02684279|521410113|FG000|Overall Study|Withdrawal by Subject|92|||
144603504|NCT02684279|521410113|FG000|Overall Study|non-compliance with study drug|9|||
144603505|NCT02684279|521410113|FG000|Overall Study|non compliance with study visits|2|||
144426350|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
144426351|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
144603506|NCT02684279|521410113|FG000|Overall Study|subject to have surgery|1|||
144603507|NCT02684279|521410113|FG000|Overall Study|family emergency|1|||
144426352|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
144426353|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
144426354|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
144603508|NCT02684279|521410113|FG000|Overall Study|Site closures|7|||
144603509|NCT02684279|521410113|FG000|Overall Study|Physician Decision|1|||
144603510|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
144426355|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
144426356|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
144426357|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
144426358|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
144426359|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
144426360|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
144426361|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
144426362|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
144426363|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
144426364|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
144426365|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
144426366|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
144426367|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
144426368|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
144426369|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
144426370|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
144426371|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
144426372|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
144426373|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
144603511|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
144603512|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
144603513|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
144603514|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
144603515|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
144603516|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
144603517|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
144603518|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
144603519|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
144603520|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
144603521|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
144603522|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
144603523|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
144426374|NCT02357901|520769513|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
144426375|NCT02357901|520769514|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
144426376|NCT02357901|520769515|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
144426377|NCT02357901|520769516|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
144426378|NCT00491387|520769525|FG000|Overall Study|study terminated|20|||
144426379|NCT00413192|520769528|FG000|Overall Study|Disease progression|26|||
144426380|NCT00413192|520769529|FG001|Overall Study|Disease progression|31|||
144426381|NCT00413192|520769530|FG002|Overall Study|Disease progression|16|||
144426382|NCT00413192|520769531|FG003|Overall Study|Disease progression|25|||
144426383|NCT00413192|520769528|FG000|Overall Study|Toxicity|3|||
144426384|NCT00413192|520769529|FG001|Overall Study|Toxicity|2|||
144426385|NCT00413192|520769530|FG002|Overall Study|Toxicity|2|||
144426386|NCT00413192|520769531|FG003|Overall Study|Toxicity|2|||
144426387|NCT00413192|520769528|FG000|Overall Study|Withdrawal by Subject|3|||
144426388|NCT00413192|520769529|FG001|Overall Study|Withdrawal by Subject|5|||
144426389|NCT00413192|520769530|FG002|Overall Study|Withdrawal by Subject|0|||
144426390|NCT00413192|520769531|FG003|Overall Study|Withdrawal by Subject|1|||
144426391|NCT00413192|520769528|FG000|Overall Study|Intercurrent illness|0|||
144426392|NCT00413192|520769529|FG001|Overall Study|Intercurrent illness|0|||
144426393|NCT00413192|520769530|FG002|Overall Study|Intercurrent illness|0|||
144426394|NCT00413192|520769531|FG003|Overall Study|Intercurrent illness|1|||
144426395|NCT00413192|520769528|FG000|Overall Study|Intercurrent death|0|||
144426396|NCT00413192|520769529|FG001|Overall Study|Intercurrent death|1|||
144603524|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
144603525|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
144603526|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
144603527|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
144426397|NCT00413192|520769530|FG002|Overall Study|Intercurrent death|0|||
144603528|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Early termination|0|||
144603529|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Early termination|0|||
144426398|NCT00413192|520769531|FG003|Overall Study|Intercurrent death|0|||
144426399|NCT00413192|520769528|FG000|Overall Study|Other|5|||
144426400|NCT00413192|520769529|FG001|Overall Study|Other|1|||
144426401|NCT00413192|520769530|FG002|Overall Study|Other|1|||
144426402|NCT00413192|520769531|FG003|Overall Study|Other|2|||
144426403|NCT00413192|520769528|FG000|Overall Study|Not treated|0|||
144426404|NCT00413192|520769529|FG001|Overall Study|Not treated|0|||
144426405|NCT00413192|520769530|FG002|Overall Study|Not treated|0|||
144426406|NCT00413192|520769531|FG003|Overall Study|Not treated|1|||
144426407|NCT03814746|520769532|FG000|Overall Study|Participant decision|9|||
144603530|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Early termination|34|||
144603531|NCT01493557|521411921|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
144603532|NCT01493557|521411922|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
144603533|NCT01493557|521411923|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
144603534|NCT01493557|521411921|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
144603535|NCT01493557|521411922|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
144603536|NCT01493557|521411923|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
144603537|NCT01493557|521411921|FG000|Randomized to Management Strategies|Other adverse event|8|||
144603538|NCT01493557|521411922|FG001|Randomized to Management Strategies|Other adverse event|5|||
144603539|NCT01493557|521411923|FG002|Randomized to Management Strategies|Other adverse event|0|||
144426408|NCT03814746|520769533|FG001|Overall Study|Participant decision|6|||
144426409|NCT03814746|520769534|FG002|Overall Study|Participant decision|15|||
144426410|NCT03814746|520769532|FG000|Overall Study|Physician Decision|2|||
144426411|NCT03814746|520769533|FG001|Overall Study|Physician Decision|2|||
144426412|NCT03814746|520769534|FG002|Overall Study|Physician Decision|4|||
144426413|NCT03814746|520769532|FG000|Overall Study|Death|2|||
144426414|NCT03814746|520769533|FG001|Overall Study|Death|2|||
144426415|NCT03814746|520769534|FG002|Overall Study|Death|2|||
144426416|NCT03814746|520769532|FG000|Overall Study|Adverse Event|2|||
144426417|NCT03814746|520769533|FG001|Overall Study|Adverse Event|2|||
144426418|NCT03814746|520769534|FG002|Overall Study|Adverse Event|1|||
144426419|NCT03814746|520769532|FG000|Overall Study|Lost to Follow-up|2|||
144426420|NCT03814746|520769533|FG001|Overall Study|Lost to Follow-up|1|||
144426421|NCT03814746|520769534|FG002|Overall Study|Lost to Follow-up|2|||
144426422|NCT03814746|520769532|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144426423|NCT03814746|520769533|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144426424|NCT03814746|520769534|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144426425|NCT03814746|520769532|FG000|Overall Study|Pregnancy|0|||
144426426|NCT03814746|520769533|FG001|Overall Study|Pregnancy|1|||
144426427|NCT03814746|520769534|FG002|Overall Study|Pregnancy|1|||
144426428|NCT03814746|520769532|FG000|Overall Study|Protocol Violation|1|||
144426429|NCT03814746|520769533|FG001|Overall Study|Protocol Violation|0|||
144426430|NCT03814746|520769534|FG002|Overall Study|Protocol Violation|0|||
144603540|NCT01493557|521411921|FG000|Randomized to Management Strategies|Protocol Violation|3|||
144603541|NCT01493557|521411922|FG001|Randomized to Management Strategies|Protocol Violation|0|||
144603542|NCT01493557|521411923|FG002|Randomized to Management Strategies|Protocol Violation|0|||
144603543|NCT01493557|521411921|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
144603544|NCT01493557|521411922|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
144603545|NCT01493557|521411923|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
144603546|NCT01493557|521411921|FG000|Randomized to Management Strategies|Other than stated above|1|||
144603547|NCT01493557|521411922|FG001|Randomized to Management Strategies|Other than stated above|3|||
144603548|NCT01493557|521411923|FG002|Randomized to Management Strategies|Other than stated above|0|||
144603549|NCT01493557|521411921|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
144603550|NCT01493557|521411922|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
144603551|NCT01493557|521411923|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
144603552|NCT01493557|521411921|FG000|Adding the Second Strategy|Other adverse event|1|||
144603553|NCT01493557|521411922|FG001|Adding the Second Strategy|Other adverse event|2|||
144603554|NCT01493557|521411923|FG002|Adding the Second Strategy|Other adverse event|0|||
144603555|NCT01493557|521411921|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
144426431|NCT01996826|520769537|FG000|Overall Study|Lost to Follow-up|6|||
144426432|NCT01996826|520769538|FG001|Overall Study|Lost to Follow-up|2|||
144426433|NCT01996826|520769537|FG000|Overall Study|Physician Decision|1|||
144426434|NCT01996826|520769538|FG001|Overall Study|Physician Decision|1|||
144426435|NCT00695396|520769539|FG000|Overall Study|Study Closed Prematurely|5|||
144426436|NCT00695396|520769540|FG001|Overall Study|Study Closed Prematurely|6|||
144426437|NCT00695396|520769541|FG002|Overall Study|Study Closed Prematurely|8|||
144426438|NCT00695396|520769539|FG000|Overall Study|Withdrawal by Subject|2|||
144426439|NCT00695396|520769540|FG001|Overall Study|Withdrawal by Subject|2|||
144426440|NCT00695396|520769541|FG002|Overall Study|Withdrawal by Subject|0|||
144426441|NCT01514760|520769543|FG000|Overall Study|Lost to Follow-up|2|||
144426442|NCT01266460|520769544|FG000|Overall Study|Adverse Event|3|||
144426443|NCT01266460|520769544|FG000|Overall Study|Withdrawal by Subject|5|||
144426444|NCT01266460|520769544|FG000|Overall Study|Disease Progression|18|||
144426445|NCT01266460|520769544|FG000|Overall Study|Not otherwise specified|8|||
144426446|NCT00483379|520769547|FG000|Treatment Period|Adverse Event|1|||
144426447|NCT00483379|520769548|FG001|Treatment Period|Adverse Event|0|||
144426448|NCT00483379|520769547|FG000|Treatment Period|Withdrawal by Subject|1|||
144426449|NCT00483379|520769548|FG001|Treatment Period|Withdrawal by Subject|0|||
144426450|NCT00536107|520769550|FG000|Overall Study|Death|5|||
144426451|NCT00536107|520769551|FG001|Overall Study|Death|1|||
144426452|NCT00536107|520769550|FG000|Overall Study|Incorrect enrolment|1|||
144426453|NCT00536107|520769551|FG001|Overall Study|Incorrect enrolment|0|||
144426454|NCT00536107|520769550|FG000|Overall Study|Withdrawal by Subject|0|||
144426455|NCT00536107|520769551|FG001|Overall Study|Withdrawal by Subject|1|||
144426456|NCT00536107|520769550|FG000|Overall Study|Study Termination|2|||
144426457|NCT00536107|520769551|FG001|Overall Study|Study Termination|4|||
144426458|NCT00371254|520769552|FG000|Overall Study|Disease progression|13|||
144426459|NCT00371254|520769553|FG001|Overall Study|Disease progression|13|||
144426460|NCT00371254|520769552|FG000|Overall Study|Study drug toxicity|3|||
144426461|NCT00371254|520769553|FG001|Overall Study|Study drug toxicity|5|||
144426462|NCT00371254|520769552|FG000|Overall Study|Subject request|5|||
144426463|NCT00371254|520769553|FG001|Overall Study|Subject request|0|||
144426464|NCT00371254|520769552|FG000|Overall Study|Investigator Decision|2|||
144426465|NCT00371254|520769553|FG001|Overall Study|Investigator Decision|0|||
144426466|NCT00371254|520769552|FG000|Overall Study|Adverse event unrelated to study drug|0|||
144426467|NCT00371254|520769553|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144426468|NCT00371254|520769552|FG000|Overall Study|Lost to Follow-up|0|||
144426469|NCT00371254|520769553|FG001|Overall Study|Lost to Follow-up|1|||
144426470|NCT00371254|520769552|FG000|Overall Study|Withdrawal by Subject|0|||
144426471|NCT00371254|520769553|FG001|Overall Study|Withdrawal by Subject|1|||
144426472|NCT03329690|520769556|FG000|Overall Study|Progressive disease per RECIST|85|||
144426473|NCT03329690|520769557|FG001|Overall Study|Progressive disease per RECIST|44|||
144426474|NCT03329690|520769558|FG002|Overall Study|Progressive disease per RECIST|6|||
144426475|NCT03329690|520769559|FG003|Overall Study|Progressive disease per RECIST|16|||
144426476|NCT03329690|520769560|FG004|Overall Study|Progressive disease per RECIST|20|||
144426477|NCT03329690|520769556|FG000|Overall Study|Clinical progression|7|||
144426478|NCT03329690|520769557|FG001|Overall Study|Clinical progression|4|||
144426479|NCT03329690|520769558|FG002|Overall Study|Clinical progression|1|||
144426480|NCT03329690|520769559|FG003|Overall Study|Clinical progression|1|||
144426481|NCT03329690|520769560|FG004|Overall Study|Clinical progression|1|||
144426482|NCT03329690|520769556|FG000|Overall Study|Adverse Event|22|||
144426483|NCT03329690|520769557|FG001|Overall Study|Adverse Event|4|||
144426484|NCT03329690|520769558|FG002|Overall Study|Adverse Event|0|||
144426485|NCT03329690|520769559|FG003|Overall Study|Adverse Event|1|||
144426486|NCT03329690|520769560|FG004|Overall Study|Adverse Event|2|||
144426487|NCT03329690|520769556|FG000|Overall Study|Death|2|||
144426488|NCT03329690|520769557|FG001|Overall Study|Death|0|||
144426489|NCT03329690|520769558|FG002|Overall Study|Death|0|||
144426490|NCT03329690|520769559|FG003|Overall Study|Death|1|||
144426491|NCT03329690|520769560|FG004|Overall Study|Death|0|||
144426492|NCT03329690|520769556|FG000|Overall Study|Withdrawal by Subject|2|||
144426493|NCT03329690|520769557|FG001|Overall Study|Withdrawal by Subject|3|||
144426494|NCT03329690|520769558|FG002|Overall Study|Withdrawal by Subject|0|||
144426495|NCT03329690|520769559|FG003|Overall Study|Withdrawal by Subject|1|||
144426496|NCT03329690|520769560|FG004|Overall Study|Withdrawal by Subject|0|||
144426497|NCT03329690|520769556|FG000|Overall Study|Physician Decision|1|||
144426498|NCT03329690|520769557|FG001|Overall Study|Physician Decision|0|||
144426499|NCT03329690|520769558|FG002|Overall Study|Physician Decision|0|||
144426500|NCT03329690|520769559|FG003|Overall Study|Physician Decision|0|||
144426501|NCT03329690|520769560|FG004|Overall Study|Physician Decision|1|||
144603556|NCT01493557|521411922|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
144603557|NCT01493557|521411923|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
144603558|NCT02953639|521411924|FG000|Overall Study|Adverse Event|2|||
144426502|NCT03329690|520769556|FG000|Overall Study|Miscellaneous|6|||
144426503|NCT03329690|520769557|FG001|Overall Study|Miscellaneous|0|||
144426504|NCT03329690|520769558|FG002|Overall Study|Miscellaneous|0|||
144426505|NCT03329690|520769559|FG003|Overall Study|Miscellaneous|0|||
144426506|NCT03329690|520769560|FG004|Overall Study|Miscellaneous|0|||
144426507|NCT03329690|520769556|FG000|Overall Study|Did not receive treatment|1|||
144426508|NCT03329690|520769557|FG001|Overall Study|Did not receive treatment|0|||
144426509|NCT03329690|520769558|FG002|Overall Study|Did not receive treatment|0|||
144426510|NCT03329690|520769559|FG003|Overall Study|Did not receive treatment|1|||
144426511|NCT03329690|520769560|FG004|Overall Study|Did not receive treatment|0|||
144426512|NCT01817725|520769561|FG000|Overall Study|Withdrawal by Subject|1|||
144426513|NCT02337907|520769562|FG000|Overall Study|Other than listed|1|||
144426514|NCT02337907|520769563|FG001|Overall Study|Other than listed|0|||
144426515|NCT02337907|520769564|FG002|Overall Study|Other than listed|0|||
144426516|NCT02337907|520769565|FG003|Overall Study|Other than listed|1|||
144603559|NCT02953639|521411925|FG001|Overall Study|Adverse Event|0|||
144603560|NCT02953639|521411926|FG002|Overall Study|Adverse Event|1|||
144603561|NCT02953639|521411924|FG000|Overall Study|Lost to Follow-up|8|||
144251773|NCT01084538|520120873|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
144251774|NCT01084538|520120873|FG000|Overall Study|Change of residence|2|||
144251775|NCT01084538|520120873|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
144251776|NCT01084538|520120873|FG000|Overall Study|Reason unknown|8|||
144251777|NCT01429441|520120874|FG000|Overall Study|Adverse Event|5|||
144251778|NCT01429441|520120875|FG001|Overall Study|Adverse Event|1|||
144251779|NCT01429441|520120874|FG000|Overall Study|Death|0|||
144251780|NCT01429441|520120875|FG001|Overall Study|Death|2|||
144251781|NCT01429441|520120874|FG000|Overall Study|Lost to Follow-up|5|||
144251782|NCT01429441|520120875|FG001|Overall Study|Lost to Follow-up|2|||
144251783|NCT01429441|520120874|FG000|Overall Study|Physician Decision|1|||
144251784|NCT01429441|520120875|FG001|Overall Study|Physician Decision|0|||
144603562|NCT02953639|521411925|FG001|Overall Study|Lost to Follow-up|4|||
144603563|NCT02953639|521411926|FG002|Overall Study|Lost to Follow-up|3|||
144603564|NCT02953639|521411924|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144251785|NCT01429441|520120874|FG000|Overall Study|Withdrawal by Subject|27|||
144251786|NCT01429441|520120875|FG001|Overall Study|Withdrawal by Subject|18|||
144251787|NCT00380718|520120882|FG000|Overall Study|Adverse Event|1|||
144251788|NCT00380718|520120882|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
144251789|NCT01706575|520120883|FG000|Overall Study|Participant Withdrew Consent|4|||
144251790|NCT01706575|520120883|FG000|Overall Study|Lost to Follow-up|2|||
144251791|NCT01706575|520120883|FG000|Overall Study|Started but not Treated|6|||
144426517|NCT02337907|520769566|FG004|Overall Study|Other than listed|1|||
144603565|NCT02953639|521411925|FG001|Overall Study|Non-Compliance With Study Drug|2|||
144603566|NCT02953639|521411926|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144603567|NCT02953639|521411924|FG000|Overall Study|Multiple Reasons|1|||
144603568|NCT02953639|521411925|FG001|Overall Study|Multiple Reasons|0|||
144603569|NCT02953639|521411926|FG002|Overall Study|Multiple Reasons|1|||
144603570|NCT02953639|521411924|FG000|Overall Study|Physician Decision|1|||
144603571|NCT02953639|521411925|FG001|Overall Study|Physician Decision|0|||
144603572|NCT02953639|521411926|FG002|Overall Study|Physician Decision|0|||
144182345|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
144182346|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
144182347|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
144182348|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
144182349|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
144182350|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
144182351|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
144182352|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
144182353|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
144182354|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
144182355|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
144182356|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
144182357|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
144182358|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
144182359|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
144182360|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
144182361|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
144182362|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
144182363|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
144182364|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
144182365|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144182366|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144426518|NCT02337907|520769567|FG005|Overall Study|Other than listed|0|||
144426519|NCT02337907|520769562|FG000|Overall Study|Withdrawal by Subject|2|||
144426520|NCT02337907|520769563|FG001|Overall Study|Withdrawal by Subject|3|||
144426521|NCT02337907|520769564|FG002|Overall Study|Withdrawal by Subject|0|||
144426522|NCT02337907|520769565|FG003|Overall Study|Withdrawal by Subject|2|||
144426523|NCT02337907|520769566|FG004|Overall Study|Withdrawal by Subject|5|||
144426524|NCT02337907|520769567|FG005|Overall Study|Withdrawal by Subject|0|||
144251792|NCT02912455|520120884|FG000|Overall Study|Withdrawal by Subject|0|||
144251793|NCT02912455|520120885|FG001|Overall Study|Withdrawal by Subject|1|||
144251794|NCT02912455|520120884|FG000|Overall Study|Lack of Efficacy|0|||
144251795|NCT02912455|520120885|FG001|Overall Study|Lack of Efficacy|1|||
144251796|NCT02912455|520120884|FG000|Overall Study|Lost to Follow-up|2|||
144251797|NCT02912455|520120885|FG001|Overall Study|Lost to Follow-up|1|||
144603573|NCT02953639|521411924|FG000|Overall Study|Withdrawal by Subject|7|||
144603574|NCT02953639|521411925|FG001|Overall Study|Withdrawal by Subject|8|||
144603575|NCT02953639|521411926|FG002|Overall Study|Withdrawal by Subject|10|||
144426525|NCT02337907|520769562|FG000|Overall Study|Lost to Follow-up|0|||
144426526|NCT02337907|520769563|FG001|Overall Study|Lost to Follow-up|0|||
144426527|NCT02337907|520769564|FG002|Overall Study|Lost to Follow-up|0|||
144426528|NCT02337907|520769565|FG003|Overall Study|Lost to Follow-up|0|||
144426529|NCT02337907|520769566|FG004|Overall Study|Lost to Follow-up|0|||
144426530|NCT02337907|520769567|FG005|Overall Study|Lost to Follow-up|1|||
144426531|NCT02337907|520769562|FG000|Overall Study|Adverse Event|1|||
144426532|NCT02337907|520769563|FG001|Overall Study|Adverse Event|1|||
144426533|NCT02337907|520769564|FG002|Overall Study|Adverse Event|1|||
144426534|NCT02337907|520769565|FG003|Overall Study|Adverse Event|1|||
144426535|NCT02337907|520769566|FG004|Overall Study|Adverse Event|4|||
144426536|NCT02337907|520769567|FG005|Overall Study|Adverse Event|0|||
144426537|NCT01592344|520769570|FG000|Overall Study|Adverse Event|1|||
144426538|NCT01592344|520769571|FG001|Overall Study|Adverse Event|1|||
144426539|NCT01592344|520769570|FG000|Overall Study|Lack of Efficacy|1|||
144426540|NCT01592344|520769571|FG001|Overall Study|Lack of Efficacy|0|||
144426541|NCT01592344|520769570|FG000|Overall Study|not available at primary outcome visit|2|||
144426542|NCT01592344|520769571|FG001|Overall Study|not available at primary outcome visit|4|||
144426543|NCT03165110|520769573|FG000|Overall Study|Anroid phone software incompatibility|1|||
144426544|NCT00730912|520769576|FG000|Overall Study|Discontinued|0|||
144426545|NCT00730912|520769577|FG001|Overall Study|Discontinued|0|||
144426546|NCT00730912|520769578|FG002|Overall Study|Discontinued|1|||
144426547|NCT03311659|520769583|FG000|Overall Study|Protocol Violation|1|||
144426548|NCT00613015|520769584|FG000|Overall Study|Lost to Follow-up|0|||
144426549|NCT00613015|520769585|FG001|Overall Study|Lost to Follow-up|1|||
144426550|NCT00613015|520769586|FG002|Overall Study|Lost to Follow-up|3|||
144426551|NCT00613015|520769587|FG003|Overall Study|Lost to Follow-up|3|||
144426552|NCT00613015|520769588|FG004|Overall Study|Lost to Follow-up|2|||
144426553|NCT00613015|520769589|FG005|Overall Study|Lost to Follow-up|3|||
144426554|NCT01179477|520769592|FG000|Overall Study|Death|542|||
144426555|NCT01179477|520769592|FG000|Overall Study|Unsuccessful implant|80|||
144426556|NCT01179477|520769592|FG000|Overall Study|Non-death withdrawal|438|||
144426557|NCT01179477|520769592|FG000|Overall Study|Did not complete final visit|27|||
144426558|NCT04327388|520769594|FG000|Overall Study|Adverse Event|17|||
144426559|NCT04327388|520769595|FG001|Overall Study|Adverse Event|18|||
144426560|NCT04327388|520769596|FG002|Overall Study|Adverse Event|9|||
144426561|NCT04327388|520769594|FG000|Overall Study|Other|1|||
144426562|NCT04327388|520769595|FG001|Overall Study|Other|2|||
144426563|NCT04327388|520769596|FG002|Overall Study|Other|0|||
144426564|NCT04327388|520769594|FG000|Overall Study|Randomized and not treated|2|||
144426565|NCT04327388|520769595|FG001|Overall Study|Randomized and not treated|0|||
144426566|NCT04327388|520769596|FG002|Overall Study|Randomized and not treated|2|||
144426567|NCT04053023|520769597|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
144426568|NCT04053023|520769598|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
144426569|NCT00071760|520769599|FG000|Overall Study|Adverse Event|2|||
144426570|NCT00071760|520769600|FG001|Overall Study|Adverse Event|1|||
144426571|NCT00071760|520769599|FG000|Overall Study|Lost to Follow-up|0|||
144426572|NCT00071760|520769600|FG001|Overall Study|Lost to Follow-up|3|||
144426573|NCT00071760|520769599|FG000|Overall Study|Protocol Violation|1|||
144426574|NCT00071760|520769600|FG001|Overall Study|Protocol Violation|0|||
144426575|NCT00071760|520769599|FG000|Overall Study|Withdrawal by Subject|0|||
144426576|NCT00071760|520769600|FG001|Overall Study|Withdrawal by Subject|1|||
144426577|NCT00071760|520769599|FG000|Overall Study|Insufficient Viral Load Response|1|||
144426578|NCT00071760|520769600|FG001|Overall Study|Insufficient Viral Load Response|1|||
144426579|NCT00071760|520769599|FG000|Overall Study|Lack of availability of RTV|1|||
144426580|NCT00071760|520769600|FG001|Overall Study|Lack of availability of RTV|0|||
144182367|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144182368|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
144182369|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
144426581|NCT00071760|520769599|FG000|Overall Study|Physician Decision|2|||
144426582|NCT00071760|520769600|FG001|Overall Study|Physician Decision|1|||
144426583|NCT00071760|520769599|FG000|Overall Study|Relocation|0|||
144426584|NCT00071760|520769600|FG001|Overall Study|Relocation|1|||
144426585|NCT02073279|520769601|FG000|Double-blind Period|Adverse Event|1|||
144426586|NCT02073279|520769602|FG001|Double-blind Period|Adverse Event|1|||
144426587|NCT02073279|520769601|FG000|Double-blind Period|Switched to another treatment|1|||
144426588|NCT02073279|520769602|FG001|Double-blind Period|Switched to another treatment|2|||
144426589|NCT02073279|520769601|FG000|Double-blind Period|Protocol Violation|0|||
144426590|NCT02073279|520769602|FG001|Double-blind Period|Protocol Violation|1|||
144426591|NCT02073279|520769601|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
144426592|NCT02073279|520769602|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
144426593|NCT02073279|520769601|FG000|Double-blind Period|Withdrawal by Subject|2|||
144426594|NCT02073279|520769602|FG001|Double-blind Period|Withdrawal by Subject|2|||
144426595|NCT02073279|520769601|FG000|Open-label Extension Period|Adverse Event|1|||
144426596|NCT02073279|520769602|FG001|Open-label Extension Period|Adverse Event|0|||
144426597|NCT02073279|520769601|FG000|Open-label Extension Period|Lack of Efficacy|1|||
144426598|NCT02073279|520769602|FG001|Open-label Extension Period|Lack of Efficacy|0|||
144426599|NCT02073279|520769601|FG000|Open-label Extension Period|Lost to Follow-up|0|||
144426600|NCT02073279|520769602|FG001|Open-label Extension Period|Lost to Follow-up|4|||
144426601|NCT02073279|520769601|FG000|Open-label Extension Period|Switched to another treatment|1|||
144426602|NCT02073279|520769602|FG001|Open-label Extension Period|Switched to another treatment|4|||
144426603|NCT02073279|520769601|FG000|Open-label Extension Period|Protocol Violation|0|||
144426604|NCT02073279|520769602|FG001|Open-label Extension Period|Protocol Violation|1|||
144182370|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
144182371|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
144182372|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
144182373|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
144426605|NCT02073279|520769601|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
144426606|NCT02073279|520769602|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
144426607|NCT02073279|520769601|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
144426608|NCT02073279|520769602|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
144426609|NCT04387435|520769603|FG000|Overall Study|Physician Decision|1|||
144426610|NCT00391274|520769608|FG000|Overall Study|Death Due to Study Disease|55|||
144182374|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
144182375|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
144182376|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
144182377|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
144182378|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
144182379|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
144182380|NCT01567527|519862274|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144182381|NCT01567527|519862275|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144182382|NCT01567527|519862276|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144182383|NCT01567527|519862277|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
144182384|NCT01567527|519862278|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
144426611|NCT00391274|520769609|FG001|Overall Study|Death Due to Study Disease|45|||
144426612|NCT00391274|520769608|FG000|Overall Study|Lost to Follow-up|0|||
144426613|NCT00391274|520769609|FG001|Overall Study|Lost to Follow-up|3|||
144426614|NCT00391274|520769608|FG000|Overall Study|Physician Decision|4|||
144426615|NCT00391274|520769609|FG001|Overall Study|Physician Decision|2|||
144426616|NCT00391274|520769608|FG000|Overall Study|Withdrawal by Subject|0|||
144426617|NCT00391274|520769609|FG001|Overall Study|Withdrawal by Subject|3|||
144426618|NCT00391274|520769608|FG000|Overall Study|Death Due to Adverse Event|1|||
144426619|NCT00391274|520769609|FG001|Overall Study|Death Due to Adverse Event|3|||
144426620|NCT00391274|520769608|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
144426621|NCT00391274|520769609|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
144426622|NCT00391274|520769608|FG000|Overall Study|Death Not Study Related|0|||
144426623|NCT00391274|520769609|FG001|Overall Study|Death Not Study Related|1|||
144426624|NCT03559257|520769613|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
144426625|NCT03559257|520769614|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
144426626|NCT03559257|520769613|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144426627|NCT03559257|520769614|FG001|Double Blind Treatment Period|Protocol Violation|4|||
144426628|NCT03559257|520769613|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
144182385|NCT00751023|519862279|FG000|Overall Study|Lost to Follow-up|11|||
144182386|NCT00751023|519862280|FG001|Overall Study|Lost to Follow-up|7|||
144603576|NCT02953639|521411924|FG000|Overall Study|Completed or Discontinued information is missing|1|||
144603577|NCT02953639|521411925|FG001|Overall Study|Completed or Discontinued information is missing|0|||
144182387|NCT01691612|519862281|FG000|Overall Study|deemed ineligible after 1st visit|6|||
144182388|NCT01691612|519862281|FG000|Overall Study|Adverse Event|1|||
144182389|NCT01277510|519862286|FG000|Double-blind Phase|Non-compliance|0|||
144182390|NCT01277510|519862287|FG001|Double-blind Phase|Non-compliance|1|||
144182391|NCT01277510|519862286|FG000|Double-blind Phase|Adverse Event|1|||
144182392|NCT01277510|519862287|FG001|Double-blind Phase|Adverse Event|0|||
144182393|NCT01277510|519862286|FG000|Double-blind Phase|Withdrawal by Subject|2|||
144182394|NCT01277510|519862287|FG001|Double-blind Phase|Withdrawal by Subject|0|||
144182395|NCT01277510|519862286|FG000|Double-blind Phase|Administrative decision|7|||
144182396|NCT01277510|519862287|FG001|Double-blind Phase|Administrative decision|9|||
144182397|NCT01277510|519862286|FG000|Double-blind Phase|Death|0|||
144426629|NCT03559257|520769614|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
144426630|NCT03559257|520769613|FG000|Double Blind Treatment Period|Adverse Event|0|||
144426631|NCT03559257|520769614|FG001|Double Blind Treatment Period|Adverse Event|1|||
144426632|NCT03559257|520769613|FG000|Double Blind Treatment Period|Screen Failure|0|||
144603578|NCT02953639|521411926|FG002|Overall Study|Completed or Discontinued information is missing|0|||
144603579|NCT01516970|521411927|FG000|Overall Study|Lost to Follow-up|7|||
144603580|NCT01516970|521411928|FG001|Overall Study|Lost to Follow-up|8|||
144182398|NCT01277510|519862287|FG001|Double-blind Phase|Death|1|||
144251798|NCT03084315|520120888|FG000|Overall Study|Lost to Follow-up|8|||
144426633|NCT03559257|520769614|FG001|Double Blind Treatment Period|Screen Failure|1|||
144603581|NCT01516970|521411927|FG000|Overall Study|Adverse Event|1|||
144603582|NCT01516970|521411928|FG001|Overall Study|Adverse Event|5|||
144603583|NCT01516970|521411927|FG000|Overall Study|Withdrawal by Subject|1|||
144426634|NCT03559257|520769613|FG000|Open-label Treatment Period|Adverse Event|1|||
144426635|NCT03559257|520769614|FG001|Open-label Treatment Period|Adverse Event|4|||
144426636|NCT03559257|520769613|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
144426637|NCT03559257|520769614|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
144426638|NCT03559257|520769613|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
144426639|NCT03559257|520769614|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
144426640|NCT03559257|520769613|FG000|Open-label Treatment Period|Protocol Violation|2|||
144426641|NCT03559257|520769614|FG001|Open-label Treatment Period|Protocol Violation|0|||
144426642|NCT03559257|520769613|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
144426643|NCT03559257|520769614|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
144426644|NCT03559257|520769613|FG000|Open-label Treatment Period|Physician Decision|0|||
144426645|NCT03559257|520769614|FG001|Open-label Treatment Period|Physician Decision|1|||
144426646|NCT03630120|520769616|FG000|Overall Study|Disease progression|0|||
144426647|NCT03630120|520769617|FG001|Overall Study|Disease progression|1|||
144426648|NCT03630120|520769618|FG002|Overall Study|Disease progression|1|||
144426649|NCT03630120|520769619|FG003|Overall Study|Disease progression|1|||
144426650|NCT01519960|520769620|FG000|Overall Study|Withdrawal from the study|26|||
144426651|NCT01519960|520769621|FG001|Overall Study|Withdrawal from the study|22|||
144426652|NCT01519960|520769622|FG002|Overall Study|Withdrawal from the study|5|||
144426653|NCT01387347|520769623|FG000|Overall Study|Lost to Follow-up|2|||
144426654|NCT01387347|520769624|FG001|Overall Study|Lost to Follow-up|1|||
144426655|NCT00561080|520769630|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
144426656|NCT00561080|520769631|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
144426657|NCT00561080|520769632|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
144426658|NCT00561080|520769630|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
144426659|NCT00561080|520769631|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
144426660|NCT00561080|520769632|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
144426661|NCT00561080|520769630|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
144426662|NCT00561080|520769631|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
144426663|NCT00561080|520769632|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
144426664|NCT00561080|520769630|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
144426665|NCT00561080|520769631|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
144426666|NCT00561080|520769632|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
144426667|NCT00561080|520769630|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
144426668|NCT00561080|520769631|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
144426669|NCT00561080|520769632|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
144426670|NCT00561080|520769630|FG000|Vaccination Period (up to Month 4)|Other|0|||
144426671|NCT00561080|520769631|FG001|Vaccination Period (up to Month 4)|Other|2|||
144426672|NCT00561080|520769632|FG002|Vaccination Period (up to Month 4)|Other|1|||
144426673|NCT00561080|520769630|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
144426674|NCT00561080|520769631|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
144426675|NCT00561080|520769632|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
144603584|NCT01516970|521411928|FG001|Overall Study|Withdrawal by Subject|1|||
144603585|NCT01516970|521411927|FG000|Overall Study|Other|9|||
144603586|NCT01516970|521411928|FG001|Overall Study|Other|7|||
144603587|NCT00434421|521411929|FG000|Overall Study|Withdrawal by Subject|1|||
144603588|NCT00434421|521411929|FG000|Overall Study|Non-compliance with study treatment|1|||
144603589|NCT01205438|521411930|FG000|Overall Study|Adverse Event|19|||
144603590|NCT01205438|521411931|FG001|Overall Study|Adverse Event|17|||
144603591|NCT01205438|521411932|FG002|Overall Study|Adverse Event|24|||
144603592|NCT01205438|521411930|FG000|Overall Study|Death|1|||
144603593|NCT01205438|521411931|FG001|Overall Study|Death|1|||
144603594|NCT01205438|521411932|FG002|Overall Study|Death|3|||
144603595|NCT01205438|521411930|FG000|Overall Study|Entry Criteria Not Met|16|||
144603596|NCT01205438|521411931|FG001|Overall Study|Entry Criteria Not Met|15|||
144603597|NCT01205438|521411932|FG002|Overall Study|Entry Criteria Not Met|13|||
144603598|NCT01205438|521411930|FG000|Overall Study|Lack of Efficacy|14|||
144251799|NCT03084315|520120889|FG001|Overall Study|Lost to Follow-up|7|||
144426676|NCT00561080|520769630|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
144426677|NCT00561080|520769631|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
144426678|NCT00561080|520769632|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
144603599|NCT01205438|521411931|FG001|Overall Study|Lack of Efficacy|11|||
144603600|NCT01205438|521411932|FG002|Overall Study|Lack of Efficacy|14|||
144603601|NCT01205438|521411930|FG000|Overall Study|Lost to Follow-up|6|||
144603602|NCT01205438|521411931|FG001|Overall Study|Lost to Follow-up|7|||
144723507|NCT04634409|521842401|FG018|Overall Study|Death|0|||
144603603|NCT01205438|521411932|FG002|Overall Study|Lost to Follow-up|8|||
144603604|NCT01205438|521411930|FG000|Overall Study|Withdrawal by Subject|19|||
144603605|NCT01205438|521411931|FG001|Overall Study|Withdrawal by Subject|25|||
144603606|NCT01205438|521411932|FG002|Overall Study|Withdrawal by Subject|19|||
144603607|NCT01205438|521411930|FG000|Overall Study|Physician Decision|0|||
144426679|NCT00561080|520769630|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
144426680|NCT00561080|520769631|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
144182399|NCT01277510|519862286|FG000|Double-blind Phase|Protocol-specified criteria|2|||
144182400|NCT01277510|519862287|FG001|Double-blind Phase|Protocol-specified criteria|6|||
144182401|NCT01277510|519862286|FG000|Double-blind Phase|Other|1|||
144182402|NCT01277510|519862287|FG001|Double-blind Phase|Other|1|||
144426681|NCT00561080|520769632|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
144426682|NCT00561080|520769630|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
144426683|NCT00561080|520769631|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
144426684|NCT00561080|520769632|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
144426685|NCT00423150|520769633|FG000|Overall Study|Adverse Event|11|||
144426686|NCT00423150|520769633|FG000|Overall Study|Progression of disease being studied|69|||
144426687|NCT00423150|520769633|FG000|Overall Study|Withdrawal by Subject|1|||
144426688|NCT00423150|520769633|FG000|Overall Study|Non-compliance with protocol|1|||
144426689|NCT00423150|520769633|FG000|Overall Study|Administrative|4|||
144426690|NCT02951156|520769634|FG000|Overall Study|Death|3|||
144426691|NCT02951156|520769635|FG001|Overall Study|Death|8|||
144426692|NCT02951156|520769636|FG002|Overall Study|Death|5|||
144426693|NCT02951156|520769634|FG000|Overall Study|Progressive disease|1|||
144426694|NCT02951156|520769635|FG001|Overall Study|Progressive disease|0|||
144426695|NCT02951156|520769636|FG002|Overall Study|Progressive disease|1|||
144426696|NCT02951156|520769634|FG000|Overall Study|Withdrawal by Subject|0|||
144426697|NCT02951156|520769635|FG001|Overall Study|Withdrawal by Subject|0|||
144426698|NCT02951156|520769636|FG002|Overall Study|Withdrawal by Subject|1|||
144426699|NCT02951156|520769634|FG000|Overall Study|Study terminated by sponsor|0|||
144426700|NCT02951156|520769635|FG001|Overall Study|Study terminated by sponsor|0|||
144426701|NCT02951156|520769636|FG002|Overall Study|Study terminated by sponsor|1|||
144426702|NCT02951156|520769634|FG000|Overall Study|Other|5|||
144426703|NCT02951156|520769635|FG001|Overall Study|Other|1|||
144426704|NCT02951156|520769636|FG002|Overall Study|Other|2|||
144426705|NCT04351087|520769637|FG000|Overall Study|Lost to Follow-up|7|||
144426706|NCT04351087|520769638|FG001|Overall Study|Lost to Follow-up|3|||
144426707|NCT04351087|520769637|FG000|Overall Study|Withdrawal by Subject|3|||
144426708|NCT04351087|520769638|FG001|Overall Study|Withdrawal by Subject|4|||
144426709|NCT04351087|520769637|FG000|Overall Study|Lack of Efficacy|3|||
144426710|NCT04351087|520769638|FG001|Overall Study|Lack of Efficacy|2|||
144528709|NCT05485779|521139103|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528710|NCT05485779|521139104|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528711|NCT05485779|521139105|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528712|NCT05485779|521139106|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528713|NCT05485779|521139107|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528714|NCT05485779|521139108|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
144528715|NCT04299464|521139109|FG000|Overall Study|Adverse Event|1|||
144528716|NCT04299464|521139110|FG001|Overall Study|Adverse Event|0|||
144528717|NCT04299464|521139111|FG002|Overall Study|Adverse Event|2|||
144528718|NCT04299464|521139109|FG000|Overall Study|Non-compliance with Study Drug|1|||
144528719|NCT04299464|521139110|FG001|Overall Study|Non-compliance with Study Drug|0|||
144528720|NCT04299464|521139111|FG002|Overall Study|Non-compliance with Study Drug|0|||
144528721|NCT04299464|521139109|FG000|Overall Study|Reason not Specified|0|||
144528722|NCT04299464|521139110|FG001|Overall Study|Reason not Specified|1|||
144528723|NCT04299464|521139111|FG002|Overall Study|Reason not Specified|3|||
144528724|NCT04299464|521139109|FG000|Overall Study|Physician Decision|0|||
144528725|NCT04299464|521139110|FG001|Overall Study|Physician Decision|1|||
144528726|NCT04299464|521139111|FG002|Overall Study|Physician Decision|1|||
144528727|NCT04299464|521139109|FG000|Overall Study|Withdrawal by Subject|0|||
144528728|NCT04299464|521139110|FG001|Overall Study|Withdrawal by Subject|2|||
144528729|NCT04299464|521139111|FG002|Overall Study|Withdrawal by Subject|1|||
144528730|NCT04471246|521139112|FG000|Overall Study|Lost to Follow-up|2|||
144528731|NCT04471246|521139113|FG001|Overall Study|Lost to Follow-up|2|||
144528732|NCT03030261|521139114|FG000|Overall Study|Still receiving continuation therapy|5|||
144182403|NCT01277510|519862286|FG000|Open-label Phase|Administrative decision|4|||
144182404|NCT01277510|519862287|FG001|Open-label Phase|Administrative decision|3|||
144426711|NCT03255382|520769639|FG000|Overall Study|Adverse Event|3|||
144426712|NCT03255382|520769640|FG001|Overall Study|Adverse Event|0|||
144426713|NCT03255382|520769639|FG000|Overall Study|Lost to Follow-up|2|||
144426714|NCT03255382|520769640|FG001|Overall Study|Lost to Follow-up|0|||
144426715|NCT03255382|520769639|FG000|Overall Study|Withdrawal by Subject|2|||
144426716|NCT03255382|520769640|FG001|Overall Study|Withdrawal by Subject|0|||
144426717|NCT03255382|520769639|FG000|Overall Study|Other|6|||
144426718|NCT03255382|520769640|FG001|Overall Study|Other|0|||
144426719|NCT02221284|520769643|FG000|Overall Study|Case Report Forms Uncollected|56|||
144182405|NCT01277510|519862286|FG000|Open-label Phase|Protocol-specified criteria|1|||
144251800|NCT03084315|520120888|FG000|Overall Study|Withdrawal by Subject|2|||
144251801|NCT03084315|520120889|FG001|Overall Study|Withdrawal by Subject|2|||
144251802|NCT02906033|520120892|FG000|Baseline|Protocol Violation|37|||
144251803|NCT02906033|520120893|FG001|Baseline|Protocol Violation|33|||
144251804|NCT02906033|520120892|FG000|Follow-up|Lost to Follow-up|46|||
144251805|NCT02906033|520120893|FG001|Follow-up|Lost to Follow-up|62|||
144251806|NCT01810783|520120898|FG000|Overall Study|Adverse Event|32|||
144251807|NCT01810783|520120898|FG000|Overall Study|Withdrawal by Subject|22|||
144251808|NCT01810783|520120898|FG000|Overall Study|Lack of Efficacy|12|||
144251809|NCT01810783|520120898|FG000|Overall Study|Lost to Follow-up|10|||
144251810|NCT01810783|520120898|FG000|Overall Study|Protocol Violation|5|||
144251811|NCT01810783|520120898|FG000|Overall Study|Non-compliance with IMP|4|||
144251812|NCT01810783|520120898|FG000|Overall Study|Adminstrative or other reason(s)|23|||
144251813|NCT01810783|520120898|FG000|Overall Study|Enrolled, not treated|1|||
144426720|NCT02221284|520769643|FG000|Overall Study|Protocol Deviation|5|||
144426721|NCT01374087|520769646|FG000|Overall Study|Adverse Event|1|||
144426722|NCT01374087|520769647|FG001|Overall Study|Adverse Event|0|||
144603608|NCT01205438|521411931|FG001|Overall Study|Physician Decision|3|||
144182406|NCT01277510|519862287|FG001|Open-label Phase|Protocol-specified criteria|0|||
144182407|NCT01277510|519862286|FG000|Open-label Phase|Never received investigational product|2|||
144182408|NCT01277510|519862287|FG001|Open-label Phase|Never received investigational product|0|||
144182409|NCT01685008|519862288|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
144182410|NCT01685008|519862289|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
144182411|NCT01685008|519862290|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
144182412|NCT01685008|519862291|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
144182413|NCT01685008|519862288|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
144182414|NCT01685008|519862289|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
144182415|NCT01685008|519862290|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
144182416|NCT01685008|519862291|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
144182417|NCT01685008|519862288|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
144182418|NCT01685008|519862289|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
144182419|NCT01685008|519862290|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
144426723|NCT01374087|520769646|FG000|Overall Study|Disease progression|2|||
144426724|NCT01374087|520769647|FG001|Overall Study|Disease progression|2|||
144426725|NCT01374087|520769646|FG000|Overall Study|Study discontinued|13|||
144426726|NCT01374087|520769647|FG001|Overall Study|Study discontinued|13|||
144426727|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
144426728|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
144426729|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
144426730|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
144426731|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
144426732|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
144426733|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
144426734|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
144426735|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
144426736|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
144426737|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
144426738|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
144426739|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
144426740|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
144426741|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
144426742|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
144426743|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
144426744|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
144426745|NCT00887354|520770908|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
144426746|NCT00887354|520770909|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
144426747|NCT00887354|520770908|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
144426748|NCT00887354|520770909|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
144426749|NCT00887354|520770908|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
144426750|NCT00887354|520770909|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
144426751|NCT00887354|520770908|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
144426752|NCT00887354|520770909|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
144426753|NCT00887354|520770908|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
144426754|NCT00887354|520770909|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
144426755|NCT00887354|520770908|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
144426756|NCT00887354|520770909|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
144426757|NCT01955161|520770912|FG000|Overall Study|Withdrawal before treatment|2|||
144251814|NCT00094536|520120903|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
144251815|NCT00094536|520120903|FG000|Treatment and Follow-up|Adverse Event|4|||
144251816|NCT00094536|520120903|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
144603609|NCT01205438|521411932|FG002|Overall Study|Physician Decision|2|||
144603610|NCT01205438|521411930|FG000|Overall Study|Protocol Violation|2|||
144603611|NCT01205438|521411931|FG001|Overall Study|Protocol Violation|7|||
144603612|NCT01205438|521411932|FG002|Overall Study|Protocol Violation|4|||
144603613|NCT01205438|521411930|FG000|Overall Study|Sponsor Decision|0|||
144603614|NCT01205438|521411931|FG001|Overall Study|Sponsor Decision|1|||
144603615|NCT01205438|521411932|FG002|Overall Study|Sponsor Decision|1|||
144603616|NCT00892177|521411933|FG000|Phase II|Ineligible|0|||
144603617|NCT00892177|521411934|FG001|Phase II|Ineligible|0|||
144603618|NCT00892177|521411935|FG002|Phase II|Ineligible|0|||
144603619|NCT00892177|521411936|FG003|Phase II|Ineligible|0|||
144603620|NCT00892177|521411937|FG004|Phase II|Ineligible|1|||
144603621|NCT00892177|521411938|FG005|Phase II|Ineligible|1|||
144603622|NCT00892177|521411933|FG000|Phase II|Withdrawal by Subject|0|||
144603623|NCT00892177|521411934|FG001|Phase II|Withdrawal by Subject|0|||
144603624|NCT00892177|521411935|FG002|Phase II|Withdrawal by Subject|0|||
144603625|NCT00892177|521411936|FG003|Phase II|Withdrawal by Subject|0|||
144603626|NCT00892177|521411937|FG004|Phase II|Withdrawal by Subject|4|||
144603627|NCT00892177|521411938|FG005|Phase II|Withdrawal by Subject|1|||
144603628|NCT01186939|521411942|FG000|Overall Study|Death|7|||
144603629|NCT01186939|521411942|FG000|Overall Study|Withdrawal by Subject|2|||
144603630|NCT01186939|521411942|FG000|Overall Study|No longer receiving clinical benefit|17|||
144603631|NCT01186939|521411942|FG000|Overall Study|Program closed|5|||
144603632|NCT01186939|521411942|FG000|Overall Study|Sponsor decision|4|||
144603633|NCT01186939|521411942|FG000|Overall Study|Started additional treatment|1|||
144603634|NCT01186939|521411942|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
144603635|NCT01186939|521411942|FG000|Overall Study|Myocardial infarction|1|||
144603636|NCT01186939|521411942|FG000|Overall Study|Bone marrow transplant|1|||
144603637|NCT01186939|521411942|FG000|Overall Study|Transformation to AML|1|||
144251817|NCT00094536|520120903|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
144251818|NCT00094536|520120903|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
144426758|NCT01955161|520770913|FG001|Overall Study|Withdrawal before treatment|0|||
144426759|NCT01955161|520770914|FG002|Overall Study|Withdrawal before treatment|1|||
144426760|NCT01955161|520770912|FG000|Overall Study|Adverse Event|10|||
144426761|NCT01955161|520770913|FG001|Overall Study|Adverse Event|14|||
144426762|NCT01955161|520770914|FG002|Overall Study|Adverse Event|15|||
144426763|NCT01955161|520770912|FG000|Overall Study|Death|1|||
144426764|NCT01955161|520770913|FG001|Overall Study|Death|1|||
144426765|NCT01955161|520770914|FG002|Overall Study|Death|3|||
144426766|NCT01955161|520770912|FG000|Overall Study|Withdrawal by Subject|9|||
144426767|NCT01955161|520770913|FG001|Overall Study|Withdrawal by Subject|8|||
144426768|NCT01955161|520770914|FG002|Overall Study|Withdrawal by Subject|12|||
144426769|NCT01955161|520770912|FG000|Overall Study|Protocol Violation|2|||
144426770|NCT01955161|520770913|FG001|Overall Study|Protocol Violation|0|||
144426771|NCT01955161|520770914|FG002|Overall Study|Protocol Violation|0|||
144426772|NCT01955161|520770912|FG000|Overall Study|Other reason: physician decision|0|||
144426773|NCT01955161|520770913|FG001|Overall Study|Other reason: physician decision|1|||
144426774|NCT01955161|520770914|FG002|Overall Study|Other reason: physician decision|1|||
144426775|NCT01955161|520770912|FG000|Overall Study|Other reason: disallowed medication|1|||
144426776|NCT01955161|520770913|FG001|Overall Study|Other reason: disallowed medication|0|||
144426777|NCT01955161|520770914|FG002|Overall Study|Other reason: disallowed medication|1|||
144426778|NCT01955161|520770912|FG000|Overall Study|Other reason: caregiver unavailable|1|||
144426779|NCT01955161|520770913|FG001|Overall Study|Other reason: caregiver unavailable|0|||
144426780|NCT01955161|520770914|FG002|Overall Study|Other reason: caregiver unavailable|0|||
144426781|NCT01955161|520770912|FG000|Overall Study|Other reason: moved to nursing home|0|||
144426782|NCT01955161|520770913|FG001|Overall Study|Other reason: moved to nursing home|1|||
144426783|NCT01955161|520770914|FG002|Overall Study|Other reason: moved to nursing home|0|||
144426784|NCT01955161|520770912|FG000|Overall Study|Other reason: insufficient compliance|0|||
144426785|NCT01955161|520770913|FG001|Overall Study|Other reason: insufficient compliance|0|||
144426786|NCT01955161|520770914|FG002|Overall Study|Other reason: insufficient compliance|1|||
144426787|NCT01955161|520770912|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
144426788|NCT01955161|520770913|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
144426789|NCT01955161|520770914|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
144426790|NCT01955161|520770912|FG000|Overall Study|Other reason: patient's will|0|||
144426791|NCT01955161|520770913|FG001|Overall Study|Other reason: patient's will|0|||
144426792|NCT01955161|520770914|FG002|Overall Study|Other reason: patient's will|1|||
144426793|NCT04014075|520770925|FG000|Overall Study|Progressive Disease|53|||
144426794|NCT04014075|520770925|FG000|Overall Study|Adverse Event|15|||
144426795|NCT04014075|520770925|FG000|Overall Study|Clinical Progression|4|||
144426796|NCT04014075|520770925|FG000|Overall Study|Death|2|||
144426797|NCT04014075|520770925|FG000|Overall Study|Withdrawal by Subject|2|||
144426798|NCT04014075|520770925|FG000|Overall Study|Miscellaneous|2|||
144426799|NCT04014075|520770925|FG000|Overall Study|Physician Decision|1|||
144603638|NCT03945591|521411947|FG000|Overall Study|Participant not transplanted|1|||
144603639|NCT03945591|521411947|FG000|Overall Study|Change in treatment plan|3|||
144603640|NCT03945591|521411947|FG000|Overall Study|Adverse Event|1|||
144426800|NCT05089682|520770933|FG000|Overall Study|Withdrawal by Subject|2|||
144426801|NCT01994629|520770941|FG000|Overall Study|Withdrawal by Subject|1|||
144426802|NCT01994629|520770942|FG001|Overall Study|Withdrawal by Subject|0|||
144426803|NCT01994629|520770941|FG000|Overall Study|Lost to Follow-up|0|||
144426804|NCT01994629|520770942|FG001|Overall Study|Lost to Follow-up|3|||
144426805|NCT03338062|520770943|FG000|Overall Study|Alternative Therapy|1|||
144426806|NCT03338062|520770944|FG001|Overall Study|Alternative Therapy|0|||
144723508|NCT04634409|521842402|FG019|Overall Study|Death|0|||
144723509|NCT04634409|521842403|FG020|Overall Study|Death|0|||
144426807|NCT04340362|520770948|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
144426808|NCT00975481|520770951|FG000|Second Intervention Period|Adverse Event|2|||
144426809|NCT00975481|520770952|FG001|Second Intervention Period|Adverse Event|1|||
144426810|NCT00975481|520770953|FG002|Second Intervention Period|Adverse Event|0|||
144426811|NCT00975481|520770954|FG003|Second Intervention Period|Adverse Event|0|||
144426812|NCT00975481|520770955|FG004|Second Intervention Period|Adverse Event|0|||
144426813|NCT00975481|520770956|FG005|Second Intervention Period|Adverse Event|0|||
144426814|NCT00975481|520770951|FG000|Second Intervention Period|Withdrawal by Subject|0|||
144426815|NCT00975481|520770952|FG001|Second Intervention Period|Withdrawal by Subject|0|||
144426816|NCT00975481|520770953|FG002|Second Intervention Period|Withdrawal by Subject|1|||
144426817|NCT00975481|520770954|FG003|Second Intervention Period|Withdrawal by Subject|0|||
144426818|NCT00975481|520770955|FG004|Second Intervention Period|Withdrawal by Subject|0|||
144426819|NCT00975481|520770956|FG005|Second Intervention Period|Withdrawal by Subject|0|||
144426820|NCT00975481|520770951|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
144426821|NCT00975481|520770952|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
144426822|NCT00975481|520770953|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
144426823|NCT00975481|520770954|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
144426824|NCT00975481|520770955|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
144426825|NCT00975481|520770956|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
144426826|NCT00975481|520770951|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
144426827|NCT00975481|520770952|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
144426828|NCT00975481|520770953|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
144426829|NCT00975481|520770954|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
144426830|NCT00975481|520770955|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
144426831|NCT00975481|520770956|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
144426832|NCT01092182|520770958|FG000|Overall Study|Death|0|||
144426833|NCT01092182|520770959|FG001|Overall Study|Death|5|||
144426834|NCT01092182|520770960|FG002|Overall Study|Death|3|||
144426835|NCT01092182|520770958|FG000|Overall Study|participant safety|1|||
144426836|NCT01092182|520770959|FG001|Overall Study|participant safety|2|||
144426837|NCT01092182|520770960|FG002|Overall Study|participant safety|0|||
144426838|NCT01092182|520770958|FG000|Overall Study|Physician Decision|0|||
144426839|NCT01092182|520770959|FG001|Overall Study|Physician Decision|6|||
144426840|NCT01092182|520770960|FG002|Overall Study|Physician Decision|0|||
144426841|NCT01092182|520770958|FG000|Overall Study|Did not meet criteria|0|||
144426842|NCT01092182|520770959|FG001|Overall Study|Did not meet criteria|0|||
144426843|NCT01092182|520770960|FG002|Overall Study|Did not meet criteria|25|||
144426844|NCT01092182|520770958|FG000|Overall Study|Non-compliance|0|||
144426845|NCT01092182|520770959|FG001|Overall Study|Non-compliance|3|||
144426846|NCT01092182|520770960|FG002|Overall Study|Non-compliance|0|||
144426847|NCT01092182|520770958|FG000|Overall Study|Participant refused follow-up|0|||
144426848|NCT01092182|520770959|FG001|Overall Study|Participant refused follow-up|2|||
144426849|NCT01092182|520770960|FG002|Overall Study|Participant refused follow-up|0|||
144426850|NCT05517382|520770961|FG000|Overall Study|Lost to Follow-up|0|||
144426851|NCT05517382|520770962|FG001|Overall Study|Lost to Follow-up|1|||
144426852|NCT01166178|520770964|FG000|Overall Study|Withdrawal by Subject|1|||
144426853|NCT01166178|520770965|FG001|Overall Study|Withdrawal by Subject|0|||
144426854|NCT01166178|520770964|FG000|Overall Study|Study was terminated|20|||
144426855|NCT01166178|520770965|FG001|Overall Study|Study was terminated|8|||
144426856|NCT00624052|520770970|FG000|Overall Study|Adverse Event|7|||
144426857|NCT00624052|520770971|FG001|Overall Study|Adverse Event|6|||
144426858|NCT00624052|520770972|FG002|Overall Study|Adverse Event|0|||
144426859|NCT00624052|520770973|FG003|Overall Study|Adverse Event|3|||
144426860|NCT00624052|520770970|FG000|Overall Study|Lack of Efficacy|1|||
144426861|NCT00624052|520770971|FG001|Overall Study|Lack of Efficacy|1|||
144426862|NCT00624052|520770972|FG002|Overall Study|Lack of Efficacy|0|||
144426863|NCT00624052|520770973|FG003|Overall Study|Lack of Efficacy|0|||
144426864|NCT00624052|520770970|FG000|Overall Study|Lost to Follow-up|2|||
144426865|NCT00624052|520770971|FG001|Overall Study|Lost to Follow-up|3|||
144426866|NCT00624052|520770972|FG002|Overall Study|Lost to Follow-up|1|||
144426867|NCT00624052|520770973|FG003|Overall Study|Lost to Follow-up|0|||
144723510|NCT04634409|521842404|FG021|Overall Study|Death|0|||
144182420|NCT01685008|519862291|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
144426868|NCT00624052|520770970|FG000|Overall Study|Non compliant with the protocol|2|||
144426869|NCT00624052|520770971|FG001|Overall Study|Non compliant with the protocol|1|||
144426870|NCT00624052|520770972|FG002|Overall Study|Non compliant with the protocol|1|||
144426871|NCT00624052|520770973|FG003|Overall Study|Non compliant with the protocol|1|||
144426872|NCT00624052|520770970|FG000|Overall Study|Consent withdrawn|3|||
144426873|NCT00624052|520770971|FG001|Overall Study|Consent withdrawn|1|||
144426874|NCT00624052|520770972|FG002|Overall Study|Consent withdrawn|1|||
144426875|NCT00624052|520770973|FG003|Overall Study|Consent withdrawn|0|||
144426876|NCT00624052|520770970|FG000|Overall Study|Changed job/ran out if meds|0|||
144426877|NCT00624052|520770971|FG001|Overall Study|Changed job/ran out if meds|2|||
144426878|NCT00624052|520770972|FG002|Overall Study|Changed job/ran out if meds|0|||
144426879|NCT00624052|520770973|FG003|Overall Study|Changed job/ran out if meds|0|||
144426880|NCT03839212|520770978|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
144426881|NCT00679263|520770979|FG000|Visit 2/Dose 1|Adverse Event|1|||
144426882|NCT00679263|520770980|FG001|Visit 2/Dose 1|Adverse Event|0|||
144426883|NCT00679263|520770981|FG002|Visit 2/Dose 1|Adverse Event|0|||
144426884|NCT00679263|520770979|FG000|Visit 2/Dose 1|subject not compliance|1|||
144426885|NCT00679263|520770980|FG001|Visit 2/Dose 1|subject not compliance|1|||
144426886|NCT00679263|520770981|FG002|Visit 2/Dose 1|subject not compliance|0|||
144426887|NCT05104567|520770982|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
144426888|NCT05104567|520770983|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
144426889|NCT05104567|520770984|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
144426890|NCT05104567|520770985|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
144426891|NCT05104567|520770986|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
144426892|NCT05104567|520770987|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
144426893|NCT05104567|520770988|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
144426894|NCT05104567|520770982|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
144426895|NCT05104567|520770983|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
144426896|NCT05104567|520770984|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
144426897|NCT05104567|520770985|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
144426898|NCT05104567|520770986|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
144426899|NCT05104567|520770987|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
144426900|NCT05104567|520770988|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
144426901|NCT05104567|520770982|FG000|Overall Study|Progressive disease|3|||
144426902|NCT05104567|520770983|FG001|Overall Study|Progressive disease|13|||
144426903|NCT05104567|520770984|FG002|Overall Study|Progressive disease|13|||
144426904|NCT05104567|520770985|FG003|Overall Study|Progressive disease|17|||
144426905|NCT05104567|520770986|FG004|Overall Study|Progressive disease|17|||
144426906|NCT05104567|520770987|FG005|Overall Study|Progressive disease|28|||
144426907|NCT05104567|520770988|FG006|Overall Study|Progressive disease|24|||
144426908|NCT05104567|520770982|FG000|Overall Study|Withdrawal by Subject|1|||
144426909|NCT05104567|520770983|FG001|Overall Study|Withdrawal by Subject|1|||
144426910|NCT05104567|520770984|FG002|Overall Study|Withdrawal by Subject|2|||
144426911|NCT05104567|520770985|FG003|Overall Study|Withdrawal by Subject|0|||
144426912|NCT05104567|520770986|FG004|Overall Study|Withdrawal by Subject|0|||
144426913|NCT05104567|520770987|FG005|Overall Study|Withdrawal by Subject|0|||
144426914|NCT05104567|520770988|FG006|Overall Study|Withdrawal by Subject|0|||
144426915|NCT05104567|520770982|FG000|Overall Study|Other|1|||
144426916|NCT05104567|520770983|FG001|Overall Study|Other|1|||
144426917|NCT05104567|520770984|FG002|Overall Study|Other|1|||
144426918|NCT05104567|520770985|FG003|Overall Study|Other|0|||
144426919|NCT05104567|520770986|FG004|Overall Study|Other|0|||
144426920|NCT05104567|520770987|FG005|Overall Study|Other|0|||
144426921|NCT05104567|520770988|FG006|Overall Study|Other|0|||
144426922|NCT01464346|520770992|FG000|Overall Study|Withdrawal by Subject|0|||
144426923|NCT01464346|520770993|FG001|Overall Study|Withdrawal by Subject|0|||
144426924|NCT01464346|520770994|FG002|Overall Study|Withdrawal by Subject|1|||
144426925|NCT02295995|520770995|FG000|Overall Study|Lost to Follow-up|5|||
144426926|NCT02295995|520770996|FG001|Overall Study|Lost to Follow-up|1|||
144426927|NCT01498458|520770998|FG000|Overall Study|Adverse Event|4|||
144426928|NCT01498458|520770998|FG000|Overall Study|Physician Decision|3|||
144426929|NCT02005250|520770999|FG000|Overall Study|Lost to Follow-up|15|||
144426930|NCT02005250|520771000|FG001|Overall Study|Lost to Follow-up|5|||
144426931|NCT03188094|520771005|FG000|Overall Study|Screen failure|1|||
144426932|NCT03188094|520771006|FG001|Overall Study|Screen failure|0|||
144426933|NCT03188094|520771007|FG002|Overall Study|Screen failure|0|||
144426934|NCT03188094|520771005|FG000|Overall Study|Pregnancy|3|||
144426935|NCT03188094|520771006|FG001|Overall Study|Pregnancy|0|||
144426936|NCT03188094|520771007|FG002|Overall Study|Pregnancy|0|||
144426937|NCT03188094|520771005|FG000|Overall Study|Ineligible|1|||
144426938|NCT03188094|520771006|FG001|Overall Study|Ineligible|0|||
144426939|NCT03188094|520771007|FG002|Overall Study|Ineligible|0|||
144426940|NCT03188094|520771005|FG000|Overall Study|Lost to Follow-up|0|||
144426941|NCT03188094|520771006|FG001|Overall Study|Lost to Follow-up|0|||
144426942|NCT03188094|520771007|FG002|Overall Study|Lost to Follow-up|17|||
144426943|NCT04007094|520771008|FG000|Overall Study|Lost to Follow-up|1|||
144426944|NCT04007094|520771009|FG001|Overall Study|Lost to Follow-up|1|||
144426945|NCT04350788|520771015|FG000|Overall Study|Lost to Follow-up|6|||
144426946|NCT04350788|520771016|FG001|Overall Study|Lost to Follow-up|2|||
144528733|NCT03910478|521139126|FG000|Overall Study|Death|13|||
144182421|NCT01685008|519862288|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
144182422|NCT01685008|519862289|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
144182423|NCT01685008|519862290|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
144182424|NCT01685008|519862291|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
144182425|NCT01685008|519862288|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
144182426|NCT01685008|519862289|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
144182427|NCT01685008|519862290|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
144182428|NCT01685008|519862291|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
144182429|NCT02005276|519862292|FG000|Overall Study|No longer interested|5|||
144182430|NCT02005276|519862293|FG001|Overall Study|No longer interested|2|||
144182431|NCT02005276|519862294|FG002|Overall Study|No longer interested|3|||
144182432|NCT02005276|519862295|FG003|Overall Study|No longer interested|3|||
144182433|NCT01970592|519862296|FG000|Overall Study|Withdrawal by Subject|4|||
144182434|NCT01970592|519862296|FG000|Overall Study|Physician Decision|1|||
144182435|NCT01970592|519862296|FG000|Overall Study|Adverse Event|1|||
144426947|NCT04350788|520771015|FG000|Overall Study|Withdrawal by Subject|2|||
144426948|NCT04350788|520771016|FG001|Overall Study|Withdrawal by Subject|4|||
144426949|NCT04350788|520771015|FG000|Overall Study|Protocol Violation|4|||
144426950|NCT04350788|520771016|FG001|Overall Study|Protocol Violation|0|||
144426951|NCT01581307|520771017|FG000|Overall Study|Withdrawal by Subject|1|||
144426952|NCT00378209|520771020|FG000|Overall Study|Progressive disease|11|||
144182436|NCT01320722|519862299|FG000|Overall Study|Did not Receive Intervention|3|||
144182437|NCT01320722|519862300|FG001|Overall Study|Did not Receive Intervention|2|||
144182438|NCT01320722|519862301|FG002|Overall Study|Did not Receive Intervention|1|||
144182439|NCT01320722|519862302|FG003|Overall Study|Did not Receive Intervention|1|||
144182440|NCT01320722|519862303|FG004|Overall Study|Did not Receive Intervention|2|||
144182441|NCT01320722|519862299|FG000|Overall Study|Lost to Follow-up|0|||
144426953|NCT00378209|520771020|FG000|Overall Study|Adverse Event|3|||
144426954|NCT00378209|520771020|FG000|Overall Study|Initiation of non-protocol therapy|3|||
144426955|NCT00378209|520771020|FG000|Overall Study|Physician Decision|3|||
144426956|NCT00378209|520771020|FG000|Overall Study|Death|1|||
144426957|NCT00378209|520771020|FG000|Overall Study|Treatment delay|1|||
144426958|NCT02070744|520771023|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
144426959|NCT02070744|520771024|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
144426960|NCT02070744|520771025|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
144426961|NCT02070744|520771026|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
144426962|NCT02070744|520771027|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
144426963|NCT02070744|520771023|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
144426964|NCT02070744|520771024|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
144426965|NCT02070744|520771025|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
144426966|NCT02070744|520771026|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
144426967|NCT02070744|520771027|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
144426968|NCT02070744|520771023|FG000|OLE Phase (48 Weeks)|Other|0|||
144426969|NCT02070744|520771024|FG001|OLE Phase (48 Weeks)|Other|0|||
144426970|NCT02070744|520771025|FG002|OLE Phase (48 Weeks)|Other|0|||
144426971|NCT02070744|520771026|FG003|OLE Phase (48 Weeks)|Other|0|||
144426972|NCT02070744|520771027|FG004|OLE Phase (48 Weeks)|Other|1|||
144426973|NCT01894581|520771028|FG000|Overall Study|Withdrawal by Subject|2|||
144426974|NCT01894581|520771029|FG001|Overall Study|Withdrawal by Subject|3|||
144426975|NCT01894581|520771028|FG000|Overall Study|Screen Failure|3|||
144426976|NCT01894581|520771029|FG001|Overall Study|Screen Failure|4|||
144426977|NCT03795298|520771033|FG000|Overall Study|Death|34|||
144426978|NCT03795298|520771034|FG001|Overall Study|Death|29|||
144426979|NCT03795298|520771033|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
144426980|NCT03795298|520771034|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
144426981|NCT03795298|520771033|FG000|Overall Study|Lost to Follow-up|28|||
144426982|NCT03795298|520771034|FG001|Overall Study|Lost to Follow-up|17|||
144426983|NCT03795298|520771033|FG000|Overall Study|Physician Decision|5|||
144426984|NCT03795298|520771034|FG001|Overall Study|Physician Decision|4|||
144426985|NCT03795298|520771033|FG000|Overall Study|Withdrawal by Subject|43|||
144426986|NCT03795298|520771034|FG001|Overall Study|Withdrawal by Subject|28|||
144426987|NCT03795298|520771033|FG000|Overall Study|Reason not reported|7|||
144426988|NCT03795298|520771034|FG001|Overall Study|Reason not reported|9|||
144426989|NCT01252940|520771035|FG000|Main Study Phase|Randomized but not treated|4|||
144426990|NCT01252940|520771036|FG001|Main Study Phase|Randomized but not treated|2|||
144426991|NCT01252940|520771035|FG000|Main Study Phase|Adverse Event|3|||
144426992|NCT01252940|520771036|FG001|Main Study Phase|Adverse Event|1|||
144426993|NCT01252940|520771035|FG000|Main Study Phase|Lack of Efficacy|1|||
144426994|NCT01252940|520771036|FG001|Main Study Phase|Lack of Efficacy|0|||
144426995|NCT01252940|520771035|FG000|Main Study Phase|Lost to Follow-up|6|||
144426996|NCT01252940|520771036|FG001|Main Study Phase|Lost to Follow-up|1|||
144182442|NCT01320722|519862300|FG001|Overall Study|Lost to Follow-up|1|||
144426997|NCT01252940|520771035|FG000|Main Study Phase|Physician Decision|1|||
144426998|NCT01252940|520771036|FG001|Main Study Phase|Physician Decision|0|||
144426999|NCT01252940|520771035|FG000|Main Study Phase|Protocol Violation|4|||
144427000|NCT01252940|520771036|FG001|Main Study Phase|Protocol Violation|2|||
144427001|NCT01252940|520771035|FG000|Main Study Phase|Withdrawal by Subject|6|||
144427002|NCT01252940|520771036|FG001|Main Study Phase|Withdrawal by Subject|5|||
144427003|NCT01252940|520771035|FG000|Main Study Phase|Subject Non-compliance|1|||
144427004|NCT01252940|520771036|FG001|Main Study Phase|Subject Non-compliance|1|||
144427005|NCT01252940|520771035|FG000|Extension Phase|Adverse Event|2|||
144427006|NCT01252940|520771036|FG001|Extension Phase|Adverse Event|1|||
144427007|NCT01252940|520771035|FG000|Extension Phase|Lack of Efficacy|1|||
144427008|NCT01252940|520771036|FG001|Extension Phase|Lack of Efficacy|0|||
144427009|NCT01252940|520771035|FG000|Extension Phase|Lost to Follow-up|5|||
144427010|NCT01252940|520771036|FG001|Extension Phase|Lost to Follow-up|0|||
144427011|NCT01252940|520771035|FG000|Extension Phase|Physician Decision|0|||
144427012|NCT01252940|520771036|FG001|Extension Phase|Physician Decision|1|||
144427013|NCT01252940|520771035|FG000|Extension Phase|Subject Non-compliance|1|||
144427014|NCT01252940|520771036|FG001|Extension Phase|Subject Non-compliance|0|||
144427015|NCT01252940|520771035|FG000|Extension Phase|Withdrawal by Subject|1|||
144427016|NCT01252940|520771036|FG001|Extension Phase|Withdrawal by Subject|1|||
144427017|NCT04199117|520771037|FG000|Overall Study|Withdrawal by Subject|3|||
144427018|NCT04199117|520771038|FG001|Overall Study|Withdrawal by Subject|0|||
144427019|NCT04199117|520771039|FG002|Overall Study|Withdrawal by Subject|0|||
144427020|NCT04199117|520771040|FG003|Overall Study|Withdrawal by Subject|1|||
144427021|NCT04199117|520771041|FG004|Overall Study|Withdrawal by Subject|1|||
144427022|NCT04199117|520771042|FG005|Overall Study|Withdrawal by Subject|0|||
144427023|NCT04199117|520771043|FG006|Overall Study|Withdrawal by Subject|0|||
144427024|NCT04199117|520771044|FG007|Overall Study|Withdrawal by Subject|2|||
144427025|NCT04199117|520771045|FG008|Overall Study|Withdrawal by Subject|0|||
144427026|NCT04199117|520771046|FG009|Overall Study|Withdrawal by Subject|0|||
144427027|NCT04199117|520771047|FG010|Overall Study|Withdrawal by Subject|1|||
144427028|NCT04199117|520771048|FG011|Overall Study|Withdrawal by Subject|1|||
144427029|NCT04199117|520771049|FG012|Overall Study|Withdrawal by Subject|2|||
144427030|NCT04199117|520771050|FG013|Overall Study|Withdrawal by Subject|1|||
144427031|NCT04199117|520771051|FG014|Overall Study|Withdrawal by Subject|1|||
144427032|NCT04199117|520771052|FG015|Overall Study|Withdrawal by Subject|1|||
144427033|NCT04199117|520771037|FG000|Overall Study|Death|1|||
144427034|NCT04199117|520771038|FG001|Overall Study|Death|1|||
144427035|NCT04199117|520771039|FG002|Overall Study|Death|0|||
144427036|NCT04199117|520771040|FG003|Overall Study|Death|0|||
144427037|NCT04199117|520771041|FG004|Overall Study|Death|0|||
144427038|NCT04199117|520771042|FG005|Overall Study|Death|0|||
144427039|NCT04199117|520771043|FG006|Overall Study|Death|0|||
144427040|NCT04199117|520771044|FG007|Overall Study|Death|0|||
144427041|NCT04199117|520771045|FG008|Overall Study|Death|0|||
144427042|NCT04199117|520771046|FG009|Overall Study|Death|0|||
144427043|NCT04199117|520771047|FG010|Overall Study|Death|0|||
144427044|NCT04199117|520771048|FG011|Overall Study|Death|1|||
144427045|NCT04199117|520771049|FG012|Overall Study|Death|0|||
144182443|NCT01320722|519862301|FG002|Overall Study|Lost to Follow-up|0|||
144182444|NCT01320722|519862302|FG003|Overall Study|Lost to Follow-up|1|||
144182445|NCT01320722|519862303|FG004|Overall Study|Lost to Follow-up|3|||
144182446|NCT01320722|519862299|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
144182447|NCT01320722|519862300|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
144182448|NCT01320722|519862301|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
144182449|NCT01320722|519862302|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
144182450|NCT01320722|519862303|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
144182451|NCT01320722|519862299|FG000|Overall Study|Participant Developed a Rash|0|||
144182452|NCT01320722|519862300|FG001|Overall Study|Participant Developed a Rash|0|||
144182453|NCT01320722|519862301|FG002|Overall Study|Participant Developed a Rash|2|||
144182454|NCT01320722|519862302|FG003|Overall Study|Participant Developed a Rash|1|||
144182455|NCT01320722|519862303|FG004|Overall Study|Participant Developed a Rash|1|||
144427046|NCT04199117|520771050|FG013|Overall Study|Death|1|||
144427047|NCT04199117|520771051|FG014|Overall Study|Death|0|||
144427048|NCT04199117|520771052|FG015|Overall Study|Death|0|||
144427049|NCT04199117|520771037|FG000|Overall Study|Withdrawal by PI|0|||
144427050|NCT04199117|520771038|FG001|Overall Study|Withdrawal by PI|0|||
144427051|NCT04199117|520771039|FG002|Overall Study|Withdrawal by PI|0|||
144427052|NCT04199117|520771040|FG003|Overall Study|Withdrawal by PI|0|||
144427053|NCT04199117|520771041|FG004|Overall Study|Withdrawal by PI|0|||
144427054|NCT04199117|520771042|FG005|Overall Study|Withdrawal by PI|0|||
144427055|NCT04199117|520771043|FG006|Overall Study|Withdrawal by PI|0|||
144427056|NCT04199117|520771044|FG007|Overall Study|Withdrawal by PI|0|||
144427057|NCT04199117|520771045|FG008|Overall Study|Withdrawal by PI|0|||
144528734|NCT03910478|521139127|FG001|Overall Study|Death|6|||
144528735|NCT03910478|521139126|FG000|Overall Study|Withdrawal by Subject|23|||
144528736|NCT03910478|521139127|FG001|Overall Study|Withdrawal by Subject|2|||
144182456|NCT01320722|519862299|FG000|Overall Study|Non-compliant with Medication|0|||
144182457|NCT01320722|519862300|FG001|Overall Study|Non-compliant with Medication|0|||
144427058|NCT04199117|520771046|FG009|Overall Study|Withdrawal by PI|0|||
144427059|NCT04199117|520771047|FG010|Overall Study|Withdrawal by PI|0|||
144182458|NCT01320722|519862301|FG002|Overall Study|Non-compliant with Medication|1|||
144182459|NCT01320722|519862302|FG003|Overall Study|Non-compliant with Medication|0|||
144182460|NCT01320722|519862303|FG004|Overall Study|Non-compliant with Medication|0|||
144182461|NCT01320722|519862299|FG000|Overall Study|Adverse Event|0|||
144182462|NCT01320722|519862300|FG001|Overall Study|Adverse Event|0|||
144182463|NCT01320722|519862301|FG002|Overall Study|Adverse Event|3|||
144182464|NCT01320722|519862302|FG003|Overall Study|Adverse Event|6|||
144182465|NCT01320722|519862303|FG004|Overall Study|Adverse Event|0|||
144182466|NCT01320722|519862299|FG000|Overall Study|Not Compliant with Study Procedures|0|||
144182467|NCT01320722|519862300|FG001|Overall Study|Not Compliant with Study Procedures|0|||
144182468|NCT01320722|519862301|FG002|Overall Study|Not Compliant with Study Procedures|0|||
144182469|NCT01320722|519862302|FG003|Overall Study|Not Compliant with Study Procedures|4|||
144182470|NCT01320722|519862303|FG004|Overall Study|Not Compliant with Study Procedures|0|||
144182471|NCT01320722|519862299|FG000|Overall Study|Pregnancy|0|||
144182472|NCT01320722|519862300|FG001|Overall Study|Pregnancy|0|||
144182473|NCT01320722|519862301|FG002|Overall Study|Pregnancy|0|||
144182474|NCT01320722|519862302|FG003|Overall Study|Pregnancy|1|||
144182475|NCT01320722|519862303|FG004|Overall Study|Pregnancy|0|||
144182476|NCT01320722|519862299|FG000|Overall Study|Started an Exclusionary Medication|0|||
144182477|NCT01320722|519862300|FG001|Overall Study|Started an Exclusionary Medication|0|||
144182478|NCT01320722|519862301|FG002|Overall Study|Started an Exclusionary Medication|0|||
144182479|NCT01320722|519862302|FG003|Overall Study|Started an Exclusionary Medication|0|||
144182480|NCT01320722|519862303|FG004|Overall Study|Started an Exclusionary Medication|1|||
144182481|NCT01320722|519862299|FG000|Overall Study|Withdrew due to Health Condition|0|||
144182482|NCT01320722|519862300|FG001|Overall Study|Withdrew due to Health Condition|0|||
144182483|NCT01320722|519862301|FG002|Overall Study|Withdrew due to Health Condition|0|||
144182484|NCT01320722|519862302|FG003|Overall Study|Withdrew due to Health Condition|0|||
144182485|NCT01320722|519862303|FG004|Overall Study|Withdrew due to Health Condition|1|||
144182486|NCT01091363|519862304|FG000|Overall Study|Withdrawal by Subject|11|||
144182487|NCT01091363|519862305|FG001|Overall Study|Withdrawal by Subject|15|||
144182488|NCT01091363|519862304|FG000|Overall Study|Lost to Follow-up|2|||
144182489|NCT01091363|519862305|FG001|Overall Study|Lost to Follow-up|2|||
144182490|NCT00021541|519862306|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
144182491|NCT00021541|519862307|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
144182492|NCT00021541|519862306|FG000|Period 1-First Treatment|Adverse Event|2|||
144182493|NCT00021541|519862307|FG001|Period 1-First Treatment|Adverse Event|1|||
144182494|NCT00021541|519862306|FG000|Period 1-First Treatment|non-adherence|3|||
144182495|NCT00021541|519862307|FG001|Period 1-First Treatment|non-adherence|0|||
144182496|NCT00021541|519862306|FG000|Period 1-First Treatment|Death|1|||
144182497|NCT00021541|519862307|FG001|Period 1-First Treatment|Death|0|||
144182498|NCT00021541|519862306|FG000|Period 1-First Treatment|Pts that did not progress|2|||
144182499|NCT00021541|519862307|FG001|Period 1-First Treatment|Pts that did not progress|2|||
144182500|NCT00021541|519862306|FG000|Period 1-First Treatment|Ineligible|0|||
144182501|NCT00021541|519862307|FG001|Period 1-First Treatment|Ineligible|2|||
144182502|NCT00021541|519862306|FG000|Period 2-crossover|refused phase B|2|||
144182503|NCT00021541|519862307|FG001|Period 2-crossover|refused phase B|2|||
144182504|NCT00021541|519862306|FG000|Period 2-crossover|Withdrawal by Subject|3|||
144182505|NCT00021541|519862307|FG001|Period 2-crossover|Withdrawal by Subject|4|||
144182506|NCT00021541|519862306|FG000|Period 2-crossover|Adverse Event|2|||
144182507|NCT00021541|519862307|FG001|Period 2-crossover|Adverse Event|2|||
144182508|NCT00021541|519862306|FG000|Period 2-crossover|non-adherence|1|||
144427060|NCT04199117|520771048|FG011|Overall Study|Withdrawal by PI|0|||
144427061|NCT04199117|520771049|FG012|Overall Study|Withdrawal by PI|1|||
144427062|NCT04199117|520771050|FG013|Overall Study|Withdrawal by PI|0|||
144427063|NCT04199117|520771051|FG014|Overall Study|Withdrawal by PI|0|||
144182509|NCT00021541|519862307|FG001|Period 2-crossover|non-adherence|0|||
144182510|NCT00021541|519862306|FG000|Period 2-crossover|Pts that did not progress|2|||
144182511|NCT00021541|519862307|FG001|Period 2-crossover|Pts that did not progress|3|||
144427064|NCT04199117|520771052|FG015|Overall Study|Withdrawal by PI|0|||
144427065|NCT04383743|520771053|FG000|Overall Study|Withdrawal by Subject|1|||
144427066|NCT04383743|520771053|FG000|Overall Study|Adverse Event|1|||
144182512|NCT01341405|519862314|FG000|Overall Study|Adverse Event|0|||
144427067|NCT05478252|520771056|FG000|Overall Study|Withdrawal by Subject|2|||
144427068|NCT05478252|520771057|FG001|Overall Study|Withdrawal by Subject|3|||
144427069|NCT05478252|520771056|FG000|Overall Study|Lost to Follow-up|4|||
144427070|NCT05478252|520771057|FG001|Overall Study|Lost to Follow-up|2|||
144182513|NCT01341405|519862315|FG001|Overall Study|Adverse Event|1|||
144182514|NCT01341405|519862316|FG002|Overall Study|Adverse Event|1|||
144182515|NCT01341405|519862314|FG000|Overall Study|Withdrawal by Subject|3|||
144182516|NCT01341405|519862315|FG001|Overall Study|Withdrawal by Subject|2|||
144427071|NCT05478252|520771056|FG000|Overall Study|Physician Decision|1|||
144427072|NCT05478252|520771057|FG001|Overall Study|Physician Decision|1|||
144182517|NCT01341405|519862316|FG002|Overall Study|Withdrawal by Subject|1|||
144182518|NCT05263505|519862317|FG000|Overall Study|Adverse Event|0|||
144182519|NCT05263505|519862318|FG001|Overall Study|Adverse Event|1|||
144182520|NCT02616380|519862319|FG000|Overall Study|Lost to Follow-up|1|||
144427073|NCT05478252|520771056|FG000|Overall Study|Death|1|||
144427074|NCT05478252|520771057|FG001|Overall Study|Death|0|||
144427075|NCT01816893|520771063|FG000|Washout Period|Withdrawal by Subject|2|||
144427076|NCT01816893|520771064|FG001|Washout Period|Withdrawal by Subject|0|||
144427077|NCT01536379|520773578|FG000|Overall Study|Adverse Event|1|||
144427078|NCT01536379|520773579|FG001|Overall Study|Adverse Event|2|||
144427079|NCT01536379|520773578|FG000|Overall Study|Withdrawal by Subject|1|||
144427080|NCT01536379|520773579|FG001|Overall Study|Withdrawal by Subject|1|||
144427081|NCT04439253|520773588|FG000|Overall Study|Adverse Event|1|||
144427082|NCT04439253|520773588|FG000|Overall Study|Disease progression|2|||
144427083|NCT04439253|520773588|FG000|Overall Study|Complicating disease|1|||
144427084|NCT03971695|520773589|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427085|NCT03971695|520773590|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427086|NCT03971695|520773591|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427087|NCT03971695|520773592|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
144427088|NCT03971695|520773593|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
144427089|NCT03971695|520773594|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427090|NCT03971695|520773595|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427091|NCT03971695|520773596|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427092|NCT03971695|520773597|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
144427093|NCT03971695|520773598|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
144427094|NCT03971695|520773599|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
144427095|NCT03971695|520773600|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
144427096|NCT03971695|520773601|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
144427097|NCT00939809|520773602|FG000|Overall Study|Adverse Event|2|||
144427098|NCT00939809|520773602|FG000|Overall Study|Death|1|||
144427099|NCT04447417|520773603|FG000|Overall Study|Withdrawal by Subject|1|||
144427100|NCT04447417|520773604|FG001|Overall Study|Withdrawal by Subject|0|||
144427101|NCT04447417|520773603|FG000|Overall Study|Failure to meet inclusion criteria|1|||
144427102|NCT04447417|520773604|FG001|Overall Study|Failure to meet inclusion criteria|0|||
144427103|NCT04447417|520773603|FG000|Overall Study|Lost to Follow-up|1|||
144427104|NCT04447417|520773604|FG001|Overall Study|Lost to Follow-up|0|||
144427105|NCT00858442|520773609|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
144427106|NCT00858442|520773610|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
144427107|NCT02016625|520773613|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
144427108|NCT02016625|520773614|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
144427109|NCT02016625|520773613|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
144427110|NCT02016625|520773614|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
144427111|NCT02016625|520773613|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
144427112|NCT02016625|520773614|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
144427113|NCT02155738|520773615|FG000|Overall Study|Missing critical information|1|||
144427114|NCT02155738|520773616|FG001|Overall Study|Missing critical information|0|||
144427115|NCT02155738|520773617|FG002|Overall Study|Missing critical information|0|||
144427116|NCT02155738|520773618|FG003|Overall Study|Missing critical information|1|||
144427117|NCT02356783|520773620|FG000|Overall Study|Lost to Follow-up|1|||
144427118|NCT02356783|520773621|FG001|Overall Study|Lost to Follow-up|3|||
144182521|NCT02616380|519862319|FG000|Overall Study|Other|2|||
144182522|NCT00826241|519862320|FG000|Overall Study|Withdrawal from Follow-up|1|||
144182523|NCT00826241|519862320|FG000|Overall Study|Withdrew consent|2|||
144182524|NCT00826241|519862320|FG000|Overall Study|Death|4|||
144182525|NCT00826241|519862320|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
144427119|NCT02603809|520773622|FG000|Overall Study|Withdrawal by Subject|4|||
144427120|NCT02603809|520773623|FG001|Overall Study|Withdrawal by Subject|1|||
144427121|NCT02603809|520773624|FG002|Overall Study|Withdrawal by Subject|2|||
144427122|NCT02603809|520773625|FG003|Overall Study|Withdrawal by Subject|3|||
144427123|NCT02603809|520773626|FG004|Overall Study|Withdrawal by Subject|3|||
144427124|NCT02603809|520773627|FG005|Overall Study|Withdrawal by Subject|4|||
144427125|NCT02603809|520773622|FG000|Overall Study|Lost to Follow-up|2|||
144427126|NCT02603809|520773623|FG001|Overall Study|Lost to Follow-up|3|||
144182526|NCT00826241|519862320|FG000|Overall Study|Non-compliance|1|||
144182527|NCT00826241|519862320|FG000|Overall Study|Progression of disease|1|||
144182528|NCT00826241|519862320|FG000|Overall Study|Patient refused follow-up|3|||
144427127|NCT02603809|520773624|FG002|Overall Study|Lost to Follow-up|1|||
144427128|NCT02603809|520773625|FG003|Overall Study|Lost to Follow-up|4|||
144427129|NCT02603809|520773626|FG004|Overall Study|Lost to Follow-up|2|||
144427130|NCT02603809|520773627|FG005|Overall Study|Lost to Follow-up|2|||
144427131|NCT02603809|520773622|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
144427132|NCT02603809|520773623|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
144182529|NCT00826241|519862320|FG000|Overall Study|Lost to Follow-up|9|||
144182530|NCT00826241|519862320|FG000|Overall Study|Could not obtain records|1|||
144427133|NCT02603809|520773624|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
144427134|NCT02603809|520773625|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
144427135|NCT02603809|520773626|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
144427136|NCT02603809|520773627|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
144427137|NCT02603809|520773622|FG000|Overall Study|Physician Decision|0|||
144427138|NCT02603809|520773623|FG001|Overall Study|Physician Decision|0|||
144427139|NCT02603809|520773624|FG002|Overall Study|Physician Decision|0|||
144427140|NCT02603809|520773625|FG003|Overall Study|Physician Decision|1|||
144427141|NCT02603809|520773626|FG004|Overall Study|Physician Decision|2|||
144427142|NCT02603809|520773627|FG005|Overall Study|Physician Decision|1|||
144427143|NCT02603809|520773622|FG000|Overall Study|Adverse Event|3|||
144427144|NCT02603809|520773623|FG001|Overall Study|Adverse Event|0|||
144427145|NCT02603809|520773624|FG002|Overall Study|Adverse Event|2|||
144427146|NCT02603809|520773625|FG003|Overall Study|Adverse Event|2|||
144427147|NCT02603809|520773626|FG004|Overall Study|Adverse Event|1|||
144427148|NCT02603809|520773627|FG005|Overall Study|Adverse Event|1|||
144427149|NCT02603809|520773622|FG000|Overall Study|Lack of Efficacy|0|||
144427150|NCT02603809|520773623|FG001|Overall Study|Lack of Efficacy|1|||
144427151|NCT02603809|520773624|FG002|Overall Study|Lack of Efficacy|0|||
144427152|NCT02603809|520773625|FG003|Overall Study|Lack of Efficacy|0|||
144427153|NCT02603809|520773626|FG004|Overall Study|Lack of Efficacy|0|||
144427154|NCT02603809|520773627|FG005|Overall Study|Lack of Efficacy|1|||
144427155|NCT00380978|520773629|FG000|Overall Study|Refused allocated intervention|0|||
144427156|NCT00380978|520773630|FG001|Overall Study|Refused allocated intervention|6|||
144427157|NCT00380978|520773629|FG000|Overall Study|Wrong study envelope|0|||
144427158|NCT00380978|520773630|FG001|Overall Study|Wrong study envelope|2|||
144427159|NCT00380978|520773629|FG000|Overall Study|Allocation prior to analgesia request|1|||
144427160|NCT00380978|520773630|FG001|Overall Study|Allocation prior to analgesia request|2|||
144427161|NCT00380978|520773629|FG000|Overall Study|Parous patient|1|||
144427162|NCT00380978|520773630|FG001|Overall Study|Parous patient|0|||
144427163|NCT01466348|520773631|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
144427164|NCT01466348|520773632|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
144427165|NCT03970733|520773635|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
144427166|NCT03970733|520773636|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
144427167|NCT03970733|520773637|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
144427168|NCT03970733|520773638|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
144427169|NCT03970733|520773639|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
144427170|NCT03970733|520773635|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
144427171|NCT03970733|520773636|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
144427172|NCT03970733|520773637|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
144427173|NCT03970733|520773638|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
144427174|NCT03970733|520773639|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
144427175|NCT03970733|520773635|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
144723511|NCT04634409|521842405|FG022|Overall Study|Death|0|||
144182531|NCT00826241|519862320|FG000|Overall Study|Screen failure|2|||
144182532|NCT00826241|519862320|FG000|Overall Study|Pt unable to proceed to registration|1|||
144427176|NCT03970733|520773636|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
144427177|NCT03970733|520773637|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
144427178|NCT03970733|520773638|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
144427179|NCT03970733|520773639|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
144427180|NCT03970733|520773635|FG000|Main Study Phase (18 Months)|Other|1|||
144427181|NCT03970733|520773636|FG001|Main Study Phase (18 Months)|Other|1|||
144427182|NCT03970733|520773637|FG002|Main Study Phase (18 Months)|Other|0|||
144427183|NCT03970733|520773638|FG003|Main Study Phase (18 Months)|Other|0|||
144528737|NCT03910478|521139126|FG000|Overall Study|Physician Decision|5|||
144528738|NCT03910478|521139127|FG001|Overall Study|Physician Decision|0|||
144528739|NCT03910478|521139126|FG000|Overall Study|Protocol Violation|1|||
144528740|NCT03910478|521139127|FG001|Overall Study|Protocol Violation|0|||
144528741|NCT03910478|521139126|FG000|Overall Study|Failure to meet continuation criteria|2|||
144528742|NCT03910478|521139127|FG001|Overall Study|Failure to meet continuation criteria|0|||
144528743|NCT03910478|521139126|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
144528744|NCT03910478|521139127|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
144528745|NCT04971109|521139128|FG000|Overall Study|Adverse Event|4|||
144528746|NCT04971109|521139129|FG001|Overall Study|Adverse Event|3|||
144528747|NCT04971109|521139128|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
144528748|NCT04971109|521139129|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
144723512|NCT04634409|521842406|FG023|Overall Study|Death|0|||
144723513|NCT04634409|521842407|FG024|Overall Study|Death|0|||
144427184|NCT03970733|520773639|FG004|Main Study Phase (18 Months)|Other|0|||
144427185|NCT03970733|520773635|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
144723514|NCT04634409|521842408|FG025|Overall Study|Death|0|||
144427186|NCT03970733|520773636|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
144528749|NCT04971109|521139128|FG000|Overall Study|Lost to Follow-up|8|||
144251819|NCT00094536|520120903|FG000|Treatment and Follow-up|Subject non-compliance|9|||
144251820|NCT00094536|520120903|FG000|Treatment and Follow-up|Unable to attend visits|1|||
144251821|NCT02655419|520120904|FG000|Overall Study|Enrolled but not treated|1|||
144251822|NCT02655419|520120905|FG001|Overall Study|Enrolled but not treated|5|||
144251823|NCT02655419|520120904|FG000|Overall Study|Withdrawal by Subject|4|||
144251824|NCT02655419|520120905|FG001|Overall Study|Withdrawal by Subject|1|||
144251825|NCT02655419|520120904|FG000|Overall Study|Other|0|||
144251826|NCT02655419|520120905|FG001|Overall Study|Other|1|||
144251827|NCT02071082|520120906|FG000|Overall Study|Enrolled and Never Treated|1|||
144251828|NCT02071082|520120907|FG001|Overall Study|Enrolled and Never Treated|1|||
144251829|NCT02071082|520120906|FG000|Overall Study|Adverse Event|0|||
144251830|NCT02071082|520120907|FG001|Overall Study|Adverse Event|1|||
144251831|NCT02071082|520120906|FG000|Overall Study|Withdrew Consent|0|||
144251832|NCT02071082|520120907|FG001|Overall Study|Withdrew Consent|4|||
144251833|NCT02071082|520120906|FG000|Overall Study|Lost to Follow-up|1|||
144251834|NCT02071082|520120907|FG001|Overall Study|Lost to Follow-up|1|||
144251835|NCT01900431|520120908|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
144251836|NCT01900431|520120909|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
144251837|NCT01900431|520120910|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
144427187|NCT03970733|520773637|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
144427188|NCT03970733|520773638|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
144427189|NCT03970733|520773639|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
144427190|NCT02784821|520773643|FG000|Overall Study|Death|0|||
144427191|NCT02784821|520773644|FG001|Overall Study|Death|5|||
144427192|NCT02784821|520773645|FG002|Overall Study|Death|4|||
144427193|NCT02784821|520773646|FG003|Overall Study|Death|5|||
144427194|NCT01139450|520773647|FG000|Overall Study|Withdrawal by Subject|7|||
144427195|NCT01139450|520773648|FG001|Overall Study|Withdrawal by Subject|10|||
144427196|NCT01139450|520773649|FG002|Overall Study|Withdrawal by Subject|13|||
144427197|NCT01139450|520773647|FG000|Overall Study|Lack of Efficacy|3|||
144427198|NCT01139450|520773648|FG001|Overall Study|Lack of Efficacy|1|||
144427199|NCT01139450|520773649|FG002|Overall Study|Lack of Efficacy|8|||
144427200|NCT01139450|520773647|FG000|Overall Study|Protocol Violation|6|||
144427201|NCT01139450|520773648|FG001|Overall Study|Protocol Violation|5|||
144427202|NCT01139450|520773649|FG002|Overall Study|Protocol Violation|2|||
144427203|NCT01139450|520773647|FG000|Overall Study|Lost to Follow-up|9|||
144427204|NCT01139450|520773648|FG001|Overall Study|Lost to Follow-up|7|||
144427205|NCT01139450|520773649|FG002|Overall Study|Lost to Follow-up|11|||
144427206|NCT01139450|520773647|FG000|Overall Study|Administrative|0|||
144427207|NCT01139450|520773648|FG001|Overall Study|Administrative|0|||
144427208|NCT01139450|520773649|FG002|Overall Study|Administrative|1|||
144427209|NCT01139450|520773647|FG000|Overall Study|Adverse Event|2|||
144427210|NCT01139450|520773648|FG001|Overall Study|Adverse Event|2|||
144427211|NCT01139450|520773649|FG002|Overall Study|Adverse Event|3|||
144427212|NCT02794103|520773650|FG000|Overall Study|Loss to follow up due to high sedation|3|||
144427213|NCT04608500|520773651|FG000|Overall Study|Adverse Event|2|||
144427214|NCT04608500|520773652|FG001|Overall Study|Adverse Event|0|||
144427215|NCT04608500|520773651|FG000|Overall Study|Lost to Follow-up|15|||
144427216|NCT04608500|520773652|FG001|Overall Study|Lost to Follow-up|9|||
144427217|NCT04608500|520773651|FG000|Overall Study|Participant request|11|||
144427218|NCT04608500|520773652|FG001|Overall Study|Participant request|7|||
144427219|NCT04608500|520773651|FG000|Overall Study|Protocol Violation|1|||
144427220|NCT04608500|520773652|FG001|Overall Study|Protocol Violation|0|||
144528750|NCT04971109|521139129|FG001|Overall Study|Lost to Follow-up|2|||
144528751|NCT04971109|521139128|FG000|Overall Study|Physician Decision|5|||
144528752|NCT04971109|521139129|FG001|Overall Study|Physician Decision|0|||
144528753|NCT04971109|521139128|FG000|Overall Study|Protocol Violation|0|||
144528754|NCT04971109|521139129|FG001|Overall Study|Protocol Violation|1|||
144528755|NCT04971109|521139128|FG000|Overall Study|Withdrawal by Subject|18|||
144528756|NCT04971109|521139129|FG001|Overall Study|Withdrawal by Subject|3|||
144528757|NCT04971109|521139128|FG000|Overall Study|Subject was randomized in error|1|||
144528758|NCT04971109|521139129|FG001|Overall Study|Subject was randomized in error|0|||
144251838|NCT01900431|520120908|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
144427221|NCT04608500|520773651|FG000|Overall Study|Other|6|||
144427222|NCT04608500|520773652|FG001|Overall Study|Other|2|||
144427223|NCT01881230|520773664|FG000|Overall Study|Death|2|||
144427224|NCT01881230|520773665|FG001|Overall Study|Death|0|||
144427225|NCT01881230|520773666|FG002|Overall Study|Death|1|||
144251839|NCT01900431|520120909|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
144427226|NCT01881230|520773664|FG000|Overall Study|Adverse Event|9|||
144528759|NCT05293171|521139130|FG000|Washout 5 to 7 Days|Adverse Event|1|||
144528760|NCT05293171|521139131|FG001|Washout 5 to 7 Days|Adverse Event|1|||
144251840|NCT01900431|520120910|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
144251841|NCT01900431|520120908|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
144427227|NCT01881230|520773665|FG001|Overall Study|Adverse Event|13|||
144427228|NCT01881230|520773666|FG002|Overall Study|Adverse Event|12|||
144528761|NCT05293171|521139132|FG002|Washout 5 to 7 Days|Adverse Event|0|||
144528762|NCT05293171|521139133|FG003|Washout 5 to 7 Days|Adverse Event|0|||
144182533|NCT00826241|519862320|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
144182534|NCT03407729|519862321|FG000|Overall Study|Lost to Follow-up|2|||
144182535|NCT03407729|519862322|FG001|Overall Study|Lost to Follow-up|0|||
144182536|NCT03407729|519862321|FG000|Overall Study|Unable to schedule|0|||
144182537|NCT03407729|519862322|FG001|Overall Study|Unable to schedule|3|||
144182538|NCT01050764|519862325|FG000|Overall Study|Death, before HSCT|1|||
144182539|NCT01050764|519862325|FG000|Overall Study|Donor mobilization failure, death|1|||
144182540|NCT01050764|519862325|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
144182541|NCT01898598|519862326|FG000|Overall Study|Adverse Event|1|||
144182542|NCT01898598|519862327|FG001|Overall Study|Adverse Event|0|||
144182543|NCT01898598|519862326|FG000|Overall Study|Withdrawal by Subject|3|||
144182544|NCT01898598|519862327|FG001|Overall Study|Withdrawal by Subject|0|||
144182545|NCT01898598|519862326|FG000|Overall Study|Lost to Follow-up|0|||
144182546|NCT01898598|519862327|FG001|Overall Study|Lost to Follow-up|1|||
144182547|NCT01898598|519862326|FG000|Overall Study|Other|0|||
144182548|NCT01898598|519862327|FG001|Overall Study|Other|1|||
144182549|NCT03833427|519862328|FG000|Overall Study|Death|4|||
144182550|NCT03833427|519862329|FG001|Overall Study|Death|2|||
144182551|NCT03833427|519862330|FG002|Overall Study|Death|9|||
144182552|NCT03833427|519862331|FG003|Overall Study|Death|11|||
144182553|NCT03833427|519862332|FG004|Overall Study|Death|0|||
144182554|NCT03833427|519862333|FG005|Overall Study|Death|0|||
144182555|NCT03833427|519862334|FG006|Overall Study|Death|0|||
144182556|NCT03833427|519862328|FG000|Overall Study|Withdrawal by Subject|0|||
144182557|NCT03833427|519862329|FG001|Overall Study|Withdrawal by Subject|1|||
144182558|NCT03833427|519862330|FG002|Overall Study|Withdrawal by Subject|1|||
144182559|NCT03833427|519862331|FG003|Overall Study|Withdrawal by Subject|0|||
144182560|NCT03833427|519862332|FG004|Overall Study|Withdrawal by Subject|0|||
144182561|NCT03833427|519862333|FG005|Overall Study|Withdrawal by Subject|0|||
144182562|NCT03833427|519862334|FG006|Overall Study|Withdrawal by Subject|0|||
144182563|NCT03833427|519862328|FG000|Overall Study|Sponsor Decision|0|||
144182564|NCT03833427|519862329|FG001|Overall Study|Sponsor Decision|0|||
144182565|NCT03833427|519862330|FG002|Overall Study|Sponsor Decision|1|||
144182566|NCT03833427|519862331|FG003|Overall Study|Sponsor Decision|3|||
144182567|NCT03833427|519862332|FG004|Overall Study|Sponsor Decision|0|||
144182568|NCT03833427|519862333|FG005|Overall Study|Sponsor Decision|0|||
144182569|NCT03833427|519862334|FG006|Overall Study|Sponsor Decision|0|||
144182570|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
144182571|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
144182572|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
144182573|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
144182574|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
144182575|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
144182576|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
144182577|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
144182578|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
144182579|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
144182580|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
144182581|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
144182582|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
144182583|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
144182584|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
144182585|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
144182586|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
144182587|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
144182588|NCT00950300|519862343|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
144182589|NCT00950300|519862344|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
144182590|NCT00950300|519862343|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
144182591|NCT00950300|519862344|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
144182592|NCT00950300|519862343|FG000|TFFU Period|Death|4|||
144182593|NCT00950300|519862344|FG001|TFFU Period|Death|1|||
144182594|NCT00950300|519862343|FG000|TFFU Period|Refused Treatment|10|||
144528763|NCT05293171|521139134|FG004|Washout 5 to 7 Days|Adverse Event|0|||
144182595|NCT00950300|519862344|FG001|TFFU Period|Refused Treatment|11|||
144251842|NCT01900431|520120909|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
144251843|NCT01900431|520120910|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
144528764|NCT05293171|521139135|FG005|Washout 5 to 7 Days|Adverse Event|0|||
144528765|NCT05293171|521139136|FG006|Washout 5 to 7 Days|Adverse Event|0|||
144182596|NCT00950300|519862343|FG000|TFFU Period|Failure to Return|16|||
144182597|NCT00950300|519862344|FG001|TFFU Period|Failure to Return|16|||
144182598|NCT00950300|519862343|FG000|TFFU Period|Recurrence of Disease|63|||
144182599|NCT00950300|519862344|FG001|TFFU Period|Recurrence of Disease|72|||
144251844|NCT01900431|520120908|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
144528766|NCT05293171|521139137|FG007|Washout 5 to 7 Days|Adverse Event|0|||
144182600|NCT00950300|519862343|FG000|TFFU Period|Other|4|||
144182601|NCT00950300|519862344|FG001|TFFU Period|Other|3|||
144182602|NCT00950300|519862343|FG000|SFU Period|Death|44|||
144182603|NCT00950300|519862344|FG001|SFU Period|Death|42|||
144182604|NCT00950300|519862343|FG000|SFU Period|Lost to Follow-up|30|||
144182605|NCT00950300|519862344|FG001|SFU Period|Lost to Follow-up|28|||
144182606|NCT00950300|519862343|FG000|SFU Period|Withdrawal by Subject|4|||
144182607|NCT00950300|519862344|FG001|SFU Period|Withdrawal by Subject|8|||
144182608|NCT01596127|519862346|FG000|Overall Study|Patient Ineligible|1|||
144182609|NCT00438633|519862347|FG000|Overall Study|Withdrawal by Subject|1|||
144182610|NCT00438633|519862348|FG001|Overall Study|Withdrawal by Subject|0|||
144182611|NCT00438633|519862347|FG000|Overall Study|Lost to Follow-up|15|||
144182612|NCT00438633|519862348|FG001|Overall Study|Lost to Follow-up|17|||
144182613|NCT01539239|519862349|FG000|Overall Study|Death|5|||
144182614|NCT01539239|519862350|FG001|Overall Study|Death|5|||
144182615|NCT01539239|519862349|FG000|Overall Study|Lost to Follow-up|7|||
144182616|NCT01539239|519862350|FG001|Overall Study|Lost to Follow-up|12|||
144182617|NCT00633022|519862353|FG000|Overall Study|Adverse Event|1|||
144182618|NCT00633022|519862354|FG001|Overall Study|Adverse Event|0|||
144182619|NCT00633022|519862355|FG002|Overall Study|Adverse Event|5|||
144182620|NCT00633022|519862353|FG000|Overall Study|Physician Decision|0|||
144182621|NCT00633022|519862354|FG001|Overall Study|Physician Decision|1|||
144182622|NCT00633022|519862355|FG002|Overall Study|Physician Decision|0|||
144182623|NCT04388787|519862357|FG000|Blinded Period|Patient could not follow instructions|1|||
144182624|NCT04388787|519862357|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
144182625|NCT00663234|519862358|FG000|Overall Study|Not willing to adhere to requirements|1|||
144182626|NCT01751087|519862359|FG000|Overall Study|Withdrawal by Subject|1|||
144182627|NCT01751087|519862360|FG001|Overall Study|Withdrawal by Subject|0|||
144182628|NCT01751087|519862361|FG002|Overall Study|Withdrawal by Subject|0|||
144182629|NCT01751087|519862359|FG000|Overall Study|Physician Decision|0|||
144182630|NCT01751087|519862360|FG001|Overall Study|Physician Decision|0|||
144182631|NCT01751087|519862361|FG002|Overall Study|Physician Decision|1|||
144182632|NCT04264819|519863981|FG000|Overall Study|Physician Decision|19|||
144182633|NCT04264819|519863981|FG000|Overall Study|Adverse Event|12|||
144182634|NCT04264819|519863981|FG000|Overall Study|Withdrawal by Subject|11|||
144182635|NCT04264819|519863981|FG000|Overall Study|Lost to Follow-up|2|||
144182636|NCT04264819|519863981|FG000|Overall Study|Death|2|||
144182637|NCT02846883|519863986|FG000|Overall Study|Death|0|||
144182638|NCT02846883|519863987|FG001|Overall Study|Death|1|||
144182639|NCT02846883|519863988|FG002|Overall Study|Death|1|||
144182640|NCT02846883|519863986|FG000|Overall Study|Lost to Follow-up|0|||
144182641|NCT02846883|519863987|FG001|Overall Study|Lost to Follow-up|0|||
144182642|NCT02846883|519863988|FG002|Overall Study|Lost to Follow-up|1|||
144182643|NCT02846883|519863986|FG000|Overall Study|Withdrawal by Subject|1|||
144182644|NCT02846883|519863987|FG001|Overall Study|Withdrawal by Subject|0|||
144182645|NCT02846883|519863988|FG002|Overall Study|Withdrawal by Subject|0|||
144182646|NCT02846883|519863986|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
144182647|NCT02846883|519863987|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
144182648|NCT02846883|519863988|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
144182649|NCT02846883|519863986|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
144182650|NCT02846883|519863987|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
144182651|NCT02846883|519863988|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
144182652|NCT00108628|519863994|FG000|Overall Study|Withdrawal by Subject|17|||
144182653|NCT00108628|519863995|FG001|Overall Study|Withdrawal by Subject|9|||
144182654|NCT00108628|519863994|FG000|Overall Study|Lack of Efficacy|2|||
144182655|NCT00108628|519863995|FG001|Overall Study|Lack of Efficacy|1|||
144182656|NCT00108628|519863994|FG000|Overall Study|Death|1|||
144427229|NCT01881230|520773664|FG000|Overall Study|Progressive Disease|31|||
144427230|NCT01881230|520773665|FG001|Overall Study|Progressive Disease|35|||
144182657|NCT00108628|519863995|FG001|Overall Study|Death|0|||
144182658|NCT01453153|519863996|FG000|Overall Study|Physician Decision|0|||
144182659|NCT01453153|519863997|FG001|Overall Study|Physician Decision|0|||
144182660|NCT01453153|519863998|FG002|Overall Study|Physician Decision|1|||
144182661|NCT01453153|519863996|FG000|Overall Study|Progressive Disease|3|||
144427231|NCT01881230|520773666|FG002|Overall Study|Progressive Disease|36|||
144427232|NCT01881230|520773664|FG000|Overall Study|Symptomatic Deterioration|3|||
144427233|NCT01881230|520773665|FG001|Overall Study|Symptomatic Deterioration|3|||
144182662|NCT01453153|519863997|FG001|Overall Study|Progressive Disease|2|||
144182663|NCT01453153|519863998|FG002|Overall Study|Progressive Disease|16|||
144182664|NCT01453153|519863996|FG000|Overall Study|Withdrawal by Subject|0|||
144182665|NCT01453153|519863997|FG001|Overall Study|Withdrawal by Subject|1|||
144182666|NCT01453153|519863998|FG002|Overall Study|Withdrawal by Subject|2|||
144182667|NCT01453153|519863996|FG000|Overall Study|Adverse Event|1|||
144182668|NCT01453153|519863997|FG001|Overall Study|Adverse Event|1|||
144182669|NCT01453153|519863998|FG002|Overall Study|Adverse Event|1|||
144182670|NCT03547635|519863999|FG000|Overall Study|Adverse Event|5|||
144182671|NCT03547635|519864000|FG001|Overall Study|Adverse Event|2|||
144182672|NCT03547635|519864001|FG002|Overall Study|Adverse Event|3|||
144182673|NCT03547635|519863999|FG000|Overall Study|Lost to Follow-up|1|||
144427234|NCT01881230|520773666|FG002|Overall Study|Symptomatic Deterioration|1|||
144427235|NCT01881230|520773664|FG000|Overall Study|Withdrawal by Subject|6|||
144427236|NCT01881230|520773665|FG001|Overall Study|Withdrawal by Subject|4|||
144427237|NCT01881230|520773666|FG002|Overall Study|Withdrawal by Subject|6|||
144427238|NCT01881230|520773664|FG000|Overall Study|Physician Decision|4|||
144427239|NCT01881230|520773665|FG001|Overall Study|Physician Decision|3|||
144427240|NCT01881230|520773666|FG002|Overall Study|Physician Decision|6|||
144427241|NCT01881230|520773664|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144427242|NCT01881230|520773665|FG001|Overall Study|Non-Compliance with Study Drug|2|||
144427243|NCT01881230|520773666|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144427244|NCT01881230|520773664|FG000|Overall Study|Given Commercially Available Drug|0|||
144427245|NCT01881230|520773665|FG001|Overall Study|Given Commercially Available Drug|0|||
144427246|NCT01881230|520773666|FG002|Overall Study|Given Commercially Available Drug|2|||
144427247|NCT01881230|520773664|FG000|Overall Study|Protocol Violation|1|||
144427248|NCT01881230|520773665|FG001|Overall Study|Protocol Violation|1|||
144427249|NCT01881230|520773666|FG002|Overall Study|Protocol Violation|0|||
144427250|NCT01881230|520773664|FG000|Overall Study|Miscellaneous|3|||
144427251|NCT01881230|520773665|FG001|Overall Study|Miscellaneous|3|||
144427252|NCT01881230|520773666|FG002|Overall Study|Miscellaneous|0|||
144427253|NCT01881230|520773664|FG000|Overall Study|Untreated: Other|0|||
144427254|NCT01881230|520773665|FG001|Overall Study|Untreated: Other|0|||
144427255|NCT01881230|520773666|FG002|Overall Study|Untreated: Other|1|||
144427256|NCT01881230|520773664|FG000|Overall Study|Untreated: Death|0|||
144427257|NCT01881230|520773665|FG001|Overall Study|Untreated: Death|0|||
144427258|NCT01881230|520773666|FG002|Overall Study|Untreated: Death|1|||
144427259|NCT01881230|520773664|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
144427260|NCT01881230|520773665|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
144427261|NCT01881230|520773666|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
144427262|NCT00112502|520773667|FG000|Overall Study|Withdrawal by Subject|0|||
144427263|NCT00112502|520773668|FG001|Overall Study|Withdrawal by Subject|1|||
144427264|NCT00112502|520773669|FG002|Overall Study|Withdrawal by Subject|1|||
144427265|NCT00112502|520773670|FG003|Overall Study|Withdrawal by Subject|4|||
144427266|NCT00112502|520773671|FG004|Overall Study|Withdrawal by Subject|2|||
144427267|NCT00112502|520773672|FG005|Overall Study|Withdrawal by Subject|5|||
144427268|NCT00112502|520773673|FG006|Overall Study|Withdrawal by Subject|3|||
144427269|NCT00112502|520773674|FG007|Overall Study|Withdrawal by Subject|7|||
144427270|NCT02747420|520773675|FG000|Overall Study|Lost to Follow-up|4|||
144427271|NCT02747420|520773676|FG001|Overall Study|Lost to Follow-up|2|||
144427272|NCT02747420|520773675|FG000|Overall Study|Withdrawal by Subject|3|||
144427273|NCT02747420|520773676|FG001|Overall Study|Withdrawal by Subject|2|||
144427274|NCT05129488|520773677|FG000|Overall Study|Protocol Violation|3|||
144427275|NCT02608268|520773678|FG000|Overall Study|Adverse Event|0|||
144427276|NCT02608268|520773679|FG001|Overall Study|Adverse Event|0|||
144427277|NCT02608268|520773680|FG002|Overall Study|Adverse Event|1|||
144427278|NCT02608268|520773681|FG003|Overall Study|Adverse Event|0|||
144427279|NCT02608268|520773682|FG004|Overall Study|Adverse Event|0|||
144427280|NCT02608268|520773683|FG005|Overall Study|Adverse Event|0|||
144427281|NCT02608268|520773684|FG006|Overall Study|Adverse Event|0|||
144427282|NCT02608268|520773685|FG007|Overall Study|Adverse Event|0|||
144427283|NCT02608268|520773686|FG008|Overall Study|Adverse Event|0|||
144427284|NCT02608268|520773687|FG009|Overall Study|Adverse Event|0|||
144427285|NCT02608268|520773688|FG010|Overall Study|Adverse Event|0|||
144427286|NCT02608268|520773689|FG011|Overall Study|Adverse Event|0|||
144427287|NCT02608268|520773690|FG012|Overall Study|Adverse Event|2|||
144427288|NCT02608268|520773691|FG013|Overall Study|Adverse Event|0|||
144427289|NCT02608268|520773692|FG014|Overall Study|Adverse Event|0|||
144427290|NCT02608268|520773693|FG015|Overall Study|Adverse Event|0|||
144427291|NCT02608268|520773694|FG016|Overall Study|Adverse Event|0|||
144427292|NCT02608268|520773695|FG017|Overall Study|Adverse Event|0|||
144427293|NCT02608268|520773696|FG018|Overall Study|Adverse Event|0|||
144427294|NCT02608268|520773697|FG019|Overall Study|Adverse Event|0|||
144427295|NCT02608268|520773698|FG020|Overall Study|Adverse Event|1|||
144427296|NCT02608268|520773699|FG021|Overall Study|Adverse Event|1|||
144427297|NCT02608268|520773700|FG022|Overall Study|Adverse Event|0|||
144427298|NCT02608268|520773701|FG023|Overall Study|Adverse Event|0|||
144427299|NCT02608268|520773702|FG024|Overall Study|Adverse Event|1|||
144427300|NCT02608268|520773703|FG025|Overall Study|Adverse Event|0|||
144427301|NCT02608268|520773704|FG026|Overall Study|Adverse Event|0|||
144427302|NCT02608268|520773705|FG027|Overall Study|Adverse Event|0|||
144427303|NCT02608268|520773706|FG028|Overall Study|Adverse Event|1|||
144427304|NCT02608268|520773707|FG029|Overall Study|Adverse Event|0|||
144427305|NCT02608268|520773678|FG000|Overall Study|Death|1|||
144603641|NCT01118325|521411955|FG000|Overall Study|Adverse Event|1|||
144427306|NCT02608268|520773679|FG001|Overall Study|Death|0|||
144427307|NCT02608268|520773680|FG002|Overall Study|Death|0|||
144427308|NCT02608268|520773681|FG003|Overall Study|Death|0|||
144427309|NCT02608268|520773682|FG004|Overall Study|Death|0|||
144427310|NCT02608268|520773683|FG005|Overall Study|Death|0|||
144427311|NCT02608268|520773684|FG006|Overall Study|Death|0|||
144427312|NCT02608268|520773685|FG007|Overall Study|Death|0|||
144427313|NCT02608268|520773686|FG008|Overall Study|Death|1|||
144427314|NCT02608268|520773687|FG009|Overall Study|Death|1|||
144427315|NCT02608268|520773688|FG010|Overall Study|Death|0|||
144427316|NCT02608268|520773689|FG011|Overall Study|Death|0|||
144427317|NCT02608268|520773690|FG012|Overall Study|Death|0|||
144427318|NCT02608268|520773691|FG013|Overall Study|Death|0|||
144427319|NCT02608268|520773692|FG014|Overall Study|Death|0|||
144427320|NCT02608268|520773693|FG015|Overall Study|Death|1|||
144427321|NCT02608268|520773694|FG016|Overall Study|Death|0|||
144427322|NCT02608268|520773695|FG017|Overall Study|Death|1|||
144427323|NCT02608268|520773696|FG018|Overall Study|Death|0|||
144427324|NCT02608268|520773697|FG019|Overall Study|Death|1|||
144427325|NCT02608268|520773698|FG020|Overall Study|Death|1|||
144427326|NCT02608268|520773699|FG021|Overall Study|Death|0|||
144427327|NCT02608268|520773700|FG022|Overall Study|Death|0|||
144427328|NCT02608268|520773701|FG023|Overall Study|Death|0|||
144427329|NCT02608268|520773702|FG024|Overall Study|Death|1|||
144427330|NCT02608268|520773703|FG025|Overall Study|Death|2|||
144427331|NCT02608268|520773704|FG026|Overall Study|Death|0|||
144427332|NCT02608268|520773705|FG027|Overall Study|Death|1|||
144427333|NCT02608268|520773706|FG028|Overall Study|Death|4|||
144427334|NCT02608268|520773707|FG029|Overall Study|Death|0|||
144427335|NCT02608268|520773678|FG000|Overall Study|Physician Decision|0|||
144427336|NCT02608268|520773679|FG001|Overall Study|Physician Decision|0|||
144427337|NCT02608268|520773680|FG002|Overall Study|Physician Decision|0|||
144427338|NCT02608268|520773681|FG003|Overall Study|Physician Decision|0|||
144427339|NCT02608268|520773682|FG004|Overall Study|Physician Decision|0|||
144427340|NCT02608268|520773683|FG005|Overall Study|Physician Decision|0|||
144427341|NCT02608268|520773684|FG006|Overall Study|Physician Decision|0|||
144427342|NCT02608268|520773685|FG007|Overall Study|Physician Decision|0|||
144427343|NCT02608268|520773686|FG008|Overall Study|Physician Decision|0|||
144427344|NCT02608268|520773687|FG009|Overall Study|Physician Decision|0|||
144427345|NCT02608268|520773688|FG010|Overall Study|Physician Decision|1|||
144427346|NCT02608268|520773689|FG011|Overall Study|Physician Decision|0|||
144427347|NCT02608268|520773690|FG012|Overall Study|Physician Decision|0|||
144427348|NCT02608268|520773691|FG013|Overall Study|Physician Decision|1|||
144427349|NCT02608268|520773692|FG014|Overall Study|Physician Decision|0|||
144427350|NCT02608268|520773693|FG015|Overall Study|Physician Decision|0|||
144427351|NCT02608268|520773694|FG016|Overall Study|Physician Decision|0|||
144427352|NCT02608268|520773695|FG017|Overall Study|Physician Decision|0|||
144427353|NCT02608268|520773696|FG018|Overall Study|Physician Decision|0|||
144427354|NCT02608268|520773697|FG019|Overall Study|Physician Decision|0|||
144427355|NCT02608268|520773698|FG020|Overall Study|Physician Decision|0|||
144427356|NCT02608268|520773699|FG021|Overall Study|Physician Decision|0|||
144427357|NCT02608268|520773700|FG022|Overall Study|Physician Decision|1|||
144427358|NCT02608268|520773701|FG023|Overall Study|Physician Decision|1|||
144427359|NCT02608268|520773702|FG024|Overall Study|Physician Decision|1|||
144427360|NCT02608268|520773703|FG025|Overall Study|Physician Decision|0|||
144427361|NCT02608268|520773704|FG026|Overall Study|Physician Decision|0|||
144427362|NCT02608268|520773705|FG027|Overall Study|Physician Decision|2|||
144427363|NCT02608268|520773706|FG028|Overall Study|Physician Decision|1|||
144427364|NCT02608268|520773707|FG029|Overall Study|Physician Decision|1|||
144427365|NCT02608268|520773678|FG000|Overall Study|Progressive disease|12|||
144427366|NCT02608268|520773679|FG001|Overall Study|Progressive disease|8|||
144427367|NCT02608268|520773680|FG002|Overall Study|Progressive disease|13|||
144427368|NCT02608268|520773681|FG003|Overall Study|Progressive disease|5|||
144427369|NCT02608268|520773682|FG004|Overall Study|Progressive disease|2|||
144528767|NCT05293171|521139138|FG008|Washout 5 to 7 Days|Adverse Event|0|||
144427370|NCT02608268|520773683|FG005|Overall Study|Progressive disease|4|||
144427371|NCT02608268|520773684|FG006|Overall Study|Progressive disease|6|||
144427372|NCT02608268|520773685|FG007|Overall Study|Progressive disease|2|||
144427373|NCT02608268|520773686|FG008|Overall Study|Progressive disease|5|||
144427374|NCT02608268|520773687|FG009|Overall Study|Progressive disease|6|||
144427375|NCT02608268|520773688|FG010|Overall Study|Progressive disease|5|||
144427376|NCT02608268|520773689|FG011|Overall Study|Progressive disease|5|||
144427377|NCT02608268|520773690|FG012|Overall Study|Progressive disease|4|||
144427378|NCT02608268|520773691|FG013|Overall Study|Progressive disease|11|||
144182674|NCT03547635|519864000|FG001|Overall Study|Lost to Follow-up|3|||
144427379|NCT02608268|520773692|FG014|Overall Study|Progressive disease|6|||
144427380|NCT02608268|520773693|FG015|Overall Study|Progressive disease|3|||
144427381|NCT02608268|520773694|FG016|Overall Study|Progressive disease|5|||
144427382|NCT02608268|520773695|FG017|Overall Study|Progressive disease|5|||
144427383|NCT02608268|520773696|FG018|Overall Study|Progressive disease|5|||
144427384|NCT02608268|520773697|FG019|Overall Study|Progressive disease|2|||
144427385|NCT02608268|520773698|FG020|Overall Study|Progressive disease|10|||
144427386|NCT02608268|520773699|FG021|Overall Study|Progressive disease|4|||
144427387|NCT02608268|520773700|FG022|Overall Study|Progressive disease|5|||
144427388|NCT02608268|520773701|FG023|Overall Study|Progressive disease|5|||
144427389|NCT02608268|520773702|FG024|Overall Study|Progressive disease|3|||
144427390|NCT02608268|520773703|FG025|Overall Study|Progressive disease|11|||
144427391|NCT02608268|520773704|FG026|Overall Study|Progressive disease|16|||
144427392|NCT02608268|520773705|FG027|Overall Study|Progressive disease|11|||
144427393|NCT02608268|520773706|FG028|Overall Study|Progressive disease|10|||
144427394|NCT02608268|520773707|FG029|Overall Study|Progressive disease|15|||
144427395|NCT02608268|520773678|FG000|Overall Study|Subject/guardian decision|1|||
144427396|NCT02608268|520773679|FG001|Overall Study|Subject/guardian decision|1|||
144427397|NCT02608268|520773680|FG002|Overall Study|Subject/guardian decision|2|||
144427398|NCT02608268|520773681|FG003|Overall Study|Subject/guardian decision|0|||
144427399|NCT02608268|520773682|FG004|Overall Study|Subject/guardian decision|0|||
144427400|NCT02608268|520773683|FG005|Overall Study|Subject/guardian decision|0|||
144427401|NCT02608268|520773684|FG006|Overall Study|Subject/guardian decision|0|||
144427402|NCT02608268|520773685|FG007|Overall Study|Subject/guardian decision|0|||
144427403|NCT02608268|520773686|FG008|Overall Study|Subject/guardian decision|2|||
144427404|NCT02608268|520773687|FG009|Overall Study|Subject/guardian decision|2|||
144427405|NCT02608268|520773688|FG010|Overall Study|Subject/guardian decision|0|||
144427406|NCT02608268|520773689|FG011|Overall Study|Subject/guardian decision|1|||
144427407|NCT02608268|520773690|FG012|Overall Study|Subject/guardian decision|0|||
144427408|NCT02608268|520773691|FG013|Overall Study|Subject/guardian decision|1|||
144427409|NCT02608268|520773692|FG014|Overall Study|Subject/guardian decision|0|||
144427410|NCT02608268|520773693|FG015|Overall Study|Subject/guardian decision|1|||
144427411|NCT02608268|520773694|FG016|Overall Study|Subject/guardian decision|0|||
144427412|NCT02608268|520773695|FG017|Overall Study|Subject/guardian decision|0|||
144427413|NCT02608268|520773696|FG018|Overall Study|Subject/guardian decision|1|||
144427414|NCT02608268|520773697|FG019|Overall Study|Subject/guardian decision|0|||
144427415|NCT02608268|520773698|FG020|Overall Study|Subject/guardian decision|0|||
144427416|NCT02608268|520773699|FG021|Overall Study|Subject/guardian decision|0|||
144427417|NCT02608268|520773700|FG022|Overall Study|Subject/guardian decision|1|||
144427418|NCT02608268|520773701|FG023|Overall Study|Subject/guardian decision|0|||
144427419|NCT02608268|520773702|FG024|Overall Study|Subject/guardian decision|0|||
144427420|NCT02608268|520773703|FG025|Overall Study|Subject/guardian decision|1|||
144427421|NCT02608268|520773704|FG026|Overall Study|Subject/guardian decision|1|||
144427422|NCT02608268|520773705|FG027|Overall Study|Subject/guardian decision|1|||
144427423|NCT02608268|520773706|FG028|Overall Study|Subject/guardian decision|1|||
144427424|NCT02608268|520773707|FG029|Overall Study|Subject/guardian decision|0|||
144427425|NCT01030523|520773708|FG000|Initial Study (5 Years)|Death|1|||
144427426|NCT01030523|520773709|FG001|Initial Study (5 Years)|Death|0|||
144427427|NCT01030523|520773708|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
144427428|NCT01030523|520773709|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
144427429|NCT01030523|520773708|FG000|Initial Study (5 Years)|Implant failure|1|||
144427430|NCT01030523|520773709|FG001|Initial Study (5 Years)|Implant failure|0|||
144427431|NCT01030523|520773708|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
144427432|NCT01030523|520773709|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
144427433|NCT01030523|520773708|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
144427434|NCT01030523|520773709|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
144427435|NCT01030523|520773708|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
144427436|NCT01030523|520773709|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
144427437|NCT03662542|520773712|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
144427438|NCT03662542|520773713|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427439|NCT03662542|520773714|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427440|NCT03662542|520773715|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427441|NCT03662542|520773716|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427442|NCT03662542|520773717|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427443|NCT03662542|520773718|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427444|NCT03662542|520773719|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427445|NCT03662542|520773720|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
144427446|NCT03662542|520773712|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427447|NCT03662542|520773713|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
144427448|NCT03662542|520773714|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427449|NCT03662542|520773715|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427450|NCT03662542|520773716|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427451|NCT03662542|520773717|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427452|NCT03662542|520773718|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427453|NCT03662542|520773719|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427454|NCT03662542|520773720|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
144427455|NCT03662542|520773712|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
144427456|NCT03662542|520773713|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
144427457|NCT03662542|520773714|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
144427458|NCT03662542|520773715|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
144603642|NCT01118325|521411956|FG001|Overall Study|Adverse Event|0|||
144182675|NCT03547635|519864001|FG002|Overall Study|Lost to Follow-up|4|||
144182676|NCT03547635|519863999|FG000|Overall Study|Withdrawal by Subject|1|||
144182677|NCT03547635|519864000|FG001|Overall Study|Withdrawal by Subject|0|||
144603643|NCT01118325|521411957|FG002|Overall Study|Adverse Event|1|||
144427459|NCT03662542|520773716|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
144427460|NCT03662542|520773717|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
144427461|NCT03662542|520773718|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
144427462|NCT03662542|520773719|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
144427463|NCT03662542|520773720|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
144427464|NCT03662542|520773712|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
144427465|NCT03662542|520773713|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427466|NCT03662542|520773714|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427467|NCT03662542|520773715|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427468|NCT03662542|520773716|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427469|NCT03662542|520773717|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427470|NCT03662542|520773718|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427471|NCT03662542|520773719|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427472|NCT03662542|520773720|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
144427473|NCT03662542|520773712|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427474|NCT03662542|520773713|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427475|NCT03662542|520773714|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427476|NCT03662542|520773715|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427477|NCT03662542|520773716|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427478|NCT03662542|520773717|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
144427479|NCT03662542|520773718|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427480|NCT03662542|520773719|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427481|NCT03662542|520773720|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
144427482|NCT03662542|520773712|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427483|NCT03662542|520773713|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427484|NCT03662542|520773714|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427485|NCT03662542|520773715|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
144427486|NCT03662542|520773716|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
144427487|NCT03662542|520773717|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427488|NCT03662542|520773718|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427489|NCT03662542|520773719|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427490|NCT03662542|520773720|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
144427491|NCT03662542|520773712|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
144427492|NCT03662542|520773713|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
144427493|NCT03662542|520773714|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
144427494|NCT03662542|520773715|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
144427495|NCT03662542|520773716|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
144427496|NCT03662542|520773717|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
144427497|NCT03662542|520773718|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
144427498|NCT03662542|520773719|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
144427499|NCT03662542|520773720|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
144427500|NCT03662542|520773712|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427501|NCT03662542|520773713|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427502|NCT03662542|520773714|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427503|NCT03662542|520773715|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427504|NCT03662542|520773716|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
144427505|NCT03662542|520773717|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
144427506|NCT03662542|520773718|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427507|NCT03662542|520773719|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427508|NCT03662542|520773720|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
144427509|NCT03662542|520773712|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427510|NCT03662542|520773713|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427511|NCT03662542|520773714|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427512|NCT03662542|520773715|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427513|NCT03662542|520773716|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427514|NCT03662542|520773717|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
144427515|NCT03662542|520773718|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427516|NCT03662542|520773719|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427517|NCT03662542|520773720|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
144427518|NCT03662542|520773712|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427519|NCT03662542|520773713|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427520|NCT03662542|520773714|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427521|NCT03662542|520773715|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427522|NCT03662542|520773716|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427523|NCT03662542|520773717|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
144528768|NCT05293171|521139139|FG009|Washout 5 to 7 Days|Adverse Event|0|||
144528769|NCT05293171|521139140|FG010|Washout 5 to 7 Days|Adverse Event|0|||
144528770|NCT05293171|521139141|FG011|Washout 5 to 7 Days|Adverse Event|0|||
144182678|NCT03547635|519864001|FG002|Overall Study|Withdrawal by Subject|0|||
144528771|NCT05293171|521139130|FG000|Washout 5 to 7 Days|Adverse Event|0|||
144528772|NCT05293171|521139131|FG001|Washout 5 to 7 Days|Adverse Event|0|||
144427524|NCT03662542|520773718|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427525|NCT03662542|520773719|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
144182679|NCT03547635|519863999|FG000|Overall Study|Withdrawal By PI|0|||
144182680|NCT03547635|519864000|FG001|Overall Study|Withdrawal By PI|1|||
144182681|NCT03547635|519864001|FG002|Overall Study|Withdrawal By PI|0|||
144182682|NCT03547635|519863999|FG000|Overall Study|Withdrawal by Sponsor|0|||
144182683|NCT03547635|519864000|FG001|Overall Study|Withdrawal by Sponsor|0|||
144182684|NCT03547635|519864001|FG002|Overall Study|Withdrawal by Sponsor|1|||
144182685|NCT03547635|519863999|FG000|Overall Study|Errant Randomization before Treatment|0|||
144182686|NCT03547635|519864000|FG001|Overall Study|Errant Randomization before Treatment|1|||
144182687|NCT03547635|519864001|FG002|Overall Study|Errant Randomization before Treatment|0|||
144182688|NCT03547635|519863999|FG000|Overall Study|Withdrawal by Subject|1|||
144182689|NCT03547635|519864000|FG001|Overall Study|Withdrawal by Subject|0|||
144182690|NCT03547635|519864001|FG002|Overall Study|Withdrawal by Subject|0|||
144182691|NCT02415387|519864006|FG000|Overall Study|Withdrawal by Subject|6|||
144182692|NCT02415387|519864007|FG001|Overall Study|Withdrawal by Subject|1|||
144182693|NCT02415387|519864006|FG000|Overall Study|blood draw problem|0|||
144182694|NCT02415387|519864007|FG001|Overall Study|blood draw problem|1|||
144182695|NCT02415387|519864006|FG000|Overall Study|Protocol Violation|1|||
144182696|NCT02415387|519864007|FG001|Overall Study|Protocol Violation|0|||
144182697|NCT03243396|519864008|FG000|Overall Study|Lost to Follow-up|2|||
144182698|NCT03243396|519864009|FG001|Overall Study|Lost to Follow-up|3|||
144182699|NCT03243396|519864010|FG002|Overall Study|Lost to Follow-up|15|||
144182700|NCT03243396|519864011|FG003|Overall Study|Lost to Follow-up|8|||
144182701|NCT03243396|519864012|FG004|Overall Study|Lost to Follow-up|1|||
144182702|NCT03243396|519864013|FG005|Overall Study|Lost to Follow-up|4|||
144182703|NCT03243396|519864014|FG006|Overall Study|Lost to Follow-up|9|||
144182704|NCT00452348|519864016|FG000|Overall Study|Adverse Event|6|||
144182705|NCT00452348|519864017|FG001|Overall Study|Adverse Event|9|||
144182706|NCT00452348|519864016|FG000|Overall Study|Lack of Efficacy|10|||
144182707|NCT00452348|519864017|FG001|Overall Study|Lack of Efficacy|9|||
144182708|NCT00452348|519864016|FG000|Overall Study|Lost to Follow-up|14|||
144182709|NCT00452348|519864017|FG001|Overall Study|Lost to Follow-up|8|||
144182710|NCT00452348|519864016|FG000|Overall Study|Protocol Violation|22|||
144182711|NCT00452348|519864017|FG001|Overall Study|Protocol Violation|28|||
144182712|NCT00452348|519864016|FG000|Overall Study|Withdrawal by Subject|18|||
144182713|NCT00452348|519864017|FG001|Overall Study|Withdrawal by Subject|21|||
144182714|NCT00452348|519864016|FG000|Overall Study|Other|9|||
144182715|NCT00452348|519864017|FG001|Overall Study|Other|9|||
144182716|NCT01257581|519864026|FG000|Overall Study|Early Termination|3|||
144182717|NCT01257581|519864027|FG001|Overall Study|Early Termination|1|||
144182718|NCT01257581|519864028|FG002|Overall Study|Early Termination|2|||
144182719|NCT01257581|519864026|FG000|Overall Study|Death|2|||
144182720|NCT01257581|519864027|FG001|Overall Study|Death|2|||
144182721|NCT01257581|519864028|FG002|Overall Study|Death|4|||
144182722|NCT00517192|519864033|FG000|Overall Study|Adverse Event|1|||
144182723|NCT00517192|519864034|FG001|Overall Study|Adverse Event|1|||
144182724|NCT00517192|519864033|FG000|Overall Study|Lost to Follow-up|1|||
144182725|NCT00517192|519864034|FG001|Overall Study|Lost to Follow-up|1|||
144182726|NCT00517192|519864033|FG000|Overall Study|Withdrawal by Subject|1|||
144182727|NCT00517192|519864034|FG001|Overall Study|Withdrawal by Subject|0|||
144182728|NCT00517192|519864033|FG000|Overall Study|Early termination of the trial|16|||
144182729|NCT00517192|519864034|FG001|Overall Study|Early termination of the trial|18|||
144182730|NCT03167606|519864035|FG000|Overall Study|Lost to Follow-up|73|||
144182731|NCT03167606|519864036|FG001|Overall Study|Lost to Follow-up|64|||
144182732|NCT03167606|519864035|FG000|Overall Study|Withdrawal by Subject|6|||
144182733|NCT03167606|519864036|FG001|Overall Study|Withdrawal by Subject|5|||
144182734|NCT03167606|519864035|FG000|Overall Study|Withdrawal by Investigator|0|||
144182735|NCT03167606|519864036|FG001|Overall Study|Withdrawal by Investigator|2|||
144182736|NCT02483416|519864037|FG000|Overall Study|Other reason|0|||
144182737|NCT02483416|519864038|FG001|Overall Study|Other reason|1|||
144427526|NCT03662542|520773720|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
144427527|NCT03662542|520773712|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144182738|NCT02483416|519864037|FG000|Overall Study|Treatment stop|3|||
144182739|NCT02483416|519864038|FG001|Overall Study|Treatment stop|0|||
144182740|NCT00611884|519864042|FG000|Overall Study|Adverse Event|1|||
144182741|NCT00611884|519864043|FG001|Overall Study|Adverse Event|0|||
144182742|NCT00611884|519864044|FG002|Overall Study|Adverse Event|0|||
144182743|NCT00611884|519864045|FG003|Overall Study|Adverse Event|1|||
144182744|NCT00611884|519864042|FG000|Overall Study|Non-Compliance|1|||
144182745|NCT00611884|519864043|FG001|Overall Study|Non-Compliance|4|||
144182746|NCT00611884|519864044|FG002|Overall Study|Non-Compliance|2|||
144182747|NCT00611884|519864045|FG003|Overall Study|Non-Compliance|2|||
144182748|NCT00611884|519864042|FG000|Overall Study|Lack of Efficacy|0|||
144182749|NCT00611884|519864043|FG001|Overall Study|Lack of Efficacy|1|||
144182750|NCT00611884|519864044|FG002|Overall Study|Lack of Efficacy|0|||
144182751|NCT00611884|519864045|FG003|Overall Study|Lack of Efficacy|0|||
144182752|NCT00611884|519864042|FG000|Overall Study|Unclassified|7|||
144182753|NCT00611884|519864043|FG001|Overall Study|Unclassified|4|||
144251845|NCT01900431|520120909|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
144251846|NCT01900431|520120910|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
144251847|NCT01900431|520120908|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
144251848|NCT01900431|520120909|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
144251849|NCT01900431|520120910|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
144251850|NCT01900431|520120908|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
144251851|NCT01900431|520120909|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
144251852|NCT01900431|520120910|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
144251853|NCT01900431|520120908|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
144251854|NCT01900431|520120909|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
144251855|NCT01900431|520120910|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
144251856|NCT01900431|520120908|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
144427528|NCT03662542|520773713|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144427529|NCT03662542|520773714|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144427530|NCT03662542|520773715|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144427531|NCT03662542|520773716|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144427532|NCT03662542|520773717|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144427533|NCT03662542|520773718|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
144427534|NCT03662542|520773719|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
144427535|NCT03662542|520773720|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
144427536|NCT03662542|520773712|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427537|NCT03662542|520773713|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427538|NCT03662542|520773714|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427539|NCT03662542|520773715|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427540|NCT03662542|520773716|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427541|NCT03662542|520773717|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427542|NCT03662542|520773718|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
144427543|NCT03662542|520773719|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
144427544|NCT03662542|520773720|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
144427545|NCT03662542|520773712|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
144427546|NCT03662542|520773713|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
144603644|NCT03678103|521411962|FG000|Overall Study|Withdrawn prior to completion|4|||
144603645|NCT02092350|521411963|FG000|Overall Study|Adverse Event|0|||
144182754|NCT00611884|519864044|FG002|Overall Study|Unclassified|2|||
144182755|NCT00611884|519864045|FG003|Overall Study|Unclassified|3|||
144182756|NCT00981799|519864046|FG000|Overall Study|Adverse Event|1|||
144182757|NCT00981799|519864047|FG001|Overall Study|Adverse Event|1|||
144182758|NCT00981799|519864048|FG002|Overall Study|Adverse Event|0|||
144182759|NCT00981799|519864049|FG003|Overall Study|Adverse Event|0|||
144182760|NCT03433703|519864050|FG000|Overall Study|Study terminated by Sponsor|2|||
144182761|NCT01617096|519864060|FG000|Overall Study|Withdrawal by Subject|96|||
144182762|NCT01617096|519864061|FG001|Overall Study|Withdrawal by Subject|81|||
144182763|NCT01617096|519864060|FG000|Overall Study|Lost to Follow-up|37|||
144182764|NCT01617096|519864061|FG001|Overall Study|Lost to Follow-up|32|||
144182765|NCT01617096|519864060|FG000|Overall Study|Physician Decision|10|||
144182766|NCT01617096|519864061|FG001|Overall Study|Physician Decision|18|||
144182767|NCT01617096|519864060|FG000|Overall Study|Death|4|||
144182768|NCT01617096|519864061|FG001|Overall Study|Death|3|||
144427547|NCT03662542|520773714|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
144427548|NCT03662542|520773715|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
144427549|NCT03662542|520773716|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
144427550|NCT03662542|520773717|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
144427551|NCT03662542|520773718|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
144427552|NCT03662542|520773719|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
144427553|NCT03662542|520773720|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
144427554|NCT01217060|520773722|FG000|Overall Study|Withdrawal by Subject|1|||
144427555|NCT01290666|520773730|FG000|Overall Study|Lost to Follow-up|11|||
144427556|NCT01290666|520773730|FG000|Overall Study|Withdrawal by Subject|23|||
144427557|NCT01290666|520773730|FG000|Overall Study|Early Termination of Study|4|||
144427558|NCT01652664|520773731|FG000|Overall Study|Treatment Failure|5|||
144427559|NCT01652664|520773732|FG001|Overall Study|Treatment Failure|1|||
144603646|NCT02092350|521411964|FG001|Overall Study|Adverse Event|3|||
144182769|NCT01617096|519864060|FG000|Overall Study|Other|1|||
144182770|NCT01617096|519864061|FG001|Overall Study|Other|3|||
144182771|NCT02046122|519864066|FG000|Overall Study|Physician Decision|8|||
144427560|NCT01652664|520773731|FG000|Overall Study|Inadequate IOP control|1|||
144427561|NCT01652664|520773732|FG001|Overall Study|Inadequate IOP control|0|||
144427562|NCT03538158|520773733|FG000|Overall Study|Lost to Follow-up|13|||
144427563|NCT03538158|520773734|FG001|Overall Study|Lost to Follow-up|7|||
144427564|NCT03538158|520773733|FG000|Overall Study|Withdrawal by Subject|2|||
144182772|NCT02046122|519864066|FG000|Overall Study|Withdrawal by Subject|1|||
144182773|NCT04535986|519864069|FG000|Overall Study|Death|4|||
144182774|NCT04535986|519864070|FG001|Overall Study|Death|5|||
144427565|NCT03538158|520773734|FG001|Overall Study|Withdrawal by Subject|1|||
144427566|NCT01454570|520773737|FG000|Overall Study|Withdrawal by Subject|2|||
144427567|NCT01454570|520773737|FG000|Overall Study|Screen Failure|7|||
144427568|NCT00772707|520773738|FG000|Overall Study|Withdrawn|3|||
144427569|NCT00909779|520773740|FG000|Overall Study|Adverse Event|53|||
144427570|NCT00909779|520773741|FG001|Overall Study|Adverse Event|55|||
144427571|NCT00909779|520773740|FG000|Overall Study|Lack of Efficacy|7|||
144427572|NCT00909779|520773741|FG001|Overall Study|Lack of Efficacy|4|||
144427573|NCT00909779|520773740|FG000|Overall Study|Lost to Follow-up|19|||
144427574|NCT00909779|520773741|FG001|Overall Study|Lost to Follow-up|15|||
144427575|NCT00909779|520773740|FG000|Overall Study|Physician Decision|8|||
144427576|NCT00909779|520773741|FG001|Overall Study|Physician Decision|2|||
144427577|NCT00909779|520773740|FG000|Overall Study|Protocol Violation|2|||
144427578|NCT00909779|520773741|FG001|Overall Study|Protocol Violation|5|||
144427579|NCT00909779|520773740|FG000|Overall Study|Withdrawal by Subject|116|||
144427580|NCT00909779|520773741|FG001|Overall Study|Withdrawal by Subject|80|||
144427581|NCT00909779|520773740|FG000|Overall Study|Site Ceasing Operation|2|||
144427582|NCT00909779|520773741|FG001|Overall Study|Site Ceasing Operation|2|||
144427583|NCT00909779|520773740|FG000|Overall Study|Medical Monitor Decision|1|||
144427584|NCT00909779|520773741|FG001|Overall Study|Medical Monitor Decision|0|||
144427585|NCT00909779|520773740|FG000|Overall Study|Noncompliance|1|||
144427586|NCT00909779|520773741|FG001|Overall Study|Noncompliance|1|||
144427587|NCT00909779|520773740|FG000|Overall Study|Randomized in error|1|||
144427588|NCT00909779|520773741|FG001|Overall Study|Randomized in error|1|||
144427589|NCT00099437|520773744|FG000|Overall Study|Lost to Follow-up|30|||
144427590|NCT00099437|520773745|FG001|Overall Study|Lost to Follow-up|33|||
144427591|NCT00099437|520773744|FG000|Overall Study|Death|293|||
144427592|NCT00099437|520773745|FG001|Overall Study|Death|261|||
144427593|NCT00099437|520773744|FG000|Overall Study|Withdrawal by Subject|6|||
144427594|NCT00099437|520773745|FG001|Overall Study|Withdrawal by Subject|10|||
144427595|NCT00099437|520773744|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
144427596|NCT00099437|520773745|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
144427597|NCT02410954|520773746|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
144427598|NCT02410954|520773747|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
144427599|NCT02410954|520773746|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
144427600|NCT02410954|520773747|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
144427601|NCT02738333|520773748|FG000|Overall Study|Death|1|||
144427602|NCT02738333|520773749|FG001|Overall Study|Death|0|||
144528773|NCT05293171|521139132|FG002|Washout 5 to 7 Days|Adverse Event|0|||
144528774|NCT05293171|521139133|FG003|Washout 5 to 7 Days|Adverse Event|0|||
144528775|NCT05293171|521139134|FG004|Washout 5 to 7 Days|Adverse Event|0|||
144528776|NCT05293171|521139135|FG005|Washout 5 to 7 Days|Adverse Event|1|||
144528777|NCT05293171|521139136|FG006|Washout 5 to 7 Days|Adverse Event|0|||
144528778|NCT05293171|521139137|FG007|Washout 5 to 7 Days|Adverse Event|0|||
144182775|NCT04535986|519864069|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
144182776|NCT04535986|519864070|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
144182777|NCT04535986|519864069|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
144182778|NCT04535986|519864070|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
144182779|NCT04535986|519864069|FG000|Overall Study|Adverse Event|10|||
144182780|NCT04535986|519864070|FG001|Overall Study|Adverse Event|1|||
144182781|NCT04535986|519864069|FG000|Overall Study|Lack of Efficacy|3|||
144182782|NCT04535986|519864070|FG001|Overall Study|Lack of Efficacy|2|||
144182783|NCT04535986|519864069|FG000|Overall Study|Investigator discretion|3|||
144182784|NCT04535986|519864070|FG001|Overall Study|Investigator discretion|0|||
144182785|NCT04535986|519864069|FG000|Overall Study|Withdrawal by Subject|32|||
144182786|NCT04535986|519864070|FG001|Overall Study|Withdrawal by Subject|14|||
144182787|NCT04535986|519864069|FG000|Overall Study|Lost to Follow-up|5|||
144182788|NCT04535986|519864070|FG001|Overall Study|Lost to Follow-up|3|||
144182789|NCT04535986|519864069|FG000|Overall Study|Other|7|||
144182790|NCT04535986|519864070|FG001|Overall Study|Other|3|||
144182791|NCT01196390|519864071|FG000|Overall Study|Protocol Violation|4|||
144182792|NCT01196390|519864072|FG001|Overall Study|Protocol Violation|5|||
144182793|NCT03141151|519864081|FG000|Overall Study|Lost to Follow-up|3|||
144182794|NCT03141151|519864082|FG001|Overall Study|Lost to Follow-up|2|||
144182795|NCT03141151|519864081|FG000|Overall Study|Withdrawal by Subject|3|||
144182796|NCT03141151|519864082|FG001|Overall Study|Withdrawal by Subject|2|||
144182797|NCT04561115|519864083|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
144182798|NCT04561115|519864084|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
144182799|NCT04561115|519864083|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
144182800|NCT04561115|519864084|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
144182801|NCT04561115|519864083|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
144427603|NCT02738333|520773750|FG002|Overall Study|Death|0|||
144427604|NCT02738333|520773748|FG000|Overall Study|Lost to Follow-up|1|||
144528779|NCT05293171|521139138|FG008|Washout 5 to 7 Days|Adverse Event|0|||
144427605|NCT02738333|520773749|FG001|Overall Study|Lost to Follow-up|0|||
144427606|NCT02738333|520773750|FG002|Overall Study|Lost to Follow-up|0|||
144427607|NCT00791518|520773751|FG000|Overall Study|Protocol Violation|93|||
144427608|NCT05172544|520773752|FG000|Overall Study|Withdrawal by Subject|1|||
144427609|NCT05172544|520773753|FG001|Overall Study|Withdrawal by Subject|0|||
144427610|NCT05172544|520773754|FG002|Overall Study|Withdrawal by Subject|0|||
144427611|NCT05172544|520773752|FG000|Overall Study|Physician Decision|0|||
144427612|NCT05172544|520773753|FG001|Overall Study|Physician Decision|0|||
144427613|NCT05172544|520773754|FG002|Overall Study|Physician Decision|1|||
144427614|NCT04829318|520773755|FG000|Overall Study|Adverse Event|6|||
144427615|NCT04829318|520773755|FG000|Overall Study|Death|1|||
144427616|NCT04829318|520773755|FG000|Overall Study|Lost to Follow-up|1|||
144427617|NCT04829318|520773755|FG000|Overall Study|Physician Decision|1|||
144427618|NCT04829318|520773755|FG000|Overall Study|Withdrawal by Subject|19|||
144427619|NCT04829318|520773755|FG000|Overall Study|Site terminated by sponsor|1|||
144427620|NCT04829318|520773755|FG000|Overall Study|Sponsor decision|5|||
144427621|NCT04829318|520773755|FG000|Overall Study|Other|1|||
144427622|NCT00271947|520773756|FG000|Overall Study|Lost to Follow-up|1|||
144427623|NCT01522365|520773759|FG000|Overall Study|Withdrawal by Subject|1|||
144427624|NCT01522365|520773760|FG001|Overall Study|Withdrawal by Subject|1|||
144427625|NCT01522365|520773759|FG000|Overall Study|Lost to Follow-up|1|||
144427626|NCT01522365|520773760|FG001|Overall Study|Lost to Follow-up|1|||
144427627|NCT00651755|520773761|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
144427628|NCT00651755|520773762|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
144427629|NCT00651755|520773761|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
144427630|NCT00651755|520773762|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
144427631|NCT02466555|520773763|FG000|Overall Study|Lost to Follow-up|2|||
144427632|NCT04170348|520773764|FG000|Overall Study|Lost to Follow-up|2|||
144427633|NCT04170348|520773765|FG001|Overall Study|Lost to Follow-up|2|||
144427634|NCT04170348|520773764|FG000|Overall Study|Withdrawal by Subject|1|||
144427635|NCT04170348|520773765|FG001|Overall Study|Withdrawal by Subject|5|||
144427636|NCT04170348|520773764|FG000|Overall Study|Non-adherence|1|||
144427637|NCT04170348|520773765|FG001|Overall Study|Non-adherence|1|||
144427638|NCT04170348|520773764|FG000|Overall Study|Adverse Event|1|||
144427639|NCT04170348|520773765|FG001|Overall Study|Adverse Event|0|||
144427640|NCT01120756|520773766|FG000|Overall Study|Withdrawal by Subject|1|||
144427641|NCT01120756|520773767|FG001|Overall Study|Withdrawal by Subject|1|||
144427642|NCT00698581|520773771|FG000|Overall Study|Lack of Efficacy|23|||
144427643|NCT00698581|520773772|FG001|Overall Study|Lack of Efficacy|11|||
144427644|NCT00698581|520773771|FG000|Overall Study|Withdrawal by Subject|6|||
144427645|NCT00698581|520773772|FG001|Overall Study|Withdrawal by Subject|0|||
144427646|NCT00698581|520773771|FG000|Overall Study|Other reason|9|||
144427647|NCT00698581|520773772|FG001|Overall Study|Other reason|1|||
144427648|NCT00698581|520773771|FG000|Overall Study|SAE, non-fatal|1|||
144427649|NCT00698581|520773772|FG001|Overall Study|SAE, non-fatal|0|||
144427650|NCT00698581|520773771|FG000|Overall Study|AE, non-serious non-fatal|4|||
144427651|NCT00698581|520773772|FG001|Overall Study|AE, non-serious non-fatal|0|||
144427652|NCT00698581|520773771|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144427653|NCT00698581|520773772|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
144427654|NCT00698581|520773771|FG000|Overall Study|AE of unknown type|1|||
144427655|NCT00698581|520773772|FG001|Overall Study|AE of unknown type|0|||
144427656|NCT03760146|520773773|FG000|Overall Study|Adverse Event|11|||
144427657|NCT03760146|520773774|FG001|Overall Study|Adverse Event|8|||
144427658|NCT03760146|520773775|FG002|Overall Study|Adverse Event|0|||
144427659|NCT03760146|520773776|FG003|Overall Study|Adverse Event|0|||
144427660|NCT03760146|520773777|FG004|Overall Study|Adverse Event|0|||
144427661|NCT03760146|520773778|FG005|Overall Study|Adverse Event|0|||
144427662|NCT03760146|520773773|FG000|Overall Study|Death|1|||
144427663|NCT03760146|520773774|FG001|Overall Study|Death|0|||
144427664|NCT03760146|520773775|FG002|Overall Study|Death|0|||
144427665|NCT03760146|520773776|FG003|Overall Study|Death|0|||
144427666|NCT03760146|520773777|FG004|Overall Study|Death|0|||
144427667|NCT03760146|520773778|FG005|Overall Study|Death|0|||
144427668|NCT03760146|520773773|FG000|Overall Study|Lost to Follow-up|41|||
144427669|NCT03760146|520773774|FG001|Overall Study|Lost to Follow-up|28|||
144427670|NCT03760146|520773775|FG002|Overall Study|Lost to Follow-up|9|||
144427671|NCT03760146|520773776|FG003|Overall Study|Lost to Follow-up|2|||
144528780|NCT05293171|521139139|FG009|Washout 5 to 7 Days|Adverse Event|0|||
144528781|NCT05293171|521139140|FG010|Washout 5 to 7 Days|Adverse Event|0|||
144427672|NCT03760146|520773777|FG004|Overall Study|Lost to Follow-up|14|||
144427673|NCT03760146|520773778|FG005|Overall Study|Lost to Follow-up|8|||
144427674|NCT03760146|520773773|FG000|Overall Study|No longer met eligibility criteria|3|||
144427675|NCT03760146|520773774|FG001|Overall Study|No longer met eligibility criteria|9|||
144427676|NCT03760146|520773775|FG002|Overall Study|No longer met eligibility criteria|0|||
144427677|NCT03760146|520773776|FG003|Overall Study|No longer met eligibility criteria|0|||
144427678|NCT03760146|520773777|FG004|Overall Study|No longer met eligibility criteria|1|||
144427679|NCT03760146|520773778|FG005|Overall Study|No longer met eligibility criteria|0|||
144427680|NCT03760146|520773773|FG000|Overall Study|Protocol Violation|21|||
144528782|NCT05293171|521139141|FG011|Washout 5 to 7 Days|Adverse Event|0|||
144427681|NCT03760146|520773774|FG001|Overall Study|Protocol Violation|13|||
144427682|NCT03760146|520773775|FG002|Overall Study|Protocol Violation|1|||
144427683|NCT03760146|520773776|FG003|Overall Study|Protocol Violation|0|||
144427684|NCT03760146|520773777|FG004|Overall Study|Protocol Violation|1|||
144427685|NCT03760146|520773778|FG005|Overall Study|Protocol Violation|0|||
144427686|NCT03760146|520773773|FG000|Overall Study|Withdrawal by Subject|19|||
144427687|NCT03760146|520773774|FG001|Overall Study|Withdrawal by Subject|20|||
144427688|NCT03760146|520773775|FG002|Overall Study|Withdrawal by Subject|1|||
144427689|NCT03760146|520773776|FG003|Overall Study|Withdrawal by Subject|0|||
144427690|NCT03760146|520773777|FG004|Overall Study|Withdrawal by Subject|1|||
144427691|NCT03760146|520773778|FG005|Overall Study|Withdrawal by Subject|0|||
144427692|NCT01082965|520773779|FG000|Overall Study|Protocol Violation|0|||
144427693|NCT01082965|520773780|FG001|Overall Study|Protocol Violation|1|||
144427694|NCT01082965|520773779|FG000|Overall Study|Other|1|||
144427695|NCT01082965|520773780|FG001|Overall Study|Other|1|||
144427696|NCT02587065|520773781|FG000|Overall Study|Adverse Event|14|||
144427697|NCT02587065|520773781|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
144427698|NCT02587065|520773781|FG000|Overall Study|Non-adherence to the Protocol|3|||
144427699|NCT02587065|520773781|FG000|Overall Study|Discontinuation of Study Medication|2|||
144427700|NCT02587065|520773781|FG000|Overall Study|Reason not Specified|3|||
144427701|NCT01848756|520773782|FG000|Overall Study|Adverse Event|1|||
144427702|NCT01848756|520773782|FG000|Overall Study|Withdrawal by Subject|1|||
144427703|NCT01848756|520773782|FG000|Overall Study|Enrolled in Error|1|||
144427704|NCT03245008|520773783|FG000|Overall Study|Adverse Event|15|||
144427705|NCT03245008|520773784|FG001|Overall Study|Adverse Event|18|||
144427706|NCT03245008|520773785|FG002|Overall Study|Adverse Event|15|||
144427707|NCT03245008|520773786|FG003|Overall Study|Adverse Event|0|||
144427708|NCT03245008|520773787|FG004|Overall Study|Adverse Event|1|||
144427709|NCT03245008|520773783|FG000|Overall Study|Lack of Efficacy|0|||
144427710|NCT03245008|520773784|FG001|Overall Study|Lack of Efficacy|1|||
144427711|NCT03245008|520773785|FG002|Overall Study|Lack of Efficacy|0|||
144427712|NCT03245008|520773786|FG003|Overall Study|Lack of Efficacy|0|||
144427713|NCT03245008|520773787|FG004|Overall Study|Lack of Efficacy|0|||
144427714|NCT03245008|520773783|FG000|Overall Study|Lost to Follow-up|4|||
144427715|NCT03245008|520773784|FG001|Overall Study|Lost to Follow-up|1|||
144427716|NCT03245008|520773785|FG002|Overall Study|Lost to Follow-up|0|||
144427717|NCT03245008|520773786|FG003|Overall Study|Lost to Follow-up|0|||
144427718|NCT03245008|520773787|FG004|Overall Study|Lost to Follow-up|1|||
144427719|NCT03245008|520773783|FG000|Overall Study|Physician Decision|1|||
144427720|NCT03245008|520773784|FG001|Overall Study|Physician Decision|3|||
144427721|NCT03245008|520773785|FG002|Overall Study|Physician Decision|4|||
144427722|NCT03245008|520773786|FG003|Overall Study|Physician Decision|0|||
144427723|NCT03245008|520773787|FG004|Overall Study|Physician Decision|0|||
144427724|NCT03245008|520773783|FG000|Overall Study|Protocol Violation|0|||
144427725|NCT03245008|520773784|FG001|Overall Study|Protocol Violation|1|||
144427726|NCT03245008|520773785|FG002|Overall Study|Protocol Violation|0|||
144427727|NCT03245008|520773786|FG003|Overall Study|Protocol Violation|0|||
144427728|NCT03245008|520773787|FG004|Overall Study|Protocol Violation|0|||
144427729|NCT03245008|520773783|FG000|Overall Study|Withdrawal by Subject|20|||
144427730|NCT03245008|520773784|FG001|Overall Study|Withdrawal by Subject|19|||
144427731|NCT03245008|520773785|FG002|Overall Study|Withdrawal by Subject|11|||
144427732|NCT03245008|520773786|FG003|Overall Study|Withdrawal by Subject|0|||
144528783|NCT03987022|521139142|FG000|Overall Study|Lost to Follow-up|2|||
144528784|NCT03987022|521139143|FG001|Overall Study|Lost to Follow-up|2|||
144528785|NCT03987022|521139142|FG000|Overall Study|Withdrawal by Subject|1|||
144528786|NCT03987022|521139143|FG001|Overall Study|Withdrawal by Subject|0|||
144528787|NCT04024020|521139146|FG000|Overall Study|Withdrawal by Subject|2|||
144528788|NCT04024020|521139147|FG001|Overall Study|Withdrawal by Subject|2|||
144182802|NCT04561115|519864084|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
144528789|NCT02240238|521139148|FG000|Phase 1|Adverse Event|0|||
144182803|NCT01745094|519864085|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
144427733|NCT03245008|520773787|FG004|Overall Study|Withdrawal by Subject|0|||
144427734|NCT03245008|520773783|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
144427735|NCT03245008|520773784|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
144427736|NCT03245008|520773785|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
144427737|NCT03245008|520773786|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
144427738|NCT03245008|520773787|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
144427739|NCT03245008|520773783|FG000|Overall Study|Failure to meet randomization criteria|0|||
144427740|NCT03245008|520773784|FG001|Overall Study|Failure to meet randomization criteria|1|||
144427741|NCT03245008|520773785|FG002|Overall Study|Failure to meet randomization criteria|0|||
144427742|NCT03245008|520773786|FG003|Overall Study|Failure to meet randomization criteria|1|||
144427743|NCT03245008|520773787|FG004|Overall Study|Failure to meet randomization criteria|0|||
144427744|NCT02075658|520773788|FG000|Overall Study|Physician Decision|2|||
144427745|NCT02075658|520773789|FG001|Overall Study|Physician Decision|2|||
144528790|NCT02240238|521139149|FG001|Phase 1|Adverse Event|0|||
144528791|NCT02240238|521139150|FG002|Phase 1|Adverse Event|0|||
144251857|NCT01900431|520120909|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
144251858|NCT01900431|520120910|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
144251859|NCT01900431|520120908|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
144251860|NCT01900431|520120909|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
144251861|NCT01900431|520120910|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
144251862|NCT04503668|520120911|FG000|Overall Study|Incomplete data|4|||
144251863|NCT04503668|520120912|FG001|Overall Study|Incomplete data|3|||
144251864|NCT04503668|520120911|FG000|Overall Study|Withdrawal by Subject|1|||
144251865|NCT04503668|520120912|FG001|Overall Study|Withdrawal by Subject|1|||
144251866|NCT04503668|520120911|FG000|Overall Study|Adverse Event|2|||
144251867|NCT04503668|520120912|FG001|Overall Study|Adverse Event|0|||
144251868|NCT03403621|520120913|FG000|Overall Study|Withdrawal by Subject|2|||
144251869|NCT03403621|520120914|FG001|Overall Study|Withdrawal by Subject|2|||
144251870|NCT00395642|520120915|FG000|Overall Study|Death|4|||
144251871|NCT00395642|520120915|FG000|Overall Study|Lost to Follow-up|1|||
144251872|NCT00395642|520120915|FG000|Overall Study|Physician Decision|7|||
144251873|NCT00395642|520120915|FG000|Overall Study|Withdrawal by Subject|1|||
144251874|NCT00659776|520120917|FG000|Overall Study|Withdrawal by Subject|12|||
144251875|NCT00659776|520120918|FG001|Overall Study|Withdrawal by Subject|2|||
144251876|NCT00659776|520120919|FG002|Overall Study|Withdrawal by Subject|0|||
144251877|NCT00628927|520120920|FG000|Overall Study|Problems performing blood draw|6|||
144251878|NCT00628927|520120921|FG001|Overall Study|Problems performing blood draw|0|||
144251879|NCT00628927|520120920|FG000|Overall Study|Lost to Follow-up|1|||
144251880|NCT00628927|520120921|FG001|Overall Study|Lost to Follow-up|0|||
144251881|NCT00628927|520120920|FG000|Overall Study|Equipment failure|1|||
144251882|NCT00628927|520120921|FG001|Overall Study|Equipment failure|0|||
144251883|NCT01298141|520120922|FG000|Overall Study|Adverse Event|3|||
144251884|NCT01298141|520120922|FG000|Overall Study|Refusal of Required Study Procedures|1|||
144251885|NCT01298141|520120922|FG000|Overall Study|Withdrawal by Subject|6|||
144251886|NCT01298141|520120922|FG000|Overall Study|Termination of Study by the Investigator|5|||
144251887|NCT01298141|520120922|FG000|Overall Study|Other|5|||
144251888|NCT01298141|520120922|FG000|Overall Study|Lost to Follow-up|1|||
144251889|NCT01298141|520120922|FG000|Overall Study|Death|6|||
144251890|NCT01298141|520120922|FG000|Overall Study|Not treated|4|||
144251891|NCT01687283|520122560|FG000|Overall Study|Adverse Event|11|||
144251892|NCT01687283|520122561|FG001|Overall Study|Adverse Event|4|||
144251893|NCT01687283|520122560|FG000|Overall Study|Lack of Efficacy|3|||
144251894|NCT01687283|520122561|FG001|Overall Study|Lack of Efficacy|1|||
144251895|NCT01687283|520122560|FG000|Overall Study|Protocol Violation|1|||
144251896|NCT01687283|520122561|FG001|Overall Study|Protocol Violation|3|||
144251897|NCT01687283|520122560|FG000|Overall Study|protocol defined stopping criteria|8|||
144251898|NCT01687283|520122561|FG001|Overall Study|protocol defined stopping criteria|10|||
144251899|NCT01687283|520122560|FG000|Overall Study|Lost to Follow-up|1|||
144427746|NCT01286012|520773790|FG000|Overall Study|Adverse Event|3|||
144427747|NCT01286012|520773791|FG001|Overall Study|Adverse Event|3|||
144427748|NCT01286012|520773790|FG000|Overall Study|Death|2|||
144427749|NCT01286012|520773791|FG001|Overall Study|Death|3|||
144427750|NCT01286012|520773790|FG000|Overall Study|Protocol Violation|1|||
144427751|NCT01286012|520773791|FG001|Overall Study|Protocol Violation|1|||
144427752|NCT01286012|520773790|FG000|Overall Study|Withdrawal by Subject|4|||
144427753|NCT01286012|520773791|FG001|Overall Study|Withdrawal by Subject|4|||
144427754|NCT01286012|520773790|FG000|Overall Study|Physician Decision|2|||
144427755|NCT01286012|520773791|FG001|Overall Study|Physician Decision|0|||
144427756|NCT01286012|520773790|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
144427757|NCT01286012|520773791|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
144427758|NCT01602380|520773795|FG000|Overall Study|Death|147|||
144427759|NCT01602380|520773796|FG001|Overall Study|Death|145|||
144427760|NCT01602380|520773795|FG000|Overall Study|Withdrawal by Subject|39|||
144427761|NCT01602380|520773796|FG001|Overall Study|Withdrawal by Subject|41|||
144427762|NCT01602380|520773795|FG000|Overall Study|Lost to Follow-up|15|||
144427763|NCT01602380|520773796|FG001|Overall Study|Lost to Follow-up|12|||
144427764|NCT01602380|520773795|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144427765|NCT01602380|520773796|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
144427766|NCT01602380|520773795|FG000|Overall Study|Other|2|||
144427767|NCT01602380|520773796|FG001|Overall Study|Other|0|||
144427768|NCT03482791|520773801|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
144251900|NCT01687283|520122561|FG001|Overall Study|Lost to Follow-up|1|||
144251901|NCT01687283|520122560|FG000|Overall Study|Investigator discretion|2|||
144251902|NCT01687283|520122561|FG001|Overall Study|Investigator discretion|0|||
144251903|NCT01687283|520122560|FG000|Overall Study|Withdrawal by Subject|9|||
144427769|NCT03482791|520773802|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
144427770|NCT03989440|520775397|FG000|Overall Study|COVID-19 travel restrictions|0|||
144251904|NCT01687283|520122561|FG001|Overall Study|Withdrawal by Subject|8|||
144427771|NCT03989440|520775398|FG001|Overall Study|COVID-19 travel restrictions|0|||
144427772|NCT03989440|520775399|FG002|Overall Study|COVID-19 travel restrictions|1|||
144251905|NCT01859949|520122565|FG000|Overall Study|Family Matters|0|||
144182804|NCT01745094|519864086|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
144427773|NCT03989440|520775400|FG003|Overall Study|COVID-19 travel restrictions|0|||
144427774|NCT03989440|520775401|FG004|Overall Study|COVID-19 travel restrictions|0|||
144427775|NCT03989440|520775402|FG005|Overall Study|COVID-19 travel restrictions|0|||
144427776|NCT03989440|520775397|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
144427777|NCT03989440|520775398|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
144427778|NCT03989440|520775399|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
144427779|NCT03989440|520775400|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
144427780|NCT03989440|520775401|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
144427781|NCT03989440|520775402|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
144427782|NCT00588822|520775403|FG000|Overall Study|progression of disease|8|||
144427783|NCT02082210|520775404|FG000|Overall Study|Death|0|||
144427784|NCT02082210|520775405|FG001|Overall Study|Death|0|||
144427785|NCT02082210|520775406|FG002|Overall Study|Death|1|||
144427786|NCT02082210|520775407|FG003|Overall Study|Death|1|||
144427787|NCT02082210|520775408|FG004|Overall Study|Death|1|||
144427788|NCT02082210|520775409|FG005|Overall Study|Death|0|||
144427789|NCT02082210|520775404|FG000|Overall Study|Withdrawal by Subject|0|||
144427790|NCT02082210|520775405|FG001|Overall Study|Withdrawal by Subject|0|||
144427791|NCT02082210|520775406|FG002|Overall Study|Withdrawal by Subject|0|||
144427792|NCT02082210|520775407|FG003|Overall Study|Withdrawal by Subject|1|||
144427793|NCT02082210|520775408|FG004|Overall Study|Withdrawal by Subject|2|||
144427794|NCT02082210|520775409|FG005|Overall Study|Withdrawal by Subject|2|||
144427795|NCT02082210|520775404|FG000|Overall Study|Clinical Progression|0|||
144427796|NCT02082210|520775405|FG001|Overall Study|Clinical Progression|0|||
144427797|NCT02082210|520775406|FG002|Overall Study|Clinical Progression|0|||
144427798|NCT02082210|520775407|FG003|Overall Study|Clinical Progression|1|||
144427799|NCT02082210|520775408|FG004|Overall Study|Clinical Progression|0|||
144427800|NCT02082210|520775409|FG005|Overall Study|Clinical Progression|0|||
144427801|NCT02082210|520775404|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
144427802|NCT02082210|520775405|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
144427803|NCT02082210|520775406|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
144427804|NCT02082210|520775407|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
144427805|NCT02082210|520775408|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
144427806|NCT02082210|520775409|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
144427807|NCT02082210|520775404|FG000|Overall Study|Physician Decision|0|||
144427808|NCT02082210|520775405|FG001|Overall Study|Physician Decision|0|||
144427809|NCT02082210|520775406|FG002|Overall Study|Physician Decision|1|||
144427810|NCT02082210|520775407|FG003|Overall Study|Physician Decision|1|||
144427811|NCT02082210|520775408|FG004|Overall Study|Physician Decision|0|||
144427812|NCT02082210|520775409|FG005|Overall Study|Physician Decision|0|||
144427813|NCT01727141|520775414|FG000|Overall Study|Physician Decision|0|||
144427814|NCT01727141|520775415|FG001|Overall Study|Physician Decision|1|||
144427815|NCT01727141|520775416|FG002|Overall Study|Physician Decision|0|||
144427816|NCT01727141|520775417|FG003|Overall Study|Physician Decision|2|||
144427817|NCT01727141|520775414|FG000|Overall Study|Lost to Follow-up|0|||
144427818|NCT01727141|520775415|FG001|Overall Study|Lost to Follow-up|2|||
144427819|NCT01727141|520775416|FG002|Overall Study|Lost to Follow-up|0|||
144427820|NCT01727141|520775417|FG003|Overall Study|Lost to Follow-up|0|||
144427821|NCT01727141|520775414|FG000|Overall Study|Death|0|||
144427822|NCT01727141|520775415|FG001|Overall Study|Death|1|||
144427823|NCT01727141|520775416|FG002|Overall Study|Death|1|||
144427824|NCT01727141|520775417|FG003|Overall Study|Death|1|||
144182805|NCT01745094|519864087|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
144427825|NCT01727141|520775414|FG000|Overall Study|Protocol deviation|1|||
144427826|NCT01727141|520775415|FG001|Overall Study|Protocol deviation|1|||
144182806|NCT01745094|519864088|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
144182807|NCT01745094|519864085|FG000|Overall Study|Adverse Event|0|||
144182808|NCT01745094|519864086|FG001|Overall Study|Adverse Event|0|||
144182809|NCT01745094|519864087|FG002|Overall Study|Adverse Event|3|||
144427827|NCT01727141|520775416|FG002|Overall Study|Protocol deviation|0|||
144427828|NCT01727141|520775417|FG003|Overall Study|Protocol deviation|1|||
144427829|NCT01727141|520775414|FG000|Overall Study|Withdrawal by Subject|4|||
144427830|NCT01727141|520775415|FG001|Overall Study|Withdrawal by Subject|4|||
144427831|NCT01727141|520775416|FG002|Overall Study|Withdrawal by Subject|2|||
144427832|NCT01727141|520775417|FG003|Overall Study|Withdrawal by Subject|11|||
144427833|NCT02584504|520775418|FG000|Double-blind Treatment|Participant withdrew consent|0|||
144427834|NCT02584504|520775419|FG001|Double-blind Treatment|Participant withdrew consent|0|||
144427835|NCT02584504|520775420|FG002|Double-blind Treatment|Participant withdrew consent|1|||
144427836|NCT02584504|520775418|FG000|Double-blind Treatment|Adverse Event|0|||
144427837|NCT02584504|520775419|FG001|Double-blind Treatment|Adverse Event|1|||
144427838|NCT02584504|520775420|FG002|Double-blind Treatment|Adverse Event|0|||
144427839|NCT02584504|520775418|FG000|Double-blind Treatment|Family Matter|0|||
144427840|NCT02584504|520775419|FG001|Double-blind Treatment|Family Matter|1|||
144427841|NCT02584504|520775420|FG002|Double-blind Treatment|Family Matter|0|||
144427842|NCT02584504|520775418|FG000|Open-label Treatment|Participant withdrew consent|0|||
144528792|NCT02240238|521139151|FG003|Phase 1|Adverse Event|0|||
144182810|NCT01745094|519864088|FG003|Overall Study|Adverse Event|0|||
144182811|NCT01745094|519864085|FG000|Overall Study|Withdrawal by Subject|2|||
144182812|NCT01745094|519864086|FG001|Overall Study|Withdrawal by Subject|0|||
144182813|NCT01745094|519864087|FG002|Overall Study|Withdrawal by Subject|1|||
144182814|NCT01745094|519864088|FG003|Overall Study|Withdrawal by Subject|2|||
144182815|NCT01745094|519864085|FG000|Overall Study|Protocol Violation|1|||
144182816|NCT01745094|519864086|FG001|Overall Study|Protocol Violation|0|||
144182817|NCT01745094|519864087|FG002|Overall Study|Protocol Violation|3|||
144182818|NCT01745094|519864088|FG003|Overall Study|Protocol Violation|1|||
144182819|NCT01745094|519864085|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
144182820|NCT01745094|519864086|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
144182821|NCT01745094|519864087|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
144182822|NCT01745094|519864088|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
144182823|NCT01745094|519864085|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
144182824|NCT01745094|519864086|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
144182825|NCT01745094|519864087|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
144182826|NCT01745094|519864088|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
144182827|NCT01745094|519864085|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
144182828|NCT01745094|519864086|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
144182829|NCT01745094|519864087|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
144182830|NCT01745094|519864088|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
144182831|NCT01097694|519864089|FG000|Overall Study|Adverse Event|5|||
144182832|NCT01097694|519864090|FG001|Overall Study|Adverse Event|0|||
144182833|NCT01097694|519864089|FG000|Overall Study|Lost to Follow-up|0|||
144182834|NCT01097694|519864090|FG001|Overall Study|Lost to Follow-up|3|||
144182835|NCT01097694|519864089|FG000|Overall Study|Withdrawal by Subject|3|||
144182836|NCT01097694|519864090|FG001|Overall Study|Withdrawal by Subject|1|||
144182837|NCT03922750|519864091|FG000|Overall Study|Unclassified|0|||
144182838|NCT03922750|519864092|FG001|Overall Study|Unclassified|0|||
144182839|NCT03922750|519864093|FG002|Overall Study|Unclassified|1|||
144182840|NCT03922750|519864091|FG000|Overall Study|Adverse Event|0|||
144182841|NCT03922750|519864092|FG001|Overall Study|Adverse Event|1|||
144182842|NCT03922750|519864093|FG002|Overall Study|Adverse Event|0|||
144182843|NCT02985398|519864094|FG000|Overall Study|Adverse Event|1|||
144182844|NCT02985398|519864094|FG000|Overall Study|Lost to Follow-up|4|||
144182845|NCT02985398|519864094|FG000|Overall Study|Withdrawal by Subject|8|||
144182846|NCT02985398|519864094|FG000|Overall Study|Study Burden|9|||
144182847|NCT00283842|519864099|FG000|Overall Study|Adverse Event|8|||
144182848|NCT00283842|519864100|FG001|Overall Study|Adverse Event|7|||
144182849|NCT00283842|519864101|FG002|Overall Study|Adverse Event|21|||
144182850|NCT00283842|519864102|FG003|Overall Study|Adverse Event|21|||
144182851|NCT00283842|519864103|FG004|Overall Study|Adverse Event|5|||
144182852|NCT00283842|519864099|FG000|Overall Study|Protocol Violation|1|||
144182853|NCT00283842|519864100|FG001|Overall Study|Protocol Violation|5|||
144182854|NCT00283842|519864101|FG002|Overall Study|Protocol Violation|4|||
144182855|NCT00283842|519864102|FG003|Overall Study|Protocol Violation|0|||
144182856|NCT00283842|519864103|FG004|Overall Study|Protocol Violation|0|||
144182857|NCT00283842|519864099|FG000|Overall Study|Protocol deviation|0|||
144182858|NCT00283842|519864100|FG001|Overall Study|Protocol deviation|0|||
144182859|NCT00283842|519864101|FG002|Overall Study|Protocol deviation|0|||
144182860|NCT00283842|519864102|FG003|Overall Study|Protocol deviation|0|||
144182861|NCT00283842|519864103|FG004|Overall Study|Protocol deviation|2|||
144182862|NCT00283842|519864099|FG000|Overall Study|Withdrawal by Subject|2|||
144182863|NCT00283842|519864100|FG001|Overall Study|Withdrawal by Subject|1|||
144182864|NCT00283842|519864101|FG002|Overall Study|Withdrawal by Subject|1|||
144182865|NCT00283842|519864102|FG003|Overall Study|Withdrawal by Subject|5|||
144182866|NCT00283842|519864103|FG004|Overall Study|Withdrawal by Subject|4|||
144182867|NCT00283842|519864099|FG000|Overall Study|Lack of Efficacy|1|||
144182868|NCT00283842|519864100|FG001|Overall Study|Lack of Efficacy|3|||
144528793|NCT02240238|521139152|FG004|Phase 1|Adverse Event|0|||
144528794|NCT02240238|521139153|FG005|Phase 1|Adverse Event|0|||
144528795|NCT02240238|521139154|FG006|Phase 1|Adverse Event|3|||
144528796|NCT02240238|521139155|FG007|Phase 1|Adverse Event|1|||
144182869|NCT00283842|519864101|FG002|Overall Study|Lack of Efficacy|1|||
144182870|NCT00283842|519864102|FG003|Overall Study|Lack of Efficacy|0|||
144528797|NCT02240238|521139156|FG008|Phase 1|Adverse Event|0|||
144182871|NCT00283842|519864103|FG004|Overall Study|Lack of Efficacy|3|||
144182872|NCT00283842|519864099|FG000|Overall Study|Lost to Follow-up|0|||
144182873|NCT00283842|519864100|FG001|Overall Study|Lost to Follow-up|2|||
144182874|NCT00283842|519864101|FG002|Overall Study|Lost to Follow-up|4|||
144182875|NCT00283842|519864102|FG003|Overall Study|Lost to Follow-up|1|||
144182876|NCT00283842|519864103|FG004|Overall Study|Lost to Follow-up|1|||
144182877|NCT02004691|519864104|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
144182878|NCT02004691|519864105|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
144528798|NCT02240238|521139157|FG009|Phase 1|Adverse Event|0|||
144528799|NCT02240238|521139158|FG010|Phase 1|Adverse Event|0|||
144528800|NCT02240238|521139159|FG011|Phase 1|Adverse Event|0|||
144528801|NCT02240238|521139148|FG000|Phase 1|Death|0|||
144528802|NCT02240238|521139149|FG001|Phase 1|Death|0|||
144528803|NCT02240238|521139150|FG002|Phase 1|Death|0|||
144528804|NCT02240238|521139151|FG003|Phase 1|Death|0|||
144528805|NCT02240238|521139152|FG004|Phase 1|Death|0|||
144528806|NCT02240238|521139153|FG005|Phase 1|Death|1|||
144528807|NCT02240238|521139154|FG006|Phase 1|Death|0|||
144528808|NCT02240238|521139155|FG007|Phase 1|Death|0|||
144182879|NCT02004691|519864104|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
144182880|NCT02004691|519864105|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
144182881|NCT02004691|519864104|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
144427843|NCT02584504|520775419|FG001|Open-label Treatment|Participant withdrew consent|0|||
144427844|NCT02584504|520775420|FG002|Open-label Treatment|Participant withdrew consent|4|||
144427845|NCT02584504|520775418|FG000|Open-label Treatment|Adverse Event|2|||
144427846|NCT02584504|520775419|FG001|Open-label Treatment|Adverse Event|2|||
144427847|NCT02584504|520775420|FG002|Open-label Treatment|Adverse Event|3|||
144427848|NCT02584504|520775418|FG000|Open-label Treatment|Physician Decision|0|||
144427849|NCT02584504|520775419|FG001|Open-label Treatment|Physician Decision|1|||
144427850|NCT02584504|520775420|FG002|Open-label Treatment|Physician Decision|0|||
144427851|NCT02584504|520775418|FG000|Open-label Treatment|Entered but not treated|0|||
144427852|NCT02584504|520775419|FG001|Open-label Treatment|Entered but not treated|1|||
144427853|NCT02584504|520775420|FG002|Open-label Treatment|Entered but not treated|1|||
144427854|NCT02246673|520775425|FG000|Overall Study|Sponsor Decision|1|||
144427855|NCT02246673|520775426|FG001|Overall Study|Sponsor Decision|0|||
144427856|NCT02246673|520775427|FG002|Overall Study|Sponsor Decision|0|||
144427857|NCT02246673|520775428|FG003|Overall Study|Sponsor Decision|0|||
144427858|NCT02246673|520775429|FG004|Overall Study|Sponsor Decision|0|||
144427859|NCT02246673|520775425|FG000|Overall Study|Withdrawal by Subject|0|||
144427860|NCT02246673|520775426|FG001|Overall Study|Withdrawal by Subject|0|||
144427861|NCT02246673|520775427|FG002|Overall Study|Withdrawal by Subject|0|||
144427862|NCT02246673|520775428|FG003|Overall Study|Withdrawal by Subject|0|||
144427863|NCT02246673|520775429|FG004|Overall Study|Withdrawal by Subject|1|||
144427864|NCT02246673|520775425|FG000|Overall Study|Lost to Follow-up|0|||
144427865|NCT02246673|520775426|FG001|Overall Study|Lost to Follow-up|0|||
144427866|NCT02246673|520775427|FG002|Overall Study|Lost to Follow-up|0|||
144427867|NCT02246673|520775428|FG003|Overall Study|Lost to Follow-up|1|||
144427868|NCT02246673|520775429|FG004|Overall Study|Lost to Follow-up|0|||
144427869|NCT02246673|520775425|FG000|Overall Study|Protocol Violation|0|||
144427870|NCT02246673|520775426|FG001|Overall Study|Protocol Violation|0|||
144427871|NCT02246673|520775427|FG002|Overall Study|Protocol Violation|0|||
144427872|NCT02246673|520775428|FG003|Overall Study|Protocol Violation|1|||
144427873|NCT02246673|520775429|FG004|Overall Study|Protocol Violation|0|||
144427874|NCT02914769|520775431|FG000|Overall Study|Protocol Violation|3|||
144427875|NCT02914769|520775432|FG001|Overall Study|Protocol Violation|2|||
144427876|NCT02914769|520775431|FG000|Overall Study|Withdrawal by Subject|0|||
144427877|NCT02914769|520775432|FG001|Overall Study|Withdrawal by Subject|1|||
144427878|NCT02488681|520775434|FG000|Overall Study|Implant unsuccessful|7|||
144427879|NCT05413369|520775435|FG000|Overall Study|Adverse Event|1|||
144427880|NCT05413369|520775436|FG001|Overall Study|Adverse Event|1|||
144427881|NCT05413369|520775435|FG000|Overall Study|Withdrawal by Subject|13|||
144427882|NCT05413369|520775436|FG001|Overall Study|Withdrawal by Subject|4|||
144427883|NCT05413369|520775435|FG000|Overall Study|Non-compliance with study schedule|2|||
144427884|NCT05413369|520775436|FG001|Overall Study|Non-compliance with study schedule|1|||
144427885|NCT05413369|520775435|FG000|Overall Study|Other|1|||
144427886|NCT05413369|520775436|FG001|Overall Study|Other|1|||
144427887|NCT02809677|520775438|FG000|Overall Study|Withdrawal by Subject|8|||
144427888|NCT00720057|520775441|FG000|Overall Study|Lost to Follow-up|0|||
144182882|NCT02004691|519864105|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
144427889|NCT00720057|520775442|FG001|Overall Study|Lost to Follow-up|2|||
144427890|NCT00720057|520775441|FG000|Overall Study|Protocol Violation|1|||
144427891|NCT00720057|520775442|FG001|Overall Study|Protocol Violation|0|||
144603647|NCT02092350|521411963|FG000|Overall Study|Death|2|||
144603648|NCT02092350|521411964|FG001|Overall Study|Death|5|||
144182883|NCT02004691|519864104|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
144427892|NCT00720057|520775441|FG000|Overall Study|Withdrawal by Subject|0|||
144427893|NCT00720057|520775442|FG001|Overall Study|Withdrawal by Subject|1|||
144427894|NCT04969224|520775445|FG000|Overall Study|Adverse Event|1|||
144528809|NCT02240238|521139156|FG008|Phase 1|Death|0|||
144528810|NCT02240238|521139157|FG009|Phase 1|Death|0|||
144603649|NCT02092350|521411963|FG000|Overall Study|Lost to Follow-up|3|||
144182884|NCT02004691|519864105|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
144427895|NCT04969224|520775445|FG000|Overall Study|Enrolled but never dosed|1|||
144251906|NCT01859949|520122566|FG001|Overall Study|Family Matters|1|||
144427896|NCT01498952|520775450|FG000|Overall Study|Death|2|||
144427897|NCT01498952|520775451|FG001|Overall Study|Death|2|||
144427898|NCT01498952|520775452|FG002|Overall Study|Death|0|||
144528811|NCT02240238|521139158|FG010|Phase 1|Death|0|||
144528812|NCT02240238|521139159|FG011|Phase 1|Death|0|||
144528813|NCT02240238|521139148|FG000|Phase 1|Sponsor termination|0|||
144528814|NCT02240238|521139149|FG001|Phase 1|Sponsor termination|0|||
144427899|NCT01498952|520775453|FG003|Overall Study|Death|0|||
144427900|NCT01498952|520775454|FG004|Overall Study|Death|0|||
144427901|NCT02726074|520775455|FG000|Overall Study|Withdrawal by Subject|4|||
144427902|NCT02726074|520775455|FG000|Overall Study|Adverse Event|14|||
144427903|NCT02726074|520775455|FG000|Overall Study|Protocol Violation|3|||
144427904|NCT02726074|520775455|FG000|Overall Study|Lost to Follow-up|2|||
144603650|NCT02092350|521411964|FG001|Overall Study|Lost to Follow-up|1|||
144603651|NCT02092350|521411963|FG000|Overall Study|Protocol Violation|1|||
144603652|NCT02092350|521411964|FG001|Overall Study|Protocol Violation|0|||
144603653|NCT02092350|521411963|FG000|Overall Study|Physician Decision|1|||
144603654|NCT02092350|521411964|FG001|Overall Study|Physician Decision|1|||
144603655|NCT02092350|521411963|FG000|Overall Study|Screen Failure|1|||
144603656|NCT02092350|521411964|FG001|Overall Study|Screen Failure|0|||
144182885|NCT02004691|519864104|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
144182886|NCT02004691|519864105|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
144427905|NCT02726074|520775455|FG000|Overall Study|Others|3|||
144427906|NCT00579826|520775456|FG000|Overall Study|Withdrawal by Subject|5|||
144427907|NCT00579826|520775457|FG001|Overall Study|Withdrawal by Subject|3|||
144427908|NCT01679002|520775458|FG000|Overall Study|Adverse Event|1|||
144427909|NCT01679002|520775459|FG001|Overall Study|Adverse Event|1|||
144427910|NCT01679002|520775460|FG002|Overall Study|Adverse Event|0|||
144427911|NCT00454987|520775461|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
144427912|NCT00454987|520775462|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
144427913|NCT00454987|520775463|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
144427914|NCT00454987|520775461|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
144427915|NCT00454987|520775462|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
144427916|NCT00454987|520775463|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
144427917|NCT00454987|520775461|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
144427918|NCT00454987|520775462|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
144427919|NCT00454987|520775463|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
144427920|NCT01176266|520775464|FG000|Overall Study|Death|6|||
144182887|NCT02004691|519864104|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
144182888|NCT02004691|519864105|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
144427921|NCT01176266|520775464|FG000|Overall Study|Withdrawal by Subject|3|||
144427922|NCT00728130|520775465|FG000|Overall Study|Withdrawal by Subject|1|||
144427923|NCT00728130|520775465|FG000|Overall Study|Paperwork not completed in time|1|||
144528815|NCT02240238|521139150|FG002|Phase 1|Sponsor termination|0|||
144528816|NCT02240238|521139151|FG003|Phase 1|Sponsor termination|0|||
144528817|NCT02240238|521139152|FG004|Phase 1|Sponsor termination|0|||
144528818|NCT02240238|521139153|FG005|Phase 1|Sponsor termination|1|||
144528819|NCT02240238|521139154|FG006|Phase 1|Sponsor termination|0|||
144528820|NCT02240238|521139155|FG007|Phase 1|Sponsor termination|0|||
144528821|NCT02240238|521139156|FG008|Phase 1|Sponsor termination|0|||
144528822|NCT02240238|521139157|FG009|Phase 1|Sponsor termination|0|||
144528823|NCT02240238|521139158|FG010|Phase 1|Sponsor termination|0|||
144528824|NCT02240238|521139159|FG011|Phase 1|Sponsor termination|0|||
144528825|NCT02240238|521139148|FG000|Phase 1|Withdrawal by Subject|0|||
144528826|NCT02240238|521139149|FG001|Phase 1|Withdrawal by Subject|0|||
144528827|NCT02240238|521139150|FG002|Phase 1|Withdrawal by Subject|0|||
144528828|NCT02240238|521139151|FG003|Phase 1|Withdrawal by Subject|0|||
144528829|NCT02240238|521139152|FG004|Phase 1|Withdrawal by Subject|0|||
144528830|NCT02240238|521139153|FG005|Phase 1|Withdrawal by Subject|2|||
144528831|NCT02240238|521139154|FG006|Phase 1|Withdrawal by Subject|0|||
144528832|NCT02240238|521139155|FG007|Phase 1|Withdrawal by Subject|0|||
144528833|NCT02240238|521139156|FG008|Phase 1|Withdrawal by Subject|0|||
144528834|NCT02240238|521139157|FG009|Phase 1|Withdrawal by Subject|0|||
144528835|NCT02240238|521139158|FG010|Phase 1|Withdrawal by Subject|0|||
144528836|NCT02240238|521139159|FG011|Phase 1|Withdrawal by Subject|0|||
144528837|NCT02240238|521139148|FG000|Phase 1|Physician Decision|0|||
144528838|NCT02240238|521139149|FG001|Phase 1|Physician Decision|0|||
144528839|NCT02240238|521139150|FG002|Phase 1|Physician Decision|0|||
144528840|NCT02240238|521139151|FG003|Phase 1|Physician Decision|0|||
144528841|NCT02240238|521139152|FG004|Phase 1|Physician Decision|0|||
144603657|NCT02092350|521411963|FG000|Overall Study|Withdrawal by Subject|2|||
144603658|NCT02092350|521411964|FG001|Overall Study|Withdrawal by Subject|2|||
144603659|NCT01829425|521411975|FG000|Overall Study|Withdrawal by Subject|4|||
144603660|NCT01829425|521411976|FG001|Overall Study|Withdrawal by Subject|3|||
144182889|NCT02472639|519864106|FG000|Overall Study|Physician Decision|4|||
144182890|NCT02472639|519864107|FG001|Overall Study|Physician Decision|3|||
144182891|NCT04049097|519864108|FG000|Overall Study|Adverse Event|18|||
144427924|NCT00728130|520775465|FG000|Overall Study|Physician Decision|1|||
144427925|NCT00304356|520775469|FG000|Nitazoxanide|Physician Decision|5|||
144528842|NCT02240238|521139153|FG005|Phase 1|Physician Decision|2|||
144528843|NCT02240238|521139154|FG006|Phase 1|Physician Decision|0|||
144528844|NCT02240238|521139155|FG007|Phase 1|Physician Decision|0|||
144528845|NCT02240238|521139156|FG008|Phase 1|Physician Decision|0|||
144528846|NCT02240238|521139157|FG009|Phase 1|Physician Decision|0|||
144603661|NCT01829425|521411975|FG000|Overall Study|Lost to Follow-up|2|||
144182892|NCT04049097|519864108|FG000|Overall Study|Death|2|||
144182893|NCT04049097|519864108|FG000|Overall Study|Lost to Follow-up|1|||
144182894|NCT04049097|519864108|FG000|Overall Study|Physician Decision|2|||
144182895|NCT04049097|519864108|FG000|Overall Study|Withdrawal by Subject|9|||
144182896|NCT04049097|519864108|FG000|Overall Study|Protocol Violation|2|||
144182897|NCT04049097|519864108|FG000|Overall Study|Other|1|||
144182898|NCT04049097|519864108|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
144427926|NCT00304356|520775469|FG000|Nitazoxanide|Physician Decision|1|||
144427927|NCT00304356|520775469|FG000|Nitazoxanide|number is 0|1|||
144427928|NCT00304356|520775469|FG000|Nitazoxanide|Physician Decision|1|||
144427929|NCT00304356|520775469|FG000|Nitazoxanide|Physician Decision|1|||
144427930|NCT00304356|520775469|FG000|Nitazoxanide|Physician Decision|1|||
144427931|NCT04120974|520775473|FG000|Overall Study|Death|1|||
144427932|NCT04120974|520775473|FG000|Overall Study|Physician Decision|1|||
144427933|NCT04120974|520775473|FG000|Overall Study|Lost to Follow-up|6|||
144427934|NCT00973479|520775476|FG000|Overall Study|Lost to Follow-up|0|||
144427935|NCT00973479|520775477|FG001|Overall Study|Lost to Follow-up|3|||
144427936|NCT00973479|520775476|FG000|Overall Study|Death|2|||
144427937|NCT00973479|520775477|FG001|Overall Study|Death|2|||
144427938|NCT00973479|520775476|FG000|Overall Study|Withdrawal by Subject|15|||
144427939|NCT00973479|520775477|FG001|Overall Study|Withdrawal by Subject|16|||
144427940|NCT00973479|520775476|FG000|Overall Study|Lack of Efficacy|5|||
144427941|NCT00973479|520775477|FG001|Overall Study|Lack of Efficacy|7|||
144427942|NCT00973479|520775476|FG000|Overall Study|Adverse Event|12|||
144427943|NCT00973479|520775477|FG001|Overall Study|Adverse Event|32|||
144427944|NCT00973479|520775476|FG000|Overall Study|Protocol Violation|2|||
144427945|NCT00973479|520775477|FG001|Overall Study|Protocol Violation|2|||
144427946|NCT00973479|520775476|FG000|Overall Study|Other|1|||
144427947|NCT00973479|520775477|FG001|Overall Study|Other|7|||
144427948|NCT05075850|520775478|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
144427949|NCT04256785|520775479|FG000|Overall Study|Adverse Event|8|||
144427950|NCT04256785|520775480|FG001|Overall Study|Adverse Event|6|||
144427951|NCT04256785|520775479|FG000|Overall Study|Lack of Efficacy|3|||
144427952|NCT04256785|520775480|FG001|Overall Study|Lack of Efficacy|4|||
144427953|NCT04256785|520775479|FG000|Overall Study|Lost to Follow-up|7|||
144427954|NCT04256785|520775480|FG001|Overall Study|Lost to Follow-up|7|||
144427955|NCT04256785|520775479|FG000|Overall Study|Protocol Violation|1|||
144427956|NCT04256785|520775480|FG001|Overall Study|Protocol Violation|0|||
144427957|NCT04256785|520775479|FG000|Overall Study|Withdrawal by Subject|4|||
144427958|NCT04256785|520775480|FG001|Overall Study|Withdrawal by Subject|1|||
144427959|NCT04256785|520775479|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
144427960|NCT04256785|520775480|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
144182899|NCT03828539|519864117|FG000|Overall Study|Adverse Event|3|||
144182900|NCT03828539|519864118|FG001|Overall Study|Adverse Event|12|||
144182901|NCT03828539|519864117|FG000|Overall Study|Patient's/guardian's decision|3|||
144182902|NCT03828539|519864118|FG001|Overall Study|Patient's/guardian's decision|5|||
144182903|NCT03828539|519864117|FG000|Overall Study|Lost to Follow-up|4|||
144182904|NCT03828539|519864118|FG001|Overall Study|Lost to Follow-up|2|||
144182905|NCT03828539|519864117|FG000|Overall Study|Protocol Violation|3|||
144182906|NCT03828539|519864118|FG001|Overall Study|Protocol Violation|2|||
144182907|NCT03828539|519864117|FG000|Overall Study|Withdrawal of informed consent|2|||
144182908|NCT03828539|519864118|FG001|Overall Study|Withdrawal of informed consent|1|||
144182909|NCT03828539|519864117|FG000|Overall Study|New therapy for study indication|1|||
144182910|NCT03828539|519864118|FG001|Overall Study|New therapy for study indication|0|||
144182911|NCT00057941|519864119|FG000|Overall Study|Death|1|||
144182912|NCT00057941|519864120|FG001|Overall Study|Death|2|||
144182913|NCT00057941|519864119|FG000|Overall Study|Adverse Event|7|||
144182914|NCT00057941|519864120|FG001|Overall Study|Adverse Event|9|||
144182915|NCT00057941|519864119|FG000|Overall Study|Lack of Efficacy|54|||
144182916|NCT00057941|519864120|FG001|Overall Study|Lack of Efficacy|53|||
144251907|NCT01859949|520122565|FG000|Overall Study|Physician Decision|2|||
144427961|NCT01265849|520775481|FG000|Overall Study|Randomized//Treatment not initiated|1|||
144427962|NCT01265849|520775482|FG001|Overall Study|Randomized//Treatment not initiated|4|||
144427963|NCT01265849|520775483|FG002|Overall Study|Randomized//Treatment not initiated|0|||
144182917|NCT00057941|519864119|FG000|Overall Study|Withdrawal by Subject|6|||
144427964|NCT01265849|520775481|FG000|Overall Study|Physician Decision|1|||
144427965|NCT01265849|520775482|FG001|Overall Study|Physician Decision|2|||
144427966|NCT01265849|520775483|FG002|Overall Study|Physician Decision|0|||
144427967|NCT01265849|520775481|FG000|Overall Study|Lost to Follow-up|18|||
144427968|NCT01265849|520775482|FG001|Overall Study|Lost to Follow-up|15|||
144427969|NCT01265849|520775483|FG002|Overall Study|Lost to Follow-up|5|||
144427970|NCT01265849|520775481|FG000|Overall Study|Not otherwise specified|1|||
144182918|NCT00057941|519864120|FG001|Overall Study|Withdrawal by Subject|1|||
144182919|NCT00057941|519864119|FG000|Overall Study|still on treatment|3|||
144182920|NCT00057941|519864120|FG001|Overall Study|still on treatment|1|||
144182921|NCT00057941|519864119|FG000|Overall Study|insurance, symptomatic deterioration|1|||
144182922|NCT00057941|519864120|FG001|Overall Study|insurance, symptomatic deterioration|3|||
144427971|NCT01265849|520775482|FG001|Overall Study|Not otherwise specified|6|||
144427972|NCT01265849|520775483|FG002|Overall Study|Not otherwise specified|1|||
144603662|NCT01829425|521411976|FG001|Overall Study|Lost to Follow-up|1|||
144603663|NCT05211739|521411977|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
144603664|NCT05211739|521411978|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
144603665|NCT05211739|521411977|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
144603666|NCT05211739|521411978|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
144603667|NCT05211739|521411977|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
144603668|NCT05211739|521411978|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
144603669|NCT05211739|521411977|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
144603670|NCT05211739|521411978|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
144603671|NCT03681951|521411979|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
144603672|NCT03681951|521411980|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144427973|NCT01265849|520775481|FG000|Overall Study|Withdrawal by Subject|25|||
144427974|NCT01265849|520775482|FG001|Overall Study|Withdrawal by Subject|34|||
144427975|NCT01265849|520775483|FG002|Overall Study|Withdrawal by Subject|13|||
144427976|NCT01170091|520775485|FG000|Overall Study|Missing efficacy evaluation|3|||
144427977|NCT01170091|520775485|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
144427978|NCT03194321|520775486|FG000|Overall Study|Withdrawal by Subject|1|||
144427979|NCT03194321|520775486|FG000|Overall Study|Lost to Follow-up|1|||
144427980|NCT03194321|520775486|FG000|Overall Study|Travel for Follow-up|1|||
144427981|NCT00271609|520775487|FG000|Overall Study|Adverse Event|11|||
144427982|NCT00271609|520775488|FG001|Overall Study|Adverse Event|3|||
144427983|NCT00271609|520775487|FG000|Overall Study|Withdrawal by Subject|2|||
144427984|NCT00271609|520775488|FG001|Overall Study|Withdrawal by Subject|0|||
144427985|NCT02188589|520775489|FG000|Overall Study|Withdrawal by Subject|5|||
144427986|NCT03341533|520775490|FG000|Overall Study|Withdrawal by Subject|1|||
144427987|NCT03341533|520775491|FG001|Overall Study|Withdrawal by Subject|1|||
144427988|NCT03341533|520775490|FG000|Overall Study|Not eligible after randomization|2|||
144427989|NCT03341533|520775491|FG001|Overall Study|Not eligible after randomization|1|||
144427990|NCT01675128|520775492|FG000|Overall Study|Disease progression on study|1|||
144427991|NCT01675128|520775493|FG001|Overall Study|Disease progression on study|1|||
144427992|NCT01675128|520775494|FG002|Overall Study|Disease progression on study|1|||
144427993|NCT01675128|520775492|FG000|Overall Study|Refused further treatment|1|||
144427994|NCT01675128|520775493|FG001|Overall Study|Refused further treatment|0|||
144427995|NCT01675128|520775494|FG002|Overall Study|Refused further treatment|0|||
144427996|NCT01675128|520775492|FG000|Overall Study|Pulmonary complication; off study|0|||
144427997|NCT01675128|520775493|FG001|Overall Study|Pulmonary complication; off study|1|||
144427998|NCT01675128|520775494|FG002|Overall Study|Pulmonary complication; off study|0|||
144427999|NCT03526458|520775495|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
144428000|NCT03526458|520775496|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
144428001|NCT03526458|520775495|FG000|Overall Study|Stone passed, surgery cancelled|2|||
144428002|NCT03526458|520775496|FG001|Overall Study|Stone passed, surgery cancelled|1|||
144428003|NCT03526458|520775495|FG000|Overall Study|Withdrawal by Subject|1|||
144428004|NCT03526458|520775496|FG001|Overall Study|Withdrawal by Subject|0|||
144428005|NCT03526458|520775495|FG000|Overall Study|Physician Decision|2|||
144428006|NCT03526458|520775496|FG001|Overall Study|Physician Decision|1|||
144428007|NCT03526458|520775495|FG000|Overall Study|Lack of equipment|1|||
144428008|NCT03526458|520775496|FG001|Overall Study|Lack of equipment|1|||
144428009|NCT03011307|520775497|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
144428010|NCT03011307|520775498|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
144428011|NCT03011307|520775497|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
144428012|NCT03011307|520775498|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
144428013|NCT03011307|520775497|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
144428014|NCT03011307|520775498|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
144428015|NCT01782664|520775499|FG000|Overall Study|Adverse Event|2|||
144428016|NCT01782664|520775500|FG001|Overall Study|Adverse Event|2|||
144603673|NCT03681951|521411981|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144603674|NCT03681951|521411982|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144603675|NCT03681951|521411983|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144603676|NCT03681951|521411984|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144603677|NCT03681951|521411985|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144603678|NCT03681951|521411986|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
144603679|NCT03681951|521411979|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
144603680|NCT03681951|521411980|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144428017|NCT01782664|520775501|FG002|Overall Study|Adverse Event|2|||
144428018|NCT01782664|520775502|FG003|Overall Study|Adverse Event|2|||
144428019|NCT01782664|520775503|FG004|Overall Study|Adverse Event|0|||
144428020|NCT01782664|520775504|FG005|Overall Study|Adverse Event|0|||
144428021|NCT01782664|520775499|FG000|Overall Study|Lack of Efficacy|2|||
144182923|NCT00057941|519864119|FG000|Overall Study|Ineligible|2|||
144182924|NCT00057941|519864120|FG001|Overall Study|Ineligible|5|||
144182925|NCT02760433|519864121|FG000|Overall Study|Lost to Follow-up|1|||
144182926|NCT02760433|519864122|FG001|Overall Study|Lost to Follow-up|0|||
144182927|NCT02760433|519864123|FG002|Overall Study|Lost to Follow-up|1|||
144182928|NCT02760433|519864124|FG003|Overall Study|Lost to Follow-up|0|||
144182929|NCT02760433|519864125|FG004|Overall Study|Lost to Follow-up|0|||
144182930|NCT02760433|519864121|FG000|Overall Study|Withdrawal by Subject|23|||
144182931|NCT02760433|519864122|FG001|Overall Study|Withdrawal by Subject|9|||
144182932|NCT02760433|519864123|FG002|Overall Study|Withdrawal by Subject|0|||
144182933|NCT02760433|519864124|FG003|Overall Study|Withdrawal by Subject|2|||
144182934|NCT02760433|519864125|FG004|Overall Study|Withdrawal by Subject|9|||
144182935|NCT02760433|519864121|FG000|Overall Study|Lack of Response At Week 14|0|||
144182936|NCT02760433|519864122|FG001|Overall Study|Lack of Response At Week 14|0|||
144182937|NCT02760433|519864123|FG002|Overall Study|Lack of Response At Week 14|0|||
144182938|NCT02760433|519864124|FG003|Overall Study|Lack of Response At Week 14|0|||
144182939|NCT02760433|519864125|FG004|Overall Study|Lack of Response At Week 14|1|||
144182940|NCT02760433|519864121|FG000|Overall Study|Subject refused to continue the study|1|||
144182941|NCT02760433|519864122|FG001|Overall Study|Subject refused to continue the study|0|||
144182942|NCT02760433|519864123|FG002|Overall Study|Subject refused to continue the study|0|||
144182943|NCT02760433|519864124|FG003|Overall Study|Subject refused to continue the study|0|||
144182944|NCT02760433|519864125|FG004|Overall Study|Subject refused to continue the study|0|||
144182945|NCT02760433|519864121|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
144182946|NCT02760433|519864122|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
144182947|NCT02760433|519864123|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
144182948|NCT02760433|519864124|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
144182949|NCT02760433|519864125|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
144182950|NCT02760433|519864121|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
144182951|NCT02760433|519864122|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
144182952|NCT02760433|519864123|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
144182953|NCT02760433|519864124|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
144182954|NCT02760433|519864125|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
144182955|NCT00766493|519864126|FG000|30 Days Post-Procedure|Discontinued|7|||
144182956|NCT00766493|519864126|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
144182957|NCT00766493|519864126|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
144182958|NCT03439085|519864128|FG000|Overall Study|Death|2|||
144182959|NCT03439085|519864128|FG000|Overall Study|Screen Failure|20|||
144182960|NCT01863433|519864129|FG000|Overall Study|Protocol Violation|1|||
144182961|NCT03919695|519864130|FG000|3-month Follow-up|Death|1|||
144182962|NCT03919695|519864131|FG001|3-month Follow-up|Death|1|||
144182963|NCT03919695|519864130|FG000|3-month Follow-up|unable to contact|0|||
144182964|NCT03919695|519864131|FG001|3-month Follow-up|unable to contact|3|||
144182965|NCT03919695|519864130|FG000|3-month Follow-up|in prison|0|||
144182966|NCT03919695|519864131|FG001|3-month Follow-up|in prison|1|||
144182967|NCT03919695|519864130|FG000|6-month Follow-up|Death|0|||
144182968|NCT03919695|519864131|FG001|6-month Follow-up|Death|1|||
144182969|NCT03919695|519864130|FG000|6-month Follow-up|Lost to Follow-up|1|||
144182970|NCT03919695|519864131|FG001|6-month Follow-up|Lost to Follow-up|2|||
144182971|NCT03919695|519864130|FG000|6-month Follow-up|in prison|0|||
144182972|NCT03919695|519864131|FG001|6-month Follow-up|in prison|2|||
144182973|NCT03919695|519864130|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
144182974|NCT03919695|519864131|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
144182975|NCT03919695|519864130|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
144182976|NCT03919695|519864131|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
144182977|NCT05135273|519865631|FG000|Overall Study|Recruited into the army|0|||
144182978|NCT05135273|519865632|FG001|Overall Study|Recruited into the army|0|||
144182979|NCT05135273|519865633|FG002|Overall Study|Recruited into the army|0|||
144182980|NCT05135273|519865634|FG003|Overall Study|Recruited into the army|0|||
144182981|NCT05135273|519865635|FG004|Overall Study|Recruited into the army|1|||
144182982|NCT05135273|519865636|FG005|Overall Study|Recruited into the army|0|||
144182983|NCT05135273|519865637|FG006|Overall Study|Recruited into the army|0|||
144182984|NCT05135273|519865638|FG007|Overall Study|Recruited into the army|0|||
144182985|NCT05135273|519865631|FG000|Overall Study|Moved away from study site|0|||
144182986|NCT05135273|519865632|FG001|Overall Study|Moved away from study site|0|||
144182987|NCT05135273|519865633|FG002|Overall Study|Moved away from study site|0|||
144182988|NCT05135273|519865634|FG003|Overall Study|Moved away from study site|0|||
144182989|NCT05135273|519865635|FG004|Overall Study|Moved away from study site|0|||
144428022|NCT01782664|520775500|FG001|Overall Study|Lack of Efficacy|0|||
144428023|NCT01782664|520775501|FG002|Overall Study|Lack of Efficacy|2|||
144428024|NCT01782664|520775502|FG003|Overall Study|Lack of Efficacy|2|||
144428025|NCT01782664|520775503|FG004|Overall Study|Lack of Efficacy|0|||
144182990|NCT05135273|519865636|FG005|Overall Study|Moved away from study site|1|||
144428026|NCT01782664|520775504|FG005|Overall Study|Lack of Efficacy|0|||
144428027|NCT01782664|520775499|FG000|Overall Study|Protocol Violation|0|||
144428028|NCT01782664|520775500|FG001|Overall Study|Protocol Violation|1|||
144428029|NCT01782664|520775501|FG002|Overall Study|Protocol Violation|0|||
144428030|NCT01782664|520775502|FG003|Overall Study|Protocol Violation|1|||
144428031|NCT01782664|520775503|FG004|Overall Study|Protocol Violation|0|||
144428032|NCT01782664|520775504|FG005|Overall Study|Protocol Violation|0|||
144428033|NCT01782664|520775499|FG000|Overall Study|Withdrawal by Subject|2|||
144428034|NCT01782664|520775500|FG001|Overall Study|Withdrawal by Subject|2|||
144428035|NCT01782664|520775501|FG002|Overall Study|Withdrawal by Subject|0|||
144428036|NCT01782664|520775502|FG003|Overall Study|Withdrawal by Subject|0|||
144428037|NCT01782664|520775503|FG004|Overall Study|Withdrawal by Subject|0|||
144428038|NCT01782664|520775504|FG005|Overall Study|Withdrawal by Subject|0|||
144428039|NCT02642432|520775507|FG000|Overall Study|Adverse Event|2|||
144428040|NCT02642432|520775507|FG000|Overall Study|Withdrew Consent|1|||
144428041|NCT02642432|520775507|FG000|Overall Study|Lost to Follow-up|2|||
144428042|NCT02642432|520775507|FG000|Overall Study|Other|3|||
144428043|NCT03999892|520775508|FG000|Overall Study|Lost to Follow-up|1|||
144428044|NCT02447081|520775509|FG000|Overall Study|Death|161|||
144428045|NCT02447081|520775509|FG000|Overall Study|Lost to Follow-up|36|||
144428046|NCT02447081|520775509|FG000|Overall Study|Visit not completed|17|||
144428047|NCT02447081|520775509|FG000|Overall Study|unsuccessful implant procedure|10|||
144428048|NCT05778786|520775510|FG000|Period 1|COVID-19 Related|3|||
144428049|NCT05778786|520775511|FG001|Period 1|COVID-19 Related|3|||
144428050|NCT05778786|520775510|FG000|Period 1|Withdrew Consent during Study|1|||
144428051|NCT05778786|520775511|FG001|Period 1|Withdrew Consent during Study|0|||
144428052|NCT05778786|520775510|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
144428053|NCT05778786|520775511|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
144428054|NCT05778786|520775510|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
144428055|NCT05778786|520775511|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
144428056|NCT02406651|520775516|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
144428057|NCT00718328|520775521|FG000|Overall Study|Lost to Follow-up|1|||
144428058|NCT00718328|520775522|FG001|Overall Study|Lost to Follow-up|0|||
144428059|NCT02865915|520775523|FG000|Overall Study|Pregnancy|1|||
144428060|NCT02865915|520775524|FG001|Overall Study|Pregnancy|0|||
144428061|NCT02865915|520775523|FG000|Overall Study|Withdrawal by Subject|1|||
144428062|NCT02865915|520775524|FG001|Overall Study|Withdrawal by Subject|1|||
144428063|NCT02865915|520775523|FG000|Overall Study|Adverse Event|0|||
144428064|NCT02865915|520775524|FG001|Overall Study|Adverse Event|4|||
144428065|NCT02865915|520775523|FG000|Overall Study|Lost to Follow-up|0|||
144428066|NCT02865915|520775524|FG001|Overall Study|Lost to Follow-up|1|||
144428067|NCT02865915|520775523|FG000|Overall Study|Protocol Violation|0|||
144428068|NCT02865915|520775524|FG001|Overall Study|Protocol Violation|1|||
144428069|NCT02865915|520775523|FG000|Overall Study|Study terminated by sponsor|23|||
144428070|NCT02865915|520775524|FG001|Overall Study|Study terminated by sponsor|18|||
144428071|NCT02865915|520775523|FG000|Overall Study|Dosing group discontinued|0|||
144428072|NCT02865915|520775524|FG001|Overall Study|Dosing group discontinued|5|||
144428073|NCT00663052|520775527|FG000|Overall Study|Adverse Event|6|||
144428074|NCT00663052|520775528|FG001|Overall Study|Adverse Event|3|||
144428075|NCT00663052|520775527|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
144428076|NCT00663052|520775528|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
144428077|NCT00663052|520775527|FG000|Overall Study|Protocol Violation|1|||
144428078|NCT00663052|520775528|FG001|Overall Study|Protocol Violation|0|||
144428079|NCT00663052|520775527|FG000|Overall Study|Withdrawal by Subject|2|||
144528847|NCT02240238|521139158|FG010|Phase 1|Physician Decision|0|||
144528848|NCT02240238|521139159|FG011|Phase 1|Physician Decision|0|||
144528849|NCT02240238|521139148|FG000|Phase 2|Adverse Event|0|||
144528850|NCT02240238|521139149|FG001|Phase 2|Adverse Event|0|||
144528851|NCT02240238|521139150|FG002|Phase 2|Adverse Event|0|||
144528852|NCT02240238|521139151|FG003|Phase 2|Adverse Event|0|||
144528853|NCT02240238|521139152|FG004|Phase 2|Adverse Event|0|||
144528854|NCT02240238|521139153|FG005|Phase 2|Adverse Event|0|||
144528855|NCT02240238|521139154|FG006|Phase 2|Adverse Event|0|||
144528856|NCT02240238|521139155|FG007|Phase 2|Adverse Event|0|||
144528857|NCT02240238|521139156|FG008|Phase 2|Adverse Event|0|||
144528858|NCT02240238|521139157|FG009|Phase 2|Adverse Event|7|||
144528859|NCT02240238|521139158|FG010|Phase 2|Adverse Event|14|||
144528860|NCT02240238|521139159|FG011|Phase 2|Adverse Event|2|||
144528861|NCT02240238|521139148|FG000|Phase 2|Death|0|||
144528862|NCT02240238|521139149|FG001|Phase 2|Death|0|||
144528863|NCT02240238|521139150|FG002|Phase 2|Death|0|||
144528864|NCT02240238|521139151|FG003|Phase 2|Death|0|||
144528865|NCT02240238|521139152|FG004|Phase 2|Death|0|||
144528866|NCT02240238|521139153|FG005|Phase 2|Death|0|||
144528867|NCT02240238|521139154|FG006|Phase 2|Death|0|||
144528868|NCT02240238|521139155|FG007|Phase 2|Death|0|||
144528869|NCT02240238|521139156|FG008|Phase 2|Death|0|||
144528870|NCT02240238|521139157|FG009|Phase 2|Death|3|||
144528871|NCT02240238|521139158|FG010|Phase 2|Death|2|||
144528872|NCT02240238|521139159|FG011|Phase 2|Death|1|||
144428080|NCT00663052|520775528|FG001|Overall Study|Withdrawal by Subject|5|||
144428081|NCT00663052|520775527|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
144428082|NCT00663052|520775528|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
144428083|NCT00663052|520775527|FG000|Overall Study|Other|0|||
144428084|NCT00663052|520775528|FG001|Overall Study|Other|1|||
144428085|NCT05041322|520775533|FG000|Baseline|Withdrawal by Subject|1|||
144428086|NCT05041322|520775534|FG001|Baseline|Withdrawal by Subject|0|||
144428087|NCT05041322|520775533|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
144428088|NCT05041322|520775534|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
144428089|NCT05041322|520775533|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
144428090|NCT05041322|520775534|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
144428091|NCT04814433|520775535|FG000|Overall Study|Survey not returned|4|||
144428092|NCT04814433|520775536|FG001|Overall Study|Survey not returned|8|||
144428093|NCT04814433|520775537|FG002|Overall Study|Survey not returned|4|||
144428094|NCT04814433|520775538|FG003|Overall Study|Survey not returned|5|||
144428095|NCT01239368|520777648|FG000|Overall Study|Principal investigator discretion|1|||
144428096|NCT01239368|520777649|FG001|Overall Study|Principal investigator discretion|0|||
144428097|NCT01239368|520777650|FG002|Overall Study|Principal investigator discretion|0|||
144428098|NCT01239368|520777651|FG003|Overall Study|Principal investigator discretion|0|||
144428099|NCT01239368|520777652|FG004|Overall Study|Principal investigator discretion|1|||
144428100|NCT01239368|520777653|FG005|Overall Study|Principal investigator discretion|2|||
144428101|NCT01239368|520777654|FG006|Overall Study|Principal investigator discretion|0|||
144428102|NCT01239368|520777655|FG007|Overall Study|Principal investigator discretion|0|||
144428103|NCT01239368|520777656|FG008|Overall Study|Principal investigator discretion|0|||
144428104|NCT01239368|520777657|FG009|Overall Study|Principal investigator discretion|1|||
144428105|NCT01239368|520777648|FG000|Overall Study|Disease progression on study|1|||
144428106|NCT01239368|520777649|FG001|Overall Study|Disease progression on study|1|||
144428107|NCT01239368|520777650|FG002|Overall Study|Disease progression on study|1|||
144428108|NCT01239368|520777651|FG003|Overall Study|Disease progression on study|1|||
144428109|NCT01239368|520777652|FG004|Overall Study|Disease progression on study|4|||
144428110|NCT01239368|520777653|FG005|Overall Study|Disease progression on study|2|||
144428111|NCT01239368|520777654|FG006|Overall Study|Disease progression on study|5|||
144428112|NCT01239368|520777655|FG007|Overall Study|Disease progression on study|0|||
144428113|NCT01239368|520777656|FG008|Overall Study|Disease progression on study|0|||
144428114|NCT01239368|520777657|FG009|Overall Study|Disease progression on study|2|||
144428115|NCT01239368|520777648|FG000|Overall Study|Refused further treatment|0|||
144428116|NCT01239368|520777649|FG001|Overall Study|Refused further treatment|0|||
144428117|NCT01239368|520777650|FG002|Overall Study|Refused further treatment|0|||
144428118|NCT01239368|520777651|FG003|Overall Study|Refused further treatment|0|||
144428119|NCT01239368|520777652|FG004|Overall Study|Refused further treatment|0|||
144428120|NCT01239368|520777653|FG005|Overall Study|Refused further treatment|0|||
144428121|NCT01239368|520777654|FG006|Overall Study|Refused further treatment|0|||
144428122|NCT01239368|520777655|FG007|Overall Study|Refused further treatment|0|||
144428123|NCT01239368|520777656|FG008|Overall Study|Refused further treatment|0|||
144428124|NCT01239368|520777657|FG009|Overall Study|Refused further treatment|1|||
144428125|NCT01239368|520777648|FG000|Overall Study|Death|0|||
144428126|NCT01239368|520777649|FG001|Overall Study|Death|0|||
144428127|NCT01239368|520777650|FG002|Overall Study|Death|0|||
144428128|NCT01239368|520777651|FG003|Overall Study|Death|0|||
144428129|NCT01239368|520777652|FG004|Overall Study|Death|0|||
144428130|NCT01239368|520777653|FG005|Overall Study|Death|0|||
144428131|NCT01239368|520777654|FG006|Overall Study|Death|1|||
144428132|NCT01239368|520777655|FG007|Overall Study|Death|0|||
144428133|NCT01239368|520777656|FG008|Overall Study|Death|0|||
144428134|NCT01239368|520777657|FG009|Overall Study|Death|0|||
144428135|NCT04709575|520777658|FG000|Overall Study|Withdrawal by Subject|6|||
144428136|NCT04709575|520777659|FG001|Overall Study|Withdrawal by Subject|2|||
144428137|NCT04709575|520777658|FG000|Overall Study|Lost to Follow-up|2|||
144428138|NCT04709575|520777659|FG001|Overall Study|Lost to Follow-up|2|||
144428139|NCT04709575|520777658|FG000|Overall Study|Adverse Event|1|||
144428140|NCT04709575|520777659|FG001|Overall Study|Adverse Event|0|||
144428141|NCT04709575|520777658|FG000|Overall Study|Protocol Violation|1|||
144428142|NCT04709575|520777659|FG001|Overall Study|Protocol Violation|1|||
144428143|NCT00702403|520777660|FG000|From Consent to Engraftment|Progressive leukemia|6|||
144528873|NCT02240238|521139148|FG000|Phase 2|Disease progression|0|||
144428144|NCT00702403|520777660|FG000|From Consent to Engraftment|Critically ill|2|||
144428145|NCT00702403|520777660|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
144428146|NCT00702403|520777660|FG000|From Consent to Engraftment|Myocardial infarction|1|||
144428147|NCT00702403|520777660|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
144428148|NCT00702403|520777660|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
144428149|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
144428150|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
144428151|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Non-compliance|2|||
144428152|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
144428153|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
144428154|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Suicide|1|||
144428155|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
144428156|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
144428157|NCT00702403|520777660|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
144428158|NCT00192504|520777663|FG000|Overall Study|Lost to Follow-up|1|||
144428159|NCT00192504|520777664|FG001|Overall Study|Lost to Follow-up|0|||
144428160|NCT00192504|520777665|FG002|Overall Study|Lost to Follow-up|0|||
144428161|NCT00192504|520777666|FG003|Overall Study|Lost to Follow-up|0|||
144428162|NCT00192504|520777663|FG000|Overall Study|Dosing window missed|0|||
144428163|NCT00192504|520777664|FG001|Overall Study|Dosing window missed|0|||
144428164|NCT00192504|520777665|FG002|Overall Study|Dosing window missed|1|||
144428165|NCT00192504|520777666|FG003|Overall Study|Dosing window missed|0|||
144428166|NCT02189473|520777667|FG000|Overall Study|Death|22|||
144428167|NCT02189473|520777668|FG001|Overall Study|Death|23|||
144428168|NCT02189473|520777667|FG000|Overall Study|Lost to Follow-up|1|||
144428169|NCT02189473|520777668|FG001|Overall Study|Lost to Follow-up|2|||
144428170|NCT05123222|520777669|FG000|Overall Study|Lost to Follow-up|2|||
144428171|NCT05123222|520777670|FG001|Overall Study|Lost to Follow-up|0|||
144428172|NCT05123222|520777671|FG002|Overall Study|Lost to Follow-up|0|||
144428173|NCT05123222|520777672|FG003|Overall Study|Lost to Follow-up|0|||
144428174|NCT05123222|520777669|FG000|Overall Study|Protocol Violation|0|||
144428175|NCT05123222|520777670|FG001|Overall Study|Protocol Violation|0|||
144428176|NCT05123222|520777671|FG002|Overall Study|Protocol Violation|1|||
144428177|NCT05123222|520777672|FG003|Overall Study|Protocol Violation|0|||
144603681|NCT03681951|521411981|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144603682|NCT03681951|521411982|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144603683|NCT03681951|521411983|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144603684|NCT03681951|521411984|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144603685|NCT03681951|521411985|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144428178|NCT00914810|520777675|FG000|Overall Study|Withdrawal by Subject|1|||
144428179|NCT00914810|520777676|FG001|Overall Study|Withdrawal by Subject|0|||
144428180|NCT00914810|520777675|FG000|Overall Study|Relocated out of state|1|||
144428181|NCT00914810|520777676|FG001|Overall Study|Relocated out of state|0|||
144428182|NCT00914810|520777675|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
144428183|NCT00914810|520777676|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
144428184|NCT00265343|520777677|FG000|Overall Study|Adverse Event|10|||
144428185|NCT00265343|520777678|FG001|Overall Study|Adverse Event|7|||
144428186|NCT00265343|520777677|FG000|Overall Study|Withdrawal by Subject|3|||
144428187|NCT00265343|520777678|FG001|Overall Study|Withdrawal by Subject|9|||
144428188|NCT00265343|520777677|FG000|Overall Study|Other|8|||
144428189|NCT00265343|520777678|FG001|Overall Study|Other|3|||
144428190|NCT00706641|520777683|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
144428191|NCT00706641|520777683|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
144428192|NCT00706641|520777683|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
144428193|NCT04782856|520777687|FG000|Overall Study|Withdrawal by Subject|0|||
144428194|NCT04782856|520777688|FG001|Overall Study|Withdrawal by Subject|1|||
144428195|NCT02535741|520777689|FG000|Overall Study|Adverse Event|3|||
144428196|NCT02535741|520777689|FG000|Overall Study|Withdrawal by Subject|9|||
144428197|NCT02535741|520777689|FG000|Overall Study|Lost to Follow-up|10|||
144428198|NCT02535741|520777689|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
144428199|NCT02535741|520777689|FG000|Overall Study|Missing data|6|||
144428200|NCT00798369|520777690|FG000|Overall Study|Subject withdrew consent|0|||
144428201|NCT00798369|520777691|FG001|Overall Study|Subject withdrew consent|0|||
144428202|NCT00798369|520777692|FG002|Overall Study|Subject withdrew consent|1|||
144428203|NCT00798369|520777693|FG003|Overall Study|Subject withdrew consent|1|||
144428204|NCT00798369|520777694|FG004|Overall Study|Subject withdrew consent|0|||
144428205|NCT00798369|520777695|FG005|Overall Study|Subject withdrew consent|2|||
144428206|NCT00798369|520777690|FG000|Overall Study|Lost to Follow-up|1|||
144428207|NCT00798369|520777691|FG001|Overall Study|Lost to Follow-up|1|||
144603686|NCT03681951|521411986|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
144603687|NCT03681951|521411979|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
144603688|NCT03681951|521411980|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144428208|NCT00798369|520777692|FG002|Overall Study|Lost to Follow-up|1|||
144428209|NCT00798369|520777693|FG003|Overall Study|Lost to Follow-up|0|||
144428210|NCT00798369|520777694|FG004|Overall Study|Lost to Follow-up|1|||
144428211|NCT00798369|520777695|FG005|Overall Study|Lost to Follow-up|0|||
144428212|NCT00798369|520777690|FG000|Overall Study|Adminstrative problems|0|||
144428213|NCT00798369|520777691|FG001|Overall Study|Adminstrative problems|0|||
144428214|NCT00798369|520777692|FG002|Overall Study|Adminstrative problems|0|||
144428215|NCT00798369|520777693|FG003|Overall Study|Adminstrative problems|0|||
144428216|NCT00798369|520777694|FG004|Overall Study|Adminstrative problems|0|||
144428217|NCT00798369|520777695|FG005|Overall Study|Adminstrative problems|1|||
144428218|NCT04475588|520777696|FG000|Overall Study|Adverse Event|2|||
144428219|NCT04475588|520777697|FG001|Overall Study|Adverse Event|0|||
144428220|NCT01327300|520777698|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
144428221|NCT01327300|520777699|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
144428222|NCT03020823|520777700|FG000|Overall Study|Physician Decision|4|||
144428223|NCT03020823|520777700|FG000|Overall Study|Lack of Efficacy|4|||
144428224|NCT03020823|520777700|FG000|Overall Study|Adverse Event|2|||
144428225|NCT03739112|520777702|FG000|Overall Study|Adverse Event|2|||
144428226|NCT03739112|520777703|FG001|Overall Study|Adverse Event|2|||
144428227|NCT03739112|520777702|FG000|Overall Study|Withdrawal by Subject|38|||
144428228|NCT03739112|520777703|FG001|Overall Study|Withdrawal by Subject|19|||
144428229|NCT03739112|520777702|FG000|Overall Study|Lost to Follow-up|31|||
144428230|NCT03739112|520777703|FG001|Overall Study|Lost to Follow-up|33|||
144428231|NCT03739112|520777702|FG000|Overall Study|Protocol Deviation|12|||
144428232|NCT03739112|520777703|FG001|Overall Study|Protocol Deviation|9|||
144428233|NCT03739112|520777702|FG000|Overall Study|Physician Decision|1|||
144428234|NCT03739112|520777703|FG001|Overall Study|Physician Decision|0|||
144428235|NCT03739112|520777702|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
144428236|NCT03739112|520777703|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
144428237|NCT03739112|520777702|FG000|Overall Study|Site went on hold|65|||
144428238|NCT03739112|520777703|FG001|Overall Study|Site went on hold|67|||
144428239|NCT03739112|520777702|FG000|Overall Study|Other than specified|8|||
144428240|NCT03739112|520777703|FG001|Overall Study|Other than specified|5|||
144428241|NCT03739112|520777702|FG000|Overall Study|Randomized but not vaccinated|31|||
144428242|NCT03739112|520777703|FG001|Overall Study|Randomized but not vaccinated|25|||
144428243|NCT04762680|520777705|FG000|Phase 2|Adverse Event|0|||
144428244|NCT04762680|520777706|FG001|Phase 2|Adverse Event|1|||
144428245|NCT04762680|520777707|FG002|Phase 2|Adverse Event|0|||
144428246|NCT04762680|520777708|FG003|Phase 2|Adverse Event|0|||
144428247|NCT04762680|520777709|FG004|Phase 2|Adverse Event|0|||
144428248|NCT04762680|520777710|FG005|Phase 2|Adverse Event|0|||
144428249|NCT04762680|520777711|FG006|Phase 2|Adverse Event|0|||
144428250|NCT04762680|520777712|FG007|Phase 2|Adverse Event|0|||
144428251|NCT04762680|520777713|FG008|Phase 2|Adverse Event|0|||
144428252|NCT04762680|520777714|FG009|Phase 2|Adverse Event|0|||
144428253|NCT04762680|520777715|FG010|Phase 2|Adverse Event|0|||
144428254|NCT04762680|520777716|FG011|Phase 2|Adverse Event|0|||
144428255|NCT04762680|520777717|FG012|Phase 2|Adverse Event|0|||
144428256|NCT04762680|520777718|FG013|Phase 2|Adverse Event|0|||
144428257|NCT04762680|520777719|FG014|Phase 2|Adverse Event|0|||
144428258|NCT04762680|520777720|FG015|Phase 2|Adverse Event|0|||
144428259|NCT04762680|520777721|FG016|Phase 2|Adverse Event|0|||
144428260|NCT04762680|520777722|FG017|Phase 2|Adverse Event|0|||
144428261|NCT04762680|520777723|FG018|Phase 2|Adverse Event|0|||
144428262|NCT04762680|520777724|FG019|Phase 2|Adverse Event|0|||
144428263|NCT04762680|520777725|FG020|Phase 2|Adverse Event|0|||
144428264|NCT04762680|520777726|FG021|Phase 2|Adverse Event|0|||
144428265|NCT04762680|520777705|FG000|Phase 2|Protocol Violation|5|||
144428266|NCT04762680|520777706|FG001|Phase 2|Protocol Violation|5|||
144428267|NCT04762680|520777707|FG002|Phase 2|Protocol Violation|1|||
144428268|NCT04762680|520777708|FG003|Phase 2|Protocol Violation|0|||
144428269|NCT04762680|520777709|FG004|Phase 2|Protocol Violation|0|||
144428270|NCT04762680|520777710|FG005|Phase 2|Protocol Violation|0|||
144428271|NCT04762680|520777711|FG006|Phase 2|Protocol Violation|0|||
144428272|NCT04762680|520777712|FG007|Phase 2|Protocol Violation|0|||
144428273|NCT04762680|520777713|FG008|Phase 2|Protocol Violation|0|||
144428274|NCT04762680|520777714|FG009|Phase 2|Protocol Violation|0|||
144428275|NCT04762680|520777715|FG010|Phase 2|Protocol Violation|0|||
144428276|NCT04762680|520777716|FG011|Phase 2|Protocol Violation|0|||
144428277|NCT04762680|520777717|FG012|Phase 2|Protocol Violation|0|||
144428278|NCT04762680|520777718|FG013|Phase 2|Protocol Violation|0|||
144428279|NCT04762680|520777719|FG014|Phase 2|Protocol Violation|0|||
144428280|NCT04762680|520777720|FG015|Phase 2|Protocol Violation|0|||
144428281|NCT04762680|520777721|FG016|Phase 2|Protocol Violation|0|||
144428282|NCT04762680|520777722|FG017|Phase 2|Protocol Violation|0|||
144428283|NCT04762680|520777723|FG018|Phase 2|Protocol Violation|0|||
144428284|NCT04762680|520777724|FG019|Phase 2|Protocol Violation|0|||
144428285|NCT04762680|520777725|FG020|Phase 2|Protocol Violation|0|||
144428286|NCT04762680|520777726|FG021|Phase 2|Protocol Violation|0|||
144182991|NCT05135273|519865637|FG006|Overall Study|Moved away from study site|1|||
144428287|NCT04762680|520777705|FG000|Phase 2|Withdrawal by Subject|23|||
144182992|NCT05135273|519865638|FG007|Overall Study|Moved away from study site|0|||
144182993|NCT05135273|519865631|FG000|Overall Study|Travel|0|||
144428288|NCT04762680|520777706|FG001|Phase 2|Withdrawal by Subject|21|||
144428289|NCT04762680|520777707|FG002|Phase 2|Withdrawal by Subject|28|||
144428290|NCT04762680|520777708|FG003|Phase 2|Withdrawal by Subject|0|||
144428291|NCT04762680|520777709|FG004|Phase 2|Withdrawal by Subject|0|||
144428292|NCT04762680|520777710|FG005|Phase 2|Withdrawal by Subject|0|||
144428293|NCT04762680|520777711|FG006|Phase 2|Withdrawal by Subject|0|||
144428294|NCT04762680|520777712|FG007|Phase 2|Withdrawal by Subject|0|||
144428295|NCT04762680|520777713|FG008|Phase 2|Withdrawal by Subject|0|||
144428296|NCT04762680|520777714|FG009|Phase 2|Withdrawal by Subject|0|||
144723515|NCT04634409|521842409|FG026|Overall Study|Death|0|||
144723516|NCT04634409|521842383|FG000|Overall Study|Adverse Event|0|||
144251908|NCT01859949|520122566|FG001|Overall Study|Physician Decision|4|||
144251909|NCT01859949|520122565|FG000|Overall Study|Withdrawal by Subject|11|||
144251910|NCT01859949|520122566|FG001|Overall Study|Withdrawal by Subject|10|||
144251911|NCT01859949|520122565|FG000|Overall Study|Protocol Violation|1|||
144251912|NCT01859949|520122566|FG001|Overall Study|Protocol Violation|1|||
144251913|NCT01859949|520122565|FG000|Overall Study|Adverse Event|0|||
144251914|NCT01859949|520122566|FG001|Overall Study|Adverse Event|1|||
144251915|NCT01344759|520122567|FG000|Overall Study|Patients failed to reach sedation level|0|||
144251916|NCT01344759|520122568|FG001|Overall Study|Patients failed to reach sedation level|2|||
144251917|NCT01153009|520122569|FG000|Overall Study|Adverse Event|4|||
144251918|NCT01153009|520122570|FG001|Overall Study|Adverse Event|14|||
144251919|NCT01153009|520122571|FG002|Overall Study|Adverse Event|14|||
144251920|NCT01153009|520122572|FG003|Overall Study|Adverse Event|10|||
144251921|NCT01153009|520122569|FG000|Overall Study|Lack of Efficacy|9|||
144251922|NCT01153009|520122570|FG001|Overall Study|Lack of Efficacy|0|||
144251923|NCT01153009|520122571|FG002|Overall Study|Lack of Efficacy|2|||
144251924|NCT01153009|520122572|FG003|Overall Study|Lack of Efficacy|1|||
144251925|NCT01153009|520122569|FG000|Overall Study|Noncompliance with Study Medication|1|||
144251926|NCT01153009|520122570|FG001|Overall Study|Noncompliance with Study Medication|3|||
144251927|NCT01153009|520122571|FG002|Overall Study|Noncompliance with Study Medication|4|||
144251928|NCT01153009|520122572|FG003|Overall Study|Noncompliance with Study Medication|1|||
144251929|NCT01153009|520122569|FG000|Overall Study|Protocol Deviations|4|||
144251930|NCT01153009|520122570|FG001|Overall Study|Protocol Deviations|3|||
144251931|NCT01153009|520122571|FG002|Overall Study|Protocol Deviations|3|||
144251932|NCT01153009|520122572|FG003|Overall Study|Protocol Deviations|2|||
144251933|NCT01153009|520122569|FG000|Overall Study|Withdrawal of Consent|5|||
144528874|NCT02240238|521139149|FG001|Phase 2|Disease progression|0|||
144528875|NCT02240238|521139150|FG002|Phase 2|Disease progression|0|||
144251934|NCT01153009|520122570|FG001|Overall Study|Withdrawal of Consent|5|||
144251935|NCT01153009|520122571|FG002|Overall Study|Withdrawal of Consent|4|||
144251936|NCT01153009|520122572|FG003|Overall Study|Withdrawal of Consent|6|||
144528876|NCT02240238|521139151|FG003|Phase 2|Disease progression|0|||
144528877|NCT02240238|521139152|FG004|Phase 2|Disease progression|0|||
144528878|NCT02240238|521139153|FG005|Phase 2|Disease progression|0|||
144528879|NCT02240238|521139154|FG006|Phase 2|Disease progression|0|||
144528880|NCT02240238|521139155|FG007|Phase 2|Disease progression|0|||
144528881|NCT02240238|521139156|FG008|Phase 2|Disease progression|0|||
144528882|NCT02240238|521139157|FG009|Phase 2|Disease progression|5|||
144528883|NCT02240238|521139158|FG010|Phase 2|Disease progression|11|||
144528884|NCT02240238|521139159|FG011|Phase 2|Disease progression|1|||
144528885|NCT02240238|521139148|FG000|Phase 2|Withdrawal by Subject|0|||
144528886|NCT02240238|521139149|FG001|Phase 2|Withdrawal by Subject|0|||
144528887|NCT02240238|521139150|FG002|Phase 2|Withdrawal by Subject|0|||
144603689|NCT03681951|521411981|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144603690|NCT03681951|521411982|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144603691|NCT03681951|521411983|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144603692|NCT03681951|521411984|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144603693|NCT03681951|521411985|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144603694|NCT03681951|521411986|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
144251937|NCT01153009|520122569|FG000|Overall Study|Lost to Follow-up|8|||
144251938|NCT01153009|520122570|FG001|Overall Study|Lost to Follow-up|8|||
144251939|NCT01153009|520122571|FG002|Overall Study|Lost to Follow-up|11|||
144603695|NCT02187809|521411987|FG000|Overall Study|The study was terminated|3|||
144603696|NCT01020448|521411988|FG000|Pre-assignment|Adverse Event|6|||
144603697|NCT01020448|521411988|FG000|Pre-assignment|Withdrawal by Subject|5|||
144603698|NCT01020448|521411988|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
144603699|NCT01020448|521411988|FG000|Treatment|Adverse Event|11|||
144723517|NCT04634409|521842384|FG001|Overall Study|Adverse Event|0|||
144723518|NCT04634409|521842385|FG002|Overall Study|Adverse Event|1|||
144723519|NCT04634409|521842386|FG003|Overall Study|Adverse Event|0|||
144723520|NCT04634409|521842387|FG004|Overall Study|Adverse Event|0|||
144723521|NCT04634409|521842388|FG005|Overall Study|Adverse Event|1|||
144723522|NCT04634409|521842389|FG006|Overall Study|Adverse Event|0|||
144251940|NCT01153009|520122572|FG003|Overall Study|Lost to Follow-up|15|||
144251941|NCT01153009|520122569|FG000|Overall Study|Other|1|||
144251942|NCT01153009|520122570|FG001|Overall Study|Other|1|||
144251943|NCT01153009|520122571|FG002|Overall Study|Other|3|||
144251944|NCT01153009|520122572|FG003|Overall Study|Other|2|||
144251945|NCT01709409|520122580|FG000|Overall Study|Protocol Violation|1|||
144251946|NCT01709409|520122581|FG001|Overall Study|Protocol Violation|0|||
144251947|NCT02412878|520122582|FG000|Overall Study|Withdrawal by Subject|19|||
144251948|NCT02412878|520122583|FG001|Overall Study|Withdrawal by Subject|10|||
144528888|NCT02240238|521139151|FG003|Phase 2|Withdrawal by Subject|0|||
144528889|NCT02240238|521139152|FG004|Phase 2|Withdrawal by Subject|0|||
144528890|NCT02240238|521139153|FG005|Phase 2|Withdrawal by Subject|0|||
144528891|NCT02240238|521139154|FG006|Phase 2|Withdrawal by Subject|0|||
144428297|NCT04762680|520777715|FG010|Phase 2|Withdrawal by Subject|0|||
144428298|NCT04762680|520777716|FG011|Phase 2|Withdrawal by Subject|0|||
144428299|NCT04762680|520777717|FG012|Phase 2|Withdrawal by Subject|0|||
144428300|NCT04762680|520777718|FG013|Phase 2|Withdrawal by Subject|0|||
144428301|NCT04762680|520777719|FG014|Phase 2|Withdrawal by Subject|0|||
144428302|NCT04762680|520777720|FG015|Phase 2|Withdrawal by Subject|0|||
144428303|NCT04762680|520777721|FG016|Phase 2|Withdrawal by Subject|0|||
144428304|NCT04762680|520777722|FG017|Phase 2|Withdrawal by Subject|0|||
144428305|NCT04762680|520777723|FG018|Phase 2|Withdrawal by Subject|0|||
144428306|NCT04762680|520777724|FG019|Phase 2|Withdrawal by Subject|0|||
144428307|NCT04762680|520777725|FG020|Phase 2|Withdrawal by Subject|0|||
144428308|NCT04762680|520777726|FG021|Phase 2|Withdrawal by Subject|0|||
144428309|NCT04762680|520777705|FG000|Phase 2|Lost to Follow-up|14|||
144428310|NCT04762680|520777706|FG001|Phase 2|Lost to Follow-up|8|||
144428311|NCT04762680|520777707|FG002|Phase 2|Lost to Follow-up|9|||
144428312|NCT04762680|520777708|FG003|Phase 2|Lost to Follow-up|0|||
144428313|NCT04762680|520777709|FG004|Phase 2|Lost to Follow-up|0|||
144428314|NCT04762680|520777710|FG005|Phase 2|Lost to Follow-up|0|||
144428315|NCT04762680|520777711|FG006|Phase 2|Lost to Follow-up|0|||
144428316|NCT04762680|520777712|FG007|Phase 2|Lost to Follow-up|0|||
144428317|NCT04762680|520777713|FG008|Phase 2|Lost to Follow-up|0|||
144428318|NCT04762680|520777714|FG009|Phase 2|Lost to Follow-up|0|||
144428319|NCT04762680|520777715|FG010|Phase 2|Lost to Follow-up|0|||
144428320|NCT04762680|520777716|FG011|Phase 2|Lost to Follow-up|0|||
144428321|NCT04762680|520777717|FG012|Phase 2|Lost to Follow-up|0|||
144428322|NCT04762680|520777718|FG013|Phase 2|Lost to Follow-up|0|||
144428323|NCT04762680|520777719|FG014|Phase 2|Lost to Follow-up|0|||
144428324|NCT04762680|520777720|FG015|Phase 2|Lost to Follow-up|0|||
144428325|NCT04762680|520777721|FG016|Phase 2|Lost to Follow-up|0|||
144428326|NCT04762680|520777722|FG017|Phase 2|Lost to Follow-up|0|||
144428327|NCT04762680|520777723|FG018|Phase 2|Lost to Follow-up|0|||
144428328|NCT04762680|520777724|FG019|Phase 2|Lost to Follow-up|0|||
144428329|NCT04762680|520777725|FG020|Phase 2|Lost to Follow-up|0|||
144428330|NCT04762680|520777726|FG021|Phase 2|Lost to Follow-up|0|||
144428331|NCT04762680|520777705|FG000|Phase 3|Adverse Event|0|||
144428332|NCT04762680|520777706|FG001|Phase 3|Adverse Event|0|||
144428333|NCT04762680|520777707|FG002|Phase 3|Adverse Event|0|||
144428334|NCT04762680|520777708|FG003|Phase 3|Adverse Event|1|||
144428335|NCT04762680|520777709|FG004|Phase 3|Adverse Event|0|||
144428336|NCT04762680|520777710|FG005|Phase 3|Adverse Event|0|||
144428337|NCT04762680|520777711|FG006|Phase 3|Adverse Event|0|||
144428338|NCT04762680|520777712|FG007|Phase 3|Adverse Event|0|||
144428339|NCT04762680|520777713|FG008|Phase 3|Adverse Event|0|||
144428340|NCT04762680|520777714|FG009|Phase 3|Adverse Event|0|||
144428341|NCT04762680|520777715|FG010|Phase 3|Adverse Event|0|||
144182994|NCT05135273|519865632|FG001|Overall Study|Travel|0|||
144182995|NCT05135273|519865633|FG002|Overall Study|Travel|0|||
144182996|NCT05135273|519865634|FG003|Overall Study|Travel|0|||
144182997|NCT05135273|519865635|FG004|Overall Study|Travel|0|||
144182998|NCT05135273|519865636|FG005|Overall Study|Travel|0|||
144182999|NCT05135273|519865637|FG006|Overall Study|Travel|0|||
144428342|NCT04762680|520777716|FG011|Phase 3|Adverse Event|0|||
144603700|NCT01020448|521411988|FG000|Treatment|Consent Withdrawn|3|||
144723523|NCT04634409|521842390|FG007|Overall Study|Adverse Event|0|||
144183000|NCT05135273|519865638|FG007|Overall Study|Travel|1|||
144183001|NCT01958060|519865641|FG000|Overall Study|Not treated|2|||
144183002|NCT01958060|519865642|FG001|Overall Study|Not treated|0|||
144183003|NCT01958060|519865643|FG002|Overall Study|Not treated|0|||
144183004|NCT01958060|519865644|FG003|Overall Study|Not treated|0|||
144183005|NCT01958060|519865645|FG004|Overall Study|Not treated|1|||
144183006|NCT01958060|519865646|FG005|Overall Study|Not treated|0|||
144251949|NCT02412878|520122582|FG000|Overall Study|Lost to Follow-up|2|||
144251950|NCT02412878|520122583|FG001|Overall Study|Lost to Follow-up|3|||
144428343|NCT04762680|520777717|FG012|Phase 3|Adverse Event|0|||
144428344|NCT04762680|520777718|FG013|Phase 3|Adverse Event|0|||
144428345|NCT04762680|520777719|FG014|Phase 3|Adverse Event|0|||
144428346|NCT04762680|520777720|FG015|Phase 3|Adverse Event|0|||
144428347|NCT04762680|520777721|FG016|Phase 3|Adverse Event|0|||
144428348|NCT04762680|520777722|FG017|Phase 3|Adverse Event|3|||
144428349|NCT04762680|520777723|FG018|Phase 3|Adverse Event|0|||
144428350|NCT04762680|520777724|FG019|Phase 3|Adverse Event|0|||
144428351|NCT04762680|520777725|FG020|Phase 3|Adverse Event|0|||
144428352|NCT04762680|520777726|FG021|Phase 3|Adverse Event|0|||
144428353|NCT04762680|520777705|FG000|Phase 3|Protocol Violation|0|||
144428354|NCT04762680|520777706|FG001|Phase 3|Protocol Violation|0|||
144428355|NCT04762680|520777707|FG002|Phase 3|Protocol Violation|0|||
144428356|NCT04762680|520777708|FG003|Phase 3|Protocol Violation|4|||
144428357|NCT04762680|520777709|FG004|Phase 3|Protocol Violation|1|||
144428358|NCT04762680|520777710|FG005|Phase 3|Protocol Violation|5|||
144428359|NCT04762680|520777711|FG006|Phase 3|Protocol Violation|1|||
144428360|NCT04762680|520777712|FG007|Phase 3|Protocol Violation|0|||
144428361|NCT04762680|520777713|FG008|Phase 3|Protocol Violation|0|||
144428362|NCT04762680|520777714|FG009|Phase 3|Protocol Violation|0|||
144428363|NCT04762680|520777715|FG010|Phase 3|Protocol Violation|0|||
144428364|NCT04762680|520777716|FG011|Phase 3|Protocol Violation|2|||
144428365|NCT04762680|520777717|FG012|Phase 3|Protocol Violation|3|||
144183007|NCT01705717|519865647|FG000|Overall Study|Adverse Event|2|||
144183008|NCT01705717|519865648|FG001|Overall Study|Adverse Event|2|||
144428366|NCT04762680|520777718|FG013|Phase 3|Protocol Violation|0|||
144428367|NCT04762680|520777719|FG014|Phase 3|Protocol Violation|0|||
144428368|NCT04762680|520777720|FG015|Phase 3|Protocol Violation|1|||
144428369|NCT04762680|520777721|FG016|Phase 3|Protocol Violation|0|||
144428370|NCT04762680|520777722|FG017|Phase 3|Protocol Violation|10|||
144428371|NCT04762680|520777723|FG018|Phase 3|Protocol Violation|0|||
144428372|NCT04762680|520777724|FG019|Phase 3|Protocol Violation|0|||
144428373|NCT04762680|520777725|FG020|Phase 3|Protocol Violation|0|||
144428374|NCT04762680|520777726|FG021|Phase 3|Protocol Violation|0|||
144428375|NCT04762680|520777705|FG000|Phase 3|Withdrawal by Subject|0|||
144428376|NCT04762680|520777706|FG001|Phase 3|Withdrawal by Subject|0|||
144428377|NCT04762680|520777707|FG002|Phase 3|Withdrawal by Subject|0|||
144183009|NCT01705717|519865647|FG000|Overall Study|Lack of Efficacy|0|||
144183010|NCT01705717|519865648|FG001|Overall Study|Lack of Efficacy|1|||
144183011|NCT01705717|519865647|FG000|Overall Study|Other|0|||
144183012|NCT01705717|519865648|FG001|Overall Study|Other|2|||
144183013|NCT00500318|519865650|FG000|Overall Study|Adverse Event|3|||
144183014|NCT00500318|519865651|FG001|Overall Study|Adverse Event|8|||
144183015|NCT00500318|519865650|FG000|Overall Study|Protocol Violation|1|||
144183016|NCT00500318|519865651|FG001|Overall Study|Protocol Violation|3|||
144183017|NCT00500318|519865650|FG000|Overall Study|Withdrawal by Subject|1|||
144183018|NCT00500318|519865651|FG001|Overall Study|Withdrawal by Subject|2|||
144183019|NCT00500318|519865650|FG000|Overall Study|Lack of Efficacy|0|||
144183020|NCT00500318|519865651|FG001|Overall Study|Lack of Efficacy|3|||
144183021|NCT00500318|519865650|FG000|Overall Study|Other Reason|0|||
144183022|NCT00500318|519865651|FG001|Overall Study|Other Reason|1|||
144428378|NCT04762680|520777708|FG003|Phase 3|Withdrawal by Subject|13|||
144428379|NCT04762680|520777709|FG004|Phase 3|Withdrawal by Subject|17|||
144428380|NCT04762680|520777710|FG005|Phase 3|Withdrawal by Subject|12|||
144428381|NCT04762680|520777711|FG006|Phase 3|Withdrawal by Subject|8|||
144428382|NCT04762680|520777712|FG007|Phase 3|Withdrawal by Subject|3|||
144183023|NCT01350934|519865683|FG000|Base Study|Adverse Event|6|||
144183024|NCT01350934|519865684|FG001|Base Study|Adverse Event|0|||
144183025|NCT01350934|519865683|FG000|Base Study|Lost to Follow-up|1|||
144183026|NCT01350934|519865684|FG001|Base Study|Lost to Follow-up|0|||
144183027|NCT01350934|519865683|FG000|Base Study|Protocol Violation|1|||
144183028|NCT01350934|519865684|FG001|Base Study|Protocol Violation|1|||
144183029|NCT01350934|519865683|FG000|Base Study|Withdrawal by Subject|1|||
144183030|NCT01350934|519865684|FG001|Base Study|Withdrawal by Subject|2|||
144183031|NCT01350934|519865683|FG000|Base Study|Non-Compliance With Study Drug|2|||
144183032|NCT01350934|519865684|FG001|Base Study|Non-Compliance With Study Drug|0|||
144183033|NCT01350934|519865683|FG000|Extension Study|Adverse Event|2|||
144183034|NCT01350934|519865684|FG001|Extension Study|Adverse Event|1|||
144183035|NCT01350934|519865683|FG000|Extension Study|Lost to Follow-up|2|||
144183036|NCT01350934|519865684|FG001|Extension Study|Lost to Follow-up|0|||
144183037|NCT01350934|519865683|FG000|Extension Study|Protocol Violation|1|||
144183038|NCT01350934|519865684|FG001|Extension Study|Protocol Violation|1|||
144183039|NCT01350934|519865683|FG000|Extension Study|Lack of Efficacy|0|||
144183040|NCT01350934|519865684|FG001|Extension Study|Lack of Efficacy|1|||
144183041|NCT01350934|519865683|FG000|Extension Study|Withdrawal by Subject|0|||
144183042|NCT01350934|519865684|FG001|Extension Study|Withdrawal by Subject|1|||
144183043|NCT01011335|519865687|FG000|Overall Study|Lost to Follow-up|0|||
144183044|NCT01011335|519865688|FG001|Overall Study|Lost to Follow-up|0|||
144183045|NCT01011335|519865689|FG002|Overall Study|Lost to Follow-up|1|||
144183046|NCT01011335|519865690|FG003|Overall Study|Lost to Follow-up|1|||
144183047|NCT01011335|519865691|FG004|Overall Study|Lost to Follow-up|1|||
144428383|NCT04762680|520777713|FG008|Phase 3|Withdrawal by Subject|2|||
144428384|NCT04762680|520777714|FG009|Phase 3|Withdrawal by Subject|4|||
144428385|NCT04762680|520777715|FG010|Phase 3|Withdrawal by Subject|3|||
144183048|NCT01011335|519865692|FG005|Overall Study|Lost to Follow-up|1|||
144183049|NCT01011335|519865693|FG006|Overall Study|Lost to Follow-up|2|||
144183050|NCT01011335|519865694|FG007|Overall Study|Lost to Follow-up|2|||
144183051|NCT01011335|519865695|FG008|Overall Study|Lost to Follow-up|1|||
144183052|NCT01011335|519865696|FG009|Overall Study|Lost to Follow-up|0|||
144183053|NCT01011335|519865697|FG010|Overall Study|Lost to Follow-up|0|||
144183054|NCT01011335|519865698|FG011|Overall Study|Lost to Follow-up|1|||
144183055|NCT01011335|519865699|FG012|Overall Study|Lost to Follow-up|2|||
144183056|NCT01011335|519865687|FG000|Overall Study|Protocol Violation|0|||
144183057|NCT01011335|519865688|FG001|Overall Study|Protocol Violation|1|||
144183058|NCT01011335|519865689|FG002|Overall Study|Protocol Violation|0|||
144183059|NCT01011335|519865690|FG003|Overall Study|Protocol Violation|0|||
144183060|NCT01011335|519865691|FG004|Overall Study|Protocol Violation|0|||
144183061|NCT01011335|519865692|FG005|Overall Study|Protocol Violation|0|||
144183062|NCT01011335|519865693|FG006|Overall Study|Protocol Violation|0|||
144428386|NCT04762680|520777716|FG011|Phase 3|Withdrawal by Subject|1|||
144428387|NCT04762680|520777717|FG012|Phase 3|Withdrawal by Subject|3|||
144428388|NCT04762680|520777718|FG013|Phase 3|Withdrawal by Subject|2|||
144428389|NCT04762680|520777719|FG014|Phase 3|Withdrawal by Subject|1|||
144428390|NCT04762680|520777720|FG015|Phase 3|Withdrawal by Subject|4|||
144251951|NCT02190721|520122584|FG000|Overall Study|Patient was out of the city|0|||
144251952|NCT02190721|520122585|FG001|Overall Study|Patient was out of the city|1|||
144428391|NCT04762680|520777721|FG016|Phase 3|Withdrawal by Subject|6|||
144428392|NCT04762680|520777722|FG017|Phase 3|Withdrawal by Subject|32|||
144428393|NCT04762680|520777723|FG018|Phase 3|Withdrawal by Subject|0|||
144428394|NCT04762680|520777724|FG019|Phase 3|Withdrawal by Subject|0|||
144428395|NCT04762680|520777725|FG020|Phase 3|Withdrawal by Subject|0|||
144428396|NCT04762680|520777726|FG021|Phase 3|Withdrawal by Subject|0|||
144428397|NCT04762680|520777705|FG000|Phase 3|Lost to Follow-up|0|||
144428398|NCT04762680|520777706|FG001|Phase 3|Lost to Follow-up|0|||
144428399|NCT04762680|520777707|FG002|Phase 3|Lost to Follow-up|0|||
144428400|NCT04762680|520777708|FG003|Phase 3|Lost to Follow-up|9|||
144428401|NCT04762680|520777709|FG004|Phase 3|Lost to Follow-up|22|||
144428402|NCT04762680|520777710|FG005|Phase 3|Lost to Follow-up|24|||
144428403|NCT04762680|520777711|FG006|Phase 3|Lost to Follow-up|2|||
144428404|NCT04762680|520777712|FG007|Phase 3|Lost to Follow-up|4|||
144428405|NCT04762680|520777713|FG008|Phase 3|Lost to Follow-up|6|||
144428406|NCT04762680|520777714|FG009|Phase 3|Lost to Follow-up|4|||
144428407|NCT04762680|520777715|FG010|Phase 3|Lost to Follow-up|3|||
144428408|NCT04762680|520777716|FG011|Phase 3|Lost to Follow-up|0|||
144428409|NCT04762680|520777717|FG012|Phase 3|Lost to Follow-up|5|||
144428410|NCT04762680|520777718|FG013|Phase 3|Lost to Follow-up|4|||
144428411|NCT04762680|520777719|FG014|Phase 3|Lost to Follow-up|6|||
144428412|NCT04762680|520777720|FG015|Phase 3|Lost to Follow-up|1|||
144428413|NCT04762680|520777721|FG016|Phase 3|Lost to Follow-up|1|||
144428414|NCT04762680|520777722|FG017|Phase 3|Lost to Follow-up|66|||
144428415|NCT04762680|520777723|FG018|Phase 3|Lost to Follow-up|0|||
144428416|NCT04762680|520777724|FG019|Phase 3|Lost to Follow-up|0|||
144428417|NCT04762680|520777725|FG020|Phase 3|Lost to Follow-up|0|||
144428418|NCT04762680|520777726|FG021|Phase 3|Lost to Follow-up|0|||
144428419|NCT04762680|520777705|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428420|NCT04762680|520777706|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428421|NCT04762680|520777707|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428422|NCT04762680|520777708|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428423|NCT04762680|520777709|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428424|NCT04762680|520777710|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428425|NCT04762680|520777711|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428426|NCT04762680|520777712|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428427|NCT04762680|520777713|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428428|NCT04762680|520777714|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428429|NCT04762680|520777715|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428430|NCT04762680|520777716|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428431|NCT04762680|520777717|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144251953|NCT02190721|520122586|FG002|Overall Study|Patient was out of the city|0|||
144251954|NCT04571385|520122587|FG000|Overall Study|Participant non-compliance|1|||
144251955|NCT04571385|520122588|FG001|Overall Study|Participant non-compliance|0|||
144251956|NCT04571385|520122589|FG002|Overall Study|Participant non-compliance|0|||
144428432|NCT04762680|520777718|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428433|NCT04762680|520777719|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428434|NCT04762680|520777720|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428435|NCT04762680|520777721|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428436|NCT04762680|520777722|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428437|NCT04762680|520777723|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428438|NCT04762680|520777724|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428439|NCT04762680|520777725|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
144428440|NCT04762680|520777726|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
144428441|NCT04762680|520777705|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428442|NCT04762680|520777706|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428443|NCT04762680|520777707|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428444|NCT04762680|520777708|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428445|NCT04762680|520777709|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
144603701|NCT01020448|521411988|FG000|Treatment|Disease Progression|2|||
144603702|NCT01020448|521411988|FG000|Treatment|Lack of Efficacy|8|||
144251957|NCT04571385|520122587|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
144428446|NCT04762680|520777710|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428447|NCT04762680|520777711|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428448|NCT04762680|520777712|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
144603703|NCT01020448|521411988|FG000|Treatment|Lost to Follow-up|2|||
144603704|NCT01505010|521411989|FG000|Overall Study|Protocol Violation|0|||
144428449|NCT04762680|520777713|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428450|NCT04762680|520777714|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
144603705|NCT01505010|521411990|FG001|Overall Study|Protocol Violation|1|||
144428451|NCT04762680|520777715|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428452|NCT04762680|520777716|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428453|NCT04762680|520777717|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428454|NCT04762680|520777718|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428455|NCT04762680|520777719|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
144183063|NCT01011335|519865694|FG007|Overall Study|Protocol Violation|0|||
144183064|NCT01011335|519865695|FG008|Overall Study|Protocol Violation|0|||
144183065|NCT01011335|519865696|FG009|Overall Study|Protocol Violation|0|||
144183066|NCT01011335|519865697|FG010|Overall Study|Protocol Violation|0|||
144183067|NCT01011335|519865698|FG011|Overall Study|Protocol Violation|0|||
144183068|NCT01011335|519865699|FG012|Overall Study|Protocol Violation|0|||
144183069|NCT01011335|519865687|FG000|Overall Study|Moved/deployed or no booster|1|||
144183070|NCT01011335|519865688|FG001|Overall Study|Moved/deployed or no booster|0|||
144183071|NCT01011335|519865689|FG002|Overall Study|Moved/deployed or no booster|0|||
144183072|NCT01011335|519865690|FG003|Overall Study|Moved/deployed or no booster|1|||
144183073|NCT01011335|519865691|FG004|Overall Study|Moved/deployed or no booster|0|||
144183074|NCT01011335|519865692|FG005|Overall Study|Moved/deployed or no booster|0|||
144183075|NCT01011335|519865693|FG006|Overall Study|Moved/deployed or no booster|1|||
144183076|NCT01011335|519865694|FG007|Overall Study|Moved/deployed or no booster|0|||
144183077|NCT01011335|519865695|FG008|Overall Study|Moved/deployed or no booster|1|||
144183078|NCT01011335|519865696|FG009|Overall Study|Moved/deployed or no booster|0|||
144183079|NCT01011335|519865697|FG010|Overall Study|Moved/deployed or no booster|2|||
144183080|NCT01011335|519865698|FG011|Overall Study|Moved/deployed or no booster|0|||
144183081|NCT01011335|519865699|FG012|Overall Study|Moved/deployed or no booster|0|||
144183082|NCT01011335|519865687|FG000|Overall Study|Adverse Event|0|||
144183083|NCT01011335|519865688|FG001|Overall Study|Adverse Event|0|||
144183084|NCT01011335|519865689|FG002|Overall Study|Adverse Event|0|||
144183085|NCT01011335|519865690|FG003|Overall Study|Adverse Event|0|||
144183086|NCT01011335|519865691|FG004|Overall Study|Adverse Event|0|||
144183087|NCT01011335|519865692|FG005|Overall Study|Adverse Event|0|||
144183088|NCT01011335|519865693|FG006|Overall Study|Adverse Event|0|||
144183089|NCT01011335|519865694|FG007|Overall Study|Adverse Event|0|||
144183090|NCT01011335|519865695|FG008|Overall Study|Adverse Event|0|||
144183091|NCT01011335|519865696|FG009|Overall Study|Adverse Event|0|||
144183092|NCT01011335|519865697|FG010|Overall Study|Adverse Event|4|||
144183093|NCT01011335|519865698|FG011|Overall Study|Adverse Event|0|||
144183094|NCT01011335|519865699|FG012|Overall Study|Adverse Event|1|||
144183095|NCT01765751|519865705|FG000|Overall Study|Lost to Follow-up|0|||
144528892|NCT02240238|521139155|FG007|Phase 2|Withdrawal by Subject|0|||
144528893|NCT02240238|521139156|FG008|Phase 2|Withdrawal by Subject|0|||
144528894|NCT02240238|521139157|FG009|Phase 2|Withdrawal by Subject|1|||
144528895|NCT02240238|521139158|FG010|Phase 2|Withdrawal by Subject|1|||
144528896|NCT02240238|521139159|FG011|Phase 2|Withdrawal by Subject|0|||
144528897|NCT02240238|521139148|FG000|Phase 2|Physician Decision|0|||
144528898|NCT02240238|521139149|FG001|Phase 2|Physician Decision|0|||
144528899|NCT02240238|521139150|FG002|Phase 2|Physician Decision|0|||
144528900|NCT02240238|521139151|FG003|Phase 2|Physician Decision|0|||
144528901|NCT02240238|521139152|FG004|Phase 2|Physician Decision|0|||
144528902|NCT02240238|521139153|FG005|Phase 2|Physician Decision|0|||
144528903|NCT02240238|521139154|FG006|Phase 2|Physician Decision|0|||
144528904|NCT02240238|521139155|FG007|Phase 2|Physician Decision|0|||
144528905|NCT02240238|521139156|FG008|Phase 2|Physician Decision|0|||
144528906|NCT02240238|521139157|FG009|Phase 2|Physician Decision|1|||
144528907|NCT02240238|521139158|FG010|Phase 2|Physician Decision|3|||
144528908|NCT02240238|521139159|FG011|Phase 2|Physician Decision|0|||
144528909|NCT02240238|521139148|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528910|NCT02240238|521139149|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528911|NCT02240238|521139150|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528912|NCT02240238|521139151|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528913|NCT02240238|521139152|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528914|NCT02240238|521139153|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528915|NCT02240238|521139154|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528916|NCT02240238|521139155|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528917|NCT02240238|521139156|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528918|NCT02240238|521139157|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
144603706|NCT01505010|521411989|FG000|Overall Study|Lost to Follow-up|0|||
144183096|NCT01765751|519865706|FG001|Overall Study|Lost to Follow-up|2|||
144183097|NCT01765751|519865707|FG002|Overall Study|Lost to Follow-up|1|||
144183098|NCT00799708|519865708|FG000|Overall Study|non-compliance|1|||
144183099|NCT00799708|519865709|FG001|Overall Study|non-compliance|0|||
144183100|NCT00799708|519865710|FG002|Overall Study|non-compliance|0|||
144183101|NCT00880334|519865711|FG000|Randomized Phase|Physician Decision|1|||
144183102|NCT00880334|519865712|FG001|Randomized Phase|Physician Decision|0|||
144183103|NCT00880334|519865711|FG000|Randomized Phase|Withdrawal by Subject|2|||
144183104|NCT00880334|519865712|FG001|Randomized Phase|Withdrawal by Subject|1|||
144183105|NCT00880334|519865711|FG000|Randomized Phase|Inadequate Labs|1|||
144528919|NCT02240238|521139158|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144723524|NCT04634409|521842391|FG008|Overall Study|Adverse Event|0|||
144723525|NCT04634409|521842392|FG009|Overall Study|Adverse Event|0|||
144723526|NCT04634409|521842393|FG010|Overall Study|Adverse Event|0|||
144723527|NCT04634409|521842394|FG011|Overall Study|Adverse Event|0|||
144723528|NCT04634409|521842395|FG012|Overall Study|Adverse Event|0|||
144723529|NCT04634409|521842396|FG013|Overall Study|Adverse Event|0|||
144723530|NCT04634409|521842397|FG014|Overall Study|Adverse Event|0|||
144723531|NCT04634409|521842398|FG015|Overall Study|Adverse Event|0|||
144723532|NCT04634409|521842399|FG016|Overall Study|Adverse Event|0|||
144723533|NCT04634409|521842400|FG017|Overall Study|Adverse Event|0|||
144723534|NCT04634409|521842401|FG018|Overall Study|Adverse Event|0|||
144723535|NCT04634409|521842402|FG019|Overall Study|Adverse Event|0|||
144723536|NCT04634409|521842403|FG020|Overall Study|Adverse Event|0|||
144723537|NCT04634409|521842404|FG021|Overall Study|Adverse Event|0|||
144723538|NCT04634409|521842405|FG022|Overall Study|Adverse Event|0|||
144723539|NCT04634409|521842406|FG023|Overall Study|Adverse Event|0|||
144723540|NCT04634409|521842407|FG024|Overall Study|Adverse Event|0|||
144723541|NCT04634409|521842408|FG025|Overall Study|Adverse Event|0|||
144723542|NCT04634409|521842409|FG026|Overall Study|Adverse Event|0|||
144723543|NCT04634409|521842383|FG000|Overall Study|Lost to Follow-up|3|||
144723544|NCT04634409|521842384|FG001|Overall Study|Lost to Follow-up|1|||
144723545|NCT04634409|521842385|FG002|Overall Study|Lost to Follow-up|1|||
144723546|NCT04634409|521842386|FG003|Overall Study|Lost to Follow-up|3|||
144723547|NCT04634409|521842387|FG004|Overall Study|Lost to Follow-up|1|||
144723548|NCT04634409|521842388|FG005|Overall Study|Lost to Follow-up|1|||
144723549|NCT04634409|521842389|FG006|Overall Study|Lost to Follow-up|1|||
144723550|NCT04634409|521842390|FG007|Overall Study|Lost to Follow-up|3|||
144723551|NCT04634409|521842391|FG008|Overall Study|Lost to Follow-up|3|||
144723552|NCT04634409|521842392|FG009|Overall Study|Lost to Follow-up|11|||
144723553|NCT04634409|521842393|FG010|Overall Study|Lost to Follow-up|8|||
144723554|NCT04634409|521842394|FG011|Overall Study|Lost to Follow-up|15|||
144723555|NCT04634409|521842395|FG012|Overall Study|Lost to Follow-up|3|||
144723556|NCT04634409|521842396|FG013|Overall Study|Lost to Follow-up|2|||
144723557|NCT04634409|521842397|FG014|Overall Study|Lost to Follow-up|7|||
144723558|NCT04634409|521842398|FG015|Overall Study|Lost to Follow-up|0|||
144183106|NCT00880334|519865712|FG001|Randomized Phase|Inadequate Labs|1|||
144183107|NCT00880334|519865711|FG000|Randomized Phase|Brain Metastasis|0|||
144723559|NCT04634409|521842399|FG016|Overall Study|Lost to Follow-up|0|||
144723560|NCT04634409|521842400|FG017|Overall Study|Lost to Follow-up|0|||
144723561|NCT04634409|521842401|FG018|Overall Study|Lost to Follow-up|0|||
144428456|NCT04762680|520777720|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428457|NCT04762680|520777721|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428458|NCT04762680|520777722|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428459|NCT04762680|520777723|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428460|NCT04762680|520777724|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
144428461|NCT04762680|520777725|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428462|NCT04762680|520777726|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
144428463|NCT04307446|520777729|FG000|Overall Study|Lost to Follow-up|2|||
144428464|NCT04307446|520777730|FG001|Overall Study|Lost to Follow-up|0|||
144428465|NCT00697515|520777734|FG000|Dose Optimization Period|Adverse Event|4|||
144428466|NCT00697515|520777735|FG001|Dose Optimization Period|Adverse Event|0|||
144428467|NCT00697515|520777734|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
144428468|NCT00697515|520777735|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
144428469|NCT00697515|520777734|FG000|Dose Optimization Period|Lost to Follow-up|2|||
144428470|NCT00697515|520777735|FG001|Dose Optimization Period|Lost to Follow-up|0|||
144428471|NCT00697515|520777734|FG000|Dose Optimization Period|sponsor request|2|||
144723562|NCT04634409|521842402|FG019|Overall Study|Lost to Follow-up|0|||
144723563|NCT04634409|521842403|FG020|Overall Study|Lost to Follow-up|0|||
144723564|NCT04634409|521842404|FG021|Overall Study|Lost to Follow-up|0|||
144183108|NCT00880334|519865712|FG001|Randomized Phase|Brain Metastasis|1|||
144183109|NCT00880334|519865711|FG000|Randomized Phase|Crossover Participants|0|||
144183110|NCT00880334|519865712|FG001|Randomized Phase|Crossover Participants|37|||
144183111|NCT03343639|519865713|FG000|Overall Study|Withdrawal by Subject|10|||
144183112|NCT03343639|519865714|FG001|Overall Study|Withdrawal by Subject|6|||
144183113|NCT03343639|519865713|FG000|Overall Study|Lost to Follow-up|4|||
144428472|NCT00697515|520777735|FG001|Dose Optimization Period|sponsor request|0|||
144723565|NCT04634409|521842405|FG022|Overall Study|Lost to Follow-up|0|||
144723566|NCT04634409|521842406|FG023|Overall Study|Lost to Follow-up|0|||
144183114|NCT03343639|519865714|FG001|Overall Study|Lost to Follow-up|5|||
144723567|NCT04634409|521842407|FG024|Overall Study|Lost to Follow-up|0|||
144183115|NCT03343639|519865713|FG000|Overall Study|Protocol Violation|0|||
144183116|NCT03343639|519865714|FG001|Overall Study|Protocol Violation|1|||
144183117|NCT02473393|519865715|FG000|Overall Study|Adverse Event|0|||
144723568|NCT04634409|521842408|FG025|Overall Study|Lost to Follow-up|0|||
144723569|NCT04634409|521842409|FG026|Overall Study|Lost to Follow-up|0|||
144428473|NCT00697515|520777734|FG000|Dose Optimization Period|called to active duty|1|||
144723570|NCT04634409|521842383|FG000|Overall Study|Withdrawal by Subject|3|||
144723571|NCT04634409|521842384|FG001|Overall Study|Withdrawal by Subject|1|||
144723572|NCT04634409|521842385|FG002|Overall Study|Withdrawal by Subject|6|||
144183118|NCT02473393|519865716|FG001|Overall Study|Adverse Event|0|||
144428474|NCT00697515|520777735|FG001|Dose Optimization Period|called to active duty|0|||
144428475|NCT00697515|520777734|FG000|Dose Optimization Period|elevated QTc|1|||
144428476|NCT00697515|520777735|FG001|Dose Optimization Period|elevated QTc|0|||
144428477|NCT00697515|520777734|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
144428478|NCT00697515|520777735|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
144428479|NCT00697515|520777734|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
144428480|NCT00697515|520777735|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
144428481|NCT00697515|520777734|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
144428482|NCT00697515|520777735|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
144428483|NCT00697515|520777734|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
144428484|NCT00697515|520777735|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
144428485|NCT02603432|520777736|FG000|Overall Study|Adverse Event|1|||
144428486|NCT02603432|520777737|FG001|Overall Study|Adverse Event|0|||
144428487|NCT02603432|520777736|FG000|Overall Study|Death|221|||
144428488|NCT02603432|520777737|FG001|Overall Study|Death|242|||
144428489|NCT02603432|520777736|FG000|Overall Study|Lost to Follow-up|3|||
144428490|NCT02603432|520777737|FG001|Overall Study|Lost to Follow-up|9|||
144428491|NCT02603432|520777736|FG000|Overall Study|Progressive Disease|7|||
144428492|NCT02603432|520777737|FG001|Overall Study|Progressive Disease|5|||
144428493|NCT02603432|520777736|FG000|Overall Study|Withdrawal by Subject|12|||
144428494|NCT02603432|520777737|FG001|Overall Study|Withdrawal by Subject|18|||
144428495|NCT02603432|520777736|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
144428496|NCT02603432|520777737|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144428497|NCT02603432|520777736|FG000|Overall Study|Study terminated by sponsor|74|||
144428498|NCT02603432|520777737|FG001|Overall Study|Study terminated by sponsor|75|||
144428499|NCT02603432|520777736|FG000|Overall Study|Other|13|||
144428500|NCT02603432|520777737|FG001|Overall Study|Other|0|||
144428501|NCT00581776|520777738|FG000|Overall Study|Disease progression or no response|3|||
144428502|NCT02063854|520777742|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
144428503|NCT02063854|520777743|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
144428504|NCT02063854|520777744|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
144428505|NCT02063854|520777745|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
144528920|NCT02240238|521139159|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
144528921|NCT02240238|521139148|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528922|NCT02240238|521139149|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528923|NCT02240238|521139150|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528924|NCT02240238|521139151|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528925|NCT02240238|521139152|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528926|NCT02240238|521139153|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528927|NCT02240238|521139154|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528928|NCT02240238|521139155|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528929|NCT02240238|521139156|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528930|NCT02240238|521139157|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
144528931|NCT02240238|521139158|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144183119|NCT02473393|519865717|FG002|Overall Study|Adverse Event|1|||
144183120|NCT02473393|519865718|FG003|Overall Study|Adverse Event|0|||
144183121|NCT02473393|519865715|FG000|Overall Study|Withdrawal by Subject|0|||
144428506|NCT02063854|520777746|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
144428507|NCT02063854|520777747|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
144428508|NCT02063854|520777748|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
144428509|NCT02063854|520777742|FG000|Overall Study|Major Protocol Deviation|0|||
144428510|NCT02063854|520777743|FG001|Overall Study|Major Protocol Deviation|0|||
144428511|NCT02063854|520777744|FG002|Overall Study|Major Protocol Deviation|3|||
144428512|NCT02063854|520777745|FG003|Overall Study|Major Protocol Deviation|0|||
144428513|NCT02063854|520777746|FG004|Overall Study|Major Protocol Deviation|0|||
144428514|NCT02063854|520777747|FG005|Overall Study|Major Protocol Deviation|0|||
144428515|NCT02063854|520777748|FG006|Overall Study|Major Protocol Deviation|0|||
144428516|NCT02063854|520777742|FG000|Overall Study|Voluntary Withdrawal|2|||
144428517|NCT02063854|520777743|FG001|Overall Study|Voluntary Withdrawal|0|||
144428518|NCT02063854|520777744|FG002|Overall Study|Voluntary Withdrawal|8|||
144428519|NCT02063854|520777745|FG003|Overall Study|Voluntary Withdrawal|1|||
144428520|NCT02063854|520777746|FG004|Overall Study|Voluntary Withdrawal|3|||
144428521|NCT02063854|520777747|FG005|Overall Study|Voluntary Withdrawal|6|||
144428522|NCT02063854|520777748|FG006|Overall Study|Voluntary Withdrawal|1|||
144183122|NCT02473393|519865716|FG001|Overall Study|Withdrawal by Subject|0|||
144428523|NCT02063854|520777742|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
144428524|NCT02063854|520777743|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
144428525|NCT02063854|520777744|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
144428526|NCT02063854|520777745|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
144428527|NCT02063854|520777746|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
144428528|NCT02063854|520777747|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
144428529|NCT02063854|520777748|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
144428530|NCT02063854|520777742|FG000|Overall Study|Reason Not Specified|1|||
144428531|NCT02063854|520777743|FG001|Overall Study|Reason Not Specified|0|||
144428532|NCT02063854|520777744|FG002|Overall Study|Reason Not Specified|0|||
144183123|NCT02473393|519865717|FG002|Overall Study|Withdrawal by Subject|1|||
144183124|NCT02473393|519865718|FG003|Overall Study|Withdrawal by Subject|1|||
144183125|NCT02460835|519865721|FG000|Overall Study|Disease progression prior to treatment|3|||
144183126|NCT02460835|519865721|FG000|Overall Study|Unable to complete planning scans|2|||
144183127|NCT02460835|519865721|FG000|Overall Study|Decrease in performance status|1|||
144183128|NCT02460835|519865721|FG000|Overall Study|Withdrawal by Subject|3|||
144183129|NCT02460835|519865721|FG000|Overall Study|Underwent fractionated RT|10|||
144183130|NCT02460835|519865721|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
144183131|NCT01157234|519865722|FG000|Overall Study|Withdrawal by Subject|1|||
144183132|NCT01157234|519865723|FG001|Overall Study|Withdrawal by Subject|0|||
144183133|NCT00668395|519865741|FG000|Overall Study|Withdrawal by Subject|4|||
144183134|NCT00668395|519865742|FG001|Overall Study|Withdrawal by Subject|4|||
144183135|NCT00668395|519865743|FG002|Overall Study|Withdrawal by Subject|1|||
144183136|NCT00668395|519865741|FG000|Overall Study|Adverse Event|1|||
144183137|NCT00668395|519865742|FG001|Overall Study|Adverse Event|1|||
144183138|NCT00668395|519865743|FG002|Overall Study|Adverse Event|0|||
144183139|NCT00668395|519865741|FG000|Overall Study|Physician Decision|1|||
144183140|NCT00668395|519865742|FG001|Overall Study|Physician Decision|1|||
144183141|NCT00668395|519865743|FG002|Overall Study|Physician Decision|0|||
144183142|NCT00697827|519865744|FG000|Overall Study|enrolled but not treated|2|||
144183143|NCT00697827|519865745|FG001|Overall Study|enrolled but not treated|1|||
144183144|NCT00550147|519865746|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
144183145|NCT00550147|519865746|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
144183146|NCT00550147|519865746|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
144183147|NCT00550147|519865746|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
144183148|NCT00550147|519865746|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
144183149|NCT00046839|519865747|FG000|Overall Study|Ineligible / No protocol treatment|0|||
144183150|NCT00046839|519865748|FG001|Overall Study|Ineligible / No protocol treatment|2|||
144183151|NCT00046839|519865747|FG000|Overall Study|Withdrawal of consent|1|||
144183152|NCT00046839|519865748|FG001|Overall Study|Withdrawal of consent|0|||
144183153|NCT01211262|519865749|FG000|Overall Study|Progressive Disease|18|||
144183154|NCT01211262|519865750|FG001|Overall Study|Progressive Disease|9|||
144183155|NCT01211262|519865749|FG000|Overall Study|Adverse Event|4|||
144183156|NCT01211262|519865750|FG001|Overall Study|Adverse Event|0|||
144183157|NCT01211262|519865749|FG000|Overall Study|Withdrawal of Consent|1|||
144183158|NCT01211262|519865750|FG001|Overall Study|Withdrawal of Consent|0|||
144183159|NCT01211262|519865749|FG000|Overall Study|Other|0|||
144183160|NCT01211262|519865750|FG001|Overall Study|Other|1|||
144183161|NCT01963260|519865751|FG000|Overall Study|Withdrawal by Subject|2|||
144183162|NCT01963260|519865752|FG001|Overall Study|Withdrawal by Subject|0|||
144183163|NCT01963260|519865753|FG002|Overall Study|Withdrawal by Subject|0|||
144183164|NCT01963260|519865754|FG003|Overall Study|Withdrawal by Subject|1|||
144428533|NCT02063854|520777745|FG003|Overall Study|Reason Not Specified|0|||
144428534|NCT02063854|520777746|FG004|Overall Study|Reason Not Specified|0|||
144428535|NCT02063854|520777747|FG005|Overall Study|Reason Not Specified|0|||
144428536|NCT02063854|520777748|FG006|Overall Study|Reason Not Specified|0|||
144428537|NCT02063854|520777742|FG000|Overall Study|Did Not Receive Study Drug|0|||
144428538|NCT02063854|520777743|FG001|Overall Study|Did Not Receive Study Drug|0|||
144528932|NCT02240238|521139159|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
144528933|NCT02240238|521139148|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528934|NCT02240238|521139149|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528935|NCT02240238|521139150|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528936|NCT02240238|521139151|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528937|NCT02240238|521139152|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144183165|NCT01963260|519865755|FG004|Overall Study|Withdrawal by Subject|2|||
144428539|NCT02063854|520777744|FG002|Overall Study|Did Not Receive Study Drug|0|||
144183166|NCT01963260|519865756|FG005|Overall Study|Withdrawal by Subject|0|||
144183167|NCT01963260|519865757|FG006|Overall Study|Withdrawal by Subject|0|||
144183168|NCT01963260|519865758|FG007|Overall Study|Withdrawal by Subject|0|||
144183169|NCT01963260|519865759|FG008|Overall Study|Withdrawal by Subject|0|||
144183170|NCT01963260|519865760|FG009|Overall Study|Withdrawal by Subject|0|||
144183171|NCT00160524|519865761|FG000|Overall Study|Adverse Event|119|||
144183172|NCT00160524|519865761|FG000|Overall Study|Adverse Event and Other|94|||
144428540|NCT02063854|520777745|FG003|Overall Study|Did Not Receive Study Drug|0|||
144428541|NCT02063854|520777746|FG004|Overall Study|Did Not Receive Study Drug|0|||
144538440|NCT01500200|521174195|FG000|Stage 1|Adverse Event|1|||
144183173|NCT00160524|519865761|FG000|Overall Study|Protocol Violation|16|||
144183174|NCT00160524|519865761|FG000|Overall Study|Protocol Violation and Other|2|||
144183175|NCT00160524|519865761|FG000|Overall Study|Withdrawal by Subject|141|||
144183176|NCT00160524|519865761|FG000|Overall Study|Withdrawal by Subject and Other|17|||
144183177|NCT00160524|519865761|FG000|Overall Study|Physician Decision|27|||
144428542|NCT02063854|520777747|FG005|Overall Study|Did Not Receive Study Drug|1|||
144428543|NCT02063854|520777748|FG006|Overall Study|Did Not Receive Study Drug|0|||
144428544|NCT02255981|520777751|FG000|Overall Study|Lost to Follow-up|3|||
144428545|NCT02255981|520777751|FG000|Overall Study|Withdrawal by Subject|1|||
144428546|NCT01046682|520777752|FG000|Overall Study|Adverse Event|2|||
144428547|NCT01046682|520777753|FG001|Overall Study|Adverse Event|0|||
144428548|NCT03425331|520777758|FG000|Overall Study|Withdrawal by Subject|1|||
144428549|NCT03425331|520777758|FG000|Overall Study|Death|1|||
144428550|NCT03425331|520777758|FG000|Overall Study|Adverse Event|1|||
144428551|NCT03425331|520777758|FG000|Overall Study|Disease Progression|2|||
144428552|NCT01413360|520777759|FG000|Overall Study|Lost to Follow-up|2|||
144428553|NCT01413360|520777759|FG000|Overall Study|Adverse Event|1|||
144428554|NCT02418468|520777760|FG000|Overall Study|Adverse Event|1|||
144428555|NCT02418468|520777761|FG001|Overall Study|Adverse Event|0|||
144428556|NCT02418468|520777760|FG000|Overall Study|Withdrawal of informed consent|1|||
144428557|NCT02418468|520777761|FG001|Overall Study|Withdrawal of informed consent|1|||
144428558|NCT04356963|520777765|FG000|First Session|Withdrawal by Subject|1|||
144428559|NCT04356963|520777765|FG000|Second Session|Withdrawal by Subject|3|||
144428560|NCT04356963|520777765|FG000|Second Session|Lost to Follow-up|1|||
144428561|NCT04356963|520777765|FG000|Third Session|Lost to Follow-up|6|||
144428562|NCT04356963|520777765|FG000|Third Session|Withdrawal by Subject|1|||
144428563|NCT00949325|520777766|FG000|Overall Study|Adverse Event|0|||
144428564|NCT00949325|520777767|FG001|Overall Study|Adverse Event|2|||
144428565|NCT00949325|520777768|FG002|Overall Study|Adverse Event|0|||
144428566|NCT05533632|520777769|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
144428567|NCT05533632|520777769|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
144428568|NCT05533632|520777769|FG000|Overall Study|Lost to Follow-up|1|||
144428569|NCT05533632|520777769|FG000|Overall Study|Withdrawal by Subject|4|||
144428570|NCT05533632|520777769|FG000|Overall Study|Adverse Event|4|||
144428571|NCT00643682|520777773|FG000|Overall Study|did not keep appointment|522|||
144428572|NCT00643682|520777774|FG001|Overall Study|did not keep appointment|509|||
144428573|NCT03755414|520777775|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
144428574|NCT03755414|520777776|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
144428575|NCT03755414|520777777|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
144428576|NCT03755414|520777775|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
144428577|NCT03755414|520777776|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
144428578|NCT03755414|520777777|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
144428579|NCT03755414|520777775|FG000|Overall Study|Non-compliance|0|||
144428580|NCT03755414|520777776|FG001|Overall Study|Non-compliance|1|||
144428581|NCT03755414|520777777|FG002|Overall Study|Non-compliance|0|||
144428582|NCT02153112|520777778|FG000|Overall Study|Adverse Event|0|||
144428583|NCT02153112|520777779|FG001|Overall Study|Adverse Event|0|||
144428584|NCT02153112|520777780|FG002|Overall Study|Adverse Event|1|||
144428585|NCT02153112|520777781|FG003|Overall Study|Adverse Event|0|||
144428586|NCT02153112|520777782|FG004|Overall Study|Adverse Event|0|||
144428587|NCT02153112|520777783|FG005|Overall Study|Adverse Event|0|||
144428588|NCT02153112|520777784|FG006|Overall Study|Adverse Event|0|||
144428589|NCT02153112|520777785|FG007|Overall Study|Adverse Event|0|||
144428590|NCT02153112|520777786|FG008|Overall Study|Adverse Event|0|||
144428591|NCT02153112|520777787|FG009|Overall Study|Adverse Event|0|||
144428592|NCT02153112|520777778|FG000|Overall Study|Lost to Follow-up|1|||
144428593|NCT02153112|520777779|FG001|Overall Study|Lost to Follow-up|1|||
144183178|NCT00160524|519865761|FG000|Overall Study|Physician Decision and Other|6|||
144183179|NCT00160524|519865761|FG000|Overall Study|Lost to Follow-up|13|||
144183180|NCT00160524|519865761|FG000|Overall Study|Lost to Follow-up and Other|1|||
144251958|NCT04571385|520122588|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
144428594|NCT02153112|520777780|FG002|Overall Study|Lost to Follow-up|0|||
144428595|NCT02153112|520777781|FG003|Overall Study|Lost to Follow-up|0|||
144428596|NCT02153112|520777782|FG004|Overall Study|Lost to Follow-up|2|||
144428597|NCT02153112|520777783|FG005|Overall Study|Lost to Follow-up|1|||
144183181|NCT00160524|519865761|FG000|Overall Study|Lack of Efficacy|21|||
144183182|NCT00160524|519865761|FG000|Overall Study|Lack of Efficacy and Other|1|||
144428598|NCT02153112|520777784|FG006|Overall Study|Lost to Follow-up|1|||
144428599|NCT02153112|520777785|FG007|Overall Study|Lost to Follow-up|0|||
144428600|NCT02153112|520777786|FG008|Overall Study|Lost to Follow-up|1|||
144428601|NCT02153112|520777787|FG009|Overall Study|Lost to Follow-up|1|||
144428602|NCT02153112|520777778|FG000|Overall Study|Withdrawal by Subject|3|||
144428603|NCT02153112|520777779|FG001|Overall Study|Withdrawal by Subject|1|||
144428604|NCT02153112|520777780|FG002|Overall Study|Withdrawal by Subject|2|||
144428605|NCT02153112|520777781|FG003|Overall Study|Withdrawal by Subject|2|||
144183183|NCT00160524|519865761|FG000|Overall Study|Other|20|||
144183184|NCT01547728|519865762|FG000|Overall Study|Change in procedure and equipment|1|||
144183185|NCT01547728|519865762|FG000|Overall Study|Drug not ready for subject|1|||
144183186|NCT01547728|519865762|FG000|Overall Study|Screen failure|39|||
144183187|NCT02151149|519865763|FG000|Treatment Period|Death|2|||
144183188|NCT02151149|519865764|FG001|Treatment Period|Death|3|||
144183189|NCT02151149|519865763|FG000|Treatment Period|Adverse Event|17|||
144183190|NCT02151149|519865764|FG001|Treatment Period|Adverse Event|14|||
144183191|NCT02151149|519865763|FG000|Treatment Period|Progressive Disease|25|||
144183192|NCT02151149|519865764|FG001|Treatment Period|Progressive Disease|24|||
144183193|NCT02151149|519865763|FG000|Treatment Period|Symptomatic Deterioration|2|||
144183194|NCT02151149|519865764|FG001|Treatment Period|Symptomatic Deterioration|10|||
144183195|NCT02151149|519865763|FG000|Treatment Period|Withdrawal by Subject|13|||
144183196|NCT02151149|519865764|FG001|Treatment Period|Withdrawal by Subject|11|||
144183197|NCT02151149|519865763|FG000|Treatment Period|Miscellaneous|8|||
144183198|NCT02151149|519865764|FG001|Treatment Period|Miscellaneous|7|||
144183199|NCT02151149|519865763|FG000|Treatment Period|Participants randomized but not treated|3|||
144183200|NCT02151149|519865764|FG001|Treatment Period|Participants randomized but not treated|2|||
144183201|NCT02151149|519865763|FG000|Follow-Up Period|Lost to Follow-up|2|||
144428606|NCT02153112|520777782|FG004|Overall Study|Withdrawal by Subject|1|||
144428607|NCT02153112|520777783|FG005|Overall Study|Withdrawal by Subject|1|||
144428608|NCT02153112|520777784|FG006|Overall Study|Withdrawal by Subject|7|||
144428609|NCT02153112|520777785|FG007|Overall Study|Withdrawal by Subject|2|||
144428610|NCT02153112|520777786|FG008|Overall Study|Withdrawal by Subject|13|||
144428611|NCT02153112|520777787|FG009|Overall Study|Withdrawal by Subject|12|||
144428612|NCT02153112|520777778|FG000|Overall Study|Reason not Specified|0|||
144428613|NCT02153112|520777779|FG001|Overall Study|Reason not Specified|0|||
144428614|NCT02153112|520777780|FG002|Overall Study|Reason not Specified|0|||
144428615|NCT02153112|520777781|FG003|Overall Study|Reason not Specified|0|||
144428616|NCT02153112|520777782|FG004|Overall Study|Reason not Specified|0|||
144428617|NCT02153112|520777783|FG005|Overall Study|Reason not Specified|0|||
144428618|NCT02153112|520777784|FG006|Overall Study|Reason not Specified|0|||
144428619|NCT02153112|520777785|FG007|Overall Study|Reason not Specified|0|||
144428620|NCT02153112|520777786|FG008|Overall Study|Reason not Specified|1|||
144428621|NCT02153112|520777787|FG009|Overall Study|Reason not Specified|1|||
144428622|NCT00003641|520777788|FG000|Overall Study|Withdrawal by Subject|0|||
144428623|NCT00003641|520777789|FG001|Overall Study|Withdrawal by Subject|100|||
144428624|NCT00003641|520777788|FG000|Overall Study|Adverse Event|0|||
144428625|NCT00003641|520777789|FG001|Overall Study|Adverse Event|38|||
144428626|NCT00003641|520777788|FG000|Overall Study|Disease progression|0|||
144428627|NCT00003641|520777789|FG001|Overall Study|Disease progression|2|||
144428628|NCT00003641|520777788|FG000|Overall Study|Unknown/missing|0|||
144428629|NCT00003641|520777789|FG001|Overall Study|Unknown/missing|22|||
144428630|NCT00003641|520777788|FG000|Overall Study|Should not receive interferon therapy|2|||
144428631|NCT00003641|520777789|FG001|Overall Study|Should not receive interferon therapy|0|||
144428632|NCT00003641|520777788|FG000|Overall Study|Never started interferon|567|||
144428633|NCT00003641|520777789|FG001|Overall Study|Never started interferon|12|||
144528938|NCT02240238|521139153|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528939|NCT02240238|521139154|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528940|NCT02240238|521139155|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528941|NCT02240238|521139156|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528942|NCT02240238|521139157|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528943|NCT02240238|521139158|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
144528944|NCT02240238|521139159|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
144528945|NCT02240238|521139148|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528946|NCT02240238|521139149|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528947|NCT02240238|521139150|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528948|NCT02240238|521139151|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528949|NCT02240238|521139152|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528950|NCT02240238|521139153|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528951|NCT02240238|521139154|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528952|NCT02240238|521139155|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528953|NCT02240238|521139156|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528954|NCT02240238|521139157|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144528955|NCT02240238|521139158|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
144528956|NCT02240238|521139159|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
144428634|NCT02068222|520777795|FG000|Overall Study|Lost to Follow-up|1|||
144428635|NCT00281684|520777798|FG000|Overall Study|Lost to Follow-up|0|||
144428636|NCT00281684|520777799|FG001|Overall Study|Lost to Follow-up|0|||
144428637|NCT00281684|520777800|FG002|Overall Study|Lost to Follow-up|1|||
144428638|NCT00281684|520777801|FG003|Overall Study|Lost to Follow-up|0|||
144428639|NCT00281684|520777798|FG000|Overall Study|Withdrawal by Subject|1|||
144428640|NCT00281684|520777799|FG001|Overall Study|Withdrawal by Subject|0|||
144528957|NCT02240238|521139148|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528958|NCT02240238|521139149|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144428641|NCT00281684|520777800|FG002|Overall Study|Withdrawal by Subject|0|||
144428642|NCT00281684|520777801|FG003|Overall Study|Withdrawal by Subject|0|||
144428643|NCT03642717|520777804|FG000|Overall Study|Lost to Follow-up|2|||
144428644|NCT03642717|520777804|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
144428645|NCT03642717|520777804|FG000|Overall Study|Taken study drug prior to contract date|3|||
144428646|NCT01559012|520777805|FG000|Overall Study|Withdrawal by Subject|0|||
144428647|NCT01559012|520777806|FG001|Overall Study|Withdrawal by Subject|1|||
144428648|NCT00302458|520777807|FG000|Overall Study|Lost to Follow-up|1|||
144428649|NCT00302458|520777807|FG000|Overall Study|Ineligible after screening|1|||
144428650|NCT00302458|520777807|FG000|Overall Study|Withdrawal by Subject|1|||
144428651|NCT00946712|520777810|FG000|Overall Study|Adverse Event|118|||
144428652|NCT00946712|520777811|FG001|Overall Study|Adverse Event|124|||
144428653|NCT00946712|520777810|FG000|Overall Study|Disease progression|308|||
144428654|NCT00946712|520777811|FG001|Overall Study|Disease progression|404|||
144428655|NCT00946712|520777810|FG000|Overall Study|Death|21|||
144428656|NCT00946712|520777811|FG001|Overall Study|Death|22|||
144428657|NCT00946712|520777810|FG000|Overall Study|No treatment given|25|||
144428658|NCT00946712|520777811|FG001|Overall Study|No treatment given|29|||
144428659|NCT00946712|520777810|FG000|Overall Study|Other reasons|61|||
144428660|NCT00946712|520777811|FG001|Overall Study|Other reasons|73|||
144428661|NCT00946712|520777810|FG000|Overall Study|On Treatment|0|||
144428662|NCT00946712|520777811|FG001|Overall Study|On Treatment|4|||
144428663|NCT00946712|520777810|FG000|Overall Study|Ineligible|14|||
144428664|NCT00946712|520777811|FG001|Overall Study|Ineligible|6|||
144428665|NCT00853723|520777813|FG000|Overall Study|Adverse Event|3|||
144428666|NCT00853723|520777814|FG001|Overall Study|Adverse Event|4|||
144428667|NCT00853723|520777815|FG002|Overall Study|Adverse Event|1|||
144428668|NCT00853723|520777813|FG000|Overall Study|Withdrawal by Subject|2|||
144428669|NCT00853723|520777814|FG001|Overall Study|Withdrawal by Subject|1|||
144428670|NCT00853723|520777815|FG002|Overall Study|Withdrawal by Subject|0|||
144428671|NCT00853723|520777813|FG000|Overall Study|Protocol Violation|1|||
144428672|NCT00853723|520777814|FG001|Overall Study|Protocol Violation|2|||
144428673|NCT00853723|520777815|FG002|Overall Study|Protocol Violation|1|||
144428674|NCT00445965|520777816|FG000|Overall Study|Adverse Event|2|||
144428675|NCT00445965|520777816|FG000|Overall Study|Physician Decision|1|||
144428676|NCT00445965|520777816|FG000|Overall Study|Enrolled but not treated|1|||
144428677|NCT00445965|520777816|FG000|Overall Study|Removed due to progressive disease|29|||
144428678|NCT02867709|520777817|FG000|Treatment Period|Adverse Event|1|||
144428679|NCT02867709|520777818|FG001|Treatment Period|Adverse Event|1|||
144428680|NCT02867709|520777819|FG002|Treatment Period|Adverse Event|2|||
144428681|NCT02867709|520777817|FG000|Treatment Period|Withdrawal of Consent|7|||
144428682|NCT02867709|520777818|FG001|Treatment Period|Withdrawal of Consent|9|||
144428683|NCT02867709|520777819|FG002|Treatment Period|Withdrawal of Consent|8|||
144428684|NCT02867709|520777817|FG000|Treatment Period|Lost to Follow-up|17|||
144428685|NCT02867709|520777818|FG001|Treatment Period|Lost to Follow-up|20|||
144428686|NCT02867709|520777819|FG002|Treatment Period|Lost to Follow-up|20|||
144428687|NCT02867709|520777817|FG000|Treatment Period|Lack of Qualifying Event|42|||
144428688|NCT02867709|520777818|FG001|Treatment Period|Lack of Qualifying Event|55|||
144428689|NCT02867709|520777819|FG002|Treatment Period|Lack of Qualifying Event|42|||
144428690|NCT02867709|520777817|FG000|Treatment Period|Protocol Violation|3|||
144428691|NCT02867709|520777818|FG001|Treatment Period|Protocol Violation|2|||
144428692|NCT02867709|520777819|FG002|Treatment Period|Protocol Violation|3|||
144428693|NCT02867709|520777817|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
144428694|NCT02867709|520777818|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
144428695|NCT02867709|520777819|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
144428696|NCT02867709|520777817|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
144428697|NCT02867709|520777818|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
144428698|NCT02867709|520777819|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
144428699|NCT02867709|520777817|FG000|Safety Follow-up Period|Pregnancy|0|||
144428700|NCT02867709|520777818|FG001|Safety Follow-up Period|Pregnancy|1|||
144428701|NCT02867709|520777819|FG002|Safety Follow-up Period|Pregnancy|0|||
144428702|NCT02867709|520777817|FG000|Safety Follow-up Period|Protocol Violation|0|||
144428703|NCT02867709|520777818|FG001|Safety Follow-up Period|Protocol Violation|1|||
144428704|NCT02867709|520777819|FG002|Safety Follow-up Period|Protocol Violation|1|||
144428705|NCT04056195|520777820|FG000|Overall Study|Adverse Event|1|||
144428706|NCT04056195|520777821|FG001|Overall Study|Adverse Event|0|||
144428707|NCT04056195|520777822|FG002|Overall Study|Adverse Event|0|||
144428708|NCT04056195|520777820|FG000|Overall Study|Withdrawal by Subject|0|||
144428709|NCT04056195|520777821|FG001|Overall Study|Withdrawal by Subject|1|||
144428710|NCT04056195|520777822|FG002|Overall Study|Withdrawal by Subject|1|||
144428711|NCT04056195|520777820|FG000|Overall Study|Physician Decision|1|||
144428712|NCT04056195|520777821|FG001|Overall Study|Physician Decision|1|||
144428713|NCT04056195|520777822|FG002|Overall Study|Physician Decision|1|||
144428714|NCT05497284|520777823|FG000|Overall Study|Adverse Event|1|||
144428715|NCT05497284|520777824|FG001|Overall Study|Adverse Event|0|||
144428716|NCT05497284|520777823|FG000|Overall Study|Physician Decision|0|||
144428717|NCT05497284|520777824|FG001|Overall Study|Physician Decision|1|||
144428718|NCT05497284|520777823|FG000|Overall Study|Study terminated by sponsor|7|||
144251959|NCT04571385|520122589|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
144251960|NCT04571385|520122587|FG000|Overall Study|Screen failure|0|||
144251961|NCT04571385|520122588|FG001|Overall Study|Screen failure|0|||
144251962|NCT04571385|520122589|FG002|Overall Study|Screen failure|1|||
144251963|NCT01212159|520122591|FG000|Overall Study|Withdrawal by Subject|12|||
144251964|NCT01212159|520122592|FG001|Overall Study|Withdrawal by Subject|12|||
144251965|NCT04676152|520122593|FG000|Overall Study|screen fail|9|||
144251966|NCT01928199|520122594|FG000|Overall Study|Lost to Follow-up|2|||
144183202|NCT02151149|519865764|FG001|Follow-Up Period|Lost to Follow-up|3|||
144183203|NCT02151149|519865763|FG000|Follow-Up Period|Death|37|||
144183204|NCT02151149|519865764|FG001|Follow-Up Period|Death|34|||
144183205|NCT03950674|519865765|FG000|Overall Study|Death|16|||
144183206|NCT03950674|519865766|FG001|Overall Study|Death|15|||
144183207|NCT03950674|519865765|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
144251967|NCT01928199|520122595|FG001|Overall Study|Lost to Follow-up|1|||
144251968|NCT01928199|520122594|FG000|Overall Study|Withdrawal by Subject|3|||
144251969|NCT01928199|520122595|FG001|Overall Study|Withdrawal by Subject|5|||
144251970|NCT03300050|520122598|FG000|Overall Study|Lost to Follow-up|2|||
144251971|NCT03300050|520122599|FG001|Overall Study|Lost to Follow-up|1|||
144251972|NCT03300050|520122600|FG002|Overall Study|Lost to Follow-up|0|||
144251973|NCT03300050|520122601|FG003|Overall Study|Lost to Follow-up|0|||
144251974|NCT03300050|520122602|FG004|Overall Study|Lost to Follow-up|1|||
144251975|NCT03300050|520122598|FG000|Overall Study|Withdrawal by Subject|1|||
144251976|NCT03300050|520122599|FG001|Overall Study|Withdrawal by Subject|1|||
144251977|NCT03300050|520122600|FG002|Overall Study|Withdrawal by Subject|1|||
144251978|NCT03300050|520122601|FG003|Overall Study|Withdrawal by Subject|0|||
144251979|NCT03300050|520122602|FG004|Overall Study|Withdrawal by Subject|0|||
144251980|NCT03300050|520122598|FG000|Overall Study|Death|0|||
144251981|NCT03300050|520122599|FG001|Overall Study|Death|0|||
144251982|NCT03300050|520122600|FG002|Overall Study|Death|1|||
144251983|NCT03300050|520122601|FG003|Overall Study|Death|0|||
144251984|NCT03300050|520122602|FG004|Overall Study|Death|0|||
144251985|NCT03300050|520122598|FG000|Overall Study|Not Eligible at Randomization|0|||
144251986|NCT03300050|520122599|FG001|Overall Study|Not Eligible at Randomization|0|||
144603707|NCT01505010|521411990|FG001|Overall Study|Lost to Follow-up|1|||
144603708|NCT01006265|521411999|FG000|Overall Study|Lost to Follow-up|1|||
144603709|NCT01006265|521412000|FG001|Overall Study|Lost to Follow-up|0|||
144603710|NCT01006265|521412001|FG002|Overall Study|Lost to Follow-up|1|||
144183208|NCT03950674|519865766|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
144183209|NCT02224053|519865769|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
144183210|NCT02224053|519865769|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
144183211|NCT02224053|519865769|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
144183212|NCT02224053|519865769|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
144183213|NCT02224053|519865769|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
144183214|NCT01499160|519865771|FG000|Overall Study|Adverse Event|1|||
144183215|NCT01499160|519865771|FG000|Overall Study|Withdrawal by Subject|1|||
144183216|NCT03448692|519865772|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
144183217|NCT03448692|519865773|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
144183218|NCT03448692|519865772|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
144183219|NCT03448692|519865773|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
144183220|NCT03448692|519865772|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
144183221|NCT03448692|519865773|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
144183222|NCT03448692|519865772|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
144183223|NCT03448692|519865773|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
144183224|NCT03448692|519865772|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
144603711|NCT01006265|521412002|FG003|Overall Study|Lost to Follow-up|0|||
144603712|NCT01006265|521411999|FG000|Overall Study|Withdrawal by Subject|4|||
144603713|NCT01006265|521412000|FG001|Overall Study|Withdrawal by Subject|7|||
144603714|NCT01006265|521412001|FG002|Overall Study|Withdrawal by Subject|5|||
144603715|NCT01006265|521412002|FG003|Overall Study|Withdrawal by Subject|5|||
144603716|NCT01006265|521411999|FG000|Overall Study|Administrative reason|1|||
144603717|NCT01006265|521412000|FG001|Overall Study|Administrative reason|2|||
144183225|NCT03448692|519865773|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
144251987|NCT03300050|520122600|FG002|Overall Study|Not Eligible at Randomization|1|||
144428719|NCT05497284|520777824|FG001|Overall Study|Study terminated by sponsor|4|||
144603718|NCT01006265|521412001|FG002|Overall Study|Administrative reason|3|||
144603719|NCT01006265|521412002|FG003|Overall Study|Administrative reason|0|||
144603720|NCT02101021|521412006|FG000|Overall Study|Death|4|||
144251988|NCT03300050|520122601|FG003|Overall Study|Not Eligible at Randomization|1|||
144251989|NCT03300050|520122602|FG004|Overall Study|Not Eligible at Randomization|0|||
144251990|NCT02722746|520122604|FG000|Overall Study|Withdrawal by Subject|0|||
144251991|NCT02722746|520122605|FG001|Overall Study|Withdrawal by Subject|1|||
144603721|NCT02101021|521412007|FG001|Overall Study|Death|3|||
144603722|NCT02101021|521412008|FG002|Overall Study|Death|6|||
144428720|NCT05497284|520777823|FG000|Overall Study|Subject Decision|0|||
144428721|NCT05497284|520777824|FG001|Overall Study|Subject Decision|1|||
144428722|NCT05760300|520777825|FG000|Overall Study|Adverse Event|0|||
144428723|NCT05760300|520777826|FG001|Overall Study|Adverse Event|0|||
144428724|NCT05760300|520777827|FG002|Overall Study|Adverse Event|1|||
144428725|NCT05760300|520777828|FG003|Overall Study|Adverse Event|0|||
144428726|NCT05760300|520777825|FG000|Overall Study|Participant Decision|1|||
144428727|NCT05760300|520777826|FG001|Overall Study|Participant Decision|0|||
144428728|NCT05760300|520777827|FG002|Overall Study|Participant Decision|0|||
144428729|NCT05760300|520777828|FG003|Overall Study|Participant Decision|0|||
144428730|NCT03878446|520777829|FG000|Overall Study|Withdrawn by parent or guardian|1|||
144428731|NCT03878446|520777830|FG001|Overall Study|Withdrawn by parent or guardian|0|||
144428732|NCT03878446|520777831|FG002|Overall Study|Withdrawn by parent or guardian|0|||
144428733|NCT03878446|520777832|FG003|Overall Study|Withdrawn by parent or guardian|0|||
144428734|NCT03878446|520777833|FG004|Overall Study|Withdrawn by parent or guardian|0|||
144428735|NCT03615105|520777834|FG000|Overall Study|Protocol Violation|1|||
144428736|NCT03615105|520777835|FG001|Overall Study|Protocol Violation|0|||
144428737|NCT03615105|520777836|FG002|Overall Study|Protocol Violation|0|||
144428738|NCT03615105|520777834|FG000|Overall Study|Death|0|||
144428739|NCT03615105|520777835|FG001|Overall Study|Death|2|||
144428740|NCT03615105|520777836|FG002|Overall Study|Death|0|||
144428741|NCT03313804|520777837|FG000|Treatment|Death|5|||
144428742|NCT03313804|520777837|FG000|Treatment|still on treatment|2|||
144428743|NCT03313804|520777837|FG000|Follow Up|still on follow up|3|||
144428744|NCT01502423|520777838|FG000|Overall Study|Withdrawal by Subject|0|||
144428745|NCT01502423|520777839|FG001|Overall Study|Withdrawal by Subject|1|||
144428746|NCT03181399|520779112|FG000|6 Months on Treatment|Protocol non-compliance|7|||
144428747|NCT03181399|520779112|FG000|6 Months on Treatment|Adverse Event|4|||
144428748|NCT03181399|520779112|FG000|6 Months on Treatment|Tried alternative treatment|2|||
144428749|NCT03181399|520779112|FG000|6 Months on Treatment|Lost to Follow-up|2|||
144428750|NCT03181399|520779112|FG000|6 Months on Treatment|Personal reasons|1|||
144428751|NCT03181399|520779112|FG000|3 Months Off-treatment|Parent unable to travel|1|||
144428752|NCT01254227|520779115|FG000|Overall Study|Withdrawal by Subject|6|||
144428753|NCT01254227|520779115|FG000|Overall Study|Lost to Follow-up|6|||
144428754|NCT01254227|520779115|FG000|Overall Study|Adverse Event|5|||
144428755|NCT01254227|520779115|FG000|Overall Study|Abnormal test procedure result|5|||
144428756|NCT01254227|520779115|FG000|Overall Study|Administrative problems|2|||
144428757|NCT01254227|520779115|FG000|Overall Study|Death|1|||
144428758|NCT01254227|520779115|FG000|Overall Study|Protocol deviation|1|||
144428759|NCT03257631|520779117|FG000|Overall Study|Death|1|||
144428760|NCT03257631|520779118|FG001|Overall Study|Death|0|||
144428761|NCT03257631|520779119|FG002|Overall Study|Death|1|||
144428762|NCT03257631|520779120|FG003|Overall Study|Death|1|||
144428763|NCT03257631|520779117|FG000|Overall Study|Progressive Disease|10|||
144428764|NCT03257631|520779118|FG001|Overall Study|Progressive Disease|9|||
144428765|NCT03257631|520779119|FG002|Overall Study|Progressive Disease|17|||
144428766|NCT03257631|520779120|FG003|Overall Study|Progressive Disease|8|||
144428767|NCT03257631|520779117|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144428768|NCT03257631|520779118|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144428769|NCT03257631|520779119|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
144428770|NCT03257631|520779120|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
144428771|NCT03257631|520779117|FG000|Overall Study|Adverse Event|0|||
144428772|NCT03257631|520779118|FG001|Overall Study|Adverse Event|0|||
144428773|NCT03257631|520779119|FG002|Overall Study|Adverse Event|2|||
144428774|NCT03257631|520779120|FG003|Overall Study|Adverse Event|0|||
144428775|NCT01063764|520779121|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
144428776|NCT01063764|520779121|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
144528959|NCT02240238|521139150|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528960|NCT02240238|521139151|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528961|NCT02240238|521139152|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528962|NCT02240238|521139153|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528963|NCT02240238|521139154|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528964|NCT02240238|521139155|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528965|NCT02240238|521139156|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144723573|NCT04634409|521842386|FG003|Overall Study|Withdrawal by Subject|4|||
144428777|NCT01063764|520779121|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
144428778|NCT01063764|520779121|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
144428779|NCT01063764|520779121|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
144428780|NCT01063764|520779121|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
144428781|NCT01063764|520779121|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
144428782|NCT02436759|520779122|FG000|Overall Study|Adverse Event|3|||
144428783|NCT02436759|520779123|FG001|Overall Study|Adverse Event|0|||
144428784|NCT02436759|520779122|FG000|Overall Study|Protocol Violation|1|||
144428785|NCT02436759|520779123|FG001|Overall Study|Protocol Violation|0|||
144428786|NCT02436759|520779122|FG000|Overall Study|Withdrawal by Subject|0|||
144528966|NCT02240238|521139157|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144428787|NCT02436759|520779123|FG001|Overall Study|Withdrawal by Subject|1|||
144428788|NCT02529137|520779126|FG000|Overall Study|Discontinuation for different reasons|8|||
144428789|NCT00952341|520779130|FG000|Cycle 1|Adverse Event|4|||
144428790|NCT00952341|520779131|FG001|Cycle 1|Adverse Event|1|||
144428791|NCT00952341|520779130|FG000|Cycle 1|Withdrawal by Subject|3|||
144428792|NCT00952341|520779131|FG001|Cycle 1|Withdrawal by Subject|8|||
144428793|NCT00952341|520779130|FG000|Cycle 1|Protocol Violation|2|||
144428794|NCT00952341|520779131|FG001|Cycle 1|Protocol Violation|1|||
144428795|NCT00952341|520779130|FG000|Cycle 1|Lost to Follow-up|11|||
144428796|NCT00952341|520779131|FG001|Cycle 1|Lost to Follow-up|2|||
144428797|NCT00952341|520779130|FG000|Cycle 1|Physician Decision|0|||
144183226|NCT03428945|519865774|FG000|Overall Study|Lost to Follow-up|5|||
144183227|NCT03428945|519865775|FG001|Overall Study|Lost to Follow-up|3|||
144183228|NCT03428945|519865774|FG000|Overall Study|Withdrawal by Subject|10|||
144183229|NCT03428945|519865775|FG001|Overall Study|Withdrawal by Subject|10|||
144183230|NCT00982228|519865776|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
144183231|NCT00982228|519865777|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
144183232|NCT00982228|519865776|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
144183233|NCT00982228|519865777|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
144183234|NCT00982228|519865776|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
144183235|NCT00982228|519865777|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
144183236|NCT00982228|519865776|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
144183237|NCT00982228|519865777|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
144183238|NCT00982228|519865776|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
144183239|NCT00982228|519865777|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
144183240|NCT00982228|519865776|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
144183241|NCT00982228|519865777|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
144183242|NCT00982228|519865776|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
144183243|NCT00982228|519865777|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
144183244|NCT00982228|519865776|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
144428798|NCT00952341|520779131|FG001|Cycle 1|Physician Decision|1|||
144428799|NCT00952341|520779130|FG000|Cycle 2|Withdrawal by Subject|1|||
144428800|NCT00952341|520779131|FG001|Cycle 2|Withdrawal by Subject|1|||
144428801|NCT00952341|520779130|FG000|Cycle 2|Protocol Violation|1|||
144428802|NCT00952341|520779131|FG001|Cycle 2|Protocol Violation|0|||
144428803|NCT00952341|520779130|FG000|Cycle 2|Lost to Follow-up|6|||
144428804|NCT00952341|520779131|FG001|Cycle 2|Lost to Follow-up|9|||
144428805|NCT00952341|520779130|FG000|Cycle 2|Physician Decision|1|||
144428806|NCT00952341|520779131|FG001|Cycle 2|Physician Decision|1|||
144428807|NCT00952341|520779130|FG000|Cycle 2|Progressive Disease|0|||
144428808|NCT00952341|520779131|FG001|Cycle 2|Progressive Disease|1|||
144428809|NCT00297037|520779134|FG000|Overall Study|Withdrawal by Subject|2|||
144428810|NCT00297037|520779135|FG001|Overall Study|Withdrawal by Subject|0|||
144428811|NCT04461015|520779136|FG000|Overall Study|IV access lost during the study|0|||
144428812|NCT04461015|520779137|FG001|Overall Study|IV access lost during the study|1|||
144428813|NCT04461015|520779136|FG000|Overall Study|Withdrawal by Subject|0|||
144428814|NCT04461015|520779137|FG001|Overall Study|Withdrawal by Subject|1|||
144428815|NCT00930579|520779142|FG000|Overall Study|Withdrawal by Subject|1|||
144428816|NCT00930579|520779142|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
144428817|NCT02864251|520779146|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
144428818|NCT02864251|520779147|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
144428819|NCT02864251|520779148|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
144428820|NCT02864251|520779146|FG000|Pre-Treatment|Withdrawal by Participant|0|||
144428821|NCT02864251|520779147|FG001|Pre-Treatment|Withdrawal by Participant|0|||
144428822|NCT02864251|520779148|FG002|Pre-Treatment|Withdrawal by Participant|4|||
144183245|NCT00982228|519865777|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
144183246|NCT00982228|519865776|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
144183247|NCT00982228|519865777|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
144183248|NCT00982228|519865776|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
144183249|NCT00982228|519865777|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
144183250|NCT01438476|519865778|FG000|Overall Study|Protocol Violation|1|||
144183251|NCT01438476|519865779|FG001|Overall Study|Protocol Violation|0|||
144183252|NCT01438476|519865778|FG000|Overall Study|Withdrawal by Subject|1|||
144183253|NCT01438476|519865779|FG001|Overall Study|Withdrawal by Subject|0|||
144183254|NCT01438476|519865778|FG000|Overall Study|No Surgery- Disease|8|||
144183255|NCT01438476|519865779|FG001|Overall Study|No Surgery- Disease|10|||
144183256|NCT01438476|519865778|FG000|Overall Study|Communication barrier|0|||
144428823|NCT02864251|520779146|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
144428824|NCT02864251|520779147|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
144428825|NCT02864251|520779148|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
144428826|NCT02864251|520779146|FG000|Pre-Treatment|Other Reasons|0|||
144428827|NCT02864251|520779147|FG001|Pre-Treatment|Other Reasons|1|||
144428828|NCT02864251|520779148|FG002|Pre-Treatment|Other Reasons|1|||
144428829|NCT02864251|520779146|FG000|Treatment|Disease Progression|109|||
144428830|NCT02864251|520779147|FG001|Treatment|Disease Progression|52|||
144428831|NCT02864251|520779148|FG002|Treatment|Disease Progression|101|||
144428832|NCT02864251|520779146|FG000|Treatment|Study Drug Toxicity|9|||
144428833|NCT02864251|520779147|FG001|Treatment|Study Drug Toxicity|4|||
144428834|NCT02864251|520779148|FG002|Treatment|Study Drug Toxicity|10|||
144428835|NCT02864251|520779146|FG000|Treatment|Death|0|||
144428836|NCT02864251|520779147|FG001|Treatment|Death|2|||
144428837|NCT02864251|520779148|FG002|Treatment|Death|3|||
144428838|NCT02864251|520779146|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
144428839|NCT02864251|520779147|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
144428840|NCT02864251|520779148|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
144428841|NCT02864251|520779146|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
144428842|NCT02864251|520779147|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
144428843|NCT02864251|520779148|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
144428844|NCT02864251|520779146|FG000|Treatment|Withdrawal by Participant|8|||
144428845|NCT02864251|520779147|FG001|Treatment|Withdrawal by Participant|5|||
144428846|NCT02864251|520779148|FG002|Treatment|Withdrawal by Participant|13|||
144428847|NCT02864251|520779146|FG000|Treatment|Maximum Clinical Benefit|1|||
144428848|NCT02864251|520779147|FG001|Treatment|Maximum Clinical Benefit|0|||
144603723|NCT02101021|521412009|FG003|Overall Study|Death|0|||
144603724|NCT02101021|521412010|FG004|Overall Study|Death|3|||
144603725|NCT02101021|521412006|FG000|Overall Study|Withdrew Consent from study|1|||
144603726|NCT02101021|521412007|FG001|Overall Study|Withdrew Consent from study|1|||
144603727|NCT02101021|521412008|FG002|Overall Study|Withdrew Consent from study|0|||
144603728|NCT02101021|521412009|FG003|Overall Study|Withdrew Consent from study|2|||
144603729|NCT02101021|521412010|FG004|Overall Study|Withdrew Consent from study|0|||
144603730|NCT02101021|521412006|FG000|Overall Study|Lost to Follow-up|1|||
144603731|NCT02101021|521412007|FG001|Overall Study|Lost to Follow-up|0|||
144603732|NCT02101021|521412008|FG002|Overall Study|Lost to Follow-up|0|||
144603733|NCT02101021|521412009|FG003|Overall Study|Lost to Follow-up|0|||
144603734|NCT02101021|521412010|FG004|Overall Study|Lost to Follow-up|0|||
144603735|NCT02101021|521412006|FG000|Overall Study|Study Terminated by Sponsor|1|||
144603736|NCT02101021|521412007|FG001|Overall Study|Study Terminated by Sponsor|0|||
144603737|NCT02101021|521412008|FG002|Overall Study|Study Terminated by Sponsor|1|||
144603738|NCT02101021|521412009|FG003|Overall Study|Study Terminated by Sponsor|1|||
144603739|NCT02101021|521412010|FG004|Overall Study|Study Terminated by Sponsor|1|||
144603740|NCT00387764|521412011|FG000|Overall Study|Adverse Event|12|||
144603741|NCT00387764|521412011|FG000|Overall Study|Withdrawal by Subject|8|||
144603742|NCT00387764|521412011|FG000|Overall Study|Sponsor Terminated Study|1|||
144603743|NCT00387764|521412011|FG000|Overall Study|Physician Decision|1|||
144603744|NCT00387764|521412011|FG000|Overall Study|Other|2|||
144603745|NCT00387764|521412011|FG000|Overall Study|Death|7|||
144603746|NCT01326728|521412012|FG000|Overall Study|Death|13|||
144603747|NCT01326728|521412013|FG001|Overall Study|Death|0|||
144603748|NCT01326728|521412012|FG000|Overall Study|Early closure of study|34|||
144603749|NCT01326728|521412013|FG001|Overall Study|Early closure of study|9|||
144603750|NCT02966223|521412014|FG000|Overall Study|Physician Decision|3|||
144603751|NCT02966223|521412014|FG000|Overall Study|Withdrawal by Subject|11|||
144603752|NCT02966223|521412014|FG000|Overall Study|Lost to Follow-up|1|||
144603753|NCT01184053|521412015|FG000|Overall Study|progression while on treatment|3|||
144603754|NCT03785678|521412016|FG000|Overall Study|Death|44|||
144603755|NCT03785678|521412017|FG001|Overall Study|Death|42|||
144183257|NCT01438476|519865779|FG001|Overall Study|Communication barrier|1|||
144183258|NCT00360490|519865782|FG000|Overall Study|Adverse Event|4|||
144183259|NCT00360490|519865783|FG001|Overall Study|Adverse Event|2|||
144183260|NCT00360490|519865782|FG000|Overall Study|Lost to Follow-up|2|||
144183261|NCT00360490|519865783|FG001|Overall Study|Lost to Follow-up|1|||
144183262|NCT00360490|519865782|FG000|Overall Study|Physician Decision|2|||
144183263|NCT00360490|519865783|FG001|Overall Study|Physician Decision|1|||
144183264|NCT00360490|519865782|FG000|Overall Study|Protocol Violation|0|||
144183265|NCT00360490|519865783|FG001|Overall Study|Protocol Violation|4|||
144183266|NCT00360490|519865782|FG000|Overall Study|Withdrawal by Subject|1|||
144183267|NCT00360490|519865783|FG001|Overall Study|Withdrawal by Subject|3|||
144183268|NCT02289820|519865784|FG000|Overall Study|Withdrawal by Subject|2|||
144183269|NCT02289820|519865785|FG001|Overall Study|Withdrawal by Subject|1|||
144183270|NCT02289820|519865786|FG002|Overall Study|Withdrawal by Subject|2|||
144183271|NCT02289820|519865787|FG003|Overall Study|Withdrawal by Subject|1|||
144183272|NCT02289820|519865788|FG004|Overall Study|Withdrawal by Subject|0|||
144183273|NCT02289820|519865789|FG005|Overall Study|Withdrawal by Subject|0|||
144183274|NCT02289820|519865790|FG006|Overall Study|Withdrawal by Subject|1|||
144183275|NCT02289820|519865784|FG000|Overall Study|Death|0|||
144183276|NCT02289820|519865785|FG001|Overall Study|Death|0|||
144183277|NCT02289820|519865786|FG002|Overall Study|Death|1|||
144183278|NCT02289820|519865787|FG003|Overall Study|Death|0|||
144428849|NCT02864251|520779148|FG002|Treatment|Maximum Clinical Benefit|1|||
144428850|NCT02864251|520779146|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
144428851|NCT02864251|520779147|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
144603756|NCT03785678|521412016|FG000|Overall Study|Lost to Follow-up|4|||
144428852|NCT02864251|520779148|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
144428853|NCT02864251|520779146|FG000|Treatment|Other Reasons|1|||
144428854|NCT02864251|520779147|FG001|Treatment|Other Reasons|1|||
144428855|NCT02864251|520779148|FG002|Treatment|Other Reasons|4|||
144428856|NCT02864251|520779146|FG000|Treatment|Administrative Reason by Sponsor|1|||
144428857|NCT02864251|520779147|FG001|Treatment|Administrative Reason by Sponsor|0|||
144428858|NCT02864251|520779148|FG002|Treatment|Administrative Reason by Sponsor|0|||
144428859|NCT03506373|520779149|FG000|Overall Study|Adverse Event|6|||
144428860|NCT03506373|520779149|FG000|Overall Study|Withdrawal by Subject|2|||
144428861|NCT03506373|520779149|FG000|Overall Study|Disease progression|5|||
144428862|NCT03506373|520779149|FG000|Overall Study|Other|3|||
144428863|NCT00107198|520779150|FG000|Overall Study|Lack of Efficacy|28|||
144428864|NCT00107198|520779150|FG000|Overall Study|Lost to Follow-up|12|||
144428865|NCT00107198|520779150|FG000|Overall Study|Protocol Violation|1|||
144428866|NCT00107198|520779150|FG000|Overall Study|Withdrawal by Subject|6|||
144428867|NCT00107198|520779150|FG000|Overall Study|Ineligible|5|||
144428868|NCT02120950|520779151|FG000|Overall Study|Adverse Event|5|||
144428869|NCT02120950|520779152|FG001|Overall Study|Adverse Event|4|||
144428870|NCT02120950|520779153|FG002|Overall Study|Adverse Event|3|||
144428871|NCT02120950|520779151|FG000|Overall Study|Death|3|||
144428872|NCT02120950|520779152|FG001|Overall Study|Death|0|||
144428873|NCT02120950|520779153|FG002|Overall Study|Death|1|||
144428874|NCT02120950|520779151|FG000|Overall Study|Withdrawal by Subject|6|||
144428875|NCT02120950|520779152|FG001|Overall Study|Withdrawal by Subject|3|||
144428876|NCT02120950|520779153|FG002|Overall Study|Withdrawal by Subject|2|||
144428877|NCT02120950|520779151|FG000|Overall Study|Protocol Violation|1|||
144428878|NCT02120950|520779152|FG001|Overall Study|Protocol Violation|1|||
144428879|NCT02120950|520779153|FG002|Overall Study|Protocol Violation|7|||
144428880|NCT02120950|520779151|FG000|Overall Study|Other reasons|5|||
144428881|NCT02120950|520779152|FG001|Overall Study|Other reasons|4|||
144428882|NCT02120950|520779153|FG002|Overall Study|Other reasons|1|||
144428883|NCT02120950|520779151|FG000|Overall Study|Lost to Follow-up|0|||
144428884|NCT02120950|520779152|FG001|Overall Study|Lost to Follow-up|2|||
144428885|NCT02120950|520779153|FG002|Overall Study|Lost to Follow-up|1|||
144428886|NCT02625090|520779156|FG000|Overall Study|Participant wants to be pregnant|2|||
144428887|NCT02625090|520779156|FG000|Overall Study|For the Promoter|1|||
144428888|NCT02625090|520779156|FG000|Overall Study|Sponsor's Decision|9|||
144428889|NCT02625090|520779156|FG000|Overall Study|Somnolence|1|||
144428890|NCT02625090|520779156|FG000|Overall Study|Study terminated by Sponsor|7|||
144428891|NCT02625090|520779156|FG000|Overall Study|Negative Benefit/Risk|1|||
144428892|NCT02625090|520779156|FG000|Overall Study|Protocol Deviation|2|||
144428893|NCT02625090|520779156|FG000|Overall Study|Lack of Efficacy|16|||
144428894|NCT02625090|520779156|FG000|Overall Study|Adverse Event|3|||
144428895|NCT02250443|520779157|FG000|Overall Study|Administrative problems|7|||
144428896|NCT02250443|520779157|FG000|Overall Study|Adverse Event|3|||
144428897|NCT01549964|520779158|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
144428898|NCT01549964|520779159|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
144428899|NCT01549964|520779160|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
144428900|NCT01549964|520779161|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
144428901|NCT01549964|520779158|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
144428902|NCT01549964|520779159|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
144428903|NCT01549964|520779160|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
144428904|NCT01549964|520779161|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
144428905|NCT01549964|520779158|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
144528967|NCT02240238|521139158|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
144528968|NCT02240238|521139159|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
144528969|NCT02240238|521139148|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528970|NCT02240238|521139149|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528971|NCT02240238|521139150|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528972|NCT02240238|521139151|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144538441|NCT01500200|521174196|FG001|Stage 1|Adverse Event|4|||
144183279|NCT02289820|519865788|FG004|Overall Study|Death|0|||
144183280|NCT02289820|519865789|FG005|Overall Study|Death|0|||
144183281|NCT02289820|519865790|FG006|Overall Study|Death|0|||
144183282|NCT02289820|519865784|FG000|Overall Study|Lost to Follow-up|0|||
144183283|NCT02289820|519865785|FG001|Overall Study|Lost to Follow-up|0|||
144428906|NCT01549964|520779159|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
144428907|NCT01549964|520779160|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
144428908|NCT01549964|520779161|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
144428909|NCT01549964|520779158|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
144428910|NCT01549964|520779159|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
144428911|NCT01549964|520779160|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
144428912|NCT01549964|520779161|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
144428913|NCT01549964|520779158|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
144723574|NCT04634409|521842387|FG004|Overall Study|Withdrawal by Subject|2|||
144428914|NCT01549964|520779159|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
144428915|NCT01549964|520779160|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
144428916|NCT01549964|520779161|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
144428917|NCT01549964|520779158|FG000|24-Week Treatment Period|Other|1|||
144428918|NCT01549964|520779159|FG001|24-Week Treatment Period|Other|0|||
144428919|NCT01549964|520779160|FG002|24-Week Treatment Period|Other|1|||
144183284|NCT02289820|519865786|FG002|Overall Study|Lost to Follow-up|3|||
144183285|NCT02289820|519865787|FG003|Overall Study|Lost to Follow-up|1|||
144183286|NCT02289820|519865788|FG004|Overall Study|Lost to Follow-up|0|||
144183287|NCT02289820|519865789|FG005|Overall Study|Lost to Follow-up|1|||
144183288|NCT02289820|519865790|FG006|Overall Study|Lost to Follow-up|1|||
144183289|NCT02289820|519865784|FG000|Overall Study|withdrawal of consent|0|||
144183290|NCT02289820|519865785|FG001|Overall Study|withdrawal of consent|1|||
144183291|NCT02289820|519865786|FG002|Overall Study|withdrawal of consent|0|||
144428920|NCT01549964|520779161|FG003|24-Week Treatment Period|Other|0|||
144428921|NCT01549964|520779158|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
144428922|NCT01549964|520779159|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
144428923|NCT01549964|520779160|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
144428924|NCT01549964|520779161|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
144428925|NCT01549964|520779158|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
144428926|NCT01549964|520779159|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
144428927|NCT01549964|520779160|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
144428928|NCT01549964|520779161|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
144428929|NCT01549964|520779158|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
144428930|NCT01549964|520779159|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
144428931|NCT01549964|520779160|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
144428932|NCT01549964|520779161|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
144428933|NCT01549964|520779158|FG000|80-Week Extension Period|Pregnancy|0|||
144428934|NCT01549964|520779159|FG001|80-Week Extension Period|Pregnancy|0|||
144428935|NCT01549964|520779160|FG002|80-Week Extension Period|Pregnancy|1|||
144428936|NCT01549964|520779161|FG003|80-Week Extension Period|Pregnancy|0|||
144428937|NCT01549964|520779158|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
144428938|NCT01549964|520779159|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
144428939|NCT01549964|520779160|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
144428940|NCT01549964|520779161|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
144428941|NCT01549964|520779158|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
144428942|NCT01549964|520779159|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
144428943|NCT01549964|520779160|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
144428944|NCT01549964|520779161|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
144428945|NCT01549964|520779158|FG000|80-Week Extension Period|Lost to Follow-up|1|||
144428946|NCT01549964|520779159|FG001|80-Week Extension Period|Lost to Follow-up|0|||
144428947|NCT01549964|520779160|FG002|80-Week Extension Period|Lost to Follow-up|2|||
144428948|NCT01549964|520779161|FG003|80-Week Extension Period|Lost to Follow-up|1|||
144428949|NCT01549964|520779158|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
144428950|NCT01549964|520779159|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
144428951|NCT01549964|520779160|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
144428952|NCT01549964|520779161|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
144428953|NCT00751348|520779169|FG000|Overall Study|Withdrawal by Subject|5|||
144428954|NCT00751348|520779170|FG001|Overall Study|Withdrawal by Subject|2|||
144428955|NCT00751348|520779169|FG000|Overall Study|Migration from study area|1|||
144528973|NCT02240238|521139152|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528974|NCT02240238|521139153|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528975|NCT02240238|521139154|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528976|NCT02240238|521139155|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528977|NCT02240238|521139156|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528978|NCT02240238|521139157|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528979|NCT02240238|521139158|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
144528980|NCT02240238|521139159|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
144528981|NCT02240238|521139148|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144538442|NCT01500200|521174197|FG002|Stage 1|Adverse Event|5|||
144723575|NCT04634409|521842388|FG005|Overall Study|Withdrawal by Subject|0|||
144183292|NCT02289820|519865787|FG003|Overall Study|withdrawal of consent|0|||
144183293|NCT02289820|519865788|FG004|Overall Study|withdrawal of consent|0|||
144183294|NCT02289820|519865789|FG005|Overall Study|withdrawal of consent|0|||
144251992|NCT02722746|520122606|FG002|Overall Study|Withdrawal by Subject|0|||
144251993|NCT02722746|520122604|FG000|Overall Study|Protocol Violation|8|||
144428956|NCT00751348|520779170|FG001|Overall Study|Migration from study area|0|||
144428957|NCT04191382|520779174|FG000|Overall Study|Withdrawal by Subject|1|||
144428958|NCT04191382|520779175|FG001|Overall Study|Withdrawal by Subject|0|||
144428959|NCT04191382|520779176|FG002|Overall Study|Withdrawal by Subject|0|||
144428960|NCT05237206|520779177|FG000|Overall Study|screen failure-did not receive treatment|8|||
144428961|NCT05237206|520779177|FG000|Overall Study|did not receive treatment|3|||
144428962|NCT02205333|520779180|FG000|Overall Study|Death|5|||
144428963|NCT02205333|520779181|FG001|Overall Study|Death|6|||
144428964|NCT02205333|520779182|FG002|Overall Study|Death|2|||
144428965|NCT02205333|520779183|FG003|Overall Study|Death|6|||
144428966|NCT02205333|520779184|FG004|Overall Study|Death|5|||
144428967|NCT02205333|520779185|FG005|Overall Study|Death|3|||
144428968|NCT02205333|520779186|FG006|Overall Study|Death|3|||
144428969|NCT02205333|520779187|FG007|Overall Study|Death|2|||
144428970|NCT02205333|520779188|FG008|Overall Study|Death|0|||
144428971|NCT02205333|520779180|FG000|Overall Study|Withdrawal by Subject|1|||
144428972|NCT02205333|520779181|FG001|Overall Study|Withdrawal by Subject|0|||
144428973|NCT02205333|520779182|FG002|Overall Study|Withdrawal by Subject|0|||
144428974|NCT02205333|520779183|FG003|Overall Study|Withdrawal by Subject|1|||
144428975|NCT02205333|520779184|FG004|Overall Study|Withdrawal by Subject|0|||
144428976|NCT02205333|520779185|FG005|Overall Study|Withdrawal by Subject|0|||
144428977|NCT02205333|520779186|FG006|Overall Study|Withdrawal by Subject|2|||
144428978|NCT02205333|520779187|FG007|Overall Study|Withdrawal by Subject|0|||
144428979|NCT02205333|520779188|FG008|Overall Study|Withdrawal by Subject|0|||
144428980|NCT01476696|520779191|FG000|Overall Study|Sponsor decision|2|||
144428981|NCT01476696|520779192|FG001|Overall Study|Sponsor decision|1|||
144428982|NCT01476696|520779193|FG002|Overall Study|Sponsor decision|0|||
144428983|NCT01476696|520779191|FG000|Overall Study|Withdrawal by Subject|1|||
144428984|NCT01476696|520779192|FG001|Overall Study|Withdrawal by Subject|0|||
144428985|NCT01476696|520779193|FG002|Overall Study|Withdrawal by Subject|0|||
144428986|NCT03054870|520779195|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
144428987|NCT03054870|520779195|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
144428988|NCT02009046|520779196|FG000|Overall Study|Lost to Follow-up|256|||
144428989|NCT02009046|520779197|FG001|Overall Study|Lost to Follow-up|206|||
144428990|NCT03965962|520779203|FG000|Overall Study|Adverse Event|1|||
144428991|NCT03965962|520779204|FG001|Overall Study|Adverse Event|0|||
144428992|NCT03965962|520779205|FG002|Overall Study|Adverse Event|0|||
144428993|NCT03965962|520779206|FG003|Overall Study|Adverse Event|0|||
144428994|NCT03965962|520779203|FG000|Overall Study|Protocol Violation|21|||
144428995|NCT03965962|520779204|FG001|Overall Study|Protocol Violation|4|||
144428996|NCT03965962|520779205|FG002|Overall Study|Protocol Violation|10|||
144428997|NCT03965962|520779206|FG003|Overall Study|Protocol Violation|5|||
144428998|NCT03965962|520779203|FG000|Overall Study|Lost to Follow-up|0|||
144428999|NCT03965962|520779204|FG001|Overall Study|Lost to Follow-up|1|||
144429000|NCT03965962|520779205|FG002|Overall Study|Lost to Follow-up|0|||
144429001|NCT03965962|520779206|FG003|Overall Study|Lost to Follow-up|0|||
144429002|NCT03965962|520779203|FG000|Overall Study|Withdrawal by Subject|3|||
144429003|NCT03965962|520779204|FG001|Overall Study|Withdrawal by Subject|0|||
144429004|NCT03965962|520779205|FG002|Overall Study|Withdrawal by Subject|0|||
144429005|NCT03965962|520779206|FG003|Overall Study|Withdrawal by Subject|1|||
144429006|NCT02154581|520779215|FG000|Overall Study|Lost to Follow-up|7|||
144429007|NCT02154581|520779216|FG001|Overall Study|Lost to Follow-up|8|||
144429008|NCT00741039|520779217|FG000|Overall Study|Patient non-compliance|2|||
144429009|NCT00741039|520779218|FG001|Overall Study|Patient non-compliance|0|||
144429010|NCT00878709|520779219|FG000|Overall Study|Withdrawal by Subject|197|||
144429011|NCT00878709|520779220|FG001|Overall Study|Withdrawal by Subject|120|||
144429012|NCT00878709|520779219|FG000|Overall Study|Lost to Follow-up|35|||
144429013|NCT00878709|520779220|FG001|Overall Study|Lost to Follow-up|33|||
144429014|NCT00878709|520779219|FG000|Overall Study|Other Reasons|93|||
144429015|NCT00878709|520779220|FG001|Overall Study|Other Reasons|84|||
144429016|NCT01712854|520779221|FG000|Overall Study|Physician Decision|1|||
144429017|NCT02225743|520779222|FG000|Overall Study|Withdrawal by Subject|18|||
144429018|NCT03886220|520779225|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
144429019|NCT03886220|520779226|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
144429020|NCT03886220|520779225|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
144429021|NCT03886220|520779226|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144429022|NCT03886220|520779225|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
144429023|NCT03886220|520779226|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
144429024|NCT00768300|520779227|FG000|Overall Study|Randomized but not treated|1|||
144429025|NCT00768300|520779228|FG001|Overall Study|Randomized but not treated|1|||
144429026|NCT00768300|520779227|FG000|Overall Study|Adverse Event|10|||
144429027|NCT00768300|520779228|FG001|Overall Study|Adverse Event|2|||
144429028|NCT00768300|520779227|FG000|Overall Study|Protocol Violation|6|||
144429029|NCT00768300|520779228|FG001|Overall Study|Protocol Violation|1|||
144429030|NCT00768300|520779227|FG000|Overall Study|Withdrawal by Subject|13|||
144429031|NCT00768300|520779228|FG001|Overall Study|Withdrawal by Subject|7|||
144429032|NCT00768300|520779227|FG000|Overall Study|Physician Decision|2|||
144429033|NCT00768300|520779228|FG001|Overall Study|Physician Decision|3|||
144429034|NCT00768300|520779227|FG000|Overall Study|Study discontinued by Sponsor|271|||
144429035|NCT00768300|520779228|FG001|Overall Study|Study discontinued by Sponsor|140|||
144429036|NCT00768300|520779227|FG000|Overall Study|Death|21|||
144429037|NCT00768300|520779228|FG001|Overall Study|Death|5|||
144429038|NCT00768300|520779227|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
144429039|NCT00768300|520779228|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
144429040|NCT00768300|520779227|FG000|Overall Study|Screen failure following randomization|1|||
144429041|NCT00768300|520779228|FG001|Overall Study|Screen failure following randomization|0|||
144429042|NCT00768300|520779227|FG000|Overall Study|Received lung transplant|1|||
144429043|NCT00768300|520779228|FG001|Overall Study|Received lung transplant|1|||
144429044|NCT00768300|520779227|FG000|Overall Study|Lost to Follow-up|0|||
144429045|NCT00768300|520779228|FG001|Overall Study|Lost to Follow-up|1|||
144429046|NCT00768300|520779227|FG000|Overall Study|Began prohibited concomitant medication|0|||
144429047|NCT00768300|520779228|FG001|Overall Study|Began prohibited concomitant medication|1|||
144429048|NCT00768300|520779227|FG000|Overall Study|Treated but never dosed with Study drug|1|||
144429049|NCT00768300|520779228|FG001|Overall Study|Treated but never dosed with Study drug|0|||
144429050|NCT00768300|520779227|FG000|Overall Study|Missing data|1|||
144429051|NCT00768300|520779228|FG001|Overall Study|Missing data|0|||
144429052|NCT00322842|520779229|FG000|Overall Study|Withdrawal by Subject|0|||
144429053|NCT00322842|520779230|FG001|Overall Study|Withdrawal by Subject|1|||
144429054|NCT00322842|520779229|FG000|Overall Study|Lost to Follow-up|0|||
144429055|NCT00322842|520779230|FG001|Overall Study|Lost to Follow-up|1|||
144429056|NCT00322842|520779229|FG000|Overall Study|Refused transplant|1|||
144429057|NCT00322842|520779230|FG001|Overall Study|Refused transplant|0|||
144429058|NCT00322842|520779229|FG000|Overall Study|Death|1|||
144429059|NCT00322842|520779230|FG001|Overall Study|Death|0|||
144429060|NCT03082599|520779233|FG000|Overall Study|Lost to Follow-up|1|||
144429061|NCT03082599|520779234|FG001|Overall Study|Lost to Follow-up|0|||
144429062|NCT00832585|520779247|FG000|Overall Study|Withdrawal by Subject|1|||
144429063|NCT00832585|520779247|FG000|Overall Study|Lost to Follow-up|1|||
144429064|NCT00673179|520779250|FG000|Overall Study|Toxicity/Complications|3|||
144429065|NCT00673179|520779251|FG001|Overall Study|Toxicity/Complications|0|||
144429066|NCT01531387|520779252|FG000|Overall Study|Early termination of study|11|||
144429067|NCT01531387|520779253|FG001|Overall Study|Early termination of study|11|||
144429068|NCT00567892|520779254|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
144429069|NCT00567892|520779255|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
144429070|NCT00567892|520779256|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
144429071|NCT00567892|520779257|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
144429072|NCT00567892|520779254|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
144429073|NCT00567892|520779255|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
144429074|NCT00567892|520779256|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
144429075|NCT00567892|520779257|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
144429076|NCT01545817|520780673|FG000|Pazopanib|Disease progression|51|||
144429077|NCT01545817|520780674|FG001|Pazopanib|Disease progression|0|||
144429078|NCT01545817|520780673|FG000|Pazopanib|Adverse Event|19|||
144429079|NCT01545817|520780674|FG001|Pazopanib|Adverse Event|0|||
144429080|NCT01545817|520780673|FG000|Pazopanib|Other reason|4|||
144429081|NCT01545817|520780674|FG001|Pazopanib|Other reason|0|||
144429082|NCT01545817|520780673|FG000|Everolimus|Other reason|0|||
144429083|NCT01545817|520780674|FG001|Everolimus|Other reason|7|||
144429084|NCT01545817|520780673|FG000|Everolimus|Disease progression|0|||
144429085|NCT01545817|520780674|FG001|Everolimus|Disease progression|25|||
144429086|NCT01545817|520780673|FG000|Everolimus|Adverse Event|0|||
144429087|NCT01545817|520780674|FG001|Everolimus|Adverse Event|6|||
144429088|NCT00066066|520780677|FG000|Overall Study|Lost to Follow-up|6|||
144429089|NCT00066066|520780678|FG001|Overall Study|Lost to Follow-up|4|||
144429090|NCT00066066|520780679|FG002|Overall Study|Lost to Follow-up|7|||
144429091|NCT00066066|520780680|FG003|Overall Study|Lost to Follow-up|4|||
144429092|NCT00066066|520780681|FG004|Overall Study|Lost to Follow-up|3|||
144429093|NCT00066066|520780682|FG005|Overall Study|Lost to Follow-up|5|||
144429094|NCT01541969|520780691|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
144603757|NCT03785678|521412017|FG001|Overall Study|Lost to Follow-up|2|||
144603758|NCT03785678|521412016|FG000|Overall Study|Physician Decision|0|||
144603759|NCT03785678|521412017|FG001|Overall Study|Physician Decision|2|||
144603760|NCT03785678|521412016|FG000|Overall Study|Withdrawal by Subject|5|||
144603761|NCT03785678|521412017|FG001|Overall Study|Withdrawal by Subject|3|||
144603762|NCT04399122|521412018|FG000|Overall Study|Lost to Follow-up|2|||
144603763|NCT04399122|521412019|FG001|Overall Study|Lost to Follow-up|0|||
144429095|NCT01541969|520780692|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
144429096|NCT01541969|520780691|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
144429097|NCT01541969|520780692|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
144429098|NCT01541969|520780691|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
144429099|NCT01541969|520780692|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
144429100|NCT01541969|520780691|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
144429101|NCT01541969|520780692|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
144429102|NCT01541969|520780691|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
144429103|NCT01541969|520780692|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
144429104|NCT01541969|520780691|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
144429105|NCT01541969|520780692|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
144429106|NCT01541969|520780691|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
144429107|NCT01541969|520780692|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
144429108|NCT01541969|520780691|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
144429109|NCT01541969|520780692|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
144429110|NCT01541969|520780691|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
144429111|NCT01541969|520780692|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
144429112|NCT01541969|520780691|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
144429113|NCT01541969|520780692|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
144429114|NCT01365507|520780693|FG000|Overall Study|Withdrawal Criteria|8|||
144429115|NCT01365507|520780694|FG001|Overall Study|Withdrawal Criteria|5|||
144429116|NCT01365507|520780693|FG000|Overall Study|Unclassified|1|||
144429117|NCT01365507|520780694|FG001|Overall Study|Unclassified|4|||
144429118|NCT03265249|520780697|FG000|Overall Study|Withdrawal by Subject|0|||
144429119|NCT03265249|520780698|FG001|Overall Study|Withdrawal by Subject|1|||
144429120|NCT01614990|520780699|FG000|Overall Study|Protocol Violation|1|||
144429121|NCT01614990|520780700|FG001|Overall Study|Protocol Violation|1|||
144429122|NCT02255500|520780705|FG000|Overall Study|Withdrawal by Subject|1|||
144429123|NCT02255500|520780706|FG001|Overall Study|Withdrawal by Subject|0|||
144429124|NCT01012622|520780709|FG000|Overall Study|Withdrawal by Subject|6|||
144429125|NCT01012622|520780709|FG000|Overall Study|Lost to Follow-up|5|||
144429126|NCT01012622|520780709|FG000|Overall Study|Adverse Event|7|||
144429127|NCT01012622|520780709|FG000|Overall Study|non-compliance with the drug|9|||
144429128|NCT01012622|520780709|FG000|Overall Study|Other|1|||
144429129|NCT01012622|520780709|FG000|Overall Study|screening failure|1|||
144429130|NCT01012622|520780709|FG000|Overall Study|withdrawal of consent by a parent|2|||
144429131|NCT04254978|520780710|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
144429132|NCT04254978|520780710|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
144429133|NCT04254978|520780710|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
144429134|NCT04254978|520780710|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
144429135|NCT04254978|520780710|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
144429136|NCT04254978|520780710|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
144429137|NCT02510794|520780716|FG000|Overall Study|Adverse Event|0|||
144429138|NCT02510794|520780717|FG001|Overall Study|Adverse Event|1|||
144429139|NCT02510794|520780718|FG002|Overall Study|Adverse Event|0|||
144429140|NCT02510794|520780719|FG003|Overall Study|Adverse Event|0|||
144429141|NCT02510794|520780716|FG000|Overall Study|Death|1|||
144429142|NCT02510794|520780717|FG001|Overall Study|Death|2|||
144429143|NCT02510794|520780718|FG002|Overall Study|Death|1|||
144429144|NCT02510794|520780719|FG003|Overall Study|Death|1|||
144429145|NCT02510794|520780716|FG000|Overall Study|Lack of Efficacy|3|||
144429146|NCT02510794|520780717|FG001|Overall Study|Lack of Efficacy|1|||
144429147|NCT02510794|520780718|FG002|Overall Study|Lack of Efficacy|1|||
144429148|NCT02510794|520780719|FG003|Overall Study|Lack of Efficacy|0|||
144429149|NCT02510794|520780716|FG000|Overall Study|Participant moved out of the area|0|||
144429150|NCT02510794|520780717|FG001|Overall Study|Participant moved out of the area|0|||
144429151|NCT02510794|520780718|FG002|Overall Study|Participant moved out of the area|0|||
144429152|NCT02510794|520780719|FG003|Overall Study|Participant moved out of the area|1|||
144429153|NCT02510794|520780716|FG000|Overall Study|Physician Decision|3|||
144603764|NCT04399122|521412018|FG000|Overall Study|Withdrawal by Subject|1|||
144603765|NCT04399122|521412019|FG001|Overall Study|Withdrawal by Subject|0|||
144603766|NCT02536755|521412023|FG000|Overall Study|Adverse Event|4|||
144603767|NCT02301936|521412024|FG000|Overall Study|Lost to Follow-up|1|||
144603768|NCT02301936|521412025|FG001|Overall Study|Lost to Follow-up|0|||
144603769|NCT03065023|521412026|FG000|Overall Study|Progressive Disease|0|||
144603770|NCT03065023|521412027|FG001|Overall Study|Progressive Disease|1|||
144429154|NCT02510794|520780717|FG001|Overall Study|Physician Decision|0|||
144429155|NCT02510794|520780718|FG002|Overall Study|Physician Decision|0|||
144429156|NCT02510794|520780719|FG003|Overall Study|Physician Decision|0|||
144429157|NCT02510794|520780716|FG000|Overall Study|Protocol Violation|0|||
144429158|NCT02510794|520780717|FG001|Overall Study|Protocol Violation|0|||
144429159|NCT02510794|520780718|FG002|Overall Study|Protocol Violation|1|||
144429160|NCT02510794|520780719|FG003|Overall Study|Protocol Violation|0|||
144429161|NCT02510794|520780716|FG000|Overall Study|Withdrawal by Subject|1|||
144429162|NCT02510794|520780717|FG001|Overall Study|Withdrawal by Subject|2|||
144429163|NCT02510794|520780718|FG002|Overall Study|Withdrawal by Subject|4|||
144429164|NCT02510794|520780719|FG003|Overall Study|Withdrawal by Subject|3|||
144429165|NCT01649375|520780720|FG000|Up to Week 16|Adverse Event|2|||
144429166|NCT01649375|520780721|FG001|Up to Week 16|Adverse Event|5|||
144429167|NCT01649375|520780722|FG002|Up to Week 16|Adverse Event|4|||
144429168|NCT01649375|520780723|FG003|Up to Week 16|Adverse Event|0|||
144183295|NCT02289820|519865790|FG006|Overall Study|withdrawal of consent|0|||
144183296|NCT02786927|519865797|FG000|Overall Study|Adverse Event|1|||
144429169|NCT01649375|520780724|FG004|Up to Week 16|Adverse Event|0|||
144429170|NCT01649375|520780720|FG000|Up to Week 16|Lack of Efficacy|0|||
144429171|NCT01649375|520780721|FG001|Up to Week 16|Lack of Efficacy|0|||
144429172|NCT01649375|520780722|FG002|Up to Week 16|Lack of Efficacy|1|||
144429173|NCT01649375|520780723|FG003|Up to Week 16|Lack of Efficacy|0|||
144429174|NCT01649375|520780724|FG004|Up to Week 16|Lack of Efficacy|0|||
144429175|NCT01649375|520780720|FG000|Up to Week 16|Physician Decision|0|||
144429176|NCT01649375|520780721|FG001|Up to Week 16|Physician Decision|0|||
144429177|NCT01649375|520780722|FG002|Up to Week 16|Physician Decision|1|||
144429178|NCT01649375|520780723|FG003|Up to Week 16|Physician Decision|0|||
144429179|NCT01649375|520780724|FG004|Up to Week 16|Physician Decision|0|||
144429180|NCT01649375|520780720|FG000|Up to Week 16|Withdrawal by Subject|2|||
144429181|NCT01649375|520780721|FG001|Up to Week 16|Withdrawal by Subject|1|||
144429182|NCT01649375|520780722|FG002|Up to Week 16|Withdrawal by Subject|2|||
144429183|NCT01649375|520780723|FG003|Up to Week 16|Withdrawal by Subject|0|||
144429184|NCT01649375|520780724|FG004|Up to Week 16|Withdrawal by Subject|0|||
144429185|NCT01649375|520780720|FG000|Up to Week 16|Death|1|||
144429186|NCT01649375|520780721|FG001|Up to Week 16|Death|0|||
144429187|NCT01649375|520780722|FG002|Up to Week 16|Death|0|||
144429188|NCT01649375|520780723|FG003|Up to Week 16|Death|0|||
144429189|NCT01649375|520780724|FG004|Up to Week 16|Death|0|||
144429190|NCT01649375|520780720|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
144429191|NCT01649375|520780721|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
144429192|NCT01649375|520780722|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
144429193|NCT01649375|520780723|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
144429194|NCT01649375|520780724|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
144429195|NCT01649375|520780720|FG000|Week 16 up to Week 260|Non-compliance|0|||
144429196|NCT01649375|520780721|FG001|Week 16 up to Week 260|Non-compliance|1|||
144429197|NCT01649375|520780722|FG002|Week 16 up to Week 260|Non-compliance|0|||
144429198|NCT01649375|520780723|FG003|Week 16 up to Week 260|Non-compliance|1|||
144429199|NCT01649375|520780724|FG004|Week 16 up to Week 260|Non-compliance|0|||
144429200|NCT01649375|520780720|FG000|Week 16 up to Week 260|Physician Decision|0|||
144429201|NCT01649375|520780721|FG001|Week 16 up to Week 260|Physician Decision|2|||
144429202|NCT01649375|520780722|FG002|Week 16 up to Week 260|Physician Decision|0|||
144429203|NCT01649375|520780723|FG003|Week 16 up to Week 260|Physician Decision|0|||
144429204|NCT01649375|520780724|FG004|Week 16 up to Week 260|Physician Decision|0|||
144429205|NCT01649375|520780720|FG000|Week 16 up to Week 260|Technical issues|0|||
144429206|NCT01649375|520780721|FG001|Week 16 up to Week 260|Technical issues|1|||
144429207|NCT01649375|520780722|FG002|Week 16 up to Week 260|Technical issues|0|||
144429208|NCT01649375|520780723|FG003|Week 16 up to Week 260|Technical issues|1|||
144429209|NCT01649375|520780724|FG004|Week 16 up to Week 260|Technical issues|0|||
144429210|NCT01649375|520780720|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
144429211|NCT01649375|520780721|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
144429212|NCT01649375|520780722|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
144429213|NCT01649375|520780723|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
144429214|NCT01649375|520780724|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
144429215|NCT01649375|520780720|FG000|Week 16 up to Week 260|Death|1|||
144429216|NCT01649375|520780721|FG001|Week 16 up to Week 260|Death|1|||
144429217|NCT01649375|520780722|FG002|Week 16 up to Week 260|Death|0|||
144429218|NCT01649375|520780723|FG003|Week 16 up to Week 260|Death|0|||
144429219|NCT01649375|520780724|FG004|Week 16 up to Week 260|Death|0|||
144429220|NCT01649375|520780720|FG000|Week 16 up to Week 260|Adverse Event|5|||
144429221|NCT01649375|520780721|FG001|Week 16 up to Week 260|Adverse Event|2|||
144429222|NCT01649375|520780722|FG002|Week 16 up to Week 260|Adverse Event|0|||
144429223|NCT01649375|520780723|FG003|Week 16 up to Week 260|Adverse Event|3|||
144528982|NCT02240238|521139149|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528983|NCT02240238|521139150|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528984|NCT02240238|521139151|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144723576|NCT04634409|521842389|FG006|Overall Study|Withdrawal by Subject|0|||
144723577|NCT04634409|521842390|FG007|Overall Study|Withdrawal by Subject|2|||
144183297|NCT02786927|519865797|FG000|Overall Study|Protocol Violation|4|||
144429224|NCT01649375|520780724|FG004|Week 16 up to Week 260|Adverse Event|2|||
144429225|NCT01124604|520780725|FG000|Overall Study|Adverse Event|10|||
144429226|NCT01124604|520780726|FG001|Overall Study|Adverse Event|1|||
144723578|NCT04634409|521842391|FG008|Overall Study|Withdrawal by Subject|3|||
144183298|NCT01801917|519865798|FG000|Period 1 - Randomized|Adverse Event|1|||
144429227|NCT01124604|520780725|FG000|Overall Study|Lack of Efficacy|1|||
144429228|NCT01124604|520780726|FG001|Overall Study|Lack of Efficacy|0|||
144429229|NCT01124604|520780725|FG000|Overall Study|Withdrawal by Subject|4|||
144429230|NCT01124604|520780726|FG001|Overall Study|Withdrawal by Subject|0|||
144429231|NCT01124604|520780725|FG000|Overall Study|Disease Progression|0|||
144429232|NCT01124604|520780726|FG001|Overall Study|Disease Progression|1|||
144429233|NCT03102918|520780727|FG000|Overall Study|Protocol Violation|1|||
144429234|NCT03102918|520780728|FG001|Overall Study|Protocol Violation|0|||
144429235|NCT04765358|520780731|FG000|Overall Study|Withdrawal by Subject|1|||
144429236|NCT02066467|520780734|FG000|Overall Study|Did not undergo implant procedure|24|||
144429237|NCT02066467|520780734|FG000|Overall Study|Attempted to implant withoput success|43|||
144429238|NCT02066467|520780734|FG000|Overall Study|Consent ineligible|1|||
144429239|NCT02066467|520780734|FG000|Overall Study|Death|54|||
144429240|NCT02066467|520780734|FG000|Overall Study|Lost to Follow-up|51|||
144429241|NCT02066467|520780734|FG000|Overall Study|Adverse Event|20|||
144429242|NCT02066467|520780734|FG000|Overall Study|Withdrawal by Subject|16|||
144429243|NCT02066467|520780734|FG000|Overall Study|Physician Decision|2|||
144429244|NCT02066467|520780734|FG000|Overall Study|Not defined|4|||
144429245|NCT05352815|520780735|FG000|Overall Study|Withdrawal by Subject|28|||
144429246|NCT05352815|520780736|FG001|Overall Study|Withdrawal by Subject|24|||
144429247|NCT05352815|520780735|FG000|Overall Study|Lost to Follow-up|4|||
144429248|NCT05352815|520780736|FG001|Overall Study|Lost to Follow-up|7|||
144429249|NCT05352815|520780735|FG000|Overall Study|Death|2|||
144429250|NCT05352815|520780736|FG001|Overall Study|Death|3|||
144429251|NCT05352815|520780735|FG000|Overall Study|Site closure|1|||
144429252|NCT05352815|520780736|FG001|Overall Study|Site closure|0|||
144429253|NCT02759120|520780739|FG000|Overall Study|Death|34|||
144429254|NCT02759120|520780740|FG001|Overall Study|Death|36|||
144429255|NCT02759120|520780739|FG000|Overall Study|Lost to Follow-up|4|||
144429256|NCT02759120|520780740|FG001|Overall Study|Lost to Follow-up|7|||
144429257|NCT02759120|520780739|FG000|Overall Study|Physician Decision|3|||
144429258|NCT02759120|520780740|FG001|Overall Study|Physician Decision|0|||
144429259|NCT02759120|520780739|FG000|Overall Study|Withdrawal by Subject|28|||
144429260|NCT02759120|520780740|FG001|Overall Study|Withdrawal by Subject|15|||
144429261|NCT02759120|520780739|FG000|Overall Study|Moved out of area|3|||
144429262|NCT02759120|520780740|FG001|Overall Study|Moved out of area|4|||
144429263|NCT02759120|520780739|FG000|Overall Study|Lung transplant|3|||
144429264|NCT02759120|520780740|FG001|Overall Study|Lung transplant|5|||
144429265|NCT02759120|520780739|FG000|Overall Study|Other reason not completed|10|||
144429266|NCT02759120|520780740|FG001|Overall Study|Other reason not completed|12|||
144429267|NCT03056755|520780742|FG000|Treatment- Core Phase|Progressive disease|89|||
144429268|NCT03056755|520780743|FG001|Treatment- Core Phase|Progressive disease|88|||
144429269|NCT03056755|520780744|FG002|Treatment- Core Phase|Progressive disease|90|||
144429270|NCT03056755|520780742|FG000|Treatment- Core Phase|Adverse Event|20|||
144429271|NCT03056755|520780743|FG001|Treatment- Core Phase|Adverse Event|14|||
144429272|NCT03056755|520780744|FG002|Treatment- Core Phase|Adverse Event|13|||
144429273|NCT03056755|520780742|FG000|Treatment- Core Phase|Physician Decision|7|||
144429274|NCT03056755|520780743|FG001|Treatment- Core Phase|Physician Decision|13|||
144429275|NCT03056755|520780744|FG002|Treatment- Core Phase|Physician Decision|5|||
144429276|NCT03056755|520780742|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
144429277|NCT03056755|520780743|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
144429278|NCT03056755|520780744|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
144429279|NCT03056755|520780742|FG000|Treatment- Core Phase|Death|3|||
144429280|NCT03056755|520780743|FG001|Treatment- Core Phase|Death|2|||
144429281|NCT03056755|520780744|FG002|Treatment- Core Phase|Death|4|||
144429282|NCT03056755|520780742|FG000|Treatment- Core Phase|Protocol deviation|1|||
144429283|NCT03056755|520780743|FG001|Treatment- Core Phase|Protocol deviation|1|||
144429284|NCT03056755|520780744|FG002|Treatment- Core Phase|Protocol deviation|0|||
144429285|NCT03056755|520780742|FG000|Treatment- Core Phase|Technical problems|1|||
144429286|NCT03056755|520780743|FG001|Treatment- Core Phase|Technical problems|0|||
144429287|NCT03056755|520780744|FG002|Treatment- Core Phase|Technical problems|0|||
144429288|NCT03056755|520780742|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
144429289|NCT03056755|520780743|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
144429290|NCT03056755|520780744|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
144429291|NCT03056755|520780742|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
144429292|NCT03056755|520780743|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
144429293|NCT03056755|520780744|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
144429294|NCT03056755|520780742|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
144429295|NCT03056755|520780743|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
144429296|NCT03056755|520780744|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
144429297|NCT03056755|520780742|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
144429298|NCT03056755|520780743|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
144429299|NCT03056755|520780744|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
144429300|NCT00464568|520780747|FG000|Overall Study|Adverse Event|2|||
144251994|NCT02722746|520122605|FG001|Overall Study|Protocol Violation|4|||
144429301|NCT00405587|520780748|FG000|Overall Study|Death|0|||
144429302|NCT00405587|520780749|FG001|Overall Study|Death|0|||
144429303|NCT00405587|520780750|FG002|Overall Study|Death|0|||
144429304|NCT00405587|520780751|FG003|Overall Study|Death|1|||
144429305|NCT00405587|520780748|FG000|Overall Study|Disease Progression|22|||
144429306|NCT00405587|520780749|FG001|Overall Study|Disease Progression|23|||
144429307|NCT00405587|520780750|FG002|Overall Study|Disease Progression|21|||
144429308|NCT00405587|520780751|FG003|Overall Study|Disease Progression|17|||
144429309|NCT00405587|520780748|FG000|Overall Study|Physician Decision|3|||
144429310|NCT00405587|520780749|FG001|Overall Study|Physician Decision|2|||
144429311|NCT00405587|520780750|FG002|Overall Study|Physician Decision|0|||
144429312|NCT00405587|520780751|FG003|Overall Study|Physician Decision|0|||
144429313|NCT00405587|520780748|FG000|Overall Study|Adverse Event|1|||
144429314|NCT00405587|520780749|FG001|Overall Study|Adverse Event|0|||
144429315|NCT00405587|520780750|FG002|Overall Study|Adverse Event|0|||
144429316|NCT00405587|520780751|FG003|Overall Study|Adverse Event|0|||
144429317|NCT00405587|520780748|FG000|Overall Study|Lost to Follow-up|0|||
144429318|NCT00405587|520780749|FG001|Overall Study|Lost to Follow-up|1|||
144429319|NCT00405587|520780750|FG002|Overall Study|Lost to Follow-up|1|||
144429320|NCT00405587|520780751|FG003|Overall Study|Lost to Follow-up|0|||
144429321|NCT00405587|520780748|FG000|Overall Study|Radiation induced necrosis|0|||
144429322|NCT00405587|520780749|FG001|Overall Study|Radiation induced necrosis|1|||
144429323|NCT00405587|520780750|FG002|Overall Study|Radiation induced necrosis|0|||
144429324|NCT00405587|520780751|FG003|Overall Study|Radiation induced necrosis|0|||
144429325|NCT00405587|520780748|FG000|Overall Study|Withdrawal by Subject|0|||
144429326|NCT00405587|520780749|FG001|Overall Study|Withdrawal by Subject|0|||
144429327|NCT00405587|520780750|FG002|Overall Study|Withdrawal by Subject|0|||
144429328|NCT00405587|520780751|FG003|Overall Study|Withdrawal by Subject|2|||
144429329|NCT00405587|520780748|FG000|Overall Study|Participant not dosed|0|||
144429330|NCT00405587|520780749|FG001|Overall Study|Participant not dosed|1|||
144429331|NCT00405587|520780750|FG002|Overall Study|Participant not dosed|0|||
144429332|NCT00405587|520780751|FG003|Overall Study|Participant not dosed|0|||
144429333|NCT03406858|520780752|FG000|Overall Study|Failure to receive treatment drug.|1|||
144429334|NCT03406858|520780752|FG000|Overall Study|ineligible|1|||
144429335|NCT02419742|520780757|FG000|Overall Study|Adverse Event|2|||
144429336|NCT02419742|520780758|FG001|Overall Study|Adverse Event|0|||
144429337|NCT02419742|520780757|FG000|Overall Study|Disease Progression|0|||
144429338|NCT02419742|520780758|FG001|Overall Study|Disease Progression|1|||
144429339|NCT02419742|520780757|FG000|Overall Study|Withdrew Consent|2|||
144429340|NCT02419742|520780758|FG001|Overall Study|Withdrew Consent|1|||
144429341|NCT02419742|520780757|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
144429342|NCT02419742|520780758|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
144429343|NCT00507442|520780759|FG000|Overall Study|Adverse Event|8|||
144429344|NCT00507442|520780760|FG001|Overall Study|Adverse Event|11|||
144429345|NCT00507442|520780761|FG002|Overall Study|Adverse Event|4|||
144429346|NCT00507442|520780762|FG003|Overall Study|Adverse Event|1|||
144429347|NCT00507442|520780759|FG000|Overall Study|Protocol Violation|0|||
144429348|NCT00507442|520780760|FG001|Overall Study|Protocol Violation|1|||
144429349|NCT00507442|520780761|FG002|Overall Study|Protocol Violation|0|||
144429350|NCT00507442|520780762|FG003|Overall Study|Protocol Violation|0|||
144429351|NCT00507442|520780759|FG000|Overall Study|Lost to Follow-up|0|||
144429352|NCT00507442|520780760|FG001|Overall Study|Lost to Follow-up|0|||
144429353|NCT00507442|520780761|FG002|Overall Study|Lost to Follow-up|1|||
144429354|NCT00507442|520780762|FG003|Overall Study|Lost to Follow-up|0|||
144429355|NCT00507442|520780759|FG000|Overall Study|Physician Decision|0|||
144429356|NCT00507442|520780760|FG001|Overall Study|Physician Decision|2|||
144429357|NCT00507442|520780761|FG002|Overall Study|Physician Decision|4|||
144429358|NCT00507442|520780762|FG003|Overall Study|Physician Decision|1|||
144429359|NCT00507442|520780759|FG000|Overall Study|Progressive Disease|2|||
144429360|NCT00507442|520780760|FG001|Overall Study|Progressive Disease|4|||
144429361|NCT00507442|520780761|FG002|Overall Study|Progressive Disease|2|||
144429362|NCT00507442|520780762|FG003|Overall Study|Progressive Disease|0|||
144429363|NCT00507442|520780759|FG000|Overall Study|Withdrawal by Subject|4|||
144429364|NCT00507442|520780760|FG001|Overall Study|Withdrawal by Subject|4|||
144429365|NCT00507442|520780761|FG002|Overall Study|Withdrawal by Subject|2|||
144429366|NCT00507442|520780762|FG003|Overall Study|Withdrawal by Subject|1|||
144429367|NCT00507442|520780759|FG000|Overall Study|Other|2|||
144429368|NCT00507442|520780760|FG001|Overall Study|Other|5|||
144429369|NCT00507442|520780761|FG002|Overall Study|Other|2|||
144429370|NCT00507442|520780762|FG003|Overall Study|Other|2|||
144429371|NCT02672423|520780764|FG000|Period 1|Adverse Event|0|||
144429372|NCT02672423|520780765|FG001|Period 1|Adverse Event|0|||
144429373|NCT02672423|520780766|FG002|Period 1|Adverse Event|0|||
144429374|NCT02672423|520780767|FG003|Period 1|Adverse Event|0|||
144429375|NCT02672423|520780768|FG004|Period 1|Adverse Event|1|||
144429376|NCT02672423|520780769|FG005|Period 1|Adverse Event|0|||
144429377|NCT02672423|520780770|FG006|Period 1|Adverse Event|0|||
144429378|NCT02672423|520780771|FG007|Period 1|Adverse Event|0|||
144429379|NCT02672423|520780772|FG008|Period 1|Adverse Event|0|||
144429380|NCT02672423|520780773|FG009|Period 1|Adverse Event|0|||
144429381|NCT02672423|520780764|FG000|Period 2|Withdrawal by Subject|0|||
144429382|NCT02672423|520780765|FG001|Period 2|Withdrawal by Subject|0|||
144429383|NCT02672423|520780766|FG002|Period 2|Withdrawal by Subject|1|||
144429384|NCT02672423|520780767|FG003|Period 2|Withdrawal by Subject|0|||
144429385|NCT02672423|520780768|FG004|Period 2|Withdrawal by Subject|0|||
144429386|NCT02672423|520780769|FG005|Period 2|Withdrawal by Subject|0|||
144429387|NCT02672423|520780770|FG006|Period 2|Withdrawal by Subject|0|||
144429388|NCT02672423|520780771|FG007|Period 2|Withdrawal by Subject|0|||
144429389|NCT02672423|520780772|FG008|Period 2|Withdrawal by Subject|0|||
144429390|NCT02672423|520780773|FG009|Period 2|Withdrawal by Subject|0|||
144429391|NCT02672423|520780764|FG000|Period 3|Withdrawal by Subject|0|||
144429392|NCT02672423|520780765|FG001|Period 3|Withdrawal by Subject|0|||
144429393|NCT02672423|520780766|FG002|Period 3|Withdrawal by Subject|0|||
144429394|NCT02672423|520780767|FG003|Period 3|Withdrawal by Subject|0|||
144429395|NCT02672423|520780768|FG004|Period 3|Withdrawal by Subject|0|||
144429396|NCT02672423|520780769|FG005|Period 3|Withdrawal by Subject|0|||
144429397|NCT02672423|520780770|FG006|Period 3|Withdrawal by Subject|0|||
144429398|NCT02672423|520780771|FG007|Period 3|Withdrawal by Subject|1|||
144429399|NCT02672423|520780772|FG008|Period 3|Withdrawal by Subject|0|||
144429400|NCT02672423|520780773|FG009|Period 3|Withdrawal by Subject|0|||
144429401|NCT02672423|520780764|FG000|Period 3|Physician Decision|0|||
144429402|NCT02672423|520780765|FG001|Period 3|Physician Decision|0|||
144429403|NCT02672423|520780766|FG002|Period 3|Physician Decision|0|||
144429404|NCT02672423|520780767|FG003|Period 3|Physician Decision|0|||
144429405|NCT02672423|520780768|FG004|Period 3|Physician Decision|0|||
144429406|NCT02672423|520780769|FG005|Period 3|Physician Decision|1|||
144429407|NCT02672423|520780770|FG006|Period 3|Physician Decision|0|||
144429408|NCT02672423|520780771|FG007|Period 3|Physician Decision|0|||
144429409|NCT02672423|520780772|FG008|Period 3|Physician Decision|0|||
144429410|NCT02672423|520780773|FG009|Period 3|Physician Decision|0|||
144429411|NCT00885755|520780781|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
144429412|NCT00885755|520780782|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
144429413|NCT00885755|520780783|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
144429414|NCT00885755|520780781|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
144429415|NCT00885755|520780782|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
144429416|NCT00885755|520780783|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
144429417|NCT00885755|520780781|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
144429418|NCT00885755|520780782|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
144429419|NCT00885755|520780783|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
144429420|NCT00885755|520780781|FG000|Part I: Trastuzumab+Taxane|Death|0|||
144429421|NCT00885755|520780782|FG001|Part I: Trastuzumab+Taxane|Death|0|||
144429422|NCT00885755|520780783|FG002|Part I: Trastuzumab+Taxane|Death|1|||
144429423|NCT00885755|520780781|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
144429424|NCT00885755|520780782|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
144429425|NCT00885755|520780783|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
144429426|NCT01852812|520780791|FG000|Overall Study|Adverse Event|0|||
144429427|NCT01852812|520780792|FG001|Overall Study|Adverse Event|0|||
144429428|NCT01852812|520780793|FG002|Overall Study|Adverse Event|1|||
144429429|NCT01852812|520780791|FG000|Overall Study|Non-compliance With Study Drug|0|||
144429430|NCT01852812|520780792|FG001|Overall Study|Non-compliance With Study Drug|1|||
144429431|NCT01852812|520780793|FG002|Overall Study|Non-compliance With Study Drug|0|||
144429432|NCT02290821|520780794|FG000|Overall Study|Withdrawal by Subject|1|||
144429433|NCT02290821|520780795|FG001|Overall Study|Withdrawal by Subject|1|||
144429434|NCT02290821|520780794|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
144429435|NCT02290821|520780795|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
144429436|NCT02290821|520780794|FG000|Overall Study|Lost to Follow-up|3|||
144429437|NCT02290821|520780795|FG001|Overall Study|Lost to Follow-up|2|||
144429438|NCT02438722|520780796|FG000|Overall Study|Adverse Event|12|||
144429439|NCT02438722|520780797|FG001|Overall Study|Adverse Event|9|||
144429440|NCT02438722|520780796|FG000|Overall Study|Refusal unrelated to AE|2|||
144429441|NCT02438722|520780797|FG001|Overall Study|Refusal unrelated to AE|5|||
144429442|NCT02438722|520780796|FG000|Overall Study|Disease progression/relapse|46|||
144429443|NCT02438722|520780797|FG001|Overall Study|Disease progression/relapse|51|||
144429444|NCT02438722|520780796|FG000|Overall Study|Death|0|||
144429445|NCT02438722|520780797|FG001|Overall Study|Death|3|||
144429446|NCT02438722|520780796|FG000|Overall Study|Physician Decision|2|||
144429447|NCT02438722|520780797|FG001|Overall Study|Physician Decision|2|||
144528985|NCT02240238|521139152|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144538443|NCT01500200|521174198|FG003|Stage 1|Adverse Event|0|||
144429448|NCT02438722|520780796|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
144429449|NCT02438722|520780797|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
144429450|NCT02438722|520780796|FG000|Overall Study|Withdrawal by Subject|0|||
144429451|NCT02438722|520780797|FG001|Overall Study|Withdrawal by Subject|1|||
144429452|NCT02438722|520780796|FG000|Overall Study|On protocol treatment|15|||
144429453|NCT02438722|520780797|FG001|Overall Study|On protocol treatment|14|||
144429454|NCT02438722|520780796|FG000|Overall Study|Did not receive protocol treatment|5|||
144429455|NCT02438722|520780797|FG001|Overall Study|Did not receive protocol treatment|0|||
144429456|NCT01520363|520780798|FG000|Overall Study|Withdrawal by Subject|2|||
144429457|NCT01520363|520780799|FG001|Overall Study|Withdrawal by Subject|0|||
144429458|NCT02677987|520780802|FG000|Overall Study|Withdrawal by Subject|3|||
144429459|NCT02677987|520780803|FG001|Overall Study|Withdrawal by Subject|0|||
144429460|NCT02677987|520780802|FG000|Overall Study|Lost to Follow-up|1|||
144429461|NCT02677987|520780803|FG001|Overall Study|Lost to Follow-up|0|||
144429462|NCT01344161|520780804|FG000|Overall Study|Lost to Follow-up|4|||
144429463|NCT01344161|520780805|FG001|Overall Study|Lost to Follow-up|1|||
144429464|NCT01344161|520780804|FG000|Overall Study|Pregnancy|0|||
144429465|NCT01344161|520780805|FG001|Overall Study|Pregnancy|1|||
144429466|NCT01344161|520780804|FG000|Overall Study|Protocol Violation|1|||
144429467|NCT01344161|520780805|FG001|Overall Study|Protocol Violation|1|||
144429468|NCT04690751|520780806|FG000|Overall Study|Protocol Violation|0|||
144429469|NCT04690751|520780807|FG001|Overall Study|Protocol Violation|1|||
144429470|NCT04690751|520780808|FG002|Overall Study|Protocol Violation|0|||
144429471|NCT04690751|520780809|FG003|Overall Study|Protocol Violation|1|||
144429472|NCT04690751|520780810|FG004|Overall Study|Protocol Violation|2|||
144429473|NCT04690751|520780811|FG005|Overall Study|Protocol Violation|0|||
144429474|NCT04690751|520780806|FG000|Overall Study|Adverse Event|0|||
144429475|NCT04690751|520780807|FG001|Overall Study|Adverse Event|0|||
144429476|NCT04690751|520780808|FG002|Overall Study|Adverse Event|1|||
144429477|NCT04690751|520780809|FG003|Overall Study|Adverse Event|0|||
144429478|NCT04690751|520780810|FG004|Overall Study|Adverse Event|0|||
144429479|NCT04690751|520780811|FG005|Overall Study|Adverse Event|0|||
144429480|NCT04690751|520780806|FG000|Overall Study|Positive urine drug screen test|0|||
144429481|NCT04690751|520780807|FG001|Overall Study|Positive urine drug screen test|0|||
144429482|NCT04690751|520780808|FG002|Overall Study|Positive urine drug screen test|0|||
144429483|NCT04690751|520780809|FG003|Overall Study|Positive urine drug screen test|0|||
144429484|NCT04690751|520780810|FG004|Overall Study|Positive urine drug screen test|1|||
144429485|NCT04690751|520780811|FG005|Overall Study|Positive urine drug screen test|0|||
144429486|NCT04364620|520780812|FG000|Overall Study|Disease Progression|20|||
144429487|NCT04364620|520780812|FG000|Overall Study|Adverse Event|5|||
144429488|NCT04364620|520780812|FG000|Overall Study|Physician Decision|4|||
144429489|NCT04364620|520780812|FG000|Overall Study|Death|3|||
144429490|NCT04364620|520780812|FG000|Overall Study|Other|2|||
144429491|NCT04364620|520780812|FG000|Overall Study|Withdrawal by Subject|1|||
144429492|NCT00699972|520782536|FG000|Overall Study|Adverse Event|7|||
144429493|NCT00699972|520782537|FG001|Overall Study|Adverse Event|9|||
144429494|NCT00699972|520782538|FG002|Overall Study|Adverse Event|24|||
144429495|NCT00699972|520782536|FG000|Overall Study|Lost to Follow-up|0|||
144429496|NCT00699972|520782537|FG001|Overall Study|Lost to Follow-up|2|||
144429497|NCT00699972|520782538|FG002|Overall Study|Lost to Follow-up|0|||
144429498|NCT00699972|520782536|FG000|Overall Study|Withdrawal by Subject|3|||
144429499|NCT00699972|520782537|FG001|Overall Study|Withdrawal by Subject|7|||
144429500|NCT00699972|520782538|FG002|Overall Study|Withdrawal by Subject|4|||
144429501|NCT00699972|520782536|FG000|Overall Study|Lack of Efficacy|2|||
144429502|NCT00699972|520782537|FG001|Overall Study|Lack of Efficacy|0|||
144429503|NCT00699972|520782538|FG002|Overall Study|Lack of Efficacy|2|||
144251995|NCT02722746|520122606|FG002|Overall Study|Protocol Violation|6|||
144251996|NCT01618916|520122613|FG000|Overall Study|Adverse Event|1|||
144251997|NCT01618916|520122614|FG001|Overall Study|Adverse Event|0|||
144251998|NCT01618916|520122615|FG002|Overall Study|Adverse Event|0|||
144251999|NCT01618916|520122616|FG003|Overall Study|Adverse Event|0|||
144252000|NCT01618916|520122617|FG004|Overall Study|Adverse Event|0|||
144252001|NCT01618916|520122618|FG005|Overall Study|Adverse Event|0|||
144252002|NCT01618916|520122613|FG000|Overall Study|Withdrawal by Subject|0|||
144252003|NCT01618916|520122614|FG001|Overall Study|Withdrawal by Subject|1|||
144252004|NCT01618916|520122615|FG002|Overall Study|Withdrawal by Subject|1|||
144252005|NCT01618916|520122616|FG003|Overall Study|Withdrawal by Subject|0|||
144252006|NCT01618916|520122617|FG004|Overall Study|Withdrawal by Subject|1|||
144252007|NCT01618916|520122618|FG005|Overall Study|Withdrawal by Subject|0|||
144252008|NCT01618916|520122613|FG000|Overall Study|Lost to Follow-up|1|||
144252009|NCT01618916|520122614|FG001|Overall Study|Lost to Follow-up|0|||
144252010|NCT01618916|520122615|FG002|Overall Study|Lost to Follow-up|0|||
144252011|NCT01618916|520122616|FG003|Overall Study|Lost to Follow-up|2|||
144252012|NCT01618916|520122617|FG004|Overall Study|Lost to Follow-up|0|||
144252013|NCT01618916|520122618|FG005|Overall Study|Lost to Follow-up|0|||
144252014|NCT01853696|520122619|FG000|Overall Study|Withdrawal by Subject|1|||
144252015|NCT01853696|520122620|FG001|Overall Study|Withdrawal by Subject|1|||
144252016|NCT01853696|520122619|FG000|Overall Study|Lost to Follow-up|5|||
144252017|NCT01853696|520122620|FG001|Overall Study|Lost to Follow-up|4|||
144252018|NCT03004924|520122621|FG000|Overall Study|Adverse Event|6|||
144252019|NCT03004924|520122622|FG001|Overall Study|Adverse Event|5|||
144252020|NCT03004924|520122623|FG002|Overall Study|Adverse Event|10|||
144252021|NCT03004924|520122621|FG000|Overall Study|Protocol Violation|4|||
144252022|NCT03004924|520122622|FG001|Overall Study|Protocol Violation|0|||
144252023|NCT03004924|520122623|FG002|Overall Study|Protocol Violation|1|||
144252024|NCT03004924|520122621|FG000|Overall Study|Withdrawal by Subject|5|||
144252025|NCT03004924|520122622|FG001|Overall Study|Withdrawal by Subject|3|||
144429504|NCT00699972|520782536|FG000|Overall Study|Administrative/Other|3|||
144429505|NCT00699972|520782537|FG001|Overall Study|Administrative/Other|1|||
144429506|NCT00699972|520782538|FG002|Overall Study|Administrative/Other|4|||
144429507|NCT00699972|520782536|FG000|Overall Study|Randomized, Not Treated|1|||
144429508|NCT00699972|520782537|FG001|Overall Study|Randomized, Not Treated|0|||
144429509|NCT00699972|520782538|FG002|Overall Study|Randomized, Not Treated|1|||
144429510|NCT02967692|520782539|FG000|Overall Study|Progressive disease|3|||
144429511|NCT02967692|520782540|FG001|Overall Study|Progressive disease|15|||
144603771|NCT03065023|521412028|FG002|Overall Study|Progressive Disease|0|||
144603772|NCT03065023|521412029|FG003|Overall Study|Progressive Disease|0|||
144603773|NCT03065023|521412030|FG004|Overall Study|Progressive Disease|0|||
144603774|NCT03065023|521412026|FG000|Overall Study|Death|2|||
144603775|NCT03065023|521412027|FG001|Overall Study|Death|0|||
144603776|NCT03065023|521412028|FG002|Overall Study|Death|1|||
144603777|NCT03065023|521412029|FG003|Overall Study|Death|1|||
144603778|NCT03065023|521412030|FG004|Overall Study|Death|0|||
144603779|NCT03065023|521412026|FG000|Overall Study|Lost to Follow-up|0|||
144603780|NCT03065023|521412027|FG001|Overall Study|Lost to Follow-up|1|||
144603781|NCT03065023|521412028|FG002|Overall Study|Lost to Follow-up|0|||
144603782|NCT03065023|521412029|FG003|Overall Study|Lost to Follow-up|0|||
144603783|NCT03065023|521412030|FG004|Overall Study|Lost to Follow-up|0|||
144603784|NCT03065023|521412026|FG000|Overall Study|Participant Decision|0|||
144603785|NCT03065023|521412027|FG001|Overall Study|Participant Decision|0|||
144603786|NCT03065023|521412028|FG002|Overall Study|Participant Decision|0|||
144603787|NCT03065023|521412029|FG003|Overall Study|Participant Decision|1|||
144603788|NCT03065023|521412030|FG004|Overall Study|Participant Decision|0|||
144603789|NCT03065023|521412026|FG000|Overall Study|Withdrawal by Subject|0|||
144603790|NCT03065023|521412027|FG001|Overall Study|Withdrawal by Subject|0|||
144603791|NCT03065023|521412028|FG002|Overall Study|Withdrawal by Subject|0|||
144183299|NCT01801917|519865799|FG001|Period 1 - Randomized|Adverse Event|0|||
144183300|NCT01801917|519865800|FG002|Period 1 - Randomized|Adverse Event|1|||
144183301|NCT01801917|519865801|FG003|Period 1 - Randomized|Adverse Event|0|||
144603792|NCT03065023|521412029|FG003|Overall Study|Withdrawal by Subject|1|||
144603793|NCT03065023|521412030|FG004|Overall Study|Withdrawal by Subject|0|||
144603794|NCT00705432|521412031|FG000|Treatment Period|Adverse Event|45|||
144603795|NCT00705432|521412032|FG001|Treatment Period|Adverse Event|37|||
144603796|NCT00705432|521412033|FG002|Treatment Period|Adverse Event|51|||
144603797|NCT00705432|521412034|FG003|Treatment Period|Adverse Event|12|||
144603798|NCT00705432|521412035|FG004|Treatment Period|Adverse Event|8|||
144603799|NCT00705432|521412036|FG005|Treatment Period|Adverse Event|9|||
144603800|NCT00705432|521412031|FG000|Treatment Period|Treatment failure|92|||
144603801|NCT00705432|521412032|FG001|Treatment Period|Treatment failure|42|||
144603802|NCT00705432|521412033|FG002|Treatment Period|Treatment failure|33|||
144603803|NCT00705432|521412034|FG003|Treatment Period|Treatment failure|25|||
144603804|NCT00705432|521412035|FG004|Treatment Period|Treatment failure|13|||
144603805|NCT00705432|521412036|FG005|Treatment Period|Treatment failure|14|||
144603806|NCT00705432|521412031|FG000|Treatment Period|Non medical reason|26|||
144603807|NCT00705432|521412032|FG001|Treatment Period|Non medical reason|32|||
144603808|NCT00705432|521412033|FG002|Treatment Period|Non medical reason|37|||
144603809|NCT00705432|521412034|FG003|Treatment Period|Non medical reason|4|||
144603810|NCT00705432|521412035|FG004|Treatment Period|Non medical reason|7|||
144603811|NCT00705432|521412036|FG005|Treatment Period|Non medical reason|7|||
144603812|NCT00705432|521412031|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
144603813|NCT00705432|521412032|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
144603814|NCT00705432|521412033|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
144603815|NCT00705432|521412034|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
144603816|NCT00705432|521412035|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
144603817|NCT00705432|521412036|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
144603818|NCT00705432|521412031|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
144603819|NCT00705432|521412032|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
144603820|NCT00705432|521412033|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
144183302|NCT01924364|519865802|FG000|Overall Study|Physician Decision|3|||
144183303|NCT00265785|519865803|FG000|Overall Study|Adverse Event|4|||
144183304|NCT00265785|519865803|FG000|Overall Study|Withdrawal by Subject|3|||
144183305|NCT00265785|519865803|FG000|Overall Study|Progression/Relapse|15|||
144183306|NCT00265785|519865803|FG000|Overall Study|Not protocol specified|2|||
144183307|NCT00265785|519865803|FG000|Overall Study|Ineligible|1|||
144183308|NCT00265785|519865803|FG000|Overall Study|Did not receive protocol treatment|2|||
144183309|NCT02416934|519865805|FG000|Overall Study|given steroids|1|||
144183310|NCT02416934|519865806|FG001|Overall Study|given steroids|2|||
144183311|NCT02416934|519865805|FG000|Overall Study|Lost to Follow-up|0|||
144183312|NCT02416934|519865806|FG001|Overall Study|Lost to Follow-up|2|||
144183313|NCT02416934|519865805|FG000|Overall Study|Withdrawal by Subject|1|||
144183314|NCT02416934|519865806|FG001|Overall Study|Withdrawal by Subject|0|||
144183315|NCT02416934|519865805|FG000|Overall Study|recruited during continuing renewal proc|0|||
144183316|NCT02416934|519865806|FG001|Overall Study|recruited during continuing renewal proc|1|||
144183317|NCT02416934|519865805|FG000|Overall Study|Protocol Violation|0|||
144183318|NCT02416934|519865806|FG001|Overall Study|Protocol Violation|1|||
144183319|NCT02416934|519865805|FG000|Overall Study|surgery started late|0|||
144603821|NCT00705432|521412034|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
144603822|NCT00705432|521412035|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
144603823|NCT00705432|521412036|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
144603824|NCT00375219|521412037|FG000|Overall Study|Failure to achieve a response|16|||
144603825|NCT00375219|521412038|FG001|Overall Study|Failure to achieve a response|2|||
144603826|NCT00375219|521412039|FG002|Overall Study|Failure to achieve a response|0|||
144603827|NCT00375219|521412037|FG000|Overall Study|Adverse Event|8|||
144603828|NCT00375219|521412038|FG001|Overall Study|Adverse Event|2|||
144603829|NCT00375219|521412039|FG002|Overall Study|Adverse Event|1|||
144603830|NCT00375219|521412037|FG000|Overall Study|Protocol Violation|1|||
144603831|NCT00375219|521412038|FG001|Overall Study|Protocol Violation|0|||
144603832|NCT00375219|521412039|FG002|Overall Study|Protocol Violation|1|||
144252026|NCT03004924|520122623|FG002|Overall Study|Withdrawal by Subject|5|||
144252027|NCT03004924|520122621|FG000|Overall Study|Lost to Follow-up|6|||
144252028|NCT03004924|520122622|FG001|Overall Study|Lost to Follow-up|1|||
144252029|NCT03004924|520122623|FG002|Overall Study|Lost to Follow-up|4|||
144252030|NCT03004924|520122621|FG000|Overall Study|Lack of Efficacy|2|||
144252031|NCT03004924|520122622|FG001|Overall Study|Lack of Efficacy|4|||
144252032|NCT03004924|520122623|FG002|Overall Study|Lack of Efficacy|2|||
144252033|NCT03004924|520122621|FG000|Overall Study|Physician Decision|1|||
144252034|NCT03004924|520122622|FG001|Overall Study|Physician Decision|0|||
144252035|NCT03004924|520122623|FG002|Overall Study|Physician Decision|1|||
144252036|NCT03004924|520122621|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144252037|NCT03004924|520122622|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144252038|NCT03004924|520122623|FG002|Overall Study|Withdrawal by parent/guardian|2|||
144252039|NCT03004924|520122621|FG000|Overall Study|Screen Failure|1|||
144252040|NCT03004924|520122622|FG001|Overall Study|Screen Failure|0|||
144252041|NCT03004924|520122623|FG002|Overall Study|Screen Failure|0|||
144252042|NCT03004924|520122621|FG000|Overall Study|Pregnancy|0|||
144252043|NCT03004924|520122622|FG001|Overall Study|Pregnancy|1|||
144252044|NCT03004924|520122623|FG002|Overall Study|Pregnancy|0|||
144252045|NCT03004924|520122621|FG000|Overall Study|Terminated by Sponsor|0|||
144252046|NCT03004924|520122622|FG001|Overall Study|Terminated by Sponsor|0|||
144252047|NCT03004924|520122623|FG002|Overall Study|Terminated by Sponsor|1|||
144252048|NCT03004924|520122621|FG000|Overall Study|Missed Study Visit|0|||
144252049|NCT03004924|520122622|FG001|Overall Study|Missed Study Visit|0|||
144252050|NCT03004924|520122623|FG002|Overall Study|Missed Study Visit|2|||
144252051|NCT03004924|520122621|FG000|Overall Study|HSV1 Positive|1|||
144252052|NCT03004924|520122622|FG001|Overall Study|HSV1 Positive|0|||
144252053|NCT03004924|520122623|FG002|Overall Study|HSV1 Positive|0|||
144252054|NCT01404949|520122638|FG000|Overall Study|Not Treated|1|||
144252055|NCT00002525|520122639|FG000|Overall Study|Adverse Event|36|||
144252056|NCT00002525|520122640|FG001|Overall Study|Adverse Event|0|||
144252057|NCT00002525|520122639|FG000|Overall Study|Death|5|||
144252058|NCT00002525|520122640|FG001|Overall Study|Death|0|||
144252059|NCT00002525|520122639|FG000|Overall Study|Withdrawal by Subject|11|||
144252060|NCT00002525|520122640|FG001|Overall Study|Withdrawal by Subject|0|||
144252061|NCT00002525|520122639|FG000|Overall Study|Start non-protocol therapy|1|||
144252062|NCT00002525|520122640|FG001|Overall Study|Start non-protocol therapy|0|||
144252063|NCT00002525|520122639|FG000|Overall Study|Other complicating disease|1|||
144252064|NCT00002525|520122640|FG001|Overall Study|Other complicating disease|0|||
144252065|NCT00002525|520122639|FG000|Overall Study|Duke's A, B1, D disease|92|||
144252066|NCT00002525|520122640|FG001|Overall Study|Duke's A, B1, D disease|0|||
144252067|NCT00002525|520122639|FG000|Overall Study|Error|6|||
144252068|NCT00002525|520122640|FG001|Overall Study|Error|0|||
144252069|NCT00002525|520122639|FG000|Overall Study|Other|26|||
144252070|NCT00002525|520122640|FG001|Overall Study|Other|0|||
144252071|NCT00002525|520122639|FG000|Overall Study|Never start protocol therapy|8|||
144252072|NCT00002525|520122640|FG001|Overall Study|Never start protocol therapy|0|||
144252073|NCT00435188|520122645|FG000|Overall Study|Death|1|||
144252074|NCT00435188|520122646|FG001|Overall Study|Death|6|||
144252075|NCT00435188|520122645|FG000|Overall Study|Withdrawal by Subject|16|||
144252076|NCT00435188|520122646|FG001|Overall Study|Withdrawal by Subject|11|||
144252077|NCT00435188|520122645|FG000|Overall Study|Lost to Follow-up|5|||
144252078|NCT00435188|520122646|FG001|Overall Study|Lost to Follow-up|6|||
144603833|NCT00375219|521412037|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
144723579|NCT04634409|521842392|FG009|Overall Study|Withdrawal by Subject|2|||
144723580|NCT04634409|521842393|FG010|Overall Study|Withdrawal by Subject|3|||
144252079|NCT00575510|520122647|FG000|Overall Study|Lost to Follow-up|4|||
144252080|NCT00575510|520122648|FG001|Overall Study|Lost to Follow-up|6|||
144252081|NCT00575510|520122649|FG002|Overall Study|Lost to Follow-up|9|||
144252082|NCT00575510|520122647|FG000|Overall Study|Withdrawal by Subject|1|||
144252083|NCT00575510|520122648|FG001|Overall Study|Withdrawal by Subject|0|||
144252084|NCT00575510|520122649|FG002|Overall Study|Withdrawal by Subject|0|||
144252085|NCT00575510|520122647|FG000|Overall Study|Clinic Called Patient|7|||
144252086|NCT00575510|520122648|FG001|Overall Study|Clinic Called Patient|7|||
144252087|NCT00575510|520122649|FG002|Overall Study|Clinic Called Patient|7|||
144252088|NCT00575510|520122647|FG000|Overall Study|Pregnancy|0|||
144252089|NCT00575510|520122648|FG001|Overall Study|Pregnancy|0|||
144252090|NCT00575510|520122649|FG002|Overall Study|Pregnancy|1|||
144252091|NCT02651688|520122655|FG000|Overall Study|Non-compliance|0|||
144252092|NCT02651688|520122656|FG001|Overall Study|Non-compliance|0|||
144603834|NCT00375219|521412038|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
144603835|NCT00375219|521412039|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
144252093|NCT02651688|520122657|FG002|Overall Study|Non-compliance|1|||
144252094|NCT02651688|520122655|FG000|Overall Study|Principal Investigator (PI) decision|0|||
144252095|NCT02651688|520122656|FG001|Overall Study|Principal Investigator (PI) decision|2|||
144252096|NCT02651688|520122657|FG002|Overall Study|Principal Investigator (PI) decision|0|||
144252097|NCT02651688|520122655|FG000|Overall Study|Lost to Follow-up|1|||
144252098|NCT02651688|520122656|FG001|Overall Study|Lost to Follow-up|3|||
144252099|NCT02651688|520122657|FG002|Overall Study|Lost to Follow-up|0|||
144252100|NCT02651688|520122655|FG000|Overall Study|Withdrawal by Subject|1|||
144252101|NCT02651688|520122656|FG001|Overall Study|Withdrawal by Subject|0|||
144252102|NCT02651688|520122657|FG002|Overall Study|Withdrawal by Subject|2|||
144252103|NCT04527978|520122658|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
144252104|NCT04527978|520122659|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
144252105|NCT00055497|520122660|FG000|Overall Study|Adverse Event|1|||
144252106|NCT00055497|520122661|FG001|Overall Study|Adverse Event|1|||
144252107|NCT00055497|520122662|FG002|Overall Study|Adverse Event|1|||
144252108|NCT00055497|520122663|FG003|Overall Study|Adverse Event|28|||
144252109|NCT00055497|520122660|FG000|Overall Study|Withdrawal by Subject|3|||
144252110|NCT00055497|520122661|FG001|Overall Study|Withdrawal by Subject|1|||
144252111|NCT00055497|520122662|FG002|Overall Study|Withdrawal by Subject|1|||
144252112|NCT00055497|520122663|FG003|Overall Study|Withdrawal by Subject|15|||
144252113|NCT00055497|520122660|FG000|Overall Study|Lost to Follow-up|0|||
144252114|NCT00055497|520122661|FG001|Overall Study|Lost to Follow-up|1|||
144252115|NCT00055497|520122662|FG002|Overall Study|Lost to Follow-up|0|||
144252116|NCT00055497|520122663|FG003|Overall Study|Lost to Follow-up|5|||
144252117|NCT00055497|520122660|FG000|Overall Study|Protocol Violation|0|||
144252118|NCT00055497|520122661|FG001|Overall Study|Protocol Violation|0|||
144252119|NCT00055497|520122662|FG002|Overall Study|Protocol Violation|0|||
144252120|NCT00055497|520122663|FG003|Overall Study|Protocol Violation|3|||
144252121|NCT00055497|520122660|FG000|Overall Study|Lack of Efficacy|1|||
144252122|NCT00055497|520122661|FG001|Overall Study|Lack of Efficacy|0|||
144429512|NCT02967692|520782541|FG002|Overall Study|Progressive disease|114|||
144429513|NCT02967692|520782542|FG003|Overall Study|Progressive disease|151|||
144429514|NCT02967692|520782539|FG000|Overall Study|Subject/guardian decision|1|||
144429515|NCT02967692|520782540|FG001|Overall Study|Subject/guardian decision|1|||
144429516|NCT02967692|520782541|FG002|Overall Study|Subject/guardian decision|14|||
144429517|NCT02967692|520782542|FG003|Overall Study|Subject/guardian decision|22|||
144429518|NCT02967692|520782539|FG000|Overall Study|Death|0|||
144429519|NCT02967692|520782540|FG001|Overall Study|Death|1|||
144429520|NCT02967692|520782541|FG002|Overall Study|Death|13|||
144429521|NCT02967692|520782542|FG003|Overall Study|Death|13|||
144429522|NCT02967692|520782539|FG000|Overall Study|Protocol deviation|1|||
144429523|NCT02967692|520782540|FG001|Overall Study|Protocol deviation|0|||
144429524|NCT02967692|520782541|FG002|Overall Study|Protocol deviation|1|||
144429525|NCT02967692|520782542|FG003|Overall Study|Protocol deviation|1|||
144429526|NCT02967692|520782539|FG000|Overall Study|Lost to Follow-up|0|||
144429527|NCT02967692|520782540|FG001|Overall Study|Lost to Follow-up|0|||
144429528|NCT02967692|520782541|FG002|Overall Study|Lost to Follow-up|1|||
144429529|NCT02967692|520782542|FG003|Overall Study|Lost to Follow-up|0|||
144429530|NCT02967692|520782539|FG000|Overall Study|Physician Decision|0|||
144429531|NCT02967692|520782540|FG001|Overall Study|Physician Decision|0|||
144429532|NCT02967692|520782541|FG002|Overall Study|Physician Decision|22|||
144429533|NCT02967692|520782542|FG003|Overall Study|Physician Decision|13|||
144429534|NCT02967692|520782539|FG000|Overall Study|Adverse Event|2|||
144429535|NCT02967692|520782540|FG001|Overall Study|Adverse Event|9|||
144429536|NCT02967692|520782541|FG002|Overall Study|Adverse Event|60|||
144429537|NCT02967692|520782542|FG003|Overall Study|Adverse Event|28|||
144429538|NCT02967692|520782539|FG000|Overall Study|Study terminated by sponsor|2|||
144429539|NCT02967692|520782540|FG001|Overall Study|Study terminated by sponsor|1|||
144429540|NCT02967692|520782541|FG002|Overall Study|Study terminated by sponsor|42|||
144429541|NCT02967692|520782542|FG003|Overall Study|Study terminated by sponsor|37|||
144429542|NCT02268409|520782543|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
144429543|NCT02268409|520782543|FG000|Overall Study|Death|1|||
144429544|NCT02268409|520782543|FG000|Overall Study|Lost to Follow-up|1|||
144429545|NCT02268409|520782543|FG000|Overall Study|Protocol Violation|3|||
144252123|NCT00055497|520122662|FG002|Overall Study|Lack of Efficacy|0|||
144429546|NCT02268409|520782543|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
144429547|NCT02268409|520782543|FG000|Overall Study|Withdrawal by Subject|5|||
144252124|NCT00055497|520122663|FG003|Overall Study|Lack of Efficacy|27|||
144252125|NCT00055497|520122660|FG000|Overall Study|Administrative Reasons|0|||
144252126|NCT00055497|520122661|FG001|Overall Study|Administrative Reasons|0|||
144252127|NCT00055497|520122662|FG002|Overall Study|Administrative Reasons|0|||
144252128|NCT00055497|520122663|FG003|Overall Study|Administrative Reasons|1|||
144429548|NCT00156533|520782546|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
144429549|NCT00156533|520782547|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
144429550|NCT00156533|520782548|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
144252129|NCT00055497|520122660|FG000|Overall Study|Other|0|||
144252130|NCT00055497|520122661|FG001|Overall Study|Other|0|||
144429551|NCT00156533|520782549|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
144429552|NCT00156533|520782546|FG000|Overall Study|Withdrawal by Subject|1|||
144429553|NCT00156533|520782547|FG001|Overall Study|Withdrawal by Subject|0|||
144429554|NCT00156533|520782548|FG002|Overall Study|Withdrawal by Subject|0|||
144429555|NCT00156533|520782549|FG003|Overall Study|Withdrawal by Subject|1|||
144429556|NCT00156533|520782546|FG000|Overall Study|Failed Screening|1|||
144429557|NCT00156533|520782547|FG001|Overall Study|Failed Screening|0|||
144429558|NCT00156533|520782548|FG002|Overall Study|Failed Screening|1|||
144429559|NCT00156533|520782549|FG003|Overall Study|Failed Screening|1|||
144429560|NCT04865354|520782550|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
144429561|NCT04865354|520782551|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
144429562|NCT04865354|520782550|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
144429563|NCT04865354|520782551|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
144429564|NCT04865354|520782550|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
144429565|NCT04865354|520782551|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
144429566|NCT02520011|520782552|FG000|Overall Study|Adverse Event|0|||
144429567|NCT02520011|520782553|FG001|Overall Study|Adverse Event|1|||
144429568|NCT02520011|520782554|FG002|Overall Study|Adverse Event|2|||
144429569|NCT02520011|520782552|FG000|Overall Study|Death|0|||
144429570|NCT02520011|520782553|FG001|Overall Study|Death|8|||
144429571|NCT02520011|520782554|FG002|Overall Study|Death|1|||
144429572|NCT02520011|520782552|FG000|Overall Study|Lack of Efficacy|4|||
144429573|NCT02520011|520782553|FG001|Overall Study|Lack of Efficacy|26|||
144429574|NCT02520011|520782554|FG002|Overall Study|Lack of Efficacy|4|||
144429575|NCT02520011|520782552|FG000|Overall Study|Physician Decision|0|||
144429576|NCT02520011|520782553|FG001|Overall Study|Physician Decision|2|||
144429577|NCT02520011|520782554|FG002|Overall Study|Physician Decision|0|||
144429578|NCT02520011|520782552|FG000|Overall Study|Withdrawal by Subject|1|||
144429579|NCT02520011|520782553|FG001|Overall Study|Withdrawal by Subject|3|||
144429580|NCT02520011|520782554|FG002|Overall Study|Withdrawal by Subject|0|||
144429581|NCT02520011|520782552|FG000|Overall Study|Protocol Deviation|0|||
144429582|NCT02520011|520782553|FG001|Overall Study|Protocol Deviation|1|||
144429583|NCT02520011|520782554|FG002|Overall Study|Protocol Deviation|0|||
144429584|NCT02520011|520782552|FG000|Overall Study|Patient went to hospice|0|||
144429585|NCT02520011|520782553|FG001|Overall Study|Patient went to hospice|1|||
144429586|NCT02520011|520782554|FG002|Overall Study|Patient went to hospice|0|||
144429587|NCT02520011|520782552|FG000|Overall Study|Progressive disease following response|0|||
144429588|NCT02520011|520782553|FG001|Overall Study|Progressive disease following response|4|||
144429589|NCT02520011|520782554|FG002|Overall Study|Progressive disease following response|2|||
144429590|NCT02515942|520782555|FG000|Overall Study|Adverse Event|5|||
144429591|NCT02515942|520782556|FG001|Overall Study|Adverse Event|0|||
144429592|NCT02515942|520782557|FG002|Overall Study|Adverse Event|0|||
144429593|NCT02515942|520782555|FG000|Overall Study|Death|0|||
144429594|NCT02515942|520782556|FG001|Overall Study|Death|0|||
144429595|NCT02515942|520782557|FG002|Overall Study|Death|1|||
144429596|NCT02515942|520782555|FG000|Overall Study|Lack of Efficacy|0|||
144429597|NCT02515942|520782556|FG001|Overall Study|Lack of Efficacy|0|||
144429598|NCT02515942|520782557|FG002|Overall Study|Lack of Efficacy|1|||
144429599|NCT02515942|520782555|FG000|Overall Study|Lost to Follow-up|2|||
144429600|NCT02515942|520782556|FG001|Overall Study|Lost to Follow-up|0|||
144429601|NCT02515942|520782557|FG002|Overall Study|Lost to Follow-up|0|||
144429602|NCT02515942|520782555|FG000|Overall Study|Withdrawal by Subject|0|||
144429603|NCT02515942|520782556|FG001|Overall Study|Withdrawal by Subject|3|||
144429604|NCT02515942|520782557|FG002|Overall Study|Withdrawal by Subject|2|||
144429605|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
144429606|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
144429607|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
144429608|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
144429609|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
144429610|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
144429611|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
144429612|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
144429613|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
144429614|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
144429615|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
144429616|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
144429617|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
144429618|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
144429619|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
144538444|NCT01500200|521174199|FG004|Stage 1|Adverse Event|0|||
144538445|NCT01500200|521174200|FG005|Stage 1|Adverse Event|0|||
144538446|NCT01500200|521174195|FG000|Stage 1|Lost to Follow-up|2|||
144538447|NCT01500200|521174196|FG001|Stage 1|Lost to Follow-up|2|||
144538448|NCT01500200|521174197|FG002|Stage 1|Lost to Follow-up|1|||
144538449|NCT01500200|521174198|FG003|Stage 1|Lost to Follow-up|0|||
144538450|NCT01500200|521174199|FG004|Stage 1|Lost to Follow-up|0|||
144538451|NCT01500200|521174200|FG005|Stage 1|Lost to Follow-up|0|||
144429620|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
144429621|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
144429622|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
144429623|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
144429624|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
144429625|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
144429626|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
144429627|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
144429628|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
144429629|NCT00277212|520782561|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
144429630|NCT00277212|520782562|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
144429631|NCT00277212|520782563|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
144429632|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
144429633|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
144429634|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
144429635|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
144429636|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
144429637|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
144429638|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
144429639|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
144429640|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
144429641|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
144429642|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
144429643|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
144429644|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
144429645|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
144429646|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
144429647|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
144429648|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
144429649|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
144429650|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
144429651|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
144429652|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
144429653|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
144429654|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
144429655|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
144429656|NCT00277212|520782561|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
144429657|NCT00277212|520782562|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
144429658|NCT00277212|520782563|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
144429659|NCT00902564|520782564|FG000|Overall Study|Withdrawal by Subject|2|||
144429660|NCT03336216|520782570|FG000|Randomization|Not reported|2|||
144429661|NCT03336216|520782571|FG001|Randomization|Not reported|0|||
144429662|NCT03336216|520782572|FG002|Randomization|Not reported|1|||
144429663|NCT03336216|520782573|FG003|Randomization|Not reported|0|||
144429664|NCT03336216|520782570|FG000|Randomization|Other reasons|1|||
144429665|NCT03336216|520782571|FG001|Randomization|Other reasons|1|||
144429666|NCT03336216|520782572|FG002|Randomization|Other reasons|1|||
144429667|NCT03336216|520782573|FG003|Randomization|Other reasons|0|||
144429668|NCT03336216|520782570|FG000|Randomization|Participant no longer meets study criteria|0|||
144429669|NCT03336216|520782571|FG001|Randomization|Participant no longer meets study criteria|2|||
144429670|NCT03336216|520782572|FG002|Randomization|Participant no longer meets study criteria|4|||
144429671|NCT03336216|520782573|FG003|Randomization|Participant no longer meets study criteria|1|||
144183320|NCT02416934|519865806|FG001|Overall Study|surgery started late|1|||
144429672|NCT03336216|520782570|FG000|Randomization|Lost to Follow-up|1|||
144528986|NCT02240238|521139153|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528987|NCT02240238|521139154|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528988|NCT02240238|521139155|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528989|NCT02240238|521139156|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528990|NCT02240238|521139157|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144528991|NCT02240238|521139158|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
144528992|NCT02240238|521139159|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
144183321|NCT02416934|519865805|FG000|Overall Study|re-operation|1|||
144183322|NCT02416934|519865806|FG001|Overall Study|re-operation|0|||
144183323|NCT00860262|519865812|FG000|Overall Study|Adverse Event|9|||
144429673|NCT03336216|520782571|FG001|Randomization|Lost to Follow-up|0|||
144528993|NCT02240238|521139148|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144183324|NCT00860262|519865813|FG001|Overall Study|Adverse Event|6|||
144429674|NCT03336216|520782572|FG002|Randomization|Lost to Follow-up|0|||
144429675|NCT03336216|520782573|FG003|Randomization|Lost to Follow-up|0|||
144429676|NCT03336216|520782570|FG000|Randomization|Participant withdrew consent|9|||
144429677|NCT03336216|520782571|FG001|Randomization|Participant withdrew consent|1|||
144429678|NCT03336216|520782572|FG002|Randomization|Participant withdrew consent|0|||
144429679|NCT03336216|520782573|FG003|Randomization|Participant withdrew consent|0|||
144429680|NCT03336216|520782570|FG000|Randomization|Adverse Event|1|||
144429681|NCT03336216|520782571|FG001|Randomization|Adverse Event|1|||
144429682|NCT03336216|520782572|FG002|Randomization|Adverse Event|0|||
144429683|NCT03336216|520782573|FG003|Randomization|Adverse Event|0|||
144429684|NCT03336216|520782570|FG000|Treatment|Adverse Event|2|||
144429685|NCT03336216|520782571|FG001|Treatment|Adverse Event|3|||
144429686|NCT03336216|520782572|FG002|Treatment|Adverse Event|4|||
144429687|NCT03336216|520782573|FG003|Treatment|Adverse Event|4|||
144429688|NCT03336216|520782570|FG000|Treatment|Participant request to discontinue treatment|2|||
144429689|NCT03336216|520782571|FG001|Treatment|Participant request to discontinue treatment|1|||
144429690|NCT03336216|520782572|FG002|Treatment|Participant request to discontinue treatment|2|||
144429691|NCT03336216|520782573|FG003|Treatment|Participant request to discontinue treatment|2|||
144429692|NCT03336216|520782570|FG000|Treatment|Participant withdrew consent|7|||
144429693|NCT03336216|520782571|FG001|Treatment|Participant withdrew consent|2|||
144429694|NCT03336216|520782572|FG002|Treatment|Participant withdrew consent|3|||
144429695|NCT03336216|520782573|FG003|Treatment|Participant withdrew consent|2|||
144429696|NCT03336216|520782570|FG000|Treatment|Death|2|||
144429697|NCT03336216|520782571|FG001|Treatment|Death|3|||
144429698|NCT03336216|520782572|FG002|Treatment|Death|3|||
144429699|NCT03336216|520782573|FG003|Treatment|Death|4|||
144429700|NCT03336216|520782570|FG000|Treatment|Participant no longer meets study criteria|0|||
144429701|NCT03336216|520782571|FG001|Treatment|Participant no longer meets study criteria|1|||
144429702|NCT03336216|520782572|FG002|Treatment|Participant no longer meets study criteria|0|||
144429703|NCT03336216|520782573|FG003|Treatment|Participant no longer meets study criteria|0|||
144429704|NCT03336216|520782570|FG000|Treatment|Other reasons|2|||
144429705|NCT03336216|520782571|FG001|Treatment|Other reasons|0|||
144429706|NCT03336216|520782572|FG002|Treatment|Other reasons|0|||
144429707|NCT03336216|520782573|FG003|Treatment|Other reasons|3|||
144429708|NCT03336216|520782570|FG000|Treatment|Disease progression|23|||
144429709|NCT03336216|520782571|FG001|Treatment|Disease progression|34|||
144429710|NCT03336216|520782572|FG002|Treatment|Disease progression|33|||
144429711|NCT03336216|520782573|FG003|Treatment|Disease progression|26|||
144429712|NCT03336216|520782570|FG000|Treatment|Study drug toxicity|0|||
144429713|NCT03336216|520782571|FG001|Treatment|Study drug toxicity|3|||
144429714|NCT03336216|520782572|FG002|Treatment|Study drug toxicity|2|||
144429715|NCT03336216|520782573|FG003|Treatment|Study drug toxicity|0|||
144429716|NCT03336216|520782570|FG000|Treatment|Adverse Event unrelated to study drug|1|||
144429717|NCT03336216|520782571|FG001|Treatment|Adverse Event unrelated to study drug|1|||
144429718|NCT03336216|520782572|FG002|Treatment|Adverse Event unrelated to study drug|1|||
144429719|NCT03336216|520782573|FG003|Treatment|Adverse Event unrelated to study drug|0|||
144429720|NCT03336216|520782570|FG000|Treatment|Disease Recurrence|1|||
144429721|NCT03336216|520782571|FG001|Treatment|Disease Recurrence|0|||
144429722|NCT03336216|520782572|FG002|Treatment|Disease Recurrence|0|||
144429723|NCT03336216|520782573|FG003|Treatment|Disease Recurrence|0|||
144429724|NCT03239470|520782574|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
144429725|NCT03239470|520782575|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
144429726|NCT00922766|520782578|FG000|Overall Study|Death|3|||
144429727|NCT00922766|520782578|FG000|Overall Study|Withdrawal by Subject|2|||
144429728|NCT00922766|520782578|FG000|Overall Study|Other|1|||
144429729|NCT00922766|520782578|FG000|Overall Study|Adverse Event|1|||
144429730|NCT00666757|520782579|FG000|Overall Study|Lost to Follow-up|39|||
144429731|NCT00666757|520782580|FG001|Overall Study|Lost to Follow-up|35|||
144528994|NCT02240238|521139149|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144528995|NCT02240238|521139150|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144538452|NCT01500200|521174195|FG000|Stage 1|Withdrawal by Subject|3|||
144429732|NCT00666757|520782579|FG000|Overall Study|Protocol Violation|23|||
144429733|NCT00666757|520782580|FG001|Overall Study|Protocol Violation|24|||
144429734|NCT00666757|520782579|FG000|Overall Study|Adverse Event|22|||
144429735|NCT00666757|520782580|FG001|Overall Study|Adverse Event|12|||
144429736|NCT00666757|520782579|FG000|Overall Study|Withdrawal by Subject|13|||
144429737|NCT00666757|520782580|FG001|Overall Study|Withdrawal by Subject|17|||
144429738|NCT00666757|520782579|FG000|Overall Study|Lack of Efficacy|3|||
144429739|NCT00666757|520782580|FG001|Overall Study|Lack of Efficacy|6|||
144429740|NCT00666757|520782579|FG000|Overall Study|Physician Decision|0|||
144429741|NCT00666757|520782580|FG001|Overall Study|Physician Decision|2|||
144429742|NCT00666757|520782579|FG000|Overall Study|Sponsor decision|0|||
144429743|NCT00666757|520782580|FG001|Overall Study|Sponsor decision|1|||
144429744|NCT01231581|520782581|FG000|Overall Study|Lost to Follow-up|2|||
144429745|NCT01231581|520782582|FG001|Overall Study|Lost to Follow-up|2|||
144429746|NCT01231581|520782581|FG000|Overall Study|Withdrawal by Subject|6|||
144429747|NCT01231581|520782582|FG001|Overall Study|Withdrawal by Subject|9|||
144429748|NCT01231581|520782581|FG000|Overall Study|Study Closed/Terminated|6|||
144429749|NCT01231581|520782582|FG001|Overall Study|Study Closed/Terminated|5|||
144429750|NCT01231581|520782581|FG000|Overall Study|Death|65|||
144429751|NCT01231581|520782582|FG001|Overall Study|Death|64|||
144429752|NCT01231581|520782581|FG000|Overall Study|Ongoing|1|||
144429753|NCT01231581|520782582|FG001|Overall Study|Ongoing|0|||
144429754|NCT05954052|520782583|FG000|Overall Study|Adverse Event|1|||
144429755|NCT01723163|520782586|FG000|Treatment Phase|Withdrawal by Subject|14|||
144429756|NCT01723163|520782587|FG001|Treatment Phase|Withdrawal by Subject|6|||
144429757|NCT01723163|520782586|FG000|Treatment Phase|Withdrawal by PI|5|||
144429758|NCT01723163|520782587|FG001|Treatment Phase|Withdrawal by PI|1|||
144429759|NCT01723163|520782586|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
144429760|NCT01723163|520782587|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
144429761|NCT01723163|520782586|FG000|3-Month Follow-up|Unable to Contact|12|||
144429762|NCT01723163|520782587|FG001|3-Month Follow-up|Unable to Contact|19|||
144429763|NCT01723163|520782586|FG000|6-Month Follow-up|Death|1|||
144429764|NCT01723163|520782587|FG001|6-Month Follow-up|Death|0|||
144429765|NCT01723163|520782586|FG000|6-Month Follow-up|Unable to Contact|17|||
144429766|NCT01723163|520782587|FG001|6-Month Follow-up|Unable to Contact|15|||
144429767|NCT01723163|520782586|FG000|12-Month Follow-up|Death|1|||
144429768|NCT01723163|520782587|FG001|12-Month Follow-up|Death|0|||
144429769|NCT01723163|520782586|FG000|12-Month Follow-up|Unable to Contact|23|||
144429770|NCT01723163|520782587|FG001|12-Month Follow-up|Unable to Contact|28|||
144429771|NCT02731729|520782590|FG000|Overall Study|Death|2|||
144429772|NCT02731729|520782591|FG001|Overall Study|Death|2|||
144429773|NCT02731729|520782590|FG000|Overall Study|Study terminated by Sponsor|6|||
144429774|NCT02731729|520782591|FG001|Overall Study|Study terminated by Sponsor|6|||
144429775|NCT02731729|520782590|FG000|Overall Study|Withdrawal by Subject|1|||
144429776|NCT02731729|520782591|FG001|Overall Study|Withdrawal by Subject|0|||
144429777|NCT01316276|520782592|FG000|Overall Study|Death|1|||
144429778|NCT01316276|520782592|FG000|Overall Study|Adverse Event|19|||
144429779|NCT01316276|520782592|FG000|Overall Study|Withdrawal of consent|24|||
144429780|NCT01316276|520782592|FG000|Overall Study|Lost to Follow-up|1|||
144429781|NCT01316276|520782592|FG000|Overall Study|Other|22|||
144429782|NCT02596854|520782593|FG000|Overall Study|Withdrawn|8|||
144429783|NCT04343521|520782598|FG000|Overall Study|Adverse Event|0|||
144429784|NCT04343521|520782599|FG001|Overall Study|Adverse Event|2|||
144429785|NCT04343521|520782598|FG000|Overall Study|Death|1|||
144429786|NCT04343521|520782599|FG001|Overall Study|Death|2|||
144429787|NCT04343521|520782598|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
144429788|NCT04343521|520782599|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
144429789|NCT04343521|520782598|FG000|Overall Study|Withdrawal by Subject|70|||
144429790|NCT04343521|520782599|FG001|Overall Study|Withdrawal by Subject|95|||
144429791|NCT04343521|520782598|FG000|Overall Study|Withdrawal by study team|6|||
144429792|NCT04343521|520782599|FG001|Overall Study|Withdrawal by study team|12|||
144429793|NCT02939560|520782602|FG000|Overall Study|Withdrawal by Subject|2|||
144429794|NCT02939560|520782602|FG000|Overall Study|Protocol Violation|1|||
144429795|NCT03340025|520782603|FG000|Overall Study|Lost to Follow-up|2|||
144429796|NCT03340025|520782604|FG001|Overall Study|Lost to Follow-up|2|||
144429797|NCT02420691|520782607|FG000|Overall Study|Adverse Event|3|||
144429798|NCT02420691|520782607|FG000|Overall Study|Withdrawal by Subject|3|||
144528996|NCT02240238|521139151|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144528997|NCT02240238|521139152|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144528998|NCT02240238|521139153|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144528999|NCT02240238|521139154|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144529000|NCT02240238|521139155|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144529001|NCT02240238|521139156|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144529002|NCT02240238|521139157|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144529003|NCT02240238|521139158|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
144529004|NCT02240238|521139159|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
144529005|NCT03088878|521139160|FG000|Overall Study|Adverse Event|0|||
144529006|NCT03088878|521139161|FG001|Overall Study|Adverse Event|0|||
144529007|NCT03088878|521139162|FG002|Overall Study|Adverse Event|0|||
144429799|NCT03897179|520782610|FG000|Overall Study|Withdrawal by Subject|1|||
144429800|NCT00704535|520782611|FG000|Overall Study|Adverse Event|2|||
144429801|NCT00704535|520782611|FG000|Overall Study|Death|2|||
144429802|NCT00704535|520782611|FG000|Overall Study|Lost to Follow-up|8|||
144429803|NCT00704535|520782611|FG000|Overall Study|Protocol Violation|10|||
144429804|NCT00704535|520782611|FG000|Overall Study|Completed status not on Case Report Form|124|||
144429805|NCT05694546|520782613|FG000|Overall Study|Lost to Follow-up|11|||
144429806|NCT02424383|520782614|FG000|Overall Study|Withdrawal by Subject|32|||
144429807|NCT02424383|520782614|FG000|Overall Study|Death|170|||
144429808|NCT02424383|520782614|FG000|Overall Study|Sponsor's decision|3|||
144429809|NCT02424383|520782614|FG000|Overall Study|Investigator's decision|44|||
144429810|NCT02424383|520782614|FG000|Overall Study|Lost to Follow-up|81|||
144429811|NCT02424383|520782614|FG000|Overall Study|Other|7|||
144429812|NCT02424383|520782614|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
144429813|NCT01251380|520782618|FG000|Overall Study|Other (Not otherwise specified)|12|||
144429814|NCT01251380|520782618|FG000|Overall Study|Withdrawal by Subject|6|||
144429815|NCT01251380|520782618|FG000|Overall Study|Lack of Efficacy|1|||
144429816|NCT01251380|520782618|FG000|Overall Study|Adverse Event|1|||
144429817|NCT01251380|520782618|FG000|Overall Study|Lost to Follow-up|2|||
144429818|NCT01154218|520782619|FG000|Third Intervention Period|Adverse Event|0|||
144429819|NCT01154218|520782620|FG001|Third Intervention Period|Adverse Event|1|||
144429820|NCT01154218|520782621|FG002|Third Intervention Period|Adverse Event|0|||
144429821|NCT01154218|520782622|FG003|Third Intervention Period|Adverse Event|0|||
144429822|NCT01154218|520782619|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144429823|NCT01154218|520782620|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144429824|NCT01154218|520782621|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144429825|NCT01154218|520782622|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
144429826|NCT01154218|520782619|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
144429827|NCT01154218|520782620|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
144429828|NCT01154218|520782621|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
144429829|NCT01154218|520782622|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
144429830|NCT00362115|520782625|FG000|Overall Study|Adverse Event|0|||
144429831|NCT00362115|520782626|FG001|Overall Study|Adverse Event|1|||
144429832|NCT00362115|520782627|FG002|Overall Study|Adverse Event|1|||
144429833|NCT00362115|520782628|FG003|Overall Study|Adverse Event|1|||
144429834|NCT00362115|520782629|FG004|Overall Study|Adverse Event|2|||
144429835|NCT00362115|520782630|FG005|Overall Study|Adverse Event|2|||
144429836|NCT00362115|520782631|FG006|Overall Study|Adverse Event|1|||
144429837|NCT00362115|520782625|FG000|Overall Study|Protocol Violation|0|||
144429838|NCT00362115|520782626|FG001|Overall Study|Protocol Violation|0|||
144429839|NCT00362115|520782627|FG002|Overall Study|Protocol Violation|0|||
144429840|NCT00362115|520782628|FG003|Overall Study|Protocol Violation|0|||
144429841|NCT00362115|520782629|FG004|Overall Study|Protocol Violation|0|||
144429842|NCT00362115|520782630|FG005|Overall Study|Protocol Violation|1|||
144429843|NCT00362115|520782631|FG006|Overall Study|Protocol Violation|0|||
144429844|NCT00362115|520782625|FG000|Overall Study|Lost to Follow-up|0|||
144429845|NCT00362115|520782626|FG001|Overall Study|Lost to Follow-up|1|||
144429846|NCT00362115|520782627|FG002|Overall Study|Lost to Follow-up|0|||
144429847|NCT00362115|520782628|FG003|Overall Study|Lost to Follow-up|0|||
144429848|NCT00362115|520782629|FG004|Overall Study|Lost to Follow-up|2|||
144429849|NCT00362115|520782630|FG005|Overall Study|Lost to Follow-up|0|||
144429850|NCT00362115|520782631|FG006|Overall Study|Lost to Follow-up|1|||
144429851|NCT00362115|520782625|FG000|Overall Study|Withdrawal by Subject|1|||
144429852|NCT00362115|520782626|FG001|Overall Study|Withdrawal by Subject|3|||
144429853|NCT00362115|520782627|FG002|Overall Study|Withdrawal by Subject|1|||
144429854|NCT00362115|520782628|FG003|Overall Study|Withdrawal by Subject|0|||
144429855|NCT00362115|520782629|FG004|Overall Study|Withdrawal by Subject|1|||
144429856|NCT00362115|520782630|FG005|Overall Study|Withdrawal by Subject|3|||
144429857|NCT00362115|520782631|FG006|Overall Study|Withdrawal by Subject|4|||
144429858|NCT00362115|520782625|FG000|Overall Study|Lack of Efficacy|1|||
144429859|NCT00362115|520782626|FG001|Overall Study|Lack of Efficacy|0|||
144429860|NCT00362115|520782627|FG002|Overall Study|Lack of Efficacy|5|||
144429861|NCT00362115|520782628|FG003|Overall Study|Lack of Efficacy|2|||
144429862|NCT00362115|520782629|FG004|Overall Study|Lack of Efficacy|2|||
144429863|NCT00362115|520782630|FG005|Overall Study|Lack of Efficacy|0|||
144429864|NCT00362115|520782631|FG006|Overall Study|Lack of Efficacy|3|||
144429865|NCT00362115|520782625|FG000|Overall Study|Physician Decision|0|||
144429866|NCT00362115|520782626|FG001|Overall Study|Physician Decision|0|||
144429867|NCT00362115|520782627|FG002|Overall Study|Physician Decision|0|||
144183325|NCT00860262|519865814|FG002|Overall Study|Adverse Event|7|||
144429868|NCT00362115|520782628|FG003|Overall Study|Physician Decision|0|||
144429869|NCT00362115|520782629|FG004|Overall Study|Physician Decision|0|||
144429870|NCT00362115|520782630|FG005|Overall Study|Physician Decision|0|||
144429871|NCT00362115|520782631|FG006|Overall Study|Physician Decision|3|||
144429872|NCT00362115|520782625|FG000|Overall Study|Other|0|||
144429873|NCT00362115|520782626|FG001|Overall Study|Other|1|||
144429874|NCT00362115|520782627|FG002|Overall Study|Other|0|||
144429875|NCT00362115|520782628|FG003|Overall Study|Other|1|||
144429876|NCT00362115|520782629|FG004|Overall Study|Other|0|||
144429877|NCT00362115|520782630|FG005|Overall Study|Other|1|||
144429878|NCT00362115|520782631|FG006|Overall Study|Other|0|||
144429879|NCT00768144|520782632|FG000|Overall Study|Adverse Event|13|||
144429880|NCT00768144|520782632|FG000|Overall Study|Progressive Disease|21|||
144429881|NCT00768144|520782632|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
144429882|NCT00768144|520782632|FG000|Overall Study|Pt Withdrew Consent|1|||
144429883|NCT01150123|520782633|FG000|Overall Study|Withdrawal by Subject|1|||
144429884|NCT01150123|520782634|FG001|Overall Study|Withdrawal by Subject|1|||
144429885|NCT01150123|520782635|FG002|Overall Study|Withdrawal by Subject|2|||
144183326|NCT00860262|519865812|FG000|Overall Study|Protocol Violation|0|||
144429886|NCT01150123|520782636|FG003|Overall Study|Withdrawal by Subject|1|||
144429887|NCT01150123|520782637|FG004|Overall Study|Withdrawal by Subject|1|||
144429888|NCT01150123|520782638|FG005|Overall Study|Withdrawal by Subject|1|||
144429889|NCT01150123|520782639|FG006|Overall Study|Withdrawal by Subject|0|||
144429890|NCT01150123|520782640|FG007|Overall Study|Withdrawal by Subject|3|||
144429891|NCT01150123|520782641|FG008|Overall Study|Withdrawal by Subject|2|||
144429892|NCT01150123|520782642|FG009|Overall Study|Withdrawal by Subject|0|||
144429893|NCT01150123|520782643|FG010|Overall Study|Withdrawal by Subject|1|||
144429894|NCT01150123|520782644|FG011|Overall Study|Withdrawal by Subject|0|||
144429895|NCT01150123|520782645|FG012|Overall Study|Withdrawal by Subject|1|||
144429896|NCT01150123|520782646|FG013|Overall Study|Withdrawal by Subject|0|||
144429897|NCT01150123|520782647|FG014|Overall Study|Withdrawal by Subject|0|||
144429898|NCT01150123|520782648|FG015|Overall Study|Withdrawal by Subject|1|||
144429899|NCT01150123|520782649|FG016|Overall Study|Withdrawal by Subject|0|||
144429900|NCT01150123|520782650|FG017|Overall Study|Withdrawal by Subject|1|||
144429901|NCT01150123|520782633|FG000|Overall Study|Lost to Follow-up|2|||
144429902|NCT01150123|520782634|FG001|Overall Study|Lost to Follow-up|1|||
144429903|NCT01150123|520782635|FG002|Overall Study|Lost to Follow-up|2|||
144429904|NCT01150123|520782636|FG003|Overall Study|Lost to Follow-up|2|||
144429905|NCT01150123|520782637|FG004|Overall Study|Lost to Follow-up|2|||
144429906|NCT01150123|520782638|FG005|Overall Study|Lost to Follow-up|5|||
144429907|NCT01150123|520782639|FG006|Overall Study|Lost to Follow-up|0|||
144429908|NCT01150123|520782640|FG007|Overall Study|Lost to Follow-up|0|||
144429909|NCT01150123|520782641|FG008|Overall Study|Lost to Follow-up|3|||
144429910|NCT01150123|520782642|FG009|Overall Study|Lost to Follow-up|1|||
144429911|NCT01150123|520782643|FG010|Overall Study|Lost to Follow-up|1|||
144429912|NCT01150123|520782644|FG011|Overall Study|Lost to Follow-up|1|||
144429913|NCT01150123|520782645|FG012|Overall Study|Lost to Follow-up|2|||
144429914|NCT01150123|520782646|FG013|Overall Study|Lost to Follow-up|0|||
144429915|NCT01150123|520782647|FG014|Overall Study|Lost to Follow-up|0|||
144429916|NCT01150123|520782648|FG015|Overall Study|Lost to Follow-up|0|||
144429917|NCT01150123|520782649|FG016|Overall Study|Lost to Follow-up|0|||
144429918|NCT01150123|520782650|FG017|Overall Study|Lost to Follow-up|0|||
144429919|NCT00323492|520782661|FG000|Study Phase 1|Adverse Event|2|||
144429920|NCT00323492|520782662|FG001|Study Phase 1|Adverse Event|0|||
144429921|NCT00323492|520782663|FG002|Study Phase 1|Adverse Event|0|||
144429922|NCT00323492|520782661|FG000|Study Phase 2|Adverse Event|1|||
144429923|NCT00323492|520782662|FG001|Study Phase 2|Adverse Event|0|||
144429924|NCT00323492|520782663|FG002|Study Phase 2|Adverse Event|0|||
144429925|NCT00323492|520782661|FG000|Study Phase 2|Physician Decision|1|||
144429926|NCT00323492|520782662|FG001|Study Phase 2|Physician Decision|0|||
144429927|NCT00323492|520782663|FG002|Study Phase 2|Physician Decision|0|||
144429928|NCT00323492|520782661|FG000|Study Phase 2|Lost to Follow-up|1|||
144429929|NCT00323492|520782662|FG001|Study Phase 2|Lost to Follow-up|0|||
144429930|NCT00323492|520782663|FG002|Study Phase 2|Lost to Follow-up|0|||
144429931|NCT00323492|520782661|FG000|Study Phase 2|Withdrawal by Subject|0|||
144429932|NCT00323492|520782662|FG001|Study Phase 2|Withdrawal by Subject|1|||
144429933|NCT00323492|520782663|FG002|Study Phase 2|Withdrawal by Subject|0|||
144429934|NCT00323492|520782661|FG000|Study Phase 2|Noncompliance with study schedule|0|||
144429935|NCT00323492|520782662|FG001|Study Phase 2|Noncompliance with study schedule|0|||
144429936|NCT00323492|520782663|FG002|Study Phase 2|Noncompliance with study schedule|1|||
144429937|NCT00323492|520782661|FG000|Study Phase 2|Protocol Violation|1|||
144429938|NCT00323492|520782662|FG001|Study Phase 2|Protocol Violation|0|||
144429939|NCT00323492|520782663|FG002|Study Phase 2|Protocol Violation|0|||
144429940|NCT01466387|520782664|FG000|Overall Study|Adverse Event|0|||
144429941|NCT01466387|520782665|FG001|Overall Study|Adverse Event|0|||
144429942|NCT01466387|520782666|FG002|Overall Study|Adverse Event|1|||
144429943|NCT01466387|520782667|FG003|Overall Study|Adverse Event|1|||
144429944|NCT01466387|520782668|FG004|Overall Study|Adverse Event|0|||
144429945|NCT01466387|520782669|FG005|Overall Study|Adverse Event|0|||
144429946|NCT01466387|520782664|FG000|Overall Study|Lost to Follow-up|0|||
144429947|NCT01466387|520782665|FG001|Overall Study|Lost to Follow-up|0|||
144429948|NCT01466387|520782666|FG002|Overall Study|Lost to Follow-up|0|||
144429949|NCT01466387|520782667|FG003|Overall Study|Lost to Follow-up|0|||
144429950|NCT01466387|520782668|FG004|Overall Study|Lost to Follow-up|0|||
144183327|NCT00860262|519865813|FG001|Overall Study|Protocol Violation|1|||
144429951|NCT01466387|520782669|FG005|Overall Study|Lost to Follow-up|1|||
144429952|NCT01466387|520782664|FG000|Overall Study|Protocol Violation|1|||
144429953|NCT01466387|520782665|FG001|Overall Study|Protocol Violation|0|||
144183328|NCT00860262|519865814|FG002|Overall Study|Protocol Violation|0|||
144183329|NCT00860262|519865812|FG000|Overall Study|Lost to Follow-up|2|||
144183330|NCT00860262|519865813|FG001|Overall Study|Lost to Follow-up|0|||
144429954|NCT01466387|520782666|FG002|Overall Study|Protocol Violation|0|||
144429955|NCT01466387|520782667|FG003|Overall Study|Protocol Violation|1|||
144429956|NCT01466387|520782668|FG004|Overall Study|Protocol Violation|0|||
144429957|NCT01466387|520782669|FG005|Overall Study|Protocol Violation|0|||
144429958|NCT02347189|520782670|FG000|Overall Study|No implant attempted of study device|9|||
144429959|NCT02347189|520782670|FG000|Overall Study|No primary outcome data available|2|||
144429960|NCT04248933|520782676|FG000|Overall Study|Lost to Follow-up|9|||
144429961|NCT04248933|520782676|FG000|Overall Study|Withdrawal by Subject|2|||
144429962|NCT00578942|520782677|FG000|Overall Study|Lost to Follow-up|1|||
144429963|NCT00600938|520782678|FG000|Core Study|Abnormal test procedure result(s)|3|||
144429964|NCT00600938|520782679|FG001|Core Study|Abnormal test procedure result(s)|2|||
144429965|NCT00600938|520782680|FG002|Core Study|Abnormal test procedure result(s)|0|||
144429966|NCT00600938|520782681|FG003|Core Study|Abnormal test procedure result(s)|0|||
144429967|NCT00600938|520782678|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
144429968|NCT00600938|520782679|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
144429969|NCT00600938|520782680|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
144429970|NCT00600938|520782681|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
144429971|NCT00600938|520782678|FG000|Core Study|Patient withdrew consent|7|||
144429972|NCT00600938|520782679|FG001|Core Study|Patient withdrew consent|12|||
144429973|NCT00600938|520782680|FG002|Core Study|Patient withdrew consent|0|||
144429974|NCT00600938|520782681|FG003|Core Study|Patient withdrew consent|0|||
144429975|NCT00600938|520782678|FG000|Core Study|Lost to Follow-up|3|||
144429976|NCT00600938|520782679|FG001|Core Study|Lost to Follow-up|2|||
144429977|NCT00600938|520782680|FG002|Core Study|Lost to Follow-up|0|||
144429978|NCT00600938|520782681|FG003|Core Study|Lost to Follow-up|0|||
144429979|NCT00600938|520782678|FG000|Core Study|Death|1|||
144429980|NCT00600938|520782679|FG001|Core Study|Death|1|||
144429981|NCT00600938|520782680|FG002|Core Study|Death|0|||
144429982|NCT00600938|520782681|FG003|Core Study|Death|0|||
144429983|NCT00600938|520782678|FG000|Core Study|Protocol Violation|1|||
144429984|NCT00600938|520782679|FG001|Core Study|Protocol Violation|2|||
144429985|NCT00600938|520782680|FG002|Core Study|Protocol Violation|0|||
144429986|NCT00600938|520782681|FG003|Core Study|Protocol Violation|0|||
144429987|NCT00600938|520782678|FG000|Extension Study|Adverse Event|1|||
144429988|NCT00600938|520782679|FG001|Extension Study|Adverse Event|0|||
144429989|NCT00600938|520782680|FG002|Extension Study|Adverse Event|2|||
144429990|NCT00600938|520782681|FG003|Extension Study|Adverse Event|0|||
144429991|NCT00600938|520782678|FG000|Extension Study|Abnormal test procedure results|0|||
144429992|NCT00600938|520782679|FG001|Extension Study|Abnormal test procedure results|1|||
144429993|NCT00600938|520782680|FG002|Extension Study|Abnormal test procedure results|1|||
144429994|NCT00600938|520782681|FG003|Extension Study|Abnormal test procedure results|1|||
144429995|NCT00600938|520782678|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
144429996|NCT00600938|520782679|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
144429997|NCT00600938|520782680|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
144429998|NCT00600938|520782681|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
144429999|NCT00600938|520782678|FG000|Extension Study|Withdrawal by Subject|2|||
144430000|NCT00600938|520782679|FG001|Extension Study|Withdrawal by Subject|2|||
144430001|NCT00600938|520782680|FG002|Extension Study|Withdrawal by Subject|3|||
144430002|NCT00600938|520782681|FG003|Extension Study|Withdrawal by Subject|0|||
144430003|NCT00600938|520782678|FG000|Extension Study|Lost to Follow-up|1|||
144430004|NCT00600938|520782679|FG001|Extension Study|Lost to Follow-up|1|||
144430005|NCT00600938|520782680|FG002|Extension Study|Lost to Follow-up|2|||
144430006|NCT00600938|520782681|FG003|Extension Study|Lost to Follow-up|0|||
144430007|NCT00600938|520782678|FG000|Extension Study|Death|1|||
144430008|NCT00600938|520782679|FG001|Extension Study|Death|0|||
144430009|NCT00600938|520782680|FG002|Extension Study|Death|0|||
144430010|NCT00600938|520782681|FG003|Extension Study|Death|0|||
144430011|NCT02680639|520782682|FG000|Screening Period|Screen Failure|7|||
144430012|NCT02680639|520782683|FG001|Screening Period|Screen Failure|0|||
144430013|NCT02680639|520782684|FG002|Screening Period|Screen Failure|0|||
144430014|NCT02946047|520782688|FG000|Overall Study|Adverse Event|1|||
144430015|NCT02946047|520782689|FG001|Overall Study|Adverse Event|0|||
144430016|NCT02946047|520782690|FG002|Overall Study|Adverse Event|0|||
144430017|NCT02946047|520782691|FG003|Overall Study|Adverse Event|0|||
144430018|NCT04439318|520782692|FG000|Overall Study|Ineligible|1|||
144430019|NCT04439318|520782692|FG000|Overall Study|Never Started Treatment|3|||
144430020|NCT04439318|520782692|FG000|Overall Study|Adverse Event|10|||
144430021|NCT04439318|520782692|FG000|Overall Study|Death|2|||
144430022|NCT04439318|520782692|FG000|Overall Study|Disease Progression|25|||
144430023|NCT04439318|520782692|FG000|Overall Study|Other Complicating Disease|2|||
144430024|NCT04439318|520782692|FG000|Overall Study|Withdrawal by Subject|4|||
144430025|NCT04439318|520782692|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
144252131|NCT00055497|520122662|FG002|Overall Study|Other|0|||
144252132|NCT00055497|520122663|FG003|Overall Study|Other|11|||
144430026|NCT04439318|520782692|FG000|Overall Study|Non-Compliance|1|||
144430027|NCT04439318|520782692|FG000|Overall Study|Still on Treatment|1|||
144430028|NCT03873987|520784745|FG000|Overall Study|Adverse Event|1|||
144430029|NCT03873987|520784746|FG001|Overall Study|Adverse Event|0|||
144430030|NCT03873987|520784745|FG000|Overall Study|staff was unable to start a new IV line|1|||
144430031|NCT03873987|520784746|FG001|Overall Study|staff was unable to start a new IV line|0|||
144430032|NCT03873987|520784745|FG000|Overall Study|Lost to Follow-up|0|||
144430033|NCT03873987|520784746|FG001|Overall Study|Lost to Follow-up|1|||
144430034|NCT01465022|520784747|FG000|Overall Study|Lost to Follow-up|15|||
144430035|NCT01465022|520784748|FG001|Overall Study|Lost to Follow-up|14|||
144430036|NCT01465022|520784749|FG002|Overall Study|Lost to Follow-up|0|||
144430037|NCT01465022|520784747|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
144430038|NCT01465022|520784748|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
144430039|NCT01465022|520784749|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
144430040|NCT01465022|520784747|FG000|Overall Study|Not Randomized|0|||
144430041|NCT01465022|520784748|FG001|Overall Study|Not Randomized|0|||
144430042|NCT01465022|520784749|FG002|Overall Study|Not Randomized|70|||
144430043|NCT01957462|520784750|FG000|Test Period 1|Withdrawal by Subject|1|||
144430044|NCT01957462|520784751|FG001|Test Period 1|Withdrawal by Subject|0|||
144430045|NCT01957462|520784750|FG000|Test Period 1|Adverse Event|1|||
144430046|NCT01957462|520784751|FG001|Test Period 1|Adverse Event|0|||
144430047|NCT03616912|520784752|FG000|Overall Study|Adverse Event|17|||
144430048|NCT03616912|520784753|FG001|Overall Study|Adverse Event|21|||
144430049|NCT03616912|520784754|FG002|Overall Study|Adverse Event|9|||
144430050|NCT03616912|520784755|FG003|Overall Study|Adverse Event|0|||
144430051|NCT03616912|520784756|FG004|Overall Study|Adverse Event|0|||
144430052|NCT03616912|520784757|FG005|Overall Study|Adverse Event|0|||
144430053|NCT03616912|520784752|FG000|Overall Study|Death|1|||
144430054|NCT03616912|520784753|FG001|Overall Study|Death|1|||
144430055|NCT03616912|520784754|FG002|Overall Study|Death|0|||
144430056|NCT03616912|520784755|FG003|Overall Study|Death|0|||
144430057|NCT03616912|520784756|FG004|Overall Study|Death|0|||
144430058|NCT03616912|520784757|FG005|Overall Study|Death|0|||
144430059|NCT03616912|520784752|FG000|Overall Study|Lack of Efficacy|13|||
144430060|NCT03616912|520784753|FG001|Overall Study|Lack of Efficacy|6|||
144430061|NCT03616912|520784754|FG002|Overall Study|Lack of Efficacy|8|||
144430062|NCT03616912|520784755|FG003|Overall Study|Lack of Efficacy|4|||
144430063|NCT03616912|520784756|FG004|Overall Study|Lack of Efficacy|5|||
144430064|NCT03616912|520784757|FG005|Overall Study|Lack of Efficacy|1|||
144430065|NCT03616912|520784752|FG000|Overall Study|Lost to Follow-up|1|||
144430066|NCT03616912|520784753|FG001|Overall Study|Lost to Follow-up|2|||
144430067|NCT03616912|520784754|FG002|Overall Study|Lost to Follow-up|3|||
144430068|NCT03616912|520784755|FG003|Overall Study|Lost to Follow-up|0|||
144430069|NCT03616912|520784756|FG004|Overall Study|Lost to Follow-up|0|||
144430070|NCT03616912|520784757|FG005|Overall Study|Lost to Follow-up|0|||
144430071|NCT03616912|520784752|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
144430072|NCT03616912|520784753|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
144430073|NCT03616912|520784754|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
144430074|NCT03616912|520784755|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
144430075|NCT03616912|520784756|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
144430076|NCT03616912|520784757|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
144430077|NCT03616912|520784752|FG000|Overall Study|Withdrawal by Subject|12|||
144430078|NCT03616912|520784753|FG001|Overall Study|Withdrawal by Subject|12|||
144430079|NCT03616912|520784754|FG002|Overall Study|Withdrawal by Subject|15|||
144430080|NCT03616912|520784755|FG003|Overall Study|Withdrawal by Subject|2|||
144430081|NCT03616912|520784756|FG004|Overall Study|Withdrawal by Subject|0|||
144430082|NCT03616912|520784757|FG005|Overall Study|Withdrawal by Subject|2|||
144430083|NCT03616912|520784752|FG000|Overall Study|Study Terminated by Sponsor|0|||
144430084|NCT03616912|520784753|FG001|Overall Study|Study Terminated by Sponsor|0|||
144430085|NCT03616912|520784754|FG002|Overall Study|Study Terminated by Sponsor|0|||
144430086|NCT03616912|520784755|FG003|Overall Study|Study Terminated by Sponsor|10|||
144430087|NCT03616912|520784756|FG004|Overall Study|Study Terminated by Sponsor|9|||
144430088|NCT03616912|520784757|FG005|Overall Study|Study Terminated by Sponsor|11|||
144430089|NCT03616912|520784752|FG000|Overall Study|Protocol Deviation|1|||
144430090|NCT03616912|520784753|FG001|Overall Study|Protocol Deviation|1|||
144430091|NCT03616912|520784754|FG002|Overall Study|Protocol Deviation|0|||
144430092|NCT03616912|520784755|FG003|Overall Study|Protocol Deviation|0|||
144430093|NCT03616912|520784756|FG004|Overall Study|Protocol Deviation|0|||
144430094|NCT03616912|520784757|FG005|Overall Study|Protocol Deviation|0|||
144430095|NCT03616912|520784752|FG000|Overall Study|Pregnancy|1|||
144430096|NCT03616912|520784753|FG001|Overall Study|Pregnancy|0|||
144430097|NCT03616912|520784754|FG002|Overall Study|Pregnancy|4|||
144430098|NCT03616912|520784755|FG003|Overall Study|Pregnancy|0|||
144430099|NCT03616912|520784756|FG004|Overall Study|Pregnancy|0|||
144430100|NCT03616912|520784757|FG005|Overall Study|Pregnancy|0|||
144430101|NCT03616912|520784752|FG000|Overall Study|Protocol Violation|1|||
144430102|NCT03616912|520784753|FG001|Overall Study|Protocol Violation|0|||
144430103|NCT03616912|520784754|FG002|Overall Study|Protocol Violation|2|||
144603836|NCT00375219|521412037|FG000|Overall Study|Lost to Follow-up|1|||
144603837|NCT00375219|521412038|FG001|Overall Study|Lost to Follow-up|1|||
144603838|NCT00375219|521412039|FG002|Overall Study|Lost to Follow-up|0|||
144603839|NCT00375219|521412037|FG000|Overall Study|Disease progression|18|||
144603840|NCT00375219|521412038|FG001|Overall Study|Disease progression|9|||
144603841|NCT00375219|521412039|FG002|Overall Study|Disease progression|12|||
144603842|NCT00375219|521412037|FG000|Overall Study|Death|4|||
144430104|NCT03616912|520784755|FG003|Overall Study|Protocol Violation|0|||
144430105|NCT03616912|520784756|FG004|Overall Study|Protocol Violation|0|||
144430106|NCT03616912|520784757|FG005|Overall Study|Protocol Violation|0|||
144430107|NCT03616912|520784752|FG000|Overall Study|Physician Decision|2|||
144430108|NCT03616912|520784753|FG001|Overall Study|Physician Decision|0|||
144430109|NCT03616912|520784754|FG002|Overall Study|Physician Decision|0|||
144430110|NCT03616912|520784755|FG003|Overall Study|Physician Decision|0|||
144430111|NCT03616912|520784756|FG004|Overall Study|Physician Decision|1|||
144430112|NCT03616912|520784757|FG005|Overall Study|Physician Decision|0|||
144430113|NCT03616912|520784752|FG000|Overall Study|Randomized But Never Treated|0|||
144603843|NCT00375219|521412038|FG001|Overall Study|Death|3|||
144252133|NCT02112877|520122665|FG000|Overall Study|Withdrawal by Subject|1|||
144252134|NCT02112877|520122666|FG001|Overall Study|Withdrawal by Subject|7|||
144430114|NCT03616912|520784753|FG001|Overall Study|Randomized But Never Treated|2|||
144430115|NCT03616912|520784754|FG002|Overall Study|Randomized But Never Treated|0|||
144430116|NCT03616912|520784755|FG003|Overall Study|Randomized But Never Treated|0|||
144430117|NCT03616912|520784756|FG004|Overall Study|Randomized But Never Treated|0|||
144430118|NCT03616912|520784757|FG005|Overall Study|Randomized But Never Treated|0|||
144430119|NCT01856790|520784758|FG000|Closed Loop Control|Withdrawal by Subject|2|||
144430120|NCT01856790|520784758|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
144430121|NCT01921829|520784759|FG000|Overall Study|Withdrawal by Subject|0|||
144430122|NCT01921829|520784760|FG001|Overall Study|Withdrawal by Subject|1|||
144430123|NCT01762943|520784762|FG000|Overall Study|Physician Decision|1|||
144430124|NCT01762943|520784763|FG001|Overall Study|Physician Decision|1|||
144430125|NCT01762943|520784762|FG000|Overall Study|Protocol Violation|1|||
144430126|NCT01762943|520784763|FG001|Overall Study|Protocol Violation|0|||
144430127|NCT01762943|520784762|FG000|Overall Study|Withdrawal by Subject|2|||
144430128|NCT01762943|520784763|FG001|Overall Study|Withdrawal by Subject|1|||
144430129|NCT00539838|520784764|FG000|Overall Study|Fail to return|2|||
144430130|NCT00539838|520784765|FG001|Overall Study|Fail to return|0|||
144430131|NCT00539838|520784766|FG002|Overall Study|Fail to return|0|||
144430132|NCT00539838|520784764|FG000|Overall Study|Withdrawal by Subject|0|||
144430133|NCT00539838|520784765|FG001|Overall Study|Withdrawal by Subject|4|||
144430134|NCT00539838|520784766|FG002|Overall Study|Withdrawal by Subject|0|||
144430135|NCT00539838|520784764|FG000|Overall Study|Death|0|||
144430136|NCT00539838|520784765|FG001|Overall Study|Death|2|||
144430137|NCT00539838|520784766|FG002|Overall Study|Death|0|||
144430138|NCT00539838|520784764|FG000|Overall Study|Did not cooperate|1|||
144430139|NCT00539838|520784765|FG001|Overall Study|Did not cooperate|0|||
144430140|NCT00539838|520784766|FG002|Overall Study|Did not cooperate|1|||
144430141|NCT00539838|520784764|FG000|Overall Study|Administrative|4|||
144430142|NCT00539838|520784765|FG001|Overall Study|Administrative|0|||
144430143|NCT00539838|520784766|FG002|Overall Study|Administrative|8|||
144430144|NCT02658890|520784769|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430145|NCT02658890|520784770|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430146|NCT02658890|520784771|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430147|NCT02658890|520784772|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430148|NCT02658890|520784773|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430149|NCT02658890|520784774|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430150|NCT02658890|520784775|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430151|NCT02658890|520784776|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430152|NCT02658890|520784777|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
144430153|NCT02658890|520784778|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430154|NCT02658890|520784779|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430155|NCT02658890|520784780|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430156|NCT02658890|520784781|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430157|NCT02658890|520784782|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430158|NCT02658890|520784783|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430159|NCT02658890|520784784|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430160|NCT02658890|520784785|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430161|NCT02658890|520784786|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430162|NCT02658890|520784787|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430163|NCT02658890|520784788|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430164|NCT02658890|520784789|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430165|NCT02658890|520784790|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430166|NCT02658890|520784791|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430167|NCT02658890|520784792|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430168|NCT02658890|520784793|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144252135|NCT02112877|520122665|FG000|Overall Study|Visit Missed|1|||
144430169|NCT02658890|520784794|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430170|NCT02658890|520784795|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430171|NCT02658890|520784769|FG000|Treatment Phase|Adverse Event|0|||
144430172|NCT02658890|520784770|FG001|Treatment Phase|Adverse Event|1|||
144430173|NCT02658890|520784771|FG002|Treatment Phase|Adverse Event|2|||
144430174|NCT02658890|520784772|FG003|Treatment Phase|Adverse Event|2|||
144430175|NCT02658890|520784773|FG004|Treatment Phase|Adverse Event|1|||
144430176|NCT02658890|520784774|FG005|Treatment Phase|Adverse Event|0|||
144430177|NCT02658890|520784775|FG006|Treatment Phase|Adverse Event|0|||
144430178|NCT02658890|520784776|FG007|Treatment Phase|Adverse Event|2|||
144430179|NCT02658890|520784777|FG008|Treatment Phase|Adverse Event|1|||
144430180|NCT02658890|520784778|FG009|Treatment Phase|Adverse Event|2|||
144430181|NCT02658890|520784779|FG010|Treatment Phase|Adverse Event|3|||
144430182|NCT02658890|520784780|FG011|Treatment Phase|Adverse Event|0|||
144430183|NCT02658890|520784781|FG012|Treatment Phase|Adverse Event|1|||
144430184|NCT02658890|520784782|FG013|Treatment Phase|Adverse Event|4|||
144430185|NCT02658890|520784783|FG014|Treatment Phase|Adverse Event|0|||
144430186|NCT02658890|520784784|FG015|Treatment Phase|Adverse Event|0|||
144430187|NCT02658890|520784785|FG016|Treatment Phase|Adverse Event|0|||
144430188|NCT02658890|520784786|FG017|Treatment Phase|Adverse Event|0|||
144430189|NCT02658890|520784787|FG018|Treatment Phase|Adverse Event|5|||
144430190|NCT02658890|520784788|FG019|Treatment Phase|Adverse Event|1|||
144430191|NCT02658890|520784789|FG020|Treatment Phase|Adverse Event|3|||
144430192|NCT02658890|520784790|FG021|Treatment Phase|Adverse Event|0|||
144430193|NCT02658890|520784791|FG022|Treatment Phase|Adverse Event|5|||
144430194|NCT02658890|520784792|FG023|Treatment Phase|Adverse Event|0|||
144430195|NCT02658890|520784793|FG024|Treatment Phase|Adverse Event|0|||
144430196|NCT02658890|520784794|FG025|Treatment Phase|Adverse Event|2|||
144430197|NCT02658890|520784795|FG026|Treatment Phase|Adverse Event|1|||
144430198|NCT02658890|520784769|FG000|Treatment Phase|Death|0|||
144430199|NCT02658890|520784770|FG001|Treatment Phase|Death|0|||
144430200|NCT02658890|520784771|FG002|Treatment Phase|Death|0|||
144430201|NCT02658890|520784772|FG003|Treatment Phase|Death|0|||
144430202|NCT02658890|520784773|FG004|Treatment Phase|Death|0|||
144529008|NCT03088878|521139163|FG003|Overall Study|Adverse Event|0|||
144529009|NCT03088878|521139164|FG004|Overall Study|Adverse Event|4|||
144529010|NCT03088878|521139165|FG005|Overall Study|Adverse Event|2|||
144529011|NCT03088878|521139166|FG006|Overall Study|Adverse Event|1|||
144529012|NCT03088878|521139167|FG007|Overall Study|Adverse Event|0|||
144529013|NCT03088878|521139168|FG008|Overall Study|Adverse Event|0|||
144529014|NCT03088878|521139169|FG009|Overall Study|Adverse Event|0|||
144183331|NCT00860262|519865814|FG002|Overall Study|Lost to Follow-up|1|||
144183332|NCT00860262|519865812|FG000|Overall Study|Withdrawal by Subject|4|||
144183333|NCT00860262|519865813|FG001|Overall Study|Withdrawal by Subject|8|||
144183334|NCT00860262|519865814|FG002|Overall Study|Withdrawal by Subject|6|||
144183335|NCT00860262|519865812|FG000|Overall Study|Lack of Efficacy|0|||
144430203|NCT02658890|520784774|FG005|Treatment Phase|Death|0|||
144430204|NCT02658890|520784775|FG006|Treatment Phase|Death|0|||
144430205|NCT02658890|520784776|FG007|Treatment Phase|Death|0|||
144430206|NCT02658890|520784777|FG008|Treatment Phase|Death|0|||
144430207|NCT02658890|520784778|FG009|Treatment Phase|Death|0|||
144529015|NCT03088878|521139170|FG010|Overall Study|Adverse Event|0|||
144183336|NCT00860262|519865813|FG001|Overall Study|Lack of Efficacy|4|||
144183337|NCT00860262|519865814|FG002|Overall Study|Lack of Efficacy|3|||
144183338|NCT00860262|519865812|FG000|Overall Study|Other|5|||
144183339|NCT00860262|519865813|FG001|Overall Study|Other|3|||
144183340|NCT00860262|519865814|FG002|Overall Study|Other|1|||
144183341|NCT03201003|519865819|FG000|Overall Study|Adverse Event|14|||
144183342|NCT03201003|519865820|FG001|Overall Study|Adverse Event|1|||
144183343|NCT03201003|519865819|FG000|Overall Study|Other reasons|5|||
144183344|NCT03201003|519865820|FG001|Overall Study|Other reasons|1|||
144183345|NCT03201003|519865819|FG000|Overall Study|Withdrawal by Subject|4|||
144183346|NCT03201003|519865820|FG001|Overall Study|Withdrawal by Subject|1|||
144183347|NCT03201003|519865819|FG000|Overall Study|Lost to Follow-up|2|||
144183348|NCT03201003|519865820|FG001|Overall Study|Lost to Follow-up|0|||
144183349|NCT03201003|519865819|FG000|Overall Study|Protocol Violation|1|||
144183350|NCT03201003|519865820|FG001|Overall Study|Protocol Violation|0|||
144183351|NCT00834613|519865821|FG000|First Intervention|Protocol Violation|1|||
144183352|NCT00834613|519865822|FG001|First Intervention|Protocol Violation|0|||
144183353|NCT00697619|519865825|FG000|Overall Study|Lack of Efficacy|2|||
144183354|NCT00697619|519865826|FG001|Overall Study|Lack of Efficacy|2|||
144183355|NCT00697619|519865825|FG000|Overall Study|Adverse Event|4|||
144183356|NCT00697619|519865826|FG001|Overall Study|Adverse Event|6|||
144183357|NCT01188226|519867448|FG000|Overall Study|Withdrawal by Subject|4|||
144183358|NCT04832971|519867449|FG000|Overall Study|Death|1|||
144183359|NCT04832971|519867450|FG001|Overall Study|Death|0|||
144183360|NCT04832971|519867451|FG002|Overall Study|Death|0|||
144183361|NCT04832971|519867452|FG003|Overall Study|Death|0|||
144183362|NCT04832971|519867449|FG000|Overall Study|Lost to Follow-up|1|||
144183363|NCT04832971|519867450|FG001|Overall Study|Lost to Follow-up|1|||
144183364|NCT04832971|519867451|FG002|Overall Study|Lost to Follow-up|1|||
144183365|NCT04832971|519867452|FG003|Overall Study|Lost to Follow-up|0|||
144183366|NCT04832971|519867449|FG000|Overall Study|Withdrawal by Subject|1|||
144183367|NCT04832971|519867450|FG001|Overall Study|Withdrawal by Subject|3|||
144183368|NCT04832971|519867451|FG002|Overall Study|Withdrawal by Subject|2|||
144183369|NCT04832971|519867452|FG003|Overall Study|Withdrawal by Subject|2|||
144183370|NCT04832971|519867449|FG000|Overall Study|Other, Not Specified|0|||
144183371|NCT04832971|519867450|FG001|Overall Study|Other, Not Specified|0|||
144183372|NCT04832971|519867451|FG002|Overall Study|Other, Not Specified|1|||
144183373|NCT04832971|519867452|FG003|Overall Study|Other, Not Specified|0|||
144183374|NCT04980456|519867453|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
144252136|NCT02112877|520122666|FG001|Overall Study|Visit Missed|6|||
144430208|NCT02658890|520784779|FG010|Treatment Phase|Death|0|||
144430209|NCT02658890|520784780|FG011|Treatment Phase|Death|0|||
144183375|NCT04980456|519867454|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
144183376|NCT04980456|519867453|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
144183377|NCT04980456|519867454|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
144183378|NCT04980456|519867453|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
144183379|NCT04980456|519867454|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
144183380|NCT04980456|519867453|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
144183381|NCT04980456|519867454|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
144183382|NCT02293460|519867455|FG000|Overall Study|Protocol Violation|1|||
144183383|NCT02293460|519867455|FG000|Overall Study|Lack of Efficacy|2|||
144183384|NCT02293460|519867455|FG000|Overall Study|Adverse Event|2|||
144183385|NCT02293460|519867455|FG000|Overall Study|Withdrawal by Subject|1|||
144183386|NCT01074008|519867456|FG000|Overall Study|Adverse Event|0|||
144183387|NCT01074008|519867457|FG001|Overall Study|Adverse Event|1|||
144183388|NCT01074008|519867458|FG002|Overall Study|Adverse Event|0|||
144183389|NCT01074008|519867459|FG003|Overall Study|Adverse Event|0|||
144183390|NCT01074008|519867460|FG004|Overall Study|Adverse Event|0|||
144183391|NCT01074008|519867461|FG005|Overall Study|Adverse Event|0|||
144183392|NCT01074008|519867462|FG006|Overall Study|Adverse Event|0|||
144183393|NCT01074008|519867463|FG007|Overall Study|Adverse Event|0|||
144183394|NCT01074008|519867464|FG008|Overall Study|Adverse Event|0|||
144183395|NCT01074008|519867456|FG000|Overall Study|Withdrawal by Subject|1|||
144183396|NCT01074008|519867457|FG001|Overall Study|Withdrawal by Subject|1|||
144183397|NCT01074008|519867458|FG002|Overall Study|Withdrawal by Subject|1|||
144183398|NCT01074008|519867459|FG003|Overall Study|Withdrawal by Subject|0|||
144183399|NCT01074008|519867460|FG004|Overall Study|Withdrawal by Subject|1|||
144183400|NCT01074008|519867461|FG005|Overall Study|Withdrawal by Subject|0|||
144183401|NCT01074008|519867462|FG006|Overall Study|Withdrawal by Subject|0|||
144183402|NCT01074008|519867463|FG007|Overall Study|Withdrawal by Subject|0|||
144183403|NCT01074008|519867464|FG008|Overall Study|Withdrawal by Subject|0|||
144183404|NCT01074008|519867456|FG000|Overall Study|Lost to Follow-up|0|||
144183405|NCT01074008|519867457|FG001|Overall Study|Lost to Follow-up|1|||
144183406|NCT01074008|519867458|FG002|Overall Study|Lost to Follow-up|1|||
144183407|NCT01074008|519867459|FG003|Overall Study|Lost to Follow-up|1|||
144183408|NCT01074008|519867460|FG004|Overall Study|Lost to Follow-up|1|||
144183409|NCT01074008|519867461|FG005|Overall Study|Lost to Follow-up|0|||
144183410|NCT01074008|519867462|FG006|Overall Study|Lost to Follow-up|1|||
144183411|NCT01074008|519867463|FG007|Overall Study|Lost to Follow-up|0|||
144183412|NCT01074008|519867464|FG008|Overall Study|Lost to Follow-up|4|||
144183413|NCT00224484|519867467|FG000|Overall Study|Serious Adverse Event|1|||
144183414|NCT00224484|519867468|FG001|Overall Study|Serious Adverse Event|1|||
144183415|NCT00224484|519867469|FG002|Overall Study|Serious Adverse Event|0|||
144183416|NCT00224484|519867467|FG000|Overall Study|Non-Serious Adverse Event|5|||
144183417|NCT00224484|519867468|FG001|Overall Study|Non-Serious Adverse Event|7|||
144183418|NCT00224484|519867469|FG002|Overall Study|Non-Serious Adverse Event|3|||
144183419|NCT00224484|519867467|FG000|Overall Study|Protocol Violation|2|||
144183420|NCT00224484|519867468|FG001|Overall Study|Protocol Violation|2|||
144183421|NCT00224484|519867469|FG002|Overall Study|Protocol Violation|0|||
144183422|NCT00224484|519867467|FG000|Overall Study|Withdrawal by Subject|49|||
144183423|NCT00224484|519867468|FG001|Overall Study|Withdrawal by Subject|18|||
144183424|NCT00224484|519867469|FG002|Overall Study|Withdrawal by Subject|16|||
144183425|NCT00224484|519867467|FG000|Overall Study|Migrated/moved from study area|18|||
144183426|NCT00224484|519867468|FG001|Overall Study|Migrated/moved from study area|5|||
144183427|NCT00224484|519867469|FG002|Overall Study|Migrated/moved from study area|5|||
144183428|NCT00224484|519867467|FG000|Overall Study|Lost to Follow-up|66|||
144183429|NCT00224484|519867468|FG001|Overall Study|Lost to Follow-up|28|||
144183430|NCT00224484|519867469|FG002|Overall Study|Lost to Follow-up|36|||
144183431|NCT00224484|519867467|FG000|Overall Study|Reason not specified|5|||
144183432|NCT00224484|519867468|FG001|Overall Study|Reason not specified|4|||
144183433|NCT00224484|519867469|FG002|Overall Study|Reason not specified|2|||
144183434|NCT02805309|519867470|FG000|Overall Study|Lost to Follow-up|2|||
144183435|NCT02805309|519867471|FG001|Overall Study|Lost to Follow-up|2|||
144603844|NCT00375219|521412039|FG002|Overall Study|Death|7|||
144183436|NCT02805309|519867472|FG002|Overall Study|Lost to Follow-up|2|||
144183437|NCT02805309|519867470|FG000|Overall Study|Post-Randomization Exclusion|0|||
144183438|NCT02805309|519867471|FG001|Overall Study|Post-Randomization Exclusion|2|||
144183439|NCT02805309|519867472|FG002|Overall Study|Post-Randomization Exclusion|1|||
144603845|NCT00375219|521412037|FG000|Overall Study|Hematologic resistance|1|||
144183440|NCT01636934|519867475|FG000|Overall Study|Withdrawal by Subject|3|||
144183441|NCT01636934|519867476|FG001|Overall Study|Withdrawal by Subject|2|||
144183442|NCT01636934|519867475|FG000|Overall Study|Chemo cancel|1|||
144183443|NCT01636934|519867476|FG001|Overall Study|Chemo cancel|0|||
144183444|NCT01636934|519867475|FG000|Overall Study|Too ill to continue|1|||
144183445|NCT01636934|519867476|FG001|Overall Study|Too ill to continue|0|||
144183446|NCT01636934|519867475|FG000|Overall Study|Never started study medication|1|||
144183447|NCT01636934|519867476|FG001|Overall Study|Never started study medication|1|||
144183448|NCT03687242|519867481|FG000|Overall Study|Adverse Event|1|||
144183449|NCT00377156|519867484|FG000|Overall Study|Death|23|||
144183450|NCT00377156|519867485|FG001|Overall Study|Death|19|||
144183451|NCT00377156|519867484|FG000|Overall Study|Withdrawal by Subject|16|||
144183452|NCT00377156|519867485|FG001|Overall Study|Withdrawal by Subject|24|||
144183453|NCT00377156|519867484|FG000|Overall Study|Had follow-up <90 d|3|||
144183454|NCT00377156|519867485|FG001|Overall Study|Had follow-up <90 d|6|||
144183455|NCT00377156|519867484|FG000|Overall Study|Cancellation|1|||
144183456|NCT00377156|519867485|FG001|Overall Study|Cancellation|0|||
144183457|NCT00377156|519867484|FG000|Overall Study|Refused testing|0|||
144183458|NCT00377156|519867485|FG001|Overall Study|Refused testing|1|||
144183459|NCT00377156|519867484|FG000|Overall Study|Ineligible|0|||
144183460|NCT00377156|519867485|FG001|Overall Study|Ineligible|1|||
144183461|NCT00377156|519867484|FG000|Overall Study|Disability or language problem|0|||
144183462|NCT00377156|519867485|FG001|Overall Study|Disability or language problem|1|||
144183463|NCT00377156|519867484|FG000|Overall Study|Other|5|||
144183464|NCT00377156|519867485|FG001|Overall Study|Other|2|||
144183465|NCT00288704|519867486|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
144183466|NCT00288704|519867487|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
144183467|NCT00288704|519867488|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
144183468|NCT00288704|519867486|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
144183469|NCT00288704|519867487|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
144183470|NCT00288704|519867488|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
144183471|NCT00288704|519867486|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
144183472|NCT00288704|519867487|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
144183473|NCT00288704|519867488|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
144183474|NCT00288704|519867486|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
144183475|NCT00288704|519867487|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
144183476|NCT00288704|519867488|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
144183477|NCT00288704|519867486|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
144183478|NCT00288704|519867487|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
144183479|NCT00288704|519867488|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
144183480|NCT00288704|519867486|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
144183481|NCT00288704|519867487|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
144183482|NCT00288704|519867488|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
144183483|NCT00288704|519867486|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
144183484|NCT00288704|519867487|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
144183485|NCT00288704|519867488|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
144183486|NCT01579006|519867489|FG000|Overall Study|Lack of Efficacy|10|||
144183487|NCT01579006|519867489|FG000|Overall Study|Adverse Event|13|||
144183488|NCT01579006|519867489|FG000|Overall Study|Withdrawal by Subject|5|||
144183489|NCT01579006|519867489|FG000|Overall Study|Non-compliance|3|||
144183490|NCT01579006|519867489|FG000|Overall Study|Due to participant's health fund|1|||
144183491|NCT01579006|519867489|FG000|Overall Study|Scheduled surgery|1|||
144183492|NCT01802216|519867492|FG000|4 Month Visit|Participant did not show to visit|3|||
144183493|NCT01802216|519867493|FG001|4 Month Visit|Participant did not show to visit|4|||
144183494|NCT01802216|519867492|FG000|8 Month Visit|Participant did not show to visit|3|||
144183495|NCT01802216|519867493|FG001|8 Month Visit|Participant did not show to visit|5|||
144183496|NCT01802216|519867492|FG000|12 Month Visit|Participant did not show to visit|3|||
144183497|NCT01802216|519867493|FG001|12 Month Visit|Participant did not show to visit|4|||
144183498|NCT02246764|519867494|FG000|Overall Study|Adverse Event|15|||
144183499|NCT02246764|519867495|FG001|Overall Study|Adverse Event|29|||
144183500|NCT02246764|519867496|FG002|Overall Study|Adverse Event|1|||
144183501|NCT02246764|519867494|FG000|Overall Study|Withdrawal by Subject|0|||
144183502|NCT02246764|519867495|FG001|Overall Study|Withdrawal by Subject|0|||
144183503|NCT02246764|519867496|FG002|Overall Study|Withdrawal by Subject|1|||
144183504|NCT02246764|519867494|FG000|Overall Study|Disallowed Concomitant Medication|1|||
144183505|NCT02246764|519867495|FG001|Overall Study|Disallowed Concomitant Medication|0|||
144183506|NCT02246764|519867496|FG002|Overall Study|Disallowed Concomitant Medication|0|||
144183507|NCT02246764|519867494|FG000|Overall Study|Physician Decision|0|||
144183508|NCT02246764|519867495|FG001|Overall Study|Physician Decision|2|||
144430210|NCT02658890|520784781|FG012|Treatment Phase|Death|0|||
144430211|NCT02658890|520784782|FG013|Treatment Phase|Death|0|||
144430212|NCT02658890|520784783|FG014|Treatment Phase|Death|0|||
144430213|NCT02658890|520784784|FG015|Treatment Phase|Death|0|||
144430214|NCT02658890|520784785|FG016|Treatment Phase|Death|0|||
144430215|NCT02658890|520784786|FG017|Treatment Phase|Death|0|||
144430216|NCT02658890|520784787|FG018|Treatment Phase|Death|1|||
144183509|NCT02246764|519867496|FG002|Overall Study|Physician Decision|1|||
144183510|NCT02246764|519867494|FG000|Overall Study|Protocol Violation|2|||
144183511|NCT02246764|519867495|FG001|Overall Study|Protocol Violation|1|||
144183512|NCT02246764|519867496|FG002|Overall Study|Protocol Violation|1|||
144183513|NCT05393271|519867497|FG000|Overall Study|Physician Decision|0|||
144183514|NCT05393271|519867498|FG001|Overall Study|Physician Decision|0|||
144183515|NCT05393271|519867499|FG002|Overall Study|Physician Decision|0|||
144430217|NCT02658890|520784788|FG019|Treatment Phase|Death|0|||
144430218|NCT02658890|520784789|FG020|Treatment Phase|Death|0|||
144183516|NCT05393271|519867500|FG003|Overall Study|Physician Decision|0|||
144183517|NCT05393271|519867501|FG004|Overall Study|Physician Decision|0|||
144183518|NCT05393271|519867502|FG005|Overall Study|Physician Decision|0|||
144183519|NCT05393271|519867503|FG006|Overall Study|Physician Decision|1|||
144183520|NCT05393271|519867504|FG007|Overall Study|Physician Decision|0|||
144183521|NCT05393271|519867505|FG008|Overall Study|Physician Decision|0|||
144183522|NCT05393271|519867506|FG009|Overall Study|Physician Decision|0|||
144183523|NCT05393271|519867507|FG010|Overall Study|Physician Decision|0|||
144183524|NCT00413049|519867512|FG000|Overall Study|Adverse Event|10|||
144183525|NCT00413049|519867513|FG001|Overall Study|Adverse Event|8|||
144183526|NCT00413049|519867512|FG000|Overall Study|Withdrawal by Subject|7|||
144183527|NCT00413049|519867513|FG001|Overall Study|Withdrawal by Subject|5|||
144183528|NCT00413049|519867512|FG000|Overall Study|Lost to Follow-up|2|||
144183529|NCT00413049|519867513|FG001|Overall Study|Lost to Follow-up|3|||
144183530|NCT00413049|519867512|FG000|Overall Study|Protocol Violation|3|||
144183531|NCT00413049|519867513|FG001|Overall Study|Protocol Violation|1|||
144183532|NCT00413049|519867512|FG000|Overall Study|Subject no longer requires study drug|0|||
144183533|NCT00413049|519867513|FG001|Overall Study|Subject no longer requires study drug|1|||
144183534|NCT00413049|519867512|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144183535|NCT00413049|519867513|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144183536|NCT00413049|519867512|FG000|Overall Study|Lack of Efficacy|1|||
144183537|NCT00413049|519867513|FG001|Overall Study|Lack of Efficacy|0|||
144183538|NCT03314857|519867516|FG000|Overall Study|Death|4|||
144183539|NCT03314857|519867516|FG000|Overall Study|Physician Decision|1|||
144183540|NCT01408888|519867519|FG000|First Intervention|Adverse Event|0|||
144183541|NCT01408888|519867520|FG001|First Intervention|Adverse Event|1|||
144183542|NCT01408888|519867519|FG000|First Intervention|Withdrawal by Subject|0|||
144183543|NCT01408888|519867520|FG001|First Intervention|Withdrawal by Subject|2|||
144183544|NCT01408888|519867519|FG000|Second Intervention|Withdrawal by Subject|1|||
144183545|NCT01408888|519867520|FG001|Second Intervention|Withdrawal by Subject|0|||
144183546|NCT01408888|519867519|FG000|Second Intervention|Adverse Event|1|||
144183547|NCT01408888|519867520|FG001|Second Intervention|Adverse Event|0|||
144183548|NCT00695110|519867525|FG000|Treatment Period 1|Adverse Event|1|||
144183549|NCT00695110|519867525|FG000|Treatment Period 1|Withdrawal by Subject|2|||
144183550|NCT00695110|519867525|FG000|Treatment Period 3|Withdrawal by Subject|1|||
144183551|NCT00695110|519867525|FG000|Treatment Period 4|Adverse Event|1|||
144183552|NCT02104817|519867526|FG000|Overall Study|Death|363|||
144183553|NCT02104817|519867527|FG001|Overall Study|Death|330|||
144723581|NCT04634409|521842394|FG011|Overall Study|Withdrawal by Subject|2|||
144723582|NCT04634409|521842395|FG012|Overall Study|Withdrawal by Subject|2|||
144723583|NCT04634409|521842396|FG013|Overall Study|Withdrawal by Subject|1|||
144723584|NCT04634409|521842397|FG014|Overall Study|Withdrawal by Subject|5|||
144723585|NCT04634409|521842398|FG015|Overall Study|Withdrawal by Subject|0|||
144723586|NCT04634409|521842399|FG016|Overall Study|Withdrawal by Subject|0|||
144723587|NCT04634409|521842400|FG017|Overall Study|Withdrawal by Subject|1|||
144723588|NCT04634409|521842401|FG018|Overall Study|Withdrawal by Subject|0|||
144723589|NCT04634409|521842402|FG019|Overall Study|Withdrawal by Subject|0|||
144723590|NCT04634409|521842403|FG020|Overall Study|Withdrawal by Subject|0|||
144723591|NCT04634409|521842404|FG021|Overall Study|Withdrawal by Subject|0|||
144723592|NCT04634409|521842405|FG022|Overall Study|Withdrawal by Subject|0|||
144723593|NCT04634409|521842406|FG023|Overall Study|Withdrawal by Subject|1|||
144723594|NCT04634409|521842407|FG024|Overall Study|Withdrawal by Subject|0|||
144723595|NCT04634409|521842408|FG025|Overall Study|Withdrawal by Subject|0|||
144183554|NCT02104817|519867526|FG000|Overall Study|Lost to Follow-up|3|||
144183555|NCT02104817|519867527|FG001|Overall Study|Lost to Follow-up|2|||
144183556|NCT02104817|519867526|FG000|Overall Study|Protocol Violation|0|||
144183557|NCT02104817|519867527|FG001|Overall Study|Protocol Violation|1|||
144183558|NCT02104817|519867526|FG000|Overall Study|Study terminated by sponsor|5854|||
144183559|NCT02104817|519867527|FG001|Overall Study|Study terminated by sponsor|5901|||
144183560|NCT02104817|519867526|FG000|Overall Study|Withdrawal by Subject|111|||
144430219|NCT02658890|520784790|FG021|Treatment Phase|Death|0|||
144430220|NCT02658890|520784791|FG022|Treatment Phase|Death|0|||
144430221|NCT02658890|520784792|FG023|Treatment Phase|Death|0|||
144430222|NCT02658890|520784793|FG024|Treatment Phase|Death|0|||
144430223|NCT02658890|520784794|FG025|Treatment Phase|Death|0|||
144430224|NCT02658890|520784795|FG026|Treatment Phase|Death|0|||
144183561|NCT02104817|519867527|FG001|Overall Study|Withdrawal by Subject|78|||
144183562|NCT02104817|519867526|FG000|Overall Study|Other reasons|128|||
144183563|NCT02104817|519867527|FG001|Overall Study|Other reasons|135|||
144183564|NCT02575339|519867528|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
144183565|NCT02575339|519867529|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
144183566|NCT02575339|519867530|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
144183567|NCT02575339|519867528|FG000|Study Treatment|Disease Progression|5|||
144183568|NCT02575339|519867529|FG001|Study Treatment|Disease Progression|2|||
144430225|NCT02658890|520784769|FG000|Treatment Phase|Lost to Follow-up|0|||
144430226|NCT02658890|520784770|FG001|Treatment Phase|Lost to Follow-up|0|||
144723596|NCT04634409|521842409|FG026|Overall Study|Withdrawal by Subject|0|||
144723597|NCT04634409|521842383|FG000|Overall Study|Other - As reported by Investigator|1|||
144183569|NCT02575339|519867530|FG002|Study Treatment|Disease Progression|0|||
144183570|NCT02575339|519867528|FG000|Study Treatment|Adverse Event|1|||
144183571|NCT02575339|519867529|FG001|Study Treatment|Adverse Event|2|||
144183572|NCT02575339|519867530|FG002|Study Treatment|Adverse Event|0|||
144603846|NCT00375219|521412038|FG001|Overall Study|Hematologic resistance|0|||
144603847|NCT00375219|521412039|FG002|Overall Study|Hematologic resistance|0|||
144603848|NCT00375219|521412037|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
144603849|NCT00375219|521412038|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
144603850|NCT00375219|521412039|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
144603851|NCT00375219|521412037|FG000|Overall Study|Allograft|2|||
144603852|NCT00375219|521412038|FG001|Overall Study|Allograft|0|||
144603853|NCT00375219|521412039|FG002|Overall Study|Allograft|0|||
144603854|NCT00375219|521412037|FG000|Overall Study|Cord blood transplantation|1|||
144603855|NCT00375219|521412038|FG001|Overall Study|Cord blood transplantation|0|||
144603856|NCT00375219|521412039|FG002|Overall Study|Cord blood transplantation|0|||
144603857|NCT00375219|521412037|FG000|Overall Study|Withdrawal by Subject|1|||
144603858|NCT00375219|521412038|FG001|Overall Study|Withdrawal by Subject|0|||
144603859|NCT00375219|521412039|FG002|Overall Study|Withdrawal by Subject|0|||
144603860|NCT01667107|521412040|FG000|Overall Study|Adverse Event|4|||
144603861|NCT01667107|521412041|FG001|Overall Study|Adverse Event|3|||
144603862|NCT01667107|521412040|FG000|Overall Study|Tolerability issues|0|||
144603863|NCT01667107|521412041|FG001|Overall Study|Tolerability issues|2|||
144603864|NCT01667107|521412040|FG000|Overall Study|Protocol Violation|0|||
144603865|NCT01667107|521412041|FG001|Overall Study|Protocol Violation|1|||
144603866|NCT01667107|521412040|FG000|Overall Study|Lack of Efficacy|0|||
144603867|NCT01667107|521412041|FG001|Overall Study|Lack of Efficacy|1|||
144603868|NCT01162239|521412044|FG000|Treatment Phase|Withdrawal by Subject|1|||
144603869|NCT01162239|521412045|FG001|Treatment Phase|Withdrawal by Subject|3|||
144603870|NCT01162239|521412046|FG002|Treatment Phase|Withdrawal by Subject|2|||
144603871|NCT01162239|521412047|FG003|Treatment Phase|Withdrawal by Subject|3|||
144603872|NCT01162239|521412044|FG000|Treatment Phase|Death|0|||
144603873|NCT01162239|521412045|FG001|Treatment Phase|Death|0|||
144603874|NCT01162239|521412046|FG002|Treatment Phase|Death|0|||
144603875|NCT01162239|521412047|FG003|Treatment Phase|Death|1|||
144603876|NCT01162239|521412044|FG000|Treatment Phase|Lost to Follow-up|5|||
144603877|NCT01162239|521412045|FG001|Treatment Phase|Lost to Follow-up|4|||
144603878|NCT01162239|521412046|FG002|Treatment Phase|Lost to Follow-up|2|||
144603879|NCT01162239|521412047|FG003|Treatment Phase|Lost to Follow-up|1|||
144603880|NCT01162239|521412044|FG000|Extended Follow-up|Lost to Follow-up|8|||
144603881|NCT01162239|521412045|FG001|Extended Follow-up|Lost to Follow-up|13|||
144603882|NCT01162239|521412046|FG002|Extended Follow-up|Lost to Follow-up|8|||
144603883|NCT01162239|521412047|FG003|Extended Follow-up|Lost to Follow-up|6|||
144603884|NCT05975840|521412048|FG000|Overall Study|Other|1|||
144603885|NCT05975840|521412049|FG001|Overall Study|Other|0|||
144603886|NCT05975840|521412050|FG002|Overall Study|Other|0|||
144603887|NCT05975840|521412051|FG003|Overall Study|Other|0|||
144603888|NCT05975840|521412052|FG004|Overall Study|Other|1|||
144603889|NCT05975840|521412053|FG005|Overall Study|Other|0|||
144603890|NCT05975840|521412054|FG006|Overall Study|Other|0|||
144603891|NCT05975840|521412055|FG007|Overall Study|Other|0|||
144603892|NCT05975840|521412048|FG000|Overall Study|Lost to Follow-up|3|||
144603893|NCT05975840|521412049|FG001|Overall Study|Lost to Follow-up|6|||
144603894|NCT05975840|521412050|FG002|Overall Study|Lost to Follow-up|3|||
144183573|NCT02575339|519867528|FG000|Follow up|Death|6|||
144183574|NCT02575339|519867529|FG001|Follow up|Death|2|||
144183575|NCT02575339|519867530|FG002|Follow up|Death|0|||
144183576|NCT02575339|519867528|FG000|Follow up|Study Terminated|0|||
144183577|NCT02575339|519867529|FG001|Follow up|Study Terminated|2|||
144183578|NCT02575339|519867530|FG002|Follow up|Study Terminated|0|||
144183579|NCT02575339|519867528|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
144430227|NCT02658890|520784771|FG002|Treatment Phase|Lost to Follow-up|0|||
144430228|NCT02658890|520784772|FG003|Treatment Phase|Lost to Follow-up|0|||
144430229|NCT02658890|520784773|FG004|Treatment Phase|Lost to Follow-up|0|||
144603895|NCT05975840|521412051|FG003|Overall Study|Lost to Follow-up|1|||
144603896|NCT05975840|521412052|FG004|Overall Study|Lost to Follow-up|4|||
144183580|NCT02575339|519867529|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
144430230|NCT02658890|520784774|FG005|Treatment Phase|Lost to Follow-up|0|||
144603897|NCT05975840|521412053|FG005|Overall Study|Lost to Follow-up|1|||
144603898|NCT05975840|521412054|FG006|Overall Study|Lost to Follow-up|2|||
144603899|NCT05975840|521412055|FG007|Overall Study|Lost to Follow-up|4|||
144603900|NCT05975840|521412048|FG000|Overall Study|Migrated/moved from the study area|1|||
144183581|NCT02575339|519867530|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
144603901|NCT05975840|521412049|FG001|Overall Study|Migrated/moved from the study area|0|||
144603902|NCT05975840|521412050|FG002|Overall Study|Migrated/moved from the study area|0|||
144603903|NCT05975840|521412051|FG003|Overall Study|Migrated/moved from the study area|0|||
144603904|NCT05975840|521412052|FG004|Overall Study|Migrated/moved from the study area|0|||
144430231|NCT02658890|520784775|FG006|Treatment Phase|Lost to Follow-up|1|||
144430232|NCT02658890|520784776|FG007|Treatment Phase|Lost to Follow-up|0|||
144183582|NCT04633642|519867531|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
144183583|NCT04633642|519867532|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
144183584|NCT04675775|519867533|FG000|Overall Study|Withdrawal by Subject|7|||
144183585|NCT02340780|519867534|FG000|Overall Study|Ineligible|1|||
144183586|NCT01957150|519867535|FG000|Overall Study|Adverse Event|23|||
144183587|NCT01957150|519867536|FG001|Overall Study|Adverse Event|20|||
144183588|NCT01957150|519867535|FG000|Overall Study|Withdrawal by Subject|13|||
144183589|NCT01957150|519867536|FG001|Overall Study|Withdrawal by Subject|17|||
144183590|NCT01957150|519867535|FG000|Overall Study|Physician Decision|3|||
144183591|NCT01957150|519867536|FG001|Overall Study|Physician Decision|6|||
144183592|NCT01957150|519867535|FG000|Overall Study|Lost to Follow-up|4|||
144183593|NCT01957150|519867536|FG001|Overall Study|Lost to Follow-up|4|||
144183594|NCT01957150|519867535|FG000|Overall Study|Protocol Violation|1|||
144183595|NCT01957150|519867536|FG001|Overall Study|Protocol Violation|0|||
144183596|NCT01957150|519867535|FG000|Overall Study|Lack of Efficacy|11|||
144183597|NCT01957150|519867536|FG001|Overall Study|Lack of Efficacy|11|||
144183598|NCT03223909|519867537|FG000|Overall Study|Protocol Violation|48|||
144183599|NCT03223909|519867538|FG001|Overall Study|Protocol Violation|45|||
144183600|NCT03223909|519867539|FG002|Overall Study|Protocol Violation|16|||
144183601|NCT01698554|519867540|FG000|Overall Study|Adverse Event|2|||
144183602|NCT01698554|519867541|FG001|Overall Study|Adverse Event|5|||
144183603|NCT01698554|519867542|FG002|Overall Study|Adverse Event|0|||
144183604|NCT01698554|519867543|FG003|Overall Study|Adverse Event|1|||
144183605|NCT01698554|519867540|FG000|Overall Study|Lost to Follow-up|1|||
144183606|NCT01698554|519867541|FG001|Overall Study|Lost to Follow-up|0|||
144183607|NCT01698554|519867542|FG002|Overall Study|Lost to Follow-up|0|||
144183608|NCT01698554|519867543|FG003|Overall Study|Lost to Follow-up|0|||
144183609|NCT01698554|519867540|FG000|Overall Study|Personal Reasons|0|||
144183610|NCT01698554|519867541|FG001|Overall Study|Personal Reasons|5|||
144183611|NCT01698554|519867542|FG002|Overall Study|Personal Reasons|1|||
144183612|NCT01698554|519867543|FG003|Overall Study|Personal Reasons|1|||
144183613|NCT01698554|519867540|FG000|Overall Study|Protocol Violation|2|||
144603905|NCT05975840|521412053|FG005|Overall Study|Migrated/moved from the study area|0|||
144603906|NCT05975840|521412054|FG006|Overall Study|Migrated/moved from the study area|0|||
144603907|NCT05975840|521412055|FG007|Overall Study|Migrated/moved from the study area|0|||
144603908|NCT05975840|521412048|FG000|Overall Study|Withdrawal by Subject|0|||
144603909|NCT05975840|521412049|FG001|Overall Study|Withdrawal by Subject|5|||
144603910|NCT05975840|521412050|FG002|Overall Study|Withdrawal by Subject|2|||
144603911|NCT05975840|521412051|FG003|Overall Study|Withdrawal by Subject|2|||
144183614|NCT01698554|519867541|FG001|Overall Study|Protocol Violation|0|||
144183615|NCT01698554|519867542|FG002|Overall Study|Protocol Violation|1|||
144183616|NCT01698554|519867543|FG003|Overall Study|Protocol Violation|0|||
144183617|NCT01698554|519867540|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144183618|NCT01698554|519867541|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144183619|NCT01698554|519867542|FG002|Overall Study|Other Miscellaneous Reasons|0|||
144183620|NCT01698554|519867543|FG003|Overall Study|Other Miscellaneous Reasons|0|||
144183621|NCT00640926|519867544|FG000|Overall Study|Adverse Event|2|||
144183622|NCT00640926|519867545|FG001|Overall Study|Adverse Event|3|||
144183623|NCT00640926|519867546|FG002|Overall Study|Adverse Event|2|||
144183624|NCT00640926|519867544|FG000|Overall Study|Lack of Efficacy|0|||
144183625|NCT00640926|519867545|FG001|Overall Study|Lack of Efficacy|2|||
144183626|NCT00640926|519867546|FG002|Overall Study|Lack of Efficacy|1|||
144183627|NCT00640926|519867544|FG000|Overall Study|Protocol Violation|2|||
144183628|NCT00640926|519867545|FG001|Overall Study|Protocol Violation|0|||
144183629|NCT00640926|519867546|FG002|Overall Study|Protocol Violation|2|||
144183630|NCT00640926|519867544|FG000|Overall Study|Lost to Follow-up|3|||
144183631|NCT00640926|519867545|FG001|Overall Study|Lost to Follow-up|1|||
144183632|NCT00640926|519867546|FG002|Overall Study|Lost to Follow-up|2|||
144183633|NCT00640926|519867544|FG000|Overall Study|Withdrawal by Subject|1|||
144183634|NCT00640926|519867545|FG001|Overall Study|Withdrawal by Subject|0|||
144183635|NCT00640926|519867546|FG002|Overall Study|Withdrawal by Subject|1|||
144183636|NCT01841073|519867547|FG000|Overall Study|Adverse Event|1|||
144183637|NCT01841073|519867548|FG001|Overall Study|Adverse Event|1|||
144183638|NCT01841073|519867547|FG000|Overall Study|Physician Decision|1|||
144183639|NCT01841073|519867548|FG001|Overall Study|Physician Decision|0|||
144183640|NCT01841073|519867547|FG000|Overall Study|Lost to Follow-up|0|||
144183641|NCT01841073|519867548|FG001|Overall Study|Lost to Follow-up|2|||
144183642|NCT02858037|519867551|FG000|Overall Study|Death|1|||
144183643|NCT02858037|519867551|FG000|Overall Study|Withdrawal by Subject|18|||
144183644|NCT02858037|519867551|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
144183645|NCT02858037|519867551|FG000|Overall Study|Lost to Follow-up|3|||
144183646|NCT02858037|519867551|FG000|Overall Study|Other|4|||
144183647|NCT04768114|519867552|FG000|Overall Study|Lost to Follow-up|5|||
144183648|NCT04768114|519867553|FG001|Overall Study|Lost to Follow-up|10|||
144183649|NCT04768114|519867552|FG000|Overall Study|Withdrawal by Subject|0|||
144183650|NCT04768114|519867553|FG001|Overall Study|Withdrawal by Subject|1|||
144183651|NCT04892147|519867558|FG000|Overall Study|Withdrawal by Subject|2|||
144183652|NCT04892147|519867559|FG001|Overall Study|Withdrawal by Subject|0|||
144183653|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
144183654|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
144183655|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
144183656|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
144183657|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
144183658|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
144183659|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
144183660|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
144183661|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
144183662|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
144183663|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
144183664|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
144183665|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
144183666|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
144183667|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
144183668|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
144183669|NCT01067521|519867560|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
144183670|NCT01067521|519867561|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
144183671|NCT01067521|519867560|FG000|Open-Label Period|Death|3|||
144183672|NCT01067521|519867561|FG001|Open-Label Period|Death|1|||
144183673|NCT01067521|519867560|FG000|Open-Label Period|Adverse Event|30|||
144252137|NCT01693185|520122667|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
144252138|NCT01693185|520122668|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
144252139|NCT01606748|520122683|FG000|Overall Study|Adverse Event|1|||
144252140|NCT01606748|520122684|FG001|Overall Study|Adverse Event|0|||
144252141|NCT01606748|520122683|FG000|Overall Study|Progressive Disease|1|||
144252142|NCT01606748|520122684|FG001|Overall Study|Progressive Disease|0|||
144252143|NCT01606748|520122683|FG000|Overall Study|Withdrawal by Subject|1|||
144252144|NCT01606748|520122684|FG001|Overall Study|Withdrawal by Subject|0|||
144252145|NCT00621517|520122688|FG000|Overall Study|Lost to Follow-up|3|||
144252146|NCT00621517|520122689|FG001|Overall Study|Lost to Follow-up|3|||
144252147|NCT00621517|520122688|FG000|Overall Study|Withdrawal by Subject|3|||
144252148|NCT00621517|520122689|FG001|Overall Study|Withdrawal by Subject|4|||
144252149|NCT00621517|520122688|FG000|Overall Study|Adverse Event|1|||
144252150|NCT00621517|520122689|FG001|Overall Study|Adverse Event|0|||
144430233|NCT02658890|520784777|FG008|Treatment Phase|Lost to Follow-up|0|||
144430234|NCT02658890|520784778|FG009|Treatment Phase|Lost to Follow-up|0|||
144430235|NCT02658890|520784779|FG010|Treatment Phase|Lost to Follow-up|0|||
144430236|NCT02658890|520784780|FG011|Treatment Phase|Lost to Follow-up|0|||
144430237|NCT02658890|520784781|FG012|Treatment Phase|Lost to Follow-up|0|||
144430238|NCT02658890|520784782|FG013|Treatment Phase|Lost to Follow-up|0|||
144430239|NCT02658890|520784783|FG014|Treatment Phase|Lost to Follow-up|0|||
144430240|NCT02658890|520784784|FG015|Treatment Phase|Lost to Follow-up|0|||
144430241|NCT02658890|520784785|FG016|Treatment Phase|Lost to Follow-up|0|||
144430242|NCT02658890|520784786|FG017|Treatment Phase|Lost to Follow-up|0|||
144430243|NCT02658890|520784787|FG018|Treatment Phase|Lost to Follow-up|0|||
144430244|NCT02658890|520784788|FG019|Treatment Phase|Lost to Follow-up|0|||
144430245|NCT02658890|520784789|FG020|Treatment Phase|Lost to Follow-up|0|||
144430246|NCT02658890|520784790|FG021|Treatment Phase|Lost to Follow-up|0|||
144430247|NCT02658890|520784791|FG022|Treatment Phase|Lost to Follow-up|0|||
144430248|NCT02658890|520784792|FG023|Treatment Phase|Lost to Follow-up|0|||
144430249|NCT02658890|520784793|FG024|Treatment Phase|Lost to Follow-up|0|||
144430250|NCT02658890|520784794|FG025|Treatment Phase|Lost to Follow-up|0|||
144430251|NCT02658890|520784795|FG026|Treatment Phase|Lost to Follow-up|0|||
144430252|NCT02658890|520784769|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
144430253|NCT02658890|520784770|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
144430254|NCT02658890|520784771|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
144430255|NCT02658890|520784772|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
144430256|NCT02658890|520784773|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
144430257|NCT02658890|520784774|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
144430258|NCT02658890|520784775|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
144430259|NCT02658890|520784776|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
144430260|NCT02658890|520784777|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
144430261|NCT02658890|520784778|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
144430262|NCT02658890|520784779|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
144430263|NCT02658890|520784780|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
144430264|NCT02658890|520784781|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
144430265|NCT02658890|520784782|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
144430266|NCT02658890|520784783|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
144430267|NCT02658890|520784784|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
144430268|NCT02658890|520784785|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
144430269|NCT02658890|520784786|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
144430270|NCT02658890|520784787|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
144252151|NCT01863732|520122691|FG000|Overall Study|Adverse Event|2|||
144603912|NCT05975840|521412052|FG004|Overall Study|Withdrawal by Subject|0|||
144603913|NCT05975840|521412053|FG005|Overall Study|Withdrawal by Subject|2|||
144603914|NCT05975840|521412054|FG006|Overall Study|Withdrawal by Subject|2|||
144603915|NCT05975840|521412055|FG007|Overall Study|Withdrawal by Subject|1|||
144603916|NCT05975840|521412048|FG000|Overall Study|Protocol Violation|0|||
144603917|NCT05975840|521412049|FG001|Overall Study|Protocol Violation|1|||
144603918|NCT05975840|521412050|FG002|Overall Study|Protocol Violation|0|||
144603919|NCT05975840|521412051|FG003|Overall Study|Protocol Violation|0|||
144603920|NCT05975840|521412052|FG004|Overall Study|Protocol Violation|0|||
144603921|NCT05975840|521412053|FG005|Overall Study|Protocol Violation|0|||
144603922|NCT05975840|521412054|FG006|Overall Study|Protocol Violation|0|||
144183674|NCT01067521|519867561|FG001|Open-Label Period|Adverse Event|28|||
144183675|NCT01067521|519867560|FG000|Open-Label Period|Withdrawal by Subject|160|||
144183676|NCT01067521|519867561|FG001|Open-Label Period|Withdrawal by Subject|88|||
144183677|NCT01067521|519867560|FG000|Open-Label Period|Physician Decision|13|||
144183678|NCT01067521|519867561|FG001|Open-Label Period|Physician Decision|11|||
144183679|NCT01067521|519867560|FG000|Open-Label Period|Non-compliance with study drug|5|||
144183680|NCT01067521|519867561|FG001|Open-Label Period|Non-compliance with study drug|0|||
144183681|NCT01067521|519867560|FG000|Open-Label Period|Protocol Violation|3|||
144183682|NCT01067521|519867561|FG001|Open-Label Period|Protocol Violation|0|||
144183683|NCT01067521|519867560|FG000|Open-Label Period|Pregnancy|14|||
144183684|NCT01067521|519867561|FG001|Open-Label Period|Pregnancy|8|||
144183685|NCT01067521|519867560|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
144183686|NCT01067521|519867561|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
144183687|NCT01067521|519867560|FG000|Open-Label Period|Lost to Follow-up|21|||
144183688|NCT01067521|519867561|FG001|Open-Label Period|Lost to Follow-up|20|||
144183689|NCT01685216|519867562|FG000|Overall Study|Did not receive study drug|1|||
144183690|NCT02911935|519867563|FG000|Overall Study|Lost to Follow-up|5|||
144183691|NCT02911935|519867564|FG001|Overall Study|Lost to Follow-up|7|||
144183692|NCT01294449|519867565|FG000|Overall Study|Death|11|||
144183693|NCT01294449|519867566|FG001|Overall Study|Death|12|||
144183694|NCT01294449|519867565|FG000|Overall Study|Withdrawal by Subject|1|||
144183695|NCT01294449|519867566|FG001|Overall Study|Withdrawal by Subject|3|||
144183696|NCT01688882|519867567|FG000|Overall Study|Adverse Event|1|||
144183697|NCT01688882|519867568|FG001|Overall Study|Adverse Event|0|||
144183698|NCT01688882|519867567|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144183699|NCT01688882|519867568|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144183700|NCT01688882|519867567|FG000|Overall Study|Administrative problems|1|||
144183701|NCT01688882|519867568|FG001|Overall Study|Administrative problems|0|||
144183702|NCT00124618|519867569|FG000|Overall Study|Ineligible|1|||
144183703|NCT02387762|519867570|FG000|Overall Study|Withdrawal by Subject|1|||
144183704|NCT02387762|519867571|FG001|Overall Study|Withdrawal by Subject|0|||
144183705|NCT00593827|519867572|FG000|Overall Study|On Active Treatment/Pending|0|||
144183706|NCT00593827|519867573|FG001|Overall Study|On Active Treatment/Pending|2|||
144183707|NCT01160640|519867574|FG000|Overall Study|Physician Decision|3|||
144183708|NCT01160640|519867575|FG001|Overall Study|Physician Decision|3|||
144183709|NCT01160640|519867574|FG000|Overall Study|Incarceration|1|||
144183710|NCT01160640|519867575|FG001|Overall Study|Incarceration|0|||
144183711|NCT01160640|519867574|FG000|Overall Study|Withdrawal by Subject|0|||
144183712|NCT01160640|519867575|FG001|Overall Study|Withdrawal by Subject|3|||
144183713|NCT02169336|519867576|FG000|Overall Study|Lack of Efficacy|1|||
144183714|NCT02169336|519867577|FG001|Overall Study|Lack of Efficacy|1|||
144183715|NCT02169336|519867578|FG002|Overall Study|Lack of Efficacy|0|||
144183716|NCT02169336|519867576|FG000|Overall Study|Adverse Event|2|||
144183717|NCT02169336|519867577|FG001|Overall Study|Adverse Event|3|||
144183718|NCT02169336|519867578|FG002|Overall Study|Adverse Event|1|||
144183719|NCT02169336|519867576|FG000|Overall Study|Withdrawal by Subject|1|||
144183720|NCT02169336|519867577|FG001|Overall Study|Withdrawal by Subject|0|||
144183721|NCT02169336|519867578|FG002|Overall Study|Withdrawal by Subject|0|||
144183722|NCT02169336|519867576|FG000|Overall Study|Physician Decision|0|||
144183723|NCT02169336|519867577|FG001|Overall Study|Physician Decision|0|||
144183724|NCT02169336|519867578|FG002|Overall Study|Physician Decision|1|||
144183725|NCT02169336|519867576|FG000|Overall Study|Subject declined to continue dosing|0|||
144603923|NCT05975840|521412055|FG007|Overall Study|Protocol Violation|0|||
144603924|NCT05975840|521412048|FG000|Overall Study|Adverse Event|0|||
144603925|NCT05975840|521412049|FG001|Overall Study|Adverse Event|0|||
144603926|NCT05975840|521412050|FG002|Overall Study|Adverse Event|0|||
144603927|NCT05975840|521412051|FG003|Overall Study|Adverse Event|1|||
144603928|NCT05975840|521412052|FG004|Overall Study|Adverse Event|0|||
144603929|NCT05975840|521412053|FG005|Overall Study|Adverse Event|0|||
144183726|NCT02169336|519867577|FG001|Overall Study|Subject declined to continue dosing|0|||
144183727|NCT02169336|519867578|FG002|Overall Study|Subject declined to continue dosing|1|||
144183728|NCT01598896|519867583|FG000|Overall Study|Withdrawal by Subject|0|||
144183729|NCT01598896|519867584|FG001|Overall Study|Withdrawal by Subject|1|||
144183730|NCT01598896|519867583|FG000|Overall Study|Lack of Efficacy|0|||
144183731|NCT01598896|519867584|FG001|Overall Study|Lack of Efficacy|1|||
144603930|NCT05975840|521412054|FG006|Overall Study|Adverse Event|0|||
144603931|NCT05975840|521412055|FG007|Overall Study|Adverse Event|0|||
144183732|NCT03382041|519867585|FG000|Overall Study|Consent Form Lost|2|||
144183733|NCT03382041|519867586|FG001|Overall Study|Consent Form Lost|1|||
144183734|NCT03382041|519867585|FG000|Overall Study|Withdrawal by Subject|1|||
144183735|NCT03382041|519867586|FG001|Overall Study|Withdrawal by Subject|4|||
144183736|NCT03382041|519867585|FG000|Overall Study|Lost to Follow-up|1|||
144183737|NCT03382041|519867586|FG001|Overall Study|Lost to Follow-up|4|||
144183738|NCT01374451|519867587|FG000|Overall Study|Administrative problems|1|||
144183739|NCT01374451|519867588|FG001|Overall Study|Administrative problems|0|||
144183740|NCT01337596|519867589|FG000|Overall Study|Withdrawal by Subject|0|||
144183741|NCT01337596|519867590|FG001|Overall Study|Withdrawal by Subject|0|||
144183742|NCT01337596|519867591|FG002|Overall Study|Withdrawal by Subject|0|||
144183743|NCT01337596|519867592|FG003|Overall Study|Withdrawal by Subject|0|||
144183744|NCT01337596|519867593|FG004|Overall Study|Withdrawal by Subject|2|||
144183745|NCT01337596|519867594|FG005|Overall Study|Withdrawal by Subject|0|||
144183746|NCT01337596|519867595|FG006|Overall Study|Withdrawal by Subject|0|||
144183747|NCT01337596|519867596|FG007|Overall Study|Withdrawal by Subject|0|||
144183748|NCT01337596|519867597|FG008|Overall Study|Withdrawal by Subject|0|||
144183749|NCT04640194|519867598|FG000|Overall Study|Adverse Event|3|||
144183750|NCT04640194|519867599|FG001|Overall Study|Adverse Event|7|||
144183751|NCT04640194|519867600|FG002|Overall Study|Adverse Event|0|||
144183752|NCT04640194|519867601|FG003|Overall Study|Adverse Event|5|||
144183753|NCT04640194|519867602|FG004|Overall Study|Adverse Event|0|||
144183754|NCT04640194|519867603|FG005|Overall Study|Adverse Event|4|||
144183755|NCT04640194|519867604|FG006|Overall Study|Adverse Event|0|||
144183756|NCT04640194|519867598|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
144183757|NCT04640194|519867599|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
144183758|NCT04640194|519867600|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
144183759|NCT04640194|519867601|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
144183760|NCT04640194|519867602|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
144183761|NCT04640194|519867603|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
144183762|NCT04640194|519867604|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
144183763|NCT04640194|519867598|FG000|Overall Study|fibrinogen level too low|0|||
144183764|NCT04640194|519867599|FG001|Overall Study|fibrinogen level too low|0|||
144183765|NCT04640194|519867600|FG002|Overall Study|fibrinogen level too low|0|||
144183766|NCT04640194|519867601|FG003|Overall Study|fibrinogen level too low|1|||
144183767|NCT04640194|519867602|FG004|Overall Study|fibrinogen level too low|0|||
144183768|NCT04640194|519867603|FG005|Overall Study|fibrinogen level too low|0|||
144183769|NCT04640194|519867604|FG006|Overall Study|fibrinogen level too low|0|||
144183770|NCT04640194|519867598|FG000|Overall Study|mild bleeding|0|||
144183771|NCT04640194|519867599|FG001|Overall Study|mild bleeding|0|||
144183772|NCT04640194|519867600|FG002|Overall Study|mild bleeding|0|||
144183773|NCT04640194|519867601|FG003|Overall Study|mild bleeding|1|||
144183774|NCT04640194|519867602|FG004|Overall Study|mild bleeding|0|||
144183775|NCT04640194|519867603|FG005|Overall Study|mild bleeding|0|||
144183776|NCT04640194|519867604|FG006|Overall Study|mild bleeding|0|||
144183777|NCT04640194|519867598|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
144183778|NCT04640194|519867599|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
144183779|NCT04640194|519867600|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
144183780|NCT04640194|519867601|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
144183781|NCT04640194|519867602|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
144183782|NCT04640194|519867603|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
144183783|NCT04640194|519867604|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
144183784|NCT01709903|519867608|FG000|Overall Study|administrative problems|2|||
144183785|NCT01709903|519867609|FG001|Overall Study|administrative problems|6|||
144183786|NCT01709903|519867608|FG000|Overall Study|Abnormal test procedure results|1|||
144183787|NCT01709903|519867609|FG001|Overall Study|Abnormal test procedure results|0|||
144183788|NCT01709903|519867608|FG000|Overall Study|In ability to use device|1|||
144183789|NCT01709903|519867609|FG001|Overall Study|In ability to use device|1|||
144183790|NCT01709903|519867608|FG000|Overall Study|no longer needed study drug|0|||
144183791|NCT01709903|519867609|FG001|Overall Study|no longer needed study drug|1|||
144183792|NCT01709903|519867608|FG000|Overall Study|Lost to Follow-up|0|||
144183793|NCT01709903|519867609|FG001|Overall Study|Lost to Follow-up|2|||
144183794|NCT01709903|519867608|FG000|Overall Study|Death|2|||
144183795|NCT01709903|519867609|FG001|Overall Study|Death|0|||
144183796|NCT01709903|519867608|FG000|Overall Study|Protocol Violation|3|||
144183797|NCT01709903|519867609|FG001|Overall Study|Protocol Violation|2|||
144183798|NCT01709903|519867608|FG000|Overall Study|Lack of Efficacy|3|||
144183799|NCT01709903|519867609|FG001|Overall Study|Lack of Efficacy|3|||
144183800|NCT01709903|519867608|FG000|Overall Study|Withdrawal by Subject|6|||
144529016|NCT03088878|521139171|FG011|Overall Study|Adverse Event|0|||
144183801|NCT01709903|519867609|FG001|Overall Study|Withdrawal by Subject|6|||
144183802|NCT01709903|519867608|FG000|Overall Study|Adverse Event|11|||
144529017|NCT03088878|521139172|FG012|Overall Study|Adverse Event|5|||
144529018|NCT03088878|521139173|FG013|Overall Study|Adverse Event|3|||
144529019|NCT03088878|521139160|FG000|Overall Study|Clinical Progression|0|||
144183803|NCT01709903|519867609|FG001|Overall Study|Adverse Event|18|||
144183804|NCT02061280|519867610|FG000|Overall Study|Protocol Violation|12|||
144183805|NCT02061280|519867611|FG001|Overall Study|Protocol Violation|8|||
144183806|NCT02061280|519867610|FG000|Overall Study|moved out of state|0|||
144183807|NCT02061280|519867611|FG001|Overall Study|moved out of state|1|||
144183808|NCT02061280|519867610|FG000|Overall Study|Withdrawal by Subject|1|||
144183809|NCT02061280|519867611|FG001|Overall Study|Withdrawal by Subject|2|||
144183810|NCT02061280|519867610|FG000|Overall Study|Lost to Follow-up|5|||
144183811|NCT02061280|519867611|FG001|Overall Study|Lost to Follow-up|1|||
144183812|NCT00724958|519867616|FG000|Overall Study|Adverse Event|28|||
144183813|NCT00724958|519867616|FG000|Overall Study|Loss of Response|40|||
144183814|NCT00724958|519867616|FG000|Overall Study|No Response|18|||
144183815|NCT00724958|519867616|FG000|Overall Study|Remission|7|||
144183816|NCT00724958|519867616|FG000|Overall Study|Other Reason|76|||
144183817|NCT00724958|519867616|FG000|Overall Study|No documentation for end of therapy|13|||
144183818|NCT00965731|519867618|FG000|Overall Study|Death|0|||
144183819|NCT00965731|519867619|FG001|Overall Study|Death|4|||
144183820|NCT00965731|519867618|FG000|Overall Study|Withdrawal by Subject|0|||
144183821|NCT00965731|519867619|FG001|Overall Study|Withdrawal by Subject|1|||
144183822|NCT00965731|519867618|FG000|Overall Study|Other|7|||
144183823|NCT00965731|519867619|FG001|Overall Study|Other|15|||
144183824|NCT04773600|519867620|FG000|Overall Study|Withdrawal by Subject|15|||
144183825|NCT04773600|519867621|FG001|Overall Study|Withdrawal by Subject|9|||
144183826|NCT04773600|519867620|FG000|Overall Study|Lost to Follow-up|10|||
144183827|NCT04773600|519867621|FG001|Overall Study|Lost to Follow-up|6|||
144183828|NCT04773600|519867620|FG000|Overall Study|Adverse Event|8|||
144183829|NCT04773600|519867621|FG001|Overall Study|Adverse Event|2|||
144183830|NCT04773600|519867620|FG000|Overall Study|Lack of Efficacy|2|||
144183831|NCT04773600|519867621|FG001|Overall Study|Lack of Efficacy|3|||
144183832|NCT04773600|519867620|FG000|Overall Study|Noncompliance|2|||
144183833|NCT04773600|519867621|FG001|Overall Study|Noncompliance|0|||
144183834|NCT04773600|519867620|FG000|Overall Study|Protocol Violation|2|||
144183835|NCT04773600|519867621|FG001|Overall Study|Protocol Violation|0|||
144183836|NCT04773600|519867620|FG000|Overall Study|Physician Decision|0|||
144183837|NCT04773600|519867621|FG001|Overall Study|Physician Decision|1|||
144183838|NCT04773600|519867620|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
144183839|NCT04773600|519867621|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
144183840|NCT04773600|519867620|FG000|Overall Study|Emergency Travel Out of Country|1|||
144183841|NCT04773600|519867621|FG001|Overall Study|Emergency Travel Out of Country|0|||
144183842|NCT05061992|519869591|FG000|Overall Study|Excess bowel movements|1|||
144183843|NCT05061992|519869592|FG001|Overall Study|Excess bowel movements|0|||
144183844|NCT05061992|519869591|FG000|Overall Study|Complications of Medical Care|1|||
144183845|NCT05061992|519869592|FG001|Overall Study|Complications of Medical Care|0|||
144183846|NCT05061992|519869591|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
144183847|NCT05061992|519869592|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
144183848|NCT05061992|519869591|FG000|Overall Study|Withdrawal by Subject|0|||
144183849|NCT05061992|519869592|FG001|Overall Study|Withdrawal by Subject|1|||
144183850|NCT02697617|519869593|FG000|Overall Study|Withdrawal by Subject|0|||
144183851|NCT02697617|519869594|FG001|Overall Study|Withdrawal by Subject|2|||
144183852|NCT02697617|519869593|FG000|Overall Study|Pregnancy|1|||
144183853|NCT02697617|519869594|FG001|Overall Study|Pregnancy|0|||
144183854|NCT00063258|519869599|FG000|Overall Study|Physician Decision|2|||
144183855|NCT00063258|519869600|FG001|Overall Study|Physician Decision|0|||
144183856|NCT00063258|519869599|FG000|Overall Study|Lack of Efficacy|2|||
144183857|NCT00063258|519869600|FG001|Overall Study|Lack of Efficacy|0|||
144183858|NCT04167618|519869601|FG000|Overall Study|Trial terminated by sponsor|1|||
144183859|NCT04167618|519869602|FG001|Overall Study|Trial terminated by sponsor|1|||
144183860|NCT02943993|519869605|FG000|Overall Study|Withdrawal by Subject|52|||
144183861|NCT02943993|519869605|FG000|Overall Study|Transfer to another institution|6|||
144183862|NCT02943993|519869605|FG000|Overall Study|Lost to Follow-up|135|||
144183863|NCT02943993|519869605|FG000|Overall Study|Death|98|||
144252152|NCT01863732|520122692|FG001|Overall Study|Adverse Event|0|||
144252153|NCT01863732|520122693|FG002|Overall Study|Adverse Event|3|||
144538453|NCT01500200|521174196|FG001|Stage 1|Withdrawal by Subject|0|||
144183864|NCT02943993|519869605|FG000|Overall Study|Other reason for premature termination|32|||
144183865|NCT02943993|519869605|FG000|Overall Study|Missing reason for termination|7|||
144183866|NCT00965757|519869619|FG000|Double-blind Phase|Progression of concomitant disease|1|||
144183867|NCT00965757|519869620|FG001|Double-blind Phase|Progression of concomitant disease|2|||
144183868|NCT00965757|519869621|FG002|Double-blind Phase|Progression of concomitant disease|0|||
144183869|NCT00965757|519869622|FG003|Double-blind Phase|Progression of concomitant disease|0|||
144183870|NCT00965757|519869619|FG000|Double-blind Phase|Adverse drug reaction|2|||
144183871|NCT00965757|519869620|FG001|Double-blind Phase|Adverse drug reaction|1|||
144183872|NCT00965757|519869621|FG002|Double-blind Phase|Adverse drug reaction|0|||
144183873|NCT00965757|519869622|FG003|Double-blind Phase|Adverse drug reaction|0|||
144538454|NCT01500200|521174197|FG002|Stage 1|Withdrawal by Subject|0|||
144538455|NCT01500200|521174198|FG003|Stage 1|Withdrawal by Subject|0|||
144538456|NCT01500200|521174199|FG004|Stage 1|Withdrawal by Subject|0|||
144183874|NCT00965757|519869619|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
144183875|NCT00965757|519869620|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
144183876|NCT00965757|519869621|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
144183877|NCT00965757|519869622|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
144183878|NCT00965757|519869619|FG000|Double-blind Phase|Lack of Efficacy|7|||
144183879|NCT00965757|519869620|FG001|Double-blind Phase|Lack of Efficacy|11|||
144183880|NCT00965757|519869621|FG002|Double-blind Phase|Lack of Efficacy|0|||
144183881|NCT00965757|519869622|FG003|Double-blind Phase|Lack of Efficacy|0|||
144183882|NCT00965757|519869619|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
144183883|NCT00965757|519869620|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
144183884|NCT00965757|519869621|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
144183885|NCT00965757|519869622|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
144183886|NCT00965757|519869619|FG000|Double-blind Phase|Lost to Follow-up|0|||
144183887|NCT00965757|519869620|FG001|Double-blind Phase|Lost to Follow-up|1|||
144183888|NCT00965757|519869621|FG002|Double-blind Phase|Lost to Follow-up|0|||
144183889|NCT00965757|519869622|FG003|Double-blind Phase|Lost to Follow-up|0|||
144183890|NCT00965757|519869619|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
144183891|NCT00965757|519869620|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
144183892|NCT00965757|519869621|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
144183893|NCT00965757|519869622|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
144183894|NCT00965757|519869619|FG000|Double-blind Phase|Other|1|||
144183895|NCT00965757|519869620|FG001|Double-blind Phase|Other|0|||
144183896|NCT00965757|519869621|FG002|Double-blind Phase|Other|0|||
144183897|NCT00965757|519869622|FG003|Double-blind Phase|Other|0|||
144183898|NCT00965757|519869619|FG000|Extension Phase|Progression of concomitant disease|0|||
144183899|NCT00965757|519869620|FG001|Extension Phase|Progression of concomitant disease|0|||
144183900|NCT00965757|519869621|FG002|Extension Phase|Progression of concomitant disease|4|||
144183901|NCT00965757|519869622|FG003|Extension Phase|Progression of concomitant disease|2|||
144183902|NCT00965757|519869619|FG000|Extension Phase|Adverse drug reaction|0|||
144183903|NCT00965757|519869620|FG001|Extension Phase|Adverse drug reaction|0|||
144183904|NCT00965757|519869621|FG002|Extension Phase|Adverse drug reaction|6|||
144183905|NCT00965757|519869622|FG003|Extension Phase|Adverse drug reaction|3|||
144183906|NCT00965757|519869619|FG000|Extension Phase|Abnormal Laboratory Value|0|||
144183907|NCT00965757|519869620|FG001|Extension Phase|Abnormal Laboratory Value|0|||
144183908|NCT00965757|519869621|FG002|Extension Phase|Abnormal Laboratory Value|6|||
144183909|NCT00965757|519869622|FG003|Extension Phase|Abnormal Laboratory Value|1|||
144183910|NCT00965757|519869619|FG000|Extension Phase|Lack of Efficacy|0|||
144183911|NCT00965757|519869620|FG001|Extension Phase|Lack of Efficacy|0|||
144183912|NCT00965757|519869621|FG002|Extension Phase|Lack of Efficacy|8|||
144183913|NCT00965757|519869622|FG003|Extension Phase|Lack of Efficacy|12|||
144183914|NCT00965757|519869619|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
144183915|NCT00965757|519869620|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
144183916|NCT00965757|519869621|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
144183917|NCT00965757|519869622|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
144183918|NCT00965757|519869619|FG000|Extension Phase|Lost to Follow-up|0|||
144183919|NCT00965757|519869620|FG001|Extension Phase|Lost to Follow-up|0|||
144183920|NCT00965757|519869621|FG002|Extension Phase|Lost to Follow-up|0|||
144183921|NCT00965757|519869622|FG003|Extension Phase|Lost to Follow-up|1|||
144183922|NCT00965757|519869619|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
144183923|NCT00965757|519869620|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
144183924|NCT00965757|519869621|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
144183925|NCT00965757|519869622|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
144183926|NCT00965757|519869619|FG000|Extension Phase|Protocol Violation|0|||
144183927|NCT00965757|519869620|FG001|Extension Phase|Protocol Violation|0|||
144183928|NCT00965757|519869621|FG002|Extension Phase|Protocol Violation|0|||
144183929|NCT00965757|519869622|FG003|Extension Phase|Protocol Violation|1|||
144183930|NCT00965757|519869619|FG000|Extension Phase|Other|0|||
144183931|NCT00965757|519869620|FG001|Extension Phase|Other|0|||
144183932|NCT00965757|519869621|FG002|Extension Phase|Other|2|||
144529020|NCT03088878|521139161|FG001|Overall Study|Clinical Progression|0|||
144529021|NCT03088878|521139162|FG002|Overall Study|Clinical Progression|0|||
144529022|NCT03088878|521139163|FG003|Overall Study|Clinical Progression|0|||
144529023|NCT03088878|521139164|FG004|Overall Study|Clinical Progression|2|||
144529024|NCT03088878|521139165|FG005|Overall Study|Clinical Progression|0|||
144529025|NCT03088878|521139166|FG006|Overall Study|Clinical Progression|0|||
144529026|NCT03088878|521139167|FG007|Overall Study|Clinical Progression|0|||
144183933|NCT00965757|519869622|FG003|Extension Phase|Other|1|||
144183934|NCT03807440|519869623|FG000|Overall Study|No documentation of index date 2|320|||
144183935|NCT03807440|519869623|FG000|Overall Study|No informed consent for index date 2|117|||
144183936|NCT02451358|519869624|FG000|Overall Study|Withdrawal by Subject|1|||
144183937|NCT02451358|519869625|FG001|Overall Study|Withdrawal by Subject|1|||
144183938|NCT02451358|519869626|FG002|Overall Study|Withdrawal by Subject|0|||
144183939|NCT02451358|519869627|FG003|Overall Study|Withdrawal by Subject|0|||
144183940|NCT02451358|519869624|FG000|Overall Study|Protocol Violation|0|||
144183941|NCT02451358|519869625|FG001|Overall Study|Protocol Violation|1|||
144183942|NCT02451358|519869626|FG002|Overall Study|Protocol Violation|1|||
144183943|NCT02451358|519869627|FG003|Overall Study|Protocol Violation|0|||
144183944|NCT00252564|519869630|FG000|Overall Study|Adverse Event|17|||
144183945|NCT00252564|519869631|FG001|Overall Study|Adverse Event|13|||
144183946|NCT00252564|519869630|FG000|Overall Study|Unrelated Complication|2|||
144183947|NCT00252564|519869631|FG001|Overall Study|Unrelated Complication|1|||
144183948|NCT00252564|519869630|FG000|Overall Study|Disease Progression|14|||
144183949|NCT00252564|519869631|FG001|Overall Study|Disease Progression|20|||
144183950|NCT00252564|519869630|FG000|Overall Study|Death|0|||
144183951|NCT00252564|519869631|FG001|Overall Study|Death|3|||
144529027|NCT03088878|521139168|FG008|Overall Study|Clinical Progression|0|||
144529028|NCT03088878|521139169|FG009|Overall Study|Clinical Progression|0|||
144529029|NCT03088878|521139170|FG010|Overall Study|Clinical Progression|0|||
144529030|NCT03088878|521139171|FG011|Overall Study|Clinical Progression|0|||
144529031|NCT03088878|521139172|FG012|Overall Study|Clinical Progression|0|||
144529032|NCT03088878|521139173|FG013|Overall Study|Clinical Progression|0|||
144529033|NCT03088878|521139160|FG000|Overall Study|Death|0|||
144183952|NCT00252564|519869630|FG000|Overall Study|Physician Decision|1|||
144183953|NCT00252564|519869631|FG001|Overall Study|Physician Decision|0|||
144183954|NCT00252564|519869630|FG000|Overall Study|Lost to Follow-up|1|||
144183955|NCT00252564|519869631|FG001|Overall Study|Lost to Follow-up|0|||
144183956|NCT00252564|519869630|FG000|Overall Study|Patient Request|4|||
144183957|NCT00252564|519869631|FG001|Overall Study|Patient Request|5|||
144183958|NCT00252564|519869630|FG000|Overall Study|Withdrawal by Subject|0|||
144183959|NCT00252564|519869631|FG001|Overall Study|Withdrawal by Subject|2|||
144183960|NCT01583530|519869632|FG000|Overall Study|Adverse Event|0|||
144183961|NCT01583530|519869633|FG001|Overall Study|Adverse Event|0|||
144183962|NCT01583530|519869634|FG002|Overall Study|Adverse Event|0|||
144183963|NCT01583530|519869635|FG003|Overall Study|Adverse Event|0|||
144183964|NCT01583530|519869636|FG004|Overall Study|Adverse Event|0|||
144183965|NCT01583530|519869637|FG005|Overall Study|Adverse Event|1|||
144183966|NCT01583530|519869632|FG000|Overall Study|Withdrawal by Subject|0|||
144183967|NCT01583530|519869633|FG001|Overall Study|Withdrawal by Subject|3|||
144183968|NCT01583530|519869634|FG002|Overall Study|Withdrawal by Subject|0|||
144183969|NCT01583530|519869635|FG003|Overall Study|Withdrawal by Subject|1|||
144183970|NCT01583530|519869636|FG004|Overall Study|Withdrawal by Subject|1|||
144183971|NCT01583530|519869637|FG005|Overall Study|Withdrawal by Subject|2|||
144183972|NCT01583530|519869632|FG000|Overall Study|Lost to Follow-up|0|||
144183973|NCT01583530|519869633|FG001|Overall Study|Lost to Follow-up|0|||
144183974|NCT01583530|519869634|FG002|Overall Study|Lost to Follow-up|0|||
144183975|NCT01583530|519869635|FG003|Overall Study|Lost to Follow-up|0|||
144183976|NCT01583530|519869636|FG004|Overall Study|Lost to Follow-up|3|||
144183977|NCT01583530|519869637|FG005|Overall Study|Lost to Follow-up|0|||
144183978|NCT01583530|519869632|FG000|Overall Study|Lack of compliance|0|||
144183979|NCT01583530|519869633|FG001|Overall Study|Lack of compliance|0|||
144183980|NCT01583530|519869634|FG002|Overall Study|Lack of compliance|0|||
144183981|NCT01583530|519869635|FG003|Overall Study|Lack of compliance|0|||
144183982|NCT01583530|519869636|FG004|Overall Study|Lack of compliance|1|||
144183983|NCT01583530|519869637|FG005|Overall Study|Lack of compliance|0|||
144183984|NCT02416180|519869638|FG000|Overall Study|Withdrawal by Subject|1|||
144183985|NCT03414034|519869639|FG000|Overall Study|Adverse Event|6|||
144183986|NCT03414034|519869640|FG001|Overall Study|Adverse Event|1|||
144183987|NCT03414034|519869641|FG002|Overall Study|Adverse Event|1|||
144183988|NCT03414034|519869639|FG000|Overall Study|Death|0|||
144183989|NCT03414034|519869640|FG001|Overall Study|Death|0|||
144183990|NCT03414034|519869641|FG002|Overall Study|Death|1|||
144183991|NCT03414034|519869639|FG000|Overall Study|Non-compliance With Study Drug|0|||
144183992|NCT03414034|519869640|FG001|Overall Study|Non-compliance With Study Drug|0|||
144183993|NCT03414034|519869641|FG002|Overall Study|Non-compliance With Study Drug|1|||
144183994|NCT03414034|519869639|FG000|Overall Study|Physician Decision|1|||
144183995|NCT03414034|519869640|FG001|Overall Study|Physician Decision|3|||
144529034|NCT03088878|521139161|FG001|Overall Study|Death|0|||
144183996|NCT03414034|519869641|FG002|Overall Study|Physician Decision|2|||
144183997|NCT03414034|519869639|FG000|Overall Study|Withdrawal of Informed Consent|2|||
144183998|NCT03414034|519869640|FG001|Overall Study|Withdrawal of Informed Consent|1|||
144183999|NCT03414034|519869641|FG002|Overall Study|Withdrawal of Informed Consent|4|||
144184000|NCT03414034|519869639|FG000|Overall Study|Progressive Disease|15|||
144184001|NCT03414034|519869640|FG001|Overall Study|Progressive Disease|15|||
144184002|NCT03414034|519869641|FG002|Overall Study|Progressive Disease|17|||
144184003|NCT03414034|519869639|FG000|Overall Study|Miscellaneous|0|||
144184004|NCT03414034|519869640|FG001|Overall Study|Miscellaneous|0|||
144184005|NCT03414034|519869641|FG002|Overall Study|Miscellaneous|2|||
144184006|NCT04010227|519869643|FG000|Overall Study|Death|1|||
144184007|NCT04010227|519869644|FG001|Overall Study|Death|2|||
144184008|NCT04010227|519869643|FG000|Overall Study|Medical Reasons|4|||
144529035|NCT03088878|521139162|FG002|Overall Study|Death|0|||
144529036|NCT03088878|521139163|FG003|Overall Study|Death|0|||
144184009|NCT04010227|519869644|FG001|Overall Study|Medical Reasons|3|||
144184010|NCT04010227|519869643|FG000|Overall Study|Withdrawal by Subject|2|||
144184011|NCT04010227|519869644|FG001|Overall Study|Withdrawal by Subject|0|||
144184012|NCT04010227|519869643|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
144184013|NCT04010227|519869644|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
144184014|NCT01332968|519869645|FG000|Induction Period|Adverse Event|23|||
144184015|NCT01332968|519869646|FG001|Induction Period|Adverse Event|26|||
144184016|NCT01332968|519869647|FG002|Induction Period|Adverse Event|0|||
144184017|NCT01332968|519869648|FG003|Induction Period|Adverse Event|0|||
144184018|NCT01332968|519869649|FG004|Induction Period|Adverse Event|0|||
144184019|NCT01332968|519869650|FG005|Induction Period|Adverse Event|0|||
144184020|NCT01332968|519869651|FG006|Induction Period|Adverse Event|0|||
144184021|NCT01332968|519869652|FG007|Induction Period|Adverse Event|0|||
144184022|NCT01332968|519869645|FG000|Induction Period|Death|1|||
144184023|NCT01332968|519869646|FG001|Induction Period|Death|4|||
144184024|NCT01332968|519869647|FG002|Induction Period|Death|0|||
144184025|NCT01332968|519869648|FG003|Induction Period|Death|0|||
144184026|NCT01332968|519869649|FG004|Induction Period|Death|0|||
144184027|NCT01332968|519869650|FG005|Induction Period|Death|0|||
144184028|NCT01332968|519869651|FG006|Induction Period|Death|0|||
144184029|NCT01332968|519869652|FG007|Induction Period|Death|0|||
144184030|NCT01332968|519869645|FG000|Induction Period|Non-compliance|1|||
144184031|NCT01332968|519869646|FG001|Induction Period|Non-compliance|0|||
144184032|NCT01332968|519869647|FG002|Induction Period|Non-compliance|0|||
144184033|NCT01332968|519869648|FG003|Induction Period|Non-compliance|0|||
144184034|NCT01332968|519869649|FG004|Induction Period|Non-compliance|0|||
144184035|NCT01332968|519869650|FG005|Induction Period|Non-compliance|0|||
144184036|NCT01332968|519869651|FG006|Induction Period|Non-compliance|0|||
144184037|NCT01332968|519869652|FG007|Induction Period|Non-compliance|0|||
144184038|NCT01332968|519869645|FG000|Induction Period|Other|2|||
144184039|NCT01332968|519869646|FG001|Induction Period|Other|2|||
144184040|NCT01332968|519869647|FG002|Induction Period|Other|0|||
144184041|NCT01332968|519869648|FG003|Induction Period|Other|0|||
144184042|NCT01332968|519869649|FG004|Induction Period|Other|0|||
144184043|NCT01332968|519869650|FG005|Induction Period|Other|0|||
144184044|NCT01332968|519869651|FG006|Induction Period|Other|0|||
144184045|NCT01332968|519869652|FG007|Induction Period|Other|0|||
144184046|NCT01332968|519869645|FG000|Induction Period|Physician Decision|6|||
144184047|NCT01332968|519869646|FG001|Induction Period|Physician Decision|1|||
144184048|NCT01332968|519869647|FG002|Induction Period|Physician Decision|0|||
144184049|NCT01332968|519869648|FG003|Induction Period|Physician Decision|0|||
144184050|NCT01332968|519869649|FG004|Induction Period|Physician Decision|0|||
144184051|NCT01332968|519869650|FG005|Induction Period|Physician Decision|0|||
144184052|NCT01332968|519869651|FG006|Induction Period|Physician Decision|0|||
144184053|NCT01332968|519869652|FG007|Induction Period|Physician Decision|0|||
144184054|NCT01332968|519869645|FG000|Induction Period|Progressive Disease|15|||
144184055|NCT01332968|519869646|FG001|Induction Period|Progressive Disease|7|||
144184056|NCT01332968|519869647|FG002|Induction Period|Progressive Disease|0|||
144184057|NCT01332968|519869648|FG003|Induction Period|Progressive Disease|0|||
144184058|NCT01332968|519869649|FG004|Induction Period|Progressive Disease|0|||
144184059|NCT01332968|519869650|FG005|Induction Period|Progressive Disease|0|||
144184060|NCT01332968|519869651|FG006|Induction Period|Progressive Disease|0|||
144184061|NCT01332968|519869652|FG007|Induction Period|Progressive Disease|0|||
144184062|NCT01332968|519869645|FG000|Induction Period|Protocol Violation|3|||
144184063|NCT01332968|519869646|FG001|Induction Period|Protocol Violation|4|||
144184064|NCT01332968|519869647|FG002|Induction Period|Protocol Violation|0|||
144184065|NCT01332968|519869648|FG003|Induction Period|Protocol Violation|0|||
144184066|NCT01332968|519869649|FG004|Induction Period|Protocol Violation|0|||
144184067|NCT01332968|519869650|FG005|Induction Period|Protocol Violation|0|||
144184068|NCT01332968|519869651|FG006|Induction Period|Protocol Violation|0|||
144184069|NCT01332968|519869652|FG007|Induction Period|Protocol Violation|0|||
144184070|NCT01332968|519869645|FG000|Induction Period|Withdrawal by Subject|3|||
144184071|NCT01332968|519869646|FG001|Induction Period|Withdrawal by Subject|5|||
144184072|NCT01332968|519869647|FG002|Induction Period|Withdrawal by Subject|0|||
144184073|NCT01332968|519869648|FG003|Induction Period|Withdrawal by Subject|0|||
144184074|NCT01332968|519869649|FG004|Induction Period|Withdrawal by Subject|0|||
144184075|NCT01332968|519869650|FG005|Induction Period|Withdrawal by Subject|0|||
144184076|NCT01332968|519869651|FG006|Induction Period|Withdrawal by Subject|0|||
144184077|NCT01332968|519869652|FG007|Induction Period|Withdrawal by Subject|0|||
144184078|NCT01332968|519869645|FG000|Induction Period|Randomised but not treated|4|||
144184079|NCT01332968|519869646|FG001|Induction Period|Randomised but not treated|7|||
144184080|NCT01332968|519869647|FG002|Induction Period|Randomised but not treated|0|||
144529037|NCT03088878|521139164|FG004|Overall Study|Death|2|||
144184081|NCT01332968|519869648|FG003|Induction Period|Randomised but not treated|0|||
144184082|NCT01332968|519869649|FG004|Induction Period|Randomised but not treated|0|||
144184083|NCT01332968|519869650|FG005|Induction Period|Randomised but not treated|0|||
144184084|NCT01332968|519869651|FG006|Induction Period|Randomised but not treated|0|||
144184085|NCT01332968|519869652|FG007|Induction Period|Randomised but not treated|0|||
144184086|NCT01332968|519869645|FG000|Maintenance/Observation Period|Adverse Event|0|||
144529038|NCT03088878|521139165|FG005|Overall Study|Death|0|||
144184087|NCT01332968|519869646|FG001|Maintenance/Observation Period|Adverse Event|0|||
144184088|NCT01332968|519869647|FG002|Maintenance/Observation Period|Adverse Event|53|||
144184089|NCT01332968|519869648|FG003|Maintenance/Observation Period|Adverse Event|66|||
144184090|NCT01332968|519869649|FG004|Maintenance/Observation Period|Adverse Event|0|||
144184091|NCT01332968|519869650|FG005|Maintenance/Observation Period|Adverse Event|0|||
144184092|NCT01332968|519869651|FG006|Maintenance/Observation Period|Adverse Event|0|||
144184093|NCT01332968|519869652|FG007|Maintenance/Observation Period|Adverse Event|0|||
144184094|NCT01332968|519869645|FG000|Maintenance/Observation Period|Death|0|||
144184095|NCT01332968|519869646|FG001|Maintenance/Observation Period|Death|0|||
144184096|NCT01332968|519869647|FG002|Maintenance/Observation Period|Death|5|||
144184097|NCT01332968|519869648|FG003|Maintenance/Observation Period|Death|6|||
144184098|NCT01332968|519869649|FG004|Maintenance/Observation Period|Death|0|||
144184099|NCT01332968|519869650|FG005|Maintenance/Observation Period|Death|0|||
144184100|NCT01332968|519869651|FG006|Maintenance/Observation Period|Death|0|||
144184101|NCT01332968|519869652|FG007|Maintenance/Observation Period|Death|0|||
144184102|NCT01332968|519869645|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
144184103|NCT01332968|519869646|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
144184104|NCT01332968|519869647|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
144184105|NCT01332968|519869648|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
144184106|NCT01332968|519869649|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
144184107|NCT01332968|519869650|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
144184108|NCT01332968|519869651|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
144184109|NCT01332968|519869652|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
144184110|NCT01332968|519869645|FG000|Maintenance/Observation Period|Non-compliance|0|||
144184111|NCT01332968|519869646|FG001|Maintenance/Observation Period|Non-compliance|0|||
144184112|NCT01332968|519869647|FG002|Maintenance/Observation Period|Non-compliance|4|||
144184113|NCT01332968|519869648|FG003|Maintenance/Observation Period|Non-compliance|3|||
144184114|NCT01332968|519869649|FG004|Maintenance/Observation Period|Non-compliance|0|||
144184115|NCT01332968|519869650|FG005|Maintenance/Observation Period|Non-compliance|0|||
144184116|NCT01332968|519869651|FG006|Maintenance/Observation Period|Non-compliance|0|||
144184117|NCT01332968|519869652|FG007|Maintenance/Observation Period|Non-compliance|0|||
144184118|NCT01332968|519869645|FG000|Maintenance/Observation Period|Other|0|||
144184119|NCT01332968|519869646|FG001|Maintenance/Observation Period|Other|0|||
144184120|NCT01332968|519869647|FG002|Maintenance/Observation Period|Other|4|||
144184121|NCT01332968|519869648|FG003|Maintenance/Observation Period|Other|7|||
144184122|NCT01332968|519869649|FG004|Maintenance/Observation Period|Other|0|||
144184123|NCT01332968|519869650|FG005|Maintenance/Observation Period|Other|0|||
144184124|NCT01332968|519869651|FG006|Maintenance/Observation Period|Other|0|||
144184125|NCT01332968|519869652|FG007|Maintenance/Observation Period|Other|0|||
144184126|NCT01332968|519869645|FG000|Maintenance/Observation Period|Physician Decision|0|||
144184127|NCT01332968|519869646|FG001|Maintenance/Observation Period|Physician Decision|0|||
144184128|NCT01332968|519869647|FG002|Maintenance/Observation Period|Physician Decision|14|||
144184129|NCT01332968|519869648|FG003|Maintenance/Observation Period|Physician Decision|19|||
144184130|NCT01332968|519869649|FG004|Maintenance/Observation Period|Physician Decision|0|||
144184131|NCT01332968|519869650|FG005|Maintenance/Observation Period|Physician Decision|1|||
144184132|NCT01332968|519869651|FG006|Maintenance/Observation Period|Physician Decision|0|||
144184133|NCT01332968|519869652|FG007|Maintenance/Observation Period|Physician Decision|0|||
144184134|NCT01332968|519869645|FG000|Maintenance/Observation Period|Progressive Disease|0|||
144184135|NCT01332968|519869646|FG001|Maintenance/Observation Period|Progressive Disease|0|||
144184136|NCT01332968|519869647|FG002|Maintenance/Observation Period|Progressive Disease|72|||
144184137|NCT01332968|519869648|FG003|Maintenance/Observation Period|Progressive Disease|40|||
144184138|NCT01332968|519869649|FG004|Maintenance/Observation Period|Progressive Disease|0|||
144184139|NCT01332968|519869650|FG005|Maintenance/Observation Period|Progressive Disease|0|||
144184140|NCT01332968|519869651|FG006|Maintenance/Observation Period|Progressive Disease|0|||
144184141|NCT01332968|519869652|FG007|Maintenance/Observation Period|Progressive Disease|0|||
144184142|NCT01332968|519869645|FG000|Maintenance/Observation Period|Protocol Violation|0|||
144184143|NCT01332968|519869646|FG001|Maintenance/Observation Period|Protocol Violation|0|||
144184144|NCT01332968|519869647|FG002|Maintenance/Observation Period|Protocol Violation|1|||
144184145|NCT01332968|519869648|FG003|Maintenance/Observation Period|Protocol Violation|1|||
144184146|NCT01332968|519869649|FG004|Maintenance/Observation Period|Protocol Violation|0|||
144184147|NCT01332968|519869650|FG005|Maintenance/Observation Period|Protocol Violation|0|||
144184148|NCT01332968|519869651|FG006|Maintenance/Observation Period|Protocol Violation|0|||
144184149|NCT01332968|519869652|FG007|Maintenance/Observation Period|Protocol Violation|0|||
144184150|NCT01332968|519869645|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
144184151|NCT01332968|519869646|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
144184152|NCT01332968|519869647|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
144184153|NCT01332968|519869648|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
144184154|NCT01332968|519869649|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
144184155|NCT01332968|519869650|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
144184156|NCT01332968|519869651|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
144184157|NCT01332968|519869652|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
144184158|NCT01332968|519869645|FG000|Follow-Up Period|Adverse Event|0|||
144184159|NCT01332968|519869646|FG001|Follow-Up Period|Adverse Event|0|||
144184160|NCT01332968|519869647|FG002|Follow-Up Period|Adverse Event|0|||
144184161|NCT01332968|519869648|FG003|Follow-Up Period|Adverse Event|0|||
144184162|NCT01332968|519869649|FG004|Follow-Up Period|Adverse Event|0|||
144184163|NCT01332968|519869650|FG005|Follow-Up Period|Adverse Event|0|||
144184164|NCT01332968|519869651|FG006|Follow-Up Period|Adverse Event|0|||
144184165|NCT01332968|519869652|FG007|Follow-Up Period|Adverse Event|4|||
144184166|NCT01332968|519869645|FG000|Follow-Up Period|Death|0|||
144723598|NCT04634409|521842384|FG001|Overall Study|Other - As reported by Investigator|0|||
144184167|NCT01332968|519869646|FG001|Follow-Up Period|Death|0|||
144184168|NCT01332968|519869647|FG002|Follow-Up Period|Death|0|||
144184169|NCT01332968|519869648|FG003|Follow-Up Period|Death|0|||
144184170|NCT01332968|519869649|FG004|Follow-Up Period|Death|0|||
144184171|NCT01332968|519869650|FG005|Follow-Up Period|Death|0|||
144723599|NCT04634409|521842385|FG002|Overall Study|Other - As reported by Investigator|0|||
144723600|NCT04634409|521842386|FG003|Overall Study|Other - As reported by Investigator|0|||
144723601|NCT04634409|521842387|FG004|Overall Study|Other - As reported by Investigator|0|||
144723602|NCT04634409|521842388|FG005|Overall Study|Other - As reported by Investigator|0|||
144723603|NCT04634409|521842389|FG006|Overall Study|Other - As reported by Investigator|0|||
144723604|NCT04634409|521842390|FG007|Overall Study|Other - As reported by Investigator|6|||
144723605|NCT04634409|521842391|FG008|Overall Study|Other - As reported by Investigator|4|||
144723606|NCT04634409|521842392|FG009|Overall Study|Other - As reported by Investigator|0|||
144723607|NCT04634409|521842393|FG010|Overall Study|Other - As reported by Investigator|1|||
144723608|NCT04634409|521842394|FG011|Overall Study|Other - As reported by Investigator|2|||
144723609|NCT04634409|521842395|FG012|Overall Study|Other - As reported by Investigator|2|||
144723610|NCT04634409|521842396|FG013|Overall Study|Other - As reported by Investigator|1|||
144723611|NCT04634409|521842397|FG014|Overall Study|Other - As reported by Investigator|0|||
144723612|NCT04634409|521842398|FG015|Overall Study|Other - As reported by Investigator|0|||
144723613|NCT04634409|521842399|FG016|Overall Study|Other - As reported by Investigator|0|||
144723614|NCT04634409|521842400|FG017|Overall Study|Other - As reported by Investigator|0|||
144723615|NCT04634409|521842401|FG018|Overall Study|Other - As reported by Investigator|0|||
144723616|NCT04634409|521842402|FG019|Overall Study|Other - As reported by Investigator|0|||
144723617|NCT04634409|521842403|FG020|Overall Study|Other - As reported by Investigator|0|||
144723618|NCT04634409|521842404|FG021|Overall Study|Other - As reported by Investigator|0|||
144723619|NCT04634409|521842405|FG022|Overall Study|Other - As reported by Investigator|0|||
144723620|NCT04634409|521842406|FG023|Overall Study|Other - As reported by Investigator|0|||
144723621|NCT04634409|521842407|FG024|Overall Study|Other - As reported by Investigator|0|||
144723622|NCT04634409|521842408|FG025|Overall Study|Other - As reported by Investigator|0|||
144723623|NCT04634409|521842409|FG026|Overall Study|Other - As reported by Investigator|0|||
144723624|NCT01497938|521842410|FG000|Overall Study|Adverse Event|0|||
144723625|NCT01497938|521842411|FG001|Overall Study|Adverse Event|1|||
144723626|NCT01497938|521842410|FG000|Overall Study|Physician Decision|0|||
144723627|NCT01497938|521842411|FG001|Overall Study|Physician Decision|1|||
144184172|NCT01332968|519869651|FG006|Follow-Up Period|Death|27|||
144184173|NCT01332968|519869652|FG007|Follow-Up Period|Death|30|||
144184174|NCT01332968|519869645|FG000|Follow-Up Period|Lost to Follow-up|0|||
144184175|NCT01332968|519869646|FG001|Follow-Up Period|Lost to Follow-up|0|||
144184176|NCT01332968|519869647|FG002|Follow-Up Period|Lost to Follow-up|0|||
144184177|NCT01332968|519869648|FG003|Follow-Up Period|Lost to Follow-up|0|||
144184178|NCT01332968|519869649|FG004|Follow-Up Period|Lost to Follow-up|0|||
144184179|NCT01332968|519869650|FG005|Follow-Up Period|Lost to Follow-up|0|||
144184180|NCT01332968|519869651|FG006|Follow-Up Period|Lost to Follow-up|11|||
144184181|NCT01332968|519869652|FG007|Follow-Up Period|Lost to Follow-up|15|||
144184182|NCT01332968|519869645|FG000|Follow-Up Period|Non-compliance|0|||
144184183|NCT01332968|519869646|FG001|Follow-Up Period|Non-compliance|0|||
144184184|NCT01332968|519869647|FG002|Follow-Up Period|Non-compliance|0|||
144184185|NCT01332968|519869648|FG003|Follow-Up Period|Non-compliance|0|||
144184186|NCT01332968|519869649|FG004|Follow-Up Period|Non-compliance|0|||
144723628|NCT01497938|521842410|FG000|Overall Study|Withdrawal by Subject|4|||
144723629|NCT01497938|521842411|FG001|Overall Study|Withdrawal by Subject|0|||
144723630|NCT01497938|521842410|FG000|Overall Study|Device Violation|1|||
144723631|NCT01497938|521842411|FG001|Overall Study|Device Violation|0|||
144723632|NCT00365352|521842412|FG000|Overall Study|Adverse Event|6|||
144184187|NCT01332968|519869650|FG005|Follow-Up Period|Non-compliance|0|||
144184188|NCT01332968|519869651|FG006|Follow-Up Period|Non-compliance|4|||
144184189|NCT01332968|519869652|FG007|Follow-Up Period|Non-compliance|9|||
144723633|NCT00365352|521842413|FG001|Overall Study|Adverse Event|7|||
144723634|NCT00365352|521842414|FG002|Overall Study|Adverse Event|8|||
144723635|NCT00365352|521842412|FG000|Overall Study|Participant Withdrew Consent|8|||
144184190|NCT01332968|519869645|FG000|Follow-Up Period|Other|0|||
144184191|NCT01332968|519869646|FG001|Follow-Up Period|Other|0|||
144184192|NCT01332968|519869647|FG002|Follow-Up Period|Other|0|||
144184193|NCT01332968|519869648|FG003|Follow-Up Period|Other|0|||
144184194|NCT01332968|519869649|FG004|Follow-Up Period|Other|0|||
144184195|NCT01332968|519869650|FG005|Follow-Up Period|Other|0|||
144184196|NCT01332968|519869651|FG006|Follow-Up Period|Other|18|||
144184197|NCT01332968|519869652|FG007|Follow-Up Period|Other|21|||
144184198|NCT01332968|519869645|FG000|Follow-Up Period|Physician Decision|0|||
144184199|NCT01332968|519869646|FG001|Follow-Up Period|Physician Decision|0|||
144184200|NCT01332968|519869647|FG002|Follow-Up Period|Physician Decision|0|||
144184201|NCT01332968|519869648|FG003|Follow-Up Period|Physician Decision|0|||
144184202|NCT01332968|519869649|FG004|Follow-Up Period|Physician Decision|0|||
144184203|NCT01332968|519869650|FG005|Follow-Up Period|Physician Decision|0|||
144184204|NCT01332968|519869651|FG006|Follow-Up Period|Physician Decision|12|||
144184205|NCT01332968|519869652|FG007|Follow-Up Period|Physician Decision|15|||
144184206|NCT01332968|519869645|FG000|Follow-Up Period|Progressive Disease|0|||
144184207|NCT01332968|519869646|FG001|Follow-Up Period|Progressive Disease|0|||
144184208|NCT01332968|519869647|FG002|Follow-Up Period|Progressive Disease|0|||
144184209|NCT01332968|519869648|FG003|Follow-Up Period|Progressive Disease|0|||
144184210|NCT01332968|519869649|FG004|Follow-Up Period|Progressive Disease|0|||
144184211|NCT01332968|519869650|FG005|Follow-Up Period|Progressive Disease|0|||
144184212|NCT01332968|519869651|FG006|Follow-Up Period|Progressive Disease|126|||
144184213|NCT01332968|519869652|FG007|Follow-Up Period|Progressive Disease|106|||
144184214|NCT01332968|519869645|FG000|Follow-Up Period|Protocol Violation|0|||
144184215|NCT01332968|519869646|FG001|Follow-Up Period|Protocol Violation|0|||
144184216|NCT01332968|519869647|FG002|Follow-Up Period|Protocol Violation|0|||
144184217|NCT01332968|519869648|FG003|Follow-Up Period|Protocol Violation|0|||
144184218|NCT01332968|519869649|FG004|Follow-Up Period|Protocol Violation|0|||
144184219|NCT01332968|519869650|FG005|Follow-Up Period|Protocol Violation|0|||
144184220|NCT01332968|519869651|FG006|Follow-Up Period|Protocol Violation|1|||
144184221|NCT01332968|519869652|FG007|Follow-Up Period|Protocol Violation|0|||
144184222|NCT01332968|519869645|FG000|Follow-Up Period|Withdrawal by Subject|0|||
144184223|NCT01332968|519869646|FG001|Follow-Up Period|Withdrawal by Subject|0|||
144184224|NCT01332968|519869647|FG002|Follow-Up Period|Withdrawal by Subject|0|||
144184225|NCT01332968|519869648|FG003|Follow-Up Period|Withdrawal by Subject|0|||
144184226|NCT01332968|519869649|FG004|Follow-Up Period|Withdrawal by Subject|0|||
144184227|NCT01332968|519869650|FG005|Follow-Up Period|Withdrawal by Subject|0|||
144184228|NCT01332968|519869651|FG006|Follow-Up Period|Withdrawal by Subject|29|||
144184229|NCT01332968|519869652|FG007|Follow-Up Period|Withdrawal by Subject|32|||
144184230|NCT01332968|519869645|FG000|Follow-Up Period|No reason provided|0|||
144184231|NCT01332968|519869646|FG001|Follow-Up Period|No reason provided|0|||
144184232|NCT01332968|519869647|FG002|Follow-Up Period|No reason provided|0|||
144184233|NCT01332968|519869648|FG003|Follow-Up Period|No reason provided|0|||
144184234|NCT01332968|519869649|FG004|Follow-Up Period|No reason provided|0|||
144184235|NCT01332968|519869650|FG005|Follow-Up Period|No reason provided|0|||
144184236|NCT01332968|519869651|FG006|Follow-Up Period|No reason provided|2|||
144184237|NCT01332968|519869652|FG007|Follow-Up Period|No reason provided|3|||
144184238|NCT04320745|519869657|FG000|Overall Study|Adverse Event|26|||
144184239|NCT04320745|519869657|FG000|Overall Study|Withdrawal by Subject|4|||
144184240|NCT04320745|519869657|FG000|Overall Study|Lost to Follow-up|12|||
144184241|NCT04320745|519869657|FG000|Overall Study|Protocol Deviation|2|||
144184242|NCT04320745|519869657|FG000|Overall Study|Non-compliance With Study Drug|2|||
144184243|NCT04320745|519869657|FG000|Overall Study|Reason Not Specified|1|||
144184244|NCT02050321|519869662|FG000|Overall Study|Withdrawal by Subject|1|||
144184245|NCT02050321|519869662|FG000|Overall Study|Adverse Event|1|||
144184246|NCT00702507|519869663|FG000|Initial Treatment Phase|Adverse Event|2|||
144184247|NCT00702507|519869663|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
144184248|NCT00702507|519869663|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
144184249|NCT00702507|519869663|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
144184250|NCT00702507|519869663|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
144184251|NCT00702507|519869663|FG000|Follow-up Phase|Protocol Violation|2|||
144184252|NCT00702507|519869663|FG000|Follow-up Phase|Lost to Follow-up|23|||
144184253|NCT00702507|519869663|FG000|Follow-up Phase|Late Enrollment|1|||
144184254|NCT02308696|519869665|FG000|Overall Study|Lost to Follow-up|28|||
144184255|NCT02308696|519869666|FG001|Overall Study|Lost to Follow-up|21|||
144184256|NCT02308696|519869665|FG000|Overall Study|Death|8|||
144184257|NCT02308696|519869666|FG001|Overall Study|Death|4|||
144184258|NCT02308696|519869665|FG000|Overall Study|Moved to a Higher Level of Care|17|||
144184259|NCT02308696|519869666|FG001|Overall Study|Moved to a Higher Level of Care|6|||
144184260|NCT00715676|519869672|FG000|Overall Study|Adverse Event|3|||
144184261|NCT00715676|519869673|FG001|Overall Study|Adverse Event|5|||
144184262|NCT00715676|519869674|FG002|Overall Study|Adverse Event|21|||
144184263|NCT00715676|519869672|FG000|Overall Study|Withdrawal by Subject|1|||
144184264|NCT00715676|519869673|FG001|Overall Study|Withdrawal by Subject|3|||
144184265|NCT00715676|519869674|FG002|Overall Study|Withdrawal by Subject|8|||
144184266|NCT00715676|519869672|FG000|Overall Study|Lost to Follow-up|1|||
144184267|NCT00715676|519869673|FG001|Overall Study|Lost to Follow-up|2|||
144184268|NCT00715676|519869674|FG002|Overall Study|Lost to Follow-up|1|||
144184269|NCT00715676|519869672|FG000|Overall Study|Terminated by Sponsor|1|||
144184270|NCT00715676|519869673|FG001|Overall Study|Terminated by Sponsor|0|||
144184271|NCT00715676|519869674|FG002|Overall Study|Terminated by Sponsor|0|||
144184272|NCT00715676|519869672|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
144184273|NCT00715676|519869673|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
144184274|NCT00715676|519869674|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
144184275|NCT00715676|519869672|FG000|Overall Study|Use of Exclusionary Medication|0|||
144184276|NCT00715676|519869673|FG001|Overall Study|Use of Exclusionary Medication|0|||
144184277|NCT00715676|519869674|FG002|Overall Study|Use of Exclusionary Medication|1|||
144184278|NCT00715676|519869672|FG000|Overall Study|Elevated Blood Glucose|0|||
144184279|NCT00715676|519869673|FG001|Overall Study|Elevated Blood Glucose|1|||
144184280|NCT00715676|519869674|FG002|Overall Study|Elevated Blood Glucose|0|||
144184281|NCT04994431|519869675|FG000|Overall Study|Adverse Event|1|||
144184282|NCT04994431|519869676|FG001|Overall Study|Adverse Event|0|||
144184283|NCT01849458|519869677|FG000|Overall Study|Lost to Follow-up|4|||
144184284|NCT04194008|519869680|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
144184285|NCT04194008|519869680|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
144184286|NCT04194008|519869680|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
144184287|NCT04194008|519869680|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
144184288|NCT04194008|519869680|FG000|Treatment Phase With Nerivio|Missing data|4|||
144184289|NCT04194008|519869680|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
144184290|NCT02522780|519869684|FG000|Overall Study|Consent withdrawn by subject|5|||
144184291|NCT02522780|519869685|FG001|Overall Study|Consent withdrawn by subject|7|||
144184292|NCT02522780|519869684|FG000|Overall Study|Protocol deviation|1|||
144184293|NCT02522780|519869685|FG001|Overall Study|Protocol deviation|3|||
144184294|NCT02522780|519869684|FG000|Overall Study|Subject refused endoscopic procedure|0|||
144184295|NCT02522780|519869685|FG001|Overall Study|Subject refused endoscopic procedure|1|||
144184296|NCT02522780|519869684|FG000|Overall Study|Adverse event, non-fatal|11|||
144184297|NCT02522780|519869685|FG001|Overall Study|Adverse event, non-fatal|16|||
144184298|NCT02260635|519869686|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
144184299|NCT02260635|519869687|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
144184300|NCT02260635|519869686|FG000|Open-Label Extension|Study Termination|25|||
144184301|NCT02260635|519869687|FG001|Open-Label Extension|Study Termination|25|||
144184302|NCT02260635|519869686|FG000|Open-Label Extension|Withdrawal by Subject|1|||
144184303|NCT02260635|519869687|FG001|Open-Label Extension|Withdrawal by Subject|0|||
144184304|NCT01517867|519869688|FG000|Overall Study|never started treatment|29|||
144184305|NCT01517867|519869689|FG001|Overall Study|never started treatment|32|||
144184306|NCT01517867|519869688|FG000|Overall Study|Withdrawal by Subject|34|||
144184307|NCT01517867|519869689|FG001|Overall Study|Withdrawal by Subject|30|||
144184308|NCT01517867|519869688|FG000|Overall Study|Still in treatment at study end|0|||
144184309|NCT01517867|519869689|FG001|Overall Study|Still in treatment at study end|3|||
144184310|NCT03294317|519869691|FG000|Overall Study|Physician Decision|1|||
144184311|NCT03294317|519869691|FG000|Overall Study|Withdrawal by Subject|6|||
144184312|NCT03294317|519869691|FG000|Overall Study|Lost to Follow-up|1|||
144184313|NCT03294317|519869691|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
144184314|NCT03294317|519869691|FG000|Overall Study|Failed HB lead implant|8|||
144184315|NCT03294317|519869691|FG000|Overall Study|Received CRT instead|1|||
144184316|NCT03294317|519869691|FG000|Overall Study|Exited after lead revision|2|||
144184317|NCT03847974|519869692|FG000|Overall Study|relocated out of region|3|||
144184318|NCT03847974|519869692|FG000|Overall Study|Withdrawal by Subject|2|||
144184319|NCT03847974|519869692|FG000|Overall Study|Adverse Event|1|||
144184320|NCT04307849|519869693|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
144184321|NCT04307849|519869694|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
144184322|NCT04307849|519869695|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
144184323|NCT04307849|519869696|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
144184324|NCT04307849|519869697|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
144184325|NCT04307849|519869698|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
144184326|NCT04307849|519869693|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
144184327|NCT04307849|519869694|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
144184328|NCT04307849|519869695|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
144184329|NCT04307849|519869696|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
144184330|NCT04307849|519869697|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
144184331|NCT04307849|519869698|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
144184332|NCT04307849|519869693|FG000|Overall Study|Family member did not want them to continue|0|||
144184333|NCT04307849|519869694|FG001|Overall Study|Family member did not want them to continue|0|||
144184334|NCT04307849|519869695|FG002|Overall Study|Family member did not want them to continue|1|||
144184335|NCT04307849|519869696|FG003|Overall Study|Family member did not want them to continue|0|||
144184336|NCT04307849|519869697|FG004|Overall Study|Family member did not want them to continue|0|||
144184337|NCT04307849|519869698|FG005|Overall Study|Family member did not want them to continue|0|||
144184338|NCT04307849|519869693|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
144184339|NCT04307849|519869694|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
144430271|NCT02658890|520784788|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
144430272|NCT02658890|520784789|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
144184340|NCT04307849|519869695|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
144184341|NCT04307849|519869696|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
144184342|NCT04307849|519869697|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
144184343|NCT04307849|519869698|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
144184344|NCT00603512|519869699|FG000|Overall Study|Adverse Event|0|||
144184345|NCT00603512|519869700|FG001|Overall Study|Adverse Event|2|||
144184346|NCT00603512|519869701|FG002|Overall Study|Adverse Event|4|||
144184347|NCT00603512|519869702|FG003|Overall Study|Adverse Event|4|||
144184348|NCT00603512|519869703|FG004|Overall Study|Adverse Event|2|||
144184349|NCT00603512|519869699|FG000|Overall Study|Lack of Efficacy|0|||
144184350|NCT00603512|519869700|FG001|Overall Study|Lack of Efficacy|1|||
144184351|NCT00603512|519869701|FG002|Overall Study|Lack of Efficacy|0|||
144184352|NCT00603512|519869702|FG003|Overall Study|Lack of Efficacy|0|||
144184353|NCT00603512|519869703|FG004|Overall Study|Lack of Efficacy|1|||
144184354|NCT00603512|519869699|FG000|Overall Study|Other|2|||
144184355|NCT00603512|519869700|FG001|Overall Study|Other|1|||
144184356|NCT00603512|519869701|FG002|Overall Study|Other|0|||
144184357|NCT00603512|519869702|FG003|Overall Study|Other|1|||
144184358|NCT00603512|519869703|FG004|Overall Study|Other|1|||
144184359|NCT00603512|519869699|FG000|Overall Study|Withdrawal by Subject|0|||
144184360|NCT00603512|519869700|FG001|Overall Study|Withdrawal by Subject|0|||
144184361|NCT00603512|519869701|FG002|Overall Study|Withdrawal by Subject|0|||
144184362|NCT00603512|519869702|FG003|Overall Study|Withdrawal by Subject|0|||
144184363|NCT00603512|519869703|FG004|Overall Study|Withdrawal by Subject|1|||
144184364|NCT00603512|519869699|FG000|Overall Study|Randomized but not treated|0|||
144184365|NCT00603512|519869700|FG001|Overall Study|Randomized but not treated|1|||
144184366|NCT00603512|519869701|FG002|Overall Study|Randomized but not treated|1|||
144184367|NCT00603512|519869702|FG003|Overall Study|Randomized but not treated|2|||
144184368|NCT00603512|519869703|FG004|Overall Study|Randomized but not treated|0|||
144184369|NCT04979858|519869704|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
144184370|NCT04979858|519869705|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
144184371|NCT04253236|519869706|FG000|Overall Study|Adverse Event|1|||
144184372|NCT04253236|519869707|FG001|Overall Study|Adverse Event|0|||
144184373|NCT04253236|519869706|FG000|Overall Study|Safety Concerns|1|||
144184374|NCT04253236|519869707|FG001|Overall Study|Safety Concerns|0|||
144184375|NCT04253236|519869706|FG000|Overall Study|Study Terminated by Sponsor|1|||
144184376|NCT04253236|519869707|FG001|Overall Study|Study Terminated by Sponsor|0|||
144184377|NCT02654015|519869708|FG000|Overall Study|Death|12|||
144184378|NCT02654015|519869708|FG000|Overall Study|Lost to Follow-up|3|||
144184379|NCT05317195|519869709|FG000|Randomization|Withdrawal by Subject|1|||
144184380|NCT05317195|519869709|FG000|Randomization|Discontinued|6|||
144184381|NCT05317195|519869709|FG000|Admission|Withdrawal by Subject|2|||
144184382|NCT00889252|519869710|FG000|Overall Study|Adverse Event|2|||
144184383|NCT00889252|519869711|FG001|Overall Study|Adverse Event|4|||
144184384|NCT00889252|519869710|FG000|Overall Study|Withdrawal by Subject|3|||
144184385|NCT00889252|519869711|FG001|Overall Study|Withdrawal by Subject|0|||
144184386|NCT00889252|519869710|FG000|Overall Study|Protocol Violation|2|||
144184387|NCT00889252|519869711|FG001|Overall Study|Protocol Violation|0|||
144184388|NCT02212457|519869712|FG000|Overall Study|Adverse Event|1|||
144184389|NCT02212457|519869713|FG001|Overall Study|Adverse Event|2|||
144184390|NCT02212457|519869714|FG002|Overall Study|Adverse Event|2|||
144184391|NCT02212457|519869715|FG003|Overall Study|Adverse Event|2|||
144184392|NCT02212457|519869716|FG004|Overall Study|Adverse Event|0|||
144184393|NCT02212457|519869717|FG005|Overall Study|Adverse Event|1|||
144184394|NCT02212457|519869712|FG000|Overall Study|Withdrawal by Subject|8|||
144184395|NCT02212457|519869713|FG001|Overall Study|Withdrawal by Subject|10|||
144184396|NCT02212457|519869714|FG002|Overall Study|Withdrawal by Subject|8|||
144184397|NCT02212457|519869715|FG003|Overall Study|Withdrawal by Subject|6|||
144184398|NCT02212457|519869716|FG004|Overall Study|Withdrawal by Subject|5|||
144184399|NCT02212457|519869717|FG005|Overall Study|Withdrawal by Subject|4|||
144184400|NCT02212457|519869712|FG000|Overall Study|Lost to Follow-up|6|||
144184401|NCT02212457|519869713|FG001|Overall Study|Lost to Follow-up|7|||
144184402|NCT02212457|519869714|FG002|Overall Study|Lost to Follow-up|4|||
144184403|NCT02212457|519869715|FG003|Overall Study|Lost to Follow-up|1|||
144184404|NCT02212457|519869716|FG004|Overall Study|Lost to Follow-up|8|||
144184405|NCT02212457|519869717|FG005|Overall Study|Lost to Follow-up|4|||
144184406|NCT02212457|519869712|FG000|Overall Study|Protocol Violation|2|||
144184407|NCT02212457|519869713|FG001|Overall Study|Protocol Violation|1|||
144184408|NCT02212457|519869714|FG002|Overall Study|Protocol Violation|0|||
144184409|NCT02212457|519869715|FG003|Overall Study|Protocol Violation|1|||
144184410|NCT02212457|519869716|FG004|Overall Study|Protocol Violation|2|||
144184411|NCT02212457|519869717|FG005|Overall Study|Protocol Violation|3|||
144184412|NCT02212457|519869712|FG000|Overall Study|Other|2|||
144184413|NCT02212457|519869713|FG001|Overall Study|Other|1|||
144184414|NCT02212457|519869714|FG002|Overall Study|Other|2|||
144184415|NCT02212457|519869715|FG003|Overall Study|Other|1|||
144184416|NCT02212457|519869716|FG004|Overall Study|Other|0|||
144184417|NCT02212457|519869717|FG005|Overall Study|Other|1|||
144184418|NCT00393705|519869718|FG000|Overall Study|Adverse Event|0|||
144184419|NCT00393705|519869719|FG001|Overall Study|Adverse Event|2|||
144184420|NCT00393705|519869718|FG000|Overall Study|Death|0|||
144184421|NCT00393705|519869719|FG001|Overall Study|Death|1|||
144184422|NCT00393705|519869718|FG000|Overall Study|Lost to Follow-up|2|||
144184423|NCT00393705|519869719|FG001|Overall Study|Lost to Follow-up|2|||
144184424|NCT00393705|519869718|FG000|Overall Study|Entry Criteria Not Met|10|||
144184425|NCT00393705|519869719|FG001|Overall Study|Entry Criteria Not Met|10|||
144184426|NCT00393705|519869718|FG000|Overall Study|Protocol Violation|4|||
144184427|NCT00393705|519869719|FG001|Overall Study|Protocol Violation|3|||
144184428|NCT00393705|519869718|FG000|Overall Study|Withdrawal by Subject|5|||
144184429|NCT00393705|519869719|FG001|Overall Study|Withdrawal by Subject|3|||
144184430|NCT00393705|519869718|FG000|Overall Study|Physician Decision|2|||
144184431|NCT00393705|519869719|FG001|Overall Study|Physician Decision|2|||
144184432|NCT00642811|519869722|FG000|Overall Study|Adverse Event|2|||
144184433|NCT00642811|519869723|FG001|Overall Study|Adverse Event|3|||
144184434|NCT00642811|519869724|FG002|Overall Study|Adverse Event|0|||
144184435|NCT00642811|519869725|FG003|Overall Study|Adverse Event|0|||
144430273|NCT02658890|520784790|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
144430274|NCT02658890|520784791|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
144184436|NCT00642811|519869726|FG004|Overall Study|Adverse Event|0|||
144430275|NCT02658890|520784792|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
144184437|NCT00642811|519869727|FG005|Overall Study|Adverse Event|1|||
144430276|NCT02658890|520784793|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
144430277|NCT02658890|520784794|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
144430278|NCT02658890|520784795|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
144430279|NCT02658890|520784769|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
144430280|NCT02658890|520784770|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
144430281|NCT02658890|520784771|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
144430282|NCT02658890|520784772|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
144430283|NCT02658890|520784773|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
144430284|NCT02658890|520784774|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
144430285|NCT02658890|520784775|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
144430286|NCT02658890|520784776|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
144430287|NCT02658890|520784777|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
144430288|NCT02658890|520784778|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
144430289|NCT02658890|520784779|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
144430290|NCT02658890|520784780|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
144430291|NCT02658890|520784781|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
144430292|NCT02658890|520784782|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
144430293|NCT02658890|520784783|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
144430294|NCT02658890|520784784|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
144430295|NCT02658890|520784785|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
144430296|NCT02658890|520784786|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
144430297|NCT02658890|520784787|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
144430298|NCT02658890|520784788|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
144430299|NCT02658890|520784789|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
144430300|NCT02658890|520784790|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
144430301|NCT02658890|520784791|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
144430302|NCT02658890|520784792|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
144430303|NCT02658890|520784793|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
144430304|NCT02658890|520784794|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
144430305|NCT02658890|520784795|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
144430306|NCT02658890|520784769|FG000|Treatment Phase|Other Reasons|0|||
144430307|NCT02658890|520784770|FG001|Treatment Phase|Other Reasons|0|||
144430308|NCT02658890|520784771|FG002|Treatment Phase|Other Reasons|0|||
144430309|NCT02658890|520784772|FG003|Treatment Phase|Other Reasons|0|||
144430310|NCT02658890|520784773|FG004|Treatment Phase|Other Reasons|0|||
144430311|NCT02658890|520784774|FG005|Treatment Phase|Other Reasons|0|||
144430312|NCT02658890|520784775|FG006|Treatment Phase|Other Reasons|1|||
144430313|NCT02658890|520784776|FG007|Treatment Phase|Other Reasons|0|||
144430314|NCT02658890|520784777|FG008|Treatment Phase|Other Reasons|1|||
144430315|NCT02658890|520784778|FG009|Treatment Phase|Other Reasons|0|||
144529039|NCT03088878|521139166|FG006|Overall Study|Death|0|||
144430316|NCT02658890|520784779|FG010|Treatment Phase|Other Reasons|0|||
144430317|NCT02658890|520784780|FG011|Treatment Phase|Other Reasons|0|||
144430318|NCT02658890|520784781|FG012|Treatment Phase|Other Reasons|0|||
144430319|NCT02658890|520784782|FG013|Treatment Phase|Other Reasons|2|||
144184438|NCT00642811|519869722|FG000|Overall Study|Developement of discontinuation criteria|0|||
144184439|NCT00642811|519869723|FG001|Overall Study|Developement of discontinuation criteria|0|||
144184440|NCT00642811|519869724|FG002|Overall Study|Developement of discontinuation criteria|0|||
144184441|NCT00642811|519869725|FG003|Overall Study|Developement of discontinuation criteria|0|||
144184442|NCT00642811|519869726|FG004|Overall Study|Developement of discontinuation criteria|1|||
144184443|NCT00642811|519869727|FG005|Overall Study|Developement of discontinuation criteria|0|||
144184444|NCT00642811|519869722|FG000|Overall Study|Severe Non-compliance to protocol|1|||
144184445|NCT00642811|519869723|FG001|Overall Study|Severe Non-compliance to protocol|0|||
144184446|NCT00642811|519869724|FG002|Overall Study|Severe Non-compliance to protocol|0|||
144184447|NCT00642811|519869725|FG003|Overall Study|Severe Non-compliance to protocol|0|||
144184448|NCT00642811|519869726|FG004|Overall Study|Severe Non-compliance to protocol|0|||
144184449|NCT00642811|519869727|FG005|Overall Study|Severe Non-compliance to protocol|0|||
144184450|NCT00642811|519869722|FG000|Overall Study|Other|0|||
144184451|NCT00642811|519869723|FG001|Overall Study|Other|1|||
144184452|NCT00642811|519869724|FG002|Overall Study|Other|0|||
144184453|NCT00642811|519869725|FG003|Overall Study|Other|1|||
144184454|NCT00642811|519869726|FG004|Overall Study|Other|0|||
144184455|NCT00642811|519869727|FG005|Overall Study|Other|0|||
144184456|NCT01120691|519869728|FG000|Overall Study|Adverse Event|59|||
144184457|NCT01120691|519869729|FG001|Overall Study|Adverse Event|67|||
144184458|NCT01120691|519869730|FG002|Overall Study|Adverse Event|47|||
144184459|NCT01120691|519869728|FG000|Overall Study|Subject withdrew consent|33|||
144184460|NCT01120691|519869729|FG001|Overall Study|Subject withdrew consent|50|||
144184461|NCT01120691|519869730|FG002|Overall Study|Subject withdrew consent|44|||
144184462|NCT01120691|519869728|FG000|Overall Study|Death|21|||
144184463|NCT01120691|519869729|FG001|Overall Study|Death|22|||
144184464|NCT01120691|519869730|FG002|Overall Study|Death|24|||
144184465|NCT01120691|519869728|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
144184466|NCT01120691|519869729|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
144184467|NCT01120691|519869730|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
144184468|NCT01120691|519869728|FG000|Overall Study|Administrative problems|15|||
144184469|NCT01120691|519869729|FG001|Overall Study|Administrative problems|8|||
144184470|NCT01120691|519869730|FG002|Overall Study|Administrative problems|9|||
144184471|NCT01120691|519869728|FG000|Overall Study|Protocol deviation|13|||
144184472|NCT01120691|519869729|FG001|Overall Study|Protocol deviation|12|||
144184473|NCT01120691|519869730|FG002|Overall Study|Protocol deviation|12|||
144184474|NCT01120691|519869728|FG000|Overall Study|Lost to Follow-up|5|||
144184475|NCT01120691|519869729|FG001|Overall Study|Lost to Follow-up|6|||
144184476|NCT01120691|519869730|FG002|Overall Study|Lost to Follow-up|4|||
144184477|NCT01120691|519869728|FG000|Overall Study|Abnormal test procedure result(s)|3|||
144184478|NCT01120691|519869729|FG001|Overall Study|Abnormal test procedure result(s)|2|||
144184479|NCT01120691|519869730|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144184480|NCT01120691|519869728|FG000|Overall Study|Patient's inability to use the device|3|||
144184481|NCT01120691|519869729|FG001|Overall Study|Patient's inability to use the device|1|||
144184482|NCT01120691|519869730|FG002|Overall Study|Patient's inability to use the device|0|||
144184483|NCT01120691|519869728|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144184484|NCT01120691|519869729|FG001|Overall Study|Abnormal laboratory value(s)|3|||
144184485|NCT01120691|519869730|FG002|Overall Study|Abnormal laboratory value(s)|4|||
144184486|NCT04553406|519869734|FG000|Overall Study|Study Discontinuation|0|||
144184487|NCT04553406|519869735|FG001|Overall Study|Study Discontinuation|1|||
144184488|NCT03370510|519869736|FG000|Overall Study|COVID-19|2|||
144184489|NCT03370510|519869737|FG001|Overall Study|COVID-19|0|||
144184490|NCT00772148|519869738|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
144184491|NCT00772148|519869739|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
144184492|NCT00772148|519869738|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
144184493|NCT00772148|519869739|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
144184494|NCT00772148|519869738|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
144184495|NCT00772148|519869739|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
144184496|NCT00772148|519869738|FG000|Maintenance Phase (Week 52)|Death|2|||
144184497|NCT00772148|519869739|FG001|Maintenance Phase (Week 52)|Death|2|||
144184498|NCT00772148|519869738|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
144184499|NCT00772148|519869739|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
144184500|NCT00772148|519869738|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
144184501|NCT00772148|519869739|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
144184502|NCT00772148|519869738|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
144184503|NCT00772148|519869739|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
144184504|NCT01525628|519869742|FG000|Overall Study|Adverse Event|1|||
144184505|NCT01525628|519869743|FG001|Overall Study|Adverse Event|1|||
144184506|NCT01525628|519869744|FG002|Overall Study|Adverse Event|2|||
144184507|NCT01525628|519869745|FG003|Overall Study|Adverse Event|0|||
144184508|NCT01525628|519869746|FG004|Overall Study|Adverse Event|1|||
144184509|NCT01525628|519869742|FG000|Overall Study|Lack of Efficacy|0|||
144184510|NCT01525628|519869743|FG001|Overall Study|Lack of Efficacy|2|||
144184511|NCT01525628|519869744|FG002|Overall Study|Lack of Efficacy|2|||
144529040|NCT03088878|521139167|FG007|Overall Study|Death|0|||
144184512|NCT01525628|519869745|FG003|Overall Study|Lack of Efficacy|1|||
144184513|NCT01525628|519869746|FG004|Overall Study|Lack of Efficacy|2|||
144184514|NCT01525628|519869742|FG000|Overall Study|Protocol Violation|0|||
144184515|NCT01525628|519869743|FG001|Overall Study|Protocol Violation|0|||
144184516|NCT01525628|519869744|FG002|Overall Study|Protocol Violation|1|||
144184517|NCT01525628|519869745|FG003|Overall Study|Protocol Violation|0|||
144184518|NCT01525628|519869746|FG004|Overall Study|Protocol Violation|0|||
144184519|NCT01525628|519869742|FG000|Overall Study|Lost to Follow-up|1|||
144184520|NCT01525628|519869743|FG001|Overall Study|Lost to Follow-up|1|||
144184521|NCT01525628|519869744|FG002|Overall Study|Lost to Follow-up|0|||
144184522|NCT01525628|519869745|FG003|Overall Study|Lost to Follow-up|0|||
144184523|NCT01525628|519869746|FG004|Overall Study|Lost to Follow-up|0|||
144184524|NCT01525628|519869742|FG000|Overall Study|Withdrawal by Subject|0|||
144184525|NCT01525628|519869743|FG001|Overall Study|Withdrawal by Subject|1|||
144184526|NCT01525628|519869744|FG002|Overall Study|Withdrawal by Subject|0|||
144184527|NCT01525628|519869745|FG003|Overall Study|Withdrawal by Subject|0|||
144184528|NCT01525628|519869746|FG004|Overall Study|Withdrawal by Subject|0|||
144184529|NCT01525628|519869742|FG000|Overall Study|Other reason not defined above|0|||
144184530|NCT01525628|519869743|FG001|Overall Study|Other reason not defined above|0|||
144184531|NCT01525628|519869744|FG002|Overall Study|Other reason not defined above|0|||
144184532|NCT01525628|519869745|FG003|Overall Study|Other reason not defined above|3|||
144184533|NCT01525628|519869746|FG004|Overall Study|Other reason not defined above|0|||
144184534|NCT03573336|519869747|FG000|Overall Study|Study terminated|2|||
144184535|NCT03573336|519869748|FG001|Overall Study|Study terminated|4|||
144184536|NCT03573336|519869749|FG002|Overall Study|Study terminated|2|||
144184537|NCT02614898|519869750|FG000|Overall Study|Participated until study termination|10|||
144184538|NCT02614898|519869751|FG001|Overall Study|Participated until study termination|26|||
144184539|NCT02614898|519869750|FG000|Overall Study|Lost to Follow-up|0|||
144184540|NCT02614898|519869751|FG001|Overall Study|Lost to Follow-up|2|||
144184541|NCT02614898|519869750|FG000|Overall Study|Physician Decision|1|||
144184542|NCT02614898|519869751|FG001|Overall Study|Physician Decision|8|||
144184543|NCT02614898|519869750|FG000|Overall Study|Study Terminated by Sponsor|3|||
144184544|NCT02614898|519869751|FG001|Overall Study|Study Terminated by Sponsor|0|||
144184545|NCT02614898|519869750|FG000|Overall Study|Withdrawal by Subject|0|||
144184546|NCT02614898|519869751|FG001|Overall Study|Withdrawal by Subject|2|||
144184547|NCT02614898|519869750|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144184548|NCT02614898|519869751|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144184549|NCT02614898|519869750|FG000|Overall Study|Other-Additional Information Unavailable|0|||
144184550|NCT02614898|519869751|FG001|Overall Study|Other-Additional Information Unavailable|11|||
144184551|NCT02614898|519869750|FG000|Overall Study|Missing|0|||
144184552|NCT02614898|519869751|FG001|Overall Study|Missing|1|||
144184553|NCT00239005|519869752|FG000|Overall Study|Adverse Event|6|||
144184554|NCT00239005|519869753|FG001|Overall Study|Adverse Event|6|||
144184555|NCT00239005|519869752|FG000|Overall Study|Withdrawal by Subject|3|||
144184556|NCT00239005|519869753|FG001|Overall Study|Withdrawal by Subject|4|||
144184557|NCT00239005|519869752|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
144184558|NCT00239005|519869753|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
144184559|NCT00239005|519869752|FG000|Overall Study|Protocol Violation|1|||
144184560|NCT00239005|519869753|FG001|Overall Study|Protocol Violation|0|||
144184561|NCT00239005|519869752|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
144184562|NCT00239005|519869753|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
144184563|NCT00239005|519869752|FG000|Overall Study|Lost to Follow-up|0|||
144184564|NCT00239005|519869753|FG001|Overall Study|Lost to Follow-up|1|||
144184565|NCT00787605|519869754|FG000|Overall Study|Administrative Problems|3|||
144184566|NCT00787605|519869755|FG001|Overall Study|Administrative Problems|0|||
144184567|NCT00787605|519869754|FG000|Overall Study|Adverse Event|14|||
144184568|NCT00787605|519869755|FG001|Overall Study|Adverse Event|25|||
144184569|NCT00787605|519869754|FG000|Overall Study|Lost to Follow-up|3|||
144184570|NCT00787605|519869755|FG001|Overall Study|Lost to Follow-up|6|||
144184571|NCT00787605|519869754|FG000|Overall Study|Protocol Violation|7|||
144184572|NCT00787605|519869755|FG001|Overall Study|Protocol Violation|3|||
144184573|NCT00787605|519869754|FG000|Overall Study|Withdrawal by Subject|6|||
144184574|NCT00787605|519869755|FG001|Overall Study|Withdrawal by Subject|13|||
144184575|NCT00787605|519869754|FG000|Overall Study|Lack of Efficacy|13|||
144184576|NCT00787605|519869755|FG001|Overall Study|Lack of Efficacy|9|||
144184577|NCT00688844|519869756|FG000|Overall Study|Lost to Follow-up|10|||
144184578|NCT01223027|519869758|FG000|Overall Study|Adverse Event|20|||
144184579|NCT01223027|519869759|FG001|Overall Study|Adverse Event|10|||
144603932|NCT05975840|521412048|FG000|Overall Study|Death|0|||
144184580|NCT01223027|519869758|FG000|Overall Study|Death|42|||
144184581|NCT01223027|519869759|FG001|Overall Study|Death|42|||
144184582|NCT01223027|519869758|FG000|Overall Study|Lost to Follow-up|2|||
144603933|NCT05975840|521412049|FG001|Overall Study|Death|1|||
144184583|NCT01223027|519869759|FG001|Overall Study|Lost to Follow-up|1|||
144184584|NCT01223027|519869758|FG000|Overall Study|Physician Decision|4|||
144184585|NCT01223027|519869759|FG001|Overall Study|Physician Decision|8|||
144184586|NCT01223027|519869758|FG000|Overall Study|Progressive Disease|167|||
144184587|NCT01223027|519869759|FG001|Overall Study|Progressive Disease|183|||
144184588|NCT01223027|519869758|FG000|Overall Study|Protocol Violation|2|||
144184589|NCT01223027|519869759|FG001|Overall Study|Protocol Violation|1|||
144184590|NCT01223027|519869758|FG000|Overall Study|Subject/guardian decicion|18|||
144184591|NCT01223027|519869759|FG001|Overall Study|Subject/guardian decicion|16|||
144184592|NCT01223027|519869758|FG000|Overall Study|New therapy for study indication|17|||
144184593|NCT01223027|519869759|FG001|Overall Study|New therapy for study indication|8|||
144184594|NCT01223027|519869758|FG000|Overall Study|Study terminated by sponsor|2|||
144184595|NCT01223027|519869759|FG001|Overall Study|Study terminated by sponsor|8|||
144184596|NCT03493919|519869761|FG000|Overall Study|Other|2|||
144184597|NCT03493919|519869762|FG001|Overall Study|Other|0|||
144184598|NCT03493919|519869763|FG002|Overall Study|Other|1|||
144184599|NCT03493919|519869764|FG003|Overall Study|Other|0|||
144184600|NCT03493919|519869761|FG000|Overall Study|Withdrawal by Subject|9|||
144184601|NCT03493919|519869762|FG001|Overall Study|Withdrawal by Subject|3|||
144184602|NCT03493919|519869763|FG002|Overall Study|Withdrawal by Subject|1|||
144184603|NCT03493919|519869764|FG003|Overall Study|Withdrawal by Subject|1|||
144184604|NCT03493919|519869761|FG000|Overall Study|Lost to Follow-up|5|||
144184605|NCT03493919|519869762|FG001|Overall Study|Lost to Follow-up|0|||
144184606|NCT03493919|519869763|FG002|Overall Study|Lost to Follow-up|0|||
144184607|NCT03493919|519869764|FG003|Overall Study|Lost to Follow-up|3|||
144184608|NCT03493919|519869761|FG000|Overall Study|Adverse Event|0|||
144184609|NCT03493919|519869762|FG001|Overall Study|Adverse Event|1|||
144184610|NCT03493919|519869763|FG002|Overall Study|Adverse Event|0|||
144184611|NCT03493919|519869764|FG003|Overall Study|Adverse Event|0|||
144184612|NCT01977456|519869765|FG000|Overall Study|Death|5|||
144184613|NCT02722616|519871721|FG000|Overall Study|Sponsor closed study after one month|2|||
144184614|NCT02722616|519871722|FG001|Overall Study|Sponsor closed study after one month|0|||
144184615|NCT02722616|519871723|FG002|Overall Study|Sponsor closed study after one month|0|||
144184616|NCT02031237|519871724|FG000|Overall Study|Death|1|||
144184617|NCT02031237|519871725|FG001|Overall Study|Death|5|||
144184618|NCT02031237|519871726|FG002|Overall Study|Death|0|||
144184619|NCT02031237|519871724|FG000|Overall Study|Physician Decision|0|||
144184620|NCT02031237|519871725|FG001|Overall Study|Physician Decision|1|||
144184621|NCT02031237|519871726|FG002|Overall Study|Physician Decision|0|||
144184622|NCT02031237|519871724|FG000|Overall Study|Withdrawal by Subject|2|||
144184623|NCT02031237|519871725|FG001|Overall Study|Withdrawal by Subject|2|||
144184624|NCT02031237|519871726|FG002|Overall Study|Withdrawal by Subject|0|||
144184625|NCT02031237|519871724|FG000|Overall Study|Protocol Violation|2|||
144184626|NCT02031237|519871725|FG001|Overall Study|Protocol Violation|6|||
144184627|NCT02031237|519871726|FG002|Overall Study|Protocol Violation|0|||
144184628|NCT02031237|519871724|FG000|Overall Study|Alternate Treatment Given|0|||
144184629|NCT02031237|519871725|FG001|Overall Study|Alternate Treatment Given|0|||
144184630|NCT02031237|519871726|FG002|Overall Study|Alternate Treatment Given|3|||
144184631|NCT01841060|519871732|FG000|Overall Study|Protocol Violation|10|||
144184632|NCT02459418|519871736|FG000|Overall Study|Exclusion Criteria|4|||
144184633|NCT02459418|519871737|FG001|Overall Study|Exclusion Criteria|0|||
144184634|NCT02459418|519871736|FG000|Overall Study|Protocol Violation|0|||
144184635|NCT02459418|519871737|FG001|Overall Study|Protocol Violation|2|||
144184636|NCT02459418|519871736|FG000|Overall Study|Physician Decision|0|||
144184637|NCT02459418|519871737|FG001|Overall Study|Physician Decision|2|||
144184638|NCT02459418|519871736|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
144184639|NCT02459418|519871737|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
144184640|NCT02459418|519871736|FG000|Overall Study|Adverse Event|0|||
144184641|NCT02459418|519871737|FG001|Overall Study|Adverse Event|1|||
144184642|NCT02459418|519871736|FG000|Overall Study|Withdrawal by Subject|1|||
144184643|NCT02459418|519871737|FG001|Overall Study|Withdrawal by Subject|1|||
144184644|NCT02459418|519871736|FG000|Overall Study|Elevated Creatine Kinase|1|||
144184645|NCT02459418|519871737|FG001|Overall Study|Elevated Creatine Kinase|0|||
144184646|NCT02459418|519871736|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
144184647|NCT02459418|519871737|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
144184648|NCT00653159|519871738|FG000|Overall Study|Adverse Event|4|||
144184649|NCT00653159|519871739|FG001|Overall Study|Adverse Event|1|||
144184650|NCT00653159|519871738|FG000|Overall Study|Lost to Follow-up|1|||
144184651|NCT00653159|519871739|FG001|Overall Study|Lost to Follow-up|2|||
144184652|NCT01872715|519871740|FG000|Overall Study|Adverse Event|1|||
144184653|NCT01872715|519871740|FG000|Overall Study|Protocol Violation|1|||
144184654|NCT01872715|519871740|FG000|Overall Study|Withdrawal by Subject|2|||
144184655|NCT00683592|519871741|FG000|Overall Study|Adverse Event|12|||
144430320|NCT02658890|520784783|FG014|Treatment Phase|Other Reasons|0|||
144184656|NCT00683592|519871742|FG001|Overall Study|Adverse Event|4|||
144184657|NCT00683592|519871741|FG000|Overall Study|Withdrawal by Subject|11|||
144184658|NCT00683592|519871742|FG001|Overall Study|Withdrawal by Subject|11|||
144184659|NCT00683592|519871741|FG000|Overall Study|Lost to Follow-up|17|||
144184660|NCT00683592|519871742|FG001|Overall Study|Lost to Follow-up|17|||
144184661|NCT00683592|519871741|FG000|Overall Study|Lack of Efficacy|3|||
144184662|NCT00683592|519871742|FG001|Overall Study|Lack of Efficacy|7|||
144430321|NCT02658890|520784784|FG015|Treatment Phase|Other Reasons|0|||
144184663|NCT00683592|519871741|FG000|Overall Study|Physician Decision|0|||
144184664|NCT00683592|519871742|FG001|Overall Study|Physician Decision|1|||
144184665|NCT00683592|519871741|FG000|Overall Study|Non-compliance|3|||
144184666|NCT00683592|519871742|FG001|Overall Study|Non-compliance|5|||
144184667|NCT00683592|519871741|FG000|Overall Study|Other|1|||
144184668|NCT00683592|519871742|FG001|Overall Study|Other|1|||
144430322|NCT02658890|520784785|FG016|Treatment Phase|Other Reasons|0|||
144184669|NCT03303417|519871750|FG000|Overall Study|Withdrawal by Subject|1|||
144184670|NCT03303417|519871751|FG001|Overall Study|Withdrawal by Subject|1|||
144184671|NCT01848210|519871754|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
144184672|NCT01848210|519871755|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
144184673|NCT01848210|519871754|FG000|Overall Study|Lost to Follow-up|24|||
144184674|NCT01848210|519871755|FG001|Overall Study|Lost to Follow-up|12|||
144184675|NCT01848210|519871754|FG000|Overall Study|Protocol Violation|3|||
144184676|NCT01848210|519871755|FG001|Overall Study|Protocol Violation|5|||
144184677|NCT01848210|519871754|FG000|Overall Study|Use of Forbidden Drugs|9|||
144184678|NCT01848210|519871755|FG001|Overall Study|Use of Forbidden Drugs|10|||
144184679|NCT01848210|519871754|FG000|Overall Study|Impedition Condition|5|||
144184680|NCT01848210|519871755|FG001|Overall Study|Impedition Condition|9|||
144184681|NCT01848210|519871754|FG000|Overall Study|Adverse Event|7|||
144184682|NCT01848210|519871755|FG001|Overall Study|Adverse Event|9|||
144184683|NCT01848210|519871754|FG000|Overall Study|Discontinuation Criterion|5|||
144184684|NCT01848210|519871755|FG001|Overall Study|Discontinuation Criterion|7|||
144184685|NCT01848210|519871754|FG000|Overall Study|Hypesensitivity|1|||
144184686|NCT01848210|519871755|FG001|Overall Study|Hypesensitivity|0|||
144184687|NCT01848210|519871754|FG000|Overall Study|Hepatic Function Alteration|4|||
144184688|NCT01848210|519871755|FG001|Overall Study|Hepatic Function Alteration|0|||
144184689|NCT01848210|519871754|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
144184690|NCT01848210|519871755|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
144184691|NCT01848210|519871754|FG000|Overall Study|Administrative|1|||
144184692|NCT01848210|519871755|FG001|Overall Study|Administrative|0|||
144184693|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
144184694|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
144184695|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
144184696|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
144184697|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
144184698|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
144184699|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
144184700|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
144184701|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
144184702|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
144184703|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
144184704|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
144184705|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
144184706|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
144184707|NCT04592419|519871756|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
144184708|NCT04592419|519871757|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
144184709|NCT04592419|519871756|FG000|Open-Label Extension Period|Adverse Event|1|||
144184710|NCT04592419|519871757|FG001|Open-Label Extension Period|Adverse Event|2|||
144184711|NCT04592419|519871756|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
144184712|NCT04592419|519871757|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
144184713|NCT04592419|519871756|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
144184714|NCT04592419|519871757|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
144184715|NCT04592419|519871756|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
144184716|NCT04592419|519871757|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
144184717|NCT04592419|519871756|FG000|Open-Label Extension Period|Sponsor Request|73|||
144184718|NCT04592419|519871757|FG001|Open-Label Extension Period|Sponsor Request|84|||
144184719|NCT00381849|519871758|FG000|Wash Out|Withdrawal by Subject|0|||
144184720|NCT00381849|519871759|FG001|Wash Out|Withdrawal by Subject|1|||
144723636|NCT00365352|521842413|FG001|Overall Study|Participant Withdrew Consent|3|||
144184721|NCT01765270|519871763|FG000|Overall Study|Physician Decision|1|||
144184722|NCT01765270|519871764|FG001|Overall Study|Physician Decision|0|||
144184723|NCT01765270|519871763|FG000|Overall Study|Withdrawal by Subject|0|||
144184724|NCT01765270|519871764|FG001|Overall Study|Withdrawal by Subject|1|||
144184725|NCT00329160|519871765|FG000|Overall Study|Adverse Event|27|||
144184726|NCT00329160|519871765|FG000|Overall Study|Withdrawal by Subject|13|||
144184727|NCT00329160|519871765|FG000|Overall Study|Protocol Violation|2|||
144184728|NCT00329160|519871765|FG000|Overall Study|Did not Receive Study Drug|1|||
144184729|NCT00329160|519871765|FG000|Overall Study|Incomplete IVUS|45|||
144184730|NCT00493792|519871766|FG000|Overall Study|Death|55|||
144184731|NCT00493792|519871767|FG001|Overall Study|Death|50|||
144184732|NCT00493792|519871766|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
144184733|NCT00493792|519871767|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
144184734|NCT00685035|519871769|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
144184735|NCT00685035|519871770|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
144184736|NCT05996198|519871774|FG000|Overall Study|Withdrawal by Subject|1|||
144252154|NCT01863732|520122694|FG003|Overall Study|Adverse Event|3|||
144430323|NCT02658890|520784786|FG017|Treatment Phase|Other Reasons|0|||
144430324|NCT02658890|520784787|FG018|Treatment Phase|Other Reasons|1|||
144184737|NCT05996198|519871775|FG001|Overall Study|Withdrawal by Subject|0|||
144184738|NCT04968925|519871776|FG000|Phase I- Period 1|COVID-19 related|0|||
144184739|NCT04968925|519871777|FG001|Phase I- Period 1|COVID-19 related|1|||
144184740|NCT04968925|519871778|FG002|Phase I- Period 1|COVID-19 related|0|||
144184741|NCT04968925|519871779|FG003|Phase I- Period 1|COVID-19 related|0|||
144184742|NCT04968925|519871776|FG000|Phase I- Period 1|Subject enrolled in error|1|||
144184743|NCT04968925|519871777|FG001|Phase I- Period 1|Subject enrolled in error|1|||
144184744|NCT04968925|519871778|FG002|Phase I- Period 1|Subject enrolled in error|0|||
144184745|NCT04968925|519871779|FG003|Phase I- Period 1|Subject enrolled in error|0|||
144184746|NCT04968925|519871776|FG000|Phase II- Period 1|COVID-19 Related|0|||
144184747|NCT04968925|519871777|FG001|Phase II- Period 1|COVID-19 Related|0|||
144184748|NCT04968925|519871778|FG002|Phase II- Period 1|COVID-19 Related|6|||
144184749|NCT04968925|519871779|FG003|Phase II- Period 1|COVID-19 Related|6|||
144184750|NCT04968925|519871776|FG000|Phase II- Period 1|Subject enrolled in error|0|||
144184751|NCT04968925|519871777|FG001|Phase II- Period 1|Subject enrolled in error|0|||
144184752|NCT04968925|519871778|FG002|Phase II- Period 1|Subject enrolled in error|1|||
144184753|NCT04968925|519871779|FG003|Phase II- Period 1|Subject enrolled in error|0|||
144184754|NCT04968925|519871776|FG000|Phase II -Period 2|COVID-19 related|0|||
144184755|NCT04968925|519871777|FG001|Phase II -Period 2|COVID-19 related|0|||
144184756|NCT04968925|519871778|FG002|Phase II -Period 2|COVID-19 related|4|||
144184757|NCT04968925|519871779|FG003|Phase II -Period 2|COVID-19 related|3|||
144184758|NCT04968925|519871776|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
144184759|NCT04968925|519871777|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
144184760|NCT04968925|519871778|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
144184761|NCT04968925|519871779|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
144184762|NCT00876265|519871780|FG000|Overall Study|Miscellaneous reasons|4|||
144184763|NCT00876265|519871780|FG000|Overall Study|Lost to Follow-up|6|||
144184764|NCT00876265|519871780|FG000|Overall Study|Withdrawal by Subject|2|||
144184765|NCT01755975|519871781|FG000|Overall Study|Adverse Event|0|||
144184766|NCT01755975|519871782|FG001|Overall Study|Adverse Event|0|||
144184767|NCT01755975|519871783|FG002|Overall Study|Adverse Event|1|||
144184768|NCT01755975|519871784|FG003|Overall Study|Adverse Event|0|||
144184769|NCT01755975|519871785|FG004|Overall Study|Adverse Event|2|||
144184770|NCT03653026|519871786|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
144184771|NCT03653026|519871787|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
144184772|NCT03653026|519871788|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
144184773|NCT03653026|519871789|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
144184774|NCT03653026|519871786|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
144184775|NCT03653026|519871787|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
144184776|NCT03653026|519871788|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144184777|NCT03653026|519871789|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144184778|NCT03653026|519871786|FG000|Part 1: Placebo-controlled Period|Other|0|||
144184779|NCT03653026|519871787|FG001|Part 1: Placebo-controlled Period|Other|3|||
144184780|NCT03653026|519871788|FG002|Part 1: Placebo-controlled Period|Other|0|||
144184781|NCT03653026|519871789|FG003|Part 1: Placebo-controlled Period|Other|0|||
144184782|NCT03653026|519871786|FG000|Part 2: Open-label Extension|Adverse Event|0|||
144184783|NCT03653026|519871787|FG001|Part 2: Open-label Extension|Adverse Event|0|||
144184784|NCT03653026|519871788|FG002|Part 2: Open-label Extension|Adverse Event|1|||
144184785|NCT03653026|519871789|FG003|Part 2: Open-label Extension|Adverse Event|1|||
144184786|NCT03653026|519871786|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
144430325|NCT02658890|520784788|FG019|Treatment Phase|Other Reasons|0|||
144430326|NCT02658890|520784789|FG020|Treatment Phase|Other Reasons|0|||
144430327|NCT02658890|520784790|FG021|Treatment Phase|Other Reasons|0|||
144430328|NCT02658890|520784791|FG022|Treatment Phase|Other Reasons|0|||
144430329|NCT02658890|520784792|FG023|Treatment Phase|Other Reasons|0|||
144430330|NCT02658890|520784793|FG024|Treatment Phase|Other Reasons|1|||
144430331|NCT02658890|520784794|FG025|Treatment Phase|Other Reasons|0|||
144430332|NCT02658890|520784795|FG026|Treatment Phase|Other Reasons|1|||
144430333|NCT02658890|520784769|FG000|Treatment Phase|Progressive Disease|6|||
144430334|NCT02658890|520784770|FG001|Treatment Phase|Progressive Disease|7|||
144430335|NCT02658890|520784771|FG002|Treatment Phase|Progressive Disease|6|||
144430336|NCT02658890|520784772|FG003|Treatment Phase|Progressive Disease|12|||
144430337|NCT02658890|520784773|FG004|Treatment Phase|Progressive Disease|6|||
144430338|NCT02658890|520784774|FG005|Treatment Phase|Progressive Disease|18|||
144184787|NCT03653026|519871787|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
144184788|NCT03653026|519871788|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
144184789|NCT03653026|519871789|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
144184790|NCT03653026|519871786|FG000|Part 2: Open-label Extension|Other|0|||
144184791|NCT03653026|519871787|FG001|Part 2: Open-label Extension|Other|0|||
144184792|NCT03653026|519871788|FG002|Part 2: Open-label Extension|Other|1|||
144184793|NCT03653026|519871789|FG003|Part 2: Open-label Extension|Other|2|||
144430339|NCT02658890|520784775|FG006|Treatment Phase|Progressive Disease|12|||
144430340|NCT02658890|520784776|FG007|Treatment Phase|Progressive Disease|19|||
144184794|NCT02457819|519871795|FG000|Overall Study|reason not given|8|||
144603934|NCT05975840|521412050|FG002|Overall Study|Death|0|||
144603935|NCT05975840|521412051|FG003|Overall Study|Death|0|||
144184795|NCT02457819|519871795|FG000|Overall Study|Withdrawal by Subject|24|||
144184796|NCT02457819|519871795|FG000|Overall Study|Protocol Violation|1|||
144184797|NCT02457819|519871795|FG000|Overall Study|non compliance with study drug|4|||
144184798|NCT02457819|519871795|FG000|Overall Study|Lost to Follow-up|10|||
144184799|NCT02457819|519871795|FG000|Overall Study|Lack of Efficacy|19|||
144184800|NCT02457819|519871795|FG000|Overall Study|Adverse Event|33|||
144184801|NCT00852917|519871796|FG000|Overall Study|Adverse Event|13|||
144184802|NCT00852917|519871797|FG001|Overall Study|Adverse Event|20|||
144184803|NCT00852917|519871798|FG002|Overall Study|Adverse Event|35|||
144184804|NCT00852917|519871799|FG003|Overall Study|Adverse Event|17|||
144184805|NCT00852917|519871796|FG000|Overall Study|Lack of Efficacy|21|||
144184806|NCT00852917|519871797|FG001|Overall Study|Lack of Efficacy|11|||
144184807|NCT00852917|519871798|FG002|Overall Study|Lack of Efficacy|11|||
144184808|NCT00852917|519871799|FG003|Overall Study|Lack of Efficacy|47|||
144184809|NCT00852917|519871796|FG000|Overall Study|Withdrawal by Subject|4|||
144184810|NCT00852917|519871797|FG001|Overall Study|Withdrawal by Subject|8|||
144184811|NCT00852917|519871798|FG002|Overall Study|Withdrawal by Subject|10|||
144184812|NCT00852917|519871799|FG003|Overall Study|Withdrawal by Subject|9|||
144184813|NCT00852917|519871796|FG000|Overall Study|Physician Decision|6|||
144184814|NCT00852917|519871797|FG001|Overall Study|Physician Decision|7|||
144184815|NCT00852917|519871798|FG002|Overall Study|Physician Decision|2|||
144184816|NCT00852917|519871799|FG003|Overall Study|Physician Decision|19|||
144184817|NCT00852917|519871796|FG000|Overall Study|Death|0|||
144184818|NCT00852917|519871797|FG001|Overall Study|Death|0|||
144184819|NCT00852917|519871798|FG002|Overall Study|Death|0|||
144184820|NCT00852917|519871799|FG003|Overall Study|Death|1|||
144184821|NCT02161549|519871800|FG000|Overall Study|Physician Decision|6|||
144184822|NCT02161549|519871801|FG001|Overall Study|Physician Decision|2|||
144184823|NCT00979212|519871802|FG000|Overall Study|Protocol Violation|1|||
144184824|NCT00979212|519871803|FG001|Overall Study|Protocol Violation|8|||
144184825|NCT00979212|519871802|FG000|Overall Study|No protocol therapy received|1|||
144184826|NCT00979212|519871803|FG001|Overall Study|No protocol therapy received|0|||
144184827|NCT04886063|519871806|FG000|Overall Study|Adverse Event|50|||
144184828|NCT04886063|519871806|FG000|Overall Study|Lack of Efficacy|31|||
144184829|NCT04886063|519871806|FG000|Overall Study|Withdrawal by Subject|45|||
144184830|NCT04886063|519871806|FG000|Overall Study|Physician Decision|3|||
144184831|NCT04886063|519871806|FG000|Overall Study|Protocol Violation|3|||
144184832|NCT04886063|519871806|FG000|Overall Study|Site closure|4|||
144184833|NCT04886063|519871806|FG000|Overall Study|Nursing home replacement|3|||
144184834|NCT04886063|519871806|FG000|Overall Study|Lost to Follow-up|5|||
144184835|NCT04886063|519871806|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
144184836|NCT04886063|519871806|FG000|Overall Study|>1 reason|20|||
144184837|NCT00177164|519871809|FG000|Overall Study|Protocol Violation|0|||
144184838|NCT00177164|519871810|FG001|Overall Study|Protocol Violation|7|||
144184839|NCT00177164|519871809|FG000|Overall Study|Lost to Follow-up|4|||
144184840|NCT00177164|519871810|FG001|Overall Study|Lost to Follow-up|5|||
144184841|NCT00177164|519871809|FG000|Overall Study|increase in alcohol and drug use|1|||
144184842|NCT00177164|519871810|FG001|Overall Study|increase in alcohol and drug use|2|||
144184843|NCT00177164|519871809|FG000|Overall Study|Adverse Event|1|||
144184844|NCT00177164|519871810|FG001|Overall Study|Adverse Event|0|||
144603936|NCT05975840|521412052|FG004|Overall Study|Death|0|||
144603937|NCT05975840|521412053|FG005|Overall Study|Death|0|||
144603938|NCT05975840|521412054|FG006|Overall Study|Death|0|||
144603939|NCT05975840|521412055|FG007|Overall Study|Death|1|||
144603940|NCT04448756|521412058|FG000|Overall Study|Adverse Event|0|||
144603941|NCT04448756|521412059|FG001|Overall Study|Adverse Event|1|||
144603942|NCT04448756|521412060|FG002|Overall Study|Adverse Event|0|||
144603943|NCT04448756|521412058|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
144603944|NCT04448756|521412059|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
144184845|NCT00177164|519871809|FG000|Overall Study|discharge from hospital|1|||
144184846|NCT00177164|519871810|FG001|Overall Study|discharge from hospital|0|||
144184847|NCT00177164|519871809|FG000|Overall Study|Lack of Efficacy|2|||
144184848|NCT00177164|519871810|FG001|Overall Study|Lack of Efficacy|1|||
144603945|NCT04448756|521412060|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
144603946|NCT04448756|521412058|FG000|Overall Study|Withdrawal by Subject|0|||
144603947|NCT04448756|521412059|FG001|Overall Study|Withdrawal by Subject|3|||
144603948|NCT04448756|521412060|FG002|Overall Study|Withdrawal by Subject|1|||
144184849|NCT00177164|519871809|FG000|Overall Study|Pregnancy|0|||
144184850|NCT00177164|519871810|FG001|Overall Study|Pregnancy|1|||
144184851|NCT01344018|519871816|FG000|Overall Study|Death|22|||
144184852|NCT01344018|519871817|FG001|Overall Study|Death|25|||
144184853|NCT01344018|519871816|FG000|Overall Study|Lost to Follow-up|4|||
144184854|NCT01344018|519871817|FG001|Overall Study|Lost to Follow-up|7|||
144184855|NCT05070754|519871818|FG000|Overall Study|Withdrawal by Subject|0|||
144184856|NCT05070754|519871819|FG001|Overall Study|Withdrawal by Subject|0|||
144184857|NCT05070754|519871820|FG002|Overall Study|Withdrawal by Subject|0|||
144603949|NCT04448756|521412058|FG000|Overall Study|Death|2|||
144723637|NCT00365352|521842414|FG002|Overall Study|Participant Withdrew Consent|4|||
144723638|NCT00365352|521842412|FG000|Overall Study|Lack of Efficacy|3|||
144723639|NCT00365352|521842413|FG001|Overall Study|Lack of Efficacy|0|||
144723640|NCT00365352|521842414|FG002|Overall Study|Lack of Efficacy|0|||
144723641|NCT00365352|521842412|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
144723642|NCT00365352|521842413|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
144723643|NCT00365352|521842414|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
144723644|NCT00365352|521842412|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
144723645|NCT00365352|521842413|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
144723646|NCT00365352|521842414|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
144723647|NCT00365352|521842412|FG000|Overall Study|Lost to Follow-up|1|||
144723648|NCT00365352|521842413|FG001|Overall Study|Lost to Follow-up|1|||
144723649|NCT00365352|521842414|FG002|Overall Study|Lost to Follow-up|0|||
144723650|NCT00365352|521842412|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
144723651|NCT00365352|521842413|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
144723652|NCT00365352|521842414|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
144723653|NCT00462982|521842419|FG000|Overall Study|Adverse Event|1|||
144723654|NCT00462982|521842419|FG000|Overall Study|Patient Not Treated|2|||
144723655|NCT02109133|521842422|FG000|Overall Study|Lost to Follow-up|1|||
144723656|NCT02109133|521842423|FG001|Overall Study|Lost to Follow-up|0|||
144723657|NCT05200858|521842426|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
144723658|NCT05200858|521842427|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
144723659|NCT05200858|521842428|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
144723660|NCT05200858|521842429|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
144723661|NCT00409578|521842430|FG000|Overall Study|Adverse Event|27|||
144723662|NCT00409578|521842431|FG001|Overall Study|Adverse Event|37|||
144723663|NCT00409578|521842432|FG002|Overall Study|Adverse Event|25|||
144723664|NCT00409578|521842433|FG003|Overall Study|Adverse Event|33|||
144723665|NCT00409578|521842430|FG000|Overall Study|Abnormal laboratory value(s)|2|||
144723666|NCT00409578|521842431|FG001|Overall Study|Abnormal laboratory value(s)|2|||
144723667|NCT00409578|521842432|FG002|Overall Study|Abnormal laboratory value(s)|2|||
144723668|NCT00409578|521842433|FG003|Overall Study|Abnormal laboratory value(s)|4|||
144723669|NCT00409578|521842430|FG000|Overall Study|Lack of Efficacy|0|||
144723670|NCT00409578|521842431|FG001|Overall Study|Lack of Efficacy|0|||
144723671|NCT00409578|521842432|FG002|Overall Study|Lack of Efficacy|0|||
144723672|NCT00409578|521842433|FG003|Overall Study|Lack of Efficacy|2|||
144723673|NCT00409578|521842430|FG000|Overall Study|Subject no longer requires study drug|0|||
144723674|NCT00409578|521842431|FG001|Overall Study|Subject no longer requires study drug|0|||
144723675|NCT00409578|521842432|FG002|Overall Study|Subject no longer requires study drug|0|||
144723676|NCT00409578|521842433|FG003|Overall Study|Subject no longer requires study drug|1|||
144723677|NCT00409578|521842430|FG000|Overall Study|Withdrawal by Subject|8|||
144723678|NCT00409578|521842431|FG001|Overall Study|Withdrawal by Subject|15|||
144723679|NCT00409578|521842432|FG002|Overall Study|Withdrawal by Subject|16|||
144723680|NCT00409578|521842433|FG003|Overall Study|Withdrawal by Subject|17|||
144723681|NCT00409578|521842430|FG000|Overall Study|Lost to Follow-up|2|||
144723682|NCT00409578|521842431|FG001|Overall Study|Lost to Follow-up|0|||
144723683|NCT00409578|521842432|FG002|Overall Study|Lost to Follow-up|2|||
144723684|NCT00409578|521842433|FG003|Overall Study|Lost to Follow-up|2|||
144723685|NCT00409578|521842430|FG000|Overall Study|Administrative problems|8|||
144723686|NCT00409578|521842431|FG001|Overall Study|Administrative problems|9|||
144723687|NCT00409578|521842432|FG002|Overall Study|Administrative problems|2|||
144723688|NCT00409578|521842433|FG003|Overall Study|Administrative problems|4|||
144723689|NCT00409578|521842430|FG000|Overall Study|Death|2|||
144723690|NCT00409578|521842431|FG001|Overall Study|Death|4|||
144723691|NCT00409578|521842432|FG002|Overall Study|Death|4|||
144723692|NCT00409578|521842433|FG003|Overall Study|Death|2|||
144723693|NCT00409578|521842430|FG000|Overall Study|Protocol Violation|3|||
144723694|NCT00409578|521842431|FG001|Overall Study|Protocol Violation|2|||
144723695|NCT00409578|521842432|FG002|Overall Study|Protocol Violation|3|||
144723696|NCT00409578|521842433|FG003|Overall Study|Protocol Violation|1|||
144723697|NCT00409578|521842430|FG000|Overall Study|Missing|0|||
144723698|NCT00409578|521842431|FG001|Overall Study|Missing|1|||
144723699|NCT00409578|521842432|FG002|Overall Study|Missing|0|||
144723700|NCT00409578|521842433|FG003|Overall Study|Missing|1|||
144723701|NCT02448771|521842434|FG000|Overall Study|Disease Progression|30|||
144723702|NCT02448771|521842434|FG000|Overall Study|Unacceptable Toxicity|1|||
144723703|NCT02448771|521842434|FG000|Overall Study|Physician Decision|3|||
144723704|NCT02448771|521842434|FG000|Overall Study|Started new therapy|2|||
144723705|NCT02683187|521842436|FG000|Overall Study|Failed IV access|3|||
144723706|NCT02683187|521842436|FG000|Overall Study|Withdrawal by Subject|5|||
144723707|NCT04256421|521842437|FG000|Overall Study|Death|171|||
144723708|NCT04256421|521842438|FG001|Overall Study|Death|180|||
144723709|NCT04256421|521842437|FG000|Overall Study|Lost to Follow-up|1|||
144723710|NCT04256421|521842438|FG001|Overall Study|Lost to Follow-up|1|||
144723711|NCT04256421|521842437|FG000|Overall Study|Withdrawal by Subject|9|||
144723712|NCT04256421|521842438|FG001|Overall Study|Withdrawal by Subject|10|||
144723713|NCT04256421|521842437|FG000|Overall Study|Ongoing in Study|66|||
144184858|NCT05070754|519871821|FG003|Overall Study|Withdrawal by Subject|1|||
144184859|NCT05070754|519871818|FG000|Overall Study|Protocol Violation|0|||
144184860|NCT05070754|519871819|FG001|Overall Study|Protocol Violation|0|||
144184861|NCT05070754|519871820|FG002|Overall Study|Protocol Violation|0|||
144184862|NCT05070754|519871821|FG003|Overall Study|Protocol Violation|1|||
144184863|NCT01398787|519871822|FG000|Overall Study|Adverse Event|1|||
144184864|NCT02351167|519871823|FG000|Overall Study|Withdrawal by Subject|19|||
144184865|NCT02351167|519871824|FG001|Overall Study|Withdrawal by Subject|18|||
144184866|NCT02351167|519871825|FG002|Overall Study|Withdrawal by Subject|21|||
144184867|NCT03419962|519871828|FG000|Overall Study|Change to other medication|1|||
144184868|NCT03419962|519871828|FG000|Overall Study|Refusal of continuing with trial drug|1|||
144184869|NCT03419962|519871828|FG000|Overall Study|Lost to Follow-up|3|||
144184870|NCT03419962|519871828|FG000|Overall Study|Difficulty in inhaling the doses|1|||
144184871|NCT03419962|519871828|FG000|Overall Study|Missing completion data|31|||
144184872|NCT04142658|519871833|FG000|Overall Study|Death|2|||
144184873|NCT04142658|519871834|FG001|Overall Study|Death|1|||
144184874|NCT04142658|519871833|FG000|Overall Study|Lost to Follow-up|4|||
144184875|NCT04142658|519871834|FG001|Overall Study|Lost to Follow-up|13|||
144184876|NCT04142658|519871833|FG000|Overall Study|Withdrawal by Subject|9|||
144184877|NCT04142658|519871834|FG001|Overall Study|Withdrawal by Subject|16|||
144184878|NCT01781234|519871835|FG000|Overall Study|Adverse Event|2|||
144184879|NCT01781234|519871836|FG001|Overall Study|Adverse Event|0|||
144184880|NCT01781234|519871835|FG000|Overall Study|Protocol Violation|3|||
144184881|NCT01781234|519871836|FG001|Overall Study|Protocol Violation|0|||
144184882|NCT01781234|519871835|FG000|Overall Study|Withdrawal by Subject|4|||
144184883|NCT01781234|519871836|FG001|Overall Study|Withdrawal by Subject|3|||
144184884|NCT00830167|519871837|FG000|Overall Study|Lack of Efficacy|26|||
144184885|NCT00830167|519871838|FG001|Overall Study|Lack of Efficacy|10|||
144184886|NCT00830167|519871837|FG000|Overall Study|Adverse Event|8|||
144184887|NCT00830167|519871838|FG001|Overall Study|Adverse Event|24|||
144184888|NCT00830167|519871837|FG000|Overall Study|Not meeting entrance criteria|2|||
144184889|NCT00830167|519871838|FG001|Overall Study|Not meeting entrance criteria|5|||
144184890|NCT00830167|519871837|FG000|Overall Study|Withdrawal by Subject|2|||
144184891|NCT00830167|519871838|FG001|Overall Study|Withdrawal by Subject|0|||
144184892|NCT00830167|519871837|FG000|Overall Study|Lost to Follow-up|0|||
144184893|NCT00830167|519871838|FG001|Overall Study|Lost to Follow-up|1|||
144184894|NCT00830167|519871837|FG000|Overall Study|Protocol Violation|0|||
144184895|NCT00830167|519871838|FG001|Overall Study|Protocol Violation|1|||
144184896|NCT00830167|519871837|FG000|Overall Study|Other|2|||
144184897|NCT00830167|519871838|FG001|Overall Study|Other|2|||
144184898|NCT00609154|519871839|FG000|Overall Study|Protocol Violation|1|||
144184899|NCT00609154|519871840|FG001|Overall Study|Protocol Violation|2|||
144184900|NCT00609154|519871839|FG000|Overall Study|Unable to establish IV access|0|||
144184901|NCT00609154|519871840|FG001|Overall Study|Unable to establish IV access|4|||
144184902|NCT00609154|519871839|FG000|Overall Study|Adverse Event|0|||
144184903|NCT00609154|519871840|FG001|Overall Study|Adverse Event|2|||
144184904|NCT04106817|519871846|FG000|Overall Study|Lost to Follow-up|1|||
144184905|NCT04106817|519871847|FG001|Overall Study|Lost to Follow-up|0|||
144184906|NCT04106817|519871848|FG002|Overall Study|Lost to Follow-up|0|||
144184907|NCT03310619|519871849|FG000|Pre-Treatment Period|Death|1|||
144603950|NCT04448756|521412059|FG001|Overall Study|Death|1|||
144603951|NCT04448756|521412060|FG002|Overall Study|Death|0|||
144603952|NCT02733185|521412061|FG000|Overall Study|Withdrawal by Subject|12|||
144603953|NCT02733185|521412062|FG001|Overall Study|Withdrawal by Subject|10|||
144603954|NCT02733185|521412063|FG002|Overall Study|Withdrawal by Subject|17|||
144603955|NCT02733185|521412064|FG003|Overall Study|Withdrawal by Subject|21|||
144603956|NCT02733185|521412061|FG000|Overall Study|Death|46|||
144603957|NCT02733185|521412062|FG001|Overall Study|Death|34|||
144603958|NCT02733185|521412063|FG002|Overall Study|Death|35|||
144603959|NCT02733185|521412064|FG003|Overall Study|Death|43|||
144603960|NCT02733185|521412061|FG000|Overall Study|Lost to Follow-up|17|||
144603961|NCT02733185|521412062|FG001|Overall Study|Lost to Follow-up|18|||
144603962|NCT02733185|521412063|FG002|Overall Study|Lost to Follow-up|16|||
144184908|NCT03310619|519871850|FG001|Pre-Treatment Period|Death|0|||
144184909|NCT03310619|519871851|FG002|Pre-Treatment Period|Death|0|||
144184910|NCT03310619|519871852|FG003|Pre-Treatment Period|Death|0|||
144603963|NCT02733185|521412064|FG003|Overall Study|Lost to Follow-up|11|||
144184911|NCT03310619|519871853|FG004|Pre-Treatment Period|Death|1|||
144184912|NCT03310619|519871854|FG005|Pre-Treatment Period|Death|0|||
144184913|NCT03310619|519871855|FG006|Pre-Treatment Period|Death|0|||
144184914|NCT03310619|519871856|FG007|Pre-Treatment Period|Death|0|||
144184915|NCT03310619|519871849|FG000|Pre-Treatment Period|Other reasons|2|||
144184916|NCT03310619|519871850|FG001|Pre-Treatment Period|Other reasons|1|||
144184917|NCT03310619|519871851|FG002|Pre-Treatment Period|Other reasons|2|||
144184918|NCT03310619|519871852|FG003|Pre-Treatment Period|Other reasons|0|||
144184919|NCT03310619|519871853|FG004|Pre-Treatment Period|Other reasons|0|||
144184920|NCT03310619|519871854|FG005|Pre-Treatment Period|Other reasons|0|||
144603964|NCT04252287|521412065|FG000|Overall Study|Death|5|||
144603965|NCT04252287|521412066|FG001|Overall Study|Death|3|||
144184921|NCT03310619|519871855|FG006|Pre-Treatment Period|Other reasons|2|||
144184922|NCT03310619|519871856|FG007|Pre-Treatment Period|Other reasons|0|||
144184923|NCT03310619|519871849|FG000|Treatment Period|Death|1|||
144184924|NCT03310619|519871850|FG001|Treatment Period|Death|2|||
144184925|NCT03310619|519871851|FG002|Treatment Period|Death|0|||
144184926|NCT03310619|519871852|FG003|Treatment Period|Death|0|||
144184927|NCT03310619|519871853|FG004|Treatment Period|Death|1|||
144184928|NCT03310619|519871854|FG005|Treatment Period|Death|0|||
144184929|NCT03310619|519871855|FG006|Treatment Period|Death|2|||
144184930|NCT03310619|519871856|FG007|Treatment Period|Death|0|||
144184931|NCT03310619|519871849|FG000|Treatment Period|Adverse Event|0|||
144184932|NCT03310619|519871850|FG001|Treatment Period|Adverse Event|1|||
144184933|NCT03310619|519871851|FG002|Treatment Period|Adverse Event|4|||
144184934|NCT03310619|519871852|FG003|Treatment Period|Adverse Event|1|||
144184935|NCT03310619|519871853|FG004|Treatment Period|Adverse Event|0|||
144184936|NCT03310619|519871854|FG005|Treatment Period|Adverse Event|0|||
144184937|NCT03310619|519871855|FG006|Treatment Period|Adverse Event|0|||
144184938|NCT03310619|519871856|FG007|Treatment Period|Adverse Event|0|||
144184939|NCT03310619|519871849|FG000|Treatment Period|Withdrawal by participant|0|||
144184940|NCT03310619|519871850|FG001|Treatment Period|Withdrawal by participant|0|||
144184941|NCT03310619|519871851|FG002|Treatment Period|Withdrawal by participant|1|||
144184942|NCT03310619|519871852|FG003|Treatment Period|Withdrawal by participant|0|||
144184943|NCT03310619|519871853|FG004|Treatment Period|Withdrawal by participant|0|||
144184944|NCT03310619|519871854|FG005|Treatment Period|Withdrawal by participant|0|||
144184945|NCT03310619|519871855|FG006|Treatment Period|Withdrawal by participant|0|||
144184946|NCT03310619|519871856|FG007|Treatment Period|Withdrawal by participant|0|||
144184947|NCT03310619|519871849|FG000|Treatment Period|Lost to Follow-up|0|||
144184948|NCT03310619|519871850|FG001|Treatment Period|Lost to Follow-up|0|||
144184949|NCT03310619|519871851|FG002|Treatment Period|Lost to Follow-up|0|||
144184950|NCT03310619|519871852|FG003|Treatment Period|Lost to Follow-up|0|||
144184951|NCT03310619|519871853|FG004|Treatment Period|Lost to Follow-up|0|||
144184952|NCT03310619|519871854|FG005|Treatment Period|Lost to Follow-up|0|||
144184953|NCT03310619|519871855|FG006|Treatment Period|Lost to Follow-up|0|||
144184954|NCT03310619|519871856|FG007|Treatment Period|Lost to Follow-up|1|||
144184955|NCT03310619|519871849|FG000|Treatment Period|Study terminated by sponsor|0|||
144184956|NCT03310619|519871850|FG001|Treatment Period|Study terminated by sponsor|0|||
144184957|NCT03310619|519871851|FG002|Treatment Period|Study terminated by sponsor|0|||
144184958|NCT03310619|519871852|FG003|Treatment Period|Study terminated by sponsor|0|||
144184959|NCT03310619|519871853|FG004|Treatment Period|Study terminated by sponsor|0|||
144184960|NCT03310619|519871854|FG005|Treatment Period|Study terminated by sponsor|0|||
144184961|NCT03310619|519871855|FG006|Treatment Period|Study terminated by sponsor|0|||
144184962|NCT03310619|519871856|FG007|Treatment Period|Study terminated by sponsor|1|||
144184963|NCT03310619|519871849|FG000|Treatment Period|Physician Decision|0|||
144184964|NCT03310619|519871850|FG001|Treatment Period|Physician Decision|0|||
144184965|NCT03310619|519871851|FG002|Treatment Period|Physician Decision|0|||
144184966|NCT03310619|519871852|FG003|Treatment Period|Physician Decision|0|||
144184967|NCT03310619|519871853|FG004|Treatment Period|Physician Decision|3|||
144184968|NCT03310619|519871854|FG005|Treatment Period|Physician Decision|0|||
144184969|NCT03310619|519871855|FG006|Treatment Period|Physician Decision|0|||
144184970|NCT03310619|519871856|FG007|Treatment Period|Physician Decision|0|||
144184971|NCT03310619|519871849|FG000|Treatment Period|Other reasons|1|||
144184972|NCT03310619|519871850|FG001|Treatment Period|Other reasons|0|||
144184973|NCT03310619|519871851|FG002|Treatment Period|Other reasons|2|||
144184974|NCT03310619|519871852|FG003|Treatment Period|Other reasons|0|||
144184975|NCT03310619|519871853|FG004|Treatment Period|Other reasons|0|||
144184976|NCT03310619|519871854|FG005|Treatment Period|Other reasons|0|||
144184977|NCT03310619|519871855|FG006|Treatment Period|Other reasons|0|||
144184978|NCT03310619|519871856|FG007|Treatment Period|Other reasons|0|||
144184979|NCT00152516|519871857|FG000|Overall Study|Adverse Event|18|||
144184980|NCT00152516|519871857|FG000|Overall Study|Lack and Loss of Efficacy|30|||
144184981|NCT00152516|519871857|FG000|Overall Study|Lost to Follow-up|5|||
144184982|NCT00152516|519871857|FG000|Overall Study|Withdrawal by Subject|8|||
144184983|NCT00152516|519871857|FG000|Overall Study|Protocol Violation|3|||
144723714|NCT04256421|521842438|FG001|Overall Study|Ongoing in Study|52|||
144723715|NCT04736199|521844181|FG000|Overall Study|Adverse Event|28|||
144723716|NCT04736199|521844182|FG001|Overall Study|Adverse Event|22|||
144723717|NCT04736199|521844181|FG000|Overall Study|Death|9|||
144184984|NCT00152516|519871857|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
144184985|NCT00152516|519871857|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
144184986|NCT00152516|519871857|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
144184987|NCT00152516|519871857|FG000|Overall Study|Other: Non-Compliance|2|||
144184988|NCT00152516|519871857|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
144184989|NCT00152516|519871857|FG000|Overall Study|Other: Moved Out Of State|1|||
144184990|NCT00152516|519871857|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
144184991|NCT00152516|519871857|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
144184992|NCT00926367|519871859|FG000|Overall Study|Withdrawal by Subject|0|||
144184993|NCT00926367|519871860|FG001|Overall Study|Withdrawal by Subject|1|||
144184994|NCT00926367|519871859|FG000|Overall Study|Lost to Follow-up|1|||
144184995|NCT00926367|519871860|FG001|Overall Study|Lost to Follow-up|0|||
144184996|NCT00926367|519871859|FG000|Overall Study|Skin Irritation|1|||
144184997|NCT00926367|519871860|FG001|Overall Study|Skin Irritation|2|||
144184998|NCT02725411|519871861|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
144184999|NCT02725411|519871862|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
144185000|NCT02725411|519871863|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
144185001|NCT02725411|519871861|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
144185002|NCT02725411|519871862|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
144185003|NCT02725411|519871863|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
144185004|NCT02725411|519871861|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
144185005|NCT02725411|519871862|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
144185006|NCT02725411|519871863|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
144185007|NCT02725411|519871861|FG000|Treatment Period (56 Weeks)|Other|1|||
144185008|NCT02725411|519871862|FG001|Treatment Period (56 Weeks)|Other|4|||
144185009|NCT02725411|519871863|FG002|Treatment Period (56 Weeks)|Other|5|||
144185010|NCT02725411|519871861|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
144185011|NCT02725411|519871862|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
144185012|NCT02725411|519871863|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
144185013|NCT02725411|519871861|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
144185014|NCT02725411|519871862|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
144185015|NCT02725411|519871863|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
144185016|NCT02725411|519871861|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
144185017|NCT02725411|519871862|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
144185018|NCT02725411|519871863|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
144185019|NCT02725411|519871861|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
144185020|NCT02725411|519871862|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
144185021|NCT02725411|519871863|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
144185022|NCT02725411|519871861|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
144185023|NCT02725411|519871862|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
144185024|NCT02725411|519871863|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
144185025|NCT02725411|519871861|FG000|Follow-up Period (24 Weeks)|Other|1|||
144185026|NCT02725411|519871862|FG001|Follow-up Period (24 Weeks)|Other|4|||
144185027|NCT02725411|519871863|FG002|Follow-up Period (24 Weeks)|Other|2|||
144185028|NCT02725411|519871861|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
144185029|NCT02725411|519871862|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
144185030|NCT02725411|519871863|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
144185031|NCT00756717|519871866|FG000|Overall Study|Withdrawal by Subject|2|||
144185032|NCT01896505|519871869|FG000|Overall Study|Adverse Event|1|||
144185033|NCT01896505|519871870|FG001|Overall Study|Adverse Event|0|||
144185034|NCT01896505|519871871|FG002|Overall Study|Adverse Event|2|||
144185035|NCT01896505|519871872|FG003|Overall Study|Adverse Event|1|||
144185036|NCT01896505|519871873|FG004|Overall Study|Adverse Event|1|||
144185037|NCT01896505|519871874|FG005|Overall Study|Adverse Event|0|||
144185038|NCT01896505|519871869|FG000|Overall Study|Physician Decision|1|||
144185039|NCT01896505|519871870|FG001|Overall Study|Physician Decision|3|||
144185040|NCT01896505|519871871|FG002|Overall Study|Physician Decision|2|||
144185041|NCT01896505|519871872|FG003|Overall Study|Physician Decision|0|||
144185042|NCT01896505|519871873|FG004|Overall Study|Physician Decision|0|||
144185043|NCT01896505|519871874|FG005|Overall Study|Physician Decision|1|||
144185044|NCT01896505|519871869|FG000|Overall Study|Withdrawal by Subject|1|||
144185045|NCT01896505|519871870|FG001|Overall Study|Withdrawal by Subject|0|||
144185046|NCT01896505|519871871|FG002|Overall Study|Withdrawal by Subject|3|||
144185047|NCT01896505|519871872|FG003|Overall Study|Withdrawal by Subject|1|||
144185048|NCT01896505|519871873|FG004|Overall Study|Withdrawal by Subject|0|||
144185049|NCT01896505|519871874|FG005|Overall Study|Withdrawal by Subject|0|||
144185050|NCT01896505|519871869|FG000|Overall Study|Disease Progression|7|||
144185051|NCT01896505|519871870|FG001|Overall Study|Disease Progression|5|||
144185052|NCT01896505|519871871|FG002|Overall Study|Disease Progression|8|||
144185053|NCT01896505|519871872|FG003|Overall Study|Disease Progression|4|||
144603966|NCT04252287|521412065|FG000|Overall Study|Lost to Follow-up|4|||
144603967|NCT04252287|521412066|FG001|Overall Study|Lost to Follow-up|6|||
144603968|NCT04252287|521412065|FG000|Overall Study|Withdrawal by Subject|19|||
144430341|NCT02658890|520784777|FG008|Treatment Phase|Progressive Disease|26|||
144430342|NCT02658890|520784778|FG009|Treatment Phase|Progressive Disease|8|||
144430343|NCT02658890|520784779|FG010|Treatment Phase|Progressive Disease|7|||
144603969|NCT04252287|521412066|FG001|Overall Study|Withdrawal by Subject|16|||
144185054|NCT01896505|519871873|FG004|Overall Study|Disease Progression|4|||
144185055|NCT01896505|519871874|FG005|Overall Study|Disease Progression|4|||
144185056|NCT01896505|519871869|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
144185057|NCT01896505|519871870|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
144185058|NCT01896505|519871871|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
144185059|NCT01896505|519871872|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
144603970|NCT04252287|521412065|FG000|Overall Study|Protocol Violation|3|||
144185060|NCT01896505|519871873|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
144185061|NCT01896505|519871874|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
144185062|NCT01896505|519871869|FG000|Overall Study|Intercurrent illness|0|||
144185063|NCT01896505|519871870|FG001|Overall Study|Intercurrent illness|1|||
144185064|NCT01896505|519871871|FG002|Overall Study|Intercurrent illness|0|||
144185065|NCT01896505|519871872|FG003|Overall Study|Intercurrent illness|0|||
144185066|NCT01896505|519871873|FG004|Overall Study|Intercurrent illness|0|||
144185067|NCT01896505|519871874|FG005|Overall Study|Intercurrent illness|0|||
144185068|NCT01896505|519871869|FG000|Overall Study|Death|0|||
144185069|NCT01896505|519871870|FG001|Overall Study|Death|0|||
144185070|NCT01896505|519871871|FG002|Overall Study|Death|1|||
144185071|NCT01896505|519871872|FG003|Overall Study|Death|1|||
144185072|NCT01896505|519871873|FG004|Overall Study|Death|0|||
144185073|NCT01896505|519871874|FG005|Overall Study|Death|1|||
144185074|NCT02466386|519871875|FG000|Overall Study|Adverse Event|5|||
144185075|NCT02466386|519871875|FG000|Overall Study|Protocol Violation|2|||
144185076|NCT02466386|519871875|FG000|Overall Study|Withdrawal by Subject|14|||
144185077|NCT02466386|519871875|FG000|Overall Study|Lost to Follow-up|5|||
144185078|NCT02466386|519871875|FG000|Overall Study|Lack of Efficacy|8|||
144185079|NCT02466386|519871875|FG000|Overall Study|Other|10|||
144185080|NCT03259789|519871876|FG000|Overall Study|Adverse Event|3|||
144185081|NCT03259789|519871877|FG001|Overall Study|Adverse Event|2|||
144185082|NCT03259789|519871878|FG002|Overall Study|Adverse Event|1|||
144185083|NCT03259789|519871876|FG000|Overall Study|Withdrawal by Subject|9|||
144185084|NCT03259789|519871877|FG001|Overall Study|Withdrawal by Subject|5|||
144185085|NCT03259789|519871878|FG002|Overall Study|Withdrawal by Subject|1|||
144185086|NCT03259789|519871876|FG000|Overall Study|Lost to Follow-up|5|||
144185087|NCT03259789|519871877|FG001|Overall Study|Lost to Follow-up|9|||
144185088|NCT03259789|519871878|FG002|Overall Study|Lost to Follow-up|4|||
144185089|NCT03259789|519871876|FG000|Overall Study|Physician Decision|0|||
144185090|NCT03259789|519871877|FG001|Overall Study|Physician Decision|1|||
144185091|NCT03259789|519871878|FG002|Overall Study|Physician Decision|0|||
144185092|NCT02063217|519871879|FG000|Overall Study|Withdrawal by Subject|1|||
144185093|NCT02063217|519871880|FG001|Overall Study|Withdrawal by Subject|0|||
144185094|NCT02063217|519871881|FG002|Overall Study|Withdrawal by Subject|0|||
144185095|NCT04291508|519871882|FG000|Overall Study|Withdrawal by Subject|1|||
144185096|NCT04291508|519871883|FG001|Overall Study|Withdrawal by Subject|0|||
144185097|NCT04291508|519871884|FG002|Overall Study|Withdrawal by Subject|1|||
144185098|NCT04291508|519871885|FG003|Overall Study|Withdrawal by Subject|0|||
144185099|NCT04291508|519871882|FG000|Overall Study|lost to follow up|4|||
144185100|NCT04291508|519871883|FG001|Overall Study|lost to follow up|0|||
144185101|NCT04291508|519871884|FG002|Overall Study|lost to follow up|1|||
144185102|NCT04291508|519871885|FG003|Overall Study|lost to follow up|0|||
144185103|NCT00420095|519871887|FG000|Overall Study|Adverse Event|1|||
144185104|NCT00420095|519871888|FG001|Overall Study|Adverse Event|0|||
144185105|NCT00420095|519871887|FG000|Overall Study|Protocol Violation|1|||
144185106|NCT00420095|519871888|FG001|Overall Study|Protocol Violation|1|||
144185107|NCT00420095|519871887|FG000|Overall Study|Lost to Follow-up|1|||
144185108|NCT00420095|519871888|FG001|Overall Study|Lost to Follow-up|0|||
144185109|NCT03108820|519871889|FG000|Overall Study|Lost to Follow-up|30|||
144185110|NCT03108820|519871890|FG001|Overall Study|Lost to Follow-up|28|||
144185111|NCT03108820|519871889|FG000|Overall Study|Withdrawal by Subject|32|||
144185112|NCT03108820|519871890|FG001|Overall Study|Withdrawal by Subject|24|||
144185113|NCT03108820|519871889|FG000|Overall Study|Death|6|||
144185114|NCT03108820|519871890|FG001|Overall Study|Death|11|||
144185115|NCT00089973|519871897|FG000|Overall Study|Adverse Event|3|||
144185116|NCT00089973|519871897|FG000|Overall Study|Withdrawal by Subject|1|||
144430344|NCT02658890|520784780|FG011|Treatment Phase|Progressive Disease|9|||
144430345|NCT02658890|520784781|FG012|Treatment Phase|Progressive Disease|8|||
144430346|NCT02658890|520784782|FG013|Treatment Phase|Progressive Disease|29|||
144185117|NCT00089973|519871897|FG000|Overall Study|Disease progression|45|||
144185118|NCT00089973|519871897|FG000|Overall Study|Death|1|||
144185119|NCT01475487|519871898|FG000|Overall Study|had to leave early for personal reasons|2|||
144185120|NCT01475487|519871899|FG001|Overall Study|had to leave early for personal reasons|1|||
144185121|NCT04428645|519871904|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
144185122|NCT00559637|519873472|FG000|Overall Study|Adverse Event|22|||
144185123|NCT00559637|519873472|FG000|Overall Study|Withdrawal by Subject|4|||
144185124|NCT00559637|519873472|FG000|Overall Study|Protocol Violation|6|||
144185125|NCT00559637|519873472|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
144185126|NCT00559637|519873472|FG000|Overall Study|Failure to return|6|||
144185127|NCT00559637|519873472|FG000|Overall Study|Insufficient response|3|||
144185128|NCT00559637|519873472|FG000|Overall Study|Started requiring dialysis after month 7|2|||
144185129|NCT00559637|519873472|FG000|Overall Study|Suspected lung cancer|1|||
144185130|NCT00559637|519873472|FG000|Overall Study|Participation in another study|1|||
144185131|NCT00559637|519873472|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
144185132|NCT00559637|519873472|FG000|Overall Study|Change of center|1|||
144185133|NCT00559637|519873472|FG000|Overall Study|Change of home|1|||
144185134|NCT00559637|519873472|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
144185135|NCT00676650|519873476|FG000|Overall Study|Death|45|||
144185136|NCT00676650|519873477|FG001|Overall Study|Death|14|||
144185137|NCT00676650|519873476|FG000|Overall Study|Adverse Event|159|||
144185138|NCT00676650|519873477|FG001|Overall Study|Adverse Event|21|||
144185139|NCT00676650|519873476|FG000|Overall Study|Global deterioration of health status|66|||
144185140|NCT00676650|519873477|FG001|Overall Study|Global deterioration of health status|31|||
144185141|NCT00676650|519873476|FG000|Overall Study|Lost to Follow-up|0|||
144185142|NCT00676650|519873477|FG001|Overall Study|Lost to Follow-up|1|||
144185143|NCT00676650|519873476|FG000|Overall Study|Objective progression or relapse|189|||
144185144|NCT00676650|519873477|FG001|Overall Study|Objective progression or relapse|140|||
144185145|NCT00676650|519873476|FG000|Overall Study|Other|14|||
144185146|NCT00676650|519873477|FG001|Overall Study|Other|10|||
144185147|NCT00676650|519873476|FG000|Overall Study|Protocol Violation|3|||
144185148|NCT00676650|519873477|FG001|Overall Study|Protocol Violation|1|||
144185149|NCT00676650|519873476|FG000|Overall Study|Study terminated by sponsor|57|||
144185150|NCT00676650|519873477|FG001|Overall Study|Study terminated by sponsor|43|||
144185151|NCT00676650|519873476|FG000|Overall Study|Withdrawal by Subject|48|||
144185152|NCT00676650|519873477|FG001|Overall Study|Withdrawal by Subject|24|||
144185153|NCT00676650|519873476|FG000|Overall Study|Randomized but not treated|3|||
144185154|NCT00676650|519873477|FG001|Overall Study|Randomized but not treated|4|||
144185155|NCT02297841|519873481|FG000|Overall Study|Withdrawal by Subject|1|||
144185156|NCT02297841|519873481|FG000|Overall Study|Protocol Violation|7|||
144185157|NCT03429049|519873482|FG000|Overall Study|Adverse Event|2|||
144185158|NCT03429049|519873483|FG001|Overall Study|Adverse Event|3|||
144185159|NCT03429049|519873482|FG000|Overall Study|Death|0|||
144185160|NCT03429049|519873483|FG001|Overall Study|Death|1|||
144185161|NCT03429049|519873482|FG000|Overall Study|Lack of Efficacy|4|||
144185162|NCT03429049|519873483|FG001|Overall Study|Lack of Efficacy|2|||
144185163|NCT03429049|519873482|FG000|Overall Study|Lost to Follow-up|9|||
144185164|NCT03429049|519873483|FG001|Overall Study|Lost to Follow-up|8|||
144185165|NCT03429049|519873482|FG000|Overall Study|Physician Decision|1|||
144185166|NCT03429049|519873483|FG001|Overall Study|Physician Decision|0|||
144185167|NCT03429049|519873482|FG000|Overall Study|Protocol Violation|3|||
144185168|NCT03429049|519873483|FG001|Overall Study|Protocol Violation|0|||
144185169|NCT03429049|519873482|FG000|Overall Study|Sponsor Decision|2|||
144185170|NCT03429049|519873483|FG001|Overall Study|Sponsor Decision|0|||
144185171|NCT03429049|519873482|FG000|Overall Study|Withdrawal by Subject|4|||
144185172|NCT03429049|519873483|FG001|Overall Study|Withdrawal by Subject|20|||
144185173|NCT03429049|519873482|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
144185174|NCT03429049|519873483|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
144185175|NCT02419573|519873484|FG000|Overall Study|Lost to Follow-up|3|||
144185176|NCT02419573|519873485|FG001|Overall Study|Lost to Follow-up|0|||
144185177|NCT02419573|519873484|FG000|Overall Study|Withdrawal by Subject|1|||
144185178|NCT02419573|519873485|FG001|Overall Study|Withdrawal by Subject|0|||
144185179|NCT04501094|519873486|FG000|Overall Study|Death (unrelated to research)|1|||
144603971|NCT04252287|521412066|FG001|Overall Study|Protocol Violation|4|||
144603972|NCT01791803|521412068|FG000|Overall Study|Withdrawal by Subject|0|||
144603973|NCT01791803|521412069|FG001|Overall Study|Withdrawal by Subject|0|||
144603974|NCT01791803|521412070|FG002|Overall Study|Withdrawal by Subject|0|||
144603975|NCT01791803|521412071|FG003|Overall Study|Withdrawal by Subject|2|||
144603976|NCT01791803|521412068|FG000|Overall Study|Physician Decision|0|||
144603977|NCT01791803|521412069|FG001|Overall Study|Physician Decision|2|||
144603978|NCT01791803|521412070|FG002|Overall Study|Physician Decision|0|||
144603979|NCT01791803|521412071|FG003|Overall Study|Physician Decision|1|||
144603980|NCT01791803|521412068|FG000|Overall Study|Death|0|||
144603981|NCT01791803|521412069|FG001|Overall Study|Death|0|||
144603982|NCT01791803|521412070|FG002|Overall Study|Death|2|||
144603983|NCT01791803|521412071|FG003|Overall Study|Death|2|||
144603984|NCT04572854|521412072|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
144603985|NCT04572854|521412073|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
144603986|NCT04572854|521412074|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
144603987|NCT04572854|521412075|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
144185180|NCT04501094|519873487|FG001|Overall Study|Death (unrelated to research)|0|||
144185181|NCT00396630|519873490|FG000|Overall Study|Lost to Follow-up|1|||
144603988|NCT04572854|521412072|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
144603989|NCT04572854|521412073|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
144723718|NCT04736199|521844182|FG001|Overall Study|Death|3|||
144185182|NCT00396630|519873491|FG001|Overall Study|Lost to Follow-up|1|||
144185183|NCT00396630|519873490|FG000|Overall Study|Withdrawal by Subject|1|||
144185184|NCT00396630|519873491|FG001|Overall Study|Withdrawal by Subject|1|||
144185185|NCT00396630|519873490|FG000|Overall Study|Not vaccinated at Visit 3|3|||
144185186|NCT00396630|519873491|FG001|Overall Study|Not vaccinated at Visit 3|3|||
144185187|NCT00996437|519873496|FG000|Overall Study|Death|1|||
144185188|NCT00996437|519873497|FG001|Overall Study|Death|0|||
144185189|NCT00996437|519873496|FG000|Overall Study|Dropped|2|||
144185190|NCT00996437|519873497|FG001|Overall Study|Dropped|2|||
144185191|NCT00996437|519873496|FG000|Overall Study|Missed|2|||
144723719|NCT04736199|521844181|FG000|Overall Study|Lost to Follow-up|4|||
144723720|NCT04736199|521844182|FG001|Overall Study|Lost to Follow-up|1|||
144723721|NCT04736199|521844181|FG000|Overall Study|Physician Decision|5|||
144723722|NCT04736199|521844182|FG001|Overall Study|Physician Decision|9|||
144723723|NCT04736199|521844181|FG000|Overall Study|Withdrawal by Subject|21|||
144723724|NCT04736199|521844182|FG001|Overall Study|Withdrawal by Subject|9|||
144723725|NCT04736199|521844181|FG000|Overall Study|Progressive disease|120|||
144723726|NCT04736199|521844182|FG001|Overall Study|Progressive disease|101|||
144723727|NCT04736199|521844181|FG000|Overall Study|Subject decision|13|||
144723728|NCT04736199|521844182|FG001|Overall Study|Subject decision|13|||
144723729|NCT04736199|521844181|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
144185192|NCT00996437|519873497|FG001|Overall Study|Missed|5|||
144185193|NCT01933919|519873498|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
144185194|NCT01933919|519873499|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
144185195|NCT01933919|519873498|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
144185196|NCT01933919|519873499|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
144185197|NCT01933919|519873498|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
144185198|NCT01933919|519873499|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
144185199|NCT01933919|519873498|FG000|Open-label Long-term Phase|Adverse Event|2|||
144185200|NCT01933919|519873499|FG001|Open-label Long-term Phase|Adverse Event|0|||
144185201|NCT01933919|519873498|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
144185202|NCT01933919|519873499|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
144185203|NCT01933919|519873498|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
144185204|NCT01933919|519873499|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
144185205|NCT01933919|519873498|FG000|Open-label Long-term Phase|Other|1|||
144185206|NCT01933919|519873499|FG001|Open-label Long-term Phase|Other|2|||
144185207|NCT00763555|519873503|FG000|Overall Study|Adverse Event|2|||
144185208|NCT00763555|519873504|FG001|Overall Study|Adverse Event|1|||
144185209|NCT00763555|519873503|FG000|Overall Study|Withdrawal by Subject|2|||
144185210|NCT00763555|519873504|FG001|Overall Study|Withdrawal by Subject|6|||
144185211|NCT00763555|519873503|FG000|Overall Study|Lost to Follow-up|0|||
144185212|NCT00763555|519873504|FG001|Overall Study|Lost to Follow-up|3|||
144185213|NCT03710590|519873505|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
144185214|NCT03710590|519873506|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
144185215|NCT02510261|519873508|FG000|Overall Study|Adverse Event|5|||
144185216|NCT02510261|519873509|FG001|Overall Study|Adverse Event|8|||
144185217|NCT02510261|519873510|FG002|Overall Study|Adverse Event|0|||
144185218|NCT02510261|519873508|FG000|Overall Study|Physician Decision|1|||
144185219|NCT02510261|519873509|FG001|Overall Study|Physician Decision|5|||
144185220|NCT02510261|519873510|FG002|Overall Study|Physician Decision|0|||
144185221|NCT02510261|519873508|FG000|Overall Study|Death|19|||
144185222|NCT02510261|519873509|FG001|Overall Study|Death|19|||
144185223|NCT02510261|519873510|FG002|Overall Study|Death|0|||
144185224|NCT02510261|519873508|FG000|Overall Study|Withdrawal by Subject|3|||
144185225|NCT02510261|519873509|FG001|Overall Study|Withdrawal by Subject|10|||
144185226|NCT02510261|519873510|FG002|Overall Study|Withdrawal by Subject|3|||
144185227|NCT00108082|519873511|FG000|Overall Study|Adverse Event|14|||
144185228|NCT00108082|519873512|FG001|Overall Study|Adverse Event|12|||
144185229|NCT00108082|519873513|FG002|Overall Study|Adverse Event|17|||
144185230|NCT00108082|519873511|FG000|Overall Study|Lost to Follow-up|6|||
144185231|NCT00108082|519873512|FG001|Overall Study|Lost to Follow-up|3|||
144185232|NCT00108082|519873513|FG002|Overall Study|Lost to Follow-up|7|||
144252155|NCT01863732|520122691|FG000|Overall Study|Lack of Efficacy|1|||
144252156|NCT01863732|520122692|FG001|Overall Study|Lack of Efficacy|0|||
144252157|NCT01863732|520122693|FG002|Overall Study|Lack of Efficacy|2|||
144252158|NCT01863732|520122694|FG003|Overall Study|Lack of Efficacy|1|||
144252159|NCT01863732|520122691|FG000|Overall Study|Lost to Follow-up|2|||
144603990|NCT04572854|521412074|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
144603991|NCT04572854|521412075|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
144603992|NCT00972777|521412076|FG000|Overall Study|Adverse Event|3|||
144603993|NCT00972777|521412077|FG001|Overall Study|Adverse Event|2|||
144603994|NCT00972777|521412076|FG000|Overall Study|Lost to Follow-up|0|||
144603995|NCT00972777|521412077|FG001|Overall Study|Lost to Follow-up|4|||
144603996|NCT00972777|521412076|FG000|Overall Study|Withdrawal by Subject|4|||
144603997|NCT00972777|521412077|FG001|Overall Study|Withdrawal by Subject|5|||
144185233|NCT00108082|519873511|FG000|Overall Study|Consent Withdrawn|3|||
144185234|NCT00108082|519873512|FG001|Overall Study|Consent Withdrawn|3|||
144185235|NCT00108082|519873513|FG002|Overall Study|Consent Withdrawn|5|||
144185236|NCT00108082|519873511|FG000|Overall Study|Protocol Violation|1|||
144185237|NCT00108082|519873512|FG001|Overall Study|Protocol Violation|2|||
144185238|NCT00108082|519873513|FG002|Overall Study|Protocol Violation|0|||
144185239|NCT00108082|519873511|FG000|Overall Study|Lack of Efficacy|3|||
144185240|NCT00108082|519873512|FG001|Overall Study|Lack of Efficacy|1|||
144185241|NCT00108082|519873513|FG002|Overall Study|Lack of Efficacy|2|||
144252160|NCT01863732|520122692|FG001|Overall Study|Lost to Follow-up|2|||
144603998|NCT00972777|521412076|FG000|Overall Study|Physician Decision|4|||
144603999|NCT00972777|521412077|FG001|Overall Study|Physician Decision|0|||
144185242|NCT00108082|519873511|FG000|Overall Study|Amendment 4: > Month 12|5|||
144185243|NCT00108082|519873512|FG001|Overall Study|Amendment 4: > Month 12|7|||
144185244|NCT00108082|519873513|FG002|Overall Study|Amendment 4: > Month 12|5|||
144185245|NCT00108082|519873511|FG000|Overall Study|Woman of Child-bearing Potential|2|||
144185246|NCT00108082|519873512|FG001|Overall Study|Woman of Child-bearing Potential|0|||
144185247|NCT00108082|519873513|FG002|Overall Study|Woman of Child-bearing Potential|2|||
144185248|NCT00108082|519873511|FG000|Overall Study|Incorrectly Randomized|0|||
144185249|NCT00108082|519873512|FG001|Overall Study|Incorrectly Randomized|0|||
144185250|NCT00108082|519873513|FG002|Overall Study|Incorrectly Randomized|2|||
144185251|NCT00108082|519873511|FG000|Overall Study|Non-compliance|1|||
144185252|NCT00108082|519873512|FG001|Overall Study|Non-compliance|0|||
144185253|NCT00108082|519873513|FG002|Overall Study|Non-compliance|2|||
144185254|NCT00108082|519873511|FG000|Overall Study|Stopped Study Medication|0|||
144185255|NCT00108082|519873512|FG001|Overall Study|Stopped Study Medication|0|||
144185256|NCT00108082|519873513|FG002|Overall Study|Stopped Study Medication|1|||
144185257|NCT00108082|519873511|FG000|Overall Study|Site Closed Study|0|||
144185258|NCT00108082|519873512|FG001|Overall Study|Site Closed Study|2|||
144185259|NCT00108082|519873513|FG002|Overall Study|Site Closed Study|0|||
144185260|NCT00108082|519873511|FG000|Overall Study|Protocol Amendment|0|||
144185261|NCT00108082|519873512|FG001|Overall Study|Protocol Amendment|1|||
144185262|NCT00108082|519873513|FG002|Overall Study|Protocol Amendment|0|||
144185263|NCT00108082|519873511|FG000|Overall Study|Study Medication Not Tapered|0|||
144185264|NCT00108082|519873512|FG001|Overall Study|Study Medication Not Tapered|1|||
144185265|NCT00108082|519873513|FG002|Overall Study|Study Medication Not Tapered|0|||
144185266|NCT00108082|519873511|FG000|Overall Study|Subject Left Site Location|1|||
144185267|NCT00108082|519873512|FG001|Overall Study|Subject Left Site Location|0|||
144185268|NCT00108082|519873513|FG002|Overall Study|Subject Left Site Location|0|||
144185269|NCT00108082|519873511|FG000|Overall Study|Investigator Not at Site|1|||
144185270|NCT00108082|519873512|FG001|Overall Study|Investigator Not at Site|0|||
144185271|NCT00108082|519873513|FG002|Overall Study|Investigator Not at Site|0|||
144185272|NCT00108082|519873511|FG000|Overall Study|Blood Pressure Not Controlled|1|||
144185273|NCT00108082|519873512|FG001|Overall Study|Blood Pressure Not Controlled|0|||
144185274|NCT00108082|519873513|FG002|Overall Study|Blood Pressure Not Controlled|0|||
144185275|NCT02940730|519873516|FG000|Intervention 2|Physician Decision|7|||
144185276|NCT02940730|519873517|FG001|Intervention 2|Physician Decision|0|||
144185277|NCT01045707|519873519|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
144185278|NCT01045707|519873520|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
144185279|NCT01045707|519873519|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
144185280|NCT01045707|519873520|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
144185281|NCT01045707|519873519|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
144185282|NCT01045707|519873520|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
144185283|NCT01045707|519873519|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
144185284|NCT01045707|519873520|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
144185285|NCT01045707|519873519|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
144185286|NCT01045707|519873520|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
144185287|NCT01045707|519873519|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
144185288|NCT01045707|519873520|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
144185289|NCT01045707|519873519|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
144185290|NCT01045707|519873520|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
144185291|NCT01045707|519873519|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
144185292|NCT01045707|519873520|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
144185293|NCT01045707|519873519|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
144529041|NCT03088878|521139168|FG008|Overall Study|Death|0|||
144529042|NCT03088878|521139169|FG009|Overall Study|Death|0|||
144529043|NCT03088878|521139170|FG010|Overall Study|Death|0|||
144529044|NCT03088878|521139171|FG011|Overall Study|Death|1|||
144185294|NCT01045707|519873520|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
144185295|NCT00348816|519873521|FG000|Overall Study|Noncompliance with radiation treatment|1|||
144185296|NCT00848042|519873522|FG000|Overall Study|Death|1|||
144185297|NCT00848042|519873523|FG001|Overall Study|Death|2|||
144185298|NCT00848042|519873524|FG002|Overall Study|Death|0|||
144185299|NCT00848042|519873522|FG000|Overall Study|Other Therapy|3|||
144185300|NCT00848042|519873523|FG001|Overall Study|Other Therapy|0|||
144185301|NCT00848042|519873524|FG002|Overall Study|Other Therapy|0|||
144185302|NCT01190930|519873525|FG000|Induction|Adverse Event|17|||
144185303|NCT01190930|519873526|FG001|Induction|Adverse Event|0|||
144185304|NCT01190930|519873527|FG002|Induction|Adverse Event|0|||
144185305|NCT01190930|519873528|FG003|Induction|Adverse Event|0|||
144185306|NCT01190930|519873529|FG004|Induction|Adverse Event|0|||
144185307|NCT01190930|519873530|FG005|Induction|Adverse Event|0|||
144185308|NCT01190930|519873531|FG006|Induction|Adverse Event|0|||
144185309|NCT01190930|519873532|FG007|Induction|Adverse Event|0|||
144185310|NCT01190930|519873533|FG008|Induction|Adverse Event|0|||
144185311|NCT01190930|519873534|FG009|Induction|Adverse Event|0|||
144529045|NCT03088878|521139172|FG012|Overall Study|Death|0|||
144529046|NCT03088878|521139173|FG013|Overall Study|Death|0|||
144723730|NCT04736199|521844182|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
144723731|NCT04736199|521844181|FG000|Overall Study|Additional primary malignancy|1|||
144723732|NCT04736199|521844182|FG001|Overall Study|Additional primary malignancy|0|||
144723733|NCT04736199|521844181|FG000|Overall Study|Non-compliance with study drug|0|||
144723734|NCT04736199|521844182|FG001|Overall Study|Non-compliance with study drug|1|||
144723735|NCT04736199|521844181|FG000|Overall Study|Other reason|0|||
144723736|NCT04736199|521844182|FG001|Overall Study|Other reason|1|||
144723737|NCT04736199|521844181|FG000|Overall Study|Ongoing with study drug|240|||
144723738|NCT04736199|521844182|FG001|Overall Study|Ongoing with study drug|63|||
144723739|NCT04736199|521844181|FG000|Overall Study|Study drug never administered|3|||
144723740|NCT04736199|521844182|FG001|Overall Study|Study drug never administered|0|||
144723741|NCT05514119|521844186|FG000|Overall Study|Ineligible due to disease progression|1|||
144723742|NCT05568225|521844187|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
144723743|NCT05568225|521844188|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
144723744|NCT05568225|521844189|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
144723745|NCT05568225|521844187|FG000|Primary Treatment Period|Physician Decision|0|||
144723746|NCT05568225|521844188|FG001|Primary Treatment Period|Physician Decision|1|||
144723747|NCT05568225|521844189|FG002|Primary Treatment Period|Physician Decision|0|||
144723748|NCT05568225|521844187|FG000|Primary Treatment Period|Disease progression|0|||
144723749|NCT05568225|521844188|FG001|Primary Treatment Period|Disease progression|1|||
144723750|NCT05568225|521844189|FG002|Primary Treatment Period|Disease progression|0|||
144723751|NCT05568225|521844187|FG000|Primary Treatment Period|Lack of Efficacy|0|||
144723752|NCT05568225|521844188|FG001|Primary Treatment Period|Lack of Efficacy|1|||
144723753|NCT05568225|521844189|FG002|Primary Treatment Period|Lack of Efficacy|0|||
144723754|NCT05568225|521844187|FG000|Primary Treatment Period|Withdrawal of conset|1|||
144723755|NCT05568225|521844188|FG001|Primary Treatment Period|Withdrawal of conset|0|||
144723756|NCT05568225|521844189|FG002|Primary Treatment Period|Withdrawal of conset|4|||
144723757|NCT05568225|521844187|FG000|Primary Treatment Period|Adverse Event|1|||
144723758|NCT05568225|521844188|FG001|Primary Treatment Period|Adverse Event|0|||
144723759|NCT05568225|521844189|FG002|Primary Treatment Period|Adverse Event|0|||
144723760|NCT05568225|521844187|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
144723761|NCT05568225|521844188|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
144723762|NCT05568225|521844189|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
144723763|NCT05568225|521844187|FG000|Extension Treatment Period|Protocol Violation|0|||
144723764|NCT05568225|521844188|FG001|Extension Treatment Period|Protocol Violation|0|||
144723765|NCT05568225|521844189|FG002|Extension Treatment Period|Protocol Violation|1|||
144604000|NCT00972777|521412076|FG000|Overall Study|Protocol Violation|0|||
144604001|NCT00972777|521412077|FG001|Overall Study|Protocol Violation|2|||
144604002|NCT00972777|521412076|FG000|Overall Study|Screening Failure|2|||
144604003|NCT00972777|521412077|FG001|Overall Study|Screening Failure|1|||
144604004|NCT00972777|521412076|FG000|Overall Study|Missed visit|1|||
144604005|NCT00972777|521412077|FG001|Overall Study|Missed visit|0|||
144604006|NCT01093326|521412078|FG000|Overall Study|Death|0|||
144604007|NCT01093326|521412079|FG001|Overall Study|Death|1|||
144604008|NCT01093326|521412080|FG002|Overall Study|Death|0|||
144604009|NCT01093326|521412078|FG000|Overall Study|Lack of Efficacy|7|||
144604010|NCT01093326|521412079|FG001|Overall Study|Lack of Efficacy|6|||
144604011|NCT01093326|521412080|FG002|Overall Study|Lack of Efficacy|3|||
144604012|NCT01093326|521412078|FG000|Overall Study|Lost to Follow-up|2|||
144604013|NCT01093326|521412079|FG001|Overall Study|Lost to Follow-up|5|||
144604014|NCT01093326|521412080|FG002|Overall Study|Lost to Follow-up|4|||
144604015|NCT01093326|521412078|FG000|Overall Study|Physician Decision|3|||
144604016|NCT01093326|521412079|FG001|Overall Study|Physician Decision|1|||
144604017|NCT01093326|521412080|FG002|Overall Study|Physician Decision|3|||
144604018|NCT01093326|521412078|FG000|Overall Study|Withdrawal by Subject|30|||
144723766|NCT05568225|521844187|FG000|Extension Treatment Period|Lack of Efficacy|0|||
144185312|NCT01190930|519873525|FG000|Induction|Death|34|||
144185313|NCT01190930|519873526|FG001|Induction|Death|0|||
144185314|NCT01190930|519873527|FG002|Induction|Death|0|||
144185315|NCT01190930|519873528|FG003|Induction|Death|0|||
144185316|NCT01190930|519873529|FG004|Induction|Death|0|||
144185317|NCT01190930|519873530|FG005|Induction|Death|0|||
144604019|NCT01093326|521412079|FG001|Overall Study|Withdrawal by Subject|27|||
144604020|NCT01093326|521412080|FG002|Overall Study|Withdrawal by Subject|26|||
144723767|NCT05568225|521844188|FG001|Extension Treatment Period|Lack of Efficacy|0|||
144604021|NCT01093326|521412078|FG000|Overall Study|Adverse Event|2|||
144185318|NCT01190930|519873531|FG006|Induction|Death|0|||
144604022|NCT01093326|521412079|FG001|Overall Study|Adverse Event|1|||
144185319|NCT01190930|519873532|FG007|Induction|Death|0|||
144185320|NCT01190930|519873533|FG008|Induction|Death|0|||
144185321|NCT01190930|519873534|FG009|Induction|Death|0|||
144604023|NCT01093326|521412080|FG002|Overall Study|Adverse Event|4|||
144185322|NCT01190930|519873525|FG000|Induction|Lost to Follow-up|1|||
144185323|NCT01190930|519873526|FG001|Induction|Lost to Follow-up|0|||
144604024|NCT01093326|521412078|FG000|Overall Study|Other|0|||
144604025|NCT01093326|521412079|FG001|Overall Study|Other|0|||
144185324|NCT01190930|519873527|FG002|Induction|Lost to Follow-up|0|||
144185325|NCT01190930|519873528|FG003|Induction|Lost to Follow-up|0|||
144185326|NCT01190930|519873529|FG004|Induction|Lost to Follow-up|0|||
144185327|NCT01190930|519873530|FG005|Induction|Lost to Follow-up|0|||
144185328|NCT01190930|519873531|FG006|Induction|Lost to Follow-up|0|||
144185329|NCT01190930|519873532|FG007|Induction|Lost to Follow-up|0|||
144185330|NCT01190930|519873533|FG008|Induction|Lost to Follow-up|0|||
144185331|NCT01190930|519873534|FG009|Induction|Lost to Follow-up|0|||
144185332|NCT01190930|519873525|FG000|Induction|Physician Decision|125|||
144185333|NCT01190930|519873526|FG001|Induction|Physician Decision|3|||
144185334|NCT01190930|519873527|FG002|Induction|Physician Decision|0|||
144185335|NCT01190930|519873528|FG003|Induction|Physician Decision|0|||
144185336|NCT01190930|519873529|FG004|Induction|Physician Decision|0|||
144185337|NCT01190930|519873530|FG005|Induction|Physician Decision|0|||
144185338|NCT01190930|519873531|FG006|Induction|Physician Decision|0|||
144185339|NCT01190930|519873532|FG007|Induction|Physician Decision|0|||
144185340|NCT01190930|519873533|FG008|Induction|Physician Decision|0|||
144185341|NCT01190930|519873534|FG009|Induction|Physician Decision|0|||
144185342|NCT01190930|519873525|FG000|Induction|Withdrawal by Subject|9|||
144185343|NCT01190930|519873526|FG001|Induction|Withdrawal by Subject|0|||
144185344|NCT01190930|519873527|FG002|Induction|Withdrawal by Subject|0|||
144185345|NCT01190930|519873528|FG003|Induction|Withdrawal by Subject|0|||
144185346|NCT01190930|519873529|FG004|Induction|Withdrawal by Subject|0|||
144185347|NCT01190930|519873530|FG005|Induction|Withdrawal by Subject|0|||
144185348|NCT01190930|519873531|FG006|Induction|Withdrawal by Subject|0|||
144185349|NCT01190930|519873532|FG007|Induction|Withdrawal by Subject|0|||
144185350|NCT01190930|519873533|FG008|Induction|Withdrawal by Subject|0|||
144185351|NCT01190930|519873534|FG009|Induction|Withdrawal by Subject|0|||
144185352|NCT01190930|519873525|FG000|Induction|Refusal|235|||
144185353|NCT01190930|519873526|FG001|Induction|Refusal|0|||
144185354|NCT01190930|519873527|FG002|Induction|Refusal|0|||
144185355|NCT01190930|519873528|FG003|Induction|Refusal|0|||
144185356|NCT01190930|519873529|FG004|Induction|Refusal|0|||
144185357|NCT01190930|519873530|FG005|Induction|Refusal|0|||
144185358|NCT01190930|519873531|FG006|Induction|Refusal|0|||
144185359|NCT01190930|519873532|FG007|Induction|Refusal|0|||
144185360|NCT01190930|519873533|FG008|Induction|Refusal|0|||
144185361|NCT01190930|519873534|FG009|Induction|Refusal|0|||
144185362|NCT01190930|519873525|FG000|Induction|Inevaluable|23|||
144185363|NCT01190930|519873526|FG001|Induction|Inevaluable|1|||
144604026|NCT01093326|521412080|FG002|Overall Study|Other|1|||
144604027|NCT04223791|521412081|FG000|Overall Study|Lost to Follow-up|0|||
144604028|NCT04223791|521412082|FG001|Overall Study|Lost to Follow-up|4|||
144604029|NCT04223791|521412081|FG000|Overall Study|Physician Decision|5|||
144604030|NCT04223791|521412082|FG001|Overall Study|Physician Decision|1|||
144604031|NCT04223791|521412081|FG000|Overall Study|Protocol Violation|1|||
144604032|NCT04223791|521412082|FG001|Overall Study|Protocol Violation|1|||
144604033|NCT04223791|521412081|FG000|Overall Study|Withdrawal by Subject|10|||
144604034|NCT04223791|521412082|FG001|Overall Study|Withdrawal by Subject|12|||
144604035|NCT04223791|521412081|FG000|Overall Study|Pregnancy|1|||
144604036|NCT04223791|521412082|FG001|Overall Study|Pregnancy|1|||
144604037|NCT04223791|521412081|FG000|Overall Study|Ongoing in Study|305|||
144604038|NCT04223791|521412082|FG001|Overall Study|Ongoing in Study|302|||
144604039|NCT02246582|521414203|FG000|Overall Study|Withdrawal by Subject|3|||
144604040|NCT02246582|521414204|FG001|Overall Study|Withdrawal by Subject|4|||
144604041|NCT03441334|521414208|FG000|Overall Study|Withdrawal by Subject|1|||
144604042|NCT03441334|521414209|FG001|Overall Study|Withdrawal by Subject|0|||
144604043|NCT02592551|521414216|FG000|Overall Study|Not evaluable|1|||
144604044|NCT02592551|521414217|FG001|Overall Study|Not evaluable|3|||
144185364|NCT01190930|519873527|FG002|Induction|Inevaluable|0|||
144604045|NCT02592551|521414218|FG002|Overall Study|Not evaluable|0|||
144185365|NCT01190930|519873528|FG003|Induction|Inevaluable|0|||
144604046|NCT01876251|521414221|FG000|Overall Study|Clinical progression|1|||
144604047|NCT01876251|521414222|FG001|Overall Study|Clinical progression|0|||
144430347|NCT02658890|520784783|FG014|Treatment Phase|Progressive Disease|6|||
144604048|NCT01876251|521414223|FG002|Overall Study|Clinical progression|0|||
144185366|NCT01190930|519873529|FG004|Induction|Inevaluable|0|||
144185367|NCT01190930|519873530|FG005|Induction|Inevaluable|0|||
144185368|NCT01190930|519873531|FG006|Induction|Inevaluable|0|||
144185369|NCT01190930|519873532|FG007|Induction|Inevaluable|0|||
144185370|NCT01190930|519873533|FG008|Induction|Inevaluable|0|||
144185371|NCT01190930|519873534|FG009|Induction|Inevaluable|0|||
144604049|NCT01876251|521414221|FG000|Overall Study|Death|2|||
144604050|NCT01876251|521414222|FG001|Overall Study|Death|0|||
144604051|NCT01876251|521414223|FG002|Overall Study|Death|1|||
144604052|NCT01876251|521414221|FG000|Overall Study|Participant started new treatment|1|||
144185372|NCT01190930|519873525|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
144185373|NCT01190930|519873526|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144185374|NCT01190930|519873527|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144185375|NCT01190930|519873528|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144185376|NCT01190930|519873529|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144185377|NCT01190930|519873530|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144604053|NCT01876251|521414222|FG001|Overall Study|Participant started new treatment|0|||
144604054|NCT01876251|521414223|FG002|Overall Study|Participant started new treatment|1|||
144604055|NCT01876251|521414221|FG000|Overall Study|Participant refused further follow-up|0|||
144604056|NCT01876251|521414222|FG001|Overall Study|Participant refused further follow-up|0|||
144604057|NCT01876251|521414223|FG002|Overall Study|Participant refused further follow-up|1|||
144604058|NCT01876251|521414221|FG000|Overall Study|Study terminated|1|||
144604059|NCT01876251|521414222|FG001|Overall Study|Study terminated|0|||
144604060|NCT01876251|521414223|FG002|Overall Study|Study terminated|0|||
144604061|NCT01876251|521414221|FG000|Overall Study|Objective progression or relapse|10|||
144604062|NCT01876251|521414222|FG001|Overall Study|Objective progression or relapse|3|||
144604063|NCT01876251|521414223|FG002|Overall Study|Objective progression or relapse|8|||
144604064|NCT03335163|521414232|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
144604065|NCT03335163|521414232|FG000|Overall Study|Withdrawal by Subject|18|||
144604066|NCT02020863|521414234|FG000|Overall Study|Discovery of Metastatic disease|4|||
144604067|NCT02020863|521414234|FG000|Overall Study|Team chose not to place an a line|1|||
144604068|NCT01920594|521414235|FG000|Overall Study|Adverse Event|4|||
144604069|NCT01920594|521414236|FG001|Overall Study|Adverse Event|2|||
144604070|NCT01920594|521414235|FG000|Overall Study|Lost to Follow-up|1|||
144604071|NCT01920594|521414236|FG001|Overall Study|Lost to Follow-up|0|||
144604072|NCT01920594|521414235|FG000|Overall Study|Recovery|2|||
144604073|NCT01920594|521414236|FG001|Overall Study|Recovery|0|||
144604074|NCT01920594|521414235|FG000|Overall Study|Investigator discretion|0|||
144604075|NCT01920594|521414236|FG001|Overall Study|Investigator discretion|1|||
144604076|NCT02460497|521414241|FG000|Overall Study|Participant Requested Withdrawal|4|||
144604077|NCT02460497|521414241|FG000|Overall Study|Non-Compliance|1|||
144604078|NCT02460497|521414241|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
144604079|NCT02460497|521414241|FG000|Overall Study|Lost to Follow-up|2|||
144604080|NCT02460497|521414241|FG000|Overall Study|Investigator Decision|1|||
144604081|NCT01650285|521414244|FG000|Overall Study|Adverse Event|1|||
144604082|NCT00659529|521414245|FG000|Overall Study|Withdrawal by Subject|4|||
144604083|NCT00659529|521414245|FG000|Overall Study|Protocol Violation|3|||
144604084|NCT00659529|521414245|FG000|Overall Study|Screen failure|9|||
144604085|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
144604086|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
144604087|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
144604088|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
144604089|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
144604090|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
144604091|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
144604092|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
144604093|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
144604094|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
144604095|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
144604096|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
144604097|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
144604098|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
144604099|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
144604100|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
144604101|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
144604102|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
144604103|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
144604104|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
144604105|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
144604106|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
144604107|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
144604108|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
144604109|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
144604110|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
144604111|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
144604112|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
144185378|NCT01190930|519873531|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144430348|NCT02658890|520784784|FG015|Treatment Phase|Progressive Disease|2|||
144604113|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
144604114|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
144604115|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
144604116|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
144604117|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
144185379|NCT01190930|519873532|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144185380|NCT01190930|519873533|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144604118|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
144604119|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
144604120|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
144604121|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
144604122|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
144604123|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
144604124|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
144604125|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
144604126|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
144604127|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
144604128|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
144604129|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
144604130|NCT03627767|521414250|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
144604131|NCT03627767|521414251|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
144604132|NCT03627767|521414252|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
144604133|NCT03627767|521414253|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
144604134|NCT03627767|521414254|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
144604135|NCT03627767|521414250|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
144604136|NCT03627767|521414251|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
144604137|NCT03627767|521414252|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
144604138|NCT03627767|521414253|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
144185381|NCT01190930|519873534|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
144185382|NCT01190930|519873525|FG000|Induction|High Risk Downs|80|||
144604139|NCT03627767|521414254|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
144604140|NCT03627767|521414250|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
144604141|NCT03627767|521414251|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
144604142|NCT03627767|521414252|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
144604143|NCT03627767|521414253|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
144604144|NCT03627767|521414254|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
144604145|NCT03627767|521414250|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
144604146|NCT03627767|521414251|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
144604147|NCT03627767|521414252|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
144604148|NCT03627767|521414253|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
144604149|NCT03627767|521414254|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
144604150|NCT03627767|521414250|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
144604151|NCT03627767|521414251|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
144604152|NCT03627767|521414252|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
144604153|NCT03627767|521414253|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
144604154|NCT03627767|521414254|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
144604155|NCT03627767|521414250|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
144604156|NCT03627767|521414251|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
144604157|NCT03627767|521414252|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
144604158|NCT03627767|521414253|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
144604159|NCT03627767|521414254|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
144604160|NCT03627767|521414250|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
144604161|NCT03627767|521414251|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
144604162|NCT03627767|521414252|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
144604163|NCT03627767|521414253|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
144604164|NCT03627767|521414254|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
144604165|NCT03627767|521414250|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
144604166|NCT03627767|521414251|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
144604167|NCT03627767|521414252|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
144604168|NCT03627767|521414253|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
144604169|NCT03627767|521414254|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
144604170|NCT03627767|521414250|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
144604171|NCT03627767|521414251|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
144604172|NCT03627767|521414252|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
144723768|NCT05568225|521844189|FG002|Extension Treatment Period|Lack of Efficacy|1|||
144185383|NCT01190930|519873526|FG001|Induction|High Risk Downs|0|||
144185384|NCT01190930|519873527|FG002|Induction|High Risk Downs|0|||
144185385|NCT01190930|519873528|FG003|Induction|High Risk Downs|0|||
144185386|NCT01190930|519873529|FG004|Induction|High Risk Downs|0|||
144604173|NCT03627767|521414253|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
144723769|NCT02228382|521844190|FG000|Overall Study|Death|5|||
144185387|NCT01190930|519873530|FG005|Induction|High Risk Downs|0|||
144185388|NCT01190930|519873531|FG006|Induction|High Risk Downs|0|||
144185389|NCT01190930|519873532|FG007|Induction|High Risk Downs|0|||
144185390|NCT01190930|519873533|FG008|Induction|High Risk Downs|0|||
144185391|NCT01190930|519873534|FG009|Induction|High Risk Downs|0|||
144185392|NCT01190930|519873525|FG000|Induction|Enrollment onto another COG Protocol|1|||
144185393|NCT01190930|519873526|FG001|Induction|Enrollment onto another COG Protocol|0|||
144185394|NCT01190930|519873527|FG002|Induction|Enrollment onto another COG Protocol|0|||
144185395|NCT01190930|519873528|FG003|Induction|Enrollment onto another COG Protocol|0|||
144185396|NCT01190930|519873529|FG004|Induction|Enrollment onto another COG Protocol|0|||
144185397|NCT01190930|519873530|FG005|Induction|Enrollment onto another COG Protocol|0|||
144185398|NCT01190930|519873531|FG006|Induction|Enrollment onto another COG Protocol|0|||
144185399|NCT01190930|519873532|FG007|Induction|Enrollment onto another COG Protocol|0|||
144185400|NCT01190930|519873533|FG008|Induction|Enrollment onto another COG Protocol|0|||
144185401|NCT01190930|519873534|FG009|Induction|Enrollment onto another COG Protocol|0|||
144185402|NCT01190930|519873525|FG000|Induction|Average Risk|1847|||
144185403|NCT01190930|519873526|FG001|Induction|Average Risk|0|||
144185404|NCT01190930|519873527|FG002|Induction|Average Risk|0|||
144185405|NCT01190930|519873528|FG003|Induction|Average Risk|0|||
144185406|NCT01190930|519873529|FG004|Induction|Average Risk|0|||
144185407|NCT01190930|519873530|FG005|Induction|Average Risk|0|||
144185408|NCT01190930|519873531|FG006|Induction|Average Risk|0|||
144185409|NCT01190930|519873532|FG007|Induction|Average Risk|0|||
144185410|NCT01190930|519873533|FG008|Induction|Average Risk|0|||
144185411|NCT01190930|519873534|FG009|Induction|Average Risk|0|||
144185412|NCT01190930|519873525|FG000|Induction|High Risk|1227|||
144185413|NCT01190930|519873526|FG001|Induction|High Risk|0|||
144185414|NCT01190930|519873527|FG002|Induction|High Risk|0|||
144185415|NCT01190930|519873528|FG003|Induction|High Risk|0|||
144185416|NCT01190930|519873529|FG004|Induction|High Risk|0|||
144185417|NCT01190930|519873530|FG005|Induction|High Risk|0|||
144185418|NCT01190930|519873531|FG006|Induction|High Risk|0|||
144185419|NCT01190930|519873532|FG007|Induction|High Risk|0|||
144185420|NCT01190930|519873533|FG008|Induction|High Risk|0|||
144185421|NCT01190930|519873534|FG009|Induction|High Risk|0|||
144185422|NCT01190930|519873525|FG000|Induction|Low Risk|443|||
144185423|NCT01190930|519873526|FG001|Induction|Low Risk|0|||
144185424|NCT01190930|519873527|FG002|Induction|Low Risk|0|||
144185425|NCT01190930|519873528|FG003|Induction|Low Risk|0|||
144185426|NCT01190930|519873529|FG004|Induction|Low Risk|0|||
144185427|NCT01190930|519873530|FG005|Induction|Low Risk|0|||
144185428|NCT01190930|519873531|FG006|Induction|Low Risk|0|||
144185429|NCT01190930|519873532|FG007|Induction|Low Risk|0|||
144185430|NCT01190930|519873533|FG008|Induction|Low Risk|0|||
144185431|NCT01190930|519873534|FG009|Induction|Low Risk|0|||
144185432|NCT01190930|519873525|FG000|Induction|Very High Risk|1012|||
144185433|NCT01190930|519873526|FG001|Induction|Very High Risk|0|||
144185434|NCT01190930|519873527|FG002|Induction|Very High Risk|0|||
144185435|NCT01190930|519873528|FG003|Induction|Very High Risk|0|||
144185436|NCT01190930|519873529|FG004|Induction|Very High Risk|0|||
144185437|NCT01190930|519873530|FG005|Induction|Very High Risk|0|||
144185438|NCT01190930|519873531|FG006|Induction|Very High Risk|0|||
144185439|NCT01190930|519873532|FG007|Induction|Very High Risk|0|||
144185440|NCT01190930|519873533|FG008|Induction|Very High Risk|0|||
144185441|NCT01190930|519873534|FG009|Induction|Very High Risk|0|||
144185442|NCT01190930|519873525|FG000|Induction|Philadelphia chromosome-positive|99|||
144185443|NCT01190930|519873526|FG001|Induction|Philadelphia chromosome-positive|0|||
144185444|NCT01190930|519873527|FG002|Induction|Philadelphia chromosome-positive|0|||
144185445|NCT01190930|519873528|FG003|Induction|Philadelphia chromosome-positive|0|||
144185446|NCT01190930|519873529|FG004|Induction|Philadelphia chromosome-positive|0|||
144185447|NCT01190930|519873530|FG005|Induction|Philadelphia chromosome-positive|0|||
144185448|NCT01190930|519873531|FG006|Induction|Philadelphia chromosome-positive|0|||
144185449|NCT01190930|519873532|FG007|Induction|Philadelphia chromosome-positive|0|||
144185450|NCT01190930|519873533|FG008|Induction|Philadelphia chromosome-positive|0|||
144185451|NCT01190930|519873534|FG009|Induction|Philadelphia chromosome-positive|0|||
144185452|NCT01190930|519873525|FG000|Induction|Incomplete Induction data|63|||
144185453|NCT01190930|519873526|FG001|Induction|Incomplete Induction data|0|||
144185454|NCT01190930|519873527|FG002|Induction|Incomplete Induction data|0|||
144185455|NCT01190930|519873528|FG003|Induction|Incomplete Induction data|0|||
144252161|NCT01863732|520122693|FG002|Overall Study|Lost to Follow-up|1|||
144185456|NCT01190930|519873529|FG004|Induction|Incomplete Induction data|0|||
144185457|NCT01190930|519873530|FG005|Induction|Incomplete Induction data|0|||
144185458|NCT01190930|519873531|FG006|Induction|Incomplete Induction data|0|||
144430349|NCT02658890|520784785|FG016|Treatment Phase|Progressive Disease|32|||
144185459|NCT01190930|519873532|FG007|Induction|Incomplete Induction data|0|||
144430350|NCT02658890|520784786|FG017|Treatment Phase|Progressive Disease|14|||
144185460|NCT01190930|519873533|FG008|Induction|Incomplete Induction data|0|||
144185461|NCT01190930|519873534|FG009|Induction|Incomplete Induction data|0|||
144185462|NCT01190930|519873525|FG000|Induction|Progressive disease|0|||
144185463|NCT01190930|519873526|FG001|Induction|Progressive disease|1|||
144185464|NCT01190930|519873527|FG002|Induction|Progressive disease|0|||
144430351|NCT02658890|520784787|FG018|Treatment Phase|Progressive Disease|40|||
144430352|NCT02658890|520784788|FG019|Treatment Phase|Progressive Disease|32|||
144430353|NCT02658890|520784789|FG020|Treatment Phase|Progressive Disease|19|||
144430354|NCT02658890|520784790|FG021|Treatment Phase|Progressive Disease|30|||
144430355|NCT02658890|520784791|FG022|Treatment Phase|Progressive Disease|15|||
144430356|NCT02658890|520784792|FG023|Treatment Phase|Progressive Disease|0|||
144430357|NCT02658890|520784793|FG024|Treatment Phase|Progressive Disease|0|||
144185465|NCT01190930|519873528|FG003|Induction|Progressive disease|0|||
144185466|NCT01190930|519873529|FG004|Induction|Progressive disease|0|||
144185467|NCT01190930|519873530|FG005|Induction|Progressive disease|0|||
144185468|NCT01190930|519873531|FG006|Induction|Progressive disease|0|||
144185469|NCT01190930|519873532|FG007|Induction|Progressive disease|0|||
144185470|NCT01190930|519873533|FG008|Induction|Progressive disease|0|||
144185471|NCT01190930|519873534|FG009|Induction|Progressive disease|0|||
144185472|NCT01190930|519873525|FG000|Induction|No treatment|3|||
144185473|NCT01190930|519873526|FG001|Induction|No treatment|0|||
144185474|NCT01190930|519873527|FG002|Induction|No treatment|0|||
144185475|NCT01190930|519873528|FG003|Induction|No treatment|0|||
144185476|NCT01190930|519873529|FG004|Induction|No treatment|0|||
144185477|NCT01190930|519873530|FG005|Induction|No treatment|0|||
144185478|NCT01190930|519873531|FG006|Induction|No treatment|0|||
144185479|NCT01190930|519873532|FG007|Induction|No treatment|0|||
144185480|NCT01190930|519873533|FG008|Induction|No treatment|0|||
144185481|NCT01190930|519873534|FG009|Induction|No treatment|0|||
144185482|NCT01190930|519873525|FG000|Induction|Ineligible|69|||
144185483|NCT01190930|519873526|FG001|Induction|Ineligible|4|||
144185484|NCT01190930|519873527|FG002|Induction|Ineligible|0|||
144185485|NCT01190930|519873528|FG003|Induction|Ineligible|0|||
144185486|NCT01190930|519873529|FG004|Induction|Ineligible|0|||
144185487|NCT01190930|519873530|FG005|Induction|Ineligible|0|||
144185488|NCT01190930|519873531|FG006|Induction|Ineligible|0|||
144185489|NCT01190930|519873532|FG007|Induction|Ineligible|0|||
144185490|NCT01190930|519873533|FG008|Induction|Ineligible|0|||
144185491|NCT01190930|519873534|FG009|Induction|Ineligible|0|||
144185492|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
144185493|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
144185494|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
144185495|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
144185496|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
144185497|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
144185498|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
144185499|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
144185500|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
144185501|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
144185502|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Death|0|||
144185503|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Death|0|||
144185504|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Death|8|||
144185505|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Death|4|||
144185506|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Death|0|||
144185507|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Death|0|||
144185508|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Death|0|||
144185509|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Death|0|||
144185510|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Death|0|||
144185511|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Death|0|||
144185512|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
144185513|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
144185514|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
144185515|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
144185516|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
144185517|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
144185518|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
144185519|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
144185520|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
144185521|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
144185522|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144185523|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
144185524|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
144185525|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
144185526|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144185527|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144185528|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144185529|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144185530|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144185531|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
144430358|NCT02658890|520784794|FG025|Treatment Phase|Progressive Disease|14|||
144185532|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Refusal|0|||
144723770|NCT02228382|521844191|FG001|Overall Study|Death|7|||
144723771|NCT02228382|521844192|FG002|Overall Study|Death|5|||
144723772|NCT02228382|521844193|FG003|Overall Study|Death|0|||
144723773|NCT02228382|521844194|FG004|Overall Study|Death|2|||
144723774|NCT02228382|521844190|FG000|Overall Study|Participant refused further follow-up|0|||
144723775|NCT02228382|521844191|FG001|Overall Study|Participant refused further follow-up|0|||
144723776|NCT02228382|521844192|FG002|Overall Study|Participant refused further follow-up|1|||
144723777|NCT02228382|521844193|FG003|Overall Study|Participant refused further follow-up|0|||
144185533|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Refusal|2|||
144185534|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Refusal|694|||
144185535|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Refusal|4|||
144185536|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Refusal|0|||
144185537|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Refusal|3|||
144185538|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Refusal|0|||
144185539|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Refusal|0|||
144185540|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Refusal|0|||
144185541|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Refusal|0|||
144185542|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
144185543|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
144185544|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
144185545|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
144185546|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
144185547|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
144185548|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
144185549|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
144185550|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
144185551|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
144185552|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185553|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
144185554|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185555|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185556|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185557|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185558|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185559|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185560|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185561|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
144185562|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
144185563|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
144185564|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
144185565|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
144185566|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
144185567|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
144185568|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
144185569|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
144185570|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
144185571|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
144185572|NCT01190930|519873525|FG000|Post Induction Pre-Maintenance|Relapse|0|||
144185573|NCT01190930|519873526|FG001|Post Induction Pre-Maintenance|Relapse|0|||
144185574|NCT01190930|519873527|FG002|Post Induction Pre-Maintenance|Relapse|1|||
144185575|NCT01190930|519873528|FG003|Post Induction Pre-Maintenance|Relapse|0|||
144185576|NCT01190930|519873529|FG004|Post Induction Pre-Maintenance|Relapse|0|||
144185577|NCT01190930|519873530|FG005|Post Induction Pre-Maintenance|Relapse|0|||
144185578|NCT01190930|519873531|FG006|Post Induction Pre-Maintenance|Relapse|0|||
144185579|NCT01190930|519873532|FG007|Post Induction Pre-Maintenance|Relapse|0|||
144185580|NCT01190930|519873533|FG008|Post Induction Pre-Maintenance|Relapse|0|||
144185581|NCT01190930|519873534|FG009|Post Induction Pre-Maintenance|Relapse|0|||
144185582|NCT01190930|519873525|FG000|Maintenance|Adverse Event|0|||
144185583|NCT01190930|519873526|FG001|Maintenance|Adverse Event|0|||
144185584|NCT01190930|519873527|FG002|Maintenance|Adverse Event|0|||
144185585|NCT01190930|519873528|FG003|Maintenance|Adverse Event|0|||
144185586|NCT01190930|519873529|FG004|Maintenance|Adverse Event|0|||
144185587|NCT01190930|519873530|FG005|Maintenance|Adverse Event|1|||
144430359|NCT02658890|520784795|FG026|Treatment Phase|Progressive Disease|11|||
144430360|NCT02658890|520784769|FG000|Treatment Phase|Study Drug Toxicity|0|||
144185588|NCT01190930|519873531|FG006|Maintenance|Adverse Event|1|||
144185589|NCT01190930|519873532|FG007|Maintenance|Adverse Event|3|||
144185590|NCT01190930|519873533|FG008|Maintenance|Adverse Event|3|||
144185591|NCT01190930|519873534|FG009|Maintenance|Adverse Event|0|||
144185592|NCT01190930|519873525|FG000|Maintenance|Death|0|||
144723778|NCT02228382|521844194|FG004|Overall Study|Participant refused further follow-up|0|||
144723779|NCT02228382|521844190|FG000|Overall Study|Study terminated by sponsor|3|||
144723780|NCT02228382|521844191|FG001|Overall Study|Study terminated by sponsor|5|||
144723781|NCT02228382|521844192|FG002|Overall Study|Study terminated by sponsor|7|||
144723782|NCT02228382|521844193|FG003|Overall Study|Study terminated by sponsor|0|||
144723783|NCT02228382|521844194|FG004|Overall Study|Study terminated by sponsor|0|||
144723784|NCT02228382|521844190|FG000|Overall Study|Lost to Follow-up|0|||
144723785|NCT02228382|521844191|FG001|Overall Study|Lost to Follow-up|0|||
144723786|NCT02228382|521844192|FG002|Overall Study|Lost to Follow-up|3|||
144723787|NCT02228382|521844193|FG003|Overall Study|Lost to Follow-up|1|||
144723788|NCT02228382|521844194|FG004|Overall Study|Lost to Follow-up|0|||
144723789|NCT02228382|521844190|FG000|Overall Study|Withdrawal by Subject|0|||
144723790|NCT02228382|521844191|FG001|Overall Study|Withdrawal by Subject|3|||
144723791|NCT02228382|521844192|FG002|Overall Study|Withdrawal by Subject|2|||
144723792|NCT02228382|521844193|FG003|Overall Study|Withdrawal by Subject|1|||
144723793|NCT02228382|521844194|FG004|Overall Study|Withdrawal by Subject|0|||
144723794|NCT02228382|521844190|FG000|Overall Study|Other|2|||
144723795|NCT02228382|521844191|FG001|Overall Study|Other|3|||
144723796|NCT02228382|521844192|FG002|Overall Study|Other|3|||
144723797|NCT02228382|521844193|FG003|Overall Study|Other|0|||
144185593|NCT01190930|519873526|FG001|Maintenance|Death|0|||
144185594|NCT01190930|519873527|FG002|Maintenance|Death|0|||
144185595|NCT01190930|519873528|FG003|Maintenance|Death|1|||
144185596|NCT01190930|519873529|FG004|Maintenance|Death|0|||
144185597|NCT01190930|519873530|FG005|Maintenance|Death|0|||
144185598|NCT01190930|519873531|FG006|Maintenance|Death|2|||
144185599|NCT01190930|519873532|FG007|Maintenance|Death|2|||
144185600|NCT01190930|519873533|FG008|Maintenance|Death|2|||
144185601|NCT01190930|519873534|FG009|Maintenance|Death|2|||
144185602|NCT01190930|519873525|FG000|Maintenance|Lost to Follow-up|0|||
144185603|NCT01190930|519873526|FG001|Maintenance|Lost to Follow-up|0|||
144185604|NCT01190930|519873527|FG002|Maintenance|Lost to Follow-up|0|||
144185605|NCT01190930|519873528|FG003|Maintenance|Lost to Follow-up|0|||
144185606|NCT01190930|519873529|FG004|Maintenance|Lost to Follow-up|0|||
144185607|NCT01190930|519873530|FG005|Maintenance|Lost to Follow-up|0|||
144185608|NCT01190930|519873531|FG006|Maintenance|Lost to Follow-up|1|||
144185609|NCT01190930|519873532|FG007|Maintenance|Lost to Follow-up|1|||
144185610|NCT01190930|519873533|FG008|Maintenance|Lost to Follow-up|1|||
144185611|NCT01190930|519873534|FG009|Maintenance|Lost to Follow-up|0|||
144185612|NCT01190930|519873525|FG000|Maintenance|Physician Decision|0|||
144185613|NCT01190930|519873526|FG001|Maintenance|Physician Decision|1|||
144185614|NCT01190930|519873527|FG002|Maintenance|Physician Decision|0|||
144185615|NCT01190930|519873528|FG003|Maintenance|Physician Decision|5|||
144185616|NCT01190930|519873529|FG004|Maintenance|Physician Decision|9|||
144185617|NCT01190930|519873530|FG005|Maintenance|Physician Decision|4|||
144185618|NCT01190930|519873531|FG006|Maintenance|Physician Decision|8|||
144185619|NCT01190930|519873532|FG007|Maintenance|Physician Decision|8|||
144185620|NCT01190930|519873533|FG008|Maintenance|Physician Decision|10|||
144185621|NCT01190930|519873534|FG009|Maintenance|Physician Decision|17|||
144185622|NCT01190930|519873525|FG000|Maintenance|Withdrawal by Subject|0|||
144185623|NCT01190930|519873526|FG001|Maintenance|Withdrawal by Subject|0|||
144185624|NCT01190930|519873527|FG002|Maintenance|Withdrawal by Subject|0|||
144185625|NCT01190930|519873528|FG003|Maintenance|Withdrawal by Subject|0|||
144185626|NCT01190930|519873529|FG004|Maintenance|Withdrawal by Subject|0|||
144185627|NCT01190930|519873530|FG005|Maintenance|Withdrawal by Subject|0|||
144185628|NCT01190930|519873531|FG006|Maintenance|Withdrawal by Subject|2|||
144185629|NCT01190930|519873532|FG007|Maintenance|Withdrawal by Subject|1|||
144185630|NCT01190930|519873533|FG008|Maintenance|Withdrawal by Subject|4|||
144185631|NCT01190930|519873534|FG009|Maintenance|Withdrawal by Subject|1|||
144185632|NCT01190930|519873525|FG000|Maintenance|Refusal|0|||
144185633|NCT01190930|519873526|FG001|Maintenance|Refusal|1|||
144185634|NCT01190930|519873527|FG002|Maintenance|Refusal|0|||
144185635|NCT01190930|519873528|FG003|Maintenance|Refusal|2|||
144185636|NCT01190930|519873529|FG004|Maintenance|Refusal|0|||
144185637|NCT01190930|519873530|FG005|Maintenance|Refusal|4|||
144185638|NCT01190930|519873531|FG006|Maintenance|Refusal|5|||
144185639|NCT01190930|519873532|FG007|Maintenance|Refusal|17|||
144185640|NCT01190930|519873533|FG008|Maintenance|Refusal|13|||
144430361|NCT02658890|520784770|FG001|Treatment Phase|Study Drug Toxicity|0|||
144185641|NCT01190930|519873534|FG009|Maintenance|Refusal|6|||
144430362|NCT02658890|520784771|FG002|Treatment Phase|Study Drug Toxicity|2|||
144185642|NCT01190930|519873525|FG000|Maintenance|second malignant neoplasm|0|||
144185643|NCT01190930|519873526|FG001|Maintenance|second malignant neoplasm|0|||
144430363|NCT02658890|520784772|FG003|Treatment Phase|Study Drug Toxicity|0|||
144185644|NCT01190930|519873527|FG002|Maintenance|second malignant neoplasm|0|||
144185645|NCT01190930|519873528|FG003|Maintenance|second malignant neoplasm|1|||
144185646|NCT01190930|519873529|FG004|Maintenance|second malignant neoplasm|0|||
144185647|NCT01190930|519873530|FG005|Maintenance|second malignant neoplasm|1|||
144723798|NCT02228382|521844194|FG004|Overall Study|Other|0|||
144723799|NCT00576381|521844198|FG000|Overall Study|Reoperation|3|||
144185648|NCT01190930|519873531|FG006|Maintenance|second malignant neoplasm|0|||
144185649|NCT01190930|519873532|FG007|Maintenance|second malignant neoplasm|0|||
144185650|NCT01190930|519873533|FG008|Maintenance|second malignant neoplasm|1|||
144723800|NCT00576381|521844198|FG000|Overall Study|Adverse Event|4|||
144185651|NCT01190930|519873534|FG009|Maintenance|second malignant neoplasm|0|||
144185652|NCT01190930|519873525|FG000|Maintenance|Inevaluable|0|||
144185653|NCT01190930|519873526|FG001|Maintenance|Inevaluable|0|||
144185654|NCT01190930|519873527|FG002|Maintenance|Inevaluable|0|||
144185655|NCT01190930|519873528|FG003|Maintenance|Inevaluable|0|||
144185656|NCT01190930|519873529|FG004|Maintenance|Inevaluable|0|||
144185657|NCT01190930|519873530|FG005|Maintenance|Inevaluable|1|||
144185658|NCT01190930|519873531|FG006|Maintenance|Inevaluable|1|||
144185659|NCT01190930|519873532|FG007|Maintenance|Inevaluable|1|||
144185660|NCT01190930|519873533|FG008|Maintenance|Inevaluable|0|||
144185661|NCT01190930|519873534|FG009|Maintenance|Inevaluable|0|||
144185662|NCT01190930|519873525|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
144185663|NCT01190930|519873526|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
144185664|NCT01190930|519873527|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
144185665|NCT01190930|519873528|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
144185666|NCT01190930|519873529|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
144185667|NCT01190930|519873530|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
144185668|NCT01190930|519873531|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
144185669|NCT01190930|519873532|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
144185670|NCT01190930|519873533|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
144185671|NCT01190930|519873534|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
144185672|NCT01190930|519873525|FG000|Maintenance|Relapse|0|||
144185673|NCT01190930|519873526|FG001|Maintenance|Relapse|0|||
144185674|NCT01190930|519873527|FG002|Maintenance|Relapse|0|||
144185675|NCT01190930|519873528|FG003|Maintenance|Relapse|2|||
144185676|NCT01190930|519873529|FG004|Maintenance|Relapse|0|||
144185677|NCT01190930|519873530|FG005|Maintenance|Relapse|1|||
144185678|NCT01190930|519873531|FG006|Maintenance|Relapse|6|||
144430364|NCT02658890|520784773|FG004|Treatment Phase|Study Drug Toxicity|0|||
144430365|NCT02658890|520784774|FG005|Treatment Phase|Study Drug Toxicity|0|||
144430366|NCT02658890|520784775|FG006|Treatment Phase|Study Drug Toxicity|0|||
144430367|NCT02658890|520784776|FG007|Treatment Phase|Study Drug Toxicity|0|||
144430368|NCT02658890|520784777|FG008|Treatment Phase|Study Drug Toxicity|3|||
144430369|NCT02658890|520784778|FG009|Treatment Phase|Study Drug Toxicity|0|||
144430370|NCT02658890|520784779|FG010|Treatment Phase|Study Drug Toxicity|1|||
144430371|NCT02658890|520784780|FG011|Treatment Phase|Study Drug Toxicity|1|||
144430372|NCT02658890|520784781|FG012|Treatment Phase|Study Drug Toxicity|2|||
144430373|NCT02658890|520784782|FG013|Treatment Phase|Study Drug Toxicity|9|||
144430374|NCT02658890|520784783|FG014|Treatment Phase|Study Drug Toxicity|0|||
144430375|NCT02658890|520784784|FG015|Treatment Phase|Study Drug Toxicity|1|||
144430376|NCT02658890|520784785|FG016|Treatment Phase|Study Drug Toxicity|1|||
144430377|NCT02658890|520784786|FG017|Treatment Phase|Study Drug Toxicity|0|||
144430378|NCT02658890|520784787|FG018|Treatment Phase|Study Drug Toxicity|8|||
144430379|NCT02658890|520784788|FG019|Treatment Phase|Study Drug Toxicity|3|||
144430380|NCT02658890|520784789|FG020|Treatment Phase|Study Drug Toxicity|2|||
144430381|NCT02658890|520784790|FG021|Treatment Phase|Study Drug Toxicity|0|||
144430382|NCT02658890|520784791|FG022|Treatment Phase|Study Drug Toxicity|8|||
144529047|NCT03088878|521139160|FG000|Overall Study|Disease Progression|1|||
144430383|NCT02658890|520784792|FG023|Treatment Phase|Study Drug Toxicity|0|||
144430384|NCT02658890|520784793|FG024|Treatment Phase|Study Drug Toxicity|0|||
144430385|NCT02658890|520784794|FG025|Treatment Phase|Study Drug Toxicity|2|||
144529048|NCT03088878|521139161|FG001|Overall Study|Disease Progression|2|||
144529049|NCT03088878|521139162|FG002|Overall Study|Disease Progression|3|||
144529050|NCT03088878|521139163|FG003|Overall Study|Disease Progression|0|||
144529051|NCT03088878|521139164|FG004|Overall Study|Disease Progression|3|||
144529052|NCT03088878|521139165|FG005|Overall Study|Disease Progression|0|||
144185679|NCT01190930|519873532|FG007|Maintenance|Relapse|13|||
144185680|NCT01190930|519873533|FG008|Maintenance|Relapse|11|||
144185681|NCT01190930|519873534|FG009|Maintenance|Relapse|11|||
144185682|NCT01190930|519873525|FG000|Maintenance|Still on therapy|0|||
144185683|NCT01190930|519873526|FG001|Maintenance|Still on therapy|8|||
144185684|NCT01190930|519873527|FG002|Maintenance|Still on therapy|0|||
144185685|NCT01190930|519873528|FG003|Maintenance|Still on therapy|29|||
144185686|NCT01190930|519873529|FG004|Maintenance|Still on therapy|0|||
144185687|NCT01190930|519873530|FG005|Maintenance|Still on therapy|0|||
144185688|NCT01190930|519873531|FG006|Maintenance|Still on therapy|0|||
144185689|NCT01190930|519873532|FG007|Maintenance|Still on therapy|0|||
144185690|NCT01190930|519873533|FG008|Maintenance|Still on therapy|0|||
144185691|NCT01190930|519873534|FG009|Maintenance|Still on therapy|0|||
144185692|NCT02448563|519873539|FG000|Overall Study|Lost to Follow-up|16|||
144430386|NCT02658890|520784795|FG026|Treatment Phase|Study Drug Toxicity|0|||
144430387|NCT02658890|520784769|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430388|NCT02658890|520784770|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430389|NCT02658890|520784771|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144529053|NCT03088878|521139166|FG006|Overall Study|Disease Progression|0|||
144529054|NCT03088878|521139167|FG007|Overall Study|Disease Progression|0|||
144185693|NCT02448563|519873540|FG001|Overall Study|Lost to Follow-up|10|||
144185694|NCT02448563|519873539|FG000|Overall Study|Withdrawal by Subject|0|||
144430390|NCT02658890|520784772|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
144604174|NCT03627767|521414254|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
144604175|NCT03627767|521414250|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
144604176|NCT03627767|521414251|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
144604177|NCT03627767|521414252|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
144604178|NCT03627767|521414253|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
144723801|NCT02324465|521844202|FG000|Overall Study|device failure|0|||
144185695|NCT02448563|519873540|FG001|Overall Study|Withdrawal by Subject|1|||
144185696|NCT00113919|519873542|FG000|Overall Study|Physician Decision|8|||
144185697|NCT00113919|519873542|FG000|Overall Study|Death|6|||
144185698|NCT02340962|519873543|FG000|Overall Study|Lost to Follow-up|1|||
144185699|NCT02340962|519873544|FG001|Overall Study|Lost to Follow-up|0|||
144185700|NCT02914457|519873545|FG000|Overall Study|Withdrawal by Subject|1|||
144185701|NCT02914457|519873545|FG000|Overall Study|Physician Decision|1|||
144185702|NCT02914457|519873545|FG000|Overall Study|No veins available for lead placement|1|||
144185703|NCT02914457|519873545|FG000|Overall Study|Electrical instability of patient|1|||
144185704|NCT02914457|519873545|FG000|Overall Study|ECG acquisition error due to sweating|1|||
144185705|NCT02914457|519873545|FG000|Overall Study|Protocol Violation|1|||
144185706|NCT02661022|519873549|FG000|Overall Study|Withdrawal by Subject|3|||
144185707|NCT02661022|519873550|FG001|Overall Study|Withdrawal by Subject|0|||
144185708|NCT02661022|519873549|FG000|Overall Study|Adverse Event|1|||
144185709|NCT02661022|519873550|FG001|Overall Study|Adverse Event|1|||
144185710|NCT02661022|519873549|FG000|Overall Study|Physician Decision|1|||
144185711|NCT02661022|519873550|FG001|Overall Study|Physician Decision|0|||
144185712|NCT02661022|519873549|FG000|Overall Study|Progressive Disease|2|||
144185713|NCT02661022|519873550|FG001|Overall Study|Progressive Disease|1|||
144185714|NCT01055886|519873551|FG000|Overall Study|Withdrawal by Subject|4|||
144185715|NCT01055886|519873552|FG001|Overall Study|Withdrawal by Subject|9|||
144185716|NCT01055886|519873551|FG000|Overall Study|Lost to Follow-up|1|||
144185717|NCT01055886|519873552|FG001|Overall Study|Lost to Follow-up|1|||
144185718|NCT01055886|519873551|FG000|Overall Study|Withdrawal by PI|0|||
144185719|NCT01055886|519873552|FG001|Overall Study|Withdrawal by PI|1|||
144185720|NCT04531527|519873553|FG000|Overall Study|Found to be Ineligible|3|||
144185721|NCT00434837|519873558|FG000|Overall Study|Lost to Follow-up|20|||
144185722|NCT00434837|519873559|FG001|Overall Study|Lost to Follow-up|23|||
144185723|NCT00434837|519873560|FG002|Overall Study|Lost to Follow-up|30|||
144185724|NCT01785615|519873561|FG000|Dietary Phase|Lost to Follow-up|0|||
144185725|NCT01785615|519873562|FG001|Dietary Phase|Lost to Follow-up|0|||
144185726|NCT01785615|519873563|FG002|Dietary Phase|Lost to Follow-up|0|||
144185727|NCT01785615|519873564|FG003|Dietary Phase|Lost to Follow-up|24|||
144185728|NCT01881737|519873565|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
144185729|NCT01881737|519873565|FG000|Overall Study|Withdrawal by Subject|1|||
144185730|NCT01881737|519873565|FG000|Overall Study|Worsening of baseline behavior|1|||
144185731|NCT02058160|519873570|FG000|Overall Study|Randomized but not treated|2|||
144185732|NCT02058160|519873571|FG001|Overall Study|Randomized but not treated|4|||
144185733|NCT02058160|519873570|FG000|Overall Study|Poor compliance to protocol|4|||
144185734|NCT02058160|519873571|FG001|Overall Study|Poor compliance to protocol|1|||
144185735|NCT02058160|519873570|FG000|Overall Study|Adverse Event|12|||
144185736|NCT02058160|519873571|FG001|Overall Study|Adverse Event|3|||
144185737|NCT02058160|519873570|FG000|Overall Study|Lost to Follow-up|1|||
144185738|NCT02058160|519873571|FG001|Overall Study|Lost to Follow-up|0|||
144185739|NCT02058160|519873570|FG000|Overall Study|Other than specified above|12|||
144185740|NCT02058160|519873571|FG001|Overall Study|Other than specified above|6|||
144185741|NCT01266603|519873577|FG000|Overall Study|Adverse Event|1|||
144185742|NCT01266603|519873577|FG000|Overall Study|Lack of Efficacy|14|||
144185743|NCT01266603|519873577|FG000|Overall Study|Withdrawal by Subject|1|||
144185744|NCT01266603|519873577|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
144185745|NCT00398073|519873584|FG000|Overall Study|Withdrawal by Subject|1|||
144185746|NCT00398073|519873585|FG001|Overall Study|Withdrawal by Subject|0|||
144185747|NCT01263561|519873586|FG000|Overall Study|Death|1|||
144185748|NCT01263561|519873587|FG001|Overall Study|Death|2|||
144185749|NCT04203667|519873588|FG000|Overall Study|Withdrawal by Subject|1|||
144185750|NCT04203667|519873588|FG000|Overall Study|Lost to Follow-up|1|||
144185751|NCT04203667|519873588|FG000|Overall Study|Death|1|||
144185752|NCT04203667|519873588|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
144185753|NCT01833169|519873592|FG000|Overall Study|Disease Progression|99|||
144185754|NCT01833169|519873592|FG000|Overall Study|Adverse Event|33|||
144185755|NCT01833169|519873592|FG000|Overall Study|Withdrawal by Subject|9|||
144185756|NCT01833169|519873592|FG000|Overall Study|Death|3|||
144185757|NCT01833169|519873592|FG000|Overall Study|Physician Decision|2|||
144185758|NCT01183884|519873593|FG000|Overall Study|Progressive Disease|26|||
144185759|NCT01183884|519873593|FG000|Overall Study|Adverse Event|3|||
144185760|NCT01183884|519873593|FG000|Overall Study|Withdrawal by Subject|1|||
144185761|NCT01183884|519873593|FG000|Overall Study|Other Complicating Disease|3|||
144185762|NCT01183884|519873593|FG000|Overall Study|Not Treated|1|||
144185763|NCT01183884|519873593|FG000|Overall Study|Other|4|||
144430391|NCT02658890|520784773|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144252162|NCT01863732|520122694|FG003|Overall Study|Lost to Follow-up|1|||
144252163|NCT01863732|520122691|FG000|Overall Study|Physician Decision|1|||
144252164|NCT01863732|520122692|FG001|Overall Study|Physician Decision|0|||
144252165|NCT01863732|520122693|FG002|Overall Study|Physician Decision|1|||
144252166|NCT01863732|520122694|FG003|Overall Study|Physician Decision|0|||
144252167|NCT01863732|520122691|FG000|Overall Study|Pregnancy|0|||
144252168|NCT01863732|520122692|FG001|Overall Study|Pregnancy|0|||
144252169|NCT01863732|520122693|FG002|Overall Study|Pregnancy|0|||
144252170|NCT01863732|520122694|FG003|Overall Study|Pregnancy|1|||
144252171|NCT01863732|520122691|FG000|Overall Study|Technical problems|0|||
144252172|NCT01863732|520122692|FG001|Overall Study|Technical problems|1|||
144252173|NCT01863732|520122693|FG002|Overall Study|Technical problems|1|||
144252174|NCT01863732|520122694|FG003|Overall Study|Technical problems|0|||
144430392|NCT02658890|520784774|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430393|NCT02658890|520784775|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430394|NCT02658890|520784776|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430395|NCT02658890|520784777|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430396|NCT02658890|520784778|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
144430397|NCT02658890|520784779|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430398|NCT02658890|520784780|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430399|NCT02658890|520784781|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430400|NCT02658890|520784782|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430401|NCT02658890|520784783|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430402|NCT02658890|520784784|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430403|NCT02658890|520784785|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430404|NCT02658890|520784786|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430405|NCT02658890|520784787|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
144430406|NCT02658890|520784788|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430407|NCT02658890|520784789|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430408|NCT02658890|520784790|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430409|NCT02658890|520784791|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
144430410|NCT02658890|520784792|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430411|NCT02658890|520784793|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430412|NCT02658890|520784794|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430413|NCT02658890|520784795|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
144430414|NCT02658890|520784769|FG000|Treatment Phase|Withdrawal by Subject|0|||
144430415|NCT02658890|520784770|FG001|Treatment Phase|Withdrawal by Subject|1|||
144430416|NCT02658890|520784771|FG002|Treatment Phase|Withdrawal by Subject|0|||
144430417|NCT02658890|520784772|FG003|Treatment Phase|Withdrawal by Subject|0|||
144430418|NCT02658890|520784773|FG004|Treatment Phase|Withdrawal by Subject|0|||
144430419|NCT02658890|520784774|FG005|Treatment Phase|Withdrawal by Subject|0|||
144430420|NCT02658890|520784775|FG006|Treatment Phase|Withdrawal by Subject|1|||
144430421|NCT02658890|520784776|FG007|Treatment Phase|Withdrawal by Subject|0|||
144430422|NCT02658890|520784777|FG008|Treatment Phase|Withdrawal by Subject|0|||
144430423|NCT02658890|520784778|FG009|Treatment Phase|Withdrawal by Subject|1|||
144430424|NCT02658890|520784779|FG010|Treatment Phase|Withdrawal by Subject|0|||
144430425|NCT02658890|520784780|FG011|Treatment Phase|Withdrawal by Subject|0|||
144430426|NCT02658890|520784781|FG012|Treatment Phase|Withdrawal by Subject|1|||
144430427|NCT02658890|520784782|FG013|Treatment Phase|Withdrawal by Subject|3|||
144430428|NCT02658890|520784783|FG014|Treatment Phase|Withdrawal by Subject|0|||
144430429|NCT02658890|520784784|FG015|Treatment Phase|Withdrawal by Subject|0|||
144430430|NCT02658890|520784785|FG016|Treatment Phase|Withdrawal by Subject|1|||
144430431|NCT02658890|520784786|FG017|Treatment Phase|Withdrawal by Subject|0|||
144430432|NCT02658890|520784787|FG018|Treatment Phase|Withdrawal by Subject|4|||
144430433|NCT02658890|520784788|FG019|Treatment Phase|Withdrawal by Subject|3|||
144430434|NCT02658890|520784789|FG020|Treatment Phase|Withdrawal by Subject|0|||
144430435|NCT02658890|520784790|FG021|Treatment Phase|Withdrawal by Subject|4|||
144430436|NCT02658890|520784791|FG022|Treatment Phase|Withdrawal by Subject|1|||
144430437|NCT02658890|520784792|FG023|Treatment Phase|Withdrawal by Subject|1|||
144430438|NCT02658890|520784793|FG024|Treatment Phase|Withdrawal by Subject|0|||
144604179|NCT03627767|521414254|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
144604180|NCT03627767|521414250|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
144252175|NCT01863732|520122691|FG000|Overall Study|Subject/guardian decision|6|||
144430439|NCT02658890|520784794|FG025|Treatment Phase|Withdrawal by Subject|0|||
144430440|NCT02658890|520784795|FG026|Treatment Phase|Withdrawal by Subject|0|||
144430441|NCT02474199|520784799|FG000|Overall Study|Lost to Follow-up|1|||
144604181|NCT03627767|521414251|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
144723802|NCT02324465|521844203|FG001|Overall Study|device failure|1|||
144252176|NCT01863732|520122692|FG001|Overall Study|Subject/guardian decision|9|||
144252177|NCT01863732|520122693|FG002|Overall Study|Subject/guardian decision|3|||
144252178|NCT01863732|520122694|FG003|Overall Study|Subject/guardian decision|1|||
144252179|NCT01863732|520122691|FG000|Overall Study|Death|1|||
144430442|NCT02474199|520784800|FG001|Overall Study|Lost to Follow-up|0|||
144430443|NCT02474199|520784801|FG002|Overall Study|Lost to Follow-up|0|||
144430444|NCT02474199|520784802|FG003|Overall Study|Lost to Follow-up|0|||
144430445|NCT02474199|520784799|FG000|Overall Study|Withdrawal by Subject|1|||
144430446|NCT02474199|520784800|FG001|Overall Study|Withdrawal by Subject|2|||
144430447|NCT02474199|520784801|FG002|Overall Study|Withdrawal by Subject|0|||
144430448|NCT02474199|520784802|FG003|Overall Study|Withdrawal by Subject|1|||
144430449|NCT02474199|520784799|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
144430450|NCT02474199|520784800|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
144430451|NCT02474199|520784801|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
144430452|NCT02474199|520784802|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
144430453|NCT02474199|520784799|FG000|Overall Study|Did not meet eligibility criteria|0|||
144430454|NCT02474199|520784800|FG001|Overall Study|Did not meet eligibility criteria|0|||
144430455|NCT02474199|520784801|FG002|Overall Study|Did not meet eligibility criteria|2|||
144430456|NCT02474199|520784802|FG003|Overall Study|Did not meet eligibility criteria|2|||
144430457|NCT03090100|520784803|FG000|Overall Study|Adverse Event|9|||
144430458|NCT03090100|520784804|FG001|Overall Study|Adverse Event|11|||
144430459|NCT03090100|520784803|FG000|Overall Study|Pregnancy|1|||
144430460|NCT03090100|520784804|FG001|Overall Study|Pregnancy|1|||
144430461|NCT03090100|520784803|FG000|Overall Study|Lack of Efficacy|2|||
144430462|NCT03090100|520784804|FG001|Overall Study|Lack of Efficacy|7|||
144430463|NCT03090100|520784803|FG000|Overall Study|Lost to Follow-up|2|||
144430464|NCT03090100|520784804|FG001|Overall Study|Lost to Follow-up|2|||
144430465|NCT03090100|520784803|FG000|Overall Study|Withdrawal by Subject|7|||
144430466|NCT03090100|520784804|FG001|Overall Study|Withdrawal by Subject|19|||
144430467|NCT03090100|520784803|FG000|Overall Study|Protocol Violation|2|||
144430468|NCT03090100|520784804|FG001|Overall Study|Protocol Violation|6|||
144430469|NCT03090100|520784803|FG000|Overall Study|Non-compliance|2|||
144430470|NCT03090100|520784804|FG001|Overall Study|Non-compliance|0|||
144430471|NCT03090100|520784803|FG000|Overall Study|Other|2|||
144430472|NCT03090100|520784804|FG001|Overall Study|Other|2|||
144430473|NCT01344447|520784805|FG000|Overall Study|Adverse Event|1|||
144430474|NCT01344447|520784805|FG000|Overall Study|Protocol Violation|1|||
144430475|NCT01344447|520784805|FG000|Overall Study|Withdrawal by Subject|1|||
144430476|NCT01344447|520784805|FG000|Overall Study|The contrast was not seen|1|||
144430477|NCT01344447|520784805|FG000|Overall Study|Physician Decision|1|||
144430478|NCT01344447|520784805|FG000|Overall Study|MRA unsuccessful|1|||
144430479|NCT01344447|520784805|FG000|Overall Study|Bolus tracking failed|1|||
144430480|NCT01344447|520784805|FG000|Overall Study|Error of power injector|1|||
144430481|NCT00159588|520784806|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
144430482|NCT00159588|520784807|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
144430483|NCT00159588|520784808|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
144430484|NCT01660711|520784809|FG000|Overall Study|Adverse Event|7|||
144430485|NCT01660711|520784809|FG000|Overall Study|Withdrawal by Subject|1|||
144430486|NCT03446040|520784810|FG000|Overall Study|Disease progression|3|||
144430487|NCT03446040|520784811|FG001|Overall Study|Disease progression|3|||
144430488|NCT03446040|520784812|FG002|Overall Study|Disease progression|3|||
144430489|NCT03446040|520784813|FG003|Overall Study|Disease progression|4|||
144430490|NCT03446040|520784814|FG004|Overall Study|Disease progression|4|||
144430491|NCT03446040|520784815|FG005|Overall Study|Disease progression|6|||
144430492|NCT03446040|520784816|FG006|Overall Study|Disease progression|3|||
144430493|NCT03446040|520784817|FG007|Overall Study|Disease progression|4|||
144430494|NCT03446040|520784818|FG008|Overall Study|Disease progression|2|||
144430495|NCT03446040|520784819|FG009|Overall Study|Disease progression|4|||
144430496|NCT03446040|520784820|FG010|Overall Study|Disease progression|9|||
144604182|NCT03627767|521414252|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
144604183|NCT03627767|521414253|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
144604184|NCT03627767|521414254|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
144604185|NCT04163900|521414255|FG000|Overall Study|Radiological disease progression|112|||
144604186|NCT04163900|521414256|FG001|Overall Study|Radiological disease progression|127|||
144604187|NCT04163900|521414255|FG000|Overall Study|Study closure|98|||
144430497|NCT03446040|520784821|FG011|Overall Study|Disease progression|3|||
144430498|NCT03446040|520784822|FG012|Overall Study|Disease progression|7|||
144430499|NCT03446040|520784823|FG013|Overall Study|Disease progression|7|||
144430500|NCT03446040|520784810|FG000|Overall Study|Study drug toxicity|0|||
144430501|NCT03446040|520784811|FG001|Overall Study|Study drug toxicity|0|||
144430502|NCT03446040|520784812|FG002|Overall Study|Study drug toxicity|0|||
144430503|NCT03446040|520784813|FG003|Overall Study|Study drug toxicity|0|||
144430504|NCT03446040|520784814|FG004|Overall Study|Study drug toxicity|0|||
144430505|NCT03446040|520784815|FG005|Overall Study|Study drug toxicity|0|||
144430506|NCT03446040|520784816|FG006|Overall Study|Study drug toxicity|0|||
144430507|NCT03446040|520784817|FG007|Overall Study|Study drug toxicity|0|||
144430508|NCT03446040|520784818|FG008|Overall Study|Study drug toxicity|1|||
144430509|NCT03446040|520784819|FG009|Overall Study|Study drug toxicity|0|||
144604188|NCT04163900|521414256|FG001|Overall Study|Study closure|133|||
144430510|NCT03446040|520784820|FG010|Overall Study|Study drug toxicity|0|||
144430511|NCT03446040|520784821|FG011|Overall Study|Study drug toxicity|0|||
144604189|NCT04163900|521414255|FG000|Overall Study|Adverse Event|78|||
144430512|NCT03446040|520784822|FG012|Overall Study|Study drug toxicity|0|||
144430513|NCT03446040|520784823|FG013|Overall Study|Study drug toxicity|0|||
144430514|NCT03446040|520784810|FG000|Overall Study|Adverse Event|0|||
144430515|NCT03446040|520784811|FG001|Overall Study|Adverse Event|0|||
144430516|NCT03446040|520784812|FG002|Overall Study|Adverse Event|0|||
144430517|NCT03446040|520784813|FG003|Overall Study|Adverse Event|0|||
144430518|NCT03446040|520784814|FG004|Overall Study|Adverse Event|0|||
144430519|NCT03446040|520784815|FG005|Overall Study|Adverse Event|2|||
144430520|NCT03446040|520784816|FG006|Overall Study|Adverse Event|0|||
144430521|NCT03446040|520784817|FG007|Overall Study|Adverse Event|0|||
144430522|NCT03446040|520784818|FG008|Overall Study|Adverse Event|1|||
144430523|NCT03446040|520784819|FG009|Overall Study|Adverse Event|0|||
144430524|NCT03446040|520784820|FG010|Overall Study|Adverse Event|0|||
144430525|NCT03446040|520784821|FG011|Overall Study|Adverse Event|0|||
144430526|NCT03446040|520784822|FG012|Overall Study|Adverse Event|0|||
144430527|NCT03446040|520784823|FG013|Overall Study|Adverse Event|0|||
144430528|NCT03446040|520784810|FG000|Overall Study|Death|0|||
144430529|NCT03446040|520784811|FG001|Overall Study|Death|0|||
144430530|NCT03446040|520784812|FG002|Overall Study|Death|0|||
144430531|NCT03446040|520784813|FG003|Overall Study|Death|0|||
144430532|NCT03446040|520784814|FG004|Overall Study|Death|0|||
144430533|NCT03446040|520784815|FG005|Overall Study|Death|0|||
144430534|NCT03446040|520784816|FG006|Overall Study|Death|0|||
144430535|NCT03446040|520784817|FG007|Overall Study|Death|0|||
144430536|NCT03446040|520784818|FG008|Overall Study|Death|0|||
144430537|NCT03446040|520784819|FG009|Overall Study|Death|0|||
144430538|NCT03446040|520784820|FG010|Overall Study|Death|1|||
144430539|NCT03446040|520784821|FG011|Overall Study|Death|0|||
144430540|NCT03446040|520784822|FG012|Overall Study|Death|0|||
144430541|NCT03446040|520784823|FG013|Overall Study|Death|2|||
144430542|NCT03446040|520784810|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
144430543|NCT03446040|520784811|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
144430544|NCT03446040|520784812|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
144430545|NCT03446040|520784813|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
144430546|NCT03446040|520784814|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
144430547|NCT03446040|520784815|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
144430548|NCT03446040|520784816|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
144430549|NCT03446040|520784817|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
144430550|NCT03446040|520784818|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
144430551|NCT03446040|520784819|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
144430552|NCT03446040|520784820|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
144430553|NCT03446040|520784821|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
144430554|NCT03446040|520784822|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
144430555|NCT03446040|520784823|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
144430556|NCT03446040|520784810|FG000|Overall Study|Participant withdrew consent|0|||
144430557|NCT03446040|520784811|FG001|Overall Study|Participant withdrew consent|0|||
144430558|NCT03446040|520784812|FG002|Overall Study|Participant withdrew consent|0|||
144430559|NCT03446040|520784813|FG003|Overall Study|Participant withdrew consent|0|||
144430560|NCT03446040|520784814|FG004|Overall Study|Participant withdrew consent|0|||
144430561|NCT03446040|520784815|FG005|Overall Study|Participant withdrew consent|1|||
144430562|NCT03446040|520784816|FG006|Overall Study|Participant withdrew consent|0|||
144430563|NCT03446040|520784817|FG007|Overall Study|Participant withdrew consent|1|||
144430564|NCT03446040|520784818|FG008|Overall Study|Participant withdrew consent|0|||
144430565|NCT03446040|520784819|FG009|Overall Study|Participant withdrew consent|0|||
144430566|NCT03446040|520784820|FG010|Overall Study|Participant withdrew consent|0|||
144430567|NCT03446040|520784821|FG011|Overall Study|Participant withdrew consent|0|||
144430568|NCT03446040|520784822|FG012|Overall Study|Participant withdrew consent|0|||
144430569|NCT03446040|520784823|FG013|Overall Study|Participant withdrew consent|0|||
144430570|NCT03446040|520784810|FG000|Overall Study|Not reported|0|||
144430571|NCT03446040|520784811|FG001|Overall Study|Not reported|0|||
144430572|NCT03446040|520784812|FG002|Overall Study|Not reported|1|||
144430573|NCT03446040|520784813|FG003|Overall Study|Not reported|0|||
144430574|NCT03446040|520784814|FG004|Overall Study|Not reported|0|||
144430575|NCT03446040|520784815|FG005|Overall Study|Not reported|0|||
144430576|NCT03446040|520784816|FG006|Overall Study|Not reported|0|||
144430577|NCT03446040|520784817|FG007|Overall Study|Not reported|0|||
144430578|NCT03446040|520784818|FG008|Overall Study|Not reported|0|||
144430579|NCT03446040|520784819|FG009|Overall Study|Not reported|0|||
144430580|NCT03446040|520784820|FG010|Overall Study|Not reported|0|||
144430581|NCT03446040|520784821|FG011|Overall Study|Not reported|0|||
144430582|NCT03446040|520784822|FG012|Overall Study|Not reported|0|||
144430583|NCT03446040|520784823|FG013|Overall Study|Not reported|0|||
144430584|NCT00456521|520784824|FG000|Overall Study|Adverse Event|150|||
144430585|NCT00456521|520784825|FG001|Overall Study|Adverse Event|25|||
144430586|NCT00456521|520784824|FG000|Overall Study|Withdrawal by Subject|43|||
144430587|NCT00456521|520784825|FG001|Overall Study|Withdrawal by Subject|24|||
144430588|NCT00456521|520784824|FG000|Overall Study|Lost to Follow-up|22|||
144430589|NCT00456521|520784825|FG001|Overall Study|Lost to Follow-up|17|||
144430590|NCT00456521|520784824|FG000|Overall Study|Lack of Efficacy|3|||
144430591|NCT00456521|520784825|FG001|Overall Study|Lack of Efficacy|6|||
144430592|NCT00456521|520784824|FG000|Overall Study|Protocol Violation|4|||
144430593|NCT00456521|520784825|FG001|Overall Study|Protocol Violation|0|||
144430594|NCT00456521|520784824|FG000|Overall Study|Pregnancy|1|||
144430595|NCT00456521|520784825|FG001|Overall Study|Pregnancy|1|||
144430596|NCT00456521|520784824|FG000|Overall Study|Drug non-compliance, moved, other|26|||
144430597|NCT00456521|520784825|FG001|Overall Study|Drug non-compliance, moved, other|11|||
144430598|NCT00605475|520784826|FG000|Overall Study|Abnormal Laboratory Values|0|||
144430599|NCT00605475|520784827|FG001|Overall Study|Abnormal Laboratory Values|0|||
144430600|NCT00605475|520784828|FG002|Overall Study|Abnormal Laboratory Values|0|||
144430601|NCT00605475|520784829|FG003|Overall Study|Abnormal Laboratory Values|0|||
144430602|NCT00605475|520784830|FG004|Overall Study|Abnormal Laboratory Values|0|||
144252180|NCT01863732|520122692|FG001|Overall Study|Death|0|||
144252181|NCT01863732|520122693|FG002|Overall Study|Death|0|||
144252182|NCT01863732|520122694|FG003|Overall Study|Death|1|||
144252183|NCT01078298|520122695|FG000|Overall Study|Lost to Follow-up|12|||
144252184|NCT01078298|520122696|FG001|Overall Study|Lost to Follow-up|13|||
144252185|NCT01078298|520122695|FG000|Overall Study|Withdrawal by Subject|31|||
144252186|NCT01078298|520122696|FG001|Overall Study|Withdrawal by Subject|33|||
144252187|NCT01078298|520122695|FG000|Overall Study|Protocol Violation|6|||
144252188|NCT01078298|520122696|FG001|Overall Study|Protocol Violation|6|||
144252189|NCT01078298|520122695|FG000|Overall Study|Adverse Event|6|||
144252190|NCT01078298|520122696|FG001|Overall Study|Adverse Event|5|||
144252191|NCT01078298|520122695|FG000|Overall Study|Death|2|||
144252192|NCT01078298|520122696|FG001|Overall Study|Death|0|||
144252193|NCT01078298|520122695|FG000|Overall Study|Did not meet entrance criteria|0|||
144252194|NCT01078298|520122696|FG001|Overall Study|Did not meet entrance criteria|1|||
144252195|NCT01078298|520122695|FG000|Overall Study|Other|24|||
144252196|NCT01078298|520122696|FG001|Overall Study|Other|32|||
144252197|NCT01421147|520124644|FG000|Treatment Period|Adverse Event|2|||
144252198|NCT01421147|520124645|FG001|Treatment Period|Adverse Event|3|||
144252199|NCT01421147|520124644|FG000|Treatment Period|Lost to Follow-up|2|||
144252200|NCT01421147|520124645|FG001|Treatment Period|Lost to Follow-up|1|||
144252201|NCT01421147|520124644|FG000|Treatment Period|Physician Decision|2|||
144252202|NCT01421147|520124645|FG001|Treatment Period|Physician Decision|2|||
144252203|NCT01421147|520124644|FG000|Treatment Period|Withdrawal by Subject|10|||
144252204|NCT01421147|520124645|FG001|Treatment Period|Withdrawal by Subject|5|||
144252205|NCT01421147|520124644|FG000|Extension Period|Adverse Event|0|||
144252206|NCT01421147|520124645|FG001|Extension Period|Adverse Event|2|||
144252207|NCT01421147|520124644|FG000|Extension Period|Death|0|||
144252208|NCT01421147|520124645|FG001|Extension Period|Death|1|||
144252209|NCT01421147|520124644|FG000|Extension Period|Lost to Follow-up|2|||
144252210|NCT01421147|520124645|FG001|Extension Period|Lost to Follow-up|5|||
144252211|NCT01421147|520124644|FG000|Extension Period|Physician Decision|1|||
144430603|NCT00605475|520784831|FG005|Overall Study|Abnormal Laboratory Values|0|||
144430604|NCT00605475|520784832|FG006|Overall Study|Abnormal Laboratory Values|0|||
144430605|NCT00605475|520784833|FG007|Overall Study|Abnormal Laboratory Values|0|||
144430606|NCT00605475|520784834|FG008|Overall Study|Abnormal Laboratory Values|1|||
144430607|NCT00605475|520784835|FG009|Overall Study|Abnormal Laboratory Values|0|||
144430608|NCT00605475|520784826|FG000|Overall Study|Administrative problems|0|||
144430609|NCT00605475|520784827|FG001|Overall Study|Administrative problems|0|||
144430610|NCT00605475|520784828|FG002|Overall Study|Administrative problems|0|||
144430611|NCT00605475|520784829|FG003|Overall Study|Administrative problems|0|||
144252212|NCT01421147|520124645|FG001|Extension Period|Physician Decision|0|||
144252213|NCT01421147|520124644|FG000|Extension Period|Withdrawal by Subject|5|||
144252214|NCT01421147|520124645|FG001|Extension Period|Withdrawal by Subject|3|||
144252215|NCT03307837|520124646|FG000|Overall Study|Withdrawal by Subject|0|||
144252216|NCT03307837|520124647|FG001|Overall Study|Withdrawal by Subject|0|||
144252217|NCT03307837|520124648|FG002|Overall Study|Withdrawal by Subject|1|||
144252218|NCT03307837|520124649|FG003|Overall Study|Withdrawal by Subject|0|||
144430612|NCT00605475|520784830|FG004|Overall Study|Administrative problems|0|||
144430613|NCT00605475|520784831|FG005|Overall Study|Administrative problems|0|||
144430614|NCT00605475|520784832|FG006|Overall Study|Administrative problems|1|||
144430615|NCT00605475|520784833|FG007|Overall Study|Administrative problems|0|||
144430616|NCT00605475|520784834|FG008|Overall Study|Administrative problems|0|||
144430617|NCT00605475|520784835|FG009|Overall Study|Administrative problems|0|||
144430618|NCT00605475|520784826|FG000|Overall Study|Lost to Follow-up|0|||
144430619|NCT00605475|520784827|FG001|Overall Study|Lost to Follow-up|0|||
144430620|NCT00605475|520784828|FG002|Overall Study|Lost to Follow-up|0|||
144430621|NCT00605475|520784829|FG003|Overall Study|Lost to Follow-up|0|||
144430622|NCT00605475|520784830|FG004|Overall Study|Lost to Follow-up|0|||
144430623|NCT00605475|520784831|FG005|Overall Study|Lost to Follow-up|0|||
144430624|NCT00605475|520784832|FG006|Overall Study|Lost to Follow-up|0|||
144430625|NCT00605475|520784833|FG007|Overall Study|Lost to Follow-up|0|||
144430626|NCT00605475|520784834|FG008|Overall Study|Lost to Follow-up|1|||
144430627|NCT00605475|520784835|FG009|Overall Study|Lost to Follow-up|1|||
144430628|NCT00605475|520784826|FG000|Overall Study|Protocol Violation|0|||
144430629|NCT00605475|520784827|FG001|Overall Study|Protocol Violation|0|||
144430630|NCT00605475|520784828|FG002|Overall Study|Protocol Violation|0|||
144430631|NCT00605475|520784829|FG003|Overall Study|Protocol Violation|0|||
144430632|NCT00605475|520784830|FG004|Overall Study|Protocol Violation|1|||
144430633|NCT00605475|520784831|FG005|Overall Study|Protocol Violation|0|||
144430634|NCT00605475|520784832|FG006|Overall Study|Protocol Violation|0|||
144430635|NCT00605475|520784833|FG007|Overall Study|Protocol Violation|0|||
144430636|NCT00605475|520784834|FG008|Overall Study|Protocol Violation|0|||
144430637|NCT00605475|520784835|FG009|Overall Study|Protocol Violation|0|||
144430638|NCT00605475|520784826|FG000|Overall Study|Withdrawal by Subject|0|||
144430639|NCT00605475|520784827|FG001|Overall Study|Withdrawal by Subject|0|||
144430640|NCT00605475|520784828|FG002|Overall Study|Withdrawal by Subject|0|||
144430641|NCT00605475|520784829|FG003|Overall Study|Withdrawal by Subject|0|||
144430642|NCT00605475|520784830|FG004|Overall Study|Withdrawal by Subject|0|||
144430643|NCT00605475|520784831|FG005|Overall Study|Withdrawal by Subject|2|||
144430644|NCT00605475|520784832|FG006|Overall Study|Withdrawal by Subject|0|||
144430645|NCT00605475|520784833|FG007|Overall Study|Withdrawal by Subject|0|||
144430646|NCT00605475|520784834|FG008|Overall Study|Withdrawal by Subject|0|||
144430647|NCT00605475|520784835|FG009|Overall Study|Withdrawal by Subject|1|||
144430648|NCT00076011|520784839|FG000|Overall Study|Death|1|||
144430649|NCT00076011|520784839|FG000|Overall Study|Adverse Event|10|||
144430650|NCT00076011|520784839|FG000|Overall Study|Lack of Efficacy|25|||
144185764|NCT04718129|519873598|FG000|Overall Study|Lost to Follow-up|6|||
144430651|NCT00076011|520784839|FG000|Overall Study|Withdrawal by Subject|1|||
144430652|NCT00076011|520784839|FG000|Overall Study|Study terminated by sponsor|3|||
144430653|NCT00076011|520784839|FG000|Overall Study|Other|11|||
144430654|NCT00076011|520784839|FG000|Overall Study|Ongoing|1|||
144430655|NCT06027866|520784844|FG000|Overall Study|Withdrawal by Subject|2|||
144430656|NCT05071183|520784845|FG000|Overall Study|Death|1|||
144430657|NCT05071183|520784846|FG001|Overall Study|Death|2|||
144430658|NCT05071183|520784847|FG002|Overall Study|Death|0|||
144430659|NCT05071183|520784845|FG000|Overall Study|Other Reasons|1|||
144430660|NCT05071183|520784846|FG001|Overall Study|Other Reasons|3|||
144430661|NCT05071183|520784847|FG002|Overall Study|Other Reasons|2|||
144430662|NCT01480076|520784848|FG000|Overall Study|Run-in Failure|52|||
144430663|NCT01480076|520784848|FG000|Overall Study|Adverse Event|39|||
144430664|NCT01480076|520784848|FG000|Overall Study|Death|2|||
144430665|NCT01480076|520784848|FG000|Overall Study|Disease Progression|5|||
144430666|NCT01480076|520784848|FG000|Overall Study|Non-compliance With Study Protocol|15|||
144430667|NCT01480076|520784848|FG000|Overall Study|Withdrawal by Subject|105|||
144529055|NCT03088878|521139168|FG008|Overall Study|Disease Progression|0|||
144529056|NCT03088878|521139169|FG009|Overall Study|Disease Progression|0|||
144529057|NCT03088878|521139170|FG010|Overall Study|Disease Progression|0|||
144529058|NCT03088878|521139171|FG011|Overall Study|Disease Progression|0|||
144529059|NCT03088878|521139172|FG012|Overall Study|Disease Progression|1|||
144430668|NCT01480076|520784848|FG000|Overall Study|Lost to Follow-up|7|||
144430669|NCT01480076|520784848|FG000|Overall Study|Investigator Decision|13|||
144430670|NCT01480076|520784848|FG000|Overall Study|Other|52|||
144430671|NCT02503332|520784849|FG000|Overall Study|Adverse Event|17|||
144529060|NCT03088878|521139173|FG013|Overall Study|Disease Progression|1|||
144529061|NCT03088878|521139160|FG000|Overall Study|Initiation of Alternative Treatment|0|||
144529062|NCT03088878|521139161|FG001|Overall Study|Initiation of Alternative Treatment|0|||
144529063|NCT03088878|521139162|FG002|Overall Study|Initiation of Alternative Treatment|0|||
144529064|NCT03088878|521139163|FG003|Overall Study|Initiation of Alternative Treatment|1|||
144529065|NCT03088878|521139164|FG004|Overall Study|Initiation of Alternative Treatment|0|||
144529066|NCT03088878|521139165|FG005|Overall Study|Initiation of Alternative Treatment|0|||
144529067|NCT03088878|521139166|FG006|Overall Study|Initiation of Alternative Treatment|0|||
144529068|NCT03088878|521139167|FG007|Overall Study|Initiation of Alternative Treatment|1|||
144529069|NCT03088878|521139168|FG008|Overall Study|Initiation of Alternative Treatment|1|||
144529070|NCT03088878|521139169|FG009|Overall Study|Initiation of Alternative Treatment|0|||
144529071|NCT03088878|521139170|FG010|Overall Study|Initiation of Alternative Treatment|0|||
144529072|NCT03088878|521139171|FG011|Overall Study|Initiation of Alternative Treatment|0|||
144529073|NCT03088878|521139172|FG012|Overall Study|Initiation of Alternative Treatment|0|||
144529074|NCT03088878|521139173|FG013|Overall Study|Initiation of Alternative Treatment|0|||
144185765|NCT04718129|519873599|FG001|Overall Study|Lost to Follow-up|7|||
144430672|NCT02503332|520784850|FG001|Overall Study|Adverse Event|5|||
144529075|NCT03088878|521139160|FG000|Overall Study|Withdrawal by Subject|0|||
144529076|NCT03088878|521139161|FG001|Overall Study|Withdrawal by Subject|0|||
144529077|NCT03088878|521139162|FG002|Overall Study|Withdrawal by Subject|0|||
144529078|NCT03088878|521139163|FG003|Overall Study|Withdrawal by Subject|1|||
144529079|NCT03088878|521139164|FG004|Overall Study|Withdrawal by Subject|4|||
144529080|NCT03088878|521139165|FG005|Overall Study|Withdrawal by Subject|1|||
144430673|NCT02503332|520784851|FG002|Overall Study|Adverse Event|3|||
144430674|NCT02503332|520784852|FG003|Overall Study|Adverse Event|1|||
144430675|NCT02503332|520784849|FG000|Overall Study|Investigator's Decision|5|||
144430676|NCT02503332|520784850|FG001|Overall Study|Investigator's Decision|1|||
144430677|NCT02503332|520784851|FG002|Overall Study|Investigator's Decision|0|||
144430678|NCT02503332|520784852|FG003|Overall Study|Investigator's Decision|0|||
144430679|NCT02503332|520784849|FG000|Overall Study|Sponsor's Decision|1|||
144430680|NCT02503332|520784850|FG001|Overall Study|Sponsor's Decision|0|||
144430681|NCT02503332|520784851|FG002|Overall Study|Sponsor's Decision|0|||
144430682|NCT02503332|520784852|FG003|Overall Study|Sponsor's Decision|1|||
144430683|NCT02503332|520784849|FG000|Overall Study|Subject Request|6|||
144430684|NCT02503332|520784850|FG001|Overall Study|Subject Request|5|||
144430685|NCT02503332|520784851|FG002|Overall Study|Subject Request|2|||
144430686|NCT02503332|520784852|FG003|Overall Study|Subject Request|1|||
144430687|NCT02503332|520784849|FG000|Overall Study|Death|0|||
144430688|NCT02503332|520784850|FG001|Overall Study|Death|2|||
144430689|NCT02503332|520784851|FG002|Overall Study|Death|2|||
144430690|NCT02503332|520784852|FG003|Overall Study|Death|0|||
144430691|NCT02503332|520784849|FG000|Overall Study|Other|5|||
144430692|NCT02503332|520784850|FG001|Overall Study|Other|6|||
144430693|NCT02503332|520784851|FG002|Overall Study|Other|1|||
144430694|NCT02503332|520784852|FG003|Overall Study|Other|1|||
144430695|NCT01589445|520784855|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
144430696|NCT01589445|520784855|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
144430697|NCT01589445|520784855|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
144430698|NCT01589445|520784855|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
144430699|NCT01589445|520784855|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
144430700|NCT01589445|520784855|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
144430701|NCT01589445|520784855|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
144430702|NCT01589445|520784855|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
144430703|NCT01589445|520784855|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
144430704|NCT01589445|520784855|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
144430705|NCT00325754|520784856|FG000|Overall Study|Adverse Event|4|||
144430706|NCT00325754|520784857|FG001|Overall Study|Adverse Event|1|||
144430707|NCT01358357|520784860|FG000|Open Label Phase|Adverse Event|0|||
144529081|NCT03088878|521139166|FG006|Overall Study|Withdrawal by Subject|1|||
144529082|NCT03088878|521139167|FG007|Overall Study|Withdrawal by Subject|0|||
144529083|NCT03088878|521139168|FG008|Overall Study|Withdrawal by Subject|1|||
144529084|NCT03088878|521139169|FG009|Overall Study|Withdrawal by Subject|2|||
144529085|NCT03088878|521139170|FG010|Overall Study|Withdrawal by Subject|0|||
144529086|NCT03088878|521139171|FG011|Overall Study|Withdrawal by Subject|2|||
144529087|NCT03088878|521139172|FG012|Overall Study|Withdrawal by Subject|1|||
144529088|NCT03088878|521139173|FG013|Overall Study|Withdrawal by Subject|0|||
144529089|NCT03088878|521139160|FG000|Overall Study|Terminated by Sponsor|2|||
144529090|NCT03088878|521139161|FG001|Overall Study|Terminated by Sponsor|1|||
144529091|NCT03088878|521139162|FG002|Overall Study|Terminated by Sponsor|0|||
144529092|NCT03088878|521139163|FG003|Overall Study|Terminated by Sponsor|1|||
144529093|NCT03088878|521139164|FG004|Overall Study|Terminated by Sponsor|6|||
144529094|NCT03088878|521139165|FG005|Overall Study|Terminated by Sponsor|0|||
144529095|NCT03088878|521139166|FG006|Overall Study|Terminated by Sponsor|0|||
144529096|NCT03088878|521139167|FG007|Overall Study|Terminated by Sponsor|0|||
144529097|NCT03088878|521139168|FG008|Overall Study|Terminated by Sponsor|0|||
144529098|NCT03088878|521139169|FG009|Overall Study|Terminated by Sponsor|0|||
144529099|NCT03088878|521139170|FG010|Overall Study|Terminated by Sponsor|3|||
144529100|NCT03088878|521139171|FG011|Overall Study|Terminated by Sponsor|13|||
144529101|NCT03088878|521139172|FG012|Overall Study|Terminated by Sponsor|2|||
144529102|NCT03088878|521139173|FG013|Overall Study|Terminated by Sponsor|1|||
144529103|NCT03088878|521139160|FG000|Overall Study|Completed 2 years of Treatment|0|||
144529104|NCT03088878|521139161|FG001|Overall Study|Completed 2 years of Treatment|0|||
144529105|NCT03088878|521139162|FG002|Overall Study|Completed 2 years of Treatment|0|||
144529106|NCT03088878|521139163|FG003|Overall Study|Completed 2 years of Treatment|0|||
144529107|NCT03088878|521139164|FG004|Overall Study|Completed 2 years of Treatment|0|||
144529108|NCT03088878|521139165|FG005|Overall Study|Completed 2 years of Treatment|0|||
144529109|NCT03088878|521139166|FG006|Overall Study|Completed 2 years of Treatment|1|||
144529110|NCT03088878|521139167|FG007|Overall Study|Completed 2 years of Treatment|0|||
144529111|NCT03088878|521139168|FG008|Overall Study|Completed 2 years of Treatment|0|||
144529112|NCT03088878|521139169|FG009|Overall Study|Completed 2 years of Treatment|1|||
144529113|NCT03088878|521139170|FG010|Overall Study|Completed 2 years of Treatment|0|||
144529114|NCT03088878|521139171|FG011|Overall Study|Completed 2 years of Treatment|0|||
144529115|NCT03088878|521139172|FG012|Overall Study|Completed 2 years of Treatment|8|||
144529116|NCT03088878|521139173|FG013|Overall Study|Completed 2 years of Treatment|3|||
144529117|NCT03088878|521139160|FG000|Overall Study|Physician Decision|0|||
144529118|NCT03088878|521139161|FG001|Overall Study|Physician Decision|0|||
144529119|NCT03088878|521139162|FG002|Overall Study|Physician Decision|0|||
144529120|NCT03088878|521139163|FG003|Overall Study|Physician Decision|0|||
144185766|NCT03168906|519873600|FG000|Overall Study|Lack of Efficacy|6|||
144185767|NCT03168906|519873601|FG001|Overall Study|Lack of Efficacy|6|||
144185768|NCT01214239|519873602|FG000|Overall Study|Adverse Event|3|||
144185769|NCT01214239|519873603|FG001|Overall Study|Adverse Event|4|||
144185770|NCT01214239|519873602|FG000|Overall Study|Protocol Violation|2|||
144185771|NCT01214239|519873603|FG001|Overall Study|Protocol Violation|1|||
144430708|NCT01358357|520784861|FG001|Open Label Phase|Adverse Event|0|||
144430709|NCT01358357|520784862|FG002|Open Label Phase|Adverse Event|59|||
144430710|NCT01358357|520784860|FG000|Open Label Phase|Lack of Efficacy|0|||
144430711|NCT01358357|520784861|FG001|Open Label Phase|Lack of Efficacy|0|||
144430712|NCT01358357|520784862|FG002|Open Label Phase|Lack of Efficacy|107|||
144430713|NCT01358357|520784860|FG000|Open Label Phase|Lost to Follow-up|0|||
144430714|NCT01358357|520784861|FG001|Open Label Phase|Lost to Follow-up|0|||
144430715|NCT01358357|520784862|FG002|Open Label Phase|Lost to Follow-up|76|||
144430716|NCT01358357|520784860|FG000|Open Label Phase|Protocol Violation|0|||
144430717|NCT01358357|520784861|FG001|Open Label Phase|Protocol Violation|0|||
144430718|NCT01358357|520784862|FG002|Open Label Phase|Protocol Violation|45|||
144430719|NCT01358357|520784860|FG000|Open Label Phase|Withdrawal by Subject|0|||
144430720|NCT01358357|520784861|FG001|Open Label Phase|Withdrawal by Subject|0|||
144430721|NCT01358357|520784862|FG002|Open Label Phase|Withdrawal by Subject|112|||
144430722|NCT01358357|520784860|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
144430723|NCT01358357|520784861|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
144430724|NCT01358357|520784862|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
144430725|NCT01358357|520784860|FG000|Open Label Phase|Terminated at study completion|0|||
144430726|NCT01358357|520784861|FG001|Open Label Phase|Terminated at study completion|0|||
144430727|NCT01358357|520784862|FG002|Open Label Phase|Terminated at study completion|5|||
144430728|NCT01358357|520784860|FG000|Open Label Phase|Mood episode|0|||
144430729|NCT01358357|520784861|FG001|Open Label Phase|Mood episode|0|||
144430730|NCT01358357|520784862|FG002|Open Label Phase|Mood episode|42|||
144430731|NCT01358357|520784860|FG000|Double-Blind Phase|Adverse Event|8|||
144430732|NCT01358357|520784861|FG001|Double-Blind Phase|Adverse Event|5|||
144430733|NCT01358357|520784862|FG002|Double-Blind Phase|Adverse Event|0|||
144430734|NCT01358357|520784860|FG000|Double-Blind Phase|Lost to Follow-up|5|||
144430735|NCT01358357|520784861|FG001|Double-Blind Phase|Lost to Follow-up|7|||
144430736|NCT01358357|520784862|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144430737|NCT01358357|520784860|FG000|Double-Blind Phase|Protocol Violation|1|||
144430738|NCT01358357|520784861|FG001|Double-Blind Phase|Protocol Violation|11|||
144430739|NCT01358357|520784862|FG002|Double-Blind Phase|Protocol Violation|0|||
144430740|NCT01358357|520784860|FG000|Double-Blind Phase|Protocol Violation|16|||
144430741|NCT01358357|520784861|FG001|Double-Blind Phase|Protocol Violation|12|||
144430742|NCT01358357|520784862|FG002|Double-Blind Phase|Protocol Violation|0|||
144430743|NCT01358357|520784860|FG000|Double-Blind Phase|Terminated at study completion|2|||
144430744|NCT01358357|520784861|FG001|Double-Blind Phase|Terminated at study completion|0|||
144430745|NCT01358357|520784862|FG002|Double-Blind Phase|Terminated at study completion|0|||
144430746|NCT01358357|520784860|FG000|Double-Blind Phase|Recurrence of mood event|48|||
144430747|NCT01358357|520784861|FG001|Double-Blind Phase|Recurrence of mood event|64|||
144430748|NCT01358357|520784862|FG002|Double-Blind Phase|Recurrence of mood event|0|||
144430749|NCT01358357|520784860|FG000|Double-Blind Phase|Administrative|0|||
144430750|NCT01358357|520784861|FG001|Double-Blind Phase|Administrative|1|||
144430751|NCT01358357|520784862|FG002|Double-Blind Phase|Administrative|0|||
144430752|NCT01826487|520784863|FG000|Overall Study|Adverse Event|1|||
144430753|NCT01826487|520784864|FG001|Overall Study|Adverse Event|1|||
144430754|NCT01826487|520784863|FG000|Overall Study|Lost to Follow-up|1|||
144430755|NCT01826487|520784864|FG001|Overall Study|Lost to Follow-up|0|||
144430756|NCT01826487|520784863|FG000|Overall Study|Withdrawal by Subject|1|||
144430757|NCT01826487|520784864|FG001|Overall Study|Withdrawal by Subject|3|||
144430758|NCT01826487|520784863|FG000|Overall Study|Protocol Violation|1|||
144430759|NCT01826487|520784864|FG001|Overall Study|Protocol Violation|1|||
144430760|NCT02171260|520784871|FG000|Overall Study|Death|0|||
144430761|NCT02171260|520784872|FG001|Overall Study|Death|0|||
144430762|NCT02171260|520784873|FG002|Overall Study|Death|0|||
144430763|NCT02171260|520784874|FG003|Overall Study|Death|1|||
144430764|NCT02171260|520784871|FG000|Overall Study|Physician Decision|1|||
144430765|NCT02171260|520784872|FG001|Overall Study|Physician Decision|0|||
144430766|NCT02171260|520784873|FG002|Overall Study|Physician Decision|1|||
144430767|NCT02171260|520784874|FG003|Overall Study|Physician Decision|0|||
144430768|NCT02171260|520784871|FG000|Overall Study|Withdrawal by Subject|1|||
144430769|NCT02171260|520784872|FG001|Overall Study|Withdrawal by Subject|0|||
144529121|NCT03088878|521139164|FG004|Overall Study|Physician Decision|0|||
144185772|NCT01214239|519873602|FG000|Overall Study|Lost to Follow-up|1|||
144185773|NCT01214239|519873603|FG001|Overall Study|Lost to Follow-up|1|||
144185774|NCT01214239|519873602|FG000|Overall Study|Withdrawal by Subject|4|||
144430770|NCT02171260|520784873|FG002|Overall Study|Withdrawal by Subject|0|||
144430771|NCT02171260|520784874|FG003|Overall Study|Withdrawal by Subject|0|||
144430772|NCT02171260|520784871|FG000|Overall Study|Evidence of progressive disease|4|||
144430773|NCT02171260|520784872|FG001|Overall Study|Evidence of progressive disease|6|||
144430774|NCT02171260|520784873|FG002|Overall Study|Evidence of progressive disease|4|||
144430775|NCT02171260|520784874|FG003|Overall Study|Evidence of progressive disease|4|||
144430776|NCT02486042|520784875|FG000|Overall Study|Physician Decision|1|||
144430777|NCT02486042|520784876|FG001|Overall Study|Physician Decision|7|||
144430778|NCT02486042|520784875|FG000|Overall Study|Hospital transfer|2|||
144430779|NCT02486042|520784876|FG001|Overall Study|Hospital transfer|2|||
144430780|NCT02486042|520784875|FG000|Overall Study|Withdrawal by Subject|0|||
144430781|NCT02486042|520784876|FG001|Overall Study|Withdrawal by Subject|2|||
144430782|NCT01319877|520784877|FG000|Overall Study|Lost to Follow-up|100|||
144430783|NCT01319877|520784878|FG001|Overall Study|Lost to Follow-up|37|||
144430784|NCT01319877|520784877|FG000|Overall Study|Physician Decision|2|||
144430785|NCT01319877|520784878|FG001|Overall Study|Physician Decision|0|||
144430786|NCT01319877|520784877|FG000|Overall Study|Disease Progression|2|||
144430787|NCT01319877|520784878|FG001|Overall Study|Disease Progression|2|||
144430788|NCT01319877|520784877|FG000|Overall Study|Withdrawal by Subject|0|||
144430789|NCT01319877|520784878|FG001|Overall Study|Withdrawal by Subject|1|||
144430790|NCT01319877|520784877|FG000|Overall Study|Reason Not Specified|4|||
144430791|NCT01319877|520784878|FG001|Overall Study|Reason Not Specified|5|||
144430792|NCT00735878|520784881|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
144430793|NCT00735878|520784882|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
144430794|NCT00735878|520784883|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
144430795|NCT04404855|520784884|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
144430796|NCT04404855|520784885|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
144430797|NCT03320564|520784886|FG000|Overall Study|Protocol Violation|1|||
144430798|NCT00352846|520784887|FG000|Overall Study|Disease progression|0|||
144430799|NCT00352846|520784888|FG001|Overall Study|Disease progression|2|||
144430800|NCT00352846|520784887|FG000|Overall Study|Withdrawal by Subject|3|||
144430801|NCT00352846|520784888|FG001|Overall Study|Withdrawal by Subject|8|||
144430802|NCT00352846|520784887|FG000|Overall Study|Ineligible|3|||
144430803|NCT00352846|520784888|FG001|Overall Study|Ineligible|2|||
144430804|NCT00352846|520784887|FG000|Overall Study|Non-compliance|2|||
144430805|NCT00352846|520784888|FG001|Overall Study|Non-compliance|0|||
144430806|NCT00352846|520784887|FG000|Overall Study|Death|0|||
144430807|NCT00352846|520784888|FG001|Overall Study|Death|1|||
144430808|NCT00788827|520784889|FG000|Overall Study|Lack of Efficacy|2|||
144430809|NCT01527682|520784890|FG000|Overall Study|Protocol Violation|8|||
144430810|NCT04668950|520784894|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
144430811|NCT04668950|520784895|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
144430812|NCT04668950|520784894|FG000|Overall Study|Could not confirm started study medication|15|||
144430813|NCT04668950|520784895|FG001|Overall Study|Could not confirm started study medication|15|||
144430814|NCT04668950|520784894|FG000|Overall Study|Could not confirm baseline status|6|||
144430815|NCT04668950|520784895|FG001|Overall Study|Could not confirm baseline status|2|||
144430816|NCT04668950|520784894|FG000|Overall Study|Drop out and did not start medication|15|||
144430817|NCT04668950|520784895|FG001|Overall Study|Drop out and did not start medication|17|||
144430818|NCT04668950|520784894|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
144430819|NCT04668950|520784895|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
144604190|NCT04163900|521414256|FG001|Overall Study|Adverse Event|32|||
144604191|NCT04163900|521414255|FG000|Overall Study|Withdrawal by Subject|37|||
144604192|NCT04163900|521414256|FG001|Overall Study|Withdrawal by Subject|34|||
144604193|NCT04163900|521414255|FG000|Overall Study|Death|29|||
144604194|NCT04163900|521414256|FG001|Overall Study|Death|16|||
144604195|NCT04163900|521414255|FG000|Overall Study|Physician Decision|17|||
144604196|NCT04163900|521414256|FG001|Overall Study|Physician Decision|25|||
144604197|NCT04163900|521414255|FG000|Overall Study|Clinical disease progression|14|||
144604198|NCT04163900|521414256|FG001|Overall Study|Clinical disease progression|13|||
144604199|NCT04163900|521414255|FG000|Overall Study|Protocol Violation|3|||
144604200|NCT04163900|521414256|FG001|Overall Study|Protocol Violation|4|||
144604201|NCT04163900|521414255|FG000|Overall Study|Lost to Follow-up|0|||
144604202|NCT04163900|521414256|FG001|Overall Study|Lost to Follow-up|1|||
144604203|NCT00283049|521414257|FG000|Overall Study|Adverse Event|6|||
144185775|NCT01214239|519873603|FG001|Overall Study|Withdrawal by Subject|9|||
144185776|NCT01214239|519873602|FG000|Overall Study|Lack of Efficacy|1|||
144185777|NCT01214239|519873603|FG001|Overall Study|Lack of Efficacy|2|||
144185778|NCT01214239|519873602|FG000|Overall Study|patient's private reason|1|||
144185779|NCT01214239|519873603|FG001|Overall Study|patient's private reason|1|||
144185780|NCT00857818|519873604|FG000|Overall Study|Lack of Efficacy|1|||
144430820|NCT04668950|520784894|FG000|Overall Study|Other|2|||
144430821|NCT04668950|520784895|FG001|Overall Study|Other|4|||
144430822|NCT03979638|520784896|FG000|Period 1|Physician Decision|1|||
144430823|NCT03979638|520784897|FG001|Period 1|Physician Decision|1|||
144430824|NCT03979638|520784896|FG000|Period 1|Withdrawal by Subject|4|||
144430825|NCT03979638|520784897|FG001|Period 1|Withdrawal by Subject|3|||
144430826|NCT03979638|520784896|FG000|Period 1|Study terminated by Sponsor|1|||
144430827|NCT03979638|520784897|FG001|Period 1|Study terminated by Sponsor|3|||
144430828|NCT03979638|520784896|FG000|Period 1|Protocol Violation|1|||
144604204|NCT00283049|521414258|FG001|Overall Study|Adverse Event|1|||
144604205|NCT00283049|521414259|FG002|Overall Study|Adverse Event|4|||
144604206|NCT00283049|521414257|FG000|Overall Study|Protocol Violation|3|||
144604207|NCT00283049|521414258|FG001|Overall Study|Protocol Violation|0|||
144430829|NCT03979638|520784897|FG001|Period 1|Protocol Violation|0|||
144430830|NCT03979638|520784896|FG000|Period 2|Study terminated by Sponsor|1|||
144430831|NCT03979638|520784897|FG001|Period 2|Study terminated by Sponsor|1|||
144430832|NCT04220411|520784902|FG000|Overall Study|Adverse Event|0|||
144430833|NCT04220411|520784903|FG001|Overall Study|Adverse Event|0|||
144430834|NCT04220411|520784904|FG002|Overall Study|Adverse Event|0|||
144430835|NCT04220411|520784905|FG003|Overall Study|Adverse Event|1|||
144430836|NCT03200899|520784906|FG000|Overall Study|Lost to Follow-up|10|||
144430837|NCT03200899|520784907|FG001|Overall Study|Lost to Follow-up|23|||
144430838|NCT01400516|520784919|FG000|Primary Trial|Withdrawal by Subject|0|||
144430839|NCT01400516|520784920|FG001|Primary Trial|Withdrawal by Subject|2|||
144430840|NCT00549562|520784921|FG000|Overall Study|Adverse Event|1|||
144430841|NCT00549562|520784921|FG000|Overall Study|Lack of Efficacy|1|||
144430842|NCT00323115|520784927|FG000|Vaccine Administration|Adverse Event|1|||
144430843|NCT00323115|520784927|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
144430844|NCT02496533|520784928|FG000|Overall Study|Lack of data on outcome|3|||
144430845|NCT02496533|520784929|FG001|Overall Study|Lack of data on outcome|0|||
144430846|NCT02496533|520784928|FG000|Overall Study|Patient did not complete all measures|0|||
144430847|NCT02496533|520784929|FG001|Overall Study|Patient did not complete all measures|4|||
144430848|NCT02496533|520784928|FG000|Overall Study|Late for radiologic testing|0|||
144430849|NCT02496533|520784929|FG001|Overall Study|Late for radiologic testing|2|||
144430850|NCT00489853|520786449|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
144430851|NCT00489853|520786450|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
144430852|NCT00489853|520786451|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
144430853|NCT00489853|520786449|FG000|Wash-out Period 1|Adverse Event|0|||
144430854|NCT00489853|520786450|FG001|Wash-out Period 1|Adverse Event|1|||
144430855|NCT00489853|520786451|FG002|Wash-out Period 1|Adverse Event|1|||
144430856|NCT00489853|520786449|FG000|Wash-out Period 1|Protocol Violation|0|||
144430857|NCT00489853|520786450|FG001|Wash-out Period 1|Protocol Violation|1|||
144430858|NCT00489853|520786451|FG002|Wash-out Period 1|Protocol Violation|1|||
144430859|NCT00489853|520786449|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
144430860|NCT00489853|520786450|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
144430861|NCT00489853|520786451|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
144430862|NCT00489853|520786449|FG000|Wash-out Period 2|Adverse Event|1|||
144430863|NCT00489853|520786450|FG001|Wash-out Period 2|Adverse Event|1|||
144430864|NCT00489853|520786451|FG002|Wash-out Period 2|Adverse Event|0|||
144430865|NCT00489853|520786449|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
144430866|NCT00489853|520786450|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
144430867|NCT00489853|520786451|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
144430868|NCT00489853|520786449|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
144430869|NCT00489853|520786450|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
144430870|NCT00489853|520786451|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
144430871|NCT00004888|520786457|FG000|Overall Study|Adverse Event|5|||
144430872|NCT00004888|520786458|FG001|Overall Study|Adverse Event|10|||
144430873|NCT00004888|520786457|FG000|Overall Study|Withdrawal by Subject|0|||
144430874|NCT00004888|520786458|FG001|Overall Study|Withdrawal by Subject|3|||
144430875|NCT00004888|520786457|FG000|Overall Study|Physician Decision|1|||
144430876|NCT00004888|520786458|FG001|Overall Study|Physician Decision|1|||
144430877|NCT00004888|520786457|FG000|Overall Study|Progressive Disease|4|||
144430878|NCT00004888|520786458|FG001|Overall Study|Progressive Disease|9|||
144430879|NCT00004888|520786457|FG000|Overall Study|Death without progressive disease|0|||
144430880|NCT00004888|520786458|FG001|Overall Study|Death without progressive disease|1|||
144430881|NCT00004888|520786457|FG000|Overall Study|Toxic death|1|||
144430882|NCT00004888|520786458|FG001|Overall Study|Toxic death|0|||
144430883|NCT02579265|520786459|FG000|Overall Study|Weaned off earlier than 28 days|44|||
144430884|NCT02579265|520786460|FG001|Overall Study|Weaned off earlier than 28 days|43|||
144529122|NCT03088878|521139165|FG005|Overall Study|Physician Decision|0|||
144529123|NCT03088878|521139166|FG006|Overall Study|Physician Decision|0|||
144529124|NCT03088878|521139167|FG007|Overall Study|Physician Decision|2|||
144529125|NCT03088878|521139168|FG008|Overall Study|Physician Decision|1|||
144529126|NCT03088878|521139169|FG009|Overall Study|Physician Decision|0|||
144529127|NCT03088878|521139170|FG010|Overall Study|Physician Decision|0|||
144529128|NCT03088878|521139171|FG011|Overall Study|Physician Decision|0|||
144430885|NCT02579265|520786459|FG000|Overall Study|Adverse Event|2|||
144430886|NCT02579265|520786460|FG001|Overall Study|Adverse Event|0|||
144430887|NCT02579265|520786459|FG000|Overall Study|Any other reason not specified|0|||
144430888|NCT02579265|520786460|FG001|Overall Study|Any other reason not specified|2|||
144430889|NCT02579265|520786459|FG000|Overall Study|Withdrawal by Subject|2|||
144430890|NCT02579265|520786460|FG001|Overall Study|Withdrawal by Subject|0|||
144430891|NCT02579265|520786459|FG000|Overall Study|Physician Decision|1|||
144430892|NCT02579265|520786460|FG001|Overall Study|Physician Decision|0|||
144430893|NCT02579265|520786459|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
144430894|NCT02579265|520786460|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
144430895|NCT02174848|520786461|FG000|Overall Study|Adverse Event|2|||
144529129|NCT03088878|521139172|FG012|Overall Study|Physician Decision|0|||
144430896|NCT02174848|520786462|FG001|Overall Study|Adverse Event|1|||
144430897|NCT02174848|520786461|FG000|Overall Study|Withdrawal by Subject|3|||
144430898|NCT02174848|520786462|FG001|Overall Study|Withdrawal by Subject|3|||
144430899|NCT02174848|520786461|FG000|Overall Study|Lost to Follow-up|0|||
144430900|NCT02174848|520786462|FG001|Overall Study|Lost to Follow-up|1|||
144430901|NCT02174848|520786461|FG000|Overall Study|Worsening of disease|1|||
144430902|NCT02174848|520786462|FG001|Overall Study|Worsening of disease|1|||
144430903|NCT02174848|520786461|FG000|Overall Study|Unable to comply with study requirements|1|||
144430904|NCT02174848|520786462|FG001|Overall Study|Unable to comply with study requirements|0|||
144430905|NCT04091646|520786466|FG000|Overall Study|Adverse Event|2|||
144430906|NCT04091646|520786467|FG001|Overall Study|Adverse Event|1|||
144430907|NCT04091646|520786466|FG000|Overall Study|Lost to Follow-up|6|||
144430908|NCT04091646|520786467|FG001|Overall Study|Lost to Follow-up|2|||
144430909|NCT04091646|520786466|FG000|Overall Study|Protocol Violation|0|||
144430910|NCT04091646|520786467|FG001|Overall Study|Protocol Violation|1|||
144430911|NCT04091646|520786466|FG000|Overall Study|Withdrawal by Subject|4|||
144430912|NCT04091646|520786467|FG001|Overall Study|Withdrawal by Subject|1|||
144252219|NCT03307837|520124650|FG004|Overall Study|Withdrawal by Subject|0|||
144252220|NCT03307837|520124651|FG005|Overall Study|Withdrawal by Subject|1|||
144252221|NCT03307837|520124646|FG000|Overall Study|Lost to Follow-up|1|||
144252222|NCT03307837|520124647|FG001|Overall Study|Lost to Follow-up|1|||
144430913|NCT04091646|520786466|FG000|Overall Study|Participant Incarcerated|1|||
144430914|NCT04091646|520786467|FG001|Overall Study|Participant Incarcerated|0|||
144430915|NCT03314584|520786470|FG000|Overall Study|Withdrawal by Subject|3|||
144430916|NCT03314584|520786471|FG001|Overall Study|Withdrawal by Subject|3|||
144430917|NCT03314584|520786470|FG000|Overall Study|Lost to Follow-up|4|||
144430918|NCT03314584|520786471|FG001|Overall Study|Lost to Follow-up|0|||
144430919|NCT03615326|520786479|FG000|Overall Study|Death|266|||
144430920|NCT03615326|520786480|FG001|Overall Study|Death|286|||
144430921|NCT03615326|520786481|FG002|Overall Study|Death|14|||
144430922|NCT03615326|520786482|FG003|Overall Study|Death|17|||
144430923|NCT03615326|520786479|FG000|Overall Study|Lost to Follow-up|0|||
144430924|NCT03615326|520786480|FG001|Overall Study|Lost to Follow-up|1|||
144430925|NCT03615326|520786481|FG002|Overall Study|Lost to Follow-up|0|||
144430926|NCT03615326|520786482|FG003|Overall Study|Lost to Follow-up|0|||
144430927|NCT03615326|520786479|FG000|Overall Study|Withdrawal by Subject|1|||
144430928|NCT03615326|520786480|FG001|Overall Study|Withdrawal by Subject|3|||
144430929|NCT03615326|520786481|FG002|Overall Study|Withdrawal by Subject|0|||
144430930|NCT03615326|520786482|FG003|Overall Study|Withdrawal by Subject|0|||
144430931|NCT03615326|520786479|FG000|Overall Study|Participants Ongoing|83|||
144430932|NCT03615326|520786480|FG001|Overall Study|Participants Ongoing|58|||
144430933|NCT03615326|520786481|FG002|Overall Study|Participants Ongoing|6|||
144430934|NCT03615326|520786482|FG003|Overall Study|Participants Ongoing|3|||
144430935|NCT02532647|520786483|FG000|Overall Study|Did not receive trial medication|1|||
144430936|NCT02532647|520786484|FG001|Overall Study|Did not receive trial medication|0|||
144430937|NCT02532647|520786485|FG002|Overall Study|Did not receive trial medication|1|||
144430938|NCT04649164|520786491|FG000|Overall Study|Withdrawal by Subject|1|||
144430939|NCT04649164|520786492|FG001|Overall Study|Withdrawal by Subject|1|||
144430940|NCT04649164|520786493|FG002|Overall Study|Withdrawal by Subject|2|||
144430941|NCT04649164|520786491|FG000|Overall Study|Participant's care recipient expired|0|||
144430942|NCT04649164|520786492|FG001|Overall Study|Participant's care recipient expired|0|||
144430943|NCT04649164|520786493|FG002|Overall Study|Participant's care recipient expired|2|||
144430944|NCT03168464|520786494|FG000|Overall Study|Death|9|||
144430945|NCT03168464|520786494|FG000|Overall Study|Progression of disease|6|||
144430946|NCT00634088|520786499|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
144430947|NCT00634088|520786500|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
144430948|NCT00634088|520786501|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
144430949|NCT00634088|520786502|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
144430950|NCT00634088|520786499|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
144430951|NCT00634088|520786500|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
144430952|NCT00634088|520786501|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
144430953|NCT00634088|520786502|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
144430954|NCT00634088|520786499|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
144430955|NCT00634088|520786500|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
144430956|NCT00634088|520786501|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
144430957|NCT00634088|520786502|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
144430958|NCT00634088|520786499|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
144430959|NCT00634088|520786500|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
144430960|NCT00634088|520786501|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
144430961|NCT00634088|520786502|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
144529130|NCT03088878|521139173|FG013|Overall Study|Physician Decision|1|||
144529131|NCT03088878|521139160|FG000|Overall Study|COVID Related noncompliance|0|||
144529132|NCT03088878|521139161|FG001|Overall Study|COVID Related noncompliance|0|||
144529133|NCT03088878|521139162|FG002|Overall Study|COVID Related noncompliance|0|||
144252223|NCT03307837|520124648|FG002|Overall Study|Lost to Follow-up|0|||
144252224|NCT03307837|520124649|FG003|Overall Study|Lost to Follow-up|0|||
144430962|NCT00634088|520786499|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
144430963|NCT00634088|520786500|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
144430964|NCT00634088|520786501|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
144430965|NCT00634088|520786502|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
144430966|NCT00634088|520786499|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
144430967|NCT00634088|520786500|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
144430968|NCT00634088|520786501|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
144430969|NCT00634088|520786502|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
144430970|NCT02439320|520786509|FG000|Overall Study|Adverse Event|0|||
144430971|NCT02439320|520786510|FG001|Overall Study|Adverse Event|2|||
144430972|NCT02439320|520786511|FG002|Overall Study|Adverse Event|0|||
144430973|NCT02439320|520786509|FG000|Overall Study|Lost to Follow-up|37|||
144430974|NCT02439320|520786510|FG001|Overall Study|Lost to Follow-up|34|||
144430975|NCT02439320|520786511|FG002|Overall Study|Lost to Follow-up|42|||
144430976|NCT02439320|520786509|FG000|Overall Study|Death|0|||
144430977|NCT02439320|520786510|FG001|Overall Study|Death|1|||
144430978|NCT02439320|520786511|FG002|Overall Study|Death|0|||
144430979|NCT02439320|520786509|FG000|Overall Study|Noncompliance with Protocol|10|||
144430980|NCT02439320|520786510|FG001|Overall Study|Noncompliance with Protocol|11|||
144430981|NCT02439320|520786511|FG002|Overall Study|Noncompliance with Protocol|7|||
144430982|NCT02439320|520786509|FG000|Overall Study|Pregnancy|0|||
144430983|NCT02439320|520786510|FG001|Overall Study|Pregnancy|1|||
144430984|NCT02439320|520786511|FG002|Overall Study|Pregnancy|1|||
144430985|NCT02439320|520786509|FG000|Overall Study|Withdrawal by Subject|12|||
144430986|NCT02439320|520786510|FG001|Overall Study|Withdrawal by Subject|16|||
144430987|NCT02439320|520786511|FG002|Overall Study|Withdrawal by Subject|14|||
144430988|NCT02439320|520786509|FG000|Overall Study|Physician Decision|2|||
144430989|NCT02439320|520786510|FG001|Overall Study|Physician Decision|1|||
144430990|NCT02439320|520786511|FG002|Overall Study|Physician Decision|0|||
144430991|NCT02439320|520786509|FG000|Overall Study|Sponsor Request|0|||
144430992|NCT02439320|520786510|FG001|Overall Study|Sponsor Request|2|||
144430993|NCT02439320|520786511|FG002|Overall Study|Sponsor Request|1|||
144430994|NCT02439320|520786509|FG000|Overall Study|Randomization Failure|35|||
144430995|NCT02439320|520786510|FG001|Overall Study|Randomization Failure|46|||
144430996|NCT02439320|520786511|FG002|Overall Study|Randomization Failure|34|||
144430997|NCT03343483|520786517|FG000|Overall Study|Death|0|||
144430998|NCT03343483|520786518|FG001|Overall Study|Death|3|||
144430999|NCT03343483|520786517|FG000|Overall Study|Lost to Follow-up|9|||
144431000|NCT03343483|520786518|FG001|Overall Study|Lost to Follow-up|13|||
144431001|NCT03343483|520786517|FG000|Overall Study|Withdrawal by Subject|8|||
144431002|NCT03343483|520786518|FG001|Overall Study|Withdrawal by Subject|17|||
144431003|NCT01505608|520786519|FG000|Phase I|Lack of Efficacy|0|||
144431004|NCT01505608|520786520|FG001|Phase I|Lack of Efficacy|4|||
144431005|NCT01505608|520786519|FG000|Phase I|Adverse Event|0|||
144431006|NCT01505608|520786520|FG001|Phase I|Adverse Event|1|||
144431007|NCT01505608|520786519|FG000|Phase I|Withdrawal by Subject|0|||
144431008|NCT01505608|520786520|FG001|Phase I|Withdrawal by Subject|1|||
144431009|NCT01505608|520786519|FG000|Phase II|Lack of Efficacy|2|||
144431010|NCT01505608|520786520|FG001|Phase II|Lack of Efficacy|1|||
144431011|NCT01505608|520786519|FG000|Phase II|Protocol Violation|0|||
144431012|NCT01505608|520786520|FG001|Phase II|Protocol Violation|1|||
144431013|NCT00600756|520786524|FG000|Analysis After 6 Months|Adverse Event|43|||
144431014|NCT00600756|520786525|FG001|Analysis After 6 Months|Adverse Event|33|||
144185781|NCT00857818|519873605|FG001|Overall Study|Lack of Efficacy|0|||
144185782|NCT00857818|519873604|FG000|Overall Study|Adverse Event|3|||
144185783|NCT00857818|519873605|FG001|Overall Study|Adverse Event|0|||
144185784|NCT00857818|519873604|FG000|Overall Study|Withdrawal by Subject|0|||
144185785|NCT00857818|519873605|FG001|Overall Study|Withdrawal by Subject|4|||
144185786|NCT00857818|519873604|FG000|Overall Study|Sponsor terminated study|6|||
144185787|NCT00857818|519873605|FG001|Overall Study|Sponsor terminated study|4|||
144185788|NCT00857818|519873604|FG000|Overall Study|Investigator decision|1|||
144185789|NCT00857818|519873605|FG001|Overall Study|Investigator decision|0|||
144185790|NCT02625974|519873606|FG000|Part 1|Lost to Follow-up|9|||
144185791|NCT02625974|519873607|FG001|Part 1|Lost to Follow-up|3|||
144431015|NCT00600756|520786524|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
144529134|NCT03088878|521139163|FG003|Overall Study|COVID Related noncompliance|0|||
144185792|NCT02625974|519873606|FG000|Part 2|Lost to Follow-up|4|||
144185793|NCT02625974|519873607|FG001|Part 2|Lost to Follow-up|6|||
144185794|NCT02625974|519873606|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
144431016|NCT00600756|520786525|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
144431017|NCT00600756|520786524|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
144431018|NCT00600756|520786525|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
144431019|NCT00600756|520786524|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
144431020|NCT00600756|520786525|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
144431021|NCT00600756|520786524|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
144431022|NCT00600756|520786525|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
144431023|NCT00600756|520786524|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
144529135|NCT03088878|521139164|FG004|Overall Study|COVID Related noncompliance|0|||
144431024|NCT00600756|520786525|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
144431025|NCT00600756|520786524|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
144431026|NCT00600756|520786525|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
144431027|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
144431028|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
144431029|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
144431030|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
144431031|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
144431032|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
144431033|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
144431034|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
144431035|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
144431036|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
144431037|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
144431038|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
144431039|NCT00600756|520786524|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
144431040|NCT00600756|520786525|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
144431041|NCT03969992|520786527|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
144431042|NCT03969992|520786528|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
144431043|NCT03969992|520786529|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
144431044|NCT03969992|520786527|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
144431045|NCT03969992|520786528|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
144431046|NCT03969992|520786529|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
144431047|NCT03969992|520786527|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
144431048|NCT03969992|520786528|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
144431049|NCT03969992|520786529|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
144431050|NCT03969992|520786527|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
144431051|NCT03969992|520786528|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
144431052|NCT03969992|520786529|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
144431053|NCT03969992|520786527|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
144431054|NCT03969992|520786528|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
144431055|NCT03969992|520786529|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
144431056|NCT02063737|520786530|FG000|Overall Study|Lost to Follow-up|11|||
144431057|NCT02063737|520786531|FG001|Overall Study|Lost to Follow-up|4|||
144431058|NCT00439556|520786532|FG000|Overall Study|Patient was taken off study for non-comp|0|||
144431059|NCT00439556|520786533|FG001|Overall Study|Patient was taken off study for non-comp|1|||
144431060|NCT00439556|520786534|FG002|Overall Study|Patient was taken off study for non-comp|0|||
144431061|NCT01324388|520786537|FG000|Part 1 of Study|Adverse Event|2|||
144431062|NCT01324388|520786538|FG001|Part 1 of Study|Adverse Event|0|||
144431063|NCT01324388|520786539|FG002|Part 1 of Study|Adverse Event|0|||
144431064|NCT01324388|520786540|FG003|Part 1 of Study|Adverse Event|0|||
144431065|NCT01324388|520786537|FG000|Part 1 of Study|Protocol Violation|1|||
144431066|NCT01324388|520786538|FG001|Part 1 of Study|Protocol Violation|2|||
144431067|NCT01324388|520786539|FG002|Part 1 of Study|Protocol Violation|0|||
144431068|NCT01324388|520786540|FG003|Part 1 of Study|Protocol Violation|0|||
144431069|NCT01324388|520786537|FG000|Part 1 of Study|Physician Decision|1|||
144431070|NCT01324388|520786538|FG001|Part 1 of Study|Physician Decision|0|||
144431071|NCT01324388|520786539|FG002|Part 1 of Study|Physician Decision|0|||
144431072|NCT01324388|520786540|FG003|Part 1 of Study|Physician Decision|0|||
144431073|NCT01324388|520786537|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
144431074|NCT01324388|520786538|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
144431075|NCT01324388|520786539|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
144431076|NCT01324388|520786540|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
144431077|NCT01324388|520786537|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
144431078|NCT01324388|520786538|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
144431079|NCT01324388|520786539|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
144529136|NCT03088878|521139165|FG005|Overall Study|COVID Related noncompliance|0|||
144529137|NCT03088878|521139166|FG006|Overall Study|COVID Related noncompliance|0|||
144529138|NCT03088878|521139167|FG007|Overall Study|COVID Related noncompliance|0|||
144529139|NCT03088878|521139168|FG008|Overall Study|COVID Related noncompliance|0|||
144529140|NCT03088878|521139169|FG009|Overall Study|COVID Related noncompliance|0|||
144529141|NCT03088878|521139170|FG010|Overall Study|COVID Related noncompliance|0|||
144431080|NCT01324388|520786540|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
144431081|NCT01405963|520786541|FG000|Overall Study|Moved Away|2|||
144431082|NCT01405963|520786542|FG001|Overall Study|Moved Away|0|||
144529142|NCT03088878|521139171|FG011|Overall Study|COVID Related noncompliance|0|||
144431083|NCT01405963|520786541|FG000|Overall Study|Adverse Event|0|||
144529143|NCT03088878|521139172|FG012|Overall Study|COVID Related noncompliance|0|||
144252225|NCT03307837|520124650|FG004|Overall Study|Lost to Follow-up|0|||
144252226|NCT03307837|520124651|FG005|Overall Study|Lost to Follow-up|1|||
144252227|NCT00904917|520124653|FG000|Overall Study|Lost to Follow-up|2|||
144252228|NCT00904917|520124654|FG001|Overall Study|Lost to Follow-up|2|||
144252229|NCT00904917|520124655|FG002|Overall Study|Lost to Follow-up|2|||
144252230|NCT00904917|520124656|FG003|Overall Study|Lost to Follow-up|2|||
144252231|NCT00762034|520124657|FG000|Induction Period|Protocol Violation|1|||
144252232|NCT00762034|520124658|FG001|Induction Period|Protocol Violation|2|||
144252233|NCT00762034|520124657|FG000|Induction Period|Entry Criterion Not Met|12|||
144252234|NCT00762034|520124658|FG001|Induction Period|Entry Criterion Not Met|11|||
144252235|NCT00762034|520124657|FG000|Induction Period|Adverse Event|27|||
144252236|NCT00762034|520124658|FG001|Induction Period|Adverse Event|38|||
144252237|NCT00762034|520124657|FG000|Induction Period|Lost to Follow-up|1|||
144252238|NCT00762034|520124658|FG001|Induction Period|Lost to Follow-up|1|||
144252239|NCT00762034|520124657|FG000|Induction Period|Progressive Disease|73|||
144252240|NCT00762034|520124658|FG001|Induction Period|Progressive Disease|55|||
144252241|NCT00762034|520124657|FG000|Induction Period|Physician Decision|21|||
144252242|NCT00762034|520124658|FG001|Induction Period|Physician Decision|20|||
144252243|NCT00762034|520124657|FG000|Induction Period|Withdrawal by Subject|15|||
144252244|NCT00762034|520124658|FG001|Induction Period|Withdrawal by Subject|19|||
144252245|NCT00762034|520124657|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
144252246|NCT00762034|520124658|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
144252247|NCT00762034|520124657|FG000|Induction Period|Deaths Due to Study Disease|9|||
144252248|NCT00762034|520124658|FG001|Induction Period|Deaths Due to Study Disease|9|||
144252249|NCT00762034|520124657|FG000|Maintenance Period|Protocol Violation|1|||
144252250|NCT00762034|520124658|FG001|Maintenance Period|Protocol Violation|3|||
144252251|NCT00762034|520124657|FG000|Maintenance Period|Entry Criterion Not Met|0|||
144252252|NCT00762034|520124658|FG001|Maintenance Period|Entry Criterion Not Met|2|||
144252253|NCT00762034|520124657|FG000|Maintenance Period|Adverse Event|42|||
144252254|NCT00762034|520124658|FG001|Maintenance Period|Adverse Event|26|||
144252255|NCT00762034|520124657|FG000|Maintenance Period|Progressive Disease|186|||
144252256|NCT00762034|520124658|FG001|Maintenance Period|Progressive Disease|224|||
144252257|NCT00762034|520124657|FG000|Maintenance Period|Physician Decision|25|||
144252258|NCT00762034|520124658|FG001|Maintenance Period|Physician Decision|20|||
144252259|NCT00762034|520124657|FG000|Maintenance Period|Withdrawal by Subject|34|||
144252260|NCT00762034|520124658|FG001|Maintenance Period|Withdrawal by Subject|14|||
144252261|NCT00762034|520124657|FG000|Maintenance Period|Death not due to study disease|2|||
144252262|NCT00762034|520124658|FG001|Maintenance Period|Death not due to study disease|5|||
144252263|NCT00762034|520124657|FG000|Maintenance Period|Death due to study disease|3|||
144252264|NCT00762034|520124658|FG001|Maintenance Period|Death due to study disease|3|||
144252265|NCT00762034|520124657|FG000|Maintenance Period|Other|1|||
144252266|NCT00762034|520124658|FG001|Maintenance Period|Other|1|||
144252267|NCT02442206|520124659|FG000|Period 1|Adverse Event|1|||
144252268|NCT02442206|520124660|FG001|Period 1|Adverse Event|1|||
144252269|NCT02442206|520124659|FG000|Period 1|withdrew consent|0|||
144431084|NCT01405963|520786542|FG001|Overall Study|Adverse Event|1|||
144431085|NCT01405963|520786541|FG000|Overall Study|Lost to Follow-up|0|||
144431086|NCT01405963|520786542|FG001|Overall Study|Lost to Follow-up|1|||
144431087|NCT01498640|520786543|FG000|Overall Study|Lost to Follow-up|1|||
144431088|NCT01498640|520786543|FG000|Overall Study|Death|1|||
144431089|NCT01498640|520786543|FG000|Overall Study|Other|3|||
144431090|NCT01737047|520786544|FG000|Overall Study|Death|10|||
144431091|NCT01737047|520786545|FG001|Overall Study|Death|0|||
144431092|NCT01737047|520786546|FG002|Overall Study|Death|1|||
144431093|NCT01737047|520786544|FG000|Overall Study|Withdrawal by Subject|17|||
144431094|NCT01737047|520786545|FG001|Overall Study|Withdrawal by Subject|11|||
144431095|NCT01737047|520786546|FG002|Overall Study|Withdrawal by Subject|4|||
144431096|NCT00129129|520786547|FG000|Primary Phase|Adverse Event|2|||
144431097|NCT00129129|520786548|FG001|Primary Phase|Adverse Event|1|||
144431098|NCT00129129|520786549|FG002|Primary Phase|Adverse Event|0|||
144529144|NCT03088878|521139173|FG013|Overall Study|COVID Related noncompliance|1|||
144529145|NCT03088878|521139160|FG000|Overall Study|Drug or Study Noncompliance|0|||
144529146|NCT03088878|521139161|FG001|Overall Study|Drug or Study Noncompliance|0|||
144529147|NCT03088878|521139162|FG002|Overall Study|Drug or Study Noncompliance|0|||
144529148|NCT03088878|521139163|FG003|Overall Study|Drug or Study Noncompliance|0|||
144529149|NCT03088878|521139164|FG004|Overall Study|Drug or Study Noncompliance|0|||
144252270|NCT02442206|520124660|FG001|Period 1|withdrew consent|1|||
144252271|NCT02442206|520124659|FG000|Period 1|COPD exacerbation|0|||
144252272|NCT02442206|520124660|FG001|Period 1|COPD exacerbation|1|||
144252273|NCT02442206|520124659|FG000|Period 2|Adverse Event|1|||
144252274|NCT02442206|520124660|FG001|Period 2|Adverse Event|0|||
144252275|NCT02107313|520124662|FG000|Overall Study|One participant did not do the FED cohor|0|||
144431099|NCT00129129|520786550|FG003|Primary Phase|Adverse Event|0|||
144431100|NCT00129129|520786551|FG004|Primary Phase|Adverse Event|0|||
144252276|NCT02107313|520124663|FG001|Overall Study|One participant did not do the FED cohor|1|||
144252277|NCT01031004|520124664|FG000|Overall Study|Protocol Violation|0|||
144252278|NCT01031004|520124665|FG001|Overall Study|Protocol Violation|1|||
144529150|NCT03088878|521139165|FG005|Overall Study|Drug or Study Noncompliance|0|||
144529151|NCT03088878|521139166|FG006|Overall Study|Drug or Study Noncompliance|0|||
144529152|NCT03088878|521139167|FG007|Overall Study|Drug or Study Noncompliance|0|||
144529153|NCT03088878|521139168|FG008|Overall Study|Drug or Study Noncompliance|0|||
144529154|NCT03088878|521139169|FG009|Overall Study|Drug or Study Noncompliance|0|||
144529155|NCT03088878|521139170|FG010|Overall Study|Drug or Study Noncompliance|0|||
144529156|NCT03088878|521139171|FG011|Overall Study|Drug or Study Noncompliance|0|||
144529157|NCT03088878|521139172|FG012|Overall Study|Drug or Study Noncompliance|1|||
144529158|NCT03088878|521139173|FG013|Overall Study|Drug or Study Noncompliance|0|||
144529159|NCT02724969|521139176|FG000|Overall Study|Lost to Follow-up|12|||
144529160|NCT02724969|521139177|FG001|Overall Study|Lost to Follow-up|6|||
144529161|NCT02724969|521139176|FG000|Overall Study|Withdrawal by Subject|3|||
144529162|NCT02724969|521139177|FG001|Overall Study|Withdrawal by Subject|3|||
144529163|NCT02724969|521139176|FG000|Overall Study|Infant demise|0|||
144529164|NCT02724969|521139177|FG001|Overall Study|Infant demise|2|||
144529165|NCT02887521|521139183|FG000|Overall Study|Withdrawal by Subject|0|||
144529166|NCT02887521|521139184|FG001|Overall Study|Withdrawal by Subject|3|||
144529167|NCT05167864|521139185|FG000|Overall Study|Lost to Follow-up|7|||
144529168|NCT05167864|521139186|FG001|Overall Study|Lost to Follow-up|6|||
144529169|NCT05167864|521139187|FG002|Overall Study|Lost to Follow-up|7|||
144529170|NCT05167864|521139188|FG003|Overall Study|Lost to Follow-up|9|||
144529171|NCT00746096|521139189|FG000|Overall Study|Adverse Event|1|||
144529172|NCT00746096|521139190|FG001|Overall Study|Adverse Event|0|||
144529173|NCT00746096|521139189|FG000|Overall Study|Withdrawal by Subject|5|||
144529174|NCT00746096|521139190|FG001|Overall Study|Withdrawal by Subject|1|||
144185795|NCT02625974|519873607|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
144185796|NCT01142661|519873608|FG000|Overall Study|Adverse Event|2|||
144185797|NCT01142661|519873608|FG000|Overall Study|Withdrawal by Subject|1|||
144185798|NCT01142661|519873608|FG000|Overall Study|Physician Decision|1|||
144185799|NCT02129062|519875145|FG000|Overall Study|Death|1|||
144185800|NCT02129062|519875145|FG000|Overall Study|Disease Progression|2|||
144185801|NCT01923311|519875146|FG000|Overall Study|Pregnancy|1|||
144185802|NCT01923311|519875147|FG001|Overall Study|Pregnancy|0|||
144185803|NCT01923311|519875146|FG000|Overall Study|Investigator's Discretion|1|||
144185804|NCT01923311|519875147|FG001|Overall Study|Investigator's Discretion|0|||
144185805|NCT01923311|519875146|FG000|Overall Study|Non-Compliance with Study Drug|2|||
144185806|NCT01923311|519875147|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144185807|NCT01923311|519875146|FG000|Overall Study|Withdrew Consent|1|||
144185808|NCT01923311|519875147|FG001|Overall Study|Withdrew Consent|0|||
144185809|NCT01923311|519875146|FG000|Overall Study|Study Terminated by Sponsor|12|||
144185810|NCT01923311|519875147|FG001|Overall Study|Study Terminated by Sponsor|0|||
144185811|NCT04129944|519875149|FG000|Overall Study|Death|0|||
144185812|NCT04129944|519875150|FG001|Overall Study|Death|0|||
144185813|NCT04129944|519875151|FG002|Overall Study|Death|0|||
144185814|NCT04129944|519875152|FG003|Overall Study|Death|1|||
144185815|NCT04129944|519875149|FG000|Overall Study|Lost to Follow-up|1|||
144185816|NCT04129944|519875150|FG001|Overall Study|Lost to Follow-up|0|||
144185817|NCT04129944|519875151|FG002|Overall Study|Lost to Follow-up|0|||
144185818|NCT04129944|519875152|FG003|Overall Study|Lost to Follow-up|0|||
144185819|NCT04129944|519875149|FG000|Overall Study|Withdrawal by Subject|1|||
144185820|NCT04129944|519875150|FG001|Overall Study|Withdrawal by Subject|0|||
144185821|NCT04129944|519875151|FG002|Overall Study|Withdrawal by Subject|1|||
144185822|NCT04129944|519875152|FG003|Overall Study|Withdrawal by Subject|2|||
144185823|NCT02426541|519875159|FG000|Overall Study|Protocol Violation|1|||
144431101|NCT00129129|520786547|FG000|Primary Phase|Withdrawal by Subject|12|||
144431102|NCT00129129|520786548|FG001|Primary Phase|Withdrawal by Subject|10|||
144431103|NCT00129129|520786549|FG002|Primary Phase|Withdrawal by Subject|0|||
144431104|NCT00129129|520786550|FG003|Primary Phase|Withdrawal by Subject|0|||
144431105|NCT00129129|520786551|FG004|Primary Phase|Withdrawal by Subject|0|||
144431106|NCT00129129|520786547|FG000|Primary Phase|Migration from study area|1|||
144431107|NCT00129129|520786548|FG001|Primary Phase|Migration from study area|3|||
144431108|NCT00129129|520786549|FG002|Primary Phase|Migration from study area|0|||
144431109|NCT00129129|520786550|FG003|Primary Phase|Migration from study area|0|||
144431110|NCT00129129|520786551|FG004|Primary Phase|Migration from study area|0|||
144529175|NCT00746096|521139189|FG000|Overall Study|Lost to Follow-up|2|||
144529176|NCT00746096|521139190|FG001|Overall Study|Lost to Follow-up|1|||
144529177|NCT00746096|521139189|FG000|Overall Study|Protocol Violation|1|||
144529178|NCT00746096|521139190|FG001|Overall Study|Protocol Violation|0|||
144185824|NCT02426541|519875160|FG001|Overall Study|Protocol Violation|0|||
144185825|NCT00784979|519875161|FG000|Overall Study|incomplete data|6|||
144185826|NCT00894933|519875165|FG000|Overall Study|Lost to Follow-up|2|||
144185827|NCT00894933|519875165|FG000|Overall Study|Cancelled Procedure|1|||
144185828|NCT00894933|519875165|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
144185829|NCT04241133|519875168|FG000|Overall Study|COVID19 Precautions|14|||
144431111|NCT00129129|520786547|FG000|Primary Phase|Lost to Follow-up|8|||
144431112|NCT00129129|520786548|FG001|Primary Phase|Lost to Follow-up|6|||
144529179|NCT00746096|521139189|FG000|Overall Study|No study drug treatment|1|||
144529180|NCT00746096|521139190|FG001|Overall Study|No study drug treatment|1|||
144529181|NCT04737330|521139194|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
144185830|NCT04241133|519875169|FG001|Overall Study|COVID19 Precautions|34|||
144185831|NCT00631007|519875171|FG000|Overall Study|Adverse Event|0|||
144431113|NCT00129129|520786549|FG002|Primary Phase|Lost to Follow-up|0|||
144431114|NCT00129129|520786550|FG003|Primary Phase|Lost to Follow-up|0|||
144431115|NCT00129129|520786551|FG004|Primary Phase|Lost to Follow-up|0|||
144431116|NCT00129129|520786547|FG000|Primary Phase|Other|2|||
144431117|NCT00129129|520786548|FG001|Primary Phase|Other|5|||
144431118|NCT00129129|520786549|FG002|Primary Phase|Other|0|||
144431119|NCT00129129|520786550|FG003|Primary Phase|Other|0|||
144431120|NCT00129129|520786551|FG004|Primary Phase|Other|0|||
144431121|NCT00129129|520786547|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
144431122|NCT00129129|520786548|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
144431123|NCT00129129|520786549|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
144431124|NCT00129129|520786550|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
144431125|NCT00129129|520786551|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
144431126|NCT00129129|520786547|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
144431127|NCT00129129|520786548|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
144431128|NCT00129129|520786549|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
144431129|NCT00129129|520786550|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
144431130|NCT00129129|520786551|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
144431131|NCT00129129|520786547|FG000|Fourth Dose Phase|Migration from study area|0|||
144431132|NCT00129129|520786548|FG001|Fourth Dose Phase|Migration from study area|0|||
144431133|NCT00129129|520786549|FG002|Fourth Dose Phase|Migration from study area|0|||
144431134|NCT00129129|520786550|FG003|Fourth Dose Phase|Migration from study area|0|||
144431135|NCT00129129|520786551|FG004|Fourth Dose Phase|Migration from study area|2|||
144431136|NCT00129129|520786547|FG000|Fourth Dose Phase|Other|0|||
144431137|NCT00129129|520786548|FG001|Fourth Dose Phase|Other|0|||
144431138|NCT00129129|520786549|FG002|Fourth Dose Phase|Other|0|||
144431139|NCT00129129|520786550|FG003|Fourth Dose Phase|Other|1|||
144431140|NCT00129129|520786551|FG004|Fourth Dose Phase|Other|1|||
144185832|NCT00631007|519875172|FG001|Overall Study|Adverse Event|2|||
144185833|NCT00631007|519875173|FG002|Overall Study|Adverse Event|0|||
144431141|NCT00129129|520786547|FG000|Fourth Dose Phase|Protocol Violation|0|||
144431142|NCT00129129|520786548|FG001|Fourth Dose Phase|Protocol Violation|0|||
144431143|NCT00129129|520786549|FG002|Fourth Dose Phase|Protocol Violation|0|||
144431144|NCT00129129|520786550|FG003|Fourth Dose Phase|Protocol Violation|1|||
144431145|NCT00129129|520786551|FG004|Fourth Dose Phase|Protocol Violation|0|||
144431146|NCT03089606|520786552|FG000|Overall Study|Progression after Cycle 1|1|||
144431147|NCT00335972|520786553|FG000|Overall Study|not given treatments|0|||
144431148|NCT00335972|520786554|FG001|Overall Study|not given treatments|3|||
144431149|NCT02802592|520786558|FG000|Overall Study|Study terminated due to loss of funding|4|||
144431150|NCT02882854|520786561|FG000|Overall Study|Lost to Follow-up|1|||
144431151|NCT02882854|520786562|FG001|Overall Study|Lost to Follow-up|2|||
144431152|NCT02882854|520786561|FG000|Overall Study|Physician Decision|0|||
144431153|NCT02882854|520786562|FG001|Overall Study|Physician Decision|1|||
144431154|NCT02039674|520786563|FG000|Overall Study|Adverse Event|0|||
144431155|NCT02039674|520786564|FG001|Overall Study|Adverse Event|0|||
144431156|NCT02039674|520786565|FG002|Overall Study|Adverse Event|0|||
144431157|NCT02039674|520786566|FG003|Overall Study|Adverse Event|1|||
144431158|NCT02039674|520786567|FG004|Overall Study|Adverse Event|0|||
144431159|NCT02039674|520786568|FG005|Overall Study|Adverse Event|0|||
144431160|NCT02039674|520786569|FG006|Overall Study|Adverse Event|0|||
144529182|NCT04737330|521139195|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
144431161|NCT02039674|520786570|FG007|Overall Study|Adverse Event|0|||
144529183|NCT04737330|521139194|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
144529184|NCT04737330|521139195|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
144529185|NCT04737330|521139194|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
144529186|NCT04737330|521139195|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
144185834|NCT00631007|519875174|FG003|Overall Study|Adverse Event|2|||
144185835|NCT00631007|519875175|FG004|Overall Study|Adverse Event|3|||
144529187|NCT04737330|521139194|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
144529188|NCT04737330|521139195|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
144538457|NCT01500200|521174200|FG005|Stage 1|Withdrawal by Subject|0|||
144185836|NCT00631007|519875176|FG005|Overall Study|Adverse Event|2|||
144185837|NCT00631007|519875171|FG000|Overall Study|Lost to Follow-up|2|||
144431162|NCT02039674|520786571|FG008|Overall Study|Adverse Event|2|||
144431163|NCT02039674|520786572|FG009|Overall Study|Adverse Event|1|||
144431164|NCT02039674|520786573|FG010|Overall Study|Adverse Event|0|||
144431165|NCT02039674|520786574|FG011|Overall Study|Adverse Event|2|||
144431166|NCT02039674|520786575|FG012|Overall Study|Adverse Event|3|||
144431167|NCT02039674|520786576|FG013|Overall Study|Adverse Event|1|||
144431168|NCT02039674|520786563|FG000|Overall Study|Death|2|||
144431169|NCT02039674|520786564|FG001|Overall Study|Death|0|||
144431170|NCT02039674|520786565|FG002|Overall Study|Death|2|||
144431171|NCT02039674|520786566|FG003|Overall Study|Death|3|||
144431172|NCT02039674|520786567|FG004|Overall Study|Death|0|||
144431173|NCT02039674|520786568|FG005|Overall Study|Death|0|||
144431174|NCT02039674|520786569|FG006|Overall Study|Death|1|||
144185838|NCT00631007|519875172|FG001|Overall Study|Lost to Follow-up|1|||
144185839|NCT00631007|519875173|FG002|Overall Study|Lost to Follow-up|2|||
144185840|NCT00631007|519875174|FG003|Overall Study|Lost to Follow-up|4|||
144185841|NCT00631007|519875175|FG004|Overall Study|Lost to Follow-up|5|||
144185842|NCT00631007|519875176|FG005|Overall Study|Lost to Follow-up|3|||
144185843|NCT00631007|519875171|FG000|Overall Study|Physician Decision|1|||
144185844|NCT00631007|519875172|FG001|Overall Study|Physician Decision|0|||
144185845|NCT00631007|519875173|FG002|Overall Study|Physician Decision|1|||
144185846|NCT00631007|519875174|FG003|Overall Study|Physician Decision|0|||
144185847|NCT00631007|519875175|FG004|Overall Study|Physician Decision|0|||
144185848|NCT00631007|519875176|FG005|Overall Study|Physician Decision|2|||
144185849|NCT00631007|519875171|FG000|Overall Study|Persistent Hyperglycemia|2|||
144185850|NCT00631007|519875172|FG001|Overall Study|Persistent Hyperglycemia|2|||
144185851|NCT00631007|519875173|FG002|Overall Study|Persistent Hyperglycemia|5|||
144185852|NCT00631007|519875174|FG003|Overall Study|Persistent Hyperglycemia|1|||
144185853|NCT00631007|519875175|FG004|Overall Study|Persistent Hyperglycemia|2|||
144185854|NCT00631007|519875176|FG005|Overall Study|Persistent Hyperglycemia|5|||
144185855|NCT00631007|519875171|FG000|Overall Study|Withdrawal by Subject|4|||
144185856|NCT00631007|519875172|FG001|Overall Study|Withdrawal by Subject|5|||
144185857|NCT00631007|519875173|FG002|Overall Study|Withdrawal by Subject|2|||
144185858|NCT00631007|519875174|FG003|Overall Study|Withdrawal by Subject|2|||
144185859|NCT00631007|519875175|FG004|Overall Study|Withdrawal by Subject|1|||
144185860|NCT00631007|519875176|FG005|Overall Study|Withdrawal by Subject|3|||
144185861|NCT00631007|519875171|FG000|Overall Study|Other|2|||
144185862|NCT00631007|519875172|FG001|Overall Study|Other|1|||
144185863|NCT00631007|519875173|FG002|Overall Study|Other|0|||
144185864|NCT00631007|519875174|FG003|Overall Study|Other|0|||
144185865|NCT00631007|519875175|FG004|Overall Study|Other|1|||
144185866|NCT00631007|519875176|FG005|Overall Study|Other|0|||
144431175|NCT02039674|520786570|FG007|Overall Study|Death|0|||
144431176|NCT02039674|520786571|FG008|Overall Study|Death|2|||
144431177|NCT02039674|520786572|FG009|Overall Study|Death|0|||
144431178|NCT02039674|520786573|FG010|Overall Study|Death|1|||
144431179|NCT02039674|520786574|FG011|Overall Study|Death|3|||
144431180|NCT02039674|520786575|FG012|Overall Study|Death|2|||
144431181|NCT02039674|520786576|FG013|Overall Study|Death|8|||
144431182|NCT02039674|520786563|FG000|Overall Study|Excluded Medication|1|||
144431183|NCT02039674|520786564|FG001|Overall Study|Excluded Medication|1|||
144431184|NCT02039674|520786565|FG002|Overall Study|Excluded Medication|0|||
144431185|NCT02039674|520786566|FG003|Overall Study|Excluded Medication|1|||
144431186|NCT02039674|520786567|FG004|Overall Study|Excluded Medication|0|||
144431187|NCT02039674|520786568|FG005|Overall Study|Excluded Medication|1|||
144431188|NCT02039674|520786569|FG006|Overall Study|Excluded Medication|0|||
144431189|NCT02039674|520786570|FG007|Overall Study|Excluded Medication|0|||
144431190|NCT02039674|520786571|FG008|Overall Study|Excluded Medication|2|||
144431191|NCT02039674|520786572|FG009|Overall Study|Excluded Medication|3|||
144431192|NCT02039674|520786573|FG010|Overall Study|Excluded Medication|5|||
144431193|NCT02039674|520786574|FG011|Overall Study|Excluded Medication|6|||
144431194|NCT02039674|520786575|FG012|Overall Study|Excluded Medication|8|||
144431195|NCT02039674|520786576|FG013|Overall Study|Excluded Medication|3|||
144431196|NCT02039674|520786563|FG000|Overall Study|Lost to Follow-up|0|||
144431197|NCT02039674|520786564|FG001|Overall Study|Lost to Follow-up|0|||
144431198|NCT02039674|520786565|FG002|Overall Study|Lost to Follow-up|0|||
144431199|NCT02039674|520786566|FG003|Overall Study|Lost to Follow-up|0|||
144431200|NCT02039674|520786567|FG004|Overall Study|Lost to Follow-up|1|||
144431201|NCT02039674|520786568|FG005|Overall Study|Lost to Follow-up|1|||
144431202|NCT02039674|520786569|FG006|Overall Study|Lost to Follow-up|0|||
144185867|NCT00683787|519875177|FG000|Overall Study|Progression|3|||
144252279|NCT01031004|520124664|FG000|Overall Study|Lost to Follow-up|1|||
144252280|NCT01031004|520124665|FG001|Overall Study|Lost to Follow-up|0|||
144252281|NCT01641471|520124666|FG000|Overall Study|Withdrawal by Subject|19|||
144252282|NCT01641471|520124667|FG001|Overall Study|Withdrawal by Subject|19|||
144252283|NCT01641471|520124666|FG000|Overall Study|Lost to Follow-up|2|||
144431203|NCT02039674|520786570|FG007|Overall Study|Lost to Follow-up|0|||
144431204|NCT02039674|520786571|FG008|Overall Study|Lost to Follow-up|0|||
144431205|NCT02039674|520786572|FG009|Overall Study|Lost to Follow-up|0|||
144431206|NCT02039674|520786573|FG010|Overall Study|Lost to Follow-up|0|||
144431207|NCT02039674|520786574|FG011|Overall Study|Lost to Follow-up|2|||
144431208|NCT02039674|520786575|FG012|Overall Study|Lost to Follow-up|2|||
144185868|NCT00683787|519875178|FG001|Overall Study|Progression|3|||
144185869|NCT00683787|519875179|FG002|Overall Study|Progression|0|||
144185870|NCT00683787|519875177|FG000|Overall Study|Adverse Event|0|||
144185871|NCT00683787|519875178|FG001|Overall Study|Adverse Event|0|||
144185872|NCT00683787|519875179|FG002|Overall Study|Adverse Event|2|||
144185873|NCT02674633|519875180|FG000|Overall Study|Lost to Follow-up|3|||
144185874|NCT02674633|519875181|FG001|Overall Study|Lost to Follow-up|2|||
144431209|NCT02039674|520786576|FG013|Overall Study|Lost to Follow-up|1|||
144431210|NCT02039674|520786563|FG000|Overall Study|Physician Decision|0|||
144431211|NCT02039674|520786564|FG001|Overall Study|Physician Decision|0|||
144431212|NCT02039674|520786565|FG002|Overall Study|Physician Decision|0|||
144431213|NCT02039674|520786566|FG003|Overall Study|Physician Decision|0|||
144185875|NCT02674633|519875180|FG000|Overall Study|Physician Decision|1|||
144431214|NCT02039674|520786567|FG004|Overall Study|Physician Decision|0|||
144431215|NCT02039674|520786568|FG005|Overall Study|Physician Decision|0|||
144431216|NCT02039674|520786569|FG006|Overall Study|Physician Decision|0|||
144431217|NCT02039674|520786570|FG007|Overall Study|Physician Decision|0|||
144431218|NCT02039674|520786571|FG008|Overall Study|Physician Decision|0|||
144431219|NCT02039674|520786572|FG009|Overall Study|Physician Decision|0|||
144431220|NCT02039674|520786573|FG010|Overall Study|Physician Decision|0|||
144431221|NCT02039674|520786574|FG011|Overall Study|Physician Decision|1|||
144431222|NCT02039674|520786575|FG012|Overall Study|Physician Decision|1|||
144431223|NCT02039674|520786576|FG013|Overall Study|Physician Decision|0|||
144431224|NCT02039674|520786563|FG000|Overall Study|Progressive Disease|8|||
144431225|NCT02039674|520786564|FG001|Overall Study|Progressive Disease|8|||
144431226|NCT02039674|520786565|FG002|Overall Study|Progressive Disease|6|||
144431227|NCT02039674|520786566|FG003|Overall Study|Progressive Disease|7|||
144431228|NCT02039674|520786567|FG004|Overall Study|Progressive Disease|9|||
144431229|NCT02039674|520786568|FG005|Overall Study|Progressive Disease|10|||
144431230|NCT02039674|520786569|FG006|Overall Study|Progressive Disease|1|||
144431231|NCT02039674|520786570|FG007|Overall Study|Progressive Disease|3|||
144431232|NCT02039674|520786571|FG008|Overall Study|Progressive Disease|6|||
144431233|NCT02039674|520786572|FG009|Overall Study|Progressive Disease|4|||
144431234|NCT02039674|520786573|FG010|Overall Study|Progressive Disease|0|||
144431235|NCT02039674|520786574|FG011|Overall Study|Progressive Disease|34|||
144431236|NCT02039674|520786575|FG012|Overall Study|Progressive Disease|34|||
144431237|NCT02039674|520786576|FG013|Overall Study|Progressive Disease|18|||
144431238|NCT02039674|520786563|FG000|Overall Study|Withdrawal by Subject|1|||
144431239|NCT02039674|520786564|FG001|Overall Study|Withdrawal by Subject|2|||
144431240|NCT02039674|520786565|FG002|Overall Study|Withdrawal by Subject|3|||
144431241|NCT02039674|520786566|FG003|Overall Study|Withdrawal by Subject|0|||
144431242|NCT02039674|520786567|FG004|Overall Study|Withdrawal by Subject|1|||
144185876|NCT02674633|519875181|FG001|Overall Study|Physician Decision|0|||
144185877|NCT02674633|519875180|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144185878|NCT02674633|519875181|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
144185879|NCT00460109|519875182|FG000|Overall Study|Death|1|||
144185880|NCT01235715|519875183|FG000|Overall Study|Physician Decision|0|||
144185881|NCT01235715|519875184|FG001|Overall Study|Physician Decision|2|||
144185882|NCT03619876|519875185|FG000|Overall Study|Withdrawal by Subject|1|||
144185883|NCT03619876|519875186|FG001|Overall Study|Withdrawal by Subject|2|||
144185884|NCT03619876|519875185|FG000|Overall Study|Withdrawal due to incidental finding|0|||
144185885|NCT03619876|519875186|FG001|Overall Study|Withdrawal due to incidental finding|2|||
144185886|NCT02994394|519875187|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
144252284|NCT01641471|520124667|FG001|Overall Study|Lost to Follow-up|4|||
144252285|NCT01641471|520124666|FG000|Overall Study|Protocol Violation|2|||
144431243|NCT02039674|520786568|FG005|Overall Study|Withdrawal by Subject|0|||
144431244|NCT02039674|520786569|FG006|Overall Study|Withdrawal by Subject|0|||
144431245|NCT02039674|520786570|FG007|Overall Study|Withdrawal by Subject|0|||
144431246|NCT02039674|520786571|FG008|Overall Study|Withdrawal by Subject|0|||
144431247|NCT02039674|520786572|FG009|Overall Study|Withdrawal by Subject|1|||
144431248|NCT02039674|520786573|FG010|Overall Study|Withdrawal by Subject|1|||
144431249|NCT02039674|520786574|FG011|Overall Study|Withdrawal by Subject|4|||
144431250|NCT02039674|520786575|FG012|Overall Study|Withdrawal by Subject|6|||
144431251|NCT02039674|520786576|FG013|Overall Study|Withdrawal by Subject|2|||
144431252|NCT02039674|520786563|FG000|Overall Study|Clinical Progression|0|||
144431253|NCT02039674|520786564|FG001|Overall Study|Clinical Progression|0|||
144431254|NCT02039674|520786565|FG002|Overall Study|Clinical Progression|0|||
144431255|NCT02039674|520786566|FG003|Overall Study|Clinical Progression|0|||
144431256|NCT02039674|520786567|FG004|Overall Study|Clinical Progression|0|||
144431257|NCT02039674|520786568|FG005|Overall Study|Clinical Progression|0|||
144431258|NCT02039674|520786569|FG006|Overall Study|Clinical Progression|1|||
144431259|NCT02039674|520786570|FG007|Overall Study|Clinical Progression|0|||
144431260|NCT02039674|520786571|FG008|Overall Study|Clinical Progression|0|||
144431261|NCT02039674|520786572|FG009|Overall Study|Clinical Progression|0|||
144431262|NCT02039674|520786573|FG010|Overall Study|Clinical Progression|0|||
144431263|NCT02039674|520786574|FG011|Overall Study|Clinical Progression|0|||
144431264|NCT02039674|520786575|FG012|Overall Study|Clinical Progression|1|||
144431265|NCT02039674|520786576|FG013|Overall Study|Clinical Progression|0|||
144185887|NCT02994394|519875188|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
144185888|NCT02994394|519875189|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
144185889|NCT02994394|519875190|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
144185890|NCT02994394|519875191|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
144252286|NCT01641471|520124667|FG001|Overall Study|Protocol Violation|4|||
144431266|NCT02039674|520786563|FG000|Overall Study|Sponsor Decision|1|||
144431267|NCT02039674|520786564|FG001|Overall Study|Sponsor Decision|1|||
144431268|NCT02039674|520786565|FG002|Overall Study|Sponsor Decision|1|||
144431269|NCT02039674|520786566|FG003|Overall Study|Sponsor Decision|1|||
144431270|NCT02039674|520786567|FG004|Overall Study|Sponsor Decision|1|||
144431271|NCT02039674|520786568|FG005|Overall Study|Sponsor Decision|0|||
144431272|NCT02039674|520786569|FG006|Overall Study|Sponsor Decision|0|||
144185891|NCT02994394|519875192|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
144185892|NCT02994394|519875187|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
144185893|NCT02994394|519875188|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
144185894|NCT02994394|519875189|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
144185895|NCT02994394|519875190|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
144185896|NCT02994394|519875191|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
144529189|NCT04737330|521139194|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
144529190|NCT04737330|521139195|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
144529191|NCT04737330|521139194|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
144529192|NCT04737330|521139195|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
144529193|NCT03034356|521139203|FG000|Baseline|Lost to Follow-up|2|||
144529194|NCT03034356|521139204|FG001|Baseline|Lost to Follow-up|4|||
144529195|NCT03034356|521139203|FG000|Baseline|Withdrawal by Subject|2|||
144529196|NCT03034356|521139204|FG001|Baseline|Withdrawal by Subject|0|||
144529197|NCT03034356|521139203|FG000|Baseline|Physician Decision|0|||
144529198|NCT03034356|521139204|FG001|Baseline|Physician Decision|1|||
144529199|NCT03034356|521139203|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
144529200|NCT03034356|521139204|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
144185897|NCT02994394|519875192|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
144185898|NCT02344745|519875193|FG000|Overall Study|Data collection sheets were lost|2|||
144185899|NCT02344745|519875194|FG001|Overall Study|Data collection sheets were lost|0|||
144185900|NCT02788513|519875195|FG000|Overall Study|Withdrawal by Subject|3|||
144185901|NCT02788513|519875196|FG001|Overall Study|Withdrawal by Subject|0|||
144185902|NCT02788513|519875197|FG002|Overall Study|Withdrawal by Subject|2|||
144185903|NCT02788513|519875198|FG003|Overall Study|Withdrawal by Subject|3|||
144431273|NCT02039674|520786570|FG007|Overall Study|Sponsor Decision|0|||
144431274|NCT02039674|520786571|FG008|Overall Study|Sponsor Decision|0|||
144185904|NCT02788513|519875199|FG004|Overall Study|Withdrawal by Subject|1|||
144185905|NCT02788513|519875195|FG000|Overall Study|Lost to Follow-up|1|||
144185906|NCT02788513|519875196|FG001|Overall Study|Lost to Follow-up|0|||
144185907|NCT02788513|519875197|FG002|Overall Study|Lost to Follow-up|0|||
144185908|NCT02788513|519875198|FG003|Overall Study|Lost to Follow-up|0|||
144185909|NCT02788513|519875199|FG004|Overall Study|Lost to Follow-up|1|||
144185910|NCT02788513|519875195|FG000|Overall Study|Adverse Event|5|||
144431275|NCT02039674|520786572|FG009|Overall Study|Sponsor Decision|3|||
144431276|NCT02039674|520786573|FG010|Overall Study|Sponsor Decision|0|||
144431277|NCT02039674|520786574|FG011|Overall Study|Sponsor Decision|8|||
144431278|NCT02039674|520786575|FG012|Overall Study|Sponsor Decision|5|||
144431279|NCT02039674|520786576|FG013|Overall Study|Sponsor Decision|0|||
144431280|NCT02039674|520786563|FG000|Overall Study|Other|0|||
144431281|NCT02039674|520786564|FG001|Overall Study|Other|0|||
144431282|NCT02039674|520786565|FG002|Overall Study|Other|0|||
144185911|NCT02788513|519875196|FG001|Overall Study|Adverse Event|8|||
144185912|NCT02788513|519875197|FG002|Overall Study|Adverse Event|4|||
144185913|NCT02788513|519875198|FG003|Overall Study|Adverse Event|2|||
144185914|NCT02788513|519875199|FG004|Overall Study|Adverse Event|2|||
144185915|NCT02788513|519875195|FG000|Overall Study|Protocol Violation|0|||
144185916|NCT02788513|519875196|FG001|Overall Study|Protocol Violation|0|||
144185917|NCT02788513|519875197|FG002|Overall Study|Protocol Violation|1|||
144185918|NCT02788513|519875198|FG003|Overall Study|Protocol Violation|1|||
144185919|NCT02788513|519875199|FG004|Overall Study|Protocol Violation|0|||
144185920|NCT02788513|519875195|FG000|Overall Study|Subject decided to stop taking treatment|0|||
144185921|NCT02788513|519875196|FG001|Overall Study|Subject decided to stop taking treatment|0|||
144185922|NCT02788513|519875197|FG002|Overall Study|Subject decided to stop taking treatment|1|||
144185923|NCT02788513|519875198|FG003|Overall Study|Subject decided to stop taking treatment|0|||
144185924|NCT02788513|519875199|FG004|Overall Study|Subject decided to stop taking treatment|0|||
144431283|NCT02039674|520786566|FG003|Overall Study|Other|0|||
144431284|NCT02039674|520786567|FG004|Overall Study|Other|0|||
144431285|NCT02039674|520786568|FG005|Overall Study|Other|0|||
144431286|NCT02039674|520786569|FG006|Overall Study|Other|0|||
144431287|NCT02039674|520786570|FG007|Overall Study|Other|0|||
144529201|NCT03034356|521139203|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
144185925|NCT02788513|519875195|FG000|Overall Study|Decision by the study team|0|||
144185926|NCT02788513|519875196|FG001|Overall Study|Decision by the study team|0|||
144185927|NCT02788513|519875197|FG002|Overall Study|Decision by the study team|0|||
144185928|NCT02788513|519875198|FG003|Overall Study|Decision by the study team|0|||
144185929|NCT02788513|519875199|FG004|Overall Study|Decision by the study team|1|||
144185930|NCT04982445|519875200|FG000|Overall Study|Protocol Violation|1|||
144185931|NCT04982445|519875200|FG000|Overall Study|Withdrawal by Subject|4|||
144185932|NCT04982445|519875200|FG000|Overall Study|Lost to Follow-up|1|||
144185933|NCT00835796|519875204|FG000|First Intervention|Withdrawal by Subject|0|||
144185934|NCT00835796|519875205|FG001|First Intervention|Withdrawal by Subject|1|||
144185935|NCT02327325|519875206|FG000|Overall Study|Withdrawal by Subject|1|||
144185936|NCT02327325|519875207|FG001|Overall Study|Withdrawal by Subject|4|||
144252287|NCT01066663|520124669|FG000|Overall Study|Adverse Event|0|||
144431288|NCT02039674|520786571|FG008|Overall Study|Other|0|||
144529202|NCT03034356|521139204|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
144252288|NCT01066663|520124670|FG001|Overall Study|Adverse Event|0|||
144252289|NCT01066663|520124671|FG002|Overall Study|Adverse Event|1|||
144252290|NCT00339833|520124672|FG000|Overall Study|Withdrawal by Subject|1|||
144529203|NCT03034356|521139203|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
144252291|NCT00339833|520124673|FG001|Overall Study|Withdrawal by Subject|2|||
144252292|NCT00339833|520124672|FG000|Overall Study|toothache|0|||
144252293|NCT00339833|520124673|FG001|Overall Study|toothache|1|||
144252294|NCT00339833|520124672|FG000|Overall Study|indigestion|0|||
144252295|NCT00339833|520124673|FG001|Overall Study|indigestion|1|||
144431289|NCT02039674|520786572|FG009|Overall Study|Other|0|||
144431290|NCT02039674|520786573|FG010|Overall Study|Other|0|||
144431291|NCT02039674|520786574|FG011|Overall Study|Other|0|||
144431292|NCT02039674|520786575|FG012|Overall Study|Other|1|||
144431293|NCT02039674|520786576|FG013|Overall Study|Other|0|||
144431294|NCT01408030|520786578|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
144431295|NCT01408030|520786579|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
144431296|NCT01408030|520786580|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
144431297|NCT01408030|520786581|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
144431298|NCT01408030|520786578|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
144431299|NCT01408030|520786579|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
144431300|NCT01408030|520786580|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
144431301|NCT01408030|520786581|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
144431302|NCT01408030|520786578|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
144431303|NCT01408030|520786579|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
144431304|NCT01408030|520786580|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
144431305|NCT01408030|520786581|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
144431306|NCT01408030|520786578|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
144431307|NCT01408030|520786579|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
144431308|NCT01408030|520786580|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
144431309|NCT01408030|520786581|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
144431310|NCT01408030|520786578|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
144431311|NCT01408030|520786579|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
144431312|NCT01408030|520786580|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
144431313|NCT01408030|520786581|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
144431314|NCT01408030|520786578|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
144431315|NCT01408030|520786579|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
144431316|NCT01408030|520786580|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
144431317|NCT01408030|520786581|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
144529204|NCT03034356|521139204|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
144529205|NCT03034356|521139203|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
144529206|NCT03034356|521139204|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
144529207|NCT02684227|521139206|FG000|Overall Study|Adverse Event|1|||
144529208|NCT02684227|521139207|FG001|Overall Study|Adverse Event|7|||
144529209|NCT02684227|521139206|FG000|Overall Study|Death|0|||
144529210|NCT02684227|521139207|FG001|Overall Study|Death|2|||
144529211|NCT02684227|521139206|FG000|Overall Study|Withdrawal by Subject|0|||
144529212|NCT02684227|521139207|FG001|Overall Study|Withdrawal by Subject|1|||
144529213|NCT02684227|521139206|FG000|Overall Study|Progressive Disease|0|||
144529214|NCT02684227|521139207|FG001|Overall Study|Progressive Disease|2|||
144529215|NCT04689256|521139208|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
144529216|NCT04689256|521139209|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
144529217|NCT04428203|521139212|FG000|Overall Study|Adverse Event|1|||
144529218|NCT04428203|521139213|FG001|Overall Study|Adverse Event|0|||
144529219|NCT04428203|521139214|FG002|Overall Study|Adverse Event|0|||
144529220|NCT04428203|521139212|FG000|Overall Study|Withdrawal by Subject|1|||
144529221|NCT04428203|521139213|FG001|Overall Study|Withdrawal by Subject|0|||
144529222|NCT04428203|521139214|FG002|Overall Study|Withdrawal by Subject|1|||
144529223|NCT02823145|521139215|FG000|Enrollment|Other|1|||
144529224|NCT02823145|521139216|FG001|Enrollment|Other|0|||
144529225|NCT02823145|521139215|FG000|Treatment|Adverse Event|0|||
144529226|NCT02823145|521139216|FG001|Treatment|Adverse Event|11|||
144529227|NCT02823145|521139215|FG000|Treatment|Death|0|||
144529228|NCT02823145|521139216|FG001|Treatment|Death|3|||
144529229|NCT02823145|521139215|FG000|Treatment|Family Decision|0|||
144529230|NCT02823145|521139216|FG001|Treatment|Family Decision|1|||
144431318|NCT01408030|520786578|FG000|Observation Phase (Off Drug)|Other|1|||
144529231|NCT02823145|521139215|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
144529232|NCT02823145|521139216|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
144529233|NCT02823145|521139215|FG000|Treatment|Lack of Efficacy|0|||
144252296|NCT00339833|520124672|FG000|Overall Study|Chest pain|0|||
144431319|NCT01408030|520786579|FG001|Observation Phase (Off Drug)|Other|1|||
144431320|NCT01408030|520786580|FG002|Observation Phase (Off Drug)|Other|1|||
144431321|NCT01408030|520786581|FG003|Observation Phase (Off Drug)|Other|1|||
144529234|NCT02823145|521139216|FG001|Treatment|Lack of Efficacy|48|||
144252297|NCT00339833|520124673|FG001|Overall Study|Chest pain|1|||
144252298|NCT00339833|520124672|FG000|Overall Study|minor infection|0|||
144185937|NCT02327325|519875208|FG002|Overall Study|Withdrawal by Subject|4|||
144185938|NCT02327325|519875206|FG000|Overall Study|Excluded by Study Team|0|||
144185939|NCT02327325|519875207|FG001|Overall Study|Excluded by Study Team|0|||
144185940|NCT02327325|519875208|FG002|Overall Study|Excluded by Study Team|1|||
144185941|NCT00651183|519875209|FG000|Overall Study|Lack of Efficacy|1|||
144185942|NCT00651183|519875210|FG001|Overall Study|Lack of Efficacy|0|||
144185943|NCT00651183|519875209|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
144185944|NCT00651183|519875210|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
144185945|NCT00651183|519875209|FG000|Overall Study|Tolerability insufficient|5|||
144185946|NCT00651183|519875210|FG001|Overall Study|Tolerability insufficient|2|||
144185947|NCT00651183|519875209|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
144185948|NCT00651183|519875210|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
144185949|NCT00651183|519875209|FG000|Overall Study|Withdrawal by Subject|6|||
144185950|NCT00651183|519875210|FG001|Overall Study|Withdrawal by Subject|3|||
144185951|NCT00651183|519875209|FG000|Overall Study|Lost to Follow-up|3|||
144185952|NCT00651183|519875210|FG001|Overall Study|Lost to Follow-up|1|||
144185953|NCT00651183|519875209|FG000|Overall Study|Other reasons|4|||
144185954|NCT00651183|519875210|FG001|Overall Study|Other reasons|2|||
144185955|NCT00651183|519875209|FG000|Overall Study|missing|1|||
144185956|NCT00651183|519875210|FG001|Overall Study|missing|0|||
144185957|NCT02576717|519875217|FG000|Overall Study|Other Reasons|16|||
144185958|NCT02576717|519875218|FG001|Overall Study|Other Reasons|18|||
144185959|NCT02576717|519875219|FG002|Overall Study|Other Reasons|15|||
144185960|NCT02576717|519875217|FG000|Overall Study|Covid-19 Pandemic|0|||
144185961|NCT02576717|519875218|FG001|Overall Study|Covid-19 Pandemic|1|||
144185962|NCT02576717|519875219|FG002|Overall Study|Covid-19 Pandemic|1|||
144185963|NCT02576717|519875217|FG000|Overall Study|Sponsor Decision|0|||
144185964|NCT02576717|519875218|FG001|Overall Study|Sponsor Decision|0|||
144185965|NCT02576717|519875219|FG002|Overall Study|Sponsor Decision|1|||
144185966|NCT02576717|519875217|FG000|Overall Study|Physician Decision|3|||
144185967|NCT02576717|519875218|FG001|Overall Study|Physician Decision|8|||
144185968|NCT02576717|519875219|FG002|Overall Study|Physician Decision|9|||
144252299|NCT00339833|520124673|FG001|Overall Study|minor infection|1|||
144431322|NCT03774433|520786582|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
144431323|NCT00108160|520786583|FG000|Overall Study|Lost to Follow-up|25|||
144431324|NCT00108160|520786584|FG001|Overall Study|Lost to Follow-up|12|||
144431325|NCT00108160|520786583|FG000|Overall Study|Death|1|||
144431326|NCT00108160|520786584|FG001|Overall Study|Death|2|||
144431327|NCT00108160|520786583|FG000|Overall Study|Withdrawal by Subject|4|||
144431328|NCT00108160|520786584|FG001|Overall Study|Withdrawal by Subject|2|||
144431329|NCT00108160|520786583|FG000|Overall Study|Protocol Violation|9|||
144431330|NCT00108160|520786584|FG001|Overall Study|Protocol Violation|5|||
144431331|NCT04365556|520786593|FG000|Overall Study|No longer eligible due to treatment plan|1|||
144431332|NCT04365556|520786594|FG001|Overall Study|No longer eligible due to treatment plan|0|||
144604208|NCT00283049|521414259|FG002|Overall Study|Protocol Violation|3|||
144604209|NCT00283049|521414257|FG000|Overall Study|Death|1|||
144431333|NCT04365556|520786593|FG000|Overall Study|Lost to Follow-up|3|||
144431334|NCT04365556|520786594|FG001|Overall Study|Lost to Follow-up|2|||
144431335|NCT05083442|520788169|FG000|Overall Study|Lost to Follow-up|1|||
144431336|NCT05083442|520788170|FG001|Overall Study|Lost to Follow-up|0|||
144431337|NCT05083442|520788169|FG000|Overall Study|Lack of Efficacy|0|||
144431338|NCT05083442|520788170|FG001|Overall Study|Lack of Efficacy|1|||
144604210|NCT00283049|521414258|FG001|Overall Study|Death|1|||
144185969|NCT02576717|519875217|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
144431339|NCT05083442|520788169|FG000|Overall Study|Withdrawal by Subject|1|||
144431340|NCT05083442|520788170|FG001|Overall Study|Withdrawal by Subject|3|||
144431341|NCT05083442|520788169|FG000|Overall Study|scheduling difficulties|1|||
144431342|NCT05083442|520788170|FG001|Overall Study|scheduling difficulties|2|||
144431343|NCT00136084|520788174|FG000|Overall Study|Death|12|||
144431344|NCT00136084|520788175|FG001|Overall Study|Death|5|||
144431345|NCT00136084|520788174|FG000|Overall Study|Unacceptable toxicity|8|||
144431346|NCT00136084|520788175|FG001|Overall Study|Unacceptable toxicity|11|||
144431347|NCT00136084|520788174|FG000|Overall Study|Relapse|20|||
144431348|NCT00136084|520788175|FG001|Overall Study|Relapse|23|||
144431349|NCT00136084|520788174|FG000|Overall Study|Lost to Follow-up|2|||
144431350|NCT00136084|520788175|FG001|Overall Study|Lost to Follow-up|0|||
144431351|NCT00136084|520788174|FG000|Overall Study|No Response|1|||
144431352|NCT00136084|520788175|FG001|Overall Study|No Response|2|||
144431353|NCT00136084|520788174|FG000|Overall Study|Withdrawal by Subject|5|||
144431354|NCT00136084|520788175|FG001|Overall Study|Withdrawal by Subject|1|||
144431355|NCT00644969|520788176|FG000|Treatment Phase|Randomized, not treated|1|||
144185970|NCT02576717|519875218|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
144185971|NCT02576717|519875219|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
144185972|NCT02576717|519875217|FG000|Overall Study|Death|3|||
144185973|NCT02576717|519875218|FG001|Overall Study|Death|5|||
144185974|NCT02576717|519875219|FG002|Overall Study|Death|3|||
144252300|NCT00339833|520124672|FG000|Overall Study|Poor venous access|2|||
144604211|NCT00283049|521414259|FG002|Overall Study|Death|1|||
144185975|NCT02576717|519875217|FG000|Overall Study|Lost to Follow-up|9|||
144185976|NCT02576717|519875218|FG001|Overall Study|Lost to Follow-up|10|||
144185977|NCT02576717|519875219|FG002|Overall Study|Lost to Follow-up|19|||
144185978|NCT02576717|519875217|FG000|Overall Study|Protocol Violation|4|||
144185979|NCT02576717|519875218|FG001|Overall Study|Protocol Violation|0|||
144185980|NCT02576717|519875219|FG002|Overall Study|Protocol Violation|5|||
144185981|NCT02576717|519875217|FG000|Overall Study|Lack of Efficacy|24|||
144185982|NCT02576717|519875218|FG001|Overall Study|Lack of Efficacy|28|||
144185983|NCT02576717|519875219|FG002|Overall Study|Lack of Efficacy|20|||
144185984|NCT02576717|519875217|FG000|Overall Study|Adverse Event|26|||
144185985|NCT02576717|519875218|FG001|Overall Study|Adverse Event|32|||
144185986|NCT02576717|519875219|FG002|Overall Study|Adverse Event|26|||
144185987|NCT00399893|519875220|FG000|Overall Study|Withdrawal by Subject|1|||
144185988|NCT00399893|519875221|FG001|Overall Study|Withdrawal by Subject|0|||
144185989|NCT04412057|519875222|FG000|Overall Study|Death|3|||
144185990|NCT04412057|519875223|FG001|Overall Study|Death|7|||
144185991|NCT04412057|519875222|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
144185992|NCT04412057|519875223|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
144185993|NCT03330236|519875225|FG000|Overall Study|Death|2|||
144185994|NCT03330236|519875226|FG001|Overall Study|Death|1|||
144185995|NCT03330236|519875225|FG000|Overall Study|Withdrawal by Subject|2|||
144185996|NCT03330236|519875226|FG001|Overall Study|Withdrawal by Subject|4|||
144185997|NCT03330236|519875225|FG000|Overall Study|Lost to Follow-up|0|||
144185998|NCT03330236|519875226|FG001|Overall Study|Lost to Follow-up|2|||
144185999|NCT03330236|519875225|FG000|Overall Study|Physician Decision|2|||
144186000|NCT03330236|519875226|FG001|Overall Study|Physician Decision|0|||
144186001|NCT03330236|519875225|FG000|Overall Study|Protocol Violation|4|||
144186002|NCT03330236|519875226|FG001|Overall Study|Protocol Violation|3|||
144186003|NCT03330236|519875225|FG000|Overall Study|SedLine malfunction/blinding|19|||
144186004|NCT03330236|519875226|FG001|Overall Study|SedLine malfunction/blinding|14|||
144186005|NCT03330236|519875225|FG000|Overall Study|Volatile anesthetics used|11|||
144186006|NCT03330236|519875226|FG001|Overall Study|Volatile anesthetics used|8|||
144186007|NCT03330236|519875225|FG000|Overall Study|Surgery aborted/converted to open|60|||
144186008|NCT03330236|519875226|FG001|Overall Study|Surgery aborted/converted to open|52|||
144186009|NCT00407745|519875233|FG000|Overall Study|Lack of Efficacy|1|||
144186010|NCT00407745|519875234|FG001|Overall Study|Lack of Efficacy|2|||
144186011|NCT00407745|519875233|FG000|Overall Study|Withdrawal by Subject|3|||
144186012|NCT00407745|519875234|FG001|Overall Study|Withdrawal by Subject|3|||
144186013|NCT00407745|519875233|FG000|Overall Study|Protocol Violation|5|||
144186014|NCT00407745|519875234|FG001|Overall Study|Protocol Violation|3|||
144186015|NCT00407745|519875233|FG000|Overall Study|Adverse Event|8|||
144186016|NCT00407745|519875234|FG001|Overall Study|Adverse Event|8|||
144186017|NCT00407745|519875233|FG000|Overall Study|Other|2|||
144186018|NCT00407745|519875234|FG001|Overall Study|Other|0|||
144186019|NCT00407745|519875233|FG000|Overall Study|Randomized, unknown if treated|0|||
144186020|NCT00407745|519875234|FG001|Overall Study|Randomized, unknown if treated|1|||
144186021|NCT01522950|519875238|FG000|Overall Study|Withdrawal by Subject|3|||
144186022|NCT01522950|519875239|FG001|Overall Study|Withdrawal by Subject|2|||
144186023|NCT01522950|519875240|FG002|Overall Study|Withdrawal by Subject|1|||
144186024|NCT01522950|519875238|FG000|Overall Study|Adverse Event|3|||
144186025|NCT01522950|519875239|FG001|Overall Study|Adverse Event|1|||
144186026|NCT01522950|519875240|FG002|Overall Study|Adverse Event|1|||
144186027|NCT01522950|519875238|FG000|Overall Study|Protocol Violation|0|||
144186028|NCT01522950|519875239|FG001|Overall Study|Protocol Violation|0|||
144186029|NCT01522950|519875240|FG002|Overall Study|Protocol Violation|2|||
144186030|NCT01522950|519875238|FG000|Overall Study|Death|0|||
144186031|NCT01522950|519875239|FG001|Overall Study|Death|1|||
144186032|NCT01522950|519875240|FG002|Overall Study|Death|1|||
144431356|NCT00644969|520788177|FG001|Treatment Phase|Randomized, not treated|0|||
144604212|NCT00283049|521414257|FG000|Overall Study|Lack of Efficacy|0|||
144604213|NCT00283049|521414258|FG001|Overall Study|Lack of Efficacy|1|||
144604214|NCT00283049|521414259|FG002|Overall Study|Lack of Efficacy|1|||
144431357|NCT00644969|520788176|FG000|Treatment Phase|Adverse Event|3|||
144431358|NCT00644969|520788177|FG001|Treatment Phase|Adverse Event|0|||
144186033|NCT01522950|519875238|FG000|Overall Study|Study Medication Sensitivity|0|||
144186034|NCT01522950|519875239|FG001|Overall Study|Study Medication Sensitivity|1|||
144186035|NCT01522950|519875240|FG002|Overall Study|Study Medication Sensitivity|0|||
144186036|NCT01064531|519875244|FG000|Overall Study|Lost to Follow-up|0|||
144186037|NCT01064531|519875245|FG001|Overall Study|Lost to Follow-up|2|||
144604215|NCT00283049|521414257|FG000|Overall Study|Lost to Follow-up|4|||
144186038|NCT01064531|519875244|FG000|Overall Study|Physician Decision|0|||
144186039|NCT01064531|519875245|FG001|Overall Study|Physician Decision|1|||
144186040|NCT01064531|519875244|FG000|Overall Study|Withdrawal by Subject|2|||
144186041|NCT01064531|519875245|FG001|Overall Study|Withdrawal by Subject|2|||
144186042|NCT01064531|519875244|FG000|Overall Study|Revision due to femoral stem loosening|1|||
144186043|NCT01064531|519875245|FG001|Overall Study|Revision due to femoral stem loosening|0|||
144186044|NCT01064531|519875244|FG000|Overall Study|Revision due to dislocation|0|||
144186045|NCT01064531|519875245|FG001|Overall Study|Revision due to dislocation|1|||
144723803|NCT01031537|521844204|FG000|Overall Study|medical reasons not related to study|3|||
144723804|NCT01031537|521844204|FG000|Overall Study|Lack of Efficacy|1|||
144723805|NCT01031537|521844204|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
144723806|NCT01031537|521844204|FG000|Overall Study|moved, met exclusion criteria|10|||
144723807|NCT01031537|521844204|FG000|Overall Study|Withdrawal by Subject|5|||
144723808|NCT01031537|521844204|FG000|Overall Study|PI removal, no longer met eligibility|12|||
144723809|NCT02132247|521844205|FG000|Overall Study|Protocol Violation|1|||
144723810|NCT02132247|521844206|FG001|Overall Study|Protocol Violation|0|||
144723811|NCT00520741|521844219|FG000|Overall Study|Adverse Event|16|||
144723812|NCT00520741|521844220|FG001|Overall Study|Adverse Event|56|||
144723813|NCT00520741|521844219|FG000|Overall Study|Lack of Efficacy|11|||
144431359|NCT00644969|520788176|FG000|Treatment Phase|Withdrawal by Subject|4|||
144431360|NCT00644969|520788177|FG001|Treatment Phase|Withdrawal by Subject|0|||
144431361|NCT00644969|520788176|FG000|Treatment Phase|Lost to Follow-up|2|||
144431362|NCT00644969|520788177|FG001|Treatment Phase|Lost to Follow-up|2|||
144431363|NCT00644969|520788176|FG000|Treatment Phase|Other|4|||
144431364|NCT00644969|520788177|FG001|Treatment Phase|Other|1|||
144431365|NCT00644969|520788176|FG000|Post Treatment Phase|Death|1|||
144431366|NCT00644969|520788177|FG001|Post Treatment Phase|Death|0|||
144431367|NCT00644969|520788176|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
144431368|NCT00644969|520788177|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
144431369|NCT00644969|520788176|FG000|Post Treatment Phase|Lost to Follow-up|4|||
144431370|NCT00644969|520788177|FG001|Post Treatment Phase|Lost to Follow-up|1|||
144431371|NCT00644969|520788176|FG000|Post Treatment Phase|Other|1|||
144529235|NCT02823145|521139215|FG000|Treatment|Non-Compliance With E-Diary|0|||
144723814|NCT00520741|521844220|FG001|Overall Study|Lack of Efficacy|30|||
144723815|NCT00520741|521844219|FG000|Overall Study|Withdrawal by Subject|0|||
144723816|NCT00520741|521844220|FG001|Overall Study|Withdrawal by Subject|11|||
144529236|NCT02823145|521139216|FG001|Treatment|Non-Compliance With E-Diary|1|||
144529237|NCT02823145|521139215|FG000|Treatment|Physician Decision|0|||
144529238|NCT02823145|521139216|FG001|Treatment|Physician Decision|2|||
144723817|NCT00520741|521844219|FG000|Overall Study|Protocol Violation|2|||
144723818|NCT00520741|521844220|FG001|Overall Study|Protocol Violation|15|||
144723819|NCT00520741|521844219|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
144723820|NCT00520741|521844220|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
144723821|NCT00520741|521844219|FG000|Overall Study|Lost to Follow-up|4|||
144186046|NCT01064531|519875244|FG000|Overall Study|Death|0|||
144186047|NCT01064531|519875245|FG001|Overall Study|Death|1|||
144186048|NCT03449199|519875246|FG000|Overall Study|Lost to Follow-up|1|||
144186049|NCT03449199|519875247|FG001|Overall Study|Lost to Follow-up|1|||
144186050|NCT03449199|519875248|FG002|Overall Study|Lost to Follow-up|0|||
144186051|NCT03449199|519875246|FG000|Overall Study|Protocol Deviation|0|||
144186052|NCT03449199|519875247|FG001|Overall Study|Protocol Deviation|0|||
144186053|NCT03449199|519875248|FG002|Overall Study|Protocol Deviation|1|||
144186054|NCT03449199|519875246|FG000|Overall Study|Withdrawal by Subject|0|||
144186055|NCT03449199|519875247|FG001|Overall Study|Withdrawal by Subject|0|||
144186056|NCT03449199|519875248|FG002|Overall Study|Withdrawal by Subject|1|||
144186057|NCT01091103|519875249|FG000|Overall Study|Adverse Event|1|||
144186058|NCT01091103|519875249|FG000|Overall Study|Progressive Disease|3|||
144186059|NCT01270620|519875250|FG000|Overall Study|Withdrawal by Subject|1|||
144186060|NCT01270620|519875251|FG001|Overall Study|Withdrawal by Subject|3|||
144186061|NCT03136406|519875252|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
144186062|NCT01628549|519875256|FG000|Overall Study|Adverse Event|1|||
144186063|NCT01628549|519875257|FG001|Overall Study|Adverse Event|1|||
144186064|NCT01628549|519875258|FG002|Overall Study|Adverse Event|0|||
144186065|NCT01628549|519875259|FG003|Overall Study|Adverse Event|4|||
144186066|NCT01628549|519875256|FG000|Overall Study|Lost to Follow-up|3|||
144186067|NCT01628549|519875257|FG001|Overall Study|Lost to Follow-up|4|||
144186068|NCT01628549|519875258|FG002|Overall Study|Lost to Follow-up|3|||
144186069|NCT01628549|519875259|FG003|Overall Study|Lost to Follow-up|3|||
144529239|NCT02823145|521139215|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
144529240|NCT02823145|521139216|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
144529241|NCT02823145|521139215|FG000|Treatment|Subject needed to take prohibited medication|0|||
144723822|NCT00520741|521844220|FG001|Overall Study|Lost to Follow-up|4|||
144723823|NCT00520741|521844219|FG000|Overall Study|Other reasons for premature termination|0|||
144723824|NCT00520741|521844220|FG001|Overall Study|Other reasons for premature termination|6|||
144186070|NCT01628549|519875256|FG000|Overall Study|Withdrawal by Subject|3|||
144723825|NCT03702621|521844221|FG000|Overall Study|Physician Decision|6|||
144723826|NCT03702621|521844222|FG001|Overall Study|Physician Decision|6|||
144186071|NCT01628549|519875257|FG001|Overall Study|Withdrawal by Subject|4|||
144186072|NCT01628549|519875258|FG002|Overall Study|Withdrawal by Subject|4|||
144186073|NCT01628549|519875259|FG003|Overall Study|Withdrawal by Subject|1|||
144186074|NCT01628549|519875256|FG000|Overall Study|Protocol Violation|2|||
144186075|NCT01628549|519875257|FG001|Overall Study|Protocol Violation|1|||
144431372|NCT00644969|520788177|FG001|Post Treatment Phase|Other|0|||
144431373|NCT02449239|520788178|FG000|Induction Phase|Lack of Efficacy|64|||
144431374|NCT02449239|520788178|FG000|Induction Phase|Adverse Event|1|||
144431375|NCT02449239|520788178|FG000|Induction Phase|Lost to Follow-up|1|||
144431376|NCT02449239|520788178|FG000|Induction Phase|Protocol Violation|1|||
144431377|NCT02449239|520788178|FG000|Induction Phase|Physician Decision|1|||
144431378|NCT02449239|520788178|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
144431379|NCT02449239|520788178|FG000|Induction Phase|Withdrawal by Subject|1|||
144431380|NCT02449239|520788178|FG000|Maintenance Month 3|Lack of Efficacy|14|||
144431381|NCT02449239|520788178|FG000|Maintenance Month 6|Lack of Efficacy|10|||
144431382|NCT02449239|520788178|FG000|Maintenance Month 6|Adverse Event|2|||
144431383|NCT02449239|520788178|FG000|Maintenance Month 6|Physician Decision|1|||
144431384|NCT02449239|520788178|FG000|Maintenance Month 9|Lack of Efficacy|2|||
144431385|NCT02449239|520788178|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
144431386|NCT02449239|520788178|FG000|Maintenance Month 12|Lack of Efficacy|5|||
144431387|NCT02449239|520788178|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
144431388|NCT02449239|520788178|FG000|Maintenance Month 12|Subject moved from area|1|||
144431389|NCT02449239|520788178|FG000|Maintenance Month 15|Lack of Efficacy|1|||
144431390|NCT02449239|520788178|FG000|Maintenance Month 21|Lack of Efficacy|1|||
144431391|NCT02449239|520788178|FG000|Maintenance Month 21|Sponsor decision|1|||
144431392|NCT03509675|520788179|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
144431393|NCT03509675|520788180|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
144431394|NCT03509675|520788179|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
144431395|NCT03509675|520788180|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
144431396|NCT03509675|520788179|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
144431397|NCT03509675|520788180|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
144431398|NCT03509675|520788179|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
144431399|NCT03509675|520788180|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
144431400|NCT05620576|520788183|FG000|Overall Study|Adverse Event|1|||
144431401|NCT05620576|520788184|FG001|Overall Study|Adverse Event|1|||
144431402|NCT05620576|520788183|FG000|Overall Study|Lost to Follow-up|3|||
144431403|NCT05620576|520788184|FG001|Overall Study|Lost to Follow-up|1|||
144431404|NCT05620576|520788183|FG000|Overall Study|Physician Decision|0|||
144431405|NCT05620576|520788184|FG001|Overall Study|Physician Decision|1|||
144431406|NCT05620576|520788183|FG000|Overall Study|Protocol Deviation|1|||
144431407|NCT05620576|520788184|FG001|Overall Study|Protocol Deviation|1|||
144431408|NCT05620576|520788183|FG000|Overall Study|Withdrawal by Subject|2|||
144431409|NCT05620576|520788184|FG001|Overall Study|Withdrawal by Subject|3|||
144431410|NCT02622828|520788185|FG000|Overall Study|participant withdrew|3|||
144431411|NCT02780804|520788186|FG000|Overall Study|Death|1|||
144604216|NCT00283049|521414258|FG001|Overall Study|Lost to Follow-up|2|||
144604217|NCT00283049|521414259|FG002|Overall Study|Lost to Follow-up|5|||
144604218|NCT00283049|521414257|FG000|Overall Study|Withdrawal by Subject|26|||
144604219|NCT00283049|521414258|FG001|Overall Study|Withdrawal by Subject|24|||
144604220|NCT00283049|521414259|FG002|Overall Study|Withdrawal by Subject|19|||
144604221|NCT00283049|521414257|FG000|Overall Study|Discontinuation of Study|18|||
144604222|NCT00283049|521414258|FG001|Overall Study|Discontinuation of Study|16|||
144186076|NCT01628549|519875258|FG002|Overall Study|Protocol Violation|1|||
144186077|NCT01628549|519875259|FG003|Overall Study|Protocol Violation|0|||
144186078|NCT01628549|519875256|FG000|Overall Study|withdrawn for noncompliance|0|||
144186079|NCT01628549|519875257|FG001|Overall Study|withdrawn for noncompliance|2|||
144186080|NCT01628549|519875258|FG002|Overall Study|withdrawn for noncompliance|1|||
144186081|NCT01628549|519875259|FG003|Overall Study|withdrawn for noncompliance|0|||
144186082|NCT01628549|519875256|FG000|Overall Study|abnormal laboratory test results|0|||
144186083|NCT01628549|519875257|FG001|Overall Study|abnormal laboratory test results|0|||
144186084|NCT01628549|519875258|FG002|Overall Study|abnormal laboratory test results|1|||
144186085|NCT01628549|519875259|FG003|Overall Study|abnormal laboratory test results|0|||
144186086|NCT01628549|519875256|FG000|Overall Study|positive pregnancy test|0|||
144186087|NCT01628549|519875257|FG001|Overall Study|positive pregnancy test|0|||
144186088|NCT01628549|519875258|FG002|Overall Study|positive pregnancy test|0|||
144186089|NCT01628549|519875259|FG003|Overall Study|positive pregnancy test|1|||
144186090|NCT00372996|519875261|FG000|Overall Study|Death|11|||
144186091|NCT00372996|519875262|FG001|Overall Study|Death|4|||
144186092|NCT00372996|519875263|FG002|Overall Study|Death|8|||
144186093|NCT00372996|519875264|FG003|Overall Study|Death|7|||
144186094|NCT00372996|519875261|FG000|Overall Study|Lost to Follow-up|0|||
144186095|NCT00372996|519875262|FG001|Overall Study|Lost to Follow-up|2|||
144186096|NCT00372996|519875263|FG002|Overall Study|Lost to Follow-up|0|||
144431412|NCT02780804|520788187|FG001|Overall Study|Death|0|||
144431413|NCT02780804|520788188|FG002|Overall Study|Death|0|||
144431414|NCT02780804|520788186|FG000|Overall Study|Lack of Efficacy|5|||
144431415|NCT02780804|520788187|FG001|Overall Study|Lack of Efficacy|8|||
144431416|NCT02780804|520788188|FG002|Overall Study|Lack of Efficacy|4|||
144431417|NCT02780804|520788186|FG000|Overall Study|Physician Decision|0|||
144431418|NCT02780804|520788187|FG001|Overall Study|Physician Decision|0|||
144431419|NCT02780804|520788188|FG002|Overall Study|Physician Decision|2|||
144431420|NCT02780804|520788186|FG000|Overall Study|Withdrawal by Subject|0|||
144431421|NCT02780804|520788187|FG001|Overall Study|Withdrawal by Subject|1|||
144431422|NCT02780804|520788188|FG002|Overall Study|Withdrawal by Subject|0|||
144529242|NCT02823145|521139216|FG001|Treatment|Subject needed to take prohibited medication|1|||
144529243|NCT02823145|521139215|FG000|Treatment|Subject transferred to direct access programme|0|||
144529244|NCT02823145|521139216|FG001|Treatment|Subject transferred to direct access programme|1|||
144529245|NCT02823145|521139215|FG000|Treatment|Switching to commercially available drug|0|||
144529246|NCT02823145|521139216|FG001|Treatment|Switching to commercially available drug|11|||
144529247|NCT02823145|521139215|FG000|Treatment|Transitioned to commercial supply of medication|0|||
144529248|NCT02823145|521139216|FG001|Treatment|Transitioned to commercial supply of medication|1|||
144529249|NCT02823145|521139215|FG000|Treatment|Withdrawal By Caregiver|0|||
144529250|NCT02823145|521139216|FG001|Treatment|Withdrawal By Caregiver|1|||
144604223|NCT00283049|521414259|FG002|Overall Study|Discontinuation of Study|20|||
144604224|NCT00283049|521414257|FG000|Overall Study|No longer requires study treatment|0|||
144604225|NCT00283049|521414258|FG001|Overall Study|No longer requires study treatment|0|||
144252301|NCT00339833|520124673|FG001|Overall Study|Poor venous access|2|||
144252302|NCT00339833|520124672|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
144252303|NCT00339833|520124673|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
144252304|NCT00339833|520124672|FG000|Overall Study|Error in data records|1|||
144252305|NCT00339833|520124673|FG001|Overall Study|Error in data records|0|||
144252306|NCT02829047|520124674|FG000|Overall Study|Withdrawal by Subject|1|||
144252307|NCT01597492|520124676|FG000|Overall Study|Withdrawal by Subject|1|||
144252308|NCT01597492|520124677|FG001|Overall Study|Withdrawal by Subject|2|||
144252309|NCT01597492|520124676|FG000|Overall Study|Adverse Event|3|||
144252310|NCT01597492|520124677|FG001|Overall Study|Adverse Event|0|||
144252311|NCT01597492|520124676|FG000|Overall Study|Lost to Follow-up|0|||
144252312|NCT01597492|520124677|FG001|Overall Study|Lost to Follow-up|2|||
144252313|NCT01597492|520124676|FG000|Overall Study|Other Reason|2|||
144252314|NCT01597492|520124677|FG001|Overall Study|Other Reason|0|||
144252315|NCT00482170|520124682|FG000|Overall Study|Adverse Event|5|||
144252316|NCT00482170|520124683|FG001|Overall Study|Adverse Event|14|||
144252317|NCT00482170|520124682|FG000|Overall Study|Withdrawal by Subject|6|||
144252318|NCT00482170|520124683|FG001|Overall Study|Withdrawal by Subject|1|||
144252319|NCT00482170|520124682|FG000|Overall Study|Protocol Violation|2|||
144252320|NCT00482170|520124683|FG001|Overall Study|Protocol Violation|3|||
144252321|NCT00482170|520124682|FG000|Overall Study|Lost to Follow-up|2|||
144252322|NCT00482170|520124683|FG001|Overall Study|Lost to Follow-up|0|||
144252323|NCT00482170|520124682|FG000|Overall Study|Unspecified reason|0|||
144252324|NCT00482170|520124683|FG001|Overall Study|Unspecified reason|2|||
144252325|NCT04379700|520124684|FG000|Overall Study|Withdrawal by Subject|10|||
144252326|NCT04379700|520124684|FG000|Overall Study|Screen Fail|4|||
144252327|NCT04379700|520124684|FG000|Overall Study|Lost to Follow-up|3|||
144252328|NCT03624569|520124685|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144252329|NCT03624569|520124686|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
144252330|NCT03624569|520124685|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
144252331|NCT03624569|520124686|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
144252332|NCT01134263|520124687|FG000|Overall Study|Serious adverse event|2|||
144252333|NCT01134263|520124688|FG001|Overall Study|Serious adverse event|1|||
144252334|NCT01134263|520124689|FG002|Overall Study|Serious adverse event|1|||
144252335|NCT01134263|520124690|FG003|Overall Study|Serious adverse event|1|||
144252336|NCT01134263|520124691|FG004|Overall Study|Serious adverse event|1|||
144252337|NCT01134263|520124687|FG000|Overall Study|Other adverse event|1|||
144252338|NCT01134263|520124688|FG001|Overall Study|Other adverse event|2|||
144252339|NCT01134263|520124689|FG002|Overall Study|Other adverse event|5|||
144252340|NCT01134263|520124690|FG003|Overall Study|Other adverse event|3|||
144252341|NCT01134263|520124691|FG004|Overall Study|Other adverse event|0|||
144252342|NCT01134263|520124687|FG000|Overall Study|Protocol Violation|8|||
144252343|NCT01134263|520124688|FG001|Overall Study|Protocol Violation|7|||
144604226|NCT00283049|521414259|FG002|Overall Study|No longer requires study treatment|1|||
144604227|NCT01873417|521414260|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
144604228|NCT01873417|521414260|FG000|Overall Study|Adverse Event|24|||
144604229|NCT01873417|521414260|FG000|Overall Study|Lost to Follow-up|2|||
144252344|NCT01134263|520124689|FG002|Overall Study|Protocol Violation|2|||
144529251|NCT02823145|521139215|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
144604230|NCT01873417|521414260|FG000|Overall Study|Withdrawal by Subject|2|||
144604231|NCT01873417|521414260|FG000|Overall Study|Physician Decision|3|||
144604232|NCT00785044|521414261|FG000|Overall Study|Dosed at non-participating sites|152|||
144604233|NCT00785044|521414261|FG000|Overall Study|Death|77|||
144604234|NCT00785044|521414261|FG000|Overall Study|Lost to Follow-up|266|||
144252345|NCT01134263|520124690|FG003|Overall Study|Protocol Violation|4|||
144252346|NCT01134263|520124691|FG004|Overall Study|Protocol Violation|2|||
144252347|NCT01134263|520124687|FG000|Overall Study|Lost to Follow-up|4|||
144252348|NCT01134263|520124688|FG001|Overall Study|Lost to Follow-up|3|||
144252349|NCT01134263|520124689|FG002|Overall Study|Lost to Follow-up|5|||
144252350|NCT01134263|520124690|FG003|Overall Study|Lost to Follow-up|3|||
144252351|NCT01134263|520124691|FG004|Overall Study|Lost to Follow-up|1|||
144604235|NCT00785044|521414261|FG000|Overall Study|Withdrawal by Subject|1|||
144252352|NCT01134263|520124687|FG000|Overall Study|Withdrawal by Subject|8|||
144252353|NCT01134263|520124688|FG001|Overall Study|Withdrawal by Subject|6|||
144431423|NCT04920123|520788195|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
144431424|NCT04920123|520788196|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
144431425|NCT04920123|520788197|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
144431426|NCT02586493|520788207|FG000|Overall Study|Adverse Event|4|||
144431427|NCT02586493|520788207|FG000|Overall Study|Protocol Violation|6|||
144431428|NCT02586493|520788207|FG000|Overall Study|Lost to Follow-up|1|||
144431429|NCT02586493|520788207|FG000|Overall Study|Withdrawal by Subject|1|||
144431430|NCT06134817|520788209|FG000|Overall Study|Physician Departure - termination of study|1|||
144431431|NCT00278954|520788210|FG000|Overall Study|Adverse Event|3|||
144431432|NCT00278954|520788210|FG000|Overall Study|Lost to Follow-up|1|||
144431433|NCT00278954|520788210|FG000|Overall Study|Withdrawal by Subject|1|||
144431434|NCT02046148|520788214|FG000|Overall Study|Lost to Follow-up|1|||
144431435|NCT02046148|520788215|FG001|Overall Study|Lost to Follow-up|1|||
144431436|NCT02046148|520788214|FG000|Overall Study|Withdrawal by Subject|0|||
144431437|NCT02046148|520788215|FG001|Overall Study|Withdrawal by Subject|2|||
144431438|NCT02211131|520788225|FG000|Overall Study|Death|26|||
144431439|NCT02211131|520788226|FG001|Overall Study|Death|16|||
144431440|NCT02211131|520788225|FG000|Overall Study|Lost to Follow-up|4|||
144431441|NCT02211131|520788226|FG001|Overall Study|Lost to Follow-up|3|||
144431442|NCT02211131|520788225|FG000|Overall Study|Decision by Sponsor|1|||
144431443|NCT02211131|520788226|FG001|Overall Study|Decision by Sponsor|1|||
144431444|NCT02211131|520788225|FG000|Overall Study|Withdrawal by Subject|3|||
144431445|NCT02211131|520788226|FG001|Overall Study|Withdrawal by Subject|8|||
144431446|NCT05664490|520788227|FG000|Overall Study|Withdrawal by Subject|0|||
144431447|NCT05664490|520788228|FG001|Overall Study|Withdrawal by Subject|1|||
144431448|NCT05664490|520788227|FG000|Overall Study|Lost to Follow-up|14|||
144431449|NCT05664490|520788228|FG001|Overall Study|Lost to Follow-up|22|||
144431450|NCT05442554|520788229|FG000|Overall Study|Adverse Event|1|||
144431451|NCT01752855|520788235|FG000|Overall Study|Adverse Event|1|||
144431452|NCT01752855|520788236|FG001|Overall Study|Adverse Event|0|||
144431453|NCT01752855|520788235|FG000|Overall Study|Withdrew Consent|0|||
144431454|NCT01752855|520788236|FG001|Overall Study|Withdrew Consent|2|||
144431455|NCT01752855|520788235|FG000|Overall Study|Lack of Efficacy|0|||
144431456|NCT01752855|520788236|FG001|Overall Study|Lack of Efficacy|2|||
144431457|NCT01478321|520788237|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
144431458|NCT01478321|520788237|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
144431459|NCT01478321|520788237|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
144431460|NCT01478321|520788237|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
144431461|NCT01478321|520788237|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
144431462|NCT01478321|520788237|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
144431463|NCT01478321|520788237|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
144529252|NCT02823145|521139216|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
144529253|NCT02823145|521139215|FG000|Treatment|Withdrawal by Subject|0|||
144529254|NCT02823145|521139216|FG001|Treatment|Withdrawal by Subject|16|||
144529255|NCT02823145|521139215|FG000|Treatment|Reason unknown|0|||
144529256|NCT02823145|521139216|FG001|Treatment|Reason unknown|1|||
144529257|NCT04741776|521139217|FG000|Overall Study|Withdrawal by Subject|7|||
144529258|NCT04741776|521139218|FG001|Overall Study|Withdrawal by Subject|10|||
144529259|NCT04741776|521139219|FG002|Overall Study|Withdrawal by Subject|10|||
144529260|NCT04741776|521139220|FG003|Overall Study|Withdrawal by Subject|17|||
144529261|NCT04741776|521139217|FG000|Overall Study|Death|0|||
144529262|NCT04741776|521139218|FG001|Overall Study|Death|0|||
144529263|NCT04741776|521139219|FG002|Overall Study|Death|1|||
144529264|NCT04741776|521139220|FG003|Overall Study|Death|0|||
144529265|NCT02852655|521139236|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
144529266|NCT02852655|521139237|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
144529267|NCT02852655|521139238|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
144529268|NCT02852655|521139236|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
144529269|NCT02852655|521139237|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
144529270|NCT02852655|521139238|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
144529271|NCT02852655|521139236|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
144529272|NCT02852655|521139237|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
144529273|NCT02852655|521139238|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
144529274|NCT02852655|521139236|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
144529275|NCT02852655|521139237|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
144431464|NCT01478321|520788237|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
144431465|NCT01488097|520788239|FG000|Overall Study|Lost to Follow-up|1|||
144431466|NCT01577758|520788240|FG000|Dose Escalation Phase|Adverse Event|0|||
144431467|NCT01577758|520788241|FG001|Dose Escalation Phase|Adverse Event|0|||
144431468|NCT01577758|520788242|FG002|Dose Escalation Phase|Adverse Event|0|||
144431469|NCT01577758|520788243|FG003|Dose Escalation Phase|Adverse Event|0|||
144431470|NCT01577758|520788244|FG004|Dose Escalation Phase|Adverse Event|0|||
144431471|NCT01577758|520788245|FG005|Dose Escalation Phase|Adverse Event|2|||
144431472|NCT01577758|520788246|FG006|Dose Escalation Phase|Adverse Event|1|||
144431473|NCT01577758|520788247|FG007|Dose Escalation Phase|Adverse Event|0|||
144431474|NCT01577758|520788240|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
144431475|NCT01577758|520788241|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
144431476|NCT01577758|520788242|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
144431477|NCT01577758|520788243|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
144431478|NCT01577758|520788244|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
144431479|NCT01577758|520788245|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
144431480|NCT01577758|520788246|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
144431481|NCT01577758|520788247|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
144431482|NCT01577758|520788240|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
144431483|NCT01577758|520788241|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
144431484|NCT01577758|520788242|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
144431485|NCT01577758|520788243|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144431486|NCT01577758|520788244|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
144431487|NCT01577758|520788245|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
144431488|NCT01577758|520788246|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
144431489|NCT01577758|520788247|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
144431490|NCT01577758|520788240|FG000|Dose Escalation Phase|Progression Disease|2|||
144431491|NCT01577758|520788241|FG001|Dose Escalation Phase|Progression Disease|2|||
144431492|NCT01577758|520788242|FG002|Dose Escalation Phase|Progression Disease|1|||
144604236|NCT01628107|521414262|FG000|Overall Study|Withdrawal by Subject|17|||
144604237|NCT01628107|521414262|FG000|Overall Study|Lost to Follow-up|4|||
144604238|NCT01628107|521414262|FG000|Overall Study|Adverse Event|33|||
144604239|NCT01628107|521414262|FG000|Overall Study|Physician Decision|2|||
144186097|NCT00372996|519875264|FG003|Overall Study|Lost to Follow-up|1|||
144186098|NCT00372996|519875261|FG000|Overall Study|Withdrawal by Subject|12|||
144186099|NCT00372996|519875262|FG001|Overall Study|Withdrawal by Subject|6|||
144186100|NCT00372996|519875263|FG002|Overall Study|Withdrawal by Subject|9|||
144186101|NCT00372996|519875264|FG003|Overall Study|Withdrawal by Subject|5|||
144186102|NCT00372996|519875261|FG000|Overall Study|Study Terminated by Sponsor|4|||
144186103|NCT00372996|519875262|FG001|Overall Study|Study Terminated by Sponsor|0|||
144186104|NCT00372996|519875263|FG002|Overall Study|Study Terminated by Sponsor|4|||
144186105|NCT00372996|519875264|FG003|Overall Study|Study Terminated by Sponsor|0|||
144186106|NCT00372996|519875261|FG000|Overall Study|Other|10|||
144186107|NCT00372996|519875262|FG001|Overall Study|Other|2|||
144186108|NCT00372996|519875263|FG002|Overall Study|Other|7|||
144186109|NCT00372996|519875264|FG003|Overall Study|Other|7|||
144186110|NCT01186016|519875265|FG000|Overall Study|Withdrawal by Subject|46|||
144186111|NCT01186016|519875266|FG001|Overall Study|Withdrawal by Subject|29|||
144186112|NCT00721955|519875270|FG000|Overall Study|Adverse Event|0|||
144186113|NCT00721955|519875271|FG001|Overall Study|Adverse Event|0|||
144186114|NCT00721955|519875272|FG002|Overall Study|Adverse Event|2|||
144186115|NCT01292837|519875273|FG000|Overall Study|Adverse Event|1|||
144186116|NCT01292837|519875273|FG000|Overall Study|Further treatment determined|1|||
144186117|NCT02174276|519875276|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
144186118|NCT02174276|519875277|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
144186119|NCT02174276|519875278|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
144186120|NCT02174276|519875279|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
144186121|NCT02174276|519875276|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
144186122|NCT02174276|519875277|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
144186123|NCT02174276|519875278|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
144186124|NCT02174276|519875279|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
144186125|NCT02174276|519875276|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
144186126|NCT02174276|519875277|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
144186127|NCT02174276|519875278|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
144186128|NCT02174276|519875279|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
144186129|NCT02174276|519875276|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
144186130|NCT02174276|519875277|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
144186131|NCT02174276|519875278|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
144186132|NCT02174276|519875279|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
144431493|NCT01577758|520788243|FG003|Dose Escalation Phase|Progression Disease|2|||
144186133|NCT02174276|519875276|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
144186134|NCT02174276|519875277|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
144186135|NCT02174276|519875278|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
144186136|NCT02174276|519875279|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
144186137|NCT02174276|519875276|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
144186138|NCT02174276|519875277|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
144186139|NCT02174276|519875278|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
144186140|NCT02174276|519875279|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
144431494|NCT01577758|520788244|FG004|Dose Escalation Phase|Progression Disease|5|||
144431495|NCT01577758|520788245|FG005|Dose Escalation Phase|Progression Disease|0|||
144431496|NCT01577758|520788246|FG006|Dose Escalation Phase|Progression Disease|0|||
144431497|NCT01577758|520788247|FG007|Dose Escalation Phase|Progression Disease|0|||
144186141|NCT01206439|519875280|FG000|Overall Study|subject did not meet inclusion criteria|1|||
144186142|NCT05889039|519875281|FG000|Overall Study|error in completing survey|0|||
144186143|NCT05889039|519875282|FG001|Overall Study|error in completing survey|2|||
144186144|NCT05889039|519875283|FG002|Overall Study|error in completing survey|0|||
144186145|NCT05889039|519875284|FG003|Overall Study|error in completing survey|0|||
144186146|NCT05889039|519875281|FG000|Overall Study|Lost to Follow-up|4|||
144186147|NCT05889039|519875282|FG001|Overall Study|Lost to Follow-up|0|||
144186148|NCT05889039|519875283|FG002|Overall Study|Lost to Follow-up|0|||
144186149|NCT05889039|519875284|FG003|Overall Study|Lost to Follow-up|0|||
144186150|NCT03185741|519875292|FG000|Baseline|Withdrawal by Subject|1|||
144186151|NCT03185741|519875293|FG001|Baseline|Withdrawal by Subject|3|||
144186152|NCT03185741|519875294|FG002|Baseline|Withdrawal by Subject|2|||
144186153|NCT03185741|519875292|FG000|Baseline|Lost to Follow-up|1|||
144186154|NCT03185741|519875293|FG001|Baseline|Lost to Follow-up|2|||
144186155|NCT03185741|519875294|FG002|Baseline|Lost to Follow-up|3|||
144186156|NCT03185741|519875292|FG000|3Month|Death|1|||
144186157|NCT03185741|519875293|FG001|3Month|Death|1|||
144186158|NCT03185741|519875294|FG002|3Month|Death|2|||
144186159|NCT03185741|519875292|FG000|3Month|Withdrawal by Subject|1|||
144186160|NCT03185741|519875293|FG001|3Month|Withdrawal by Subject|5|||
144186161|NCT03185741|519875294|FG002|3Month|Withdrawal by Subject|1|||
144186162|NCT03185741|519875292|FG000|3Month|Lost to Follow-up|7|||
144186163|NCT03185741|519875293|FG001|3Month|Lost to Follow-up|9|||
144186164|NCT03185741|519875294|FG002|3Month|Lost to Follow-up|8|||
144186165|NCT03185741|519875292|FG000|3Month|Unavailable for 3Month|11|||
144186166|NCT03185741|519875293|FG001|3Month|Unavailable for 3Month|10|||
144186167|NCT03185741|519875294|FG002|3Month|Unavailable for 3Month|11|||
144186168|NCT03185741|519875292|FG000|3Month|Protocol Violation|0|||
144186169|NCT03185741|519875293|FG001|3Month|Protocol Violation|0|||
144186170|NCT03185741|519875294|FG002|3Month|Protocol Violation|3|||
144186171|NCT03185741|519875292|FG000|6Month|Death|1|||
144186172|NCT03185741|519875293|FG001|6Month|Death|1|||
144186173|NCT03185741|519875294|FG002|6Month|Death|2|||
144186174|NCT03185741|519875292|FG000|6Month|Withdrawal by Subject|2|||
144186175|NCT03185741|519875293|FG001|6Month|Withdrawal by Subject|3|||
144186176|NCT03185741|519875294|FG002|6Month|Withdrawal by Subject|1|||
144186177|NCT03185741|519875292|FG000|6Month|Lost to Follow-up|16|||
144186178|NCT03185741|519875293|FG001|6Month|Lost to Follow-up|15|||
144186179|NCT03185741|519875294|FG002|6Month|Lost to Follow-up|16|||
144186180|NCT01992094|519875295|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
144186181|NCT01992094|519875296|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
144186182|NCT01992094|519875297|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
144186183|NCT01992094|519875295|FG000|Overall Study|Adverse Event|1|||
144186184|NCT01992094|519875296|FG001|Overall Study|Adverse Event|0|||
144186185|NCT01992094|519875297|FG002|Overall Study|Adverse Event|0|||
144186186|NCT01992094|519875295|FG000|Overall Study|Death|5|||
144186187|NCT01992094|519875296|FG001|Overall Study|Death|5|||
144186188|NCT01992094|519875297|FG002|Overall Study|Death|2|||
144186189|NCT01992094|519875295|FG000|Overall Study|Lost to Follow-up|26|||
144186190|NCT01992094|519875296|FG001|Overall Study|Lost to Follow-up|9|||
144186191|NCT01992094|519875297|FG002|Overall Study|Lost to Follow-up|13|||
144186192|NCT01992094|519875295|FG000|Overall Study|OTHER|4|||
144186193|NCT01992094|519875296|FG001|Overall Study|OTHER|0|||
144186194|NCT01992094|519875297|FG002|Overall Study|OTHER|0|||
144529276|NCT02852655|521139238|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
144529277|NCT02852655|521139236|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
144529278|NCT02852655|521139237|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
144529279|NCT02852655|521139238|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
144529280|NCT02852655|521139236|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
144529281|NCT02852655|521139237|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
144529282|NCT02852655|521139238|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
144529283|NCT02852655|521139236|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
144529284|NCT02852655|521139237|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
144186195|NCT01992094|519875295|FG000|Overall Study|Protocol Violation|1|||
144186196|NCT01992094|519875296|FG001|Overall Study|Protocol Violation|0|||
144186197|NCT01992094|519875297|FG002|Overall Study|Protocol Violation|1|||
144186198|NCT01992094|519875295|FG000|Overall Study|Withdrawal by Subject|7|||
144529285|NCT02852655|521139238|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
144529286|NCT02852655|521139236|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
144186199|NCT01992094|519875296|FG001|Overall Study|Withdrawal by Subject|3|||
144186200|NCT01992094|519875297|FG002|Overall Study|Withdrawal by Subject|4|||
144186201|NCT01321697|519875298|FG000|Overall Study|Study Terminated|7|||
144186202|NCT02839798|519877125|FG000|Overall Study|Withdrawal by Subject|2|||
144186203|NCT04703855|519877126|FG000|Overall Study|Heart Transplant|1|||
144186204|NCT05258630|519877128|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
144186205|NCT05258630|519877129|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
144186206|NCT05258630|519877128|FG000|Overall Study|Lost to Follow-up|0|||
144186207|NCT05258630|519877129|FG001|Overall Study|Lost to Follow-up|2|||
144186208|NCT03431337|519877130|FG000|Overall Study|Lost to Follow-up|21|||
144529287|NCT02852655|521139237|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
144529288|NCT02852655|521139238|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
144186209|NCT03431337|519877131|FG001|Overall Study|Lost to Follow-up|19|||
144186210|NCT03431337|519877130|FG000|Overall Study|Withdrawal by Subject|8|||
144186211|NCT03431337|519877131|FG001|Overall Study|Withdrawal by Subject|3|||
144186212|NCT00401245|519877132|FG000|Double Blind Titration Phase|Adverse Event|3|||
144186213|NCT00401245|519877133|FG001|Double Blind Titration Phase|Adverse Event|2|||
144186214|NCT00401245|519877134|FG002|Double Blind Titration Phase|Adverse Event|5|||
144186215|NCT00401245|519877135|FG003|Double Blind Titration Phase|Adverse Event|12|||
144186216|NCT00401245|519877136|FG004|Double Blind Titration Phase|Adverse Event|0|||
144186217|NCT00401245|519877137|FG005|Double Blind Titration Phase|Adverse Event|0|||
144186218|NCT00401245|519877138|FG006|Double Blind Titration Phase|Adverse Event|0|||
144186219|NCT00401245|519877139|FG007|Double Blind Titration Phase|Adverse Event|0|||
144186220|NCT00401245|519877132|FG000|Double Blind Titration Phase|Other|0|||
144186221|NCT00401245|519877133|FG001|Double Blind Titration Phase|Other|0|||
144186222|NCT00401245|519877134|FG002|Double Blind Titration Phase|Other|1|||
144186223|NCT00401245|519877135|FG003|Double Blind Titration Phase|Other|0|||
144186224|NCT00401245|519877136|FG004|Double Blind Titration Phase|Other|0|||
144186225|NCT00401245|519877137|FG005|Double Blind Titration Phase|Other|0|||
144186226|NCT00401245|519877138|FG006|Double Blind Titration Phase|Other|0|||
144186227|NCT00401245|519877139|FG007|Double Blind Titration Phase|Other|0|||
144186228|NCT00401245|519877132|FG000|Double Blind Titration Phase|Protocol Violation|0|||
144186229|NCT00401245|519877133|FG001|Double Blind Titration Phase|Protocol Violation|0|||
144186230|NCT00401245|519877134|FG002|Double Blind Titration Phase|Protocol Violation|0|||
144186231|NCT00401245|519877135|FG003|Double Blind Titration Phase|Protocol Violation|1|||
144186232|NCT00401245|519877136|FG004|Double Blind Titration Phase|Protocol Violation|0|||
144186233|NCT00401245|519877137|FG005|Double Blind Titration Phase|Protocol Violation|0|||
144186234|NCT00401245|519877138|FG006|Double Blind Titration Phase|Protocol Violation|0|||
144186235|NCT00401245|519877139|FG007|Double Blind Titration Phase|Protocol Violation|0|||
144186236|NCT00401245|519877132|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
144186237|NCT00401245|519877133|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
144186238|NCT00401245|519877134|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
144186239|NCT00401245|519877135|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
144186240|NCT00401245|519877136|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
144186241|NCT00401245|519877137|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
144186242|NCT00401245|519877138|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
144186243|NCT00401245|519877139|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
144186244|NCT00401245|519877132|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
144186245|NCT00401245|519877133|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
144186246|NCT00401245|519877134|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
144186247|NCT00401245|519877135|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
144186248|NCT00401245|519877136|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
144186249|NCT00401245|519877137|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
144186250|NCT00401245|519877138|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
144186251|NCT00401245|519877139|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
144186252|NCT00401245|519877132|FG000|Open Label Phase|Adverse Event|5|||
144186253|NCT00401245|519877133|FG001|Open Label Phase|Adverse Event|14|||
144186254|NCT00401245|519877134|FG002|Open Label Phase|Adverse Event|6|||
144186255|NCT00401245|519877135|FG003|Open Label Phase|Adverse Event|7|||
144186256|NCT00401245|519877136|FG004|Open Label Phase|Adverse Event|0|||
144186257|NCT00401245|519877137|FG005|Open Label Phase|Adverse Event|0|||
144186258|NCT00401245|519877138|FG006|Open Label Phase|Adverse Event|0|||
144186259|NCT00401245|519877139|FG007|Open Label Phase|Adverse Event|0|||
144186260|NCT00401245|519877132|FG000|Open Label Phase|Lost to Follow-up|5|||
144186261|NCT00401245|519877133|FG001|Open Label Phase|Lost to Follow-up|7|||
144186262|NCT00401245|519877134|FG002|Open Label Phase|Lost to Follow-up|5|||
144186263|NCT00401245|519877135|FG003|Open Label Phase|Lost to Follow-up|4|||
144186264|NCT00401245|519877136|FG004|Open Label Phase|Lost to Follow-up|0|||
144186265|NCT00401245|519877137|FG005|Open Label Phase|Lost to Follow-up|0|||
144186266|NCT00401245|519877138|FG006|Open Label Phase|Lost to Follow-up|0|||
144186267|NCT00401245|519877139|FG007|Open Label Phase|Lost to Follow-up|0|||
144186268|NCT00401245|519877132|FG000|Open Label Phase|Other|4|||
144186269|NCT00401245|519877133|FG001|Open Label Phase|Other|8|||
144186270|NCT00401245|519877134|FG002|Open Label Phase|Other|7|||
144186271|NCT00401245|519877135|FG003|Open Label Phase|Other|8|||
144186272|NCT00401245|519877136|FG004|Open Label Phase|Other|0|||
144186273|NCT00401245|519877137|FG005|Open Label Phase|Other|0|||
144186274|NCT00401245|519877138|FG006|Open Label Phase|Other|0|||
144186275|NCT00401245|519877139|FG007|Open Label Phase|Other|0|||
144186276|NCT00401245|519877132|FG000|Open Label Phase|Protocol Violation|0|||
144529289|NCT02852655|521139236|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
144529290|NCT02852655|521139237|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
144252354|NCT01134263|520124689|FG002|Overall Study|Withdrawal by Subject|16|||
144252355|NCT01134263|520124690|FG003|Overall Study|Withdrawal by Subject|7|||
144252356|NCT01134263|520124691|FG004|Overall Study|Withdrawal by Subject|5|||
144252357|NCT01134263|520124687|FG000|Overall Study|Enrolled, but not treated|1|||
144252358|NCT01134263|520124688|FG001|Overall Study|Enrolled, but not treated|1|||
144431498|NCT01577758|520788240|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431499|NCT01577758|520788241|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431500|NCT01577758|520788242|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431501|NCT01577758|520788243|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431502|NCT01577758|520788244|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431503|NCT01577758|520788245|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431504|NCT01577758|520788246|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
144431505|NCT01577758|520788247|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
144431506|NCT01577758|520788240|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431507|NCT01577758|520788241|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431508|NCT01577758|520788242|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431509|NCT01577758|520788243|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431510|NCT01577758|520788244|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431511|NCT01577758|520788245|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431512|NCT01577758|520788246|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
144431513|NCT01577758|520788247|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
144431514|NCT01577758|520788240|FG000|mCRC Expansion Phase|Progression Disease|0|||
144431515|NCT01577758|520788241|FG001|mCRC Expansion Phase|Progression Disease|0|||
144431516|NCT01577758|520788242|FG002|mCRC Expansion Phase|Progression Disease|0|||
144431517|NCT01577758|520788243|FG003|mCRC Expansion Phase|Progression Disease|0|||
144431518|NCT01577758|520788244|FG004|mCRC Expansion Phase|Progression Disease|0|||
144431519|NCT01577758|520788245|FG005|mCRC Expansion Phase|Progression Disease|0|||
144431520|NCT01577758|520788246|FG006|mCRC Expansion Phase|Progression Disease|0|||
144431521|NCT01577758|520788247|FG007|mCRC Expansion Phase|Progression Disease|19|||
144431522|NCT02404350|520788250|FG000|Overall Study|Adverse Event|2|||
144431523|NCT02404350|520788251|FG001|Overall Study|Adverse Event|2|||
144431524|NCT02404350|520788252|FG002|Overall Study|Adverse Event|3|||
144431525|NCT02404350|520788253|FG003|Overall Study|Adverse Event|9|||
144431526|NCT02404350|520788250|FG000|Overall Study|Lack of Efficacy|3|||
144431527|NCT02404350|520788251|FG001|Overall Study|Lack of Efficacy|1|||
144431528|NCT02404350|520788252|FG002|Overall Study|Lack of Efficacy|0|||
144431529|NCT02404350|520788253|FG003|Overall Study|Lack of Efficacy|3|||
144431530|NCT02404350|520788250|FG000|Overall Study|Lost to Follow-up|2|||
144431531|NCT02404350|520788251|FG001|Overall Study|Lost to Follow-up|0|||
144431532|NCT02404350|520788252|FG002|Overall Study|Lost to Follow-up|0|||
144431533|NCT02404350|520788253|FG003|Overall Study|Lost to Follow-up|1|||
144431534|NCT02404350|520788250|FG000|Overall Study|Physician Decision|1|||
144431535|NCT02404350|520788251|FG001|Overall Study|Physician Decision|0|||
144431536|NCT02404350|520788252|FG002|Overall Study|Physician Decision|0|||
144431537|NCT02404350|520788253|FG003|Overall Study|Physician Decision|2|||
144431538|NCT02404350|520788250|FG000|Overall Study|Pregnancy|0|||
144431539|NCT02404350|520788251|FG001|Overall Study|Pregnancy|0|||
144431540|NCT02404350|520788252|FG002|Overall Study|Pregnancy|0|||
144431541|NCT02404350|520788253|FG003|Overall Study|Pregnancy|1|||
144431542|NCT02404350|520788250|FG000|Overall Study|Withdrawal by Subject|7|||
144431543|NCT02404350|520788251|FG001|Overall Study|Withdrawal by Subject|3|||
144431544|NCT02404350|520788252|FG002|Overall Study|Withdrawal by Subject|3|||
144431545|NCT02404350|520788253|FG003|Overall Study|Withdrawal by Subject|19|||
144431546|NCT02404350|520788250|FG000|Overall Study|Due to Non-compliance with treatment|0|||
144431547|NCT02404350|520788251|FG001|Overall Study|Due to Non-compliance with treatment|0|||
144431548|NCT02404350|520788252|FG002|Overall Study|Due to Non-compliance with treatment|0|||
144431549|NCT02404350|520788253|FG003|Overall Study|Due to Non-compliance with treatment|1|||
144431550|NCT02404350|520788250|FG000|Overall Study|Due to Technical problems|0|||
144431551|NCT02404350|520788251|FG001|Overall Study|Due to Technical problems|0|||
144431552|NCT02404350|520788252|FG002|Overall Study|Due to Technical problems|0|||
144431553|NCT02404350|520788253|FG003|Overall Study|Due to Technical problems|1|||
144604240|NCT01628107|521414262|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
144252359|NCT01134263|520124689|FG002|Overall Study|Enrolled, but not treated|0|||
144431554|NCT02140567|520788259|FG000|Overall Study|Problems with recording equipment|6|||
144431555|NCT02136576|520788260|FG000|Overall Study|Lost to Follow-up|2|||
144431556|NCT02136576|520788261|FG001|Overall Study|Lost to Follow-up|0|||
144431557|NCT02136576|520788262|FG002|Overall Study|Lost to Follow-up|0|||
144431558|NCT02197806|520788263|FG000|Overall Study|Adverse Event|0|||
144431559|NCT02197806|520788264|FG001|Overall Study|Adverse Event|1|||
144431560|NCT02197806|520788265|FG002|Overall Study|Adverse Event|0|||
144604241|NCT01628107|521414262|FG000|Overall Study|Non-compliant with Study Procedures|10|||
144431561|NCT02197806|520788266|FG003|Overall Study|Adverse Event|1|||
144431562|NCT00537381|520788267|FG000|Overall Study|Adverse Event|13|||
144431563|NCT00537381|520788268|FG001|Overall Study|Adverse Event|9|||
144431564|NCT00537381|520788267|FG000|Overall Study|Death|3|||
144604242|NCT01628107|521414262|FG000|Overall Study|Not Treated|8|||
144186277|NCT00401245|519877133|FG001|Open Label Phase|Protocol Violation|1|||
144186278|NCT00401245|519877134|FG002|Open Label Phase|Protocol Violation|0|||
144186279|NCT00401245|519877135|FG003|Open Label Phase|Protocol Violation|1|||
144186280|NCT00401245|519877136|FG004|Open Label Phase|Protocol Violation|0|||
144186281|NCT00401245|519877137|FG005|Open Label Phase|Protocol Violation|0|||
144186282|NCT00401245|519877138|FG006|Open Label Phase|Protocol Violation|0|||
144186283|NCT00401245|519877139|FG007|Open Label Phase|Protocol Violation|0|||
144186284|NCT00401245|519877132|FG000|Open Label Phase|Withdrawal by Subject|3|||
144529291|NCT02852655|521139238|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
144186285|NCT00401245|519877133|FG001|Open Label Phase|Withdrawal by Subject|3|||
144186286|NCT00401245|519877134|FG002|Open Label Phase|Withdrawal by Subject|2|||
144186287|NCT00401245|519877135|FG003|Open Label Phase|Withdrawal by Subject|1|||
144186288|NCT00401245|519877136|FG004|Open Label Phase|Withdrawal by Subject|0|||
144186289|NCT00401245|519877137|FG005|Open Label Phase|Withdrawal by Subject|0|||
144186290|NCT00401245|519877138|FG006|Open Label Phase|Withdrawal by Subject|0|||
144186291|NCT00401245|519877139|FG007|Open Label Phase|Withdrawal by Subject|0|||
144186292|NCT00401245|519877132|FG000|Open Label Phase|Lack of Efficacy|4|||
144186293|NCT00401245|519877133|FG001|Open Label Phase|Lack of Efficacy|2|||
144186294|NCT00401245|519877134|FG002|Open Label Phase|Lack of Efficacy|3|||
144186295|NCT00401245|519877135|FG003|Open Label Phase|Lack of Efficacy|0|||
144186296|NCT00401245|519877136|FG004|Open Label Phase|Lack of Efficacy|0|||
144186297|NCT00401245|519877137|FG005|Open Label Phase|Lack of Efficacy|0|||
144186298|NCT00401245|519877138|FG006|Open Label Phase|Lack of Efficacy|0|||
144186299|NCT00401245|519877139|FG007|Open Label Phase|Lack of Efficacy|0|||
144186300|NCT00401245|519877132|FG000|Double Blind Tapering Phase|Adverse Event|0|||
144186301|NCT00401245|519877133|FG001|Double Blind Tapering Phase|Adverse Event|0|||
144186302|NCT00401245|519877134|FG002|Double Blind Tapering Phase|Adverse Event|0|||
144186303|NCT00401245|519877135|FG003|Double Blind Tapering Phase|Adverse Event|0|||
144186304|NCT00401245|519877136|FG004|Double Blind Tapering Phase|Adverse Event|1|||
144529292|NCT00323856|521139239|FG000|Overall Study|Withdrawal by Subject|1|||
144529293|NCT00323856|521139239|FG000|Overall Study|Was uncooperative and noncompliant|1|||
144529294|NCT00323856|521139239|FG000|Overall Study|Reason not specified|1|||
144529295|NCT00323856|521139239|FG000|Overall Study|Missing|2|||
144529296|NCT04086121|521139244|FG000|Overall Study|Other than listed|8|||
144529297|NCT04086121|521139244|FG000|Overall Study|Withdrawal by Subject|3|||
144529298|NCT04086121|521139244|FG000|Overall Study|Lost to Follow-up|2|||
144529299|NCT04086121|521139244|FG000|Overall Study|Adverse Event|1|||
144529300|NCT05292391|521139247|FG000|Overall Study|Lost to Follow-up|0|||
144529301|NCT05292391|521139248|FG001|Overall Study|Lost to Follow-up|0|||
144529302|NCT05292391|521139249|FG002|Overall Study|Lost to Follow-up|0|||
144529303|NCT05292391|521139250|FG003|Overall Study|Lost to Follow-up|1|||
144529304|NCT05292391|521139251|FG004|Overall Study|Lost to Follow-up|0|||
144529305|NCT05809453|521141046|FG000|Overall Study|Withdrawal by Subject|1|||
144529306|NCT05809453|521141047|FG001|Overall Study|Withdrawal by Subject|0|||
144529307|NCT05809453|521141048|FG002|Overall Study|Withdrawal by Subject|0|||
144529308|NCT05809453|521141049|FG003|Overall Study|Withdrawal by Subject|0|||
144529309|NCT00104676|521141051|FG000|Overall Study|Death|3|||
144529310|NCT00104676|521141052|FG001|Overall Study|Death|2|||
144529311|NCT00104676|521141051|FG000|Overall Study|Withdrawal by Subject|0|||
144529312|NCT00104676|521141052|FG001|Overall Study|Withdrawal by Subject|2|||
144529313|NCT00104676|521141051|FG000|Overall Study|treatment interruption|4|||
144529314|NCT00104676|521141052|FG001|Overall Study|treatment interruption|10|||
144529315|NCT03916185|521141053|FG000|Overall Study|Lost to Follow-up|0|||
144529316|NCT03916185|521141054|FG001|Overall Study|Lost to Follow-up|1|||
144529317|NCT03916185|521141055|FG002|Overall Study|Lost to Follow-up|0|||
144529318|NCT03916185|521141056|FG003|Overall Study|Lost to Follow-up|0|||
144529319|NCT03916185|521141053|FG000|Overall Study|Moved|1|||
144529320|NCT03916185|521141054|FG001|Overall Study|Moved|0|||
144529321|NCT03916185|521141055|FG002|Overall Study|Moved|0|||
144529322|NCT03916185|521141056|FG003|Overall Study|Moved|1|||
144529323|NCT03916185|521141053|FG000|Overall Study|Not Able to Get to Clinic|1|||
144186305|NCT00401245|519877137|FG005|Double Blind Tapering Phase|Adverse Event|1|||
144252360|NCT01134263|520124690|FG003|Overall Study|Enrolled, but not treated|1|||
144529324|NCT03916185|521141054|FG001|Overall Study|Not Able to Get to Clinic|0|||
144529325|NCT03916185|521141055|FG002|Overall Study|Not Able to Get to Clinic|0|||
144529326|NCT03916185|521141056|FG003|Overall Study|Not Able to Get to Clinic|0|||
144186306|NCT00401245|519877138|FG006|Double Blind Tapering Phase|Adverse Event|2|||
144186307|NCT00401245|519877139|FG007|Double Blind Tapering Phase|Adverse Event|4|||
144186308|NCT00401245|519877132|FG000|Double Blind Tapering Phase|Investigator request|0|||
144252361|NCT01134263|520124691|FG004|Overall Study|Enrolled, but not treated|0|||
144252362|NCT03517449|520124700|FG000|Overall Study|Death|184|||
144186309|NCT00401245|519877133|FG001|Double Blind Tapering Phase|Investigator request|0|||
144252363|NCT03517449|520124701|FG001|Overall Study|Death|236|||
144529327|NCT05671653|521141057|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
144529328|NCT05671653|521141058|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
144529329|NCT05671653|521141059|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
144529330|NCT05671653|521141060|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
144529331|NCT05671653|521141061|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
144252364|NCT03517449|520124700|FG000|Overall Study|Lost to Follow-up|0|||
144252365|NCT03517449|520124701|FG001|Overall Study|Lost to Follow-up|2|||
144252366|NCT03517449|520124700|FG000|Overall Study|Withdrawal by Subject|7|||
144252367|NCT03517449|520124701|FG001|Overall Study|Withdrawal by Subject|26|||
144252368|NCT03517449|520124700|FG000|Overall Study|Participants Ongoing|220|||
144252369|NCT03517449|520124701|FG001|Overall Study|Participants Ongoing|152|||
144252370|NCT00269477|520124702|FG000|Overall Study|Protocol Violation|5|||
144252371|NCT00269477|520124703|FG001|Overall Study|Protocol Violation|5|||
144252372|NCT00269477|520124704|FG002|Overall Study|Protocol Violation|1|||
144252373|NCT00269477|520124705|FG003|Overall Study|Protocol Violation|0|||
144252374|NCT00269477|520124702|FG000|Overall Study|Missed post-vaccination blood draw|0|||
144252375|NCT00269477|520124703|FG001|Overall Study|Missed post-vaccination blood draw|1|||
144252376|NCT00269477|520124704|FG002|Overall Study|Missed post-vaccination blood draw|0|||
144252377|NCT00269477|520124705|FG003|Overall Study|Missed post-vaccination blood draw|0|||
144252378|NCT00431067|520124706|FG000|Overall Study|Other Adverse Event|9|||
144252379|NCT00431067|520124706|FG000|Overall Study|Progressive disease|30|||
144252380|NCT00431067|520124706|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
144252381|NCT00938587|520124707|FG000|Overall Study|Adverse Event|2|||
144252382|NCT00938587|520124708|FG001|Overall Study|Adverse Event|0|||
144252383|NCT00938587|520124709|FG002|Overall Study|Adverse Event|0|||
144252384|NCT00938587|520124710|FG003|Overall Study|Adverse Event|2|||
144252385|NCT00938587|520124707|FG000|Overall Study|Did not meet entrance criteria|0|||
144252386|NCT00938587|520124708|FG001|Overall Study|Did not meet entrance criteria|0|||
144252387|NCT00938587|520124709|FG002|Overall Study|Did not meet entrance criteria|1|||
144252388|NCT00938587|520124710|FG003|Overall Study|Did not meet entrance criteria|0|||
144252389|NCT00938587|520124707|FG000|Overall Study|Withdrawal by Subject|1|||
144252390|NCT00938587|520124708|FG001|Overall Study|Withdrawal by Subject|1|||
144252391|NCT00938587|520124709|FG002|Overall Study|Withdrawal by Subject|0|||
144252392|NCT00938587|520124710|FG003|Overall Study|Withdrawal by Subject|0|||
144252393|NCT00548249|520124711|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
144252394|NCT00548249|520124712|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
144252395|NCT00548249|520124713|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
144252396|NCT00548249|520124714|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
144252397|NCT00548249|520124715|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
144252398|NCT00548249|520124711|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
144252399|NCT00548249|520124712|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
144252400|NCT00548249|520124713|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
144252401|NCT00548249|520124714|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
144252402|NCT00548249|520124715|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
144252403|NCT00548249|520124711|FG000|Overall Study|Protocol Violation|1|||
144252404|NCT00548249|520124712|FG001|Overall Study|Protocol Violation|1|||
144252405|NCT00548249|520124713|FG002|Overall Study|Protocol Violation|4|||
144252406|NCT00548249|520124714|FG003|Overall Study|Protocol Violation|0|||
144252407|NCT00548249|520124715|FG004|Overall Study|Protocol Violation|3|||
144252408|NCT00548249|520124711|FG000|Overall Study|Miscellaneous|2|||
144252409|NCT00548249|520124712|FG001|Overall Study|Miscellaneous|3|||
144252410|NCT00548249|520124713|FG002|Overall Study|Miscellaneous|2|||
144252411|NCT00548249|520124714|FG003|Overall Study|Miscellaneous|0|||
144252412|NCT00548249|520124715|FG004|Overall Study|Miscellaneous|2|||
144252413|NCT00548249|520124711|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
144252414|NCT00548249|520124712|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
144252415|NCT00548249|520124713|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
144252416|NCT00548249|520124714|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
144431565|NCT00537381|520788268|FG001|Overall Study|Death|3|||
144431566|NCT00537381|520788267|FG000|Overall Study|Withdrawal by Subject|5|||
144431567|NCT00537381|520788268|FG001|Overall Study|Withdrawal by Subject|14|||
144431568|NCT00537381|520788267|FG000|Overall Study|Physician Decision|7|||
144431569|NCT00537381|520788268|FG001|Overall Study|Physician Decision|6|||
144431570|NCT00537381|520788267|FG000|Overall Study|Disease Progression|9|||
144431571|NCT00537381|520788268|FG001|Overall Study|Disease Progression|18|||
144604243|NCT01628107|521414262|FG000|Overall Study|Sponsor Decision|11|||
144604244|NCT01628107|521414262|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
144252417|NCT00548249|520124715|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
144252418|NCT00548249|520124711|FG000|Overall Study|Adverse Event|2|||
144252419|NCT00548249|520124712|FG001|Overall Study|Adverse Event|2|||
144252420|NCT00548249|520124713|FG002|Overall Study|Adverse Event|0|||
144252421|NCT00548249|520124714|FG003|Overall Study|Adverse Event|1|||
144431572|NCT00537381|520788267|FG000|Overall Study|Sponsor decision|14|||
144431573|NCT00537381|520788268|FG001|Overall Study|Sponsor decision|9|||
144431574|NCT00537381|520788267|FG000|Overall Study|Other|5|||
144431575|NCT00537381|520788268|FG001|Overall Study|Other|3|||
144431576|NCT02590939|520788269|FG000|Overall Study|Withdrawal by Subject|3|||
144604245|NCT01628107|521414262|FG000|Overall Study|Relocated|8|||
144252422|NCT00548249|520124715|FG004|Overall Study|Adverse Event|1|||
144252423|NCT00548249|520124711|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
144252424|NCT00548249|520124712|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
144186310|NCT00401245|519877134|FG002|Double Blind Tapering Phase|Investigator request|0|||
144186311|NCT00401245|519877135|FG003|Double Blind Tapering Phase|Investigator request|0|||
144186312|NCT00401245|519877136|FG004|Double Blind Tapering Phase|Investigator request|0|||
144186313|NCT00401245|519877137|FG005|Double Blind Tapering Phase|Investigator request|0|||
144186314|NCT00401245|519877138|FG006|Double Blind Tapering Phase|Investigator request|0|||
144186315|NCT00401245|519877139|FG007|Double Blind Tapering Phase|Investigator request|1|||
144186316|NCT00401245|519877132|FG000|Double Blind Tapering Phase|Other|0|||
144186317|NCT00401245|519877133|FG001|Double Blind Tapering Phase|Other|0|||
144186318|NCT00401245|519877134|FG002|Double Blind Tapering Phase|Other|0|||
144186319|NCT00401245|519877135|FG003|Double Blind Tapering Phase|Other|0|||
144186320|NCT00401245|519877136|FG004|Double Blind Tapering Phase|Other|1|||
144186321|NCT00401245|519877137|FG005|Double Blind Tapering Phase|Other|0|||
144186322|NCT00401245|519877138|FG006|Double Blind Tapering Phase|Other|2|||
144186323|NCT00401245|519877139|FG007|Double Blind Tapering Phase|Other|2|||
144186324|NCT00401245|519877132|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
144186325|NCT00401245|519877133|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
144186326|NCT00401245|519877134|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
144186327|NCT00401245|519877135|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
144186328|NCT00401245|519877136|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
144186329|NCT00401245|519877137|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
144186330|NCT00401245|519877138|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
144186331|NCT00401245|519877139|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
144186332|NCT00401245|519877132|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186333|NCT00401245|519877133|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186334|NCT00401245|519877134|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186335|NCT00401245|519877135|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186336|NCT00401245|519877136|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186337|NCT00401245|519877137|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
144186338|NCT00401245|519877138|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186339|NCT00401245|519877139|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
144186340|NCT01560819|519877143|FG000|Overall Study|Physician Decision|1|||
144186341|NCT01560819|519877144|FG001|Overall Study|Physician Decision|0|||
144186342|NCT02014441|519877145|FG000|Overall Study|Withdrawal by Subject|12|||
144186343|NCT01363011|519877146|FG000|Main Study|Adverse Event|2|||
144186344|NCT01363011|519877147|FG001|Main Study|Adverse Event|3|||
144186345|NCT01363011|519877146|FG000|Main Study|Investigator's Discretion|1|||
144186346|NCT01363011|519877147|FG001|Main Study|Investigator's Discretion|1|||
144186347|NCT01363011|519877146|FG000|Main Study|Withdrew Consent|1|||
144186348|NCT01363011|519877147|FG001|Main Study|Withdrew Consent|4|||
144186349|NCT01363011|519877146|FG000|Main Study|Protocol Violation|0|||
144186350|NCT01363011|519877147|FG001|Main Study|Protocol Violation|1|||
144186351|NCT01363011|519877146|FG000|Extension Phase|Adverse Event|1|||
144186352|NCT01363011|519877147|FG001|Extension Phase|Adverse Event|1|||
144186353|NCT01363011|519877146|FG000|Extension Phase|Lack of Efficacy|0|||
144186354|NCT01363011|519877147|FG001|Extension Phase|Lack of Efficacy|1|||
144186355|NCT01363011|519877146|FG000|Extension Phase|Investigator's Discretion|2|||
144186356|NCT01363011|519877147|FG001|Extension Phase|Investigator's Discretion|2|||
144186357|NCT01363011|519877146|FG000|Extension Phase|Withdrew Consent|0|||
144186358|NCT01363011|519877147|FG001|Extension Phase|Withdrew Consent|1|||
144186359|NCT01363011|519877146|FG000|Extension Phase|Lost to Follow-up|0|||
144186360|NCT01363011|519877147|FG001|Extension Phase|Lost to Follow-up|2|||
144186361|NCT01363011|519877146|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
144186362|NCT01363011|519877147|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
144186363|NCT00114231|519877148|FG000|Overall Study|No consent|2|||
144186364|NCT00114231|519877149|FG001|Overall Study|No consent|0|||
144186365|NCT00114231|519877148|FG000|Overall Study|QARC requirement not met|1|||
144186366|NCT00114231|519877149|FG001|Overall Study|QARC requirement not met|0|||
144186367|NCT00114231|519877148|FG000|Overall Study|Suspected metastatic disease|1|||
144186368|NCT00114231|519877149|FG001|Overall Study|Suspected metastatic disease|0|||
144186369|NCT00114231|519877148|FG000|Overall Study|No adenocarcinoma|1|||
144186370|NCT00114231|519877149|FG001|Overall Study|No adenocarcinoma|0|||
144186371|NCT00114231|519877148|FG000|Overall Study|Low creatinine clearance|0|||
144186372|NCT00114231|519877149|FG001|Overall Study|Low creatinine clearance|1|||
144186373|NCT00114231|519877148|FG000|Overall Study|Tumor size > 4cm|1|||
144186374|NCT00114231|519877149|FG001|Overall Study|Tumor size > 4cm|0|||
144186375|NCT00114231|519877148|FG000|Overall Study|Tumor fixed on digital exam|0|||
144186376|NCT00114231|519877149|FG001|Overall Study|Tumor fixed on digital exam|1|||
144186377|NCT00114231|519877148|FG000|Overall Study|No Absolute Neutrophil Count|2|||
144186378|NCT00114231|519877149|FG001|Overall Study|No Absolute Neutrophil Count|0|||
144186379|NCT00114231|519877148|FG000|Overall Study|Biopsy done after registration|1|||
144186380|NCT00114231|519877149|FG001|Overall Study|Biopsy done after registration|0|||
144186381|NCT01961882|519877154|FG000|Overall Study|Adverse Event|3|||
144186382|NCT01961882|519877155|FG001|Overall Study|Adverse Event|2|||
144186383|NCT01961882|519877154|FG000|Overall Study|Physician Decision|1|||
144186384|NCT01961882|519877155|FG001|Overall Study|Physician Decision|0|||
144604246|NCT01628107|521414262|FG000|Overall Study|Kidney Transplant|9|||
144186385|NCT01961882|519877154|FG000|Overall Study|Withdrawal by Subject|4|||
144186386|NCT01961882|519877155|FG001|Overall Study|Withdrawal by Subject|1|||
144186387|NCT01961882|519877154|FG000|Overall Study|Relapse of AML|39|||
144186388|NCT01961882|519877155|FG001|Overall Study|Relapse of AML|37|||
144186389|NCT01961882|519877154|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
144186390|NCT01961882|519877155|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
144186391|NCT01961882|519877154|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
144186392|NCT01961882|519877155|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
144186393|NCT01901848|519877156|FG000|Randomized and Treated|Lost to Follow-up|3|||
144186394|NCT01901848|519877157|FG001|Randomized and Treated|Lost to Follow-up|6|||
144186395|NCT01901848|519877156|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
144186396|NCT01901848|519877157|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
144529332|NCT05671653|521141062|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
144529333|NCT05671653|521141063|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
144529334|NCT05671653|521141064|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
144529335|NCT05671653|521141065|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
144529336|NCT05671653|521141066|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
144529337|NCT05671653|521141067|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
144529338|NCT05671653|521141068|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
144529339|NCT05671653|521141069|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
144529340|NCT05671653|521141057|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529341|NCT05671653|521141058|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529342|NCT05671653|521141059|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529343|NCT05671653|521141060|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529344|NCT05671653|521141061|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529345|NCT05671653|521141062|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
144529346|NCT05671653|521141063|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144186397|NCT01729026|519877158|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
144186398|NCT01729026|519877159|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
144186399|NCT01729026|519877158|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
144186400|NCT01729026|519877159|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
144186401|NCT02488824|519877160|FG000|Overall Study|Adverse Event|1|||
144186402|NCT02488824|519877161|FG001|Overall Study|Adverse Event|1|||
144186403|NCT02668822|519877162|FG000|Overall Study|Protocol Violation|2|||
144186404|NCT02668822|519877163|FG001|Overall Study|Protocol Violation|0|||
144186405|NCT02668822|519877162|FG000|Overall Study|Study Terminated by Sponsor|7|||
144186406|NCT02668822|519877163|FG001|Overall Study|Study Terminated by Sponsor|9|||
144186407|NCT03036839|519877164|FG000|Overall Study|Adverse Event|0|||
144186408|NCT03036839|519877165|FG001|Overall Study|Adverse Event|0|||
144186409|NCT03036839|519877166|FG002|Overall Study|Adverse Event|1|||
144186410|NCT03036839|519877164|FG000|Overall Study|Death|3|||
144186411|NCT03036839|519877165|FG001|Overall Study|Death|0|||
144186412|NCT03036839|519877166|FG002|Overall Study|Death|3|||
144186413|NCT03036839|519877164|FG000|Overall Study|Withdrew Consent|0|||
144186414|NCT03036839|519877165|FG001|Overall Study|Withdrew Consent|0|||
144186415|NCT03036839|519877166|FG002|Overall Study|Withdrew Consent|1|||
144186416|NCT00412737|519877167|FG000|Overall Study|Death|1|||
144186417|NCT00412737|519877168|FG001|Overall Study|Death|0|||
144186418|NCT00412737|519877167|FG000|Overall Study|Adverse Event|3|||
144186419|NCT00412737|519877168|FG001|Overall Study|Adverse Event|2|||
144186420|NCT00412737|519877167|FG000|Overall Study|Refused Treatment|6|||
144186421|NCT00412737|519877168|FG001|Overall Study|Refused Treatment|2|||
144186422|NCT00412737|519877167|FG000|Overall Study|Failure to Return|6|||
144186423|NCT00412737|519877168|FG001|Overall Study|Failure to Return|2|||
144186424|NCT00298740|519877169|FG000|Overall Study|Lack of Efficacy|6|||
144186425|NCT00298740|519877169|FG000|Overall Study|Withdrawal by Subject|3|||
144186426|NCT00684567|519877173|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
144186427|NCT00684567|519877173|FG000|Monotherapy Period|Adverse Event|2|||
144186428|NCT00684567|519877173|FG000|Monotherapy Period|Death|1|||
144186429|NCT00684567|519877173|FG000|Monotherapy Period|Progression of primary disease|11|||
144186430|NCT04317599|519877174|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
144186431|NCT04317599|519877174|FG000|Overall Study|treatment outside standard of care|4|||
144186432|NCT00809965|519877175|FG000|Overall Study|Death|194|||
144186433|NCT00809965|519877176|FG001|Overall Study|Death|147|||
144186434|NCT00809965|519877177|FG002|Overall Study|Death|196|||
144186435|NCT00809965|519877175|FG000|Overall Study|Lost to Follow-up|17|||
144186436|NCT00809965|519877176|FG001|Overall Study|Lost to Follow-up|10|||
144186437|NCT00809965|519877177|FG002|Overall Study|Lost to Follow-up|18|||
144186438|NCT00809965|519877175|FG000|Overall Study|Withdrawal by Subject|405|||
144186439|NCT00809965|519877176|FG001|Overall Study|Withdrawal by Subject|448|||
144186440|NCT00809965|519877177|FG002|Overall Study|Withdrawal by Subject|441|||
144186441|NCT00809965|519877175|FG000|Overall Study|Other Reason|167|||
144186442|NCT00809965|519877176|FG001|Overall Study|Other Reason|170|||
144529347|NCT05671653|521141064|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144723827|NCT02204371|521844227|FG000|Overall Study|Adverse Event|1|||
144604247|NCT01628107|521414262|FG000|Overall Study|Use of Standard of Care|9|||
144186443|NCT00809965|519877177|FG002|Overall Study|Other Reason|189|||
144186444|NCT04254809|519877181|FG000|Overall Study|Lost to Follow-up|5|||
144186445|NCT04254809|519877182|FG001|Overall Study|Lost to Follow-up|10|||
144186446|NCT02972515|519877183|FG000|Overall Study|Lost to Follow-up|78|||
144186447|NCT01928615|519877184|FG000|Overall Study|Study Terminated by Sponsor|2|||
144186448|NCT01077258|519877187|FG000|Overall Study|Lost to Follow-up|1390|||
144186449|NCT01077258|519877187|FG000|Overall Study|Adverse drug reaction|218|||
144604248|NCT01086410|521414263|FG000|Overall Study|Adverse Event|1|||
144604249|NCT01086410|521414264|FG001|Overall Study|Adverse Event|0|||
144604250|NCT01086410|521414265|FG002|Overall Study|Adverse Event|0|||
144604251|NCT01086410|521414266|FG003|Overall Study|Adverse Event|2|||
144604252|NCT01086410|521414263|FG000|Overall Study|Lack of Efficacy|1|||
144604253|NCT01086410|521414264|FG001|Overall Study|Lack of Efficacy|1|||
144604254|NCT01086410|521414265|FG002|Overall Study|Lack of Efficacy|0|||
144604255|NCT01086410|521414266|FG003|Overall Study|Lack of Efficacy|0|||
144604256|NCT01086410|521414263|FG000|Overall Study|Protocol Violation|1|||
144604257|NCT01086410|521414264|FG001|Overall Study|Protocol Violation|1|||
144604258|NCT01086410|521414265|FG002|Overall Study|Protocol Violation|0|||
144604259|NCT01086410|521414266|FG003|Overall Study|Protocol Violation|0|||
144604260|NCT01086410|521414263|FG000|Overall Study|Lost to Follow-up|0|||
144604261|NCT01086410|521414264|FG001|Overall Study|Lost to Follow-up|0|||
144604262|NCT01086410|521414265|FG002|Overall Study|Lost to Follow-up|1|||
144604263|NCT01086410|521414266|FG003|Overall Study|Lost to Follow-up|0|||
144186450|NCT01077258|519877187|FG000|Overall Study|Lack of Efficacy|663|||
144186451|NCT01077258|519877187|FG000|Overall Study|Clinical remission|37|||
144186452|NCT01077258|519877187|FG000|Overall Study|Other reasons|260|||
144186453|NCT00515216|519877188|FG000|Overall Study|Withdrawal by Subject|1|||
144186454|NCT00726895|519877190|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
144186455|NCT00726895|519877191|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144186456|NCT01450800|519877195|FG000|Overall Study|Protocol Violation|1|||
144186457|NCT01450800|519877196|FG001|Overall Study|Protocol Violation|3|||
144186458|NCT02250651|519877205|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
144186459|NCT02250651|519877206|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
144186460|NCT02250651|519877207|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
144186461|NCT02250651|519877205|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
144186462|NCT02250651|519877206|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
144186463|NCT02250651|519877207|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
144186464|NCT02250651|519877205|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
144186465|NCT02250651|519877206|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
144186466|NCT02250651|519877207|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
144186467|NCT02250651|519877205|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
144186468|NCT02250651|519877206|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
144186469|NCT02250651|519877207|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
144186470|NCT02250651|519877205|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
144186471|NCT02250651|519877206|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
144186472|NCT02250651|519877207|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
144186473|NCT02250651|519877205|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
144186474|NCT02250651|519877206|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
144186475|NCT02250651|519877207|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
144186476|NCT02250651|519877205|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
144186477|NCT02250651|519877206|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
144186478|NCT02250651|519877207|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
144186479|NCT02250651|519877205|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
144186480|NCT02250651|519877206|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
144186481|NCT02250651|519877207|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
144186482|NCT02250651|519877205|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
144186483|NCT02250651|519877206|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
144186484|NCT02250651|519877207|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
144186485|NCT02250651|519877205|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
144186486|NCT02250651|519877206|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
144186487|NCT02250651|519877207|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
144604264|NCT04196803|521414267|FG000|Overall Study|Withdrawal by Subject|1|||
144604265|NCT04196803|521414268|FG001|Overall Study|Withdrawal by Subject|3|||
144604266|NCT04196803|521414267|FG000|Overall Study|Adverse Event|4|||
144186488|NCT02250651|519877205|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
144186489|NCT02250651|519877206|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
144186490|NCT02250651|519877207|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
144604267|NCT04196803|521414268|FG001|Overall Study|Adverse Event|2|||
144604268|NCT04196803|521414267|FG000|Overall Study|Lost to Follow-up|0|||
144604269|NCT04196803|521414268|FG001|Overall Study|Lost to Follow-up|1|||
144604270|NCT01022996|521414269|FG000|Overall Study|Adverse Event|14|||
144186491|NCT02250651|519877205|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
144186492|NCT02250651|519877206|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
144186493|NCT02250651|519877207|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
144186494|NCT02250651|519877205|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
144186495|NCT02250651|519877206|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
144186496|NCT02250651|519877207|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
144186497|NCT02250651|519877205|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
144186498|NCT02250651|519877206|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
144186499|NCT02250651|519877207|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
144186500|NCT02250651|519877205|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
144186501|NCT02250651|519877206|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
144186502|NCT02250651|519877207|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
144186503|NCT03496298|519877208|FG000|Overall Study|Adverse Event|49|||
144186504|NCT03496298|519877209|FG001|Overall Study|Adverse Event|68|||
144186505|NCT03496298|519877210|FG002|Overall Study|Adverse Event|79|||
144186506|NCT03496298|519877208|FG000|Overall Study|Study terminated by Sponsor|1050|||
144186507|NCT03496298|519877209|FG001|Overall Study|Study terminated by Sponsor|1063|||
144186508|NCT03496298|519877210|FG002|Overall Study|Study terminated by Sponsor|1071|||
144186509|NCT03496298|519877208|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
144186510|NCT03496298|519877209|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
144186511|NCT03496298|519877210|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
144186512|NCT03496298|519877208|FG000|Overall Study|Withdrawal by Subject|176|||
144186513|NCT03496298|519877209|FG001|Overall Study|Withdrawal by Subject|154|||
144186514|NCT03496298|519877210|FG002|Overall Study|Withdrawal by Subject|151|||
144186515|NCT03496298|519877208|FG000|Overall Study|Other|29|||
144186516|NCT03496298|519877209|FG001|Overall Study|Other|20|||
144186517|NCT03496298|519877210|FG002|Overall Study|Other|23|||
144186518|NCT03496298|519877208|FG000|Overall Study|Randomized and not treated|1|||
144186519|NCT03496298|519877209|FG001|Overall Study|Randomized and not treated|1|||
144186520|NCT03496298|519877210|FG002|Overall Study|Randomized and not treated|1|||
144186521|NCT02608476|519877213|FG000|Overall Study|Withdrawal by Subject|30|||
144186522|NCT02608476|519877214|FG001|Overall Study|Withdrawal by Subject|37|||
144186523|NCT02608476|519877213|FG000|Overall Study|Lost to Follow-up|24|||
144186524|NCT02608476|519877214|FG001|Overall Study|Lost to Follow-up|24|||
144529348|NCT05671653|521141065|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529349|NCT05671653|521141066|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529350|NCT05671653|521141067|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529351|NCT05671653|521141068|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529352|NCT05671653|521141069|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
144529353|NCT05671653|521141057|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529354|NCT05671653|521141058|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529355|NCT05671653|521141059|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529356|NCT05671653|521141060|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529357|NCT05671653|521141061|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529358|NCT05671653|521141062|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
144529359|NCT05671653|521141063|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529360|NCT05671653|521141064|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529361|NCT05671653|521141065|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529362|NCT05671653|521141066|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529363|NCT05671653|521141067|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529364|NCT05671653|521141068|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529365|NCT05671653|521141069|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
144529366|NCT05671653|521141057|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529367|NCT05671653|521141058|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529368|NCT05671653|521141059|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529369|NCT05671653|521141060|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529370|NCT05671653|521141061|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529371|NCT05671653|521141062|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529372|NCT05671653|521141063|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144186525|NCT02608476|519877213|FG000|Overall Study|Adverse Event|2|||
144186526|NCT02608476|519877214|FG001|Overall Study|Adverse Event|8|||
144186527|NCT02608476|519877213|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
144186528|NCT02608476|519877214|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
144186529|NCT02608476|519877213|FG000|Overall Study|Noncompliance with treatment|1|||
144186530|NCT02608476|519877214|FG001|Overall Study|Noncompliance with treatment|5|||
144529373|NCT05671653|521141064|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529374|NCT05671653|521141065|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
144529375|NCT05671653|521141066|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529376|NCT05671653|521141067|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529377|NCT05671653|521141068|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144186531|NCT02608476|519877213|FG000|Overall Study|Lack of Efficacy|3|||
144186532|NCT02608476|519877214|FG001|Overall Study|Lack of Efficacy|1|||
144186533|NCT02608476|519877213|FG000|Overall Study|Other|0|||
144186534|NCT02608476|519877214|FG001|Overall Study|Other|1|||
144186535|NCT02608476|519877213|FG000|Overall Study|Physician Decision|1|||
144186536|NCT02608476|519877214|FG001|Overall Study|Physician Decision|0|||
144186537|NCT02608476|519877213|FG000|Overall Study|Pregnancy|0|||
144186538|NCT02608476|519877214|FG001|Overall Study|Pregnancy|1|||
144186539|NCT02608476|519877213|FG000|Overall Study|Progressive disease|1|||
144186540|NCT02608476|519877214|FG001|Overall Study|Progressive disease|0|||
144186541|NCT00676494|519877215|FG000|Overall Study|Missed Visit|8|||
144186542|NCT00676494|519877215|FG000|Overall Study|Withdrawal by Subject|6|||
144186543|NCT01115933|519877217|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
144186544|NCT02427399|519877218|FG000|Overall Study|Protocol Violation|14|||
144186545|NCT02427399|519877219|FG001|Overall Study|Protocol Violation|16|||
144186546|NCT02427399|519877220|FG002|Overall Study|Protocol Violation|12|||
144186547|NCT02427399|519877221|FG003|Overall Study|Protocol Violation|18|||
144186548|NCT02427399|519877222|FG004|Overall Study|Protocol Violation|15|||
144186549|NCT01086969|519877229|FG000|Overall Study|Withdrawal by Subject|1|||
144186550|NCT01086969|519877230|FG001|Overall Study|Withdrawal by Subject|2|||
144186551|NCT01086969|519877231|FG002|Overall Study|Withdrawal by Subject|0|||
144186552|NCT00819767|519877236|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144186553|NCT00819767|519877237|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144186554|NCT00685750|519877238|FG000|Overall Study|Tumor sampling failure|0|||
144186555|NCT00685750|519877239|FG001|Overall Study|Tumor sampling failure|0|||
144186556|NCT00685750|519877240|FG002|Overall Study|Tumor sampling failure|1|||
144186557|NCT00685750|519877241|FG003|Overall Study|Tumor sampling failure|0|||
144186558|NCT00685750|519877242|FG004|Overall Study|Tumor sampling failure|0|||
144186559|NCT00685750|519877243|FG005|Overall Study|Tumor sampling failure|0|||
144186560|NCT00685750|519877244|FG006|Overall Study|Tumor sampling failure|0|||
144186561|NCT00685750|519877238|FG000|Overall Study|Patient didn't receive the treatment|0|||
144186562|NCT00685750|519877239|FG001|Overall Study|Patient didn't receive the treatment|0|||
144186563|NCT00685750|519877240|FG002|Overall Study|Patient didn't receive the treatment|0|||
144186564|NCT00685750|519877241|FG003|Overall Study|Patient didn't receive the treatment|0|||
144186565|NCT00685750|519877242|FG004|Overall Study|Patient didn't receive the treatment|0|||
144186566|NCT00685750|519877243|FG005|Overall Study|Patient didn't receive the treatment|0|||
144431577|NCT02590939|520788270|FG001|Overall Study|Withdrawal by Subject|1|||
144431578|NCT02590939|520788269|FG000|Overall Study|Failed the nociceptive test|2|||
144431579|NCT02590939|520788270|FG001|Overall Study|Failed the nociceptive test|1|||
144431580|NCT03065244|520788271|FG000|Overall Study|Lost to Follow-up|1|||
144431581|NCT03065244|520788272|FG001|Overall Study|Lost to Follow-up|1|||
144431582|NCT03065244|520788271|FG000|Overall Study|Diagnosed with a different disease|1|||
144431583|NCT03065244|520788272|FG001|Overall Study|Diagnosed with a different disease|1|||
144431584|NCT03065244|520788271|FG000|Overall Study|Protocol Violation|0|||
144431585|NCT03065244|520788272|FG001|Overall Study|Protocol Violation|1|||
144431586|NCT03065244|520788271|FG000|Overall Study|Withdrawal by Subject|1|||
144431587|NCT03065244|520788272|FG001|Overall Study|Withdrawal by Subject|1|||
144431588|NCT02385084|520788274|FG000|Period 2|Protocol Violation|0|||
144431589|NCT02385084|520788275|FG001|Period 2|Protocol Violation|0|||
144431590|NCT02385084|520788276|FG002|Period 2|Protocol Violation|1|||
144431591|NCT02385084|520788277|FG003|Period 2|Protocol Violation|0|||
144431592|NCT02385084|520788278|FG004|Period 2|Protocol Violation|0|||
144431593|NCT02385084|520788279|FG005|Period 2|Protocol Violation|0|||
144431594|NCT05045144|520788280|FG000|Overall Study|Lost to Follow-up|3|||
144431595|NCT05045144|520788281|FG001|Overall Study|Lost to Follow-up|2|||
144431596|NCT05045144|520788282|FG002|Overall Study|Lost to Follow-up|3|||
144431597|NCT05045144|520788283|FG003|Overall Study|Lost to Follow-up|5|||
144431598|NCT05045144|520788284|FG004|Overall Study|Lost to Follow-up|13|||
144431599|NCT05045144|520788280|FG000|Overall Study|Withdrawal by Subject|0|||
144431600|NCT05045144|520788281|FG001|Overall Study|Withdrawal by Subject|1|||
144431601|NCT05045144|520788282|FG002|Overall Study|Withdrawal by Subject|0|||
144431602|NCT05045144|520788283|FG003|Overall Study|Withdrawal by Subject|0|||
144186567|NCT00685750|519877244|FG006|Overall Study|Patient didn't receive the treatment|1|||
144186568|NCT00685750|519877238|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144186569|NCT00685750|519877239|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144186570|NCT00685750|519877240|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
144186571|NCT00685750|519877241|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
144186572|NCT00685750|519877242|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
144186573|NCT00685750|519877243|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
144186574|NCT00685750|519877244|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
144186575|NCT02418754|519877247|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
144186576|NCT02418754|519877248|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
144186577|NCT02418754|519877249|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
144431603|NCT05045144|520788284|FG004|Overall Study|Withdrawal by Subject|0|||
144431604|NCT05045144|520788280|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144431605|NCT05045144|520788281|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144186578|NCT02418754|519877250|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
144529378|NCT05671653|521141069|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
144529379|NCT05671653|521141057|FG000|Cohort 2 Period 2|Adverse Event|0|||
144529380|NCT05671653|521141058|FG001|Cohort 2 Period 2|Adverse Event|0|||
144529381|NCT05671653|521141059|FG002|Cohort 2 Period 2|Adverse Event|0|||
144529382|NCT05671653|521141060|FG003|Cohort 2 Period 2|Adverse Event|0|||
144529383|NCT05671653|521141061|FG004|Cohort 2 Period 2|Adverse Event|0|||
144529384|NCT05671653|521141062|FG005|Cohort 2 Period 2|Adverse Event|0|||
144604271|NCT01022996|521414269|FG000|Overall Study|Withdrawal by Subject|3|||
144604272|NCT01022996|521414269|FG000|Overall Study|Lost to Follow-up|1|||
144604273|NCT01022996|521414269|FG000|Overall Study|Administrative problems|6|||
144604274|NCT01022996|521414269|FG000|Overall Study|Disease Progression|32|||
144186579|NCT02418754|519877251|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
144186580|NCT02418754|519877247|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
144186581|NCT02418754|519877248|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
144186582|NCT02418754|519877249|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
144186583|NCT02418754|519877250|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
144186584|NCT02418754|519877251|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
144186585|NCT02418754|519877247|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
144186586|NCT02418754|519877248|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
144186587|NCT02418754|519877249|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
144186588|NCT02418754|519877250|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
144186589|NCT02418754|519877251|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
144186590|NCT02418754|519877247|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
144186591|NCT02418754|519877248|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
144186592|NCT02418754|519877249|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
144186593|NCT02418754|519877250|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
144186594|NCT02418754|519877251|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
144186595|NCT02418754|519877247|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
144186596|NCT02418754|519877248|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
144186597|NCT02418754|519877249|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
144186598|NCT02418754|519877250|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
144186599|NCT02418754|519877251|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
144186600|NCT02418754|519877247|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
144186601|NCT02418754|519877248|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
144186602|NCT02418754|519877249|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
144186603|NCT02418754|519877250|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
144186604|NCT02418754|519877251|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
144186605|NCT02418754|519877247|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
144186606|NCT02418754|519877248|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
144186607|NCT02418754|519877249|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
144186608|NCT02418754|519877250|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
144186609|NCT02418754|519877251|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
144186610|NCT02418754|519877247|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
144186611|NCT02418754|519877248|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
144186612|NCT02418754|519877249|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
144186613|NCT02418754|519877250|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
144186614|NCT02418754|519877251|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
144186615|NCT02418754|519877247|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
144186616|NCT02418754|519877248|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
144186617|NCT02418754|519877249|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
144186618|NCT02418754|519877250|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
144186619|NCT02418754|519877251|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
144186620|NCT02418754|519877247|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
144186621|NCT02418754|519877248|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
144186622|NCT02418754|519877249|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
144186623|NCT02418754|519877250|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
144186624|NCT02418754|519877251|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
144186625|NCT02418754|519877247|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
144186626|NCT02418754|519877248|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
144186627|NCT02418754|519877249|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
144186628|NCT02418754|519877250|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
144186629|NCT02418754|519877251|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
144186630|NCT04974580|519877252|FG000|Overall Study|Lost to Follow-up|33|||
144529385|NCT05671653|521141063|FG006|Cohort 2 Period 2|Adverse Event|0|||
144529386|NCT05671653|521141064|FG007|Cohort 2 Period 2|Adverse Event|0|||
144529387|NCT05671653|521141065|FG008|Cohort 2 Period 2|Adverse Event|0|||
144529388|NCT05671653|521141066|FG009|Cohort 2 Period 2|Adverse Event|0|||
144529389|NCT05671653|521141067|FG010|Cohort 2 Period 2|Adverse Event|1|||
144604275|NCT01022996|521414269|FG000|Overall Study|Protocol Violation|1|||
144186631|NCT04974580|519877253|FG001|Overall Study|Lost to Follow-up|39|||
144186632|NCT04974580|519877254|FG002|Overall Study|Lost to Follow-up|30|||
144186633|NCT04974580|519877255|FG003|Overall Study|Lost to Follow-up|29|||
144186634|NCT00761176|519877272|FG000|Overall Study|Death|1|||
144186635|NCT00761176|519877273|FG001|Overall Study|Death|0|||
144186636|NCT00761176|519877272|FG000|Overall Study|Withdrawal by Subject|1|||
144186637|NCT00761176|519877273|FG001|Overall Study|Withdrawal by Subject|1|||
144186638|NCT02762994|519877274|FG000|Overall Study|Withdrawal by Subject|0|||
144186639|NCT02762994|519877275|FG001|Overall Study|Withdrawal by Subject|1|||
144186640|NCT02762994|519877276|FG002|Overall Study|Withdrawal by Subject|2|||
144186641|NCT02762994|519877277|FG003|Overall Study|Withdrawal by Subject|0|||
144186642|NCT02762994|519877274|FG000|Overall Study|Protocol Violation|1|||
144186643|NCT02762994|519877275|FG001|Overall Study|Protocol Violation|0|||
144186644|NCT02762994|519877276|FG002|Overall Study|Protocol Violation|0|||
144186645|NCT02762994|519877277|FG003|Overall Study|Protocol Violation|2|||
144186646|NCT00129116|519877278|FG000|Primary Phase|Lost to Follow-up|1|||
144186647|NCT00129116|519877279|FG001|Primary Phase|Lost to Follow-up|1|||
144186648|NCT00129116|519877280|FG002|Primary Phase|Lost to Follow-up|0|||
144186649|NCT00129116|519877281|FG003|Primary Phase|Lost to Follow-up|1|||
144186650|NCT00129116|519877282|FG004|Primary Phase|Lost to Follow-up|1|||
144186651|NCT00129116|519877278|FG000|Primary Phase|Protocol Violation|0|||
144186652|NCT00129116|519877279|FG001|Primary Phase|Protocol Violation|1|||
144186653|NCT00129116|519877280|FG002|Primary Phase|Protocol Violation|0|||
144431606|NCT05045144|520788282|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144431607|NCT05045144|520788283|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144186654|NCT00129116|519877281|FG003|Primary Phase|Protocol Violation|0|||
144186655|NCT00129116|519877282|FG004|Primary Phase|Protocol Violation|0|||
144604276|NCT00930722|521414270|FG000|Overall Study|Lost to Follow-up|16|||
144186656|NCT00129116|519877278|FG000|Primary Phase|Adverse Event|1|||
144186657|NCT00129116|519877279|FG001|Primary Phase|Adverse Event|1|||
144186658|NCT00129116|519877280|FG002|Primary Phase|Adverse Event|0|||
144186659|NCT00129116|519877281|FG003|Primary Phase|Adverse Event|0|||
144186660|NCT00129116|519877282|FG004|Primary Phase|Adverse Event|0|||
144186661|NCT00129116|519877278|FG000|Primary Phase|Withdrawal by Subject|0|||
144186662|NCT00129116|519877279|FG001|Primary Phase|Withdrawal by Subject|1|||
144186663|NCT00129116|519877280|FG002|Primary Phase|Withdrawal by Subject|0|||
144186664|NCT00129116|519877281|FG003|Primary Phase|Withdrawal by Subject|0|||
144186665|NCT00129116|519877282|FG004|Primary Phase|Withdrawal by Subject|0|||
144186666|NCT00129116|519877278|FG000|Primary Phase|Other|0|||
144186667|NCT00129116|519877279|FG001|Primary Phase|Other|0|||
144186668|NCT00129116|519877280|FG002|Primary Phase|Other|1|||
144186669|NCT00129116|519877281|FG003|Primary Phase|Other|0|||
144186670|NCT00129116|519877282|FG004|Primary Phase|Other|0|||
144186671|NCT00129116|519877278|FG000|Booster Phase|Lost to Follow-up|2|||
144186672|NCT00129116|519877279|FG001|Booster Phase|Lost to Follow-up|0|||
144186673|NCT00129116|519877280|FG002|Booster Phase|Lost to Follow-up|0|||
144186674|NCT00129116|519877281|FG003|Booster Phase|Lost to Follow-up|0|||
144186675|NCT00129116|519877282|FG004|Booster Phase|Lost to Follow-up|1|||
144186676|NCT00708682|519877283|FG000|Infant Series|Adverse Event|1|||
144186677|NCT00708682|519877283|FG000|Infant Series|Lost to Follow-up|4|||
144186678|NCT00708682|519877283|FG000|Infant Series|Protocol Violation|1|||
144186679|NCT00708682|519877283|FG000|Infant Series|Parent/legal guardian request|6|||
144186680|NCT00708682|519877283|FG000|Infant Series|Failed to return|2|||
144186681|NCT00708682|519877283|FG000|Infant Series|Other|19|||
144186682|NCT00708682|519877283|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
144186683|NCT00708682|519877283|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
144186684|NCT00708682|519877283|FG000|Toddler Dose|Lost to Follow-up|3|||
144186685|NCT00708682|519877283|FG000|Toddler Dose|Failed to Return|4|||
144186686|NCT01148225|519877286|FG000|Overall Study|Other|185|||
144186687|NCT01049581|519877289|FG000|Overall Study|Lost to Follow-up|2|||
144431608|NCT05045144|520788284|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144431609|NCT02965703|520788290|FG000|Overall Study|Withdrawal by Subject|6|||
144431610|NCT02965703|520788291|FG001|Overall Study|Withdrawal by Subject|3|||
144431611|NCT02965703|520788292|FG002|Overall Study|Withdrawal by Subject|1|||
144431612|NCT02965703|520788290|FG000|Overall Study|Protocol Violation|1|||
144431613|NCT02965703|520788291|FG001|Overall Study|Protocol Violation|0|||
144431614|NCT02965703|520788292|FG002|Overall Study|Protocol Violation|0|||
144186688|NCT01049581|519877290|FG001|Overall Study|Lost to Follow-up|1|||
144431615|NCT02965703|520788290|FG000|Overall Study|Adverse Event|1|||
144431616|NCT02965703|520788291|FG001|Overall Study|Adverse Event|1|||
144186689|NCT00810602|519877291|FG000|Overall Study|Withdrawal by Subject|8|||
144186690|NCT00810602|519877292|FG001|Overall Study|Withdrawal by Subject|3|||
144186691|NCT01557582|519877296|FG000|Overall Study|Protocol Violation|4|||
144186692|NCT01557582|519877296|FG000|Overall Study|Operator error|2|||
144186693|NCT03840382|519877297|FG000|Overall Study|Lost to Follow-up|11|||
144186694|NCT02843659|519877298|FG000|Overall Study|Subject Withdrew Consent|0|||
144431617|NCT02965703|520788292|FG002|Overall Study|Adverse Event|0|||
144431618|NCT02965703|520788290|FG000|Overall Study|Lost to Follow-up|2|||
144186695|NCT02843659|519877299|FG001|Overall Study|Subject Withdrew Consent|0|||
144723828|NCT02720510|521844233|FG000|Overall Study|Study Terminated by the sponsor|2|||
144186696|NCT02843659|519877300|FG002|Overall Study|Subject Withdrew Consent|1|||
144186697|NCT02843659|519877298|FG000|Overall Study|Administrative Reason by Sponsor|4|||
144186698|NCT02843659|519877299|FG001|Overall Study|Administrative Reason by Sponsor|5|||
144186699|NCT02843659|519877300|FG002|Overall Study|Administrative Reason by Sponsor|4|||
144186700|NCT02843659|519877298|FG000|Overall Study|Adverse Event|0|||
144186701|NCT02843659|519877299|FG001|Overall Study|Adverse Event|1|||
144186702|NCT02843659|519877300|FG002|Overall Study|Adverse Event|0|||
144186703|NCT03203642|519877301|FG000|Overall Study|Adverse Event|3|||
144186704|NCT03203642|519877302|FG001|Overall Study|Adverse Event|1|||
144186705|NCT03203642|519877301|FG000|Overall Study|Withdrawal by Subject|6|||
144186706|NCT03203642|519877302|FG001|Overall Study|Withdrawal by Subject|6|||
144186707|NCT03203642|519877301|FG000|Overall Study|Lost to Follow-up|2|||
144186708|NCT03203642|519877302|FG001|Overall Study|Lost to Follow-up|1|||
144186709|NCT03203642|519877301|FG000|Overall Study|Termination of the study by sponsor|1|||
144186710|NCT03203642|519877302|FG001|Overall Study|Termination of the study by sponsor|1|||
144186711|NCT03203642|519877301|FG000|Overall Study|Participant moved|0|||
144186712|NCT03203642|519877302|FG001|Overall Study|Participant moved|1|||
144186713|NCT03203642|519877301|FG000|Overall Study|Investigator's decision|3|||
144186714|NCT03203642|519877302|FG001|Overall Study|Investigator's decision|0|||
144186715|NCT03203642|519877301|FG000|Overall Study|Other than above specified|0|||
144186716|NCT03203642|519877302|FG001|Overall Study|Other than above specified|1|||
144186717|NCT02413294|519877303|FG000|Overall Study|Withdrawal by Subject|1|||
144186718|NCT00906373|519878926|FG000|Overall Study|Withdrawal by Subject|0|||
144186719|NCT00906373|519878927|FG001|Overall Study|Withdrawal by Subject|5|||
144186720|NCT00906373|519878926|FG000|Overall Study|Other|0|||
144186721|NCT00906373|519878927|FG001|Overall Study|Other|1|||
144186722|NCT00906373|519878926|FG000|Overall Study|Still on treatment at cutoff date|0|||
144186723|NCT00906373|519878927|FG001|Overall Study|Still on treatment at cutoff date|2|||
144186724|NCT01597479|519878928|FG000|Overall Study|Protocol Violation|1|||
144186725|NCT01597479|519878929|FG001|Overall Study|Protocol Violation|0|||
144186726|NCT01597479|519878928|FG000|Overall Study|Lost to Follow-up|1|||
144186727|NCT01597479|519878929|FG001|Overall Study|Lost to Follow-up|0|||
144186728|NCT02916693|519878930|FG000|Overall Study|Lost to Follow-up|7|||
144186729|NCT03180801|519878931|FG000|Overall Study|Physician Decision|3|||
144186730|NCT03180801|519878932|FG001|Overall Study|Physician Decision|3|||
144186731|NCT03180801|519878933|FG002|Overall Study|Physician Decision|1|||
144186732|NCT03180801|519878931|FG000|Overall Study|Non-compliance|1|||
144186733|NCT03180801|519878932|FG001|Overall Study|Non-compliance|4|||
144186734|NCT03180801|519878933|FG002|Overall Study|Non-compliance|0|||
144186735|NCT03180801|519878931|FG000|Overall Study|Inoculation Target Reached|1|||
144186736|NCT03180801|519878932|FG001|Overall Study|Inoculation Target Reached|1|||
144186737|NCT03180801|519878933|FG002|Overall Study|Inoculation Target Reached|3|||
144186738|NCT03180801|519878931|FG000|Overall Study|Adverse Event|1|||
144186739|NCT03180801|519878932|FG001|Overall Study|Adverse Event|0|||
144186740|NCT03180801|519878933|FG002|Overall Study|Adverse Event|2|||
144186741|NCT03180801|519878931|FG000|Overall Study|Withdrawal by Subject|2|||
144186742|NCT03180801|519878932|FG001|Overall Study|Withdrawal by Subject|2|||
144186743|NCT03180801|519878933|FG002|Overall Study|Withdrawal by Subject|1|||
144186744|NCT03180801|519878931|FG000|Overall Study|Lost to Follow-up|0|||
144186745|NCT03180801|519878932|FG001|Overall Study|Lost to Follow-up|2|||
144186746|NCT03180801|519878933|FG002|Overall Study|Lost to Follow-up|3|||
144186747|NCT00868296|519878936|FG000|Overall Study|Adverse Event|0|||
144186748|NCT00868296|519878937|FG001|Overall Study|Adverse Event|2|||
144186749|NCT00868296|519878936|FG000|Overall Study|Withdrawal by Subject|0|||
144186750|NCT00868296|519878937|FG001|Overall Study|Withdrawal by Subject|1|||
144186751|NCT01142908|519878938|FG000|Overall Study|Lost to Follow-up|19|||
144186752|NCT01142908|519878939|FG001|Overall Study|Lost to Follow-up|13|||
144186753|NCT01142908|519878938|FG000|Overall Study|Death|1|||
144186754|NCT01142908|519878939|FG001|Overall Study|Death|4|||
144186755|NCT01142908|519878938|FG000|Overall Study|Excluded - did not meet criteria|9|||
144252425|NCT00548249|520124713|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
144529390|NCT05671653|521141068|FG011|Cohort 2 Period 2|Adverse Event|0|||
144529391|NCT05671653|521141069|FG012|Cohort 2 Period 2|Adverse Event|0|||
144529392|NCT05671653|521141057|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
144529393|NCT05671653|521141058|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
144529394|NCT05671653|521141059|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
144529395|NCT05671653|521141060|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
144529396|NCT05671653|521141061|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
144529397|NCT05671653|521141062|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
144529398|NCT05671653|521141063|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
144529399|NCT05671653|521141064|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
144529400|NCT05671653|521141065|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
144529401|NCT05671653|521141066|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
144186756|NCT01142908|519878939|FG001|Overall Study|Excluded - did not meet criteria|5|||
144186757|NCT01142908|519878938|FG000|Overall Study|Withdrawal by Subject|3|||
144186758|NCT01142908|519878939|FG001|Overall Study|Withdrawal by Subject|0|||
144186759|NCT00035555|519878941|FG000|Overall Study|Adverse Event|5|||
144186760|NCT00035555|519878942|FG001|Overall Study|Adverse Event|8|||
144186761|NCT00035555|519878943|FG002|Overall Study|Adverse Event|9|||
144186762|NCT00035555|519878941|FG000|Overall Study|Allograft loss|1|||
144186763|NCT00035555|519878942|FG001|Overall Study|Allograft loss|1|||
144186764|NCT00035555|519878943|FG002|Overall Study|Allograft loss|2|||
144186765|NCT00035555|519878941|FG000|Overall Study|Death|0|||
144186766|NCT00035555|519878942|FG001|Overall Study|Death|0|||
144186767|NCT00035555|519878943|FG002|Overall Study|Death|2|||
144186768|NCT00035555|519878941|FG000|Overall Study|Lost to Follow-up|0|||
144186769|NCT00035555|519878942|FG001|Overall Study|Lost to Follow-up|0|||
144186770|NCT00035555|519878943|FG002|Overall Study|Lost to Follow-up|1|||
144186771|NCT00035555|519878941|FG000|Overall Study|Noncompliance|0|||
144252426|NCT00548249|520124714|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
144252427|NCT00548249|520124715|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
144252428|NCT00548249|520124711|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
144252429|NCT00548249|520124712|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
144252430|NCT00548249|520124713|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
144252431|NCT00548249|520124714|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
144252432|NCT00548249|520124715|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
144252433|NCT00548249|520124711|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
144431619|NCT02965703|520788291|FG001|Overall Study|Lost to Follow-up|1|||
144431620|NCT02965703|520788292|FG002|Overall Study|Lost to Follow-up|1|||
144431621|NCT02081079|520788293|FG000|Overall Study|Lack of Efficacy|3|||
144431622|NCT02081079|520788294|FG001|Overall Study|Lack of Efficacy|2|||
144431623|NCT02081079|520788293|FG000|Overall Study|Lost to Follow-up|1|||
144431624|NCT02081079|520788294|FG001|Overall Study|Lost to Follow-up|0|||
144431625|NCT00744627|520788295|FG000|Overall Study|Adverse Event|6|||
144431626|NCT00744627|520788296|FG001|Overall Study|Adverse Event|9|||
144431627|NCT00744627|520788295|FG000|Overall Study|Lack of Efficacy|7|||
144431628|NCT00744627|520788296|FG001|Overall Study|Lack of Efficacy|3|||
144431629|NCT00744627|520788295|FG000|Overall Study|Noncompliance|0|||
144431630|NCT00744627|520788296|FG001|Overall Study|Noncompliance|1|||
144431631|NCT00744627|520788295|FG000|Overall Study|Protocol Deviations|0|||
144431632|NCT00744627|520788296|FG001|Overall Study|Protocol Deviations|2|||
144431633|NCT00744627|520788295|FG000|Overall Study|Voluntary Withdrawal|9|||
144431634|NCT00744627|520788296|FG001|Overall Study|Voluntary Withdrawal|6|||
144431635|NCT00744627|520788295|FG000|Overall Study|Lost to Follow-up|2|||
144431636|NCT00744627|520788296|FG001|Overall Study|Lost to Follow-up|1|||
144431637|NCT00744627|520788295|FG000|Overall Study|Other|1|||
144431638|NCT00744627|520788296|FG001|Overall Study|Other|0|||
144431639|NCT02968979|520788297|FG000|Overall Study|Protocol Violation|7|||
144431640|NCT02968979|520788297|FG000|Overall Study|Withdrawal by Subject|1|||
144431641|NCT00729183|520788298|FG000|Overall Study|Adverse Event|11|||
144431642|NCT00729183|520788299|FG001|Overall Study|Adverse Event|5|||
144431643|NCT00729183|520788298|FG000|Overall Study|Lack of Efficacy|0|||
144529402|NCT05671653|521141067|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
144529403|NCT05671653|521141068|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
144529404|NCT05671653|521141069|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
144529405|NCT05671653|521141057|FG000|Cohort 2 Period 2|Pregnancy|0|||
144529406|NCT05671653|521141058|FG001|Cohort 2 Period 2|Pregnancy|0|||
144529407|NCT05671653|521141059|FG002|Cohort 2 Period 2|Pregnancy|0|||
144529408|NCT05671653|521141060|FG003|Cohort 2 Period 2|Pregnancy|0|||
144529409|NCT05671653|521141061|FG004|Cohort 2 Period 2|Pregnancy|0|||
144529410|NCT05671653|521141062|FG005|Cohort 2 Period 2|Pregnancy|0|||
144529411|NCT05671653|521141063|FG006|Cohort 2 Period 2|Pregnancy|0|||
144529412|NCT05671653|521141064|FG007|Cohort 2 Period 2|Pregnancy|0|||
144529413|NCT05671653|521141065|FG008|Cohort 2 Period 2|Pregnancy|0|||
144529414|NCT05671653|521141066|FG009|Cohort 2 Period 2|Pregnancy|0|||
144529415|NCT05671653|521141067|FG010|Cohort 2 Period 2|Pregnancy|1|||
144529416|NCT05671653|521141068|FG011|Cohort 2 Period 2|Pregnancy|0|||
144186772|NCT00035555|519878942|FG001|Overall Study|Noncompliance|1|||
144252434|NCT00548249|520124712|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
144431644|NCT00729183|520788299|FG001|Overall Study|Lack of Efficacy|1|||
144431645|NCT00729183|520788298|FG000|Overall Study|Lost to Follow-up|3|||
144431646|NCT00729183|520788299|FG001|Overall Study|Lost to Follow-up|1|||
144431647|NCT00729183|520788298|FG000|Overall Study|Physician Decision|1|||
144431648|NCT00729183|520788299|FG001|Overall Study|Physician Decision|1|||
144529417|NCT05671653|521141069|FG012|Cohort 2 Period 2|Pregnancy|0|||
144529418|NCT05671653|521141057|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529419|NCT05671653|521141058|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529420|NCT05671653|521141059|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529421|NCT05671653|521141060|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529422|NCT05671653|521141061|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529423|NCT05671653|521141062|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
144431649|NCT00729183|520788298|FG000|Overall Study|Protocol Violation|1|||
144431650|NCT00729183|520788299|FG001|Overall Study|Protocol Violation|0|||
144186773|NCT00035555|519878943|FG002|Overall Study|Noncompliance|1|||
144252435|NCT00548249|520124713|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
144252436|NCT00548249|520124714|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
144252437|NCT00548249|520124715|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
144252438|NCT00548249|520124711|FG000|Overall Study|Prolonged hospitalization|0|||
144252439|NCT00548249|520124712|FG001|Overall Study|Prolonged hospitalization|0|||
144252440|NCT00548249|520124713|FG002|Overall Study|Prolonged hospitalization|2|||
144252441|NCT00548249|520124714|FG003|Overall Study|Prolonged hospitalization|1|||
144252442|NCT00548249|520124715|FG004|Overall Study|Prolonged hospitalization|0|||
144252443|NCT00548249|520124711|FG000|Overall Study|Withdrawal by Subject|2|||
144252444|NCT00548249|520124712|FG001|Overall Study|Withdrawal by Subject|0|||
144252445|NCT00548249|520124713|FG002|Overall Study|Withdrawal by Subject|0|||
144252446|NCT00548249|520124714|FG003|Overall Study|Withdrawal by Subject|0|||
144252447|NCT00548249|520124715|FG004|Overall Study|Withdrawal by Subject|0|||
144252448|NCT00548249|520124711|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
144252449|NCT00548249|520124712|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
144252450|NCT00548249|520124713|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
144252451|NCT00548249|520124714|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
144252452|NCT00548249|520124715|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
144252453|NCT00548249|520124711|FG000|Overall Study|Sponsor's request|0|||
144252454|NCT00548249|520124712|FG001|Overall Study|Sponsor's request|0|||
144252455|NCT00548249|520124713|FG002|Overall Study|Sponsor's request|0|||
144252456|NCT00548249|520124714|FG003|Overall Study|Sponsor's request|1|||
144252457|NCT00548249|520124715|FG004|Overall Study|Sponsor's request|0|||
144252458|NCT03760458|520124717|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
144252459|NCT03760458|520124718|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
144252460|NCT03760458|520124719|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
144252461|NCT03760458|520124720|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
144252462|NCT03760458|520124721|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
144252463|NCT01464619|520124722|FG000|Overall Study|Lost to Follow-up|3|||
144252464|NCT01464619|520124723|FG001|Overall Study|Lost to Follow-up|4|||
144252465|NCT00750919|520124724|FG000|Overall Study|Adverse Event|9|||
144252466|NCT00750919|520124724|FG000|Overall Study|Withdrawal by Subject|1|||
144252467|NCT00750919|520124724|FG000|Overall Study|Lack of Efficacy|8|||
144252468|NCT00750919|520124724|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
144252469|NCT00750919|520124724|FG000|Overall Study|Other|36|||
144252470|NCT00080483|520124727|FG000|Overall Study|Lost to Follow-up|1|||
144252471|NCT00080483|520124728|FG001|Overall Study|Lost to Follow-up|1|||
144252472|NCT00080483|520124727|FG000|Overall Study|Physician Decision|1|||
144604277|NCT00930722|521414270|FG000|Overall Study|No longer willing to participate|9|||
144252473|NCT00080483|520124728|FG001|Overall Study|Physician Decision|1|||
144604278|NCT00930722|521414270|FG000|Overall Study|Study terminated by sponsor|2|||
144604279|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Adverse Event|2|||
144604280|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Adverse Event|2|||
144604281|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Adverse Event|4|||
144604282|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Adverse Event|0|||
144604283|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Adverse Event|0|||
144604284|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Progressive disease|0|||
144604285|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Progressive disease|0|||
144604286|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Progressive disease|1|||
144604287|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Progressive disease|0|||
144604288|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Progressive disease|0|||
144252474|NCT02819440|520124729|FG000|Overall Study|Adverse Event|3|||
144252475|NCT02819440|520124730|FG001|Overall Study|Adverse Event|1|||
144252476|NCT02819440|520124729|FG000|Overall Study|Lost to Follow-up|1|||
144252477|NCT02819440|520124730|FG001|Overall Study|Lost to Follow-up|3|||
144252478|NCT02819440|520124729|FG000|Overall Study|Withdrawal by Subject|9|||
144252479|NCT02819440|520124730|FG001|Overall Study|Withdrawal by Subject|8|||
144252480|NCT03304184|520124742|FG000|Overall Study|Withdrawal by Subject|1|||
144252481|NCT03304184|520124743|FG001|Overall Study|Withdrawal by Subject|2|||
144252482|NCT00731731|520124744|FG000|Overall Study|Protocol Violation|0|||
144252483|NCT00731731|520124745|FG001|Overall Study|Protocol Violation|0|||
144252484|NCT00731731|520124746|FG002|Overall Study|Protocol Violation|1|||
144252485|NCT00731731|520124744|FG000|Overall Study|Cancel prior to treatment|0|||
144252486|NCT00731731|520124745|FG001|Overall Study|Cancel prior to treatment|0|||
144252487|NCT00731731|520124746|FG002|Overall Study|Cancel prior to treatment|2|||
144604289|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
144604290|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
144604291|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
144604292|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
144604293|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
144604294|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
144604295|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
144252488|NCT01578499|520124750|FG000|Overall Study|Reason not Specified|0|||
144252489|NCT01578499|520124751|FG001|Overall Study|Reason not Specified|1|||
144252490|NCT01578499|520124750|FG000|Overall Study|Lost to Follow-up|2|||
144186774|NCT00035555|519878941|FG000|Overall Study|Prohibited medication|1|||
144186775|NCT00035555|519878942|FG001|Overall Study|Prohibited medication|1|||
144186776|NCT00035555|519878943|FG002|Overall Study|Prohibited medication|0|||
144186777|NCT00035555|519878941|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
144186778|NCT00035555|519878942|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
144186779|NCT00035555|519878943|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
144186780|NCT00035555|519878941|FG000|Overall Study|Withdrawal by Subject|2|||
144186781|NCT00035555|519878942|FG001|Overall Study|Withdrawal by Subject|0|||
144186782|NCT00035555|519878943|FG002|Overall Study|Withdrawal by Subject|2|||
144186783|NCT00035555|519878941|FG000|Overall Study|Investigator deemed not a good candidate|0|||
144186784|NCT00035555|519878942|FG001|Overall Study|Investigator deemed not a good candidate|0|||
144186785|NCT00035555|519878943|FG002|Overall Study|Investigator deemed not a good candidate|1|||
144186786|NCT00035555|519878941|FG000|Overall Study|Received cyclosporin in error|0|||
144186787|NCT00035555|519878942|FG001|Overall Study|Received cyclosporin in error|0|||
144186788|NCT00035555|519878943|FG002|Overall Study|Received cyclosporin in error|1|||
144186789|NCT00337428|519878944|FG000|Overall Study|Withdrawal by Subject|1|||
144186790|NCT00337428|519878945|FG001|Overall Study|Withdrawal by Subject|2|||
144186791|NCT00337428|519878944|FG000|Overall Study|Lack of Time|1|||
144186792|NCT00337428|519878945|FG001|Overall Study|Lack of Time|1|||
144186793|NCT00337428|519878944|FG000|Overall Study|Unwilling to Continue|1|||
144186794|NCT00337428|519878945|FG001|Overall Study|Unwilling to Continue|0|||
144186795|NCT00337428|519878944|FG000|Overall Study|Anorexia|1|||
144186796|NCT00337428|519878945|FG001|Overall Study|Anorexia|0|||
144186797|NCT02618382|519878946|FG000|Overall Study|Physician Decision|1|||
144186798|NCT02618382|519878946|FG000|Overall Study|Withdrawal by Subject|1|||
144186799|NCT02618382|519878946|FG000|Overall Study|Protocol Violation|1|||
144186800|NCT00529217|519878947|FG000|Overall Study|Lack of Efficacy|2|||
144186801|NCT00529217|519878947|FG000|Overall Study|Unable to adhere to study schedule|2|||
144186802|NCT01999894|519878948|FG000|Overall Study|Adverse Event|9|||
144186803|NCT01999894|519878948|FG000|Overall Study|Lack of Efficacy|5|||
144186804|NCT01999894|519878948|FG000|Overall Study|Protocol Violation|1|||
144186805|NCT01999894|519878948|FG000|Overall Study|Withdrawal by Subject|7|||
144186806|NCT01999894|519878948|FG000|Overall Study|Lost to Follow-up|10|||
144186807|NCT01999894|519878948|FG000|Overall Study|Other Reason|3|||
144186808|NCT01999894|519878948|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
144186809|NCT00779402|519878951|FG000|Treatment Phase 1|Disease Progression|1|||
144186810|NCT00779402|519878952|FG001|Treatment Phase 1|Disease Progression|0|||
144186811|NCT00779402|519878951|FG000|Treatment Phase 1|Adverse Event|2|||
144186812|NCT00779402|519878952|FG001|Treatment Phase 1|Adverse Event|0|||
144186813|NCT00779402|519878951|FG000|Treatment Phase 1|Protocol Violation|1|||
144186814|NCT00779402|519878952|FG001|Treatment Phase 1|Protocol Violation|0|||
144186815|NCT00779402|519878951|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
144186816|NCT00779402|519878952|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
144186817|NCT00779402|519878951|FG000|Treatment Phase 1|Lost to Follow-up|0|||
144431651|NCT00729183|520788298|FG000|Overall Study|Withdrawal by Subject|9|||
144431652|NCT00729183|520788299|FG001|Overall Study|Withdrawal by Subject|7|||
144186818|NCT00779402|519878952|FG001|Treatment Phase 1|Lost to Follow-up|1|||
144186819|NCT00779402|519878951|FG000|Treatment Phase 1|Death|0|||
144186820|NCT00779402|519878952|FG001|Treatment Phase 1|Death|1|||
144186821|NCT00779402|519878951|FG000|Treatment Phase 1|Intercurrent Illness|1|||
144186822|NCT00779402|519878952|FG001|Treatment Phase 1|Intercurrent Illness|1|||
144186823|NCT00779402|519878951|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
144186824|NCT00779402|519878952|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
144186825|NCT00779402|519878951|FG000|Treatment Phase 1|Other|4|||
144186826|NCT00779402|519878952|FG001|Treatment Phase 1|Other|2|||
144186827|NCT00779402|519878951|FG000|Treatment Phase 1|Closure of Study|3|||
144186828|NCT00779402|519878952|FG001|Treatment Phase 1|Closure of Study|2|||
144186829|NCT00779402|519878951|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
144186830|NCT00779402|519878952|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
144186831|NCT00779402|519878951|FG000|Surveillance Phase|Protocol Violation|0|||
144186832|NCT00779402|519878952|FG001|Surveillance Phase|Protocol Violation|1|||
144186833|NCT00779402|519878951|FG000|Surveillance Phase|Patient refused to continue|22|||
144186834|NCT00779402|519878952|FG001|Surveillance Phase|Patient refused to continue|14|||
144186835|NCT00779402|519878951|FG000|Surveillance Phase|Lost to Follow-up|2|||
144186836|NCT00779402|519878952|FG001|Surveillance Phase|Lost to Follow-up|1|||
144186837|NCT00779402|519878951|FG000|Surveillance Phase|Death|0|||
144186838|NCT00779402|519878952|FG001|Surveillance Phase|Death|1|||
144186839|NCT00779402|519878951|FG000|Surveillance Phase|Intercurrent Illness|2|||
144186840|NCT00779402|519878952|FG001|Surveillance Phase|Intercurrent Illness|0|||
144186841|NCT00779402|519878951|FG000|Surveillance Phase|Other|5|||
144431653|NCT03745144|520788306|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
144186842|NCT00779402|519878952|FG001|Surveillance Phase|Other|5|||
144186843|NCT00779402|519878951|FG000|Surveillance Phase|Withdrawal by Subject|4|||
144186844|NCT00779402|519878952|FG001|Surveillance Phase|Withdrawal by Subject|1|||
144186845|NCT00779402|519878951|FG000|Surveillance Phase|Closure of study|5|||
144604296|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
144431654|NCT03745144|520788307|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
144431655|NCT03745144|520788308|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
144431656|NCT03745144|520788306|FG000|Period 1|Other|0|||
144431657|NCT03745144|520788307|FG001|Period 1|Other|0|||
144431658|NCT03745144|520788308|FG002|Period 1|Other|1|||
144431659|NCT01359254|520788309|FG000|Overall Study|Death|1|||
144431660|NCT01359254|520788310|FG001|Overall Study|Death|0|||
144431661|NCT01124643|520788313|FG000|Overall Study|Death|1|||
144431662|NCT02678676|520788316|FG000|Overall Study|Death|619|||
144431663|NCT02678676|520788317|FG001|Overall Study|Death|649|||
144431664|NCT02678676|520788316|FG000|Overall Study|Withdrawal by Subject|13|||
144431665|NCT02678676|520788317|FG001|Overall Study|Withdrawal by Subject|5|||
144431666|NCT02678676|520788316|FG000|Overall Study|Lost to Follow-up|171|||
144431667|NCT02678676|520788317|FG001|Overall Study|Lost to Follow-up|151|||
144431668|NCT02678676|520788316|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
144431669|NCT02678676|520788317|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
144431670|NCT00851799|520788318|FG000|Overall Study|Death|1|||
144431671|NCT00851799|520788319|FG001|Overall Study|Death|0|||
144431672|NCT00851799|520788320|FG002|Overall Study|Death|1|||
144431673|NCT00851799|520788318|FG000|Overall Study|Lost to Follow-up|5|||
144431674|NCT00851799|520788319|FG001|Overall Study|Lost to Follow-up|3|||
144431675|NCT00851799|520788320|FG002|Overall Study|Lost to Follow-up|10|||
144431676|NCT00851799|520788318|FG000|Overall Study|Not able to get to clinic|8|||
144431677|NCT00851799|520788319|FG001|Overall Study|Not able to get to clinic|5|||
144431678|NCT00851799|520788320|FG002|Overall Study|Not able to get to clinic|9|||
144186846|NCT00779402|519878952|FG001|Surveillance Phase|Closure of study|6|||
144186847|NCT00779402|519878951|FG000|Surveillance Phase|Completed Protocol Visits|3|||
144186848|NCT00779402|519878952|FG001|Surveillance Phase|Completed Protocol Visits|2|||
144186849|NCT00779402|519878951|FG000|Long-term Follow-up|Patient refused to continue|2|||
144186850|NCT00779402|519878952|FG001|Long-term Follow-up|Patient refused to continue|0|||
144186851|NCT00779402|519878951|FG000|Long-term Follow-up|Other|5|||
144186852|NCT00779402|519878952|FG001|Long-term Follow-up|Other|0|||
144186853|NCT00779402|519878951|FG000|Long-term Follow-up|Closure of Study|8|||
144186854|NCT00779402|519878952|FG001|Long-term Follow-up|Closure of Study|4|||
144186855|NCT00779402|519878951|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
144186856|NCT00779402|519878952|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
144186857|NCT01519947|519878953|FG000|Overall Study|Death|0|||
144186858|NCT01519947|519878954|FG001|Overall Study|Death|0|||
144186859|NCT01519947|519878955|FG002|Overall Study|Death|0|||
144186860|NCT01519947|519878956|FG003|Overall Study|Death|1|||
144186861|NCT01519947|519878953|FG000|Overall Study|Protocol Violation|0|||
144186862|NCT01519947|519878954|FG001|Overall Study|Protocol Violation|0|||
144186863|NCT01519947|519878955|FG002|Overall Study|Protocol Violation|2|||
144186864|NCT01519947|519878956|FG003|Overall Study|Protocol Violation|1|||
144186865|NCT01519947|519878953|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
144186866|NCT01519947|519878954|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
144186867|NCT01519947|519878955|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
144186868|NCT01519947|519878956|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
144186869|NCT01519947|519878953|FG000|Overall Study|Development of Anemia|0|||
144431679|NCT00851799|520788318|FG000|Overall Study|Not willing to adhere to requirements|1|||
144431680|NCT00851799|520788319|FG001|Overall Study|Not willing to adhere to requirements|2|||
144431681|NCT00851799|520788320|FG002|Overall Study|Not willing to adhere to requirements|2|||
144431682|NCT00851799|520788318|FG000|Overall Study|Withdrew consent prior study completion|1|||
144431683|NCT00851799|520788319|FG001|Overall Study|Withdrew consent prior study completion|2|||
144431684|NCT00851799|520788320|FG002|Overall Study|Withdrew consent prior study completion|1|||
144431685|NCT00851799|520788318|FG000|Overall Study|Severe Debilitation|0|||
144431686|NCT00851799|520788319|FG001|Overall Study|Severe Debilitation|1|||
144431687|NCT00851799|520788320|FG002|Overall Study|Severe Debilitation|0|||
144431688|NCT00851799|520788318|FG000|Overall Study|Completed protocol due to pregnancy|0|||
144431689|NCT00851799|520788319|FG001|Overall Study|Completed protocol due to pregnancy|0|||
144431690|NCT00851799|520788320|FG002|Overall Study|Completed protocol due to pregnancy|1|||
144431691|NCT01342510|520788321|FG000|Overall Study|Protocol Violation|12|||
144723829|NCT02720510|521844234|FG001|Overall Study|Study Terminated by the sponsor|0|||
144431692|NCT01342510|520788322|FG001|Overall Study|Protocol Violation|6|||
144431693|NCT01342510|520788323|FG002|Overall Study|Protocol Violation|13|||
144431694|NCT01342510|520788324|FG003|Overall Study|Protocol Violation|11|||
144431695|NCT01449526|520788325|FG000|Overall Study|Lost to Follow-up|1|||
144431696|NCT01449526|520788326|FG001|Overall Study|Lost to Follow-up|2|||
144431697|NCT01449526|520788325|FG000|Overall Study|Withdrawal by Subject|1|||
144186870|NCT01519947|519878954|FG001|Overall Study|Development of Anemia|1|||
144186871|NCT01519947|519878955|FG002|Overall Study|Development of Anemia|0|||
144431698|NCT01449526|520788326|FG001|Overall Study|Withdrawal by Subject|1|||
144431699|NCT01449526|520788325|FG000|Overall Study|Symptoms/complaints|0|||
144431700|NCT01449526|520788326|FG001|Overall Study|Symptoms/complaints|1|||
144186872|NCT01519947|519878956|FG003|Overall Study|Development of Anemia|1|||
144186873|NCT01519947|519878953|FG000|Overall Study|Blood Transfusion|0|||
144431701|NCT01449526|520788325|FG000|Overall Study|Lack of Motivation|0|||
144431702|NCT01449526|520788326|FG001|Overall Study|Lack of Motivation|1|||
144186874|NCT01519947|519878954|FG001|Overall Study|Blood Transfusion|1|||
144186875|NCT01519947|519878955|FG002|Overall Study|Blood Transfusion|1|||
144186876|NCT01519947|519878956|FG003|Overall Study|Blood Transfusion|0|||
144186877|NCT01519947|519878953|FG000|Overall Study|Withdrawal by Subject|0|||
144186878|NCT01519947|519878954|FG001|Overall Study|Withdrawal by Subject|1|||
144186879|NCT01519947|519878955|FG002|Overall Study|Withdrawal by Subject|0|||
144186880|NCT01519947|519878956|FG003|Overall Study|Withdrawal by Subject|1|||
144186881|NCT01519947|519878953|FG000|Overall Study|Lost to Follow-up|0|||
144186882|NCT01519947|519878954|FG001|Overall Study|Lost to Follow-up|0|||
144186883|NCT01519947|519878955|FG002|Overall Study|Lost to Follow-up|3|||
144186884|NCT01519947|519878956|FG003|Overall Study|Lost to Follow-up|2|||
144186885|NCT01519947|519878953|FG000|Overall Study|Poor Response|1|||
144186886|NCT01519947|519878954|FG001|Overall Study|Poor Response|0|||
144186887|NCT01519947|519878955|FG002|Overall Study|Poor Response|0|||
144186888|NCT01519947|519878956|FG003|Overall Study|Poor Response|1|||
144186889|NCT01519947|519878953|FG000|Overall Study|Adverse Event|1|||
144186890|NCT01519947|519878954|FG001|Overall Study|Adverse Event|0|||
144186891|NCT01519947|519878955|FG002|Overall Study|Adverse Event|1|||
144186892|NCT01519947|519878956|FG003|Overall Study|Adverse Event|1|||
144186893|NCT00194792|519878957|FG000|Overall Study|Withdrawal by Subject|1|||
144186894|NCT03843125|519878960|FG000|Overall Study|Adverse Event|17|||
144431703|NCT01449526|520788325|FG000|Overall Study|Cannot maintain visits|0|||
144431704|NCT01449526|520788326|FG001|Overall Study|Cannot maintain visits|1|||
144431705|NCT04837131|520788330|FG000|Overall Study|Death|1|||
144431706|NCT04837131|520788330|FG000|Overall Study|Withdrawal by Subject|1|||
144431707|NCT04837131|520788330|FG000|Overall Study|Adverse Event|1|||
144431708|NCT04837131|520788330|FG000|Overall Study|Protocol Violation|1|||
144431709|NCT05756790|520788331|FG000|Overall Study|Withdrawal by Subject|1|||
144431710|NCT05756790|520788332|FG001|Overall Study|Withdrawal by Subject|1|||
144431711|NCT05756790|520788333|FG002|Overall Study|Withdrawal by Subject|1|||
144431712|NCT05756790|520788334|FG003|Overall Study|Withdrawal by Subject|1|||
144431713|NCT05756790|520788335|FG004|Overall Study|Withdrawal by Subject|0|||
144431714|NCT05756790|520788336|FG005|Overall Study|Withdrawal by Subject|0|||
144431715|NCT05756790|520788331|FG000|Overall Study|Protocol Violation|0|||
144431716|NCT05756790|520788332|FG001|Overall Study|Protocol Violation|0|||
144431717|NCT05756790|520788333|FG002|Overall Study|Protocol Violation|1|||
144431718|NCT05756790|520788334|FG003|Overall Study|Protocol Violation|1|||
144431719|NCT05756790|520788335|FG004|Overall Study|Protocol Violation|0|||
144431720|NCT05756790|520788336|FG005|Overall Study|Protocol Violation|0|||
144431721|NCT05756790|520788331|FG000|Overall Study|Ineligible|0|||
144431722|NCT05756790|520788332|FG001|Overall Study|Ineligible|0|||
144431723|NCT05756790|520788333|FG002|Overall Study|Ineligible|0|||
144431724|NCT05756790|520788334|FG003|Overall Study|Ineligible|0|||
144431725|NCT05756790|520788335|FG004|Overall Study|Ineligible|2|||
144431726|NCT05756790|520788336|FG005|Overall Study|Ineligible|2|||
144186895|NCT03843125|519878961|FG001|Overall Study|Adverse Event|13|||
144186896|NCT03843125|519878962|FG002|Overall Study|Adverse Event|5|||
144186897|NCT03843125|519878963|FG003|Overall Study|Adverse Event|9|||
144186898|NCT03843125|519878960|FG000|Overall Study|Death|0|||
144186899|NCT03843125|519878961|FG001|Overall Study|Death|6|||
144186900|NCT03843125|519878962|FG002|Overall Study|Death|2|||
144186901|NCT03843125|519878963|FG003|Overall Study|Death|0|||
144186902|NCT03843125|519878960|FG000|Overall Study|Lack of Efficacy|14|||
144186903|NCT03843125|519878961|FG001|Overall Study|Lack of Efficacy|11|||
144252491|NCT01578499|520124751|FG001|Overall Study|Lost to Follow-up|1|||
144186904|NCT03843125|519878962|FG002|Overall Study|Lack of Efficacy|9|||
144186905|NCT03843125|519878963|FG003|Overall Study|Lack of Efficacy|4|||
144186906|NCT03843125|519878960|FG000|Overall Study|Lost to Follow-up|3|||
144186907|NCT03843125|519878961|FG001|Overall Study|Lost to Follow-up|4|||
144186908|NCT03843125|519878962|FG002|Overall Study|Lost to Follow-up|0|||
144186909|NCT03843125|519878963|FG003|Overall Study|Lost to Follow-up|2|||
144186910|NCT03843125|519878960|FG000|Overall Study|Other|12|||
144186911|NCT03843125|519878961|FG001|Overall Study|Other|14|||
144186912|NCT03843125|519878962|FG002|Overall Study|Other|3|||
144186913|NCT03843125|519878963|FG003|Overall Study|Other|4|||
144252492|NCT01578499|520124750|FG000|Overall Study|Withdrawal by Subject|10|||
144186914|NCT03843125|519878960|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
144186915|NCT03843125|519878961|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
144186916|NCT03843125|519878962|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
144186917|NCT03843125|519878963|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
144186918|NCT03843125|519878960|FG000|Overall Study|Study Terminated by Sponsor|318|||
144186919|NCT03843125|519878961|FG001|Overall Study|Study Terminated by Sponsor|318|||
144186920|NCT03843125|519878962|FG002|Overall Study|Study Terminated by Sponsor|163|||
144529424|NCT05671653|521141063|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529425|NCT05671653|521141064|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529426|NCT05671653|521141065|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529427|NCT05671653|521141066|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529428|NCT05671653|521141067|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
144529429|NCT05671653|521141068|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529430|NCT05671653|521141069|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
144529431|NCT05671653|521141057|FG000|Cohort 2 Period 2|Other|0|||
144529432|NCT05671653|521141058|FG001|Cohort 2 Period 2|Other|0|||
144529433|NCT05671653|521141059|FG002|Cohort 2 Period 2|Other|0|||
144529434|NCT05671653|521141060|FG003|Cohort 2 Period 2|Other|0|||
144529435|NCT05671653|521141061|FG004|Cohort 2 Period 2|Other|0|||
144529436|NCT05671653|521141062|FG005|Cohort 2 Period 2|Other|0|||
144529437|NCT05671653|521141063|FG006|Cohort 2 Period 2|Other|0|||
144529438|NCT05671653|521141064|FG007|Cohort 2 Period 2|Other|0|||
144186921|NCT03843125|519878963|FG003|Overall Study|Study Terminated by Sponsor|163|||
144186922|NCT03843125|519878960|FG000|Overall Study|Withdrawal by Subject|23|||
144186923|NCT03843125|519878961|FG001|Overall Study|Withdrawal by Subject|12|||
144186924|NCT03843125|519878962|FG002|Overall Study|Withdrawal by Subject|6|||
144186925|NCT03843125|519878963|FG003|Overall Study|Withdrawal by Subject|9|||
144186926|NCT03843125|519878960|FG000|Overall Study|Missing data|0|||
144186927|NCT03843125|519878961|FG001|Overall Study|Missing data|1|||
144186928|NCT03843125|519878962|FG002|Overall Study|Missing data|1|||
144186929|NCT03843125|519878963|FG003|Overall Study|Missing data|0|||
144186930|NCT01098539|519878964|FG000|Overall Study|Adverse Event|26|||
144186931|NCT01098539|519878965|FG001|Overall Study|Adverse Event|26|||
144186932|NCT01098539|519878964|FG000|Overall Study|Protocol Violation|1|||
144186933|NCT01098539|519878965|FG001|Overall Study|Protocol Violation|4|||
144186934|NCT01098539|519878964|FG000|Overall Study|Noncompliance|3|||
144186935|NCT01098539|519878965|FG001|Overall Study|Noncompliance|5|||
144186936|NCT01098539|519878964|FG000|Overall Study|Lost to Follow-up|4|||
144186937|NCT01098539|519878965|FG001|Overall Study|Lost to Follow-up|4|||
144186938|NCT01098539|519878964|FG000|Overall Study|Withdrawal by Subject|12|||
144186939|NCT01098539|519878965|FG001|Overall Study|Withdrawal by Subject|26|||
144186940|NCT01098539|519878964|FG000|Overall Study|Physician Decision|5|||
144186941|NCT01098539|519878965|FG001|Overall Study|Physician Decision|3|||
144186942|NCT04660032|519878968|FG000|Overall Study|Protocol Violation|1|||
144186943|NCT04660032|519878969|FG001|Overall Study|Protocol Violation|1|||
144186944|NCT00090753|519878970|FG000|First Treatment Period|Adverse Event|20|||
144186945|NCT00090753|519878971|FG001|First Treatment Period|Adverse Event|8|||
144186946|NCT00090753|519878970|FG000|First Treatment Period|Death|88|||
144186947|NCT00090753|519878971|FG001|First Treatment Period|Death|62|||
144186948|NCT00090753|519878970|FG000|First Treatment Period|Lack of Efficacy|2|||
144186949|NCT00090753|519878971|FG001|First Treatment Period|Lack of Efficacy|1|||
144186950|NCT00090753|519878970|FG000|First Treatment Period|Refused Treatment|32|||
144186951|NCT00090753|519878971|FG001|First Treatment Period|Refused Treatment|25|||
144186952|NCT00090753|519878970|FG000|First Treatment Period|Lost to Follow-up|4|||
144186953|NCT00090753|519878971|FG001|First Treatment Period|Lost to Follow-up|4|||
144186954|NCT00090753|519878970|FG000|First Treatment Period|Renal Transplant|70|||
144186955|NCT00090753|519878971|FG001|First Treatment Period|Renal Transplant|50|||
144186956|NCT00090753|519878970|FG000|First Treatment Period|Mircera Commercialization|1|||
144529439|NCT05671653|521141065|FG008|Cohort 2 Period 2|Other|0|||
144529440|NCT05671653|521141066|FG009|Cohort 2 Period 2|Other|0|||
144186957|NCT00090753|519878971|FG001|First Treatment Period|Mircera Commercialization|0|||
144186958|NCT00090753|519878970|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
144186959|NCT00090753|519878971|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
144186960|NCT00090753|519878970|FG000|Extended Treatment Period|Adverse Event|11|||
144529441|NCT05671653|521141067|FG010|Cohort 2 Period 2|Other|1|||
144529442|NCT05671653|521141068|FG011|Cohort 2 Period 2|Other|0|||
144186961|NCT00090753|519878971|FG001|Extended Treatment Period|Adverse Event|0|||
144186962|NCT00090753|519878970|FG000|Extended Treatment Period|Death|58|||
144529443|NCT05671653|521141069|FG012|Cohort 2 Period 2|Other|0|||
144186963|NCT00090753|519878971|FG001|Extended Treatment Period|Death|30|||
144186964|NCT00090753|519878970|FG000|Extended Treatment Period|Lack of Efficacy|1|||
144186965|NCT00090753|519878971|FG001|Extended Treatment Period|Lack of Efficacy|0|||
144186966|NCT00090753|519878970|FG000|Extended Treatment Period|Refused Treatment|18|||
144186967|NCT00090753|519878971|FG001|Extended Treatment Period|Refused Treatment|12|||
144186968|NCT00090753|519878970|FG000|Extended Treatment Period|Lost to Follow-up|3|||
144186969|NCT00090753|519878971|FG001|Extended Treatment Period|Lost to Follow-up|1|||
144186970|NCT00090753|519878970|FG000|Extended Treatment Period|Renal Transplant|15|||
144186971|NCT00090753|519878971|FG001|Extended Treatment Period|Renal Transplant|12|||
144186972|NCT00090753|519878970|FG000|Extended Treatment Period|Mircera Commercialization|188|||
144186973|NCT00090753|519878971|FG001|Extended Treatment Period|Mircera Commercialization|93|||
144186974|NCT00090753|519878970|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
144186975|NCT00090753|519878971|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
144186976|NCT01609582|519878974|FG000|Overall Study|Adverse Event|20|||
144186977|NCT01609582|519878975|FG001|Overall Study|Adverse Event|18|||
144186978|NCT01609582|519878974|FG000|Overall Study|Lost to Follow-up|10|||
144186979|NCT01609582|519878975|FG001|Overall Study|Lost to Follow-up|10|||
144186980|NCT01609582|519878974|FG000|Overall Study|Withdrawal by Subject|21|||
144186981|NCT01609582|519878975|FG001|Overall Study|Withdrawal by Subject|15|||
144186982|NCT01609582|519878974|FG000|Overall Study|Study Terminated by Sponsor|1543|||
144186983|NCT01609582|519878975|FG001|Overall Study|Study Terminated by Sponsor|1548|||
144186984|NCT01609582|519878974|FG000|Overall Study|Other|9|||
144186985|NCT01609582|519878975|FG001|Overall Study|Other|10|||
144186986|NCT01609582|519878974|FG000|Overall Study|Randomized, but not treated|0|||
144186987|NCT01609582|519878975|FG001|Overall Study|Randomized, but not treated|3|||
144186988|NCT00250705|519878978|FG000|Overall Study|Lack of Efficacy|2|||
144186989|NCT00587431|519878979|FG000|Overall Study|Adverse Event|1|||
144186990|NCT00587431|519878980|FG001|Overall Study|Adverse Event|0|||
144186991|NCT00587431|519878979|FG000|Overall Study|Withdrawal by Subject|0|||
144186992|NCT00587431|519878980|FG001|Overall Study|Withdrawal by Subject|1|||
144186993|NCT05467982|519878981|FG000|Overall Study|Death|0|||
144186994|NCT05467982|519878982|FG001|Overall Study|Death|1|||
144186995|NCT05467982|519878981|FG000|Overall Study|Lost to Follow-up|3|||
144186996|NCT05467982|519878982|FG001|Overall Study|Lost to Follow-up|1|||
144186997|NCT05103657|519879006|FG000|Overall Study|Other reasons than listed|9|||
144186998|NCT05103657|519879007|FG001|Overall Study|Other reasons than listed|8|||
144186999|NCT05103657|519879006|FG000|Overall Study|Protocol deviation|2|||
144187000|NCT05103657|519879007|FG001|Overall Study|Protocol deviation|2|||
144187001|NCT05103657|519879006|FG000|Overall Study|No reason available|5|||
144187002|NCT05103657|519879007|FG001|Overall Study|No reason available|4|||
144187003|NCT05103657|519879006|FG000|Overall Study|Burden of study procedures|3|||
144187004|NCT05103657|519879007|FG001|Overall Study|Burden of study procedures|1|||
144187005|NCT05103657|519879006|FG000|Overall Study|Perceived lack of efficacy|1|||
144187006|NCT05103657|519879007|FG001|Overall Study|Perceived lack of efficacy|1|||
144187007|NCT05103657|519879006|FG000|Overall Study|Adverse Event|6|||
144187008|NCT05103657|519879007|FG001|Overall Study|Adverse Event|14|||
144187009|NCT05103657|519879006|FG000|Overall Study|Not Treated|1|||
144187010|NCT05103657|519879007|FG001|Overall Study|Not Treated|1|||
144187011|NCT02020967|519879008|FG000|Overall Study|Withdrawal by Subject|51|||
144187012|NCT00585312|519879011|FG000|Overall Study|Adverse Event|3|||
144187013|NCT00585312|519879012|FG001|Overall Study|Adverse Event|0|||
144187014|NCT00585312|519879011|FG000|Overall Study|Lack of Efficacy|6|||
144723830|NCT02720510|521844233|FG000|Overall Study|Adverse Event|0|||
144187015|NCT00585312|519879012|FG001|Overall Study|Lack of Efficacy|11|||
144187016|NCT00585312|519879011|FG000|Overall Study|Lost to Follow-up|1|||
144187017|NCT00585312|519879012|FG001|Overall Study|Lost to Follow-up|1|||
144187018|NCT00585312|519879011|FG000|Overall Study|Reason not specified|2|||
144252493|NCT01578499|520124751|FG001|Overall Study|Withdrawal by Subject|16|||
144252494|NCT01578499|520124750|FG000|Overall Study|Death|20|||
144252495|NCT01578499|520124751|FG001|Overall Study|Death|25|||
144252496|NCT01578499|520124750|FG000|Overall Study|Died and End of Study Page not Completed|2|||
144252497|NCT01578499|520124751|FG001|Overall Study|Died and End of Study Page not Completed|0|||
144252498|NCT00394771|520124752|FG000|Overall Study|Did not meet protocol requirements|1|||
144252499|NCT00394771|520124753|FG001|Overall Study|Did not meet protocol requirements|0|||
144252500|NCT00394771|520124754|FG002|Overall Study|Did not meet protocol requirements|2|||
144252501|NCT00394771|520124755|FG003|Overall Study|Did not meet protocol requirements|0|||
144252502|NCT00394771|520124752|FG000|Overall Study|Protocol Violation|2|||
144252503|NCT00394771|520124753|FG001|Overall Study|Protocol Violation|4|||
144252504|NCT00394771|520124754|FG002|Overall Study|Protocol Violation|9|||
144252505|NCT00394771|520124755|FG003|Overall Study|Protocol Violation|7|||
144252506|NCT00394771|520124752|FG000|Overall Study|Withdrawal by Subject|10|||
144252507|NCT00394771|520124753|FG001|Overall Study|Withdrawal by Subject|6|||
144252508|NCT00394771|520124754|FG002|Overall Study|Withdrawal by Subject|8|||
144252509|NCT00394771|520124755|FG003|Overall Study|Withdrawal by Subject|12|||
144252510|NCT00394771|520124752|FG000|Overall Study|Adverse Event|10|||
144252511|NCT00394771|520124753|FG001|Overall Study|Adverse Event|5|||
144252512|NCT00394771|520124754|FG002|Overall Study|Adverse Event|12|||
144252513|NCT00394771|520124755|FG003|Overall Study|Adverse Event|8|||
144252514|NCT00394771|520124752|FG000|Overall Study|Participant pregnant|0|||
144252515|NCT00394771|520124753|FG001|Overall Study|Participant pregnant|1|||
144252516|NCT00394771|520124754|FG002|Overall Study|Participant pregnant|2|||
144252517|NCT00394771|520124755|FG003|Overall Study|Participant pregnant|2|||
144252518|NCT00394771|520124752|FG000|Overall Study|Lost to Follow-up|15|||
144252519|NCT00394771|520124753|FG001|Overall Study|Lost to Follow-up|15|||
144252520|NCT00394771|520124754|FG002|Overall Study|Lost to Follow-up|13|||
144252521|NCT00394771|520124755|FG003|Overall Study|Lost to Follow-up|10|||
144252522|NCT00394771|520124752|FG000|Overall Study|Other|3|||
144252523|NCT00394771|520124753|FG001|Overall Study|Other|3|||
144252524|NCT00394771|520124754|FG002|Overall Study|Other|1|||
144252525|NCT00394771|520124755|FG003|Overall Study|Other|0|||
144252526|NCT02839876|520124756|FG000|Overall Study|Protocol Violation|10|||
144252527|NCT02839876|520124757|FG001|Overall Study|Protocol Violation|11|||
144252528|NCT03816007|520124760|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
144252529|NCT03816007|520124761|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
144252530|NCT03816007|520124760|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
144252531|NCT03816007|520124761|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
144252532|NCT03816007|520124760|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
144252533|NCT03816007|520124761|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
144252534|NCT01428115|520124762|FG000|Overall Study|Lack of Efficacy|3|||
144252535|NCT01428115|520124762|FG000|Overall Study|Lost to Follow-up|10|||
144252536|NCT01428115|520124762|FG000|Overall Study|Pregnancy|1|||
144252537|NCT01428115|520124762|FG000|Overall Study|Protocol Violation|3|||
144252538|NCT01428115|520124762|FG000|Overall Study|Withdrawal by Subject|4|||
144252539|NCT02620384|520124764|FG000|Overall Study|Adverse Event|2|||
144252540|NCT02620384|520124765|FG001|Overall Study|Adverse Event|1|||
144187019|NCT00585312|519879012|FG001|Overall Study|Reason not specified|0|||
144187020|NCT00585312|519879011|FG000|Overall Study|Withdrawal by Subject|5|||
144187021|NCT00585312|519879012|FG001|Overall Study|Withdrawal by Subject|1|||
144187022|NCT00585312|519879011|FG000|Overall Study|Study terminated by the sponsor|34|||
144187023|NCT00585312|519879012|FG001|Overall Study|Study terminated by the sponsor|31|||
144187024|NCT04234464|519879013|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
144187025|NCT04234464|519879014|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
144187026|NCT00983528|519879015|FG000|Overall Study|Death|4|||
144187027|NCT00983528|519879015|FG000|Overall Study|Lost to Follow-up|1|||
144252541|NCT02620384|520124764|FG000|Overall Study|Discharged prior to 2nd dose|2|||
144252542|NCT02620384|520124765|FG001|Overall Study|Discharged prior to 2nd dose|5|||
144252543|NCT02620384|520124764|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
144252544|NCT02620384|520124765|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
144187028|NCT00983528|519879015|FG000|Overall Study|Study Terminated|1|||
144252545|NCT00494221|520124766|FG000|Overall Study|Death|15|||
144252546|NCT00494221|520124767|FG001|Overall Study|Death|9|||
144187029|NCT00476593|519879016|FG000|Overall Study|Lost to Follow-up|10|||
144187030|NCT00476593|519879017|FG001|Overall Study|Lost to Follow-up|2|||
144187031|NCT00476593|519879018|FG002|Overall Study|Lost to Follow-up|8|||
144187032|NCT00476593|519879019|FG003|Overall Study|Lost to Follow-up|22|||
144252547|NCT00494221|520124768|FG002|Overall Study|Death|14|||
144252548|NCT00494221|520124766|FG000|Overall Study|Withdrawal by Subject|1|||
144252549|NCT00494221|520124767|FG001|Overall Study|Withdrawal by Subject|2|||
144252550|NCT00494221|520124768|FG002|Overall Study|Withdrawal by Subject|0|||
144252551|NCT03172364|520124775|FG000|Overall Study|Adverse Event|1|||
144187033|NCT03430011|519879020|FG000|Pre-Treatment|Death|1|||
144187034|NCT03430011|519879021|FG001|Pre-Treatment|Death|0|||
144187035|NCT03430011|519879022|FG002|Pre-Treatment|Death|0|||
144187036|NCT03430011|519879023|FG003|Pre-Treatment|Death|0|||
144187037|NCT03430011|519879024|FG004|Pre-Treatment|Death|1|||
144187038|NCT03430011|519879025|FG005|Pre-Treatment|Death|0|||
144187039|NCT03430011|519879026|FG006|Pre-Treatment|Death|1|||
144187040|NCT03430011|519879027|FG007|Pre-Treatment|Death|0|||
144187041|NCT03430011|519879020|FG000|Pre-Treatment|Screen Fail|0|||
144187042|NCT03430011|519879021|FG001|Pre-Treatment|Screen Fail|0|||
144187043|NCT03430011|519879022|FG002|Pre-Treatment|Screen Fail|0|||
144187044|NCT03430011|519879023|FG003|Pre-Treatment|Screen Fail|0|||
144187045|NCT03430011|519879024|FG004|Pre-Treatment|Screen Fail|1|||
144187046|NCT03430011|519879025|FG005|Pre-Treatment|Screen Fail|0|||
144187047|NCT03430011|519879026|FG006|Pre-Treatment|Screen Fail|0|||
144187048|NCT03430011|519879027|FG007|Pre-Treatment|Screen Fail|0|||
144187049|NCT03430011|519879020|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187050|NCT03430011|519879021|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187051|NCT03430011|519879022|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
144187052|NCT03430011|519879023|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187053|NCT03430011|519879024|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187054|NCT03430011|519879025|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187055|NCT03430011|519879026|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187056|NCT03430011|519879027|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
144187057|NCT03430011|519879020|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
144187058|NCT03430011|519879021|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
144187059|NCT03430011|519879022|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
144187060|NCT03430011|519879023|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
144187061|NCT03430011|519879024|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
144187062|NCT03430011|519879025|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
144187063|NCT03430011|519879026|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
144187064|NCT03430011|519879027|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
144187065|NCT03430011|519879020|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
144187066|NCT03430011|519879021|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
144187067|NCT03430011|519879022|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
144187068|NCT03430011|519879023|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
144187069|NCT03430011|519879024|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
144187070|NCT03430011|519879025|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
144187071|NCT03430011|519879026|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
144187072|NCT03430011|519879027|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
144187073|NCT03430011|519879020|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
144187074|NCT03430011|519879021|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
144187075|NCT03430011|519879022|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
144187076|NCT03430011|519879023|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
144187077|NCT03430011|519879024|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
144187078|NCT03430011|519879025|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
144187079|NCT03430011|519879026|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
144187080|NCT03430011|519879027|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
144187081|NCT03430011|519879020|FG000|JCARH125 Treatment|Death|4|||
144187082|NCT03430011|519879021|FG001|JCARH125 Treatment|Death|19|||
144187083|NCT03430011|519879022|FG002|JCARH125 Treatment|Death|10|||
144529444|NCT05671653|521141057|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529445|NCT05671653|521141058|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529446|NCT05671653|521141059|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529447|NCT05671653|521141060|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529448|NCT05671653|521141061|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529449|NCT05671653|521141062|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529450|NCT05671653|521141063|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529451|NCT05671653|521141064|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529452|NCT05671653|521141065|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529453|NCT05671653|521141066|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529454|NCT05671653|521141067|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529455|NCT05671653|521141068|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
144529456|NCT05671653|521141069|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
144529457|NCT01959607|521141080|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
144187084|NCT03430011|519879023|FG003|JCARH125 Treatment|Death|8|||
144187085|NCT03430011|519879024|FG004|JCARH125 Treatment|Death|5|||
144187086|NCT03430011|519879025|FG005|JCARH125 Treatment|Death|3|||
144187087|NCT03430011|519879026|FG006|JCARH125 Treatment|Death|4|||
144187088|NCT03430011|519879027|FG007|JCARH125 Treatment|Death|2|||
144187089|NCT03430011|519879020|FG000|JCARH125 Treatment|Other reasons|1|||
144187090|NCT03430011|519879021|FG001|JCARH125 Treatment|Other reasons|0|||
144187091|NCT03430011|519879022|FG002|JCARH125 Treatment|Other reasons|4|||
144187092|NCT03430011|519879023|FG003|JCARH125 Treatment|Other reasons|2|||
144187093|NCT03430011|519879024|FG004|JCARH125 Treatment|Other reasons|2|||
144187094|NCT03430011|519879025|FG005|JCARH125 Treatment|Other reasons|1|||
144604297|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
144604298|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
144604299|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
144604300|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
144604301|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
144604302|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
144604303|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
144604304|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
144604305|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
144604306|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
144604307|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
144604308|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
144604309|NCT03523728|521414271|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
144604310|NCT03523728|521414272|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
144604311|NCT03523728|521414273|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
144604312|NCT03523728|521414274|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
144604313|NCT03523728|521414275|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
144604314|NCT03523728|521414271|FG000|Stage 2 (24 Months)|Adverse Event|0|||
144604315|NCT03523728|521414272|FG001|Stage 2 (24 Months)|Adverse Event|0|||
144604316|NCT03523728|521414273|FG002|Stage 2 (24 Months)|Adverse Event|0|||
144604317|NCT03523728|521414274|FG003|Stage 2 (24 Months)|Adverse Event|1|||
144604318|NCT03523728|521414275|FG004|Stage 2 (24 Months)|Adverse Event|2|||
144604319|NCT03523728|521414271|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
144604320|NCT03523728|521414272|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
144604321|NCT03523728|521414273|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
144187095|NCT03430011|519879026|FG006|JCARH125 Treatment|Other reasons|3|||
144187096|NCT03430011|519879027|FG007|JCARH125 Treatment|Other reasons|2|||
144187097|NCT04126343|519879029|FG000|Overall Study|Adverse Event|0|||
144187098|NCT04126343|519879030|FG001|Overall Study|Adverse Event|0|||
144187099|NCT04126343|519879031|FG002|Overall Study|Adverse Event|0|||
144187100|NCT04126343|519879032|FG003|Overall Study|Adverse Event|0|||
144187101|NCT04126343|519879033|FG004|Overall Study|Adverse Event|0|||
144187102|NCT04126343|519879034|FG005|Overall Study|Adverse Event|1|||
144187103|NCT04126343|519879029|FG000|Overall Study|Withdrawal by Subject|0|||
144187104|NCT04126343|519879030|FG001|Overall Study|Withdrawal by Subject|0|||
144187105|NCT04126343|519879031|FG002|Overall Study|Withdrawal by Subject|0|||
144187106|NCT04126343|519879032|FG003|Overall Study|Withdrawal by Subject|1|||
144187107|NCT04126343|519879033|FG004|Overall Study|Withdrawal by Subject|0|||
144187108|NCT04126343|519879034|FG005|Overall Study|Withdrawal by Subject|0|||
144187109|NCT04126343|519879029|FG000|Overall Study|Related to COVID-19 pandemic|3|||
144187110|NCT04126343|519879030|FG001|Overall Study|Related to COVID-19 pandemic|4|||
144187111|NCT04126343|519879031|FG002|Overall Study|Related to COVID-19 pandemic|3|||
144187112|NCT04126343|519879032|FG003|Overall Study|Related to COVID-19 pandemic|3|||
144604322|NCT03523728|521414274|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
144604323|NCT03523728|521414275|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
144604324|NCT03523728|521414271|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
144604325|NCT03523728|521414272|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
144604326|NCT03523728|521414273|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
144187113|NCT04126343|519879033|FG004|Overall Study|Related to COVID-19 pandemic|3|||
144187114|NCT04126343|519879034|FG005|Overall Study|Related to COVID-19 pandemic|3|||
144187115|NCT00330460|519879039|FG000|Overall Study|Physician Decision|1|||
144723831|NCT02720510|521844234|FG001|Overall Study|Adverse Event|1|||
144252552|NCT03172364|520124776|FG001|Overall Study|Adverse Event|1|||
144252553|NCT03172364|520124775|FG000|Overall Study|Protocol Violation|1|||
144252554|NCT03172364|520124776|FG001|Overall Study|Protocol Violation|0|||
144252555|NCT03755518|520124777|FG000|Overall Study|Lack of Efficacy|10|||
144252556|NCT03755518|520124777|FG000|Overall Study|Adverse Event|7|||
144252557|NCT03755518|520124777|FG000|Overall Study|Study Terminated by Sponsor|5|||
144252558|NCT03755518|520124777|FG000|Overall Study|Death|1|||
144252559|NCT03755518|520124777|FG000|Overall Study|Withdrawal by Subject|3|||
144252560|NCT03755518|520124777|FG000|Overall Study|Progressive Disease|4|||
144252561|NCT03755518|520124777|FG000|Overall Study|Bone Marrow Transplant|4|||
144252562|NCT03755518|520124777|FG000|Overall Study|Physicians Decision|1|||
144252563|NCT03755518|520124777|FG000|Overall Study|Relapse|1|||
144252564|NCT03755518|520124777|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
144252565|NCT03755518|520124777|FG000|Overall Study|Withdrawal by PI|1|||
144252566|NCT01714609|520124778|FG000|Overall Study|Protocol Violation|1|||
144252567|NCT01714609|520124779|FG001|Overall Study|Protocol Violation|0|||
144252568|NCT00630747|520124780|FG000|Overall Study|Death|1|||
144252569|NCT00630747|520124780|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
144252570|NCT00630747|520124780|FG000|Overall Study|Returned to country of origin|1|||
144604327|NCT03523728|521414274|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
144604328|NCT03523728|521414275|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
144604329|NCT03523728|521414271|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
144604330|NCT03523728|521414272|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
144604331|NCT03523728|521414273|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
144604332|NCT03523728|521414274|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
144604333|NCT03523728|521414275|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
144604334|NCT03523728|521414271|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
144604335|NCT03523728|521414272|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
144187116|NCT00330460|519879040|FG001|Overall Study|Physician Decision|0|||
144187117|NCT00330460|519879039|FG000|Overall Study|Adverse Event|10|||
144187118|NCT00330460|519879040|FG001|Overall Study|Adverse Event|8|||
144604336|NCT03523728|521414273|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
144187119|NCT00330460|519879039|FG000|Overall Study|Withdrawal by Subject|18|||
144187120|NCT00330460|519879040|FG001|Overall Study|Withdrawal by Subject|17|||
144187121|NCT00330460|519879039|FG000|Overall Study|Death|1|||
144187122|NCT00330460|519879040|FG001|Overall Study|Death|1|||
144187123|NCT00330460|519879039|FG000|Overall Study|Ineligibility determined|1|||
144187124|NCT00330460|519879040|FG001|Overall Study|Ineligibility determined|3|||
144187125|NCT00330460|519879039|FG000|Overall Study|Lost to Follow-up|8|||
144187126|NCT00330460|519879040|FG001|Overall Study|Lost to Follow-up|3|||
144187127|NCT00330460|519879039|FG000|Overall Study|Noncompliance|2|||
144187128|NCT00330460|519879040|FG001|Overall Study|Noncompliance|1|||
144187129|NCT00330460|519879039|FG000|Overall Study|Other|1|||
144604337|NCT03523728|521414274|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
144604338|NCT03523728|521414275|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
144187130|NCT00330460|519879040|FG001|Overall Study|Other|0|||
144187131|NCT03712124|519879041|FG000|Overall Study|Protocol Violation|1|||
144187132|NCT03712124|519879042|FG001|Overall Study|Protocol Violation|0|||
144187133|NCT01020526|519879043|FG000|Overall Study|Withdrawal by Subject|5|||
144252571|NCT02732327|520124783|FG000|Overall Study|Protocol Violation|0|||
144252572|NCT02732327|520124784|FG001|Overall Study|Protocol Violation|1|||
144252573|NCT02306694|520124785|FG000|Overall Study|Withdrawal by Subject|3|||
144252574|NCT02306694|520124785|FG000|Overall Study|Lost to Follow-up|1|||
144187134|NCT01020526|519879043|FG000|Overall Study|Other reasons|3|||
144187135|NCT01020526|519879043|FG000|Overall Study|Insufficient clinical response|3|||
144187136|NCT01020526|519879043|FG000|Overall Study|Lost to Follow-up|1|||
144187137|NCT01020526|519879043|FG000|Overall Study|Adverse Event|2|||
144187138|NCT00879684|519879044|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
144187139|NCT00879684|519879045|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
144187140|NCT00879684|519879046|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
144187141|NCT00879684|519879047|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
144187142|NCT00879684|519879048|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
144187143|NCT00879684|519879049|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
144187144|NCT00879684|519879050|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
144187145|NCT00879684|519879044|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
144187146|NCT00879684|519879045|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
144187147|NCT00879684|519879046|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
144187148|NCT00879684|519879047|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
144187149|NCT00879684|519879048|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
144187150|NCT00879684|519879049|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
144187151|NCT00879684|519879050|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
144187152|NCT00879684|519879044|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
144187153|NCT00879684|519879045|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
144187154|NCT00879684|519879046|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
144187155|NCT00879684|519879047|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
144187156|NCT00879684|519879048|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
144187157|NCT00879684|519879049|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
144187158|NCT00879684|519879050|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
144187159|NCT00879684|519879044|FG000|Stage 1: Dose Escalation|Death|0|||
144187160|NCT00879684|519879045|FG001|Stage 1: Dose Escalation|Death|0|||
144187161|NCT00879684|519879046|FG002|Stage 1: Dose Escalation|Death|1|||
144187162|NCT00879684|519879047|FG003|Stage 1: Dose Escalation|Death|0|||
144187163|NCT00879684|519879048|FG004|Stage 1: Dose Escalation|Death|0|||
144187164|NCT00879684|519879049|FG005|Stage 1: Dose Escalation|Death|0|||
144187165|NCT00879684|519879050|FG006|Stage 1: Dose Escalation|Death|0|||
144187166|NCT00879684|519879044|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
144187167|NCT00879684|519879045|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
144187168|NCT00879684|519879046|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
144187169|NCT00879684|519879047|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
144187170|NCT00879684|519879048|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
144187171|NCT00879684|519879049|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
144187172|NCT00879684|519879050|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
144187173|NCT00879684|519879044|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
144187174|NCT00879684|519879045|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
144187175|NCT00879684|519879046|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
144187176|NCT00879684|519879047|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
144187177|NCT00879684|519879048|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
144187178|NCT00879684|519879049|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
144187179|NCT00879684|519879050|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
144187180|NCT00879684|519879044|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
144187181|NCT00879684|519879045|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
144187182|NCT00879684|519879046|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
144187183|NCT00879684|519879047|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
144187184|NCT00879684|519879048|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
144187185|NCT00879684|519879049|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
144187186|NCT00879684|519879050|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
144187187|NCT00127166|519879051|FG000|Period I|Protocol Violation|0|||
144187188|NCT00127166|519879052|FG001|Period I|Protocol Violation|2|||
144187189|NCT00127166|519879051|FG000|Period I|Withdrawal by Subject|2|||
144187190|NCT00127166|519879052|FG001|Period I|Withdrawal by Subject|0|||
144187191|NCT00127166|519879051|FG000|Period I|Patient did not meet inclusion criteria|1|||
144187192|NCT00127166|519879052|FG001|Period I|Patient did not meet inclusion criteria|0|||
144187193|NCT00127166|519879051|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
144187194|NCT00127166|519879052|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
144187195|NCT00127166|519879051|FG000|Period II|Withdrawal by Subject|2|||
144187196|NCT00127166|519879052|FG001|Period II|Withdrawal by Subject|0|||
144187197|NCT00127166|519879051|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
144187198|NCT00127166|519879052|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
144187199|NCT00105157|519879053|FG000|Double-Blind (DB)|Never Treated|1|||
144187200|NCT00105157|519879054|FG001|Double-Blind (DB)|Never Treated|0|||
144187201|NCT00105157|519879055|FG002|Double-Blind (DB)|Never Treated|0|||
144187202|NCT00105157|519879056|FG003|Double-Blind (DB)|Never Treated|0|||
144187203|NCT00105157|519879053|FG000|Double-Blind (DB)|Adverse Event|2|||
144187204|NCT00105157|519879054|FG001|Double-Blind (DB)|Adverse Event|0|||
144187205|NCT00105157|519879055|FG002|Double-Blind (DB)|Adverse Event|1|||
144187206|NCT00105157|519879056|FG003|Double-Blind (DB)|Adverse Event|1|||
144187207|NCT00105157|519879053|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
144187208|NCT00105157|519879054|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
144187209|NCT00105157|519879055|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
144187210|NCT00105157|519879056|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
144187211|NCT00105157|519879053|FG000|Open-Label Continuation of DB|Adverse Event|3|||
144187212|NCT00105157|519879054|FG001|Open-Label Continuation of DB|Adverse Event|1|||
144187213|NCT00105157|519879055|FG002|Open-Label Continuation of DB|Adverse Event|0|||
144187214|NCT00105157|519879056|FG003|Open-Label Continuation of DB|Adverse Event|0|||
144187215|NCT00105157|519879053|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
144187216|NCT00105157|519879054|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
144187217|NCT00105157|519879055|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
144187218|NCT00105157|519879056|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
144187219|NCT00105157|519879053|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
144187220|NCT00105157|519879054|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
144187221|NCT00105157|519879055|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
144187222|NCT00105157|519879056|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
144187223|NCT00105157|519879053|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
144187224|NCT00105157|519879054|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
144187225|NCT00105157|519879055|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
144187226|NCT00105157|519879056|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
144187227|NCT00105157|519879053|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
144187228|NCT00105157|519879054|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
144187229|NCT00105157|519879055|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
144187230|NCT00105157|519879056|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
144187231|NCT00105157|519879053|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
144187232|NCT00105157|519879054|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
144187233|NCT00105157|519879055|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
144187234|NCT00105157|519879056|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
144187235|NCT00105157|519879053|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
144187236|NCT00105157|519879054|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
144187237|NCT00105157|519879055|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
144187238|NCT00105157|519879056|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
144187239|NCT00105157|519879053|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
144187240|NCT00105157|519879054|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
144187241|NCT00105157|519879055|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
144187242|NCT00105157|519879056|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
144187243|NCT00105157|519879053|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
144187244|NCT00105157|519879054|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
144187245|NCT00105157|519879055|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
144187246|NCT00105157|519879056|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
144187247|NCT00105157|519879053|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
144187248|NCT00105157|519879054|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
144187249|NCT00105157|519879055|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
144187250|NCT00105157|519879056|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
144187251|NCT00105157|519879053|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
144187252|NCT00105157|519879054|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
144187253|NCT00105157|519879055|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
144187254|NCT00105157|519879056|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
144187255|NCT03689894|519879060|FG000|Overall Study|Adverse Event|1|||
144187256|NCT02030535|519879061|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
144187257|NCT01169038|519879063|FG000|Overall Study|Death|1|||
144529458|NCT01959607|521141081|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
144187258|NCT01169038|519879063|FG000|Overall Study|Adverse Event|5|||
144187259|NCT01169038|519879063|FG000|Overall Study|Required antibiotic administration|1|||
144187260|NCT01488448|519879064|FG000|Overall Study|Withdrawal by Subject|3|||
144187261|NCT01488448|519879065|FG001|Overall Study|Withdrawal by Subject|1|||
144187262|NCT01488448|519879064|FG000|Overall Study|Adverse Event|9|||
144187263|NCT01488448|519879065|FG001|Overall Study|Adverse Event|4|||
144187264|NCT01488448|519879064|FG000|Overall Study|Physician Decision|4|||
144187265|NCT01488448|519879065|FG001|Overall Study|Physician Decision|9|||
144187266|NCT01488448|519879064|FG000|Overall Study|Protocol Violation|4|||
144187267|NCT01488448|519879065|FG001|Overall Study|Protocol Violation|3|||
144187268|NCT03257254|519879066|FG000|Overall Study|Withdrawal by Subject|7|||
144187269|NCT03257254|519879066|FG000|Overall Study|Lost to Follow-up|9|||
144187270|NCT03257254|519879066|FG000|Overall Study|Study discontinued by sponsor|5|||
144187271|NCT00654641|519879067|FG000|Overall Study|Lost to Follow-up|2|||
144187272|NCT00654641|519879068|FG001|Overall Study|Lost to Follow-up|3|||
144187273|NCT02329431|519879069|FG000|Overall Study|Lost to Follow-up|20|||
144187274|NCT02329431|519879070|FG001|Overall Study|Lost to Follow-up|13|||
144529459|NCT01959607|521141082|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
144529460|NCT01959607|521141083|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
144529461|NCT02589795|521141091|FG000|Overall Study|Lost to Follow-up|1|||
144529462|NCT02589795|521141092|FG001|Overall Study|Lost to Follow-up|0|||
144529463|NCT02589795|521141093|FG002|Overall Study|Lost to Follow-up|0|||
144529464|NCT02589795|521141091|FG000|Overall Study|Withdrawal by Subject|0|||
144529465|NCT02589795|521141092|FG001|Overall Study|Withdrawal by Subject|0|||
144529466|NCT02589795|521141093|FG002|Overall Study|Withdrawal by Subject|2|||
144529467|NCT02589795|521141091|FG000|Overall Study|Protocol Violation|0|||
144529468|NCT02589795|521141092|FG001|Overall Study|Protocol Violation|0|||
144529469|NCT02589795|521141093|FG002|Overall Study|Protocol Violation|1|||
144529470|NCT05274074|521141096|FG000|Overall Study|Lost to Follow-up|2|||
144529471|NCT05274074|521141097|FG001|Overall Study|Lost to Follow-up|3|||
144529472|NCT05274074|521141096|FG000|Overall Study|Withdrawal by Subject|1|||
144529473|NCT05274074|521141097|FG001|Overall Study|Withdrawal by Subject|2|||
144529474|NCT04811040|521141098|FG000|Overall Study|Lost to Follow-up|2|||
144529475|NCT04811040|521141099|FG001|Overall Study|Lost to Follow-up|0|||
144529476|NCT04811040|521141100|FG002|Overall Study|Lost to Follow-up|0|||
144529477|NCT04811040|521141101|FG003|Overall Study|Lost to Follow-up|0|||
144529478|NCT04811040|521141098|FG000|Overall Study|Withdrew consent|1|||
144529479|NCT04811040|521141099|FG001|Overall Study|Withdrew consent|1|||
144529480|NCT04811040|521141100|FG002|Overall Study|Withdrew consent|0|||
144529481|NCT04811040|521141101|FG003|Overall Study|Withdrew consent|0|||
144529482|NCT02593773|521141102|FG000|Overall Study|Voluntary Withdrawal|3|||
144529483|NCT02593773|521141102|FG000|Overall Study|Study Terminated by Sponsor|31|||
144529484|NCT02593773|521141102|FG000|Overall Study|Death|1|||
144529485|NCT01828099|521141104|FG000|Treatment Period|Adverse Event|24|||
144529486|NCT01828099|521141105|FG001|Treatment Period|Adverse Event|23|||
144529487|NCT01828099|521141104|FG000|Treatment Period|Death|10|||
144529488|NCT01828099|521141105|FG001|Treatment Period|Death|12|||
144529489|NCT01828099|521141104|FG000|Treatment Period|Lost to Follow-up|2|||
144529490|NCT01828099|521141105|FG001|Treatment Period|Lost to Follow-up|1|||
144529491|NCT01828099|521141104|FG000|Treatment Period|Non-compliance with study treatment|1|||
144604339|NCT00621751|521414276|FG000|Overall Study|Adverse Event|0|||
144529492|NCT01828099|521141105|FG001|Treatment Period|Non-compliance with study treatment|0|||
144529493|NCT01828099|521141104|FG000|Treatment Period|Physician Decision|17|||
144529494|NCT01828099|521141105|FG001|Treatment Period|Physician Decision|16|||
144529495|NCT01828099|521141104|FG000|Treatment Period|Progressive disease|99|||
144529496|NCT01828099|521141105|FG001|Treatment Period|Progressive disease|107|||
144529497|NCT01828099|521141104|FG000|Treatment Period|Subject/guardian decision|22|||
144529498|NCT01828099|521141105|FG001|Treatment Period|Subject/guardian decision|26|||
144187275|NCT00434590|519879071|FG000|Overall Study|Administrative problems|5|||
144187276|NCT00434590|519879072|FG001|Overall Study|Administrative problems|5|||
144187277|NCT04149535|519879078|FG000|Overall Study|Death|11|||
144529499|NCT01828099|521141104|FG000|Treatment Period|Study terminated by Sponsor|13|||
144529500|NCT01828099|521141105|FG001|Treatment Period|Study terminated by Sponsor|1|||
144252575|NCT00603382|520124786|FG000|Overall Study|Adverse Event|0|||
144252576|NCT00603382|520124787|FG001|Overall Study|Adverse Event|1|||
144252577|NCT00603382|520124788|FG002|Overall Study|Adverse Event|1|||
144252578|NCT00603382|520124789|FG003|Overall Study|Adverse Event|2|||
144252579|NCT00603382|520124790|FG004|Overall Study|Adverse Event|1|||
144252580|NCT00603382|520124791|FG005|Overall Study|Adverse Event|2|||
144252581|NCT00603382|520124786|FG000|Overall Study|Lack of Efficacy|14|||
144252582|NCT00603382|520124787|FG001|Overall Study|Lack of Efficacy|9|||
144252583|NCT00603382|520124788|FG002|Overall Study|Lack of Efficacy|3|||
144252584|NCT00603382|520124789|FG003|Overall Study|Lack of Efficacy|6|||
144252585|NCT00603382|520124790|FG004|Overall Study|Lack of Efficacy|6|||
144252586|NCT00603382|520124791|FG005|Overall Study|Lack of Efficacy|11|||
144252587|NCT00603382|520124786|FG000|Overall Study|Protocol Violation|1|||
144252588|NCT00603382|520124787|FG001|Overall Study|Protocol Violation|0|||
144252589|NCT00603382|520124788|FG002|Overall Study|Protocol Violation|1|||
144252590|NCT00603382|520124789|FG003|Overall Study|Protocol Violation|2|||
144252591|NCT00603382|520124790|FG004|Overall Study|Protocol Violation|1|||
144252592|NCT00603382|520124791|FG005|Overall Study|Protocol Violation|0|||
144252593|NCT00603382|520124786|FG000|Overall Study|Lost to Follow-up|0|||
144252594|NCT00603382|520124787|FG001|Overall Study|Lost to Follow-up|1|||
144252595|NCT00603382|520124788|FG002|Overall Study|Lost to Follow-up|1|||
144252596|NCT00603382|520124789|FG003|Overall Study|Lost to Follow-up|1|||
144252597|NCT00603382|520124790|FG004|Overall Study|Lost to Follow-up|0|||
144252598|NCT00603382|520124791|FG005|Overall Study|Lost to Follow-up|1|||
144252599|NCT00603382|520124786|FG000|Overall Study|Physician Decision|0|||
144252600|NCT00603382|520124787|FG001|Overall Study|Physician Decision|0|||
144252601|NCT00603382|520124788|FG002|Overall Study|Physician Decision|2|||
144252602|NCT00603382|520124789|FG003|Overall Study|Physician Decision|0|||
144252603|NCT00603382|520124790|FG004|Overall Study|Physician Decision|1|||
144252604|NCT00603382|520124791|FG005|Overall Study|Physician Decision|3|||
144252605|NCT00603382|520124786|FG000|Overall Study|Withdrawal by Subject|3|||
144252606|NCT00603382|520124787|FG001|Overall Study|Withdrawal by Subject|3|||
144252607|NCT00603382|520124788|FG002|Overall Study|Withdrawal by Subject|1|||
144252608|NCT00603382|520124789|FG003|Overall Study|Withdrawal by Subject|1|||
144252609|NCT00603382|520124790|FG004|Overall Study|Withdrawal by Subject|0|||
144252610|NCT00603382|520124791|FG005|Overall Study|Withdrawal by Subject|1|||
144252611|NCT03782974|520124792|FG000|Overall Study|Withdrawal by Subject|7|||
144252612|NCT03782974|520124793|FG001|Overall Study|Withdrawal by Subject|7|||
144252613|NCT03782974|520124792|FG000|Overall Study|Pregnancy|1|||
144252614|NCT03782974|520124793|FG001|Overall Study|Pregnancy|0|||
144252615|NCT00583102|520124794|FG000|Overall Study|Adverse Event|3|||
144252616|NCT00448812|520124801|FG000|Year 2|Missed visit but remained in study|4|||
144252617|NCT00448812|520124802|FG001|Year 2|Missed visit but remained in study|1|||
144252618|NCT00448812|520124801|FG000|Year 3|Withdrawal by Subject|1|||
144252619|NCT00448812|520124802|FG001|Year 3|Withdrawal by Subject|3|||
144252620|NCT00448812|520124801|FG000|Year 3|Lost to Follow-up|1|||
144252621|NCT00448812|520124802|FG001|Year 3|Lost to Follow-up|0|||
144252622|NCT00448812|520124801|FG000|Year 3|Missed visit but remained in study|2|||
144252623|NCT00448812|520124802|FG001|Year 3|Missed visit but remained in study|0|||
144529501|NCT01828099|521141104|FG000|Treatment Period|Protocol deviation|1|||
144252624|NCT00448812|520124801|FG000|Year 5|Missed visit but remained in study|1|||
144252625|NCT00448812|520124802|FG001|Year 5|Missed visit but remained in study|0|||
144252626|NCT00497146|520126496|FG000|Treatment Period|Adverse Event|6|||
144252627|NCT00497146|520126497|FG001|Treatment Period|Adverse Event|2|||
144252628|NCT00497146|520126496|FG000|Treatment Period|Withdrawal by Subject|5|||
144252629|NCT00497146|520126497|FG001|Treatment Period|Withdrawal by Subject|9|||
144252630|NCT00497146|520126496|FG000|Treatment Period|Lost to Follow-up|1|||
144252631|NCT00497146|520126497|FG001|Treatment Period|Lost to Follow-up|3|||
144252632|NCT00497146|520126496|FG000|Treatment Period|Required dialysis|4|||
144252633|NCT00497146|520126497|FG001|Treatment Period|Required dialysis|1|||
144723832|NCT02720510|521844233|FG000|Overall Study|Physician Decision|1|||
144723833|NCT02720510|521844234|FG001|Overall Study|Physician Decision|2|||
144723834|NCT01618266|521844241|FG000|Overall Study|Lost to Follow-up|9|||
144723835|NCT01618266|521844241|FG000|Overall Study|Treatment satisfaction|10|||
144723836|NCT01618266|521844241|FG000|Overall Study|Other reasons|11|||
144723837|NCT01618266|521844241|FG000|Overall Study|Lack of Efficacy|23|||
144723838|NCT01618266|521844241|FG000|Overall Study|Protocol Violation|43|||
144723839|NCT00625807|521844242|FG000|Overall Study|schedule conflict|2|||
144723840|NCT00625807|521844243|FG001|Overall Study|schedule conflict|8|||
144723841|NCT03267264|521844244|FG000|Overall Study|Withdrawal by Subject|1|||
144723842|NCT03267264|521844245|FG001|Overall Study|Withdrawal by Subject|0|||
144723843|NCT03267264|521844246|FG002|Overall Study|Withdrawal by Subject|2|||
144723844|NCT03267264|521844247|FG003|Overall Study|Withdrawal by Subject|4|||
144723845|NCT02224391|521844248|FG000|Overall Study|Lost to Follow-up|26|||
144723846|NCT02224391|521844249|FG001|Overall Study|Lost to Follow-up|19|||
144723847|NCT02224391|521844248|FG000|Overall Study|Withdrawal by Subject|6|||
144723848|NCT02224391|521844249|FG001|Overall Study|Withdrawal by Subject|5|||
144723849|NCT03522948|521844250|FG000|Overall Study|Lost to Follow-up|1|||
144723850|NCT00084084|521844251|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
144723851|NCT00084084|521844251|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
144723852|NCT01802879|521844252|FG000|Overall Study|Administrative problems|2|||
144723853|NCT01802879|521844252|FG000|Overall Study|Disease progression|6|||
144723854|NCT00266409|521844253|FG000|Overall Study|Lack of Efficacy|2|||
144723855|NCT00266409|521844254|FG001|Overall Study|Lack of Efficacy|6|||
144723856|NCT00266409|521844255|FG002|Overall Study|Lack of Efficacy|1|||
144723857|NCT00266409|521844256|FG003|Overall Study|Lack of Efficacy|2|||
144723858|NCT00266409|521844253|FG000|Overall Study|Adverse Event|7|||
144723859|NCT00266409|521844254|FG001|Overall Study|Adverse Event|2|||
144723860|NCT00266409|521844255|FG002|Overall Study|Adverse Event|1|||
144723861|NCT00266409|521844256|FG003|Overall Study|Adverse Event|1|||
144723862|NCT00266409|521844253|FG000|Overall Study|Lost to Follow-up|18|||
144723863|NCT00266409|521844254|FG001|Overall Study|Lost to Follow-up|21|||
144723864|NCT00266409|521844255|FG002|Overall Study|Lost to Follow-up|6|||
144723865|NCT00266409|521844256|FG003|Overall Study|Lost to Follow-up|8|||
144723866|NCT00266409|521844253|FG000|Overall Study|Withdrawal by Subject|6|||
144723867|NCT00266409|521844254|FG001|Overall Study|Withdrawal by Subject|10|||
144723868|NCT00266409|521844255|FG002|Overall Study|Withdrawal by Subject|3|||
144187278|NCT04149535|519879079|FG001|Overall Study|Death|7|||
144187279|NCT04149535|519879078|FG000|Overall Study|Physician Decision|10|||
144723869|NCT00266409|521844256|FG003|Overall Study|Withdrawal by Subject|9|||
144723870|NCT00266409|521844253|FG000|Overall Study|Protocol Violation|5|||
144723871|NCT00266409|521844254|FG001|Overall Study|Protocol Violation|3|||
144723872|NCT00266409|521844255|FG002|Overall Study|Protocol Violation|4|||
144723873|NCT00266409|521844256|FG003|Overall Study|Protocol Violation|2|||
144723874|NCT00266409|521844253|FG000|Overall Study|Other|7|||
144187280|NCT04149535|519879079|FG001|Overall Study|Physician Decision|4|||
144723875|NCT00266409|521844254|FG001|Overall Study|Other|4|||
144723876|NCT00266409|521844255|FG002|Overall Study|Other|2|||
144723877|NCT00266409|521844256|FG003|Overall Study|Other|0|||
144723878|NCT01047345|521844263|FG000|Base Study|Adverse Event|3|||
144723879|NCT01047345|521844264|FG001|Base Study|Adverse Event|0|||
144604340|NCT00621751|521414277|FG001|Overall Study|Adverse Event|1|||
144604341|NCT00419120|521414279|FG000|Long Term Follow up Period|study ongoing|10|||
144604342|NCT01950247|521414280|FG000|Overall Study|Withdrawal by Subject|28|||
144604343|NCT01950247|521414281|FG001|Overall Study|Withdrawal by Subject|13|||
144604344|NCT01950247|521414280|FG000|Overall Study|Lost to Follow-up|18|||
144604345|NCT01950247|521414281|FG001|Overall Study|Lost to Follow-up|16|||
144604346|NCT01950247|521414280|FG000|Overall Study|Physician Decision|3|||
144604347|NCT01950247|521414281|FG001|Overall Study|Physician Decision|4|||
144604348|NCT01950247|521414280|FG000|Overall Study|Adverse Event|3|||
144604349|NCT01950247|521414281|FG001|Overall Study|Adverse Event|2|||
144604350|NCT01950247|521414280|FG000|Overall Study|Death|1|||
144604351|NCT01950247|521414281|FG001|Overall Study|Death|1|||
144604352|NCT01950247|521414280|FG000|Overall Study|Not Defined|4|||
144604353|NCT01950247|521414281|FG001|Overall Study|Not Defined|10|||
144604354|NCT01798992|521414282|FG000|Overall Study|Administrative withdrawal|0|||
144604355|NCT01798992|521414283|FG001|Overall Study|Administrative withdrawal|1|||
144604356|NCT01798992|521414284|FG002|Overall Study|Administrative withdrawal|0|||
144604357|NCT01798992|521414285|FG003|Overall Study|Administrative withdrawal|1|||
144604358|NCT01798992|521414282|FG000|Overall Study|Lost to Follow-up|0|||
144604359|NCT01798992|521414283|FG001|Overall Study|Lost to Follow-up|1|||
144604360|NCT01798992|521414284|FG002|Overall Study|Lost to Follow-up|1|||
144604361|NCT01798992|521414285|FG003|Overall Study|Lost to Follow-up|0|||
144604362|NCT01798992|521414282|FG000|Overall Study|Insufficient biopsy tissue|0|||
144604363|NCT01798992|521414283|FG001|Overall Study|Insufficient biopsy tissue|0|||
144604364|NCT01798992|521414284|FG002|Overall Study|Insufficient biopsy tissue|1|||
144604365|NCT01798992|521414285|FG003|Overall Study|Insufficient biopsy tissue|0|||
144723880|NCT01047345|521844265|FG002|Base Study|Adverse Event|0|||
144723881|NCT01047345|521844263|FG000|Base Study|Lost to Follow-up|4|||
144187281|NCT04149535|519879078|FG000|Overall Study|Withdrawal by Subject|6|||
144187282|NCT04149535|519879079|FG001|Overall Study|Withdrawal by Subject|7|||
144187283|NCT04149535|519879078|FG000|Overall Study|Not described|2|||
144187284|NCT04149535|519879079|FG001|Overall Study|Not described|0|||
144604366|NCT01069120|521414286|FG000|Overall Study|Study prematurely terminated|27|||
144604367|NCT00763971|521414287|FG000|Overall Study|Adverse Event|5|||
144604368|NCT00763971|521414288|FG001|Overall Study|Adverse Event|2|||
144604369|NCT00763971|521414289|FG002|Overall Study|Adverse Event|4|||
144604370|NCT00763971|521414287|FG000|Overall Study|Protocol Violation|3|||
144604371|NCT00763971|521414288|FG001|Overall Study|Protocol Violation|3|||
144604372|NCT00763971|521414289|FG002|Overall Study|Protocol Violation|2|||
144187285|NCT02175368|519879080|FG000|Overall Study|Lost to Follow-up|1|||
144723882|NCT01047345|521844264|FG001|Base Study|Lost to Follow-up|1|||
144723883|NCT01047345|521844265|FG002|Base Study|Lost to Follow-up|0|||
144723884|NCT01047345|521844263|FG000|Base Study|Protocol Violation|3|||
144723885|NCT01047345|521844264|FG001|Base Study|Protocol Violation|1|||
144723886|NCT01047345|521844265|FG002|Base Study|Protocol Violation|0|||
144723887|NCT01047345|521844263|FG000|Base Study|Withdrawal by Subject|12|||
144723888|NCT01047345|521844264|FG001|Base Study|Withdrawal by Subject|4|||
144723889|NCT01047345|521844265|FG002|Base Study|Withdrawal by Subject|0|||
144723890|NCT01047345|521844263|FG000|Extension|Withdrawal by Subject|0|||
144723891|NCT01047345|521844264|FG001|Extension|Withdrawal by Subject|0|||
144723892|NCT01047345|521844265|FG002|Extension|Withdrawal by Subject|1|||
144723893|NCT01047345|521844263|FG000|Extension|Lost to Follow-up|0|||
144723894|NCT01047345|521844264|FG001|Extension|Lost to Follow-up|0|||
144723895|NCT01047345|521844265|FG002|Extension|Lost to Follow-up|5|||
144723896|NCT00712010|521844266|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
144723897|NCT02187042|521844267|FG000|Overall Study|Death|1|||
144723898|NCT02187042|521844268|FG001|Overall Study|Death|1|||
144723899|NCT02187042|521844267|FG000|Overall Study|Toxicity|6|||
144723900|NCT02187042|521844268|FG001|Overall Study|Toxicity|5|||
144723901|NCT02187042|521844267|FG000|Overall Study|Participant choice|1|||
144723902|NCT02187042|521844268|FG001|Overall Study|Participant choice|0|||
144723903|NCT02187042|521844267|FG000|Overall Study|Doctor choice|1|||
144723904|NCT02187042|521844268|FG001|Overall Study|Doctor choice|0|||
144723905|NCT02187042|521844267|FG000|Overall Study|Progressive disease|4|||
144723906|NCT02187042|521844268|FG001|Overall Study|Progressive disease|8|||
144723907|NCT00282256|521844271|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
144723908|NCT00282256|521844271|FG000|Extension Treatment Period|Adverse Event|2|||
144723909|NCT00337571|521844272|FG000|Overall Study|Lack of Efficacy|3|||
144723910|NCT00337571|521844273|FG001|Overall Study|Lack of Efficacy|0|||
144723911|NCT00337571|521844274|FG002|Overall Study|Lack of Efficacy|0|||
144723912|NCT00337571|521844275|FG003|Overall Study|Lack of Efficacy|0|||
144723913|NCT00337571|521844272|FG000|Overall Study|Adverse Event|4|||
144723914|NCT00337571|521844273|FG001|Overall Study|Adverse Event|5|||
144723915|NCT00337571|521844274|FG002|Overall Study|Adverse Event|8|||
144723916|NCT00337571|521844275|FG003|Overall Study|Adverse Event|4|||
144723917|NCT00337571|521844272|FG000|Overall Study|Withdrawal by Subject|2|||
144723918|NCT00337571|521844273|FG001|Overall Study|Withdrawal by Subject|2|||
144723919|NCT00337571|521844274|FG002|Overall Study|Withdrawal by Subject|1|||
144723920|NCT00337571|521844275|FG003|Overall Study|Withdrawal by Subject|0|||
144723921|NCT00337571|521844272|FG000|Overall Study|Lost to Follow-up|3|||
144723922|NCT00337571|521844273|FG001|Overall Study|Lost to Follow-up|1|||
144723923|NCT00337571|521844274|FG002|Overall Study|Lost to Follow-up|0|||
144723924|NCT00337571|521844275|FG003|Overall Study|Lost to Follow-up|1|||
144723925|NCT00337571|521844272|FG000|Overall Study|Poor/noncompliance|1|||
144723926|NCT00337571|521844273|FG001|Overall Study|Poor/noncompliance|1|||
144723927|NCT00337571|521844274|FG002|Overall Study|Poor/noncompliance|1|||
144723928|NCT00337571|521844275|FG003|Overall Study|Poor/noncompliance|1|||
144723929|NCT00337571|521844272|FG000|Overall Study|No longer met study criteria|1|||
144723930|NCT00337571|521844273|FG001|Overall Study|No longer met study criteria|0|||
144723931|NCT00337571|521844274|FG002|Overall Study|No longer met study criteria|0|||
144723932|NCT00337571|521844275|FG003|Overall Study|No longer met study criteria|0|||
144723933|NCT00337571|521844272|FG000|Overall Study|High Potassium level|0|||
144723934|NCT00337571|521844273|FG001|Overall Study|High Potassium level|0|||
144723935|NCT00337571|521844274|FG002|Overall Study|High Potassium level|0|||
144723936|NCT00337571|521844275|FG003|Overall Study|High Potassium level|1|||
144723937|NCT00720122|521844282|FG000|Overall Study|Lost to Follow-up|1|||
144723938|NCT00720122|521844282|FG000|Overall Study|Physician Decision|1|||
144187286|NCT02875028|519879081|FG000|Washout Period|Withdrawal by Subject|0|||
144187287|NCT02875028|519879082|FG001|Washout Period|Withdrawal by Subject|1|||
144723939|NCT00720122|521844282|FG000|Overall Study|Withdrawal by Subject|7|||
144723940|NCT00510510|521844283|FG000|Overall Study|Adverse Event|4|||
144723941|NCT00510510|521844284|FG001|Overall Study|Adverse Event|3|||
144723942|NCT00510510|521844285|FG002|Overall Study|Adverse Event|6|||
144723943|NCT00510510|521844283|FG000|Overall Study|Lack of Efficacy|0|||
144723944|NCT00510510|521844284|FG001|Overall Study|Lack of Efficacy|1|||
144723945|NCT00510510|521844285|FG002|Overall Study|Lack of Efficacy|1|||
144187288|NCT05068284|519879083|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
144723946|NCT00510510|521844283|FG000|Overall Study|Subjects no longer requires study drug|0|||
144723947|NCT00510510|521844284|FG001|Overall Study|Subjects no longer requires study drug|0|||
144723948|NCT00510510|521844285|FG002|Overall Study|Subjects no longer requires study drug|2|||
144723949|NCT00510510|521844283|FG000|Overall Study|Withdrawal by Subject|1|||
144723950|NCT00510510|521844284|FG001|Overall Study|Withdrawal by Subject|2|||
144723951|NCT00510510|521844285|FG002|Overall Study|Withdrawal by Subject|3|||
144723952|NCT00510510|521844283|FG000|Overall Study|Lost to Follow-up|0|||
144723953|NCT00510510|521844284|FG001|Overall Study|Lost to Follow-up|0|||
144723954|NCT00510510|521844285|FG002|Overall Study|Lost to Follow-up|1|||
144252634|NCT00497146|520126496|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
144723955|NCT00510510|521844283|FG000|Overall Study|Protocol Violation|0|||
144723956|NCT00510510|521844284|FG001|Overall Study|Protocol Violation|3|||
144723957|NCT00510510|521844285|FG002|Overall Study|Protocol Violation|4|||
144723958|NCT04094870|521844286|FG000|Overall Study|Lost to Follow-up|1|||
144723959|NCT04094870|521844287|FG001|Overall Study|Lost to Follow-up|1|||
144723960|NCT03384745|521844288|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
144723961|NCT03384745|521844289|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
144723962|NCT03384745|521844290|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
144723963|NCT03384745|521844291|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
144723964|NCT03384745|521844292|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
144723965|NCT03384745|521844293|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
144723966|NCT03384745|521844288|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
144187289|NCT05068284|519879084|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
144187290|NCT05068284|519879085|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
144187291|NCT05068284|519879086|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
144187292|NCT05068284|519879087|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
144187293|NCT05068284|519879088|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
144187294|NCT05068284|519879089|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
144187295|NCT05068284|519879090|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
144187296|NCT05068284|519879083|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187297|NCT05068284|519879084|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187298|NCT05068284|519879085|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
144187299|NCT05068284|519879086|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187300|NCT05068284|519879087|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187301|NCT05068284|519879088|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187302|NCT05068284|519879089|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187303|NCT05068284|519879090|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
144187304|NCT05068284|519879083|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
144187305|NCT05068284|519879084|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
144187306|NCT05068284|519879085|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
144187307|NCT05068284|519879086|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
144187308|NCT05068284|519879087|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
144187309|NCT05068284|519879088|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
144187310|NCT05068284|519879089|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
144187311|NCT05068284|519879090|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
144187312|NCT05068284|519879083|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
144187313|NCT05068284|519879084|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
144187314|NCT05068284|519879085|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
144187315|NCT05068284|519879086|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
144187316|NCT05068284|519879087|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
144187317|NCT05068284|519879088|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
144187318|NCT05068284|519879089|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
144187319|NCT05068284|519879090|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
144187320|NCT05068284|519879083|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187321|NCT05068284|519879084|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187322|NCT05068284|519879085|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187323|NCT05068284|519879086|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
144187324|NCT05068284|519879087|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187325|NCT05068284|519879088|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187326|NCT05068284|519879089|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187327|NCT05068284|519879090|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
144187328|NCT05068284|519879083|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
144187329|NCT05068284|519879084|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
144187330|NCT05068284|519879085|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
144187331|NCT05068284|519879086|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
144187332|NCT05068284|519879087|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
144723967|NCT03384745|521844289|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
144187333|NCT05068284|519879088|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
144187334|NCT05068284|519879089|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
144187335|NCT05068284|519879090|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
144187336|NCT05068284|519879083|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187337|NCT05068284|519879084|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187338|NCT05068284|519879085|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
144187339|NCT05068284|519879086|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187340|NCT05068284|519879087|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187341|NCT05068284|519879088|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187342|NCT05068284|519879089|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187343|NCT05068284|519879090|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
144187344|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
144187345|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144187346|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144187347|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144187348|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144723968|NCT03384745|521844290|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
144723969|NCT03384745|521844291|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
144723970|NCT03384745|521844292|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
144723971|NCT03384745|521844293|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
144723972|NCT03384745|521844288|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
144723973|NCT03384745|521844289|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
144723974|NCT03384745|521844290|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
144723975|NCT03384745|521844291|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
144723976|NCT03384745|521844292|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
144723977|NCT03384745|521844293|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
144723978|NCT03384745|521844288|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
144723979|NCT03384745|521844289|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
144723980|NCT03384745|521844290|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
144723981|NCT03384745|521844291|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
144723982|NCT03384745|521844292|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
144723983|NCT03384745|521844293|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
144723984|NCT03384745|521844288|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
144723985|NCT03384745|521844289|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
144723986|NCT03384745|521844290|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
144723987|NCT03384745|521844291|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
144723988|NCT03384745|521844292|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
144723989|NCT03384745|521844293|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
144723990|NCT03384745|521844288|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
144723991|NCT03384745|521844289|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
144723992|NCT03384745|521844290|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
144723993|NCT03384745|521844291|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
144723994|NCT03384745|521844292|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
144723995|NCT03384745|521844293|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
144723996|NCT03384745|521844288|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
144723997|NCT03384745|521844289|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
144723998|NCT03384745|521844290|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
144723999|NCT03384745|521844291|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
144724000|NCT03384745|521844292|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
144724001|NCT03384745|521844293|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
144724002|NCT03384745|521844288|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
144724003|NCT03384745|521844289|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
144724004|NCT03384745|521844290|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
144724005|NCT03384745|521844291|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
144724006|NCT03384745|521844292|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
144724007|NCT03384745|521844293|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
144724008|NCT03384745|521844288|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
144724009|NCT03384745|521844289|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
144724010|NCT03384745|521844290|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
144724011|NCT03384745|521844291|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
144724012|NCT03384745|521844292|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
144724013|NCT03384745|521844293|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
144187349|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144187350|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144187351|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
144187352|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
144187353|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
144187354|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
144187355|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
144187356|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
144187357|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
144187358|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
144187359|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
144187360|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
144187361|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
144187362|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
144187363|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
144187364|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
144187365|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
144187366|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
144187367|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
144187368|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
144187369|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144187370|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144187371|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144187372|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144187373|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144187374|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144187375|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
144529502|NCT01828099|521141105|FG001|Treatment Period|Protocol deviation|0|||
144529503|NCT01828099|521141104|FG000|Treatment Period|No longer requires treatment|0|||
144529504|NCT01828099|521141105|FG001|Treatment Period|No longer requires treatment|1|||
144187376|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
144187377|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144187378|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144187379|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144187380|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144187381|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144187382|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144187383|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
144529505|NCT01828099|521141104|FG000|Extension-treatment Phase|Adverse Event|0|||
144529506|NCT01828099|521141105|FG001|Extension-treatment Phase|Adverse Event|17|||
144252635|NCT00497146|520126497|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
144252636|NCT00497146|520126496|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
144252637|NCT00497146|520126497|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
144252638|NCT00497146|520126496|FG000|Treatment Period|Other Reason|2|||
144252639|NCT00497146|520126497|FG001|Treatment Period|Other Reason|3|||
144252640|NCT00497146|520126496|FG000|Long-term Follow-up Period|Adverse Event|2|||
144252641|NCT00497146|520126497|FG001|Long-term Follow-up Period|Adverse Event|2|||
144252642|NCT00497146|520126496|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
144252643|NCT00497146|520126497|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
144252644|NCT00497146|520126496|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
144252645|NCT00497146|520126497|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
144252646|NCT00497146|520126496|FG000|Long-term Follow-up Period|Other|0|||
144252647|NCT00497146|520126497|FG001|Long-term Follow-up Period|Other|1|||
144252648|NCT01471444|520126498|FG000|Overall Study|Physician Decision|3|||
144252649|NCT01471444|520126499|FG001|Overall Study|Physician Decision|2|||
144252650|NCT01471444|520126498|FG000|Overall Study|Withdrawal by Subject|0|||
144252651|NCT01471444|520126499|FG001|Overall Study|Withdrawal by Subject|1|||
144252652|NCT01214668|520126510|FG000|Overall Study|Adverse Event|0|||
144252653|NCT01214668|520126511|FG001|Overall Study|Adverse Event|1|||
144252654|NCT01214668|520126512|FG002|Overall Study|Adverse Event|0|||
144724014|NCT03384745|521844288|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
144724015|NCT03384745|521844289|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
144724016|NCT03384745|521844290|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
144252655|NCT01214668|520126513|FG003|Overall Study|Adverse Event|2|||
144252656|NCT01214668|520126514|FG004|Overall Study|Adverse Event|1|||
144252657|NCT01214668|520126515|FG005|Overall Study|Adverse Event|1|||
144252658|NCT01214668|520126510|FG000|Overall Study|Death|0|||
144252659|NCT01214668|520126511|FG001|Overall Study|Death|0|||
144252660|NCT01214668|520126512|FG002|Overall Study|Death|1|||
144252661|NCT01214668|520126513|FG003|Overall Study|Death|0|||
144252662|NCT01214668|520126514|FG004|Overall Study|Death|0|||
144252663|NCT01214668|520126515|FG005|Overall Study|Death|0|||
144252664|NCT01214668|520126510|FG000|Overall Study|Progressive Disease|4|||
144252665|NCT01214668|520126511|FG001|Overall Study|Progressive Disease|2|||
144724017|NCT03384745|521844291|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
144724018|NCT03384745|521844292|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
144252666|NCT01214668|520126512|FG002|Overall Study|Progressive Disease|5|||
144252667|NCT01214668|520126513|FG003|Overall Study|Progressive Disease|4|||
144252668|NCT01214668|520126514|FG004|Overall Study|Progressive Disease|4|||
144252669|NCT01214668|520126515|FG005|Overall Study|Progressive Disease|5|||
144252670|NCT01214668|520126510|FG000|Overall Study|Withdrawal by Subject|0|||
144252671|NCT01214668|520126511|FG001|Overall Study|Withdrawal by Subject|0|||
144187384|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
144187385|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
144187386|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
144187387|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
144187388|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
144187389|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
144187390|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
144187391|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
144187392|NCT05068284|519879083|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187393|NCT05068284|519879084|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187394|NCT05068284|519879085|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187395|NCT05068284|519879086|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187396|NCT05068284|519879087|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187397|NCT05068284|519879088|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187398|NCT05068284|519879089|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
144187399|NCT05068284|519879090|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
144187400|NCT03180528|519881141|FG000|Overall Study|Adverse Event|1|||
144187401|NCT03180528|519881141|FG000|Overall Study|Withdrawal by Subject|1|||
144187402|NCT03180528|519881141|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
144187403|NCT02447887|519881142|FG000|Overall Study|Study was terminated|3|||
144187404|NCT00109837|519881143|FG000|Overall Study|Adverse Event|2|||
144187405|NCT00109837|519881143|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
144187406|NCT00109837|519881143|FG000|Overall Study|Death|1|||
144187407|NCT00109837|519881143|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
144187408|NCT00109837|519881143|FG000|Overall Study|Not treated|1|||
144187409|NCT00109837|519881143|FG000|Overall Study|Ineligible|1|||
144187410|NCT04100096|519881146|FG000|Overall Study|Adverse Event|19|||
144187411|NCT04100096|519881147|FG001|Overall Study|Adverse Event|7|||
144187412|NCT04100096|519881146|FG000|Overall Study|Lack of Efficacy|0|||
144187413|NCT04100096|519881147|FG001|Overall Study|Lack of Efficacy|1|||
144187414|NCT04100096|519881146|FG000|Overall Study|Lost to Follow-up|13|||
144187415|NCT04100096|519881147|FG001|Overall Study|Lost to Follow-up|11|||
144187416|NCT04100096|519881146|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144187417|NCT04100096|519881147|FG001|Overall Study|Non-Compliance With Study Drug|3|||
144187418|NCT04100096|519881146|FG000|Overall Study|Protocol Deviation|1|||
144187419|NCT04100096|519881147|FG001|Overall Study|Protocol Deviation|1|||
144187420|NCT04100096|519881146|FG000|Overall Study|Withdrawal by Participant|13|||
144187421|NCT04100096|519881147|FG001|Overall Study|Withdrawal by Participant|15|||
144187422|NCT00991510|519881151|FG000|Period I (Days 1-14)|Adverse Event|1|||
144187423|NCT00991510|519881152|FG001|Period I (Days 1-14)|Adverse Event|0|||
144187424|NCT00991510|519881151|FG000|Period III (Days 29-112)|Adverse Event|1|||
144187425|NCT00991510|519881152|FG001|Period III (Days 29-112)|Adverse Event|1|||
144187426|NCT01563237|519881158|FG000|Overall Study|Lost to Follow-up|6|||
144187427|NCT01563237|519881159|FG001|Overall Study|Lost to Follow-up|0|||
144187428|NCT01563237|519881158|FG000|Overall Study|Withdrawal by Subject|1|||
144187429|NCT01563237|519881159|FG001|Overall Study|Withdrawal by Subject|0|||
144187430|NCT01563237|519881158|FG000|Overall Study|Adverse Event|1|||
144187431|NCT01563237|519881159|FG001|Overall Study|Adverse Event|0|||
144187432|NCT01563237|519881158|FG000|Overall Study|Medical Reasons|1|||
144187433|NCT01563237|519881159|FG001|Overall Study|Medical Reasons|0|||
144187434|NCT01563237|519881158|FG000|Overall Study|Death|1|||
144187435|NCT01563237|519881159|FG001|Overall Study|Death|0|||
144187436|NCT00988208|519881167|FG000|Overall Study|Adverse Event|71|||
144187437|NCT00988208|519881168|FG001|Overall Study|Adverse Event|122|||
144187438|NCT00988208|519881167|FG000|Overall Study|Disease Progression|103|||
144187439|NCT00988208|519881168|FG001|Overall Study|Disease Progression|89|||
144187440|NCT00988208|519881167|FG000|Overall Study|Withdrawal by Subject|50|||
144187441|NCT00988208|519881168|FG001|Overall Study|Withdrawal by Subject|57|||
144529507|NCT01828099|521141104|FG000|Extension-treatment Phase|Death|0|||
144529508|NCT01828099|521141105|FG001|Extension-treatment Phase|Death|11|||
144529509|NCT01828099|521141104|FG000|Extension-treatment Phase|Physician Decision|0|||
144529510|NCT01828099|521141105|FG001|Extension-treatment Phase|Physician Decision|5|||
144529511|NCT01828099|521141104|FG000|Extension-treatment Phase|Progressive disease|0|||
144529512|NCT01828099|521141105|FG001|Extension-treatment Phase|Progressive disease|54|||
144252672|NCT01214668|520126512|FG002|Overall Study|Withdrawal by Subject|0|||
144252673|NCT01214668|520126513|FG003|Overall Study|Withdrawal by Subject|0|||
144252674|NCT01214668|520126514|FG004|Overall Study|Withdrawal by Subject|1|||
144252675|NCT01214668|520126515|FG005|Overall Study|Withdrawal by Subject|0|||
144252676|NCT01964989|520126516|FG000|Overall Study|Protocol Violation|3|||
144252677|NCT01964989|520126517|FG001|Overall Study|Protocol Violation|4|||
144252678|NCT01964989|520126516|FG000|Overall Study|Administrative Reason|103|||
144252679|NCT01964989|520126517|FG001|Overall Study|Administrative Reason|95|||
144252680|NCT01964989|520126516|FG000|Overall Study|Adverse Event|0|||
144252681|NCT01964989|520126517|FG001|Overall Study|Adverse Event|1|||
144252682|NCT01964989|520126516|FG000|Overall Study|Death|1|||
144252683|NCT01964989|520126517|FG001|Overall Study|Death|3|||
144252684|NCT01964989|520126516|FG000|Overall Study|Withdrawal by Subject|156|||
144252685|NCT01964989|520126517|FG001|Overall Study|Withdrawal by Subject|160|||
144252686|NCT01964989|520126516|FG000|Overall Study|Lost to Follow-up|254|||
144252687|NCT01964989|520126517|FG001|Overall Study|Lost to Follow-up|232|||
144529513|NCT01828099|521141104|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
144529514|NCT01828099|521141105|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
144529515|NCT01828099|521141104|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
144604373|NCT00763971|521414287|FG000|Overall Study|Withdrawal by Subject|4|||
144252688|NCT01964989|520126516|FG000|Overall Study|Other|267|||
144252689|NCT01964989|520126517|FG001|Overall Study|Other|252|||
144252690|NCT02769312|520126518|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
144252691|NCT02769312|520126519|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
144252692|NCT02769312|520126518|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
144252693|NCT02769312|520126519|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
144529516|NCT01828099|521141105|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
144529517|NCT05645757|521141106|FG000|Overall Study|Enrolled but treatment not administered|0|||
144604374|NCT00763971|521414288|FG001|Overall Study|Withdrawal by Subject|5|||
144529518|NCT05645757|521141107|FG001|Overall Study|Enrolled but treatment not administered|0|||
144529519|NCT05645757|521141108|FG002|Overall Study|Enrolled but treatment not administered|0|||
144529520|NCT05645757|521141109|FG003|Overall Study|Enrolled but treatment not administered|0|||
144529521|NCT05645757|521141110|FG004|Overall Study|Enrolled but treatment not administered|1|||
144529522|NCT05645757|521141111|FG005|Overall Study|Enrolled but treatment not administered|1|||
144724019|NCT03384745|521844293|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
144724020|NCT03384745|521844288|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
144252694|NCT02769312|520126518|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
144252695|NCT02769312|520126519|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
144252696|NCT02769312|520126518|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
144252697|NCT02769312|520126519|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
144252698|NCT02769312|520126518|FG000|Follow-up|Lost to Follow-up|1|||
144252699|NCT02769312|520126519|FG001|Follow-up|Lost to Follow-up|1|||
144252700|NCT02815267|520126520|FG000|Double-Blind Phase|Adverse Event|0|||
144252701|NCT02815267|520126521|FG001|Double-Blind Phase|Adverse Event|3|||
144252702|NCT02815267|520126520|FG000|Double-Blind Phase|Lost to Follow-up|17|||
144252703|NCT02815267|520126521|FG001|Double-Blind Phase|Lost to Follow-up|9|||
144252704|NCT02815267|520126520|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
144252705|NCT02815267|520126521|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
144252706|NCT02815267|520126520|FG000|Double-Blind Phase|Protocol Violation|3|||
144252707|NCT02815267|520126521|FG001|Double-Blind Phase|Protocol Violation|2|||
144252708|NCT02815267|520126520|FG000|Double-Blind Phase|Site withdrawal|1|||
144252709|NCT02815267|520126521|FG001|Double-Blind Phase|Site withdrawal|6|||
144252710|NCT02815267|520126520|FG000|Double-Blind Phase|Received a disallowed medication|1|||
144252711|NCT02815267|520126521|FG001|Double-Blind Phase|Received a disallowed medication|1|||
144252712|NCT02815267|520126520|FG000|Open-Label Phase|Adverse Event|1|||
144252713|NCT02815267|520126521|FG001|Open-Label Phase|Adverse Event|1|||
144252714|NCT02815267|520126520|FG000|Open-Label Phase|Lost to Follow-up|23|||
144252715|NCT02815267|520126521|FG001|Open-Label Phase|Lost to Follow-up|9|||
144252716|NCT02815267|520126520|FG000|Open-Label Phase|Withdrawal by Subject|24|||
144252717|NCT02815267|520126521|FG001|Open-Label Phase|Withdrawal by Subject|13|||
144252718|NCT02815267|520126520|FG000|Open-Label Phase|Protocol Violation|0|||
144252719|NCT02815267|520126521|FG001|Open-Label Phase|Protocol Violation|1|||
144252720|NCT02815267|520126520|FG000|Open-Label Phase|Administrative|21|||
144252721|NCT02815267|520126521|FG001|Open-Label Phase|Administrative|12|||
144252722|NCT02815267|520126520|FG000|Open-Label Phase|Other|2|||
144252723|NCT02815267|520126521|FG001|Open-Label Phase|Other|5|||
144252724|NCT01108237|520126522|FG000|Overall Study|No alignment data|2|||
144252725|NCT01108237|520126523|FG001|Overall Study|No alignment data|15|||
144252726|NCT01108237|520126522|FG000|Overall Study|Did not meet criteria for analysis|7|||
144529523|NCT05645757|521141112|FG006|Overall Study|Enrolled but treatment not administered|0|||
144529524|NCT05645757|521141113|FG007|Overall Study|Enrolled but treatment not administered|0|||
144724021|NCT03384745|521844289|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
144252727|NCT01108237|520126523|FG001|Overall Study|Did not meet criteria for analysis|0|||
144252728|NCT02178358|520126528|FG000|Overall Study|Withdrawal by Subject|0|||
144252729|NCT02178358|520126529|FG001|Overall Study|Withdrawal by Subject|2|||
144252730|NCT02178358|520126530|FG002|Overall Study|Withdrawal by Subject|2|||
144252731|NCT02178358|520126528|FG000|Overall Study|Lost to Follow-up|1|||
144252732|NCT02178358|520126529|FG001|Overall Study|Lost to Follow-up|0|||
144252733|NCT02178358|520126530|FG002|Overall Study|Lost to Follow-up|0|||
144252734|NCT01090050|520126531|FG000|Overall Study|Lost to Follow-up|0|||
144529525|NCT03924635|521141114|FG000|Overall Study|Withdrawal by Subject|2|||
144529526|NCT03924635|521141115|FG001|Overall Study|Withdrawal by Subject|4|||
144252735|NCT01090050|520126532|FG001|Overall Study|Lost to Follow-up|1|||
144724022|NCT03384745|521844290|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
144724023|NCT03384745|521844291|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
144724024|NCT03384745|521844292|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
144724025|NCT03384745|521844293|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
144724026|NCT01592370|521844296|FG000|Overall Study|Disease Progression|62|||
144724027|NCT01592370|521844297|FG001|Overall Study|Disease Progression|16|||
144724028|NCT01592370|521844298|FG002|Overall Study|Disease Progression|52|||
144724029|NCT01592370|521844299|FG003|Overall Study|Disease Progression|3|||
144724030|NCT01592370|521844300|FG004|Overall Study|Disease Progression|3|||
144724031|NCT01592370|521844301|FG005|Overall Study|Disease Progression|31|||
144724032|NCT01592370|521844302|FG006|Overall Study|Disease Progression|14|||
144724033|NCT01592370|521844296|FG000|Overall Study|Study Drug Toxicity|14|||
144724034|NCT01592370|521844297|FG001|Overall Study|Study Drug Toxicity|3|||
144724035|NCT01592370|521844298|FG002|Overall Study|Study Drug Toxicity|0|||
144724036|NCT01592370|521844299|FG003|Overall Study|Study Drug Toxicity|0|||
144724037|NCT01592370|521844300|FG004|Overall Study|Study Drug Toxicity|0|||
144724038|NCT01592370|521844301|FG005|Overall Study|Study Drug Toxicity|0|||
144724039|NCT01592370|521844302|FG006|Overall Study|Study Drug Toxicity|1|||
144724040|NCT01592370|521844296|FG000|Overall Study|AE unrelated to study drug|4|||
144724041|NCT01592370|521844297|FG001|Overall Study|AE unrelated to study drug|3|||
144724042|NCT01592370|521844298|FG002|Overall Study|AE unrelated to study drug|0|||
144724043|NCT01592370|521844299|FG003|Overall Study|AE unrelated to study drug|0|||
144724044|NCT01592370|521844300|FG004|Overall Study|AE unrelated to study drug|0|||
144724045|NCT01592370|521844301|FG005|Overall Study|AE unrelated to study drug|0|||
144724046|NCT01592370|521844302|FG006|Overall Study|AE unrelated to study drug|1|||
144724047|NCT01592370|521844296|FG000|Overall Study|Request to discontinue study treatment|5|||
144724048|NCT01592370|521844297|FG001|Overall Study|Request to discontinue study treatment|0|||
144724049|NCT01592370|521844298|FG002|Overall Study|Request to discontinue study treatment|2|||
144724050|NCT01592370|521844299|FG003|Overall Study|Request to discontinue study treatment|0|||
144252736|NCT01090050|520126531|FG000|Overall Study|Lack of Efficacy|1|||
144252737|NCT01090050|520126532|FG001|Overall Study|Lack of Efficacy|5|||
144252738|NCT01090050|520126531|FG000|Overall Study|Physician Decision|0|||
144252739|NCT01090050|520126532|FG001|Overall Study|Physician Decision|1|||
144252740|NCT03539484|520126533|FG000|Overall Study|Death|1|||
144252741|NCT03539484|520126534|FG001|Overall Study|Death|0|||
144252742|NCT03539484|520126535|FG002|Overall Study|Death|0|||
144252743|NCT03539484|520126536|FG003|Overall Study|Death|2|||
144252744|NCT03539484|520126537|FG004|Overall Study|Death|8|||
144252745|NCT03539484|520126538|FG005|Overall Study|Death|3|||
144252746|NCT03539484|520126539|FG006|Overall Study|Death|0|||
144252747|NCT03539484|520126533|FG000|Overall Study|Lost to Follow-up|0|||
144252748|NCT03539484|520126534|FG001|Overall Study|Lost to Follow-up|1|||
144724051|NCT01592370|521844300|FG004|Overall Study|Request to discontinue study treatment|1|||
144724052|NCT01592370|521844301|FG005|Overall Study|Request to discontinue study treatment|2|||
144724053|NCT01592370|521844302|FG006|Overall Study|Request to discontinue study treatment|0|||
144724054|NCT01592370|521844296|FG000|Overall Study|Withdrew consent|1|||
144724055|NCT01592370|521844297|FG001|Overall Study|Withdrew consent|2|||
144724056|NCT01592370|521844298|FG002|Overall Study|Withdrew consent|1|||
144724057|NCT01592370|521844299|FG003|Overall Study|Withdrew consent|1|||
144724058|NCT01592370|521844300|FG004|Overall Study|Withdrew consent|0|||
144724059|NCT01592370|521844301|FG005|Overall Study|Withdrew consent|0|||
144724060|NCT01592370|521844302|FG006|Overall Study|Withdrew consent|0|||
144724061|NCT01592370|521844296|FG000|Overall Study|Maximum clinical benefit|11|||
144724062|NCT01592370|521844297|FG001|Overall Study|Maximum clinical benefit|1|||
144724063|NCT01592370|521844298|FG002|Overall Study|Maximum clinical benefit|7|||
144724064|NCT01592370|521844299|FG003|Overall Study|Maximum clinical benefit|1|||
144724065|NCT01592370|521844300|FG004|Overall Study|Maximum clinical benefit|0|||
144724066|NCT01592370|521844301|FG005|Overall Study|Maximum clinical benefit|0|||
144724067|NCT01592370|521844302|FG006|Overall Study|Maximum clinical benefit|0|||
144724068|NCT01592370|521844296|FG000|Overall Study|No longer meets study criteria|1|||
144724069|NCT01592370|521844297|FG001|Overall Study|No longer meets study criteria|0|||
144724070|NCT01592370|521844298|FG002|Overall Study|No longer meets study criteria|0|||
144724071|NCT01592370|521844299|FG003|Overall Study|No longer meets study criteria|0|||
144724072|NCT01592370|521844300|FG004|Overall Study|No longer meets study criteria|0|||
144724073|NCT01592370|521844301|FG005|Overall Study|No longer meets study criteria|0|||
144724074|NCT01592370|521844302|FG006|Overall Study|No longer meets study criteria|0|||
144724075|NCT01592370|521844296|FG000|Overall Study|Other Reasons|6|||
144724076|NCT01592370|521844297|FG001|Overall Study|Other Reasons|0|||
144724077|NCT01592370|521844298|FG002|Overall Study|Other Reasons|10|||
144724078|NCT01592370|521844299|FG003|Overall Study|Other Reasons|0|||
144724079|NCT01592370|521844300|FG004|Overall Study|Other Reasons|0|||
144724080|NCT01592370|521844301|FG005|Overall Study|Other Reasons|1|||
144724081|NCT01592370|521844302|FG006|Overall Study|Other Reasons|0|||
144724082|NCT01592370|521844296|FG000|Overall Study|Not Treated|0|||
144724083|NCT01592370|521844297|FG001|Overall Study|Not Treated|0|||
144724084|NCT01592370|521844298|FG002|Overall Study|Not Treated|0|||
144724085|NCT01592370|521844299|FG003|Overall Study|Not Treated|0|||
144724086|NCT01592370|521844300|FG004|Overall Study|Not Treated|2|||
144724087|NCT01592370|521844301|FG005|Overall Study|Not Treated|2|||
144724088|NCT01592370|521844302|FG006|Overall Study|Not Treated|0|||
144724089|NCT02742181|521844303|FG000|Overall Study|Physician Decision|1|||
144724090|NCT02742181|521844304|FG001|Overall Study|Physician Decision|0|||
144724091|NCT00319449|521844307|FG000|Overall Study|Subject did not wish to continue|1|||
144724092|NCT00319449|521844308|FG001|Overall Study|Subject did not wish to continue|0|||
144724093|NCT00319449|521844307|FG000|Overall Study|Noncompliance with the protocol|1|||
144724094|NCT00319449|521844308|FG001|Overall Study|Noncompliance with the protocol|0|||
144724095|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
144724096|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
144724097|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
144724098|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
144724099|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
144724100|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
144724101|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
144724102|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
144724103|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
144724104|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
144724105|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
144724106|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
144724107|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
144724108|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
144187442|NCT00988208|519881167|FG000|Overall Study|Death|9|||
144724109|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
144724110|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
144724111|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
144724112|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
144724113|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
144529527|NCT04447040|521141116|FG000|Overall Study|Lost to Follow-up|2|||
144252749|NCT03539484|520126535|FG002|Overall Study|Lost to Follow-up|0|||
144252750|NCT03539484|520126536|FG003|Overall Study|Lost to Follow-up|0|||
144252751|NCT03539484|520126537|FG004|Overall Study|Lost to Follow-up|1|||
144252752|NCT03539484|520126538|FG005|Overall Study|Lost to Follow-up|0|||
144252753|NCT03539484|520126539|FG006|Overall Study|Lost to Follow-up|0|||
144252754|NCT03539484|520126533|FG000|Overall Study|Withdrawal by Subject|0|||
144252755|NCT03539484|520126534|FG001|Overall Study|Withdrawal by Subject|0|||
144252756|NCT03539484|520126535|FG002|Overall Study|Withdrawal by Subject|0|||
144252757|NCT03539484|520126536|FG003|Overall Study|Withdrawal by Subject|0|||
144252758|NCT03539484|520126537|FG004|Overall Study|Withdrawal by Subject|2|||
144252759|NCT03539484|520126538|FG005|Overall Study|Withdrawal by Subject|0|||
144252760|NCT03539484|520126539|FG006|Overall Study|Withdrawal by Subject|1|||
144252761|NCT03539484|520126533|FG000|Overall Study|Study Terminated by Sponsor|0|||
144252762|NCT03539484|520126534|FG001|Overall Study|Study Terminated by Sponsor|0|||
144252763|NCT03539484|520126535|FG002|Overall Study|Study Terminated by Sponsor|1|||
144252764|NCT03539484|520126536|FG003|Overall Study|Study Terminated by Sponsor|1|||
144252765|NCT03539484|520126537|FG004|Overall Study|Study Terminated by Sponsor|2|||
144252766|NCT03539484|520126538|FG005|Overall Study|Study Terminated by Sponsor|2|||
144252767|NCT03539484|520126539|FG006|Overall Study|Study Terminated by Sponsor|1|||
144252768|NCT02232061|520126540|FG000|Overall Study|Administrative problems|1|||
144252769|NCT02232061|520126540|FG000|Overall Study|Withdrawal by Subject|1|||
144252770|NCT00571103|520126541|FG000|Overall Study|Withdrawal by Subject|1|||
144252771|NCT00571103|520126541|FG000|Overall Study|Lost to Follow-up|1|||
144252772|NCT00948922|520126543|FG000|Overall Study|Did not start study treatment|2|||
144252773|NCT00948922|520126544|FG001|Overall Study|Did not start study treatment|5|||
144252774|NCT00948922|520126545|FG002|Overall Study|Did not start study treatment|0|||
144252775|NCT00948922|520126543|FG000|Overall Study|Withdrawal by Subject|0|||
144252776|NCT00948922|520126544|FG001|Overall Study|Withdrawal by Subject|2|||
144252777|NCT00948922|520126545|FG002|Overall Study|Withdrawal by Subject|1|||
144252778|NCT00948922|520126543|FG000|Overall Study|Death|3|||
144252779|NCT00948922|520126544|FG001|Overall Study|Death|0|||
144252780|NCT00948922|520126545|FG002|Overall Study|Death|0|||
144252781|NCT00948922|520126543|FG000|Overall Study|Disease progression|0|||
144252782|NCT00948922|520126544|FG001|Overall Study|Disease progression|1|||
144529528|NCT04447040|521141117|FG001|Overall Study|Lost to Follow-up|1|||
144529529|NCT04447040|521141118|FG002|Overall Study|Lost to Follow-up|3|||
144529530|NCT04447040|521141119|FG003|Overall Study|Lost to Follow-up|3|||
144529531|NCT04447040|521141120|FG004|Overall Study|Lost to Follow-up|1|||
144529532|NCT04447040|521141121|FG005|Overall Study|Lost to Follow-up|3|||
144529533|NCT04447040|521141116|FG000|Overall Study|Withdrawal by Subject|0|||
144529534|NCT04447040|521141117|FG001|Overall Study|Withdrawal by Subject|1|||
144529535|NCT04447040|521141118|FG002|Overall Study|Withdrawal by Subject|1|||
144252783|NCT00948922|520126545|FG002|Overall Study|Disease progression|0|||
144252784|NCT00948922|520126543|FG000|Overall Study|Insurance issues|1|||
144252785|NCT00948922|520126544|FG001|Overall Study|Insurance issues|0|||
144252786|NCT00948922|520126545|FG002|Overall Study|Insurance issues|0|||
144252787|NCT00948922|520126543|FG000|Overall Study|Transplant eligibility issues|2|||
144252788|NCT00948922|520126544|FG001|Overall Study|Transplant eligibility issues|3|||
144252789|NCT00948922|520126545|FG002|Overall Study|Transplant eligibility issues|0|||
144252790|NCT00948922|520126543|FG000|Overall Study|Not evaluable at time of analysis|0|||
144252791|NCT00948922|520126544|FG001|Overall Study|Not evaluable at time of analysis|3|||
144252792|NCT00948922|520126545|FG002|Overall Study|Not evaluable at time of analysis|0|||
144252793|NCT02784288|520126546|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
144252794|NCT02757625|520126547|FG000|Overall Study|Investigator's discretion|0|||
144252795|NCT02757625|520126548|FG001|Overall Study|Investigator's discretion|0|||
144252796|NCT02757625|520126549|FG002|Overall Study|Investigator's discretion|1|||
144252797|NCT02757625|520126550|FG003|Overall Study|Investigator's discretion|0|||
144252798|NCT02757625|520126547|FG000|Overall Study|Adverse Event|0|||
144252799|NCT02757625|520126548|FG001|Overall Study|Adverse Event|0|||
144252800|NCT02757625|520126549|FG002|Overall Study|Adverse Event|1|||
144252801|NCT02757625|520126550|FG003|Overall Study|Adverse Event|0|||
144252802|NCT02131233|520126551|FG000|Overall Study|Not Treated|2|||
144252803|NCT02131233|520126552|FG001|Overall Study|Not Treated|3|||
144252804|NCT02131233|520126551|FG000|Overall Study|Adverse Event|7|||
144252805|NCT02131233|520126552|FG001|Overall Study|Adverse Event|6|||
144252806|NCT02131233|520126551|FG000|Overall Study|Death|0|||
144252807|NCT02131233|520126552|FG001|Overall Study|Death|1|||
144252808|NCT02131233|520126551|FG000|Overall Study|Lack of Efficacy|6|||
144252809|NCT02131233|520126552|FG001|Overall Study|Lack of Efficacy|3|||
144252810|NCT02131233|520126551|FG000|Overall Study|Lost to Follow-up|14|||
144252811|NCT02131233|520126552|FG001|Overall Study|Lost to Follow-up|13|||
144252812|NCT02131233|520126551|FG000|Overall Study|Non-Compliance With Study Drug|8|||
144252813|NCT02131233|520126552|FG001|Overall Study|Non-Compliance With Study Drug|5|||
144529536|NCT04447040|521141119|FG003|Overall Study|Withdrawal by Subject|1|||
144529537|NCT04447040|521141120|FG004|Overall Study|Withdrawal by Subject|0|||
144529538|NCT04447040|521141121|FG005|Overall Study|Withdrawal by Subject|0|||
144529539|NCT04076618|521141122|FG000|Overall Study|Lost to Follow-up|2|||
144724114|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
144724115|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
144724116|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
144724117|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
144724118|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
144724119|NCT00455533|521844309|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
144724120|NCT00455533|521844310|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
144724121|NCT00455533|521844311|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
144724122|NCT00455533|521844309|FG000|Period Two: Randomized Period|Death|0|||
144724123|NCT00455533|521844310|FG001|Period Two: Randomized Period|Death|0|||
144724124|NCT00455533|521844311|FG002|Period Two: Randomized Period|Death|3|||
144724125|NCT00455533|521844309|FG000|Period Two: Randomized Period|Disease Progression|0|||
144724126|NCT00455533|521844310|FG001|Period Two: Randomized Period|Disease Progression|1|||
144724127|NCT00455533|521844311|FG002|Period Two: Randomized Period|Disease Progression|1|||
144724128|NCT00455533|521844309|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
144724129|NCT00455533|521844310|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
144724130|NCT00455533|521844311|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
144724131|NCT00455533|521844309|FG000|Period Two: Randomized Period|Other - need reasons|0|||
144252814|NCT02131233|520126551|FG000|Overall Study|Physician Decision|7|||
144252815|NCT02131233|520126552|FG001|Overall Study|Physician Decision|0|||
144252816|NCT02131233|520126551|FG000|Overall Study|Pregnancy|4|||
144252817|NCT02131233|520126552|FG001|Overall Study|Pregnancy|0|||
144252818|NCT02131233|520126551|FG000|Overall Study|Withdrawal by Subject|18|||
144252819|NCT02131233|520126552|FG001|Overall Study|Withdrawal by Subject|11|||
144252820|NCT00645671|520126553|FG000|Overall Study|Protocol Violation|1|||
144252821|NCT00645671|520126554|FG001|Overall Study|Protocol Violation|0|||
144252822|NCT00645671|520126553|FG000|Overall Study|Withdrawal by Subject|0|||
144252823|NCT00645671|520126554|FG001|Overall Study|Withdrawal by Subject|4|||
144252824|NCT00645671|520126553|FG000|Overall Study|Adverse Event|0|||
144252825|NCT00645671|520126554|FG001|Overall Study|Adverse Event|1|||
144252826|NCT00645671|520126553|FG000|Overall Study|Physician Decision|0|||
144252827|NCT00645671|520126554|FG001|Overall Study|Physician Decision|1|||
144252828|NCT02095197|520126555|FG000|Overall Study|Lost to Follow-up|0|||
144252829|NCT02095197|520126556|FG001|Overall Study|Lost to Follow-up|3|||
144252830|NCT05114564|520126558|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
144252831|NCT05114564|520126559|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
144252832|NCT05114564|520126558|FG000|First Intervention|Adverse Event|0|||
144252833|NCT05114564|520126559|FG001|First Intervention|Adverse Event|1|||
144252834|NCT00493311|520126560|FG000|Overall Study|Need for rescue medication|2|||
144252835|NCT00493311|520126561|FG001|Overall Study|Need for rescue medication|2|||
144252836|NCT02779075|520126562|FG000|Overall Study|Withdrawal by Subject|1|||
144252837|NCT02779075|520126563|FG001|Overall Study|Withdrawal by Subject|3|||
144252838|NCT02779075|520126562|FG000|Overall Study|IV lost during 2nd study|1|||
144252839|NCT02779075|520126563|FG001|Overall Study|IV lost during 2nd study|0|||
144252840|NCT00790556|520126564|FG000|Treatment Period 1|Physician Decision|1|||
144252841|NCT00790556|520126565|FG001|Treatment Period 1|Physician Decision|0|||
144252842|NCT00790556|520126564|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144252843|NCT00790556|520126565|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144252844|NCT00255840|520126566|FG000|Overall Study|Lost to Follow-up|10|||
144252845|NCT00255840|520126567|FG001|Overall Study|Lost to Follow-up|14|||
144252846|NCT00255840|520126566|FG000|Overall Study|Discontinued intervention|53|||
144252847|NCT00255840|520126567|FG001|Overall Study|Discontinued intervention|56|||
144252848|NCT00217581|520126570|FG000|Overall Study|Withdrawal by Subject|1|||
144252849|NCT00496587|520126571|FG000|Overall Study|Adverse Event|2|||
144252850|NCT00496587|520126571|FG000|Overall Study|Progressive Disease|24|||
144252851|NCT00496587|520126571|FG000|Overall Study|Withdrawal by Subject|2|||
144252852|NCT00496587|520126571|FG000|Overall Study|Death|1|||
144252853|NCT00496587|520126571|FG000|Overall Study|Complications unrelated|2|||
144252854|NCT05259917|520126576|FG000|Overall Study|Protocol Violation|0|||
144252855|NCT05259917|520126577|FG001|Overall Study|Protocol Violation|0|||
144252856|NCT05259917|520126578|FG002|Overall Study|Protocol Violation|1|||
144252857|NCT05259917|520126579|FG003|Overall Study|Protocol Violation|0|||
144252858|NCT05259917|520126580|FG004|Overall Study|Protocol Violation|0|||
144529540|NCT04076618|521141123|FG001|Overall Study|Lost to Follow-up|1|||
144529541|NCT04076618|521141124|FG002|Overall Study|Lost to Follow-up|3|||
144252859|NCT05259917|520126581|FG005|Overall Study|Protocol Violation|0|||
144252860|NCT05259917|520126576|FG000|Overall Study|Lost to Follow-up|0|||
144252861|NCT05259917|520126577|FG001|Overall Study|Lost to Follow-up|0|||
144724132|NCT00455533|521844310|FG001|Period Two: Randomized Period|Other - need reasons|1|||
144724133|NCT00455533|521844311|FG002|Period Two: Randomized Period|Other - need reasons|0|||
144724134|NCT00455533|521844309|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
144724135|NCT00455533|521844310|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
144724136|NCT00455533|521844311|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
144724137|NCT00455533|521844309|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
144724138|NCT00455533|521844310|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
144724139|NCT00455533|521844311|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
144724140|NCT02739984|521844312|FG000|Overall Study|Sponsor Decision|1|||
144724141|NCT02739984|521844313|FG001|Overall Study|Sponsor Decision|0|||
144724142|NCT02739984|521844312|FG000|Overall Study|Withdrawal by Subject|1|||
144724143|NCT02739984|521844313|FG001|Overall Study|Withdrawal by Subject|1|||
144724144|NCT02739984|521844312|FG000|Overall Study|Death|0|||
144724145|NCT02739984|521844313|FG001|Overall Study|Death|1|||
144724146|NCT02739984|521844312|FG000|Overall Study|Lost to Follow-up|3|||
144724147|NCT02739984|521844313|FG001|Overall Study|Lost to Follow-up|0|||
144724148|NCT01346410|521844314|FG000|Overall Study|Death|1|||
144724149|NCT00979628|521844315|FG000|Overall Study|received regimen < 24 hours|7|||
144724150|NCT00979628|521844316|FG001|Overall Study|received regimen < 24 hours|6|||
144724151|NCT00979628|521844317|FG002|Overall Study|received regimen < 24 hours|5|||
144724152|NCT00979628|521844315|FG000|Overall Study|received steroids|1|||
144724153|NCT00979628|521844316|FG001|Overall Study|received steroids|1|||
144724154|NCT00979628|521844317|FG002|Overall Study|received steroids|0|||
144724155|NCT00979628|521844315|FG000|Overall Study|transferred to ICU|1|||
144724156|NCT00979628|521844316|FG001|Overall Study|transferred to ICU|2|||
144724157|NCT00979628|521844317|FG002|Overall Study|transferred to ICU|1|||
144724158|NCT02576990|521844318|FG000|Overall Study|Death|29|||
144724159|NCT02576990|521844319|FG001|Overall Study|Death|18|||
144724160|NCT02576990|521844318|FG000|Overall Study|Physician Decision|1|||
144724161|NCT02576990|521844319|FG001|Overall Study|Physician Decision|0|||
144724162|NCT02576990|521844318|FG000|Overall Study|Screen failure|2|||
144724163|NCT02576990|521844319|FG001|Overall Study|Screen failure|0|||
144724164|NCT02576990|521844318|FG000|Overall Study|Sponsor's decision|24|||
144724165|NCT02576990|521844319|FG001|Overall Study|Sponsor's decision|4|||
144724166|NCT02576990|521844318|FG000|Overall Study|Withdrawal by Subject|0|||
144724167|NCT02576990|521844319|FG001|Overall Study|Withdrawal by Subject|2|||
144724168|NCT00911859|521844320|FG000|Treatment Period|Adverse Event|3|||
144724169|NCT00911859|521844321|FG001|Treatment Period|Adverse Event|3|||
144724170|NCT00911859|521844322|FG002|Treatment Period|Adverse Event|7|||
144724171|NCT00911859|521844320|FG000|Treatment Period|Death|1|||
144724172|NCT00911859|521844321|FG001|Treatment Period|Death|3|||
144724173|NCT00911859|521844322|FG002|Treatment Period|Death|5|||
144724174|NCT00911859|521844320|FG000|Treatment Period|Lack of Efficacy|1|||
144724175|NCT00911859|521844321|FG001|Treatment Period|Lack of Efficacy|7|||
144724176|NCT00911859|521844322|FG002|Treatment Period|Lack of Efficacy|5|||
144724177|NCT00911859|521844320|FG000|Treatment Period|Physician Decision|3|||
144724178|NCT00911859|521844321|FG001|Treatment Period|Physician Decision|3|||
144724179|NCT00911859|521844322|FG002|Treatment Period|Physician Decision|3|||
144724180|NCT00911859|521844320|FG000|Treatment Period|Withdrawal by Subject|0|||
144724181|NCT00911859|521844321|FG001|Treatment Period|Withdrawal by Subject|4|||
144724182|NCT00911859|521844322|FG002|Treatment Period|Withdrawal by Subject|5|||
144724183|NCT00911859|521844320|FG000|Treatment Period|Did not receive study treatment|0|||
144724184|NCT00911859|521844321|FG001|Treatment Period|Did not receive study treatment|1|||
144724185|NCT00911859|521844322|FG002|Treatment Period|Did not receive study treatment|0|||
144724186|NCT00911859|521844320|FG000|Maintainance Period|Lack of Efficacy|0|||
144724187|NCT00911859|521844321|FG001|Maintainance Period|Lack of Efficacy|0|||
144724188|NCT00911859|521844322|FG002|Maintainance Period|Lack of Efficacy|9|||
144724189|NCT00911859|521844320|FG000|Maintainance Period|Physician Decision|0|||
144724190|NCT00911859|521844321|FG001|Maintainance Period|Physician Decision|0|||
144724191|NCT00911859|521844322|FG002|Maintainance Period|Physician Decision|9|||
144724192|NCT00911859|521844320|FG000|Maintainance Period|Withdrawal by Subject|0|||
144724193|NCT00911859|521844321|FG001|Maintainance Period|Withdrawal by Subject|0|||
144724194|NCT00911859|521844322|FG002|Maintainance Period|Withdrawal by Subject|3|||
144724195|NCT00911859|521844320|FG000|Follow-up Period|Death|5|||
144187443|NCT00988208|519881168|FG001|Overall Study|Death|15|||
144187444|NCT00988208|519881167|FG000|Overall Study|Lost to Follow-up|2|||
144187445|NCT00988208|519881168|FG001|Overall Study|Lost to Follow-up|3|||
144187446|NCT00988208|519881167|FG000|Overall Study|Protocol Violation|9|||
144187447|NCT00988208|519881168|FG001|Overall Study|Protocol Violation|2|||
144252862|NCT05259917|520126578|FG002|Overall Study|Lost to Follow-up|1|||
144252863|NCT05259917|520126579|FG003|Overall Study|Lost to Follow-up|0|||
144252864|NCT05259917|520126580|FG004|Overall Study|Lost to Follow-up|0|||
144252865|NCT05259917|520126581|FG005|Overall Study|Lost to Follow-up|1|||
144252866|NCT05259917|520126576|FG000|Overall Study|Physician Decision|0|||
144252867|NCT05259917|520126577|FG001|Overall Study|Physician Decision|1|||
144252868|NCT05259917|520126578|FG002|Overall Study|Physician Decision|0|||
144252869|NCT05259917|520126579|FG003|Overall Study|Physician Decision|0|||
144252870|NCT05259917|520126580|FG004|Overall Study|Physician Decision|0|||
144252871|NCT05259917|520126581|FG005|Overall Study|Physician Decision|0|||
144252872|NCT05259917|520126576|FG000|Overall Study|Withdrawal by Subject|0|||
144252873|NCT05259917|520126577|FG001|Overall Study|Withdrawal by Subject|1|||
144252874|NCT05259917|520126578|FG002|Overall Study|Withdrawal by Subject|0|||
144252875|NCT05259917|520126579|FG003|Overall Study|Withdrawal by Subject|0|||
144252876|NCT05259917|520126580|FG004|Overall Study|Withdrawal by Subject|1|||
144252877|NCT05259917|520126581|FG005|Overall Study|Withdrawal by Subject|1|||
144252878|NCT05259917|520126576|FG000|Overall Study|Trial Termination by Sponsor|7|||
144252879|NCT05259917|520126577|FG001|Overall Study|Trial Termination by Sponsor|2|||
144252880|NCT05259917|520126578|FG002|Overall Study|Trial Termination by Sponsor|3|||
144252881|NCT05259917|520126579|FG003|Overall Study|Trial Termination by Sponsor|5|||
144252882|NCT05259917|520126580|FG004|Overall Study|Trial Termination by Sponsor|11|||
144252883|NCT05259917|520126581|FG005|Overall Study|Trial Termination by Sponsor|4|||
144252884|NCT05259917|520126576|FG000|Overall Study|Other|1|||
144252885|NCT05259917|520126577|FG001|Overall Study|Other|0|||
144252886|NCT05259917|520126578|FG002|Overall Study|Other|2|||
144252887|NCT05259917|520126579|FG003|Overall Study|Other|0|||
144252888|NCT05259917|520126580|FG004|Overall Study|Other|0|||
144252889|NCT05259917|520126581|FG005|Overall Study|Other|0|||
144252890|NCT00592592|520126582|FG000|Overall Study|Patient found ineligible upon chart review|1|||
144252891|NCT03585712|520126583|FG000|Treatment Period 1|Protocol Violation|1|||
144252892|NCT03585712|520126584|FG001|Treatment Period 1|Protocol Violation|0|||
144252893|NCT03585712|520126585|FG002|Treatment Period 1|Protocol Violation|0|||
144252894|NCT03585712|520126583|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
144252895|NCT03585712|520126584|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
144252896|NCT03585712|520126585|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
144252897|NCT03585712|520126583|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
144252898|NCT03585712|520126584|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
144252899|NCT03585712|520126585|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
144252900|NCT03585712|520126583|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
144252901|NCT03585712|520126584|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
144252902|NCT03585712|520126585|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
144252903|NCT00849290|520126586|FG000|Overall Study|Adverse Event|3|||
144252904|NCT00849290|520126586|FG000|Overall Study|Death|14|||
144252905|NCT00849290|520126586|FG000|Overall Study|Withdrawal by Subject|11|||
144252906|NCT00849290|520126586|FG000|Overall Study|Lost to Follow-up|2|||
144252907|NCT00849290|520126586|FG000|Overall Study|Protocol Violation|5|||
144252908|NCT00849290|520126586|FG000|Overall Study|Disease Progression|20|||
144252909|NCT01915771|520126591|FG000|Day 1|Withdrawal by Subject|1|||
144252910|NCT01915771|520126591|FG000|Day 15|Withdrawal by Subject|1|||
144252911|NCT02670382|520126597|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
144252912|NCT02670382|520126598|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
144252913|NCT03244618|520126601|FG000|Overall Study|Lost to Follow-up|3|||
144252914|NCT03244618|520126602|FG001|Overall Study|Lost to Follow-up|4|||
144252915|NCT03244618|520126601|FG000|Overall Study|Protocol Violation|4|||
144252916|NCT03244618|520126602|FG001|Overall Study|Protocol Violation|3|||
144252917|NCT03244618|520126601|FG000|Overall Study|Withdrawal by Subject|0|||
144252918|NCT03244618|520126602|FG001|Overall Study|Withdrawal by Subject|2|||
144252919|NCT00830518|520126603|FG000|Overall Study|Progressive Disease|18|||
144252920|NCT00830518|520126604|FG001|Overall Study|Progressive Disease|8|||
144252921|NCT00830518|520126603|FG000|Overall Study|Symptomatic Deterioration|4|||
144252922|NCT00830518|520126604|FG001|Overall Study|Symptomatic Deterioration|1|||
144252923|NCT00830518|520126603|FG000|Overall Study|Adverse Event|14|||
144252924|NCT00830518|520126604|FG001|Overall Study|Adverse Event|1|||
144529542|NCT04076618|521141122|FG000|Overall Study|Withdrawal by Subject|3|||
144529543|NCT04076618|521141123|FG001|Overall Study|Withdrawal by Subject|1|||
144252925|NCT00830518|520126603|FG000|Overall Study|Withdrawal by Patient|2|||
144529544|NCT04076618|521141124|FG002|Overall Study|Withdrawal by Subject|2|||
144529545|NCT04076618|521141122|FG000|Overall Study|Relocated out of state|0|||
144529546|NCT04076618|521141123|FG001|Overall Study|Relocated out of state|2|||
144529547|NCT04076618|521141124|FG002|Overall Study|Relocated out of state|0|||
144529548|NCT04076618|521141122|FG000|Overall Study|COVID concerns|0|||
144529549|NCT04076618|521141123|FG001|Overall Study|COVID concerns|1|||
144529550|NCT04076618|521141124|FG002|Overall Study|COVID concerns|0|||
144529551|NCT04076618|521141122|FG000|Overall Study|Adverse Event|0|||
144529552|NCT04076618|521141123|FG001|Overall Study|Adverse Event|0|||
144529553|NCT04076618|521141124|FG002|Overall Study|Adverse Event|2|||
144529554|NCT02038777|521141125|FG000|Overall Study|Death|0|||
144529555|NCT02038777|521141126|FG001|Overall Study|Death|2|||
144529556|NCT02038777|521141127|FG002|Overall Study|Death|0|||
144529557|NCT02038777|521141128|FG003|Overall Study|Death|1|||
144529558|NCT02038777|521141129|FG004|Overall Study|Death|2|||
144529559|NCT02038777|521141130|FG005|Overall Study|Death|4|||
144529560|NCT02038777|521141131|FG006|Overall Study|Death|0|||
144529561|NCT02038777|521141132|FG007|Overall Study|Death|11|||
144529562|NCT02038777|521141125|FG000|Overall Study|Lost to Follow-up|0|||
144529563|NCT02038777|521141126|FG001|Overall Study|Lost to Follow-up|0|||
144529564|NCT02038777|521141127|FG002|Overall Study|Lost to Follow-up|0|||
144529565|NCT02038777|521141128|FG003|Overall Study|Lost to Follow-up|1|||
144529566|NCT02038777|521141129|FG004|Overall Study|Lost to Follow-up|0|||
144529567|NCT02038777|521141130|FG005|Overall Study|Lost to Follow-up|0|||
144529568|NCT02038777|521141131|FG006|Overall Study|Lost to Follow-up|0|||
144529569|NCT02038777|521141132|FG007|Overall Study|Lost to Follow-up|0|||
144529570|NCT02038777|521141125|FG000|Overall Study|Other|0|||
144529571|NCT02038777|521141126|FG001|Overall Study|Other|1|||
144529572|NCT02038777|521141127|FG002|Overall Study|Other|0|||
144529573|NCT02038777|521141128|FG003|Overall Study|Other|2|||
144529574|NCT02038777|521141129|FG004|Overall Study|Other|1|||
144529575|NCT02038777|521141130|FG005|Overall Study|Other|0|||
144529576|NCT02038777|521141131|FG006|Overall Study|Other|0|||
144529577|NCT02038777|521141132|FG007|Overall Study|Other|0|||
144529578|NCT02038777|521141125|FG000|Overall Study|Randomized but not treated|0|||
144529579|NCT02038777|521141126|FG001|Overall Study|Randomized but not treated|1|||
144529580|NCT02038777|521141127|FG002|Overall Study|Randomized but not treated|0|||
144529581|NCT02038777|521141128|FG003|Overall Study|Randomized but not treated|0|||
144529582|NCT02038777|521141129|FG004|Overall Study|Randomized but not treated|0|||
144529583|NCT02038777|521141130|FG005|Overall Study|Randomized but not treated|0|||
144529584|NCT02038777|521141131|FG006|Overall Study|Randomized but not treated|0|||
144529585|NCT02038777|521141132|FG007|Overall Study|Randomized but not treated|0|||
144529586|NCT02038777|521141125|FG000|Overall Study|Started Chemotherapy|1|||
144529587|NCT02038777|521141126|FG001|Overall Study|Started Chemotherapy|0|||
144529588|NCT02038777|521141127|FG002|Overall Study|Started Chemotherapy|3|||
144529589|NCT02038777|521141128|FG003|Overall Study|Started Chemotherapy|0|||
144529590|NCT02038777|521141129|FG004|Overall Study|Started Chemotherapy|0|||
144529591|NCT02038777|521141130|FG005|Overall Study|Started Chemotherapy|0|||
144529592|NCT02038777|521141131|FG006|Overall Study|Started Chemotherapy|0|||
144529593|NCT02038777|521141132|FG007|Overall Study|Started Chemotherapy|0|||
144529594|NCT02038777|521141125|FG000|Overall Study|participation terminated by sponsor|0|||
144529595|NCT02038777|521141126|FG001|Overall Study|participation terminated by sponsor|0|||
144529596|NCT02038777|521141127|FG002|Overall Study|participation terminated by sponsor|0|||
144529597|NCT02038777|521141128|FG003|Overall Study|participation terminated by sponsor|0|||
144529598|NCT02038777|521141129|FG004|Overall Study|participation terminated by sponsor|0|||
144529599|NCT02038777|521141130|FG005|Overall Study|participation terminated by sponsor|0|||
144529600|NCT02038777|521141131|FG006|Overall Study|participation terminated by sponsor|1|||
144529601|NCT02038777|521141132|FG007|Overall Study|participation terminated by sponsor|1|||
144529602|NCT04826471|521141133|FG000|Overall Study|Lost to Follow-up|2|||
144529603|NCT04826471|521141133|FG000|Overall Study|Protocol Violation|3|||
144529604|NCT04826471|521141133|FG000|Overall Study|Withdrawal by Subject|1|||
144529605|NCT05370040|521141134|FG000|Overall Study|Lost to Follow-up|0|||
144724196|NCT00911859|521844321|FG001|Follow-up Period|Death|8|||
144724197|NCT00911859|521844322|FG002|Follow-up Period|Death|10|||
144724198|NCT00911859|521844320|FG000|Follow-up Period|Lost to Follow-up|1|||
144724199|NCT00911859|521844321|FG001|Follow-up Period|Lost to Follow-up|1|||
144724200|NCT00911859|521844322|FG002|Follow-up Period|Lost to Follow-up|0|||
144724201|NCT00911859|521844320|FG000|Follow-up Period|Withdrawal by Subject|0|||
144724202|NCT00911859|521844321|FG001|Follow-up Period|Withdrawal by Subject|4|||
144724203|NCT00911859|521844322|FG002|Follow-up Period|Withdrawal by Subject|4|||
144724204|NCT00911859|521844320|FG000|Follow-up Period|Study terminated by sponsor|5|||
144724205|NCT00911859|521844321|FG001|Follow-up Period|Study terminated by sponsor|33|||
144724206|NCT00911859|521844322|FG002|Follow-up Period|Study terminated by sponsor|27|||
144724207|NCT00767325|521844324|FG000|Overall Study|Lack of Efficacy|2|||
144724208|NCT00767325|521844324|FG000|Overall Study|Adverse Event|7|||
144724209|NCT00767325|521844324|FG000|Overall Study|Lost to Follow-up|3|||
144724210|NCT00767325|521844324|FG000|Overall Study|No longer met study criteria|2|||
144724211|NCT00767325|521844324|FG000|Overall Study|Missed visit due to family reasons|1|||
144724212|NCT03538756|521844325|FG000|Long-Term Follow-up|Adverse Event|0|||
144724213|NCT03538756|521844326|FG001|Long-Term Follow-up|Adverse Event|0|||
144529606|NCT05370040|521141135|FG001|Overall Study|Lost to Follow-up|0|||
144529607|NCT05370040|521141136|FG002|Overall Study|Lost to Follow-up|1|||
144529608|NCT05370040|521141137|FG003|Overall Study|Lost to Follow-up|0|||
144529609|NCT05370040|521141138|FG004|Overall Study|Lost to Follow-up|1|||
144724214|NCT03538756|521844327|FG002|Long-Term Follow-up|Adverse Event|6|||
144724215|NCT03538756|521844325|FG000|Long-Term Follow-up|Death|0|||
144529610|NCT05370040|521141139|FG005|Overall Study|Lost to Follow-up|0|||
144724216|NCT03538756|521844326|FG001|Long-Term Follow-up|Death|0|||
144724217|NCT03538756|521844327|FG002|Long-Term Follow-up|Death|1|||
144724218|NCT03538756|521844325|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
144252926|NCT00830518|520126604|FG001|Overall Study|Withdrawal by Patient|0|||
144252927|NCT00830518|520126603|FG000|Overall Study|Reason not Specified|8|||
144252928|NCT00830518|520126604|FG001|Overall Study|Reason not Specified|1|||
144252929|NCT01778751|520126610|FG000|Overall Study|Lost to Follow-up|1|||
144252930|NCT01778751|520126611|FG001|Overall Study|Lost to Follow-up|0|||
144252931|NCT01778751|520126610|FG000|Overall Study|Withdrawal by Subject|0|||
144252932|NCT01778751|520126611|FG001|Overall Study|Withdrawal by Subject|2|||
144252933|NCT01778751|520126610|FG000|Overall Study|Transfered care|1|||
144252934|NCT01778751|520126611|FG001|Overall Study|Transfered care|0|||
144252935|NCT02791438|520126616|FG000|Treatment Period|Adverse Event|1|||
144252936|NCT02791438|520126617|FG001|Treatment Period|Adverse Event|0|||
144252937|NCT02791438|520126616|FG000|Treatment Period|Withdrawal by Subject|0|||
144252938|NCT02791438|520126617|FG001|Treatment Period|Withdrawal by Subject|1|||
144252939|NCT02791438|520126616|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
144252940|NCT02791438|520126617|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
144252941|NCT01603394|520126618|FG000|Overall Study|Adverse Event|1|||
144252942|NCT00840034|520126619|FG000|Acute Treatment Phase|Adverse Event|6|||
144252943|NCT00840034|520126620|FG001|Acute Treatment Phase|Adverse Event|8|||
144252944|NCT00840034|520126619|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
144252945|NCT00840034|520126620|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
144252946|NCT00840034|520126619|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
144252947|NCT00840034|520126620|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
144252948|NCT00840034|520126619|FG000|Acute Treatment Phase|Physician Decision|0|||
144252949|NCT00840034|520126620|FG001|Acute Treatment Phase|Physician Decision|1|||
144252950|NCT00840034|520126619|FG000|Acute Treatment Phase|Protocol Violation|2|||
144252951|NCT00840034|520126620|FG001|Acute Treatment Phase|Protocol Violation|4|||
144252952|NCT00840034|520126619|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
144252953|NCT00840034|520126620|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
144252954|NCT00840034|520126619|FG000|Taper Phase|Adverse Event|1|||
144252955|NCT00840034|520126620|FG001|Taper Phase|Adverse Event|0|||
144252956|NCT00840034|520126619|FG000|Taper Phase|Lost to Follow-up|1|||
144252957|NCT00840034|520126620|FG001|Taper Phase|Lost to Follow-up|1|||
144252958|NCT00840034|520126619|FG000|Taper Phase|Withdrawal by Subject|1|||
144252959|NCT00840034|520126620|FG001|Taper Phase|Withdrawal by Subject|1|||
144252960|NCT01215435|520126621|FG000|Overall Study|Adverse Event|1|||
144252961|NCT01215435|520126622|FG001|Overall Study|Adverse Event|0|||
144252962|NCT01215435|520126621|FG000|Overall Study|Protocol Violation|2|||
144252963|NCT01215435|520126622|FG001|Overall Study|Protocol Violation|0|||
144252964|NCT01215435|520126621|FG000|Overall Study|Withdrawal Criteria|8|||
144252965|NCT01215435|520126622|FG001|Overall Study|Withdrawal Criteria|11|||
144252966|NCT01215435|520126621|FG000|Overall Study|Lost to Follow-up|3|||
144252967|NCT01215435|520126622|FG001|Overall Study|Lost to Follow-up|0|||
144724219|NCT03538756|521844326|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
144724220|NCT03538756|521844327|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
144252968|NCT01215435|520126621|FG000|Overall Study|Unclassified|5|||
144252969|NCT01215435|520126622|FG001|Overall Study|Unclassified|5|||
144252970|NCT01156051|520126631|FG000|Overall Study|Lost to Follow-up|1|||
144252971|NCT01156051|520126632|FG001|Overall Study|Lost to Follow-up|0|||
144252972|NCT01156051|520126631|FG000|Overall Study|patient not compliant with protocol|0|||
144252973|NCT01156051|520126632|FG001|Overall Study|patient not compliant with protocol|1|||
144252974|NCT00793546|520126635|FG000|Overall Study|Death|3|||
144252975|NCT00793546|520126636|FG001|Overall Study|Death|0|||
144252976|NCT00793546|520126635|FG000|Overall Study|Lost to Follow-up|1|||
144252977|NCT00793546|520126636|FG001|Overall Study|Lost to Follow-up|0|||
144252978|NCT00793546|520126635|FG000|Overall Study|Withdrawal by Subject|1|||
144252979|NCT00793546|520126636|FG001|Overall Study|Withdrawal by Subject|1|||
144252980|NCT00793546|520126635|FG000|Overall Study|Study Terminated by Sponsor|8|||
144252981|NCT00793546|520126636|FG001|Overall Study|Study Terminated by Sponsor|27|||
144252982|NCT00793546|520126635|FG000|Overall Study|Other|1|||
144252983|NCT00793546|520126636|FG001|Overall Study|Other|0|||
144252984|NCT00350779|520126637|FG000|Overall Study|Adverse Event|4|||
144252985|NCT00350779|520126638|FG001|Overall Study|Adverse Event|2|||
144252986|NCT00350779|520126637|FG000|Overall Study|Lack of Efficacy|0|||
144252987|NCT00350779|520126638|FG001|Overall Study|Lack of Efficacy|4|||
144252988|NCT00350779|520126637|FG000|Overall Study|Lost to Follow-up|2|||
144252989|NCT00350779|520126638|FG001|Overall Study|Lost to Follow-up|0|||
144252990|NCT00350779|520126637|FG000|Overall Study|Physician Decision|2|||
144252991|NCT00350779|520126638|FG001|Overall Study|Physician Decision|4|||
144252992|NCT00350779|520126637|FG000|Overall Study|Protocol Violation|3|||
144252993|NCT00350779|520126638|FG001|Overall Study|Protocol Violation|1|||
144252994|NCT00350779|520126637|FG000|Overall Study|Withdrawal by Subject|9|||
144252995|NCT00350779|520126638|FG001|Overall Study|Withdrawal by Subject|8|||
144529611|NCT03209973|521141140|FG000|Overall Study|Withdrawal by Subject|7|||
144529612|NCT03209973|521141140|FG000|Overall Study|Lost to Follow-up|2|||
144529613|NCT03209973|521141140|FG000|Overall Study|Death|8|||
144529614|NCT03209973|521141140|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
144529615|NCT03209973|521141140|FG000|Overall Study|Sponsor Decision|18|||
144252996|NCT00350779|520126637|FG000|Overall Study|Patient Moved|2|||
144529616|NCT03209973|521141140|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
144529617|NCT03209973|521141140|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
144529618|NCT02296684|521141146|FG000|Overall Study|Withdrawal by Subject|0|||
144529619|NCT02296684|521141147|FG001|Overall Study|Withdrawal by Subject|1|||
144529620|NCT02296684|521141148|FG002|Overall Study|Withdrawal by Subject|1|||
144529621|NCT02296684|521141146|FG000|Overall Study|Death|2|||
144529622|NCT02296684|521141147|FG001|Overall Study|Death|0|||
144529623|NCT02296684|521141148|FG002|Overall Study|Death|0|||
144529624|NCT03571581|521141149|FG000|Overall Study|Death|2|||
144529625|NCT03571581|521141149|FG000|Overall Study|Withdrawal by Subject|2|||
144529626|NCT01651403|521141151|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
144529627|NCT01651403|521141152|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
144529628|NCT01651403|521141151|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
144529629|NCT01651403|521141152|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
144529630|NCT01651403|521141151|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
144529631|NCT01651403|521141152|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
144529632|NCT01651403|521141151|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
144529633|NCT01651403|521141152|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
144529634|NCT01651403|521141151|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
144529635|NCT01651403|521141152|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
144529636|NCT01651403|521141151|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
144529637|NCT01651403|521141152|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
144529638|NCT05090683|521141153|FG000|Overall Study|Lost to Follow-up|10|||
144529639|NCT05090683|521141154|FG001|Overall Study|Lost to Follow-up|2|||
144529640|NCT05090683|521141153|FG000|Overall Study|Withdrawal by Subject|15|||
144529641|NCT05090683|521141154|FG001|Overall Study|Withdrawal by Subject|0|||
144529642|NCT03213665|521141155|FG000|Overall Study|Adverse Event|1|||
144529643|NCT03213665|521141155|FG000|Overall Study|Physician Decision|2|||
144529644|NCT03213665|521141155|FG000|Overall Study|Withdrawal by Subject|3|||
144529645|NCT03213665|521141155|FG000|Overall Study|Progressive Disease|13|||
144529646|NCT04571619|521141156|FG000|Phase 1|Death|22|||
144529647|NCT04571619|521141157|FG001|Phase 1|Death|18|||
144529648|NCT04571619|521141156|FG000|Phase 1|Withdrawal by Subject|7|||
144529649|NCT04571619|521141157|FG001|Phase 1|Withdrawal by Subject|2|||
144529650|NCT04571619|521141156|FG000|Phase 2|Death|13|||
144529651|NCT04571619|521141157|FG001|Phase 2|Death|16|||
144529652|NCT04571619|521141156|FG000|Phase 2|Withdrawal by Subject|6|||
144529653|NCT04571619|521141157|FG001|Phase 2|Withdrawal by Subject|4|||
144529654|NCT02361216|521141158|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
144529655|NCT02361216|521141159|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
144529656|NCT02361216|521141158|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
144529657|NCT02361216|521141159|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
144529658|NCT02361216|521141158|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
144529659|NCT02361216|521141159|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
144529660|NCT02361216|521141158|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
144529661|NCT02361216|521141159|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
144529662|NCT02361216|521141158|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
144529663|NCT02361216|521141159|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
144529664|NCT02361216|521141158|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
144529665|NCT02361216|521141159|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
144529666|NCT05622812|521142879|FG000|Overall Study|Withdrawal by Subject|1|||
144724221|NCT03538756|521844325|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
144724222|NCT03538756|521844326|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
144724223|NCT03538756|521844327|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
144724224|NCT03538756|521844325|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
144724225|NCT03538756|521844326|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
144724226|NCT03538756|521844327|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
144724227|NCT00752856|521844328|FG000|Overall Study|randomized but did not do viral kinetics|0|||
144724228|NCT00752856|521844329|FG001|Overall Study|randomized but did not do viral kinetics|1|||
144724229|NCT00996736|521844335|FG000|Overall Study|Death|1|||
144724230|NCT00996736|521844336|FG001|Overall Study|Death|1|||
144724231|NCT00996736|521844335|FG000|Overall Study|Lost to Follow-up|15|||
144724232|NCT00996736|521844336|FG001|Overall Study|Lost to Follow-up|14|||
144724233|NCT00996736|521844335|FG000|Overall Study|Visit not within 3-month window|5|||
144724234|NCT00996736|521844336|FG001|Overall Study|Visit not within 3-month window|3|||
144724235|NCT02688608|521844337|FG000|Overall Study|Lost to Follow-up|1|||
144724236|NCT02346201|521844339|FG000|Overall Study|Adverse Event|3|||
144724237|NCT02346201|521844340|FG001|Overall Study|Adverse Event|2|||
144724238|NCT02346201|521844339|FG000|Overall Study|Lost to Follow-up|1|||
144724239|NCT02346201|521844340|FG001|Overall Study|Lost to Follow-up|0|||
144724240|NCT02346201|521844339|FG000|Overall Study|Withdrawal by Subject|6|||
144724241|NCT02346201|521844340|FG001|Overall Study|Withdrawal by Subject|3|||
144724242|NCT02346201|521844339|FG000|Overall Study|Unavailable for future follow-up|0|||
144724243|NCT02346201|521844340|FG001|Overall Study|Unavailable for future follow-up|1|||
144724244|NCT02346201|521844339|FG000|Overall Study|Physician Decision|0|||
144724245|NCT02346201|521844340|FG001|Overall Study|Physician Decision|1|||
144724246|NCT02346201|521844339|FG000|Overall Study|Missed final visit|0|||
144724247|NCT02346201|521844340|FG001|Overall Study|Missed final visit|2|||
144724248|NCT03708211|521844342|FG000|Overall Study|Progressive Disease|10|||
144724249|NCT03708211|521844343|FG001|Overall Study|Progressive Disease|7|||
144724250|NCT03708211|521844342|FG000|Overall Study|Withdrawal by Subject|0|||
144724251|NCT03708211|521844343|FG001|Overall Study|Withdrawal by Subject|1|||
144724252|NCT03708211|521844342|FG000|Overall Study|Other|2|||
144724253|NCT03708211|521844343|FG001|Overall Study|Other|0|||
144724254|NCT00770315|521844344|FG000|Overall Study|Adverse Event|11|||
144724255|NCT00770315|521844345|FG001|Overall Study|Adverse Event|17|||
144724256|NCT00770315|521844346|FG002|Overall Study|Adverse Event|16|||
144724257|NCT00770315|521844347|FG003|Overall Study|Adverse Event|6|||
144724258|NCT00770315|521844344|FG000|Overall Study|Lost to Follow-up|9|||
144724259|NCT00770315|521844345|FG001|Overall Study|Lost to Follow-up|5|||
144724260|NCT00770315|521844346|FG002|Overall Study|Lost to Follow-up|10|||
144724261|NCT00770315|521844347|FG003|Overall Study|Lost to Follow-up|3|||
144724262|NCT00770315|521844344|FG000|Overall Study|Withdrawal by Subject|13|||
144724263|NCT00770315|521844345|FG001|Overall Study|Withdrawal by Subject|17|||
144724264|NCT00770315|521844346|FG002|Overall Study|Withdrawal by Subject|24|||
144724265|NCT00770315|521844347|FG003|Overall Study|Withdrawal by Subject|20|||
144724266|NCT00770315|521844344|FG000|Overall Study|Noncompliance with Protocol|7|||
144724267|NCT00770315|521844345|FG001|Overall Study|Noncompliance with Protocol|4|||
144724268|NCT00770315|521844346|FG002|Overall Study|Noncompliance with Protocol|7|||
144724269|NCT00770315|521844347|FG003|Overall Study|Noncompliance with Protocol|9|||
144724270|NCT02309099|521846301|FG000|Overall Study|Adverse Event|2|||
144724271|NCT02309099|521846302|FG001|Overall Study|Adverse Event|0|||
144724272|NCT02819362|521846304|FG000|Overall Study|On-site MRI could not be performed|70|||
144724273|NCT05301751|521846305|FG000|Overall Study|Withdrawal by Subject|0|||
144724274|NCT05301751|521846306|FG001|Overall Study|Withdrawal by Subject|0|||
144724275|NCT05301751|521846307|FG002|Overall Study|Withdrawal by Subject|1|||
144724276|NCT05301751|521846308|FG003|Overall Study|Withdrawal by Subject|0|||
144724277|NCT02402166|521846309|FG000|Overall Study|Adverse Event|2|||
144724278|NCT02402166|521846309|FG000|Overall Study|Withdrawal by Subject|2|||
144724279|NCT02402166|521846309|FG000|Overall Study|Lost to Follow-up|1|||
144252997|NCT00350779|520126638|FG001|Overall Study|Patient Moved|1|||
144724280|NCT03803943|521846315|FG000|Overall Study|Withdrawal by Subject|2|||
144724281|NCT03803943|521846316|FG001|Overall Study|Withdrawal by Subject|2|||
144724282|NCT03803943|521846317|FG002|Overall Study|Withdrawal by Subject|2|||
144724283|NCT03803943|521846318|FG003|Overall Study|Withdrawal by Subject|2|||
144724284|NCT01574248|521846319|FG000|Overall Study|Withdrawal by Subject|2|||
144724285|NCT01574248|521846320|FG001|Overall Study|Withdrawal by Subject|0|||
144724286|NCT01574248|521846319|FG000|Overall Study|Missing primary endpoint data|1|||
144724287|NCT01574248|521846320|FG001|Overall Study|Missing primary endpoint data|0|||
144724288|NCT01781286|521846323|FG000|Overall Study|Lost to Follow-up|0|||
144724289|NCT01781286|521846324|FG001|Overall Study|Lost to Follow-up|0|||
144724290|NCT01781286|521846325|FG002|Overall Study|Lost to Follow-up|0|||
144724291|NCT01781286|521846326|FG003|Overall Study|Lost to Follow-up|0|||
144252998|NCT00350779|520126637|FG000|Overall Study|Non-compliance with study procedures|0|||
144252999|NCT00350779|520126638|FG001|Overall Study|Non-compliance with study procedures|1|||
144253000|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
144253001|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253002|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253003|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253004|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253005|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253006|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253007|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253008|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
144253009|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
144253010|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
144253011|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
144253012|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
144253013|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
144253014|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
144253015|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
144253016|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
144253017|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
144253018|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
144253019|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
144253020|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
144253021|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
144253022|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
144253023|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
144253024|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
144253025|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
144253026|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
144253027|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
144253028|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
144253029|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
144253030|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
144253031|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
144253032|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
144253033|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
144253034|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
144253035|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
144253036|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253037|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253038|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253039|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
144253040|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253041|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
144253042|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253043|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253044|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
144253045|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
144253046|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
144253047|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
144253048|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
144253049|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
144253050|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
144253051|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
144253052|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
144253053|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
144253054|NCT00528372|520126639|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
144253055|NCT00528372|520126640|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
144253056|NCT00528372|520126641|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
144253057|NCT00528372|520126642|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
144253058|NCT00528372|520126643|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
144253059|NCT00528372|520126644|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
144253060|NCT00528372|520126645|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
144253061|NCT00528372|520126646|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
144253062|NCT00528372|520126647|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
144253063|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
144253064|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
144253065|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
144253066|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
144253067|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
144253068|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
144253069|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
144253070|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
144253071|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
144253072|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
144253073|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
144253074|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
144253075|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
144253076|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
144253077|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
144253078|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
144253079|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
144253080|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
144253081|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
144253082|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
144253083|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
144253084|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
144253085|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
144253086|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
144253087|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
144253088|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
144253089|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
144253090|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
144253091|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
144253092|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
144253093|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
144253094|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
144253095|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
144529667|NCT05622812|521142880|FG001|Overall Study|Withdrawal by Subject|4|||
144529668|NCT05622812|521142879|FG000|Overall Study|Lost to Follow-up|2|||
144529669|NCT05622812|521142880|FG001|Overall Study|Lost to Follow-up|1|||
144529670|NCT00696111|521142885|FG000|Overall Study|Withdrawal by Subject|17|||
144529671|NCT03952338|521142886|FG000|Overall Study|Lost to Follow-up|11|||
144529672|NCT03952338|521142887|FG001|Overall Study|Lost to Follow-up|17|||
144529673|NCT03952338|521142886|FG000|Overall Study|Withdrawal by Subject|1|||
144529674|NCT03952338|521142887|FG001|Overall Study|Withdrawal by Subject|1|||
144529675|NCT03952338|521142886|FG000|Overall Study|Protocol Violation|1|||
144529676|NCT03952338|521142887|FG001|Overall Study|Protocol Violation|0|||
144529677|NCT04909801|521142888|FG000|Overall Study|Lack of Efficacy|2|||
144529678|NCT04909801|521142889|FG001|Overall Study|Lack of Efficacy|1|||
144529679|NCT04909801|521142888|FG000|Overall Study|Adverse Event|1|||
144187448|NCT00988208|519881167|FG000|Overall Study|Sponsor Decision|102|||
144187449|NCT00988208|519881168|FG001|Overall Study|Sponsor Decision|78|||
144529680|NCT04909801|521142889|FG001|Overall Study|Adverse Event|2|||
144529681|NCT04909801|521142888|FG000|Overall Study|Participant request to discontinue study treatment|1|||
144187450|NCT00988208|519881167|FG000|Overall Study|Clinical Progression|17|||
144529682|NCT04909801|521142889|FG001|Overall Study|Participant request to discontinue study treatment|2|||
144529683|NCT04909801|521142888|FG000|Overall Study|Withdrawal by Subject|2|||
144529684|NCT04909801|521142889|FG001|Overall Study|Withdrawal by Subject|1|||
144529685|NCT04909801|521142888|FG000|Overall Study|other reasons|1|||
144529686|NCT04909801|521142889|FG001|Overall Study|other reasons|1|||
144529687|NCT04550221|521142890|FG000|Overall Study|Lost to Follow-up|0|||
144529688|NCT04550221|521142891|FG001|Overall Study|Lost to Follow-up|4|||
144529689|NCT04550221|521142890|FG000|Overall Study|Withdrawn|3|||
144529690|NCT04550221|521142891|FG001|Overall Study|Withdrawn|0|||
144529691|NCT04550221|521142890|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
144529692|NCT04550221|521142891|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
144529693|NCT05452460|521142892|FG000|Overall Study|Lost to Follow-up|3|||
144529694|NCT05452460|521142893|FG001|Overall Study|Lost to Follow-up|3|||
144529695|NCT05452460|521142892|FG000|Overall Study|Did not receive intervention|1|||
144529696|NCT05452460|521142893|FG001|Overall Study|Did not receive intervention|0|||
144529697|NCT00321048|521142894|FG000|Overall Study|Withdrawal by Subject|6|||
144529698|NCT00321048|521142895|FG001|Overall Study|Withdrawal by Subject|8|||
144529699|NCT03386578|521142900|FG000|PK Component|Lost to Follow-up|0|||
144529700|NCT03386578|521142901|FG001|PK Component|Lost to Follow-up|1|||
144529701|NCT03386578|521142902|FG002|PK Component|Lost to Follow-up|0|||
144529702|NCT03386578|521142903|FG003|PK Component|Lost to Follow-up|0|||
144529703|NCT03386578|521142904|FG004|PK Component|Lost to Follow-up|0|||
144529704|NCT03386578|521142905|FG005|PK Component|Lost to Follow-up|0|||
144529705|NCT03386578|521142906|FG006|PK Component|Lost to Follow-up|1|||
144529706|NCT03386578|521142907|FG007|PK Component|Lost to Follow-up|0|||
144529707|NCT03386578|521142908|FG008|PK Component|Lost to Follow-up|0|||
144529708|NCT03386578|521142909|FG009|PK Component|Lost to Follow-up|0|||
144529709|NCT03386578|521142900|FG000|PK Component|Stillbirth/Abortion|0|||
144529710|NCT03386578|521142901|FG001|PK Component|Stillbirth/Abortion|0|||
144529711|NCT03386578|521142902|FG002|PK Component|Stillbirth/Abortion|0|||
144529712|NCT03386578|521142903|FG003|PK Component|Stillbirth/Abortion|0|||
144529713|NCT03386578|521142904|FG004|PK Component|Stillbirth/Abortion|0|||
144529714|NCT03386578|521142905|FG005|PK Component|Stillbirth/Abortion|2|||
144529715|NCT03386578|521142906|FG006|PK Component|Stillbirth/Abortion|0|||
144529716|NCT03386578|521142907|FG007|PK Component|Stillbirth/Abortion|0|||
144529717|NCT03386578|521142908|FG008|PK Component|Stillbirth/Abortion|0|||
144529718|NCT03386578|521142909|FG009|PK Component|Stillbirth/Abortion|0|||
144529719|NCT03386578|521142900|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
144187451|NCT00988208|519881168|FG001|Overall Study|Clinical Progression|16|||
144187452|NCT00988208|519881167|FG000|Overall Study|Biochemical Progression|21|||
144187453|NCT00988208|519881168|FG001|Overall Study|Biochemical Progression|7|||
144187454|NCT00988208|519881167|FG000|Overall Study|Clinical Deterioration|7|||
144187455|NCT00988208|519881168|FG001|Overall Study|Clinical Deterioration|14|||
144187456|NCT00988208|519881167|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
144187457|NCT00988208|519881168|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
144187458|NCT00988208|519881167|FG000|Overall Study|Other|8|||
144187459|NCT00988208|519881168|FG001|Overall Study|Other|3|||
144187460|NCT01201759|519881171|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
144187461|NCT01201759|519881172|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
144187462|NCT01201759|519881171|FG000|Visit 3 - Washout|Adverse Event|0|||
144187463|NCT01201759|519881172|FG001|Visit 3 - Washout|Adverse Event|3|||
144529720|NCT03386578|521142901|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
144529721|NCT03386578|521142902|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
144529722|NCT03386578|521142903|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
144529723|NCT03386578|521142904|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
144187464|NCT01201759|519881171|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
144187465|NCT01201759|519881172|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
144187466|NCT01201759|519881171|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
144253096|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
144253097|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
144253098|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
144253099|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
144253100|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
144253101|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
144253102|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
144253103|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
144253104|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
144253105|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
144253106|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
144253107|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
144253108|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253109|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253110|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253111|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253112|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
144253113|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
144253114|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253115|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253116|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
144253117|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
144253118|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
144253119|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
144253120|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
144253121|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
144253122|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
144253123|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
144253124|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
144253125|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
144253126|NCT00528372|520126639|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
144253127|NCT00528372|520126640|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
144253128|NCT00528372|520126641|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
144253129|NCT00528372|520126642|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
144253130|NCT00528372|520126643|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
144253131|NCT00528372|520126644|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
144253132|NCT00528372|520126645|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
144253133|NCT00528372|520126646|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
144253134|NCT00528372|520126647|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
144253135|NCT01483599|520126652|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
144253136|NCT01483599|520126653|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253137|NCT01483599|520126654|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253138|NCT01483599|520126655|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
144253139|NCT01483599|520126656|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
144253140|NCT01483599|520126657|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
144253141|NCT01483599|520126658|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
144253142|NCT01483599|520126659|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253143|NCT01483599|520126660|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253144|NCT01483599|520126661|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253145|NCT01483599|520126662|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253146|NCT01483599|520126663|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253147|NCT01483599|520126664|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253148|NCT01483599|520126665|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
144253149|NCT01483599|520126652|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253150|NCT01483599|520126653|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
144253151|NCT01483599|520126654|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253152|NCT01483599|520126655|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
144253153|NCT01483599|520126656|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253154|NCT01483599|520126657|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253155|NCT01483599|520126658|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
144529724|NCT03386578|521142905|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
144529725|NCT03386578|521142906|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
144529726|NCT03386578|521142907|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
144253156|NCT01483599|520126659|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253157|NCT01483599|520126660|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253158|NCT01483599|520126661|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253159|NCT01483599|520126662|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253160|NCT01483599|520126663|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253161|NCT01483599|520126664|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253162|NCT01483599|520126665|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
144253163|NCT01483599|520126652|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
144253164|NCT01483599|520126653|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253165|NCT01483599|520126654|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253166|NCT01483599|520126655|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253167|NCT01483599|520126656|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253168|NCT01483599|520126657|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253169|NCT01483599|520126658|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253170|NCT01483599|520126659|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253171|NCT01483599|520126660|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253172|NCT01483599|520126661|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144604375|NCT00763971|521414289|FG002|Overall Study|Withdrawal by Subject|5|||
144604376|NCT00763971|521414287|FG000|Overall Study|Lost to Follow-up|0|||
144604377|NCT00763971|521414288|FG001|Overall Study|Lost to Follow-up|1|||
144604378|NCT00763971|521414289|FG002|Overall Study|Lost to Follow-up|0|||
144604379|NCT00763971|521414287|FG000|Overall Study|Lack of Efficacy|11|||
144604380|NCT00763971|521414288|FG001|Overall Study|Lack of Efficacy|22|||
144604381|NCT00763971|521414289|FG002|Overall Study|Lack of Efficacy|54|||
144604382|NCT00763971|521414287|FG000|Overall Study|Unable to swallow capsule|2|||
144604383|NCT00763971|521414288|FG001|Overall Study|Unable to swallow capsule|1|||
144604384|NCT00763971|521414289|FG002|Overall Study|Unable to swallow capsule|1|||
144604385|NCT00763971|521414287|FG000|Overall Study|Personal reason|3|||
144604386|NCT00763971|521414288|FG001|Overall Study|Personal reason|0|||
144604387|NCT00763971|521414289|FG002|Overall Study|Personal reason|0|||
144604388|NCT00763971|521414287|FG000|Overall Study|Exclusion criteria met|1|||
144604389|NCT00763971|521414288|FG001|Overall Study|Exclusion criteria met|0|||
144604390|NCT00763971|521414289|FG002|Overall Study|Exclusion criteria met|0|||
144604391|NCT00763971|521414287|FG000|Overall Study|Sponsor decision|1|||
144604392|NCT00763971|521414288|FG001|Overall Study|Sponsor decision|0|||
144604393|NCT00763971|521414289|FG002|Overall Study|Sponsor decision|0|||
144604394|NCT00763971|521414287|FG000|Overall Study|Due to holiday season|2|||
144604395|NCT00763971|521414288|FG001|Overall Study|Due to holiday season|0|||
144604396|NCT00763971|521414289|FG002|Overall Study|Due to holiday season|1|||
144604397|NCT00763971|521414287|FG000|Overall Study|Randomization error|0|||
144604398|NCT00763971|521414288|FG001|Overall Study|Randomization error|0|||
144604399|NCT00763971|521414289|FG002|Overall Study|Randomization error|1|||
144604400|NCT00763971|521414287|FG000|Overall Study|Medical monitor decision|0|||
144604401|NCT00763971|521414288|FG001|Overall Study|Medical monitor decision|0|||
144604402|NCT00763971|521414289|FG002|Overall Study|Medical monitor decision|1|||
144604403|NCT00763971|521414287|FG000|Overall Study|Moved to another country|0|||
144604404|NCT00763971|521414288|FG001|Overall Study|Moved to another country|1|||
144604405|NCT00763971|521414289|FG002|Overall Study|Moved to another country|0|||
144604406|NCT00763971|521414287|FG000|Overall Study|Subject wanted dose reduction|0|||
144604407|NCT00763971|521414288|FG001|Overall Study|Subject wanted dose reduction|1|||
144604408|NCT00763971|521414289|FG002|Overall Study|Subject wanted dose reduction|0|||
144604409|NCT00763971|521414287|FG000|Overall Study|Lack of availability|0|||
144604410|NCT00763971|521414288|FG001|Overall Study|Lack of availability|1|||
144604411|NCT00763971|521414289|FG002|Overall Study|Lack of availability|0|||
144604412|NCT00763971|521414287|FG000|Overall Study|Performed final visit on phone|0|||
144604413|NCT00763971|521414288|FG001|Overall Study|Performed final visit on phone|1|||
144604414|NCT00763971|521414289|FG002|Overall Study|Performed final visit on phone|0|||
144604415|NCT00763971|521414287|FG000|Overall Study|Participation in 489-326 required|1|||
144604416|NCT00763971|521414288|FG001|Overall Study|Participation in 489-326 required|0|||
144604417|NCT00763971|521414289|FG002|Overall Study|Participation in 489-326 required|0|||
144604418|NCT00710879|521414290|FG000|Overall Study|Lost to Follow-up|2|||
144604419|NCT00710879|521414291|FG001|Overall Study|Lost to Follow-up|1|||
144604420|NCT00710879|521414290|FG000|Overall Study|Protocol Violation|0|||
144604421|NCT00710879|521414291|FG001|Overall Study|Protocol Violation|3|||
144604422|NCT03823404|521414292|FG000|Overall Study|Lost to Follow-up|1|||
144604423|NCT03823404|521414293|FG001|Overall Study|Lost to Follow-up|2|||
144604424|NCT03823404|521414294|FG002|Overall Study|Lost to Follow-up|3|||
144604425|NCT03823404|521414292|FG000|Overall Study|Protocol Violation|2|||
144604426|NCT03823404|521414293|FG001|Overall Study|Protocol Violation|0|||
144604427|NCT03823404|521414294|FG002|Overall Study|Protocol Violation|2|||
144604428|NCT03823404|521414292|FG000|Overall Study|Adverse Event|35|||
144604429|NCT03823404|521414293|FG001|Overall Study|Adverse Event|38|||
144604430|NCT03823404|521414294|FG002|Overall Study|Adverse Event|8|||
144604431|NCT03823404|521414292|FG000|Overall Study|Withdrawal by Subject|38|||
144604432|NCT03823404|521414293|FG001|Overall Study|Withdrawal by Subject|40|||
144604433|NCT03823404|521414294|FG002|Overall Study|Withdrawal by Subject|35|||
144604434|NCT03823404|521414292|FG000|Overall Study|Death|4|||
144604435|NCT03823404|521414293|FG001|Overall Study|Death|0|||
144604436|NCT03823404|521414294|FG002|Overall Study|Death|0|||
144604437|NCT03823404|521414292|FG000|Overall Study|Other: Various reasons provided|5|||
144604438|NCT03823404|521414293|FG001|Overall Study|Other: Various reasons provided|5|||
144604439|NCT03823404|521414294|FG002|Overall Study|Other: Various reasons provided|6|||
144604440|NCT03631667|521414302|FG000|Overall Study|Withdrawal by Subject|3|||
144604441|NCT03383289|521414305|FG000|Overall Study|Death|83|||
144604442|NCT03383289|521414306|FG001|Overall Study|Death|78|||
144604443|NCT03383289|521414305|FG000|Overall Study|discharge from facility|84|||
144604444|NCT03383289|521414306|FG001|Overall Study|discharge from facility|84|||
144604445|NCT03383289|521414305|FG000|Overall Study|Withdrawal by Subject|4|||
144604446|NCT03383289|521414306|FG001|Overall Study|Withdrawal by Subject|1|||
144604447|NCT00884325|521414307|FG000|Overall Study|Lost to Follow-up|1|||
144604448|NCT00884325|521414308|FG001|Overall Study|Lost to Follow-up|2|||
144604449|NCT00884325|521414307|FG000|Overall Study|Lack of Efficacy|0|||
144604450|NCT00884325|521414308|FG001|Overall Study|Lack of Efficacy|1|||
144604451|NCT00884325|521414307|FG000|Overall Study|Withdrawal by Subject|1|||
144604452|NCT00884325|521414308|FG001|Overall Study|Withdrawal by Subject|1|||
144604453|NCT00884325|521414307|FG000|Overall Study|Not provided|1|||
144187467|NCT01201759|519881172|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
144187468|NCT02744755|519881182|FG000|Study Period 1|Protocol Violation|2|||
144187469|NCT02744755|519881183|FG001|Study Period 1|Protocol Violation|1|||
144187470|NCT02744755|519881182|FG000|Study Period 1|not defined|0|||
144187471|NCT02744755|519881183|FG001|Study Period 1|not defined|1|||
144187472|NCT02744755|519881182|FG000|Study Period 1|Pregnancy|1|||
144187473|NCT02744755|519881183|FG001|Study Period 1|Pregnancy|0|||
144187474|NCT02744755|519881182|FG000|Study Period 1|Adverse Event|1|||
144187475|NCT02744755|519881183|FG001|Study Period 1|Adverse Event|1|||
144187476|NCT02744755|519881182|FG000|Study Period 1|Lost to Follow-up|1|||
144187477|NCT02744755|519881183|FG001|Study Period 1|Lost to Follow-up|1|||
144187478|NCT02744755|519881182|FG000|Study Period 1|Lack of Efficacy|1|||
144253173|NCT01483599|520126662|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144604454|NCT00884325|521414308|FG001|Overall Study|Not provided|0|||
144604455|NCT00832117|521414309|FG000|Overall Study|Death|1|||
144604456|NCT00832117|521414309|FG000|Overall Study|Disease Progression|11|||
144604457|NCT04439071|521414310|FG000|Overall Study|Lost to Follow-up|0|||
144604458|NCT04439071|521414311|FG001|Overall Study|Lost to Follow-up|3|||
144187479|NCT02744755|519881183|FG001|Study Period 1|Lack of Efficacy|0|||
144187480|NCT02744755|519881182|FG000|Study Period 1|Withdrawal by Subject|8|||
144604459|NCT04439071|521414310|FG000|Overall Study|Withdrawal by Subject|3|||
144604460|NCT04439071|521414311|FG001|Overall Study|Withdrawal by Subject|8|||
144604461|NCT04439071|521414310|FG000|Overall Study|Death|6|||
144604462|NCT04439071|521414311|FG001|Overall Study|Death|4|||
144604463|NCT04439071|521414310|FG000|Overall Study|Other than specified|3|||
144604464|NCT04439071|521414311|FG001|Overall Study|Other than specified|3|||
144604465|NCT04439071|521414310|FG000|Overall Study|Randomized but not treated|2|||
144604466|NCT04439071|521414311|FG001|Overall Study|Randomized but not treated|0|||
144604467|NCT01087957|521414318|FG000|Overall Study|Death|2|||
144604468|NCT01087957|521414319|FG001|Overall Study|Death|2|||
144604469|NCT01087957|521414318|FG000|Overall Study|Lost to Follow-up|3|||
144604470|NCT01087957|521414319|FG001|Overall Study|Lost to Follow-up|4|||
144187481|NCT02744755|519881183|FG001|Study Period 1|Withdrawal by Subject|4|||
144604471|NCT01087957|521414318|FG000|Overall Study|Protocol Violation|13|||
144604472|NCT01087957|521414319|FG001|Overall Study|Protocol Violation|25|||
144604473|NCT01087957|521414318|FG000|Overall Study|Withdrawal by Subject|18|||
144604474|NCT01087957|521414319|FG001|Overall Study|Withdrawal by Subject|15|||
144604475|NCT01087957|521414318|FG000|Overall Study|Physician Decision|5|||
144187482|NCT02744755|519881182|FG000|Study Period 2|Adverse Event|5|||
144187483|NCT02744755|519881183|FG001|Study Period 2|Adverse Event|0|||
144187484|NCT02744755|519881182|FG000|Study Period 2|Protocol Violation|1|||
144187485|NCT02744755|519881183|FG001|Study Period 2|Protocol Violation|0|||
144187486|NCT02744755|519881182|FG000|Study Period 2|not defined|3|||
144187487|NCT02744755|519881183|FG001|Study Period 2|not defined|2|||
144187488|NCT02744755|519881182|FG000|Study Period 2|Lost to Follow-up|0|||
144187489|NCT02744755|519881183|FG001|Study Period 2|Lost to Follow-up|2|||
144187490|NCT02744755|519881182|FG000|Study Period 2|Withdrawal by Subject|2|||
144187491|NCT02744755|519881183|FG001|Study Period 2|Withdrawal by Subject|2|||
144187492|NCT02744755|519881182|FG000|Study Period 2|Lack of Efficacy|3|||
144187493|NCT02744755|519881183|FG001|Study Period 2|Lack of Efficacy|2|||
144187494|NCT02780167|519881184|FG000|Overall Study|Adverse Event|9|||
144187495|NCT02780167|519881185|FG001|Overall Study|Adverse Event|8|||
144187496|NCT02780167|519881186|FG002|Overall Study|Adverse Event|8|||
144187497|NCT02780167|519881187|FG003|Overall Study|Adverse Event|12|||
144187498|NCT02780167|519881188|FG004|Overall Study|Adverse Event|8|||
144187499|NCT02780167|519881184|FG000|Overall Study|Lack of Efficacy|6|||
144187500|NCT02780167|519881185|FG001|Overall Study|Lack of Efficacy|5|||
144187501|NCT02780167|519881186|FG002|Overall Study|Lack of Efficacy|6|||
144187502|NCT02780167|519881187|FG003|Overall Study|Lack of Efficacy|1|||
144187503|NCT02780167|519881188|FG004|Overall Study|Lack of Efficacy|0|||
144187504|NCT02780167|519881184|FG000|Overall Study|Lost to Follow-up|2|||
144187505|NCT02780167|519881185|FG001|Overall Study|Lost to Follow-up|0|||
144187506|NCT02780167|519881186|FG002|Overall Study|Lost to Follow-up|1|||
144187507|NCT02780167|519881187|FG003|Overall Study|Lost to Follow-up|0|||
144187508|NCT02780167|519881188|FG004|Overall Study|Lost to Follow-up|0|||
144187509|NCT02780167|519881184|FG000|Overall Study|Does not meet entrance criteria|0|||
144187510|NCT02780167|519881185|FG001|Overall Study|Does not meet entrance criteria|0|||
144187511|NCT02780167|519881186|FG002|Overall Study|Does not meet entrance criteria|1|||
144187512|NCT02780167|519881187|FG003|Overall Study|Does not meet entrance criteria|0|||
144187513|NCT02780167|519881188|FG004|Overall Study|Does not meet entrance criteria|0|||
144187514|NCT02780167|519881184|FG000|Overall Study|No longer meets eligibility criteria|0|||
144187515|NCT02780167|519881185|FG001|Overall Study|No longer meets eligibility criteria|0|||
144187516|NCT02780167|519881186|FG002|Overall Study|No longer meets eligibility criteria|0|||
144187517|NCT02780167|519881187|FG003|Overall Study|No longer meets eligibility criteria|1|||
144187518|NCT02780167|519881188|FG004|Overall Study|No longer meets eligibility criteria|1|||
144187519|NCT02780167|519881184|FG000|Overall Study|Protocol Violation|5|||
144604476|NCT01087957|521414319|FG001|Overall Study|Physician Decision|9|||
144604477|NCT01674712|521414324|FG000|Overall Study|Adverse Event|5|||
144604478|NCT01674712|521414325|FG001|Overall Study|Adverse Event|6|||
144187520|NCT02780167|519881185|FG001|Overall Study|Protocol Violation|5|||
144187521|NCT02780167|519881186|FG002|Overall Study|Protocol Violation|1|||
144187522|NCT02780167|519881187|FG003|Overall Study|Protocol Violation|1|||
144187523|NCT02780167|519881188|FG004|Overall Study|Protocol Violation|2|||
144187524|NCT02780167|519881184|FG000|Overall Study|Withdrawal by Subject|6|||
144187525|NCT02780167|519881185|FG001|Overall Study|Withdrawal by Subject|4|||
144187526|NCT02780167|519881186|FG002|Overall Study|Withdrawal by Subject|4|||
144187527|NCT02780167|519881187|FG003|Overall Study|Withdrawal by Subject|3|||
144604479|NCT01674712|521414326|FG002|Overall Study|Adverse Event|3|||
144187528|NCT02780167|519881188|FG004|Overall Study|Withdrawal by Subject|4|||
144187529|NCT02780167|519881184|FG000|Overall Study|Other|0|||
144187530|NCT02780167|519881185|FG001|Overall Study|Other|0|||
144187531|NCT02780167|519881186|FG002|Overall Study|Other|3|||
144187532|NCT02780167|519881187|FG003|Overall Study|Other|1|||
144187533|NCT02780167|519881188|FG004|Overall Study|Other|2|||
144187534|NCT02315066|519881189|FG000|Overall Study|Lost to Follow-up|0|||
144187535|NCT02315066|519881190|FG001|Overall Study|Lost to Follow-up|1|||
144187536|NCT02315066|519881191|FG002|Overall Study|Lost to Follow-up|1|||
144187537|NCT02315066|519881192|FG003|Overall Study|Lost to Follow-up|0|||
144253174|NCT01483599|520126663|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144187538|NCT02315066|519881193|FG004|Overall Study|Lost to Follow-up|1|||
144187539|NCT02315066|519881194|FG005|Overall Study|Lost to Follow-up|0|||
144187540|NCT02315066|519881195|FG006|Overall Study|Lost to Follow-up|2|||
144187541|NCT02315066|519881196|FG007|Overall Study|Lost to Follow-up|1|||
144187542|NCT02315066|519881197|FG008|Overall Study|Lost to Follow-up|0|||
144187543|NCT02315066|519881198|FG009|Overall Study|Lost to Follow-up|0|||
144187544|NCT02315066|519881199|FG010|Overall Study|Lost to Follow-up|1|||
144187545|NCT02315066|519881200|FG011|Overall Study|Lost to Follow-up|2|||
144253175|NCT01483599|520126664|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253176|NCT01483599|520126665|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
144253177|NCT01483599|520126652|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
144253178|NCT01483599|520126653|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
144253179|NCT01483599|520126654|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
144253180|NCT01483599|520126655|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
144253181|NCT01483599|520126656|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
144253182|NCT01483599|520126657|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
144253183|NCT01483599|520126658|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
144253184|NCT01483599|520126659|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
144253185|NCT01483599|520126660|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
144253186|NCT01483599|520126661|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
144253187|NCT01483599|520126662|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
144253188|NCT01483599|520126663|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
144253189|NCT01483599|520126664|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
144253190|NCT01483599|520126665|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
144253191|NCT01483599|520126652|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
144253192|NCT01483599|520126653|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
144253193|NCT01483599|520126654|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
144724292|NCT01781286|521846327|FG004|Overall Study|Lost to Follow-up|0|||
144724293|NCT01781286|521846328|FG005|Overall Study|Lost to Follow-up|1|||
144724294|NCT01781286|521846323|FG000|Overall Study|Time Constraints|2|||
144724295|NCT01781286|521846324|FG001|Overall Study|Time Constraints|0|||
144724296|NCT01781286|521846325|FG002|Overall Study|Time Constraints|2|||
144724297|NCT01781286|521846326|FG003|Overall Study|Time Constraints|0|||
144724298|NCT01781286|521846327|FG004|Overall Study|Time Constraints|0|||
144724299|NCT01781286|521846328|FG005|Overall Study|Time Constraints|0|||
144187546|NCT02315066|519881201|FG012|Overall Study|Lost to Follow-up|0|||
144187547|NCT02315066|519881202|FG013|Overall Study|Lost to Follow-up|4|||
144187548|NCT02315066|519881189|FG000|Overall Study|Death|2|||
144187549|NCT02315066|519881190|FG001|Overall Study|Death|7|||
144253194|NCT01483599|520126655|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
144253195|NCT01483599|520126656|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
144253196|NCT01483599|520126657|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
144253197|NCT01483599|520126658|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
144253198|NCT01483599|520126659|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
144253199|NCT01483599|520126660|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
144253200|NCT01483599|520126661|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
144253201|NCT01483599|520126662|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
144253202|NCT01483599|520126663|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
144253203|NCT01483599|520126664|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
144253204|NCT01483599|520126665|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
144187550|NCT02315066|519881191|FG002|Overall Study|Death|6|||
144253205|NCT01483599|520126652|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253206|NCT01483599|520126653|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253207|NCT01483599|520126654|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253208|NCT01483599|520126655|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253209|NCT01483599|520126656|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253210|NCT01483599|520126657|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253211|NCT01483599|520126658|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253212|NCT01483599|520126659|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
144253213|NCT01483599|520126660|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
144253214|NCT01483599|520126661|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253215|NCT01483599|520126662|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144724300|NCT01781286|521846323|FG000|Overall Study|Noncompliance|0|||
144724301|NCT01781286|521846324|FG001|Overall Study|Noncompliance|0|||
144724302|NCT01781286|521846325|FG002|Overall Study|Noncompliance|0|||
144187551|NCT02315066|519881192|FG003|Overall Study|Death|11|||
144187552|NCT02315066|519881193|FG004|Overall Study|Death|10|||
144187553|NCT02315066|519881194|FG005|Overall Study|Death|3|||
144187554|NCT02315066|519881195|FG006|Overall Study|Death|9|||
144187555|NCT02315066|519881196|FG007|Overall Study|Death|9|||
144187556|NCT02315066|519881197|FG008|Overall Study|Death|10|||
144187557|NCT02315066|519881198|FG009|Overall Study|Death|8|||
144187558|NCT02315066|519881199|FG010|Overall Study|Death|10|||
144187559|NCT02315066|519881200|FG011|Overall Study|Death|7|||
144187560|NCT02315066|519881201|FG012|Overall Study|Death|8|||
144187561|NCT02315066|519881202|FG013|Overall Study|Death|21|||
144187562|NCT02315066|519881189|FG000|Overall Study|Other|0|||
144187563|NCT02315066|519881190|FG001|Overall Study|Other|0|||
144187564|NCT02315066|519881191|FG002|Overall Study|Other|0|||
144187565|NCT02315066|519881192|FG003|Overall Study|Other|0|||
144187566|NCT02315066|519881193|FG004|Overall Study|Other|0|||
144187567|NCT02315066|519881194|FG005|Overall Study|Other|0|||
144187568|NCT02315066|519881195|FG006|Overall Study|Other|0|||
144187569|NCT02315066|519881196|FG007|Overall Study|Other|1|||
144187570|NCT02315066|519881197|FG008|Overall Study|Other|1|||
144187571|NCT02315066|519881198|FG009|Overall Study|Other|2|||
144187572|NCT02315066|519881199|FG010|Overall Study|Other|0|||
144187573|NCT02315066|519881200|FG011|Overall Study|Other|0|||
144187574|NCT02315066|519881201|FG012|Overall Study|Other|0|||
144187575|NCT02315066|519881202|FG013|Overall Study|Other|0|||
144187576|NCT02315066|519881189|FG000|Overall Study|Subject refused further follow-up|0|||
144187577|NCT02315066|519881190|FG001|Overall Study|Subject refused further follow-up|2|||
144187578|NCT02315066|519881191|FG002|Overall Study|Subject refused further follow-up|2|||
144187579|NCT02315066|519881192|FG003|Overall Study|Subject refused further follow-up|0|||
144187580|NCT02315066|519881193|FG004|Overall Study|Subject refused further follow-up|0|||
144187581|NCT02315066|519881194|FG005|Overall Study|Subject refused further follow-up|0|||
144187582|NCT02315066|519881195|FG006|Overall Study|Subject refused further follow-up|2|||
144187583|NCT02315066|519881196|FG007|Overall Study|Subject refused further follow-up|3|||
144187584|NCT02315066|519881197|FG008|Overall Study|Subject refused further follow-up|0|||
144187585|NCT02315066|519881198|FG009|Overall Study|Subject refused further follow-up|1|||
144187586|NCT02315066|519881199|FG010|Overall Study|Subject refused further follow-up|1|||
144187587|NCT02315066|519881200|FG011|Overall Study|Subject refused further follow-up|2|||
144187588|NCT02315066|519881201|FG012|Overall Study|Subject refused further follow-up|2|||
144187589|NCT02315066|519881202|FG013|Overall Study|Subject refused further follow-up|4|||
144187590|NCT02315066|519881189|FG000|Overall Study|Study ongoing at date of cut-off|0|||
144187591|NCT02315066|519881190|FG001|Overall Study|Study ongoing at date of cut-off|0|||
144187592|NCT02315066|519881191|FG002|Overall Study|Study ongoing at date of cut-off|0|||
144187593|NCT02315066|519881192|FG003|Overall Study|Study ongoing at date of cut-off|0|||
144187594|NCT02315066|519881193|FG004|Overall Study|Study ongoing at date of cut-off|0|||
144187595|NCT02315066|519881194|FG005|Overall Study|Study ongoing at date of cut-off|0|||
144187596|NCT02315066|519881195|FG006|Overall Study|Study ongoing at date of cut-off|0|||
144187597|NCT02315066|519881196|FG007|Overall Study|Study ongoing at date of cut-off|0|||
144187598|NCT02315066|519881197|FG008|Overall Study|Study ongoing at date of cut-off|0|||
144187599|NCT02315066|519881198|FG009|Overall Study|Study ongoing at date of cut-off|0|||
144187600|NCT02315066|519881199|FG010|Overall Study|Study ongoing at date of cut-off|0|||
144187601|NCT02315066|519881200|FG011|Overall Study|Study ongoing at date of cut-off|0|||
144187602|NCT02315066|519881201|FG012|Overall Study|Study ongoing at date of cut-off|0|||
144187603|NCT02315066|519881202|FG013|Overall Study|Study ongoing at date of cut-off|1|||
144187604|NCT04364737|519881204|FG000|Overall Study|Withdrawal by Subject|4|||
144187605|NCT04364737|519881205|FG001|Overall Study|Withdrawal by Subject|9|||
144187606|NCT04364737|519881204|FG000|Overall Study|Lost to Follow-up|1|||
144187607|NCT04364737|519881205|FG001|Overall Study|Lost to Follow-up|1|||
144187608|NCT01220609|519881206|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
144187609|NCT01220609|519881206|FG000|Overall Study|Ineligible- Wrong cell type|1|||
144187610|NCT01220609|519881206|FG000|Overall Study|Ineligible-Never treated|1|||
144724303|NCT01781286|521846326|FG003|Overall Study|Noncompliance|1|||
144724304|NCT01781286|521846327|FG004|Overall Study|Noncompliance|0|||
144724305|NCT01781286|521846328|FG005|Overall Study|Noncompliance|0|||
144724306|NCT00995410|521846329|FG000|Overall Study|Adverse Event|51|||
144724307|NCT00995410|521846329|FG000|Overall Study|Withdrawal by Subject|7|||
144724308|NCT00995410|521846329|FG000|Overall Study|Lost to Follow-up|2|||
144724309|NCT00995410|521846329|FG000|Overall Study|Misc|28|||
144724310|NCT03594123|521846330|FG000|Overall Study|Lost to Follow-up|0|||
144604480|NCT01674712|521414327|FG003|Overall Study|Adverse Event|4|||
144604481|NCT01674712|521414328|FG004|Overall Study|Adverse Event|6|||
144724311|NCT03594123|521846331|FG001|Overall Study|Lost to Follow-up|1|||
144604482|NCT01674712|521414324|FG000|Overall Study|Lost to Follow-up|1|||
144187611|NCT00112294|519881207|FG000|Overall Study|Still on study|5|||
144187612|NCT00112294|519881208|FG001|Overall Study|Still on study|0|||
144187613|NCT03235479|519881211|FG000|Overall Study|Lost to Follow-up|8|||
144187614|NCT03235479|519881212|FG001|Overall Study|Lost to Follow-up|11|||
144187615|NCT03235479|519881211|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
144187616|NCT03235479|519881212|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
144187617|NCT03235479|519881211|FG000|Overall Study|Pregnancy|1|||
144187618|NCT03235479|519881212|FG001|Overall Study|Pregnancy|0|||
144187619|NCT03235479|519881211|FG000|Overall Study|Protocol Deviation|1|||
144187620|NCT03235479|519881212|FG001|Overall Study|Protocol Deviation|3|||
144187621|NCT03235479|519881211|FG000|Overall Study|Technical Problems|3|||
144187622|NCT03235479|519881212|FG001|Overall Study|Technical Problems|2|||
144187623|NCT03235479|519881211|FG000|Overall Study|Withdrawal by Subject|2|||
144187624|NCT03235479|519881212|FG001|Overall Study|Withdrawal by Subject|2|||
144187625|NCT03235479|519881211|FG000|Overall Study|Other Reasons|3|||
144187626|NCT03235479|519881212|FG001|Overall Study|Other Reasons|5|||
144253216|NCT01483599|520126663|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
144253217|NCT01483599|520126664|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
144253218|NCT01483599|520126665|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
144253219|NCT01483599|520126652|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253220|NCT01483599|520126653|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253221|NCT01483599|520126654|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253222|NCT01483599|520126655|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253223|NCT01483599|520126656|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144187627|NCT03750695|519881219|FG000|Overall Study|Lost to Follow-up|0|||
144187628|NCT03750695|519881220|FG001|Overall Study|Lost to Follow-up|1|||
144187629|NCT01386125|519881221|FG000|Overall Study|Lost to Follow-up|3|||
144187630|NCT01386125|519881222|FG001|Overall Study|Lost to Follow-up|9|||
144529727|NCT03386578|521142908|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
144529728|NCT03386578|521142909|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
144529729|NCT03386578|521142900|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
144529730|NCT03386578|521142901|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
144529731|NCT03386578|521142902|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
144529732|NCT03386578|521142903|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
144529733|NCT03386578|521142904|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
144529734|NCT03386578|521142905|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
144529735|NCT03386578|521142906|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
144529736|NCT03386578|521142907|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
144724312|NCT03594123|521846330|FG000|Overall Study|Adverse Event|8|||
144724313|NCT03594123|521846331|FG001|Overall Study|Adverse Event|5|||
144187631|NCT01386125|519881221|FG000|Overall Study|Physician Decision|0|||
144187632|NCT01386125|519881222|FG001|Overall Study|Physician Decision|1|||
144187633|NCT01386125|519881221|FG000|Overall Study|Protocol Violation|5|||
144724314|NCT03594123|521846330|FG000|Overall Study|Site Terminated by Sponsor|4|||
144187634|NCT01386125|519881222|FG001|Overall Study|Protocol Violation|7|||
144187635|NCT01386125|519881221|FG000|Overall Study|Disease Progress|1|||
144187636|NCT01386125|519881222|FG001|Overall Study|Disease Progress|2|||
144187637|NCT01386125|519881221|FG000|Overall Study|Withdrawal by Subject|13|||
144187638|NCT01386125|519881222|FG001|Overall Study|Withdrawal by Subject|12|||
144187639|NCT01386125|519881221|FG000|Overall Study|Adverse Event|2|||
144187640|NCT01386125|519881222|FG001|Overall Study|Adverse Event|5|||
144724315|NCT03594123|521846331|FG001|Overall Study|Site Terminated by Sponsor|1|||
144187641|NCT01386125|519881221|FG000|Overall Study|Lack of Efficacy|0|||
144187642|NCT01386125|519881222|FG001|Overall Study|Lack of Efficacy|1|||
144187643|NCT01386125|519881221|FG000|Overall Study|Participant Leaving Country|1|||
144187644|NCT01386125|519881222|FG001|Overall Study|Participant Leaving Country|0|||
144187645|NCT03173560|519881223|FG000|Overall Study|Death|70|||
144187646|NCT03173560|519881224|FG001|Overall Study|Death|60|||
144187647|NCT03173560|519881223|FG000|Overall Study|Lost to Follow-up|1|||
144724316|NCT03594123|521846330|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
144724317|NCT03594123|521846331|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
144724318|NCT03594123|521846330|FG000|Overall Study|Lack of Efficacy|1|||
144724319|NCT03594123|521846331|FG001|Overall Study|Lack of Efficacy|0|||
144187648|NCT03173560|519881224|FG001|Overall Study|Lost to Follow-up|4|||
144187649|NCT03173560|519881223|FG000|Overall Study|Withdrawal by Subject|10|||
144604483|NCT01674712|521414325|FG001|Overall Study|Lost to Follow-up|0|||
144604484|NCT01674712|521414326|FG002|Overall Study|Lost to Follow-up|0|||
144604485|NCT01674712|521414327|FG003|Overall Study|Lost to Follow-up|0|||
144604486|NCT01674712|521414328|FG004|Overall Study|Lost to Follow-up|0|||
144604487|NCT01674712|521414324|FG000|Overall Study|Protocol Violation|2|||
144604488|NCT01674712|521414325|FG001|Overall Study|Protocol Violation|0|||
144604489|NCT01674712|521414326|FG002|Overall Study|Protocol Violation|0|||
144604490|NCT01674712|521414327|FG003|Overall Study|Protocol Violation|0|||
144604491|NCT01674712|521414328|FG004|Overall Study|Protocol Violation|0|||
144604492|NCT01674712|521414324|FG000|Overall Study|Withdrawal by Subject|2|||
144604493|NCT01674712|521414325|FG001|Overall Study|Withdrawal by Subject|2|||
144604494|NCT01674712|521414326|FG002|Overall Study|Withdrawal by Subject|5|||
144604495|NCT01674712|521414327|FG003|Overall Study|Withdrawal by Subject|4|||
144604496|NCT01674712|521414328|FG004|Overall Study|Withdrawal by Subject|3|||
144604497|NCT01674712|521414324|FG000|Overall Study|Administrative|0|||
144604498|NCT01674712|521414325|FG001|Overall Study|Administrative|1|||
144604499|NCT01674712|521414326|FG002|Overall Study|Administrative|0|||
144187650|NCT03173560|519881224|FG001|Overall Study|Withdrawal by Subject|5|||
144187651|NCT03173560|519881223|FG000|Overall Study|Other|0|||
144604500|NCT01674712|521414327|FG003|Overall Study|Administrative|0|||
144604501|NCT01674712|521414328|FG004|Overall Study|Administrative|1|||
144604502|NCT01674712|521414324|FG000|Overall Study|Lack of Efficacy|0|||
144604503|NCT01674712|521414325|FG001|Overall Study|Lack of Efficacy|0|||
144604504|NCT01674712|521414326|FG002|Overall Study|Lack of Efficacy|1|||
144604505|NCT01674712|521414327|FG003|Overall Study|Lack of Efficacy|0|||
144187652|NCT03173560|519881224|FG001|Overall Study|Other|1|||
144187653|NCT04480307|519881225|FG000|Overall Study|Withdrawal by Subject|0|||
144529737|NCT03386578|521142908|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
144529738|NCT03386578|521142909|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
144529739|NCT03386578|521142900|FG000|PrEP Comparison Component Step 1|Death|0|||
144529740|NCT03386578|521142901|FG001|PrEP Comparison Component Step 1|Death|0|||
144529741|NCT03386578|521142902|FG002|PrEP Comparison Component Step 1|Death|1|||
144529742|NCT03386578|521142903|FG003|PrEP Comparison Component Step 1|Death|0|||
144529743|NCT03386578|521142904|FG004|PrEP Comparison Component Step 1|Death|0|||
144529744|NCT03386578|521142905|FG005|PrEP Comparison Component Step 1|Death|0|||
144529745|NCT03386578|521142906|FG006|PrEP Comparison Component Step 1|Death|0|||
144529746|NCT03386578|521142907|FG007|PrEP Comparison Component Step 1|Death|9|||
144529747|NCT03386578|521142908|FG008|PrEP Comparison Component Step 1|Death|5|||
144187654|NCT04480307|519881226|FG001|Overall Study|Withdrawal by Subject|1|||
144187655|NCT04480307|519881227|FG002|Overall Study|Withdrawal by Subject|0|||
144187656|NCT04480307|519881228|FG003|Overall Study|Withdrawal by Subject|0|||
144529748|NCT03386578|521142909|FG009|PrEP Comparison Component Step 1|Death|0|||
144529749|NCT03386578|521142900|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144187657|NCT04480307|519881225|FG000|Overall Study|Adverse Event|0|||
144187658|NCT04480307|519881226|FG001|Overall Study|Adverse Event|0|||
144187659|NCT04480307|519881227|FG002|Overall Study|Adverse Event|0|||
144529750|NCT03386578|521142901|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144529751|NCT03386578|521142902|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144529752|NCT03386578|521142903|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
144529753|NCT03386578|521142904|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144604506|NCT01674712|521414328|FG004|Overall Study|Lack of Efficacy|1|||
144604507|NCT02606461|521414329|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
144604508|NCT02606461|521414330|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
144604509|NCT02606461|521414331|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
144604510|NCT02606461|521414332|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
144604511|NCT02606461|521414333|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
144604512|NCT02606461|521414334|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
144604513|NCT00024167|521414335|FG000|Overall Study|Death|53|||
144604514|NCT00024167|521414336|FG001|Overall Study|Death|47|||
144604515|NCT00800436|521414350|FG000|Overall Study|Withdrawal by Subject|0|||
144604516|NCT00800436|521414351|FG001|Overall Study|Withdrawal by Subject|0|||
144604517|NCT00800436|521414352|FG002|Overall Study|Withdrawal by Subject|1|||
144604518|NCT00800436|521414353|FG003|Overall Study|Withdrawal by Subject|1|||
144604519|NCT00800436|521414354|FG004|Overall Study|Withdrawal by Subject|0|||
144604520|NCT00800436|521414355|FG005|Overall Study|Withdrawal by Subject|0|||
144604521|NCT00800436|521414356|FG006|Overall Study|Withdrawal by Subject|0|||
144604522|NCT00698932|521414357|FG000|Overall Study|Adverse Event|0|||
144604523|NCT00698932|521414358|FG001|Overall Study|Adverse Event|2|||
144604524|NCT00698932|521414357|FG000|Overall Study|Incorrect enrollment|0|||
144604525|NCT00698932|521414358|FG001|Overall Study|Incorrect enrollment|2|||
144604526|NCT00698932|521414357|FG000|Overall Study|Study specific discontinuation criteria|3|||
144604527|NCT00698932|521414358|FG001|Overall Study|Study specific discontinuation criteria|4|||
144604528|NCT00698932|521414357|FG000|Overall Study|Withdrawal by Subject|11|||
144604529|NCT00698932|521414358|FG001|Overall Study|Withdrawal by Subject|23|||
144604530|NCT00698932|521414357|FG000|Overall Study|Lost to Follow-up|6|||
144604531|NCT00698932|521414358|FG001|Overall Study|Lost to Follow-up|1|||
144604532|NCT00698932|521414357|FG000|Overall Study|Severe non-compliance to protocol|1|||
144604533|NCT00698932|521414358|FG001|Overall Study|Severe non-compliance to protocol|2|||
144604534|NCT00698932|521414357|FG000|Overall Study|Safety reasons|0|||
144604535|NCT00698932|521414358|FG001|Overall Study|Safety reasons|2|||
144604536|NCT00698932|521414357|FG000|Overall Study|Death|1|||
144604537|NCT00698932|521414358|FG001|Overall Study|Death|0|||
144604538|NCT00757003|521414359|FG000|Overall Study|Death|33|||
144604539|NCT00757003|521414359|FG000|Overall Study|Lost to Follow-up|9|||
144604540|NCT00757003|521414359|FG000|Overall Study|Withdrawal by Subject|4|||
144604541|NCT00757003|521414359|FG000|Overall Study|Surgically explanted|2|||
144604542|NCT00757003|521414359|FG000|Overall Study|Not implanted|1|||
144604543|NCT00601705|521414360|FG000|Overall Study|Withdrawal by Subject|1|||
144604544|NCT04246801|521414364|FG000|Overall Study|Adverse Event|1|||
144529754|NCT03386578|521142905|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144529755|NCT03386578|521142906|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144529756|NCT03386578|521142907|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144529757|NCT03386578|521142908|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
144529758|NCT03386578|521142909|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
144529759|NCT03386578|521142900|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529760|NCT03386578|521142901|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529761|NCT03386578|521142902|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529762|NCT03386578|521142903|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529763|NCT03386578|521142904|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529764|NCT03386578|521142905|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529765|NCT03386578|521142906|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529766|NCT03386578|521142907|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
144529767|NCT03386578|521142908|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
144529768|NCT03386578|521142909|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
144529769|NCT03386578|521142900|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529770|NCT03386578|521142901|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144604545|NCT04246801|521414365|FG001|Overall Study|Adverse Event|1|||
144604546|NCT04246801|521414364|FG000|Overall Study|Protocol Violation|1|||
144604547|NCT04246801|521414365|FG001|Overall Study|Protocol Violation|1|||
144604548|NCT04246801|521414364|FG000|Overall Study|Lack of Efficacy|0|||
144604549|NCT04246801|521414365|FG001|Overall Study|Lack of Efficacy|2|||
144604550|NCT04246801|521414364|FG000|Overall Study|Lost to Follow-up|1|||
144604551|NCT04246801|521414365|FG001|Overall Study|Lost to Follow-up|1|||
144604552|NCT04246801|521414364|FG000|Overall Study|Withdrawal by Subject|2|||
144604553|NCT04246801|521414365|FG001|Overall Study|Withdrawal by Subject|1|||
144604554|NCT01368042|521414366|FG000|Overall Study|Death|14|||
144604555|NCT01368042|521414366|FG000|Overall Study|Protocol Violation|11|||
144604556|NCT01368042|521414366|FG000|Overall Study|Lost to Follow-up|4|||
144604557|NCT01368042|521414366|FG000|Overall Study|Transplanted|1|||
144604558|NCT01621542|521414367|FG000|Overall Study|Adverse Event|0|||
144604559|NCT01621542|521414368|FG001|Overall Study|Adverse Event|0|||
144604560|NCT01621542|521414369|FG002|Overall Study|Adverse Event|1|||
144604561|NCT01621542|521414370|FG003|Overall Study|Adverse Event|3|||
144604562|NCT01621542|521414371|FG004|Overall Study|Adverse Event|0|||
144604563|NCT01621542|521414372|FG005|Overall Study|Adverse Event|0|||
144604564|NCT01621542|521414367|FG000|Overall Study|Death|0|||
144187660|NCT04480307|519881228|FG003|Overall Study|Adverse Event|1|||
144187661|NCT03023137|519881231|FG000|Overall Study|Multiple pregnancy|2|||
144187662|NCT03023137|519881232|FG001|Overall Study|Multiple pregnancy|4|||
144187663|NCT03023137|519881231|FG000|Overall Study|Lost to Follow-up|1|||
144529771|NCT03386578|521142902|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529772|NCT03386578|521142903|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529773|NCT03386578|521142904|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529774|NCT03386578|521142905|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529775|NCT03386578|521142906|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529776|NCT03386578|521142907|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
144529777|NCT03386578|521142908|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
144604565|NCT01621542|521414368|FG001|Overall Study|Death|1|||
144604566|NCT01621542|521414369|FG002|Overall Study|Death|0|||
144187664|NCT03023137|519881232|FG001|Overall Study|Lost to Follow-up|1|||
144187665|NCT03023137|519881231|FG000|Overall Study|Protocol Violation|0|||
144187666|NCT03023137|519881232|FG001|Overall Study|Protocol Violation|4|||
144187667|NCT03023137|519881231|FG000|Overall Study|Lost the baby in a car accident|1|||
144187668|NCT03023137|519881232|FG001|Overall Study|Lost the baby in a car accident|0|||
144187669|NCT00732160|519881236|FG000|Overall Study|Adverse Event|1|||
144187670|NCT00732160|519881237|FG001|Overall Study|Adverse Event|0|||
144187671|NCT00732160|519881238|FG002|Overall Study|Adverse Event|1|||
144187672|NCT00732160|519881239|FG003|Overall Study|Adverse Event|1|||
144187673|NCT00732160|519881236|FG000|Overall Study|scheduling|4|||
144187674|NCT00732160|519881237|FG001|Overall Study|scheduling|4|||
144187675|NCT00732160|519881238|FG002|Overall Study|scheduling|2|||
144253224|NCT01483599|520126657|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144604567|NCT01621542|521414370|FG003|Overall Study|Death|0|||
144604568|NCT01621542|521414371|FG004|Overall Study|Death|0|||
144604569|NCT01621542|521414372|FG005|Overall Study|Death|0|||
144604570|NCT01621542|521414367|FG000|Overall Study|Physician Decision|1|||
144187676|NCT00732160|519881239|FG003|Overall Study|scheduling|1|||
144187677|NCT02795676|519881240|FG000|Overall Study|Adverse Event|2|||
144187678|NCT02795676|519881241|FG001|Overall Study|Adverse Event|0|||
144187679|NCT02795676|519881240|FG000|Overall Study|Withdrawal by Subject|3|||
144529778|NCT03386578|521142909|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
144529779|NCT02694822|521142910|FG000|Phase 1|Death|2|||
144529780|NCT02694822|521142911|FG001|Phase 1|Death|1|||
144529781|NCT02694822|521142912|FG002|Phase 1|Death|6|||
144529782|NCT02694822|521142913|FG003|Phase 1|Death|6|||
144529783|NCT02694822|521142914|FG004|Phase 1|Death|3|||
144529784|NCT02694822|521142915|FG005|Phase 1|Death|0|||
144529785|NCT02694822|521142910|FG000|Phase 1|Withdrawal by Subject|2|||
144529786|NCT02694822|521142911|FG001|Phase 1|Withdrawal by Subject|2|||
144529787|NCT02694822|521142912|FG002|Phase 1|Withdrawal by Subject|4|||
144529788|NCT02694822|521142913|FG003|Phase 1|Withdrawal by Subject|8|||
144529789|NCT02694822|521142914|FG004|Phase 1|Withdrawal by Subject|1|||
144187680|NCT02795676|519881241|FG001|Overall Study|Withdrawal by Subject|1|||
144187681|NCT01203917|519881242|FG000|Overall Study|Death|29|||
144187682|NCT01203917|519881242|FG000|Overall Study|Lost to Follow-up|2|||
144187683|NCT01203917|519881242|FG000|Overall Study|Withdrawal by Subject|3|||
144187684|NCT01203917|519881242|FG000|Overall Study|Due to objective disease progression|1|||
144187685|NCT01203917|519881242|FG000|Overall Study|Due to EGFR M+I patient|1|||
144187686|NCT01264835|519881243|FG000|Overall Study|Lost to Follow-up|1|||
144187687|NCT01466036|519881245|FG000|Overall Study|Death|1|||
144187688|NCT01466036|519881246|FG001|Overall Study|Death|1|||
144187689|NCT01466036|519881245|FG000|Overall Study|Physician Decision|0|||
144187690|NCT01466036|519881246|FG001|Overall Study|Physician Decision|4|||
144187691|NCT01466036|519881245|FG000|Overall Study|Adverse Event|2|||
144187692|NCT01466036|519881246|FG001|Overall Study|Adverse Event|6|||
144187693|NCT01466036|519881245|FG000|Overall Study|Withdrawal by Subject|2|||
144187694|NCT01466036|519881246|FG001|Overall Study|Withdrawal by Subject|8|||
144187695|NCT01466036|519881245|FG000|Overall Study|progression/relapse|14|||
144187696|NCT01466036|519881246|FG001|Overall Study|progression/relapse|21|||
144187697|NCT01466036|519881245|FG000|Overall Study|prolonged treatment delay|1|||
144187698|NCT01466036|519881246|FG001|Overall Study|prolonged treatment delay|1|||
144187699|NCT03507686|519881247|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
144187700|NCT03507686|519881248|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
144187701|NCT03507686|519881247|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
144187702|NCT03507686|519881248|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
144187703|NCT03507686|519881247|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
144187704|NCT03507686|519881248|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
144187705|NCT03507686|519881247|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
144187706|NCT03507686|519881248|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
144187707|NCT03507686|519881247|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
144187708|NCT03507686|519881248|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
144187709|NCT03507686|519881247|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
144187710|NCT03507686|519881248|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
144187711|NCT02508116|519881249|FG000|Overall Study|Lost to Follow-up|2|||
144187712|NCT02508116|519881250|FG001|Overall Study|Lost to Follow-up|3|||
144187713|NCT02508116|519881249|FG000|Overall Study|Withdrawal by Subject|3|||
144187714|NCT02508116|519881250|FG001|Overall Study|Withdrawal by Subject|2|||
144187715|NCT02508116|519881249|FG000|Overall Study|Protocol Violation|1|||
144187716|NCT02508116|519881250|FG001|Overall Study|Protocol Violation|2|||
144187717|NCT02508116|519881249|FG000|Overall Study|Physician Decision|2|||
144187718|NCT02508116|519881250|FG001|Overall Study|Physician Decision|0|||
144187719|NCT00109850|519881251|FG000|Overall Study|Adverse Event|1|||
144187720|NCT00109850|519881251|FG000|Overall Study|Death|2|||
144529790|NCT02694822|521142915|FG005|Phase 1|Withdrawal by Subject|0|||
144529791|NCT02694822|521142910|FG000|Phase 2|Death|0|||
144529792|NCT02694822|521142911|FG001|Phase 2|Death|0|||
144529793|NCT02694822|521142912|FG002|Phase 2|Death|0|||
144529794|NCT02694822|521142913|FG003|Phase 2|Death|0|||
144529795|NCT02694822|521142914|FG004|Phase 2|Death|0|||
144529796|NCT02694822|521142915|FG005|Phase 2|Death|26|||
144529797|NCT02694822|521142910|FG000|Phase 2|Withdrawal by Subject|0|||
144529798|NCT02694822|521142911|FG001|Phase 2|Withdrawal by Subject|0|||
144529799|NCT02694822|521142912|FG002|Phase 2|Withdrawal by Subject|0|||
144529800|NCT02694822|521142913|FG003|Phase 2|Withdrawal by Subject|0|||
144187721|NCT00109850|519881251|FG000|Overall Study|Ineligible|1|||
144187722|NCT03635983|519881252|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
144187723|NCT03635983|519881253|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
144187724|NCT03635983|519881252|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144187725|NCT03635983|519881253|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144187726|NCT03635983|519881252|FG000|Pre-Treatment Period|Other reasons|0|||
144529801|NCT02694822|521142914|FG004|Phase 2|Withdrawal by Subject|0|||
144529802|NCT02694822|521142915|FG005|Phase 2|Withdrawal by Subject|13|||
144529803|NCT02694822|521142910|FG000|Phase 2|Administrative Study Closure|0|||
144529804|NCT02694822|521142911|FG001|Phase 2|Administrative Study Closure|0|||
144529805|NCT02694822|521142912|FG002|Phase 2|Administrative Study Closure|0|||
144529806|NCT02694822|521142913|FG003|Phase 2|Administrative Study Closure|0|||
144529807|NCT02694822|521142914|FG004|Phase 2|Administrative Study Closure|0|||
144604571|NCT01621542|521414368|FG001|Overall Study|Physician Decision|0|||
144187727|NCT03635983|519881253|FG001|Pre-Treatment Period|Other reasons|1|||
144604572|NCT01621542|521414369|FG002|Overall Study|Physician Decision|1|||
144604573|NCT01621542|521414370|FG003|Overall Study|Physician Decision|13|||
144187728|NCT03635983|519881252|FG000|Pre-Treatment Period|Disease Progression|0|||
144604574|NCT01621542|521414371|FG004|Overall Study|Physician Decision|3|||
144604575|NCT01621542|521414372|FG005|Overall Study|Physician Decision|1|||
144604576|NCT01621542|521414367|FG000|Overall Study|Withdrawal by Subject|2|||
144604577|NCT01621542|521414368|FG001|Overall Study|Withdrawal by Subject|0|||
144187729|NCT03635983|519881253|FG001|Pre-Treatment Period|Disease Progression|1|||
144604578|NCT01621542|521414369|FG002|Overall Study|Withdrawal by Subject|1|||
144604579|NCT01621542|521414370|FG003|Overall Study|Withdrawal by Subject|3|||
144604580|NCT01621542|521414371|FG004|Overall Study|Withdrawal by Subject|3|||
144604581|NCT01621542|521414372|FG005|Overall Study|Withdrawal by Subject|3|||
144604582|NCT01621542|521414367|FG000|Overall Study|progression/treatment failure|2|||
144604583|NCT01621542|521414368|FG001|Overall Study|progression/treatment failure|4|||
144187730|NCT03635983|519881252|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
144187731|NCT03635983|519881253|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
144253225|NCT01483599|520126658|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253226|NCT01483599|520126659|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253227|NCT01483599|520126660|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
144604584|NCT01621542|521414369|FG002|Overall Study|progression/treatment failure|3|||
144604585|NCT01621542|521414370|FG003|Overall Study|progression/treatment failure|7|||
144604586|NCT01621542|521414371|FG004|Overall Study|progression/treatment failure|3|||
144604587|NCT01621542|521414372|FG005|Overall Study|progression/treatment failure|5|||
144604588|NCT01621542|521414367|FG000|Overall Study|Protocol Violation|0|||
144604589|NCT01621542|521414368|FG001|Overall Study|Protocol Violation|0|||
144604590|NCT01621542|521414369|FG002|Overall Study|Protocol Violation|0|||
144604591|NCT01621542|521414370|FG003|Overall Study|Protocol Violation|1|||
144604592|NCT01621542|521414371|FG004|Overall Study|Protocol Violation|0|||
144604593|NCT01621542|521414372|FG005|Overall Study|Protocol Violation|0|||
144604594|NCT01621542|521414367|FG000|Overall Study|study stopped by sponsor|0|||
144604595|NCT01621542|521414368|FG001|Overall Study|study stopped by sponsor|0|||
144604596|NCT01621542|521414369|FG002|Overall Study|study stopped by sponsor|0|||
144604597|NCT01621542|521414370|FG003|Overall Study|study stopped by sponsor|1|||
144604598|NCT01621542|521414371|FG004|Overall Study|study stopped by sponsor|0|||
144604599|NCT01621542|521414372|FG005|Overall Study|study stopped by sponsor|0|||
144604600|NCT02632721|521414376|FG000|Overall Study|Adverse Event|0|||
144604601|NCT02632721|521414377|FG001|Overall Study|Adverse Event|0|||
144604602|NCT02632721|521414378|FG002|Overall Study|Adverse Event|2|||
144604603|NCT02632721|521414379|FG003|Overall Study|Adverse Event|5|||
144604604|NCT02632721|521414380|FG004|Overall Study|Adverse Event|3|||
144604605|NCT02632721|521414376|FG000|Overall Study|Dose limiting toxicity|0|||
144253228|NCT01483599|520126661|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253229|NCT01483599|520126662|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253230|NCT01483599|520126663|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
144529808|NCT02694822|521142915|FG005|Phase 2|Administrative Study Closure|2|||
144529809|NCT02694822|521142910|FG000|Phase 2|Lost to Follow-up|0|||
144529810|NCT02694822|521142911|FG001|Phase 2|Lost to Follow-up|0|||
144529811|NCT02694822|521142912|FG002|Phase 2|Lost to Follow-up|0|||
144529812|NCT02694822|521142913|FG003|Phase 2|Lost to Follow-up|0|||
144529813|NCT02694822|521142914|FG004|Phase 2|Lost to Follow-up|0|||
144529814|NCT02694822|521142915|FG005|Phase 2|Lost to Follow-up|1|||
144529815|NCT02694822|521142910|FG000|Phase 2|Participant Transferred to Another Site|0|||
144529816|NCT02694822|521142911|FG001|Phase 2|Participant Transferred to Another Site|0|||
144529817|NCT02694822|521142912|FG002|Phase 2|Participant Transferred to Another Site|0|||
144529818|NCT02694822|521142913|FG003|Phase 2|Participant Transferred to Another Site|0|||
144529819|NCT02694822|521142914|FG004|Phase 2|Participant Transferred to Another Site|0|||
144529820|NCT02694822|521142915|FG005|Phase 2|Participant Transferred to Another Site|1|||
144529821|NCT01627574|521142919|FG000|Overall Study|Withdrawal by Subject|8|||
144529822|NCT01627574|521142920|FG001|Overall Study|Withdrawal by Subject|5|||
144529823|NCT01627574|521142919|FG000|Overall Study|Lost to Follow-up|13|||
144529824|NCT01627574|521142920|FG001|Overall Study|Lost to Follow-up|13|||
144529825|NCT03249090|521142930|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
144529826|NCT03249090|521142931|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
144529827|NCT03249090|521142930|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
144529828|NCT03249090|521142931|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
144529829|NCT03249090|521142930|FG000|3 Month Time Point|Voluntary withdrawal|6|||
144529830|NCT03249090|521142931|FG001|3 Month Time Point|Voluntary withdrawal|3|||
144529831|NCT03249090|521142930|FG000|3 Month Time Point|Changed oncology practice|4|||
144529832|NCT03249090|521142931|FG001|3 Month Time Point|Changed oncology practice|2|||
144529833|NCT03249090|521142930|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
144529834|NCT03249090|521142931|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
144529835|NCT03249090|521142930|FG000|12 Month Time Point|Voluntary withdrawal|35|||
144529836|NCT03249090|521142931|FG001|12 Month Time Point|Voluntary withdrawal|4|||
144529837|NCT03249090|521142930|FG000|12 Month Time Point|Changed oncology practice|20|||
144529838|NCT03249090|521142931|FG001|12 Month Time Point|Changed oncology practice|9|||
144529839|NCT04359654|521142934|FG000|Overall Study|Withdrawal by Subject|1|||
144529840|NCT04359654|521142935|FG001|Overall Study|Withdrawal by Subject|0|||
144529841|NCT04359654|521142934|FG000|Overall Study|Adverse Event|0|||
144529842|NCT04359654|521142935|FG001|Overall Study|Adverse Event|1|||
144529843|NCT06122194|521142937|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
144529844|NCT06122194|521142938|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
144529845|NCT06122194|521142939|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
144529846|NCT06122194|521142940|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
144529847|NCT04314778|521142941|FG000|Overall Study|Lost to Follow-up|5|||
144529848|NCT04314778|521142942|FG001|Overall Study|Lost to Follow-up|3|||
144529849|NCT05646355|521142943|FG000|Overall Study|Lost to Follow-up|1|||
144529850|NCT05646355|521142944|FG001|Overall Study|Lost to Follow-up|0|||
144529851|NCT05646355|521142943|FG000|Overall Study|translated materials not available for pilot|2|||
144529852|NCT05646355|521142944|FG001|Overall Study|translated materials not available for pilot|0|||
144529853|NCT05646355|521142943|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
144529854|NCT05646355|521142944|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
144472034|NCT03996291|520925370|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
144472035|NCT03996291|520925371|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
144472036|NCT03996291|520925372|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
144472037|NCT03996291|520925373|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
144472038|NCT03996291|520925374|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
144472039|NCT03996291|520925367|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
144472040|NCT03996291|520925368|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
144472041|NCT03996291|520925369|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
144472042|NCT03996291|520925370|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
144472043|NCT03996291|520925371|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
144472044|NCT03996291|520925372|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
144472045|NCT03996291|520925373|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
144472046|NCT03996291|520925374|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
144472047|NCT03996291|520925367|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
144472048|NCT03996291|520925368|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
144472049|NCT03996291|520925369|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
144472050|NCT03996291|520925370|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
144472051|NCT03996291|520925371|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
144472052|NCT03996291|520925372|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
144472053|NCT03996291|520925373|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
144472054|NCT03996291|520925374|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
144472055|NCT03996291|520925367|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472056|NCT03996291|520925368|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472057|NCT03996291|520925369|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472058|NCT03996291|520925370|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472059|NCT03996291|520925371|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
144472060|NCT03996291|520925372|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472061|NCT03996291|520925373|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472062|NCT03996291|520925374|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
144472063|NCT03248375|520925375|FG000|Overall Study|Lost to Follow-up|5|||
144472064|NCT04098250|520925376|FG000|Overall Study|Withdrawal by Subject|1|||
144472065|NCT04098250|520925377|FG001|Overall Study|Withdrawal by Subject|0|||
144472066|NCT04098250|520925376|FG000|Overall Study|Lost to Follow-up|0|||
144472067|NCT04098250|520925377|FG001|Overall Study|Lost to Follow-up|1|||
144472068|NCT00394355|520925378|FG000|Overall Study|Adverse Event|10|||
144472069|NCT00394355|520925379|FG001|Overall Study|Adverse Event|6|||
144529855|NCT04685135|521142948|FG000|Overall Study|Death|126|||
144529856|NCT04685135|521142949|FG001|Overall Study|Death|53|||
144529857|NCT04685135|521142948|FG000|Overall Study|Withdrawal by Subject|12|||
144529858|NCT04685135|521142949|FG001|Overall Study|Withdrawal by Subject|16|||
144529859|NCT03711474|521142951|FG000|Overall Study|Physician Decision|2|||
144529860|NCT03711474|521142952|FG001|Overall Study|Physician Decision|0|||
144472070|NCT00394355|520925380|FG002|Overall Study|Adverse Event|7|||
144472071|NCT00394355|520925381|FG003|Overall Study|Adverse Event|8|||
144472072|NCT00394355|520925378|FG000|Overall Study|Did not meet protocol eligibility|1|||
144529861|NCT05974501|521142953|FG000|Overall Study|Physician Decision|0|||
144724320|NCT03594123|521846330|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
144724321|NCT03594123|521846331|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
144472073|NCT00394355|520925379|FG001|Overall Study|Did not meet protocol eligibility|5|||
144472074|NCT00394355|520925380|FG002|Overall Study|Did not meet protocol eligibility|4|||
144529862|NCT05974501|521142954|FG001|Overall Study|Physician Decision|1|||
144529863|NCT03513302|521142955|FG000|First Intervention (14 Days)|Screen failure|15|||
144433966|NCT00502697|520794310|FG000|Overall Study|Withdrawal by Subject|3|||
144433967|NCT00502697|520794311|FG001|Overall Study|Withdrawal by Subject|1|||
144433968|NCT00502697|520794310|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
144433969|NCT00502697|520794311|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
144433970|NCT00502697|520794310|FG000|Overall Study|found not to meet eligibility criteria|3|||
144433971|NCT00502697|520794311|FG001|Overall Study|found not to meet eligibility criteria|4|||
144433972|NCT00502697|520794310|FG000|Overall Study|did not meet assignment criteria|4|||
144433973|NCT00502697|520794311|FG001|Overall Study|did not meet assignment criteria|2|||
144433974|NCT00589108|520794318|FG000|Overall Study|Lost to Follow-up|1|||
144433975|NCT00589108|520794319|FG001|Overall Study|Lost to Follow-up|1|||
144433976|NCT00589108|520794320|FG002|Overall Study|Lost to Follow-up|1|||
144433977|NCT00589108|520794318|FG000|Overall Study|Death|3|||
144433978|NCT00589108|520794319|FG001|Overall Study|Death|3|||
144433979|NCT00589108|520794320|FG002|Overall Study|Death|4|||
144433980|NCT03256552|520794321|FG000|Overall Study|Protocol Violation|1|||
144433981|NCT03256552|520794321|FG000|Overall Study|Physician Decision|1|||
144433982|NCT03256552|520794321|FG000|Overall Study|Adverse Event|1|||
144433983|NCT03256552|520794321|FG000|Overall Study|Withdrawal by Subject|2|||
144433984|NCT01023581|520794330|FG000|Overall Study|Adverse Event|4|||
144433985|NCT01023581|520794331|FG001|Overall Study|Adverse Event|4|||
144433986|NCT01023581|520794332|FG002|Overall Study|Adverse Event|7|||
144433987|NCT01023581|520794333|FG003|Overall Study|Adverse Event|3|||
144433988|NCT01023581|520794334|FG004|Overall Study|Adverse Event|2|||
144433989|NCT01023581|520794335|FG005|Overall Study|Adverse Event|5|||
144433990|NCT01023581|520794336|FG006|Overall Study|Adverse Event|11|||
144433991|NCT01023581|520794330|FG000|Overall Study|Major protocol deviation|2|||
144433992|NCT01023581|520794331|FG001|Overall Study|Major protocol deviation|0|||
144433993|NCT01023581|520794332|FG002|Overall Study|Major protocol deviation|3|||
144433994|NCT01023581|520794333|FG003|Overall Study|Major protocol deviation|0|||
144433995|NCT01023581|520794334|FG004|Overall Study|Major protocol deviation|0|||
144433996|NCT01023581|520794335|FG005|Overall Study|Major protocol deviation|0|||
144433997|NCT01023581|520794336|FG006|Overall Study|Major protocol deviation|0|||
144433998|NCT01023581|520794330|FG000|Overall Study|Lost to Follow-up|4|||
144433999|NCT01023581|520794331|FG001|Overall Study|Lost to Follow-up|8|||
144434000|NCT01023581|520794332|FG002|Overall Study|Lost to Follow-up|7|||
144434001|NCT01023581|520794333|FG003|Overall Study|Lost to Follow-up|2|||
144434002|NCT01023581|520794334|FG004|Overall Study|Lost to Follow-up|5|||
144434003|NCT01023581|520794335|FG005|Overall Study|Lost to Follow-up|2|||
144434004|NCT01023581|520794336|FG006|Overall Study|Lost to Follow-up|2|||
144434005|NCT01023581|520794330|FG000|Overall Study|Withdrawal by Subject|13|||
144434006|NCT01023581|520794331|FG001|Overall Study|Withdrawal by Subject|8|||
144434007|NCT01023581|520794332|FG002|Overall Study|Withdrawal by Subject|16|||
144434008|NCT01023581|520794333|FG003|Overall Study|Withdrawal by Subject|10|||
144434009|NCT01023581|520794334|FG004|Overall Study|Withdrawal by Subject|6|||
144434010|NCT01023581|520794335|FG005|Overall Study|Withdrawal by Subject|8|||
144434011|NCT01023581|520794336|FG006|Overall Study|Withdrawal by Subject|5|||
144434012|NCT01023581|520794330|FG000|Overall Study|Pregnancy|0|||
144434013|NCT01023581|520794331|FG001|Overall Study|Pregnancy|0|||
144434014|NCT01023581|520794332|FG002|Overall Study|Pregnancy|0|||
144434015|NCT01023581|520794333|FG003|Overall Study|Pregnancy|2|||
144434016|NCT01023581|520794334|FG004|Overall Study|Pregnancy|0|||
144529864|NCT03513302|521142956|FG001|First Intervention (14 Days)|Screen failure|16|||
144529865|NCT04862416|521142959|FG000|Overall Study|Withdrawal by Subject|0|||
144529866|NCT04862416|521142960|FG001|Overall Study|Withdrawal by Subject|1|||
144529867|NCT04862416|521142961|FG002|Overall Study|Withdrawal by Subject|0|||
144529868|NCT04862416|521142962|FG003|Overall Study|Withdrawal by Subject|1|||
144529869|NCT04862416|521142963|FG004|Overall Study|Withdrawal by Subject|0|||
144529870|NCT04862416|521142964|FG005|Overall Study|Withdrawal by Subject|0|||
144529871|NCT04862416|521142965|FG006|Overall Study|Withdrawal by Subject|0|||
144187732|NCT03635983|519881252|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
144187733|NCT03635983|519881253|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
144187734|NCT03635983|519881252|FG000|Treatment Period|Withdrawal by Subject|3|||
144434017|NCT01023581|520794335|FG005|Overall Study|Pregnancy|1|||
144434018|NCT01023581|520794336|FG006|Overall Study|Pregnancy|0|||
144434019|NCT01023581|520794330|FG000|Overall Study|Lack of Efficacy|9|||
144434020|NCT01023581|520794331|FG001|Overall Study|Lack of Efficacy|3|||
144434021|NCT01023581|520794332|FG002|Overall Study|Lack of Efficacy|6|||
144434022|NCT01023581|520794333|FG003|Overall Study|Lack of Efficacy|2|||
144434023|NCT01023581|520794334|FG004|Overall Study|Lack of Efficacy|1|||
144434024|NCT01023581|520794335|FG005|Overall Study|Lack of Efficacy|2|||
144434025|NCT01023581|520794336|FG006|Overall Study|Lack of Efficacy|1|||
144434026|NCT01023581|520794330|FG000|Overall Study|Physician Decision|2|||
144434027|NCT01023581|520794331|FG001|Overall Study|Physician Decision|0|||
144434028|NCT01023581|520794332|FG002|Overall Study|Physician Decision|2|||
144434029|NCT01023581|520794333|FG003|Overall Study|Physician Decision|1|||
144434030|NCT01023581|520794334|FG004|Overall Study|Physician Decision|1|||
144434031|NCT01023581|520794335|FG005|Overall Study|Physician Decision|1|||
144529872|NCT04862416|521142966|FG007|Overall Study|Withdrawal by Subject|0|||
144529873|NCT03852550|521142967|FG000|Overall Study|Lost to Follow-up|4|||
144529874|NCT03852550|521142968|FG001|Overall Study|Lost to Follow-up|3|||
144529875|NCT03852550|521142967|FG000|Overall Study|Only parent outcomes completed|0|||
144529876|NCT03852550|521142968|FG001|Overall Study|Only parent outcomes completed|1|||
144529877|NCT03852550|521142967|FG000|Overall Study|Withdrawal by Subject|1|||
144434032|NCT01023581|520794336|FG006|Overall Study|Physician Decision|1|||
144434033|NCT01023581|520794330|FG000|Overall Study|Other|1|||
144434034|NCT01023581|520794331|FG001|Overall Study|Other|0|||
144434035|NCT01023581|520794332|FG002|Overall Study|Other|1|||
144434036|NCT01023581|520794333|FG003|Overall Study|Other|0|||
144434037|NCT01023581|520794334|FG004|Overall Study|Other|1|||
144434038|NCT01023581|520794335|FG005|Overall Study|Other|0|||
144434039|NCT01023581|520794336|FG006|Overall Study|Other|0|||
144434040|NCT01176292|520794340|FG000|Overall Study|Lost to Follow-up|2|||
144434041|NCT01176292|520794341|FG001|Overall Study|Lost to Follow-up|4|||
144434042|NCT01176292|520794340|FG000|Overall Study|Adverse Event|1|||
144434043|NCT01176292|520794341|FG001|Overall Study|Adverse Event|1|||
144434044|NCT01176292|520794340|FG000|Overall Study|Physician Decision|0|||
144434045|NCT01176292|520794341|FG001|Overall Study|Physician Decision|2|||
144434046|NCT01176292|520794340|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
144434047|NCT01176292|520794341|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
144434048|NCT00997503|520794342|FG000|Overall Study|Death|53|||
144434049|NCT00997503|520794342|FG000|Overall Study|Withdrawal by Subject|76|||
144434050|NCT00997503|520794342|FG000|Overall Study|Lost to Follow-up|33|||
144434051|NCT00997503|520794342|FG000|Overall Study|Adverse Event|3|||
144434052|NCT00997503|520794342|FG000|Overall Study|Physician Decision|10|||
144434053|NCT00997503|520794342|FG000|Overall Study|Missed 12-month follow-up|85|||
144434054|NCT00997503|520794342|FG000|Overall Study|Other reason|13|||
144434055|NCT00380393|520794343|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
144434056|NCT00380393|520794344|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
144434057|NCT00380393|520794343|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
144434058|NCT00380393|520794344|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
144434059|NCT00380393|520794343|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
144434060|NCT00380393|520794344|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
144434061|NCT00380393|520794343|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
144434062|NCT00380393|520794344|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
144434063|NCT00380393|520794343|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
144434064|NCT00380393|520794344|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
144434065|NCT00380393|520794343|FG000|Month 14|Withdrawal by Subject|9|||
144434066|NCT00380393|520794344|FG001|Month 14|Withdrawal by Subject|7|||
144434067|NCT00380393|520794343|FG000|Month 14|Death|1|||
144434068|NCT00380393|520794344|FG001|Month 14|Death|0|||
144434069|NCT00380393|520794343|FG000|Month 14|Lost to Follow-up|0|||
144434070|NCT00380393|520794344|FG001|Month 14|Lost to Follow-up|1|||
144434071|NCT00380393|520794343|FG000|Month 14|Migrated/moved from study area|39|||
144434072|NCT00380393|520794344|FG001|Month 14|Migrated/moved from study area|42|||
144434073|NCT00380393|520794343|FG000|Month 14|Protocol Violation|2|||
144434074|NCT00380393|520794344|FG001|Month 14|Protocol Violation|0|||
144434075|NCT00380393|520794343|FG000|Month 14|Others|6|||
144434076|NCT00380393|520794344|FG001|Month 14|Others|6|||
144434077|NCT02256891|520794347|FG000|Overall Study|Death|0|||
144434078|NCT02256891|520794348|FG001|Overall Study|Death|2|||
144434079|NCT02256891|520794347|FG000|Overall Study|Lost to Follow-up|0|||
144529878|NCT03852550|521142968|FG001|Overall Study|Withdrawal by Subject|0|||
144529879|NCT04295512|521142971|FG000|Overall Study|Lack of family response to schedule assessment|0|||
144529880|NCT04295512|521142972|FG001|Overall Study|Lack of family response to schedule assessment|0|||
144529881|NCT04295512|521142973|FG002|Overall Study|Lack of family response to schedule assessment|0|||
144529882|NCT04295512|521142974|FG003|Overall Study|Lack of family response to schedule assessment|2|||
144529883|NCT04295512|521142971|FG000|Overall Study|Therapist did not refer eligible family|7|||
144529884|NCT04295512|521142972|FG001|Overall Study|Therapist did not refer eligible family|7|||
144529885|NCT04295512|521142973|FG002|Overall Study|Therapist did not refer eligible family|0|||
144529886|NCT04295512|521142974|FG003|Overall Study|Therapist did not refer eligible family|0|||
144529887|NCT04141891|521142979|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
144529888|NCT04141891|521142980|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
144529889|NCT04141891|521142979|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
144529890|NCT04141891|521142980|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
144434080|NCT02256891|520794348|FG001|Overall Study|Lost to Follow-up|3|||
144434081|NCT02256891|520794347|FG000|Overall Study|Physician Decision|7|||
144434082|NCT02256891|520794348|FG001|Overall Study|Physician Decision|3|||
144434083|NCT02256891|520794347|FG000|Overall Study|Screen Fail|5|||
144434084|NCT02256891|520794348|FG001|Overall Study|Screen Fail|4|||
144434085|NCT02256891|520794347|FG000|Overall Study|Equipment Malfunction|0|||
144434086|NCT02256891|520794348|FG001|Overall Study|Equipment Malfunction|1|||
144434087|NCT00218296|520794349|FG000|Overall Study|Lost to Follow-up|9|||
144434088|NCT00218296|520794350|FG001|Overall Study|Lost to Follow-up|7|||
144434089|NCT00218296|520794349|FG000|Overall Study|Withdrawal by Subject|36|||
144253231|NCT01483599|520126664|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
144253232|NCT01483599|520126665|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
144253233|NCT01483599|520126652|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253234|NCT01483599|520126653|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253235|NCT01483599|520126654|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253236|NCT01483599|520126655|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253237|NCT01483599|520126656|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253238|NCT01483599|520126657|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253239|NCT01483599|520126658|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253240|NCT01483599|520126659|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253241|NCT01483599|520126660|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
144253242|NCT01483599|520126661|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253243|NCT01483599|520126662|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
144253244|NCT01483599|520126663|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253245|NCT01483599|520126664|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
144253246|NCT01483599|520126665|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
144253247|NCT01483599|520126652|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253248|NCT01483599|520126653|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253249|NCT01483599|520126654|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253250|NCT01483599|520126655|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253251|NCT01483599|520126656|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144434090|NCT00218296|520794350|FG001|Overall Study|Withdrawal by Subject|47|||
144434091|NCT00218296|520794349|FG000|Overall Study|Randomized but did not enter treatment|66|||
144434092|NCT00218296|520794350|FG001|Overall Study|Randomized but did not enter treatment|67|||
144434093|NCT01990495|520794368|FG000|Overall Study|Physician Decision|5|||
144434094|NCT01990495|520794369|FG001|Overall Study|Physician Decision|4|||
144434095|NCT03412084|520794370|FG000|Overall Study|Withdrawal by Subject|2|||
144434096|NCT03412084|520794371|FG001|Overall Study|Withdrawal by Subject|0|||
144434097|NCT03412084|520794370|FG000|Overall Study|Participant moved|1|||
144434098|NCT03412084|520794371|FG001|Overall Study|Participant moved|0|||
144434099|NCT03412084|520794370|FG000|Overall Study|Lost to Follow-up|1|||
144434100|NCT03412084|520794371|FG001|Overall Study|Lost to Follow-up|1|||
144434101|NCT01928862|520794372|FG000|Overall Study|Lost to Follow-up|1|||
144434102|NCT01928862|520794373|FG001|Overall Study|Lost to Follow-up|0|||
144434103|NCT01928862|520794374|FG002|Overall Study|Lost to Follow-up|0|||
144434104|NCT01928862|520794375|FG003|Overall Study|Lost to Follow-up|0|||
144434105|NCT01928862|520794376|FG004|Overall Study|Lost to Follow-up|1|||
144434106|NCT02053753|520794384|FG000|Overall Study|Withdrawal by Subject|2|||
144434107|NCT02053753|520794385|FG001|Overall Study|Withdrawal by Subject|4|||
144434108|NCT02053753|520794384|FG000|Overall Study|Decision by Sponsor|1|||
144434109|NCT02053753|520794385|FG001|Overall Study|Decision by Sponsor|1|||
144434110|NCT02053753|520794384|FG000|Overall Study|Lost to Follow-up|4|||
144434111|NCT02053753|520794385|FG001|Overall Study|Lost to Follow-up|3|||
144434112|NCT02972632|520794386|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
144434113|NCT02972632|520794386|FG000|Overall Study|Lost to Follow-up|4|||
144434114|NCT02972632|520794386|FG000|Overall Study|Voluntary Withdrawal|10|||
144434115|NCT02023151|520794387|FG000|Overall Study|Lost to Follow-up|4|||
144434116|NCT04064294|520794388|FG000|Overall Study|Adverse Event|1|||
144434117|NCT04064294|520794389|FG001|Overall Study|Adverse Event|0|||
144434118|NCT04064294|520794390|FG002|Overall Study|Adverse Event|0|||
144434119|NCT03450707|520794391|FG000|Overall Study|Outside enrollment window|4|||
144434120|NCT03450707|520794392|FG001|Overall Study|Outside enrollment window|1|||
144434121|NCT03450707|520794391|FG000|Overall Study|Death|1|||
144434122|NCT03450707|520794392|FG001|Overall Study|Death|0|||
144434123|NCT03450707|520794391|FG000|Overall Study|Indication for thiamine|1|||
144434124|NCT03450707|520794392|FG001|Overall Study|Indication for thiamine|1|||
144434125|NCT03450707|520794391|FG000|Overall Study|Evidence of traumatic brain injury|1|||
144434126|NCT03450707|520794392|FG001|Overall Study|Evidence of traumatic brain injury|0|||
144434127|NCT03450707|520794391|FG000|Overall Study|Following commands|0|||
144434128|NCT03450707|520794392|FG001|Overall Study|Following commands|3|||
144434129|NCT03450707|520794391|FG000|Overall Study|Lactate < 3.5|0|||
144434130|NCT03450707|520794392|FG001|Overall Study|Lactate < 3.5|2|||
144434131|NCT03450707|520794391|FG000|Overall Study|Rearrest with ECMO|0|||
144434132|NCT03450707|520794392|FG001|Overall Study|Rearrest with ECMO|1|||
144604606|NCT02632721|521414377|FG001|Overall Study|Dose limiting toxicity|0|||
144434133|NCT03450707|520794391|FG000|Overall Study|Indication for thiamine + head CT results|0|||
144434134|NCT03450707|520794392|FG001|Overall Study|Indication for thiamine + head CT results|1|||
144434135|NCT03450707|520794391|FG000|Overall Study|Family/patient goals of care|0|||
144434136|NCT03450707|520794392|FG001|Overall Study|Family/patient goals of care|1|||
144434137|NCT01289847|520794393|FG000|Overall Study|Patient could not comply with visits|1|||
144434138|NCT03975647|520794394|FG000|Overall Study|Death|71|||
144434139|NCT03975647|520794395|FG001|Overall Study|Death|63|||
144434140|NCT03975647|520794394|FG000|Overall Study|Lost to Follow-up|2|||
144434141|NCT03975647|520794395|FG001|Overall Study|Lost to Follow-up|2|||
144434142|NCT03975647|520794394|FG000|Overall Study|Subject withdrawal of consent|7|||
144434143|NCT03975647|520794395|FG001|Overall Study|Subject withdrawal of consent|11|||
144434144|NCT01293240|520794396|FG000|Overall Study|Noncompliance|2|||
144434145|NCT05389657|520794400|FG000|Overall Study|Lost to Follow-up|7|||
144434146|NCT05389657|520794401|FG001|Overall Study|Lost to Follow-up|8|||
144434147|NCT03261947|520794402|FG000|Overall Study|Death|10|||
144434148|NCT03261947|520794403|FG001|Overall Study|Death|13|||
144434149|NCT03261947|520794404|FG002|Overall Study|Death|17|||
144434150|NCT03261947|520794405|FG003|Overall Study|Death|12|||
144434151|NCT03261947|520794406|FG004|Overall Study|Death|8|||
144434152|NCT03261947|520794402|FG000|Overall Study|Lost to Follow-up|0|||
144434153|NCT03261947|520794403|FG001|Overall Study|Lost to Follow-up|0|||
144434154|NCT03261947|520794404|FG002|Overall Study|Lost to Follow-up|2|||
144434155|NCT03261947|520794405|FG003|Overall Study|Lost to Follow-up|1|||
144434156|NCT03261947|520794406|FG004|Overall Study|Lost to Follow-up|0|||
144434157|NCT03261947|520794402|FG000|Overall Study|Withdrawal by Subject|0|||
144434158|NCT03261947|520794403|FG001|Overall Study|Withdrawal by Subject|0|||
144434159|NCT03261947|520794404|FG002|Overall Study|Withdrawal by Subject|3|||
144434160|NCT03261947|520794405|FG003|Overall Study|Withdrawal by Subject|0|||
144434161|NCT03261947|520794406|FG004|Overall Study|Withdrawal by Subject|1|||
144434162|NCT03261947|520794402|FG000|Overall Study|Site Terminated by Sponsor|0|||
144434163|NCT03261947|520794403|FG001|Overall Study|Site Terminated by Sponsor|0|||
144434164|NCT03261947|520794404|FG002|Overall Study|Site Terminated by Sponsor|4|||
144434165|NCT03261947|520794405|FG003|Overall Study|Site Terminated by Sponsor|7|||
144434166|NCT03261947|520794406|FG004|Overall Study|Site Terminated by Sponsor|5|||
144434167|NCT03261947|520794402|FG000|Overall Study|Reason not Specified|2|||
144434168|NCT03261947|520794403|FG001|Overall Study|Reason not Specified|0|||
144434169|NCT03261947|520794404|FG002|Overall Study|Reason not Specified|4|||
144434170|NCT03261947|520794405|FG003|Overall Study|Reason not Specified|1|||
144434171|NCT03261947|520794406|FG004|Overall Study|Reason not Specified|3|||
144434172|NCT00228917|520794407|FG000|Overall Study|Migrated/moved from study area|0|||
144434173|NCT00228917|520794408|FG001|Overall Study|Migrated/moved from study area|0|||
144434174|NCT00228917|520794409|FG002|Overall Study|Migrated/moved from study area|0|||
144434175|NCT00228917|520794410|FG003|Overall Study|Migrated/moved from study area|0|||
144434176|NCT00228917|520794411|FG004|Overall Study|Migrated/moved from study area|0|||
144434177|NCT00228917|520794412|FG005|Overall Study|Migrated/moved from study area|2|||
144434178|NCT00228917|520794413|FG006|Overall Study|Migrated/moved from study area|0|||
144434179|NCT00228917|520794414|FG007|Overall Study|Migrated/moved from study area|0|||
144434180|NCT00409617|520794415|FG000|Overall Study|Adverse Event|57|||
144434181|NCT00409617|520794415|FG000|Overall Study|Lack of Efficacy|54|||
144434182|NCT00409617|520794415|FG000|Overall Study|Lost to Follow-up|2|||
144434183|NCT00409617|520794415|FG000|Overall Study|Protocol Violation|24|||
144434184|NCT00409617|520794415|FG000|Overall Study|Withdrawal by Subject|8|||
144434185|NCT00409617|520794415|FG000|Overall Study|Administrative reasons|1|||
144434186|NCT00409617|520794415|FG000|Overall Study|Not described|14|||
144434187|NCT01708174|520794431|FG000|Treatment Period|Withdrawal by Subject|1|||
144434188|NCT01708174|520794432|FG001|Treatment Period|Withdrawal by Subject|0|||
144434189|NCT01708174|520794433|FG002|Treatment Period|Withdrawal by Subject|0|||
144434190|NCT01708174|520794431|FG000|Treatment Period|Progressive disease|0|||
144434191|NCT01708174|520794432|FG001|Treatment Period|Progressive disease|1|||
144434192|NCT01708174|520794433|FG002|Treatment Period|Progressive disease|0|||
144434193|NCT01708174|520794431|FG000|Treatment Period|Death|0|||
144434194|NCT01708174|520794432|FG001|Treatment Period|Death|0|||
144434195|NCT01708174|520794433|FG002|Treatment Period|Death|1|||
144434196|NCT01708174|520794431|FG000|Treatment Period|Adverse Event|0|||
144434197|NCT01708174|520794432|FG001|Treatment Period|Adverse Event|1|||
144434198|NCT01708174|520794433|FG002|Treatment Period|Adverse Event|0|||
144434199|NCT01062555|520794435|FG000|Phase 1|Death|10|||
144434200|NCT01062555|520794436|FG001|Phase 1|Death|17|||
144434201|NCT01062555|520794437|FG002|Phase 1|Death|0|||
144434202|NCT01062555|520794438|FG003|Phase 1|Death|0|||
144434203|NCT01062555|520794435|FG000|Phase 1|Graft Failure|12|||
144434204|NCT01062555|520794436|FG001|Phase 1|Graft Failure|8|||
144434205|NCT01062555|520794437|FG002|Phase 1|Graft Failure|0|||
144434206|NCT01062555|520794438|FG003|Phase 1|Graft Failure|0|||
144434207|NCT01062555|520794435|FG000|Phase 1|Withdrawal by Subject|1|||
144434208|NCT01062555|520794436|FG001|Phase 1|Withdrawal by Subject|1|||
144434209|NCT01062555|520794437|FG002|Phase 1|Withdrawal by Subject|0|||
144434210|NCT01062555|520794438|FG003|Phase 1|Withdrawal by Subject|0|||
144434211|NCT01062555|520794435|FG000|Phase 2|Death|0|||
144434212|NCT01062555|520794436|FG001|Phase 2|Death|0|||
144434213|NCT01062555|520794437|FG002|Phase 2|Death|8|||
144434214|NCT01062555|520794438|FG003|Phase 2|Death|3|||
144434215|NCT01062555|520794435|FG000|Phase 2|Graft failure|0|||
144434216|NCT01062555|520794436|FG001|Phase 2|Graft failure|0|||
144434217|NCT01062555|520794437|FG002|Phase 2|Graft failure|7|||
144434218|NCT01062555|520794438|FG003|Phase 2|Graft failure|4|||
144434219|NCT01062555|520794435|FG000|Phase 2|Withdrawal by Subject|0|||
144434220|NCT01062555|520794436|FG001|Phase 2|Withdrawal by Subject|0|||
144434221|NCT01062555|520794437|FG002|Phase 2|Withdrawal by Subject|0|||
144434222|NCT01062555|520794438|FG003|Phase 2|Withdrawal by Subject|7|||
144434223|NCT01062555|520794435|FG000|Phase 2|Protocol Violation|0|||
144434224|NCT01062555|520794436|FG001|Phase 2|Protocol Violation|0|||
144434225|NCT01062555|520794437|FG002|Phase 2|Protocol Violation|0|||
144434226|NCT01062555|520794438|FG003|Phase 2|Protocol Violation|3|||
144434227|NCT01062555|520794435|FG000|Phase 2|Physician Decision|0|||
144434228|NCT01062555|520794436|FG001|Phase 2|Physician Decision|0|||
144434229|NCT01062555|520794437|FG002|Phase 2|Physician Decision|0|||
144434230|NCT01062555|520794438|FG003|Phase 2|Physician Decision|17|||
144434231|NCT03560531|520794439|FG000|Overall Study|Death|4|||
144434232|NCT03560531|520794440|FG001|Overall Study|Death|1|||
144434233|NCT03560531|520794441|FG002|Overall Study|Death|1|||
144434234|NCT03560531|520794442|FG003|Overall Study|Death|2|||
144434235|NCT03560531|520794443|FG004|Overall Study|Death|6|||
144434236|NCT03560531|520794444|FG005|Overall Study|Death|1|||
144434237|NCT03560531|520794445|FG006|Overall Study|Death|4|||
144604607|NCT02632721|521414378|FG002|Overall Study|Dose limiting toxicity|0|||
144604608|NCT02632721|521414379|FG003|Overall Study|Dose limiting toxicity|1|||
144604609|NCT02632721|521414380|FG004|Overall Study|Dose limiting toxicity|0|||
144434238|NCT03560531|520794446|FG007|Overall Study|Death|8|||
144434239|NCT03560531|520794447|FG008|Overall Study|Death|1|||
144434240|NCT03560531|520794448|FG009|Overall Study|Death|3|||
144434241|NCT03560531|520794449|FG010|Overall Study|Death|2|||
144434242|NCT03560531|520794450|FG011|Overall Study|Death|0|||
144434243|NCT03560531|520794451|FG012|Overall Study|Death|4|||
144434244|NCT03560531|520794452|FG013|Overall Study|Death|1|||
144434245|NCT03560531|520794439|FG000|Overall Study|Lost to Follow-up|1|||
144434246|NCT03560531|520794440|FG001|Overall Study|Lost to Follow-up|1|||
144434247|NCT03560531|520794441|FG002|Overall Study|Lost to Follow-up|0|||
144434248|NCT03560531|520794442|FG003|Overall Study|Lost to Follow-up|0|||
144434249|NCT03560531|520794443|FG004|Overall Study|Lost to Follow-up|0|||
144434250|NCT03560531|520794444|FG005|Overall Study|Lost to Follow-up|0|||
144434251|NCT03560531|520794445|FG006|Overall Study|Lost to Follow-up|1|||
144434252|NCT03560531|520794446|FG007|Overall Study|Lost to Follow-up|0|||
144434253|NCT03560531|520794447|FG008|Overall Study|Lost to Follow-up|0|||
144434254|NCT03560531|520794448|FG009|Overall Study|Lost to Follow-up|0|||
144434255|NCT03560531|520794449|FG010|Overall Study|Lost to Follow-up|0|||
144434256|NCT03560531|520794450|FG011|Overall Study|Lost to Follow-up|0|||
144434257|NCT03560531|520794451|FG012|Overall Study|Lost to Follow-up|0|||
144434258|NCT03560531|520794452|FG013|Overall Study|Lost to Follow-up|0|||
144434259|NCT03560531|520794439|FG000|Overall Study|Withdrawal by Subject|1|||
144434260|NCT03560531|520794440|FG001|Overall Study|Withdrawal by Subject|0|||
144434261|NCT03560531|520794441|FG002|Overall Study|Withdrawal by Subject|0|||
144434262|NCT03560531|520794442|FG003|Overall Study|Withdrawal by Subject|0|||
144434263|NCT03560531|520794443|FG004|Overall Study|Withdrawal by Subject|0|||
144434264|NCT03560531|520794444|FG005|Overall Study|Withdrawal by Subject|0|||
144434265|NCT03560531|520794445|FG006|Overall Study|Withdrawal by Subject|0|||
144434266|NCT03560531|520794446|FG007|Overall Study|Withdrawal by Subject|3|||
144434267|NCT03560531|520794447|FG008|Overall Study|Withdrawal by Subject|2|||
144434268|NCT03560531|520794448|FG009|Overall Study|Withdrawal by Subject|0|||
144434269|NCT03560531|520794449|FG010|Overall Study|Withdrawal by Subject|0|||
144434270|NCT03560531|520794450|FG011|Overall Study|Withdrawal by Subject|0|||
144434271|NCT03560531|520794451|FG012|Overall Study|Withdrawal by Subject|2|||
144434272|NCT03560531|520794452|FG013|Overall Study|Withdrawal by Subject|0|||
144434273|NCT03560531|520794439|FG000|Overall Study|Study end per-protocol|1|||
144434274|NCT03560531|520794440|FG001|Overall Study|Study end per-protocol|1|||
144434275|NCT03560531|520794441|FG002|Overall Study|Study end per-protocol|2|||
144434276|NCT03560531|520794442|FG003|Overall Study|Study end per-protocol|0|||
144434277|NCT03560531|520794443|FG004|Overall Study|Study end per-protocol|1|||
144434278|NCT03560531|520794444|FG005|Overall Study|Study end per-protocol|0|||
144604610|NCT02632721|521414376|FG000|Overall Study|Progressive disease|3|||
144187735|NCT03635983|519881253|FG001|Treatment Period|Withdrawal by Subject|5|||
144604611|NCT02632721|521414377|FG001|Overall Study|Progressive disease|0|||
144187736|NCT03635983|519881252|FG000|Treatment Period|Death|3|||
144434279|NCT03560531|520794445|FG006|Overall Study|Study end per-protocol|0|||
144434280|NCT03560531|520794446|FG007|Overall Study|Study end per-protocol|0|||
144434281|NCT03560531|520794447|FG008|Overall Study|Study end per-protocol|0|||
144434282|NCT03560531|520794448|FG009|Overall Study|Study end per-protocol|0|||
144434283|NCT03560531|520794449|FG010|Overall Study|Study end per-protocol|0|||
144434284|NCT03560531|520794450|FG011|Overall Study|Study end per-protocol|0|||
144434285|NCT03560531|520794451|FG012|Overall Study|Study end per-protocol|0|||
144434286|NCT03560531|520794452|FG013|Overall Study|Study end per-protocol|0|||
144434287|NCT03560531|520794439|FG000|Overall Study|Early study termination by sponsor|9|||
144434288|NCT03560531|520794440|FG001|Overall Study|Early study termination by sponsor|0|||
144434289|NCT03560531|520794441|FG002|Overall Study|Early study termination by sponsor|0|||
144434290|NCT03560531|520794442|FG003|Overall Study|Early study termination by sponsor|4|||
144434291|NCT03560531|520794443|FG004|Overall Study|Early study termination by sponsor|8|||
144187737|NCT03635983|519881253|FG001|Treatment Period|Death|5|||
144187738|NCT03635983|519881252|FG000|Treatment Period|Poor/Non-compliance|2|||
144187739|NCT03635983|519881253|FG001|Treatment Period|Poor/Non-compliance|1|||
144434292|NCT03560531|520794444|FG005|Overall Study|Early study termination by sponsor|2|||
144434293|NCT03560531|520794445|FG006|Overall Study|Early study termination by sponsor|5|||
144434294|NCT03560531|520794446|FG007|Overall Study|Early study termination by sponsor|64|||
144434295|NCT03560531|520794447|FG008|Overall Study|Early study termination by sponsor|7|||
144434296|NCT03560531|520794448|FG009|Overall Study|Early study termination by sponsor|2|||
144434297|NCT03560531|520794449|FG010|Overall Study|Early study termination by sponsor|16|||
144434298|NCT03560531|520794450|FG011|Overall Study|Early study termination by sponsor|2|||
144434299|NCT03560531|520794451|FG012|Overall Study|Early study termination by sponsor|6|||
144434300|NCT03560531|520794452|FG013|Overall Study|Early study termination by sponsor|2|||
144434301|NCT01471379|520794453|FG000|Overall Study|Adverse Event|1|||
144434302|NCT01471379|520794454|FG001|Overall Study|Adverse Event|0|||
144434303|NCT01471379|520794455|FG002|Overall Study|Adverse Event|0|||
144434304|NCT01471379|520794453|FG000|Overall Study|Study terminated|0|||
144434305|NCT01471379|520794454|FG001|Overall Study|Study terminated|1|||
144434306|NCT01471379|520794455|FG002|Overall Study|Study terminated|0|||
144434307|NCT02028988|520794456|FG000|Overall Study|Withdrawal by Subject|2|||
144434308|NCT01063595|520794457|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
144434309|NCT01063595|520794458|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
144434310|NCT01063595|520794457|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
144434311|NCT01063595|520794458|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
144434312|NCT01063595|520794457|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
144434313|NCT01063595|520794458|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
144434314|NCT01063595|520794457|FG000|First Intervention|Adverse Event|1|||
144434315|NCT01063595|520794458|FG001|First Intervention|Adverse Event|4|||
144434316|NCT01063595|520794457|FG000|First Intervention|Withdrawal by Subject|1|||
144434317|NCT01063595|520794458|FG001|First Intervention|Withdrawal by Subject|0|||
144434318|NCT01063595|520794457|FG000|First Intervention|Reason not Specified|0|||
144434319|NCT01063595|520794458|FG001|First Intervention|Reason not Specified|1|||
144434320|NCT00747435|520794459|FG000|Overall Study|Lost to Follow-up|2|||
144434321|NCT00747435|520794459|FG000|Overall Study|Withdrawal by Subject|3|||
144434322|NCT00747435|520794459|FG000|Overall Study|Still undergoing follow up|1|||
144434323|NCT01933048|520796097|FG000|Overall Study|Lost to Follow-up|15|||
144434324|NCT01933048|520796098|FG001|Overall Study|Lost to Follow-up|18|||
144434325|NCT01933048|520796097|FG000|Overall Study|personal reasons|1|||
144434326|NCT01933048|520796098|FG001|Overall Study|personal reasons|1|||
144434327|NCT01933048|520796097|FG000|Overall Study|Protocol Violation|7|||
144434328|NCT01933048|520796098|FG001|Overall Study|Protocol Violation|8|||
144434329|NCT01933048|520796097|FG000|Overall Study|Physician Decision|1|||
144434330|NCT01933048|520796098|FG001|Overall Study|Physician Decision|0|||
144434331|NCT01933048|520796097|FG000|Overall Study|unknown reasons|1|||
144434332|NCT01933048|520796098|FG001|Overall Study|unknown reasons|1|||
144434333|NCT02476968|520796099|FG000|Overall Study|Other|0|||
144434334|NCT02476968|520796100|FG001|Overall Study|Other|2|||
144434335|NCT02476968|520796101|FG002|Overall Study|Other|0|||
144434336|NCT02476968|520796099|FG000|Overall Study|Lost to Follow-up|10|||
144434337|NCT02476968|520796100|FG001|Overall Study|Lost to Follow-up|0|||
144434338|NCT02476968|520796101|FG002|Overall Study|Lost to Follow-up|1|||
144434339|NCT02476968|520796099|FG000|Overall Study|Death|48|||
144434340|NCT02476968|520796100|FG001|Overall Study|Death|8|||
144434341|NCT02476968|520796101|FG002|Overall Study|Death|1|||
144434342|NCT02476968|520796099|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144434343|NCT02476968|520796100|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144434344|NCT02476968|520796101|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
144434345|NCT02476968|520796099|FG000|Overall Study|Patient decision|37|||
144434346|NCT02476968|520796100|FG001|Overall Study|Patient decision|8|||
144434347|NCT02476968|520796101|FG002|Overall Study|Patient decision|0|||
144434348|NCT01859507|520796102|FG000|Overall Study|left the country|4|||
144434349|NCT04476030|520796103|FG000|Overall Study|Withdrawal by Subject|20|||
144187740|NCT03635983|519881252|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
144434350|NCT04476030|520796104|FG001|Overall Study|Withdrawal by Subject|16|||
144434351|NCT04476030|520796103|FG000|Overall Study|Adverse Event|10|||
144434352|NCT04476030|520796104|FG001|Overall Study|Adverse Event|11|||
144434353|NCT04476030|520796103|FG000|Overall Study|Lost to Follow-up|7|||
144434354|NCT04476030|520796104|FG001|Overall Study|Lost to Follow-up|4|||
144434355|NCT04476030|520796103|FG000|Overall Study|Physician Decision|1|||
144434356|NCT04476030|520796104|FG001|Overall Study|Physician Decision|1|||
144434357|NCT04476030|520796103|FG000|Overall Study|Protocol Deviation|2|||
144434358|NCT04476030|520796104|FG001|Overall Study|Protocol Deviation|0|||
144434359|NCT04476030|520796103|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
144434360|NCT04476030|520796104|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
144434361|NCT04476030|520796103|FG000|Overall Study|Randomized but not Dosed|2|||
144434362|NCT04476030|520796104|FG001|Overall Study|Randomized but not Dosed|8|||
144434363|NCT02404311|520796105|FG000|Part A: Month 0-18|Death|2|||
144434364|NCT02404311|520796106|FG001|Part A: Month 0-18|Death|0|||
144434365|NCT02404311|520796107|FG002|Part A: Month 0-18|Death|0|||
144434366|NCT02404311|520796108|FG003|Part A: Month 0-18|Death|0|||
144434367|NCT02404311|520796109|FG004|Part A: Month 0-18|Death|0|||
144434368|NCT02404311|520796105|FG000|Part A: Month 0-18|Physician Decision|1|||
144434369|NCT02404311|520796106|FG001|Part A: Month 0-18|Physician Decision|0|||
144434370|NCT02404311|520796107|FG002|Part A: Month 0-18|Physician Decision|0|||
144434371|NCT02404311|520796108|FG003|Part A: Month 0-18|Physician Decision|0|||
144434372|NCT02404311|520796109|FG004|Part A: Month 0-18|Physician Decision|0|||
144434373|NCT02404311|520796105|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
144434374|NCT02404311|520796106|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
144434375|NCT02404311|520796107|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
144434376|NCT02404311|520796108|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
144434377|NCT02404311|520796109|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
144434378|NCT02404311|520796105|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
144434379|NCT02404311|520796106|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
144434380|NCT02404311|520796107|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
144434381|NCT02404311|520796108|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
144434382|NCT02404311|520796109|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
144187741|NCT03635983|519881253|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
144187742|NCT03635983|519881252|FG000|Treatment Period|Other reasons|7|||
144434383|NCT02404311|520796105|FG000|Part A: Month 0-18|HIV Infection|6|||
144434384|NCT02404311|520796106|FG001|Part A: Month 0-18|HIV Infection|2|||
144434385|NCT02404311|520796107|FG002|Part A: Month 0-18|HIV Infection|0|||
144434386|NCT02404311|520796108|FG003|Part A: Month 0-18|HIV Infection|0|||
144434387|NCT02404311|520796109|FG004|Part A: Month 0-18|HIV Infection|0|||
144434388|NCT02404311|520796105|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
144434389|NCT02404311|520796106|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
144434390|NCT02404311|520796107|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
144434391|NCT02404311|520796108|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
144434392|NCT02404311|520796109|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
144434393|NCT04171414|520796120|FG000|Overall Study|Death|1|||
144434394|NCT04171414|520796120|FG000|Overall Study|Withdrawal by Subject|1|||
144434395|NCT00481195|520796121|FG000|Overall Study|Adverse Event|16|||
144434396|NCT00481195|520796122|FG001|Overall Study|Adverse Event|11|||
144434397|NCT00481195|520796121|FG000|Overall Study|Lack of Efficacy|1|||
144434398|NCT00481195|520796122|FG001|Overall Study|Lack of Efficacy|3|||
144434399|NCT00481195|520796121|FG000|Overall Study|Lost to Follow-up|4|||
144434400|NCT00481195|520796122|FG001|Overall Study|Lost to Follow-up|6|||
144434401|NCT00481195|520796121|FG000|Overall Study|Physician Decision|3|||
144434402|NCT00481195|520796122|FG001|Overall Study|Physician Decision|1|||
144434403|NCT00481195|520796121|FG000|Overall Study|Protocol Violation|10|||
144434404|NCT00481195|520796122|FG001|Overall Study|Protocol Violation|7|||
144434405|NCT00481195|520796121|FG000|Overall Study|Withdrawal by Subject|3|||
144434406|NCT00481195|520796122|FG001|Overall Study|Withdrawal by Subject|9|||
144434407|NCT00481195|520796121|FG000|Overall Study|Miscellaneous|2|||
144434408|NCT00481195|520796122|FG001|Overall Study|Miscellaneous|2|||
144434409|NCT02932904|520796129|FG000|Overall Study|Reason not Specified|1|||
144434410|NCT02932904|520796130|FG001|Overall Study|Reason not Specified|0|||
144434411|NCT02932904|520796131|FG002|Overall Study|Reason not Specified|2|||
144434412|NCT02932904|520796132|FG003|Overall Study|Reason not Specified|2|||
144434413|NCT02932904|520796129|FG000|Overall Study|Noncompliance with Study Drug|2|||
144529891|NCT04141891|521142979|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
144187743|NCT03635983|519881253|FG001|Treatment Period|Other reasons|4|||
144187744|NCT03635983|519881252|FG000|Treatment Period|Disease progression|230|||
144187745|NCT03635983|519881253|FG001|Treatment Period|Disease progression|201|||
144187746|NCT03635983|519881252|FG000|Treatment Period|Study drug toxicity|35|||
144187747|NCT03635983|519881253|FG001|Treatment Period|Study drug toxicity|36|||
144187748|NCT03635983|519881252|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
144187749|NCT03635983|519881253|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
144187750|NCT03635983|519881252|FG000|Treatment Period|Maximum clinical benefit|3|||
144187751|NCT03635983|519881253|FG001|Treatment Period|Maximum clinical benefit|5|||
144187752|NCT03635983|519881252|FG000|Treatment Period|Administrative reason by the sponsor|1|||
144187753|NCT03635983|519881253|FG001|Treatment Period|Administrative reason by the sponsor|2|||
144434414|NCT02932904|520796130|FG001|Overall Study|Noncompliance with Study Drug|3|||
144434415|NCT02932904|520796131|FG002|Overall Study|Noncompliance with Study Drug|3|||
144434416|NCT02932904|520796132|FG003|Overall Study|Noncompliance with Study Drug|4|||
144434417|NCT02932904|520796129|FG000|Overall Study|Pregnancy|0|||
144434418|NCT02932904|520796130|FG001|Overall Study|Pregnancy|1|||
144434419|NCT02932904|520796131|FG002|Overall Study|Pregnancy|1|||
144434420|NCT02932904|520796132|FG003|Overall Study|Pregnancy|0|||
144434421|NCT02932904|520796129|FG000|Overall Study|Study Termination|0|||
144434422|NCT02932904|520796130|FG001|Overall Study|Study Termination|1|||
144434423|NCT02932904|520796131|FG002|Overall Study|Study Termination|0|||
144434424|NCT02932904|520796132|FG003|Overall Study|Study Termination|0|||
144434425|NCT02932904|520796129|FG000|Overall Study|Voluntary Withdrawal|2|||
144434426|NCT02932904|520796130|FG001|Overall Study|Voluntary Withdrawal|1|||
144604612|NCT02632721|521414378|FG002|Overall Study|Progressive disease|4|||
144604613|NCT02632721|521414379|FG003|Overall Study|Progressive disease|6|||
144604614|NCT02632721|521414380|FG004|Overall Study|Progressive disease|5|||
144604615|NCT02632721|521414376|FG000|Overall Study|Refused to continue taking trial medication|0|||
144604616|NCT02632721|521414377|FG001|Overall Study|Refused to continue taking trial medication|1|||
144604617|NCT02632721|521414378|FG002|Overall Study|Refused to continue taking trial medication|1|||
144604618|NCT02632721|521414379|FG003|Overall Study|Refused to continue taking trial medication|1|||
144604619|NCT02632721|521414380|FG004|Overall Study|Refused to continue taking trial medication|2|||
144604620|NCT02632721|521414376|FG000|Overall Study|Inadequate clinical condition|0|||
144434427|NCT02932904|520796131|FG002|Overall Study|Voluntary Withdrawal|4|||
144434428|NCT02932904|520796132|FG003|Overall Study|Voluntary Withdrawal|2|||
144434429|NCT02932904|520796129|FG000|Overall Study|Lost to Follow-up|5|||
144434430|NCT02932904|520796130|FG001|Overall Study|Lost to Follow-up|3|||
144434431|NCT02932904|520796131|FG002|Overall Study|Lost to Follow-up|6|||
144434432|NCT02932904|520796132|FG003|Overall Study|Lost to Follow-up|0|||
144434433|NCT02932904|520796129|FG000|Overall Study|Significant Protocol Deviation|2|||
144434434|NCT02932904|520796130|FG001|Overall Study|Significant Protocol Deviation|3|||
144434435|NCT02932904|520796131|FG002|Overall Study|Significant Protocol Deviation|6|||
144434436|NCT02932904|520796132|FG003|Overall Study|Significant Protocol Deviation|1|||
144434437|NCT02932904|520796129|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
144434438|NCT02932904|520796130|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
144434439|NCT02932904|520796131|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
144434440|NCT02932904|520796132|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
144434441|NCT02932904|520796129|FG000|Overall Study|Randomized But Not Treated|1|||
144434442|NCT02932904|520796130|FG001|Overall Study|Randomized But Not Treated|1|||
144434443|NCT02932904|520796131|FG002|Overall Study|Randomized But Not Treated|0|||
144434444|NCT02932904|520796132|FG003|Overall Study|Randomized But Not Treated|2|||
144434445|NCT00337103|520796136|FG000|Overall Study|Progressive Disease|414|||
144434446|NCT00337103|520796137|FG001|Overall Study|Progressive Disease|410|||
144434447|NCT00337103|520796136|FG000|Overall Study|Adverse Event|45|||
144434448|NCT00337103|520796137|FG001|Overall Study|Adverse Event|59|||
144529892|NCT04141891|521142980|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
144529893|NCT04141891|521142979|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
144529894|NCT04141891|521142980|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
144529895|NCT04141891|521142979|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
144529896|NCT04141891|521142980|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
144529897|NCT04141891|521142979|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
144529898|NCT04141891|521142980|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
144529899|NCT04141891|521142979|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
144529900|NCT04141891|521142980|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
144529901|NCT04141891|521142979|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
144529902|NCT04141891|521142980|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
144604621|NCT02632721|521414377|FG001|Overall Study|Inadequate clinical condition|0|||
144604622|NCT02632721|521414378|FG002|Overall Study|Inadequate clinical condition|0|||
144604623|NCT02632721|521414379|FG003|Overall Study|Inadequate clinical condition|0|||
144604624|NCT02632721|521414380|FG004|Overall Study|Inadequate clinical condition|1|||
144604625|NCT02632721|521414376|FG000|Overall Study|No meet eligibility|0|||
144604626|NCT02632721|521414377|FG001|Overall Study|No meet eligibility|0|||
144604627|NCT02632721|521414378|FG002|Overall Study|No meet eligibility|0|||
144604628|NCT02632721|521414379|FG003|Overall Study|No meet eligibility|0|||
144604629|NCT02632721|521414380|FG004|Overall Study|No meet eligibility|1|||
144604630|NCT02632721|521414376|FG000|Overall Study|Allergic reaction|0|||
144604631|NCT02632721|521414377|FG001|Overall Study|Allergic reaction|0|||
144604632|NCT02632721|521414378|FG002|Overall Study|Allergic reaction|0|||
144604633|NCT02632721|521414379|FG003|Overall Study|Allergic reaction|1|||
144187754|NCT03635983|519881252|FG000|Treatment Period|Lost to Follow-up|0|||
144187755|NCT03635983|519881253|FG001|Treatment Period|Lost to Follow-up|1|||
144187756|NCT02941523|519881261|FG000|Monotherapy|Withdrawal by Subject|0|||
144187757|NCT02941523|519881262|FG001|Monotherapy|Withdrawal by Subject|1|||
144187758|NCT02941523|519881261|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
144434449|NCT00337103|520796136|FG000|Overall Study|Subject Choice|34|||
144434450|NCT00337103|520796137|FG001|Overall Study|Subject Choice|27|||
144529903|NCT04141891|521142979|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
144529904|NCT04141891|521142980|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
144604634|NCT02632721|521414380|FG004|Overall Study|Allergic reaction|0|||
144604635|NCT02632721|521414376|FG000|Overall Study|Receiving Decitabine locally|0|||
144604636|NCT02632721|521414377|FG001|Overall Study|Receiving Decitabine locally|0|||
144187759|NCT02941523|519881262|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
144187760|NCT02941523|519881261|FG000|Carboplatin Combination Therapy|Death|1|||
144434451|NCT00337103|520796136|FG000|Overall Study|Clinical Progression|27|||
144434452|NCT00337103|520796137|FG001|Overall Study|Clinical Progression|24|||
144434453|NCT00337103|520796136|FG000|Overall Study|Physician Decision|15|||
144434454|NCT00337103|520796137|FG001|Overall Study|Physician Decision|14|||
144434455|NCT00337103|520796136|FG000|Overall Study|Withdrawal by Subject|8|||
144604637|NCT02632721|521414378|FG002|Overall Study|Receiving Decitabine locally|1|||
144604638|NCT02632721|521414379|FG003|Overall Study|Receiving Decitabine locally|0|||
144604639|NCT02632721|521414380|FG004|Overall Study|Receiving Decitabine locally|0|||
144604640|NCT02632721|521414376|FG000|Overall Study|No benefit from study treatment|1|||
144604641|NCT02632721|521414377|FG001|Overall Study|No benefit from study treatment|1|||
144604642|NCT02632721|521414378|FG002|Overall Study|No benefit from study treatment|0|||
144604643|NCT02632721|521414379|FG003|Overall Study|No benefit from study treatment|0|||
144604644|NCT02632721|521414380|FG004|Overall Study|No benefit from study treatment|1|||
144434456|NCT00337103|520796137|FG001|Overall Study|Withdrawal by Subject|5|||
144434457|NCT00337103|520796136|FG000|Overall Study|Other|5|||
144434458|NCT00337103|520796137|FG001|Overall Study|Other|6|||
144434459|NCT00337103|520796136|FG000|Overall Study|Entry Criteria Not Met|4|||
144434460|NCT00337103|520796137|FG001|Overall Study|Entry Criteria Not Met|1|||
144434461|NCT00337103|520796136|FG000|Overall Study|Lost to Follow-up|1|||
144434462|NCT00337103|520796137|FG001|Overall Study|Lost to Follow-up|2|||
144434463|NCT00337103|520796136|FG000|Overall Study|Death|1|||
144434464|NCT00337103|520796137|FG001|Overall Study|Death|0|||
144434465|NCT02016482|520796138|FG000|Period A|Adverse Event|3|||
144434466|NCT02016482|520796139|FG001|Period A|Adverse Event|5|||
144434467|NCT02016482|520796138|FG000|Period A|Withdrawal by Subject|3|||
144434468|NCT02016482|520796139|FG001|Period A|Withdrawal by Subject|4|||
144434469|NCT02016482|520796138|FG000|Period A|Lost to Follow-up|3|||
144434470|NCT02016482|520796139|FG001|Period A|Lost to Follow-up|3|||
144434471|NCT02016482|520796138|FG000|Period A|Lack of Efficacy|2|||
144434472|NCT02016482|520796139|FG001|Period A|Lack of Efficacy|1|||
144434473|NCT02016482|520796138|FG000|Period A|Other|3|||
144434474|NCT02016482|520796139|FG001|Period A|Other|0|||
144434475|NCT02016482|520796138|FG000|Period A|Protocol Violation|0|||
144434476|NCT02016482|520796139|FG001|Period A|Protocol Violation|1|||
144434477|NCT02016482|520796138|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
144434478|NCT02016482|520796139|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
144434479|NCT02016482|520796138|FG000|Period B|Withdrawal by Subject|1|||
144434480|NCT02016482|520796139|FG001|Period B|Withdrawal by Subject|1|||
144434481|NCT02016482|520796138|FG000|Period B|Lost to Follow-up|2|||
144434482|NCT02016482|520796139|FG001|Period B|Lost to Follow-up|0|||
144434483|NCT02016482|520796138|FG000|Period B|Lack of Efficacy|6|||
144434484|NCT02016482|520796139|FG001|Period B|Lack of Efficacy|4|||
144434485|NCT02016482|520796138|FG000|Period B|Other|4|||
144434486|NCT02016482|520796139|FG001|Period B|Other|0|||
144434487|NCT02016482|520796138|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
144434488|NCT02016482|520796139|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
144434489|NCT02871739|520796158|FG000|Overall Study|Lost to Follow-up|3|||
144434490|NCT02871739|520796159|FG001|Overall Study|Lost to Follow-up|2|||
144434491|NCT02871739|520796160|FG002|Overall Study|Lost to Follow-up|0|||
144434492|NCT02871739|520796161|FG003|Overall Study|Lost to Follow-up|2|||
144434493|NCT03818516|520796162|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
144434494|NCT04372602|520796163|FG000|Overall Study|Withdrawal by Subject|1|||
144434495|NCT04372602|520796164|FG001|Overall Study|Withdrawal by Subject|1|||
144434496|NCT04372602|520796163|FG000|Overall Study|Adverse Event|0|||
144434497|NCT04372602|520796164|FG001|Overall Study|Adverse Event|1|||
144434498|NCT04372602|520796163|FG000|Overall Study|Transitioned to comfort care|0|||
144434499|NCT04372602|520796164|FG001|Overall Study|Transitioned to comfort care|1|||
144434500|NCT00594464|520796165|FG000|Overall Study|Withdrawal by Subject|1|||
144434501|NCT00594464|520796165|FG000|Overall Study|Delay in operation|2|||
144434502|NCT02907359|520796166|FG000|Overall Study|Death|234|||
144434503|NCT02907359|520796167|FG001|Overall Study|Death|117|||
144434504|NCT02907359|520796166|FG000|Overall Study|Withdrawal by Subject|6|||
144434505|NCT02907359|520796167|FG001|Overall Study|Withdrawal by Subject|11|||
144434506|NCT02907359|520796166|FG000|Overall Study|Lost to Follow-up|1|||
144434507|NCT02907359|520796167|FG001|Overall Study|Lost to Follow-up|0|||
144434508|NCT01085097|520796168|FG000|Overall Study|Adverse Event|0|||
144434509|NCT01085097|520796169|FG001|Overall Study|Adverse Event|0|||
144434510|NCT01085097|520796170|FG002|Overall Study|Adverse Event|2|||
144434511|NCT01085097|520796168|FG000|Overall Study|Treatment failure|2|||
144434512|NCT01085097|520796169|FG001|Overall Study|Treatment failure|0|||
144434513|NCT01085097|520796170|FG002|Overall Study|Treatment failure|0|||
144434514|NCT06049043|520796179|FG000|Overall Study|Lost to Follow-up|11|||
144434515|NCT06049043|520796180|FG001|Overall Study|Lost to Follow-up|9|||
144434516|NCT02739269|520796187|FG000|Overall Study|Protocol Violation|5|||
144434517|NCT02739269|520796188|FG001|Overall Study|Protocol Violation|0|||
144434518|NCT02739269|520796187|FG000|Overall Study|Cycle cancellation|2|||
144434519|NCT02739269|520796188|FG001|Overall Study|Cycle cancellation|2|||
144434520|NCT02739269|520796187|FG000|Overall Study|Withdrawal by Subject|0|||
144434521|NCT02739269|520796188|FG001|Overall Study|Withdrawal by Subject|2|||
144434522|NCT01354496|520796189|FG000|Period 1|Adverse Event|0|||
144434523|NCT01354496|520796190|FG001|Period 1|Adverse Event|0|||
144434524|NCT01354496|520796191|FG002|Period 1|Adverse Event|1|||
144434525|NCT01354496|520796192|FG003|Period 1|Adverse Event|0|||
144434526|NCT01354496|520796193|FG004|Period 1|Adverse Event|0|||
144434527|NCT01354496|520796194|FG005|Period 1|Adverse Event|0|||
144187761|NCT02941523|519881262|FG001|Carboplatin Combination Therapy|Death|2|||
144187762|NCT02941523|519881261|FG000|Carboplatin Combination Therapy|Disease progression|2|||
144187763|NCT02941523|519881262|FG001|Carboplatin Combination Therapy|Disease progression|0|||
144187764|NCT02941523|519881261|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
144187765|NCT02941523|519881262|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
144187766|NCT02539368|519881263|FG000|Overall Study|Death|4|||
144434528|NCT01354496|520796189|FG000|Period 1|Physician Decision|0|||
144434529|NCT01354496|520796190|FG001|Period 1|Physician Decision|0|||
144434530|NCT01354496|520796191|FG002|Period 1|Physician Decision|1|||
144434531|NCT01354496|520796192|FG003|Period 1|Physician Decision|0|||
144434532|NCT01354496|520796193|FG004|Period 1|Physician Decision|0|||
144434533|NCT01354496|520796194|FG005|Period 1|Physician Decision|0|||
144434534|NCT01354496|520796189|FG000|Period 2|Adverse Event|0|||
144434535|NCT01354496|520796190|FG001|Period 2|Adverse Event|0|||
144434536|NCT01354496|520796191|FG002|Period 2|Adverse Event|0|||
144434537|NCT01354496|520796192|FG003|Period 2|Adverse Event|1|||
144434538|NCT01354496|520796193|FG004|Period 2|Adverse Event|0|||
144434539|NCT01354496|520796194|FG005|Period 2|Adverse Event|0|||
144434540|NCT01354496|520796189|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
144434541|NCT01354496|520796190|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
144434542|NCT01354496|520796191|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
144434543|NCT01354496|520796192|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
144434544|NCT01354496|520796193|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
144434545|NCT01354496|520796194|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
144434546|NCT01524692|520796197|FG000|Overall Study|Withdrawal by Subject|3|||
144434547|NCT03190889|520796198|FG000|Overall Study|Lost to Follow-up|7|||
144434548|NCT03190889|520796199|FG001|Overall Study|Lost to Follow-up|7|||
144187767|NCT02539368|519881264|FG001|Overall Study|Death|2|||
144434549|NCT03190889|520796200|FG002|Overall Study|Lost to Follow-up|3|||
144434550|NCT03190889|520796198|FG000|Overall Study|Withdrawal by Subject|1|||
144434551|NCT03190889|520796199|FG001|Overall Study|Withdrawal by Subject|1|||
144434552|NCT03190889|520796200|FG002|Overall Study|Withdrawal by Subject|2|||
144434553|NCT03190889|520796198|FG000|Overall Study|Did not complete protocol|4|||
144434554|NCT03190889|520796199|FG001|Overall Study|Did not complete protocol|9|||
144434555|NCT03190889|520796200|FG002|Overall Study|Did not complete protocol|0|||
144434556|NCT03190889|520796198|FG000|Overall Study|COVID-19|1|||
144434557|NCT03190889|520796199|FG001|Overall Study|COVID-19|0|||
144434558|NCT03190889|520796200|FG002|Overall Study|COVID-19|2|||
144434559|NCT04007523|520796201|FG000|Overall Study|Withdrawal by Subject|0|||
144434560|NCT04007523|520796202|FG001|Overall Study|Withdrawal by Subject|1|||
144434561|NCT04007523|520796203|FG002|Overall Study|Withdrawal by Subject|1|||
144434562|NCT04007523|520796204|FG003|Overall Study|Withdrawal by Subject|0|||
144434563|NCT04007523|520796201|FG000|Overall Study|ICU Transfer|0|||
144434564|NCT04007523|520796202|FG001|Overall Study|ICU Transfer|1|||
144434565|NCT04007523|520796203|FG002|Overall Study|ICU Transfer|0|||
144434566|NCT04007523|520796204|FG003|Overall Study|ICU Transfer|0|||
144434567|NCT04007523|520796201|FG000|Overall Study|COVID hospital closure|0|||
144434568|NCT04007523|520796202|FG001|Overall Study|COVID hospital closure|0|||
144434569|NCT04007523|520796203|FG002|Overall Study|COVID hospital closure|1|||
144434570|NCT04007523|520796204|FG003|Overall Study|COVID hospital closure|2|||
144434571|NCT04007523|520796201|FG000|Overall Study|Surgery cancelled|0|||
144434572|NCT04007523|520796202|FG001|Overall Study|Surgery cancelled|0|||
144434573|NCT04007523|520796203|FG002|Overall Study|Surgery cancelled|1|||
144434574|NCT04007523|520796204|FG003|Overall Study|Surgery cancelled|1|||
144434575|NCT00680901|520796206|FG000|Overall Study|Ongoing: On Study Treatment|1|||
144434576|NCT00680901|520796207|FG001|Overall Study|Ongoing: On Study Treatment|0|||
144434577|NCT00680901|520796206|FG000|Overall Study|Ongoing: In Follow Up|1|||
144434578|NCT00680901|520796207|FG001|Overall Study|Ongoing: In Follow Up|0|||
144434579|NCT00680901|520796206|FG000|Overall Study|Adverse Event|1|||
144434580|NCT00680901|520796207|FG001|Overall Study|Adverse Event|1|||
144434581|NCT00680901|520796206|FG000|Overall Study|Lost to Follow-up|3|||
144434582|NCT00680901|520796207|FG001|Overall Study|Lost to Follow-up|5|||
144434583|NCT00680901|520796206|FG000|Overall Study|Subject decided to withdraw from the study|4|||
144434584|NCT00680901|520796207|FG001|Overall Study|Subject decided to withdraw from the study|15|||
144434585|NCT00680901|520796206|FG000|Overall Study|Sponsor decision|1|||
144434586|NCT00680901|520796207|FG001|Overall Study|Sponsor decision|0|||
144434587|NCT00680901|520796206|FG000|Overall Study|Physician Decision|0|||
144434588|NCT00680901|520796207|FG001|Overall Study|Physician Decision|2|||
144434589|NCT00680901|520796206|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
144434590|NCT00680901|520796207|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
144434591|NCT00680901|520796206|FG000|Overall Study|Other protocol defined stopping criteria|17|||
144434592|NCT00680901|520796207|FG001|Overall Study|Other protocol defined stopping criteria|17|||
144434593|NCT00500292|520796208|FG000|Overall Study|Adverse Event|3|||
144434594|NCT00500292|520796209|FG001|Overall Study|Adverse Event|6|||
144434595|NCT00500292|520796210|FG002|Overall Study|Adverse Event|4|||
144434596|NCT00500292|520796208|FG000|Overall Study|Condition under investigation worsened|21|||
144724322|NCT02483975|521846332|FG000|Overall Study|Adverse Event|0|||
144187768|NCT02539368|519881265|FG002|Overall Study|Death|1|||
144187769|NCT02539368|519881266|FG003|Overall Study|Death|0|||
144434597|NCT00500292|520796209|FG001|Overall Study|Condition under investigation worsened|23|||
144434598|NCT00500292|520796210|FG002|Overall Study|Condition under investigation worsened|19|||
144434599|NCT00500292|520796208|FG000|Overall Study|Withdrawal by Subject|0|||
144434600|NCT00500292|520796209|FG001|Overall Study|Withdrawal by Subject|1|||
144434601|NCT00500292|520796210|FG002|Overall Study|Withdrawal by Subject|0|||
144434602|NCT00500292|520796208|FG000|Overall Study|Other|1|||
144434603|NCT00500292|520796209|FG001|Overall Study|Other|1|||
144434604|NCT00500292|520796210|FG002|Overall Study|Other|4|||
144434605|NCT03717480|520796211|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
144434606|NCT01894152|520796212|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
144434607|NCT00923559|520796213|FG000|Overall Study|Lost to Follow-up|2|||
144434608|NCT00923559|520796214|FG001|Overall Study|Lost to Follow-up|3|||
144434609|NCT01774786|520796215|FG000|Overall Study|Death|300|||
144434610|NCT01774786|520796216|FG001|Overall Study|Death|319|||
144434611|NCT01774786|520796215|FG000|Overall Study|Lost to Follow-up|6|||
144434612|NCT01774786|520796216|FG001|Overall Study|Lost to Follow-up|7|||
144434613|NCT01774786|520796215|FG000|Overall Study|Withdrawal by Subject|18|||
144434614|NCT01774786|520796216|FG001|Overall Study|Withdrawal by Subject|14|||
144434615|NCT01774786|520796215|FG000|Overall Study|Physician Decision|2|||
144434616|NCT01774786|520796216|FG001|Overall Study|Physician Decision|0|||
144434617|NCT01774786|520796215|FG000|Overall Study|Non-compliance|0|||
144434618|NCT01774786|520796216|FG001|Overall Study|Non-compliance|1|||
144434619|NCT01774786|520796215|FG000|Overall Study|Reason Not Specified|2|||
144434620|NCT01774786|520796216|FG001|Overall Study|Reason Not Specified|5|||
144434621|NCT02268812|520796217|FG000|Overall Study|Adverse Event|8|||
144434622|NCT02268812|520796218|FG001|Overall Study|Adverse Event|26|||
144434623|NCT02268812|520796219|FG002|Overall Study|Adverse Event|7|||
144434624|NCT02268812|520796220|FG003|Overall Study|Adverse Event|10|||
144187770|NCT02539368|519881267|FG004|Overall Study|Death|0|||
144187771|NCT02539368|519881263|FG000|Overall Study|Withdrawal by Subject|44|||
144434625|NCT02268812|520796217|FG000|Overall Study|Protocol deviation|0|||
144434626|NCT02268812|520796218|FG001|Overall Study|Protocol deviation|0|||
144434627|NCT02268812|520796219|FG002|Overall Study|Protocol deviation|1|||
144434628|NCT02268812|520796220|FG003|Overall Study|Protocol deviation|0|||
144434629|NCT02268812|520796217|FG000|Overall Study|Withdrawal by Subject|0|||
144434630|NCT02268812|520796218|FG001|Overall Study|Withdrawal by Subject|1|||
144434631|NCT02268812|520796219|FG002|Overall Study|Withdrawal by Subject|0|||
144434632|NCT02268812|520796220|FG003|Overall Study|Withdrawal by Subject|0|||
144434633|NCT02268812|520796217|FG000|Overall Study|Physician Decision|3|||
144434634|NCT02268812|520796218|FG001|Overall Study|Physician Decision|1|||
144434635|NCT02268812|520796219|FG002|Overall Study|Physician Decision|0|||
144434636|NCT02268812|520796220|FG003|Overall Study|Physician Decision|1|||
144434637|NCT02268812|520796217|FG000|Overall Study|Other|5|||
144434638|NCT02268812|520796218|FG001|Overall Study|Other|4|||
144434639|NCT02268812|520796219|FG002|Overall Study|Other|1|||
144434640|NCT02268812|520796220|FG003|Overall Study|Other|3|||
144434641|NCT00075582|520796221|FG000|Overall Study|Adverse Event|3|||
144434642|NCT00075582|520796222|FG001|Overall Study|Adverse Event|1|||
144187772|NCT02539368|519881264|FG001|Overall Study|Withdrawal by Subject|35|||
144434643|NCT00075582|520796221|FG000|Overall Study|Lack of Efficacy|4|||
144434644|NCT00075582|520796222|FG001|Overall Study|Lack of Efficacy|8|||
144434645|NCT00075582|520796221|FG000|Overall Study|Physician Decision|5|||
144434646|NCT00075582|520796222|FG001|Overall Study|Physician Decision|8|||
144434647|NCT00075582|520796221|FG000|Overall Study|Withdrawal by Subject|2|||
144434648|NCT00075582|520796222|FG001|Overall Study|Withdrawal by Subject|2|||
144434649|NCT00075582|520796221|FG000|Overall Study|Ineligible for study|36|||
144434650|NCT00075582|520796222|FG001|Overall Study|Ineligible for study|16|||
144434651|NCT04544293|520796223|FG000|Double-blind|Adverse Event|2|||
144187773|NCT02539368|519881265|FG002|Overall Study|Withdrawal by Subject|9|||
144187774|NCT02539368|519881266|FG003|Overall Study|Withdrawal by Subject|1|||
144187775|NCT02539368|519881267|FG004|Overall Study|Withdrawal by Subject|3|||
144434652|NCT04544293|520796224|FG001|Double-blind|Adverse Event|1|||
144529905|NCT04141891|521142979|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
144529906|NCT04141891|521142980|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
144529907|NCT04141891|521142979|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
144529908|NCT04141891|521142980|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
144434653|NCT04544293|520796223|FG000|Double-blind|Pregnancy|0|||
144434654|NCT04544293|520796224|FG001|Double-blind|Pregnancy|1|||
144434655|NCT04544293|520796223|FG000|Double-blind|Lost to Follow-up|0|||
144434656|NCT04544293|520796224|FG001|Double-blind|Lost to Follow-up|1|||
144434657|NCT04544293|520796223|FG000|Open-Label Extension|Study ongoing|79|||
144434658|NCT04544293|520796224|FG001|Open-Label Extension|Study ongoing|81|||
144434659|NCT01951157|520796226|FG000|Overall Study|Progressive Disease|12|||
144434660|NCT01951157|520796227|FG001|Overall Study|Progressive Disease|13|||
144434661|NCT01951157|520796228|FG002|Overall Study|Progressive Disease|10|||
144434662|NCT01951157|520796226|FG000|Overall Study|Treatment-unrelated AE|1|||
144434663|NCT01951157|520796227|FG001|Overall Study|Treatment-unrelated AE|0|||
144434664|NCT01951157|520796228|FG002|Overall Study|Treatment-unrelated AE|3|||
144434665|NCT01951157|520796226|FG000|Overall Study|Study Termination|0|||
144434666|NCT01951157|520796227|FG001|Overall Study|Study Termination|0|||
144434667|NCT01951157|520796228|FG002|Overall Study|Study Termination|1|||
144434668|NCT01951157|520796226|FG000|Overall Study|Physician Decision|5|||
144434669|NCT01951157|520796227|FG001|Overall Study|Physician Decision|3|||
144434670|NCT01951157|520796228|FG002|Overall Study|Physician Decision|2|||
144434671|NCT01951157|520796226|FG000|Overall Study|Non-treatmentrelated death|2|||
144434672|NCT01951157|520796227|FG001|Overall Study|Non-treatmentrelated death|2|||
144434673|NCT01951157|520796228|FG002|Overall Study|Non-treatmentrelated death|2|||
144434674|NCT01951157|520796226|FG000|Overall Study|No treated|0|||
144434675|NCT01951157|520796227|FG001|Overall Study|No treated|1|||
144434676|NCT01951157|520796228|FG002|Overall Study|No treated|0|||
144434677|NCT01951157|520796226|FG000|Overall Study|Treatment-related AE|2|||
144434678|NCT01951157|520796227|FG001|Overall Study|Treatment-related AE|0|||
144434679|NCT01951157|520796228|FG002|Overall Study|Treatment-related AE|4|||
144434680|NCT01951157|520796226|FG000|Overall Study|Consent withdrawn by subject|0|||
144434681|NCT01951157|520796227|FG001|Overall Study|Consent withdrawn by subject|1|||
144434682|NCT01951157|520796228|FG002|Overall Study|Consent withdrawn by subject|3|||
144434683|NCT01951157|520796226|FG000|Overall Study|Treatment-related death|0|||
144434684|NCT01951157|520796227|FG001|Overall Study|Treatment-related death|2|||
144434685|NCT01951157|520796228|FG002|Overall Study|Treatment-related death|0|||
144434686|NCT02268786|520796229|FG000|Overall Study|No Euploid Embryos available|42|||
144434687|NCT02268786|520796230|FG001|Overall Study|No Euploid Embryos available|0|||
144434688|NCT02268786|520796229|FG000|Overall Study|Withdrawal by Subject|7|||
144434689|NCT02268786|520796230|FG001|Overall Study|Withdrawal by Subject|14|||
144434690|NCT02268786|520796229|FG000|Overall Study|Thaw Failure|6|||
144434691|NCT02268786|520796230|FG001|Overall Study|Thaw Failure|4|||
144434692|NCT02268786|520796229|FG000|Overall Study|Protocol Violation|1|||
144434693|NCT02268786|520796230|FG001|Overall Study|Protocol Violation|0|||
144434694|NCT04809220|520796233|FG000|Overall Study|Adverse Event|4|||
144434695|NCT04809220|520796234|FG001|Overall Study|Adverse Event|0|||
144434696|NCT04809220|520796233|FG000|Overall Study|Death|1|||
144434697|NCT04809220|520796234|FG001|Overall Study|Death|0|||
144434698|NCT04809220|520796233|FG000|Overall Study|Lost to Follow-up|3|||
144434699|NCT04809220|520796234|FG001|Overall Study|Lost to Follow-up|0|||
144434700|NCT04809220|520796233|FG000|Overall Study|Physician Decision|0|||
144434701|NCT04809220|520796234|FG001|Overall Study|Physician Decision|1|||
144434702|NCT04809220|520796233|FG000|Overall Study|Withdrawal by Subject|9|||
144434703|NCT04809220|520796234|FG001|Overall Study|Withdrawal by Subject|5|||
144434704|NCT04809220|520796233|FG000|Overall Study|Due to long-term overseas business trips|1|||
144434705|NCT04809220|520796234|FG001|Overall Study|Due to long-term overseas business trips|0|||
144434706|NCT02120794|520796238|FG000|Overall Study|Withdrawal by Subject|43|||
144434707|NCT02120794|520796238|FG000|Overall Study|Adverse Event|10|||
144434708|NCT02120794|520796238|FG000|Overall Study|Physician Decision|4|||
144434709|NCT02120794|520796238|FG000|Overall Study|Due to insurance coverage|1|||
144434710|NCT00994240|520796240|FG000|Overall Study|Lost to Follow-up|3|||
144434711|NCT00994240|520796241|FG001|Overall Study|Lost to Follow-up|2|||
144434712|NCT00994240|520796240|FG000|Overall Study|Withdrawal by Subject|1|||
144434713|NCT00994240|520796241|FG001|Overall Study|Withdrawal by Subject|0|||
144434714|NCT00994240|520796240|FG000|Overall Study|study termination|2|||
144434715|NCT00994240|520796241|FG001|Overall Study|study termination|3|||
144434716|NCT01200797|520796242|FG000|Overall Study|symptomatic deterioration|2|||
144434717|NCT01200797|520796242|FG000|Overall Study|Adverse Event|4|||
144434718|NCT01200797|520796242|FG000|Overall Study|Disease Progression|13|||
144434719|NCT03608774|520796247|FG000|Overall Study|Lost to Follow-up|5|||
144434720|NCT03608774|520796248|FG001|Overall Study|Lost to Follow-up|5|||
144434721|NCT03608774|520796247|FG000|Overall Study|Withdrawal by Subject|1|||
144434722|NCT03608774|520796248|FG001|Overall Study|Withdrawal by Subject|0|||
144434723|NCT03608774|520796247|FG000|Overall Study|Protocol Violation|1|||
144434724|NCT03608774|520796248|FG001|Overall Study|Protocol Violation|0|||
144434725|NCT03608774|520796247|FG000|Overall Study|Not eligible at enrollment|0|||
144434726|NCT03608774|520796248|FG001|Overall Study|Not eligible at enrollment|1|||
144187776|NCT02539368|519881263|FG000|Overall Study|Physician Decision|49|||
144187777|NCT02539368|519881264|FG001|Overall Study|Physician Decision|15|||
144187778|NCT02539368|519881265|FG002|Overall Study|Physician Decision|7|||
144187779|NCT02539368|519881266|FG003|Overall Study|Physician Decision|0|||
144187780|NCT02539368|519881267|FG004|Overall Study|Physician Decision|2|||
144434727|NCT03608774|520796247|FG000|Overall Study|Health related event|0|||
144434728|NCT03608774|520796248|FG001|Overall Study|Health related event|1|||
144434729|NCT00642668|520796249|FG000|Overall Study|Lost to Follow-up|1|||
144434730|NCT00642668|520796249|FG000|Overall Study|Adverse Event|2|||
144434731|NCT00642668|520796249|FG000|Overall Study|Death|2|||
144434732|NCT00642668|520796249|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144434733|NCT00642668|520796249|FG000|Overall Study|Failure to Return|1|||
144434734|NCT00642668|520796249|FG000|Overall Study|Dialysis Initiation|5|||
144434735|NCT00642668|520796249|FG000|Overall Study|Blood Transfusion|2|||
144434736|NCT01586819|520796250|FG000|Overall Study|Withdrawal by Subject|1|||
144434737|NCT01586819|520796251|FG001|Overall Study|Withdrawal by Subject|0|||
144434738|NCT00896337|520796252|FG000|Overall Study|Death|7|||
144434739|NCT00896337|520796252|FG000|Overall Study|Withdrawal by Subject|7|||
144434740|NCT00896337|520796252|FG000|Overall Study|Lost to Follow-up|11|||
144434741|NCT02910167|520796260|FG000|Overall Study|Adverse Event|1|||
144434742|NCT02910167|520796260|FG000|Overall Study|Lost to Follow-up|18|||
144434743|NCT03026257|520797554|FG000|Overall Study|Adverse Event|3|||
144434744|NCT03026257|520797555|FG001|Overall Study|Adverse Event|0|||
144434745|NCT03026257|520797556|FG002|Overall Study|Adverse Event|0|||
144434746|NCT03026257|520797557|FG003|Overall Study|Adverse Event|0|||
144434747|NCT03026257|520797558|FG004|Overall Study|Adverse Event|0|||
144434748|NCT03026257|520797559|FG005|Overall Study|Adverse Event|0|||
144434749|NCT03026257|520797554|FG000|Overall Study|Lost to Follow-up|1|||
144434750|NCT03026257|520797555|FG001|Overall Study|Lost to Follow-up|0|||
144434751|NCT03026257|520797556|FG002|Overall Study|Lost to Follow-up|0|||
144434752|NCT03026257|520797557|FG003|Overall Study|Lost to Follow-up|0|||
144434753|NCT03026257|520797558|FG004|Overall Study|Lost to Follow-up|0|||
144434754|NCT03026257|520797559|FG005|Overall Study|Lost to Follow-up|0|||
144434755|NCT03026257|520797554|FG000|Overall Study|Protocol Violation|1|||
144434756|NCT03026257|520797555|FG001|Overall Study|Protocol Violation|0|||
144434757|NCT03026257|520797556|FG002|Overall Study|Protocol Violation|0|||
144434758|NCT03026257|520797557|FG003|Overall Study|Protocol Violation|1|||
144434759|NCT03026257|520797558|FG004|Overall Study|Protocol Violation|1|||
144434760|NCT03026257|520797559|FG005|Overall Study|Protocol Violation|0|||
144434761|NCT03026257|520797554|FG000|Overall Study|Withdrawal by Subject|1|||
144434762|NCT03026257|520797555|FG001|Overall Study|Withdrawal by Subject|1|||
144434763|NCT03026257|520797556|FG002|Overall Study|Withdrawal by Subject|0|||
144434764|NCT03026257|520797557|FG003|Overall Study|Withdrawal by Subject|0|||
144434765|NCT03026257|520797558|FG004|Overall Study|Withdrawal by Subject|0|||
144434766|NCT03026257|520797559|FG005|Overall Study|Withdrawal by Subject|0|||
144434767|NCT02181556|520797560|FG000|Overall Study|Withdrawal by Subject|1|||
144434768|NCT00427635|520797561|FG000|Treatment Phase|Withdrawal by Subject|1|||
144434769|NCT00427635|520797562|FG001|Treatment Phase|Withdrawal by Subject|0|||
144434770|NCT00427635|520797561|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
144434771|NCT00427635|520797562|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
144434772|NCT00838201|520797563|FG000|Overall Study|Investigator decision, or other reasons|2|||
144434773|NCT00838201|520797564|FG001|Overall Study|Investigator decision, or other reasons|3|||
144434774|NCT00838201|520797563|FG000|Overall Study|Noncompliance|0|||
144434775|NCT00838201|520797564|FG001|Overall Study|Noncompliance|1|||
144434776|NCT00838201|520797563|FG000|Overall Study|Administrative decision|1|||
144434777|NCT00838201|520797564|FG001|Overall Study|Administrative decision|2|||
144434778|NCT00838201|520797563|FG000|Overall Study|Disease progression|3|||
144434779|NCT00838201|520797564|FG001|Overall Study|Disease progression|3|||
144434780|NCT00838201|520797563|FG000|Overall Study|Consent withdrawn|16|||
144434781|NCT00838201|520797564|FG001|Overall Study|Consent withdrawn|19|||
144434782|NCT00838201|520797563|FG000|Overall Study|Lost to Follow-up|4|||
144434783|NCT00838201|520797564|FG001|Overall Study|Lost to Follow-up|3|||
144434784|NCT00838201|520797563|FG000|Overall Study|Adverse Event|5|||
144434785|NCT00838201|520797564|FG001|Overall Study|Adverse Event|9|||
144434786|NCT00838201|520797563|FG000|Overall Study|Death|11|||
144434787|NCT00838201|520797564|FG001|Overall Study|Death|13|||
144434788|NCT02042924|520797565|FG000|Overall Study|Early Death|1|||
144434789|NCT04033003|520797566|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
144529909|NCT04141891|521142979|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
144529910|NCT04141891|521142980|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
144529911|NCT04141891|521142979|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
144529912|NCT04141891|521142980|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
144529913|NCT04141891|521142979|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
144529914|NCT04141891|521142980|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
144529915|NCT03626220|521142981|FG000|Overall Study|Withdrawal by Subject|2|||
144529916|NCT03626220|521142982|FG001|Overall Study|Withdrawal by Subject|0|||
144529917|NCT05565820|521142994|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
144434790|NCT04033003|520797567|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
144529918|NCT05565820|521142995|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
144434791|NCT04033003|520797566|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
144434792|NCT04033003|520797567|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
144434793|NCT04033003|520797566|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
144434794|NCT04033003|520797567|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
144434795|NCT04033003|520797566|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
144434796|NCT04033003|520797567|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
144434797|NCT04033003|520797566|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
144434798|NCT04033003|520797567|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
144187781|NCT02539368|519881263|FG000|Overall Study|Lost to Follow-up|96|||
144434799|NCT04033003|520797566|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
144434800|NCT04033003|520797567|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
144434801|NCT04033003|520797566|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
144434802|NCT04033003|520797567|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
144434803|NCT04033003|520797566|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
144434804|NCT04033003|520797567|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
144434805|NCT04033003|520797566|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
144434806|NCT04033003|520797567|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
144434807|NCT04033003|520797566|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
144434808|NCT04033003|520797567|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
144434809|NCT04033003|520797566|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
144434810|NCT04033003|520797567|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
144434811|NCT04033003|520797566|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
144434812|NCT04033003|520797567|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
144434813|NCT04033003|520797566|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
144434814|NCT04033003|520797567|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
144434815|NCT01714310|520797568|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
144434816|NCT01714310|520797569|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
144434817|NCT01714310|520797570|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
144434818|NCT01714310|520797568|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
144434819|NCT01714310|520797569|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
144434820|NCT01714310|520797570|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
144434821|NCT01714310|520797568|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
144434822|NCT01714310|520797569|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
144434823|NCT01714310|520797570|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
144434824|NCT01714310|520797568|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
144434825|NCT01714310|520797569|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
144434826|NCT01714310|520797570|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
144434827|NCT02487394|520797571|FG000|Phase 1|Withdrawal by Subject|0|||
144434828|NCT02487394|520797572|FG001|Phase 1|Withdrawal by Subject|1|||
144434829|NCT00826267|520797577|FG000|Overall Study|Other Adverse Event|1|||
144434830|NCT00826267|520797578|FG001|Overall Study|Other Adverse Event|0|||
144434831|NCT00826267|520797579|FG002|Overall Study|Other Adverse Event|0|||
144434832|NCT01675882|520797596|FG000|Overall Study|Adverse Event|0|||
144434833|NCT01675882|520797597|FG001|Overall Study|Adverse Event|2|||
144434834|NCT01675882|520797598|FG002|Overall Study|Adverse Event|1|||
144434835|NCT01675882|520797599|FG003|Overall Study|Adverse Event|0|||
144434836|NCT01675882|520797596|FG000|Overall Study|Participant unwilling to continue|2|||
144434837|NCT01675882|520797597|FG001|Overall Study|Participant unwilling to continue|4|||
144434838|NCT01675882|520797598|FG002|Overall Study|Participant unwilling to continue|2|||
144434839|NCT01675882|520797599|FG003|Overall Study|Participant unwilling to continue|1|||
144434840|NCT01675882|520797596|FG000|Overall Study|Lost to Follow-up|0|||
144434841|NCT01675882|520797597|FG001|Overall Study|Lost to Follow-up|1|||
144434842|NCT01675882|520797598|FG002|Overall Study|Lost to Follow-up|0|||
144434843|NCT01675882|520797599|FG003|Overall Study|Lost to Follow-up|0|||
144434844|NCT01675882|520797596|FG000|Overall Study|Non-compliance|0|||
144434845|NCT01675882|520797597|FG001|Overall Study|Non-compliance|0|||
144434846|NCT01675882|520797598|FG002|Overall Study|Non-compliance|0|||
144434847|NCT01675882|520797599|FG003|Overall Study|Non-compliance|1|||
144434848|NCT02872116|520797603|FG000|Pre-Treatment|Disease Progression|0|||
144434849|NCT02872116|520797604|FG001|Pre-Treatment|Disease Progression|1|||
144434850|NCT02872116|520797605|FG002|Pre-Treatment|Disease Progression|0|||
144434851|NCT02872116|520797603|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
144434852|NCT02872116|520797604|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
144434853|NCT02872116|520797605|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
144434854|NCT02872116|520797603|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
144434855|NCT02872116|520797604|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
144434856|NCT02872116|520797605|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
144434857|NCT02872116|520797603|FG000|Pre-Treatment|Participant withdrew consent|2|||
144434858|NCT02872116|520797604|FG001|Pre-Treatment|Participant withdrew consent|20|||
144434859|NCT02872116|520797605|FG002|Pre-Treatment|Participant withdrew consent|3|||
144434860|NCT02872116|520797603|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
144434861|NCT02872116|520797604|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
144434862|NCT02872116|520797605|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
144434863|NCT02872116|520797603|FG000|Pre-Treatment|Other reasons|1|||
144434864|NCT02872116|520797604|FG001|Pre-Treatment|Other reasons|2|||
144434865|NCT02872116|520797605|FG002|Pre-Treatment|Other reasons|2|||
144434866|NCT02872116|520797603|FG000|Treatment|Death|121|||
144434867|NCT02872116|520797604|FG001|Treatment|Death|94|||
144434868|NCT02872116|520797605|FG002|Treatment|Death|68|||
144434869|NCT02872116|520797603|FG000|Treatment|Lost to Follow-up|5|||
144434870|NCT02872116|520797604|FG001|Treatment|Lost to Follow-up|7|||
144434871|NCT02872116|520797605|FG002|Treatment|Lost to Follow-up|3|||
144434872|NCT02872116|520797603|FG000|Treatment|Participant withdrew consent|20|||
144434873|NCT02872116|520797604|FG001|Treatment|Participant withdrew consent|40|||
144434874|NCT02872116|520797605|FG002|Treatment|Participant withdrew consent|8|||
144434875|NCT02872116|520797603|FG000|Treatment|Other reasons|13|||
144434876|NCT02872116|520797604|FG001|Treatment|Other reasons|12|||
144434877|NCT02872116|520797605|FG002|Treatment|Other reasons|5|||
144253252|NCT01483599|520126657|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253253|NCT01483599|520126658|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253254|NCT01483599|520126659|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253255|NCT01483599|520126660|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
144253256|NCT01483599|520126661|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253257|NCT01483599|520126662|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253258|NCT01483599|520126663|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
144253259|NCT01483599|520126664|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
144253260|NCT01483599|520126665|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
144253261|NCT01483599|520126652|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
144253262|NCT01483599|520126653|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
144253263|NCT01483599|520126654|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
144253264|NCT01483599|520126655|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
144253265|NCT01483599|520126656|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
144253266|NCT01483599|520126657|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
144253267|NCT01483599|520126658|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
144253268|NCT01483599|520126659|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
144253269|NCT01483599|520126660|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
144253270|NCT01483599|520126661|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
144253271|NCT01483599|520126662|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
144253272|NCT01483599|520126663|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
144529919|NCT05565820|521142994|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
144529920|NCT05565820|521142995|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
144529921|NCT03295721|521142996|FG000|Overall Study|Adverse Event|1|||
144529922|NCT03295721|521142997|FG001|Overall Study|Adverse Event|0|||
144529923|NCT03295721|521142998|FG002|Overall Study|Adverse Event|0|||
144529924|NCT03295721|521142996|FG000|Overall Study|Lost to Follow-up|1|||
144529925|NCT03295721|521142997|FG001|Overall Study|Lost to Follow-up|1|||
144253273|NCT01483599|520126664|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
144253274|NCT01483599|520126665|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
144253275|NCT02109445|520126666|FG000|Overall Study|Symptomatic deterioration|2|||
144434878|NCT03161483|520797609|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
144434879|NCT03161483|520797610|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
144434880|NCT03161483|520797611|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
144434881|NCT03161483|520797612|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
144434882|NCT03161483|520797609|FG000|Treatment Period|Death|1|||
144434883|NCT03161483|520797610|FG001|Treatment Period|Death|0|||
144434884|NCT03161483|520797611|FG002|Treatment Period|Death|0|||
144434885|NCT03161483|520797612|FG003|Treatment Period|Death|0|||
144434886|NCT03161483|520797609|FG000|Treatment Period|Adverse Event|5|||
144434887|NCT03161483|520797610|FG001|Treatment Period|Adverse Event|2|||
144434888|NCT03161483|520797611|FG002|Treatment Period|Adverse Event|1|||
144434889|NCT03161483|520797612|FG003|Treatment Period|Adverse Event|11|||
144434890|NCT03161483|520797609|FG000|Treatment Period|Pregnancy|1|||
144434891|NCT03161483|520797610|FG001|Treatment Period|Pregnancy|0|||
144434892|NCT03161483|520797611|FG002|Treatment Period|Pregnancy|0|||
144434893|NCT03161483|520797612|FG003|Treatment Period|Pregnancy|0|||
144434894|NCT03161483|520797609|FG000|Treatment Period|Lack of Efficacy|0|||
144434895|NCT03161483|520797610|FG001|Treatment Period|Lack of Efficacy|0|||
144434896|NCT03161483|520797611|FG002|Treatment Period|Lack of Efficacy|0|||
144434897|NCT03161483|520797612|FG003|Treatment Period|Lack of Efficacy|1|||
144434898|NCT03161483|520797609|FG000|Treatment Period|Withdrawal by Subject|2|||
144434899|NCT03161483|520797610|FG001|Treatment Period|Withdrawal by Subject|5|||
144434900|NCT03161483|520797611|FG002|Treatment Period|Withdrawal by Subject|2|||
144434901|NCT03161483|520797612|FG003|Treatment Period|Withdrawal by Subject|6|||
144529926|NCT03295721|521142998|FG002|Overall Study|Lost to Follow-up|1|||
144529927|NCT03295721|521142996|FG000|Overall Study|Withdrawal by Subject|1|||
144529928|NCT03295721|521142997|FG001|Overall Study|Withdrawal by Subject|0|||
144529929|NCT03295721|521142998|FG002|Overall Study|Withdrawal by Subject|1|||
144529930|NCT03295721|521142996|FG000|Overall Study|Death|0|||
144529931|NCT03295721|521142997|FG001|Overall Study|Death|0|||
144434902|NCT03161483|520797609|FG000|Treatment Period|Lost to Follow-up|0|||
144434903|NCT03161483|520797610|FG001|Treatment Period|Lost to Follow-up|0|||
144529932|NCT03295721|521142998|FG002|Overall Study|Death|1|||
144529933|NCT00429364|521143002|FG000|Overall Study|Withdrawal by Subject|11|||
144529934|NCT00429364|521143003|FG001|Overall Study|Withdrawal by Subject|5|||
144529935|NCT00429364|521143002|FG000|Overall Study|Physician Decision|4|||
144529936|NCT00429364|521143003|FG001|Overall Study|Physician Decision|2|||
144529937|NCT00429364|521143002|FG000|Overall Study|Lost to Follow-up|7|||
144187782|NCT02539368|519881264|FG001|Overall Study|Lost to Follow-up|21|||
144187783|NCT02539368|519881265|FG002|Overall Study|Lost to Follow-up|16|||
144187784|NCT02539368|519881266|FG003|Overall Study|Lost to Follow-up|4|||
144187785|NCT02539368|519881267|FG004|Overall Study|Lost to Follow-up|3|||
144187786|NCT02539368|519881263|FG000|Overall Study|Adverse Event|44|||
144187787|NCT02539368|519881264|FG001|Overall Study|Adverse Event|5|||
144187788|NCT02539368|519881265|FG002|Overall Study|Adverse Event|9|||
144187789|NCT02539368|519881266|FG003|Overall Study|Adverse Event|0|||
144187790|NCT02539368|519881267|FG004|Overall Study|Adverse Event|3|||
144434904|NCT03161483|520797611|FG002|Treatment Period|Lost to Follow-up|0|||
144434905|NCT03161483|520797612|FG003|Treatment Period|Lost to Follow-up|1|||
144434906|NCT03161483|520797609|FG000|Treatment Period|Protocol Violation|0|||
144434907|NCT03161483|520797610|FG001|Treatment Period|Protocol Violation|0|||
144434908|NCT03161483|520797611|FG002|Treatment Period|Protocol Violation|0|||
144434909|NCT03161483|520797612|FG003|Treatment Period|Protocol Violation|1|||
144187791|NCT02539368|519881263|FG000|Overall Study|Participant Non-compliant|13|||
144434910|NCT03161483|520797609|FG000|Treatment Period|Other reasons|1|||
144434911|NCT03161483|520797610|FG001|Treatment Period|Other reasons|1|||
144434912|NCT03161483|520797611|FG002|Treatment Period|Other reasons|0|||
144434913|NCT03161483|520797612|FG003|Treatment Period|Other reasons|0|||
144434914|NCT01907828|520797614|FG000|Overall Study|Exclusion criteria not met|0|||
144434915|NCT01907828|520797615|FG001|Overall Study|Exclusion criteria not met|1|||
144434916|NCT01907828|520797614|FG000|Overall Study|Withdrawal by Subject|3|||
144434917|NCT01907828|520797615|FG001|Overall Study|Withdrawal by Subject|4|||
144434918|NCT01907828|520797614|FG000|Overall Study|Lost to Follow-up|3|||
144434919|NCT01907828|520797615|FG001|Overall Study|Lost to Follow-up|0|||
144434920|NCT01907828|520797614|FG000|Overall Study|Participant refused 24-month follow-up|1|||
144434921|NCT01907828|520797615|FG001|Overall Study|Participant refused 24-month follow-up|0|||
144434922|NCT01907828|520797614|FG000|Overall Study|Participant met exclusion criteria|0|||
144434923|NCT01907828|520797615|FG001|Overall Study|Participant met exclusion criteria|1|||
144529938|NCT00429364|521143003|FG001|Overall Study|Lost to Follow-up|6|||
144187792|NCT02539368|519881264|FG001|Overall Study|Participant Non-compliant|2|||
144187793|NCT02539368|519881265|FG002|Overall Study|Participant Non-compliant|1|||
144187794|NCT02539368|519881266|FG003|Overall Study|Participant Non-compliant|1|||
144187795|NCT02539368|519881267|FG004|Overall Study|Participant Non-compliant|0|||
144187796|NCT02539368|519881263|FG000|Overall Study|Other|145|||
144187797|NCT02539368|519881264|FG001|Overall Study|Other|18|||
144187798|NCT02539368|519881265|FG002|Overall Study|Other|24|||
144187799|NCT02539368|519881266|FG003|Overall Study|Other|1|||
144187800|NCT02539368|519881267|FG004|Overall Study|Other|3|||
144187801|NCT02539368|519881263|FG000|Overall Study|Missing|10|||
144187802|NCT02539368|519881264|FG001|Overall Study|Missing|3|||
144187803|NCT02539368|519881265|FG002|Overall Study|Missing|0|||
144187804|NCT02539368|519881266|FG003|Overall Study|Missing|0|||
144187805|NCT02539368|519881267|FG004|Overall Study|Missing|0|||
144187806|NCT00373425|519881269|FG000|Overall Study|Relapse of NSCLC|116|||
144187807|NCT00373425|519881270|FG001|Overall Study|Relapse of NSCLC|104|||
144187808|NCT00373425|519881271|FG002|Overall Study|Relapse of NSCLC|19|||
144187809|NCT00373425|519881272|FG003|Overall Study|Relapse of NSCLC|2|||
144187810|NCT00373425|519881273|FG004|Overall Study|Relapse of NSCLC|26|||
144187811|NCT00373425|519881269|FG000|Overall Study|Adverse Event|191|||
144187812|NCT00373425|519881270|FG001|Overall Study|Adverse Event|22|||
144187813|NCT00373425|519881271|FG002|Overall Study|Adverse Event|59|||
144187814|NCT00373425|519881272|FG003|Overall Study|Adverse Event|0|||
144187815|NCT00373425|519881273|FG004|Overall Study|Adverse Event|34|||
144187816|NCT00373425|519881269|FG000|Overall Study|Patient request|35|||
144187817|NCT00373425|519881270|FG001|Overall Study|Patient request|18|||
144187818|NCT00373425|519881271|FG002|Overall Study|Patient request|43|||
144187819|NCT00373425|519881272|FG003|Overall Study|Patient request|6|||
144187820|NCT00373425|519881273|FG004|Overall Study|Patient request|7|||
144187821|NCT00373425|519881269|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
144187822|NCT00373425|519881270|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
144187823|NCT00373425|519881271|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
144187824|NCT00373425|519881272|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
144187825|NCT00373425|519881273|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
144187826|NCT00373425|519881269|FG000|Overall Study|Death|7|||
144187827|NCT00373425|519881270|FG001|Overall Study|Death|0|||
144434924|NCT01364428|520797621|FG000|Overall Study|Adverse Event|1|||
144187828|NCT00373425|519881271|FG002|Overall Study|Death|3|||
144434925|NCT01364428|520797622|FG001|Overall Study|Adverse Event|2|||
144434926|NCT01364428|520797621|FG000|Overall Study|Protocol Violation|2|||
144434927|NCT01364428|520797622|FG001|Overall Study|Protocol Violation|0|||
144529939|NCT00429364|521143002|FG000|Overall Study|Death|0|||
144187829|NCT00373425|519881272|FG003|Overall Study|Death|1|||
144187830|NCT00373425|519881273|FG004|Overall Study|Death|0|||
144187831|NCT02752802|519881274|FG000|Overall Study|Contrast Volume Not Collected|1|||
144187832|NCT02752802|519881275|FG001|Overall Study|Contrast Volume Not Collected|0|||
144187833|NCT01396421|519881282|FG000|Overall Study|Lost to Follow-up|0|||
144187834|NCT01396421|519881283|FG001|Overall Study|Lost to Follow-up|0|||
144434928|NCT01364428|520797621|FG000|Overall Study|Withdrawal Criteria|14|||
144434929|NCT01364428|520797622|FG001|Overall Study|Withdrawal Criteria|10|||
144434930|NCT01364428|520797621|FG000|Overall Study|Other|3|||
144434931|NCT01364428|520797622|FG001|Overall Study|Other|3|||
144434932|NCT01073865|520797624|FG000|Overall Study|Reasons other than below|19|||
144434933|NCT01073865|520797625|FG001|Overall Study|Reasons other than below|31|||
144434934|NCT01073865|520797624|FG000|Overall Study|Lost to Follow-up|1|||
144434935|NCT01073865|520797625|FG001|Overall Study|Lost to Follow-up|1|||
144434936|NCT01073865|520797624|FG000|Overall Study|Death|3|||
144434937|NCT01073865|520797625|FG001|Overall Study|Death|2|||
144434938|NCT01073865|520797624|FG000|Overall Study|Withdrawal by Subject|5|||
144434939|NCT01073865|520797625|FG001|Overall Study|Withdrawal by Subject|5|||
144434940|NCT00743652|520797626|FG000|Overall Study|Parent/Legal Guardian Request|3|||
144434941|NCT00743652|520797627|FG001|Overall Study|Parent/Legal Guardian Request|2|||
144434942|NCT00743652|520797628|FG002|Overall Study|Parent/Legal Guardian Request|2|||
144434943|NCT00743652|520797629|FG003|Overall Study|Parent/Legal Guardian Request|2|||
144434944|NCT00743652|520797630|FG004|Overall Study|Parent/Legal Guardian Request|0|||
144434945|NCT00743652|520797626|FG000|Overall Study|Adverse Event|3|||
144434946|NCT00743652|520797627|FG001|Overall Study|Adverse Event|0|||
144434947|NCT00743652|520797628|FG002|Overall Study|Adverse Event|0|||
144434948|NCT00743652|520797629|FG003|Overall Study|Adverse Event|0|||
144434949|NCT00743652|520797630|FG004|Overall Study|Adverse Event|0|||
144434950|NCT00743652|520797626|FG000|Overall Study|Death|2|||
144434951|NCT00743652|520797627|FG001|Overall Study|Death|0|||
144434952|NCT00743652|520797628|FG002|Overall Study|Death|0|||
144187835|NCT01396421|519881284|FG002|Overall Study|Lost to Follow-up|0|||
144187836|NCT01396421|519881285|FG003|Overall Study|Lost to Follow-up|1|||
144187837|NCT01396421|519881282|FG000|Overall Study|Adverse Event|17|||
144187838|NCT01396421|519881283|FG001|Overall Study|Adverse Event|15|||
144187839|NCT01396421|519881284|FG002|Overall Study|Adverse Event|12|||
144187840|NCT01396421|519881285|FG003|Overall Study|Adverse Event|32|||
144187841|NCT01396421|519881282|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
144187842|NCT01396421|519881283|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
144187843|NCT01396421|519881284|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
144187844|NCT01396421|519881285|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
144187845|NCT01396421|519881282|FG000|Overall Study|Physician Decision|1|||
144187846|NCT01396421|519881283|FG001|Overall Study|Physician Decision|1|||
144187847|NCT01396421|519881284|FG002|Overall Study|Physician Decision|0|||
144187848|NCT01396421|519881285|FG003|Overall Study|Physician Decision|3|||
144187849|NCT01396421|519881282|FG000|Overall Study|Withdrawal by Subject|31|||
144187850|NCT01396421|519881283|FG001|Overall Study|Withdrawal by Subject|24|||
144187851|NCT01396421|519881284|FG002|Overall Study|Withdrawal by Subject|13|||
144187852|NCT01396421|519881285|FG003|Overall Study|Withdrawal by Subject|21|||
144187853|NCT01396421|519881282|FG000|Overall Study|Protocol Deviation|2|||
144187854|NCT01396421|519881283|FG001|Overall Study|Protocol Deviation|1|||
144187855|NCT01396421|519881284|FG002|Overall Study|Protocol Deviation|1|||
144187856|NCT01396421|519881285|FG003|Overall Study|Protocol Deviation|0|||
144187857|NCT01396421|519881282|FG000|Overall Study|Lack of Efficacy|7|||
144187858|NCT01396421|519881283|FG001|Overall Study|Lack of Efficacy|17|||
144187859|NCT01396421|519881284|FG002|Overall Study|Lack of Efficacy|7|||
144187860|NCT01396421|519881285|FG003|Overall Study|Lack of Efficacy|18|||
144187861|NCT00569777|519881286|FG000|Overall Study|Withdrawal by Subject|4|||
144187862|NCT00569777|519881287|FG001|Overall Study|Withdrawal by Subject|0|||
144187863|NCT00569777|519881286|FG000|Overall Study|Adverse Event|3|||
144187864|NCT00569777|519881287|FG001|Overall Study|Adverse Event|0|||
144187865|NCT00569777|519881286|FG000|Overall Study|Lost to Follow-up|1|||
144187866|NCT00569777|519881287|FG001|Overall Study|Lost to Follow-up|0|||
144187867|NCT00569777|519881286|FG000|Overall Study|scheduled eye surgery|0|||
144187868|NCT00569777|519881287|FG001|Overall Study|scheduled eye surgery|1|||
144187869|NCT00569777|519881286|FG000|Overall Study|did not meet exclusion criteria|1|||
144187870|NCT00569777|519881287|FG001|Overall Study|did not meet exclusion criteria|2|||
144187871|NCT00569777|519881286|FG000|Overall Study|pregnant|1|||
144187872|NCT00569777|519881287|FG001|Overall Study|pregnant|0|||
144253276|NCT02109445|520126666|FG000|Overall Study|Adverse Event|1|||
144434953|NCT00743652|520797629|FG003|Overall Study|Death|0|||
144434954|NCT00743652|520797630|FG004|Overall Study|Death|0|||
144187873|NCT01835548|519881292|FG000|Dose Optimization Period|Adverse Event|0|||
144187874|NCT01835548|519881293|FG001|Dose Optimization Period|Adverse Event|0|||
144434955|NCT00743652|520797626|FG000|Overall Study|Investigator Request|0|||
144434956|NCT00743652|520797627|FG001|Overall Study|Investigator Request|0|||
144434957|NCT00743652|520797628|FG002|Overall Study|Investigator Request|0|||
144434958|NCT00743652|520797629|FG003|Overall Study|Investigator Request|2|||
144187875|NCT01835548|519881294|FG002|Dose Optimization Period|Adverse Event|1|||
144187876|NCT01835548|519881292|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
144187877|NCT01835548|519881293|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
144187878|NCT01835548|519881294|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
144187879|NCT01835548|519881292|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144434959|NCT00743652|520797630|FG004|Overall Study|Investigator Request|0|||
144434960|NCT00743652|520797626|FG000|Overall Study|Other|1|||
144434961|NCT00743652|520797627|FG001|Overall Study|Other|1|||
144434962|NCT00743652|520797628|FG002|Overall Study|Other|0|||
144434963|NCT00743652|520797629|FG003|Overall Study|Other|0|||
144434964|NCT00743652|520797630|FG004|Overall Study|Other|0|||
144187880|NCT01835548|519881293|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144187881|NCT01835548|519881294|FG002|Double-Blind Treatment Period|Adverse Event|0|||
144187882|NCT01835548|519881292|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144187883|NCT01835548|519881293|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144187884|NCT01835548|519881294|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144187885|NCT02490800|519881295|FG000|Overall Study|Adverse Event|0|||
144187886|NCT02490800|519881296|FG001|Overall Study|Adverse Event|0|||
144187887|NCT02490800|519881297|FG002|Overall Study|Adverse Event|0|||
144187888|NCT02490800|519881298|FG003|Overall Study|Adverse Event|2|||
144187889|NCT02490800|519881299|FG004|Overall Study|Adverse Event|3|||
144187890|NCT02490800|519881300|FG005|Overall Study|Adverse Event|2|||
144187891|NCT02490800|519881301|FG006|Overall Study|Adverse Event|0|||
144187892|NCT02490800|519881302|FG007|Overall Study|Adverse Event|0|||
144187893|NCT02490800|519881303|FG008|Overall Study|Adverse Event|0|||
144187894|NCT02490800|519881304|FG009|Overall Study|Adverse Event|0|||
144187895|NCT02490800|519881305|FG010|Overall Study|Adverse Event|0|||
144187896|NCT02490800|519881306|FG011|Overall Study|Adverse Event|2|||
144187897|NCT02490800|519881307|FG012|Overall Study|Adverse Event|2|||
144187898|NCT02490800|519881295|FG000|Overall Study|Withdrawal by Subject|0|||
144187899|NCT02490800|519881296|FG001|Overall Study|Withdrawal by Subject|0|||
144187900|NCT02490800|519881297|FG002|Overall Study|Withdrawal by Subject|0|||
144187901|NCT02490800|519881298|FG003|Overall Study|Withdrawal by Subject|1|||
144187902|NCT02490800|519881299|FG004|Overall Study|Withdrawal by Subject|0|||
144187903|NCT02490800|519881300|FG005|Overall Study|Withdrawal by Subject|0|||
144187904|NCT02490800|519881301|FG006|Overall Study|Withdrawal by Subject|0|||
144187905|NCT02490800|519881302|FG007|Overall Study|Withdrawal by Subject|0|||
144187906|NCT02490800|519881303|FG008|Overall Study|Withdrawal by Subject|1|||
144187907|NCT02490800|519881304|FG009|Overall Study|Withdrawal by Subject|0|||
144187908|NCT02490800|519881305|FG010|Overall Study|Withdrawal by Subject|0|||
144187909|NCT02490800|519881306|FG011|Overall Study|Withdrawal by Subject|0|||
144187910|NCT02490800|519881307|FG012|Overall Study|Withdrawal by Subject|0|||
144187911|NCT02490800|519881295|FG000|Overall Study|Progressive disease|3|||
144187912|NCT02490800|519881296|FG001|Overall Study|Progressive disease|3|||
144187913|NCT02490800|519881297|FG002|Overall Study|Progressive disease|3|||
144187914|NCT02490800|519881298|FG003|Overall Study|Progressive disease|4|||
144187915|NCT02490800|519881299|FG004|Overall Study|Progressive disease|4|||
144187916|NCT02490800|519881300|FG005|Overall Study|Progressive disease|1|||
144187917|NCT02490800|519881301|FG006|Overall Study|Progressive disease|4|||
144187918|NCT02490800|519881302|FG007|Overall Study|Progressive disease|3|||
144187919|NCT02490800|519881303|FG008|Overall Study|Progressive disease|6|||
144187920|NCT02490800|519881304|FG009|Overall Study|Progressive disease|2|||
144187921|NCT02490800|519881305|FG010|Overall Study|Progressive disease|7|||
144187922|NCT02490800|519881306|FG011|Overall Study|Progressive disease|1|||
144187923|NCT02490800|519881307|FG012|Overall Study|Progressive disease|10|||
144187924|NCT02490800|519881295|FG000|Overall Study|Patient enrolled in post-trial access|0|||
144187925|NCT02490800|519881296|FG001|Overall Study|Patient enrolled in post-trial access|0|||
144187926|NCT02490800|519881297|FG002|Overall Study|Patient enrolled in post-trial access|0|||
144187927|NCT02490800|519881298|FG003|Overall Study|Patient enrolled in post-trial access|0|||
144187928|NCT02490800|519881299|FG004|Overall Study|Patient enrolled in post-trial access|0|||
144187929|NCT02490800|519881300|FG005|Overall Study|Patient enrolled in post-trial access|0|||
144187930|NCT02490800|519881301|FG006|Overall Study|Patient enrolled in post-trial access|0|||
144187931|NCT02490800|519881302|FG007|Overall Study|Patient enrolled in post-trial access|0|||
144187932|NCT02490800|519881303|FG008|Overall Study|Patient enrolled in post-trial access|0|||
144187933|NCT02490800|519881304|FG009|Overall Study|Patient enrolled in post-trial access|1|||
144187934|NCT02490800|519881305|FG010|Overall Study|Patient enrolled in post-trial access|1|||
144187935|NCT02490800|519881306|FG011|Overall Study|Patient enrolled in post-trial access|0|||
144187936|NCT02490800|519881307|FG012|Overall Study|Patient enrolled in post-trial access|6|||
144187937|NCT00537017|519881308|FG000|Treatment Phase|Adverse Event|19|||
144187938|NCT00537017|519881308|FG000|Treatment Phase|Withdrawal by Subject|13|||
144434965|NCT00743652|520797626|FG000|Overall Study|Lost to Follow-up|1|||
144434966|NCT00743652|520797627|FG001|Overall Study|Lost to Follow-up|0|||
144434967|NCT00743652|520797628|FG002|Overall Study|Lost to Follow-up|0|||
144187939|NCT00537017|519881308|FG000|Treatment Phase|Protocol Violation|2|||
144187940|NCT00537017|519881308|FG000|Follow-up Phase|Withdrawal by Subject|9|||
144187941|NCT03365791|519881309|FG000|Overall Study|Adverse Event|5|||
144187942|NCT03365791|519881309|FG000|Overall Study|Death|1|||
144187943|NCT03365791|519881309|FG000|Overall Study|Lost to Follow-up|1|||
144187944|NCT03365791|519881309|FG000|Overall Study|Physician Decision|9|||
144187945|NCT03365791|519881309|FG000|Overall Study|Progressive disease|51|||
144253277|NCT00958412|520126667|FG000|Overall Study|Study prematurely terminated|18|||
144253278|NCT00171158|520128050|FG000|Core Study|Death|27|||
144434968|NCT00743652|520797629|FG003|Overall Study|Lost to Follow-up|0|||
144434969|NCT00743652|520797630|FG004|Overall Study|Lost to Follow-up|0|||
144434970|NCT02547129|520797634|FG000|Overall Study|Difficulty with ongoing infection|1|||
144434971|NCT02547129|520797635|FG001|Overall Study|Difficulty with ongoing infection|0|||
144434972|NCT00805766|520797636|FG000|Screening Period|Adverse Event|1|||
144434973|NCT00805766|520797636|FG000|Screening Period|Lack of Efficacy|2|||
144434974|NCT00805766|520797636|FG000|Screening Period|Pregnancy|1|||
144434975|NCT00805766|520797636|FG000|Screening Period|Responder|2|||
144434976|NCT00805766|520797636|FG000|Increased Dose Period|Adverse Event|4|||
144434977|NCT00805766|520797636|FG000|Increased Dose Period|Lack of Efficacy|7|||
144434978|NCT00805766|520797636|FG000|Increased Dose Period|Pregnancy|1|||
144434979|NCT00805766|520797636|FG000|Increased Dose Period|Withdrawal by Subject|1|||
144434980|NCT03925324|520797637|FG000|Overall Study|Death|1|||
144434981|NCT03925324|520797638|FG001|Overall Study|Death|1|||
144434982|NCT00794196|520797639|FG000|Overall Study|Lost to Follow-up|5|||
144434983|NCT00794196|520797640|FG001|Overall Study|Lost to Follow-up|23|||
144434984|NCT01256593|520797641|FG000|Overall Study|Protocol Violation|26|||
144434985|NCT01256593|520797641|FG000|Overall Study|No Drug Administration Information|2|||
144434986|NCT01256593|520797641|FG000|Overall Study|No Visit After Treatment|186|||
144434987|NCT02129803|520797647|FG000|Overall Study|Protocol Violation|4|||
144434988|NCT02129803|520797648|FG001|Overall Study|Protocol Violation|0|||
144434989|NCT02129803|520797647|FG000|Overall Study|Physician Decision|0|||
144434990|NCT02129803|520797648|FG001|Overall Study|Physician Decision|1|||
144434991|NCT02129803|520797647|FG000|Overall Study|Difficulty sleeping|1|||
144434992|NCT02129803|520797648|FG001|Overall Study|Difficulty sleeping|0|||
144434993|NCT02129803|520797647|FG000|Overall Study|Morning headache|0|||
144434994|NCT02129803|520797648|FG001|Overall Study|Morning headache|1|||
144434995|NCT02129803|520797647|FG000|Overall Study|Withdrawal by Subject|1|||
144434996|NCT02129803|520797648|FG001|Overall Study|Withdrawal by Subject|1|||
144434997|NCT00149747|520797655|FG000|Overall Study|Death|1|||
144434998|NCT00149747|520797656|FG001|Overall Study|Death|0|||
144434999|NCT00149747|520797655|FG000|Overall Study|Withdrawal by Subject|3|||
144529940|NCT00429364|521143003|FG001|Overall Study|Death|1|||
144529941|NCT00429364|521143002|FG000|Overall Study|Underwent aortic root surgery|10|||
144529942|NCT00429364|521143003|FG001|Overall Study|Underwent aortic root surgery|18|||
144529943|NCT00429364|521143002|FG000|Overall Study|Pregnancy|0|||
144529944|NCT00429364|521143003|FG001|Overall Study|Pregnancy|1|||
144529945|NCT04871529|521143004|FG000|Overall Study|Withdrawal by Subject|0|||
144187946|NCT03365791|519881309|FG000|Overall Study|Subject/guardian decision|5|||
144187947|NCT00987831|519881310|FG000|Overall Study|Never flared in 12 months|1|||
144187948|NCT00987831|519881311|FG001|Overall Study|Never flared in 12 months|0|||
144187949|NCT00987831|519881312|FG002|Overall Study|Never flared in 12 months|0|||
144187950|NCT00987831|519881310|FG000|Overall Study|Lost to Follow-up|0|||
144187951|NCT00987831|519881311|FG001|Overall Study|Lost to Follow-up|3|||
144187952|NCT00987831|519881312|FG002|Overall Study|Lost to Follow-up|0|||
144187953|NCT00794417|519882866|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
144187954|NCT00794417|519882867|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
144187955|NCT00794417|519882868|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
144187956|NCT00794417|519882869|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
144187957|NCT00794417|519882866|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
144187958|NCT00794417|519882867|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
144187959|NCT00794417|519882868|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
144187960|NCT00794417|519882869|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
144187961|NCT00794417|519882866|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
144187962|NCT00794417|519882867|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
144187963|NCT00794417|519882868|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
144187964|NCT00794417|519882869|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
144187965|NCT00794417|519882866|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
144187966|NCT00794417|519882867|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
144187967|NCT00794417|519882868|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
144187968|NCT00794417|519882869|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
144187969|NCT00794417|519882866|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
144187970|NCT00794417|519882867|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
144187971|NCT00794417|519882868|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
144187972|NCT00794417|519882869|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
144187973|NCT00794417|519882866|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
144435000|NCT00149747|520797656|FG001|Overall Study|Withdrawal by Subject|3|||
144435001|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
144435002|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
144435003|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
144435004|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
144435005|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
144435006|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
144529946|NCT04871529|521143005|FG001|Overall Study|Withdrawal by Subject|1|||
144253279|NCT00171158|520128050|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
144253280|NCT00171158|520128050|FG000|Core Study|Protocol Violation|4|||
144253281|NCT00171158|520128050|FG000|Core Study|Administrative problems|1|||
144253282|NCT00171158|520128050|FG000|Core Study|Adverse event, non-fatal|21|||
144253283|NCT00171158|520128050|FG000|Core Study|Consent withdrawn by subject|6|||
144253284|NCT00171158|520128050|FG000|Core Study|No longer required drug (BMT)|14|||
144253285|NCT00171158|520128050|FG000|Core Study|Abnormal Laboratory Values|2|||
144253286|NCT00171158|520128050|FG000|Core Study|Lost to Follow-up|1|||
144253287|NCT00171158|520128050|FG000|E2 Extension|Other|7|||
144253288|NCT02757352|520128054|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
144253289|NCT02757352|520128055|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144253290|NCT02757352|520128056|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
144253291|NCT02757352|520128057|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144253292|NCT02757352|520128058|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144253293|NCT02757352|520128059|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144435007|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
144435008|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
144435009|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
144435010|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
144435011|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
144435012|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
144435013|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
144435014|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
144435015|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
144435016|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
144529947|NCT04871529|521143004|FG000|Overall Study|Death|0|||
144529948|NCT04871529|521143005|FG001|Overall Study|Death|1|||
144529949|NCT04871529|521143004|FG000|Overall Study|Not protocol specified|0|||
144529950|NCT04871529|521143005|FG001|Overall Study|Not protocol specified|1|||
144529951|NCT05184452|521143006|FG000|Overall Study|Lost to Follow-up|0|||
144529952|NCT05184452|521143007|FG001|Overall Study|Lost to Follow-up|0|||
144529953|NCT05184452|521143008|FG002|Overall Study|Lost to Follow-up|0|||
144529954|NCT05184452|521143009|FG003|Overall Study|Lost to Follow-up|0|||
144529955|NCT05184452|521143010|FG004|Overall Study|Lost to Follow-up|0|||
144529956|NCT05184452|521143011|FG005|Overall Study|Lost to Follow-up|2|||
144529957|NCT05184452|521143012|FG006|Overall Study|Lost to Follow-up|0|||
144529958|NCT05184452|521143013|FG007|Overall Study|Lost to Follow-up|0|||
144529959|NCT05184452|521143014|FG008|Overall Study|Lost to Follow-up|0|||
144529960|NCT05184452|521143015|FG009|Overall Study|Lost to Follow-up|1|||
144435017|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
144435018|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
144435019|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
144435020|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
144435021|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
144435022|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
144435023|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
144435024|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
144435025|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
144435026|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
144435027|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
144435028|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
144435029|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
144435030|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
144435031|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
144435032|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
144435033|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
144435034|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
144435035|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
144435036|NCT03373383|520797657|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
144435037|NCT03373383|520797658|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
144435038|NCT03373383|520797659|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
144435039|NCT03373383|520797660|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
144435040|NCT03373383|520797661|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
144529961|NCT05184452|521143006|FG000|Overall Study|Withdrawal by Subject|0|||
144529962|NCT05184452|521143007|FG001|Overall Study|Withdrawal by Subject|0|||
144435041|NCT03373383|520797657|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
144529963|NCT05184452|521143008|FG002|Overall Study|Withdrawal by Subject|0|||
144529964|NCT05184452|521143009|FG003|Overall Study|Withdrawal by Subject|0|||
144529965|NCT05184452|521143010|FG004|Overall Study|Withdrawal by Subject|0|||
144529966|NCT05184452|521143011|FG005|Overall Study|Withdrawal by Subject|1|||
144253294|NCT02757352|520128060|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144253295|NCT02757352|520128061|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144187974|NCT00794417|519882867|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
144187975|NCT00794417|519882868|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
144187976|NCT00794417|519882869|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
144187977|NCT00317642|519882870|FG000|Overall Study|Not Received Either Study Drug|1|||
144187978|NCT00317642|519882871|FG001|Overall Study|Not Received Either Study Drug|3|||
144187979|NCT00317642|519882870|FG000|Overall Study|Physician Decision|15|||
144187980|NCT00317642|519882871|FG001|Overall Study|Physician Decision|7|||
144435042|NCT03373383|520797658|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
144435043|NCT03373383|520797659|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
144435044|NCT03373383|520797660|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
144435045|NCT03373383|520797661|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
144435046|NCT03742141|520797666|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
144435047|NCT00850395|520797667|FG000|Overall Study|Death|1|||
144435048|NCT00850395|520797667|FG000|Overall Study|Adverse Event|1|||
144435049|NCT00850395|520797667|FG000|Overall Study|Insufficient clinical response|3|||
144435050|NCT00850395|520797667|FG000|Overall Study|Other|5|||
144435051|NCT04371380|520797668|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
144435052|NCT04371380|520797669|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
144435053|NCT04371380|520797670|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
144435054|NCT00405548|520797673|FG000|Overall Study|Cognitive Memory problems on study day|1|||
144435055|NCT00405548|520797674|FG001|Overall Study|Cognitive Memory problems on study day|0|||
144435056|NCT00405548|520797673|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
144435057|NCT00405548|520797674|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
144435058|NCT00405548|520797673|FG000|Overall Study|Unable to self-administer shots|1|||
144435059|NCT00405548|520797674|FG001|Overall Study|Unable to self-administer shots|0|||
144435060|NCT00405548|520797673|FG000|Overall Study|Venous access failed during study day|1|||
144435061|NCT00405548|520797674|FG001|Overall Study|Venous access failed during study day|0|||
144529967|NCT05184452|521143012|FG006|Overall Study|Withdrawal by Subject|0|||
144529968|NCT05184452|521143013|FG007|Overall Study|Withdrawal by Subject|0|||
144529969|NCT05184452|521143014|FG008|Overall Study|Withdrawal by Subject|0|||
144529970|NCT05184452|521143015|FG009|Overall Study|Withdrawal by Subject|1|||
144529971|NCT05586490|521143016|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
144529972|NCT05586490|521143017|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
144529973|NCT05586490|521143018|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
144529974|NCT05586490|521143019|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
144529975|NCT05586490|521143020|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
144529976|NCT05586490|521143016|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
144529977|NCT05586490|521143017|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
144529978|NCT05586490|521143018|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
144529979|NCT05586490|521143019|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
144529980|NCT05586490|521143020|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
144529981|NCT05586490|521143016|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
144529982|NCT05586490|521143017|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
144529983|NCT05586490|521143018|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
144529984|NCT05586490|521143019|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
144529985|NCT05586490|521143020|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
144529986|NCT04032847|521143021|FG000|Overall Study|Study termination by sponsor|8|||
144529987|NCT04032847|521143022|FG001|Overall Study|Study termination by sponsor|0|||
144529988|NCT04032847|521143023|FG002|Overall Study|Study termination by sponsor|4|||
144529989|NCT04032847|521143021|FG000|Overall Study|Death|12|||
144529990|NCT04032847|521143022|FG001|Overall Study|Death|0|||
144529991|NCT04032847|521143023|FG002|Overall Study|Death|0|||
144529992|NCT04032847|521143021|FG000|Overall Study|Progressive disease|2|||
144529993|NCT04032847|521143022|FG001|Overall Study|Progressive disease|0|||
144529994|NCT04032847|521143023|FG002|Overall Study|Progressive disease|1|||
144529995|NCT03325985|521143024|FG000|Overall Study|Lost to Follow-up|122|||
144529996|NCT03325985|521143025|FG001|Overall Study|Lost to Follow-up|26|||
144529997|NCT03325985|521143026|FG002|Overall Study|Lost to Follow-up|141|||
144529998|NCT03325985|521143027|FG003|Overall Study|Lost to Follow-up|28|||
144529999|NCT03325985|521143024|FG000|Overall Study|Death|99|||
144530000|NCT03325985|521143025|FG001|Overall Study|Death|36|||
144530001|NCT03325985|521143026|FG002|Overall Study|Death|94|||
144530002|NCT03325985|521143027|FG003|Overall Study|Death|32|||
144530003|NCT03056573|521143028|FG000|Overall Study|Death|2|||
144530004|NCT03056573|521143029|FG001|Overall Study|Death|4|||
144530005|NCT03056573|521143028|FG000|Overall Study|Withdrawal by Subject|2|||
144530006|NCT03056573|521143029|FG001|Overall Study|Withdrawal by Subject|0|||
144530007|NCT03056573|521143028|FG000|Overall Study|Lost to Follow-up|1|||
144530008|NCT03056573|521143029|FG001|Overall Study|Lost to Follow-up|1|||
144530009|NCT03556293|521143030|FG000|Overall Study|Ineligible for analysis|1904|||
144435062|NCT00405548|520797673|FG000|Overall Study|Withdrawal by Subject|1|||
144187981|NCT00317642|519882870|FG000|Overall Study|Participant declined treatment|14|||
144187982|NCT00317642|519882871|FG001|Overall Study|Participant declined treatment|3|||
144187983|NCT00317642|519882870|FG000|Overall Study|Adverse Event|17|||
144187984|NCT00317642|519882871|FG001|Overall Study|Adverse Event|5|||
144187985|NCT00317642|519882870|FG000|Overall Study|Treatment Failure|56|||
144187986|NCT00317642|519882871|FG001|Overall Study|Treatment Failure|102|||
144187987|NCT00317642|519882870|FG000|Overall Study|Disease Recurrence|1|||
144435063|NCT00405548|520797674|FG001|Overall Study|Withdrawal by Subject|0|||
144435064|NCT01709695|520797675|FG000|Overall Study|Withdrawal by Subject|1|||
144435065|NCT01709695|520797676|FG001|Overall Study|Withdrawal by Subject|1|||
144435066|NCT02741700|520797681|FG000|Overall Study|Lost to Follow-up|17|||
144435067|NCT02741700|520797682|FG001|Overall Study|Lost to Follow-up|8|||
144435068|NCT02741700|520797681|FG000|Overall Study|Withdrawal by Subject|2|||
144435069|NCT02741700|520797682|FG001|Overall Study|Withdrawal by Subject|5|||
144435070|NCT02741700|520797681|FG000|Overall Study|Physician Decision|3|||
144435071|NCT02741700|520797682|FG001|Overall Study|Physician Decision|0|||
144435072|NCT02741700|520797681|FG000|Overall Study|Moved out of State|0|||
144435073|NCT02741700|520797682|FG001|Overall Study|Moved out of State|1|||
144435074|NCT02741700|520797681|FG000|Overall Study|Death|4|||
144435075|NCT02741700|520797682|FG001|Overall Study|Death|5|||
144435076|NCT01177540|520797683|FG000|Overall Study|Adverse Event|1|||
144435077|NCT01177540|520797684|FG001|Overall Study|Adverse Event|0|||
144435078|NCT01418937|520797688|FG000|Overall Study|Lost to Follow-up|5|||
144435079|NCT01418937|520797688|FG000|Overall Study|Protocol Violation|1|||
144435080|NCT01418937|520797688|FG000|Overall Study|Pregnancy|1|||
144435081|NCT01418937|520797688|FG000|Overall Study|Withdrawal by Subject|1|||
144435082|NCT04059146|520797689|FG000|Overall Study|Withdrawal by Subject|0|||
144435083|NCT04059146|520797690|FG001|Overall Study|Withdrawal by Subject|1|||
144435084|NCT01623596|520797691|FG000|Overall Study|Abnormal laboratory values|2|||
144435085|NCT01623596|520797692|FG001|Overall Study|Abnormal laboratory values|0|||
144435086|NCT01623596|520797691|FG000|Overall Study|Administrative problems|9|||
144435087|NCT01623596|520797692|FG001|Overall Study|Administrative problems|13|||
144435088|NCT01623596|520797691|FG000|Overall Study|Adverse Event|20|||
144435089|NCT01623596|520797692|FG001|Overall Study|Adverse Event|29|||
144435090|NCT01623596|520797691|FG000|Overall Study|Death|0|||
144435091|NCT01623596|520797692|FG001|Overall Study|Death|2|||
144435092|NCT01623596|520797691|FG000|Overall Study|Lost to Follow-up|12|||
144435093|NCT01623596|520797692|FG001|Overall Study|Lost to Follow-up|16|||
144435094|NCT01623596|520797691|FG000|Overall Study|Withdrawal by Subject|13|||
144435095|NCT01623596|520797692|FG001|Overall Study|Withdrawal by Subject|31|||
144435096|NCT01623596|520797691|FG000|Overall Study|Patient no longer requires study drug|1|||
144435097|NCT01623596|520797692|FG001|Overall Study|Patient no longer requires study drug|0|||
144435098|NCT01623596|520797691|FG000|Overall Study|Protocol Violation|0|||
144435099|NCT01623596|520797692|FG001|Overall Study|Protocol Violation|6|||
144435100|NCT01623596|520797691|FG000|Overall Study|Lack of Efficacy|5|||
144435101|NCT01623596|520797692|FG001|Overall Study|Lack of Efficacy|3|||
144435102|NCT01324349|520797693|FG000|Overall Study|Death|1|||
144435103|NCT01324349|520797694|FG001|Overall Study|Death|1|||
144435104|NCT01324349|520797693|FG000|Overall Study|Withdrawal by Subject|0|||
144435105|NCT01324349|520797694|FG001|Overall Study|Withdrawal by Subject|1|||
144435106|NCT01070316|520797695|FG000|Extension Phase|Lack of Efficacy|3|||
144435107|NCT01070316|520797695|FG000|Extension Phase|Withdrawal by Subject|1|||
144435108|NCT00748215|520797698|FG000|Overall Study|Withdrawal by Subject|7|||
144435109|NCT00748215|520797699|FG001|Overall Study|Withdrawal by Subject|7|||
144435110|NCT00748215|520797698|FG000|Overall Study|Treatment change|2|||
144435111|NCT00748215|520797699|FG001|Overall Study|Treatment change|1|||
144435112|NCT00748215|520797698|FG000|Overall Study|Change in patient condition|0|||
144435113|NCT00748215|520797699|FG001|Overall Study|Change in patient condition|3|||
144435114|NCT00748215|520797698|FG000|Overall Study|Non-compliant|0|||
144435115|NCT00748215|520797699|FG001|Overall Study|Non-compliant|2|||
144435116|NCT00748215|520797698|FG000|Overall Study|Adverse Event|0|||
144435117|NCT00748215|520797699|FG001|Overall Study|Adverse Event|5|||
144435118|NCT01132495|520797700|FG000|Overall Study|Various reasons|40|||
144435119|NCT01132495|520797701|FG001|Overall Study|Various reasons|38|||
144435120|NCT01132495|520797702|FG002|Overall Study|Various reasons|20|||
144435121|NCT01132495|520797703|FG003|Overall Study|Various reasons|12|||
144435122|NCT00082433|520797704|FG000|Overall Study|Adverse Event|12|||
144435123|NCT00082433|520797705|FG001|Overall Study|Adverse Event|17|||
144530010|NCT03556293|521143031|FG001|Overall Study|Ineligible for analysis|1471|||
144530011|NCT03556293|521143032|FG002|Overall Study|Ineligible for analysis|1091|||
144530012|NCT03556293|521143033|FG003|Overall Study|Ineligible for analysis|1269|||
144530013|NCT05104463|521143034|FG000|Overall Study|Adverse Event|1|||
144435124|NCT00082433|520797704|FG000|Overall Study|Death|8|||
144435125|NCT00082433|520797705|FG001|Overall Study|Death|18|||
144530014|NCT05104463|521143035|FG001|Overall Study|Adverse Event|1|||
144435126|NCT00082433|520797704|FG000|Overall Study|Disease Progression/Relapse|270|||
144530015|NCT05104463|521143034|FG000|Overall Study|Lost to Follow-up|1|||
144187988|NCT00317642|519882871|FG001|Overall Study|Disease Recurrence|2|||
144187989|NCT00317642|519882870|FG000|Overall Study|Death|14|||
144435127|NCT00082433|520797705|FG001|Overall Study|Disease Progression/Relapse|388|||
144435128|NCT00082433|520797704|FG000|Overall Study|Physician Decision|50|||
144435129|NCT00082433|520797705|FG001|Overall Study|Physician Decision|61|||
144435130|NCT00082433|520797704|FG000|Overall Study|Lost to Follow-up|1|||
144435131|NCT00082433|520797705|FG001|Overall Study|Lost to Follow-up|2|||
144435132|NCT00082433|520797704|FG000|Overall Study|Study Drug Toxicity|179|||
144435133|NCT00082433|520797705|FG001|Overall Study|Study Drug Toxicity|66|||
144435134|NCT00082433|520797704|FG000|Overall Study|Withdrawal by Subject|55|||
144435135|NCT00082433|520797705|FG001|Overall Study|Withdrawal by Subject|30|||
144435136|NCT00082433|520797704|FG000|Overall Study|Still On Treatment|2|||
144435137|NCT00082433|520797705|FG001|Overall Study|Still On Treatment|1|||
144435138|NCT00082433|520797704|FG000|Overall Study|Not Treated|12|||
144435139|NCT00082433|520797705|FG001|Overall Study|Not Treated|11|||
144435140|NCT00082433|520797704|FG000|Overall Study|Ineligible|2|||
144435141|NCT00082433|520797705|FG001|Overall Study|Ineligible|1|||
144435142|NCT00082433|520797704|FG000|Overall Study|Noncompliance|2|||
144435143|NCT00082433|520797705|FG001|Overall Study|Noncompliance|1|||
144435144|NCT00082433|520797704|FG000|Overall Study|New primary cancer|1|||
144435145|NCT00082433|520797705|FG001|Overall Study|New primary cancer|0|||
144435146|NCT00082433|520797704|FG000|Overall Study|Impending surgery|0|||
144435147|NCT00082433|520797705|FG001|Overall Study|Impending surgery|1|||
144435148|NCT01796197|520797708|FG000|Overall Study|Lost to Follow-up|1|||
144435149|NCT01796197|520797708|FG000|Overall Study|Lack of Efficacy|1|||
144435150|NCT00574405|520799291|FG000|Overall Study|Withdrawal by Subject|3|||
144435151|NCT00574405|520799292|FG001|Overall Study|Withdrawal by Subject|2|||
144435152|NCT04615949|520799293|FG000|Overall Study|Withdrawal by Subject|2|||
144435153|NCT04615949|520799294|FG001|Overall Study|Withdrawal by Subject|4|||
144253296|NCT02757352|520128062|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144253297|NCT02757352|520128063|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
144253298|NCT02757352|520128054|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253299|NCT02757352|520128055|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253300|NCT02757352|520128056|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
144253301|NCT02757352|520128057|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253302|NCT02757352|520128058|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253303|NCT02757352|520128059|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253304|NCT02757352|520128060|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253305|NCT02757352|520128061|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253306|NCT02757352|520128062|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253307|NCT02757352|520128063|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
144253308|NCT02757352|520128054|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
144435154|NCT04615949|520799293|FG000|Overall Study|Lost to Follow-up|2|||
144435155|NCT04615949|520799294|FG001|Overall Study|Lost to Follow-up|2|||
144435156|NCT04615949|520799293|FG000|Overall Study|Death|0|||
144435157|NCT04615949|520799294|FG001|Overall Study|Death|2|||
144435158|NCT03036566|520799295|FG000|Overall Study|Lost to Follow-up|3|||
144435159|NCT04380857|520799297|FG000|Overall Study|Lost to Follow-up|3|||
144435160|NCT04380857|520799298|FG001|Overall Study|Lost to Follow-up|3|||
144435161|NCT02558790|520799299|FG000|Overall Study|Lost to Follow-up|2|||
144435162|NCT02558790|520799299|FG000|Overall Study|Physician Decision|1|||
144435163|NCT02558790|520799299|FG000|Overall Study|Withdrawal by Subject|1|||
144435164|NCT02558790|520799299|FG000|Overall Study|Screen Fail|3|||
144435165|NCT01888497|520799300|FG000|Washout Period 1|Withdrawal by Subject|0|||
144435166|NCT01888497|520799301|FG001|Washout Period 1|Withdrawal by Subject|0|||
144435167|NCT01888497|520799302|FG002|Washout Period 1|Withdrawal by Subject|1|||
144435168|NCT01888497|520799303|FG003|Washout Period 1|Withdrawal by Subject|1|||
144435169|NCT01888497|520799300|FG000|Washout Period 2|Adverse Event|0|||
144530016|NCT05104463|521143035|FG001|Overall Study|Lost to Follow-up|1|||
144530017|NCT05104463|521143034|FG000|Overall Study|Physician Decision|1|||
144530018|NCT05104463|521143035|FG001|Overall Study|Physician Decision|0|||
144530019|NCT05104463|521143034|FG000|Overall Study|Protocol Violation|0|||
144530020|NCT05104463|521143035|FG001|Overall Study|Protocol Violation|2|||
144530021|NCT05104463|521143034|FG000|Overall Study|Withdrawal by Subject|1|||
144530022|NCT05104463|521143035|FG001|Overall Study|Withdrawal by Subject|1|||
144530023|NCT05267470|521143036|FG000|Overall Study|Decision by sponsor|0|||
144253309|NCT02757352|520128055|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
144253310|NCT02757352|520128056|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
144435170|NCT01888497|520799301|FG001|Washout Period 2|Adverse Event|0|||
144435171|NCT01888497|520799302|FG002|Washout Period 2|Adverse Event|0|||
144435172|NCT01888497|520799303|FG003|Washout Period 2|Adverse Event|1|||
144435173|NCT01888497|520799300|FG000|Washout Period 2|Withdrawal by Subject|0|||
144435174|NCT01888497|520799301|FG001|Washout Period 2|Withdrawal by Subject|0|||
144435175|NCT01888497|520799302|FG002|Washout Period 2|Withdrawal by Subject|0|||
144435176|NCT01888497|520799303|FG003|Washout Period 2|Withdrawal by Subject|1|||
144435177|NCT03711162|520799304|FG000|Overall Study|Adverse Event|5|||
144435178|NCT03711162|520799305|FG001|Overall Study|Adverse Event|2|||
144435179|NCT03711162|520799306|FG002|Overall Study|Adverse Event|4|||
144435180|NCT03711162|520799304|FG000|Overall Study|Death|11|||
144435181|NCT03711162|520799305|FG001|Overall Study|Death|7|||
144435182|NCT03711162|520799306|FG002|Overall Study|Death|8|||
144435183|NCT03711162|520799304|FG000|Overall Study|Lost to Follow-up|1|||
144435184|NCT03711162|520799305|FG001|Overall Study|Lost to Follow-up|0|||
144435185|NCT03711162|520799306|FG002|Overall Study|Lost to Follow-up|1|||
144435186|NCT03711162|520799304|FG000|Overall Study|Study Terminated by Sponsor|139|||
144435187|NCT03711162|520799305|FG001|Overall Study|Study Terminated by Sponsor|152|||
144435188|NCT03711162|520799306|FG002|Overall Study|Study Terminated by Sponsor|146|||
144435189|NCT03711162|520799304|FG000|Overall Study|Withdrawal by Subject|17|||
144435190|NCT03711162|520799305|FG001|Overall Study|Withdrawal by Subject|10|||
144435191|NCT03711162|520799306|FG002|Overall Study|Withdrawal by Subject|10|||
144435192|NCT03711162|520799304|FG000|Overall Study|Miscellaneous|1|||
144435193|NCT03711162|520799305|FG001|Overall Study|Miscellaneous|2|||
144435194|NCT03711162|520799306|FG002|Overall Study|Miscellaneous|2|||
144435195|NCT03711162|520799304|FG000|Overall Study|Not Treated|1|||
144435196|NCT03711162|520799305|FG001|Overall Study|Not Treated|0|||
144435197|NCT03711162|520799306|FG002|Overall Study|Not Treated|1|||
144435198|NCT03711162|520799304|FG000|Overall Study|Physician Decision|0|||
144435199|NCT03711162|520799305|FG001|Overall Study|Physician Decision|2|||
144435200|NCT03711162|520799306|FG002|Overall Study|Physician Decision|0|||
144435201|NCT03711162|520799304|FG000|Overall Study|Lack of Efficacy|0|||
144435202|NCT03711162|520799305|FG001|Overall Study|Lack of Efficacy|0|||
144435203|NCT03711162|520799306|FG002|Overall Study|Lack of Efficacy|2|||
144187990|NCT00317642|519882871|FG001|Overall Study|Death|7|||
144187991|NCT00317642|519882870|FG000|Overall Study|Not Continue to Consolidation|2|||
144187992|NCT00317642|519882871|FG001|Overall Study|Not Continue to Consolidation|0|||
144187993|NCT00317642|519882870|FG000|Overall Study|Withdrawal by Subject|0|||
144187994|NCT00317642|519882871|FG001|Overall Study|Withdrawal by Subject|1|||
144187995|NCT00317642|519882870|FG000|Overall Study|Referred For Transplantation|1|||
144187996|NCT00317642|519882871|FG001|Overall Study|Referred For Transplantation|0|||
144187997|NCT00317642|519882870|FG000|Overall Study|AML Not Centrally Confirmed|1|||
144187998|NCT00317642|519882871|FG001|Overall Study|AML Not Centrally Confirmed|5|||
144187999|NCT01239472|519882875|FG000|Overall Study|Withdrawal by Subject|5|||
144435204|NCT03711162|520799304|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
144435205|NCT03711162|520799305|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
144435206|NCT03711162|520799306|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
144435207|NCT03240133|520799307|FG000|Overall Study|Withdrawal by Subject|0|||
144435208|NCT03240133|520799308|FG001|Overall Study|Withdrawal by Subject|1|||
144435209|NCT03240133|520799309|FG002|Overall Study|Withdrawal by Subject|0|||
144435210|NCT03240133|520799307|FG000|Overall Study|Adverse Event|1|||
144435211|NCT03240133|520799308|FG001|Overall Study|Adverse Event|1|||
144435212|NCT03240133|520799309|FG002|Overall Study|Adverse Event|0|||
144435213|NCT03240133|520799307|FG000|Overall Study|Rash|1|||
144435214|NCT03240133|520799308|FG001|Overall Study|Rash|0|||
144435215|NCT03240133|520799309|FG002|Overall Study|Rash|0|||
144435216|NCT03240133|520799307|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
144435217|NCT03240133|520799308|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
144435218|NCT03240133|520799309|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
144435219|NCT03240133|520799307|FG000|Overall Study|Intercurrent illness.|0|||
144435220|NCT03240133|520799308|FG001|Overall Study|Intercurrent illness.|1|||
144435221|NCT03240133|520799309|FG002|Overall Study|Intercurrent illness.|0|||
144435222|NCT03240133|520799307|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
144435223|NCT03240133|520799308|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
144435224|NCT03240133|520799309|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
144435225|NCT02711800|520799313|FG000|Overall Study|Lost to Follow-up|1|||
144530024|NCT05267470|521143037|FG001|Overall Study|Decision by sponsor|3|||
144530025|NCT05267470|521143038|FG002|Overall Study|Decision by sponsor|19|||
144530026|NCT05267470|521143039|FG003|Overall Study|Decision by sponsor|7|||
144530027|NCT05267470|521143040|FG004|Overall Study|Decision by sponsor|3|||
144530028|NCT05267470|521143036|FG000|Overall Study|Withdrawal by Subject|1|||
144530029|NCT05267470|521143037|FG001|Overall Study|Withdrawal by Subject|1|||
144530030|NCT05267470|521143038|FG002|Overall Study|Withdrawal by Subject|2|||
144530031|NCT05267470|521143039|FG003|Overall Study|Withdrawal by Subject|2|||
144530032|NCT05267470|521143040|FG004|Overall Study|Withdrawal by Subject|0|||
144530033|NCT05267470|521143036|FG000|Overall Study|Death|3|||
144530034|NCT05267470|521143037|FG001|Overall Study|Death|5|||
144188000|NCT01239472|519882876|FG001|Overall Study|Withdrawal by Subject|1|||
144435226|NCT02711800|520799313|FG000|Overall Study|Withdrawal by Subject|1|||
144188001|NCT01239472|519882875|FG000|Overall Study|Adverse Event|0|||
144435227|NCT00097721|520799323|FG000|Overall Study|Adverse Event|8|||
144435228|NCT00097721|520799324|FG001|Overall Study|Adverse Event|1|||
144435229|NCT00097721|520799323|FG000|Overall Study|Withdrawal by Subject|6|||
144435230|NCT00097721|520799324|FG001|Overall Study|Withdrawal by Subject|1|||
144435231|NCT00097721|520799323|FG000|Overall Study|Progressive Disease|55|||
144530035|NCT05267470|521143038|FG002|Overall Study|Death|8|||
144530036|NCT05267470|521143039|FG003|Overall Study|Death|18|||
144188002|NCT01239472|519882876|FG001|Overall Study|Adverse Event|1|||
144435232|NCT00097721|520799324|FG001|Overall Study|Progressive Disease|27|||
144435233|NCT00097721|520799323|FG000|Overall Study|Physician Decision|1|||
144435234|NCT00097721|520799324|FG001|Overall Study|Physician Decision|3|||
144435235|NCT00097721|520799323|FG000|Overall Study|Reason not given|1|||
144435236|NCT00097721|520799324|FG001|Overall Study|Reason not given|1|||
144435237|NCT00314574|520799328|FG000|Overall Study|Death|3|||
144435238|NCT00314574|520799329|FG001|Overall Study|Death|0|||
144435239|NCT00314574|520799328|FG000|Overall Study|Adverse Event|11|||
144435240|NCT00314574|520799329|FG001|Overall Study|Adverse Event|16|||
144435241|NCT00314574|520799328|FG000|Overall Study|Lost to Follow-up|19|||
144435242|NCT00314574|520799329|FG001|Overall Study|Lost to Follow-up|25|||
144435243|NCT00314574|520799328|FG000|Overall Study|Withdrawal by Subject|33|||
144435244|NCT00314574|520799329|FG001|Overall Study|Withdrawal by Subject|22|||
144435245|NCT00314574|520799328|FG000|Overall Study|Physician Decision|22|||
144435246|NCT00314574|520799329|FG001|Overall Study|Physician Decision|15|||
144435247|NCT00314574|520799328|FG000|Overall Study|Pregnancy|6|||
144435248|NCT00314574|520799329|FG001|Overall Study|Pregnancy|4|||
144435249|NCT00314574|520799328|FG000|Overall Study|Data unknown at database lock|0|||
144435250|NCT00314574|520799329|FG001|Overall Study|Data unknown at database lock|1|||
144435251|NCT00449956|520799330|FG000|Overall Study|Adverse Event|7|||
144435252|NCT00449956|520799331|FG001|Overall Study|Adverse Event|1|||
144435253|NCT00449956|520799332|FG002|Overall Study|Adverse Event|6|||
144435254|NCT00449956|520799330|FG000|Overall Study|Lack of Efficacy|0|||
144435255|NCT00449956|520799331|FG001|Overall Study|Lack of Efficacy|0|||
144435256|NCT00449956|520799332|FG002|Overall Study|Lack of Efficacy|1|||
144435257|NCT00449956|520799330|FG000|Overall Study|Protocol Violation|1|||
144435258|NCT00449956|520799331|FG001|Overall Study|Protocol Violation|1|||
144435259|NCT00449956|520799332|FG002|Overall Study|Protocol Violation|1|||
144435260|NCT00449956|520799330|FG000|Overall Study|Withdrawal by Subject|0|||
144435261|NCT00449956|520799331|FG001|Overall Study|Withdrawal by Subject|1|||
144435262|NCT00449956|520799332|FG002|Overall Study|Withdrawal by Subject|0|||
144435263|NCT00449956|520799330|FG000|Overall Study|Physician Decision|2|||
144435264|NCT00449956|520799331|FG001|Overall Study|Physician Decision|1|||
144435265|NCT00449956|520799332|FG002|Overall Study|Physician Decision|1|||
144435266|NCT00004412|520799339|FG000|Randomized Period|Moved to Crossover Period|3|||
144435267|NCT00004412|520799340|FG001|Randomized Period|Moved to Crossover Period|0|||
144435268|NCT00004412|520799341|FG002|Randomized Period|Moved to Crossover Period|0|||
144435269|NCT03144180|520799347|FG000|Overall Study|STAT Delivery|1|||
144435270|NCT03144180|520799348|FG001|Overall Study|STAT Delivery|1|||
144435271|NCT03144180|520799347|FG000|Overall Study|Provider forgot to fill out forms|1|||
144435272|NCT03144180|520799348|FG001|Overall Study|Provider forgot to fill out forms|3|||
144435273|NCT03144180|520799347|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
144435274|NCT03144180|520799348|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
144435275|NCT03144180|520799347|FG000|Overall Study|Scrub tech removed tube cap|0|||
144435276|NCT03144180|520799348|FG001|Overall Study|Scrub tech removed tube cap|1|||
144435277|NCT03387813|520799351|FG000|Overall Study|Death|40|||
144435278|NCT03387813|520799352|FG001|Overall Study|Death|37|||
144435279|NCT03387813|520799353|FG002|Overall Study|Death|190|||
144435280|NCT03387813|520799351|FG000|Overall Study|Withdrawal by Subject|9|||
144435281|NCT03387813|520799352|FG001|Overall Study|Withdrawal by Subject|19|||
144435282|NCT03387813|520799353|FG002|Overall Study|Withdrawal by Subject|32|||
144435283|NCT03387813|520799351|FG000|Overall Study|Lost to Follow-up|3|||
144435284|NCT03387813|520799352|FG001|Overall Study|Lost to Follow-up|9|||
144435285|NCT03387813|520799353|FG002|Overall Study|Lost to Follow-up|15|||
144435286|NCT03387813|520799351|FG000|Overall Study|Non-Compliance|6|||
144435287|NCT03387813|520799352|FG001|Overall Study|Non-Compliance|6|||
144435288|NCT03387813|520799353|FG002|Overall Study|Non-Compliance|31|||
144435289|NCT03387813|520799351|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
144435290|NCT03387813|520799352|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
144472075|NCT00394355|520925381|FG003|Overall Study|Did not meet protocol eligibility|2|||
144472076|NCT00394355|520925378|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
144472077|NCT00394355|520925379|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
144472078|NCT00394355|520925380|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
144472079|NCT00394355|520925381|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
144472080|NCT00394355|520925378|FG000|Overall Study|Subject withdrawal - related to drug|1|||
144472081|NCT00394355|520925379|FG001|Overall Study|Subject withdrawal - related to drug|0|||
144472082|NCT00394355|520925380|FG002|Overall Study|Subject withdrawal - related to drug|0|||
144472083|NCT00394355|520925381|FG003|Overall Study|Subject withdrawal - related to drug|0|||
144472084|NCT00394355|520925378|FG000|Overall Study|Lost to Follow-up|7|||
144472085|NCT00394355|520925379|FG001|Overall Study|Lost to Follow-up|5|||
144472086|NCT00394355|520925380|FG002|Overall Study|Lost to Follow-up|4|||
144472087|NCT00394355|520925381|FG003|Overall Study|Lost to Follow-up|3|||
144472088|NCT00394355|520925378|FG000|Overall Study|Noncompliance with protocol|4|||
144472089|NCT00394355|520925379|FG001|Overall Study|Noncompliance with protocol|3|||
144472090|NCT00394355|520925380|FG002|Overall Study|Noncompliance with protocol|10|||
144435291|NCT03387813|520799353|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
144435292|NCT04327999|520799358|FG000|Overall Study|Protocol Violation|1|||
144435293|NCT02346136|520799363|FG000|Overall Study|Withdrawal by Subject|7|||
144435294|NCT02346136|520799364|FG001|Overall Study|Withdrawal by Subject|5|||
144435295|NCT02346136|520799363|FG000|Overall Study|Death|1|||
144435296|NCT02346136|520799364|FG001|Overall Study|Death|0|||
144435297|NCT02346136|520799363|FG000|Overall Study|Study termination|14|||
144435298|NCT02346136|520799364|FG001|Overall Study|Study termination|18|||
144435299|NCT03735667|520799365|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
144435300|NCT03735667|520799366|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
144435301|NCT03735667|520799367|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
144435302|NCT03735667|520799365|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
144435303|NCT03735667|520799366|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
144435304|NCT03735667|520799367|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
144435305|NCT03735667|520799365|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
144435306|NCT03735667|520799366|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
144435307|NCT03735667|520799367|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
144435308|NCT03735667|520799365|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
144435309|NCT03735667|520799366|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
144435310|NCT03735667|520799367|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
144435311|NCT03735667|520799365|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
144435312|NCT03735667|520799366|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
144435313|NCT03735667|520799367|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
144435314|NCT03735667|520799365|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
144435315|NCT03735667|520799366|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
144435316|NCT03735667|520799367|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
144435317|NCT03735667|520799365|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
144435318|NCT03735667|520799366|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
144435319|NCT03735667|520799367|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
144435320|NCT03735667|520799365|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
144435321|NCT03735667|520799366|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
144435322|NCT03735667|520799367|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
144435323|NCT03735667|520799365|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
144188003|NCT01239472|519882875|FG000|Overall Study|Lack of Efficacy|0|||
144188004|NCT01239472|519882876|FG001|Overall Study|Lack of Efficacy|1|||
144188005|NCT02695719|519882877|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
144188006|NCT02695719|519882878|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
144188007|NCT02695719|519882877|FG000|Overall Study|Significant Protocol Deviation|0|||
144188008|NCT02695719|519882878|FG001|Overall Study|Significant Protocol Deviation|1|||
144188009|NCT02695719|519882877|FG000|Overall Study|Voluntary Withdrawal|1|||
144188010|NCT02695719|519882878|FG001|Overall Study|Voluntary Withdrawal|0|||
144188011|NCT01534078|519882881|FG000|Overall Study|Death|1|||
144188012|NCT01534078|519882881|FG000|Overall Study|Withdrawal by Subject|1|||
144188013|NCT01049412|519882882|FG000|Period I|Withdrawal by Subject|4|||
144188014|NCT01049412|519882883|FG001|Period I|Withdrawal by Subject|6|||
144188015|NCT01049412|519882882|FG000|Period I|Lost to Follow-up|2|||
144188016|NCT01049412|519882883|FG001|Period I|Lost to Follow-up|2|||
144188017|NCT01049412|519882882|FG000|Period I|Physician Decision|0|||
144188018|NCT01049412|519882883|FG001|Period I|Physician Decision|3|||
144188019|NCT01049412|519882882|FG000|Period I|Protocol Violation|1|||
144188020|NCT01049412|519882883|FG001|Period I|Protocol Violation|2|||
144188021|NCT01049412|519882882|FG000|Period I|Adverse Event|1|||
144188022|NCT01049412|519882883|FG001|Period I|Adverse Event|0|||
144188023|NCT01049412|519882882|FG000|Period II|Withdrawal by Subject|2|||
144188024|NCT01049412|519882883|FG001|Period II|Withdrawal by Subject|3|||
144188025|NCT01049412|519882882|FG000|Period II|Adverse Event|1|||
144188026|NCT01049412|519882883|FG001|Period II|Adverse Event|0|||
144188027|NCT01049412|519882882|FG000|Period II|Lost to Follow-up|1|||
144188028|NCT01049412|519882883|FG001|Period II|Lost to Follow-up|0|||
144188029|NCT04205162|519882884|FG000|Overall Study|Lost to Follow-up|1|||
144188030|NCT04205162|519882885|FG001|Overall Study|Lost to Follow-up|0|||
144188031|NCT04205162|519882884|FG000|Overall Study|Withdrawal by Subject|2|||
144188032|NCT04205162|519882885|FG001|Overall Study|Withdrawal by Subject|0|||
144188033|NCT04205162|519882884|FG000|Overall Study|University closure due to COVID-19|1|||
144188034|NCT04205162|519882885|FG001|Overall Study|University closure due to COVID-19|0|||
144188035|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
144188036|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
144188037|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
144188038|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
144188039|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
144188040|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
144188041|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144188042|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144188043|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
144188044|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
144188045|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
144188046|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
144188047|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
144188048|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
144188049|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
144188050|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
144188051|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Death|2|||
144188052|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Death|1|||
144188053|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Death|0|||
144188054|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Death|0|||
144188055|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
144188056|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
144188057|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
144435324|NCT03735667|520799366|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
144435325|NCT03735667|520799367|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
144435326|NCT03735667|520799365|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
144435327|NCT03735667|520799366|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
144435328|NCT03735667|520799367|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
144435329|NCT03735667|520799365|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
144435330|NCT03735667|520799366|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
144435331|NCT03735667|520799367|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
144435332|NCT03735667|520799365|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
144435333|NCT03735667|520799366|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
144435334|NCT03735667|520799367|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
144435335|NCT02308735|520799369|FG000|Overall Study|Physician Decision|2|||
144435336|NCT02308735|520799370|FG001|Overall Study|Physician Decision|0|||
144435337|NCT02308735|520799371|FG002|Overall Study|Physician Decision|0|||
144435338|NCT02308735|520799372|FG003|Overall Study|Physician Decision|2|||
144435339|NCT03792672|520799373|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
144435340|NCT03792672|520799374|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
144435341|NCT03792672|520799375|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
144435342|NCT03792672|520799376|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
144435343|NCT03792672|520799377|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
144435344|NCT03792672|520799378|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
144435345|NCT03792672|520799373|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
144435346|NCT03792672|520799374|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
144435347|NCT03792672|520799375|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
144435348|NCT03792672|520799376|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
144435349|NCT03792672|520799377|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
144435350|NCT03792672|520799378|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
144435351|NCT03792672|520799373|FG000|Treatment Period 4 (2 Days)|Other|1|||
144435352|NCT03792672|520799374|FG001|Treatment Period 4 (2 Days)|Other|0|||
144435353|NCT03792672|520799375|FG002|Treatment Period 4 (2 Days)|Other|0|||
144435354|NCT03792672|520799376|FG003|Treatment Period 4 (2 Days)|Other|0|||
144435355|NCT03792672|520799377|FG004|Treatment Period 4 (2 Days)|Other|0|||
144435356|NCT03792672|520799378|FG005|Treatment Period 4 (2 Days)|Other|0|||
144435357|NCT00453999|520799379|FG000|Overall Study|Adverse Event|1|||
144435358|NCT00453999|520799380|FG001|Overall Study|Adverse Event|2|||
144435359|NCT00453999|520799381|FG002|Overall Study|Adverse Event|1|||
144435360|NCT00453999|520799379|FG000|Overall Study|Lost to Follow-up|0|||
144435361|NCT00453999|520799380|FG001|Overall Study|Lost to Follow-up|1|||
144435362|NCT00453999|520799381|FG002|Overall Study|Lost to Follow-up|1|||
144435363|NCT00453999|520799379|FG000|Overall Study|Withdrawal by Subject|2|||
144435364|NCT00453999|520799380|FG001|Overall Study|Withdrawal by Subject|1|||
144435365|NCT00453999|520799381|FG002|Overall Study|Withdrawal by Subject|1|||
144435366|NCT00453999|520799379|FG000|Overall Study|Subject Request|2|||
144435367|NCT00453999|520799380|FG001|Overall Study|Subject Request|1|||
144435368|NCT00453999|520799381|FG002|Overall Study|Subject Request|0|||
144435369|NCT00006478|520799389|FG000|Overall Study|Vaccine could not be produced|1|||
144435370|NCT00006478|520799389|FG000|Overall Study|Physician Decision|6|||
144435371|NCT04238728|520799395|FG000|Overall Study|Withdrawal by Subject|1|||
144435372|NCT04238728|520799395|FG000|Overall Study|Lost to Follow-up|2|||
144435373|NCT04414553|520799397|FG000|Overall Study|Lost to Follow-up|20|||
144435374|NCT01640366|520799401|FG000|Overall Study|Withdrawal by Subject|1|||
144435375|NCT01640366|520799401|FG000|Overall Study|Protocol Violation|16|||
144435376|NCT01640366|520799401|FG000|Overall Study|Lost to Follow-up|5|||
144435377|NCT02818777|520799405|FG000|Overall Study|Adverse Event|3|||
144435378|NCT04097821|520799416|FG000|Overall Study|Subject Decision|0|||
144435379|NCT04097821|520799417|FG001|Overall Study|Subject Decision|0|||
144435380|NCT04097821|520799418|FG002|Overall Study|Subject Decision|0|||
144435381|NCT04097821|520799419|FG003|Overall Study|Subject Decision|1|||
144435382|NCT04097821|520799420|FG004|Overall Study|Subject Decision|2|||
144188058|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
144188059|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
144188060|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
144188061|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
144188062|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
144188063|NCT03110380|519882888|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
144188064|NCT03110380|519882889|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
144253311|NCT02757352|520128057|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253312|NCT02757352|520128058|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253313|NCT02757352|520128059|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253314|NCT02757352|520128060|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253315|NCT02757352|520128061|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253316|NCT02757352|520128062|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253317|NCT02757352|520128063|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
144253318|NCT02757352|520128054|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253319|NCT02757352|520128055|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
144253320|NCT02757352|520128056|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253321|NCT02757352|520128057|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253322|NCT02757352|520128058|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253323|NCT02757352|520128059|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253324|NCT02757352|520128060|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253325|NCT02757352|520128061|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253326|NCT02757352|520128062|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253327|NCT02757352|520128063|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
144253328|NCT02757352|520128054|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253329|NCT02757352|520128055|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
144253330|NCT02757352|520128056|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253331|NCT02757352|520128057|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253332|NCT02757352|520128058|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253333|NCT02757352|520128059|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253334|NCT02757352|520128060|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253335|NCT02757352|520128061|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253336|NCT02757352|520128062|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253337|NCT02757352|520128063|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253338|NCT02757352|520128054|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
144253339|NCT02757352|520128055|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
144253340|NCT02757352|520128056|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
144253341|NCT02757352|520128057|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253342|NCT02757352|520128058|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253343|NCT02757352|520128059|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253344|NCT02757352|520128060|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253345|NCT02757352|520128061|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253346|NCT02757352|520128062|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253347|NCT02757352|520128063|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253348|NCT02757352|520128054|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
144253349|NCT02757352|520128055|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
144253350|NCT02757352|520128056|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
144253351|NCT02757352|520128057|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253352|NCT02757352|520128058|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253353|NCT02757352|520128059|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253354|NCT02757352|520128060|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253355|NCT02757352|520128061|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253356|NCT02757352|520128062|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253357|NCT02757352|520128063|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
144253358|NCT02757352|520128054|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253359|NCT02757352|520128055|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253360|NCT02757352|520128056|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253361|NCT02757352|520128057|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
144253362|NCT02757352|520128058|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253363|NCT02757352|520128059|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
144435383|NCT04097821|520799421|FG005|Overall Study|Subject Decision|2|||
144188065|NCT03110380|519882890|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
144188066|NCT03110380|519882891|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
144253364|NCT02757352|520128060|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253365|NCT02757352|520128061|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253366|NCT02757352|520128062|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253367|NCT02757352|520128063|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
144253368|NCT02757352|520128054|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253369|NCT02757352|520128055|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144435384|NCT04097821|520799422|FG006|Overall Study|Subject Decision|0|||
144435385|NCT04097821|520799423|FG007|Overall Study|Subject Decision|1|||
144435386|NCT04097821|520799416|FG000|Overall Study|Death|0|||
144435387|NCT04097821|520799417|FG001|Overall Study|Death|0|||
144435388|NCT04097821|520799418|FG002|Overall Study|Death|3|||
144435389|NCT04097821|520799419|FG003|Overall Study|Death|1|||
144435390|NCT04097821|520799420|FG004|Overall Study|Death|0|||
144435391|NCT04097821|520799421|FG005|Overall Study|Death|0|||
144435392|NCT04097821|520799422|FG006|Overall Study|Death|0|||
144435393|NCT04097821|520799423|FG007|Overall Study|Death|0|||
144435394|NCT04097821|520799416|FG000|Overall Study|Physician Decision|1|||
144435395|NCT04097821|520799417|FG001|Overall Study|Physician Decision|2|||
144435396|NCT04097821|520799418|FG002|Overall Study|Physician Decision|0|||
144435397|NCT04097821|520799419|FG003|Overall Study|Physician Decision|0|||
144435398|NCT04097821|520799420|FG004|Overall Study|Physician Decision|0|||
144435399|NCT04097821|520799421|FG005|Overall Study|Physician Decision|0|||
144435400|NCT04097821|520799422|FG006|Overall Study|Physician Decision|0|||
144435401|NCT04097821|520799423|FG007|Overall Study|Physician Decision|0|||
144435402|NCT04097821|520799416|FG000|Overall Study|Adverse Event|0|||
144435403|NCT04097821|520799417|FG001|Overall Study|Adverse Event|0|||
144435404|NCT04097821|520799418|FG002|Overall Study|Adverse Event|1|||
144253370|NCT02757352|520128056|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253371|NCT02757352|520128057|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
144253372|NCT02757352|520128058|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
144253373|NCT02757352|520128059|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
144253374|NCT02757352|520128060|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253375|NCT02757352|520128061|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253376|NCT02757352|520128062|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253377|NCT02757352|520128063|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144253378|NCT02757352|520128054|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253379|NCT02757352|520128055|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253380|NCT02757352|520128056|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253381|NCT02757352|520128057|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253382|NCT02757352|520128058|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
144253383|NCT02757352|520128059|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253384|NCT02757352|520128060|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253385|NCT02757352|520128061|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253386|NCT02757352|520128062|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253387|NCT02757352|520128063|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
144253388|NCT02757352|520128054|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253389|NCT02757352|520128055|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253390|NCT02757352|520128056|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253391|NCT02757352|520128057|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253392|NCT02757352|520128058|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253393|NCT02757352|520128059|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
144253394|NCT02757352|520128060|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253395|NCT02757352|520128061|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253396|NCT02757352|520128062|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253397|NCT02757352|520128063|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
144253398|NCT02757352|520128054|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144435405|NCT04097821|520799419|FG003|Overall Study|Adverse Event|1|||
144435406|NCT04097821|520799420|FG004|Overall Study|Adverse Event|0|||
144435407|NCT04097821|520799421|FG005|Overall Study|Adverse Event|0|||
144435408|NCT04097821|520799422|FG006|Overall Study|Adverse Event|0|||
144435409|NCT04097821|520799423|FG007|Overall Study|Adverse Event|0|||
144435410|NCT04097821|520799416|FG000|Overall Study|New Therapy For Study Indication|0|||
144435411|NCT04097821|520799417|FG001|Overall Study|New Therapy For Study Indication|0|||
144435412|NCT04097821|520799418|FG002|Overall Study|New Therapy For Study Indication|0|||
144253399|NCT02757352|520128055|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144435413|NCT04097821|520799419|FG003|Overall Study|New Therapy For Study Indication|0|||
144435414|NCT04097821|520799420|FG004|Overall Study|New Therapy For Study Indication|0|||
144435415|NCT04097821|520799421|FG005|Overall Study|New Therapy For Study Indication|0|||
144435416|NCT04097821|520799422|FG006|Overall Study|New Therapy For Study Indication|1|||
144435417|NCT04097821|520799423|FG007|Overall Study|New Therapy For Study Indication|0|||
144472091|NCT00394355|520925381|FG003|Overall Study|Noncompliance with protocol|8|||
144530037|NCT05267470|521143040|FG004|Overall Study|Death|1|||
144530038|NCT05267470|521143036|FG000|Overall Study|Lost to Follow-up|0|||
144530039|NCT05267470|521143037|FG001|Overall Study|Lost to Follow-up|0|||
144530040|NCT05267470|521143038|FG002|Overall Study|Lost to Follow-up|0|||
144530041|NCT05267470|521143039|FG003|Overall Study|Lost to Follow-up|1|||
144530042|NCT05267470|521143040|FG004|Overall Study|Lost to Follow-up|0|||
144530043|NCT05828017|521143041|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
144530044|NCT05425420|521143045|FG000|Overall Study|Physician Decision|1|||
144530045|NCT05425420|521143045|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
144530046|NCT02460458|521144256|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
144530047|NCT02460458|521144256|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
144530048|NCT02460458|521144256|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
144530049|NCT02460458|521144256|FG000|First Prospective Phase|Lost to Follow-up|84|||
144530050|NCT02460458|521144256|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
144530051|NCT03220035|521144257|FG000|Overall Study|Adverse Event|1|||
144530052|NCT03220035|521144257|FG000|Overall Study|Protocol Violation|1|||
144530053|NCT03220035|521144257|FG000|Overall Study|Progressive Disease|2|||
144530054|NCT05299073|521144258|FG000|Overall Study|Withdrawal by Subject|0|||
144530055|NCT05299073|521144259|FG001|Overall Study|Withdrawal by Subject|0|||
144530056|NCT05299073|521144260|FG002|Overall Study|Withdrawal by Subject|1|||
144530057|NCT05299073|521144258|FG000|Overall Study|Adverse Event|0|||
144530058|NCT05299073|521144259|FG001|Overall Study|Adverse Event|1|||
144530059|NCT05299073|521144260|FG002|Overall Study|Adverse Event|0|||
144530060|NCT05299073|521144258|FG000|Overall Study|Lost to Follow-up|0|||
144530061|NCT05299073|521144259|FG001|Overall Study|Lost to Follow-up|1|||
144530062|NCT05299073|521144260|FG002|Overall Study|Lost to Follow-up|0|||
144530063|NCT01208662|521144261|FG000|Induction and Consolidation|Disease Progression|23|||
144530064|NCT01208662|521144262|FG001|Induction and Consolidation|Disease Progression|13|||
144530065|NCT01208662|521144263|FG002|Induction and Consolidation|Disease Progression|0|||
144530066|NCT01208662|521144261|FG000|Induction and Consolidation|Adverse Event|16|||
144530067|NCT01208662|521144262|FG001|Induction and Consolidation|Adverse Event|18|||
144530068|NCT01208662|521144263|FG002|Induction and Consolidation|Adverse Event|2|||
144530069|NCT01208662|521144261|FG000|Induction and Consolidation|MD or Participant Decision|16|||
144530070|NCT01208662|521144262|FG001|Induction and Consolidation|MD or Participant Decision|34|||
144530071|NCT01208662|521144263|FG002|Induction and Consolidation|MD or Participant Decision|4|||
144530072|NCT01208662|521144261|FG000|Induction and Consolidation|Death|1|||
144530073|NCT01208662|521144262|FG001|Induction and Consolidation|Death|3|||
144530074|NCT01208662|521144263|FG002|Induction and Consolidation|Death|1|||
144530075|NCT01208662|521144261|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
144530076|NCT01208662|521144262|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
144435418|NCT02776917|520799424|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
144435419|NCT01852292|520801181|FG000|Overall Study|Untreated - did not receive study drug|3|||
144435420|NCT01852292|520801182|FG001|Overall Study|Untreated - did not receive study drug|1|||
144435421|NCT01852292|520801181|FG000|Overall Study|Death|9|||
144435422|NCT01852292|520801182|FG001|Overall Study|Death|8|||
144435423|NCT01852292|520801181|FG000|Overall Study|Patient/guardian decision|8|||
144435424|NCT01852292|520801182|FG001|Overall Study|Patient/guardian decision|4|||
144435425|NCT01852292|520801181|FG000|Overall Study|Adverse Event|8|||
144435426|NCT01852292|520801182|FG001|Overall Study|Adverse Event|11|||
144435427|NCT01852292|520801181|FG000|Overall Study|Physician Decision|6|||
144435428|NCT01852292|520801182|FG001|Overall Study|Physician Decision|2|||
144435429|NCT01852292|520801181|FG000|Overall Study|Protocol Violation|2|||
144435430|NCT01852292|520801182|FG001|Overall Study|Protocol Violation|0|||
144435431|NCT01852292|520801181|FG000|Overall Study|Non-compliance with study treatment|1|||
144435432|NCT01852292|520801182|FG001|Overall Study|Non-compliance with study treatment|0|||
144435433|NCT01852292|520801181|FG000|Overall Study|Study terminated by Sponsor|0|||
144435434|NCT01852292|520801182|FG001|Overall Study|Study terminated by Sponsor|1|||
144435435|NCT01852292|520801181|FG000|Overall Study|Progressive disease|42|||
144435436|NCT01852292|520801182|FG001|Overall Study|Progressive disease|52|||
144435437|NCT01572038|520801186|FG000|Overall Study|Death|648|||
144435438|NCT01572038|520801186|FG000|Overall Study|Withdrawal by Subject|204|||
144435439|NCT01572038|520801186|FG000|Overall Study|Lost to Follow-up|81|||
144435440|NCT01572038|520801186|FG000|Overall Study|Physician Decision|20|||
144530077|NCT01208662|521144263|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
144530078|NCT01208662|521144261|FG000|Maintenance|Disease Progression|156|||
144530079|NCT01208662|521144262|FG001|Maintenance|Disease Progression|102|||
144530080|NCT01208662|521144263|FG002|Maintenance|Disease Progression|0|||
144435441|NCT01572038|520801186|FG000|Overall Study|Patient Decision|14|||
144435442|NCT01572038|520801186|FG000|Overall Study|Progressive Disease|8|||
144435443|NCT01572038|520801186|FG000|Overall Study|Site Closed Before Completing Form|6|||
144435444|NCT01572038|520801186|FG000|Overall Study|Enrolled into Another Trial|3|||
144435445|NCT01572038|520801186|FG000|Overall Study|Participated in Another Trial|3|||
144435446|NCT01572038|520801186|FG000|Overall Study|Termination by Sponsor|2|||
144435447|NCT01572038|520801186|FG000|Overall Study|Patient Deterioration|1|||
144188067|NCT03110380|519882888|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
144435448|NCT01572038|520801186|FG000|Overall Study|Sponsor Decision|1|||
144435449|NCT04152447|520801187|FG000|Overall Study|Lost to Follow-up|1|||
144435450|NCT04152447|520801188|FG001|Overall Study|Lost to Follow-up|0|||
144435451|NCT04152447|520801187|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
144188068|NCT03110380|519882889|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
144188069|NCT03110380|519882890|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
144188070|NCT03110380|519882891|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
144188071|NCT03110380|519882888|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
144188072|NCT03110380|519882889|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
144188073|NCT03110380|519882890|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
144188074|NCT03110380|519882891|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
144188075|NCT03110380|519882888|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
144188076|NCT03110380|519882889|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
144188077|NCT03110380|519882890|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
144188078|NCT03110380|519882891|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
144188079|NCT00693225|519882897|FG000|Overall Study|Lost to Follow-up|1|||
144188080|NCT00693225|519882898|FG001|Overall Study|Lost to Follow-up|2|||
144188081|NCT00693225|519882897|FG000|Overall Study|Adverse Event|1|||
144188082|NCT00693225|519882898|FG001|Overall Study|Adverse Event|3|||
144188083|NCT01315028|519882899|FG000|Overall Study|Lost to Follow-up|1|||
144188084|NCT01315028|519882900|FG001|Overall Study|Lost to Follow-up|0|||
144188085|NCT01315028|519882899|FG000|Overall Study|Death|0|||
144188086|NCT01315028|519882900|FG001|Overall Study|Death|1|||
144188087|NCT01714739|519882901|FG000|Overall Study|Disease progression|3|||
144188088|NCT01714739|519882902|FG001|Overall Study|Disease progression|5|||
144188089|NCT01714739|519882903|FG002|Overall Study|Disease progression|5|||
144435452|NCT04152447|520801188|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
144435453|NCT04152447|520801187|FG000|Overall Study|Withdrawal by Subject|0|||
144435454|NCT04152447|520801188|FG001|Overall Study|Withdrawal by Subject|1|||
144188090|NCT01714739|519882904|FG003|Overall Study|Disease progression|204|||
144188091|NCT01714739|519882905|FG004|Overall Study|Disease progression|1|||
144188092|NCT01714739|519882906|FG005|Overall Study|Disease progression|3|||
144188093|NCT01714739|519882907|FG006|Overall Study|Disease progression|5|||
144188094|NCT01714739|519882901|FG000|Overall Study|Study drug toxicity|1|||
144188095|NCT01714739|519882902|FG001|Overall Study|Study drug toxicity|1|||
144188096|NCT01714739|519882903|FG002|Overall Study|Study drug toxicity|1|||
144188097|NCT01714739|519882904|FG003|Overall Study|Study drug toxicity|15|||
144188098|NCT01714739|519882905|FG004|Overall Study|Study drug toxicity|0|||
144188099|NCT01714739|519882906|FG005|Overall Study|Study drug toxicity|0|||
144188100|NCT01714739|519882907|FG006|Overall Study|Study drug toxicity|5|||
144188101|NCT01714739|519882901|FG000|Overall Study|Death|0|||
144188102|NCT01714739|519882902|FG001|Overall Study|Death|0|||
144188103|NCT01714739|519882903|FG002|Overall Study|Death|0|||
144188104|NCT01714739|519882904|FG003|Overall Study|Death|1|||
144188105|NCT01714739|519882905|FG004|Overall Study|Death|0|||
144188106|NCT01714739|519882906|FG005|Overall Study|Death|0|||
144188107|NCT01714739|519882907|FG006|Overall Study|Death|0|||
144188108|NCT01714739|519882901|FG000|Overall Study|Adverse Event unrelated to drug|0|||
144188109|NCT01714739|519882902|FG001|Overall Study|Adverse Event unrelated to drug|0|||
144188110|NCT01714739|519882903|FG002|Overall Study|Adverse Event unrelated to drug|3|||
144188111|NCT01714739|519882904|FG003|Overall Study|Adverse Event unrelated to drug|21|||
144188112|NCT01714739|519882905|FG004|Overall Study|Adverse Event unrelated to drug|0|||
144188113|NCT01714739|519882906|FG005|Overall Study|Adverse Event unrelated to drug|0|||
144188114|NCT01714739|519882907|FG006|Overall Study|Adverse Event unrelated to drug|0|||
144188115|NCT01714739|519882901|FG000|Overall Study|Participant request to stop therapy|0|||
144188116|NCT01714739|519882902|FG001|Overall Study|Participant request to stop therapy|1|||
144188117|NCT01714739|519882903|FG002|Overall Study|Participant request to stop therapy|0|||
144188118|NCT01714739|519882904|FG003|Overall Study|Participant request to stop therapy|6|||
144188119|NCT01714739|519882905|FG004|Overall Study|Participant request to stop therapy|0|||
144188120|NCT01714739|519882906|FG005|Overall Study|Participant request to stop therapy|0|||
144188121|NCT01714739|519882907|FG006|Overall Study|Participant request to stop therapy|0|||
144188122|NCT01714739|519882901|FG000|Overall Study|Participant withdrew consent|0|||
144724323|NCT02483975|521846333|FG001|Overall Study|Adverse Event|1|||
144188123|NCT01714739|519882902|FG001|Overall Study|Participant withdrew consent|1|||
144188124|NCT01714739|519882903|FG002|Overall Study|Participant withdrew consent|0|||
144188125|NCT01714739|519882904|FG003|Overall Study|Participant withdrew consent|8|||
144724324|NCT02483975|521846332|FG000|Overall Study|Lost to Follow-up|0|||
144188126|NCT01714739|519882905|FG004|Overall Study|Participant withdrew consent|0|||
144188127|NCT01714739|519882906|FG005|Overall Study|Participant withdrew consent|0|||
144188128|NCT01714739|519882907|FG006|Overall Study|Participant withdrew consent|0|||
144188129|NCT01714739|519882901|FG000|Overall Study|Lost to Follow-up|0|||
144188130|NCT01714739|519882902|FG001|Overall Study|Lost to Follow-up|0|||
144188131|NCT01714739|519882903|FG002|Overall Study|Lost to Follow-up|0|||
144435455|NCT04152447|520801187|FG000|Overall Study|Found ineligible after enrolling|1|||
144530081|NCT01208662|521144261|FG000|Maintenance|Adverse Event|12|||
144530082|NCT01208662|521144262|FG001|Maintenance|Adverse Event|28|||
144530083|NCT01208662|521144263|FG002|Maintenance|Adverse Event|0|||
144530084|NCT01208662|521144261|FG000|Maintenance|MD or Participant Decision|24|||
144530085|NCT01208662|521144262|FG001|Maintenance|MD or Participant Decision|36|||
144530086|NCT01208662|521144263|FG002|Maintenance|MD or Participant Decision|0|||
144530087|NCT01208662|521144261|FG000|Maintenance|Death|0|||
144530088|NCT01208662|521144262|FG001|Maintenance|Death|3|||
144530089|NCT01208662|521144263|FG002|Maintenance|Death|0|||
144530090|NCT01208662|521144261|FG000|Maintenance|Discontinued for other reasons|21|||
144530091|NCT01208662|521144262|FG001|Maintenance|Discontinued for other reasons|31|||
144530092|NCT01208662|521144263|FG002|Maintenance|Discontinued for other reasons|0|||
144530093|NCT01208662|521144261|FG000|Maintenance|Still on Treatment|78|||
144530094|NCT01208662|521144262|FG001|Maintenance|Still on Treatment|89|||
144530095|NCT01208662|521144263|FG002|Maintenance|Still on Treatment|0|||
144530096|NCT04433208|521144264|FG000|Overall Study|Withdrawal by Subject|0|||
144530097|NCT04433208|521144265|FG001|Overall Study|Withdrawal by Subject|1|||
144530098|NCT04433208|521144266|FG002|Overall Study|Withdrawal by Subject|1|||
144530099|NCT04433208|521144267|FG003|Overall Study|Withdrawal by Subject|0|||
144530100|NCT04433208|521144268|FG004|Overall Study|Withdrawal by Subject|2|||
144530101|NCT04433208|521144269|FG005|Overall Study|Withdrawal by Subject|1|||
144530102|NCT04433208|521144264|FG000|Overall Study|Lost to Follow-up|0|||
144530103|NCT04433208|521144265|FG001|Overall Study|Lost to Follow-up|0|||
144530104|NCT04433208|521144266|FG002|Overall Study|Lost to Follow-up|0|||
144530105|NCT04433208|521144267|FG003|Overall Study|Lost to Follow-up|0|||
144530106|NCT04433208|521144268|FG004|Overall Study|Lost to Follow-up|0|||
144530107|NCT04433208|521144269|FG005|Overall Study|Lost to Follow-up|1|||
144530108|NCT03676192|521144270|FG000|Induction Study Period|Adverse Event|21|||
144530109|NCT03676192|521144271|FG001|Induction Study Period|Adverse Event|20|||
144530110|NCT03676192|521144270|FG000|Induction Study Period|Death|23|||
144530111|NCT03676192|521144271|FG001|Induction Study Period|Death|20|||
144530112|NCT03676192|521144270|FG000|Induction Study Period|Lost to Follow-up|3|||
144188132|NCT01714739|519882904|FG003|Overall Study|Lost to Follow-up|1|||
144188133|NCT01714739|519882905|FG004|Overall Study|Lost to Follow-up|0|||
144188134|NCT01714739|519882906|FG005|Overall Study|Lost to Follow-up|0|||
144188135|NCT01714739|519882907|FG006|Overall Study|Lost to Follow-up|0|||
144188136|NCT01714739|519882901|FG000|Overall Study|Maximum clinical benefit|0|||
144188137|NCT01714739|519882902|FG001|Overall Study|Maximum clinical benefit|1|||
144530113|NCT03676192|521144271|FG001|Induction Study Period|Lost to Follow-up|3|||
144530114|NCT03676192|521144270|FG000|Induction Study Period|Physician Decision|6|||
144530115|NCT03676192|521144271|FG001|Induction Study Period|Physician Decision|3|||
144530116|NCT03676192|521144270|FG000|Induction Study Period|Progressive Disease|32|||
144530117|NCT03676192|521144271|FG001|Induction Study Period|Progressive Disease|21|||
144530118|NCT03676192|521144270|FG000|Induction Study Period|Protocol Violation|1|||
144530119|NCT03676192|521144271|FG001|Induction Study Period|Protocol Violation|2|||
144530120|NCT03676192|521144270|FG000|Induction Study Period|Withdrawal by Subject|20|||
144530121|NCT03676192|521144271|FG001|Induction Study Period|Withdrawal by Subject|15|||
144530122|NCT02424617|521144273|FG000|Overall Study|Adverse Event|0|||
144530123|NCT02424617|521144274|FG001|Overall Study|Adverse Event|1|||
144530124|NCT02424617|521144275|FG002|Overall Study|Adverse Event|0|||
144530125|NCT02424617|521144276|FG003|Overall Study|Adverse Event|0|||
144530126|NCT02424617|521144273|FG000|Overall Study|Investigator Decision|0|||
144530127|NCT02424617|521144274|FG001|Overall Study|Investigator Decision|0|||
144530128|NCT02424617|521144275|FG002|Overall Study|Investigator Decision|0|||
144530129|NCT02424617|521144276|FG003|Overall Study|Investigator Decision|1|||
144530130|NCT02424617|521144273|FG000|Overall Study|Withdrawal by Subject|1|||
144530131|NCT02424617|521144274|FG001|Overall Study|Withdrawal by Subject|1|||
144530132|NCT02424617|521144275|FG002|Overall Study|Withdrawal by Subject|0|||
144530133|NCT02424617|521144276|FG003|Overall Study|Withdrawal by Subject|1|||
144530134|NCT02424617|521144273|FG000|Overall Study|Progressive Disease|7|||
144530135|NCT02424617|521144274|FG001|Overall Study|Progressive Disease|6|||
144530136|NCT02424617|521144275|FG002|Overall Study|Progressive Disease|11|||
144530137|NCT02424617|521144276|FG003|Overall Study|Progressive Disease|10|||
144530138|NCT02424617|521144273|FG000|Overall Study|Other|0|||
144530139|NCT02424617|521144274|FG001|Overall Study|Other|0|||
144530140|NCT02424617|521144275|FG002|Overall Study|Other|0|||
144188138|NCT01714739|519882903|FG002|Overall Study|Maximum clinical benefit|1|||
144530141|NCT02424617|521144276|FG003|Overall Study|Other|1|||
144530142|NCT01868997|521144277|FG000|Overall Study|Adverse Event|2|||
144530143|NCT01868997|521144278|FG001|Overall Study|Adverse Event|5|||
144530144|NCT01868997|521144277|FG000|Overall Study|Lack of Efficacy|2|||
144530145|NCT01868997|521144278|FG001|Overall Study|Lack of Efficacy|0|||
144530146|NCT01868997|521144277|FG000|Overall Study|Other|3|||
144530147|NCT01868997|521144278|FG001|Overall Study|Other|1|||
144530148|NCT01960452|521144279|FG000|Overall Study|Withdrawal by Subject|2|||
144188139|NCT01714739|519882904|FG003|Overall Study|Maximum clinical benefit|3|||
144188140|NCT01714739|519882905|FG004|Overall Study|Maximum clinical benefit|0|||
144530149|NCT01960452|521144280|FG001|Overall Study|Withdrawal by Subject|1|||
144530150|NCT01960452|521144279|FG000|Overall Study|Sleep apnea in Night 1|1|||
144253400|NCT02757352|520128056|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253401|NCT02757352|520128057|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
144253402|NCT02757352|520128058|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
144253403|NCT02757352|520128059|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
144253404|NCT02757352|520128060|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253405|NCT02757352|520128061|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253406|NCT02757352|520128062|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253407|NCT02757352|520128063|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144253408|NCT02757352|520128054|FG000|Follow-Up Period|Adverse Event|0|||
144253409|NCT02757352|520128055|FG001|Follow-Up Period|Adverse Event|0|||
144253410|NCT02757352|520128056|FG002|Follow-Up Period|Adverse Event|0|||
144253411|NCT02757352|520128057|FG003|Follow-Up Period|Adverse Event|0|||
144253412|NCT02757352|520128058|FG004|Follow-Up Period|Adverse Event|0|||
144253413|NCT02757352|520128059|FG005|Follow-Up Period|Adverse Event|0|||
144253414|NCT02757352|520128060|FG006|Follow-Up Period|Adverse Event|1|||
144253415|NCT02757352|520128061|FG007|Follow-Up Period|Adverse Event|0|||
144253416|NCT02757352|520128062|FG008|Follow-Up Period|Adverse Event|2|||
144253417|NCT02757352|520128063|FG009|Follow-Up Period|Adverse Event|0|||
144253418|NCT02757352|520128054|FG000|Follow-Up Period|Lost to Follow-up|0|||
144253419|NCT02757352|520128055|FG001|Follow-Up Period|Lost to Follow-up|0|||
144253420|NCT02757352|520128056|FG002|Follow-Up Period|Lost to Follow-up|0|||
144253421|NCT02757352|520128057|FG003|Follow-Up Period|Lost to Follow-up|0|||
144253422|NCT02757352|520128058|FG004|Follow-Up Period|Lost to Follow-up|0|||
144253423|NCT02757352|520128059|FG005|Follow-Up Period|Lost to Follow-up|0|||
144253424|NCT02757352|520128060|FG006|Follow-Up Period|Lost to Follow-up|0|||
144253425|NCT02757352|520128061|FG007|Follow-Up Period|Lost to Follow-up|0|||
144253426|NCT02757352|520128062|FG008|Follow-Up Period|Lost to Follow-up|1|||
144253427|NCT02757352|520128063|FG009|Follow-Up Period|Lost to Follow-up|0|||
144253428|NCT02757352|520128054|FG000|Follow-Up Period|Lack of Efficacy|0|||
144253429|NCT02757352|520128055|FG001|Follow-Up Period|Lack of Efficacy|0|||
144253430|NCT02757352|520128056|FG002|Follow-Up Period|Lack of Efficacy|0|||
144253431|NCT02757352|520128057|FG003|Follow-Up Period|Lack of Efficacy|0|||
144253432|NCT02757352|520128058|FG004|Follow-Up Period|Lack of Efficacy|0|||
144253433|NCT02757352|520128059|FG005|Follow-Up Period|Lack of Efficacy|0|||
144253434|NCT02757352|520128060|FG006|Follow-Up Period|Lack of Efficacy|0|||
144253435|NCT02757352|520128061|FG007|Follow-Up Period|Lack of Efficacy|0|||
144253436|NCT02757352|520128062|FG008|Follow-Up Period|Lack of Efficacy|1|||
144253437|NCT02757352|520128063|FG009|Follow-Up Period|Lack of Efficacy|1|||
144253438|NCT02757352|520128054|FG000|Follow-Up Period|Withdrawal by Subject|0|||
144253439|NCT02757352|520128055|FG001|Follow-Up Period|Withdrawal by Subject|0|||
144253440|NCT02757352|520128056|FG002|Follow-Up Period|Withdrawal by Subject|0|||
144253441|NCT02757352|520128057|FG003|Follow-Up Period|Withdrawal by Subject|0|||
144253442|NCT02757352|520128058|FG004|Follow-Up Period|Withdrawal by Subject|0|||
144253443|NCT02757352|520128059|FG005|Follow-Up Period|Withdrawal by Subject|0|||
144253444|NCT02757352|520128060|FG006|Follow-Up Period|Withdrawal by Subject|0|||
144253445|NCT02757352|520128061|FG007|Follow-Up Period|Withdrawal by Subject|1|||
144253446|NCT02757352|520128062|FG008|Follow-Up Period|Withdrawal by Subject|6|||
144253447|NCT02757352|520128063|FG009|Follow-Up Period|Withdrawal by Subject|2|||
144253448|NCT03536663|520128064|FG000|Endexo|Protocol Violation|1|||
144253449|NCT03488563|520128066|FG000|Overall Study|Lost to Follow-up|7|||
144253450|NCT03488563|520128067|FG001|Overall Study|Lost to Follow-up|6|||
144253451|NCT03488563|520128068|FG002|Overall Study|Lost to Follow-up|7|||
144253452|NCT03488563|520128066|FG000|Overall Study|Withdrawal by Subject|8|||
144253453|NCT03488563|520128067|FG001|Overall Study|Withdrawal by Subject|7|||
144253454|NCT03488563|520128068|FG002|Overall Study|Withdrawal by Subject|7|||
144253455|NCT03488563|520128066|FG000|Overall Study|Physician Decision|0|||
144253456|NCT03488563|520128067|FG001|Overall Study|Physician Decision|0|||
144253457|NCT03488563|520128068|FG002|Overall Study|Physician Decision|1|||
144253458|NCT03488563|520128066|FG000|Overall Study|Protocol Violation|3|||
144253459|NCT03488563|520128067|FG001|Overall Study|Protocol Violation|2|||
144435456|NCT04152447|520801188|FG001|Overall Study|Found ineligible after enrolling|1|||
144435457|NCT04152447|520801187|FG000|Overall Study|Did not receive VR headset in time.|0|||
144435458|NCT04152447|520801188|FG001|Overall Study|Did not receive VR headset in time.|2|||
144435459|NCT03034954|520801197|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
144435460|NCT03034954|520801198|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
144435461|NCT01275066|520801205|FG000|Overall Study|Withdrawal by Subject|0|||
144253460|NCT03488563|520128068|FG002|Overall Study|Protocol Violation|6|||
144253461|NCT03488563|520128066|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
144253462|NCT03488563|520128067|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
144253463|NCT03488563|520128068|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
144253464|NCT03488563|520128066|FG000|Overall Study|Use of prohibited medication|2|||
144253465|NCT03488563|520128067|FG001|Overall Study|Use of prohibited medication|0|||
144253466|NCT03488563|520128068|FG002|Overall Study|Use of prohibited medication|0|||
144435462|NCT01275066|520801206|FG001|Overall Study|Withdrawal by Subject|0|||
144188141|NCT01714739|519882906|FG005|Overall Study|Maximum clinical benefit|0|||
144188142|NCT01714739|519882907|FG006|Overall Study|Maximum clinical benefit|0|||
144435463|NCT01275066|520801207|FG002|Overall Study|Withdrawal by Subject|1|||
144435464|NCT01275066|520801205|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
144435465|NCT01275066|520801206|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
144435466|NCT01275066|520801207|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
144435467|NCT00394212|520801210|FG000|Overall Study|Lost to Follow-up|3|||
144435468|NCT00394212|520801211|FG001|Overall Study|Lost to Follow-up|0|||
144435469|NCT00394212|520801210|FG000|Overall Study|Withdrawal by Subject|4|||
144435470|NCT00394212|520801211|FG001|Overall Study|Withdrawal by Subject|1|||
144435471|NCT00735371|520801214|FG000|Overall Study|Adverse Event|3|||
144435472|NCT00735371|520801215|FG001|Overall Study|Adverse Event|3|||
144435473|NCT00735371|520801216|FG002|Overall Study|Adverse Event|4|||
144435474|NCT00735371|520801217|FG003|Overall Study|Adverse Event|1|||
144435475|NCT00735371|520801214|FG000|Overall Study|Protocol Violation|2|||
144435476|NCT00735371|520801215|FG001|Overall Study|Protocol Violation|2|||
144435477|NCT00735371|520801216|FG002|Overall Study|Protocol Violation|0|||
144435478|NCT00735371|520801217|FG003|Overall Study|Protocol Violation|3|||
144435479|NCT00735371|520801214|FG000|Overall Study|Withdrawal by Subject|0|||
144435480|NCT00735371|520801215|FG001|Overall Study|Withdrawal by Subject|2|||
144435481|NCT00735371|520801216|FG002|Overall Study|Withdrawal by Subject|2|||
144724325|NCT02483975|521846333|FG001|Overall Study|Lost to Follow-up|1|||
144724326|NCT02483975|521846332|FG000|Overall Study|Physician Decision|2|||
144724327|NCT02483975|521846333|FG001|Overall Study|Physician Decision|0|||
144188143|NCT01714739|519882901|FG000|Overall Study|Poor/non-comliance|0|||
144188144|NCT01714739|519882902|FG001|Overall Study|Poor/non-comliance|1|||
144188145|NCT01714739|519882903|FG002|Overall Study|Poor/non-comliance|0|||
144188146|NCT01714739|519882904|FG003|Overall Study|Poor/non-comliance|1|||
144188147|NCT01714739|519882905|FG004|Overall Study|Poor/non-comliance|0|||
144188148|NCT01714739|519882906|FG005|Overall Study|Poor/non-comliance|0|||
144188149|NCT01714739|519882907|FG006|Overall Study|Poor/non-comliance|0|||
144188150|NCT01714739|519882901|FG000|Overall Study|No longer meets study criteria|0|||
144188151|NCT01714739|519882902|FG001|Overall Study|No longer meets study criteria|0|||
144188152|NCT01714739|519882903|FG002|Overall Study|No longer meets study criteria|0|||
144188153|NCT01714739|519882904|FG003|Overall Study|No longer meets study criteria|1|||
144188154|NCT01714739|519882905|FG004|Overall Study|No longer meets study criteria|0|||
144188155|NCT01714739|519882906|FG005|Overall Study|No longer meets study criteria|0|||
144188156|NCT01714739|519882907|FG006|Overall Study|No longer meets study criteria|0|||
144188157|NCT01714739|519882901|FG000|Overall Study|Other reason|0|||
144188158|NCT01714739|519882902|FG001|Overall Study|Other reason|0|||
144188159|NCT01714739|519882903|FG002|Overall Study|Other reason|0|||
144188160|NCT01714739|519882904|FG003|Overall Study|Other reason|3|||
144188161|NCT01714739|519882905|FG004|Overall Study|Other reason|1|||
144188162|NCT01714739|519882906|FG005|Overall Study|Other reason|0|||
144188163|NCT01714739|519882907|FG006|Overall Study|Other reason|0|||
144188164|NCT02274948|519882914|FG000|Overall Study|Lost to Follow-up|28|||
144188165|NCT02274948|519882915|FG001|Overall Study|Lost to Follow-up|25|||
144188166|NCT02274948|519882914|FG000|Overall Study|Withdrawal by Subject|64|||
144188167|NCT02274948|519882915|FG001|Overall Study|Withdrawal by Subject|58|||
144188168|NCT02274948|519882914|FG000|Overall Study|Stopped on family Practitioner advice|2|||
144188169|NCT02274948|519882915|FG001|Overall Study|Stopped on family Practitioner advice|5|||
144188170|NCT02274948|519882914|FG000|Overall Study|Left the area|4|||
144188171|NCT02274948|519882915|FG001|Overall Study|Left the area|3|||
144188172|NCT00707434|519882916|FG000|Overall Study|Adverse Event|1|||
144188173|NCT03585959|519882917|FG000|Overall Study|Physician Decision|1|||
144188174|NCT03585959|519882917|FG000|Overall Study|Unsuccessful Procedure|2|||
144188175|NCT02531594|519882918|FG000|Overall Study|Withdrawal by Subject|7|||
144188176|NCT02531594|519882919|FG001|Overall Study|Withdrawal by Subject|8|||
144188177|NCT00614822|519882920|FG000|Overall Study|Adverse Event|3|||
144188178|NCT04364763|519882921|FG000|Overall Study|Death|1|||
144435482|NCT00735371|520801217|FG003|Overall Study|Withdrawal by Subject|0|||
144724328|NCT03365375|521846334|FG000|Overall Study|Withdrawal by Subject|0|||
144724329|NCT03365375|521846335|FG001|Overall Study|Withdrawal by Subject|1|||
144188179|NCT04364763|519882922|FG001|Overall Study|Death|2|||
144188180|NCT04364763|519882921|FG000|Overall Study|Lost to Follow-up|1|||
144188181|NCT04364763|519882922|FG001|Overall Study|Lost to Follow-up|0|||
144724330|NCT03365375|521846334|FG000|Overall Study|Lost to Follow-up|0|||
144188182|NCT02359864|519882924|FG000|Overall Study|Withdrawal by Subject|1|||
144188183|NCT02359864|519882925|FG001|Overall Study|Withdrawal by Subject|0|||
144188184|NCT00725764|519882926|FG000|Overall Study|Withdrawal by Subject|2|||
144188185|NCT00725764|519882926|FG000|Overall Study|Physician Decision|1|||
144188186|NCT00725764|519882926|FG000|Overall Study|Progressive Disease|7|||
144188187|NCT00725764|519882926|FG000|Overall Study|Lost to Follow-up|1|||
144188188|NCT00725764|519882926|FG000|Overall Study|Death|1|||
144435483|NCT00735371|520801214|FG000|Overall Study|Lost to Follow-up|1|||
144435484|NCT00735371|520801215|FG001|Overall Study|Lost to Follow-up|1|||
144435485|NCT00735371|520801216|FG002|Overall Study|Lost to Follow-up|3|||
144435486|NCT00735371|520801217|FG003|Overall Study|Lost to Follow-up|1|||
144435487|NCT00735371|520801214|FG000|Overall Study|Lack of Efficacy|4|||
144435488|NCT00735371|520801215|FG001|Overall Study|Lack of Efficacy|2|||
144435489|NCT00735371|520801216|FG002|Overall Study|Lack of Efficacy|0|||
144435490|NCT00735371|520801217|FG003|Overall Study|Lack of Efficacy|4|||
144435491|NCT00735371|520801214|FG000|Overall Study|Sponsor Decision|3|||
144435492|NCT00735371|520801215|FG001|Overall Study|Sponsor Decision|1|||
144435493|NCT00735371|520801216|FG002|Overall Study|Sponsor Decision|0|||
144435494|NCT00735371|520801217|FG003|Overall Study|Sponsor Decision|1|||
144435495|NCT00735371|520801214|FG000|Overall Study|Protocol Violation|0|||
144435496|NCT00735371|520801215|FG001|Overall Study|Protocol Violation|1|||
144435497|NCT00735371|520801216|FG002|Overall Study|Protocol Violation|2|||
144435498|NCT00735371|520801217|FG003|Overall Study|Protocol Violation|0|||
144435499|NCT00735371|520801214|FG000|Overall Study|Prior Vyvanse Exposure|1|||
144435500|NCT00735371|520801215|FG001|Overall Study|Prior Vyvanse Exposure|1|||
144435501|NCT00735371|520801216|FG002|Overall Study|Prior Vyvanse Exposure|0|||
144435502|NCT00735371|520801217|FG003|Overall Study|Prior Vyvanse Exposure|0|||
144435503|NCT00735371|520801214|FG000|Overall Study|Exclusion criteria|1|||
144188189|NCT00725764|519882926|FG000|Overall Study|Participant non compliant with protocol|1|||
144188190|NCT00725764|519882926|FG000|Overall Study|Decline in performance status|1|||
144188191|NCT00605176|519882937|FG000|Overall Study|Adverse Event|2|||
144188192|NCT00605176|519882938|FG001|Overall Study|Adverse Event|1|||
144188193|NCT00605176|519882939|FG002|Overall Study|Adverse Event|3|||
144188194|NCT00605176|519882937|FG000|Overall Study|Withdrawal by Subject|4|||
144188195|NCT00605176|519882938|FG001|Overall Study|Withdrawal by Subject|2|||
144188196|NCT00605176|519882939|FG002|Overall Study|Withdrawal by Subject|4|||
144188197|NCT00605176|519882937|FG000|Overall Study|Lost to Follow-up|2|||
144188198|NCT00605176|519882938|FG001|Overall Study|Lost to Follow-up|2|||
144188199|NCT00605176|519882939|FG002|Overall Study|Lost to Follow-up|1|||
144188200|NCT00605176|519882937|FG000|Overall Study|Non-complicance with study procedures|1|||
144188201|NCT00605176|519882938|FG001|Overall Study|Non-complicance with study procedures|0|||
144188202|NCT00605176|519882939|FG002|Overall Study|Non-complicance with study procedures|0|||
144188203|NCT00605176|519882937|FG000|Overall Study|Use of concomitant therapy|1|||
144188204|NCT00605176|519882938|FG001|Overall Study|Use of concomitant therapy|0|||
144188205|NCT00605176|519882939|FG002|Overall Study|Use of concomitant therapy|1|||
144188206|NCT00605176|519882937|FG000|Overall Study|Other (not due to AE)|1|||
144188207|NCT00605176|519882938|FG001|Overall Study|Other (not due to AE)|1|||
144188208|NCT00605176|519882939|FG002|Overall Study|Other (not due to AE)|0|||
144188209|NCT01808248|519882950|FG000|Overall Study|Lack of Efficacy|3|||
144188210|NCT01808248|519882950|FG000|Overall Study|Withdrawal by Subject|1|||
144188211|NCT01808248|519882950|FG000|Overall Study|Lost to Follow-up|1|||
144188212|NCT00220727|519882951|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
144188213|NCT00220727|519882952|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
144188214|NCT00983476|519882953|FG000|Overall Study|Did not receive intervention|17|||
144188215|NCT00983476|519882954|FG001|Overall Study|Did not receive intervention|22|||
144188216|NCT00983476|519882955|FG002|Overall Study|Did not receive intervention|0|||
144188217|NCT00559364|519882957|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
144188218|NCT00559364|519882958|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
144188219|NCT00084799|519882959|FG000|Overall Study|Disease Progression|1|||
144188220|NCT00084799|519882960|FG001|Overall Study|Disease Progression|0|||
144188221|NCT01235442|519882961|FG000|Overall Study|Lost to Follow-up|12|||
144188222|NCT01235442|519882962|FG001|Overall Study|Lost to Follow-up|10|||
144188223|NCT01235442|519882961|FG000|Overall Study|Death|0|||
144188224|NCT01235442|519882962|FG001|Overall Study|Death|2|||
144188225|NCT01235442|519882961|FG000|Overall Study|Pregnancy|1|||
144188226|NCT01235442|519882962|FG001|Overall Study|Pregnancy|1|||
144188227|NCT01235442|519882961|FG000|Overall Study|Ineligibility determined|5|||
144188228|NCT01235442|519882962|FG001|Overall Study|Ineligibility determined|4|||
144188229|NCT01235442|519882961|FG000|Overall Study|Protocol Violation|3|||
144188230|NCT01235442|519882962|FG001|Overall Study|Protocol Violation|3|||
144188231|NCT01235442|519882961|FG000|Overall Study|Adverse Event|4|||
144188232|NCT01235442|519882962|FG001|Overall Study|Adverse Event|6|||
144435504|NCT00735371|520801215|FG001|Overall Study|Exclusion criteria|0|||
144435505|NCT00735371|520801216|FG002|Overall Study|Exclusion criteria|0|||
144435506|NCT00735371|520801217|FG003|Overall Study|Exclusion criteria|0|||
144435507|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
144530151|NCT01960452|521144280|FG001|Overall Study|Sleep apnea in Night 1|0|||
144530152|NCT01960452|521144279|FG000|Overall Study|Poor Sleep in Night 1|0|||
144530153|NCT01960452|521144280|FG001|Overall Study|Poor Sleep in Night 1|2|||
144530154|NCT01960452|521144279|FG000|Overall Study|No Sex/Age Match Night 1|1|||
144530155|NCT01960452|521144280|FG001|Overall Study|No Sex/Age Match Night 1|0|||
144530156|NCT01960452|521144279|FG000|Overall Study|No Sex/Age Match Night 2|0|||
144188233|NCT01235442|519882961|FG000|Overall Study|Withdrawal by Subject|15|||
144188234|NCT01235442|519882962|FG001|Overall Study|Withdrawal by Subject|9|||
144188235|NCT01235442|519882961|FG000|Overall Study|Lack of Efficacy|1|||
144435508|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
144435509|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
144435510|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
144435511|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
144435512|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
144435513|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
144435514|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
144435515|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
144435516|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
144435517|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
144435518|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
144435519|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
144435520|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
144435521|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
144435522|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Death|5|||
144435523|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Death|0|||
144435524|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Death|2|||
144435525|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Death|0|||
144435526|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Death|4|||
144435527|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
144435528|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
144435529|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
144435530|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
144435531|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
144435532|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
144435533|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
144435534|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
144435535|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
144435536|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
144435537|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
144435538|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
144435539|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
144435540|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
144435541|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
144435542|NCT01604343|520801218|FG000|Prior to W52 Administration(Through W52)|Other|15|||
144435543|NCT01604343|520801219|FG001|Prior to W52 Administration(Through W52)|Other|0|||
144435544|NCT01604343|520801220|FG002|Prior to W52 Administration(Through W52)|Other|10|||
144435545|NCT01604343|520801221|FG003|Prior to W52 Administration(Through W52)|Other|0|||
144435546|NCT01604343|520801222|FG004|Prior to W52 Administration(Through W52)|Other|6|||
144435547|NCT01604343|520801218|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
144435548|NCT01604343|520801219|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
144435549|NCT01604343|520801220|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
144435550|NCT01604343|520801221|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
144435551|NCT01604343|520801222|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
144435552|NCT01604343|520801218|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
144435553|NCT01604343|520801219|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
144435554|NCT01604343|520801220|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
144435555|NCT01604343|520801221|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
144435556|NCT01604343|520801222|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
144435557|NCT01604343|520801218|FG000|Week 52 to Week 104|Adverse Event|0|||
144435558|NCT01604343|520801219|FG001|Week 52 to Week 104|Adverse Event|12|||
144435559|NCT01604343|520801220|FG002|Week 52 to Week 104|Adverse Event|26|||
144435560|NCT01604343|520801221|FG003|Week 52 to Week 104|Adverse Event|21|||
144435561|NCT01604343|520801222|FG004|Week 52 to Week 104|Adverse Event|27|||
144435562|NCT01604343|520801218|FG000|Week 52 to Week 104|Death|0|||
144435563|NCT01604343|520801219|FG001|Week 52 to Week 104|Death|4|||
144188236|NCT01235442|519882962|FG001|Overall Study|Lack of Efficacy|3|||
144188237|NCT01235442|519882961|FG000|Overall Study|Noncompliance|1|||
144188238|NCT01235442|519882962|FG001|Overall Study|Noncompliance|2|||
144188239|NCT01235442|519882961|FG000|Overall Study|Administrative decision|1|||
144188240|NCT01235442|519882962|FG001|Overall Study|Administrative decision|2|||
144435564|NCT01604343|520801220|FG002|Week 52 to Week 104|Death|2|||
144435565|NCT01604343|520801221|FG003|Week 52 to Week 104|Death|5|||
144435566|NCT01604343|520801222|FG004|Week 52 to Week 104|Death|0|||
144435567|NCT01604343|520801218|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
144435568|NCT01604343|520801219|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
144435569|NCT01604343|520801220|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
144435570|NCT01604343|520801221|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
144435571|NCT01604343|520801222|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
144188241|NCT01235442|519882961|FG000|Overall Study|Other unspecified|1|||
144435572|NCT01604343|520801218|FG000|Week 52 to Week 104|Physician Decision|0|||
144435573|NCT01604343|520801219|FG001|Week 52 to Week 104|Physician Decision|1|||
144188242|NCT01235442|519882962|FG001|Overall Study|Other unspecified|2|||
144435574|NCT01604343|520801220|FG002|Week 52 to Week 104|Physician Decision|0|||
144435575|NCT01604343|520801221|FG003|Week 52 to Week 104|Physician Decision|0|||
144435576|NCT01604343|520801222|FG004|Week 52 to Week 104|Physician Decision|2|||
144435577|NCT01604343|520801218|FG000|Week 52 to Week 104|Pregnancy|0|||
144435578|NCT01604343|520801219|FG001|Week 52 to Week 104|Pregnancy|0|||
144435579|NCT01604343|520801220|FG002|Week 52 to Week 104|Pregnancy|1|||
144435580|NCT01604343|520801221|FG003|Week 52 to Week 104|Pregnancy|2|||
144435581|NCT01604343|520801222|FG004|Week 52 to Week 104|Pregnancy|1|||
144435582|NCT01604343|520801218|FG000|Week 52 to Week 104|Other|0|||
144435583|NCT01604343|520801219|FG001|Week 52 to Week 104|Other|11|||
144435584|NCT01604343|520801220|FG002|Week 52 to Week 104|Other|11|||
144435585|NCT01604343|520801221|FG003|Week 52 to Week 104|Other|6|||
144435586|NCT01604343|520801222|FG004|Week 52 to Week 104|Other|3|||
144435587|NCT01604343|520801218|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
144435588|NCT01604343|520801219|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
144435589|NCT01604343|520801220|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
144435590|NCT01604343|520801221|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
144435591|NCT01604343|520801222|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
144435592|NCT01604343|520801218|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
144435593|NCT01604343|520801219|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
144435594|NCT01604343|520801220|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
144435595|NCT01604343|520801221|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
144435596|NCT01604343|520801222|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
144435597|NCT01604343|520801218|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
144435598|NCT01604343|520801219|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
144435599|NCT01604343|520801220|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
144435600|NCT01604343|520801221|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
144435601|NCT01604343|520801222|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
144435602|NCT01446965|520801223|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
144435603|NCT01446965|520801224|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
144435604|NCT01446965|520801223|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
144435605|NCT01446965|520801224|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
144435606|NCT02871375|520801225|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
144435607|NCT02871375|520801226|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
144435608|NCT04960228|520801241|FG000|Overall Study|Withdrawal by Subject|216|||
144435609|NCT04960228|520801242|FG001|Overall Study|Withdrawal by Subject|35|||
144435610|NCT04960228|520801241|FG000|Overall Study|Failed attention check|69|||
144435611|NCT04960228|520801242|FG001|Overall Study|Failed attention check|148|||
144435612|NCT04960228|520801241|FG000|Overall Study|Flagged for response quality by Dynata|3|||
144435613|NCT04960228|520801242|FG001|Overall Study|Flagged for response quality by Dynata|3|||
144435614|NCT01987427|520801243|FG000|Overall Study|Adverse Event|4|||
144435615|NCT01987427|520801244|FG001|Overall Study|Adverse Event|2|||
144435616|NCT01987427|520801245|FG002|Overall Study|Adverse Event|8|||
144435617|NCT01987427|520801243|FG000|Overall Study|Lost to Follow-up|6|||
144435618|NCT01987427|520801244|FG001|Overall Study|Lost to Follow-up|6|||
144435619|NCT01987427|520801245|FG002|Overall Study|Lost to Follow-up|9|||
144435620|NCT01987427|520801243|FG000|Overall Study|Withdrawal by Subject|2|||
144435621|NCT01987427|520801244|FG001|Overall Study|Withdrawal by Subject|1|||
144435622|NCT01987427|520801245|FG002|Overall Study|Withdrawal by Subject|3|||
144435623|NCT01987427|520801243|FG000|Overall Study|Lack of Efficacy|1|||
144435624|NCT01987427|520801244|FG001|Overall Study|Lack of Efficacy|0|||
144435625|NCT01987427|520801245|FG002|Overall Study|Lack of Efficacy|0|||
144435626|NCT01987427|520801243|FG000|Overall Study|Other|1|||
144435627|NCT01987427|520801244|FG001|Overall Study|Other|1|||
144435628|NCT01987427|520801245|FG002|Overall Study|Other|0|||
144435629|NCT02159521|520801246|FG000|Overall Study|Enrolled but not treated|3|||
144435630|NCT02159521|520801246|FG000|Overall Study|Withdrawal by Subject|7|||
144435631|NCT02159521|520801246|FG000|Overall Study|Lost to Follow-up|6|||
144435632|NCT02159521|520801246|FG000|Overall Study|Death|1|||
144435633|NCT02159521|520801246|FG000|Overall Study|Other than specified|1|||
144435634|NCT00694369|520801247|FG000|Overall Study|Adverse Event|0|||
144435635|NCT00694369|520801248|FG001|Overall Study|Adverse Event|1|||
144435636|NCT00694369|520801249|FG002|Overall Study|Adverse Event|0|||
144435637|NCT00694369|520801250|FG003|Overall Study|Adverse Event|1|||
144435638|NCT00694369|520801251|FG004|Overall Study|Adverse Event|3|||
144604645|NCT02632721|521414376|FG000|Overall Study|Patient wish for other treatment|0|||
144188243|NCT03566238|519882963|FG000|Overall Study|Adverse Event|0|||
144435639|NCT00694369|520801247|FG000|Overall Study|Lost to Follow-up|0|||
144435640|NCT00694369|520801248|FG001|Overall Study|Lost to Follow-up|0|||
144435641|NCT00694369|520801249|FG002|Overall Study|Lost to Follow-up|1|||
144435642|NCT00694369|520801250|FG003|Overall Study|Lost to Follow-up|1|||
144435643|NCT00694369|520801251|FG004|Overall Study|Lost to Follow-up|0|||
144435644|NCT00694369|520801247|FG000|Overall Study|Physician Decision|0|||
144435645|NCT00694369|520801248|FG001|Overall Study|Physician Decision|0|||
144435646|NCT00694369|520801249|FG002|Overall Study|Physician Decision|0|||
144188244|NCT03566238|519882964|FG001|Overall Study|Adverse Event|1|||
144188245|NCT03566238|519882965|FG002|Overall Study|Adverse Event|0|||
144188246|NCT03566238|519882963|FG000|Overall Study|Lack of Efficacy|4|||
144188247|NCT03566238|519882964|FG001|Overall Study|Lack of Efficacy|2|||
144188248|NCT03566238|519882965|FG002|Overall Study|Lack of Efficacy|5|||
144188249|NCT03566238|519882963|FG000|Overall Study|Other|1|||
144188250|NCT03566238|519882964|FG001|Overall Study|Other|0|||
144435647|NCT00694369|520801250|FG003|Overall Study|Physician Decision|0|||
144435648|NCT00694369|520801251|FG004|Overall Study|Physician Decision|1|||
144435649|NCT00694369|520801247|FG000|Overall Study|Protocol Violation|0|||
144435650|NCT00694369|520801248|FG001|Overall Study|Protocol Violation|1|||
144435651|NCT00694369|520801249|FG002|Overall Study|Protocol Violation|0|||
144435652|NCT00694369|520801250|FG003|Overall Study|Protocol Violation|0|||
144435653|NCT00694369|520801251|FG004|Overall Study|Protocol Violation|0|||
144435654|NCT00694369|520801247|FG000|Overall Study|Withdrawal by Subject|1|||
144435655|NCT00694369|520801248|FG001|Overall Study|Withdrawal by Subject|1|||
144435656|NCT00694369|520801249|FG002|Overall Study|Withdrawal by Subject|1|||
144435657|NCT00694369|520801250|FG003|Overall Study|Withdrawal by Subject|1|||
144435658|NCT00694369|520801251|FG004|Overall Study|Withdrawal by Subject|2|||
144435659|NCT00907374|520801252|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
144435660|NCT00907374|520801253|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
144435661|NCT00785486|520801254|FG000|Midazolam Alone|Withdrawal by Subject|1|||
144435662|NCT03131440|520801259|FG000|Overall Study|Withdrawal by Subject|1|||
144435663|NCT03131440|520801260|FG001|Overall Study|Withdrawal by Subject|3|||
144435664|NCT03131440|520801261|FG002|Overall Study|Withdrawal by Subject|0|||
144435665|NCT03131440|520801262|FG003|Overall Study|Withdrawal by Subject|0|||
144435666|NCT03131440|520801263|FG004|Overall Study|Withdrawal by Subject|1|||
144435667|NCT03131440|520801264|FG005|Overall Study|Withdrawal by Subject|0|||
144435668|NCT03131440|520801265|FG006|Overall Study|Withdrawal by Subject|0|||
144435669|NCT03131440|520801266|FG007|Overall Study|Withdrawal by Subject|1|||
144435670|NCT03131440|520801267|FG008|Overall Study|Withdrawal by Subject|1|||
144435671|NCT03131440|520801268|FG009|Overall Study|Withdrawal by Subject|1|||
144435672|NCT03131440|520801269|FG010|Overall Study|Withdrawal by Subject|0|||
144435673|NCT03131440|520801270|FG011|Overall Study|Withdrawal by Subject|1|||
144435674|NCT03131440|520801271|FG012|Overall Study|Withdrawal by Subject|1|||
144435675|NCT03131440|520801272|FG013|Overall Study|Withdrawal by Subject|0|||
144435676|NCT03131440|520801273|FG014|Overall Study|Withdrawal by Subject|1|||
144435677|NCT03131440|520801274|FG015|Overall Study|Withdrawal by Subject|0|||
144435678|NCT03131440|520801275|FG016|Overall Study|Withdrawal by Subject|0|||
144435679|NCT03131440|520801276|FG017|Overall Study|Withdrawal by Subject|0|||
144435680|NCT03131440|520801277|FG018|Overall Study|Withdrawal by Subject|1|||
144435681|NCT03131440|520801278|FG019|Overall Study|Withdrawal by Subject|0|||
144435682|NCT03131440|520801279|FG020|Overall Study|Withdrawal by Subject|1|||
144435683|NCT03131440|520801280|FG021|Overall Study|Withdrawal by Subject|1|||
144435684|NCT03131440|520801281|FG022|Overall Study|Withdrawal by Subject|1|||
144435685|NCT03131440|520801282|FG023|Overall Study|Withdrawal by Subject|0|||
144435686|NCT03131440|520801283|FG024|Overall Study|Withdrawal by Subject|0|||
144435687|NCT03131440|520801284|FG025|Overall Study|Withdrawal by Subject|0|||
144530157|NCT01960452|521144280|FG001|Overall Study|No Sex/Age Match Night 2|2|||
144530158|NCT01960452|521144279|FG000|Overall Study|Technical Difficulties Night 2|2|||
144530159|NCT01960452|521144280|FG001|Overall Study|Technical Difficulties Night 2|0|||
144530160|NCT04066205|521144283|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
144530161|NCT04066205|521144284|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
144530162|NCT04066205|521144283|FG000|T2 Immediate Post-Intervention|did not respond|5|||
144530163|NCT04066205|521144284|FG001|T2 Immediate Post-Intervention|did not respond|3|||
144530164|NCT04778397|521144286|FG000|Overall Study|Death|59|||
144530165|NCT04778397|521144287|FG001|Overall Study|Death|54|||
144530166|NCT04778397|521144288|FG002|Overall Study|Death|11|||
144530167|NCT04778397|521144289|FG003|Overall Study|Death|9|||
144188251|NCT03566238|519882965|FG002|Overall Study|Other|0|||
144188252|NCT00388037|519882966|FG000|Overall Study|Protocol Violation|1|||
144253467|NCT03488563|520128066|FG000|Overall Study|Adverse Event|1|||
144435688|NCT03131440|520801285|FG026|Overall Study|Withdrawal by Subject|0|||
144435689|NCT03131440|520801286|FG027|Overall Study|Withdrawal by Subject|0|||
144435690|NCT03131440|520801287|FG028|Overall Study|Withdrawal by Subject|0|||
144435691|NCT03131440|520801288|FG029|Overall Study|Withdrawal by Subject|0|||
144435692|NCT03131440|520801289|FG030|Overall Study|Withdrawal by Subject|1|||
144530168|NCT04778397|521144286|FG000|Overall Study|Study Terminated by Sponsor|34|||
144188253|NCT00602537|519882967|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
144188254|NCT00602537|519882968|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
144435693|NCT03131440|520801290|FG031|Overall Study|Withdrawal by Subject|0|||
144435694|NCT03131440|520801259|FG000|Overall Study|Lost to Follow-up|0|||
144435695|NCT03131440|520801260|FG001|Overall Study|Lost to Follow-up|0|||
144435696|NCT03131440|520801261|FG002|Overall Study|Lost to Follow-up|0|||
144188255|NCT00602537|519882967|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
144188256|NCT00602537|519882968|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
144435697|NCT03131440|520801262|FG003|Overall Study|Lost to Follow-up|0|||
144435698|NCT03131440|520801263|FG004|Overall Study|Lost to Follow-up|0|||
144435699|NCT03131440|520801264|FG005|Overall Study|Lost to Follow-up|1|||
144435700|NCT03131440|520801265|FG006|Overall Study|Lost to Follow-up|0|||
144435701|NCT03131440|520801266|FG007|Overall Study|Lost to Follow-up|0|||
144435702|NCT03131440|520801267|FG008|Overall Study|Lost to Follow-up|0|||
144435703|NCT03131440|520801268|FG009|Overall Study|Lost to Follow-up|0|||
144435704|NCT03131440|520801269|FG010|Overall Study|Lost to Follow-up|0|||
144435705|NCT03131440|520801270|FG011|Overall Study|Lost to Follow-up|0|||
144435706|NCT03131440|520801271|FG012|Overall Study|Lost to Follow-up|0|||
144435707|NCT03131440|520801272|FG013|Overall Study|Lost to Follow-up|0|||
144435708|NCT03131440|520801273|FG014|Overall Study|Lost to Follow-up|0|||
144435709|NCT03131440|520801274|FG015|Overall Study|Lost to Follow-up|0|||
144435710|NCT03131440|520801275|FG016|Overall Study|Lost to Follow-up|0|||
144435711|NCT03131440|520801276|FG017|Overall Study|Lost to Follow-up|0|||
144435712|NCT03131440|520801277|FG018|Overall Study|Lost to Follow-up|0|||
144435713|NCT03131440|520801278|FG019|Overall Study|Lost to Follow-up|2|||
144435714|NCT03131440|520801279|FG020|Overall Study|Lost to Follow-up|1|||
144435715|NCT03131440|520801280|FG021|Overall Study|Lost to Follow-up|0|||
144435716|NCT03131440|520801281|FG022|Overall Study|Lost to Follow-up|1|||
144435717|NCT03131440|520801282|FG023|Overall Study|Lost to Follow-up|0|||
144435718|NCT03131440|520801283|FG024|Overall Study|Lost to Follow-up|1|||
144435719|NCT03131440|520801284|FG025|Overall Study|Lost to Follow-up|0|||
144435720|NCT03131440|520801285|FG026|Overall Study|Lost to Follow-up|0|||
144435721|NCT03131440|520801286|FG027|Overall Study|Lost to Follow-up|2|||
144435722|NCT03131440|520801287|FG028|Overall Study|Lost to Follow-up|0|||
144435723|NCT03131440|520801288|FG029|Overall Study|Lost to Follow-up|2|||
144435724|NCT03131440|520801289|FG030|Overall Study|Lost to Follow-up|0|||
144435725|NCT03131440|520801290|FG031|Overall Study|Lost to Follow-up|0|||
144435726|NCT03131440|520801259|FG000|Overall Study|Death|0|||
144435727|NCT03131440|520801260|FG001|Overall Study|Death|0|||
144435728|NCT03131440|520801261|FG002|Overall Study|Death|0|||
144435729|NCT03131440|520801262|FG003|Overall Study|Death|0|||
144435730|NCT03131440|520801263|FG004|Overall Study|Death|0|||
144435731|NCT03131440|520801264|FG005|Overall Study|Death|0|||
144435732|NCT03131440|520801265|FG006|Overall Study|Death|0|||
144435733|NCT03131440|520801266|FG007|Overall Study|Death|0|||
144435734|NCT03131440|520801267|FG008|Overall Study|Death|0|||
144435735|NCT03131440|520801268|FG009|Overall Study|Death|0|||
144435736|NCT03131440|520801269|FG010|Overall Study|Death|0|||
144435737|NCT03131440|520801270|FG011|Overall Study|Death|0|||
144435738|NCT03131440|520801271|FG012|Overall Study|Death|0|||
144435739|NCT03131440|520801272|FG013|Overall Study|Death|0|||
144435740|NCT03131440|520801273|FG014|Overall Study|Death|0|||
144435741|NCT03131440|520801274|FG015|Overall Study|Death|0|||
144435742|NCT03131440|520801275|FG016|Overall Study|Death|0|||
144435743|NCT03131440|520801276|FG017|Overall Study|Death|0|||
144435744|NCT03131440|520801277|FG018|Overall Study|Death|0|||
144435745|NCT03131440|520801278|FG019|Overall Study|Death|0|||
144435746|NCT03131440|520801279|FG020|Overall Study|Death|0|||
144435747|NCT03131440|520801280|FG021|Overall Study|Death|0|||
144435748|NCT03131440|520801281|FG022|Overall Study|Death|0|||
144435749|NCT03131440|520801282|FG023|Overall Study|Death|0|||
144435750|NCT03131440|520801283|FG024|Overall Study|Death|0|||
144435751|NCT03131440|520801284|FG025|Overall Study|Death|1|||
144435752|NCT03131440|520801285|FG026|Overall Study|Death|0|||
144435753|NCT03131440|520801286|FG027|Overall Study|Death|0|||
144435754|NCT03131440|520801287|FG028|Overall Study|Death|0|||
144435755|NCT03131440|520801288|FG029|Overall Study|Death|0|||
144435756|NCT03131440|520801289|FG030|Overall Study|Death|0|||
144435757|NCT03131440|520801290|FG031|Overall Study|Death|0|||
144435758|NCT00746941|520801293|FG000|Overall Study|Death|2|||
144435759|NCT00746941|520801294|FG001|Overall Study|Death|0|||
144435760|NCT00746941|520801295|FG002|Overall Study|Death|0|||
144435761|NCT00746941|520801296|FG003|Overall Study|Death|6|||
144604646|NCT02632721|521414377|FG001|Overall Study|Patient wish for other treatment|1|||
144604647|NCT02632721|521414378|FG002|Overall Study|Patient wish for other treatment|0|||
144435762|NCT00746941|520801293|FG000|Overall Study|Physician Decision|0|||
144435763|NCT00746941|520801294|FG001|Overall Study|Physician Decision|0|||
144435764|NCT00746941|520801295|FG002|Overall Study|Physician Decision|2|||
144435765|NCT00746941|520801296|FG003|Overall Study|Physician Decision|0|||
144435766|NCT00746941|520801293|FG000|Overall Study|Withdrawal by Subject|3|||
144435767|NCT00746941|520801294|FG001|Overall Study|Withdrawal by Subject|0|||
144435768|NCT00746941|520801295|FG002|Overall Study|Withdrawal by Subject|0|||
144435769|NCT00746941|520801296|FG003|Overall Study|Withdrawal by Subject|2|||
144435770|NCT00746941|520801293|FG000|Overall Study|Other, reason not provided|2|||
144435771|NCT00746941|520801294|FG001|Overall Study|Other, reason not provided|4|||
144435772|NCT00746941|520801295|FG002|Overall Study|Other, reason not provided|0|||
144435773|NCT00746941|520801296|FG003|Overall Study|Other, reason not provided|4|||
144435774|NCT00746941|520801293|FG000|Overall Study|Adverse Event|0|||
144435775|NCT00746941|520801294|FG001|Overall Study|Adverse Event|0|||
144435776|NCT00746941|520801295|FG002|Overall Study|Adverse Event|0|||
144435777|NCT00746941|520801296|FG003|Overall Study|Adverse Event|1|||
144188257|NCT00602537|519882967|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
144188258|NCT00602537|519882968|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
144188259|NCT00602537|519882967|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
144188260|NCT00602537|519882968|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
144188261|NCT00602537|519882967|FG000|Follow Up Study Comparison|Adverse Event|1|||
144435778|NCT03316885|520801300|FG000|Overall Study|Adverse Event|1|||
144435779|NCT03316885|520801300|FG000|Overall Study|Death|10|||
144435780|NCT03316885|520801300|FG000|Overall Study|Lost to Follow-up|4|||
144435781|NCT03316885|520801300|FG000|Overall Study|Withdrawal by Subject|9|||
144435782|NCT03316885|520801300|FG000|Overall Study|COVID related|8|||
144435783|NCT02376166|520801303|FG000|Overall Study|Adverse Event|1|||
144435784|NCT02376166|520801303|FG000|Overall Study|Discontinued metformin early|2|||
144435785|NCT00811577|520801306|FG000|Overall Study|Lost to Follow-up|7|||
144435786|NCT00811577|520801307|FG001|Overall Study|Lost to Follow-up|1|||
144435787|NCT00811577|520801306|FG000|Overall Study|Withdrawal by Subject|3|||
144435788|NCT00811577|520801307|FG001|Overall Study|Withdrawal by Subject|0|||
144435789|NCT04251221|520801308|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
144435790|NCT04251221|520801309|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
144435791|NCT00329407|520801310|FG000|Overall Study|Withdrawal by Subject|1|||
144435792|NCT00978068|520801311|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
144435793|NCT00978068|520801312|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
144435794|NCT00978068|520801311|FG000|Overall Study|Death|1|||
144435795|NCT00978068|520801312|FG001|Overall Study|Death|2|||
144435796|NCT00978068|520801311|FG000|Overall Study|Lost to Follow-up|1|||
144435797|NCT00978068|520801312|FG001|Overall Study|Lost to Follow-up|2|||
144435798|NCT00978068|520801311|FG000|Overall Study|Physician Decision|0|||
144435799|NCT00978068|520801312|FG001|Overall Study|Physician Decision|1|||
144435800|NCT00978068|520801311|FG000|Overall Study|Unable to Comply with Study|0|||
144435801|NCT00978068|520801312|FG001|Overall Study|Unable to Comply with Study|2|||
144435802|NCT01644175|520801317|FG000|Overall Study|Randomized But Not Treated|0|||
144435803|NCT01644175|520801318|FG001|Overall Study|Randomized But Not Treated|2|||
144435804|NCT01644175|520801317|FG000|Overall Study|Adverse Event|8|||
144435805|NCT01644175|520801318|FG001|Overall Study|Adverse Event|13|||
144435806|NCT01644175|520801317|FG000|Overall Study|Death|1|||
144435807|NCT01644175|520801318|FG001|Overall Study|Death|2|||
144435808|NCT01644175|520801317|FG000|Overall Study|Poor compliance to protocol|9|||
144435809|NCT01644175|520801318|FG001|Overall Study|Poor compliance to protocol|10|||
144435810|NCT01644175|520801317|FG000|Overall Study|Physician Decision|1|||
144435811|NCT01644175|520801318|FG001|Overall Study|Physician Decision|2|||
144435812|NCT01644175|520801317|FG000|Overall Study|Participant Moved|1|||
144435813|NCT01644175|520801318|FG001|Overall Study|Participant Moved|2|||
144435814|NCT01644175|520801317|FG000|Overall Study|Consent withdrawn by participant|3|||
144435815|NCT01644175|520801318|FG001|Overall Study|Consent withdrawn by participant|4|||
144435816|NCT01644175|520801317|FG000|Overall Study|Related to Autoinjector Administration|2|||
144435817|NCT01644175|520801318|FG001|Overall Study|Related to Autoinjector Administration|1|||
144435818|NCT01644175|520801317|FG000|Overall Study|Last visit outside protocol visit window|4|||
144435819|NCT01644175|520801318|FG001|Overall Study|Last visit outside protocol visit window|11|||
144435820|NCT01644175|520801317|FG000|Overall Study|Selection criteria finally not met|0|||
144435821|NCT01644175|520801318|FG001|Overall Study|Selection criteria finally not met|1|||
144435822|NCT01644175|520801317|FG000|Overall Study|Site closure|2|||
144435823|NCT01644175|520801318|FG001|Overall Study|Site closure|2|||
144435824|NCT01644175|520801317|FG000|Overall Study|Lost to Follow-up|1|||
144435825|NCT01644175|520801318|FG001|Overall Study|Lost to Follow-up|0|||
144435826|NCT01644175|520801317|FG000|Overall Study|Other than specified above|0|||
144435827|NCT01644175|520801318|FG001|Overall Study|Other than specified above|3|||
144435828|NCT04258605|520801320|FG000|Overall Study|Death|1|||
144435829|NCT04258605|520801321|FG001|Overall Study|Death|0|||
144435830|NCT04258605|520801320|FG000|Overall Study|Early study termination|21|||
144435831|NCT04258605|520801321|FG001|Overall Study|Early study termination|2|||
144435832|NCT00856908|520801345|FG000|Overall Study|Lost to Follow-up|1|||
144435833|NCT00856908|520801346|FG001|Overall Study|Lost to Follow-up|0|||
144435834|NCT01712256|520801353|FG000|Overall Study|Lost to Follow-up|1|||
144435835|NCT00962104|520801354|FG000|Overall Study|Adverse Event|10|||
144530169|NCT04778397|521144287|FG001|Overall Study|Study Terminated by Sponsor|42|||
144724331|NCT03365375|521846335|FG001|Overall Study|Lost to Follow-up|4|||
144188262|NCT00602537|519882968|FG001|Follow Up Study Comparison|Adverse Event|0|||
144435836|NCT00962104|520801355|FG001|Overall Study|Adverse Event|3|||
144435837|NCT00962104|520801354|FG000|Overall Study|Entry Criteria Not Met|1|||
144435838|NCT00962104|520801355|FG001|Overall Study|Entry Criteria Not Met|2|||
144435839|NCT00962104|520801354|FG000|Overall Study|Lack of Efficacy|0|||
144435840|NCT00962104|520801355|FG001|Overall Study|Lack of Efficacy|1|||
144435841|NCT00962104|520801354|FG000|Overall Study|Lost to Follow-up|10|||
144435842|NCT00962104|520801355|FG001|Overall Study|Lost to Follow-up|4|||
144435843|NCT00962104|520801354|FG000|Overall Study|Physician Decision|1|||
144435844|NCT00962104|520801355|FG001|Overall Study|Physician Decision|0|||
144435845|NCT00962104|520801354|FG000|Overall Study|Protocol Violation|6|||
144435846|NCT00962104|520801355|FG001|Overall Study|Protocol Violation|8|||
144435847|NCT00962104|520801354|FG000|Overall Study|Sponsor Decision|0|||
144435848|NCT00962104|520801355|FG001|Overall Study|Sponsor Decision|1|||
144435849|NCT00962104|520801354|FG000|Overall Study|Withdrawal by Subject|10|||
144435850|NCT00962104|520801355|FG001|Overall Study|Withdrawal by Subject|6|||
144435851|NCT00962104|520801354|FG000|Overall Study|Other|2|||
144435852|NCT00962104|520801355|FG001|Overall Study|Other|0|||
144435853|NCT02013167|520801356|FG000|Overall Study|Withdrawal by Subject|15|||
144435854|NCT02013167|520801357|FG001|Overall Study|Withdrawal by Subject|14|||
144435855|NCT02013167|520801356|FG000|Overall Study|Sponsor Decision|1|||
144435856|NCT02013167|520801357|FG001|Overall Study|Sponsor Decision|3|||
144435857|NCT02013167|520801356|FG000|Overall Study|Lost to Follow-up|0|||
144435858|NCT02013167|520801357|FG001|Overall Study|Lost to Follow-up|1|||
144435859|NCT02013167|520801356|FG000|Overall Study|Death|85|||
144435860|NCT02013167|520801357|FG001|Overall Study|Death|160|||
144435861|NCT00842348|520801358|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
144435862|NCT00842348|520801359|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
144435863|NCT00842348|520801358|FG000|Study 729|Disease progression/death|19|||
144435864|NCT00842348|520801359|FG001|Study 729|Disease progression/death|30|||
144435865|NCT00842348|520801358|FG000|Study 729|Adverse Event|1|||
144435866|NCT00842348|520801359|FG001|Study 729|Adverse Event|1|||
144435867|NCT00842348|520801358|FG000|Study 729|Protocol Violation|1|||
144435868|NCT00842348|520801359|FG001|Study 729|Protocol Violation|1|||
144435869|NCT00842348|520801358|FG000|Study 729|Withdrawal by Subject|2|||
144435870|NCT00842348|520801359|FG001|Study 729|Withdrawal by Subject|4|||
144435871|NCT00842348|520801358|FG000|Study 729|Due to Sponsor stopping the study|1|||
144435872|NCT00842348|520801359|FG001|Study 729|Due to Sponsor stopping the study|1|||
144435873|NCT00842348|520801358|FG000|Study 729|Due to non-availability of IP|0|||
144253468|NCT03488563|520128067|FG001|Overall Study|Adverse Event|0|||
144253469|NCT03488563|520128068|FG002|Overall Study|Adverse Event|1|||
144253470|NCT03488563|520128066|FG000|Overall Study|Subject returned for ET visit|0|||
144253471|NCT03488563|520128067|FG001|Overall Study|Subject returned for ET visit|1|||
144253472|NCT03488563|520128068|FG002|Overall Study|Subject returned for ET visit|0|||
144253473|NCT03488563|520128066|FG000|Overall Study|Sponsor's decision|0|||
144253474|NCT03488563|520128067|FG001|Overall Study|Sponsor's decision|0|||
144435874|NCT00842348|520801359|FG001|Study 729|Due to non-availability of IP|1|||
144435875|NCT00842348|520801358|FG000|Study 729|Sponsor's decision|1|||
144435876|NCT00842348|520801359|FG001|Study 729|Sponsor's decision|0|||
144435877|NCT00842348|520801358|FG000|Study 729|Surgical resection|1|||
144435878|NCT00842348|520801359|FG001|Study 729|Surgical resection|0|||
144435879|NCT01113879|520801362|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
144435880|NCT01113879|520801363|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
144435881|NCT00026793|520801364|FG000|Overall Study|Death on study due to underlying disease|4|||
144435882|NCT00026793|520801364|FG000|Overall Study|Physician Decision|2|||
144435883|NCT00026793|520801364|FG000|Overall Study|Off study|2|||
144435884|NCT04151290|520801366|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
144435885|NCT02276612|520801368|FG000|Overall Study|Death|1|||
144435886|NCT02276612|520801369|FG001|Overall Study|Death|0|||
144435887|NCT02276612|520801368|FG000|Overall Study|Pregnancy|1|||
144435888|NCT02276612|520801369|FG001|Overall Study|Pregnancy|0|||
144435889|NCT02276612|520801368|FG000|Overall Study|Withdrew Consent|1|||
144435890|NCT02276612|520801369|FG001|Overall Study|Withdrew Consent|0|||
144435891|NCT02276612|520801368|FG000|Overall Study|Lost to Follow-up|1|||
144435892|NCT02276612|520801369|FG001|Overall Study|Lost to Follow-up|0|||
144435893|NCT02196324|520801370|FG000|Overall Study|Withdrawal by Subject|8|||
144435894|NCT02196324|520801371|FG001|Overall Study|Withdrawal by Subject|4|||
144435895|NCT02196324|520801370|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
144435896|NCT02196324|520801371|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
144435897|NCT02196324|520801370|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
144530170|NCT04778397|521144288|FG002|Overall Study|Study Terminated by Sponsor|15|||
144530171|NCT04778397|521144289|FG003|Overall Study|Study Terminated by Sponsor|12|||
144530172|NCT04778397|521144286|FG000|Overall Study|Withdrew Consent|5|||
144530173|NCT04778397|521144287|FG001|Overall Study|Withdrew Consent|4|||
144530174|NCT04778397|521144288|FG002|Overall Study|Withdrew Consent|1|||
144530175|NCT04778397|521144289|FG003|Overall Study|Withdrew Consent|1|||
144530176|NCT04778397|521144286|FG000|Overall Study|Reason Not Specified|1|||
144530177|NCT04778397|521144287|FG001|Overall Study|Reason Not Specified|3|||
144530178|NCT04778397|521144288|FG002|Overall Study|Reason Not Specified|0|||
144435898|NCT02196324|520801371|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
144435899|NCT02196324|520801370|FG000|Overall Study|Other|1|||
144435900|NCT02196324|520801371|FG001|Overall Study|Other|0|||
144435901|NCT01380184|520801372|FG000|Part 1 (19 Days)|Adverse Event|1|||
144435902|NCT01380184|520801372|FG000|Part 2|Adverse Event|5|||
144435903|NCT01380184|520801372|FG000|Part 2|Disease Progression|8|||
144435904|NCT01380184|520801372|FG000|Part 2|Lost to Follow-up|1|||
144435905|NCT04243538|520801373|FG000|Overall Study|Withdrawal by Subject|0|||
144435906|NCT04243538|520801374|FG001|Overall Study|Withdrawal by Subject|2|||
144253475|NCT03488563|520128068|FG002|Overall Study|Sponsor's decision|1|||
144253476|NCT00582426|520128078|FG000|Overall Study|Lost to Follow-up|0|||
144188263|NCT00602537|519882967|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
144435907|NCT04243538|520801373|FG000|Overall Study|Lost to Follow-up|0|||
144435908|NCT04243538|520801374|FG001|Overall Study|Lost to Follow-up|3|||
144435909|NCT00655564|520801375|FG000|Overall Study|Adverse Event|1|||
144435910|NCT00655564|520801375|FG000|Overall Study|Lost to Follow-up|1|||
144435911|NCT00655564|520801375|FG000|Overall Study|Desired Alternate Therapy|1|||
144435912|NCT00344773|520801377|FG000|Overall Study|Adverse Event|2|||
144435913|NCT00344773|520801377|FG000|Overall Study|Objective Disease Progression|16|||
144435914|NCT00344773|520801377|FG000|Overall Study|Withdrawal by Subject|1|||
144435915|NCT00344773|520801377|FG000|Overall Study|Not Eligible for the study|2|||
144435916|NCT00244712|520801378|FG000|Overall Study|Adverse Event|20|||
144435917|NCT00244712|520801379|FG001|Overall Study|Adverse Event|21|||
144435918|NCT00244712|520801378|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
144435919|NCT00244712|520801379|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
144435920|NCT00244712|520801378|FG000|Overall Study|Lack of Compliance|10|||
144435921|NCT00244712|520801379|FG001|Overall Study|Lack of Compliance|11|||
144435922|NCT00244712|520801378|FG000|Overall Study|Lost to Follow-up|45|||
144435923|NCT00244712|520801379|FG001|Overall Study|Lost to Follow-up|52|||
144435924|NCT00244712|520801378|FG000|Overall Study|Withdrawal by Subject|13|||
144435925|NCT00244712|520801379|FG001|Overall Study|Withdrawal by Subject|23|||
144435926|NCT00244712|520801378|FG000|Overall Study|Protocol Violation, disease progression|13|||
144435927|NCT00244712|520801379|FG001|Overall Study|Protocol Violation, disease progression|11|||
144435928|NCT01077804|520801380|FG000|Overall Study|Unreachable|102|||
144435929|NCT01077804|520801380|FG000|Overall Study|Refused to continue|79|||
144435930|NCT01077804|520801380|FG000|Overall Study|Other|18|||
144435931|NCT02620046|520801381|FG000|Overall Study|Adverse Event|22|||
144435932|NCT02620046|520801382|FG001|Overall Study|Adverse Event|42|||
144435933|NCT02620046|520801381|FG000|Overall Study|Lost to Follow-up|4|||
144435934|NCT02620046|520801382|FG001|Overall Study|Lost to Follow-up|10|||
144435935|NCT02620046|520801381|FG000|Overall Study|Withdrawal by Subject|36|||
144435936|NCT02620046|520801382|FG001|Overall Study|Withdrawal by Subject|66|||
144435937|NCT02620046|520801381|FG000|Overall Study|Site Termination|3|||
144435938|NCT02620046|520801382|FG001|Overall Study|Site Termination|3|||
144435939|NCT02620046|520801381|FG000|Overall Study|Pregnancy|3|||
144435940|NCT02620046|520801382|FG001|Overall Study|Pregnancy|7|||
144435941|NCT02620046|520801381|FG000|Overall Study|Lack of Efficacy|81|||
144435942|NCT02620046|520801382|FG001|Overall Study|Lack of Efficacy|146|||
144435943|NCT02620046|520801381|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
144435944|NCT02620046|520801382|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
144435945|NCT02620046|520801381|FG000|Overall Study|Reason Not Specified|13|||
144435946|NCT02620046|520801382|FG001|Overall Study|Reason Not Specified|21|||
144435947|NCT02620046|520801381|FG000|Overall Study|Significant Protocol Deviation|0|||
144435948|NCT02620046|520801382|FG001|Overall Study|Significant Protocol Deviation|1|||
144435949|NCT02917031|520801388|FG000|Overall Study|Reason not specified|7|||
144435950|NCT02917031|520801389|FG001|Overall Study|Reason not specified|5|||
144435951|NCT02917031|520801390|FG002|Overall Study|Reason not specified|6|||
144435952|NCT02917031|520801388|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
144435953|NCT02917031|520801389|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
144435954|NCT02917031|520801390|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
144435955|NCT02917031|520801388|FG000|Overall Study|Withdrawal by Subject|3|||
144435956|NCT02917031|520801389|FG001|Overall Study|Withdrawal by Subject|3|||
144435957|NCT02917031|520801390|FG002|Overall Study|Withdrawal by Subject|0|||
144435958|NCT02917031|520801388|FG000|Overall Study|Physician Decision|1|||
144435959|NCT02917031|520801389|FG001|Overall Study|Physician Decision|0|||
144435960|NCT02917031|520801390|FG002|Overall Study|Physician Decision|0|||
144435961|NCT02917031|520801388|FG000|Overall Study|Adverse Event|4|||
144435962|NCT02917031|520801389|FG001|Overall Study|Adverse Event|1|||
144435963|NCT02917031|520801390|FG002|Overall Study|Adverse Event|5|||
144435964|NCT02917031|520801388|FG000|Overall Study|Death|2|||
144435965|NCT02917031|520801389|FG001|Overall Study|Death|3|||
144435966|NCT02917031|520801390|FG002|Overall Study|Death|4|||
144435967|NCT00403273|520803144|FG000|Overall Study|Lost to Follow-up|3|||
144435968|NCT00403273|520803145|FG001|Overall Study|Lost to Follow-up|2|||
144435969|NCT00403273|520803144|FG000|Overall Study|Physician Decision|0|||
144435970|NCT00403273|520803145|FG001|Overall Study|Physician Decision|1|||
144435971|NCT00403273|520803144|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
144435972|NCT00403273|520803145|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
144435973|NCT01336738|520803147|FG000|Overall Study|Adverse Event|0|||
144435974|NCT01336738|520803148|FG001|Overall Study|Adverse Event|3|||
144435975|NCT01336738|520803149|FG002|Overall Study|Adverse Event|2|||
144435976|NCT01336738|520803150|FG003|Overall Study|Adverse Event|1|||
144435977|NCT01336738|520803151|FG004|Overall Study|Adverse Event|3|||
144435978|NCT01336738|520803147|FG000|Overall Study|Lost to Follow-up|2|||
144188264|NCT00602537|519882968|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
144435979|NCT01336738|520803148|FG001|Overall Study|Lost to Follow-up|1|||
144435980|NCT01336738|520803149|FG002|Overall Study|Lost to Follow-up|2|||
144435981|NCT01336738|520803150|FG003|Overall Study|Lost to Follow-up|2|||
144435982|NCT01336738|520803151|FG004|Overall Study|Lost to Follow-up|2|||
144435983|NCT01336738|520803147|FG000|Overall Study|Did not meet entrance criteria|0|||
144435984|NCT01336738|520803148|FG001|Overall Study|Did not meet entrance criteria|1|||
144435985|NCT01336738|520803149|FG002|Overall Study|Did not meet entrance criteria|0|||
144435986|NCT01336738|520803150|FG003|Overall Study|Did not meet entrance criteria|0|||
144435987|NCT01336738|520803151|FG004|Overall Study|Did not meet entrance criteria|0|||
144435988|NCT01336738|520803147|FG000|Overall Study|Protocol Violation|0|||
144435989|NCT01336738|520803148|FG001|Overall Study|Protocol Violation|1|||
144435990|NCT01336738|520803149|FG002|Overall Study|Protocol Violation|0|||
144435991|NCT01336738|520803150|FG003|Overall Study|Protocol Violation|0|||
144435992|NCT01336738|520803151|FG004|Overall Study|Protocol Violation|0|||
144435993|NCT01336738|520803147|FG000|Overall Study|Withdrawal by Subject|2|||
144435994|NCT01336738|520803148|FG001|Overall Study|Withdrawal by Subject|0|||
144435995|NCT01336738|520803149|FG002|Overall Study|Withdrawal by Subject|2|||
144435996|NCT01336738|520803150|FG003|Overall Study|Withdrawal by Subject|1|||
144435997|NCT01336738|520803151|FG004|Overall Study|Withdrawal by Subject|1|||
144435998|NCT01336738|520803147|FG000|Overall Study|Other|3|||
144435999|NCT01336738|520803148|FG001|Overall Study|Other|3|||
144436000|NCT01336738|520803149|FG002|Overall Study|Other|2|||
144436001|NCT01336738|520803150|FG003|Overall Study|Other|3|||
144436002|NCT01336738|520803151|FG004|Overall Study|Other|4|||
144436003|NCT01083433|520803152|FG000|Overall Study|Lost to Follow-up|2|||
144436004|NCT01083433|520803153|FG001|Overall Study|Lost to Follow-up|1|||
144436005|NCT01083433|520803154|FG002|Overall Study|Lost to Follow-up|1|||
144436006|NCT01083433|520803152|FG000|Overall Study|Withdrawal by Subject|0|||
144436007|NCT01083433|520803153|FG001|Overall Study|Withdrawal by Subject|5|||
144436008|NCT01083433|520803154|FG002|Overall Study|Withdrawal by Subject|3|||
144436009|NCT01083433|520803152|FG000|Overall Study|Pregnancy|0|||
144436010|NCT01083433|520803153|FG001|Overall Study|Pregnancy|0|||
144436011|NCT01083433|520803154|FG002|Overall Study|Pregnancy|1|||
144436012|NCT01581593|520803155|FG000|Overall Study|Withdrawal by Subject|1|||
144436013|NCT04982029|520803156|FG000|Overall Study|Lost to Follow-up|2|||
144436014|NCT04982029|520803157|FG001|Overall Study|Lost to Follow-up|3|||
144436015|NCT03264404|520803158|FG000|Overall Study|Death|2|||
144436016|NCT03264404|520803158|FG000|Overall Study|Physician Decision|1|||
144436017|NCT03264404|520803158|FG000|Overall Study|Disease Progression|28|||
144436018|NCT03264404|520803158|FG000|Overall Study|Adverse Event|1|||
144436019|NCT03264404|520803158|FG000|Overall Study|Off study prior to treatment|2|||
144436020|NCT05458856|520803159|FG000|Overall Study|Withdrawal by Subject|5|||
144436021|NCT05458856|520803159|FG000|Overall Study|Death|4|||
144436022|NCT05458856|520803159|FG000|Overall Study|Protocol Deviation|3|||
144436023|NCT05458856|520803159|FG000|Overall Study|Physician Decision|1|||
144436024|NCT01920932|520803160|FG000|Overall Study|Death|1|||
144436025|NCT01920932|520803160|FG000|Overall Study|Withdrawal of consent|1|||
144436026|NCT03299842|520803161|FG000|Overall Study|Caregiver withdrew consent|2|||
144436027|NCT03299842|520803161|FG000|Overall Study|Child would not keep the watch on|3|||
144436028|NCT00071812|520803162|FG000|24-Week Double-Blind Period|Adverse Event|2|||
144436029|NCT00071812|520803163|FG001|24-Week Double-Blind Period|Adverse Event|3|||
144436030|NCT00071812|520803164|FG002|24-Week Double-Blind Period|Adverse Event|4|||
144436031|NCT00071812|520803165|FG003|24-Week Double-Blind Period|Adverse Event|4|||
144436032|NCT00071812|520803162|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
144436033|NCT00071812|520803163|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
144436034|NCT00071812|520803164|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
144436035|NCT00071812|520803165|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
144436036|NCT00071812|520803162|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
144436037|NCT00071812|520803163|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
144436038|NCT00071812|520803164|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
144436039|NCT00071812|520803165|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
144436040|NCT00071812|520803162|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
144530179|NCT04778397|521144289|FG003|Overall Study|Reason Not Specified|2|||
144530180|NCT04778397|521144286|FG000|Overall Study|Lost to Follow-up|2|||
144530181|NCT04778397|521144287|FG001|Overall Study|Lost to Follow-up|1|||
144530182|NCT04778397|521144288|FG002|Overall Study|Lost to Follow-up|0|||
144530183|NCT04778397|521144289|FG003|Overall Study|Lost to Follow-up|1|||
144530184|NCT04294641|521144290|FG000|Overall Study|Screen failure|4|||
144436041|NCT00071812|520803163|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
144436042|NCT00071812|520803164|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
144436043|NCT00071812|520803165|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
144436044|NCT00071812|520803162|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
144436045|NCT00071812|520803163|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
144436046|NCT00071812|520803164|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
144436047|NCT00071812|520803165|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
144436048|NCT00071812|520803162|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
144530185|NCT04730739|521144292|FG000|Overall Study|Death|1|||
144436049|NCT00071812|520803163|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
144436050|NCT00071812|520803164|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
144530186|NCT03308877|521144293|FG000|Overall Study|Lost to Follow-up|32|||
144530187|NCT03308877|521144294|FG001|Overall Study|Lost to Follow-up|28|||
144530188|NCT05218096|521144307|FG000|Primary Evaluation|Withdrawal by Subject|0|||
144530189|NCT05218096|521144308|FG001|Primary Evaluation|Withdrawal by Subject|0|||
144530190|NCT05218096|521144309|FG002|Primary Evaluation|Withdrawal by Subject|2|||
144530191|NCT05218096|521144310|FG003|Primary Evaluation|Withdrawal by Subject|0|||
144530192|NCT05218096|521144311|FG004|Primary Evaluation|Withdrawal by Subject|0|||
144530193|NCT05218096|521144307|FG000|Primary Evaluation|Physician Decision|1|||
144530194|NCT05218096|521144308|FG001|Primary Evaluation|Physician Decision|0|||
144530195|NCT05218096|521144309|FG002|Primary Evaluation|Physician Decision|0|||
144530196|NCT05218096|521144310|FG003|Primary Evaluation|Physician Decision|0|||
144530197|NCT05218096|521144311|FG004|Primary Evaluation|Physician Decision|0|||
144530198|NCT05218096|521144307|FG000|Extended Treatment|Clinical Deterioration|1|||
144530199|NCT05218096|521144308|FG001|Extended Treatment|Clinical Deterioration|1|||
144530200|NCT05218096|521144309|FG002|Extended Treatment|Clinical Deterioration|0|||
144530201|NCT05218096|521144310|FG003|Extended Treatment|Clinical Deterioration|0|||
144530202|NCT05218096|521144311|FG004|Extended Treatment|Clinical Deterioration|0|||
144530203|NCT05218096|521144307|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
144530204|NCT05218096|521144308|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
144530205|NCT05218096|521144309|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
144530206|NCT05218096|521144310|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
144188265|NCT00602537|519882967|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
144188266|NCT00602537|519882968|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
144188267|NCT02412722|519882971|FG000|Overall Study|Adverse Event|0|||
144188268|NCT02412722|519882972|FG001|Overall Study|Adverse Event|2|||
144188269|NCT02412722|519882973|FG002|Overall Study|Adverse Event|0|||
144188270|NCT02412722|519882974|FG003|Overall Study|Adverse Event|3|||
144188271|NCT02412722|519882975|FG004|Overall Study|Adverse Event|0|||
144436051|NCT00071812|520803165|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
144436052|NCT00071812|520803162|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
144436053|NCT00071812|520803163|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
144436054|NCT00071812|520803164|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
144436055|NCT00071812|520803165|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
144436056|NCT00071812|520803162|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
144436057|NCT00071812|520803163|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
144436058|NCT00071812|520803164|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
144436059|NCT00071812|520803165|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
144436060|NCT00071812|520803162|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144436061|NCT00071812|520803163|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144436062|NCT00071812|520803164|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144436063|NCT00071812|520803165|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
144436064|NCT00071812|520803162|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
144436065|NCT00071812|520803163|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
144436066|NCT00071812|520803164|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
144436067|NCT00071812|520803165|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
144436068|NCT01816139|520803166|FG000|Overall Study|Adverse Event|6|||
144436069|NCT01816139|520803167|FG001|Overall Study|Adverse Event|8|||
144436070|NCT01816139|520803166|FG000|Overall Study|Lack of Efficacy|1|||
144436071|NCT01816139|520803167|FG001|Overall Study|Lack of Efficacy|2|||
144436072|NCT01816139|520803166|FG000|Overall Study|Lost to Follow-up|5|||
144436073|NCT01816139|520803167|FG001|Overall Study|Lost to Follow-up|3|||
144436074|NCT01816139|520803166|FG000|Overall Study|Withdrew Consent|6|||
144436075|NCT01816139|520803167|FG001|Overall Study|Withdrew Consent|4|||
144436076|NCT01816139|520803166|FG000|Overall Study|Protocol Violation|6|||
144436077|NCT01816139|520803167|FG001|Overall Study|Protocol Violation|3|||
144436078|NCT01816139|520803166|FG000|Overall Study|Reason not Specified|4|||
144436079|NCT01816139|520803167|FG001|Overall Study|Reason not Specified|2|||
144436080|NCT04013191|520803168|FG000|Overall Study|Adverse Event|1|||
144436081|NCT04013191|520803169|FG001|Overall Study|Adverse Event|0|||
144436082|NCT00588445|520803170|FG000|Overall Study|Protocol Violation|1|||
144436083|NCT00588445|520803170|FG000|Overall Study|Withdrawal by Subject|3|||
144436084|NCT00588445|520803170|FG000|Overall Study|Disease Progression|1|||
144436085|NCT00588445|520803170|FG000|Overall Study|Not Treated|10|||
144436086|NCT00116831|520803173|FG000|Overall Study|Adverse Event|14|||
144436087|NCT00116831|520803174|FG001|Overall Study|Adverse Event|16|||
144436088|NCT00116831|520803173|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
144436089|NCT00116831|520803174|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
144436090|NCT00116831|520803173|FG000|Overall Study|Lost to Follow-up|8|||
144530207|NCT05218096|521144311|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
144530208|NCT05218096|521144307|FG000|Extended Treatment|Withdrawal by Subject|1|||
144530209|NCT05218096|521144308|FG001|Extended Treatment|Withdrawal by Subject|3|||
144436091|NCT00116831|520803174|FG001|Overall Study|Lost to Follow-up|6|||
144436092|NCT00116831|520803173|FG000|Overall Study|Protocol Violation|3|||
144436093|NCT00116831|520803174|FG001|Overall Study|Protocol Violation|6|||
144436094|NCT00116831|520803173|FG000|Overall Study|Hypoglycaemic events|1|||
144436095|NCT00116831|520803174|FG001|Overall Study|Hypoglycaemic events|0|||
144436096|NCT00116831|520803173|FG000|Overall Study|Low haemoglobin on screening|1|||
144436097|NCT00116831|520803174|FG001|Overall Study|Low haemoglobin on screening|0|||
144436098|NCT00116831|520803173|FG000|Overall Study|Withdrawn investigational product|1|||
144436099|NCT00116831|520803174|FG001|Overall Study|Withdrawn investigational product|0|||
144436100|NCT00116831|520803173|FG000|Overall Study|Withdrawal by Subject|32|||
144436101|NCT00116831|520803174|FG001|Overall Study|Withdrawal by Subject|32|||
144436102|NCT00116831|520803173|FG000|Overall Study|Insufficient therapeutic effect|0|||
144436103|NCT00116831|520803174|FG001|Overall Study|Insufficient therapeutic effect|1|||
144436104|NCT00116831|520803173|FG000|Overall Study|Missing data for participant|1|||
144436105|NCT00116831|520803174|FG001|Overall Study|Missing data for participant|0|||
144436106|NCT02945410|520803175|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
144436107|NCT02945410|520803176|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
144436108|NCT02945410|520803177|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
144436109|NCT02945410|520803178|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
144436110|NCT02945410|520803179|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
144436111|NCT02945410|520803180|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
144436112|NCT02945410|520803175|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
144436113|NCT02945410|520803176|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
144436114|NCT02945410|520803177|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
144436115|NCT02945410|520803178|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
144436116|NCT02945410|520803179|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
144436117|NCT02945410|520803180|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
144436118|NCT02945410|520803175|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
144436119|NCT02945410|520803176|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
144436120|NCT02945410|520803177|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
144436121|NCT02945410|520803178|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
144436122|NCT02945410|520803179|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
144436123|NCT02945410|520803180|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
144436124|NCT04904185|520803181|FG000|Overall Study|Expansion failure|1|||
144436125|NCT04904185|520803182|FG001|Overall Study|Expansion failure|0|||
144436126|NCT04904185|520803181|FG000|Overall Study|Late response on prior treatment|1|||
144436127|NCT04904185|520803182|FG001|Overall Study|Late response on prior treatment|0|||
144436128|NCT01344369|520803185|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
144436129|NCT01344369|520803186|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
144436130|NCT01344369|520803185|FG000|Washout of 28 Days|Physician Decision|0|||
144436131|NCT01344369|520803186|FG001|Washout of 28 Days|Physician Decision|1|||
144436132|NCT01344369|520803185|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
144436133|NCT01344369|520803186|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
144436134|NCT00110812|520803187|FG000|Main Study|Death|0|||
144436135|NCT00110812|520803188|FG001|Main Study|Death|0|||
144436136|NCT00110812|520803189|FG002|Main Study|Death|2|||
144530210|NCT05218096|521144309|FG002|Extended Treatment|Withdrawal by Subject|0|||
144530211|NCT05218096|521144310|FG003|Extended Treatment|Withdrawal by Subject|2|||
144530212|NCT05218096|521144311|FG004|Extended Treatment|Withdrawal by Subject|2|||
144530213|NCT05218096|521144307|FG000|Extended Treatment|Lack of Efficacy|3|||
144530214|NCT05218096|521144308|FG001|Extended Treatment|Lack of Efficacy|0|||
144530215|NCT05218096|521144309|FG002|Extended Treatment|Lack of Efficacy|0|||
144530216|NCT05218096|521144310|FG003|Extended Treatment|Lack of Efficacy|0|||
144530217|NCT05218096|521144311|FG004|Extended Treatment|Lack of Efficacy|0|||
144530218|NCT05218096|521144307|FG000|Extended Treatment|Physician Decision|0|||
144530219|NCT05218096|521144308|FG001|Extended Treatment|Physician Decision|1|||
144530220|NCT05218096|521144309|FG002|Extended Treatment|Physician Decision|0|||
144530221|NCT05218096|521144310|FG003|Extended Treatment|Physician Decision|0|||
144530222|NCT05218096|521144311|FG004|Extended Treatment|Physician Decision|0|||
144530223|NCT05218096|521144307|FG000|Open-label Extension|Adverse Event|1|||
144530224|NCT05218096|521144308|FG001|Open-label Extension|Adverse Event|0|||
144530225|NCT05218096|521144309|FG002|Open-label Extension|Adverse Event|0|||
144530226|NCT05218096|521144310|FG003|Open-label Extension|Adverse Event|0|||
144530227|NCT05218096|521144311|FG004|Open-label Extension|Adverse Event|1|||
144530228|NCT05218096|521144307|FG000|Open-label Extension|Pregnancy|0|||
144530229|NCT05218096|521144308|FG001|Open-label Extension|Pregnancy|0|||
144436137|NCT00110812|520803187|FG000|Main Study|Withdrawal by Subject|0|||
144436138|NCT00110812|520803188|FG001|Main Study|Withdrawal by Subject|0|||
144436139|NCT00110812|520803189|FG002|Main Study|Withdrawal by Subject|1|||
144530230|NCT05218096|521144309|FG002|Open-label Extension|Pregnancy|0|||
144530231|NCT05218096|521144310|FG003|Open-label Extension|Pregnancy|0|||
144530232|NCT05218096|521144311|FG004|Open-label Extension|Pregnancy|1|||
144604648|NCT02632721|521414379|FG003|Overall Study|Patient wish for other treatment|0|||
144436140|NCT00110812|520803187|FG000|Main Study|Lost to Follow-up|8|||
144530233|NCT05218096|521144307|FG000|Open-label Extension|Lack of Efficacy|1|||
144530234|NCT05218096|521144308|FG001|Open-label Extension|Lack of Efficacy|2|||
144604649|NCT02632721|521414380|FG004|Overall Study|Patient wish for other treatment|0|||
144724332|NCT02166697|521846336|FG000|Overall Study|Protocol Violation|347|||
144530235|NCT05218096|521144309|FG002|Open-label Extension|Lack of Efficacy|0|||
144436141|NCT00110812|520803188|FG001|Main Study|Lost to Follow-up|11|||
144436142|NCT00110812|520803189|FG002|Main Study|Lost to Follow-up|10|||
144436143|NCT00110812|520803187|FG000|Extended Follow-up|Death|1|||
144436144|NCT00110812|520803188|FG001|Extended Follow-up|Death|0|||
144436145|NCT00110812|520803189|FG002|Extended Follow-up|Death|3|||
144436146|NCT00110812|520803187|FG000|Extended Follow-up|Withdrawal by Subject|0|||
144436147|NCT00110812|520803188|FG001|Extended Follow-up|Withdrawal by Subject|1|||
144436148|NCT00110812|520803189|FG002|Extended Follow-up|Withdrawal by Subject|0|||
144436149|NCT00110812|520803187|FG000|Extended Follow-up|Lost to Follow-up|1|||
144436150|NCT00110812|520803188|FG001|Extended Follow-up|Lost to Follow-up|3|||
144436151|NCT00110812|520803189|FG002|Extended Follow-up|Lost to Follow-up|1|||
144436152|NCT02342704|520803192|FG000|Overall Study|Physician Decision|0|||
144436153|NCT02342704|520803193|FG001|Overall Study|Physician Decision|3|||
144436154|NCT02342704|520803192|FG000|Overall Study|Sponsor Termination|49|||
144436155|NCT02342704|520803193|FG001|Overall Study|Sponsor Termination|43|||
144436156|NCT02342704|520803192|FG000|Overall Study|Other|0|||
144436157|NCT02342704|520803193|FG001|Overall Study|Other|1|||
144436158|NCT02342704|520803192|FG000|Overall Study|Withdrawal by Subject|1|||
144436159|NCT02342704|520803193|FG001|Overall Study|Withdrawal by Subject|0|||
144436160|NCT02342704|520803192|FG000|Overall Study|Lost to Follow-up|2|||
144436161|NCT02342704|520803193|FG001|Overall Study|Lost to Follow-up|1|||
144436162|NCT02342704|520803192|FG000|Overall Study|Adverse Event|1|||
144436163|NCT02342704|520803193|FG001|Overall Study|Adverse Event|3|||
144436164|NCT02919670|520803194|FG000|Overall Study|Only 17 participants met compliance|43|||
144436165|NCT02919670|520803195|FG001|Overall Study|Only 17 participants met compliance|39|||
144436166|NCT00240071|520803196|FG000|Overall Study|Withdrawal by Subject|3|||
144436167|NCT03100825|520803197|FG000|Overall Study|Participant/Guardian Decision|7|||
144436168|NCT03100825|520803197|FG000|Overall Study|Physician Decision|1|||
144436169|NCT00436748|520803202|FG000|Overall Study|Ineligibility Determined|1|||
144436170|NCT00436748|520803203|FG001|Overall Study|Ineligibility Determined|1|||
144436171|NCT00436748|520803202|FG000|Overall Study|Adverse Event|0|||
144436172|NCT00436748|520803203|FG001|Overall Study|Adverse Event|2|||
144436173|NCT00436748|520803202|FG000|Overall Study|Consent Withdrawn|1|||
144436174|NCT00436748|520803203|FG001|Overall Study|Consent Withdrawn|4|||
144436175|NCT00436748|520803202|FG000|Overall Study|Administrative Decision|1|||
144436176|NCT00436748|520803203|FG001|Overall Study|Administrative Decision|0|||
144436177|NCT00436748|520803202|FG000|Overall Study|Lost to Follow-up|0|||
144436178|NCT00436748|520803203|FG001|Overall Study|Lost to Follow-up|1|||
144436179|NCT00436748|520803202|FG000|Overall Study|Protocol-specified Criteria|5|||
144436180|NCT00436748|520803203|FG001|Overall Study|Protocol-specified Criteria|4|||
144436181|NCT00436748|520803202|FG000|Overall Study|Other|3|||
144436182|NCT00436748|520803203|FG001|Overall Study|Other|0|||
144436183|NCT01610791|520803204|FG000|Overall Study|Lost to Follow-up|7|||
144436184|NCT01610791|520803204|FG000|Overall Study|Adverse Event|6|||
144436185|NCT01610791|520803204|FG000|Overall Study|Physician Decision|1|||
144436186|NCT01610791|520803204|FG000|Overall Study|Adverse event and Investigator decision|1|||
144436187|NCT01610791|520803204|FG000|Overall Study|Death|1|||
144436188|NCT01610791|520803204|FG000|Overall Study|Not determined|5|||
144436189|NCT02086110|520803213|FG000|Overall Study|Withdrawal by Subject|1|||
144436190|NCT02086110|520803214|FG001|Overall Study|Withdrawal by Subject|1|||
144436191|NCT00578175|520803215|FG000|Overall Study|Adverse Event|0|||
144436192|NCT00578175|520803216|FG001|Overall Study|Adverse Event|1|||
144436193|NCT00578175|520803217|FG002|Overall Study|Adverse Event|1|||
144436194|NCT00578175|520803215|FG000|Overall Study|Other reasons|70|||
144436195|NCT00578175|520803216|FG001|Overall Study|Other reasons|42|||
144436196|NCT00578175|520803217|FG002|Overall Study|Other reasons|23|||
144436197|NCT01203072|520803221|FG000|Overall Study|Adverse Event|5|||
144436198|NCT01203072|520803222|FG001|Overall Study|Adverse Event|3|||
144436199|NCT01203072|520803223|FG002|Overall Study|Adverse Event|2|||
144436200|NCT01203072|520803224|FG003|Overall Study|Adverse Event|4|||
144530236|NCT05218096|521144310|FG003|Open-label Extension|Lack of Efficacy|0|||
144530237|NCT05218096|521144311|FG004|Open-label Extension|Lack of Efficacy|0|||
144436201|NCT01203072|520803225|FG004|Overall Study|Adverse Event|2|||
144436202|NCT01203072|520803221|FG000|Overall Study|Lack of Efficacy|1|||
144436203|NCT01203072|520803222|FG001|Overall Study|Lack of Efficacy|0|||
144436204|NCT01203072|520803223|FG002|Overall Study|Lack of Efficacy|0|||
144436205|NCT01203072|520803224|FG003|Overall Study|Lack of Efficacy|0|||
144530238|NCT05218096|521144307|FG000|Open-label Extension|Lost to Follow-up|1|||
144436206|NCT01203072|520803225|FG004|Overall Study|Lack of Efficacy|0|||
144530239|NCT05218096|521144308|FG001|Open-label Extension|Lost to Follow-up|0|||
144436207|NCT01203072|520803221|FG000|Overall Study|Lost to Follow-up|0|||
144436208|NCT01203072|520803222|FG001|Overall Study|Lost to Follow-up|1|||
144530240|NCT05218096|521144309|FG002|Open-label Extension|Lost to Follow-up|0|||
144436209|NCT01203072|520803223|FG002|Overall Study|Lost to Follow-up|0|||
144436210|NCT01203072|520803224|FG003|Overall Study|Lost to Follow-up|0|||
144436211|NCT01203072|520803225|FG004|Overall Study|Lost to Follow-up|0|||
144436212|NCT01203072|520803221|FG000|Overall Study|Protocol Violation|2|||
144436213|NCT01203072|520803222|FG001|Overall Study|Protocol Violation|0|||
144436214|NCT01203072|520803223|FG002|Overall Study|Protocol Violation|0|||
144436215|NCT01203072|520803224|FG003|Overall Study|Protocol Violation|0|||
144436216|NCT01203072|520803225|FG004|Overall Study|Protocol Violation|1|||
144436217|NCT01203072|520803221|FG000|Overall Study|Withdrawal by Subject|2|||
144436218|NCT01203072|520803222|FG001|Overall Study|Withdrawal by Subject|2|||
144436219|NCT01203072|520803223|FG002|Overall Study|Withdrawal by Subject|1|||
144436220|NCT01203072|520803224|FG003|Overall Study|Withdrawal by Subject|2|||
144436221|NCT01203072|520803225|FG004|Overall Study|Withdrawal by Subject|3|||
144436222|NCT02272413|520803227|FG000|Randomized Through Treatment Start|Not treated|3|||
144436223|NCT02272413|520803228|FG001|Randomized Through Treatment Start|Not treated|5|||
144436224|NCT02272413|520803227|FG000|Pre-switch Period|Adverse Event|38|||
144436225|NCT02272413|520803228|FG001|Pre-switch Period|Adverse Event|37|||
144436226|NCT02272413|520803227|FG000|Pre-switch Period|Death|26|||
144436227|NCT02272413|520803228|FG001|Pre-switch Period|Death|26|||
144436228|NCT02272413|520803227|FG000|Pre-switch Period|Withdrawal by Subject|27|||
144436229|NCT02272413|520803228|FG001|Pre-switch Period|Withdrawal by Subject|15|||
144436230|NCT02272413|520803227|FG000|Pre-switch Period|Physician Decision|6|||
144436231|NCT02272413|520803228|FG001|Pre-switch Period|Physician Decision|18|||
144436232|NCT02272413|520803227|FG000|Pre-switch Period|Progressive disease|185|||
144436233|NCT02272413|520803228|FG001|Pre-switch Period|Progressive disease|173|||
144436234|NCT02272413|520803227|FG000|Pre-switch Period|Lost to Follow-up|0|||
144436235|NCT02272413|520803228|FG001|Pre-switch Period|Lost to Follow-up|2|||
144436236|NCT02272413|520803227|FG000|Pre-switch Period|Protocol Violation|1|||
144436237|NCT02272413|520803228|FG001|Pre-switch Period|Protocol Violation|0|||
144436238|NCT02272413|520803227|FG000|Pre-switch Period|Other than listed|10|||
144436239|NCT02272413|520803228|FG001|Pre-switch Period|Other than listed|11|||
144436240|NCT02272413|520803227|FG000|Post-switch Period|Adverse Event|4|||
144530241|NCT05218096|521144310|FG003|Open-label Extension|Lost to Follow-up|0|||
144530242|NCT05218096|521144311|FG004|Open-label Extension|Lost to Follow-up|0|||
144530243|NCT05218096|521144307|FG000|Open-label Extension|Death|0|||
144530244|NCT05218096|521144308|FG001|Open-label Extension|Death|0|||
144530245|NCT05218096|521144309|FG002|Open-label Extension|Death|0|||
144530246|NCT05218096|521144310|FG003|Open-label Extension|Death|1|||
144530247|NCT05218096|521144311|FG004|Open-label Extension|Death|0|||
144530248|NCT05218096|521144307|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
144530249|NCT05218096|521144308|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
144530250|NCT05218096|521144309|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
144530251|NCT05218096|521144310|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
144604650|NCT02632721|521414376|FG000|Overall Study|Relapsed Pneumonia|0|||
144604651|NCT02632721|521414377|FG001|Overall Study|Relapsed Pneumonia|0|||
144604652|NCT02632721|521414378|FG002|Overall Study|Relapsed Pneumonia|0|||
144604653|NCT02632721|521414379|FG003|Overall Study|Relapsed Pneumonia|0|||
144604654|NCT02632721|521414380|FG004|Overall Study|Relapsed Pneumonia|1|||
144604655|NCT02632721|521414376|FG000|Overall Study|Therapy refractory AML|0|||
144604656|NCT02632721|521414377|FG001|Overall Study|Therapy refractory AML|0|||
144604657|NCT02632721|521414378|FG002|Overall Study|Therapy refractory AML|0|||
144604658|NCT02632721|521414379|FG003|Overall Study|Therapy refractory AML|0|||
144604659|NCT02632721|521414380|FG004|Overall Study|Therapy refractory AML|1|||
144604660|NCT02632721|521414376|FG000|Overall Study|Increase of white blood cell count|0|||
144604661|NCT02632721|521414377|FG001|Overall Study|Increase of white blood cell count|0|||
144604662|NCT02632721|521414378|FG002|Overall Study|Increase of white blood cell count|0|||
144604663|NCT02632721|521414379|FG003|Overall Study|Increase of white blood cell count|0|||
144604664|NCT02632721|521414380|FG004|Overall Study|Increase of white blood cell count|1|||
144604665|NCT02632721|521414376|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
144604666|NCT02632721|521414377|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
144604667|NCT02632721|521414378|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
144604668|NCT02632721|521414379|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
144604669|NCT02632721|521414380|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
144604670|NCT00544648|521414381|FG000|Overall Study|Withdrawal by Subject|1|||
144604671|NCT00544648|521414382|FG001|Overall Study|Withdrawal by Subject|0|||
144604672|NCT00544648|521414381|FG000|Overall Study|Adverse Event|1|||
144604673|NCT00544648|521414382|FG001|Overall Study|Adverse Event|1|||
144604674|NCT00544648|521414381|FG000|Overall Study|progression of disease|1|||
144604675|NCT00544648|521414382|FG001|Overall Study|progression of disease|0|||
144604676|NCT01572675|521414383|FG000|Overall Study|End of prescribed treatment|140|||
144604677|NCT01572675|521414384|FG001|Overall Study|End of prescribed treatment|118|||
144604678|NCT01572675|521414383|FG000|Overall Study|Recovery|16|||
144604679|NCT01572675|521414384|FG001|Overall Study|Recovery|23|||
144604680|NCT01572675|521414383|FG000|Overall Study|Lack of Efficacy|31|||
144604681|NCT01572675|521414384|FG001|Overall Study|Lack of Efficacy|31|||
144436241|NCT02272413|520803228|FG001|Post-switch Period|Adverse Event|4|||
144436242|NCT02272413|520803227|FG000|Post-switch Period|Death|3|||
144436243|NCT02272413|520803228|FG001|Post-switch Period|Death|2|||
144436244|NCT02272413|520803227|FG000|Post-switch Period|Withdrawal by Subject|1|||
144436245|NCT02272413|520803228|FG001|Post-switch Period|Withdrawal by Subject|2|||
144436246|NCT02272413|520803227|FG000|Post-switch Period|Physician Decision|1|||
144530252|NCT05218096|521144311|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
144530253|NCT05863156|521144316|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
144530254|NCT05863156|521144317|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
144530255|NCT05863156|521144318|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
144530256|NCT05147116|521144319|FG000|Overall Study|Withdrawal by Subject|0|||
144530257|NCT05147116|521144320|FG001|Overall Study|Withdrawal by Subject|1|||
144530258|NCT01221948|521144325|FG000|Overall Study|Physician Decision|5|||
144530259|NCT01221948|521144325|FG000|Overall Study|Withdrawal by Subject|2|||
144530260|NCT01221948|521144325|FG000|Overall Study|not disclosed|2|||
144530261|NCT01221948|521144325|FG000|Overall Study|Death|1|||
144530262|NCT01221948|521144325|FG000|Overall Study|Protocol Violation|4|||
144436247|NCT02272413|520803228|FG001|Post-switch Period|Physician Decision|1|||
144436248|NCT02272413|520803227|FG000|Post-switch Period|Progressive disease|21|||
144436249|NCT02272413|520803228|FG001|Post-switch Period|Progressive disease|21|||
144436250|NCT02272413|520803227|FG000|Post-switch Period|Study terminated by sponsor|8|||
144436251|NCT02272413|520803228|FG001|Post-switch Period|Study terminated by sponsor|11|||
144436252|NCT02272413|520803227|FG000|Post-switch Period|Other than listed|4|||
144436253|NCT02272413|520803228|FG001|Post-switch Period|Other than listed|5|||
144436254|NCT02286193|520803231|FG000|Overall Study|Referred: CRS unable to make contact|62|||
144436255|NCT02286193|520803231|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
144436256|NCT02286193|520803231|FG000|Overall Study|Referred: Declined service|38|||
144436257|NCT00423891|520803232|FG000|Enrolled|Withdrawal by Subject|0|||
144436258|NCT00423891|520803233|FG001|Enrolled|Withdrawal by Subject|0|||
144436259|NCT00423891|520803234|FG002|Enrolled|Withdrawal by Subject|1|||
144436260|NCT00423891|520803232|FG000|Enrolled|Lost to Follow-up|0|||
144436261|NCT00423891|520803233|FG001|Enrolled|Lost to Follow-up|0|||
144436262|NCT00423891|520803234|FG002|Enrolled|Lost to Follow-up|1|||
144436263|NCT00423891|520803232|FG000|Enrolled|No longer met criteria|11|||
144436264|NCT00423891|520803233|FG001|Enrolled|No longer met criteria|2|||
144436265|NCT00423891|520803234|FG002|Enrolled|No longer met criteria|1|||
144436266|NCT00423891|520803232|FG000|Treatment|Withdrawal by Subject|1|||
144436267|NCT00423891|520803233|FG001|Treatment|Withdrawal by Subject|0|||
144436268|NCT00423891|520803234|FG002|Treatment|Withdrawal by Subject|0|||
144436269|NCT00423891|520803232|FG000|Treatment|Lost to Follow-up|1|||
144436270|NCT00423891|520803233|FG001|Treatment|Lost to Follow-up|0|||
144436271|NCT00423891|520803234|FG002|Treatment|Lost to Follow-up|0|||
144436272|NCT00423891|520803232|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
144436273|NCT00423891|520803233|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
144436274|NCT00423891|520803234|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
144436275|NCT00423891|520803232|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
144436276|NCT00423891|520803233|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
144436277|NCT00423891|520803234|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
144436278|NCT02852265|520803235|FG000|3-month Follow-up|Lost to Follow-up|1|||
144436279|NCT02852265|520803236|FG001|3-month Follow-up|Lost to Follow-up|1|||
144436280|NCT01988571|520803237|FG000|Overall Study|Death|3|||
144436281|NCT01988571|520803238|FG001|Overall Study|Death|1|||
144436282|NCT01988571|520803237|FG000|Overall Study|Physician Decision|2|||
144436283|NCT01988571|520803238|FG001|Overall Study|Physician Decision|1|||
144436284|NCT01988571|520803237|FG000|Overall Study|Lost to Follow-up|3|||
144436285|NCT01988571|520803238|FG001|Overall Study|Lost to Follow-up|0|||
144436286|NCT01988571|520803237|FG000|Overall Study|Withdrawal by Subject|31|||
144436287|NCT01988571|520803238|FG001|Overall Study|Withdrawal by Subject|33|||
144436288|NCT01417481|520803239|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
144436289|NCT01417481|520803240|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
144436290|NCT00829296|520803241|FG000|Overall Study|Adverse Event|5|||
144436291|NCT00829296|520803242|FG001|Overall Study|Adverse Event|4|||
144436292|NCT03029624|520803243|FG000|Overall Study|Adverse Event|1|||
144436293|NCT03029624|520803243|FG000|Overall Study|Withdrawal by Subject|1|||
144436294|NCT03029624|520803243|FG000|Overall Study|Lack of Efficacy|1|||
144436295|NCT03029624|520803243|FG000|Overall Study|MRI need|2|||
144530263|NCT03756662|521144326|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
144530264|NCT01009788|521144335|FG000|Overall Study|Withdrawal by Subject|1|||
144436296|NCT00775437|520803259|FG000|Overall Study|Loss of efficacy|2|||
144436297|NCT00775437|520803259|FG000|Overall Study|Withdrawal by Subject|3|||
144530265|NCT01009788|521144336|FG001|Overall Study|Withdrawal by Subject|0|||
144530266|NCT01309672|521144337|FG000|Overall Study|Lack of Efficacy|20|||
144530267|NCT01309672|521144337|FG000|Overall Study|Other|9|||
144530268|NCT01309672|521144337|FG000|Overall Study|Adverse Event|5|||
144530269|NCT01309672|521144337|FG000|Overall Study|Withdrawal by Subject|3|||
144530270|NCT01254864|521144338|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
144530271|NCT01254864|521144339|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
144530272|NCT01254864|521144340|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
144530273|NCT01254864|521144338|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
144530274|NCT01254864|521144339|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
144436298|NCT00775437|520803259|FG000|Overall Study|Lost to Follow-up|1|||
144436299|NCT01183975|520803260|FG000|Overall Study|Lost to Follow-up|73|||
144436300|NCT04180020|520803261|FG000|Overall Study|missed visit|18|||
144436301|NCT04180020|520803262|FG001|Overall Study|missed visit|16|||
144436302|NCT04180020|520803261|FG000|Overall Study|Death|2|||
144436303|NCT04180020|520803262|FG001|Overall Study|Death|3|||
144436304|NCT04180020|520803261|FG000|Overall Study|Withdrawal by Subject|1|||
144436305|NCT04180020|520803262|FG001|Overall Study|Withdrawal by Subject|5|||
144436306|NCT04180020|520803261|FG000|Overall Study|incarcerated|1|||
144436307|NCT04180020|520803262|FG001|Overall Study|incarcerated|1|||
144436308|NCT04180020|520803261|FG000|Overall Study|Physician Decision|0|||
144436309|NCT04180020|520803262|FG001|Overall Study|Physician Decision|2|||
144436310|NCT02244580|520803269|FG000|Overall Study|No cancer tissues available|241|||
144436311|NCT02442778|520803270|FG000|Overall Study|Adverse Event|2|||
144436312|NCT02442778|520803271|FG001|Overall Study|Adverse Event|6|||
144436313|NCT02442778|520803272|FG002|Overall Study|Adverse Event|6|||
144436314|NCT02442778|520803270|FG000|Overall Study|Death|0|||
144436315|NCT02442778|520803271|FG001|Overall Study|Death|2|||
144436316|NCT02442778|520803272|FG002|Overall Study|Death|0|||
144436317|NCT02442778|520803270|FG000|Overall Study|Lack of Efficacy|1|||
144436318|NCT02442778|520803271|FG001|Overall Study|Lack of Efficacy|0|||
144436319|NCT02442778|520803272|FG002|Overall Study|Lack of Efficacy|0|||
144436320|NCT02442778|520803270|FG000|Overall Study|Lost to Follow-up|1|||
144436321|NCT02442778|520803271|FG001|Overall Study|Lost to Follow-up|1|||
144436322|NCT02442778|520803272|FG002|Overall Study|Lost to Follow-up|1|||
144436323|NCT02442778|520803270|FG000|Overall Study|Non-compliance with study drug|2|||
144436324|NCT02442778|520803271|FG001|Overall Study|Non-compliance with study drug|0|||
144604682|NCT01572675|521414383|FG000|Overall Study|Intolerance|6|||
144436325|NCT02442778|520803272|FG002|Overall Study|Non-compliance with study drug|1|||
144436326|NCT02442778|520803270|FG000|Overall Study|Physician Decision|1|||
144436327|NCT02442778|520803271|FG001|Overall Study|Physician Decision|1|||
144436328|NCT02442778|520803272|FG002|Overall Study|Physician Decision|1|||
144436329|NCT02442778|520803270|FG000|Overall Study|Protocol Deviation|3|||
144436330|NCT02442778|520803271|FG001|Overall Study|Protocol Deviation|0|||
144436331|NCT02442778|520803272|FG002|Overall Study|Protocol Deviation|1|||
144436332|NCT02442778|520803270|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
144436333|NCT02442778|520803271|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
144436334|NCT02442778|520803272|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
144436335|NCT02442778|520803270|FG000|Overall Study|Withdrawal by Subject|4|||
144436336|NCT02442778|520803271|FG001|Overall Study|Withdrawal by Subject|4|||
144436337|NCT02442778|520803272|FG002|Overall Study|Withdrawal by Subject|3|||
144436338|NCT02442778|520803270|FG000|Overall Study|Reason not specified|1|||
144604683|NCT01572675|521414384|FG001|Overall Study|Intolerance|5|||
144604684|NCT01572675|521414383|FG000|Overall Study|Improved symptoms|8|||
144604685|NCT01572675|521414384|FG001|Overall Study|Improved symptoms|2|||
144604686|NCT01572675|521414383|FG000|Overall Study|Surgical intervention|3|||
144604687|NCT01572675|521414384|FG001|Overall Study|Surgical intervention|6|||
144604688|NCT01572675|521414383|FG000|Overall Study|Withdrawal by Subject|5|||
144604689|NCT01572675|521414384|FG001|Overall Study|Withdrawal by Subject|1|||
144604690|NCT01572675|521414383|FG000|Overall Study|Physician Decision|2|||
144604691|NCT01572675|521414384|FG001|Overall Study|Physician Decision|2|||
144604692|NCT01572675|521414383|FG000|Overall Study|Death unrelated to coxibs|1|||
144604693|NCT01572675|521414384|FG001|Overall Study|Death unrelated to coxibs|1|||
144604694|NCT01572675|521414383|FG000|Overall Study|Other disease detected|1|||
144604695|NCT01572675|521414384|FG001|Overall Study|Other disease detected|1|||
144604696|NCT01572675|521414383|FG000|Overall Study|Unknown reason|1|||
144604697|NCT01572675|521414384|FG001|Overall Study|Unknown reason|1|||
144604698|NCT01572675|521414383|FG000|Overall Study|Rheumatologist new evaluation|0|||
144604699|NCT01572675|521414384|FG001|Overall Study|Rheumatologist new evaluation|1|||
144604700|NCT01572675|521414383|FG000|Overall Study|Missing data|1|||
144604701|NCT01572675|521414384|FG001|Overall Study|Missing data|4|||
144436339|NCT02442778|520803271|FG001|Overall Study|Reason not specified|4|||
144436340|NCT02442778|520803272|FG002|Overall Study|Reason not specified|0|||
144436341|NCT04964128|520803273|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
144436342|NCT04964128|520803273|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
144604702|NCT01572675|521414383|FG000|Overall Study|Lost to Follow-up|22|||
144604703|NCT01572675|521414384|FG001|Overall Study|Lost to Follow-up|27|||
144604704|NCT02877927|521414387|FG000|Overall Study|Adverse Event|1|||
144436343|NCT01148511|520803275|FG000|Exposed to Study Drug|Protocol Violation|2|||
144436344|NCT01148511|520803276|FG001|Exposed to Study Drug|Protocol Violation|0|||
144436345|NCT01148511|520803277|FG002|Exposed to Study Drug|Protocol Violation|0|||
144436346|NCT01148511|520803275|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
144436347|NCT01148511|520803276|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
144436348|NCT01148511|520803277|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
144436349|NCT01148511|520803275|FG000|Randomized|Adverse Event|0|||
144604705|NCT02877927|521414388|FG001|Overall Study|Adverse Event|0|||
144604706|NCT02877927|521414387|FG000|Overall Study|Lost to Follow-up|37|||
144604707|NCT02877927|521414388|FG001|Overall Study|Lost to Follow-up|38|||
144436350|NCT01148511|520803276|FG001|Randomized|Adverse Event|1|||
144436351|NCT01148511|520803277|FG002|Randomized|Adverse Event|0|||
144436352|NCT01148511|520803275|FG000|Randomized|Protocol Violation|0|||
144436353|NCT01148511|520803276|FG001|Randomized|Protocol Violation|2|||
144436354|NCT01148511|520803277|FG002|Randomized|Protocol Violation|1|||
144436355|NCT01148511|520803275|FG000|Randomized|Lost to Follow-up|0|||
144436356|NCT01148511|520803276|FG001|Randomized|Lost to Follow-up|1|||
144436357|NCT01148511|520803277|FG002|Randomized|Lost to Follow-up|1|||
144436358|NCT01148511|520803275|FG000|Randomized|Consent withdrawal|0|||
144436359|NCT01148511|520803276|FG001|Randomized|Consent withdrawal|5|||
144436360|NCT01148511|520803277|FG002|Randomized|Consent withdrawal|3|||
144436361|NCT01148511|520803275|FG000|Randomized|Other|0|||
144436362|NCT01148511|520803276|FG001|Randomized|Other|1|||
144436363|NCT01148511|520803277|FG002|Randomized|Other|1|||
144436364|NCT03323658|520803278|FG000|Overall Study|Adverse Event|0|||
144436365|NCT03323658|520803279|FG001|Overall Study|Adverse Event|1|||
144436366|NCT03323658|520803280|FG002|Overall Study|Adverse Event|0|||
144436367|NCT03913091|520803281|FG000|Overall Study|Lost to Follow-up|18|||
144436368|NCT03913091|520803282|FG001|Overall Study|Lost to Follow-up|11|||
144436369|NCT03913091|520803281|FG000|Overall Study|Required additional meds/surgery|1|||
144436370|NCT03913091|520803282|FG001|Overall Study|Required additional meds/surgery|2|||
144436371|NCT03913091|520803281|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
144436372|NCT03913091|520803282|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
144436373|NCT04536727|520803283|FG000|Overall Study|Lost to Follow-up|1|||
144436374|NCT04536727|520803284|FG001|Overall Study|Lost to Follow-up|1|||
144436375|NCT04536727|520803283|FG000|Overall Study|Death|0|||
144436376|NCT04536727|520803284|FG001|Overall Study|Death|1|||
144436377|NCT00500370|520803296|FG000|Overall Study|Adverse Event|9|||
144436378|NCT00500370|520803297|FG001|Overall Study|Adverse Event|3|||
144436379|NCT00500370|520803296|FG000|Overall Study|Lost to Follow-up|10|||
144436380|NCT00500370|520803297|FG001|Overall Study|Lost to Follow-up|10|||
144436381|NCT00500370|520803296|FG000|Overall Study|Protocol Violation|2|||
144436382|NCT00500370|520803297|FG001|Overall Study|Protocol Violation|4|||
144436383|NCT00500370|520803296|FG000|Overall Study|Sponsor Decision|2|||
144436384|NCT00500370|520803297|FG001|Overall Study|Sponsor Decision|0|||
144436385|NCT00500370|520803296|FG000|Overall Study|Subject Decision|10|||
144436386|NCT00500370|520803297|FG001|Overall Study|Subject Decision|17|||
144436387|NCT05627518|520803298|FG000|Treatment Period 1|Adverse Event|0|||
144436388|NCT05627518|520803299|FG001|Treatment Period 1|Adverse Event|0|||
144436389|NCT05627518|520803300|FG002|Treatment Period 1|Adverse Event|1|||
144436390|NCT05627518|520803301|FG003|Treatment Period 1|Adverse Event|0|||
144436391|NCT05627518|520803302|FG004|Treatment Period 1|Adverse Event|0|||
144436392|NCT05627518|520803303|FG005|Treatment Period 1|Adverse Event|0|||
144436393|NCT05627518|520803304|FG006|Treatment Period 1|Adverse Event|0|||
144436394|NCT05627518|520803305|FG007|Treatment Period 1|Adverse Event|1|||
144436395|NCT05627518|520803298|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144436396|NCT05627518|520803299|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144436397|NCT05627518|520803300|FG002|Treatment Period 1|Withdrawal by Subject|1|||
144436398|NCT05627518|520803301|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144436399|NCT05627518|520803302|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144436400|NCT05627518|520803303|FG005|Treatment Period 1|Withdrawal by Subject|1|||
144436401|NCT05627518|520803304|FG006|Treatment Period 1|Withdrawal by Subject|0|||
144436402|NCT05627518|520803305|FG007|Treatment Period 1|Withdrawal by Subject|0|||
144436403|NCT05627518|520803298|FG000|Treatment Period 1|Protocol Violation|0|||
144436404|NCT05627518|520803299|FG001|Treatment Period 1|Protocol Violation|0|||
144436405|NCT05627518|520803300|FG002|Treatment Period 1|Protocol Violation|0|||
144436406|NCT05627518|520803301|FG003|Treatment Period 1|Protocol Violation|0|||
144436407|NCT05627518|520803302|FG004|Treatment Period 1|Protocol Violation|0|||
144436408|NCT05627518|520803303|FG005|Treatment Period 1|Protocol Violation|0|||
144436409|NCT05627518|520803304|FG006|Treatment Period 1|Protocol Violation|6|||
144436410|NCT05627518|520803305|FG007|Treatment Period 1|Protocol Violation|6|||
144436411|NCT05627518|520803298|FG000|Treatment Period 2|Adverse Event|1|||
144436412|NCT05627518|520803299|FG001|Treatment Period 2|Adverse Event|0|||
144436413|NCT05627518|520803300|FG002|Treatment Period 2|Adverse Event|0|||
144436414|NCT05627518|520803301|FG003|Treatment Period 2|Adverse Event|0|||
144530275|NCT01254864|521144340|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
144530276|NCT01254864|521144338|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
144436415|NCT05627518|520803302|FG004|Treatment Period 2|Adverse Event|0|||
144436416|NCT05627518|520803303|FG005|Treatment Period 2|Adverse Event|0|||
144436417|NCT05627518|520803304|FG006|Treatment Period 2|Adverse Event|0|||
144436418|NCT05627518|520803305|FG007|Treatment Period 2|Adverse Event|0|||
144436419|NCT05627518|520803298|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144436420|NCT05627518|520803299|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144436421|NCT05627518|520803300|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144530277|NCT01254864|521144339|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
144436422|NCT05627518|520803301|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144724333|NCT01505530|521846340|FG000|Overall Study|Progressive Disease|19|||
144436423|NCT05627518|520803302|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144436424|NCT05627518|520803303|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144188272|NCT02412722|519882976|FG005|Overall Study|Adverse Event|3|||
144188273|NCT02412722|519882971|FG000|Overall Study|Progressive Disease|6|||
144188274|NCT02412722|519882972|FG001|Overall Study|Progressive Disease|4|||
144188275|NCT02412722|519882973|FG002|Overall Study|Progressive Disease|4|||
144188276|NCT02412722|519882974|FG003|Overall Study|Progressive Disease|9|||
144188277|NCT02412722|519882975|FG004|Overall Study|Progressive Disease|3|||
144188278|NCT02412722|519882976|FG005|Overall Study|Progressive Disease|3|||
144436425|NCT05627518|520803304|FG006|Treatment Period 2|Withdrawal by Subject|0|||
144436426|NCT05627518|520803305|FG007|Treatment Period 2|Withdrawal by Subject|0|||
144436427|NCT04804813|520803306|FG000|Overall Study|Protocol Violation|2|||
144436428|NCT04804813|520803307|FG001|Overall Study|Protocol Violation|0|||
144436429|NCT04804813|520803306|FG000|Overall Study|Withdrawal by Subject|1|||
144436430|NCT04804813|520803307|FG001|Overall Study|Withdrawal by Subject|0|||
144436431|NCT03003520|520805891|FG000|Overall Study|Adverse Event|9|||
144436432|NCT03003520|520805892|FG001|Overall Study|Adverse Event|0|||
144436433|NCT03003520|520805891|FG000|Overall Study|Death|1|||
144436434|NCT03003520|520805892|FG001|Overall Study|Death|0|||
144436435|NCT03003520|520805891|FG000|Overall Study|Other reasons|4|||
144436436|NCT03003520|520805892|FG001|Overall Study|Other reasons|0|||
144436437|NCT03003520|520805891|FG000|Overall Study|Withdrawal by Subject|6|||
144436438|NCT03003520|520805892|FG001|Overall Study|Withdrawal by Subject|0|||
144436439|NCT03003520|520805891|FG000|Overall Study|Progressive disease|9|||
144436440|NCT03003520|520805892|FG001|Overall Study|Progressive disease|1|||
144436441|NCT01332149|520805893|FG000|Overall Study|Adverse Event|11|||
144436442|NCT01332149|520805894|FG001|Overall Study|Adverse Event|9|||
144436443|NCT01332149|520805893|FG000|Overall Study|Other unspecified|5|||
144436444|NCT01332149|520805894|FG001|Overall Study|Other unspecified|7|||
144436445|NCT01332149|520805893|FG000|Overall Study|Protocol Violation|1|||
144436446|NCT01332149|520805894|FG001|Overall Study|Protocol Violation|3|||
144436447|NCT01332149|520805893|FG000|Overall Study|Withdrawal by Subject|4|||
144436448|NCT01332149|520805894|FG001|Overall Study|Withdrawal by Subject|5|||
144436449|NCT01332149|520805893|FG000|Overall Study|Lost to Follow-up|1|||
144436450|NCT01332149|520805894|FG001|Overall Study|Lost to Follow-up|1|||
144436451|NCT01332149|520805893|FG000|Overall Study|Insufficient clinical response|4|||
144436452|NCT01332149|520805894|FG001|Overall Study|Insufficient clinical response|7|||
144436453|NCT01332149|520805893|FG000|Overall Study|Did not meet entrance criteria|3|||
144436454|NCT01332149|520805894|FG001|Overall Study|Did not meet entrance criteria|4|||
144436455|NCT01332149|520805893|FG000|Overall Study|Randomized but not treated|1|||
144436456|NCT01332149|520805894|FG001|Overall Study|Randomized but not treated|2|||
144436457|NCT02565381|520805895|FG000|Overall Study|Lost to Follow-up|1|||
144436458|NCT02565381|520805896|FG001|Overall Study|Lost to Follow-up|0|||
144436459|NCT02565381|520805897|FG002|Overall Study|Lost to Follow-up|1|||
144436460|NCT01914666|520805905|FG000|Treatment Period|Lack of Efficacy|0|||
144436461|NCT01914666|520805906|FG001|Treatment Period|Lack of Efficacy|0|||
144436462|NCT01914666|520805907|FG002|Treatment Period|Lack of Efficacy|2|||
144436463|NCT01914666|520805905|FG000|Treatment Period|Adverse Event|10|||
144436464|NCT01914666|520805906|FG001|Treatment Period|Adverse Event|4|||
144436465|NCT01914666|520805907|FG002|Treatment Period|Adverse Event|2|||
144436466|NCT01914666|520805905|FG000|Treatment Period|Withdrawal by Subject|3|||
144436467|NCT01914666|520805906|FG001|Treatment Period|Withdrawal by Subject|2|||
144436468|NCT01914666|520805907|FG002|Treatment Period|Withdrawal by Subject|2|||
144436469|NCT01914666|520805905|FG000|Treatment Period|Physician Decision|0|||
144436470|NCT01914666|520805906|FG001|Treatment Period|Physician Decision|0|||
144436471|NCT01914666|520805907|FG002|Treatment Period|Physician Decision|2|||
144436472|NCT02586012|520805908|FG000|Overall Study|Withdrawal by Subject|1|||
144436473|NCT02586012|520805909|FG001|Overall Study|Withdrawal by Subject|1|||
144436474|NCT02586012|520805910|FG002|Overall Study|Withdrawal by Subject|0|||
144436475|NCT02586012|520805911|FG003|Overall Study|Withdrawal by Subject|1|||
144436476|NCT02586012|520805912|FG004|Overall Study|Withdrawal by Subject|0|||
144436477|NCT02586012|520805913|FG005|Overall Study|Withdrawal by Subject|2|||
144436478|NCT02586012|520805908|FG000|Overall Study|Protocol Violation|0|||
144436479|NCT02586012|520805909|FG001|Overall Study|Protocol Violation|0|||
144436480|NCT02586012|520805910|FG002|Overall Study|Protocol Violation|0|||
144436481|NCT02586012|520805911|FG003|Overall Study|Protocol Violation|0|||
144436482|NCT02586012|520805912|FG004|Overall Study|Protocol Violation|0|||
144436483|NCT02586012|520805913|FG005|Overall Study|Protocol Violation|1|||
144436484|NCT02586012|520805908|FG000|Overall Study|study terminated|0|||
144436485|NCT02586012|520805909|FG001|Overall Study|study terminated|2|||
144436486|NCT02586012|520805910|FG002|Overall Study|study terminated|1|||
144436487|NCT02586012|520805911|FG003|Overall Study|study terminated|1|||
144436488|NCT02586012|520805912|FG004|Overall Study|study terminated|1|||
144436489|NCT02586012|520805913|FG005|Overall Study|study terminated|0|||
144436490|NCT02388737|520805915|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
144436491|NCT02388737|520805916|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
144436492|NCT02388737|520805917|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
144436493|NCT02388737|520805915|FG000|Overall Study|Major Protocol Deviation|18|||
144188279|NCT02412722|519882971|FG000|Overall Study|Withdrawal by Subject|2|||
144436494|NCT02388737|520805916|FG001|Overall Study|Major Protocol Deviation|25|||
144253477|NCT00582426|520128079|FG001|Overall Study|Lost to Follow-up|2|||
144253478|NCT00582426|520128078|FG000|Overall Study|Adverse Event|4|||
144436495|NCT02388737|520805917|FG002|Overall Study|Major Protocol Deviation|22|||
144436496|NCT02388737|520805915|FG000|Overall Study|Lost to Follow-up|5|||
144436497|NCT02388737|520805916|FG001|Overall Study|Lost to Follow-up|1|||
144436498|NCT02388737|520805917|FG002|Overall Study|Lost to Follow-up|4|||
144436499|NCT02388737|520805915|FG000|Overall Study|Voluntary Withdrawal|10|||
144436500|NCT02388737|520805916|FG001|Overall Study|Voluntary Withdrawal|18|||
144436501|NCT02388737|520805917|FG002|Overall Study|Voluntary Withdrawal|17|||
144436502|NCT02388737|520805915|FG000|Overall Study|Lack of Efficacy|3|||
144436503|NCT02388737|520805916|FG001|Overall Study|Lack of Efficacy|0|||
144436504|NCT02388737|520805917|FG002|Overall Study|Lack of Efficacy|3|||
144436505|NCT02388737|520805915|FG000|Overall Study|Reason Not Specified|5|||
144436506|NCT02388737|520805916|FG001|Overall Study|Reason Not Specified|5|||
144436507|NCT02388737|520805917|FG002|Overall Study|Reason Not Specified|4|||
144436508|NCT00358527|520805922|FG000|Overall Study|Adverse Event|4|||
144436509|NCT00358527|520805923|FG001|Overall Study|Adverse Event|0|||
144436510|NCT00358527|520805922|FG000|Overall Study|Withdrawal by Subject|1|||
144436511|NCT00358527|520805923|FG001|Overall Study|Withdrawal by Subject|1|||
144436512|NCT00358527|520805922|FG000|Overall Study|Non-compliance with protocol|6|||
144436513|NCT00358527|520805923|FG001|Overall Study|Non-compliance with protocol|1|||
144436514|NCT00358527|520805922|FG000|Overall Study|Administrative|2|||
144436515|NCT00358527|520805923|FG001|Overall Study|Administrative|1|||
144436516|NCT00749463|520805924|FG000|Overall Study|Adverse Event|0|||
144436517|NCT00749463|520805925|FG001|Overall Study|Adverse Event|4|||
144436518|NCT00749463|520805926|FG002|Overall Study|Adverse Event|1|||
144436519|NCT00749463|520805924|FG000|Overall Study|Withdrawal by Subject|1|||
144436520|NCT00749463|520805925|FG001|Overall Study|Withdrawal by Subject|0|||
144436521|NCT00749463|520805926|FG002|Overall Study|Withdrawal by Subject|0|||
144436522|NCT00913744|520805928|FG000|Overall Study|Adverse Event|2|||
144436523|NCT00913744|520805929|FG001|Overall Study|Adverse Event|0|||
144436524|NCT00913744|520805928|FG000|Overall Study|Withdrawal by Subject|2|||
144436525|NCT00913744|520805929|FG001|Overall Study|Withdrawal by Subject|1|||
144436526|NCT00913744|520805928|FG000|Overall Study|Death|1|||
144436527|NCT00913744|520805929|FG001|Overall Study|Death|0|||
144436528|NCT01886833|520805930|FG000|Overall Study|IgA not available from both periods|204|||
144436529|NCT01454726|520805931|FG000|Overall Study|Withdrawal by Subject|0|||
144436530|NCT01454726|520805932|FG001|Overall Study|Withdrawal by Subject|1|||
144436531|NCT01632891|520805935|FG000|Overall Study|Lost to Follow-up|0|||
144436532|NCT01632891|520805936|FG001|Overall Study|Lost to Follow-up|1|||
144436533|NCT01632891|520805935|FG000|Overall Study|Withdrawal by Subject|1|||
144436534|NCT01632891|520805936|FG001|Overall Study|Withdrawal by Subject|0|||
144436535|NCT00333229|520805937|FG000|Overall Study|Lack of Efficacy|0|||
144436536|NCT00333229|520805938|FG001|Overall Study|Lack of Efficacy|1|||
144436537|NCT00782210|520805954|FG000|Overall Study|Adverse Event|21|||
144436538|NCT00782210|520805955|FG001|Overall Study|Adverse Event|17|||
144436539|NCT00782210|520805956|FG002|Overall Study|Adverse Event|16|||
144436540|NCT00782210|520805954|FG000|Overall Study|Lost to Follow-up|2|||
144436541|NCT00782210|520805955|FG001|Overall Study|Lost to Follow-up|1|||
144436542|NCT00782210|520805956|FG002|Overall Study|Lost to Follow-up|2|||
144436543|NCT00782210|520805954|FG000|Overall Study|Withdrawal by Subject|11|||
144436544|NCT00782210|520805955|FG001|Overall Study|Withdrawal by Subject|8|||
144436545|NCT00782210|520805956|FG002|Overall Study|Withdrawal by Subject|11|||
144436546|NCT00782210|520805954|FG000|Overall Study|Non compliance with protocol|0|||
144436547|NCT00782210|520805955|FG001|Overall Study|Non compliance with protocol|3|||
144436548|NCT00782210|520805956|FG002|Overall Study|Non compliance with protocol|2|||
144436549|NCT00782210|520805954|FG000|Overall Study|Lack of Efficacy|13|||
144436550|NCT00782210|520805955|FG001|Overall Study|Lack of Efficacy|4|||
144436551|NCT00782210|520805956|FG002|Overall Study|Lack of Efficacy|1|||
144253479|NCT00582426|520128079|FG001|Overall Study|Adverse Event|2|||
144253480|NCT00582426|520128078|FG000|Overall Study|Protocol Violation|6|||
144436552|NCT00782210|520805954|FG000|Overall Study|Other reason not described above|3|||
144436553|NCT00782210|520805955|FG001|Overall Study|Other reason not described above|2|||
144436554|NCT00782210|520805956|FG002|Overall Study|Other reason not described above|3|||
144253481|NCT00582426|520128079|FG001|Overall Study|Protocol Violation|2|||
144436555|NCT01641367|520805957|FG000|Cohorts|Death|18|||
144436556|NCT01641367|520805958|FG001|Cohorts|Death|1|||
144436557|NCT01641367|520805959|FG002|Cohorts|Death|2|||
144436558|NCT01641367|520805960|FG003|Cohorts|Death|0|||
144436559|NCT01641367|520805961|FG004|Cohorts|Death|1|||
144436560|NCT01641367|520805962|FG005|Cohorts|Death|1|||
144436561|NCT01641367|520805963|FG006|Cohorts|Death|0|||
144436562|NCT01641367|520805964|FG007|Cohorts|Death|0|||
144436563|NCT01641367|520805957|FG000|Cohorts|Lost to Follow-up|16|||
144436564|NCT01641367|520805958|FG001|Cohorts|Lost to Follow-up|0|||
144436565|NCT01641367|520805959|FG002|Cohorts|Lost to Follow-up|2|||
144436566|NCT01641367|520805960|FG003|Cohorts|Lost to Follow-up|0|||
144436567|NCT01641367|520805961|FG004|Cohorts|Lost to Follow-up|2|||
144436568|NCT01641367|520805962|FG005|Cohorts|Lost to Follow-up|0|||
144436569|NCT01641367|520805963|FG006|Cohorts|Lost to Follow-up|0|||
144436570|NCT01641367|520805964|FG007|Cohorts|Lost to Follow-up|0|||
144436571|NCT01641367|520805957|FG000|Randomized Adherence Intervention|Death|0|||
144436572|NCT01641367|520805958|FG001|Randomized Adherence Intervention|Death|0|||
144436573|NCT01641367|520805959|FG002|Randomized Adherence Intervention|Death|0|||
144436574|NCT01641367|520805960|FG003|Randomized Adherence Intervention|Death|0|||
144436575|NCT01641367|520805961|FG004|Randomized Adherence Intervention|Death|0|||
144436576|NCT01641367|520805962|FG005|Randomized Adherence Intervention|Death|0|||
144436577|NCT01641367|520805963|FG006|Randomized Adherence Intervention|Death|11|||
144436578|NCT01641367|520805964|FG007|Randomized Adherence Intervention|Death|12|||
144436579|NCT01641367|520805957|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
144436580|NCT01641367|520805958|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
144436581|NCT01641367|520805959|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
144436582|NCT01641367|520805960|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
144436583|NCT01641367|520805961|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
144436584|NCT01641367|520805962|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
144436585|NCT01641367|520805963|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
144436586|NCT01641367|520805964|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
144436587|NCT00850200|520805968|FG000|Overall Study|Physician Decision|2|||
144436588|NCT00850200|520805968|FG000|Overall Study|Did not recieve treatment|2|||
144436589|NCT00850200|520805968|FG000|Overall Study|Withdrawal by Subject|1|||
144436590|NCT00048542|520805974|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
144436591|NCT00048542|520805975|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
144436592|NCT00048542|520805976|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144436593|NCT00048542|520805977|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144436594|NCT00048542|520805978|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
144436595|NCT00048542|520805979|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
144436596|NCT00048542|520805980|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
144436597|NCT00048542|520805981|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
144436598|NCT00048542|520805974|FG000|Double-Blind Phase|Protocol Violation|0|||
144436599|NCT00048542|520805975|FG001|Double-Blind Phase|Protocol Violation|0|||
144436600|NCT00048542|520805976|FG002|Double-Blind Phase|Protocol Violation|1|||
144436601|NCT00048542|520805977|FG003|Double-Blind Phase|Protocol Violation|0|||
144436602|NCT00048542|520805978|FG004|Double-Blind Phase|Protocol Violation|0|||
144436603|NCT00048542|520805979|FG005|Double-Blind Phase|Protocol Violation|0|||
144436604|NCT00048542|520805980|FG006|Double-Blind Phase|Protocol Violation|0|||
144436605|NCT00048542|520805981|FG007|Double-Blind Phase|Protocol Violation|0|||
144436606|NCT00048542|520805974|FG000|Double-Blind Phase|Sponsor request or decision|2|||
144436607|NCT00048542|520805975|FG001|Double-Blind Phase|Sponsor request or decision|0|||
144436608|NCT00048542|520805976|FG002|Double-Blind Phase|Sponsor request or decision|0|||
144436609|NCT00048542|520805977|FG003|Double-Blind Phase|Sponsor request or decision|0|||
144436610|NCT00048542|520805978|FG004|Double-Blind Phase|Sponsor request or decision|0|||
144436611|NCT00048542|520805979|FG005|Double-Blind Phase|Sponsor request or decision|0|||
144436612|NCT00048542|520805980|FG006|Double-Blind Phase|Sponsor request or decision|0|||
144436613|NCT00048542|520805981|FG007|Double-Blind Phase|Sponsor request or decision|0|||
144436614|NCT00048542|520805974|FG000|Double-Blind Phase|Randomized in error|1|||
144436615|NCT00048542|520805975|FG001|Double-Blind Phase|Randomized in error|0|||
144436616|NCT00048542|520805976|FG002|Double-Blind Phase|Randomized in error|0|||
144436617|NCT00048542|520805977|FG003|Double-Blind Phase|Randomized in error|0|||
144436618|NCT00048542|520805978|FG004|Double-Blind Phase|Randomized in error|0|||
144436619|NCT00048542|520805979|FG005|Double-Blind Phase|Randomized in error|0|||
144436620|NCT00048542|520805980|FG006|Double-Blind Phase|Randomized in error|0|||
144436621|NCT00048542|520805981|FG007|Double-Blind Phase|Randomized in error|0|||
144436622|NCT00048542|520805974|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
144436623|NCT00048542|520805975|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
144436624|NCT00048542|520805976|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
144436625|NCT00048542|520805977|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
144436626|NCT00048542|520805978|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
144436627|NCT00048542|520805979|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
144436628|NCT00048542|520805980|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
144436629|NCT00048542|520805981|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
144436630|NCT00048542|520805974|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436631|NCT00048542|520805975|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436632|NCT00048542|520805976|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436633|NCT00048542|520805977|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436634|NCT00048542|520805978|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436635|NCT00048542|520805979|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
144436636|NCT00048542|520805980|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436637|NCT00048542|520805981|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
144436638|NCT00048542|520805974|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
144436639|NCT00048542|520805975|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
144472092|NCT00394355|520925378|FG000|Overall Study|Administrative|0|||
144436640|NCT00048542|520805976|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
144436641|NCT00048542|520805977|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
144436642|NCT00048542|520805978|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
144436643|NCT00048542|520805979|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
144436644|NCT00048542|520805980|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
144436645|NCT00048542|520805981|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
144436646|NCT00048542|520805974|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
144436647|NCT00048542|520805975|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
144436648|NCT00048542|520805976|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
144436649|NCT00048542|520805977|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
144436650|NCT00048542|520805978|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
144436651|NCT00048542|520805979|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
144436652|NCT00048542|520805980|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
144436653|NCT00048542|520805981|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
144436654|NCT00048542|520805974|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
144436655|NCT00048542|520805975|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
144436656|NCT00048542|520805976|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
144436657|NCT00048542|520805977|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
144436658|NCT00048542|520805978|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
144436659|NCT00048542|520805979|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
144436660|NCT00048542|520805980|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
144436661|NCT00048542|520805981|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
144436662|NCT00048542|520805974|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
144436663|NCT00048542|520805975|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
144436664|NCT00048542|520805976|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
144436665|NCT00048542|520805977|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
144436666|NCT00048542|520805978|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
144436667|NCT00048542|520805979|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
144436668|NCT00048542|520805980|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
144436669|NCT00048542|520805981|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
144436670|NCT00048542|520805974|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
144436671|NCT00048542|520805975|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
144436672|NCT00048542|520805976|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
144436673|NCT00048542|520805977|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
144436674|NCT00048542|520805978|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
144436675|NCT00048542|520805979|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
144436676|NCT00048542|520805980|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
144436677|NCT00048542|520805981|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
144436678|NCT00048542|520805974|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
144436679|NCT00048542|520805975|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
144436680|NCT00048542|520805976|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
144436681|NCT00048542|520805977|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
144436682|NCT00048542|520805978|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
144436683|NCT00048542|520805979|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
144436684|NCT00048542|520805980|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
144436685|NCT00048542|520805981|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
144436686|NCT00048542|520805974|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
144436687|NCT00048542|520805975|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
144436688|NCT00048542|520805976|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
144436689|NCT00048542|520805977|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
144436690|NCT00048542|520805978|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
144436691|NCT00048542|520805979|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
144436692|NCT00048542|520805980|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
144436693|NCT00048542|520805981|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
144436694|NCT00048542|520805974|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
144436695|NCT00048542|520805975|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
144436696|NCT00048542|520805976|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
144436697|NCT00048542|520805977|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
144436698|NCT00048542|520805978|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
144530278|NCT01254864|521144340|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
144436699|NCT00048542|520805979|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
144436700|NCT00048542|520805980|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
144436701|NCT00048542|520805981|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
144530279|NCT01254864|521144338|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
144436702|NCT00048542|520805974|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
144436703|NCT00048542|520805975|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
144436704|NCT00048542|520805976|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
144436705|NCT00048542|520805977|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
144436706|NCT00048542|520805978|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
144436707|NCT00048542|520805979|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
144436708|NCT00048542|520805980|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
144436709|NCT00048542|520805981|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
144436710|NCT04098458|520805983|FG000|Overall Study|Death|1|||
144436711|NCT04098458|520805983|FG000|Overall Study|did not meet study inclusion criteria|3|||
144436712|NCT00006489|520805984|FG000|Overall Study|Adverse Event|3|||
144436713|NCT00006489|520805985|FG001|Overall Study|Adverse Event|2|||
144436714|NCT00006489|520805986|FG002|Overall Study|Adverse Event|4|||
144436715|NCT00006489|520805987|FG003|Overall Study|Adverse Event|3|||
144436716|NCT00006489|520805984|FG000|Overall Study|Withdrawal by Subject|10|||
144436717|NCT00006489|520805985|FG001|Overall Study|Withdrawal by Subject|9|||
144436718|NCT00006489|520805986|FG002|Overall Study|Withdrawal by Subject|9|||
144436719|NCT00006489|520805987|FG003|Overall Study|Withdrawal by Subject|6|||
144436720|NCT00006489|520805984|FG000|Overall Study|Scheduling Conflict|0|||
144436721|NCT00006489|520805985|FG001|Overall Study|Scheduling Conflict|3|||
144436722|NCT00006489|520805986|FG002|Overall Study|Scheduling Conflict|2|||
144436723|NCT00006489|520805987|FG003|Overall Study|Scheduling Conflict|1|||
144436724|NCT00006489|520805984|FG000|Overall Study|Death|0|||
144436725|NCT00006489|520805985|FG001|Overall Study|Death|0|||
144436726|NCT00006489|520805986|FG002|Overall Study|Death|0|||
144436727|NCT00006489|520805987|FG003|Overall Study|Death|1|||
144436728|NCT01869192|520805988|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
144436729|NCT01869192|520805989|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
144436730|NCT01869192|520805988|FG000|Postoperative Chemotherapy|Physician Decision|0|||
144436731|NCT01869192|520805989|FG001|Postoperative Chemotherapy|Physician Decision|2|||
144436732|NCT01828034|520805997|FG000|Overall Study|Withdrawal by Subject|0|||
144436733|NCT01828034|520805998|FG001|Overall Study|Withdrawal by Subject|0|||
144436734|NCT01828034|520805999|FG002|Overall Study|Withdrawal by Subject|0|||
144436735|NCT01828034|520806000|FG003|Overall Study|Withdrawal by Subject|1|||
144436736|NCT01800916|520806001|FG000|Test Period 1 (1 Week)|Convex product user|0|||
144436737|NCT01800916|520806002|FG001|Test Period 1 (1 Week)|Convex product user|0|||
144436738|NCT01800916|520806003|FG002|Test Period 1 (1 Week)|Convex product user|0|||
144436739|NCT01800916|520806004|FG003|Test Period 1 (1 Week)|Convex product user|1|||
144436740|NCT01800916|520806005|FG004|Test Period 1 (1 Week)|Convex product user|0|||
144436741|NCT01800916|520806006|FG005|Test Period 1 (1 Week)|Convex product user|0|||
144436742|NCT01800916|520806007|FG006|Test Period 1 (1 Week)|Convex product user|0|||
144436743|NCT01800916|520806008|FG007|Test Period 1 (1 Week)|Convex product user|0|||
144436744|NCT01800916|520806009|FG008|Test Period 1 (1 Week)|Convex product user|0|||
144436745|NCT01800916|520806001|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
144436746|NCT01800916|520806002|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
144436747|NCT01800916|520806003|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
144436748|NCT01800916|520806004|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
144436749|NCT01800916|520806005|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
144436750|NCT01800916|520806006|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
144436751|NCT01800916|520806007|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
144436752|NCT01800916|520806008|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
144436753|NCT01800916|520806009|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
144436754|NCT01232296|520806010|FG000|Overall Study|Adverse Event|24|||
144436755|NCT01232296|520806011|FG001|Overall Study|Adverse Event|12|||
144436756|NCT01232296|520806010|FG000|Overall Study|Physician Decision|1|||
144436757|NCT01232296|520806011|FG001|Overall Study|Physician Decision|1|||
144436758|NCT01232296|520806010|FG000|Overall Study|Progressive disease|43|||
144436759|NCT01232296|520806011|FG001|Overall Study|Progressive disease|61|||
144436760|NCT01232296|520806010|FG000|Overall Study|Study terminated by sponsor|0|||
144436761|NCT01232296|520806011|FG001|Overall Study|Study terminated by sponsor|1|||
144436762|NCT01232296|520806010|FG000|Overall Study|Technical problems|3|||
144436763|NCT01232296|520806011|FG001|Overall Study|Technical problems|0|||
144436764|NCT01232296|520806010|FG000|Overall Study|Subject/guardian decision|10|||
144436765|NCT01232296|520806011|FG001|Overall Study|Subject/guardian decision|2|||
144436766|NCT01232296|520806010|FG000|Overall Study|Death|1|||
144436767|NCT01232296|520806011|FG001|Overall Study|Death|6|||
144436768|NCT01479621|520806018|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
144436769|NCT01479621|520806019|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144188280|NCT02412722|519882972|FG001|Overall Study|Withdrawal by Subject|0|||
144436770|NCT01479621|520806020|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144436771|NCT01479621|520806021|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144436772|NCT01479621|520806022|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144436773|NCT01479621|520806023|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144436774|NCT01479621|520806024|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
144436775|NCT01479621|520806018|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
144436776|NCT01479621|520806019|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144436777|NCT01479621|520806020|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144436778|NCT01479621|520806021|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144436779|NCT01479621|520806022|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144436780|NCT01479621|520806023|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144436781|NCT01479621|520806024|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
144436782|NCT01479621|520806018|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
144436783|NCT01479621|520806019|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144436784|NCT01479621|520806020|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144436785|NCT01479621|520806021|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144436786|NCT01479621|520806022|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144436787|NCT01479621|520806023|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144436788|NCT01479621|520806024|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
144436789|NCT01479621|520806018|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
144436790|NCT01479621|520806019|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144436791|NCT01479621|520806020|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144436792|NCT01479621|520806021|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144436793|NCT01479621|520806022|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144436794|NCT01479621|520806023|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144436795|NCT01479621|520806024|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
144436796|NCT01479621|520806018|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
144436797|NCT01479621|520806019|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144436798|NCT01479621|520806020|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144436799|NCT01479621|520806021|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144436800|NCT01479621|520806022|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144436801|NCT01479621|520806023|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144436802|NCT01479621|520806024|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
144436803|NCT01479621|520806018|FG000|Treatment Period|Adverse Event|0|||
144436804|NCT01479621|520806019|FG001|Treatment Period|Adverse Event|0|||
144436805|NCT01479621|520806020|FG002|Treatment Period|Adverse Event|0|||
144436806|NCT01479621|520806021|FG003|Treatment Period|Adverse Event|0|||
144436807|NCT01479621|520806022|FG004|Treatment Period|Adverse Event|1|||
144436808|NCT01479621|520806023|FG005|Treatment Period|Adverse Event|2|||
144436809|NCT01479621|520806024|FG006|Treatment Period|Adverse Event|2|||
144436810|NCT01479621|520806018|FG000|Treatment Period|Withdrawal by Subject|0|||
144436811|NCT01479621|520806019|FG001|Treatment Period|Withdrawal by Subject|4|||
144436812|NCT01479621|520806020|FG002|Treatment Period|Withdrawal by Subject|2|||
144436813|NCT01479621|520806021|FG003|Treatment Period|Withdrawal by Subject|2|||
144436814|NCT01479621|520806022|FG004|Treatment Period|Withdrawal by Subject|5|||
144436815|NCT01479621|520806023|FG005|Treatment Period|Withdrawal by Subject|5|||
144436816|NCT01479621|520806024|FG006|Treatment Period|Withdrawal by Subject|1|||
144436817|NCT01479621|520806018|FG000|Treatment Period|Physician Decision|0|||
144436818|NCT01479621|520806019|FG001|Treatment Period|Physician Decision|0|||
144436819|NCT01479621|520806020|FG002|Treatment Period|Physician Decision|0|||
144436820|NCT01479621|520806021|FG003|Treatment Period|Physician Decision|0|||
144436821|NCT01479621|520806022|FG004|Treatment Period|Physician Decision|1|||
144436822|NCT01479621|520806023|FG005|Treatment Period|Physician Decision|1|||
144436823|NCT01479621|520806024|FG006|Treatment Period|Physician Decision|0|||
144436824|NCT01479621|520806018|FG000|Treatment Period|Non-compliance to study drug|0|||
144436825|NCT01479621|520806019|FG001|Treatment Period|Non-compliance to study drug|1|||
144436826|NCT01479621|520806020|FG002|Treatment Period|Non-compliance to study drug|0|||
144436827|NCT01479621|520806021|FG003|Treatment Period|Non-compliance to study drug|0|||
144436828|NCT01479621|520806022|FG004|Treatment Period|Non-compliance to study drug|0|||
144436829|NCT01479621|520806023|FG005|Treatment Period|Non-compliance to study drug|0|||
144436830|NCT01479621|520806024|FG006|Treatment Period|Non-compliance to study drug|1|||
144436831|NCT01479621|520806018|FG000|Treatment Period|Protocol Violation|0|||
144436832|NCT01479621|520806019|FG001|Treatment Period|Protocol Violation|9|||
144436833|NCT01479621|520806020|FG002|Treatment Period|Protocol Violation|6|||
144436834|NCT01479621|520806021|FG003|Treatment Period|Protocol Violation|5|||
144188281|NCT02412722|519882973|FG002|Overall Study|Withdrawal by Subject|1|||
144436835|NCT01479621|520806022|FG004|Treatment Period|Protocol Violation|2|||
144188282|NCT02412722|519882974|FG003|Overall Study|Withdrawal by Subject|2|||
144436836|NCT01479621|520806023|FG005|Treatment Period|Protocol Violation|10|||
144436837|NCT01479621|520806024|FG006|Treatment Period|Protocol Violation|6|||
144436838|NCT01479621|520806018|FG000|Treatment Period|Pregnancy|0|||
144436839|NCT01479621|520806019|FG001|Treatment Period|Pregnancy|0|||
144436840|NCT01479621|520806020|FG002|Treatment Period|Pregnancy|2|||
144436841|NCT01479621|520806021|FG003|Treatment Period|Pregnancy|0|||
144436842|NCT01479621|520806022|FG004|Treatment Period|Pregnancy|0|||
144436843|NCT01479621|520806023|FG005|Treatment Period|Pregnancy|0|||
144436844|NCT01479621|520806024|FG006|Treatment Period|Pregnancy|0|||
144436845|NCT01479621|520806018|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
144436846|NCT01479621|520806019|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
144436847|NCT01479621|520806020|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
144436848|NCT01479621|520806021|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
144436849|NCT01479621|520806022|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
144436850|NCT01479621|520806023|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
144436851|NCT01479621|520806024|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
144436852|NCT01479621|520806018|FG000|Treatment Period|Lost to Follow-up|0|||
144436853|NCT01479621|520806019|FG001|Treatment Period|Lost to Follow-up|0|||
144436854|NCT01479621|520806020|FG002|Treatment Period|Lost to Follow-up|1|||
144436855|NCT01479621|520806021|FG003|Treatment Period|Lost to Follow-up|0|||
144436856|NCT01479621|520806022|FG004|Treatment Period|Lost to Follow-up|2|||
144436857|NCT01479621|520806023|FG005|Treatment Period|Lost to Follow-up|2|||
144436858|NCT01479621|520806024|FG006|Treatment Period|Lost to Follow-up|1|||
144436859|NCT01479621|520806018|FG000|Treatment Period|Met stopping criteria|0|||
144436860|NCT01479621|520806019|FG001|Treatment Period|Met stopping criteria|8|||
144436861|NCT01479621|520806020|FG002|Treatment Period|Met stopping criteria|7|||
144436862|NCT01479621|520806021|FG003|Treatment Period|Met stopping criteria|4|||
144436863|NCT01479621|520806022|FG004|Treatment Period|Met stopping criteria|9|||
144436864|NCT01479621|520806023|FG005|Treatment Period|Met stopping criteria|20|||
144436865|NCT01479621|520806024|FG006|Treatment Period|Met stopping criteria|6|||
144436866|NCT00606892|520806033|FG000|First Intervention|Protocol Violation|1|||
144436867|NCT00606892|520806034|FG001|First Intervention|Protocol Violation|4|||
144436868|NCT04225923|520806035|FG000|Overall Study|Protocol Violation|1|||
144436869|NCT04225923|520806036|FG001|Overall Study|Protocol Violation|0|||
144436870|NCT04225923|520806037|FG002|Overall Study|Protocol Violation|1|||
144436871|NCT04225923|520806035|FG000|Overall Study|Withdrawal by Subject|4|||
144436872|NCT04225923|520806036|FG001|Overall Study|Withdrawal by Subject|1|||
144436873|NCT04225923|520806037|FG002|Overall Study|Withdrawal by Subject|3|||
144436874|NCT04225923|520806035|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
144436875|NCT04225923|520806036|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
144436876|NCT04225923|520806037|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
144436877|NCT00855309|520806038|FG000|Overall Study|patient never recieved drug|1|||
144436878|NCT00855309|520806039|FG001|Overall Study|patient never recieved drug|0|||
144436879|NCT01585766|520806040|FG000|Overall Study|Withdrawal by Subject|0|||
144436880|NCT01585766|520806041|FG001|Overall Study|Withdrawal by Subject|1|||
144436881|NCT01585766|520806042|FG002|Overall Study|Withdrawal by Subject|1|||
144436882|NCT01585766|520806043|FG003|Overall Study|Withdrawal by Subject|0|||
144436883|NCT01585766|520806044|FG004|Overall Study|Withdrawal by Subject|0|||
144436884|NCT01585766|520806045|FG005|Overall Study|Withdrawal by Subject|0|||
144436885|NCT01585766|520806040|FG000|Overall Study|Death|0|||
144436886|NCT01585766|520806041|FG001|Overall Study|Death|1|||
144436887|NCT01585766|520806042|FG002|Overall Study|Death|0|||
144436888|NCT01585766|520806043|FG003|Overall Study|Death|0|||
144436889|NCT01585766|520806044|FG004|Overall Study|Death|0|||
144436890|NCT01585766|520806045|FG005|Overall Study|Death|0|||
144436891|NCT01585766|520806040|FG000|Overall Study|Physician Decision|0|||
144436892|NCT01585766|520806041|FG001|Overall Study|Physician Decision|0|||
144436893|NCT01585766|520806042|FG002|Overall Study|Physician Decision|1|||
144436894|NCT01585766|520806043|FG003|Overall Study|Physician Decision|0|||
144436895|NCT01585766|520806044|FG004|Overall Study|Physician Decision|0|||
144436896|NCT01585766|520806045|FG005|Overall Study|Physician Decision|0|||
144436897|NCT04116710|520806046|FG000|Overall Study|Death|4|||
144436898|NCT04116710|520806047|FG001|Overall Study|Death|6|||
144436899|NCT04116710|520806048|FG002|Overall Study|Death|3|||
144436900|NCT04116710|520806049|FG003|Overall Study|Death|1|||
144436901|NCT04116710|520806046|FG000|Overall Study|Withdrawal by Subject|0|||
144436902|NCT04116710|520806047|FG001|Overall Study|Withdrawal by Subject|0|||
144436903|NCT04116710|520806048|FG002|Overall Study|Withdrawal by Subject|0|||
144436904|NCT04116710|520806049|FG003|Overall Study|Withdrawal by Subject|1|||
144436905|NCT00582933|520806050|FG000|Overall Study|Physician Decision|3|||
144436906|NCT02319031|520806051|FG000|Treatment Period|Death|1|||
144436907|NCT02319031|520806052|FG001|Treatment Period|Death|0|||
144436908|NCT02689258|520806056|FG000|Overall Study|Subject Non-Compliance|0|||
144436909|NCT02689258|520806057|FG001|Overall Study|Subject Non-Compliance|1|||
144436910|NCT02689258|520806058|FG002|Overall Study|Subject Non-Compliance|0|||
144436911|NCT02689258|520806059|FG003|Overall Study|Subject Non-Compliance|0|||
144436912|NCT02689258|520806060|FG004|Overall Study|Subject Non-Compliance|0|||
144436913|NCT02689258|520806061|FG005|Overall Study|Subject Non-Compliance|0|||
144436914|NCT02689258|520806062|FG006|Overall Study|Subject Non-Compliance|0|||
144436915|NCT02689258|520806063|FG007|Overall Study|Subject Non-Compliance|0|||
144436916|NCT02689258|520806064|FG008|Overall Study|Subject Non-Compliance|0|||
144436917|NCT02689258|520806065|FG009|Overall Study|Subject Non-Compliance|0|||
144604708|NCT02877927|521414387|FG000|Overall Study|Withdrawal by Subject|11|||
144604709|NCT02877927|521414388|FG001|Overall Study|Withdrawal by Subject|12|||
144188283|NCT02412722|519882975|FG004|Overall Study|Withdrawal by Subject|1|||
144188284|NCT02412722|519882976|FG005|Overall Study|Withdrawal by Subject|1|||
144188285|NCT02412722|519882971|FG000|Overall Study|Lost to Follow-up|0|||
144188286|NCT02412722|519882972|FG001|Overall Study|Lost to Follow-up|0|||
144188287|NCT02412722|519882973|FG002|Overall Study|Lost to Follow-up|0|||
144188288|NCT02412722|519882974|FG003|Overall Study|Lost to Follow-up|0|||
144436918|NCT02689258|520806066|FG010|Overall Study|Subject Non-Compliance|0|||
144436919|NCT02689258|520806067|FG011|Overall Study|Subject Non-Compliance|0|||
144436920|NCT02689258|520806056|FG000|Overall Study|Subject Refusal to Continue|0|||
144436921|NCT02689258|520806057|FG001|Overall Study|Subject Refusal to Continue|1|||
144436922|NCT02689258|520806058|FG002|Overall Study|Subject Refusal to Continue|0|||
144436923|NCT02689258|520806059|FG003|Overall Study|Subject Refusal to Continue|0|||
144436924|NCT02689258|520806060|FG004|Overall Study|Subject Refusal to Continue|0|||
144436925|NCT02689258|520806061|FG005|Overall Study|Subject Refusal to Continue|0|||
144436926|NCT02689258|520806062|FG006|Overall Study|Subject Refusal to Continue|0|||
144436927|NCT02689258|520806063|FG007|Overall Study|Subject Refusal to Continue|0|||
144436928|NCT02689258|520806064|FG008|Overall Study|Subject Refusal to Continue|1|||
144436929|NCT02689258|520806065|FG009|Overall Study|Subject Refusal to Continue|0|||
144436930|NCT02689258|520806066|FG010|Overall Study|Subject Refusal to Continue|0|||
144436931|NCT02689258|520806067|FG011|Overall Study|Subject Refusal to Continue|1|||
144436932|NCT02689258|520806056|FG000|Overall Study|Other|0|||
144436933|NCT02689258|520806057|FG001|Overall Study|Other|2|||
144436934|NCT02689258|520806058|FG002|Overall Study|Other|0|||
144436935|NCT02689258|520806059|FG003|Overall Study|Other|0|||
144436936|NCT02689258|520806060|FG004|Overall Study|Other|1|||
144436937|NCT02689258|520806061|FG005|Overall Study|Other|0|||
144436938|NCT02689258|520806062|FG006|Overall Study|Other|0|||
144436939|NCT02689258|520806063|FG007|Overall Study|Other|0|||
144436940|NCT02689258|520806064|FG008|Overall Study|Other|1|||
144436941|NCT02689258|520806065|FG009|Overall Study|Other|0|||
144436942|NCT02689258|520806066|FG010|Overall Study|Other|0|||
144436943|NCT02689258|520806067|FG011|Overall Study|Other|0|||
144436944|NCT04753164|520806069|FG000|Overall Study|Adverse Event|0|||
144436945|NCT04753164|520806070|FG001|Overall Study|Adverse Event|2|||
144436946|NCT04753164|520806069|FG000|Overall Study|Withdrawal by Subject|9|||
144436947|NCT04753164|520806070|FG001|Overall Study|Withdrawal by Subject|7|||
144436948|NCT04753164|520806069|FG000|Overall Study|Lost to Follow-up|6|||
144436949|NCT04753164|520806070|FG001|Overall Study|Lost to Follow-up|6|||
144436950|NCT04753164|520806069|FG000|Overall Study|Other|12|||
144436951|NCT04753164|520806070|FG001|Overall Study|Other|5|||
144436952|NCT00696137|520806072|FG000|Overall Study|Withdrawal by Subject|2|||
144436953|NCT01371656|520806073|FG000|Overall Study|Death|7|||
144436954|NCT01371656|520806074|FG001|Overall Study|Death|4|||
144436955|NCT01371656|520806073|FG000|Overall Study|Physician Decision|46|||
144436956|NCT01371656|520806074|FG001|Overall Study|Physician Decision|7|||
144436957|NCT01371656|520806073|FG000|Overall Study|Withdrawal by Subject|7|||
144436958|NCT01371656|520806074|FG001|Overall Study|Withdrawal by Subject|0|||
144436959|NCT01371656|520806073|FG000|Overall Study|Ineligible|4|||
144436960|NCT01371656|520806074|FG001|Overall Study|Ineligible|3|||
144436961|NCT01465464|520806080|FG000|Overall Study|Adverse Event|96|||
144436962|NCT01465464|520806081|FG001|Overall Study|Adverse Event|49|||
144436963|NCT01465464|520806080|FG000|Overall Study|Lack of Efficacy|139|||
144436964|NCT01465464|520806081|FG001|Overall Study|Lack of Efficacy|190|||
144436965|NCT01465464|520806080|FG000|Overall Study|Physician Decision|13|||
144436966|NCT01465464|520806081|FG001|Overall Study|Physician Decision|5|||
144436967|NCT01465464|520806080|FG000|Overall Study|Protocol Violation|1|||
144436968|NCT01465464|520806081|FG001|Overall Study|Protocol Violation|1|||
144436969|NCT01465464|520806080|FG000|Overall Study|Withdrawal by Subject|46|||
144436970|NCT01465464|520806081|FG001|Overall Study|Withdrawal by Subject|30|||
144436971|NCT01465464|520806080|FG000|Overall Study|Other|9|||
144436972|NCT01465464|520806081|FG001|Overall Study|Other|3|||
144436973|NCT01465464|520806080|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
144436974|NCT01465464|520806081|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
144436975|NCT01116232|520806086|FG000|Overall Study|Progressive diease|4|||
144436976|NCT03554291|520806087|FG000|Overall Study|Death|2|||
144436977|NCT03554291|520806088|FG001|Overall Study|Death|1|||
144436978|NCT03554291|520806087|FG000|Overall Study|Lost to Follow-up|1|||
144436979|NCT03554291|520806088|FG001|Overall Study|Lost to Follow-up|0|||
144436980|NCT03554291|520806087|FG000|Overall Study|Withdrawal by Subject|1|||
144436981|NCT03554291|520806088|FG001|Overall Study|Withdrawal by Subject|0|||
144188289|NCT02412722|519882975|FG004|Overall Study|Lost to Follow-up|1|||
144436982|NCT03554291|520806087|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
144436983|NCT03554291|520806088|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
144436984|NCT01228747|520806089|FG000|Overall Study|Adverse Event|8|||
144436985|NCT01228747|520806090|FG001|Overall Study|Adverse Event|4|||
144436986|NCT01228747|520806089|FG000|Overall Study|Lack of Efficacy|40|||
144436987|NCT01228747|520806090|FG001|Overall Study|Lack of Efficacy|27|||
144436988|NCT01228747|520806089|FG000|Overall Study|Protocol Violation|6|||
144436989|NCT01228747|520806090|FG001|Overall Study|Protocol Violation|5|||
144436990|NCT01228747|520806089|FG000|Overall Study|Lost to Follow-up|4|||
144436991|NCT01228747|520806090|FG001|Overall Study|Lost to Follow-up|3|||
144436992|NCT01228747|520806089|FG000|Overall Study|Withdrawal by Subject|5|||
144436993|NCT01228747|520806090|FG001|Overall Study|Withdrawal by Subject|1|||
144436994|NCT01228747|520806089|FG000|Overall Study|Other Reason|2|||
144436995|NCT01228747|520806090|FG001|Overall Study|Other Reason|5|||
144436996|NCT02036502|520806091|FG000|Part 1:Dose Determination/Escalation|Death|3|||
144436997|NCT02036502|520806092|FG001|Part 1:Dose Determination/Escalation|Death|2|||
144436998|NCT02036502|520806093|FG002|Part 1:Dose Determination/Escalation|Death|0|||
144436999|NCT02036502|520806094|FG003|Part 1:Dose Determination/Escalation|Death|0|||
144437000|NCT02036502|520806095|FG004|Part 1:Dose Determination/Escalation|Death|0|||
144437001|NCT02036502|520806096|FG005|Part 1:Dose Determination/Escalation|Death|0|||
144437002|NCT02036502|520806097|FG006|Part 1:Dose Determination/Escalation|Death|0|||
144437003|NCT02036502|520806098|FG007|Part 1:Dose Determination/Escalation|Death|0|||
144437004|NCT02036502|520806091|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
144437005|NCT02036502|520806092|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437006|NCT02036502|520806093|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437007|NCT02036502|520806094|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437008|NCT02036502|520806095|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437009|NCT02036502|520806096|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437010|NCT02036502|520806097|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437011|NCT02036502|520806098|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
144437012|NCT02036502|520806091|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437013|NCT02036502|520806092|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
144437014|NCT02036502|520806093|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437015|NCT02036502|520806094|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437016|NCT02036502|520806095|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437017|NCT02036502|520806096|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437018|NCT02036502|520806097|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437019|NCT02036502|520806098|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
144437020|NCT02036502|520806091|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
144437021|NCT02036502|520806092|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
144437022|NCT02036502|520806093|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
144437023|NCT02036502|520806094|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
144437024|NCT02036502|520806095|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
144437025|NCT02036502|520806096|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
144437026|NCT02036502|520806097|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
144437027|NCT02036502|520806098|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
144437028|NCT02036502|520806091|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
144437029|NCT02036502|520806092|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
144437030|NCT02036502|520806093|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
144437031|NCT02036502|520806094|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
144437032|NCT02036502|520806095|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
144437033|NCT02036502|520806096|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
144437034|NCT02036502|520806097|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
144437035|NCT02036502|520806098|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
144437036|NCT02036502|520806091|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437037|NCT02036502|520806092|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437038|NCT02036502|520806093|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
144437039|NCT02036502|520806094|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437040|NCT02036502|520806095|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437041|NCT02036502|520806096|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437042|NCT02036502|520806097|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437043|NCT02036502|520806098|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
144437044|NCT02036502|520806091|FG000|Part 2:Dose Confirmation|Death|0|||
144437045|NCT02036502|520806092|FG001|Part 2:Dose Confirmation|Death|0|||
144437046|NCT02036502|520806093|FG002|Part 2:Dose Confirmation|Death|1|||
144437047|NCT02036502|520806094|FG003|Part 2:Dose Confirmation|Death|0|||
144437048|NCT02036502|520806095|FG004|Part 2:Dose Confirmation|Death|0|||
144437049|NCT02036502|520806096|FG005|Part 2:Dose Confirmation|Death|0|||
144437050|NCT02036502|520806097|FG006|Part 2:Dose Confirmation|Death|0|||
144437051|NCT02036502|520806098|FG007|Part 2:Dose Confirmation|Death|0|||
144437052|NCT02036502|520806091|FG000|Part 2:Dose Confirmation|Not treated|0|||
144437053|NCT02036502|520806092|FG001|Part 2:Dose Confirmation|Not treated|0|||
144437054|NCT02036502|520806093|FG002|Part 2:Dose Confirmation|Not treated|0|||
144437055|NCT02036502|520806094|FG003|Part 2:Dose Confirmation|Not treated|1|||
144604710|NCT02877927|521414387|FG000|Overall Study|Physician Decision|0|||
144437056|NCT02036502|520806095|FG004|Part 2:Dose Confirmation|Not treated|0|||
144437057|NCT02036502|520806096|FG005|Part 2:Dose Confirmation|Not treated|0|||
144437058|NCT02036502|520806097|FG006|Part 2:Dose Confirmation|Not treated|0|||
144437059|NCT02036502|520806098|FG007|Part 2:Dose Confirmation|Not treated|0|||
144437060|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Adverse Event|0|||
144437061|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Adverse Event|0|||
144437062|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Adverse Event|0|||
144437063|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Adverse Event|0|||
144437064|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Adverse Event|0|||
144437065|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Adverse Event|4|||
144437066|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Adverse Event|0|||
144437067|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Adverse Event|2|||
144437068|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Death|0|||
144437069|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Death|0|||
144437070|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Death|0|||
144437071|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Death|0|||
144437072|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Death|0|||
144437073|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Death|24|||
144437074|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Death|0|||
144437075|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Death|3|||
144437076|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437077|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437078|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437079|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437080|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437081|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437082|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
144437083|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
144437084|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Physician Decision|0|||
144437085|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Physician Decision|0|||
144437086|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Physician Decision|0|||
144437087|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Physician Decision|0|||
144437088|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Physician Decision|0|||
144437089|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Physician Decision|1|||
144437090|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Physician Decision|0|||
144437091|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Physician Decision|0|||
144437092|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
144437093|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
144437094|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
144437095|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
144437096|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
144437097|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
144437098|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
144437099|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
144437100|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
144437101|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
144437102|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
144437103|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
144437104|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
144437105|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
144437106|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
144437107|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
144437108|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
144437109|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
144437110|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
144437111|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
144437112|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
144437113|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
144437114|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
144437115|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
144437116|NCT02036502|520806091|FG000|Part 3:Dose Expansion|Not Treated|0|||
144437117|NCT02036502|520806092|FG001|Part 3:Dose Expansion|Not Treated|0|||
144437118|NCT02036502|520806093|FG002|Part 3:Dose Expansion|Not Treated|0|||
144437119|NCT02036502|520806094|FG003|Part 3:Dose Expansion|Not Treated|0|||
144437120|NCT02036502|520806095|FG004|Part 3:Dose Expansion|Not Treated|0|||
144437121|NCT02036502|520806096|FG005|Part 3:Dose Expansion|Not Treated|2|||
144437122|NCT02036502|520806097|FG006|Part 3:Dose Expansion|Not Treated|0|||
144437123|NCT02036502|520806098|FG007|Part 3:Dose Expansion|Not Treated|0|||
144437124|NCT01068509|520806104|FG000|Overall Study|Death|0|||
144437125|NCT01068509|520806105|FG001|Overall Study|Death|0|||
144437126|NCT01068509|520806106|FG002|Overall Study|Death|1|||
144437127|NCT01068509|520806104|FG000|Overall Study|Disease Progression|5|||
144437128|NCT01068509|520806105|FG001|Overall Study|Disease Progression|20|||
144437129|NCT01068509|520806106|FG002|Overall Study|Disease Progression|18|||
144437130|NCT01068509|520806104|FG000|Overall Study|Lost to Follow-up|1|||
144437131|NCT01068509|520806105|FG001|Overall Study|Lost to Follow-up|0|||
144437132|NCT01068509|520806106|FG002|Overall Study|Lost to Follow-up|0|||
144437133|NCT01068509|520806104|FG000|Overall Study|Withdrew Consent|0|||
144437134|NCT01068509|520806105|FG001|Overall Study|Withdrew Consent|1|||
144437135|NCT01068509|520806106|FG002|Overall Study|Withdrew Consent|2|||
144437136|NCT01068509|520806104|FG000|Overall Study|Reason Not Specified|0|||
144437137|NCT01068509|520806105|FG001|Overall Study|Reason Not Specified|1|||
144437138|NCT01068509|520806106|FG002|Overall Study|Reason Not Specified|0|||
144437139|NCT02357940|520806111|FG000|Overall Study|Adverse Event|0|||
144437140|NCT02357940|520806112|FG001|Overall Study|Adverse Event|1|||
144437141|NCT02357940|520806111|FG000|Overall Study|Investigator's judgement|0|||
144437142|NCT02357940|520806112|FG001|Overall Study|Investigator's judgement|1|||
144437143|NCT01165138|520806113|FG000|Overall Study|Adverse Event|0|||
144437144|NCT01165138|520806114|FG001|Overall Study|Adverse Event|1|||
144437145|NCT01165138|520806115|FG002|Overall Study|Adverse Event|0|||
144437146|NCT01165138|520806116|FG003|Overall Study|Adverse Event|2|||
144437147|NCT01165138|520806113|FG000|Overall Study|Lack of Efficacy|0|||
144437148|NCT01165138|520806114|FG001|Overall Study|Lack of Efficacy|32|||
144437149|NCT01165138|520806115|FG002|Overall Study|Lack of Efficacy|6|||
144437150|NCT01165138|520806116|FG003|Overall Study|Lack of Efficacy|7|||
144437151|NCT01165138|520806113|FG000|Overall Study|Protocol Violation|0|||
144437152|NCT01165138|520806114|FG001|Overall Study|Protocol Violation|7|||
144437153|NCT01165138|520806115|FG002|Overall Study|Protocol Violation|0|||
144437154|NCT01165138|520806116|FG003|Overall Study|Protocol Violation|2|||
144437155|NCT01165138|520806113|FG000|Overall Study|Lost to Follow-up|0|||
144437156|NCT01165138|520806114|FG001|Overall Study|Lost to Follow-up|0|||
144437157|NCT01165138|520806115|FG002|Overall Study|Lost to Follow-up|1|||
144437158|NCT01165138|520806116|FG003|Overall Study|Lost to Follow-up|2|||
144437159|NCT01165138|520806113|FG000|Overall Study|Physician Decision|0|||
144437160|NCT01165138|520806114|FG001|Overall Study|Physician Decision|6|||
144437161|NCT01165138|520806115|FG002|Overall Study|Physician Decision|7|||
144437162|NCT01165138|520806116|FG003|Overall Study|Physician Decision|6|||
144437163|NCT01165138|520806113|FG000|Overall Study|Withdrawal by Subject|0|||
144437164|NCT01165138|520806114|FG001|Overall Study|Withdrawal by Subject|6|||
144437165|NCT01165138|520806115|FG002|Overall Study|Withdrawal by Subject|6|||
144437166|NCT01165138|520806116|FG003|Overall Study|Withdrawal by Subject|3|||
144437167|NCT02641379|520806117|FG000|Overall Study|Exclusion criterion during screening|1|||
144437168|NCT02641379|520806118|FG001|Overall Study|Exclusion criterion during screening|0|||
144437169|NCT02641379|520806119|FG002|Overall Study|Exclusion criterion during screening|0|||
144437170|NCT02641379|520806120|FG003|Overall Study|Exclusion criterion during screening|1|||
144437171|NCT02641379|520806121|FG004|Overall Study|Exclusion criterion during screening|2|||
144437172|NCT02641379|520806122|FG005|Overall Study|Exclusion criterion during screening|0|||
144437173|NCT02641379|520806123|FG006|Overall Study|Exclusion criterion during screening|0|||
144437174|NCT02641379|520806124|FG007|Overall Study|Exclusion criterion during screening|0|||
144437175|NCT02641379|520806125|FG008|Overall Study|Exclusion criterion during screening|0|||
144437176|NCT02641379|520806126|FG009|Overall Study|Exclusion criterion during screening|0|||
144437177|NCT02641379|520806127|FG010|Overall Study|Exclusion criterion during screening|0|||
144437178|NCT02641379|520806117|FG000|Overall Study|Withdrawal of informed consent|0|||
144437179|NCT02641379|520806118|FG001|Overall Study|Withdrawal of informed consent|1|||
144437180|NCT02641379|520806119|FG002|Overall Study|Withdrawal of informed consent|0|||
144437181|NCT02641379|520806120|FG003|Overall Study|Withdrawal of informed consent|0|||
144437182|NCT02641379|520806121|FG004|Overall Study|Withdrawal of informed consent|0|||
144437183|NCT02641379|520806122|FG005|Overall Study|Withdrawal of informed consent|0|||
144437184|NCT02641379|520806123|FG006|Overall Study|Withdrawal of informed consent|0|||
144437185|NCT02641379|520806124|FG007|Overall Study|Withdrawal of informed consent|1|||
144437186|NCT02641379|520806125|FG008|Overall Study|Withdrawal of informed consent|0|||
144437187|NCT02641379|520806126|FG009|Overall Study|Withdrawal of informed consent|0|||
144437188|NCT02641379|520806127|FG010|Overall Study|Withdrawal of informed consent|0|||
144437189|NCT02641379|520806117|FG000|Overall Study|Adverse Event|7|||
144437190|NCT02641379|520806118|FG001|Overall Study|Adverse Event|8|||
144437191|NCT02641379|520806119|FG002|Overall Study|Adverse Event|2|||
144437192|NCT02641379|520806120|FG003|Overall Study|Adverse Event|2|||
144437193|NCT02641379|520806121|FG004|Overall Study|Adverse Event|5|||
144437194|NCT02641379|520806122|FG005|Overall Study|Adverse Event|1|||
144437195|NCT02641379|520806123|FG006|Overall Study|Adverse Event|5|||
144437196|NCT02641379|520806124|FG007|Overall Study|Adverse Event|0|||
144437197|NCT02641379|520806125|FG008|Overall Study|Adverse Event|1|||
144437198|NCT02641379|520806126|FG009|Overall Study|Adverse Event|1|||
144188290|NCT02412722|519882976|FG005|Overall Study|Lost to Follow-up|0|||
144437199|NCT02641379|520806127|FG010|Overall Study|Adverse Event|5|||
144437200|NCT02641379|520806117|FG000|Overall Study|Lack of Efficacy|0|||
144437201|NCT02641379|520806118|FG001|Overall Study|Lack of Efficacy|0|||
144437202|NCT02641379|520806119|FG002|Overall Study|Lack of Efficacy|2|||
144437203|NCT02641379|520806120|FG003|Overall Study|Lack of Efficacy|0|||
144437204|NCT02641379|520806121|FG004|Overall Study|Lack of Efficacy|0|||
144188291|NCT02412722|519882971|FG000|Overall Study|Received drug in run-in and discontinued|0|||
144437205|NCT02641379|520806122|FG005|Overall Study|Lack of Efficacy|2|||
144437206|NCT02641379|520806123|FG006|Overall Study|Lack of Efficacy|0|||
144437207|NCT02641379|520806124|FG007|Overall Study|Lack of Efficacy|5|||
144530280|NCT01254864|521144339|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
144530281|NCT01254864|521144340|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
144530282|NCT01254864|521144338|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
144530283|NCT01254864|521144339|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
144530284|NCT01254864|521144340|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
144530285|NCT01254864|521144338|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
144530286|NCT01254864|521144339|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
144530287|NCT01254864|521144340|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
144530288|NCT01254864|521144338|FG000|Randomization Phase|Adverse Event|0|||
144530289|NCT01254864|521144339|FG001|Randomization Phase|Adverse Event|5|||
144530290|NCT01254864|521144340|FG002|Randomization Phase|Adverse Event|17|||
144530291|NCT01254864|521144338|FG000|Randomization Phase|Death|0|||
144530292|NCT01254864|521144339|FG001|Randomization Phase|Death|1|||
144530293|NCT01254864|521144340|FG002|Randomization Phase|Death|0|||
144530294|NCT01254864|521144338|FG000|Randomization Phase|Lost to Follow-up|0|||
144530295|NCT01254864|521144339|FG001|Randomization Phase|Lost to Follow-up|0|||
144530296|NCT01254864|521144340|FG002|Randomization Phase|Lost to Follow-up|1|||
144530297|NCT01254864|521144338|FG000|Randomization Phase|Physician Decision|0|||
144530298|NCT01254864|521144339|FG001|Randomization Phase|Physician Decision|20|||
144530299|NCT01254864|521144340|FG002|Randomization Phase|Physician Decision|25|||
144530300|NCT01254864|521144338|FG000|Randomization Phase|Withdrawal by Subject|0|||
144530301|NCT01254864|521144339|FG001|Randomization Phase|Withdrawal by Subject|4|||
144530302|NCT01254864|521144340|FG002|Randomization Phase|Withdrawal by Subject|2|||
144530303|NCT01254864|521144338|FG000|Randomization Phase|Non-Compliance|0|||
144530304|NCT01254864|521144339|FG001|Randomization Phase|Non-Compliance|1|||
144530305|NCT01254864|521144340|FG002|Randomization Phase|Non-Compliance|0|||
144530306|NCT01254864|521144338|FG000|Randomization Phase|Comorbidities|0|||
144530307|NCT01254864|521144339|FG001|Randomization Phase|Comorbidities|2|||
144530308|NCT01254864|521144340|FG002|Randomization Phase|Comorbidities|1|||
144530309|NCT04625725|521144343|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
144530310|NCT04625725|521144344|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
144530311|NCT04625725|521144345|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
144530312|NCT04625725|521144346|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
144437208|NCT02641379|520806125|FG008|Overall Study|Lack of Efficacy|0|||
144437209|NCT02641379|520806126|FG009|Overall Study|Lack of Efficacy|0|||
144437210|NCT02641379|520806127|FG010|Overall Study|Lack of Efficacy|0|||
144437211|NCT02641379|520806117|FG000|Overall Study|Participant unable to attend study visit|4|||
144437212|NCT02641379|520806118|FG001|Overall Study|Participant unable to attend study visit|10|||
144437213|NCT02641379|520806119|FG002|Overall Study|Participant unable to attend study visit|1|||
144437214|NCT02641379|520806120|FG003|Overall Study|Participant unable to attend study visit|2|||
144437215|NCT02641379|520806121|FG004|Overall Study|Participant unable to attend study visit|5|||
144437216|NCT02641379|520806122|FG005|Overall Study|Participant unable to attend study visit|1|||
144437217|NCT02641379|520806123|FG006|Overall Study|Participant unable to attend study visit|1|||
144437218|NCT02641379|520806124|FG007|Overall Study|Participant unable to attend study visit|1|||
144437219|NCT02641379|520806125|FG008|Overall Study|Participant unable to attend study visit|0|||
144437220|NCT02641379|520806126|FG009|Overall Study|Participant unable to attend study visit|2|||
144437221|NCT02641379|520806127|FG010|Overall Study|Participant unable to attend study visit|0|||
144530313|NCT04625725|521144347|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
144530314|NCT04625725|521144348|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
144530315|NCT04625725|521144343|FG000|Provent Main Study|Withdrawal by Subject|242|||
144530316|NCT04625725|521144344|FG001|Provent Main Study|Withdrawal by Subject|144|||
144530317|NCT04625725|521144345|FG002|Provent Main Study|Withdrawal by Subject|0|||
144530318|NCT04625725|521144346|FG003|Provent Main Study|Withdrawal by Subject|0|||
144530319|NCT04625725|521144347|FG004|Provent Main Study|Withdrawal by Subject|0|||
144530320|NCT04625725|521144348|FG005|Provent Main Study|Withdrawal by Subject|0|||
144530321|NCT04625725|521144343|FG000|Provent Main Study|Physician Decision|5|||
144530322|NCT04625725|521144344|FG001|Provent Main Study|Physician Decision|0|||
144530323|NCT04625725|521144345|FG002|Provent Main Study|Physician Decision|0|||
144530324|NCT04625725|521144346|FG003|Provent Main Study|Physician Decision|0|||
144530325|NCT04625725|521144347|FG004|Provent Main Study|Physician Decision|0|||
144530326|NCT04625725|521144348|FG005|Provent Main Study|Physician Decision|0|||
144530327|NCT04625725|521144343|FG000|Provent Main Study|Protocol Violation|1|||
144530328|NCT04625725|521144344|FG001|Provent Main Study|Protocol Violation|0|||
144530329|NCT04625725|521144345|FG002|Provent Main Study|Protocol Violation|0|||
144530330|NCT04625725|521144346|FG003|Provent Main Study|Protocol Violation|0|||
144437222|NCT02641379|520806117|FG000|Overall Study|Participant's compliance|0|||
144437223|NCT02641379|520806118|FG001|Overall Study|Participant's compliance|1|||
144437224|NCT02641379|520806119|FG002|Overall Study|Participant's compliance|0|||
144437225|NCT02641379|520806120|FG003|Overall Study|Participant's compliance|1|||
144437226|NCT02641379|520806121|FG004|Overall Study|Participant's compliance|0|||
144530331|NCT04625725|521144347|FG004|Provent Main Study|Protocol Violation|0|||
144530332|NCT04625725|521144348|FG005|Provent Main Study|Protocol Violation|0|||
144437227|NCT02641379|520806122|FG005|Overall Study|Participant's compliance|2|||
144437228|NCT02641379|520806123|FG006|Overall Study|Participant's compliance|0|||
144437229|NCT02641379|520806124|FG007|Overall Study|Participant's compliance|0|||
144437230|NCT02641379|520806125|FG008|Overall Study|Participant's compliance|1|||
144437231|NCT02641379|520806126|FG009|Overall Study|Participant's compliance|1|||
144437232|NCT02641379|520806127|FG010|Overall Study|Participant's compliance|1|||
144437233|NCT02641379|520806117|FG000|Overall Study|Participant cannot be reached|4|||
144437234|NCT02641379|520806118|FG001|Overall Study|Participant cannot be reached|4|||
144437235|NCT02641379|520806119|FG002|Overall Study|Participant cannot be reached|0|||
144437236|NCT02641379|520806120|FG003|Overall Study|Participant cannot be reached|8|||
144437237|NCT02641379|520806121|FG004|Overall Study|Participant cannot be reached|2|||
144437238|NCT02641379|520806122|FG005|Overall Study|Participant cannot be reached|1|||
144437239|NCT02641379|520806123|FG006|Overall Study|Participant cannot be reached|0|||
144437240|NCT02641379|520806124|FG007|Overall Study|Participant cannot be reached|1|||
144437241|NCT02641379|520806125|FG008|Overall Study|Participant cannot be reached|0|||
144437242|NCT02641379|520806126|FG009|Overall Study|Participant cannot be reached|2|||
144437243|NCT02641379|520806127|FG010|Overall Study|Participant cannot be reached|1|||
144437244|NCT02641379|520806117|FG000|Overall Study|PCR positive at Week 24|15|||
144437245|NCT02641379|520806118|FG001|Overall Study|PCR positive at Week 24|21|||
144437246|NCT02641379|520806119|FG002|Overall Study|PCR positive at Week 24|62|||
144437247|NCT02641379|520806120|FG003|Overall Study|PCR positive at Week 24|0|||
144437248|NCT02641379|520806121|FG004|Overall Study|PCR positive at Week 24|0|||
144437249|NCT02641379|520806122|FG005|Overall Study|PCR positive at Week 24|6|||
144437250|NCT02641379|520806123|FG006|Overall Study|PCR positive at Week 24|3|||
144437251|NCT02641379|520806124|FG007|Overall Study|PCR positive at Week 24|8|||
144437252|NCT02641379|520806125|FG008|Overall Study|PCR positive at Week 24|0|||
144437253|NCT02641379|520806126|FG009|Overall Study|PCR positive at Week 24|1|||
144437254|NCT02641379|520806127|FG010|Overall Study|PCR positive at Week 24|0|||
144437255|NCT02641379|520806117|FG000|Overall Study|PCR positive at follow up 2|1|||
144437256|NCT02641379|520806118|FG001|Overall Study|PCR positive at follow up 2|0|||
144437257|NCT02641379|520806119|FG002|Overall Study|PCR positive at follow up 2|0|||
144437258|NCT02641379|520806120|FG003|Overall Study|PCR positive at follow up 2|0|||
144437259|NCT02641379|520806121|FG004|Overall Study|PCR positive at follow up 2|0|||
144437260|NCT02641379|520806122|FG005|Overall Study|PCR positive at follow up 2|0|||
144437261|NCT02641379|520806123|FG006|Overall Study|PCR positive at follow up 2|0|||
144437262|NCT02641379|520806124|FG007|Overall Study|PCR positive at follow up 2|0|||
144437263|NCT02641379|520806125|FG008|Overall Study|PCR positive at follow up 2|0|||
144437264|NCT02641379|520806126|FG009|Overall Study|PCR positive at follow up 2|0|||
144437265|NCT02641379|520806127|FG010|Overall Study|PCR positive at follow up 2|0|||
144437266|NCT02641379|520806117|FG000|Overall Study|Participant showed relapse|1|||
144437267|NCT02641379|520806118|FG001|Overall Study|Participant showed relapse|0|||
144437268|NCT02641379|520806119|FG002|Overall Study|Participant showed relapse|0|||
144437269|NCT02641379|520806120|FG003|Overall Study|Participant showed relapse|0|||
144437270|NCT02641379|520806121|FG004|Overall Study|Participant showed relapse|0|||
144437271|NCT02641379|520806122|FG005|Overall Study|Participant showed relapse|0|||
144437272|NCT02641379|520806123|FG006|Overall Study|Participant showed relapse|1|||
144437273|NCT02641379|520806124|FG007|Overall Study|Participant showed relapse|0|||
144437274|NCT02641379|520806125|FG008|Overall Study|Participant showed relapse|0|||
144437275|NCT02641379|520806126|FG009|Overall Study|Participant showed relapse|0|||
144437276|NCT02641379|520806127|FG010|Overall Study|Participant showed relapse|0|||
144437277|NCT02641379|520806117|FG000|Overall Study|Participant stopped study/treatment|1|||
144437278|NCT02641379|520806118|FG001|Overall Study|Participant stopped study/treatment|3|||
144437279|NCT02641379|520806119|FG002|Overall Study|Participant stopped study/treatment|1|||
144437280|NCT02641379|520806120|FG003|Overall Study|Participant stopped study/treatment|0|||
144437281|NCT02641379|520806121|FG004|Overall Study|Participant stopped study/treatment|0|||
144437282|NCT02641379|520806122|FG005|Overall Study|Participant stopped study/treatment|1|||
144437283|NCT02641379|520806123|FG006|Overall Study|Participant stopped study/treatment|2|||
144437284|NCT02641379|520806124|FG007|Overall Study|Participant stopped study/treatment|0|||
144437285|NCT02641379|520806125|FG008|Overall Study|Participant stopped study/treatment|1|||
144437286|NCT02641379|520806126|FG009|Overall Study|Participant stopped study/treatment|0|||
144437287|NCT02641379|520806127|FG010|Overall Study|Participant stopped study/treatment|0|||
144437288|NCT02641379|520806117|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
144437289|NCT02641379|520806118|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
144437290|NCT02641379|520806119|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
144437291|NCT02641379|520806120|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
144437292|NCT02641379|520806121|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
144437293|NCT02641379|520806122|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
144437294|NCT02641379|520806123|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
144437295|NCT02641379|520806124|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
144437296|NCT02641379|520806125|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
144437297|NCT02641379|520806126|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
144437298|NCT02641379|520806127|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
144437299|NCT02641379|520806117|FG000|Overall Study|Financial problems|0|||
144437300|NCT02641379|520806118|FG001|Overall Study|Financial problems|1|||
144437301|NCT02641379|520806119|FG002|Overall Study|Financial problems|0|||
144437302|NCT02641379|520806120|FG003|Overall Study|Financial problems|0|||
144437303|NCT02641379|520806121|FG004|Overall Study|Financial problems|0|||
144437304|NCT02641379|520806122|FG005|Overall Study|Financial problems|0|||
144437305|NCT02641379|520806123|FG006|Overall Study|Financial problems|0|||
144437306|NCT02641379|520806124|FG007|Overall Study|Financial problems|0|||
144437307|NCT02641379|520806125|FG008|Overall Study|Financial problems|0|||
144437308|NCT02641379|520806126|FG009|Overall Study|Financial problems|0|||
144437309|NCT02641379|520806127|FG010|Overall Study|Financial problems|0|||
144437310|NCT02641379|520806117|FG000|Overall Study|PCR positive at Week 68|0|||
144437311|NCT02641379|520806118|FG001|Overall Study|PCR positive at Week 68|1|||
144437312|NCT02641379|520806119|FG002|Overall Study|PCR positive at Week 68|0|||
144437313|NCT02641379|520806120|FG003|Overall Study|PCR positive at Week 68|0|||
144437314|NCT02641379|520806121|FG004|Overall Study|PCR positive at Week 68|0|||
144437315|NCT02641379|520806122|FG005|Overall Study|PCR positive at Week 68|0|||
144437316|NCT02641379|520806123|FG006|Overall Study|PCR positive at Week 68|0|||
144437317|NCT02641379|520806124|FG007|Overall Study|PCR positive at Week 68|0|||
144437318|NCT02641379|520806125|FG008|Overall Study|PCR positive at Week 68|0|||
144437319|NCT02641379|520806126|FG009|Overall Study|PCR positive at Week 68|0|||
144437320|NCT02641379|520806127|FG010|Overall Study|PCR positive at Week 68|0|||
144437321|NCT02641379|520806117|FG000|Overall Study|PCR positive at Week 48|0|||
144437322|NCT02641379|520806118|FG001|Overall Study|PCR positive at Week 48|1|||
144437323|NCT02641379|520806119|FG002|Overall Study|PCR positive at Week 48|0|||
144437324|NCT02641379|520806120|FG003|Overall Study|PCR positive at Week 48|0|||
144437325|NCT02641379|520806121|FG004|Overall Study|PCR positive at Week 48|0|||
144437326|NCT02641379|520806122|FG005|Overall Study|PCR positive at Week 48|0|||
144437327|NCT02641379|520806123|FG006|Overall Study|PCR positive at Week 48|0|||
144437328|NCT02641379|520806124|FG007|Overall Study|PCR positive at Week 48|0|||
144437329|NCT02641379|520806125|FG008|Overall Study|PCR positive at Week 48|0|||
144437330|NCT02641379|520806126|FG009|Overall Study|PCR positive at Week 48|0|||
144437331|NCT02641379|520806127|FG010|Overall Study|PCR positive at Week 48|0|||
144437332|NCT02641379|520806117|FG000|Overall Study|PCR not performed at Week 12|0|||
144437333|NCT02641379|520806118|FG001|Overall Study|PCR not performed at Week 12|0|||
144437334|NCT02641379|520806119|FG002|Overall Study|PCR not performed at Week 12|1|||
144437335|NCT02641379|520806120|FG003|Overall Study|PCR not performed at Week 12|0|||
144437336|NCT02641379|520806121|FG004|Overall Study|PCR not performed at Week 12|0|||
144437337|NCT02641379|520806122|FG005|Overall Study|PCR not performed at Week 12|0|||
144437338|NCT02641379|520806123|FG006|Overall Study|PCR not performed at Week 12|0|||
144437339|NCT02641379|520806124|FG007|Overall Study|PCR not performed at Week 12|0|||
144437340|NCT02641379|520806125|FG008|Overall Study|PCR not performed at Week 12|0|||
144437341|NCT02641379|520806126|FG009|Overall Study|PCR not performed at Week 12|0|||
144437342|NCT02641379|520806127|FG010|Overall Study|PCR not performed at Week 12|0|||
144437343|NCT02641379|520806117|FG000|Overall Study|No PCR at baseline|0|||
144437344|NCT02641379|520806118|FG001|Overall Study|No PCR at baseline|0|||
144437345|NCT02641379|520806119|FG002|Overall Study|No PCR at baseline|1|||
144437346|NCT02641379|520806120|FG003|Overall Study|No PCR at baseline|0|||
144437347|NCT02641379|520806121|FG004|Overall Study|No PCR at baseline|0|||
144437348|NCT02641379|520806122|FG005|Overall Study|No PCR at baseline|0|||
144437349|NCT02641379|520806123|FG006|Overall Study|No PCR at baseline|0|||
144437350|NCT02641379|520806124|FG007|Overall Study|No PCR at baseline|0|||
144437351|NCT02641379|520806125|FG008|Overall Study|No PCR at baseline|0|||
144437352|NCT02641379|520806126|FG009|Overall Study|No PCR at baseline|0|||
144437353|NCT02641379|520806127|FG010|Overall Study|No PCR at baseline|0|||
144437354|NCT02641379|520806117|FG000|Overall Study|PCR positive at Week 28|0|||
144437355|NCT02641379|520806118|FG001|Overall Study|PCR positive at Week 28|0|||
144437356|NCT02641379|520806119|FG002|Overall Study|PCR positive at Week 28|1|||
144437357|NCT02641379|520806120|FG003|Overall Study|PCR positive at Week 28|0|||
144437358|NCT02641379|520806121|FG004|Overall Study|PCR positive at Week 28|0|||
144437359|NCT02641379|520806122|FG005|Overall Study|PCR positive at Week 28|0|||
144530333|NCT04625725|521144343|FG000|Provent Main Study|Lost to Follow-up|357|||
144437360|NCT02641379|520806123|FG006|Overall Study|PCR positive at Week 28|0|||
144530334|NCT04625725|521144344|FG001|Provent Main Study|Lost to Follow-up|200|||
144437361|NCT02641379|520806124|FG007|Overall Study|PCR positive at Week 28|0|||
144437362|NCT02641379|520806125|FG008|Overall Study|PCR positive at Week 28|0|||
144437363|NCT02641379|520806126|FG009|Overall Study|PCR positive at Week 28|0|||
144437364|NCT02641379|520806127|FG010|Overall Study|PCR positive at Week 28|0|||
144437365|NCT02641379|520806117|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
144437366|NCT02641379|520806118|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
144530335|NCT04625725|521144345|FG002|Provent Main Study|Lost to Follow-up|0|||
144437367|NCT02641379|520806119|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
144437368|NCT02641379|520806120|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
144437369|NCT02641379|520806121|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
144437370|NCT02641379|520806122|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
144530336|NCT04625725|521144346|FG003|Provent Main Study|Lost to Follow-up|0|||
144530337|NCT04625725|521144347|FG004|Provent Main Study|Lost to Follow-up|0|||
144530338|NCT04625725|521144348|FG005|Provent Main Study|Lost to Follow-up|0|||
144530339|NCT04625725|521144343|FG000|Provent Main Study|Death|22|||
144530340|NCT04625725|521144344|FG001|Provent Main Study|Death|10|||
144530341|NCT04625725|521144345|FG002|Provent Main Study|Death|0|||
144530342|NCT04625725|521144346|FG003|Provent Main Study|Death|0|||
144530343|NCT04625725|521144347|FG004|Provent Main Study|Death|0|||
144530344|NCT04625725|521144348|FG005|Provent Main Study|Death|0|||
144530345|NCT04625725|521144343|FG000|Provent Main Study|Adverse Event|2|||
144530346|NCT04625725|521144344|FG001|Provent Main Study|Adverse Event|1|||
144530347|NCT04625725|521144345|FG002|Provent Main Study|Adverse Event|0|||
144530348|NCT04625725|521144346|FG003|Provent Main Study|Adverse Event|0|||
144530349|NCT04625725|521144347|FG004|Provent Main Study|Adverse Event|0|||
144530350|NCT04625725|521144348|FG005|Provent Main Study|Adverse Event|0|||
144530351|NCT04625725|521144343|FG000|Provent Main Study|Participants dosed in sub-study|310|||
144530352|NCT04625725|521144344|FG001|Provent Main Study|Participants dosed in sub-study|193|||
144530353|NCT04625725|521144345|FG002|Provent Main Study|Participants dosed in sub-study|0|||
144530354|NCT04625725|521144346|FG003|Provent Main Study|Participants dosed in sub-study|0|||
144530355|NCT04625725|521144347|FG004|Provent Main Study|Participants dosed in sub-study|0|||
144530356|NCT04625725|521144348|FG005|Provent Main Study|Participants dosed in sub-study|0|||
144530357|NCT04625725|521144343|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
144530358|NCT04625725|521144344|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
144530359|NCT04625725|521144345|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
144530360|NCT04625725|521144346|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
144530361|NCT04625725|521144347|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
144530362|NCT04625725|521144348|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
144530363|NCT04625725|521144343|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
144530364|NCT04625725|521144344|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
144530365|NCT04625725|521144345|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
144530366|NCT04625725|521144346|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
144530367|NCT04625725|521144347|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
144530368|NCT04625725|521144348|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
144530369|NCT04625725|521144343|FG000|Provent Main Study|INCARCERATION|3|||
144530370|NCT04625725|521144344|FG001|Provent Main Study|INCARCERATION|0|||
144530371|NCT04625725|521144345|FG002|Provent Main Study|INCARCERATION|0|||
144530372|NCT04625725|521144346|FG003|Provent Main Study|INCARCERATION|0|||
144530373|NCT04625725|521144347|FG004|Provent Main Study|INCARCERATION|0|||
144530374|NCT04625725|521144348|FG005|Provent Main Study|INCARCERATION|0|||
144530375|NCT04625725|521144343|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
144530376|NCT04625725|521144344|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
144530377|NCT04625725|521144345|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
144530378|NCT04625725|521144346|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
144530379|NCT04625725|521144347|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
144530380|NCT04625725|521144348|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
144530381|NCT04625725|521144343|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
144530382|NCT04625725|521144344|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
144530383|NCT04625725|521144345|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
144530384|NCT04625725|521144346|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
144530385|NCT04625725|521144347|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
144530386|NCT04625725|521144348|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
144530387|NCT04625725|521144343|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
144530388|NCT04625725|521144344|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
144530389|NCT04625725|521144345|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
144530390|NCT04625725|521144346|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
144530391|NCT04625725|521144347|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
144530392|NCT04625725|521144348|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
144530393|NCT04625725|521144343|FG000|Provent Main Study|MISSING REASON|0|||
144530394|NCT04625725|521144344|FG001|Provent Main Study|MISSING REASON|1|||
144530395|NCT04625725|521144345|FG002|Provent Main Study|MISSING REASON|0|||
144530396|NCT04625725|521144346|FG003|Provent Main Study|MISSING REASON|0|||
144530397|NCT04625725|521144347|FG004|Provent Main Study|MISSING REASON|0|||
144530398|NCT04625725|521144348|FG005|Provent Main Study|MISSING REASON|0|||
144530399|NCT04625725|521144343|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
144530400|NCT04625725|521144344|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
144530401|NCT04625725|521144345|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
144530402|NCT04625725|521144346|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
144253482|NCT00582426|520128078|FG000|Overall Study|Death|4|||
144530403|NCT04625725|521144347|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
144530404|NCT04625725|521144348|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
144530405|NCT04625725|521144343|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
144530406|NCT04625725|521144344|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
144604711|NCT02877927|521414388|FG001|Overall Study|Physician Decision|1|||
144253483|NCT00582426|520128079|FG001|Overall Study|Death|3|||
144604712|NCT02877927|521414387|FG000|Overall Study|Missed EOT/PTE Visit|5|||
144604713|NCT02877927|521414388|FG001|Overall Study|Missed EOT/PTE Visit|6|||
144604714|NCT00601250|521414389|FG000|Overall Study|Adverse Event|3|||
144604715|NCT00601250|521414390|FG001|Overall Study|Adverse Event|9|||
144604716|NCT00601250|521414389|FG000|Overall Study|Protocol Violation|3|||
144604717|NCT00601250|521414390|FG001|Overall Study|Protocol Violation|2|||
144604718|NCT00601250|521414389|FG000|Overall Study|Lost to Follow-up|2|||
144604719|NCT00601250|521414390|FG001|Overall Study|Lost to Follow-up|6|||
144604720|NCT00601250|521414389|FG000|Overall Study|Withdrawal by Subject|4|||
144604721|NCT00601250|521414390|FG001|Overall Study|Withdrawal by Subject|13|||
144437371|NCT02641379|520806123|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
144437372|NCT02641379|520806124|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
144437373|NCT02641379|520806125|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
144437374|NCT02641379|520806126|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
144437375|NCT02641379|520806127|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
144437376|NCT02641379|520806117|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
144437377|NCT02641379|520806118|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
144437378|NCT02641379|520806119|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
144437379|NCT02641379|520806120|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
144437380|NCT02641379|520806121|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
144437381|NCT02641379|520806122|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
144437382|NCT02641379|520806123|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
144437383|NCT02641379|520806124|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
144437384|NCT02641379|520806125|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
144437385|NCT02641379|520806126|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
144437386|NCT02641379|520806127|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
144437387|NCT02641379|520806117|FG000|Overall Study|Baseline viral load unavailable|0|||
144437388|NCT02641379|520806118|FG001|Overall Study|Baseline viral load unavailable|0|||
144437389|NCT02641379|520806119|FG002|Overall Study|Baseline viral load unavailable|0|||
144437390|NCT02641379|520806120|FG003|Overall Study|Baseline viral load unavailable|1|||
144437391|NCT02641379|520806121|FG004|Overall Study|Baseline viral load unavailable|0|||
144437392|NCT02641379|520806122|FG005|Overall Study|Baseline viral load unavailable|0|||
144437393|NCT02641379|520806123|FG006|Overall Study|Baseline viral load unavailable|0|||
144437394|NCT02641379|520806124|FG007|Overall Study|Baseline viral load unavailable|0|||
144437395|NCT02641379|520806125|FG008|Overall Study|Baseline viral load unavailable|0|||
144437396|NCT02641379|520806126|FG009|Overall Study|Baseline viral load unavailable|0|||
144437397|NCT02641379|520806127|FG010|Overall Study|Baseline viral load unavailable|0|||
144437398|NCT02641379|520806117|FG000|Overall Study|Blood could not be drawn|0|||
144437399|NCT02641379|520806118|FG001|Overall Study|Blood could not be drawn|0|||
144437400|NCT02641379|520806119|FG002|Overall Study|Blood could not be drawn|0|||
144437401|NCT02641379|520806120|FG003|Overall Study|Blood could not be drawn|0|||
144437402|NCT02641379|520806121|FG004|Overall Study|Blood could not be drawn|1|||
144437403|NCT02641379|520806122|FG005|Overall Study|Blood could not be drawn|0|||
144437404|NCT02641379|520806123|FG006|Overall Study|Blood could not be drawn|0|||
144437405|NCT02641379|520806124|FG007|Overall Study|Blood could not be drawn|0|||
144437406|NCT02641379|520806125|FG008|Overall Study|Blood could not be drawn|0|||
144437407|NCT02641379|520806126|FG009|Overall Study|Blood could not be drawn|0|||
144437408|NCT02641379|520806127|FG010|Overall Study|Blood could not be drawn|0|||
144437409|NCT02641379|520806117|FG000|Overall Study|Protocol Violation|0|||
144437410|NCT02641379|520806118|FG001|Overall Study|Protocol Violation|0|||
144437411|NCT02641379|520806119|FG002|Overall Study|Protocol Violation|0|||
144437412|NCT02641379|520806120|FG003|Overall Study|Protocol Violation|0|||
144437413|NCT02641379|520806121|FG004|Overall Study|Protocol Violation|2|||
144437414|NCT02641379|520806122|FG005|Overall Study|Protocol Violation|0|||
144437415|NCT02641379|520806123|FG006|Overall Study|Protocol Violation|0|||
144437416|NCT02641379|520806124|FG007|Overall Study|Protocol Violation|0|||
144437417|NCT02641379|520806125|FG008|Overall Study|Protocol Violation|1|||
144437418|NCT02641379|520806126|FG009|Overall Study|Protocol Violation|0|||
144437419|NCT02641379|520806127|FG010|Overall Study|Protocol Violation|0|||
144437420|NCT02641379|520806117|FG000|Overall Study|Participation in sili rescue study|0|||
144437421|NCT02641379|520806118|FG001|Overall Study|Participation in sili rescue study|0|||
144437422|NCT02641379|520806119|FG002|Overall Study|Participation in sili rescue study|0|||
144437423|NCT02641379|520806120|FG003|Overall Study|Participation in sili rescue study|0|||
144437424|NCT02641379|520806121|FG004|Overall Study|Participation in sili rescue study|0|||
144437425|NCT02641379|520806122|FG005|Overall Study|Participation in sili rescue study|1|||
144437426|NCT02641379|520806123|FG006|Overall Study|Participation in sili rescue study|0|||
144437427|NCT02641379|520806124|FG007|Overall Study|Participation in sili rescue study|0|||
144437428|NCT02641379|520806125|FG008|Overall Study|Participation in sili rescue study|0|||
144437429|NCT02641379|520806126|FG009|Overall Study|Participation in sili rescue study|0|||
144437430|NCT02641379|520806127|FG010|Overall Study|Participation in sili rescue study|0|||
144437431|NCT02641379|520806117|FG000|Overall Study|Lost to Follow-up|0|||
144437432|NCT02641379|520806118|FG001|Overall Study|Lost to Follow-up|0|||
144437433|NCT02641379|520806119|FG002|Overall Study|Lost to Follow-up|0|||
144604722|NCT00601250|521414389|FG000|Overall Study|Other incl. lack of efficacy|2|||
144437434|NCT02641379|520806120|FG003|Overall Study|Lost to Follow-up|0|||
144437435|NCT02641379|520806121|FG004|Overall Study|Lost to Follow-up|0|||
144437436|NCT02641379|520806122|FG005|Overall Study|Lost to Follow-up|0|||
144437437|NCT02641379|520806123|FG006|Overall Study|Lost to Follow-up|0|||
144437438|NCT02641379|520806124|FG007|Overall Study|Lost to Follow-up|0|||
144437439|NCT02641379|520806125|FG008|Overall Study|Lost to Follow-up|1|||
144437440|NCT02641379|520806126|FG009|Overall Study|Lost to Follow-up|0|||
144437441|NCT02641379|520806127|FG010|Overall Study|Lost to Follow-up|0|||
144437442|NCT02641379|520806117|FG000|Overall Study|Source data not found|0|||
144437443|NCT02641379|520806118|FG001|Overall Study|Source data not found|0|||
144437444|NCT02641379|520806119|FG002|Overall Study|Source data not found|0|||
144437445|NCT02641379|520806120|FG003|Overall Study|Source data not found|0|||
144437446|NCT02641379|520806121|FG004|Overall Study|Source data not found|0|||
144437447|NCT02641379|520806122|FG005|Overall Study|Source data not found|1|||
144437448|NCT02641379|520806123|FG006|Overall Study|Source data not found|0|||
144437449|NCT02641379|520806124|FG007|Overall Study|Source data not found|0|||
144437450|NCT02641379|520806125|FG008|Overall Study|Source data not found|0|||
144437451|NCT02641379|520806126|FG009|Overall Study|Source data not found|0|||
144437452|NCT02641379|520806127|FG010|Overall Study|Source data not found|0|||
144437453|NCT02641379|520806117|FG000|Overall Study|Participant showed weight reduction|0|||
144437454|NCT02641379|520806118|FG001|Overall Study|Participant showed weight reduction|0|||
144437455|NCT02641379|520806119|FG002|Overall Study|Participant showed weight reduction|0|||
144437456|NCT02641379|520806120|FG003|Overall Study|Participant showed weight reduction|0|||
144437457|NCT02641379|520806121|FG004|Overall Study|Participant showed weight reduction|0|||
144437458|NCT02641379|520806122|FG005|Overall Study|Participant showed weight reduction|0|||
144437459|NCT02641379|520806123|FG006|Overall Study|Participant showed weight reduction|0|||
144437460|NCT02641379|520806124|FG007|Overall Study|Participant showed weight reduction|1|||
144437461|NCT02641379|520806125|FG008|Overall Study|Participant showed weight reduction|0|||
144437462|NCT02641379|520806126|FG009|Overall Study|Participant showed weight reduction|0|||
144437463|NCT02641379|520806127|FG010|Overall Study|Participant showed weight reduction|0|||
144437464|NCT02641379|520806117|FG000|Overall Study|Non-response Week 12|0|||
144437465|NCT02641379|520806118|FG001|Overall Study|Non-response Week 12|0|||
144437466|NCT02641379|520806119|FG002|Overall Study|Non-response Week 12|0|||
144437467|NCT02641379|520806120|FG003|Overall Study|Non-response Week 12|0|||
144437468|NCT02641379|520806121|FG004|Overall Study|Non-response Week 12|0|||
144437469|NCT02641379|520806122|FG005|Overall Study|Non-response Week 12|0|||
144437470|NCT02641379|520806123|FG006|Overall Study|Non-response Week 12|0|||
144437471|NCT02641379|520806124|FG007|Overall Study|Non-response Week 12|1|||
144437472|NCT02641379|520806125|FG008|Overall Study|Non-response Week 12|0|||
144437473|NCT02641379|520806126|FG009|Overall Study|Non-response Week 12|0|||
144437474|NCT02641379|520806127|FG010|Overall Study|Non-response Week 12|0|||
144437475|NCT02641379|520806117|FG000|Overall Study|No 2 Log drop at Week 12|0|||
144437476|NCT02641379|520806118|FG001|Overall Study|No 2 Log drop at Week 12|0|||
144437477|NCT02641379|520806119|FG002|Overall Study|No 2 Log drop at Week 12|0|||
144437478|NCT02641379|520806120|FG003|Overall Study|No 2 Log drop at Week 12|0|||
144437479|NCT02641379|520806121|FG004|Overall Study|No 2 Log drop at Week 12|0|||
144437480|NCT02641379|520806122|FG005|Overall Study|No 2 Log drop at Week 12|0|||
144437481|NCT02641379|520806123|FG006|Overall Study|No 2 Log drop at Week 12|0|||
144437482|NCT02641379|520806124|FG007|Overall Study|No 2 Log drop at Week 12|0|||
144437483|NCT02641379|520806125|FG008|Overall Study|No 2 Log drop at Week 12|0|||
144437484|NCT02641379|520806126|FG009|Overall Study|No 2 Log drop at Week 12|0|||
144437485|NCT02641379|520806127|FG010|Overall Study|No 2 Log drop at Week 12|1|||
144437486|NCT02641379|520806117|FG000|Overall Study|Negative PCR result|0|||
144437487|NCT02641379|520806118|FG001|Overall Study|Negative PCR result|0|||
144437488|NCT02641379|520806119|FG002|Overall Study|Negative PCR result|0|||
144437489|NCT02641379|520806120|FG003|Overall Study|Negative PCR result|0|||
144437490|NCT02641379|520806121|FG004|Overall Study|Negative PCR result|0|||
144437491|NCT02641379|520806122|FG005|Overall Study|Negative PCR result|0|||
144437492|NCT02641379|520806123|FG006|Overall Study|Negative PCR result|0|||
144437493|NCT02641379|520806124|FG007|Overall Study|Negative PCR result|0|||
144437494|NCT02641379|520806125|FG008|Overall Study|Negative PCR result|0|||
144437495|NCT02641379|520806126|FG009|Overall Study|Negative PCR result|1|||
144437496|NCT02641379|520806127|FG010|Overall Study|Negative PCR result|0|||
144530407|NCT04625725|521144345|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
144530408|NCT04625725|521144346|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
144437497|NCT02641379|520806117|FG000|Overall Study|Participant's PCR high|0|||
144437498|NCT02641379|520806118|FG001|Overall Study|Participant's PCR high|0|||
144437499|NCT02641379|520806119|FG002|Overall Study|Participant's PCR high|0|||
144437500|NCT02641379|520806120|FG003|Overall Study|Participant's PCR high|0|||
144437501|NCT02641379|520806121|FG004|Overall Study|Participant's PCR high|0|||
144437502|NCT02641379|520806122|FG005|Overall Study|Participant's PCR high|0|||
144437503|NCT02641379|520806123|FG006|Overall Study|Participant's PCR high|0|||
144437504|NCT02641379|520806124|FG007|Overall Study|Participant's PCR high|1|||
144437505|NCT02641379|520806125|FG008|Overall Study|Participant's PCR high|0|||
144437506|NCT02641379|520806126|FG009|Overall Study|Participant's PCR high|0|||
144437507|NCT02641379|520806127|FG010|Overall Study|Participant's PCR high|0|||
144437508|NCT02641379|520806117|FG000|Overall Study|Participant treated after Week 24|0|||
144437509|NCT02641379|520806118|FG001|Overall Study|Participant treated after Week 24|0|||
144437510|NCT02641379|520806119|FG002|Overall Study|Participant treated after Week 24|0|||
144437511|NCT02641379|520806120|FG003|Overall Study|Participant treated after Week 24|0|||
144437512|NCT02641379|520806121|FG004|Overall Study|Participant treated after Week 24|0|||
144437513|NCT02641379|520806122|FG005|Overall Study|Participant treated after Week 24|0|||
144437514|NCT02641379|520806123|FG006|Overall Study|Participant treated after Week 24|0|||
144437515|NCT02641379|520806124|FG007|Overall Study|Participant treated after Week 24|0|||
144437516|NCT02641379|520806125|FG008|Overall Study|Participant treated after Week 24|1|||
144437517|NCT02641379|520806126|FG009|Overall Study|Participant treated after Week 24|0|||
144437518|NCT02641379|520806127|FG010|Overall Study|Participant treated after Week 24|0|||
144437519|NCT02641379|520806117|FG000|Overall Study|Missing PCR result at Week 8|0|||
144437520|NCT02641379|520806118|FG001|Overall Study|Missing PCR result at Week 8|0|||
144437521|NCT02641379|520806119|FG002|Overall Study|Missing PCR result at Week 8|0|||
144437522|NCT02641379|520806120|FG003|Overall Study|Missing PCR result at Week 8|0|||
144437523|NCT02641379|520806121|FG004|Overall Study|Missing PCR result at Week 8|0|||
144437524|NCT02641379|520806122|FG005|Overall Study|Missing PCR result at Week 8|0|||
144437525|NCT02641379|520806123|FG006|Overall Study|Missing PCR result at Week 8|0|||
144437526|NCT02641379|520806124|FG007|Overall Study|Missing PCR result at Week 8|0|||
144437527|NCT02641379|520806125|FG008|Overall Study|Missing PCR result at Week 8|0|||
144437528|NCT02641379|520806126|FG009|Overall Study|Missing PCR result at Week 8|1|||
144437529|NCT02641379|520806127|FG010|Overall Study|Missing PCR result at Week 8|0|||
144437530|NCT02641379|520806117|FG000|Overall Study|PCR positive|0|||
144437531|NCT02641379|520806118|FG001|Overall Study|PCR positive|0|||
144437532|NCT02641379|520806119|FG002|Overall Study|PCR positive|0|||
144437533|NCT02641379|520806120|FG003|Overall Study|PCR positive|0|||
144437534|NCT02641379|520806121|FG004|Overall Study|PCR positive|0|||
144437535|NCT02641379|520806122|FG005|Overall Study|PCR positive|0|||
144437536|NCT02641379|520806123|FG006|Overall Study|PCR positive|1|||
144437537|NCT02641379|520806124|FG007|Overall Study|PCR positive|0|||
144437538|NCT02641379|520806125|FG008|Overall Study|PCR positive|0|||
144437539|NCT02641379|520806126|FG009|Overall Study|PCR positive|0|||
144437540|NCT02641379|520806127|FG010|Overall Study|PCR positive|0|||
144437541|NCT03568942|520807672|FG000|Overall Study|Family emergency|1|||
144437542|NCT03568942|520807672|FG000|Overall Study|Lost to Follow-up|1|||
144437543|NCT04200248|520807676|FG000|Overall Study|Personal reasons|0|||
144437544|NCT04200248|520807677|FG001|Overall Study|Personal reasons|0|||
144437545|NCT04200248|520807678|FG002|Overall Study|Personal reasons|1|||
144437546|NCT04200248|520807676|FG000|Overall Study|Discontinued prior to treatment|3|||
144437547|NCT04200248|520807677|FG001|Overall Study|Discontinued prior to treatment|3|||
144437548|NCT04200248|520807678|FG002|Overall Study|Discontinued prior to treatment|2|||
144437549|NCT02433834|520807685|FG000|Overall Study|Protocol-specified criteria|7|||
144437550|NCT02433834|520807685|FG000|Overall Study|Protocol Violation|3|||
144437551|NCT02433834|520807685|FG000|Overall Study|Lost to Follow-up|6|||
144437552|NCT02433834|520807685|FG000|Overall Study|Withdrawal by Subject|14|||
144437553|NCT02433834|520807685|FG000|Overall Study|Adverse Event|6|||
144437554|NCT02433834|520807685|FG000|Overall Study|Physician Decision|1|||
144437555|NCT02223767|520807686|FG000|Overall Study|Withdrawal by Subject|4|||
144437556|NCT02223767|520807687|FG001|Overall Study|Withdrawal by Subject|4|||
144437557|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
144530409|NCT04625725|521144347|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
144530410|NCT04625725|521144348|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
144530411|NCT04625725|521144343|FG000|Provent Sub Study|Lost to Follow-up|0|||
144530412|NCT04625725|521144344|FG001|Provent Sub Study|Lost to Follow-up|0|||
144530413|NCT04625725|521144345|FG002|Provent Sub Study|Lost to Follow-up|20|||
144530414|NCT04625725|521144346|FG003|Provent Sub Study|Lost to Follow-up|10|||
144530415|NCT04625725|521144347|FG004|Provent Sub Study|Lost to Follow-up|6|||
144530416|NCT04625725|521144348|FG005|Provent Sub Study|Lost to Follow-up|4|||
144530417|NCT04625725|521144343|FG000|Provent Sub Study|Death|0|||
144530418|NCT04625725|521144344|FG001|Provent Sub Study|Death|0|||
144530419|NCT04625725|521144345|FG002|Provent Sub Study|Death|8|||
144530420|NCT04625725|521144346|FG003|Provent Sub Study|Death|5|||
144530421|NCT04625725|521144347|FG004|Provent Sub Study|Death|0|||
144530422|NCT04625725|521144348|FG005|Provent Sub Study|Death|1|||
144530423|NCT04625725|521144343|FG000|Provent Sub Study|Adverse Event|0|||
144530424|NCT04625725|521144344|FG001|Provent Sub Study|Adverse Event|0|||
144530425|NCT04625725|521144345|FG002|Provent Sub Study|Adverse Event|0|||
144437558|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
144724334|NCT01505530|521846341|FG001|Overall Study|Progressive Disease|17|||
144437559|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
144437560|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
144437561|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
144530426|NCT04625725|521144346|FG003|Provent Sub Study|Adverse Event|0|||
144530427|NCT04625725|521144347|FG004|Provent Sub Study|Adverse Event|0|||
144437562|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
144437563|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
144437564|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
144437565|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
144437566|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
144437567|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
144437568|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
144437569|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
144437570|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
144437571|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
144437572|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
144437573|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
144437574|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
144437575|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
144437576|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
144437577|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
144437578|NCT00934544|520807690|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
144437579|NCT00934544|520807691|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
144437580|NCT00934544|520807692|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
144437581|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
144437582|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
144437583|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
144437584|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
144437585|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
144437586|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
144437587|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
144437588|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
144437589|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
144437590|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
144437591|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
144437592|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
144437593|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
144437594|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
144437595|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
144437596|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
144437597|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
144437598|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
144437599|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
144437600|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
144437601|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
144437602|NCT00934544|520807690|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
144437603|NCT00934544|520807691|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
144437604|NCT00934544|520807692|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
144437605|NCT00302003|520807693|FG000|Overall Study|Lack of Efficacy|62|||
144437606|NCT00302003|520807693|FG000|Overall Study|Lost to Follow-up|1|||
144437607|NCT00302003|520807693|FG000|Overall Study|Physician Decision|2|||
144437608|NCT00302003|520807693|FG000|Overall Study|Withdrawal by Subject|5|||
144188292|NCT02412722|519882972|FG001|Overall Study|Received drug in run-in and discontinued|2|||
144188293|NCT02412722|519882973|FG002|Overall Study|Received drug in run-in and discontinued|0|||
144188294|NCT02412722|519882974|FG003|Overall Study|Received drug in run-in and discontinued|0|||
144188295|NCT02412722|519882975|FG004|Overall Study|Received drug in run-in and discontinued|0|||
144188296|NCT02412722|519882976|FG005|Overall Study|Received drug in run-in and discontinued|0|||
144188297|NCT02412722|519882971|FG000|Overall Study|Reason not Specified|3|||
144188298|NCT02412722|519882972|FG001|Overall Study|Reason not Specified|0|||
144188299|NCT02412722|519882973|FG002|Overall Study|Reason not Specified|2|||
144188300|NCT02412722|519882974|FG003|Overall Study|Reason not Specified|1|||
144188301|NCT02412722|519882975|FG004|Overall Study|Reason not Specified|2|||
144188302|NCT02412722|519882976|FG005|Overall Study|Reason not Specified|6|||
144188303|NCT04449341|519882979|FG000|Overall Study|Protocol Violation|1|||
144188304|NCT04449341|519882980|FG001|Overall Study|Protocol Violation|0|||
144188305|NCT04499482|519882981|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
144188306|NCT04330157|519882982|FG000|Overall Study|Protocol Violation|4|||
144188307|NCT04330157|519882982|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
144188308|NCT04314843|519882983|FG000|Overall Study|Death|2|||
144188309|NCT04314843|519882984|FG001|Overall Study|Death|2|||
144188310|NCT04314843|519882983|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
144188311|NCT04314843|519882984|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
144437609|NCT00302003|520807693|FG000|Overall Study|Ineligible|9|||
144437610|NCT00302003|520807693|FG000|Overall Study|Protocol Violation|1|||
144437611|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
144437612|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
144437613|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
144437614|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
144437615|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
144437616|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
144437617|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
144437618|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
144437619|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
144437620|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
144437621|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
144437622|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
144437623|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
144437624|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
144437625|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
144437626|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
144437627|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
144437628|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
144437629|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
144437630|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
144437631|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
144437632|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
144437633|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
144437634|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
144437635|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
144437636|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
144437637|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
144437638|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
144437639|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
144437640|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
144437641|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
144437642|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
144437643|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
144437644|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
144437645|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
144437646|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
144437647|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
144437648|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
144437649|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
144437650|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
144437651|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
144437652|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
144437653|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
144437654|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
144437655|NCT01218516|520807694|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
144437656|NCT01218516|520807695|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
144437657|NCT01218516|520807696|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
144437658|NCT01218516|520807697|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
144437659|NCT00283439|520807698|FG000|Overall Study|Adverse Event|0|||
144437660|NCT00283439|520807699|FG001|Overall Study|Adverse Event|0|||
144437661|NCT00283439|520807700|FG002|Overall Study|Adverse Event|0|||
144437662|NCT00283439|520807701|FG003|Overall Study|Adverse Event|1|||
144437663|NCT00283439|520807698|FG000|Overall Study|Death|0|||
144437664|NCT00283439|520807699|FG001|Overall Study|Death|0|||
144188312|NCT01899326|519882985|FG000|Overall Study|Withdrawal by Subject|1|||
144188313|NCT01899326|519882985|FG000|Overall Study|Adverse Event|2|||
144188314|NCT01899326|519882985|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
144437665|NCT00283439|520807700|FG002|Overall Study|Death|1|||
144188315|NCT03558139|519882987|FG000|Overall Study|Consent Withdrawn|1|||
144437666|NCT00283439|520807701|FG003|Overall Study|Death|0|||
144437667|NCT00283439|520807698|FG000|Overall Study|Disease progression|0|||
144437668|NCT00283439|520807699|FG001|Overall Study|Disease progression|1|||
144437669|NCT00283439|520807700|FG002|Overall Study|Disease progression|0|||
144437670|NCT00283439|520807701|FG003|Overall Study|Disease progression|0|||
144437671|NCT00283439|520807698|FG000|Overall Study|Requirement for alternative therapy|1|||
144437672|NCT00283439|520807699|FG001|Overall Study|Requirement for alternative therapy|2|||
144437673|NCT00283439|520807700|FG002|Overall Study|Requirement for alternative therapy|5|||
144437674|NCT00283439|520807701|FG003|Overall Study|Requirement for alternative therapy|2|||
144437675|NCT00283439|520807698|FG000|Overall Study|Stem cell transplant|6|||
144437676|NCT00283439|520807699|FG001|Overall Study|Stem cell transplant|6|||
144437677|NCT00283439|520807700|FG002|Overall Study|Stem cell transplant|4|||
144437678|NCT00283439|520807701|FG003|Overall Study|Stem cell transplant|3|||
144437679|NCT00283439|520807698|FG000|Overall Study|Treatment discontinued|0|||
144437680|NCT00283439|520807699|FG001|Overall Study|Treatment discontinued|2|||
144437681|NCT00283439|520807700|FG002|Overall Study|Treatment discontinued|1|||
144437682|NCT00283439|520807701|FG003|Overall Study|Treatment discontinued|3|||
144437683|NCT00283439|520807698|FG000|Overall Study|Other|1|||
144437684|NCT00283439|520807699|FG001|Overall Study|Other|0|||
144437685|NCT00283439|520807700|FG002|Overall Study|Other|0|||
144437686|NCT00283439|520807701|FG003|Overall Study|Other|0|||
144437687|NCT01539226|520807702|FG000|Overall Study|Withdrawal by Subject|24|||
144437688|NCT01539226|520807703|FG001|Overall Study|Withdrawal by Subject|54|||
144437689|NCT01539226|520807702|FG000|Overall Study|Lost to Follow-up|20|||
144437690|NCT01539226|520807703|FG001|Overall Study|Lost to Follow-up|54|||
144437691|NCT01539226|520807702|FG000|Overall Study|Death|1|||
144437692|NCT01539226|520807703|FG001|Overall Study|Death|2|||
144437693|NCT01539226|520807702|FG000|Overall Study|Adverse Event|2|||
144437694|NCT01539226|520807703|FG001|Overall Study|Adverse Event|0|||
144437695|NCT01539226|520807702|FG000|Overall Study|Pregnancy|13|||
144437696|NCT01539226|520807703|FG001|Overall Study|Pregnancy|29|||
144437697|NCT01539226|520807702|FG000|Overall Study|inappropriate enrollment|0|||
144437698|NCT01539226|520807703|FG001|Overall Study|inappropriate enrollment|1|||
144437699|NCT01539226|520807702|FG000|Overall Study|Multiple Reasons|3|||
144437700|NCT01539226|520807703|FG001|Overall Study|Multiple Reasons|1|||
144437701|NCT01539226|520807702|FG000|Overall Study|not HIV seroconversion-related|93|||
144437702|NCT01539226|520807703|FG001|Overall Study|not HIV seroconversion-related|176|||
144437703|NCT01539226|520807702|FG000|Overall Study|HIV seroconversion-related|55|||
144437704|NCT01539226|520807703|FG001|Overall Study|HIV seroconversion-related|80|||
144437705|NCT01539226|520807702|FG000|Overall Study|Non-compliance|6|||
144437706|NCT01539226|520807703|FG001|Overall Study|Non-compliance|8|||
144437707|NCT02118428|520807711|FG000|Overall Study|Physician Decision|0|||
144437708|NCT02118428|520807712|FG001|Overall Study|Physician Decision|1|||
144437709|NCT02118428|520807713|FG002|Overall Study|Physician Decision|0|||
144437710|NCT02118428|520807711|FG000|Overall Study|Withdrawal by Subject|2|||
144437711|NCT02118428|520807712|FG001|Overall Study|Withdrawal by Subject|2|||
144437712|NCT02118428|520807713|FG002|Overall Study|Withdrawal by Subject|0|||
144437713|NCT02118428|520807711|FG000|Overall Study|Death|7|||
144437714|NCT02118428|520807712|FG001|Overall Study|Death|5|||
144437715|NCT02118428|520807713|FG002|Overall Study|Death|0|||
144437716|NCT02118428|520807711|FG000|Overall Study|Lost to Follow-up|3|||
144437717|NCT02118428|520807712|FG001|Overall Study|Lost to Follow-up|1|||
144437718|NCT02118428|520807713|FG002|Overall Study|Lost to Follow-up|0|||
144437719|NCT02118428|520807711|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
144437720|NCT02118428|520807712|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
144437721|NCT02118428|520807713|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
144437722|NCT00654381|520807714|FG000|1st Stage|Adverse Event|3|||
144437723|NCT00654381|520807715|FG001|1st Stage|Adverse Event|3|||
144437724|NCT00654381|520807716|FG002|1st Stage|Adverse Event|3|||
144437725|NCT00654381|520807717|FG003|1st Stage|Adverse Event|3|||
144437726|NCT00654381|520807718|FG004|1st Stage|Adverse Event|2|||
144437727|NCT00654381|520807719|FG005|1st Stage|Adverse Event|1|||
144530428|NCT04625725|521144348|FG005|Provent Sub Study|Adverse Event|1|||
144530429|NCT04625725|521144343|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
144530430|NCT04625725|521144344|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
144530431|NCT04625725|521144345|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
144437728|NCT00654381|520807714|FG000|1st Stage|Withdrawal by Subject|0|||
144437729|NCT00654381|520807715|FG001|1st Stage|Withdrawal by Subject|0|||
144437730|NCT00654381|520807716|FG002|1st Stage|Withdrawal by Subject|0|||
144437731|NCT00654381|520807717|FG003|1st Stage|Withdrawal by Subject|1|||
144437732|NCT00654381|520807718|FG004|1st Stage|Withdrawal by Subject|0|||
144437733|NCT00654381|520807719|FG005|1st Stage|Withdrawal by Subject|1|||
144437734|NCT00654381|520807714|FG000|1st Stage|Investigator's decision|0|||
144437735|NCT00654381|520807715|FG001|1st Stage|Investigator's decision|0|||
144437736|NCT00654381|520807716|FG002|1st Stage|Investigator's decision|0|||
144437737|NCT00654381|520807717|FG003|1st Stage|Investigator's decision|1|||
144437738|NCT00654381|520807718|FG004|1st Stage|Investigator's decision|0|||
144437739|NCT00654381|520807719|FG005|1st Stage|Investigator's decision|0|||
144437740|NCT00654381|520807714|FG000|2nd Stage|Adverse Event|2|||
144437741|NCT00654381|520807715|FG001|2nd Stage|Adverse Event|0|||
144437742|NCT00654381|520807716|FG002|2nd Stage|Adverse Event|2|||
144437743|NCT00654381|520807717|FG003|2nd Stage|Adverse Event|3|||
144437744|NCT00654381|520807718|FG004|2nd Stage|Adverse Event|7|||
144437745|NCT00654381|520807719|FG005|2nd Stage|Adverse Event|2|||
144437746|NCT00654381|520807714|FG000|2nd Stage|Withdrawal by Subject|0|||
144437747|NCT00654381|520807715|FG001|2nd Stage|Withdrawal by Subject|0|||
144437748|NCT00654381|520807716|FG002|2nd Stage|Withdrawal by Subject|0|||
144437749|NCT00654381|520807717|FG003|2nd Stage|Withdrawal by Subject|0|||
144437750|NCT00654381|520807718|FG004|2nd Stage|Withdrawal by Subject|1|||
144437751|NCT00654381|520807719|FG005|2nd Stage|Withdrawal by Subject|1|||
144437752|NCT00654381|520807714|FG000|2nd Stage|Investigator's decision|0|||
144437753|NCT00654381|520807715|FG001|2nd Stage|Investigator's decision|0|||
144437754|NCT00654381|520807716|FG002|2nd Stage|Investigator's decision|1|||
144437755|NCT00654381|520807717|FG003|2nd Stage|Investigator's decision|1|||
144437756|NCT00654381|520807718|FG004|2nd Stage|Investigator's decision|0|||
144437757|NCT00654381|520807719|FG005|2nd Stage|Investigator's decision|0|||
144437758|NCT00654381|520807714|FG000|Extension Stage|Adverse Event|1|||
144437759|NCT00654381|520807715|FG001|Extension Stage|Adverse Event|2|||
144437760|NCT00654381|520807716|FG002|Extension Stage|Adverse Event|9|||
144437761|NCT00654381|520807717|FG003|Extension Stage|Adverse Event|7|||
144437762|NCT00654381|520807718|FG004|Extension Stage|Adverse Event|1|||
144437763|NCT00654381|520807719|FG005|Extension Stage|Adverse Event|1|||
144437764|NCT00654381|520807714|FG000|Extension Stage|Protocol Violation|0|||
144437765|NCT00654381|520807715|FG001|Extension Stage|Protocol Violation|0|||
144437766|NCT00654381|520807716|FG002|Extension Stage|Protocol Violation|0|||
144437767|NCT00654381|520807717|FG003|Extension Stage|Protocol Violation|1|||
144437768|NCT00654381|520807718|FG004|Extension Stage|Protocol Violation|0|||
144437769|NCT00654381|520807719|FG005|Extension Stage|Protocol Violation|0|||
144437770|NCT00654381|520807714|FG000|Extension Stage|Lack of Efficacy|0|||
144437771|NCT00654381|520807715|FG001|Extension Stage|Lack of Efficacy|0|||
144437772|NCT00654381|520807716|FG002|Extension Stage|Lack of Efficacy|1|||
144437773|NCT00654381|520807717|FG003|Extension Stage|Lack of Efficacy|0|||
144437774|NCT00654381|520807718|FG004|Extension Stage|Lack of Efficacy|0|||
144437775|NCT00654381|520807719|FG005|Extension Stage|Lack of Efficacy|0|||
144437776|NCT00654381|520807714|FG000|Extension Stage|Withdrawal by Subject|0|||
144437777|NCT00654381|520807715|FG001|Extension Stage|Withdrawal by Subject|0|||
144437778|NCT00654381|520807716|FG002|Extension Stage|Withdrawal by Subject|1|||
144437779|NCT00654381|520807717|FG003|Extension Stage|Withdrawal by Subject|1|||
144437780|NCT00654381|520807718|FG004|Extension Stage|Withdrawal by Subject|1|||
144437781|NCT00654381|520807719|FG005|Extension Stage|Withdrawal by Subject|1|||
144437782|NCT00654381|520807714|FG000|Extension Stage|Closure of the trial site|0|||
144437783|NCT00654381|520807715|FG001|Extension Stage|Closure of the trial site|0|||
144437784|NCT00654381|520807716|FG002|Extension Stage|Closure of the trial site|0|||
144437785|NCT00654381|520807717|FG003|Extension Stage|Closure of the trial site|0|||
144437786|NCT00654381|520807718|FG004|Extension Stage|Closure of the trial site|1|||
144437787|NCT00654381|520807719|FG005|Extension Stage|Closure of the trial site|1|||
144437788|NCT00994448|520807720|FG000|Overall Study|Adverse Event|1|||
144437789|NCT00994448|520807721|FG001|Overall Study|Adverse Event|0|||
144437790|NCT00994448|520807720|FG000|Overall Study|Lost to Follow-up|5|||
144437791|NCT00994448|520807721|FG001|Overall Study|Lost to Follow-up|1|||
144437792|NCT00994448|520807720|FG000|Overall Study|Withdrawal by Subject|1|||
144437793|NCT00994448|520807721|FG001|Overall Study|Withdrawal by Subject|1|||
144437794|NCT00994448|520807720|FG000|Overall Study|Physician Decision|1|||
144437795|NCT00994448|520807721|FG001|Overall Study|Physician Decision|0|||
144437796|NCT04164901|520807724|FG000|Overall Study|Withdrawal by Subject|4|||
144437797|NCT04164901|520807725|FG001|Overall Study|Withdrawal by Subject|4|||
144437798|NCT05358821|520807726|FG000|Overall Study|Withdrawal by Subject|0|||
144437799|NCT05358821|520807727|FG001|Overall Study|Withdrawal by Subject|1|||
144437800|NCT05358821|520807728|FG002|Overall Study|Withdrawal by Subject|0|||
144437801|NCT05358821|520807726|FG000|Overall Study|Withdrawal of Consent|0|||
144437802|NCT05358821|520807727|FG001|Overall Study|Withdrawal of Consent|0|||
144437803|NCT05358821|520807728|FG002|Overall Study|Withdrawal of Consent|1|||
144437804|NCT02775344|520807729|FG000|Overall Study|No ovarian cyst identified|3|||
144437805|NCT02775344|520807730|FG001|Overall Study|No ovarian cyst identified|2|||
144437806|NCT04627064|520807731|FG000|Overall Study|Progressive disease|8|||
144437807|NCT04627064|520807732|FG001|Overall Study|Progressive disease|0|||
144437808|NCT04627064|520807731|FG000|Overall Study|Withdrawal by Subject|2|||
144437809|NCT04627064|520807732|FG001|Overall Study|Withdrawal by Subject|0|||
144437810|NCT04627064|520807731|FG000|Overall Study|Physician Decision|1|||
144437811|NCT04627064|520807732|FG001|Overall Study|Physician Decision|0|||
144437812|NCT00235872|520807735|FG000|Overall Study|Adverse Event|34|||
144437813|NCT00235872|520807735|FG000|Overall Study|Death|1|||
144437814|NCT00235872|520807735|FG000|Overall Study|Lost to Follow-up|1|||
144437815|NCT00235872|520807735|FG000|Overall Study|Withdrawal by Subject|50|||
144437816|NCT00235872|520807735|FG000|Overall Study|Administrative reason|61|||
144437817|NCT02126969|520807736|FG000|Overall Study|Withdrawal by Subject|1|||
144437818|NCT02126969|520807737|FG001|Overall Study|Withdrawal by Subject|2|||
144437819|NCT01533246|520807740|FG000|Overall Study|Adverse Event|1|||
144437820|NCT01533246|520807740|FG000|Overall Study|Withdrawal by Subject|1|||
144437821|NCT00354172|520807741|FG000|Overall Study|Did not receive transplant|1|||
144437822|NCT00937547|520807742|FG000|Overall Study|misdiagnosis|1|||
144437823|NCT00937547|520807743|FG001|Overall Study|misdiagnosis|6|||
144437824|NCT00937547|520807744|FG002|Overall Study|misdiagnosis|7|||
144437825|NCT01234467|520807745|FG000|Overall Study|Adverse Event|3|||
144437826|NCT01234467|520807745|FG000|Overall Study|Death|2|||
144437827|NCT01234467|520807745|FG000|Overall Study|Withdrawal by Subject|2|||
144437828|NCT01234467|520807745|FG000|Overall Study|Disease Progression|2|||
144437829|NCT01234467|520807745|FG000|Overall Study|Clinical deterioration|1|||
144437830|NCT01234467|520807745|FG000|Overall Study|Physician Decision|1|||
144437831|NCT01234467|520807745|FG000|Overall Study|Other complicating disease (stroke)|1|||
144437832|NCT04370691|520807746|FG000|Overall Study|Pending visit|48|||
144437833|NCT04370691|520807746|FG000|Overall Study|Have Not Reached Lower Window|15|||
144437834|NCT04370691|520807746|FG000|Overall Study|Termination|14|||
144437835|NCT04370691|520807746|FG000|Overall Study|Missed or Overdue|10|||
144437836|NCT03216850|520807754|FG000|Overall Study|Pre-analytical error|6|||
144437837|NCT03274986|520807757|FG000|Overall Study|Withdrawal by Subject|0|||
144437838|NCT03274986|520807758|FG001|Overall Study|Withdrawal by Subject|1|||
144437839|NCT03274986|520807757|FG000|Overall Study|Lost to Follow-up|0|||
144437840|NCT03274986|520807758|FG001|Overall Study|Lost to Follow-up|1|||
144437841|NCT00603746|520807759|FG000|Overall Study|Adverse Event|2|||
144437842|NCT00603746|520807760|FG001|Overall Study|Adverse Event|3|||
144437843|NCT00603746|520807761|FG002|Overall Study|Adverse Event|0|||
144437844|NCT00603746|520807762|FG003|Overall Study|Adverse Event|1|||
144437845|NCT00603746|520807763|FG004|Overall Study|Adverse Event|0|||
144437846|NCT00603746|520807764|FG005|Overall Study|Adverse Event|4|||
144437847|NCT00603746|520807759|FG000|Overall Study|Lack of Efficacy|34|||
144437848|NCT00603746|520807760|FG001|Overall Study|Lack of Efficacy|11|||
144437849|NCT00603746|520807761|FG002|Overall Study|Lack of Efficacy|6|||
144437850|NCT00603746|520807762|FG003|Overall Study|Lack of Efficacy|11|||
144437851|NCT00603746|520807763|FG004|Overall Study|Lack of Efficacy|12|||
144437852|NCT00603746|520807764|FG005|Overall Study|Lack of Efficacy|8|||
144437853|NCT00603746|520807759|FG000|Overall Study|Protocol Violation|0|||
144437854|NCT00603746|520807760|FG001|Overall Study|Protocol Violation|3|||
144437855|NCT00603746|520807761|FG002|Overall Study|Protocol Violation|1|||
144437856|NCT00603746|520807762|FG003|Overall Study|Protocol Violation|0|||
144437857|NCT00603746|520807763|FG004|Overall Study|Protocol Violation|1|||
144437858|NCT00603746|520807764|FG005|Overall Study|Protocol Violation|0|||
144437859|NCT00603746|520807759|FG000|Overall Study|Lost to Follow-up|0|||
144437860|NCT00603746|520807760|FG001|Overall Study|Lost to Follow-up|1|||
144437861|NCT00603746|520807761|FG002|Overall Study|Lost to Follow-up|1|||
144437862|NCT00603746|520807762|FG003|Overall Study|Lost to Follow-up|0|||
144437863|NCT00603746|520807763|FG004|Overall Study|Lost to Follow-up|0|||
144437864|NCT00603746|520807764|FG005|Overall Study|Lost to Follow-up|0|||
144437865|NCT00603746|520807759|FG000|Overall Study|Physician Decision|1|||
144437866|NCT00603746|520807760|FG001|Overall Study|Physician Decision|0|||
144437867|NCT00603746|520807761|FG002|Overall Study|Physician Decision|0|||
144437868|NCT00603746|520807762|FG003|Overall Study|Physician Decision|0|||
144437869|NCT00603746|520807763|FG004|Overall Study|Physician Decision|1|||
144437870|NCT00603746|520807764|FG005|Overall Study|Physician Decision|0|||
144437871|NCT00603746|520807759|FG000|Overall Study|Withdrawal by Subject|1|||
144437872|NCT00603746|520807760|FG001|Overall Study|Withdrawal by Subject|0|||
144437873|NCT00603746|520807761|FG002|Overall Study|Withdrawal by Subject|0|||
144437874|NCT00603746|520807762|FG003|Overall Study|Withdrawal by Subject|1|||
144437875|NCT00603746|520807763|FG004|Overall Study|Withdrawal by Subject|3|||
144188316|NCT03558139|519882988|FG001|Overall Study|Consent Withdrawn|1|||
144188317|NCT03558139|519882989|FG002|Overall Study|Consent Withdrawn|4|||
144188318|NCT03558139|519882987|FG000|Overall Study|Death|5|||
144437876|NCT00603746|520807764|FG005|Overall Study|Withdrawal by Subject|1|||
144437877|NCT01524627|520807767|FG000|Overall Study|Physician Decision|0|||
144437878|NCT01524627|520807768|FG001|Overall Study|Physician Decision|1|||
144437879|NCT01524627|520807767|FG000|Overall Study|Lost to Follow-up|1|||
144437880|NCT01524627|520807768|FG001|Overall Study|Lost to Follow-up|1|||
144437881|NCT00969553|520807769|FG000|Overall Study|Progressive disease (PD)|2|||
144437882|NCT00969553|520807770|FG001|Overall Study|Progressive disease (PD)|2|||
144437883|NCT00969553|520807771|FG002|Overall Study|Progressive disease (PD)|6|||
144188319|NCT03558139|519882988|FG001|Overall Study|Death|3|||
144437884|NCT00969553|520807772|FG003|Overall Study|Progressive disease (PD)|9|||
144437885|NCT00969553|520807773|FG004|Overall Study|Progressive disease (PD)|2|||
144437886|NCT00969553|520807774|FG005|Overall Study|Progressive disease (PD)|4|||
144437887|NCT00969553|520807775|FG006|Overall Study|Progressive disease (PD)|2|||
144437888|NCT00969553|520807776|FG007|Overall Study|Progressive disease (PD)|12|||
144437889|NCT00969553|520807777|FG008|Overall Study|Progressive disease (PD)|3|||
144437890|NCT00969553|520807769|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
144188320|NCT03558139|519882989|FG002|Overall Study|Death|8|||
144437891|NCT00969553|520807770|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437892|NCT00969553|520807771|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437893|NCT00969553|520807772|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437894|NCT00969553|520807773|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
144437895|NCT00969553|520807774|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437896|NCT00969553|520807775|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437897|NCT00969553|520807776|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437898|NCT00969553|520807777|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
144437899|NCT00969553|520807769|FG000|Overall Study|Other Adverse Event|0|||
144437900|NCT00969553|520807770|FG001|Overall Study|Other Adverse Event|0|||
144437901|NCT00969553|520807771|FG002|Overall Study|Other Adverse Event|0|||
144437902|NCT00969553|520807772|FG003|Overall Study|Other Adverse Event|1|||
144437903|NCT00969553|520807773|FG004|Overall Study|Other Adverse Event|0|||
144437904|NCT00969553|520807774|FG005|Overall Study|Other Adverse Event|0|||
144437905|NCT00969553|520807775|FG006|Overall Study|Other Adverse Event|1|||
144437906|NCT00969553|520807776|FG007|Overall Study|Other Adverse Event|0|||
144437907|NCT00969553|520807777|FG008|Overall Study|Other Adverse Event|0|||
144437908|NCT00969553|520807769|FG000|Overall Study|Refused cont. medication|1|||
144437909|NCT00969553|520807770|FG001|Overall Study|Refused cont. medication|1|||
144437910|NCT00969553|520807771|FG002|Overall Study|Refused cont. medication|0|||
144437911|NCT00969553|520807772|FG003|Overall Study|Refused cont. medication|2|||
144437912|NCT00969553|520807773|FG004|Overall Study|Refused cont. medication|0|||
144437913|NCT00969553|520807774|FG005|Overall Study|Refused cont. medication|0|||
144437914|NCT00969553|520807775|FG006|Overall Study|Refused cont. medication|0|||
144437915|NCT00969553|520807776|FG007|Overall Study|Refused cont. medication|1|||
144437916|NCT00969553|520807777|FG008|Overall Study|Refused cont. medication|0|||
144437917|NCT00969553|520807769|FG000|Overall Study|Not specified above|0|||
144437918|NCT00969553|520807770|FG001|Overall Study|Not specified above|0|||
144437919|NCT00969553|520807771|FG002|Overall Study|Not specified above|0|||
144437920|NCT00969553|520807772|FG003|Overall Study|Not specified above|4|||
144437921|NCT00969553|520807773|FG004|Overall Study|Not specified above|0|||
144437922|NCT00969553|520807774|FG005|Overall Study|Not specified above|0|||
144437923|NCT00969553|520807775|FG006|Overall Study|Not specified above|1|||
144437924|NCT00969553|520807776|FG007|Overall Study|Not specified above|1|||
144437925|NCT00969553|520807777|FG008|Overall Study|Not specified above|0|||
144437926|NCT00615056|520807778|FG000|Overall Study|Death|31|||
144437927|NCT00615056|520807779|FG001|Overall Study|Death|31|||
144437928|NCT00615056|520807780|FG002|Overall Study|Death|21|||
144437929|NCT00615056|520807781|FG003|Overall Study|Death|23|||
144437930|NCT00615056|520807778|FG000|Overall Study|Lost to Follow-up|1|||
144437931|NCT00615056|520807779|FG001|Overall Study|Lost to Follow-up|2|||
144437932|NCT00615056|520807780|FG002|Overall Study|Lost to Follow-up|4|||
144437933|NCT00615056|520807781|FG003|Overall Study|Lost to Follow-up|5|||
144437934|NCT00615056|520807778|FG000|Overall Study|Other|13|||
144437935|NCT00615056|520807779|FG001|Overall Study|Other|15|||
144437936|NCT00615056|520807780|FG002|Overall Study|Other|10|||
144437937|NCT00615056|520807781|FG003|Overall Study|Other|7|||
144437938|NCT00615056|520807778|FG000|Overall Study|Objective progression or relapse|0|||
144437939|NCT00615056|520807779|FG001|Overall Study|Objective progression or relapse|2|||
144437940|NCT00615056|520807780|FG002|Overall Study|Objective progression or relapse|0|||
144437941|NCT00615056|520807781|FG003|Overall Study|Objective progression or relapse|0|||
144437942|NCT00615056|520807778|FG000|Overall Study|Withdrawal by Subject|0|||
144437943|NCT00615056|520807779|FG001|Overall Study|Withdrawal by Subject|1|||
144437944|NCT00615056|520807780|FG002|Overall Study|Withdrawal by Subject|1|||
144538458|NCT01500200|521174195|FG000|Stage 1|Noncompliance with Study Drug|1|||
144724335|NCT01505530|521846342|FG002|Overall Study|Progressive Disease|18|||
144437945|NCT00615056|520807781|FG003|Overall Study|Withdrawal by Subject|0|||
144437946|NCT00615056|520807778|FG000|Overall Study|Discontinued by Sponsor|1|||
144437947|NCT00615056|520807779|FG001|Overall Study|Discontinued by Sponsor|0|||
144437948|NCT00615056|520807780|FG002|Overall Study|Discontinued by Sponsor|0|||
144437949|NCT00615056|520807781|FG003|Overall Study|Discontinued by Sponsor|0|||
144437950|NCT00615056|520807778|FG000|Overall Study|Randomized but not treated|3|||
144437951|NCT00615056|520807779|FG001|Overall Study|Randomized but not treated|0|||
144437952|NCT00615056|520807780|FG002|Overall Study|Randomized but not treated|0|||
144437953|NCT00615056|520807781|FG003|Overall Study|Randomized but not treated|0|||
144437954|NCT00717769|520807782|FG000|Overall Study|Adverse Event|9|||
144437955|NCT00717769|520807783|FG001|Overall Study|Adverse Event|6|||
144437956|NCT00717769|520807784|FG002|Overall Study|Adverse Event|1|||
144437957|NCT00717769|520807782|FG000|Overall Study|Lack of compliance|0|||
144437958|NCT00717769|520807783|FG001|Overall Study|Lack of compliance|2|||
144437959|NCT00717769|520807784|FG002|Overall Study|Lack of compliance|0|||
144437960|NCT00717769|520807782|FG000|Overall Study|Lost to Follow-up|3|||
144437961|NCT00717769|520807783|FG001|Overall Study|Lost to Follow-up|4|||
144437962|NCT00717769|520807784|FG002|Overall Study|Lost to Follow-up|0|||
144437963|NCT00717769|520807782|FG000|Overall Study|Lack of Efficacy|1|||
144437964|NCT00717769|520807783|FG001|Overall Study|Lack of Efficacy|2|||
144437965|NCT00717769|520807784|FG002|Overall Study|Lack of Efficacy|0|||
144437966|NCT00717769|520807782|FG000|Overall Study|Protocol Violation|0|||
144437967|NCT00717769|520807783|FG001|Overall Study|Protocol Violation|2|||
144188321|NCT03558139|519882987|FG000|Overall Study|Lost to Follow-up|0|||
144188322|NCT03558139|519882988|FG001|Overall Study|Lost to Follow-up|0|||
144188323|NCT03558139|519882989|FG002|Overall Study|Lost to Follow-up|3|||
144188324|NCT03558139|519882987|FG000|Overall Study|Study Ended Per Protocol|0|||
144188325|NCT03558139|519882988|FG001|Overall Study|Study Ended Per Protocol|3|||
144188326|NCT03558139|519882989|FG002|Overall Study|Study Ended Per Protocol|6|||
144188327|NCT00551616|519882992|FG000|Overall Study|Lost to Follow-up|48|||
144188328|NCT00551616|519882993|FG001|Overall Study|Lost to Follow-up|40|||
144188329|NCT02808819|519882994|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
144188330|NCT02808819|519882995|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
144188331|NCT02808819|519882994|FG000|Overall Study|Withdrawal by Subject|10|||
144188332|NCT02808819|519882995|FG001|Overall Study|Withdrawal by Subject|13|||
144188333|NCT02808819|519882994|FG000|Overall Study|Site terminated by sponsor|2|||
144188334|NCT02808819|519882995|FG001|Overall Study|Site terminated by sponsor|0|||
144188335|NCT02808819|519882994|FG000|Overall Study|Pregnancy|1|||
144188336|NCT02808819|519882995|FG001|Overall Study|Pregnancy|0|||
144188337|NCT02808819|519882994|FG000|Overall Study|Lost to Follow-up|1|||
144188338|NCT02808819|519882995|FG001|Overall Study|Lost to Follow-up|6|||
144188339|NCT02808819|519882994|FG000|Overall Study|Protocol Violation|0|||
144188340|NCT02808819|519882995|FG001|Overall Study|Protocol Violation|1|||
144188341|NCT02808819|519882994|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
144188342|NCT02808819|519882995|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
144188343|NCT02808819|519882994|FG000|Overall Study|Death|1|||
144188344|NCT02808819|519882995|FG001|Overall Study|Death|0|||
144437968|NCT00717769|520807784|FG002|Overall Study|Protocol Violation|0|||
144437969|NCT00717769|520807782|FG000|Overall Study|Sponsor decision|1|||
144437970|NCT00717769|520807783|FG001|Overall Study|Sponsor decision|0|||
144437971|NCT00717769|520807784|FG002|Overall Study|Sponsor decision|10|||
144437972|NCT00717769|520807782|FG000|Overall Study|Withdrew consent|2|||
144437973|NCT00717769|520807783|FG001|Overall Study|Withdrew consent|2|||
144437974|NCT00717769|520807784|FG002|Overall Study|Withdrew consent|0|||
144437975|NCT04327986|520807786|FG000|Overall Study|Physician Decision|2|||
144437976|NCT04327986|520807787|FG001|Overall Study|Physician Decision|0|||
144437977|NCT04327986|520807788|FG002|Overall Study|Physician Decision|0|||
144437978|NCT04327986|520807786|FG000|Overall Study|Death|1|||
144437979|NCT04327986|520807787|FG001|Overall Study|Death|0|||
144437980|NCT04327986|520807788|FG002|Overall Study|Death|0|||
144437981|NCT04248816|520807789|FG000|Overall Study|Ineligible post-randomization|7|||
144437982|NCT04248816|520807790|FG001|Overall Study|Ineligible post-randomization|21|||
144437983|NCT04248816|520807791|FG002|Overall Study|Ineligible post-randomization|25|||
144437984|NCT03350503|520807792|FG000|Overall Study|Adverse Event|5|||
144437985|NCT03350503|520807792|FG000|Overall Study|Withdrawal by Subject|5|||
144437986|NCT03350503|520807792|FG000|Overall Study|Continuation impossible due to move|4|||
144437987|NCT03350503|520807792|FG000|Overall Study|Physician Decision|3|||
144437988|NCT01399593|520807796|FG000|Overall Study|Physician Decision|1|||
144437989|NCT01399593|520807797|FG001|Overall Study|Physician Decision|0|||
144437990|NCT01399593|520807796|FG000|Overall Study|Adverse Event|1|||
144437991|NCT01399593|520807797|FG001|Overall Study|Adverse Event|0|||
144437992|NCT01399593|520807796|FG000|Overall Study|Death|1|||
144437993|NCT01399593|520807797|FG001|Overall Study|Death|1|||
144437994|NCT01399593|520807796|FG000|Overall Study|Transplantectomy|0|||
144437995|NCT01399593|520807797|FG001|Overall Study|Transplantectomy|1|||
144437996|NCT02357147|520807800|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
144437997|NCT02357147|520807801|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
144188345|NCT02808819|519882994|FG000|Overall Study|Adverse Event|3|||
144188346|NCT02808819|519882995|FG001|Overall Study|Adverse Event|4|||
144188347|NCT01588548|519883003|FG000|Overall Study|Withdrawal by Subject|0|||
144188348|NCT01588548|519883004|FG001|Overall Study|Withdrawal by Subject|1|||
144188349|NCT01588548|519883005|FG002|Overall Study|Withdrawal by Subject|1|||
144188350|NCT01588548|519883006|FG003|Overall Study|Withdrawal by Subject|1|||
144253484|NCT00582426|520128078|FG000|Overall Study|Withdrawal by Subject|3|||
144437998|NCT02357147|520807800|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
144437999|NCT02357147|520807801|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
144188351|NCT01588548|519883007|FG004|Overall Study|Withdrawal by Subject|2|||
144188352|NCT01588548|519883008|FG005|Overall Study|Withdrawal by Subject|3|||
144188353|NCT01588548|519883003|FG000|Overall Study|Adverse Event|0|||
144188354|NCT01588548|519883004|FG001|Overall Study|Adverse Event|0|||
144188355|NCT01588548|519883005|FG002|Overall Study|Adverse Event|1|||
144188356|NCT01588548|519883006|FG003|Overall Study|Adverse Event|2|||
144188357|NCT01588548|519883007|FG004|Overall Study|Adverse Event|1|||
144188358|NCT01588548|519883008|FG005|Overall Study|Adverse Event|0|||
144438000|NCT02357147|520807800|FG000|Combination Treatment Phase|Investigator Discretion|1|||
144438001|NCT02357147|520807801|FG001|Combination Treatment Phase|Investigator Discretion|1|||
144438002|NCT02357147|520807800|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
144472093|NCT00394355|520925379|FG001|Overall Study|Administrative|1|||
144472094|NCT00394355|520925380|FG002|Overall Study|Administrative|1|||
144472095|NCT00394355|520925381|FG003|Overall Study|Administrative|1|||
144188359|NCT01588548|519883003|FG000|Overall Study|Condition Under Investigation Worsened|3|||
144188360|NCT01588548|519883004|FG001|Overall Study|Condition Under Investigation Worsened|6|||
144188361|NCT01588548|519883005|FG002|Overall Study|Condition Under Investigation Worsened|4|||
144188362|NCT01588548|519883006|FG003|Overall Study|Condition Under Investigation Worsened|4|||
144188363|NCT01588548|519883007|FG004|Overall Study|Condition Under Investigation Worsened|3|||
144188364|NCT01588548|519883008|FG005|Overall Study|Condition Under Investigation Worsened|3|||
144188365|NCT00292227|519883009|FG000|Patch Period|Adverse Event|1|||
144438003|NCT02357147|520807801|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
144438004|NCT02357147|520807800|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
144438005|NCT02357147|520807801|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
144438006|NCT02357147|520807800|FG000|Combination Treatment Phase|Adverse Event|12|||
144438007|NCT02357147|520807801|FG001|Combination Treatment Phase|Adverse Event|4|||
144438008|NCT02357147|520807800|FG000|Combination Treatment Phase|Death|1|||
144438009|NCT02357147|520807801|FG001|Combination Treatment Phase|Death|1|||
144438010|NCT02357147|520807800|FG000|Combination Treatment Phase|Sponsor Decision|0|||
144438011|NCT02357147|520807801|FG001|Combination Treatment Phase|Sponsor Decision|12|||
144438012|NCT02357147|520807800|FG000|Combination Treatment Phase|Other|1|||
144438013|NCT02357147|520807801|FG001|Combination Treatment Phase|Other|0|||
144438014|NCT02357147|520807800|FG000|Combination Treatment Phase|Not treated|0|||
144438015|NCT02357147|520807801|FG001|Combination Treatment Phase|Not treated|2|||
144438016|NCT02357147|520807800|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
144438017|NCT02357147|520807801|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
144438018|NCT02357147|520807800|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144188366|NCT00292227|519883010|FG001|Patch Period|Adverse Event|0|||
144188367|NCT00292227|519883011|FG002|Patch Period|Adverse Event|2|||
144253485|NCT00582426|520128079|FG001|Overall Study|Withdrawal by Subject|2|||
144253486|NCT00582426|520128078|FG000|Overall Study|Disease Progression|2|||
144253487|NCT00582426|520128079|FG001|Overall Study|Disease Progression|2|||
144253488|NCT00582426|520128078|FG000|Overall Study|Use of illicit drugs|1|||
144253489|NCT00582426|520128079|FG001|Overall Study|Use of illicit drugs|0|||
144253490|NCT02626000|520128082|FG000|Overall Study|Decision by Sponsor|1|||
144253491|NCT02626000|520128082|FG000|Overall Study|Death|29|||
144253492|NCT02164318|520128083|FG000|Overall Study|Withdrawal by Subject|0|||
144253493|NCT02164318|520128084|FG001|Overall Study|Withdrawal by Subject|1|||
144253494|NCT02164318|520128085|FG002|Overall Study|Withdrawal by Subject|0|||
144438019|NCT02357147|520807801|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
144438020|NCT02357147|520807800|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
144438021|NCT02357147|520807801|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
144438022|NCT02357147|520807800|FG000|Maintenance Treatment Phase|Adverse Event|0|||
144438023|NCT02357147|520807801|FG001|Maintenance Treatment Phase|Adverse Event|3|||
144438024|NCT02357147|520807800|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
144438025|NCT02357147|520807801|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
144438026|NCT02357147|520807800|FG000|Maintenance Treatment Phase|Not Treated|1|||
144438027|NCT02357147|520807801|FG001|Maintenance Treatment Phase|Not Treated|0|||
144438028|NCT03962543|520807804|FG000|Treatment Phase|Death|0|||
144438029|NCT03962543|520807805|FG001|Treatment Phase|Death|1|||
144438030|NCT03962543|520807804|FG000|Treatment Phase|Withdrawal by Subject|3|||
144438031|NCT03962543|520807805|FG001|Treatment Phase|Withdrawal by Subject|0|||
144438032|NCT03962543|520807804|FG000|Treatment Phase|Adverse Event|3|||
144438033|NCT03962543|520807805|FG001|Treatment Phase|Adverse Event|12|||
144438034|NCT03962543|520807804|FG000|Treatment Phase|Lost to Follow-up|1|||
144438035|NCT03962543|520807805|FG001|Treatment Phase|Lost to Follow-up|2|||
144438036|NCT03962543|520807804|FG000|Treatment Phase|Radiographic PD|9|||
144438037|NCT03962543|520807805|FG001|Treatment Phase|Radiographic PD|3|||
144438038|NCT03962543|520807804|FG000|Treatment Phase|Participant Decision|3|||
144253495|NCT02164318|520128086|FG003|Overall Study|Withdrawal by Subject|1|||
144253496|NCT00662311|520128087|FG000|Overall Study|Respiratory Infection|1|||
144253497|NCT00662311|520128088|FG001|Overall Study|Respiratory Infection|0|||
144253498|NCT00662311|520128089|FG002|Overall Study|Respiratory Infection|0|||
144253499|NCT01467271|520128092|FG000|Overall Study|Death|84|||
144253500|NCT01467271|520128092|FG000|Overall Study|Lost to Follow-up|83|||
144253501|NCT01467271|520128092|FG000|Overall Study|Retraction of patient's consent|21|||
144253502|NCT01467271|520128092|FG000|Overall Study|Other reason|14|||
144253503|NCT03084302|520128097|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
144530432|NCT04625725|521144346|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
144188368|NCT00292227|519883009|FG000|Patch Period|Withdrawal by Subject|0|||
144438039|NCT03962543|520807805|FG001|Treatment Phase|Participant Decision|8|||
144438040|NCT03962543|520807804|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
144438041|NCT03962543|520807805|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
144188369|NCT00292227|519883010|FG001|Patch Period|Withdrawal by Subject|0|||
144438042|NCT03962543|520807804|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
144438043|NCT03962543|520807805|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
144188370|NCT00292227|519883011|FG002|Patch Period|Withdrawal by Subject|1|||
144188371|NCT01634854|519883016|FG000|Overall Study|Cesarean delivery|2|||
144188372|NCT01634854|519883017|FG001|Overall Study|Cesarean delivery|7|||
144188373|NCT02688387|519884833|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188374|NCT02688387|519884834|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188375|NCT02688387|519884835|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
144188376|NCT02688387|519884836|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188377|NCT02688387|519884837|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188378|NCT02688387|519884838|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188379|NCT02688387|519884839|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188380|NCT02688387|519884840|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188381|NCT02688387|519884841|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188382|NCT02688387|519884842|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188383|NCT02688387|519884843|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188384|NCT02688387|519884844|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188385|NCT02688387|519884845|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188386|NCT02688387|519884846|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144438044|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
144438045|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
144438046|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
144438047|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
144438048|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
144438049|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
144438050|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
144438051|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
144438052|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
144438053|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
144438054|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
144438055|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
144438056|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
144438057|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
144438058|NCT03962543|520807804|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
144438059|NCT03962543|520807805|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
144438060|NCT00560950|520807806|FG000|Overall Study|Lost to Follow-up|1|||
144438061|NCT00560950|520807807|FG001|Overall Study|Lost to Follow-up|0|||
144438062|NCT02970968|520809432|FG000|Overall Study|Withdrawal by Subject|3|||
144438063|NCT02970968|520809433|FG001|Overall Study|Withdrawal by Subject|3|||
144438064|NCT02970968|520809432|FG000|Overall Study|Adverse Event|1|||
144438065|NCT02970968|520809433|FG001|Overall Study|Adverse Event|2|||
144438066|NCT02970968|520809432|FG000|Overall Study|Lost to Follow-up|1|||
144438067|NCT02970968|520809433|FG001|Overall Study|Lost to Follow-up|1|||
144438068|NCT02970968|520809432|FG000|Overall Study|Non-Compliance|0|||
144438069|NCT02970968|520809433|FG001|Overall Study|Non-Compliance|1|||
144438070|NCT05308901|520809434|FG000|Overall Study|Death|6|||
144438071|NCT03252522|520809435|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
144438072|NCT03252522|520809436|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
144438073|NCT03252522|520809437|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
144438074|NCT03252522|520809435|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
144438075|NCT03252522|520809436|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
144438076|NCT03252522|520809437|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
144438077|NCT03252522|520809435|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
144438078|NCT03252522|520809436|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
144438079|NCT03252522|520809437|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
144438080|NCT03252522|520809435|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
144438081|NCT03252522|520809436|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
144438082|NCT03252522|520809437|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
144438083|NCT03252522|520809435|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
144438084|NCT03252522|520809436|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
144188387|NCT02688387|519884847|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188388|NCT02688387|519884848|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144438085|NCT03252522|520809437|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
144438086|NCT03252522|520809435|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
144438087|NCT03252522|520809436|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
144438088|NCT03252522|520809437|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
144253504|NCT03084302|520128097|FG000|Overall Study|No valid objective monitor data|6|||
144438089|NCT03252522|520809435|FG000|Phase 2: Open Label|Adverse Event|0|||
144438090|NCT03252522|520809436|FG001|Phase 2: Open Label|Adverse Event|0|||
144438091|NCT03252522|520809437|FG002|Phase 2: Open Label|Adverse Event|2|||
144188389|NCT02688387|519884849|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188390|NCT02688387|519884850|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144253505|NCT01411319|520128098|FG000|Overall Study|Lost to Follow-up|1|||
144188391|NCT02688387|519884851|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188392|NCT02688387|519884852|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188393|NCT02688387|519884853|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188394|NCT02688387|519884854|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
144188395|NCT02688387|519884833|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188396|NCT02688387|519884834|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188397|NCT02688387|519884835|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188398|NCT02688387|519884836|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
144188399|NCT02688387|519884837|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188400|NCT02688387|519884838|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188401|NCT02688387|519884839|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188402|NCT02688387|519884840|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188403|NCT02688387|519884841|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188404|NCT02688387|519884842|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188405|NCT02688387|519884843|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188406|NCT02688387|519884844|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188407|NCT02688387|519884845|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188408|NCT02688387|519884846|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188409|NCT02688387|519884847|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188410|NCT02688387|519884848|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188411|NCT02688387|519884849|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188412|NCT02688387|519884850|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188413|NCT02688387|519884851|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188414|NCT02688387|519884852|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188415|NCT02688387|519884853|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188416|NCT02688387|519884854|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188417|NCT02688387|519884833|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188418|NCT02688387|519884834|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
144188419|NCT02688387|519884835|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188420|NCT02688387|519884836|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188421|NCT02688387|519884837|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188422|NCT02688387|519884838|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188423|NCT02688387|519884839|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188424|NCT02688387|519884840|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188425|NCT02688387|519884841|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188426|NCT02688387|519884842|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188427|NCT02688387|519884843|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188428|NCT02688387|519884844|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188429|NCT02688387|519884845|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188430|NCT02688387|519884846|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188431|NCT02688387|519884847|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188432|NCT02688387|519884848|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188433|NCT02688387|519884849|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188434|NCT02688387|519884850|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188435|NCT02688387|519884851|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188436|NCT02688387|519884852|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188437|NCT02688387|519884853|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144188438|NCT02688387|519884854|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
144438092|NCT03252522|520809435|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
144438093|NCT03252522|520809436|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
144438094|NCT03252522|520809437|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
144438095|NCT01940120|520809441|FG000|Overall Study|Death|40|||
144438096|NCT01940120|520809441|FG000|Overall Study|Withdrawal by Subject|8|||
144438097|NCT03277846|520809442|FG000|Overall Study|Inpatient stay too brief|12|||
144438098|NCT03277846|520809443|FG001|Overall Study|Inpatient stay too brief|11|||
144438099|NCT02554656|520809444|FG000|Overall Study|Protocol Violation|3|||
144438100|NCT03240575|520809445|FG000|Overall Study|Adverse Event|0|||
144438101|NCT03240575|520809446|FG001|Overall Study|Adverse Event|2|||
144438102|NCT03240575|520809447|FG002|Overall Study|Adverse Event|0|||
144438103|NCT03240575|520809448|FG003|Overall Study|Adverse Event|1|||
144438104|NCT03240575|520809445|FG000|Overall Study|Withdrawal by Subject|2|||
144530433|NCT04625725|521144347|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
144253506|NCT02496039|520128099|FG000|Overall Study|Adverse Event|3|||
144438105|NCT03240575|520809446|FG001|Overall Study|Withdrawal by Subject|11|||
144438106|NCT03240575|520809447|FG002|Overall Study|Withdrawal by Subject|0|||
144188439|NCT02688387|519884833|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188440|NCT02688387|519884834|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188441|NCT02688387|519884835|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
144188442|NCT02688387|519884836|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188443|NCT02688387|519884837|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
144188444|NCT02688387|519884838|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188445|NCT02688387|519884839|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188446|NCT02688387|519884840|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188447|NCT02688387|519884841|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188448|NCT02688387|519884842|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188449|NCT02688387|519884843|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188450|NCT02688387|519884844|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188451|NCT02688387|519884845|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188452|NCT02688387|519884846|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188453|NCT02688387|519884847|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188454|NCT02688387|519884848|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188455|NCT02688387|519884849|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188456|NCT02688387|519884850|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188457|NCT02688387|519884851|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188458|NCT02688387|519884852|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188459|NCT02688387|519884853|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188460|NCT02688387|519884854|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
144188461|NCT02688387|519884833|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
144188462|NCT02688387|519884834|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188463|NCT02688387|519884835|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188464|NCT02688387|519884836|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188465|NCT02688387|519884837|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188466|NCT02688387|519884838|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188467|NCT02688387|519884839|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188468|NCT02688387|519884840|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188469|NCT02688387|519884841|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188470|NCT02688387|519884842|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188471|NCT02688387|519884843|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188472|NCT02688387|519884844|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188473|NCT02688387|519884845|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188474|NCT02688387|519884846|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188475|NCT02688387|519884847|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188476|NCT02688387|519884848|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188477|NCT02688387|519884849|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188478|NCT02688387|519884850|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188479|NCT02688387|519884851|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188480|NCT02688387|519884852|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188481|NCT02688387|519884853|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188482|NCT02688387|519884854|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
144188483|NCT02688387|519884833|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188484|NCT02688387|519884834|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144438107|NCT03240575|520809448|FG003|Overall Study|Withdrawal by Subject|1|||
144438108|NCT03240575|520809445|FG000|Overall Study|Other|0|||
144438109|NCT03240575|520809446|FG001|Overall Study|Other|1|||
144438110|NCT03240575|520809447|FG002|Overall Study|Other|0|||
144438111|NCT03240575|520809448|FG003|Overall Study|Other|0|||
144438112|NCT04144166|520809451|FG000|Overall Study|Discharged before study start|1|||
144438113|NCT04144166|520809451|FG000|Overall Study|Pregnancy|1|||
144438114|NCT04144166|520809451|FG000|Overall Study|Nail polish could not be removed from finger|1|||
144438115|NCT00697346|520809452|FG000|Overall Study|Adverse Event|4|||
144438116|NCT00697346|520809453|FG001|Overall Study|Adverse Event|5|||
144438117|NCT00697346|520809454|FG002|Overall Study|Adverse Event|0|||
144438118|NCT00697346|520809452|FG000|Overall Study|Progressive Disease|19|||
144438119|NCT00697346|520809453|FG001|Overall Study|Progressive Disease|18|||
144438120|NCT00697346|520809454|FG002|Overall Study|Progressive Disease|0|||
144438121|NCT00697346|520809452|FG000|Overall Study|Symptomatic Deterioration|0|||
144438122|NCT00697346|520809453|FG001|Overall Study|Symptomatic Deterioration|1|||
144438123|NCT00697346|520809454|FG002|Overall Study|Symptomatic Deterioration|0|||
144438124|NCT00697346|520809452|FG000|Overall Study|Withdrawal by Subject|2|||
144438125|NCT00697346|520809453|FG001|Overall Study|Withdrawal by Subject|2|||
144438126|NCT00697346|520809454|FG002|Overall Study|Withdrawal by Subject|0|||
144530434|NCT04625725|521144348|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
144530435|NCT04625725|521144343|FG000|Provent Sub Study|Withdrawal by Subject|0|||
144530436|NCT04625725|521144344|FG001|Provent Sub Study|Withdrawal by Subject|0|||
144530437|NCT04625725|521144345|FG002|Provent Sub Study|Withdrawal by Subject|11|||
144530438|NCT04625725|521144346|FG003|Provent Sub Study|Withdrawal by Subject|13|||
144530439|NCT04625725|521144347|FG004|Provent Sub Study|Withdrawal by Subject|5|||
144530440|NCT04625725|521144348|FG005|Provent Sub Study|Withdrawal by Subject|6|||
144530441|NCT04625725|521144343|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
144530442|NCT04625725|521144344|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
144530443|NCT04625725|521144345|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
144530444|NCT04625725|521144346|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
144530445|NCT04625725|521144347|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
144188485|NCT02688387|519884835|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188486|NCT02688387|519884836|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188487|NCT02688387|519884837|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188488|NCT02688387|519884838|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188489|NCT02688387|519884839|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188490|NCT02688387|519884840|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188491|NCT02688387|519884841|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144438127|NCT00697346|520809452|FG000|Overall Study|Reason not Specified|3|||
144438128|NCT00697346|520809453|FG001|Overall Study|Reason not Specified|0|||
144438129|NCT00697346|520809454|FG002|Overall Study|Reason not Specified|1|||
144438130|NCT03643562|520809455|FG000|Overall Study|Adverse Event|1|||
144438131|NCT03643562|520809456|FG001|Overall Study|Adverse Event|0|||
144438132|NCT03643562|520809455|FG000|Overall Study|Lack of Efficacy|0|||
144438133|NCT03643562|520809456|FG001|Overall Study|Lack of Efficacy|1|||
144438134|NCT03643562|520809455|FG000|Overall Study|Physician Decision|0|||
144438135|NCT03643562|520809456|FG001|Overall Study|Physician Decision|1|||
144438136|NCT03643562|520809455|FG000|Overall Study|Study Terminated by Sponsor|2|||
144438137|NCT03643562|520809456|FG001|Overall Study|Study Terminated by Sponsor|10|||
144438138|NCT03643562|520809455|FG000|Overall Study|Withdrawal by Subject|2|||
144438139|NCT03643562|520809456|FG001|Overall Study|Withdrawal by Subject|2|||
144438140|NCT03643562|520809455|FG000|Overall Study|Other than specified|3|||
144438141|NCT03643562|520809456|FG001|Overall Study|Other than specified|2|||
144438142|NCT04145895|520809457|FG000|Overall Study|Physician Decision|2|||
144438143|NCT04145895|520809458|FG001|Overall Study|Physician Decision|0|||
144438144|NCT04145895|520809457|FG000|Overall Study|Withdrawal by Subject|0|||
144438145|NCT04145895|520809458|FG001|Overall Study|Withdrawal by Subject|2|||
144438146|NCT01236755|520809459|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
144438147|NCT01236755|520809459|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
144438148|NCT01236755|520809459|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
144438149|NCT01236755|520809459|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
144438150|NCT01481116|520809460|FG000|Overall Study|Adverse Event|26|||
144438151|NCT01481116|520809461|FG001|Overall Study|Adverse Event|26|||
144438152|NCT01481116|520809462|FG002|Overall Study|Adverse Event|42|||
144438153|NCT01481116|520809460|FG000|Overall Study|Major Protocol Deviation|3|||
144438154|NCT01481116|520809461|FG001|Overall Study|Major Protocol Deviation|7|||
144438155|NCT01481116|520809462|FG002|Overall Study|Major Protocol Deviation|1|||
144438156|NCT01481116|520809460|FG000|Overall Study|Lost to Follow-up|8|||
144438157|NCT01481116|520809461|FG001|Overall Study|Lost to Follow-up|12|||
144438158|NCT01481116|520809462|FG002|Overall Study|Lost to Follow-up|11|||
144438159|NCT01481116|520809460|FG000|Overall Study|Withdrawal by Subject|37|||
144438160|NCT01481116|520809461|FG001|Overall Study|Withdrawal by Subject|33|||
144438161|NCT01481116|520809462|FG002|Overall Study|Withdrawal by Subject|37|||
144438162|NCT01481116|520809460|FG000|Overall Study|Study Termination|730|||
144438163|NCT01481116|520809461|FG001|Overall Study|Study Termination|729|||
144438164|NCT01481116|520809462|FG002|Overall Study|Study Termination|713|||
144438165|NCT01481116|520809460|FG000|Overall Study|Pregnancy|0|||
144438166|NCT01481116|520809461|FG001|Overall Study|Pregnancy|0|||
144438167|NCT01481116|520809462|FG002|Overall Study|Pregnancy|1|||
144530446|NCT04625725|521144348|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
144530447|NCT04132518|521144351|FG000|Overall Study|Prematurely withdrawn from the study|0|||
144438168|NCT01481116|520809460|FG000|Overall Study|Lack of Efficacy|3|||
144438169|NCT01481116|520809461|FG001|Overall Study|Lack of Efficacy|3|||
144438170|NCT01481116|520809462|FG002|Overall Study|Lack of Efficacy|1|||
144438171|NCT01481116|520809460|FG000|Overall Study|Contraindications|1|||
144438172|NCT01481116|520809461|FG001|Overall Study|Contraindications|1|||
144438173|NCT01481116|520809462|FG002|Overall Study|Contraindications|0|||
144530448|NCT04132518|521144352|FG001|Overall Study|Prematurely withdrawn from the study|9|||
144188492|NCT02688387|519884842|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188493|NCT02688387|519884843|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
144438174|NCT01481116|520809460|FG000|Overall Study|Other|1|||
144438175|NCT01481116|520809461|FG001|Overall Study|Other|1|||
144438176|NCT01481116|520809462|FG002|Overall Study|Other|0|||
144438177|NCT01481116|520809460|FG000|Overall Study|Participant Started Taking Glipizide|1|||
144188494|NCT02688387|519884844|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188495|NCT02688387|519884845|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188496|NCT02688387|519884846|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188497|NCT02688387|519884847|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188498|NCT02688387|519884848|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188499|NCT02688387|519884849|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188500|NCT02688387|519884850|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144438178|NCT01481116|520809461|FG001|Overall Study|Participant Started Taking Glipizide|0|||
144438179|NCT01481116|520809462|FG002|Overall Study|Participant Started Taking Glipizide|0|||
144438180|NCT01481116|520809460|FG000|Overall Study|Participant Moved Out of Area|2|||
144438181|NCT01481116|520809461|FG001|Overall Study|Participant Moved Out of Area|0|||
144188501|NCT02688387|519884851|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188502|NCT02688387|519884852|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188503|NCT02688387|519884853|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188504|NCT02688387|519884854|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
144188505|NCT02688387|519884833|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188506|NCT02688387|519884834|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188507|NCT02688387|519884835|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188508|NCT02688387|519884836|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188509|NCT02688387|519884837|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188510|NCT02688387|519884838|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188511|NCT02688387|519884839|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188512|NCT02688387|519884840|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188513|NCT02688387|519884841|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188514|NCT02688387|519884842|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188515|NCT02688387|519884843|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188516|NCT02688387|519884844|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188517|NCT02688387|519884845|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188518|NCT02688387|519884846|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188519|NCT02688387|519884847|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
144188520|NCT02688387|519884848|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188521|NCT02688387|519884849|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188522|NCT02688387|519884850|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188523|NCT02688387|519884851|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188524|NCT02688387|519884852|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188525|NCT02688387|519884853|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188526|NCT02688387|519884854|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
144188527|NCT02688387|519884833|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188528|NCT02688387|519884834|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188529|NCT02688387|519884835|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188530|NCT02688387|519884836|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188531|NCT02688387|519884837|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188532|NCT02688387|519884838|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188533|NCT02688387|519884839|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188534|NCT02688387|519884840|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188535|NCT02688387|519884841|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188536|NCT02688387|519884842|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188537|NCT02688387|519884843|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188538|NCT02688387|519884844|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188539|NCT02688387|519884845|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188540|NCT02688387|519884846|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188541|NCT02688387|519884847|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188542|NCT02688387|519884848|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188543|NCT02688387|519884849|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188544|NCT02688387|519884850|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188545|NCT02688387|519884851|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188546|NCT02688387|519884852|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188547|NCT02688387|519884853|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
144188548|NCT02688387|519884854|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
144188549|NCT02688387|519884833|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144438182|NCT01481116|520809462|FG002|Overall Study|Participant Moved Out of Area|1|||
144438183|NCT01481116|520809460|FG000|Overall Study|Participant Moved Out of Country|1|||
144438184|NCT01481116|520809461|FG001|Overall Study|Participant Moved Out of Country|0|||
144438185|NCT01481116|520809462|FG002|Overall Study|Participant Moved Out of Country|1|||
144438186|NCT01481116|520809460|FG000|Overall Study|Investigator Decision|3|||
144438187|NCT01481116|520809461|FG001|Overall Study|Investigator Decision|2|||
144438188|NCT01481116|520809462|FG002|Overall Study|Investigator Decision|1|||
144188550|NCT02688387|519884834|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144438189|NCT01481116|520809460|FG000|Overall Study|Sponsor Decision|0|||
144438190|NCT01481116|520809461|FG001|Overall Study|Sponsor Decision|1|||
144438191|NCT01481116|520809462|FG002|Overall Study|Sponsor Decision|3|||
144438192|NCT01481116|520809460|FG000|Overall Study|Non-Compliant With Study Drug|0|||
144438193|NCT01481116|520809461|FG001|Overall Study|Non-Compliant With Study Drug|1|||
144188551|NCT02688387|519884835|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188552|NCT02688387|519884836|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188553|NCT02688387|519884837|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188554|NCT02688387|519884838|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188555|NCT02688387|519884839|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188556|NCT02688387|519884840|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188557|NCT02688387|519884841|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188558|NCT02688387|519884842|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188559|NCT02688387|519884843|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188560|NCT02688387|519884844|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188561|NCT02688387|519884845|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188562|NCT02688387|519884846|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188563|NCT02688387|519884847|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188564|NCT02688387|519884848|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188565|NCT02688387|519884849|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188566|NCT02688387|519884850|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188567|NCT02688387|519884851|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
144188568|NCT02688387|519884852|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188569|NCT02688387|519884853|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
144188570|NCT02688387|519884854|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
144188571|NCT02688387|519884833|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188572|NCT02688387|519884834|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188573|NCT02688387|519884835|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188574|NCT02688387|519884836|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188575|NCT02688387|519884837|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188576|NCT02688387|519884838|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188577|NCT02688387|519884839|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188578|NCT02688387|519884840|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188579|NCT02688387|519884841|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188580|NCT02688387|519884842|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188581|NCT02688387|519884843|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188582|NCT02688387|519884844|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188583|NCT02688387|519884845|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188584|NCT02688387|519884846|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188585|NCT02688387|519884847|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188586|NCT02688387|519884848|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188587|NCT02688387|519884849|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188588|NCT02688387|519884850|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188589|NCT02688387|519884851|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188590|NCT02688387|519884852|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
144188591|NCT02688387|519884853|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188592|NCT02688387|519884854|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
144188593|NCT00802178|519884855|FG000|Overall Study|Lack of Efficacy|36|||
144188594|NCT00802178|519884855|FG000|Overall Study|Insufficient tolerability (IT)|17|||
144188595|NCT00802178|519884855|FG000|Overall Study|Withdrawal by Subject|18|||
144188596|NCT00802178|519884855|FG000|Overall Study|Other|32|||
144188597|NCT00802178|519884855|FG000|Overall Study|Lack of efficacy and patient wish|1|||
144188598|NCT00802178|519884855|FG000|Overall Study|IT and patient wish|8|||
144188599|NCT00802178|519884855|FG000|Overall Study|Patients wish and other reason|1|||
144188600|NCT00831233|519884856|FG000|Overall Study|Adverse Event|0|||
144188601|NCT00831233|519884857|FG001|Overall Study|Adverse Event|1|||
144188602|NCT00831233|519884856|FG000|Overall Study|Protocol Violation|1|||
144188603|NCT00831233|519884857|FG001|Overall Study|Protocol Violation|0|||
144188604|NCT00831233|519884856|FG000|Overall Study|Selection Criteria Not Met|2|||
144188605|NCT00831233|519884857|FG001|Overall Study|Selection Criteria Not Met|0|||
144188606|NCT01976728|519884858|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
144188607|NCT01976728|519884859|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
144188608|NCT01976728|519884860|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
144188609|NCT01976728|519884861|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
144188610|NCT02356211|519884862|FG000|Overall Study|Withdrawal by Subject|2|||
144188611|NCT02356211|519884863|FG001|Overall Study|Withdrawal by Subject|2|||
144438194|NCT01481116|520809462|FG002|Overall Study|Non-Compliant With Study Drug|1|||
144188612|NCT02356211|519884862|FG000|Overall Study|ineligible|1|||
144253507|NCT02496039|520128099|FG000|Overall Study|Protocol Violation|1|||
144188613|NCT02356211|519884863|FG001|Overall Study|ineligible|8|||
144188614|NCT02211014|519884864|FG000|Overall Study|Adverse Event|0|||
144188615|NCT02211014|519884865|FG001|Overall Study|Adverse Event|2|||
144188616|NCT02211014|519884864|FG000|Overall Study|Physician Decision|1|||
144188617|NCT02211014|519884865|FG001|Overall Study|Physician Decision|2|||
144188618|NCT02211014|519884864|FG000|Overall Study|Started another cancer therapy|1|||
144188619|NCT02211014|519884865|FG001|Overall Study|Started another cancer therapy|0|||
144188620|NCT02211014|519884864|FG000|Overall Study|Withdrawal by Subject|0|||
144188621|NCT02211014|519884865|FG001|Overall Study|Withdrawal by Subject|1|||
144188622|NCT02211014|519884864|FG000|Overall Study|In agreement with patient, no benefit|0|||
144188623|NCT02211014|519884865|FG001|Overall Study|In agreement with patient, no benefit|1|||
144188624|NCT00966381|519884866|FG000|Overall Study|Withdrawal by Subject|2|||
144188625|NCT00966381|519884867|FG001|Overall Study|Withdrawal by Subject|2|||
144188626|NCT01124695|519884868|FG000|Overall Study|Disease progression|77|||
144188627|NCT01124695|519884868|FG000|Overall Study|Adverse Event|11|||
144188628|NCT01124695|519884868|FG000|Overall Study|Death|1|||
144188629|NCT01124695|519884868|FG000|Overall Study|Withdrawal by Subject|7|||
144188630|NCT01124695|519884868|FG000|Overall Study|Physician Decision|3|||
144188631|NCT01124695|519884868|FG000|Overall Study|Alternative therapy|9|||
144188632|NCT01124695|519884868|FG000|Overall Study|No documentation that patient went off treatment|4|||
144188633|NCT01124695|519884868|FG000|Overall Study|Ineligible|9|||
144188634|NCT01124695|519884868|FG000|Overall Study|Ineligible and never start treatment|2|||
144188635|NCT01796964|519884873|FG000|Overall Study|Adverse Event|1|||
144188636|NCT01796964|519884874|FG001|Overall Study|Adverse Event|1|||
144188637|NCT01796964|519884873|FG000|Overall Study|Death|1|||
144188638|NCT01796964|519884874|FG001|Overall Study|Death|0|||
144188639|NCT01796964|519884873|FG000|Overall Study|Protocol Violation|0|||
144188640|NCT01796964|519884874|FG001|Overall Study|Protocol Violation|1|||
144188641|NCT01796964|519884873|FG000|Overall Study|Withdrawal by Subject|1|||
144188642|NCT01796964|519884874|FG001|Overall Study|Withdrawal by Subject|1|||
144188643|NCT04025684|519884875|FG000|Overall Study|Withdrawal by Subject|1|||
144188644|NCT04025684|519884876|FG001|Overall Study|Withdrawal by Subject|1|||
144188645|NCT04025684|519884877|FG002|Overall Study|Withdrawal by Subject|0|||
144188646|NCT04025684|519884878|FG003|Overall Study|Withdrawal by Subject|0|||
144188647|NCT04025684|519884875|FG000|Overall Study|Multiple reasons|1|||
144188648|NCT04025684|519884876|FG001|Overall Study|Multiple reasons|3|||
144188649|NCT04025684|519884877|FG002|Overall Study|Multiple reasons|0|||
144188650|NCT04025684|519884878|FG003|Overall Study|Multiple reasons|1|||
144188651|NCT02000531|519884885|FG000|Overall Study|Lost to Follow-up|1|||
144188652|NCT02000531|519884886|FG001|Overall Study|Lost to Follow-up|0|||
144188653|NCT02000531|519884885|FG000|Overall Study|Discontinued due to data cut-off|3|||
144188654|NCT02000531|519884886|FG001|Overall Study|Discontinued due to data cut-off|8|||
144188655|NCT01345318|519884893|FG000|Overall Study|Adverse Event|16|||
144188656|NCT01345318|519884893|FG000|Overall Study|Lack of Efficacy|17|||
144188657|NCT01345318|519884893|FG000|Overall Study|Lost to Follow-up|2|||
144188658|NCT01345318|519884893|FG000|Overall Study|Protocol Violation|1|||
144188659|NCT01345318|519884893|FG000|Overall Study|Withdrawal by Subject|41|||
144188660|NCT01345318|519884893|FG000|Overall Study|Other|3|||
144188661|NCT00573170|519884894|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
144188662|NCT00573170|519884895|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
144188663|NCT00573170|519884896|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
144188664|NCT00573170|519884897|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
144188665|NCT00573170|519884898|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
144188666|NCT00573170|519884899|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
144188667|NCT00573170|519884894|FG000|First Washout Period|Adverse Event|1|||
144188668|NCT00573170|519884895|FG001|First Washout Period|Adverse Event|1|||
144188669|NCT00573170|519884896|FG002|First Washout Period|Adverse Event|0|||
144188670|NCT00573170|519884897|FG003|First Washout Period|Adverse Event|0|||
144188671|NCT00573170|519884898|FG004|First Washout Period|Adverse Event|0|||
144188672|NCT00573170|519884899|FG005|First Washout Period|Adverse Event|1|||
144188673|NCT00573170|519884894|FG000|First Washout Period|Lack of Efficacy|0|||
144188674|NCT00573170|519884895|FG001|First Washout Period|Lack of Efficacy|0|||
144188675|NCT00573170|519884896|FG002|First Washout Period|Lack of Efficacy|0|||
144188676|NCT00573170|519884897|FG003|First Washout Period|Lack of Efficacy|0|||
144188677|NCT00573170|519884898|FG004|First Washout Period|Lack of Efficacy|0|||
144188678|NCT00573170|519884899|FG005|First Washout Period|Lack of Efficacy|1|||
144188679|NCT00573170|519884894|FG000|First Washout Period|Lost to Follow-up|1|||
144188680|NCT00573170|519884895|FG001|First Washout Period|Lost to Follow-up|1|||
144188681|NCT00573170|519884896|FG002|First Washout Period|Lost to Follow-up|0|||
144188682|NCT00573170|519884897|FG003|First Washout Period|Lost to Follow-up|2|||
144188683|NCT00573170|519884898|FG004|First Washout Period|Lost to Follow-up|0|||
144188684|NCT00573170|519884899|FG005|First Washout Period|Lost to Follow-up|2|||
144188685|NCT00573170|519884894|FG000|First Washout Period|Withdrawal by Subject|2|||
144188686|NCT00573170|519884895|FG001|First Washout Period|Withdrawal by Subject|0|||
144188687|NCT00573170|519884896|FG002|First Washout Period|Withdrawal by Subject|0|||
144188688|NCT00573170|519884897|FG003|First Washout Period|Withdrawal by Subject|2|||
144188689|NCT00573170|519884898|FG004|First Washout Period|Withdrawal by Subject|3|||
144188690|NCT00573170|519884899|FG005|First Washout Period|Withdrawal by Subject|3|||
144188691|NCT00573170|519884894|FG000|First Washout Period|Other|4|||
144188692|NCT00573170|519884895|FG001|First Washout Period|Other|0|||
144188693|NCT00573170|519884896|FG002|First Washout Period|Other|1|||
144188694|NCT00573170|519884897|FG003|First Washout Period|Other|1|||
144188695|NCT00573170|519884898|FG004|First Washout Period|Other|0|||
144188696|NCT00573170|519884899|FG005|First Washout Period|Other|0|||
144188697|NCT00573170|519884894|FG000|Second Washout Period|Adverse Event|1|||
144188698|NCT00573170|519884895|FG001|Second Washout Period|Adverse Event|0|||
144188699|NCT00573170|519884896|FG002|Second Washout Period|Adverse Event|0|||
144188700|NCT00573170|519884897|FG003|Second Washout Period|Adverse Event|0|||
144188701|NCT00573170|519884898|FG004|Second Washout Period|Adverse Event|1|||
144188702|NCT00573170|519884899|FG005|Second Washout Period|Adverse Event|0|||
144188703|NCT00573170|519884894|FG000|Second Washout Period|Protocol Violation|2|||
144188704|NCT00573170|519884895|FG001|Second Washout Period|Protocol Violation|1|||
144188705|NCT00573170|519884896|FG002|Second Washout Period|Protocol Violation|1|||
144188706|NCT00573170|519884897|FG003|Second Washout Period|Protocol Violation|0|||
144188707|NCT00573170|519884898|FG004|Second Washout Period|Protocol Violation|0|||
144188708|NCT00573170|519884899|FG005|Second Washout Period|Protocol Violation|0|||
144188709|NCT00573170|519884894|FG000|Second Washout Period|Withdrawal by Subject|1|||
144188710|NCT00573170|519884895|FG001|Second Washout Period|Withdrawal by Subject|1|||
144188711|NCT00573170|519884896|FG002|Second Washout Period|Withdrawal by Subject|2|||
144188712|NCT00573170|519884897|FG003|Second Washout Period|Withdrawal by Subject|0|||
144188713|NCT00573170|519884898|FG004|Second Washout Period|Withdrawal by Subject|1|||
144188714|NCT00573170|519884899|FG005|Second Washout Period|Withdrawal by Subject|0|||
144188715|NCT00573170|519884894|FG000|Second Washout Period|Lost to Follow-up|0|||
144188716|NCT00573170|519884895|FG001|Second Washout Period|Lost to Follow-up|0|||
144188717|NCT00573170|519884896|FG002|Second Washout Period|Lost to Follow-up|0|||
144188718|NCT00573170|519884897|FG003|Second Washout Period|Lost to Follow-up|1|||
144188719|NCT00573170|519884898|FG004|Second Washout Period|Lost to Follow-up|0|||
144188720|NCT00573170|519884899|FG005|Second Washout Period|Lost to Follow-up|0|||
144188721|NCT00573170|519884894|FG000|Second Washout Period|Other|1|||
144188722|NCT00573170|519884895|FG001|Second Washout Period|Other|2|||
144188723|NCT00573170|519884896|FG002|Second Washout Period|Other|1|||
144188724|NCT00573170|519884897|FG003|Second Washout Period|Other|4|||
144188725|NCT00573170|519884898|FG004|Second Washout Period|Other|6|||
144188726|NCT00573170|519884899|FG005|Second Washout Period|Other|2|||
144188727|NCT00573170|519884894|FG000|Third Treatment Period|Withdrawal by Subject|1|||
144188728|NCT00573170|519884895|FG001|Third Treatment Period|Withdrawal by Subject|0|||
144188729|NCT00573170|519884896|FG002|Third Treatment Period|Withdrawal by Subject|0|||
144188730|NCT00573170|519884897|FG003|Third Treatment Period|Withdrawal by Subject|0|||
144188731|NCT00573170|519884898|FG004|Third Treatment Period|Withdrawal by Subject|0|||
144188732|NCT00573170|519884899|FG005|Third Treatment Period|Withdrawal by Subject|0|||
144188733|NCT00573170|519884894|FG000|Third Treatment Period|Lost to Follow-up|0|||
144188734|NCT00573170|519884895|FG001|Third Treatment Period|Lost to Follow-up|0|||
144188735|NCT00573170|519884896|FG002|Third Treatment Period|Lost to Follow-up|0|||
144188736|NCT00573170|519884897|FG003|Third Treatment Period|Lost to Follow-up|0|||
144188737|NCT00573170|519884898|FG004|Third Treatment Period|Lost to Follow-up|0|||
144188738|NCT00573170|519884899|FG005|Third Treatment Period|Lost to Follow-up|2|||
144188739|NCT05966090|519884900|FG000|Overall Study|Lost to Follow-up|6|||
144188740|NCT05966090|519884901|FG001|Overall Study|Lost to Follow-up|6|||
144188741|NCT05966090|519884900|FG000|Overall Study|Adverse Event|1|||
144188742|NCT05966090|519884901|FG001|Overall Study|Adverse Event|1|||
144188743|NCT05966090|519884900|FG000|Overall Study|Withdrawal by Subject|1|||
144188744|NCT05966090|519884901|FG001|Overall Study|Withdrawal by Subject|1|||
144188745|NCT05966090|519884900|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144188746|NCT05966090|519884901|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
144188747|NCT05966090|519884900|FG000|Overall Study|Other|1|||
144188748|NCT05966090|519884901|FG001|Overall Study|Other|1|||
144724336|NCT01505530|521846340|FG000|Overall Study|Adverse Event|1|||
144188749|NCT02001051|519884902|FG000|Overall Study|Deemed not eligible following enrollment|0|||
144188750|NCT02001051|519884903|FG001|Overall Study|Deemed not eligible following enrollment|1|||
144188751|NCT00309985|519884910|FG000|Overall Study|Disease progression|12|||
144188752|NCT00309985|519884911|FG001|Overall Study|Disease progression|0|||
144188753|NCT00309985|519884910|FG000|Overall Study|Adverse Event|30|||
144188754|NCT00309985|519884911|FG001|Overall Study|Adverse Event|0|||
144188755|NCT00309985|519884910|FG000|Overall Study|Death|2|||
144188756|NCT00309985|519884911|FG001|Overall Study|Death|0|||
144188757|NCT00309985|519884910|FG000|Overall Study|Withdrawal by Subject|5|||
144188758|NCT00309985|519884911|FG001|Overall Study|Withdrawal by Subject|1|||
144188759|NCT00309985|519884910|FG000|Overall Study|Physician Decision|3|||
144188760|NCT00309985|519884911|FG001|Overall Study|Physician Decision|0|||
144188761|NCT00309985|519884910|FG000|Overall Study|Never started treatment|7|||
144188762|NCT00309985|519884911|FG001|Overall Study|Never started treatment|0|||
144188763|NCT00309985|519884910|FG000|Overall Study|Complicating disease|1|||
144188764|NCT00309985|519884911|FG001|Overall Study|Complicating disease|0|||
144188765|NCT00309985|519884910|FG000|Overall Study|Non-compliance|1|||
144188766|NCT00309985|519884911|FG001|Overall Study|Non-compliance|0|||
144188767|NCT00309985|519884910|FG000|Overall Study|Chemotherapy discontinued only|1|||
144188768|NCT00309985|519884911|FG001|Overall Study|Chemotherapy discontinued only|0|||
144188769|NCT01256060|519884922|FG000|Overall Study|Lost to Follow-up|0|||
144188770|NCT01256060|519884923|FG001|Overall Study|Lost to Follow-up|1|||
144188771|NCT01256060|519884924|FG002|Overall Study|Lost to Follow-up|0|||
144188772|NCT01256060|519884925|FG003|Overall Study|Lost to Follow-up|0|||
144188773|NCT00985231|519884926|FG000|Overall Study|ineligible|1|||
144188774|NCT00985231|519884927|FG001|Overall Study|ineligible|0|||
144188775|NCT00985231|519884926|FG000|Overall Study|Protocol Violation|1|||
144188776|NCT00985231|519884927|FG001|Overall Study|Protocol Violation|0|||
144188777|NCT00985231|519884926|FG000|Overall Study|Withdrawal by Subject|1|||
144188778|NCT00985231|519884927|FG001|Overall Study|Withdrawal by Subject|0|||
144188779|NCT00985231|519884926|FG000|Overall Study|Lost to Follow-up|0|||
144188780|NCT00985231|519884927|FG001|Overall Study|Lost to Follow-up|1|||
144188781|NCT00985231|519884926|FG000|Overall Study|Study related symptoms & complaints|0|||
144188782|NCT00985231|519884927|FG001|Overall Study|Study related symptoms & complaints|2|||
144188783|NCT00089076|519884931|FG000|Overall Study|Alternate Therapy|1|||
144188784|NCT00089076|519884931|FG000|Overall Study|Withdrawal by Subject|2|||
144188785|NCT00089076|519884931|FG000|Overall Study|Progression|7|||
144188786|NCT01857973|519884934|FG000|Overall Study|Subject did not meet required BG range|3|||
144188787|NCT01857973|519884934|FG000|Overall Study|drop out after 3 failed attempts|1|||
144188788|NCT01857973|519884934|FG000|Overall Study|Physician Decision|1|||
144188789|NCT01701973|519884935|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188790|NCT01701973|519884936|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
144188791|NCT01701973|519884937|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188792|NCT01701973|519884938|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188793|NCT01701973|519884939|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188794|NCT01701973|519884940|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188795|NCT01701973|519884941|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188796|NCT01701973|519884942|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
144188797|NCT02663882|519884945|FG000|Overall Study|Lost to Follow-up|4|||
144188798|NCT02663882|519884946|FG001|Overall Study|Lost to Follow-up|2|||
144188799|NCT01083680|519884950|FG000|Overall Study|Lost to Follow-up|2758|||
144188800|NCT01083680|519884950|FG000|Overall Study|Withdrawal by Subject|1086|||
144188801|NCT00003531|519884953|FG000|Overall Study|Not evaluable|10|||
144188802|NCT00346164|519884954|FG000|Overall Study|Adverse Event|0|||
144188803|NCT00346164|519884955|FG001|Overall Study|Adverse Event|0|||
144188804|NCT00346164|519884956|FG002|Overall Study|Adverse Event|0|||
144188805|NCT00346164|519884957|FG003|Overall Study|Adverse Event|1|||
144188806|NCT00346164|519884954|FG000|Overall Study|Lack of Efficacy|0|||
144188807|NCT00346164|519884955|FG001|Overall Study|Lack of Efficacy|1|||
144188808|NCT00346164|519884956|FG002|Overall Study|Lack of Efficacy|7|||
144188809|NCT00346164|519884957|FG003|Overall Study|Lack of Efficacy|25|||
144188810|NCT00346164|519884954|FG000|Overall Study|Physician Decision|0|||
144188811|NCT00346164|519884955|FG001|Overall Study|Physician Decision|1|||
144188812|NCT00346164|519884956|FG002|Overall Study|Physician Decision|2|||
144188813|NCT00346164|519884957|FG003|Overall Study|Physician Decision|27|||
144188814|NCT00346164|519884954|FG000|Overall Study|Protocol Violation|6|||
144188815|NCT00346164|519884955|FG001|Overall Study|Protocol Violation|2|||
144188816|NCT00346164|519884956|FG002|Overall Study|Protocol Violation|10|||
144188817|NCT00346164|519884957|FG003|Overall Study|Protocol Violation|4|||
144188818|NCT00346164|519884954|FG000|Overall Study|Withdrawal by Subject|0|||
144188819|NCT00346164|519884955|FG001|Overall Study|Withdrawal by Subject|0|||
144188820|NCT00346164|519884956|FG002|Overall Study|Withdrawal by Subject|2|||
144188821|NCT00346164|519884957|FG003|Overall Study|Withdrawal by Subject|0|||
144188822|NCT00346164|519884954|FG000|Overall Study|Ineligible|11|||
144188823|NCT00346164|519884955|FG001|Overall Study|Ineligible|2|||
144188824|NCT00346164|519884956|FG002|Overall Study|Ineligible|2|||
144188825|NCT00346164|519884957|FG003|Overall Study|Ineligible|23|||
144188826|NCT00346164|519884954|FG000|Overall Study|Refusal of further protocol therapy|0|||
144188827|NCT00346164|519884955|FG001|Overall Study|Refusal of further protocol therapy|1|||
144188828|NCT00346164|519884956|FG002|Overall Study|Refusal of further protocol therapy|3|||
144724337|NCT01505530|521846341|FG001|Overall Study|Adverse Event|1|||
144188829|NCT00346164|519884957|FG003|Overall Study|Refusal of further protocol therapy|15|||
144188830|NCT00346164|519884954|FG000|Overall Study|Inability to start week 16 tx on time|0|||
144188831|NCT00346164|519884955|FG001|Overall Study|Inability to start week 16 tx on time|0|||
144188832|NCT00346164|519884956|FG002|Overall Study|Inability to start week 16 tx on time|0|||
144188833|NCT00346164|519884957|FG003|Overall Study|Inability to start week 16 tx on time|11|||
144188834|NCT01198873|519884958|FG000|Overall Study|Adverse Event|4|||
144188835|NCT01198873|519884959|FG001|Overall Study|Adverse Event|7|||
144188836|NCT01198873|519884958|FG000|Overall Study|Study closure|29|||
144188837|NCT01198873|519884959|FG001|Overall Study|Study closure|23|||
144188838|NCT01198873|519884958|FG000|Overall Study|Other than above|4|||
144188839|NCT01198873|519884959|FG001|Overall Study|Other than above|2|||
144188840|NCT02692482|519884960|FG000|Overall Study|Death|2|||
144188841|NCT02692482|519884961|FG001|Overall Study|Death|2|||
144188842|NCT02692482|519884960|FG000|Overall Study|Withdrawal by Subject|1|||
144188843|NCT02692482|519884961|FG001|Overall Study|Withdrawal by Subject|2|||
144188844|NCT02260258|519884965|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
144188845|NCT02260258|519884966|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
144188846|NCT01610063|519884967|FG000|Overall Study|Lost to Follow-up|42|||
144188847|NCT01610063|519884968|FG001|Overall Study|Lost to Follow-up|20|||
144188848|NCT03314662|519884969|FG000|Overall Study|Withdrawal by Subject|1|||
144188849|NCT03314662|519884970|FG001|Overall Study|Withdrawal by Subject|1|||
144188850|NCT03314662|519884971|FG002|Overall Study|Withdrawal by Subject|1|||
144188851|NCT03314662|519884969|FG000|Overall Study|Lost to Follow-up|5|||
144188852|NCT03314662|519884970|FG001|Overall Study|Lost to Follow-up|4|||
144188853|NCT03314662|519884971|FG002|Overall Study|Lost to Follow-up|4|||
144188854|NCT03314662|519884969|FG000|Overall Study|Death|2|||
144188855|NCT03314662|519884970|FG001|Overall Study|Death|0|||
144188856|NCT03314662|519884971|FG002|Overall Study|Death|0|||
144188857|NCT00925301|519884978|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
144188858|NCT00925301|519884979|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
144188859|NCT00925301|519884980|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
144188860|NCT00925301|519884981|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
144188861|NCT00925301|519884978|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
144188862|NCT00925301|519884979|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
144188863|NCT00925301|519884980|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
144188864|NCT00925301|519884981|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
144188865|NCT00925301|519884978|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
144188866|NCT00925301|519884979|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
144188867|NCT00925301|519884980|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
144188868|NCT00925301|519884981|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
144188869|NCT00925301|519884978|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
144188870|NCT00925301|519884979|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
144188871|NCT00925301|519884980|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
144188872|NCT00925301|519884981|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
144188873|NCT00925301|519884978|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
144188874|NCT00925301|519884979|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
144188875|NCT00925301|519884980|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
144188876|NCT00925301|519884981|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
144188877|NCT00925301|519884978|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
144188878|NCT00925301|519884979|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
144188879|NCT00925301|519884980|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
144530449|NCT04132518|521144353|FG002|Overall Study|Prematurely withdrawn from the study|1|||
144530450|NCT04056611|521144356|FG000|Overall Study|Physician Decision|1|||
144530451|NCT02631746|521144357|FG000|Overall Study|Lack of Efficacy|3|||
144530452|NCT05069896|521144359|FG000|Overall Study|Adverse Event|0|||
144530453|NCT05069896|521144360|FG001|Overall Study|Adverse Event|1|||
144530454|NCT05069896|521144361|FG002|Overall Study|Adverse Event|1|||
144530455|NCT05069896|521144362|FG003|Overall Study|Adverse Event|0|||
144530456|NCT05069896|521144363|FG004|Overall Study|Adverse Event|0|||
144530457|NCT05069896|521144364|FG005|Overall Study|Adverse Event|0|||
144530458|NCT05069896|521144359|FG000|Overall Study|Lost to Follow-up|0|||
144530459|NCT05069896|521144360|FG001|Overall Study|Lost to Follow-up|0|||
144530460|NCT05069896|521144361|FG002|Overall Study|Lost to Follow-up|1|||
144530461|NCT05069896|521144362|FG003|Overall Study|Lost to Follow-up|0|||
144530462|NCT05069896|521144363|FG004|Overall Study|Lost to Follow-up|1|||
144530463|NCT05069896|521144364|FG005|Overall Study|Lost to Follow-up|2|||
144530464|NCT04068831|521144365|FG000|Overall Study|Disease Progression|10|||
144530465|NCT04068831|521144366|FG001|Overall Study|Disease Progression|8|||
144530466|NCT02839265|521144368|FG000|Overall Study|Screen Failure|2|||
144530467|NCT02839265|521144368|FG000|Overall Study|Death|1|||
144530468|NCT02839265|521144368|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
144530469|NCT04167553|521144371|FG000|Overall Study|Withdrawal by Subject|1|||
144530470|NCT04167553|521144372|FG001|Overall Study|Withdrawal by Subject|0|||
144530471|NCT04167553|521144373|FG002|Overall Study|Withdrawal by Subject|1|||
144530472|NCT04167553|521144374|FG003|Overall Study|Withdrawal by Subject|2|||
144530473|NCT04167553|521144375|FG004|Overall Study|Withdrawal by Subject|1|||
144188880|NCT00925301|519884981|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
144188881|NCT00925301|519884978|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
144530474|NCT04167553|521144376|FG005|Overall Study|Withdrawal by Subject|0|||
144530475|NCT04167553|521144377|FG006|Overall Study|Withdrawal by Subject|0|||
144530476|NCT04167553|521144371|FG000|Overall Study|Physician Decision|0|||
144530477|NCT04167553|521144372|FG001|Overall Study|Physician Decision|0|||
144530478|NCT04167553|521144373|FG002|Overall Study|Physician Decision|0|||
144530479|NCT04167553|521144374|FG003|Overall Study|Physician Decision|0|||
144530480|NCT04167553|521144375|FG004|Overall Study|Physician Decision|2|||
144530481|NCT04167553|521144376|FG005|Overall Study|Physician Decision|2|||
144530482|NCT04167553|521144377|FG006|Overall Study|Physician Decision|0|||
144530483|NCT04167553|521144371|FG000|Overall Study|Lost to Follow-up|0|||
144530484|NCT04167553|521144372|FG001|Overall Study|Lost to Follow-up|0|||
144530485|NCT04167553|521144373|FG002|Overall Study|Lost to Follow-up|2|||
144604723|NCT00601250|521414390|FG001|Overall Study|Other incl. lack of efficacy|9|||
144604724|NCT01810016|521414391|FG000|Overall Study|Progressive disease|1|||
144604725|NCT01810016|521414392|FG001|Overall Study|Progressive disease|1|||
144604726|NCT01810016|521414393|FG002|Overall Study|Progressive disease|0|||
144604727|NCT01810016|521414391|FG000|Overall Study|Death|0|||
144604728|NCT01810016|521414392|FG001|Overall Study|Death|0|||
144604729|NCT01810016|521414393|FG002|Overall Study|Death|1|||
144604730|NCT02553265|521415797|FG000|Enrollment|Death|0|||
144604731|NCT02553265|521415798|FG001|Enrollment|Death|0|||
144604732|NCT02553265|521415799|FG002|Enrollment|Death|1|||
144604733|NCT02553265|521415797|FG000|First Intervention (28 Days)|Adverse Event|1|||
144604734|NCT02553265|521415798|FG001|First Intervention (28 Days)|Adverse Event|0|||
144604735|NCT02553265|521415799|FG002|First Intervention (28 Days)|Adverse Event|0|||
144604736|NCT02553265|521415797|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
144604737|NCT02553265|521415798|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
144604738|NCT02553265|521415799|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
144724338|NCT01505530|521846342|FG002|Overall Study|Adverse Event|0|||
144724339|NCT01505530|521846340|FG000|Overall Study|Withdrawal by Subject|7|||
144188882|NCT00925301|519884979|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
144188883|NCT00925301|519884980|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
144188884|NCT00925301|519884981|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
144188885|NCT03043560|519884982|FG000|Overall Study|Discontinued Intervention|1|||
144188886|NCT03043560|519884983|FG001|Overall Study|Discontinued Intervention|2|||
144188887|NCT03043560|519884982|FG000|Overall Study|Lost to Follow-up|0|||
144188888|NCT03043560|519884983|FG001|Overall Study|Lost to Follow-up|1|||
144188889|NCT01117766|519884984|FG000|First Intervention|Adverse Event|0|||
144530486|NCT04167553|521144374|FG003|Overall Study|Lost to Follow-up|0|||
144530487|NCT04167553|521144375|FG004|Overall Study|Lost to Follow-up|0|||
144530488|NCT04167553|521144376|FG005|Overall Study|Lost to Follow-up|0|||
144530489|NCT04167553|521144377|FG006|Overall Study|Lost to Follow-up|0|||
144530490|NCT05660434|521144379|FG000|Overall Study|Never obtained study materials|2|||
144530491|NCT05660434|521144380|FG001|Overall Study|Never obtained study materials|1|||
144530492|NCT04479761|521144395|FG000|Overall Study|could not perform the balance tasks|1|||
144530493|NCT04479761|521144396|FG001|Overall Study|could not perform the balance tasks|0|||
144530494|NCT04479761|521144397|FG002|Overall Study|could not perform the balance tasks|0|||
144530495|NCT04479761|521144395|FG000|Overall Study|Adverse Event|1|||
144530496|NCT04479761|521144396|FG001|Overall Study|Adverse Event|0|||
144530497|NCT04479761|521144397|FG002|Overall Study|Adverse Event|0|||
144530498|NCT04479761|521144395|FG000|Overall Study|one control did not meet screening criteria|0|||
144530499|NCT04479761|521144396|FG001|Overall Study|one control did not meet screening criteria|0|||
144530500|NCT04479761|521144397|FG002|Overall Study|one control did not meet screening criteria|1|||
144530501|NCT04479761|521144395|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
144530502|NCT04479761|521144396|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
144530503|NCT04479761|521144397|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
144530504|NCT04183283|521146246|FG000|Period 1|Withdrawal by Subject|0|||
144530505|NCT04183283|521146247|FG001|Period 1|Withdrawal by Subject|1|||
144530506|NCT04183283|521146248|FG002|Period 1|Withdrawal by Subject|0|||
144530507|NCT04183283|521146249|FG003|Period 1|Withdrawal by Subject|0|||
144530508|NCT04183283|521146246|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
144530509|NCT04183283|521146247|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
144530510|NCT04183283|521146248|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
144530511|NCT04183283|521146249|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
144530512|NCT04197336|521146250|FG000|Overall Study|Withdrawal by Subject|1|||
144530513|NCT04101357|521146251|FG000|Overall Study|Death|1|||
144530514|NCT04101357|521146252|FG001|Overall Study|Death|1|||
144530515|NCT04101357|521146253|FG002|Overall Study|Death|1|||
144530516|NCT04101357|521146254|FG003|Overall Study|Death|2|||
144530517|NCT04101357|521146255|FG004|Overall Study|Death|4|||
144530518|NCT04101357|521146256|FG005|Overall Study|Death|11|||
144530519|NCT04101357|521146257|FG006|Overall Study|Death|4|||
144530520|NCT04101357|521146258|FG007|Overall Study|Death|4|||
144530521|NCT04101357|521146259|FG008|Overall Study|Death|5|||
144530522|NCT04101357|521146260|FG009|Overall Study|Death|2|||
144604739|NCT02553265|521415797|FG000|Second Intervention (28 Days)|Adverse Event|1|||
144188890|NCT01117766|519884985|FG001|First Intervention|Adverse Event|1|||
144530523|NCT04101357|521146261|FG010|Overall Study|Death|3|||
144604740|NCT02553265|521415798|FG001|Second Intervention (28 Days)|Adverse Event|0|||
144530524|NCT04101357|521146251|FG000|Overall Study|Trial closure|0|||
144530525|NCT04101357|521146252|FG001|Overall Study|Trial closure|0|||
144188891|NCT01117766|519884984|FG000|First Intervention|Protocol Violation|1|||
144188892|NCT01117766|519884985|FG001|First Intervention|Protocol Violation|0|||
144188893|NCT01117766|519884984|FG000|Washout Period|Protocol Violation|0|||
144188894|NCT01117766|519884985|FG001|Washout Period|Protocol Violation|2|||
144188895|NCT01117766|519884984|FG000|Second Intervention|Lost to Follow-up|1|||
144188896|NCT01117766|519884985|FG001|Second Intervention|Lost to Follow-up|0|||
144188897|NCT01117766|519884984|FG000|Second Intervention|Other|1|||
144188898|NCT01117766|519884985|FG001|Second Intervention|Other|2|||
144188899|NCT01117766|519884984|FG000|Second Intervention|Adverse Event|0|||
144188900|NCT01117766|519884985|FG001|Second Intervention|Adverse Event|2|||
144188901|NCT01117766|519884984|FG000|Second Intervention|Withdrawal by Subject|0|||
144188902|NCT01117766|519884985|FG001|Second Intervention|Withdrawal by Subject|1|||
144188903|NCT04405739|519884986|FG000|Overall Study|Adverse Event|0|||
144188904|NCT04405739|519884987|FG001|Overall Study|Adverse Event|1|||
144188905|NCT04405739|519884988|FG002|Overall Study|Adverse Event|0|||
144188906|NCT04405739|519884989|FG003|Overall Study|Adverse Event|0|||
144188907|NCT04405739|519884986|FG000|Overall Study|Lost to Follow-up|0|||
144188908|NCT04405739|519884987|FG001|Overall Study|Lost to Follow-up|2|||
144188909|NCT04405739|519884988|FG002|Overall Study|Lost to Follow-up|1|||
144188910|NCT04405739|519884989|FG003|Overall Study|Lost to Follow-up|3|||
144188911|NCT04405739|519884986|FG000|Overall Study|Withdrawal by Subject|0|||
144188912|NCT04405739|519884987|FG001|Overall Study|Withdrawal by Subject|2|||
144188913|NCT04405739|519884988|FG002|Overall Study|Withdrawal by Subject|1|||
144188914|NCT04405739|519884989|FG003|Overall Study|Withdrawal by Subject|1|||
144188915|NCT04405739|519884986|FG000|Overall Study|Death|0|||
144188916|NCT04405739|519884987|FG001|Overall Study|Death|0|||
144188917|NCT04405739|519884988|FG002|Overall Study|Death|1|||
144188918|NCT04405739|519884989|FG003|Overall Study|Death|0|||
144188919|NCT04405739|519884986|FG000|Overall Study|Transferred to rehab|0|||
144188920|NCT04405739|519884987|FG001|Overall Study|Transferred to rehab|0|||
144188921|NCT04405739|519884988|FG002|Overall Study|Transferred to rehab|0|||
144188922|NCT04405739|519884989|FG003|Overall Study|Transferred to rehab|1|||
144188923|NCT04405739|519884986|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
144188924|NCT04405739|519884987|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
144188925|NCT04405739|519884988|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
144188926|NCT04405739|519884989|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
144188927|NCT00438659|519884990|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
144188928|NCT00438659|519884991|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
144188929|NCT00438659|519884990|FG000|Overall Study|Cancel|5|||
144188930|NCT00438659|519884991|FG001|Overall Study|Cancel|2|||
144188931|NCT05766787|519884992|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
144188932|NCT05766787|519884993|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
144188933|NCT05766787|519884992|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
144188934|NCT05766787|519884993|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
144188935|NCT05766787|519884992|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
144188936|NCT05766787|519884993|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
144188937|NCT01436643|519884994|FG000|2-week Pre-treatment|Abnormal test result|0|||
144188938|NCT01436643|519884995|FG001|2-week Pre-treatment|Abnormal test result|0|||
144188939|NCT01436643|519884996|FG002|2-week Pre-treatment|Abnormal test result|0|||
144188940|NCT01436643|519884997|FG003|2-week Pre-treatment|Abnormal test result|1|||
144188941|NCT01436643|519884994|FG000|2-week Pre-treatment|Adverse Event|0|||
144188942|NCT01436643|519884995|FG001|2-week Pre-treatment|Adverse Event|0|||
144188943|NCT01436643|519884996|FG002|2-week Pre-treatment|Adverse Event|0|||
144188944|NCT01436643|519884997|FG003|2-week Pre-treatment|Adverse Event|5|||
144188945|NCT01436643|519884994|FG000|2-week Pre-treatment|Protocol Violation|0|||
144188946|NCT01436643|519884995|FG001|2-week Pre-treatment|Protocol Violation|0|||
144604741|NCT02553265|521415799|FG002|Second Intervention (28 Days)|Adverse Event|0|||
144724340|NCT01505530|521846341|FG001|Overall Study|Withdrawal by Subject|8|||
144188947|NCT01436643|519884996|FG002|2-week Pre-treatment|Protocol Violation|0|||
144188948|NCT01436643|519884997|FG003|2-week Pre-treatment|Protocol Violation|4|||
144188949|NCT01436643|519884994|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
144188950|NCT01436643|519884995|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
144188951|NCT01436643|519884996|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
144188952|NCT01436643|519884997|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
144188953|NCT01436643|519884994|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
144188954|NCT01436643|519884995|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
144188955|NCT01436643|519884996|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
144188956|NCT01436643|519884997|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
144188957|NCT01436643|519884994|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
144188958|NCT01436643|519884995|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
144188959|NCT01436643|519884996|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
144188960|NCT01436643|519884997|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
144188961|NCT01867606|519884998|FG000|Overall Study|Withdrawal by Subject|10|||
144188962|NCT01867606|519884999|FG001|Overall Study|Withdrawal by Subject|14|||
144188963|NCT01867606|519884998|FG000|Overall Study|Protocol Violation|0|||
144188964|NCT01867606|519884999|FG001|Overall Study|Protocol Violation|1|||
144188965|NCT01378962|519885000|FG000|Overall Study|Death|14|||
144188966|NCT01378962|519885000|FG000|Overall Study|Lost to Follow-up|1|||
144188967|NCT01378962|519885000|FG000|Overall Study|Other|2|||
144188968|NCT02056652|519885001|FG000|Overall Study|Withdrawal by Subject|1|||
144188969|NCT02056652|519885002|FG001|Overall Study|Withdrawal by Subject|0|||
144188970|NCT02056652|519885001|FG000|Overall Study|Lost to Follow-up|0|||
144188971|NCT02056652|519885002|FG001|Overall Study|Lost to Follow-up|3|||
144188972|NCT01917968|519885003|FG000|Overall Study|Death|3|||
144188973|NCT01917968|519885004|FG001|Overall Study|Death|2|||
144188974|NCT01917968|519885003|FG000|Overall Study|Lost to Follow-up|21|||
144188975|NCT01917968|519885004|FG001|Overall Study|Lost to Follow-up|39|||
144188976|NCT01917968|519885003|FG000|Overall Study|Physician Decision|1|||
144188977|NCT01917968|519885004|FG001|Overall Study|Physician Decision|2|||
144188978|NCT01917968|519885003|FG000|Overall Study|Withdrawal by Subject|20|||
144188979|NCT01917968|519885004|FG001|Overall Study|Withdrawal by Subject|35|||
144188980|NCT01917968|519885003|FG000|Overall Study|Subject Relocation|5|||
144188981|NCT01917968|519885004|FG001|Overall Study|Subject Relocation|1|||
144188982|NCT01917968|519885003|FG000|Overall Study|36M Missed Visit|3|||
144188983|NCT01917968|519885004|FG001|Overall Study|36M Missed Visit|2|||
144188984|NCT01917968|519885003|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
144188985|NCT01917968|519885004|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
144188986|NCT01917968|519885003|FG000|Overall Study|Change in Family Circumstances|0|||
144188987|NCT01917968|519885004|FG001|Overall Study|Change in Family Circumstances|1|||
144188988|NCT01917968|519885003|FG000|Overall Study|No Data Available|0|||
144188989|NCT01917968|519885004|FG001|Overall Study|No Data Available|2|||
144188990|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
144188991|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
144188992|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
144188993|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
144188994|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
144188995|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
144188996|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
144188997|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
144188998|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
144188999|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
144189000|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
144189001|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
144189002|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
144189003|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
144189004|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
144189005|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
144189006|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
144189007|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
144189008|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
144189009|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
144189010|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
144189011|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
144189012|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
144189013|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
144189014|NCT01435928|519885005|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
144189015|NCT01435928|519885006|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
144438195|NCT01481116|520809460|FG000|Overall Study|Investigator's Discretion|2|||
144438196|NCT01481116|520809461|FG001|Overall Study|Investigator's Discretion|0|||
144438197|NCT01481116|520809462|FG002|Overall Study|Investigator's Discretion|0|||
144438198|NCT01481116|520809460|FG000|Overall Study|Death|2|||
144438199|NCT01481116|520809461|FG001|Overall Study|Death|1|||
144438200|NCT01481116|520809462|FG002|Overall Study|Death|0|||
144438201|NCT01481116|520809460|FG000|Overall Study|Hypoglycemic Event|4|||
144438202|NCT01481116|520809461|FG001|Overall Study|Hypoglycemic Event|0|||
144438203|NCT01481116|520809462|FG002|Overall Study|Hypoglycemic Event|0|||
144438204|NCT00805935|520809463|FG000|Overall Study|Stimulation Failure|1|||
144438205|NCT00805935|520809464|FG001|Overall Study|Stimulation Failure|5|||
144438206|NCT00805935|520809465|FG002|Overall Study|Stimulation Failure|2|||
144438207|NCT00805935|520809466|FG003|Overall Study|Stimulation Failure|2|||
144438208|NCT00805935|520809463|FG000|Overall Study|Cycle cancelled|0|||
144438209|NCT00805935|520809464|FG001|Overall Study|Cycle cancelled|0|||
144438210|NCT00805935|520809465|FG002|Overall Study|Cycle cancelled|2|||
144189016|NCT01435928|519885007|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
144189017|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
144189018|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
144189019|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
144189020|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
144438211|NCT00805935|520809466|FG003|Overall Study|Cycle cancelled|0|||
144189021|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
144189022|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
144189023|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
144189024|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
144189025|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
144189026|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
144189027|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
144189028|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
144189029|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
144189030|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
144189031|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
144189032|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
144189033|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
144189034|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
144189035|NCT01435928|519885005|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
144438212|NCT00805935|520809463|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
144438213|NCT00805935|520809464|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
144438214|NCT00805935|520809465|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
144438215|NCT00805935|520809466|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
144438216|NCT00805935|520809463|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
144438217|NCT00805935|520809464|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
144438218|NCT00805935|520809465|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
144438219|NCT00805935|520809466|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
144438220|NCT00805935|520809463|FG000|Overall Study|Lost to Follow-up|1|||
144438221|NCT00805935|520809464|FG001|Overall Study|Lost to Follow-up|0|||
144438222|NCT00805935|520809465|FG002|Overall Study|Lost to Follow-up|0|||
144438223|NCT00805935|520809466|FG003|Overall Study|Lost to Follow-up|0|||
144438224|NCT00805935|520809463|FG000|Overall Study|No positive serum pregnancy|8|||
144438225|NCT00805935|520809464|FG001|Overall Study|No positive serum pregnancy|7|||
144438226|NCT00805935|520809465|FG002|Overall Study|No positive serum pregnancy|6|||
144438227|NCT00805935|520809466|FG003|Overall Study|No positive serum pregnancy|5|||
144438228|NCT00805935|520809463|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
144438229|NCT00805935|520809464|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
144438230|NCT00805935|520809465|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
144438231|NCT00805935|520809466|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
144438232|NCT00805935|520809463|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
144530526|NCT04101357|521146253|FG002|Overall Study|Trial closure|0|||
144530527|NCT04101357|521146254|FG003|Overall Study|Trial closure|0|||
144189036|NCT01435928|519885006|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
144189037|NCT01435928|519885007|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
144189038|NCT02105701|519885009|FG000|Overall Study|Lost to Follow-up|1|||
144189039|NCT02105701|519885010|FG001|Overall Study|Lost to Follow-up|0|||
144189040|NCT02105701|519885011|FG002|Overall Study|Lost to Follow-up|2|||
144189041|NCT02105701|519885012|FG003|Overall Study|Lost to Follow-up|1|||
144189042|NCT02105701|519885009|FG000|Overall Study|Protocol Violation|0|||
144189043|NCT02105701|519885010|FG001|Overall Study|Protocol Violation|0|||
144189044|NCT02105701|519885011|FG002|Overall Study|Protocol Violation|1|||
144189045|NCT02105701|519885012|FG003|Overall Study|Protocol Violation|0|||
144189046|NCT02105701|519885009|FG000|Overall Study|Withdrawal by Subject|2|||
144189047|NCT02105701|519885010|FG001|Overall Study|Withdrawal by Subject|1|||
144189048|NCT02105701|519885011|FG002|Overall Study|Withdrawal by Subject|0|||
144189049|NCT02105701|519885012|FG003|Overall Study|Withdrawal by Subject|1|||
144189050|NCT02105701|519885009|FG000|Overall Study|Death|1|||
144189051|NCT02105701|519885010|FG001|Overall Study|Death|0|||
144189052|NCT02105701|519885011|FG002|Overall Study|Death|0|||
144189053|NCT02105701|519885012|FG003|Overall Study|Death|0|||
144189054|NCT03234608|519885013|FG000|Overall Study|Lost to Follow-up|23|||
144189055|NCT03234608|519885014|FG001|Overall Study|Lost to Follow-up|21|||
144530528|NCT04101357|521146255|FG004|Overall Study|Trial closure|0|||
144189056|NCT01362296|519885015|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
144189057|NCT01362296|519885016|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
144189058|NCT01362296|519885017|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
144189059|NCT01362296|519885018|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
144189060|NCT01362296|519885015|FG000|Randomized Phase (RP)|Physician Decision|1|||
144189061|NCT01362296|519885016|FG001|Randomized Phase (RP)|Physician Decision|9|||
144189062|NCT01362296|519885017|FG002|Randomized Phase (RP)|Physician Decision|0|||
144189063|NCT01362296|519885018|FG003|Randomized Phase (RP)|Physician Decision|0|||
144189064|NCT01362296|519885015|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
144189065|NCT01362296|519885016|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
144438233|NCT00805935|520809464|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
144438234|NCT00805935|520809465|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
144530529|NCT04101357|521146256|FG005|Overall Study|Trial closure|2|||
144189066|NCT01362296|519885017|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
144189067|NCT01362296|519885018|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
144189068|NCT01362296|519885015|FG000|Randomized Phase (RP)|Adverse Event|20|||
144189069|NCT01362296|519885016|FG001|Randomized Phase (RP)|Adverse Event|4|||
144189070|NCT01362296|519885017|FG002|Randomized Phase (RP)|Adverse Event|0|||
144189071|NCT01362296|519885018|FG003|Randomized Phase (RP)|Adverse Event|0|||
144189072|NCT01362296|519885015|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
144189073|NCT01362296|519885016|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
144189074|NCT01362296|519885017|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
144189075|NCT01362296|519885018|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
144189076|NCT01362296|519885015|FG000|Crossover Phase|PD including Death due to PD|0|||
144189077|NCT01362296|519885016|FG001|Crossover Phase|PD including Death due to PD|0|||
144189078|NCT01362296|519885017|FG002|Crossover Phase|PD including Death due to PD|16|||
144189079|NCT01362296|519885018|FG003|Crossover Phase|PD including Death due to PD|1|||
144189080|NCT01362296|519885015|FG000|Crossover Phase|Withdrawal by Subject|0|||
144189081|NCT01362296|519885016|FG001|Crossover Phase|Withdrawal by Subject|0|||
144189082|NCT01362296|519885017|FG002|Crossover Phase|Withdrawal by Subject|2|||
144189083|NCT01362296|519885018|FG003|Crossover Phase|Withdrawal by Subject|1|||
144189084|NCT01362296|519885015|FG000|Crossover Phase|Adverse Event|0|||
144189085|NCT01362296|519885016|FG001|Crossover Phase|Adverse Event|0|||
144189086|NCT01362296|519885017|FG002|Crossover Phase|Adverse Event|4|||
144189087|NCT01362296|519885018|FG003|Crossover Phase|Adverse Event|0|||
144189088|NCT01362296|519885015|FG000|Crossover Phase|Study Closed/Terminated|0|||
144189089|NCT01362296|519885016|FG001|Crossover Phase|Study Closed/Terminated|0|||
144189090|NCT01362296|519885017|FG002|Crossover Phase|Study Closed/Terminated|1|||
144189091|NCT01362296|519885018|FG003|Crossover Phase|Study Closed/Terminated|0|||
144189092|NCT03693950|519885019|FG000|Overall Study|Withdrawal by Subject|1|||
144189093|NCT03693950|519885020|FG001|Overall Study|Withdrawal by Subject|0|||
144189094|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
144189095|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189096|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189097|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189098|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189099|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189100|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144438235|NCT00805935|520809466|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
144438236|NCT00805935|520809463|FG000|Overall Study|Biochemical pregnancy|0|||
144438237|NCT00805935|520809464|FG001|Overall Study|Biochemical pregnancy|1|||
144438238|NCT00805935|520809465|FG002|Overall Study|Biochemical pregnancy|0|||
144438239|NCT00805935|520809466|FG003|Overall Study|Biochemical pregnancy|0|||
144438240|NCT00805935|520809463|FG000|Overall Study|Chemical pregnancy|0|||
144438241|NCT00805935|520809464|FG001|Overall Study|Chemical pregnancy|5|||
144189101|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189102|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
144189103|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
144189104|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189105|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189106|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189107|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189108|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189109|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189110|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144530530|NCT04101357|521146257|FG006|Overall Study|Trial closure|2|||
144438242|NCT00805935|520809465|FG002|Overall Study|Chemical pregnancy|3|||
144189111|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
144189112|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
144189113|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189114|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189115|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189116|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189117|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189118|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189119|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189120|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
144189121|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
144189122|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144438243|NCT00805935|520809466|FG003|Overall Study|Chemical pregnancy|2|||
144438244|NCT00805935|520809463|FG000|Overall Study|Ectopic pregnancy|0|||
144438245|NCT00805935|520809464|FG001|Overall Study|Ectopic pregnancy|0|||
144530531|NCT04101357|521146258|FG007|Overall Study|Trial closure|0|||
144189123|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189124|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189125|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189126|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189127|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189128|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189129|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
144189130|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
144604742|NCT02553265|521415797|FG000|Third Intervention (28 Days)|Adverse Event|1|||
144189131|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189132|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189133|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189134|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189135|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189136|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144438246|NCT00805935|520809465|FG002|Overall Study|Ectopic pregnancy|1|||
144438247|NCT00805935|520809466|FG003|Overall Study|Ectopic pregnancy|0|||
144438248|NCT00805935|520809463|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
144438249|NCT00805935|520809464|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
144438250|NCT00805935|520809465|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
144438251|NCT00805935|520809466|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
144438252|NCT02347527|520809467|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
144438253|NCT02347527|520809468|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
144438254|NCT02347527|520809469|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
144438255|NCT02347527|520809470|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
144438256|NCT02347527|520809467|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
144438257|NCT02347527|520809468|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
144438258|NCT02347527|520809469|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
144438259|NCT02347527|520809470|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
144438260|NCT02347527|520809467|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
144438261|NCT02347527|520809468|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
144438262|NCT02347527|520809469|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
144438263|NCT02347527|520809470|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
144438264|NCT02347527|520809467|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
144438265|NCT02347527|520809468|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
144438266|NCT02347527|520809469|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
144438267|NCT02347527|520809470|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
144438268|NCT02347527|520809467|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
144438269|NCT02347527|520809468|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
144438270|NCT02347527|520809469|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
144438271|NCT02347527|520809470|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
144438272|NCT02643251|520809471|FG000|Overall Study|Adverse Event|3|||
144604743|NCT02553265|521415798|FG001|Third Intervention (28 Days)|Adverse Event|0|||
144604744|NCT02553265|521415799|FG002|Third Intervention (28 Days)|Adverse Event|0|||
144604745|NCT02553265|521415797|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
144604746|NCT02553265|521415798|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
144604747|NCT02553265|521415799|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
144604748|NCT01809132|521415805|FG000|Overall Study|Withdrawal by Subject|0|||
144604749|NCT01809132|521415806|FG001|Overall Study|Withdrawal by Subject|0|||
144604750|NCT01809132|521415807|FG002|Overall Study|Withdrawal by Subject|1|||
144604751|NCT03583450|521415808|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
144604752|NCT03583450|521415809|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
144604753|NCT01446016|521415810|FG000|Overall Study|Lost to Follow-up|3|||
144604754|NCT01446016|521415810|FG000|Overall Study|Withdrawal by Subject|1|||
144604755|NCT01446016|521415810|FG000|Overall Study|Toxicity|3|||
144604756|NCT00698204|521415813|FG000|Overall Study|Withdrawal by Subject|1|||
144604757|NCT00698204|521415814|FG001|Overall Study|Withdrawal by Subject|0|||
144604758|NCT01179672|521415815|FG000|Overall Study|Adverse Event|17|||
144724341|NCT01505530|521846342|FG002|Overall Study|Withdrawal by Subject|6|||
144724342|NCT01505530|521846340|FG000|Overall Study|Physician Decision|6|||
144724343|NCT01505530|521846341|FG001|Overall Study|Physician Decision|2|||
144724344|NCT01505530|521846342|FG002|Overall Study|Physician Decision|5|||
144189137|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189138|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
144189139|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
144189140|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189141|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144438273|NCT02643251|520809472|FG001|Overall Study|Adverse Event|1|||
144438274|NCT02643251|520809471|FG000|Overall Study|Withdrawal by Subject|2|||
144438275|NCT02643251|520809472|FG001|Overall Study|Withdrawal by Subject|0|||
144438276|NCT02643251|520809471|FG000|Overall Study|Lost to Follow-up|4|||
144438277|NCT02643251|520809472|FG001|Overall Study|Lost to Follow-up|1|||
144438278|NCT02643251|520809471|FG000|Overall Study|Protocol Violation|1|||
144438279|NCT02643251|520809472|FG001|Overall Study|Protocol Violation|0|||
144438280|NCT02643251|520809471|FG000|Overall Study|PI Decision to terminate patient|1|||
144438281|NCT02643251|520809472|FG001|Overall Study|PI Decision to terminate patient|0|||
144438282|NCT01466270|520809473|FG000|Overall Study|Withdrawal by Subject|4|||
144438283|NCT01466270|520809474|FG001|Overall Study|Withdrawal by Subject|1|||
144438284|NCT01466270|520809473|FG000|Overall Study|Physician Decision|1|||
144438285|NCT01466270|520809474|FG001|Overall Study|Physician Decision|0|||
144438286|NCT01466270|520809473|FG000|Overall Study|Lost to Follow-up|1|||
144438287|NCT01466270|520809474|FG001|Overall Study|Lost to Follow-up|3|||
144438288|NCT01466270|520809473|FG000|Overall Study|Progression|1|||
144438289|NCT01466270|520809474|FG001|Overall Study|Progression|0|||
144438290|NCT01466270|520809473|FG000|Overall Study|Toxicity|4|||
144438291|NCT01466270|520809474|FG001|Overall Study|Toxicity|1|||
144438292|NCT01466270|520809473|FG000|Overall Study|Multiple|1|||
144438293|NCT01466270|520809474|FG001|Overall Study|Multiple|1|||
144438294|NCT02821962|520809475|FG000|Overall Study|Lost to Follow-up|2|||
144438295|NCT02821962|520809476|FG001|Overall Study|Lost to Follow-up|0|||
144438296|NCT04206293|520809479|FG000|Overall Study|Consent withdrawal|1|||
144438297|NCT00706966|520809481|FG000|Overall Study|Adverse Event|1|||
144438298|NCT03400332|520809486|FG000|Pre-Treatment|Other reasons|0|||
144438299|NCT03400332|520809487|FG001|Pre-Treatment|Other reasons|0|||
144438300|NCT03400332|520809488|FG002|Pre-Treatment|Other reasons|0|||
144438301|NCT03400332|520809489|FG003|Pre-Treatment|Other reasons|0|||
144438302|NCT03400332|520809490|FG004|Pre-Treatment|Other reasons|0|||
144438303|NCT03400332|520809491|FG005|Pre-Treatment|Other reasons|0|||
144438304|NCT03400332|520809492|FG006|Pre-Treatment|Other reasons|0|||
144438305|NCT03400332|520809493|FG007|Pre-Treatment|Other reasons|0|||
144438306|NCT03400332|520809494|FG008|Pre-Treatment|Other reasons|1|||
144438307|NCT03400332|520809486|FG000|Pre-Treatment|No longer met study criteria|0|||
144438308|NCT03400332|520809487|FG001|Pre-Treatment|No longer met study criteria|0|||
144438309|NCT03400332|520809488|FG002|Pre-Treatment|No longer met study criteria|0|||
144438310|NCT03400332|520809489|FG003|Pre-Treatment|No longer met study criteria|0|||
144438311|NCT03400332|520809490|FG004|Pre-Treatment|No longer met study criteria|0|||
144438312|NCT03400332|520809491|FG005|Pre-Treatment|No longer met study criteria|0|||
144438313|NCT03400332|520809492|FG006|Pre-Treatment|No longer met study criteria|0|||
144438314|NCT03400332|520809493|FG007|Pre-Treatment|No longer met study criteria|0|||
144438315|NCT03400332|520809494|FG008|Pre-Treatment|No longer met study criteria|1|||
144438316|NCT03400332|520809486|FG000|Pre-Treatment|Withdrawal by Subject|0|||
144438317|NCT03400332|520809487|FG001|Pre-Treatment|Withdrawal by Subject|0|||
144438318|NCT03400332|520809488|FG002|Pre-Treatment|Withdrawal by Subject|0|||
144438319|NCT03400332|520809489|FG003|Pre-Treatment|Withdrawal by Subject|0|||
144530532|NCT04101357|521146259|FG008|Overall Study|Trial closure|0|||
144189142|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189143|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189144|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189145|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189146|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189147|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
144189148|NCT00739973|519885021|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
144189149|NCT00739973|519885022|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144189150|NCT00739973|519885023|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144189151|NCT00739973|519885024|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144189152|NCT00739973|519885025|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144438320|NCT03400332|520809490|FG004|Pre-Treatment|Withdrawal by Subject|0|||
144438321|NCT03400332|520809491|FG005|Pre-Treatment|Withdrawal by Subject|0|||
144438322|NCT03400332|520809492|FG006|Pre-Treatment|Withdrawal by Subject|0|||
144189153|NCT00739973|519885026|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144438323|NCT03400332|520809493|FG007|Pre-Treatment|Withdrawal by Subject|0|||
144438324|NCT03400332|520809494|FG008|Pre-Treatment|Withdrawal by Subject|1|||
144438325|NCT03400332|520809486|FG000|Treatment|Participant withdrew consent|2|||
144438326|NCT03400332|520809487|FG001|Treatment|Participant withdrew consent|2|||
144438327|NCT03400332|520809488|FG002|Treatment|Participant withdrew consent|0|||
144438328|NCT03400332|520809489|FG003|Treatment|Participant withdrew consent|0|||
144438329|NCT03400332|520809490|FG004|Treatment|Participant withdrew consent|3|||
144438330|NCT03400332|520809491|FG005|Treatment|Participant withdrew consent|3|||
144438331|NCT03400332|520809492|FG006|Treatment|Participant withdrew consent|1|||
144530533|NCT04101357|521146260|FG009|Overall Study|Trial closure|0|||
144530534|NCT04101357|521146261|FG010|Overall Study|Trial closure|1|||
144530535|NCT04101357|521146251|FG000|Overall Study|Lost to Follow-up|0|||
144530536|NCT04101357|521146252|FG001|Overall Study|Lost to Follow-up|0|||
144530537|NCT04101357|521146253|FG002|Overall Study|Lost to Follow-up|0|||
144530538|NCT04101357|521146254|FG003|Overall Study|Lost to Follow-up|1|||
144530539|NCT04101357|521146255|FG004|Overall Study|Lost to Follow-up|0|||
144530540|NCT04101357|521146256|FG005|Overall Study|Lost to Follow-up|0|||
144530541|NCT04101357|521146257|FG006|Overall Study|Lost to Follow-up|0|||
144530542|NCT04101357|521146258|FG007|Overall Study|Lost to Follow-up|1|||
144530543|NCT04101357|521146259|FG008|Overall Study|Lost to Follow-up|0|||
144530544|NCT04101357|521146260|FG009|Overall Study|Lost to Follow-up|0|||
144530545|NCT04101357|521146261|FG010|Overall Study|Lost to Follow-up|0|||
144530546|NCT04101357|521146251|FG000|Overall Study|Withdrawal by Subject|1|||
144530547|NCT04101357|521146252|FG001|Overall Study|Withdrawal by Subject|0|||
144530548|NCT04101357|521146253|FG002|Overall Study|Withdrawal by Subject|0|||
144530549|NCT04101357|521146254|FG003|Overall Study|Withdrawal by Subject|0|||
144530550|NCT04101357|521146255|FG004|Overall Study|Withdrawal by Subject|0|||
144530551|NCT04101357|521146256|FG005|Overall Study|Withdrawal by Subject|0|||
144530552|NCT04101357|521146257|FG006|Overall Study|Withdrawal by Subject|0|||
144530553|NCT04101357|521146258|FG007|Overall Study|Withdrawal by Subject|0|||
144530554|NCT04101357|521146259|FG008|Overall Study|Withdrawal by Subject|1|||
144530555|NCT04101357|521146260|FG009|Overall Study|Withdrawal by Subject|1|||
144530556|NCT04101357|521146261|FG010|Overall Study|Withdrawal by Subject|0|||
144530557|NCT04101357|521146251|FG000|Overall Study|Other|0|||
144530558|NCT04101357|521146252|FG001|Overall Study|Other|0|||
144530559|NCT04101357|521146253|FG002|Overall Study|Other|0|||
144530560|NCT04101357|521146254|FG003|Overall Study|Other|0|||
144530561|NCT04101357|521146255|FG004|Overall Study|Other|0|||
144530562|NCT04101357|521146256|FG005|Overall Study|Other|1|||
144530563|NCT04101357|521146257|FG006|Overall Study|Other|2|||
144530564|NCT04101357|521146258|FG007|Overall Study|Other|1|||
144530565|NCT04101357|521146259|FG008|Overall Study|Other|0|||
144530566|NCT04101357|521146260|FG009|Overall Study|Other|0|||
144530567|NCT04101357|521146261|FG010|Overall Study|Other|0|||
144530568|NCT04101357|521146251|FG000|Overall Study|Enrolled but not treated|0|||
144530569|NCT04101357|521146252|FG001|Overall Study|Enrolled but not treated|0|||
144530570|NCT04101357|521146253|FG002|Overall Study|Enrolled but not treated|0|||
144530571|NCT04101357|521146254|FG003|Overall Study|Enrolled but not treated|0|||
144530572|NCT04101357|521146255|FG004|Overall Study|Enrolled but not treated|0|||
144530573|NCT04101357|521146256|FG005|Overall Study|Enrolled but not treated|1|||
144530574|NCT04101357|521146257|FG006|Overall Study|Enrolled but not treated|1|||
144530575|NCT04101357|521146258|FG007|Overall Study|Enrolled but not treated|0|||
144530576|NCT04101357|521146259|FG008|Overall Study|Enrolled but not treated|0|||
144530577|NCT04101357|521146260|FG009|Overall Study|Enrolled but not treated|0|||
144530578|NCT04101357|521146261|FG010|Overall Study|Enrolled but not treated|0|||
144530579|NCT05868382|521146262|FG000|Overall Study|Lost to Follow-up|5|||
144530580|NCT05868382|521146263|FG001|Overall Study|Lost to Follow-up|0|||
144530581|NCT05868382|521146264|FG002|Overall Study|Lost to Follow-up|6|||
144530582|NCT05868382|521146265|FG003|Overall Study|Lost to Follow-up|4|||
144530583|NCT05868382|521146266|FG004|Overall Study|Lost to Follow-up|2|||
144530584|NCT05868382|521146267|FG005|Overall Study|Lost to Follow-up|6|||
144530585|NCT05868382|521146262|FG000|Overall Study|Withdrawal by Subject|1|||
144530586|NCT05868382|521146263|FG001|Overall Study|Withdrawal by Subject|0|||
144530587|NCT05868382|521146264|FG002|Overall Study|Withdrawal by Subject|0|||
144530588|NCT05868382|521146265|FG003|Overall Study|Withdrawal by Subject|0|||
144530589|NCT05868382|521146266|FG004|Overall Study|Withdrawal by Subject|1|||
144530590|NCT05868382|521146267|FG005|Overall Study|Withdrawal by Subject|0|||
144530591|NCT04585815|521146268|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
144530592|NCT04585815|521146269|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
144530593|NCT04585815|521146270|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
144530594|NCT04585815|521146271|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
144530595|NCT04585815|521146272|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
144530596|NCT04585815|521146273|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
144530597|NCT04585815|521146274|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
144530598|NCT04585815|521146268|FG000|Sub-study A- Treatment Phase|Death|0|||
144530599|NCT04585815|521146269|FG001|Sub-study A- Treatment Phase|Death|1|||
144530600|NCT04585815|521146270|FG002|Sub-study A- Treatment Phase|Death|0|||
144724345|NCT01505530|521846340|FG000|Overall Study|Sponsor Decision|1|||
144724346|NCT01505530|521846341|FG001|Overall Study|Sponsor Decision|8|||
144724347|NCT01505530|521846342|FG002|Overall Study|Sponsor Decision|7|||
144530601|NCT04585815|521146271|FG003|Sub-study A- Treatment Phase|Death|0|||
144530602|NCT04585815|521146272|FG004|Sub-study A- Treatment Phase|Death|0|||
144530603|NCT04585815|521146273|FG005|Sub-study A- Treatment Phase|Death|0|||
144530604|NCT04585815|521146274|FG006|Sub-study A- Treatment Phase|Death|0|||
144530605|NCT04585815|521146268|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
144530606|NCT04585815|521146269|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
144604759|NCT01179672|521415816|FG001|Overall Study|Adverse Event|8|||
144189154|NCT00739973|519885027|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144189155|NCT00739973|519885028|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144189156|NCT00739973|519885029|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
144189157|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
144189158|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
144189159|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
144189160|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
144189161|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
144189162|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
144189163|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
144189164|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
144189165|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
144189166|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189167|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189168|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189169|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189170|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
144189171|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189172|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189173|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
144189174|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
144189175|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
144189176|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
144189177|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189178|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189179|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189180|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189181|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189182|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189183|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
144189184|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
144189185|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
144189186|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
144189187|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
144189188|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
144189189|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
144189190|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
144438332|NCT03400332|520809493|FG007|Treatment|Participant withdrew consent|1|||
144438333|NCT03400332|520809494|FG008|Treatment|Participant withdrew consent|1|||
144438334|NCT03400332|520809486|FG000|Treatment|Other reasons|0|||
144438335|NCT03400332|520809487|FG001|Treatment|Other reasons|1|||
144438336|NCT03400332|520809488|FG002|Treatment|Other reasons|1|||
144438337|NCT03400332|520809489|FG003|Treatment|Other reasons|0|||
144438338|NCT03400332|520809490|FG004|Treatment|Other reasons|3|||
144438339|NCT03400332|520809491|FG005|Treatment|Other reasons|1|||
144438340|NCT03400332|520809492|FG006|Treatment|Other reasons|2|||
144438341|NCT03400332|520809493|FG007|Treatment|Other reasons|0|||
144438342|NCT03400332|520809494|FG008|Treatment|Other reasons|1|||
144438343|NCT03400332|520809486|FG000|Treatment|Lost to Follow-up|0|||
144438344|NCT03400332|520809487|FG001|Treatment|Lost to Follow-up|1|||
144438345|NCT03400332|520809488|FG002|Treatment|Lost to Follow-up|0|||
144438346|NCT03400332|520809489|FG003|Treatment|Lost to Follow-up|0|||
144438347|NCT03400332|520809490|FG004|Treatment|Lost to Follow-up|0|||
144438348|NCT03400332|520809491|FG005|Treatment|Lost to Follow-up|0|||
144438349|NCT03400332|520809492|FG006|Treatment|Lost to Follow-up|0|||
144438350|NCT03400332|520809493|FG007|Treatment|Lost to Follow-up|0|||
144438351|NCT03400332|520809494|FG008|Treatment|Lost to Follow-up|0|||
144438352|NCT03400332|520809486|FG000|Treatment|Death|3|||
144438353|NCT03400332|520809487|FG001|Treatment|Death|1|||
144438354|NCT03400332|520809488|FG002|Treatment|Death|2|||
144438355|NCT03400332|520809489|FG003|Treatment|Death|3|||
144438356|NCT03400332|520809490|FG004|Treatment|Death|6|||
144438357|NCT03400332|520809491|FG005|Treatment|Death|2|||
144438358|NCT03400332|520809492|FG006|Treatment|Death|1|||
144438359|NCT03400332|520809493|FG007|Treatment|Death|3|||
144438360|NCT03400332|520809494|FG008|Treatment|Death|6|||
144438361|NCT04476017|520809497|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
144438362|NCT04476017|520809498|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
144438363|NCT02704364|520809499|FG000|Overall Study|Adverse Event|1|||
144438364|NCT02704364|520809500|FG001|Overall Study|Adverse Event|1|||
144438365|NCT02704364|520809501|FG002|Overall Study|Adverse Event|0|||
144438366|NCT02704364|520809499|FG000|Overall Study|Noncompliance with study drug|1|||
144438367|NCT02704364|520809500|FG001|Overall Study|Noncompliance with study drug|1|||
144438368|NCT02704364|520809501|FG002|Overall Study|Noncompliance with study drug|0|||
144438369|NCT02704364|520809499|FG000|Overall Study|Other|0|||
144438370|NCT02704364|520809500|FG001|Overall Study|Other|1|||
144438371|NCT02704364|520809501|FG002|Overall Study|Other|1|||
144438372|NCT00846742|520809502|FG000|Overall Study|Withdrawal by Subject|1|||
144189191|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
144189192|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
144189193|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189194|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144438373|NCT03909165|520809506|FG000|Overall Study|Physician Decision|0|||
144438374|NCT03909165|520809507|FG001|Overall Study|Physician Decision|1|||
144438375|NCT03909165|520809508|FG002|Overall Study|Physician Decision|0|||
144438376|NCT03909165|520809509|FG003|Overall Study|Physician Decision|0|||
144438377|NCT03909165|520809510|FG004|Overall Study|Physician Decision|0|||
144438378|NCT03909165|520809506|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144438379|NCT03909165|520809507|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144438380|NCT03909165|520809508|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144438381|NCT03909165|520809509|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144438382|NCT03909165|520809510|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144438383|NCT03909165|520809506|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
144438384|NCT03909165|520809507|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
144438385|NCT03909165|520809508|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
144438386|NCT03909165|520809509|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
144438387|NCT03909165|520809510|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
144438388|NCT03909165|520809506|FG000|Overall Study|Previous Drug Exposure|0|||
144438389|NCT03909165|520809507|FG001|Overall Study|Previous Drug Exposure|0|||
144438390|NCT03909165|520809508|FG002|Overall Study|Previous Drug Exposure|1|||
144438391|NCT03909165|520809509|FG003|Overall Study|Previous Drug Exposure|0|||
144438392|NCT03909165|520809510|FG004|Overall Study|Previous Drug Exposure|0|||
144189195|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
144189196|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189197|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189198|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189199|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189200|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189201|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
144189202|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
144189203|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
144189204|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
144189205|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
144189206|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
144189207|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
144189208|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
144189209|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
144189210|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
144189211|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
144189212|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
144189213|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
144189214|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
144189215|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
144189216|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
144189217|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
144530607|NCT04585815|521146270|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
144530608|NCT04585815|521146271|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
144189218|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
144189219|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
144189220|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189221|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189222|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144438393|NCT03909165|520809506|FG000|Overall Study|Early Discharge|1|||
144438394|NCT03909165|520809507|FG001|Overall Study|Early Discharge|0|||
144438395|NCT03909165|520809508|FG002|Overall Study|Early Discharge|0|||
144724348|NCT01505530|521846340|FG000|Overall Study|Death|7|||
144530609|NCT04585815|521146272|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
144530610|NCT04585815|521146273|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
144530611|NCT04585815|521146274|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
144530612|NCT04585815|521146268|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
144530613|NCT04585815|521146269|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
144530614|NCT04585815|521146270|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
144530615|NCT04585815|521146271|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
144530616|NCT04585815|521146272|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
144530617|NCT04585815|521146273|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
144530618|NCT04585815|521146274|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
144530619|NCT04585815|521146268|FG000|Sub-study A- Treatment Phase|Other|1|||
144530620|NCT04585815|521146269|FG001|Sub-study A- Treatment Phase|Other|0|||
144530621|NCT04585815|521146270|FG002|Sub-study A- Treatment Phase|Other|0|||
144530622|NCT04585815|521146271|FG003|Sub-study A- Treatment Phase|Other|0|||
144530623|NCT04585815|521146272|FG004|Sub-study A- Treatment Phase|Other|0|||
144530624|NCT04585815|521146273|FG005|Sub-study A- Treatment Phase|Other|0|||
144530625|NCT04585815|521146274|FG006|Sub-study A- Treatment Phase|Other|0|||
144530626|NCT04585815|521146268|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
144530627|NCT04585815|521146269|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
144530628|NCT04585815|521146270|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
144530629|NCT04585815|521146271|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
144530630|NCT04585815|521146272|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
144530631|NCT04585815|521146273|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
144530632|NCT04585815|521146274|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
144530633|NCT04585815|521146268|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
144530634|NCT04585815|521146269|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
144530635|NCT04585815|521146270|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
144530636|NCT04585815|521146271|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
144530637|NCT04585815|521146272|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
144530638|NCT04585815|521146273|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
144530639|NCT04585815|521146274|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
144530640|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
144530641|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
144530642|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
144530643|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
144530644|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
144530645|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
144530646|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
144530647|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Death|0|||
144530648|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Death|0|||
144530649|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Death|0|||
144530650|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Death|1|||
144530651|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Death|0|||
144530652|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Death|0|||
144530653|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Death|0|||
144530654|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
144530655|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
144530656|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
144530657|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
144530658|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
144189223|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189224|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189225|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189226|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
144530659|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
144530660|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
144530661|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
144530662|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
144530663|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
144530664|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
144530665|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
144530666|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
144530667|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
144530668|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
144530669|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
144530670|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
144530671|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
144438396|NCT03909165|520809509|FG003|Overall Study|Early Discharge|0|||
144438397|NCT03909165|520809510|FG004|Overall Study|Early Discharge|0|||
144438398|NCT00414661|520809511|FG000|Overall Study|Death|2|||
144438399|NCT00414661|520809512|FG001|Overall Study|Death|5|||
144438400|NCT00414661|520809513|FG002|Overall Study|Death|0|||
144438401|NCT00414661|520809514|FG003|Overall Study|Death|0|||
144438402|NCT00414661|520809511|FG000|Overall Study|Lost to Follow-up|1|||
144438403|NCT00414661|520809512|FG001|Overall Study|Lost to Follow-up|4|||
144438404|NCT00414661|520809513|FG002|Overall Study|Lost to Follow-up|0|||
144438405|NCT00414661|520809514|FG003|Overall Study|Lost to Follow-up|1|||
144438406|NCT00414661|520809511|FG000|Overall Study|Withdrawal by Subject|5|||
144438407|NCT00414661|520809512|FG001|Overall Study|Withdrawal by Subject|2|||
144438408|NCT00414661|520809513|FG002|Overall Study|Withdrawal by Subject|2|||
144438409|NCT00414661|520809514|FG003|Overall Study|Withdrawal by Subject|2|||
144438410|NCT00414661|520809511|FG000|Overall Study|Other|6|||
144438411|NCT00414661|520809512|FG001|Overall Study|Other|3|||
144189227|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189228|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
144189229|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
144189230|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
144189231|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
144189232|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
144189233|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
144189234|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
144189235|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
144189236|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
144189237|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
144189238|NCT00739973|519885021|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189239|NCT00739973|519885022|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
144189240|NCT00739973|519885023|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189241|NCT00739973|519885024|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189242|NCT00739973|519885025|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189243|NCT00739973|519885026|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189244|NCT00739973|519885027|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
144189245|NCT00739973|519885028|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189246|NCT00739973|519885029|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
144189247|NCT03253094|519885030|FG000|Overall Study|Adverse Event|2|||
144189248|NCT03253094|519885031|FG001|Overall Study|Adverse Event|0|||
144189249|NCT03253094|519885032|FG002|Overall Study|Adverse Event|0|||
144189250|NCT03253094|519885033|FG003|Overall Study|Adverse Event|0|||
144189251|NCT03253094|519885034|FG004|Overall Study|Adverse Event|0|||
144189252|NCT03253094|519885035|FG005|Overall Study|Adverse Event|0|||
144189253|NCT03253094|519885030|FG000|Overall Study|Lack of Efficacy|0|||
144189254|NCT03253094|519885031|FG001|Overall Study|Lack of Efficacy|0|||
144189255|NCT03253094|519885032|FG002|Overall Study|Lack of Efficacy|2|||
144189256|NCT03253094|519885033|FG003|Overall Study|Lack of Efficacy|1|||
144189257|NCT03253094|519885034|FG004|Overall Study|Lack of Efficacy|2|||
144189258|NCT03253094|519885035|FG005|Overall Study|Lack of Efficacy|1|||
144189259|NCT03253094|519885030|FG000|Overall Study|Lost to Follow-up|0|||
144189260|NCT03253094|519885031|FG001|Overall Study|Lost to Follow-up|0|||
144189261|NCT03253094|519885032|FG002|Overall Study|Lost to Follow-up|1|||
144189262|NCT03253094|519885033|FG003|Overall Study|Lost to Follow-up|1|||
144189263|NCT03253094|519885034|FG004|Overall Study|Lost to Follow-up|0|||
144189264|NCT03253094|519885035|FG005|Overall Study|Lost to Follow-up|1|||
144189265|NCT03253094|519885030|FG000|Overall Study|Physician Decision|1|||
144189266|NCT03253094|519885031|FG001|Overall Study|Physician Decision|0|||
144189267|NCT03253094|519885032|FG002|Overall Study|Physician Decision|0|||
144189268|NCT03253094|519885033|FG003|Overall Study|Physician Decision|1|||
144189269|NCT03253094|519885034|FG004|Overall Study|Physician Decision|0|||
144189270|NCT03253094|519885035|FG005|Overall Study|Physician Decision|2|||
144189271|NCT03253094|519885030|FG000|Overall Study|Withdrawal by Subject|1|||
144189272|NCT03253094|519885031|FG001|Overall Study|Withdrawal by Subject|2|||
144438412|NCT00414661|520809513|FG002|Overall Study|Other|0|||
144438413|NCT00414661|520809514|FG003|Overall Study|Other|0|||
144438414|NCT00559962|520809518|FG000|Overall Study|Adverse Event|1|||
144438415|NCT00559962|520809519|FG001|Overall Study|Adverse Event|7|||
144438416|NCT00559962|520809520|FG002|Overall Study|Adverse Event|8|||
144438417|NCT00559962|520809521|FG003|Overall Study|Adverse Event|5|||
144438418|NCT00559962|520809522|FG004|Overall Study|Adverse Event|11|||
144438419|NCT00559962|520809523|FG005|Overall Study|Adverse Event|4|||
144438420|NCT00559962|520809524|FG006|Overall Study|Adverse Event|4|||
144438421|NCT00559962|520809525|FG007|Overall Study|Adverse Event|2|||
144438422|NCT00559962|520809518|FG000|Overall Study|Lost to Follow-up|0|||
144189273|NCT03253094|519885032|FG002|Overall Study|Withdrawal by Subject|1|||
144189274|NCT03253094|519885033|FG003|Overall Study|Withdrawal by Subject|0|||
144189275|NCT03253094|519885034|FG004|Overall Study|Withdrawal by Subject|3|||
144189276|NCT03253094|519885035|FG005|Overall Study|Withdrawal by Subject|0|||
144189277|NCT03253094|519885030|FG000|Overall Study|Other|0|||
144189278|NCT03253094|519885031|FG001|Overall Study|Other|1|||
144189279|NCT03253094|519885032|FG002|Overall Study|Other|2|||
144189280|NCT03253094|519885033|FG003|Overall Study|Other|1|||
144189281|NCT03253094|519885034|FG004|Overall Study|Other|0|||
144189282|NCT03253094|519885035|FG005|Overall Study|Other|0|||
144189283|NCT02219308|519885036|FG000|Overall Study|Withdrawal by Subject|1|||
144189284|NCT02219308|519885037|FG001|Overall Study|Withdrawal by Subject|2|||
144189285|NCT01989676|519886854|FG000|Overall Study|Death|52|||
144438423|NCT00559962|520809519|FG001|Overall Study|Lost to Follow-up|1|||
144438424|NCT00559962|520809520|FG002|Overall Study|Lost to Follow-up|0|||
144438425|NCT00559962|520809521|FG003|Overall Study|Lost to Follow-up|0|||
144438426|NCT00559962|520809522|FG004|Overall Study|Lost to Follow-up|0|||
144438427|NCT00559962|520809523|FG005|Overall Study|Lost to Follow-up|0|||
144438428|NCT00559962|520809524|FG006|Overall Study|Lost to Follow-up|0|||
144438429|NCT00559962|520809525|FG007|Overall Study|Lost to Follow-up|0|||
144438430|NCT00559962|520809518|FG000|Overall Study|Withdrawal by Subject|1|||
144438431|NCT00559962|520809519|FG001|Overall Study|Withdrawal by Subject|1|||
144438432|NCT00559962|520809520|FG002|Overall Study|Withdrawal by Subject|2|||
144438433|NCT00559962|520809521|FG003|Overall Study|Withdrawal by Subject|0|||
144438434|NCT00559962|520809522|FG004|Overall Study|Withdrawal by Subject|3|||
144438435|NCT00559962|520809523|FG005|Overall Study|Withdrawal by Subject|1|||
144438436|NCT00559962|520809524|FG006|Overall Study|Withdrawal by Subject|0|||
144438437|NCT00559962|520809525|FG007|Overall Study|Withdrawal by Subject|2|||
144438438|NCT00559962|520809518|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
144438439|NCT00559962|520809519|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
144438440|NCT00559962|520809520|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
144438441|NCT00559962|520809521|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
144438442|NCT00559962|520809522|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
144438443|NCT00559962|520809523|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
144438444|NCT00559962|520809524|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
144438445|NCT00559962|520809525|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
144438446|NCT01461096|520809527|FG000|Overall Study|Death|3|||
144438447|NCT01461096|520809528|FG001|Overall Study|Death|6|||
144438448|NCT01461096|520809527|FG000|Overall Study|Severe debilitation, unable to continue|1|||
144438449|NCT01461096|520809528|FG001|Overall Study|Severe debilitation, unable to continue|1|||
144438450|NCT01461096|520809527|FG000|Overall Study|Subj not able to get to clinic|15|||
144438451|NCT01461096|520809528|FG001|Overall Study|Subj not able to get to clinic|13|||
144438452|NCT01461096|520809527|FG000|Overall Study|Site is closing|27|||
144438453|NCT01461096|520809528|FG001|Overall Study|Site is closing|30|||
144438454|NCT01461096|520809527|FG000|Overall Study|Withdrawal by Subject|5|||
144438455|NCT01461096|520809528|FG001|Overall Study|Withdrawal by Subject|3|||
144438456|NCT01461096|520809527|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
144438457|NCT01461096|520809528|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
144438458|NCT01461096|520809527|FG000|Overall Study|Lost to Follow-up|8|||
144438459|NCT01461096|520809528|FG001|Overall Study|Lost to Follow-up|4|||
144438460|NCT04889625|520809529|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
144438461|NCT04889625|520809530|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
144438462|NCT04889625|520809529|FG000|Period 1|Subject out of window|0|||
144438463|NCT04889625|520809530|FG001|Period 1|Subject out of window|1|||
144438464|NCT04889625|520809529|FG000|Period 1|Wrong add power dispensed|0|||
144438465|NCT04889625|520809530|FG001|Period 1|Wrong add power dispensed|1|||
144438466|NCT04889625|520809529|FG000|Period 1|Discontinued due to fitting guide error|1|||
144438467|NCT04889625|520809530|FG001|Period 1|Discontinued due to fitting guide error|1|||
144604760|NCT01179672|521415815|FG000|Overall Study|Withdrawal by Subject|10|||
144189286|NCT01989676|519886855|FG001|Overall Study|Death|60|||
144189287|NCT01989676|519886854|FG000|Overall Study|Protocol Violation|2|||
144604761|NCT01179672|521415816|FG001|Overall Study|Withdrawal by Subject|12|||
144189288|NCT01989676|519886855|FG001|Overall Study|Protocol Violation|1|||
144438468|NCT04889625|520809529|FG000|Period 2|Test article no longer available|1|||
144438469|NCT04889625|520809530|FG001|Period 2|Test article no longer available|0|||
144438470|NCT04889625|520809529|FG000|Period 2|Incorrect lens dispensed|1|||
144438471|NCT04889625|520809530|FG001|Period 2|Incorrect lens dispensed|0|||
144438472|NCT04889625|520809529|FG000|Period 2|Wrong add power dispensed|0|||
144438473|NCT04889625|520809530|FG001|Period 2|Wrong add power dispensed|1|||
144189289|NCT01989676|519886854|FG000|Overall Study|Lost to Follow-up|8|||
144189290|NCT01989676|519886855|FG001|Overall Study|Lost to Follow-up|18|||
144189291|NCT01989676|519886854|FG000|Overall Study|No longer willing to participate in study|26|||
144438474|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
144438475|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
144438476|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
144438477|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
144438478|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
144438479|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
144438480|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
144438481|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
144438482|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
144438483|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
144438484|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
144438485|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
144438486|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
144438487|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
144438488|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
144438489|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
144438490|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
144438491|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
144438492|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Death|0|||
144438493|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Death|0|||
144438494|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Death|1|||
144438495|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Death|0|||
144438496|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Death|0|||
144438497|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Death|0|||
144438498|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Death|0|||
144438499|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Death|0|||
144438500|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Death|0|||
144438501|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
144438502|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
144438503|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
144438504|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
144438505|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
144438506|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
144438507|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
144438508|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
144438509|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
144438510|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
144438511|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
144438512|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
144530672|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
144530673|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
144530674|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
144530675|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
144724349|NCT01505530|521846341|FG001|Overall Study|Death|6|||
144724350|NCT01505530|521846342|FG002|Overall Study|Death|5|||
144724351|NCT01505530|521846340|FG000|Overall Study|entry criteria not met|0|||
144724352|NCT01505530|521846341|FG001|Overall Study|entry criteria not met|1|||
144724353|NCT01505530|521846342|FG002|Overall Study|entry criteria not met|0|||
144724354|NCT01966042|521846348|FG000|Overall Study|Death|2|||
144724355|NCT02492958|521846349|FG000|Overall Study|Withdrawal by Subject|0|||
144724356|NCT02492958|521846350|FG001|Overall Study|Withdrawal by Subject|0|||
144724357|NCT02492958|521846351|FG002|Overall Study|Withdrawal by Subject|1|||
144724358|NCT02492958|521846352|FG003|Overall Study|Withdrawal by Subject|0|||
144724359|NCT02492958|521846349|FG000|Overall Study|Adverse Event|1|||
144724360|NCT02492958|521846350|FG001|Overall Study|Adverse Event|0|||
144724361|NCT02492958|521846351|FG002|Overall Study|Adverse Event|1|||
144724362|NCT02492958|521846352|FG003|Overall Study|Adverse Event|0|||
144724363|NCT00948675|521846353|FG000|Overall Study|Lost to Follow-up|1|||
144724364|NCT00948675|521846354|FG001|Overall Study|Lost to Follow-up|0|||
144724365|NCT01984242|521846355|FG000|Overall Study|Death|52|||
144724366|NCT01984242|521846356|FG001|Overall Study|Death|50|||
144724367|NCT01984242|521846357|FG002|Overall Study|Death|52|||
144724368|NCT01984242|521846355|FG000|Overall Study|Withdrawal by Subject|5|||
144724369|NCT01984242|521846356|FG001|Overall Study|Withdrawal by Subject|3|||
144724370|NCT01984242|521846357|FG002|Overall Study|Withdrawal by Subject|10|||
144724371|NCT01984242|521846355|FG000|Overall Study|Physician Decision|0|||
144724372|NCT01984242|521846356|FG001|Overall Study|Physician Decision|0|||
144438513|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
144438514|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
144438515|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
144438516|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
144724373|NCT01984242|521846357|FG002|Overall Study|Physician Decision|1|||
144724374|NCT01984242|521846355|FG000|Overall Study|Lost to Follow-up|4|||
144724375|NCT01984242|521846356|FG001|Overall Study|Lost to Follow-up|0|||
144724376|NCT01984242|521846357|FG002|Overall Study|Lost to Follow-up|3|||
144724377|NCT01984242|521846355|FG000|Overall Study|Sponsor Decision|1|||
144724378|NCT01984242|521846356|FG001|Overall Study|Sponsor Decision|0|||
144724379|NCT01984242|521846357|FG002|Overall Study|Sponsor Decision|0|||
144724380|NCT01984242|521846355|FG000|Overall Study|Non-Compliance|1|||
144724381|NCT01984242|521846356|FG001|Overall Study|Non-Compliance|0|||
144724382|NCT01984242|521846357|FG002|Overall Study|Non-Compliance|0|||
144724383|NCT01984242|521846355|FG000|Overall Study|Study terminated by Sponsor|38|||
144724384|NCT01984242|521846356|FG001|Overall Study|Study terminated by Sponsor|50|||
144724385|NCT01984242|521846357|FG002|Overall Study|Study terminated by Sponsor|34|||
144724386|NCT01984242|521846355|FG000|Overall Study|Disease Progression|0|||
144724387|NCT01984242|521846356|FG001|Overall Study|Disease Progression|0|||
144724388|NCT01984242|521846357|FG002|Overall Study|Disease Progression|1|||
144724389|NCT00449150|521846358|FG000|Overall Study|Adverse Event|11|||
144724390|NCT00449150|521846359|FG001|Overall Study|Adverse Event|18|||
144724391|NCT00449150|521846360|FG002|Overall Study|Adverse Event|9|||
144724392|NCT00449150|521846358|FG000|Overall Study|Lack of Efficacy|1|||
144724393|NCT00449150|521846359|FG001|Overall Study|Lack of Efficacy|2|||
144724394|NCT00449150|521846360|FG002|Overall Study|Lack of Efficacy|2|||
144724395|NCT00449150|521846358|FG000|Overall Study|Other|16|||
144724396|NCT00449150|521846359|FG001|Overall Study|Other|13|||
144724397|NCT00449150|521846360|FG002|Overall Study|Other|14|||
144724398|NCT00449150|521846358|FG000|Overall Study|Withdrawal by Subject|17|||
144724399|NCT00449150|521846359|FG001|Overall Study|Withdrawal by Subject|18|||
144724400|NCT00449150|521846360|FG002|Overall Study|Withdrawal by Subject|21|||
144724401|NCT00449150|521846358|FG000|Overall Study|Protocol Violation|1|||
144724402|NCT00449150|521846359|FG001|Overall Study|Protocol Violation|2|||
144724403|NCT00449150|521846360|FG002|Overall Study|Protocol Violation|1|||
144724404|NCT00770510|521846362|FG000|Overall Study|Lost to Follow-up|2|||
144724405|NCT00770510|521846362|FG000|Overall Study|Pregnancy|1|||
144724406|NCT00770510|521846362|FG000|Overall Study|Withdrawal by Subject|2|||
144724407|NCT02246478|521846367|FG000|Multiple-dose Phase|Protocol Violation|1|||
144724408|NCT02246478|521846368|FG001|Multiple-dose Phase|Protocol Violation|0|||
144724409|NCT02246478|521846369|FG002|Multiple-dose Phase|Protocol Violation|0|||
144724410|NCT02246478|521846370|FG003|Multiple-dose Phase|Protocol Violation|1|||
144724411|NCT00536575|521846371|FG000|Overall Study|Withdrawal by Subject|1|||
144724412|NCT00536575|521846371|FG000|Overall Study|Death|1|||
144724413|NCT02465567|521846372|FG000|Overall Study|Adverse Event|118|||
144724414|NCT02465567|521846373|FG001|Overall Study|Adverse Event|113|||
144724415|NCT02465567|521846374|FG002|Overall Study|Adverse Event|147|||
144724416|NCT02465567|521846375|FG003|Overall Study|Adverse Event|138|||
144724417|NCT02465567|521846372|FG000|Overall Study|Lack of Efficacy|103|||
144724418|NCT02465567|521846373|FG001|Overall Study|Lack of Efficacy|102|||
144724419|NCT02465567|521846374|FG002|Overall Study|Lack of Efficacy|171|||
144724420|NCT02465567|521846375|FG003|Overall Study|Lack of Efficacy|135|||
144724421|NCT02465567|521846372|FG000|Overall Study|Withdrawal by Subject|104|||
144724422|NCT02465567|521846373|FG001|Overall Study|Withdrawal by Subject|94|||
144724423|NCT02465567|521846374|FG002|Overall Study|Withdrawal by Subject|123|||
144724424|NCT02465567|521846375|FG003|Overall Study|Withdrawal by Subject|130|||
144724425|NCT02465567|521846372|FG000|Overall Study|Physician Decision|23|||
144724426|NCT02465567|521846373|FG001|Overall Study|Physician Decision|33|||
144724427|NCT02465567|521846374|FG002|Overall Study|Physician Decision|38|||
144724428|NCT02465567|521846375|FG003|Overall Study|Physician Decision|28|||
144724429|NCT02465567|521846372|FG000|Overall Study|Major Protocol Deviation|24|||
144724430|NCT02465567|521846373|FG001|Overall Study|Major Protocol Deviation|26|||
144724431|NCT02465567|521846374|FG002|Overall Study|Major Protocol Deviation|22|||
144724432|NCT02465567|521846375|FG003|Overall Study|Major Protocol Deviation|25|||
144724433|NCT02465567|521846372|FG000|Overall Study|Lost to Follow-up|25|||
144724434|NCT02465567|521846373|FG001|Overall Study|Lost to Follow-up|21|||
144724435|NCT02465567|521846374|FG002|Overall Study|Lost to Follow-up|19|||
144530676|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
144530677|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
144530678|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
144530679|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
144530680|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
144530681|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
144530682|NCT04585815|521146268|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
144724436|NCT02465567|521846375|FG003|Overall Study|Lost to Follow-up|15|||
144724437|NCT02465567|521846372|FG000|Overall Study|Protocol Specified Criteria|20|||
144724438|NCT02465567|521846373|FG001|Overall Study|Protocol Specified Criteria|10|||
144724439|NCT02465567|521846374|FG002|Overall Study|Protocol Specified Criteria|9|||
144724440|NCT02465567|521846375|FG003|Overall Study|Protocol Specified Criteria|12|||
144724441|NCT02465567|521846372|FG000|Overall Study|Administrative Reasons|12|||
144724442|NCT02465567|521846373|FG001|Overall Study|Administrative Reasons|9|||
144724443|NCT02465567|521846374|FG002|Overall Study|Administrative Reasons|11|||
144724444|NCT02465567|521846375|FG003|Overall Study|Administrative Reasons|5|||
144724445|NCT02465567|521846372|FG000|Overall Study|Randomized but not treated|1|||
144724446|NCT02465567|521846373|FG001|Overall Study|Randomized but not treated|5|||
144724447|NCT02465567|521846374|FG002|Overall Study|Randomized but not treated|4|||
144724448|NCT02465567|521846375|FG003|Overall Study|Randomized but not treated|5|||
144724449|NCT02465567|521846372|FG000|Overall Study|enrolled in >1 studies|18|||
144724450|NCT02465567|521846373|FG001|Overall Study|enrolled in >1 studies|11|||
144724451|NCT02465567|521846374|FG002|Overall Study|enrolled in >1 studies|19|||
144724452|NCT02465567|521846375|FG003|Overall Study|enrolled in >1 studies|15|||
144724453|NCT02465567|521846372|FG000|Overall Study|missing PI Signature|1|||
144724454|NCT02465567|521846373|FG001|Overall Study|missing PI Signature|0|||
144724455|NCT02465567|521846374|FG002|Overall Study|missing PI Signature|0|||
144724456|NCT02465567|521846375|FG003|Overall Study|missing PI Signature|0|||
144724457|NCT06331156|521846376|FG000|Overall Study|Adverse Event|1|||
144724458|NCT06331156|521846377|FG001|Overall Study|Adverse Event|0|||
144724459|NCT06331156|521846376|FG000|Overall Study|Lost to Follow-up|1|||
144724460|NCT06331156|521846377|FG001|Overall Study|Lost to Follow-up|0|||
144724461|NCT06331156|521846376|FG000|Overall Study|Migrated / Moved from the study area|4|||
144724462|NCT06331156|521846377|FG001|Overall Study|Migrated / Moved from the study area|3|||
144724463|NCT06331156|521846376|FG000|Overall Study|Other|7|||
144724464|NCT06331156|521846377|FG001|Overall Study|Other|0|||
144724465|NCT06331156|521846376|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
144724466|NCT06331156|521846377|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
144724467|NCT01457053|521846384|FG000|Overall Study|Unable to undergo selected treatment|1|||
144724468|NCT01457053|521846385|FG001|Overall Study|Unable to undergo selected treatment|1|||
144724469|NCT00814463|521846387|FG000|Overall Study|Lost to Follow-up|1|||
144724470|NCT02430870|521846389|FG000|Part 2|Voluntary Withdrawal|0|||
144724471|NCT02430870|521846390|FG001|Part 2|Voluntary Withdrawal|0|||
144724472|NCT02430870|521846391|FG002|Part 2|Voluntary Withdrawal|0|||
144724473|NCT02430870|521846392|FG003|Part 2|Voluntary Withdrawal|0|||
144724474|NCT02430870|521846393|FG004|Part 2|Voluntary Withdrawal|0|||
144724475|NCT02430870|521846394|FG005|Part 2|Voluntary Withdrawal|0|||
144724476|NCT02430870|521846395|FG006|Part 2|Voluntary Withdrawal|1|||
144724477|NCT02430870|521846396|FG007|Part 2|Voluntary Withdrawal|0|||
144724478|NCT02430870|521846389|FG000|Part 2|Other Reason Not Specified|0|||
144724479|NCT02430870|521846390|FG001|Part 2|Other Reason Not Specified|0|||
144724480|NCT02430870|521846391|FG002|Part 2|Other Reason Not Specified|0|||
144724481|NCT02430870|521846392|FG003|Part 2|Other Reason Not Specified|0|||
144724482|NCT02430870|521846393|FG004|Part 2|Other Reason Not Specified|0|||
144724483|NCT02430870|521846394|FG005|Part 2|Other Reason Not Specified|0|||
144724484|NCT02430870|521846395|FG006|Part 2|Other Reason Not Specified|0|||
144724485|NCT02430870|521846396|FG007|Part 2|Other Reason Not Specified|1|||
144724486|NCT02780687|521846397|FG000|Overall Study|Adverse Event|1|||
144724487|NCT02780687|521846398|FG001|Overall Study|Adverse Event|1|||
144724488|NCT02780687|521846397|FG000|Overall Study|Withdrawal by Subject|2|||
144724489|NCT02780687|521846398|FG001|Overall Study|Withdrawal by Subject|1|||
144724490|NCT02780687|521846397|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
144724491|NCT02780687|521846398|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
144724492|NCT02780687|521846397|FG000|Overall Study|progressive disease|29|||
144724493|NCT02780687|521846398|FG001|Overall Study|progressive disease|6|||
144724494|NCT03982433|521846399|FG000|Overall Study|Lost to Follow-up|1|||
144724495|NCT04257929|521846402|FG000|Overall Study|Adverse Event|1|||
144724496|NCT04257929|521846403|FG001|Overall Study|Adverse Event|0|||
144724497|NCT04257929|521846404|FG002|Overall Study|Adverse Event|1|||
144724498|NCT04257929|521846402|FG000|Overall Study|Withdrawal by Subject|1|||
144724499|NCT04257929|521846403|FG001|Overall Study|Withdrawal by Subject|0|||
144724500|NCT04257929|521846404|FG002|Overall Study|Withdrawal by Subject|0|||
144724501|NCT04257929|521846402|FG000|Overall Study|COVID-19|0|||
144724502|NCT04257929|521846403|FG001|Overall Study|COVID-19|1|||
144724503|NCT04257929|521846404|FG002|Overall Study|COVID-19|1|||
144724504|NCT04257929|521846402|FG000|Overall Study|Lost to Follow-up|0|||
144724505|NCT04257929|521846403|FG001|Overall Study|Lost to Follow-up|0|||
144724506|NCT04257929|521846404|FG002|Overall Study|Lost to Follow-up|1|||
144724507|NCT00984295|521846407|FG000|Overall Study|Lost to Follow-up|31|||
144530683|NCT04585815|521146269|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
144530684|NCT04585815|521146270|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
144530685|NCT04585815|521146271|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
144530686|NCT04585815|521146272|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
144530687|NCT04585815|521146273|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
144724508|NCT00984295|521846408|FG001|Overall Study|Lost to Follow-up|12|||
144530688|NCT04585815|521146274|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
144530689|NCT04585815|521146268|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
144530690|NCT04585815|521146269|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
144724509|NCT00984295|521846409|FG002|Overall Study|Lost to Follow-up|13|||
144724510|NCT00984295|521846407|FG000|Overall Study|Protocol Violation|2|||
144530691|NCT04585815|521146270|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
144724511|NCT00984295|521846408|FG001|Overall Study|Protocol Violation|1|||
144724512|NCT00984295|521846409|FG002|Overall Study|Protocol Violation|4|||
144724513|NCT00984295|521846407|FG000|Overall Study|Withdrawal by Subject|18|||
144724514|NCT00984295|521846408|FG001|Overall Study|Withdrawal by Subject|9|||
144724515|NCT00984295|521846409|FG002|Overall Study|Withdrawal by Subject|12|||
144724516|NCT00984295|521846407|FG000|Overall Study|CAE - discontinued test vaccine|0|||
144724517|NCT00984295|521846408|FG001|Overall Study|CAE - discontinued test vaccine|1|||
144724518|NCT00984295|521846409|FG002|Overall Study|CAE - discontinued test vaccine|3|||
144438517|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
144438518|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
144438519|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
144438520|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
144438521|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
144438522|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
144438523|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
144438524|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
144438525|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
144438526|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
144438527|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
144438528|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
144438529|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
144438530|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
144438531|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
144438532|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
144438533|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
144438534|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
144438535|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
144438536|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
144438537|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
144438538|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
144438539|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
144438540|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
144438541|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
144438542|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
144438543|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
144438544|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
144438545|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
144438546|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438547|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
144438548|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438549|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438550|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438551|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438552|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438553|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438554|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
144438555|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
144438556|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
144438557|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
144438558|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
144438559|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
144604762|NCT01179672|521415815|FG000|Overall Study|Entry Criteria Not Met|0|||
144604763|NCT01179672|521415816|FG001|Overall Study|Entry Criteria Not Met|2|||
144604764|NCT01179672|521415815|FG000|Overall Study|Lost to Follow-up|0|||
144604765|NCT01179672|521415816|FG001|Overall Study|Lost to Follow-up|1|||
144604766|NCT01179672|521415815|FG000|Overall Study|Protocol Violation|2|||
144604767|NCT01179672|521415816|FG001|Overall Study|Protocol Violation|2|||
144604768|NCT01179672|521415815|FG000|Overall Study|Physician Decision|1|||
144604769|NCT01179672|521415816|FG001|Overall Study|Physician Decision|1|||
144604770|NCT01949155|521415818|FG000|Overall Study|Lost to Follow-up|1|||
144604771|NCT01949155|521415819|FG001|Overall Study|Lost to Follow-up|0|||
144604772|NCT01949155|521415818|FG000|Overall Study|Protocol Violation|1|||
144604773|NCT01949155|521415819|FG001|Overall Study|Protocol Violation|0|||
144604774|NCT00314249|521415820|FG000|Overall Study|Adverse Event|73|||
144604775|NCT00314249|521415821|FG001|Overall Study|Adverse Event|94|||
144604776|NCT00314249|521415820|FG000|Overall Study|Lack of Efficacy|33|||
144604777|NCT00314249|521415821|FG001|Overall Study|Lack of Efficacy|24|||
144604778|NCT00314249|521415820|FG000|Overall Study|Withdrawal by Subject|21|||
144604779|NCT00314249|521415821|FG001|Overall Study|Withdrawal by Subject|28|||
144604780|NCT00314249|521415820|FG000|Overall Study|Lost to Follow-up|15|||
144604781|NCT00314249|521415821|FG001|Overall Study|Lost to Follow-up|9|||
144438560|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
144438561|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
144604782|NCT00314249|521415820|FG000|Overall Study|Physician Decision|1|||
144604783|NCT00314249|521415821|FG001|Overall Study|Physician Decision|1|||
144604784|NCT00314249|521415820|FG000|Overall Study|Withdrawn for other reasons|4|||
144604785|NCT00314249|521415821|FG001|Overall Study|Withdrawn for other reasons|1|||
144604786|NCT00314249|521415820|FG000|Overall Study|Non-Compliant|5|||
144724519|NCT00984295|521846407|FG000|Overall Study|Missed one or more blood samplings|3|||
144189292|NCT01989676|519886855|FG001|Overall Study|No longer willing to participate in study|26|||
144189293|NCT01989676|519886854|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
144189294|NCT01989676|519886855|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
144189295|NCT01989676|519886854|FG000|Overall Study|Other|4|||
144189296|NCT01989676|519886855|FG001|Overall Study|Other|3|||
144438562|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
144438563|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
144438564|NCT00404352|520809542|FG000|Double Blind (up to 24 Month)|Other|0|||
144438565|NCT00404352|520809543|FG001|Double Blind (up to 24 Month)|Other|1|||
144438566|NCT00404352|520809544|FG002|Double Blind (up to 24 Month)|Other|0|||
144438567|NCT00404352|520809545|FG003|Double Blind (up to 24 Month)|Other|0|||
144438568|NCT00404352|520809546|FG004|Double Blind (up to 24 Month)|Other|0|||
144438569|NCT00404352|520809547|FG005|Double Blind (up to 24 Month)|Other|0|||
144438570|NCT00404352|520809548|FG006|Double Blind (up to 24 Month)|Other|0|||
144438571|NCT00404352|520809549|FG007|Double Blind (up to 24 Month)|Other|0|||
144438572|NCT00404352|520809550|FG008|Double Blind (up to 24 Month)|Other|0|||
144438573|NCT00404352|520809542|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
144438574|NCT00404352|520809543|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
144438575|NCT00404352|520809544|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
144438576|NCT00404352|520809545|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
144438577|NCT00404352|520809546|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
144438578|NCT00404352|520809547|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
144438579|NCT00404352|520809548|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
144438580|NCT00404352|520809549|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
144438581|NCT00404352|520809550|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
144438582|NCT00404352|520809542|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
144438583|NCT00404352|520809543|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
144438584|NCT00404352|520809544|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
144438585|NCT00404352|520809545|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
144438586|NCT00404352|520809546|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
144438587|NCT00404352|520809547|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
144438588|NCT00404352|520809548|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
144438589|NCT00404352|520809549|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
144438590|NCT00404352|520809550|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
144438591|NCT00404352|520809542|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438592|NCT00404352|520809543|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438593|NCT00404352|520809544|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438594|NCT00404352|520809545|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438595|NCT00404352|520809546|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
144438596|NCT00404352|520809547|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144189297|NCT03941834|519886856|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
144438597|NCT00404352|520809548|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438598|NCT00404352|520809549|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438599|NCT00404352|520809550|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
144438600|NCT00404352|520809542|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438601|NCT00404352|520809543|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438602|NCT00404352|520809544|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438603|NCT00404352|520809545|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438604|NCT00404352|520809546|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438605|NCT00404352|520809547|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
144438606|NCT00404352|520809548|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438607|NCT00404352|520809549|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438608|NCT00404352|520809550|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
144438609|NCT00404352|520809542|FG000|Open Label (up to 24 Month)|Disease progression|0|||
144438610|NCT00404352|520809543|FG001|Open Label (up to 24 Month)|Disease progression|0|||
144438611|NCT00404352|520809544|FG002|Open Label (up to 24 Month)|Disease progression|0|||
144438612|NCT00404352|520809545|FG003|Open Label (up to 24 Month)|Disease progression|1|||
144438613|NCT00404352|520809546|FG004|Open Label (up to 24 Month)|Disease progression|0|||
144438614|NCT00404352|520809547|FG005|Open Label (up to 24 Month)|Disease progression|0|||
144438615|NCT00404352|520809548|FG006|Open Label (up to 24 Month)|Disease progression|0|||
144438616|NCT00404352|520809549|FG007|Open Label (up to 24 Month)|Disease progression|0|||
144189298|NCT03941834|519886857|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
144189299|NCT03941834|519886858|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
144438617|NCT00404352|520809550|FG008|Open Label (up to 24 Month)|Disease progression|0|||
144438618|NCT00404352|520809542|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144530692|NCT04585815|521146271|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
144604787|NCT00314249|521415821|FG001|Overall Study|Non-Compliant|6|||
144724520|NCT00984295|521846408|FG001|Overall Study|Missed one or more blood samplings|7|||
144724521|NCT00984295|521846409|FG002|Overall Study|Missed one or more blood samplings|2|||
144724522|NCT00984295|521846407|FG000|Overall Study|Incomplete safety follow-up|11|||
144438619|NCT00404352|520809543|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144604788|NCT00210184|521415822|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
144604789|NCT02316340|521415823|FG000|First Progression|Clinical progression|2|||
144604790|NCT02316340|521415824|FG001|First Progression|Clinical progression|1|||
144604791|NCT02316340|521415823|FG000|First Progression|Withdrawal by Subject|1|||
144604792|NCT02316340|521415824|FG001|First Progression|Withdrawal by Subject|0|||
144604793|NCT01835015|521415825|FG000|Overall Study|Adverse Event|0|||
144604794|NCT01835015|521415826|FG001|Overall Study|Adverse Event|0|||
144472096|NCT00394355|520925378|FG000|Overall Study|Lack of Efficacy|0|||
144472097|NCT00394355|520925379|FG001|Overall Study|Lack of Efficacy|0|||
144472098|NCT00394355|520925380|FG002|Overall Study|Lack of Efficacy|2|||
144472099|NCT00394355|520925381|FG003|Overall Study|Lack of Efficacy|3|||
144472100|NCT00698646|520925387|FG000|Overall Study|Adverse Event|8|||
144472101|NCT00698646|520925388|FG001|Overall Study|Adverse Event|7|||
144472102|NCT00698646|520925389|FG002|Overall Study|Adverse Event|8|||
144472103|NCT00698646|520925387|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
144472104|NCT00698646|520925388|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
144472105|NCT00698646|520925389|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
144472106|NCT00698646|520925387|FG000|Overall Study|Protocol Deviation|6|||
144472107|NCT00698646|520925388|FG001|Overall Study|Protocol Deviation|2|||
144472108|NCT00698646|520925389|FG002|Overall Study|Protocol Deviation|3|||
144472109|NCT00698646|520925387|FG000|Overall Study|Withdrawal by Subject|10|||
144472110|NCT00698646|520925388|FG001|Overall Study|Withdrawal by Subject|11|||
144472111|NCT00698646|520925389|FG002|Overall Study|Withdrawal by Subject|8|||
144472112|NCT00698646|520925387|FG000|Overall Study|Lost to Follow-up|0|||
144472113|NCT00698646|520925388|FG001|Overall Study|Lost to Follow-up|0|||
144472114|NCT00698646|520925389|FG002|Overall Study|Lost to Follow-up|2|||
144472115|NCT00698646|520925387|FG000|Overall Study|Administrative problems|1|||
144472116|NCT00698646|520925388|FG001|Overall Study|Administrative problems|0|||
144472117|NCT00698646|520925389|FG002|Overall Study|Administrative problems|1|||
144472118|NCT00511875|520925392|FG000|Overall Study|Lost to Follow-up|4|||
144472119|NCT00511875|520925393|FG001|Overall Study|Lost to Follow-up|0|||
144472120|NCT00511875|520925392|FG000|Overall Study|Missing variables|1|||
144472121|NCT00511875|520925393|FG001|Overall Study|Missing variables|0|||
144472122|NCT00766675|520926652|FG000|Overall Study|Adverse Event|16|||
144472123|NCT00766675|520926652|FG000|Overall Study|Lost to Follow-up|2|||
144472124|NCT00766675|520926652|FG000|Overall Study|Withdrawal by Subject|11|||
144472125|NCT00766675|520926652|FG000|Overall Study|Protocol Violation|8|||
144472126|NCT00766675|520926652|FG000|Overall Study|Participant took prohibited medication|1|||
144472127|NCT00766675|520926652|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
144472128|NCT00766675|520926652|FG000|Overall Study|Insufficient therapy|1|||
144472129|NCT03308825|520926653|FG000|Overall Study|Lost to Follow-up|2|||
144472130|NCT03308825|520926654|FG001|Overall Study|Lost to Follow-up|2|||
144472131|NCT03308825|520926655|FG002|Overall Study|Lost to Follow-up|1|||
144472132|NCT03308825|520926656|FG003|Overall Study|Lost to Follow-up|0|||
144472133|NCT03308825|520926653|FG000|Overall Study|Protocol Violation|0|||
144472134|NCT03308825|520926654|FG001|Overall Study|Protocol Violation|2|||
144472135|NCT03308825|520926655|FG002|Overall Study|Protocol Violation|0|||
144472136|NCT03308825|520926656|FG003|Overall Study|Protocol Violation|0|||
144472137|NCT02044848|520926658|FG000|Overall Study|Administrative Problems|2|||
144472138|NCT02044848|520926659|FG001|Overall Study|Administrative Problems|3|||
144472139|NCT00045708|520926660|FG000|Phase 1|early progressive disease|0|||
144472140|NCT00045708|520926661|FG001|Phase 1|early progressive disease|1|||
144472141|NCT00045708|520926662|FG002|Phase 1|early progressive disease|0|||
144472142|NCT00685945|520926664|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
144472143|NCT03183388|520926665|FG000|Overall Study|Lost to Follow-up|3|||
144472144|NCT03183388|520926666|FG001|Overall Study|Lost to Follow-up|5|||
144472145|NCT03183388|520926665|FG000|Overall Study|Physician Decision|1|||
144472146|NCT03183388|520926666|FG001|Overall Study|Physician Decision|4|||
144472147|NCT03183388|520926665|FG000|Overall Study|Withdrawal by Subject|4|||
144472148|NCT03183388|520926666|FG001|Overall Study|Withdrawal by Subject|1|||
144472149|NCT03183388|520926665|FG000|Overall Study|Moved|1|||
144472150|NCT03183388|520926666|FG001|Overall Study|Moved|0|||
144472151|NCT03183388|520926665|FG000|Overall Study|Met Exclusion Criteria|2|||
144472152|NCT03183388|520926666|FG001|Overall Study|Met Exclusion Criteria|2|||
144472153|NCT03183388|520926665|FG000|Overall Study|COVID Pandemic Related|2|||
144472154|NCT03183388|520926666|FG001|Overall Study|COVID Pandemic Related|4|||
144472155|NCT01493960|520926669|FG000|Overall Study|Adverse Event|0|||
144472156|NCT01493960|520926670|FG001|Overall Study|Adverse Event|1|||
144472157|NCT01493960|520926669|FG000|Overall Study|Lack of Efficacy|15|||
144472158|NCT01493960|520926670|FG001|Overall Study|Lack of Efficacy|9|||
144472159|NCT01493960|520926669|FG000|Overall Study|Protocol Violation|3|||
144472160|NCT01493960|520926670|FG001|Overall Study|Protocol Violation|0|||
144472161|NCT01493960|520926669|FG000|Overall Study|Withdrawal by Subject|10|||
144472162|NCT01493960|520926670|FG001|Overall Study|Withdrawal by Subject|4|||
144472163|NCT01493960|520926669|FG000|Overall Study|Non-specified|4|||
144189300|NCT03941834|519886856|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
144189301|NCT03941834|519886857|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
144189302|NCT03941834|519886858|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
144189303|NCT03941834|519886856|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
144189304|NCT03941834|519886857|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
144189305|NCT03941834|519886858|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
144189306|NCT03941834|519886856|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
144189307|NCT03941834|519886857|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
144189308|NCT03941834|519886858|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
144189309|NCT03941834|519886856|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
144189310|NCT03941834|519886857|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
144189311|NCT03941834|519886858|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
144189312|NCT03941834|519886856|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
144189313|NCT03941834|519886857|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
144189314|NCT03941834|519886858|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
144189315|NCT01606228|519886861|FG000|Overall Study|Lost to Follow-up|20|||
144189316|NCT01606228|519886861|FG000|Overall Study|Withdrawal by Subject|3|||
144189317|NCT01606228|519886861|FG000|Overall Study|Non-compliant|3|||
144189318|NCT01606228|519886861|FG000|Overall Study|Lack of Efficacy|2|||
144189319|NCT01606228|519886861|FG000|Overall Study|Adverse Event|1|||
144189320|NCT01115855|519886862|FG000|Overall Study|Adverse Event|16|||
144189321|NCT01115855|519886863|FG001|Overall Study|Adverse Event|18|||
144189322|NCT01115855|519886862|FG000|Overall Study|Death|6|||
144189323|NCT01115855|519886863|FG001|Overall Study|Death|5|||
144189324|NCT01115855|519886862|FG000|Overall Study|Lab Abnormality|1|||
144189325|NCT01115855|519886863|FG001|Overall Study|Lab Abnormality|1|||
144189326|NCT01115855|519886862|FG000|Overall Study|Protocol Violation|0|||
144189327|NCT01115855|519886863|FG001|Overall Study|Protocol Violation|1|||
144189328|NCT01115855|519886862|FG000|Overall Study|Withdrawal by Subject|5|||
144189329|NCT01115855|519886863|FG001|Overall Study|Withdrawal by Subject|5|||
144189330|NCT01115855|519886862|FG000|Overall Study|Other|8|||
144189331|NCT01115855|519886863|FG001|Overall Study|Other|6|||
144189332|NCT00480324|519886864|FG000|Overall Study|Adverse Event|1|||
144189333|NCT00480324|519886865|FG001|Overall Study|Adverse Event|1|||
144189334|NCT00480324|519886864|FG000|Overall Study|Protocol Violation|0|||
144189335|NCT00480324|519886865|FG001|Overall Study|Protocol Violation|1|||
144189336|NCT00480324|519886864|FG000|Overall Study|Withdrawal by Subject|14|||
144189337|NCT00480324|519886865|FG001|Overall Study|Withdrawal by Subject|5|||
144189338|NCT00480324|519886864|FG000|Overall Study|Lost to Follow-up|17|||
144189339|NCT00480324|519886865|FG001|Overall Study|Lost to Follow-up|8|||
144189340|NCT00480324|519886864|FG000|Overall Study|Subject's mother pregnant|0|||
144189341|NCT00480324|519886865|FG001|Overall Study|Subject's mother pregnant|1|||
144189342|NCT00784134|519886866|FG000|Overall Study|Lost to Follow-up|3|||
144189343|NCT00784134|519886867|FG001|Overall Study|Lost to Follow-up|6|||
144189344|NCT03785145|519886868|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
144189345|NCT03785145|519886869|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
144189346|NCT03785145|519886868|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
144189347|NCT03785145|519886869|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
144189348|NCT03785145|519886868|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
144189349|NCT03785145|519886869|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
144189350|NCT03785145|519886868|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
144189351|NCT03785145|519886869|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
144189352|NCT03785145|519886868|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
144189353|NCT03785145|519886869|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
144189354|NCT03785145|519886868|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
144438620|NCT00404352|520809544|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144189355|NCT03785145|519886869|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
144189356|NCT03785145|519886868|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
144438621|NCT00404352|520809545|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144438622|NCT00404352|520809546|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144438623|NCT00404352|520809547|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144438624|NCT00404352|520809548|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
144438625|NCT00404352|520809549|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
144604795|NCT01835015|521415827|FG002|Overall Study|Adverse Event|1|||
144604796|NCT01835015|521415828|FG003|Overall Study|Adverse Event|0|||
144189357|NCT03785145|519886869|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
144189358|NCT03785145|519886868|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
144189359|NCT03785145|519886869|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
144189360|NCT03785145|519886868|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
144189361|NCT03785145|519886869|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
144438626|NCT00404352|520809550|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
144189362|NCT03785145|519886868|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
144189363|NCT03785145|519886869|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
144189364|NCT03785145|519886868|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
144189365|NCT03785145|519886869|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
144189366|NCT00097786|519886870|FG000|Overall Study|lost to follow-up for all-cause death|296|||
144189367|NCT00097786|519886871|FG001|Overall Study|lost to follow-up for all-cause death|292|||
144189368|NCT00097786|519886872|FG002|Overall Study|lost to follow-up for all-cause death|313|||
144189369|NCT00097786|519886873|FG003|Overall Study|lost to follow-up for all-cause death|310|||
144189370|NCT02960438|519886874|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
144189371|NCT02960438|519886875|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
144189372|NCT02960438|519886876|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
144189373|NCT02960438|519886877|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
144189374|NCT02960438|519886874|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
144189375|NCT02960438|519886875|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
144189376|NCT02960438|519886876|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
144189377|NCT02960438|519886877|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
144189378|NCT02960438|519886874|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
144189379|NCT02960438|519886875|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
144189380|NCT02960438|519886876|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
144189381|NCT02960438|519886877|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
144189382|NCT02960438|519886874|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
144189383|NCT02960438|519886875|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
144189384|NCT02960438|519886876|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
144189385|NCT02960438|519886877|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
144438627|NCT00404352|520809542|FG000|Open Label Extension (up to 36 Months)|Other|0|||
144438628|NCT00404352|520809543|FG001|Open Label Extension (up to 36 Months)|Other|0|||
144438629|NCT00404352|520809544|FG002|Open Label Extension (up to 36 Months)|Other|0|||
144438630|NCT00404352|520809545|FG003|Open Label Extension (up to 36 Months)|Other|0|||
144438631|NCT00404352|520809546|FG004|Open Label Extension (up to 36 Months)|Other|0|||
144438632|NCT00404352|520809547|FG005|Open Label Extension (up to 36 Months)|Other|0|||
144438633|NCT00404352|520809548|FG006|Open Label Extension (up to 36 Months)|Other|0|||
144438634|NCT00404352|520809549|FG007|Open Label Extension (up to 36 Months)|Other|0|||
144438635|NCT00404352|520809550|FG008|Open Label Extension (up to 36 Months)|Other|2|||
144438636|NCT03047135|520809551|FG000|Overall Study|Still being treated|3|||
144438637|NCT00323414|520809552|FG000|Overall Study|Withdrawal by Subject|0|||
144438638|NCT00323414|520809553|FG001|Overall Study|Withdrawal by Subject|1|||
144438639|NCT01077960|520809554|FG000|Overall Study|Adverse Event|6|||
144438640|NCT01077960|520809554|FG000|Overall Study|Protocol Violation|3|||
144438641|NCT01077960|520809554|FG000|Overall Study|Lost to Follow-up|5|||
144438642|NCT01077960|520809554|FG000|Overall Study|Subject decision|1|||
144438643|NCT01077960|520809554|FG000|Overall Study|Reason unspecified|1|||
144438644|NCT05619692|520809555|FG000|Overall Study|Adverse Event|2|||
144438645|NCT05619692|520809556|FG001|Overall Study|Adverse Event|2|||
144438646|NCT05619692|520809555|FG000|Overall Study|Withdrawal by Participant|3|||
144438647|NCT05619692|520809556|FG001|Overall Study|Withdrawal by Participant|4|||
144438648|NCT05619692|520809555|FG000|Overall Study|Lost to Follow-up|2|||
144438649|NCT05619692|520809556|FG001|Overall Study|Lost to Follow-up|1|||
144438650|NCT05619692|520809555|FG000|Overall Study|Randomized but not treated|1|||
144438651|NCT05619692|520809556|FG001|Overall Study|Randomized but not treated|3|||
144438652|NCT01398956|520809557|FG000|Overall Study|Withdrawal by Subject|4|||
144438653|NCT01398956|520809557|FG000|Overall Study|AE, non-serious non-fatal|4|||
144438654|NCT01398956|520809557|FG000|Overall Study|Withdrawal Criteria No.3|1|||
144438655|NCT01398956|520809557|FG000|Overall Study|Subject moved a long distance|1|||
144438656|NCT00451035|520809558|FG000|Overall Study|Disease progression|11|||
144438657|NCT00451035|520809558|FG000|Overall Study|Death|3|||
144438658|NCT00451035|520809558|FG000|Overall Study|New anti-neoplastic therapy|3|||
144438659|NCT00692770|520809572|FG000|Overall Study|Protocol Violation|2|||
144438660|NCT00692770|520809573|FG001|Overall Study|Protocol Violation|7|||
144438661|NCT00692770|520809572|FG000|Overall Study|Withdrawal by Subject|97|||
144438662|NCT00692770|520809573|FG001|Overall Study|Withdrawal by Subject|36|||
144438663|NCT00692770|520809572|FG000|Overall Study|Adverse Event|136|||
144438664|NCT00692770|520809573|FG001|Overall Study|Adverse Event|41|||
144438665|NCT00692770|520809572|FG000|Overall Study|Death|10|||
144438666|NCT00692770|520809573|FG001|Overall Study|Death|5|||
144438667|NCT00692770|520809572|FG000|Overall Study|Lost to Follow-up|7|||
144438668|NCT00692770|520809573|FG001|Overall Study|Lost to Follow-up|3|||
144438669|NCT00692770|520809572|FG000|Overall Study|Non-compliant with study medication|11|||
144438670|NCT00692770|520809573|FG001|Overall Study|Non-compliant with study medication|5|||
144438671|NCT00692770|520809572|FG000|Overall Study|Progression by clinical judgment|2|||
144438672|NCT00692770|520809573|FG001|Overall Study|Progression by clinical judgment|3|||
144438673|NCT00692770|520809572|FG000|Overall Study|Physician decision not protocol driven|10|||
144189386|NCT02960438|519886874|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
144189387|NCT02960438|519886875|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
144189388|NCT02960438|519886876|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
144189389|NCT02960438|519886877|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
144189390|NCT02960438|519886874|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
144189391|NCT02960438|519886875|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
144189392|NCT02960438|519886876|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
144189393|NCT02960438|519886877|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
144189394|NCT02960438|519886874|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
144189395|NCT02960438|519886875|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
144189396|NCT02960438|519886876|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
144189397|NCT02960438|519886877|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
144189398|NCT02960438|519886874|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
144189399|NCT02960438|519886875|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
144189400|NCT02960438|519886876|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
144189401|NCT02960438|519886877|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
144189402|NCT02960438|519886874|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
144189403|NCT02960438|519886875|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
144189404|NCT02960438|519886876|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
144189405|NCT02960438|519886877|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
144189406|NCT02960438|519886874|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
144189407|NCT02960438|519886875|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
144189408|NCT02960438|519886876|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
144189409|NCT02960438|519886877|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
144189410|NCT02960438|519886874|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
144189411|NCT02960438|519886875|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
144189412|NCT02960438|519886876|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
144189413|NCT02960438|519886877|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
144189414|NCT02960438|519886874|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
144189415|NCT02960438|519886875|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
144189416|NCT02960438|519886876|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
144189417|NCT02960438|519886877|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
144189418|NCT03686150|519886878|FG000|Overall Study|Withdrawal by Subject|1|||
144189419|NCT03686150|519886879|FG001|Overall Study|Withdrawal by Subject|1|||
144189420|NCT03686150|519886880|FG002|Overall Study|Withdrawal by Subject|1|||
144189421|NCT03686150|519886881|FG003|Overall Study|Withdrawal by Subject|0|||
144189422|NCT03686150|519886882|FG004|Overall Study|Withdrawal by Subject|1|||
144189423|NCT03686150|519886883|FG005|Overall Study|Withdrawal by Subject|2|||
144189424|NCT03686150|519886878|FG000|Overall Study|Physician Decision|1|||
144189425|NCT03686150|519886879|FG001|Overall Study|Physician Decision|0|||
144189426|NCT03686150|519886880|FG002|Overall Study|Physician Decision|0|||
144189427|NCT03686150|519886881|FG003|Overall Study|Physician Decision|0|||
144189428|NCT03686150|519886882|FG004|Overall Study|Physician Decision|0|||
144189429|NCT03686150|519886883|FG005|Overall Study|Physician Decision|1|||
144189430|NCT03686150|519886878|FG000|Overall Study|Lost to Follow-up|0|||
144189431|NCT03686150|519886879|FG001|Overall Study|Lost to Follow-up|1|||
144189432|NCT03686150|519886880|FG002|Overall Study|Lost to Follow-up|0|||
144189433|NCT03686150|519886881|FG003|Overall Study|Lost to Follow-up|0|||
144189434|NCT03686150|519886882|FG004|Overall Study|Lost to Follow-up|0|||
144189435|NCT03686150|519886883|FG005|Overall Study|Lost to Follow-up|0|||
144189436|NCT02443324|519886885|FG000|Overall Study|Death|4|||
144189437|NCT02443324|519886886|FG001|Overall Study|Death|1|||
144189438|NCT02443324|519886887|FG002|Overall Study|Death|0|||
144189439|NCT02443324|519886888|FG003|Overall Study|Death|3|||
144189440|NCT02443324|519886889|FG004|Overall Study|Death|1|||
144189441|NCT02443324|519886890|FG005|Overall Study|Death|3|||
144189442|NCT02443324|519886891|FG006|Overall Study|Death|2|||
144189443|NCT02443324|519886885|FG000|Overall Study|Lost to Follow-up|0|||
144530693|NCT04585815|521146272|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
144530694|NCT04585815|521146273|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
144530695|NCT04585815|521146274|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
144530696|NCT04585815|521146268|FG000|Sub-study B- Follow-up Phase|Death|0|||
144530697|NCT04585815|521146269|FG001|Sub-study B- Follow-up Phase|Death|0|||
144530698|NCT04585815|521146270|FG002|Sub-study B- Follow-up Phase|Death|1|||
144189444|NCT02443324|519886886|FG001|Overall Study|Lost to Follow-up|0|||
144189445|NCT02443324|519886887|FG002|Overall Study|Lost to Follow-up|0|||
144530699|NCT04585815|521146271|FG003|Sub-study B- Follow-up Phase|Death|3|||
144530700|NCT04585815|521146272|FG004|Sub-study B- Follow-up Phase|Death|0|||
144530701|NCT04585815|521146273|FG005|Sub-study B- Follow-up Phase|Death|0|||
144530702|NCT04585815|521146274|FG006|Sub-study B- Follow-up Phase|Death|1|||
144530703|NCT02497950|521146277|FG000|Overall Study|Death|209|||
144189446|NCT02443324|519886888|FG003|Overall Study|Lost to Follow-up|1|||
144189447|NCT02443324|519886889|FG004|Overall Study|Lost to Follow-up|0|||
144189448|NCT02443324|519886890|FG005|Overall Study|Lost to Follow-up|1|||
144189449|NCT02443324|519886891|FG006|Overall Study|Lost to Follow-up|0|||
144189450|NCT02443324|519886885|FG000|Overall Study|Physician Decision|0|||
144189451|NCT02443324|519886886|FG001|Overall Study|Physician Decision|3|||
144189452|NCT02443324|519886887|FG002|Overall Study|Physician Decision|5|||
144189453|NCT02443324|519886888|FG003|Overall Study|Physician Decision|1|||
144189454|NCT02443324|519886889|FG004|Overall Study|Physician Decision|1|||
144189455|NCT02443324|519886890|FG005|Overall Study|Physician Decision|0|||
144189456|NCT02443324|519886891|FG006|Overall Study|Physician Decision|2|||
144189457|NCT02443324|519886885|FG000|Overall Study|Progressive Disease|20|||
144189458|NCT02443324|519886886|FG001|Overall Study|Progressive Disease|20|||
144189459|NCT02443324|519886887|FG002|Overall Study|Progressive Disease|13|||
144189460|NCT02443324|519886888|FG003|Overall Study|Progressive Disease|10|||
144189461|NCT02443324|519886889|FG004|Overall Study|Progressive Disease|13|||
144189462|NCT02443324|519886890|FG005|Overall Study|Progressive Disease|17|||
144189463|NCT02443324|519886891|FG006|Overall Study|Progressive Disease|10|||
144189464|NCT02443324|519886885|FG000|Overall Study|Withdrawal by Subject|0|||
144189465|NCT02443324|519886886|FG001|Overall Study|Withdrawal by Subject|0|||
144189466|NCT02443324|519886887|FG002|Overall Study|Withdrawal by Subject|3|||
144189467|NCT02443324|519886888|FG003|Overall Study|Withdrawal by Subject|1|||
144189468|NCT02443324|519886889|FG004|Overall Study|Withdrawal by Subject|1|||
144189469|NCT02443324|519886890|FG005|Overall Study|Withdrawal by Subject|0|||
144189470|NCT02443324|519886891|FG006|Overall Study|Withdrawal by Subject|1|||
144189471|NCT02443324|519886885|FG000|Overall Study|Adverse Event|0|||
144189472|NCT02443324|519886886|FG001|Overall Study|Adverse Event|1|||
144189473|NCT02443324|519886887|FG002|Overall Study|Adverse Event|3|||
144189474|NCT02443324|519886888|FG003|Overall Study|Adverse Event|0|||
144189475|NCT02443324|519886889|FG004|Overall Study|Adverse Event|4|||
144189476|NCT02443324|519886890|FG005|Overall Study|Adverse Event|3|||
144189477|NCT02443324|519886891|FG006|Overall Study|Adverse Event|3|||
144189478|NCT02443324|519886885|FG000|Overall Study|Enrolled but Never Treated|0|||
144189479|NCT02443324|519886886|FG001|Overall Study|Enrolled but Never Treated|0|||
144189480|NCT02443324|519886887|FG002|Overall Study|Enrolled but Never Treated|1|||
144189481|NCT02443324|519886888|FG003|Overall Study|Enrolled but Never Treated|0|||
144189482|NCT02443324|519886889|FG004|Overall Study|Enrolled but Never Treated|1|||
144189483|NCT02443324|519886890|FG005|Overall Study|Enrolled but Never Treated|0|||
144189484|NCT02443324|519886891|FG006|Overall Study|Enrolled but Never Treated|1|||
144189485|NCT01647711|519886892|FG000|Overall Study|Progressive disease|6|||
144189486|NCT01647711|519886893|FG001|Overall Study|Progressive disease|2|||
144189487|NCT01647711|519886894|FG002|Overall Study|Progressive disease|6|||
144189488|NCT01647711|519886895|FG003|Overall Study|Progressive disease|8|||
144189489|NCT01647711|519886896|FG004|Overall Study|Progressive disease|2|||
144189490|NCT01647711|519886892|FG000|Overall Study|Other adverse event|0|||
144438674|NCT00692770|520809573|FG001|Overall Study|Physician decision not protocol driven|14|||
144438675|NCT00692770|520809572|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
144438676|NCT00692770|520809573|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
144438677|NCT00692770|520809572|FG000|Overall Study|Protocol driven decision point|3|||
144438678|NCT00692770|520809573|FG001|Overall Study|Protocol driven decision point|7|||
144438679|NCT00692770|520809572|FG000|Overall Study|Completed all planned assessments|79|||
144438680|NCT00692770|520809573|FG001|Overall Study|Completed all planned assessments|101|||
144438681|NCT00692770|520809572|FG000|Overall Study|Radiological and clinical progression|8|||
144438682|NCT00692770|520809573|FG001|Overall Study|Radiological and clinical progression|8|||
144438683|NCT00692770|520809572|FG000|Overall Study|Clinical endpoint reached|16|||
144438684|NCT00692770|520809573|FG001|Overall Study|Clinical endpoint reached|43|||
144438685|NCT00692770|520809572|FG000|Overall Study|Study terminated by sponsor|2|||
144438686|NCT00692770|520809573|FG001|Overall Study|Study terminated by sponsor|2|||
144438687|NCT00692770|520809572|FG000|Overall Study|Randomized but not treated|3|||
144604797|NCT01835015|521415829|FG004|Overall Study|Adverse Event|0|||
144604798|NCT03334409|521415830|FG000|Overall Study|Did not meet inclusion criteria|1|||
144604799|NCT03334409|521415831|FG001|Overall Study|Did not meet inclusion criteria|0|||
144604800|NCT00975715|521415832|FG000|Titration Period|Adverse Event|6|||
144604801|NCT00975715|521415833|FG001|Titration Period|Adverse Event|0|||
144189491|NCT01647711|519886893|FG001|Overall Study|Other adverse event|0|||
144189492|NCT01647711|519886894|FG002|Overall Study|Other adverse event|2|||
144189493|NCT01647711|519886895|FG003|Overall Study|Other adverse event|0|||
144189494|NCT01647711|519886896|FG004|Overall Study|Other adverse event|2|||
144438688|NCT00692770|520809573|FG001|Overall Study|Randomized but not treated|4|||
144604802|NCT00975715|521415832|FG000|Titration Period|Protocol Violation|1|||
144189495|NCT01647711|519886892|FG000|Overall Study|Protocol Violation|0|||
144189496|NCT01647711|519886893|FG001|Overall Study|Protocol Violation|0|||
144189497|NCT01647711|519886894|FG002|Overall Study|Protocol Violation|0|||
144189498|NCT01647711|519886895|FG003|Overall Study|Protocol Violation|0|||
144189499|NCT01647711|519886896|FG004|Overall Study|Protocol Violation|1|||
144189500|NCT01647711|519886892|FG000|Overall Study|Refused to continue taking medication|0|||
144189501|NCT01647711|519886893|FG001|Overall Study|Refused to continue taking medication|0|||
144438689|NCT00262067|520809581|FG000|Overall Study|Death|190|||
144530704|NCT02497950|521146277|FG000|Overall Study|Transplanted|85|||
144530705|NCT02497950|521146277|FG000|Overall Study|Explanted|8|||
144530706|NCT02497950|521146277|FG000|Overall Study|Device Permanently Deactivated|4|||
144530707|NCT02497950|521146277|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
144530708|NCT02497950|521146277|FG000|Overall Study|Lost to Follow-up|6|||
144530709|NCT02497950|521146277|FG000|Overall Study|Withdrawal by Subject|2|||
144530710|NCT02497950|521146277|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
144530711|NCT02497950|521146277|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
144530712|NCT04660539|521146278|FG000|Overall Study|Adverse Event|10|||
144530713|NCT04660539|521146278|FG000|Overall Study|Lack of Efficacy|4|||
144530714|NCT04660539|521146278|FG000|Overall Study|Lost to Follow-up|5|||
144530715|NCT04660539|521146278|FG000|Overall Study|Non-Compliance With Study Drug|3|||
144530716|NCT04660539|521146278|FG000|Overall Study|Reason not Specified|12|||
144530717|NCT04660539|521146278|FG000|Overall Study|Pregnancy|2|||
144530718|NCT04660539|521146278|FG000|Overall Study|Protocol Violation|2|||
144530719|NCT04660539|521146278|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
144530720|NCT04660539|521146278|FG000|Overall Study|Withdrawal by Subject|21|||
144530721|NCT03655028|521146281|FG000|12-weeks Follow up|Death|1|||
144530722|NCT03655028|521146282|FG001|12-weeks Follow up|Death|0|||
144530723|NCT03655028|521146281|FG000|12-weeks Follow up|Physician Decision|3|||
144530724|NCT03655028|521146282|FG001|12-weeks Follow up|Physician Decision|3|||
144530725|NCT03655028|521146281|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
144530726|NCT03655028|521146282|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
144530727|NCT03655028|521146281|FG000|12-weeks Follow up|Lost to Follow-up|4|||
144530728|NCT03655028|521146282|FG001|12-weeks Follow up|Lost to Follow-up|4|||
144530729|NCT03655028|521146281|FG000|24-weeks|Lost to Follow-up|1|||
144530730|NCT03655028|521146282|FG001|24-weeks|Lost to Follow-up|1|||
144530731|NCT03655028|521146281|FG000|24-weeks|Death|0|||
144530732|NCT03655028|521146282|FG001|24-weeks|Death|1|||
144530733|NCT05618587|521146283|FG000|Overall Study|Lost to Follow-up|2|||
144530734|NCT05618587|521146284|FG001|Overall Study|Lost to Follow-up|0|||
144530735|NCT05256654|521146285|FG000|Overall Study|Adverse Event|0|||
144530736|NCT05256654|521146286|FG001|Overall Study|Adverse Event|0|||
144530737|NCT05256654|521146287|FG002|Overall Study|Adverse Event|1|||
144530738|NCT05256654|521146288|FG003|Overall Study|Adverse Event|0|||
144604803|NCT00975715|521415833|FG001|Titration Period|Protocol Violation|0|||
144604804|NCT00975715|521415832|FG000|Maintenance Period|Adverse Event|2|||
144604805|NCT00975715|521415833|FG001|Maintenance Period|Adverse Event|1|||
144604806|NCT01241552|521415834|FG000|Overall Study|Lack of Efficacy|1|||
144724523|NCT00984295|521846408|FG001|Overall Study|Incomplete safety follow-up|2|||
144438690|NCT00262067|520809582|FG001|Overall Study|Death|89|||
144438691|NCT00262067|520809583|FG002|Overall Study|Death|186|||
144438692|NCT00262067|520809584|FG003|Overall Study|Death|99|||
144438693|NCT00262067|520809581|FG000|Overall Study|Lost to Follow-up|5|||
144438694|NCT00262067|520809582|FG001|Overall Study|Lost to Follow-up|4|||
144438695|NCT00262067|520809583|FG002|Overall Study|Lost to Follow-up|7|||
144438696|NCT00262067|520809584|FG003|Overall Study|Lost to Follow-up|5|||
144438697|NCT00262067|520809581|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
144438698|NCT00262067|520809582|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
144438699|NCT00262067|520809583|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
144438700|NCT00262067|520809584|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
144438701|NCT00262067|520809581|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
144438702|NCT00262067|520809582|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
144438703|NCT00262067|520809583|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
144438704|NCT00262067|520809584|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
144438705|NCT03829046|520809585|FG000|Overall Study|Withdrawal by Subject|1|||
144438706|NCT03829046|520809586|FG001|Overall Study|Withdrawal by Subject|0|||
144438707|NCT04477304|520809587|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
144438708|NCT04477304|520809588|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
144438709|NCT01904604|520811026|FG000|Overall Study|Withdrew before receiving dosing|0|||
144438710|NCT01904604|520811027|FG001|Overall Study|Withdrew before receiving dosing|1|||
144438711|NCT01904604|520811028|FG002|Overall Study|Withdrew before receiving dosing|0|||
144438712|NCT01904604|520811026|FG000|Overall Study|Non-compliance|1|||
144438713|NCT01904604|520811027|FG001|Overall Study|Non-compliance|0|||
144438714|NCT01904604|520811028|FG002|Overall Study|Non-compliance|0|||
144438715|NCT01904604|520811026|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
144438716|NCT01904604|520811027|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
144438717|NCT01904604|520811028|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
144438718|NCT01904604|520811026|FG000|Overall Study|Patch site reactions|1|||
144438719|NCT01904604|520811027|FG001|Overall Study|Patch site reactions|1|||
144438720|NCT01904604|520811028|FG002|Overall Study|Patch site reactions|0|||
144438721|NCT01904604|520811026|FG000|Overall Study|Increased syncope|0|||
144438722|NCT01904604|520811027|FG001|Overall Study|Increased syncope|1|||
144530739|NCT05256654|521146285|FG000|Overall Study|Lost to Follow-up|0|||
144530740|NCT05256654|521146286|FG001|Overall Study|Lost to Follow-up|0|||
144530741|NCT05256654|521146287|FG002|Overall Study|Lost to Follow-up|0|||
144189502|NCT01647711|519886894|FG002|Overall Study|Refused to continue taking medication|0|||
144189503|NCT01647711|519886895|FG003|Overall Study|Refused to continue taking medication|2|||
144189504|NCT01647711|519886896|FG004|Overall Study|Refused to continue taking medication|1|||
144189505|NCT01647711|519886892|FG000|Overall Study|Other reason not defined|0|||
144189506|NCT01647711|519886893|FG001|Overall Study|Other reason not defined|1|||
144189507|NCT01647711|519886894|FG002|Overall Study|Other reason not defined|1|||
144189508|NCT01647711|519886895|FG003|Overall Study|Other reason not defined|1|||
144189509|NCT01647711|519886896|FG004|Overall Study|Other reason not defined|0|||
144189510|NCT01844531|519886900|FG000|Overall Study|Withdrawal by Subject|0|||
144189511|NCT01844531|519886901|FG001|Overall Study|Withdrawal by Subject|1|||
144189512|NCT01844531|519886902|FG002|Overall Study|Withdrawal by Subject|0|||
144189513|NCT01844531|519886903|FG003|Overall Study|Withdrawal by Subject|0|||
144189514|NCT01546922|519886904|FG000|First Period of 10 Weeks|Protocol Violation|3|||
144189515|NCT01546922|519886905|FG001|First Period of 10 Weeks|Protocol Violation|1|||
144189516|NCT01546922|519886904|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
144189517|NCT01546922|519886905|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
144189518|NCT01546922|519886904|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
144189519|NCT01546922|519886905|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
144189520|NCT01546922|519886904|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
144189521|NCT01546922|519886905|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
144189522|NCT01546922|519886904|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
144189523|NCT01546922|519886905|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
144189524|NCT01613378|519886906|FG000|Overall Study|Lack of Efficacy|13|||
144189525|NCT01613378|519886906|FG000|Overall Study|Adverse Event|11|||
144253508|NCT03297021|520128100|FG000|Overall Study|Incomplete/illegible data sheet|4|||
144253509|NCT03297021|520128101|FG001|Overall Study|Incomplete/illegible data sheet|2|||
144253510|NCT03297021|520128102|FG002|Overall Study|Incomplete/illegible data sheet|3|||
144253511|NCT03297021|520128100|FG000|Overall Study|Missing Post-Op Data|1|||
144253512|NCT03297021|520128101|FG001|Overall Study|Missing Post-Op Data|2|||
144438723|NCT01904604|520811028|FG002|Overall Study|Increased syncope|0|||
144438724|NCT01904604|520811026|FG000|Overall Study|Unrelated illness|0|||
144438725|NCT01904604|520811027|FG001|Overall Study|Unrelated illness|1|||
144438726|NCT01904604|520811028|FG002|Overall Study|Unrelated illness|0|||
144438727|NCT01904604|520811026|FG000|Overall Study|Passed Week 52 OFC|1|||
144438728|NCT01904604|520811027|FG001|Overall Study|Passed Week 52 OFC|0|||
144438729|NCT01904604|520811028|FG002|Overall Study|Passed Week 52 OFC|0|||
144438730|NCT01904604|520811026|FG000|Overall Study|Withdrawal by Subject|1|||
144438731|NCT01904604|520811027|FG001|Overall Study|Withdrawal by Subject|2|||
144189526|NCT01613378|519886906|FG000|Overall Study|Withdrawal by Subject|8|||
144189527|NCT01613378|519886906|FG000|Overall Study|Death|2|||
144189528|NCT01613378|519886906|FG000|Overall Study|Lost to Follow-up|1|||
144189529|NCT01613378|519886906|FG000|Overall Study|Other Reason|4|||
144189530|NCT00743509|519886908|FG000|Overall Study|Withdrawal by Subject|2|||
144189531|NCT00418522|519886909|FG000|Overall Study|Adverse Event|7|||
144189532|NCT00418522|519886910|FG001|Overall Study|Adverse Event|1|||
144189533|NCT00418522|519886909|FG000|Overall Study|Lack of Efficacy|1|||
144189534|NCT00418522|519886910|FG001|Overall Study|Lack of Efficacy|3|||
144189535|NCT00418522|519886909|FG000|Overall Study|Lost to Follow-up|10|||
144189536|NCT00418522|519886910|FG001|Overall Study|Lost to Follow-up|4|||
144189537|NCT00418522|519886909|FG000|Overall Study|Withdrawal by Subject|31|||
144189538|NCT00418522|519886910|FG001|Overall Study|Withdrawal by Subject|7|||
144189539|NCT00418522|519886909|FG000|Overall Study|Other|27|||
144189540|NCT00418522|519886910|FG001|Overall Study|Other|23|||
144438732|NCT01904604|520811028|FG002|Overall Study|Withdrawal by Subject|0|||
144438733|NCT01904604|520811026|FG000|Overall Study|Participant Relocated|1|||
144438734|NCT01904604|520811027|FG001|Overall Study|Participant Relocated|1|||
144438735|NCT01904604|520811028|FG002|Overall Study|Participant Relocated|1|||
144438736|NCT01904604|520811026|FG000|Overall Study|Lost to Follow-up|0|||
144438737|NCT01904604|520811027|FG001|Overall Study|Lost to Follow-up|0|||
144438738|NCT01904604|520811028|FG002|Overall Study|Lost to Follow-up|1|||
144438739|NCT01945489|520811029|FG000|Cycle 1|Adverse Event|2|||
144438740|NCT01945489|520811030|FG001|Cycle 1|Adverse Event|0|||
144438741|NCT01945489|520811029|FG000|Cycle 1|Lost to Follow-up|4|||
144189541|NCT00418522|519886909|FG000|Overall Study|Randomized but did not receive treatment|7|||
144189542|NCT00418522|519886910|FG001|Overall Study|Randomized but did not receive treatment|4|||
144438742|NCT01945489|520811030|FG001|Cycle 1|Lost to Follow-up|0|||
144438743|NCT01945489|520811029|FG000|Cycle 1|Personal Reasons|4|||
144189543|NCT01652729|519886911|FG000|Overall Study|Withdrawal by Subject|14|||
144189544|NCT01652729|519886912|FG001|Overall Study|Withdrawal by Subject|7|||
144189545|NCT01652729|519886913|FG002|Overall Study|Withdrawal by Subject|7|||
144438744|NCT01945489|520811030|FG001|Cycle 1|Personal Reasons|2|||
144438745|NCT01945489|520811029|FG000|Cycle 1|Protocol Violation|0|||
144438746|NCT01945489|520811030|FG001|Cycle 1|Protocol Violation|1|||
144189546|NCT01652729|519886911|FG000|Overall Study|Adverse Event|4|||
144189547|NCT01652729|519886912|FG001|Overall Study|Adverse Event|0|||
144189548|NCT01652729|519886913|FG002|Overall Study|Adverse Event|3|||
144438747|NCT01945489|520811029|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
144189549|NCT01652729|519886911|FG000|Overall Study|Physician Decision|1|||
144189550|NCT01652729|519886912|FG001|Overall Study|Physician Decision|0|||
144189551|NCT01652729|519886913|FG002|Overall Study|Physician Decision|1|||
144189552|NCT01652729|519886911|FG000|Overall Study|Protocol Violation|1|||
144189553|NCT01652729|519886912|FG001|Overall Study|Protocol Violation|0|||
144189554|NCT01652729|519886913|FG002|Overall Study|Protocol Violation|0|||
144189555|NCT01652729|519886911|FG000|Overall Study|Lost to Follow-up|6|||
144438748|NCT01945489|520811030|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
144438749|NCT01945489|520811029|FG000|Cycle 2|Adverse Event|1|||
144438750|NCT01945489|520811030|FG001|Cycle 2|Adverse Event|0|||
144438751|NCT01945489|520811029|FG000|Cycle 2|Lost to Follow-up|0|||
144189556|NCT01652729|519886912|FG001|Overall Study|Lost to Follow-up|6|||
144438752|NCT01945489|520811030|FG001|Cycle 2|Lost to Follow-up|1|||
144438753|NCT03752619|520811038|FG000|Overall Study|Lost to Follow-up|2|||
144438754|NCT03752619|520811039|FG001|Overall Study|Lost to Follow-up|1|||
144438755|NCT03752619|520811038|FG000|Overall Study|Withdrawal by Subject|1|||
144438756|NCT03752619|520811039|FG001|Overall Study|Withdrawal by Subject|1|||
144438757|NCT03752619|520811038|FG000|Overall Study|Adverse Event|0|||
144438758|NCT03752619|520811039|FG001|Overall Study|Adverse Event|1|||
144438759|NCT05040152|520811040|FG000|Overall Study|Withdrawal by Subject|5|||
144438760|NCT05040152|520811041|FG001|Overall Study|Withdrawal by Subject|0|||
144438761|NCT05040152|520811040|FG000|Overall Study|Lost to Follow-up|0|||
144438762|NCT05040152|520811041|FG001|Overall Study|Lost to Follow-up|2|||
144438763|NCT03907683|520811042|FG000|Overall Study|Pregnancy|1|||
144438764|NCT03907683|520811042|FG000|Overall Study|Withdrawal by Subject|1|||
144438765|NCT02075840|520811045|FG000|Overall Study|Withdrawal by Subject|13|||
144438766|NCT02075840|520811046|FG001|Overall Study|Withdrawal by Subject|22|||
144438767|NCT02075840|520811045|FG000|Overall Study|Reason not specified|1|||
144438768|NCT02075840|520811046|FG001|Overall Study|Reason not specified|0|||
144438769|NCT02075840|520811045|FG000|Overall Study|Adverse Event|0|||
144438770|NCT02075840|520811046|FG001|Overall Study|Adverse Event|2|||
144438771|NCT02075840|520811045|FG000|Overall Study|Death|35|||
144438772|NCT02075840|520811046|FG001|Overall Study|Death|40|||
144438773|NCT02075840|520811045|FG000|Overall Study|Lost to Follow-up|3|||
144438774|NCT02075840|520811046|FG001|Overall Study|Lost to Follow-up|2|||
144438775|NCT02075840|520811045|FG000|Overall Study|Physician Decision|1|||
144438776|NCT02075840|520811046|FG001|Overall Study|Physician Decision|3|||
144438777|NCT02075840|520811045|FG000|Overall Study|Ongoing at CCOD|99|||
144438778|NCT02075840|520811046|FG001|Overall Study|Ongoing at CCOD|82|||
144438779|NCT02018458|520811055|FG000|Overall Study|Death|4|||
144438780|NCT02027844|520811058|FG000|Overall Study|Withdrawal by Subject|3|||
144438781|NCT02027844|520811059|FG001|Overall Study|Withdrawal by Subject|2|||
144438782|NCT02027844|520811060|FG002|Overall Study|Withdrawal by Subject|1|||
144438783|NCT02027844|520811058|FG000|Overall Study|Lost to Follow-up|0|||
144438784|NCT02027844|520811059|FG001|Overall Study|Lost to Follow-up|2|||
144438785|NCT02027844|520811060|FG002|Overall Study|Lost to Follow-up|1|||
144438786|NCT02027844|520811058|FG000|Overall Study|Protocol Violation|0|||
144438787|NCT02027844|520811059|FG001|Overall Study|Protocol Violation|2|||
144438788|NCT02027844|520811060|FG002|Overall Study|Protocol Violation|0|||
144438789|NCT02027844|520811058|FG000|Overall Study|Incomlete data|2|||
144438790|NCT02027844|520811059|FG001|Overall Study|Incomlete data|0|||
144438791|NCT02027844|520811060|FG002|Overall Study|Incomlete data|0|||
144438792|NCT00357370|520811061|FG000|Cohort 2|Lack of Efficacy|0|||
144438793|NCT00357370|520811062|FG001|Cohort 2|Lack of Efficacy|2|||
144438794|NCT00357370|520811063|FG002|Cohort 2|Lack of Efficacy|1|||
144438795|NCT00357370|520811061|FG000|Cohort 2|Adverse Event|1|||
144438796|NCT00357370|520811062|FG001|Cohort 2|Adverse Event|1|||
144438797|NCT00357370|520811063|FG002|Cohort 2|Adverse Event|1|||
144438798|NCT00357370|520811061|FG000|Cohort 2|Lost to Follow-up|0|||
144438799|NCT00357370|520811062|FG001|Cohort 2|Lost to Follow-up|1|||
144438800|NCT00357370|520811063|FG002|Cohort 2|Lost to Follow-up|0|||
144189557|NCT01652729|519886913|FG002|Overall Study|Lost to Follow-up|3|||
144189558|NCT01652729|519886911|FG000|Overall Study|Administrative|1|||
144438801|NCT00357370|520811061|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
144438802|NCT00357370|520811062|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
144438803|NCT00357370|520811063|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
144438804|NCT00357370|520811061|FG000|Cohort 2|Withdrawal by Subject|0|||
144438805|NCT00357370|520811062|FG001|Cohort 2|Withdrawal by Subject|2|||
144438806|NCT00357370|520811063|FG002|Cohort 2|Withdrawal by Subject|0|||
144438807|NCT02552316|520811066|FG000|Overall Study|Withdrawal by Subject|1|||
144438808|NCT02552316|520811066|FG000|Overall Study|Withdrawal due to non-compliance|1|||
144438809|NCT02659020|520811067|FG000|Overall Study|Adverse Event|0|||
144438810|NCT02659020|520811068|FG001|Overall Study|Adverse Event|0|||
144438811|NCT02659020|520811069|FG002|Overall Study|Adverse Event|0|||
144438812|NCT02659020|520811070|FG003|Overall Study|Adverse Event|2|||
144189559|NCT01652729|519886912|FG001|Overall Study|Administrative|0|||
144189560|NCT01652729|519886913|FG002|Overall Study|Administrative|0|||
144438813|NCT02659020|520811071|FG004|Overall Study|Adverse Event|0|||
144438814|NCT02659020|520811072|FG005|Overall Study|Adverse Event|0|||
144438815|NCT02659020|520811073|FG006|Overall Study|Adverse Event|2|||
144438816|NCT02659020|520811067|FG000|Overall Study|Lost to Follow-up|1|||
144189561|NCT00483548|519886914|FG000|Overall Study|Randomized; not treated with study drug|1|||
144189562|NCT00483548|519886915|FG001|Overall Study|Randomized; not treated with study drug|3|||
144189563|NCT00483548|519886914|FG000|Overall Study|Adverse Event|25|||
144189564|NCT00483548|519886915|FG001|Overall Study|Adverse Event|14|||
144189565|NCT00483548|519886914|FG000|Overall Study|Laboratory abnormality|1|||
144189566|NCT00483548|519886915|FG001|Overall Study|Laboratory abnormality|2|||
144189567|NCT00483548|519886914|FG000|Overall Study|Lack of Efficacy|4|||
144189568|NCT00483548|519886915|FG001|Overall Study|Lack of Efficacy|8|||
144189569|NCT00483548|519886914|FG000|Overall Study|Protocol Violation|11|||
144189570|NCT00483548|519886915|FG001|Overall Study|Protocol Violation|7|||
144189571|NCT00483548|519886914|FG000|Overall Study|Pregnancy|1|||
144189572|NCT00483548|519886915|FG001|Overall Study|Pregnancy|0|||
144189573|NCT00483548|519886914|FG000|Overall Study|Protocol required discontinuation|6|||
144189574|NCT00483548|519886915|FG001|Overall Study|Protocol required discontinuation|6|||
144189575|NCT00483548|519886914|FG000|Overall Study|Unable to comply with protocol schedule|1|||
144189576|NCT00483548|519886915|FG001|Overall Study|Unable to comply with protocol schedule|0|||
144189577|NCT00483548|519886914|FG000|Overall Study|Non-compliance with medication|2|||
144189578|NCT00483548|519886915|FG001|Overall Study|Non-compliance with medication|0|||
144189579|NCT00483548|519886914|FG000|Overall Study|Lost to Follow-up|3|||
144438817|NCT02659020|520811068|FG001|Overall Study|Lost to Follow-up|2|||
144438818|NCT02659020|520811069|FG002|Overall Study|Lost to Follow-up|1|||
144438819|NCT02659020|520811070|FG003|Overall Study|Lost to Follow-up|6|||
144438820|NCT02659020|520811071|FG004|Overall Study|Lost to Follow-up|1|||
144438821|NCT02659020|520811072|FG005|Overall Study|Lost to Follow-up|5|||
144438822|NCT02659020|520811073|FG006|Overall Study|Lost to Follow-up|0|||
144438823|NCT02659020|520811067|FG000|Overall Study|Physician Decision|0|||
144438824|NCT02659020|520811068|FG001|Overall Study|Physician Decision|0|||
144438825|NCT02659020|520811069|FG002|Overall Study|Physician Decision|0|||
144438826|NCT02659020|520811070|FG003|Overall Study|Physician Decision|1|||
144438827|NCT02659020|520811071|FG004|Overall Study|Physician Decision|1|||
144438828|NCT02659020|520811072|FG005|Overall Study|Physician Decision|0|||
144438829|NCT02659020|520811073|FG006|Overall Study|Physician Decision|1|||
144438830|NCT02659020|520811067|FG000|Overall Study|Withdrawal by Subject|2|||
144438831|NCT02659020|520811068|FG001|Overall Study|Withdrawal by Subject|1|||
144438832|NCT02659020|520811069|FG002|Overall Study|Withdrawal by Subject|0|||
144438833|NCT02659020|520811070|FG003|Overall Study|Withdrawal by Subject|3|||
144438834|NCT02659020|520811071|FG004|Overall Study|Withdrawal by Subject|3|||
144438835|NCT02659020|520811072|FG005|Overall Study|Withdrawal by Subject|6|||
144438836|NCT02659020|520811073|FG006|Overall Study|Withdrawal by Subject|3|||
144438837|NCT02659020|520811067|FG000|Overall Study|Progressive Disease|0|||
144438838|NCT02659020|520811068|FG001|Overall Study|Progressive Disease|0|||
144438839|NCT02659020|520811069|FG002|Overall Study|Progressive Disease|0|||
144438840|NCT02659020|520811070|FG003|Overall Study|Progressive Disease|4|||
144438841|NCT02659020|520811071|FG004|Overall Study|Progressive Disease|1|||
144438842|NCT02659020|520811072|FG005|Overall Study|Progressive Disease|0|||
144438843|NCT02659020|520811073|FG006|Overall Study|Progressive Disease|2|||
144438844|NCT02457598|520811074|FG000|Overall Study|Progressive Disease|2|||
144438845|NCT02457598|520811075|FG001|Overall Study|Progressive Disease|2|||
144438846|NCT02457598|520811076|FG002|Overall Study|Progressive Disease|1|||
144438847|NCT02457598|520811077|FG003|Overall Study|Progressive Disease|11|||
144438848|NCT02457598|520811078|FG004|Overall Study|Progressive Disease|7|||
144438849|NCT02457598|520811079|FG005|Overall Study|Progressive Disease|3|||
144438850|NCT02457598|520811080|FG006|Overall Study|Progressive Disease|2|||
144438851|NCT02457598|520811081|FG007|Overall Study|Progressive Disease|1|||
144438852|NCT02457598|520811082|FG008|Overall Study|Progressive Disease|1|||
144438853|NCT02457598|520811083|FG009|Overall Study|Progressive Disease|2|||
144438854|NCT02457598|520811084|FG010|Overall Study|Progressive Disease|45|||
144438855|NCT02457598|520811085|FG011|Overall Study|Progressive Disease|6|||
144438856|NCT02457598|520811086|FG012|Overall Study|Progressive Disease|2|||
144438857|NCT02457598|520811087|FG013|Overall Study|Progressive Disease|2|||
144438858|NCT02457598|520811088|FG014|Overall Study|Progressive Disease|10|||
144438859|NCT02457598|520811089|FG015|Overall Study|Progressive Disease|1|||
144438860|NCT02457598|520811090|FG016|Overall Study|Progressive Disease|1|||
144438861|NCT02457598|520811074|FG000|Overall Study|Investigator's Discretion|0|||
144438862|NCT02457598|520811075|FG001|Overall Study|Investigator's Discretion|2|||
144438863|NCT02457598|520811076|FG002|Overall Study|Investigator's Discretion|2|||
144438864|NCT02457598|520811077|FG003|Overall Study|Investigator's Discretion|2|||
144438865|NCT02457598|520811078|FG004|Overall Study|Investigator's Discretion|0|||
144438866|NCT02457598|520811079|FG005|Overall Study|Investigator's Discretion|0|||
144189580|NCT00483548|519886915|FG001|Overall Study|Lost to Follow-up|4|||
144189581|NCT00483548|519886914|FG000|Overall Study|Withdrawal by Subject|5|||
144438867|NCT02457598|520811080|FG006|Overall Study|Investigator's Discretion|0|||
144438868|NCT02457598|520811081|FG007|Overall Study|Investigator's Discretion|1|||
144438869|NCT02457598|520811082|FG008|Overall Study|Investigator's Discretion|2|||
144438870|NCT02457598|520811083|FG009|Overall Study|Investigator's Discretion|0|||
144438871|NCT02457598|520811084|FG010|Overall Study|Investigator's Discretion|10|||
144438872|NCT02457598|520811085|FG011|Overall Study|Investigator's Discretion|2|||
144438873|NCT02457598|520811086|FG012|Overall Study|Investigator's Discretion|2|||
144189582|NCT00483548|519886915|FG001|Overall Study|Withdrawal by Subject|2|||
144189583|NCT01280617|519886921|FG000|Overall Study|Adverse Event|0|||
144189584|NCT01280617|519886922|FG001|Overall Study|Adverse Event|1|||
144189585|NCT00804141|519886923|FG000|Overall Study|Adverse Event|157|||
144189586|NCT00804141|519886923|FG000|Overall Study|Death|4|||
144189587|NCT00804141|519886923|FG000|Overall Study|Failed to return|96|||
144189588|NCT00804141|519886923|FG000|Overall Study|Investigator request|8|||
144189589|NCT00804141|519886923|FG000|Overall Study|Protocol Violation|85|||
144189590|NCT00804141|519886923|FG000|Overall Study|Withdrawal by Subject|131|||
144189591|NCT00804141|519886923|FG000|Overall Study|Lack of Efficacy|46|||
144189592|NCT00804141|519886923|FG000|Overall Study|Other than specified|30|||
144189593|NCT00804141|519886923|FG000|Overall Study|Enrolled but not treated|6|||
144189594|NCT00572039|519886924|FG000|Overall Study|Withdrawal by Subject|9|||
144189595|NCT00572039|519886925|FG001|Overall Study|Withdrawal by Subject|6|||
144189596|NCT00572039|519886924|FG000|Overall Study|Death|2|||
144189597|NCT00572039|519886925|FG001|Overall Study|Death|3|||
144189598|NCT00572039|519886924|FG000|Overall Study|Ill|5|||
144189599|NCT00572039|519886925|FG001|Overall Study|Ill|1|||
144189600|NCT02418455|519886926|FG000|48-Week Treatment Period|Other- Not Specified|1|||
144189601|NCT02418455|519886926|FG000|Continuation Period|Sponsor Decision|7|||
144189602|NCT01011556|519886933|FG000|Overall Study|Adverse Event|1|||
144189603|NCT01011556|519886934|FG001|Overall Study|Adverse Event|3|||
144189604|NCT01011556|519886935|FG002|Overall Study|Adverse Event|2|||
144189605|NCT01011556|519886936|FG003|Overall Study|Adverse Event|1|||
144189606|NCT01011556|519886933|FG000|Overall Study|Lost to Follow-up|1|||
144189607|NCT01011556|519886934|FG001|Overall Study|Lost to Follow-up|0|||
144189608|NCT01011556|519886935|FG002|Overall Study|Lost to Follow-up|0|||
144189609|NCT01011556|519886936|FG003|Overall Study|Lost to Follow-up|0|||
144189610|NCT01011556|519886933|FG000|Overall Study|Physician Decision|1|||
144189611|NCT01011556|519886934|FG001|Overall Study|Physician Decision|0|||
144189612|NCT01011556|519886935|FG002|Overall Study|Physician Decision|0|||
144189613|NCT01011556|519886936|FG003|Overall Study|Physician Decision|1|||
144189614|NCT01011556|519886933|FG000|Overall Study|Protocol Violation|0|||
144189615|NCT01011556|519886934|FG001|Overall Study|Protocol Violation|1|||
144189616|NCT01011556|519886935|FG002|Overall Study|Protocol Violation|0|||
144189617|NCT01011556|519886936|FG003|Overall Study|Protocol Violation|0|||
144189618|NCT01011556|519886933|FG000|Overall Study|Withdrawal by Subject|1|||
144189619|NCT01011556|519886934|FG001|Overall Study|Withdrawal by Subject|2|||
144189620|NCT01011556|519886935|FG002|Overall Study|Withdrawal by Subject|4|||
144189621|NCT01011556|519886936|FG003|Overall Study|Withdrawal by Subject|4|||
144189622|NCT01011556|519886933|FG000|Overall Study|Sponsor decision|0|||
144189623|NCT01011556|519886934|FG001|Overall Study|Sponsor decision|1|||
144189624|NCT01011556|519886935|FG002|Overall Study|Sponsor decision|1|||
144189625|NCT01011556|519886936|FG003|Overall Study|Sponsor decision|2|||
144189626|NCT01011556|519886933|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
144189627|NCT01011556|519886934|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
144189628|NCT01011556|519886935|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
144189629|NCT01011556|519886936|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
144189630|NCT02147587|519886937|FG000|Overall Study|Adverse Event|9|||
144189631|NCT02147587|519886938|FG001|Overall Study|Adverse Event|4|||
144189632|NCT02147587|519886937|FG000|Overall Study|Lack of Efficacy|2|||
144189633|NCT02147587|519886938|FG001|Overall Study|Lack of Efficacy|1|||
144189634|NCT01355302|519886939|FG000|Phase 1b|Death|4|||
144189635|NCT01355302|519886940|FG001|Phase 1b|Death|0|||
144189636|NCT01355302|519886941|FG002|Phase 1b|Death|0|||
144189637|NCT01355302|519886939|FG000|Phase 1b|Study terminated by sponsor|2|||
144189638|NCT01355302|519886940|FG001|Phase 1b|Study terminated by sponsor|0|||
144189639|NCT01355302|519886941|FG002|Phase 1b|Study terminated by sponsor|0|||
144189640|NCT01546519|519886942|FG000|Overall Study|Adverse Event|0|||
144189641|NCT01546519|519886943|FG001|Overall Study|Adverse Event|0|||
144189642|NCT01546519|519886944|FG002|Overall Study|Adverse Event|1|||
144530742|NCT05256654|521146288|FG003|Overall Study|Lost to Follow-up|1|||
144530743|NCT05256654|521146285|FG000|Overall Study|Withdrawal by Subject|1|||
144530744|NCT05256654|521146286|FG001|Overall Study|Withdrawal by Subject|2|||
144530745|NCT05256654|521146287|FG002|Overall Study|Withdrawal by Subject|1|||
144530746|NCT05256654|521146288|FG003|Overall Study|Withdrawal by Subject|3|||
144530747|NCT05256654|521146285|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
144189643|NCT01546519|519886945|FG003|Overall Study|Adverse Event|1|||
144189644|NCT01546519|519886942|FG000|Overall Study|Death|0|||
144189645|NCT01546519|519886943|FG001|Overall Study|Death|1|||
144189646|NCT01546519|519886944|FG002|Overall Study|Death|3|||
144189647|NCT01546519|519886945|FG003|Overall Study|Death|1|||
144189648|NCT01546519|519886942|FG000|Overall Study|related to disease progression|2|||
144189649|NCT01546519|519886943|FG001|Overall Study|related to disease progression|2|||
144604807|NCT01241552|521415835|FG001|Overall Study|Lack of Efficacy|0|||
144189650|NCT01546519|519886944|FG002|Overall Study|related to disease progression|2|||
144189651|NCT01546519|519886945|FG003|Overall Study|related to disease progression|1|||
144189652|NCT01546519|519886942|FG000|Overall Study|Physician Decision|6|||
144189653|NCT01546519|519886943|FG001|Overall Study|Physician Decision|5|||
144189654|NCT01546519|519886944|FG002|Overall Study|Physician Decision|2|||
144189655|NCT01546519|519886945|FG003|Overall Study|Physician Decision|3|||
144189656|NCT01546519|519886942|FG000|Overall Study|Withdrawal by Subject|1|||
144189657|NCT01546519|519886943|FG001|Overall Study|Withdrawal by Subject|0|||
144189658|NCT01546519|519886944|FG002|Overall Study|Withdrawal by Subject|0|||
144189659|NCT01546519|519886945|FG003|Overall Study|Withdrawal by Subject|0|||
144189660|NCT00263887|519886946|FG000|Overall Study|Withdrawal by Subject|1|||
144189661|NCT00263887|519886947|FG001|Overall Study|Withdrawal by Subject|1|||
144189662|NCT00263887|519886946|FG000|Overall Study|Lung transplantation|1|||
144189663|NCT00263887|519886947|FG001|Overall Study|Lung transplantation|2|||
144189664|NCT00263887|519886946|FG000|Overall Study|Too ill to attend visit|1|||
144189665|NCT00263887|519886947|FG001|Overall Study|Too ill to attend visit|0|||
144189666|NCT00263887|519886946|FG000|Overall Study|Adverse Event|0|||
144189667|NCT00263887|519886947|FG001|Overall Study|Adverse Event|2|||
144189668|NCT00263887|519886946|FG000|Overall Study|Disease progression|0|||
144189669|NCT00263887|519886947|FG001|Overall Study|Disease progression|1|||
144189670|NCT00263887|519886946|FG000|Overall Study|Lack of Efficacy|0|||
144189671|NCT00263887|519886947|FG001|Overall Study|Lack of Efficacy|1|||
144189672|NCT01009515|519886954|FG000|Overall Study|Withdrawal by Subject|3|||
144189673|NCT01175473|519886960|FG000|Overall Study|Adverse Event|2|||
144189674|NCT01175473|519886961|FG001|Overall Study|Adverse Event|2|||
144189675|NCT01857206|519886971|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
144189676|NCT01857206|519886972|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
144189677|NCT01857206|519886971|FG000|Overall Study|Lost to Follow-up|9|||
144189678|NCT01857206|519886972|FG001|Overall Study|Lost to Follow-up|6|||
144189679|NCT01857206|519886971|FG000|Overall Study|Unclassified|3|||
144189680|NCT01857206|519886972|FG001|Overall Study|Unclassified|3|||
144189681|NCT01857206|519886971|FG000|Overall Study|Withdrawal by Subject|1|||
144189682|NCT01857206|519886972|FG001|Overall Study|Withdrawal by Subject|0|||
144438874|NCT02457598|520811087|FG013|Overall Study|Investigator's Discretion|1|||
144438875|NCT02457598|520811088|FG014|Overall Study|Investigator's Discretion|5|||
144438876|NCT02457598|520811089|FG015|Overall Study|Investigator's Discretion|0|||
144438877|NCT02457598|520811090|FG016|Overall Study|Investigator's Discretion|0|||
144438878|NCT02457598|520811074|FG000|Overall Study|Study Terminated by Sponsor|0|||
144438879|NCT02457598|520811075|FG001|Overall Study|Study Terminated by Sponsor|1|||
144438880|NCT02457598|520811076|FG002|Overall Study|Study Terminated by Sponsor|0|||
144438881|NCT02457598|520811077|FG003|Overall Study|Study Terminated by Sponsor|4|||
144438882|NCT02457598|520811078|FG004|Overall Study|Study Terminated by Sponsor|1|||
144189683|NCT00575380|519886975|FG000|Overall Study|Withdrawal by Subject|1|||
144189684|NCT00575380|519886976|FG001|Overall Study|Withdrawal by Subject|0|||
144189685|NCT00575380|519886975|FG000|Overall Study|Adverse Event|0|||
144189686|NCT00575380|519886976|FG001|Overall Study|Adverse Event|1|||
144189687|NCT00575380|519886975|FG000|Overall Study|Various|0|||
144189688|NCT00575380|519886976|FG001|Overall Study|Various|2|||
144189689|NCT00869440|519886983|FG000|Overall Study|Withdrawal by Subject|1|||
144189690|NCT00869440|519886984|FG001|Overall Study|Withdrawal by Subject|0|||
144189691|NCT00869440|519886985|FG002|Overall Study|Withdrawal by Subject|0|||
144189692|NCT00869440|519886986|FG003|Overall Study|Withdrawal by Subject|0|||
144189693|NCT00869440|519886983|FG000|Overall Study|Physician Decision|1|||
144189694|NCT00869440|519886984|FG001|Overall Study|Physician Decision|1|||
144189695|NCT00869440|519886985|FG002|Overall Study|Physician Decision|0|||
144189696|NCT00869440|519886986|FG003|Overall Study|Physician Decision|0|||
144189697|NCT03546647|519886987|FG000|Overall Study|Adverse Event|1|||
144189698|NCT03546647|519886988|FG001|Overall Study|Adverse Event|0|||
144189699|NCT00124462|519886989|FG000|Overall Study|Lost to Follow-up|3|||
144189700|NCT00124462|519886990|FG001|Overall Study|Lost to Follow-up|3|||
144189701|NCT00124462|519886989|FG000|Overall Study|Physician Decision|3|||
144189702|NCT00124462|519886990|FG001|Overall Study|Physician Decision|4|||
144189703|NCT00124462|519886989|FG000|Overall Study|Withdrawal by Subject|4|||
144189704|NCT00124462|519886990|FG001|Overall Study|Withdrawal by Subject|5|||
144189705|NCT00124462|519886989|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
144189706|NCT00124462|519886990|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
144189707|NCT02400476|519886991|FG000|Overall Study|Adverse Event|57|||
144189708|NCT02400476|519886992|FG001|Overall Study|Adverse Event|10|||
144189709|NCT02400476|519886993|FG002|Overall Study|Adverse Event|22|||
144189710|NCT02400476|519886994|FG003|Overall Study|Adverse Event|19|||
144189711|NCT02400476|519886995|FG004|Overall Study|Adverse Event|5|||
144189712|NCT02400476|519886996|FG005|Overall Study|Adverse Event|8|||
144438883|NCT02457598|520811079|FG005|Overall Study|Study Terminated by Sponsor|0|||
144189713|NCT02400476|519886991|FG000|Overall Study|Withdrawal by Subject|4|||
144189714|NCT02400476|519886992|FG001|Overall Study|Withdrawal by Subject|1|||
144189715|NCT02400476|519886993|FG002|Overall Study|Withdrawal by Subject|12|||
144189716|NCT02400476|519886994|FG003|Overall Study|Withdrawal by Subject|7|||
144189717|NCT02400476|519886995|FG004|Overall Study|Withdrawal by Subject|5|||
144189718|NCT02400476|519886996|FG005|Overall Study|Withdrawal by Subject|5|||
144189719|NCT02400476|519886991|FG000|Overall Study|Lost to Follow-up|0|||
144438884|NCT02457598|520811080|FG006|Overall Study|Study Terminated by Sponsor|1|||
144438885|NCT02457598|520811081|FG007|Overall Study|Study Terminated by Sponsor|0|||
144438886|NCT02457598|520811082|FG008|Overall Study|Study Terminated by Sponsor|0|||
144438887|NCT02457598|520811083|FG009|Overall Study|Study Terminated by Sponsor|0|||
144438888|NCT02457598|520811084|FG010|Overall Study|Study Terminated by Sponsor|4|||
144438889|NCT02457598|520811085|FG011|Overall Study|Study Terminated by Sponsor|0|||
144438890|NCT02457598|520811086|FG012|Overall Study|Study Terminated by Sponsor|1|||
144438891|NCT02457598|520811087|FG013|Overall Study|Study Terminated by Sponsor|0|||
144438892|NCT02457598|520811088|FG014|Overall Study|Study Terminated by Sponsor|8|||
144438893|NCT02457598|520811089|FG015|Overall Study|Study Terminated by Sponsor|1|||
144438894|NCT02457598|520811090|FG016|Overall Study|Study Terminated by Sponsor|0|||
144438895|NCT02457598|520811074|FG000|Overall Study|Adverse Event|0|||
144438896|NCT02457598|520811075|FG001|Overall Study|Adverse Event|1|||
144438897|NCT02457598|520811076|FG002|Overall Study|Adverse Event|1|||
144438898|NCT02457598|520811077|FG003|Overall Study|Adverse Event|4|||
144438899|NCT02457598|520811078|FG004|Overall Study|Adverse Event|1|||
144438900|NCT02457598|520811079|FG005|Overall Study|Adverse Event|0|||
144438901|NCT02457598|520811080|FG006|Overall Study|Adverse Event|0|||
144438902|NCT02457598|520811081|FG007|Overall Study|Adverse Event|1|||
144438903|NCT02457598|520811082|FG008|Overall Study|Adverse Event|0|||
144438904|NCT02457598|520811083|FG009|Overall Study|Adverse Event|1|||
144438905|NCT02457598|520811084|FG010|Overall Study|Adverse Event|6|||
144438906|NCT02457598|520811085|FG011|Overall Study|Adverse Event|0|||
144438907|NCT02457598|520811086|FG012|Overall Study|Adverse Event|0|||
144438908|NCT02457598|520811087|FG013|Overall Study|Adverse Event|1|||
144438909|NCT02457598|520811088|FG014|Overall Study|Adverse Event|2|||
144438910|NCT02457598|520811089|FG015|Overall Study|Adverse Event|0|||
144438911|NCT02457598|520811090|FG016|Overall Study|Adverse Event|0|||
144438912|NCT02457598|520811074|FG000|Overall Study|Death|0|||
144438913|NCT02457598|520811075|FG001|Overall Study|Death|0|||
144438914|NCT02457598|520811076|FG002|Overall Study|Death|0|||
144438915|NCT02457598|520811077|FG003|Overall Study|Death|3|||
144438916|NCT02457598|520811078|FG004|Overall Study|Death|0|||
144438917|NCT02457598|520811079|FG005|Overall Study|Death|1|||
144438918|NCT02457598|520811080|FG006|Overall Study|Death|0|||
144438919|NCT02457598|520811081|FG007|Overall Study|Death|0|||
144438920|NCT02457598|520811082|FG008|Overall Study|Death|0|||
144438921|NCT02457598|520811083|FG009|Overall Study|Death|0|||
144438922|NCT02457598|520811084|FG010|Overall Study|Death|3|||
144438923|NCT02457598|520811085|FG011|Overall Study|Death|0|||
144438924|NCT02457598|520811086|FG012|Overall Study|Death|0|||
144438925|NCT02457598|520811087|FG013|Overall Study|Death|1|||
144438926|NCT02457598|520811088|FG014|Overall Study|Death|2|||
144438927|NCT02457598|520811089|FG015|Overall Study|Death|0|||
144438928|NCT02457598|520811090|FG016|Overall Study|Death|1|||
144438929|NCT02457598|520811074|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438930|NCT02457598|520811075|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
144438931|NCT02457598|520811076|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438932|NCT02457598|520811077|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
144438933|NCT02457598|520811078|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438934|NCT02457598|520811079|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438935|NCT02457598|520811080|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438936|NCT02457598|520811081|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
144438937|NCT02457598|520811082|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
144189720|NCT02400476|519886992|FG001|Overall Study|Lost to Follow-up|0|||
144189721|NCT02400476|519886993|FG002|Overall Study|Lost to Follow-up|0|||
144189722|NCT02400476|519886994|FG003|Overall Study|Lost to Follow-up|1|||
144189723|NCT02400476|519886995|FG004|Overall Study|Lost to Follow-up|3|||
144438938|NCT02457598|520811083|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438939|NCT02457598|520811084|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
144438940|NCT02457598|520811085|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438941|NCT02457598|520811086|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438942|NCT02457598|520811087|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
144438943|NCT02457598|520811088|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
144189724|NCT02400476|519886996|FG005|Overall Study|Lost to Follow-up|1|||
144189725|NCT02400476|519886991|FG000|Overall Study|Physician Decision|0|||
144438944|NCT02457598|520811089|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
144438945|NCT02457598|520811090|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
144438946|NCT02457598|520811074|FG000|Overall Study|Withdrew Consent|0|||
144438947|NCT02457598|520811075|FG001|Overall Study|Withdrew Consent|0|||
144438948|NCT02457598|520811076|FG002|Overall Study|Withdrew Consent|0|||
144438949|NCT02457598|520811077|FG003|Overall Study|Withdrew Consent|0|||
144189726|NCT02400476|519886992|FG001|Overall Study|Physician Decision|0|||
144438950|NCT02457598|520811078|FG004|Overall Study|Withdrew Consent|0|||
144438951|NCT02457598|520811079|FG005|Overall Study|Withdrew Consent|0|||
144438952|NCT02457598|520811080|FG006|Overall Study|Withdrew Consent|0|||
144438953|NCT02457598|520811081|FG007|Overall Study|Withdrew Consent|2|||
144438954|NCT02457598|520811082|FG008|Overall Study|Withdrew Consent|0|||
144189727|NCT02400476|519886993|FG002|Overall Study|Physician Decision|1|||
144438955|NCT02457598|520811083|FG009|Overall Study|Withdrew Consent|0|||
144438956|NCT02457598|520811084|FG010|Overall Study|Withdrew Consent|3|||
144438957|NCT02457598|520811085|FG011|Overall Study|Withdrew Consent|0|||
144438958|NCT02457598|520811086|FG012|Overall Study|Withdrew Consent|0|||
144438959|NCT02457598|520811087|FG013|Overall Study|Withdrew Consent|1|||
144438960|NCT02457598|520811088|FG014|Overall Study|Withdrew Consent|0|||
144438961|NCT02457598|520811089|FG015|Overall Study|Withdrew Consent|0|||
144438962|NCT02457598|520811090|FG016|Overall Study|Withdrew Consent|0|||
144438963|NCT02457598|520811074|FG000|Overall Study|Unacceptable Toxicity|0|||
144438964|NCT02457598|520811075|FG001|Overall Study|Unacceptable Toxicity|0|||
144438965|NCT02457598|520811076|FG002|Overall Study|Unacceptable Toxicity|0|||
144438966|NCT02457598|520811077|FG003|Overall Study|Unacceptable Toxicity|0|||
144438967|NCT02457598|520811078|FG004|Overall Study|Unacceptable Toxicity|0|||
144438968|NCT02457598|520811079|FG005|Overall Study|Unacceptable Toxicity|0|||
144438969|NCT02457598|520811080|FG006|Overall Study|Unacceptable Toxicity|0|||
144438970|NCT02457598|520811081|FG007|Overall Study|Unacceptable Toxicity|0|||
144438971|NCT02457598|520811082|FG008|Overall Study|Unacceptable Toxicity|0|||
144438972|NCT02457598|520811083|FG009|Overall Study|Unacceptable Toxicity|0|||
144438973|NCT02457598|520811084|FG010|Overall Study|Unacceptable Toxicity|1|||
144438974|NCT02457598|520811085|FG011|Overall Study|Unacceptable Toxicity|0|||
144438975|NCT02457598|520811086|FG012|Overall Study|Unacceptable Toxicity|1|||
144438976|NCT02457598|520811087|FG013|Overall Study|Unacceptable Toxicity|1|||
144438977|NCT02457598|520811088|FG014|Overall Study|Unacceptable Toxicity|1|||
144438978|NCT02457598|520811089|FG015|Overall Study|Unacceptable Toxicity|0|||
144438979|NCT02457598|520811090|FG016|Overall Study|Unacceptable Toxicity|0|||
144438980|NCT02457598|520811074|FG000|Overall Study|Intercurrent Illness|0|||
144438981|NCT02457598|520811075|FG001|Overall Study|Intercurrent Illness|0|||
144438982|NCT02457598|520811076|FG002|Overall Study|Intercurrent Illness|0|||
144438983|NCT02457598|520811077|FG003|Overall Study|Intercurrent Illness|0|||
144438984|NCT02457598|520811078|FG004|Overall Study|Intercurrent Illness|0|||
144438985|NCT02457598|520811079|FG005|Overall Study|Intercurrent Illness|0|||
144438986|NCT02457598|520811080|FG006|Overall Study|Intercurrent Illness|0|||
144438987|NCT02457598|520811081|FG007|Overall Study|Intercurrent Illness|0|||
144438988|NCT02457598|520811082|FG008|Overall Study|Intercurrent Illness|0|||
144438989|NCT02457598|520811083|FG009|Overall Study|Intercurrent Illness|0|||
144438990|NCT02457598|520811084|FG010|Overall Study|Intercurrent Illness|1|||
144438991|NCT02457598|520811085|FG011|Overall Study|Intercurrent Illness|0|||
144438992|NCT02457598|520811086|FG012|Overall Study|Intercurrent Illness|0|||
144438993|NCT02457598|520811087|FG013|Overall Study|Intercurrent Illness|0|||
144438994|NCT02457598|520811088|FG014|Overall Study|Intercurrent Illness|0|||
144438995|NCT02457598|520811089|FG015|Overall Study|Intercurrent Illness|0|||
144438996|NCT02457598|520811090|FG016|Overall Study|Intercurrent Illness|0|||
144438997|NCT02457598|520811074|FG000|Overall Study|Protocol Violation|0|||
144438998|NCT02457598|520811075|FG001|Overall Study|Protocol Violation|0|||
144438999|NCT02457598|520811076|FG002|Overall Study|Protocol Violation|0|||
144439000|NCT02457598|520811077|FG003|Overall Study|Protocol Violation|0|||
144189728|NCT02400476|519886994|FG003|Overall Study|Physician Decision|1|||
144189729|NCT02400476|519886995|FG004|Overall Study|Physician Decision|0|||
144189730|NCT02400476|519886996|FG005|Overall Study|Physician Decision|1|||
144189731|NCT02400476|519886991|FG000|Overall Study|Other, Disease Progression|0|||
144189732|NCT02400476|519886992|FG001|Overall Study|Other, Disease Progression|1|||
144189733|NCT02400476|519886993|FG002|Overall Study|Other, Disease Progression|2|||
144439001|NCT02457598|520811078|FG004|Overall Study|Protocol Violation|0|||
144439002|NCT02457598|520811079|FG005|Overall Study|Protocol Violation|0|||
144439003|NCT02457598|520811080|FG006|Overall Study|Protocol Violation|0|||
144439004|NCT02457598|520811081|FG007|Overall Study|Protocol Violation|0|||
144439005|NCT02457598|520811082|FG008|Overall Study|Protocol Violation|0|||
144439006|NCT02457598|520811083|FG009|Overall Study|Protocol Violation|0|||
144439007|NCT02457598|520811084|FG010|Overall Study|Protocol Violation|1|||
144439008|NCT02457598|520811085|FG011|Overall Study|Protocol Violation|0|||
144439009|NCT02457598|520811086|FG012|Overall Study|Protocol Violation|0|||
144439010|NCT02457598|520811087|FG013|Overall Study|Protocol Violation|0|||
144439011|NCT02457598|520811088|FG014|Overall Study|Protocol Violation|0|||
144439012|NCT02457598|520811089|FG015|Overall Study|Protocol Violation|0|||
144439013|NCT02457598|520811090|FG016|Overall Study|Protocol Violation|0|||
144439014|NCT03837899|520811091|FG000|Overall Study|Death|6|||
144189734|NCT02400476|519886994|FG003|Overall Study|Other, Disease Progression|1|||
144439015|NCT03837899|520811092|FG001|Overall Study|Death|8|||
144439016|NCT03837899|520811093|FG002|Overall Study|Death|3|||
144439017|NCT03837899|520811094|FG003|Overall Study|Death|7|||
144439018|NCT03837899|520811095|FG004|Overall Study|Death|8|||
144439019|NCT03837899|520811096|FG005|Overall Study|Death|7|||
144439020|NCT03837899|520811091|FG000|Overall Study|Moved to post-trial access program|0|||
144439021|NCT03837899|520811092|FG001|Overall Study|Moved to post-trial access program|1|||
144439022|NCT03837899|520811093|FG002|Overall Study|Moved to post-trial access program|0|||
144439023|NCT03837899|520811094|FG003|Overall Study|Moved to post-trial access program|0|||
144439024|NCT03837899|520811095|FG004|Overall Study|Moved to post-trial access program|0|||
144439025|NCT03837899|520811096|FG005|Overall Study|Moved to post-trial access program|0|||
144439026|NCT03837899|520811091|FG000|Overall Study|Other|0|||
144189735|NCT02400476|519886995|FG004|Overall Study|Other, Disease Progression|2|||
144189736|NCT02400476|519886996|FG005|Overall Study|Other, Disease Progression|1|||
144189737|NCT02400476|519886991|FG000|Overall Study|Other, Decreased Quality of Life|0|||
144189738|NCT02400476|519886992|FG001|Overall Study|Other, Decreased Quality of Life|0|||
144189739|NCT02400476|519886993|FG002|Overall Study|Other, Decreased Quality of Life|2|||
144189740|NCT02400476|519886994|FG003|Overall Study|Other, Decreased Quality of Life|0|||
144189741|NCT02400476|519886995|FG004|Overall Study|Other, Decreased Quality of Life|0|||
144189742|NCT02400476|519886996|FG005|Overall Study|Other, Decreased Quality of Life|0|||
144189743|NCT02400476|519886991|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
144189744|NCT02400476|519886992|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
144189745|NCT02400476|519886993|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
144189746|NCT02400476|519886994|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
144189747|NCT02400476|519886995|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
144189748|NCT02400476|519886996|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
144189749|NCT02487082|519886997|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
144189750|NCT02487082|519886998|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
144189751|NCT02487082|519886997|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
144439027|NCT03837899|520811092|FG001|Overall Study|Other|0|||
144439028|NCT03837899|520811093|FG002|Overall Study|Other|0|||
144439029|NCT03837899|520811094|FG003|Overall Study|Other|0|||
144439030|NCT03837899|520811095|FG004|Overall Study|Other|0|||
144439031|NCT03837899|520811096|FG005|Overall Study|Other|2|||
144439032|NCT03837899|520811091|FG000|Overall Study|Lost to Follow-up|0|||
144439033|NCT03837899|520811092|FG001|Overall Study|Lost to Follow-up|1|||
144439034|NCT03837899|520811093|FG002|Overall Study|Lost to Follow-up|0|||
144439035|NCT03837899|520811094|FG003|Overall Study|Lost to Follow-up|0|||
144439036|NCT03837899|520811095|FG004|Overall Study|Lost to Follow-up|0|||
144439037|NCT03837899|520811096|FG005|Overall Study|Lost to Follow-up|0|||
144189752|NCT02487082|519886998|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
144189753|NCT00588731|519886999|FG000|Overall Study|Withdrawal by Subject|3|||
144189754|NCT00588731|519887000|FG001|Overall Study|Withdrawal by Subject|2|||
144189755|NCT00251316|519887001|FG000|Overall Study|Physician Decision|2|||
144189756|NCT00251316|519887002|FG001|Overall Study|Physician Decision|3|||
144189757|NCT03297294|519887003|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
144189758|NCT03297294|519887004|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
144189759|NCT03297294|519887005|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144189760|NCT03297294|519887006|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144189761|NCT03297294|519887007|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144189762|NCT03297294|519887003|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
144189763|NCT03297294|519887004|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
144189764|NCT03297294|519887005|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144189765|NCT03297294|519887006|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144189766|NCT03297294|519887007|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144189767|NCT03297294|519887003|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
144189768|NCT03297294|519887004|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
144189769|NCT03297294|519887005|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144189770|NCT03297294|519887006|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144189771|NCT03297294|519887007|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144189772|NCT03297294|519887003|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
144189773|NCT03297294|519887004|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
144189774|NCT03297294|519887005|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144189775|NCT03297294|519887006|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144189776|NCT03297294|519887007|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144189777|NCT03297294|519887003|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
144189778|NCT03297294|519887004|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
144189779|NCT03297294|519887005|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
144189780|NCT03297294|519887006|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
144189781|NCT03297294|519887007|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
144189782|NCT03139240|519887008|FG000|Overall Study|Lost to Follow-up|0|||
144189783|NCT03139240|519887009|FG001|Overall Study|Lost to Follow-up|1|||
144189784|NCT03139240|519887010|FG002|Overall Study|Lost to Follow-up|1|||
144189785|NCT03139240|519887011|FG003|Overall Study|Lost to Follow-up|0|||
144189786|NCT04569786|519887012|FG000|Overall Study|Lost to Follow-up|1|||
144189787|NCT04569786|519887013|FG001|Overall Study|Lost to Follow-up|0|||
144439038|NCT03837899|520811091|FG000|Overall Study|Withdrawal by Subject|0|||
144439039|NCT03837899|520811092|FG001|Overall Study|Withdrawal by Subject|0|||
144439040|NCT03837899|520811093|FG002|Overall Study|Withdrawal by Subject|0|||
144439041|NCT03837899|520811094|FG003|Overall Study|Withdrawal by Subject|1|||
144189788|NCT04569786|519887014|FG002|Overall Study|Lost to Follow-up|4|||
144439042|NCT03837899|520811095|FG004|Overall Study|Withdrawal by Subject|0|||
144439043|NCT03837899|520811096|FG005|Overall Study|Withdrawal by Subject|0|||
144189789|NCT04569786|519887015|FG003|Overall Study|Lost to Follow-up|1|||
144189790|NCT04569786|519887016|FG004|Overall Study|Lost to Follow-up|0|||
144189791|NCT04569786|519887012|FG000|Overall Study|Withdrawal by Subject|0|||
144189792|NCT04569786|519887013|FG001|Overall Study|Withdrawal by Subject|0|||
144189793|NCT04569786|519887014|FG002|Overall Study|Withdrawal by Subject|0|||
144189794|NCT04569786|519887015|FG003|Overall Study|Withdrawal by Subject|5|||
144189795|NCT04569786|519887016|FG004|Overall Study|Withdrawal by Subject|1|||
144189796|NCT04569786|519887012|FG000|Overall Study|Physician Decision|0|||
144189797|NCT04569786|519887013|FG001|Overall Study|Physician Decision|0|||
144189798|NCT04569786|519887014|FG002|Overall Study|Physician Decision|0|||
144189799|NCT04569786|519887015|FG003|Overall Study|Physician Decision|1|||
144189800|NCT04569786|519887016|FG004|Overall Study|Physician Decision|0|||
144189801|NCT03942211|519887019|FG000|Overall Study|Death|1|||
144189802|NCT03942211|519887020|FG001|Overall Study|Death|0|||
144189803|NCT03942211|519887019|FG000|Overall Study|Study terminated by sponsor|5|||
144189804|NCT03942211|519887020|FG001|Overall Study|Study terminated by sponsor|3|||
144189805|NCT03942211|519887019|FG000|Overall Study|Adverse Event|0|||
144189806|NCT03942211|519887020|FG001|Overall Study|Adverse Event|1|||
144189807|NCT01955044|519887021|FG000|Overall Study|Death|1|||
144189808|NCT01955044|519887022|FG001|Overall Study|Death|1|||
144189809|NCT01955044|519887023|FG002|Overall Study|Death|0|||
144189810|NCT00824369|519887024|FG000|Overall Study|Nolonger willing to participate in study|1|||
144189811|NCT00824369|519887025|FG001|Overall Study|Nolonger willing to participate in study|0|||
144189812|NCT00824369|519887026|FG002|Overall Study|Nolonger willing to participate in study|1|||
144189813|NCT00824369|519887027|FG003|Overall Study|Nolonger willing to participate in study|2|||
144189814|NCT00824369|519887028|FG004|Overall Study|Nolonger willing to participate in study|0|||
144189815|NCT00824369|519887029|FG005|Overall Study|Nolonger willing to participate in study|1|||
144189816|NCT00824369|519887024|FG000|Overall Study|Lost to Follow-up|0|||
144189817|NCT00824369|519887025|FG001|Overall Study|Lost to Follow-up|0|||
144189818|NCT00824369|519887026|FG002|Overall Study|Lost to Follow-up|0|||
144189819|NCT00824369|519887027|FG003|Overall Study|Lost to Follow-up|0|||
144189820|NCT00824369|519887028|FG004|Overall Study|Lost to Follow-up|1|||
144189821|NCT00824369|519887029|FG005|Overall Study|Lost to Follow-up|0|||
144189822|NCT00248170|519887030|FG000|Overall Study|Withdrawal by Subject|71|||
144189823|NCT00248170|519887031|FG001|Overall Study|Withdrawal by Subject|79|||
144189824|NCT00248170|519887030|FG000|Overall Study|Protocol Violation|35|||
144189825|NCT00248170|519887031|FG001|Overall Study|Protocol Violation|30|||
144189826|NCT00248170|519887030|FG000|Overall Study|Lost to Follow-up|28|||
144189827|NCT00248170|519887031|FG001|Overall Study|Lost to Follow-up|35|||
144189828|NCT00248170|519887030|FG000|Overall Study|Disease progression|196|||
144189829|NCT00248170|519887031|FG001|Overall Study|Disease progression|216|||
144189830|NCT00248170|519887030|FG000|Overall Study|Death|28|||
144189831|NCT00248170|519887031|FG001|Overall Study|Death|47|||
144189832|NCT00248170|519887030|FG000|Overall Study|Adverse Event|311|||
144189833|NCT00248170|519887031|FG001|Overall Study|Adverse Event|296|||
144189834|NCT00248170|519887030|FG000|Overall Study|Administrative problems|22|||
144189835|NCT00248170|519887031|FG001|Overall Study|Administrative problems|25|||
144189836|NCT00248170|519887030|FG000|Overall Study|Abnormal test procedure(s) result|49|||
144189837|NCT00248170|519887031|FG001|Overall Study|Abnormal test procedure(s) result|61|||
144189838|NCT00248170|519887030|FG000|Overall Study|Abnormal laboratory values|4|||
144189839|NCT00248170|519887031|FG001|Overall Study|Abnormal laboratory values|0|||
144189840|NCT00248170|519887030|FG000|Overall Study|Protocol deviation|17|||
144189841|NCT00248170|519887031|FG001|Overall Study|Protocol deviation|19|||
144189842|NCT00749411|519887041|FG000|Overall Study|Adverse Event|0|||
144189843|NCT00749411|519887042|FG001|Overall Study|Adverse Event|2|||
144189844|NCT00749411|519887041|FG000|Overall Study|Lack of Efficacy|0|||
144189845|NCT00749411|519887042|FG001|Overall Study|Lack of Efficacy|1|||
144189846|NCT00749411|519887041|FG000|Overall Study|Protocol Violation|1|||
144189847|NCT00749411|519887042|FG001|Overall Study|Protocol Violation|1|||
144189848|NCT00749411|519887041|FG000|Overall Study|Protocol-defined stopping criteria|0|||
144189849|NCT00749411|519887042|FG001|Overall Study|Protocol-defined stopping criteria|1|||
144189850|NCT03581188|519889294|FG000|Overall Study|Inclusion criteria not met|3|||
144189851|NCT03581188|519889295|FG001|Overall Study|Inclusion criteria not met|2|||
144189852|NCT03581188|519889294|FG000|Overall Study|Lost to Follow-up|5|||
144189853|NCT03581188|519889295|FG001|Overall Study|Lost to Follow-up|5|||
144189854|NCT03581188|519889294|FG000|Overall Study|Discontinued intervention|11|||
144189855|NCT03581188|519889295|FG001|Overall Study|Discontinued intervention|8|||
144189856|NCT02938442|519889296|FG000|Overall Study|Death|0|||
144189857|NCT02938442|519889297|FG001|Overall Study|Death|1|||
144189858|NCT02938442|519889296|FG000|Overall Study|Lost to Follow-up|0|||
144189859|NCT02938442|519889297|FG001|Overall Study|Lost to Follow-up|1|||
144189860|NCT02938442|519889296|FG000|Overall Study|Physician Decision|0|||
144530748|NCT05256654|521146286|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
144189861|NCT02938442|519889297|FG001|Overall Study|Physician Decision|1|||
144189862|NCT02938442|519889296|FG000|Overall Study|Withdrawal by Subject|2|||
144189863|NCT02938442|519889297|FG001|Overall Study|Withdrawal by Subject|0|||
144189864|NCT04403399|519889298|FG000|Period 2|Physician Decision|0|||
144189865|NCT04403399|519889299|FG001|Period 2|Physician Decision|1|||
144189866|NCT02070757|519889303|FG000|Overall Study|Adverse Event|107|||
144189867|NCT02070757|519889304|FG001|Overall Study|Adverse Event|99|||
144189868|NCT02070757|519889303|FG000|Overall Study|Lost to Follow-up|7|||
144189869|NCT02070757|519889304|FG001|Overall Study|Lost to Follow-up|4|||
144189870|NCT02070757|519889303|FG000|Overall Study|Protocol Violation|0|||
144189871|NCT02070757|519889304|FG001|Overall Study|Protocol Violation|4|||
144189872|NCT02070757|519889303|FG000|Overall Study|Withdrawal by Subject|1|||
144189873|NCT02070757|519889304|FG001|Overall Study|Withdrawal by Subject|3|||
144189874|NCT02070757|519889303|FG000|Overall Study|Investigator Decision|0|||
144189875|NCT02070757|519889304|FG001|Overall Study|Investigator Decision|2|||
144189876|NCT02070757|519889303|FG000|Overall Study|Discharged from Study Hospital|2|||
144189877|NCT02070757|519889304|FG001|Overall Study|Discharged from Study Hospital|2|||
144189878|NCT04086641|519889307|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
144439044|NCT03837899|520811091|FG000|Overall Study|Study specific discontinuation criteria|0|||
144439045|NCT03837899|520811092|FG001|Overall Study|Study specific discontinuation criteria|1|||
144439046|NCT03837899|520811093|FG002|Overall Study|Study specific discontinuation criteria|0|||
144439047|NCT03837899|520811094|FG003|Overall Study|Study specific discontinuation criteria|0|||
144439048|NCT03837899|520811095|FG004|Overall Study|Study specific discontinuation criteria|3|||
144439049|NCT03837899|520811096|FG005|Overall Study|Study specific discontinuation criteria|1|||
144439050|NCT02703636|520811106|FG000|Overall Study|Adverse Event|14|||
144439051|NCT02703636|520811106|FG000|Overall Study|Study stopped by sponsor|1|||
144189879|NCT04086641|519889308|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
144189880|NCT00792623|519889309|FG000|Overall Study|Adverse Event|2|||
144189881|NCT00792623|519889309|FG000|Overall Study|Withdrawal by Subject|5|||
144189882|NCT00880087|519889310|FG000|Overall Study|Lost to Follow-up|0|||
144189883|NCT00880087|519889311|FG001|Overall Study|Lost to Follow-up|2|||
144189884|NCT00126126|519889312|FG000|Overall Study|Lost to Follow-up|0|||
144189885|NCT00126126|519889313|FG001|Overall Study|Lost to Follow-up|2|||
144189886|NCT03756883|519889316|FG000|Overall Study|Adverse Event|2|||
144189887|NCT03756883|519889317|FG001|Overall Study|Adverse Event|2|||
144189888|NCT03756883|519889318|FG002|Overall Study|Adverse Event|2|||
144189889|NCT03756883|519889316|FG000|Overall Study|Lack of Efficacy|0|||
144189890|NCT03756883|519889317|FG001|Overall Study|Lack of Efficacy|1|||
144189891|NCT03756883|519889318|FG002|Overall Study|Lack of Efficacy|2|||
144189892|NCT03756883|519889316|FG000|Overall Study|Lost to Follow-up|3|||
144189893|NCT03756883|519889317|FG001|Overall Study|Lost to Follow-up|3|||
144439052|NCT02703636|520811106|FG000|Overall Study|Withdrawal by Subject|1|||
144439053|NCT04334460|520811115|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
144189894|NCT03756883|519889318|FG002|Overall Study|Lost to Follow-up|0|||
144189895|NCT03756883|519889316|FG000|Overall Study|Protocol Violation|2|||
144189896|NCT03756883|519889317|FG001|Overall Study|Protocol Violation|0|||
144189897|NCT03756883|519889318|FG002|Overall Study|Protocol Violation|1|||
144189898|NCT03756883|519889316|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
144189899|NCT03756883|519889317|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
144189900|NCT03756883|519889318|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
144189901|NCT03756883|519889316|FG000|Overall Study|Withdrawal by Subject|4|||
144189902|NCT03756883|519889317|FG001|Overall Study|Withdrawal by Subject|1|||
144189903|NCT03756883|519889318|FG002|Overall Study|Withdrawal by Subject|0|||
144189904|NCT03756883|519889316|FG000|Overall Study|Other Reasons|2|||
144189905|NCT03756883|519889317|FG001|Overall Study|Other Reasons|4|||
144189906|NCT03756883|519889318|FG002|Overall Study|Other Reasons|0|||
144189907|NCT01470417|519889319|FG000|Overall Study|Disease progression|0|||
144439054|NCT04334460|520811116|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
144439055|NCT04334460|520811115|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
144439056|NCT04334460|520811116|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
144189908|NCT01470417|519889320|FG001|Overall Study|Disease progression|2|||
144189909|NCT02973321|519889323|FG000|Overall Study|Other than specified|0|||
144189910|NCT02973321|519889324|FG001|Overall Study|Other than specified|5|||
144189911|NCT02973321|519889325|FG002|Overall Study|Other than specified|3|||
144189912|NCT02973321|519889326|FG003|Overall Study|Other than specified|3|||
144189913|NCT02973321|519889327|FG004|Overall Study|Other than specified|1|||
144253513|NCT03297021|520128102|FG002|Overall Study|Missing Post-Op Data|1|||
144253514|NCT01557517|520128104|FG000|Overall Study|Death|1|||
144472164|NCT01493960|520926670|FG001|Overall Study|Non-specified|4|||
144189914|NCT02973321|519889323|FG000|Overall Study|Lack of Efficacy|0|||
144189915|NCT02973321|519889324|FG001|Overall Study|Lack of Efficacy|0|||
144189916|NCT02973321|519889325|FG002|Overall Study|Lack of Efficacy|0|||
144189917|NCT02973321|519889326|FG003|Overall Study|Lack of Efficacy|0|||
144189918|NCT02973321|519889327|FG004|Overall Study|Lack of Efficacy|1|||
144189919|NCT02973321|519889323|FG000|Overall Study|Adverse Event|1|||
144189920|NCT02973321|519889324|FG001|Overall Study|Adverse Event|10|||
144189921|NCT02973321|519889325|FG002|Overall Study|Adverse Event|11|||
144189922|NCT02973321|519889326|FG003|Overall Study|Adverse Event|13|||
144189923|NCT02973321|519889327|FG004|Overall Study|Adverse Event|3|||
144189924|NCT01098110|519889329|FG000|Overall Study|Withdrawal by Subject|14|||
144189925|NCT01098110|519889330|FG001|Overall Study|Withdrawal by Subject|24|||
144189926|NCT01098110|519889331|FG002|Overall Study|Withdrawal by Subject|19|||
144189927|NCT01098110|519889329|FG000|Overall Study|Adverse Event|30|||
144189928|NCT01098110|519889330|FG001|Overall Study|Adverse Event|32|||
144189929|NCT01098110|519889331|FG002|Overall Study|Adverse Event|43|||
144189930|NCT01098110|519889329|FG000|Overall Study|Lack of Efficacy|13|||
144189931|NCT01098110|519889330|FG001|Overall Study|Lack of Efficacy|9|||
144189932|NCT01098110|519889331|FG002|Overall Study|Lack of Efficacy|27|||
144189933|NCT01098110|519889329|FG000|Overall Study|Other|4|||
144189934|NCT01098110|519889330|FG001|Overall Study|Other|7|||
144189935|NCT01098110|519889331|FG002|Overall Study|Other|5|||
144189936|NCT01098110|519889329|FG000|Overall Study|Untreated|1|||
144189937|NCT01098110|519889330|FG001|Overall Study|Untreated|1|||
144189938|NCT01098110|519889331|FG002|Overall Study|Untreated|0|||
144189939|NCT00865514|519889332|FG000|Overall Study|Infusion cost exceeded funding|2|||
144189940|NCT02865395|519889333|FG000|Overall Study|Physician Decision|6|||
144189941|NCT02865395|519889334|FG001|Overall Study|Physician Decision|10|||
144189942|NCT02865395|519889335|FG002|Overall Study|Physician Decision|7|||
144189943|NCT00530348|519889336|FG000|Overall Study|Adverse Event|5|||
144189944|NCT00530348|519889337|FG001|Overall Study|Adverse Event|1|||
144189945|NCT00530348|519889336|FG000|Overall Study|Death|0|||
144189946|NCT00530348|519889337|FG001|Overall Study|Death|1|||
144189947|NCT00530348|519889336|FG000|Overall Study|Lack of Efficacy|2|||
144189948|NCT00530348|519889337|FG001|Overall Study|Lack of Efficacy|0|||
144189949|NCT00530348|519889336|FG000|Overall Study|Lost to Follow-up|0|||
144189950|NCT00530348|519889337|FG001|Overall Study|Lost to Follow-up|2|||
144189951|NCT00530348|519889336|FG000|Overall Study|Physician Decision|1|||
144189952|NCT00530348|519889337|FG001|Overall Study|Physician Decision|2|||
144189953|NCT00530348|519889336|FG000|Overall Study|Pregnancy|1|||
144189954|NCT00530348|519889337|FG001|Overall Study|Pregnancy|0|||
144189955|NCT00530348|519889336|FG000|Overall Study|Withdrawal by Subject|12|||
144189956|NCT00530348|519889337|FG001|Overall Study|Withdrawal by Subject|12|||
144189957|NCT00530348|519889336|FG000|Overall Study|Randomised in error|1|||
144189958|NCT00530348|519889337|FG001|Overall Study|Randomised in error|0|||
144189959|NCT00530348|519889336|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
144189960|NCT00530348|519889337|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
144189961|NCT01557920|519889344|FG000|Overall Study|Withdrawal by Subject|2|||
144189962|NCT01557920|519889345|FG001|Overall Study|Withdrawal by Subject|3|||
144189963|NCT01557920|519889344|FG000|Overall Study|Lack of Efficacy|1|||
144189964|NCT01557920|519889345|FG001|Overall Study|Lack of Efficacy|0|||
144189965|NCT04220775|519889352|FG000|Overall Study|Adverse Event|1|||
144189966|NCT04220775|519889353|FG001|Overall Study|Adverse Event|0|||
144189967|NCT04220775|519889352|FG000|Overall Study|Disease Progression|1|||
144189968|NCT04220775|519889353|FG001|Overall Study|Disease Progression|0|||
144189969|NCT00808509|519889354|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
144189970|NCT00808509|519889355|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
144189971|NCT00808509|519889354|FG000|Randomized Phase|Reduced methotrexate dose|1|||
144189972|NCT00808509|519889355|FG001|Randomized Phase|Reduced methotrexate dose|2|||
144189973|NCT00808509|519889354|FG000|Randomized Phase|Patient refused rescue therapy|0|||
144189974|NCT00808509|519889355|FG001|Randomized Phase|Patient refused rescue therapy|3|||
144189975|NCT00436917|519889356|FG000|Overall Study|Withdrawal by Subject|13|||
144189976|NCT00436917|519889356|FG000|Overall Study|Adverse Event|2|||
144189977|NCT00436917|519889356|FG000|Overall Study|Physician Decision|1|||
144189978|NCT00436917|519889356|FG000|Overall Study|Death|1|||
144189979|NCT00436917|519889356|FG000|Overall Study|Lost to Follow-up|1|||
144189980|NCT00436917|519889356|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
144189981|NCT00436917|519889356|FG000|Overall Study|Increased creatinine|1|||
144189982|NCT00436917|519889356|FG000|Overall Study|Personal conflicts of patient|1|||
144189983|NCT00931463|519889357|FG000|Overall Study|Death|8|||
144189984|NCT00931463|519889358|FG001|Overall Study|Death|4|||
144189985|NCT00931463|519889357|FG000|Overall Study|Withdrawal by Subject|5|||
144439057|NCT03778931|520811117|FG000|Overall Study|Withdrawal by Subject|12|||
144439058|NCT03778931|520811118|FG001|Overall Study|Withdrawal by Subject|25|||
144439059|NCT03778931|520811117|FG000|Overall Study|Physician Decision|1|||
144439060|NCT03778931|520811118|FG001|Overall Study|Physician Decision|3|||
144439061|NCT03778931|520811117|FG000|Overall Study|Participant Noncompliance|1|||
144439062|NCT03778931|520811118|FG001|Overall Study|Participant Noncompliance|1|||
144604808|NCT01241552|521415836|FG002|Overall Study|Lack of Efficacy|0|||
144604809|NCT01241552|521415837|FG003|Overall Study|Lack of Efficacy|0|||
144189986|NCT00931463|519889358|FG001|Overall Study|Withdrawal by Subject|0|||
144189987|NCT00931463|519889357|FG000|Overall Study|Lost to Follow-up|4|||
144189988|NCT00931463|519889358|FG001|Overall Study|Lost to Follow-up|1|||
144439063|NCT03778931|520811117|FG000|Overall Study|Lost to Follow-up|4|||
144604810|NCT01241552|521415834|FG000|Overall Study|Death|26|||
144189989|NCT02169791|519889359|FG000|Overall Study|Death|6|||
144189990|NCT02169791|519889359|FG000|Overall Study|patient withdrew consent|1|||
144189991|NCT01040793|519889364|FG000|Overall Study|Adverse Event|5|||
144189992|NCT01040793|519889365|FG001|Overall Study|Adverse Event|3|||
144189993|NCT01040793|519889366|FG002|Overall Study|Adverse Event|0|||
144189994|NCT01040793|519889367|FG003|Overall Study|Adverse Event|2|||
144189995|NCT01040793|519889368|FG004|Overall Study|Adverse Event|2|||
144189996|NCT01040793|519889369|FG005|Overall Study|Adverse Event|1|||
144189997|NCT01040793|519889364|FG000|Overall Study|Protocol Violation|1|||
144439064|NCT03778931|520811118|FG001|Overall Study|Lost to Follow-up|1|||
144189998|NCT01040793|519889365|FG001|Overall Study|Protocol Violation|1|||
144189999|NCT01040793|519889366|FG002|Overall Study|Protocol Violation|1|||
144190000|NCT01040793|519889367|FG003|Overall Study|Protocol Violation|0|||
144190001|NCT01040793|519889368|FG004|Overall Study|Protocol Violation|1|||
144190002|NCT01040793|519889369|FG005|Overall Study|Protocol Violation|0|||
144190003|NCT01040793|519889364|FG000|Overall Study|Lost to Follow-up|0|||
144190004|NCT01040793|519889365|FG001|Overall Study|Lost to Follow-up|1|||
144190005|NCT01040793|519889366|FG002|Overall Study|Lost to Follow-up|1|||
144190006|NCT01040793|519889367|FG003|Overall Study|Lost to Follow-up|0|||
144190007|NCT01040793|519889368|FG004|Overall Study|Lost to Follow-up|0|||
144190008|NCT01040793|519889369|FG005|Overall Study|Lost to Follow-up|0|||
144190009|NCT01040793|519889364|FG000|Overall Study|Withdrawal by Subject|0|||
144190010|NCT01040793|519889365|FG001|Overall Study|Withdrawal by Subject|0|||
144190011|NCT01040793|519889366|FG002|Overall Study|Withdrawal by Subject|0|||
144190012|NCT01040793|519889367|FG003|Overall Study|Withdrawal by Subject|2|||
144190013|NCT01040793|519889368|FG004|Overall Study|Withdrawal by Subject|0|||
144190014|NCT01040793|519889369|FG005|Overall Study|Withdrawal by Subject|0|||
144190015|NCT01040793|519889364|FG000|Overall Study|Other reasons not listed above|0|||
144439065|NCT03778931|520811117|FG000|Overall Study|Death|69|||
144439066|NCT03778931|520811118|FG001|Overall Study|Death|79|||
144439067|NCT02130765|520811126|FG000|Overall Study|Did not receive treatment|4|||
144439068|NCT02130765|520811127|FG001|Overall Study|Did not receive treatment|0|||
144439069|NCT02130765|520811128|FG002|Overall Study|Did not receive treatment|0|||
144439070|NCT02130765|520811129|FG003|Overall Study|Did not receive treatment|0|||
144439071|NCT01537783|520811137|FG000|Overall Study|Lost to Follow-up|11|||
144439072|NCT01537783|520811138|FG001|Overall Study|Lost to Follow-up|2|||
144439073|NCT01554618|520811139|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
144439074|NCT01554618|520811140|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
144439075|NCT01554618|520811139|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
144439076|NCT01554618|520811140|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
144439077|NCT01554618|520811139|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
144439078|NCT01554618|520811140|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
144439079|NCT01554618|520811139|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
144439080|NCT01554618|520811140|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
144439081|NCT01554618|520811139|FG000|Open-Label Extension Period|Physician Decision|0|||
144439082|NCT01554618|520811140|FG001|Open-Label Extension Period|Physician Decision|1|||
144190016|NCT01040793|519889365|FG001|Overall Study|Other reasons not listed above|0|||
144439083|NCT01554618|520811139|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
144530749|NCT05256654|521146287|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
144530750|NCT05256654|521146288|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
144530751|NCT05256654|521146285|FG000|Overall Study|Other|0|||
144530752|NCT05256654|521146286|FG001|Overall Study|Other|0|||
144530753|NCT05256654|521146287|FG002|Overall Study|Other|0|||
144530754|NCT05256654|521146288|FG003|Overall Study|Other|1|||
144530755|NCT03442309|521146296|FG000|Overall Study|Lost to Follow-up|1676|||
144530756|NCT03442309|521146297|FG001|Overall Study|Lost to Follow-up|1642|||
144530757|NCT05204654|521146298|FG000|Overall Study|Study terminated due to time restraint|2|||
144530758|NCT05204654|521146299|FG001|Overall Study|Study terminated due to time restraint|2|||
144530759|NCT05207956|521146304|FG000|Overall Study|Lost to follow up|1|||
144530760|NCT05207956|521146305|FG001|Overall Study|Lost to follow up|2|||
144530761|NCT01828112|521146308|FG000|Treatment Phase|Adverse Event|7|||
144530762|NCT01828112|521146309|FG001|Treatment Phase|Adverse Event|8|||
144530763|NCT01828112|521146310|FG002|Treatment Phase|Adverse Event|0|||
144190017|NCT01040793|519889366|FG002|Overall Study|Other reasons not listed above|1|||
144190018|NCT01040793|519889367|FG003|Overall Study|Other reasons not listed above|0|||
144190019|NCT01040793|519889368|FG004|Overall Study|Other reasons not listed above|1|||
144190020|NCT01040793|519889369|FG005|Overall Study|Other reasons not listed above|0|||
144190021|NCT03573817|519889371|FG000|Overall Study|Adverse Event|0|||
144253515|NCT01557517|520128105|FG001|Overall Study|Death|0|||
144253516|NCT01557517|520128104|FG000|Overall Study|Refused further treatment|0|||
144439084|NCT01554618|520811140|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
144439085|NCT00477672|520811141|FG000|Overall Study|Adverse Event|3|||
144530764|NCT01828112|521146308|FG000|Treatment Phase|Death|9|||
144530765|NCT01828112|521146309|FG001|Treatment Phase|Death|5|||
144190022|NCT03573817|519889372|FG001|Overall Study|Adverse Event|2|||
144190023|NCT03573817|519889371|FG000|Overall Study|Protocol Violation|0|||
144190024|NCT03573817|519889372|FG001|Overall Study|Protocol Violation|1|||
144190025|NCT03573817|519889371|FG000|Overall Study|Withdrawal by Subject|1|||
144190026|NCT03573817|519889372|FG001|Overall Study|Withdrawal by Subject|1|||
144190027|NCT03554317|519889373|FG000|Overall Study|Withdrawal by Subject|1|||
144530766|NCT01828112|521146310|FG002|Treatment Phase|Death|0|||
144530767|NCT01828112|521146308|FG000|Treatment Phase|No longer required treatment|0|||
144530768|NCT01828112|521146309|FG001|Treatment Phase|No longer required treatment|1|||
144530769|NCT01828112|521146310|FG002|Treatment Phase|No longer required treatment|0|||
144530770|NCT01828112|521146308|FG000|Treatment Phase|Physician Decision|6|||
144530771|NCT01828112|521146309|FG001|Treatment Phase|Physician Decision|7|||
144530772|NCT01828112|521146310|FG002|Treatment Phase|Physician Decision|0|||
144530773|NCT01828112|521146308|FG000|Treatment Phase|Pregnancy|1|||
144530774|NCT01828112|521146309|FG001|Treatment Phase|Pregnancy|0|||
144530775|NCT01828112|521146310|FG002|Treatment Phase|Pregnancy|0|||
144530776|NCT01828112|521146308|FG000|Treatment Phase|Progressive disease|79|||
144530777|NCT01828112|521146309|FG001|Treatment Phase|Progressive disease|87|||
144530778|NCT01828112|521146310|FG002|Treatment Phase|Progressive disease|0|||
144530779|NCT01828112|521146308|FG000|Treatment Phase|Study terminated by sponsor|1|||
144530780|NCT01828112|521146309|FG001|Treatment Phase|Study terminated by sponsor|0|||
144530781|NCT01828112|521146310|FG002|Treatment Phase|Study terminated by sponsor|0|||
144530782|NCT01828112|521146308|FG000|Treatment Phase|Subject/guardian decision|12|||
144530783|NCT01828112|521146309|FG001|Treatment Phase|Subject/guardian decision|8|||
144530784|NCT01828112|521146310|FG002|Treatment Phase|Subject/guardian decision|0|||
144530785|NCT01828112|521146308|FG000|Extension Treatment Phase|Adverse Event|0|||
144530786|NCT01828112|521146309|FG001|Extension Treatment Phase|Adverse Event|0|||
144530787|NCT01828112|521146310|FG002|Extension Treatment Phase|Adverse Event|6|||
144530788|NCT01828112|521146308|FG000|Extension Treatment Phase|Death|0|||
144530789|NCT01828112|521146309|FG001|Extension Treatment Phase|Death|0|||
144530790|NCT01828112|521146310|FG002|Extension Treatment Phase|Death|17|||
144530791|NCT01828112|521146308|FG000|Extension Treatment Phase|Physician Decision|0|||
144530792|NCT01828112|521146309|FG001|Extension Treatment Phase|Physician Decision|0|||
144530793|NCT01828112|521146310|FG002|Extension Treatment Phase|Physician Decision|5|||
144530794|NCT01828112|521146308|FG000|Extension Treatment Phase|Progressive disease|0|||
144530795|NCT01828112|521146309|FG001|Extension Treatment Phase|Progressive disease|0|||
144530796|NCT01828112|521146310|FG002|Extension Treatment Phase|Progressive disease|46|||
144530797|NCT01828112|521146308|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
144530798|NCT01828112|521146309|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
144530799|NCT01828112|521146310|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
144530800|NCT01828112|521146308|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
144530801|NCT01828112|521146309|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
144530802|NCT01828112|521146310|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
144530803|NCT04308681|521146316|FG000|Pre-Treatment|Not reported|1|||
144530804|NCT04308681|521146317|FG001|Pre-Treatment|Not reported|1|||
144530805|NCT04308681|521146318|FG002|Pre-Treatment|Not reported|0|||
144530806|NCT04308681|521146319|FG003|Pre-Treatment|Not reported|0|||
144530807|NCT04308681|521146320|FG004|Pre-Treatment|Not reported|0|||
144530808|NCT04308681|521146321|FG005|Pre-Treatment|Not reported|2|||
144530809|NCT04308681|521146322|FG006|Pre-Treatment|Not reported|0|||
144530810|NCT04308681|521146323|FG007|Pre-Treatment|Not reported|0|||
144530811|NCT04308681|521146316|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
144530812|NCT04308681|521146317|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
144530813|NCT04308681|521146318|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
144530814|NCT04308681|521146319|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
144530815|NCT04308681|521146320|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
144530816|NCT04308681|521146321|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
144530817|NCT04308681|521146322|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
144530818|NCT04308681|521146323|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
144190028|NCT03554317|519889373|FG000|Overall Study|PSA Progression|3|||
144190029|NCT03554317|519889373|FG000|Overall Study|Radiographic Progression|4|||
144190030|NCT00939627|519889374|FG000|Overall Study|Disease Progression|16|||
144190031|NCT00939627|519889375|FG001|Overall Study|Disease Progression|12|||
144190032|NCT00939627|519889376|FG002|Overall Study|Disease Progression|0|||
144190033|NCT00939627|519889374|FG000|Overall Study|Adverse Event|6|||
144190034|NCT00939627|519889375|FG001|Overall Study|Adverse Event|7|||
144190035|NCT00939627|519889376|FG002|Overall Study|Adverse Event|0|||
144190036|NCT00939627|519889374|FG000|Overall Study|Death|0|||
144530819|NCT04308681|521146316|FG000|Treatment up to Week 26|Other reasons|2|||
144530820|NCT04308681|521146317|FG001|Treatment up to Week 26|Other reasons|0|||
144530821|NCT04308681|521146318|FG002|Treatment up to Week 26|Other reasons|0|||
144530822|NCT04308681|521146319|FG003|Treatment up to Week 26|Other reasons|0|||
144530823|NCT04308681|521146320|FG004|Treatment up to Week 26|Other reasons|1|||
144530824|NCT04308681|521146321|FG005|Treatment up to Week 26|Other reasons|1|||
144530825|NCT04308681|521146322|FG006|Treatment up to Week 26|Other reasons|0|||
144530826|NCT04308681|521146323|FG007|Treatment up to Week 26|Other reasons|0|||
144530827|NCT04308681|521146316|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
144530828|NCT04308681|521146317|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
144530829|NCT04308681|521146318|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
144530830|NCT04308681|521146319|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
144530831|NCT04308681|521146320|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
144530832|NCT04308681|521146321|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
144530833|NCT04308681|521146322|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
144530834|NCT04308681|521146323|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
144530835|NCT04308681|521146316|FG000|Treatment up to Week 26|Adverse Event|6|||
144530836|NCT04308681|521146317|FG001|Treatment up to Week 26|Adverse Event|5|||
144530837|NCT04308681|521146318|FG002|Treatment up to Week 26|Adverse Event|5|||
144530838|NCT04308681|521146319|FG003|Treatment up to Week 26|Adverse Event|0|||
144530839|NCT04308681|521146320|FG004|Treatment up to Week 26|Adverse Event|6|||
144530840|NCT04308681|521146321|FG005|Treatment up to Week 26|Adverse Event|1|||
144530841|NCT04308681|521146322|FG006|Treatment up to Week 26|Adverse Event|0|||
144530842|NCT04308681|521146323|FG007|Treatment up to Week 26|Adverse Event|0|||
144530843|NCT04308681|521146316|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
144530844|NCT04308681|521146317|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
144530845|NCT04308681|521146318|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
144530846|NCT04308681|521146319|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
144530847|NCT04308681|521146320|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
144530848|NCT04308681|521146321|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
144530849|NCT04308681|521146322|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
144530850|NCT04308681|521146323|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
144530851|NCT04308681|521146316|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
144530852|NCT04308681|521146317|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
144530853|NCT04308681|521146318|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
144530854|NCT04308681|521146319|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
144530855|NCT04308681|521146320|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
144530856|NCT04308681|521146321|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
144530857|NCT04308681|521146322|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
144530858|NCT04308681|521146323|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
144530859|NCT04308681|521146316|FG000|OTE - 26 Weeks|Death|0|||
144530860|NCT04308681|521146317|FG001|OTE - 26 Weeks|Death|1|||
144530861|NCT04308681|521146318|FG002|OTE - 26 Weeks|Death|0|||
144530862|NCT04308681|521146319|FG003|OTE - 26 Weeks|Death|0|||
144530863|NCT04308681|521146320|FG004|OTE - 26 Weeks|Death|0|||
144530864|NCT04308681|521146321|FG005|OTE - 26 Weeks|Death|0|||
144439086|NCT00477672|520811142|FG001|Overall Study|Adverse Event|5|||
144439087|NCT00477672|520811143|FG002|Overall Study|Adverse Event|6|||
144439088|NCT00477672|520811141|FG000|Overall Study|Death|0|||
144439089|NCT00477672|520811142|FG001|Overall Study|Death|1|||
144439090|NCT00477672|520811143|FG002|Overall Study|Death|0|||
144439091|NCT00477672|520811141|FG000|Overall Study|Disease progression|0|||
144439092|NCT00477672|520811142|FG001|Overall Study|Disease progression|1|||
144439093|NCT00477672|520811143|FG002|Overall Study|Disease progression|0|||
144439094|NCT00477672|520811141|FG000|Overall Study|Physician Decision|1|||
144439095|NCT00477672|520811142|FG001|Overall Study|Physician Decision|0|||
144439096|NCT00477672|520811143|FG002|Overall Study|Physician Decision|0|||
144439097|NCT00477672|520811141|FG000|Overall Study|Protocol noncompliance|0|||
144439098|NCT00477672|520811142|FG001|Overall Study|Protocol noncompliance|2|||
144439099|NCT00477672|520811143|FG002|Overall Study|Protocol noncompliance|0|||
144439100|NCT00477672|520811141|FG000|Overall Study|Consent withdrawn|2|||
144439101|NCT00477672|520811142|FG001|Overall Study|Consent withdrawn|5|||
144439102|NCT00477672|520811143|FG002|Overall Study|Consent withdrawn|10|||
144439103|NCT00477672|520811141|FG000|Overall Study|Discretion of Sponsor|1|||
144439104|NCT00477672|520811142|FG001|Overall Study|Discretion of Sponsor|2|||
144439105|NCT00477672|520811143|FG002|Overall Study|Discretion of Sponsor|0|||
144439106|NCT02722928|520811146|FG000|Overall Study|Standard CT was not as required per prot|5|||
144439107|NCT02722928|520811147|FG001|Overall Study|Standard CT was not as required per prot|13|||
144439108|NCT02722928|520811146|FG000|Overall Study|Required Intraoperative MRI|5|||
144439109|NCT02722928|520811147|FG001|Overall Study|Required Intraoperative MRI|7|||
144439110|NCT04011410|520811148|FG000|Overall Study|Withdrawal by Subject|1|||
144439111|NCT01557400|520811149|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
144439112|NCT01557400|520811149|FG000|Overall Study|Adverse Event|3|||
144439113|NCT01557400|520811149|FG000|Overall Study|Lost to Follow-up|5|||
144439114|NCT01557400|520811149|FG000|Overall Study|Withdrawal by Subject|9|||
144439115|NCT01393405|520811152|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
144439116|NCT01393405|520811153|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
144439117|NCT01393405|520811154|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
144530865|NCT04308681|521146322|FG006|OTE - 26 Weeks|Death|1|||
144530866|NCT04308681|521146323|FG007|OTE - 26 Weeks|Death|0|||
144530867|NCT04308681|521146316|FG000|OTE - 26 Weeks|Adverse Event|0|||
144530868|NCT04308681|521146317|FG001|OTE - 26 Weeks|Adverse Event|2|||
144530869|NCT04308681|521146318|FG002|OTE - 26 Weeks|Adverse Event|8|||
144530870|NCT04308681|521146319|FG003|OTE - 26 Weeks|Adverse Event|3|||
144530871|NCT04308681|521146320|FG004|OTE - 26 Weeks|Adverse Event|0|||
144530872|NCT04308681|521146321|FG005|OTE - 26 Weeks|Adverse Event|1|||
144530873|NCT04308681|521146322|FG006|OTE - 26 Weeks|Adverse Event|2|||
144439118|NCT01393405|520811152|FG000|Induction Period (week1-16)|Adverse Event|16|||
144439119|NCT01393405|520811153|FG001|Induction Period (week1-16)|Adverse Event|0|||
144439120|NCT01393405|520811154|FG002|Induction Period (week1-16)|Adverse Event|0|||
144439121|NCT01393405|520811152|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
144439122|NCT01393405|520811153|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
144439123|NCT01393405|520811154|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
144439124|NCT01393405|520811152|FG000|Maintenance Period Week|Lack of Efficacy|0|||
144439125|NCT01393405|520811153|FG001|Maintenance Period Week|Lack of Efficacy|22|||
144439126|NCT01393405|520811154|FG002|Maintenance Period Week|Lack of Efficacy|22|||
144439127|NCT01393405|520811152|FG000|Maintenance Period Week|Adverse Event|0|||
144439128|NCT01393405|520811153|FG001|Maintenance Period Week|Adverse Event|5|||
144439129|NCT01393405|520811154|FG002|Maintenance Period Week|Adverse Event|2|||
144439130|NCT01393405|520811152|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
144439131|NCT01393405|520811153|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
144439132|NCT01393405|520811154|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
144439133|NCT01393405|520811152|FG000|Maintenance Period Week|Lost to Follow-up|0|||
144439134|NCT01393405|520811153|FG001|Maintenance Period Week|Lost to Follow-up|1|||
144439135|NCT01393405|520811154|FG002|Maintenance Period Week|Lost to Follow-up|0|||
144439136|NCT04365699|520811157|FG000|Overall Study|Death|2|||
144439137|NCT04365699|520811158|FG001|Overall Study|Death|5|||
144439138|NCT04365699|520811159|FG002|Overall Study|Death|15|||
144439139|NCT02321462|520811162|FG000|Overall Study|Withdrawal by Subject|5|||
144439140|NCT02321462|520811163|FG001|Overall Study|Withdrawal by Subject|2|||
144439141|NCT02321462|520811162|FG000|Overall Study|Subject withdrawn before any treatment|1|||
144439142|NCT02321462|520811163|FG001|Overall Study|Subject withdrawn before any treatment|1|||
144439143|NCT00834912|520811164|FG000|Treatment Period 1|Adverse Event|0|||
144439144|NCT00834912|520811165|FG001|Treatment Period 1|Adverse Event|1|||
144439145|NCT00834912|520811166|FG002|Treatment Period 1|Adverse Event|0|||
144439146|NCT00834912|520811167|FG003|Treatment Period 1|Adverse Event|1|||
144439147|NCT00834912|520811168|FG004|Treatment Period 1|Adverse Event|0|||
144439148|NCT00834912|520811169|FG005|Treatment Period 1|Adverse Event|0|||
144439149|NCT00834912|520811164|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144439150|NCT00834912|520811165|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144439151|NCT00834912|520811166|FG002|Treatment Period 2|Withdrawal by Subject|1|||
144439152|NCT00834912|520811167|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144439153|NCT00834912|520811168|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144439154|NCT00834912|520811169|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144439155|NCT03044197|520811170|FG000|Overall Study|Withdrawal by Subject|3|||
144439156|NCT03044197|520811171|FG001|Overall Study|Withdrawal by Subject|1|||
144439157|NCT02849548|520811174|FG000|Overall Study|Lost to Follow-up|1|||
144439158|NCT02849548|520811175|FG001|Overall Study|Lost to Follow-up|2|||
144439159|NCT02849548|520811174|FG000|Overall Study|Protocol Violation|1|||
144439160|NCT02849548|520811175|FG001|Overall Study|Protocol Violation|0|||
144439161|NCT00714259|520811176|FG000|Overall Study|Death|2|||
144439162|NCT00256698|520811179|FG000|Overall Study|Withdrawal by Subject|7|||
144439163|NCT00256698|520811180|FG001|Overall Study|Withdrawal by Subject|7|||
144439164|NCT00256698|520811179|FG000|Overall Study|Adverse Event|13|||
144190037|NCT00939627|519889375|FG001|Overall Study|Death|2|||
144190038|NCT00939627|519889376|FG002|Overall Study|Death|0|||
144190039|NCT00939627|519889374|FG000|Overall Study|Withdrawal by Subject|2|||
144190040|NCT00939627|519889375|FG001|Overall Study|Withdrawal by Subject|4|||
144190041|NCT00939627|519889376|FG002|Overall Study|Withdrawal by Subject|0|||
144190042|NCT00939627|519889374|FG000|Overall Study|Other complicating disease|1|||
144190043|NCT00939627|519889375|FG001|Overall Study|Other complicating disease|1|||
144190044|NCT00939627|519889376|FG002|Overall Study|Other complicating disease|0|||
144190045|NCT00939627|519889374|FG000|Overall Study|Not compliant|2|||
144190046|NCT00939627|519889375|FG001|Overall Study|Not compliant|0|||
144190047|NCT00939627|519889376|FG002|Overall Study|Not compliant|0|||
144190048|NCT00939627|519889374|FG000|Overall Study|No off-tx reason given|0|||
144190049|NCT00939627|519889375|FG001|Overall Study|No off-tx reason given|2|||
144190050|NCT00939627|519889376|FG002|Overall Study|No off-tx reason given|0|||
144190051|NCT00612677|519889379|FG000|Overall Study|study closed before treatment started|1|||
144190052|NCT00860743|519889380|FG000|Overall Study|Withdrawal by Subject|3|||
144190053|NCT00860743|519889381|FG001|Overall Study|Withdrawal by Subject|0|||
144190054|NCT00823199|519889382|FG000|Overall Study|Withdrawal by Subject|2|||
144190055|NCT02776553|519889383|FG000|Overall Study|Lost to Follow-up|1|||
144190056|NCT02776553|519889384|FG001|Overall Study|Lost to Follow-up|0|||
144190057|NCT02776553|519889383|FG000|Overall Study|got liver transplant|1|||
144190058|NCT02776553|519889384|FG001|Overall Study|got liver transplant|2|||
144439165|NCT00256698|520811180|FG001|Overall Study|Adverse Event|6|||
144439166|NCT00256698|520811179|FG000|Overall Study|Protocol Violation|6|||
144439167|NCT00256698|520811180|FG001|Overall Study|Protocol Violation|5|||
144439168|NCT00256698|520811179|FG000|Overall Study|Lost to Follow-up|1|||
144439169|NCT00256698|520811180|FG001|Overall Study|Lost to Follow-up|3|||
144439170|NCT00256698|520811179|FG000|Overall Study|disease progression|97|||
144190059|NCT02776553|519889383|FG000|Overall Study|had other surgery|1|||
144190060|NCT02776553|519889384|FG001|Overall Study|had other surgery|0|||
144439171|NCT00256698|520811180|FG001|Overall Study|disease progression|105|||
144439172|NCT00256698|520811179|FG000|Overall Study|still ongoing at data cut-off|41|||
144439173|NCT00256698|520811180|FG001|Overall Study|still ongoing at data cut-off|46|||
144439174|NCT00256698|520811179|FG000|Overall Study|withdrawn due to osteoporosis|1|||
144439175|NCT00256698|520811180|FG001|Overall Study|withdrawn due to osteoporosis|0|||
144439176|NCT00256698|520811179|FG000|Overall Study|Prematurely Discontinued|1|||
144439177|NCT00256698|520811180|FG001|Overall Study|Prematurely Discontinued|0|||
144439178|NCT01589822|520812724|FG000|Overall Study|Withdrawal by Subject|1|||
144439179|NCT01589822|520812725|FG001|Overall Study|Withdrawal by Subject|2|||
144439180|NCT01589822|520812726|FG002|Overall Study|Withdrawal by Subject|0|||
144439181|NCT01589822|520812724|FG000|Overall Study|Death|1|||
144439182|NCT01589822|520812725|FG001|Overall Study|Death|0|||
144724524|NCT00984295|521846409|FG002|Overall Study|Incomplete safety follow-up|3|||
144190061|NCT02776553|519889383|FG000|Overall Study|Protocol Violation|0|||
144190062|NCT02776553|519889384|FG001|Overall Study|Protocol Violation|1|||
144190063|NCT01998243|519889385|FG000|Overall Study|Pregnancy|0|||
144190064|NCT01998243|519889386|FG001|Overall Study|Pregnancy|1|||
144190065|NCT01998243|519889385|FG000|Overall Study|Protocol Violation|5|||
144190066|NCT01998243|519889386|FG001|Overall Study|Protocol Violation|2|||
144190067|NCT01998243|519889385|FG000|Overall Study|Withdrawal by Subject|3|||
144190068|NCT01998243|519889386|FG001|Overall Study|Withdrawal by Subject|4|||
144190069|NCT01640184|519889387|FG000|Overall Study|Death|1|||
144190070|NCT01640184|519889388|FG001|Overall Study|Death|0|||
144190071|NCT01640184|519889389|FG002|Overall Study|Death|0|||
144190072|NCT01640184|519889387|FG000|Overall Study|Lost to Follow-up|4|||
144190073|NCT01640184|519889388|FG001|Overall Study|Lost to Follow-up|1|||
144724525|NCT04582539|521846410|FG000|Overall Study|Death|1|||
144190074|NCT01640184|519889389|FG002|Overall Study|Lost to Follow-up|0|||
144190075|NCT01640184|519889387|FG000|Overall Study|Physician Decision|3|||
144190076|NCT01640184|519889388|FG001|Overall Study|Physician Decision|0|||
144190077|NCT01640184|519889389|FG002|Overall Study|Physician Decision|0|||
144190078|NCT01640184|519889387|FG000|Overall Study|Withdrawal by Subject|0|||
144190079|NCT01640184|519889388|FG001|Overall Study|Withdrawal by Subject|1|||
144724526|NCT04582539|521846411|FG001|Overall Study|Death|1|||
144724527|NCT04582539|521846412|FG002|Overall Study|Death|0|||
144724528|NCT04582539|521846413|FG003|Overall Study|Death|1|||
144724529|NCT04582539|521846414|FG004|Overall Study|Death|0|||
144253517|NCT01557517|520128105|FG001|Overall Study|Refused further treatment|2|||
144253518|NCT01557517|520128104|FG000|Overall Study|Adverse Event|0|||
144253519|NCT01557517|520128105|FG001|Overall Study|Adverse Event|2|||
144253520|NCT01557517|520128104|FG000|Overall Study|Pt declined before treatment started|1|||
144253521|NCT01557517|520128105|FG001|Overall Study|Pt declined before treatment started|0|||
144253522|NCT00162097|520128106|FG000|Overall Study|Participant no longer met study criteria|0|||
144253523|NCT00162097|520128107|FG001|Overall Study|Participant no longer met study criteria|0|||
144190080|NCT01640184|519889389|FG002|Overall Study|Withdrawal by Subject|1|||
144190081|NCT01640184|519889387|FG000|Overall Study|Protocol Violation|0|||
144190082|NCT01640184|519889388|FG001|Overall Study|Protocol Violation|0|||
144190083|NCT01640184|519889389|FG002|Overall Study|Protocol Violation|1|||
144253524|NCT00162097|520128108|FG002|Overall Study|Participant no longer met study criteria|0|||
144190084|NCT00613730|519889393|FG000|Overall Study|Disease progression|2|||
144190085|NCT00613730|519889393|FG000|Overall Study|Administrative decision|1|||
144439183|NCT01589822|520812726|FG002|Overall Study|Death|0|||
144190086|NCT00479388|519889394|FG000|Overall Study|Adverse Event|90|||
144439184|NCT01589822|520812724|FG000|Overall Study|Missed 90 day visit|2|||
144439185|NCT01589822|520812725|FG001|Overall Study|Missed 90 day visit|1|||
144439186|NCT01589822|520812726|FG002|Overall Study|Missed 90 day visit|1|||
144439187|NCT05168475|520812727|FG000|Period 1|Protocol Violation|1|||
144439188|NCT05168475|520812727|FG000|Period 1|IMP shortage|2|||
144439189|NCT05168475|520812727|FG000|Period 1|Not randomised|2|||
144439190|NCT05168475|520812727|FG000|Period 2|IMP shortage|1|||
144439191|NCT01140477|520812728|FG000|Overall Study|Lost to Follow-up|4|||
144439192|NCT01140477|520812729|FG001|Overall Study|Lost to Follow-up|0|||
144439193|NCT01140477|520812728|FG000|Overall Study|Withdrawal by Subject|1|||
144439194|NCT01140477|520812729|FG001|Overall Study|Withdrawal by Subject|4|||
144439195|NCT01140477|520812728|FG000|Overall Study|Surgical complication preventing implant|2|||
144439196|NCT01140477|520812729|FG001|Overall Study|Surgical complication preventing implant|0|||
144439197|NCT01140477|520812728|FG000|Overall Study|Death|1|||
144439198|NCT01140477|520812729|FG001|Overall Study|Death|1|||
144439199|NCT01140477|520812728|FG000|Overall Study|Subject explanted|0|||
144439200|NCT01140477|520812729|FG001|Overall Study|Subject explanted|1|||
144439201|NCT00773175|520812730|FG000|Overall Study|Adverse Event|2|||
144439202|NCT00773175|520812731|FG001|Overall Study|Adverse Event|0|||
144439203|NCT00773175|520812730|FG000|Overall Study|Consent Withdrawn|0|||
144439204|NCT00773175|520812731|FG001|Overall Study|Consent Withdrawn|2|||
144439205|NCT04482179|520812732|FG000|Overall Study|Death|1|||
144439206|NCT04482179|520812733|FG001|Overall Study|Death|0|||
144439207|NCT04482179|520812732|FG000|Overall Study|Withdrawal by Subject|1|||
144439208|NCT04482179|520812733|FG001|Overall Study|Withdrawal by Subject|0|||
144439209|NCT00503841|520812734|FG000|Overall Study|All screen failures|44|||
144439210|NCT01302964|520812739|FG000|Overall Study|Adverse Event|1|||
144439211|NCT01302964|520812740|FG001|Overall Study|Adverse Event|0|||
144439212|NCT05723770|520812741|FG000|Overall Study|Lost to Follow-up|4|||
144439213|NCT05723770|520812741|FG000|Overall Study|Withdrawal by Subject|2|||
144439214|NCT04127786|520812742|FG000|Primary Series|Adverse Event|1|||
144439215|NCT04127786|520812743|FG001|Primary Series|Adverse Event|0|||
144439216|NCT04127786|520812744|FG002|Primary Series|Adverse Event|0|||
144439217|NCT04127786|520812745|FG003|Primary Series|Adverse Event|1|||
144439218|NCT04127786|520812746|FG004|Primary Series|Adverse Event|0|||
144439219|NCT04127786|520812747|FG005|Primary Series|Adverse Event|1|||
144439220|NCT04127786|520812742|FG000|Primary Series|Protocol Violation|5|||
144439221|NCT04127786|520812743|FG001|Primary Series|Protocol Violation|3|||
144439222|NCT04127786|520812744|FG002|Primary Series|Protocol Violation|4|||
144439223|NCT04127786|520812745|FG003|Primary Series|Protocol Violation|3|||
144439224|NCT04127786|520812746|FG004|Primary Series|Protocol Violation|2|||
144439225|NCT04127786|520812747|FG005|Primary Series|Protocol Violation|0|||
144439226|NCT04127786|520812742|FG000|Primary Series|Withdrawal by Subject|0|||
144439227|NCT04127786|520812743|FG001|Primary Series|Withdrawal by Subject|0|||
144439228|NCT04127786|520812744|FG002|Primary Series|Withdrawal by Subject|0|||
144439229|NCT04127786|520812745|FG003|Primary Series|Withdrawal by Subject|1|||
144439230|NCT04127786|520812746|FG004|Primary Series|Withdrawal by Subject|0|||
144439231|NCT04127786|520812747|FG005|Primary Series|Withdrawal by Subject|0|||
144439232|NCT04127786|520812742|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
144439233|NCT04127786|520812743|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
144439234|NCT04127786|520812744|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
144439235|NCT04127786|520812745|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
144439236|NCT04127786|520812746|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
144439237|NCT04127786|520812747|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
144439238|NCT04127786|520812742|FG000|Booster Phase|Withdrawal by Subject|2|||
144439239|NCT04127786|520812743|FG001|Booster Phase|Withdrawal by Subject|0|||
144439240|NCT04127786|520812744|FG002|Booster Phase|Withdrawal by Subject|0|||
144439241|NCT04127786|520812745|FG003|Booster Phase|Withdrawal by Subject|0|||
144439242|NCT04127786|520812746|FG004|Booster Phase|Withdrawal by Subject|0|||
144439243|NCT04127786|520812747|FG005|Booster Phase|Withdrawal by Subject|0|||
144439244|NCT03569371|520812755|FG000|Overall Study|Lack of Efficacy|1|||
144439245|NCT03569371|520812755|FG000|Overall Study|Lost to Follow-up|1|||
144439246|NCT03569371|520812755|FG000|Overall Study|Adverse Event|1|||
144439247|NCT01982253|520812758|FG000|Overall Study|Withdrawal by Subject|1|||
144439248|NCT01982253|520812759|FG001|Overall Study|Withdrawal by Subject|0|||
144439249|NCT01982253|520812760|FG002|Overall Study|Withdrawal by Subject|0|||
144439250|NCT01982253|520812758|FG000|Overall Study|Study terminated by sponsor|1|||
144439251|NCT01982253|520812759|FG001|Overall Study|Study terminated by sponsor|4|||
144190087|NCT00479388|519889395|FG001|Overall Study|Adverse Event|45|||
144190088|NCT00479388|519889394|FG000|Overall Study|Lost to Follow-up|0|||
144190089|NCT00479388|519889395|FG001|Overall Study|Lost to Follow-up|2|||
144190090|NCT00479388|519889394|FG000|Overall Study|Protocol Violation|10|||
144190091|NCT00479388|519889395|FG001|Overall Study|Protocol Violation|9|||
144190092|NCT00479388|519889394|FG000|Overall Study|Withdrawal by Subject|32|||
144190093|NCT00479388|519889395|FG001|Overall Study|Withdrawal by Subject|17|||
144190094|NCT00104247|519889396|FG000|Overall Study|Withdrawal by Subject|1|||
144190095|NCT00104247|519889397|FG001|Overall Study|Withdrawal by Subject|0|||
144190096|NCT00104247|519889396|FG000|Overall Study|Noncompliant with dosing|0|||
144190097|NCT00104247|519889397|FG001|Overall Study|Noncompliant with dosing|1|||
144190098|NCT01644149|519889398|FG000|Overall Study|Withdrawal by Subject|1|||
144190099|NCT01644149|519889399|FG001|Overall Study|Withdrawal by Subject|0|||
144190100|NCT01644149|519889398|FG000|Overall Study|Lost to Follow-up|3|||
144439252|NCT01982253|520812760|FG002|Overall Study|Study terminated by sponsor|4|||
144439253|NCT03848845|520812761|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
144439254|NCT03848845|520812762|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
144439255|NCT03848845|520812763|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
144439256|NCT03848845|520812764|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
144439257|NCT03848845|520812761|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
144439258|NCT03848845|520812762|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
144439259|NCT03848845|520812763|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
144439260|NCT03848845|520812764|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
144439261|NCT03848845|520812761|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
144190101|NCT01644149|519889399|FG001|Overall Study|Lost to Follow-up|1|||
144190102|NCT00690482|519889402|FG000|Overall Study|Adverse Event|2|||
144190103|NCT00690482|519889403|FG001|Overall Study|Adverse Event|1|||
144190104|NCT00690482|519889402|FG000|Overall Study|Incorrect enrolment|0|||
144190105|NCT00690482|519889403|FG001|Overall Study|Incorrect enrolment|1|||
144190106|NCT00690482|519889402|FG000|Overall Study|Study-specific discontinuation criteria|1|||
144190107|NCT00690482|519889403|FG001|Overall Study|Study-specific discontinuation criteria|0|||
144190108|NCT00690482|519889402|FG000|Overall Study|Intake of prohibited medicine|1|||
144190109|NCT00690482|519889403|FG001|Overall Study|Intake of prohibited medicine|0|||
144190110|NCT00690482|519889402|FG000|Overall Study|withdrew consent at rand.day|0|||
144190111|NCT00690482|519889403|FG001|Overall Study|withdrew consent at rand.day|1|||
144190112|NCT00724373|519889404|FG000|Overall Study|Adverse Event|41|||
144190113|NCT00724373|519889404|FG000|Overall Study|Lack of Efficacy|82|||
144190114|NCT00724373|519889404|FG000|Overall Study|Lost to Follow-up|7|||
144190115|NCT00724373|519889404|FG000|Overall Study|Non-compliance|2|||
144190116|NCT00724373|519889404|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
144190117|NCT00724373|519889404|FG000|Overall Study|Participant moved away|1|||
144190118|NCT00724373|519889404|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
144190119|NCT00724373|519889404|FG000|Overall Study|Only to have 24 week regimen|1|||
144190120|NCT00724373|519889404|FG000|Overall Study|Viral Relapse|1|||
144190121|NCT00724373|519889404|FG000|Overall Study|Acute HCV infection|1|||
144190122|NCT00724373|519889404|FG000|Overall Study|Drug Relapse|1|||
144190123|NCT00724373|519889404|FG000|Overall Study|Tolerability|23|||
144190124|NCT01506908|519889405|FG000|Overall Study|Adverse Event|1|||
144190125|NCT01506908|519889406|FG001|Overall Study|Adverse Event|0|||
144190126|NCT03718117|519889414|FG000|Overall Study|Death|12|||
144190127|NCT03718117|519889415|FG001|Overall Study|Death|11|||
144190128|NCT03718117|519889416|FG002|Overall Study|Death|0|||
144190129|NCT03718117|519889414|FG000|Overall Study|Other|0|||
144190130|NCT03718117|519889415|FG001|Overall Study|Other|1|||
144190131|NCT03718117|519889416|FG002|Overall Study|Other|0|||
144190132|NCT03718117|519889414|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
144190133|NCT03718117|519889415|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
144190134|NCT03718117|519889416|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
144190135|NCT03718117|519889414|FG000|Overall Study|Participant not met eligibility criteria|0|||
144190136|NCT03718117|519889415|FG001|Overall Study|Participant not met eligibility criteria|0|||
144190137|NCT03718117|519889416|FG002|Overall Study|Participant not met eligibility criteria|2|||
144190138|NCT01382251|519889417|FG000|Overall Study|Surgeries cancelled or delayed|16|||
144190139|NCT01382251|519889418|FG001|Overall Study|Surgeries cancelled or delayed|16|||
144190140|NCT01382251|519889417|FG000|Overall Study|Lost to Follow-up|4|||
144190141|NCT01382251|519889418|FG001|Overall Study|Lost to Follow-up|4|||
144190142|NCT01382251|519889417|FG000|Overall Study|Contacted after study closed|1|||
144190143|NCT01382251|519889418|FG001|Overall Study|Contacted after study closed|1|||
144190144|NCT01117987|519889419|FG000|Overall Study|Protocol deviation|0|||
144190145|NCT01117987|519889420|FG001|Overall Study|Protocol deviation|1|||
144190146|NCT01117987|519889419|FG000|Overall Study|Subject no longer requires study drug|1|||
144190147|NCT01117987|519889420|FG001|Overall Study|Subject no longer requires study drug|0|||
144190148|NCT01117987|519889419|FG000|Overall Study|Lost to Follow-up|1|||
144190149|NCT01117987|519889420|FG001|Overall Study|Lost to Follow-up|1|||
144190150|NCT01117987|519889419|FG000|Overall Study|Abnormal test procedure result|2|||
144190151|NCT01117987|519889420|FG001|Overall Study|Abnormal test procedure result|0|||
144190152|NCT01117987|519889419|FG000|Overall Study|Lack of Efficacy|3|||
144190153|NCT01117987|519889420|FG001|Overall Study|Lack of Efficacy|4|||
144190154|NCT01117987|519889419|FG000|Overall Study|Death|5|||
144190155|NCT01117987|519889420|FG001|Overall Study|Death|10|||
144190156|NCT01117987|519889419|FG000|Overall Study|Withdrawal by Subject|5|||
144190157|NCT01117987|519889420|FG001|Overall Study|Withdrawal by Subject|10|||
144190158|NCT01117987|519889419|FG000|Overall Study|Adverse Event|19|||
144190159|NCT01117987|519889420|FG001|Overall Study|Adverse Event|26|||
144190160|NCT01117987|519889419|FG000|Overall Study|Administrative problems|25|||
144190161|NCT01117987|519889420|FG001|Overall Study|Administrative problems|22|||
144190162|NCT04232540|519889424|FG000|Overall Study|Lost to Follow-up|1|||
144190163|NCT04232540|519889425|FG001|Overall Study|Lost to Follow-up|0|||
144190164|NCT01181531|519889431|FG000|Overall Study|Other|17|||
144190165|NCT01181531|519889432|FG001|Overall Study|Other|12|||
144190166|NCT01181531|519889431|FG000|Overall Study|Partial consent by subject withdrawn|0|||
144190167|NCT01181531|519889432|FG001|Overall Study|Partial consent by subject withdrawn|1|||
144190168|NCT01181531|519889431|FG000|Overall Study|Physician Decision|3|||
144190169|NCT01181531|519889432|FG001|Overall Study|Physician Decision|1|||
144190170|NCT01181531|519889431|FG000|Overall Study|Noncompliance|2|||
144190171|NCT01181531|519889432|FG001|Overall Study|Noncompliance|2|||
144190172|NCT01181531|519889431|FG000|Overall Study|Ineligibility determined|1|||
144190173|NCT01181531|519889432|FG001|Overall Study|Ineligibility determined|2|||
144190174|NCT01181531|519889431|FG000|Overall Study|Protocol Specified Criteria|15|||
144190175|NCT01181531|519889432|FG001|Overall Study|Protocol Specified Criteria|8|||
144190176|NCT01181531|519889431|FG000|Overall Study|Pregnancy|0|||
144190177|NCT01181531|519889432|FG001|Overall Study|Pregnancy|1|||
144190178|NCT01181531|519889431|FG000|Overall Study|Withdrawal by Subject|8|||
144190179|NCT01181531|519889432|FG001|Overall Study|Withdrawal by Subject|7|||
144190180|NCT01181531|519889431|FG000|Overall Study|Protocol Violation|6|||
144190181|NCT01181531|519889432|FG001|Overall Study|Protocol Violation|6|||
144190182|NCT01181531|519889431|FG000|Overall Study|Death|9|||
144190183|NCT01181531|519889432|FG001|Overall Study|Death|12|||
144190184|NCT01181531|519889431|FG000|Overall Study|Adverse Event|0|||
144190185|NCT01181531|519889432|FG001|Overall Study|Adverse Event|1|||
144190186|NCT02339090|519889433|FG000|Overall Study|Adverse Event|1|||
144190187|NCT02339090|519889434|FG001|Overall Study|Adverse Event|0|||
144190188|NCT02339090|519889433|FG000|Overall Study|Lost to Follow-up|0|||
144190189|NCT02339090|519889434|FG001|Overall Study|Lost to Follow-up|1|||
144190190|NCT02339090|519889433|FG000|Overall Study|Non-compliance With Study Drug|0|||
144190191|NCT02339090|519889434|FG001|Overall Study|Non-compliance With Study Drug|1|||
144190192|NCT02339090|519889433|FG000|Overall Study|Withdrawal by Subject|2|||
144190193|NCT02339090|519889434|FG001|Overall Study|Withdrawal by Subject|1|||
144190194|NCT02339090|519889433|FG000|Overall Study|Poor Growth|3|||
144190195|NCT02339090|519889434|FG001|Overall Study|Poor Growth|0|||
144190196|NCT02339090|519889433|FG000|Overall Study|Randomized but not treated|0|||
144190197|NCT02339090|519889434|FG001|Overall Study|Randomized but not treated|2|||
144190198|NCT02737592|519889438|FG000|Overall Study|Withdrawal by Subject|1|||
144190199|NCT00576303|519889439|FG000|Dose Titration Period|Early withdrawal|17|||
144190200|NCT00576303|519889439|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
144190201|NCT00576303|519889439|FG000|Long Term Safety Period|Early withdrawal|16|||
144190202|NCT00442546|519889440|FG000|Overall Study|Adverse Event|11|||
144190203|NCT00442546|519889441|FG001|Overall Study|Adverse Event|17|||
144190204|NCT00442546|519889442|FG002|Overall Study|Adverse Event|13|||
144190205|NCT00442546|519889440|FG000|Overall Study|Lost to Follow-up|1|||
144190206|NCT00442546|519889441|FG001|Overall Study|Lost to Follow-up|2|||
144190207|NCT00442546|519889442|FG002|Overall Study|Lost to Follow-up|1|||
144190208|NCT00442546|519889440|FG000|Overall Study|Other|4|||
144190209|NCT00442546|519889441|FG001|Overall Study|Other|9|||
144190210|NCT00442546|519889442|FG002|Overall Study|Other|6|||
144190211|NCT00442546|519889440|FG000|Overall Study|Withdrawal by Subject|5|||
144190212|NCT00442546|519889441|FG001|Overall Study|Withdrawal by Subject|5|||
144190213|NCT00442546|519889442|FG002|Overall Study|Withdrawal by Subject|7|||
144190214|NCT00442546|519889440|FG000|Overall Study|Randomized But Not Treated|5|||
144190215|NCT00442546|519889441|FG001|Overall Study|Randomized But Not Treated|4|||
144190216|NCT00442546|519889442|FG002|Overall Study|Randomized But Not Treated|6|||
144190217|NCT03123783|519889443|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
144190218|NCT03123783|519889444|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
144190219|NCT03123783|519889445|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
144190220|NCT03123783|519889446|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
144190221|NCT03123783|519889447|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
144190222|NCT03123783|519889448|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
144190223|NCT03123783|519889449|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
144190224|NCT03123783|519889443|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
144190225|NCT03123783|519889444|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
144190226|NCT03123783|519889445|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
144190227|NCT03123783|519889446|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
144190228|NCT03123783|519889447|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
144439262|NCT03848845|520812762|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
144439263|NCT03848845|520812763|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
144439264|NCT03848845|520812764|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
144439265|NCT03848845|520812761|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
144439266|NCT03848845|520812762|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
144439267|NCT03848845|520812763|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
144439268|NCT03848845|520812764|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
144439269|NCT02789176|520812765|FG000|Overall Study|Death|0|||
144439270|NCT02789176|520812766|FG001|Overall Study|Death|0|||
144439271|NCT02789176|520812767|FG002|Overall Study|Death|3|||
144439272|NCT02789176|520812768|FG003|Overall Study|Death|0|||
144439273|NCT02789176|520812765|FG000|Overall Study|Withdrawal by Subject|0|||
144439274|NCT02789176|520812766|FG001|Overall Study|Withdrawal by Subject|0|||
144439275|NCT02789176|520812767|FG002|Overall Study|Withdrawal by Subject|1|||
144439276|NCT02789176|520812768|FG003|Overall Study|Withdrawal by Subject|0|||
144439277|NCT02789176|520812765|FG000|Overall Study|Lost to Follow-up|8|||
144439278|NCT02789176|520812766|FG001|Overall Study|Lost to Follow-up|2|||
144439279|NCT02789176|520812767|FG002|Overall Study|Lost to Follow-up|6|||
144439280|NCT02789176|520812768|FG003|Overall Study|Lost to Follow-up|1|||
144439281|NCT00596011|520812770|FG000|Overall Study|Withdrawal by Subject|2|||
144439282|NCT00596011|520812771|FG001|Overall Study|Withdrawal by Subject|3|||
144439283|NCT00596011|520812770|FG000|Overall Study|Adverse Event|11|||
144439284|NCT00596011|520812771|FG001|Overall Study|Adverse Event|7|||
144439285|NCT01944059|520812772|FG000|Overall Study|Lost to Follow-up|1|||
144190229|NCT03123783|519889448|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
144190230|NCT03123783|519889449|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
144190231|NCT03123783|519889443|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
144190232|NCT03123783|519889444|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
144439286|NCT01944059|520812772|FG000|Overall Study|Physician Decision|3|||
144439287|NCT01944059|520812772|FG000|Overall Study|Withdrawal by Subject|1|||
144439288|NCT01944059|520812772|FG000|Overall Study|Adverse Event|2|||
144190233|NCT03123783|519889445|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
144190234|NCT03123783|519889446|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
144190235|NCT03123783|519889447|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
144190236|NCT03123783|519889448|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
144190237|NCT03123783|519889449|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
144190238|NCT03123783|519889443|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
144190239|NCT03123783|519889444|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
144190240|NCT03123783|519889445|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
144190241|NCT03123783|519889446|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
144190242|NCT03123783|519889447|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
144190243|NCT03123783|519889448|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
144190244|NCT03123783|519889449|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
144190245|NCT03183141|519889454|FG000|Overall Study|Withdrawal by Subject|2|||
144190246|NCT03183141|519889455|FG001|Overall Study|Withdrawal by Subject|4|||
144190247|NCT03183141|519889454|FG000|Overall Study|Death|0|||
144190248|NCT03183141|519889455|FG001|Overall Study|Death|8|||
144190249|NCT02756637|519889456|FG000|Overall Study|Not eligible for initial SWOG study|10|||
144190250|NCT02756637|519889457|FG001|Overall Study|Not eligible for initial SWOG study|10|||
144190251|NCT02756637|519889456|FG000|Overall Study|No available NLR value|44|||
144190252|NCT02756637|519889457|FG001|Overall Study|No available NLR value|44|||
144190253|NCT02756637|519889456|FG000|Overall Study|Did not complete curative therapy|33|||
144190254|NCT02756637|519889457|FG001|Overall Study|Did not complete curative therapy|0|||
144190255|NCT01507090|519889458|FG000|Overall Study|incomplete dataset|18|||
144190256|NCT01619579|519891317|FG000|Overall Study|Withdrawal by Subject|0|||
144190257|NCT01619579|519891318|FG001|Overall Study|Withdrawal by Subject|3|||
144190258|NCT02012452|519891320|FG000|Overall Study|Lost to Follow-up|2|||
144190259|NCT02012452|519891321|FG001|Overall Study|Lost to Follow-up|1|||
144190260|NCT02012452|519891320|FG000|Overall Study|Withdrawal by Subject|4|||
144190261|NCT02012452|519891321|FG001|Overall Study|Withdrawal by Subject|0|||
144190262|NCT02190279|519891322|FG000|Overall Study|Withdrawal consent|1|||
144190263|NCT02190279|519891323|FG001|Overall Study|Withdrawal consent|0|||
144190264|NCT02190279|519891324|FG002|Overall Study|Withdrawal consent|1|||
144190265|NCT02190279|519891322|FG000|Overall Study|Lost to Follow-up|2|||
144190266|NCT02190279|519891323|FG001|Overall Study|Lost to Follow-up|0|||
144190267|NCT02190279|519891324|FG002|Overall Study|Lost to Follow-up|0|||
144190268|NCT02190279|519891322|FG000|Overall Study|Refused further treatment|0|||
144190269|NCT02190279|519891323|FG001|Overall Study|Refused further treatment|0|||
144190270|NCT02190279|519891324|FG002|Overall Study|Refused further treatment|1|||
144190271|NCT02190279|519891322|FG000|Overall Study|Screening failure|0|||
144190272|NCT02190279|519891323|FG001|Overall Study|Screening failure|0|||
144190273|NCT02190279|519891324|FG002|Overall Study|Screening failure|1|||
144190274|NCT01316419|519891325|FG000|Overall Study|Not treated|103|||
144439289|NCT02365636|520812782|FG000|Overall Study|Adverse Event|3|||
144439290|NCT02365636|520812783|FG001|Overall Study|Adverse Event|3|||
144439291|NCT02365636|520812784|FG002|Overall Study|Adverse Event|2|||
144439292|NCT02365636|520812782|FG000|Overall Study|Protocol Violation|1|||
144439293|NCT02365636|520812783|FG001|Overall Study|Protocol Violation|4|||
144439294|NCT02365636|520812784|FG002|Overall Study|Protocol Violation|0|||
144439295|NCT02365636|520812782|FG000|Overall Study|Lost to Follow-up|0|||
144439296|NCT02365636|520812783|FG001|Overall Study|Lost to Follow-up|0|||
144439297|NCT02365636|520812784|FG002|Overall Study|Lost to Follow-up|1|||
144439298|NCT02365636|520812782|FG000|Overall Study|Other|2|||
144439299|NCT02365636|520812783|FG001|Overall Study|Other|0|||
144439300|NCT02365636|520812784|FG002|Overall Study|Other|0|||
144439301|NCT00355238|520812785|FG000|Overall Study|Adverse event unrelated to study drug|2|||
144439302|NCT00355238|520812786|FG001|Overall Study|Adverse event unrelated to study drug|2|||
144604811|NCT01241552|521415835|FG001|Overall Study|Death|30|||
144604812|NCT01241552|521415836|FG002|Overall Study|Death|20|||
144439303|NCT00355238|520812787|FG002|Overall Study|Adverse event unrelated to study drug|0|||
144439304|NCT00355238|520812788|FG003|Overall Study|Adverse event unrelated to study drug|1|||
144604813|NCT01241552|521415837|FG003|Overall Study|Death|25|||
144190275|NCT01316419|519891325|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
144439305|NCT00355238|520812785|FG000|Overall Study|Death|1|||
144439306|NCT00355238|520812786|FG001|Overall Study|Death|0|||
144190276|NCT01316419|519891325|FG000|Overall Study|Lost to Follow-up|19|||
144190277|NCT00983918|519891330|FG000|Overall Study|conversion to open cholecystectomy|0|||
144190278|NCT00983918|519891331|FG001|Overall Study|conversion to open cholecystectomy|2|||
144439307|NCT00355238|520812787|FG002|Overall Study|Death|0|||
144439308|NCT00355238|520812788|FG003|Overall Study|Death|0|||
144439309|NCT00355238|520812785|FG000|Overall Study|Disease progression|37|||
144439310|NCT00355238|520812786|FG001|Overall Study|Disease progression|36|||
144439311|NCT00355238|520812787|FG002|Overall Study|Disease progression|16|||
144604814|NCT01241552|521415834|FG000|Overall Study|Adverse Event|1|||
144190279|NCT00983918|519891332|FG002|Overall Study|conversion to open cholecystectomy|2|||
144190280|NCT00983918|519891333|FG003|Overall Study|conversion to open cholecystectomy|2|||
144190281|NCT00986570|519891350|FG000|Overall Study|Lost to Follow-up|6|||
144190282|NCT00986570|519891350|FG000|Overall Study|Potential bias for objective assessment|1|||
144190283|NCT05212883|519891351|FG000|Overall Study|Invalid test result|125|||
144190284|NCT03170869|519891354|FG000|Overall Study|Protocol Violation|5|||
144190285|NCT03170869|519891354|FG000|Overall Study|Early study termination|3|||
144190286|NCT01501110|519891355|FG000|Overall Study|Death|0|||
144190287|NCT01501110|519891356|FG001|Overall Study|Death|1|||
144190288|NCT01439724|519891357|FG000|Overall Study|missing consultation|9|||
144190289|NCT01439724|519891358|FG001|Overall Study|missing consultation|8|||
144190290|NCT00271024|519891360|FG000|Overall Study|Lost Interest|3|||
144190291|NCT00271024|519891361|FG001|Overall Study|Lost Interest|4|||
144190292|NCT00271024|519891362|FG002|Overall Study|Lost Interest|2|||
144190293|NCT00271024|519891363|FG003|Overall Study|Lost Interest|3|||
144190294|NCT00271024|519891360|FG000|Overall Study|Unknown/Unspecified|11|||
144190295|NCT00271024|519891361|FG001|Overall Study|Unknown/Unspecified|11|||
144190296|NCT00271024|519891362|FG002|Overall Study|Unknown/Unspecified|8|||
144190297|NCT00271024|519891363|FG003|Overall Study|Unknown/Unspecified|4|||
144190298|NCT00271024|519891360|FG000|Overall Study|Protocol Violation|1|||
144190299|NCT00271024|519891361|FG001|Overall Study|Protocol Violation|6|||
144190300|NCT00271024|519891362|FG002|Overall Study|Protocol Violation|5|||
144190301|NCT00271024|519891363|FG003|Overall Study|Protocol Violation|11|||
144190302|NCT00271024|519891360|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
144190303|NCT00271024|519891361|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
144190304|NCT00271024|519891362|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
144190305|NCT00271024|519891363|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
144190306|NCT00271024|519891360|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
144190307|NCT00271024|519891361|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
144190308|NCT00271024|519891362|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
144190309|NCT00271024|519891363|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
144190310|NCT01719562|519891370|FG000|Overall Study|Lost to Follow-up|1|||
144190311|NCT01719562|519891371|FG001|Overall Study|Lost to Follow-up|0|||
144190312|NCT01719562|519891370|FG000|Overall Study|Death|1|||
144190313|NCT01719562|519891371|FG001|Overall Study|Death|0|||
144190314|NCT01719562|519891370|FG000|Overall Study|New cancer diagnosis|1|||
144190315|NCT01719562|519891371|FG001|Overall Study|New cancer diagnosis|0|||
144190316|NCT02013531|519891372|FG000|Overall Study|Lost to Follow-up|3|||
144190317|NCT02013531|519891372|FG000|Overall Study|Met Withdrawal Criteria|1|||
144190318|NCT02013531|519891372|FG000|Overall Study|Withdrawal by Subject|1|||
144190319|NCT03877926|519891373|FG000|Overall Study|Adverse Event|1|||
144190320|NCT03877926|519891374|FG001|Overall Study|Adverse Event|0|||
144190321|NCT03877926|519891375|FG002|Overall Study|Adverse Event|0|||
144190322|NCT03877926|519891376|FG003|Overall Study|Adverse Event|0|||
144190323|NCT03877926|519891373|FG000|Overall Study|Death|2|||
144190324|NCT03877926|519891374|FG001|Overall Study|Death|2|||
144190325|NCT03877926|519891375|FG002|Overall Study|Death|2|||
144190326|NCT03877926|519891376|FG003|Overall Study|Death|0|||
144190327|NCT03877926|519891373|FG000|Overall Study|Lost to Follow-up|41|||
144190328|NCT03877926|519891374|FG001|Overall Study|Lost to Follow-up|52|||
144190329|NCT03877926|519891375|FG002|Overall Study|Lost to Follow-up|45|||
144190330|NCT03877926|519891376|FG003|Overall Study|Lost to Follow-up|17|||
144190331|NCT03877926|519891373|FG000|Overall Study|Physician Decision|2|||
144190332|NCT03877926|519891374|FG001|Overall Study|Physician Decision|0|||
144253525|NCT00162097|520128109|FG003|Overall Study|Participant no longer met study criteria|1|||
144604815|NCT01241552|521415835|FG001|Overall Study|Adverse Event|1|||
144604816|NCT01241552|521415836|FG002|Overall Study|Adverse Event|0|||
144604817|NCT01241552|521415837|FG003|Overall Study|Adverse Event|0|||
144604818|NCT01241552|521415834|FG000|Overall Study|Technical Problems|2|||
144604819|NCT01241552|521415835|FG001|Overall Study|Technical Problems|0|||
144604820|NCT01241552|521415836|FG002|Overall Study|Technical Problems|2|||
144604821|NCT01241552|521415837|FG003|Overall Study|Technical Problems|2|||
144604822|NCT01241552|521415834|FG000|Overall Study|Progressive Disease|0|||
144190333|NCT03877926|519891375|FG002|Overall Study|Physician Decision|2|||
144190334|NCT03877926|519891376|FG003|Overall Study|Physician Decision|0|||
144439312|NCT00355238|520812788|FG003|Overall Study|Disease progression|11|||
144190335|NCT03877926|519891373|FG000|Overall Study|Withdrawal by Subject|18|||
144190336|NCT03877926|519891374|FG001|Overall Study|Withdrawal by Subject|21|||
144190337|NCT03877926|519891375|FG002|Overall Study|Withdrawal by Subject|12|||
144190338|NCT03877926|519891376|FG003|Overall Study|Withdrawal by Subject|4|||
144190339|NCT03877926|519891373|FG000|Overall Study|Other - Various|4|||
144190340|NCT03877926|519891374|FG001|Overall Study|Other - Various|1|||
144190341|NCT03877926|519891375|FG002|Overall Study|Other - Various|1|||
144190342|NCT03877926|519891376|FG003|Overall Study|Other - Various|0|||
144190343|NCT03877926|519891373|FG000|Overall Study|Not Treated|3|||
144190344|NCT03877926|519891374|FG001|Overall Study|Not Treated|1|||
144190345|NCT03877926|519891375|FG002|Overall Study|Not Treated|1|||
144190346|NCT03877926|519891376|FG003|Overall Study|Not Treated|0|||
144190347|NCT00537199|519891382|FG000|Overall Study|Study Terminated|1|||
144190348|NCT01684878|519891390|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
144190349|NCT01684878|519891391|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
144190350|NCT01684878|519891392|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
144190351|NCT01684878|519891393|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
144190352|NCT01684878|519891390|FG000|Part 1: Safety Run in Phase|Death|15|||
144190353|NCT01684878|519891391|FG001|Part 1: Safety Run in Phase|Death|20|||
144190354|NCT01684878|519891392|FG002|Part 1: Safety Run in Phase|Death|0|||
144190355|NCT01684878|519891393|FG003|Part 1: Safety Run in Phase|Death|0|||
144190356|NCT01684878|519891390|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
144190357|NCT01684878|519891391|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
144190358|NCT01684878|519891392|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
144190359|NCT01684878|519891393|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
144190360|NCT01684878|519891390|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
144190361|NCT01684878|519891391|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
144190362|NCT01684878|519891392|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
144190363|NCT01684878|519891393|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
144190364|NCT01684878|519891390|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
144190365|NCT01684878|519891391|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
144190366|NCT01684878|519891392|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
144190367|NCT01684878|519891393|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
144190368|NCT01684878|519891390|FG000|Part 2: Randomized Phase|Death|0|||
144190369|NCT01684878|519891391|FG001|Part 2: Randomized Phase|Death|0|||
144190370|NCT01684878|519891392|FG002|Part 2: Randomized Phase|Death|62|||
144190371|NCT01684878|519891393|FG003|Part 2: Randomized Phase|Death|68|||
144253526|NCT01204918|520128110|FG000|Overall Study|Withdrawal by Subject|4|||
144253527|NCT01204918|520128111|FG001|Overall Study|Withdrawal by Subject|10|||
144439313|NCT00355238|520812785|FG000|Overall Study|Study drug toxicity|11|||
144439314|NCT00355238|520812786|FG001|Overall Study|Study drug toxicity|7|||
144439315|NCT00355238|520812787|FG002|Overall Study|Study drug toxicity|5|||
144439316|NCT00355238|520812788|FG003|Overall Study|Study drug toxicity|2|||
144439317|NCT00355238|520812785|FG000|Overall Study|Participant withdrew consent|3|||
144439318|NCT00355238|520812786|FG001|Overall Study|Participant withdrew consent|1|||
144439319|NCT00355238|520812787|FG002|Overall Study|Participant withdrew consent|0|||
144439320|NCT00355238|520812788|FG003|Overall Study|Participant withdrew consent|0|||
144439321|NCT00355238|520812785|FG000|Overall Study|Participant request to discontinue study treatment|1|||
144439322|NCT00355238|520812786|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144439323|NCT00355238|520812787|FG002|Overall Study|Participant request to discontinue study treatment|1|||
144439324|NCT00355238|520812788|FG003|Overall Study|Participant request to discontinue study treatment|0|||
144439325|NCT01454934|520812789|FG000|Overall Study|Clinical progression|28|||
144439326|NCT01454934|520812790|FG001|Overall Study|Clinical progression|25|||
144439327|NCT01454934|520812789|FG000|Overall Study|Other|6|||
144439328|NCT01454934|520812790|FG001|Overall Study|Other|17|||
144439329|NCT01454934|520812789|FG000|Overall Study|Adverse Event|28|||
144439330|NCT01454934|520812790|FG001|Overall Study|Adverse Event|24|||
144439331|NCT01454934|520812789|FG000|Overall Study|Withdrawn consent|2|||
144439332|NCT01454934|520812790|FG001|Overall Study|Withdrawn consent|5|||
144439333|NCT01454934|520812789|FG000|Overall Study|Withdrawal by Subject|11|||
144439334|NCT01454934|520812790|FG001|Overall Study|Withdrawal by Subject|15|||
144439335|NCT01454934|520812789|FG000|Overall Study|Disease progression|194|||
144439336|NCT01454934|520812790|FG001|Overall Study|Disease progression|181|||
144439337|NCT01454934|520812789|FG000|Overall Study|Lost to Follow-up|0|||
144439338|NCT01454934|520812790|FG001|Overall Study|Lost to Follow-up|1|||
144439339|NCT01454934|520812789|FG000|Overall Study|Not treated|1|||
144439340|NCT01454934|520812790|FG001|Overall Study|Not treated|2|||
144439341|NCT00430092|520812793|FG000|Overall Study|Adverse Event|0|||
144439342|NCT00430092|520812794|FG001|Overall Study|Adverse Event|0|||
144439343|NCT00430092|520812795|FG002|Overall Study|Adverse Event|1|||
144439344|NCT00430092|520812793|FG000|Overall Study|Lack of Efficacy|5|||
144439345|NCT00430092|520812794|FG001|Overall Study|Lack of Efficacy|2|||
144439346|NCT00430092|520812795|FG002|Overall Study|Lack of Efficacy|54|||
144439347|NCT00430092|520812793|FG000|Overall Study|Lost to Follow-up|1|||
144439348|NCT00430092|520812794|FG001|Overall Study|Lost to Follow-up|0|||
144190372|NCT01684878|519891390|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
144190373|NCT01684878|519891391|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
144190374|NCT01684878|519891392|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
144190375|NCT01684878|519891393|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
144190376|NCT01684878|519891390|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
144190377|NCT01684878|519891391|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
144190378|NCT01684878|519891392|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
144253528|NCT01204918|520128112|FG002|Overall Study|Withdrawal by Subject|5|||
144439349|NCT00430092|520812795|FG002|Overall Study|Lost to Follow-up|0|||
144439350|NCT00430092|520812793|FG000|Overall Study|Protocol Violation|0|||
144439351|NCT00430092|520812794|FG001|Overall Study|Protocol Violation|1|||
144439352|NCT00430092|520812795|FG002|Overall Study|Protocol Violation|1|||
144253529|NCT01280682|520128115|FG000|Overall Study|Lost to Follow-up|0|||
144253530|NCT01280682|520128116|FG001|Overall Study|Lost to Follow-up|6|||
144253531|NCT01280682|520128115|FG000|Overall Study|Withdrawal by Subject|0|||
144439353|NCT00430092|520812793|FG000|Overall Study|Withdrawal by Subject|0|||
144439354|NCT00430092|520812794|FG001|Overall Study|Withdrawal by Subject|1|||
144439355|NCT00430092|520812795|FG002|Overall Study|Withdrawal by Subject|1|||
144439356|NCT05923229|520812802|FG000|Overall Study|Withdrawal by Subject|3|||
144439357|NCT05923229|520812803|FG001|Overall Study|Withdrawal by Subject|0|||
144439358|NCT05923229|520812802|FG000|Overall Study|Health related|2|||
144439359|NCT05923229|520812803|FG001|Overall Study|Health related|1|||
144439360|NCT03064126|520812804|FG000|Overall Study|Death|40|||
144439361|NCT03064126|520812805|FG001|Overall Study|Death|16|||
144439362|NCT03064126|520812806|FG002|Overall Study|Death|4|||
144439363|NCT03064126|520812807|FG003|Overall Study|Death|2|||
144439364|NCT03064126|520812804|FG000|Overall Study|Withdrawal by Subject|17|||
144439365|NCT03064126|520812805|FG001|Overall Study|Withdrawal by Subject|9|||
144439366|NCT03064126|520812806|FG002|Overall Study|Withdrawal by Subject|0|||
144439367|NCT03064126|520812807|FG003|Overall Study|Withdrawal by Subject|2|||
144439368|NCT03064126|520812804|FG000|Overall Study|Lost to Follow-up|7|||
144439369|NCT03064126|520812805|FG001|Overall Study|Lost to Follow-up|3|||
144439370|NCT03064126|520812806|FG002|Overall Study|Lost to Follow-up|0|||
144439371|NCT03064126|520812807|FG003|Overall Study|Lost to Follow-up|0|||
144439372|NCT03064126|520812804|FG000|Overall Study|Adverse Event|2|||
144439373|NCT03064126|520812805|FG001|Overall Study|Adverse Event|0|||
144439374|NCT03064126|520812806|FG002|Overall Study|Adverse Event|0|||
144439375|NCT03064126|520812807|FG003|Overall Study|Adverse Event|0|||
144439376|NCT03064126|520812804|FG000|Overall Study|Physician Decision|3|||
144439377|NCT03064126|520812805|FG001|Overall Study|Physician Decision|0|||
144439378|NCT03064126|520812806|FG002|Overall Study|Physician Decision|0|||
144439379|NCT03064126|520812807|FG003|Overall Study|Physician Decision|0|||
144439380|NCT03064126|520812804|FG000|Overall Study|Other reason for early termination|3|||
144439381|NCT03064126|520812805|FG001|Overall Study|Other reason for early termination|2|||
144439382|NCT03064126|520812806|FG002|Overall Study|Other reason for early termination|0|||
144439383|NCT03064126|520812807|FG003|Overall Study|Other reason for early termination|0|||
144439384|NCT03064126|520812804|FG000|Overall Study|Missed Visit|3|||
144439385|NCT03064126|520812805|FG001|Overall Study|Missed Visit|1|||
144439386|NCT03064126|520812806|FG002|Overall Study|Missed Visit|0|||
144190379|NCT01684878|519891393|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
144190380|NCT01435031|519891397|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
144190381|NCT01435031|519891397|FG000|ITT at 1 Month|Death|1|||
144190382|NCT01435031|519891397|FG000|ITT at 1 Month|Lost to Follow-up|4|||
144190383|NCT01435031|519891397|FG000|ITT at 6 Months|Death|2|||
144190384|NCT01435031|519891397|FG000|ITT at 6 Months|Lost to Follow-up|3|||
144190385|NCT01435031|519891397|FG000|ITT at 1 Year|Death|1|||
144190386|NCT01435031|519891397|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
144190387|NCT01435031|519891397|FG000|ITT at 1 Year|Lost to Follow-up|6|||
144439387|NCT03064126|520812807|FG003|Overall Study|Missed Visit|0|||
144439388|NCT05288556|520812811|FG000|Overall Study|Protocol Violation|1|||
144190388|NCT01435031|519891397|FG000|ITT at 2 Years|Death|7|||
144190389|NCT01435031|519891397|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
144253532|NCT01280682|520128116|FG001|Overall Study|Withdrawal by Subject|7|||
144253533|NCT02007278|520128117|FG000|Overall Study|Failure to comply with an eligibility|0|||
144253534|NCT02007278|520128118|FG001|Overall Study|Failure to comply with an eligibility|1|||
144253535|NCT02007278|520128117|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
144253536|NCT02007278|520128118|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
144253537|NCT02007278|520128117|FG000|Overall Study|Incorrect medication administration|1|||
144253538|NCT02007278|520128118|FG001|Overall Study|Incorrect medication administration|0|||
144253539|NCT02007278|520128117|FG000|Overall Study|Mis-randomization|1|||
144253540|NCT02007278|520128118|FG001|Overall Study|Mis-randomization|1|||
144253541|NCT03230838|520128120|FG000|Overall Study|Withdrawal by Subject|3|||
144439389|NCT05288556|520812811|FG000|Overall Study|Withdrawal by Subject|1|||
144439390|NCT02465528|520812812|FG000|Overall Study|Progressive disease|0|||
144253542|NCT03230838|520128121|FG001|Overall Study|Withdrawal by Subject|0|||
144439391|NCT02465528|520812813|FG001|Overall Study|Progressive disease|2|||
144439392|NCT02465528|520812814|FG002|Overall Study|Progressive disease|9|||
144439393|NCT02465528|520812815|FG003|Overall Study|Progressive disease|4|||
144530874|NCT04308681|521146323|FG007|OTE - 26 Weeks|Adverse Event|0|||
144190390|NCT01435031|519891397|FG000|ITT at 2 Years|Lost to Follow-up|4|||
144190391|NCT01435031|519891397|FG000|ITT at 3 Years|Death|5|||
144190392|NCT01435031|519891397|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
144253543|NCT03230838|520128120|FG000|Overall Study|Temperature excursion|1|||
144604823|NCT01241552|521415835|FG001|Overall Study|Progressive Disease|0|||
144253544|NCT03230838|520128121|FG001|Overall Study|Temperature excursion|0|||
144439394|NCT02465528|520812812|FG000|Overall Study|Study terminated by sponsor|1|||
144439395|NCT02465528|520812813|FG001|Overall Study|Study terminated by sponsor|2|||
144439396|NCT02465528|520812814|FG002|Overall Study|Study terminated by sponsor|0|||
144439397|NCT02465528|520812815|FG003|Overall Study|Study terminated by sponsor|0|||
144439398|NCT02465528|520812812|FG000|Overall Study|Withdrawal by Subject|0|||
144439399|NCT02465528|520812813|FG001|Overall Study|Withdrawal by Subject|0|||
144439400|NCT02465528|520812814|FG002|Overall Study|Withdrawal by Subject|2|||
144439401|NCT02465528|520812815|FG003|Overall Study|Withdrawal by Subject|0|||
144439402|NCT02465528|520812812|FG000|Overall Study|Adverse Event|0|||
144439403|NCT02465528|520812813|FG001|Overall Study|Adverse Event|0|||
144439404|NCT02465528|520812814|FG002|Overall Study|Adverse Event|0|||
144439405|NCT02465528|520812815|FG003|Overall Study|Adverse Event|1|||
144439406|NCT02465528|520812812|FG000|Overall Study|Physician Decision|0|||
144439407|NCT02465528|520812813|FG001|Overall Study|Physician Decision|0|||
144439408|NCT02465528|520812814|FG002|Overall Study|Physician Decision|1|||
144439409|NCT02465528|520812815|FG003|Overall Study|Physician Decision|0|||
144439410|NCT01428193|520812816|FG000|Overall Study|Physician Decision|1|||
144439411|NCT01428193|520812816|FG000|Overall Study|Elevated screening liver enzymes|1|||
144439412|NCT03762083|520812817|FG000|Overall Study|Withdrawal by Subject|2|||
144439413|NCT03762083|520812817|FG000|Overall Study|Physician Decision|1|||
144439414|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
144439415|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
144439416|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Graft loss|1|||
144439417|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Graft loss|2|||
144439418|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Death|5|||
144439419|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Death|3|||
144439420|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
144439421|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
144439422|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
144439423|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
144439424|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
144439425|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
144439426|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
144439427|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
144439428|NCT00378014|520812818|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
144439429|NCT00378014|520812819|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
144439430|NCT00378014|520812818|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
144439431|NCT00378014|520812819|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
144439432|NCT00378014|520812818|FG000|Extension (Month 12 to Month 59)|Death|1|||
144439433|NCT00378014|520812819|FG001|Extension (Month 12 to Month 59)|Death|2|||
144439434|NCT00378014|520812818|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
144439435|NCT00378014|520812819|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
144439436|NCT00378014|520812818|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
144439437|NCT00378014|520812819|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
144439438|NCT00378014|520812818|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
144439439|NCT00378014|520812819|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
144439440|NCT00378014|520812818|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
144439441|NCT00378014|520812819|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
144439442|NCT00727714|520812824|FG000|Overall Study|Lost to Follow-up|2|||
144439443|NCT04382911|520812826|FG000|Overall Study|unable to be imaged prior to surgery|2|||
144439444|NCT04049760|520812832|FG000|Overall Study|Withdrawal by Subject|1|||
144439445|NCT04697628|520812833|FG000|Overall Study|Withdrawal by Subject|17|||
144439446|NCT04697628|520812834|FG001|Overall Study|Withdrawal by Subject|23|||
144439447|NCT04697628|520812833|FG000|Overall Study|Lost to Follow-up|0|||
144439448|NCT04697628|520812834|FG001|Overall Study|Lost to Follow-up|4|||
144439449|NCT04697628|520812833|FG000|Overall Study|On-going in study|122|||
144439450|NCT04697628|520812834|FG001|Overall Study|On-going in study|91|||
144439451|NCT00974571|520812835|FG000|Overall Study|Adverse Event|31|||
144439452|NCT00974571|520812836|FG001|Overall Study|Adverse Event|4|||
144439453|NCT00974571|520812837|FG002|Overall Study|Adverse Event|27|||
144439454|NCT00974571|520812835|FG000|Overall Study|Lack of Efficacy|3|||
144439455|NCT00974571|520812836|FG001|Overall Study|Lack of Efficacy|2|||
144439456|NCT00974571|520812837|FG002|Overall Study|Lack of Efficacy|9|||
144439457|NCT00974571|520812835|FG000|Overall Study|Lost to Follow-up|2|||
144439458|NCT00974571|520812836|FG001|Overall Study|Lost to Follow-up|1|||
144439459|NCT00974571|520812837|FG002|Overall Study|Lost to Follow-up|2|||
144439460|NCT00974571|520812835|FG000|Overall Study|Protocol Violation|13|||
144439461|NCT00974571|520812836|FG001|Overall Study|Protocol Violation|4|||
144439462|NCT00974571|520812837|FG002|Overall Study|Protocol Violation|18|||
144439463|NCT00974571|520812835|FG000|Overall Study|Withdrawal by Subject|14|||
144439464|NCT00974571|520812836|FG001|Overall Study|Withdrawal by Subject|5|||
144439465|NCT00974571|520812837|FG002|Overall Study|Withdrawal by Subject|16|||
144439466|NCT00974571|520812835|FG000|Overall Study|Patient Moved|1|||
144439467|NCT00974571|520812836|FG001|Overall Study|Patient Moved|0|||
144439468|NCT00974571|520812837|FG002|Overall Study|Patient Moved|1|||
144439469|NCT00974571|520812835|FG000|Overall Study|Other|4|||
144439470|NCT00974571|520812836|FG001|Overall Study|Other|0|||
144439471|NCT00974571|520812837|FG002|Overall Study|Other|10|||
144439472|NCT00393939|520812838|FG000|Overall Study|Protocol Violation|1|||
144439473|NCT00393939|520812839|FG001|Overall Study|Protocol Violation|1|||
144439474|NCT00393939|520812838|FG000|Overall Study|Lost to Follow-up|2|||
144439475|NCT00393939|520812839|FG001|Overall Study|Lost to Follow-up|4|||
144439476|NCT00393939|520812838|FG000|Overall Study|Death|10|||
144439477|NCT00393939|520812839|FG001|Overall Study|Death|4|||
144439478|NCT00393939|520812838|FG000|Overall Study|Sponsor|5|||
144439479|NCT00393939|520812839|FG001|Overall Study|Sponsor|13|||
144439480|NCT00393939|520812838|FG000|Overall Study|Objective progression or relapse|239|||
144439481|NCT00393939|520812839|FG001|Overall Study|Objective progression or relapse|223|||
144439482|NCT00393939|520812838|FG000|Overall Study|Withdrawal by Subject|2|||
144439483|NCT00393939|520812839|FG001|Overall Study|Withdrawal by Subject|7|||
144439484|NCT00393939|520812838|FG000|Overall Study|Other|37|||
144439485|NCT00393939|520812839|FG001|Overall Study|Other|45|||
144190393|NCT01435031|519891397|FG000|ITT at 3 Years|Lost to Follow-up|4|||
144190394|NCT01435031|519891397|FG000|ITT at 4 Years|Death|4|||
144190395|NCT01435031|519891397|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
144190396|NCT01435031|519891397|FG000|ITT at 4 Years|Lost to Follow-up|1|||
144190397|NCT02927834|519891398|FG000|Overall Study|Lost to Follow-up|1|||
144190398|NCT02927834|519891399|FG001|Overall Study|Lost to Follow-up|2|||
144190399|NCT02927834|519891400|FG002|Overall Study|Lost to Follow-up|2|||
144190400|NCT02492841|519891401|FG000|Overall Study|Lost to Follow-up|34|||
144190401|NCT02492841|519891402|FG001|Overall Study|Lost to Follow-up|31|||
144190402|NCT02492841|519891403|FG002|Overall Study|Lost to Follow-up|35|||
144190403|NCT01876368|519891406|FG000|Overall Study|Adverse Event|2|||
144190404|NCT01876368|519891407|FG001|Overall Study|Adverse Event|5|||
144190405|NCT01876368|519891406|FG000|Overall Study|Lack of Efficacy|1|||
144190406|NCT01876368|519891407|FG001|Overall Study|Lack of Efficacy|0|||
144190407|NCT01876368|519891406|FG000|Overall Study|Lost to Follow-up|0|||
144190408|NCT01876368|519891407|FG001|Overall Study|Lost to Follow-up|1|||
144439486|NCT02385799|520812840|FG000|Overall Study|Lost to Follow-up|1|||
144439487|NCT02385799|520812841|FG001|Overall Study|Lost to Follow-up|2|||
144190409|NCT01876368|519891406|FG000|Overall Study|Non-compliance with study treatment|0|||
144190410|NCT01876368|519891407|FG001|Overall Study|Non-compliance with study treatment|1|||
144190411|NCT01876368|519891406|FG000|Overall Study|Physician Decision|0|||
144190412|NCT01876368|519891407|FG001|Overall Study|Physician Decision|2|||
144190413|NCT01876368|519891406|FG000|Overall Study|Protocol deviation|3|||
144190414|NCT01876368|519891407|FG001|Overall Study|Protocol deviation|3|||
144190415|NCT01876368|519891406|FG000|Overall Study|Subject/guardian decision|3|||
144190416|NCT01876368|519891407|FG001|Overall Study|Subject/guardian decision|1|||
144190417|NCT02563769|519891410|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
144190418|NCT02563769|519891411|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
144190419|NCT02563769|519891412|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
144190420|NCT04798482|519891418|FG000|Overall Study|Physician Decision|1|||
144190421|NCT04798482|519891418|FG000|Overall Study|Lost eligibility|1|||
144190422|NCT01930175|519891419|FG000|Core Study|Lost to Follow-up|0|||
144190423|NCT01930175|519891420|FG001|Core Study|Lost to Follow-up|1|||
144190424|NCT01930175|519891421|FG002|Core Study|Lost to Follow-up|0|||
144190425|NCT01930175|519891419|FG000|Core Study|Adverse Event|0|||
144190426|NCT01930175|519891420|FG001|Core Study|Adverse Event|0|||
144190427|NCT01930175|519891421|FG002|Core Study|Adverse Event|1|||
144190428|NCT02820740|519891422|FG000|Overall Study|Did not have procedure|2|||
144190429|NCT00605917|519891423|FG000|Overall Study|Protocol Violation|79|||
144190430|NCT00890552|519891424|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
144190431|NCT00890552|519891424|FG000|On-treatment|Early prog disease/ death|10|||
144190432|NCT04965389|519891426|FG000|Overall Study|Other reasons|1|||
144190433|NCT04965389|519891427|FG001|Overall Study|Other reasons|0|||
144190434|NCT04965389|519891428|FG002|Overall Study|Other reasons|0|||
144190435|NCT04965389|519891429|FG003|Overall Study|Other reasons|0|||
144190436|NCT04965389|519891426|FG000|Overall Study|Participant withdrew consent|0|||
144190437|NCT04965389|519891427|FG001|Overall Study|Participant withdrew consent|1|||
144190438|NCT04965389|519891428|FG002|Overall Study|Participant withdrew consent|0|||
144190439|NCT04965389|519891429|FG003|Overall Study|Participant withdrew consent|0|||
144190440|NCT04965389|519891426|FG000|Overall Study|Poor/Non-compliance|0|||
144190441|NCT04965389|519891427|FG001|Overall Study|Poor/Non-compliance|1|||
144190442|NCT04965389|519891428|FG002|Overall Study|Poor/Non-compliance|0|||
144190443|NCT04965389|519891429|FG003|Overall Study|Poor/Non-compliance|0|||
144190444|NCT03903159|519891430|FG000|Overall Study|Discharged with Staff Approval|2|||
144190445|NCT03903159|519891430|FG000|Overall Study|Discharged at Staff Request|2|||
144190446|NCT03903159|519891430|FG000|Overall Study|Discharged Against Staff Advice|1|||
144190447|NCT00206102|519891436|FG000|Overall Study|Adverse Event|119|||
144190448|NCT00206102|519891437|FG001|Overall Study|Adverse Event|82|||
144190449|NCT00206102|519891436|FG000|Overall Study|Protocol Violation|0|||
144190450|NCT00206102|519891437|FG001|Overall Study|Protocol Violation|2|||
144190451|NCT00206102|519891436|FG000|Overall Study|Lack of therapeutic response|16|||
144439488|NCT02385799|520812840|FG000|Overall Study|Adverse Event|4|||
144439489|NCT02385799|520812841|FG001|Overall Study|Adverse Event|2|||
144439490|NCT02385799|520812840|FG000|Overall Study|Withdrawal by Subject|0|||
144190452|NCT00206102|519891437|FG001|Overall Study|Lack of therapeutic response|11|||
144190453|NCT00206102|519891436|FG000|Overall Study|Lost to Follow-up|95|||
144190454|NCT00206102|519891437|FG001|Overall Study|Lost to Follow-up|66|||
144190455|NCT00206102|519891436|FG000|Overall Study|Withdrawal by Subject|118|||
144190456|NCT00206102|519891437|FG001|Overall Study|Withdrawal by Subject|101|||
144190457|NCT00206102|519891436|FG000|Overall Study|Study-specific discontinuation criteria|18|||
144190458|NCT00206102|519891437|FG001|Overall Study|Study-specific discontinuation criteria|17|||
144190459|NCT00206102|519891436|FG000|Overall Study|None of those categories|42|||
144190460|NCT00206102|519891437|FG001|Overall Study|None of those categories|36|||
144190461|NCT04117945|519891438|FG000|Overall Study|Death|1|||
144190462|NCT04117945|519891439|FG001|Overall Study|Death|0|||
144190463|NCT04117945|519891438|FG000|Overall Study|Withdrawal by Subject|3|||
144190464|NCT04117945|519891439|FG001|Overall Study|Withdrawal by Subject|1|||
144190465|NCT04117945|519891438|FG000|Overall Study|Disease Progression|0|||
144439491|NCT02385799|520812841|FG001|Overall Study|Withdrawal by Subject|4|||
144190466|NCT04117945|519891439|FG001|Overall Study|Disease Progression|2|||
144190467|NCT04117945|519891438|FG000|Overall Study|Ineligible|8|||
144190468|NCT04117945|519891439|FG001|Overall Study|Ineligible|7|||
144190469|NCT00562120|519891445|FG000|First Intervention Period|Adverse Event|1|||
144190470|NCT00562120|519891446|FG001|First Intervention Period|Adverse Event|0|||
144190471|NCT00562120|519891447|FG002|First Intervention Period|Adverse Event|0|||
144190472|NCT00562120|519891448|FG003|First Intervention Period|Adverse Event|0|||
144190473|NCT00562120|519891445|FG000|First Intervention Period|Randomized but not Treated|1|||
144190474|NCT00562120|519891446|FG001|First Intervention Period|Randomized but not Treated|0|||
144190475|NCT00562120|519891447|FG002|First Intervention Period|Randomized but not Treated|0|||
144190476|NCT00562120|519891448|FG003|First Intervention Period|Randomized but not Treated|0|||
144190477|NCT02148445|519891449|FG000|Overall Study|Death|1|||
144190478|NCT02148445|519891450|FG001|Overall Study|Death|3|||
144190479|NCT03450629|519891451|FG000|Overall Study|Adverse Event|15|||
144190480|NCT03450629|519891452|FG001|Overall Study|Adverse Event|14|||
144190481|NCT03450629|519891451|FG000|Overall Study|Physician Decision|2|||
144190482|NCT03450629|519891452|FG001|Overall Study|Physician Decision|2|||
144190483|NCT03450629|519891451|FG000|Overall Study|Lack of Efficacy|2|||
144190484|NCT03450629|519891452|FG001|Overall Study|Lack of Efficacy|0|||
144190485|NCT03450629|519891451|FG000|Overall Study|Lost to Follow-up|4|||
144190486|NCT03450629|519891452|FG001|Overall Study|Lost to Follow-up|2|||
144190487|NCT03450629|519891451|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144190488|NCT03450629|519891452|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
144190489|NCT03450629|519891451|FG000|Overall Study|Non-Compliance With Study Drug|2|||
144190490|NCT03450629|519891452|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144190491|NCT03450629|519891451|FG000|Overall Study|Protocol Violation|11|||
144190492|NCT03450629|519891452|FG001|Overall Study|Protocol Violation|8|||
144190493|NCT03450629|519891451|FG000|Overall Study|Withdrawal by Subject|12|||
144190494|NCT03450629|519891452|FG001|Overall Study|Withdrawal by Subject|6|||
144190495|NCT04230876|519891453|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
144190496|NCT04230876|519891454|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
144190497|NCT02093923|519891456|FG000|Overall Study|Lost to Follow-up|0|||
144190498|NCT02093923|519891457|FG001|Overall Study|Lost to Follow-up|0|||
144190499|NCT02093923|519891458|FG002|Overall Study|Lost to Follow-up|0|||
144190500|NCT02093923|519891459|FG003|Overall Study|Lost to Follow-up|1|||
144190501|NCT02093923|519891460|FG004|Overall Study|Lost to Follow-up|0|||
144190502|NCT02093923|519891456|FG000|Overall Study|Screen failure after randomization|0|||
144190503|NCT02093923|519891457|FG001|Overall Study|Screen failure after randomization|0|||
144190504|NCT02093923|519891458|FG002|Overall Study|Screen failure after randomization|0|||
144190505|NCT02093923|519891459|FG003|Overall Study|Screen failure after randomization|1|||
144190506|NCT02093923|519891460|FG004|Overall Study|Screen failure after randomization|0|||
144190507|NCT03438006|519891461|FG000|Overall Study|Adverse Event|1|||
144190508|NCT03438006|519891461|FG000|Overall Study|Lost to Follow-up|67|||
144190509|NCT03438006|519891461|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
144190510|NCT03438006|519891461|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
144190511|NCT01662362|519891476|FG000|Overall Study|Lost to Follow-up|38|||
144439492|NCT00547703|520812842|FG000|Overall Study|Lost to Follow-up|1|||
144439493|NCT00547703|520812843|FG001|Overall Study|Lost to Follow-up|0|||
144439494|NCT02275481|520812844|FG000|Overall Study|Death|2|||
144439495|NCT02275481|520812845|FG001|Overall Study|Death|1|||
144439496|NCT02275481|520812844|FG000|Overall Study|Lost to Follow-up|2|||
144439497|NCT02275481|520812845|FG001|Overall Study|Lost to Follow-up|0|||
144439498|NCT02275481|520812844|FG000|Overall Study|Withdrawal by Subject|3|||
144190512|NCT03078478|519891477|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
144190513|NCT03078478|519891478|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
144439499|NCT02275481|520812845|FG001|Overall Study|Withdrawal by Subject|0|||
144439500|NCT02275481|520812844|FG000|Overall Study|all other reasons combined|2|||
144190514|NCT03078478|519891477|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
144190515|NCT03078478|519891478|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
144190516|NCT03078478|519891477|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
144190517|NCT03078478|519891478|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
144190518|NCT03078478|519891477|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
144190519|NCT03078478|519891478|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
144190520|NCT03078478|519891477|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
144190521|NCT03078478|519891478|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
144190522|NCT03078478|519891477|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
144190523|NCT03078478|519891478|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
144190524|NCT03078478|519891477|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
144190525|NCT03078478|519891478|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
144190526|NCT03078478|519891477|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
144190527|NCT03078478|519891478|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
144190528|NCT02792218|519891479|FG000|Overall Study|Patient/guardian decision|15|||
144190529|NCT02792218|519891480|FG001|Overall Study|Patient/guardian decision|42|||
144190530|NCT02792218|519891479|FG000|Overall Study|Adverse Event|15|||
144190531|NCT02792218|519891480|FG001|Overall Study|Adverse Event|14|||
144190532|NCT02792218|519891479|FG000|Overall Study|Lost to Follow-up|10|||
144190533|NCT02792218|519891480|FG001|Overall Study|Lost to Follow-up|5|||
144439501|NCT02275481|520812845|FG001|Overall Study|all other reasons combined|1|||
144439502|NCT02275481|520812844|FG000|Overall Study|Physician Decision|0|||
144439503|NCT02275481|520812845|FG001|Overall Study|Physician Decision|1|||
144439504|NCT01838642|520812847|FG000|Overall Study|Died on study|1|||
144439505|NCT01215227|520812851|FG000|Overall Study|Adverse Event|11|||
144439506|NCT01215227|520812852|FG001|Overall Study|Adverse Event|11|||
144439507|NCT01215227|520812853|FG002|Overall Study|Adverse Event|4|||
144439508|NCT01215227|520812854|FG003|Overall Study|Adverse Event|8|||
144439509|NCT01215227|520812855|FG004|Overall Study|Adverse Event|7|||
144439510|NCT01215227|520812856|FG005|Overall Study|Adverse Event|6|||
144439511|NCT01215227|520812851|FG000|Overall Study|Treatment Failure|8|||
144439512|NCT01215227|520812852|FG001|Overall Study|Treatment Failure|4|||
144439513|NCT01215227|520812853|FG002|Overall Study|Treatment Failure|1|||
144439514|NCT01215227|520812854|FG003|Overall Study|Treatment Failure|5|||
144439515|NCT01215227|520812855|FG004|Overall Study|Treatment Failure|1|||
144439516|NCT01215227|520812856|FG005|Overall Study|Treatment Failure|1|||
144439517|NCT01215227|520812851|FG000|Overall Study|Lost to Follow-up|1|||
144439518|NCT01215227|520812852|FG001|Overall Study|Lost to Follow-up|4|||
144439519|NCT01215227|520812853|FG002|Overall Study|Lost to Follow-up|1|||
144439520|NCT01215227|520812854|FG003|Overall Study|Lost to Follow-up|1|||
144439521|NCT01215227|520812855|FG004|Overall Study|Lost to Follow-up|1|||
144439522|NCT01215227|520812856|FG005|Overall Study|Lost to Follow-up|2|||
144439523|NCT01215227|520812851|FG000|Overall Study|Subject Withdrew Consent|16|||
144439524|NCT01215227|520812852|FG001|Overall Study|Subject Withdrew Consent|20|||
144439525|NCT01215227|520812853|FG002|Overall Study|Subject Withdrew Consent|7|||
144439526|NCT01215227|520812854|FG003|Overall Study|Subject Withdrew Consent|10|||
144439527|NCT01215227|520812855|FG004|Overall Study|Subject Withdrew Consent|11|||
144439528|NCT01215227|520812856|FG005|Overall Study|Subject Withdrew Consent|8|||
144439529|NCT01215227|520812851|FG000|Overall Study|Non-Compliance With Protocol|2|||
144439530|NCT01215227|520812852|FG001|Overall Study|Non-Compliance With Protocol|6|||
144439531|NCT01215227|520812853|FG002|Overall Study|Non-Compliance With Protocol|1|||
144439532|NCT01215227|520812854|FG003|Overall Study|Non-Compliance With Protocol|0|||
144439533|NCT01215227|520812855|FG004|Overall Study|Non-Compliance With Protocol|0|||
144439534|NCT01215227|520812856|FG005|Overall Study|Non-Compliance With Protocol|0|||
144439535|NCT01215227|520812851|FG000|Overall Study|Administrative|83|||
144439536|NCT01215227|520812852|FG001|Overall Study|Administrative|73|||
144439537|NCT01215227|520812853|FG002|Overall Study|Administrative|42|||
144439538|NCT01215227|520812854|FG003|Overall Study|Administrative|24|||
144190534|NCT02792218|519891479|FG000|Overall Study|Lack of Efficacy|1|||
144190535|NCT02792218|519891480|FG001|Overall Study|Lack of Efficacy|12|||
144190536|NCT02792218|519891479|FG000|Overall Study|Physician Decision|4|||
144190537|NCT02792218|519891480|FG001|Overall Study|Physician Decision|4|||
144190538|NCT02792218|519891479|FG000|Overall Study|Protocol deviation|3|||
144190539|NCT02792218|519891480|FG001|Overall Study|Protocol deviation|2|||
144190540|NCT02792218|519891479|FG000|Overall Study|New therapy for study indication|0|||
144190541|NCT02792218|519891480|FG001|Overall Study|New therapy for study indication|1|||
144190542|NCT02792218|519891479|FG000|Overall Study|Non-compliance with study treatment|0|||
144190543|NCT02792218|519891480|FG001|Overall Study|Non-compliance with study treatment|1|||
144190544|NCT02792218|519891479|FG000|Overall Study|Pregnancy|1|||
144190545|NCT02792218|519891480|FG001|Overall Study|Pregnancy|0|||
144439539|NCT01215227|520812855|FG004|Overall Study|Administrative|28|||
144439540|NCT01215227|520812856|FG005|Overall Study|Administrative|40|||
144190546|NCT00955721|519891481|FG000|Overall Study|Physician Decision|1|||
144253545|NCT02886884|520128122|FG000|Follow-up|Withdrawal by Subject|0|||
144439541|NCT01215227|520812851|FG000|Overall Study|Missing Status|0|||
144604824|NCT01241552|521415836|FG002|Overall Study|Progressive Disease|1|||
144604825|NCT01241552|521415837|FG003|Overall Study|Progressive Disease|2|||
144604826|NCT01241552|521415834|FG000|Overall Study|Protocol Violation|0|||
144253546|NCT02886884|520128123|FG001|Follow-up|Withdrawal by Subject|0|||
144439542|NCT01215227|520812852|FG001|Overall Study|Missing Status|1|||
144439543|NCT01215227|520812853|FG002|Overall Study|Missing Status|0|||
144439544|NCT01215227|520812854|FG003|Overall Study|Missing Status|0|||
144190547|NCT00955721|519891482|FG001|Overall Study|Physician Decision|0|||
144190548|NCT00955721|519891481|FG000|Overall Study|Death|1|||
144190549|NCT00955721|519891482|FG001|Overall Study|Death|0|||
144190550|NCT00955721|519891481|FG000|Overall Study|Withdrawal by Subject|1|||
144190551|NCT00955721|519891482|FG001|Overall Study|Withdrawal by Subject|0|||
144190552|NCT01253317|519891487|FG000|Overall Study|Adverse Event|2|||
144190553|NCT04034355|519891495|FG000|Overall Study|Study terminated by Sponsor|10|||
144190554|NCT04034355|519891496|FG001|Overall Study|Study terminated by Sponsor|17|||
144439545|NCT01215227|520812855|FG004|Overall Study|Missing Status|0|||
144439546|NCT01215227|520812856|FG005|Overall Study|Missing Status|0|||
144439547|NCT01215227|520812851|FG000|Overall Study|Randomized but not treated|0|||
144439548|NCT01215227|520812852|FG001|Overall Study|Randomized but not treated|0|||
144439549|NCT01215227|520812853|FG002|Overall Study|Randomized but not treated|1|||
144439550|NCT01215227|520812854|FG003|Overall Study|Randomized but not treated|1|||
144439551|NCT01215227|520812855|FG004|Overall Study|Randomized but not treated|0|||
144439552|NCT01215227|520812856|FG005|Overall Study|Randomized but not treated|1|||
144439553|NCT00291668|520812857|FG000|Overall Study|Lack of Efficacy|1|||
144439554|NCT00291668|520812858|FG001|Overall Study|Lack of Efficacy|0|||
144439555|NCT00291668|520812859|FG002|Overall Study|Lack of Efficacy|0|||
144439556|NCT00291668|520812857|FG000|Overall Study|SAE, non-fatal|1|||
144439557|NCT00291668|520812858|FG001|Overall Study|SAE, non-fatal|1|||
144439558|NCT00291668|520812859|FG002|Overall Study|SAE, non-fatal|1|||
144439559|NCT00291668|520812857|FG000|Overall Study|AE, non-serious non-fatal|1|||
144439560|NCT00291668|520812858|FG001|Overall Study|AE, non-serious non-fatal|0|||
144439561|NCT00291668|520812859|FG002|Overall Study|AE, non-serious non-fatal|0|||
144439562|NCT00291668|520812857|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144439563|NCT00291668|520812858|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
144439564|NCT00291668|520812859|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
144439565|NCT00313612|520812862|FG000|Overall Study|Patient never received treatment|0|||
144439566|NCT00313612|520812863|FG001|Overall Study|Patient never received treatment|1|||
144439567|NCT02777125|520812864|FG000|Overall Study|Consent form violation|14|||
144439568|NCT02777125|520812865|FG001|Overall Study|Consent form violation|12|||
144439569|NCT02777125|520812864|FG000|Overall Study|Assent form violation|21|||
144439570|NCT02777125|520812865|FG001|Overall Study|Assent form violation|23|||
144439571|NCT02777125|520812864|FG000|Overall Study|Protocol Violation|8|||
144439572|NCT02777125|520812865|FG001|Overall Study|Protocol Violation|12|||
144439573|NCT02283788|520812868|FG000|Overall Study|Adverse Event|1|||
144439574|NCT02283788|520812869|FG001|Overall Study|Adverse Event|3|||
144439575|NCT02283788|520812870|FG002|Overall Study|Adverse Event|5|||
144439576|NCT02283788|520812871|FG003|Overall Study|Adverse Event|1|||
144439577|NCT02283788|520812868|FG000|Overall Study|Withdrawal by Subject|0|||
144439578|NCT02283788|520812869|FG001|Overall Study|Withdrawal by Subject|1|||
144439579|NCT02283788|520812870|FG002|Overall Study|Withdrawal by Subject|0|||
144439580|NCT02283788|520812871|FG003|Overall Study|Withdrawal by Subject|1|||
144439581|NCT00653224|520815191|FG000|Overall Study|Adverse Event|2|||
144439582|NCT00653224|520815192|FG001|Overall Study|Adverse Event|1|||
144439583|NCT00653224|520815191|FG000|Overall Study|Lack of Efficacy|1|||
144190555|NCT04034355|519891495|FG000|Overall Study|Withdrawal by Subject|12|||
144190556|NCT04034355|519891496|FG001|Overall Study|Withdrawal by Subject|11|||
144190557|NCT04034355|519891495|FG000|Overall Study|Site terminated by Sponsor|4|||
144190558|NCT04034355|519891496|FG001|Overall Study|Site terminated by Sponsor|5|||
144190559|NCT04034355|519891495|FG000|Overall Study|Adverse Event|2|||
144190560|NCT04034355|519891496|FG001|Overall Study|Adverse Event|0|||
144190561|NCT04034355|519891495|FG000|Overall Study|Death|1|||
144190562|NCT04034355|519891496|FG001|Overall Study|Death|1|||
144190563|NCT04034355|519891495|FG000|Overall Study|Not reported|2|||
144190564|NCT04034355|519891496|FG001|Overall Study|Not reported|0|||
144190565|NCT04034355|519891495|FG000|Overall Study|Lost to Follow-up|1|||
144190566|NCT04034355|519891496|FG001|Overall Study|Lost to Follow-up|0|||
144439584|NCT00653224|520815192|FG001|Overall Study|Lack of Efficacy|2|||
144439585|NCT00653224|520815191|FG000|Overall Study|Loss of efficacy|1|||
144439586|NCT00653224|520815192|FG001|Overall Study|Loss of efficacy|0|||
144439587|NCT00653224|520815191|FG000|Overall Study|Lost to Follow-up|1|||
144439588|NCT00653224|520815192|FG001|Overall Study|Lost to Follow-up|0|||
144439589|NCT00653224|520815191|FG000|Overall Study|Other|2|||
144604827|NCT01241552|521415835|FG001|Overall Study|Protocol Violation|2|||
144604828|NCT01241552|521415836|FG002|Overall Study|Protocol Violation|6|||
144604829|NCT01241552|521415837|FG003|Overall Study|Protocol Violation|1|||
144604830|NCT01241552|521415834|FG000|Overall Study|Withdrawal by Subject|7|||
144190567|NCT04034355|519891495|FG000|Overall Study|Physician Decision|1|||
144190568|NCT04034355|519891496|FG001|Overall Study|Physician Decision|0|||
144190569|NCT04034355|519891495|FG000|Overall Study|Protocol Violation|0|||
144190570|NCT04034355|519891496|FG001|Overall Study|Protocol Violation|1|||
144439590|NCT00653224|520815192|FG001|Overall Study|Other|4|||
144724530|NCT04582539|521846410|FG000|Overall Study|Lost to Follow-up|1|||
144190571|NCT04034355|519891495|FG000|Overall Study|Progressive disease|1|||
144190572|NCT04034355|519891496|FG001|Overall Study|Progressive disease|0|||
144439591|NCT00348556|520815193|FG000|Overall Study|Adverse Event|1|||
144439592|NCT00192075|520815194|FG000|Overall Study|Disease Progression|23|||
144439593|NCT00192075|520815195|FG001|Overall Study|Disease Progression|6|||
144439594|NCT00192075|520815194|FG000|Overall Study|Adverse Event|1|||
144439595|NCT00192075|520815195|FG001|Overall Study|Adverse Event|3|||
144439596|NCT00192075|520815194|FG000|Overall Study|Death|0|||
144439597|NCT00192075|520815195|FG001|Overall Study|Death|1|||
144439598|NCT00192075|520815194|FG000|Overall Study|Lack of Efficacy|0|||
144439599|NCT00192075|520815195|FG001|Overall Study|Lack of Efficacy|0|||
144439600|NCT00192075|520815194|FG000|Overall Study|Physician Decision|3|||
144439601|NCT00192075|520815195|FG001|Overall Study|Physician Decision|0|||
144439602|NCT00192075|520815194|FG000|Overall Study|Withdrawal by Subject|5|||
144439603|NCT00192075|520815195|FG001|Overall Study|Withdrawal by Subject|5|||
144439604|NCT00192075|520815194|FG000|Overall Study|Patient Non-Compliance|0|||
144439605|NCT00192075|520815195|FG001|Overall Study|Patient Non-Compliance|1|||
144439606|NCT00192075|520815194|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
144439607|NCT00192075|520815195|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
144439608|NCT00192075|520815194|FG000|Overall Study|Other|5|||
144439609|NCT00192075|520815195|FG001|Overall Study|Other|2|||
144439610|NCT03325166|520815200|FG000|Overall Study|Adverse Event|1|||
144439611|NCT01633944|520815201|FG000|Open-label Titration Phase|Adverse Event|109|||
144439612|NCT01633944|520815202|FG001|Open-label Titration Phase|Adverse Event|0|||
144439613|NCT01633944|520815203|FG002|Open-label Titration Phase|Adverse Event|0|||
144439614|NCT01633944|520815201|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
144439615|NCT01633944|520815202|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
144439616|NCT01633944|520815203|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
144439617|NCT01633944|520815201|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
144439618|NCT01633944|520815202|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
144439619|NCT01633944|520815203|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
144439620|NCT01633944|520815201|FG000|Open-label Titration Phase|Protocol Violation|24|||
144439621|NCT01633944|520815202|FG001|Open-label Titration Phase|Protocol Violation|0|||
144439622|NCT01633944|520815203|FG002|Open-label Titration Phase|Protocol Violation|0|||
144439623|NCT01633944|520815201|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
144439624|NCT01633944|520815202|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
144439625|NCT01633944|520815203|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
144439626|NCT01633944|520815201|FG000|Open-label Titration Phase|Other|68|||
144439627|NCT01633944|520815202|FG001|Open-label Titration Phase|Other|0|||
144439628|NCT01633944|520815203|FG002|Open-label Titration Phase|Other|0|||
144439629|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Adverse Event|0|||
144439630|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Adverse Event|13|||
144439631|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Adverse Event|7|||
144439632|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
144439633|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
144439634|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
144439635|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144439636|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
144439637|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
144439638|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
144439639|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
144439640|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
144439641|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
144439642|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
144439643|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
144439644|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
144530875|NCT04308681|521146316|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
144190573|NCT04678817|519893337|FG000|Overall Study|Lost to Follow-up|28|||
144190574|NCT04678817|519893338|FG001|Overall Study|Lost to Follow-up|0|||
144190575|NCT04678817|519893339|FG002|Overall Study|Lost to Follow-up|0|||
144190576|NCT02124902|519893344|FG000|Overall Study|Adverse Event|7|||
144190577|NCT02124902|519893345|FG001|Overall Study|Adverse Event|2|||
144190578|NCT02124902|519893344|FG000|Overall Study|Went to alternative treatment|4|||
144190579|NCT02124902|519893345|FG001|Overall Study|Went to alternative treatment|0|||
144190580|NCT02124902|519893344|FG000|Overall Study|Withdrawal by Subject|2|||
144530876|NCT04308681|521146317|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
144439645|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
144439646|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
144439647|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
144190581|NCT02124902|519893345|FG001|Overall Study|Withdrawal by Subject|1|||
144439648|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
144439649|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
144530877|NCT04308681|521146318|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
144190582|NCT02124902|519893344|FG000|Overall Study|Physician Decision|2|||
144190583|NCT02124902|519893345|FG001|Overall Study|Physician Decision|0|||
144190584|NCT02124902|519893344|FG000|Overall Study|Not eligible|1|||
144190585|NCT02124902|519893345|FG001|Overall Study|Not eligible|0|||
144439650|NCT01633944|520815201|FG000|Double-blind Treatment Phase|Other|0|||
144439651|NCT01633944|520815202|FG001|Double-blind Treatment Phase|Other|7|||
144439652|NCT01633944|520815203|FG002|Double-blind Treatment Phase|Other|0|||
144439653|NCT00463060|520815204|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
144439654|NCT00463060|520815204|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
144439655|NCT01400841|520815205|FG000|Initial Study Phase (6 Months)|Death|1|||
144439656|NCT01400841|520815205|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
144604831|NCT01241552|521415835|FG001|Overall Study|Withdrawal by Subject|15|||
144604832|NCT01241552|521415836|FG002|Overall Study|Withdrawal by Subject|14|||
144604833|NCT01241552|521415837|FG003|Overall Study|Withdrawal by Subject|15|||
144604834|NCT01241552|521415834|FG000|Overall Study|Physician Decision|2|||
144604835|NCT01241552|521415835|FG001|Overall Study|Physician Decision|4|||
144604836|NCT01241552|521415836|FG002|Overall Study|Physician Decision|2|||
144604837|NCT01241552|521415837|FG003|Overall Study|Physician Decision|3|||
144604838|NCT01241552|521415834|FG000|Overall Study|Lost to Follow-up|2|||
144604839|NCT01241552|521415835|FG001|Overall Study|Lost to Follow-up|11|||
144604840|NCT01241552|521415836|FG002|Overall Study|Lost to Follow-up|15|||
144604841|NCT01241552|521415837|FG003|Overall Study|Lost to Follow-up|16|||
144604842|NCT04004429|521415840|FG000|Overall Study|Protocol Violation|1|||
144604843|NCT04004429|521415841|FG001|Overall Study|Protocol Violation|0|||
144724531|NCT04582539|521846411|FG001|Overall Study|Lost to Follow-up|0|||
144724532|NCT04582539|521846412|FG002|Overall Study|Lost to Follow-up|0|||
144724533|NCT04582539|521846413|FG003|Overall Study|Lost to Follow-up|0|||
144190586|NCT02124902|519893344|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
144190587|NCT02124902|519893345|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
144190588|NCT02999984|519893353|FG000|Overall Study|Treatment Failure|1|||
144190589|NCT00754013|519893354|FG000|Overall Study|Lost to Follow-up|1|||
144190590|NCT00754013|519893355|FG001|Overall Study|Lost to Follow-up|1|||
144190591|NCT00754013|519893354|FG000|Overall Study|didn't return after study termed|3|||
144190592|NCT00754013|519893355|FG001|Overall Study|didn't return after study termed|4|||
144190593|NCT03346070|519893367|FG000|Overall Study|Death|0|||
144190594|NCT03346070|519893368|FG001|Overall Study|Death|0|||
144190595|NCT03346070|519893369|FG002|Overall Study|Death|0|||
144190596|NCT03346070|519893370|FG003|Overall Study|Death|0|||
144190597|NCT03346070|519893371|FG004|Overall Study|Death|1|||
144190598|NCT03346070|519893367|FG000|Overall Study|Lost to Follow-up|0|||
144190599|NCT03346070|519893368|FG001|Overall Study|Lost to Follow-up|1|||
144190600|NCT03346070|519893369|FG002|Overall Study|Lost to Follow-up|2|||
144190601|NCT03346070|519893370|FG003|Overall Study|Lost to Follow-up|0|||
144190602|NCT03346070|519893371|FG004|Overall Study|Lost to Follow-up|0|||
144190603|NCT03346070|519893367|FG000|Overall Study|Physician Decision|0|||
144190604|NCT03346070|519893368|FG001|Overall Study|Physician Decision|0|||
144190605|NCT03346070|519893369|FG002|Overall Study|Physician Decision|0|||
144190606|NCT03346070|519893370|FG003|Overall Study|Physician Decision|1|||
144190607|NCT03346070|519893371|FG004|Overall Study|Physician Decision|1|||
144190608|NCT03346070|519893367|FG000|Overall Study|Withdrawal by Subject|1|||
144190609|NCT03346070|519893368|FG001|Overall Study|Withdrawal by Subject|0|||
144190610|NCT03346070|519893369|FG002|Overall Study|Withdrawal by Subject|0|||
144190611|NCT03346070|519893370|FG003|Overall Study|Withdrawal by Subject|1|||
144190612|NCT03346070|519893371|FG004|Overall Study|Withdrawal by Subject|0|||
144190613|NCT03346070|519893367|FG000|Overall Study|Study medication not received as planned|2|||
144190614|NCT03346070|519893368|FG001|Overall Study|Study medication not received as planned|3|||
144190615|NCT03346070|519893369|FG002|Overall Study|Study medication not received as planned|2|||
144190616|NCT03346070|519893370|FG003|Overall Study|Study medication not received as planned|3|||
144190617|NCT03346070|519893371|FG004|Overall Study|Study medication not received as planned|2|||
144190618|NCT03346070|519893367|FG000|Overall Study|Screen Failure|0|||
144190619|NCT03346070|519893368|FG001|Overall Study|Screen Failure|0|||
144190620|NCT03346070|519893369|FG002|Overall Study|Screen Failure|0|||
144190621|NCT03346070|519893370|FG003|Overall Study|Screen Failure|1|||
144190622|NCT03346070|519893371|FG004|Overall Study|Screen Failure|1|||
144190623|NCT01213836|519893372|FG000|Period 1, First Intervention|Adverse Event|2|||
144190624|NCT01213836|519893373|FG001|Period 1, First Intervention|Adverse Event|1|||
144190625|NCT01213836|519893372|FG000|Period 1, First Intervention|Protocol Violation|0|||
144439657|NCT00910715|520815206|FG000|Overall Study|Lost to Follow-up|22|||
144439658|NCT00910715|520815207|FG001|Overall Study|Lost to Follow-up|26|||
144439659|NCT00910715|520815208|FG002|Overall Study|Lost to Follow-up|0|||
144604844|NCT04004429|521415842|FG002|Overall Study|Protocol Violation|0|||
144604845|NCT04004429|521415840|FG000|Overall Study|Physician Decision|0|||
144604846|NCT04004429|521415841|FG001|Overall Study|Physician Decision|1|||
144604847|NCT04004429|521415842|FG002|Overall Study|Physician Decision|1|||
144724534|NCT04582539|521846414|FG004|Overall Study|Lost to Follow-up|0|||
144190626|NCT01213836|519893373|FG001|Period 1, First Intervention|Protocol Violation|1|||
144190627|NCT01213836|519893372|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
144190628|NCT01213836|519893373|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
144190629|NCT00255151|519893374|FG000|Overall Study|Adverse Event|10|||
144190630|NCT00255151|519893375|FG001|Overall Study|Adverse Event|6|||
144604848|NCT04004429|521415840|FG000|Overall Study|Withdrawal by Subject|1|||
144439660|NCT00770120|520815211|FG000|Overall Study|Progression|31|||
144439661|NCT00770120|520815211|FG000|Overall Study|Adverse Event|11|||
144439662|NCT00770120|520815211|FG000|Overall Study|Not Protocol Specified|11|||
144439663|NCT00770120|520815211|FG000|Overall Study|Death|3|||
144439664|NCT00770120|520815211|FG000|Overall Study|Withdrawal by Subject|2|||
144439665|NCT00770120|520815211|FG000|Overall Study|Ineligible|1|||
144439666|NCT00770120|520815211|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
144439667|NCT00770120|520815211|FG000|Overall Study|Reason under Review|1|||
144439668|NCT01782313|520815212|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
144439669|NCT01782313|520815212|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
144439670|NCT01782313|520815212|FG000|Treated Cycle 3|Progressive Disease|21|||
144439671|NCT01782313|520815212|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
144439672|NCT01782313|520815212|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
144439673|NCT01782313|520815212|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
144439674|NCT01782313|520815212|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
144439675|NCT01782313|520815212|FG000|Survival Follow up|Lost to Follow-up|1|||
144439676|NCT03795610|520815217|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
144439677|NCT03795610|520815217|FG000|Overall Study|Withdrawal by Subject|1|||
144439678|NCT03795610|520815217|FG000|Overall Study|Screen Failure (Unknown)|1|||
144439679|NCT00116558|520815218|FG000|Overall Study|Death|11|||
144439680|NCT00116558|520815219|FG001|Overall Study|Death|5|||
144439681|NCT00116558|520815220|FG002|Overall Study|Death|3|||
144439682|NCT00116558|520815218|FG000|Overall Study|Withdrawal by Subject|17|||
144439683|NCT00116558|520815219|FG001|Overall Study|Withdrawal by Subject|3|||
144439684|NCT00116558|520815220|FG002|Overall Study|Withdrawal by Subject|12|||
144439685|NCT00116558|520815218|FG000|Overall Study|disease progression|3|||
144439686|NCT00116558|520815219|FG001|Overall Study|disease progression|7|||
144439687|NCT00116558|520815220|FG002|Overall Study|disease progression|18|||
144439688|NCT03491150|520815221|FG000|Overall Study|Adverse Event|1|||
144439689|NCT03491150|520815222|FG001|Overall Study|Adverse Event|0|||
144439690|NCT03491150|520815221|FG000|Overall Study|Study Terminated by Sponsor|74|||
144439691|NCT03491150|520815222|FG001|Overall Study|Study Terminated by Sponsor|70|||
144439692|NCT03491150|520815221|FG000|Overall Study|Other|0|||
144439693|NCT03491150|520815222|FG001|Overall Study|Other|1|||
144439694|NCT03491150|520815221|FG000|Overall Study|Withdrawal by Subject|1|||
144439695|NCT03491150|520815222|FG001|Overall Study|Withdrawal by Subject|2|||
144439696|NCT01143090|520815223|FG000|Overall Study|Lack of Efficacy|2|||
144439697|NCT01143090|520815223|FG000|Overall Study|Adverse Event|17|||
144439698|NCT01143090|520815223|FG000|Overall Study|Lost to Follow-up|9|||
144439699|NCT01143090|520815223|FG000|Overall Study|Protocol Violation|2|||
144439700|NCT01143090|520815223|FG000|Overall Study|Withdrawal by Subject|18|||
144439701|NCT01143090|520815223|FG000|Overall Study|Non-compliance with study drug|1|||
144439702|NCT01143090|520815223|FG000|Overall Study|Failure to meet eligibility criteria|1|||
144439703|NCT01143090|520815223|FG000|Overall Study|Administrative|1|||
144439704|NCT00325234|520815229|FG000|Overall Study|Adverse Event|10|||
144439705|NCT00325234|520815230|FG001|Overall Study|Adverse Event|7|||
144439706|NCT00325234|520815229|FG000|Overall Study|Death due to Study Disease|1|||
144439707|NCT00325234|520815230|FG001|Overall Study|Death due to Study Disease|0|||
144439708|NCT00325234|520815229|FG000|Overall Study|Entry Criteria Not Met|1|||
144439709|NCT00325234|520815230|FG001|Overall Study|Entry Criteria Not Met|2|||
144439710|NCT00325234|520815229|FG000|Overall Study|Subject Decision|6|||
144190631|NCT00255151|519893376|FG002|Overall Study|Adverse Event|9|||
144190632|NCT00255151|519893374|FG000|Overall Study|Lost to Follow-up|4|||
144190633|NCT00255151|519893375|FG001|Overall Study|Lost to Follow-up|3|||
144190634|NCT00255151|519893376|FG002|Overall Study|Lost to Follow-up|4|||
144190635|NCT00255151|519893374|FG000|Overall Study|Withdrawal by Subject|18|||
144190636|NCT00255151|519893375|FG001|Overall Study|Withdrawal by Subject|17|||
144190637|NCT00255151|519893376|FG002|Overall Study|Withdrawal by Subject|8|||
144190638|NCT00255151|519893374|FG000|Overall Study|Noncompliance|0|||
144190639|NCT00255151|519893375|FG001|Overall Study|Noncompliance|1|||
144190640|NCT00255151|519893376|FG002|Overall Study|Noncompliance|2|||
144190641|NCT00255151|519893374|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
144190642|NCT00255151|519893375|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
144190643|NCT00255151|519893376|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
144190644|NCT00255151|519893374|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
144190645|NCT00255151|519893375|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
144190646|NCT00255151|519893376|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
144190647|NCT00255151|519893374|FG000|Overall Study|Possible Barrett's Esophagus|1|||
144439711|NCT00325234|520815230|FG001|Overall Study|Subject Decision|8|||
144439712|NCT00325234|520815229|FG000|Overall Study|Physician Decision|17|||
144439713|NCT00325234|520815230|FG001|Overall Study|Physician Decision|12|||
144439714|NCT00325234|520815229|FG000|Overall Study|Progressive Disease|34|||
144439715|NCT00325234|520815230|FG001|Overall Study|Progressive Disease|37|||
144190648|NCT00255151|519893375|FG001|Overall Study|Possible Barrett's Esophagus|3|||
144190649|NCT00255151|519893376|FG002|Overall Study|Possible Barrett's Esophagus|8|||
144190650|NCT00255151|519893374|FG000|Overall Study|Esophageal Stricture|0|||
144439716|NCT02644967|520815235|FG000|Overall Study|Death|26|||
144439717|NCT02644967|520815235|FG000|Overall Study|Physician Decision|1|||
144439718|NCT02644967|520815235|FG000|Overall Study|Withdrawal by Subject|2|||
144439719|NCT02644967|520815235|FG000|Overall Study|Protocol Violation|1|||
144439720|NCT02644967|520815235|FG000|Overall Study|Progressive Disease|1|||
144439721|NCT02644967|520815235|FG000|Overall Study|Study Terminated by Sponsor|4|||
144439722|NCT02287896|520815236|FG000|Second Injection Visit|Withdrawal by Subject|0|||
144439723|NCT02287896|520815237|FG001|Second Injection Visit|Withdrawal by Subject|1|||
144439724|NCT03746522|520815238|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
144439725|NCT03746522|520815239|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
144439726|NCT03746522|520815240|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
144439727|NCT03746522|520815238|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
144439728|NCT03746522|520815239|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
144439729|NCT03746522|520815240|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
144439730|NCT03746522|520815238|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
144439731|NCT03746522|520815239|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
144439732|NCT03746522|520815240|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
144439733|NCT03746522|520815238|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
144439734|NCT03746522|520815239|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
144439735|NCT03746522|520815240|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
144439736|NCT03746522|520815238|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
144439737|NCT03746522|520815239|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
144439738|NCT03746522|520815240|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
144439739|NCT01639040|520815241|FG000|Overall Study|Adverse Event|1|||
144439740|NCT01639040|520815242|FG001|Overall Study|Adverse Event|0|||
144439741|NCT00486265|520815243|FG000|Overall Study|Adverse Event|1|||
144439742|NCT00486265|520815243|FG000|Overall Study|Lack of Efficacy|8|||
144439743|NCT01452412|520815244|FG000|Overall Study|Withdrawal by Subject|15|||
144439744|NCT01452412|520815245|FG001|Overall Study|Withdrawal by Subject|11|||
144439745|NCT01452412|520815244|FG000|Overall Study|Adverse Event|4|||
144439746|NCT01452412|520815245|FG001|Overall Study|Adverse Event|3|||
144439747|NCT01452412|520815244|FG000|Overall Study|Lost to Follow-up|5|||
144439748|NCT01452412|520815245|FG001|Overall Study|Lost to Follow-up|3|||
144439749|NCT01452412|520815244|FG000|Overall Study|Death|1|||
144439750|NCT01452412|520815245|FG001|Overall Study|Death|0|||
144439751|NCT01452412|520815244|FG000|Overall Study|Initiated dialysis|1|||
144439752|NCT01452412|520815245|FG001|Overall Study|Initiated dialysis|0|||
144439753|NCT01452412|520815244|FG000|Overall Study|Other|2|||
144439754|NCT01452412|520815245|FG001|Overall Study|Other|0|||
144439755|NCT05132127|520815246|FG000|Overall Study|Adverse Event|1|||
144439756|NCT03013543|520815247|FG000|Overall Study|Withdrawal by Subject|0|||
144439757|NCT03013543|520815248|FG001|Overall Study|Withdrawal by Subject|2|||
144439758|NCT03013543|520815249|FG002|Overall Study|Withdrawal by Subject|0|||
144439759|NCT03013543|520815250|FG003|Overall Study|Withdrawal by Subject|5|||
144439760|NCT03013543|520815251|FG004|Overall Study|Withdrawal by Subject|6|||
144439761|NCT03013543|520815252|FG005|Overall Study|Withdrawal by Subject|2|||
144190651|NCT00255151|519893375|FG001|Overall Study|Esophageal Stricture|0|||
144190652|NCT00255151|519893376|FG002|Overall Study|Esophageal Stricture|1|||
144190653|NCT00255151|519893374|FG000|Overall Study|Therapeutic Failure|11|||
144190654|NCT00255151|519893375|FG001|Overall Study|Therapeutic Failure|2|||
144190655|NCT00255151|519893376|FG002|Overall Study|Therapeutic Failure|3|||
144190656|NCT00706095|519893383|FG000|Overall Study|Progressive Disease|4|||
144190657|NCT00706095|519893384|FG001|Overall Study|Progressive Disease|5|||
144190658|NCT00706095|519893385|FG002|Overall Study|Progressive Disease|3|||
144190659|NCT00706095|519893383|FG000|Overall Study|Clinical Progression|1|||
144439762|NCT03013543|520815253|FG006|Overall Study|Withdrawal by Subject|3|||
144439763|NCT03013543|520815254|FG007|Overall Study|Withdrawal by Subject|1|||
144439764|NCT03013543|520815255|FG008|Overall Study|Withdrawal by Subject|0|||
144439765|NCT03013543|520815256|FG009|Overall Study|Withdrawal by Subject|4|||
144439766|NCT03013543|520815247|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
144439767|NCT03013543|520815248|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
144439768|NCT03013543|520815249|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
144439769|NCT03013543|520815250|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
144439770|NCT03013543|520815251|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
144439771|NCT03013543|520815252|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
144439772|NCT03013543|520815253|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
144439773|NCT03013543|520815254|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
144439774|NCT03013543|520815255|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
144439775|NCT03013543|520815256|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
144439776|NCT03013543|520815247|FG000|Overall Study|Other|0|||
144439777|NCT03013543|520815248|FG001|Overall Study|Other|0|||
144439778|NCT03013543|520815249|FG002|Overall Study|Other|2|||
144439779|NCT03013543|520815250|FG003|Overall Study|Other|0|||
144439780|NCT03013543|520815251|FG004|Overall Study|Other|2|||
144190660|NCT00706095|519893384|FG001|Overall Study|Clinical Progression|2|||
144439781|NCT03013543|520815252|FG005|Overall Study|Other|0|||
144439782|NCT03013543|520815253|FG006|Overall Study|Other|0|||
144439783|NCT03013543|520815254|FG007|Overall Study|Other|0|||
144439784|NCT03013543|520815255|FG008|Overall Study|Other|1|||
144439785|NCT03013543|520815256|FG009|Overall Study|Other|0|||
144439786|NCT03013543|520815247|FG000|Overall Study|Adverse Event|0|||
144439787|NCT03013543|520815248|FG001|Overall Study|Adverse Event|0|||
144439788|NCT03013543|520815249|FG002|Overall Study|Adverse Event|0|||
144439789|NCT03013543|520815250|FG003|Overall Study|Adverse Event|3|||
144439790|NCT03013543|520815251|FG004|Overall Study|Adverse Event|2|||
144439791|NCT03013543|520815252|FG005|Overall Study|Adverse Event|1|||
144439792|NCT03013543|520815253|FG006|Overall Study|Adverse Event|3|||
144439793|NCT03013543|520815254|FG007|Overall Study|Adverse Event|8|||
144439794|NCT03013543|520815255|FG008|Overall Study|Adverse Event|0|||
144439795|NCT03013543|520815256|FG009|Overall Study|Adverse Event|2|||
144439796|NCT03013543|520815247|FG000|Overall Study|Death|0|||
144439797|NCT03013543|520815248|FG001|Overall Study|Death|0|||
144439798|NCT03013543|520815249|FG002|Overall Study|Death|0|||
144439799|NCT03013543|520815250|FG003|Overall Study|Death|1|||
144439800|NCT03013543|520815251|FG004|Overall Study|Death|0|||
144439801|NCT03013543|520815252|FG005|Overall Study|Death|0|||
144439802|NCT03013543|520815253|FG006|Overall Study|Death|0|||
144439803|NCT03013543|520815254|FG007|Overall Study|Death|0|||
144439804|NCT03013543|520815255|FG008|Overall Study|Death|0|||
144439805|NCT03013543|520815256|FG009|Overall Study|Death|0|||
144439806|NCT03013543|520815247|FG000|Overall Study|Lack of Efficacy|0|||
144439807|NCT03013543|520815248|FG001|Overall Study|Lack of Efficacy|0|||
144439808|NCT03013543|520815249|FG002|Overall Study|Lack of Efficacy|0|||
144439809|NCT03013543|520815250|FG003|Overall Study|Lack of Efficacy|1|||
144439810|NCT03013543|520815251|FG004|Overall Study|Lack of Efficacy|0|||
144439811|NCT03013543|520815252|FG005|Overall Study|Lack of Efficacy|0|||
144439812|NCT03013543|520815253|FG006|Overall Study|Lack of Efficacy|0|||
144439813|NCT03013543|520815254|FG007|Overall Study|Lack of Efficacy|0|||
144439814|NCT03013543|520815255|FG008|Overall Study|Lack of Efficacy|0|||
144439815|NCT03013543|520815256|FG009|Overall Study|Lack of Efficacy|0|||
144439816|NCT03013543|520815247|FG000|Overall Study|Lost to Follow-up|0|||
144439817|NCT03013543|520815248|FG001|Overall Study|Lost to Follow-up|0|||
144439818|NCT03013543|520815249|FG002|Overall Study|Lost to Follow-up|0|||
144439819|NCT03013543|520815250|FG003|Overall Study|Lost to Follow-up|1|||
144439820|NCT03013543|520815251|FG004|Overall Study|Lost to Follow-up|0|||
144439821|NCT03013543|520815252|FG005|Overall Study|Lost to Follow-up|0|||
144439822|NCT03013543|520815253|FG006|Overall Study|Lost to Follow-up|1|||
144439823|NCT03013543|520815254|FG007|Overall Study|Lost to Follow-up|0|||
144439824|NCT03013543|520815255|FG008|Overall Study|Lost to Follow-up|0|||
144439825|NCT03013543|520815256|FG009|Overall Study|Lost to Follow-up|2|||
144439826|NCT03013543|520815247|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144439827|NCT03013543|520815248|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144439828|NCT03013543|520815249|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144439829|NCT03013543|520815250|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144439830|NCT03013543|520815251|FG004|Overall Study|Non-Compliance With Study Drug|0|||
144439831|NCT03013543|520815252|FG005|Overall Study|Non-Compliance With Study Drug|0|||
144439832|NCT03013543|520815253|FG006|Overall Study|Non-Compliance With Study Drug|0|||
144439833|NCT03013543|520815254|FG007|Overall Study|Non-Compliance With Study Drug|0|||
144439834|NCT03013543|520815255|FG008|Overall Study|Non-Compliance With Study Drug|1|||
144190661|NCT00706095|519893385|FG002|Overall Study|Clinical Progression|2|||
144190662|NCT00706095|519893383|FG000|Overall Study|Withdrawal by Subject|1|||
144190663|NCT00706095|519893384|FG001|Overall Study|Withdrawal by Subject|0|||
144190664|NCT00706095|519893385|FG002|Overall Study|Withdrawal by Subject|0|||
144190665|NCT01685073|519893386|FG000|Overall Study|Lost to Follow-up|6|||
144190666|NCT01685073|519893387|FG001|Overall Study|Lost to Follow-up|8|||
144190667|NCT01685073|519893386|FG000|Overall Study|Withdrawal by Subject|24|||
144439835|NCT03013543|520815256|FG009|Overall Study|Non-Compliance With Study Drug|0|||
144190668|NCT01685073|519893387|FG001|Overall Study|Withdrawal by Subject|24|||
144190669|NCT02065713|519893398|FG000|Overall Study|Adverse Event|0|||
144439836|NCT03013543|520815247|FG000|Overall Study|Physician Decision|0|||
144439837|NCT03013543|520815248|FG001|Overall Study|Physician Decision|0|||
144439838|NCT03013543|520815249|FG002|Overall Study|Physician Decision|0|||
144604849|NCT04004429|521415841|FG001|Overall Study|Withdrawal by Subject|1|||
144190670|NCT02065713|519893399|FG001|Overall Study|Adverse Event|1|||
144439839|NCT03013543|520815250|FG003|Overall Study|Physician Decision|0|||
144439840|NCT03013543|520815251|FG004|Overall Study|Physician Decision|1|||
144190671|NCT02065713|519893398|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144439841|NCT03013543|520815252|FG005|Overall Study|Physician Decision|0|||
144439842|NCT03013543|520815253|FG006|Overall Study|Physician Decision|0|||
144439843|NCT03013543|520815254|FG007|Overall Study|Physician Decision|0|||
144439844|NCT03013543|520815255|FG008|Overall Study|Physician Decision|0|||
144439845|NCT03013543|520815256|FG009|Overall Study|Physician Decision|0|||
144439846|NCT03013543|520815247|FG000|Overall Study|Protocol Violation|0|||
144439847|NCT03013543|520815248|FG001|Overall Study|Protocol Violation|0|||
144439848|NCT03013543|520815249|FG002|Overall Study|Protocol Violation|0|||
144439849|NCT03013543|520815250|FG003|Overall Study|Protocol Violation|0|||
144439850|NCT03013543|520815251|FG004|Overall Study|Protocol Violation|0|||
144439851|NCT03013543|520815252|FG005|Overall Study|Protocol Violation|0|||
144439852|NCT03013543|520815253|FG006|Overall Study|Protocol Violation|0|||
144439853|NCT03013543|520815254|FG007|Overall Study|Protocol Violation|0|||
144439854|NCT03013543|520815255|FG008|Overall Study|Protocol Violation|0|||
144439855|NCT03013543|520815256|FG009|Overall Study|Protocol Violation|1|||
144439856|NCT02043015|520815269|FG000|Overall Study|Lost to Follow-up|4|||
144439857|NCT02043015|520815269|FG000|Overall Study|Withdrawal by Subject|4|||
144439858|NCT02043015|520815269|FG000|Overall Study|Removed once target enrollment reached|15|||
144439859|NCT02043015|520815269|FG000|Overall Study|Participant moved away from study city|4|||
144439860|NCT02043015|520815269|FG000|Overall Study|Incarceration|1|||
144439861|NCT01403974|520815270|FG000|Overall Study|Progressive disease according to RECIST|3|||
144439862|NCT01403974|520815271|FG001|Overall Study|Progressive disease according to RECIST|3|||
144439863|NCT01403974|520815272|FG002|Overall Study|Progressive disease according to RECIST|2|||
144439864|NCT01403974|520815273|FG003|Overall Study|Progressive disease according to RECIST|3|||
144439865|NCT01403974|520815274|FG004|Overall Study|Progressive disease according to RECIST|3|||
144439866|NCT01403974|520815275|FG005|Overall Study|Progressive disease according to RECIST|2|||
144439867|NCT01403974|520815276|FG006|Overall Study|Progressive disease according to RECIST|3|||
144439868|NCT01403974|520815277|FG007|Overall Study|Progressive disease according to RECIST|2|||
144439869|NCT01403974|520815278|FG008|Overall Study|Progressive disease according to RECIST|6|||
144439870|NCT01403974|520815279|FG009|Overall Study|Progressive disease according to RECIST|2|||
144439871|NCT01403974|520815280|FG010|Overall Study|Progressive disease according to RECIST|3|||
144439872|NCT01403974|520815281|FG011|Overall Study|Progressive disease according to RECIST|2|||
144439873|NCT01403974|520815282|FG012|Overall Study|Progressive disease according to RECIST|2|||
144439874|NCT01403974|520815283|FG013|Overall Study|Progressive disease according to RECIST|3|||
144439875|NCT01403974|520815284|FG014|Overall Study|Progressive disease according to RECIST|1|||
144439876|NCT01403974|520815285|FG015|Overall Study|Progressive disease according to RECIST|8|||
144439877|NCT01403974|520815270|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
144439878|NCT01403974|520815271|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
144439879|NCT01403974|520815272|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
144439880|NCT01403974|520815273|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
144439881|NCT01403974|520815274|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
144439882|NCT01403974|520815275|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
144439883|NCT01403974|520815276|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
144439884|NCT01403974|520815277|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
144439885|NCT01403974|520815278|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
144439886|NCT01403974|520815279|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
144439887|NCT01403974|520815280|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
144439888|NCT01403974|520815281|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
144439889|NCT01403974|520815282|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
144439890|NCT01403974|520815283|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
144439891|NCT01403974|520815284|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
144439892|NCT01403974|520815285|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
144439893|NCT01403974|520815270|FG000|Overall Study|Refused to continue study medication|0|||
144439894|NCT01403974|520815271|FG001|Overall Study|Refused to continue study medication|0|||
144439895|NCT01403974|520815272|FG002|Overall Study|Refused to continue study medication|0|||
144439896|NCT01403974|520815273|FG003|Overall Study|Refused to continue study medication|0|||
144439897|NCT01403974|520815274|FG004|Overall Study|Refused to continue study medication|0|||
144439898|NCT01403974|520815275|FG005|Overall Study|Refused to continue study medication|1|||
144439899|NCT01403974|520815276|FG006|Overall Study|Refused to continue study medication|0|||
144439900|NCT01403974|520815277|FG007|Overall Study|Refused to continue study medication|0|||
144439901|NCT01403974|520815278|FG008|Overall Study|Refused to continue study medication|1|||
144439902|NCT01403974|520815279|FG009|Overall Study|Refused to continue study medication|0|||
144439903|NCT01403974|520815280|FG010|Overall Study|Refused to continue study medication|1|||
144439904|NCT01403974|520815281|FG011|Overall Study|Refused to continue study medication|0|||
144439905|NCT01403974|520815282|FG012|Overall Study|Refused to continue study medication|0|||
144439906|NCT01403974|520815283|FG013|Overall Study|Refused to continue study medication|0|||
144439907|NCT01403974|520815284|FG014|Overall Study|Refused to continue study medication|0|||
144439908|NCT01403974|520815285|FG015|Overall Study|Refused to continue study medication|4|||
144439909|NCT01403974|520815270|FG000|Overall Study|Adverse Event|0|||
144439910|NCT01403974|520815271|FG001|Overall Study|Adverse Event|0|||
144439911|NCT01403974|520815272|FG002|Overall Study|Adverse Event|1|||
144439912|NCT01403974|520815273|FG003|Overall Study|Adverse Event|0|||
144439913|NCT01403974|520815274|FG004|Overall Study|Adverse Event|0|||
144439914|NCT01403974|520815275|FG005|Overall Study|Adverse Event|0|||
144439915|NCT01403974|520815276|FG006|Overall Study|Adverse Event|0|||
144439916|NCT01403974|520815277|FG007|Overall Study|Adverse Event|1|||
144439917|NCT01403974|520815278|FG008|Overall Study|Adverse Event|0|||
144530878|NCT04308681|521146319|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
144190672|NCT02065713|519893399|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144190673|NCT01005329|519893402|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
144439918|NCT01403974|520815279|FG009|Overall Study|Adverse Event|0|||
144439919|NCT01403974|520815280|FG010|Overall Study|Adverse Event|0|||
144439920|NCT01403974|520815281|FG011|Overall Study|Adverse Event|0|||
144439921|NCT01403974|520815282|FG012|Overall Study|Adverse Event|1|||
144439922|NCT01403974|520815283|FG013|Overall Study|Adverse Event|0|||
144439923|NCT01403974|520815284|FG014|Overall Study|Adverse Event|0|||
144439924|NCT01403974|520815285|FG015|Overall Study|Adverse Event|0|||
144439925|NCT01403974|520815270|FG000|Overall Study|Other than specified|0|||
144439926|NCT01403974|520815271|FG001|Overall Study|Other than specified|0|||
144439927|NCT01403974|520815272|FG002|Overall Study|Other than specified|0|||
144439928|NCT01403974|520815273|FG003|Overall Study|Other than specified|0|||
144439929|NCT01403974|520815274|FG004|Overall Study|Other than specified|0|||
144439930|NCT01403974|520815275|FG005|Overall Study|Other than specified|0|||
144439931|NCT01403974|520815276|FG006|Overall Study|Other than specified|0|||
144439932|NCT01403974|520815277|FG007|Overall Study|Other than specified|0|||
144439933|NCT01403974|520815278|FG008|Overall Study|Other than specified|0|||
144439934|NCT01403974|520815279|FG009|Overall Study|Other than specified|1|||
144190674|NCT02129647|519893407|FG000|Overall Study|Adverse Event|2|||
144439935|NCT01403974|520815280|FG010|Overall Study|Other than specified|0|||
144530879|NCT04308681|521146320|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
144530880|NCT04308681|521146321|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
144190675|NCT02129647|519893407|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
144190676|NCT02225665|519893408|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
144190677|NCT02225665|519893409|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
144190678|NCT02225665|519893408|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
144190679|NCT02225665|519893409|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
144190680|NCT01311557|519893410|FG000|Overall Study|Serious adverse event|0|||
144190681|NCT01311557|519893411|FG001|Overall Study|Serious adverse event|1|||
144190682|NCT01311557|519893410|FG000|Overall Study|Protocol Violation|4|||
144190683|NCT01311557|519893411|FG001|Overall Study|Protocol Violation|2|||
144190684|NCT01311557|519893410|FG000|Overall Study|Lost to Follow-up|0|||
144530881|NCT04308681|521146322|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
144530882|NCT04308681|521146323|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
144530883|NCT05873556|521146328|FG000|Overall Study|Lost to Follow-up|4|||
144530884|NCT05873556|521146329|FG001|Overall Study|Lost to Follow-up|1|||
144530885|NCT03606408|521146330|FG000|Overall Study|Adverse Event|13|||
144530886|NCT03606408|521146330|FG000|Overall Study|Withdrawal by Subject|7|||
144530887|NCT03606408|521146330|FG000|Overall Study|Physician Decision|4|||
144530888|NCT03606408|521146330|FG000|Overall Study|Lack of Efficacy|2|||
144530889|NCT03606408|521146330|FG000|Overall Study|Death|1|||
144530890|NCT03606408|521146330|FG000|Overall Study|new therapy for study indication|1|||
144530891|NCT03292484|521146336|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
144530892|NCT03292484|521146336|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
144530893|NCT03292484|521146336|FG000|Overall Study|Protocol Violation|2|||
144530894|NCT03292484|521146336|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
144530895|NCT03292484|521146336|FG000|Overall Study|Sponsor decision|349|||
144530896|NCT03292484|521146336|FG000|Overall Study|Lost to Follow-up|7|||
144530897|NCT03292484|521146336|FG000|Overall Study|Coronavirus Disease 2019|1|||
144530898|NCT03292484|521146336|FG000|Overall Study|Other|20|||
144530899|NCT05290493|521146343|FG000|Overall Study|Withdrawal by Subject|2|||
144530900|NCT05290493|521146344|FG001|Overall Study|Withdrawal by Subject|2|||
144530901|NCT05290493|521146343|FG000|Overall Study|Adverse Event|1|||
144530902|NCT05290493|521146344|FG001|Overall Study|Adverse Event|0|||
144530903|NCT05012163|521146348|FG000|Overall Study|Protocol Violation|0|||
144530904|NCT05012163|521146349|FG001|Overall Study|Protocol Violation|0|||
144530905|NCT05012163|521146350|FG002|Overall Study|Protocol Violation|1|||
144530906|NCT05012163|521146351|FG003|Overall Study|Protocol Violation|1|||
144190685|NCT01311557|519893411|FG001|Overall Study|Lost to Follow-up|1|||
144190686|NCT01311557|519893410|FG000|Overall Study|Withdrawal by Subject|1|||
144190687|NCT01311557|519893411|FG001|Overall Study|Withdrawal by Subject|2|||
144190688|NCT00608517|519893412|FG000|Overall Study|Death|1|||
144253547|NCT02886884|520128124|FG002|Follow-up|Withdrawal by Subject|0|||
144439936|NCT01403974|520815281|FG011|Overall Study|Other than specified|1|||
144439937|NCT01403974|520815282|FG012|Overall Study|Other than specified|0|||
144439938|NCT01403974|520815283|FG013|Overall Study|Other than specified|0|||
144439939|NCT01403974|520815284|FG014|Overall Study|Other than specified|0|||
144439940|NCT01403974|520815285|FG015|Overall Study|Other than specified|0|||
144530907|NCT04003246|521146354|FG000|Overall Study|Death|9|||
144530908|NCT05524402|521146366|FG000|Overall Study|Withdrawal by Subject|3|||
144530909|NCT05524402|521146367|FG001|Overall Study|Withdrawal by Subject|1|||
144190689|NCT00608517|519893413|FG001|Overall Study|Death|0|||
144439941|NCT01494610|520815288|FG000|Period 1|Withdrawal by Subject|1|||
144439942|NCT01494610|520815289|FG001|Period 1|Withdrawal by Subject|1|||
144439943|NCT01494610|520815288|FG000|Period 3|Adverse Event|1|||
144439944|NCT01494610|520815289|FG001|Period 3|Adverse Event|0|||
144439945|NCT01494610|520815288|FG000|Period 3|Withdrawal by Subject|1|||
144439946|NCT01494610|520815289|FG001|Period 3|Withdrawal by Subject|0|||
144439947|NCT01494610|520815288|FG000|Period 4|Protocol Violation|1|||
144190690|NCT00608517|519893414|FG002|Overall Study|Death|0|||
144190691|NCT01833533|519893415|FG000|Overall Study|Adverse Event|0|||
144190692|NCT01833533|519893416|FG001|Overall Study|Adverse Event|1|||
144190693|NCT01833533|519893415|FG000|Overall Study|Lost to Follow-up|4|||
144439948|NCT01494610|520815289|FG001|Period 4|Protocol Violation|0|||
144439949|NCT03995953|520815292|FG000|Overall Study|Death|3|||
144439950|NCT03995953|520815293|FG001|Overall Study|Death|0|||
144439951|NCT03995953|520815294|FG002|Overall Study|Death|3|||
144439952|NCT03995953|520815295|FG003|Overall Study|Death|0|||
144439953|NCT03995953|520815296|FG004|Overall Study|Death|3|||
144439954|NCT03995953|520815297|FG005|Overall Study|Death|0|||
144439955|NCT03995953|520815298|FG006|Overall Study|Death|0|||
144439956|NCT03995953|520815299|FG007|Overall Study|Death|0|||
144439957|NCT03995953|520815300|FG008|Overall Study|Death|1|||
144439958|NCT03995953|520815301|FG009|Overall Study|Death|0|||
144439959|NCT03995953|520815302|FG010|Overall Study|Death|0|||
144439960|NCT03995953|520815303|FG011|Overall Study|Death|0|||
144439961|NCT03995953|520815292|FG000|Overall Study|Lost to Follow-up|6|||
144439962|NCT03995953|520815293|FG001|Overall Study|Lost to Follow-up|54|||
144439963|NCT03995953|520815294|FG002|Overall Study|Lost to Follow-up|3|||
144439964|NCT03995953|520815295|FG003|Overall Study|Lost to Follow-up|32|||
144439965|NCT03995953|520815296|FG004|Overall Study|Lost to Follow-up|5|||
144439966|NCT03995953|520815297|FG005|Overall Study|Lost to Follow-up|44|||
144439967|NCT03995953|520815298|FG006|Overall Study|Lost to Follow-up|0|||
144439968|NCT03995953|520815299|FG007|Overall Study|Lost to Follow-up|31|||
144439969|NCT03995953|520815300|FG008|Overall Study|Lost to Follow-up|8|||
144439970|NCT03995953|520815301|FG009|Overall Study|Lost to Follow-up|36|||
144439971|NCT03995953|520815302|FG010|Overall Study|Lost to Follow-up|5|||
144439972|NCT03995953|520815303|FG011|Overall Study|Lost to Follow-up|41|||
144439973|NCT03995953|520815292|FG000|Overall Study|Withdrawal by Subject|4|||
144439974|NCT03995953|520815293|FG001|Overall Study|Withdrawal by Subject|0|||
144439975|NCT03995953|520815294|FG002|Overall Study|Withdrawal by Subject|1|||
144439976|NCT03995953|520815295|FG003|Overall Study|Withdrawal by Subject|0|||
144439977|NCT03995953|520815296|FG004|Overall Study|Withdrawal by Subject|1|||
144439978|NCT03995953|520815297|FG005|Overall Study|Withdrawal by Subject|0|||
144439979|NCT03995953|520815298|FG006|Overall Study|Withdrawal by Subject|1|||
144439980|NCT03995953|520815299|FG007|Overall Study|Withdrawal by Subject|0|||
144439981|NCT03995953|520815300|FG008|Overall Study|Withdrawal by Subject|3|||
144439982|NCT03995953|520815301|FG009|Overall Study|Withdrawal by Subject|0|||
144439983|NCT03995953|520815302|FG010|Overall Study|Withdrawal by Subject|3|||
144439984|NCT03995953|520815303|FG011|Overall Study|Withdrawal by Subject|0|||
144439985|NCT03995953|520815292|FG000|Overall Study|Health Issues|0|||
144439986|NCT03995953|520815293|FG001|Overall Study|Health Issues|0|||
144439987|NCT03995953|520815294|FG002|Overall Study|Health Issues|0|||
144439988|NCT03995953|520815295|FG003|Overall Study|Health Issues|0|||
144439989|NCT03995953|520815296|FG004|Overall Study|Health Issues|1|||
144439990|NCT03995953|520815297|FG005|Overall Study|Health Issues|0|||
144439991|NCT03995953|520815298|FG006|Overall Study|Health Issues|0|||
144439992|NCT03995953|520815299|FG007|Overall Study|Health Issues|0|||
144439993|NCT03995953|520815300|FG008|Overall Study|Health Issues|4|||
144439994|NCT03995953|520815301|FG009|Overall Study|Health Issues|0|||
144439995|NCT03995953|520815302|FG010|Overall Study|Health Issues|0|||
144439996|NCT03995953|520815303|FG011|Overall Study|Health Issues|0|||
144439997|NCT03995953|520815292|FG000|Overall Study|Relocated|11|||
144439998|NCT03995953|520815293|FG001|Overall Study|Relocated|0|||
144439999|NCT03995953|520815294|FG002|Overall Study|Relocated|16|||
144530910|NCT05524402|521146366|FG000|Overall Study|Lost to Follow-up|2|||
144190694|NCT01833533|519893416|FG001|Overall Study|Lost to Follow-up|9|||
144190695|NCT01833533|519893415|FG000|Overall Study|To Enter an Extension Study|0|||
144190696|NCT01833533|519893416|FG001|Overall Study|To Enter an Extension Study|4|||
144190697|NCT01833533|519893415|FG000|Overall Study|Other|2|||
144253548|NCT02886884|520128125|FG003|Follow-up|Withdrawal by Subject|1|||
144440000|NCT03995953|520815295|FG003|Overall Study|Relocated|0|||
144440001|NCT03995953|520815296|FG004|Overall Study|Relocated|14|||
144440002|NCT03995953|520815297|FG005|Overall Study|Relocated|0|||
144440003|NCT03995953|520815298|FG006|Overall Study|Relocated|16|||
144440004|NCT03995953|520815299|FG007|Overall Study|Relocated|0|||
144440005|NCT03995953|520815300|FG008|Overall Study|Relocated|14|||
144190698|NCT01833533|519893416|FG001|Overall Study|Other|7|||
144253549|NCT03420222|520128131|FG000|Overall Study|Withdrawal by Subject|5|||
144440006|NCT03995953|520815301|FG009|Overall Study|Relocated|0|||
144440007|NCT03995953|520815302|FG010|Overall Study|Relocated|15|||
144440008|NCT03995953|520815303|FG011|Overall Study|Relocated|0|||
144440009|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
144440010|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
144440011|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
144440012|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
144440013|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
144440014|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
144440015|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
144440016|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
144440017|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
144440018|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
144440019|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
144440020|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
144440021|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
144440022|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
144440023|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
144440024|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
144440025|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
144440026|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
144440027|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
144440028|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
144440029|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
144440030|NCT02161718|520815306|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
144440031|NCT02161718|520815307|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
144440032|NCT02161718|520815308|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
144440033|NCT02161718|520815306|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
144440034|NCT02161718|520815307|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
144440035|NCT02161718|520815308|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
144440036|NCT02161718|520815306|FG000|Post- Randomization Period|Lost to Follow-up|0|||
144440037|NCT02161718|520815307|FG001|Post- Randomization Period|Lost to Follow-up|9|||
144440038|NCT02161718|520815308|FG002|Post- Randomization Period|Lost to Follow-up|15|||
144440039|NCT02161718|520815306|FG000|Post- Randomization Period|Adverse Event|0|||
144440040|NCT02161718|520815307|FG001|Post- Randomization Period|Adverse Event|9|||
144440041|NCT02161718|520815308|FG002|Post- Randomization Period|Adverse Event|10|||
144440042|NCT02161718|520815306|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
144440043|NCT02161718|520815307|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
144440044|NCT02161718|520815308|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
144440045|NCT02161718|520815306|FG000|Post- Randomization Period|Physician Decision|0|||
144440046|NCT02161718|520815307|FG001|Post- Randomization Period|Physician Decision|2|||
144440047|NCT02161718|520815308|FG002|Post- Randomization Period|Physician Decision|4|||
144440048|NCT02161718|520815306|FG000|Post- Randomization Period|Protocol Violation|0|||
144440049|NCT02161718|520815307|FG001|Post- Randomization Period|Protocol Violation|2|||
144440050|NCT02161718|520815308|FG002|Post- Randomization Period|Protocol Violation|3|||
144440051|NCT02161718|520815306|FG000|Post- Randomization Period|Lack of Efficacy|0|||
144440052|NCT02161718|520815307|FG001|Post- Randomization Period|Lack of Efficacy|0|||
144440053|NCT02161718|520815308|FG002|Post- Randomization Period|Lack of Efficacy|1|||
144440054|NCT02161718|520815306|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
144440055|NCT02161718|520815307|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
144440056|NCT02161718|520815308|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
144440057|NCT02161718|520815306|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
144440058|NCT02161718|520815307|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
144440059|NCT02161718|520815308|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
144440060|NCT02161718|520815306|FG000|Post- Randomization Period|Relocation|0|||
144440061|NCT02161718|520815307|FG001|Post- Randomization Period|Relocation|3|||
144440062|NCT02161718|520815308|FG002|Post- Randomization Period|Relocation|0|||
144440063|NCT01256710|520815313|FG000|Overall Study|Death|449|||
144440064|NCT01256710|520815313|FG000|Overall Study|System Explant|67|||
144440065|NCT01256710|520815313|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
144440066|NCT01256710|520815313|FG000|Overall Study|Lost to Follow-up|67|||
144440067|NCT01256710|520815313|FG000|Overall Study|Withdrawal by Subject|29|||
144440068|NCT01256710|520815313|FG000|Overall Study|Physician Decision|9|||
144440069|NCT01256710|520815313|FG000|Overall Study|Subject Noncompliance|2|||
144440070|NCT01256710|520815313|FG000|Overall Study|Study Terminated by Sponsor|273|||
144440071|NCT01205165|520815314|FG000|Overall Study|Lost to Follow-up|2|||
144440072|NCT02681302|520815318|FG000|Overall Study|Withdrawal by Subject|1|||
144190699|NCT02502734|519893417|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
144190700|NCT02502734|519893418|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
144440073|NCT02681302|520815319|FG001|Overall Study|Withdrawal by Subject|1|||
144440074|NCT02681302|520815320|FG002|Overall Study|Withdrawal by Subject|0|||
144190701|NCT02502734|519893417|FG000|Washout Period|Adverse Event|1|||
144440075|NCT02681302|520815321|FG003|Overall Study|Withdrawal by Subject|0|||
144440076|NCT02681302|520815322|FG004|Overall Study|Withdrawal by Subject|1|||
144190702|NCT02502734|519893418|FG001|Washout Period|Adverse Event|0|||
144440077|NCT02681302|520815323|FG005|Overall Study|Withdrawal by Subject|0|||
144440078|NCT02681302|520815318|FG000|Overall Study|Screen Failure|2|||
144724535|NCT04582539|521846410|FG000|Overall Study|Study Terminated by Sponsor|1|||
144724536|NCT04582539|521846411|FG001|Overall Study|Study Terminated by Sponsor|3|||
144724537|NCT04582539|521846412|FG002|Overall Study|Study Terminated by Sponsor|2|||
144190703|NCT03649412|519893422|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
144190704|NCT03649412|519893423|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
144190705|NCT03649412|519893422|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
144190706|NCT03649412|519893423|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
144440079|NCT02681302|520815319|FG001|Overall Study|Screen Failure|4|||
144440080|NCT02681302|520815320|FG002|Overall Study|Screen Failure|2|||
144440081|NCT02681302|520815321|FG003|Overall Study|Screen Failure|0|||
144440082|NCT02681302|520815322|FG004|Overall Study|Screen Failure|1|||
144440083|NCT02681302|520815323|FG005|Overall Study|Screen Failure|1|||
144440084|NCT02681302|520815318|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
144440085|NCT02681302|520815319|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
144440086|NCT02681302|520815320|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
144440087|NCT02681302|520815321|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
144440088|NCT02681302|520815322|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
144440089|NCT02681302|520815323|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
144440090|NCT02942017|520815324|FG000|Overall Study|Adverse Event|0|||
144440091|NCT02942017|520815325|FG001|Overall Study|Adverse Event|1|||
144440092|NCT02942017|520815324|FG000|Overall Study|Withdrawal by Subject|0|||
144440093|NCT02942017|520815325|FG001|Overall Study|Withdrawal by Subject|1|||
144440094|NCT02942017|520815324|FG000|Overall Study|Lost to Follow-up|1|||
144440095|NCT02942017|520815325|FG001|Overall Study|Lost to Follow-up|1|||
144440096|NCT02942017|520815324|FG000|Overall Study|Randomized but not dosed|1|||
144440097|NCT02942017|520815325|FG001|Overall Study|Randomized but not dosed|3|||
144440098|NCT04399161|520815326|FG000|Overall Study|Withdrawal by Subject|1|||
144440099|NCT04399161|520815327|FG001|Overall Study|Withdrawal by Subject|0|||
144440100|NCT04399161|520815328|FG002|Overall Study|Withdrawal by Subject|2|||
144440101|NCT04399161|520815326|FG000|Overall Study|Protocol Violation|1|||
144440102|NCT04399161|520815327|FG001|Overall Study|Protocol Violation|2|||
144440103|NCT04399161|520815328|FG002|Overall Study|Protocol Violation|0|||
144440104|NCT03417141|520815329|FG000|Overall Study|Withdrawal by Subject|1|||
144440105|NCT03417141|520815329|FG000|Overall Study|Protocol Violation|3|||
144440106|NCT01736696|520815330|FG000|Overall Study|Withdrawal by Subject|0|||
144440107|NCT01736696|520815331|FG001|Overall Study|Withdrawal by Subject|0|||
144440108|NCT01736696|520815332|FG002|Overall Study|Withdrawal by Subject|1|||
144440109|NCT01736696|520815333|FG003|Overall Study|Withdrawal by Subject|0|||
144440110|NCT01736696|520815334|FG004|Overall Study|Withdrawal by Subject|0|||
144440111|NCT01736696|520815335|FG005|Overall Study|Withdrawal by Subject|0|||
144440112|NCT01736696|520815336|FG006|Overall Study|Withdrawal by Subject|0|||
144440113|NCT00838565|520815337|FG000|Overall Study|Withdrawal by Subject|0|||
144440114|NCT00838565|520815338|FG001|Overall Study|Withdrawal by Subject|0|||
144440115|NCT00838565|520815339|FG002|Overall Study|Withdrawal by Subject|1|||
144440116|NCT00838565|520815340|FG003|Overall Study|Withdrawal by Subject|0|||
144440117|NCT00838565|520815341|FG004|Overall Study|Withdrawal by Subject|0|||
144440118|NCT00838565|520815342|FG005|Overall Study|Withdrawal by Subject|2|||
144440119|NCT00838565|520815337|FG000|Overall Study|Other|0|||
144440120|NCT00838565|520815338|FG001|Overall Study|Other|2|||
144440121|NCT00838565|520815339|FG002|Overall Study|Other|0|||
144440122|NCT00838565|520815340|FG003|Overall Study|Other|0|||
144440123|NCT00838565|520815341|FG004|Overall Study|Other|0|||
144440124|NCT00838565|520815342|FG005|Overall Study|Other|0|||
144440125|NCT00838565|520815337|FG000|Overall Study|Randomized but not Treated|0|||
144440126|NCT00838565|520815338|FG001|Overall Study|Randomized but not Treated|1|||
144440127|NCT00838565|520815339|FG002|Overall Study|Randomized but not Treated|0|||
144440128|NCT00838565|520815340|FG003|Overall Study|Randomized but not Treated|0|||
144440129|NCT00838565|520815341|FG004|Overall Study|Randomized but not Treated|0|||
144440130|NCT00838565|520815342|FG005|Overall Study|Randomized but not Treated|0|||
144440131|NCT00458484|520815343|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
144440132|NCT00458484|520815344|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
144440133|NCT00458484|520815345|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
144440134|NCT00458484|520815346|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
144440135|NCT00458484|520815347|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
144440136|NCT00458484|520815348|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
144440137|NCT00458484|520815349|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
144440138|NCT03571516|520815350|FG000|Overall Study|Severe diarrhea|1|||
144440139|NCT03571516|520815351|FG001|Overall Study|Severe diarrhea|0|||
144440140|NCT03571516|520815350|FG000|Overall Study|Withdrawal by Subject|0|||
144440141|NCT03571516|520815351|FG001|Overall Study|Withdrawal by Subject|1|||
144440142|NCT02281552|520815359|FG000|Overall Study|Medication error|1|||
144440143|NCT02281552|520815360|FG001|Overall Study|Medication error|0|||
144440144|NCT02281552|520815359|FG000|Overall Study|Insufficient clinical response|0|||
144440145|NCT02281552|520815360|FG001|Overall Study|Insufficient clinical response|1|||
144440146|NCT02281552|520815359|FG000|Overall Study|Adverse Event|3|||
144440147|NCT02281552|520815360|FG001|Overall Study|Adverse Event|9|||
144440148|NCT01434290|520815361|FG000|Overall Study|Protocol Violation|6|||
144440149|NCT01434290|520815362|FG001|Overall Study|Protocol Violation|3|||
144440150|NCT01434290|520815361|FG000|Overall Study|No protocol treatment|2|||
144440151|NCT01434290|520815362|FG001|Overall Study|No protocol treatment|4|||
144440152|NCT01224639|520815363|FG000|Overall Study|Withdrawal by Subject|0|||
144190707|NCT03649412|519893422|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
144440153|NCT01224639|520815364|FG001|Overall Study|Withdrawal by Subject|0|||
144440154|NCT01224639|520815365|FG002|Overall Study|Withdrawal by Subject|0|||
144440155|NCT01224639|520815366|FG003|Overall Study|Withdrawal by Subject|0|||
144440156|NCT01224639|520815367|FG004|Overall Study|Withdrawal by Subject|2|||
144440157|NCT01224639|520815368|FG005|Overall Study|Withdrawal by Subject|0|||
144440158|NCT01224639|520815369|FG006|Overall Study|Withdrawal by Subject|1|||
144440159|NCT01224639|520815370|FG007|Overall Study|Withdrawal by Subject|1|||
144440160|NCT01224639|520815363|FG000|Overall Study|Adverse Event|0|||
144440161|NCT01224639|520815364|FG001|Overall Study|Adverse Event|0|||
144440162|NCT01224639|520815365|FG002|Overall Study|Adverse Event|0|||
144440163|NCT01224639|520815366|FG003|Overall Study|Adverse Event|0|||
144440164|NCT01224639|520815367|FG004|Overall Study|Adverse Event|0|||
144440165|NCT01224639|520815368|FG005|Overall Study|Adverse Event|0|||
144440166|NCT01224639|520815369|FG006|Overall Study|Adverse Event|0|||
144440167|NCT01224639|520815370|FG007|Overall Study|Adverse Event|1|||
144440168|NCT03465878|520815373|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
144440169|NCT03465878|520815374|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
144440170|NCT03465878|520815375|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
144440171|NCT03465878|520815376|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
144440172|NCT03465878|520815373|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
144440173|NCT03465878|520815374|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
144440174|NCT03465878|520815375|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
144440175|NCT03465878|520815376|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
144440176|NCT03465878|520815373|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
144440177|NCT03465878|520815374|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
144440178|NCT03465878|520815375|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
144440179|NCT03465878|520815376|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
144440180|NCT04656132|520815377|FG000|Overall Study|Lost to Follow-up|4|||
144440181|NCT04656132|520815377|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
144440182|NCT04019041|520815378|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
144440183|NCT04019041|520815379|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
144440184|NCT04019041|520815380|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
144604850|NCT04004429|521415842|FG002|Overall Study|Withdrawal by Subject|1|||
144604851|NCT00646906|521415843|FG000|Crossover Period 1|Withdrawal by Subject|1|||
144604852|NCT00646906|521415844|FG001|Crossover Period 1|Withdrawal by Subject|0|||
144604853|NCT00646906|521415845|FG002|Crossover Period 1|Withdrawal by Subject|0|||
144604854|NCT00646906|521415846|FG003|Crossover Period 1|Withdrawal by Subject|0|||
144604855|NCT00646906|521415847|FG004|Crossover Period 1|Withdrawal by Subject|0|||
144604856|NCT00646906|521415848|FG005|Crossover Period 1|Withdrawal by Subject|1|||
144604857|NCT00646906|521415849|FG006|Crossover Period 1|Withdrawal by Subject|0|||
144604858|NCT00646906|521415843|FG000|Crossover Period 2|Withdrawal by Subject|0|||
144724538|NCT04582539|521846413|FG003|Overall Study|Study Terminated by Sponsor|2|||
144724539|NCT04582539|521846414|FG004|Overall Study|Study Terminated by Sponsor|3|||
144190708|NCT03649412|519893423|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144440185|NCT04019041|520815381|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
144440186|NCT04019041|520815382|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
144440187|NCT04019041|520815383|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
144440188|NCT04019041|520815378|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
144472165|NCT01679236|520926675|FG000|Overall Study|Lost to Follow-up|15|||
144472166|NCT01679236|520926676|FG001|Overall Study|Lost to Follow-up|15|||
144472167|NCT00284141|520926677|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
144472168|NCT00284141|520926677|FG000|Overall Study|Adverse Event|19|||
144472169|NCT00284141|520926677|FG000|Overall Study|Participant's request|9|||
144472170|NCT00284141|520926677|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
144472171|NCT00284141|520926677|FG000|Overall Study|Clinical deterioration / death|2|||
144472172|NCT00284141|520926677|FG000|Overall Study|General decline|1|||
144472173|NCT00284141|520926677|FG000|Overall Study|Pneumonia|1|||
144472174|NCT00284141|520926677|FG000|Overall Study|Did not take study medication|2|||
144472175|NCT00284141|520926677|FG000|Overall Study|Ongoing treatment|2|||
144472176|NCT03935217|520926681|FG000|Overall Study|Adverse Event|1|||
144472177|NCT03935217|520926682|FG001|Overall Study|Adverse Event|0|||
144440189|NCT04019041|520815379|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
144440190|NCT04019041|520815380|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
144440191|NCT04019041|520815381|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
144440192|NCT04019041|520815382|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
144440193|NCT04019041|520815383|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
144440194|NCT04019041|520815378|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
144440195|NCT04019041|520815379|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
144440196|NCT04019041|520815380|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
144440197|NCT04019041|520815381|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
144440198|NCT04019041|520815382|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
144440199|NCT04019041|520815383|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
144440200|NCT04019041|520815378|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
144440201|NCT04019041|520815379|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
144440202|NCT04019041|520815380|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
144440203|NCT04019041|520815381|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
144440204|NCT04019041|520815382|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
144440205|NCT04019041|520815383|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
144440206|NCT04019041|520815378|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
144440207|NCT04019041|520815379|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
144440208|NCT04019041|520815380|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
144440209|NCT04019041|520815381|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
144440210|NCT04019041|520815382|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
144440211|NCT04019041|520815383|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
144440212|NCT04019041|520815378|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
144440213|NCT04019041|520815379|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
144440214|NCT04019041|520815380|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
144440215|NCT04019041|520815381|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
144440216|NCT04019041|520815382|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
144440217|NCT04019041|520815383|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
144440218|NCT04019041|520815378|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
144440219|NCT04019041|520815379|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
144440220|NCT04019041|520815380|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
144440221|NCT04019041|520815381|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
144440222|NCT04019041|520815382|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
144440223|NCT04019041|520815383|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
144440224|NCT04019041|520815378|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
144440225|NCT04019041|520815379|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
144440226|NCT04019041|520815380|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
144440227|NCT04019041|520815381|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
144440228|NCT04019041|520815382|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
144440229|NCT04019041|520815383|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
144440230|NCT04019041|520815378|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144440231|NCT04019041|520815379|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144440232|NCT04019041|520815380|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144440233|NCT04019041|520815381|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144440234|NCT04019041|520815382|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
144440235|NCT04019041|520815383|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
144440236|NCT02540954|520815385|FG000|Overall Study|Physician Decision|3|||
144440237|NCT02540954|520815386|FG001|Overall Study|Physician Decision|1|||
144440238|NCT02540954|520815385|FG000|Overall Study|Withdrawal by Subject|6|||
144440239|NCT02540954|520815386|FG001|Overall Study|Withdrawal by Subject|5|||
144440240|NCT02540954|520815385|FG000|Overall Study|Lost to Follow-up|1|||
144440241|NCT02540954|520815386|FG001|Overall Study|Lost to Follow-up|1|||
144440242|NCT02540954|520815385|FG000|Overall Study|Adverse Event|4|||
144440243|NCT02540954|520815386|FG001|Overall Study|Adverse Event|2|||
144440244|NCT02540954|520815385|FG000|Overall Study|Death|0|||
144440245|NCT02540954|520815386|FG001|Overall Study|Death|3|||
144440246|NCT02540954|520815385|FG000|Overall Study|Treatment failure|1|||
144440247|NCT02540954|520815386|FG001|Overall Study|Treatment failure|0|||
144440248|NCT02540954|520815385|FG000|Overall Study|Other reason|4|||
144440249|NCT02540954|520815386|FG001|Overall Study|Other reason|2|||
144440250|NCT03925727|520815387|FG000|Overall Study|Adverse Event|4|||
144440251|NCT03925727|520815388|FG001|Overall Study|Adverse Event|0|||
144440252|NCT03925727|520815389|FG002|Overall Study|Adverse Event|3|||
144440253|NCT03925727|520815387|FG000|Overall Study|Protocol Violation|1|||
144440254|NCT03925727|520815388|FG001|Overall Study|Protocol Violation|2|||
144440255|NCT03925727|520815389|FG002|Overall Study|Protocol Violation|2|||
144440256|NCT03925727|520815387|FG000|Overall Study|Withdrawal by Subject|3|||
144440257|NCT03925727|520815388|FG001|Overall Study|Withdrawal by Subject|2|||
144440258|NCT03925727|520815389|FG002|Overall Study|Withdrawal by Subject|4|||
144440259|NCT03925727|520815387|FG000|Overall Study|Administrative Reasons|3|||
144440260|NCT03925727|520815388|FG001|Overall Study|Administrative Reasons|1|||
144440261|NCT03925727|520815389|FG002|Overall Study|Administrative Reasons|2|||
144440262|NCT03925727|520815387|FG000|Overall Study|Randomized in error or Disqualified|8|||
144440263|NCT03925727|520815388|FG001|Overall Study|Randomized in error or Disqualified|1|||
144440264|NCT03925727|520815389|FG002|Overall Study|Randomized in error or Disqualified|7|||
144440265|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
144440266|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
144440267|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
144440268|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
144440269|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
144440270|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
144440271|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
144440272|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
144440273|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
144440274|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
144440275|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
144440276|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
144440277|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
144440278|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
144440279|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
144440280|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
144440281|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
144440282|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
144440283|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
144440284|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
144440285|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Other|3|||
144440286|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Other|0|||
144530911|NCT05524402|521146367|FG001|Overall Study|Lost to Follow-up|1|||
144530912|NCT03381586|521146368|FG000|Overall Study|Adverse Event|1|||
144530913|NCT03381586|521146369|FG001|Overall Study|Adverse Event|1|||
144530914|NCT03381586|521146368|FG000|Overall Study|Protocol Violation|1|||
144530915|NCT03381586|521146369|FG001|Overall Study|Protocol Violation|0|||
144530916|NCT03381586|521146368|FG000|Overall Study|Withdrawal by Subject|1|||
144530917|NCT03381586|521146369|FG001|Overall Study|Withdrawal by Subject|2|||
144530918|NCT03673501|521146375|FG000|Overall Study|Participants ongoing.|36|||
144530919|NCT03673501|521146376|FG001|Overall Study|Participants ongoing.|24|||
144530920|NCT05838027|521146377|FG000|Overall Study|Lost to Follow-up|5|||
144530921|NCT05838027|521146378|FG001|Overall Study|Lost to Follow-up|1|||
144530922|NCT05838027|521146377|FG000|Overall Study|Withdrawal by Subject|1|||
144530923|NCT05838027|521146378|FG001|Overall Study|Withdrawal by Subject|0|||
144530924|NCT05237284|521146379|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
144530925|NCT05237284|521146380|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
144530926|NCT05237284|521146381|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
144530927|NCT05237284|521146382|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
144530928|NCT05237284|521146379|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
144530929|NCT05237284|521146380|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
144530930|NCT05237284|521146381|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
144530931|NCT05237284|521146382|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
144530932|NCT05237284|521146379|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
144530933|NCT05237284|521146380|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
144530934|NCT05237284|521146381|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
144530935|NCT05237284|521146382|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
144530936|NCT05237284|521146379|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
144530937|NCT05237284|521146380|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
144530938|NCT05237284|521146381|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
144530939|NCT05237284|521146382|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
144724540|NCT04582539|521846410|FG000|Overall Study|Physician Decision|0|||
144190709|NCT03649412|519893422|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
144190710|NCT03649412|519893423|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
144190711|NCT03649412|519893422|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
144440287|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Other|2|||
144440288|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Other|2|||
144530940|NCT05237284|521146379|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
144530941|NCT05237284|521146380|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
144530942|NCT05237284|521146381|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
144530943|NCT05237284|521146382|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
144530944|NCT05237284|521146379|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
144440289|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Other|7|||
144440290|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440291|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144530945|NCT05237284|521146380|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
144440292|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440293|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
144440294|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440295|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440296|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440297|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440298|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440299|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
144440300|NCT00213148|520815390|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
144440301|NCT00213148|520815391|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
144604859|NCT00646906|521415844|FG001|Crossover Period 2|Withdrawal by Subject|1|||
144604860|NCT00646906|521415845|FG002|Crossover Period 2|Withdrawal by Subject|2|||
144604861|NCT00646906|521415846|FG003|Crossover Period 2|Withdrawal by Subject|1|||
144604862|NCT00646906|521415847|FG004|Crossover Period 2|Withdrawal by Subject|0|||
144604863|NCT00646906|521415848|FG005|Crossover Period 2|Withdrawal by Subject|0|||
144604864|NCT00646906|521415849|FG006|Crossover Period 2|Withdrawal by Subject|0|||
144604865|NCT00646906|521415843|FG000|Crossover Period 2|Physician Decision|0|||
144604866|NCT00646906|521415844|FG001|Crossover Period 2|Physician Decision|0|||
144604867|NCT00646906|521415845|FG002|Crossover Period 2|Physician Decision|0|||
144604868|NCT00646906|521415846|FG003|Crossover Period 2|Physician Decision|0|||
144604869|NCT00646906|521415847|FG004|Crossover Period 2|Physician Decision|0|||
144604870|NCT00646906|521415848|FG005|Crossover Period 2|Physician Decision|0|||
144604871|NCT00646906|521415849|FG006|Crossover Period 2|Physician Decision|1|||
144604872|NCT02448225|521415850|FG000|Overall Study|Withdrawal by Subject|1|||
144604873|NCT02448225|521415850|FG000|Overall Study|Did not get FSPG scan|18|||
144604874|NCT02448225|521415850|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
144604875|NCT04060563|521415853|FG000|Overall Study|Lost to Follow-up|1|||
144604876|NCT04060563|521415854|FG001|Overall Study|Lost to Follow-up|1|||
144604877|NCT04060563|521415853|FG000|Overall Study|Physician Decision|0|||
144604878|NCT04060563|521415854|FG001|Overall Study|Physician Decision|1|||
144604879|NCT00851682|521415855|FG000|Overall Study|screen failure|5|||
144604880|NCT00851682|521415856|FG001|Overall Study|screen failure|0|||
144604881|NCT01379573|521415857|FG000|Overall Study|Lost to Follow-up|1|||
144604882|NCT01379573|521415857|FG000|Overall Study|Screen Failure|10|||
144604883|NCT00962390|521415859|FG000|Overall Study|Adverse Event|0|||
144604884|NCT00962390|521415860|FG001|Overall Study|Adverse Event|0|||
144604885|NCT00962390|521415861|FG002|Overall Study|Adverse Event|3|||
144604886|NCT00962390|521415862|FG003|Overall Study|Adverse Event|1|||
144604887|NCT00962390|521415859|FG000|Overall Study|Lost to Follow-up|2|||
144604888|NCT00962390|521415860|FG001|Overall Study|Lost to Follow-up|2|||
144604889|NCT00962390|521415861|FG002|Overall Study|Lost to Follow-up|0|||
144604890|NCT00962390|521415862|FG003|Overall Study|Lost to Follow-up|0|||
144604891|NCT00962390|521415859|FG000|Overall Study|Protocol Violation|1|||
144604892|NCT00962390|521415860|FG001|Overall Study|Protocol Violation|0|||
144604893|NCT00962390|521415861|FG002|Overall Study|Protocol Violation|0|||
144604894|NCT00962390|521415862|FG003|Overall Study|Protocol Violation|0|||
144604895|NCT00962390|521415859|FG000|Overall Study|Withdrawal by Subject|1|||
144604896|NCT00962390|521415860|FG001|Overall Study|Withdrawal by Subject|1|||
144604897|NCT00962390|521415861|FG002|Overall Study|Withdrawal by Subject|1|||
144604898|NCT00962390|521415862|FG003|Overall Study|Withdrawal by Subject|0|||
144604899|NCT02613884|521415863|FG000|Overall Study|Death|1|||
144604900|NCT02613884|521415863|FG000|Overall Study|Lost to Follow-up|1|||
144604901|NCT02844920|521415866|FG000|Overall Study|Lost to Follow-up|2|||
144604902|NCT01910116|521415867|FG000|Overall Study|Adverse Event|0|||
144604903|NCT01910116|521415868|FG001|Overall Study|Adverse Event|3|||
144604904|NCT01910116|521415867|FG000|Overall Study|Lack of Efficacy|3|||
144190712|NCT03649412|519893423|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
144440302|NCT00213148|520815392|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
144440303|NCT00213148|520815393|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
144440304|NCT00213148|520815394|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
144440305|NCT00213148|520815390|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
144604905|NCT01910116|521415868|FG001|Overall Study|Lack of Efficacy|4|||
144604906|NCT01910116|521415867|FG000|Overall Study|Lost to Follow-up|1|||
144604907|NCT01910116|521415868|FG001|Overall Study|Lost to Follow-up|0|||
144604908|NCT01910116|521415867|FG000|Overall Study|Protocol Violation|1|||
144604909|NCT01910116|521415868|FG001|Overall Study|Protocol Violation|2|||
144604910|NCT01910116|521415867|FG000|Overall Study|Withdrawal by Subject|8|||
144604911|NCT01910116|521415868|FG001|Overall Study|Withdrawal by Subject|3|||
144440306|NCT00213148|520815391|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
144440307|NCT00213148|520815392|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
144440308|NCT00213148|520815393|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
144604912|NCT01910116|521415867|FG000|Overall Study|uncertain allocation|1|||
144604913|NCT01910116|521415868|FG001|Overall Study|uncertain allocation|3|||
144604914|NCT01910116|521415867|FG000|Overall Study|incomplete data|0|||
144604915|NCT01910116|521415868|FG001|Overall Study|incomplete data|1|||
144604916|NCT01849497|521415869|FG000|Overall Study|Withdrawal by Subject|1|||
144440309|NCT00213148|520815394|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
144440310|NCT00213148|520815390|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
144440311|NCT00213148|520815391|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
144440312|NCT00213148|520815392|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
144440313|NCT00213148|520815393|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
144440314|NCT00213148|520815394|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
144440315|NCT00213148|520815390|FG000|Cycle 2 (1 Month)|Other|2|||
144440316|NCT00213148|520815391|FG001|Cycle 2 (1 Month)|Other|1|||
144440317|NCT00213148|520815392|FG002|Cycle 2 (1 Month)|Other|2|||
144440318|NCT00213148|520815393|FG003|Cycle 2 (1 Month)|Other|8|||
144440319|NCT00213148|520815394|FG004|Cycle 2 (1 Month)|Other|7|||
144440320|NCT00213148|520815390|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440321|NCT00213148|520815391|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
144440322|NCT00213148|520815392|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440323|NCT00213148|520815393|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440324|NCT00213148|520815394|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
144440325|NCT00213148|520815390|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
144440326|NCT00213148|520815391|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440327|NCT00213148|520815392|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440328|NCT00213148|520815393|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440329|NCT00213148|520815394|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
144440330|NCT00213148|520815390|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
144440331|NCT00213148|520815391|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
144440332|NCT00213148|520815392|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
144440333|NCT00213148|520815393|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
144440334|NCT00213148|520815394|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
144440335|NCT00213148|520815390|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
144440336|NCT00213148|520815391|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
144440337|NCT00213148|520815392|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
144440338|NCT00213148|520815393|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
144440339|NCT00213148|520815394|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
144440340|NCT00213148|520815390|FG000|Cycle 3 (1 Month)|Other|0|||
144440341|NCT00213148|520815391|FG001|Cycle 3 (1 Month)|Other|0|||
144440342|NCT00213148|520815392|FG002|Cycle 3 (1 Month)|Other|1|||
144440343|NCT00213148|520815393|FG003|Cycle 3 (1 Month)|Other|1|||
144440344|NCT00213148|520815394|FG004|Cycle 3 (1 Month)|Other|0|||
144440345|NCT03080961|520815396|FG000|Overall Study|Withdrawal by Subject|3|||
144440346|NCT01574352|520815397|FG000|Overall Study|Withdrawal by Subject|6|||
144440347|NCT01574352|520815398|FG001|Overall Study|Withdrawal by Subject|13|||
144440348|NCT01574352|520815397|FG000|Overall Study|Injury in non-camp related sport|1|||
144440349|NCT01574352|520815398|FG001|Overall Study|Injury in non-camp related sport|0|||
144440350|NCT00245765|520815399|FG000|Overall Study|Adverse Event|1|||
144440351|NCT00245765|520815400|FG001|Overall Study|Adverse Event|1|||
144440352|NCT00245765|520815401|FG002|Overall Study|Adverse Event|0|||
144604917|NCT01849497|521415870|FG001|Overall Study|Withdrawal by Subject|2|||
144604918|NCT01849497|521415869|FG000|Overall Study|Sponsor Decision|0|||
144604919|NCT01849497|521415870|FG001|Overall Study|Sponsor Decision|1|||
144604920|NCT01849497|521415869|FG000|Overall Study|Lost to Follow-up|0|||
144604921|NCT01849497|521415870|FG001|Overall Study|Lost to Follow-up|1|||
144604922|NCT00911625|521415871|FG000|Overall Study|Lost to Follow-up|7|||
144604923|NCT00911625|521415872|FG001|Overall Study|Lost to Follow-up|0|||
144604924|NCT02729740|521415875|FG000|Overall Study|Early Termination|130|||
144604925|NCT02729740|521415875|FG000|Overall Study|Other|1|||
144604926|NCT00307333|521415876|FG000|Overall Study|Lost to Follow-up|11|||
144604927|NCT00307333|521415877|FG001|Overall Study|Lost to Follow-up|3|||
144604928|NCT01245387|521415878|FG000|Overall Study|Lost to Follow-up|106|||
144604929|NCT01245387|521415878|FG000|Overall Study|Lack of Efficacy|195|||
144604930|NCT01245387|521415878|FG000|Overall Study|Adverse Event|9|||
144604931|NCT01245387|521415878|FG000|Overall Study|Death|3|||
144604932|NCT01245387|521415878|FG000|Overall Study|Other|131|||
144604933|NCT01245387|521415878|FG000|Overall Study|Missing discontinuation status|369|||
144604934|NCT02146599|521415879|FG000|Overall Study|Failed to meet inclusion criteria|5|||
144604935|NCT00760669|521415880|FG000|Overall Study|Not assessed for overall improvement|18|||
144604936|NCT00760669|521415880|FG000|Overall Study|Participants missing efficacy assessment|6|||
144604937|NCT00760669|521415880|FG000|Overall Study|Participants with overlapping cases|1|||
144604938|NCT00760669|521415880|FG000|Overall Study|Took drug before entering in contract|5|||
144604939|NCT02663271|521415884|FG000|Overall Study|Withdrawal by Subject|5|||
144724541|NCT04582539|521846411|FG001|Overall Study|Physician Decision|1|||
144440353|NCT00245765|520815399|FG000|Overall Study|Lack of Efficacy|14|||
144440354|NCT00245765|520815400|FG001|Overall Study|Lack of Efficacy|7|||
144440355|NCT00245765|520815401|FG002|Overall Study|Lack of Efficacy|0|||
144440356|NCT00245765|520815399|FG000|Overall Study|Lost to Follow-up|1|||
144440357|NCT00245765|520815400|FG001|Overall Study|Lost to Follow-up|2|||
144440358|NCT00245765|520815401|FG002|Overall Study|Lost to Follow-up|0|||
144604940|NCT02663271|521415884|FG000|Overall Study|Lack of Efficacy|1|||
144604941|NCT03346057|521415885|FG000|Overall Study|Death|1|||
144604942|NCT03346057|521415886|FG001|Overall Study|Death|2|||
144604943|NCT03346057|521415887|FG002|Overall Study|Death|0|||
144604944|NCT03346057|521415888|FG003|Overall Study|Death|0|||
144604945|NCT03346057|521415885|FG000|Overall Study|Lost to Follow-up|0|||
144604946|NCT03346057|521415886|FG001|Overall Study|Lost to Follow-up|2|||
144604947|NCT03346057|521415887|FG002|Overall Study|Lost to Follow-up|1|||
144604948|NCT03346057|521415888|FG003|Overall Study|Lost to Follow-up|0|||
144604949|NCT03346057|521415885|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
144190713|NCT03649412|519893422|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
144190714|NCT03649412|519893423|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
144190715|NCT03920280|519893424|FG000|Overall Study|Adverse Event|2|||
144190716|NCT03920280|519893425|FG001|Overall Study|Adverse Event|3|||
144190717|NCT03920280|519893424|FG000|Overall Study|Lost to Follow-up|0|||
144190718|NCT03920280|519893425|FG001|Overall Study|Lost to Follow-up|1|||
144190719|NCT03920280|519893424|FG000|Overall Study|Withdrawal by Subject|1|||
144190720|NCT03920280|519893425|FG001|Overall Study|Withdrawal by Subject|1|||
144190721|NCT03920280|519893424|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
144190722|NCT03920280|519893425|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
144190723|NCT01740791|519893426|FG000|Overall Study|Randomized but never treated|5|||
144190724|NCT01740791|519893427|FG001|Overall Study|Randomized but never treated|3|||
144190725|NCT01740791|519893428|FG002|Overall Study|Randomized but never treated|2|||
144190726|NCT01740791|519893429|FG003|Overall Study|Randomized but never treated|2|||
144190727|NCT01740791|519893430|FG004|Overall Study|Randomized but never treated|1|||
144190728|NCT01740791|519893431|FG005|Overall Study|Randomized but never treated|3|||
144190729|NCT01740791|519893426|FG000|Overall Study|Lost to Follow-up|2|||
144190730|NCT01740791|519893427|FG001|Overall Study|Lost to Follow-up|0|||
144190731|NCT01740791|519893428|FG002|Overall Study|Lost to Follow-up|2|||
144190732|NCT01740791|519893429|FG003|Overall Study|Lost to Follow-up|3|||
144190733|NCT01740791|519893430|FG004|Overall Study|Lost to Follow-up|2|||
144190734|NCT01740791|519893431|FG005|Overall Study|Lost to Follow-up|3|||
144190735|NCT01740791|519893426|FG000|Overall Study|Withdrew Consent|4|||
144190736|NCT01740791|519893427|FG001|Overall Study|Withdrew Consent|0|||
144190737|NCT01740791|519893428|FG002|Overall Study|Withdrew Consent|1|||
144190738|NCT01740791|519893429|FG003|Overall Study|Withdrew Consent|2|||
144190739|NCT01740791|519893430|FG004|Overall Study|Withdrew Consent|0|||
144190740|NCT01740791|519893431|FG005|Overall Study|Withdrew Consent|3|||
144190741|NCT01740791|519893426|FG000|Overall Study|Investigator's discretion|1|||
144190742|NCT01740791|519893427|FG001|Overall Study|Investigator's discretion|0|||
144190743|NCT01740791|519893428|FG002|Overall Study|Investigator's discretion|1|||
144190744|NCT01740791|519893429|FG003|Overall Study|Investigator's discretion|0|||
144190745|NCT01740791|519893430|FG004|Overall Study|Investigator's discretion|0|||
144190746|NCT01740791|519893431|FG005|Overall Study|Investigator's discretion|1|||
144190747|NCT01740791|519893426|FG000|Overall Study|Adverse Event|0|||
144190748|NCT01740791|519893427|FG001|Overall Study|Adverse Event|0|||
144440359|NCT00245765|520815399|FG000|Overall Study|Withdrawal by Subject|1|||
144440360|NCT00245765|520815400|FG001|Overall Study|Withdrawal by Subject|0|||
144440361|NCT00245765|520815401|FG002|Overall Study|Withdrawal by Subject|3|||
144440362|NCT00245765|520815399|FG000|Overall Study|Other reason|2|||
144440363|NCT00245765|520815400|FG001|Overall Study|Other reason|0|||
144604950|NCT03346057|521415886|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
144604951|NCT03346057|521415887|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
144604952|NCT03346057|521415888|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
144604953|NCT03346057|521415885|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
144604954|NCT03346057|521415886|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
144604955|NCT03346057|521415887|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
144604956|NCT03346057|521415888|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
144604957|NCT03346057|521415885|FG000|Overall Study|Physician Decision|3|||
144604958|NCT03346057|521415886|FG001|Overall Study|Physician Decision|2|||
144604959|NCT03346057|521415887|FG002|Overall Study|Physician Decision|0|||
144604960|NCT03346057|521415888|FG003|Overall Study|Physician Decision|2|||
144604961|NCT03346057|521415885|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
144724542|NCT04582539|521846412|FG002|Overall Study|Physician Decision|0|||
144724543|NCT04582539|521846413|FG003|Overall Study|Physician Decision|0|||
144440364|NCT00245765|520815401|FG002|Overall Study|Other reason|1|||
144604962|NCT03346057|521415886|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
144604963|NCT03346057|521415887|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
144604964|NCT03346057|521415888|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
144190749|NCT01740791|519893428|FG002|Overall Study|Adverse Event|0|||
144190750|NCT01740791|519893429|FG003|Overall Study|Adverse Event|0|||
144190751|NCT01740791|519893430|FG004|Overall Study|Adverse Event|0|||
144190752|NCT01740791|519893431|FG005|Overall Study|Adverse Event|1|||
144604965|NCT03346057|521415885|FG000|Overall Study|Withdrawal by Subject|1|||
144724544|NCT04582539|521846414|FG004|Overall Study|Physician Decision|0|||
144190753|NCT01463982|519893432|FG000|Overall Study|Withdrawal by Subject|0|||
144440365|NCT00245765|520815399|FG000|Overall Study|Other|13|||
144440366|NCT00245765|520815400|FG001|Overall Study|Other|4|||
144604966|NCT03346057|521415886|FG001|Overall Study|Withdrawal by Subject|0|||
144724545|NCT04582539|521846410|FG000|Overall Study|Withdrawal by Subject|1|||
144440367|NCT00245765|520815401|FG002|Overall Study|Other|4|||
144440368|NCT02741115|520815402|FG000|Overall Study|Adverse Event|1|||
144440369|NCT02741115|520815403|FG001|Overall Study|Adverse Event|0|||
144440370|NCT02741115|520815402|FG000|Overall Study|Lost to Follow-up|7|||
144440371|NCT02741115|520815403|FG001|Overall Study|Lost to Follow-up|4|||
144440372|NCT02741115|520815402|FG000|Overall Study|Withdrawal by Subject|4|||
144440373|NCT02741115|520815403|FG001|Overall Study|Withdrawal by Subject|2|||
144440374|NCT04602624|520815404|FG000|Overall Study|Protocol Deviation|1|||
144440375|NCT04602624|520815404|FG000|Overall Study|Withdrawal by Participant|1|||
144440376|NCT06425458|520815405|FG000|Overall Study|Removed by study team|2|||
144440377|NCT06425458|520815405|FG000|Overall Study|Lost to Follow-up|5|||
144440378|NCT03945981|520815408|FG000|Overall Study|Lost to Follow-up|12|||
144440379|NCT03945981|520815408|FG000|Overall Study|Physician Decision|4|||
144440380|NCT03945981|520815408|FG000|Overall Study|Withdrawal by Subject|6|||
144440381|NCT03945981|520815408|FG000|Overall Study|Protocol Violation|1|||
144440382|NCT04466891|520815409|FG000|Overall Study|Death|60|||
144440383|NCT04466891|520815410|FG001|Overall Study|Death|6|||
144440384|NCT04466891|520815409|FG000|Overall Study|Withdrawal by Subject|8|||
144440385|NCT04466891|520815410|FG001|Overall Study|Withdrawal by Subject|1|||
144440386|NCT04466891|520815409|FG000|Overall Study|Study terminated by sponsor|5|||
144440387|NCT04466891|520815410|FG001|Overall Study|Study terminated by sponsor|0|||
144440388|NCT04466891|520815409|FG000|Overall Study|Lost to Follow-up|2|||
144440389|NCT04466891|520815410|FG001|Overall Study|Lost to Follow-up|0|||
144440390|NCT04466891|520815409|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
144440391|NCT04466891|520815410|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
144440392|NCT00445328|520815411|FG000|Overall Study|Death|0|||
144440393|NCT00445328|520815412|FG001|Overall Study|Death|1|||
144440394|NCT00445328|520815411|FG000|Overall Study|Adverse Event|0|||
144440395|NCT00445328|520815412|FG001|Overall Study|Adverse Event|3|||
144440396|NCT00445328|520815411|FG000|Overall Study|Other|0|||
144440397|NCT00445328|520815412|FG001|Overall Study|Other|2|||
144440398|NCT00445328|520815411|FG000|Overall Study|Withdrawal by Subject|2|||
144440399|NCT00445328|520815412|FG001|Overall Study|Withdrawal by Subject|0|||
144440400|NCT00445328|520815411|FG000|Overall Study|Protocol Violation|1|||
144440401|NCT00445328|520815412|FG001|Overall Study|Protocol Violation|0|||
144440402|NCT00779675|520816960|FG000|Treatment Period|Adverse Event|87|||
144440403|NCT00779675|520816960|FG000|Treatment Period|Treatment Failure|80|||
144440404|NCT00779675|520816960|FG000|Treatment Period|Transferred to Another Study|38|||
144440405|NCT00779675|520816960|FG000|Treatment Period|Lost to Follow-up|23|||
144440406|NCT00779675|520816960|FG000|Treatment Period|Withdrawal by Subject|46|||
144440407|NCT00779675|520816960|FG000|Treatment Period|Protocol Violation|54|||
144440408|NCT00779675|520816960|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
144440409|NCT00779675|520816960|FG000|Treatment Period|Administrative|3|||
144440410|NCT00779675|520816960|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
144440411|NCT00779675|520816960|FG000|Extended Treatment Period|Protocol Violation|13|||
144440412|NCT00779675|520816960|FG000|Extended Treatment Period|Adverse Event|6|||
144440413|NCT00779675|520816960|FG000|Extended Treatment Period|Treatment Failure|11|||
144440414|NCT00779675|520816960|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
144440415|NCT00779675|520816960|FG000|Extended Treatment Period|Lost to Follow-up|6|||
144440416|NCT01440322|520816961|FG000|Overall Study|Discomfort|2|||
144440417|NCT01440322|520816962|FG001|Overall Study|Discomfort|0|||
144440418|NCT01440322|520816961|FG000|Overall Study|Biomicroscopy|1|||
144440419|NCT01440322|520816962|FG001|Overall Study|Biomicroscopy|0|||
144440420|NCT01440322|520816961|FG000|Overall Study|Symptoms and Problems|1|||
144440421|NCT01440322|520816962|FG001|Overall Study|Symptoms and Problems|0|||
144530946|NCT05237284|521146381|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
144530947|NCT05237284|521146382|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
144530948|NCT05237284|521146379|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
144530949|NCT05237284|521146380|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
144530950|NCT05237284|521146381|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
144530951|NCT05237284|521146382|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
144530952|NCT05237284|521146379|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
144530953|NCT05237284|521146380|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
144530954|NCT05237284|521146381|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
144440422|NCT01440322|520816961|FG000|Overall Study|Unacceptable Subjective Vision|1|||
144440423|NCT01440322|520816962|FG001|Overall Study|Unacceptable Subjective Vision|0|||
144440424|NCT01440322|520816961|FG000|Overall Study|Other Product Related|1|||
144440425|NCT01440322|520816962|FG001|Overall Study|Other Product Related|0|||
144440426|NCT01440322|520816961|FG000|Overall Study|Unrelated Medical Problem|0|||
144440427|NCT01440322|520816962|FG001|Overall Study|Unrelated Medical Problem|1|||
144440428|NCT01440322|520816961|FG000|Overall Study|Other Non-Product Related|1|||
144440429|NCT01440322|520816962|FG001|Overall Study|Other Non-Product Related|0|||
144440430|NCT01956110|520816972|FG000|Overall Study|Protocol Violation|25|||
144440431|NCT01956110|520816973|FG001|Overall Study|Protocol Violation|11|||
144190754|NCT01463982|519893433|FG001|Overall Study|Withdrawal by Subject|1|||
144190755|NCT01463982|519893434|FG002|Overall Study|Withdrawal by Subject|1|||
144190756|NCT01463982|519893435|FG003|Overall Study|Withdrawal by Subject|0|||
144190757|NCT01463982|519893432|FG000|Overall Study|Treatment delay over 5 week|0|||
144190758|NCT01463982|519893433|FG001|Overall Study|Treatment delay over 5 week|0|||
144190759|NCT01463982|519893434|FG002|Overall Study|Treatment delay over 5 week|1|||
144190760|NCT01463982|519893435|FG003|Overall Study|Treatment delay over 5 week|0|||
144190761|NCT02075606|519893438|FG000|Overall Study|Adverse Event|5|||
144190762|NCT02075606|519893438|FG000|Overall Study|Withdrawal by Subject|1|||
144190763|NCT02075606|519893438|FG000|Overall Study|Death|1|||
144190764|NCT02075606|519893438|FG000|Overall Study|Investigator's decision|1|||
144190765|NCT02075606|519893438|FG000|Overall Study|Symptom management|1|||
144190766|NCT02075606|519893438|FG000|Overall Study|Increasing Symptoms|1|||
144190767|NCT04019054|519893441|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
144190768|NCT04019054|519893442|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
144190769|NCT04019054|519893441|FG000|Overall Study|Withdrawal by Subject|3|||
144190770|NCT04019054|519893442|FG001|Overall Study|Withdrawal by Subject|1|||
144190771|NCT01261624|519893447|FG000|Week 0 to Week 12|Disease Progression|1|||
144190772|NCT01261624|519893448|FG001|Week 0 to Week 12|Disease Progression|1|||
144190773|NCT01261624|519893447|FG000|Week 0 to Week 12|Insufficient Response|0|||
144190774|NCT01261624|519893448|FG001|Week 0 to Week 12|Insufficient Response|2|||
144190775|NCT01261624|519893447|FG000|Week 13 to Week 24|Insufficient Response|0|||
144190776|NCT01261624|519893448|FG001|Week 13 to Week 24|Insufficient Response|1|||
144190777|NCT00508027|519893453|FG000|Dose Level 1|Lost to Follow-up|4|||
144190778|NCT00508027|519893453|FG000|Dose Level 1|Withdrawal by Subject|2|||
144190779|NCT00508027|519893453|FG000|Dose Level 1|Physician Decision|2|||
144724546|NCT04582539|521846411|FG001|Overall Study|Withdrawal by Subject|0|||
144724547|NCT04582539|521846412|FG002|Overall Study|Withdrawal by Subject|2|||
144724548|NCT04582539|521846413|FG003|Overall Study|Withdrawal by Subject|1|||
144724549|NCT04582539|521846414|FG004|Overall Study|Withdrawal by Subject|0|||
144440432|NCT01956110|520816972|FG000|Overall Study|Adverse Event|9|||
144440433|NCT01956110|520816973|FG001|Overall Study|Adverse Event|10|||
144440434|NCT01956110|520816972|FG000|Overall Study|Personal reasons|1|||
144440435|NCT01956110|520816973|FG001|Overall Study|Personal reasons|1|||
144440436|NCT00701129|520816977|FG000|Overall Study|Death|2|||
144604967|NCT03346057|521415887|FG002|Overall Study|Withdrawal by Subject|0|||
144604968|NCT03346057|521415888|FG003|Overall Study|Withdrawal by Subject|0|||
144604969|NCT02921269|521415889|FG000|Overall Study|Did not complete DLT period|1|||
144604970|NCT01174238|521415900|FG000|Overall Study|Lost to Follow-up|2|||
144604971|NCT00504153|521415902|FG000|Overall Study|Withdrawal by Subject|1|||
144604972|NCT00504153|521415902|FG000|Overall Study|Adverse Event|4|||
144604973|NCT00504153|521415902|FG000|Overall Study|Death|1|||
144604974|NCT02322229|521415903|FG000|Overall Study|Physician Decision|2|||
144604975|NCT00521053|521415904|FG000|Observation Phase|Disease Progression|55|||
144604976|NCT00521053|521415904|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
144604977|NCT00521053|521415904|FG000|Observation Phase|Death|2|||
144724550|NCT04582539|521846410|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
144724551|NCT04582539|521846411|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
144724552|NCT04582539|521846412|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
144190780|NCT00508027|519893453|FG000|Dose Level 2|Lost to Follow-up|2|||
144190781|NCT00508027|519893453|FG000|Dose Level 2|Withdrawal by Subject|2|||
144190782|NCT02039063|519893454|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
144190783|NCT02039063|519893455|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
144190784|NCT02039063|519893456|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
144190785|NCT02039063|519893457|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
144190786|NCT02039063|519893454|FG000|Treatment Phase|Progression of disease|0|||
144190787|NCT02039063|519893455|FG001|Treatment Phase|Progression of disease|0|||
144190788|NCT02039063|519893456|FG002|Treatment Phase|Progression of disease|1|||
144190789|NCT02039063|519893457|FG003|Treatment Phase|Progression of disease|1|||
144190790|NCT02039063|519893454|FG000|Extension Phase|Inadequate therapeutic effect|0|||
144190791|NCT02039063|519893455|FG001|Extension Phase|Inadequate therapeutic effect|1|||
144190792|NCT02039063|519893456|FG002|Extension Phase|Inadequate therapeutic effect|2|||
144190793|NCT02039063|519893457|FG003|Extension Phase|Inadequate therapeutic effect|0|||
144190794|NCT02039063|519893454|FG000|Extension Phase|Progression of disease|0|||
144190795|NCT02039063|519893455|FG001|Extension Phase|Progression of disease|0|||
144440437|NCT02412631|520816978|FG000|Overall Study|Adverse Event|1|||
144190796|NCT02039063|519893456|FG002|Extension Phase|Progression of disease|0|||
144190797|NCT02039063|519893457|FG003|Extension Phase|Progression of disease|1|||
144440438|NCT02412631|520816979|FG001|Overall Study|Adverse Event|2|||
144604978|NCT00521053|521415904|FG000|Observation Phase|Adverse Event|1|||
144604979|NCT00521053|521415904|FG000|Observation Phase|Other non-study melanoma treatment|1|||
144604980|NCT00521053|521415904|FG000|Observation Phase|Physician Decision|1|||
144190798|NCT02039063|519893454|FG000|Extension Phase|Adverse Event|0|||
144190799|NCT02039063|519893455|FG001|Extension Phase|Adverse Event|0|||
144530955|NCT05237284|521146382|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
144530956|NCT05237284|521146379|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
144530957|NCT05237284|521146380|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
144530958|NCT05237284|521146381|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
144530959|NCT05237284|521146382|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
144530960|NCT04599634|521146383|FG000|Overall Study|Dose limiting toxicity|0|||
144530961|NCT04599634|521146384|FG001|Overall Study|Dose limiting toxicity|0|||
144530962|NCT04599634|521146385|FG002|Overall Study|Dose limiting toxicity|2|||
144530963|NCT04599634|521146386|FG003|Overall Study|Dose limiting toxicity|0|||
144530964|NCT03714815|521146389|FG000|Overall Study|Physician Decision|2|||
144530965|NCT03714815|521146389|FG000|Overall Study|Withdrawal by Subject|2|||
144530966|NCT03714815|521146389|FG000|Overall Study|Death|11|||
144530967|NCT03733925|521146394|FG000|Overall Study|Lost to Follow-up|1|||
144530968|NCT03733925|521146394|FG000|Overall Study|Withdrawal by Subject|2|||
144530969|NCT03733925|521146394|FG000|Overall Study|Adverse Event|2|||
144530970|NCT03733925|521146394|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144530971|NCT02224144|521146395|FG000|Overall Study|Lost to Follow-up|3|||
144724553|NCT04582539|521846413|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
144724554|NCT04582539|521846414|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
144724555|NCT00788957|521846423|FG000|Part 1|Death|8|||
144724556|NCT00788957|521846424|FG001|Part 1|Death|0|||
144724557|NCT00788957|521846425|FG002|Part 1|Death|0|||
144440439|NCT02412631|520816978|FG000|Overall Study|Lost to Follow-up|5|||
144440440|NCT02412631|520816979|FG001|Overall Study|Lost to Follow-up|9|||
144440441|NCT02412631|520816978|FG000|Overall Study|Withdrawal by Subject|9|||
144440442|NCT02412631|520816979|FG001|Overall Study|Withdrawal by Subject|3|||
144440443|NCT02412631|520816978|FG000|Overall Study|Early stop by FDA|5|||
144440444|NCT02412631|520816979|FG001|Overall Study|Early stop by FDA|2|||
144440445|NCT02412631|520816978|FG000|Overall Study|Unspecified reason|6|||
144440446|NCT02412631|520816979|FG001|Overall Study|Unspecified reason|8|||
144440447|NCT02884089|520816987|FG000|Period 1|Dosing error|2|||
144440448|NCT02884089|520816988|FG001|Period 1|Dosing error|2|||
144440449|NCT02884089|520816989|FG002|Period 1|Dosing error|0|||
144440450|NCT02884089|520816990|FG003|Period 1|Dosing error|0|||
144440451|NCT02884089|520816987|FG000|Washout Period 1|Lost to Follow-up|0|||
144440452|NCT02884089|520816988|FG001|Washout Period 1|Lost to Follow-up|1|||
144440453|NCT02884089|520816989|FG002|Washout Period 1|Lost to Follow-up|0|||
144440454|NCT02884089|520816990|FG003|Washout Period 1|Lost to Follow-up|1|||
144440455|NCT02884089|520816987|FG000|Washout Period 1|Withdrawal by Subject|0|||
144440456|NCT02884089|520816988|FG001|Washout Period 1|Withdrawal by Subject|1|||
144440457|NCT02884089|520816989|FG002|Washout Period 1|Withdrawal by Subject|0|||
144440458|NCT02884089|520816990|FG003|Washout Period 1|Withdrawal by Subject|0|||
144440459|NCT02884089|520816987|FG000|Period 2|Adverse Event|1|||
144530972|NCT02224144|521146396|FG001|Overall Study|Lost to Follow-up|1|||
144604981|NCT04029961|521415905|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
144604982|NCT04029961|521415906|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
144604983|NCT04029961|521415905|FG000|Overall Study|Change in Treatment Course|0|||
144604984|NCT04029961|521415906|FG001|Overall Study|Change in Treatment Course|1|||
144604985|NCT02281357|521415907|FG000|Overall Study|Adverse Event|2|||
144604986|NCT02281357|521415908|FG001|Overall Study|Adverse Event|1|||
144604987|NCT02281357|521415907|FG000|Overall Study|Lost to Follow-up|1|||
144604988|NCT02281357|521415908|FG001|Overall Study|Lost to Follow-up|0|||
144604989|NCT02281357|521415907|FG000|Overall Study|Withdrawal by Subject|4|||
144604990|NCT02281357|521415908|FG001|Overall Study|Withdrawal by Subject|3|||
144604991|NCT00228566|521415909|FG000|Overall Study|Adverse Event|31|||
144604992|NCT00228566|521415909|FG000|Overall Study|Lack of Efficacy|14|||
144604993|NCT00228566|521415909|FG000|Overall Study|Lost to Follow-up|16|||
144604994|NCT00228566|521415909|FG000|Overall Study|Physician Decision|5|||
144604995|NCT00228566|521415909|FG000|Overall Study|Withdrawal by Subject|4|||
144604996|NCT00228566|521415909|FG000|Overall Study|Miscellaneous|1|||
144604997|NCT01624259|521415910|FG000|Overall Study|Adverse Event|18|||
144604998|NCT01624259|521415911|FG001|Overall Study|Adverse Event|18|||
144604999|NCT01624259|521415910|FG000|Overall Study|Protocol Violation|1|||
144724558|NCT00788957|521846426|FG003|Part 1|Death|0|||
144440460|NCT02884089|520816988|FG001|Period 2|Adverse Event|0|||
144440461|NCT02884089|520816989|FG002|Period 2|Adverse Event|0|||
144440462|NCT02884089|520816990|FG003|Period 2|Adverse Event|0|||
144440463|NCT02884089|520816987|FG000|Period 3|Withdrawal by Subject|0|||
144530973|NCT02224144|521146395|FG000|Overall Study|Death|2|||
144530974|NCT02224144|521146396|FG001|Overall Study|Death|0|||
144605000|NCT01624259|521415911|FG001|Overall Study|Protocol Violation|2|||
144605001|NCT01624259|521415910|FG000|Overall Study|Withdrawal by Subject|5|||
144605002|NCT01624259|521415911|FG001|Overall Study|Withdrawal by Subject|7|||
144605003|NCT01624259|521415910|FG000|Overall Study|Physician Decision|1|||
144605004|NCT01624259|521415911|FG001|Overall Study|Physician Decision|1|||
144605005|NCT01624259|521415910|FG000|Overall Study|Lost to Follow-up|2|||
144724559|NCT00788957|521846427|FG004|Part 1|Death|0|||
144724560|NCT00788957|521846428|FG005|Part 1|Death|0|||
144724561|NCT00788957|521846423|FG000|Part 1|Lost to Follow-up|1|||
144724562|NCT00788957|521846424|FG001|Part 1|Lost to Follow-up|0|||
144724563|NCT00788957|521846425|FG002|Part 1|Lost to Follow-up|0|||
144724564|NCT00788957|521846426|FG003|Part 1|Lost to Follow-up|0|||
144724565|NCT00788957|521846427|FG004|Part 1|Lost to Follow-up|0|||
144724566|NCT00788957|521846428|FG005|Part 1|Lost to Follow-up|0|||
144724567|NCT00788957|521846423|FG000|Part 2|Withdrawal by Subject|0|||
144724568|NCT00788957|521846424|FG001|Part 2|Withdrawal by Subject|9|||
144724569|NCT00788957|521846425|FG002|Part 2|Withdrawal by Subject|5|||
144724570|NCT00788957|521846426|FG003|Part 2|Withdrawal by Subject|3|||
144724571|NCT00788957|521846427|FG004|Part 2|Withdrawal by Subject|0|||
144724572|NCT00788957|521846428|FG005|Part 2|Withdrawal by Subject|0|||
144724573|NCT00788957|521846423|FG000|Part 2|Death|0|||
144724574|NCT00788957|521846424|FG001|Part 2|Death|32|||
144724575|NCT00788957|521846425|FG002|Part 2|Death|35|||
144724576|NCT00788957|521846426|FG003|Part 2|Death|37|||
144724577|NCT00788957|521846427|FG004|Part 2|Death|0|||
144724578|NCT00788957|521846428|FG005|Part 2|Death|0|||
144724579|NCT00788957|521846423|FG000|Part 2|Lost to Follow-up|0|||
144724580|NCT00788957|521846424|FG001|Part 2|Lost to Follow-up|0|||
144724581|NCT00788957|521846425|FG002|Part 2|Lost to Follow-up|3|||
144724582|NCT00788957|521846426|FG003|Part 2|Lost to Follow-up|0|||
144724583|NCT00788957|521846427|FG004|Part 2|Lost to Follow-up|0|||
144724584|NCT00788957|521846428|FG005|Part 2|Lost to Follow-up|0|||
144724585|NCT00788957|521846423|FG000|Part 2|On-study at time of data cut-off|0|||
144724586|NCT00788957|521846424|FG001|Part 2|On-study at time of data cut-off|1|||
144724587|NCT00788957|521846425|FG002|Part 2|On-study at time of data cut-off|1|||
144724588|NCT00788957|521846426|FG003|Part 2|On-study at time of data cut-off|1|||
144253550|NCT03420222|520128132|FG001|Overall Study|Withdrawal by Subject|0|||
144253551|NCT03420222|520128131|FG000|Overall Study|Physician Decision|0|||
144440464|NCT02884089|520816988|FG001|Period 3|Withdrawal by Subject|0|||
144440465|NCT02884089|520816989|FG002|Period 3|Withdrawal by Subject|1|||
144440466|NCT02884089|520816990|FG003|Period 3|Withdrawal by Subject|0|||
144440467|NCT02884089|520816987|FG000|Washout Period 3|Withdrawal by Subject|0|||
144440468|NCT02884089|520816988|FG001|Washout Period 3|Withdrawal by Subject|0|||
144440469|NCT02884089|520816989|FG002|Washout Period 3|Withdrawal by Subject|1|||
144440470|NCT02884089|520816990|FG003|Washout Period 3|Withdrawal by Subject|0|||
144440471|NCT02884089|520816987|FG000|Washout Period 3|Lost to Follow-up|0|||
144440472|NCT02884089|520816988|FG001|Washout Period 3|Lost to Follow-up|0|||
144440473|NCT02884089|520816989|FG002|Washout Period 3|Lost to Follow-up|0|||
144440474|NCT02884089|520816990|FG003|Washout Period 3|Lost to Follow-up|1|||
144440475|NCT02884089|520816987|FG000|Period 4|Withdrawal by Subject|0|||
144440476|NCT02884089|520816988|FG001|Period 4|Withdrawal by Subject|1|||
144440477|NCT02884089|520816989|FG002|Period 4|Withdrawal by Subject|0|||
144440478|NCT02884089|520816990|FG003|Period 4|Withdrawal by Subject|0|||
144440479|NCT02884089|520816987|FG000|Period 4|Lost to Follow-up|1|||
144440480|NCT02884089|520816988|FG001|Period 4|Lost to Follow-up|0|||
144440481|NCT02884089|520816989|FG002|Period 4|Lost to Follow-up|0|||
144440482|NCT02884089|520816990|FG003|Period 4|Lost to Follow-up|0|||
144440483|NCT02884089|520816987|FG000|Follow-up Visit|Withdrawal by Subject|1|||
144440484|NCT02884089|520816988|FG001|Follow-up Visit|Withdrawal by Subject|0|||
144440485|NCT02884089|520816989|FG002|Follow-up Visit|Withdrawal by Subject|0|||
144530975|NCT02224144|521146395|FG000|Overall Study|Withdrawal by Subject|0|||
144530976|NCT02224144|521146396|FG001|Overall Study|Withdrawal by Subject|1|||
144530977|NCT03276676|521146399|FG000|Overall Study|Withdrawal by Subject|2|||
144530978|NCT03276676|521146400|FG001|Overall Study|Withdrawal by Subject|1|||
144530979|NCT02962076|521146402|FG000|Overall Study|MHED tracer not available|5|||
144530980|NCT02962076|521146402|FG000|Overall Study|Protocol Violation|1|||
144530981|NCT02962076|521146402|FG000|Overall Study|Physician Decision|1|||
144530982|NCT02988661|521146403|FG000|Overall Study|Death|2|||
144530983|NCT02988661|521146404|FG001|Overall Study|Death|18|||
144530984|NCT02988661|521146403|FG000|Overall Study|Lost to Follow-up|0|||
144530985|NCT02988661|521146404|FG001|Overall Study|Lost to Follow-up|33|||
144530986|NCT02988661|521146403|FG000|Overall Study|Withdrawal by Subject|0|||
144724589|NCT00788957|521846427|FG004|Part 2|On-study at time of data cut-off|0|||
144253552|NCT03420222|520128132|FG001|Overall Study|Physician Decision|1|||
144440486|NCT02884089|520816990|FG003|Follow-up Visit|Withdrawal by Subject|1|||
144440487|NCT01631474|520816991|FG000|Overall Study|Lost to Follow-up|8|||
144440488|NCT01631474|520816992|FG001|Overall Study|Lost to Follow-up|5|||
144440489|NCT01631474|520816993|FG002|Overall Study|Lost to Follow-up|7|||
144440490|NCT01631474|520816994|FG003|Overall Study|Lost to Follow-up|5|||
144724590|NCT00788957|521846428|FG005|Part 2|On-study at time of data cut-off|0|||
144724591|NCT00788957|521846423|FG000|Part 3|Withdrawal by Subject|0|||
144440491|NCT01631474|520816995|FG004|Overall Study|Lost to Follow-up|5|||
144530987|NCT02988661|521146404|FG001|Overall Study|Withdrawal by Subject|6|||
144530988|NCT02988661|521146403|FG000|Overall Study|Unable to complete the 18-month survey|1|||
144724592|NCT00788957|521846424|FG001|Part 3|Withdrawal by Subject|0|||
144724593|NCT00788957|521846425|FG002|Part 3|Withdrawal by Subject|0|||
144724594|NCT00788957|521846426|FG003|Part 3|Withdrawal by Subject|0|||
144724595|NCT00788957|521846427|FG004|Part 3|Withdrawal by Subject|0|||
144605006|NCT01624259|521415911|FG001|Overall Study|Lost to Follow-up|3|||
144605007|NCT01624259|521415910|FG000|Overall Study|Abnormal laboratory measure|3|||
144605008|NCT01624259|521415911|FG001|Overall Study|Abnormal laboratory measure|0|||
144605009|NCT01479829|521415917|FG000|Overall Study|Withdrawal by Subject|8|||
144605010|NCT01479829|521415918|FG001|Overall Study|Withdrawal by Subject|10|||
144605011|NCT02229539|521417005|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
144605012|NCT02229539|521417006|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
144605013|NCT02229539|521417007|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
144605014|NCT02229539|521417005|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
144605015|NCT02229539|521417006|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
144605016|NCT02229539|521417007|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
144605017|NCT02229539|521417005|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
144605018|NCT02229539|521417006|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
144605019|NCT02229539|521417007|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
144605020|NCT02229539|521417005|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
144605021|NCT02229539|521417006|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
144605022|NCT02229539|521417007|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
144605023|NCT02229539|521417005|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
144605024|NCT02229539|521417006|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
144605025|NCT02229539|521417007|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
144605026|NCT02229539|521417005|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
144605027|NCT02229539|521417006|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
144605028|NCT02229539|521417007|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
144605029|NCT02060383|521417008|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
144605030|NCT02060383|521417009|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
144190800|NCT02039063|519893456|FG002|Extension Phase|Adverse Event|1|||
144440492|NCT01631474|520816991|FG000|Overall Study|Withdrawal by Subject|4|||
144440493|NCT01631474|520816992|FG001|Overall Study|Withdrawal by Subject|4|||
144440494|NCT01631474|520816993|FG002|Overall Study|Withdrawal by Subject|2|||
144440495|NCT01631474|520816994|FG003|Overall Study|Withdrawal by Subject|6|||
144440496|NCT01631474|520816995|FG004|Overall Study|Withdrawal by Subject|5|||
144440497|NCT01631474|520816991|FG000|Overall Study|Lack of Efficacy|2|||
144440498|NCT01631474|520816992|FG001|Overall Study|Lack of Efficacy|2|||
144440499|NCT01631474|520816993|FG002|Overall Study|Lack of Efficacy|0|||
144440500|NCT01631474|520816994|FG003|Overall Study|Lack of Efficacy|0|||
144440501|NCT01631474|520816995|FG004|Overall Study|Lack of Efficacy|2|||
144440502|NCT01631474|520816991|FG000|Overall Study|Noncompliance with Study Drug|0|||
144440503|NCT01631474|520816992|FG001|Overall Study|Noncompliance with Study Drug|0|||
144440504|NCT01631474|520816993|FG002|Overall Study|Noncompliance with Study Drug|0|||
144440505|NCT01631474|520816994|FG003|Overall Study|Noncompliance with Study Drug|0|||
144440506|NCT01631474|520816995|FG004|Overall Study|Noncompliance with Study Drug|1|||
144440507|NCT01631474|520816991|FG000|Overall Study|Adverse Event|0|||
144440508|NCT01631474|520816992|FG001|Overall Study|Adverse Event|1|||
144440509|NCT01631474|520816993|FG002|Overall Study|Adverse Event|0|||
144440510|NCT01631474|520816994|FG003|Overall Study|Adverse Event|0|||
144440511|NCT01631474|520816995|FG004|Overall Study|Adverse Event|0|||
144440512|NCT01467076|520816996|FG000|Overall Study|Lost to Follow-up|1|||
144440513|NCT01467076|520816997|FG001|Overall Study|Lost to Follow-up|0|||
144440514|NCT01467076|520816998|FG002|Overall Study|Lost to Follow-up|0|||
144440515|NCT03354429|520816999|FG000|Overall Study|Withdrawal by Subject|8|||
144440516|NCT03354429|520817000|FG001|Overall Study|Withdrawal by Subject|7|||
144440517|NCT03354429|520816999|FG000|Overall Study|Lost to Follow-up|1|||
144440518|NCT03354429|520817000|FG001|Overall Study|Lost to Follow-up|0|||
144190801|NCT02039063|519893457|FG003|Extension Phase|Adverse Event|0|||
144190802|NCT00467831|519893459|FG000|Overall Study|Death|2|||
144190803|NCT00467831|519893459|FG000|Overall Study|Withdrawal by Subject|1|||
144190804|NCT01832402|519893462|FG000|Overall Study|Lost to Follow-up|2|||
144190805|NCT01832402|519893463|FG001|Overall Study|Lost to Follow-up|0|||
144190806|NCT01832402|519893462|FG000|Overall Study|Withdrawal by Subject|3|||
144440519|NCT02624284|520817001|FG000|Overall Study|Withdrawal by Subject|3|||
144440520|NCT02624284|520817002|FG001|Overall Study|Withdrawal by Subject|6|||
144440521|NCT02624284|520817003|FG002|Overall Study|Withdrawal by Subject|3|||
144440522|NCT02624284|520817001|FG000|Overall Study|Protocol Violation|9|||
144440523|NCT02624284|520817002|FG001|Overall Study|Protocol Violation|10|||
144440524|NCT02624284|520817003|FG002|Overall Study|Protocol Violation|7|||
144440525|NCT02624284|520817001|FG000|Overall Study|Revealed exclusionary condition|2|||
144605031|NCT02060383|521417010|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
144605032|NCT02060383|521417011|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
144724596|NCT00788957|521846428|FG005|Part 3|Withdrawal by Subject|2|||
144605033|NCT02060383|521417012|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
144724597|NCT00788957|521846423|FG000|Part 3|Death|0|||
144190807|NCT01832402|519893463|FG001|Overall Study|Withdrawal by Subject|3|||
144440526|NCT02624284|520817002|FG001|Overall Study|Revealed exclusionary condition|2|||
144440527|NCT02624284|520817003|FG002|Overall Study|Revealed exclusionary condition|0|||
144440528|NCT02624284|520817001|FG000|Overall Study|Adverse Event|0|||
144440529|NCT02624284|520817002|FG001|Overall Study|Adverse Event|0|||
144440530|NCT02624284|520817003|FG002|Overall Study|Adverse Event|1|||
144440531|NCT00546715|520817004|FG000|Overall Study|Withdrawal by Subject|0|||
144440532|NCT00546715|520817005|FG001|Overall Study|Withdrawal by Subject|1|||
144440533|NCT00546715|520817006|FG002|Overall Study|Withdrawal by Subject|0|||
144190808|NCT01832402|519893462|FG000|Overall Study|Declining Performance status|2|||
144190809|NCT01832402|519893463|FG001|Overall Study|Declining Performance status|1|||
144190810|NCT03417830|519893465|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
144190811|NCT03417830|519893466|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
144190812|NCT03827018|519893469|FG000|Overall Study|Adverse Event|1|||
144190813|NCT03827018|519893470|FG001|Overall Study|Adverse Event|0|||
144190814|NCT03827018|519893469|FG000|Overall Study|Withdrawal by Subject|2|||
144190815|NCT03827018|519893470|FG001|Overall Study|Withdrawal by Subject|2|||
144190816|NCT03827018|519893469|FG000|Overall Study|Lack of Efficacy|0|||
144190817|NCT03827018|519893470|FG001|Overall Study|Lack of Efficacy|1|||
144190818|NCT00268892|519893471|FG000|Overall Study|Adverse Event|14|||
144190819|NCT00268892|519893472|FG001|Overall Study|Adverse Event|17|||
144190820|NCT00268892|519893473|FG002|Overall Study|Adverse Event|20|||
144190821|NCT00268892|519893471|FG000|Overall Study|Lack of Efficacy|1|||
144190822|NCT00268892|519893472|FG001|Overall Study|Lack of Efficacy|3|||
144190823|NCT00268892|519893473|FG002|Overall Study|Lack of Efficacy|0|||
144190824|NCT00268892|519893471|FG000|Overall Study|Withdrawal by Subject|14|||
144190825|NCT00268892|519893472|FG001|Overall Study|Withdrawal by Subject|15|||
144190826|NCT00268892|519893473|FG002|Overall Study|Withdrawal by Subject|13|||
144190827|NCT00268892|519893471|FG000|Overall Study|Physician Decision|0|||
144190828|NCT00268892|519893472|FG001|Overall Study|Physician Decision|1|||
144190829|NCT00268892|519893473|FG002|Overall Study|Physician Decision|0|||
144190830|NCT00268892|519893471|FG000|Overall Study|Lost to Follow-up|5|||
144190831|NCT00268892|519893472|FG001|Overall Study|Lost to Follow-up|2|||
144190832|NCT00268892|519893473|FG002|Overall Study|Lost to Follow-up|4|||
144190833|NCT00268892|519893471|FG000|Overall Study|Protocol Violation|0|||
144440534|NCT00546715|520817007|FG003|Overall Study|Withdrawal by Subject|0|||
144440535|NCT00418691|520817008|FG000|Overall Study|Lost to Follow-up|1|||
144440536|NCT00418691|520817009|FG001|Overall Study|Lost to Follow-up|2|||
144440537|NCT00418691|520817010|FG002|Overall Study|Lost to Follow-up|3|||
144440538|NCT00418691|520817008|FG000|Overall Study|Started new medication voiding entry|0|||
144440539|NCT00418691|520817009|FG001|Overall Study|Started new medication voiding entry|0|||
144440540|NCT00418691|520817010|FG002|Overall Study|Started new medication voiding entry|1|||
144440541|NCT00418691|520817008|FG000|Overall Study|Progressive Disease|1|||
144440542|NCT00418691|520817009|FG001|Overall Study|Progressive Disease|0|||
144440543|NCT00418691|520817010|FG002|Overall Study|Progressive Disease|1|||
144440544|NCT04649151|520817011|FG000|Overall Study|Pregnancy|0|||
144440545|NCT04649151|520817012|FG001|Overall Study|Pregnancy|0|||
144440546|NCT04649151|520817013|FG002|Overall Study|Pregnancy|0|||
144440547|NCT04649151|520817014|FG003|Overall Study|Pregnancy|0|||
144440548|NCT04649151|520817015|FG004|Overall Study|Pregnancy|3|||
144440549|NCT04649151|520817011|FG000|Overall Study|Physician Decision|10|||
144440550|NCT04649151|520817012|FG001|Overall Study|Physician Decision|0|||
144440551|NCT04649151|520817013|FG002|Overall Study|Physician Decision|0|||
144440552|NCT04649151|520817014|FG003|Overall Study|Physician Decision|1|||
144440553|NCT04649151|520817015|FG004|Overall Study|Physician Decision|1|||
144440554|NCT04649151|520817011|FG000|Overall Study|Protocol Deviation|25|||
144440555|NCT04649151|520817012|FG001|Overall Study|Protocol Deviation|3|||
144440556|NCT04649151|520817013|FG002|Overall Study|Protocol Deviation|0|||
144440557|NCT04649151|520817014|FG003|Overall Study|Protocol Deviation|0|||
144440558|NCT04649151|520817015|FG004|Overall Study|Protocol Deviation|0|||
144440559|NCT04649151|520817011|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
144440560|NCT04649151|520817012|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
144440561|NCT04649151|520817013|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
144440562|NCT04649151|520817014|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
144440563|NCT04649151|520817015|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
144440564|NCT04649151|520817011|FG000|Overall Study|Withdrawal by Subject|370|||
144440565|NCT04649151|520817012|FG001|Overall Study|Withdrawal by Subject|113|||
144440566|NCT04649151|520817013|FG002|Overall Study|Withdrawal by Subject|2|||
144440567|NCT04649151|520817014|FG003|Overall Study|Withdrawal by Subject|7|||
144440568|NCT04649151|520817015|FG004|Overall Study|Withdrawal by Subject|15|||
144440569|NCT04649151|520817011|FG000|Overall Study|Adverse Event|1|||
144190834|NCT00268892|519893472|FG001|Overall Study|Protocol Violation|1|||
144190835|NCT00268892|519893473|FG002|Overall Study|Protocol Violation|0|||
144190836|NCT00268892|519893471|FG000|Overall Study|Disease Progression|1|||
144190837|NCT00268892|519893472|FG001|Overall Study|Disease Progression|1|||
144190838|NCT00268892|519893473|FG002|Overall Study|Disease Progression|0|||
144440570|NCT04649151|520817012|FG001|Overall Study|Adverse Event|0|||
144440571|NCT04649151|520817013|FG002|Overall Study|Adverse Event|0|||
144440572|NCT04649151|520817014|FG003|Overall Study|Adverse Event|0|||
144440573|NCT04649151|520817015|FG004|Overall Study|Adverse Event|0|||
144440574|NCT04649151|520817011|FG000|Overall Study|Lost to Follow-up|256|||
144724598|NCT00788957|521846424|FG001|Part 3|Death|0|||
144724599|NCT00788957|521846425|FG002|Part 3|Death|0|||
144724600|NCT00788957|521846426|FG003|Part 3|Death|0|||
144724601|NCT00788957|521846427|FG004|Part 3|Death|8|||
144724602|NCT00788957|521846428|FG005|Part 3|Death|8|||
144724603|NCT00788957|521846423|FG000|Part 3|On-study at time of data cut-off|0|||
144724604|NCT00788957|521846424|FG001|Part 3|On-study at time of data cut-off|0|||
144724605|NCT00788957|521846425|FG002|Part 3|On-study at time of data cut-off|0|||
144724606|NCT00788957|521846426|FG003|Part 3|On-study at time of data cut-off|0|||
144724607|NCT00788957|521846427|FG004|Part 3|On-study at time of data cut-off|1|||
144724608|NCT00788957|521846428|FG005|Part 3|On-study at time of data cut-off|0|||
144724609|NCT03276975|521846429|FG000|Overall Study|Withdrawal by Subject|1|||
144724610|NCT03276975|521846430|FG001|Overall Study|Withdrawal by Subject|0|||
144724611|NCT00662129|521846431|FG000|Overall Study|Protocol Violation|1|||
144724612|NCT00662129|521846431|FG000|Overall Study|Cancel prior to beginning treatment|1|||
144724613|NCT00662129|521846431|FG000|Overall Study|Ineligible|1|||
144724614|NCT02153736|521846438|FG000|Overall Study|Lost to Follow-up|1|||
144724615|NCT02153736|521846439|FG001|Overall Study|Lost to Follow-up|0|||
144724616|NCT02153736|521846438|FG000|Overall Study|Medical status change made ineligible|1|||
144724617|NCT02153736|521846439|FG001|Overall Study|Medical status change made ineligible|0|||
144724618|NCT02153736|521846438|FG000|Overall Study|Death|0|||
144724619|NCT02153736|521846439|FG001|Overall Study|Death|1|||
144724620|NCT02153736|521846438|FG000|Overall Study|Withdrawal by Subject|0|||
144724621|NCT02153736|521846439|FG001|Overall Study|Withdrawal by Subject|1|||
144724622|NCT00796510|521846448|FG000|Overall Study|Death|1|||
144724623|NCT00796510|521846449|FG001|Overall Study|Death|0|||
144724624|NCT00796510|521846448|FG000|Overall Study|Study Terminated|2|||
144440575|NCT04649151|520817012|FG001|Overall Study|Lost to Follow-up|29|||
144440576|NCT04649151|520817013|FG002|Overall Study|Lost to Follow-up|10|||
144440577|NCT04649151|520817014|FG003|Overall Study|Lost to Follow-up|3|||
144440578|NCT04649151|520817015|FG004|Overall Study|Lost to Follow-up|6|||
144440579|NCT04649151|520817011|FG000|Overall Study|Other than specified|59|||
144440580|NCT04649151|520817012|FG001|Overall Study|Other than specified|294|||
144440581|NCT04649151|520817013|FG002|Overall Study|Other than specified|0|||
144440582|NCT04649151|520817014|FG003|Overall Study|Other than specified|0|||
144440583|NCT04649151|520817015|FG004|Overall Study|Other than specified|4|||
144440584|NCT04649151|520817011|FG000|Overall Study|Death|0|||
144440585|NCT04649151|520817012|FG001|Overall Study|Death|0|||
144440586|NCT04649151|520817013|FG002|Overall Study|Death|0|||
144440587|NCT04649151|520817014|FG003|Overall Study|Death|0|||
144440588|NCT04649151|520817015|FG004|Overall Study|Death|1|||
144440589|NCT02975934|520817016|FG000|Treatment Phase|Never initiated study drug|0|||
144440590|NCT02975934|520817017|FG001|Treatment Phase|Never initiated study drug|5|||
144440591|NCT02975934|520817018|FG002|Treatment Phase|Never initiated study drug|0|||
144440592|NCT00433654|520817021|FG000|Overall Study|Death|4|||
144440593|NCT00433654|520817022|FG001|Overall Study|Death|0|||
144440594|NCT00433654|520817021|FG000|Overall Study|Missed visit|6|||
144440595|NCT00433654|520817022|FG001|Overall Study|Missed visit|3|||
144440596|NCT00433654|520817021|FG000|Overall Study|Subject not yet due for visit|4|||
144440597|NCT00433654|520817022|FG001|Overall Study|Subject not yet due for visit|0|||
144440598|NCT00433654|520817021|FG000|Overall Study|Withdrawal by Subject|1|||
144440599|NCT00433654|520817022|FG001|Overall Study|Withdrawal by Subject|2|||
144440600|NCT06034496|520817023|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
144440601|NCT06034496|520817024|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
144440602|NCT06034496|520817023|FG000|Overall Study|Withdrawal by Subject|5|||
144440603|NCT06034496|520817024|FG001|Overall Study|Withdrawal by Subject|4|||
144440604|NCT04033159|520817048|FG000|Washout Period|Physician Decision|0|||
144724625|NCT00796510|521846449|FG001|Overall Study|Study Terminated|0|||
144724626|NCT05030753|521846450|FG000|9-week|Lost to Follow-up|10|||
144724627|NCT05030753|521846451|FG001|9-week|Lost to Follow-up|7|||
144724628|NCT05030753|521846450|FG000|9-week|Withdrawal by Subject|1|||
144724629|NCT05030753|521846451|FG001|9-week|Withdrawal by Subject|0|||
144724630|NCT05030753|521846450|FG000|9-week|Excluded from analysis due to missing covariates|2|||
144724631|NCT05030753|521846451|FG001|9-week|Excluded from analysis due to missing covariates|1|||
144724632|NCT05030753|521846450|FG000|6-month post intervention|Lost to Follow-up|5|||
144724633|NCT05030753|521846451|FG001|6-month post intervention|Lost to Follow-up|4|||
144724634|NCT05030753|521846450|FG000|6-month post intervention|Withdrawal by Subject|4|||
144724635|NCT05030753|521846451|FG001|6-month post intervention|Withdrawal by Subject|0|||
144724636|NCT05030753|521846450|FG000|18-month post intervention|Lost to Follow-up|3|||
144724637|NCT05030753|521846451|FG001|18-month post intervention|Lost to Follow-up|1|||
144724638|NCT02579096|521846452|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
144440605|NCT04033159|520817049|FG001|Washout Period|Physician Decision|1|||
144440606|NCT04033159|520817050|FG002|Washout Period|Physician Decision|0|||
144440607|NCT04033159|520817048|FG000|Washout Period|Study terminated by Sponsor|0|||
144440608|NCT04033159|520817049|FG001|Washout Period|Study terminated by Sponsor|7|||
144440609|NCT04033159|520817050|FG002|Washout Period|Study terminated by Sponsor|0|||
144440610|NCT04033159|520817048|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
144190839|NCT00268892|519893471|FG000|Overall Study|Trial Site Closed|4|||
144190840|NCT00268892|519893472|FG001|Overall Study|Trial Site Closed|2|||
144190841|NCT00268892|519893473|FG002|Overall Study|Trial Site Closed|2|||
144190842|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
144190843|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
144190844|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
144190845|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
144190846|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
144440611|NCT04033159|520817049|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
144440612|NCT04033159|520817050|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
144440613|NCT05179421|520817051|FG000|First Infusion Day|Adverse Event|1|||
144440614|NCT05179421|520817052|FG001|First Infusion Day|Adverse Event|0|||
144440615|NCT01120210|520817056|FG000|MAIN INFUSION|Adverse Event|1|||
144440616|NCT01120210|520817057|FG001|MAIN INFUSION|Adverse Event|0|||
144440617|NCT01120210|520817056|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
144440618|NCT01120210|520817057|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
144440619|NCT00006184|520817058|FG000|Overall Study|Death|1|||
144440620|NCT00006184|520817059|FG001|Overall Study|Death|0|||
144190847|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
144190848|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
144440621|NCT02948842|520817067|FG000|Overall Study|Withdrawal by Subject|4|||
144440622|NCT02350309|520817068|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
144440623|NCT02350309|520817069|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
144440624|NCT02350309|520817070|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
144440625|NCT02350309|520817071|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
144440626|NCT02350309|520817072|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
144440627|NCT02350309|520817073|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
144440628|NCT02350309|520817068|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
144440629|NCT02350309|520817069|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
144440630|NCT02350309|520817070|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
144440631|NCT02350309|520817071|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
144440632|NCT02350309|520817072|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
144440633|NCT02350309|520817073|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
144440634|NCT00207142|520817074|FG000|Induction Phase|Adverse Event|9|||
144440635|NCT00207142|520817075|FG001|Induction Phase|Adverse Event|0|||
144440636|NCT00207142|520817076|FG002|Induction Phase|Adverse Event|0|||
144440637|NCT00207142|520817077|FG003|Induction Phase|Adverse Event|0|||
144440638|NCT00207142|520817074|FG000|Induction Phase|Death|1|||
144440639|NCT00207142|520817075|FG001|Induction Phase|Death|0|||
144440640|NCT00207142|520817076|FG002|Induction Phase|Death|0|||
144440641|NCT00207142|520817077|FG003|Induction Phase|Death|0|||
144440642|NCT00207142|520817074|FG000|Induction Phase|Lack of Efficacy|1|||
144440643|NCT00207142|520817075|FG001|Induction Phase|Lack of Efficacy|0|||
144440644|NCT00207142|520817076|FG002|Induction Phase|Lack of Efficacy|0|||
144440645|NCT00207142|520817077|FG003|Induction Phase|Lack of Efficacy|0|||
144440646|NCT00207142|520817074|FG000|Induction Phase|Lost to Follow-up|5|||
144530989|NCT02988661|521146404|FG001|Overall Study|Unable to complete the 18-month survey|27|||
144530990|NCT05736458|521146405|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
144530991|NCT05736458|521146406|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
144530992|NCT05736458|521146407|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
144530993|NCT05736458|521146405|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
144530994|NCT05736458|521146406|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
144190849|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
144190850|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
144190851|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
144190852|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
144190853|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
144530995|NCT05736458|521146407|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
144530996|NCT05736458|521146405|FG000|TMS/fMRI #1|Physician Decision|0|||
144530997|NCT05736458|521146406|FG001|TMS/fMRI #1|Physician Decision|0|||
144530998|NCT05736458|521146407|FG002|TMS/fMRI #1|Physician Decision|2|||
144530999|NCT05736458|521146405|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
144190854|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Death|0|||
144440647|NCT00207142|520817075|FG001|Induction Phase|Lost to Follow-up|0|||
144440648|NCT00207142|520817076|FG002|Induction Phase|Lost to Follow-up|0|||
144440649|NCT00207142|520817077|FG003|Induction Phase|Lost to Follow-up|0|||
144440650|NCT00207142|520817074|FG000|Induction Phase|Physician Decision|2|||
144440651|NCT00207142|520817075|FG001|Induction Phase|Physician Decision|0|||
144440652|NCT00207142|520817076|FG002|Induction Phase|Physician Decision|0|||
144440653|NCT00207142|520817077|FG003|Induction Phase|Physician Decision|0|||
144440654|NCT00207142|520817074|FG000|Induction Phase|Poor/noncompliance|2|||
144440655|NCT00207142|520817075|FG001|Induction Phase|Poor/noncompliance|0|||
144440656|NCT00207142|520817076|FG002|Induction Phase|Poor/noncompliance|0|||
144531000|NCT05736458|521146406|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
144605034|NCT02060383|521417008|FG000|Core Phase|Adverse Event|2|||
144440657|NCT00207142|520817077|FG003|Induction Phase|Poor/noncompliance|0|||
144440658|NCT00207142|520817074|FG000|Induction Phase|Pregnancy|1|||
144440659|NCT00207142|520817075|FG001|Induction Phase|Pregnancy|0|||
144440660|NCT00207142|520817076|FG002|Induction Phase|Pregnancy|0|||
144440661|NCT00207142|520817077|FG003|Induction Phase|Pregnancy|0|||
144440662|NCT00207142|520817074|FG000|Induction Phase|Subject no longer meets study criteria|3|||
144440663|NCT00207142|520817075|FG001|Induction Phase|Subject no longer meets study criteria|0|||
144440664|NCT00207142|520817076|FG002|Induction Phase|Subject no longer meets study criteria|0|||
144440665|NCT00207142|520817077|FG003|Induction Phase|Subject no longer meets study criteria|0|||
144440666|NCT00207142|520817074|FG000|Induction Phase|Withdrawal by Subject|4|||
144440667|NCT00207142|520817075|FG001|Induction Phase|Withdrawal by Subject|0|||
144440668|NCT00207142|520817076|FG002|Induction Phase|Withdrawal by Subject|0|||
144440669|NCT00207142|520817077|FG003|Induction Phase|Withdrawal by Subject|0|||
144440670|NCT00207142|520817074|FG000|Induction Phase|Incarceration|1|||
144440671|NCT00207142|520817075|FG001|Induction Phase|Incarceration|0|||
144440672|NCT00207142|520817076|FG002|Induction Phase|Incarceration|0|||
144440673|NCT00207142|520817077|FG003|Induction Phase|Incarceration|0|||
144440674|NCT00207142|520817074|FG000|Induction Phase|Missing lab data|1|||
144440675|NCT00207142|520817075|FG001|Induction Phase|Missing lab data|0|||
144440676|NCT00207142|520817076|FG002|Induction Phase|Missing lab data|0|||
144440677|NCT00207142|520817077|FG003|Induction Phase|Missing lab data|0|||
144440678|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
144440679|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
144440680|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
144440681|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
144440682|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
144440683|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
144440684|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
144440685|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
144440686|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
144440687|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
144724639|NCT02579096|521846453|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
144190855|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Death|1|||
144440688|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
144440689|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
144440690|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
144440691|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
144440692|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
144472178|NCT03935217|520926681|FG000|Overall Study|Lost to Follow-up|0|||
144472179|NCT03935217|520926682|FG001|Overall Study|Lost to Follow-up|1|||
144472180|NCT03935217|520926681|FG000|Overall Study|Withdrawal by Subject|0|||
144472181|NCT03935217|520926682|FG001|Overall Study|Withdrawal by Subject|2|||
144472182|NCT00847405|520926683|FG000|First Intervention|Adverse Event|0|||
144472183|NCT00847405|520926684|FG001|First Intervention|Adverse Event|1|||
144472184|NCT00847405|520926683|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144472185|NCT00847405|520926684|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144472186|NCT01728792|520926685|FG000|Overall Study|Withdrawal of Consent|1|||
144472187|NCT01728792|520926686|FG001|Overall Study|Withdrawal of Consent|1|||
144472188|NCT01728792|520926687|FG002|Overall Study|Withdrawal of Consent|0|||
144472189|NCT01728792|520926688|FG003|Overall Study|Withdrawal of Consent|1|||
144472190|NCT01728792|520926689|FG004|Overall Study|Withdrawal of Consent|0|||
144472191|NCT01728792|520926685|FG000|Overall Study|Lost to Follow-up|2|||
144472192|NCT01728792|520926686|FG001|Overall Study|Lost to Follow-up|1|||
144472193|NCT01728792|520926687|FG002|Overall Study|Lost to Follow-up|4|||
144472194|NCT01728792|520926688|FG003|Overall Study|Lost to Follow-up|2|||
144472195|NCT01728792|520926689|FG004|Overall Study|Lost to Follow-up|0|||
144472196|NCT03559218|520926690|FG000|Overall Study|Withdrawal by Subject|1|||
144472197|NCT03559218|520926691|FG001|Overall Study|Withdrawal by Subject|0|||
144472198|NCT04277455|520926694|FG000|Overall Study|Lost to Follow-up|1|||
144472199|NCT01782742|520926698|FG000|Double-blind Treatment Phase|Adverse Event|1|||
144472200|NCT01782742|520926699|FG001|Double-blind Treatment Phase|Adverse Event|0|||
144472201|NCT01679301|520926700|FG000|Screening Period|screen failure|3|||
144472202|NCT01679301|520926701|FG001|Screening Period|screen failure|0|||
144472203|NCT01679301|520926702|FG002|Screening Period|screen failure|0|||
144472204|NCT01181726|520926703|FG000|First Intervention|Adverse Event|1|||
144472205|NCT01181726|520926704|FG001|First Intervention|Adverse Event|0|||
144472206|NCT02487810|520926705|FG000|Overall Study|Withdrawal by Subject|1|||
144472207|NCT02487810|520926706|FG001|Overall Study|Withdrawal by Subject|0|||
144472208|NCT01889186|520926707|FG000|Overall Study|Adverse event- not related to progression|18|||
144472209|NCT01889186|520926708|FG001|Overall Study|Adverse event- not related to progression|5|||
144472210|NCT01889186|520926707|FG000|Overall Study|Adverse event- related to progression|7|||
144472211|NCT01889186|520926708|FG001|Overall Study|Adverse event- related to progression|2|||
144472212|NCT01889186|520926707|FG000|Overall Study|COVID-19 logistical restrictions|1|||
144440693|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
144440694|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
144440695|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
144440696|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
144440697|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
144440698|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
144440699|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
144440700|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
144440701|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
144440702|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
144440703|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
144440704|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
144440705|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
144440706|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Death|0|||
144440707|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Death|0|||
144440708|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Death|0|||
144440709|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Death|1|||
144440710|NCT00207142|520817074|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
144440711|NCT00207142|520817075|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
144440712|NCT00207142|520817076|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
144440713|NCT00207142|520817077|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
144440714|NCT02253810|520817080|FG000|Overall Study|Withdrawal by Subject|2|||
144440715|NCT02253810|520817081|FG001|Overall Study|Withdrawal by Subject|1|||
144440716|NCT02253810|520817080|FG000|Overall Study|Unknown concomitant procedure|3|||
144440717|NCT02253810|520817081|FG001|Overall Study|Unknown concomitant procedure|2|||
144605035|NCT02060383|521417009|FG001|Core Phase|Adverse Event|0|||
144605036|NCT02060383|521417010|FG002|Core Phase|Adverse Event|0|||
144605037|NCT02060383|521417011|FG003|Core Phase|Adverse Event|2|||
144605038|NCT02060383|521417012|FG004|Core Phase|Adverse Event|6|||
144605039|NCT02060383|521417008|FG000|Core Phase|Administrative problems|0|||
144605040|NCT02060383|521417009|FG001|Core Phase|Administrative problems|1|||
144605041|NCT02060383|521417010|FG002|Core Phase|Administrative problems|0|||
144605042|NCT02060383|521417011|FG003|Core Phase|Administrative problems|0|||
144605043|NCT02060383|521417012|FG004|Core Phase|Administrative problems|0|||
144605044|NCT02060383|521417008|FG000|Core Phase|Protocol Violation|0|||
144605045|NCT02060383|521417009|FG001|Core Phase|Protocol Violation|0|||
144605046|NCT02060383|521417010|FG002|Core Phase|Protocol Violation|0|||
144605047|NCT02060383|521417011|FG003|Core Phase|Protocol Violation|1|||
144605048|NCT02060383|521417012|FG004|Core Phase|Protocol Violation|0|||
144605049|NCT02060383|521417008|FG000|Core Phase|Withdrawal by Subject|0|||
144605050|NCT02060383|521417009|FG001|Core Phase|Withdrawal by Subject|0|||
144605051|NCT02060383|521417010|FG002|Core Phase|Withdrawal by Subject|0|||
144605052|NCT02060383|521417011|FG003|Core Phase|Withdrawal by Subject|4|||
144605053|NCT02060383|521417012|FG004|Core Phase|Withdrawal by Subject|2|||
144605054|NCT02060383|521417008|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
144605055|NCT02060383|521417009|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
144605056|NCT02060383|521417010|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
144605057|NCT02060383|521417011|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
144605058|NCT02060383|521417012|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
144605059|NCT02060383|521417008|FG000|Extension Phase|Adverse Event|1|||
144605060|NCT02060383|521417009|FG001|Extension Phase|Adverse Event|1|||
144605061|NCT02060383|521417010|FG002|Extension Phase|Adverse Event|2|||
144605062|NCT02060383|521417011|FG003|Extension Phase|Adverse Event|0|||
144605063|NCT02060383|521417012|FG004|Extension Phase|Adverse Event|1|||
144605064|NCT02060383|521417008|FG000|Extension Phase|Withdrawal by Subject|0|||
144605065|NCT02060383|521417009|FG001|Extension Phase|Withdrawal by Subject|1|||
144605066|NCT02060383|521417010|FG002|Extension Phase|Withdrawal by Subject|0|||
144190856|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Death|0|||
144190857|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Death|0|||
144190858|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
144605067|NCT02060383|521417011|FG003|Extension Phase|Withdrawal by Subject|0|||
144605068|NCT02060383|521417012|FG004|Extension Phase|Withdrawal by Subject|2|||
144605069|NCT02060383|521417008|FG000|Extension Phase|Administrative problems|1|||
144605070|NCT02060383|521417009|FG001|Extension Phase|Administrative problems|0|||
144605071|NCT02060383|521417010|FG002|Extension Phase|Administrative problems|0|||
144605072|NCT02060383|521417011|FG003|Extension Phase|Administrative problems|0|||
144440718|NCT00314366|520817082|FG000|Overall Study|not treated due to patient medical condi|1|||
144440719|NCT00314366|520817083|FG001|Overall Study|not treated due to patient medical condi|0|||
144440720|NCT01393743|520817084|FG000|Core Study|Adverse Event|5|||
144440721|NCT01393743|520817085|FG001|Core Study|Adverse Event|9|||
144440722|NCT01393743|520817086|FG002|Core Study|Adverse Event|0|||
144440723|NCT01393743|520817084|FG000|Core Study|Lost to Follow-up|1|||
144440724|NCT01393743|520817085|FG001|Core Study|Lost to Follow-up|1|||
144605073|NCT02060383|521417012|FG004|Extension Phase|Administrative problems|0|||
144605074|NCT02060383|521417008|FG000|Extension Phase|Death|0|||
144724640|NCT02579096|521846452|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
144724641|NCT02579096|521846453|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
144724642|NCT02579096|521846452|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
144724643|NCT02579096|521846453|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
144724644|NCT02579096|521846452|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
144724645|NCT02579096|521846453|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
144724646|NCT02579096|521846452|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
144190859|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
144190860|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
144190861|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
144190862|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
144190863|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
144190864|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
144190865|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
144440725|NCT01393743|520817086|FG002|Core Study|Lost to Follow-up|0|||
144440726|NCT01393743|520817084|FG000|Core Study|Participant's Choice|2|||
144440727|NCT01393743|520817085|FG001|Core Study|Participant's Choice|3|||
144440728|NCT01393743|520817086|FG002|Core Study|Participant's Choice|0|||
144440729|NCT01393743|520817084|FG000|Core Study|Inadequate therapeutic effect|2|||
144440730|NCT01393743|520817085|FG001|Core Study|Inadequate therapeutic effect|0|||
144440731|NCT01393743|520817086|FG002|Core Study|Inadequate therapeutic effect|0|||
144440732|NCT01393743|520817084|FG000|Extension Phase|Adverse Event|0|||
144440733|NCT01393743|520817085|FG001|Extension Phase|Adverse Event|0|||
144440734|NCT01393743|520817086|FG002|Extension Phase|Adverse Event|12|||
144440735|NCT01393743|520817084|FG000|Extension Phase|Lost to Follow-up|0|||
144440736|NCT01393743|520817085|FG001|Extension Phase|Lost to Follow-up|0|||
144440737|NCT01393743|520817086|FG002|Extension Phase|Lost to Follow-up|2|||
144440738|NCT01393743|520817084|FG000|Extension Phase|Participant choice|0|||
144440739|NCT01393743|520817085|FG001|Extension Phase|Participant choice|0|||
144440740|NCT01393743|520817086|FG002|Extension Phase|Participant choice|16|||
144440741|NCT01393743|520817084|FG000|Extension Phase|Inadequate therapeutic effect|0|||
144440742|NCT01393743|520817085|FG001|Extension Phase|Inadequate therapeutic effect|0|||
144440743|NCT01393743|520817086|FG002|Extension Phase|Inadequate therapeutic effect|7|||
144440744|NCT01393743|520817084|FG000|Extension Phase|Withdrawal by Subject|0|||
144440745|NCT01393743|520817085|FG001|Extension Phase|Withdrawal by Subject|0|||
144440746|NCT01393743|520817086|FG002|Extension Phase|Withdrawal by Subject|8|||
144440747|NCT01393743|520817084|FG000|Extension Phase|Pregnancy|0|||
144440748|NCT01393743|520817085|FG001|Extension Phase|Pregnancy|0|||
144440749|NCT01393743|520817086|FG002|Extension Phase|Pregnancy|1|||
144440750|NCT01393743|520817084|FG000|Extension Phase|Other|0|||
144440751|NCT01393743|520817085|FG001|Extension Phase|Other|0|||
144440752|NCT01393743|520817086|FG002|Extension Phase|Other|14|||
144440753|NCT03400033|520817087|FG000|Overall Study|Withdrawal by Subject|1|||
144440754|NCT03400033|520817088|FG001|Overall Study|Withdrawal by Subject|2|||
144440755|NCT02469610|520817098|FG000|Overall Study|Death|1|||
144440756|NCT02469610|520817099|FG001|Overall Study|Death|0|||
144440757|NCT02469610|520817098|FG000|Overall Study|Lost to Follow-up|1|||
144440758|NCT02469610|520817099|FG001|Overall Study|Lost to Follow-up|0|||
144440759|NCT02469610|520817098|FG000|Overall Study|exclusion criteria|2|||
144440760|NCT02469610|520817099|FG001|Overall Study|exclusion criteria|1|||
144440761|NCT01723228|520817100|FG000|Overall Study|Adverse Event|2|||
144440762|NCT01723228|520817101|FG001|Overall Study|Adverse Event|6|||
144440763|NCT01723228|520817100|FG000|Overall Study|Withdrawal by Subject|2|||
144440764|NCT01723228|520817101|FG001|Overall Study|Withdrawal by Subject|1|||
144440765|NCT01723228|520817100|FG000|Overall Study|Protocol Violation|0|||
144440766|NCT01723228|520817101|FG001|Overall Study|Protocol Violation|2|||
144440767|NCT01723228|520817100|FG000|Overall Study|Lost to Follow-up|2|||
144440768|NCT01723228|520817101|FG001|Overall Study|Lost to Follow-up|1|||
144531001|NCT05736458|521146407|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
144190866|NCT00545688|519893485|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
144440769|NCT01723228|520817100|FG000|Overall Study|Other|2|||
144440770|NCT01723228|520817101|FG001|Overall Study|Other|1|||
144440771|NCT01806896|520817102|FG000|Overall Study|Adverse Event|2|||
144440772|NCT01806896|520817103|FG001|Overall Study|Adverse Event|0|||
144440773|NCT01806896|520817102|FG000|Overall Study|Other|1|||
144440774|NCT01806896|520817103|FG001|Overall Study|Other|0|||
144440775|NCT02434770|520817104|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
144440776|NCT02434770|520817105|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
144440777|NCT02434770|520817106|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
144190867|NCT00545688|519893486|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
144440778|NCT02434770|520817104|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
144440779|NCT02434770|520817105|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
144440780|NCT02434770|520817106|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
144440781|NCT02434770|520817104|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
144440782|NCT02434770|520817105|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
144440783|NCT02434770|520817106|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
144538459|NCT01500200|521174196|FG001|Stage 1|Noncompliance with Study Drug|0|||
144531002|NCT02668692|521147843|FG000|Overall Study|Adverse Event|1|||
144531003|NCT02668692|521147844|FG001|Overall Study|Adverse Event|0|||
144253553|NCT02697734|520128133|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
144531004|NCT03523572|521147845|FG000|Dose Escalation|Progressive disease|1|||
144531005|NCT03523572|521147846|FG001|Dose Escalation|Progressive disease|0|||
144531006|NCT03523572|521147847|FG002|Dose Escalation|Progressive disease|0|||
144531007|NCT03523572|521147848|FG003|Dose Escalation|Progressive disease|0|||
144531008|NCT03523572|521147849|FG004|Dose Escalation|Progressive disease|0|||
144531009|NCT03523572|521147850|FG005|Dose Escalation|Progressive disease|0|||
144531010|NCT03523572|521147845|FG000|Dose Escalation|Clinical Progression|0|||
144253554|NCT02697734|520128134|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
144253555|NCT02697734|520128133|FG000|Core Phase - up to Week 48|Adverse Event|1|||
144253556|NCT02697734|520128134|FG001|Core Phase - up to Week 48|Adverse Event|2|||
144253557|NCT02697734|520128133|FG000|Core Phase - up to Week 48|Physician Decision|1|||
144253558|NCT02697734|520128134|FG001|Core Phase - up to Week 48|Physician Decision|0|||
144253559|NCT02697734|520128133|FG000|Optional Extension Phase|Adverse Event|5|||
144253560|NCT02697734|520128134|FG001|Optional Extension Phase|Adverse Event|1|||
144531011|NCT03523572|521147846|FG001|Dose Escalation|Clinical Progression|1|||
144531012|NCT03523572|521147847|FG002|Dose Escalation|Clinical Progression|0|||
144531013|NCT03523572|521147848|FG003|Dose Escalation|Clinical Progression|0|||
144531014|NCT03523572|521147849|FG004|Dose Escalation|Clinical Progression|0|||
144531015|NCT03523572|521147850|FG005|Dose Escalation|Clinical Progression|0|||
144531016|NCT03523572|521147845|FG000|Dose Escalation|Adverse Event|2|||
144531017|NCT03523572|521147846|FG001|Dose Escalation|Adverse Event|0|||
144531018|NCT03523572|521147847|FG002|Dose Escalation|Adverse Event|0|||
144531019|NCT03523572|521147848|FG003|Dose Escalation|Adverse Event|0|||
144531020|NCT03523572|521147849|FG004|Dose Escalation|Adverse Event|0|||
144531021|NCT03523572|521147850|FG005|Dose Escalation|Adverse Event|0|||
144531022|NCT03523572|521147845|FG000|Dose Escalation|Physician Decision|1|||
144531023|NCT03523572|521147846|FG001|Dose Escalation|Physician Decision|1|||
144531024|NCT03523572|521147847|FG002|Dose Escalation|Physician Decision|0|||
144531025|NCT03523572|521147848|FG003|Dose Escalation|Physician Decision|0|||
144531026|NCT03523572|521147849|FG004|Dose Escalation|Physician Decision|0|||
144531027|NCT03523572|521147850|FG005|Dose Escalation|Physician Decision|0|||
144531028|NCT03523572|521147845|FG000|Dose Expansion|Progressive Disease|0|||
144531029|NCT03523572|521147846|FG001|Dose Expansion|Progressive Disease|0|||
144531030|NCT03523572|521147847|FG002|Dose Expansion|Progressive Disease|9|||
144531031|NCT03523572|521147848|FG003|Dose Expansion|Progressive Disease|11|||
144531032|NCT03523572|521147849|FG004|Dose Expansion|Progressive Disease|15|||
144531033|NCT03523572|521147850|FG005|Dose Expansion|Progressive Disease|2|||
144531034|NCT03523572|521147845|FG000|Dose Expansion|Clinical Progression|0|||
144531035|NCT03523572|521147846|FG001|Dose Expansion|Clinical Progression|0|||
144531036|NCT03523572|521147847|FG002|Dose Expansion|Clinical Progression|2|||
144531037|NCT03523572|521147848|FG003|Dose Expansion|Clinical Progression|2|||
144531038|NCT03523572|521147849|FG004|Dose Expansion|Clinical Progression|2|||
144531039|NCT03523572|521147850|FG005|Dose Expansion|Clinical Progression|0|||
144531040|NCT03523572|521147845|FG000|Dose Expansion|Adverse Event|0|||
144531041|NCT03523572|521147846|FG001|Dose Expansion|Adverse Event|0|||
144531042|NCT03523572|521147847|FG002|Dose Expansion|Adverse Event|10|||
144531043|NCT03523572|521147848|FG003|Dose Expansion|Adverse Event|1|||
144531044|NCT03523572|521147849|FG004|Dose Expansion|Adverse Event|5|||
144531045|NCT03523572|521147850|FG005|Dose Expansion|Adverse Event|2|||
144531046|NCT03523572|521147845|FG000|Dose Expansion|Withdrawal by Subject|0|||
144531047|NCT03523572|521147846|FG001|Dose Expansion|Withdrawal by Subject|0|||
144531048|NCT03523572|521147847|FG002|Dose Expansion|Withdrawal by Subject|1|||
144531049|NCT03523572|521147848|FG003|Dose Expansion|Withdrawal by Subject|1|||
144531050|NCT03523572|521147849|FG004|Dose Expansion|Withdrawal by Subject|0|||
144531051|NCT03523572|521147850|FG005|Dose Expansion|Withdrawal by Subject|0|||
144531052|NCT03523572|521147845|FG000|Dose Expansion|Physician Decision|0|||
144531053|NCT03523572|521147846|FG001|Dose Expansion|Physician Decision|0|||
144531054|NCT03523572|521147847|FG002|Dose Expansion|Physician Decision|1|||
144531055|NCT03523572|521147848|FG003|Dose Expansion|Physician Decision|0|||
144531056|NCT03523572|521147849|FG004|Dose Expansion|Physician Decision|1|||
144531057|NCT03523572|521147850|FG005|Dose Expansion|Physician Decision|0|||
144531058|NCT03523572|521147845|FG000|Dose Expansion|Miscellaneous|0|||
144531059|NCT03523572|521147846|FG001|Dose Expansion|Miscellaneous|0|||
144531060|NCT03523572|521147847|FG002|Dose Expansion|Miscellaneous|0|||
144531061|NCT03523572|521147848|FG003|Dose Expansion|Miscellaneous|0|||
144253561|NCT02697734|520128133|FG000|Optional Extension Phase|Physician Decision|0|||
144531062|NCT03523572|521147849|FG004|Dose Expansion|Miscellaneous|3|||
144531063|NCT03523572|521147850|FG005|Dose Expansion|Miscellaneous|0|||
144531064|NCT05269966|521147851|FG000|Overall Study|Adverse Event|4|||
144531065|NCT05269966|521147851|FG000|Overall Study|Withdrawal by Subject|1|||
144531066|NCT05269966|521147851|FG000|Overall Study|Lost to Follow-up|4|||
144531067|NCT05269966|521147851|FG000|Overall Study|Physician Decision|1|||
144531068|NCT02315703|521147857|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
144531069|NCT02315703|521147858|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
144440784|NCT02434770|520817104|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
144440785|NCT02434770|520817105|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
144440786|NCT02434770|520817106|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
144440787|NCT02434770|520817104|FG000|Week 1 to Week 18|Death|1|||
144440788|NCT02434770|520817105|FG001|Week 1 to Week 18|Death|0|||
144440789|NCT02434770|520817106|FG002|Week 1 to Week 18|Death|0|||
144440790|NCT02434770|520817104|FG000|Week 18 to Week|Lost to Follow-up|2|||
144440791|NCT02434770|520817105|FG001|Week 18 to Week|Lost to Follow-up|2|||
144440792|NCT02434770|520817106|FG002|Week 18 to Week|Lost to Follow-up|1|||
144440793|NCT02434770|520817104|FG000|Week 18 to Week|Withdrawal by Subject|0|||
144440794|NCT02434770|520817105|FG001|Week 18 to Week|Withdrawal by Subject|0|||
144440795|NCT02434770|520817106|FG002|Week 18 to Week|Withdrawal by Subject|2|||
144440796|NCT02434770|520817104|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
144440797|NCT02434770|520817105|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
144440798|NCT02434770|520817106|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
144440799|NCT00660348|520817107|FG000|Overall Study|Withdrawal by Subject|1|||
144440800|NCT00660348|520817108|FG001|Overall Study|Withdrawal by Subject|0|||
144440801|NCT01282424|520817114|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
144531070|NCT02315703|521147859|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
144531071|NCT02315703|521147860|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
144531072|NCT02315703|521147861|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
144531073|NCT02315703|521147862|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
144531074|NCT02315703|521147863|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
144531075|NCT02315703|521147864|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
144531076|NCT02315703|521147857|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
144531077|NCT02315703|521147858|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
144531078|NCT02315703|521147859|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
144531079|NCT02315703|521147860|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
144531080|NCT02315703|521147861|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
144531081|NCT02315703|521147862|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
144531082|NCT02315703|521147863|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
144531083|NCT02315703|521147864|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
144531084|NCT02315703|521147857|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
144531085|NCT02315703|521147858|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
144531086|NCT02315703|521147859|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
144531087|NCT02315703|521147860|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
144531088|NCT02315703|521147861|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
144531089|NCT02315703|521147862|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
144531090|NCT02315703|521147863|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
144531091|NCT02315703|521147864|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
144531092|NCT02315703|521147857|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531093|NCT02315703|521147858|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531094|NCT02315703|521147859|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531095|NCT02315703|521147860|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531096|NCT02315703|521147861|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531097|NCT02315703|521147862|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531098|NCT02315703|521147863|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
144531099|NCT02315703|521147864|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
144531100|NCT02315703|521147857|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
144531101|NCT02315703|521147858|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
144531102|NCT02315703|521147859|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
144531103|NCT02315703|521147860|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
144531104|NCT02315703|521147861|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
144531105|NCT02315703|521147862|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
144531106|NCT02315703|521147863|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
144531107|NCT02315703|521147864|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
144531108|NCT02315703|521147857|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
144531109|NCT02315703|521147858|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
144531110|NCT02315703|521147859|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
144531111|NCT02315703|521147860|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
144440802|NCT01282424|520817114|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
144440803|NCT01282424|520817114|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
144531112|NCT02315703|521147861|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
144531113|NCT02315703|521147862|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
144531114|NCT02315703|521147863|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
144531115|NCT02315703|521147864|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
144531116|NCT02315703|521147857|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
144440804|NCT01282424|520817114|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
144440805|NCT01282424|520817114|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
144440806|NCT01282424|520817114|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
144440807|NCT01282424|520817114|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
144440808|NCT01282424|520817114|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
144440809|NCT00528528|520817115|FG000|Overall Study|Lost to Follow-up|0|||
144440810|NCT00528528|520817116|FG001|Overall Study|Lost to Follow-up|0|||
144440811|NCT00528528|520817117|FG002|Overall Study|Lost to Follow-up|1|||
144440812|NCT00528528|520817118|FG003|Overall Study|Lost to Follow-up|1|||
144440813|NCT00528528|520817115|FG000|Overall Study|Ineligible to continue the trial|0|||
144440814|NCT00528528|520817116|FG001|Overall Study|Ineligible to continue the trial|0|||
144440815|NCT00528528|520817117|FG002|Overall Study|Ineligible to continue the trial|0|||
144440816|NCT00528528|520817118|FG003|Overall Study|Ineligible to continue the trial|1|||
144440817|NCT00528528|520817115|FG000|Overall Study|Other|0|||
144440818|NCT00528528|520817116|FG001|Overall Study|Other|1|||
144440819|NCT00528528|520817117|FG002|Overall Study|Other|0|||
144440820|NCT00528528|520817118|FG003|Overall Study|Other|0|||
144440821|NCT00528528|520817115|FG000|Overall Study|Withdrawal by Subject|3|||
144440822|NCT00528528|520817116|FG001|Overall Study|Withdrawal by Subject|2|||
144440823|NCT00528528|520817117|FG002|Overall Study|Withdrawal by Subject|1|||
144440824|NCT00528528|520817118|FG003|Overall Study|Withdrawal by Subject|1|||
144440825|NCT00528528|520817115|FG000|Overall Study|Ongoing participant|0|||
144440826|NCT00528528|520817116|FG001|Overall Study|Ongoing participant|0|||
144440827|NCT00528528|520817117|FG002|Overall Study|Ongoing participant|1|||
144440828|NCT00528528|520817118|FG003|Overall Study|Ongoing participant|0|||
144440829|NCT03508219|520817121|FG000|Overall Study|Death|2|||
144440830|NCT03508219|520817121|FG000|Overall Study|Withdrawal by Subject|1|||
144440831|NCT03508219|520817121|FG000|Overall Study|Lost to Follow-up|4|||
144440832|NCT03508219|520817121|FG000|Overall Study|Missed visit|2|||
144440833|NCT00316199|520817122|FG000|Overall Study|Adverse Event|2|||
144440834|NCT00316199|520817122|FG000|Overall Study|Death|8|||
144440835|NCT00316199|520817122|FG000|Overall Study|Lost to Follow-up|2|||
144440836|NCT00590954|520817123|FG000|Overall Study|Inevaluable|2|||
144440837|NCT02782949|520817125|FG000|Overall Study|Protocol Violation|1|||
144440838|NCT02782949|520817126|FG001|Overall Study|Protocol Violation|0|||
144440839|NCT02782949|520817125|FG000|Overall Study|Withdrawal by Subject|0|||
144440840|NCT02782949|520817126|FG001|Overall Study|Withdrawal by Subject|1|||
144440841|NCT03316872|520817127|FG000|Overall Study|Death|1|||
144440842|NCT06023394|520817130|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
144440843|NCT06023394|520817131|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
144440844|NCT06023394|520817130|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
144440845|NCT06023394|520817131|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
144440846|NCT06023394|520817130|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
144440847|NCT06023394|520817131|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
144724647|NCT02579096|521846453|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
144724648|NCT02579096|521846452|FG000|Phase 2, Weeks 25 - 48|Death|2|||
144724649|NCT02579096|521846453|FG001|Phase 2, Weeks 25 - 48|Death|4|||
144190868|NCT00545688|519893487|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
144440848|NCT06023394|520817130|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
144440849|NCT06023394|520817131|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
144440850|NCT01101841|520818462|FG000|Overall Study|Adverse Event|15|||
144440851|NCT01101841|520818463|FG001|Overall Study|Adverse Event|15|||
144440852|NCT01101841|520818462|FG000|Overall Study|Lost to Follow-up|9|||
144440853|NCT01101841|520818463|FG001|Overall Study|Lost to Follow-up|3|||
144440854|NCT01101841|520818462|FG000|Overall Study|Withdrawal by Subject|21|||
144440855|NCT01101841|520818463|FG001|Overall Study|Withdrawal by Subject|40|||
144440856|NCT01101841|520818462|FG000|Overall Study|Protocol Violation|1|||
144440857|NCT01101841|520818463|FG001|Overall Study|Protocol Violation|1|||
144440858|NCT01101841|520818462|FG000|Overall Study|Physician Decision|0|||
144440859|NCT01101841|520818463|FG001|Overall Study|Physician Decision|2|||
144440860|NCT01101841|520818462|FG000|Overall Study|Lack of Efficacy|0|||
144190869|NCT00545688|519893488|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
144190870|NCT00545688|519893485|FG000|Adjuvant Treatment Period|Disease Progression|3|||
144440861|NCT01101841|520818463|FG001|Overall Study|Lack of Efficacy|2|||
144440862|NCT01101841|520818462|FG000|Overall Study|Other|0|||
144440863|NCT01101841|520818463|FG001|Overall Study|Other|1|||
144440864|NCT01101841|520818462|FG000|Overall Study|Suicidality Tracking Scale|3|||
144440865|NCT01101841|520818463|FG001|Overall Study|Suicidality Tracking Scale|1|||
144440866|NCT01101841|520818462|FG000|Overall Study|Eligibility Criteria|1|||
144440867|NCT01101841|520818463|FG001|Overall Study|Eligibility Criteria|2|||
144440868|NCT02896400|520818467|FG000|1 Month Follow-up|Lost to Follow-up|7|||
144440869|NCT02896400|520818468|FG001|1 Month Follow-up|Lost to Follow-up|7|||
144440870|NCT02896400|520818469|FG002|1 Month Follow-up|Lost to Follow-up|5|||
144440871|NCT02896400|520818470|FG003|1 Month Follow-up|Lost to Follow-up|8|||
144440872|NCT02896400|520818471|FG004|1 Month Follow-up|Lost to Follow-up|9|||
144531117|NCT02315703|521147858|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
144531118|NCT02315703|521147859|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
144531119|NCT02315703|521147860|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
144531120|NCT02315703|521147861|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
144531121|NCT02315703|521147862|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
144531122|NCT02315703|521147863|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
144190871|NCT00545688|519893486|FG001|Adjuvant Treatment Period|Disease Progression|3|||
144190872|NCT00545688|519893487|FG002|Adjuvant Treatment Period|Disease Progression|0|||
144190873|NCT00545688|519893488|FG003|Adjuvant Treatment Period|Disease Progression|7|||
144190874|NCT00545688|519893485|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
144190875|NCT00545688|519893486|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
144190876|NCT00545688|519893487|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
144190877|NCT00545688|519893488|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
144190878|NCT00545688|519893485|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
144190879|NCT00545688|519893486|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
144190880|NCT00545688|519893487|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
144190881|NCT00545688|519893488|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
144190882|NCT00545688|519893485|FG000|Adjuvant Treatment Period|Adverse Event|0|||
144531123|NCT02315703|521147864|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
144531124|NCT02315703|521147857|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531125|NCT02315703|521147858|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
144531126|NCT02315703|521147859|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531127|NCT02315703|521147860|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531128|NCT02315703|521147861|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531129|NCT02315703|521147862|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531130|NCT02315703|521147863|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531131|NCT02315703|521147864|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
144531132|NCT02315703|521147857|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
144190883|NCT00545688|519893486|FG001|Adjuvant Treatment Period|Adverse Event|3|||
144440873|NCT02896400|520818472|FG005|1 Month Follow-up|Lost to Follow-up|6|||
144531133|NCT02315703|521147858|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
144531134|NCT02315703|521147859|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
144531135|NCT02315703|521147860|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
144531136|NCT02315703|521147861|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
144531137|NCT02315703|521147862|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
144531138|NCT02315703|521147863|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
144531139|NCT02315703|521147864|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
144531140|NCT03625115|521147865|FG000|Overall Study|Withdrawal by Subject|4|||
144531141|NCT03625115|521147866|FG001|Overall Study|Withdrawal by Subject|7|||
144531142|NCT03625115|521147865|FG000|Overall Study|Lost to Follow-up|17|||
144531143|NCT03625115|521147866|FG001|Overall Study|Lost to Follow-up|24|||
144531144|NCT04304144|521147867|FG000|DLT Observation Period|Physician Decision|0|||
144531145|NCT04304144|521147868|FG001|DLT Observation Period|Physician Decision|1|||
144531146|NCT04304144|521147869|FG002|DLT Observation Period|Physician Decision|0|||
144531147|NCT04304144|521147870|FG003|DLT Observation Period|Physician Decision|0|||
144531148|NCT04304144|521147867|FG000|Continued Treatment Period|Adverse Event|0|||
144531149|NCT04304144|521147868|FG001|Continued Treatment Period|Adverse Event|1|||
144531150|NCT04304144|521147869|FG002|Continued Treatment Period|Adverse Event|0|||
144531151|NCT04304144|521147870|FG003|Continued Treatment Period|Adverse Event|0|||
144531152|NCT04304144|521147867|FG000|Continued Treatment Period|Death|0|||
144531153|NCT04304144|521147868|FG001|Continued Treatment Period|Death|0|||
144190884|NCT00545688|519893487|FG002|Adjuvant Treatment Period|Adverse Event|2|||
144190885|NCT00545688|519893488|FG003|Adjuvant Treatment Period|Adverse Event|2|||
144190886|NCT00545688|519893485|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
144440874|NCT02896400|520818473|FG006|1 Month Follow-up|Lost to Follow-up|5|||
144190887|NCT00545688|519893486|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
144440875|NCT02896400|520818474|FG007|1 Month Follow-up|Lost to Follow-up|6|||
144440876|NCT02896400|520818475|FG008|1 Month Follow-up|Lost to Follow-up|4|||
144440877|NCT02896400|520818476|FG009|1 Month Follow-up|Lost to Follow-up|7|||
144440878|NCT02896400|520818477|FG010|1 Month Follow-up|Lost to Follow-up|5|||
144440879|NCT02896400|520818478|FG011|1 Month Follow-up|Lost to Follow-up|5|||
144440880|NCT02896400|520818479|FG012|1 Month Follow-up|Lost to Follow-up|3|||
144440881|NCT02896400|520818480|FG013|1 Month Follow-up|Lost to Follow-up|4|||
144190888|NCT00545688|519893487|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
144440882|NCT02896400|520818481|FG014|1 Month Follow-up|Lost to Follow-up|1|||
144531154|NCT04304144|521147869|FG002|Continued Treatment Period|Death|1|||
144531155|NCT04304144|521147870|FG003|Continued Treatment Period|Death|2|||
144531156|NCT04304144|521147867|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
144531157|NCT04304144|521147868|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
144531158|NCT04304144|521147869|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
144440883|NCT02896400|520818482|FG015|1 Month Follow-up|Lost to Follow-up|2|||
144440884|NCT02896400|520818467|FG000|1 Month Follow-up|Death|0|||
144190889|NCT00545688|519893488|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
144190890|NCT00545688|519893485|FG000|Follow-Up Period|Death|4|||
144190891|NCT00545688|519893486|FG001|Follow-Up Period|Death|2|||
144190892|NCT00545688|519893487|FG002|Follow-Up Period|Death|2|||
144190893|NCT00545688|519893488|FG003|Follow-Up Period|Death|6|||
144190894|NCT00545688|519893485|FG000|Follow-Up Period|Disease Progression|6|||
144190895|NCT00545688|519893486|FG001|Follow-Up Period|Disease Progression|5|||
144190896|NCT00545688|519893487|FG002|Follow-Up Period|Disease Progression|9|||
144190897|NCT00545688|519893488|FG003|Follow-Up Period|Disease Progression|9|||
144190898|NCT00545688|519893485|FG000|Follow-Up Period|Refused Treatment|6|||
144190899|NCT00545688|519893486|FG001|Follow-Up Period|Refused Treatment|2|||
144190900|NCT00545688|519893487|FG002|Follow-Up Period|Refused Treatment|0|||
144190901|NCT00545688|519893488|FG003|Follow-Up Period|Refused Treatment|2|||
144190902|NCT00545688|519893485|FG000|Follow-Up Period|Lost to Follow-up|3|||
144190903|NCT00545688|519893486|FG001|Follow-Up Period|Lost to Follow-up|3|||
144190904|NCT00545688|519893487|FG002|Follow-Up Period|Lost to Follow-up|3|||
144190905|NCT00545688|519893488|FG003|Follow-Up Period|Lost to Follow-up|1|||
144190906|NCT00545688|519893485|FG000|Follow-Up Period|Unspecified Reason|2|||
144190907|NCT00545688|519893486|FG001|Follow-Up Period|Unspecified Reason|5|||
144190908|NCT00545688|519893487|FG002|Follow-Up Period|Unspecified Reason|6|||
144190909|NCT00545688|519893488|FG003|Follow-Up Period|Unspecified Reason|8|||
144190910|NCT00545688|519893485|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
144190911|NCT00545688|519893486|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
144190912|NCT00545688|519893487|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
144190913|NCT00545688|519893488|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
144190914|NCT00546910|519894602|FG000|Overall Study|Adverse Event|2|||
144190915|NCT00546910|519894603|FG001|Overall Study|Adverse Event|3|||
144190916|NCT00546910|519894602|FG000|Overall Study|Lack of Efficacy|5|||
144190917|NCT00546910|519894603|FG001|Overall Study|Lack of Efficacy|7|||
144190918|NCT00546910|519894602|FG000|Overall Study|Physician Decision|0|||
144190919|NCT00546910|519894603|FG001|Overall Study|Physician Decision|1|||
144190920|NCT00546910|519894602|FG000|Overall Study|Withdrawal by Subject|2|||
144190921|NCT00546910|519894603|FG001|Overall Study|Withdrawal by Subject|0|||
144190922|NCT01467479|519894604|FG000|Overall Study|No Study Medication|1|||
144190923|NCT01467479|519894605|FG001|Overall Study|No Study Medication|0|||
144190924|NCT01467479|519894606|FG002|Overall Study|No Study Medication|2|||
144190925|NCT01467479|519894604|FG000|Overall Study|Adverse Event|1|||
144190926|NCT01467479|519894605|FG001|Overall Study|Adverse Event|2|||
144190927|NCT01467479|519894606|FG002|Overall Study|Adverse Event|0|||
144190928|NCT01467479|519894604|FG000|Overall Study|Death|0|||
144190929|NCT01467479|519894605|FG001|Overall Study|Death|0|||
144190930|NCT01467479|519894606|FG002|Overall Study|Death|1|||
144190931|NCT01467479|519894604|FG000|Overall Study|Lost to Follow-up|2|||
144190932|NCT01467479|519894605|FG001|Overall Study|Lost to Follow-up|5|||
144190933|NCT01467479|519894606|FG002|Overall Study|Lost to Follow-up|3|||
144190934|NCT01467479|519894604|FG000|Overall Study|Withdrawal of Consent|3|||
144190935|NCT01467479|519894605|FG001|Overall Study|Withdrawal of Consent|7|||
144190936|NCT01467479|519894606|FG002|Overall Study|Withdrawal of Consent|7|||
144190937|NCT01467479|519894604|FG000|Overall Study|Study Terminated by Sponsor|1|||
144190938|NCT01467479|519894605|FG001|Overall Study|Study Terminated by Sponsor|3|||
144190939|NCT01467479|519894606|FG002|Overall Study|Study Terminated by Sponsor|3|||
144190940|NCT01467479|519894604|FG000|Overall Study|Other|1|||
144190941|NCT01467479|519894605|FG001|Overall Study|Other|0|||
144190942|NCT01467479|519894606|FG002|Overall Study|Other|0|||
144190943|NCT02284347|519894616|FG000|Overall Study|Lost to Follow-up|2|||
144190944|NCT02284347|519894616|FG000|Overall Study|Withdrawn prior to treatment|1|||
144190945|NCT01684215|519894620|FG000|Phase 1, Part 1|Adverse Event|1|||
144190946|NCT01684215|519894621|FG001|Phase 1, Part 1|Adverse Event|0|||
144190947|NCT01684215|519894622|FG002|Phase 1, Part 1|Adverse Event|0|||
144190948|NCT01684215|519894623|FG003|Phase 1, Part 1|Adverse Event|0|||
144190949|NCT01684215|519894620|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
144190950|NCT01684215|519894621|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
144190951|NCT01684215|519894622|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
144531159|NCT04304144|521147870|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
144531160|NCT04304144|521147867|FG000|Continued Treatment Period|Other than specified|2|||
144531161|NCT04304144|521147868|FG001|Continued Treatment Period|Other than specified|0|||
144531162|NCT04304144|521147869|FG002|Continued Treatment Period|Other than specified|1|||
144190952|NCT01684215|519894623|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
144190953|NCT01684215|519894620|FG000|Phase 1, Part 2|Adverse Event|0|||
144190954|NCT01684215|519894621|FG001|Phase 1, Part 2|Adverse Event|0|||
144605075|NCT02060383|521417009|FG001|Extension Phase|Death|0|||
144190955|NCT01684215|519894622|FG002|Phase 1, Part 2|Adverse Event|1|||
144190956|NCT01684215|519894623|FG003|Phase 1, Part 2|Adverse Event|0|||
144190957|NCT01684215|519894620|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
144190958|NCT01684215|519894621|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
144190959|NCT01684215|519894622|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
144190960|NCT01684215|519894623|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
144190961|NCT01684215|519894620|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
144190962|NCT01684215|519894621|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
144190963|NCT01684215|519894622|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
144190964|NCT01684215|519894623|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
144190965|NCT01684215|519894620|FG000|Phase 2|Death|0|||
144190966|NCT01684215|519894621|FG001|Phase 2|Death|0|||
144190967|NCT01684215|519894622|FG002|Phase 2|Death|0|||
144190968|NCT01684215|519894623|FG003|Phase 2|Death|8|||
144190969|NCT01684215|519894620|FG000|Phase 2|Study terminated by sponsor|0|||
144190970|NCT01684215|519894621|FG001|Phase 2|Study terminated by sponsor|0|||
144190971|NCT01684215|519894622|FG002|Phase 2|Study terminated by sponsor|0|||
144190972|NCT01684215|519894623|FG003|Phase 2|Study terminated by sponsor|30|||
144190973|NCT01684215|519894620|FG000|Phase 2|Enrolled but not treated|0|||
144190974|NCT01684215|519894621|FG001|Phase 2|Enrolled but not treated|0|||
144190975|NCT01684215|519894622|FG002|Phase 2|Enrolled but not treated|0|||
144190976|NCT01684215|519894623|FG003|Phase 2|Enrolled but not treated|1|||
144190977|NCT01684215|519894620|FG000|Phase 2|Lost to Follow-up|0|||
144190978|NCT01684215|519894621|FG001|Phase 2|Lost to Follow-up|0|||
144190979|NCT01684215|519894622|FG002|Phase 2|Lost to Follow-up|0|||
144190980|NCT01684215|519894623|FG003|Phase 2|Lost to Follow-up|4|||
144190981|NCT01301482|519894624|FG000|Overall Study|Withdrawal by Subject|1|||
144190982|NCT01552369|519894627|FG000|Overall Study|Did not consent to extended follow up|8|||
144190983|NCT01552369|519894628|FG001|Overall Study|Did not consent to extended follow up|9|||
144190984|NCT01915940|519894630|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
144190985|NCT01915940|519894631|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
144190986|NCT01915940|519894632|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
144190987|NCT01915940|519894630|FG000|Treatment Period|Decision of Participant|0|||
144190988|NCT01915940|519894631|FG001|Treatment Period|Decision of Participant|1|||
144190989|NCT01915940|519894632|FG002|Treatment Period|Decision of Participant|3|||
144190990|NCT01915940|519894630|FG000|Treatment Period|Adverse Event|0|||
144190991|NCT01915940|519894631|FG001|Treatment Period|Adverse Event|9|||
144531163|NCT04304144|521147870|FG003|Continued Treatment Period|Other than specified|1|||
144531164|NCT02446236|521147873|FG000|Overall Study|Screen Failure|1|||
144531165|NCT02446236|521147874|FG001|Overall Study|Screen Failure|0|||
144531166|NCT02446236|521147875|FG002|Overall Study|Screen Failure|1|||
144531167|NCT02446236|521147873|FG000|Overall Study|Actively Receiving Therapy|0|||
144531168|NCT02446236|521147874|FG001|Overall Study|Actively Receiving Therapy|0|||
144531169|NCT02446236|521147875|FG002|Overall Study|Actively Receiving Therapy|1|||
144531170|NCT04862234|521147878|FG000|Overall Study|Surgery cancellation|1|||
144531171|NCT04862234|521147879|FG001|Overall Study|Surgery cancellation|2|||
144531172|NCT04862234|521147878|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
144531173|NCT04862234|521147879|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
144531174|NCT04862234|521147878|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
144531175|NCT04862234|521147879|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
144531176|NCT05280574|521147880|FG000|Overall Study|Withdrawal by Subject|0|||
144531177|NCT05280574|521147881|FG001|Overall Study|Withdrawal by Subject|2|||
144531178|NCT05280574|521147882|FG002|Overall Study|Withdrawal by Subject|0|||
144531179|NCT03213873|521147883|FG000|Overall Study|Withdrawal by Subject|8|||
144531180|NCT03213873|521147884|FG001|Overall Study|Withdrawal by Subject|9|||
144531181|NCT03213873|521147883|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
144531182|NCT03213873|521147884|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
144531183|NCT03213873|521147883|FG000|Overall Study|Lost to Follow-up|0|||
144531184|NCT03213873|521147884|FG001|Overall Study|Lost to Follow-up|2|||
144531185|NCT04709419|521147891|FG000|Overall Study|Physician Decision|1|||
144531186|NCT04709419|521147892|FG001|Overall Study|Physician Decision|0|||
144531187|NCT05683340|521147893|FG000|Overall Study|Adverse Event|1|||
144531188|NCT05683340|521147894|FG001|Overall Study|Adverse Event|1|||
144531189|NCT05683340|521147893|FG000|Overall Study|Protocol Violation|1|||
144531190|NCT05683340|521147894|FG001|Overall Study|Protocol Violation|0|||
144605076|NCT02060383|521417010|FG002|Extension Phase|Death|1|||
144605077|NCT02060383|521417011|FG003|Extension Phase|Death|0|||
144190992|NCT01915940|519894632|FG002|Treatment Period|Adverse Event|1|||
144190993|NCT01915940|519894630|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
144190994|NCT01915940|519894631|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
144190995|NCT01915940|519894632|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
144190996|NCT00614926|519894633|FG000|Overall Study|Burden of travel|1|||
144190997|NCT00614926|519894634|FG001|Overall Study|Burden of travel|0|||
144190998|NCT00614926|519894633|FG000|Overall Study|Adverse Event|3|||
144531191|NCT05683340|521147893|FG000|Overall Study|Withdrawal by Subject|0|||
144531192|NCT05683340|521147894|FG001|Overall Study|Withdrawal by Subject|2|||
144531193|NCT03505008|521147895|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
144531194|NCT03505008|521147896|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
144531195|NCT03505008|521147897|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
144605078|NCT02060383|521417012|FG004|Extension Phase|Death|1|||
144190999|NCT00614926|519894634|FG001|Overall Study|Adverse Event|0|||
144191000|NCT04039919|519894639|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144191001|NCT04039919|519894640|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144191002|NCT04039919|519894641|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144191003|NCT04039919|519894642|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144191004|NCT04039919|519894643|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144191005|NCT04039919|519894639|FG000|Treatment Period 1|Sponsor's decision|0|||
144191006|NCT04039919|519894640|FG001|Treatment Period 1|Sponsor's decision|0|||
144191007|NCT04039919|519894641|FG002|Treatment Period 1|Sponsor's decision|0|||
144191008|NCT04039919|519894642|FG003|Treatment Period 1|Sponsor's decision|0|||
144191009|NCT04039919|519894643|FG004|Treatment Period 1|Sponsor's decision|16|||
144191010|NCT04039919|519894639|FG000|Treatment Period 5|Withdrawal by Subject|1|||
144191011|NCT04039919|519894640|FG001|Treatment Period 5|Withdrawal by Subject|0|||
144191012|NCT04039919|519894641|FG002|Treatment Period 5|Withdrawal by Subject|0|||
144191013|NCT04039919|519894642|FG003|Treatment Period 5|Withdrawal by Subject|0|||
144191014|NCT04039919|519894643|FG004|Treatment Period 5|Withdrawal by Subject|0|||
144191015|NCT02310789|519894644|FG000|Overall Study|Adverse Event|1|||
144191016|NCT01197417|519894645|FG000|Overall Study|Physician Decision|3|||
144191017|NCT01197417|519894646|FG001|Overall Study|Physician Decision|2|||
144191018|NCT01197417|519894645|FG000|Overall Study|Withdrawal by Subject|2|||
144191019|NCT01197417|519894646|FG001|Overall Study|Withdrawal by Subject|4|||
144191020|NCT01197417|519894645|FG000|Overall Study|Site miscommunication|0|||
144191021|NCT01197417|519894646|FG001|Overall Study|Site miscommunication|1|||
144191022|NCT01197417|519894645|FG000|Overall Study|Subject transferred to intensive care|0|||
144191023|NCT01197417|519894646|FG001|Overall Study|Subject transferred to intensive care|1|||
144191024|NCT01197417|519894645|FG000|Overall Study|Not consented in time to receive drug|0|||
144191025|NCT01197417|519894646|FG001|Overall Study|Not consented in time to receive drug|1|||
144440885|NCT02896400|520818468|FG001|1 Month Follow-up|Death|0|||
144440886|NCT02896400|520818469|FG002|1 Month Follow-up|Death|0|||
144440887|NCT02896400|520818470|FG003|1 Month Follow-up|Death|0|||
144440888|NCT02896400|520818471|FG004|1 Month Follow-up|Death|0|||
144440889|NCT02896400|520818472|FG005|1 Month Follow-up|Death|0|||
144440890|NCT02896400|520818473|FG006|1 Month Follow-up|Death|0|||
144440891|NCT02896400|520818474|FG007|1 Month Follow-up|Death|0|||
144440892|NCT02896400|520818475|FG008|1 Month Follow-up|Death|0|||
144440893|NCT02896400|520818476|FG009|1 Month Follow-up|Death|0|||
144440894|NCT02896400|520818477|FG010|1 Month Follow-up|Death|0|||
144440895|NCT02896400|520818478|FG011|1 Month Follow-up|Death|0|||
144440896|NCT02896400|520818479|FG012|1 Month Follow-up|Death|0|||
144440897|NCT02896400|520818480|FG013|1 Month Follow-up|Death|0|||
144605079|NCT02060383|521417008|FG000|Extension Phase|Protocol Violation|0|||
144605080|NCT02060383|521417009|FG001|Extension Phase|Protocol Violation|0|||
144605081|NCT02060383|521417010|FG002|Extension Phase|Protocol Violation|0|||
144605082|NCT02060383|521417011|FG003|Extension Phase|Protocol Violation|0|||
144605083|NCT02060383|521417012|FG004|Extension Phase|Protocol Violation|1|||
144605084|NCT00088907|521417013|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
144605085|NCT00088907|521417014|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
144605086|NCT00088907|521417013|FG000|Randomized Study (Step 1)|Adverse Event|14|||
144605087|NCT00088907|521417014|FG001|Randomized Study (Step 1)|Adverse Event|19|||
144605088|NCT00088907|521417013|FG000|Randomized Study (Step 1)|Death|11|||
144605089|NCT00088907|521417014|FG001|Randomized Study (Step 1)|Death|12|||
144605090|NCT00088907|521417013|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
144605091|NCT00088907|521417014|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
144605092|NCT00088907|521417013|FG000|Randomized Study (Step 1)|complicating disease|3|||
144605093|NCT00088907|521417014|FG001|Randomized Study (Step 1)|complicating disease|1|||
144605094|NCT00088907|521417013|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
144605095|NCT00088907|521417014|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
144605096|NCT00088907|521417013|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
144605097|NCT00088907|521417014|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
144605098|NCT00088907|521417013|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
144605099|NCT00088907|521417014|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
144605100|NCT00088907|521417013|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
144191026|NCT01197417|519894645|FG000|Overall Study|Hypotension|1|||
144191027|NCT01197417|519894646|FG001|Overall Study|Hypotension|2|||
144191028|NCT01197417|519894645|FG000|Overall Study|Found to be ineligible|2|||
144191029|NCT01197417|519894646|FG001|Overall Study|Found to be ineligible|5|||
144191030|NCT01197417|519894645|FG000|Overall Study|No 25-hour magnesium level|0|||
144191031|NCT01197417|519894646|FG001|Overall Study|No 25-hour magnesium level|2|||
144440898|NCT02896400|520818481|FG014|1 Month Follow-up|Death|0|||
144440899|NCT02896400|520818482|FG015|1 Month Follow-up|Death|1|||
144440900|NCT02896400|520818467|FG000|3 Month Follow-up|Lost to Follow-up|6|||
144440901|NCT02896400|520818468|FG001|3 Month Follow-up|Lost to Follow-up|3|||
144440902|NCT02896400|520818469|FG002|3 Month Follow-up|Lost to Follow-up|6|||
144605101|NCT00088907|521417014|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
144440903|NCT02896400|520818470|FG003|3 Month Follow-up|Lost to Follow-up|11|||
144191032|NCT03250299|519894647|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
144440904|NCT02896400|520818471|FG004|3 Month Follow-up|Lost to Follow-up|12|||
144605102|NCT00088907|521417013|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
144191033|NCT03250299|519894648|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
144191034|NCT03250299|519894649|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
144191035|NCT03250299|519894650|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
144191036|NCT03250299|519894651|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
144191037|NCT03250299|519894647|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
144191038|NCT03250299|519894648|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
144191039|NCT03250299|519894649|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
144191040|NCT03250299|519894650|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
144191041|NCT03250299|519894651|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
144191042|NCT03250299|519894647|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
144191043|NCT03250299|519894648|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
144191044|NCT03250299|519894649|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
144191045|NCT03250299|519894650|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
144191046|NCT03250299|519894651|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
144191047|NCT03250299|519894647|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
144191048|NCT03250299|519894648|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
144191049|NCT03250299|519894649|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
144191050|NCT03250299|519894650|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
144191051|NCT03250299|519894651|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
144191052|NCT02813421|519894656|FG000|Overall Study|Withdrawal by Subject|1|||
144191053|NCT02813421|519894657|FG001|Overall Study|Withdrawal by Subject|2|||
144191054|NCT02813421|519894656|FG000|Overall Study|Lost to Follow-up|1|||
144191055|NCT02813421|519894657|FG001|Overall Study|Lost to Follow-up|1|||
144191056|NCT00977548|519894658|FG000|Overall Study|Ineligible|4|||
144191057|NCT00977548|519894658|FG000|Overall Study|Adverse Event|8|||
144191058|NCT00977548|519894658|FG000|Overall Study|Withdrawal by Subject|1|||
144191059|NCT01042535|519894659|FG000|Overall Study|disease progression prior to treatment|3|||
144191060|NCT01042535|519894659|FG000|Overall Study|disease progression during treatment|3|||
144191061|NCT01042535|519894659|FG000|Overall Study|complications from other disease|2|||
144191062|NCT01546142|519894662|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
144440905|NCT02896400|520818472|FG005|3 Month Follow-up|Lost to Follow-up|6|||
144440906|NCT02896400|520818473|FG006|3 Month Follow-up|Lost to Follow-up|4|||
144440907|NCT02896400|520818474|FG007|3 Month Follow-up|Lost to Follow-up|3|||
144440908|NCT02896400|520818475|FG008|3 Month Follow-up|Lost to Follow-up|6|||
144440909|NCT02896400|520818476|FG009|3 Month Follow-up|Lost to Follow-up|5|||
144440910|NCT02896400|520818477|FG010|3 Month Follow-up|Lost to Follow-up|6|||
144440911|NCT02896400|520818478|FG011|3 Month Follow-up|Lost to Follow-up|6|||
144440912|NCT02896400|520818479|FG012|3 Month Follow-up|Lost to Follow-up|3|||
144440913|NCT02896400|520818480|FG013|3 Month Follow-up|Lost to Follow-up|5|||
144440914|NCT02896400|520818481|FG014|3 Month Follow-up|Lost to Follow-up|3|||
144440915|NCT02896400|520818482|FG015|3 Month Follow-up|Lost to Follow-up|2|||
144440916|NCT02896400|520818467|FG000|3 Month Follow-up|Death|0|||
144440917|NCT02896400|520818468|FG001|3 Month Follow-up|Death|0|||
144440918|NCT02896400|520818469|FG002|3 Month Follow-up|Death|0|||
144440919|NCT02896400|520818470|FG003|3 Month Follow-up|Death|0|||
144440920|NCT02896400|520818471|FG004|3 Month Follow-up|Death|0|||
144440921|NCT02896400|520818472|FG005|3 Month Follow-up|Death|0|||
144440922|NCT02896400|520818473|FG006|3 Month Follow-up|Death|0|||
144440923|NCT02896400|520818474|FG007|3 Month Follow-up|Death|0|||
144440924|NCT02896400|520818475|FG008|3 Month Follow-up|Death|0|||
144440925|NCT02896400|520818476|FG009|3 Month Follow-up|Death|0|||
144440926|NCT02896400|520818477|FG010|3 Month Follow-up|Death|0|||
144440927|NCT02896400|520818478|FG011|3 Month Follow-up|Death|0|||
144440928|NCT02896400|520818479|FG012|3 Month Follow-up|Death|0|||
144440929|NCT02896400|520818480|FG013|3 Month Follow-up|Death|1|||
144440930|NCT02896400|520818481|FG014|3 Month Follow-up|Death|1|||
144191063|NCT01546142|519894663|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
144191064|NCT01546142|519894662|FG000|Overall Study|Subject Noncompliance|1|||
144191065|NCT01546142|519894663|FG001|Overall Study|Subject Noncompliance|1|||
144191066|NCT01546142|519894662|FG000|Overall Study|Adverse Event|6|||
144191067|NCT01546142|519894663|FG001|Overall Study|Adverse Event|3|||
144191068|NCT01546142|519894662|FG000|Overall Study|Lost to Follow-up|20|||
144191069|NCT01546142|519894663|FG001|Overall Study|Lost to Follow-up|15|||
144191070|NCT01546142|519894662|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
144191071|NCT01546142|519894663|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
144191072|NCT01546142|519894662|FG000|Overall Study|Subject Randomized but Not Treated|1|||
144191073|NCT01546142|519894663|FG001|Overall Study|Subject Randomized but Not Treated|0|||
144191074|NCT00107042|519894670|FG000|Overall Study|Lost to Follow-up|9|||
144440931|NCT02896400|520818482|FG015|3 Month Follow-up|Death|0|||
144440932|NCT02896400|520818467|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440933|NCT02896400|520818468|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
144440934|NCT02896400|520818469|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440935|NCT02896400|520818470|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440936|NCT02896400|520818471|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
144440937|NCT02896400|520818472|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440938|NCT02896400|520818473|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
144531196|NCT03505008|521147898|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
144531197|NCT03505008|521147895|FG000|Before Week 24 Randomization|Adverse Event|10|||
144531198|NCT03505008|521147896|FG001|Before Week 24 Randomization|Adverse Event|0|||
144531199|NCT03505008|521147897|FG002|Before Week 24 Randomization|Adverse Event|0|||
144531200|NCT03505008|521147898|FG003|Before Week 24 Randomization|Adverse Event|0|||
144531201|NCT03505008|521147895|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
144531202|NCT03505008|521147896|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
144531203|NCT03505008|521147897|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
144531204|NCT03505008|521147898|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
144531205|NCT03505008|521147895|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
144531206|NCT03505008|521147896|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
144531207|NCT03505008|521147897|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
144531208|NCT03505008|521147898|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
144531209|NCT03505008|521147895|FG000|Before Week 24 Randomization|Physician Decision|2|||
144440939|NCT02896400|520818474|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
144440940|NCT02896400|520818475|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440941|NCT02896400|520818476|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440942|NCT02896400|520818477|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
144440943|NCT02896400|520818478|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
144440944|NCT02896400|520818479|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440945|NCT02896400|520818480|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
144440946|NCT02896400|520818481|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
144440947|NCT02896400|520818482|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
144440948|NCT02896400|520818467|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
144440949|NCT02896400|520818468|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
144440950|NCT02896400|520818469|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
144440951|NCT02896400|520818470|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
144440952|NCT02896400|520818471|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
144440953|NCT02896400|520818472|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
144440954|NCT02896400|520818473|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
144440955|NCT02896400|520818474|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
144440956|NCT02896400|520818475|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
144440957|NCT02896400|520818476|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
144440958|NCT02896400|520818477|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
144440959|NCT02896400|520818478|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
144440960|NCT02896400|520818479|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
144440961|NCT02896400|520818480|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
144440962|NCT02896400|520818481|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
144440963|NCT02896400|520818482|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
144440964|NCT00634647|520818483|FG000|Overall Study|death on study|3|||
144440965|NCT00634647|520818483|FG000|Overall Study|refused further treatment|3|||
144531210|NCT03505008|521147896|FG001|Before Week 24 Randomization|Physician Decision|0|||
144531211|NCT03505008|521147897|FG002|Before Week 24 Randomization|Physician Decision|0|||
144531212|NCT03505008|521147898|FG003|Before Week 24 Randomization|Physician Decision|0|||
144531213|NCT03505008|521147895|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
144531214|NCT03505008|521147896|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
144531215|NCT03505008|521147897|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
144531216|NCT03505008|521147898|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
144531217|NCT03505008|521147895|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
144531218|NCT03505008|521147896|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
144531219|NCT03505008|521147897|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
144531220|NCT03505008|521147898|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
144531221|NCT03505008|521147895|FG000|Before Week 24 Randomization|Complication|1|||
144531222|NCT03505008|521147896|FG001|Before Week 24 Randomization|Complication|0|||
144531223|NCT03505008|521147897|FG002|Before Week 24 Randomization|Complication|0|||
144531224|NCT03505008|521147898|FG003|Before Week 24 Randomization|Complication|0|||
144531225|NCT03505008|521147895|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
144531226|NCT03505008|521147896|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
144605103|NCT00088907|521417014|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
144191075|NCT00107042|519894671|FG001|Overall Study|Lost to Follow-up|7|||
144191076|NCT00107042|519894670|FG000|Overall Study|Withdrawal by Subject|6|||
144531227|NCT03505008|521147897|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
144605104|NCT00088907|521417013|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
144605105|NCT00088907|521417014|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
144605106|NCT03426787|521417015|FG000|Overall Study|Withdrawal by Subject|6|||
144605107|NCT03426787|521417015|FG000|Overall Study|Lost to Follow-up|7|||
144605108|NCT03426787|521417015|FG000|Overall Study|Unrelated to intervention death|1|||
144605109|NCT00395863|521417016|FG000|Overall Study|Patients did not complete both exams|2|||
144605110|NCT00395863|521417017|FG001|Overall Study|Patients did not complete both exams|3|||
144605111|NCT05162027|521417020|FG000|Overall Study|Adverse Event|1|||
144605112|NCT05162027|521417021|FG001|Overall Study|Adverse Event|0|||
144605113|NCT00907257|521417024|FG000|Overall Study|Adverse Event|0|||
144605114|NCT00907257|521417025|FG001|Overall Study|Adverse Event|4|||
144605115|NCT00907257|521417024|FG000|Overall Study|Protocol Violation|1|||
144253562|NCT02697734|520128134|FG001|Optional Extension Phase|Physician Decision|1|||
144253563|NCT02334384|520128135|FG000|Overall Study|Lost to Follow-up|1|||
144440966|NCT00634647|520818483|FG000|Overall Study|declined to participate before treatment|1|||
144440967|NCT02984020|520818484|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
144440968|NCT02984020|520818484|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
144440969|NCT02984020|520818484|FG000|Overall Study|Other significant protocol violation|2|||
144440970|NCT00667342|520818485|FG000|Overall Study|Protocol Violation|1|||
144440971|NCT00667342|520818486|FG001|Overall Study|Protocol Violation|0|||
144440972|NCT00667342|520818487|FG002|Overall Study|Protocol Violation|0|||
144440973|NCT00667342|520818485|FG000|Overall Study|Withdrawal by Subject|1|||
144440974|NCT00667342|520818486|FG001|Overall Study|Withdrawal by Subject|0|||
144440975|NCT00667342|520818487|FG002|Overall Study|Withdrawal by Subject|0|||
144440976|NCT00667342|520818485|FG000|Overall Study|Physician Decision|3|||
144440977|NCT00667342|520818486|FG001|Overall Study|Physician Decision|0|||
144440978|NCT00667342|520818487|FG002|Overall Study|Physician Decision|0|||
144440979|NCT00667342|520818485|FG000|Overall Study|Relapse or tumor progression|9|||
144440980|NCT00667342|520818486|FG001|Overall Study|Relapse or tumor progression|0|||
144440981|NCT00667342|520818487|FG002|Overall Study|Relapse or tumor progression|7|||
144440982|NCT00667342|520818485|FG000|Overall Study|Adverse Event|0|||
144440983|NCT00667342|520818486|FG001|Overall Study|Adverse Event|0|||
144440984|NCT00667342|520818487|FG002|Overall Study|Adverse Event|1|||
144440985|NCT00667342|520818485|FG000|Overall Study|Ineligible|0|||
144440986|NCT00667342|520818486|FG001|Overall Study|Ineligible|0|||
144440987|NCT00667342|520818487|FG002|Overall Study|Ineligible|1|||
144440988|NCT01896895|520818488|FG000|Double-blind MP|Physician Decision|0|||
144440989|NCT01896895|520818489|FG001|Double-blind MP|Physician Decision|0|||
144440990|NCT01896895|520818490|FG002|Double-blind MP|Physician Decision|1|||
144440991|NCT01896895|520818491|FG003|Double-blind MP|Physician Decision|0|||
144440992|NCT01896895|520818488|FG000|Double-blind MP|Withdrawal by Subject|0|||
144440993|NCT01896895|520818489|FG001|Double-blind MP|Withdrawal by Subject|2|||
144440994|NCT01896895|520818490|FG002|Double-blind MP|Withdrawal by Subject|1|||
144440995|NCT01896895|520818491|FG003|Double-blind MP|Withdrawal by Subject|0|||
144440996|NCT01896895|520818488|FG000|Double-blind MP|Lost to Follow-up|1|||
144440997|NCT01896895|520818489|FG001|Double-blind MP|Lost to Follow-up|0|||
144440998|NCT01896895|520818490|FG002|Double-blind MP|Lost to Follow-up|1|||
144440999|NCT01896895|520818491|FG003|Double-blind MP|Lost to Follow-up|0|||
144441000|NCT01207778|520818492|FG000|Overall Study|Lost to Follow-up|0|||
144441001|NCT01207778|520818493|FG001|Overall Study|Lost to Follow-up|3|||
144441002|NCT01207778|520818494|FG002|Overall Study|Lost to Follow-up|3|||
144441003|NCT03107988|520818495|FG000|Overall Study|Adverse Event|0|||
144441004|NCT03107988|520818496|FG001|Overall Study|Adverse Event|0|||
144441005|NCT03107988|520818497|FG002|Overall Study|Adverse Event|0|||
144441006|NCT03107988|520818498|FG003|Overall Study|Adverse Event|1|||
144441007|NCT03107988|520818499|FG004|Overall Study|Adverse Event|0|||
144441008|NCT03107988|520818500|FG005|Overall Study|Adverse Event|1|||
144441009|NCT03107988|520818501|FG006|Overall Study|Adverse Event|0|||
144441010|NCT03107988|520818502|FG007|Overall Study|Adverse Event|1|||
144441011|NCT03107988|520818503|FG008|Overall Study|Adverse Event|0|||
144441012|NCT03107988|520818504|FG009|Overall Study|Adverse Event|0|||
144441013|NCT03107988|520818505|FG010|Overall Study|Adverse Event|0|||
144441014|NCT03107988|520818506|FG011|Overall Study|Adverse Event|0|||
144605116|NCT00907257|521417025|FG001|Overall Study|Protocol Violation|2|||
144605117|NCT00907257|521417024|FG000|Overall Study|Lost to Follow-up|3|||
144605118|NCT00907257|521417025|FG001|Overall Study|Lost to Follow-up|3|||
144441015|NCT03107988|520818507|FG012|Overall Study|Adverse Event|0|||
144441016|NCT03107988|520818495|FG000|Overall Study|Disease Progression or Relapse|1|||
144441017|NCT03107988|520818496|FG001|Overall Study|Disease Progression or Relapse|2|||
144441018|NCT03107988|520818497|FG002|Overall Study|Disease Progression or Relapse|2|||
144441019|NCT03107988|520818498|FG003|Overall Study|Disease Progression or Relapse|5|||
144441020|NCT03107988|520818499|FG004|Overall Study|Disease Progression or Relapse|1|||
144605119|NCT00907257|521417024|FG000|Overall Study|Withdrawal by Subject|1|||
144605120|NCT00907257|521417025|FG001|Overall Study|Withdrawal by Subject|2|||
144605121|NCT00907257|521417024|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
144253564|NCT02334384|520128136|FG001|Overall Study|Lost to Follow-up|1|||
144253565|NCT00625183|520128137|FG000|Overall Study|Disease Progression|1|||
144441021|NCT03107988|520818500|FG005|Overall Study|Disease Progression or Relapse|1|||
144441022|NCT03107988|520818501|FG006|Overall Study|Disease Progression or Relapse|0|||
144441023|NCT03107988|520818502|FG007|Overall Study|Disease Progression or Relapse|0|||
144441024|NCT03107988|520818503|FG008|Overall Study|Disease Progression or Relapse|0|||
144441025|NCT03107988|520818504|FG009|Overall Study|Disease Progression or Relapse|1|||
144441026|NCT03107988|520818505|FG010|Overall Study|Disease Progression or Relapse|4|||
144441027|NCT03107988|520818506|FG011|Overall Study|Disease Progression or Relapse|0|||
144441028|NCT03107988|520818507|FG012|Overall Study|Disease Progression or Relapse|0|||
144441029|NCT03107988|520818495|FG000|Overall Study|Ineligible|0|||
144441030|NCT03107988|520818496|FG001|Overall Study|Ineligible|0|||
144441031|NCT03107988|520818497|FG002|Overall Study|Ineligible|0|||
144441032|NCT03107988|520818498|FG003|Overall Study|Ineligible|0|||
144441033|NCT03107988|520818499|FG004|Overall Study|Ineligible|0|||
144441034|NCT03107988|520818500|FG005|Overall Study|Ineligible|0|||
144441035|NCT03107988|520818501|FG006|Overall Study|Ineligible|0|||
144441036|NCT03107988|520818502|FG007|Overall Study|Ineligible|0|||
144441037|NCT03107988|520818503|FG008|Overall Study|Ineligible|1|||
144441038|NCT03107988|520818504|FG009|Overall Study|Ineligible|0|||
144441039|NCT03107988|520818505|FG010|Overall Study|Ineligible|0|||
144441040|NCT03107988|520818506|FG011|Overall Study|Ineligible|0|||
144441041|NCT03107988|520818507|FG012|Overall Study|Ineligible|0|||
144441042|NCT04709237|520818508|FG000|Overall Study|Lost to Follow-up|1|||
144441043|NCT04709237|520818509|FG001|Overall Study|Lost to Follow-up|0|||
144441044|NCT04709237|520818510|FG002|Overall Study|Lost to Follow-up|0|||
144441045|NCT00145509|520818511|FG000|Overall Study|Adverse Event|10|||
144441046|NCT00145509|520818512|FG001|Overall Study|Adverse Event|3|||
144441047|NCT00145509|520818511|FG000|Overall Study|Lack of Efficacy|3|||
144441048|NCT00145509|520818512|FG001|Overall Study|Lack of Efficacy|1|||
144441049|NCT00145509|520818511|FG000|Overall Study|Lost to Follow-up|5|||
144441050|NCT00145509|520818512|FG001|Overall Study|Lost to Follow-up|9|||
144441051|NCT00145509|520818511|FG000|Overall Study|Withdrew Consent|2|||
144441052|NCT00145509|520818512|FG001|Overall Study|Withdrew Consent|7|||
144441053|NCT00145509|520818511|FG000|Overall Study|Reason not provided|2|||
144441054|NCT00145509|520818512|FG001|Overall Study|Reason not provided|1|||
144441055|NCT01359592|520818513|FG000|Initial Registration|Adverse Event|1|||
144441056|NCT01359592|520818514|FG001|Initial Registration|Adverse Event|0|||
144441057|NCT01359592|520818515|FG002|Initial Registration|Adverse Event|0|||
144441058|NCT01359592|520818516|FG003|Initial Registration|Adverse Event|0|||
144441059|NCT01359592|520818513|FG000|Initial Registration|Death|1|||
144441060|NCT01359592|520818514|FG001|Initial Registration|Death|0|||
144191077|NCT00107042|519894671|FG001|Overall Study|Withdrawal by Subject|1|||
144191078|NCT00107042|519894670|FG000|Overall Study|Moved out of area|5|||
144441061|NCT01359592|520818515|FG002|Initial Registration|Death|0|||
144441062|NCT01359592|520818516|FG003|Initial Registration|Death|0|||
144441063|NCT01359592|520818513|FG000|Initial Registration|Other reason not protocol specified|1|||
144441064|NCT01359592|520818514|FG001|Initial Registration|Other reason not protocol specified|0|||
144441065|NCT01359592|520818515|FG002|Initial Registration|Other reason not protocol specified|0|||
144441066|NCT01359592|520818516|FG003|Initial Registration|Other reason not protocol specified|0|||
144441067|NCT01359592|520818513|FG000|Initial Registration|Ineligible|26|||
144441068|NCT01359592|520818514|FG001|Initial Registration|Ineligible|0|||
144441069|NCT01359592|520818515|FG002|Initial Registration|Ineligible|0|||
144441070|NCT01359592|520818516|FG003|Initial Registration|Ineligible|0|||
144441071|NCT01359592|520818513|FG000|PET-Directed Therapy|Adverse Event|0|||
144441072|NCT01359592|520818514|FG001|PET-Directed Therapy|Adverse Event|0|||
144441073|NCT01359592|520818515|FG002|PET-Directed Therapy|Adverse Event|1|||
144441074|NCT01359592|520818516|FG003|PET-Directed Therapy|Adverse Event|0|||
144441075|NCT01359592|520818513|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
144441076|NCT01359592|520818514|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
144441077|NCT01359592|520818515|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
144441078|NCT01359592|520818516|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
144191079|NCT00107042|519894671|FG001|Overall Study|Moved out of area|3|||
144191080|NCT00107042|519894670|FG000|Overall Study|Pregnancy|1|||
144191081|NCT00107042|519894671|FG001|Overall Study|Pregnancy|1|||
144191082|NCT00107042|519894670|FG000|Overall Study|Inadvertent enrollment|0|||
144191083|NCT00107042|519894671|FG001|Overall Study|Inadvertent enrollment|1|||
144191084|NCT00107042|519894670|FG000|Overall Study|vaccinated outside window|1|||
144441079|NCT01359592|520818513|FG000|PET-Directed Therapy|Ineligible|0|||
144441080|NCT01359592|520818514|FG001|PET-Directed Therapy|Ineligible|0|||
144441081|NCT01359592|520818515|FG002|PET-Directed Therapy|Ineligible|24|||
144441082|NCT01359592|520818516|FG003|PET-Directed Therapy|Ineligible|0|||
144441083|NCT00326612|520818519|FG000|Overall Study|They did not have a seizure requiring tx|129|||
144441084|NCT00326612|520818520|FG001|Overall Study|They did not have a seizure requiring tx|137|||
144441085|NCT00419562|520818521|FG000|Overall Study|Lost to Follow-up|12|||
144191085|NCT00107042|519894671|FG001|Overall Study|vaccinated outside window|1|||
144191086|NCT00107042|519894670|FG000|Overall Study|Disallowed medications|0|||
144191087|NCT00107042|519894671|FG001|Overall Study|Disallowed medications|2|||
144441086|NCT00419562|520818522|FG001|Overall Study|Lost to Follow-up|13|||
144441087|NCT00419562|520818521|FG000|Overall Study|Withdrawal by Subject|20|||
144441088|NCT00419562|520818522|FG001|Overall Study|Withdrawal by Subject|18|||
144441089|NCT00419562|520818521|FG000|Overall Study|Participant Institutionalized|1|||
144441090|NCT00419562|520818522|FG001|Overall Study|Participant Institutionalized|0|||
144441091|NCT00640510|520818523|FG000|Overall Study|Lack of Efficacy|0|||
144441092|NCT00640510|520818524|FG001|Overall Study|Lack of Efficacy|1|||
144441093|NCT00640510|520818523|FG000|Overall Study|Protocol Violation|1|||
144441094|NCT00640510|520818524|FG001|Overall Study|Protocol Violation|0|||
144441095|NCT00640510|520818523|FG000|Overall Study|Physician Decision|0|||
144441096|NCT00640510|520818524|FG001|Overall Study|Physician Decision|1|||
144441097|NCT00749775|520818529|FG000|Overall Study|Protocol Violation|24|||
144441098|NCT00749775|520818529|FG000|Overall Study|Lost to Follow-up|36|||
144441099|NCT00749775|520818529|FG000|Overall Study|No visit after first day of treatment|44|||
144441100|NCT00749775|520818529|FG000|Overall Study|No drug administration|3|||
144441101|NCT00958776|520818530|FG000|Overall Study|Adverse Event|0|||
144441102|NCT00958776|520818531|FG001|Overall Study|Adverse Event|1|||
144441103|NCT00958776|520818530|FG000|Overall Study|Physician Decision|1|||
144441104|NCT00958776|520818531|FG001|Overall Study|Physician Decision|0|||
144441105|NCT00958776|520818530|FG000|Overall Study|Lost to Follow-up|2|||
144441106|NCT00958776|520818531|FG001|Overall Study|Lost to Follow-up|6|||
144441107|NCT00958776|520818530|FG000|Overall Study|Withdrawal by Subject|7|||
144441108|NCT00958776|520818531|FG001|Overall Study|Withdrawal by Subject|16|||
144441109|NCT00958776|520818530|FG000|Overall Study|Protocol Violation|1|||
144441110|NCT00958776|520818531|FG001|Overall Study|Protocol Violation|1|||
144441111|NCT00958776|520818530|FG000|Overall Study|Death|2|||
144441112|NCT00958776|520818531|FG001|Overall Study|Death|1|||
144441113|NCT00958776|520818530|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
144441114|NCT00958776|520818531|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
144441115|NCT00958776|520818530|FG000|Overall Study|Missing|1|||
144441116|NCT00958776|520818531|FG001|Overall Study|Missing|1|||
144441117|NCT00480636|520818532|FG000|Overall Study|Death|12|||
144441118|NCT00480636|520818532|FG000|Overall Study|Lost to Follow-up|4|||
144441119|NCT00480636|520818532|FG000|Overall Study|Other|2|||
144441120|NCT00480636|520818532|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
144441121|NCT02583256|520818533|FG000|Overall Study|Withdrawal by Subject|0|||
144441122|NCT02583256|520818534|FG001|Overall Study|Withdrawal by Subject|1|||
144441123|NCT02583256|520818535|FG002|Overall Study|Withdrawal by Subject|1|||
144441124|NCT02583256|520818536|FG003|Overall Study|Withdrawal by Subject|0|||
144441125|NCT02583256|520818533|FG000|Overall Study|Lost to Follow-up|1|||
144441126|NCT02583256|520818534|FG001|Overall Study|Lost to Follow-up|1|||
144441127|NCT02583256|520818535|FG002|Overall Study|Lost to Follow-up|0|||
144441128|NCT02583256|520818536|FG003|Overall Study|Lost to Follow-up|1|||
144441129|NCT02583256|520818533|FG000|Overall Study|Administrative/Other|2|||
144441130|NCT02583256|520818534|FG001|Overall Study|Administrative/Other|0|||
144441131|NCT02583256|520818535|FG002|Overall Study|Administrative/Other|1|||
144441132|NCT02583256|520818536|FG003|Overall Study|Administrative/Other|2|||
144441133|NCT02506816|520818547|FG000|Overall Study|Adverse Event|3|||
144441134|NCT02177266|520818548|FG000|Overall Study|Adverse Event|0|||
144441135|NCT02177266|520818549|FG001|Overall Study|Adverse Event|1|||
144441136|NCT02177266|520818548|FG000|Overall Study|Withdrawal by Subject|1|||
144441137|NCT02177266|520818549|FG001|Overall Study|Withdrawal by Subject|0|||
144441138|NCT03019627|520818551|FG000|Overall Study|Adverse Event|8|||
144441139|NCT03019627|520818552|FG001|Overall Study|Adverse Event|0|||
144441140|NCT03019627|520818551|FG000|Overall Study|Unrelated to adverse event|1|||
144441141|NCT03019627|520818552|FG001|Overall Study|Unrelated to adverse event|3|||
144441142|NCT03019627|520818551|FG000|Overall Study|Lost to Follow-up|2|||
144441143|NCT03019627|520818552|FG001|Overall Study|Lost to Follow-up|1|||
144191088|NCT03919448|519894672|FG000|Overall Study|Withdrawal by Subject|1|||
144191089|NCT03919448|519894673|FG001|Overall Study|Withdrawal by Subject|0|||
144191090|NCT03919448|519894674|FG002|Overall Study|Withdrawal by Subject|0|||
144191091|NCT03438539|519894676|FG000|Overall Study|Lost to Follow-up|8|||
144191092|NCT03438539|519894677|FG001|Overall Study|Lost to Follow-up|4|||
144191093|NCT03438539|519894678|FG002|Overall Study|Lost to Follow-up|10|||
144191094|NCT03438539|519894679|FG003|Overall Study|Lost to Follow-up|9|||
144191095|NCT03438539|519894680|FG004|Overall Study|Lost to Follow-up|3|||
144191096|NCT03438539|519894681|FG005|Overall Study|Lost to Follow-up|8|||
144191097|NCT04213209|519894685|FG000|Overall Study|Protocol Violation|1|||
144191098|NCT04213209|519894686|FG001|Overall Study|Protocol Violation|0|||
144441144|NCT03019627|520818551|FG000|Overall Study|not compliance|2|||
144441145|NCT03019627|520818552|FG001|Overall Study|not compliance|2|||
144441146|NCT03019627|520818551|FG000|Overall Study|Other|2|||
144441147|NCT03019627|520818552|FG001|Overall Study|Other|2|||
144441148|NCT03364049|520818553|FG000|Overall Study|Death|6|||
144441149|NCT03364049|520818554|FG001|Overall Study|Death|4|||
144441150|NCT03364049|520818555|FG002|Overall Study|Death|5|||
144441151|NCT03364049|520818556|FG003|Overall Study|Death|14|||
144441152|NCT03364049|520818553|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
144441153|NCT03364049|520818554|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
144472213|NCT01889186|520926708|FG001|Overall Study|COVID-19 logistical restrictions|0|||
144191099|NCT04213209|519894687|FG002|Overall Study|Protocol Violation|0|||
144191100|NCT04213209|519894688|FG003|Overall Study|Protocol Violation|0|||
144441154|NCT03364049|520818555|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
144441155|NCT03364049|520818556|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
144441156|NCT03364049|520818553|FG000|Overall Study|Withdrawal by Subject|0|||
144441157|NCT03364049|520818554|FG001|Overall Study|Withdrawal by Subject|1|||
144441158|NCT03364049|520818555|FG002|Overall Study|Withdrawal by Subject|1|||
144441159|NCT03364049|520818556|FG003|Overall Study|Withdrawal by Subject|1|||
144441160|NCT01802775|520818561|FG000|Overall Study|Death|0|||
144441161|NCT01802775|520818562|FG001|Overall Study|Death|3|||
144441162|NCT01802775|520818561|FG000|Overall Study|Reason not provided|0|||
144191101|NCT04213209|519894689|FG004|Overall Study|Protocol Violation|0|||
144441163|NCT01802775|520818562|FG001|Overall Study|Reason not provided|1|||
144441164|NCT01802775|520818561|FG000|Overall Study|Physician Decision|1|||
144441165|NCT01802775|520818562|FG001|Overall Study|Physician Decision|0|||
144441166|NCT01802775|520818561|FG000|Overall Study|Adverse Event|1|||
144441167|NCT01802775|520818562|FG001|Overall Study|Adverse Event|1|||
144441168|NCT01802775|520818561|FG000|Overall Study|Withdrawal by Subject|3|||
144441169|NCT01802775|520818562|FG001|Overall Study|Withdrawal by Subject|5|||
144441170|NCT01802775|520818561|FG000|Overall Study|Lost to Follow-up|1|||
144441171|NCT01802775|520818562|FG001|Overall Study|Lost to Follow-up|2|||
144441172|NCT01067352|520818563|FG000|Overall Study|Withdrawal by Subject|1|||
144441173|NCT01067352|520818564|FG001|Overall Study|Withdrawal by Subject|2|||
144441174|NCT01067352|520818565|FG002|Overall Study|Withdrawal by Subject|1|||
144441175|NCT01067352|520818563|FG000|Overall Study|Physician Decision|0|||
144531228|NCT03505008|521147898|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
144531229|NCT03505008|521147895|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
144531230|NCT03505008|521147896|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
144531231|NCT03505008|521147897|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
144531232|NCT03505008|521147898|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
144531233|NCT03505008|521147895|FG000|After Week 24 Randomization|Adverse Event|0|||
144531234|NCT03505008|521147896|FG001|After Week 24 Randomization|Adverse Event|1|||
144531235|NCT03505008|521147897|FG002|After Week 24 Randomization|Adverse Event|2|||
144531236|NCT03505008|521147898|FG003|After Week 24 Randomization|Adverse Event|2|||
144531237|NCT03505008|521147895|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
144531238|NCT03505008|521147896|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
144531239|NCT03505008|521147897|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
144531240|NCT03505008|521147898|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
144531241|NCT03505008|521147895|FG000|After Week 24 Randomization|Protocol Violation|0|||
144531242|NCT03505008|521147896|FG001|After Week 24 Randomization|Protocol Violation|0|||
144531243|NCT03505008|521147897|FG002|After Week 24 Randomization|Protocol Violation|1|||
144531244|NCT03505008|521147898|FG003|After Week 24 Randomization|Protocol Violation|0|||
144531245|NCT02780700|521147899|FG000|Overall Study|Progressive disease|1|||
144531246|NCT03583333|521147900|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
144531247|NCT03583333|521147901|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
144531248|NCT03583333|521147900|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
144531249|NCT03583333|521147901|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
144531250|NCT03583333|521147900|FG000|Overall Study|Withdrawal by Subject|9|||
144531251|NCT03583333|521147901|FG001|Overall Study|Withdrawal by Subject|5|||
144531252|NCT03583333|521147900|FG000|Overall Study|Physician Decision|3|||
144531253|NCT03583333|521147901|FG001|Overall Study|Physician Decision|2|||
144531254|NCT03583333|521147900|FG000|Overall Study|Death|12|||
144531255|NCT03583333|521147901|FG001|Overall Study|Death|7|||
144531256|NCT03926130|521147902|FG000|Overall Study|Adverse Event|9|||
144531257|NCT03926130|521147903|FG001|Overall Study|Adverse Event|11|||
144531258|NCT03926130|521147904|FG002|Overall Study|Adverse Event|2|||
144531259|NCT03926130|521147905|FG003|Overall Study|Adverse Event|0|||
144531260|NCT03926130|521147902|FG000|Overall Study|Death|2|||
144531261|NCT03926130|521147903|FG001|Overall Study|Death|0|||
144531262|NCT03926130|521147904|FG002|Overall Study|Death|1|||
144531263|NCT03926130|521147905|FG003|Overall Study|Death|0|||
144531264|NCT03926130|521147902|FG000|Overall Study|Lack of Efficacy|14|||
144531265|NCT03926130|521147903|FG001|Overall Study|Lack of Efficacy|11|||
144531266|NCT03926130|521147904|FG002|Overall Study|Lack of Efficacy|7|||
144531267|NCT03926130|521147905|FG003|Overall Study|Lack of Efficacy|1|||
144531268|NCT03926130|521147902|FG000|Overall Study|Lost to Follow-up|0|||
144191102|NCT04213209|519894690|FG005|Overall Study|Protocol Violation|0|||
144191103|NCT00892281|519894700|FG000|Overall Study|Adverse Event|65|||
144191104|NCT00892281|519894701|FG001|Overall Study|Adverse Event|8|||
144531269|NCT03926130|521147903|FG001|Overall Study|Lost to Follow-up|7|||
144531270|NCT03926130|521147904|FG002|Overall Study|Lost to Follow-up|1|||
144531271|NCT03926130|521147905|FG003|Overall Study|Lost to Follow-up|0|||
144531272|NCT03926130|521147902|FG000|Overall Study|As Reported by Investigator|2|||
144531273|NCT03926130|521147903|FG001|Overall Study|As Reported by Investigator|6|||
144531274|NCT03926130|521147904|FG002|Overall Study|As Reported by Investigator|6|||
144191105|NCT00892281|519894700|FG000|Overall Study|Lost to Follow-up|81|||
144441176|NCT01067352|520818564|FG001|Overall Study|Physician Decision|1|||
144191106|NCT00892281|519894701|FG001|Overall Study|Lost to Follow-up|8|||
144191107|NCT00892281|519894700|FG000|Overall Study|Pregnancy|1|||
144191108|NCT00892281|519894701|FG001|Overall Study|Pregnancy|0|||
144191109|NCT00892281|519894700|FG000|Overall Study|Protocol Violation|7|||
144441177|NCT01067352|520818565|FG002|Overall Study|Physician Decision|0|||
144441178|NCT01096784|520818566|FG000|Overall Study|Withdrawal by Subject|2|||
144441179|NCT01096784|520818567|FG001|Overall Study|Withdrawal by Subject|1|||
144441180|NCT01096784|520818566|FG000|Overall Study|Adverse Event|11|||
144441181|NCT01096784|520818567|FG001|Overall Study|Adverse Event|9|||
144441182|NCT01096784|520818566|FG000|Overall Study|Protocol Deviation|2|||
144441183|NCT01096784|520818567|FG001|Overall Study|Protocol Deviation|2|||
144441184|NCT01096784|520818566|FG000|Overall Study|Administrative Decision|0|||
144441185|NCT01096784|520818567|FG001|Overall Study|Administrative Decision|1|||
144441186|NCT01096784|520818566|FG000|Overall Study|Other Unspecified|0|||
144441187|NCT01096784|520818567|FG001|Overall Study|Other Unspecified|1|||
144441188|NCT03761628|520818568|FG000|Overall Study|Withdrawal by Subject|3|||
144441189|NCT03761628|520818568|FG000|Overall Study|Physician Decision|1|||
144441190|NCT03761628|520818568|FG000|Overall Study|Pregnancy|1|||
144441191|NCT03761628|520818568|FG000|Overall Study|Lost to Follow-up|1|||
144441192|NCT03362502|520818570|FG000|Overall Study|Death|0|||
144441193|NCT03362502|520818571|FG001|Overall Study|Death|0|||
144441194|NCT03362502|520818572|FG002|Overall Study|Death|1|||
144441195|NCT03277261|520818581|FG000|Overall Study|Adverse Event|17|||
144441196|NCT03277261|520818582|FG001|Overall Study|Adverse Event|1|||
144441197|NCT03277261|520818581|FG000|Overall Study|Participant Withdrawal of Consent|6|||
144441198|NCT03277261|520818582|FG001|Overall Study|Participant Withdrawal of Consent|15|||
144441199|NCT03277261|520818581|FG000|Overall Study|Investigator / Sponsor Decision|4|||
144441200|NCT03277261|520818582|FG001|Overall Study|Investigator / Sponsor Decision|2|||
144441201|NCT03277261|520818581|FG000|Overall Study|Pregnancy|2|||
144441202|NCT03277261|520818582|FG001|Overall Study|Pregnancy|0|||
144441203|NCT03277261|520818581|FG000|Overall Study|Lost to Follow-up|2|||
144441204|NCT03277261|520818582|FG001|Overall Study|Lost to Follow-up|2|||
144441205|NCT03277261|520818581|FG000|Overall Study|Lack of Efficacy|2|||
144441206|NCT03277261|520818582|FG001|Overall Study|Lack of Efficacy|2|||
144441207|NCT03277261|520818581|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
144441208|NCT03277261|520818582|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
144441209|NCT00499603|520818583|FG000|Overall Study|Adverse Event|0|||
144441210|NCT00499603|520818584|FG001|Overall Study|Adverse Event|1|||
144441211|NCT03323099|520818585|FG000|Overall Study|Withdrawal by Subject|6|||
144441212|NCT03323099|520818586|FG001|Overall Study|Withdrawal by Subject|12|||
144441213|NCT03323099|520818585|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
144441214|NCT03323099|520818586|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
144441215|NCT05220397|520818587|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
144441216|NCT05220397|520818588|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
144441217|NCT05220397|520818589|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
144441218|NCT05220397|520818590|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
144441219|NCT05220397|520818591|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
144441220|NCT01502644|520818592|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
144441221|NCT01502644|520818593|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
144441222|NCT01502644|520818594|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
144441223|NCT01502644|520818595|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
144441224|NCT01502644|520818592|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
144441225|NCT01502644|520818593|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
144441226|NCT01502644|520818594|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
144441227|NCT01502644|520818595|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
144441228|NCT01502644|520818592|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
144441229|NCT01502644|520818593|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
144441230|NCT01502644|520818594|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
144441231|NCT01502644|520818595|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
144441232|NCT01502644|520818592|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
144191110|NCT00892281|519894701|FG001|Overall Study|Protocol Violation|2|||
144191111|NCT00892281|519894700|FG000|Overall Study|Withdrawal by Subject|86|||
144441233|NCT01502644|520818593|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
144441234|NCT01502644|520818594|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
144441235|NCT01502644|520818595|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
144441236|NCT01502644|520818592|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
144441237|NCT01502644|520818593|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
144191112|NCT00892281|519894701|FG001|Overall Study|Withdrawal by Subject|14|||
144191113|NCT00892281|519894700|FG000|Overall Study|Subject failed to return for final visit|2|||
144253566|NCT02279745|520128138|FG000|Overall Study|Adverse Event|7|||
144605122|NCT00907257|521417025|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
144605123|NCT00907257|521417024|FG000|Overall Study|Moved|1|||
144191114|NCT00892281|519894701|FG001|Overall Study|Subject failed to return for final visit|0|||
144441238|NCT01502644|520818594|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
144441239|NCT01502644|520818595|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
144441240|NCT01526889|520818598|FG000|Treatment Period|Adverse Event|2|||
144441241|NCT01526889|520818599|FG001|Treatment Period|Adverse Event|0|||
144441242|NCT01526889|520818598|FG000|Treatment Extension Period|Administrative problems|1|||
144441243|NCT01526889|520818599|FG001|Treatment Extension Period|Administrative problems|0|||
144441244|NCT01110915|520818600|FG000|Overall Study|Death|2|||
144441245|NCT01110915|520818601|FG001|Overall Study|Death|1|||
144441246|NCT01110915|520818600|FG000|Overall Study|Lost to Follow-up|1|||
144441247|NCT01110915|520818601|FG001|Overall Study|Lost to Follow-up|0|||
144441248|NCT01110915|520818600|FG000|Overall Study|Withdrawal by Subject|7|||
144441249|NCT01110915|520818601|FG001|Overall Study|Withdrawal by Subject|1|||
144441250|NCT01857063|520818602|FG000|Period 1 (7 Days)|Adverse Event|0|||
144441251|NCT01857063|520818603|FG001|Period 1 (7 Days)|Adverse Event|1|||
144441252|NCT01857063|520818602|FG000|Period 1 (7 Days)|Physician Decision|1|||
144531275|NCT03926130|521147905|FG003|Overall Study|As Reported by Investigator|0|||
144531276|NCT03926130|521147902|FG000|Overall Study|Physician Decision|3|||
144531277|NCT03926130|521147903|FG001|Overall Study|Physician Decision|2|||
144531278|NCT03926130|521147904|FG002|Overall Study|Physician Decision|1|||
144531279|NCT03926130|521147905|FG003|Overall Study|Physician Decision|0|||
144531280|NCT03926130|521147902|FG000|Overall Study|Pregnancy|2|||
144531281|NCT03926130|521147903|FG001|Overall Study|Pregnancy|2|||
144531282|NCT03926130|521147904|FG002|Overall Study|Pregnancy|1|||
144531283|NCT03926130|521147905|FG003|Overall Study|Pregnancy|0|||
144531284|NCT03926130|521147902|FG000|Overall Study|Withdrawal by Subject|20|||
144531285|NCT03926130|521147903|FG001|Overall Study|Withdrawal by Subject|28|||
144531286|NCT03926130|521147904|FG002|Overall Study|Withdrawal by Subject|18|||
144531287|NCT03926130|521147905|FG003|Overall Study|Withdrawal by Subject|1|||
144531288|NCT03926130|521147902|FG000|Overall Study|Non-Compliance|1|||
144531289|NCT03926130|521147903|FG001|Overall Study|Non-Compliance|1|||
144531290|NCT03926130|521147904|FG002|Overall Study|Non-Compliance|0|||
144531291|NCT03926130|521147905|FG003|Overall Study|Non-Compliance|0|||
144531292|NCT03926130|521147902|FG000|Overall Study|Disposition Not Captured|0|||
144531293|NCT03926130|521147903|FG001|Overall Study|Disposition Not Captured|2|||
144531294|NCT03926130|521147904|FG002|Overall Study|Disposition Not Captured|1|||
144531295|NCT03926130|521147905|FG003|Overall Study|Disposition Not Captured|0|||
144531296|NCT03824366|521147922|FG000|Overall Study|Death|1|||
144531297|NCT03824366|521147922|FG000|Overall Study|Previously unidentified metal artifact|1|||
144531298|NCT03824366|521147922|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
144531299|NCT03824366|521147922|FG000|Overall Study|Withdrawal by Subject|1|||
144531300|NCT04544007|521147925|FG000|Overall Study|Withdrawal by Subject|1|||
144531301|NCT04544007|521147925|FG000|Overall Study|Confirmed Progressive Disease|1|||
144531302|NCT03485729|521147929|FG000|Overall Study|Withdrawal by Subject|0|||
144531303|NCT03485729|521147930|FG001|Overall Study|Withdrawal by Subject|0|||
144531304|NCT03485729|521147931|FG002|Overall Study|Withdrawal by Subject|1|||
144531305|NCT03485729|521147929|FG000|Overall Study|Disease progression|8|||
144531306|NCT03485729|521147930|FG001|Overall Study|Disease progression|13|||
144531307|NCT03485729|521147931|FG002|Overall Study|Disease progression|1|||
144531308|NCT03485729|521147929|FG000|Overall Study|Hospice care|1|||
144531309|NCT03485729|521147930|FG001|Overall Study|Hospice care|0|||
144531310|NCT03485729|521147931|FG002|Overall Study|Hospice care|0|||
144531311|NCT03485729|521147929|FG000|Overall Study|Poor performance status|1|||
144531312|NCT03485729|521147930|FG001|Overall Study|Poor performance status|0|||
144531313|NCT03485729|521147931|FG002|Overall Study|Poor performance status|0|||
144531314|NCT03485729|521147929|FG000|Overall Study|Illness|0|||
144531315|NCT03485729|521147930|FG001|Overall Study|Illness|1|||
144531316|NCT03485729|521147931|FG002|Overall Study|Illness|0|||
144531317|NCT05856435|521147937|FG000|Overall Study|Lost to Follow-up|6|||
144531318|NCT02323880|521147938|FG000|Overall Study|Adverse Event|2|||
144531319|NCT02323880|521147939|FG001|Overall Study|Adverse Event|0|||
144531320|NCT02323880|521147940|FG002|Overall Study|Adverse Event|1|||
144531321|NCT02323880|521147941|FG003|Overall Study|Adverse Event|1|||
144531322|NCT02323880|521147942|FG004|Overall Study|Adverse Event|1|||
144531323|NCT02323880|521147943|FG005|Overall Study|Adverse Event|0|||
144531324|NCT02323880|521147944|FG006|Overall Study|Adverse Event|1|||
144531325|NCT02323880|521147945|FG007|Overall Study|Adverse Event|0|||
144531326|NCT02323880|521147938|FG000|Overall Study|Death|0|||
144531327|NCT02323880|521147939|FG001|Overall Study|Death|0|||
144531328|NCT02323880|521147940|FG002|Overall Study|Death|0|||
144531329|NCT02323880|521147941|FG003|Overall Study|Death|0|||
144191115|NCT00892281|519894700|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
144441253|NCT01857063|520818603|FG001|Period 1 (7 Days)|Physician Decision|0|||
144441254|NCT01857063|520818602|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
144441255|NCT01857063|520818603|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
144531330|NCT02323880|521147942|FG004|Overall Study|Death|0|||
144191116|NCT00892281|519894701|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
144191117|NCT00892281|519894700|FG000|Overall Study|Final visit completed 4 weeks late|0|||
144191118|NCT00892281|519894701|FG001|Overall Study|Final visit completed 4 weeks late|1|||
144191119|NCT00892281|519894700|FG000|Overall Study|Subject completed day after study closed|1|||
144191120|NCT00892281|519894701|FG001|Overall Study|Subject completed day after study closed|0|||
144191121|NCT00892281|519894700|FG000|Overall Study|Family emergency|1|||
144191122|NCT00892281|519894701|FG001|Overall Study|Family emergency|0|||
144191123|NCT00892281|519894700|FG000|Overall Study|Last visit not done - death in family|1|||
144191124|NCT00892281|519894701|FG001|Overall Study|Last visit not done - death in family|0|||
144191125|NCT00892281|519894700|FG000|Overall Study|Did not meet incl/excl criteria|1|||
144191126|NCT00892281|519894701|FG001|Overall Study|Did not meet incl/excl criteria|0|||
144191127|NCT00892281|519894700|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
144191128|NCT00892281|519894701|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
144191129|NCT00892281|519894700|FG000|Overall Study|Unable to redeem the drug voucher|1|||
144191130|NCT00892281|519894701|FG001|Overall Study|Unable to redeem the drug voucher|0|||
144191131|NCT00892281|519894700|FG000|Overall Study|Subject not good candidate for study|1|||
144191132|NCT00892281|519894701|FG001|Overall Study|Subject not good candidate for study|0|||
144191133|NCT00892281|519894700|FG000|Overall Study|Subject did not return for any visits|1|||
144191134|NCT00892281|519894701|FG001|Overall Study|Subject did not return for any visits|0|||
144191135|NCT00892281|519894700|FG000|Overall Study|Subject missed several visits/lost meds|1|||
144191136|NCT00892281|519894701|FG001|Overall Study|Subject missed several visits/lost meds|0|||
144191137|NCT00892281|519894700|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
144191138|NCT00892281|519894701|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
144441256|NCT01857063|520818602|FG000|Period 2 (7 Days)|Adverse Event|2|||
144441257|NCT01857063|520818603|FG001|Period 2 (7 Days)|Adverse Event|1|||
144441258|NCT01857063|520818602|FG000|Period 2 (7 Days)|Physician Decision|1|||
144441259|NCT01857063|520818603|FG001|Period 2 (7 Days)|Physician Decision|1|||
144441260|NCT01857063|520818602|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
144441261|NCT01857063|520818603|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
144441262|NCT05059600|520818604|FG000|Overall Study|Enrolled but not Treated|10|||
144441263|NCT01455012|520818609|FG000|Overall Study|Adverse Event|0|||
144441264|NCT01455012|520818610|FG001|Overall Study|Adverse Event|2|||
144441265|NCT01455012|520818609|FG000|Overall Study|Lack of Efficacy|6|||
144441266|NCT01455012|520818610|FG001|Overall Study|Lack of Efficacy|1|||
144441267|NCT01455012|520818609|FG000|Overall Study|Withdrawal by Subject|3|||
144441268|NCT01455012|520818610|FG001|Overall Study|Withdrawal by Subject|1|||
144441269|NCT01455012|520818609|FG000|Overall Study|Unknown reason|2|||
144605124|NCT00907257|521417025|FG001|Overall Study|Moved|0|||
144605125|NCT00907257|521417024|FG000|Overall Study|Personal Reasons|6|||
144605126|NCT00907257|521417025|FG001|Overall Study|Personal Reasons|1|||
144605127|NCT00880555|521417026|FG000|Overall Study|Physician Decision|0|||
144605128|NCT00880555|521417027|FG001|Overall Study|Physician Decision|8|||
144605129|NCT00880555|521417028|FG002|Overall Study|Physician Decision|0|||
144605130|NCT00880555|521417029|FG003|Overall Study|Physician Decision|2|||
144605131|NCT00880555|521417030|FG004|Overall Study|Physician Decision|1|||
144605132|NCT00880555|521417031|FG005|Overall Study|Physician Decision|0|||
144605133|NCT00880555|521417026|FG000|Overall Study|Withdrawal by Subject|1|||
144605134|NCT00880555|521417027|FG001|Overall Study|Withdrawal by Subject|1|||
144605135|NCT00880555|521417028|FG002|Overall Study|Withdrawal by Subject|0|||
144605136|NCT00880555|521417029|FG003|Overall Study|Withdrawal by Subject|0|||
144605137|NCT00880555|521417030|FG004|Overall Study|Withdrawal by Subject|0|||
144605138|NCT00880555|521417031|FG005|Overall Study|Withdrawal by Subject|0|||
144605139|NCT00880555|521417026|FG000|Overall Study|Lack of resources (hired rater)|9|||
144605140|NCT00880555|521417027|FG001|Overall Study|Lack of resources (hired rater)|7|||
144605141|NCT00880555|521417028|FG002|Overall Study|Lack of resources (hired rater)|5|||
144605142|NCT00880555|521417029|FG003|Overall Study|Lack of resources (hired rater)|0|||
144605143|NCT00880555|521417030|FG004|Overall Study|Lack of resources (hired rater)|0|||
144605144|NCT00880555|521417031|FG005|Overall Study|Lack of resources (hired rater)|0|||
144605145|NCT00880555|521417026|FG000|Overall Study|Death|0|||
144605146|NCT00880555|521417027|FG001|Overall Study|Death|0|||
144605147|NCT00880555|521417028|FG002|Overall Study|Death|0|||
144191139|NCT00892281|519894700|FG000|Overall Study|Scheduled for knee replacement|0|||
144191140|NCT00892281|519894701|FG001|Overall Study|Scheduled for knee replacement|1|||
144191141|NCT00892281|519894700|FG000|Overall Study|PI complained of inadequate compensation|3|||
144191142|NCT00892281|519894701|FG001|Overall Study|PI complained of inadequate compensation|0|||
144191143|NCT00892281|519894700|FG000|Overall Study|Subject lost interest in program|0|||
144253567|NCT02279745|520128138|FG000|Overall Study|Death|6|||
144441270|NCT01455012|520818610|FG001|Overall Study|Unknown reason|0|||
144441271|NCT04552587|520818611|FG000|Overall Study|Lost to Follow-up|4|||
144605148|NCT00880555|521417029|FG003|Overall Study|Death|0|||
144605149|NCT00880555|521417030|FG004|Overall Study|Death|0|||
144605150|NCT00880555|521417031|FG005|Overall Study|Death|1|||
144605151|NCT00880555|521417026|FG000|Overall Study|Lost to Follow-up|0|||
144191144|NCT00892281|519894701|FG001|Overall Study|Subject lost interest in program|1|||
144724650|NCT02579096|521846452|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
144724651|NCT02579096|521846453|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
144724652|NCT02579096|521846452|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
144724653|NCT02579096|521846453|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
144724654|NCT02579096|521846452|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
144724655|NCT02579096|521846453|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
144724656|NCT02579096|521846452|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
144724657|NCT02579096|521846453|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
144724658|NCT02579096|521846452|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
144724659|NCT02579096|521846453|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
144724660|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Death|3|||
144724661|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Death|2|||
144724662|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
144724663|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
144724664|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
144724665|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
144724666|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
144724667|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
144724668|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
144724669|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
144724670|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
144724671|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
144724672|NCT02579096|521846452|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
144724673|NCT02579096|521846453|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
144724674|NCT02097121|521846458|FG000|Overall Study|Other, not specified|4|||
144724675|NCT02097121|521846459|FG001|Overall Study|Other, not specified|2|||
144724676|NCT02097121|521846460|FG002|Overall Study|Other, not specified|3|||
144724677|NCT02097121|521846458|FG000|Overall Study|Lack of Efficacy|2|||
144724678|NCT02097121|521846459|FG001|Overall Study|Lack of Efficacy|1|||
144724679|NCT02097121|521846460|FG002|Overall Study|Lack of Efficacy|3|||
144724680|NCT02097121|521846458|FG000|Overall Study|Withdrawal by Subject|0|||
144724681|NCT02097121|521846459|FG001|Overall Study|Withdrawal by Subject|1|||
144724682|NCT02097121|521846460|FG002|Overall Study|Withdrawal by Subject|2|||
144724683|NCT02097121|521846458|FG000|Overall Study|Adverse Event|0|||
144724684|NCT02097121|521846459|FG001|Overall Study|Adverse Event|1|||
144724685|NCT02097121|521846460|FG002|Overall Study|Adverse Event|0|||
144724686|NCT02097121|521846458|FG000|Overall Study|Lost to Follow-up|1|||
144724687|NCT02097121|521846459|FG001|Overall Study|Lost to Follow-up|1|||
144724688|NCT02097121|521846460|FG002|Overall Study|Lost to Follow-up|2|||
144724689|NCT00661999|521846461|FG000|Overall Study|Adverse Event|11|||
144724690|NCT00661999|521846462|FG001|Overall Study|Adverse Event|5|||
144724691|NCT00661999|521846463|FG002|Overall Study|Adverse Event|8|||
144724692|NCT00661999|521846461|FG000|Overall Study|Death|8|||
144724693|NCT00661999|521846462|FG001|Overall Study|Death|6|||
144724694|NCT00661999|521846463|FG002|Overall Study|Death|3|||
144724695|NCT00661999|521846461|FG000|Overall Study|Other Reasons|5|||
144724696|NCT00661999|521846462|FG001|Overall Study|Other Reasons|12|||
144724697|NCT00661999|521846463|FG002|Overall Study|Other Reasons|23|||
144724698|NCT00661999|521846461|FG000|Overall Study|Withdrawal by Subject|30|||
144724699|NCT00661999|521846462|FG001|Overall Study|Withdrawal by Subject|23|||
144724700|NCT00661999|521846463|FG002|Overall Study|Withdrawal by Subject|14|||
144191145|NCT00892281|519894700|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
144605152|NCT00880555|521417027|FG001|Overall Study|Lost to Follow-up|1|||
144605153|NCT00880555|521417028|FG002|Overall Study|Lost to Follow-up|0|||
144605154|NCT00880555|521417029|FG003|Overall Study|Lost to Follow-up|0|||
144605155|NCT00880555|521417030|FG004|Overall Study|Lost to Follow-up|0|||
144605156|NCT00880555|521417031|FG005|Overall Study|Lost to Follow-up|0|||
144605157|NCT00791258|521417032|FG000|Overall Study|Adverse Event|87|||
144605158|NCT00791258|521417032|FG000|Overall Study|Lost to Follow-up|18|||
144605159|NCT00791258|521417032|FG000|Overall Study|Protocol Violation|109|||
144605160|NCT00791258|521417032|FG000|Overall Study|Withdrawal by Subject|40|||
144605161|NCT00791258|521417032|FG000|Overall Study|Did not take medication for >3 days|1|||
144191146|NCT00892281|519894701|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
144724701|NCT00661999|521846461|FG000|Overall Study|Alternative Treatment|1|||
144724702|NCT00661999|521846462|FG001|Overall Study|Alternative Treatment|0|||
144724703|NCT00661999|521846463|FG002|Overall Study|Alternative Treatment|0|||
144191147|NCT00892281|519894700|FG000|Overall Study|Death in family|1|||
144724704|NCT00661999|521846461|FG000|Overall Study|Other Medical Problems|4|||
144724705|NCT00661999|521846462|FG001|Overall Study|Other Medical Problems|4|||
144724706|NCT00661999|521846463|FG002|Overall Study|Other Medical Problems|9|||
144605162|NCT00791258|521417032|FG000|Overall Study|subject left area|2|||
144724707|NCT03066999|521846464|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
144724708|NCT03066999|521846465|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
144605163|NCT00791258|521417032|FG000|Overall Study|non-compliance|3|||
144724709|NCT01790568|521846466|FG000|Overall Study|Progression prior to transplant|0|||
144441272|NCT01822132|520818612|FG000|Overall Study|Lost to Follow-up|4|||
144441273|NCT01822132|520818613|FG001|Overall Study|Lost to Follow-up|2|||
144441274|NCT00613509|520818614|FG000|Cycle 1|Adverse Event|2|||
144441275|NCT00613509|520818615|FG001|Cycle 1|Adverse Event|1|||
144441276|NCT00613509|520818614|FG000|Cycle 1|Disease Progression|2|||
144441277|NCT00613509|520818615|FG001|Cycle 1|Disease Progression|6|||
144441278|NCT00613509|520818614|FG000|Cycle 1|Unacceptable Toxicity|1|||
144441279|NCT00613509|520818615|FG001|Cycle 1|Unacceptable Toxicity|0|||
144441280|NCT00613509|520818614|FG000|Cycle 1|Other administrative reason|0|||
144441281|NCT00613509|520818615|FG001|Cycle 1|Other administrative reason|1|||
144441282|NCT04074317|520818620|FG000|Third Period|Withdrawal by Subject|0|||
144441283|NCT04074317|520818621|FG001|Third Period|Withdrawal by Subject|0|||
144441284|NCT04074317|520818622|FG002|Third Period|Withdrawal by Subject|0|||
144441285|NCT04074317|520818623|FG003|Third Period|Withdrawal by Subject|1|||
144441286|NCT04074317|520818624|FG004|Third Period|Withdrawal by Subject|0|||
144441287|NCT04074317|520818625|FG005|Third Period|Withdrawal by Subject|0|||
144441288|NCT01700179|520820011|FG000|Overall Study|Physician Decision|2|||
144441289|NCT01433263|520820014|FG000|Overall Study|Adverse Event|3|||
144441290|NCT01433263|520820015|FG001|Overall Study|Adverse Event|1|||
144441291|NCT01433263|520820014|FG000|Overall Study|Death|5|||
144441292|NCT01433263|520820015|FG001|Overall Study|Death|3|||
144441293|NCT01433263|520820014|FG000|Overall Study|Lost to Follow-up|0|||
144441294|NCT01433263|520820015|FG001|Overall Study|Lost to Follow-up|1|||
144441295|NCT01433263|520820014|FG000|Overall Study|Protocol Deviation|1|||
144441296|NCT01433263|520820015|FG001|Overall Study|Protocol Deviation|0|||
144531331|NCT02323880|521147943|FG005|Overall Study|Death|1|||
144531332|NCT02323880|521147944|FG006|Overall Study|Death|0|||
144531333|NCT02323880|521147945|FG007|Overall Study|Death|0|||
144531334|NCT02323880|521147938|FG000|Overall Study|Lack of Efficacy|4|||
144531335|NCT02323880|521147939|FG001|Overall Study|Lack of Efficacy|11|||
144531336|NCT02323880|521147940|FG002|Overall Study|Lack of Efficacy|5|||
144531337|NCT02323880|521147941|FG003|Overall Study|Lack of Efficacy|5|||
144531338|NCT02323880|521147942|FG004|Overall Study|Lack of Efficacy|4|||
144531339|NCT02323880|521147943|FG005|Overall Study|Lack of Efficacy|8|||
144531340|NCT02323880|521147944|FG006|Overall Study|Lack of Efficacy|4|||
144531341|NCT02323880|521147945|FG007|Overall Study|Lack of Efficacy|6|||
144531342|NCT02323880|521147938|FG000|Overall Study|Physician Decision|0|||
144605164|NCT00791258|521417032|FG000|Overall Study|Subject incarcerated|1|||
144605165|NCT00791258|521417032|FG000|Overall Study|Subject required restricted medication|1|||
144605166|NCT00791258|521417032|FG000|Overall Study|Lack of Efficacy|1|||
144605167|NCT00041080|521417033|FG000|Overall Study|Adverse Event|21|||
144605168|NCT00041080|521417034|FG001|Overall Study|Adverse Event|1|||
144605169|NCT00041080|521417033|FG000|Overall Study|Withdrawal by Subject|6|||
144605170|NCT00041080|521417034|FG001|Overall Study|Withdrawal by Subject|6|||
144605171|NCT00041080|521417033|FG000|Overall Study|Concommitant Illness/Other|1|||
144605172|NCT00041080|521417034|FG001|Overall Study|Concommitant Illness/Other|2|||
144605173|NCT00041080|521417033|FG000|Overall Study|Did not start therapy|1|||
144605174|NCT00041080|521417034|FG001|Overall Study|Did not start therapy|1|||
144605175|NCT00041080|521417033|FG000|Overall Study|Ineligible|1|||
144605176|NCT00041080|521417034|FG001|Overall Study|Ineligible|0|||
144605177|NCT00436618|521417035|FG000|Overall Study|Withdrawal by Subject|5|||
144605178|NCT00436618|521417036|FG001|Overall Study|Withdrawal by Subject|8|||
144605179|NCT00436618|521417037|FG002|Overall Study|Withdrawal by Subject|11|||
144605180|NCT00436618|521417035|FG000|Overall Study|Adverse Event|8|||
144605181|NCT00436618|521417036|FG001|Overall Study|Adverse Event|8|||
144605182|NCT00436618|521417037|FG002|Overall Study|Adverse Event|9|||
144605183|NCT00436618|521417035|FG000|Overall Study|Alternate Treatment|3|||
144605184|NCT00436618|521417036|FG001|Overall Study|Alternate Treatment|4|||
144605185|NCT00436618|521417037|FG002|Overall Study|Alternate Treatment|12|||
144605186|NCT00436618|521417035|FG000|Overall Study|Other Medical Problems|3|||
144605187|NCT00436618|521417036|FG001|Overall Study|Other Medical Problems|1|||
144605188|NCT00436618|521417037|FG002|Overall Study|Other Medical Problems|7|||
144605189|NCT00436618|521417035|FG000|Overall Study|Death|4|||
144605190|NCT00436618|521417036|FG001|Overall Study|Death|2|||
144605191|NCT00436618|521417037|FG002|Overall Study|Death|3|||
144605192|NCT00436618|521417035|FG000|Overall Study|New Primary or Other Reasons|6|||
144605193|NCT00436618|521417036|FG001|Overall Study|New Primary or Other Reasons|2|||
144531343|NCT02323880|521147939|FG001|Overall Study|Physician Decision|0|||
144605194|NCT00436618|521417037|FG002|Overall Study|New Primary or Other Reasons|12|||
144605195|NCT00436618|521417035|FG000|Overall Study|Still on treatment|1|||
144191148|NCT00892281|519894701|FG001|Overall Study|Death in family|0|||
144441297|NCT01433263|520820014|FG000|Overall Study|Withdrawal by Subject|10|||
144441298|NCT01433263|520820015|FG001|Overall Study|Withdrawal by Subject|7|||
144441299|NCT00646204|520820016|FG000|Overall Study|Adverse Event|3|||
144605196|NCT00436618|521417036|FG001|Overall Study|Still on treatment|2|||
144441300|NCT00646204|520820017|FG001|Overall Study|Adverse Event|0|||
144531344|NCT02323880|521147940|FG002|Overall Study|Physician Decision|0|||
144441301|NCT00646204|520820016|FG000|Overall Study|Withdrawal by Subject|1|||
144441302|NCT00646204|520820017|FG001|Overall Study|Withdrawal by Subject|0|||
144191149|NCT00892281|519894700|FG000|Overall Study|Lack of efficacy of study product|2|||
144191150|NCT00892281|519894701|FG001|Overall Study|Lack of efficacy of study product|0|||
144191151|NCT00892281|519894700|FG000|Overall Study|Subject not seen by PI at final visit|1|||
144191152|NCT00892281|519894701|FG001|Overall Study|Subject not seen by PI at final visit|0|||
144441303|NCT00293384|520820023|FG000|Overall Study|Non-compliance|2|||
144441304|NCT00293384|520820023|FG000|Overall Study|Missed dosage/study drug|1|||
144441305|NCT00293384|520820023|FG000|Overall Study|Ineligible|2|||
144441306|NCT02610192|520820025|FG000|Overall Study|Received other treatment|8|||
144441307|NCT02610192|520820025|FG000|Overall Study|Physician Decision|1|||
144191153|NCT00892281|519894700|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
144191154|NCT00892281|519894701|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
144191155|NCT00892281|519894700|FG000|Overall Study|Missed multiple visits|1|||
144191156|NCT00892281|519894701|FG001|Overall Study|Missed multiple visits|0|||
144191157|NCT00892281|519894700|FG000|Overall Study|Missed visits rescheduled out of window|1|||
144191158|NCT00892281|519894701|FG001|Overall Study|Missed visits rescheduled out of window|0|||
144191159|NCT00892281|519894700|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
144191160|NCT00892281|519894701|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
144191161|NCT00892281|519894700|FG000|Overall Study|Subject had history of drug abuse|1|||
144191162|NCT00892281|519894701|FG001|Overall Study|Subject had history of drug abuse|0|||
144191163|NCT00892281|519894700|FG000|Overall Study|Rash on hand|1|||
144191164|NCT00892281|519894701|FG001|Overall Study|Rash on hand|0|||
144191165|NCT00892281|519894700|FG000|Overall Study|Visit 4 date out of window|1|||
144191166|NCT00892281|519894701|FG001|Overall Study|Visit 4 date out of window|0|||
144441308|NCT01344057|520820027|FG000|Overall Study|Premature Withdrawal|1|||
144441309|NCT04300296|520820031|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
144441310|NCT04300296|520820032|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
144441311|NCT04300296|520820033|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
144441312|NCT04300296|520820034|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
144441313|NCT04300296|520820035|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
144441314|NCT04300296|520820036|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
144441315|NCT04300296|520820031|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
144441316|NCT04300296|520820032|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
144441317|NCT04300296|520820033|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
144441318|NCT04300296|520820034|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
144441319|NCT04300296|520820035|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
144441320|NCT04300296|520820036|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
144441321|NCT04300296|520820031|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
144441322|NCT04300296|520820032|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
144441323|NCT04300296|520820033|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
144441324|NCT04300296|520820034|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
144441325|NCT04300296|520820035|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
144441326|NCT04300296|520820036|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
144441327|NCT04300296|520820031|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
144441328|NCT04300296|520820032|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
144441329|NCT04300296|520820033|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
144441330|NCT04300296|520820034|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
144441331|NCT04300296|520820035|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
144441332|NCT04300296|520820036|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
144441333|NCT04300296|520820031|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
144441334|NCT04300296|520820032|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
144441335|NCT04300296|520820033|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
144441336|NCT04300296|520820034|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
144441337|NCT04300296|520820035|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
144441338|NCT04300296|520820036|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
144441339|NCT04300296|520820031|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
144441340|NCT04300296|520820032|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
144441341|NCT04300296|520820033|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
144441342|NCT04300296|520820034|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
144191167|NCT00655850|519894702|FG000|Overall Study|Death|2|||
144253568|NCT02279745|520128138|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
144253569|NCT02279745|520128138|FG000|Overall Study|Withdrawal by Subject|2|||
144441343|NCT04300296|520820035|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
144441344|NCT04300296|520820036|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
144441345|NCT04300296|520820031|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
144531345|NCT02323880|521147941|FG003|Overall Study|Physician Decision|0|||
144531346|NCT02323880|521147942|FG004|Overall Study|Physician Decision|1|||
144191168|NCT00655850|519894702|FG000|Overall Study|Withdrawal by Subject|1|||
144191169|NCT00941720|519894713|FG000|Overall Study|Withdrawal by Subject|1|||
144191170|NCT00941720|519894713|FG000|Overall Study|Insurance denied participation|11|||
144191171|NCT00941720|519894713|FG000|Overall Study|ineligible|2|||
144191172|NCT04099641|519894715|FG000|Overall Study|Death|46|||
144191173|NCT04099641|519894716|FG001|Overall Study|Death|12|||
144191174|NCT04099641|519894715|FG000|Overall Study|Lost to Follow-up|1|||
144191175|NCT04099641|519894716|FG001|Overall Study|Lost to Follow-up|0|||
144191176|NCT04099641|519894715|FG000|Overall Study|Withdrawal by Subject|2|||
144191177|NCT04099641|519894716|FG001|Overall Study|Withdrawal by Subject|0|||
144191178|NCT00895037|519894717|FG000|Overall Study|Death|0|||
144191179|NCT00895037|519894718|FG001|Overall Study|Death|2|||
144191180|NCT00895037|519894719|FG002|Overall Study|Death|1|||
144191181|NCT02244424|519894728|FG000|Overall Study|Lost to Follow-up|20|||
144191182|NCT02244424|519894729|FG001|Overall Study|Lost to Follow-up|10|||
144191183|NCT01937351|519896136|FG000|Overall Study|Withdrawal by Subject|4|||
144191184|NCT01937351|519896137|FG001|Overall Study|Withdrawal by Subject|2|||
144191185|NCT01937351|519896136|FG000|Overall Study|Death|1|||
144191186|NCT01937351|519896137|FG001|Overall Study|Death|0|||
144191187|NCT01937351|519896136|FG000|Overall Study|Not treated w device, per protocol fail|4|||
144191188|NCT01937351|519896137|FG001|Overall Study|Not treated w device, per protocol fail|0|||
144191189|NCT01961687|519896138|FG000|Overall Study|Lost to Follow-up|19|||
144191190|NCT01961687|519896138|FG000|Overall Study|Re-operation|17|||
144191191|NCT01961687|519896138|FG000|Overall Study|Death|7|||
144191192|NCT01961687|519896138|FG000|Overall Study|Withdrawal by Subject|6|||
144191193|NCT01961687|519896138|FG000|Overall Study|Adverse Event|6|||
144441346|NCT04300296|520820032|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
144441347|NCT04300296|520820033|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
144441348|NCT04300296|520820034|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
144191194|NCT01961687|519896138|FG000|Overall Study|Moved to area without study site|2|||
144191195|NCT01961687|519896138|FG000|Overall Study|Sponsor decision|2|||
144191196|NCT01961687|519896138|FG000|Overall Study|Physician Decision|1|||
144191197|NCT01961687|519896138|FG000|Overall Study|Unable to meet follow-up requirements|1|||
144191198|NCT01730040|519896139|FG000|Overall Study|Randomized but not treated|0|||
144191199|NCT01730040|519896140|FG001|Overall Study|Randomized but not treated|0|||
144191200|NCT01730040|519896141|FG002|Overall Study|Randomized but not treated|0|||
144191201|NCT01730040|519896142|FG003|Overall Study|Randomized but not treated|0|||
144191202|NCT01730040|519896143|FG004|Overall Study|Randomized but not treated|0|||
144191203|NCT01730040|519896144|FG005|Overall Study|Randomized but not treated|1|||
144191204|NCT01730040|519896145|FG006|Overall Study|Randomized but not treated|0|||
144191205|NCT01730040|519896139|FG000|Overall Study|Subject moved|0|||
144191206|NCT01730040|519896140|FG001|Overall Study|Subject moved|0|||
144191207|NCT01730040|519896141|FG002|Overall Study|Subject moved|1|||
144191208|NCT01730040|519896142|FG003|Overall Study|Subject moved|0|||
144441349|NCT04300296|520820035|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
144441350|NCT04300296|520820036|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
144441351|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Adverse Event|9|||
144441352|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Adverse Event|2|||
144441353|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
144441354|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
144441355|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
144441356|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
144441357|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Physician Decision|1|||
144441358|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Physician Decision|1|||
144441359|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Pregnancy|2|||
144531347|NCT02323880|521147943|FG005|Overall Study|Physician Decision|1|||
144531348|NCT02323880|521147944|FG006|Overall Study|Physician Decision|1|||
144531349|NCT02323880|521147945|FG007|Overall Study|Physician Decision|0|||
144531350|NCT02323880|521147938|FG000|Overall Study|Withdrawal by Subject|0|||
144531351|NCT02323880|521147939|FG001|Overall Study|Withdrawal by Subject|2|||
144531352|NCT02323880|521147940|FG002|Overall Study|Withdrawal by Subject|0|||
144531353|NCT02323880|521147941|FG003|Overall Study|Withdrawal by Subject|0|||
144531354|NCT02323880|521147942|FG004|Overall Study|Withdrawal by Subject|0|||
144191209|NCT01730040|519896143|FG004|Overall Study|Subject moved|0|||
144191210|NCT01730040|519896144|FG005|Overall Study|Subject moved|0|||
144191211|NCT01730040|519896145|FG006|Overall Study|Subject moved|1|||
144191212|NCT01730040|519896139|FG000|Overall Study|Physician Decision|0|||
144191213|NCT01730040|519896140|FG001|Overall Study|Physician Decision|0|||
144191214|NCT01730040|519896141|FG002|Overall Study|Physician Decision|0|||
144191215|NCT01730040|519896142|FG003|Overall Study|Physician Decision|0|||
144191216|NCT01730040|519896143|FG004|Overall Study|Physician Decision|0|||
144191217|NCT01730040|519896144|FG005|Overall Study|Physician Decision|1|||
144191218|NCT01730040|519896145|FG006|Overall Study|Physician Decision|1|||
144191219|NCT01730040|519896139|FG000|Overall Study|Other than specified|7|||
144191220|NCT01730040|519896140|FG001|Overall Study|Other than specified|8|||
144191221|NCT01730040|519896141|FG002|Overall Study|Other than specified|5|||
144191222|NCT01730040|519896142|FG003|Overall Study|Other than specified|5|||
144191223|NCT01730040|519896143|FG004|Overall Study|Other than specified|5|||
144441360|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Pregnancy|0|||
144441361|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
144191224|NCT01730040|519896144|FG005|Overall Study|Other than specified|4|||
144191225|NCT01730040|519896145|FG006|Overall Study|Other than specified|4|||
144191226|NCT01730040|519896139|FG000|Overall Study|Adverse Event|4|||
144191227|NCT01730040|519896140|FG001|Overall Study|Adverse Event|3|||
144191228|NCT01730040|519896141|FG002|Overall Study|Adverse Event|5|||
144191229|NCT01730040|519896142|FG003|Overall Study|Adverse Event|3|||
144191230|NCT01730040|519896143|FG004|Overall Study|Adverse Event|1|||
144191231|NCT01730040|519896144|FG005|Overall Study|Adverse Event|1|||
144191232|NCT01730040|519896145|FG006|Overall Study|Adverse Event|2|||
144191233|NCT01730040|519896139|FG000|Overall Study|Poor compliance to protocol|2|||
144191234|NCT01730040|519896140|FG001|Overall Study|Poor compliance to protocol|4|||
144441362|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
144441363|NCT02896127|520820039|FG000|COMPLETED WEEK 52|Technical problems|1|||
144441364|NCT02896127|520820040|FG001|COMPLETED WEEK 52|Technical problems|0|||
144441365|NCT02896127|520820039|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
144441366|NCT02896127|520820040|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
144441367|NCT02896127|520820039|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
144441368|NCT02896127|520820040|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
144441369|NCT02896127|520820039|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
144441370|NCT02896127|520820040|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
144441371|NCT02896127|520820039|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
144441372|NCT02896127|520820040|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
144441373|NCT02896127|520820039|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
144441374|NCT02896127|520820040|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
144441375|NCT00326911|520820041|FG000|Overall Study|Hospitalization prior to treatment|0|||
144441376|NCT00326911|520820042|FG001|Overall Study|Hospitalization prior to treatment|1|||
144441377|NCT00326911|520820041|FG000|Overall Study|Physician decision prior to treatment|1|||
144441378|NCT00326911|520820042|FG001|Overall Study|Physician decision prior to treatment|0|||
144441379|NCT00326911|520820041|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
144441380|NCT00326911|520820042|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
144441381|NCT04537806|520820048|FG000|Overall Study|Randomized but not treated|1|||
144441382|NCT04537806|520820049|FG001|Overall Study|Randomized but not treated|0|||
144441383|NCT04537806|520820048|FG000|Overall Study|Adverse Event|1|||
144441384|NCT04537806|520820049|FG001|Overall Study|Adverse Event|1|||
144441385|NCT02477020|520820055|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
144441386|NCT02477020|520820056|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
144531355|NCT02323880|521147943|FG005|Overall Study|Withdrawal by Subject|0|||
144531356|NCT02323880|521147944|FG006|Overall Study|Withdrawal by Subject|0|||
144531357|NCT02323880|521147945|FG007|Overall Study|Withdrawal by Subject|0|||
144531358|NCT02828358|521147953|FG000|Overall Study|Physician Decision|7|||
144531359|NCT02828358|521147954|FG001|Overall Study|Physician Decision|1|||
144531360|NCT02828358|521147953|FG000|Overall Study|Treatment Failure|6|||
144531361|NCT02828358|521147954|FG001|Overall Study|Treatment Failure|0|||
144531362|NCT02828358|521147953|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
144531363|NCT02828358|521147954|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
144531364|NCT02828358|521147953|FG000|Overall Study|Refusal of further protocol therapy|2|||
144531365|NCT02828358|521147954|FG001|Overall Study|Refusal of further protocol therapy|0|||
144531366|NCT02828358|521147953|FG000|Overall Study|Relapse|25|||
144531367|NCT02828358|521147954|FG001|Overall Study|Relapse|0|||
144531368|NCT02828358|521147953|FG000|Overall Study|Still on therapy|5|||
144531369|NCT02828358|521147954|FG001|Overall Study|Still on therapy|0|||
144531370|NCT03213678|521147956|FG000|Overall Study|Death|1|||
144531371|NCT03213678|521147956|FG000|Overall Study|Physician Decision|1|||
144531372|NCT03213678|521147956|FG000|Overall Study|Progressive disease|16|||
144531373|NCT04218851|521147957|FG000|Overall Study|Death|1|||
144531374|NCT04218851|521147958|FG001|Overall Study|Death|3|||
144531375|NCT03174275|521147961|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
144531376|NCT03174275|521147961|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
144531377|NCT03174275|521147961|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
144531378|NCT03174275|521147961|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
144531379|NCT03174275|521147961|FG000|Adjuvant Chemotherapy|Progression|1|||
144191235|NCT01730040|519896141|FG002|Overall Study|Poor compliance to protocol|0|||
144191236|NCT01730040|519896142|FG003|Overall Study|Poor compliance to protocol|0|||
144191237|NCT01730040|519896143|FG004|Overall Study|Poor compliance to protocol|0|||
144191238|NCT01730040|519896144|FG005|Overall Study|Poor compliance to protocol|0|||
144441387|NCT02477020|520820055|FG000|Overall Study|Voluntary Withdrawal|7|||
144441388|NCT02477020|520820056|FG001|Overall Study|Voluntary Withdrawal|16|||
144441389|NCT02477020|520820055|FG000|Overall Study|Reason not Specified|3|||
144531380|NCT03174275|521147961|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
144531381|NCT03174275|521147961|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
144531382|NCT03174275|521147961|FG000|Adjuvant Durvalumab|Progression|1|||
144191239|NCT01730040|519896145|FG006|Overall Study|Poor compliance to protocol|1|||
144191240|NCT00544817|519896146|FG000|Combined Modality|Lack of Efficacy|2|||
144441390|NCT02477020|520820056|FG001|Overall Study|Reason not Specified|1|||
144441391|NCT02477020|520820055|FG000|Overall Study|Lack of Efficacy|14|||
144441392|NCT02477020|520820056|FG001|Overall Study|Lack of Efficacy|5|||
144441393|NCT00519649|520820057|FG000|Overall Study|Withdrawal by Subject|1|||
144441394|NCT01465802|520820058|FG000|Overall Study|Study terminated by sponsor|1|||
144441395|NCT01465802|520820059|FG001|Overall Study|Study terminated by sponsor|0|||
144441396|NCT01465802|520820060|FG002|Overall Study|Study terminated by sponsor|0|||
144441397|NCT01465802|520820061|FG003|Overall Study|Study terminated by sponsor|1|||
144441398|NCT01465802|520820062|FG004|Overall Study|Study terminated by sponsor|7|||
144441399|NCT01465802|520820058|FG000|Overall Study|Withdrawal by Subject|7|||
144441400|NCT01465802|520820059|FG001|Overall Study|Withdrawal by Subject|7|||
144441401|NCT01465802|520820060|FG002|Overall Study|Withdrawal by Subject|0|||
144441402|NCT01465802|520820061|FG003|Overall Study|Withdrawal by Subject|8|||
144441403|NCT01465802|520820062|FG004|Overall Study|Withdrawal by Subject|1|||
144441404|NCT01465802|520820058|FG000|Overall Study|Lost to Follow-up|1|||
144441405|NCT01465802|520820059|FG001|Overall Study|Lost to Follow-up|1|||
144441406|NCT01465802|520820060|FG002|Overall Study|Lost to Follow-up|0|||
144441407|NCT01465802|520820061|FG003|Overall Study|Lost to Follow-up|0|||
144441408|NCT01465802|520820062|FG004|Overall Study|Lost to Follow-up|0|||
144441409|NCT01465802|520820058|FG000|Overall Study|Reason not specified|9|||
144441410|NCT01465802|520820059|FG001|Overall Study|Reason not specified|4|||
144441411|NCT01465802|520820060|FG002|Overall Study|Reason not specified|0|||
144441412|NCT01465802|520820061|FG003|Overall Study|Reason not specified|10|||
144441413|NCT01465802|520820062|FG004|Overall Study|Reason not specified|2|||
144441414|NCT01465802|520820058|FG000|Overall Study|Death|15|||
144441415|NCT01465802|520820059|FG001|Overall Study|Death|12|||
144441416|NCT01465802|520820060|FG002|Overall Study|Death|0|||
144441417|NCT01465802|520820061|FG003|Overall Study|Death|10|||
144441418|NCT01465802|520820062|FG004|Overall Study|Death|2|||
144441419|NCT01340976|520820063|FG000|Overall Study|Physician Decision|2|||
144441420|NCT01340976|520820064|FG001|Overall Study|Physician Decision|0|||
144441421|NCT01340976|520820065|FG002|Overall Study|Physician Decision|1|||
144441422|NCT01340976|520820066|FG003|Overall Study|Physician Decision|1|||
144441423|NCT01340976|520820067|FG004|Overall Study|Physician Decision|1|||
144441424|NCT01340976|520820068|FG005|Overall Study|Physician Decision|0|||
144724710|NCT01790568|521846467|FG001|Overall Study|Progression prior to transplant|1|||
144724711|NCT01361126|521846468|FG000|Overall Study|Sponsor decision|0|||
144724712|NCT01361126|521846469|FG001|Overall Study|Sponsor decision|2|||
144724713|NCT01508936|521846471|FG000|Overall Study|Adverse Event|11|||
144441425|NCT01340976|520820063|FG000|Overall Study|Death|0|||
144441426|NCT01340976|520820064|FG001|Overall Study|Death|1|||
144441427|NCT01340976|520820065|FG002|Overall Study|Death|0|||
144441428|NCT01340976|520820066|FG003|Overall Study|Death|0|||
144441429|NCT01340976|520820067|FG004|Overall Study|Death|0|||
144441430|NCT01340976|520820068|FG005|Overall Study|Death|0|||
144441431|NCT01340976|520820063|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
144441432|NCT01340976|520820064|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
144441433|NCT01340976|520820065|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
144441434|NCT01340976|520820066|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
144441435|NCT01340976|520820067|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
144441436|NCT01340976|520820068|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
144441437|NCT01340976|520820063|FG000|Overall Study|Withdrawal by Subject|0|||
144441438|NCT01340976|520820064|FG001|Overall Study|Withdrawal by Subject|0|||
144441439|NCT01340976|520820065|FG002|Overall Study|Withdrawal by Subject|0|||
144441440|NCT01340976|520820066|FG003|Overall Study|Withdrawal by Subject|1|||
144441441|NCT01340976|520820067|FG004|Overall Study|Withdrawal by Subject|1|||
144441442|NCT01340976|520820068|FG005|Overall Study|Withdrawal by Subject|0|||
144441443|NCT01340976|520820063|FG000|Overall Study|Other anemia treatment|1|||
144441444|NCT01340976|520820064|FG001|Overall Study|Other anemia treatment|0|||
144441445|NCT01340976|520820065|FG002|Overall Study|Other anemia treatment|2|||
144441446|NCT01340976|520820066|FG003|Overall Study|Other anemia treatment|1|||
144441447|NCT01340976|520820067|FG004|Overall Study|Other anemia treatment|0|||
144441448|NCT01340976|520820068|FG005|Overall Study|Other anemia treatment|1|||
144441449|NCT01340976|520820063|FG000|Overall Study|Adverse Event|0|||
144441450|NCT01340976|520820064|FG001|Overall Study|Adverse Event|1|||
144441451|NCT01340976|520820065|FG002|Overall Study|Adverse Event|0|||
144441452|NCT01340976|520820066|FG003|Overall Study|Adverse Event|0|||
144441453|NCT01340976|520820067|FG004|Overall Study|Adverse Event|0|||
144441454|NCT01340976|520820068|FG005|Overall Study|Adverse Event|0|||
144441455|NCT02953821|520820069|FG000|Overall Study|Adverse Event|0|||
144441456|NCT02953821|520820070|FG001|Overall Study|Adverse Event|4|||
144441457|NCT02953821|520820069|FG000|Overall Study|Death|1|||
144724714|NCT01508936|521846472|FG001|Overall Study|Adverse Event|32|||
144191241|NCT00544817|519896146|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
144441458|NCT02953821|520820070|FG001|Overall Study|Death|0|||
144441459|NCT02953821|520820069|FG000|Overall Study|Progressive Disease|5|||
144441460|NCT02953821|520820070|FG001|Overall Study|Progressive Disease|1|||
144441461|NCT02953821|520820069|FG000|Overall Study|Lost to Follow-up|2|||
144441462|NCT02953821|520820070|FG001|Overall Study|Lost to Follow-up|0|||
144441463|NCT02953821|520820069|FG000|Overall Study|Physician Decision|1|||
144441464|NCT02953821|520820070|FG001|Overall Study|Physician Decision|1|||
144441465|NCT02953821|520820069|FG000|Overall Study|Withdrawal by Subject|3|||
144441466|NCT02953821|520820070|FG001|Overall Study|Withdrawal by Subject|3|||
144441467|NCT02953821|520820069|FG000|Overall Study|Change of address|0|||
144441468|NCT02953821|520820070|FG001|Overall Study|Change of address|1|||
144441469|NCT02953821|520820069|FG000|Overall Study|Lack of Efficacy|1|||
144605197|NCT00436618|521417037|FG002|Overall Study|Still on treatment|7|||
144605198|NCT01011439|521417038|FG000|Overall Study|Death|37|||
144605199|NCT01011439|521417038|FG000|Overall Study|Lost to Follow-up|4|||
144605200|NCT01011439|521417038|FG000|Overall Study|Withdrawal by Subject|1|||
144605201|NCT01011439|521417038|FG000|Overall Study|Sponsor's decision|15|||
144191242|NCT00544817|519896146|FG000|Combined Modality|Adverse Event|2|||
144191243|NCT00544817|519896146|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
144191244|NCT00544817|519896146|FG000|No Treatment Interval|Lack of Efficacy|8|||
144191245|NCT00544817|519896146|FG000|No Treatment Interval|Physician Decision|3|||
144191246|NCT00544817|519896146|FG000|No Treatment Interval|Adverse Event|1|||
144191247|NCT00544817|519896146|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
144191248|NCT00544817|519896146|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
144191249|NCT00544817|519896146|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
144191250|NCT01221090|519896147|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
144191251|NCT01221090|519896148|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
144605202|NCT05418673|521417039|FG000|Overall Study|Study Terminated by Sponsor|2|||
144191252|NCT01221090|519896149|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
144191253|NCT01221090|519896150|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
144191254|NCT01221090|519896147|FG000|Overall Study|Withdrawal by Subject|0|||
144605203|NCT05418673|521417040|FG001|Overall Study|Study Terminated by Sponsor|4|||
144605204|NCT05418673|521417039|FG000|Overall Study|Lost to Follow-up|1|||
144605205|NCT05418673|521417040|FG001|Overall Study|Lost to Follow-up|0|||
144605206|NCT01986920|521417043|FG000|A- 101 25%|Withdrawal by Subject|1|||
144605207|NCT01986920|521417044|FG001|A- 101 25%|Withdrawal by Subject|0|||
144605208|NCT01986920|521417045|FG002|A- 101 25%|Withdrawal by Subject|0|||
144605209|NCT01986920|521417046|FG003|A- 101 25%|Withdrawal by Subject|0|||
144605210|NCT01986920|521417043|FG000|A-101 32.5%|Withdrawal by Subject|0|||
144605211|NCT01986920|521417044|FG001|A-101 32.5%|Withdrawal by Subject|1|||
144605212|NCT01986920|521417045|FG002|A-101 32.5%|Withdrawal by Subject|0|||
144605213|NCT01986920|521417046|FG003|A-101 32.5%|Withdrawal by Subject|0|||
144605214|NCT01986920|521417043|FG000|A-101 40%|Withdrawal by Subject|0|||
144605215|NCT01986920|521417044|FG001|A-101 40%|Withdrawal by Subject|0|||
144605216|NCT01986920|521417045|FG002|A-101 40%|Withdrawal by Subject|1|||
144605217|NCT01986920|521417046|FG003|A-101 40%|Withdrawal by Subject|0|||
144605218|NCT01986920|521417043|FG000|Placebo|Withdrawal by Subject|0|||
144605219|NCT01986920|521417044|FG001|Placebo|Withdrawal by Subject|0|||
144605220|NCT01986920|521417045|FG002|Placebo|Withdrawal by Subject|0|||
144605221|NCT01986920|521417046|FG003|Placebo|Withdrawal by Subject|1|||
144605222|NCT00874770|521417051|FG000|Overall Study|Lack of Efficacy|2|||
144605223|NCT00874770|521417052|FG001|Overall Study|Lack of Efficacy|0|||
144605224|NCT00874770|521417053|FG002|Overall Study|Lack of Efficacy|0|||
144605225|NCT00874770|521417054|FG003|Overall Study|Lack of Efficacy|2|||
144605226|NCT00874770|521417051|FG000|Overall Study|Adverse Event|1|||
144605227|NCT00874770|521417052|FG001|Overall Study|Adverse Event|1|||
144605228|NCT00874770|521417053|FG002|Overall Study|Adverse Event|4|||
144605229|NCT00874770|521417054|FG003|Overall Study|Adverse Event|2|||
144605230|NCT00874770|521417051|FG000|Overall Study|Lost to Follow-up|1|||
144191255|NCT01221090|519896148|FG001|Overall Study|Withdrawal by Subject|22|||
144191256|NCT01221090|519896149|FG002|Overall Study|Withdrawal by Subject|27|||
144191257|NCT01221090|519896150|FG003|Overall Study|Withdrawal by Subject|2|||
144191258|NCT04776746|519896151|FG000|Overall Study|Study terminated by sponsor|61|||
144191259|NCT04776746|519896151|FG000|Overall Study|Adverse Event|5|||
144605231|NCT00874770|521417052|FG001|Overall Study|Lost to Follow-up|0|||
144724715|NCT01508936|521846471|FG000|Overall Study|Lack of Efficacy|0|||
144191260|NCT04776746|519896151|FG000|Overall Study|Death|4|||
144191261|NCT04776746|519896151|FG000|Overall Study|Lack of Efficacy|3|||
144605232|NCT00874770|521417053|FG002|Overall Study|Lost to Follow-up|0|||
144605233|NCT00874770|521417054|FG003|Overall Study|Lost to Follow-up|1|||
144441470|NCT02953821|520820070|FG001|Overall Study|Lack of Efficacy|0|||
144441471|NCT02953821|520820069|FG000|Overall Study|Out of state for indeterminate time|0|||
144605234|NCT00874770|521417051|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
144191262|NCT04776746|519896151|FG000|Overall Study|Noncompliance with study drug|2|||
144605235|NCT00874770|521417052|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
144191263|NCT04776746|519896151|FG000|Overall Study|Not related to COVID-19|2|||
144191264|NCT00440466|519896152|FG000|Overall Study|Death|3|||
144605236|NCT00874770|521417053|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
144605237|NCT00874770|521417054|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
144605238|NCT05215262|521417055|FG000|Overall Study|Lost to Follow-up|12|||
144605239|NCT05215262|521417056|FG001|Overall Study|Lost to Follow-up|0|||
144605240|NCT00718549|521417059|FG000|Induction Phase|Disease Progression|1|||
144605241|NCT00718549|521417060|FG001|Induction Phase|Disease Progression|0|||
144724716|NCT01508936|521846472|FG001|Overall Study|Lack of Efficacy|1|||
144724717|NCT01508936|521846471|FG000|Overall Study|Withdrawal by Subject|4|||
144724718|NCT01508936|521846472|FG001|Overall Study|Withdrawal by Subject|18|||
144191265|NCT00440466|519896153|FG001|Overall Study|Death|2|||
144191266|NCT00440466|519896154|FG002|Overall Study|Death|9|||
144191267|NCT00440466|519896152|FG000|Overall Study|Adverse Event|3|||
144191268|NCT00440466|519896153|FG001|Overall Study|Adverse Event|4|||
144191269|NCT00440466|519896154|FG002|Overall Study|Adverse Event|11|||
144191270|NCT00440466|519896152|FG000|Overall Study|Lost to Follow-up|1|||
144191271|NCT00440466|519896153|FG001|Overall Study|Lost to Follow-up|0|||
144191272|NCT00440466|519896154|FG002|Overall Study|Lost to Follow-up|2|||
144605242|NCT00718549|521417061|FG002|Induction Phase|Disease Progression|0|||
144605243|NCT00718549|521417059|FG000|Induction Phase|Eligibility Criteria Violation|2|||
144605244|NCT00718549|521417060|FG001|Induction Phase|Eligibility Criteria Violation|0|||
144605245|NCT00718549|521417061|FG002|Induction Phase|Eligibility Criteria Violation|0|||
144605246|NCT00718549|521417059|FG000|Induction Phase|Early Termination - No Additional Info|59|||
144605247|NCT00718549|521417060|FG001|Induction Phase|Early Termination - No Additional Info|0|||
144605248|NCT00718549|521417061|FG002|Induction Phase|Early Termination - No Additional Info|0|||
144605249|NCT00718549|521417059|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
144605250|NCT00718549|521417060|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
144605251|NCT00718549|521417061|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
144605252|NCT00718549|521417059|FG000|Maintenance/ Observation Phase|Death|0|||
144605253|NCT00718549|521417060|FG001|Maintenance/ Observation Phase|Death|1|||
144605254|NCT00718549|521417061|FG002|Maintenance/ Observation Phase|Death|2|||
144605255|NCT00718549|521417059|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
144605256|NCT00718549|521417060|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
144605257|NCT00718549|521417061|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
144605258|NCT00718549|521417059|FG000|Maintenance/ Observation Phase|Progression|0|||
144605259|NCT00718549|521417060|FG001|Maintenance/ Observation Phase|Progression|5|||
144605260|NCT00718549|521417061|FG002|Maintenance/ Observation Phase|Progression|14|||
144605261|NCT00718549|521417059|FG000|Maintenance/ Observation Phase|Relapse|0|||
144605262|NCT00718549|521417060|FG001|Maintenance/ Observation Phase|Relapse|3|||
144605263|NCT00718549|521417061|FG002|Maintenance/ Observation Phase|Relapse|2|||
144605264|NCT01353508|521417062|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
144191273|NCT00440466|519896152|FG000|Overall Study|Physician Decision|2|||
144191274|NCT00440466|519896153|FG001|Overall Study|Physician Decision|0|||
144191275|NCT00440466|519896154|FG002|Overall Study|Physician Decision|1|||
144191276|NCT00440466|519896152|FG000|Overall Study|Protocol Violation|2|||
144191277|NCT00440466|519896153|FG001|Overall Study|Protocol Violation|0|||
144191278|NCT00440466|519896154|FG002|Overall Study|Protocol Violation|4|||
144191279|NCT00440466|519896152|FG000|Overall Study|Withdrawal by Subject|2|||
144191280|NCT00440466|519896153|FG001|Overall Study|Withdrawal by Subject|5|||
144191281|NCT00440466|519896154|FG002|Overall Study|Withdrawal by Subject|9|||
144191282|NCT00440466|519896152|FG000|Overall Study|Began Dialysis|0|||
144191283|NCT00440466|519896153|FG001|Overall Study|Began Dialysis|0|||
144191284|NCT00440466|519896154|FG002|Overall Study|Began Dialysis|1|||
144191285|NCT00440466|519896152|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
144191286|NCT00440466|519896153|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
144191287|NCT00440466|519896154|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
144191288|NCT02459665|519896155|FG000|Overall Study|Withdrawal by Subject|0|||
144191289|NCT02459665|519896156|FG001|Overall Study|Withdrawal by Subject|1|||
144191290|NCT02459665|519896157|FG002|Overall Study|Withdrawal by Subject|1|||
144253570|NCT02279745|520128138|FG000|Overall Study|Pregnancy|1|||
144441472|NCT02953821|520820070|FG001|Overall Study|Out of state for indeterminate time|1|||
144605265|NCT01353508|521417063|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
144605266|NCT01353508|521417064|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
144605267|NCT01353508|521417065|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
144724719|NCT01508936|521846471|FG000|Overall Study|Protocol Violation|2|||
144441473|NCT02953821|520820069|FG000|Overall Study|No improvement|0|||
144605268|NCT01353508|521417062|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
144605269|NCT01353508|521417063|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
144605270|NCT01353508|521417064|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
144605271|NCT01353508|521417065|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
144724720|NCT01508936|521846472|FG001|Overall Study|Protocol Violation|3|||
144724721|NCT01508936|521846471|FG000|Overall Study|Lost to Follow-up|2|||
144191291|NCT02459665|519896158|FG003|Overall Study|Withdrawal by Subject|2|||
144441474|NCT02953821|520820070|FG001|Overall Study|No improvement|1|||
144191292|NCT01223235|519896159|FG000|Overall Study|Withdrawal by Subject|1|||
144191293|NCT01360866|519896162|FG000|Overall Study|Lost to Follow-up|11|||
144191294|NCT01360866|519896163|FG001|Overall Study|Lost to Follow-up|28|||
144191295|NCT01360866|519896164|FG002|Overall Study|Lost to Follow-up|41|||
144191296|NCT01360866|519896165|FG003|Overall Study|Lost to Follow-up|0|||
144191297|NCT01360866|519896162|FG000|Overall Study|Adverse Event|56|||
144441475|NCT02953821|520820069|FG000|Overall Study|Refused follow-up visit|2|||
144441476|NCT02953821|520820070|FG001|Overall Study|Refused follow-up visit|1|||
144441477|NCT02103478|520820071|FG000|Overall Study|Adverse Event|0|||
144441478|NCT02103478|520820072|FG001|Overall Study|Adverse Event|0|||
144441479|NCT02103478|520820073|FG002|Overall Study|Adverse Event|1|||
144441480|NCT02103478|520820074|FG003|Overall Study|Adverse Event|1|||
144441481|NCT02103478|520820075|FG004|Overall Study|Adverse Event|2|||
144441482|NCT02103478|520820076|FG005|Overall Study|Adverse Event|1|||
144441483|NCT02103478|520820077|FG006|Overall Study|Adverse Event|0|||
144441484|NCT02103478|520820078|FG007|Overall Study|Adverse Event|0|||
144441485|NCT02103478|520820079|FG008|Overall Study|Adverse Event|0|||
144441486|NCT02103478|520820071|FG000|Overall Study|Death|2|||
144441487|NCT02103478|520820072|FG001|Overall Study|Death|2|||
144441488|NCT02103478|520820073|FG002|Overall Study|Death|1|||
144441489|NCT02103478|520820074|FG003|Overall Study|Death|1|||
144441490|NCT02103478|520820075|FG004|Overall Study|Death|5|||
144441491|NCT02103478|520820076|FG005|Overall Study|Death|15|||
144441492|NCT02103478|520820077|FG006|Overall Study|Death|14|||
144441493|NCT02103478|520820078|FG007|Overall Study|Death|10|||
144441494|NCT02103478|520820079|FG008|Overall Study|Death|11|||
144441495|NCT02103478|520820071|FG000|Overall Study|Progressive Disease|2|||
144441496|NCT02103478|520820072|FG001|Overall Study|Progressive Disease|1|||
144441497|NCT02103478|520820073|FG002|Overall Study|Progressive Disease|2|||
144441498|NCT02103478|520820074|FG003|Overall Study|Progressive Disease|0|||
144441499|NCT02103478|520820075|FG004|Overall Study|Progressive Disease|9|||
144441500|NCT02103478|520820076|FG005|Overall Study|Progressive Disease|1|||
144441501|NCT02103478|520820077|FG006|Overall Study|Progressive Disease|2|||
144441502|NCT02103478|520820078|FG007|Overall Study|Progressive Disease|0|||
144441503|NCT02103478|520820079|FG008|Overall Study|Progressive Disease|1|||
144441504|NCT02103478|520820071|FG000|Overall Study|Withdrawal by Subject|2|||
144441505|NCT02103478|520820072|FG001|Overall Study|Withdrawal by Subject|0|||
144441506|NCT02103478|520820073|FG002|Overall Study|Withdrawal by Subject|0|||
144441507|NCT02103478|520820074|FG003|Overall Study|Withdrawal by Subject|4|||
144441508|NCT02103478|520820075|FG004|Overall Study|Withdrawal by Subject|0|||
144441509|NCT02103478|520820076|FG005|Overall Study|Withdrawal by Subject|0|||
144441510|NCT02103478|520820077|FG006|Overall Study|Withdrawal by Subject|1|||
144441511|NCT02103478|520820078|FG007|Overall Study|Withdrawal by Subject|1|||
144441512|NCT02103478|520820079|FG008|Overall Study|Withdrawal by Subject|0|||
144441513|NCT02103478|520820071|FG000|Overall Study|Lost to Follow-up|0|||
144441514|NCT02103478|520820072|FG001|Overall Study|Lost to Follow-up|0|||
144441515|NCT02103478|520820073|FG002|Overall Study|Lost to Follow-up|0|||
144441516|NCT02103478|520820074|FG003|Overall Study|Lost to Follow-up|0|||
144441517|NCT02103478|520820075|FG004|Overall Study|Lost to Follow-up|0|||
144441518|NCT02103478|520820076|FG005|Overall Study|Lost to Follow-up|0|||
144441519|NCT02103478|520820077|FG006|Overall Study|Lost to Follow-up|0|||
144441520|NCT02103478|520820078|FG007|Overall Study|Lost to Follow-up|1|||
144441521|NCT02103478|520820079|FG008|Overall Study|Lost to Follow-up|0|||
144441522|NCT02103478|520820071|FG000|Overall Study|Other|1|||
144441523|NCT02103478|520820072|FG001|Overall Study|Other|3|||
144605272|NCT04422990|521417070|FG000|Overall Study|Withdrawal by Subject|0|||
144605273|NCT04422990|521417071|FG001|Overall Study|Withdrawal by Subject|1|||
144605274|NCT04422990|521417070|FG000|Overall Study|Travel|3|||
144605275|NCT04422990|521417071|FG001|Overall Study|Travel|0|||
144605276|NCT00433914|521417072|FG000|Overall Study|Withdrawal by Subject|0|||
144605277|NCT00433914|521417073|FG001|Overall Study|Withdrawal by Subject|2|||
144605278|NCT00433914|521417072|FG000|Overall Study|Lost to Follow-up|0|||
144605279|NCT00433914|521417073|FG001|Overall Study|Lost to Follow-up|1|||
144605280|NCT02486653|521417076|FG000|Overall Study|Withdrawal by Subject|1|||
144605281|NCT02486653|521417077|FG001|Overall Study|Withdrawal by Subject|3|||
144191298|NCT01360866|519896163|FG001|Overall Study|Adverse Event|61|||
144191299|NCT01360866|519896164|FG002|Overall Study|Adverse Event|134|||
144191300|NCT01360866|519896165|FG003|Overall Study|Adverse Event|6|||
144191301|NCT01360866|519896162|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
144191302|NCT01360866|519896163|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
144441524|NCT02103478|520820073|FG002|Overall Study|Other|2|||
144441525|NCT02103478|520820074|FG003|Overall Study|Other|0|||
144441526|NCT02103478|520820075|FG004|Overall Study|Other|3|||
144441527|NCT02103478|520820076|FG005|Overall Study|Other|8|||
144441528|NCT02103478|520820077|FG006|Overall Study|Other|8|||
144441529|NCT02103478|520820078|FG007|Overall Study|Other|4|||
144441530|NCT02103478|520820079|FG008|Overall Study|Other|2|||
144605282|NCT02486653|521417076|FG000|Overall Study|Protocol Violation|1|||
144605283|NCT02486653|521417077|FG001|Overall Study|Protocol Violation|0|||
144191303|NCT01360866|519896164|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
144441531|NCT00723606|520820080|FG000|Overall Study|Adverse Event|2|||
144441532|NCT00723606|520820081|FG001|Overall Study|Adverse Event|5|||
144441533|NCT00723606|520820080|FG000|Overall Study|Other|2|||
144441534|NCT00723606|520820081|FG001|Overall Study|Other|0|||
144441535|NCT00723606|520820080|FG000|Overall Study|Withdrawal by Subject|0|||
144191304|NCT01360866|519896165|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
144191305|NCT01360866|519896162|FG000|Overall Study|Withdrawn by Investigator|9|||
144191306|NCT01360866|519896163|FG001|Overall Study|Withdrawn by Investigator|8|||
144191307|NCT01360866|519896164|FG002|Overall Study|Withdrawn by Investigator|31|||
144441536|NCT00723606|520820081|FG001|Overall Study|Withdrawal by Subject|2|||
144441537|NCT00976898|520820082|FG000|Overall Study|Protocol Violation|1|||
144441538|NCT00976898|520820082|FG000|Overall Study|Adverse Event|1|||
144441539|NCT00976898|520820082|FG000|Overall Study|Physician Decision|1|||
144441540|NCT00976898|520820082|FG000|Overall Study|Liver Transplant|1|||
144441541|NCT00976898|520820082|FG000|Overall Study|Progressive Disease|1|||
144441542|NCT05107128|520820083|FG000|Overall Study|Adverse Event|2|||
144441543|NCT05107128|520820084|FG001|Overall Study|Adverse Event|0|||
144441544|NCT05107128|520820083|FG000|Overall Study|Withdrawal by Subject|3|||
144441545|NCT05107128|520820084|FG001|Overall Study|Withdrawal by Subject|3|||
144441546|NCT05107128|520820083|FG000|Overall Study|Withdrawal of Consent|0|||
144441547|NCT05107128|520820084|FG001|Overall Study|Withdrawal of Consent|1|||
144441548|NCT05107128|520820083|FG000|Overall Study|Reason Not Specified|2|||
144441549|NCT05107128|520820084|FG001|Overall Study|Reason Not Specified|0|||
144441550|NCT00058825|520820085|FG000|Overall Study|Relapse|9|||
144441551|NCT00058825|520820085|FG000|Overall Study|Progressive Disease|5|||
144441552|NCT00058825|520820085|FG000|Overall Study|Graft Failure|5|||
144441553|NCT00058825|520820085|FG000|Overall Study|Death|3|||
144441554|NCT04115358|520820086|FG000|Overall Study|exfoliation|0|||
144441555|NCT04115358|520820087|FG001|Overall Study|exfoliation|0|||
144441556|NCT04115358|520820088|FG002|Overall Study|exfoliation|1|||
144441557|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441558|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
144441559|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
144441560|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
144441561|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144605284|NCT02486653|521417076|FG000|Overall Study|surgery cancelled|4|||
144605285|NCT02486653|521417077|FG001|Overall Study|surgery cancelled|1|||
144605286|NCT00766090|521417078|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605287|NCT00766090|521417079|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605288|NCT00766090|521417080|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605289|NCT00766090|521417081|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605290|NCT00766090|521417082|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605291|NCT00766090|521417083|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605292|NCT00766090|521417084|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605293|NCT00766090|521417085|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605294|NCT00766090|521417086|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
144605295|NCT00766090|521417087|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605296|NCT00766090|521417088|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605297|NCT00766090|521417089|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144605298|NCT00766090|521417078|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
144605299|NCT00766090|521417079|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605300|NCT00766090|521417080|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605301|NCT00766090|521417081|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605302|NCT00766090|521417082|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605303|NCT00766090|521417083|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605304|NCT00766090|521417084|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605305|NCT00766090|521417085|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605306|NCT00766090|521417086|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605307|NCT00766090|521417087|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605308|NCT00766090|521417088|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605309|NCT00766090|521417089|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
144605310|NCT00766090|521417078|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
144605311|NCT00766090|521417079|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605312|NCT00766090|521417080|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605313|NCT00766090|521417081|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
144724722|NCT01508936|521846472|FG001|Overall Study|Lost to Follow-up|9|||
144724723|NCT01508936|521846471|FG000|Overall Study|Other|0|||
144191308|NCT01360866|519896165|FG003|Overall Study|Withdrawn by Investigator|2|||
144191309|NCT01360866|519896162|FG000|Overall Study|Withdrawal by participant|79|||
144724724|NCT01508936|521846472|FG001|Overall Study|Other|5|||
144724725|NCT01508936|521846471|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
144724726|NCT01508936|521846472|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
144441562|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441563|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441564|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441565|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441566|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441567|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144605314|NCT00766090|521417082|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605315|NCT00766090|521417083|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605316|NCT00766090|521417084|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605317|NCT00766090|521417085|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605318|NCT00766090|521417086|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605319|NCT00766090|521417087|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605320|NCT00766090|521417088|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605321|NCT00766090|521417089|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144605322|NCT00766090|521417078|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605323|NCT00766090|521417079|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605324|NCT00766090|521417080|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
144605325|NCT00766090|521417081|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605326|NCT00766090|521417082|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605327|NCT00766090|521417083|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605328|NCT00766090|521417084|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605329|NCT00766090|521417085|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605330|NCT00766090|521417086|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605331|NCT00766090|521417087|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605332|NCT00766090|521417088|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605333|NCT00766090|521417089|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
144605334|NCT00766090|521417078|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144441568|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441569|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441570|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441571|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441572|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441573|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441574|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441575|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441576|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441577|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441578|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441579|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441580|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
144441581|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441582|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
144441583|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441584|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441585|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441586|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441587|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441588|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441589|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441590|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441591|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441592|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441593|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441594|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441595|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441596|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441597|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144605335|NCT00766090|521417079|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605336|NCT00766090|521417080|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605337|NCT00766090|521417081|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605338|NCT00766090|521417082|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
144605339|NCT00766090|521417083|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605340|NCT00766090|521417084|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605341|NCT00766090|521417085|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605342|NCT00766090|521417086|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605343|NCT00766090|521417087|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605344|NCT00766090|521417088|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144441598|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441599|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441600|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441601|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441602|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441603|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441604|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
144441605|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144191310|NCT01360866|519896163|FG001|Overall Study|Withdrawal by participant|89|||
144191311|NCT01360866|519896164|FG002|Overall Study|Withdrawal by participant|168|||
144191312|NCT01360866|519896165|FG003|Overall Study|Withdrawal by participant|8|||
144191313|NCT01360866|519896162|FG000|Overall Study|Protocol Deviation|25|||
144191314|NCT01360866|519896163|FG001|Overall Study|Protocol Deviation|33|||
144191315|NCT01360866|519896164|FG002|Overall Study|Protocol Deviation|61|||
144191316|NCT01360866|519896165|FG003|Overall Study|Protocol Deviation|2|||
144191317|NCT01360866|519896162|FG000|Overall Study|Lack of Efficacy|30|||
144441606|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
144441607|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441608|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441609|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441610|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441611|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441612|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441613|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441614|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441615|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441616|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441617|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441618|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441619|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441620|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441621|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441622|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441623|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441624|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441625|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441626|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441627|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441628|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
144441629|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
144441630|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
144441631|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
144441632|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
144191318|NCT01360866|519896163|FG001|Overall Study|Lack of Efficacy|40|||
144191319|NCT01360866|519896164|FG002|Overall Study|Lack of Efficacy|30|||
144191320|NCT01360866|519896165|FG003|Overall Study|Lack of Efficacy|4|||
144441633|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441634|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441635|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441636|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441637|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441638|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441639|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441640|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441641|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441642|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441643|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441644|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441645|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441646|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441647|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441648|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144191321|NCT03702049|519896166|FG000|Overall Study|Lost to Follow-up|4|||
144441649|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441650|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441651|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441652|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
144441653|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
144441654|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
144441655|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
144441656|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
144441657|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441658|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144191322|NCT03702049|519896166|FG000|Overall Study|Physician Decision|1|||
144191323|NCT01014624|519896175|FG000|Overall Study|Adverse Event|0|||
144191324|NCT01014624|519896176|FG001|Overall Study|Adverse Event|1|||
144191325|NCT01014624|519896175|FG000|Overall Study|Protocol Violation|1|||
144191326|NCT01014624|519896176|FG001|Overall Study|Protocol Violation|0|||
144441659|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441660|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441661|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441662|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441663|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441664|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441665|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441666|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441667|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441668|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441669|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441670|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441671|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441672|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441673|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441674|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441675|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441676|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
144441677|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441678|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
144441679|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441680|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
144441681|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441682|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441683|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441684|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441685|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441686|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441687|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441688|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441689|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441690|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441691|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144531383|NCT03174275|521147961|FG000|Adjuvant Durvalumab|Adverse Event|3|||
144531384|NCT03174275|521147961|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
144531385|NCT03174275|521147961|FG000|Adjuvant Radiotherapy|Progression|1|||
144531386|NCT03174275|521147961|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
144531387|NCT02413489|521147962|FG000|Overall Study|Death|11|||
144724727|NCT00679367|521846473|FG000|Overall Study|Adverse Event|7|||
144724728|NCT00679367|521846473|FG000|Overall Study|inability to swallow oral drugs|1|||
144724729|NCT00679367|521846473|FG000|Overall Study|Lack of Efficacy|3|||
144724730|NCT00679367|521846473|FG000|Overall Study|Withdrawal by Subject|1|||
144531388|NCT02413489|521147963|FG001|Overall Study|Death|3|||
144531389|NCT02413489|521147964|FG002|Overall Study|Death|4|||
144531390|NCT02413489|521147962|FG000|Overall Study|Withdrawal by Subject|2|||
144531391|NCT02413489|521147963|FG001|Overall Study|Withdrawal by Subject|0|||
144191327|NCT01014624|519896175|FG000|Overall Study|Withdrawal by Subject|1|||
144531392|NCT02413489|521147964|FG002|Overall Study|Withdrawal by Subject|0|||
144531393|NCT02413489|521147962|FG000|Overall Study|Study Terminated By Sponsor|2|||
144531394|NCT02413489|521147963|FG001|Overall Study|Study Terminated By Sponsor|13|||
144531395|NCT02413489|521147964|FG002|Overall Study|Study Terminated By Sponsor|1|||
144531396|NCT05285137|521147965|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
144531397|NCT05285137|521147966|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
144531398|NCT05285137|521147967|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
144531399|NCT05285137|521147968|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
144191328|NCT01014624|519896176|FG001|Overall Study|Withdrawal by Subject|0|||
144191329|NCT01117337|519896181|FG000|Overall Study|Lost to Follow-up|4|||
144441692|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441693|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441694|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441695|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441696|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441697|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144724731|NCT03365947|521846474|FG000|Overall Study|Lost to Follow-up|0|||
144441698|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441699|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441700|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
144441701|NCT02346240|520820089|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441702|NCT02346240|520820090|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441703|NCT02346240|520820091|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
144441704|NCT02346240|520820092|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441705|NCT02346240|520820093|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441706|NCT02346240|520820094|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441707|NCT02346240|520820095|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441708|NCT02346240|520820096|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441709|NCT02346240|520820097|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441710|NCT02346240|520820098|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441711|NCT02346240|520820099|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441712|NCT02346240|520820100|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441713|NCT02346240|520820101|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441714|NCT02346240|520820102|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441715|NCT02346240|520820103|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441716|NCT02346240|520820104|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441717|NCT02346240|520820105|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441718|NCT02346240|520820106|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441719|NCT02346240|520820107|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441720|NCT02346240|520820108|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441721|NCT02346240|520820109|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441722|NCT02346240|520820110|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144531400|NCT05285137|521147969|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
144531401|NCT05285137|521147970|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
144531402|NCT05285137|521147971|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
144531403|NCT05285137|521147972|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
144191330|NCT01117337|519896182|FG001|Overall Study|Lost to Follow-up|0|||
144531404|NCT05285137|521147973|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
144531405|NCT05285137|521147965|FG000|Overall Study|Lost to Follow-up|0|||
144531406|NCT05285137|521147966|FG001|Overall Study|Lost to Follow-up|0|||
144531407|NCT05285137|521147967|FG002|Overall Study|Lost to Follow-up|1|||
144531408|NCT05285137|521147968|FG003|Overall Study|Lost to Follow-up|3|||
144531409|NCT05285137|521147969|FG004|Overall Study|Lost to Follow-up|0|||
144531410|NCT05285137|521147970|FG005|Overall Study|Lost to Follow-up|0|||
144531411|NCT05285137|521147971|FG006|Overall Study|Lost to Follow-up|1|||
144531412|NCT05285137|521147972|FG007|Overall Study|Lost to Follow-up|0|||
144531413|NCT05285137|521147973|FG008|Overall Study|Lost to Follow-up|0|||
144531414|NCT05285137|521147965|FG000|Overall Study|Physician Decision|0|||
144531415|NCT05285137|521147966|FG001|Overall Study|Physician Decision|1|||
144531416|NCT05285137|521147967|FG002|Overall Study|Physician Decision|0|||
144531417|NCT05285137|521147968|FG003|Overall Study|Physician Decision|0|||
144531418|NCT05285137|521147969|FG004|Overall Study|Physician Decision|0|||
144531419|NCT05285137|521147970|FG005|Overall Study|Physician Decision|0|||
144531420|NCT05285137|521147971|FG006|Overall Study|Physician Decision|0|||
144531421|NCT05285137|521147972|FG007|Overall Study|Physician Decision|0|||
144531422|NCT05285137|521147973|FG008|Overall Study|Physician Decision|0|||
144531423|NCT05285137|521147965|FG000|Overall Study|Pregnancy|0|||
144531424|NCT05285137|521147966|FG001|Overall Study|Pregnancy|0|||
144531425|NCT05285137|521147967|FG002|Overall Study|Pregnancy|0|||
144531426|NCT05285137|521147968|FG003|Overall Study|Pregnancy|0|||
144531427|NCT05285137|521147969|FG004|Overall Study|Pregnancy|0|||
144531428|NCT05285137|521147970|FG005|Overall Study|Pregnancy|0|||
144531429|NCT05285137|521147971|FG006|Overall Study|Pregnancy|1|||
144531430|NCT05285137|521147972|FG007|Overall Study|Pregnancy|0|||
144531431|NCT05285137|521147973|FG008|Overall Study|Pregnancy|0|||
144531432|NCT05285137|521147965|FG000|Overall Study|Withdrawal by Subject|0|||
144605345|NCT00766090|521417089|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144605346|NCT00766090|521417078|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144441723|NCT02346240|520820111|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441724|NCT02346240|520820112|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
144441725|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144531433|NCT05285137|521147966|FG001|Overall Study|Withdrawal by Subject|1|||
144531434|NCT05285137|521147967|FG002|Overall Study|Withdrawal by Subject|2|||
144531435|NCT05285137|521147968|FG003|Overall Study|Withdrawal by Subject|1|||
144531436|NCT05285137|521147969|FG004|Overall Study|Withdrawal by Subject|0|||
144531437|NCT05285137|521147970|FG005|Overall Study|Withdrawal by Subject|0|||
144531438|NCT05285137|521147971|FG006|Overall Study|Withdrawal by Subject|0|||
144531439|NCT05285137|521147972|FG007|Overall Study|Withdrawal by Subject|0|||
144191331|NCT02791893|519896188|FG000|Blinded Phase|Lost to Follow-up|2|||
144191332|NCT02791893|519896189|FG001|Blinded Phase|Lost to Follow-up|2|||
144191333|NCT02791893|519896188|FG000|Blinded Phase|Withdrawal by Subject|1|||
144191334|NCT02791893|519896189|FG001|Blinded Phase|Withdrawal by Subject|2|||
144191335|NCT02791893|519896188|FG000|Open Label Phase|Lost to Follow-up|3|||
144191336|NCT02791893|519896189|FG001|Open Label Phase|Lost to Follow-up|0|||
144191337|NCT02791893|519896188|FG000|Open Label Phase|Withdrawal by Subject|0|||
144191338|NCT02791893|519896189|FG001|Open Label Phase|Withdrawal by Subject|2|||
144191339|NCT01048502|519896193|FG000|Overall Study|Lost to Follow-up|2|||
144191340|NCT01048502|519896194|FG001|Overall Study|Lost to Follow-up|0|||
144441726|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441727|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441728|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441729|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441730|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441731|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441732|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
144441733|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
144441734|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441735|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441736|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441737|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441738|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
144441739|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
144441740|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
144441741|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
144441742|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441743|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441744|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441745|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441746|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441747|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441748|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144441749|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441750|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441751|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441752|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144191341|NCT01048502|519896195|FG002|Overall Study|Lost to Follow-up|0|||
144191342|NCT01048502|519896196|FG003|Overall Study|Lost to Follow-up|0|||
144191343|NCT01048502|519896193|FG000|Overall Study|Adverse Event|1|||
144191344|NCT01048502|519896194|FG001|Overall Study|Adverse Event|0|||
144191345|NCT01048502|519896195|FG002|Overall Study|Adverse Event|0|||
144191346|NCT01048502|519896196|FG003|Overall Study|Adverse Event|0|||
144191347|NCT01048502|519896193|FG000|Overall Study|Withdrawal by Subject|1|||
144191348|NCT01048502|519896194|FG001|Overall Study|Withdrawal by Subject|4|||
144191349|NCT01048502|519896195|FG002|Overall Study|Withdrawal by Subject|5|||
144191350|NCT01048502|519896196|FG003|Overall Study|Withdrawal by Subject|3|||
144191351|NCT01048502|519896193|FG000|Overall Study|Physician Decision|0|||
144191352|NCT01048502|519896194|FG001|Overall Study|Physician Decision|3|||
144191353|NCT01048502|519896195|FG002|Overall Study|Physician Decision|0|||
144191354|NCT01048502|519896196|FG003|Overall Study|Physician Decision|1|||
144441753|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441754|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441755|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441756|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441757|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441758|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144191355|NCT00685802|519896197|FG000|Washout Period of 7 Days|Protocol Violation|2|||
144191356|NCT00685802|519896198|FG001|Washout Period of 7 Days|Protocol Violation|0|||
144191357|NCT00685802|519896197|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
144441759|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441760|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441761|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441762|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
144441763|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144605347|NCT00766090|521417079|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144191358|NCT00685802|519896198|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144191359|NCT01333072|519896199|FG000|Overall Study|Lost to Follow-up|3|||
144191360|NCT01333072|519896200|FG001|Overall Study|Lost to Follow-up|0|||
144191361|NCT01333072|519896199|FG000|Overall Study|Adverse Event|2|||
144441764|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
144441765|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441766|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441767|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441768|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441769|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441770|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441771|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441772|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144441773|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441774|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441775|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441776|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441777|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441778|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441779|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441780|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441781|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441782|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441783|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441784|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441785|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441786|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441787|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
144441788|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441789|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441790|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441791|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441792|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441793|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441794|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441795|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441796|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144441797|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441798|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441799|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441800|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441801|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441802|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144531440|NCT05285137|521147973|FG008|Overall Study|Withdrawal by Subject|1|||
144531441|NCT03717935|521147978|FG000|Overall Study|Withdrawal by Subject|0|||
144531442|NCT03717935|521147979|FG001|Overall Study|Withdrawal by Subject|2|||
144531443|NCT01447719|521147982|FG000|Overall Study|Image acquisition failure|2|||
144531444|NCT01447719|521147982|FG000|Overall Study|Invalid image or not imaged|3|||
144531445|NCT01447719|521147982|FG000|Overall Study|Subject still living at end of study|79|||
144531446|NCT01447719|521147982|FG000|Overall Study|Withdrawal by Subject|2|||
144531447|NCT01447719|521147982|FG000|Overall Study|Family withdrew autopsy consent|7|||
144531448|NCT05100628|521147983|FG000|Overall Study|Progressive Disease|1|||
144531449|NCT05100628|521147984|FG001|Overall Study|Progressive Disease|0|||
144531450|NCT05100628|521147985|FG002|Overall Study|Progressive Disease|0|||
144531451|NCT05100628|521147986|FG003|Overall Study|Progressive Disease|0|||
144531452|NCT05100628|521147983|FG000|Overall Study|Study Terminated by Sponsor|0|||
144531453|NCT05100628|521147984|FG001|Overall Study|Study Terminated by Sponsor|0|||
144531454|NCT05100628|521147985|FG002|Overall Study|Study Terminated by Sponsor|3|||
144531455|NCT05100628|521147986|FG003|Overall Study|Study Terminated by Sponsor|0|||
144531456|NCT05100628|521147983|FG000|Overall Study|unkown|0|||
144531457|NCT05100628|521147984|FG001|Overall Study|unkown|1|||
144531458|NCT05100628|521147985|FG002|Overall Study|unkown|0|||
144531459|NCT05100628|521147986|FG003|Overall Study|unkown|0|||
144441803|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144441804|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144441805|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144441806|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441807|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144441808|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
144441809|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144531460|NCT02575950|521147987|FG000|Overall Study|Withdrawal by Subject|0|||
144531461|NCT02575950|521147988|FG001|Overall Study|Withdrawal by Subject|0|||
144191362|NCT01333072|519896200|FG001|Overall Study|Adverse Event|4|||
144441810|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
144441811|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
144441812|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
144441813|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144441814|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441815|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441816|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441817|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441818|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441819|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441820|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144441821|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441822|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441823|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441824|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441825|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441826|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441827|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441828|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441829|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441830|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441831|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441832|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441833|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441834|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
144441835|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
144441836|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
144441837|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
144441838|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441839|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441840|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441841|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441842|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441843|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441844|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144441845|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441846|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441847|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441848|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144605348|NCT00766090|521417080|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
144605349|NCT00766090|521417081|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605350|NCT00766090|521417082|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605351|NCT00766090|521417083|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605352|NCT00766090|521417084|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605353|NCT00766090|521417085|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605354|NCT00766090|521417086|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605355|NCT00766090|521417087|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144724732|NCT03365947|521846475|FG001|Overall Study|Lost to Follow-up|0|||
144724733|NCT03365947|521846476|FG002|Overall Study|Lost to Follow-up|0|||
144191363|NCT01333072|519896199|FG000|Overall Study|Physician Decision|1|||
144191364|NCT01333072|519896200|FG001|Overall Study|Physician Decision|0|||
144191365|NCT00619359|519896203|FG000|Overall Study|Adverse Event|32|||
144191366|NCT00619359|519896204|FG001|Overall Study|Adverse Event|36|||
144191367|NCT00619359|519896203|FG000|Overall Study|Lost to Follow-up|12|||
144191368|NCT00619359|519896204|FG001|Overall Study|Lost to Follow-up|16|||
144191369|NCT00619359|519896203|FG000|Overall Study|Physician Decision|0|||
144253571|NCT02279745|520128138|FG000|Overall Study|Study Non-compliance|1|||
144441849|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441850|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441851|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
144441852|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441853|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441854|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441855|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144191370|NCT00619359|519896204|FG001|Overall Study|Physician Decision|7|||
144191371|NCT00619359|519896203|FG000|Overall Study|Protocol Violation|1|||
144191372|NCT00619359|519896204|FG001|Overall Study|Protocol Violation|1|||
144191373|NCT00619359|519896203|FG000|Overall Study|Withdrawal by Subject|19|||
144191374|NCT00619359|519896204|FG001|Overall Study|Withdrawal by Subject|20|||
144191375|NCT00619359|519896203|FG000|Overall Study|Progressive Disease|3|||
144191376|NCT00619359|519896204|FG001|Overall Study|Progressive Disease|1|||
144191377|NCT00493454|519896205|FG000|Overall Study|Withdrawal by Subject|1|||
144441856|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441857|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441858|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441859|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441860|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441861|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441862|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441863|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441864|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441865|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441866|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441867|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441868|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
144441869|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441870|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441871|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441872|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441873|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441874|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441875|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441876|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441877|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
144441878|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441879|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441880|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
144441881|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441882|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
144441883|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
144441884|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441885|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144605356|NCT00766090|521417088|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605357|NCT00766090|521417089|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
144605358|NCT00766090|521417078|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
144605359|NCT00766090|521417079|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
144605360|NCT00766090|521417080|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
144605361|NCT00766090|521417081|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
144605362|NCT00766090|521417082|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
144605363|NCT00766090|521417083|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
144605364|NCT00766090|521417084|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
144605365|NCT00766090|521417085|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
144605366|NCT00766090|521417086|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
144605367|NCT00766090|521417087|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
144605368|NCT00766090|521417088|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
144605369|NCT00766090|521417089|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
144605370|NCT00766090|521417078|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605371|NCT00766090|521417079|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605372|NCT00766090|521417080|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605373|NCT00766090|521417081|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605374|NCT00766090|521417082|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605375|NCT00766090|521417083|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
144605376|NCT00766090|521417084|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605377|NCT00766090|521417085|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144724734|NCT03365947|521846477|FG003|Overall Study|Lost to Follow-up|0|||
144191378|NCT00103038|519896208|FG000|Overall Study|Withdrawal by Subject|8|||
144191379|NCT00103038|519896208|FG000|Overall Study|Screen failure|3|||
144191380|NCT00103038|519896208|FG000|Overall Study|Death|1|||
144191381|NCT00103038|519896208|FG000|Overall Study|Physician Decision|1|||
144191382|NCT03095118|519896214|FG000|Overall Study|Adverse Event|1|||
144191383|NCT03095118|519896214|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
144191384|NCT02674386|519896215|FG000|Overall Study|Lost to Follow-up|0|||
144191385|NCT02674386|519896216|FG001|Overall Study|Lost to Follow-up|1|||
144191386|NCT02674386|519896217|FG002|Overall Study|Lost to Follow-up|1|||
144191387|NCT02674386|519896215|FG000|Overall Study|Withdrawal by Subject|0|||
144191388|NCT02674386|519896216|FG001|Overall Study|Withdrawal by Subject|4|||
144191389|NCT02674386|519896217|FG002|Overall Study|Withdrawal by Subject|0|||
144191390|NCT02674386|519896215|FG000|Overall Study|Other|0|||
144191391|NCT02674386|519896216|FG001|Overall Study|Other|1|||
144191392|NCT02674386|519896217|FG002|Overall Study|Other|0|||
144191393|NCT02674386|519896215|FG000|Overall Study|Enrolled but not evaluated|0|||
144191394|NCT02674386|519896216|FG001|Overall Study|Enrolled but not evaluated|4|||
144191395|NCT02674386|519896217|FG002|Overall Study|Enrolled but not evaluated|0|||
144191396|NCT02462486|519896222|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
144191397|NCT02462486|519896223|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
144191398|NCT02462486|519896224|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
144191399|NCT02462486|519896222|FG000|Overall Study|Adverse Event|53|||
144191400|NCT02462486|519896223|FG001|Overall Study|Adverse Event|48|||
144191401|NCT02462486|519896224|FG002|Overall Study|Adverse Event|21|||
144191402|NCT02462486|519896222|FG000|Overall Study|Lack of Efficacy|6|||
144191403|NCT02462486|519896223|FG001|Overall Study|Lack of Efficacy|12|||
144191404|NCT02462486|519896224|FG002|Overall Study|Lack of Efficacy|3|||
144191405|NCT02462486|519896222|FG000|Overall Study|Lost to Follow-up|3|||
144191406|NCT02462486|519896223|FG001|Overall Study|Lost to Follow-up|4|||
144191407|NCT02462486|519896224|FG002|Overall Study|Lost to Follow-up|2|||
144191408|NCT02462486|519896222|FG000|Overall Study|Withdrawal by Subject|25|||
144191409|NCT02462486|519896223|FG001|Overall Study|Withdrawal by Subject|22|||
144191410|NCT02462486|519896224|FG002|Overall Study|Withdrawal by Subject|19|||
144191411|NCT02462486|519896222|FG000|Overall Study|Protocol Violation|3|||
144191412|NCT02462486|519896223|FG001|Overall Study|Protocol Violation|1|||
144191413|NCT02462486|519896224|FG002|Overall Study|Protocol Violation|1|||
144191414|NCT02462486|519896222|FG000|Overall Study|Reason not Specified|3|||
144191415|NCT02462486|519896223|FG001|Overall Study|Reason not Specified|4|||
144191416|NCT02462486|519896224|FG002|Overall Study|Reason not Specified|3|||
144191417|NCT01483625|519896225|FG000|Overall Study|Adverse Event|1|||
144191418|NCT01483625|519896226|FG001|Overall Study|Adverse Event|1|||
144191419|NCT01483625|519896225|FG000|Overall Study|Refused to continue medication|2|||
144191420|NCT01483625|519896226|FG001|Overall Study|Refused to continue medication|1|||
144191421|NCT01483625|519896225|FG000|Overall Study|Due to other reason|1|||
144191422|NCT01483625|519896226|FG001|Overall Study|Due to other reason|0|||
144191423|NCT02310763|519896227|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
144191424|NCT02310763|519896228|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
144191425|NCT02310763|519896229|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
144191426|NCT02310763|519896227|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
144191427|NCT02310763|519896228|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
144191428|NCT02310763|519896229|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
144191429|NCT02310763|519896227|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
144191430|NCT02310763|519896228|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
144441886|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441887|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441888|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441889|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441890|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441891|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441892|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
144441893|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441894|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144191431|NCT02310763|519896229|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
144191432|NCT02310763|519896227|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
144191433|NCT02310763|519896228|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
144191434|NCT02310763|519896229|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
144191435|NCT02310763|519896227|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
144191436|NCT02310763|519896228|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
144191437|NCT02310763|519896229|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
144191438|NCT01731886|519896230|FG000|Overall Study|Death|1|||
144191439|NCT01731886|519896231|FG001|Overall Study|Death|0|||
144191440|NCT01731886|519896230|FG000|Overall Study|Never started treatment|0|||
144191441|NCT01731886|519896231|FG001|Overall Study|Never started treatment|1|||
144191442|NCT01731886|519896230|FG000|Overall Study|Non-compliant|1|||
144191443|NCT01731886|519896231|FG001|Overall Study|Non-compliant|0|||
144191444|NCT02280187|519896234|FG000|Overall Study|Lost to Follow-up|218|||
144191445|NCT02094261|519896235|FG000|Overall Study|Death|24|||
144191446|NCT02094261|519896235|FG000|Overall Study|Lost to Follow-up|1|||
144441895|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144191447|NCT02094261|519896235|FG000|Overall Study|Withdrawal by Subject|4|||
144191448|NCT02094261|519896235|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
144191449|NCT04668274|519896236|FG000|Part 1 Study Period 1|Adverse Event|3|||
144191450|NCT04668274|519896237|FG001|Part 1 Study Period 1|Adverse Event|0|||
144191451|NCT04668274|519896238|FG002|Part 1 Study Period 1|Adverse Event|0|||
144191452|NCT04668274|519896239|FG003|Part 1 Study Period 1|Adverse Event|0|||
144191453|NCT04668274|519896236|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
144191454|NCT04668274|519896237|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
144191455|NCT04668274|519896238|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
144191456|NCT04668274|519896239|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
144191457|NCT04668274|519896236|FG000|Part 1 Study Period 2|Other|0|||
144191458|NCT04668274|519896237|FG001|Part 1 Study Period 2|Other|1|||
144191459|NCT04668274|519896238|FG002|Part 1 Study Period 2|Other|0|||
144191460|NCT04668274|519896239|FG003|Part 1 Study Period 2|Other|0|||
144191461|NCT04668274|519896236|FG000|Part 1 Study Period 3|Adverse Event|0|||
144191462|NCT04668274|519896237|FG001|Part 1 Study Period 3|Adverse Event|0|||
144191463|NCT04668274|519896238|FG002|Part 1 Study Period 3|Adverse Event|1|||
144191464|NCT04668274|519896239|FG003|Part 1 Study Period 3|Adverse Event|0|||
144191465|NCT04668274|519896236|FG000|Part 1 Study Period 3|Other|0|||
144191466|NCT04668274|519896237|FG001|Part 1 Study Period 3|Other|0|||
144441896|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441897|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441898|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441899|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441900|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441901|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441902|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
144441903|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441904|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441905|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441906|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441907|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441908|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441909|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441910|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441911|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441912|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441913|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441914|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441915|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441916|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
144441917|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441918|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441919|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441920|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441921|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441922|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441923|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441924|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441925|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441926|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144531462|NCT02575950|521147989|FG002|Overall Study|Withdrawal by Subject|0|||
144531463|NCT02575950|521147990|FG003|Overall Study|Withdrawal by Subject|2|||
144531464|NCT02575950|521147987|FG000|Overall Study|Lost to Follow-up|0|||
144531465|NCT02575950|521147988|FG001|Overall Study|Lost to Follow-up|1|||
144191467|NCT04668274|519896238|FG002|Part 1 Study Period 3|Other|2|||
144191468|NCT04668274|519896239|FG003|Part 1 Study Period 3|Other|0|||
144191469|NCT04668274|519896236|FG000|Part 2 Study Period 4|Other|0|||
144191470|NCT04668274|519896237|FG001|Part 2 Study Period 4|Other|0|||
144191471|NCT04668274|519896238|FG002|Part 2 Study Period 4|Other|0|||
144191472|NCT04668274|519896239|FG003|Part 2 Study Period 4|Other|1|||
144191473|NCT02363439|519896242|FG000|Overall Study|Lack of Efficacy|4|||
144441927|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
144441928|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441929|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441930|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441931|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441932|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441933|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441934|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441935|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441936|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441937|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441938|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441939|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441940|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
144441941|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441942|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441943|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441944|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441945|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441946|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441947|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441948|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441949|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441950|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441951|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441952|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441953|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441954|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441955|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
144441956|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441957|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441958|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441959|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441960|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441961|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441962|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144531466|NCT02575950|521147989|FG002|Overall Study|Lost to Follow-up|0|||
144531467|NCT02575950|521147990|FG003|Overall Study|Lost to Follow-up|3|||
144531468|NCT04271046|521147991|FG000|Overall Study|Death|0|||
144531469|NCT04271046|521147992|FG001|Overall Study|Death|2|||
144531470|NCT04271046|521147993|FG002|Overall Study|Death|0|||
144191474|NCT00171340|519896245|FG000|Overall Study|Adverse Event|46|||
144191475|NCT00171340|519896246|FG001|Overall Study|Adverse Event|42|||
144191476|NCT00171340|519896245|FG000|Overall Study|Lack of Efficacy|29|||
144191477|NCT00171340|519896246|FG001|Overall Study|Lack of Efficacy|41|||
144191478|NCT00171340|519896245|FG000|Overall Study|Protocol Violation|7|||
144191479|NCT00171340|519896246|FG001|Overall Study|Protocol Violation|8|||
144191480|NCT00171340|519896245|FG000|Overall Study|Withdrawal by Subject|22|||
144191481|NCT00171340|519896246|FG001|Overall Study|Withdrawal by Subject|19|||
144191482|NCT00171340|519896245|FG000|Overall Study|Lost to Follow-up|0|||
144191483|NCT00171340|519896246|FG001|Overall Study|Lost to Follow-up|5|||
144191484|NCT00171340|519896245|FG000|Overall Study|Abnormal Laboratory Results|2|||
144191485|NCT00171340|519896246|FG001|Overall Study|Abnormal Laboratory Results|0|||
144191486|NCT00171340|519896245|FG000|Overall Study|Abnormal Test Procedure Results|6|||
144191487|NCT00171340|519896246|FG001|Overall Study|Abnormal Test Procedure Results|11|||
144191488|NCT00171340|519896245|FG000|Overall Study|No Longer Required Study Drug|1|||
144191489|NCT00171340|519896246|FG001|Overall Study|No Longer Required Study Drug|1|||
144191490|NCT00171340|519896245|FG000|Overall Study|Administrative Problems|5|||
144191491|NCT00171340|519896246|FG001|Overall Study|Administrative Problems|2|||
144191492|NCT00171340|519896245|FG000|Overall Study|Death|6|||
144191493|NCT00171340|519896246|FG001|Overall Study|Death|6|||
144191494|NCT01682148|519896247|FG000|Overall Study|Withdrawal by Subject|2|||
144191495|NCT01682148|519896248|FG001|Overall Study|Withdrawal by Subject|0|||
144191496|NCT01682148|519896247|FG000|Overall Study|Lost to Follow-up|1|||
144191497|NCT01682148|519896248|FG001|Overall Study|Lost to Follow-up|2|||
144441963|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441964|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
144441965|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441966|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441967|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441968|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441969|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441970|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441971|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441972|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441973|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441974|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441975|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441976|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441977|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441978|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441979|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
144441980|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441981|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441982|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441983|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441984|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441985|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441986|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441987|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441988|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
144441989|NCT02346240|520820089|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441990|NCT02346240|520820090|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441991|NCT02346240|520820091|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441992|NCT02346240|520820092|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441993|NCT02346240|520820093|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441994|NCT02346240|520820094|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144191498|NCT01682148|519896247|FG000|Overall Study|Protocol Violation|1|||
144191499|NCT01682148|519896248|FG001|Overall Study|Protocol Violation|1|||
144191500|NCT02470091|519896255|FG000|Overall Study|Withdrawal by Subject|1|||
144191501|NCT02470091|519896256|FG001|Overall Study|Withdrawal by Subject|0|||
144441995|NCT02346240|520820095|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441996|NCT02346240|520820096|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144191502|NCT02470091|519896255|FG000|Overall Study|Ineligible|0|||
144441997|NCT02346240|520820097|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441998|NCT02346240|520820098|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144441999|NCT02346240|520820099|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442000|NCT02346240|520820100|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442001|NCT02346240|520820101|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442002|NCT02346240|520820102|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442003|NCT02346240|520820103|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
144442004|NCT02346240|520820104|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442005|NCT02346240|520820105|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442006|NCT02346240|520820106|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442007|NCT02346240|520820107|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442008|NCT02346240|520820108|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442009|NCT02346240|520820109|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442010|NCT02346240|520820110|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442011|NCT02346240|520820111|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442012|NCT02346240|520820112|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
144442013|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144531471|NCT04271046|521147994|FG003|Overall Study|Death|2|||
144531472|NCT04271046|521147991|FG000|Overall Study|Lost to Follow-up|12|||
144531473|NCT04271046|521147992|FG001|Overall Study|Lost to Follow-up|12|||
144191503|NCT02470091|519896256|FG001|Overall Study|Ineligible|2|||
144191504|NCT00303667|519896257|FG000|Overall Study|Death|0|||
144191505|NCT00303667|519896258|FG001|Overall Study|Death|4|||
144191506|NCT01192399|519896259|FG000|Overall Study|Lack of Efficacy|2|||
144191507|NCT01029392|519896261|FG000|Overall Study|Withdrawal by Subject|18|||
144191508|NCT01029392|519896262|FG001|Overall Study|Withdrawal by Subject|11|||
144191509|NCT01029392|519896261|FG000|Overall Study|Physician Decision|2|||
144605378|NCT00766090|521417086|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605379|NCT00766090|521417087|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605380|NCT00766090|521417088|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605381|NCT00766090|521417089|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
144605382|NCT00766090|521417078|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605383|NCT00766090|521417079|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
144605384|NCT00766090|521417080|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605385|NCT00766090|521417081|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
144605386|NCT00766090|521417082|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144191510|NCT01029392|519896262|FG001|Overall Study|Physician Decision|0|||
144191511|NCT00536484|519896263|FG000|Overall Study|Adverse Event|21|||
144191512|NCT00536484|519896264|FG001|Overall Study|Adverse Event|34|||
144191513|NCT00536484|519896263|FG000|Overall Study|Withdrawal by Subject|11|||
144191514|NCT00536484|519896264|FG001|Overall Study|Withdrawal by Subject|11|||
144191515|NCT00536484|519896263|FG000|Overall Study|Lost to Follow-up|8|||
144191516|NCT00536484|519896264|FG001|Overall Study|Lost to Follow-up|6|||
144191517|NCT00536484|519896263|FG000|Overall Study|Lack of Efficacy|16|||
144442014|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442015|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442016|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442017|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442018|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442019|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442020|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442021|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442022|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442023|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442024|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144605387|NCT00766090|521417083|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605388|NCT00766090|521417084|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605389|NCT00766090|521417085|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605390|NCT00766090|521417086|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605391|NCT00766090|521417087|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144191518|NCT00536484|519896264|FG001|Overall Study|Lack of Efficacy|5|||
144191519|NCT00536484|519896263|FG000|Overall Study|Other|4|||
144191520|NCT00536484|519896264|FG001|Overall Study|Other|0|||
144191521|NCT02139124|519896265|FG000|Overall Study|Adverse Event|2|||
144191522|NCT02139124|519896266|FG001|Overall Study|Adverse Event|0|||
144191523|NCT02139124|519896267|FG002|Overall Study|Adverse Event|1|||
144191524|NCT02139124|519896268|FG003|Overall Study|Adverse Event|2|||
144191525|NCT02139124|519896269|FG004|Overall Study|Adverse Event|5|||
144605392|NCT00766090|521417088|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
144605393|NCT00766090|521417089|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
144191526|NCT02139124|519896265|FG000|Overall Study|Withdrawal by Subject|2|||
144191527|NCT02139124|519896266|FG001|Overall Study|Withdrawal by Subject|2|||
144191528|NCT02139124|519896267|FG002|Overall Study|Withdrawal by Subject|2|||
144191529|NCT02139124|519896268|FG003|Overall Study|Withdrawal by Subject|2|||
144191530|NCT02139124|519896269|FG004|Overall Study|Withdrawal by Subject|3|||
144191531|NCT02139124|519896265|FG000|Overall Study|Protocol Violation|0|||
144191532|NCT02139124|519896266|FG001|Overall Study|Protocol Violation|0|||
144191533|NCT02139124|519896267|FG002|Overall Study|Protocol Violation|0|||
144191534|NCT02139124|519896268|FG003|Overall Study|Protocol Violation|1|||
144191535|NCT02139124|519896269|FG004|Overall Study|Protocol Violation|1|||
144191536|NCT02139124|519896265|FG000|Overall Study|non-compliant|1|||
144191537|NCT02139124|519896266|FG001|Overall Study|non-compliant|0|||
144191538|NCT02139124|519896267|FG002|Overall Study|non-compliant|0|||
144191539|NCT02139124|519896268|FG003|Overall Study|non-compliant|2|||
144191540|NCT02139124|519896269|FG004|Overall Study|non-compliant|0|||
144191541|NCT02139124|519896265|FG000|Overall Study|incarceration|0|||
144442025|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144191542|NCT02139124|519896266|FG001|Overall Study|incarceration|0|||
144191543|NCT02139124|519896267|FG002|Overall Study|incarceration|1|||
144442026|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442027|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442028|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144191544|NCT02139124|519896268|FG003|Overall Study|incarceration|0|||
144191545|NCT02139124|519896269|FG004|Overall Study|incarceration|0|||
144191546|NCT02139124|519896265|FG000|Overall Study|subject moved|1|||
144191547|NCT02139124|519896266|FG001|Overall Study|subject moved|0|||
144191548|NCT02139124|519896267|FG002|Overall Study|subject moved|0|||
144442029|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
144442030|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
144442031|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
144442032|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
144442033|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
144442034|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
144442035|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
144442036|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
144442037|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442038|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442039|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442040|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442041|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442042|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442043|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442044|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442045|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442046|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442047|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442048|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442049|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442050|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442051|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442052|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442053|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442054|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442055|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
144442056|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
144442057|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442058|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
144442059|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442060|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
144442061|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442062|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442063|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442064|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442065|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442066|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442067|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442068|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144531474|NCT04271046|521147993|FG002|Overall Study|Lost to Follow-up|11|||
144531475|NCT04271046|521147994|FG003|Overall Study|Lost to Follow-up|11|||
144531476|NCT04271046|521147991|FG000|Overall Study|Patient with Dementia Died|2|||
144531477|NCT04271046|521147992|FG001|Overall Study|Patient with Dementia Died|0|||
144531478|NCT04271046|521147993|FG002|Overall Study|Patient with Dementia Died|2|||
144531479|NCT04271046|521147994|FG003|Overall Study|Patient with Dementia Died|0|||
144531480|NCT04271046|521147991|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
144531481|NCT04271046|521147992|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
144531482|NCT04271046|521147993|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
144531483|NCT04271046|521147994|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
144531484|NCT04230681|521147995|FG000|Overall Study|Physician Decision|2|||
144531485|NCT04230681|521147996|FG001|Overall Study|Physician Decision|3|||
144531486|NCT04230681|521147995|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
144531487|NCT04230681|521147996|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
144531488|NCT04230681|521147995|FG000|Overall Study|IV inadvertently removed|0|||
144442069|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442070|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442071|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442072|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442073|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144724735|NCT03365947|521846478|FG004|Overall Study|Lost to Follow-up|0|||
144191549|NCT02139124|519896268|FG003|Overall Study|subject moved|0|||
144442074|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442075|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442076|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442077|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144724736|NCT03365947|521846479|FG005|Overall Study|Lost to Follow-up|1|||
144191550|NCT02139124|519896269|FG004|Overall Study|subject moved|0|||
144191551|NCT02139124|519896265|FG000|Overall Study|Lost to Follow-up|3|||
144191552|NCT02139124|519896266|FG001|Overall Study|Lost to Follow-up|2|||
144191553|NCT02139124|519896267|FG002|Overall Study|Lost to Follow-up|0|||
144191554|NCT02139124|519896268|FG003|Overall Study|Lost to Follow-up|5|||
144442078|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442079|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
144442080|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442081|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442082|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
144442083|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442084|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144442085|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442086|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442087|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442088|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442089|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442090|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442091|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442092|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442093|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442094|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442095|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442096|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442097|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442098|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442099|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442100|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442101|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442102|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442103|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442104|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442105|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442106|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
144442107|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442108|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
144442109|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442110|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442111|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442112|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442113|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442114|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442115|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442116|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442117|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442118|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442119|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442120|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442121|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442122|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442123|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144531489|NCT04230681|521147996|FG001|Overall Study|IV inadvertently removed|1|||
144191555|NCT02139124|519896269|FG004|Overall Study|Lost to Follow-up|4|||
144191556|NCT02691741|519896270|FG000|Overall Study|Adverse Event|0|||
144724737|NCT03365947|521846480|FG006|Overall Study|Lost to Follow-up|0|||
144724738|NCT03365947|521846481|FG007|Overall Study|Lost to Follow-up|0|||
144191557|NCT02691741|519896271|FG001|Overall Study|Adverse Event|2|||
144191558|NCT02691741|519896270|FG000|Overall Study|Lost to Follow-up|1|||
144191559|NCT02691741|519896271|FG001|Overall Study|Lost to Follow-up|0|||
144191560|NCT02691741|519896270|FG000|Overall Study|Physician Decision|0|||
144191561|NCT02691741|519896271|FG001|Overall Study|Physician Decision|1|||
144442124|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442125|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442126|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
144191562|NCT02691741|519896270|FG000|Overall Study|Withdrawal by Subject|0|||
144442127|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
144531490|NCT03106740|521148980|FG000|Overall Study|Lost to Follow-up|2|||
144724739|NCT03365947|521846482|FG008|Overall Study|Lost to Follow-up|0|||
144253572|NCT02279745|520128138|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
144442128|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
144442129|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144442130|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
144442131|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
144442132|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
144442133|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442134|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442135|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442136|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442137|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442138|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442139|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442140|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442141|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442142|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442143|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442144|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442145|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442146|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442147|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442148|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442149|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442150|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442151|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
144442152|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
144442153|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144442154|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
144442155|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
144442156|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
144442157|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442158|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442159|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442160|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144253573|NCT03469999|520128139|FG000|Overall Study|Lost to Follow-up|2|||
144442161|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442162|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442163|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442164|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442165|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442166|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442167|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442168|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442169|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442170|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442171|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442172|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144531491|NCT03106740|521148981|FG001|Overall Study|Lost to Follow-up|2|||
144531492|NCT03106740|521148980|FG000|Overall Study|Withdrawal by Subject|2|||
144531493|NCT03106740|521148981|FG001|Overall Study|Withdrawal by Subject|4|||
144531494|NCT03106740|521148980|FG000|Overall Study|Physician Decision|0|||
144531495|NCT03106740|521148981|FG001|Overall Study|Physician Decision|1|||
144531496|NCT03106740|521148980|FG000|Overall Study|Partial data|1|||
144531497|NCT03106740|521148981|FG001|Overall Study|Partial data|0|||
144531498|NCT04565990|521148982|FG000|Overall Study|Death|5|||
144531499|NCT04565990|521148982|FG000|Overall Study|Lost to Follow-up|1|||
144531500|NCT04565990|521148982|FG000|Overall Study|Withdrawal by Subject|1|||
144531501|NCT04797858|521148983|FG000|Overall Study|Withdrawal by Subject|0|||
144531502|NCT04797858|521148984|FG001|Overall Study|Withdrawal by Subject|1|||
144531503|NCT04797858|521148983|FG000|Overall Study|Excluded due to administrative error|7|||
144531504|NCT04797858|521148984|FG001|Overall Study|Excluded due to administrative error|8|||
144531505|NCT04414722|521148990|FG000|Overall Study|Lost to Follow-up|3|||
144531506|NCT04414722|521148991|FG001|Overall Study|Lost to Follow-up|4|||
144531507|NCT04414722|521148992|FG002|Overall Study|Lost to Follow-up|3|||
144531508|NCT04414722|521148993|FG003|Overall Study|Lost to Follow-up|2|||
144442173|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442174|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442175|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
144442176|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442177|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
144442178|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
144442179|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
144442180|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
144442181|NCT02346240|520820089|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442182|NCT02346240|520820090|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442183|NCT02346240|520820091|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442184|NCT02346240|520820092|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442185|NCT02346240|520820093|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442186|NCT02346240|520820094|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442187|NCT02346240|520820095|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442188|NCT02346240|520820096|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442189|NCT02346240|520820097|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442190|NCT02346240|520820098|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442191|NCT02346240|520820099|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442192|NCT02346240|520820100|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442193|NCT02346240|520820101|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442194|NCT02346240|520820102|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442195|NCT02346240|520820103|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442196|NCT02346240|520820104|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442197|NCT02346240|520820105|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442198|NCT02346240|520820106|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442199|NCT02346240|520820107|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
144442200|NCT02346240|520820108|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144191563|NCT02691741|519896271|FG001|Overall Study|Withdrawal by Subject|4|||
144442201|NCT02346240|520820109|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442202|NCT02346240|520820110|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442203|NCT02346240|520820111|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442204|NCT02346240|520820112|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
144442205|NCT01573624|520820113|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
144442206|NCT01573624|520820114|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
144442207|NCT01573624|520820115|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
144442208|NCT01573624|520820116|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
144442209|NCT01573624|520820117|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
144442210|NCT01573624|520820118|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
144442211|NCT01573624|520820119|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
144442212|NCT01573624|520820113|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
144442213|NCT01573624|520820114|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
144442214|NCT01573624|520820115|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
144442215|NCT01573624|520820116|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
144531509|NCT04414722|521148994|FG004|Overall Study|Lost to Follow-up|3|||
144531510|NCT04414722|521148990|FG000|Overall Study|Withdrawal by Subject|6|||
144531511|NCT04414722|521148991|FG001|Overall Study|Withdrawal by Subject|3|||
144531512|NCT04414722|521148992|FG002|Overall Study|Withdrawal by Subject|1|||
144531513|NCT04414722|521148993|FG003|Overall Study|Withdrawal by Subject|5|||
144531514|NCT04414722|521148994|FG004|Overall Study|Withdrawal by Subject|1|||
144531515|NCT04414722|521148990|FG000|Overall Study|Physician Decision|0|||
144531516|NCT04414722|521148991|FG001|Overall Study|Physician Decision|1|||
144191564|NCT03069417|519896272|FG000|Overall Study|Lost to Follow-up|2|||
144531517|NCT04414722|521148992|FG002|Overall Study|Physician Decision|2|||
144531518|NCT04414722|521148993|FG003|Overall Study|Physician Decision|0|||
144531519|NCT04414722|521148994|FG004|Overall Study|Physician Decision|0|||
144531520|NCT04414722|521148990|FG000|Overall Study|Non-participatory|0|||
144191565|NCT03069417|519896273|FG001|Overall Study|Lost to Follow-up|0|||
144442216|NCT01573624|520820117|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
144442217|NCT01573624|520820118|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
144442218|NCT01573624|520820119|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
144442219|NCT01573624|520820113|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
144531521|NCT04414722|521148991|FG001|Overall Study|Non-participatory|1|||
144531522|NCT04414722|521148992|FG002|Overall Study|Non-participatory|1|||
144531523|NCT04414722|521148993|FG003|Overall Study|Non-participatory|0|||
144442220|NCT01573624|520820114|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
144442221|NCT01573624|520820115|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
144442222|NCT01573624|520820116|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
144442223|NCT01573624|520820117|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
144442224|NCT01573624|520820118|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
144442225|NCT01573624|520820119|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
144442226|NCT01573624|520820113|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144442227|NCT01573624|520820114|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144442228|NCT01573624|520820115|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144442229|NCT01573624|520820116|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144442230|NCT01573624|520820117|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144442231|NCT01573624|520820118|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
144442232|NCT01573624|520820119|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144442233|NCT01573624|520820113|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
144442234|NCT01573624|520820114|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
144442235|NCT01573624|520820115|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
144442236|NCT01573624|520820116|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
144442237|NCT01573624|520820117|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
144442238|NCT01573624|520820118|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
144442239|NCT01573624|520820119|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
144442240|NCT01573624|520820113|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
144442241|NCT01573624|520820114|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
144442242|NCT01573624|520820115|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
144442243|NCT01573624|520820116|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
144442244|NCT01573624|520820117|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
144442245|NCT01573624|520820118|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
144442246|NCT01573624|520820119|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
144442247|NCT01573624|520820113|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
144442248|NCT01573624|520820114|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
144442249|NCT01573624|520820115|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
144442250|NCT01573624|520820116|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
144531524|NCT04414722|521148994|FG004|Overall Study|Non-participatory|0|||
144531525|NCT04766892|521148996|FG000|Overall Study|Withdrawal by Subject|1|||
144531526|NCT04766892|521148996|FG000|Overall Study|Lost to Follow-up|1|||
144531527|NCT04766892|521148996|FG000|Overall Study|Adverse Event|3|||
144531528|NCT04766892|521148996|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
144531529|NCT05906784|521148997|FG000|Overall Study|Lost to Follow-up|2|||
144531530|NCT05906784|521148998|FG001|Overall Study|Lost to Follow-up|1|||
144531531|NCT05906784|521148999|FG002|Overall Study|Lost to Follow-up|1|||
144531532|NCT05906784|521149000|FG003|Overall Study|Lost to Follow-up|1|||
144531533|NCT03476343|521149014|FG000|Overall Study|Clinical exam moved to another scanner|7|||
144531534|NCT03476343|521149014|FG000|Overall Study|Clinical order cancelled|4|||
144531535|NCT03476343|521149014|FG000|Overall Study|Neonate did not settle down for the scan|1|||
144531536|NCT04820322|521149019|FG000|Overall Study|Adverse Event|1|||
144531537|NCT04820322|521149020|FG001|Overall Study|Adverse Event|0|||
144531538|NCT03181516|521149021|FG000|Overall Study|Withdrawal by Subject|14|||
144531539|NCT03181516|521149022|FG001|Overall Study|Withdrawal by Subject|7|||
144531540|NCT03181516|521149021|FG000|Overall Study|Lost to Follow-up|2|||
144442251|NCT01573624|520820117|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
144442252|NCT01573624|520820118|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
144442253|NCT01573624|520820119|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
144442254|NCT01573624|520820113|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
144442255|NCT01573624|520820114|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144531541|NCT03181516|521149022|FG001|Overall Study|Lost to Follow-up|2|||
144531542|NCT05715528|521149025|FG000|Overall Study|Randomized but never treated|11|||
144531543|NCT05715528|521149026|FG001|Overall Study|Randomized but never treated|13|||
144531544|NCT05715528|521149025|FG000|Overall Study|Withdrew consent|7|||
144531545|NCT05715528|521149026|FG001|Overall Study|Withdrew consent|15|||
144531546|NCT05715528|521149025|FG000|Overall Study|Lost to Follow-up|5|||
144531547|NCT05715528|521149026|FG001|Overall Study|Lost to Follow-up|13|||
144531548|NCT05715528|521149025|FG000|Overall Study|Investigator's discretion|3|||
144442256|NCT01573624|520820115|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
144442257|NCT01573624|520820116|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
144442258|NCT01573624|520820117|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144442259|NCT01573624|520820118|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144531549|NCT05715528|521149026|FG001|Overall Study|Investigator's discretion|1|||
144531550|NCT05715528|521149025|FG000|Overall Study|Protocol Violation|2|||
144531551|NCT05715528|521149026|FG001|Overall Study|Protocol Violation|0|||
144531552|NCT05715528|521149025|FG000|Overall Study|Non-compliance with study drug|0|||
144531553|NCT05715528|521149026|FG001|Overall Study|Non-compliance with study drug|1|||
144531554|NCT03118518|521149027|FG000|Overall Study|Early Exit after treatment|2|||
144531555|NCT03118518|521149028|FG001|Overall Study|Early Exit after treatment|8|||
144531556|NCT03118518|521149027|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
144531557|NCT03118518|521149028|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
144531558|NCT02998528|521149034|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
144531559|NCT02998528|521149035|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
144531560|NCT02998528|521149036|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
144531561|NCT02998528|521149034|FG000|Randomization Period|Participant withdrew consent|0|||
144531562|NCT02998528|521149035|FG001|Randomization Period|Participant withdrew consent|3|||
144531563|NCT02998528|521149036|FG002|Randomization Period|Participant withdrew consent|0|||
144605394|NCT00766090|521417078|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605395|NCT00766090|521417079|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605396|NCT00766090|521417080|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605397|NCT00766090|521417081|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605398|NCT00766090|521417082|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
144605399|NCT00766090|521417083|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605400|NCT00766090|521417084|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605401|NCT00766090|521417085|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605402|NCT00766090|521417086|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605403|NCT00766090|521417087|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605404|NCT00766090|521417088|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605405|NCT00766090|521417089|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
144605406|NCT01230554|521417093|FG000|Overall Study|Lost to Follow-up|2|||
144605407|NCT01230554|521417093|FG000|Overall Study|Inability to maintain visit schedule|1|||
144605408|NCT01289821|521417094|FG000|Treatment Period|Withdrawal by Subject|1|||
144605409|NCT01289821|521417094|FG000|Treatment Period|Physician Decision|3|||
144605410|NCT01289821|521417094|FG000|Treatment Period|Adverse Event|4|||
144605411|NCT01289821|521417094|FG000|Treatment Period|Radiological Progression|43|||
144605412|NCT01289821|521417094|FG000|Treatment Period|Clinical Progression|2|||
144605413|NCT01289821|521417094|FG000|Treatment Period|Therapeutic procedure required|1|||
144605414|NCT01289821|521417094|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
144605415|NCT01289821|521417094|FG000|Safety Follow-up Period|Protocol Violation|3|||
144605416|NCT01289821|521417094|FG000|Safety Follow-up Period|Unspecified reason|1|||
144605417|NCT01289821|521417094|FG000|Survival Follow-up Period|Protocol Violation|1|||
144605418|NCT01289821|521417094|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
144605419|NCT01289821|521417094|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
144605420|NCT03061175|521417111|FG000|Baseline|Participant was deemed ineligible|1|||
144605421|NCT03061175|521417112|FG001|Baseline|Participant was deemed ineligible|0|||
144605422|NCT03061175|521417111|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
144605423|NCT03061175|521417112|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
144605424|NCT03061175|521417111|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
144605425|NCT03061175|521417112|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
144605426|NCT03061175|521417111|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
144605427|NCT03061175|521417112|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
144605428|NCT03044249|521417113|FG000|Overall Study|Adverse Event|4|||
144605429|NCT03044249|521417114|FG001|Overall Study|Adverse Event|9|||
144605430|NCT03044249|521417113|FG000|Overall Study|Lost to Follow-up|1|||
144605431|NCT03044249|521417114|FG001|Overall Study|Lost to Follow-up|0|||
144605432|NCT03044249|521417113|FG000|Overall Study|Non-compliance with Study Drug|1|||
144605433|NCT03044249|521417114|FG001|Overall Study|Non-compliance with Study Drug|0|||
144605434|NCT03044249|521417113|FG000|Overall Study|Study Terminated by Sponsor|2|||
144605435|NCT03044249|521417114|FG001|Overall Study|Study Terminated by Sponsor|0|||
144605436|NCT03044249|521417113|FG000|Overall Study|Withdrawal by Subject|2|||
144605437|NCT03044249|521417114|FG001|Overall Study|Withdrawal by Subject|5|||
144605438|NCT04166383|521417116|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
144605439|NCT04166383|521417116|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
144605440|NCT04166383|521417116|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
144531564|NCT02998528|521149034|FG000|Randomization Period|Participant no longer meets study criteria|1|||
144605441|NCT03044886|521417118|FG000|Overall Study|Lost to Follow-up|15|||
144605442|NCT03044886|521417119|FG001|Overall Study|Lost to Follow-up|10|||
144605443|NCT03044886|521417120|FG002|Overall Study|Lost to Follow-up|12|||
144605444|NCT00732251|521417127|FG000|Overall Study|Lost to Follow-up|3|||
144605445|NCT00732251|521417127|FG000|Overall Study|Withdrawal by Subject|3|||
144531565|NCT02998528|521149035|FG001|Randomization Period|Participant no longer meets study criteria|3|||
144531566|NCT02998528|521149036|FG002|Randomization Period|Participant no longer meets study criteria|2|||
144531567|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
144724740|NCT03365947|521846483|FG009|Overall Study|Lost to Follow-up|0|||
144442260|NCT01573624|520820119|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
144442261|NCT01573624|520820113|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
144442262|NCT01573624|520820114|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
144442263|NCT01573624|520820115|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
144442264|NCT01573624|520820116|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
144442265|NCT01573624|520820117|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
144442266|NCT01573624|520820118|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
144442267|NCT01573624|520820119|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
144442268|NCT01573624|520820113|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144442269|NCT01573624|520820114|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144442270|NCT01573624|520820115|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144442271|NCT01573624|520820116|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
144442272|NCT01573624|520820117|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144442273|NCT01573624|520820118|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
144442274|NCT01573624|520820119|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
144442275|NCT01573624|520820113|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442276|NCT01573624|520820114|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442277|NCT01573624|520820115|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442278|NCT01573624|520820116|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442279|NCT01573624|520820117|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442280|NCT01573624|520820118|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442281|NCT01573624|520820119|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442282|NCT01573624|520820113|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
144442283|NCT01573624|520820114|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
144442284|NCT01573624|520820115|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
144442285|NCT01573624|520820116|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
144442286|NCT01573624|520820117|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
144442287|NCT01573624|520820118|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
144442288|NCT01573624|520820119|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
144442289|NCT01573624|520820113|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
144442290|NCT01573624|520820114|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
144442291|NCT01573624|520820115|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
144442292|NCT01573624|520820116|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
144442293|NCT01573624|520820117|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
144442294|NCT01573624|520820118|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
144442295|NCT01573624|520820119|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
144442296|NCT01573624|520820113|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
144442297|NCT01573624|520820114|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
144442298|NCT01573624|520820115|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
144442299|NCT01573624|520820116|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
144442300|NCT01573624|520820117|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
144442301|NCT01573624|520820118|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
144442302|NCT01573624|520820119|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
144442303|NCT01573624|520820113|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144442304|NCT01573624|520820114|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
144442305|NCT01573624|520820115|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
144442306|NCT01573624|520820116|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144442307|NCT01573624|520820117|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144442308|NCT01573624|520820118|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
144442309|NCT01573624|520820119|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144442310|NCT01573624|520820113|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
144442311|NCT01573624|520820114|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
144531568|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
144531569|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
144531570|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
144531571|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
144531572|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
144531573|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
144531574|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
144531575|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
144531576|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
144191566|NCT03069417|519896272|FG000|Overall Study|Reason Unknown|4|||
144191567|NCT03069417|519896273|FG001|Overall Study|Reason Unknown|7|||
144191568|NCT00402025|519896274|FG000|Overall Study|Adverse Event|0|||
144191569|NCT00402025|519896275|FG001|Overall Study|Adverse Event|0|||
144191570|NCT00402025|519896276|FG002|Overall Study|Adverse Event|2|||
144191571|NCT00402025|519896274|FG000|Overall Study|Death|0|||
144191572|NCT00402025|519896275|FG001|Overall Study|Death|1|||
144191573|NCT00402025|519896276|FG002|Overall Study|Death|5|||
144191574|NCT00402025|519896274|FG000|Overall Study|Disease Progression|1|||
144191575|NCT00402025|519896275|FG001|Overall Study|Disease Progression|1|||
144191576|NCT00402025|519896276|FG002|Overall Study|Disease Progression|2|||
144191577|NCT00402025|519896274|FG000|Overall Study|Physician Decision|1|||
144191578|NCT00402025|519896275|FG001|Overall Study|Physician Decision|1|||
144191579|NCT00402025|519896276|FG002|Overall Study|Physician Decision|0|||
144191580|NCT00402025|519896274|FG000|Overall Study|Participant Decision|0|||
144191581|NCT00402025|519896275|FG001|Overall Study|Participant Decision|0|||
144191582|NCT00402025|519896276|FG002|Overall Study|Participant Decision|1|||
144191583|NCT03064438|519898302|FG000|Overall Study|Lost to Follow-up|1|||
144191584|NCT03064438|519898303|FG001|Overall Study|Lost to Follow-up|0|||
144191585|NCT03064438|519898302|FG000|Overall Study|Withdrawal by Subject|0|||
144191586|NCT03064438|519898303|FG001|Overall Study|Withdrawal by Subject|1|||
144191587|NCT02658487|519898308|FG000|Overall Study|Death|2|||
144191588|NCT02658487|519898308|FG000|Overall Study|Disease progression|10|||
144191589|NCT02658487|519898308|FG000|Overall Study|Alternative therapy|1|||
144191590|NCT02658487|519898308|FG000|Overall Study|Adverse Event|1|||
144191591|NCT02658487|519898308|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
144191592|NCT02658487|519898308|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
144191593|NCT01647958|519898309|FG000|Initial Study|Lost to Follow-up|2|||
144191594|NCT01647958|519898310|FG001|Initial Study|Lost to Follow-up|3|||
144191595|NCT01647958|519898309|FG000|Continuation Phase|treatment received during Overall Study|39|||
144191596|NCT01647958|519898310|FG001|Continuation Phase|treatment received during Overall Study|0|||
144191597|NCT01647958|519898309|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
144191598|NCT01647958|519898310|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
144442312|NCT01573624|520820115|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
144442313|NCT01573624|520820116|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
144442314|NCT01573624|520820117|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
144442315|NCT01573624|520820118|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
144442316|NCT01573624|520820119|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
144442317|NCT01573624|520820113|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
144442318|NCT01573624|520820114|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
144442319|NCT01573624|520820115|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
144442320|NCT01573624|520820116|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
144442321|NCT01573624|520820117|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
144442322|NCT01573624|520820118|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
144442323|NCT01573624|520820119|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
144442324|NCT01573624|520820113|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
144442325|NCT01573624|520820114|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
144442326|NCT01573624|520820115|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
144442327|NCT01573624|520820116|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
144442328|NCT01573624|520820117|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
144442329|NCT01573624|520820118|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
144442330|NCT01573624|520820119|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
144442331|NCT01573624|520820113|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
144531577|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
144531578|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
144531579|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
144531580|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
144531581|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
144531582|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Death|1|||
144531583|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Death|0|||
144531584|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Death|0|||
144531585|NCT02998528|521149034|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
144531586|NCT02998528|521149035|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
144531587|NCT02998528|521149036|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
144191599|NCT02676284|519898311|FG000|Overall Study|Withdrawal by Subject|1|||
144191600|NCT00708708|519898313|FG000|Overall Study|Another therapy instead of Enbrel|141|||
144191601|NCT00708708|519898313|FG000|Overall Study|Lost to Follow-up|52|||
144191602|NCT00708708|519898313|FG000|Overall Study|Withdrawal by Subject|51|||
144191603|NCT00708708|519898313|FG000|Overall Study|Intolerance|42|||
144191604|NCT00708708|519898313|FG000|Overall Study|Another therapy along with Enbrel|15|||
144191605|NCT00708708|519898313|FG000|Overall Study|Other unspecified|11|||
144442332|NCT01573624|520820114|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
144442333|NCT01573624|520820115|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
144442334|NCT01573624|520820116|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
144442335|NCT01573624|520820117|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
144442336|NCT01573624|520820118|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
144442337|NCT01573624|520820119|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
144442338|NCT01573624|520820113|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
144442339|NCT01573624|520820114|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
144442340|NCT01573624|520820115|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
144442341|NCT01573624|520820116|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
144442342|NCT01573624|520820117|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
144442343|NCT01573624|520820118|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
144442344|NCT01573624|520820119|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
144442345|NCT01573624|520820113|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144442346|NCT01573624|520820114|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144442347|NCT01573624|520820115|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144442348|NCT01573624|520820116|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144442349|NCT01573624|520820117|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
144442350|NCT01573624|520820118|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
144442351|NCT01573624|520820119|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
144442352|NCT01573624|520820113|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442353|NCT01573624|520820114|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442354|NCT01573624|520820115|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442355|NCT01573624|520820116|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442356|NCT01573624|520820117|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442357|NCT01573624|520820118|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
144442358|NCT01573624|520820119|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
144442359|NCT01573624|520820113|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
144442360|NCT01573624|520820114|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144442361|NCT01573624|520820115|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144442362|NCT01573624|520820116|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144442363|NCT01573624|520820117|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
144442364|NCT01573624|520820118|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
144442365|NCT01573624|520820119|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
144442366|NCT01573624|520820113|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
144442367|NCT01573624|520820114|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
144442368|NCT01573624|520820115|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
144442369|NCT01573624|520820116|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
144442370|NCT01573624|520820117|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
144442371|NCT01573624|520820118|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
144442372|NCT01573624|520820119|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
144442373|NCT01573624|520820113|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
144442374|NCT01573624|520820114|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
144442375|NCT01573624|520820115|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
144442376|NCT01573624|520820116|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
144442377|NCT01573624|520820117|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
144442378|NCT01573624|520820118|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
144442379|NCT01573624|520820119|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
144442380|NCT01573624|520820113|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
144442381|NCT01573624|520820114|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
144442382|NCT01573624|520820115|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
144442383|NCT01573624|520820116|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
144442384|NCT01573624|520820117|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
144442385|NCT01573624|520820118|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
144442386|NCT01573624|520820119|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
144442387|NCT01573624|520820113|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
144442388|NCT01573624|520820114|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
144442389|NCT01573624|520820115|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
144442390|NCT01573624|520820116|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
144531588|NCT02998528|521149034|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
144531589|NCT02998528|521149035|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
144531590|NCT02998528|521149036|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
144442391|NCT01573624|520820117|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
144442392|NCT01573624|520820118|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
144442393|NCT01573624|520820119|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
144442394|NCT02519712|520820121|FG000|Overall Study|Disease Relapse|1|||
144442395|NCT02519712|520820121|FG000|Overall Study|Disease Progression|1|||
144442396|NCT02519712|520820121|FG000|Overall Study|Accruals are donors|2|||
144442397|NCT01524770|520820123|FG000|First Intervention|Withdrawal by Subject|1|||
144442398|NCT01524770|520820124|FG001|First Intervention|Withdrawal by Subject|0|||
144442399|NCT01524770|520820123|FG000|First Intervention|Adverse Event|1|||
144442400|NCT01524770|520820124|FG001|First Intervention|Adverse Event|1|||
144442401|NCT01524770|520820123|FG000|First Intervention|Protocol Violation|1|||
144442402|NCT01524770|520820124|FG001|First Intervention|Protocol Violation|0|||
144442403|NCT02167256|520820126|FG000|Overall Study|Adverse Event|13|||
144442404|NCT02167256|520820127|FG001|Overall Study|Adverse Event|6|||
144442405|NCT02167256|520820126|FG000|Overall Study|Withdrawal by Subject|4|||
144442406|NCT02167256|520820127|FG001|Overall Study|Withdrawal by Subject|4|||
144442407|NCT02167256|520820126|FG000|Overall Study|non-compliance|3|||
144442408|NCT02167256|520820127|FG001|Overall Study|non-compliance|0|||
144442409|NCT02167256|520820126|FG000|Overall Study|Study partner unable to participate|1|||
144442410|NCT02167256|520820127|FG001|Overall Study|Study partner unable to participate|0|||
144442411|NCT01387607|520820135|FG000|Overall Study|Adverse Event|23|||
144442412|NCT01387607|520820136|FG001|Overall Study|Adverse Event|11|||
144442413|NCT01387607|520820135|FG000|Overall Study|Lack of Efficacy|8|||
144442414|NCT01387607|520820136|FG001|Overall Study|Lack of Efficacy|6|||
144442415|NCT01387607|520820135|FG000|Overall Study|Lost to Follow-up|2|||
144442416|NCT01387607|520820136|FG001|Overall Study|Lost to Follow-up|1|||
144442417|NCT01387607|520820135|FG000|Overall Study|No longer meets eligibility criteria|0|||
144442418|NCT01387607|520820136|FG001|Overall Study|No longer meets eligibility criteria|1|||
144442419|NCT01387607|520820135|FG000|Overall Study|Protocol Violation|1|||
144442420|NCT01387607|520820136|FG001|Overall Study|Protocol Violation|5|||
144442421|NCT01387607|520820135|FG000|Overall Study|Withdrawal by Subject|13|||
144442422|NCT01387607|520820136|FG001|Overall Study|Withdrawal by Subject|14|||
144442423|NCT01387607|520820135|FG000|Overall Study|Other|1|||
144442424|NCT01387607|520820136|FG001|Overall Study|Other|1|||
144442425|NCT01387607|520820135|FG000|Overall Study|Randomized, not treated|3|||
144442426|NCT01387607|520820136|FG001|Overall Study|Randomized, not treated|6|||
144442427|NCT00689481|520820138|FG000|Overall Study|Adverse Event|7|||
144442428|NCT00689481|520820139|FG001|Overall Study|Adverse Event|1|||
144605446|NCT00732251|521417127|FG000|Overall Study|Early Term due to Site Closure|1|||
144605447|NCT00805025|521417128|FG000|Overall Study|Screened but not enrolled/treated|42|||
144605448|NCT00805025|521417128|FG000|Overall Study|Adverse Event|4|||
144605449|NCT00805025|521417128|FG000|Overall Study|Withdrawal by Subject|2|||
144605450|NCT00805025|521417128|FG000|Overall Study|Physician Decision|1|||
144605451|NCT03007979|521417132|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
144605452|NCT00232141|521417133|FG000|Overall Study|Adverse Event|9|||
144605453|NCT00232141|521417134|FG001|Overall Study|Adverse Event|4|||
144605454|NCT00232141|521417133|FG000|Overall Study|Lack of Efficacy|0|||
144605455|NCT00232141|521417134|FG001|Overall Study|Lack of Efficacy|3|||
144724741|NCT03365947|521846484|FG010|Overall Study|Lost to Follow-up|0|||
144724742|NCT03365947|521846485|FG011|Overall Study|Lost to Follow-up|0|||
144724743|NCT03365947|521846486|FG012|Overall Study|Lost to Follow-up|0|||
144724744|NCT03365947|521846487|FG013|Overall Study|Lost to Follow-up|0|||
144724745|NCT03365947|521846488|FG014|Overall Study|Lost to Follow-up|0|||
144724746|NCT03365947|521846489|FG015|Overall Study|Lost to Follow-up|0|||
144724747|NCT03365947|521846490|FG016|Overall Study|Lost to Follow-up|0|||
144724748|NCT03365947|521846491|FG017|Overall Study|Lost to Follow-up|0|||
144724749|NCT03365947|521846492|FG018|Overall Study|Lost to Follow-up|0|||
144724750|NCT02518685|521846493|FG000|Overall Study|Adverse Event|29|||
144442429|NCT00689481|520820138|FG000|Overall Study|Lost to Follow-up|4|||
144442430|NCT00689481|520820139|FG001|Overall Study|Lost to Follow-up|3|||
144442431|NCT00689481|520820138|FG000|Overall Study|Lack of Efficacy|4|||
144442432|NCT00689481|520820139|FG001|Overall Study|Lack of Efficacy|3|||
144191606|NCT00708708|519898313|FG000|Overall Study|Good effectiveness|9|||
144253574|NCT04424914|520128140|FG000|Overall Study|Other|0|||
144442433|NCT00689481|520820138|FG000|Overall Study|Non-compliance with study treatment|1|||
144442434|NCT00689481|520820139|FG001|Overall Study|Non-compliance with study treatment|1|||
144442435|NCT00689481|520820138|FG000|Overall Study|Withdrawal by Subject|8|||
144442436|NCT00689481|520820139|FG001|Overall Study|Withdrawal by Subject|4|||
144442437|NCT00689481|520820138|FG000|Overall Study|Excluded medication started during study|0|||
144442438|NCT00689481|520820139|FG001|Overall Study|Excluded medication started during study|1|||
144442439|NCT00689481|520820138|FG000|Overall Study|Subject early term, left on vacation|0|||
144442440|NCT00689481|520820139|FG001|Overall Study|Subject early term, left on vacation|1|||
144442441|NCT03091192|520820142|FG000|Overall Study|Study terminated by sponsor|21|||
144442442|NCT03091192|520820143|FG001|Overall Study|Study terminated by sponsor|14|||
144442443|NCT03091192|520820142|FG000|Overall Study|Death|9|||
144605456|NCT00232141|521417133|FG000|Overall Study|Lost to Follow-up|9|||
144724751|NCT02518685|521846494|FG001|Overall Study|Adverse Event|1|||
144442444|NCT03091192|520820143|FG001|Overall Study|Death|13|||
144442445|NCT03091192|520820142|FG000|Overall Study|Withdrawal by Subject|2|||
144442446|NCT03091192|520820143|FG001|Overall Study|Withdrawal by Subject|0|||
144442447|NCT03091192|520820142|FG000|Overall Study|Lost to Follow-up|1|||
144442448|NCT03091192|520820143|FG001|Overall Study|Lost to Follow-up|0|||
144442449|NCT05645432|520820144|FG000|Overall Study|Withdrawal by Subject|1|||
144442450|NCT03195478|520820145|FG000|Overall Study|Disease Progression|5|||
144442451|NCT03195478|520820146|FG001|Overall Study|Disease Progression|4|||
144442452|NCT03195478|520820147|FG002|Overall Study|Disease Progression|6|||
144442453|NCT03195478|520820148|FG003|Overall Study|Disease Progression|1|||
144442454|NCT03195478|520820145|FG000|Overall Study|Study Drug Toxicity|2|||
144442455|NCT03195478|520820146|FG001|Overall Study|Study Drug Toxicity|0|||
144442456|NCT03195478|520820147|FG002|Overall Study|Study Drug Toxicity|0|||
144442457|NCT03195478|520820148|FG003|Overall Study|Study Drug Toxicity|1|||
144442458|NCT03195478|520820145|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
144442459|NCT03195478|520820146|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
144442460|NCT03195478|520820147|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
144442461|NCT03195478|520820148|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
144442462|NCT03195478|520820145|FG000|Overall Study|Participant Withdrew Consent|1|||
144442463|NCT03195478|520820146|FG001|Overall Study|Participant Withdrew Consent|0|||
144442464|NCT03195478|520820147|FG002|Overall Study|Participant Withdrew Consent|0|||
144442465|NCT03195478|520820148|FG003|Overall Study|Participant Withdrew Consent|0|||
144442466|NCT03195478|520820145|FG000|Overall Study|Maximum Clinical benefit|0|||
144442467|NCT03195478|520820146|FG001|Overall Study|Maximum Clinical benefit|0|||
144442468|NCT03195478|520820147|FG002|Overall Study|Maximum Clinical benefit|1|||
144442469|NCT03195478|520820148|FG003|Overall Study|Maximum Clinical benefit|0|||
144442470|NCT03195478|520820145|FG000|Overall Study|Other Reasons|0|||
144442471|NCT03195478|520820146|FG001|Overall Study|Other Reasons|0|||
144442472|NCT03195478|520820147|FG002|Overall Study|Other Reasons|1|||
144531591|NCT02998528|521149034|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
144531592|NCT02998528|521149035|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
144531593|NCT02998528|521149036|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
144531594|NCT02998528|521149034|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
144531595|NCT02998528|521149035|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
144531596|NCT02998528|521149036|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
144531597|NCT02998528|521149034|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
144531598|NCT02998528|521149035|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
144531599|NCT02998528|521149036|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
144531600|NCT02998528|521149034|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
144531601|NCT02998528|521149035|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
144531602|NCT02998528|521149036|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
144531603|NCT05035654|521149039|FG000|Overall Study|Physician Decision|0|||
144531604|NCT05035654|521149040|FG001|Overall Study|Physician Decision|1|||
144531605|NCT05035654|521149041|FG002|Overall Study|Physician Decision|0|||
144531606|NCT05035654|521149039|FG000|Overall Study|Adverse Event|0|||
144531607|NCT05035654|521149040|FG001|Overall Study|Adverse Event|1|||
144531608|NCT05035654|521149041|FG002|Overall Study|Adverse Event|0|||
144531609|NCT05035654|521149039|FG000|Overall Study|Withdrawal by Subject|0|||
144531610|NCT05035654|521149040|FG001|Overall Study|Withdrawal by Subject|0|||
144531611|NCT05035654|521149041|FG002|Overall Study|Withdrawal by Subject|4|||
144531612|NCT05035654|521149039|FG000|Overall Study|Bilateral Dislodgement|1|||
144531613|NCT05035654|521149040|FG001|Overall Study|Bilateral Dislodgement|0|||
144531614|NCT05035654|521149041|FG002|Overall Study|Bilateral Dislodgement|0|||
144605457|NCT00232141|521417134|FG001|Overall Study|Lost to Follow-up|6|||
144605458|NCT00232141|521417133|FG000|Overall Study|Other|8|||
144605459|NCT00232141|521417134|FG001|Overall Study|Other|10|||
144605460|NCT00232141|521417133|FG000|Overall Study|Withdrawal by Subject|5|||
144605461|NCT00232141|521417134|FG001|Overall Study|Withdrawal by Subject|3|||
144442473|NCT03195478|520820148|FG003|Overall Study|Other Reasons|0|||
144442474|NCT03548584|520821892|FG000|Overall Study|Lost to Follow-up|0|||
144442475|NCT03548584|520821893|FG001|Overall Study|Lost to Follow-up|0|||
144442476|NCT03548584|520821894|FG002|Overall Study|Lost to Follow-up|1|||
144442477|NCT03548584|520821892|FG000|Overall Study|Adverse Event|1|||
144442478|NCT03548584|520821893|FG001|Overall Study|Adverse Event|11|||
144442479|NCT03548584|520821894|FG002|Overall Study|Adverse Event|5|||
144442480|NCT03548584|520821892|FG000|Overall Study|Site Terminated by Sponsor|1|||
144442481|NCT03548584|520821893|FG001|Overall Study|Site Terminated by Sponsor|3|||
144442482|NCT03548584|520821894|FG002|Overall Study|Site Terminated by Sponsor|2|||
144442483|NCT03548584|520821892|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
144531615|NCT04880733|521149042|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
144605462|NCT02273726|521417135|FG000|Overall Study|Death|70|||
144442484|NCT03548584|520821893|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
144605463|NCT02273726|521417136|FG001|Overall Study|Death|62|||
144191607|NCT00708708|519898313|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
144191608|NCT00708708|519898313|FG000|Overall Study|Administrative reasons|7|||
144191609|NCT00708708|519898313|FG000|Overall Study|Lack of effectiveness|4|||
144191610|NCT00708708|519898313|FG000|Overall Study|Lack of compliance|3|||
144191611|NCT00708708|519898313|FG000|Overall Study|Pregnancy|3|||
144191612|NCT00708708|519898313|FG000|Overall Study|Adverse Event|3|||
144191613|NCT00708708|519898313|FG000|Overall Study|Missing values|392|||
144191614|NCT01567826|519898317|FG000|Overall Study|Lost to Follow-up|3|||
144191615|NCT01567826|519898318|FG001|Overall Study|Lost to Follow-up|2|||
144191616|NCT00865098|519898324|FG000|Overall Study|Progressive disease|1|||
144191617|NCT01715896|519898325|FG000|Overall Study|Lost to Follow-up|0|||
144191618|NCT01715896|519898326|FG001|Overall Study|Lost to Follow-up|2|||
144191619|NCT01715896|519898325|FG000|Overall Study|Withdrawal by Subject|1|||
144191620|NCT01715896|519898326|FG001|Overall Study|Withdrawal by Subject|4|||
144191621|NCT01715896|519898325|FG000|Overall Study|Other|2|||
144191622|NCT01715896|519898326|FG001|Overall Study|Other|5|||
144191623|NCT03336242|519898332|FG000|Overall Study|Adverse Event|0|||
144191624|NCT03336242|519898333|FG001|Overall Study|Adverse Event|1|||
144191625|NCT00252174|519898337|FG000|Overall Study|Withdrawal by Subject|0|||
144191626|NCT00252174|519898338|FG001|Overall Study|Withdrawal by Subject|1|||
144191627|NCT00252174|519898339|FG002|Overall Study|Withdrawal by Subject|0|||
144191628|NCT02224573|519898340|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
144191629|NCT02224573|519898341|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
144191630|NCT02224573|519898340|FG000|Treatment Phase|Started on Other IMP|1|||
144191631|NCT02224573|519898341|FG001|Treatment Phase|Started on Other IMP|0|||
144191632|NCT02224573|519898340|FG000|Treatment Phase|Participant Discontinued IMP|0|||
144191633|NCT02224573|519898341|FG001|Treatment Phase|Participant Discontinued IMP|1|||
144191634|NCT02224573|519898340|FG000|Treatment Phase|Lack of Efficacy|15|||
144191635|NCT02224573|519898341|FG001|Treatment Phase|Lack of Efficacy|8|||
144191636|NCT02224573|519898340|FG000|Treatment Phase|Began Commercial Product|1|||
144191637|NCT02224573|519898341|FG001|Treatment Phase|Began Commercial Product|0|||
144191638|NCT02224573|519898340|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
144191639|NCT02224573|519898341|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
144191640|NCT02224573|519898340|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
144191641|NCT02224573|519898341|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
144191642|NCT02224573|519898340|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
144191643|NCT02224573|519898341|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
144191644|NCT02224573|519898340|FG000|Treatment Phase|Continued Compassionate Use|1|||
144191645|NCT02224573|519898341|FG001|Treatment Phase|Continued Compassionate Use|0|||
144191646|NCT02224573|519898340|FG000|Treatment Phase|Lack of Efficiency|2|||
144191647|NCT02224573|519898341|FG001|Treatment Phase|Lack of Efficiency|1|||
144191648|NCT02224573|519898340|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
144191649|NCT02224573|519898341|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
144191650|NCT02224573|519898340|FG000|Treatment Phase|Participant Moved|2|||
144191651|NCT02224573|519898341|FG001|Treatment Phase|Participant Moved|0|||
144191652|NCT02224573|519898340|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
144191653|NCT02224573|519898341|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
144191654|NCT02224573|519898340|FG000|Treatment Phase|Refused Medication|1|||
144191655|NCT02224573|519898341|FG001|Treatment Phase|Refused Medication|1|||
144442485|NCT03548584|520821894|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
144442486|NCT03548584|520821892|FG000|Overall Study|Lack of Efficacy|0|||
144442487|NCT03548584|520821893|FG001|Overall Study|Lack of Efficacy|1|||
144442488|NCT03548584|520821894|FG002|Overall Study|Lack of Efficacy|0|||
144442489|NCT03548584|520821892|FG000|Overall Study|Non-compliance with Study Drug|0|||
144442490|NCT03548584|520821893|FG001|Overall Study|Non-compliance with Study Drug|1|||
144442491|NCT03548584|520821894|FG002|Overall Study|Non-compliance with Study Drug|0|||
144442492|NCT03548584|520821892|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
144531616|NCT04880733|521149043|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
144531617|NCT04880733|521149044|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
144191656|NCT02224573|519898340|FG000|Treatment Phase|Adverse Event|26|||
144191657|NCT02224573|519898341|FG001|Treatment Phase|Adverse Event|38|||
144442493|NCT03548584|520821893|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
144442494|NCT03548584|520821894|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
144442495|NCT00533949|520821895|FG000|Overall Study|Protocol Violation|12|||
144531618|NCT04880733|521149042|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
144191658|NCT02224573|519898340|FG000|Treatment Phase|Placed in Group Home|0|||
144191659|NCT02224573|519898341|FG001|Treatment Phase|Placed in Group Home|1|||
144191660|NCT02224573|519898340|FG000|Treatment Phase|Pursued Other Trials|1|||
144191661|NCT02224573|519898341|FG001|Treatment Phase|Pursued Other Trials|0|||
144191662|NCT02224573|519898340|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
144191663|NCT02224573|519898341|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
144191664|NCT02224573|519898340|FG000|Treatment Phase|Lost to Follow-up|2|||
144191665|NCT02224573|519898341|FG001|Treatment Phase|Lost to Follow-up|1|||
144191666|NCT02224573|519898340|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
144191667|NCT02224573|519898341|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
144191668|NCT02224573|519898340|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
144191669|NCT02224573|519898341|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
144191670|NCT02224573|519898340|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
144191671|NCT02224573|519898341|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
144442496|NCT00533949|520821896|FG001|Overall Study|Protocol Violation|12|||
144442497|NCT00533949|520821897|FG002|Overall Study|Protocol Violation|9|||
144442498|NCT00533949|520821898|FG003|Overall Study|Protocol Violation|9|||
144442499|NCT00533949|520821895|FG000|Overall Study|Withdrawal by Subject|3|||
144442500|NCT00533949|520821896|FG001|Overall Study|Withdrawal by Subject|2|||
144442501|NCT00533949|520821897|FG002|Overall Study|Withdrawal by Subject|1|||
144442502|NCT00533949|520821898|FG003|Overall Study|Withdrawal by Subject|1|||
144442503|NCT00727194|520821899|FG000|Screening Period|Low QMG scores|0|||
144442504|NCT00727194|520821900|FG001|Screening Period|Low QMG scores|0|||
144442505|NCT00727194|520821901|FG002|Screening Period|Low QMG scores|6|||
144442506|NCT00727194|520821899|FG000|Screening Period|Lacked AChR antibodies|0|||
144442507|NCT00727194|520821900|FG001|Screening Period|Lacked AChR antibodies|0|||
144442508|NCT00727194|520821901|FG002|Screening Period|Lacked AChR antibodies|5|||
144442509|NCT00727194|520821899|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
144531619|NCT04880733|521149043|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
144605464|NCT02273726|521417135|FG000|Overall Study|Withdrawal by Subject|41|||
144191672|NCT02224573|519898340|FG000|Taper Phase|Adverse Event|1|||
144531620|NCT04880733|521149044|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
144531621|NCT04880733|521149042|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
144531622|NCT04880733|521149043|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
144531623|NCT04880733|521149044|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
144531624|NCT04880733|521149042|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
144531625|NCT04880733|521149043|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
144531626|NCT04880733|521149044|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
144531627|NCT04880733|521149042|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
144531628|NCT04880733|521149043|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
144531629|NCT04880733|521149044|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
144531630|NCT05533190|521149047|FG000|Overall Study|Lost to Follow-up|19|||
144531631|NCT05533190|521149048|FG001|Overall Study|Lost to Follow-up|7|||
144531632|NCT05533190|521149047|FG000|Overall Study|Failed to download app|1|||
144531633|NCT05533190|521149048|FG001|Overall Study|Failed to download app|0|||
144531634|NCT05533190|521149047|FG000|Overall Study|Thought app was a scam|1|||
144531635|NCT05533190|521149048|FG001|Overall Study|Thought app was a scam|0|||
144531636|NCT05533190|521149047|FG000|Overall Study|Withdrawal by Subject|2|||
144531637|NCT05533190|521149048|FG001|Overall Study|Withdrawal by Subject|0|||
144531638|NCT04934072|521149050|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
144531639|NCT04934072|521149051|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
144531640|NCT04934072|521149052|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
144531641|NCT04934072|521149053|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
144531642|NCT04934072|521149054|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
144531643|NCT04934072|521149050|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
144531644|NCT04934072|521149051|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
144531645|NCT04934072|521149052|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
144531646|NCT04934072|521149053|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
144531647|NCT04934072|521149054|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
144531648|NCT04934072|521149050|FG000|Day 0 to Week 52|Other|3|||
144531649|NCT04934072|521149051|FG001|Day 0 to Week 52|Other|1|||
144531650|NCT04934072|521149052|FG002|Day 0 to Week 52|Other|0|||
144531651|NCT04934072|521149053|FG003|Day 0 to Week 52|Other|0|||
144531652|NCT04934072|521149054|FG004|Day 0 to Week 52|Other|0|||
144531653|NCT04934072|521149050|FG000|Day 0 to Week 52|Adverse Event|1|||
144531654|NCT04934072|521149051|FG001|Day 0 to Week 52|Adverse Event|3|||
144531655|NCT04934072|521149052|FG002|Day 0 to Week 52|Adverse Event|0|||
144531656|NCT04934072|521149053|FG003|Day 0 to Week 52|Adverse Event|0|||
144531657|NCT04934072|521149054|FG004|Day 0 to Week 52|Adverse Event|0|||
144442510|NCT00727194|520821900|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
144531658|NCT04934072|521149050|FG000|Week 52 to Week 78|Adverse Event|0|||
144531659|NCT04934072|521149051|FG001|Week 52 to Week 78|Adverse Event|0|||
144442511|NCT00727194|520821901|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
144442512|NCT00727194|520821899|FG000|Screening Period|Severe infections|0|||
144531660|NCT04934072|521149052|FG002|Week 52 to Week 78|Adverse Event|0|||
144531661|NCT04934072|521149053|FG003|Week 52 to Week 78|Adverse Event|1|||
144531662|NCT04934072|521149054|FG004|Week 52 to Week 78|Adverse Event|1|||
144531663|NCT04934072|521149050|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
144605465|NCT02273726|521417136|FG001|Overall Study|Withdrawal by Subject|29|||
144605466|NCT02273726|521417135|FG000|Overall Study|Kidney transplant|31|||
144442513|NCT00727194|520821900|FG001|Screening Period|Severe infections|0|||
144442514|NCT00727194|520821901|FG002|Screening Period|Severe infections|2|||
144442515|NCT00727194|520821899|FG000|Screening Period|History of thymoma|0|||
144442516|NCT00727194|520821900|FG001|Screening Period|History of thymoma|0|||
144442517|NCT00727194|520821901|FG002|Screening Period|History of thymoma|1|||
144442518|NCT00727194|520821899|FG000|Treatment Period 2|Lack of Efficacy|0|||
144442519|NCT00727194|520821900|FG001|Treatment Period 2|Lack of Efficacy|1|||
144605467|NCT02273726|521417136|FG001|Overall Study|Kidney transplant|39|||
144605468|NCT02273726|521417135|FG000|Overall Study|Physician Decision|30|||
144605469|NCT02273726|521417136|FG001|Overall Study|Physician Decision|15|||
144605470|NCT02273726|521417135|FG000|Overall Study|Adverse Event|27|||
144605471|NCT02273726|521417136|FG001|Overall Study|Adverse Event|9|||
144605472|NCT02273726|521417135|FG000|Overall Study|Lost to Follow-up|6|||
144605473|NCT02273726|521417136|FG001|Overall Study|Lost to Follow-up|3|||
144605474|NCT02273726|521417135|FG000|Overall Study|Lack of Efficacy|6|||
144605475|NCT02273726|521417136|FG001|Overall Study|Lack of Efficacy|1|||
144605476|NCT02273726|521417135|FG000|Overall Study|Protocol Violation|4|||
144605477|NCT02273726|521417136|FG001|Overall Study|Protocol Violation|0|||
144605478|NCT02273726|521417135|FG000|Overall Study|Other than specified|28|||
144605479|NCT02273726|521417136|FG001|Overall Study|Other than specified|30|||
144605480|NCT04263896|521417138|FG000|Overall Study|Withdrawal by Subject|2|||
144605481|NCT04263896|521417139|FG001|Overall Study|Withdrawal by Subject|4|||
144605482|NCT04263896|521417138|FG000|Overall Study|converted to open procedure|0|||
144605483|NCT04263896|521417139|FG001|Overall Study|converted to open procedure|1|||
144605484|NCT04263896|521417138|FG000|Overall Study|Lost to Follow-up|9|||
144605485|NCT04263896|521417139|FG001|Overall Study|Lost to Follow-up|11|||
144605486|NCT04263896|521417138|FG000|Overall Study|surveys lost in mail|5|||
144605487|NCT04263896|521417139|FG001|Overall Study|surveys lost in mail|3|||
144605488|NCT04263896|521417138|FG000|Overall Study|excluded from analysis|1|||
144605489|NCT04263896|521417139|FG001|Overall Study|excluded from analysis|0|||
144605490|NCT04050670|521418929|FG000|Period 3|Physician Decision|0|||
144605491|NCT04050670|521418930|FG001|Period 3|Physician Decision|1|||
144605492|NCT04050670|521418931|FG002|Period 3|Physician Decision|0|||
144605493|NCT00761306|521418932|FG000|Overall Study|Adverse Event|5|||
144605494|NCT00761306|521418932|FG000|Overall Study|Lack of Efficacy|4|||
144605495|NCT00761306|521418932|FG000|Overall Study|Protocol Violation|2|||
144605496|NCT00761306|521418932|FG000|Overall Study|Withdrawal of Consent|3|||
144605497|NCT00761306|521418932|FG000|Overall Study|Lost to Follow-up|1|||
144605498|NCT00761306|521418932|FG000|Overall Study|Administrative or Other Reasons|5|||
144605499|NCT00268437|521418933|FG000|Overall Study|Ineligible|1|||
144605500|NCT02615470|521418934|FG000|Overall Study|Lost to Follow-up|21|||
144605501|NCT02615470|521418935|FG001|Overall Study|Lost to Follow-up|32|||
144605502|NCT03713034|521418936|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
144442520|NCT00727194|520821901|FG002|Treatment Period 2|Lack of Efficacy|0|||
144442521|NCT04269161|520821902|FG000|Overall Study|Change of modality and no longer eligible|3|||
144442522|NCT04269161|520821903|FG001|Overall Study|Change of modality and no longer eligible|3|||
144605503|NCT03713034|521418937|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
144605504|NCT02982239|521418940|FG000|Overall Study|Lost to Follow-up|3|||
144605505|NCT02982239|521418941|FG001|Overall Study|Lost to Follow-up|2|||
144605506|NCT01168973|521418948|FG000|Overall Study|Progressive Disease|341|||
144605507|NCT01168973|521418949|FG001|Overall Study|Progressive Disease|429|||
144605508|NCT01168973|521418948|FG000|Overall Study|Adverse Event|94|||
144605509|NCT01168973|521418949|FG001|Overall Study|Adverse Event|55|||
144605510|NCT01168973|521418948|FG000|Overall Study|Withdrawal by Subject|90|||
144605511|NCT01168973|521418949|FG001|Overall Study|Withdrawal by Subject|53|||
144605512|NCT01168973|521418948|FG000|Overall Study|Death|42|||
144605513|NCT01168973|521418949|FG001|Overall Study|Death|45|||
144605514|NCT01168973|521418948|FG000|Overall Study|Physician Decision|37|||
144605515|NCT01168973|521418949|FG001|Overall Study|Physician Decision|19|||
144605516|NCT01168973|521418948|FG000|Overall Study|Sponsor Decision|2|||
144605517|NCT01168973|521418949|FG001|Overall Study|Sponsor Decision|1|||
144605518|NCT01168973|521418948|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
144605519|NCT01168973|521418949|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
144605520|NCT02767323|521418950|FG000|Overall Study|Withdrawal by Subject|17|||
144605521|NCT02767323|521418951|FG001|Overall Study|Withdrawal by Subject|5|||
144605522|NCT02767323|521418952|FG002|Overall Study|Withdrawal by Subject|13|||
144605523|NCT02767323|521418953|FG003|Overall Study|Withdrawal by Subject|0|||
144605524|NCT02767323|521418950|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
144605525|NCT02767323|521418951|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
144605526|NCT02767323|521418952|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
144191673|NCT02224573|519898341|FG001|Taper Phase|Adverse Event|1|||
144191674|NCT02546362|519898342|FG000|4-week Treatment Period|Lost to Follow-up|1|||
144191675|NCT02546362|519898342|FG000|4-week Treatment Period|Change in medication|2|||
144191676|NCT02546362|519898342|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
144191677|NCT02546362|519898342|FG000|12-week Treatment Period|Lost to Follow-up|2|||
144191678|NCT02546362|519898342|FG000|12-week Treatment Period|Change in medication|1|||
144253575|NCT04424914|520128141|FG001|Overall Study|Other|0|||
144724752|NCT02518685|521846493|FG000|Overall Study|Withdrawal by Subject|10|||
144724753|NCT02518685|521846494|FG001|Overall Study|Withdrawal by Subject|3|||
144724754|NCT02518685|521846493|FG000|Overall Study|relocation, study fatigue|7|||
144724755|NCT02518685|521846494|FG001|Overall Study|relocation, study fatigue|2|||
144724756|NCT02518685|521846493|FG000|Overall Study|Pregnancy|1|||
144724757|NCT02518685|521846494|FG001|Overall Study|Pregnancy|0|||
144724758|NCT02518685|521846493|FG000|Overall Study|Physician Decision|1|||
144724759|NCT02518685|521846494|FG001|Overall Study|Physician Decision|0|||
144724760|NCT02518685|521846493|FG000|Overall Study|Lost to Follow-up|1|||
144724761|NCT02518685|521846494|FG001|Overall Study|Lost to Follow-up|4|||
144724762|NCT02785913|521849079|FG000|Overall Study|Adverse Event|5|||
144724763|NCT02785913|521849079|FG000|Overall Study|Death|2|||
144724764|NCT02785913|521849079|FG000|Overall Study|Progression|18|||
144724765|NCT02785913|521849079|FG000|Overall Study|Not protocol specified|1|||
144724766|NCT02841709|521849080|FG000|5th Intervention|Adverse Event|2|||
144724767|NCT02841709|521849081|FG001|5th Intervention|Adverse Event|0|||
144724768|NCT02841709|521849082|FG002|5th Intervention|Adverse Event|0|||
144724769|NCT02841709|521849083|FG003|5th Intervention|Adverse Event|0|||
144724770|NCT02841709|521849084|FG004|5th Intervention|Adverse Event|2|||
144724771|NCT01929109|521849085|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
144724772|NCT01929109|521849086|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
144724773|NCT01929109|521849087|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
144724774|NCT01929109|521849088|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
144724775|NCT01929109|521849089|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
144724776|NCT01027143|521849092|FG000|Overall Study|Lost to Follow-up|9|||
144724777|NCT01027143|521849093|FG001|Overall Study|Lost to Follow-up|4|||
144724778|NCT00502775|521849105|FG000|Overall Study|Adverse Event|1|||
144724779|NCT00502775|521849106|FG001|Overall Study|Adverse Event|2|||
144724780|NCT00502775|521849107|FG002|Overall Study|Adverse Event|1|||
144724781|NCT00502775|521849105|FG000|Overall Study|Protocol Violation|1|||
144724782|NCT00502775|521849106|FG001|Overall Study|Protocol Violation|5|||
144724783|NCT00502775|521849107|FG002|Overall Study|Protocol Violation|2|||
144724784|NCT00502775|521849105|FG000|Overall Study|Withdrawal by Subject|1|||
144724785|NCT00502775|521849106|FG001|Overall Study|Withdrawal by Subject|1|||
144724786|NCT00502775|521849107|FG002|Overall Study|Withdrawal by Subject|2|||
144724787|NCT00502775|521849105|FG000|Overall Study|Sponsor Terminated Study|1|||
144724788|NCT00502775|521849106|FG001|Overall Study|Sponsor Terminated Study|0|||
144724789|NCT00502775|521849107|FG002|Overall Study|Sponsor Terminated Study|1|||
144724790|NCT00502775|521849105|FG000|Overall Study|Non-compliance with eDiary|4|||
144724791|NCT00502775|521849106|FG001|Overall Study|Non-compliance with eDiary|1|||
144724792|NCT00502775|521849107|FG002|Overall Study|Non-compliance with eDiary|1|||
144724793|NCT00502775|521849105|FG000|Overall Study|Subject unable to swallow capsule|1|||
144724794|NCT00502775|521849106|FG001|Overall Study|Subject unable to swallow capsule|0|||
144724795|NCT00502775|521849107|FG002|Overall Study|Subject unable to swallow capsule|1|||
144724796|NCT00502775|521849105|FG000|Overall Study|Logpad compliance <80%|1|||
144724797|NCT00502775|521849106|FG001|Overall Study|Logpad compliance <80%|0|||
144724798|NCT00502775|521849107|FG002|Overall Study|Logpad compliance <80%|0|||
144724799|NCT00502775|521849105|FG000|Overall Study|Randomized in error|0|||
144724800|NCT00502775|521849106|FG001|Overall Study|Randomized in error|1|||
144724801|NCT00502775|521849107|FG002|Overall Study|Randomized in error|1|||
144724802|NCT00502775|521849105|FG000|Overall Study|Non-compliance|0|||
144724803|NCT00502775|521849106|FG001|Overall Study|Non-compliance|2|||
144724804|NCT00502775|521849107|FG002|Overall Study|Non-compliance|2|||
144724805|NCT00502775|521849105|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
144724806|NCT00502775|521849106|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
144724807|NCT00502775|521849107|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
144724808|NCT00502775|521849105|FG000|Overall Study|Declining pollen counts|0|||
144442523|NCT04269161|520821902|FG000|Overall Study|Required procedure outside of NICU|1|||
144442524|NCT04269161|520821903|FG001|Overall Study|Required procedure outside of NICU|0|||
144442525|NCT04269161|520821902|FG000|Overall Study|Equipment issue|1|||
144442526|NCT04269161|520821903|FG001|Overall Study|Equipment issue|1|||
144724809|NCT00502775|521849106|FG001|Overall Study|Declining pollen counts|1|||
144724810|NCT00502775|521849107|FG002|Overall Study|Declining pollen counts|1|||
144724811|NCT00502775|521849105|FG000|Overall Study|Subject in jail|0|||
144724812|NCT00502775|521849106|FG001|Overall Study|Subject in jail|1|||
144724813|NCT00502775|521849107|FG002|Overall Study|Subject in jail|0|||
144724814|NCT00502775|521849105|FG000|Overall Study|Subject took disallowed drug|0|||
144724815|NCT00502775|521849106|FG001|Overall Study|Subject took disallowed drug|0|||
144724816|NCT00502775|521849107|FG002|Overall Study|Subject took disallowed drug|1|||
144724817|NCT02016300|521849115|FG000|Overall Study|Lost to Follow-up|0|||
144253576|NCT04424914|520128142|FG002|Overall Study|Other|28|||
144724818|NCT02016300|521849116|FG001|Overall Study|Lost to Follow-up|3|||
144724819|NCT06165744|521849119|FG000|Overall Study|Non device-related adverse event|1|||
144724820|NCT01545076|521849120|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
144724821|NCT01545076|521849121|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
144442527|NCT01677195|520821904|FG000|Overall Study|Lost to Follow-up|14|||
144724822|NCT01545076|521849122|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
144191679|NCT01138826|519898343|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
144191680|NCT01138826|519898344|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
144191681|NCT01138826|519898345|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
144191682|NCT01138826|519898346|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
144191683|NCT01138826|519898347|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
144191684|NCT01138826|519898348|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
144191685|NCT05206448|519898349|FG000|Overall Study|Lost to Follow-up|2|||
144191686|NCT05206448|519898350|FG001|Overall Study|Lost to Follow-up|2|||
144191687|NCT05206448|519898349|FG000|Overall Study|Withdrawal by Subject|2|||
144191688|NCT05206448|519898350|FG001|Overall Study|Withdrawal by Subject|0|||
144191689|NCT05206448|519898349|FG000|Overall Study|found ineligible after randomization|1|||
144191690|NCT05206448|519898350|FG001|Overall Study|found ineligible after randomization|1|||
144191691|NCT05206448|519898349|FG000|Overall Study|unable to complete study due to personal constraints|1|||
144191692|NCT05206448|519898350|FG001|Overall Study|unable to complete study due to personal constraints|0|||
144191693|NCT05206448|519898349|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
144191694|NCT05206448|519898350|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
144191695|NCT01557842|519898351|FG000|Overall Study|Lost to Follow-up|0|||
144191696|NCT01557842|519898352|FG001|Overall Study|Lost to Follow-up|1|||
144191697|NCT01557842|519898351|FG000|Overall Study|Death|1|||
144191698|NCT01557842|519898352|FG001|Overall Study|Death|0|||
144191699|NCT01557842|519898351|FG000|Overall Study|Lack of Efficacy|0|||
144191700|NCT01557842|519898352|FG001|Overall Study|Lack of Efficacy|1|||
144191701|NCT01557842|519898351|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
144191702|NCT01557842|519898352|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
144191703|NCT01557842|519898351|FG000|Overall Study|Study Terminated by Sponsor|3|||
144191704|NCT01557842|519898352|FG001|Overall Study|Study Terminated by Sponsor|4|||
144191705|NCT01557842|519898351|FG000|Overall Study|Not Ablated|2|||
144191706|NCT01557842|519898352|FG001|Overall Study|Not Ablated|0|||
144191707|NCT02457611|519898356|FG000|Overall Study|Lost to Follow-up|3|||
144191708|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
144191709|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
144191710|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
144191711|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
144191712|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
144191713|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
144191714|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
144191715|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
144191716|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
144191717|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
144191718|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
144191719|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
144191720|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
144191721|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
144191722|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
144191723|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
144191724|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
144191725|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
144191726|NCT00384293|519898357|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
144442528|NCT01677195|520821905|FG001|Overall Study|Lost to Follow-up|22|||
144442529|NCT01677195|520821906|FG002|Overall Study|Lost to Follow-up|22|||
144442530|NCT01677195|520821904|FG000|Overall Study|Withdrawal by Subject|1|||
144442531|NCT01677195|520821905|FG001|Overall Study|Withdrawal by Subject|0|||
144442532|NCT01677195|520821906|FG002|Overall Study|Withdrawal by Subject|1|||
144442533|NCT01677195|520821904|FG000|Overall Study|Adverse Event|6|||
144442534|NCT01677195|520821905|FG001|Overall Study|Adverse Event|4|||
144442535|NCT01677195|520821906|FG002|Overall Study|Adverse Event|1|||
144442536|NCT01677195|520821904|FG000|Overall Study|Physician Decision|1|||
144442537|NCT01677195|520821905|FG001|Overall Study|Physician Decision|2|||
144442538|NCT01677195|520821906|FG002|Overall Study|Physician Decision|2|||
144442539|NCT01677195|520821904|FG000|Overall Study|Pregnancy|0|||
144442540|NCT01677195|520821905|FG001|Overall Study|Pregnancy|1|||
144442541|NCT01677195|520821906|FG002|Overall Study|Pregnancy|0|||
144442542|NCT01677195|520821904|FG000|Overall Study|Protocol Violation|7|||
144442543|NCT01677195|520821905|FG001|Overall Study|Protocol Violation|3|||
144442544|NCT01677195|520821906|FG002|Overall Study|Protocol Violation|4|||
144442545|NCT04368429|520821907|FG000|Overall Study|Adverse Event|1|||
144442546|NCT04368429|520821908|FG001|Overall Study|Adverse Event|0|||
144442547|NCT03633396|520821911|FG000|Overall Study|Withdrawal by Subject|4|||
144442548|NCT03633396|520821912|FG001|Overall Study|Withdrawal by Subject|4|||
144442549|NCT03633396|520821911|FG000|Overall Study|Adverse Event|1|||
144442550|NCT03633396|520821912|FG001|Overall Study|Adverse Event|1|||
144442551|NCT03633396|520821911|FG000|Overall Study|Lack of Efficacy|1|||
144442552|NCT03633396|520821912|FG001|Overall Study|Lack of Efficacy|0|||
144442553|NCT03633396|520821911|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
144442554|NCT03633396|520821912|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
144442555|NCT01012817|520821913|FG000|Overall Study|Withdrawal by Subject|0|||
144442556|NCT01012817|520821914|FG001|Overall Study|Withdrawal by Subject|0|||
144442557|NCT01012817|520821915|FG002|Overall Study|Withdrawal by Subject|0|||
144442558|NCT01012817|520821916|FG003|Overall Study|Withdrawal by Subject|1|||
144442559|NCT01012817|520821917|FG004|Overall Study|Withdrawal by Subject|0|||
144442560|NCT01012817|520821918|FG005|Overall Study|Withdrawal by Subject|0|||
144442561|NCT01012817|520821919|FG006|Overall Study|Withdrawal by Subject|0|||
144442562|NCT01012817|520821920|FG007|Overall Study|Withdrawal by Subject|1|||
144442563|NCT01012817|520821921|FG008|Overall Study|Withdrawal by Subject|0|||
144442564|NCT01012817|520821922|FG009|Overall Study|Withdrawal by Subject|0|||
144442565|NCT01012817|520821923|FG010|Overall Study|Withdrawal by Subject|1|||
144442566|NCT01012817|520821924|FG011|Overall Study|Withdrawal by Subject|1|||
144442567|NCT01012817|520821925|FG012|Overall Study|Withdrawal by Subject|0|||
144442568|NCT01012817|520821926|FG013|Overall Study|Withdrawal by Subject|1|||
144531664|NCT04934072|521149051|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
144531665|NCT04934072|521149052|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
144531666|NCT04934072|521149053|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
144531667|NCT04934072|521149054|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
144531668|NCT04934072|521149050|FG000|Week 52 to Week 78|Other|0|||
144531669|NCT04934072|521149051|FG001|Week 52 to Week 78|Other|0|||
144531670|NCT04934072|521149052|FG002|Week 52 to Week 78|Other|1|||
144531671|NCT04934072|521149053|FG003|Week 52 to Week 78|Other|0|||
144531672|NCT04934072|521149054|FG004|Week 52 to Week 78|Other|0|||
144531673|NCT01820611|521149060|FG000|Overall Study|Death|8|||
144531674|NCT01820611|521149060|FG000|Overall Study|Adverse Event|1|||
144531675|NCT01820611|521149060|FG000|Overall Study|Withdrawal by Subject|9|||
144531676|NCT04456296|521149061|FG000|Overall Study|Withdrawal by Subject|14|||
144531677|NCT04456296|521149062|FG001|Overall Study|Withdrawal by Subject|21|||
144531678|NCT04456296|521149063|FG002|Overall Study|Withdrawal by Subject|21|||
144531679|NCT04456296|521149061|FG000|Overall Study|Adverse Event|2|||
144531680|NCT04456296|521149062|FG001|Overall Study|Adverse Event|2|||
144531681|NCT04456296|521149063|FG002|Overall Study|Adverse Event|2|||
144531682|NCT04456296|521149061|FG000|Overall Study|Death|1|||
144531683|NCT04456296|521149062|FG001|Overall Study|Death|0|||
144531684|NCT04456296|521149063|FG002|Overall Study|Death|0|||
144531685|NCT04456296|521149061|FG000|Overall Study|Lost to Follow-up|3|||
144531686|NCT04456296|521149062|FG001|Overall Study|Lost to Follow-up|5|||
144531687|NCT04456296|521149063|FG002|Overall Study|Lost to Follow-up|6|||
144531688|NCT04456296|521149061|FG000|Overall Study|Other than specified|0|||
144531689|NCT04456296|521149062|FG001|Overall Study|Other than specified|1|||
144531690|NCT04456296|521149063|FG002|Overall Study|Other than specified|4|||
144531691|NCT04456296|521149061|FG000|Overall Study|Randomized, not treated|2|||
144531692|NCT04456296|521149062|FG001|Overall Study|Randomized, not treated|1|||
144531693|NCT04456296|521149063|FG002|Overall Study|Randomized, not treated|0|||
144531694|NCT01199133|521149070|FG000|Year 1|Adverse Event|16|||
144531695|NCT01199133|521149071|FG001|Year 1|Adverse Event|4|||
144531696|NCT01199133|521149070|FG000|Year 1|Withdrawal by Subject|8|||
144531697|NCT01199133|521149071|FG001|Year 1|Withdrawal by Subject|4|||
144531698|NCT01199133|521149070|FG000|Year 1|Any other reason not above-mentioned|6|||
144531699|NCT01199133|521149071|FG001|Year 1|Any other reason not above-mentioned|7|||
144531700|NCT01199133|521149070|FG000|Year 2|Adverse Event|1|||
144531701|NCT01199133|521149071|FG001|Year 2|Adverse Event|0|||
144531702|NCT01199133|521149070|FG000|Year 2|Withdrawal by Subject|1|||
144531703|NCT01199133|521149071|FG001|Year 2|Withdrawal by Subject|1|||
144531704|NCT01199133|521149070|FG000|Year 2|Any other reason not above-mentioned|1|||
144531705|NCT01199133|521149071|FG001|Year 2|Any other reason not above-mentioned|2|||
144531706|NCT03252288|521149075|FG000|Overall Study|Death|1|||
144531707|NCT03252288|521149076|FG001|Overall Study|Death|0|||
144531708|NCT03252288|521149077|FG002|Overall Study|Death|0|||
144531709|NCT03252288|521149075|FG000|Overall Study|Death|11|||
144531710|NCT03252288|521149076|FG001|Overall Study|Death|0|||
144531711|NCT03252288|521149077|FG002|Overall Study|Death|0|||
144531712|NCT03252288|521149075|FG000|Overall Study|Withdrawal by Subject|2|||
144531713|NCT03252288|521149076|FG001|Overall Study|Withdrawal by Subject|0|||
144531714|NCT03252288|521149077|FG002|Overall Study|Withdrawal by Subject|0|||
144442569|NCT01012817|520821913|FG000|Overall Study|Adverse Event|0|||
144442570|NCT01012817|520821914|FG001|Overall Study|Adverse Event|0|||
144442571|NCT01012817|520821915|FG002|Overall Study|Adverse Event|0|||
144442572|NCT01012817|520821916|FG003|Overall Study|Adverse Event|0|||
144442573|NCT01012817|520821917|FG004|Overall Study|Adverse Event|0|||
144442574|NCT01012817|520821918|FG005|Overall Study|Adverse Event|1|||
144442575|NCT01012817|520821919|FG006|Overall Study|Adverse Event|0|||
144531715|NCT03252288|521149075|FG000|Overall Study|Lost to Follow-up|79|||
144531716|NCT03252288|521149076|FG001|Overall Study|Lost to Follow-up|0|||
144531717|NCT03252288|521149077|FG002|Overall Study|Lost to Follow-up|0|||
144531718|NCT03252288|521149075|FG000|Overall Study|Loss of baseline data on tablets|6|||
144531719|NCT03252288|521149076|FG001|Overall Study|Loss of baseline data on tablets|0|||
144531720|NCT03252288|521149077|FG002|Overall Study|Loss of baseline data on tablets|0|||
144531721|NCT03993392|521149081|FG000|Overall Study|Withdrawal by Subject|3|||
144531722|NCT03993392|521149081|FG000|Overall Study|Lost to Follow-up|2|||
144531723|NCT03993392|521149081|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
144531724|NCT02518048|521149082|FG000|Overall Study|Withdrawal by Subject|1|||
144531725|NCT05654662|521149083|FG000|Overall Study|Withdrawal by Subject|1|||
144531726|NCT05654662|521149084|FG001|Overall Study|Withdrawal by Subject|0|||
144531727|NCT05654662|521149083|FG000|Overall Study|A death in the family|1|||
144531728|NCT05654662|521149084|FG001|Overall Study|A death in the family|0|||
144531729|NCT06262477|521150729|FG000|Overall Study|Withdrawal by Subject|1|||
144531730|NCT06262477|521150730|FG001|Overall Study|Withdrawal by Subject|0|||
144531731|NCT06262477|521150729|FG000|Overall Study|Adverse Event|0|||
144531732|NCT06262477|521150730|FG001|Overall Study|Adverse Event|1|||
144531733|NCT06262477|521150729|FG000|Overall Study|Lost to Follow-up|0|||
144531734|NCT06262477|521150730|FG001|Overall Study|Lost to Follow-up|1|||
144531735|NCT04108130|521150731|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
144531736|NCT04108130|521150732|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
144531737|NCT04108130|521150731|FG000|Overall Study|Consent Withdrawn|9|||
144531738|NCT04108130|521150732|FG001|Overall Study|Consent Withdrawn|6|||
144531739|NCT04108130|521150731|FG000|Overall Study|Surgery Cancelled|4|||
144531740|NCT04108130|521150732|FG001|Overall Study|Surgery Cancelled|4|||
144531741|NCT04108130|521150731|FG000|Overall Study|Found Ineligible for Study|4|||
144531742|NCT04108130|521150732|FG001|Overall Study|Found Ineligible for Study|3|||
144531743|NCT04108130|521150731|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
144531744|NCT04108130|521150732|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
144531745|NCT04108130|521150731|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
144531746|NCT04108130|521150732|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
144531747|NCT05507333|521150733|FG000|Overall Study|Protocol Violation|1|||
144531748|NCT04615273|521150736|FG000|Overall Study|Withdrawal by Subject|3|||
144531749|NCT04615273|521150737|FG001|Overall Study|Withdrawal by Subject|1|||
144531750|NCT04615273|521150738|FG002|Overall Study|Withdrawal by Subject|2|||
144531751|NCT04615273|521150736|FG000|Overall Study|Adverse Event|1|||
144531752|NCT04615273|521150737|FG001|Overall Study|Adverse Event|0|||
144531753|NCT04615273|521150738|FG002|Overall Study|Adverse Event|1|||
144531754|NCT04615273|521150736|FG000|Overall Study|Lost to Follow-up|0|||
144531755|NCT04615273|521150737|FG001|Overall Study|Lost to Follow-up|1|||
144531756|NCT04615273|521150738|FG002|Overall Study|Lost to Follow-up|0|||
144531757|NCT04615273|521150736|FG000|Overall Study|Physician Decision|0|||
144531758|NCT04615273|521150737|FG001|Overall Study|Physician Decision|0|||
144531759|NCT04615273|521150738|FG002|Overall Study|Physician Decision|1|||
144531760|NCT04615273|521150736|FG000|Overall Study|Other|0|||
144531761|NCT04615273|521150737|FG001|Overall Study|Other|1|||
144531762|NCT04615273|521150738|FG002|Overall Study|Other|0|||
144531763|NCT04615273|521150736|FG000|Overall Study|Randomized but not treated|1|||
144531764|NCT04615273|521150737|FG001|Overall Study|Randomized but not treated|3|||
144531765|NCT04615273|521150738|FG002|Overall Study|Randomized but not treated|1|||
144531766|NCT03677141|521150739|FG000|Overall Study|Death|2|||
144531767|NCT03677141|521150740|FG001|Overall Study|Death|1|||
144531768|NCT03677141|521150741|FG002|Overall Study|Death|6|||
144531769|NCT03677141|521150742|FG003|Overall Study|Death|9|||
144531770|NCT03677141|521150743|FG004|Overall Study|Death|5|||
144531771|NCT03677141|521150744|FG005|Overall Study|Death|3|||
144531772|NCT03677141|521150739|FG000|Overall Study|Lost to Follow-up|0|||
144531773|NCT03677141|521150740|FG001|Overall Study|Lost to Follow-up|0|||
144531774|NCT03677141|521150741|FG002|Overall Study|Lost to Follow-up|0|||
144531775|NCT03677141|521150742|FG003|Overall Study|Lost to Follow-up|2|||
144531776|NCT03677141|521150743|FG004|Overall Study|Lost to Follow-up|0|||
144531777|NCT03677141|521150744|FG005|Overall Study|Lost to Follow-up|0|||
144531778|NCT03677141|521150739|FG000|Overall Study|Screen failure or enrolled in error|0|||
144531779|NCT03677141|521150740|FG001|Overall Study|Screen failure or enrolled in error|0|||
144531780|NCT03677141|521150741|FG002|Overall Study|Screen failure or enrolled in error|0|||
144531781|NCT03677141|521150742|FG003|Overall Study|Screen failure or enrolled in error|0|||
144531782|NCT03677141|521150743|FG004|Overall Study|Screen failure or enrolled in error|2|||
144531783|NCT03677141|521150744|FG005|Overall Study|Screen failure or enrolled in error|0|||
144531784|NCT03677141|521150739|FG000|Overall Study|Physician Decision|0|||
144531785|NCT03677141|521150740|FG001|Overall Study|Physician Decision|0|||
144531786|NCT03677141|521150741|FG002|Overall Study|Physician Decision|0|||
144531787|NCT03677141|521150742|FG003|Overall Study|Physician Decision|0|||
144531788|NCT03677141|521150743|FG004|Overall Study|Physician Decision|1|||
144531789|NCT03677141|521150744|FG005|Overall Study|Physician Decision|0|||
144531790|NCT03677141|521150739|FG000|Overall Study|Withdrawal by Subject|0|||
144531791|NCT03677141|521150740|FG001|Overall Study|Withdrawal by Subject|0|||
144531792|NCT03677141|521150741|FG002|Overall Study|Withdrawal by Subject|1|||
144531793|NCT03677141|521150742|FG003|Overall Study|Withdrawal by Subject|1|||
144531794|NCT03677141|521150743|FG004|Overall Study|Withdrawal by Subject|1|||
144531795|NCT03677141|521150744|FG005|Overall Study|Withdrawal by Subject|0|||
144724823|NCT01545076|521849123|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
144724824|NCT01545076|521849124|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
144724825|NCT01545076|521849120|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
144724826|NCT01545076|521849121|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
144724827|NCT01545076|521849122|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
144724828|NCT01545076|521849123|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
144724829|NCT01545076|521849124|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
144724830|NCT01545076|521849120|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
144724831|NCT01545076|521849121|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
144724832|NCT01545076|521849122|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
144724833|NCT01545076|521849123|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
144724834|NCT01545076|521849124|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
144724835|NCT01545076|521849120|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
144724836|NCT01545076|521849121|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
144724837|NCT01545076|521849122|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
144724838|NCT01545076|521849123|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
144724839|NCT01545076|521849124|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
144724840|NCT01545076|521849120|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
144724841|NCT01545076|521849121|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
144724842|NCT01545076|521849122|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
144724843|NCT01545076|521849123|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
144724844|NCT01545076|521849124|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
144724845|NCT01545076|521849120|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
144724846|NCT01545076|521849121|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
144724847|NCT01545076|521849122|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
144724848|NCT01545076|521849123|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
144724849|NCT01545076|521849124|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
144724850|NCT01545076|521849120|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
144724851|NCT01545076|521849121|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
144724852|NCT01545076|521849122|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
144724853|NCT01545076|521849123|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
144724854|NCT01545076|521849124|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
144724855|NCT01545076|521849120|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
144724856|NCT01545076|521849121|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
144724857|NCT01545076|521849122|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
144724858|NCT01545076|521849123|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
144724859|NCT01545076|521849124|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
144724860|NCT01545076|521849120|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
144724861|NCT01545076|521849121|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
144191727|NCT00384293|519898358|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
144191728|NCT00384293|519898359|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
144191729|NCT00384293|519898357|FG000|Post-randomization Period|Adverse Event|0|||
144191730|NCT00384293|519898358|FG001|Post-randomization Period|Adverse Event|23|||
144191731|NCT00384293|519898359|FG002|Post-randomization Period|Adverse Event|7|||
144191732|NCT00384293|519898357|FG000|Post-randomization Period|Lost to Follow-up|0|||
144191733|NCT00384293|519898358|FG001|Post-randomization Period|Lost to Follow-up|2|||
144531796|NCT05976334|521150752|FG000|Part B|Death|0|||
144531797|NCT05976334|521150753|FG001|Part B|Death|1|||
144531798|NCT05976334|521150752|FG000|Part B|Study Terminated by Sponsor|0|||
144531799|NCT05976334|521150753|FG001|Part B|Study Terminated by Sponsor|1|||
144531800|NCT05976334|521150752|FG000|Part B|Reason Not Specified|0|||
144531801|NCT05976334|521150753|FG001|Part B|Reason Not Specified|1|||
144531802|NCT05363163|521150754|FG000|Overall Study|Withdrawal by Subject|13|||
144531803|NCT01314105|521150758|FG000|Overall Study|Progressive Disease|6|||
144531804|NCT01314105|521150759|FG001|Overall Study|Progressive Disease|10|||
144531805|NCT01314105|521150758|FG000|Overall Study|Refused to continue taking medication|0|||
144531806|NCT01314105|521150759|FG001|Overall Study|Refused to continue taking medication|1|||
144531807|NCT01314105|521150758|FG000|Overall Study|Other Adverse Event|1|||
144531808|NCT01314105|521150759|FG001|Overall Study|Other Adverse Event|1|||
144191734|NCT00384293|519898359|FG002|Post-randomization Period|Lost to Follow-up|1|||
144531809|NCT04526886|521150760|FG000|Overall Study|Physician Decision|4|||
144191735|NCT00384293|519898357|FG000|Post-randomization Period|Protocol Violation|0|||
144191736|NCT00384293|519898358|FG001|Post-randomization Period|Protocol Violation|1|||
144531810|NCT03156465|521150770|FG000|Overall Study|Withdrawal by Subject|2|||
144531811|NCT03640286|521150771|FG000|Overall Study|Adverse Event|6|||
144531812|NCT03640286|521150772|FG001|Overall Study|Adverse Event|6|||
144605527|NCT02767323|521418953|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
144191737|NCT00384293|519898359|FG002|Post-randomization Period|Protocol Violation|0|||
144191738|NCT00384293|519898357|FG000|Post-randomization Period|Withdrawal by Subject|0|||
144191739|NCT00384293|519898358|FG001|Post-randomization Period|Withdrawal by Subject|8|||
144191740|NCT00384293|519898359|FG002|Post-randomization Period|Withdrawal by Subject|6|||
144191741|NCT00384293|519898357|FG000|Post-randomization Period|Trial Termination|0|||
144191742|NCT00384293|519898358|FG001|Post-randomization Period|Trial Termination|180|||
144191743|NCT00384293|519898359|FG002|Post-randomization Period|Trial Termination|204|||
144191744|NCT00384293|519898357|FG000|Post-randomization Period|Patient Randomized in Error|0|||
144191745|NCT00384293|519898358|FG001|Post-randomization Period|Patient Randomized in Error|0|||
144191746|NCT00384293|519898359|FG002|Post-randomization Period|Patient Randomized in Error|1|||
144191747|NCT03005067|519898360|FG000|Overall Study|Withdrawal by Subject|3|||
144191748|NCT03005067|519898361|FG001|Overall Study|Withdrawal by Subject|2|||
144191749|NCT03005067|519898360|FG000|Overall Study|Adverse Event|4|||
144191750|NCT03005067|519898361|FG001|Overall Study|Adverse Event|3|||
144191751|NCT03005067|519898360|FG000|Overall Study|Other (reason not specified)|3|||
144191752|NCT03005067|519898361|FG001|Overall Study|Other (reason not specified)|1|||
144191753|NCT03005067|519898360|FG000|Overall Study|Protocol Violation|0|||
144191754|NCT03005067|519898361|FG001|Overall Study|Protocol Violation|1|||
144191755|NCT01790113|519898365|FG000|Overall Study|Adverse Event|2|||
144191756|NCT01790113|519898366|FG001|Overall Study|Adverse Event|7|||
144191757|NCT01790113|519898365|FG000|Overall Study|Study ended due to FDA clearance|1|||
144191758|NCT01790113|519898366|FG001|Overall Study|Study ended due to FDA clearance|68|||
144191759|NCT01056640|519898369|FG000|Overall Study|Withdrawal by Subject|11|||
144191760|NCT01056640|519898370|FG001|Overall Study|Withdrawal by Subject|8|||
144191761|NCT01056640|519898369|FG000|Overall Study|Death|15|||
144191762|NCT01056640|519898370|FG001|Overall Study|Death|4|||
144191763|NCT01803269|519898371|FG000|Overall Study|Withdrawal by Subject|3|||
144191764|NCT01803269|519898372|FG001|Overall Study|Withdrawal by Subject|0|||
144191765|NCT01803269|519898373|FG002|Overall Study|Withdrawal by Subject|0|||
144191766|NCT01202877|519898376|FG000|Overall Study|Disease Progression|0|||
144191767|NCT01202877|519898377|FG001|Overall Study|Disease Progression|1|||
144191768|NCT01202877|519898378|FG002|Overall Study|Disease Progression|2|||
144191769|NCT01202877|519898376|FG000|Overall Study|Adverse Event|0|||
144191770|NCT01202877|519898377|FG001|Overall Study|Adverse Event|0|||
144191771|NCT01202877|519898378|FG002|Overall Study|Adverse Event|2|||
144191772|NCT01202877|519898376|FG000|Overall Study|Withdrawal by Subject|0|||
144191773|NCT01202877|519898377|FG001|Overall Study|Withdrawal by Subject|0|||
144191774|NCT01202877|519898378|FG002|Overall Study|Withdrawal by Subject|1|||
144191775|NCT01202877|519898376|FG000|Overall Study|Death|0|||
144191776|NCT01202877|519898377|FG001|Overall Study|Death|0|||
144191777|NCT01202877|519898378|FG002|Overall Study|Death|1|||
144191778|NCT00396331|519898379|FG000|Overall Study|Failed to mobilize - no transplant|8|||
144191779|NCT00396331|519898379|FG000|Overall Study|Did not go on to transplant|5|||
144191780|NCT00396331|519898379|FG000|Overall Study|Lost to Follow-up|3|||
144191781|NCT00396331|519898379|FG000|Overall Study|Death|16|||
144191782|NCT00680186|519898380|FG000|Overall Study|Adverse Event|47|||
144191783|NCT00680186|519898381|FG001|Overall Study|Adverse Event|44|||
144191784|NCT00680186|519898380|FG000|Overall Study|Protocol Violation|31|||
144191785|NCT00680186|519898381|FG001|Overall Study|Protocol Violation|26|||
144191786|NCT00680186|519898380|FG000|Overall Study|Lost to Follow-up|11|||
144191787|NCT00680186|519898381|FG001|Overall Study|Lost to Follow-up|6|||
144191788|NCT00680186|519898380|FG000|Overall Study|Withdrawal by Subject|32|||
144191789|NCT00680186|519898381|FG001|Overall Study|Withdrawal by Subject|39|||
144191790|NCT00680186|519898380|FG000|Overall Study|Other|4|||
144191791|NCT00680186|519898381|FG001|Overall Study|Other|1|||
144191792|NCT01351350|519898384|FG000|Overall Study|Disease Progression|5|||
144442576|NCT01012817|520821920|FG007|Overall Study|Adverse Event|0|||
144442577|NCT01012817|520821921|FG008|Overall Study|Adverse Event|0|||
144442578|NCT01012817|520821922|FG009|Overall Study|Adverse Event|0|||
144442579|NCT01012817|520821923|FG010|Overall Study|Adverse Event|1|||
144442580|NCT01012817|520821924|FG011|Overall Study|Adverse Event|0|||
144442581|NCT01012817|520821925|FG012|Overall Study|Adverse Event|0|||
144191793|NCT01351350|519898385|FG001|Overall Study|Disease Progression|13|||
144191794|NCT01351350|519898386|FG002|Overall Study|Disease Progression|6|||
144191795|NCT01351350|519898387|FG003|Overall Study|Disease Progression|8|||
144442582|NCT01012817|520821926|FG013|Overall Study|Adverse Event|1|||
144191796|NCT01351350|519898388|FG004|Overall Study|Disease Progression|5|||
144191797|NCT01351350|519898384|FG000|Overall Study|Adverse Event|1|||
144191798|NCT01351350|519898385|FG001|Overall Study|Adverse Event|10|||
144442583|NCT03756558|520821927|FG000|Overall Study|Death|1|||
144605528|NCT02230254|521418954|FG000|Overall Study|Lost to Follow-up|3|||
144191799|NCT01351350|519898386|FG002|Overall Study|Adverse Event|1|||
144191800|NCT01351350|519898387|FG003|Overall Study|Adverse Event|2|||
144191801|NCT01351350|519898388|FG004|Overall Study|Adverse Event|0|||
144191802|NCT01351350|519898384|FG000|Overall Study|Participant Decision|2|||
144442584|NCT03756558|520821927|FG000|Overall Study|Lost to Follow-up|2|||
144191803|NCT01351350|519898385|FG001|Overall Study|Participant Decision|6|||
144191804|NCT01351350|519898386|FG002|Overall Study|Participant Decision|3|||
144442585|NCT03756558|520821927|FG000|Overall Study|Withdrawal by Subject|2|||
144442586|NCT02472756|520821928|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
144442587|NCT02472756|520821928|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
144442588|NCT02472756|520821928|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
144442589|NCT02472756|520821928|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
144442590|NCT02472756|520821928|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
144442591|NCT02143414|520821929|FG000|Induction|Adverse Event|1|||
144442592|NCT02143414|520821930|FG001|Induction|Adverse Event|2|||
144442593|NCT02143414|520821929|FG000|Induction|Death|1|||
144442594|NCT02143414|520821930|FG001|Induction|Death|2|||
144442595|NCT02143414|520821929|FG000|Induction|Patient refusal|1|||
144442596|NCT02143414|520821930|FG001|Induction|Patient refusal|1|||
144442597|NCT02143414|520821929|FG000|Induction|Refractory|1|||
144442598|NCT02143414|520821930|FG001|Induction|Refractory|0|||
144531813|NCT03640286|521150771|FG000|Overall Study|Lost to Follow-up|3|||
144442599|NCT02143414|520821929|FG000|Induction|Began alternative treatment|1|||
144531814|NCT03640286|521150772|FG001|Overall Study|Lost to Follow-up|6|||
144531815|NCT03640286|521150771|FG000|Overall Study|Pregnancy|1|||
144531816|NCT03640286|521150772|FG001|Overall Study|Pregnancy|0|||
144531817|NCT03640286|521150771|FG000|Overall Study|Withdrawal by Subject|10|||
144531818|NCT03640286|521150772|FG001|Overall Study|Withdrawal by Subject|10|||
144531819|NCT03640286|521150771|FG000|Overall Study|Non-compliance|4|||
144531820|NCT03640286|521150772|FG001|Overall Study|Non-compliance|10|||
144531821|NCT03640286|521150771|FG000|Overall Study|Medication change|1|||
144531822|NCT03640286|521150772|FG001|Overall Study|Medication change|0|||
144531823|NCT03640286|521150771|FG000|Overall Study|Other|1|||
144531824|NCT03640286|521150772|FG001|Overall Study|Other|2|||
144531825|NCT03640286|521150771|FG000|Overall Study|Joined another lifestyle program|0|||
144531826|NCT03640286|521150772|FG001|Overall Study|Joined another lifestyle program|1|||
144531827|NCT04580914|521150774|FG000|Overall Study|Withdrawal by Subject|6|||
144531828|NCT04580914|521150774|FG000|Overall Study|Lost to Follow-up|2|||
144531829|NCT02909686|521150791|FG000|Overall Study|Physician Decision|3|||
144531830|NCT02909686|521150791|FG000|Overall Study|Withdrawal by Subject|2|||
144531831|NCT02473445|521150792|FG000|Overall Study|Withdrawal by Subject|2|||
144531832|NCT02473445|521150792|FG000|Overall Study|Sponsor Decision|20|||
144531833|NCT03484819|521150793|FG000|Overall Study|Death|2|||
144531834|NCT03484819|521150793|FG000|Overall Study|Adverse Event|2|||
144531835|NCT03484819|521150793|FG000|Overall Study|Physician Decision|1|||
144531836|NCT03484819|521150793|FG000|Overall Study|Withdrawal by Subject|2|||
144531837|NCT03484819|521150793|FG000|Overall Study|Disease Progression|4|||
144531838|NCT03484819|521150793|FG000|Overall Study|Complicating Condition|1|||
144531839|NCT05970861|521150794|FG000|Overall Study|Physician Decision|4|||
144531840|NCT05970861|521150795|FG001|Overall Study|Physician Decision|4|||
144531841|NCT05970861|521150794|FG000|Overall Study|Lost to Follow-up|4|||
144531842|NCT05970861|521150795|FG001|Overall Study|Lost to Follow-up|3|||
144531843|NCT02990338|521150796|FG000|Overall Study|Randomized and not treated|4|||
144531844|NCT02990338|521150797|FG001|Overall Study|Randomized and not treated|2|||
144531845|NCT02990338|521150796|FG000|Overall Study|Adverse Event|23|||
144531846|NCT02990338|521150797|FG001|Overall Study|Adverse Event|22|||
144531847|NCT02990338|521150796|FG000|Overall Study|Progressive disease|118|||
144531848|NCT02990338|521150797|FG001|Overall Study|Progressive disease|107|||
144531849|NCT02990338|521150796|FG000|Overall Study|Poor compliance to protocol|0|||
144531850|NCT02990338|521150797|FG001|Overall Study|Poor compliance to protocol|1|||
144531851|NCT02990338|521150796|FG000|Overall Study|Withdrawal by Subject|6|||
144531852|NCT02990338|521150797|FG001|Overall Study|Withdrawal by Subject|8|||
144531853|NCT02990338|521150796|FG000|Overall Study|Physician's decision|2|||
144531854|NCT02990338|521150797|FG001|Overall Study|Physician's decision|6|||
144531855|NCT02990338|521150796|FG000|Overall Study|Treatment extension study|0|||
144531856|NCT02990338|521150797|FG001|Overall Study|Treatment extension study|6|||
144531857|NCT02990338|521150796|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
144531858|NCT02990338|521150797|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
144531859|NCT02990338|521150796|FG000|Overall Study|Continue with therapy available commercially|0|||
144531860|NCT02990338|521150797|FG001|Overall Study|Continue with therapy available commercially|1|||
144531861|NCT04186819|521150798|FG000|Overall Study|Adverse Event|1|||
144531862|NCT04186819|521150798|FG000|Overall Study|Lost to Follow-up|1|||
144531863|NCT04186819|521150798|FG000|Overall Study|Opted for EBRT|1|||
144531864|NCT04186819|521150798|FG000|Overall Study|Opted SBRT|1|||
144531865|NCT04186819|521150798|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
144531866|NCT04186819|521150798|FG000|Overall Study|Physician Decision|1|||
144442600|NCT02143414|520821930|FG001|Induction|Began alternative treatment|0|||
144442601|NCT02143414|520821929|FG000|Induction|Ineligible for postremission|5|||
144442602|NCT02143414|520821930|FG001|Induction|Ineligible for postremission|1|||
144531867|NCT04186819|521150798|FG000|Overall Study|RP Delayed|1|||
144531868|NCT04186819|521150798|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
144531869|NCT04186819|521150798|FG000|Overall Study|Subject declined for financial reasons|1|||
144531870|NCT04186819|521150798|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
144605529|NCT02023242|521418956|FG000|Overall Study|Lost to Follow-up|3|||
144442603|NCT02143414|520821929|FG000|Post-remission|Adverse Event|0|||
144442604|NCT02143414|520821930|FG001|Post-remission|Adverse Event|2|||
144442605|NCT02143414|520821929|FG000|Post-remission|Disease progression/relapse|5|||
144442606|NCT02143414|520821930|FG001|Post-remission|Disease progression/relapse|0|||
144442607|NCT02143414|520821929|FG000|Maintenance|Adverse Event|4|||
144442608|NCT02143414|520821930|FG001|Maintenance|Adverse Event|6|||
144442609|NCT02143414|520821929|FG000|Maintenance|Disease progression/relapse|3|||
144442610|NCT02143414|520821930|FG001|Maintenance|Disease progression/relapse|2|||
144442611|NCT02143414|520821929|FG000|Maintenance|Patient refusal|2|||
144442612|NCT02143414|520821930|FG001|Maintenance|Patient refusal|1|||
144442613|NCT02143414|520821929|FG000|Maintenance|Physician Decision|1|||
144442614|NCT02143414|520821930|FG001|Maintenance|Physician Decision|0|||
144442615|NCT02143414|520821929|FG000|Maintenance|Death|0|||
144442616|NCT02143414|520821930|FG001|Maintenance|Death|1|||
144442617|NCT02143414|520821929|FG000|Maintenance|On protocol treatment|0|||
144442618|NCT02143414|520821930|FG001|Maintenance|On protocol treatment|6|||
144442619|NCT00978731|520821934|FG000|Overall Study|Death|4|||
144442620|NCT00978731|520821935|FG001|Overall Study|Death|1|||
144442621|NCT00978731|520821936|FG002|Overall Study|Death|1|||
144442622|NCT00978731|520821937|FG003|Overall Study|Death|0|||
144442623|NCT00978731|520821934|FG000|Overall Study|Lost to Follow-up|0|||
144442624|NCT00978731|520821935|FG001|Overall Study|Lost to Follow-up|0|||
144442625|NCT00978731|520821936|FG002|Overall Study|Lost to Follow-up|0|||
144605530|NCT02023242|521418957|FG001|Overall Study|Lost to Follow-up|1|||
144605531|NCT02023242|521418956|FG000|Overall Study|Death|0|||
144605532|NCT02023242|521418957|FG001|Overall Study|Death|1|||
144605533|NCT04854434|521418963|FG000|Overall Study|Death|1|||
144605534|NCT04854434|521418964|FG001|Overall Study|Death|3|||
144605535|NCT04854434|521418965|FG002|Overall Study|Death|4|||
144605536|NCT04854434|521418963|FG000|Overall Study|Study Terminated by Sponsor|2|||
144605537|NCT04854434|521418964|FG001|Overall Study|Study Terminated by Sponsor|0|||
144605538|NCT04854434|521418965|FG002|Overall Study|Study Terminated by Sponsor|0|||
144605539|NCT04854434|521418963|FG000|Overall Study|Other|1|||
144605540|NCT04854434|521418964|FG001|Overall Study|Other|1|||
144605541|NCT04854434|521418965|FG002|Overall Study|Other|0|||
144605542|NCT03349775|521418966|FG000|Overall Study|Side Effects|1|||
144605543|NCT03349775|521418967|FG001|Overall Study|Side Effects|2|||
144605544|NCT03349775|521418966|FG000|Overall Study|Withdrawal by Subject|1|||
144605545|NCT03349775|521418967|FG001|Overall Study|Withdrawal by Subject|1|||
144605546|NCT03349775|521418966|FG000|Overall Study|No primary outcome measurements|0|||
144605547|NCT03349775|521418967|FG001|Overall Study|No primary outcome measurements|1|||
144605548|NCT02667275|521418968|FG000|Overall Study|Protocol Violation|11|||
144605549|NCT02667275|521418969|FG001|Overall Study|Protocol Violation|7|||
144605550|NCT02667275|521418968|FG000|Overall Study|Lost to Follow-up|0|||
144605551|NCT02667275|521418969|FG001|Overall Study|Lost to Follow-up|2|||
144605552|NCT02667275|521418968|FG000|Overall Study|Withdrawal by Subject|0|||
144605553|NCT02667275|521418969|FG001|Overall Study|Withdrawal by Subject|5|||
144605554|NCT02667275|521418968|FG000|Overall Study|Discontinued early without completing|0|||
144605555|NCT02667275|521418969|FG001|Overall Study|Discontinued early without completing|1|||
144605556|NCT01756040|521418970|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
144605557|NCT01756040|521418970|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
144605558|NCT01756040|521418970|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
144605559|NCT01274715|521418971|FG000|Overall Study|Lost to Follow-up|1|||
144605560|NCT01274715|521418971|FG000|Overall Study|After consent, met exclusion criteria.|1|||
144605561|NCT01274715|521418971|FG000|Overall Study|After consent, met exclusion criteria.|1|||
144605562|NCT01274715|521418971|FG000|Overall Study|After consent, met exclusion criteria.|1|||
144605563|NCT04479436|521418972|FG000|Overall Study|Progressive disease|26|||
144605564|NCT04479436|521418973|FG001|Overall Study|Progressive disease|1|||
144605565|NCT04479436|521418972|FG000|Overall Study|Adverse Event|6|||
144605566|NCT04479436|521418973|FG001|Overall Study|Adverse Event|0|||
144605567|NCT04479436|521418972|FG000|Overall Study|Withdrawal by Subject|5|||
144605568|NCT04479436|521418973|FG001|Overall Study|Withdrawal by Subject|0|||
144442626|NCT00978731|520821937|FG003|Overall Study|Lost to Follow-up|1|||
144442627|NCT00978731|520821934|FG000|Overall Study|Adverse Event|5|||
144442628|NCT00978731|520821935|FG001|Overall Study|Adverse Event|2|||
144605569|NCT04479436|521418972|FG000|Overall Study|Clinical progression|1|||
144605570|NCT04479436|521418973|FG001|Overall Study|Clinical progression|0|||
144605571|NCT04479436|521418972|FG000|Overall Study|Physician Decision|1|||
144605572|NCT04479436|521418973|FG001|Overall Study|Physician Decision|0|||
144605573|NCT02357134|521418974|FG000|Overall Study|Lost to Follow-up|1|||
144191805|NCT01351350|519898387|FG003|Overall Study|Participant Decision|3|||
144442629|NCT00978731|520821936|FG002|Overall Study|Adverse Event|0|||
144442630|NCT00978731|520821937|FG003|Overall Study|Adverse Event|0|||
144442631|NCT00978731|520821934|FG000|Overall Study|Participant's request|1|||
144442632|NCT00978731|520821935|FG001|Overall Study|Participant's request|0|||
144442633|NCT00978731|520821936|FG002|Overall Study|Participant's request|0|||
144442634|NCT00978731|520821937|FG003|Overall Study|Participant's request|0|||
144605574|NCT02357134|521418975|FG001|Overall Study|Lost to Follow-up|0|||
144605575|NCT02357134|521418976|FG002|Overall Study|Lost to Follow-up|0|||
144724862|NCT01545076|521849122|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
144442635|NCT00978731|520821934|FG000|Overall Study|Administrative reason|3|||
144442636|NCT00978731|520821935|FG001|Overall Study|Administrative reason|3|||
144442637|NCT00978731|520821936|FG002|Overall Study|Administrative reason|1|||
144442638|NCT00978731|520821937|FG003|Overall Study|Administrative reason|0|||
144442639|NCT00978731|520821934|FG000|Overall Study|Deterioration without progression|0|||
144442640|NCT00978731|520821935|FG001|Overall Study|Deterioration without progression|1|||
144442641|NCT00978731|520821936|FG002|Overall Study|Deterioration without progression|0|||
144442642|NCT00978731|520821937|FG003|Overall Study|Deterioration without progression|0|||
144442643|NCT00978731|520821934|FG000|Overall Study|Disease progression/relapse|5|||
144442644|NCT00978731|520821935|FG001|Overall Study|Disease progression/relapse|4|||
144442645|NCT00978731|520821936|FG002|Overall Study|Disease progression/relapse|2|||
144442646|NCT00978731|520821937|FG003|Overall Study|Disease progression/relapse|2|||
144442647|NCT00978731|520821934|FG000|Overall Study|Study closure|3|||
144442648|NCT00978731|520821935|FG001|Overall Study|Study closure|4|||
144442649|NCT00978731|520821936|FG002|Overall Study|Study closure|1|||
144442650|NCT00978731|520821937|FG003|Overall Study|Study closure|1|||
144442651|NCT00978731|520821934|FG000|Overall Study|No response|1|||
144442652|NCT00978731|520821935|FG001|Overall Study|No response|0|||
144442653|NCT00978731|520821936|FG002|Overall Study|No response|0|||
144442654|NCT00978731|520821937|FG003|Overall Study|No response|0|||
144442655|NCT00110266|520821938|FG000|Overall Study|Adverse Event|27|||
144442656|NCT00110266|520821938|FG000|Overall Study|Abnormal laboratory value|15|||
144442657|NCT00110266|520821938|FG000|Overall Study|Withdrawal by Subject|16|||
144442658|NCT00110266|520821938|FG000|Overall Study|Death|17|||
144442659|NCT00110266|520821938|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144442660|NCT00110266|520821938|FG000|Overall Study|Participant condition no longer requires study drug|1|||
144442661|NCT03912233|520821939|FG000|Overall Study|Adverse Event|1|||
144442662|NCT03912233|520821940|FG001|Overall Study|Adverse Event|0|||
144442663|NCT03912233|520821941|FG002|Overall Study|Adverse Event|0|||
144442664|NCT03912233|520821942|FG003|Overall Study|Adverse Event|0|||
144442665|NCT03912233|520821943|FG004|Overall Study|Adverse Event|0|||
144724863|NCT01545076|521849123|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
144724864|NCT01545076|521849124|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
144724865|NCT01546987|521849125|FG000|Overall Study|Protocol Violation|3|||
144724866|NCT01546987|521849126|FG001|Overall Study|Protocol Violation|4|||
144724867|NCT02518113|521849127|FG000|Overall Study|Adverse Event|1|||
144724868|NCT02518113|521849128|FG001|Overall Study|Adverse Event|0|||
144442666|NCT03912233|520821944|FG005|Overall Study|Adverse Event|0|||
144442667|NCT03912233|520821939|FG000|Overall Study|Physician Decision|1|||
144442668|NCT03912233|520821940|FG001|Overall Study|Physician Decision|0|||
144442669|NCT03912233|520821941|FG002|Overall Study|Physician Decision|0|||
144442670|NCT03912233|520821942|FG003|Overall Study|Physician Decision|0|||
144724869|NCT02518113|521849129|FG002|Overall Study|Adverse Event|1|||
144724870|NCT02518113|521849130|FG003|Overall Study|Adverse Event|0|||
144724871|NCT02518113|521849127|FG000|Overall Study|Death|1|||
144724872|NCT02518113|521849128|FG001|Overall Study|Death|2|||
144724873|NCT02518113|521849129|FG002|Overall Study|Death|0|||
144724874|NCT02518113|521849130|FG003|Overall Study|Death|0|||
144724875|NCT02518113|521849127|FG000|Overall Study|Physician Decision|0|||
144191806|NCT01351350|519898388|FG004|Overall Study|Participant Decision|2|||
144442671|NCT03912233|520821943|FG004|Overall Study|Physician Decision|0|||
144442672|NCT03912233|520821944|FG005|Overall Study|Physician Decision|0|||
144442673|NCT03912233|520821939|FG000|Overall Study|Other|0|||
144442674|NCT03912233|520821940|FG001|Overall Study|Other|0|||
144442675|NCT03912233|520821941|FG002|Overall Study|Other|0|||
144442676|NCT03912233|520821942|FG003|Overall Study|Other|0|||
144442677|NCT03912233|520821943|FG004|Overall Study|Other|7|||
144442678|NCT03912233|520821944|FG005|Overall Study|Other|12|||
144191807|NCT01351350|519898384|FG000|Overall Study|Enrolled but not Treated|0|||
144724876|NCT02518113|521849128|FG001|Overall Study|Physician Decision|1|||
144191808|NCT01351350|519898385|FG001|Overall Study|Enrolled but not Treated|0|||
144191809|NCT01351350|519898386|FG002|Overall Study|Enrolled but not Treated|1|||
144442679|NCT00501540|520821946|FG000|Overall Study|Death|5|||
144442680|NCT04879745|520821947|FG000|Overall Study|Lost to Follow-up|4|||
144442681|NCT04879745|520821948|FG001|Overall Study|Lost to Follow-up|1|||
144442682|NCT03219333|520821949|FG000|Overall Study|Withdrawal by Subject|9|||
144442683|NCT03219333|520821950|FG001|Overall Study|Withdrawal by Subject|4|||
144442684|NCT03219333|520821949|FG000|Overall Study|Lost to Follow-up|1|||
144442685|NCT03219333|520821950|FG001|Overall Study|Lost to Follow-up|1|||
144724877|NCT02518113|521849129|FG002|Overall Study|Physician Decision|0|||
144724878|NCT02518113|521849130|FG003|Overall Study|Physician Decision|0|||
144191810|NCT01351350|519898387|FG003|Overall Study|Enrolled but not Treated|0|||
144724879|NCT02518113|521849127|FG000|Overall Study|Progressive Disease|1|||
144191811|NCT01351350|519898388|FG004|Overall Study|Enrolled but not Treated|0|||
144442686|NCT03219333|520821949|FG000|Overall Study|Death|104|||
144442687|NCT03219333|520821950|FG001|Overall Study|Death|72|||
144472214|NCT01889186|520926707|FG000|Overall Study|Investigator request|1|||
144724880|NCT02518113|521849128|FG001|Overall Study|Progressive Disease|2|||
144724881|NCT02518113|521849129|FG002|Overall Study|Progressive Disease|3|||
144724882|NCT02518113|521849130|FG003|Overall Study|Progressive Disease|0|||
144724883|NCT00797108|521849131|FG000|Overall Study|Adverse Event|1|||
144724884|NCT00797108|521849132|FG001|Overall Study|Adverse Event|0|||
144724885|NCT00797108|521849133|FG002|Overall Study|Adverse Event|3|||
144724886|NCT00797108|521849131|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
144724887|NCT00797108|521849132|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
144724888|NCT00797108|521849133|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
144724889|NCT00797108|521849131|FG000|Overall Study|Global Deterioration of Health Status|0|||
144724890|NCT00797108|521849132|FG001|Overall Study|Global Deterioration of Health Status|1|||
144724891|NCT00797108|521849133|FG002|Overall Study|Global Deterioration of Health Status|0|||
144724892|NCT00797108|521849131|FG000|Overall Study|Lack of Efficacy|1|||
144724893|NCT00797108|521849132|FG001|Overall Study|Lack of Efficacy|0|||
144724894|NCT00797108|521849133|FG002|Overall Study|Lack of Efficacy|1|||
144724895|NCT00797108|521849131|FG000|Overall Study|Other|0|||
144724896|NCT00797108|521849132|FG001|Overall Study|Other|0|||
144724897|NCT00797108|521849133|FG002|Overall Study|Other|2|||
144724898|NCT00797108|521849131|FG000|Overall Study|Randomized but not Treated|2|||
144724899|NCT00797108|521849132|FG001|Overall Study|Randomized but not Treated|0|||
144724900|NCT00797108|521849133|FG002|Overall Study|Randomized but not Treated|0|||
144724901|NCT00287118|521849134|FG000|Overall Study|Adverse Event|30|||
144724902|NCT00287118|521849134|FG000|Overall Study|Death|1|||
144724903|NCT00287118|521849134|FG000|Overall Study|Lack of Efficacy|11|||
144724904|NCT00287118|521849134|FG000|Overall Study|Lost to Follow-up|1|||
144724905|NCT00287118|521849134|FG000|Overall Study|Protocol Violation|2|||
144724906|NCT00287118|521849134|FG000|Overall Study|Other|7|||
144724907|NCT01631864|521849135|FG000|Overall Study|Withdrawal by Subject|0|||
144724908|NCT01631864|521849136|FG001|Overall Study|Withdrawal by Subject|1|||
144724909|NCT01631864|521849135|FG000|Overall Study|Adverse Event|2|||
144724910|NCT01631864|521849136|FG001|Overall Study|Adverse Event|3|||
144724911|NCT04373434|521849141|FG000|Overall Study|Lost to Follow-up|37|||
144724912|NCT04373434|521849142|FG001|Overall Study|Lost to Follow-up|32|||
144724913|NCT04373434|521849141|FG000|Overall Study|Refused at 9 months|1|||
144724914|NCT04373434|521849142|FG001|Overall Study|Refused at 9 months|2|||
144724915|NCT04373434|521849141|FG000|Overall Study|Refused at 4 months|7|||
144724916|NCT04373434|521849142|FG001|Overall Study|Refused at 4 months|3|||
144724917|NCT04373434|521849141|FG000|Overall Study|Excluded|2|||
144724918|NCT04373434|521849142|FG001|Overall Study|Excluded|0|||
144724919|NCT00527423|521849143|FG000|Overall Study|Protocol Violation|1|||
144724920|NCT00527423|521849143|FG000|Overall Study|Adverse Event|5|||
144724921|NCT00527423|521849143|FG000|Overall Study|Physician Decision|4|||
144724922|NCT00527423|521849143|FG000|Overall Study|Withdrawal by Subject|10|||
144724923|NCT00527423|521849143|FG000|Overall Study|Lost to Follow-up|4|||
144724924|NCT00527423|521849143|FG000|Overall Study|OTHER|4|||
144724925|NCT00527423|521849143|FG000|Overall Study|Death|9|||
144724926|NCT03194464|521849147|FG000|Overall Study|data not usable|2|||
144724927|NCT01860976|521849154|FG000|Blinded Treatment|Adverse Event|1|||
144724928|NCT01860976|521849155|FG001|Blinded Treatment|Adverse Event|3|||
144724929|NCT01860976|521849154|FG000|Blinded Treatment|Lack of Efficacy|5|||
144724930|NCT01860976|521849155|FG001|Blinded Treatment|Lack of Efficacy|12|||
144724931|NCT01860976|521849154|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
144724932|NCT01860976|521849155|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
144724933|NCT01860976|521849154|FG000|Blinded Treatment|Withdrawal by Subject|3|||
144724934|NCT01860976|521849155|FG001|Blinded Treatment|Withdrawal by Subject|5|||
144724935|NCT01860976|521849154|FG000|Blinded Treatment|Subject no longer met criteria|1|||
144724936|NCT01860976|521849155|FG001|Blinded Treatment|Subject no longer met criteria|0|||
144724937|NCT01860976|521849154|FG000|Blinded Treatment|Entered Open-Label in error|0|||
144724938|NCT01860976|521849155|FG001|Blinded Treatment|Entered Open-Label in error|1|||
144724939|NCT01860976|521849154|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
144724940|NCT01860976|521849155|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
144724941|NCT01860976|521849154|FG000|Open-Label|Adverse Event|2|||
144724942|NCT01860976|521849155|FG001|Open-Label|Adverse Event|4|||
144724943|NCT01860976|521849154|FG000|Open-Label|Lack of Efficacy|16|||
144724944|NCT01860976|521849155|FG001|Open-Label|Lack of Efficacy|8|||
144724945|NCT01860976|521849154|FG000|Open-Label|Lost to Follow-up|1|||
144724946|NCT01860976|521849155|FG001|Open-Label|Lost to Follow-up|2|||
144724947|NCT01860976|521849154|FG000|Open-Label|Subject request discontinue treatment|4|||
144724948|NCT01860976|521849155|FG001|Open-Label|Subject request discontinue treatment|3|||
144724949|NCT01860976|521849154|FG000|Open-Label|Withdrawal by Subject|4|||
144724950|NCT01860976|521849155|FG001|Open-Label|Withdrawal by Subject|1|||
144724951|NCT01860976|521849154|FG000|Open-Label|Other Reasons|1|||
144724952|NCT01860976|521849155|FG001|Open-Label|Other Reasons|1|||
144724953|NCT01860976|521849154|FG000|Long Term Extension|Adverse Event|4|||
144724954|NCT01860976|521849155|FG001|Long Term Extension|Adverse Event|0|||
144191812|NCT00775528|519898391|FG000|Overall Study|Protocol Violation|1|||
144724955|NCT01860976|521849154|FG000|Long Term Extension|Lack of Efficacy|2|||
144724956|NCT01860976|521849155|FG001|Long Term Extension|Lack of Efficacy|0|||
144724957|NCT01860976|521849154|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
144442688|NCT03219333|520821949|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
144442689|NCT03219333|520821950|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
144442690|NCT03219333|520821949|FG000|Overall Study|Other|2|||
144442691|NCT03219333|520821950|FG001|Overall Study|Other|2|||
144442692|NCT02566759|520821951|FG000|All Parts|Withdrawal by Subject|0|||
144442693|NCT02566759|520821952|FG001|All Parts|Withdrawal by Subject|1|||
144442694|NCT02566759|520821953|FG002|All Parts|Withdrawal by Subject|0|||
144442695|NCT02566759|520821954|FG003|All Parts|Withdrawal by Subject|0|||
144442696|NCT02566759|520821955|FG004|All Parts|Withdrawal by Subject|0|||
144442697|NCT02566759|520821956|FG005|All Parts|Withdrawal by Subject|0|||
144442698|NCT02566759|520821957|FG006|All Parts|Withdrawal by Subject|0|||
144531871|NCT04186819|521150798|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
144531872|NCT04186819|521150798|FG000|Overall Study|The subject opted for other treatment option|2|||
144531873|NCT04186819|521150798|FG000|Overall Study|The subject opted for other treatment options|1|||
144531874|NCT04186819|521150798|FG000|Overall Study|Withdrawal by Subject|3|||
144531875|NCT04186819|521150798|FG000|Overall Study|Reason not specified|1|||
144531876|NCT03988621|521150800|FG000|Overall Study|Lost to Follow-up|16|||
144531877|NCT03988621|521150801|FG001|Overall Study|Lost to Follow-up|17|||
144531878|NCT03988621|521150800|FG000|Overall Study|Withdrawal by Subject|14|||
144531879|NCT03988621|521150801|FG001|Overall Study|Withdrawal by Subject|7|||
144531880|NCT03988621|521150800|FG000|Overall Study|Patient Lost to Follow Up|15|||
144531881|NCT03988621|521150801|FG001|Overall Study|Patient Lost to Follow Up|15|||
144531882|NCT03988621|521150800|FG000|Overall Study|Patient death|1|||
144531883|NCT03988621|521150801|FG001|Overall Study|Patient death|5|||
144531884|NCT05013385|521150802|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
144531885|NCT04247802|521150803|FG000|Overall Study|Withdrawal by Subject|1|||
144531886|NCT04247802|521150804|FG001|Overall Study|Withdrawal by Subject|3|||
144531887|NCT04247802|521150803|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
144531888|NCT04247802|521150804|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
144531889|NCT02905331|521150806|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
144531890|NCT02905331|521150807|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
144531891|NCT02905331|521150808|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
144531892|NCT02905331|521150806|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
144531893|NCT02905331|521150807|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
144531894|NCT02905331|521150808|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
144531895|NCT02905331|521150806|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
144531896|NCT02905331|521150807|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
144531897|NCT02905331|521150808|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
144531898|NCT02905331|521150806|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
144531899|NCT02905331|521150807|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
144531900|NCT02905331|521150808|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
144531901|NCT02905331|521150806|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
144531902|NCT02905331|521150807|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
144531903|NCT02905331|521150808|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
144531904|NCT04102111|521150816|FG000|Overall Study|Withdrawal by Subject|2|||
144531905|NCT04102111|521150817|FG001|Overall Study|Withdrawal by Subject|3|||
144531906|NCT04102111|521150816|FG000|Overall Study|Adverse Event|1|||
144531907|NCT04102111|521150817|FG001|Overall Study|Adverse Event|1|||
144531908|NCT04102111|521150816|FG000|Overall Study|Study terminated by sponsor|1|||
144531909|NCT04102111|521150817|FG001|Overall Study|Study terminated by sponsor|3|||
144531910|NCT03334695|521150818|FG000|Overall Study|Lost to Follow-up|3|||
144531911|NCT03334695|521150819|FG001|Overall Study|Lost to Follow-up|3|||
144531912|NCT03334695|521150818|FG000|Overall Study|Physician Decision|1|||
144531913|NCT03334695|521150819|FG001|Overall Study|Physician Decision|2|||
144531914|NCT03334695|521150818|FG000|Overall Study|Protocol Violation|0|||
144531915|NCT03334695|521150819|FG001|Overall Study|Protocol Violation|1|||
144531916|NCT02542631|521150820|FG000|Overall Study|Adverse Event|1|||
144531917|NCT02542631|521150821|FG001|Overall Study|Adverse Event|1|||
144531918|NCT02542631|521150820|FG000|Overall Study|Sponsor Termination|1|||
144531919|NCT02542631|521150821|FG001|Overall Study|Sponsor Termination|0|||
144531920|NCT02542631|521150820|FG000|Overall Study|Withdrawal by Subject|11|||
144531921|NCT02542631|521150821|FG001|Overall Study|Withdrawal by Subject|16|||
144531922|NCT02542631|521150820|FG000|Overall Study|Protocol Violation|1|||
144531923|NCT02542631|521150821|FG001|Overall Study|Protocol Violation|1|||
144442699|NCT02566759|520821958|FG007|All Parts|Withdrawal by Subject|0|||
144531924|NCT02542631|521150820|FG000|Overall Study|Physician Decision|6|||
144531925|NCT02542631|521150821|FG001|Overall Study|Physician Decision|4|||
144531926|NCT02542631|521150820|FG000|Overall Study|Lost to Follow-up|6|||
144531927|NCT02542631|521150821|FG001|Overall Study|Lost to Follow-up|5|||
144531928|NCT02542631|521150820|FG000|Overall Study|Death|1|||
144531929|NCT02542631|521150821|FG001|Overall Study|Death|2|||
144442700|NCT02566759|520821959|FG008|All Parts|Withdrawal by Subject|0|||
144442701|NCT02566759|520821960|FG009|All Parts|Withdrawal by Subject|0|||
144605576|NCT02357134|521418977|FG003|Overall Study|Lost to Follow-up|0|||
144605577|NCT01301456|521418978|FG000|Stage 1|Withdrawal by Subject|0|||
144605578|NCT01301456|521418979|FG001|Stage 1|Withdrawal by Subject|0|||
144605579|NCT01301456|521418980|FG002|Stage 1|Withdrawal by Subject|1|||
144605580|NCT01301456|521418981|FG003|Stage 1|Withdrawal by Subject|0|||
144605581|NCT01301456|521418982|FG004|Stage 1|Withdrawal by Subject|1|||
144605582|NCT01301456|521418983|FG005|Stage 1|Withdrawal by Subject|0|||
144605583|NCT01301456|521418984|FG006|Stage 1|Withdrawal by Subject|0|||
144605584|NCT01301456|521418985|FG007|Stage 1|Withdrawal by Subject|0|||
144605585|NCT01301456|521418986|FG008|Stage 1|Withdrawal by Subject|0|||
144605586|NCT01301456|521418987|FG009|Stage 1|Withdrawal by Subject|0|||
144605587|NCT01301456|521418988|FG010|Stage 1|Withdrawal by Subject|0|||
144605588|NCT01301456|521418989|FG011|Stage 1|Withdrawal by Subject|0|||
144605589|NCT01301456|521418978|FG000|Stage 1|Randomized but not treated|0|||
144605590|NCT01301456|521418979|FG001|Stage 1|Randomized but not treated|0|||
144605591|NCT01301456|521418980|FG002|Stage 1|Randomized but not treated|0|||
144605592|NCT01301456|521418981|FG003|Stage 1|Randomized but not treated|0|||
144605593|NCT01301456|521418982|FG004|Stage 1|Randomized but not treated|0|||
144605594|NCT01301456|521418983|FG005|Stage 1|Randomized but not treated|0|||
144605595|NCT01301456|521418984|FG006|Stage 1|Randomized but not treated|1|||
144605596|NCT01301456|521418985|FG007|Stage 1|Randomized but not treated|0|||
144605597|NCT01301456|521418986|FG008|Stage 1|Randomized but not treated|0|||
144605598|NCT01301456|521418987|FG009|Stage 1|Randomized but not treated|0|||
144605599|NCT01301456|521418988|FG010|Stage 1|Randomized but not treated|0|||
144605600|NCT01301456|521418989|FG011|Stage 1|Randomized but not treated|0|||
144605601|NCT01301456|521418978|FG000|Stage 2|Adverse Event|0|||
144605602|NCT01301456|521418979|FG001|Stage 2|Adverse Event|0|||
144605603|NCT01301456|521418980|FG002|Stage 2|Adverse Event|0|||
144605604|NCT01301456|521418981|FG003|Stage 2|Adverse Event|0|||
144605605|NCT01301456|521418982|FG004|Stage 2|Adverse Event|0|||
144605606|NCT01301456|521418983|FG005|Stage 2|Adverse Event|0|||
144605607|NCT01301456|521418984|FG006|Stage 2|Adverse Event|0|||
144605608|NCT01301456|521418985|FG007|Stage 2|Adverse Event|0|||
144605609|NCT01301456|521418986|FG008|Stage 2|Adverse Event|0|||
144605610|NCT01301456|521418987|FG009|Stage 2|Adverse Event|0|||
144253577|NCT04424914|520128140|FG000|Overall Study|Withdrawal by Subject|3|||
144253578|NCT04424914|520128141|FG001|Overall Study|Withdrawal by Subject|0|||
144253579|NCT04424914|520128142|FG002|Overall Study|Withdrawal by Subject|0|||
144253580|NCT04424914|520128140|FG000|Overall Study|Study terminated by sponsor|23|||
144253581|NCT04424914|520128141|FG001|Overall Study|Study terminated by sponsor|7|||
144253582|NCT04424914|520128142|FG002|Overall Study|Study terminated by sponsor|0|||
144253583|NCT04424914|520128140|FG000|Overall Study|Lost to Follow-up|0|||
144442702|NCT02566759|520821961|FG010|All Parts|Withdrawal by Subject|0|||
144442703|NCT02566759|520821962|FG011|All Parts|Withdrawal by Subject|0|||
144442704|NCT02566759|520821963|FG012|All Parts|Withdrawal by Subject|0|||
144442705|NCT02566759|520821964|FG013|All Parts|Withdrawal by Subject|0|||
144442706|NCT02566759|520821965|FG014|All Parts|Withdrawal by Subject|0|||
144442707|NCT02566759|520821966|FG015|All Parts|Withdrawal by Subject|0|||
144442708|NCT02566759|520821967|FG016|All Parts|Withdrawal by Subject|0|||
144442709|NCT02566759|520821951|FG000|All Parts|Adverse Event|0|||
144442710|NCT02566759|520821952|FG001|All Parts|Adverse Event|0|||
144442711|NCT02566759|520821953|FG002|All Parts|Adverse Event|0|||
144442712|NCT02566759|520821954|FG003|All Parts|Adverse Event|0|||
144442713|NCT02566759|520821955|FG004|All Parts|Adverse Event|0|||
144442714|NCT02566759|520821956|FG005|All Parts|Adverse Event|0|||
144442715|NCT02566759|520821957|FG006|All Parts|Adverse Event|0|||
144442716|NCT02566759|520821958|FG007|All Parts|Adverse Event|0|||
144442717|NCT02566759|520821959|FG008|All Parts|Adverse Event|0|||
144442718|NCT02566759|520821960|FG009|All Parts|Adverse Event|0|||
144442719|NCT02566759|520821961|FG010|All Parts|Adverse Event|0|||
144442720|NCT02566759|520821962|FG011|All Parts|Adverse Event|0|||
144605611|NCT01301456|521418988|FG010|Stage 2|Adverse Event|1|||
144605612|NCT01301456|521418989|FG011|Stage 2|Adverse Event|0|||
144605613|NCT05097716|521418992|FG000|Period 1|Adverse Event|1|||
144605614|NCT05097716|521418992|FG000|Period 1|Close contact with highly-transmissible infection|1|||
144605615|NCT00616434|521418993|FG000|Overall Study|Adverse Event|5|||
144253584|NCT04424914|520128141|FG001|Overall Study|Lost to Follow-up|0|||
144253585|NCT04424914|520128142|FG002|Overall Study|Lost to Follow-up|1|||
144253586|NCT04424914|520128140|FG000|Overall Study|Death|3|||
144442721|NCT02566759|520821963|FG012|All Parts|Adverse Event|1|||
144605616|NCT00616434|521418994|FG001|Overall Study|Adverse Event|2|||
144605617|NCT00616434|521418993|FG000|Overall Study|Physician Decision|0|||
144605618|NCT00616434|521418994|FG001|Overall Study|Physician Decision|4|||
144605619|NCT00616434|521418993|FG000|Overall Study|Withdrawal by Subject|1|||
144442722|NCT02566759|520821964|FG013|All Parts|Adverse Event|3|||
144442723|NCT02566759|520821965|FG014|All Parts|Adverse Event|0|||
144442724|NCT02566759|520821966|FG015|All Parts|Adverse Event|0|||
144442725|NCT02566759|520821967|FG016|All Parts|Adverse Event|0|||
144442726|NCT02566759|520821951|FG000|All Parts|Other|0|||
144442727|NCT02566759|520821952|FG001|All Parts|Other|0|||
144605620|NCT00616434|521418994|FG001|Overall Study|Withdrawal by Subject|1|||
144605621|NCT00616434|521418993|FG000|Overall Study|Protocol deviation|0|||
144191813|NCT02087176|519898392|FG000|Overall Study|Withdrawal by Subject|1|||
144191814|NCT02087176|519898392|FG000|Overall Study|Death|10|||
144191815|NCT02087176|519898392|FG000|Overall Study|Censored|19|||
144442728|NCT02566759|520821953|FG002|All Parts|Other|0|||
144442729|NCT02566759|520821954|FG003|All Parts|Other|0|||
144442730|NCT02566759|520821955|FG004|All Parts|Other|0|||
144442731|NCT02566759|520821956|FG005|All Parts|Other|0|||
144442732|NCT02566759|520821957|FG006|All Parts|Other|0|||
144442733|NCT02566759|520821958|FG007|All Parts|Other|0|||
144442734|NCT02566759|520821959|FG008|All Parts|Other|0|||
144442735|NCT02566759|520821960|FG009|All Parts|Other|0|||
144442736|NCT02566759|520821961|FG010|All Parts|Other|0|||
144442737|NCT02566759|520821962|FG011|All Parts|Other|0|||
144442738|NCT02566759|520821963|FG012|All Parts|Other|0|||
144442739|NCT02566759|520821964|FG013|All Parts|Other|2|||
144442740|NCT02566759|520821965|FG014|All Parts|Other|0|||
144442741|NCT02566759|520821966|FG015|All Parts|Other|0|||
144442742|NCT02566759|520821967|FG016|All Parts|Other|0|||
144442743|NCT02566759|520821951|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442744|NCT02566759|520821952|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442745|NCT02566759|520821953|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442746|NCT02566759|520821954|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442747|NCT02566759|520821955|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442748|NCT02566759|520821956|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442749|NCT02566759|520821957|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442750|NCT02566759|520821958|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442751|NCT02566759|520821959|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442752|NCT02566759|520821960|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442753|NCT02566759|520821961|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442754|NCT02566759|520821962|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442755|NCT02566759|520821963|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442756|NCT02566759|520821964|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442757|NCT02566759|520821965|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442758|NCT02566759|520821966|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
144442759|NCT02566759|520821967|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
144442760|NCT01126541|520821968|FG000|Overall Study|Adverse Event|0|||
144442761|NCT01126541|520821969|FG001|Overall Study|Adverse Event|2|||
144442762|NCT01126541|520821970|FG002|Overall Study|Adverse Event|4|||
144442763|NCT01126541|520821968|FG000|Overall Study|Death|0|||
144442764|NCT01126541|520821969|FG001|Overall Study|Death|1|||
144442765|NCT01126541|520821970|FG002|Overall Study|Death|0|||
144442766|NCT01126541|520821968|FG000|Overall Study|Lack of Efficacy|6|||
144442767|NCT01126541|520821969|FG001|Overall Study|Lack of Efficacy|1|||
144442768|NCT01126541|520821970|FG002|Overall Study|Lack of Efficacy|11|||
144442769|NCT01126541|520821968|FG000|Overall Study|Lost to Follow-up|1|||
144442770|NCT01126541|520821969|FG001|Overall Study|Lost to Follow-up|2|||
144442771|NCT01126541|520821970|FG002|Overall Study|Lost to Follow-up|2|||
144442772|NCT01126541|520821968|FG000|Overall Study|Withdrawal by Subject|2|||
144442773|NCT01126541|520821969|FG001|Overall Study|Withdrawal by Subject|5|||
144442774|NCT01126541|520821970|FG002|Overall Study|Withdrawal by Subject|6|||
144442775|NCT01126541|520821968|FG000|Overall Study|Protocol Violation|0|||
144442776|NCT01126541|520821969|FG001|Overall Study|Protocol Violation|0|||
144442777|NCT01126541|520821970|FG002|Overall Study|Protocol Violation|1|||
144442778|NCT01126541|520821968|FG000|Overall Study|Administrative reason or other|1|||
144442779|NCT01126541|520821969|FG001|Overall Study|Administrative reason or other|1|||
144442780|NCT01126541|520821970|FG002|Overall Study|Administrative reason or other|2|||
144442781|NCT03670810|520821973|FG000|Main Study|Adverse Event|37|||
144442782|NCT03670810|520821974|FG001|Main Study|Adverse Event|38|||
144442783|NCT03670810|520821975|FG002|Main Study|Adverse Event|3|||
144442784|NCT03670810|520821976|FG003|Main Study|Adverse Event|4|||
144442785|NCT03670810|520821977|FG004|Main Study|Adverse Event|4|||
144442786|NCT03670810|520821978|FG005|Main Study|Adverse Event|5|||
144442787|NCT03670810|520821979|FG006|Main Study|Adverse Event|0|||
144442788|NCT03670810|520821980|FG007|Main Study|Adverse Event|0|||
144442789|NCT03670810|520821981|FG008|Main Study|Adverse Event|0|||
144442790|NCT03670810|520821973|FG000|Main Study|Lack of Efficacy|8|||
144442791|NCT03670810|520821974|FG001|Main Study|Lack of Efficacy|9|||
144442792|NCT03670810|520821975|FG002|Main Study|Lack of Efficacy|3|||
144442793|NCT03670810|520821976|FG003|Main Study|Lack of Efficacy|4|||
144442794|NCT03670810|520821977|FG004|Main Study|Lack of Efficacy|0|||
144442795|NCT03670810|520821978|FG005|Main Study|Lack of Efficacy|0|||
144442796|NCT03670810|520821979|FG006|Main Study|Lack of Efficacy|0|||
144442797|NCT03670810|520821980|FG007|Main Study|Lack of Efficacy|0|||
144442798|NCT03670810|520821981|FG008|Main Study|Lack of Efficacy|0|||
144442799|NCT03670810|520821973|FG000|Main Study|Lost to Follow-up|9|||
144442800|NCT03670810|520821974|FG001|Main Study|Lost to Follow-up|7|||
144442801|NCT03670810|520821975|FG002|Main Study|Lost to Follow-up|4|||
144442802|NCT03670810|520821976|FG003|Main Study|Lost to Follow-up|6|||
144442803|NCT03670810|520821977|FG004|Main Study|Lost to Follow-up|1|||
144442804|NCT03670810|520821978|FG005|Main Study|Lost to Follow-up|0|||
144191816|NCT02087176|519898392|FG000|Overall Study|Study Terminated by Sponsor|2|||
144191817|NCT00285584|519898393|FG000|Month 3|Lost to Follow-up|3|||
144442805|NCT03670810|520821979|FG006|Main Study|Lost to Follow-up|0|||
144442806|NCT03670810|520821980|FG007|Main Study|Lost to Follow-up|0|||
144442807|NCT03670810|520821981|FG008|Main Study|Lost to Follow-up|0|||
144442808|NCT03670810|520821973|FG000|Main Study|Non-compliance with Study Drug|0|||
144442809|NCT03670810|520821974|FG001|Main Study|Non-compliance with Study Drug|2|||
144442810|NCT03670810|520821975|FG002|Main Study|Non-compliance with Study Drug|3|||
144442811|NCT03670810|520821976|FG003|Main Study|Non-compliance with Study Drug|0|||
144442812|NCT03670810|520821977|FG004|Main Study|Non-compliance with Study Drug|0|||
144442813|NCT03670810|520821978|FG005|Main Study|Non-compliance with Study Drug|0|||
144442814|NCT03670810|520821979|FG006|Main Study|Non-compliance with Study Drug|0|||
144442815|NCT03670810|520821980|FG007|Main Study|Non-compliance with Study Drug|1|||
144191818|NCT00285584|519898394|FG001|Month 3|Lost to Follow-up|3|||
144191819|NCT00285584|519898393|FG000|Month 3|Withdrawal by Subject|1|||
144442816|NCT03670810|520821981|FG008|Main Study|Non-compliance with Study Drug|0|||
144442817|NCT03670810|520821973|FG000|Main Study|Physician Decision|3|||
144442818|NCT03670810|520821974|FG001|Main Study|Physician Decision|0|||
144442819|NCT03670810|520821975|FG002|Main Study|Physician Decision|1|||
144191820|NCT00285584|519898394|FG001|Month 3|Withdrawal by Subject|0|||
144191821|NCT00285584|519898393|FG000|Month 6|Lost to Follow-up|0|||
144191822|NCT00285584|519898394|FG001|Month 6|Lost to Follow-up|1|||
144191823|NCT01103479|519898405|FG000|Overall Study|Up to date with CRC screening|1|||
144191824|NCT01103479|519898406|FG001|Overall Study|Up to date with CRC screening|9|||
144191825|NCT01103479|519898407|FG002|Overall Study|Up to date with CRC screening|12|||
144191826|NCT01103479|519898405|FG000|Overall Study|Family history of CRC|1|||
144191827|NCT01103479|519898406|FG001|Overall Study|Family history of CRC|0|||
144191828|NCT01103479|519898407|FG002|Overall Study|Family history of CRC|2|||
144191829|NCT01103479|519898405|FG000|Overall Study|Active cancer|1|||
144191830|NCT01103479|519898406|FG001|Overall Study|Active cancer|0|||
144191831|NCT01103479|519898407|FG002|Overall Study|Active cancer|0|||
144191832|NCT01103479|519898405|FG000|Overall Study|Saw non-study physician|2|||
144191833|NCT01103479|519898406|FG001|Overall Study|Saw non-study physician|0|||
144191834|NCT01103479|519898407|FG002|Overall Study|Saw non-study physician|0|||
144191835|NCT01523587|519898408|FG000|Overall Study|Other than listed|5|||
144191836|NCT01523587|519898409|FG001|Overall Study|Other than listed|5|||
144191837|NCT01523587|519898408|FG000|Overall Study|Worsening of underlying cancer disease|19|||
144191838|NCT01523587|519898409|FG001|Overall Study|Worsening of underlying cancer disease|34|||
144191839|NCT01523587|519898408|FG000|Overall Study|Adverse Event|68|||
144191840|NCT01523587|519898409|FG001|Overall Study|Adverse Event|52|||
144442820|NCT03670810|520821976|FG003|Main Study|Physician Decision|0|||
144442821|NCT03670810|520821977|FG004|Main Study|Physician Decision|0|||
144442822|NCT03670810|520821978|FG005|Main Study|Physician Decision|0|||
144442823|NCT03670810|520821979|FG006|Main Study|Physician Decision|1|||
144442824|NCT03670810|520821980|FG007|Main Study|Physician Decision|1|||
144442825|NCT03670810|520821981|FG008|Main Study|Physician Decision|0|||
144442826|NCT03670810|520821973|FG000|Main Study|Pregnancy|1|||
144442827|NCT03670810|520821974|FG001|Main Study|Pregnancy|2|||
144442828|NCT03670810|520821975|FG002|Main Study|Pregnancy|0|||
144442829|NCT03670810|520821976|FG003|Main Study|Pregnancy|0|||
144442830|NCT03670810|520821977|FG004|Main Study|Pregnancy|0|||
144442831|NCT03670810|520821978|FG005|Main Study|Pregnancy|0|||
144442832|NCT03670810|520821979|FG006|Main Study|Pregnancy|0|||
144442833|NCT03670810|520821980|FG007|Main Study|Pregnancy|0|||
144442834|NCT03670810|520821981|FG008|Main Study|Pregnancy|0|||
144442835|NCT03670810|520821973|FG000|Main Study|Protocol Deviation|2|||
144442836|NCT03670810|520821974|FG001|Main Study|Protocol Deviation|12|||
144442837|NCT03670810|520821975|FG002|Main Study|Protocol Deviation|8|||
144191841|NCT01523587|519898408|FG000|Overall Study|Protocol Violation|5|||
144191842|NCT01523587|519898409|FG001|Overall Study|Protocol Violation|3|||
144191843|NCT01523587|519898408|FG000|Overall Study|Lost to Follow-up|2|||
144191844|NCT01523587|519898409|FG001|Overall Study|Lost to Follow-up|2|||
144442838|NCT03670810|520821976|FG003|Main Study|Protocol Deviation|4|||
144442839|NCT03670810|520821977|FG004|Main Study|Protocol Deviation|0|||
144442840|NCT03670810|520821978|FG005|Main Study|Protocol Deviation|0|||
144191845|NCT01523587|519898408|FG000|Overall Study|Withdrawal by Subject|28|||
144191846|NCT01523587|519898409|FG001|Overall Study|Withdrawal by Subject|20|||
144442841|NCT03670810|520821979|FG006|Main Study|Protocol Deviation|0|||
144442842|NCT03670810|520821980|FG007|Main Study|Protocol Deviation|0|||
144442843|NCT03670810|520821981|FG008|Main Study|Protocol Deviation|0|||
144442844|NCT03670810|520821973|FG000|Main Study|Withdrawal by Subject|21|||
144442845|NCT03670810|520821974|FG001|Main Study|Withdrawal by Subject|21|||
144442846|NCT03670810|520821975|FG002|Main Study|Withdrawal by Subject|8|||
144442847|NCT03670810|520821976|FG003|Main Study|Withdrawal by Subject|9|||
144442848|NCT03670810|520821977|FG004|Main Study|Withdrawal by Subject|5|||
144442849|NCT03670810|520821978|FG005|Main Study|Withdrawal by Subject|2|||
144442850|NCT03670810|520821979|FG006|Main Study|Withdrawal by Subject|1|||
144442851|NCT03670810|520821980|FG007|Main Study|Withdrawal by Subject|1|||
144442852|NCT03670810|520821981|FG008|Main Study|Withdrawal by Subject|0|||
144472215|NCT01889186|520926708|FG001|Overall Study|Investigator request|1|||
144191847|NCT01523587|519898408|FG000|Overall Study|Withdrew due to Progressive disease|265|||
144191848|NCT01523587|519898409|FG001|Overall Study|Withdrew due to Progressive disease|279|||
144191849|NCT01523587|519898408|FG000|Overall Study|Randomised but bot treated|6|||
144191850|NCT01523587|519898409|FG001|Overall Study|Randomised but bot treated|2|||
144191851|NCT01298778|519898410|FG000|Overall Study|Lost to Follow-up|2|||
144191852|NCT01298778|519898411|FG001|Overall Study|Lost to Follow-up|3|||
144191853|NCT01298778|519898410|FG000|Overall Study|Incorrect use of VAS|1|||
144605622|NCT00616434|521418994|FG001|Overall Study|Protocol deviation|1|||
144605623|NCT00467779|521418997|FG000|Stage 1|Adverse Event|1|||
144605624|NCT00467779|521418998|FG001|Stage 1|Adverse Event|0|||
144605625|NCT00467779|521418999|FG002|Stage 1|Adverse Event|0|||
144605626|NCT00467779|521419000|FG003|Stage 1|Adverse Event|0|||
144605627|NCT00467779|521419001|FG004|Stage 1|Adverse Event|0|||
144724958|NCT01860976|521849155|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
144724959|NCT01860976|521849154|FG000|Long Term Extension|Lost to Follow-up|2|||
144724960|NCT01860976|521849155|FG001|Long Term Extension|Lost to Follow-up|0|||
144724961|NCT01860976|521849154|FG000|Long Term Extension|subject withdrew consent|7|||
144191854|NCT01298778|519898411|FG001|Overall Study|Incorrect use of VAS|0|||
144191855|NCT01298778|519898410|FG000|Overall Study|Withdrawal by Subject|0|||
144191856|NCT01298778|519898411|FG001|Overall Study|Withdrawal by Subject|1|||
144191857|NCT01298778|519898410|FG000|Overall Study|Protocol Violation|0|||
144191858|NCT01298778|519898411|FG001|Overall Study|Protocol Violation|1|||
144191859|NCT01298778|519898410|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
144191860|NCT01298778|519898411|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
144191861|NCT02709486|519898417|FG000|Overall Study|Adverse Event|2|||
144191862|NCT02709486|519898418|FG001|Overall Study|Adverse Event|5|||
144191863|NCT02709486|519898419|FG002|Overall Study|Adverse Event|3|||
144531930|NCT02542631|521150820|FG000|Overall Study|Other|2|||
144531931|NCT02542631|521150821|FG001|Overall Study|Other|1|||
144531932|NCT02542631|521150820|FG000|Overall Study|Used Prohibited Medication|2|||
144531933|NCT02542631|521150821|FG001|Overall Study|Used Prohibited Medication|1|||
144531934|NCT02641730|521150822|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
144531935|NCT02641730|521150823|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144531936|NCT02641730|521150824|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
144531937|NCT02641730|521150825|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
144531938|NCT02641730|521150826|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
144531939|NCT02641730|521150822|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
144531940|NCT02641730|521150823|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
144531941|NCT02641730|521150824|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
144531942|NCT02641730|521150825|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
144531943|NCT02641730|521150826|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
144531944|NCT02641730|521150822|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
144531945|NCT02641730|521150823|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
144531946|NCT02641730|521150824|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
144531947|NCT02641730|521150825|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
144531948|NCT02641730|521150826|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
144531949|NCT02641730|521150822|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144531950|NCT02641730|521150823|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144531951|NCT02641730|521150824|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144531952|NCT02641730|521150825|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
144531953|NCT02641730|521150826|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
144531954|NCT02641730|521150822|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
144531955|NCT02641730|521150823|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
144531956|NCT02641730|521150824|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
144531957|NCT02641730|521150825|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
144531958|NCT02641730|521150826|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
144531959|NCT02641730|521150822|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
144531960|NCT02641730|521150823|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
144531961|NCT02641730|521150824|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
144531962|NCT02641730|521150825|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
144531963|NCT02641730|521150826|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
144531964|NCT05460871|521150827|FG000|Overall Study|Withdrawal by Subject|1|||
144531965|NCT05460871|521150828|FG001|Overall Study|Withdrawal by Subject|2|||
144531966|NCT02938923|521150829|FG000|Overall Study|Death|1|||
144531967|NCT02938923|521150830|FG001|Overall Study|Death|0|||
144531968|NCT02938923|521150831|FG002|Overall Study|Death|0|||
144531969|NCT02938923|521150829|FG000|Overall Study|Physician Decision|0|||
144531970|NCT02938923|521150830|FG001|Overall Study|Physician Decision|2|||
144531971|NCT02938923|521150831|FG002|Overall Study|Physician Decision|0|||
144531972|NCT02938923|521150829|FG000|Overall Study|Withdrawal by Subject|0|||
144531973|NCT02938923|521150830|FG001|Overall Study|Withdrawal by Subject|1|||
144531974|NCT02938923|521150831|FG002|Overall Study|Withdrawal by Subject|1|||
144605628|NCT00467779|521419002|FG005|Stage 1|Adverse Event|1|||
144191864|NCT02709486|519898417|FG000|Overall Study|Death|0|||
144191865|NCT02709486|519898418|FG001|Overall Study|Death|0|||
144191866|NCT02709486|519898419|FG002|Overall Study|Death|2|||
144191867|NCT02709486|519898417|FG000|Overall Study|Insufficient clinical response|7|||
144191868|NCT02709486|519898418|FG001|Overall Study|Insufficient clinical response|3|||
144191869|NCT02709486|519898419|FG002|Overall Study|Insufficient clinical response|3|||
144191870|NCT02709486|519898417|FG000|Overall Study|Lost to Follow-up|3|||
144191871|NCT02709486|519898418|FG001|Overall Study|Lost to Follow-up|2|||
144191872|NCT02709486|519898419|FG002|Overall Study|Lost to Follow-up|2|||
144191873|NCT02709486|519898417|FG000|Overall Study|Other|0|||
144191874|NCT02709486|519898418|FG001|Overall Study|Other|2|||
144191875|NCT02709486|519898419|FG002|Overall Study|Other|3|||
144191876|NCT02709486|519898417|FG000|Overall Study|Withdrawal by Subject|32|||
144191877|NCT02709486|519898418|FG001|Overall Study|Withdrawal by Subject|22|||
144191878|NCT02709486|519898419|FG002|Overall Study|Withdrawal by Subject|32|||
144191879|NCT00606502|519898420|FG000|Randomization|Randomized but not treated|3|||
144191880|NCT00606502|519898421|FG001|Randomization|Randomized but not treated|0|||
144191881|NCT00606502|519898420|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
144191882|NCT00606502|519898421|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
144191883|NCT02443545|519898424|FG000|Overall Study|Adverse Event|1|||
144191884|NCT02443545|519898425|FG001|Overall Study|Adverse Event|1|||
144191885|NCT02443545|519898424|FG000|Overall Study|Lost to Follow-up|0|||
144191886|NCT02443545|519898425|FG001|Overall Study|Lost to Follow-up|2|||
144191887|NCT02443545|519898424|FG000|Overall Study|Physician Decision|3|||
144191888|NCT02443545|519898425|FG001|Overall Study|Physician Decision|0|||
144191889|NCT02443545|519898424|FG000|Overall Study|Protocol Violation|8|||
144191890|NCT02443545|519898425|FG001|Overall Study|Protocol Violation|1|||
144191891|NCT02443545|519898424|FG000|Overall Study|Pregnancy|1|||
144724962|NCT01860976|521849155|FG001|Long Term Extension|subject withdrew consent|0|||
144724963|NCT02354586|521849156|FG000|Overall Study|Death|230|||
144724964|NCT02354586|521849156|FG000|Overall Study|Withdrawal by Subject|59|||
144724965|NCT02354586|521849156|FG000|Overall Study|Lost to Follow-up|11|||
144191892|NCT02443545|519898425|FG001|Overall Study|Pregnancy|1|||
144191893|NCT02443545|519898424|FG000|Overall Study|Withdrawal by Subject|6|||
144724966|NCT02354586|521849156|FG000|Overall Study|Sponsor decision|51|||
144724967|NCT02354586|521849156|FG000|Overall Study|Site closure|2|||
144724968|NCT02354586|521849156|FG000|Overall Study|Intercurrent illness|1|||
144724969|NCT02354586|521849156|FG000|Overall Study|Protocol Violation|3|||
144724970|NCT02354586|521849156|FG000|Overall Study|Physician Decision|13|||
144724971|NCT02354586|521849156|FG000|Overall Study|Lack of Efficacy|86|||
144724972|NCT02354586|521849156|FG000|Overall Study|Adverse Event|7|||
144724973|NCT02153398|521849157|FG000|Overall Study|Withdrawal by Subject|1|||
144724974|NCT02153398|521849158|FG001|Overall Study|Withdrawal by Subject|0|||
144724975|NCT02153398|521849159|FG002|Overall Study|Withdrawal by Subject|0|||
144724976|NCT02153398|521849160|FG003|Overall Study|Withdrawal by Subject|0|||
144724977|NCT02153398|521849161|FG004|Overall Study|Withdrawal by Subject|0|||
144724978|NCT02153398|521849157|FG000|Overall Study|Adverse Event|0|||
144724979|NCT02153398|521849158|FG001|Overall Study|Adverse Event|0|||
144724980|NCT02153398|521849159|FG002|Overall Study|Adverse Event|1|||
144724981|NCT02153398|521849160|FG003|Overall Study|Adverse Event|1|||
144724982|NCT02153398|521849161|FG004|Overall Study|Adverse Event|0|||
144724983|NCT00721409|521849163|FG000|Overall Study|Global deterioration of health status|2|||
144724984|NCT00721409|521849164|FG001|Overall Study|Global deterioration of health status|6|||
144724985|NCT00721409|521849165|FG002|Overall Study|Global deterioration of health status|3|||
144724986|NCT00721409|521849163|FG000|Overall Study|Death|0|||
144724987|NCT00721409|521849164|FG001|Overall Study|Death|1|||
144724988|NCT00721409|521849165|FG002|Overall Study|Death|0|||
144724989|NCT00721409|521849163|FG000|Overall Study|Randomized not Treated|0|||
144724990|NCT00721409|521849164|FG001|Overall Study|Randomized not Treated|1|||
144724991|NCT00721409|521849165|FG002|Overall Study|Randomized not Treated|4|||
144724992|NCT00721409|521849163|FG000|Overall Study|Reason not specified|1|||
144191894|NCT02443545|519898425|FG001|Overall Study|Withdrawal by Subject|3|||
144724993|NCT00721409|521849164|FG001|Overall Study|Reason not specified|0|||
144191895|NCT02443545|519898424|FG000|Overall Study|Termination of study|20|||
144191896|NCT02443545|519898425|FG001|Overall Study|Termination of study|11|||
144191897|NCT02549573|519898429|FG000|Overall Study|Withdrawal by Subject|0|||
144191898|NCT02549573|519898430|FG001|Overall Study|Withdrawal by Subject|2|||
144724994|NCT00721409|521849165|FG002|Overall Study|Reason not specified|2|||
144191899|NCT02549573|519898429|FG000|Overall Study|Protocol Violation|0|||
144191900|NCT02549573|519898430|FG001|Overall Study|Protocol Violation|1|||
144191901|NCT02610816|519898434|FG000|Phase 1|Withdrawal by Subject|2|||
144191902|NCT02610816|519898435|FG001|Phase 1|Withdrawal by Subject|6|||
144191903|NCT02610816|519898436|FG002|Phase 1|Withdrawal by Subject|0|||
144191904|NCT02610816|519898437|FG003|Phase 1|Withdrawal by Subject|0|||
144191905|NCT02610816|519898434|FG000|Phase 1|Lost to Follow-up|2|||
144191906|NCT02610816|519898435|FG001|Phase 1|Lost to Follow-up|1|||
144191907|NCT02610816|519898436|FG002|Phase 1|Lost to Follow-up|0|||
144605629|NCT00467779|521419003|FG006|Stage 1|Adverse Event|2|||
144724995|NCT00721409|521849163|FG000|Overall Study|Adverse Event|0|||
144191908|NCT02610816|519898437|FG003|Phase 1|Lost to Follow-up|0|||
144191909|NCT02610816|519898434|FG000|Phase 1|Physician Decision|0|||
144191910|NCT02610816|519898435|FG001|Phase 1|Physician Decision|1|||
144191911|NCT02610816|519898436|FG002|Phase 1|Physician Decision|0|||
144191912|NCT02610816|519898437|FG003|Phase 1|Physician Decision|0|||
144191913|NCT02610816|519898434|FG000|Phase 2|Withdrawal by Subject|0|||
144191914|NCT02610816|519898435|FG001|Phase 2|Withdrawal by Subject|0|||
144191915|NCT02610816|519898436|FG002|Phase 2|Withdrawal by Subject|9|||
144191916|NCT02610816|519898437|FG003|Phase 2|Withdrawal by Subject|3|||
144191917|NCT02610816|519898434|FG000|Phase 2|Lost to Follow-up|0|||
144191918|NCT02610816|519898435|FG001|Phase 2|Lost to Follow-up|0|||
144191919|NCT02610816|519898436|FG002|Phase 2|Lost to Follow-up|2|||
144191920|NCT02610816|519898437|FG003|Phase 2|Lost to Follow-up|0|||
144191921|NCT02610816|519898434|FG000|Phase 2|Physician Decision|0|||
144191922|NCT02610816|519898435|FG001|Phase 2|Physician Decision|0|||
144191923|NCT02610816|519898436|FG002|Phase 2|Physician Decision|0|||
144191924|NCT02610816|519898437|FG003|Phase 2|Physician Decision|2|||
144191925|NCT02610816|519898434|FG000|Phase 2|Pregnancy|0|||
144191926|NCT02610816|519898435|FG001|Phase 2|Pregnancy|0|||
144191927|NCT02610816|519898436|FG002|Phase 2|Pregnancy|0|||
144191928|NCT02610816|519898437|FG003|Phase 2|Pregnancy|1|||
144191929|NCT01855048|519898438|FG000|Overall Study|Withdrawal by Subject|0|||
144191930|NCT01855048|519898439|FG001|Overall Study|Withdrawal by Subject|1|||
144191931|NCT01855048|519898440|FG002|Overall Study|Withdrawal by Subject|0|||
144191932|NCT01855048|519898441|FG003|Overall Study|Withdrawal by Subject|0|||
144191933|NCT01855048|519898442|FG004|Overall Study|Withdrawal by Subject|1|||
144191934|NCT01855048|519898443|FG005|Overall Study|Withdrawal by Subject|0|||
144191935|NCT01425528|519898444|FG000|Overall Study|Withdrawal by Subject|1|||
144191936|NCT01425528|519898445|FG001|Overall Study|Withdrawal by Subject|1|||
144191937|NCT02697773|519898446|FG000|Overall Study|Adverse Event|2|||
144191938|NCT02697773|519898447|FG001|Overall Study|Adverse Event|1|||
144605630|NCT00467779|521419004|FG007|Stage 1|Adverse Event|1|||
144605631|NCT00467779|521419005|FG008|Stage 1|Adverse Event|0|||
144605632|NCT00467779|521419006|FG009|Stage 1|Adverse Event|0|||
144605633|NCT00467779|521419007|FG010|Stage 1|Adverse Event|0|||
144605634|NCT00467779|521419008|FG011|Stage 1|Adverse Event|0|||
144605635|NCT00467779|521419009|FG012|Stage 1|Adverse Event|0|||
144605636|NCT00467779|521419010|FG013|Stage 1|Adverse Event|0|||
144605637|NCT00467779|521419011|FG014|Stage 1|Adverse Event|0|||
144605638|NCT00467779|521418997|FG000|Stage 1|Disease Progression|2|||
144605639|NCT00467779|521418998|FG001|Stage 1|Disease Progression|2|||
144605640|NCT00467779|521418999|FG002|Stage 1|Disease Progression|2|||
144605641|NCT00467779|521419000|FG003|Stage 1|Disease Progression|3|||
144605642|NCT00467779|521419001|FG004|Stage 1|Disease Progression|2|||
144605643|NCT00467779|521419002|FG005|Stage 1|Disease Progression|2|||
144605644|NCT00467779|521419003|FG006|Stage 1|Disease Progression|4|||
144605645|NCT00467779|521419004|FG007|Stage 1|Disease Progression|5|||
144605646|NCT00467779|521419005|FG008|Stage 1|Disease Progression|0|||
144605647|NCT00467779|521419006|FG009|Stage 1|Disease Progression|0|||
144605648|NCT00467779|521419007|FG010|Stage 1|Disease Progression|0|||
144605649|NCT00467779|521419008|FG011|Stage 1|Disease Progression|0|||
144605650|NCT00467779|521419009|FG012|Stage 1|Disease Progression|0|||
144605651|NCT00467779|521419010|FG013|Stage 1|Disease Progression|0|||
144605652|NCT00467779|521419011|FG014|Stage 1|Disease Progression|0|||
144605653|NCT00467779|521418997|FG000|Stage 1|Unspecified Reason|1|||
144605654|NCT00467779|521418998|FG001|Stage 1|Unspecified Reason|0|||
144605655|NCT00467779|521418999|FG002|Stage 1|Unspecified Reason|1|||
144605656|NCT00467779|521419000|FG003|Stage 1|Unspecified Reason|0|||
144605657|NCT00467779|521419001|FG004|Stage 1|Unspecified Reason|1|||
144605658|NCT00467779|521419002|FG005|Stage 1|Unspecified Reason|2|||
144605659|NCT00467779|521419003|FG006|Stage 1|Unspecified Reason|0|||
144605660|NCT00467779|521419004|FG007|Stage 1|Unspecified Reason|0|||
144605661|NCT00467779|521419005|FG008|Stage 1|Unspecified Reason|0|||
144191939|NCT02697773|519898448|FG002|Overall Study|Adverse Event|2|||
144605662|NCT00467779|521419006|FG009|Stage 1|Unspecified Reason|0|||
144605663|NCT00467779|521419007|FG010|Stage 1|Unspecified Reason|0|||
144605664|NCT00467779|521419008|FG011|Stage 1|Unspecified Reason|0|||
144605665|NCT00467779|521419009|FG012|Stage 1|Unspecified Reason|0|||
144605666|NCT00467779|521419010|FG013|Stage 1|Unspecified Reason|0|||
144605667|NCT00467779|521419011|FG014|Stage 1|Unspecified Reason|0|||
144605668|NCT00467779|521418997|FG000|Stage 1|Physician Decision|0|||
144605669|NCT00467779|521418998|FG001|Stage 1|Physician Decision|1|||
144191940|NCT02697773|519898446|FG000|Overall Study|Death|0|||
144191941|NCT02697773|519898447|FG001|Overall Study|Death|0|||
144191942|NCT02697773|519898448|FG002|Overall Study|Death|2|||
144191943|NCT02697773|519898446|FG000|Overall Study|Lack of Efficacy|4|||
144191944|NCT02697773|519898447|FG001|Overall Study|Lack of Efficacy|6|||
144191945|NCT02697773|519898448|FG002|Overall Study|Lack of Efficacy|6|||
144191946|NCT02697773|519898446|FG000|Overall Study|Lost to Follow-up|5|||
144191947|NCT02697773|519898447|FG001|Overall Study|Lost to Follow-up|5|||
144605670|NCT00467779|521418999|FG002|Stage 1|Physician Decision|0|||
144605671|NCT00467779|521419000|FG003|Stage 1|Physician Decision|0|||
144191948|NCT02697773|519898448|FG002|Overall Study|Lost to Follow-up|7|||
144191949|NCT02697773|519898446|FG000|Overall Study|Other|15|||
144442853|NCT03670810|520821973|FG000|Main Study|Participant did not want to take the three other treatments|1|||
144442854|NCT03670810|520821974|FG001|Main Study|Participant did not want to take the three other treatments|0|||
144442855|NCT03670810|520821975|FG002|Main Study|Participant did not want to take the three other treatments|0|||
144442856|NCT03670810|520821976|FG003|Main Study|Participant did not want to take the three other treatments|0|||
144442857|NCT03670810|520821977|FG004|Main Study|Participant did not want to take the three other treatments|0|||
144442858|NCT03670810|520821978|FG005|Main Study|Participant did not want to take the three other treatments|0|||
144442859|NCT03670810|520821979|FG006|Main Study|Participant did not want to take the three other treatments|0|||
144442860|NCT03670810|520821980|FG007|Main Study|Participant did not want to take the three other treatments|0|||
144442861|NCT03670810|520821981|FG008|Main Study|Participant did not want to take the three other treatments|0|||
144442862|NCT03670810|520821973|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442863|NCT03670810|520821974|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
144531975|NCT00721149|521150832|FG000|Overall Study|Physician Decision|1|||
144531976|NCT04583280|521150835|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
144531977|NCT04583280|521150836|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
144531978|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
144724996|NCT00721409|521849164|FG001|Overall Study|Adverse Event|13|||
144724997|NCT00721409|521849165|FG002|Overall Study|Adverse Event|2|||
144191950|NCT02697773|519898447|FG001|Overall Study|Other|11|||
144191951|NCT02697773|519898448|FG002|Overall Study|Other|10|||
144191952|NCT02697773|519898446|FG000|Overall Study|Protocol Violation|1|||
144191953|NCT02697773|519898447|FG001|Overall Study|Protocol Violation|1|||
144191954|NCT02697773|519898448|FG002|Overall Study|Protocol Violation|0|||
144191955|NCT02697773|519898446|FG000|Overall Study|Withdrawal by Subject|10|||
144191956|NCT02697773|519898447|FG001|Overall Study|Withdrawal by Subject|13|||
144191957|NCT02697773|519898448|FG002|Overall Study|Withdrawal by Subject|13|||
144191958|NCT02697773|519898446|FG000|Overall Study|Randomized but not treated|1|||
144191959|NCT02697773|519898447|FG001|Overall Study|Randomized but not treated|1|||
144191960|NCT02697773|519898448|FG002|Overall Study|Randomized but not treated|0|||
144191961|NCT00613834|519898449|FG000|Overall Study|Withdrawal by Subject|0|||
144191962|NCT00613834|519898450|FG001|Overall Study|Withdrawal by Subject|3|||
144191963|NCT00842530|519898451|FG000|Overall Study|Serious adverse event|0|||
144191964|NCT00842530|519898452|FG001|Overall Study|Serious adverse event|6|||
144191965|NCT00842530|519898451|FG000|Overall Study|Other adverse event|6|||
144191966|NCT00842530|519898452|FG001|Overall Study|Other adverse event|1|||
144191967|NCT00842530|519898451|FG000|Overall Study|Protocol Violation|32|||
144191968|NCT00842530|519898452|FG001|Overall Study|Protocol Violation|14|||
144191969|NCT00842530|519898451|FG000|Overall Study|Lost to Follow-up|6|||
144191970|NCT00842530|519898452|FG001|Overall Study|Lost to Follow-up|8|||
144724998|NCT00721409|521849163|FG000|Overall Study|Lost to Follow-up|0|||
144191971|NCT00842530|519898451|FG000|Overall Study|Withdrawal by Subject|73|||
144191972|NCT00842530|519898452|FG001|Overall Study|Withdrawal by Subject|28|||
144442864|NCT03670810|520821975|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144531979|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
144531980|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
144531981|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
144531982|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
144531983|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
144531984|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
144531985|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
144531986|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
144531987|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
144531988|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
144531989|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
144531990|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
144531991|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
144531992|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
144531993|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
144531994|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
144531995|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
144531996|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
144531997|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
144531998|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
144531999|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
144532000|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
144191973|NCT02939950|519898453|FG000|Overall Study|Lost to Follow-up|13|||
144191974|NCT02939950|519898454|FG001|Overall Study|Lost to Follow-up|16|||
144191975|NCT02939950|519898453|FG000|Overall Study|Positive slit lamp findings|0|||
144191976|NCT02939950|519898454|FG001|Overall Study|Positive slit lamp findings|1|||
144191977|NCT02939950|519898453|FG000|Overall Study|Chalazion upper lid|0|||
144191978|NCT02939950|519898454|FG001|Overall Study|Chalazion upper lid|1|||
144191979|NCT02939950|519898453|FG000|Overall Study|Lack of motivation|0|||
144191980|NCT02939950|519898454|FG001|Overall Study|Lack of motivation|2|||
144191981|NCT02939950|519898453|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
144191982|NCT02939950|519898454|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
144191983|NCT02939950|519898453|FG000|Overall Study|Military orders|1|||
144191984|NCT02939950|519898454|FG001|Overall Study|Military orders|0|||
144191985|NCT02939950|519898453|FG000|Overall Study|Participant Relocated|5|||
144191986|NCT02939950|519898454|FG001|Overall Study|Participant Relocated|3|||
144191987|NCT02939950|519898453|FG000|Overall Study|Study related symptoms|8|||
144191988|NCT02939950|519898454|FG001|Overall Study|Study related symptoms|8|||
144191989|NCT02939950|519898453|FG000|Overall Study|Unacceptable lens movement|2|||
144191990|NCT02939950|519898454|FG001|Overall Study|Unacceptable lens movement|0|||
144191991|NCT02939950|519898453|FG000|Overall Study|Protocol Violation|6|||
144191992|NCT02939950|519898454|FG001|Overall Study|Protocol Violation|3|||
144191993|NCT02939950|519898453|FG000|Overall Study|Physician Decision|2|||
144191994|NCT02939950|519898454|FG001|Overall Study|Physician Decision|0|||
144191995|NCT02939950|519898453|FG000|Overall Study|Pregnancy|6|||
144191996|NCT02939950|519898454|FG001|Overall Study|Pregnancy|7|||
144191997|NCT02939950|519898453|FG000|Overall Study|Withdrawal by Subject|12|||
144191998|NCT02939950|519898454|FG001|Overall Study|Withdrawal by Subject|28|||
144191999|NCT02939950|519898453|FG000|Overall Study|Adverse Event|7|||
144192000|NCT02939950|519898454|FG001|Overall Study|Adverse Event|3|||
144192001|NCT02939950|519898453|FG000|Overall Study|Randomized, not dispensed|1|||
144192002|NCT02939950|519898454|FG001|Overall Study|Randomized, not dispensed|0|||
144192003|NCT02939950|519898453|FG000|Overall Study|Ineligible at Baseline|2|||
144192004|NCT02939950|519898454|FG001|Overall Study|Ineligible at Baseline|8|||
144192005|NCT02243293|519898455|FG000|Overall Study|Adverse Event|1|||
144442865|NCT03670810|520821976|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442866|NCT03670810|520821977|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442867|NCT03670810|520821978|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442868|NCT03670810|520821979|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442869|NCT03670810|520821980|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442870|NCT03670810|520821981|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
144442871|NCT03670810|520821973|FG000|Main Study|Travel and Coronavirus issues|0|||
144442872|NCT03670810|520821974|FG001|Main Study|Travel and Coronavirus issues|0|||
144442873|NCT03670810|520821975|FG002|Main Study|Travel and Coronavirus issues|0|||
144442874|NCT03670810|520821976|FG003|Main Study|Travel and Coronavirus issues|1|||
144442875|NCT03670810|520821977|FG004|Main Study|Travel and Coronavirus issues|0|||
144442876|NCT03670810|520821978|FG005|Main Study|Travel and Coronavirus issues|0|||
144442877|NCT03670810|520821979|FG006|Main Study|Travel and Coronavirus issues|0|||
144442878|NCT03670810|520821980|FG007|Main Study|Travel and Coronavirus issues|0|||
144442879|NCT03670810|520821981|FG008|Main Study|Travel and Coronavirus issues|0|||
144442880|NCT03670810|520821973|FG000|Open Label Extension|Protocol Deviation|0|||
144442881|NCT03670810|520821974|FG001|Open Label Extension|Protocol Deviation|0|||
144442882|NCT03670810|520821975|FG002|Open Label Extension|Protocol Deviation|0|||
144442883|NCT03670810|520821976|FG003|Open Label Extension|Protocol Deviation|0|||
144442884|NCT03670810|520821977|FG004|Open Label Extension|Protocol Deviation|0|||
144442885|NCT03670810|520821978|FG005|Open Label Extension|Protocol Deviation|0|||
144442886|NCT03670810|520821979|FG006|Open Label Extension|Protocol Deviation|0|||
144442887|NCT03670810|520821980|FG007|Open Label Extension|Protocol Deviation|0|||
144442888|NCT03670810|520821981|FG008|Open Label Extension|Protocol Deviation|5|||
144442889|NCT03670810|520821973|FG000|Open Label Extension|Death|0|||
144532001|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
144192006|NCT02243293|519898456|FG001|Overall Study|Adverse Event|0|||
144192007|NCT02243293|519898457|FG002|Overall Study|Adverse Event|0|||
144192008|NCT02243293|519898458|FG003|Overall Study|Adverse Event|0|||
144192009|NCT02243293|519898459|FG004|Overall Study|Adverse Event|0|||
144192010|NCT02243293|519898460|FG005|Overall Study|Adverse Event|0|||
144442890|NCT03670810|520821974|FG001|Open Label Extension|Death|0|||
144442891|NCT03670810|520821975|FG002|Open Label Extension|Death|0|||
144442892|NCT03670810|520821976|FG003|Open Label Extension|Death|0|||
144442893|NCT03670810|520821977|FG004|Open Label Extension|Death|0|||
144532002|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
144192011|NCT02243293|519898461|FG006|Overall Study|Adverse Event|0|||
144192012|NCT02243293|519898462|FG007|Overall Study|Adverse Event|0|||
144192013|NCT02243293|519898463|FG008|Overall Study|Adverse Event|0|||
144192014|NCT02243293|519898464|FG009|Overall Study|Adverse Event|0|||
144192015|NCT02243293|519898465|FG010|Overall Study|Adverse Event|0|||
144192016|NCT02243293|519898466|FG011|Overall Study|Adverse Event|0|||
144442894|NCT03670810|520821978|FG005|Open Label Extension|Death|0|||
144442895|NCT03670810|520821979|FG006|Open Label Extension|Death|0|||
144442896|NCT03670810|520821980|FG007|Open Label Extension|Death|0|||
144442897|NCT03670810|520821981|FG008|Open Label Extension|Death|1|||
144532003|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
144532004|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
144532005|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
144532006|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
144532007|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
144532008|NCT04614948|521150837|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
144532009|NCT04614948|521150838|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
144532010|NCT04614948|521150839|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
144532011|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
144532012|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
144532013|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
144532014|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
144532015|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
144532016|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
144532017|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
144532018|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
144532019|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
144532020|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
144532021|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
144532022|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
144532023|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
144532024|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
144532025|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
144532026|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
144532027|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
144532028|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
144532029|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
144532030|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
144532031|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
144532032|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
144532033|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
144532034|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
144532035|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
144532036|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
144532037|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
144532038|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
144532039|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
144532040|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
144532041|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
144532042|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
144532043|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
144532044|NCT04614948|521150837|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
144532045|NCT04614948|521150838|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
144532046|NCT04614948|521150839|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
144532047|NCT00631475|521150840|FG000|Overall Study|Death|18|||
144532048|NCT00631475|521150840|FG000|Overall Study|Adverse Event|14|||
144532049|NCT00631475|521150840|FG000|Overall Study|Withdrew consent|5|||
144532050|NCT00631475|521150840|FG000|Overall Study|Preparation for lung transplant|8|||
144532051|NCT00303459|521150841|FG000|Overall Study|Death|33|||
144532052|NCT00303459|521150842|FG001|Overall Study|Death|44|||
144532053|NCT00303459|521150841|FG000|Overall Study|Withdrawal of consent|32|||
144532054|NCT00303459|521150842|FG001|Overall Study|Withdrawal of consent|26|||
144532055|NCT00303459|521150841|FG000|Overall Study|Lost to Follow-up|5|||
144532056|NCT00303459|521150842|FG001|Overall Study|Lost to Follow-up|4|||
144532057|NCT00303459|521150841|FG000|Overall Study|Administrative reason|7|||
144532058|NCT00303459|521150842|FG001|Overall Study|Administrative reason|7|||
144532059|NCT00303459|521150841|FG000|Overall Study|Decision by the investigator|5|||
144532060|NCT00303459|521150842|FG001|Overall Study|Decision by the investigator|7|||
144532061|NCT00303459|521150841|FG000|Overall Study|Lung transplantation|1|||
144532062|NCT00303459|521150842|FG001|Overall Study|Lung transplantation|1|||
144532063|NCT01570361|521150843|FG000|Overall Study|Subject discontinued|1|||
144532064|NCT01570361|521150844|FG001|Overall Study|Subject discontinued|2|||
144532065|NCT01570361|521150843|FG000|Overall Study|Sponsor closing the study|51|||
144532066|NCT01570361|521150844|FG001|Overall Study|Sponsor closing the study|50|||
144532067|NCT01570361|521150843|FG000|Overall Study|Subject excluded|5|||
144192017|NCT02243293|519898467|FG012|Overall Study|Adverse Event|0|||
144192018|NCT02243293|519898468|FG013|Overall Study|Adverse Event|0|||
144192019|NCT02243293|519898469|FG014|Overall Study|Adverse Event|0|||
144192020|NCT02243293|519898470|FG015|Overall Study|Adverse Event|1|||
144192021|NCT02243293|519898471|FG016|Overall Study|Adverse Event|0|||
144192022|NCT02243293|519898472|FG017|Overall Study|Adverse Event|0|||
144192023|NCT02243293|519898473|FG018|Overall Study|Adverse Event|0|||
144192024|NCT02243293|519898474|FG019|Overall Study|Adverse Event|0|||
144192025|NCT02243293|519898475|FG020|Overall Study|Adverse Event|1|||
144192026|NCT02243293|519898476|FG021|Overall Study|Adverse Event|0|||
144192027|NCT02243293|519898455|FG000|Overall Study|Withdrawal by Subject|1|||
144192028|NCT02243293|519898456|FG001|Overall Study|Withdrawal by Subject|0|||
144192029|NCT02243293|519898457|FG002|Overall Study|Withdrawal by Subject|0|||
144192030|NCT02243293|519898458|FG003|Overall Study|Withdrawal by Subject|0|||
144192031|NCT02243293|519898459|FG004|Overall Study|Withdrawal by Subject|0|||
144192032|NCT02243293|519898460|FG005|Overall Study|Withdrawal by Subject|0|||
144192033|NCT02243293|519898461|FG006|Overall Study|Withdrawal by Subject|0|||
144192034|NCT02243293|519898462|FG007|Overall Study|Withdrawal by Subject|0|||
144192035|NCT02243293|519898463|FG008|Overall Study|Withdrawal by Subject|0|||
144192036|NCT02243293|519898464|FG009|Overall Study|Withdrawal by Subject|1|||
144192037|NCT02243293|519898465|FG010|Overall Study|Withdrawal by Subject|0|||
144192038|NCT02243293|519898466|FG011|Overall Study|Withdrawal by Subject|1|||
144192039|NCT02243293|519898467|FG012|Overall Study|Withdrawal by Subject|0|||
144192040|NCT02243293|519898468|FG013|Overall Study|Withdrawal by Subject|0|||
144192041|NCT02243293|519898469|FG014|Overall Study|Withdrawal by Subject|0|||
144192042|NCT02243293|519898470|FG015|Overall Study|Withdrawal by Subject|0|||
144192043|NCT02243293|519898471|FG016|Overall Study|Withdrawal by Subject|0|||
144192044|NCT02243293|519898472|FG017|Overall Study|Withdrawal by Subject|0|||
144192045|NCT02243293|519898473|FG018|Overall Study|Withdrawal by Subject|0|||
144192046|NCT02243293|519898474|FG019|Overall Study|Withdrawal by Subject|0|||
144192047|NCT02243293|519898475|FG020|Overall Study|Withdrawal by Subject|0|||
144192048|NCT02243293|519898476|FG021|Overall Study|Withdrawal by Subject|1|||
144192049|NCT02243293|519898455|FG000|Overall Study|Lost to Follow-up|0|||
144192050|NCT02243293|519898456|FG001|Overall Study|Lost to Follow-up|1|||
144192051|NCT02243293|519898457|FG002|Overall Study|Lost to Follow-up|1|||
144192052|NCT02243293|519898458|FG003|Overall Study|Lost to Follow-up|1|||
144192053|NCT02243293|519898459|FG004|Overall Study|Lost to Follow-up|0|||
144192054|NCT02243293|519898460|FG005|Overall Study|Lost to Follow-up|0|||
144192055|NCT02243293|519898461|FG006|Overall Study|Lost to Follow-up|3|||
144192056|NCT02243293|519898462|FG007|Overall Study|Lost to Follow-up|0|||
144192057|NCT02243293|519898463|FG008|Overall Study|Lost to Follow-up|0|||
144192058|NCT02243293|519898464|FG009|Overall Study|Lost to Follow-up|0|||
144192059|NCT02243293|519898465|FG010|Overall Study|Lost to Follow-up|0|||
144442898|NCT03670810|520821973|FG000|Open Label Extension|COVID-19|0|||
144442899|NCT03670810|520821974|FG001|Open Label Extension|COVID-19|0|||
144442900|NCT03670810|520821975|FG002|Open Label Extension|COVID-19|0|||
144442901|NCT03670810|520821976|FG003|Open Label Extension|COVID-19|0|||
144442902|NCT03670810|520821977|FG004|Open Label Extension|COVID-19|0|||
144442903|NCT03670810|520821978|FG005|Open Label Extension|COVID-19|0|||
144442904|NCT03670810|520821979|FG006|Open Label Extension|COVID-19|0|||
144442905|NCT03670810|520821980|FG007|Open Label Extension|COVID-19|0|||
144532068|NCT01570361|521150844|FG001|Overall Study|Subject excluded|3|||
144192060|NCT02243293|519898466|FG011|Overall Study|Lost to Follow-up|2|||
144442906|NCT03670810|520821981|FG008|Open Label Extension|COVID-19|1|||
144442907|NCT03670810|520821973|FG000|Open Label Extension|Lack of Efficacy|0|||
144442908|NCT03670810|520821974|FG001|Open Label Extension|Lack of Efficacy|0|||
144442909|NCT03670810|520821975|FG002|Open Label Extension|Lack of Efficacy|0|||
144442910|NCT03670810|520821976|FG003|Open Label Extension|Lack of Efficacy|0|||
144442911|NCT03670810|520821977|FG004|Open Label Extension|Lack of Efficacy|0|||
144442912|NCT03670810|520821978|FG005|Open Label Extension|Lack of Efficacy|0|||
144442913|NCT03670810|520821979|FG006|Open Label Extension|Lack of Efficacy|0|||
144442914|NCT03670810|520821980|FG007|Open Label Extension|Lack of Efficacy|0|||
144442915|NCT03670810|520821981|FG008|Open Label Extension|Lack of Efficacy|39|||
144442916|NCT03670810|520821973|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
144442917|NCT03670810|520821974|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
144442918|NCT03670810|520821975|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
144442919|NCT03670810|520821976|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
144442920|NCT03670810|520821977|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
144192061|NCT02243293|519898467|FG012|Overall Study|Lost to Follow-up|0|||
144192062|NCT02243293|519898468|FG013|Overall Study|Lost to Follow-up|0|||
144192063|NCT02243293|519898469|FG014|Overall Study|Lost to Follow-up|0|||
144192064|NCT02243293|519898470|FG015|Overall Study|Lost to Follow-up|0|||
144192065|NCT02243293|519898471|FG016|Overall Study|Lost to Follow-up|3|||
144192066|NCT02243293|519898472|FG017|Overall Study|Lost to Follow-up|1|||
144192067|NCT02243293|519898473|FG018|Overall Study|Lost to Follow-up|0|||
144192068|NCT02243293|519898474|FG019|Overall Study|Lost to Follow-up|0|||
144532069|NCT01570361|521150843|FG000|Overall Study|Subject withdrew consent|14|||
144192069|NCT02243293|519898475|FG020|Overall Study|Lost to Follow-up|1|||
144192070|NCT02243293|519898476|FG021|Overall Study|Lost to Follow-up|2|||
144192071|NCT02243293|519898455|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
144192072|NCT02243293|519898456|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
144192073|NCT02243293|519898457|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
144192074|NCT02243293|519898458|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
144192075|NCT02243293|519898459|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
144192076|NCT02243293|519898460|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
144192077|NCT02243293|519898461|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
144192078|NCT02243293|519898462|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
144532070|NCT01570361|521150844|FG001|Overall Study|Subject withdrew consent|9|||
144192079|NCT02243293|519898463|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
144192080|NCT02243293|519898464|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
144192081|NCT02243293|519898465|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
144192082|NCT02243293|519898466|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
144192083|NCT02243293|519898467|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
144192084|NCT02243293|519898468|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
144192085|NCT02243293|519898469|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
144192086|NCT02243293|519898470|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
144192087|NCT02243293|519898471|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
144192088|NCT02243293|519898472|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
144192089|NCT02243293|519898473|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
144192090|NCT02243293|519898474|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
144192091|NCT02243293|519898475|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
144192092|NCT02243293|519898476|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
144192093|NCT02243293|519898455|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
144192094|NCT02243293|519898456|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
144192095|NCT02243293|519898457|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
144192096|NCT02243293|519898458|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
144192097|NCT02243293|519898459|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
144192098|NCT02243293|519898460|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
144192099|NCT02243293|519898461|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
144192100|NCT02243293|519898462|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
144192101|NCT02243293|519898463|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
144192102|NCT02243293|519898464|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
144192103|NCT02243293|519898465|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
144192104|NCT02243293|519898466|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
144192105|NCT02243293|519898467|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
144192106|NCT02243293|519898468|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
144192107|NCT02243293|519898469|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
144192108|NCT02243293|519898470|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
144192109|NCT02243293|519898471|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
144192110|NCT02243293|519898472|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
144192111|NCT02243293|519898473|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
144192112|NCT02243293|519898474|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
144192113|NCT02243293|519898475|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
144192114|NCT02243293|519898476|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
144192115|NCT00440115|519898477|FG000|Overall Study|Death|7|||
144192116|NCT00440115|519898478|FG001|Overall Study|Death|9|||
144192117|NCT00440115|519898479|FG002|Overall Study|Death|5|||
144192118|NCT00440115|519898477|FG000|Overall Study|Incarceration|0|||
144192119|NCT00440115|519898478|FG001|Overall Study|Incarceration|2|||
144192120|NCT00440115|519898479|FG002|Overall Study|Incarceration|1|||
144192121|NCT03366194|519898486|FG000|Overall Study|Lost to Follow-up|2|||
144192122|NCT02953678|519898489|FG000|Overall Study|Adverse Event|20|||
144192123|NCT02953678|519898489|FG000|Overall Study|Death|7|||
144192124|NCT02953678|519898489|FG000|Overall Study|Physician Decision|23|||
144192125|NCT02953678|519898489|FG000|Overall Study|Progressive Disease of GVHD|7|||
144192126|NCT02953678|519898489|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
144192127|NCT02953678|519898489|FG000|Overall Study|Withdrawal by participant|3|||
144532071|NCT01570361|521150843|FG000|Overall Study|Adverse Event|2|||
144532072|NCT01570361|521150844|FG001|Overall Study|Adverse Event|1|||
144532073|NCT01570361|521150843|FG000|Overall Study|Lost to Follow-up|4|||
144532074|NCT01570361|521150844|FG001|Overall Study|Lost to Follow-up|4|||
144532075|NCT01570361|521150843|FG000|Overall Study|Death|5|||
144532076|NCT01570361|521150844|FG001|Overall Study|Death|4|||
144532077|NCT01570361|521150843|FG000|Overall Study|Other|0|||
144192128|NCT02953678|519898489|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
144532078|NCT01570361|521150844|FG001|Overall Study|Other|2|||
144192129|NCT02953678|519898489|FG000|Overall Study|Participants were transferred to commercial product.|3|||
144192130|NCT01432574|519900705|FG000|Overall Study|Moved|2|||
144192131|NCT01432574|519900705|FG000|Overall Study|Not interested|1|||
144532079|NCT04129554|521150845|FG000|Overall Study|Withdrawal by Subject|4|||
144192132|NCT00856830|519900710|FG000|Irinotecan & Bendamustine|Death|0|||
144192133|NCT00856830|519900711|FG001|Irinotecan & Bendamustine|Death|0|||
144192134|NCT00856830|519900712|FG002|Irinotecan & Bendamustine|Death|0|||
144192135|NCT00856830|519900713|FG003|Irinotecan & Bendamustine|Death|2|||
144192136|NCT00856830|519900710|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
144192137|NCT00856830|519900711|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
144192138|NCT00856830|519900712|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
144192139|NCT00856830|519900713|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
144192140|NCT03768726|519900716|FG000|Treatment Phase|Adverse Event|2|||
144192141|NCT03768726|519900717|FG001|Treatment Phase|Adverse Event|2|||
144192142|NCT03768726|519900716|FG000|Treatment Phase|Lost to Follow-up|1|||
144192143|NCT03768726|519900717|FG001|Treatment Phase|Lost to Follow-up|0|||
144192144|NCT03768726|519900716|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
144192145|NCT03768726|519900717|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
144192146|NCT03768726|519900716|FG000|Treatment Phase|Withdrawal by Subject|3|||
144192147|NCT03768726|519900717|FG001|Treatment Phase|Withdrawal by Subject|1|||
144192148|NCT03768726|519900716|FG000|Follow-Up|Adverse Event|2|||
144192149|NCT03768726|519900717|FG001|Follow-Up|Adverse Event|2|||
144192150|NCT03768726|519900716|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
144192151|NCT03768726|519900717|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
144192152|NCT03768726|519900716|FG000|Follow-Up|Withdrawal by Subject|2|||
144192153|NCT03768726|519900717|FG001|Follow-Up|Withdrawal by Subject|0|||
144192154|NCT03768726|519900716|FG000|Follow-Up|Other|1|||
144192155|NCT03768726|519900717|FG001|Follow-Up|Other|0|||
144192156|NCT01286558|519900718|FG000|Overall Study|Adverse Event|1|||
144192157|NCT01286558|519900719|FG001|Overall Study|Adverse Event|1|||
144192158|NCT01286558|519900718|FG000|Overall Study|Withdrawal by Subject|0|||
144192159|NCT01286558|519900719|FG001|Overall Study|Withdrawal by Subject|1|||
144192160|NCT01787279|519900721|FG000|Overall Study|Lost to Follow-up|2|||
144192161|NCT01787279|519900721|FG000|Overall Study|Lack of Efficacy|1|||
144192162|NCT00140413|519900723|FG000|Overall Study|Lost to Follow-up|1|||
144192163|NCT00140413|519900724|FG001|Overall Study|Lost to Follow-up|0|||
144192164|NCT00140413|519900723|FG000|Overall Study|Withdrawal by Subject|2|||
144192165|NCT00140413|519900724|FG001|Overall Study|Withdrawal by Subject|0|||
144192166|NCT02694549|519900725|FG000|Overall Study|screen failures|2|||
144192167|NCT03265288|519900728|FG000|Overall Study|Adverse Event|0|||
144192168|NCT03265288|519900729|FG001|Overall Study|Adverse Event|1|||
144192169|NCT03265288|519900728|FG000|Overall Study|Withdrawal by Subject|13|||
144192170|NCT03265288|519900729|FG001|Overall Study|Withdrawal by Subject|5|||
144192171|NCT03265288|519900728|FG000|Overall Study|Drug Withdrawn|3|||
144192172|NCT03265288|519900729|FG001|Overall Study|Drug Withdrawn|3|||
144192173|NCT03265288|519900728|FG000|Overall Study|Any Other Reason|7|||
144192174|NCT03265288|519900729|FG001|Overall Study|Any Other Reason|3|||
144192175|NCT00099268|519900735|FG000|Overall Study|Withdrawal by Subject|46|||
144192176|NCT00099268|519900736|FG001|Overall Study|Withdrawal by Subject|28|||
144192177|NCT00099268|519900735|FG000|Overall Study|Adverse Event|19|||
144192178|NCT00099268|519900736|FG001|Overall Study|Adverse Event|19|||
144442921|NCT03670810|520821978|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
144442922|NCT03670810|520821979|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
144442923|NCT03670810|520821980|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
144442924|NCT03670810|520821981|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
144442925|NCT03670810|520821973|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144192179|NCT00099268|519900735|FG000|Overall Study|Protocol Violation|9|||
144192180|NCT00099268|519900736|FG001|Overall Study|Protocol Violation|8|||
144192181|NCT00099268|519900735|FG000|Overall Study|Lost to Follow-up|6|||
144192182|NCT00099268|519900736|FG001|Overall Study|Lost to Follow-up|4|||
144192183|NCT00099268|519900735|FG000|Overall Study|Lack of Efficacy|5|||
144192184|NCT00099268|519900736|FG001|Overall Study|Lack of Efficacy|18|||
144192185|NCT00099268|519900735|FG000|Overall Study|Administrative problems|4|||
144724999|NCT00721409|521849164|FG001|Overall Study|Lost to Follow-up|0|||
144192186|NCT00099268|519900736|FG001|Overall Study|Administrative problems|4|||
144192187|NCT00099268|519900735|FG000|Overall Study|Death|3|||
144192188|NCT00099268|519900736|FG001|Overall Study|Death|1|||
144192189|NCT00918463|519900739|FG000|Overall Study|Death|1|||
144192190|NCT00918463|519900739|FG000|Overall Study|Lack of Efficacy|1|||
144192191|NCT05506358|519900744|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
144192192|NCT05506358|519900745|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
144192193|NCT05506358|519900746|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
144442926|NCT03670810|520821974|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144442927|NCT03670810|520821975|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144192194|NCT05506358|519900747|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
144192195|NCT05506358|519900748|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
144192196|NCT05506358|519900744|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
144442928|NCT03670810|520821976|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144192197|NCT05506358|519900745|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
144192198|NCT05506358|519900746|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
144192199|NCT05506358|519900747|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
144192200|NCT05506358|519900748|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
144192201|NCT05506358|519900744|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
144192202|NCT05506358|519900745|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
144192203|NCT05506358|519900746|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
144192204|NCT05506358|519900747|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
144192205|NCT05506358|519900748|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
144442929|NCT03670810|520821977|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144442930|NCT03670810|520821978|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144442931|NCT03670810|520821979|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144442932|NCT03670810|520821980|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
144442933|NCT03670810|520821981|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
144442934|NCT03670810|520821973|FG000|Open Label Extension|Withdrawal by Subject|0|||
144442935|NCT03670810|520821974|FG001|Open Label Extension|Withdrawal by Subject|0|||
144442936|NCT03670810|520821975|FG002|Open Label Extension|Withdrawal by Subject|0|||
144442937|NCT03670810|520821976|FG003|Open Label Extension|Withdrawal by Subject|0|||
144442938|NCT03670810|520821977|FG004|Open Label Extension|Withdrawal by Subject|0|||
144442939|NCT03670810|520821978|FG005|Open Label Extension|Withdrawal by Subject|0|||
144442940|NCT03670810|520821979|FG006|Open Label Extension|Withdrawal by Subject|0|||
144442941|NCT03670810|520821980|FG007|Open Label Extension|Withdrawal by Subject|0|||
144442942|NCT03670810|520821981|FG008|Open Label Extension|Withdrawal by Subject|46|||
144442943|NCT03670810|520821973|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144442944|NCT03670810|520821974|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144532080|NCT04129554|521150846|FG001|Overall Study|Withdrawal by Subject|3|||
144532081|NCT04129554|521150845|FG000|Overall Study|Other|0|||
144532082|NCT04129554|521150846|FG001|Overall Study|Other|2|||
144532083|NCT03606512|521150847|FG000|Overall Study|Lost to Follow-up|0|||
144532084|NCT03606512|521150848|FG001|Overall Study|Lost to Follow-up|1|||
144532085|NCT03606512|521150847|FG000|Overall Study|'moved from study area|0|||
144532086|NCT03606512|521150848|FG001|Overall Study|'moved from study area|1|||
144532087|NCT05513937|521150849|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
144532088|NCT05513937|521150850|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
144532089|NCT05513937|521150851|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
144532090|NCT05513937|521150852|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
144532091|NCT05513937|521150849|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
144532092|NCT05513937|521150850|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
144532093|NCT05513937|521150851|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
144532094|NCT05513937|521150852|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
144532095|NCT05513937|521150849|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
144532096|NCT05513937|521150850|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
144532097|NCT05513937|521150851|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
144532098|NCT05513937|521150852|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
144532099|NCT05513937|521150849|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
144532100|NCT05513937|521150850|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
144532101|NCT05513937|521150851|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
144532102|NCT05513937|521150852|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
144532103|NCT05513937|521150849|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
144532104|NCT05513937|521150850|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
144532105|NCT05513937|521150851|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
144532106|NCT05513937|521150852|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
144532107|NCT05513937|521150849|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
144532108|NCT05513937|521150850|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
144532109|NCT05513937|521150851|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
144532110|NCT05513937|521150852|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
144532111|NCT02846545|521150853|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
144532112|NCT02846545|521150854|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
144725000|NCT00721409|521849165|FG002|Overall Study|Lost to Follow-up|1|||
144442945|NCT03670810|520821975|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144442946|NCT03670810|520821976|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144532113|NCT02846545|521150853|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
144605672|NCT00467779|521419001|FG004|Stage 1|Physician Decision|0|||
144192206|NCT05506358|519900744|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
144192207|NCT05506358|519900745|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
144192208|NCT05506358|519900746|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
144192209|NCT05506358|519900747|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
144192210|NCT05506358|519900748|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
144192211|NCT05506358|519900744|FG000|Overall Study|HbE trait|0|||
144442947|NCT03670810|520821977|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144442948|NCT03670810|520821978|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144442949|NCT03670810|520821979|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144442950|NCT03670810|520821980|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
144442951|NCT03670810|520821981|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
144442952|NCT03670810|520821973|FG000|Open Label Extension|Physician Decision|0|||
144442953|NCT03670810|520821974|FG001|Open Label Extension|Physician Decision|0|||
144442954|NCT03670810|520821975|FG002|Open Label Extension|Physician Decision|0|||
144442955|NCT03670810|520821976|FG003|Open Label Extension|Physician Decision|0|||
144442956|NCT03670810|520821977|FG004|Open Label Extension|Physician Decision|0|||
144442957|NCT03670810|520821978|FG005|Open Label Extension|Physician Decision|0|||
144442958|NCT03670810|520821979|FG006|Open Label Extension|Physician Decision|0|||
144442959|NCT03670810|520821980|FG007|Open Label Extension|Physician Decision|0|||
144442960|NCT03670810|520821981|FG008|Open Label Extension|Physician Decision|2|||
144442961|NCT03670810|520821973|FG000|Open Label Extension|Non-compliance with study drug|0|||
144532114|NCT02846545|521150854|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
144532115|NCT02846545|521150853|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
144532116|NCT02846545|521150854|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
144532117|NCT02846545|521150853|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
144532118|NCT02846545|521150854|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
144532119|NCT02846545|521150853|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
144532120|NCT02846545|521150854|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
144532121|NCT03691298|521150857|FG000|Overall Study|Lost to Follow-up|8|||
144532122|NCT03691298|521150857|FG000|Overall Study|Sponsor terminated study|2|||
144532123|NCT05962814|521150861|FG000|Overall Study|failed eligibility|1|||
144532124|NCT03057054|521150862|FG000|Overall Study|Death|4|||
144532125|NCT03057054|521150863|FG001|Overall Study|Death|4|||
144532126|NCT03057054|521150862|FG000|Overall Study|Withdrawal by Subject|6|||
144532127|NCT03057054|521150863|FG001|Overall Study|Withdrawal by Subject|3|||
144532128|NCT03057054|521150862|FG000|Overall Study|Ineligible|1|||
144532129|NCT03057054|521150863|FG001|Overall Study|Ineligible|1|||
144532130|NCT01130883|521152301|FG000|Overall Study|Patient Noncompliance|6|||
144532131|NCT01130883|521152301|FG000|Overall Study|Reason Unknown|1|||
144532132|NCT01130883|521152301|FG000|Overall Study|Adverse Event|3|||
144532133|NCT02585323|521152302|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
144532134|NCT02585323|521152303|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
144532135|NCT02585323|521152302|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
144532136|NCT02585323|521152303|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
144532137|NCT02585323|521152302|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
144532138|NCT02585323|521152303|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
144532139|NCT02585323|521152302|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
144532140|NCT02585323|521152303|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
144532141|NCT01880515|521152309|FG000|Overall Study|Lost to Follow-up|3|||
144532142|NCT01880515|521152310|FG001|Overall Study|Lost to Follow-up|2|||
144532143|NCT01880515|521152309|FG000|Overall Study|Disease Progression|5|||
144532144|NCT01880515|521152310|FG001|Overall Study|Disease Progression|7|||
144532145|NCT05247034|521152311|FG000|Overall Study|Lost to Follow-up|3|||
144532146|NCT05247034|521152312|FG001|Overall Study|Lost to Follow-up|2|||
144532147|NCT05247034|521152311|FG000|Overall Study|Organizational problems when attending appointments|1|||
144532148|NCT05247034|521152312|FG001|Overall Study|Organizational problems when attending appointments|0|||
144532149|NCT03981926|521152315|FG000|Overall Study|Lost to Follow-up|5|||
144532150|NCT03981926|521152316|FG001|Overall Study|Lost to Follow-up|9|||
144532151|NCT06262347|521152317|FG000|Overall Study|Lost to Follow-up|4|||
144605673|NCT00467779|521419002|FG005|Stage 1|Physician Decision|0|||
144192212|NCT05506358|519900745|FG001|Overall Study|HbE trait|0|||
144192213|NCT05506358|519900746|FG002|Overall Study|HbE trait|0|||
144192214|NCT05506358|519900747|FG003|Overall Study|HbE trait|1|||
144192215|NCT05506358|519900748|FG004|Overall Study|HbE trait|0|||
144532152|NCT06262347|521152318|FG001|Overall Study|Lost to Follow-up|3|||
144532153|NCT06262347|521152317|FG000|Overall Study|Withdrawal by Subject|0|||
144532154|NCT06262347|521152318|FG001|Overall Study|Withdrawal by Subject|1|||
144532155|NCT05464069|521152319|FG000|Overall Study|Protocol Violation|3|||
144532156|NCT05464069|521152320|FG001|Overall Study|Protocol Violation|2|||
144532157|NCT04136912|521152326|FG000|Overall Study|Operational reasons|0|||
144532158|NCT04136912|521152327|FG001|Overall Study|Operational reasons|0|||
144532159|NCT04136912|521152328|FG002|Overall Study|Operational reasons|2|||
144192216|NCT02017860|519900750|FG000|Overall Study|Adverse Event|1|||
144725001|NCT00721409|521849163|FG000|Overall Study|Withdrawal by Subject|1|||
144725002|NCT00721409|521849164|FG001|Overall Study|Withdrawal by Subject|6|||
144192217|NCT02017860|519900750|FG000|Overall Study|Withdrawal by Subject|1|||
144253587|NCT04424914|520128141|FG001|Overall Study|Death|1|||
144253588|NCT04424914|520128142|FG002|Overall Study|Death|0|||
144253589|NCT00460746|520128143|FG000|Overall Study|Adverse Event|1|||
144442962|NCT03670810|520821974|FG001|Open Label Extension|Non-compliance with study drug|0|||
144442963|NCT03670810|520821975|FG002|Open Label Extension|Non-compliance with study drug|0|||
144442964|NCT03670810|520821976|FG003|Open Label Extension|Non-compliance with study drug|0|||
144442965|NCT03670810|520821977|FG004|Open Label Extension|Non-compliance with study drug|0|||
144442966|NCT03670810|520821978|FG005|Open Label Extension|Non-compliance with study drug|0|||
144192218|NCT02010255|519900761|FG000|Overall Study|Death|0|||
144192219|NCT02010255|519900762|FG001|Overall Study|Death|1|||
144192220|NCT02010255|519900763|FG002|Overall Study|Death|4|||
144192221|NCT02010255|519900764|FG003|Overall Study|Death|4|||
144192222|NCT02010255|519900765|FG004|Overall Study|Death|2|||
144192223|NCT02010255|519900766|FG005|Overall Study|Death|0|||
144192224|NCT02010255|519900767|FG006|Overall Study|Death|1|||
144192225|NCT02010255|519900768|FG007|Overall Study|Death|1|||
144192226|NCT02010255|519900769|FG008|Overall Study|Death|1|||
144442967|NCT03670810|520821979|FG006|Open Label Extension|Non-compliance with study drug|0|||
144442968|NCT03670810|520821980|FG007|Open Label Extension|Non-compliance with study drug|0|||
144442969|NCT03670810|520821981|FG008|Open Label Extension|Non-compliance with study drug|5|||
144442970|NCT03670810|520821973|FG000|Open Label Extension|Pregnancy|0|||
144442971|NCT03670810|520821974|FG001|Open Label Extension|Pregnancy|0|||
144442972|NCT03670810|520821975|FG002|Open Label Extension|Pregnancy|0|||
144442973|NCT03670810|520821976|FG003|Open Label Extension|Pregnancy|0|||
144442974|NCT03670810|520821977|FG004|Open Label Extension|Pregnancy|0|||
144442975|NCT03670810|520821978|FG005|Open Label Extension|Pregnancy|0|||
144442976|NCT03670810|520821979|FG006|Open Label Extension|Pregnancy|0|||
144442977|NCT03670810|520821980|FG007|Open Label Extension|Pregnancy|0|||
144442978|NCT03670810|520821981|FG008|Open Label Extension|Pregnancy|3|||
144442979|NCT03670810|520821973|FG000|Open Label Extension|Adverse Event|0|||
144442980|NCT03670810|520821974|FG001|Open Label Extension|Adverse Event|0|||
144442981|NCT03670810|520821975|FG002|Open Label Extension|Adverse Event|0|||
144442982|NCT03670810|520821976|FG003|Open Label Extension|Adverse Event|0|||
144442983|NCT03670810|520821977|FG004|Open Label Extension|Adverse Event|0|||
144442984|NCT03670810|520821978|FG005|Open Label Extension|Adverse Event|0|||
144442985|NCT03670810|520821979|FG006|Open Label Extension|Adverse Event|0|||
144442986|NCT03670810|520821980|FG007|Open Label Extension|Adverse Event|0|||
144442987|NCT03670810|520821981|FG008|Open Label Extension|Adverse Event|24|||
144442988|NCT03670810|520821973|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
144442989|NCT03670810|520821974|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
144442990|NCT03670810|520821975|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
144442991|NCT03670810|520821976|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
144442992|NCT03670810|520821977|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
144442993|NCT03670810|520821978|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
144442994|NCT03670810|520821979|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
144442995|NCT03670810|520821980|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
144442996|NCT03670810|520821981|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
144442997|NCT03670810|520821973|FG000|Open Label Extension|Lost to Follow-up|0|||
144442998|NCT03670810|520821974|FG001|Open Label Extension|Lost to Follow-up|0|||
144442999|NCT03670810|520821975|FG002|Open Label Extension|Lost to Follow-up|0|||
144443000|NCT03670810|520821976|FG003|Open Label Extension|Lost to Follow-up|0|||
144443001|NCT03670810|520821977|FG004|Open Label Extension|Lost to Follow-up|0|||
144443002|NCT03670810|520821978|FG005|Open Label Extension|Lost to Follow-up|0|||
144443003|NCT03670810|520821979|FG006|Open Label Extension|Lost to Follow-up|0|||
144443004|NCT03670810|520821980|FG007|Open Label Extension|Lost to Follow-up|0|||
144443005|NCT03670810|520821981|FG008|Open Label Extension|Lost to Follow-up|23|||
144443006|NCT05459129|520821982|FG000|Overall Study|Death|1|||
144443007|NCT05459129|520821983|FG001|Overall Study|Death|0|||
144443008|NCT05459129|520821982|FG000|Overall Study|Study Terminated By Sponsor|5|||
144605674|NCT00467779|521419003|FG006|Stage 1|Physician Decision|0|||
144192227|NCT02010255|519900770|FG009|Overall Study|Death|0|||
144192228|NCT02010255|519900771|FG010|Overall Study|Death|1|||
144192229|NCT02010255|519900772|FG011|Overall Study|Death|1|||
144192230|NCT02010255|519900773|FG012|Overall Study|Death|0|||
144253590|NCT00460746|520128143|FG000|Overall Study|Lost to Follow-up|1|||
144443009|NCT05459129|520821983|FG001|Overall Study|Study Terminated By Sponsor|6|||
144443010|NCT04182100|520821984|FG000|Overall Study|Adverse Event|1|||
144443011|NCT04182100|520821984|FG000|Overall Study|Withdrawal by Subject|1|||
144443012|NCT04304001|520821988|FG000|Overall Study|Lost to Follow-up|13|||
144605675|NCT00467779|521419004|FG007|Stage 1|Physician Decision|0|||
144192231|NCT02010255|519900774|FG013|Overall Study|Death|0|||
144192232|NCT02010255|519900761|FG000|Overall Study|Lack of Efficacy|4|||
144192233|NCT02010255|519900762|FG001|Overall Study|Lack of Efficacy|1|||
144192234|NCT02010255|519900763|FG002|Overall Study|Lack of Efficacy|2|||
144192235|NCT02010255|519900764|FG003|Overall Study|Lack of Efficacy|1|||
144192236|NCT02010255|519900765|FG004|Overall Study|Lack of Efficacy|1|||
144192237|NCT02010255|519900766|FG005|Overall Study|Lack of Efficacy|0|||
144192238|NCT02010255|519900767|FG006|Overall Study|Lack of Efficacy|0|||
144192239|NCT02010255|519900768|FG007|Overall Study|Lack of Efficacy|0|||
144192240|NCT02010255|519900769|FG008|Overall Study|Lack of Efficacy|0|||
144192241|NCT02010255|519900770|FG009|Overall Study|Lack of Efficacy|0|||
144192242|NCT02010255|519900771|FG010|Overall Study|Lack of Efficacy|1|||
144192243|NCT02010255|519900772|FG011|Overall Study|Lack of Efficacy|0|||
144192244|NCT02010255|519900773|FG012|Overall Study|Lack of Efficacy|0|||
144192245|NCT02010255|519900774|FG013|Overall Study|Lack of Efficacy|0|||
144192246|NCT02010255|519900761|FG000|Overall Study|Withdrew Consent|1|||
144192247|NCT02010255|519900762|FG001|Overall Study|Withdrew Consent|0|||
144192248|NCT02010255|519900763|FG002|Overall Study|Withdrew Consent|0|||
144192249|NCT02010255|519900764|FG003|Overall Study|Withdrew Consent|1|||
144192250|NCT02010255|519900765|FG004|Overall Study|Withdrew Consent|0|||
144192251|NCT02010255|519900766|FG005|Overall Study|Withdrew Consent|0|||
144192252|NCT02010255|519900767|FG006|Overall Study|Withdrew Consent|0|||
144192253|NCT02010255|519900768|FG007|Overall Study|Withdrew Consent|0|||
144192254|NCT02010255|519900769|FG008|Overall Study|Withdrew Consent|0|||
144192255|NCT02010255|519900770|FG009|Overall Study|Withdrew Consent|0|||
144192256|NCT02010255|519900771|FG010|Overall Study|Withdrew Consent|0|||
144192257|NCT02010255|519900772|FG011|Overall Study|Withdrew Consent|0|||
144192258|NCT02010255|519900773|FG012|Overall Study|Withdrew Consent|0|||
144192259|NCT02010255|519900774|FG013|Overall Study|Withdrew Consent|0|||
144192260|NCT02010255|519900761|FG000|Overall Study|Adverse Event|1|||
144192261|NCT02010255|519900762|FG001|Overall Study|Adverse Event|0|||
144192262|NCT02010255|519900763|FG002|Overall Study|Adverse Event|0|||
144192263|NCT02010255|519900764|FG003|Overall Study|Adverse Event|0|||
144192264|NCT02010255|519900765|FG004|Overall Study|Adverse Event|0|||
144192265|NCT02010255|519900766|FG005|Overall Study|Adverse Event|0|||
144192266|NCT02010255|519900767|FG006|Overall Study|Adverse Event|0|||
144192267|NCT02010255|519900768|FG007|Overall Study|Adverse Event|0|||
144192268|NCT02010255|519900769|FG008|Overall Study|Adverse Event|0|||
144192269|NCT02010255|519900770|FG009|Overall Study|Adverse Event|0|||
144725003|NCT00721409|521849165|FG002|Overall Study|Withdrawal by Subject|5|||
144192270|NCT02010255|519900771|FG010|Overall Study|Adverse Event|0|||
144192271|NCT02010255|519900772|FG011|Overall Study|Adverse Event|0|||
144192272|NCT02010255|519900773|FG012|Overall Study|Adverse Event|0|||
144192273|NCT02010255|519900774|FG013|Overall Study|Adverse Event|0|||
144192274|NCT02010255|519900761|FG000|Overall Study|Lost to Follow-up|0|||
144192275|NCT02010255|519900762|FG001|Overall Study|Lost to Follow-up|0|||
144192276|NCT02010255|519900763|FG002|Overall Study|Lost to Follow-up|1|||
144192277|NCT02010255|519900764|FG003|Overall Study|Lost to Follow-up|0|||
144192278|NCT02010255|519900765|FG004|Overall Study|Lost to Follow-up|1|||
144192279|NCT02010255|519900766|FG005|Overall Study|Lost to Follow-up|0|||
144192280|NCT02010255|519900767|FG006|Overall Study|Lost to Follow-up|0|||
144192281|NCT02010255|519900768|FG007|Overall Study|Lost to Follow-up|0|||
144192282|NCT02010255|519900769|FG008|Overall Study|Lost to Follow-up|0|||
144192283|NCT02010255|519900770|FG009|Overall Study|Lost to Follow-up|0|||
144192284|NCT02010255|519900771|FG010|Overall Study|Lost to Follow-up|0|||
144192285|NCT02010255|519900772|FG011|Overall Study|Lost to Follow-up|0|||
144192286|NCT02010255|519900773|FG012|Overall Study|Lost to Follow-up|0|||
144192287|NCT02010255|519900774|FG013|Overall Study|Lost to Follow-up|0|||
144192288|NCT02010255|519900761|FG000|Overall Study|Randomized but Not Treated|0|||
144192289|NCT02010255|519900762|FG001|Overall Study|Randomized but Not Treated|0|||
144532160|NCT04999111|521152329|FG000|Overall Study|Lost to Follow-up|21|||
144532161|NCT04999111|521152330|FG001|Overall Study|Lost to Follow-up|16|||
144532162|NCT04999111|521152331|FG002|Overall Study|Lost to Follow-up|2|||
144532163|NCT04999111|521152332|FG003|Overall Study|Lost to Follow-up|26|||
144532164|NCT04999111|521152333|FG004|Overall Study|Lost to Follow-up|30|||
144532165|NCT04999111|521152334|FG005|Overall Study|Lost to Follow-up|6|||
144532166|NCT04999111|521152329|FG000|Overall Study|Physician Decision|1|||
144532167|NCT04999111|521152330|FG001|Overall Study|Physician Decision|3|||
144725004|NCT00721409|521849163|FG000|Overall Study|Objective progression or relapse|8|||
144192290|NCT02010255|519900763|FG002|Overall Study|Randomized but Not Treated|0|||
144192291|NCT02010255|519900764|FG003|Overall Study|Randomized but Not Treated|0|||
144192292|NCT02010255|519900765|FG004|Overall Study|Randomized but Not Treated|0|||
144192293|NCT02010255|519900766|FG005|Overall Study|Randomized but Not Treated|0|||
144532168|NCT04999111|521152331|FG002|Overall Study|Physician Decision|0|||
144192294|NCT02010255|519900767|FG006|Overall Study|Randomized but Not Treated|0|||
144192295|NCT02010255|519900768|FG007|Overall Study|Randomized but Not Treated|0|||
144192296|NCT02010255|519900769|FG008|Overall Study|Randomized but Not Treated|0|||
144192297|NCT02010255|519900770|FG009|Overall Study|Randomized but Not Treated|0|||
144192298|NCT02010255|519900771|FG010|Overall Study|Randomized but Not Treated|0|||
144192299|NCT02010255|519900772|FG011|Overall Study|Randomized but Not Treated|0|||
144192300|NCT02010255|519900773|FG012|Overall Study|Randomized but Not Treated|0|||
144532169|NCT04999111|521152332|FG003|Overall Study|Physician Decision|1|||
144532170|NCT04999111|521152333|FG004|Overall Study|Physician Decision|2|||
144725005|NCT00721409|521849164|FG001|Overall Study|Objective progression or relapse|55|||
144725006|NCT00721409|521849165|FG002|Overall Study|Objective progression or relapse|62|||
144725007|NCT00810368|521849166|FG000|Overall Study|Lost to Follow-up|4|||
144725008|NCT00810368|521849167|FG001|Overall Study|Lost to Follow-up|2|||
144725009|NCT00810368|521849166|FG000|Overall Study|Lack of Efficacy|2|||
144725010|NCT00810368|521849167|FG001|Overall Study|Lack of Efficacy|0|||
144725011|NCT00623103|521849168|FG000|Overall Study|Adverse Event|70|||
144725012|NCT00623103|521849169|FG001|Overall Study|Adverse Event|60|||
144725013|NCT00623103|521849168|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144725014|NCT00623103|521849169|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
144725015|NCT00623103|521849168|FG000|Overall Study|Withdrawal by Subject|18|||
144725016|NCT00623103|521849169|FG001|Overall Study|Withdrawal by Subject|24|||
144725017|NCT00623103|521849168|FG000|Overall Study|Lost to Follow-up|4|||
144725018|NCT00623103|521849169|FG001|Overall Study|Lost to Follow-up|1|||
144725019|NCT00623103|521849168|FG000|Overall Study|Administrative problems|2|||
144725020|NCT00623103|521849169|FG001|Overall Study|Administrative problems|4|||
144725021|NCT00623103|521849168|FG000|Overall Study|Death|11|||
144725022|NCT00623103|521849169|FG001|Overall Study|Death|11|||
144725023|NCT00623103|521849168|FG000|Overall Study|Protocol deviation|2|||
144725024|NCT00623103|521849169|FG001|Overall Study|Protocol deviation|1|||
144725025|NCT01400425|521849170|FG000|Overall Study|Withdrawal by Subject|10|||
144725026|NCT00818883|521849174|FG000|Overall Study|Adverse Event|28|||
144725027|NCT00818883|521849175|FG001|Overall Study|Adverse Event|19|||
144725028|NCT00818883|521849174|FG000|Overall Study|Protocol Violation|2|||
144725029|NCT00818883|521849175|FG001|Overall Study|Protocol Violation|2|||
144725030|NCT00818883|521849174|FG000|Overall Study|Lost to Follow-up|3|||
144725031|NCT00818883|521849175|FG001|Overall Study|Lost to Follow-up|2|||
144725032|NCT00818883|521849174|FG000|Overall Study|Withdrawal by Subject|16|||
144725033|NCT00818883|521849175|FG001|Overall Study|Withdrawal by Subject|14|||
144725034|NCT00818883|521849174|FG000|Overall Study|Lack of Efficacy|0|||
144725035|NCT00818883|521849175|FG001|Overall Study|Lack of Efficacy|2|||
144725036|NCT00818883|521849174|FG000|Overall Study|Other|2|||
144725037|NCT00818883|521849175|FG001|Overall Study|Other|7|||
144725038|NCT00454636|521849176|FG000|Overall Study|Adverse Event|10|||
144725039|NCT00454636|521849177|FG001|Overall Study|Adverse Event|6|||
144725040|NCT00454636|521849178|FG002|Overall Study|Adverse Event|9|||
144725041|NCT00454636|521849179|FG003|Overall Study|Adverse Event|15|||
144725042|NCT00454636|521849176|FG000|Overall Study|Disease Progression|11|||
144725043|NCT00454636|521849177|FG001|Overall Study|Disease Progression|12|||
144725044|NCT00454636|521849178|FG002|Overall Study|Disease Progression|4|||
144725045|NCT00454636|521849179|FG003|Overall Study|Disease Progression|11|||
144532171|NCT04999111|521152334|FG005|Overall Study|Physician Decision|0|||
144725046|NCT00454636|521849176|FG000|Overall Study|Protocol Violation|3|||
144725047|NCT00454636|521849177|FG001|Overall Study|Protocol Violation|2|||
144725048|NCT00454636|521849178|FG002|Overall Study|Protocol Violation|3|||
144725049|NCT00454636|521849179|FG003|Overall Study|Protocol Violation|3|||
144725050|NCT00454636|521849176|FG000|Overall Study|Death|6|||
144725051|NCT00454636|521849177|FG001|Overall Study|Death|1|||
144725052|NCT00454636|521849178|FG002|Overall Study|Death|1|||
144725053|NCT00454636|521849179|FG003|Overall Study|Death|1|||
144725054|NCT00454636|521849176|FG000|Overall Study|Patient refusal|1|||
144725055|NCT00454636|521849177|FG001|Overall Study|Patient refusal|1|||
144532172|NCT04999111|521152329|FG000|Overall Study|Withdrawal by Subject|23|||
144532173|NCT04999111|521152330|FG001|Overall Study|Withdrawal by Subject|29|||
144532174|NCT04999111|521152331|FG002|Overall Study|Withdrawal by Subject|15|||
144532175|NCT04999111|521152332|FG003|Overall Study|Withdrawal by Subject|30|||
144532176|NCT04999111|521152333|FG004|Overall Study|Withdrawal by Subject|35|||
144532177|NCT04999111|521152334|FG005|Overall Study|Withdrawal by Subject|10|||
144532178|NCT04999111|521152329|FG000|Overall Study|Other|6|||
144532179|NCT04999111|521152330|FG001|Overall Study|Other|6|||
144532180|NCT04999111|521152331|FG002|Overall Study|Other|3|||
144532181|NCT04999111|521152332|FG003|Overall Study|Other|8|||
144532182|NCT04999111|521152333|FG004|Overall Study|Other|8|||
144532183|NCT04999111|521152334|FG005|Overall Study|Other|5|||
144725056|NCT00454636|521849178|FG002|Overall Study|Patient refusal|3|||
144725057|NCT00454636|521849179|FG003|Overall Study|Patient refusal|2|||
144725058|NCT00454636|521849176|FG000|Overall Study|Lost to Follow-up|0|||
144725059|NCT00454636|521849177|FG001|Overall Study|Lost to Follow-up|1|||
144725060|NCT00454636|521849178|FG002|Overall Study|Lost to Follow-up|0|||
144725061|NCT00454636|521849179|FG003|Overall Study|Lost to Follow-up|0|||
144725062|NCT01400113|521849180|FG000|Overall Study|Withdrawal by Subject|1|||
144725063|NCT01400113|521849181|FG001|Overall Study|Withdrawal by Subject|1|||
144725064|NCT01890915|521849189|FG000|Overall Study|Adverse Event|1|||
144532184|NCT04999111|521152329|FG000|Overall Study|Non-compliance with study schedule|1|||
144532185|NCT04999111|521152330|FG001|Overall Study|Non-compliance with study schedule|0|||
144532186|NCT04999111|521152331|FG002|Overall Study|Non-compliance with study schedule|0|||
144725065|NCT01890915|521849190|FG001|Overall Study|Adverse Event|0|||
144725066|NCT01890915|521849189|FG000|Overall Study|Protocol Violation|2|||
144725067|NCT01890915|521849190|FG001|Overall Study|Protocol Violation|0|||
144725068|NCT01890915|521849189|FG000|Overall Study|Equipment Malfunction|0|||
144192301|NCT02010255|519900774|FG013|Overall Study|Randomized but Not Treated|1|||
144192302|NCT01341587|519900775|FG000|Overall Study|Lost to Follow-up|2|||
144192303|NCT01341587|519900776|FG001|Overall Study|Lost to Follow-up|0|||
144192304|NCT01341587|519900775|FG000|Overall Study|stopped using the meters|2|||
144192305|NCT01341587|519900776|FG001|Overall Study|stopped using the meters|10|||
144192306|NCT00351351|519900777|FG000|Overall Study|surgical access pbs; device issues|9|||
144192307|NCT00351351|519900778|FG001|Overall Study|surgical access pbs; device issues|4|||
144192308|NCT03176784|519900779|FG000|Overall Study|Lost to Follow-up|77|||
144192309|NCT03176784|519900780|FG001|Overall Study|Lost to Follow-up|79|||
144192310|NCT03176784|519900781|FG002|Overall Study|Lost to Follow-up|79|||
144443013|NCT04304001|520821989|FG001|Overall Study|Lost to Follow-up|9|||
144443014|NCT02504372|520821990|FG000|Overall Study|Death|136|||
144443015|NCT02504372|520821991|FG001|Overall Study|Death|154|||
144443016|NCT02504372|520821990|FG000|Overall Study|Lost to Follow-up|0|||
144443017|NCT02504372|520821991|FG001|Overall Study|Lost to Follow-up|2|||
144443018|NCT02504372|520821990|FG000|Overall Study|Withdrawal of consent|25|||
144443019|NCT02504372|520821991|FG001|Overall Study|Withdrawal of consent|16|||
144192311|NCT03176784|519900782|FG003|Overall Study|Lost to Follow-up|49|||
144192312|NCT03176784|519900779|FG000|Overall Study|Withdrawal by Subject|28|||
144192313|NCT03176784|519900780|FG001|Overall Study|Withdrawal by Subject|34|||
144192314|NCT03176784|519900781|FG002|Overall Study|Withdrawal by Subject|34|||
144192315|NCT03176784|519900782|FG003|Overall Study|Withdrawal by Subject|21|||
144192316|NCT00904748|519900783|FG000|Overall Study|Withdrawal by Subject|1|||
144192317|NCT00904748|519900784|FG001|Overall Study|Withdrawal by Subject|1|||
144192318|NCT00904748|519900785|FG002|Overall Study|Withdrawal by Subject|1|||
144192319|NCT00904748|519900786|FG003|Overall Study|Withdrawal by Subject|2|||
144192320|NCT00904748|519900787|FG004|Overall Study|Withdrawal by Subject|0|||
144443020|NCT02504372|520821990|FG000|Overall Study|Participants ongoing|429|||
144443021|NCT02504372|520821991|FG001|Overall Study|Participants ongoing|415|||
144192321|NCT00904748|519900788|FG005|Overall Study|Withdrawal by Subject|0|||
144192322|NCT00904748|519900783|FG000|Overall Study|Adverse Event|0|||
144192323|NCT00904748|519900784|FG001|Overall Study|Adverse Event|0|||
144192324|NCT00904748|519900785|FG002|Overall Study|Adverse Event|0|||
144192325|NCT00904748|519900786|FG003|Overall Study|Adverse Event|0|||
144192326|NCT00904748|519900787|FG004|Overall Study|Adverse Event|1|||
144192327|NCT00904748|519900788|FG005|Overall Study|Adverse Event|0|||
144192328|NCT04647383|519900789|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
144192329|NCT04647383|519900790|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
144192330|NCT04647383|519900791|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
144192331|NCT04647383|519900792|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
144192332|NCT00873119|519900799|FG000|Overall Study|Patient request|4|||
144192333|NCT00873119|519900800|FG001|Overall Study|Patient request|2|||
144192334|NCT00873119|519900799|FG000|Overall Study|Adverse Event|8|||
144192335|NCT00873119|519900800|FG001|Overall Study|Adverse Event|0|||
144192336|NCT00873119|519900799|FG000|Overall Study|Progressive disease|26|||
144443022|NCT04530552|520821994|FG000|Overall Study|Physician Decision|0|||
144443023|NCT04530552|520821995|FG001|Overall Study|Physician Decision|1|||
144443024|NCT04530552|520821994|FG000|Overall Study|Withdrawal by Subject|0|||
144443025|NCT04530552|520821995|FG001|Overall Study|Withdrawal by Subject|1|||
144443026|NCT04530552|520821994|FG000|Overall Study|Adverse Event|0|||
144443027|NCT04530552|520821995|FG001|Overall Study|Adverse Event|1|||
144443028|NCT04530552|520821994|FG000|Overall Study|No surgery|0|||
144443029|NCT04530552|520821995|FG001|Overall Study|No surgery|1|||
144443030|NCT02052739|520821999|FG000|Overall Study|Withdrew due to Adverse Event|3|||
144443031|NCT02052739|520822000|FG001|Overall Study|Withdrew due to Adverse Event|0|||
144443032|NCT02052739|520821999|FG000|Overall Study|Participant Died|2|||
144443033|NCT02052739|520822000|FG001|Overall Study|Participant Died|1|||
144443034|NCT00670228|520822001|FG000|Overall Study|Adverse Event|1|||
144443035|NCT00670228|520822002|FG001|Overall Study|Adverse Event|0|||
144192337|NCT00873119|519900800|FG001|Overall Study|Progressive disease|18|||
144192338|NCT00873119|519900799|FG000|Overall Study|Death|2|||
144192339|NCT00873119|519900800|FG001|Overall Study|Death|1|||
144192340|NCT00873119|519900799|FG000|Overall Study|Other|2|||
144192341|NCT00873119|519900800|FG001|Overall Study|Other|5|||
144725069|NCT01890915|521849190|FG001|Overall Study|Equipment Malfunction|1|||
144725070|NCT02114697|521849191|FG000|Overall Study|Study terminated|5|||
144725071|NCT02114697|521849192|FG001|Overall Study|Study terminated|4|||
144192342|NCT00873119|519900799|FG000|Overall Study|Not treated|2|||
144443036|NCT00670228|520822001|FG000|Overall Study|Death or MACE|0|||
144725072|NCT00424489|521849193|FG000|Overall Study|Death|3|||
144192343|NCT00873119|519900800|FG001|Overall Study|Not treated|0|||
144443037|NCT00670228|520822002|FG001|Overall Study|Death or MACE|1|||
144192344|NCT03812991|519900801|FG000|Overall Study|Lost to Follow-up|3|||
144192345|NCT03812991|519900802|FG001|Overall Study|Lost to Follow-up|1|||
144443038|NCT00670228|520822001|FG000|Overall Study|Not treated|2|||
144443039|NCT00670228|520822002|FG001|Overall Study|Not treated|2|||
144192346|NCT00466726|519900803|FG000|Overall Study|Not evaluable for response|14|||
144192347|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
144192348|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
144192349|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
144192350|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
144192351|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
144192352|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
144192353|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
144192354|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
144192355|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
144192356|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
144192357|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
144192358|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
144192359|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
144192360|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
144192361|NCT04740931|519900804|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
144192362|NCT04740931|519900805|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
144192363|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
144192364|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
144192365|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
144192366|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
144192367|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
144192368|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
144192369|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
144192370|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
144443040|NCT00670228|520822001|FG000|Overall Study|Not meeting the selection criteria|2|||
144443041|NCT00670228|520822002|FG001|Overall Study|Not meeting the selection criteria|0|||
144443042|NCT05267054|520822003|FG000|Overall Study|Death|13|||
144443043|NCT05267054|520822004|FG001|Overall Study|Death|14|||
144443044|NCT05267054|520822003|FG000|Overall Study|Study Ended by Sponsor|9|||
144192371|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
144192372|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
144443045|NCT05267054|520822004|FG001|Overall Study|Study Ended by Sponsor|13|||
144443046|NCT05267054|520822003|FG000|Overall Study|Lost to Follow-up|1|||
144443047|NCT05267054|520822004|FG001|Overall Study|Lost to Follow-up|1|||
144443048|NCT05267054|520822003|FG000|Overall Study|Withdrawal by Subject|1|||
144443049|NCT05267054|520822004|FG001|Overall Study|Withdrawal by Subject|1|||
144192373|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
144192374|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
144192375|NCT04740931|519900804|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
144192376|NCT04740931|519900805|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
144192377|NCT04403763|519900806|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
144192378|NCT04403763|519900807|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
144192379|NCT04403763|519900808|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
144192380|NCT04403763|519900809|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
144443050|NCT01552226|520822005|FG000|Overall Study|Withdrawal by Subject|4|||
144443051|NCT01552226|520822006|FG001|Overall Study|Withdrawal by Subject|4|||
144443052|NCT03604692|520822007|FG000|Overall Study|Investigator's Decision|0|||
144443053|NCT03604692|520822008|FG001|Overall Study|Investigator's Decision|0|||
144443054|NCT03604692|520822009|FG002|Overall Study|Investigator's Decision|0|||
144443055|NCT03604692|520822010|FG003|Overall Study|Investigator's Decision|1|||
144443056|NCT03604692|520822011|FG004|Overall Study|Investigator's Decision|0|||
144443057|NCT03604692|520822012|FG005|Overall Study|Investigator's Decision|7|||
144443058|NCT03604692|520822007|FG000|Overall Study|Withdrawal by Subject|0|||
144443059|NCT03604692|520822008|FG001|Overall Study|Withdrawal by Subject|0|||
144443060|NCT03604692|520822009|FG002|Overall Study|Withdrawal by Subject|0|||
144443061|NCT03604692|520822010|FG003|Overall Study|Withdrawal by Subject|0|||
144443062|NCT03604692|520822011|FG004|Overall Study|Withdrawal by Subject|0|||
144443063|NCT03604692|520822012|FG005|Overall Study|Withdrawal by Subject|2|||
144443064|NCT03604692|520822007|FG000|Overall Study|Progressive Disease|1|||
144443065|NCT03604692|520822008|FG001|Overall Study|Progressive Disease|0|||
144443066|NCT03604692|520822009|FG002|Overall Study|Progressive Disease|1|||
144443067|NCT03604692|520822010|FG003|Overall Study|Progressive Disease|0|||
144443068|NCT03604692|520822011|FG004|Overall Study|Progressive Disease|3|||
144443069|NCT03604692|520822012|FG005|Overall Study|Progressive Disease|4|||
144443070|NCT03604692|520822007|FG000|Overall Study|Difficulty Coming into Site|0|||
144443071|NCT03604692|520822008|FG001|Overall Study|Difficulty Coming into Site|0|||
144443072|NCT03604692|520822009|FG002|Overall Study|Difficulty Coming into Site|0|||
144443073|NCT03604692|520822010|FG003|Overall Study|Difficulty Coming into Site|0|||
144443074|NCT03604692|520822011|FG004|Overall Study|Difficulty Coming into Site|0|||
144443075|NCT03604692|520822012|FG005|Overall Study|Difficulty Coming into Site|1|||
144443076|NCT03604692|520822007|FG000|Overall Study|Death|0|||
144443077|NCT03604692|520822008|FG001|Overall Study|Death|0|||
144443078|NCT03604692|520822009|FG002|Overall Study|Death|1|||
144443079|NCT03604692|520822010|FG003|Overall Study|Death|0|||
144443080|NCT03604692|520822011|FG004|Overall Study|Death|0|||
144192381|NCT04403763|519900810|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
144192382|NCT04403763|519900811|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
144192383|NCT04403763|519900812|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
144192384|NCT04403763|519900806|FG000|Stage 1|Early termination due to PK tube failure|0|||
144192385|NCT04403763|519900807|FG001|Stage 1|Early termination due to PK tube failure|0|||
144192386|NCT04403763|519900808|FG002|Stage 1|Early termination due to PK tube failure|1|||
144192387|NCT04403763|519900809|FG003|Stage 1|Early termination due to PK tube failure|0|||
144192388|NCT04403763|519900810|FG004|Stage 1|Early termination due to PK tube failure|0|||
144192389|NCT04403763|519900811|FG005|Stage 1|Early termination due to PK tube failure|0|||
144192390|NCT04403763|519900812|FG006|Stage 1|Early termination due to PK tube failure|0|||
144192391|NCT04403763|519900806|FG000|Stage 2A|Adverse Event|0|||
144192392|NCT04403763|519900807|FG001|Stage 2A|Adverse Event|0|||
144192393|NCT04403763|519900808|FG002|Stage 2A|Adverse Event|0|||
144192394|NCT04403763|519900809|FG003|Stage 2A|Adverse Event|0|||
144192395|NCT04403763|519900810|FG004|Stage 2A|Adverse Event|0|||
144192396|NCT04403763|519900811|FG005|Stage 2A|Adverse Event|0|||
144192397|NCT04403763|519900812|FG006|Stage 2A|Adverse Event|1|||
144192398|NCT00350402|519900813|FG000|Overall Study|Lost to Follow-up|1|||
144192399|NCT00350402|519900814|FG001|Overall Study|Lost to Follow-up|1|||
144192400|NCT01376310|519900815|FG000|Overall Study|Study closed/terminated|1|||
144192401|NCT01376310|519900816|FG001|Overall Study|Study closed/terminated|2|||
144192402|NCT01376310|519900815|FG000|Overall Study|Withdrawal by Subject|8|||
144192403|NCT01376310|519900816|FG001|Overall Study|Withdrawal by Subject|2|||
144532187|NCT04999111|521152332|FG003|Overall Study|Non-compliance with study schedule|1|||
144532188|NCT04999111|521152333|FG004|Overall Study|Non-compliance with study schedule|1|||
144532189|NCT04999111|521152334|FG005|Overall Study|Non-compliance with study schedule|1|||
144532190|NCT04999111|521152329|FG000|Overall Study|Randomized but not vaccinated|1|||
144532191|NCT04999111|521152330|FG001|Overall Study|Randomized but not vaccinated|2|||
144532192|NCT04999111|521152331|FG002|Overall Study|Randomized but not vaccinated|0|||
144532193|NCT04999111|521152332|FG003|Overall Study|Randomized but not vaccinated|3|||
144532194|NCT04999111|521152333|FG004|Overall Study|Randomized but not vaccinated|3|||
144532195|NCT04999111|521152334|FG005|Overall Study|Randomized but not vaccinated|0|||
144532196|NCT04999111|521152329|FG000|Overall Study|Adverse Event|1|||
144532197|NCT04999111|521152330|FG001|Overall Study|Adverse Event|1|||
144532198|NCT04999111|521152331|FG002|Overall Study|Adverse Event|0|||
144532199|NCT04999111|521152332|FG003|Overall Study|Adverse Event|0|||
144532200|NCT04999111|521152333|FG004|Overall Study|Adverse Event|0|||
144532201|NCT04999111|521152334|FG005|Overall Study|Adverse Event|0|||
144532202|NCT04999111|521152329|FG000|Overall Study|Initiated prohibited medication|0|||
144532203|NCT04999111|521152330|FG001|Overall Study|Initiated prohibited medication|0|||
144532204|NCT04999111|521152331|FG002|Overall Study|Initiated prohibited medication|0|||
144532205|NCT04999111|521152332|FG003|Overall Study|Initiated prohibited medication|0|||
144532206|NCT04999111|521152333|FG004|Overall Study|Initiated prohibited medication|1|||
144532207|NCT04999111|521152334|FG005|Overall Study|Initiated prohibited medication|0|||
144532208|NCT02437136|521152340|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
144532209|NCT02437136|521152341|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
144532210|NCT02437136|521152342|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
144532211|NCT02437136|521152343|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
144532212|NCT02437136|521152344|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
144532213|NCT02437136|521152345|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
144532214|NCT02437136|521152346|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
144532215|NCT02437136|521152340|FG000|Expansion (Phase 2)|Death|0|||
144532216|NCT02437136|521152341|FG001|Expansion (Phase 2)|Death|0|||
144532217|NCT02437136|521152342|FG002|Expansion (Phase 2)|Death|0|||
144532218|NCT02437136|521152343|FG003|Expansion (Phase 2)|Death|6|||
144532219|NCT02437136|521152344|FG004|Expansion (Phase 2)|Death|37|||
144532220|NCT02437136|521152345|FG005|Expansion (Phase 2)|Death|29|||
144532221|NCT02437136|521152346|FG006|Expansion (Phase 2)|Death|24|||
144532222|NCT02437136|521152340|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
144532223|NCT02437136|521152341|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
144532224|NCT02437136|521152342|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
144532225|NCT02437136|521152343|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
144192404|NCT01376310|519900815|FG000|Overall Study|Physician Decision|26|||
144192405|NCT01376310|519900816|FG001|Overall Study|Physician Decision|7|||
144192406|NCT01376310|519900815|FG000|Overall Study|Lost to Follow-up|1|||
144192407|NCT01376310|519900816|FG001|Overall Study|Lost to Follow-up|0|||
144192408|NCT01884688|519900819|FG000|Overall Study|Screen Failure|2|||
144192409|NCT01807117|519900820|FG000|Overall Study|Physician Decision|2|||
144532226|NCT02437136|521152344|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
144532227|NCT02437136|521152345|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
144532228|NCT02437136|521152346|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
144532229|NCT02437136|521152340|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
144532230|NCT02437136|521152341|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
144532231|NCT02437136|521152342|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
144532232|NCT02437136|521152343|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
144532233|NCT02437136|521152344|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
144192410|NCT01807117|519900820|FG000|Overall Study|Disease diagnosis not a study disease|1|||
144192411|NCT00834899|519900821|FG000|Overall Study|Withdrawal by Subject|1|||
144192412|NCT00834899|519900822|FG001|Overall Study|Withdrawal by Subject|1|||
144192413|NCT01534637|519900823|FG000|Overall Study|Physician Decision|3|||
144192414|NCT01534637|519900823|FG000|Overall Study|Lack of Efficacy|3|||
144192415|NCT01534637|519900823|FG000|Overall Study|Withdrawal by Subject|1|||
144192416|NCT01534637|519900823|FG000|Overall Study|Adverse Event|1|||
144192417|NCT01534637|519900823|FG000|Overall Study|Liver Mets before treatment|1|||
144192418|NCT02377921|519900829|FG000|Overall Study|Subject non-compliance|1|||
144192419|NCT02377921|519900830|FG001|Overall Study|Subject non-compliance|1|||
144192420|NCT00706355|519900839|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
144192421|NCT00706355|519900840|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
144192422|NCT00706355|519900841|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
144192423|NCT00706355|519900842|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
144192424|NCT00706355|519900839|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
144192425|NCT00706355|519900840|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
144192426|NCT00706355|519900841|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
144443081|NCT03604692|520822012|FG005|Overall Study|Death|0|||
144443082|NCT03604692|520822007|FG000|Overall Study|Drug Intolerance|0|||
144443083|NCT03604692|520822008|FG001|Overall Study|Drug Intolerance|0|||
144443084|NCT03604692|520822009|FG002|Overall Study|Drug Intolerance|0|||
144443085|NCT03604692|520822010|FG003|Overall Study|Drug Intolerance|1|||
144443086|NCT03604692|520822011|FG004|Overall Study|Drug Intolerance|0|||
144443087|NCT03604692|520822012|FG005|Overall Study|Drug Intolerance|0|||
144443088|NCT03604692|520822007|FG000|Overall Study|Noncompliance with follow-up visit|0|||
144443089|NCT03604692|520822008|FG001|Overall Study|Noncompliance with follow-up visit|0|||
144443090|NCT03604692|520822009|FG002|Overall Study|Noncompliance with follow-up visit|0|||
144443091|NCT03604692|520822010|FG003|Overall Study|Noncompliance with follow-up visit|1|||
144443092|NCT03604692|520822011|FG004|Overall Study|Noncompliance with follow-up visit|0|||
144443093|NCT03604692|520822012|FG005|Overall Study|Noncompliance with follow-up visit|0|||
144443094|NCT03604692|520822007|FG000|Overall Study|Not Treated|0|||
144443095|NCT03604692|520822008|FG001|Overall Study|Not Treated|0|||
144443096|NCT03604692|520822009|FG002|Overall Study|Not Treated|0|||
144443097|NCT03604692|520822010|FG003|Overall Study|Not Treated|0|||
144443098|NCT03604692|520822011|FG004|Overall Study|Not Treated|1|||
144443099|NCT03604692|520822012|FG005|Overall Study|Not Treated|0|||
144443100|NCT00637195|520822013|FG000|Overall Study|Lost to Follow-up|1|||
144443101|NCT00637195|520822014|FG001|Overall Study|Lost to Follow-up|0|||
144443102|NCT00637195|520822013|FG000|Overall Study|Other|2|||
144443103|NCT00637195|520822014|FG001|Overall Study|Other|0|||
144443104|NCT00637195|520822013|FG000|Overall Study|Withdrawal by Subject|0|||
144443105|NCT00637195|520822014|FG001|Overall Study|Withdrawal by Subject|1|||
144443106|NCT02388997|520822015|FG000|Overall Study|Adverse Event|1|||
144443107|NCT02388997|520822016|FG001|Overall Study|Adverse Event|2|||
144443108|NCT02388997|520822015|FG000|Overall Study|Withdrawal by Subject|2|||
144443109|NCT02388997|520822016|FG001|Overall Study|Withdrawal by Subject|1|||
144443110|NCT02388997|520822015|FG000|Overall Study|Lung function exclusion criteria|0|||
144443111|NCT02388997|520822016|FG001|Overall Study|Lung function exclusion criteria|2|||
144443112|NCT02388997|520822015|FG000|Overall Study|Tested positive for virus during run-in|0|||
144443113|NCT02388997|520822016|FG001|Overall Study|Tested positive for virus during run-in|1|||
144443114|NCT00376168|520822023|FG000|Overall Study|Adverse Event|1|||
144443115|NCT00376168|520822024|FG001|Overall Study|Adverse Event|1|||
144443116|NCT00376168|520822023|FG000|Overall Study|Pregnancy|1|||
144443117|NCT00376168|520822024|FG001|Overall Study|Pregnancy|0|||
144443118|NCT01020019|520822025|FG000|Overall Study|Lost to Follow-up|21|||
144443119|NCT01020019|520822026|FG001|Overall Study|Lost to Follow-up|18|||
144443120|NCT01020019|520822025|FG000|Overall Study|Adverse Event|1|||
144443121|NCT01020019|520822026|FG001|Overall Study|Adverse Event|5|||
144443122|NCT01020019|520822025|FG000|Overall Study|not interested in treatment|4|||
144443123|NCT01020019|520822026|FG001|Overall Study|not interested in treatment|4|||
144443124|NCT01020019|520822025|FG000|Overall Study|moving|0|||
144443125|NCT01020019|520822026|FG001|Overall Study|moving|2|||
144443126|NCT04958109|520822027|FG000|Overall Study|Withdrawal by Subject|0|||
144443127|NCT04958109|520822028|FG001|Overall Study|Withdrawal by Subject|1|||
144443128|NCT04958109|520822027|FG000|Overall Study|Lost to Follow-up|0|||
144532234|NCT02437136|521152345|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
144532235|NCT02437136|521152346|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
144443129|NCT04958109|520822028|FG001|Overall Study|Lost to Follow-up|1|||
144443130|NCT02214121|520822029|FG000|Part A|Patient decision|2|||
144443131|NCT02214121|520822030|FG001|Part A|Patient decision|0|||
144443132|NCT02214121|520822031|FG002|Part A|Patient decision|0|||
144443133|NCT02214121|520822029|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
144443134|NCT02214121|520822030|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
144443135|NCT02214121|520822031|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
144443136|NCT02214121|520822029|FG000|Part A|Other|1|||
144443137|NCT02214121|520822030|FG001|Part A|Other|0|||
144443138|NCT02214121|520822031|FG002|Part A|Other|0|||
144532236|NCT02056834|521152347|FG000|Overall Study|Lost to Follow-up|7|||
144192427|NCT00706355|519900842|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
144192428|NCT00706355|519900839|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
144192429|NCT00706355|519900840|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
144192430|NCT00706355|519900841|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
144192431|NCT00706355|519900842|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
144192432|NCT00706355|519900839|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
144192433|NCT00706355|519900840|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
144192434|NCT00706355|519900841|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
144192435|NCT00706355|519900842|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
144192436|NCT00706355|519900839|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
144192437|NCT00706355|519900840|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
144192438|NCT00706355|519900841|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
144192439|NCT00706355|519900842|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
144192440|NCT00706355|519900839|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
144192441|NCT00706355|519900840|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
144192442|NCT00706355|519900841|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
144192443|NCT00706355|519900842|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
144192444|NCT00706355|519900839|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
144192445|NCT00706355|519900840|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
144192446|NCT00706355|519900841|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
144192447|NCT00706355|519900842|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
144192448|NCT00706355|519900839|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
144192449|NCT00706355|519900840|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
144192450|NCT00706355|519900841|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
144192451|NCT00706355|519900842|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
144192452|NCT00706355|519900839|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
144192453|NCT00706355|519900840|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
144192454|NCT00706355|519900841|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
144192455|NCT00706355|519900842|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
144192456|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
144192457|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
144192458|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
144192459|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
144192460|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
144192461|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
144192462|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
144192463|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
144192464|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
144192465|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
144192466|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
144192467|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
144192468|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
144192469|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
144192470|NCT02510014|519900843|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
144192471|NCT02510014|519900844|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
144192472|NCT02510014|519900843|FG000|Treatment Period|Adverse Event|11|||
144192473|NCT02510014|519900844|FG001|Treatment Period|Adverse Event|4|||
144192474|NCT02510014|519900843|FG000|Treatment Period|Withdrawal symptoms|3|||
144192475|NCT02510014|519900844|FG001|Treatment Period|Withdrawal symptoms|0|||
144192476|NCT02510014|519900843|FG000|Treatment Period|Lost to Follow-up|80|||
144192477|NCT02510014|519900844|FG001|Treatment Period|Lost to Follow-up|19|||
144192478|NCT02510014|519900843|FG000|Treatment Period|Physician Decision|5|||
144192479|NCT02510014|519900844|FG001|Treatment Period|Physician Decision|0|||
144192480|NCT02510014|519900843|FG000|Treatment Period|Withdrawal by Subject|67|||
144192481|NCT02510014|519900844|FG001|Treatment Period|Withdrawal by Subject|24|||
144192482|NCT02510014|519900843|FG000|Treatment Period|Withdrawn by the investigator|7|||
144443139|NCT02214121|520822029|FG000|Part B|Patient decision|0|||
144443140|NCT02214121|520822030|FG001|Part B|Patient decision|1|||
144443141|NCT02214121|520822031|FG002|Part B|Patient decision|0|||
144443142|NCT02214121|520822029|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
144443143|NCT02214121|520822030|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
144443144|NCT02214121|520822031|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
144443145|NCT02214121|520822029|FG000|Part B|Lost to Follow-up|0|||
144443146|NCT02214121|520822030|FG001|Part B|Lost to Follow-up|0|||
144532237|NCT06106022|521152351|FG000|Overall Study|Lost to Follow-up|1|||
144532238|NCT06106022|521152352|FG001|Overall Study|Lost to Follow-up|0|||
144192483|NCT02510014|519900844|FG001|Treatment Period|Withdrawn by the investigator|1|||
144192484|NCT02510014|519900843|FG000|Treatment Period|Protocol Violation|4|||
144443147|NCT02214121|520822031|FG002|Part B|Lost to Follow-up|1|||
144725073|NCT03552757|521849196|FG000|Overall Study|Withdrawal by Subject|10|||
144725074|NCT03552757|521849197|FG001|Overall Study|Withdrawal by Subject|5|||
144725075|NCT03552757|521849198|FG002|Overall Study|Withdrawal by Subject|12|||
144725076|NCT03552757|521849196|FG000|Overall Study|Lost to Follow-up|2|||
144725077|NCT03552757|521849197|FG001|Overall Study|Lost to Follow-up|7|||
144725078|NCT03552757|521849198|FG002|Overall Study|Lost to Follow-up|7|||
144725079|NCT03552757|521849196|FG000|Overall Study|Death|1|||
144192485|NCT02510014|519900844|FG001|Treatment Period|Protocol Violation|4|||
144192486|NCT02510014|519900843|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
144192487|NCT02510014|519900844|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
144192488|NCT01020799|519900847|FG000|Overall Study|Adverse Event|4|||
144192489|NCT01020799|519900848|FG001|Overall Study|Adverse Event|3|||
144192490|NCT01020799|519900849|FG002|Overall Study|Adverse Event|2|||
144192491|NCT01020799|519900847|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
144192492|NCT01020799|519900848|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
144192493|NCT01020799|519900849|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
144192494|NCT01020799|519900847|FG000|Overall Study|Protocol Violation|3|||
144192495|NCT01020799|519900848|FG001|Overall Study|Protocol Violation|2|||
144192496|NCT01020799|519900849|FG002|Overall Study|Protocol Violation|0|||
144192497|NCT01020799|519900847|FG000|Overall Study|Withdrawal by Subject|2|||
144192498|NCT01020799|519900848|FG001|Overall Study|Withdrawal by Subject|2|||
144192499|NCT01020799|519900849|FG002|Overall Study|Withdrawal by Subject|3|||
144192500|NCT01020799|519900847|FG000|Overall Study|Lost to Follow-up|6|||
144192501|NCT01020799|519900848|FG001|Overall Study|Lost to Follow-up|4|||
144192502|NCT01020799|519900849|FG002|Overall Study|Lost to Follow-up|2|||
144192503|NCT04179019|519900850|FG000|Overall Study|Lost to Follow-up|2|||
144192504|NCT04179019|519900850|FG000|Overall Study|Physician Decision|2|||
144192505|NCT04179019|519900850|FG000|Overall Study|Withdrawal by Subject|5|||
144192506|NCT04179019|519900850|FG000|Overall Study|Adverse Event|4|||
144192507|NCT02083926|519900851|FG000|Overall Study|Withdrawal by Subject|1|||
144192508|NCT02083926|519900852|FG001|Overall Study|Withdrawal by Subject|0|||
144192509|NCT00384176|519900855|FG000|Overall Study|Death|239|||
144192510|NCT00384176|519900856|FG001|Overall Study|Death|247|||
144192511|NCT00384176|519900857|FG002|Overall Study|Death|105|||
144192512|NCT00384176|519900855|FG000|Overall Study|Withdrawal by Subject|52|||
144192513|NCT00384176|519900856|FG001|Overall Study|Withdrawal by Subject|48|||
144192514|NCT00384176|519900857|FG002|Overall Study|Withdrawal by Subject|22|||
144192515|NCT00384176|519900855|FG000|Overall Study|Lost to Follow-up|16|||
144192516|NCT00384176|519900856|FG001|Overall Study|Lost to Follow-up|18|||
144192517|NCT00384176|519900857|FG002|Overall Study|Lost to Follow-up|4|||
144192518|NCT00384176|519900855|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
144192519|NCT00384176|519900856|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
144192520|NCT00384176|519900857|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
144192521|NCT00384176|519900855|FG000|Overall Study|Longer QTC as Visit 1|1|||
144192522|NCT00384176|519900856|FG001|Overall Study|Longer QTC as Visit 1|0|||
144192523|NCT00384176|519900857|FG002|Overall Study|Longer QTC as Visit 1|0|||
144192524|NCT00384176|519900855|FG000|Overall Study|Toxicity of treatment|1|||
144192525|NCT00384176|519900856|FG001|Overall Study|Toxicity of treatment|0|||
144192526|NCT00384176|519900857|FG002|Overall Study|Toxicity of treatment|0|||
144192527|NCT00384176|519900855|FG000|Overall Study|Did not receive study treatment|0|||
144192528|NCT00384176|519900856|FG001|Overall Study|Did not receive study treatment|1|||
144192529|NCT00384176|519900857|FG002|Overall Study|Did not receive study treatment|1|||
144192530|NCT00384176|519900855|FG000|Overall Study|Physician Decision|0|||
144192531|NCT00384176|519900856|FG001|Overall Study|Physician Decision|2|||
144192532|NCT00384176|519900857|FG002|Overall Study|Physician Decision|0|||
144192533|NCT00384176|519900855|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
144192534|NCT00384176|519900856|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
144192535|NCT00384176|519900857|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
144192536|NCT03465436|519900858|FG000|Period 1|Protocol Violation|0|||
144192537|NCT03465436|519900859|FG001|Period 1|Protocol Violation|0|||
144192538|NCT03465436|519900860|FG002|Period 1|Protocol Violation|1|||
144192539|NCT03465436|519900861|FG003|Period 1|Protocol Violation|0|||
144192540|NCT03465436|519900858|FG000|Period 2|Protocol Violation|0|||
144192541|NCT03465436|519900859|FG001|Period 2|Protocol Violation|1|||
144192542|NCT03465436|519900860|FG002|Period 2|Protocol Violation|0|||
144192543|NCT03465436|519900861|FG003|Period 2|Protocol Violation|0|||
144192544|NCT03465436|519900858|FG000|Period 3|Protocol Violation|1|||
144192545|NCT03465436|519900859|FG001|Period 3|Protocol Violation|1|||
144192546|NCT03465436|519900860|FG002|Period 3|Protocol Violation|0|||
144192547|NCT03465436|519900861|FG003|Period 3|Protocol Violation|0|||
144192548|NCT03465436|519900858|FG000|Period 4|Protocol Violation|0|||
144192549|NCT03465436|519900859|FG001|Period 4|Protocol Violation|0|||
144192550|NCT03465436|519900860|FG002|Period 4|Protocol Violation|1|||
144192551|NCT03465436|519900861|FG003|Period 4|Protocol Violation|0|||
144192552|NCT01813071|519900862|FG000|Overall Study|Protocol Violation|0|||
144192553|NCT01813071|519900863|FG001|Overall Study|Protocol Violation|0|||
144192554|NCT01813071|519900864|FG002|Overall Study|Protocol Violation|0|||
144532239|NCT06106022|521152351|FG000|Overall Study|Voluntary Withdrawal|0|||
144532240|NCT06106022|521152352|FG001|Overall Study|Voluntary Withdrawal|2|||
144532241|NCT04089865|521152354|FG000|Overall Study|Withdrawal by Subject|2|||
144532242|NCT04089865|521152355|FG001|Overall Study|Withdrawal by Subject|2|||
144532243|NCT04089865|521152356|FG002|Overall Study|Withdrawal by Subject|7|||
144532244|NCT04089865|521152357|FG003|Overall Study|Withdrawal by Subject|2|||
144532245|NCT05524116|521152368|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
144532246|NCT05524116|521152369|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
144532247|NCT05524116|521152368|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
144532248|NCT05524116|521152369|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
144532249|NCT05524116|521152368|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
144532250|NCT05524116|521152369|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
144532251|NCT05524116|521152368|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
144532252|NCT05524116|521152369|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
144532253|NCT05524116|521152368|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
144532254|NCT05524116|521152369|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
144532255|NCT04778410|521152380|FG000|Safety Run-in Period|Death|5|||
144532256|NCT04778410|521152381|FG001|Safety Run-in Period|Death|6|||
144532257|NCT04778410|521152382|FG002|Safety Run-in Period|Death|0|||
144532258|NCT04778410|521152383|FG003|Safety Run-in Period|Death|0|||
144532259|NCT04778410|521152384|FG004|Safety Run-in Period|Death|0|||
144532260|NCT04778410|521152385|FG005|Safety Run-in Period|Death|0|||
144532261|NCT04778410|521152380|FG000|Phase 2 Period|Death|0|||
144532262|NCT04778410|521152381|FG001|Phase 2 Period|Death|0|||
144532263|NCT04778410|521152382|FG002|Phase 2 Period|Death|0|||
144532264|NCT04778410|521152383|FG003|Phase 2 Period|Death|5|||
144532265|NCT04778410|521152384|FG004|Phase 2 Period|Death|18|||
144532266|NCT04778410|521152385|FG005|Phase 2 Period|Death|0|||
144532267|NCT04778410|521152380|FG000|Phase 2 Period|Lost to Follow-up|0|||
144532268|NCT04778410|521152381|FG001|Phase 2 Period|Lost to Follow-up|0|||
144532269|NCT04778410|521152382|FG002|Phase 2 Period|Lost to Follow-up|0|||
144532270|NCT04778410|521152383|FG003|Phase 2 Period|Lost to Follow-up|1|||
144532271|NCT04778410|521152384|FG004|Phase 2 Period|Lost to Follow-up|1|||
144532272|NCT04778410|521152385|FG005|Phase 2 Period|Lost to Follow-up|0|||
144532273|NCT04778410|521152380|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
144532274|NCT04778410|521152381|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
144532275|NCT04778410|521152382|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
144532276|NCT04778410|521152383|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
144532277|NCT04778410|521152384|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
144532278|NCT04778410|521152385|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
144532279|NCT04778410|521152380|FG000|Phase 2 Period|Withdrew Consent|0|||
144532280|NCT04778410|521152381|FG001|Phase 2 Period|Withdrew Consent|0|||
144532281|NCT04778410|521152382|FG002|Phase 2 Period|Withdrew Consent|0|||
144532282|NCT04778410|521152383|FG003|Phase 2 Period|Withdrew Consent|0|||
144532283|NCT04778410|521152384|FG004|Phase 2 Period|Withdrew Consent|2|||
144532284|NCT04778410|521152385|FG005|Phase 2 Period|Withdrew Consent|0|||
144532285|NCT05900154|521152389|FG000|Follow-Up Period|Lost to Follow-up|1|||
144532286|NCT05900154|521152390|FG001|Follow-Up Period|Lost to Follow-up|2|||
144532287|NCT05900154|521152391|FG002|Follow-Up Period|Lost to Follow-up|1|||
144532288|NCT05900154|521152392|FG003|Follow-Up Period|Lost to Follow-up|0|||
144532289|NCT05900154|521152393|FG004|Follow-Up Period|Lost to Follow-up|1|||
144532290|NCT05900154|521152394|FG005|Follow-Up Period|Lost to Follow-up|1|||
144532291|NCT01121588|521152395|FG000|Overall Study|Death|5|||
144532292|NCT01121588|521152396|FG001|Overall Study|Death|3|||
144532293|NCT01121588|521152397|FG002|Overall Study|Death|13|||
144532294|NCT01121588|521152395|FG000|Overall Study|Study Terminated by Sponsor|1|||
144532295|NCT01121588|521152396|FG001|Overall Study|Study Terminated by Sponsor|1|||
144532296|NCT01121588|521152397|FG002|Overall Study|Study Terminated by Sponsor|0|||
144532297|NCT01121588|521152395|FG000|Overall Study|Participant Refused Further Followup|2|||
144532298|NCT01121588|521152396|FG001|Overall Study|Participant Refused Further Followup|0|||
144532299|NCT01121588|521152397|FG002|Overall Study|Participant Refused Further Followup|2|||
144532300|NCT01121588|521152395|FG000|Overall Study|Lost to Follow-up|0|||
144532301|NCT01121588|521152396|FG001|Overall Study|Lost to Follow-up|1|||
144532302|NCT01121588|521152397|FG002|Overall Study|Lost to Follow-up|1|||
144532303|NCT01121588|521152395|FG000|Overall Study|Non-Specified Reasons|9|||
144532304|NCT01121588|521152396|FG001|Overall Study|Non-Specified Reasons|4|||
144532305|NCT01121588|521152397|FG002|Overall Study|Non-Specified Reasons|2|||
144532306|NCT02944968|521152400|FG000|Overall Study|Subject excluded before study procedure|1|||
144532307|NCT02944968|521152400|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
144532308|NCT05158504|521152401|FG000|Overall Study|Lost to Follow-up|2|||
144532309|NCT05158504|521152402|FG001|Overall Study|Lost to Follow-up|3|||
144532310|NCT02492711|521152407|FG000|Overall Study|Adverse Event|9|||
144532311|NCT02492711|521152408|FG001|Overall Study|Adverse Event|9|||
144532312|NCT02492711|521152409|FG002|Overall Study|Adverse Event|2|||
144532313|NCT02492711|521152407|FG000|Overall Study|Death|3|||
144532314|NCT02492711|521152408|FG001|Overall Study|Death|3|||
144605676|NCT00467779|521419005|FG008|Stage 1|Physician Decision|0|||
144605677|NCT00467779|521419006|FG009|Stage 1|Physician Decision|0|||
144605678|NCT00467779|521419007|FG010|Stage 1|Physician Decision|0|||
144605679|NCT00467779|521419008|FG011|Stage 1|Physician Decision|0|||
144605680|NCT00467779|521419009|FG012|Stage 1|Physician Decision|0|||
144605681|NCT00467779|521419010|FG013|Stage 1|Physician Decision|0|||
144605682|NCT00467779|521419011|FG014|Stage 1|Physician Decision|0|||
144605683|NCT00467779|521418997|FG000|Stage 1|Withdrawal by Subject|0|||
144605684|NCT00467779|521418998|FG001|Stage 1|Withdrawal by Subject|0|||
144605685|NCT00467779|521418999|FG002|Stage 1|Withdrawal by Subject|0|||
144605686|NCT00467779|521419000|FG003|Stage 1|Withdrawal by Subject|0|||
144605687|NCT00467779|521419001|FG004|Stage 1|Withdrawal by Subject|0|||
144605688|NCT00467779|521419002|FG005|Stage 1|Withdrawal by Subject|0|||
144605689|NCT00467779|521419003|FG006|Stage 1|Withdrawal by Subject|1|||
144605690|NCT00467779|521419004|FG007|Stage 1|Withdrawal by Subject|1|||
144605691|NCT00467779|521419005|FG008|Stage 1|Withdrawal by Subject|0|||
144605692|NCT00467779|521419006|FG009|Stage 1|Withdrawal by Subject|0|||
144605693|NCT00467779|521419007|FG010|Stage 1|Withdrawal by Subject|0|||
144605694|NCT00467779|521419008|FG011|Stage 1|Withdrawal by Subject|0|||
144605695|NCT00467779|521419009|FG012|Stage 1|Withdrawal by Subject|0|||
144605696|NCT00467779|521419010|FG013|Stage 1|Withdrawal by Subject|0|||
144605697|NCT00467779|521419011|FG014|Stage 1|Withdrawal by Subject|0|||
144605698|NCT00467779|521418997|FG000|Stage 1A|Adverse Event|0|||
144605699|NCT00467779|521418998|FG001|Stage 1A|Adverse Event|0|||
144605700|NCT00467779|521418999|FG002|Stage 1A|Adverse Event|0|||
144605701|NCT00467779|521419000|FG003|Stage 1A|Adverse Event|0|||
144605702|NCT00467779|521419001|FG004|Stage 1A|Adverse Event|0|||
144605703|NCT00467779|521419002|FG005|Stage 1A|Adverse Event|0|||
144605704|NCT00467779|521419003|FG006|Stage 1A|Adverse Event|0|||
144605705|NCT00467779|521419004|FG007|Stage 1A|Adverse Event|0|||
144605706|NCT00467779|521419005|FG008|Stage 1A|Adverse Event|0|||
144605707|NCT00467779|521419006|FG009|Stage 1A|Adverse Event|0|||
144605708|NCT00467779|521419007|FG010|Stage 1A|Adverse Event|0|||
144605709|NCT00467779|521419008|FG011|Stage 1A|Adverse Event|0|||
144605710|NCT00467779|521419009|FG012|Stage 1A|Adverse Event|1|||
144192555|NCT01813071|519900865|FG003|Overall Study|Protocol Violation|0|||
144192556|NCT01813071|519900866|FG004|Overall Study|Protocol Violation|1|||
144192557|NCT01813071|519900867|FG005|Overall Study|Protocol Violation|4|||
144443148|NCT00715793|520822032|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
144443149|NCT00715793|520822033|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
144443150|NCT00715793|520822032|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
144443151|NCT00715793|520822033|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
144443152|NCT02114879|520822036|FG000|Overall Study|Withdrawal by Subject|9|||
144443153|NCT02114879|520822037|FG001|Overall Study|Withdrawal by Subject|5|||
144443154|NCT02114879|520822036|FG000|Overall Study|Death|6|||
144443155|NCT02114879|520822037|FG001|Overall Study|Death|11|||
144443156|NCT02114879|520822036|FG000|Overall Study|Lost to Follow-up|4|||
144443157|NCT02114879|520822037|FG001|Overall Study|Lost to Follow-up|6|||
144443158|NCT02114879|520822036|FG000|Overall Study|Physician Decision|0|||
144443159|NCT02114879|520822037|FG001|Overall Study|Physician Decision|2|||
144443160|NCT02152995|520822038|FG000|Overall Study|Withdrawal by Subject|1|||
144443161|NCT02152995|520822039|FG001|Overall Study|Withdrawal by Subject|0|||
144443162|NCT01365273|520822040|FG000|Overall Study|Lost to Follow-up|1|||
144443163|NCT01365273|520822041|FG001|Overall Study|Lost to Follow-up|0|||
144443164|NCT01365273|520822040|FG000|Overall Study|Protocol Violation|0|||
144443165|NCT01365273|520822041|FG001|Overall Study|Protocol Violation|1|||
144443166|NCT01365273|520822040|FG000|Overall Study|Physician Decision|1|||
144443167|NCT01365273|520822041|FG001|Overall Study|Physician Decision|0|||
144443168|NCT04907032|520822043|FG000|Overall Study|Withdrawal by Subject|7|||
144443169|NCT04907032|520822044|FG001|Overall Study|Withdrawal by Subject|1|||
144443170|NCT04847674|520822053|FG000|Overall Study|Withdrawal by Subject|0|||
144443171|NCT04847674|520822054|FG001|Overall Study|Withdrawal by Subject|1|||
144443172|NCT04847674|520822055|FG002|Overall Study|Withdrawal by Subject|0|||
144192558|NCT01813071|519900868|FG006|Overall Study|Protocol Violation|2|||
144443173|NCT04847674|520822053|FG000|Overall Study|Lost to Follow-up|0|||
144443174|NCT04847674|520822054|FG001|Overall Study|Lost to Follow-up|0|||
144443175|NCT04847674|520822055|FG002|Overall Study|Lost to Follow-up|2|||
144443176|NCT04847674|520822053|FG000|Overall Study|Other than specified|21|||
144605711|NCT00467779|521419010|FG013|Stage 1A|Adverse Event|0|||
144605712|NCT00467779|521419011|FG014|Stage 1A|Adverse Event|0|||
144192559|NCT01813071|519900869|FG007|Overall Study|Protocol Violation|4|||
144443177|NCT04847674|520822054|FG001|Overall Study|Other than specified|20|||
144605713|NCT00467779|521418997|FG000|Stage 1A|Death|0|||
144605714|NCT00467779|521418998|FG001|Stage 1A|Death|0|||
144605715|NCT00467779|521418999|FG002|Stage 1A|Death|0|||
144605716|NCT00467779|521419000|FG003|Stage 1A|Death|0|||
144605717|NCT00467779|521419001|FG004|Stage 1A|Death|0|||
144605718|NCT00467779|521419002|FG005|Stage 1A|Death|0|||
144605719|NCT00467779|521419003|FG006|Stage 1A|Death|0|||
144605720|NCT00467779|521419004|FG007|Stage 1A|Death|0|||
144605721|NCT00467779|521419005|FG008|Stage 1A|Death|0|||
144605722|NCT00467779|521419006|FG009|Stage 1A|Death|0|||
144532315|NCT02492711|521152409|FG002|Overall Study|Death|0|||
144532316|NCT02492711|521152407|FG000|Overall Study|Withdrawal by Subject|10|||
144532317|NCT02492711|521152408|FG001|Overall Study|Withdrawal by Subject|16|||
144532318|NCT02492711|521152409|FG002|Overall Study|Withdrawal by Subject|5|||
144532319|NCT02492711|521152407|FG000|Overall Study|Physician Decision|10|||
144532320|NCT02492711|521152408|FG001|Overall Study|Physician Decision|6|||
144532321|NCT02492711|521152409|FG002|Overall Study|Physician Decision|4|||
144532322|NCT02492711|521152407|FG000|Overall Study|Lost to Follow-up|0|||
144532323|NCT02492711|521152408|FG001|Overall Study|Lost to Follow-up|0|||
144532324|NCT02492711|521152409|FG002|Overall Study|Lost to Follow-up|1|||
144532325|NCT02492711|521152407|FG000|Overall Study|study treatment delay|2|||
144532326|NCT02492711|521152408|FG001|Overall Study|study treatment delay|1|||
144532327|NCT02492711|521152409|FG002|Overall Study|study treatment delay|0|||
144532328|NCT02492711|521152407|FG000|Overall Study|change in chemotherapy|0|||
144532329|NCT02492711|521152408|FG001|Overall Study|change in chemotherapy|1|||
144532330|NCT02492711|521152409|FG002|Overall Study|change in chemotherapy|0|||
144532331|NCT02492711|521152407|FG000|Overall Study|never treated|2|||
144532332|NCT02492711|521152408|FG001|Overall Study|never treated|4|||
144532333|NCT02492711|521152409|FG002|Overall Study|never treated|0|||
144532334|NCT02492711|521152407|FG000|Overall Study|Other|0|||
144605723|NCT00467779|521419007|FG010|Stage 1A|Death|0|||
144605724|NCT00467779|521419008|FG011|Stage 1A|Death|1|||
144605725|NCT00467779|521419009|FG012|Stage 1A|Death|1|||
144605726|NCT00467779|521419010|FG013|Stage 1A|Death|0|||
144605727|NCT00467779|521419011|FG014|Stage 1A|Death|0|||
144605728|NCT00467779|521418997|FG000|Stage 1A|Disease Progression|0|||
144605729|NCT00467779|521418998|FG001|Stage 1A|Disease Progression|0|||
144605730|NCT00467779|521418999|FG002|Stage 1A|Disease Progression|0|||
144605731|NCT00467779|521419000|FG003|Stage 1A|Disease Progression|0|||
144605732|NCT00467779|521419001|FG004|Stage 1A|Disease Progression|0|||
144605733|NCT00467779|521419002|FG005|Stage 1A|Disease Progression|0|||
144605734|NCT00467779|521419003|FG006|Stage 1A|Disease Progression|0|||
144605735|NCT00467779|521419004|FG007|Stage 1A|Disease Progression|0|||
144605736|NCT00467779|521419005|FG008|Stage 1A|Disease Progression|0|||
144605737|NCT00467779|521419006|FG009|Stage 1A|Disease Progression|2|||
144605738|NCT00467779|521419007|FG010|Stage 1A|Disease Progression|2|||
144605739|NCT00467779|521419008|FG011|Stage 1A|Disease Progression|5|||
144605740|NCT00467779|521419009|FG012|Stage 1A|Disease Progression|2|||
144605741|NCT00467779|521419010|FG013|Stage 1A|Disease Progression|0|||
144605742|NCT00467779|521419011|FG014|Stage 1A|Disease Progression|0|||
144605743|NCT00467779|521418997|FG000|Stage 1A|Physician Decision|0|||
144605744|NCT00467779|521418998|FG001|Stage 1A|Physician Decision|0|||
144605745|NCT00467779|521418999|FG002|Stage 1A|Physician Decision|0|||
144605746|NCT00467779|521419000|FG003|Stage 1A|Physician Decision|0|||
144605747|NCT00467779|521419001|FG004|Stage 1A|Physician Decision|0|||
144605748|NCT00467779|521419002|FG005|Stage 1A|Physician Decision|0|||
144605749|NCT00467779|521419003|FG006|Stage 1A|Physician Decision|0|||
144605750|NCT00467779|521419004|FG007|Stage 1A|Physician Decision|0|||
144605751|NCT00467779|521419005|FG008|Stage 1A|Physician Decision|0|||
144605752|NCT00467779|521419006|FG009|Stage 1A|Physician Decision|1|||
144605753|NCT00467779|521419007|FG010|Stage 1A|Physician Decision|0|||
144605754|NCT00467779|521419008|FG011|Stage 1A|Physician Decision|0|||
144605755|NCT00467779|521419009|FG012|Stage 1A|Physician Decision|0|||
144605756|NCT00467779|521419010|FG013|Stage 1A|Physician Decision|0|||
144605757|NCT00467779|521419011|FG014|Stage 1A|Physician Decision|0|||
144605758|NCT00467779|521418997|FG000|Stage 1A|Withdrawal by Subject|0|||
144605759|NCT00467779|521418998|FG001|Stage 1A|Withdrawal by Subject|0|||
144605760|NCT00467779|521418999|FG002|Stage 1A|Withdrawal by Subject|0|||
144605761|NCT00467779|521419000|FG003|Stage 1A|Withdrawal by Subject|0|||
144532335|NCT02492711|521152408|FG001|Overall Study|Other|0|||
144605762|NCT00467779|521419001|FG004|Stage 1A|Withdrawal by Subject|0|||
144605763|NCT00467779|521419002|FG005|Stage 1A|Withdrawal by Subject|0|||
144605764|NCT00467779|521419003|FG006|Stage 1A|Withdrawal by Subject|0|||
144605765|NCT00467779|521419004|FG007|Stage 1A|Withdrawal by Subject|0|||
144605766|NCT00467779|521419005|FG008|Stage 1A|Withdrawal by Subject|0|||
144605767|NCT00467779|521419006|FG009|Stage 1A|Withdrawal by Subject|0|||
144605768|NCT00467779|521419007|FG010|Stage 1A|Withdrawal by Subject|1|||
144605769|NCT00467779|521419008|FG011|Stage 1A|Withdrawal by Subject|1|||
144532336|NCT02492711|521152409|FG002|Overall Study|Other|1|||
144532337|NCT03663205|521152410|FG000|Overall Study|Death|144|||
144532338|NCT03663205|521152411|FG001|Overall Study|Death|69|||
144532339|NCT03663205|521152410|FG000|Overall Study|Sponsor decision|53|||
144532340|NCT03663205|521152411|FG001|Overall Study|Sponsor decision|19|||
144532341|NCT03663205|521152410|FG000|Overall Study|Withdrawal by Subject|8|||
144532342|NCT03663205|521152411|FG001|Overall Study|Withdrawal by Subject|11|||
144532343|NCT03663205|521152410|FG000|Overall Study|Lost to Follow-up|7|||
144605770|NCT00467779|521419009|FG012|Stage 1A|Withdrawal by Subject|1|||
144605771|NCT00467779|521419010|FG013|Stage 1A|Withdrawal by Subject|0|||
144605772|NCT00467779|521419011|FG014|Stage 1A|Withdrawal by Subject|0|||
144605773|NCT00467779|521418997|FG000|Stage 1A|Unspecified Reason|0|||
144605774|NCT00467779|521418998|FG001|Stage 1A|Unspecified Reason|0|||
144605775|NCT00467779|521418999|FG002|Stage 1A|Unspecified Reason|0|||
144192560|NCT01813071|519900870|FG008|Overall Study|Protocol Violation|2|||
144192561|NCT01813071|519900862|FG000|Overall Study|Withdrawal by Subject|0|||
144192562|NCT01813071|519900863|FG001|Overall Study|Withdrawal by Subject|0|||
144192563|NCT01813071|519900864|FG002|Overall Study|Withdrawal by Subject|0|||
144443178|NCT04847674|520822055|FG002|Overall Study|Other than specified|20|||
144443179|NCT02705820|520822056|FG000|Overall Study|Death|2|||
144443180|NCT02705820|520822056|FG000|Overall Study|Disease Progression|34|||
144443181|NCT02705820|520822056|FG000|Overall Study|Clinical Deterioration|3|||
144443182|NCT00677807|520822057|FG000|Overall Study|Adverse Event|4|||
144443183|NCT00677807|520822058|FG001|Overall Study|Adverse Event|1|||
144443184|NCT00677807|520822059|FG002|Overall Study|Adverse Event|6|||
144443185|NCT00677807|520822057|FG000|Overall Study|Lack of Efficacy|0|||
144443186|NCT00677807|520822058|FG001|Overall Study|Lack of Efficacy|0|||
144443187|NCT00677807|520822059|FG002|Overall Study|Lack of Efficacy|2|||
144605776|NCT00467779|521419000|FG003|Stage 1A|Unspecified Reason|0|||
144605777|NCT00467779|521419001|FG004|Stage 1A|Unspecified Reason|0|||
144605778|NCT00467779|521419002|FG005|Stage 1A|Unspecified Reason|0|||
144605779|NCT00467779|521419003|FG006|Stage 1A|Unspecified Reason|0|||
144605780|NCT00467779|521419004|FG007|Stage 1A|Unspecified Reason|0|||
144605781|NCT00467779|521419005|FG008|Stage 1A|Unspecified Reason|0|||
144605782|NCT00467779|521419006|FG009|Stage 1A|Unspecified Reason|0|||
144605783|NCT00467779|521419007|FG010|Stage 1A|Unspecified Reason|0|||
144605784|NCT00467779|521419008|FG011|Stage 1A|Unspecified Reason|1|||
144605785|NCT00467779|521419009|FG012|Stage 1A|Unspecified Reason|1|||
144605786|NCT00467779|521419010|FG013|Stage 1A|Unspecified Reason|0|||
144605787|NCT00467779|521419011|FG014|Stage 1A|Unspecified Reason|0|||
144605788|NCT00467779|521418997|FG000|Stage 2|Adverse Event|0|||
144605789|NCT00467779|521418998|FG001|Stage 2|Adverse Event|0|||
144605790|NCT00467779|521418999|FG002|Stage 2|Adverse Event|0|||
144605791|NCT00467779|521419000|FG003|Stage 2|Adverse Event|0|||
144605792|NCT00467779|521419001|FG004|Stage 2|Adverse Event|0|||
144605793|NCT00467779|521419002|FG005|Stage 2|Adverse Event|0|||
144605794|NCT00467779|521419003|FG006|Stage 2|Adverse Event|0|||
144605795|NCT00467779|521419004|FG007|Stage 2|Adverse Event|0|||
144605796|NCT00467779|521419005|FG008|Stage 2|Adverse Event|1|||
144605797|NCT00467779|521419006|FG009|Stage 2|Adverse Event|0|||
144605798|NCT00467779|521419007|FG010|Stage 2|Adverse Event|0|||
144605799|NCT00467779|521419008|FG011|Stage 2|Adverse Event|0|||
144605800|NCT00467779|521419009|FG012|Stage 2|Adverse Event|0|||
144605801|NCT00467779|521419010|FG013|Stage 2|Adverse Event|0|||
144605802|NCT00467779|521419011|FG014|Stage 2|Adverse Event|0|||
144605803|NCT00467779|521418997|FG000|Stage 2|Death|0|||
144605804|NCT00467779|521418998|FG001|Stage 2|Death|0|||
144605805|NCT00467779|521418999|FG002|Stage 2|Death|0|||
144605806|NCT00467779|521419000|FG003|Stage 2|Death|0|||
144605807|NCT00467779|521419001|FG004|Stage 2|Death|0|||
144605808|NCT00467779|521419002|FG005|Stage 2|Death|0|||
144605809|NCT00467779|521419003|FG006|Stage 2|Death|0|||
144605810|NCT00467779|521419004|FG007|Stage 2|Death|0|||
144605811|NCT00467779|521419005|FG008|Stage 2|Death|1|||
144605812|NCT00467779|521419006|FG009|Stage 2|Death|0|||
144605813|NCT00467779|521419007|FG010|Stage 2|Death|0|||
144605814|NCT00467779|521419008|FG011|Stage 2|Death|0|||
144605815|NCT00467779|521419009|FG012|Stage 2|Death|0|||
144605816|NCT00467779|521419010|FG013|Stage 2|Death|0|||
144605817|NCT00467779|521419011|FG014|Stage 2|Death|0|||
144605818|NCT00467779|521418997|FG000|Stage 2|Disease Progression|0|||
144605819|NCT00467779|521418998|FG001|Stage 2|Disease Progression|0|||
144605820|NCT00467779|521418999|FG002|Stage 2|Disease Progression|0|||
144605821|NCT00467779|521419000|FG003|Stage 2|Disease Progression|0|||
144605822|NCT00467779|521419001|FG004|Stage 2|Disease Progression|0|||
144605823|NCT00467779|521419002|FG005|Stage 2|Disease Progression|0|||
144605824|NCT00467779|521419003|FG006|Stage 2|Disease Progression|0|||
144605825|NCT00467779|521419004|FG007|Stage 2|Disease Progression|0|||
144605826|NCT00467779|521419005|FG008|Stage 2|Disease Progression|16|||
144605827|NCT00467779|521419006|FG009|Stage 2|Disease Progression|0|||
144605828|NCT00467779|521419007|FG010|Stage 2|Disease Progression|0|||
144605829|NCT00467779|521419008|FG011|Stage 2|Disease Progression|0|||
144605830|NCT00467779|521419009|FG012|Stage 2|Disease Progression|0|||
144605831|NCT00467779|521419010|FG013|Stage 2|Disease Progression|0|||
144605832|NCT00467779|521419011|FG014|Stage 2|Disease Progression|0|||
144605833|NCT00467779|521418997|FG000|Stage 2|Unspecified Reason|0|||
144605834|NCT00467779|521418998|FG001|Stage 2|Unspecified Reason|0|||
144605835|NCT00467779|521418999|FG002|Stage 2|Unspecified Reason|0|||
144605836|NCT00467779|521419000|FG003|Stage 2|Unspecified Reason|0|||
144443188|NCT00677807|520822057|FG000|Overall Study|Participant no longer needs study drug|0|||
144253591|NCT02669667|520128146|FG000|Overall Study|Lost to Follow-up|0|||
144605837|NCT00467779|521419001|FG004|Stage 2|Unspecified Reason|0|||
144605838|NCT00467779|521419002|FG005|Stage 2|Unspecified Reason|0|||
144605839|NCT00467779|521419003|FG006|Stage 2|Unspecified Reason|0|||
144605840|NCT00467779|521419004|FG007|Stage 2|Unspecified Reason|0|||
144605841|NCT00467779|521419005|FG008|Stage 2|Unspecified Reason|3|||
144605842|NCT00467779|521419006|FG009|Stage 2|Unspecified Reason|0|||
144605843|NCT00467779|521419007|FG010|Stage 2|Unspecified Reason|0|||
144192564|NCT01813071|519900865|FG003|Overall Study|Withdrawal by Subject|0|||
144192565|NCT01813071|519900866|FG004|Overall Study|Withdrawal by Subject|0|||
144192566|NCT01813071|519900867|FG005|Overall Study|Withdrawal by Subject|1|||
144192567|NCT01813071|519900868|FG006|Overall Study|Withdrawal by Subject|0|||
144192568|NCT01813071|519900869|FG007|Overall Study|Withdrawal by Subject|0|||
144192569|NCT01813071|519900870|FG008|Overall Study|Withdrawal by Subject|0|||
144192570|NCT01813071|519900862|FG000|Overall Study|Adverse Event|0|||
144192571|NCT01813071|519900863|FG001|Overall Study|Adverse Event|0|||
144192572|NCT01813071|519900864|FG002|Overall Study|Adverse Event|0|||
144192573|NCT01813071|519900865|FG003|Overall Study|Adverse Event|0|||
144192574|NCT01813071|519900866|FG004|Overall Study|Adverse Event|0|||
144192575|NCT01813071|519900867|FG005|Overall Study|Adverse Event|1|||
144192576|NCT01813071|519900868|FG006|Overall Study|Adverse Event|0|||
144192577|NCT01813071|519900869|FG007|Overall Study|Adverse Event|0|||
144192578|NCT01813071|519900870|FG008|Overall Study|Adverse Event|0|||
144192579|NCT01813071|519900862|FG000|Overall Study|Physician Decision|0|||
144192580|NCT01813071|519900863|FG001|Overall Study|Physician Decision|0|||
144192581|NCT01813071|519900864|FG002|Overall Study|Physician Decision|0|||
144192582|NCT01813071|519900865|FG003|Overall Study|Physician Decision|0|||
144192583|NCT01813071|519900866|FG004|Overall Study|Physician Decision|0|||
144192584|NCT01813071|519900867|FG005|Overall Study|Physician Decision|0|||
144192585|NCT01813071|519900868|FG006|Overall Study|Physician Decision|1|||
144192586|NCT01813071|519900869|FG007|Overall Study|Physician Decision|0|||
144192587|NCT01813071|519900870|FG008|Overall Study|Physician Decision|0|||
144192588|NCT01813071|519900862|FG000|Overall Study|Met inc/exc criteria|0|||
144192589|NCT01813071|519900863|FG001|Overall Study|Met inc/exc criteria|0|||
144192590|NCT01813071|519900864|FG002|Overall Study|Met inc/exc criteria|0|||
144192591|NCT01813071|519900865|FG003|Overall Study|Met inc/exc criteria|0|||
144192592|NCT01813071|519900866|FG004|Overall Study|Met inc/exc criteria|0|||
144192593|NCT01813071|519900867|FG005|Overall Study|Met inc/exc criteria|1|||
144192594|NCT01813071|519900868|FG006|Overall Study|Met inc/exc criteria|0|||
144192595|NCT01813071|519900869|FG007|Overall Study|Met inc/exc criteria|1|||
144192596|NCT01813071|519900870|FG008|Overall Study|Met inc/exc criteria|1|||
144192597|NCT00854373|519900871|FG000|Overall Study|Withdrawal by Subject|1|||
144192598|NCT00854373|519900872|FG001|Overall Study|Withdrawal by Subject|3|||
144192599|NCT00854373|519900871|FG000|Overall Study|Forgot to take study drug|1|||
144192600|NCT00854373|519900872|FG001|Overall Study|Forgot to take study drug|1|||
144192601|NCT00307931|519900873|FG000|Overall Study|Adverse Event|1|||
144192602|NCT04553913|519900874|FG000|Overall Study|patient's block resolved prior to PACU|1|||
144192603|NCT04553913|519900874|FG000|Overall Study|did not use the device properly|5|||
144192604|NCT01481324|519900875|FG000|Overall Study|Missing Data|0|||
144192605|NCT01481324|519900876|FG001|Overall Study|Missing Data|2|||
144443189|NCT00677807|520822058|FG001|Overall Study|Participant no longer needs study drug|0|||
144443190|NCT00677807|520822059|FG002|Overall Study|Participant no longer needs study drug|1|||
144443191|NCT00677807|520822057|FG000|Overall Study|Withdrawal by Subject|10|||
144443192|NCT00677807|520822058|FG001|Overall Study|Withdrawal by Subject|3|||
144443193|NCT00677807|520822059|FG002|Overall Study|Withdrawal by Subject|6|||
144443194|NCT00677807|520822057|FG000|Overall Study|Lost to Follow-up|2|||
144443195|NCT00677807|520822058|FG001|Overall Study|Lost to Follow-up|2|||
144532344|NCT03663205|521152411|FG001|Overall Study|Lost to Follow-up|9|||
144532345|NCT03663205|521152410|FG000|Overall Study|Transferred to long term extension study|11|||
144532346|NCT03663205|521152411|FG001|Overall Study|Transferred to long term extension study|3|||
144532347|NCT04633538|521152416|FG000|Overall Study|Death|1|||
144532348|NCT04633538|521152416|FG000|Overall Study|Lost to Follow-up|3|||
144532349|NCT04633538|521152416|FG000|Overall Study|Withdrawal by Subject|1|||
144532350|NCT02938520|521152417|FG000|Overall Study|On-going at the time of analysis|258|||
144532351|NCT02938520|521152418|FG001|Overall Study|On-going at the time of analysis|261|||
144532352|NCT02938520|521152417|FG000|Overall Study|Physician Decision|2|||
144532353|NCT02938520|521152418|FG001|Overall Study|Physician Decision|5|||
144532354|NCT02938520|521152417|FG000|Overall Study|Lost to Follow-up|2|||
144532355|NCT02938520|521152418|FG001|Overall Study|Lost to Follow-up|2|||
144532356|NCT02938520|521152417|FG000|Overall Study|Withdrawal by Subject|7|||
144192606|NCT01481324|519900877|FG002|Overall Study|Missing Data|2|||
144192607|NCT01172821|519900878|FG000|Overall Study|Adverse Event|5|||
144192608|NCT01172821|519900879|FG001|Overall Study|Adverse Event|2|||
144192609|NCT01172821|519900880|FG002|Overall Study|Adverse Event|2|||
144192610|NCT01172821|519900881|FG003|Overall Study|Adverse Event|7|||
144443196|NCT00677807|520822059|FG002|Overall Study|Lost to Follow-up|2|||
144192611|NCT01172821|519900878|FG000|Overall Study|Protocol Violation|0|||
144192612|NCT01172821|519900879|FG001|Overall Study|Protocol Violation|2|||
144532357|NCT02938520|521152418|FG001|Overall Study|Withdrawal by Subject|7|||
144532358|NCT02938520|521152417|FG000|Overall Study|Protocol Violation|0|||
144532359|NCT02938520|521152418|FG001|Overall Study|Protocol Violation|1|||
144532360|NCT02938520|521152417|FG000|Overall Study|Lack of Efficacy|5|||
144192613|NCT01172821|519900880|FG002|Overall Study|Protocol Violation|1|||
144192614|NCT01172821|519900881|FG003|Overall Study|Protocol Violation|2|||
144192615|NCT01172821|519900878|FG000|Overall Study|Lost to Follow-up|4|||
144192616|NCT01172821|519900879|FG001|Overall Study|Lost to Follow-up|1|||
144192617|NCT01172821|519900880|FG002|Overall Study|Lost to Follow-up|2|||
144192618|NCT01172821|519900881|FG003|Overall Study|Lost to Follow-up|2|||
144192619|NCT01172821|519900878|FG000|Overall Study|Withdrawal by Subject|2|||
144192620|NCT01172821|519900879|FG001|Overall Study|Withdrawal by Subject|3|||
144443197|NCT00677807|520822057|FG000|Overall Study|Administrative problems|1|||
144443198|NCT00677807|520822058|FG001|Overall Study|Administrative problems|1|||
144443199|NCT00677807|520822059|FG002|Overall Study|Administrative problems|2|||
144443200|NCT00677807|520822057|FG000|Overall Study|Death|0|||
144443201|NCT00677807|520822058|FG001|Overall Study|Death|1|||
144443202|NCT00677807|520822059|FG002|Overall Study|Death|1|||
144443203|NCT00677807|520822057|FG000|Overall Study|Protocol Deviation|1|||
144443204|NCT00677807|520822058|FG001|Overall Study|Protocol Deviation|3|||
144443205|NCT00677807|520822059|FG002|Overall Study|Protocol Deviation|0|||
144443206|NCT00989833|520822065|FG000|Overall Study|Lost to Follow-up|0|||
144443207|NCT00989833|520822066|FG001|Overall Study|Lost to Follow-up|1|||
144443208|NCT00989833|520822067|FG002|Overall Study|Lost to Follow-up|0|||
144443209|NCT00989833|520822065|FG000|Overall Study|Protocol Violation|1|||
144192621|NCT01172821|519900880|FG002|Overall Study|Withdrawal by Subject|3|||
144192622|NCT01172821|519900881|FG003|Overall Study|Withdrawal by Subject|3|||
144192623|NCT01172821|519900878|FG000|Overall Study|Other|3|||
144192624|NCT01172821|519900879|FG001|Overall Study|Other|4|||
144192625|NCT01172821|519900880|FG002|Overall Study|Other|5|||
144192626|NCT01172821|519900881|FG003|Overall Study|Other|3|||
144192627|NCT00710749|519900882|FG000|First Intervention|Withdrawal by Subject|1|||
144192628|NCT00710749|519900883|FG001|First Intervention|Withdrawal by Subject|0|||
144192629|NCT00952276|519900885|FG000|Overall Study|Withdrawal by Subject|1|||
144192630|NCT00952276|519900886|FG001|Overall Study|Withdrawal by Subject|0|||
144192631|NCT00952276|519900887|FG002|Overall Study|Withdrawal by Subject|0|||
144192632|NCT00952276|519900888|FG003|Overall Study|Withdrawal by Subject|1|||
144192633|NCT00952276|519900889|FG004|Overall Study|Withdrawal by Subject|0|||
144192634|NCT02985879|519900890|FG000|Overall Study|Adverse Event|7|||
144443210|NCT00989833|520822066|FG001|Overall Study|Protocol Violation|2|||
144443211|NCT00989833|520822067|FG002|Overall Study|Protocol Violation|1|||
144443212|NCT00989833|520822065|FG000|Overall Study|Withdrawal by Subject|0|||
144443213|NCT00989833|520822066|FG001|Overall Study|Withdrawal by Subject|0|||
144443214|NCT00989833|520822067|FG002|Overall Study|Withdrawal by Subject|1|||
144443215|NCT00989833|520822065|FG000|Overall Study|Incorrectly randomized|1|||
144443216|NCT00989833|520822066|FG001|Overall Study|Incorrectly randomized|0|||
144443217|NCT00989833|520822067|FG002|Overall Study|Incorrectly randomized|0|||
144532361|NCT02938520|521152418|FG001|Overall Study|Lack of Efficacy|3|||
144532362|NCT02938520|521152417|FG000|Overall Study|Adverse Event|9|||
144532363|NCT02938520|521152418|FG001|Overall Study|Adverse Event|4|||
144532364|NCT03245840|521152419|FG000|Overall Study|Adverse Event|6|||
144532365|NCT03245840|521152420|FG001|Overall Study|Adverse Event|0|||
144532366|NCT03245840|521152419|FG000|Overall Study|Death|2|||
144532367|NCT03245840|521152420|FG001|Overall Study|Death|0|||
144532368|NCT03245840|521152419|FG000|Overall Study|Withdrawal by Subject|31|||
144532369|NCT03245840|521152420|FG001|Overall Study|Withdrawal by Subject|1|||
144532370|NCT03245840|521152419|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144532371|NCT03245840|521152420|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144532372|NCT03245840|521152419|FG000|Overall Study|Physician Decision|4|||
144532373|NCT03245840|521152420|FG001|Overall Study|Physician Decision|1|||
144532374|NCT03245840|521152419|FG000|Overall Study|Study Terminated by Sponsor|56|||
144532375|NCT03245840|521152420|FG001|Overall Study|Study Terminated by Sponsor|6|||
144532376|NCT03245840|521152419|FG000|Overall Study|Site Terminated by Sponsor|4|||
144532377|NCT03245840|521152420|FG001|Overall Study|Site Terminated by Sponsor|0|||
144532378|NCT03245840|521152419|FG000|Overall Study|Lost to Follow-up|12|||
144532379|NCT03245840|521152420|FG001|Overall Study|Lost to Follow-up|2|||
144532380|NCT03245840|521152419|FG000|Overall Study|Pregnancy|2|||
144532381|NCT03245840|521152420|FG001|Overall Study|Pregnancy|0|||
144532382|NCT03245840|521152419|FG000|Overall Study|Non-Compliance with Study Drug|2|||
144532383|NCT03245840|521152420|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144532384|NCT03245840|521152419|FG000|Overall Study|Not treated|1|||
144532385|NCT03245840|521152420|FG001|Overall Study|Not treated|1|||
144532386|NCT05507437|521154250|FG000|Overall Study|Withdrawal by Subject|1|||
144532387|NCT05507437|521154251|FG001|Overall Study|Withdrawal by Subject|1|||
144532388|NCT05507437|521154250|FG000|Overall Study|Death|3|||
144532389|NCT05507437|521154251|FG001|Overall Study|Death|0|||
144532390|NCT01064440|521154252|FG000|Overall Study|Lost to Follow-up|1|||
144532391|NCT01064440|521154253|FG001|Overall Study|Lost to Follow-up|1|||
144532392|NCT01064440|521154254|FG002|Overall Study|Lost to Follow-up|1|||
144192635|NCT02985879|519900891|FG001|Overall Study|Adverse Event|9|||
144443218|NCT00414388|520822068|FG000|Overall Study|Adverse Event|1|||
144532393|NCT01064440|521154252|FG000|Overall Study|Non-compliance|0|||
144532394|NCT01064440|521154253|FG001|Overall Study|Non-compliance|1|||
144532395|NCT01064440|521154254|FG002|Overall Study|Non-compliance|0|||
144532396|NCT01064440|521154252|FG000|Overall Study|Death|1|||
144532397|NCT01064440|521154253|FG001|Overall Study|Death|0|||
144532398|NCT01064440|521154254|FG002|Overall Study|Death|1|||
144532399|NCT01064440|521154252|FG000|Overall Study|Withdrawal by Subject|0|||
144192636|NCT02985879|519900892|FG002|Overall Study|Adverse Event|7|||
144192637|NCT02985879|519900890|FG000|Overall Study|Withdrew consent|6|||
144192638|NCT02985879|519900891|FG001|Overall Study|Withdrew consent|8|||
144192639|NCT02985879|519900892|FG002|Overall Study|Withdrew consent|10|||
144192640|NCT02985879|519900890|FG000|Overall Study|Lost to Follow-up|1|||
144443219|NCT03467425|520822069|FG000|Overall Study|Adverse Event|9|||
144443220|NCT03467425|520822070|FG001|Overall Study|Adverse Event|9|||
144443221|NCT03467425|520822069|FG000|Overall Study|Lack of Efficacy|3|||
144443222|NCT03467425|520822070|FG001|Overall Study|Lack of Efficacy|1|||
144443223|NCT03467425|520822069|FG000|Overall Study|Protocol Violation|0|||
144443224|NCT03467425|520822070|FG001|Overall Study|Protocol Violation|1|||
144443225|NCT03467425|520822069|FG000|Overall Study|Lost to Follow-up|18|||
144443226|NCT03467425|520822070|FG001|Overall Study|Lost to Follow-up|25|||
144443227|NCT03467425|520822069|FG000|Overall Study|Physician Decision|2|||
144443228|NCT03467425|520822070|FG001|Overall Study|Physician Decision|1|||
144443229|NCT03467425|520822069|FG000|Overall Study|Withdrawal by Subject|15|||
144443230|NCT03467425|520822070|FG001|Overall Study|Withdrawal by Subject|17|||
144443231|NCT01864291|520822071|FG000|Overall Study|need for revision surgery|2|||
144443232|NCT00023673|520823583|FG000|Overall Study|Ineligible / no protocol treatment|0|||
144443233|NCT00023673|520823584|FG001|Overall Study|Ineligible / no protocol treatment|0|||
144443234|NCT00023673|520823585|FG002|Overall Study|Ineligible / no protocol treatment|0|||
144443235|NCT00023673|520823586|FG003|Overall Study|Ineligible / no protocol treatment|1|||
144443236|NCT00023673|520823583|FG000|Overall Study|Patient withdrew consent|0|||
144443237|NCT00023673|520823584|FG001|Overall Study|Patient withdrew consent|0|||
144443238|NCT00023673|520823585|FG002|Overall Study|Patient withdrew consent|0|||
144443239|NCT00023673|520823586|FG003|Overall Study|Patient withdrew consent|1|||
144443240|NCT03285646|520823599|FG000|Overall Study|Adverse Event|1|||
144443241|NCT03285646|520823600|FG001|Overall Study|Adverse Event|0|||
144443242|NCT03285646|520823599|FG000|Overall Study|Withdrawal by Subject|10|||
144443243|NCT03285646|520823600|FG001|Overall Study|Withdrawal by Subject|2|||
144443244|NCT03285646|520823599|FG000|Overall Study|Lost to Follow-up|2|||
144443245|NCT03285646|520823600|FG001|Overall Study|Lost to Follow-up|1|||
144443246|NCT03285646|520823599|FG000|Overall Study|Investigator/Sponsor Decision|0|||
144443247|NCT03285646|520823600|FG001|Overall Study|Investigator/Sponsor Decision|1|||
144443248|NCT00306592|520823601|FG000|Overall Study|Adverse Event|8|||
144443249|NCT00306592|520823602|FG001|Overall Study|Adverse Event|15|||
144443250|NCT00306592|520823601|FG000|Overall Study|Lost to Follow-up|1|||
144443251|NCT00306592|520823602|FG001|Overall Study|Lost to Follow-up|0|||
144443252|NCT00306592|520823601|FG000|Overall Study|Noncompliance|0|||
144443253|NCT00306592|520823602|FG001|Overall Study|Noncompliance|2|||
144443254|NCT00306592|520823601|FG000|Overall Study|Persistent Antibodies|6|||
144443255|NCT00306592|520823602|FG001|Overall Study|Persistent Antibodies|3|||
144443256|NCT00306592|520823601|FG000|Overall Study|Voluntary|10|||
144443257|NCT00306592|520823602|FG001|Overall Study|Voluntary|6|||
144443258|NCT00306592|520823601|FG000|Overall Study|Other|5|||
144443259|NCT00306592|520823602|FG001|Overall Study|Other|10|||
144443260|NCT00306592|520823601|FG000|Overall Study|Other|1|||
144443261|NCT00306592|520823602|FG001|Overall Study|Other|2|||
144443262|NCT00306592|520823601|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
144443263|NCT00306592|520823602|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
144443264|NCT04101526|520823604|FG000|Overall Study|Did not complete all sleep diary entries|0|||
144443265|NCT04101526|520823605|FG001|Overall Study|Did not complete all sleep diary entries|1|||
144443266|NCT00548808|520823608|FG000|Overall Study|Lost to Follow-up|9|||
144443267|NCT00548808|520823609|FG001|Overall Study|Lost to Follow-up|3|||
144443268|NCT00548808|520823608|FG000|Overall Study|Protocol Violation|8|||
144443269|NCT00548808|520823609|FG001|Overall Study|Protocol Violation|8|||
144443270|NCT00548808|520823608|FG000|Overall Study|Withdrawal by Subject|8|||
144443271|NCT00548808|520823609|FG001|Overall Study|Withdrawal by Subject|4|||
144443272|NCT00548808|520823608|FG000|Overall Study|Physician Decision|6|||
144443273|NCT00548808|520823609|FG001|Overall Study|Physician Decision|3|||
144532400|NCT01064440|521154253|FG001|Overall Study|Withdrawal by Subject|1|||
144532401|NCT01064440|521154254|FG002|Overall Study|Withdrawal by Subject|1|||
144192641|NCT02985879|519900891|FG001|Overall Study|Lost to Follow-up|0|||
144443274|NCT00548808|520823608|FG000|Overall Study|Adverse Event|4|||
144443275|NCT00548808|520823609|FG001|Overall Study|Adverse Event|5|||
144443276|NCT00548808|520823608|FG000|Overall Study|Death|2|||
144443277|NCT00548808|520823609|FG001|Overall Study|Death|0|||
144443278|NCT00548808|520823608|FG000|Overall Study|Entry Criteria Not Met|2|||
144443279|NCT00548808|520823609|FG001|Overall Study|Entry Criteria Not Met|2|||
144192642|NCT02985879|519900892|FG002|Overall Study|Lost to Follow-up|2|||
144192643|NCT02985879|519900890|FG000|Overall Study|Other, not specified|62|||
144192644|NCT02985879|519900891|FG001|Overall Study|Other, not specified|58|||
144443280|NCT00548808|520823608|FG000|Overall Study|Lack of Efficacy|2|||
144443281|NCT00548808|520823609|FG001|Overall Study|Lack of Efficacy|0|||
144443282|NCT00548808|520823608|FG000|Overall Study|Sponsor Decision|1|||
144443283|NCT00548808|520823609|FG001|Overall Study|Sponsor Decision|1|||
144443284|NCT05044234|520823611|FG000|Overall Study|Lost to Follow-up|2|||
144532402|NCT01064440|521154252|FG000|Overall Study|Other: amputation|1|||
144532403|NCT01064440|521154253|FG001|Overall Study|Other: amputation|0|||
144532404|NCT01064440|521154254|FG002|Overall Study|Other: amputation|0|||
144532405|NCT03972150|521154256|FG000|Overall Study|Adverse Event|0|||
144532406|NCT03972150|521154257|FG001|Overall Study|Adverse Event|1|||
144532407|NCT03972150|521154258|FG002|Overall Study|Adverse Event|1|||
144532408|NCT03972150|521154259|FG003|Overall Study|Adverse Event|0|||
144532409|NCT03972150|521154260|FG004|Overall Study|Adverse Event|0|||
144532410|NCT03972150|521154256|FG000|Overall Study|Progressive disease|3|||
144532411|NCT03972150|521154257|FG001|Overall Study|Progressive disease|5|||
144532412|NCT03972150|521154258|FG002|Overall Study|Progressive disease|2|||
144532413|NCT03972150|521154259|FG003|Overall Study|Progressive disease|2|||
144532414|NCT03972150|521154260|FG004|Overall Study|Progressive disease|3|||
144532415|NCT03580356|521154264|FG000|Treatment Period|Withdrawal by Subject|13|||
144532416|NCT03580356|521154265|FG001|Treatment Period|Withdrawal by Subject|0|||
144532417|NCT03580356|521154266|FG002|Treatment Period|Withdrawal by Subject|13|||
144532418|NCT03580356|521154267|FG003|Treatment Period|Withdrawal by Subject|1|||
144532419|NCT03580356|521154268|FG004|Treatment Period|Withdrawal by Subject|17|||
144532420|NCT03580356|521154269|FG005|Treatment Period|Withdrawal by Subject|0|||
144532421|NCT03580356|521154270|FG006|Treatment Period|Withdrawal by Subject|5|||
144532422|NCT03580356|521154271|FG007|Treatment Period|Withdrawal by Subject|0|||
144532423|NCT03580356|521154264|FG000|Treatment Period|Adverse Event|10|||
144532424|NCT03580356|521154265|FG001|Treatment Period|Adverse Event|0|||
144532425|NCT03580356|521154266|FG002|Treatment Period|Adverse Event|13|||
144532426|NCT03580356|521154267|FG003|Treatment Period|Adverse Event|0|||
144532427|NCT03580356|521154268|FG004|Treatment Period|Adverse Event|5|||
144532428|NCT03580356|521154269|FG005|Treatment Period|Adverse Event|0|||
144532429|NCT03580356|521154270|FG006|Treatment Period|Adverse Event|8|||
144532430|NCT03580356|521154271|FG007|Treatment Period|Adverse Event|0|||
144532431|NCT03580356|521154264|FG000|Treatment Period|Protocol Violation|5|||
144532432|NCT03580356|521154265|FG001|Treatment Period|Protocol Violation|0|||
144532433|NCT03580356|521154266|FG002|Treatment Period|Protocol Violation|6|||
144532434|NCT03580356|521154267|FG003|Treatment Period|Protocol Violation|1|||
144532435|NCT03580356|521154268|FG004|Treatment Period|Protocol Violation|9|||
144532436|NCT03580356|521154269|FG005|Treatment Period|Protocol Violation|1|||
144532437|NCT03580356|521154270|FG006|Treatment Period|Protocol Violation|1|||
144532438|NCT03580356|521154271|FG007|Treatment Period|Protocol Violation|0|||
144532439|NCT03580356|521154264|FG000|Treatment Period|Lack of Efficacy|6|||
144443285|NCT05044234|520823612|FG001|Overall Study|Lost to Follow-up|1|||
144443286|NCT05044234|520823613|FG002|Overall Study|Lost to Follow-up|1|||
144443287|NCT05044234|520823614|FG003|Overall Study|Lost to Follow-up|2|||
144443288|NCT05044234|520823611|FG000|Overall Study|Withdrawal by Subject|6|||
144443289|NCT05044234|520823612|FG001|Overall Study|Withdrawal by Subject|4|||
144443290|NCT05044234|520823613|FG002|Overall Study|Withdrawal by Subject|5|||
144192645|NCT02985879|519900892|FG002|Overall Study|Other, not specified|58|||
144199338|NCT03107026|519928871|FG001|Overall Study|non compliance with study visits|2|||
144199339|NCT03107026|519928872|FG002|Overall Study|non compliance with study visits|0|||
144199340|NCT03107026|519928870|FG000|Overall Study|non-compliance with study drug|2|||
144199341|NCT03107026|519928871|FG001|Overall Study|non-compliance with study drug|2|||
144199342|NCT03107026|519928872|FG002|Overall Study|non-compliance with study drug|3|||
144443291|NCT05044234|520823614|FG003|Overall Study|Withdrawal by Subject|8|||
144443292|NCT05044234|520823611|FG000|Overall Study|Study terminated by Sponsor|21|||
144443293|NCT05044234|520823612|FG001|Overall Study|Study terminated by Sponsor|21|||
144443294|NCT05044234|520823613|FG002|Overall Study|Study terminated by Sponsor|20|||
144443295|NCT05044234|520823614|FG003|Overall Study|Study terminated by Sponsor|14|||
144443296|NCT05044234|520823611|FG000|Overall Study|Other, not specified|0|||
144443297|NCT05044234|520823612|FG001|Overall Study|Other, not specified|0|||
144443298|NCT05044234|520823613|FG002|Overall Study|Other, not specified|1|||
144443299|NCT05044234|520823614|FG003|Overall Study|Other, not specified|2|||
144443300|NCT05044234|520823611|FG000|Overall Study|Delayed data entry|0|||
144443301|NCT05044234|520823612|FG001|Overall Study|Delayed data entry|0|||
144443302|NCT05044234|520823613|FG002|Overall Study|Delayed data entry|0|||
144443303|NCT05044234|520823614|FG003|Overall Study|Delayed data entry|1|||
144532440|NCT03580356|521154265|FG001|Treatment Period|Lack of Efficacy|0|||
144532441|NCT03580356|521154266|FG002|Treatment Period|Lack of Efficacy|2|||
144532442|NCT03580356|521154267|FG003|Treatment Period|Lack of Efficacy|0|||
144532443|NCT03580356|521154268|FG004|Treatment Period|Lack of Efficacy|3|||
144532444|NCT03580356|521154269|FG005|Treatment Period|Lack of Efficacy|0|||
144532445|NCT03580356|521154270|FG006|Treatment Period|Lack of Efficacy|3|||
144532446|NCT03580356|521154271|FG007|Treatment Period|Lack of Efficacy|0|||
144443304|NCT00279708|520823615|FG000|Overall Study|Withdrawal by Subject|2|||
144199343|NCT03107026|519928870|FG000|Overall Study|Physician Decision|0|||
144199344|NCT03107026|519928871|FG001|Overall Study|Physician Decision|1|||
144443305|NCT00279708|520823616|FG001|Overall Study|Withdrawal by Subject|3|||
144443306|NCT00279708|520823615|FG000|Overall Study|Adverse Event|1|||
144443307|NCT00279708|520823616|FG001|Overall Study|Adverse Event|1|||
144532447|NCT03580356|521154264|FG000|Treatment Period|Pregnancy|1|||
144532448|NCT03580356|521154265|FG001|Treatment Period|Pregnancy|0|||
144532449|NCT03580356|521154266|FG002|Treatment Period|Pregnancy|7|||
144532450|NCT03580356|521154267|FG003|Treatment Period|Pregnancy|0|||
144443308|NCT02940691|520823617|FG000|Overall Study|Lost to Follow-up|5|||
144443309|NCT02940691|520823617|FG000|Overall Study|Incarceration|1|||
144443310|NCT01023659|520823618|FG000|Overall Study|Lost to Follow-up|73|||
144443311|NCT01023659|520823619|FG001|Overall Study|Lost to Follow-up|228|||
144443312|NCT01023659|520823620|FG002|Overall Study|Lost to Follow-up|99|||
144443313|NCT02331446|520823621|FG000|Overall Study|Lost to Follow-up|2|||
144443314|NCT02331446|520823622|FG001|Overall Study|Lost to Follow-up|1|||
144443315|NCT02331446|520823623|FG002|Overall Study|Lost to Follow-up|0|||
144443316|NCT02331446|520823624|FG003|Overall Study|Lost to Follow-up|1|||
144443317|NCT02331446|520823621|FG000|Overall Study|Personal Problem|2|||
144443318|NCT02331446|520823622|FG001|Overall Study|Personal Problem|0|||
144443319|NCT02331446|520823623|FG002|Overall Study|Personal Problem|0|||
144443320|NCT02331446|520823624|FG003|Overall Study|Personal Problem|0|||
144443321|NCT02331446|520823621|FG000|Overall Study|Disease|0|||
144443322|NCT02331446|520823622|FG001|Overall Study|Disease|2|||
144443323|NCT02331446|520823623|FG002|Overall Study|Disease|2|||
144443324|NCT02331446|520823624|FG003|Overall Study|Disease|1|||
144443325|NCT02331446|520823621|FG000|Overall Study|Physician Decision|0|||
144443326|NCT02331446|520823622|FG001|Overall Study|Physician Decision|1|||
144443327|NCT02331446|520823623|FG002|Overall Study|Physician Decision|0|||
144443328|NCT02331446|520823624|FG003|Overall Study|Physician Decision|1|||
144443329|NCT02331446|520823621|FG000|Overall Study|Lost before baseline analysis|0|||
144443330|NCT02331446|520823622|FG001|Overall Study|Lost before baseline analysis|1|||
144443331|NCT02331446|520823623|FG002|Overall Study|Lost before baseline analysis|1|||
144443332|NCT02331446|520823624|FG003|Overall Study|Lost before baseline analysis|0|||
144443333|NCT01049919|520823626|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
144443334|NCT01049919|520823627|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
144443335|NCT01049919|520823626|FG000|Overall Study|Withdrawal by Subject|5|||
144443336|NCT01049919|520823627|FG001|Overall Study|Withdrawal by Subject|0|||
144443337|NCT01049919|520823626|FG000|Overall Study|Lost to Follow-up|6|||
144443338|NCT01049919|520823627|FG001|Overall Study|Lost to Follow-up|1|||
144443339|NCT01049919|520823626|FG000|Overall Study|Physician Decision|2|||
144443340|NCT01049919|520823627|FG001|Overall Study|Physician Decision|0|||
144443341|NCT01049919|520823626|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
144443342|NCT01049919|520823627|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
144443343|NCT01049919|520823626|FG000|Overall Study|Early study termination by sponsor.|2|||
144443344|NCT01049919|520823627|FG001|Overall Study|Early study termination by sponsor.|0|||
144443345|NCT02984995|520823628|FG000|Overall Study|Required stem cell transplant|13|||
144443346|NCT02984995|520823629|FG001|Overall Study|Required stem cell transplant|2|||
144532451|NCT03580356|521154268|FG004|Treatment Period|Pregnancy|2|||
144532452|NCT03580356|521154269|FG005|Treatment Period|Pregnancy|0|||
144532453|NCT03580356|521154270|FG006|Treatment Period|Pregnancy|1|||
144192646|NCT04974619|519902597|FG000|Overall Study|Lost to Follow-up|0|||
144192647|NCT04974619|519902598|FG001|Overall Study|Lost to Follow-up|0|||
144192648|NCT04974619|519902599|FG002|Overall Study|Lost to Follow-up|1|||
144192649|NCT04974619|519902597|FG000|Overall Study|Withdrawal by Subject|0|||
144192650|NCT04974619|519902598|FG001|Overall Study|Withdrawal by Subject|0|||
144192651|NCT04974619|519902599|FG002|Overall Study|Withdrawal by Subject|1|||
144192652|NCT04974619|519902597|FG000|Overall Study|Protocol Violation|0|||
144192653|NCT04974619|519902598|FG001|Overall Study|Protocol Violation|1|||
144192654|NCT04974619|519902599|FG002|Overall Study|Protocol Violation|0|||
144192655|NCT03959527|519902606|FG000|Overall Study|Withdrawal by Subject|8|||
144192656|NCT03959527|519902607|FG001|Overall Study|Withdrawal by Subject|3|||
144192657|NCT03959527|519902606|FG000|Overall Study|Lost to Follow-up|31|||
144192658|NCT03959527|519902607|FG001|Overall Study|Lost to Follow-up|15|||
144192659|NCT03959527|519902606|FG000|Overall Study|Did not meet eligibility criteria|1|||
144192660|NCT03959527|519902607|FG001|Overall Study|Did not meet eligibility criteria|1|||
144192661|NCT03959527|519902606|FG000|Overall Study|Protocol Violation|10|||
144192662|NCT03959527|519902607|FG001|Overall Study|Protocol Violation|5|||
144192663|NCT01688466|519902608|FG000|Overall Study|Withdrawal by Subject|2|||
144192664|NCT01688466|519902609|FG001|Overall Study|Withdrawal by Subject|1|||
144192665|NCT01688466|519902608|FG000|Overall Study|Death|0|||
144192666|NCT01688466|519902609|FG001|Overall Study|Death|1|||
144192667|NCT01688466|519902608|FG000|Overall Study|Adverse Event|0|||
144443347|NCT02984995|520823628|FG000|Overall Study|Progressive disease|11|||
144443348|NCT02984995|520823629|FG001|Overall Study|Progressive disease|1|||
144443349|NCT02984995|520823628|FG000|Overall Study|Adverse Event|1|||
144532454|NCT03580356|521154271|FG007|Treatment Period|Pregnancy|0|||
144532455|NCT03580356|521154264|FG000|Treatment Period|Physician Decision|2|||
144443350|NCT02984995|520823629|FG001|Overall Study|Adverse Event|0|||
144443351|NCT01401530|520823630|FG000|Overall Study|Disease Progression|1|||
144443352|NCT01401530|520823631|FG001|Overall Study|Disease Progression|2|||
144443353|NCT01401530|520823632|FG002|Overall Study|Disease Progression|1|||
144192668|NCT01688466|519902609|FG001|Overall Study|Adverse Event|4|||
144192669|NCT01688466|519902608|FG000|Overall Study|Not evaluable|0|||
144192670|NCT01688466|519902609|FG001|Overall Study|Not evaluable|1|||
144192671|NCT01000610|519902614|FG000|Overall Study|Adverse Event|1|||
144192672|NCT01000610|519902614|FG000|Overall Study|Lost to Follow-up|4|||
144192673|NCT01000610|519902614|FG000|Overall Study|Treatment failure|1|||
144192674|NCT00595335|519902619|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
144192675|NCT00595335|519902620|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
144192676|NCT00595335|519902619|FG000|Baseline to Six Months|Disease Progression|1|||
144192677|NCT00595335|519902620|FG001|Baseline to Six Months|Disease Progression|1|||
144192678|NCT00595335|519902619|FG000|Baseline to Six Months|Adverse Event|1|||
144192679|NCT00595335|519902620|FG001|Baseline to Six Months|Adverse Event|0|||
144443354|NCT01401530|520823630|FG000|Overall Study|Adverse Event|1|||
144443355|NCT01401530|520823631|FG001|Overall Study|Adverse Event|1|||
144443356|NCT01401530|520823632|FG002|Overall Study|Adverse Event|1|||
144443357|NCT01401530|520823630|FG000|Overall Study|Participant Choice|1|||
144443358|NCT01401530|520823631|FG001|Overall Study|Participant Choice|2|||
144443359|NCT01401530|520823632|FG002|Overall Study|Participant Choice|1|||
144443360|NCT01401530|520823630|FG000|Overall Study|Physician Decision|0|||
144532456|NCT03580356|521154265|FG001|Treatment Period|Physician Decision|0|||
144532457|NCT03580356|521154266|FG002|Treatment Period|Physician Decision|1|||
144532458|NCT03580356|521154267|FG003|Treatment Period|Physician Decision|0|||
144192680|NCT00595335|519902619|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
144192681|NCT00595335|519902620|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
144192682|NCT00595335|519902619|FG000|Six Months to Twelve Months|Disease Progression|1|||
144192683|NCT00595335|519902620|FG001|Six Months to Twelve Months|Disease Progression|0|||
144192684|NCT00493779|519902632|FG000|Overall Study|Logistical issue at site|1|||
144192685|NCT01131299|519902633|FG000|Overall Study|Withdrawal by Subject|4|||
144192686|NCT01131299|519902634|FG001|Overall Study|Withdrawal by Subject|7|||
144192687|NCT01885182|519902642|FG000|Overall Study|Adverse Event|11|||
144192688|NCT01885182|519902643|FG001|Overall Study|Adverse Event|13|||
144192689|NCT01885182|519902642|FG000|Overall Study|Withdrawal by Subject|13|||
144192690|NCT01885182|519902643|FG001|Overall Study|Withdrawal by Subject|6|||
144192691|NCT01885182|519902642|FG000|Overall Study|Lost to Follow-up|2|||
144192692|NCT01885182|519902643|FG001|Overall Study|Lost to Follow-up|2|||
144192693|NCT01885182|519902642|FG000|Overall Study|Lack of Efficacy|8|||
144192694|NCT01885182|519902643|FG001|Overall Study|Lack of Efficacy|1|||
144192695|NCT01207440|519902650|FG000|Overall Study|Adverse Event|46|||
144192696|NCT01207440|519902651|FG001|Overall Study|Adverse Event|11|||
144192697|NCT01207440|519902652|FG002|Overall Study|Adverse Event|7|||
144192698|NCT01207440|519902653|FG003|Overall Study|Adverse Event|2|||
144192699|NCT01207440|519902654|FG004|Overall Study|Adverse Event|6|||
144192700|NCT01207440|519902655|FG005|Overall Study|Adverse Event|6|||
144192701|NCT01207440|519902656|FG006|Overall Study|Adverse Event|2|||
144192702|NCT01207440|519902650|FG000|Overall Study|Death|6|||
144192703|NCT01207440|519902651|FG001|Overall Study|Death|3|||
144192704|NCT01207440|519902652|FG002|Overall Study|Death|2|||
144192705|NCT01207440|519902653|FG003|Overall Study|Death|2|||
144443361|NCT01401530|520823631|FG001|Overall Study|Physician Decision|1|||
144443362|NCT01401530|520823632|FG002|Overall Study|Physician Decision|0|||
144532459|NCT03580356|521154268|FG004|Treatment Period|Physician Decision|4|||
144532460|NCT03580356|521154269|FG005|Treatment Period|Physician Decision|0|||
144532461|NCT03580356|521154270|FG006|Treatment Period|Physician Decision|2|||
144532462|NCT03580356|521154271|FG007|Treatment Period|Physician Decision|0|||
144532463|NCT03580356|521154264|FG000|Treatment Period|Lost to Follow-up|1|||
144532464|NCT03580356|521154265|FG001|Treatment Period|Lost to Follow-up|1|||
144532465|NCT03580356|521154266|FG002|Treatment Period|Lost to Follow-up|1|||
144532466|NCT03580356|521154267|FG003|Treatment Period|Lost to Follow-up|0|||
144532467|NCT03580356|521154268|FG004|Treatment Period|Lost to Follow-up|3|||
144192706|NCT01207440|519902654|FG004|Overall Study|Death|7|||
144192707|NCT01207440|519902655|FG005|Overall Study|Death|5|||
144192708|NCT01207440|519902656|FG006|Overall Study|Death|1|||
144192709|NCT01207440|519902650|FG000|Overall Study|Lack of Efficacy|13|||
144192710|NCT01207440|519902651|FG001|Overall Study|Lack of Efficacy|2|||
144192711|NCT01207440|519902652|FG002|Overall Study|Lack of Efficacy|5|||
144192712|NCT01207440|519902653|FG003|Overall Study|Lack of Efficacy|1|||
144192713|NCT01207440|519902654|FG004|Overall Study|Lack of Efficacy|2|||
144192714|NCT01207440|519902655|FG005|Overall Study|Lack of Efficacy|3|||
144443363|NCT01470469|520823633|FG000|Overall Study|Withdrawal by Subject|4|||
144532468|NCT03580356|521154269|FG005|Treatment Period|Lost to Follow-up|0|||
144532469|NCT03580356|521154270|FG006|Treatment Period|Lost to Follow-up|1|||
144532470|NCT03580356|521154271|FG007|Treatment Period|Lost to Follow-up|0|||
144532471|NCT03580356|521154264|FG000|Treatment Period|Death|0|||
144532472|NCT03580356|521154265|FG001|Treatment Period|Death|0|||
144532473|NCT03580356|521154266|FG002|Treatment Period|Death|1|||
144532474|NCT03580356|521154267|FG003|Treatment Period|Death|0|||
144532475|NCT03580356|521154268|FG004|Treatment Period|Death|0|||
144725080|NCT03552757|521849197|FG001|Overall Study|Death|1|||
144192715|NCT01207440|519902656|FG006|Overall Study|Lack of Efficacy|0|||
144192716|NCT01207440|519902650|FG000|Overall Study|Lost to Follow-up|0|||
144192717|NCT01207440|519902651|FG001|Overall Study|Lost to Follow-up|0|||
144192718|NCT01207440|519902652|FG002|Overall Study|Lost to Follow-up|2|||
144192719|NCT01207440|519902653|FG003|Overall Study|Lost to Follow-up|1|||
144443364|NCT01470469|520823634|FG001|Overall Study|Withdrawal by Subject|6|||
144192720|NCT01207440|519902654|FG004|Overall Study|Lost to Follow-up|0|||
144192721|NCT01207440|519902655|FG005|Overall Study|Lost to Follow-up|0|||
144192722|NCT01207440|519902656|FG006|Overall Study|Lost to Follow-up|0|||
144192723|NCT01207440|519902650|FG000|Overall Study|Non-compliance with Study Drug|3|||
144192724|NCT01207440|519902651|FG001|Overall Study|Non-compliance with Study Drug|0|||
144192725|NCT01207440|519902652|FG002|Overall Study|Non-compliance with Study Drug|1|||
144443365|NCT01470469|520823633|FG000|Overall Study|Lack of Efficacy|1|||
144443366|NCT01470469|520823634|FG001|Overall Study|Lack of Efficacy|7|||
144443367|NCT01470469|520823633|FG000|Overall Study|Adverse Event|0|||
144443368|NCT01470469|520823634|FG001|Overall Study|Adverse Event|7|||
144443369|NCT01470469|520823633|FG000|Overall Study|Lost to Follow-up|2|||
144443370|NCT01470469|520823634|FG001|Overall Study|Lost to Follow-up|2|||
144443371|NCT01470469|520823633|FG000|Overall Study|Protocol Violation|1|||
144443372|NCT01470469|520823634|FG001|Overall Study|Protocol Violation|1|||
144443373|NCT01470469|520823633|FG000|Overall Study|Other|2|||
144443374|NCT01470469|520823634|FG001|Overall Study|Other|1|||
144443375|NCT03969212|520823640|FG000|Overall Study|Adverse Event|1|||
144443376|NCT03969212|520823641|FG001|Overall Study|Adverse Event|0|||
144443377|NCT03969212|520823642|FG002|Overall Study|Adverse Event|0|||
144443378|NCT03969212|520823643|FG003|Overall Study|Adverse Event|0|||
144443379|NCT03969212|520823640|FG000|Overall Study|Lost to Follow-up|2|||
144605844|NCT00467779|521419008|FG011|Stage 2|Unspecified Reason|0|||
144605845|NCT00467779|521419009|FG012|Stage 2|Unspecified Reason|0|||
144605846|NCT00467779|521419010|FG013|Stage 2|Unspecified Reason|0|||
144605847|NCT00467779|521419011|FG014|Stage 2|Unspecified Reason|0|||
144605848|NCT00467779|521418997|FG000|Stage 2A|Adverse Event|0|||
144605849|NCT00467779|521418998|FG001|Stage 2A|Adverse Event|0|||
144605850|NCT00467779|521418999|FG002|Stage 2A|Adverse Event|0|||
144605851|NCT00467779|521419000|FG003|Stage 2A|Adverse Event|0|||
144605852|NCT00467779|521419001|FG004|Stage 2A|Adverse Event|0|||
144605853|NCT00467779|521419002|FG005|Stage 2A|Adverse Event|0|||
144443380|NCT03969212|520823641|FG001|Overall Study|Lost to Follow-up|2|||
144443381|NCT03969212|520823642|FG002|Overall Study|Lost to Follow-up|2|||
144443382|NCT03969212|520823643|FG003|Overall Study|Lost to Follow-up|2|||
144443383|NCT03969212|520823640|FG000|Overall Study|Protocol Violation|0|||
144443384|NCT03969212|520823641|FG001|Overall Study|Protocol Violation|0|||
144443385|NCT03969212|520823642|FG002|Overall Study|Protocol Violation|0|||
144443386|NCT03969212|520823643|FG003|Overall Study|Protocol Violation|1|||
144443387|NCT03969212|520823640|FG000|Overall Study|Withdrawal by Subject|7|||
144443388|NCT03969212|520823641|FG001|Overall Study|Withdrawal by Subject|13|||
144443389|NCT03969212|520823642|FG002|Overall Study|Withdrawal by Subject|5|||
144443390|NCT03969212|520823643|FG003|Overall Study|Withdrawal by Subject|11|||
144443391|NCT03969212|520823640|FG000|Overall Study|Physician Decision|0|||
144443392|NCT03969212|520823641|FG001|Overall Study|Physician Decision|0|||
144443393|NCT03969212|520823642|FG002|Overall Study|Physician Decision|1|||
144443394|NCT03969212|520823643|FG003|Overall Study|Physician Decision|0|||
144443395|NCT03969212|520823640|FG000|Overall Study|Reason not Specified|22|||
144443396|NCT03969212|520823641|FG001|Overall Study|Reason not Specified|23|||
144443397|NCT03969212|520823642|FG002|Overall Study|Reason not Specified|28|||
144443398|NCT03969212|520823643|FG003|Overall Study|Reason not Specified|26|||
144443399|NCT00280566|520823646|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
144443400|NCT00280566|520823647|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
144443401|NCT00280566|520823648|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
144443402|NCT00280566|520823646|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
144443403|NCT00280566|520823647|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
144443404|NCT00280566|520823648|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
144443405|NCT00280566|520823646|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
144443406|NCT00280566|520823647|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
144443407|NCT00280566|520823648|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
144605854|NCT00467779|521419003|FG006|Stage 2A|Adverse Event|0|||
144605855|NCT00467779|521419004|FG007|Stage 2A|Adverse Event|0|||
144605856|NCT00467779|521419005|FG008|Stage 2A|Adverse Event|0|||
144605857|NCT00467779|521419006|FG009|Stage 2A|Adverse Event|0|||
144605858|NCT00467779|521419007|FG010|Stage 2A|Adverse Event|0|||
144605859|NCT00467779|521419008|FG011|Stage 2A|Adverse Event|0|||
144605860|NCT00467779|521419009|FG012|Stage 2A|Adverse Event|0|||
144192726|NCT01207440|519902653|FG003|Overall Study|Non-compliance with Study Drug|0|||
144192727|NCT01207440|519902654|FG004|Overall Study|Non-compliance with Study Drug|0|||
144192728|NCT01207440|519902655|FG005|Overall Study|Non-compliance with Study Drug|0|||
144443408|NCT00280566|520823646|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
144443409|NCT00280566|520823647|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
144443410|NCT00280566|520823648|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
144443411|NCT00280566|520823646|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
144443412|NCT00280566|520823647|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
144443413|NCT00280566|520823648|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
144443414|NCT00280566|520823646|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
144605861|NCT00467779|521419010|FG013|Stage 2A|Adverse Event|2|||
144605862|NCT00467779|521419011|FG014|Stage 2A|Adverse Event|0|||
144443415|NCT00280566|520823647|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
144443416|NCT00280566|520823648|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
144443417|NCT00280566|520823646|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
144443418|NCT00280566|520823647|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
144443419|NCT00280566|520823648|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
144443420|NCT00280566|520823646|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
144192729|NCT01207440|519902656|FG006|Overall Study|Non-compliance with Study Drug|0|||
144192730|NCT01207440|519902650|FG000|Overall Study|Physician Decision|6|||
144192731|NCT01207440|519902651|FG001|Overall Study|Physician Decision|5|||
144192732|NCT01207440|519902652|FG002|Overall Study|Physician Decision|5|||
144192733|NCT01207440|519902653|FG003|Overall Study|Physician Decision|0|||
144192734|NCT01207440|519902654|FG004|Overall Study|Physician Decision|1|||
144443421|NCT00280566|520823647|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
144192735|NCT01207440|519902655|FG005|Overall Study|Physician Decision|0|||
144192736|NCT01207440|519902656|FG006|Overall Study|Physician Decision|0|||
144192737|NCT01207440|519902650|FG000|Overall Study|Progressive Disease|19|||
144192738|NCT01207440|519902651|FG001|Overall Study|Progressive Disease|10|||
144192739|NCT01207440|519902652|FG002|Overall Study|Progressive Disease|19|||
144192740|NCT01207440|519902653|FG003|Overall Study|Progressive Disease|7|||
144192741|NCT01207440|519902654|FG004|Overall Study|Progressive Disease|23|||
144192742|NCT01207440|519902655|FG005|Overall Study|Progressive Disease|27|||
144192743|NCT01207440|519902656|FG006|Overall Study|Progressive Disease|0|||
144192744|NCT01207440|519902650|FG000|Overall Study|Protocol Violation|2|||
144192745|NCT01207440|519902651|FG001|Overall Study|Protocol Violation|0|||
144192746|NCT01207440|519902652|FG002|Overall Study|Protocol Violation|0|||
144192747|NCT01207440|519902653|FG003|Overall Study|Protocol Violation|0|||
144192748|NCT01207440|519902654|FG004|Overall Study|Protocol Violation|0|||
144192749|NCT01207440|519902655|FG005|Overall Study|Protocol Violation|0|||
144192750|NCT01207440|519902656|FG006|Overall Study|Protocol Violation|0|||
144192751|NCT01207440|519902650|FG000|Overall Study|Site Terminated by Sponsor|69|||
144192752|NCT01207440|519902651|FG001|Overall Study|Site Terminated by Sponsor|19|||
144192753|NCT01207440|519902652|FG002|Overall Study|Site Terminated by Sponsor|12|||
144192754|NCT01207440|519902653|FG003|Overall Study|Site Terminated by Sponsor|2|||
144192755|NCT01207440|519902654|FG004|Overall Study|Site Terminated by Sponsor|3|||
144192756|NCT01207440|519902655|FG005|Overall Study|Site Terminated by Sponsor|0|||
144192757|NCT01207440|519902656|FG006|Overall Study|Site Terminated by Sponsor|2|||
144192758|NCT01207440|519902650|FG000|Overall Study|Withdrawal by Subject|29|||
144192759|NCT01207440|519902651|FG001|Overall Study|Withdrawal by Subject|4|||
144192760|NCT01207440|519902652|FG002|Overall Study|Withdrawal by Subject|5|||
144192761|NCT01207440|519902653|FG003|Overall Study|Withdrawal by Subject|3|||
144192762|NCT01207440|519902654|FG004|Overall Study|Withdrawal by Subject|2|||
144192763|NCT01207440|519902655|FG005|Overall Study|Withdrawal by Subject|2|||
144192764|NCT01207440|519902656|FG006|Overall Study|Withdrawal by Subject|0|||
144192765|NCT01207440|519902650|FG000|Overall Study|Reason Not Specified|10|||
144192766|NCT01207440|519902651|FG001|Overall Study|Reason Not Specified|10|||
144192767|NCT01207440|519902652|FG002|Overall Study|Reason Not Specified|7|||
144192768|NCT01207440|519902653|FG003|Overall Study|Reason Not Specified|0|||
144192769|NCT01207440|519902654|FG004|Overall Study|Reason Not Specified|4|||
144192770|NCT01207440|519902655|FG005|Overall Study|Reason Not Specified|3|||
144192771|NCT01207440|519902656|FG006|Overall Study|Reason Not Specified|0|||
144192772|NCT03341000|519902657|FG000|Overall Study|Adverse Event|1|||
144192773|NCT01592721|519902658|FG000|Long-term Follow-up|Death|1|||
144192774|NCT02516410|519902662|FG000|Overall Study|Adverse Event|0|||
144192775|NCT02516410|519902663|FG001|Overall Study|Adverse Event|1|||
144192776|NCT02516410|519902662|FG000|Overall Study|Withdrawal by Subject|0|||
144192777|NCT02516410|519902663|FG001|Overall Study|Withdrawal by Subject|1|||
144192778|NCT01475253|519902668|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
144192779|NCT01475253|519902669|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
144192780|NCT01475253|519902670|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
144192781|NCT01475253|519902671|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
144192782|NCT01475253|519902668|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
144192783|NCT01475253|519902669|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
144192784|NCT01475253|519902670|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
144192785|NCT01475253|519902671|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
144192786|NCT03135899|519902672|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192787|NCT03135899|519902673|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192788|NCT03135899|519902674|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192789|NCT03135899|519902675|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192790|NCT03135899|519902676|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192791|NCT03135899|519902677|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192792|NCT03135899|519902678|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
144192793|NCT03135899|519902679|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
144192794|NCT03135899|519902672|FG000|Overall Study|Withdrawal by Subject|0|||
144192795|NCT03135899|519902673|FG001|Overall Study|Withdrawal by Subject|0|||
144192796|NCT03135899|519902674|FG002|Overall Study|Withdrawal by Subject|0|||
144192797|NCT03135899|519902675|FG003|Overall Study|Withdrawal by Subject|0|||
144192798|NCT03135899|519902676|FG004|Overall Study|Withdrawal by Subject|0|||
144192799|NCT03135899|519902677|FG005|Overall Study|Withdrawal by Subject|2|||
144192800|NCT03135899|519902678|FG006|Overall Study|Withdrawal by Subject|0|||
144192801|NCT03135899|519902679|FG007|Overall Study|Withdrawal by Subject|0|||
144192802|NCT04146363|519902680|FG000|Induction Period|Adverse Event|1|||
144192803|NCT04146363|519902681|FG001|Induction Period|Adverse Event|2|||
144192804|NCT04146363|519902682|FG002|Induction Period|Adverse Event|0|||
144192805|NCT04146363|519902683|FG003|Induction Period|Adverse Event|0|||
144192806|NCT04146363|519902684|FG004|Induction Period|Adverse Event|0|||
144192807|NCT04146363|519902685|FG005|Induction Period|Adverse Event|0|||
144192808|NCT04146363|519902686|FG006|Induction Period|Adverse Event|0|||
144192809|NCT04146363|519902687|FG007|Induction Period|Adverse Event|0|||
144192810|NCT04146363|519902688|FG008|Induction Period|Adverse Event|0|||
144192811|NCT04146363|519902689|FG009|Induction Period|Adverse Event|0|||
144192812|NCT04146363|519902690|FG010|Induction Period|Adverse Event|0|||
144192813|NCT04146363|519902680|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
144253592|NCT02669667|520128147|FG001|Overall Study|Lost to Follow-up|0|||
144253593|NCT02669667|520128148|FG002|Overall Study|Lost to Follow-up|0|||
144253594|NCT02669667|520128149|FG003|Overall Study|Lost to Follow-up|0|||
144253595|NCT02669667|520128150|FG004|Overall Study|Lost to Follow-up|0|||
144253596|NCT02669667|520128151|FG005|Overall Study|Lost to Follow-up|1|||
144253597|NCT02669667|520128152|FG006|Overall Study|Lost to Follow-up|0|||
144253598|NCT03383692|520128157|FG000|Overall Study|Progressive disease as per RECIST|3|||
144253599|NCT03383692|520128158|FG001|Overall Study|Progressive disease as per RECIST|3|||
144253600|NCT03383692|520128157|FG000|Overall Study|Clinical progression|0|||
144443422|NCT00280566|520823648|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
144443423|NCT00280566|520823646|FG000|Period 2 Double Blind|Adverse Event|0|||
144605863|NCT00467779|521418997|FG000|Stage 2A|Death|0|||
144253601|NCT03383692|520128158|FG001|Overall Study|Clinical progression|1|||
144253602|NCT03383692|520128157|FG000|Overall Study|Adverse Event|3|||
144253603|NCT03383692|520128158|FG001|Overall Study|Adverse Event|0|||
144253604|NCT00586898|520128163|FG000|Overall Study|Adverse Event|1|||
144253605|NCT00586898|520128163|FG000|Overall Study|Patiemt Non-compliance|1|||
144253606|NCT00586898|520128163|FG000|Overall Study|Evaluable for Toxicity Only|5|||
144253607|NCT02101359|520128164|FG000|Overall Study|Not included|23|||
144253608|NCT02101359|520128165|FG001|Overall Study|Not included|13|||
144253609|NCT02101359|520128164|FG000|Overall Study|Withdrawal by Subject|5|||
144253610|NCT02101359|520128165|FG001|Overall Study|Withdrawal by Subject|4|||
144253611|NCT02101359|520128164|FG000|Overall Study|Lost to Follow-up|1|||
144253612|NCT02101359|520128165|FG001|Overall Study|Lost to Follow-up|0|||
144253613|NCT02101359|520128164|FG000|Overall Study|Protocol Violation|0|||
144253614|NCT02101359|520128165|FG001|Overall Study|Protocol Violation|2|||
144253615|NCT00742027|520128166|FG000|Overall Study|Disease Progression|76|||
144253616|NCT00742027|520128166|FG000|Overall Study|New Cancer Therapy|19|||
144253617|NCT00742027|520128166|FG000|Overall Study|Withdrawal by Subject|18|||
144253618|NCT00742027|520128166|FG000|Overall Study|Death|7|||
144253619|NCT00742027|520128166|FG000|Overall Study|Lost to Follow-up|4|||
144443424|NCT00280566|520823647|FG001|Period 2 Double Blind|Adverse Event|11|||
144443425|NCT00280566|520823648|FG002|Period 2 Double Blind|Adverse Event|15|||
144443426|NCT00280566|520823646|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
144443427|NCT00280566|520823647|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
144605864|NCT00467779|521418998|FG001|Stage 2A|Death|0|||
144605865|NCT00467779|521418999|FG002|Stage 2A|Death|0|||
144605866|NCT00467779|521419000|FG003|Stage 2A|Death|0|||
144605867|NCT00467779|521419001|FG004|Stage 2A|Death|0|||
144192814|NCT04146363|519902681|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
144192815|NCT04146363|519902682|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
144192816|NCT04146363|519902683|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
144192817|NCT04146363|519902684|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
144192818|NCT04146363|519902685|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
144192819|NCT04146363|519902686|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
144192820|NCT04146363|519902687|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
144192821|NCT04146363|519902688|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
144192822|NCT04146363|519902689|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
144192823|NCT04146363|519902690|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
144253620|NCT00742027|520128166|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
144253621|NCT00742027|520128166|FG000|Overall Study|Missing|2|||
144253622|NCT00742027|520128166|FG000|Overall Study|Administrative Problems|1|||
144253623|NCT01994902|520128167|FG000|Test Period 1|Withdrawal by Subject|3|||
144253624|NCT01994902|520128168|FG001|Test Period 1|Withdrawal by Subject|0|||
144253625|NCT01994902|520128167|FG000|Test Period 1|device deficiency with adverse event|0|||
144253626|NCT01994902|520128168|FG001|Test Period 1|device deficiency with adverse event|1|||
144253627|NCT01994902|520128167|FG000|Test Period 1|Adverse Event|2|||
144253628|NCT01994902|520128168|FG001|Test Period 1|Adverse Event|1|||
144253629|NCT01994902|520128167|FG000|Test Period 1|Lack of Efficacy|0|||
144253630|NCT01994902|520128168|FG001|Test Period 1|Lack of Efficacy|1|||
144605868|NCT00467779|521419002|FG005|Stage 2A|Death|0|||
144605869|NCT00467779|521419003|FG006|Stage 2A|Death|0|||
144443428|NCT00280566|520823648|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
144443429|NCT00280566|520823646|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
144443430|NCT00280566|520823647|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
144443431|NCT00280566|520823648|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
144443432|NCT00280566|520823646|FG000|Period 2 Double Blind|miscellaneous|0|||
144443433|NCT00280566|520823647|FG001|Period 2 Double Blind|miscellaneous|10|||
144443434|NCT00280566|520823648|FG002|Period 2 Double Blind|miscellaneous|5|||
144443435|NCT01147653|520823649|FG000|Year 2|Withdrawal by Subject|2|||
144443436|NCT01147653|520823650|FG001|Year 2|Withdrawal by Subject|3|||
144443437|NCT01302392|520823651|FG000|Overall Study|Lost to Follow-up|1|||
144443438|NCT01302392|520823652|FG001|Overall Study|Lost to Follow-up|0|||
144443439|NCT01302392|520823651|FG000|Overall Study|Withdrawal by Subject|6|||
144443440|NCT01302392|520823652|FG001|Overall Study|Withdrawal by Subject|1|||
144443441|NCT01469065|520823656|FG000|Overall Study|Lack of Efficacy|0|||
144443442|NCT01469065|520823657|FG001|Overall Study|Lack of Efficacy|0|||
144443443|NCT01469065|520823658|FG002|Overall Study|Lack of Efficacy|0|||
144443444|NCT01469065|520823659|FG003|Overall Study|Lack of Efficacy|0|||
144443445|NCT01469065|520823660|FG004|Overall Study|Lack of Efficacy|1|||
144443446|NCT01469065|520823656|FG000|Overall Study|Other|0|||
144443447|NCT01469065|520823657|FG001|Overall Study|Other|1|||
144443448|NCT01469065|520823658|FG002|Overall Study|Other|0|||
144443449|NCT01469065|520823659|FG003|Overall Study|Other|0|||
144443450|NCT01469065|520823660|FG004|Overall Study|Other|0|||
144443451|NCT05091528|520823666|FG000|Overall Study|Study Termination by Sponsor|0|||
144443452|NCT05091528|520823667|FG001|Overall Study|Study Termination by Sponsor|1|||
144443453|NCT05091528|520823668|FG002|Overall Study|Study Termination by Sponsor|0|||
144443454|NCT05091528|520823669|FG003|Overall Study|Study Termination by Sponsor|1|||
144443455|NCT02115282|520823670|FG000|Overall Study|Disease progression during treatment|216|||
144443456|NCT02115282|520823671|FG001|Overall Study|Disease progression during treatment|229|||
144605870|NCT00467779|521419004|FG007|Stage 2A|Death|0|||
144605871|NCT00467779|521419005|FG008|Stage 2A|Death|0|||
144605872|NCT00467779|521419006|FG009|Stage 2A|Death|0|||
144605873|NCT00467779|521419007|FG010|Stage 2A|Death|0|||
144605874|NCT00467779|521419008|FG011|Stage 2A|Death|0|||
144605875|NCT00467779|521419009|FG012|Stage 2A|Death|0|||
144605876|NCT00467779|521419010|FG013|Stage 2A|Death|1|||
144605877|NCT00467779|521419011|FG014|Stage 2A|Death|0|||
144605878|NCT00467779|521418997|FG000|Stage 2A|Disease Progression|0|||
144605879|NCT00467779|521418998|FG001|Stage 2A|Disease Progression|0|||
144605880|NCT00467779|521418999|FG002|Stage 2A|Disease Progression|0|||
144605881|NCT00467779|521419000|FG003|Stage 2A|Disease Progression|0|||
144605882|NCT00467779|521419001|FG004|Stage 2A|Disease Progression|0|||
144605883|NCT00467779|521419002|FG005|Stage 2A|Disease Progression|0|||
144605884|NCT00467779|521419003|FG006|Stage 2A|Disease Progression|0|||
144605885|NCT00467779|521419004|FG007|Stage 2A|Disease Progression|0|||
144605886|NCT00467779|521419005|FG008|Stage 2A|Disease Progression|0|||
144605887|NCT00467779|521419006|FG009|Stage 2A|Disease Progression|0|||
144605888|NCT00467779|521419007|FG010|Stage 2A|Disease Progression|0|||
144605889|NCT00467779|521419008|FG011|Stage 2A|Disease Progression|0|||
144605890|NCT00467779|521419009|FG012|Stage 2A|Disease Progression|0|||
144605891|NCT00467779|521419010|FG013|Stage 2A|Disease Progression|10|||
144605892|NCT00467779|521419011|FG014|Stage 2A|Disease Progression|0|||
144605893|NCT00467779|521418997|FG000|Stage 2A|Unspecified Reason|0|||
144605894|NCT00467779|521418998|FG001|Stage 2A|Unspecified Reason|0|||
144605895|NCT00467779|521418999|FG002|Stage 2A|Unspecified Reason|0|||
144605896|NCT00467779|521419000|FG003|Stage 2A|Unspecified Reason|0|||
144605897|NCT00467779|521419001|FG004|Stage 2A|Unspecified Reason|0|||
144605898|NCT00467779|521419002|FG005|Stage 2A|Unspecified Reason|0|||
144605899|NCT00467779|521419003|FG006|Stage 2A|Unspecified Reason|0|||
144605900|NCT00467779|521419004|FG007|Stage 2A|Unspecified Reason|0|||
144605901|NCT00467779|521419005|FG008|Stage 2A|Unspecified Reason|0|||
144605902|NCT00467779|521419006|FG009|Stage 2A|Unspecified Reason|0|||
144192824|NCT04146363|519902680|FG000|Induction Period|Lack of Efficacy|7|||
144443457|NCT02115282|520823670|FG000|Overall Study|Adverse Event|49|||
144443458|NCT02115282|520823671|FG001|Overall Study|Adverse Event|23|||
144443459|NCT02115282|520823670|FG000|Overall Study|Death|1|||
144443460|NCT02115282|520823671|FG001|Overall Study|Death|3|||
144605903|NCT00467779|521419007|FG010|Stage 2A|Unspecified Reason|0|||
144443461|NCT02115282|520823670|FG000|Overall Study|Alternative therapy|1|||
144443462|NCT02115282|520823671|FG001|Overall Study|Alternative therapy|1|||
144443463|NCT02115282|520823670|FG000|Overall Study|Complicating disease|0|||
144605904|NCT00467779|521419008|FG011|Stage 2A|Unspecified Reason|0|||
144443464|NCT02115282|520823671|FG001|Overall Study|Complicating disease|3|||
144443465|NCT02115282|520823670|FG000|Overall Study|Withdrawal by Subject|12|||
144605905|NCT00467779|521419009|FG012|Stage 2A|Unspecified Reason|0|||
144605906|NCT00467779|521419010|FG013|Stage 2A|Unspecified Reason|7|||
144605907|NCT00467779|521419011|FG014|Stage 2A|Unspecified Reason|0|||
144605908|NCT00467779|521418997|FG000|Stage 2A|Withdrawal by Subject|0|||
144605909|NCT00467779|521418998|FG001|Stage 2A|Withdrawal by Subject|0|||
144605910|NCT00467779|521418999|FG002|Stage 2A|Withdrawal by Subject|0|||
144605911|NCT00467779|521419000|FG003|Stage 2A|Withdrawal by Subject|0|||
144443466|NCT02115282|520823671|FG001|Overall Study|Withdrawal by Subject|10|||
144443467|NCT02115282|520823670|FG000|Overall Study|Symptomatic progression/deterioration|7|||
144443468|NCT02115282|520823671|FG001|Overall Study|Symptomatic progression/deterioration|18|||
144443469|NCT02115282|520823670|FG000|Overall Study|Non-compliance|5|||
144443470|NCT02115282|520823671|FG001|Overall Study|Non-compliance|1|||
144443471|NCT02115282|520823670|FG000|Overall Study|Protocol Violation|2|||
144443472|NCT02115282|520823671|FG001|Overall Study|Protocol Violation|2|||
144443473|NCT02115282|520823670|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
144253631|NCT01994902|520128167|FG000|Test Period 1|bag too small|1|||
144253632|NCT01994902|520128168|FG001|Test Period 1|bag too small|0|||
144253633|NCT01994902|520128167|FG000|Test Period 2|Withdrawal by Subject|0|||
144253634|NCT01994902|520128168|FG001|Test Period 2|Withdrawal by Subject|2|||
144253635|NCT01994902|520128167|FG000|Test Period 2|Lack of Efficacy|0|||
144253636|NCT01994902|520128168|FG001|Test Period 2|Lack of Efficacy|1|||
144253637|NCT01994902|520128167|FG000|Test Period 2|Other|0|||
144253638|NCT01994902|520128168|FG001|Test Period 2|Other|3|||
144253639|NCT01180049|520128169|FG000|Overall Study|Other|9|||
144253640|NCT01180049|520128170|FG001|Overall Study|Other|7|||
144253641|NCT01180049|520128169|FG000|Overall Study|Lost to Follow-up|8|||
144253642|NCT01180049|520128170|FG001|Overall Study|Lost to Follow-up|6|||
144253643|NCT01180049|520128169|FG000|Overall Study|Death|36|||
144253644|NCT01180049|520128170|FG001|Overall Study|Death|35|||
144253645|NCT01738191|520128173|FG000|Overall Study|Withdrawal by Subject|4|||
144253646|NCT01738191|520128174|FG001|Overall Study|Withdrawal by Subject|1|||
144253647|NCT02483572|520128175|FG000|Overall Study|Withdrawal by Subject|1|||
144253648|NCT02483572|520128176|FG001|Overall Study|Withdrawal by Subject|0|||
144253649|NCT02483572|520128175|FG000|Overall Study|Lost to Follow-up|1|||
144253650|NCT02483572|520128176|FG001|Overall Study|Lost to Follow-up|0|||
144253651|NCT02483572|520128175|FG000|Overall Study|Physician Decision|0|||
144253652|NCT02483572|520128176|FG001|Overall Study|Physician Decision|1|||
144443474|NCT02115282|520823671|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
144192825|NCT04146363|519902681|FG001|Induction Period|Lack of Efficacy|2|||
144443475|NCT02115282|520823670|FG000|Overall Study|Not start protocol therapy|9|||
144443476|NCT02115282|520823671|FG001|Overall Study|Not start protocol therapy|10|||
144443477|NCT01541826|520823674|FG000|Overall Study|Lost to Follow-up|2|||
144443478|NCT01541826|520823675|FG001|Overall Study|Lost to Follow-up|3|||
144443479|NCT01541826|520823676|FG002|Overall Study|Lost to Follow-up|0|||
144443480|NCT01541826|520823674|FG000|Overall Study|Withdrawal by Subject|2|||
144443481|NCT01541826|520823675|FG001|Overall Study|Withdrawal by Subject|0|||
144443482|NCT01541826|520823676|FG002|Overall Study|Withdrawal by Subject|0|||
144443483|NCT00006916|520823678|FG000|Overall Study|Device not inserted|4|||
144443484|NCT00006916|520823678|FG000|Overall Study|Complication of device insertion|1|||
144443485|NCT00558103|520823679|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
144443486|NCT00558103|520823680|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
144443487|NCT00558103|520823681|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
144443488|NCT00558103|520823682|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
144443489|NCT00558103|520823683|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
144443490|NCT00558103|520823684|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
144443491|NCT00558103|520823679|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
144532476|NCT03580356|521154269|FG005|Treatment Period|Death|0|||
144192826|NCT04146363|519902682|FG002|Induction Period|Lack of Efficacy|0|||
144192827|NCT04146363|519902683|FG003|Induction Period|Lack of Efficacy|0|||
144192828|NCT04146363|519902684|FG004|Induction Period|Lack of Efficacy|0|||
144192829|NCT04146363|519902685|FG005|Induction Period|Lack of Efficacy|0|||
144192830|NCT04146363|519902686|FG006|Induction Period|Lack of Efficacy|0|||
144192831|NCT04146363|519902687|FG007|Induction Period|Lack of Efficacy|0|||
144192832|NCT04146363|519902688|FG008|Induction Period|Lack of Efficacy|0|||
144192833|NCT04146363|519902689|FG009|Induction Period|Lack of Efficacy|0|||
144532477|NCT03580356|521154270|FG006|Treatment Period|Death|0|||
144532478|NCT03580356|521154271|FG007|Treatment Period|Death|0|||
144532479|NCT03580356|521154264|FG000|Treatment Period|Technical problems|0|||
144532480|NCT03580356|521154265|FG001|Treatment Period|Technical problems|0|||
144192834|NCT04146363|519902690|FG010|Induction Period|Lack of Efficacy|0|||
144192835|NCT04146363|519902680|FG000|Induction Period|Lost to Follow-up|1|||
144253653|NCT03796676|520128181|FG000|Overall Study|Adverse Event|2|||
144253654|NCT03796676|520128182|FG001|Overall Study|Adverse Event|1|||
144443492|NCT00558103|520823680|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
144443493|NCT00558103|520823681|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
144443494|NCT00558103|520823682|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
144443495|NCT00558103|520823683|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
144443496|NCT00558103|520823684|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
144253655|NCT03796676|520128183|FG002|Overall Study|Adverse Event|2|||
144532481|NCT03580356|521154266|FG002|Treatment Period|Technical problems|0|||
144253656|NCT03796676|520128181|FG000|Overall Study|Lost to Follow-up|2|||
144253657|NCT03796676|520128182|FG001|Overall Study|Lost to Follow-up|1|||
144192836|NCT04146363|519902681|FG001|Induction Period|Lost to Follow-up|4|||
144253658|NCT03796676|520128183|FG002|Overall Study|Lost to Follow-up|0|||
144532482|NCT03580356|521154267|FG003|Treatment Period|Technical problems|0|||
144532483|NCT03580356|521154268|FG004|Treatment Period|Technical problems|1|||
144532484|NCT03580356|521154269|FG005|Treatment Period|Technical problems|0|||
144532485|NCT03580356|521154270|FG006|Treatment Period|Technical problems|0|||
144532486|NCT03580356|521154271|FG007|Treatment Period|Technical problems|0|||
144443497|NCT00558103|520823679|FG000|Randomized Treatment Phase|Disease Progression|1|||
144443498|NCT00558103|520823680|FG001|Randomized Treatment Phase|Disease Progression|0|||
144443499|NCT00558103|520823681|FG002|Randomized Treatment Phase|Disease Progression|1|||
144443500|NCT00558103|520823682|FG003|Randomized Treatment Phase|Disease Progression|0|||
144443501|NCT00558103|520823683|FG004|Randomized Treatment Phase|Disease Progression|0|||
144443502|NCT00558103|520823684|FG005|Randomized Treatment Phase|Disease Progression|0|||
144443503|NCT00558103|520823679|FG000|Randomized Treatment Phase|Adverse Event|0|||
144443504|NCT00558103|520823680|FG001|Randomized Treatment Phase|Adverse Event|0|||
144443505|NCT00558103|520823681|FG002|Randomized Treatment Phase|Adverse Event|0|||
144443506|NCT00558103|520823682|FG003|Randomized Treatment Phase|Adverse Event|1|||
144443507|NCT00558103|520823683|FG004|Randomized Treatment Phase|Adverse Event|1|||
144443508|NCT00558103|520823684|FG005|Randomized Treatment Phase|Adverse Event|0|||
144443509|NCT00558103|520823679|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
144443510|NCT00558103|520823680|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
144443511|NCT00558103|520823681|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
144443512|NCT00558103|520823682|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
144443513|NCT00558103|520823683|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
144443514|NCT00558103|520823684|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
144443515|NCT00558103|520823679|FG000|Monotherapy Extension Phase|Disease Progression|0|||
144443516|NCT00558103|520823680|FG001|Monotherapy Extension Phase|Disease Progression|0|||
144443517|NCT00558103|520823681|FG002|Monotherapy Extension Phase|Disease Progression|0|||
144443518|NCT00558103|520823682|FG003|Monotherapy Extension Phase|Disease Progression|0|||
144443519|NCT00558103|520823683|FG004|Monotherapy Extension Phase|Disease Progression|0|||
144443520|NCT00558103|520823684|FG005|Monotherapy Extension Phase|Disease Progression|8|||
144443521|NCT00308711|520823686|FG000|Overall Study|Withdrawal by Subject|1|||
144443522|NCT00308711|520823687|FG001|Overall Study|Withdrawal by Subject|0|||
144443523|NCT00308711|520823688|FG002|Overall Study|Withdrawal by Subject|1|||
144532487|NCT03580356|521154264|FG000|Treatment Period|Misrandomized, no treatment|0|||
144532488|NCT03580356|521154265|FG001|Treatment Period|Misrandomized, no treatment|0|||
144443524|NCT00308711|520823686|FG000|Overall Study|Protocol Violation|0|||
144443525|NCT00308711|520823687|FG001|Overall Study|Protocol Violation|1|||
144532489|NCT03580356|521154266|FG002|Treatment Period|Misrandomized, no treatment|1|||
144532490|NCT03580356|521154267|FG003|Treatment Period|Misrandomized, no treatment|0|||
144532491|NCT03580356|521154268|FG004|Treatment Period|Misrandomized, no treatment|2|||
144532492|NCT03580356|521154269|FG005|Treatment Period|Misrandomized, no treatment|0|||
144532493|NCT03580356|521154270|FG006|Treatment Period|Misrandomized, no treatment|0|||
144532494|NCT03580356|521154271|FG007|Treatment Period|Misrandomized, no treatment|0|||
144532495|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
144532496|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
144532497|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
144532498|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
144532499|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
144532500|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
144532501|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
144532502|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
144532503|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
144605912|NCT00467779|521419001|FG004|Stage 2A|Withdrawal by Subject|0|||
144605913|NCT00467779|521419002|FG005|Stage 2A|Withdrawal by Subject|0|||
144605914|NCT00467779|521419003|FG006|Stage 2A|Withdrawal by Subject|0|||
144605915|NCT00467779|521419004|FG007|Stage 2A|Withdrawal by Subject|0|||
144605916|NCT00467779|521419005|FG008|Stage 2A|Withdrawal by Subject|0|||
144605917|NCT00467779|521419006|FG009|Stage 2A|Withdrawal by Subject|0|||
144605918|NCT00467779|521419007|FG010|Stage 2A|Withdrawal by Subject|0|||
144605919|NCT00467779|521419008|FG011|Stage 2A|Withdrawal by Subject|0|||
144605920|NCT00467779|521419009|FG012|Stage 2A|Withdrawal by Subject|0|||
144605921|NCT00467779|521419010|FG013|Stage 2A|Withdrawal by Subject|1|||
144605922|NCT00467779|521419011|FG014|Stage 2A|Withdrawal by Subject|0|||
144605923|NCT00467779|521418997|FG000|Stage 3|Adverse Event|0|||
144605924|NCT00467779|521418998|FG001|Stage 3|Adverse Event|0|||
144605925|NCT00467779|521418999|FG002|Stage 3|Adverse Event|0|||
144605926|NCT00467779|521419000|FG003|Stage 3|Adverse Event|0|||
144605927|NCT00467779|521419001|FG004|Stage 3|Adverse Event|0|||
144443526|NCT00308711|520823688|FG002|Overall Study|Protocol Violation|1|||
144443527|NCT00308711|520823686|FG000|Overall Study|Lost to Follow-up|0|||
144443528|NCT00308711|520823687|FG001|Overall Study|Lost to Follow-up|1|||
144443529|NCT00308711|520823688|FG002|Overall Study|Lost to Follow-up|0|||
144443530|NCT00308711|520823686|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
144605928|NCT00467779|521419002|FG005|Stage 3|Adverse Event|0|||
144605929|NCT00467779|521419003|FG006|Stage 3|Adverse Event|0|||
144192837|NCT04146363|519902682|FG002|Induction Period|Lost to Follow-up|0|||
144192838|NCT04146363|519902683|FG003|Induction Period|Lost to Follow-up|0|||
144192839|NCT04146363|519902684|FG004|Induction Period|Lost to Follow-up|0|||
144192840|NCT04146363|519902685|FG005|Induction Period|Lost to Follow-up|0|||
144192841|NCT04146363|519902686|FG006|Induction Period|Lost to Follow-up|0|||
144192842|NCT04146363|519902687|FG007|Induction Period|Lost to Follow-up|0|||
144192843|NCT04146363|519902688|FG008|Induction Period|Lost to Follow-up|0|||
144192844|NCT04146363|519902689|FG009|Induction Period|Lost to Follow-up|0|||
144192845|NCT04146363|519902690|FG010|Induction Period|Lost to Follow-up|0|||
144192846|NCT04146363|519902680|FG000|Induction Period|Positive quantiferon test|0|||
144192847|NCT04146363|519902681|FG001|Induction Period|Positive quantiferon test|1|||
144192848|NCT04146363|519902682|FG002|Induction Period|Positive quantiferon test|0|||
144192849|NCT04146363|519902683|FG003|Induction Period|Positive quantiferon test|0|||
144192850|NCT04146363|519902684|FG004|Induction Period|Positive quantiferon test|0|||
144192851|NCT04146363|519902685|FG005|Induction Period|Positive quantiferon test|0|||
144192852|NCT04146363|519902686|FG006|Induction Period|Positive quantiferon test|0|||
144192853|NCT04146363|519902687|FG007|Induction Period|Positive quantiferon test|0|||
144192854|NCT04146363|519902688|FG008|Induction Period|Positive quantiferon test|0|||
144192855|NCT04146363|519902689|FG009|Induction Period|Positive quantiferon test|0|||
144192856|NCT04146363|519902690|FG010|Induction Period|Positive quantiferon test|0|||
144192857|NCT04146363|519902680|FG000|Induction Period|Protocol Deviation|5|||
144192858|NCT04146363|519902681|FG001|Induction Period|Protocol Deviation|6|||
144192859|NCT04146363|519902682|FG002|Induction Period|Protocol Deviation|0|||
144192860|NCT04146363|519902683|FG003|Induction Period|Protocol Deviation|0|||
144192861|NCT04146363|519902684|FG004|Induction Period|Protocol Deviation|0|||
144192862|NCT04146363|519902685|FG005|Induction Period|Protocol Deviation|0|||
144443531|NCT00308711|520823687|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
144443532|NCT00308711|520823688|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
144443533|NCT00308711|520823686|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
144443534|NCT00308711|520823687|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
144443535|NCT00308711|520823688|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
144443536|NCT01420081|520823689|FG000|Overall Study|Death|1|||
144443537|NCT01420081|520823690|FG001|Overall Study|Death|0|||
144443538|NCT01420081|520823691|FG002|Overall Study|Death|8|||
144443539|NCT01420081|520823692|FG003|Overall Study|Death|0|||
144443540|NCT01420081|520823693|FG004|Overall Study|Death|7|||
144443541|NCT01420081|520823694|FG005|Overall Study|Death|12|||
144443542|NCT01420081|520823695|FG006|Overall Study|Death|0|||
144443543|NCT01420081|520823696|FG007|Overall Study|Death|1|||
144443544|NCT01420081|520823697|FG008|Overall Study|Death|1|||
144443545|NCT01420081|520823689|FG000|Overall Study|Lost to Follow-up|0|||
144443546|NCT01420081|520823690|FG001|Overall Study|Lost to Follow-up|0|||
144443547|NCT01420081|520823691|FG002|Overall Study|Lost to Follow-up|0|||
144443548|NCT01420081|520823692|FG003|Overall Study|Lost to Follow-up|0|||
144443549|NCT01420081|520823693|FG004|Overall Study|Lost to Follow-up|1|||
144443550|NCT01420081|520823694|FG005|Overall Study|Lost to Follow-up|1|||
144443551|NCT01420081|520823695|FG006|Overall Study|Lost to Follow-up|0|||
144443552|NCT01420081|520823696|FG007|Overall Study|Lost to Follow-up|0|||
144443553|NCT01420081|520823697|FG008|Overall Study|Lost to Follow-up|0|||
144443554|NCT01420081|520823689|FG000|Overall Study|Study Terminated by Sponsor|2|||
144443555|NCT01420081|520823690|FG001|Overall Study|Study Terminated by Sponsor|1|||
144443556|NCT01420081|520823691|FG002|Overall Study|Study Terminated by Sponsor|1|||
144192863|NCT04146363|519902686|FG006|Induction Period|Protocol Deviation|0|||
144192864|NCT04146363|519902687|FG007|Induction Period|Protocol Deviation|0|||
144192865|NCT04146363|519902688|FG008|Induction Period|Protocol Deviation|0|||
144192866|NCT04146363|519902689|FG009|Induction Period|Protocol Deviation|0|||
144192867|NCT04146363|519902690|FG010|Induction Period|Protocol Deviation|0|||
144192868|NCT04146363|519902680|FG000|Induction Period|Withdrawal by Subject|6|||
144192869|NCT04146363|519902681|FG001|Induction Period|Withdrawal by Subject|3|||
144192870|NCT04146363|519902682|FG002|Induction Period|Withdrawal by Subject|0|||
144192871|NCT04146363|519902683|FG003|Induction Period|Withdrawal by Subject|0|||
144192872|NCT04146363|519902684|FG004|Induction Period|Withdrawal by Subject|0|||
144443557|NCT01420081|520823692|FG003|Overall Study|Study Terminated by Sponsor|3|||
144443558|NCT01420081|520823693|FG004|Overall Study|Study Terminated by Sponsor|11|||
144443559|NCT01420081|520823694|FG005|Overall Study|Study Terminated by Sponsor|7|||
144443560|NCT01420081|520823695|FG006|Overall Study|Study Terminated by Sponsor|3|||
144192873|NCT04146363|519902685|FG005|Induction Period|Withdrawal by Subject|0|||
144443561|NCT01420081|520823696|FG007|Overall Study|Study Terminated by Sponsor|2|||
144443562|NCT01420081|520823697|FG008|Overall Study|Study Terminated by Sponsor|2|||
144192874|NCT04146363|519902686|FG006|Induction Period|Withdrawal by Subject|0|||
144192875|NCT04146363|519902687|FG007|Induction Period|Withdrawal by Subject|0|||
144192876|NCT04146363|519902688|FG008|Induction Period|Withdrawal by Subject|0|||
144192877|NCT04146363|519902689|FG009|Induction Period|Withdrawal by Subject|0|||
144443563|NCT01420081|520823689|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
144443564|NCT01420081|520823690|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
144605930|NCT00467779|521419004|FG007|Stage 3|Adverse Event|0|||
144443565|NCT01420081|520823691|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
144605931|NCT00467779|521419005|FG008|Stage 3|Adverse Event|0|||
144605932|NCT00467779|521419006|FG009|Stage 3|Adverse Event|0|||
144605933|NCT00467779|521419007|FG010|Stage 3|Adverse Event|0|||
144605934|NCT00467779|521419008|FG011|Stage 3|Adverse Event|0|||
144605935|NCT00467779|521419009|FG012|Stage 3|Adverse Event|0|||
144605936|NCT00467779|521419010|FG013|Stage 3|Adverse Event|0|||
144605937|NCT00467779|521419011|FG014|Stage 3|Adverse Event|2|||
144605938|NCT00467779|521418997|FG000|Stage 3|Death|0|||
144605939|NCT00467779|521418998|FG001|Stage 3|Death|0|||
144605940|NCT00467779|521418999|FG002|Stage 3|Death|0|||
144605941|NCT00467779|521419000|FG003|Stage 3|Death|0|||
144605942|NCT00467779|521419001|FG004|Stage 3|Death|0|||
144605943|NCT00467779|521419002|FG005|Stage 3|Death|0|||
144605944|NCT00467779|521419003|FG006|Stage 3|Death|0|||
144605945|NCT00467779|521419004|FG007|Stage 3|Death|0|||
144605946|NCT00467779|521419005|FG008|Stage 3|Death|0|||
144605947|NCT00467779|521419006|FG009|Stage 3|Death|0|||
144605948|NCT00467779|521419007|FG010|Stage 3|Death|0|||
144605949|NCT00467779|521419008|FG011|Stage 3|Death|0|||
144605950|NCT00467779|521419009|FG012|Stage 3|Death|0|||
144605951|NCT00467779|521419010|FG013|Stage 3|Death|0|||
144605952|NCT00467779|521419011|FG014|Stage 3|Death|1|||
144605953|NCT00467779|521418997|FG000|Stage 3|Disease Progression|0|||
144605954|NCT00467779|521418998|FG001|Stage 3|Disease Progression|0|||
144605955|NCT00467779|521418999|FG002|Stage 3|Disease Progression|0|||
144605956|NCT00467779|521419000|FG003|Stage 3|Disease Progression|0|||
144605957|NCT00467779|521419001|FG004|Stage 3|Disease Progression|0|||
144605958|NCT00467779|521419002|FG005|Stage 3|Disease Progression|0|||
144605959|NCT00467779|521419003|FG006|Stage 3|Disease Progression|0|||
144605960|NCT00467779|521419004|FG007|Stage 3|Disease Progression|0|||
144605961|NCT00467779|521419005|FG008|Stage 3|Disease Progression|0|||
144605962|NCT00467779|521419006|FG009|Stage 3|Disease Progression|0|||
144605963|NCT00467779|521419007|FG010|Stage 3|Disease Progression|0|||
144605964|NCT00467779|521419008|FG011|Stage 3|Disease Progression|0|||
144605965|NCT00467779|521419009|FG012|Stage 3|Disease Progression|0|||
144605966|NCT00467779|521419010|FG013|Stage 3|Disease Progression|0|||
144605967|NCT00467779|521419011|FG014|Stage 3|Disease Progression|9|||
144605968|NCT00467779|521418997|FG000|Stage 3|Unspecified Reason|0|||
144605969|NCT00467779|521418998|FG001|Stage 3|Unspecified Reason|0|||
144605970|NCT00467779|521418999|FG002|Stage 3|Unspecified Reason|0|||
144605971|NCT00467779|521419000|FG003|Stage 3|Unspecified Reason|0|||
144605972|NCT00467779|521419001|FG004|Stage 3|Unspecified Reason|0|||
144605973|NCT00467779|521419002|FG005|Stage 3|Unspecified Reason|0|||
144605974|NCT00467779|521419003|FG006|Stage 3|Unspecified Reason|0|||
144605975|NCT00467779|521419004|FG007|Stage 3|Unspecified Reason|0|||
144605976|NCT00467779|521419005|FG008|Stage 3|Unspecified Reason|0|||
144605977|NCT00467779|521419006|FG009|Stage 3|Unspecified Reason|0|||
144605978|NCT00467779|521419007|FG010|Stage 3|Unspecified Reason|0|||
144605979|NCT00467779|521419008|FG011|Stage 3|Unspecified Reason|0|||
144605980|NCT00467779|521419009|FG012|Stage 3|Unspecified Reason|0|||
144605981|NCT00467779|521419010|FG013|Stage 3|Unspecified Reason|0|||
144605982|NCT00467779|521419011|FG014|Stage 3|Unspecified Reason|5|||
144605983|NCT01509079|521419012|FG000|Overall Study|Lack of Efficacy|0|||
144605984|NCT01509079|521419013|FG001|Overall Study|Lack of Efficacy|2|||
144605985|NCT01509079|521419012|FG000|Overall Study|started an excluded medication|0|||
144605986|NCT01509079|521419013|FG001|Overall Study|started an excluded medication|1|||
144605987|NCT05111041|521419014|FG000|Overall Study|Lost to Follow-up|6|||
144605988|NCT05111041|521419015|FG001|Overall Study|Lost to Follow-up|7|||
144605989|NCT05111041|521419014|FG000|Overall Study|Withdrawal by Subject|1|||
144605990|NCT05111041|521419015|FG001|Overall Study|Withdrawal by Subject|0|||
144605991|NCT04667377|521419016|FG000|Dose Escalation Period|Other not specified below|3|||
144605992|NCT04667377|521419017|FG001|Dose Escalation Period|Other not specified below|3|||
144605993|NCT04667377|521419018|FG002|Dose Escalation Period|Other not specified below|2|||
144605994|NCT04667377|521419019|FG003|Dose Escalation Period|Other not specified below|1|||
144605995|NCT04667377|521419020|FG004|Dose Escalation Period|Other not specified below|3|||
144605996|NCT04667377|521419016|FG000|Dose Escalation Period|Protocol Violation|2|||
144605997|NCT04667377|521419017|FG001|Dose Escalation Period|Protocol Violation|2|||
144605998|NCT04667377|521419018|FG002|Dose Escalation Period|Protocol Violation|0|||
144605999|NCT04667377|521419019|FG003|Dose Escalation Period|Protocol Violation|2|||
144606000|NCT04667377|521419020|FG004|Dose Escalation Period|Protocol Violation|1|||
144606001|NCT04667377|521419016|FG000|Dose Escalation Period|Burden of study procedures|2|||
144606002|NCT04667377|521419017|FG001|Dose Escalation Period|Burden of study procedures|1|||
144606003|NCT04667377|521419018|FG002|Dose Escalation Period|Burden of study procedures|1|||
144606004|NCT04667377|521419019|FG003|Dose Escalation Period|Burden of study procedures|1|||
144606005|NCT04667377|521419020|FG004|Dose Escalation Period|Burden of study procedures|5|||
144606006|NCT04667377|521419016|FG000|Dose Escalation Period|Change of residence|0|||
144606007|NCT04667377|521419017|FG001|Dose Escalation Period|Change of residence|0|||
144606008|NCT04667377|521419018|FG002|Dose Escalation Period|Change of residence|1|||
144606009|NCT04667377|521419019|FG003|Dose Escalation Period|Change of residence|0|||
144606010|NCT04667377|521419020|FG004|Dose Escalation Period|Change of residence|0|||
144443566|NCT01420081|520823692|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
144443567|NCT01420081|520823693|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
144443568|NCT01420081|520823694|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
144443569|NCT01420081|520823695|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
144443570|NCT01420081|520823696|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
144443571|NCT01420081|520823697|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
144443572|NCT01420081|520823689|FG000|Overall Study|Other Reasons|0|||
144443573|NCT01420081|520823690|FG001|Overall Study|Other Reasons|0|||
144443574|NCT01420081|520823691|FG002|Overall Study|Other Reasons|1|||
144443575|NCT01420081|520823692|FG003|Overall Study|Other Reasons|0|||
144443576|NCT01420081|520823693|FG004|Overall Study|Other Reasons|0|||
144443577|NCT01420081|520823694|FG005|Overall Study|Other Reasons|0|||
144443578|NCT01420081|520823695|FG006|Overall Study|Other Reasons|0|||
144443579|NCT01420081|520823696|FG007|Overall Study|Other Reasons|0|||
144443580|NCT01420081|520823697|FG008|Overall Study|Other Reasons|0|||
144443581|NCT02318693|520823699|FG000|Overall Study|Protocol Violation|0|||
144443582|NCT02318693|520823700|FG001|Overall Study|Protocol Violation|1|||
144443583|NCT00218543|520823701|FG000|Overall Study|Lost to Follow-up|8|||
144443584|NCT00218543|520823701|FG000|Overall Study|relocated|1|||
144443585|NCT00218543|520823701|FG000|Overall Study|Withdrawal by Subject|1|||
144443586|NCT00218543|520823701|FG000|Overall Study|Physician Decision|3|||
144443587|NCT00218543|520823701|FG000|Overall Study|Adverse Event|2|||
144443588|NCT02448875|520823702|FG000|Overall Study|Adverse Event|2|||
144443589|NCT02448875|520823703|FG001|Overall Study|Adverse Event|1|||
144253659|NCT03796676|520128181|FG000|Overall Study|Protocol Violation|0|||
144253660|NCT03796676|520128182|FG001|Overall Study|Protocol Violation|0|||
144253661|NCT03796676|520128183|FG002|Overall Study|Protocol Violation|1|||
144253662|NCT03796676|520128181|FG000|Overall Study|Withdrawal by Subject|1|||
144253663|NCT03796676|520128182|FG001|Overall Study|Withdrawal by Subject|1|||
144253664|NCT03796676|520128183|FG002|Overall Study|Withdrawal by Subject|0|||
144253665|NCT03796676|520128181|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
144253666|NCT03796676|520128182|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
144253667|NCT03796676|520128183|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
144253668|NCT02432144|520128187|FG000|Overall Study|Participant Non-Compliance|1|||
144253669|NCT01905592|520128189|FG000|Overall Study|Disease Progression|51|||
144253670|NCT01905592|520128190|FG001|Overall Study|Disease Progression|110|||
144443590|NCT02448875|520823704|FG002|Overall Study|Adverse Event|0|||
144443591|NCT02448875|520823702|FG000|Overall Study|Lost to Follow-up|1|||
144443592|NCT02448875|520823703|FG001|Overall Study|Lost to Follow-up|0|||
144443593|NCT02448875|520823704|FG002|Overall Study|Lost to Follow-up|0|||
144443594|NCT02448875|520823702|FG000|Overall Study|Investigator Decision|3|||
144443595|NCT02448875|520823703|FG001|Overall Study|Investigator Decision|0|||
144443596|NCT02448875|520823704|FG002|Overall Study|Investigator Decision|1|||
144443597|NCT02448875|520823702|FG000|Overall Study|Withdrawal by Subject|1|||
144443598|NCT02448875|520823703|FG001|Overall Study|Withdrawal by Subject|0|||
144443599|NCT02448875|520823704|FG002|Overall Study|Withdrawal by Subject|0|||
144443600|NCT03337724|520823709|FG000|Overall Study|Reason not Specified|12|||
144443601|NCT03337724|520823710|FG001|Overall Study|Reason not Specified|21|||
144443602|NCT03337724|520823711|FG002|Overall Study|Reason not Specified|9|||
144443603|NCT03337724|520823712|FG003|Overall Study|Reason not Specified|9|||
144443604|NCT03337724|520823713|FG004|Overall Study|Reason not Specified|29|||
144443605|NCT03337724|520823709|FG000|Overall Study|Withdrawal by Subject|13|||
144443606|NCT03337724|520823710|FG001|Overall Study|Withdrawal by Subject|15|||
144443607|NCT03337724|520823711|FG002|Overall Study|Withdrawal by Subject|4|||
144443608|NCT03337724|520823712|FG003|Overall Study|Withdrawal by Subject|15|||
144443609|NCT03337724|520823713|FG004|Overall Study|Withdrawal by Subject|6|||
144443610|NCT03337724|520823709|FG000|Overall Study|Protocol Deviation|0|||
144443611|NCT03337724|520823710|FG001|Overall Study|Protocol Deviation|1|||
144443612|NCT03337724|520823711|FG002|Overall Study|Protocol Deviation|1|||
144443613|NCT03337724|520823712|FG003|Overall Study|Protocol Deviation|1|||
144443614|NCT03337724|520823713|FG004|Overall Study|Protocol Deviation|0|||
144443615|NCT03337724|520823709|FG000|Overall Study|Adverse Event|1|||
144443616|NCT03337724|520823710|FG001|Overall Study|Adverse Event|1|||
144443617|NCT03337724|520823711|FG002|Overall Study|Adverse Event|0|||
144443618|NCT03337724|520823712|FG003|Overall Study|Adverse Event|1|||
144532504|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
144725081|NCT03552757|521849198|FG002|Overall Study|Death|1|||
144725082|NCT02660242|521849204|FG000|Glucose Tabs|Lost to Follow-up|1|||
144725083|NCT02660242|521849204|FG000|Glucagon Injection|Lost to Follow-up|1|||
144253671|NCT01905592|520128189|FG000|Overall Study|Toxicity|1|||
144253672|NCT01905592|520128190|FG001|Overall Study|Toxicity|16|||
144443619|NCT03337724|520823713|FG004|Overall Study|Adverse Event|0|||
144443620|NCT03337724|520823709|FG000|Overall Study|Death|40|||
144443621|NCT03337724|520823710|FG001|Overall Study|Death|89|||
144443622|NCT03337724|520823711|FG002|Overall Study|Death|43|||
144443623|NCT03337724|520823712|FG003|Overall Study|Death|76|||
144443624|NCT03337724|520823713|FG004|Overall Study|Death|50|||
144725084|NCT02796664|521849206|FG000|Overall Study|Withdrawal by Subject|0|||
144443625|NCT03337724|520823709|FG000|Overall Study|Lost to Follow-up|5|||
144443626|NCT03337724|520823710|FG001|Overall Study|Lost to Follow-up|5|||
144443627|NCT03337724|520823711|FG002|Overall Study|Lost to Follow-up|4|||
144443628|NCT03337724|520823712|FG003|Overall Study|Lost to Follow-up|7|||
144443629|NCT03337724|520823713|FG004|Overall Study|Lost to Follow-up|4|||
144443630|NCT03337724|520823709|FG000|Overall Study|Physician Decision|16|||
144443631|NCT03337724|520823710|FG001|Overall Study|Physician Decision|34|||
144443632|NCT03337724|520823711|FG002|Overall Study|Physician Decision|14|||
144443633|NCT03337724|520823712|FG003|Overall Study|Physician Decision|34|||
144443634|NCT03337724|520823713|FG004|Overall Study|Physician Decision|13|||
144443635|NCT03337724|520823709|FG000|Overall Study|Progressive Disease|0|||
144443636|NCT03337724|520823710|FG001|Overall Study|Progressive Disease|2|||
144443637|NCT03337724|520823711|FG002|Overall Study|Progressive Disease|1|||
144443638|NCT03337724|520823712|FG003|Overall Study|Progressive Disease|2|||
144443639|NCT03337724|520823713|FG004|Overall Study|Progressive Disease|0|||
144443640|NCT03337724|520823709|FG000|Overall Study|Symptomatic Deterioration|0|||
144443641|NCT03337724|520823710|FG001|Overall Study|Symptomatic Deterioration|0|||
144443642|NCT03337724|520823711|FG002|Overall Study|Symptomatic Deterioration|0|||
144443643|NCT03337724|520823712|FG003|Overall Study|Symptomatic Deterioration|1|||
144443644|NCT03337724|520823713|FG004|Overall Study|Symptomatic Deterioration|0|||
144443645|NCT00773097|520823714|FG000|Overall Study|Withdrawal by Subject|1|||
144443646|NCT00773097|520823714|FG000|Overall Study|Physician Decision|6|||
144443647|NCT01038778|520823717|FG000|Overall Study|Withdrawal by Subject|0|||
144443648|NCT01038778|520823718|FG001|Overall Study|Withdrawal by Subject|2|||
144443649|NCT01038778|520823719|FG002|Overall Study|Withdrawal by Subject|3|||
144443650|NCT01607905|520825546|FG000|Overall Study|Withdrawal by participant|7|||
144443651|NCT01607905|520825547|FG001|Overall Study|Withdrawal by participant|2|||
144443652|NCT01607905|520825548|FG002|Overall Study|Withdrawal by participant|4|||
144443653|NCT01607905|520825549|FG003|Overall Study|Withdrawal by participant|6|||
144443654|NCT01607905|520825550|FG004|Overall Study|Withdrawal by participant|0|||
144443655|NCT01607905|520825551|FG005|Overall Study|Withdrawal by participant|4|||
144443656|NCT01607905|520825552|FG006|Overall Study|Withdrawal by participant|12|||
144443657|NCT01607905|520825546|FG000|Overall Study|Incidence or severity of AEs|5|||
144443658|NCT01607905|520825547|FG001|Overall Study|Incidence or severity of AEs|1|||
144443659|NCT01607905|520825548|FG002|Overall Study|Incidence or severity of AEs|1|||
144443660|NCT01607905|520825549|FG003|Overall Study|Incidence or severity of AEs|3|||
144443661|NCT01607905|520825550|FG004|Overall Study|Incidence or severity of AEs|0|||
144443662|NCT01607905|520825551|FG005|Overall Study|Incidence or severity of AEs|2|||
144443663|NCT01607905|520825552|FG006|Overall Study|Incidence or severity of AEs|8|||
144443664|NCT01607905|520825546|FG000|Overall Study|Disease progression|44|||
144443665|NCT01607905|520825547|FG001|Overall Study|Disease progression|16|||
144443666|NCT01607905|520825548|FG002|Overall Study|Disease progression|15|||
144443667|NCT01607905|520825549|FG003|Overall Study|Disease progression|11|||
144443668|NCT01607905|520825550|FG004|Overall Study|Disease progression|6|||
144443669|NCT01607905|520825551|FG005|Overall Study|Disease progression|7|||
144443670|NCT01607905|520825552|FG006|Overall Study|Disease progression|21|||
144443671|NCT01607905|520825546|FG000|Overall Study|Non-compliance with study procedures|0|||
144443672|NCT01607905|520825547|FG001|Overall Study|Non-compliance with study procedures|0|||
144443673|NCT01607905|520825548|FG002|Overall Study|Non-compliance with study procedures|0|||
144443674|NCT01607905|520825549|FG003|Overall Study|Non-compliance with study procedures|0|||
144443675|NCT01607905|520825550|FG004|Overall Study|Non-compliance with study procedures|0|||
144443676|NCT01607905|520825551|FG005|Overall Study|Non-compliance with study procedures|0|||
144443677|NCT01607905|520825552|FG006|Overall Study|Non-compliance with study procedures|1|||
144443678|NCT01607905|520825546|FG000|Overall Study|Death|1|||
144443679|NCT01607905|520825547|FG001|Overall Study|Death|1|||
144443680|NCT01607905|520825548|FG002|Overall Study|Death|1|||
144443681|NCT01607905|520825549|FG003|Overall Study|Death|1|||
144443682|NCT01607905|520825550|FG004|Overall Study|Death|0|||
144443683|NCT01607905|520825551|FG005|Overall Study|Death|0|||
144443684|NCT01607905|520825552|FG006|Overall Study|Death|3|||
144443685|NCT01607905|520825546|FG000|Overall Study|Other treatments become available|1|||
144443686|NCT01607905|520825547|FG001|Overall Study|Other treatments become available|0|||
144443687|NCT01607905|520825548|FG002|Overall Study|Other treatments become available|0|||
144443688|NCT01607905|520825549|FG003|Overall Study|Other treatments become available|0|||
144443689|NCT01607905|520825550|FG004|Overall Study|Other treatments become available|0|||
144443690|NCT01607905|520825551|FG005|Overall Study|Other treatments become available|0|||
144532505|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
144532506|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
144443691|NCT01607905|520825552|FG006|Overall Study|Other treatments become available|1|||
144532507|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
144443692|NCT01607905|520825546|FG000|Overall Study|Investigator discretion|0|||
144443693|NCT01607905|520825547|FG001|Overall Study|Investigator discretion|0|||
144443694|NCT01607905|520825548|FG002|Overall Study|Investigator discretion|0|||
144443695|NCT01607905|520825549|FG003|Overall Study|Investigator discretion|0|||
144443696|NCT01607905|520825550|FG004|Overall Study|Investigator discretion|0|||
144192878|NCT04146363|519902690|FG010|Induction Period|Withdrawal by Subject|0|||
144192879|NCT04146363|519902680|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192880|NCT04146363|519902681|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192881|NCT04146363|519902682|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192882|NCT04146363|519902683|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192883|NCT04146363|519902684|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192884|NCT04146363|519902685|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192885|NCT04146363|519902686|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
144192886|NCT04146363|519902687|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
144192887|NCT04146363|519902688|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192888|NCT04146363|519902689|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192889|NCT04146363|519902690|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
144192890|NCT04146363|519902680|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192891|NCT04146363|519902681|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144443697|NCT01607905|520825551|FG005|Overall Study|Investigator discretion|1|||
144443698|NCT01607905|520825552|FG006|Overall Study|Investigator discretion|0|||
144443699|NCT01607905|520825546|FG000|Overall Study|Other|1|||
144443700|NCT01607905|520825547|FG001|Overall Study|Other|0|||
144443701|NCT01607905|520825548|FG002|Overall Study|Other|0|||
144443702|NCT01607905|520825549|FG003|Overall Study|Other|0|||
144443703|NCT01607905|520825550|FG004|Overall Study|Other|0|||
144443704|NCT01607905|520825551|FG005|Overall Study|Other|0|||
144443705|NCT01607905|520825552|FG006|Overall Study|Other|1|||
144443706|NCT01607905|520825546|FG000|Overall Study|Randomized but not treated|1|||
144443707|NCT01607905|520825547|FG001|Overall Study|Randomized but not treated|0|||
144443708|NCT01607905|520825548|FG002|Overall Study|Randomized but not treated|0|||
144443709|NCT01607905|520825549|FG003|Overall Study|Randomized but not treated|0|||
144443710|NCT01607905|520825550|FG004|Overall Study|Randomized but not treated|1|||
144443711|NCT01607905|520825551|FG005|Overall Study|Randomized but not treated|1|||
144443712|NCT01607905|520825552|FG006|Overall Study|Randomized but not treated|0|||
144443713|NCT02349711|520825554|FG000|Overall Study|Withdrawal by Subject|2|||
144443714|NCT02349711|520825555|FG001|Overall Study|Withdrawal by Subject|1|||
144443715|NCT02349711|520825554|FG000|Overall Study|Lost to Follow-up|1|||
144443716|NCT02349711|520825555|FG001|Overall Study|Lost to Follow-up|1|||
144443717|NCT01105533|520825561|FG000|Overall Study|Death|0|||
144443718|NCT01105533|520825562|FG001|Overall Study|Death|0|||
144443719|NCT01105533|520825563|FG002|Overall Study|Death|0|||
144443720|NCT01105533|520825564|FG003|Overall Study|Death|0|||
144443721|NCT01105533|520825565|FG004|Overall Study|Death|1|||
144443722|NCT01105533|520825566|FG005|Overall Study|Death|0|||
144443723|NCT01105533|520825567|FG006|Overall Study|Death|0|||
144443724|NCT01105533|520825568|FG007|Overall Study|Death|0|||
144443725|NCT01105533|520825569|FG008|Overall Study|Death|0|||
144443726|NCT01105533|520825561|FG000|Overall Study|Lack of Efficacy|1|||
144443727|NCT01105533|520825562|FG001|Overall Study|Lack of Efficacy|1|||
144443728|NCT01105533|520825563|FG002|Overall Study|Lack of Efficacy|3|||
144443729|NCT01105533|520825564|FG003|Overall Study|Lack of Efficacy|3|||
144443730|NCT01105533|520825565|FG004|Overall Study|Lack of Efficacy|4|||
144443731|NCT01105533|520825566|FG005|Overall Study|Lack of Efficacy|5|||
144443732|NCT01105533|520825567|FG006|Overall Study|Lack of Efficacy|3|||
144443733|NCT01105533|520825568|FG007|Overall Study|Lack of Efficacy|2|||
144443734|NCT01105533|520825569|FG008|Overall Study|Lack of Efficacy|9|||
144443735|NCT01105533|520825561|FG000|Overall Study|Adverse Event|0|||
144443736|NCT01105533|520825562|FG001|Overall Study|Adverse Event|0|||
144443737|NCT01105533|520825563|FG002|Overall Study|Adverse Event|0|||
144443738|NCT01105533|520825564|FG003|Overall Study|Adverse Event|0|||
144192892|NCT04146363|519902682|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144443739|NCT01105533|520825565|FG004|Overall Study|Adverse Event|1|||
144443740|NCT01105533|520825566|FG005|Overall Study|Adverse Event|2|||
144443741|NCT01105533|520825567|FG006|Overall Study|Adverse Event|2|||
144725085|NCT02796664|521849207|FG001|Overall Study|Withdrawal by Subject|3|||
144725086|NCT02796664|521849206|FG000|Overall Study|Noncompliance|1|||
144725087|NCT02796664|521849207|FG001|Overall Study|Noncompliance|1|||
144192893|NCT04146363|519902683|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192894|NCT04146363|519902684|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192895|NCT04146363|519902685|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144443742|NCT01105533|520825568|FG007|Overall Study|Adverse Event|0|||
144443743|NCT01105533|520825569|FG008|Overall Study|Adverse Event|1|||
144199345|NCT03107026|519928872|FG002|Overall Study|Physician Decision|0|||
144443744|NCT01105533|520825561|FG000|Overall Study|Other|0|||
144443745|NCT01105533|520825562|FG001|Overall Study|Other|0|||
144443746|NCT01105533|520825563|FG002|Overall Study|Other|0|||
144443747|NCT01105533|520825564|FG003|Overall Study|Other|0|||
144443748|NCT01105533|520825565|FG004|Overall Study|Other|1|||
144443749|NCT01105533|520825566|FG005|Overall Study|Other|0|||
144443750|NCT01105533|520825567|FG006|Overall Study|Other|3|||
144443751|NCT01105533|520825568|FG007|Overall Study|Other|1|||
144443752|NCT01105533|520825569|FG008|Overall Study|Other|2|||
144192896|NCT04146363|519902686|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192897|NCT04146363|519902687|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
144192898|NCT04146363|519902688|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192899|NCT04146363|519902689|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192900|NCT04146363|519902690|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
144192901|NCT04146363|519902680|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192902|NCT04146363|519902681|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192903|NCT04146363|519902682|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192904|NCT04146363|519902683|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192905|NCT04146363|519902684|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192906|NCT04146363|519902685|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192907|NCT04146363|519902686|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
144192908|NCT04146363|519902687|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
144192909|NCT04146363|519902688|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144253673|NCT01905592|520128189|FG000|Overall Study|Physician Decision|0|||
144443753|NCT01105533|520825561|FG000|Overall Study|Physician Decision|0|||
144443754|NCT01105533|520825562|FG001|Overall Study|Physician Decision|0|||
144443755|NCT01105533|520825563|FG002|Overall Study|Physician Decision|0|||
144443756|NCT01105533|520825564|FG003|Overall Study|Physician Decision|0|||
144443757|NCT01105533|520825565|FG004|Overall Study|Physician Decision|0|||
144443758|NCT01105533|520825566|FG005|Overall Study|Physician Decision|0|||
144443759|NCT01105533|520825567|FG006|Overall Study|Physician Decision|0|||
144443760|NCT01105533|520825568|FG007|Overall Study|Physician Decision|1|||
144443761|NCT01105533|520825569|FG008|Overall Study|Physician Decision|0|||
144253674|NCT01905592|520128190|FG001|Overall Study|Physician Decision|2|||
144253675|NCT01905592|520128189|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
144443762|NCT02096835|520825570|FG000|Overall Study|Withdrawal by Subject|1|||
144443763|NCT02096835|520825571|FG001|Overall Study|Withdrawal by Subject|0|||
144443764|NCT02096835|520825572|FG002|Overall Study|Withdrawal by Subject|0|||
144443765|NCT02096835|520825570|FG000|Overall Study|converted to open procedures|1|||
144443766|NCT02096835|520825571|FG001|Overall Study|converted to open procedures|0|||
144443767|NCT02096835|520825572|FG002|Overall Study|converted to open procedures|0|||
144253676|NCT01905592|520128190|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
144253677|NCT01905592|520128189|FG000|Overall Study|Protocol Violation|0|||
144253678|NCT01905592|520128190|FG001|Overall Study|Protocol Violation|1|||
144443768|NCT02096835|520825570|FG000|Overall Study|Lost to Follow-up|1|||
144443769|NCT02096835|520825571|FG001|Overall Study|Lost to Follow-up|0|||
144443770|NCT02096835|520825572|FG002|Overall Study|Lost to Follow-up|1|||
144443771|NCT03892889|520825573|FG000|Overall Study|Adverse Event|17|||
144725088|NCT02796664|521849206|FG000|Overall Study|Death|0|||
144253679|NCT01905592|520128189|FG000|Overall Study|Sponsor's decision|1|||
144253680|NCT01905592|520128190|FG001|Overall Study|Sponsor's decision|1|||
144253681|NCT01905592|520128189|FG000|Overall Study|Not treated|7|||
144253682|NCT01905592|520128190|FG001|Overall Study|Not treated|3|||
144253683|NCT01905592|520128189|FG000|Overall Study|Withdrawal by Subject|10|||
144253684|NCT01905592|520128190|FG001|Overall Study|Withdrawal by Subject|2|||
144253685|NCT00385827|520129988|FG000|Part 1|Adverse Event|1|||
144253686|NCT00385827|520129989|FG001|Part 1|Adverse Event|0|||
144253687|NCT00385827|520129990|FG002|Part 1|Adverse Event|0|||
144253688|NCT00385827|520129988|FG000|Part 1|Death|2|||
144253689|NCT00385827|520129989|FG001|Part 1|Death|0|||
144253690|NCT00385827|520129990|FG002|Part 1|Death|0|||
144253691|NCT00385827|520129988|FG000|Part 1|Lack of Efficacy|5|||
144253692|NCT00385827|520129989|FG001|Part 1|Lack of Efficacy|0|||
144253693|NCT00385827|520129990|FG002|Part 1|Lack of Efficacy|0|||
144725089|NCT02796664|521849207|FG001|Overall Study|Death|1|||
144725090|NCT01531205|521849211|FG000|Overall Study|Did not proceed to surgery|1|||
144192910|NCT04146363|519902689|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192911|NCT04146363|519902690|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
144192912|NCT04146363|519902680|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192913|NCT04146363|519902681|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192914|NCT04146363|519902682|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
144192915|NCT04146363|519902683|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192916|NCT04146363|519902684|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
144253694|NCT00385827|520129988|FG000|Part 1|Other|1|||
144253695|NCT00385827|520129989|FG001|Part 1|Other|0|||
144253696|NCT00385827|520129990|FG002|Part 1|Other|0|||
144253697|NCT00385827|520129988|FG000|Part 2|Adverse Event|0|||
144443772|NCT03892889|520825573|FG000|Overall Study|Lack of Efficacy|1|||
144443773|NCT03892889|520825573|FG000|Overall Study|Lost to Follow-up|46|||
144443774|NCT03892889|520825573|FG000|Overall Study|Non-compliance with study drug|22|||
144443775|NCT03892889|520825573|FG000|Overall Study|Pregnancy|1|||
144443776|NCT03892889|520825573|FG000|Overall Study|Protocol Deviation|3|||
144443777|NCT03892889|520825573|FG000|Overall Study|Withdrawal by Subject|50|||
144253698|NCT00385827|520129989|FG001|Part 2|Adverse Event|6|||
144253699|NCT00385827|520129990|FG002|Part 2|Adverse Event|10|||
144253700|NCT00385827|520129988|FG000|Part 2|Death|0|||
144443778|NCT03892889|520825573|FG000|Overall Study|Withdrawal by Caregiver|1|||
144443779|NCT03892889|520825573|FG000|Overall Study|Study Terminated by Sponsor|50|||
144443780|NCT03892889|520825573|FG000|Overall Study|Physician Decision|8|||
144443781|NCT03892889|520825573|FG000|Overall Study|Reason not Specified|5|||
144443782|NCT02453594|520825574|FG000|Overall Study|Protocol Violation|0|||
144443783|NCT02453594|520825575|FG001|Overall Study|Protocol Violation|0|||
144443784|NCT02453594|520825576|FG002|Overall Study|Protocol Violation|1|||
144443785|NCT02453594|520825574|FG000|Overall Study|Cohort Was Closed|17|||
144443786|NCT02453594|520825575|FG001|Overall Study|Cohort Was Closed|21|||
144443787|NCT02453594|520825576|FG002|Overall Study|Cohort Was Closed|14|||
144443788|NCT02453594|520825574|FG000|Overall Study|Death|20|||
144443789|NCT02453594|520825575|FG001|Overall Study|Death|24|||
144443790|NCT02453594|520825576|FG002|Overall Study|Death|16|||
144443791|NCT02453594|520825574|FG000|Overall Study|Lost to Follow-up|6|||
144443792|NCT02453594|520825575|FG001|Overall Study|Lost to Follow-up|14|||
144443793|NCT02453594|520825576|FG002|Overall Study|Lost to Follow-up|2|||
144443794|NCT02453594|520825574|FG000|Overall Study|Physician Decision|2|||
144443795|NCT02453594|520825575|FG001|Overall Study|Physician Decision|4|||
144443796|NCT02453594|520825576|FG002|Overall Study|Physician Decision|0|||
144443797|NCT02453594|520825574|FG000|Overall Study|Site Terminated by Sponsor|1|||
144443798|NCT02453594|520825575|FG001|Overall Study|Site Terminated by Sponsor|0|||
144443799|NCT02453594|520825576|FG002|Overall Study|Site Terminated by Sponsor|1|||
144443800|NCT02453594|520825574|FG000|Overall Study|Transitioned to Extension Study|16|||
144443801|NCT02453594|520825575|FG001|Overall Study|Transitioned to Extension Study|9|||
144443802|NCT02453594|520825576|FG002|Overall Study|Transitioned to Extension Study|16|||
144443803|NCT02453594|520825574|FG000|Overall Study|Withdrawal by Subject|7|||
144443804|NCT02453594|520825575|FG001|Overall Study|Withdrawal by Subject|9|||
144443805|NCT02453594|520825576|FG002|Overall Study|Withdrawal by Subject|11|||
144443806|NCT02097134|520825577|FG000|Overall Study|Physician Decision|4|||
144443807|NCT02097134|520825577|FG000|Overall Study|Non-Protocol Therapy|1|||
144443808|NCT02097134|520825577|FG000|Overall Study|Progressive Disease|3|||
144443809|NCT02097134|520825577|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
144443810|NCT02488629|520825585|FG000|Overall Study|Lack of Efficacy|3|||
144443811|NCT02488629|520825586|FG001|Overall Study|Lack of Efficacy|1|||
144443812|NCT02488629|520825587|FG002|Overall Study|Lack of Efficacy|0|||
144443813|NCT02488629|520825588|FG003|Overall Study|Lack of Efficacy|0|||
144443814|NCT02488629|520825585|FG000|Overall Study|Withdrawal by Subject|0|||
144443815|NCT02488629|520825586|FG001|Overall Study|Withdrawal by Subject|1|||
144443816|NCT02488629|520825587|FG002|Overall Study|Withdrawal by Subject|0|||
144443817|NCT02488629|520825588|FG003|Overall Study|Withdrawal by Subject|0|||
144443818|NCT02652624|520825589|FG000|Randomized Phase|Pregnancy|3|||
144443819|NCT02652624|520825590|FG001|Randomized Phase|Pregnancy|1|||
144443820|NCT02652624|520825589|FG000|Randomized Phase|Investigator's Discretion|0|||
144443821|NCT02652624|520825590|FG001|Randomized Phase|Investigator's Discretion|2|||
144443822|NCT02652624|520825589|FG000|Randomized Phase|Death|0|||
144443823|NCT02652624|520825590|FG001|Randomized Phase|Death|1|||
144443824|NCT02652624|520825589|FG000|Randomized Phase|Lost to Follow-up|0|||
144443825|NCT02652624|520825590|FG001|Randomized Phase|Lost to Follow-up|1|||
144443826|NCT02652624|520825589|FG000|Extension Phase|Lost to Follow-up|3|||
144443827|NCT02652624|520825590|FG001|Extension Phase|Lost to Follow-up|1|||
144443828|NCT02652624|520825589|FG000|Extension Phase|Pregnancy|1|||
144443829|NCT02652624|520825590|FG001|Extension Phase|Pregnancy|1|||
144443830|NCT02652624|520825589|FG000|Extension Phase|Adverse Event|0|||
144443831|NCT02652624|520825590|FG001|Extension Phase|Adverse Event|1|||
144443832|NCT02652624|520825589|FG000|Extension Phase|Withdrew Consent|0|||
144443833|NCT02652624|520825590|FG001|Extension Phase|Withdrew Consent|1|||
144443834|NCT00654628|520825591|FG000|6-week Active Treatment Period|Adverse Event|9|||
144443835|NCT00654628|520825591|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
144532508|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
144532509|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
144532510|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
144443836|NCT00654628|520825591|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
144443837|NCT00654628|520825591|FG000|6-week Active Treatment Period|Out of window period|1|||
144443838|NCT00654628|520825591|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
144532511|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
144532512|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
144532513|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
144443839|NCT00654628|520825591|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
144443840|NCT00912405|520825594|FG000|Overall Study|Lost to Follow-up|5|||
144532514|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
144725091|NCT01089647|521849212|FG000|Overall Study|Lost to Follow-up|2|||
144443841|NCT01434823|520825595|FG000|Overall Study|Incomplete data in medical record|4|||
144443842|NCT01434823|520825596|FG001|Overall Study|Incomplete data in medical record|7|||
144443843|NCT01797536|520825597|FG000|Overall Study|Adverse Event|0|||
144725092|NCT01089647|521849213|FG001|Overall Study|Lost to Follow-up|2|||
144443844|NCT01797536|520825598|FG001|Overall Study|Adverse Event|1|||
144443845|NCT01797536|520825599|FG002|Overall Study|Adverse Event|0|||
144443846|NCT01797536|520825600|FG003|Overall Study|Adverse Event|0|||
144725093|NCT01089647|521849212|FG000|Overall Study|Withdrawal by Subject|2|||
144725094|NCT01089647|521849213|FG001|Overall Study|Withdrawal by Subject|1|||
144725095|NCT01089647|521849212|FG000|Overall Study|Adverse Event|0|||
144725096|NCT01089647|521849213|FG001|Overall Study|Adverse Event|1|||
144725097|NCT00927810|521849214|FG000|Overall Study|Withdrawal by Subject|0|||
144725098|NCT00927810|521849215|FG001|Overall Study|Withdrawal by Subject|3|||
144725099|NCT00927810|521849216|FG002|Overall Study|Withdrawal by Subject|0|||
144725100|NCT00927810|521849217|FG003|Overall Study|Withdrawal by Subject|1|||
144725101|NCT00927810|521849214|FG000|Overall Study|Lost to Follow-up|0|||
144725102|NCT00927810|521849215|FG001|Overall Study|Lost to Follow-up|2|||
144725103|NCT00927810|521849216|FG002|Overall Study|Lost to Follow-up|1|||
144725104|NCT00927810|521849217|FG003|Overall Study|Lost to Follow-up|1|||
144725105|NCT00927810|521849214|FG000|Overall Study|Death|0|||
144725106|NCT00927810|521849215|FG001|Overall Study|Death|2|||
144725107|NCT00927810|521849216|FG002|Overall Study|Death|0|||
144192917|NCT04146363|519902685|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
144443847|NCT00813124|520825601|FG000|Overall Study|Death|2|||
144443848|NCT00813124|520825601|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
144443849|NCT00813124|520825601|FG000|Overall Study|Withdrawal by Subject|1|||
144443850|NCT00767676|520825602|FG000|Overall Study|Investigator error|54|||
144443851|NCT00079274|520825605|FG000|Overall Study|Withdrawal by Subject|111|||
144443852|NCT00079274|520825606|FG001|Overall Study|Withdrawal by Subject|10|||
144443853|NCT00079274|520825607|FG002|Overall Study|Withdrawal by Subject|12|||
144443854|NCT00079274|520825608|FG003|Overall Study|Withdrawal by Subject|163|||
144443855|NCT00079274|520825609|FG004|Overall Study|Withdrawal by Subject|7|||
144443856|NCT00079274|520825610|FG005|Overall Study|Withdrawal by Subject|8|||
144443857|NCT00079274|520825611|FG006|Overall Study|Withdrawal by Subject|0|||
144443858|NCT00079274|520825605|FG000|Overall Study|Adverse Event|130|||
144443859|NCT00079274|520825606|FG001|Overall Study|Adverse Event|8|||
144192918|NCT04146363|519902686|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192919|NCT04146363|519902687|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192920|NCT04146363|519902688|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192921|NCT04146363|519902689|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192922|NCT04146363|519902690|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
144192923|NCT04146363|519902680|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192924|NCT04146363|519902681|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192925|NCT04146363|519902682|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192926|NCT04146363|519902683|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192927|NCT04146363|519902684|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
144192928|NCT04146363|519902685|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
144192929|NCT04146363|519902686|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
144192930|NCT04146363|519902687|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
144192931|NCT04146363|519902688|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192932|NCT04146363|519902689|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192933|NCT04146363|519902690|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
144192934|NCT04146363|519902680|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192935|NCT04146363|519902681|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192936|NCT04146363|519902682|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
144192937|NCT04146363|519902683|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192938|NCT04146363|519902684|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192939|NCT04146363|519902685|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
144192940|NCT04146363|519902686|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
144192941|NCT04146363|519902687|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
144192942|NCT04146363|519902688|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192943|NCT04146363|519902689|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192944|NCT04146363|519902690|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
144192945|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192946|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192947|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192948|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192949|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
144443860|NCT00079274|520825607|FG002|Overall Study|Adverse Event|8|||
144443861|NCT00079274|520825608|FG003|Overall Study|Adverse Event|184|||
144443862|NCT00079274|520825609|FG004|Overall Study|Adverse Event|7|||
144725108|NCT00927810|521849217|FG003|Overall Study|Death|0|||
144725109|NCT00927810|521849214|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144725110|NCT00927810|521849215|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144725111|NCT00927810|521849216|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144725112|NCT00927810|521849217|FG003|Overall Study|Abnormal laboratory value(s)|0|||
144725113|NCT00198029|521849221|FG000|Overall Study|Withdrawal by Subject|4|||
144192950|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192951|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192952|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192953|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
144192954|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
144192955|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
144192956|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192957|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192958|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192959|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192960|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192961|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192962|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192963|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144192964|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
144192965|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
144192966|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
144192967|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192968|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192969|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192970|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192971|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192972|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192973|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192974|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192975|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
144192976|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
144192977|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144192978|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192979|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192980|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192981|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192982|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192983|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192984|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192985|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192986|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
144192987|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
144192988|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
144192989|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192990|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192991|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192992|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192993|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192994|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192995|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192996|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144192997|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
144192998|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
144192999|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
144193000|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193001|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
144253701|NCT00385827|520129989|FG001|Part 2|Death|0|||
144253702|NCT00385827|520129990|FG002|Part 2|Death|2|||
144253703|NCT00385827|520129988|FG000|Part 2|Lack of Efficacy|0|||
144253704|NCT00385827|520129989|FG001|Part 2|Lack of Efficacy|14|||
144253705|NCT00385827|520129990|FG002|Part 2|Lack of Efficacy|13|||
144253706|NCT00385827|520129988|FG000|Part 2|Randomized but not treated|0|||
144253707|NCT00385827|520129989|FG001|Part 2|Randomized but not treated|2|||
144253708|NCT00385827|520129990|FG002|Part 2|Randomized but not treated|2|||
144193002|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193003|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193004|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193005|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193006|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193007|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193008|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
144253709|NCT00385827|520129988|FG000|Part 2|Other|0|||
144253710|NCT00385827|520129989|FG001|Part 2|Other|11|||
144443863|NCT00079274|520825610|FG005|Overall Study|Adverse Event|8|||
144443864|NCT00079274|520825611|FG006|Overall Study|Adverse Event|0|||
144443865|NCT00079274|520825605|FG000|Overall Study|Recurrence|21|||
144443866|NCT00079274|520825606|FG001|Overall Study|Recurrence|0|||
144443867|NCT00079274|520825607|FG002|Overall Study|Recurrence|1|||
144443868|NCT00079274|520825608|FG003|Overall Study|Recurrence|15|||
144443869|NCT00079274|520825609|FG004|Overall Study|Recurrence|0|||
144443870|NCT00079274|520825610|FG005|Overall Study|Recurrence|2|||
144443871|NCT00079274|520825611|FG006|Overall Study|Recurrence|0|||
144443872|NCT00079274|520825605|FG000|Overall Study|Alternate Treatment|6|||
144443873|NCT00079274|520825606|FG001|Overall Study|Alternate Treatment|1|||
144443874|NCT00079274|520825607|FG002|Overall Study|Alternate Treatment|0|||
144443875|NCT00079274|520825608|FG003|Overall Study|Alternate Treatment|3|||
144443876|NCT00079274|520825609|FG004|Overall Study|Alternate Treatment|0|||
144443877|NCT00079274|520825610|FG005|Overall Study|Alternate Treatment|0|||
144443878|NCT00079274|520825611|FG006|Overall Study|Alternate Treatment|0|||
144443879|NCT00079274|520825605|FG000|Overall Study|Other Medical Problems|6|||
144443880|NCT00079274|520825606|FG001|Overall Study|Other Medical Problems|1|||
144443881|NCT00079274|520825607|FG002|Overall Study|Other Medical Problems|0|||
144443882|NCT00079274|520825608|FG003|Overall Study|Other Medical Problems|7|||
144443883|NCT00079274|520825609|FG004|Overall Study|Other Medical Problems|0|||
144443884|NCT00079274|520825610|FG005|Overall Study|Other Medical Problems|0|||
144443885|NCT00079274|520825611|FG006|Overall Study|Other Medical Problems|0|||
144443886|NCT00079274|520825605|FG000|Overall Study|Death|4|||
144443887|NCT00079274|520825606|FG001|Overall Study|Death|0|||
144443888|NCT00079274|520825607|FG002|Overall Study|Death|1|||
144443889|NCT00079274|520825608|FG003|Overall Study|Death|15|||
144532515|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
144532516|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
144532517|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
144532518|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
144532519|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
144532520|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
144532521|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
144606011|NCT04667377|521419016|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
144606012|NCT04667377|521419017|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
144606013|NCT04667377|521419018|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
144606014|NCT04667377|521419019|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
144606015|NCT04667377|521419020|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
144606016|NCT04667377|521419016|FG000|Dose Escalation Period|Adverse Event|9|||
144606017|NCT04667377|521419017|FG001|Dose Escalation Period|Adverse Event|10|||
144606018|NCT04667377|521419018|FG002|Dose Escalation Period|Adverse Event|12|||
144606019|NCT04667377|521419019|FG003|Dose Escalation Period|Adverse Event|17|||
144606020|NCT04667377|521419020|FG004|Dose Escalation Period|Adverse Event|3|||
144606021|NCT04667377|521419016|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
144606022|NCT04667377|521419017|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
144606023|NCT04667377|521419018|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
144606024|NCT04667377|521419019|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
144606025|NCT04667377|521419020|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
144606026|NCT04667377|521419016|FG000|Dose Escalation Period|Not treated|1|||
144606027|NCT04667377|521419017|FG001|Dose Escalation Period|Not treated|0|||
144606028|NCT04667377|521419018|FG002|Dose Escalation Period|Not treated|0|||
144606029|NCT04667377|521419019|FG003|Dose Escalation Period|Not treated|0|||
144606030|NCT04667377|521419020|FG004|Dose Escalation Period|Not treated|0|||
144606031|NCT04667377|521419016|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
144606032|NCT04667377|521419017|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
144606033|NCT04667377|521419018|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
144606034|NCT04667377|521419019|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
144606035|NCT04667377|521419020|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
144606036|NCT04667377|521419016|FG000|Dose Escalation Period|Lost to Follow-up|0|||
144606037|NCT04667377|521419017|FG001|Dose Escalation Period|Lost to Follow-up|1|||
144606038|NCT04667377|521419018|FG002|Dose Escalation Period|Lost to Follow-up|0|||
144606039|NCT04667377|521419019|FG003|Dose Escalation Period|Lost to Follow-up|0|||
144606040|NCT04667377|521419020|FG004|Dose Escalation Period|Lost to Follow-up|0|||
144606041|NCT04667377|521419016|FG000|Maintenance Period|Perceived lack of efficacy|0|||
144606042|NCT04667377|521419017|FG001|Maintenance Period|Perceived lack of efficacy|2|||
144443890|NCT00079274|520825609|FG004|Overall Study|Death|0|||
144443891|NCT00079274|520825610|FG005|Overall Study|Death|0|||
144443892|NCT00079274|520825611|FG006|Overall Study|Death|0|||
144443893|NCT00079274|520825605|FG000|Overall Study|Cytogenetic resistance|0|||
144443894|NCT00079274|520825606|FG001|Overall Study|Cytogenetic resistance|0|||
144443895|NCT00079274|520825607|FG002|Overall Study|Cytogenetic resistance|0|||
144443896|NCT00079274|520825608|FG003|Overall Study|Cytogenetic resistance|2|||
144443897|NCT00079274|520825609|FG004|Overall Study|Cytogenetic resistance|0|||
144606043|NCT04667377|521419018|FG002|Maintenance Period|Perceived lack of efficacy|1|||
144606044|NCT04667377|521419019|FG003|Maintenance Period|Perceived lack of efficacy|0|||
144193009|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
144193010|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
144193011|NCT04146363|519902680|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144443898|NCT00079274|520825610|FG005|Overall Study|Cytogenetic resistance|0|||
144443899|NCT00079274|520825611|FG006|Overall Study|Cytogenetic resistance|0|||
144443900|NCT00079274|520825605|FG000|Overall Study|Other|43|||
144443901|NCT00079274|520825606|FG001|Overall Study|Other|7|||
144443902|NCT00079274|520825607|FG002|Overall Study|Other|5|||
144443903|NCT00079274|520825608|FG003|Overall Study|Other|55|||
144443904|NCT00079274|520825609|FG004|Overall Study|Other|1|||
144443905|NCT00079274|520825610|FG005|Overall Study|Other|2|||
144443906|NCT00079274|520825611|FG006|Overall Study|Other|0|||
144443907|NCT00617240|520825614|FG000|Overall Study|Lack of Efficacy|1|||
144443908|NCT00617240|520825615|FG001|Overall Study|Lack of Efficacy|0|||
144443909|NCT01611259|520825616|FG000|Overall Study|Physician Decision|1|||
144443910|NCT01611259|520825616|FG000|Overall Study|Lack of Efficacy|2|||
144443911|NCT01611259|520825616|FG000|Overall Study|Adverse Event|4|||
144443912|NCT01611259|520825616|FG000|Overall Study|Withdrawal by Subject|7|||
144443913|NCT00353366|520825618|FG000|Overall Study|Adverse Event|8|||
144443914|NCT00353366|520825618|FG000|Overall Study|Protocol Violation|12|||
144443915|NCT00353366|520825618|FG000|Overall Study|Withdrawal by Subject|12|||
144443916|NCT00353366|520825618|FG000|Overall Study|Lost to Follow-up|92|||
144443917|NCT00353366|520825618|FG000|Overall Study|Other|19|||
144443918|NCT00259857|520825619|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
144443919|NCT00259857|520825620|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
144443920|NCT00259857|520825619|FG000|24 Months Treatment|Lost to Follow-up|0|||
144443921|NCT00259857|520825620|FG001|24 Months Treatment|Lost to Follow-up|3|||
144443922|NCT02375672|520825624|FG000|Overall Study|remain on follow up|20|||
144443923|NCT03921411|520825625|FG000|Overall Study|Withdrawal by Subject|1|||
144443924|NCT03921411|520825625|FG000|Overall Study|Protocol Deviation|2|||
144443925|NCT03921411|520825625|FG000|Overall Study|Enrolled, but never treated|2|||
144443926|NCT02098109|520825626|FG000|Overall Study|Protocol Violation|3|||
144443927|NCT02098109|520825627|FG001|Overall Study|Protocol Violation|0|||
144443928|NCT02143843|520825628|FG000|Overall Study|Adverse Event|8|||
144443929|NCT02143843|520825628|FG000|Overall Study|Lack of Efficacy|2|||
144443930|NCT02143843|520825628|FG000|Overall Study|Withdrawal by Subject|2|||
144443931|NCT02702401|520825633|FG000|Overall Study|Death|242|||
144443932|NCT02702401|520825634|FG001|Overall Study|Death|125|||
144443933|NCT02702401|520825633|FG000|Overall Study|Withdrawal by Subject|15|||
144443934|NCT02702401|520825634|FG001|Overall Study|Withdrawal by Subject|5|||
144443935|NCT02702401|520825633|FG000|Overall Study|Sponsor Decision|19|||
144443936|NCT02702401|520825634|FG001|Overall Study|Sponsor Decision|3|||
144443937|NCT02702401|520825633|FG000|Overall Study|Physician Decision|1|||
144443938|NCT02702401|520825634|FG001|Overall Study|Physician Decision|2|||
144443939|NCT02702401|520825633|FG000|Overall Study|Lost to Follow-up|1|||
144443940|NCT02702401|520825634|FG001|Overall Study|Lost to Follow-up|0|||
144443941|NCT01462357|520825639|FG000|Overall Study|Death|0|||
144443942|NCT01462357|520825640|FG001|Overall Study|Death|0|||
144443943|NCT01462357|520825641|FG002|Overall Study|Death|1|||
144443944|NCT01462357|520825639|FG000|Overall Study|Withdrawal by Subject|3|||
144443945|NCT01462357|520825640|FG001|Overall Study|Withdrawal by Subject|11|||
144443946|NCT01462357|520825641|FG002|Overall Study|Withdrawal by Subject|3|||
144443947|NCT01462357|520825639|FG000|Overall Study|Migrated/moved from study area|2|||
144443948|NCT01462357|520825640|FG001|Overall Study|Migrated/moved from study area|3|||
144443949|NCT01462357|520825641|FG002|Overall Study|Migrated/moved from study area|1|||
144443950|NCT01462357|520825639|FG000|Overall Study|Lost to Follow-up|3|||
144443951|NCT01462357|520825640|FG001|Overall Study|Lost to Follow-up|5|||
144443952|NCT01462357|520825641|FG002|Overall Study|Lost to Follow-up|7|||
144443953|NCT04292730|520825642|FG000|Overall Study|Lost to Follow-up|8|||
144443954|NCT04292730|520825643|FG001|Overall Study|Lost to Follow-up|12|||
144443955|NCT04292730|520825644|FG002|Overall Study|Lost to Follow-up|12|||
144443956|NCT04292730|520825645|FG003|Overall Study|Lost to Follow-up|48|||
144443957|NCT04292730|520825642|FG000|Overall Study|Death|2|||
144443958|NCT04292730|520825643|FG001|Overall Study|Death|2|||
144443959|NCT04292730|520825644|FG002|Overall Study|Death|4|||
144532522|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
144443960|NCT04292730|520825645|FG003|Overall Study|Death|12|||
144443961|NCT04292730|520825642|FG000|Overall Study|Withdrew Consent|2|||
144443962|NCT04292730|520825643|FG001|Overall Study|Withdrew Consent|2|||
144443963|NCT04292730|520825644|FG002|Overall Study|Withdrew Consent|5|||
144443964|NCT04292730|520825645|FG003|Overall Study|Withdrew Consent|6|||
144443965|NCT04292730|520825642|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144532523|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
144443966|NCT04292730|520825643|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144532524|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
144532525|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
144443967|NCT04292730|520825644|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144443968|NCT04292730|520825645|FG003|Overall Study|Non-Compliance with Study Drug|0|||
144443969|NCT04292730|520825642|FG000|Overall Study|Protocol Violation|0|||
144443970|NCT04292730|520825643|FG001|Overall Study|Protocol Violation|0|||
144443971|NCT04292730|520825644|FG002|Overall Study|Protocol Violation|1|||
144443972|NCT04292730|520825645|FG003|Overall Study|Protocol Violation|0|||
144443973|NCT04292730|520825642|FG000|Overall Study|Randomized but not Treated|8|||
144443974|NCT04292730|520825643|FG001|Overall Study|Randomized but not Treated|4|||
144443975|NCT04292730|520825644|FG002|Overall Study|Randomized but not Treated|0|||
144443976|NCT04292730|520825645|FG003|Overall Study|Randomized but not Treated|14|||
144443977|NCT01527292|520825646|FG000|Overall Study|Physician Decision|0|||
144443978|NCT01527292|520825647|FG001|Overall Study|Physician Decision|3|||
144443979|NCT01482767|520825648|FG000|Overall Study|Death|1|||
144443980|NCT01482767|520825649|FG001|Overall Study|Death|1|||
144443981|NCT01482767|520825648|FG000|Overall Study|Withdrawal by Subject|7|||
144443982|NCT01482767|520825649|FG001|Overall Study|Withdrawal by Subject|5|||
144725114|NCT02001558|521849222|FG000|Overall Study|Lost to Follow-up|8|||
144725115|NCT02001558|521849223|FG001|Overall Study|Lost to Follow-up|14|||
144725116|NCT04117607|521849224|FG000|Overall Study|Early Termination|0|||
144725117|NCT04117607|521849225|FG001|Overall Study|Early Termination|1|||
144725118|NCT04117607|521849226|FG002|Overall Study|Early Termination|0|||
144725119|NCT04117607|521849227|FG003|Overall Study|Early Termination|0|||
144725120|NCT04117607|521849228|FG004|Overall Study|Early Termination|0|||
144725121|NCT04117607|521849229|FG005|Overall Study|Early Termination|0|||
144725122|NCT04117607|521849230|FG006|Overall Study|Early Termination|1|||
144725123|NCT04117607|521849231|FG007|Overall Study|Early Termination|0|||
144725124|NCT04117607|521849232|FG008|Overall Study|Early Termination|0|||
144725125|NCT04117607|521849233|FG009|Overall Study|Early Termination|0|||
144725126|NCT04117607|521849234|FG010|Overall Study|Early Termination|0|||
144725127|NCT04117607|521849235|FG011|Overall Study|Early Termination|0|||
144725128|NCT04117607|521849236|FG012|Overall Study|Early Termination|0|||
144725129|NCT04117607|521849237|FG013|Overall Study|Early Termination|0|||
144725130|NCT01626079|521849239|FG000|Overall Study|Death|167|||
144725131|NCT01626079|521849240|FG001|Overall Study|Death|192|||
144725132|NCT01626079|521849241|FG002|Overall Study|Death|39|||
144725133|NCT01626079|521849239|FG000|Overall Study|Withdrawal by Subject|23|||
144725134|NCT01626079|521849240|FG001|Overall Study|Withdrawal by Subject|37|||
144725135|NCT01626079|521849241|FG002|Overall Study|Withdrawal by Subject|5|||
144725136|NCT01626079|521849239|FG000|Overall Study|Lost to Follow-up|7|||
144725137|NCT01626079|521849240|FG001|Overall Study|Lost to Follow-up|4|||
144725138|NCT01626079|521849241|FG002|Overall Study|Lost to Follow-up|2|||
144725139|NCT01626079|521849239|FG000|Overall Study|Missed Visits|1|||
144725140|NCT01626079|521849240|FG001|Overall Study|Missed Visits|4|||
144725141|NCT01626079|521849241|FG002|Overall Study|Missed Visits|6|||
144725142|NCT05049460|521849242|FG000|Overall Study|Withdrawal by Subject|2|||
144725143|NCT05049460|521849243|FG001|Overall Study|Withdrawal by Subject|2|||
144725144|NCT05049460|521849242|FG000|Overall Study|Lost to Follow-up|2|||
144725145|NCT05049460|521849243|FG001|Overall Study|Lost to Follow-up|2|||
144725146|NCT04333095|521849246|FG000|Overall Study|Protocol Violation|4|||
144725147|NCT04333095|521849247|FG001|Overall Study|Protocol Violation|0|||
144725148|NCT04333095|521849246|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
144725149|NCT04333095|521849247|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
144725150|NCT04333095|521849246|FG000|Overall Study|Mini Sternotomy|4|||
144725151|NCT04333095|521849247|FG001|Overall Study|Mini Sternotomy|5|||
144725152|NCT03740165|521849248|FG000|Overall Study|Death|232|||
144725153|NCT03740165|521849249|FG001|Overall Study|Death|242|||
144725154|NCT03740165|521849250|FG002|Overall Study|Death|229|||
144725155|NCT03740165|521849248|FG000|Overall Study|Lost to Follow-up|0|||
144725156|NCT03740165|521849249|FG001|Overall Study|Lost to Follow-up|0|||
144725157|NCT03740165|521849250|FG002|Overall Study|Lost to Follow-up|1|||
144725158|NCT03740165|521849248|FG000|Overall Study|Withdrawal by Subject|7|||
144725159|NCT03740165|521849249|FG001|Overall Study|Withdrawal by Subject|4|||
144443983|NCT01482767|520825648|FG000|Overall Study|Lost to Follow-up|12|||
144443984|NCT01482767|520825649|FG001|Overall Study|Lost to Follow-up|6|||
144443985|NCT01482767|520825648|FG000|Overall Study|Adverse Event|0|||
144725160|NCT03740165|521849250|FG002|Overall Study|Withdrawal by Subject|3|||
144725161|NCT03740165|521849248|FG000|Overall Study|Ongoing in Study|216|||
144725162|NCT03740165|521849249|FG001|Overall Study|Ongoing in Study|212|||
144725163|NCT03740165|521849250|FG002|Overall Study|Ongoing in Study|221|||
144725164|NCT03049618|521849251|FG000|Overall Study|Death|1|||
144443986|NCT01482767|520825649|FG001|Overall Study|Adverse Event|3|||
144443987|NCT01482767|520825648|FG000|Overall Study|Site closure|22|||
144443988|NCT01482767|520825649|FG001|Overall Study|Site closure|14|||
144532526|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
144725165|NCT03049618|521849252|FG001|Overall Study|Death|0|||
144725166|NCT03049618|521849251|FG000|Overall Study|Lack of Efficacy|1|||
144725167|NCT03049618|521849252|FG001|Overall Study|Lack of Efficacy|2|||
144725168|NCT02994056|521849253|FG000|Overall Study|Death|8|||
144725169|NCT02994056|521849253|FG000|Overall Study|Withdrew Consent|1|||
144725170|NCT04803357|521849254|FG000|Overall Study|Withdrawal by Subject|31|||
144443989|NCT01482767|520825648|FG000|Overall Study|Non-adherence to study requirements|4|||
144193012|NCT04146363|519902681|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193013|NCT04146363|519902682|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144443990|NCT01482767|520825649|FG001|Overall Study|Non-adherence to study requirements|7|||
144443991|NCT01482767|520825648|FG000|Overall Study|Alternate HCV treatment|7|||
144443992|NCT01482767|520825649|FG001|Overall Study|Alternate HCV treatment|8|||
144443993|NCT01482767|520825648|FG000|Overall Study|Ineligible|0|||
144443994|NCT01482767|520825649|FG001|Overall Study|Ineligible|5|||
144443995|NCT01482767|520825648|FG000|Overall Study|Nurse error|1|||
144443996|NCT01482767|520825649|FG001|Overall Study|Nurse error|0|||
144443997|NCT01247090|520825654|FG000|Overall Study|Physician Decision|1|||
144443998|NCT01247090|520825655|FG001|Overall Study|Physician Decision|0|||
144443999|NCT01247090|520825656|FG002|Overall Study|Physician Decision|0|||
144444000|NCT01247090|520825654|FG000|Overall Study|Withdrawal by Subject|0|||
144444001|NCT01247090|520825655|FG001|Overall Study|Withdrawal by Subject|1|||
144444002|NCT01247090|520825656|FG002|Overall Study|Withdrawal by Subject|0|||
144444003|NCT02457325|520825660|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
144444004|NCT02457325|520825661|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
144444005|NCT03385239|520825664|FG000|Overall Study|Voluntary Withdrawal|2|||
144444006|NCT03385239|520825665|FG001|Overall Study|Voluntary Withdrawal|3|||
144444007|NCT03385239|520825666|FG002|Overall Study|Voluntary Withdrawal|2|||
144444008|NCT03385239|520825667|FG003|Overall Study|Voluntary Withdrawal|3|||
144444009|NCT03385239|520825668|FG004|Overall Study|Voluntary Withdrawal|0|||
144444010|NCT03385239|520825664|FG000|Overall Study|Adverse Event|0|||
144444011|NCT03385239|520825665|FG001|Overall Study|Adverse Event|0|||
144444012|NCT03385239|520825666|FG002|Overall Study|Adverse Event|1|||
144444013|NCT03385239|520825667|FG003|Overall Study|Adverse Event|0|||
144444014|NCT03385239|520825668|FG004|Overall Study|Adverse Event|0|||
144444015|NCT03385239|520825664|FG000|Overall Study|Other|0|||
144444016|NCT03385239|520825665|FG001|Overall Study|Other|0|||
144444017|NCT03385239|520825666|FG002|Overall Study|Other|0|||
144444018|NCT03385239|520825667|FG003|Overall Study|Other|1|||
144444019|NCT03385239|520825668|FG004|Overall Study|Other|0|||
144444020|NCT01574703|520825669|FG000|Overall Study|Adverse Event|0|||
144444021|NCT01574703|520825670|FG001|Overall Study|Adverse Event|2|||
144444022|NCT01574703|520825671|FG002|Overall Study|Adverse Event|1|||
144444023|NCT01574703|520825672|FG003|Overall Study|Adverse Event|1|||
144444024|NCT01574703|520825669|FG000|Overall Study|Protocol Violation|0|||
144444025|NCT01574703|520825670|FG001|Overall Study|Protocol Violation|0|||
144444026|NCT01574703|520825671|FG002|Overall Study|Protocol Violation|0|||
144444027|NCT01574703|520825672|FG003|Overall Study|Protocol Violation|1|||
144444028|NCT01574703|520825669|FG000|Overall Study|Unspecified Reason|27|||
144444029|NCT01574703|520825670|FG001|Overall Study|Unspecified Reason|15|||
144444030|NCT01574703|520825671|FG002|Overall Study|Unspecified Reason|20|||
144444031|NCT01574703|520825672|FG003|Overall Study|Unspecified Reason|16|||
144444032|NCT01574703|520825669|FG000|Overall Study|Withdrawal by Subject|53|||
144444033|NCT01574703|520825670|FG001|Overall Study|Withdrawal by Subject|52|||
144444034|NCT01574703|520825671|FG002|Overall Study|Withdrawal by Subject|36|||
144444035|NCT01574703|520825672|FG003|Overall Study|Withdrawal by Subject|61|||
144193014|NCT04146363|519902683|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193015|NCT04146363|519902684|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193016|NCT04146363|519902685|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193017|NCT04146363|519902686|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193018|NCT04146363|519902687|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193019|NCT04146363|519902688|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193020|NCT04146363|519902689|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
144193021|NCT04146363|519902690|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
144193022|NCT02914236|519902691|FG000|Overall Study|Lost to Follow-up|1|||
144193023|NCT01287039|519902692|FG000|Overall Study|Noncompliance with study procedures|0|||
144253711|NCT00385827|520129990|FG002|Part 2|Other|21|||
144253712|NCT04227405|520129991|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
144253713|NCT04227405|520129992|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
144253714|NCT04227405|520129991|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
144444036|NCT01574703|520825669|FG000|Overall Study|Met Withdrawal Criteria|0|||
144444037|NCT01574703|520825670|FG001|Overall Study|Met Withdrawal Criteria|1|||
144444038|NCT01574703|520825671|FG002|Overall Study|Met Withdrawal Criteria|1|||
144532527|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
144532528|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
144532529|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
144444039|NCT01574703|520825672|FG003|Overall Study|Met Withdrawal Criteria|0|||
144444040|NCT01574703|520825669|FG000|Overall Study|Lost to Follow-up|43|||
144444041|NCT01574703|520825670|FG001|Overall Study|Lost to Follow-up|41|||
144444042|NCT01574703|520825671|FG002|Overall Study|Lost to Follow-up|46|||
144532530|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
144444043|NCT01574703|520825672|FG003|Overall Study|Lost to Follow-up|35|||
144444044|NCT01574703|520825669|FG000|Overall Study|Death|2|||
144253715|NCT04227405|520129992|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
144444045|NCT01574703|520825670|FG001|Overall Study|Death|1|||
144444046|NCT01574703|520825671|FG002|Overall Study|Death|1|||
144444047|NCT01574703|520825672|FG003|Overall Study|Death|0|||
144444048|NCT02751983|520825673|FG000|Treatment|Stopped ACT, but Remained in study|2|||
144444049|NCT02751983|520825674|FG001|Treatment|Stopped ACT, but Remained in study|0|||
144444050|NCT02751983|520825673|FG000|Treatment|Discharged prior to beginning ACT|2|||
144444051|NCT02751983|520825674|FG001|Treatment|Discharged prior to beginning ACT|0|||
144444052|NCT02751983|520825673|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
144444053|NCT02751983|520825674|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
144444054|NCT02751983|520825673|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
144444055|NCT02751983|520825674|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
144444056|NCT02751983|520825673|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
144444057|NCT02751983|520825674|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
144444058|NCT03139916|520825677|FG000|Overall Study|Withdrawal by Subject|2|||
144444059|NCT03139916|520825677|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
144444060|NCT03591575|520825678|FG000|Overall Study|Adverse Event|2|||
144444061|NCT03591575|520825679|FG001|Overall Study|Adverse Event|0|||
144444062|NCT03591575|520825678|FG000|Overall Study|Withdrawal by Subject|4|||
144444063|NCT03591575|520825679|FG001|Overall Study|Withdrawal by Subject|1|||
144444064|NCT00025883|520825680|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
144444065|NCT00025883|520825680|FG000|Overall Study|no baseline data|1|||
144444066|NCT00025883|520825680|FG000|Overall Study|Death|1|||
144444067|NCT00025883|520825680|FG000|Overall Study|Adverse Event|1|||
144444068|NCT00025883|520825680|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
144444069|NCT01282216|520825681|FG000|Overall Study|Graft failure|0|||
144444070|NCT01282216|520825682|FG001|Overall Study|Graft failure|0|||
144444071|NCT01282216|520825683|FG002|Overall Study|Graft failure|3|||
144444072|NCT01282216|520825684|FG003|Overall Study|Graft failure|2|||
144444073|NCT01282216|520825681|FG000|Overall Study|Physician Decision|0|||
144444074|NCT01282216|520825682|FG001|Overall Study|Physician Decision|0|||
144444075|NCT01282216|520825683|FG002|Overall Study|Physician Decision|11|||
144444076|NCT01282216|520825684|FG003|Overall Study|Physician Decision|0|||
144444077|NCT01282216|520825681|FG000|Overall Study|Relapse|0|||
144444078|NCT01282216|520825682|FG001|Overall Study|Relapse|0|||
144253716|NCT04227405|520129991|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
144253717|NCT04227405|520129992|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
144253718|NCT04985942|520129993|FG000|Overall Study|Adverse Event|14|||
144444079|NCT01282216|520825683|FG002|Overall Study|Relapse|17|||
144444080|NCT01282216|520825684|FG003|Overall Study|Relapse|6|||
144444081|NCT01282216|520825681|FG000|Overall Study|Death|0|||
144444082|NCT01282216|520825682|FG001|Overall Study|Death|0|||
144444083|NCT01282216|520825683|FG002|Overall Study|Death|2|||
144444084|NCT01282216|520825684|FG003|Overall Study|Death|0|||
144444085|NCT02908529|520825687|FG000|Overall Study|Lost to Follow-up|0|||
144444086|NCT02908529|520825688|FG001|Overall Study|Lost to Follow-up|2|||
144444087|NCT04084769|520825695|FG000|Overall Study|Protocol Violation|1|||
144444088|NCT04084769|520825696|FG001|Overall Study|Protocol Violation|3|||
144444089|NCT04084769|520825697|FG002|Overall Study|Protocol Violation|0|||
144444090|NCT04084769|520825698|FG003|Overall Study|Protocol Violation|1|||
144444091|NCT04084769|520825695|FG000|Overall Study|Withdrawal by Subject|0|||
144444092|NCT04084769|520825696|FG001|Overall Study|Withdrawal by Subject|1|||
144444093|NCT04084769|520825697|FG002|Overall Study|Withdrawal by Subject|0|||
144444094|NCT04084769|520825698|FG003|Overall Study|Withdrawal by Subject|0|||
144444095|NCT04084769|520825695|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144444096|NCT04084769|520825696|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144444097|NCT04084769|520825697|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144444098|NCT04084769|520825698|FG003|Overall Study|Withdrawal by parent/guardian|1|||
144444099|NCT04084769|520825695|FG000|Overall Study|Lost to Follow-up|2|||
144444100|NCT04084769|520825696|FG001|Overall Study|Lost to Follow-up|0|||
144444101|NCT04084769|520825697|FG002|Overall Study|Lost to Follow-up|0|||
144444102|NCT04084769|520825698|FG003|Overall Study|Lost to Follow-up|0|||
144444103|NCT01660412|520825699|FG000|Overall Study|Protocol Violation|0|||
144444104|NCT01660412|520825700|FG001|Overall Study|Protocol Violation|3|||
144444105|NCT03013491|520825701|FG000|Main Study|Death|2|||
144444106|NCT03013491|520825702|FG001|Main Study|Death|2|||
144444107|NCT03013491|520825703|FG002|Main Study|Death|5|||
144444108|NCT03013491|520825704|FG003|Main Study|Death|3|||
144444109|NCT03013491|520825705|FG004|Main Study|Death|9|||
144444110|NCT03013491|520825706|FG005|Main Study|Death|12|||
144444111|NCT03013491|520825707|FG006|Main Study|Death|3|||
144444112|NCT03013491|520825708|FG007|Main Study|Death|5|||
144444113|NCT03013491|520825709|FG008|Main Study|Death|1|||
144444114|NCT03013491|520825710|FG009|Main Study|Death|2|||
144444115|NCT03013491|520825711|FG010|Main Study|Death|4|||
144444116|NCT03013491|520825712|FG011|Main Study|Death|1|||
144444117|NCT03013491|520825713|FG012|Main Study|Death|1|||
144444118|NCT03013491|520825714|FG013|Main Study|Death|4|||
144444119|NCT03013491|520825715|FG014|Main Study|Death|0|||
144444120|NCT03013491|520825716|FG015|Main Study|Death|3|||
144725171|NCT04803357|521849255|FG001|Overall Study|Withdrawal by Subject|5|||
144725172|NCT02879643|521849256|FG000|Overall Study|Adverse Event|0|||
144725173|NCT02879643|521849257|FG001|Overall Study|Adverse Event|0|||
144725174|NCT02879643|521849258|FG002|Overall Study|Adverse Event|1|||
144725175|NCT02879643|521849259|FG003|Overall Study|Adverse Event|1|||
144725176|NCT02879643|521849260|FG004|Overall Study|Adverse Event|0|||
144725177|NCT00182091|521849261|FG000|Overall Study|Withdrawal by Subject|1|||
144725178|NCT00182091|521849262|FG001|Overall Study|Withdrawal by Subject|0|||
144725179|NCT00182091|521849263|FG002|Overall Study|Withdrawal by Subject|0|||
144725180|NCT00182091|521849264|FG003|Overall Study|Withdrawal by Subject|0|||
144725181|NCT05665595|521851192|FG000|Overall Study|Ongoing|692|||
144725182|NCT05665595|521851193|FG001|Overall Study|Ongoing|698|||
144725183|NCT05665595|521851192|FG000|Overall Study|Withdrawal by Subject|2|||
144725184|NCT05665595|521851193|FG001|Overall Study|Withdrawal by Subject|2|||
144725185|NCT05665595|521851192|FG000|Overall Study|Lost to Follow-up|1|||
144725186|NCT05665595|521851193|FG001|Overall Study|Lost to Follow-up|0|||
144725187|NCT05665595|521851192|FG000|Overall Study|Death|6|||
144253719|NCT04985942|520129994|FG001|Overall Study|Adverse Event|2|||
144253720|NCT04985942|520129993|FG000|Overall Study|Lack of Efficacy|0|||
144444121|NCT03013491|520825717|FG016|Main Study|Death|5|||
144444122|NCT03013491|520825718|FG017|Main Study|Death|1|||
144444123|NCT03013491|520825719|FG018|Main Study|Death|47|||
144444124|NCT03013491|520825701|FG000|Main Study|Lost to Follow-up|0|||
144444125|NCT03013491|520825702|FG001|Main Study|Lost to Follow-up|0|||
144444126|NCT03013491|520825703|FG002|Main Study|Lost to Follow-up|1|||
144444127|NCT03013491|520825704|FG003|Main Study|Lost to Follow-up|0|||
144444128|NCT03013491|520825705|FG004|Main Study|Lost to Follow-up|1|||
144444129|NCT03013491|520825706|FG005|Main Study|Lost to Follow-up|0|||
144444130|NCT03013491|520825707|FG006|Main Study|Lost to Follow-up|0|||
144444131|NCT03013491|520825708|FG007|Main Study|Lost to Follow-up|0|||
144444132|NCT03013491|520825709|FG008|Main Study|Lost to Follow-up|0|||
144444133|NCT03013491|520825710|FG009|Main Study|Lost to Follow-up|0|||
144444134|NCT03013491|520825711|FG010|Main Study|Lost to Follow-up|0|||
144444135|NCT03013491|520825712|FG011|Main Study|Lost to Follow-up|0|||
144444136|NCT03013491|520825713|FG012|Main Study|Lost to Follow-up|0|||
144444137|NCT03013491|520825714|FG013|Main Study|Lost to Follow-up|0|||
144444138|NCT03013491|520825715|FG014|Main Study|Lost to Follow-up|0|||
144444139|NCT03013491|520825716|FG015|Main Study|Lost to Follow-up|0|||
144444140|NCT03013491|520825717|FG016|Main Study|Lost to Follow-up|0|||
144444141|NCT03013491|520825718|FG017|Main Study|Lost to Follow-up|0|||
144444142|NCT03013491|520825719|FG018|Main Study|Lost to Follow-up|3|||
144444143|NCT03013491|520825701|FG000|Main Study|Termination of the study by Sponsor|0|||
144444144|NCT03013491|520825702|FG001|Main Study|Termination of the study by Sponsor|0|||
144444145|NCT03013491|520825703|FG002|Main Study|Termination of the study by Sponsor|2|||
144444146|NCT03013491|520825704|FG003|Main Study|Termination of the study by Sponsor|0|||
144444147|NCT03013491|520825705|FG004|Main Study|Termination of the study by Sponsor|1|||
144444148|NCT03013491|520825706|FG005|Main Study|Termination of the study by Sponsor|2|||
144444149|NCT03013491|520825707|FG006|Main Study|Termination of the study by Sponsor|0|||
144444150|NCT03013491|520825708|FG007|Main Study|Termination of the study by Sponsor|0|||
144444151|NCT03013491|520825709|FG008|Main Study|Termination of the study by Sponsor|1|||
144444152|NCT03013491|520825710|FG009|Main Study|Termination of the study by Sponsor|1|||
144444153|NCT03013491|520825711|FG010|Main Study|Termination of the study by Sponsor|1|||
144253721|NCT04985942|520129994|FG001|Overall Study|Lack of Efficacy|3|||
144253722|NCT04985942|520129993|FG000|Overall Study|Lost to Follow-up|1|||
144253723|NCT04985942|520129994|FG001|Overall Study|Lost to Follow-up|1|||
144253724|NCT04985942|520129993|FG000|Overall Study|Protocol Violation|1|||
144444154|NCT03013491|520825712|FG011|Main Study|Termination of the study by Sponsor|2|||
144444155|NCT03013491|520825713|FG012|Main Study|Termination of the study by Sponsor|0|||
144444156|NCT03013491|520825714|FG013|Main Study|Termination of the study by Sponsor|0|||
144444157|NCT03013491|520825715|FG014|Main Study|Termination of the study by Sponsor|0|||
144444158|NCT03013491|520825716|FG015|Main Study|Termination of the study by Sponsor|0|||
144444159|NCT03013491|520825717|FG016|Main Study|Termination of the study by Sponsor|0|||
144444160|NCT03013491|520825718|FG017|Main Study|Termination of the study by Sponsor|1|||
144444161|NCT03013491|520825719|FG018|Main Study|Termination of the study by Sponsor|13|||
144444162|NCT03013491|520825701|FG000|Main Study|Withdrawal by Subject|0|||
144444163|NCT03013491|520825702|FG001|Main Study|Withdrawal by Subject|0|||
144725188|NCT05665595|521851193|FG001|Overall Study|Death|1|||
144725189|NCT05771428|521851194|FG000|Overall Study|Adverse Event|0|||
144725190|NCT05771428|521851195|FG001|Overall Study|Adverse Event|1|||
144725191|NCT05771428|521851196|FG002|Overall Study|Adverse Event|1|||
144725192|NCT05771428|521851197|FG003|Overall Study|Adverse Event|1|||
144725193|NCT05771428|521851194|FG000|Overall Study|Withdrawal by Subject|3|||
144725194|NCT05771428|521851195|FG001|Overall Study|Withdrawal by Subject|2|||
144444164|NCT03013491|520825703|FG002|Main Study|Withdrawal by Subject|0|||
144444165|NCT03013491|520825704|FG003|Main Study|Withdrawal by Subject|4|||
144444166|NCT03013491|520825705|FG004|Main Study|Withdrawal by Subject|2|||
144725195|NCT05771428|521851196|FG002|Overall Study|Withdrawal by Subject|1|||
144253725|NCT04985942|520129994|FG001|Overall Study|Protocol Violation|1|||
144193024|NCT01287039|519902693|FG001|Overall Study|Noncompliance with study procedures|1|||
144193025|NCT01287039|519902692|FG000|Overall Study|Change of location/residence|0|||
144193026|NCT01287039|519902693|FG001|Overall Study|Change of location/residence|3|||
144193027|NCT01287039|519902692|FG000|Overall Study|Elective surgery|0|||
144193028|NCT01287039|519902693|FG001|Overall Study|Elective surgery|1|||
144193029|NCT01287039|519902692|FG000|Overall Study|Protocol Violation|2|||
144193030|NCT01287039|519902693|FG001|Overall Study|Protocol Violation|3|||
144193031|NCT01287039|519902692|FG000|Overall Study|Excluded medication taken|1|||
144193032|NCT01287039|519902693|FG001|Overall Study|Excluded medication taken|0|||
144193033|NCT01287039|519902692|FG000|Overall Study|Noncompliance with study medication|0|||
144193034|NCT01287039|519902693|FG001|Overall Study|Noncompliance with study medication|1|||
144193035|NCT01287039|519902692|FG000|Overall Study|Problem with travel|0|||
144193036|NCT01287039|519902693|FG001|Overall Study|Problem with travel|1|||
144193037|NCT01287039|519902692|FG000|Overall Study|Death|1|||
144193038|NCT01287039|519902693|FG001|Overall Study|Death|0|||
144193039|NCT01287039|519902692|FG000|Overall Study|Change of residence|1|||
144193040|NCT01287039|519902693|FG001|Overall Study|Change of residence|0|||
144193041|NCT01287039|519902692|FG000|Overall Study|Adverse Event|7|||
144193042|NCT01287039|519902693|FG001|Overall Study|Adverse Event|4|||
144193043|NCT01287039|519902692|FG000|Overall Study|Withdrawal by Subject|14|||
144193044|NCT01287039|519902693|FG001|Overall Study|Withdrawal by Subject|11|||
144193045|NCT01287039|519902692|FG000|Overall Study|Lost to Follow-up|3|||
144193046|NCT01287039|519902693|FG001|Overall Study|Lost to Follow-up|2|||
144193047|NCT04109313|519902694|FG000|Overall Study|Pregnancy|1|||
144193048|NCT04109313|519902694|FG000|Overall Study|Adverse Event|11|||
144193049|NCT04109313|519902694|FG000|Overall Study|Lack of Efficacy|11|||
144193050|NCT04109313|519902694|FG000|Overall Study|Lost to Follow-up|1|||
144193051|NCT04109313|519902694|FG000|Overall Study|Physician Decision|2|||
144193052|NCT04109313|519902694|FG000|Overall Study|Subject Decision|13|||
144193053|NCT04109313|519902694|FG000|Overall Study|Covid-19 situation|2|||
144193054|NCT01272921|519902695|FG000|Overall Study|Protocol Violation|2|||
144193055|NCT01272921|519902696|FG001|Overall Study|Protocol Violation|1|||
144193056|NCT01132664|519902697|FG000|Phase lb|Adverse Event|0|||
144193057|NCT01132664|519902698|FG001|Phase lb|Adverse Event|1|||
144606045|NCT04667377|521419020|FG004|Maintenance Period|Perceived lack of efficacy|1|||
144606046|NCT04667377|521419016|FG000|Maintenance Period|Adverse Event|2|||
144606047|NCT04667377|521419017|FG001|Maintenance Period|Adverse Event|8|||
144606048|NCT04667377|521419018|FG002|Maintenance Period|Adverse Event|5|||
144606049|NCT04667377|521419019|FG003|Maintenance Period|Adverse Event|4|||
144606050|NCT04667377|521419020|FG004|Maintenance Period|Adverse Event|1|||
144606051|NCT04667377|521419016|FG000|Maintenance Period|Adverse event: COVID infection|0|||
144606052|NCT04667377|521419017|FG001|Maintenance Period|Adverse event: COVID infection|1|||
144606053|NCT04667377|521419018|FG002|Maintenance Period|Adverse event: COVID infection|0|||
144606054|NCT04667377|521419019|FG003|Maintenance Period|Adverse event: COVID infection|0|||
144606055|NCT04667377|521419020|FG004|Maintenance Period|Adverse event: COVID infection|0|||
144606056|NCT04667377|521419016|FG000|Maintenance Period|COVID-related|0|||
144606057|NCT04667377|521419017|FG001|Maintenance Period|COVID-related|0|||
144606058|NCT04667377|521419018|FG002|Maintenance Period|COVID-related|1|||
144606059|NCT04667377|521419019|FG003|Maintenance Period|COVID-related|1|||
144606060|NCT04667377|521419020|FG004|Maintenance Period|COVID-related|0|||
144193058|NCT01132664|519902699|FG002|Phase lb|Adverse Event|0|||
144193059|NCT01132664|519902700|FG003|Phase lb|Adverse Event|0|||
144193060|NCT01132664|519902701|FG004|Phase lb|Adverse Event|0|||
144193061|NCT01132664|519902697|FG000|Phase lb|Withdrawal by Subject|1|||
144193062|NCT01132664|519902698|FG001|Phase lb|Withdrawal by Subject|2|||
144193063|NCT01132664|519902699|FG002|Phase lb|Withdrawal by Subject|0|||
144193064|NCT01132664|519902700|FG003|Phase lb|Withdrawal by Subject|0|||
144193065|NCT01132664|519902701|FG004|Phase lb|Withdrawal by Subject|0|||
144193066|NCT01132664|519902697|FG000|Phase lb|Disease Progression|4|||
144193067|NCT01132664|519902698|FG001|Phase lb|Disease Progression|9|||
144606061|NCT04667377|521419016|FG000|Maintenance Period|Protocol Violation|1|||
144193068|NCT01132664|519902699|FG002|Phase lb|Disease Progression|0|||
144193069|NCT01132664|519902700|FG003|Phase lb|Disease Progression|0|||
144193070|NCT01132664|519902701|FG004|Phase lb|Disease Progression|0|||
144193071|NCT01132664|519902697|FG000|Phase ll|Death|0|||
144193072|NCT01132664|519902698|FG001|Phase ll|Death|0|||
144606062|NCT04667377|521419017|FG001|Maintenance Period|Protocol Violation|0|||
144606063|NCT04667377|521419018|FG002|Maintenance Period|Protocol Violation|0|||
144606064|NCT04667377|521419019|FG003|Maintenance Period|Protocol Violation|0|||
144606065|NCT04667377|521419020|FG004|Maintenance Period|Protocol Violation|1|||
144193073|NCT01132664|519902699|FG002|Phase ll|Death|2|||
144193074|NCT01132664|519902700|FG003|Phase ll|Death|0|||
144444167|NCT03013491|520825706|FG005|Main Study|Withdrawal by Subject|1|||
144193075|NCT01132664|519902701|FG004|Phase ll|Death|0|||
144193076|NCT01132664|519902697|FG000|Phase ll|Adverse Event|0|||
144193077|NCT01132664|519902698|FG001|Phase ll|Adverse Event|0|||
144193078|NCT01132664|519902699|FG002|Phase ll|Adverse Event|10|||
144193079|NCT01132664|519902700|FG003|Phase ll|Adverse Event|0|||
144193080|NCT01132664|519902701|FG004|Phase ll|Adverse Event|0|||
144193081|NCT01132664|519902697|FG000|Phase ll|Withdrawal by Subject|0|||
144193082|NCT01132664|519902698|FG001|Phase ll|Withdrawal by Subject|0|||
144193083|NCT01132664|519902699|FG002|Phase ll|Withdrawal by Subject|3|||
144193084|NCT01132664|519902700|FG003|Phase ll|Withdrawal by Subject|0|||
144193085|NCT01132664|519902701|FG004|Phase ll|Withdrawal by Subject|0|||
144193086|NCT01132664|519902697|FG000|Phase ll|Disease progression|0|||
144193087|NCT01132664|519902698|FG001|Phase ll|Disease progression|0|||
144193088|NCT01132664|519902699|FG002|Phase ll|Disease progression|35|||
144193089|NCT01132664|519902700|FG003|Phase ll|Disease progression|0|||
144193090|NCT01132664|519902701|FG004|Phase ll|Disease progression|0|||
144193091|NCT01132664|519902697|FG000|BM Cohort|Disease progression|0|||
144193092|NCT01132664|519902698|FG001|BM Cohort|Disease progression|0|||
144193093|NCT01132664|519902699|FG002|BM Cohort|Disease progression|0|||
144193094|NCT01132664|519902700|FG003|BM Cohort|Disease progression|3|||
144193095|NCT01132664|519902701|FG004|BM Cohort|Disease progression|4|||
144444168|NCT03013491|520825707|FG006|Main Study|Withdrawal by Subject|0|||
144444169|NCT03013491|520825708|FG007|Main Study|Withdrawal by Subject|0|||
144444170|NCT03013491|520825709|FG008|Main Study|Withdrawal by Subject|0|||
144193096|NCT01132664|519902697|FG000|BM Cohort|Adverse Event|0|||
144193097|NCT01132664|519902698|FG001|BM Cohort|Adverse Event|0|||
144193098|NCT01132664|519902699|FG002|BM Cohort|Adverse Event|0|||
144193099|NCT01132664|519902700|FG003|BM Cohort|Adverse Event|0|||
144444171|NCT03013491|520825710|FG009|Main Study|Withdrawal by Subject|0|||
144444172|NCT03013491|520825711|FG010|Main Study|Withdrawal by Subject|1|||
144444173|NCT03013491|520825712|FG011|Main Study|Withdrawal by Subject|2|||
144193100|NCT01132664|519902701|FG004|BM Cohort|Adverse Event|1|||
144193101|NCT01132664|519902697|FG000|BM Cohort|Withdrawal by Subject|0|||
144193102|NCT01132664|519902698|FG001|BM Cohort|Withdrawal by Subject|0|||
144193103|NCT01132664|519902699|FG002|BM Cohort|Withdrawal by Subject|0|||
144193104|NCT01132664|519902700|FG003|BM Cohort|Withdrawal by Subject|0|||
144193105|NCT01132664|519902701|FG004|BM Cohort|Withdrawal by Subject|1|||
144193106|NCT05016622|519902703|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
144193107|NCT05016622|519902703|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
144193108|NCT02954159|519902704|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
144193109|NCT02954159|519902705|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
144193110|NCT02954159|519902704|FG000|Overall Study|Withdrawal by Subject|0|||
144193111|NCT02954159|519902705|FG001|Overall Study|Withdrawal by Subject|1|||
144193112|NCT03575871|519902708|FG000|Overall Study|Adverse Event|5|||
144193113|NCT03575871|519902709|FG001|Overall Study|Adverse Event|5|||
144193114|NCT03575871|519902710|FG002|Overall Study|Adverse Event|8|||
144193115|NCT03575871|519902708|FG000|Overall Study|Death|1|||
144193116|NCT03575871|519902709|FG001|Overall Study|Death|0|||
144193117|NCT03575871|519902710|FG002|Overall Study|Death|0|||
144193118|NCT03575871|519902708|FG000|Overall Study|Lack of Efficacy|5|||
144193119|NCT03575871|519902709|FG001|Overall Study|Lack of Efficacy|4|||
144193120|NCT03575871|519902710|FG002|Overall Study|Lack of Efficacy|7|||
144193121|NCT03575871|519902708|FG000|Overall Study|Lost to Follow-up|1|||
144193122|NCT03575871|519902709|FG001|Overall Study|Lost to Follow-up|1|||
144193123|NCT03575871|519902710|FG002|Overall Study|Lost to Follow-up|1|||
144193124|NCT03575871|519902708|FG000|Overall Study|Protocol Deviation|1|||
144444174|NCT03013491|520825713|FG012|Main Study|Withdrawal by Subject|0|||
144444175|NCT03013491|520825714|FG013|Main Study|Withdrawal by Subject|2|||
144444176|NCT03013491|520825715|FG014|Main Study|Withdrawal by Subject|0|||
144444177|NCT03013491|520825716|FG015|Main Study|Withdrawal by Subject|0|||
144444178|NCT03013491|520825717|FG016|Main Study|Withdrawal by Subject|0|||
144444179|NCT03013491|520825718|FG017|Main Study|Withdrawal by Subject|0|||
144444180|NCT03013491|520825719|FG018|Main Study|Withdrawal by Subject|18|||
144444181|NCT03013491|520825701|FG000|Main Study|Disease progression|0|||
144444182|NCT03013491|520825702|FG001|Main Study|Disease progression|0|||
144444183|NCT03013491|520825703|FG002|Main Study|Disease progression|0|||
144444184|NCT03013491|520825704|FG003|Main Study|Disease progression|1|||
144444185|NCT03013491|520825705|FG004|Main Study|Disease progression|0|||
144444186|NCT03013491|520825706|FG005|Main Study|Disease progression|0|||
144444187|NCT03013491|520825707|FG006|Main Study|Disease progression|0|||
144444188|NCT03013491|520825708|FG007|Main Study|Disease progression|0|||
144444189|NCT03013491|520825709|FG008|Main Study|Disease progression|1|||
144444190|NCT03013491|520825710|FG009|Main Study|Disease progression|0|||
144444191|NCT03013491|520825711|FG010|Main Study|Disease progression|1|||
144444192|NCT03013491|520825712|FG011|Main Study|Disease progression|0|||
144444193|NCT03013491|520825713|FG012|Main Study|Disease progression|0|||
144444194|NCT03013491|520825714|FG013|Main Study|Disease progression|0|||
144444195|NCT03013491|520825715|FG014|Main Study|Disease progression|0|||
144444196|NCT03013491|520825716|FG015|Main Study|Disease progression|0|||
144193125|NCT03575871|519902709|FG001|Overall Study|Protocol Deviation|1|||
144444197|NCT03013491|520825717|FG016|Main Study|Disease progression|0|||
144444198|NCT03013491|520825718|FG017|Main Study|Disease progression|0|||
144444199|NCT03013491|520825719|FG018|Main Study|Disease progression|4|||
144193126|NCT03575871|519902710|FG002|Overall Study|Protocol Deviation|1|||
144193127|NCT03575871|519902708|FG000|Overall Study|Withdrawal by Subject|6|||
144193128|NCT03575871|519902709|FG001|Overall Study|Withdrawal by Subject|1|||
144444200|NCT03013491|520825701|FG000|Main Study|Symptomatic deterioration|0|||
144444201|NCT03013491|520825702|FG001|Main Study|Symptomatic deterioration|0|||
144444202|NCT03013491|520825703|FG002|Main Study|Symptomatic deterioration|0|||
144444203|NCT03013491|520825704|FG003|Main Study|Symptomatic deterioration|0|||
144193129|NCT03575871|519902710|FG002|Overall Study|Withdrawal by Subject|9|||
144193130|NCT03575871|519902708|FG000|Overall Study|Other than specified|2|||
144193131|NCT03575871|519902709|FG001|Overall Study|Other than specified|2|||
144444204|NCT03013491|520825705|FG004|Main Study|Symptomatic deterioration|0|||
144444205|NCT03013491|520825706|FG005|Main Study|Symptomatic deterioration|1|||
144444206|NCT03013491|520825707|FG006|Main Study|Symptomatic deterioration|0|||
144444207|NCT03013491|520825708|FG007|Main Study|Symptomatic deterioration|0|||
144444208|NCT03013491|520825709|FG008|Main Study|Symptomatic deterioration|0|||
144444209|NCT03013491|520825710|FG009|Main Study|Symptomatic deterioration|0|||
144444210|NCT03013491|520825711|FG010|Main Study|Symptomatic deterioration|0|||
144444211|NCT03013491|520825712|FG011|Main Study|Symptomatic deterioration|0|||
144444212|NCT03013491|520825713|FG012|Main Study|Symptomatic deterioration|0|||
144444213|NCT03013491|520825714|FG013|Main Study|Symptomatic deterioration|0|||
144606066|NCT04667377|521419016|FG000|Maintenance Period|Burden of study procedures|1|||
144606067|NCT04667377|521419017|FG001|Maintenance Period|Burden of study procedures|2|||
144606068|NCT04667377|521419018|FG002|Maintenance Period|Burden of study procedures|0|||
144606069|NCT04667377|521419019|FG003|Maintenance Period|Burden of study procedures|1|||
144606070|NCT04667377|521419020|FG004|Maintenance Period|Burden of study procedures|0|||
144606071|NCT04667377|521419016|FG000|Maintenance Period|Change of residence|0|||
144606072|NCT04667377|521419017|FG001|Maintenance Period|Change of residence|1|||
144606073|NCT04667377|521419018|FG002|Maintenance Period|Change of residence|0|||
144606074|NCT04667377|521419019|FG003|Maintenance Period|Change of residence|0|||
144606075|NCT04667377|521419020|FG004|Maintenance Period|Change of residence|1|||
144606076|NCT04667377|521419016|FG000|Maintenance Period|Missing|1|||
144606077|NCT04667377|521419017|FG001|Maintenance Period|Missing|0|||
144606078|NCT04667377|521419018|FG002|Maintenance Period|Missing|0|||
144606079|NCT04667377|521419019|FG003|Maintenance Period|Missing|0|||
144606080|NCT04667377|521419020|FG004|Maintenance Period|Missing|0|||
144606081|NCT04667377|521419016|FG000|Maintenance Period|Other than listed above|2|||
144606082|NCT04667377|521419017|FG001|Maintenance Period|Other than listed above|0|||
144606083|NCT04667377|521419018|FG002|Maintenance Period|Other than listed above|3|||
144606084|NCT04667377|521419019|FG003|Maintenance Period|Other than listed above|2|||
144606085|NCT04667377|521419020|FG004|Maintenance Period|Other than listed above|6|||
144606086|NCT04667377|521419016|FG000|Maintenance Period|Withdrawal by Subject|0|||
144606087|NCT04667377|521419017|FG001|Maintenance Period|Withdrawal by Subject|1|||
144606088|NCT04667377|521419018|FG002|Maintenance Period|Withdrawal by Subject|0|||
144606089|NCT04667377|521419019|FG003|Maintenance Period|Withdrawal by Subject|0|||
144606090|NCT04667377|521419020|FG004|Maintenance Period|Withdrawal by Subject|0|||
144606091|NCT04667377|521419016|FG000|Maintenance Period|Lost to Follow-up|1|||
144606092|NCT04667377|521419017|FG001|Maintenance Period|Lost to Follow-up|0|||
144606093|NCT04667377|521419018|FG002|Maintenance Period|Lost to Follow-up|1|||
144606094|NCT04667377|521419019|FG003|Maintenance Period|Lost to Follow-up|0|||
144606095|NCT04667377|521419020|FG004|Maintenance Period|Lost to Follow-up|1|||
144606096|NCT00359021|521419021|FG000|Overall Study|Adverse Event|26|||
144606097|NCT00359021|521419022|FG001|Overall Study|Adverse Event|8|||
144606098|NCT00359021|521419021|FG000|Overall Study|Subject Non-Compliant|1|||
144606099|NCT00359021|521419022|FG001|Overall Study|Subject Non-Compliant|2|||
144606100|NCT00359021|521419021|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
144606101|NCT00359021|521419022|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
144606102|NCT00359021|521419021|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
144606103|NCT00359021|521419022|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
144606104|NCT00359021|521419021|FG000|Overall Study|Withdrawal by Subject|2|||
144606105|NCT00359021|521419022|FG001|Overall Study|Withdrawal by Subject|9|||
144606106|NCT00359021|521419021|FG000|Overall Study|Lost to Follow-up|1|||
144606107|NCT00359021|521419022|FG001|Overall Study|Lost to Follow-up|0|||
144606108|NCT00359021|521419021|FG000|Overall Study|Other|4|||
144606109|NCT00359021|521419022|FG001|Overall Study|Other|1|||
144193132|NCT03575871|519902710|FG002|Overall Study|Other than specified|0|||
144444214|NCT03013491|520825715|FG014|Main Study|Symptomatic deterioration|0|||
144444215|NCT03013491|520825716|FG015|Main Study|Symptomatic deterioration|0|||
144606110|NCT00359021|521419021|FG000|Overall Study|Pregnancy|1|||
144606111|NCT00359021|521419022|FG001|Overall Study|Pregnancy|0|||
144606112|NCT02066311|521419023|FG000|Overall Study|Adverse Event|4|||
144444216|NCT03013491|520825717|FG016|Main Study|Symptomatic deterioration|0|||
144606113|NCT02066311|521419023|FG000|Overall Study|Withdrawal by Subject|1|||
144606114|NCT01338415|521419024|FG000|Core + Extension|Adverse Event|8|||
144606115|NCT01338415|521419025|FG001|Core + Extension|Adverse Event|6|||
144193133|NCT01045993|519902711|FG000|Overall Study|Treated-later found eligibility not met|0|||
144606116|NCT01338415|521419026|FG002|Core + Extension|Adverse Event|0|||
144606117|NCT01338415|521419024|FG000|Core + Extension|Withdrawal by Subject|1|||
144444217|NCT03013491|520825718|FG017|Main Study|Symptomatic deterioration|0|||
144606118|NCT01338415|521419025|FG001|Core + Extension|Withdrawal by Subject|1|||
144193134|NCT01045993|519902712|FG001|Overall Study|Treated-later found eligibility not met|1|||
144444218|NCT03013491|520825719|FG018|Main Study|Symptomatic deterioration|0|||
144444219|NCT03013491|520825701|FG000|Main Study|Protocol version 8.0 approval|0|||
144444220|NCT03013491|520825702|FG001|Main Study|Protocol version 8.0 approval|0|||
144444221|NCT03013491|520825703|FG002|Main Study|Protocol version 8.0 approval|0|||
144444222|NCT03013491|520825704|FG003|Main Study|Protocol version 8.0 approval|0|||
144444223|NCT03013491|520825705|FG004|Main Study|Protocol version 8.0 approval|0|||
144444224|NCT03013491|520825706|FG005|Main Study|Protocol version 8.0 approval|0|||
144444225|NCT03013491|520825707|FG006|Main Study|Protocol version 8.0 approval|0|||
144444226|NCT03013491|520825708|FG007|Main Study|Protocol version 8.0 approval|0|||
144444227|NCT03013491|520825709|FG008|Main Study|Protocol version 8.0 approval|0|||
144193135|NCT01045993|519902713|FG002|Overall Study|Treated-later found eligibility not met|0|||
144193136|NCT01045993|519902714|FG003|Overall Study|Treated-later found eligibility not met|0|||
144193137|NCT01659736|519902715|FG000|Treatment Period|Adverse Event|1|||
144193138|NCT01659736|519902716|FG001|Treatment Period|Adverse Event|1|||
144193139|NCT01659736|519902715|FG000|Treatment Period|Protocol Violation|3|||
144444228|NCT03013491|520825710|FG009|Main Study|Protocol version 8.0 approval|0|||
144444229|NCT03013491|520825711|FG010|Main Study|Protocol version 8.0 approval|1|||
144444230|NCT03013491|520825712|FG011|Main Study|Protocol version 8.0 approval|0|||
144444231|NCT03013491|520825713|FG012|Main Study|Protocol version 8.0 approval|0|||
144444232|NCT03013491|520825714|FG013|Main Study|Protocol version 8.0 approval|0|||
144444233|NCT03013491|520825715|FG014|Main Study|Protocol version 8.0 approval|0|||
144444234|NCT03013491|520825716|FG015|Main Study|Protocol version 8.0 approval|0|||
144444235|NCT03013491|520825717|FG016|Main Study|Protocol version 8.0 approval|0|||
144444236|NCT03013491|520825718|FG017|Main Study|Protocol version 8.0 approval|0|||
144444237|NCT03013491|520825719|FG018|Main Study|Protocol version 8.0 approval|0|||
144444238|NCT03013491|520825701|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
144444239|NCT03013491|520825702|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
144444240|NCT03013491|520825703|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
144444241|NCT03013491|520825704|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
144444242|NCT03013491|520825705|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
144444243|NCT03013491|520825706|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
144444244|NCT03013491|520825707|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
144444245|NCT03013491|520825708|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
144444246|NCT03013491|520825709|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
144444247|NCT03013491|520825710|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
144444248|NCT03013491|520825711|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
144444249|NCT03013491|520825712|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
144444250|NCT03013491|520825713|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
144444251|NCT03013491|520825714|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
144444252|NCT03013491|520825715|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
144444253|NCT03013491|520825716|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
144444254|NCT03013491|520825717|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
144444255|NCT03013491|520825718|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
144444256|NCT03013491|520825719|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
144444257|NCT03013491|520825701|FG000|Main Study|Start of new anticancer therapy|0|||
144444258|NCT03013491|520825702|FG001|Main Study|Start of new anticancer therapy|0|||
144444259|NCT03013491|520825703|FG002|Main Study|Start of new anticancer therapy|0|||
144444260|NCT03013491|520825704|FG003|Main Study|Start of new anticancer therapy|0|||
144444261|NCT03013491|520825705|FG004|Main Study|Start of new anticancer therapy|0|||
144444262|NCT03013491|520825706|FG005|Main Study|Start of new anticancer therapy|0|||
144444263|NCT03013491|520825707|FG006|Main Study|Start of new anticancer therapy|0|||
144444264|NCT03013491|520825708|FG007|Main Study|Start of new anticancer therapy|0|||
144444265|NCT03013491|520825709|FG008|Main Study|Start of new anticancer therapy|0|||
144444266|NCT03013491|520825710|FG009|Main Study|Start of new anticancer therapy|0|||
144444267|NCT03013491|520825711|FG010|Main Study|Start of new anticancer therapy|0|||
144444268|NCT03013491|520825712|FG011|Main Study|Start of new anticancer therapy|0|||
144444269|NCT03013491|520825713|FG012|Main Study|Start of new anticancer therapy|0|||
144444270|NCT03013491|520825714|FG013|Main Study|Start of new anticancer therapy|0|||
144444271|NCT03013491|520825715|FG014|Main Study|Start of new anticancer therapy|0|||
144444272|NCT03013491|520825716|FG015|Main Study|Start of new anticancer therapy|0|||
144444273|NCT03013491|520825717|FG016|Main Study|Start of new anticancer therapy|0|||
144444274|NCT03013491|520825718|FG017|Main Study|Start of new anticancer therapy|0|||
144444275|NCT03013491|520825719|FG018|Main Study|Start of new anticancer therapy|2|||
144444276|NCT03013491|520825701|FG000|Long-term Extension|Disease progression|0|||
144444277|NCT03013491|520825702|FG001|Long-term Extension|Disease progression|0|||
144532531|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
144193140|NCT01659736|519902716|FG001|Treatment Period|Protocol Violation|1|||
144193141|NCT01659736|519902715|FG000|Treatment Period|Withdrawal by Subject|1|||
144193142|NCT01659736|519902716|FG001|Treatment Period|Withdrawal by Subject|0|||
144193143|NCT01659736|519902715|FG000|3-month Follow-up|Lost to Follow-up|0|||
144193144|NCT01659736|519902716|FG001|3-month Follow-up|Lost to Follow-up|1|||
144193145|NCT02581163|519902722|FG000|Overall Study|Failure to return|15|||
144193146|NCT02581163|519902722|FG000|Overall Study|Insufficient virological response|3|||
144193147|NCT02581163|519902722|FG000|Overall Study|Withdrew consent|1|||
144193148|NCT02581163|519902722|FG000|Overall Study|Death|1|||
144193149|NCT02581163|519902722|FG000|Overall Study|Other, not specified|9|||
144193150|NCT01570283|519902723|FG000|Cohort 1: Dose Level 1|Death|0|||
144193151|NCT01570283|519902724|FG001|Cohort 1: Dose Level 1|Death|1|||
144193152|NCT01570283|519902725|FG002|Cohort 1: Dose Level 1|Death|0|||
144193153|NCT01570283|519902726|FG003|Cohort 1: Dose Level 1|Death|0|||
144193154|NCT01570283|519902727|FG004|Cohort 1: Dose Level 1|Death|0|||
144193155|NCT01570283|519902728|FG005|Cohort 1: Dose Level 1|Death|0|||
144193156|NCT01570283|519902723|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
144193157|NCT01570283|519902724|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
144193158|NCT01570283|519902725|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
144193159|NCT01570283|519902726|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
144193160|NCT01570283|519902727|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
144193161|NCT01570283|519902728|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
144193162|NCT01570283|519902723|FG000|Cohort 2: Dose Level 2|Death|0|||
144193163|NCT01570283|519902724|FG001|Cohort 2: Dose Level 2|Death|0|||
144193164|NCT01570283|519902725|FG002|Cohort 2: Dose Level 2|Death|1|||
144193165|NCT01570283|519902726|FG003|Cohort 2: Dose Level 2|Death|0|||
144193166|NCT01570283|519902727|FG004|Cohort 2: Dose Level 2|Death|0|||
144193167|NCT01570283|519902728|FG005|Cohort 2: Dose Level 2|Death|0|||
144193168|NCT01570283|519902723|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
144193169|NCT01570283|519902724|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
144193170|NCT01570283|519902725|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
144193171|NCT01570283|519902726|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
144193172|NCT01570283|519902727|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
144193173|NCT01570283|519902728|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
144193174|NCT01570283|519902723|FG000|Cohort 3: Dose Level 3|Death|0|||
144193175|NCT01570283|519902724|FG001|Cohort 3: Dose Level 3|Death|0|||
144193176|NCT01570283|519902725|FG002|Cohort 3: Dose Level 3|Death|0|||
144193177|NCT01570283|519902726|FG003|Cohort 3: Dose Level 3|Death|0|||
144193178|NCT01570283|519902727|FG004|Cohort 3: Dose Level 3|Death|0|||
144193179|NCT01570283|519902728|FG005|Cohort 3: Dose Level 3|Death|1|||
144193180|NCT01570283|519902723|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
144193181|NCT01570283|519902724|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
144193182|NCT01570283|519902725|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
144193183|NCT01570283|519902726|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
144193184|NCT01570283|519902727|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
144193185|NCT01570283|519902728|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
144193186|NCT00262041|519902731|FG000|Overall Study|Withdrawal by Subject|0|||
144193187|NCT00262041|519902732|FG001|Overall Study|Withdrawal by Subject|3|||
144193188|NCT00262041|519902733|FG002|Overall Study|Withdrawal by Subject|1|||
144193189|NCT00262041|519902731|FG000|Overall Study|Lost to Follow-up|1|||
144193190|NCT00262041|519902732|FG001|Overall Study|Lost to Follow-up|1|||
144193191|NCT00262041|519902733|FG002|Overall Study|Lost to Follow-up|5|||
144193192|NCT00262041|519902731|FG000|Overall Study|Unable to classify|1|||
144193193|NCT00262041|519902732|FG001|Overall Study|Unable to classify|0|||
144193194|NCT00262041|519902733|FG002|Overall Study|Unable to classify|0|||
144193195|NCT03578237|519902736|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
144193196|NCT03578237|519902737|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
144193197|NCT01173471|519902738|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144193198|NCT01173471|519902739|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144193199|NCT01173471|519902740|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
144193200|NCT01173471|519902741|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
144193201|NCT01173471|519902738|FG000|Overall Study|Condition under investigation worsened|2|||
144193202|NCT01173471|519902739|FG001|Overall Study|Condition under investigation worsened|0|||
144193203|NCT01173471|519902740|FG002|Overall Study|Condition under investigation worsened|0|||
144193204|NCT01173471|519902741|FG003|Overall Study|Condition under investigation worsened|0|||
144193205|NCT01173471|519902738|FG000|Overall Study|Lost to Follow-up|0|||
144193206|NCT01173471|519902739|FG001|Overall Study|Lost to Follow-up|0|||
144193207|NCT01173471|519902740|FG002|Overall Study|Lost to Follow-up|1|||
144193208|NCT01173471|519902741|FG003|Overall Study|Lost to Follow-up|0|||
144193209|NCT01173471|519902738|FG000|Overall Study|Reason given as Other|0|||
144193210|NCT01173471|519902739|FG001|Overall Study|Reason given as Other|0|||
144193211|NCT01173471|519902740|FG002|Overall Study|Reason given as Other|1|||
144193212|NCT01173471|519902741|FG003|Overall Study|Reason given as Other|0|||
144193213|NCT04132336|519902742|FG000|Overall Study|Investigator Decision|0|||
144444278|NCT03013491|520825703|FG002|Long-term Extension|Disease progression|0|||
144444279|NCT03013491|520825704|FG003|Long-term Extension|Disease progression|1|||
144444280|NCT03013491|520825705|FG004|Long-term Extension|Disease progression|0|||
144444281|NCT03013491|520825706|FG005|Long-term Extension|Disease progression|0|||
144444282|NCT03013491|520825707|FG006|Long-term Extension|Disease progression|0|||
144444283|NCT03013491|520825708|FG007|Long-term Extension|Disease progression|0|||
144444284|NCT03013491|520825709|FG008|Long-term Extension|Disease progression|0|||
144444285|NCT03013491|520825710|FG009|Long-term Extension|Disease progression|0|||
144444286|NCT03013491|520825711|FG010|Long-term Extension|Disease progression|0|||
144444287|NCT03013491|520825712|FG011|Long-term Extension|Disease progression|0|||
144444288|NCT03013491|520825713|FG012|Long-term Extension|Disease progression|0|||
144444289|NCT03013491|520825714|FG013|Long-term Extension|Disease progression|0|||
144444290|NCT03013491|520825715|FG014|Long-term Extension|Disease progression|0|||
144444291|NCT03013491|520825716|FG015|Long-term Extension|Disease progression|0|||
144444292|NCT03013491|520825717|FG016|Long-term Extension|Disease progression|0|||
144444293|NCT03013491|520825718|FG017|Long-term Extension|Disease progression|0|||
144444294|NCT03013491|520825719|FG018|Long-term Extension|Disease progression|1|||
144444295|NCT03013491|520825701|FG000|Long-term Extension|Withdrawal by Subject|0|||
144444296|NCT03013491|520825702|FG001|Long-term Extension|Withdrawal by Subject|0|||
144444297|NCT03013491|520825703|FG002|Long-term Extension|Withdrawal by Subject|0|||
144444298|NCT03013491|520825704|FG003|Long-term Extension|Withdrawal by Subject|0|||
144444299|NCT03013491|520825705|FG004|Long-term Extension|Withdrawal by Subject|0|||
144444300|NCT03013491|520825706|FG005|Long-term Extension|Withdrawal by Subject|0|||
144444301|NCT03013491|520825707|FG006|Long-term Extension|Withdrawal by Subject|0|||
144444302|NCT03013491|520825708|FG007|Long-term Extension|Withdrawal by Subject|1|||
144444303|NCT03013491|520825709|FG008|Long-term Extension|Withdrawal by Subject|0|||
144444304|NCT03013491|520825710|FG009|Long-term Extension|Withdrawal by Subject|0|||
144444305|NCT03013491|520825711|FG010|Long-term Extension|Withdrawal by Subject|0|||
144444306|NCT03013491|520825712|FG011|Long-term Extension|Withdrawal by Subject|0|||
144444307|NCT03013491|520825713|FG012|Long-term Extension|Withdrawal by Subject|0|||
144444308|NCT03013491|520825714|FG013|Long-term Extension|Withdrawal by Subject|0|||
144444309|NCT03013491|520825715|FG014|Long-term Extension|Withdrawal by Subject|0|||
144444310|NCT03013491|520825716|FG015|Long-term Extension|Withdrawal by Subject|0|||
144444311|NCT03013491|520825717|FG016|Long-term Extension|Withdrawal by Subject|0|||
144532532|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
144725196|NCT05771428|521851197|FG003|Overall Study|Withdrawal by Subject|4|||
144199346|NCT00394524|519928875|FG000|Overall Study|Protocol Violation|2|||
144444312|NCT03013491|520825718|FG017|Long-term Extension|Withdrawal by Subject|0|||
144444313|NCT03013491|520825719|FG018|Long-term Extension|Withdrawal by Subject|0|||
144444314|NCT03013491|520825701|FG000|Long-term Extension|Adverse Event|0|||
144532533|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
144532534|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
144532535|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
144532536|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
144532537|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
144532538|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
144532539|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
144532540|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
144532541|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
144532542|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
144532543|NCT03580356|521154264|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
144532544|NCT03580356|521154265|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
144532545|NCT03580356|521154266|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
144532546|NCT03580356|521154267|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
144532547|NCT03580356|521154268|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
144532548|NCT03580356|521154269|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
144532549|NCT03580356|521154270|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
144532550|NCT03580356|521154271|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
144532551|NCT02834390|521154272|FG000|Induction Phase|Progressive disease|0|||
144532552|NCT02834390|521154273|FG001|Induction Phase|Progressive disease|1|||
144532553|NCT02834390|521154272|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
144532554|NCT02834390|521154273|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
144532555|NCT02834390|521154272|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
144532556|NCT02834390|521154273|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
144532557|NCT02834390|521154272|FG000|Consolidation Phase|Physician Decision|1|||
144532558|NCT02834390|521154273|FG001|Consolidation Phase|Physician Decision|1|||
144532559|NCT03536884|521154274|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
144532560|NCT03536884|521154275|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
144532561|NCT03536884|521154276|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144532562|NCT03536884|521154277|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144532563|NCT03536884|521154278|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144532564|NCT03536884|521154279|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144193214|NCT04132336|519902743|FG001|Overall Study|Investigator Decision|1|||
144193215|NCT04132336|519902744|FG002|Overall Study|Investigator Decision|0|||
144444315|NCT03013491|520825702|FG001|Long-term Extension|Adverse Event|0|||
144444316|NCT03013491|520825703|FG002|Long-term Extension|Adverse Event|0|||
144444317|NCT03013491|520825704|FG003|Long-term Extension|Adverse Event|0|||
144444318|NCT03013491|520825705|FG004|Long-term Extension|Adverse Event|0|||
144444319|NCT03013491|520825706|FG005|Long-term Extension|Adverse Event|0|||
144444320|NCT03013491|520825707|FG006|Long-term Extension|Adverse Event|0|||
144444321|NCT03013491|520825708|FG007|Long-term Extension|Adverse Event|0|||
144444322|NCT03013491|520825709|FG008|Long-term Extension|Adverse Event|0|||
144444323|NCT03013491|520825710|FG009|Long-term Extension|Adverse Event|0|||
144444324|NCT03013491|520825711|FG010|Long-term Extension|Adverse Event|0|||
144444325|NCT03013491|520825712|FG011|Long-term Extension|Adverse Event|0|||
144444326|NCT03013491|520825713|FG012|Long-term Extension|Adverse Event|0|||
144444327|NCT03013491|520825714|FG013|Long-term Extension|Adverse Event|0|||
144444328|NCT03013491|520825715|FG014|Long-term Extension|Adverse Event|0|||
144444329|NCT03013491|520825716|FG015|Long-term Extension|Adverse Event|0|||
144444330|NCT03013491|520825717|FG016|Long-term Extension|Adverse Event|0|||
144444331|NCT03013491|520825718|FG017|Long-term Extension|Adverse Event|0|||
144444332|NCT03013491|520825719|FG018|Long-term Extension|Adverse Event|1|||
144444333|NCT03013491|520825701|FG000|Long-term Extension|Death|0|||
144444334|NCT03013491|520825702|FG001|Long-term Extension|Death|0|||
144444335|NCT03013491|520825703|FG002|Long-term Extension|Death|0|||
144444336|NCT03013491|520825704|FG003|Long-term Extension|Death|0|||
144444337|NCT03013491|520825705|FG004|Long-term Extension|Death|0|||
144444338|NCT03013491|520825706|FG005|Long-term Extension|Death|0|||
144444339|NCT03013491|520825707|FG006|Long-term Extension|Death|0|||
144444340|NCT03013491|520825708|FG007|Long-term Extension|Death|0|||
144444341|NCT03013491|520825709|FG008|Long-term Extension|Death|0|||
144444342|NCT03013491|520825710|FG009|Long-term Extension|Death|0|||
144444343|NCT03013491|520825711|FG010|Long-term Extension|Death|0|||
144444344|NCT03013491|520825712|FG011|Long-term Extension|Death|0|||
144444345|NCT03013491|520825713|FG012|Long-term Extension|Death|0|||
144444346|NCT03013491|520825714|FG013|Long-term Extension|Death|0|||
144444347|NCT03013491|520825715|FG014|Long-term Extension|Death|0|||
144444348|NCT03013491|520825716|FG015|Long-term Extension|Death|0|||
144444349|NCT03013491|520825717|FG016|Long-term Extension|Death|0|||
144444350|NCT03013491|520825718|FG017|Long-term Extension|Death|0|||
144444351|NCT03013491|520825719|FG018|Long-term Extension|Death|1|||
144444352|NCT04579679|520825722|FG000|Overall Study|New Antitumor Therapy|6|||
144444353|NCT04579679|520825723|FG001|Overall Study|New Antitumor Therapy|4|||
144444354|NCT04579679|520825724|FG002|Overall Study|New Antitumor Therapy|7|||
144444355|NCT04579679|520825725|FG003|Overall Study|New Antitumor Therapy|0|||
144444356|NCT04579679|520825722|FG000|Overall Study|Withdrawal of Consent|1|||
144444357|NCT04579679|520825723|FG001|Overall Study|Withdrawal of Consent|1|||
144444358|NCT04579679|520825724|FG002|Overall Study|Withdrawal of Consent|2|||
144444359|NCT04579679|520825725|FG003|Overall Study|Withdrawal of Consent|4|||
144444360|NCT04579679|520825722|FG000|Overall Study|Death|2|||
144444361|NCT04579679|520825723|FG001|Overall Study|Death|2|||
144444362|NCT04579679|520825724|FG002|Overall Study|Death|2|||
144444363|NCT04579679|520825725|FG003|Overall Study|Death|0|||
144444364|NCT04579679|520825722|FG000|Overall Study|Adverse Event|0|||
144444365|NCT04579679|520825723|FG001|Overall Study|Adverse Event|4|||
144444366|NCT04579679|520825724|FG002|Overall Study|Adverse Event|0|||
144444367|NCT04579679|520825725|FG003|Overall Study|Adverse Event|0|||
144444368|NCT04579679|520825722|FG000|Overall Study|Disease Progression|9|||
144444369|NCT04579679|520825723|FG001|Overall Study|Disease Progression|13|||
144444370|NCT04579679|520825724|FG002|Overall Study|Disease Progression|7|||
144444371|NCT04579679|520825725|FG003|Overall Study|Disease Progression|0|||
144444372|NCT04579679|520825722|FG000|Overall Study|Physician Decision|0|||
144444373|NCT04579679|520825723|FG001|Overall Study|Physician Decision|0|||
144444374|NCT04579679|520825724|FG002|Overall Study|Physician Decision|1|||
144444375|NCT04579679|520825725|FG003|Overall Study|Physician Decision|0|||
144444376|NCT04579679|520825722|FG000|Overall Study|Study Terminated by Sponsor|2|||
144444377|NCT04579679|520825723|FG001|Overall Study|Study Terminated by Sponsor|7|||
144444378|NCT04579679|520825724|FG002|Overall Study|Study Terminated by Sponsor|1|||
144444379|NCT04579679|520825725|FG003|Overall Study|Study Terminated by Sponsor|0|||
144532565|NCT03536884|521154280|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144532566|NCT03536884|521154281|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144193216|NCT04132336|519902745|FG003|Overall Study|Investigator Decision|0|||
144444380|NCT03238911|520825726|FG000|Overall Study|Withdrawal by Subject|1|||
144444381|NCT03238911|520825727|FG001|Overall Study|Withdrawal by Subject|2|||
144444382|NCT03238911|520825726|FG000|Overall Study|Lost to Follow-up|2|||
144444383|NCT03238911|520825727|FG001|Overall Study|Lost to Follow-up|1|||
144532567|NCT03536884|521154282|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144444384|NCT02239536|520825728|FG000|Overall Study|Non-neoplastic polyp|23|||
144444385|NCT02239536|520825729|FG001|Overall Study|Non-neoplastic polyp|17|||
144444386|NCT04740034|520825735|FG000|Overall Study|Death|0|||
144444387|NCT04740034|520825736|FG001|Overall Study|Death|1|||
144444388|NCT04740034|520825737|FG002|Overall Study|Death|2|||
144444389|NCT04740034|520825738|FG003|Overall Study|Death|3|||
144193217|NCT04132336|519902746|FG004|Overall Study|Investigator Decision|0|||
144193218|NCT04132336|519902747|FG005|Overall Study|Investigator Decision|0|||
144193219|NCT04132336|519902748|FG006|Overall Study|Investigator Decision|0|||
144193220|NCT02488330|519902750|FG000|Overall Study|Adverse Event|1|||
144193221|NCT02488330|519902750|FG000|Overall Study|Physician Decision|2|||
144193222|NCT02488330|519902750|FG000|Overall Study|Death|2|||
144193223|NCT02488330|519902750|FG000|Overall Study|Disease Progression|3|||
144193224|NCT02488330|519902750|FG000|Overall Study|Study Termination by Sponsor|4|||
144193225|NCT00584844|519902751|FG000|Overall Study|Withdrawal by Subject|59|||
144193226|NCT00584844|519902751|FG000|Overall Study|Screen Failure|20|||
144193227|NCT01206816|519902754|FG000|Overall Study|Protocol Violation|0|||
144193228|NCT01206816|519902755|FG001|Overall Study|Protocol Violation|0|||
144193229|NCT01206816|519902756|FG002|Overall Study|Protocol Violation|1|||
144193230|NCT01206816|519902757|FG003|Overall Study|Protocol Violation|0|||
144193231|NCT01206816|519902758|FG004|Overall Study|Protocol Violation|0|||
144193232|NCT01206816|519902759|FG005|Overall Study|Protocol Violation|0|||
144193233|NCT01206816|519902760|FG006|Overall Study|Protocol Violation|0|||
144193234|NCT01206816|519902754|FG000|Overall Study|Withdrawal by Subject|0|||
144193235|NCT01206816|519902755|FG001|Overall Study|Withdrawal by Subject|0|||
144193236|NCT01206816|519902756|FG002|Overall Study|Withdrawal by Subject|1|||
144193237|NCT01206816|519902757|FG003|Overall Study|Withdrawal by Subject|0|||
144193238|NCT01206816|519902758|FG004|Overall Study|Withdrawal by Subject|0|||
144193239|NCT01206816|519902759|FG005|Overall Study|Withdrawal by Subject|0|||
144193240|NCT01206816|519902760|FG006|Overall Study|Withdrawal by Subject|0|||
144193241|NCT01206816|519902754|FG000|Overall Study|Progressive disease|3|||
144193242|NCT01206816|519902755|FG001|Overall Study|Progressive disease|3|||
144193243|NCT01206816|519902756|FG002|Overall Study|Progressive disease|13|||
144193244|NCT01206816|519902757|FG003|Overall Study|Progressive disease|3|||
144193245|NCT01206816|519902758|FG004|Overall Study|Progressive disease|3|||
144193246|NCT01206816|519902759|FG005|Overall Study|Progressive disease|16|||
144193247|NCT01206816|519902760|FG006|Overall Study|Progressive disease|3|||
144193248|NCT01206816|519902754|FG000|Overall Study|Other AE|0|||
144193249|NCT01206816|519902755|FG001|Overall Study|Other AE|0|||
144193250|NCT01206816|519902756|FG002|Overall Study|Other AE|4|||
144193251|NCT01206816|519902757|FG003|Overall Study|Other AE|0|||
144193252|NCT01206816|519902758|FG004|Overall Study|Other AE|0|||
144193253|NCT01206816|519902759|FG005|Overall Study|Other AE|3|||
144444390|NCT04740034|520825739|FG004|Overall Study|Death|4|||
144444391|NCT04740034|520825740|FG005|Overall Study|Death|4|||
144444392|NCT04740034|520825741|FG006|Overall Study|Death|2|||
144444393|NCT04740034|520825742|FG007|Overall Study|Death|2|||
144444394|NCT04740034|520825743|FG008|Overall Study|Death|2|||
144444395|NCT04740034|520825744|FG009|Overall Study|Death|4|||
144444396|NCT04740034|520825745|FG010|Overall Study|Death|0|||
144444397|NCT04740034|520825735|FG000|Overall Study|Lost to Follow-up|0|||
144444398|NCT04740034|520825736|FG001|Overall Study|Lost to Follow-up|0|||
144444399|NCT04740034|520825737|FG002|Overall Study|Lost to Follow-up|0|||
144444400|NCT04740034|520825738|FG003|Overall Study|Lost to Follow-up|1|||
144444401|NCT04740034|520825739|FG004|Overall Study|Lost to Follow-up|2|||
144444402|NCT04740034|520825740|FG005|Overall Study|Lost to Follow-up|2|||
144444403|NCT04740034|520825741|FG006|Overall Study|Lost to Follow-up|0|||
144444404|NCT04740034|520825742|FG007|Overall Study|Lost to Follow-up|0|||
144444405|NCT04740034|520825743|FG008|Overall Study|Lost to Follow-up|0|||
144444406|NCT04740034|520825744|FG009|Overall Study|Lost to Follow-up|1|||
144444407|NCT04740034|520825745|FG010|Overall Study|Lost to Follow-up|0|||
144444408|NCT04740034|520825735|FG000|Overall Study|Withdrawal by Subject|1|||
144444409|NCT04740034|520825736|FG001|Overall Study|Withdrawal by Subject|0|||
144444410|NCT04740034|520825737|FG002|Overall Study|Withdrawal by Subject|0|||
144444411|NCT04740034|520825738|FG003|Overall Study|Withdrawal by Subject|0|||
144532568|NCT03536884|521154283|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144532569|NCT03536884|521154284|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144444412|NCT04740034|520825739|FG004|Overall Study|Withdrawal by Subject|0|||
144444413|NCT04740034|520825740|FG005|Overall Study|Withdrawal by Subject|0|||
144444414|NCT04740034|520825741|FG006|Overall Study|Withdrawal by Subject|0|||
144532570|NCT03536884|521154285|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
144532571|NCT03536884|521154274|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144193254|NCT01206816|519902760|FG006|Overall Study|Other AE|2|||
144193255|NCT01206816|519902754|FG000|Overall Study|other than stated above|0|||
144193256|NCT01206816|519902755|FG001|Overall Study|other than stated above|0|||
144193257|NCT01206816|519902756|FG002|Overall Study|other than stated above|1|||
144193258|NCT01206816|519902757|FG003|Overall Study|other than stated above|0|||
144193259|NCT01206816|519902758|FG004|Overall Study|other than stated above|0|||
144193260|NCT01206816|519902759|FG005|Overall Study|other than stated above|0|||
144193261|NCT01206816|519902760|FG006|Overall Study|other than stated above|1|||
144193262|NCT01939496|519902761|FG000|Overall Study|Adverse Event|2|||
144193263|NCT01939496|519902762|FG001|Overall Study|Adverse Event|0|||
144193264|NCT01939496|519902763|FG002|Overall Study|Adverse Event|0|||
144193265|NCT01939496|519902761|FG000|Overall Study|Lost to Follow-up|1|||
144444415|NCT04740034|520825742|FG007|Overall Study|Withdrawal by Subject|1|||
144606119|NCT01338415|521419026|FG002|Core + Extension|Withdrawal by Subject|0|||
144606120|NCT01338415|521419024|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
144606121|NCT01338415|521419025|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
144606122|NCT01338415|521419026|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
144444416|NCT04740034|520825743|FG008|Overall Study|Withdrawal by Subject|0|||
144606123|NCT01338415|521419024|FG000|Core + Extension|Other (administrative reason)|1|||
144444417|NCT04740034|520825744|FG009|Overall Study|Withdrawal by Subject|1|||
144444418|NCT04740034|520825745|FG010|Overall Study|Withdrawal by Subject|0|||
144444419|NCT04740034|520825735|FG000|Overall Study|Decision by sponsor|0|||
144444420|NCT04740034|520825736|FG001|Overall Study|Decision by sponsor|0|||
144444421|NCT04740034|520825737|FG002|Overall Study|Decision by sponsor|1|||
144444422|NCT04740034|520825738|FG003|Overall Study|Decision by sponsor|0|||
144444423|NCT04740034|520825739|FG004|Overall Study|Decision by sponsor|0|||
144444424|NCT04740034|520825740|FG005|Overall Study|Decision by sponsor|0|||
144444425|NCT04740034|520825741|FG006|Overall Study|Decision by sponsor|1|||
144444426|NCT04740034|520825742|FG007|Overall Study|Decision by sponsor|2|||
144444427|NCT04740034|520825743|FG008|Overall Study|Decision by sponsor|1|||
144444428|NCT04740034|520825744|FG009|Overall Study|Decision by sponsor|1|||
144444429|NCT04740034|520825745|FG010|Overall Study|Decision by sponsor|2|||
144444430|NCT02742103|520827302|FG000|Overall Study|Protocol Violation|1|||
144444431|NCT02742103|520827303|FG001|Overall Study|Protocol Violation|0|||
144444432|NCT02742103|520827302|FG000|Overall Study|Death|2|||
144444433|NCT02742103|520827303|FG001|Overall Study|Death|2|||
144444434|NCT02742103|520827302|FG000|Overall Study|Adverse Event|1|||
144444435|NCT02742103|520827303|FG001|Overall Study|Adverse Event|0|||
144444436|NCT02742103|520827302|FG000|Overall Study|Moved to another town|0|||
144444437|NCT02742103|520827303|FG001|Overall Study|Moved to another town|1|||
144444438|NCT02742103|520827302|FG000|Overall Study|Withdrawal by Subject|5|||
144444439|NCT02742103|520827303|FG001|Overall Study|Withdrawal by Subject|2|||
144444440|NCT04346615|520827306|FG000|Overall Study|Lost to Follow-up|0|||
144444441|NCT04346615|520827307|FG001|Overall Study|Lost to Follow-up|2|||
144444442|NCT04346615|520827306|FG000|Overall Study|Withdrawal by Subject|1|||
144444443|NCT04346615|520827307|FG001|Overall Study|Withdrawal by Subject|0|||
144444444|NCT04346615|520827306|FG000|Overall Study|Death|5|||
144444445|NCT04346615|520827307|FG001|Overall Study|Death|1|||
144444446|NCT04346615|520827306|FG000|Overall Study|Other|0|||
144444447|NCT04346615|520827307|FG001|Overall Study|Other|2|||
144444448|NCT04346615|520827306|FG000|Overall Study|Randomized not treated|1|||
144606124|NCT01338415|521419025|FG001|Core + Extension|Other (administrative reason)|0|||
144606125|NCT01338415|521419026|FG002|Core + Extension|Other (administrative reason)|0|||
144606126|NCT01338415|521419024|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
144606127|NCT01338415|521419025|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
144606128|NCT01338415|521419026|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
144606129|NCT01338415|521419024|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
144606130|NCT01338415|521419025|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
144606131|NCT01338415|521419026|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
144606132|NCT01338415|521419024|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
144606133|NCT01338415|521419025|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
144606134|NCT01338415|521419026|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
144606135|NCT01338415|521419024|FG000|Exceptional Use Treatment Period|Death|0|||
144606136|NCT01338415|521419025|FG001|Exceptional Use Treatment Period|Death|0|||
144606137|NCT01338415|521419026|FG002|Exceptional Use Treatment Period|Death|1|||
144606138|NCT00233363|521419027|FG000|Overall Study|Adverse Event|1|||
144606139|NCT00233363|521419028|FG001|Overall Study|Adverse Event|2|||
144606140|NCT00233363|521419027|FG000|Overall Study|Lack of Efficacy|0|||
144606141|NCT00233363|521419028|FG001|Overall Study|Lack of Efficacy|2|||
144606142|NCT00233363|521419027|FG000|Overall Study|Withdrawal by Subject|1|||
144606143|NCT00233363|521419028|FG001|Overall Study|Withdrawal by Subject|1|||
144606144|NCT00233363|521419027|FG000|Overall Study|Aggravation of complication|1|||
144444449|NCT04346615|520827307|FG001|Overall Study|Randomized not treated|0|||
144606145|NCT00233363|521419028|FG001|Overall Study|Aggravation of complication|0|||
144606146|NCT01526551|521419034|FG000|Overall Study|Lack of returned parental consent form|424|||
144606147|NCT04880447|521419035|FG000|Overall Study|No vaccination information|1|||
144606148|NCT04880447|521419035|FG000|Overall Study|No adverse event information (missing information)|1|||
144606149|NCT04880447|521419035|FG000|Overall Study|Disease not covered in this study|35|||
144606150|NCT01576172|521419040|FG000|Overall Study|Ineligible|2|||
144444450|NCT00991302|520827312|FG000|Overall Study|Death|0|||
144444451|NCT00991302|520827313|FG001|Overall Study|Death|1|||
144444452|NCT00991302|520827312|FG000|Overall Study|Lost to Follow-up|14|||
144444453|NCT00991302|520827313|FG001|Overall Study|Lost to Follow-up|12|||
144606151|NCT01576172|521419041|FG001|Overall Study|Ineligible|1|||
144444454|NCT01709318|520827314|FG000|Overall Study|Adverse Event|3|||
144444455|NCT01709318|520827315|FG001|Overall Study|Adverse Event|4|||
144444456|NCT01709318|520827316|FG002|Overall Study|Adverse Event|2|||
144444457|NCT01709318|520827317|FG003|Overall Study|Adverse Event|2|||
144444458|NCT01709318|520827318|FG004|Overall Study|Adverse Event|0|||
144444459|NCT01709318|520827319|FG005|Overall Study|Adverse Event|1|||
144444460|NCT01709318|520827320|FG006|Overall Study|Adverse Event|2|||
144444461|NCT01709318|520827314|FG000|Overall Study|Lost to Follow-up|2|||
144444462|NCT01709318|520827315|FG001|Overall Study|Lost to Follow-up|0|||
144444463|NCT01709318|520827316|FG002|Overall Study|Lost to Follow-up|0|||
144444464|NCT01709318|520827317|FG003|Overall Study|Lost to Follow-up|0|||
144444465|NCT01709318|520827318|FG004|Overall Study|Lost to Follow-up|1|||
144444466|NCT01709318|520827319|FG005|Overall Study|Lost to Follow-up|1|||
144444467|NCT01709318|520827320|FG006|Overall Study|Lost to Follow-up|1|||
144444468|NCT01709318|520827314|FG000|Overall Study|Non-compliance with Study Drug|0|||
144444469|NCT01709318|520827315|FG001|Overall Study|Non-compliance with Study Drug|2|||
144444470|NCT01709318|520827316|FG002|Overall Study|Non-compliance with Study Drug|1|||
144444471|NCT01709318|520827317|FG003|Overall Study|Non-compliance with Study Drug|1|||
144444472|NCT01709318|520827318|FG004|Overall Study|Non-compliance with Study Drug|0|||
144444473|NCT01709318|520827319|FG005|Overall Study|Non-compliance with Study Drug|0|||
144444474|NCT01709318|520827320|FG006|Overall Study|Non-compliance with Study Drug|2|||
144444475|NCT01709318|520827314|FG000|Overall Study|Physician Decision|0|||
144444476|NCT01709318|520827315|FG001|Overall Study|Physician Decision|0|||
144444477|NCT01709318|520827316|FG002|Overall Study|Physician Decision|0|||
144444478|NCT01709318|520827317|FG003|Overall Study|Physician Decision|0|||
144444479|NCT01709318|520827318|FG004|Overall Study|Physician Decision|0|||
144444480|NCT01709318|520827319|FG005|Overall Study|Physician Decision|0|||
144444481|NCT01709318|520827320|FG006|Overall Study|Physician Decision|1|||
144444482|NCT01709318|520827314|FG000|Overall Study|Pregnancy|0|||
144444483|NCT01709318|520827315|FG001|Overall Study|Pregnancy|0|||
144444484|NCT01709318|520827316|FG002|Overall Study|Pregnancy|0|||
144444485|NCT01709318|520827317|FG003|Overall Study|Pregnancy|0|||
144444486|NCT01709318|520827318|FG004|Overall Study|Pregnancy|1|||
144444487|NCT01709318|520827319|FG005|Overall Study|Pregnancy|0|||
144444488|NCT01709318|520827320|FG006|Overall Study|Pregnancy|0|||
144444489|NCT01709318|520827314|FG000|Overall Study|Protocol Violation|0|||
144444490|NCT01709318|520827315|FG001|Overall Study|Protocol Violation|0|||
144444491|NCT01709318|520827316|FG002|Overall Study|Protocol Violation|0|||
144444492|NCT01709318|520827317|FG003|Overall Study|Protocol Violation|0|||
144444493|NCT01709318|520827318|FG004|Overall Study|Protocol Violation|2|||
144444494|NCT01709318|520827319|FG005|Overall Study|Protocol Violation|0|||
144444495|NCT01709318|520827320|FG006|Overall Study|Protocol Violation|1|||
144444496|NCT01709318|520827314|FG000|Overall Study|Technical Problems|1|||
144444497|NCT01709318|520827315|FG001|Overall Study|Technical Problems|0|||
144444498|NCT01709318|520827316|FG002|Overall Study|Technical Problems|0|||
144444499|NCT01709318|520827317|FG003|Overall Study|Technical Problems|0|||
144444500|NCT01709318|520827318|FG004|Overall Study|Technical Problems|0|||
144444501|NCT01709318|520827319|FG005|Overall Study|Technical Problems|0|||
144444502|NCT01709318|520827320|FG006|Overall Study|Technical Problems|0|||
144444503|NCT01709318|520827314|FG000|Overall Study|Withdrawal by Subject|3|||
144444504|NCT01709318|520827315|FG001|Overall Study|Withdrawal by Subject|0|||
144444505|NCT01709318|520827316|FG002|Overall Study|Withdrawal by Subject|3|||
144444506|NCT01709318|520827317|FG003|Overall Study|Withdrawal by Subject|3|||
144444507|NCT01709318|520827318|FG004|Overall Study|Withdrawal by Subject|0|||
144444508|NCT01709318|520827319|FG005|Overall Study|Withdrawal by Subject|2|||
144444509|NCT01709318|520827320|FG006|Overall Study|Withdrawal by Subject|4|||
144444510|NCT01709318|520827314|FG000|Overall Study|Other Protocol Specified Criteria|0|||
144444511|NCT01709318|520827315|FG001|Overall Study|Other Protocol Specified Criteria|1|||
144444512|NCT01709318|520827316|FG002|Overall Study|Other Protocol Specified Criteria|0|||
144444513|NCT01709318|520827317|FG003|Overall Study|Other Protocol Specified Criteria|0|||
144444514|NCT01709318|520827318|FG004|Overall Study|Other Protocol Specified Criteria|0|||
144444515|NCT01709318|520827319|FG005|Overall Study|Other Protocol Specified Criteria|0|||
144444516|NCT01709318|520827320|FG006|Overall Study|Other Protocol Specified Criteria|0|||
144444517|NCT03370341|520827321|FG000|Overall Study|Lost to Follow-up|0|||
144444518|NCT03370341|520827322|FG001|Overall Study|Lost to Follow-up|1|||
144444519|NCT01707004|520827323|FG000|Overall Study|Physician Decision|3|||
144444520|NCT02573324|520827325|FG000|Overall Study|Withdrawal by Subject|26|||
144444521|NCT02573324|520827326|FG001|Overall Study|Withdrawal by Subject|23|||
144444522|NCT02573324|520827327|FG002|Overall Study|Withdrawal by Subject|3|||
144444523|NCT02573324|520827325|FG000|Overall Study|Lost to Follow-up|4|||
144444524|NCT02573324|520827326|FG001|Overall Study|Lost to Follow-up|5|||
144444525|NCT02573324|520827327|FG002|Overall Study|Lost to Follow-up|0|||
144444526|NCT02573324|520827325|FG000|Overall Study|Study Terminated by Sponsor|107|||
144444527|NCT02573324|520827326|FG001|Overall Study|Study Terminated by Sponsor|89|||
144444528|NCT02573324|520827327|FG002|Overall Study|Study Terminated by Sponsor|2|||
144444529|NCT02573324|520827325|FG000|Overall Study|Death|182|||
144444530|NCT02573324|520827326|FG001|Overall Study|Death|200|||
144444531|NCT02573324|520827327|FG002|Overall Study|Death|1|||
144444532|NCT02573324|520827325|FG000|Overall Study|Other, Not Specified|20|||
144444533|NCT02573324|520827326|FG001|Overall Study|Other, Not Specified|27|||
144444534|NCT02573324|520827327|FG002|Overall Study|Other, Not Specified|0|||
144444535|NCT02573324|520827325|FG000|Overall Study|Unknown Reason|2|||
144193266|NCT01939496|519902762|FG001|Overall Study|Lost to Follow-up|1|||
144193267|NCT01939496|519902763|FG002|Overall Study|Lost to Follow-up|0|||
144193268|NCT01939496|519902761|FG000|Overall Study|Physician Decision|1|||
144193269|NCT01939496|519902762|FG001|Overall Study|Physician Decision|0|||
144193270|NCT01939496|519902763|FG002|Overall Study|Physician Decision|0|||
144444536|NCT02573324|520827326|FG001|Overall Study|Unknown Reason|0|||
144444537|NCT02573324|520827327|FG002|Overall Study|Unknown Reason|0|||
144444538|NCT00679341|520827328|FG000|Overall Study|Disease progression|42|||
144444539|NCT00679341|520827329|FG001|Overall Study|Disease progression|36|||
144444540|NCT00679341|520827328|FG000|Overall Study|Adverse Event|5|||
144444541|NCT00679341|520827329|FG001|Overall Study|Adverse Event|6|||
144444542|NCT00679341|520827328|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
144444543|NCT00679341|520827329|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
144444544|NCT00679341|520827328|FG000|Overall Study|Death|1|||
144444545|NCT00679341|520827329|FG001|Overall Study|Death|1|||
144444546|NCT00679341|520827328|FG000|Overall Study|Other|1|||
144444547|NCT00679341|520827329|FG001|Overall Study|Other|0|||
144444548|NCT00679341|520827328|FG000|Overall Study|Physician Decision|1|||
144444549|NCT00679341|520827329|FG001|Overall Study|Physician Decision|0|||
144444550|NCT00679341|520827328|FG000|Overall Study|Not treated|0|||
144444551|NCT00679341|520827329|FG001|Overall Study|Not treated|2|||
144444552|NCT00679341|520827328|FG000|Overall Study|Physician/patient decision to withdraw|0|||
144444553|NCT00679341|520827329|FG001|Overall Study|Physician/patient decision to withdraw|6|||
144444554|NCT00953329|520827332|FG000|Overall Study|Lack of Efficacy|1|||
144444555|NCT00120042|520827333|FG000|Overall Study|all completed protocl|0|||
144444556|NCT00120042|520827334|FG001|Overall Study|all completed protocl|0|||
144444557|NCT00120042|520827335|FG002|Overall Study|all completed protocl|0|||
144444558|NCT00796861|520827342|FG000|Overall Study|Withdrawal by Subject|2|||
144444559|NCT00796861|520827342|FG000|Overall Study|Death|2|||
144444560|NCT03852316|520827343|FG000|Overall Study|Protocol Violation|1|||
144444561|NCT03852316|520827343|FG000|Overall Study|Withdrawal by Subject|2|||
144444562|NCT03852316|520827343|FG000|Overall Study|Enrolled but Device not Utilized|1|||
144444563|NCT00529386|520827346|FG000|Overall Study|Lost to Follow-up|1|||
144444564|NCT04532112|520827347|FG000|Overall Study|Adverse Event|3|||
144444565|NCT04532112|520827348|FG001|Overall Study|Adverse Event|0|||
144444566|NCT03592641|520827349|FG000|Overall Study|Withdrawal by Subject|1|||
144444567|NCT00436280|520827350|FG000|Period 1: Induction|Adverse Event|8|||
144444568|NCT00436280|520827350|FG000|Period 1: Induction|Progressive Disease|12|||
144444569|NCT00436280|520827350|FG000|Period 1: Induction|Stable Disease|6|||
144444570|NCT00436280|520827350|FG000|Period 1: Induction|Withdrawal by Subject|1|||
144444571|NCT00436280|520827350|FG000|Period 1: Induction|Death|1|||
144444572|NCT00436280|520827350|FG000|Period 2: Consolidation|Adverse Event|1|||
144444573|NCT00436280|520827350|FG000|Period 2: Consolidation|Progressive Disease|10|||
144444574|NCT00436280|520827350|FG000|Period 2: Consolidation|Stable Disease|1|||
144444575|NCT00436280|520827350|FG000|Period 2: Consolidation|Physician Decision|2|||
144444576|NCT00436280|520827350|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
144444577|NCT00436280|520827350|FG000|Period 2: Consolidation|Death|1|||
144444578|NCT00436280|520827350|FG000|Period 3: Maintenance|Adverse Event|6|||
144444579|NCT00436280|520827350|FG000|Period 3: Maintenance|Progressive Disease|12|||
144444580|NCT02039427|520827355|FG000|Overall Study|Duration of surgery > 3h|1|||
144444581|NCT02039427|520827356|FG001|Overall Study|Duration of surgery > 3h|1|||
144444582|NCT02039427|520827357|FG002|Overall Study|Duration of surgery > 3h|0|||
144444583|NCT02039427|520827358|FG003|Overall Study|Duration of surgery > 3h|0|||
144444584|NCT02039427|520827355|FG000|Overall Study|Withdrawal on concent|0|||
144444585|NCT02039427|520827356|FG001|Overall Study|Withdrawal on concent|0|||
144444586|NCT02039427|520827357|FG002|Overall Study|Withdrawal on concent|0|||
144444587|NCT02039427|520827358|FG003|Overall Study|Withdrawal on concent|1|||
144444588|NCT02039427|520827355|FG000|Overall Study|Cancellation of surgery|0|||
144444589|NCT02039427|520827356|FG001|Overall Study|Cancellation of surgery|0|||
144444590|NCT02039427|520827357|FG002|Overall Study|Cancellation of surgery|1|||
144444591|NCT02039427|520827358|FG003|Overall Study|Cancellation of surgery|0|||
144444592|NCT02039427|520827355|FG000|Overall Study|Loss of follow - up|1|||
144444593|NCT02039427|520827356|FG001|Overall Study|Loss of follow - up|0|||
144444594|NCT02039427|520827357|FG002|Overall Study|Loss of follow - up|2|||
144444595|NCT02039427|520827358|FG003|Overall Study|Loss of follow - up|4|||
144444596|NCT02039427|520827355|FG000|Overall Study|Steroid Use|1|||
144444597|NCT02039427|520827356|FG001|Overall Study|Steroid Use|0|||
144532572|NCT03536884|521154275|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
144532573|NCT03536884|521154276|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144193271|NCT01939496|519902761|FG000|Overall Study|Protocol Violation|3|||
144193272|NCT01939496|519902762|FG001|Overall Study|Protocol Violation|0|||
144444598|NCT02039427|520827357|FG002|Overall Study|Steroid Use|0|||
144444599|NCT02039427|520827358|FG003|Overall Study|Steroid Use|0|||
144444600|NCT00844545|520827359|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
144444601|NCT00844545|520827359|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
144444602|NCT00844545|520827359|FG000|Extension Treatment Period|Adverse Event|2|||
144444603|NCT00844545|520827359|FG000|Post Treatment Period|Withdrawal by Subject|1|||
144444604|NCT01532687|520827366|FG000|Overall Study|Death|2|||
144193273|NCT01939496|519902763|FG002|Overall Study|Protocol Violation|0|||
144193274|NCT01939496|519902761|FG000|Overall Study|Withdrawal by Subject|0|||
144193275|NCT01939496|519902762|FG001|Overall Study|Withdrawal by Subject|1|||
144444605|NCT01532687|520827367|FG001|Overall Study|Death|0|||
144444606|NCT01532687|520827366|FG000|Overall Study|Adverse Event|6|||
144444607|NCT01532687|520827367|FG001|Overall Study|Adverse Event|1|||
144444608|NCT01532687|520827366|FG000|Overall Study|Withdrawal by Subject|1|||
144444609|NCT01532687|520827367|FG001|Overall Study|Withdrawal by Subject|0|||
144444610|NCT01532687|520827366|FG000|Overall Study|Physician Decision|2|||
144193276|NCT01939496|519902763|FG002|Overall Study|Withdrawal by Subject|1|||
144193277|NCT01939496|519902761|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
144193278|NCT01939496|519902762|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
144193279|NCT01939496|519902763|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
144193280|NCT01939496|519902761|FG000|Overall Study|Other|2|||
144193281|NCT01939496|519902762|FG001|Overall Study|Other|0|||
144193282|NCT01939496|519902763|FG002|Overall Study|Other|1|||
144193283|NCT00645944|519902767|FG000|Randomized|Withdrawal by Subject|1|||
144193284|NCT00645944|519902768|FG001|Randomized|Withdrawal by Subject|2|||
144193285|NCT00645944|519902767|FG000|Received Medication|Adverse Event|2|||
144193286|NCT00645944|519902768|FG001|Received Medication|Adverse Event|1|||
144193287|NCT00645944|519902767|FG000|Received Medication|Withdrawal by Subject|1|||
144193288|NCT00645944|519902768|FG001|Received Medication|Withdrawal by Subject|1|||
144193289|NCT00645944|519902767|FG000|Received Medication|Lost to Follow-up|1|||
144193290|NCT00645944|519902768|FG001|Received Medication|Lost to Follow-up|0|||
144193291|NCT00645944|519902767|FG000|Received Medication|Protocol Violation|2|||
144193292|NCT00645944|519902768|FG001|Received Medication|Protocol Violation|1|||
144193293|NCT02377063|519902772|FG000|Overall Study|Non-compliance|5|||
144193294|NCT01524913|519902776|FG000|Overall Study|Lost to Follow-up|4|||
144193295|NCT01524913|519902777|FG001|Overall Study|Lost to Follow-up|0|||
144193296|NCT01524913|519902778|FG002|Overall Study|Lost to Follow-up|0|||
144193297|NCT00702208|519902779|FG000|Overall Study|Lost to Follow-up|28|||
144193298|NCT00702208|519902779|FG000|Overall Study|Did not self-lavage|1|||
144193299|NCT00702208|519902779|FG000|Overall Study|Unsatisfactory colposcopy|2|||
144193300|NCT02149121|519902782|FG000|Main Study Period|Lack of Efficacy|2|||
144193301|NCT02149121|519902783|FG001|Main Study Period|Lack of Efficacy|2|||
144193302|NCT02149121|519902784|FG002|Main Study Period|Lack of Efficacy|1|||
144193303|NCT02149121|519902785|FG003|Main Study Period|Lack of Efficacy|0|||
144193304|NCT02149121|519902786|FG004|Main Study Period|Lack of Efficacy|0|||
144193305|NCT02149121|519902787|FG005|Main Study Period|Lack of Efficacy|0|||
144193306|NCT02149121|519902788|FG006|Main Study Period|Lack of Efficacy|0|||
144193307|NCT02149121|519902782|FG000|Main Study Period|Withdrawal by Subject|9|||
144193308|NCT02149121|519902783|FG001|Main Study Period|Withdrawal by Subject|5|||
144193309|NCT02149121|519902784|FG002|Main Study Period|Withdrawal by Subject|1|||
144193310|NCT02149121|519902785|FG003|Main Study Period|Withdrawal by Subject|0|||
144193311|NCT02149121|519902786|FG004|Main Study Period|Withdrawal by Subject|0|||
144193312|NCT02149121|519902787|FG005|Main Study Period|Withdrawal by Subject|0|||
144193313|NCT02149121|519902788|FG006|Main Study Period|Withdrawal by Subject|0|||
144193314|NCT02149121|519902782|FG000|Main Study Period|Adverse Event|2|||
144193315|NCT02149121|519902783|FG001|Main Study Period|Adverse Event|5|||
144193316|NCT02149121|519902784|FG002|Main Study Period|Adverse Event|1|||
144193317|NCT02149121|519902785|FG003|Main Study Period|Adverse Event|0|||
144193318|NCT02149121|519902786|FG004|Main Study Period|Adverse Event|0|||
144193319|NCT02149121|519902787|FG005|Main Study Period|Adverse Event|0|||
144193320|NCT02149121|519902788|FG006|Main Study Period|Adverse Event|0|||
144193321|NCT02149121|519902782|FG000|Main Study Period|Protocol Violation|2|||
144193322|NCT02149121|519902783|FG001|Main Study Period|Protocol Violation|0|||
144193323|NCT02149121|519902784|FG002|Main Study Period|Protocol Violation|0|||
144193324|NCT02149121|519902785|FG003|Main Study Period|Protocol Violation|0|||
144193325|NCT02149121|519902786|FG004|Main Study Period|Protocol Violation|0|||
144444611|NCT01532687|520827367|FG001|Overall Study|Physician Decision|1|||
144444612|NCT01532687|520827366|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
144444613|NCT01532687|520827367|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
144444614|NCT00403455|520827368|FG000|Overall Study|Withdrawal by Subject|1|||
144193326|NCT02149121|519902787|FG005|Main Study Period|Protocol Violation|0|||
144193327|NCT02149121|519902788|FG006|Main Study Period|Protocol Violation|0|||
144193328|NCT02149121|519902782|FG000|Main Study Period|Lost to Follow-up|2|||
144193329|NCT02149121|519902783|FG001|Main Study Period|Lost to Follow-up|1|||
144193330|NCT02149121|519902784|FG002|Main Study Period|Lost to Follow-up|0|||
144193331|NCT02149121|519902785|FG003|Main Study Period|Lost to Follow-up|0|||
144193332|NCT02149121|519902786|FG004|Main Study Period|Lost to Follow-up|0|||
144444615|NCT03160703|520827369|FG000|Overall Study|Withdrawal by Subject|0|||
144193333|NCT02149121|519902787|FG005|Main Study Period|Lost to Follow-up|0|||
144193334|NCT02149121|519902788|FG006|Main Study Period|Lost to Follow-up|0|||
144193335|NCT02149121|519902782|FG000|Main Study Period|Death|1|||
144193336|NCT02149121|519902783|FG001|Main Study Period|Death|0|||
144193337|NCT02149121|519902784|FG002|Main Study Period|Death|0|||
144444616|NCT03160703|520827370|FG001|Overall Study|Withdrawal by Subject|0|||
144444617|NCT03160703|520827371|FG002|Overall Study|Withdrawal by Subject|0|||
144444618|NCT03160703|520827372|FG003|Overall Study|Withdrawal by Subject|1|||
144444619|NCT00226941|520827379|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
144444620|NCT00226941|520827380|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
144193338|NCT02149121|519902785|FG003|Main Study Period|Death|0|||
144193339|NCT02149121|519902786|FG004|Main Study Period|Death|0|||
144193340|NCT02149121|519902787|FG005|Main Study Period|Death|0|||
144193341|NCT02149121|519902788|FG006|Main Study Period|Death|0|||
144193342|NCT02149121|519902782|FG000|Main Study Period|Physician Decision|1|||
144193343|NCT02149121|519902783|FG001|Main Study Period|Physician Decision|0|||
144193344|NCT02149121|519902784|FG002|Main Study Period|Physician Decision|0|||
144193345|NCT02149121|519902785|FG003|Main Study Period|Physician Decision|0|||
144193346|NCT02149121|519902786|FG004|Main Study Period|Physician Decision|0|||
144193347|NCT02149121|519902787|FG005|Main Study Period|Physician Decision|0|||
144193348|NCT02149121|519902788|FG006|Main Study Period|Physician Decision|0|||
144193349|NCT02149121|519902782|FG000|Main Study Period|Developed any malignancy|0|||
144193350|NCT02149121|519902783|FG001|Main Study Period|Developed any malignancy|1|||
144193351|NCT02149121|519902784|FG002|Main Study Period|Developed any malignancy|1|||
144193352|NCT02149121|519902785|FG003|Main Study Period|Developed any malignancy|0|||
144193353|NCT02149121|519902786|FG004|Main Study Period|Developed any malignancy|0|||
144193354|NCT02149121|519902787|FG005|Main Study Period|Developed any malignancy|0|||
144193355|NCT02149121|519902788|FG006|Main Study Period|Developed any malignancy|0|||
144193356|NCT02149121|519902782|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
144193357|NCT02149121|519902783|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
144193358|NCT02149121|519902784|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
144193359|NCT02149121|519902785|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
144193360|NCT02149121|519902786|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
144193361|NCT02149121|519902787|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
144193362|NCT02149121|519902788|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
144193363|NCT02149121|519902782|FG000|Main Study Period|Disease progression|0|||
144193364|NCT02149121|519902783|FG001|Main Study Period|Disease progression|1|||
144193365|NCT02149121|519902784|FG002|Main Study Period|Disease progression|0|||
144193366|NCT02149121|519902785|FG003|Main Study Period|Disease progression|0|||
144193367|NCT02149121|519902786|FG004|Main Study Period|Disease progression|0|||
144193368|NCT02149121|519902787|FG005|Main Study Period|Disease progression|0|||
144193369|NCT02149121|519902788|FG006|Main Study Period|Disease progression|0|||
144193370|NCT02149121|519902782|FG000|Extension Study Period|Withdrawal by Subject|0|||
144193371|NCT02149121|519902783|FG001|Extension Study Period|Withdrawal by Subject|0|||
144193372|NCT02149121|519902784|FG002|Extension Study Period|Withdrawal by Subject|0|||
144193373|NCT02149121|519902785|FG003|Extension Study Period|Withdrawal by Subject|1|||
144193374|NCT02149121|519902786|FG004|Extension Study Period|Withdrawal by Subject|0|||
144193375|NCT02149121|519902787|FG005|Extension Study Period|Withdrawal by Subject|2|||
144193376|NCT02149121|519902788|FG006|Extension Study Period|Withdrawal by Subject|0|||
144193377|NCT02427984|519902789|FG000|Overall Study|Lost to Follow-up|13|||
144193378|NCT02427984|519902790|FG001|Overall Study|Lost to Follow-up|5|||
144193379|NCT02427984|519902791|FG002|Overall Study|Lost to Follow-up|18|||
144193380|NCT05626803|519904972|FG000|Overall Study|Lost to Follow-up|0|||
144193381|NCT05626803|519904973|FG001|Overall Study|Lost to Follow-up|1|||
144193382|NCT05626803|519904974|FG002|Overall Study|Lost to Follow-up|0|||
144193383|NCT05626803|519904975|FG003|Overall Study|Lost to Follow-up|0|||
144193384|NCT01010126|519904976|FG000|Overall Study|Withdrawal by Subject|1|||
144193385|NCT01010126|519904977|FG001|Overall Study|Withdrawal by Subject|0|||
144193386|NCT01010126|519904978|FG002|Overall Study|Withdrawal by Subject|1|||
144193387|NCT01010126|519904979|FG003|Overall Study|Withdrawal by Subject|0|||
144193388|NCT01010126|519904980|FG004|Overall Study|Withdrawal by Subject|3|||
144193389|NCT01010126|519904981|FG005|Overall Study|Withdrawal by Subject|0|||
144193390|NCT00493246|519904982|FG000|Overall Study|Withdrawal by Subject|0|||
144193391|NCT00493246|519904983|FG001|Overall Study|Withdrawal by Subject|0|||
144193392|NCT00493246|519904984|FG002|Overall Study|Withdrawal by Subject|0|||
144193393|NCT00493246|519904985|FG003|Overall Study|Withdrawal by Subject|0|||
144193394|NCT00493246|519904986|FG004|Overall Study|Withdrawal by Subject|1|||
144193395|NCT00493246|519904987|FG005|Overall Study|Withdrawal by Subject|0|||
144193396|NCT00493246|519904988|FG006|Overall Study|Withdrawal by Subject|0|||
144444621|NCT00226941|520827381|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
144444622|NCT00226941|520827382|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
144444623|NCT00226941|520827379|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
144193397|NCT00493246|519904989|FG007|Overall Study|Withdrawal by Subject|0|||
144444624|NCT00226941|520827380|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
144725197|NCT05771428|521851194|FG000|Overall Study|Other|0|||
144193398|NCT00493246|519904982|FG000|Overall Study|No access to draw blood|0|||
144193399|NCT00493246|519904983|FG001|Overall Study|No access to draw blood|0|||
144193400|NCT00493246|519904984|FG002|Overall Study|No access to draw blood|0|||
144193401|NCT00493246|519904985|FG003|Overall Study|No access to draw blood|0|||
144193402|NCT00493246|519904986|FG004|Overall Study|No access to draw blood|0|||
144444625|NCT00226941|520827381|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
144444626|NCT00226941|520827382|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
144444627|NCT01513291|520827383|FG000|Treatment Period|Adverse Event|8|||
144444628|NCT01513291|520827384|FG001|Treatment Period|Adverse Event|4|||
144444629|NCT01513291|520827385|FG002|Treatment Period|Adverse Event|0|||
144444630|NCT01513291|520827386|FG003|Treatment Period|Adverse Event|0|||
144444631|NCT01513291|520827387|FG004|Treatment Period|Adverse Event|0|||
144444632|NCT01513291|520827383|FG000|Treatment Period|Lack of Efficacy|3|||
144444633|NCT01513291|520827384|FG001|Treatment Period|Lack of Efficacy|0|||
144444634|NCT01513291|520827385|FG002|Treatment Period|Lack of Efficacy|0|||
144444635|NCT01513291|520827386|FG003|Treatment Period|Lack of Efficacy|0|||
144444636|NCT01513291|520827387|FG004|Treatment Period|Lack of Efficacy|0|||
144444637|NCT01513291|520827383|FG000|Treatment Period|Lost to Follow-up|2|||
144444638|NCT01513291|520827384|FG001|Treatment Period|Lost to Follow-up|3|||
144444639|NCT01513291|520827385|FG002|Treatment Period|Lost to Follow-up|0|||
144444640|NCT01513291|520827386|FG003|Treatment Period|Lost to Follow-up|0|||
144444641|NCT01513291|520827387|FG004|Treatment Period|Lost to Follow-up|0|||
144444642|NCT01513291|520827383|FG000|Treatment Period|Physician Decision|1|||
144444643|NCT01513291|520827384|FG001|Treatment Period|Physician Decision|0|||
144444644|NCT01513291|520827385|FG002|Treatment Period|Physician Decision|0|||
144444645|NCT01513291|520827386|FG003|Treatment Period|Physician Decision|0|||
144193403|NCT00493246|519904987|FG005|Overall Study|No access to draw blood|1|||
144193404|NCT00493246|519904988|FG006|Overall Study|No access to draw blood|0|||
144193405|NCT00493246|519904989|FG007|Overall Study|No access to draw blood|0|||
144193406|NCT00493246|519904982|FG000|Overall Study|Lost to Follow-up|0|||
144193407|NCT00493246|519904983|FG001|Overall Study|Lost to Follow-up|0|||
144193408|NCT00493246|519904984|FG002|Overall Study|Lost to Follow-up|0|||
144193409|NCT00493246|519904985|FG003|Overall Study|Lost to Follow-up|0|||
144193410|NCT00493246|519904986|FG004|Overall Study|Lost to Follow-up|0|||
144193411|NCT00493246|519904987|FG005|Overall Study|Lost to Follow-up|0|||
144193412|NCT00493246|519904988|FG006|Overall Study|Lost to Follow-up|1|||
144193413|NCT00493246|519904989|FG007|Overall Study|Lost to Follow-up|0|||
144193414|NCT02698865|519904990|FG000|Overall Study|Other|11|||
144193415|NCT02698865|519904991|FG001|Overall Study|Other|11|||
144193416|NCT02698865|519904990|FG000|Overall Study|Withdrawal by Subject|20|||
144193417|NCT02698865|519904991|FG001|Overall Study|Withdrawal by Subject|16|||
144193418|NCT02698865|519904990|FG000|Overall Study|Physician Decision|0|||
144193419|NCT02698865|519904991|FG001|Overall Study|Physician Decision|4|||
144193420|NCT02698865|519904990|FG000|Overall Study|Lost to Follow-up|4|||
144193421|NCT02698865|519904991|FG001|Overall Study|Lost to Follow-up|2|||
144193422|NCT03861481|519904994|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
144193423|NCT03861481|519904995|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
144193424|NCT03861481|519904994|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
144193425|NCT03861481|519904995|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
144193426|NCT03861481|519904994|FG000|Overall Study|Relapse|1|||
144193427|NCT03861481|519904995|FG001|Overall Study|Relapse|0|||
144193428|NCT03861481|519904994|FG000|Overall Study|Withdrawal by Subject|0|||
144193429|NCT03861481|519904995|FG001|Overall Study|Withdrawal by Subject|1|||
144193430|NCT03861481|519904994|FG000|Overall Study|Lack of Efficacy|4|||
144193431|NCT03861481|519904995|FG001|Overall Study|Lack of Efficacy|5|||
144193432|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
144193433|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
144193434|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
144193435|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
144444646|NCT01513291|520827387|FG004|Treatment Period|Physician Decision|0|||
144444647|NCT01513291|520827383|FG000|Treatment Period|Protocol Violation|1|||
144444648|NCT01513291|520827384|FG001|Treatment Period|Protocol Violation|2|||
144444649|NCT01513291|520827385|FG002|Treatment Period|Protocol Violation|0|||
144444650|NCT01513291|520827386|FG003|Treatment Period|Protocol Violation|0|||
144444651|NCT01513291|520827387|FG004|Treatment Period|Protocol Violation|0|||
144532574|NCT03536884|521154277|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532575|NCT03536884|521154278|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532576|NCT03536884|521154279|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144193436|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
144444652|NCT01513291|520827383|FG000|Treatment Period|Withdrawal by Subject|8|||
144193437|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
144444653|NCT01513291|520827384|FG001|Treatment Period|Withdrawal by Subject|5|||
144444654|NCT01513291|520827385|FG002|Treatment Period|Withdrawal by Subject|0|||
144444655|NCT01513291|520827386|FG003|Treatment Period|Withdrawal by Subject|0|||
144444656|NCT01513291|520827387|FG004|Treatment Period|Withdrawal by Subject|0|||
144193438|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
144193439|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
144193440|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
144199347|NCT00394524|519928876|FG001|Overall Study|Protocol Violation|3|||
144444657|NCT01513291|520827383|FG000|Treatment Period|Randomized not treated|0|||
144444658|NCT01513291|520827384|FG001|Treatment Period|Randomized not treated|2|||
144444659|NCT01513291|520827385|FG002|Treatment Period|Randomized not treated|0|||
144444660|NCT01513291|520827386|FG003|Treatment Period|Randomized not treated|0|||
144444661|NCT01513291|520827387|FG004|Treatment Period|Randomized not treated|0|||
144193441|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
144193442|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
144193443|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
144193444|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
144193445|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
144193446|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
144193447|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
144193448|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
144193449|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
144193450|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
144193451|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
144193452|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
144193453|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
144193454|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
144193455|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
144193456|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
144193457|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
144193458|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
144193459|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
144193460|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
144193461|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
144193462|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
144193463|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
144193464|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
144193465|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
144193466|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
144193467|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
144193468|NCT00773734|519904996|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
144193469|NCT00773734|519904997|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
144193470|NCT00773734|519904998|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
144193471|NCT00773734|519904999|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
144193472|NCT00773734|519905000|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
144193473|NCT00773734|519905001|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
144193474|NCT00773734|519904996|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
144193475|NCT00773734|519904997|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
144193476|NCT00773734|519904998|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
144193477|NCT00773734|519904999|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
144193478|NCT00773734|519905000|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
144193479|NCT00773734|519905001|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
144193480|NCT00773734|519904996|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
144193481|NCT00773734|519904997|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
144193482|NCT00773734|519904998|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
144193483|NCT00773734|519904999|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
144193484|NCT00773734|519905000|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
144193485|NCT00773734|519905001|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
144193486|NCT00773734|519904996|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
144193487|NCT00773734|519904997|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
144193488|NCT00773734|519904998|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
144193489|NCT00773734|519904999|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
144193490|NCT00773734|519905000|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
144193491|NCT00773734|519905001|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
144193492|NCT00773734|519904996|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
144193493|NCT00773734|519904997|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
144193494|NCT00773734|519904998|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
144193495|NCT00773734|519904999|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
144193496|NCT00773734|519905000|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
144444662|NCT01513291|520827383|FG000|Run-out Period|Lost to Follow-up|0|||
144193497|NCT00773734|519905001|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
144193498|NCT00773734|519904996|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
144199348|NCT00394524|519928875|FG000|Overall Study|Death|1|||
144199349|NCT00394524|519928876|FG001|Overall Study|Death|0|||
144199350|NCT00394524|519928875|FG000|Overall Study|Withdrawal by Subject|0|||
144193499|NCT00773734|519904997|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
144193500|NCT00773734|519904998|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
144193501|NCT00773734|519904999|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
144193502|NCT00773734|519905000|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
144193503|NCT00773734|519905001|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
144193504|NCT00773734|519904996|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
144193505|NCT00773734|519904997|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
144193506|NCT00773734|519904998|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
144193507|NCT00773734|519904999|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
144193508|NCT00773734|519905000|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
144193509|NCT00773734|519905001|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
144193510|NCT00773734|519904996|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
144193511|NCT00773734|519904997|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
144193512|NCT00773734|519904998|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
144193513|NCT00773734|519904999|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
144193514|NCT00773734|519905000|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
144193515|NCT00773734|519905001|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
144193516|NCT00773734|519904996|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
144193517|NCT00773734|519904997|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
144193518|NCT00773734|519904998|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
144193519|NCT00773734|519904999|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
144193520|NCT00773734|519905000|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
144193521|NCT00773734|519905001|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
144193522|NCT00773734|519904996|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
144193523|NCT00773734|519904997|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
144193524|NCT00773734|519904998|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
144193525|NCT00773734|519904999|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
144193526|NCT00773734|519905000|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
144193527|NCT00773734|519905001|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
144193528|NCT00773734|519904996|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
144193529|NCT00773734|519904997|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
144193530|NCT00773734|519904998|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
144193531|NCT00773734|519904999|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
144444663|NCT01513291|520827384|FG001|Run-out Period|Lost to Follow-up|0|||
144444664|NCT01513291|520827385|FG002|Run-out Period|Lost to Follow-up|0|||
144444665|NCT01513291|520827386|FG003|Run-out Period|Lost to Follow-up|1|||
144444666|NCT01513291|520827387|FG004|Run-out Period|Lost to Follow-up|0|||
144444667|NCT01513291|520827383|FG000|Run-out Period|Withdrawal by Subject|0|||
144444668|NCT01513291|520827384|FG001|Run-out Period|Withdrawal by Subject|0|||
144444669|NCT01513291|520827385|FG002|Run-out Period|Withdrawal by Subject|0|||
144444670|NCT01513291|520827386|FG003|Run-out Period|Withdrawal by Subject|1|||
144444671|NCT01513291|520827387|FG004|Run-out Period|Withdrawal by Subject|0|||
144444672|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
144444673|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
144444674|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
144444675|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
144444676|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
144444677|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
144444678|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
144444679|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
144444680|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
144444681|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
144444682|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
144444683|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
144444684|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
144444685|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
144444686|NCT03732638|520827388|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
144725198|NCT05771428|521851195|FG001|Overall Study|Other|1|||
144725199|NCT05771428|521851196|FG002|Overall Study|Other|2|||
144193532|NCT00773734|519905000|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
144193533|NCT00773734|519905001|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
144193534|NCT00773734|519904996|FG000|Extension: Active Treatment Week 24-52|Other|0|||
144444687|NCT03732638|520827389|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
144444688|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
144444689|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
144444690|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
144444691|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
144444692|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
144444693|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
144444694|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
144444695|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
144444696|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
144444697|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
144444698|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
144444699|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
144444700|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
144444701|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
144444702|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
144444703|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
144444704|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
144444705|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
144444706|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
144444707|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
144444708|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
144444709|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
144444710|NCT03732638|520827388|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
144444711|NCT03732638|520827389|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
144444712|NCT03732638|520827388|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
144444713|NCT03732638|520827389|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
144444714|NCT03732638|520827388|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
144444715|NCT03732638|520827389|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
144444716|NCT03732638|520827388|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
144444717|NCT03732638|520827389|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
144444718|NCT03732638|520827388|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
144444719|NCT03732638|520827389|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
144444720|NCT01358981|520827390|FG000|Period 1|Withdrawal by Subject|0|||
144444721|NCT01358981|520827391|FG001|Period 1|Withdrawal by Subject|0|||
144444722|NCT01358981|520827392|FG002|Period 1|Withdrawal by Subject|0|||
144444723|NCT01358981|520827393|FG003|Period 1|Withdrawal by Subject|1|||
144444724|NCT01358981|520827394|FG004|Period 1|Withdrawal by Subject|0|||
144444725|NCT01358981|520827395|FG005|Period 1|Withdrawal by Subject|0|||
144444726|NCT01358981|520827396|FG006|Period 1|Withdrawal by Subject|0|||
144444727|NCT04354831|520827397|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
144444728|NCT04354831|520827398|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
144444729|NCT03728582|520827399|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
144444730|NCT03728582|520827400|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
144444731|NCT03728582|520827399|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
144444732|NCT03728582|520827400|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
144444733|NCT02732847|520827401|FG000|Overall Study|some filled early|42|||
144444734|NCT02732847|520827402|FG001|Overall Study|some filled early|42|||
144444735|NCT01018264|520827403|FG000|Overall Study|Withdrawal by Subject|1|||
144444736|NCT01018264|520827404|FG001|Overall Study|Withdrawal by Subject|0|||
144532577|NCT03536884|521154280|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532578|NCT03536884|521154281|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532579|NCT03536884|521154282|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532580|NCT03536884|521154283|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532581|NCT03536884|521154284|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532582|NCT03536884|521154285|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
144532583|NCT03536884|521154274|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
144532584|NCT03536884|521154275|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
144532585|NCT03536884|521154276|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532586|NCT03536884|521154277|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532587|NCT03536884|521154278|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532588|NCT03536884|521154279|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532589|NCT03536884|521154280|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532590|NCT03536884|521154281|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532591|NCT03536884|521154282|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532592|NCT03536884|521154283|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144606152|NCT01576172|521419040|FG000|Overall Study|Withdrawal by Subject|2|||
144606153|NCT01576172|521419041|FG001|Overall Study|Withdrawal by Subject|0|||
144444737|NCT01018264|520827403|FG000|Overall Study|Lost to Follow-up|0|||
144444738|NCT01018264|520827404|FG001|Overall Study|Lost to Follow-up|1|||
144444739|NCT01252290|520827408|FG000|Overall Study|Withdrawal by Subject|1|||
144444740|NCT02075437|520827409|FG000|Overall Study|Withdrawal by Subject|5|||
144444741|NCT02075437|520827409|FG000|Overall Study|Lost to Follow-up|1|||
144444742|NCT04439240|520827410|FG000|Overall Study|Ineligible|2|||
144532593|NCT03536884|521154284|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144193535|NCT00773734|519904997|FG001|Extension: Active Treatment Week 24-52|Other|0|||
144193536|NCT00773734|519904998|FG002|Extension: Active Treatment Week 24-52|Other|1|||
144444743|NCT04439240|520827410|FG000|Overall Study|Never started treatment|2|||
144444744|NCT04439240|520827410|FG000|Overall Study|Adverse Event|12|||
144444745|NCT04439240|520827410|FG000|Overall Study|Death|2|||
144444746|NCT04439240|520827410|FG000|Overall Study|Disease progression|25|||
144444747|NCT04439240|520827410|FG000|Overall Study|Other diseases|2|||
144444748|NCT04439240|520827410|FG000|Overall Study|Withdrawal by Subject|3|||
144444749|NCT04439240|520827410|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
144444750|NCT04439240|520827410|FG000|Overall Study|Symptomatic decline|1|||
144444751|NCT04439240|520827410|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
144444752|NCT04439240|520827410|FG000|Overall Study|Clinical progression|1|||
144444753|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
144444754|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
144444755|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
144444756|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
144444757|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
144444758|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
144444759|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
144444760|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
144444761|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
144444762|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
144444763|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
144444764|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
144193537|NCT00773734|519904999|FG003|Extension: Active Treatment Week 24-52|Other|2|||
144193538|NCT00773734|519905000|FG004|Extension: Active Treatment Week 24-52|Other|0|||
144444765|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
144444766|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
144444767|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
144444768|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
144444769|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
144444770|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
144444771|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
144444772|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
144444773|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
144444774|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
144444775|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
144444776|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
144193539|NCT00773734|519905001|FG005|Extension: Active Treatment Week 24-52|Other|1|||
144444777|NCT04542070|520827411|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
144444778|NCT04542070|520827412|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
144444779|NCT04542070|520827413|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
144444780|NCT04542070|520827414|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
144444781|NCT04542070|520827411|FG000|Maintenance + Extension Period|Adverse Event|10|||
144444782|NCT04542070|520827412|FG001|Maintenance + Extension Period|Adverse Event|2|||
144444783|NCT04542070|520827413|FG002|Maintenance + Extension Period|Adverse Event|0|||
144444784|NCT04542070|520827414|FG003|Maintenance + Extension Period|Adverse Event|0|||
144444785|NCT04542070|520827411|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
144444786|NCT04542070|520827412|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
144444787|NCT04542070|520827413|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
144444788|NCT04542070|520827414|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
144444789|NCT04542070|520827411|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
144444790|NCT04542070|520827412|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
144444791|NCT04542070|520827413|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
144444792|NCT04542070|520827414|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
144444793|NCT04542070|520827411|FG000|Maintenance + Extension Period|Physician Decision|1|||
144444794|NCT04542070|520827412|FG001|Maintenance + Extension Period|Physician Decision|1|||
144444795|NCT04542070|520827413|FG002|Maintenance + Extension Period|Physician Decision|0|||
144444796|NCT04542070|520827414|FG003|Maintenance + Extension Period|Physician Decision|0|||
144444797|NCT04542070|520827411|FG000|Maintenance + Extension Period|Protocol Violation|2|||
144444798|NCT04542070|520827412|FG001|Maintenance + Extension Period|Protocol Violation|5|||
144444799|NCT04542070|520827413|FG002|Maintenance + Extension Period|Protocol Violation|0|||
144444800|NCT04542070|520827414|FG003|Maintenance + Extension Period|Protocol Violation|0|||
144444801|NCT04542070|520827411|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
144444802|NCT04542070|520827412|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
144444803|NCT04542070|520827413|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
144725200|NCT05771428|521851197|FG003|Overall Study|Other|1|||
144532594|NCT03536884|521154285|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
144532595|NCT03536884|521154274|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532596|NCT03536884|521154275|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
144532597|NCT03536884|521154276|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532598|NCT03536884|521154277|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532599|NCT03536884|521154278|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532600|NCT03536884|521154279|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532601|NCT03536884|521154280|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532602|NCT03536884|521154281|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532603|NCT03536884|521154282|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532604|NCT03536884|521154283|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532605|NCT03536884|521154284|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532606|NCT03536884|521154285|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
144532607|NCT03536884|521154274|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532608|NCT03536884|521154275|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
144532609|NCT03536884|521154276|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532610|NCT03536884|521154277|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532611|NCT03536884|521154278|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532612|NCT03536884|521154279|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532613|NCT03536884|521154280|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532614|NCT03536884|521154281|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532615|NCT03536884|521154282|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532616|NCT03536884|521154283|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532617|NCT03536884|521154284|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532618|NCT03536884|521154285|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
144532619|NCT03536884|521154274|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532620|NCT03536884|521154275|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
144532621|NCT03536884|521154276|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532622|NCT03536884|521154277|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532623|NCT03536884|521154278|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532624|NCT03536884|521154279|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532625|NCT03536884|521154280|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532626|NCT03536884|521154281|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532627|NCT03536884|521154282|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532628|NCT03536884|521154283|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532629|NCT03536884|521154284|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532630|NCT03536884|521154285|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
144532631|NCT03536884|521154274|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532632|NCT03536884|521154275|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532633|NCT03536884|521154276|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
144532634|NCT03536884|521154277|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532635|NCT03536884|521154278|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
144532636|NCT03536884|521154279|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532637|NCT03536884|521154280|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532638|NCT03536884|521154281|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532639|NCT03536884|521154282|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532640|NCT03536884|521154283|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532641|NCT03536884|521154284|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532642|NCT03536884|521154285|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
144532643|NCT03536884|521154274|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532644|NCT03536884|521154275|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532645|NCT03536884|521154276|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
144532646|NCT03536884|521154277|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
144532647|NCT03536884|521154278|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
144532648|NCT03536884|521154279|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532649|NCT03536884|521154280|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532650|NCT03536884|521154281|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532651|NCT03536884|521154282|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532652|NCT03536884|521154283|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144606154|NCT01576172|521419040|FG000|Overall Study|Insurance issue|1|||
144606155|NCT01576172|521419041|FG001|Overall Study|Insurance issue|0|||
144606156|NCT00239226|521419046|FG000|Overall Study|permAF during stabilization period|0|||
144606157|NCT00239226|521419047|FG001|Overall Study|permAF during stabilization period|0|||
144444804|NCT04542070|520827414|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
144193540|NCT00773734|519904996|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
144193541|NCT00773734|519904997|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
144193542|NCT00773734|519904998|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
144193543|NCT00773734|519904999|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
144444805|NCT04542070|520827411|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
144444806|NCT04542070|520827412|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
144444807|NCT04542070|520827413|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
144444808|NCT04542070|520827414|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
144193544|NCT00773734|519905000|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
144193545|NCT00773734|519905001|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
144193546|NCT00773734|519904996|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
144193547|NCT00773734|519904997|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
144193548|NCT00773734|519904998|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
144193549|NCT00773734|519904999|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
144193550|NCT00773734|519905000|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
144193551|NCT00773734|519905001|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
144193552|NCT00773734|519904996|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
144193553|NCT00773734|519904997|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
144193554|NCT00773734|519904998|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
144193555|NCT00773734|519904999|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
144193556|NCT00773734|519905000|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
144193557|NCT00773734|519905001|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
144193558|NCT00773734|519904996|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
144193559|NCT00773734|519904997|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
144193560|NCT00773734|519904998|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
144193561|NCT00773734|519904999|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
144193562|NCT00773734|519905000|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
144193563|NCT00773734|519905001|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
144193564|NCT02148913|519905002|FG000|Overall Study|Death|0|||
144193565|NCT02148913|519905003|FG001|Overall Study|Death|1|||
144193566|NCT02148913|519905004|FG002|Overall Study|Death|0|||
144193567|NCT02148913|519905005|FG003|Overall Study|Death|0|||
144193568|NCT00468728|519905006|FG000|Treatment|criteria for mITT population|4|||
144193569|NCT00468728|519905007|FG001|Treatment|criteria for mITT population|11|||
144193570|NCT00468728|519905006|FG000|Follow-up|mITT failure|34|||
144193571|NCT00468728|519905007|FG001|Follow-up|mITT failure|31|||
144193572|NCT01642914|519905008|FG000|Overall Study|Adverse Event|11|||
144193573|NCT01642914|519905009|FG001|Overall Study|Adverse Event|7|||
144193574|NCT01642914|519905010|FG002|Overall Study|Adverse Event|15|||
144193575|NCT01642914|519905008|FG000|Overall Study|Lack of Efficacy|9|||
144193576|NCT01642914|519905009|FG001|Overall Study|Lack of Efficacy|4|||
144193577|NCT01642914|519905010|FG002|Overall Study|Lack of Efficacy|2|||
144193578|NCT01642914|519905008|FG000|Overall Study|Protocol Violation|15|||
144193579|NCT01642914|519905009|FG001|Overall Study|Protocol Violation|13|||
144193580|NCT01642914|519905010|FG002|Overall Study|Protocol Violation|6|||
144193581|NCT01642914|519905008|FG000|Overall Study|Withdrawal by Subject|5|||
144444809|NCT04542070|520827411|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
144444810|NCT04542070|520827412|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
144532653|NCT03536884|521154284|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144193582|NCT01642914|519905009|FG001|Overall Study|Withdrawal by Subject|5|||
144193583|NCT01642914|519905010|FG002|Overall Study|Withdrawal by Subject|10|||
144193584|NCT01642914|519905008|FG000|Overall Study|Lost to Follow-up|5|||
144193585|NCT01642914|519905009|FG001|Overall Study|Lost to Follow-up|3|||
144444811|NCT04542070|520827413|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
144444812|NCT04542070|520827414|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
144444813|NCT04542070|520827411|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
144444814|NCT04542070|520827412|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
144444815|NCT04542070|520827413|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
144532654|NCT03536884|521154285|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
144532655|NCT03536884|521154274|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144193586|NCT01642914|519905010|FG002|Overall Study|Lost to Follow-up|7|||
144444816|NCT04542070|520827414|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
144444817|NCT04542070|520827411|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
144444818|NCT04542070|520827412|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
144444819|NCT04542070|520827413|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
144444820|NCT04542070|520827414|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
144444821|NCT04542070|520827411|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
144444822|NCT04542070|520827412|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
144444823|NCT04542070|520827413|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
144532656|NCT03536884|521154275|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144193587|NCT01642914|519905008|FG000|Overall Study|Other Reason|1|||
144193588|NCT01642914|519905009|FG001|Overall Study|Other Reason|0|||
144193589|NCT01642914|519905010|FG002|Overall Study|Other Reason|0|||
144193590|NCT04319159|519905011|FG000|Overall Study|Screening failure|13|||
144193591|NCT04319159|519905011|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
144193592|NCT04319159|519905011|FG000|Overall Study|Withdrawal by Subject|1|||
144193593|NCT06005597|519905014|FG000|Overall Study|Lost to Follow-up|1|||
144193594|NCT06005597|519905015|FG001|Overall Study|Lost to Follow-up|2|||
144193595|NCT06005597|519905016|FG002|Overall Study|Lost to Follow-up|1|||
144193596|NCT06005597|519905017|FG003|Overall Study|Lost to Follow-up|2|||
144193597|NCT06005597|519905014|FG000|Overall Study|Death|1|||
144193598|NCT06005597|519905015|FG001|Overall Study|Death|1|||
144193599|NCT06005597|519905016|FG002|Overall Study|Death|1|||
144193600|NCT06005597|519905017|FG003|Overall Study|Death|0|||
144193601|NCT02370914|519905018|FG000|Overall Study|Protocol Violation|2|||
144193602|NCT01478828|519905020|FG000|Overall Study|Adverse Event|1|||
144193603|NCT05611996|519905021|FG000|Overall Study|Ineligible|1|||
144193604|NCT05611996|519905021|FG000|Overall Study|Withdrawal by Subject|9|||
144193605|NCT02025010|519905022|FG000|Overall Study|Symptomatic or radiographic progression|36|||
144193606|NCT02025010|519905022|FG000|Overall Study|Adverse Event|6|||
144193607|NCT02025010|519905022|FG000|Overall Study|Physician Decision|7|||
144193608|NCT02025010|519905022|FG000|Overall Study|Withdrawal by Subject|3|||
144193609|NCT02025010|519905022|FG000|Overall Study|Intercurrent illness|3|||
144193610|NCT02025010|519905022|FG000|Overall Study|Patients still on treatment|3|||
144193611|NCT02025010|519905022|FG000|Overall Study|Never initiate the treatment|2|||
144193612|NCT05560763|519905023|FG000|Overall Study|Withdrawal by Subject|4|||
144193613|NCT01300052|519905025|FG000|Overall Study|Adverse Event|3|||
144193614|NCT01300052|519905026|FG001|Overall Study|Adverse Event|0|||
144193615|NCT01300052|519905025|FG000|Overall Study|Withdrawal by Subject|2|||
144193616|NCT01300052|519905026|FG001|Overall Study|Withdrawal by Subject|2|||
144193617|NCT01300052|519905025|FG000|Overall Study|Protocol Violation|1|||
144193618|NCT01300052|519905026|FG001|Overall Study|Protocol Violation|1|||
144193619|NCT03451006|519905027|FG000|Overall Study|Withdrawal by Subject|2|||
144193620|NCT03451006|519905028|FG001|Overall Study|Withdrawal by Subject|2|||
144193621|NCT00949988|519905029|FG000|Overall Study|Withdrawal by Subject|3|||
144193622|NCT02547766|519905030|FG000|Overall Study|Withdrawal by Subject|1|||
144193623|NCT01929395|519905031|FG000|Overall Study|Did not complete - non-related toxicity|1|||
144193624|NCT01929395|519905032|FG001|Overall Study|Did not complete - non-related toxicity|0|||
144193625|NCT01929395|519905033|FG002|Overall Study|Did not complete - non-related toxicity|0|||
144193626|NCT01929395|519905031|FG000|Overall Study|Withdrawal by Subject|0|||
144193627|NCT01929395|519905032|FG001|Overall Study|Withdrawal by Subject|1|||
144193628|NCT01929395|519905033|FG002|Overall Study|Withdrawal by Subject|0|||
144193629|NCT01929395|519905031|FG000|Overall Study|Screen Fail|0|||
144193630|NCT01929395|519905032|FG001|Overall Study|Screen Fail|0|||
144193631|NCT01929395|519905033|FG002|Overall Study|Screen Fail|1|||
144193632|NCT00484419|519905037|FG000|Overall Study|Adverse Event|3|||
144193633|NCT00484419|519905038|FG001|Overall Study|Adverse Event|0|||
144193634|NCT00484419|519905039|FG002|Overall Study|Adverse Event|0|||
144193635|NCT00484419|519905037|FG000|Overall Study|Lost to Follow-up|1|||
144444824|NCT04542070|520827414|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
144444825|NCT04542070|520827411|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
144444826|NCT04542070|520827412|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
144444827|NCT04542070|520827413|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
144444828|NCT04542070|520827414|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
144444829|NCT03049813|520827417|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
144444830|NCT03049813|520827418|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
144193636|NCT00484419|519905038|FG001|Overall Study|Lost to Follow-up|0|||
144444831|NCT03049813|520827419|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
144444832|NCT03049813|520827420|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
144444833|NCT03049813|520827417|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
144444834|NCT03049813|520827418|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
144444835|NCT03049813|520827419|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
144444836|NCT03049813|520827420|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
144444837|NCT03049813|520827417|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
144444838|NCT03049813|520827418|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
144193637|NCT00484419|519905039|FG002|Overall Study|Lost to Follow-up|2|||
144193638|NCT00484419|519905037|FG000|Overall Study|Withdrawal by Subject|3|||
144193639|NCT00484419|519905038|FG001|Overall Study|Withdrawal by Subject|1|||
144606158|NCT00239226|521419048|FG002|Overall Study|permAF during stabilization period|0|||
144193640|NCT00484419|519905039|FG002|Overall Study|Withdrawal by Subject|1|||
144193641|NCT00484419|519905037|FG000|Overall Study|subject met discontinuation criteria|2|||
144193642|NCT00484419|519905038|FG001|Overall Study|subject met discontinuation criteria|2|||
144193643|NCT00484419|519905039|FG002|Overall Study|subject met discontinuation criteria|4|||
144444839|NCT03049813|520827419|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
144444840|NCT03049813|520827420|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
144444841|NCT03049813|520827417|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
144444842|NCT03049813|520827418|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
144444843|NCT03049813|520827419|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
144444844|NCT03049813|520827420|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
144444845|NCT01813019|520827421|FG000|Overall Study|Adverse Event|0|||
144444846|NCT01813019|520827422|FG001|Overall Study|Adverse Event|3|||
144444847|NCT01813019|520827421|FG000|Overall Study|Withdrawal by Subject|3|||
144444848|NCT01813019|520827422|FG001|Overall Study|Withdrawal by Subject|2|||
144444849|NCT01813019|520827421|FG000|Overall Study|administrative problems|2|||
144444850|NCT01813019|520827422|FG001|Overall Study|administrative problems|0|||
144444851|NCT01813019|520827421|FG000|Overall Study|Protocol Deviation|2|||
144444852|NCT01813019|520827422|FG001|Overall Study|Protocol Deviation|1|||
144444853|NCT01696032|520827428|FG000|Overall Study|Withdrawal by Subject|0|||
144444854|NCT01696032|520827429|FG001|Overall Study|Withdrawal by Subject|0|||
144444855|NCT01696032|520827430|FG002|Overall Study|Withdrawal by Subject|1|||
144444856|NCT01696032|520827431|FG003|Overall Study|Withdrawal by Subject|2|||
144444857|NCT01696032|520827428|FG000|Overall Study|Death|14|||
144444858|NCT01696032|520827429|FG001|Overall Study|Death|4|||
144444859|NCT01696032|520827430|FG002|Overall Study|Death|43|||
144444860|NCT01696032|520827431|FG003|Overall Study|Death|18|||
144444861|NCT01696032|520827428|FG000|Overall Study|Lost to Follow-up|0|||
144444862|NCT01696032|520827429|FG001|Overall Study|Lost to Follow-up|1|||
144444863|NCT01696032|520827430|FG002|Overall Study|Lost to Follow-up|0|||
144444864|NCT01696032|520827431|FG003|Overall Study|Lost to Follow-up|0|||
144444865|NCT01696032|520827428|FG000|Overall Study|Database lock|0|||
144444866|NCT01696032|520827429|FG001|Overall Study|Database lock|1|||
144444867|NCT01696032|520827430|FG002|Overall Study|Database lock|7|||
144444868|NCT01696032|520827431|FG003|Overall Study|Database lock|2|||
144444869|NCT03025828|520827434|FG000|Overall Study|Lost to Follow-up|1|||
144444870|NCT03306264|520827439|FG000|Overall Study|Death|33|||
144444871|NCT03306264|520827440|FG001|Overall Study|Death|25|||
144444872|NCT03306264|520827441|FG002|Overall Study|Death|34|||
144444873|NCT03306264|520827442|FG003|Overall Study|Death|34|||
144444874|NCT03306264|520827439|FG000|Overall Study|Complete Consent Withdrawal|4|||
144444875|NCT03306264|520827440|FG001|Overall Study|Complete Consent Withdrawal|4|||
144444876|NCT03306264|520827441|FG002|Overall Study|Complete Consent Withdrawal|1|||
144444877|NCT03306264|520827442|FG003|Overall Study|Complete Consent Withdrawal|8|||
144444878|NCT03306264|520827439|FG000|Overall Study|Lost to Follow-up|1|||
144444879|NCT03306264|520827440|FG001|Overall Study|Lost to Follow-up|0|||
144444880|NCT03306264|520827441|FG002|Overall Study|Lost to Follow-up|1|||
144444881|NCT03306264|520827442|FG003|Overall Study|Lost to Follow-up|0|||
144444882|NCT03306264|520827439|FG000|Overall Study|Rollover to ASTX727-06|10|||
144444883|NCT03306264|520827440|FG001|Overall Study|Rollover to ASTX727-06|18|||
144444884|NCT03306264|520827441|FG002|Overall Study|Rollover to ASTX727-06|4|||
144444885|NCT03306264|520827442|FG003|Overall Study|Rollover to ASTX727-06|2|||
144444886|NCT03306264|520827439|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
144444887|NCT03306264|520827440|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
144444888|NCT03306264|520827441|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
144444889|NCT03306264|520827442|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
144444890|NCT00094653|520827444|FG000|Overall Study|Death|306|||
144444891|NCT00094653|520827445|FG001|Overall Study|Death|100|||
144444892|NCT00094653|520827446|FG002|Overall Study|Death|119|||
144444893|NCT00094653|520827444|FG000|Overall Study|Subject Withdrew Consent|10|||
144444894|NCT00094653|520827445|FG001|Overall Study|Subject Withdrew Consent|2|||
144444895|NCT00094653|520827446|FG002|Overall Study|Subject Withdrew Consent|3|||
144444896|NCT00094653|520827444|FG000|Overall Study|Other|2|||
144444897|NCT00094653|520827445|FG001|Overall Study|Other|2|||
144193644|NCT00484419|519905037|FG000|Overall Study|required restricted medication|1|||
144193645|NCT00484419|519905038|FG001|Overall Study|required restricted medication|0|||
144444898|NCT00094653|520827446|FG002|Overall Study|Other|2|||
144444899|NCT00094653|520827444|FG000|Overall Study|Lost to Follow-up|3|||
144444900|NCT00094653|520827445|FG001|Overall Study|Lost to Follow-up|2|||
144444901|NCT00094653|520827446|FG002|Overall Study|Lost to Follow-up|1|||
144444902|NCT00094653|520827444|FG000|Overall Study|Protocol Violation|0|||
144444903|NCT00094653|520827445|FG001|Overall Study|Protocol Violation|0|||
144444904|NCT00094653|520827446|FG002|Overall Study|Protocol Violation|1|||
144193646|NCT00484419|519905039|FG002|Overall Study|required restricted medication|1|||
144444905|NCT03120013|520827450|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144444906|NCT03120013|520827451|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144444907|NCT01565291|520827452|FG000|Overall Study|Withdrawal by Subject|1|||
144444908|NCT01565291|520827453|FG001|Overall Study|Withdrawal by Subject|0|||
144444909|NCT00806546|520827454|FG000|Overall Study|Enrolled, not treated|35|||
144444910|NCT00806546|520827454|FG000|Overall Study|Lost to Follow-up|32|||
144444911|NCT00806546|520827454|FG000|Overall Study|Adverse Event|74|||
144444912|NCT00806546|520827454|FG000|Overall Study|Withdrawal by Subject|75|||
144444913|NCT00806546|520827454|FG000|Overall Study|Protocol Violation|49|||
144444914|NCT00806546|520827454|FG000|Overall Study|Various|42|||
144444915|NCT01466192|520827455|FG000|Overall Study|Physician Decision|1|||
144444916|NCT01466192|520827455|FG000|Overall Study|Withdrawal by Subject|3|||
144444917|NCT00678561|520827456|FG000|Overall Study|Adverse Event|0|||
144444918|NCT00678561|520827457|FG001|Overall Study|Adverse Event|1|||
144444919|NCT00678561|520827458|FG002|Overall Study|Adverse Event|1|||
144444920|NCT00678561|520827459|FG003|Overall Study|Adverse Event|0|||
144444921|NCT00678561|520827460|FG004|Overall Study|Adverse Event|1|||
144444922|NCT00678561|520827461|FG005|Overall Study|Adverse Event|0|||
144444923|NCT00678561|520827462|FG006|Overall Study|Adverse Event|0|||
144444924|NCT00678561|520827463|FG007|Overall Study|Adverse Event|0|||
144444925|NCT00678561|520827456|FG000|Overall Study|Protocol Violation|0|||
144444926|NCT00678561|520827457|FG001|Overall Study|Protocol Violation|0|||
144444927|NCT00678561|520827458|FG002|Overall Study|Protocol Violation|0|||
144444928|NCT00678561|520827459|FG003|Overall Study|Protocol Violation|0|||
144444929|NCT00678561|520827460|FG004|Overall Study|Protocol Violation|1|||
144444930|NCT00678561|520827461|FG005|Overall Study|Protocol Violation|1|||
144444931|NCT00678561|520827462|FG006|Overall Study|Protocol Violation|0|||
144444932|NCT00678561|520827463|FG007|Overall Study|Protocol Violation|0|||
144444933|NCT00678561|520827456|FG000|Overall Study|Withdrawal by Subject|0|||
144444934|NCT00678561|520827457|FG001|Overall Study|Withdrawal by Subject|0|||
144444935|NCT00678561|520827458|FG002|Overall Study|Withdrawal by Subject|0|||
144444936|NCT00678561|520827459|FG003|Overall Study|Withdrawal by Subject|0|||
144444937|NCT00678561|520827460|FG004|Overall Study|Withdrawal by Subject|0|||
144444938|NCT00678561|520827461|FG005|Overall Study|Withdrawal by Subject|0|||
144444939|NCT00678561|520827462|FG006|Overall Study|Withdrawal by Subject|0|||
144444940|NCT00678561|520827463|FG007|Overall Study|Withdrawal by Subject|1|||
144444941|NCT01451424|520827464|FG000|Overall Study|Withdrawal by Subject|1|||
144444942|NCT01451424|520827465|FG001|Overall Study|Withdrawal by Subject|1|||
144444943|NCT01451424|520827466|FG002|Overall Study|Withdrawal by Subject|0|||
144444944|NCT01451424|520827467|FG003|Overall Study|Withdrawal by Subject|2|||
144444945|NCT01451424|520827464|FG000|Overall Study|Lost to Follow-up|0|||
144444946|NCT01451424|520827465|FG001|Overall Study|Lost to Follow-up|1|||
144444947|NCT01451424|520827466|FG002|Overall Study|Lost to Follow-up|0|||
144444948|NCT01451424|520827467|FG003|Overall Study|Lost to Follow-up|1|||
144444949|NCT01451424|520827464|FG000|Overall Study|Physician Decision|0|||
144444950|NCT01451424|520827465|FG001|Overall Study|Physician Decision|0|||
144444951|NCT01451424|520827466|FG002|Overall Study|Physician Decision|1|||
144444952|NCT01451424|520827467|FG003|Overall Study|Physician Decision|1|||
144606159|NCT00239226|521419049|FG003|Overall Study|permAF during stabilization period|3|||
144606160|NCT00239226|521419046|FG000|Overall Study|Lost to Follow-up|1|||
144606161|NCT00239226|521419047|FG001|Overall Study|Lost to Follow-up|0|||
144606162|NCT00239226|521419048|FG002|Overall Study|Lost to Follow-up|1|||
144606163|NCT00239226|521419049|FG003|Overall Study|Lost to Follow-up|0|||
144606164|NCT03024970|521419055|FG000|First Intervention|Adverse Event|1|||
144606165|NCT03024970|521419056|FG001|First Intervention|Adverse Event|0|||
144444953|NCT01451424|520827464|FG000|Overall Study|Adverse Event|0|||
144444954|NCT01451424|520827465|FG001|Overall Study|Adverse Event|0|||
144444955|NCT01451424|520827466|FG002|Overall Study|Adverse Event|0|||
144444956|NCT01451424|520827467|FG003|Overall Study|Adverse Event|1|||
144606166|NCT03024970|521419055|FG000|Second Intervention|Lost to Follow-up|1|||
144606167|NCT03024970|521419056|FG001|Second Intervention|Lost to Follow-up|0|||
144606168|NCT00131469|521419057|FG000|Overall Study|Withdrawal by Subject|3|||
144606169|NCT00131469|521419058|FG001|Overall Study|Withdrawal by Subject|4|||
144606170|NCT00131469|521419057|FG000|Overall Study|Protocol Violation|3|||
144193647|NCT00484419|519905037|FG000|Overall Study|Physician Decision|1|||
144193648|NCT00484419|519905038|FG001|Overall Study|Physician Decision|1|||
144193649|NCT00484419|519905039|FG002|Overall Study|Physician Decision|1|||
144193650|NCT00484419|519905037|FG000|Overall Study|subject unable to receive medication|1|||
144193651|NCT00484419|519905038|FG001|Overall Study|subject unable to receive medication|0|||
144193652|NCT00484419|519905039|FG002|Overall Study|subject unable to receive medication|0|||
144193653|NCT00484419|519905037|FG000|Overall Study|subject relocated|0|||
144193654|NCT00484419|519905038|FG001|Overall Study|subject relocated|1|||
144193655|NCT00484419|519905039|FG002|Overall Study|subject relocated|0|||
144193656|NCT00484419|519905037|FG000|Overall Study|sponsor decision, randomized in error|0|||
144193657|NCT00484419|519905038|FG001|Overall Study|sponsor decision, randomized in error|0|||
144193658|NCT00484419|519905039|FG002|Overall Study|sponsor decision, randomized in error|2|||
144193659|NCT01829113|519905041|FG000|Overall Study|Disease Progression|37|||
144444957|NCT02553421|520827470|FG000|Overall Study|Lost to Follow-up|21|||
144444958|NCT02553421|520827471|FG001|Overall Study|Lost to Follow-up|1|||
144444959|NCT02553421|520827470|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
144444960|NCT02553421|520827471|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
144444961|NCT02553421|520827470|FG000|Overall Study|Improper Device Placement|3|||
144193660|NCT01829113|519905042|FG001|Overall Study|Disease Progression|48|||
144444962|NCT02553421|520827471|FG001|Overall Study|Improper Device Placement|0|||
144606171|NCT00131469|521419058|FG001|Overall Study|Protocol Violation|1|||
144606172|NCT00131469|521419057|FG000|Overall Study|Death|0|||
144193661|NCT01829113|519905041|FG000|Overall Study|Adverse Event|14|||
144193662|NCT01829113|519905042|FG001|Overall Study|Adverse Event|10|||
144193663|NCT01829113|519905041|FG000|Overall Study|Withdrawal by Subject|17|||
144193664|NCT01829113|519905042|FG001|Overall Study|Withdrawal by Subject|10|||
144193665|NCT01829113|519905041|FG000|Overall Study|Death|4|||
144193666|NCT01829113|519905042|FG001|Overall Study|Death|6|||
144193667|NCT01829113|519905041|FG000|Overall Study|Sponsor Decision|1|||
144193668|NCT01829113|519905042|FG001|Overall Study|Sponsor Decision|1|||
144193669|NCT01829113|519905041|FG000|Overall Study|No Study Treatment Received|3|||
144193670|NCT01829113|519905042|FG001|Overall Study|No Study Treatment Received|2|||
144193671|NCT01829113|519905041|FG000|Overall Study|Physician Decision|1|||
144193672|NCT01829113|519905042|FG001|Overall Study|Physician Decision|1|||
144193673|NCT00355472|519905043|FG000|Overall Study|Physician Decision|1|||
144444963|NCT03665038|520827474|FG000|Overall Study|Lost to Follow-up|0|||
144444964|NCT03665038|520827475|FG001|Overall Study|Lost to Follow-up|0|||
144193674|NCT05444543|519905048|FG000|Overall Study|Withdrawal by Subject|1|||
144193675|NCT05444543|519905049|FG001|Overall Study|Withdrawal by Subject|0|||
144193676|NCT05444543|519905048|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
144193677|NCT05444543|519905049|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
144193678|NCT05444543|519905048|FG000|Overall Study|Adverse Event|0|||
144193679|NCT05444543|519905049|FG001|Overall Study|Adverse Event|1|||
144193680|NCT05444543|519905048|FG000|Overall Study|Family relocating at a distance from study site|0|||
144193681|NCT05444543|519905049|FG001|Overall Study|Family relocating at a distance from study site|1|||
144193682|NCT03847194|519905050|FG000|Overall Study|Lost to Follow-up|2|||
144193683|NCT03847194|519905051|FG001|Overall Study|Lost to Follow-up|5|||
144193684|NCT03847194|519905050|FG000|Overall Study|Withdrawal by Subject|1|||
144193685|NCT03847194|519905051|FG001|Overall Study|Withdrawal by Subject|2|||
144193686|NCT03847194|519905050|FG000|Overall Study|Death|0|||
144193687|NCT03847194|519905051|FG001|Overall Study|Death|1|||
144193688|NCT01144403|519905053|FG000|Overall Study|Lost to Follow-up|3|||
144193689|NCT01144403|519905053|FG000|Overall Study|Death|1|||
144193690|NCT01144403|519905053|FG000|Overall Study|Adverse Event|1|||
144193691|NCT03891329|519905054|FG000|Overall Study|Death|5|||
144193692|NCT03891329|519905054|FG000|Overall Study|Lost to Follow-up|4|||
144444965|NCT03665038|520827476|FG002|Overall Study|Lost to Follow-up|1|||
144444966|NCT04524403|520829427|FG000|Overall Study|Withdrawal by Subject|10|||
144444967|NCT04524403|520829428|FG001|Overall Study|Withdrawal by Subject|3|||
144444968|NCT04524403|520829429|FG002|Overall Study|Withdrawal by Subject|8|||
144444969|NCT04524403|520829427|FG000|Overall Study|Lost to Follow-up|3|||
144444970|NCT04524403|520829428|FG001|Overall Study|Lost to Follow-up|4|||
144444971|NCT04524403|520829429|FG002|Overall Study|Lost to Follow-up|3|||
144444972|NCT04524403|520829427|FG000|Overall Study|Adverse Event|3|||
144606173|NCT00131469|521419058|FG001|Overall Study|Death|1|||
144606174|NCT00131469|521419057|FG000|Overall Study|Lost to Follow-up|0|||
144606175|NCT00131469|521419058|FG001|Overall Study|Lost to Follow-up|1|||
144606176|NCT00131469|521419057|FG000|Overall Study|scan not analyzable|3|||
144606177|NCT00131469|521419058|FG001|Overall Study|scan not analyzable|6|||
144606178|NCT01106027|521419059|FG000|Overall Study|Lost graft early, discontinued|1|||
144606179|NCT02871778|521419060|FG000|Part A: Treatment Period 1|Adverse Event|1|||
144444973|NCT04524403|520829428|FG001|Overall Study|Adverse Event|1|||
144444974|NCT04524403|520829429|FG002|Overall Study|Adverse Event|4|||
144444975|NCT04524403|520829427|FG000|Overall Study|Non-compliant with study drug|1|||
144444976|NCT04524403|520829428|FG001|Overall Study|Non-compliant with study drug|2|||
144444977|NCT04524403|520829429|FG002|Overall Study|Non-compliant with study drug|3|||
144444978|NCT04524403|520829427|FG000|Overall Study|Moved|0|||
144444979|NCT04524403|520829428|FG001|Overall Study|Moved|1|||
144444980|NCT04524403|520829429|FG002|Overall Study|Moved|0|||
144444981|NCT02383758|520829430|FG000|Overall Study|Withdrawal by Subject|0|||
144444982|NCT02383758|520829431|FG001|Overall Study|Withdrawal by Subject|2|||
144444983|NCT02033889|520829436|FG000|Overall Study|Adverse Event|3|||
144444984|NCT02033889|520829437|FG001|Overall Study|Adverse Event|1|||
144444985|NCT02033889|520829438|FG002|Overall Study|Adverse Event|3|||
144444986|NCT02033889|520829436|FG000|Overall Study|Death|3|||
144193693|NCT03891329|519905054|FG000|Overall Study|Physician Decision|4|||
144444987|NCT02033889|520829437|FG001|Overall Study|Death|1|||
144444988|NCT02033889|520829438|FG002|Overall Study|Death|2|||
144606180|NCT02871778|521419061|FG001|Part A: Treatment Period 1|Adverse Event|1|||
144606181|NCT02871778|521419062|FG002|Part A: Treatment Period 1|Adverse Event|1|||
144193694|NCT03891329|519905054|FG000|Overall Study|Device explanted|3|||
144193695|NCT03891329|519905054|FG000|Overall Study|No study device implanted|3|||
144193696|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
144193697|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
144193698|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
144444989|NCT02033889|520829436|FG000|Overall Study|Excluded Medication|1|||
144444990|NCT02033889|520829437|FG001|Overall Study|Excluded Medication|1|||
144444991|NCT02033889|520829438|FG002|Overall Study|Excluded Medication|0|||
144444992|NCT02033889|520829436|FG000|Overall Study|Lost to Follow-up|8|||
144606182|NCT02871778|521419063|FG003|Part A: Treatment Period 1|Adverse Event|0|||
144725201|NCT05771428|521851194|FG000|Overall Study|Randomized but Not Treated|0|||
144444993|NCT02033889|520829437|FG001|Overall Study|Lost to Follow-up|5|||
144444994|NCT02033889|520829438|FG002|Overall Study|Lost to Follow-up|6|||
144444995|NCT02033889|520829436|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144444996|NCT02033889|520829437|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144444997|NCT02033889|520829438|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144444998|NCT02033889|520829436|FG000|Overall Study|Physician Decision|0|||
144444999|NCT02033889|520829437|FG001|Overall Study|Physician Decision|1|||
144445000|NCT02033889|520829438|FG002|Overall Study|Physician Decision|1|||
144445001|NCT02033889|520829436|FG000|Overall Study|Participant moved|0|||
144445002|NCT02033889|520829437|FG001|Overall Study|Participant moved|1|||
144445003|NCT02033889|520829438|FG002|Overall Study|Participant moved|0|||
144445004|NCT02033889|520829436|FG000|Overall Study|Withdrawal by Subject|18|||
144445005|NCT02033889|520829437|FG001|Overall Study|Withdrawal by Subject|10|||
144445006|NCT02033889|520829438|FG002|Overall Study|Withdrawal by Subject|13|||
144445007|NCT01513317|520829440|FG000|Overall Study|Withdrawal by Subject|15|||
144445008|NCT01513317|520829441|FG001|Overall Study|Withdrawal by Subject|4|||
144445009|NCT01513317|520829440|FG000|Overall Study|Death|1|||
144445010|NCT01513317|520829441|FG001|Overall Study|Death|1|||
144445011|NCT01513317|520829440|FG000|Overall Study|Study terminated by sponsor|18|||
144445012|NCT01513317|520829441|FG001|Overall Study|Study terminated by sponsor|18|||
144445013|NCT01513317|520829440|FG000|Overall Study|Other|0|||
144445014|NCT01513317|520829441|FG001|Overall Study|Other|1|||
144445015|NCT01610700|520829442|FG000|Overall Study|Adverse Event|3|||
144445016|NCT01610700|520829443|FG001|Overall Study|Adverse Event|1|||
144445017|NCT01610700|520829442|FG000|Overall Study|Withdrawal by Subject|0|||
144445018|NCT01610700|520829443|FG001|Overall Study|Withdrawal by Subject|1|||
144445019|NCT01610700|520829442|FG000|Overall Study|subject took one dose of street cannabis|0|||
144445020|NCT01610700|520829443|FG001|Overall Study|subject took one dose of street cannabis|1|||
144445021|NCT02564198|520829444|FG000|Overall Study|Withdrawal by Subject|2|||
144445022|NCT02564198|520829445|FG001|Overall Study|Withdrawal by Subject|4|||
144445023|NCT02564198|520829446|FG002|Overall Study|Withdrawal by Subject|0|||
144445024|NCT02564198|520829444|FG000|Overall Study|Adverse Event|0|||
144445025|NCT02564198|520829445|FG001|Overall Study|Adverse Event|1|||
144445026|NCT02564198|520829446|FG002|Overall Study|Adverse Event|0|||
144445027|NCT02649972|520829447|FG000|Overall Study|Not treated|1|||
144445028|NCT02167035|520829448|FG000|Overall Study|Adverse Event|2|||
144445029|NCT02167035|520829449|FG001|Overall Study|Adverse Event|2|||
144445030|NCT02167035|520829448|FG000|Overall Study|Lost to Follow-up|3|||
144445031|NCT02167035|520829449|FG001|Overall Study|Lost to Follow-up|3|||
144445032|NCT02167035|520829448|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
144445033|NCT02167035|520829449|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
144445034|NCT02148003|520829450|FG000|Overall Study|Failed inclusion criteria|1|||
144445035|NCT02148003|520829451|FG001|Overall Study|Failed inclusion criteria|0|||
144445036|NCT02148003|520829450|FG000|Overall Study|Met exclusion criteria|0|||
144445037|NCT02148003|520829451|FG001|Overall Study|Met exclusion criteria|1|||
144445038|NCT02148003|520829450|FG000|Overall Study|Withdrawal by Subject|0|||
144445039|NCT02148003|520829451|FG001|Overall Study|Withdrawal by Subject|1|||
144445040|NCT02738775|520829452|FG000|Overall Study|Withdrawal by Subject|0|||
144445041|NCT02738775|520829453|FG001|Overall Study|Withdrawal by Subject|1|||
144445042|NCT02738775|520829454|FG002|Overall Study|Withdrawal by Subject|0|||
144445043|NCT02738775|520829455|FG003|Overall Study|Withdrawal by Subject|0|||
144445044|NCT02738775|520829456|FG004|Overall Study|Withdrawal by Subject|0|||
144606183|NCT02871778|521419064|FG004|Part A: Treatment Period 1|Adverse Event|0|||
144606184|NCT02871778|521419065|FG005|Part A: Treatment Period 1|Adverse Event|0|||
144606185|NCT02871778|521419066|FG006|Part A: Treatment Period 1|Adverse Event|0|||
144606186|NCT02871778|521419067|FG007|Part A: Treatment Period 1|Adverse Event|0|||
144606187|NCT02871778|521419060|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
144606188|NCT02871778|521419061|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
144606189|NCT02871778|521419062|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
144606190|NCT02871778|521419063|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
144445045|NCT02738775|520829457|FG005|Overall Study|Withdrawal by Subject|0|||
144445046|NCT02738775|520829452|FG000|Overall Study|Adverse Event|0|||
144445047|NCT02738775|520829453|FG001|Overall Study|Adverse Event|0|||
144445048|NCT02738775|520829454|FG002|Overall Study|Adverse Event|0|||
144193699|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
144445049|NCT02738775|520829455|FG003|Overall Study|Adverse Event|1|||
144445050|NCT02738775|520829456|FG004|Overall Study|Adverse Event|0|||
144445051|NCT02738775|520829457|FG005|Overall Study|Adverse Event|0|||
144445052|NCT02738775|520829452|FG000|Overall Study|Pregnancy|0|||
144445053|NCT02738775|520829453|FG001|Overall Study|Pregnancy|1|||
144445054|NCT02738775|520829454|FG002|Overall Study|Pregnancy|0|||
144445055|NCT02738775|520829455|FG003|Overall Study|Pregnancy|0|||
144445056|NCT02738775|520829456|FG004|Overall Study|Pregnancy|0|||
144445057|NCT02738775|520829457|FG005|Overall Study|Pregnancy|0|||
144445058|NCT02738775|520829452|FG000|Overall Study|Missing|0|||
144445059|NCT02738775|520829453|FG001|Overall Study|Missing|0|||
144445060|NCT02738775|520829454|FG002|Overall Study|Missing|0|||
144445061|NCT02738775|520829455|FG003|Overall Study|Missing|0|||
144445062|NCT02738775|520829456|FG004|Overall Study|Missing|0|||
144445063|NCT02738775|520829457|FG005|Overall Study|Missing|1|||
144445064|NCT01785524|520829458|FG000|Overall Study|Withdrawal by Subject|2|||
144445065|NCT01785524|520829459|FG001|Overall Study|Withdrawal by Subject|2|||
144445066|NCT01060384|520829460|FG000|Overall Study|Withdrawal by Subject|0|||
144445067|NCT01060384|520829461|FG001|Overall Study|Withdrawal by Subject|1|||
144445068|NCT01060384|520829462|FG002|Overall Study|Withdrawal by Subject|0|||
144445069|NCT01060384|520829463|FG003|Overall Study|Withdrawal by Subject|0|||
144445070|NCT01060384|520829464|FG004|Overall Study|Withdrawal by Subject|0|||
144606191|NCT02871778|521419064|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
144445071|NCT01060384|520829460|FG000|Overall Study|Death|0|||
144445072|NCT01060384|520829461|FG001|Overall Study|Death|0|||
144445073|NCT01060384|520829462|FG002|Overall Study|Death|0|||
144445074|NCT01060384|520829463|FG003|Overall Study|Death|0|||
144445075|NCT01060384|520829464|FG004|Overall Study|Death|1|||
144445076|NCT01060384|520829460|FG000|Overall Study|Intercurrent illness|0|||
144445077|NCT01060384|520829461|FG001|Overall Study|Intercurrent illness|0|||
144445078|NCT01060384|520829462|FG002|Overall Study|Intercurrent illness|0|||
144445079|NCT01060384|520829463|FG003|Overall Study|Intercurrent illness|0|||
144445080|NCT01060384|520829464|FG004|Overall Study|Intercurrent illness|1|||
144445081|NCT00812929|520829467|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
144445082|NCT00812929|520829468|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
144445083|NCT00812929|520829469|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
144445084|NCT00812929|520829470|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
144445085|NCT00812929|520829471|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
144445086|NCT00812929|520829472|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
144445087|NCT00812929|520829473|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
144445088|NCT00812929|520829474|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
144445089|NCT00812929|520829475|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
144445090|NCT00812929|520829476|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
144445091|NCT00812929|520829467|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
144445092|NCT00812929|520829468|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
144445093|NCT00812929|520829469|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
144445094|NCT00812929|520829470|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
144445095|NCT00812929|520829471|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
144445096|NCT00812929|520829472|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
144445097|NCT00812929|520829473|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
144445098|NCT00812929|520829474|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
144445099|NCT00812929|520829475|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
144445100|NCT00812929|520829476|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
144445101|NCT00812929|520829467|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
144445102|NCT00812929|520829468|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
144445103|NCT00812929|520829469|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
144445104|NCT00812929|520829470|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
144445105|NCT00812929|520829471|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
144445106|NCT00812929|520829472|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
144445107|NCT00812929|520829473|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
144445108|NCT00812929|520829474|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
144445109|NCT00812929|520829475|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
144445110|NCT00812929|520829476|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
144445111|NCT03217136|520829483|FG000|Overall Study|Lost to Follow-up|2|||
144445112|NCT03217136|520829484|FG001|Overall Study|Lost to Follow-up|1|||
144445113|NCT03217136|520829483|FG000|Overall Study|Site Randomized Participant in Error|0|||
144445114|NCT03217136|520829484|FG001|Overall Study|Site Randomized Participant in Error|1|||
144445115|NCT03217136|520829483|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
144445116|NCT03217136|520829484|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
144445117|NCT03217136|520829483|FG000|Overall Study|Dispensing Error|1|||
144193700|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
144193701|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
144445118|NCT03217136|520829484|FG001|Overall Study|Dispensing Error|0|||
144614803|NCT01624662|521450215|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
144445119|NCT03217136|520829483|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144445120|NCT03217136|520829484|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144445121|NCT00678691|520829485|FG000|Overall Study|Adverse Event|6|||
144193702|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
144445122|NCT00678691|520829486|FG001|Overall Study|Adverse Event|4|||
144445123|NCT02939404|520829487|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
144445124|NCT02939404|520829488|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
144445125|NCT02939404|520829487|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
144445126|NCT02939404|520829488|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
144445127|NCT06640829|520829501|FG000|Overall Study|Withdrawal by Subject|1|||
144445128|NCT06640829|520829501|FG000|Overall Study|Lost to Follow-up|1|||
144445129|NCT01350128|520829502|FG000|Overall Study|Withdrawal by Subject|3|||
144445130|NCT01350128|520829502|FG000|Overall Study|Protocol discontinuation criteria|8|||
144445131|NCT01350128|520829502|FG000|Overall Study|Physician Decision|1|||
144445132|NCT01350128|520829502|FG000|Overall Study|Lost to Follow-up|2|||
144445133|NCT01859715|520829505|FG000|Overall Study|No 2nd VAS|16|||
144445134|NCT01859715|520829506|FG001|Overall Study|No 2nd VAS|8|||
144445135|NCT01859715|520829507|FG002|Overall Study|No 2nd VAS|23|||
144445136|NCT00086580|520829508|FG000|Treatment Period|Disease progression|9|||
144445137|NCT00086580|520829509|FG001|Treatment Period|Disease progression|8|||
144445138|NCT00086580|520829508|FG000|Treatment Period|Unable to comply with protocol|3|||
144445139|NCT00086580|520829509|FG001|Treatment Period|Unable to comply with protocol|1|||
144445140|NCT00086580|520829508|FG000|Treatment Period|Withdrawal by Subject|7|||
144445141|NCT00086580|520829509|FG001|Treatment Period|Withdrawal by Subject|8|||
144445142|NCT00086580|520829508|FG000|Treatment Period|Physician Decision|13|||
144445143|NCT00086580|520829509|FG001|Treatment Period|Physician Decision|7|||
144445144|NCT00086580|520829508|FG000|Treatment Period|AE - not treatment related|7|||
144445145|NCT00086580|520829509|FG001|Treatment Period|AE - not treatment related|7|||
144445146|NCT00086580|520829508|FG000|Treatment Period|Toxicity - treatment related|15|||
144445147|NCT00086580|520829509|FG001|Treatment Period|Toxicity - treatment related|15|||
144445148|NCT00086580|520829508|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
144445149|NCT00086580|520829509|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
144445150|NCT00086580|520829508|FG000|Treatment Period|Death|5|||
144445151|NCT00086580|520829509|FG001|Treatment Period|Death|7|||
144445152|NCT00086580|520829508|FG000|Treatment Period|Other|5|||
144445153|NCT00086580|520829509|FG001|Treatment Period|Other|3|||
144445154|NCT00086580|520829508|FG000|Follow-up Period|Disease progression|72|||
144445155|NCT00086580|520829509|FG001|Follow-up Period|Disease progression|99|||
144606192|NCT02871778|521419065|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
144193703|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
144193704|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
144193705|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
144445156|NCT00086580|520829508|FG000|Follow-up Period|Unable to comply with protocol|5|||
144445157|NCT00086580|520829509|FG001|Follow-up Period|Unable to comply with protocol|0|||
144445158|NCT00086580|520829508|FG000|Follow-up Period|Withdrawal by Subject|6|||
144445159|NCT00086580|520829509|FG001|Follow-up Period|Withdrawal by Subject|6|||
144445160|NCT00086580|520829508|FG000|Follow-up Period|Physician Decision|0|||
144606193|NCT02871778|521419066|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
144606194|NCT02871778|521419067|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
144606195|NCT02871778|521419060|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606196|NCT02871778|521419061|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606197|NCT02871778|521419062|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
144606198|NCT02871778|521419063|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606199|NCT02871778|521419064|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606200|NCT02871778|521419065|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606201|NCT02871778|521419066|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606202|NCT02871778|521419067|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
144606203|NCT02871778|521419060|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606204|NCT02871778|521419061|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606205|NCT02871778|521419062|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
144606206|NCT02871778|521419063|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606207|NCT02871778|521419064|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606208|NCT02871778|521419065|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606209|NCT02871778|521419066|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606210|NCT02871778|521419067|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
144606211|NCT02871778|521419060|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606212|NCT02871778|521419061|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
144606213|NCT02871778|521419062|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606214|NCT02871778|521419063|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606215|NCT02871778|521419064|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606216|NCT02871778|521419065|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606217|NCT02871778|521419066|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606218|NCT02871778|521419067|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
144606219|NCT02871778|521419060|FG000|Part A: Treatment Period 2|Adverse Event|2|||
144606220|NCT02871778|521419061|FG001|Part A: Treatment Period 2|Adverse Event|2|||
144606221|NCT02871778|521419062|FG002|Part A: Treatment Period 2|Adverse Event|0|||
144445161|NCT00086580|520829509|FG001|Follow-up Period|Physician Decision|1|||
144445162|NCT00086580|520829508|FG000|Follow-up Period|AE - not related|1|||
144445163|NCT00086580|520829509|FG001|Follow-up Period|AE - not related|0|||
144445164|NCT00086580|520829508|FG000|Follow-up Period|Death|13|||
144445165|NCT00086580|520829509|FG001|Follow-up Period|Death|7|||
144445166|NCT00086580|520829508|FG000|Follow-up Period|Other|7|||
144445167|NCT00086580|520829509|FG001|Follow-up Period|Other|6|||
144193706|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
144606222|NCT02871778|521419063|FG003|Part A: Treatment Period 2|Adverse Event|0|||
144606223|NCT02871778|521419064|FG004|Part A: Treatment Period 2|Adverse Event|0|||
144606224|NCT02871778|521419065|FG005|Part A: Treatment Period 2|Adverse Event|0|||
144606225|NCT02871778|521419066|FG006|Part A: Treatment Period 2|Adverse Event|0|||
144606226|NCT02871778|521419067|FG007|Part A: Treatment Period 2|Adverse Event|0|||
144606227|NCT02871778|521419060|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606228|NCT02871778|521419061|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606229|NCT02871778|521419062|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606230|NCT02871778|521419063|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
144606231|NCT02871778|521419064|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606232|NCT02871778|521419065|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606233|NCT02871778|521419066|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606234|NCT02871778|521419067|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
144606235|NCT02871778|521419060|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
144606236|NCT02871778|521419061|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
144606237|NCT02871778|521419062|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
144606238|NCT02871778|521419063|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
144606239|NCT02871778|521419064|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
144606240|NCT02871778|521419065|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
144606241|NCT02871778|521419066|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
144606242|NCT02871778|521419067|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
144606243|NCT02871778|521419060|FG000|Part B: Treatment Period 3|Adverse Event|0|||
144606244|NCT02871778|521419061|FG001|Part B: Treatment Period 3|Adverse Event|0|||
144606245|NCT02871778|521419062|FG002|Part B: Treatment Period 3|Adverse Event|0|||
144606246|NCT02871778|521419063|FG003|Part B: Treatment Period 3|Adverse Event|0|||
144606247|NCT02871778|521419064|FG004|Part B: Treatment Period 3|Adverse Event|1|||
144606248|NCT02871778|521419065|FG005|Part B: Treatment Period 3|Adverse Event|1|||
144606249|NCT02871778|521419066|FG006|Part B: Treatment Period 3|Adverse Event|1|||
144606250|NCT02871778|521419067|FG007|Part B: Treatment Period 3|Adverse Event|0|||
144606251|NCT02653300|521419069|FG000|Overall Study|Withdrawal by Subject|2|||
144606252|NCT01235793|521419080|FG000|Overall Study|Death|6|||
144606253|NCT02456662|521419083|FG000|Overall Study|Lost to Follow-up|2|||
144606254|NCT02456662|521419084|FG001|Overall Study|Lost to Follow-up|1|||
144606255|NCT03828292|521419085|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
144606256|NCT03828292|521419086|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
144606257|NCT03828292|521419087|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
144606258|NCT03828292|521419088|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
144606259|NCT03828292|521419089|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
144606260|NCT03828292|521419090|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
144606261|NCT03828292|521419085|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
144606262|NCT03828292|521419086|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
144606263|NCT03828292|521419087|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
144606264|NCT03828292|521419088|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
144606265|NCT03828292|521419089|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
144606266|NCT03828292|521419090|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
144606267|NCT03828292|521419085|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
144606268|NCT03828292|521419086|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
144606269|NCT03828292|521419087|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
144606270|NCT03828292|521419088|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
144606271|NCT03828292|521419089|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
144606272|NCT03828292|521419090|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
144606273|NCT03828292|521419085|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
144606274|NCT03828292|521419086|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
144606275|NCT03828292|521419087|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
144606276|NCT03828292|521419088|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
144606277|NCT03828292|521419089|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
144606278|NCT03828292|521419090|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
144606279|NCT03828292|521419085|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
144606280|NCT03828292|521419086|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
144606281|NCT03828292|521419087|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
144606282|NCT03828292|521419088|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
144606283|NCT03828292|521419089|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
144606284|NCT03828292|521419090|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
144606285|NCT01444456|521419091|FG000|Overall Study|Withdrawal by Subject|21|||
144606286|NCT01444456|521419091|FG000|Overall Study|Physician Decision|9|||
144606287|NCT01444456|521419091|FG000|Overall Study|Lost to Follow-up|37|||
144193707|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
144193708|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
144445168|NCT00086580|520829508|FG000|Observation Period|Unable to comply with protocol|1|||
144445169|NCT00086580|520829509|FG001|Observation Period|Unable to comply with protocol|1|||
144445170|NCT00086580|520829508|FG000|Observation Period|Withdrawal by Subject|4|||
144445171|NCT00086580|520829509|FG001|Observation Period|Withdrawal by Subject|2|||
144445172|NCT00086580|520829508|FG000|Observation Period|Death|33|||
144445173|NCT00086580|520829509|FG001|Observation Period|Death|55|||
144445174|NCT00086580|520829508|FG000|Observation Period|Other|8|||
144445175|NCT00086580|520829509|FG001|Observation Period|Other|7|||
144193709|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
144193710|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
144445176|NCT00261716|520829513|FG000|Overall Study|Withdrawal by Subject|6|||
144445177|NCT00261716|520829514|FG001|Overall Study|Withdrawal by Subject|8|||
144445178|NCT00261716|520829513|FG000|Overall Study|Lost to Follow-up|0|||
144445179|NCT00261716|520829514|FG001|Overall Study|Lost to Follow-up|2|||
144445180|NCT02047110|520829517|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
144445181|NCT02047110|520829518|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
144445182|NCT02047110|520829519|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
144445183|NCT02047110|520829520|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
144445184|NCT02047110|520829517|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
144445185|NCT02047110|520829518|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
144445186|NCT02047110|520829519|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
144445187|NCT02047110|520829520|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
144445188|NCT02047110|520829517|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
144445189|NCT02047110|520829518|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
144445190|NCT02047110|520829519|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
144445191|NCT02047110|520829520|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
144445192|NCT02047110|520829517|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
144445193|NCT02047110|520829518|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
144445194|NCT02047110|520829519|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
144445195|NCT02047110|520829520|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
144445196|NCT02047110|520829517|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
144445197|NCT02047110|520829518|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
144445198|NCT02047110|520829519|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
144445199|NCT02047110|520829520|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
144445200|NCT02047110|520829517|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
144445201|NCT02047110|520829518|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
144445202|NCT02047110|520829519|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
144445203|NCT02047110|520829520|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
144445204|NCT02047110|520829517|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
144445205|NCT02047110|520829518|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
144445206|NCT02047110|520829519|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
144445207|NCT02047110|520829520|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
144445208|NCT02047110|520829517|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
144445209|NCT02047110|520829518|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
144445210|NCT02047110|520829519|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
144445211|NCT02047110|520829520|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
144445212|NCT02047110|520829517|FG000|Escape Treatment Period|Adverse Event|1|||
144445213|NCT02047110|520829518|FG001|Escape Treatment Period|Adverse Event|2|||
144445214|NCT02047110|520829519|FG002|Escape Treatment Period|Adverse Event|2|||
144445215|NCT02047110|520829520|FG003|Escape Treatment Period|Adverse Event|0|||
144445216|NCT02047110|520829517|FG000|Escape Treatment Period|Other than specified|1|||
144445217|NCT02047110|520829518|FG001|Escape Treatment Period|Other than specified|2|||
144445218|NCT02047110|520829519|FG002|Escape Treatment Period|Other than specified|0|||
144445219|NCT02047110|520829520|FG003|Escape Treatment Period|Other than specified|1|||
144445220|NCT02047110|520829517|FG000|OLE Treatment Period|Other than specified|0|||
144445221|NCT02047110|520829518|FG001|OLE Treatment Period|Other than specified|0|||
144445222|NCT02047110|520829519|FG002|OLE Treatment Period|Other than specified|1|||
144445223|NCT02047110|520829520|FG003|OLE Treatment Period|Other than specified|0|||
144445224|NCT01632800|520829523|FG000|Overall Study|Subject did not fit in apparatus|1|||
144445225|NCT01000051|520829524|FG000|Overall Study|Withdrawal by Subject|1|||
144445226|NCT01000051|520829525|FG001|Overall Study|Withdrawal by Subject|1|||
144445227|NCT01000051|520829524|FG000|Overall Study|Disease Progression|1|||
144445228|NCT01000051|520829525|FG001|Overall Study|Disease Progression|0|||
144445229|NCT01000051|520829524|FG000|Overall Study|Serious noncompliance|1|||
144445230|NCT01000051|520829525|FG001|Overall Study|Serious noncompliance|0|||
144445231|NCT02247349|520829526|FG000|Overall Study|Disease Progression|7|||
144445232|NCT02247349|520829527|FG001|Overall Study|Disease Progression|4|||
144445233|NCT02247349|520829528|FG002|Overall Study|Disease Progression|26|||
144445234|NCT02247349|520829529|FG003|Overall Study|Disease Progression|31|||
144445235|NCT02247349|520829530|FG004|Overall Study|Disease Progression|16|||
144445236|NCT02247349|520829531|FG005|Overall Study|Disease Progression|6|||
144445237|NCT02247349|520829526|FG000|Overall Study|Study drug toxicity|0|||
144193711|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
144193712|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
144193713|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
144193714|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
144193715|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
144193716|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
144193717|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
144193718|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
144193719|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
144445238|NCT02247349|520829527|FG001|Overall Study|Study drug toxicity|1|||
144445239|NCT02247349|520829528|FG002|Overall Study|Study drug toxicity|1|||
144445240|NCT02247349|520829529|FG003|Overall Study|Study drug toxicity|1|||
144445241|NCT02247349|520829530|FG004|Overall Study|Study drug toxicity|2|||
144193720|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
144193721|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
144193722|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
144193723|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
144193724|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Death|0|||
144193725|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Death|1|||
144193726|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Death|0|||
144193727|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Death|0|||
144193728|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
144193729|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
144193730|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
144193731|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
144193732|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
144193733|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
144193734|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
144193735|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
144193736|NCT02990806|519905055|FG000|Stage 1 (22 Weeks)|Other|1|||
144193737|NCT02990806|519905056|FG001|Stage 1 (22 Weeks)|Other|3|||
144193738|NCT02990806|519905057|FG002|Stage 1 (22 Weeks)|Other|0|||
144253726|NCT04985942|520129993|FG000|Overall Study|Withdrawal by Subject|5|||
144445242|NCT02247349|520829531|FG005|Overall Study|Study drug toxicity|2|||
144445243|NCT02247349|520829526|FG000|Overall Study|Death|0|||
144445244|NCT02247349|520829527|FG001|Overall Study|Death|0|||
144445245|NCT02247349|520829528|FG002|Overall Study|Death|0|||
144445246|NCT02247349|520829529|FG003|Overall Study|Death|1|||
144445247|NCT02247349|520829530|FG004|Overall Study|Death|0|||
144445248|NCT02247349|520829531|FG005|Overall Study|Death|0|||
144445249|NCT02247349|520829526|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
144445250|NCT02247349|520829527|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
144445251|NCT02247349|520829528|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
144445252|NCT02247349|520829529|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
144445253|NCT02247349|520829530|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
144445254|NCT02247349|520829531|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
144445255|NCT02247349|520829526|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144193739|NCT02990806|519905058|FG003|Stage 1 (22 Weeks)|Other|0|||
144193740|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
144193741|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
144193742|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
144193743|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
144445256|NCT02247349|520829527|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144445257|NCT02247349|520829528|FG002|Overall Study|Participant request to discontinue study treatment|1|||
144445258|NCT02247349|520829529|FG003|Overall Study|Participant request to discontinue study treatment|2|||
144445259|NCT02247349|520829530|FG004|Overall Study|Participant request to discontinue study treatment|1|||
144445260|NCT02247349|520829531|FG005|Overall Study|Participant request to discontinue study treatment|0|||
144445261|NCT02247349|520829526|FG000|Overall Study|Withdrawal by Subject|0|||
144445262|NCT02247349|520829527|FG001|Overall Study|Withdrawal by Subject|1|||
144445263|NCT02247349|520829528|FG002|Overall Study|Withdrawal by Subject|0|||
144445264|NCT02247349|520829529|FG003|Overall Study|Withdrawal by Subject|0|||
144445265|NCT02247349|520829530|FG004|Overall Study|Withdrawal by Subject|0|||
144445266|NCT02247349|520829531|FG005|Overall Study|Withdrawal by Subject|0|||
144445267|NCT02247349|520829526|FG000|Overall Study|Administrative reason by sponsor|0|||
144445268|NCT02247349|520829527|FG001|Overall Study|Administrative reason by sponsor|0|||
144445269|NCT02247349|520829528|FG002|Overall Study|Administrative reason by sponsor|0|||
144445270|NCT02247349|520829529|FG003|Overall Study|Administrative reason by sponsor|0|||
144445271|NCT02247349|520829530|FG004|Overall Study|Administrative reason by sponsor|1|||
144445272|NCT02247349|520829531|FG005|Overall Study|Administrative reason by sponsor|0|||
144445273|NCT02247349|520829526|FG000|Overall Study|Other reasons|0|||
144445274|NCT02247349|520829527|FG001|Overall Study|Other reasons|0|||
144445275|NCT02247349|520829528|FG002|Overall Study|Other reasons|1|||
144445276|NCT02247349|520829529|FG003|Overall Study|Other reasons|0|||
144445277|NCT02247349|520829530|FG004|Overall Study|Other reasons|0|||
144445278|NCT02247349|520829531|FG005|Overall Study|Other reasons|0|||
144445279|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Adverse Event|41|||
144445280|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Adverse Event|24|||
144445281|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
144445282|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
144445283|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
144445284|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
144445285|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Physician Decision|0|||
144445286|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Physician Decision|6|||
144445287|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
144445288|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
144445289|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
144445290|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
144445291|NCT00673452|520829532|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
144445292|NCT00673452|520829533|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
144445293|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
144445294|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
144445295|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
144445296|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
144445297|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
144445298|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
144445299|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
144445300|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
144445301|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
144445302|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
144445303|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
144445304|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
144445305|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
144445306|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
144445307|NCT00673452|520829532|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
144445308|NCT00673452|520829533|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
144445309|NCT01193556|520829538|FG000|Overall Study|Study termination|26|||
144445310|NCT01193556|520829539|FG001|Overall Study|Study termination|25|||
144445311|NCT02203591|520829541|FG000|Overall Study|Did not meet treatment day baseline|147|||
144445312|NCT02203591|520829542|FG001|Overall Study|Did not meet treatment day baseline|141|||
144445313|NCT02203591|520829543|FG002|Overall Study|Did not meet treatment day baseline|150|||
144445314|NCT02203591|520829544|FG003|Overall Study|Did not meet treatment day baseline|45|||
144445315|NCT02203591|520829545|FG004|Overall Study|Did not meet treatment day baseline|33|||
144445316|NCT02203591|520829546|FG005|Overall Study|Did not meet treatment day baseline|35|||
144445317|NCT02203591|520829547|FG006|Overall Study|Did not meet treatment day baseline|29|||
144445318|NCT02203591|520829548|FG007|Overall Study|Did not meet treatment day baseline|12|||
144445319|NCT02203591|520829541|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
144445320|NCT02203591|520829542|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
144445321|NCT02203591|520829543|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
144445322|NCT02203591|520829544|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
144445323|NCT02203591|520829545|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
144445324|NCT02203591|520829546|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
144445325|NCT02203591|520829547|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
144445326|NCT02203591|520829548|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
144445327|NCT00813358|520829568|FG000|Overall Study|Death|32|||
144445328|NCT00813358|520829568|FG000|Overall Study|Lost to Follow-up|12|||
144445329|NCT00813358|520829568|FG000|Overall Study|other endpoints|5|||
144445330|NCT00813358|520829568|FG000|Overall Study|Withdrawal by Subject|20|||
144445331|NCT00700011|520829570|FG000|Overall Study|Death|0|||
144445332|NCT00700011|520829571|FG001|Overall Study|Death|1|||
144445333|NCT00004031|520829572|FG000|Overall Study|Adverse Event|5|||
144445334|NCT00004031|520829573|FG001|Overall Study|Adverse Event|0|||
144445335|NCT00004031|520829572|FG000|Overall Study|Refusal unrelated to adverse events|2|||
144445336|NCT00004031|520829573|FG001|Overall Study|Refusal unrelated to adverse events|11|||
144445337|NCT00004031|520829572|FG000|Overall Study|Progression/relapse|9|||
144445338|NCT00004031|520829573|FG001|Overall Study|Progression/relapse|4|||
144445339|NCT00004031|520829572|FG000|Overall Study|Death|3|||
144445340|NCT00004031|520829573|FG001|Overall Study|Death|1|||
144445341|NCT00004031|520829572|FG000|Overall Study|Other- not protocol specified|3|||
144445342|NCT00004031|520829573|FG001|Overall Study|Other- not protocol specified|3|||
144445343|NCT00004031|520829572|FG000|Overall Study|Reason under review|3|||
144445344|NCT00004031|520829573|FG001|Overall Study|Reason under review|2|||
144445345|NCT02920983|520829574|FG000|Dispense 1|Unacceptable Lens Fit|0|||
144445346|NCT02920983|520829575|FG001|Dispense 1|Unacceptable Lens Fit|0|||
144445347|NCT02920983|520829576|FG002|Dispense 1|Unacceptable Lens Fit|0|||
144445348|NCT02920983|520829577|FG003|Dispense 1|Unacceptable Lens Fit|0|||
144193744|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Death|1|||
144193745|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Death|0|||
144193746|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Death|0|||
144193747|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Death|0|||
144193748|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
144193749|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
144193750|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
144193751|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
144193752|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
144193753|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
144193754|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
144193755|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
144193756|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
144193757|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
144193758|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
144193759|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
144193760|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
144193761|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
144193762|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
144193763|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
144193764|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
144193765|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
144193766|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
144193767|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
144193768|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
144193769|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
144193770|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
144193771|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
144193772|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
144193773|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
144193774|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
144193775|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
144193776|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
144193777|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
144193778|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
144193779|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
144193780|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
144193781|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
144193782|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
144193783|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
144193784|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Other|3|||
144193785|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Other|0|||
144193786|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Other|4|||
144193787|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Other|1|||
144193788|NCT02990806|519905055|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
144193789|NCT02990806|519905056|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
144193790|NCT02990806|519905057|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
144445349|NCT02920983|520829578|FG004|Dispense 1|Unacceptable Lens Fit|1|||
144445350|NCT02920983|520829579|FG005|Dispense 1|Unacceptable Lens Fit|0|||
144445351|NCT02920983|520829574|FG000|Dispense 2|Unscceptable lens fit|1|||
144445352|NCT02920983|520829575|FG001|Dispense 2|Unscceptable lens fit|0|||
144445353|NCT02920983|520829576|FG002|Dispense 2|Unscceptable lens fit|0|||
144445354|NCT02920983|520829577|FG003|Dispense 2|Unscceptable lens fit|0|||
144445355|NCT02920983|520829578|FG004|Dispense 2|Unscceptable lens fit|1|||
144445356|NCT02920983|520829579|FG005|Dispense 2|Unscceptable lens fit|0|||
144445357|NCT02920983|520829574|FG000|Dispense 3|Unacceptable Lens Fit|1|||
144445358|NCT02920983|520829575|FG001|Dispense 3|Unacceptable Lens Fit|1|||
144445359|NCT02920983|520829576|FG002|Dispense 3|Unacceptable Lens Fit|0|||
144445360|NCT02920983|520829577|FG003|Dispense 3|Unacceptable Lens Fit|0|||
144445361|NCT02920983|520829578|FG004|Dispense 3|Unacceptable Lens Fit|1|||
144445362|NCT02920983|520829579|FG005|Dispense 3|Unacceptable Lens Fit|0|||
144193791|NCT02990806|519905058|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
144445363|NCT03551210|520829580|FG000|Overall Study|Adverse Event|5|||
144445364|NCT03551210|520829581|FG001|Overall Study|Adverse Event|6|||
144193792|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
144445365|NCT03551210|520829580|FG000|Overall Study|Withdrawal by Subject|1|||
144445366|NCT03551210|520829581|FG001|Overall Study|Withdrawal by Subject|7|||
144445367|NCT03551210|520829580|FG000|Overall Study|Needed in other antibiotic treatment|2|||
144445368|NCT03551210|520829581|FG001|Overall Study|Needed in other antibiotic treatment|5|||
144445369|NCT03551210|520829580|FG000|Overall Study|Lost to Follow-up|1|||
144445370|NCT03551210|520829581|FG001|Overall Study|Lost to Follow-up|1|||
144532657|NCT03536884|521154276|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144193793|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
144193794|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
144193795|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
144193796|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
144193797|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
144193798|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
144193799|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
144253727|NCT04985942|520129994|FG001|Overall Study|Withdrawal by Subject|4|||
144445371|NCT03551210|520829580|FG000|Overall Study|Absence of visit 4 and 5|1|||
144445372|NCT03551210|520829581|FG001|Overall Study|Absence of visit 4 and 5|0|||
144445373|NCT03551210|520829580|FG000|Overall Study|No drug for dispensing|0|||
144445374|NCT03551210|520829581|FG001|Overall Study|No drug for dispensing|1|||
144445375|NCT03265119|520829582|FG000|Overall Study|Adverse Event|2|||
144445376|NCT03265119|520829583|FG001|Overall Study|Adverse Event|1|||
144445377|NCT03265119|520829582|FG000|Overall Study|Lack of Efficacy|3|||
144445378|NCT03265119|520829583|FG001|Overall Study|Lack of Efficacy|0|||
144445379|NCT03265119|520829582|FG000|Overall Study|Protocol Violation|1|||
144445380|NCT03265119|520829583|FG001|Overall Study|Protocol Violation|2|||
144445381|NCT03265119|520829582|FG000|Overall Study|Withdrawal by Subject|2|||
144445382|NCT03265119|520829583|FG001|Overall Study|Withdrawal by Subject|4|||
144445383|NCT03265119|520829582|FG000|Overall Study|Lost to Follow-up|1|||
144445384|NCT03265119|520829583|FG001|Overall Study|Lost to Follow-up|0|||
144445385|NCT03265119|520829582|FG000|Overall Study|Lack of Compliance|1|||
144445386|NCT03265119|520829583|FG001|Overall Study|Lack of Compliance|0|||
144445387|NCT03890367|520829588|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144445388|NCT03890367|520829589|FG001|Overall Study|Withdrawal by parent/guardian|3|||
144445389|NCT03890367|520829590|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144445390|NCT03890367|520829588|FG000|Overall Study|Protocol deviation|2|||
144532658|NCT03536884|521154277|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
144532659|NCT03536884|521154278|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
144532660|NCT03536884|521154279|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144532661|NCT03536884|521154280|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144606288|NCT01444456|521419091|FG000|Overall Study|Death|73|||
144606289|NCT01444456|521419091|FG000|Overall Study|Ineligibility determined|23|||
144606290|NCT01444456|521419091|FG000|Overall Study|Other|18|||
144606291|NCT01444456|521419091|FG000|Overall Study|Not treated|104|||
144606292|NCT04376827|521419095|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
144606293|NCT04376827|521419096|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
144606294|NCT04376827|521419095|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
144606295|NCT04376827|521419096|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
144606296|NCT04376827|521419095|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
144606297|NCT04376827|521419096|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
144606298|NCT04376827|521419095|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
144606299|NCT04376827|521419096|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
144606300|NCT04376827|521419095|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
144606301|NCT04376827|521419096|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
144606302|NCT02142738|521420953|FG000|Overall Study|Adverse Event|13|||
144606303|NCT02142738|521420954|FG001|Overall Study|Adverse Event|9|||
144606304|NCT02142738|521420953|FG000|Overall Study|Death|92|||
144606305|NCT02142738|521420954|FG001|Overall Study|Death|112|||
144606306|NCT02142738|521420953|FG000|Overall Study|Lost to Follow-up|0|||
144606307|NCT02142738|521420954|FG001|Overall Study|Lost to Follow-up|3|||
144606308|NCT02142738|521420953|FG000|Overall Study|Withdrawal by Subject|6|||
144606309|NCT02142738|521420954|FG001|Overall Study|Withdrawal by Subject|7|||
144606310|NCT02142738|521420953|FG000|Overall Study|Follow up ended by sponsor|43|||
144253728|NCT03252145|520129995|FG000|Overall Study|Withdrawal by Subject|1|||
144532662|NCT03536884|521154281|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144532663|NCT03536884|521154282|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144532664|NCT03536884|521154283|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144532665|NCT03536884|521154284|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144532666|NCT03536884|521154285|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
144532667|NCT03536884|521154274|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532668|NCT03536884|521154275|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532669|NCT03536884|521154276|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
144532670|NCT03536884|521154277|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
144532671|NCT03536884|521154278|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
144532672|NCT03536884|521154279|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144606311|NCT02142738|521420954|FG001|Overall Study|Follow up ended by sponsor|20|||
144445391|NCT03890367|520829589|FG001|Overall Study|Protocol deviation|2|||
144445392|NCT03890367|520829590|FG002|Overall Study|Protocol deviation|1|||
144445393|NCT03890367|520829588|FG000|Overall Study|Lost to Follow-up|1|||
144445394|NCT03890367|520829589|FG001|Overall Study|Lost to Follow-up|1|||
144445395|NCT03890367|520829590|FG002|Overall Study|Lost to Follow-up|0|||
144445396|NCT03085927|520831296|FG000|Overall Study|Withdrawal by Subject|1|||
144445397|NCT03085927|520831297|FG001|Overall Study|Withdrawal by Subject|4|||
144445398|NCT03085927|520831296|FG000|Overall Study|Lost to Follow-up|3|||
144445399|NCT03085927|520831297|FG001|Overall Study|Lost to Follow-up|1|||
144445400|NCT03085927|520831296|FG000|Overall Study|Death|1|||
144445401|NCT03085927|520831297|FG001|Overall Study|Death|0|||
144445402|NCT03085927|520831296|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
144532673|NCT03536884|521154280|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532674|NCT03536884|521154281|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532675|NCT03536884|521154282|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532676|NCT03536884|521154283|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532677|NCT03536884|521154284|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532678|NCT03536884|521154285|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
144532679|NCT03536884|521154274|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532680|NCT03536884|521154275|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532681|NCT03536884|521154276|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
144532682|NCT03536884|521154277|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
144532683|NCT03536884|521154278|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
144532684|NCT03536884|521154279|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532685|NCT03536884|521154280|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532686|NCT03536884|521154281|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532687|NCT03536884|521154282|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532688|NCT03536884|521154283|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532689|NCT03536884|521154284|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532690|NCT03536884|521154285|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
144532691|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532692|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532693|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532694|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532695|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532696|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
144532697|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
144532698|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
144532699|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
144532700|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532701|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532702|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
144532703|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532704|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532705|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532706|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532707|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532708|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
144532709|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
144532710|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
144532711|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
144532712|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532713|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532714|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
144532715|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532716|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532717|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532718|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532719|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532720|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
144532721|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532722|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
144532723|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532724|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144606312|NCT03688880|521420955|FG000|Overall Study|Withdrawal by Subject|0|||
144606313|NCT03688880|521420956|FG001|Overall Study|Withdrawal by Subject|2|||
144606314|NCT03688880|521420955|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
144445403|NCT03085927|520831297|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
144445404|NCT03085927|520831296|FG000|Overall Study|Dyad Became Ineligible|0|||
144532725|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532726|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
144532727|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532728|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532729|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532730|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144193800|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
144193801|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
144193802|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
144193803|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
144445405|NCT03085927|520831297|FG001|Overall Study|Dyad Became Ineligible|1|||
144445406|NCT00600821|520831298|FG000|Overall Study|Death|45|||
144445407|NCT00600821|520831299|FG001|Overall Study|Death|46|||
144445408|NCT00600821|520831298|FG000|Overall Study|Lost to Follow-up|2|||
144193804|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
144193805|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
144193806|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
144193807|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
144193808|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
144193809|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
144193810|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
144193811|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
144193812|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
144193813|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
144193814|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
144193815|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
144193816|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
144193817|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
144193818|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
144193819|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
144193820|NCT02990806|519905055|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
144193821|NCT02990806|519905056|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
144193822|NCT02990806|519905057|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
144193823|NCT02990806|519905058|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
144193824|NCT01010750|519905059|FG000|Second Intervention|Adverse Event|0|||
144193825|NCT01010750|519905060|FG001|Second Intervention|Adverse Event|1|||
144193826|NCT01010750|519905061|FG002|Second Intervention|Adverse Event|0|||
144193827|NCT01010750|519905062|FG003|Second Intervention|Adverse Event|0|||
144193828|NCT01010750|519905063|FG004|Second Intervention|Adverse Event|0|||
144193829|NCT01010750|519905064|FG005|Second Intervention|Adverse Event|0|||
144193830|NCT02654587|519905065|FG000|Overall Study|patient alive at end of study|22|||
144193831|NCT02654587|519905066|FG001|Overall Study|patient alive at end of study|8|||
144193832|NCT02654587|519905065|FG000|Overall Study|Withdrawal by Subject|1|||
144193833|NCT02654587|519905066|FG001|Overall Study|Withdrawal by Subject|7|||
144193834|NCT01825837|519905067|FG000|PART I|Withdrawal by Subject|0|||
144193835|NCT01825837|519905068|FG001|PART I|Withdrawal by Subject|0|||
144193836|NCT01825837|519905069|FG002|PART I|Withdrawal by Subject|0|||
144193837|NCT01825837|519905070|FG003|PART I|Withdrawal by Subject|6|||
144193838|NCT01825837|519905067|FG000|PART I|Patient non-compliance|0|||
144193839|NCT01825837|519905068|FG001|PART I|Patient non-compliance|0|||
144193840|NCT01825837|519905069|FG002|PART I|Patient non-compliance|0|||
144193841|NCT01825837|519905070|FG003|PART I|Patient non-compliance|1|||
144193842|NCT01825837|519905067|FG000|PART I|Treatment failure|0|||
144193843|NCT01825837|519905068|FG001|PART I|Treatment failure|0|||
144193844|NCT01825837|519905069|FG002|PART I|Treatment failure|0|||
144193845|NCT01825837|519905070|FG003|PART I|Treatment failure|7|||
144193846|NCT01825837|519905067|FG000|PART I|reason unspecified|0|||
144193847|NCT01825837|519905068|FG001|PART I|reason unspecified|0|||
144193848|NCT01825837|519905069|FG002|PART I|reason unspecified|0|||
144193849|NCT01825837|519905070|FG003|PART I|reason unspecified|3|||
144193850|NCT01825837|519905067|FG000|PART II|Withdrawal by Subject|3|||
144193851|NCT01825837|519905068|FG001|PART II|Withdrawal by Subject|3|||
144445409|NCT00600821|520831299|FG001|Overall Study|Lost to Follow-up|2|||
144445410|NCT00600821|520831298|FG000|Overall Study|Withdrawal by Subject|1|||
144193852|NCT01825837|519905069|FG002|PART II|Withdrawal by Subject|7|||
144193853|NCT01825837|519905070|FG003|PART II|Withdrawal by Subject|0|||
144193854|NCT01825837|519905067|FG000|PART II|Patient non-compliance|5|||
144193855|NCT01825837|519905068|FG001|PART II|Patient non-compliance|2|||
144193856|NCT01825837|519905069|FG002|PART II|Patient non-compliance|4|||
144193857|NCT01825837|519905070|FG003|PART II|Patient non-compliance|0|||
144193858|NCT01825837|519905067|FG000|PART II|Adverse Event|3|||
144193859|NCT01825837|519905068|FG001|PART II|Adverse Event|3|||
144193860|NCT01825837|519905069|FG002|PART II|Adverse Event|1|||
144193861|NCT01825837|519905070|FG003|PART II|Adverse Event|0|||
144193862|NCT01825837|519905067|FG000|PART II|Treatment failure|6|||
144193863|NCT01825837|519905068|FG001|PART II|Treatment failure|4|||
144193864|NCT01825837|519905069|FG002|PART II|Treatment failure|5|||
144193865|NCT01825837|519905070|FG003|PART II|Treatment failure|0|||
144193866|NCT01825837|519905067|FG000|PART II|reason unspecified|2|||
144445411|NCT00600821|520831299|FG001|Overall Study|Withdrawal by Subject|1|||
144606315|NCT03688880|521420956|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
144606316|NCT03688880|521420955|FG000|Overall Study|Lost to Follow-up|4|||
144606317|NCT03688880|521420956|FG001|Overall Study|Lost to Follow-up|7|||
144606318|NCT03688880|521420955|FG000|Overall Study|Adverse Event|0|||
144606319|NCT03688880|521420956|FG001|Overall Study|Adverse Event|2|||
144606320|NCT03688880|521420955|FG000|Overall Study|Device deficiencies|0|||
144606321|NCT03688880|521420956|FG001|Overall Study|Device deficiencies|2|||
144606322|NCT03688880|521420955|FG000|Overall Study|Other|10|||
144606323|NCT03688880|521420956|FG001|Overall Study|Other|16|||
144606324|NCT01704287|521420957|FG000|Initial Treatment Period|Death|139|||
144193867|NCT01825837|519905068|FG001|PART II|reason unspecified|2|||
144193868|NCT01825837|519905069|FG002|PART II|reason unspecified|2|||
144193869|NCT01825837|519905070|FG003|PART II|reason unspecified|0|||
144193870|NCT03648879|519905077|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
144193871|NCT02339740|519905078|FG000|Overall Study|Death|1|||
144193872|NCT02339740|519905079|FG001|Overall Study|Death|0|||
144193873|NCT02339740|519905078|FG000|Overall Study|Physician Decision|0|||
144193874|NCT02339740|519905079|FG001|Overall Study|Physician Decision|2|||
144193875|NCT02339740|519905078|FG000|Overall Study|Withdrawal by Subject|5|||
144193876|NCT02339740|519905079|FG001|Overall Study|Withdrawal by Subject|1|||
144193877|NCT02339740|519905078|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
144193878|NCT02339740|519905079|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
144193879|NCT02096588|519905080|FG000|Overall Study|Lack of Efficacy|2|||
144193880|NCT02096588|519905081|FG001|Overall Study|Lack of Efficacy|0|||
144193881|NCT02096588|519905080|FG000|Overall Study|Withdrawal by Subject|0|||
144193882|NCT02096588|519905081|FG001|Overall Study|Withdrawal by Subject|1|||
144193883|NCT01258101|519905083|FG000|Overall Study|Adverse Event|5|||
144193884|NCT01258101|519905084|FG001|Overall Study|Adverse Event|6|||
144445412|NCT00600821|520831298|FG000|Overall Study|Terminated by sponsor|8|||
144445413|NCT00600821|520831299|FG001|Overall Study|Terminated by sponsor|6|||
144445414|NCT00600821|520831298|FG000|Overall Study|Objective progression or relapse|0|||
144445415|NCT00600821|520831299|FG001|Overall Study|Objective progression or relapse|1|||
144445416|NCT00600821|520831298|FG000|Overall Study|Randomized but not treated|0|||
144445417|NCT00600821|520831299|FG001|Overall Study|Randomized but not treated|1|||
144445418|NCT00600821|520831298|FG000|Overall Study|Other|2|||
144445419|NCT00600821|520831299|FG001|Overall Study|Other|3|||
144445420|NCT02602288|520831300|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
144445421|NCT02602288|520831301|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
144445422|NCT02602288|520831300|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
144445423|NCT02602288|520831301|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
144445424|NCT02602288|520831300|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
144445425|NCT02602288|520831301|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
144445426|NCT02602288|520831300|FG000|12 Month Follow-up|Lost to Follow-up|0|||
144445427|NCT02602288|520831301|FG001|12 Month Follow-up|Lost to Follow-up|4|||
144445428|NCT02602288|520831300|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
144445429|NCT02602288|520831301|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
144445430|NCT00194012|520831302|FG000|Randomized Phase|Lack of Efficacy|8|||
144445431|NCT00194012|520831303|FG001|Randomized Phase|Lack of Efficacy|18|||
144445432|NCT00194012|520831302|FG000|Randomized Phase|Study nonadherence|2|||
144445433|NCT00194012|520831303|FG001|Randomized Phase|Study nonadherence|1|||
144445434|NCT00194012|520831302|FG000|Randomized Phase|Withdrawal by Subject|3|||
144445435|NCT00194012|520831303|FG001|Randomized Phase|Withdrawal by Subject|3|||
144445436|NCT00194012|520831302|FG000|Randomized Phase|Adverse Event|2|||
144445437|NCT00194012|520831303|FG001|Randomized Phase|Adverse Event|1|||
144445438|NCT00194012|520831302|FG000|Randomized Phase|Participant reported having a rash|1|||
144445439|NCT00194012|520831303|FG001|Randomized Phase|Participant reported having a rash|0|||
144445440|NCT00194012|520831302|FG000|Randomized Phase|Emesis and enuresis|0|||
144445441|NCT00194012|520831303|FG001|Randomized Phase|Emesis and enuresis|1|||
144445442|NCT00194012|520831302|FG000|Randomized Phase|Oral/nasal twitching|0|||
144445443|NCT00194012|520831303|FG001|Randomized Phase|Oral/nasal twitching|1|||
144445444|NCT00194012|520831302|FG000|Open Label Extension (OLE)|Weight Gain|1|||
144445445|NCT00194012|520831303|FG001|Open Label Extension (OLE)|Weight Gain|0|||
144445446|NCT00194012|520831302|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
144445447|NCT00194012|520831303|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
144445448|NCT00194012|520831302|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
144445449|NCT00194012|520831303|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
144445450|NCT00194012|520831302|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
144445451|NCT00194012|520831303|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
144606325|NCT01704287|521420958|FG001|Initial Treatment Period|Death|129|||
144193885|NCT01258101|519905085|FG002|Overall Study|Adverse Event|0|||
144193886|NCT01258101|519905086|FG003|Overall Study|Adverse Event|0|||
144193887|NCT01258101|519905083|FG000|Overall Study|Extra exclusion criterion amended|2|||
144193888|NCT01258101|519905084|FG001|Overall Study|Extra exclusion criterion amended|1|||
144193889|NCT01258101|519905085|FG002|Overall Study|Extra exclusion criterion amended|1|||
144445452|NCT02066298|520831307|FG000|Overall Study|Lost to Follow-up|3|||
144445453|NCT02066298|520831308|FG001|Overall Study|Lost to Follow-up|2|||
144445454|NCT02066298|520831309|FG002|Overall Study|Lost to Follow-up|3|||
144445455|NCT02066298|520831310|FG003|Overall Study|Lost to Follow-up|2|||
144445456|NCT02066298|520831311|FG004|Overall Study|Lost to Follow-up|3|||
144445457|NCT02066298|520831312|FG005|Overall Study|Lost to Follow-up|4|||
144445458|NCT02066298|520831307|FG000|Overall Study|Withdrawal by Subject|6|||
144445459|NCT02066298|520831308|FG001|Overall Study|Withdrawal by Subject|6|||
144445460|NCT02066298|520831309|FG002|Overall Study|Withdrawal by Subject|6|||
144445461|NCT02066298|520831310|FG003|Overall Study|Withdrawal by Subject|4|||
144445462|NCT02066298|520831311|FG004|Overall Study|Withdrawal by Subject|5|||
144445463|NCT02066298|520831312|FG005|Overall Study|Withdrawal by Subject|8|||
144445464|NCT02066298|520831307|FG000|Overall Study|Physician Decision|0|||
144445465|NCT02066298|520831308|FG001|Overall Study|Physician Decision|0|||
144445466|NCT02066298|520831309|FG002|Overall Study|Physician Decision|1|||
144445467|NCT02066298|520831310|FG003|Overall Study|Physician Decision|0|||
144445468|NCT02066298|520831311|FG004|Overall Study|Physician Decision|1|||
144445469|NCT02066298|520831312|FG005|Overall Study|Physician Decision|0|||
144445470|NCT04260191|520831313|FG000|Overall Study|Decision by Sponsor|0|||
144445471|NCT04260191|520831314|FG001|Overall Study|Decision by Sponsor|1|||
144445472|NCT04260191|520831315|FG002|Overall Study|Decision by Sponsor|0|||
144445473|NCT04260191|520831313|FG000|Overall Study|Withdrawal by Subject|1|||
144445474|NCT04260191|520831314|FG001|Overall Study|Withdrawal by Subject|0|||
144445475|NCT04260191|520831315|FG002|Overall Study|Withdrawal by Subject|3|||
144445476|NCT04260191|520831313|FG000|Overall Study|Death|4|||
144445477|NCT04260191|520831314|FG001|Overall Study|Death|3|||
144445478|NCT04260191|520831315|FG002|Overall Study|Death|2|||
144445479|NCT00630877|520831318|FG000|Overall Study|Adverse Event|11|||
144445480|NCT00630877|520831319|FG001|Overall Study|Adverse Event|8|||
144445481|NCT00630877|520831320|FG002|Overall Study|Adverse Event|7|||
144445482|NCT00630877|520831318|FG000|Overall Study|Withdrawal by Subject|3|||
144445483|NCT00630877|520831319|FG001|Overall Study|Withdrawal by Subject|4|||
144445484|NCT00630877|520831320|FG002|Overall Study|Withdrawal by Subject|0|||
144445485|NCT00630877|520831318|FG000|Overall Study|Lost to Follow-up|2|||
144445486|NCT00630877|520831319|FG001|Overall Study|Lost to Follow-up|0|||
144445487|NCT00630877|520831320|FG002|Overall Study|Lost to Follow-up|0|||
144445488|NCT00630877|520831318|FG000|Overall Study|Noncompliance|2|||
144445489|NCT00630877|520831319|FG001|Overall Study|Noncompliance|3|||
144445490|NCT00630877|520831320|FG002|Overall Study|Noncompliance|1|||
144445491|NCT00630877|520831318|FG000|Overall Study|Protocol violation|1|||
144445492|NCT00630877|520831319|FG001|Overall Study|Protocol violation|0|||
144445493|NCT00630877|520831320|FG002|Overall Study|Protocol violation|1|||
144532731|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532732|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
144532733|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532734|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
144532735|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
144532736|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532737|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532738|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
144532739|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532740|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532741|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532742|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532743|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532744|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
144532745|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
144532746|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
144532747|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
144532748|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532749|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532750|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
144532751|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144445494|NCT00630877|520831318|FG000|Overall Study|Personal reasons|0|||
144445495|NCT00630877|520831319|FG001|Overall Study|Personal reasons|0|||
144532752|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532753|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144445496|NCT00630877|520831320|FG002|Overall Study|Personal reasons|1|||
144445497|NCT01643473|520831321|FG000|Overall Study|Lost to Follow-up|1|||
144445498|NCT01643473|520831322|FG001|Overall Study|Lost to Follow-up|0|||
144445499|NCT01519518|520831323|FG000|Overall Study|Consent not available|7|||
144445500|NCT01519518|520831324|FG001|Overall Study|Consent not available|10|||
144445501|NCT02343458|520831327|FG000|Overall Study|Adverse Event|15|||
144445502|NCT02343458|520831328|FG001|Overall Study|Adverse Event|14|||
144445503|NCT02343458|520831329|FG002|Overall Study|Adverse Event|15|||
144445504|NCT02343458|520831330|FG003|Overall Study|Adverse Event|3|||
144532754|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144445505|NCT02343458|520831327|FG000|Overall Study|Lack of Efficacy|3|||
144445506|NCT02343458|520831328|FG001|Overall Study|Lack of Efficacy|8|||
144445507|NCT02343458|520831329|FG002|Overall Study|Lack of Efficacy|4|||
144445508|NCT02343458|520831330|FG003|Overall Study|Lack of Efficacy|8|||
144445509|NCT02343458|520831327|FG000|Overall Study|Withdrawal by Subject|18|||
144445510|NCT02343458|520831328|FG001|Overall Study|Withdrawal by Subject|17|||
144445511|NCT02343458|520831329|FG002|Overall Study|Withdrawal by Subject|23|||
144445512|NCT02343458|520831330|FG003|Overall Study|Withdrawal by Subject|14|||
144445513|NCT02343458|520831327|FG000|Overall Study|Physician Decision|1|||
144445514|NCT02343458|520831328|FG001|Overall Study|Physician Decision|4|||
144445515|NCT02343458|520831329|FG002|Overall Study|Physician Decision|2|||
144445516|NCT02343458|520831330|FG003|Overall Study|Physician Decision|2|||
144445517|NCT02343458|520831327|FG000|Overall Study|Lost to Follow-up|5|||
144445518|NCT02343458|520831328|FG001|Overall Study|Lost to Follow-up|5|||
144445519|NCT02343458|520831329|FG002|Overall Study|Lost to Follow-up|3|||
144445520|NCT02343458|520831330|FG003|Overall Study|Lost to Follow-up|1|||
144445521|NCT02343458|520831327|FG000|Overall Study|Protocol Violation|2|||
144445522|NCT02343458|520831328|FG001|Overall Study|Protocol Violation|5|||
144445523|NCT02343458|520831329|FG002|Overall Study|Protocol Violation|2|||
144445524|NCT02343458|520831330|FG003|Overall Study|Protocol Violation|2|||
144445525|NCT02343458|520831327|FG000|Overall Study|Protocol Specified Criteria|17|||
144445526|NCT02343458|520831328|FG001|Overall Study|Protocol Specified Criteria|13|||
144445527|NCT02343458|520831329|FG002|Overall Study|Protocol Specified Criteria|14|||
144445528|NCT02343458|520831330|FG003|Overall Study|Protocol Specified Criteria|8|||
144445529|NCT01312909|520831331|FG000|Overall Study|Randomized but not treated|1|||
144445530|NCT01312909|520831332|FG001|Overall Study|Randomized but not treated|3|||
144445531|NCT01312909|520831333|FG002|Overall Study|Randomized but not treated|1|||
144445532|NCT01312909|520831331|FG000|Overall Study|Adverse Event|1|||
144445533|NCT01312909|520831332|FG001|Overall Study|Adverse Event|0|||
144193890|NCT01258101|519905086|FG003|Overall Study|Extra exclusion criterion amended|1|||
144193891|NCT01258101|519905083|FG000|Overall Study|Informed consent has been withdrawn|2|||
144193892|NCT01258101|519905084|FG001|Overall Study|Informed consent has been withdrawn|2|||
144193893|NCT01258101|519905085|FG002|Overall Study|Informed consent has been withdrawn|1|||
144193894|NCT01258101|519905086|FG003|Overall Study|Informed consent has been withdrawn|1|||
144193895|NCT01258101|519905083|FG000|Overall Study|Patient is not able to attend visits|8|||
144193896|NCT01258101|519905084|FG001|Overall Study|Patient is not able to attend visits|9|||
144193897|NCT01258101|519905085|FG002|Overall Study|Patient is not able to attend visits|7|||
144193898|NCT01258101|519905086|FG003|Overall Study|Patient is not able to attend visits|6|||
144445534|NCT01312909|520831333|FG002|Overall Study|Adverse Event|3|||
144445535|NCT01312909|520831331|FG000|Overall Study|Protocol Violation|2|||
144445536|NCT01312909|520831332|FG001|Overall Study|Protocol Violation|0|||
144445537|NCT01312909|520831333|FG002|Overall Study|Protocol Violation|2|||
144445538|NCT01312909|520831331|FG000|Overall Study|Other|9|||
144445539|NCT01312909|520831332|FG001|Overall Study|Other|6|||
144445540|NCT01312909|520831333|FG002|Overall Study|Other|11|||
144445541|NCT01312909|520831331|FG000|Overall Study|Withdrawal by Subject|8|||
144445542|NCT01312909|520831332|FG001|Overall Study|Withdrawal by Subject|10|||
144445543|NCT01312909|520831333|FG002|Overall Study|Withdrawal by Subject|7|||
144445544|NCT01312909|520831331|FG000|Overall Study|Lost to Follow-up|21|||
144445545|NCT01312909|520831332|FG001|Overall Study|Lost to Follow-up|17|||
144445546|NCT01312909|520831333|FG002|Overall Study|Lost to Follow-up|20|||
144445547|NCT01312909|520831331|FG000|Overall Study|Insufficient clinical response|0|||
144445548|NCT01312909|520831332|FG001|Overall Study|Insufficient clinical response|0|||
144445549|NCT01312909|520831333|FG002|Overall Study|Insufficient clinical response|1|||
144445550|NCT01312909|520831331|FG000|Overall Study|Entrance criteria not met|0|||
144445551|NCT01312909|520831332|FG001|Overall Study|Entrance criteria not met|0|||
144445552|NCT01312909|520831333|FG002|Overall Study|Entrance criteria not met|2|||
144445553|NCT01913041|520831334|FG000|Overall Study|Protocol Violation|35|||
144445554|NCT01913041|520831334|FG000|Overall Study|Withdrawal by Subject|3|||
144445555|NCT01913041|520831334|FG000|Overall Study|Physician Decision|1|||
144445556|NCT00424372|520831335|FG000|Overall Study|Death|1|||
144445557|NCT00424372|520831335|FG000|Overall Study|Adverse Event|18|||
144445558|NCT00424372|520831335|FG000|Overall Study|Lack of Efficacy|6|||
144193899|NCT01258101|519905083|FG000|Overall Study|Patient´s compliance|4|||
144193900|NCT01258101|519905084|FG001|Overall Study|Patient´s compliance|3|||
144445559|NCT00424372|520831335|FG000|Overall Study|Withdrawal by Subject|4|||
144532755|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144193901|NCT01258101|519905085|FG002|Overall Study|Patient´s compliance|1|||
144193902|NCT01258101|519905086|FG003|Overall Study|Patient´s compliance|2|||
144445560|NCT00424372|520831335|FG000|Overall Study|Protocol Violation|1|||
144445561|NCT00424372|520831335|FG000|Overall Study|Health deterioration|1|||
144445562|NCT04622254|520831336|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
144445563|NCT04622254|520831337|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
144445564|NCT04622254|520831338|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
144445565|NCT04622254|520831339|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
144445566|NCT04622254|520831340|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
144445567|NCT04622254|520831341|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
144445568|NCT04622254|520831336|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
144445569|NCT04622254|520831337|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
144445570|NCT04622254|520831338|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
144445571|NCT04622254|520831339|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
144445572|NCT04622254|520831340|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
144445573|NCT04622254|520831341|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
144445574|NCT04622254|520831336|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
144445575|NCT04622254|520831337|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
144445576|NCT04622254|520831338|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
144445577|NCT04622254|520831339|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
144445578|NCT04622254|520831340|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
144445579|NCT04622254|520831341|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
144445580|NCT04622254|520831336|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144445581|NCT04622254|520831337|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
144445582|NCT04622254|520831338|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
144445583|NCT04622254|520831339|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144445584|NCT04622254|520831340|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144445585|NCT04622254|520831341|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144445586|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144445587|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144445588|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144445589|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
144445590|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144445591|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144445592|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144445593|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144445594|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144445595|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
144445596|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144445597|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
144445598|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144445599|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144445600|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144445601|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
144445602|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144445603|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144445604|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144445605|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144445606|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144445607|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
144445608|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144445609|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144445610|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
144445611|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
144445612|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
144445613|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
144445614|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
144445615|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
144445616|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
144445617|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
144445618|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
144445619|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
144445620|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
144445621|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
144445622|NCT04622254|520831336|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
144445623|NCT04622254|520831337|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
144445624|NCT04622254|520831338|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
144606326|NCT01704287|521420959|FG002|Initial Treatment Period|Death|71|||
144606327|NCT01704287|521420960|FG003|Initial Treatment Period|Death|0|||
144606328|NCT01704287|521420961|FG004|Initial Treatment Period|Death|0|||
144606329|NCT01704287|521420957|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
144606330|NCT01704287|521420958|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
144606331|NCT01704287|521420959|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
144445625|NCT04622254|520831339|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
144445626|NCT04622254|520831340|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
144445627|NCT04622254|520831341|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
144445628|NCT03228680|520831342|FG000|Overall Study|Adverse Event|13|||
144445629|NCT03228680|520831343|FG001|Overall Study|Adverse Event|18|||
144445630|NCT03228680|520831342|FG000|Overall Study|Randomization failure|0|||
144445631|NCT03228680|520831343|FG001|Overall Study|Randomization failure|1|||
144445632|NCT03228680|520831342|FG000|Overall Study|Withdrawal by Subject|1|||
144445633|NCT03228680|520831343|FG001|Overall Study|Withdrawal by Subject|0|||
144445634|NCT03228680|520831342|FG000|Overall Study|Other|9|||
144445635|NCT03228680|520831343|FG001|Overall Study|Other|16|||
144445636|NCT02489981|520831344|FG000|Overall Study|Adverse Event|21|||
144445637|NCT02489981|520831344|FG000|Overall Study|Insufficient effectiveness|16|||
144445638|NCT02489981|520831344|FG000|Overall Study|Improved|31|||
144445639|NCT02489981|520831344|FG000|Overall Study|Lost to Follow-up|31|||
144445640|NCT02489981|520831344|FG000|Overall Study|Other than listed|28|||
144445641|NCT03586869|520831347|FG000|Overall Study|Progressive Disease|3|||
144445642|NCT00087568|520831348|FG000|Overall Study|Adverse Event|4|||
144445643|NCT00087568|520831349|FG001|Overall Study|Adverse Event|0|||
144445644|NCT00087568|520831348|FG000|Overall Study|Withdrawal by Subject|1|||
144445645|NCT00087568|520831349|FG001|Overall Study|Withdrawal by Subject|1|||
144445646|NCT00087568|520831348|FG000|Overall Study|Lost to Follow-up|1|||
144445647|NCT00087568|520831349|FG001|Overall Study|Lost to Follow-up|0|||
144445648|NCT00087568|520831348|FG000|Overall Study|Lack of Efficacy|24|||
144445649|NCT00087568|520831349|FG001|Overall Study|Lack of Efficacy|1|||
144445650|NCT02992899|520831354|FG000|Overall Study|Withdrawal by Subject|1|||
144445651|NCT02992899|520831355|FG001|Overall Study|Withdrawal by Subject|0|||
144445652|NCT02992899|520831354|FG000|Overall Study|Lost to Follow-up|1|||
144445653|NCT02992899|520831355|FG001|Overall Study|Lost to Follow-up|3|||
144445654|NCT02370888|520831356|FG000|Overall Study|disease progression|2|||
144445655|NCT02370888|520831356|FG000|Overall Study|did not meet chimerism criteria|6|||
144445656|NCT01034397|520831357|FG000|Overall Study|Lack of compliance|0|||
144445657|NCT01034397|520831358|FG001|Overall Study|Lack of compliance|1|||
144445658|NCT01034397|520831357|FG000|Overall Study|Lack of Efficacy|3|||
144445659|NCT01034397|520831358|FG001|Overall Study|Lack of Efficacy|0|||
144445660|NCT01034397|520831357|FG000|Overall Study|Adverse Event|4|||
144445661|NCT01034397|520831358|FG001|Overall Study|Adverse Event|0|||
144445662|NCT01034397|520831357|FG000|Overall Study|Other|0|||
144445663|NCT01034397|520831358|FG001|Overall Study|Other|1|||
144445664|NCT03192150|520831365|FG000|Overall Study|Adverse Event|14|||
144445665|NCT03192150|520831366|FG001|Overall Study|Adverse Event|12|||
144445666|NCT03192150|520831365|FG000|Overall Study|Lack of Efficacy|23|||
144445667|NCT03192150|520831366|FG001|Overall Study|Lack of Efficacy|30|||
144445668|NCT03192150|520831365|FG000|Overall Study|Lost to Follow-up|1|||
144445669|NCT03192150|520831366|FG001|Overall Study|Lost to Follow-up|1|||
144445670|NCT03192150|520831365|FG000|Overall Study|Withdrawal by Subject|4|||
144445671|NCT03192150|520831366|FG001|Overall Study|Withdrawal by Subject|2|||
144445672|NCT03192150|520831365|FG000|Overall Study|Protocol Violation|5|||
144445673|NCT03192150|520831366|FG001|Overall Study|Protocol Violation|2|||
144445674|NCT03192150|520831365|FG000|Overall Study|Surgery Canceled|6|||
144445675|NCT03192150|520831366|FG001|Overall Study|Surgery Canceled|2|||
144445676|NCT03192150|520831365|FG000|Overall Study|Other-Various Administrative Reasons|2|||
144445677|NCT03192150|520831366|FG001|Overall Study|Other-Various Administrative Reasons|5|||
144445678|NCT02579616|520831367|FG000|Overall Study|Participants did not receive treatment|3|||
144445679|NCT00482391|520831368|FG000|Overall Study|Withdrawal by Subject|1|||
144445680|NCT00482391|520831368|FG000|Overall Study|Adverse Event|1|||
144445681|NCT00482391|520831368|FG000|Overall Study|Death|1|||
144445682|NCT01448850|520831369|FG000|Overall Study|Death|3|||
144445683|NCT01448850|520831370|FG001|Overall Study|Death|6|||
144445684|NCT01448850|520831369|FG000|Overall Study|Withdrawal by Subject|13|||
144445685|NCT01448850|520831370|FG001|Overall Study|Withdrawal by Subject|21|||
144445686|NCT01448850|520831369|FG000|Overall Study|Lost to Follow-up|3|||
144445687|NCT01448850|520831370|FG001|Overall Study|Lost to Follow-up|1|||
144445688|NCT01448850|520831369|FG000|Overall Study|Other|15|||
144445689|NCT01448850|520831370|FG001|Overall Study|Other|12|||
144445690|NCT02664038|520831373|FG000|13 Week|Lost to Follow-up|7|||
144445691|NCT02664038|520831374|FG001|13 Week|Lost to Follow-up|14|||
144445692|NCT02664038|520831373|FG000|13 Week|Withdrawal by Subject|1|||
144532756|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
144532757|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532758|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532759|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532760|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532761|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532762|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
144532763|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532764|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532765|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144445693|NCT02664038|520831374|FG001|13 Week|Withdrawal by Subject|0|||
144445694|NCT02664038|520831373|FG000|26 Week|Lost to Follow-up|5|||
144445695|NCT02664038|520831374|FG001|26 Week|Lost to Follow-up|4|||
144445696|NCT02606136|520831381|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
144445697|NCT02606136|520831381|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
144445698|NCT02606136|520831381|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
144445699|NCT02606136|520831381|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
144445700|NCT03296696|520831382|FG000|Overall Study|Started Other Antitumor Therapy|1|||
144445701|NCT03296696|520831383|FG001|Overall Study|Started Other Antitumor Therapy|2|||
144445702|NCT03296696|520831384|FG002|Overall Study|Started Other Antitumor Therapy|1|||
144445703|NCT03296696|520831385|FG003|Overall Study|Started Other Antitumor Therapy|2|||
144445704|NCT03296696|520831386|FG004|Overall Study|Started Other Antitumor Therapy|1|||
144445705|NCT03296696|520831387|FG005|Overall Study|Started Other Antitumor Therapy|1|||
144445706|NCT03296696|520831388|FG006|Overall Study|Started Other Antitumor Therapy|2|||
144445707|NCT03296696|520831389|FG007|Overall Study|Started Other Antitumor Therapy|3|||
144445708|NCT03296696|520831390|FG008|Overall Study|Started Other Antitumor Therapy|1|||
144445709|NCT03296696|520831391|FG009|Overall Study|Started Other Antitumor Therapy|0|||
144445710|NCT03296696|520831382|FG000|Overall Study|Death|0|||
144445711|NCT03296696|520831383|FG001|Overall Study|Death|1|||
144445712|NCT03296696|520831384|FG002|Overall Study|Death|1|||
144445713|NCT03296696|520831385|FG003|Overall Study|Death|2|||
144445714|NCT03296696|520831386|FG004|Overall Study|Death|2|||
144445715|NCT03296696|520831387|FG005|Overall Study|Death|3|||
144445716|NCT03296696|520831388|FG006|Overall Study|Death|1|||
144445717|NCT03296696|520831389|FG007|Overall Study|Death|2|||
144445718|NCT03296696|520831390|FG008|Overall Study|Death|0|||
144445719|NCT03296696|520831391|FG009|Overall Study|Death|0|||
144445720|NCT03296696|520831382|FG000|Overall Study|Withdrawal by Subject|0|||
144445721|NCT03296696|520831383|FG001|Overall Study|Withdrawal by Subject|0|||
144445722|NCT03296696|520831384|FG002|Overall Study|Withdrawal by Subject|1|||
144445723|NCT03296696|520831385|FG003|Overall Study|Withdrawal by Subject|0|||
144445724|NCT03296696|520831386|FG004|Overall Study|Withdrawal by Subject|1|||
144445725|NCT03296696|520831387|FG005|Overall Study|Withdrawal by Subject|0|||
144445726|NCT03296696|520831388|FG006|Overall Study|Withdrawal by Subject|0|||
144445727|NCT03296696|520831389|FG007|Overall Study|Withdrawal by Subject|0|||
144445728|NCT03296696|520831390|FG008|Overall Study|Withdrawal by Subject|0|||
144445729|NCT03296696|520831391|FG009|Overall Study|Withdrawal by Subject|1|||
144445730|NCT04694131|520831394|FG000|Overall Study|Withdrawal by Subject|7|||
144445731|NCT04694131|520831394|FG000|Overall Study|Screen Failure|1|||
144445732|NCT04694131|520831394|FG000|Overall Study|High stimulation threshold|3|||
144445733|NCT04456699|520831395|FG000|Overall Study|Death|48|||
144445734|NCT04456699|520831396|FG001|Overall Study|Death|50|||
144445735|NCT04456699|520831397|FG002|Overall Study|Death|52|||
144445736|NCT04456699|520831395|FG000|Overall Study|Physician Decision|0|||
144445737|NCT04456699|520831396|FG001|Overall Study|Physician Decision|0|||
144445738|NCT04456699|520831397|FG002|Overall Study|Physician Decision|2|||
144445739|NCT04456699|520831395|FG000|Overall Study|Sponsor Decision|55|||
144445740|NCT04456699|520831396|FG001|Overall Study|Sponsor Decision|61|||
144445741|NCT04456699|520831397|FG002|Overall Study|Sponsor Decision|50|||
144445742|NCT04456699|520831395|FG000|Overall Study|Withdrawal by Subject|8|||
144445743|NCT04456699|520831396|FG001|Overall Study|Withdrawal by Subject|4|||
144445744|NCT04456699|520831397|FG002|Overall Study|Withdrawal by Subject|5|||
144445745|NCT03495908|520831403|FG000|Overall Study|Withdrawal by Subject|3|||
144445746|NCT03495908|520831404|FG001|Overall Study|Withdrawal by Subject|1|||
144445747|NCT03495908|520831403|FG000|Overall Study|Lost to Follow-up|1|||
144445748|NCT03495908|520831404|FG001|Overall Study|Lost to Follow-up|4|||
144445749|NCT03495908|520831403|FG000|Overall Study|Adverse Event|0|||
144445750|NCT03495908|520831404|FG001|Overall Study|Adverse Event|2|||
144445751|NCT03495908|520831403|FG000|Overall Study|Death|1|||
144445752|NCT03495908|520831404|FG001|Overall Study|Death|0|||
144445753|NCT03495908|520831403|FG000|Overall Study|Physician Decision|5|||
144445754|NCT03495908|520831404|FG001|Overall Study|Physician Decision|4|||
144445755|NCT03495908|520831403|FG000|Overall Study|No documented reason|0|||
144445756|NCT03495908|520831404|FG001|Overall Study|No documented reason|2|||
144445757|NCT04936685|520831409|FG000|Overall Study|Protocol Violation|1|||
144445758|NCT04936685|520831410|FG001|Overall Study|Protocol Violation|0|||
144445759|NCT02075320|520831413|FG000|Overall Study|Withdrawal by Subject|2|||
144445760|NCT02410811|520831415|FG000|Overall Study|Withdrawal by Subject|0|||
144445761|NCT02410811|520831416|FG001|Overall Study|Withdrawal by Subject|0|||
144445762|NCT02410811|520831417|FG002|Overall Study|Withdrawal by Subject|1|||
144445763|NCT02410811|520831418|FG003|Overall Study|Withdrawal by Subject|0|||
144445764|NCT02985736|520831421|FG000|Overall Study|Lost to Follow-up|3|||
144445765|NCT00382733|520831422|FG000|Overall Study|Withdrawal by Subject|0|||
144445766|NCT00382733|520831423|FG001|Overall Study|Withdrawal by Subject|1|||
144445767|NCT00382733|520831424|FG002|Overall Study|Withdrawal by Subject|0|||
144445768|NCT00382733|520831425|FG003|Overall Study|Withdrawal by Subject|0|||
144445769|NCT00382733|520831426|FG004|Overall Study|Withdrawal by Subject|0|||
144445770|NCT00550836|520831427|FG000|Overall Study|Withdrawal by Subject|3|||
144445771|NCT00550836|520831428|FG001|Overall Study|Withdrawal by Subject|9|||
144445772|NCT01458171|520831431|FG000|Overall Study|Adverse Event|1|||
144193903|NCT01258101|519905083|FG000|Overall Study|Lost to Follow-up|5|||
144193904|NCT01258101|519905084|FG001|Overall Study|Lost to Follow-up|5|||
144193905|NCT01258101|519905085|FG002|Overall Study|Lost to Follow-up|0|||
144193906|NCT01258101|519905086|FG003|Overall Study|Lost to Follow-up|6|||
144445773|NCT00578565|520831432|FG000|Overall Study|Adverse Event|3|||
144445774|NCT01559311|520831433|FG000|Overall Study|Protocol Violation|0|||
144445775|NCT01559311|520831434|FG001|Overall Study|Protocol Violation|0|||
144445776|NCT01559311|520831435|FG002|Overall Study|Protocol Violation|2|||
144445777|NCT01559311|520831433|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
144445778|NCT01559311|520831434|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
144445779|NCT01559311|520831435|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
144445780|NCT01559311|520831433|FG000|Overall Study|Withdrawal by Subject|2|||
144445781|NCT01559311|520831434|FG001|Overall Study|Withdrawal by Subject|1|||
144445782|NCT01559311|520831435|FG002|Overall Study|Withdrawal by Subject|0|||
144445783|NCT01559311|520831433|FG000|Overall Study|Death|0|||
144193907|NCT01258101|519905083|FG000|Overall Study|PCR positive at week 24|0|||
144193908|NCT01258101|519905084|FG001|Overall Study|PCR positive at week 24|0|||
144193909|NCT01258101|519905085|FG002|Overall Study|PCR positive at week 24|0|||
144193910|NCT01258101|519905086|FG003|Overall Study|PCR positive at week 24|1|||
144193911|NCT01258101|519905083|FG000|Overall Study|Other reason|7|||
144193912|NCT01258101|519905084|FG001|Overall Study|Other reason|8|||
144193913|NCT01258101|519905085|FG002|Overall Study|Other reason|1|||
144193914|NCT01258101|519905086|FG003|Overall Study|Other reason|8|||
144193915|NCT00063882|519905087|FG000|Overall Study|Protocol Violation|3|||
144193916|NCT00063882|519905088|FG001|Overall Study|Protocol Violation|3|||
144193917|NCT00063882|519905087|FG000|Overall Study|Withdrawal by Subject|2|||
144193918|NCT00063882|519905088|FG001|Overall Study|Withdrawal by Subject|1|||
144193919|NCT03438227|519905090|FG000|Overall Study|Withdrawal by Subject|10|||
144193920|NCT03438227|519905091|FG001|Overall Study|Withdrawal by Subject|5|||
144193921|NCT02972502|519905093|FG000|Overall Study|Lost to Follow-up|3|||
144193922|NCT02972502|519905094|FG001|Overall Study|Lost to Follow-up|1|||
144193923|NCT02972502|519905093|FG000|Overall Study|Withdrawal by Subject|1|||
144193924|NCT02972502|519905094|FG001|Overall Study|Withdrawal by Subject|1|||
144193925|NCT00293202|519905098|FG000|Overall Study|Withdrawal by Subject|1|||
144193926|NCT00293202|519905099|FG001|Overall Study|Withdrawal by Subject|2|||
144193927|NCT00293202|519905098|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
144193928|NCT00293202|519905099|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
144193929|NCT00293202|519905098|FG000|Overall Study|on-hold due to fistula maturation time|1|||
144193930|NCT00293202|519905099|FG001|Overall Study|on-hold due to fistula maturation time|0|||
144193931|NCT02442271|519905100|FG000|Overall Study|Adverse Event|1|||
144193932|NCT02442271|519905100|FG000|Overall Study|Withdrew Consent|1|||
144193933|NCT02442271|519905100|FG000|Overall Study|Lost to Follow-up|1|||
144193934|NCT02442271|519905100|FG000|Overall Study|Other|1|||
144193935|NCT01560507|519905104|FG000|Overall Study|Lost to Follow-up|3|||
144193936|NCT01560507|519905105|FG001|Overall Study|Lost to Follow-up|1|||
144193937|NCT01560507|519905106|FG002|Overall Study|Lost to Follow-up|2|||
144193938|NCT01560507|519905104|FG000|Overall Study|Withdrawal by Subject|1|||
144193939|NCT01560507|519905105|FG001|Overall Study|Withdrawal by Subject|1|||
144193940|NCT01560507|519905106|FG002|Overall Study|Withdrawal by Subject|0|||
144193941|NCT01660022|519905107|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
144193942|NCT01660022|519905108|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
144193943|NCT01660022|519905109|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
144193944|NCT01660022|519905110|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
144193945|NCT01660022|519905111|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
144193946|NCT01660022|519905112|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
144193947|NCT01660022|519905107|FG000|First Sequence (7 Days)|Adverse Event|0|||
144193948|NCT01660022|519905108|FG001|First Sequence (7 Days)|Adverse Event|0|||
144193949|NCT01660022|519905109|FG002|First Sequence (7 Days)|Adverse Event|0|||
144193950|NCT01660022|519905110|FG003|First Sequence (7 Days)|Adverse Event|0|||
144193951|NCT01660022|519905111|FG004|First Sequence (7 Days)|Adverse Event|1|||
144193952|NCT01660022|519905112|FG005|First Sequence (7 Days)|Adverse Event|3|||
144193953|NCT01660022|519905107|FG000|First Sequence (7 Days)|Protocol Violation|0|||
144193954|NCT01660022|519905108|FG001|First Sequence (7 Days)|Protocol Violation|0|||
144193955|NCT01660022|519905109|FG002|First Sequence (7 Days)|Protocol Violation|0|||
144193956|NCT01660022|519905110|FG003|First Sequence (7 Days)|Protocol Violation|0|||
144445784|NCT01559311|520831434|FG001|Overall Study|Death|2|||
144193957|NCT01660022|519905111|FG004|First Sequence (7 Days)|Protocol Violation|0|||
144193958|NCT01660022|519905112|FG005|First Sequence (7 Days)|Protocol Violation|1|||
144193959|NCT02746627|519905114|FG000|Overall Study|Withdrawal by Subject|1|||
144193960|NCT02746627|519905115|FG001|Overall Study|Withdrawal by Subject|1|||
144193961|NCT02746627|519905116|FG002|Overall Study|Withdrawal by Subject|1|||
144193962|NCT00766831|519905117|FG000|Overall Study|Withdrawal by Subject|4|||
144193963|NCT00766831|519905117|FG000|Overall Study|Lost to Follow-up|3|||
144445785|NCT01559311|520831435|FG002|Overall Study|Death|3|||
144445786|NCT01559311|520831433|FG000|Overall Study|Lost to Follow-up|0|||
144193964|NCT00766831|519905117|FG000|Overall Study|Adverse Event|20|||
144193965|NCT00766831|519905117|FG000|Overall Study|Protocol Violation|15|||
144193966|NCT00766831|519905117|FG000|Overall Study|Physician Decision|5|||
144193967|NCT00766831|519905117|FG000|Overall Study|Withdrawal of consent|26|||
144445787|NCT01559311|520831434|FG001|Overall Study|Lost to Follow-up|3|||
144445788|NCT01559311|520831435|FG002|Overall Study|Lost to Follow-up|2|||
144445789|NCT01559311|520831433|FG000|Overall Study|Adverse Event|0|||
144445790|NCT01559311|520831434|FG001|Overall Study|Adverse Event|0|||
144445791|NCT01559311|520831435|FG002|Overall Study|Adverse Event|1|||
144445792|NCT05013905|520831436|FG000|Overall Study|Adverse Event|1|||
144445793|NCT05013905|520831436|FG000|Overall Study|Lack of Efficacy|1|||
144445794|NCT01849588|520831437|FG000|Overall Study|Lack of Efficacy|3|||
144445795|NCT00515827|520831438|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
144445796|NCT00515827|520831439|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
144445797|NCT00515827|520831438|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
144445798|NCT00515827|520831439|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
144445799|NCT00480779|520831445|FG000|Overall Study|Other|2|||
144445800|NCT00480779|520831446|FG001|Overall Study|Other|0|||
144445801|NCT00480779|520831445|FG000|Overall Study|Job and Health-related|0|||
144445802|NCT00480779|520831446|FG001|Overall Study|Job and Health-related|3|||
144445803|NCT00854581|520831451|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
144445804|NCT00854581|520831451|FG000|Induction (Up to Day 21)|Death|1|||
144445805|NCT00854581|520831451|FG000|Induction (Up to Day 21)|Physician Decision|1|||
144445806|NCT00854581|520831451|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
144445807|NCT01339390|520831452|FG000|Overall Study|Death|32|||
144445808|NCT01339390|520831453|FG001|Overall Study|Death|29|||
144445809|NCT01339390|520831452|FG000|Overall Study|Lost to Follow-up|125|||
144445810|NCT01339390|520831453|FG001|Overall Study|Lost to Follow-up|127|||
144445811|NCT00378703|520831456|FG000|Overall Study|Disease progression|59|||
144445812|NCT00378703|520831457|FG001|Overall Study|Disease progression|43|||
144445813|NCT00378703|520831458|FG002|Overall Study|Disease progression|48|||
144445814|NCT00378703|520831459|FG003|Overall Study|Disease progression|49|||
144445815|NCT00378703|520831456|FG000|Overall Study|Adverse Event|11|||
144445816|NCT00378703|520831457|FG001|Overall Study|Adverse Event|17|||
144445817|NCT00378703|520831458|FG002|Overall Study|Adverse Event|20|||
144445818|NCT00378703|520831459|FG003|Overall Study|Adverse Event|18|||
144445819|NCT00378703|520831456|FG000|Overall Study|Death|2|||
144445820|NCT00378703|520831457|FG001|Overall Study|Death|2|||
144532766|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532767|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532768|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532769|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
144532770|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532771|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532772|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532773|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532774|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
144532775|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532776|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532777|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532778|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532779|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532780|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532781|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
144532782|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532783|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532784|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532785|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532786|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
144532787|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532788|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
144193968|NCT00766831|519905117|FG000|Overall Study|Non cooperation by participants|14|||
144445821|NCT00378703|520831458|FG002|Overall Study|Death|4|||
144445822|NCT00378703|520831459|FG003|Overall Study|Death|3|||
144445823|NCT00378703|520831456|FG000|Overall Study|Withdrawal by Subject|4|||
144445824|NCT00378703|520831457|FG001|Overall Study|Withdrawal by Subject|8|||
144193969|NCT00766831|519905117|FG000|Overall Study|Other|28|||
144445825|NCT00378703|520831458|FG002|Overall Study|Withdrawal by Subject|5|||
144445826|NCT00378703|520831459|FG003|Overall Study|Withdrawal by Subject|7|||
144445827|NCT00378703|520831456|FG000|Overall Study|Physician Decision|1|||
144193970|NCT03166124|519905118|FG000|Treatment Period 1|Adverse Event|0|||
144193971|NCT03166124|519905119|FG001|Treatment Period 1|Adverse Event|0|||
144193972|NCT03166124|519905120|FG002|Treatment Period 1|Adverse Event|1|||
144193973|NCT03166124|519905121|FG003|Treatment Period 1|Adverse Event|0|||
144193974|NCT03166124|519905118|FG000|Wash-out Period|Withdrawal by Subject|0|||
144193975|NCT03166124|519905119|FG001|Wash-out Period|Withdrawal by Subject|1|||
144193976|NCT03166124|519905120|FG002|Wash-out Period|Withdrawal by Subject|0|||
144193977|NCT03166124|519905121|FG003|Wash-out Period|Withdrawal by Subject|1|||
144193978|NCT03166124|519905118|FG000|Wash-out Period|Adverse Event|0|||
144193979|NCT03166124|519905119|FG001|Wash-out Period|Adverse Event|1|||
144193980|NCT03166124|519905120|FG002|Wash-out Period|Adverse Event|1|||
144193981|NCT03166124|519905121|FG003|Wash-out Period|Adverse Event|0|||
144193982|NCT00788593|519905124|FG000|Placebo Run-in Phase|Adverse Event|2|||
144193983|NCT00788593|519905125|FG001|Placebo Run-in Phase|Adverse Event|0|||
144193984|NCT00788593|519905126|FG002|Placebo Run-in Phase|Adverse Event|0|||
144253729|NCT03252145|520129996|FG001|Overall Study|Withdrawal by Subject|0|||
144445828|NCT00378703|520831457|FG001|Overall Study|Physician Decision|4|||
144445829|NCT00378703|520831458|FG002|Overall Study|Physician Decision|1|||
144445830|NCT00378703|520831459|FG003|Overall Study|Physician Decision|0|||
144445831|NCT00378703|520831456|FG000|Overall Study|Alternative therapy|4|||
144445832|NCT00378703|520831457|FG001|Overall Study|Alternative therapy|2|||
144445833|NCT00378703|520831458|FG002|Overall Study|Alternative therapy|0|||
144445834|NCT00378703|520831459|FG003|Overall Study|Alternative therapy|0|||
144445835|NCT00378703|520831456|FG000|Overall Study|Other complicated disease|0|||
144445836|NCT00378703|520831457|FG001|Overall Study|Other complicated disease|2|||
144445837|NCT00378703|520831458|FG002|Overall Study|Other complicated disease|2|||
144445838|NCT00378703|520831459|FG003|Overall Study|Other complicated disease|0|||
144445839|NCT00378703|520831456|FG000|Overall Study|Symptomatic deterioration|0|||
144445840|NCT00378703|520831457|FG001|Overall Study|Symptomatic deterioration|1|||
144445841|NCT00378703|520831458|FG002|Overall Study|Symptomatic deterioration|0|||
144445842|NCT00378703|520831459|FG003|Overall Study|Symptomatic deterioration|2|||
144445843|NCT00378703|520831456|FG000|Overall Study|Surgery|1|||
144445844|NCT00378703|520831457|FG001|Overall Study|Surgery|0|||
144445845|NCT00378703|520831458|FG002|Overall Study|Surgery|0|||
144445846|NCT00378703|520831459|FG003|Overall Study|Surgery|1|||
144445847|NCT00378703|520831456|FG000|Overall Study|Joint decision of physician and patient|1|||
144445848|NCT00378703|520831457|FG001|Overall Study|Joint decision of physician and patient|0|||
144445849|NCT00378703|520831458|FG002|Overall Study|Joint decision of physician and patient|0|||
144445850|NCT00378703|520831459|FG003|Overall Study|Joint decision of physician and patient|0|||
144445851|NCT00378703|520831456|FG000|Overall Study|Adverse events and progressive disease|0|||
144445852|NCT00378703|520831457|FG001|Overall Study|Adverse events and progressive disease|0|||
144445853|NCT00378703|520831458|FG002|Overall Study|Adverse events and progressive disease|0|||
144445854|NCT00378703|520831459|FG003|Overall Study|Adverse events and progressive disease|1|||
144445855|NCT00378703|520831456|FG000|Overall Study|Relocation|0|||
144445856|NCT00378703|520831457|FG001|Overall Study|Relocation|0|||
144445857|NCT00378703|520831458|FG002|Overall Study|Relocation|1|||
144445858|NCT00378703|520831459|FG003|Overall Study|Relocation|0|||
144445859|NCT00378703|520831456|FG000|Overall Study|Ineligible|4|||
144445860|NCT00378703|520831457|FG001|Overall Study|Ineligible|7|||
144445861|NCT00378703|520831458|FG002|Overall Study|Ineligible|7|||
144445862|NCT00378703|520831459|FG003|Overall Study|Ineligible|7|||
144532789|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532790|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532791|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532792|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
144532793|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532794|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532795|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532796|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
144532797|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
144445863|NCT00378703|520831456|FG000|Overall Study|Never started treatment|1|||
144445864|NCT00378703|520831457|FG001|Overall Study|Never started treatment|4|||
144445865|NCT00378703|520831458|FG002|Overall Study|Never started treatment|0|||
144445866|NCT00378703|520831459|FG003|Overall Study|Never started treatment|0|||
144606332|NCT01704287|521420960|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
144725202|NCT05771428|521851195|FG001|Overall Study|Randomized but Not Treated|0|||
144725203|NCT05771428|521851196|FG002|Overall Study|Randomized but Not Treated|1|||
144725204|NCT05771428|521851197|FG003|Overall Study|Randomized but Not Treated|0|||
144193985|NCT00788593|519905124|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
144193986|NCT00788593|519905125|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
144193987|NCT00788593|519905126|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
144445867|NCT00378703|520831456|FG000|Overall Study|Other|1|||
144445868|NCT00378703|520831457|FG001|Overall Study|Other|1|||
144445869|NCT00378703|520831458|FG002|Overall Study|Other|2|||
144445870|NCT00378703|520831459|FG003|Overall Study|Other|3|||
144532798|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
144725205|NCT04025229|521851198|FG000|Overall Study|Adverse Event|1|||
144445871|NCT01541930|520831467|FG000|Overall Study|Withdrawal by Subject|1|||
144445872|NCT01957475|520831468|FG000|Test Period 1|Withdrawal by Subject|1|||
144445873|NCT01957475|520831469|FG001|Test Period 1|Withdrawal by Subject|0|||
144445874|NCT01957475|520831468|FG000|Test Period 1|Other|1|||
144445875|NCT01957475|520831469|FG001|Test Period 1|Other|0|||
144445876|NCT01957475|520831468|FG000|Test Period 1|Lack of Efficacy|0|||
144445877|NCT01957475|520831469|FG001|Test Period 1|Lack of Efficacy|1|||
144445878|NCT01957475|520831468|FG000|Test Period 2|Adverse Event|1|||
144445879|NCT01957475|520831469|FG001|Test Period 2|Adverse Event|0|||
144445880|NCT04497987|520831472|FG000|Overall Study|Adverse Event|1|||
144445881|NCT04497987|520831473|FG001|Overall Study|Adverse Event|0|||
144445882|NCT04497987|520831472|FG000|Overall Study|Death|21|||
144445883|NCT04497987|520831473|FG001|Overall Study|Death|13|||
144445884|NCT04497987|520831472|FG000|Overall Study|Lost to Follow-up|19|||
144445885|NCT04497987|520831473|FG001|Overall Study|Lost to Follow-up|17|||
144725206|NCT04025229|521851199|FG001|Overall Study|Adverse Event|0|||
144725207|NCT04025229|521851198|FG000|Overall Study|Withdrawal by Subject|0|||
144725208|NCT04025229|521851199|FG001|Overall Study|Withdrawal by Subject|2|||
144725209|NCT04025229|521851198|FG000|Overall Study|Death|0|||
144725210|NCT04025229|521851199|FG001|Overall Study|Death|1|||
144725211|NCT04025229|521851198|FG000|Overall Study|Physician Decision|0|||
144725212|NCT04025229|521851199|FG001|Overall Study|Physician Decision|1|||
144725213|NCT03815942|521851200|FG000|Overall Study|Withdrawal by Subject|0|||
144725214|NCT03815942|521851201|FG001|Overall Study|Withdrawal by Subject|17|||
144725215|NCT01298570|521851202|FG000|Overall Study|Disease progression, relapse during acti|64|||
144725216|NCT01298570|521851203|FG001|Overall Study|Disease progression, relapse during acti|40|||
144725217|NCT01298570|521851202|FG000|Overall Study|Adverse Event|20|||
144445886|NCT04497987|520831472|FG000|Overall Study|Other - as reported by the investigator|22|||
144445887|NCT04497987|520831473|FG001|Overall Study|Other - as reported by the investigator|16|||
144445888|NCT04497987|520831472|FG000|Overall Study|Physician Decision|1|||
144445889|NCT04497987|520831473|FG001|Overall Study|Physician Decision|0|||
144445890|NCT04497987|520831472|FG000|Overall Study|Withdrawal by Subject|35|||
144445891|NCT04497987|520831473|FG001|Overall Study|Withdrawal by Subject|21|||
144445892|NCT00646958|520833172|FG000|Overall Study|Lack of Efficacy|1|||
144445893|NCT00646958|520833173|FG001|Overall Study|Lack of Efficacy|0|||
144445894|NCT00646958|520833174|FG002|Overall Study|Lack of Efficacy|0|||
144445895|NCT00646958|520833172|FG000|Overall Study|Adverse Event|4|||
144445896|NCT00646958|520833173|FG001|Overall Study|Adverse Event|0|||
144445897|NCT00646958|520833174|FG002|Overall Study|Adverse Event|0|||
144445898|NCT00646958|520833172|FG000|Overall Study|Lost to Follow-up|1|||
144445899|NCT00646958|520833173|FG001|Overall Study|Lost to Follow-up|5|||
144445900|NCT00646958|520833174|FG002|Overall Study|Lost to Follow-up|7|||
144445901|NCT00646958|520833172|FG000|Overall Study|Protocol Violation|1|||
144445902|NCT00646958|520833173|FG001|Overall Study|Protocol Violation|1|||
144445903|NCT00646958|520833174|FG002|Overall Study|Protocol Violation|0|||
144445904|NCT00646958|520833172|FG000|Overall Study|Abnormal screening lab tests|1|||
144445905|NCT00646958|520833173|FG001|Overall Study|Abnormal screening lab tests|1|||
144445906|NCT00646958|520833174|FG002|Overall Study|Abnormal screening lab tests|0|||
144445907|NCT00646958|520833172|FG000|Overall Study|Withdrawal by Subject|1|||
144445908|NCT00646958|520833173|FG001|Overall Study|Withdrawal by Subject|2|||
144445909|NCT00646958|520833174|FG002|Overall Study|Withdrawal by Subject|0|||
144445910|NCT00646958|520833172|FG000|Overall Study|Did not receive study drug|2|||
144445911|NCT00646958|520833173|FG001|Overall Study|Did not receive study drug|0|||
144445912|NCT00646958|520833174|FG002|Overall Study|Did not receive study drug|2|||
144445913|NCT01639001|520833189|FG000|Overall Study|Refused further follow-up|9|||
144445914|NCT01639001|520833190|FG001|Overall Study|Refused further follow-up|12|||
144445915|NCT01639001|520833189|FG000|Overall Study|Lost to Follow-up|3|||
144725218|NCT01298570|521851203|FG001|Overall Study|Adverse Event|2|||
144725219|NCT01298570|521851202|FG000|Overall Study|Withdrawal by Subject|21|||
144725220|NCT01298570|521851203|FG001|Overall Study|Withdrawal by Subject|6|||
144445916|NCT01639001|520833190|FG001|Overall Study|Lost to Follow-up|0|||
144445917|NCT01639001|520833189|FG000|Overall Study|Death|62|||
144445918|NCT01639001|520833190|FG001|Overall Study|Death|61|||
144445919|NCT01639001|520833189|FG000|Overall Study|Randomized but not treated|0|||
144445920|NCT01639001|520833190|FG001|Overall Study|Randomized but not treated|2|||
144445921|NCT01639001|520833189|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
144445922|NCT01639001|520833190|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
144445923|NCT02200042|520833193|FG000|Overall Study|Withdrawal by Subject|0|||
144445924|NCT02200042|520833194|FG001|Overall Study|Withdrawal by Subject|1|||
144445925|NCT01969838|520833195|FG000|Double-blind Phase|Adverse Event|10|||
144445926|NCT01969838|520833196|FG001|Double-blind Phase|Adverse Event|4|||
144445927|NCT01969838|520833197|FG002|Double-blind Phase|Adverse Event|0|||
144445928|NCT01969838|520833198|FG003|Double-blind Phase|Adverse Event|0|||
144445929|NCT01969838|520833195|FG000|Double-blind Phase|Death|5|||
144725221|NCT01298570|521851202|FG000|Overall Study|Treatment delay > 4 weeks|4|||
144725222|NCT01298570|521851203|FG001|Overall Study|Treatment delay > 4 weeks|5|||
144445930|NCT01969838|520833196|FG001|Double-blind Phase|Death|2|||
144445931|NCT01969838|520833197|FG002|Double-blind Phase|Death|0|||
144725223|NCT01298570|521851202|FG000|Overall Study|Physician Decision|4|||
144445932|NCT01969838|520833198|FG003|Double-blind Phase|Death|0|||
144445933|NCT01969838|520833195|FG000|Double-blind Phase|Physician Decision|5|||
144445934|NCT01969838|520833196|FG001|Double-blind Phase|Physician Decision|1|||
144445935|NCT01969838|520833197|FG002|Double-blind Phase|Physician Decision|0|||
144445936|NCT01969838|520833198|FG003|Double-blind Phase|Physician Decision|0|||
144445937|NCT01969838|520833195|FG000|Double-blind Phase|Subject Decision|4|||
144445938|NCT01969838|520833196|FG001|Double-blind Phase|Subject Decision|2|||
144445939|NCT01969838|520833197|FG002|Double-blind Phase|Subject Decision|0|||
144445940|NCT01969838|520833198|FG003|Double-blind Phase|Subject Decision|0|||
144445941|NCT01969838|520833195|FG000|Double-blind Phase|Disease Progression|2|||
144445942|NCT01969838|520833196|FG001|Double-blind Phase|Disease Progression|0|||
144445943|NCT01969838|520833197|FG002|Double-blind Phase|Disease Progression|0|||
144445944|NCT01969838|520833198|FG003|Double-blind Phase|Disease Progression|0|||
144445945|NCT01969838|520833195|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
144445946|NCT01969838|520833196|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
144445947|NCT01969838|520833197|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
144445948|NCT01969838|520833198|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
144445949|NCT01969838|520833195|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
144445950|NCT01969838|520833196|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
144445951|NCT01969838|520833197|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
144445952|NCT01969838|520833198|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
144445953|NCT01969838|520833195|FG000|Open-label Phase|Adverse Event|0|||
144445954|NCT01969838|520833196|FG001|Open-label Phase|Adverse Event|0|||
144445955|NCT01969838|520833197|FG002|Open-label Phase|Adverse Event|37|||
144445956|NCT01969838|520833198|FG003|Open-label Phase|Adverse Event|49|||
144445957|NCT01969838|520833195|FG000|Open-label Phase|Disease Progression|0|||
144445958|NCT01969838|520833196|FG001|Open-label Phase|Disease Progression|0|||
144445959|NCT01969838|520833197|FG002|Open-label Phase|Disease Progression|26|||
144445960|NCT01969838|520833198|FG003|Open-label Phase|Disease Progression|27|||
144445961|NCT01969838|520833195|FG000|Open-label Phase|Lack of Efficacy|0|||
144445962|NCT01969838|520833196|FG001|Open-label Phase|Lack of Efficacy|0|||
144445963|NCT01969838|520833197|FG002|Open-label Phase|Lack of Efficacy|17|||
144532799|NCT03536884|521154274|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532800|NCT03536884|521154275|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532801|NCT03536884|521154276|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532802|NCT03536884|521154277|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532803|NCT03536884|521154278|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532804|NCT03536884|521154279|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532805|NCT03536884|521154280|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532806|NCT03536884|521154281|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532807|NCT03536884|521154282|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
144532808|NCT03536884|521154283|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532809|NCT03536884|521154284|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532810|NCT03536884|521154285|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
144532811|NCT03536884|521154274|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532812|NCT03536884|521154275|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532813|NCT03536884|521154276|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532814|NCT03536884|521154277|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532815|NCT03536884|521154278|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532816|NCT03536884|521154279|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532817|NCT03536884|521154280|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532818|NCT03536884|521154281|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532819|NCT03536884|521154282|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144532820|NCT03536884|521154283|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
144532821|NCT03536884|521154284|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
144532822|NCT03536884|521154285|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
144532823|NCT03536884|521154274|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532824|NCT03536884|521154275|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532825|NCT03536884|521154276|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532826|NCT03536884|521154277|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532827|NCT03536884|521154278|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144725224|NCT01298570|521851203|FG001|Overall Study|Physician Decision|2|||
144725225|NCT01298570|521851202|FG000|Overall Study|Other complicating disease|2|||
144445964|NCT01969838|520833198|FG003|Open-label Phase|Lack of Efficacy|19|||
144445965|NCT01969838|520833195|FG000|Open-label Phase|Subject Decision|0|||
144445966|NCT01969838|520833196|FG001|Open-label Phase|Subject Decision|0|||
144445967|NCT01969838|520833197|FG002|Open-label Phase|Subject Decision|14|||
144445968|NCT01969838|520833198|FG003|Open-label Phase|Subject Decision|15|||
144445969|NCT01969838|520833195|FG000|Open-label Phase|Death|0|||
144445970|NCT01969838|520833196|FG001|Open-label Phase|Death|0|||
144445971|NCT01969838|520833197|FG002|Open-label Phase|Death|13|||
144532828|NCT03536884|521154279|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532829|NCT03536884|521154280|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532830|NCT03536884|521154281|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532831|NCT03536884|521154282|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144532832|NCT03536884|521154283|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
144532833|NCT03536884|521154284|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
144532834|NCT03536884|521154285|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
144532835|NCT03536884|521154274|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532836|NCT03536884|521154275|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532837|NCT03536884|521154276|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532838|NCT03536884|521154277|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532839|NCT03536884|521154278|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532840|NCT03536884|521154279|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532841|NCT03536884|521154280|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532842|NCT03536884|521154281|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532843|NCT03536884|521154282|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532844|NCT03536884|521154283|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532845|NCT03536884|521154284|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
144532846|NCT03536884|521154285|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
144532847|NCT03536884|521154274|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532848|NCT03536884|521154275|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532849|NCT03536884|521154276|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532850|NCT03536884|521154277|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532851|NCT03536884|521154278|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532852|NCT03536884|521154279|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532853|NCT03536884|521154280|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532854|NCT03536884|521154281|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532855|NCT03536884|521154282|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532856|NCT03536884|521154283|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532857|NCT03536884|521154284|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
144532858|NCT03536884|521154285|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
144532859|NCT03536884|521154274|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144193988|NCT00788593|519905124|FG000|Placebo Run-in Phase|Protocol Violation|2|||
144193989|NCT00788593|519905125|FG001|Placebo Run-in Phase|Protocol Violation|0|||
144193990|NCT00788593|519905126|FG002|Placebo Run-in Phase|Protocol Violation|0|||
144532860|NCT03536884|521154275|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532861|NCT03536884|521154276|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532862|NCT03536884|521154277|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532863|NCT03536884|521154278|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532864|NCT03536884|521154279|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532865|NCT03536884|521154280|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532866|NCT03536884|521154281|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532867|NCT03536884|521154282|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532868|NCT03536884|521154283|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532869|NCT03536884|521154284|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
144532870|NCT03536884|521154285|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
144532871|NCT05424380|521154295|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
144532872|NCT05424380|521154296|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
144532873|NCT05424380|521154297|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
144532874|NCT05424380|521154298|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
144532875|NCT05424380|521154299|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
144532876|NCT05424380|521154300|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
144532877|NCT05424380|521154295|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
144532878|NCT05424380|521154296|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
144532879|NCT05424380|521154297|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
144532880|NCT05424380|521154298|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
144532881|NCT05424380|521154299|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
144193991|NCT00788593|519905124|FG000|First Intervention Period|Adverse Event|0|||
144193992|NCT00788593|519905125|FG001|First Intervention Period|Adverse Event|1|||
144193993|NCT00788593|519905126|FG002|First Intervention Period|Adverse Event|0|||
144445972|NCT01969838|520833198|FG003|Open-label Phase|Death|11|||
144445973|NCT01969838|520833195|FG000|Open-label Phase|Physician Decision|0|||
144445974|NCT01969838|520833196|FG001|Open-label Phase|Physician Decision|0|||
144445975|NCT01969838|520833197|FG002|Open-label Phase|Physician Decision|9|||
144445976|NCT01969838|520833198|FG003|Open-label Phase|Physician Decision|14|||
144445977|NCT01969838|520833195|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
144445978|NCT01969838|520833196|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
144445979|NCT01969838|520833197|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
144445980|NCT01969838|520833198|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
144445981|NCT00408993|520833199|FG000|Overall Study|Adverse Event|15|||
144445982|NCT00408993|520833200|FG001|Overall Study|Adverse Event|4|||
144445983|NCT00408993|520833199|FG000|Overall Study|Protocol Violation|1|||
144445984|NCT00408993|520833200|FG001|Overall Study|Protocol Violation|6|||
144445985|NCT00408993|520833199|FG000|Overall Study|Lack of Efficacy|1|||
144445986|NCT00408993|520833200|FG001|Overall Study|Lack of Efficacy|4|||
144445987|NCT00408993|520833199|FG000|Overall Study|Withdrawal by Subject|2|||
144445988|NCT00408993|520833200|FG001|Overall Study|Withdrawal by Subject|3|||
144445989|NCT03738865|520833201|FG000|Overall Study|Withdrawal by Subject|3|||
144445990|NCT03738865|520833202|FG001|Overall Study|Withdrawal by Subject|3|||
144445991|NCT03738865|520833201|FG000|Overall Study|Adverse Event|2|||
144445992|NCT03738865|520833202|FG001|Overall Study|Adverse Event|0|||
144445993|NCT03738865|520833201|FG000|Overall Study|Physician Decision|0|||
144445994|NCT03738865|520833202|FG001|Overall Study|Physician Decision|1|||
144445995|NCT00298896|520833203|FG000|Overall Study|Death|3|||
144445996|NCT00298896|520833203|FG000|Overall Study|Physician Decision|2|||
144445997|NCT00298896|520833203|FG000|Overall Study|Intercurrent Illness|1|||
144445998|NCT00298896|520833203|FG000|Overall Study|Disease Progression|41|||
144445999|NCT00298896|520833203|FG000|Overall Study|Withdrawal by Subject|2|||
144446000|NCT00298896|520833203|FG000|Overall Study|Assigned to treatment in error|1|||
144446001|NCT02880371|520833204|FG000|Phase 1b|Lost to Follow-up|1|||
144446002|NCT02880371|520833205|FG001|Phase 1b|Lost to Follow-up|0|||
144446003|NCT02880371|520833206|FG002|Phase 1b|Lost to Follow-up|0|||
144446004|NCT02880371|520833207|FG003|Phase 1b|Lost to Follow-up|0|||
144446005|NCT02880371|520833208|FG004|Phase 1b|Lost to Follow-up|0|||
144446006|NCT02880371|520833209|FG005|Phase 1b|Lost to Follow-up|0|||
144446007|NCT02880371|520833210|FG006|Phase 1b|Lost to Follow-up|0|||
144446008|NCT02880371|520833211|FG007|Phase 1b|Lost to Follow-up|0|||
144446009|NCT02880371|520833204|FG000|Phase 1b|Participants terminated by Sponsor|1|||
144446010|NCT02880371|520833205|FG001|Phase 1b|Participants terminated by Sponsor|0|||
144446011|NCT02880371|520833206|FG002|Phase 1b|Participants terminated by Sponsor|0|||
144446012|NCT02880371|520833207|FG003|Phase 1b|Participants terminated by Sponsor|0|||
144446013|NCT02880371|520833208|FG004|Phase 1b|Participants terminated by Sponsor|0|||
144446014|NCT02880371|520833209|FG005|Phase 1b|Participants terminated by Sponsor|0|||
144446015|NCT02880371|520833210|FG006|Phase 1b|Participants terminated by Sponsor|0|||
144446016|NCT02880371|520833211|FG007|Phase 1b|Participants terminated by Sponsor|0|||
144532882|NCT05424380|521154300|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
144532883|NCT05424380|521154295|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
144532884|NCT05424380|521154296|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
144532885|NCT05424380|521154297|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
144532886|NCT05424380|521154298|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
144532887|NCT05424380|521154299|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
144532888|NCT05424380|521154300|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
144532889|NCT05424380|521154295|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
144532890|NCT05424380|521154296|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
144532891|NCT05424380|521154297|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
144532892|NCT05424380|521154298|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
144532893|NCT05424380|521154299|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
144532894|NCT05424380|521154300|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
144532895|NCT05424380|521154295|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
144532896|NCT05424380|521154296|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
144532897|NCT05424380|521154297|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
144532898|NCT05424380|521154298|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
144532899|NCT05424380|521154299|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
144532900|NCT05424380|521154300|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
144532901|NCT05424380|521154295|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
144532902|NCT05424380|521154296|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
144446017|NCT02880371|520833204|FG000|Phase 1b|Withdrawal by Subject|0|||
144446018|NCT02880371|520833205|FG001|Phase 1b|Withdrawal by Subject|0|||
144446019|NCT02880371|520833206|FG002|Phase 1b|Withdrawal by Subject|1|||
144446020|NCT02880371|520833207|FG003|Phase 1b|Withdrawal by Subject|0|||
144446021|NCT02880371|520833208|FG004|Phase 1b|Withdrawal by Subject|0|||
144446022|NCT02880371|520833209|FG005|Phase 1b|Withdrawal by Subject|0|||
144446023|NCT02880371|520833210|FG006|Phase 1b|Withdrawal by Subject|0|||
144446024|NCT02880371|520833211|FG007|Phase 1b|Withdrawal by Subject|0|||
144606333|NCT01704287|521420961|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
144606334|NCT01704287|521420957|FG000|Initial Treatment Period|Lost to Follow-up|5|||
144446025|NCT02880371|520833204|FG000|Phase 1b|Death|4|||
144446026|NCT02880371|520833205|FG001|Phase 1b|Death|6|||
144446027|NCT02880371|520833206|FG002|Phase 1b|Death|5|||
144446028|NCT02880371|520833207|FG003|Phase 1b|Death|1|||
144606335|NCT01704287|521420958|FG001|Initial Treatment Period|Lost to Follow-up|3|||
144606336|NCT01704287|521420959|FG002|Initial Treatment Period|Lost to Follow-up|0|||
144606337|NCT01704287|521420960|FG003|Initial Treatment Period|Lost to Follow-up|0|||
144446029|NCT02880371|520833208|FG004|Phase 1b|Death|0|||
144446030|NCT02880371|520833209|FG005|Phase 1b|Death|0|||
144446031|NCT02880371|520833210|FG006|Phase 1b|Death|0|||
144446032|NCT02880371|520833211|FG007|Phase 1b|Death|0|||
144446033|NCT02880371|520833204|FG000|Phase 1b|Enrolled but not Treated|0|||
144446034|NCT02880371|520833205|FG001|Phase 1b|Enrolled but not Treated|1|||
144446035|NCT02880371|520833206|FG002|Phase 1b|Enrolled but not Treated|0|||
144446036|NCT02880371|520833207|FG003|Phase 1b|Enrolled but not Treated|0|||
144446037|NCT02880371|520833208|FG004|Phase 1b|Enrolled but not Treated|0|||
144446038|NCT02880371|520833209|FG005|Phase 1b|Enrolled but not Treated|0|||
144446039|NCT02880371|520833210|FG006|Phase 1b|Enrolled but not Treated|0|||
144446040|NCT02880371|520833211|FG007|Phase 1b|Enrolled but not Treated|0|||
144446041|NCT02880371|520833204|FG000|Phase 2|Enrolled but not Treated|0|||
144446042|NCT02880371|520833205|FG001|Phase 2|Enrolled but not Treated|0|||
144446043|NCT02880371|520833206|FG002|Phase 2|Enrolled but not Treated|0|||
144446044|NCT02880371|520833207|FG003|Phase 2|Enrolled but not Treated|0|||
144446045|NCT02880371|520833208|FG004|Phase 2|Enrolled but not Treated|0|||
144446046|NCT02880371|520833209|FG005|Phase 2|Enrolled but not Treated|1|||
144446047|NCT02880371|520833210|FG006|Phase 2|Enrolled but not Treated|1|||
144446048|NCT02880371|520833211|FG007|Phase 2|Enrolled but not Treated|0|||
144446049|NCT02880371|520833204|FG000|Phase 2|Other|0|||
144446050|NCT02880371|520833205|FG001|Phase 2|Other|0|||
144446051|NCT02880371|520833206|FG002|Phase 2|Other|0|||
144446052|NCT02880371|520833207|FG003|Phase 2|Other|0|||
144446053|NCT02880371|520833208|FG004|Phase 2|Other|0|||
144446054|NCT02880371|520833209|FG005|Phase 2|Other|1|||
144446055|NCT02880371|520833210|FG006|Phase 2|Other|2|||
144446056|NCT02880371|520833211|FG007|Phase 2|Other|1|||
144446057|NCT02880371|520833204|FG000|Phase 2|Participants terminated by Sponsor|0|||
144446058|NCT02880371|520833205|FG001|Phase 2|Participants terminated by Sponsor|0|||
144446059|NCT02880371|520833206|FG002|Phase 2|Participants terminated by Sponsor|0|||
144446060|NCT02880371|520833207|FG003|Phase 2|Participants terminated by Sponsor|0|||
144446061|NCT02880371|520833208|FG004|Phase 2|Participants terminated by Sponsor|1|||
144446062|NCT02880371|520833209|FG005|Phase 2|Participants terminated by Sponsor|6|||
144446063|NCT02880371|520833210|FG006|Phase 2|Participants terminated by Sponsor|1|||
144446064|NCT02880371|520833211|FG007|Phase 2|Participants terminated by Sponsor|5|||
144446065|NCT02880371|520833204|FG000|Phase 2|Death|0|||
144446066|NCT02880371|520833205|FG001|Phase 2|Death|0|||
144446067|NCT02880371|520833206|FG002|Phase 2|Death|0|||
144446068|NCT02880371|520833207|FG003|Phase 2|Death|0|||
144446069|NCT02880371|520833208|FG004|Phase 2|Death|1|||
144446070|NCT02880371|520833209|FG005|Phase 2|Death|10|||
144446071|NCT02880371|520833210|FG006|Phase 2|Death|20|||
144446072|NCT02880371|520833211|FG007|Phase 2|Death|5|||
144446073|NCT02880371|520833204|FG000|Phase 2|Lost to Follow-up|0|||
144446074|NCT02880371|520833205|FG001|Phase 2|Lost to Follow-up|0|||
144446075|NCT02880371|520833206|FG002|Phase 2|Lost to Follow-up|0|||
144446076|NCT02880371|520833207|FG003|Phase 2|Lost to Follow-up|0|||
144446077|NCT02880371|520833208|FG004|Phase 2|Lost to Follow-up|0|||
144446078|NCT02880371|520833209|FG005|Phase 2|Lost to Follow-up|0|||
144446079|NCT02880371|520833210|FG006|Phase 2|Lost to Follow-up|3|||
144446080|NCT02880371|520833211|FG007|Phase 2|Lost to Follow-up|0|||
144446081|NCT02880371|520833204|FG000|Phase 2|Withdrawal by Subject|0|||
144446082|NCT02880371|520833205|FG001|Phase 2|Withdrawal by Subject|0|||
144446083|NCT02880371|520833206|FG002|Phase 2|Withdrawal by Subject|0|||
144446084|NCT02880371|520833207|FG003|Phase 2|Withdrawal by Subject|0|||
144446085|NCT02880371|520833208|FG004|Phase 2|Withdrawal by Subject|0|||
144446086|NCT02880371|520833209|FG005|Phase 2|Withdrawal by Subject|1|||
144446087|NCT02880371|520833210|FG006|Phase 2|Withdrawal by Subject|1|||
144446088|NCT02880371|520833211|FG007|Phase 2|Withdrawal by Subject|0|||
144446089|NCT02880371|520833204|FG000|Phase 2|End of Study page not completed by error|0|||
144446090|NCT02880371|520833205|FG001|Phase 2|End of Study page not completed by error|0|||
144446091|NCT02880371|520833206|FG002|Phase 2|End of Study page not completed by error|0|||
144446092|NCT02880371|520833207|FG003|Phase 2|End of Study page not completed by error|0|||
144446093|NCT02880371|520833208|FG004|Phase 2|End of Study page not completed by error|0|||
144446094|NCT02880371|520833209|FG005|Phase 2|End of Study page not completed by error|1|||
144446095|NCT02880371|520833210|FG006|Phase 2|End of Study page not completed by error|0|||
144446096|NCT02880371|520833211|FG007|Phase 2|End of Study page not completed by error|0|||
144446097|NCT02660359|520833212|FG000|Overall Study|Protocol Deviation|0|||
144446098|NCT02660359|520833213|FG001|Overall Study|Protocol Deviation|0|||
144446099|NCT02660359|520833214|FG002|Overall Study|Protocol Deviation|1|||
144446100|NCT02660359|520833212|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
144446101|NCT02660359|520833213|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
144446102|NCT02660359|520833214|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
144446103|NCT02660359|520833212|FG000|Overall Study|Lack of Efficacy|1|||
144446104|NCT02660359|520833213|FG001|Overall Study|Lack of Efficacy|1|||
144446105|NCT02660359|520833214|FG002|Overall Study|Lack of Efficacy|1|||
144446106|NCT02660359|520833212|FG000|Overall Study|Adverse Event|0|||
144446107|NCT02660359|520833213|FG001|Overall Study|Adverse Event|1|||
144446108|NCT02660359|520833214|FG002|Overall Study|Adverse Event|0|||
144446109|NCT02660359|520833212|FG000|Overall Study|Other|2|||
144446110|NCT02660359|520833213|FG001|Overall Study|Other|1|||
144446111|NCT02660359|520833214|FG002|Overall Study|Other|3|||
144446112|NCT02660359|520833212|FG000|Overall Study|Withdrawal by Subject|7|||
144446113|NCT02660359|520833213|FG001|Overall Study|Withdrawal by Subject|5|||
144446114|NCT02660359|520833214|FG002|Overall Study|Withdrawal by Subject|8|||
144446115|NCT02660359|520833212|FG000|Overall Study|Lost to Follow-up|3|||
144446116|NCT02660359|520833213|FG001|Overall Study|Lost to Follow-up|3|||
144446117|NCT02660359|520833214|FG002|Overall Study|Lost to Follow-up|0|||
144446118|NCT03394391|520833218|FG000|Overall Study|Lost to Follow-up|1|||
144446119|NCT03394391|520833219|FG001|Overall Study|Lost to Follow-up|2|||
144446120|NCT00451282|520833222|FG000|Overall Study|Lost to Follow-up|6|||
144446121|NCT00451282|520833223|FG001|Overall Study|Lost to Follow-up|5|||
144446122|NCT00098839|520833224|FG000|Overall Study|Adverse Event|5|||
144446123|NCT00098839|520833225|FG001|Overall Study|Adverse Event|2|||
144446124|NCT00098839|520833224|FG000|Overall Study|Death|1|||
144446125|NCT00098839|520833225|FG001|Overall Study|Death|2|||
144446126|NCT00098839|520833224|FG000|Overall Study|Physician Decision|4|||
144446127|NCT00098839|520833225|FG001|Overall Study|Physician Decision|14|||
144446128|NCT00098839|520833224|FG000|Overall Study|Withdrawal by Subject|1|||
144446129|NCT00098839|520833225|FG001|Overall Study|Withdrawal by Subject|0|||
144446130|NCT00098839|520833224|FG000|Overall Study|Refusal of further protocol therapy|3|||
144446131|NCT00098839|520833225|FG001|Overall Study|Refusal of further protocol therapy|1|||
144446132|NCT00098839|520833224|FG000|Overall Study|Relapse|6|||
144446133|NCT00098839|520833225|FG001|Overall Study|Relapse|3|||
144446134|NCT00098839|520833224|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
144446135|NCT00098839|520833225|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
144446136|NCT00098839|520833224|FG000|Overall Study|Ineligible|2|||
144446137|NCT00098839|520833225|FG001|Overall Study|Ineligible|0|||
144446138|NCT03348904|520833227|FG000|Overall Study|Administrative reason by the sponsor|0|||
144446139|NCT03348904|520833228|FG001|Overall Study|Administrative reason by the sponsor|1|||
144446140|NCT03348904|520833229|FG002|Overall Study|Administrative reason by the sponsor|0|||
144446141|NCT01743092|520833231|FG000|Overall Study|Lost to Follow-up|14|||
144446142|NCT01743092|520833232|FG001|Overall Study|Lost to Follow-up|15|||
144446143|NCT01332305|520833233|FG000|Overall Study|Adverse Event|1|||
144446144|NCT01332305|520833234|FG001|Overall Study|Adverse Event|4|||
144446145|NCT01332305|520833235|FG002|Overall Study|Adverse Event|6|||
144446146|NCT01332305|520833236|FG003|Overall Study|Adverse Event|3|||
144446147|NCT01332305|520833237|FG004|Overall Study|Adverse Event|5|||
144446148|NCT01332305|520833233|FG000|Overall Study|Withdrawal by Subject|6|||
144446149|NCT01332305|520833234|FG001|Overall Study|Withdrawal by Subject|5|||
144446150|NCT01332305|520833235|FG002|Overall Study|Withdrawal by Subject|4|||
144446151|NCT01332305|520833236|FG003|Overall Study|Withdrawal by Subject|1|||
144446152|NCT01332305|520833237|FG004|Overall Study|Withdrawal by Subject|0|||
144446153|NCT01332305|520833233|FG000|Overall Study|Lost to Follow-up|0|||
144446154|NCT01332305|520833234|FG001|Overall Study|Lost to Follow-up|2|||
144446155|NCT01332305|520833235|FG002|Overall Study|Lost to Follow-up|3|||
144446156|NCT01332305|520833236|FG003|Overall Study|Lost to Follow-up|2|||
144446157|NCT01332305|520833237|FG004|Overall Study|Lost to Follow-up|3|||
144446158|NCT01332305|520833233|FG000|Overall Study|Protocol Violation|1|||
144446159|NCT01332305|520833234|FG001|Overall Study|Protocol Violation|2|||
144446160|NCT01332305|520833235|FG002|Overall Study|Protocol Violation|1|||
144446161|NCT01332305|520833236|FG003|Overall Study|Protocol Violation|0|||
144446162|NCT01332305|520833237|FG004|Overall Study|Protocol Violation|3|||
144446163|NCT01332305|520833233|FG000|Overall Study|Withdrawal by Sponsor|1|||
144446164|NCT01332305|520833234|FG001|Overall Study|Withdrawal by Sponsor|0|||
144446165|NCT01332305|520833235|FG002|Overall Study|Withdrawal by Sponsor|0|||
144446166|NCT01332305|520833236|FG003|Overall Study|Withdrawal by Sponsor|1|||
144446167|NCT01332305|520833237|FG004|Overall Study|Withdrawal by Sponsor|1|||
144446168|NCT01332305|520833233|FG000|Overall Study|Treatment Failure|1|||
144446169|NCT01332305|520833234|FG001|Overall Study|Treatment Failure|1|||
144446170|NCT01332305|520833235|FG002|Overall Study|Treatment Failure|0|||
144446171|NCT01332305|520833236|FG003|Overall Study|Treatment Failure|0|||
144446172|NCT01332305|520833237|FG004|Overall Study|Treatment Failure|0|||
144446173|NCT01332305|520833233|FG000|Overall Study|Physician Decision|0|||
144446174|NCT01332305|520833234|FG001|Overall Study|Physician Decision|0|||
144446175|NCT01332305|520833235|FG002|Overall Study|Physician Decision|0|||
144532903|NCT05424380|521154297|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
144446176|NCT01332305|520833236|FG003|Overall Study|Physician Decision|1|||
144446177|NCT01332305|520833237|FG004|Overall Study|Physician Decision|0|||
144446178|NCT04027686|520833238|FG000|Overall Study|Lost to Follow-up|2|||
144446179|NCT04027686|520833239|FG001|Overall Study|Lost to Follow-up|0|||
144193994|NCT00788593|519905124|FG000|Second Intervention Period|Lost to Follow-up|0|||
144193995|NCT00788593|519905125|FG001|Second Intervention Period|Lost to Follow-up|1|||
144193996|NCT00788593|519905126|FG002|Second Intervention Period|Lost to Follow-up|0|||
144193997|NCT00788593|519905124|FG000|Second Intervention Period|Other|0|||
144446180|NCT04027686|520833238|FG000|Overall Study|Withdrawal by Subject|0|||
144446181|NCT04027686|520833239|FG001|Overall Study|Withdrawal by Subject|1|||
144446182|NCT01263873|520833240|FG000|Overall Study|One provider unable to complete numbers|1|||
144446183|NCT01263873|520833241|FG001|Overall Study|One provider unable to complete numbers|1|||
144446184|NCT00642304|520833242|FG000|Overall Study|Adverse Event|1|||
144446185|NCT00642304|520833242|FG000|Overall Study|Death|1|||
144446186|NCT00642304|520833242|FG000|Overall Study|Blood transfusion|2|||
144446187|NCT00642304|520833242|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
144446188|NCT00642304|520833242|FG000|Overall Study|Transplantation|1|||
144446189|NCT01430585|520833248|FG000|Overall Study|Death|1|||
144446190|NCT01430585|520833248|FG000|Overall Study|Objective Progression or Relapse|3|||
144446191|NCT01430585|520833248|FG000|Overall Study|Study Terminated by Sponsor|3|||
144446192|NCT01430585|520833248|FG000|Overall Study|Other|7|||
144446193|NCT00779766|520833249|FG000|Month 24|Serious Adverse Event|2|||
144446194|NCT00779766|520833250|FG001|Month 24|Serious Adverse Event|3|||
144446195|NCT00779766|520833249|FG000|Month 24|Adverse Event|3|||
144446196|NCT00779766|520833250|FG001|Month 24|Adverse Event|3|||
144446197|NCT00779766|520833249|FG000|Month 24|Protocol Violation|3|||
144446198|NCT00779766|520833250|FG001|Month 24|Protocol Violation|1|||
144446199|NCT00779766|520833249|FG000|Month 24|Withdrawal by Subject|159|||
144446200|NCT00779766|520833250|FG001|Month 24|Withdrawal by Subject|127|||
144446201|NCT00779766|520833249|FG000|Month 24|Migrated/moved from study area|138|||
144446202|NCT00779766|520833250|FG001|Month 24|Migrated/moved from study area|162|||
144446203|NCT00779766|520833249|FG000|Month 24|Lost to Follow-up|9|||
144446204|NCT00779766|520833250|FG001|Month 24|Lost to Follow-up|9|||
144446205|NCT00779766|520833249|FG000|Month 24|Other|18|||
144446206|NCT00779766|520833250|FG001|Month 24|Other|27|||
144446207|NCT00779766|520833249|FG000|Month 48|Withdrawal by Subject|68|||
144446208|NCT00779766|520833250|FG001|Month 48|Withdrawal by Subject|63|||
144446209|NCT00779766|520833249|FG000|Month 48|Migrated/moved from study area|76|||
144446210|NCT00779766|520833250|FG001|Month 48|Migrated/moved from study area|75|||
144446211|NCT00779766|520833249|FG000|Month 48|Lost to Follow-up|29|||
144446212|NCT00779766|520833250|FG001|Month 48|Lost to Follow-up|30|||
144446213|NCT00779766|520833249|FG000|Month 48|Other|1|||
144446214|NCT00779766|520833250|FG001|Month 48|Other|0|||
144446215|NCT00779766|520833249|FG000|Month 72|Withdrawal by Subject|55|||
144446216|NCT00779766|520833250|FG001|Month 72|Withdrawal by Subject|71|||
144446217|NCT00779766|520833249|FG000|Month 72|Migrated/moved from study area|124|||
144446218|NCT00779766|520833250|FG001|Month 72|Migrated/moved from study area|109|||
144446219|NCT00779766|520833249|FG000|Month 72|Lost to Follow-up|6|||
144446220|NCT00779766|520833250|FG001|Month 72|Lost to Follow-up|8|||
144446221|NCT00779766|520833249|FG000|Month 72|Other|0|||
144446222|NCT00779766|520833250|FG001|Month 72|Other|1|||
144446223|NCT01412424|520833255|FG000|Core Treatment Period|Treatment Failure|24|||
144446224|NCT01412424|520833255|FG000|Core Treatment Period|Adverse Event|21|||
144446225|NCT01412424|520833255|FG000|Core Treatment Period|Patient Request|5|||
144446226|NCT01412424|520833255|FG000|Core Treatment Period|Lost to Follow-up|2|||
144446227|NCT01412424|520833255|FG000|Core Treatment Period|Sponsor Request|1|||
144446228|NCT01412424|520833255|FG000|Extension Treatment Period|Adverse Event|2|||
144446229|NCT01412424|520833255|FG000|Extension Treatment Period|Treatment Failure|2|||
144446230|NCT01412424|520833255|FG000|Extension Treatment Period|Patient Request|2|||
144446231|NCT03235024|520833264|FG000|Overall Study|Adverse Event|2|||
144446232|NCT03235024|520833265|FG001|Overall Study|Adverse Event|2|||
144446233|NCT03235024|520833264|FG000|Overall Study|Death|1|||
144446234|NCT03235024|520833265|FG001|Overall Study|Death|0|||
144446235|NCT03235024|520833264|FG000|Overall Study|Lost to Follow-up|2|||
144446236|NCT03235024|520833265|FG001|Overall Study|Lost to Follow-up|5|||
144446237|NCT03235024|520833264|FG000|Overall Study|Protocol Violation|1|||
144446238|NCT03235024|520833265|FG001|Overall Study|Protocol Violation|0|||
144446239|NCT03235024|520833264|FG000|Overall Study|Withdrawal by Subject|0|||
144446240|NCT03235024|520833265|FG001|Overall Study|Withdrawal by Subject|3|||
144446241|NCT02357576|520833266|FG000|Treatment Period|Withdrawal by Subject|0|||
144446242|NCT02357576|520833267|FG001|Treatment Period|Withdrawal by Subject|1|||
144446243|NCT02357576|520833266|FG000|Treatment Period|Physician Decision|0|||
144446244|NCT02357576|520833267|FG001|Treatment Period|Physician Decision|1|||
144446245|NCT02357576|520833266|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
144446246|NCT02357576|520833267|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
144446247|NCT02357576|520833266|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
144446248|NCT02357576|520833267|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
144446249|NCT02357576|520833266|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
144193998|NCT00788593|519905125|FG001|Second Intervention Period|Other|0|||
144193999|NCT00788593|519905126|FG002|Second Intervention Period|Other|1|||
144446250|NCT02357576|520833267|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
144446251|NCT02357576|520833266|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
144446252|NCT02357576|520833267|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
144446253|NCT00699699|520833268|FG000|Overall Study|Adverse Event|36|||
144446254|NCT00699699|520833268|FG000|Overall Study|Individual different reasons|21|||
144446255|NCT00705575|520833269|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144446256|NCT00705575|520833270|FG001|Overall Study|Abnormal laboratory value(s)|3|||
144446257|NCT00705575|520833269|FG000|Overall Study|Abnormal test procedure result(s)|2|||
144446258|NCT00705575|520833270|FG001|Overall Study|Abnormal test procedure result(s)|12|||
144446259|NCT00705575|520833269|FG000|Overall Study|Adverse Event|11|||
144446260|NCT00705575|520833270|FG001|Overall Study|Adverse Event|15|||
144446261|NCT00705575|520833269|FG000|Overall Study|Lost to Follow-up|3|||
144446262|NCT00705575|520833270|FG001|Overall Study|Lost to Follow-up|4|||
144446263|NCT00705575|520833269|FG000|Overall Study|Protocol Violation|2|||
144446264|NCT00705575|520833270|FG001|Overall Study|Protocol Violation|2|||
144446265|NCT00705575|520833269|FG000|Overall Study|Withdrawal by Subject|5|||
144446266|NCT00705575|520833270|FG001|Overall Study|Withdrawal by Subject|10|||
144446267|NCT02170727|520833272|FG000|Overall Study|Lost to Follow-up|1|||
144446268|NCT02170727|520833273|FG001|Overall Study|Lost to Follow-up|0|||
144446269|NCT02170727|520833272|FG000|Overall Study|Withdrawal by Subject|2|||
144446270|NCT02170727|520833273|FG001|Overall Study|Withdrawal by Subject|0|||
144446271|NCT01959581|520833276|FG000|Overall Study|Lost to Follow-up|5|||
144446272|NCT00414050|520833277|FG000|Overall Study|Adverse Event|1|||
144446273|NCT00414050|520833278|FG001|Overall Study|Adverse Event|1|||
144446274|NCT00414050|520833279|FG002|Overall Study|Adverse Event|1|||
144446275|NCT00414050|520833280|FG003|Overall Study|Adverse Event|1|||
144446276|NCT00414050|520833277|FG000|Overall Study|Lost to Follow-up|2|||
144446277|NCT00414050|520833278|FG001|Overall Study|Lost to Follow-up|2|||
144446278|NCT00414050|520833279|FG002|Overall Study|Lost to Follow-up|1|||
144446279|NCT00414050|520833280|FG003|Overall Study|Lost to Follow-up|1|||
144446280|NCT00414050|520833277|FG000|Overall Study|Withdrawal by Subject|5|||
144446281|NCT00414050|520833278|FG001|Overall Study|Withdrawal by Subject|3|||
144446282|NCT00414050|520833279|FG002|Overall Study|Withdrawal by Subject|2|||
144446283|NCT00414050|520833280|FG003|Overall Study|Withdrawal by Subject|4|||
144446284|NCT00414050|520833277|FG000|Overall Study|Subject discontinued for other reason|1|||
144446285|NCT00414050|520833278|FG001|Overall Study|Subject discontinued for other reason|2|||
144446286|NCT00414050|520833279|FG002|Overall Study|Subject discontinued for other reason|2|||
144446287|NCT00414050|520833280|FG003|Overall Study|Subject discontinued for other reason|1|||
144446288|NCT00414050|520833277|FG000|Overall Study|Subject Moved|0|||
144446289|NCT00414050|520833278|FG001|Overall Study|Subject Moved|0|||
144446290|NCT00414050|520833279|FG002|Overall Study|Subject Moved|0|||
144446291|NCT00414050|520833280|FG003|Overall Study|Subject Moved|1|||
144446292|NCT03773757|520833282|FG000|Overall Study|Withdrawal by Subject|2|||
144446293|NCT03773757|520833283|FG001|Overall Study|Withdrawal by Subject|4|||
144446294|NCT00057746|520833284|FG000|Overall Study|Withdrawal by Subject|0|||
144446295|NCT00057746|520833285|FG001|Overall Study|Withdrawal by Subject|0|||
144446296|NCT00057746|520833286|FG002|Overall Study|Withdrawal by Subject|1|||
144446297|NCT01109316|520833287|FG000|Study Period 1|Adverse Event|0|||
144446298|NCT01109316|520833288|FG001|Study Period 1|Adverse Event|0|||
144446299|NCT01109316|520833289|FG002|Study Period 1|Adverse Event|1|||
144446300|NCT01109316|520833290|FG003|Study Period 1|Adverse Event|0|||
144446301|NCT01109316|520833291|FG004|Study Period 1|Adverse Event|0|||
144446302|NCT01109316|520833292|FG005|Study Period 1|Adverse Event|0|||
144446303|NCT01109316|520833287|FG000|Study Period 1|Lost to Follow-up|0|||
144446304|NCT01109316|520833288|FG001|Study Period 1|Lost to Follow-up|0|||
144446305|NCT01109316|520833289|FG002|Study Period 1|Lost to Follow-up|1|||
144446306|NCT01109316|520833290|FG003|Study Period 1|Lost to Follow-up|1|||
144446307|NCT01109316|520833291|FG004|Study Period 1|Lost to Follow-up|0|||
144446308|NCT01109316|520833292|FG005|Study Period 1|Lost to Follow-up|0|||
144446309|NCT01109316|520833287|FG000|Study Period 1|Withdrawal by Subject|0|||
144446310|NCT01109316|520833288|FG001|Study Period 1|Withdrawal by Subject|0|||
144446311|NCT01109316|520833289|FG002|Study Period 1|Withdrawal by Subject|1|||
144253730|NCT03252145|520129995|FG000|Overall Study|Complicating Disease|1|||
144253731|NCT03252145|520129996|FG001|Overall Study|Complicating Disease|2|||
144446312|NCT01109316|520833290|FG003|Study Period 1|Withdrawal by Subject|0|||
144446313|NCT01109316|520833291|FG004|Study Period 1|Withdrawal by Subject|2|||
144446314|NCT01109316|520833292|FG005|Study Period 1|Withdrawal by Subject|0|||
144253732|NCT02499263|520130001|FG000|Overall Study|Lost to Follow-up|9|||
144446315|NCT01109316|520833287|FG000|Study Period 1|Sponsor Decision|0|||
144446316|NCT01109316|520833288|FG001|Study Period 1|Sponsor Decision|0|||
144446317|NCT01109316|520833289|FG002|Study Period 1|Sponsor Decision|0|||
144446318|NCT01109316|520833290|FG003|Study Period 1|Sponsor Decision|0|||
144446319|NCT01109316|520833291|FG004|Study Period 1|Sponsor Decision|0|||
144446320|NCT01109316|520833292|FG005|Study Period 1|Sponsor Decision|2|||
144446321|NCT01109316|520833287|FG000|Study Period 2|Entry Criteria Not Met|0|||
144446322|NCT01109316|520833288|FG001|Study Period 2|Entry Criteria Not Met|1|||
144446323|NCT01109316|520833289|FG002|Study Period 2|Entry Criteria Not Met|0|||
144446324|NCT01109316|520833290|FG003|Study Period 2|Entry Criteria Not Met|0|||
144446325|NCT01109316|520833291|FG004|Study Period 2|Entry Criteria Not Met|0|||
144446326|NCT01109316|520833292|FG005|Study Period 2|Entry Criteria Not Met|0|||
144446327|NCT01109316|520833287|FG000|Study Period 2|Physician Decision|0|||
144446328|NCT01109316|520833288|FG001|Study Period 2|Physician Decision|0|||
144446329|NCT01109316|520833289|FG002|Study Period 2|Physician Decision|0|||
144446330|NCT01109316|520833290|FG003|Study Period 2|Physician Decision|1|||
144446331|NCT01109316|520833291|FG004|Study Period 2|Physician Decision|0|||
144446332|NCT01109316|520833292|FG005|Study Period 2|Physician Decision|0|||
144446333|NCT01109316|520833287|FG000|Study Period 2|Protocol Violation|1|||
144446334|NCT01109316|520833288|FG001|Study Period 2|Protocol Violation|0|||
144446335|NCT01109316|520833289|FG002|Study Period 2|Protocol Violation|0|||
144446336|NCT01109316|520833290|FG003|Study Period 2|Protocol Violation|0|||
144446337|NCT01109316|520833291|FG004|Study Period 2|Protocol Violation|0|||
144446338|NCT01109316|520833292|FG005|Study Period 2|Protocol Violation|0|||
144446339|NCT01109316|520833287|FG000|Study Period 2|Withdrawal by Subject|0|||
144446340|NCT01109316|520833288|FG001|Study Period 2|Withdrawal by Subject|0|||
144446341|NCT01109316|520833289|FG002|Study Period 2|Withdrawal by Subject|1|||
144446342|NCT01109316|520833290|FG003|Study Period 2|Withdrawal by Subject|0|||
144446343|NCT01109316|520833291|FG004|Study Period 2|Withdrawal by Subject|0|||
144446344|NCT01109316|520833292|FG005|Study Period 2|Withdrawal by Subject|1|||
144446345|NCT01109316|520833287|FG000|Study Period 3|Lost to Follow-up|0|||
144446346|NCT01109316|520833288|FG001|Study Period 3|Lost to Follow-up|0|||
144446347|NCT01109316|520833289|FG002|Study Period 3|Lost to Follow-up|0|||
144446348|NCT01109316|520833290|FG003|Study Period 3|Lost to Follow-up|0|||
144446349|NCT01109316|520833291|FG004|Study Period 3|Lost to Follow-up|1|||
144446350|NCT01109316|520833292|FG005|Study Period 3|Lost to Follow-up|0|||
144446351|NCT01109316|520833287|FG000|Study Period 3|Withdrawal by Subject|1|||
144446352|NCT01109316|520833288|FG001|Study Period 3|Withdrawal by Subject|0|||
144446353|NCT01109316|520833289|FG002|Study Period 3|Withdrawal by Subject|0|||
144446354|NCT01109316|520833290|FG003|Study Period 3|Withdrawal by Subject|0|||
144446355|NCT01109316|520833291|FG004|Study Period 3|Withdrawal by Subject|1|||
144446356|NCT01109316|520833292|FG005|Study Period 3|Withdrawal by Subject|0|||
144446357|NCT03511560|520833298|FG000|Overall Study|Death|0|||
144446358|NCT03511560|520833299|FG001|Overall Study|Death|1|||
144446359|NCT03511560|520833298|FG000|Overall Study|Adverse Event|0|||
144446360|NCT03511560|520833299|FG001|Overall Study|Adverse Event|2|||
144446361|NCT03511560|520833298|FG000|Overall Study|Transplant cancelled|0|||
144446362|NCT03511560|520833299|FG001|Overall Study|Transplant cancelled|1|||
144446363|NCT03511560|520833298|FG000|Overall Study|Patient switched to another drug|1|||
144446364|NCT03511560|520833299|FG001|Overall Study|Patient switched to another drug|0|||
144446365|NCT00179413|520833304|FG000|Overall Study|Adverse Event|38|||
144446366|NCT00179413|520833305|FG001|Overall Study|Adverse Event|20|||
144446367|NCT00179413|520833304|FG000|Overall Study|Withdrawal by Subject|87|||
144446368|NCT00179413|520833305|FG001|Overall Study|Withdrawal by Subject|95|||
144446369|NCT00439140|520833306|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
144532904|NCT05424380|521154298|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
144446370|NCT00439140|520833307|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
144446371|NCT00439140|520833308|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
144446372|NCT00439140|520833306|FG000|Treatment Cycle 1|Personal reasons|0|||
144446373|NCT00439140|520833307|FG001|Treatment Cycle 1|Personal reasons|2|||
144446374|NCT00439140|520833308|FG002|Treatment Cycle 1|Personal reasons|0|||
144446375|NCT00439140|520833306|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
144446376|NCT00439140|520833307|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
144446377|NCT00439140|520833308|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
144446378|NCT00439140|520833306|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
144446379|NCT00439140|520833307|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
144446380|NCT00439140|520833308|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
144446381|NCT00439140|520833306|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
144446382|NCT00439140|520833307|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
144446383|NCT00439140|520833308|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
144446384|NCT01192152|520833312|FG000|Period 1|left prematurely (while on treatment B)|0|||
144446385|NCT01192152|520833313|FG001|Period 1|left prematurely (while on treatment B)|1|||
144446386|NCT01192152|520833312|FG000|Period 3|family emergency|1|||
144446387|NCT01192152|520833313|FG001|Period 3|family emergency|0|||
144446388|NCT01009099|520833315|FG000|Overall Study|Lost to Follow-up|1|||
144532905|NCT05424380|521154299|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
144446389|NCT01009099|520833316|FG001|Overall Study|Lost to Follow-up|0|||
144532906|NCT05424380|521154300|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
144532907|NCT05424380|521154295|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
144446390|NCT01009099|520833315|FG000|Overall Study|Physician Decision|3|||
144446391|NCT01009099|520833316|FG001|Overall Study|Physician Decision|2|||
144532908|NCT05424380|521154296|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
144532909|NCT05424380|521154297|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
144532910|NCT05424380|521154298|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
144532911|NCT05424380|521154299|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
144532912|NCT05424380|521154300|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
144532913|NCT05424380|521154295|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
144532914|NCT05424380|521154296|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
144532915|NCT05424380|521154297|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
144532916|NCT05424380|521154298|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
144532917|NCT05424380|521154299|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
144532918|NCT05424380|521154300|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
144532919|NCT05424380|521154295|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532920|NCT05424380|521154296|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532921|NCT05424380|521154297|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144725226|NCT01298570|521851203|FG001|Overall Study|Other complicating disease|1|||
144725227|NCT01298570|521851202|FG000|Overall Study|Surgery|2|||
144725228|NCT01298570|521851203|FG001|Overall Study|Surgery|1|||
144725229|NCT01298570|521851202|FG000|Overall Study|Symptomatic progression/deterioration|3|||
144194000|NCT00515034|519905127|FG000|Overall Study|Adverse Event|2|||
144194001|NCT00515034|519905128|FG001|Overall Study|Adverse Event|0|||
144194002|NCT00515034|519905129|FG002|Overall Study|Adverse Event|1|||
144194003|NCT00515034|519905130|FG003|Overall Study|Adverse Event|0|||
144194004|NCT00515034|519905127|FG000|Overall Study|Death|4|||
144194005|NCT00515034|519905128|FG001|Overall Study|Death|2|||
144194006|NCT00515034|519905129|FG002|Overall Study|Death|1|||
144194007|NCT00515034|519905130|FG003|Overall Study|Death|3|||
144194008|NCT00515034|519905127|FG000|Overall Study|Withdrawal by Subject|1|||
144194009|NCT00515034|519905128|FG001|Overall Study|Withdrawal by Subject|0|||
144194010|NCT00515034|519905129|FG002|Overall Study|Withdrawal by Subject|3|||
144194011|NCT00515034|519905130|FG003|Overall Study|Withdrawal by Subject|0|||
144194012|NCT00515034|519905127|FG000|Overall Study|Physician Decision|0|||
144194013|NCT00515034|519905128|FG001|Overall Study|Physician Decision|0|||
144194014|NCT00515034|519905129|FG002|Overall Study|Physician Decision|1|||
144194015|NCT00515034|519905130|FG003|Overall Study|Physician Decision|1|||
144446392|NCT01009099|520833315|FG000|Overall Study|Withdrawal by Subject|1|||
144446393|NCT01009099|520833316|FG001|Overall Study|Withdrawal by Subject|1|||
144446394|NCT01009099|520833315|FG000|Overall Study|Death|0|||
144446395|NCT01009099|520833316|FG001|Overall Study|Death|1|||
144446396|NCT01552772|520833317|FG000|Overall Study|Lost to Follow-up|2|||
144446397|NCT01552772|520833317|FG000|Overall Study|Adverse Event|1|||
144446398|NCT01552772|520833317|FG000|Overall Study|Protocol Deviation|1|||
144446399|NCT01310413|520834935|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
144446400|NCT01310413|520834936|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
144446401|NCT01310413|520834937|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
144446402|NCT01310413|520834938|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
144446403|NCT01310413|520834939|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
144446404|NCT01310413|520834940|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
144446405|NCT01310413|520834941|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
144446406|NCT01310413|520834935|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
144446407|NCT01310413|520834936|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
144446408|NCT01310413|520834937|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
144446409|NCT01310413|520834938|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
144446410|NCT01310413|520834939|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
144446411|NCT01310413|520834940|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
144446412|NCT01310413|520834941|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
144446413|NCT01310413|520834935|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
144446414|NCT01310413|520834936|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
144446415|NCT01310413|520834937|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
144446416|NCT01310413|520834938|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
144446417|NCT01310413|520834939|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
144446418|NCT01310413|520834940|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
144446419|NCT01310413|520834941|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
144446420|NCT01310413|520834935|FG000|Day 0 to Day 385|Other|1|||
144446421|NCT01310413|520834936|FG001|Day 0 to Day 385|Other|0|||
144446422|NCT01310413|520834937|FG002|Day 0 to Day 385|Other|3|||
144446423|NCT01310413|520834938|FG003|Day 0 to Day 385|Other|0|||
144446424|NCT01310413|520834939|FG004|Day 0 to Day 385|Other|0|||
144446425|NCT01310413|520834940|FG005|Day 0 to Day 385|Other|0|||
144446426|NCT01310413|520834941|FG006|Day 0 to Day 385|Other|0|||
144532922|NCT05424380|521154298|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
144446427|NCT01310413|520834935|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
144446428|NCT01310413|520834936|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
144725230|NCT01298570|521851203|FG001|Overall Study|Symptomatic progression/deterioration|2|||
144725231|NCT01298570|521851202|FG000|Overall Study|Death|0|||
144725232|NCT01298570|521851203|FG001|Overall Study|Death|1|||
144725233|NCT01298570|521851202|FG000|Overall Study|Ineligibility|0|||
144446429|NCT01310413|520834937|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
144446430|NCT01310413|520834938|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
144194016|NCT00515034|519905127|FG000|Overall Study|Other|1|||
144194017|NCT00515034|519905128|FG001|Overall Study|Other|0|||
144194018|NCT00515034|519905129|FG002|Overall Study|Other|2|||
144194019|NCT00515034|519905130|FG003|Overall Study|Other|1|||
144606338|NCT01704287|521420961|FG004|Initial Treatment Period|Lost to Follow-up|0|||
144606339|NCT01704287|521420957|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
144446431|NCT01310413|520834939|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
144446432|NCT01310413|520834940|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
144446433|NCT01310413|520834941|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
144446434|NCT01310413|520834935|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
144446435|NCT01310413|520834936|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
144446436|NCT01310413|520834937|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
144532923|NCT05424380|521154299|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532924|NCT05424380|521154300|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532925|NCT05424380|521154295|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
144532926|NCT05424380|521154296|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
144532927|NCT05424380|521154297|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
144532928|NCT05424380|521154298|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
144446437|NCT01310413|520834938|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
144446438|NCT01310413|520834939|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
144446439|NCT01310413|520834940|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
144446440|NCT01310413|520834941|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
144446441|NCT02391948|520834942|FG000|6-month Assessment|Death|0|||
144446442|NCT02391948|520834943|FG001|6-month Assessment|Death|0|||
144446443|NCT02391948|520834944|FG002|6-month Assessment|Death|0|||
144532929|NCT05424380|521154299|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
144606340|NCT01704287|521420958|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
144606341|NCT01704287|521420959|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
144606342|NCT01704287|521420960|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
144606343|NCT01704287|521420961|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
144606344|NCT01704287|521420957|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
144606345|NCT01704287|521420958|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
144606346|NCT01704287|521420959|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
144606347|NCT01704287|521420960|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
144606348|NCT01704287|521420961|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
144606349|NCT01704287|521420957|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
144606350|NCT01704287|521420958|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
144606351|NCT01704287|521420959|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
144606352|NCT01704287|521420960|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
144606353|NCT01704287|521420961|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
144606354|NCT01704287|521420957|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
144606355|NCT01704287|521420958|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
144606356|NCT01704287|521420959|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
144606357|NCT01704287|521420960|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
144606358|NCT01704287|521420961|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
144606359|NCT04024228|521420963|FG000|Overall Study|Adverse Event|1|||
144606360|NCT04024228|521420964|FG001|Overall Study|Adverse Event|0|||
144606361|NCT04024228|521420963|FG000|Overall Study|Protocol Deviation|0|||
144606362|NCT04024228|521420964|FG001|Overall Study|Protocol Deviation|2|||
144606363|NCT04024228|521420963|FG000|Overall Study|Withdrawal by Subject|3|||
144606364|NCT04024228|521420964|FG001|Overall Study|Withdrawal by Subject|4|||
144606365|NCT02982590|521420967|FG000|Overall Study|Lost to Follow-up|0|||
144606366|NCT02982590|521420968|FG001|Overall Study|Lost to Follow-up|1|||
144606367|NCT02982590|521420967|FG000|Overall Study|Death|4|||
144606368|NCT02982590|521420968|FG001|Overall Study|Death|0|||
144606369|NCT02713542|521420974|FG000|Overall Study|Use of prohibited medication|14|||
144606370|NCT02713542|521420975|FG001|Overall Study|Use of prohibited medication|5|||
144606371|NCT02713542|521420974|FG000|Overall Study|Withdrawal by Subject|4|||
144606372|NCT02713542|521420975|FG001|Overall Study|Withdrawal by Subject|1|||
144606373|NCT00709111|521420988|FG000|Overall Study|Withdrawal by Subject|1|||
144606374|NCT00709111|521420988|FG000|Overall Study|Unable to attend clinic visits|1|||
144606375|NCT01994382|521420993|FG000|Overall Study|Informed consent withdrawn|0|||
144606376|NCT01994382|521420994|FG001|Overall Study|Informed consent withdrawn|0|||
144606377|NCT01994382|521420995|FG002|Overall Study|Informed consent withdrawn|0|||
144606378|NCT01994382|521420996|FG003|Overall Study|Informed consent withdrawn|0|||
144606379|NCT01994382|521420997|FG004|Overall Study|Informed consent withdrawn|0|||
144606380|NCT01994382|521420998|FG005|Overall Study|Informed consent withdrawn|0|||
144194020|NCT02858726|519905131|FG000|Overall Study|Adverse Event|4|||
144446444|NCT02391948|520834945|FG003|6-month Assessment|Death|0|||
144446445|NCT02391948|520834946|FG004|6-month Assessment|Death|1|||
144606381|NCT01994382|521420999|FG006|Overall Study|Informed consent withdrawn|1|||
144606382|NCT01994382|521421000|FG007|Overall Study|Informed consent withdrawn|0|||
144606383|NCT01994382|521421001|FG008|Overall Study|Informed consent withdrawn|0|||
144606384|NCT01994382|521421002|FG009|Overall Study|Informed consent withdrawn|0|||
144446446|NCT02391948|520834942|FG000|6-month Assessment|Withdrawal by Subject|0|||
144446447|NCT02391948|520834943|FG001|6-month Assessment|Withdrawal by Subject|0|||
144194021|NCT02858726|519905132|FG001|Overall Study|Adverse Event|4|||
144194022|NCT02858726|519905133|FG002|Overall Study|Adverse Event|9|||
144194023|NCT02858726|519905134|FG003|Overall Study|Adverse Event|1|||
144194024|NCT02858726|519905131|FG000|Overall Study|Physician Decision|0|||
144446448|NCT02391948|520834944|FG002|6-month Assessment|Withdrawal by Subject|1|||
144446449|NCT02391948|520834945|FG003|6-month Assessment|Withdrawal by Subject|2|||
144446450|NCT02391948|520834946|FG004|6-month Assessment|Withdrawal by Subject|0|||
144446451|NCT02391948|520834942|FG000|6-month Assessment|Lost to Follow-up|4|||
144446452|NCT02391948|520834943|FG001|6-month Assessment|Lost to Follow-up|5|||
144446453|NCT02391948|520834944|FG002|6-month Assessment|Lost to Follow-up|2|||
144446454|NCT02391948|520834945|FG003|6-month Assessment|Lost to Follow-up|3|||
144446455|NCT02391948|520834946|FG004|6-month Assessment|Lost to Follow-up|1|||
144446456|NCT02391948|520834942|FG000|6-month Assessment|Medical issue/illness|1|||
144446457|NCT02391948|520834943|FG001|6-month Assessment|Medical issue/illness|1|||
144446458|NCT02391948|520834944|FG002|6-month Assessment|Medical issue/illness|0|||
144446459|NCT02391948|520834945|FG003|6-month Assessment|Medical issue/illness|0|||
144446460|NCT02391948|520834946|FG004|6-month Assessment|Medical issue/illness|0|||
144446461|NCT02391948|520834942|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
144446462|NCT02391948|520834943|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
144446463|NCT02391948|520834944|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
144446464|NCT02391948|520834945|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
144446465|NCT02391948|520834946|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
144446466|NCT02391948|520834942|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
144446467|NCT02391948|520834943|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
144446468|NCT02391948|520834944|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
144446469|NCT02391948|520834945|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
144446470|NCT02391948|520834946|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
144446471|NCT02391948|520834942|FG000|12-month Assessment|Death|0|||
144446472|NCT02391948|520834943|FG001|12-month Assessment|Death|0|||
144446473|NCT02391948|520834944|FG002|12-month Assessment|Death|0|||
144446474|NCT02391948|520834945|FG003|12-month Assessment|Death|1|||
144446475|NCT02391948|520834946|FG004|12-month Assessment|Death|0|||
144446476|NCT02391948|520834942|FG000|12-month Assessment|Withdrawal by Subject|1|||
144446477|NCT02391948|520834943|FG001|12-month Assessment|Withdrawal by Subject|0|||
144446478|NCT02391948|520834944|FG002|12-month Assessment|Withdrawal by Subject|0|||
144446479|NCT02391948|520834945|FG003|12-month Assessment|Withdrawal by Subject|1|||
144446480|NCT02391948|520834946|FG004|12-month Assessment|Withdrawal by Subject|0|||
144446481|NCT02391948|520834942|FG000|12-month Assessment|Lost to Follow-up|5|||
144446482|NCT02391948|520834943|FG001|12-month Assessment|Lost to Follow-up|4|||
144446483|NCT02391948|520834944|FG002|12-month Assessment|Lost to Follow-up|4|||
144446484|NCT02391948|520834945|FG003|12-month Assessment|Lost to Follow-up|4|||
144446485|NCT02391948|520834946|FG004|12-month Assessment|Lost to Follow-up|5|||
144446486|NCT02391948|520834942|FG000|12-month Assessment|Medical issue/illness|0|||
144446487|NCT02391948|520834943|FG001|12-month Assessment|Medical issue/illness|1|||
144446488|NCT02391948|520834944|FG002|12-month Assessment|Medical issue/illness|0|||
144446489|NCT02391948|520834945|FG003|12-month Assessment|Medical issue/illness|1|||
144446490|NCT02391948|520834946|FG004|12-month Assessment|Medical issue/illness|0|||
144446491|NCT02391948|520834942|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
144446492|NCT02391948|520834943|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
144446493|NCT02391948|520834944|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
144446494|NCT02391948|520834945|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
144446495|NCT02391948|520834946|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
144446496|NCT02391948|520834942|FG000|18-month Assessment|Death|0|||
144446497|NCT02391948|520834943|FG001|18-month Assessment|Death|0|||
144446498|NCT02391948|520834944|FG002|18-month Assessment|Death|0|||
144446499|NCT02391948|520834945|FG003|18-month Assessment|Death|1|||
144446500|NCT02391948|520834946|FG004|18-month Assessment|Death|1|||
144446501|NCT02391948|520834942|FG000|18-month Assessment|Withdrawal by Subject|1|||
144725234|NCT01298570|521851203|FG001|Overall Study|Ineligibility|1|||
144725235|NCT00076102|521851204|FG000|Overall Study|Clinical progression|1|||
144725236|NCT00076102|521851204|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
144725237|NCT00076102|521851204|FG000|Overall Study|plexiform neurofibroma surgery|1|||
144725238|NCT00076102|521851204|FG000|Overall Study|refusal of further therapy|2|||
144194025|NCT02858726|519905132|FG001|Overall Study|Physician Decision|0|||
144194026|NCT02858726|519905133|FG002|Overall Study|Physician Decision|1|||
144194027|NCT02858726|519905134|FG003|Overall Study|Physician Decision|0|||
144446502|NCT02391948|520834943|FG001|18-month Assessment|Withdrawal by Subject|0|||
144446503|NCT02391948|520834944|FG002|18-month Assessment|Withdrawal by Subject|0|||
144446504|NCT02391948|520834945|FG003|18-month Assessment|Withdrawal by Subject|1|||
144446505|NCT02391948|520834946|FG004|18-month Assessment|Withdrawal by Subject|0|||
144446506|NCT02391948|520834942|FG000|18-month Assessment|Lost to Follow-up|2|||
144446507|NCT02391948|520834943|FG001|18-month Assessment|Lost to Follow-up|6|||
144446508|NCT02391948|520834944|FG002|18-month Assessment|Lost to Follow-up|2|||
144446509|NCT02391948|520834945|FG003|18-month Assessment|Lost to Follow-up|2|||
144532930|NCT05424380|521154300|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
144532931|NCT05424380|521154295|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
144532932|NCT05424380|521154296|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
144446510|NCT02391948|520834946|FG004|18-month Assessment|Lost to Follow-up|3|||
144446511|NCT02391948|520834942|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
144446512|NCT02391948|520834943|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
144446513|NCT02391948|520834944|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
144446514|NCT02391948|520834945|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
144446515|NCT02391948|520834946|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
144446516|NCT02391948|520834942|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
144446517|NCT02391948|520834943|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
144446518|NCT02391948|520834944|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
144446519|NCT02391948|520834945|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
144446520|NCT02391948|520834946|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
144532933|NCT05424380|521154297|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
144532934|NCT05424380|521154298|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
144725239|NCT01402908|521851206|FG000|Overall Study|Withdrawal by Subject|30|||
144446521|NCT02391948|520834942|FG000|24-month Assessment|Death|0|||
144532935|NCT05424380|521154299|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
144532936|NCT05424380|521154300|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
144532937|NCT05424380|521154295|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
144532938|NCT05424380|521154296|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
144532939|NCT05424380|521154297|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
144532940|NCT05424380|521154298|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
144532941|NCT05424380|521154299|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
144532942|NCT05424380|521154300|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
144532943|NCT05424380|521154295|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532944|NCT05424380|521154296|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532945|NCT05424380|521154297|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532946|NCT05424380|521154298|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532947|NCT05424380|521154299|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
144532948|NCT05424380|521154300|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
144532949|NCT05424380|521154295|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
144532950|NCT05424380|521154296|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
144532951|NCT05424380|521154297|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
144532952|NCT05424380|521154298|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
144532953|NCT05424380|521154299|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
144532954|NCT05424380|521154300|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
144446522|NCT02391948|520834943|FG001|24-month Assessment|Death|0|||
144446523|NCT02391948|520834944|FG002|24-month Assessment|Death|0|||
144446524|NCT02391948|520834945|FG003|24-month Assessment|Death|0|||
144446525|NCT02391948|520834946|FG004|24-month Assessment|Death|1|||
144446526|NCT02391948|520834942|FG000|24-month Assessment|Withdrawal by Subject|1|||
144446527|NCT02391948|520834943|FG001|24-month Assessment|Withdrawal by Subject|1|||
144446528|NCT02391948|520834944|FG002|24-month Assessment|Withdrawal by Subject|0|||
144446529|NCT02391948|520834945|FG003|24-month Assessment|Withdrawal by Subject|0|||
144446530|NCT02391948|520834946|FG004|24-month Assessment|Withdrawal by Subject|1|||
144446531|NCT02391948|520834942|FG000|24-month Assessment|Lost to Follow-up|5|||
144446532|NCT02391948|520834943|FG001|24-month Assessment|Lost to Follow-up|4|||
144446533|NCT02391948|520834944|FG002|24-month Assessment|Lost to Follow-up|0|||
144446534|NCT02391948|520834945|FG003|24-month Assessment|Lost to Follow-up|0|||
144446535|NCT02391948|520834946|FG004|24-month Assessment|Lost to Follow-up|0|||
144446536|NCT02391948|520834942|FG000|24-month Assessment|Medical issue/illness|0|||
144446537|NCT02391948|520834943|FG001|24-month Assessment|Medical issue/illness|0|||
144446538|NCT02391948|520834944|FG002|24-month Assessment|Medical issue/illness|1|||
144446539|NCT02391948|520834945|FG003|24-month Assessment|Medical issue/illness|0|||
144446540|NCT02391948|520834946|FG004|24-month Assessment|Medical issue/illness|0|||
144446541|NCT02391948|520834942|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
144446542|NCT02391948|520834943|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
144446543|NCT02391948|520834944|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
144446544|NCT02391948|520834945|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
144446545|NCT02391948|520834946|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
144532955|NCT00844415|521154307|FG000|Overall Study|Withdrawal by Subject|1|||
144532956|NCT03015532|521154308|FG000|Overall Study|Adverse Event|0|||
144532957|NCT03015532|521154309|FG001|Overall Study|Adverse Event|0|||
144532958|NCT03015532|521154310|FG002|Overall Study|Adverse Event|0|||
144725240|NCT01402908|521851207|FG001|Overall Study|Withdrawal by Subject|17|||
144725241|NCT01402908|521851206|FG000|Overall Study|Lost to Follow-up|3|||
144725242|NCT01402908|521851207|FG001|Overall Study|Lost to Follow-up|1|||
144446546|NCT02866682|520834949|FG000|Overall Study|Death|0|||
144194028|NCT02858726|519905131|FG000|Overall Study|Protocol Violation|0|||
144194029|NCT02858726|519905132|FG001|Overall Study|Protocol Violation|0|||
144194030|NCT02858726|519905133|FG002|Overall Study|Protocol Violation|0|||
144194031|NCT02858726|519905134|FG003|Overall Study|Protocol Violation|1|||
144194032|NCT02858726|519905131|FG000|Overall Study|Study Terminated by Sponsor|0|||
144194033|NCT02858726|519905132|FG001|Overall Study|Study Terminated by Sponsor|0|||
144194034|NCT02858726|519905133|FG002|Overall Study|Study Terminated by Sponsor|0|||
144194035|NCT02858726|519905134|FG003|Overall Study|Study Terminated by Sponsor|1|||
144194036|NCT02858726|519905131|FG000|Overall Study|Withdrawal by Subject|1|||
144194037|NCT02858726|519905132|FG001|Overall Study|Withdrawal by Subject|2|||
144194038|NCT02858726|519905133|FG002|Overall Study|Withdrawal by Subject|1|||
144194039|NCT02858726|519905134|FG003|Overall Study|Withdrawal by Subject|0|||
144194040|NCT02858726|519905131|FG000|Overall Study|Noncompliance|0|||
144194041|NCT02858726|519905132|FG001|Overall Study|Noncompliance|1|||
144194042|NCT02858726|519905133|FG002|Overall Study|Noncompliance|0|||
144194043|NCT02858726|519905134|FG003|Overall Study|Noncompliance|0|||
144194044|NCT00233987|519905141|FG000|Overall Study|Withdrawal by Subject|1|||
144194045|NCT00233987|519905141|FG000|Overall Study|Lack of Efficacy|2|||
144194046|NCT00233987|519905141|FG000|Overall Study|Reason Under Review|1|||
144194047|NCT00233987|519905141|FG000|Overall Study|Other - Not Protocol Specified|5|||
144194048|NCT00233987|519905141|FG000|Overall Study|Eligible but No Treatment Received|2|||
144194049|NCT00233987|519905141|FG000|Overall Study|Ineligible|4|||
144194050|NCT01688726|519905144|FG000|Overall Study|Adverse Event|1|||
144194051|NCT01688726|519905145|FG001|Overall Study|Adverse Event|0|||
144194052|NCT01688726|519905144|FG000|Overall Study|Relocated abroad|0|||
144194053|NCT01688726|519905145|FG001|Overall Study|Relocated abroad|1|||
144194054|NCT04459715|519905149|FG000|Overall Study|Adverse Event|3|||
144194055|NCT04459715|519905150|FG001|Overall Study|Adverse Event|3|||
144194056|NCT04459715|519905149|FG000|Overall Study|Death|111|||
144194057|NCT04459715|519905150|FG001|Overall Study|Death|93|||
144194058|NCT04459715|519905149|FG000|Overall Study|Lost to Follow-up|10|||
144194059|NCT04459715|519905150|FG001|Overall Study|Lost to Follow-up|9|||
144446547|NCT02866682|520834950|FG001|Overall Study|Death|1|||
144446548|NCT02866682|520834949|FG000|Overall Study|Lost to Follow-up|0|||
144446549|NCT02866682|520834950|FG001|Overall Study|Lost to Follow-up|4|||
144446550|NCT02866682|520834949|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
144446551|NCT02866682|520834950|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
144446552|NCT02866682|520834949|FG000|Overall Study|Other|0|||
144446553|NCT02866682|520834950|FG001|Overall Study|Other|1|||
144446554|NCT00201006|520834951|FG000|Overall Study|Withdrawal by Subject|7|||
144446555|NCT00201006|520834952|FG001|Overall Study|Withdrawal by Subject|2|||
144446556|NCT00201006|520834953|FG002|Overall Study|Withdrawal by Subject|3|||
144446557|NCT00201006|520834951|FG000|Overall Study|Adverse Event|1|||
144446558|NCT00201006|520834952|FG001|Overall Study|Adverse Event|0|||
144446559|NCT00201006|520834953|FG002|Overall Study|Adverse Event|1|||
144446560|NCT00938431|520834957|FG000|Overall Study|Adverse Event|5|||
144446561|NCT00938431|520834958|FG001|Overall Study|Adverse Event|8|||
144446562|NCT00938431|520834959|FG002|Overall Study|Adverse Event|6|||
144446563|NCT00938431|520834957|FG000|Overall Study|Lack of Efficacy|0|||
144446564|NCT00938431|520834958|FG001|Overall Study|Lack of Efficacy|1|||
144446565|NCT00938431|520834959|FG002|Overall Study|Lack of Efficacy|0|||
144446566|NCT00938431|520834957|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
144446567|NCT00938431|520834958|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
144446568|NCT00938431|520834959|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
144446569|NCT00938431|520834957|FG000|Overall Study|Dosing compliance issue|0|||
144446570|NCT00938431|520834958|FG001|Overall Study|Dosing compliance issue|0|||
144446571|NCT00938431|520834959|FG002|Overall Study|Dosing compliance issue|1|||
144446572|NCT00938431|520834957|FG000|Overall Study|Reached maximum dose early|0|||
144446573|NCT00938431|520834958|FG001|Overall Study|Reached maximum dose early|0|||
144446574|NCT00938431|520834959|FG002|Overall Study|Reached maximum dose early|1|||
144446575|NCT02086591|520834960|FG000|Overall Study|Adverse Event|1|||
144446576|NCT02086591|520834960|FG000|Overall Study|Withdrawal by Subject|1|||
144446577|NCT02086591|520834960|FG000|Overall Study|protocol terminated|3|||
144446578|NCT04574362|520834961|FG000|Overall Study|Other|0|||
144446579|NCT04574362|520834962|FG001|Overall Study|Other|5|||
144446580|NCT04574362|520834961|FG000|Overall Study|COVID-19|0|||
144446581|NCT04574362|520834962|FG001|Overall Study|COVID-19|1|||
144194060|NCT04459715|519905149|FG000|Overall Study|Other Reasons|4|||
144194061|NCT04459715|519905150|FG001|Overall Study|Other Reasons|5|||
144194062|NCT04459715|519905149|FG000|Overall Study|PROTOCOL DEVIATION|0|||
144194063|NCT04459715|519905150|FG001|Overall Study|PROTOCOL DEVIATION|1|||
144253733|NCT02499263|520130001|FG000|Overall Study|Participant's withdrawal of consent|4|||
144446582|NCT04574362|520834961|FG000|Overall Study|Adverse Event|1|||
144446583|NCT04574362|520834962|FG001|Overall Study|Adverse Event|1|||
144194064|NCT04459715|519905149|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
144194065|NCT04459715|519905150|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
144194066|NCT04459715|519905149|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
144194067|NCT04459715|519905150|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
144446584|NCT04574362|520834961|FG000|Overall Study|Withdrawal by Subject|2|||
144446585|NCT04574362|520834962|FG001|Overall Study|Withdrawal by Subject|4|||
144446586|NCT04574362|520834961|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
144446587|NCT04574362|520834962|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
144446588|NCT04574362|520834961|FG000|Overall Study|Participant refused to come to the hospital|1|||
144446589|NCT04574362|520834962|FG001|Overall Study|Participant refused to come to the hospital|0|||
144446590|NCT04574362|520834961|FG000|Overall Study|Participant refused the visit|1|||
144446591|NCT04574362|520834962|FG001|Overall Study|Participant refused the visit|0|||
144446592|NCT04574362|520834961|FG000|Overall Study|Participant quit early because of business trip|1|||
144446593|NCT04574362|520834962|FG001|Overall Study|Participant quit early because of business trip|0|||
144446594|NCT00047463|520834963|FG000|Overall Study|Withdrawal by Subject|0|||
144446595|NCT00047463|520834964|FG001|Overall Study|Withdrawal by Subject|3|||
144446596|NCT00113516|520834965|FG000|Part 1|Adverse Event|6|||
144446597|NCT00113516|520834966|FG001|Part 1|Adverse Event|0|||
144446598|NCT00113516|520834965|FG000|Part 1|Death|3|||
144446599|NCT00113516|520834966|FG001|Part 1|Death|0|||
144446600|NCT00113516|520834965|FG000|Part 1|Other|3|||
144446601|NCT00113516|520834966|FG001|Part 1|Other|0|||
144446602|NCT00113516|520834965|FG000|Part 1|Withdrawal by Subject|2|||
144446603|NCT00113516|520834966|FG001|Part 1|Withdrawal by Subject|0|||
144446604|NCT00113516|520834965|FG000|Part 1|Lack of Efficacy|2|||
144446605|NCT00113516|520834966|FG001|Part 1|Lack of Efficacy|0|||
144446606|NCT00113516|520834965|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
144446607|NCT00113516|520834966|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
144446608|NCT00113516|520834965|FG000|Part 1|Laboratory Abnormality|1|||
144446609|NCT00113516|520834966|FG001|Part 1|Laboratory Abnormality|0|||
144446610|NCT00113516|520834965|FG000|Part 1|Ongoing|1|||
144446611|NCT00113516|520834966|FG001|Part 1|Ongoing|0|||
144446612|NCT00113516|520834965|FG000|Part 1|Missing|65|||
144446613|NCT00113516|520834966|FG001|Part 1|Missing|0|||
144446614|NCT00113516|520834965|FG000|Part 2|Adverse Event|0|||
144446615|NCT00113516|520834966|FG001|Part 2|Adverse Event|16|||
144446616|NCT00113516|520834965|FG000|Part 2|Death|0|||
144446617|NCT00113516|520834966|FG001|Part 2|Death|5|||
144446618|NCT00113516|520834965|FG000|Part 2|Lack of Efficacy|0|||
144446619|NCT00113516|520834966|FG001|Part 2|Lack of Efficacy|37|||
144446620|NCT00113516|520834965|FG000|Part 2|Withdrawal by Subject|0|||
144446621|NCT00113516|520834966|FG001|Part 2|Withdrawal by Subject|3|||
144446622|NCT00113516|520834965|FG000|Part 2|Other|0|||
144446623|NCT00113516|520834966|FG001|Part 2|Other|3|||
144446624|NCT00113516|520834965|FG000|Part 2|Laboratory Abnormality|0|||
144446625|NCT00113516|520834966|FG001|Part 2|Laboratory Abnormality|1|||
144446626|NCT00113516|520834965|FG000|Part 2|Ongoing|0|||
144446627|NCT00113516|520834966|FG001|Part 2|Ongoing|1|||
144446628|NCT02178475|520834967|FG000|Overall Study|Withdrawal by Subject|7|||
144446629|NCT02178475|520834967|FG000|Overall Study|Lost to Follow-up|10|||
144446630|NCT02178475|520834967|FG000|Overall Study|Death|13|||
144446631|NCT02178475|520834967|FG000|Overall Study|Protocol-specified Criteria|99|||
144446632|NCT01274637|520834970|FG000|Overall Study|Withdrawal by Subject|0|||
144446633|NCT01274637|520834971|FG001|Overall Study|Withdrawal by Subject|1|||
144446634|NCT01274637|520834970|FG000|Overall Study|Lost to Follow-up|0|||
144446635|NCT01274637|520834971|FG001|Overall Study|Lost to Follow-up|1|||
144446636|NCT01490060|520834972|FG000|Cycle 1|Change of Treatment|0|||
144446637|NCT01490060|520834973|FG001|Cycle 1|Change of Treatment|1|||
144446638|NCT01490060|520834974|FG002|Cycle 1|Change of Treatment|1|||
144446639|NCT01490060|520834975|FG003|Cycle 1|Change of Treatment|1|||
144446640|NCT01490060|520834972|FG000|Cycle 1|Insurance Denied|0|||
144446641|NCT01490060|520834973|FG001|Cycle 1|Insurance Denied|0|||
144446642|NCT01490060|520834974|FG002|Cycle 1|Insurance Denied|2|||
144446643|NCT01490060|520834975|FG003|Cycle 1|Insurance Denied|0|||
144446644|NCT01490060|520834972|FG000|Cycle 1|Withdrawal by Subject|0|||
144253734|NCT02499263|520130001|FG000|Overall Study|Lack of Efficacy|22|||
144446645|NCT01490060|520834973|FG001|Cycle 1|Withdrawal by Subject|0|||
144446646|NCT01490060|520834974|FG002|Cycle 1|Withdrawal by Subject|0|||
144446647|NCT01490060|520834975|FG003|Cycle 1|Withdrawal by Subject|1|||
144446648|NCT01490060|520834972|FG000|Cycle 1|Treatment at Another Facility|0|||
144446649|NCT01490060|520834973|FG001|Cycle 1|Treatment at Another Facility|0|||
144446650|NCT01490060|520834974|FG002|Cycle 1|Treatment at Another Facility|0|||
144446651|NCT01490060|520834975|FG003|Cycle 1|Treatment at Another Facility|1|||
144446652|NCT01490060|520834972|FG000|Cycle 2|Change of Treatment|1|||
144446653|NCT01490060|520834973|FG001|Cycle 2|Change of Treatment|1|||
144446654|NCT01490060|520834974|FG002|Cycle 2|Change of Treatment|0|||
144446655|NCT01490060|520834975|FG003|Cycle 2|Change of Treatment|0|||
144446656|NCT01490060|520834972|FG000|Cycle 2|Non-Compliance|0|||
144446657|NCT01490060|520834973|FG001|Cycle 2|Non-Compliance|0|||
144446658|NCT01490060|520834974|FG002|Cycle 2|Non-Compliance|1|||
144446659|NCT01490060|520834975|FG003|Cycle 2|Non-Compliance|0|||
144446660|NCT01490060|520834972|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
144446661|NCT01490060|520834973|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
144446662|NCT01490060|520834974|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
144446663|NCT01490060|520834975|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
144446664|NCT03698773|520834978|FG000|Overall Study|Lost to Follow-up|2|||
144446665|NCT03698773|520834979|FG001|Overall Study|Lost to Follow-up|1|||
144446666|NCT03075644|520834982|FG000|Overall Study|Withdrawal by Subject|1|||
144446667|NCT03075644|520834983|FG001|Overall Study|Withdrawal by Subject|1|||
144446668|NCT01706250|520834989|FG000|Overall Study|Lost to Follow-up|2|||
144446669|NCT03286140|520834990|FG000|Overall Study|Withdrawal by Subject|10|||
144446670|NCT03286140|520834991|FG001|Overall Study|Withdrawal by Subject|5|||
144446671|NCT03286140|520834990|FG000|Overall Study|Lost to Follow-up|5|||
144446672|NCT03286140|520834991|FG001|Overall Study|Lost to Follow-up|10|||
144446673|NCT03286140|520834990|FG000|Overall Study|Failure to comply|0|||
144446674|NCT03286140|520834991|FG001|Overall Study|Failure to comply|1|||
144446675|NCT02486406|520834992|FG000|Overall Study|Withdrew consent|1|||
144446676|NCT02486406|520834993|FG001|Overall Study|Withdrew consent|0|||
144446677|NCT02486406|520834994|FG002|Overall Study|Withdrew consent|0|||
144446678|NCT02486406|520834995|FG003|Overall Study|Withdrew consent|1|||
144446679|NCT02486406|520834992|FG000|Overall Study|Lost to Follow-up|1|||
144446680|NCT02486406|520834993|FG001|Overall Study|Lost to Follow-up|3|||
144446681|NCT02486406|520834994|FG002|Overall Study|Lost to Follow-up|1|||
144446682|NCT02486406|520834995|FG003|Overall Study|Lost to Follow-up|3|||
144446683|NCT02486406|520834992|FG000|Overall Study|Other, not specified|0|||
144446684|NCT02486406|520834993|FG001|Overall Study|Other, not specified|0|||
144446685|NCT02486406|520834994|FG002|Overall Study|Other, not specified|1|||
144446686|NCT02486406|520834995|FG003|Overall Study|Other, not specified|0|||
144446687|NCT01826825|520834996|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
144446688|NCT01826825|520834997|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
144446689|NCT01858194|520834998|FG000|Overall Study|Total Artificial Heart Implant|0|||
144446690|NCT01858194|520834999|FG001|Overall Study|Total Artificial Heart Implant|1|||
144446691|NCT01858194|520834998|FG000|Overall Study|Lost to Follow-up|0|||
144446692|NCT01858194|520834999|FG001|Overall Study|Lost to Follow-up|1|||
144446693|NCT03254134|520835001|FG000|Overall Study|Not eligible patients|599|||
144446694|NCT03254134|520835002|FG001|Overall Study|Not eligible patients|3630|||
144446695|NCT02563028|520835003|FG000|Overall Study|Lack of equipment|1|||
144446696|NCT02563028|520835003|FG000|Overall Study|Unable to elicit VEP post induction|1|||
144446697|NCT03181542|520835004|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
144446698|NCT03181542|520835005|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
144446699|NCT01856543|520835006|FG000|Overall Study|Treatment discontinued|6|||
144446700|NCT01856543|520835007|FG001|Overall Study|Treatment discontinued|3|||
144446701|NCT01856543|520835006|FG000|Overall Study|Withdrawn before start|7|||
144446702|NCT01856543|520835007|FG001|Overall Study|Withdrawn before start|3|||
144446703|NCT00799617|520835008|FG000|Main Testosterone Trial|Randomized in error|1|||
144446704|NCT00799617|520835009|FG001|Main Testosterone Trial|Randomized in error|1|||
144446705|NCT00799617|520835008|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
144446706|NCT00799617|520835009|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
144446707|NCT00799617|520835008|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
144446708|NCT00799617|520835009|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
144446709|NCT00799617|520835008|FG000|Sexual Funtion Trial|No Baseline Data|4|||
144446710|NCT00799617|520835009|FG001|Sexual Funtion Trial|No Baseline Data|7|||
144446711|NCT00799617|520835008|FG000|Physical Function Trial|Lost to Follow-up|6|||
144446712|NCT00799617|520835009|FG001|Physical Function Trial|Lost to Follow-up|11|||
144446713|NCT00799617|520835008|FG000|Vitality Trial|Lost to Follow-up|7|||
144446714|NCT00799617|520835009|FG001|Vitality Trial|Lost to Follow-up|22|||
144446715|NCT00799617|520835008|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
144194068|NCT04459715|519905149|FG000|Overall Study|Withdrawal by Subject|22|||
144194069|NCT04459715|519905150|FG001|Overall Study|Withdrawal by Subject|22|||
144446716|NCT00799617|520835009|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
144446717|NCT00799617|520835008|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
144446718|NCT00799617|520835009|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
144446719|NCT00799617|520835008|FG000|Bone Trial|Month 12 scan not available|6|||
144446720|NCT00799617|520835009|FG001|Bone Trial|Month 12 scan not available|16|||
144446721|NCT00799617|520835008|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
144446722|NCT00799617|520835009|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
144446723|NCT00799617|520835008|FG000|Anemia Trial|Withdrawal by Subject|3|||
144446724|NCT00799617|520835009|FG001|Anemia Trial|Withdrawal by Subject|3|||
144446725|NCT04545515|520835010|FG000|Overall Study|Adverse Event|1|||
144446726|NCT04545515|520835010|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
144446727|NCT04545515|520835010|FG000|Overall Study|Commercial drug is available for participant|7|||
144446728|NCT02501096|520835011|FG000|Overall Study|Lost to Follow-up|0|||
144446729|NCT02501096|520835012|FG001|Overall Study|Lost to Follow-up|0|||
144446730|NCT02501096|520835013|FG002|Overall Study|Lost to Follow-up|0|||
144446731|NCT02501096|520835014|FG003|Overall Study|Lost to Follow-up|0|||
144446732|NCT02501096|520835015|FG004|Overall Study|Lost to Follow-up|1|||
144446733|NCT02501096|520835016|FG005|Overall Study|Lost to Follow-up|1|||
144725243|NCT01402908|521851206|FG000|Overall Study|Physician Decision|1|||
144194070|NCT03821272|519906374|FG000|Overall Study|Death|1|||
144532959|NCT03015532|521154311|FG003|Overall Study|Adverse Event|0|||
144532960|NCT03015532|521154312|FG004|Overall Study|Adverse Event|0|||
144725244|NCT01402908|521851207|FG001|Overall Study|Physician Decision|0|||
144725245|NCT01739790|521851208|FG000|Overall Study|Early Trial Termination|2|||
144446734|NCT02501096|520835017|FG006|Overall Study|Lost to Follow-up|3|||
144446735|NCT02501096|520835018|FG007|Overall Study|Lost to Follow-up|0|||
144532961|NCT03015532|521154313|FG005|Overall Study|Adverse Event|2|||
144532962|NCT03015532|521154314|FG006|Overall Study|Adverse Event|1|||
144532963|NCT03015532|521154315|FG007|Overall Study|Adverse Event|0|||
144532964|NCT03015532|521154308|FG000|Overall Study|Withdrawal by Subject|0|||
144532965|NCT03015532|521154309|FG001|Overall Study|Withdrawal by Subject|0|||
144532966|NCT03015532|521154310|FG002|Overall Study|Withdrawal by Subject|0|||
144532967|NCT03015532|521154311|FG003|Overall Study|Withdrawal by Subject|0|||
144532968|NCT03015532|521154312|FG004|Overall Study|Withdrawal by Subject|0|||
144532969|NCT03015532|521154313|FG005|Overall Study|Withdrawal by Subject|0|||
144532970|NCT03015532|521154314|FG006|Overall Study|Withdrawal by Subject|1|||
144532971|NCT03015532|521154315|FG007|Overall Study|Withdrawal by Subject|0|||
144532972|NCT04629339|521154316|FG000|Overall Study|Death|1|||
144532973|NCT04629339|521154317|FG001|Overall Study|Death|0|||
144532974|NCT04629339|521154318|FG002|Overall Study|Death|2|||
144532975|NCT04629339|521154319|FG003|Overall Study|Death|2|||
144532976|NCT04629339|521154320|FG004|Overall Study|Death|0|||
144532977|NCT04629339|521154316|FG000|Overall Study|Disease Progression|0|||
144532978|NCT04629339|521154317|FG001|Overall Study|Disease Progression|0|||
144532979|NCT04629339|521154318|FG002|Overall Study|Disease Progression|1|||
144532980|NCT04629339|521154319|FG003|Overall Study|Disease Progression|1|||
144446736|NCT02501096|520835019|FG008|Overall Study|Lost to Follow-up|0|||
144446737|NCT02501096|520835011|FG000|Overall Study|Withdrawal by Subject|1|||
144446738|NCT02501096|520835012|FG001|Overall Study|Withdrawal by Subject|0|||
144446739|NCT02501096|520835013|FG002|Overall Study|Withdrawal by Subject|7|||
144446740|NCT02501096|520835014|FG003|Overall Study|Withdrawal by Subject|13|||
144446741|NCT02501096|520835015|FG004|Overall Study|Withdrawal by Subject|2|||
144446742|NCT02501096|520835016|FG005|Overall Study|Withdrawal by Subject|2|||
144446743|NCT02501096|520835017|FG006|Overall Study|Withdrawal by Subject|2|||
144446744|NCT02501096|520835018|FG007|Overall Study|Withdrawal by Subject|3|||
144446745|NCT02501096|520835019|FG008|Overall Study|Withdrawal by Subject|0|||
144446746|NCT02501096|520835011|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
144446747|NCT02501096|520835012|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
144446748|NCT02501096|520835013|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
144446749|NCT02501096|520835014|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
144446750|NCT02501096|520835015|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
144446751|NCT02501096|520835016|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
144446752|NCT02501096|520835017|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
144446753|NCT02501096|520835018|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
144446754|NCT02501096|520835019|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
144446755|NCT02501096|520835011|FG000|Overall Study|Death|1|||
144446756|NCT02501096|520835012|FG001|Overall Study|Death|1|||
144446757|NCT02501096|520835013|FG002|Overall Study|Death|88|||
144446758|NCT02501096|520835014|FG003|Overall Study|Death|74|||
144446759|NCT02501096|520835015|FG004|Overall Study|Death|15|||
144532981|NCT04629339|521154320|FG004|Overall Study|Disease Progression|0|||
144532982|NCT04629339|521154316|FG000|Overall Study|Lost to Follow-up|0|||
144532983|NCT04629339|521154317|FG001|Overall Study|Lost to Follow-up|0|||
144446760|NCT02501096|520835016|FG005|Overall Study|Death|16|||
144446761|NCT02501096|520835017|FG006|Overall Study|Death|15|||
144446762|NCT02501096|520835018|FG007|Overall Study|Death|16|||
144446763|NCT02501096|520835019|FG008|Overall Study|Death|1|||
144532984|NCT04629339|521154318|FG002|Overall Study|Lost to Follow-up|0|||
144532985|NCT04629339|521154319|FG003|Overall Study|Lost to Follow-up|1|||
144532986|NCT04629339|521154320|FG004|Overall Study|Lost to Follow-up|0|||
144532987|NCT04629339|521154316|FG000|Overall Study|Physician Decision|0|||
144532988|NCT04629339|521154317|FG001|Overall Study|Physician Decision|1|||
144532989|NCT04629339|521154318|FG002|Overall Study|Physician Decision|0|||
144532990|NCT04629339|521154319|FG003|Overall Study|Physician Decision|0|||
144532991|NCT04629339|521154320|FG004|Overall Study|Physician Decision|0|||
144532992|NCT04629339|521154316|FG000|Overall Study|Study Terminated by Sponsor|0|||
144532993|NCT04629339|521154317|FG001|Overall Study|Study Terminated by Sponsor|0|||
144532994|NCT04629339|521154318|FG002|Overall Study|Study Terminated by Sponsor|0|||
144532995|NCT04629339|521154319|FG003|Overall Study|Study Terminated by Sponsor|1|||
144532996|NCT04629339|521154320|FG004|Overall Study|Study Terminated by Sponsor|0|||
144532997|NCT04629339|521154316|FG000|Overall Study|Withdrawal by Subject|0|||
144532998|NCT04629339|521154317|FG001|Overall Study|Withdrawal by Subject|0|||
144532999|NCT04629339|521154318|FG002|Overall Study|Withdrawal by Subject|2|||
144533000|NCT04629339|521154319|FG003|Overall Study|Withdrawal by Subject|2|||
144533001|NCT04629339|521154320|FG004|Overall Study|Withdrawal by Subject|0|||
144725246|NCT01739790|521851209|FG001|Overall Study|Early Trial Termination|4|||
144533002|NCT03914469|521154321|FG000|Overall Study|Lost to Follow-up|1|||
144725247|NCT02581345|521851210|FG000|Part 1: up to Week 16|Adverse Event|3|||
144446764|NCT01848990|520835020|FG000|Overall Study|Adverse Event|6|||
144446765|NCT01848990|520835021|FG001|Overall Study|Adverse Event|2|||
144446766|NCT01848990|520835022|FG002|Overall Study|Adverse Event|0|||
144446767|NCT01848990|520835020|FG000|Overall Study|Lost to Follow-up|6|||
144446768|NCT01848990|520835021|FG001|Overall Study|Lost to Follow-up|2|||
144446769|NCT01848990|520835022|FG002|Overall Study|Lost to Follow-up|2|||
144446770|NCT01848990|520835020|FG000|Overall Study|Protocol Violation|1|||
144446771|NCT01848990|520835021|FG001|Overall Study|Protocol Violation|1|||
144446772|NCT01848990|520835022|FG002|Overall Study|Protocol Violation|0|||
144446773|NCT01848990|520835020|FG000|Overall Study|Withdrawal by Subject|29|||
144446774|NCT01848990|520835021|FG001|Overall Study|Withdrawal by Subject|10|||
144446775|NCT01848990|520835022|FG002|Overall Study|Withdrawal by Subject|11|||
144446776|NCT01848990|520835020|FG000|Overall Study|Physician Decision|1|||
144446777|NCT01848990|520835021|FG001|Overall Study|Physician Decision|1|||
144446778|NCT01848990|520835022|FG002|Overall Study|Physician Decision|0|||
144446779|NCT01848990|520835020|FG000|Overall Study|Non Compliance|1|||
144446780|NCT01848990|520835021|FG001|Overall Study|Non Compliance|0|||
144446781|NCT01848990|520835022|FG002|Overall Study|Non Compliance|0|||
144446782|NCT01848990|520835020|FG000|Overall Study|Death|1|||
144446783|NCT01848990|520835021|FG001|Overall Study|Death|0|||
144446784|NCT01848990|520835022|FG002|Overall Study|Death|1|||
144446785|NCT01848990|520835020|FG000|Overall Study|Other|1|||
144446786|NCT01848990|520835021|FG001|Overall Study|Other|4|||
144446787|NCT01848990|520835022|FG002|Overall Study|Other|2|||
144446788|NCT01712984|520835023|FG000|Overall Study|Adverse Event|0|||
144446789|NCT01712984|520835024|FG001|Overall Study|Adverse Event|0|||
144446790|NCT01712984|520835025|FG002|Overall Study|Adverse Event|1|||
144446791|NCT01712984|520835023|FG000|Overall Study|Protocol Violation|2|||
144446792|NCT01712984|520835024|FG001|Overall Study|Protocol Violation|0|||
144446793|NCT01712984|520835025|FG002|Overall Study|Protocol Violation|1|||
144446794|NCT01712984|520835023|FG000|Overall Study|Lost to Follow-up|8|||
144446795|NCT01712984|520835024|FG001|Overall Study|Lost to Follow-up|10|||
144446796|NCT01712984|520835025|FG002|Overall Study|Lost to Follow-up|1|||
144446797|NCT01712984|520835023|FG000|Overall Study|Withdrawal by Subject|6|||
144446798|NCT01712984|520835024|FG001|Overall Study|Withdrawal by Subject|6|||
144446799|NCT01712984|520835025|FG002|Overall Study|Withdrawal by Subject|7|||
144446800|NCT00096044|520835028|FG000|Overall Study|Withdrawal by Subject|9|||
144446801|NCT00096044|520835028|FG000|Overall Study|Adverse Event|21|||
144446802|NCT00096044|520835028|FG000|Overall Study|Disease Progression|4|||
144446803|NCT03149237|520835029|FG000|Overall Study|Withdrawal by Subject|4|||
144446804|NCT03149237|520835030|FG001|Overall Study|Withdrawal by Subject|5|||
144446805|NCT02442830|520835031|FG000|Overall Study|Technical Failure|0|||
144446806|NCT02442830|520835032|FG001|Overall Study|Technical Failure|1|||
144533003|NCT03914469|521154322|FG001|Overall Study|Lost to Follow-up|4|||
144533004|NCT00677365|521154323|FG000|Overall Study|Adverse Event|2|||
144533005|NCT00677365|521154324|FG001|Overall Study|Adverse Event|1|||
144533006|NCT00677365|521154325|FG002|Overall Study|Adverse Event|1|||
144533007|NCT00677365|521154326|FG003|Overall Study|Adverse Event|2|||
144533008|NCT00677365|521154323|FG000|Overall Study|Withdrawal by Subject|0|||
144533009|NCT00677365|521154324|FG001|Overall Study|Withdrawal by Subject|0|||
144533010|NCT00677365|521154325|FG002|Overall Study|Withdrawal by Subject|1|||
144533011|NCT00677365|521154326|FG003|Overall Study|Withdrawal by Subject|0|||
144533012|NCT00677365|521154323|FG000|Overall Study|Other reason|0|||
144533013|NCT00677365|521154324|FG001|Overall Study|Other reason|0|||
144533014|NCT00677365|521154325|FG002|Overall Study|Other reason|0|||
144533015|NCT00677365|521154326|FG003|Overall Study|Other reason|1|||
144533016|NCT04084574|521154327|FG000|Overall Study|Lost to Follow-up|1|||
144533017|NCT04084574|521154328|FG001|Overall Study|Lost to Follow-up|0|||
144533018|NCT04084574|521154327|FG000|Overall Study|Physician Decision|1|||
144533019|NCT04084574|521154328|FG001|Overall Study|Physician Decision|0|||
144533020|NCT04084574|521154327|FG000|Overall Study|Relocated out of state|1|||
144533021|NCT04084574|521154328|FG001|Overall Study|Relocated out of state|0|||
144446807|NCT04587193|520835033|FG000|Overall Study|Screen failure after consent|3|||
144533022|NCT02874742|521154329|FG000|Overall Study|Death|0|||
144533023|NCT02874742|521154330|FG001|Overall Study|Death|1|||
144533024|NCT02874742|521154331|FG002|Overall Study|Death|0|||
144533025|NCT02874742|521154329|FG000|Overall Study|Lost to Follow-up|5|||
144533026|NCT02874742|521154330|FG001|Overall Study|Lost to Follow-up|4|||
144533027|NCT02874742|521154331|FG002|Overall Study|Lost to Follow-up|1|||
144533028|NCT02874742|521154329|FG000|Overall Study|Withdrawal by Subject|17|||
144446808|NCT04587193|520835034|FG001|Overall Study|Screen failure after consent|0|||
144446809|NCT04587193|520835033|FG000|Overall Study|Device broke during study|3|||
144446810|NCT04587193|520835034|FG001|Overall Study|Device broke during study|2|||
144446811|NCT00437034|520835035|FG000|Overall Study|Adverse Event|1|||
144446812|NCT00437034|520835035|FG000|Overall Study|Disease progression during treatment|5|||
144446813|NCT03878134|520835038|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
144446814|NCT03851016|520835039|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144446815|NCT03851016|520835040|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
144533029|NCT02874742|521154330|FG001|Overall Study|Withdrawal by Subject|8|||
144446816|NCT00853658|520835041|FG000|Overall Study|Death|713|||
144446817|NCT00853658|520835042|FG001|Overall Study|Death|768|||
144446818|NCT00853658|520835043|FG002|Overall Study|Death|753|||
144446819|NCT00853658|520835041|FG000|Overall Study|Lost to Follow-up|11|||
144446820|NCT00853658|520835042|FG001|Overall Study|Lost to Follow-up|6|||
144446821|NCT00853658|520835043|FG002|Overall Study|Lost to Follow-up|11|||
144446822|NCT00853658|520835041|FG000|Overall Study|H.A. Request|26|||
144446823|NCT00853658|520835042|FG001|Overall Study|H.A. Request|23|||
144446824|NCT00853658|520835043|FG002|Overall Study|H.A. Request|19|||
144446825|NCT00853658|520835041|FG000|Overall Study|IRB request|0|||
144446826|NCT00853658|520835042|FG001|Overall Study|IRB request|0|||
144446827|NCT00853658|520835043|FG002|Overall Study|IRB request|2|||
144446828|NCT00853658|520835041|FG000|Overall Study|Vital Status known (alive) at study end|2|||
144446829|NCT00853658|520835042|FG001|Overall Study|Vital Status known (alive) at study end|3|||
144446830|NCT00853658|520835043|FG002|Overall Study|Vital Status known (alive) at study end|3|||
144446831|NCT00853658|520835041|FG000|Overall Study|Vital Status unknown at study end|1|||
144446832|NCT00853658|520835042|FG001|Overall Study|Vital Status unknown at study end|1|||
144446833|NCT00853658|520835043|FG002|Overall Study|Vital Status unknown at study end|0|||
144446834|NCT00853658|520835041|FG000|Overall Study|Vital Status at study end N/A|8|||
144446835|NCT00853658|520835042|FG001|Overall Study|Vital Status at study end N/A|10|||
144446836|NCT00853658|520835043|FG002|Overall Study|Vital Status at study end N/A|10|||
144446837|NCT00853658|520835041|FG000|Overall Study|Patient's request|21|||
144446838|NCT00853658|520835042|FG001|Overall Study|Patient's request|17|||
144446839|NCT00853658|520835043|FG002|Overall Study|Patient's request|11|||
144446840|NCT00853658|520835041|FG000|Overall Study|Missing study completion information|5|||
144446841|NCT00853658|520835042|FG001|Overall Study|Missing study completion information|4|||
144446842|NCT00853658|520835043|FG002|Overall Study|Missing study completion information|6|||
144446843|NCT00586469|520835045|FG000|Overall Study|Adverse Event|0|||
144446844|NCT00586469|520835046|FG001|Overall Study|Adverse Event|1|||
144446845|NCT01227512|520835049|FG000|Overall Study|Physician Decision|6|||
144446846|NCT01227512|520835050|FG001|Overall Study|Physician Decision|6|||
144446847|NCT01227512|520835049|FG000|Overall Study|Adverse Event|4|||
144446848|NCT01227512|520835050|FG001|Overall Study|Adverse Event|3|||
144446849|NCT01227512|520835049|FG000|Overall Study|Withdrawal by Subject|3|||
144446850|NCT01227512|520835050|FG001|Overall Study|Withdrawal by Subject|0|||
144446851|NCT01227512|520835049|FG000|Overall Study|Participant met withdrawal criteria|0|||
144446852|NCT01227512|520835050|FG001|Overall Study|Participant met withdrawal criteria|1|||
144446853|NCT04055116|520835057|FG000|First Intervention|Physician Decision|2|||
144446854|NCT04055116|520835058|FG001|First Intervention|Physician Decision|7|||
144446855|NCT02774681|520835059|FG000|Treatment on Study|Progressive Disease|7|||
144446856|NCT02774681|520835059|FG000|Follow-Up for 3 Years|Death|11|||
144446857|NCT02774681|520835059|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
144446858|NCT00512096|520835061|FG000|Overall Study|Adverse Event|2|||
144446859|NCT00512096|520835061|FG000|Overall Study|Withdrawal by Subject|2|||
144446860|NCT00512096|520835061|FG000|Overall Study|Lack of Efficacy|3|||
144446861|NCT01069289|520835066|FG000|Overall Study|Withdrawal by Subject|15|||
144446862|NCT01069289|520835067|FG001|Overall Study|Withdrawal by Subject|26|||
144446863|NCT01069289|520835066|FG000|Overall Study|Adverse Event|21|||
144446864|NCT01069289|520835067|FG001|Overall Study|Adverse Event|28|||
144446865|NCT01069289|520835066|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144446866|NCT01069289|520835067|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144446867|NCT01069289|520835066|FG000|Overall Study|Severe non-compliance to protocol|3|||
144446868|NCT01069289|520835067|FG001|Overall Study|Severe non-compliance to protocol|2|||
144446869|NCT01069289|520835066|FG000|Overall Study|Due to deteriorating health condition|1|||
144446870|NCT01069289|520835067|FG001|Overall Study|Due to deteriorating health condition|0|||
144446871|NCT00298038|520835068|FG000|Overall Study|Lost to Follow-up|0|||
144446872|NCT00298038|520835069|FG001|Overall Study|Lost to Follow-up|1|||
144446873|NCT00298038|520835068|FG000|Overall Study|Liver Transplant|0|||
144446874|NCT00298038|520835069|FG001|Overall Study|Liver Transplant|1|||
144446875|NCT00298038|520835068|FG000|Overall Study|Protocol Violation|1|||
144194071|NCT03821272|519906375|FG001|Overall Study|Death|0|||
144194072|NCT03821272|519906374|FG000|Overall Study|Physician Decision|1|||
144446876|NCT00298038|520835069|FG001|Overall Study|Protocol Violation|3|||
144446877|NCT00298038|520835068|FG000|Overall Study|Death|6|||
144446878|NCT00298038|520835069|FG001|Overall Study|Death|3|||
144446879|NCT00298038|520835068|FG000|Overall Study|Withdrawal by Subject|6|||
144446880|NCT00298038|520835069|FG001|Overall Study|Withdrawal by Subject|9|||
144446881|NCT00298038|520835068|FG000|Overall Study|Adverse Event|8|||
144446882|NCT00298038|520835069|FG001|Overall Study|Adverse Event|7|||
144446883|NCT00298038|520835068|FG000|Overall Study|Breakthrough overt HE episode|28|||
144446884|NCT00298038|520835069|FG001|Overall Study|Breakthrough overt HE episode|69|||
144446885|NCT00298038|520835068|FG000|Overall Study|Noncompliance|1|||
144446886|NCT00298038|520835069|FG001|Overall Study|Noncompliance|0|||
144446887|NCT00298038|520835068|FG000|Overall Study|Cocaine Abuse|1|||
144446888|NCT00298038|520835069|FG001|Overall Study|Cocaine Abuse|0|||
144446889|NCT00298038|520835068|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
144194073|NCT03821272|519906375|FG001|Overall Study|Physician Decision|0|||
144194074|NCT03821272|519906374|FG000|Overall Study|Withdrawal by Subject|1|||
144194075|NCT03821272|519906375|FG001|Overall Study|Withdrawal by Subject|0|||
144194076|NCT05904769|519906376|FG000|Overall Study|Physician Decision|0|||
144194077|NCT05904769|519906377|FG001|Overall Study|Physician Decision|6|||
144194078|NCT00380692|519906391|FG000|Study Period II - Double Blind|Adverse Event|1|||
144194079|NCT00380692|519906392|FG001|Study Period II - Double Blind|Adverse Event|0|||
144446890|NCT00298038|520835069|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
144446891|NCT02696096|520835070|FG000|Overall Study|ruled out at screening|1|||
144446892|NCT02696096|520835070|FG000|Overall Study|did not attend second fMRI|1|||
144446893|NCT02707640|520835071|FG000|Overall Study|Adverse Event|4|||
144446894|NCT02707640|520835072|FG001|Overall Study|Adverse Event|2|||
144194080|NCT00380692|519906391|FG000|Study Period II - Double Blind|Protocol Violation|2|||
144194081|NCT00380692|519906392|FG001|Study Period II - Double Blind|Protocol Violation|2|||
144446895|NCT02707640|520835071|FG000|Overall Study|Death|1|||
144446896|NCT02707640|520835072|FG001|Overall Study|Death|2|||
144446897|NCT02707640|520835071|FG000|Overall Study|Physician Decision|2|||
144446898|NCT02707640|520835072|FG001|Overall Study|Physician Decision|0|||
144446899|NCT02707640|520835071|FG000|Overall Study|Withdrawal by Subject|0|||
144446900|NCT02707640|520835072|FG001|Overall Study|Withdrawal by Subject|1|||
144446901|NCT02707640|520835071|FG000|Overall Study|Participant's Personal Decision|1|||
144446902|NCT02707640|520835072|FG001|Overall Study|Participant's Personal Decision|2|||
144446903|NCT02707640|520835071|FG000|Overall Study|Sponsor Discretion|1|||
144446904|NCT02707640|520835072|FG001|Overall Study|Sponsor Discretion|0|||
144446905|NCT02556710|520836546|FG000|Overall Study|Surgical treatment|3|||
144446906|NCT02556710|520836547|FG001|Overall Study|Surgical treatment|0|||
144446907|NCT02556710|520836546|FG000|Overall Study|Required proscribed pain medication|2|||
144446908|NCT02556710|520836547|FG001|Overall Study|Required proscribed pain medication|1|||
144446909|NCT02556710|520836546|FG000|Overall Study|Lack of Efficacy|1|||
144446910|NCT02556710|520836547|FG001|Overall Study|Lack of Efficacy|0|||
144446911|NCT02556710|520836546|FG000|Overall Study|Worsening osteoarthritis|1|||
144446912|NCT02556710|520836547|FG001|Overall Study|Worsening osteoarthritis|0|||
144446913|NCT02556710|520836546|FG000|Overall Study|Moved out of state|1|||
144446914|NCT02556710|520836547|FG001|Overall Study|Moved out of state|0|||
144446915|NCT02556710|520836546|FG000|Overall Study|Missing reason|3|||
144446916|NCT02556710|520836547|FG001|Overall Study|Missing reason|1|||
144446917|NCT02556710|520836546|FG000|Overall Study|Pain as lack of efficacy|0|||
144446918|NCT02556710|520836547|FG001|Overall Study|Pain as lack of efficacy|4|||
144446919|NCT02564471|520836552|FG000|Overall Study|Adverse Event|1|||
144446920|NCT02564471|520836553|FG001|Overall Study|Adverse Event|0|||
144446921|NCT02564471|520836554|FG002|Overall Study|Adverse Event|0|||
144446922|NCT02564471|520836555|FG003|Overall Study|Adverse Event|0|||
144446923|NCT02564471|520836552|FG000|Overall Study|Withdrawal by Subject|2|||
144446924|NCT02564471|520836553|FG001|Overall Study|Withdrawal by Subject|1|||
144446925|NCT02564471|520836554|FG002|Overall Study|Withdrawal by Subject|3|||
144446926|NCT02564471|520836555|FG003|Overall Study|Withdrawal by Subject|0|||
144446927|NCT02564471|520836552|FG000|Overall Study|Lost to Follow-up|0|||
144446928|NCT02564471|520836553|FG001|Overall Study|Lost to Follow-up|2|||
144446929|NCT02564471|520836554|FG002|Overall Study|Lost to Follow-up|0|||
144446930|NCT02564471|520836555|FG003|Overall Study|Lost to Follow-up|0|||
144446931|NCT00941733|520836556|FG000|Overall Study|Death|24|||
144446932|NCT00941733|520836557|FG001|Overall Study|Death|10|||
144446933|NCT00941733|520836556|FG000|Overall Study|Withdrawal by Subject|14|||
144446934|NCT00941733|520836557|FG001|Overall Study|Withdrawal by Subject|6|||
144446935|NCT00941733|520836556|FG000|Overall Study|Adverse Event|20|||
144446936|NCT00941733|520836557|FG001|Overall Study|Adverse Event|4|||
144446937|NCT00941733|520836556|FG000|Overall Study|Lost to Follow-up|1|||
144446938|NCT00941733|520836557|FG001|Overall Study|Lost to Follow-up|2|||
144446939|NCT00941733|520836556|FG000|Overall Study|Protocol Violation|15|||
144446940|NCT00941733|520836557|FG001|Overall Study|Protocol Violation|6|||
144446941|NCT01076400|520836559|FG000|Overall Study|Adverse Event|2|||
144533030|NCT02874742|521154331|FG002|Overall Study|Withdrawal by Subject|0|||
144533031|NCT02874742|521154329|FG000|Overall Study|Other|4|||
144533032|NCT02874742|521154330|FG001|Overall Study|Other|1|||
144533033|NCT02874742|521154331|FG002|Overall Study|Other|0|||
144533034|NCT02874742|521154329|FG000|Overall Study|Progressive Disease|1|||
144533035|NCT02874742|521154330|FG001|Overall Study|Progressive Disease|0|||
144533036|NCT02874742|521154331|FG002|Overall Study|Progressive Disease|0|||
144533037|NCT02874742|521154329|FG000|Overall Study|Screen Failure|0|||
144533038|NCT02874742|521154330|FG001|Overall Study|Screen Failure|2|||
144533039|NCT02874742|521154331|FG002|Overall Study|Screen Failure|0|||
144446942|NCT01076400|520836560|FG001|Overall Study|Adverse Event|0|||
144446943|NCT01076400|520836561|FG002|Overall Study|Adverse Event|0|||
144533040|NCT00964392|521154336|FG000|Overall Study|Withdrawal by Subject|4|||
144533041|NCT00964392|521154337|FG001|Overall Study|Withdrawal by Subject|6|||
144533042|NCT00964392|521154336|FG000|Overall Study|Lost to Follow-up|4|||
144533043|NCT00964392|521154337|FG001|Overall Study|Lost to Follow-up|10|||
144725248|NCT02581345|521851211|FG001|Part 1: up to Week 16|Adverse Event|8|||
144446944|NCT01076400|520836559|FG000|Overall Study|Progressive Disease|5|||
144725249|NCT02581345|521851212|FG002|Part 1: up to Week 16|Adverse Event|0|||
144446945|NCT01076400|520836560|FG001|Overall Study|Progressive Disease|0|||
144446946|NCT01076400|520836561|FG002|Overall Study|Progressive Disease|0|||
144446947|NCT00612066|520836564|FG000|Overall Study|Adverse Event|1|||
144446948|NCT03019536|520836566|FG000|Overall Study|Withdrawal by Subject|1|||
144446949|NCT03019536|520836567|FG001|Overall Study|Withdrawal by Subject|1|||
144446950|NCT03019536|520836568|FG002|Overall Study|Withdrawal by Subject|0|||
144446951|NCT03019536|520836566|FG000|Overall Study|Adverse Event|0|||
144446952|NCT03019536|520836567|FG001|Overall Study|Adverse Event|0|||
144446953|NCT03019536|520836568|FG002|Overall Study|Adverse Event|2|||
144446954|NCT00182689|520836574|FG000|Overall Study|Adverse Event|8|||
144446955|NCT00182689|520836575|FG001|Overall Study|Adverse Event|11|||
144446956|NCT00182689|520836574|FG000|Overall Study|Withdrawal by Subject|2|||
144446957|NCT00182689|520836575|FG001|Overall Study|Withdrawal by Subject|2|||
144446958|NCT00182689|520836574|FG000|Overall Study|Progression|27|||
144446959|NCT00182689|520836575|FG001|Overall Study|Progression|29|||
144446960|NCT00182689|520836574|FG000|Overall Study|Death|1|||
144446961|NCT00182689|520836575|FG001|Overall Study|Death|0|||
144446962|NCT00182689|520836574|FG000|Overall Study|not protocol specified|0|||
144446963|NCT00182689|520836575|FG001|Overall Study|not protocol specified|3|||
144446964|NCT00182689|520836574|FG000|Overall Study|Ineligible|1|||
144446965|NCT00182689|520836575|FG001|Overall Study|Ineligible|4|||
144446966|NCT00182689|520836574|FG000|Overall Study|Never received treatment|1|||
144446967|NCT00182689|520836575|FG001|Overall Study|Never received treatment|0|||
144446968|NCT00659646|520836576|FG000|Overall Study|Protocol Violation|12|||
144446969|NCT00659646|520836577|FG001|Overall Study|Protocol Violation|8|||
144446970|NCT00659646|520836576|FG000|Overall Study|Adverse Event|1|||
144446971|NCT00659646|520836577|FG001|Overall Study|Adverse Event|0|||
144446972|NCT00659646|520836576|FG000|Overall Study|Lost to Follow-up|1|||
144446973|NCT00659646|520836577|FG001|Overall Study|Lost to Follow-up|0|||
144446974|NCT00659646|520836576|FG000|Overall Study|protocol noncompliance after randomized|1|||
144446975|NCT00659646|520836577|FG001|Overall Study|protocol noncompliance after randomized|0|||
144446976|NCT02348489|520836578|FG000|Overall Study|Death|336|||
144446977|NCT02348489|520836579|FG001|Overall Study|Death|335|||
144446978|NCT02348489|520836578|FG000|Overall Study|Withdrawal by Subject|14|||
144446979|NCT02348489|520836579|FG001|Overall Study|Withdrawal by Subject|27|||
144446980|NCT02348489|520836578|FG000|Overall Study|Lost to Follow-up|3|||
144446981|NCT02348489|520836579|FG001|Overall Study|Lost to Follow-up|5|||
144446982|NCT02212730|520836580|FG000|Overall Study|Tumor not of the required cell histology|1|||
144446983|NCT02212730|520836581|FG001|Overall Study|Tumor not of the required cell histology|0|||
144446984|NCT02212730|520836580|FG000|Overall Study|Withdrawal by Subject|1|||
144446985|NCT02212730|520836581|FG001|Overall Study|Withdrawal by Subject|0|||
144446986|NCT02212730|520836580|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
144446987|NCT02212730|520836581|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
144446988|NCT02944578|520836582|FG000|Overall Study|Physician Decision|1|||
144533044|NCT00964392|521154336|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
144533045|NCT00964392|521154337|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
144533046|NCT00964392|521154336|FG000|Overall Study|Not completed|44|||
144533047|NCT00964392|521154337|FG001|Overall Study|Not completed|168|||
144533048|NCT02577354|521154338|FG000|Overall Study|Lack of Efficacy|4|||
144533049|NCT02577354|521154339|FG001|Overall Study|Lack of Efficacy|4|||
144533050|NCT02577354|521154338|FG000|Overall Study|Lost to Follow-up|3|||
144533051|NCT02577354|521154339|FG001|Overall Study|Lost to Follow-up|1|||
144533052|NCT02577354|521154338|FG000|Overall Study|Missed Visit|4|||
144533053|NCT02577354|521154339|FG001|Overall Study|Missed Visit|3|||
144533054|NCT02577354|521154338|FG000|Overall Study|Adverse Event|4|||
144533055|NCT02577354|521154339|FG001|Overall Study|Adverse Event|5|||
144533056|NCT04424316|521154342|FG000|Overall Study|Adverse Event|0|||
144533057|NCT04424316|521154343|FG001|Overall Study|Adverse Event|1|||
144533058|NCT04424316|521154344|FG002|Overall Study|Adverse Event|0|||
144533059|NCT04424316|521154345|FG003|Overall Study|Adverse Event|0|||
144533060|NCT04424316|521154342|FG000|Overall Study|Death|1|||
144533061|NCT04424316|521154343|FG001|Overall Study|Death|0|||
144533062|NCT04424316|521154344|FG002|Overall Study|Death|8|||
144533063|NCT04424316|521154345|FG003|Overall Study|Death|14|||
144533064|NCT04424316|521154342|FG000|Overall Study|Lost to Follow-up|93|||
144533065|NCT04424316|521154343|FG001|Overall Study|Lost to Follow-up|88|||
144533066|NCT04424316|521154344|FG002|Overall Study|Lost to Follow-up|224|||
144533067|NCT04424316|521154345|FG003|Overall Study|Lost to Follow-up|211|||
144533068|NCT04424316|521154342|FG000|Overall Study|No longer met eligibility criteria|1|||
144446989|NCT02944578|520836583|FG001|Overall Study|Physician Decision|0|||
144446990|NCT00577122|520836586|FG000|Overall Study|Adverse Event|0|||
144446991|NCT00577122|520836587|FG001|Overall Study|Adverse Event|2|||
144446992|NCT00577122|520836586|FG000|Overall Study|Progression, relapse during active trt|6|||
144446993|NCT00577122|520836587|FG001|Overall Study|Progression, relapse during active trt|8|||
144446994|NCT00577122|520836586|FG000|Overall Study|Prog, refract disease during active trt|8|||
144446995|NCT00577122|520836587|FG001|Overall Study|Prog, refract disease during active trt|5|||
144533069|NCT04424316|521154343|FG001|Overall Study|No longer met eligibility criteria|0|||
144533070|NCT04424316|521154344|FG002|Overall Study|No longer met eligibility criteria|0|||
144194082|NCT00380692|519906391|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
144194083|NCT00380692|519906392|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
144194084|NCT00380692|519906391|FG000|Study Period II - Double Blind|Physician Decision|0|||
144194085|NCT00380692|519906392|FG001|Study Period II - Double Blind|Physician Decision|1|||
144194086|NCT00380692|519906391|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
144194087|NCT00380692|519906392|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
144194088|NCT00380692|519906391|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
144446996|NCT00577122|520836586|FG000|Overall Study|Alternative Therapy|0|||
144194089|NCT00380692|519906392|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
144194090|NCT00380692|519906391|FG000|Study Period III - Open Label|Adverse Event|5|||
144446997|NCT00577122|520836587|FG001|Overall Study|Alternative Therapy|1|||
144446998|NCT00440271|520836589|FG000|Overall Study|Protocol Violation|1|||
144446999|NCT00440271|520836590|FG001|Overall Study|Protocol Violation|1|||
144447000|NCT00440271|520836589|FG000|Overall Study|Adverse Event|0|||
144447001|NCT00440271|520836590|FG001|Overall Study|Adverse Event|1|||
144447002|NCT00440271|520836589|FG000|Overall Study|Lost to Follow-up|1|||
144447003|NCT00440271|520836590|FG001|Overall Study|Lost to Follow-up|0|||
144447004|NCT00440271|520836589|FG000|Overall Study|Withdrawal by Subject|0|||
144447005|NCT00440271|520836590|FG001|Overall Study|Withdrawal by Subject|2|||
144447006|NCT00440271|520836589|FG000|Overall Study|Lack of Efficacy|0|||
144447007|NCT00440271|520836590|FG001|Overall Study|Lack of Efficacy|1|||
144447008|NCT00440271|520836589|FG000|Overall Study|Due to closure of trial|8|||
144447009|NCT00440271|520836590|FG001|Overall Study|Due to closure of trial|10|||
144447010|NCT00440271|520836589|FG000|Overall Study|Other|2|||
144447011|NCT00440271|520836590|FG001|Overall Study|Other|0|||
144447012|NCT00456092|520836591|FG000|Extension Phase|Grade 2 or Greater AE|2|||
144447013|NCT00456092|520836592|FG001|Extension Phase|Grade 2 or Greater AE|2|||
144447014|NCT00456092|520836593|FG002|Extension Phase|Grade 2 or Greater AE|0|||
144447015|NCT00456092|520836594|FG003|Extension Phase|Grade 2 or Greater AE|0|||
144447016|NCT00456092|520836595|FG004|Extension Phase|Grade 2 or Greater AE|2|||
144447017|NCT00456092|520836591|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
144447018|NCT00456092|520836592|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
144447019|NCT00456092|520836593|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
144447020|NCT00456092|520836594|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
144447021|NCT00456092|520836595|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
144447022|NCT00456092|520836591|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
144447023|NCT00456092|520836592|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
144447024|NCT00456092|520836593|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
144447025|NCT00456092|520836594|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
144447026|NCT00456092|520836595|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
144447027|NCT00456092|520836591|FG000|Extension Phase|Withdrew Consent|2|||
144447028|NCT00456092|520836592|FG001|Extension Phase|Withdrew Consent|0|||
144447029|NCT00456092|520836593|FG002|Extension Phase|Withdrew Consent|0|||
144447030|NCT00456092|520836594|FG003|Extension Phase|Withdrew Consent|0|||
144447031|NCT00456092|520836595|FG004|Extension Phase|Withdrew Consent|0|||
144447032|NCT00456092|520836591|FG000|Extension Phase|Lost to Follow-up|1|||
144447033|NCT00456092|520836592|FG001|Extension Phase|Lost to Follow-up|1|||
144447034|NCT00456092|520836593|FG002|Extension Phase|Lost to Follow-up|0|||
144447035|NCT00456092|520836594|FG003|Extension Phase|Lost to Follow-up|0|||
144447036|NCT00456092|520836595|FG004|Extension Phase|Lost to Follow-up|1|||
144447037|NCT00456092|520836591|FG000|Extension Phase|Other|2|||
144447038|NCT00456092|520836592|FG001|Extension Phase|Other|0|||
144447039|NCT00456092|520836593|FG002|Extension Phase|Other|0|||
144447040|NCT00456092|520836594|FG003|Extension Phase|Other|1|||
144447041|NCT00456092|520836595|FG004|Extension Phase|Other|1|||
144447042|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
144447043|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
144447044|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
144447045|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
144447046|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
144447047|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
144447048|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
144194091|NCT00380692|519906392|FG001|Study Period III - Open Label|Adverse Event|3|||
144447049|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
144447050|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
144447051|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
144447052|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
144447053|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
144447054|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
144447055|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
144447056|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
144447057|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
144447058|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
144447059|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
144447060|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
144447061|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
144447062|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
144447063|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
144606385|NCT01994382|521421003|FG010|Overall Study|Informed consent withdrawn|0|||
144606386|NCT01994382|521421004|FG011|Overall Study|Informed consent withdrawn|0|||
144606387|NCT01994382|521421005|FG012|Overall Study|Informed consent withdrawn|0|||
144606388|NCT01994382|521421006|FG013|Overall Study|Informed consent withdrawn|0|||
144194092|NCT00380692|519906391|FG000|Study Period III - Open Label|Protocol Violation|0|||
144194093|NCT00380692|519906392|FG001|Study Period III - Open Label|Protocol Violation|0|||
144194094|NCT00380692|519906391|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
144194095|NCT00380692|519906392|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
144194096|NCT00380692|519906391|FG000|Study Period III - Open Label|Physician Decision|0|||
144194097|NCT00380692|519906392|FG001|Study Period III - Open Label|Physician Decision|3|||
144194098|NCT00380692|519906391|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
144194099|NCT00380692|519906392|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
144194100|NCT00380692|519906391|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
144194101|NCT00380692|519906392|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
144194102|NCT01220297|519906396|FG000|Overall Study|Death|2|||
144194103|NCT01220297|519906396|FG000|Overall Study|Lost to Follow-up|1|||
144447064|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
144447065|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
144606389|NCT01994382|521421007|FG014|Overall Study|Informed consent withdrawn|0|||
144606390|NCT01994382|521421008|FG015|Overall Study|Informed consent withdrawn|0|||
144606391|NCT01994382|521421009|FG016|Overall Study|Informed consent withdrawn|0|||
144606392|NCT01994382|521420993|FG000|Overall Study|Progressive disease|3|||
144606393|NCT01994382|521420994|FG001|Overall Study|Progressive disease|4|||
144606394|NCT01994382|521420995|FG002|Overall Study|Progressive disease|4|||
144606395|NCT01994382|521420996|FG003|Overall Study|Progressive disease|3|||
144606396|NCT01994382|521420997|FG004|Overall Study|Progressive disease|2|||
144606397|NCT01994382|521420998|FG005|Overall Study|Progressive disease|3|||
144606398|NCT01994382|521420999|FG006|Overall Study|Progressive disease|3|||
144606399|NCT01994382|521421000|FG007|Overall Study|Progressive disease|6|||
144606400|NCT01994382|521421001|FG008|Overall Study|Progressive disease|2|||
144606401|NCT01994382|521421002|FG009|Overall Study|Progressive disease|2|||
144606402|NCT01994382|521421003|FG010|Overall Study|Progressive disease|13|||
144606403|NCT01994382|521421004|FG011|Overall Study|Progressive disease|8|||
144606404|NCT01994382|521421005|FG012|Overall Study|Progressive disease|7|||
144606405|NCT01994382|521421006|FG013|Overall Study|Progressive disease|3|||
144606406|NCT01994382|521421007|FG014|Overall Study|Progressive disease|6|||
144606407|NCT01994382|521421008|FG015|Overall Study|Progressive disease|44|||
144606408|NCT01994382|521421009|FG016|Overall Study|Progressive disease|28|||
144606409|NCT01994382|521420993|FG000|Overall Study|Physician Decision|0|||
144606410|NCT01994382|521420994|FG001|Overall Study|Physician Decision|1|||
144606411|NCT01994382|521420995|FG002|Overall Study|Physician Decision|0|||
144606412|NCT01994382|521420996|FG003|Overall Study|Physician Decision|0|||
144606413|NCT01994382|521420997|FG004|Overall Study|Physician Decision|0|||
144606414|NCT01994382|521420998|FG005|Overall Study|Physician Decision|0|||
144606415|NCT01994382|521420999|FG006|Overall Study|Physician Decision|0|||
144194104|NCT02119286|519906398|FG000|Overall Study|Adverse Event|9|||
144447066|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
144447067|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
144447068|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
144447069|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
144447070|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
144447071|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
144447072|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
144447073|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
144447074|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
144447075|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
144447076|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
144447077|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
144447078|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
144447079|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
144606416|NCT01994382|521421000|FG007|Overall Study|Physician Decision|0|||
144606417|NCT01994382|521421001|FG008|Overall Study|Physician Decision|0|||
144606418|NCT01994382|521421002|FG009|Overall Study|Physician Decision|0|||
144606419|NCT01994382|521421003|FG010|Overall Study|Physician Decision|3|||
144606420|NCT01994382|521421004|FG011|Overall Study|Physician Decision|1|||
144194105|NCT02119286|519906399|FG001|Overall Study|Adverse Event|7|||
144606421|NCT01994382|521421005|FG012|Overall Study|Physician Decision|1|||
144447080|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
144447081|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
144447082|NCT00456092|520836591|FG000|Treatment Phase (12 Weeks)|Other|1|||
144447083|NCT00456092|520836592|FG001|Treatment Phase (12 Weeks)|Other|0|||
144447084|NCT00456092|520836593|FG002|Treatment Phase (12 Weeks)|Other|1|||
144447085|NCT00456092|520836594|FG003|Treatment Phase (12 Weeks)|Other|0|||
144447086|NCT00456092|520836595|FG004|Treatment Phase (12 Weeks)|Other|0|||
144447087|NCT00723801|520836603|FG000|Overall Study|Lost to Follow-up|1|||
144447088|NCT00723801|520836604|FG001|Overall Study|Lost to Follow-up|2|||
144447089|NCT00723801|520836603|FG000|Overall Study|Protocol Violation|2|||
144447090|NCT00723801|520836604|FG001|Overall Study|Protocol Violation|1|||
144447091|NCT01565993|520836613|FG000|Overall Study|Physician Decision|0|||
144447092|NCT01565993|520836614|FG001|Overall Study|Physician Decision|3|||
144447093|NCT01824303|520836615|FG000|Randomized Study|Withdrawal by Subject|1|||
144447094|NCT01824303|520836616|FG001|Randomized Study|Withdrawal by Subject|1|||
144447095|NCT01824303|520836615|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
144447096|NCT01824303|520836616|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
144447097|NCT04086472|520836617|FG000|Overall Study|Lost to Follow-up|1|||
144447098|NCT04086472|520836618|FG001|Overall Study|Lost to Follow-up|0|||
144447099|NCT04086472|520836619|FG002|Overall Study|Lost to Follow-up|0|||
144447100|NCT04086472|520836620|FG003|Overall Study|Lost to Follow-up|0|||
144447101|NCT04086472|520836621|FG004|Overall Study|Lost to Follow-up|1|||
144447102|NCT04086472|520836617|FG000|Overall Study|Physician Decision|0|||
144447103|NCT04086472|520836618|FG001|Overall Study|Physician Decision|1|||
144447104|NCT04086472|520836619|FG002|Overall Study|Physician Decision|1|||
144447105|NCT04086472|520836620|FG003|Overall Study|Physician Decision|0|||
144447106|NCT04086472|520836621|FG004|Overall Study|Physician Decision|0|||
144447107|NCT04086472|520836617|FG000|Overall Study|Withdrawal by Subject|1|||
144447108|NCT04086472|520836618|FG001|Overall Study|Withdrawal by Subject|1|||
144447109|NCT04086472|520836619|FG002|Overall Study|Withdrawal by Subject|1|||
144447110|NCT04086472|520836620|FG003|Overall Study|Withdrawal by Subject|0|||
144447111|NCT04086472|520836621|FG004|Overall Study|Withdrawal by Subject|0|||
144447112|NCT04086472|520836617|FG000|Overall Study|Various reasons|2|||
144447113|NCT04086472|520836618|FG001|Overall Study|Various reasons|0|||
144533071|NCT04424316|521154345|FG003|Overall Study|No longer met eligibility criteria|0|||
144533072|NCT04424316|521154342|FG000|Overall Study|Other|15|||
144533073|NCT04424316|521154343|FG001|Overall Study|Other|11|||
144194106|NCT02119286|519906400|FG002|Overall Study|Adverse Event|2|||
144194107|NCT02119286|519906398|FG000|Overall Study|Lack of Efficacy|11|||
144447114|NCT04086472|520836619|FG002|Overall Study|Various reasons|0|||
144533074|NCT04424316|521154344|FG002|Overall Study|Other|34|||
144533075|NCT04424316|521154345|FG003|Overall Study|Other|45|||
144533076|NCT04424316|521154342|FG000|Overall Study|Physician Decision|1|||
144533077|NCT04424316|521154343|FG001|Overall Study|Physician Decision|0|||
144533078|NCT04424316|521154344|FG002|Overall Study|Physician Decision|1|||
144533079|NCT04424316|521154345|FG003|Overall Study|Physician Decision|1|||
144533080|NCT04424316|521154342|FG000|Overall Study|Protocol Violation|0|||
144533081|NCT04424316|521154343|FG001|Overall Study|Protocol Violation|1|||
144533082|NCT04424316|521154344|FG002|Overall Study|Protocol Violation|0|||
144533083|NCT04424316|521154345|FG003|Overall Study|Protocol Violation|0|||
144533084|NCT04424316|521154342|FG000|Overall Study|Withdrawal by Subject|71|||
144533085|NCT04424316|521154343|FG001|Overall Study|Withdrawal by Subject|77|||
144533086|NCT04424316|521154344|FG002|Overall Study|Withdrawal by Subject|0|||
144533087|NCT04424316|521154345|FG003|Overall Study|Withdrawal by Subject|0|||
144533088|NCT04424316|521154342|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144533089|NCT04424316|521154343|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144533090|NCT04424316|521154344|FG002|Overall Study|Withdrawal by parent/guardian|74|||
144533091|NCT04424316|521154345|FG003|Overall Study|Withdrawal by parent/guardian|81|||
144533092|NCT04424316|521154342|FG000|Overall Study|Randomized but not vaccinated|13|||
144533093|NCT04424316|521154343|FG001|Overall Study|Randomized but not vaccinated|21|||
144194108|NCT02119286|519906399|FG001|Overall Study|Lack of Efficacy|3|||
144447115|NCT04086472|520836620|FG003|Overall Study|Various reasons|3|||
144447116|NCT04086472|520836621|FG004|Overall Study|Various reasons|1|||
144447117|NCT02252081|520836622|FG000|Overall Study|Withdrawal by Subject|2|||
144447118|NCT02252081|520836623|FG001|Overall Study|Withdrawal by Subject|1|||
144447119|NCT02252081|520836622|FG000|Overall Study|Adverse Event|4|||
144447120|NCT02252081|520836623|FG001|Overall Study|Adverse Event|1|||
144447121|NCT02252081|520836622|FG000|Overall Study|non compliance & others|0|||
144533094|NCT04424316|521154344|FG002|Overall Study|Randomized but not vaccinated|0|||
144533095|NCT04424316|521154345|FG003|Overall Study|Randomized but not vaccinated|0|||
144533096|NCT04424316|521154342|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
144533097|NCT04424316|521154343|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
144533098|NCT04424316|521154344|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
144194109|NCT02119286|519906400|FG002|Overall Study|Lack of Efficacy|4|||
144447122|NCT02252081|520836623|FG001|Overall Study|non compliance & others|2|||
144533099|NCT04424316|521154345|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
144533100|NCT04109066|521154346|FG000|Pre-treatment|Participant withdrew consent|2|||
144447123|NCT00048724|520836629|FG000|Overall Study|Adverse Event|53|||
144447124|NCT00048724|520836630|FG001|Overall Study|Adverse Event|12|||
144447125|NCT00048724|520836629|FG000|Overall Study|Withdrawal by Subject|34|||
144447126|NCT00048724|520836630|FG001|Overall Study|Withdrawal by Subject|54|||
144447127|NCT00048724|520836629|FG000|Overall Study|Lost to Follow-up|5|||
144447128|NCT00048724|520836630|FG001|Overall Study|Lost to Follow-up|5|||
144447129|NCT00048724|520836629|FG000|Overall Study|Protocol-defined Clinical Event|17|||
144447130|NCT00048724|520836630|FG001|Overall Study|Protocol-defined Clinical Event|32|||
144447131|NCT00048724|520836629|FG000|Overall Study|Noncompliance With Protocol|4|||
144447132|NCT00048724|520836630|FG001|Overall Study|Noncompliance With Protocol|12|||
144447133|NCT00048724|520836629|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
144447134|NCT00048724|520836630|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
144447135|NCT00048724|520836629|FG000|Overall Study|Administrative|1|||
144447136|NCT00048724|520836630|FG001|Overall Study|Administrative|1|||
144447137|NCT04116229|520836631|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
144447138|NCT04116229|520836632|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
144447139|NCT04116229|520836631|FG000|Overall Study|Scheduling not possible.|0|||
144447140|NCT04116229|520836632|FG001|Overall Study|Scheduling not possible.|1|||
144447141|NCT02809976|520836635|FG000|Overall Study|Lost to Follow-up|1|||
144447142|NCT02809976|520836635|FG000|Overall Study|Withdrawal by Subject|1|||
144447143|NCT00211081|520836637|FG000|Overall Study|Withdrawal by Subject|2|||
144447144|NCT01600040|520836638|FG000|Overall Study|Withdrawal by Subject|1|||
144447145|NCT03755765|520836643|FG000|Overall Study|Withdrawal by Subject|2|||
144447146|NCT03755765|520836644|FG001|Overall Study|Withdrawal by Subject|4|||
144447147|NCT03755765|520836645|FG002|Overall Study|Withdrawal by Subject|4|||
144447148|NCT02104557|520836646|FG000|Overall Study|Adverse Event|24|||
144447149|NCT02104557|520836646|FG000|Overall Study|Lost to Follow-up|34|||
144447150|NCT02104557|520836646|FG000|Overall Study|Violated the usage and dosage|14|||
144447151|NCT02104557|520836646|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
144447152|NCT02104557|520836646|FG000|Overall Study|Administered Sayana prior to the contract|1|||
144447153|NCT02104557|520836646|FG000|Overall Study|Other|17|||
144447154|NCT02104557|520836646|FG000|Overall Study|Change to other contraception methods|5|||
144447155|NCT02104557|520836646|FG000|Overall Study|Discontinuation due to no pain|1|||
144447156|NCT02104557|520836646|FG000|Overall Study|Withdrawal consent|2|||
144447157|NCT02104557|520836646|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
144447158|NCT02104557|520836646|FG000|Overall Study|Discontinuation of contraception|9|||
144447159|NCT02863354|520836652|FG000|Year 1|Lost to Follow-up|1|||
144447160|NCT02863354|520836653|FG001|Year 1|Lost to Follow-up|1|||
144447161|NCT02863354|520836652|FG000|Year 1|Withdrawal by Subject|3|||
144447162|NCT02863354|520836653|FG001|Year 1|Withdrawal by Subject|0|||
144447163|NCT02863354|520836652|FG000|Year 1|Death|0|||
144447164|NCT02863354|520836653|FG001|Year 1|Death|1|||
144447165|NCT02863354|520836652|FG000|Year 2|Lost to Follow-up|2|||
144447166|NCT02863354|520836653|FG001|Year 2|Lost to Follow-up|2|||
144447167|NCT00724451|520836654|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
144447168|NCT00724451|520836654|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
144447169|NCT00724451|520836654|FG000|Overall Study|Not Eligible for Treatment|431|||
144447170|NCT00724451|520836654|FG000|Overall Study|Participant Refused Treatment|89|||
144447171|NCT00724451|520836654|FG000|Overall Study|Never Started Treatment|89|||
144447172|NCT00724451|520836654|FG000|Overall Study|Unknown; No Data Sources Available|9|||
144447173|NCT00724451|520836654|FG000|Overall Study|Physician Decision|116|||
144447174|NCT00724451|520836654|FG000|Overall Study|Withdrawal by Subject|45|||
144447175|NCT00724451|520836654|FG000|Overall Study|Investigator + Participant Decision|13|||
144447176|NCT01599650|520836655|FG000|Overall Study|Administrative issue|1|||
144447177|NCT01599650|520836656|FG001|Overall Study|Administrative issue|0|||
144447178|NCT01599650|520836657|FG002|Overall Study|Administrative issue|1|||
144447179|NCT01599650|520836655|FG000|Overall Study|Physician Decision|2|||
144447180|NCT01599650|520836656|FG001|Overall Study|Physician Decision|0|||
144447181|NCT01599650|520836657|FG002|Overall Study|Physician Decision|7|||
144447182|NCT01599650|520836655|FG000|Overall Study|Protocol Violation|0|||
144447183|NCT01599650|520836656|FG001|Overall Study|Protocol Violation|3|||
144447184|NCT01599650|520836657|FG002|Overall Study|Protocol Violation|0|||
144447185|NCT01599650|520836655|FG000|Overall Study|Death|2|||
144447186|NCT01599650|520836656|FG001|Overall Study|Death|1|||
144447187|NCT01599650|520836657|FG002|Overall Study|Death|2|||
144447188|NCT01599650|520836655|FG000|Overall Study|Lost to Follow-up|3|||
144447189|NCT01599650|520836656|FG001|Overall Study|Lost to Follow-up|3|||
144447190|NCT01599650|520836657|FG002|Overall Study|Lost to Follow-up|3|||
144447191|NCT01599650|520836655|FG000|Overall Study|Withdrawal by Subject|11|||
144447192|NCT01599650|520836656|FG001|Overall Study|Withdrawal by Subject|11|||
144447193|NCT01599650|520836657|FG002|Overall Study|Withdrawal by Subject|10|||
144447194|NCT01599650|520836655|FG000|Overall Study|Adverse Event|3|||
144447195|NCT01599650|520836656|FG001|Overall Study|Adverse Event|8|||
144447196|NCT01599650|520836657|FG002|Overall Study|Adverse Event|4|||
144447197|NCT00720876|520836658|FG000|Overall Study|found to be ineligible after starting tx|2|||
144447198|NCT03304379|520836660|FG000|Overall Study|Protocol Violation|8|||
144447199|NCT03304379|520836661|FG001|Overall Study|Protocol Violation|10|||
144447200|NCT03304379|520836662|FG002|Overall Study|Protocol Violation|5|||
144447201|NCT03304379|520836663|FG003|Overall Study|Protocol Violation|0|||
144447202|NCT03304379|520836664|FG004|Overall Study|Protocol Violation|2|||
144447203|NCT03304379|520836660|FG000|Overall Study|Adverse Event|4|||
144447204|NCT03304379|520836661|FG001|Overall Study|Adverse Event|20|||
144447205|NCT03304379|520836662|FG002|Overall Study|Adverse Event|17|||
144447206|NCT03304379|520836663|FG003|Overall Study|Adverse Event|1|||
144447207|NCT03304379|520836664|FG004|Overall Study|Adverse Event|0|||
144447208|NCT03304379|520836660|FG000|Overall Study|Lack of Efficacy|17|||
144447209|NCT03304379|520836661|FG001|Overall Study|Lack of Efficacy|16|||
144447210|NCT03304379|520836662|FG002|Overall Study|Lack of Efficacy|20|||
144447211|NCT03304379|520836663|FG003|Overall Study|Lack of Efficacy|0|||
144447212|NCT03304379|520836664|FG004|Overall Study|Lack of Efficacy|0|||
144447213|NCT03304379|520836660|FG000|Overall Study|Physician Decision|6|||
144447214|NCT03304379|520836661|FG001|Overall Study|Physician Decision|10|||
144447215|NCT03304379|520836662|FG002|Overall Study|Physician Decision|6|||
144447216|NCT03304379|520836663|FG003|Overall Study|Physician Decision|9|||
144447217|NCT03304379|520836664|FG004|Overall Study|Physician Decision|10|||
144447218|NCT03304379|520836660|FG000|Overall Study|Withdrawal by Subject|26|||
144447219|NCT03304379|520836661|FG001|Overall Study|Withdrawal by Subject|58|||
144447220|NCT03304379|520836662|FG002|Overall Study|Withdrawal by Subject|66|||
144447221|NCT03304379|520836663|FG003|Overall Study|Withdrawal by Subject|3|||
144447222|NCT03304379|520836664|FG004|Overall Study|Withdrawal by Subject|5|||
144447223|NCT03304379|520836660|FG000|Overall Study|Lost to Follow-up|8|||
144447224|NCT03304379|520836661|FG001|Overall Study|Lost to Follow-up|24|||
144725250|NCT02581345|521851213|FG003|Part 1: up to Week 16|Adverse Event|0|||
144447225|NCT03304379|520836662|FG002|Overall Study|Lost to Follow-up|35|||
144447226|NCT03304379|520836663|FG003|Overall Study|Lost to Follow-up|4|||
144447227|NCT03304379|520836664|FG004|Overall Study|Lost to Follow-up|0|||
144447228|NCT03304379|520836660|FG000|Overall Study|Death|1|||
144447229|NCT03304379|520836661|FG001|Overall Study|Death|2|||
144447230|NCT03304379|520836662|FG002|Overall Study|Death|0|||
144447231|NCT03304379|520836663|FG003|Overall Study|Death|0|||
144447232|NCT03304379|520836664|FG004|Overall Study|Death|0|||
144447233|NCT03304379|520836660|FG000|Overall Study|Other|0|||
144447234|NCT03304379|520836661|FG001|Overall Study|Other|1|||
144447235|NCT03304379|520836662|FG002|Overall Study|Other|0|||
144447236|NCT03304379|520836663|FG003|Overall Study|Other|0|||
144447237|NCT03304379|520836664|FG004|Overall Study|Other|0|||
144447238|NCT02802345|520836678|FG000|Overall Study|Not Treated|0|||
144447239|NCT02802345|520836679|FG001|Overall Study|Not Treated|1|||
144447240|NCT02802345|520836678|FG000|Overall Study|Adverse Event|28|||
144447241|NCT02802345|520836679|FG001|Overall Study|Adverse Event|20|||
144447242|NCT02802345|520836678|FG000|Overall Study|Withdrawal by Subject|3|||
144447243|NCT02802345|520836679|FG001|Overall Study|Withdrawal by Subject|3|||
144447244|NCT02802345|520836678|FG000|Overall Study|Protocol Violation|0|||
144725251|NCT02581345|521851210|FG000|Part 1: up to Week 16|Physician Decision|2|||
144447245|NCT02802345|520836679|FG001|Overall Study|Protocol Violation|1|||
144447246|NCT02802345|520836678|FG000|Overall Study|Other than listed|1|||
144447247|NCT02802345|520836679|FG001|Overall Study|Other than listed|5|||
144447248|NCT04632940|520836680|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
144447249|NCT04632940|520836681|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
144447250|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
144447251|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
144447252|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
144447253|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
144447254|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
144447255|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
144447256|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
144447257|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
144447258|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
144447259|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
144447260|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Other than specified|0|||
144447261|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Other than specified|1|||
144447262|NCT04632940|520836680|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
144447263|NCT04632940|520836681|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
144447264|NCT02550652|520836690|FG000|Overall Study|Death|1|||
144447265|NCT02550652|520836691|FG001|Overall Study|Death|4|||
144533101|NCT04109066|521154347|FG001|Pre-treatment|Participant withdrew consent|0|||
144533102|NCT04109066|521154346|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
144447266|NCT02550652|520836690|FG000|Overall Study|Lack of Efficacy|1|||
144447267|NCT02550652|520836691|FG001|Overall Study|Lack of Efficacy|0|||
144447268|NCT02550652|520836690|FG000|Overall Study|Withdrawal by Subject|4|||
144447269|NCT02550652|520836691|FG001|Overall Study|Withdrawal by Subject|7|||
144447270|NCT02550652|520836690|FG000|Overall Study|Post Trial Access|1|||
144447271|NCT02550652|520836691|FG001|Overall Study|Post Trial Access|0|||
144447272|NCT02550652|520836690|FG000|Overall Study|Lost to Follow-up|1|||
144533103|NCT04109066|521154347|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
144533104|NCT04109066|521154346|FG000|Treatment|Lack of Efficacy|2|||
144533105|NCT04109066|521154347|FG001|Treatment|Lack of Efficacy|4|||
144533106|NCT04109066|521154346|FG000|Treatment|Adverse Event|23|||
144533107|NCT04109066|521154347|FG001|Treatment|Adverse Event|7|||
144533108|NCT04109066|521154346|FG000|Treatment|Participant request to discontinue Study treatment|15|||
144533109|NCT04109066|521154347|FG001|Treatment|Participant request to discontinue Study treatment|14|||
144533110|NCT04109066|521154346|FG000|Treatment|Withdrawal by Subject|8|||
144533111|NCT04109066|521154347|FG001|Treatment|Withdrawal by Subject|8|||
144533112|NCT04109066|521154346|FG000|Treatment|Death|3|||
144447273|NCT02550652|520836691|FG001|Overall Study|Lost to Follow-up|3|||
144533113|NCT04109066|521154347|FG001|Treatment|Death|0|||
144533114|NCT04109066|521154346|FG000|Treatment|Participant no longer meets study criteria|2|||
144533115|NCT04109066|521154347|FG001|Treatment|Participant no longer meets study criteria|2|||
144533116|NCT04109066|521154346|FG000|Treatment|Administrative reasons by sponsor|2|||
144533117|NCT04109066|521154347|FG001|Treatment|Administrative reasons by sponsor|3|||
144533118|NCT04109066|521154346|FG000|Treatment|Other reasons|17|||
144533119|NCT04109066|521154347|FG001|Treatment|Other reasons|23|||
144533120|NCT04109066|521154346|FG000|Treatment|Disease Progression|4|||
144533121|NCT04109066|521154347|FG001|Treatment|Disease Progression|7|||
144533122|NCT04109066|521154346|FG000|Treatment|Study drug toxicity|12|||
144533123|NCT04109066|521154347|FG001|Treatment|Study drug toxicity|5|||
144533124|NCT04109066|521154346|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
144533125|NCT04109066|521154347|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
144533126|NCT04109066|521154346|FG000|Treatment|Disease Recurrence|0|||
144533127|NCT04109066|521154347|FG001|Treatment|Disease Recurrence|2|||
144447274|NCT02550652|520836690|FG000|Overall Study|Physician Decision|0|||
144447275|NCT02550652|520836691|FG001|Overall Study|Physician Decision|2|||
144447276|NCT02550652|520836690|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
144447277|NCT02550652|520836691|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
144447278|NCT03509948|520836695|FG000|Overall Study|Protocol Violation|0|||
144447279|NCT03509948|520836696|FG001|Overall Study|Protocol Violation|1|||
144447280|NCT03221257|520836697|FG000|Overall Study|Lost to Follow-up|0|||
144447281|NCT03221257|520836698|FG001|Overall Study|Lost to Follow-up|1|||
144447282|NCT03221257|520836697|FG000|Overall Study|Withdrawal by Subject|1|||
144533128|NCT04109066|521154346|FG000|Treatment|Not reported|4|||
144533129|NCT04109066|521154347|FG001|Treatment|Not reported|8|||
144533130|NCT05953740|521154351|FG000|Period 1|Physician Decision|0|||
144533131|NCT05953740|521154352|FG001|Period 1|Physician Decision|1|||
144533132|NCT05953740|521154353|FG002|Period 1|Physician Decision|0|||
144533133|NCT05953740|521154354|FG003|Period 1|Physician Decision|0|||
144533134|NCT05953740|521154355|FG004|Period 1|Physician Decision|0|||
144533135|NCT05953740|521154356|FG005|Period 1|Physician Decision|0|||
144533136|NCT05953740|521154357|FG006|Period 1|Physician Decision|0|||
144533137|NCT05953740|521154358|FG007|Period 1|Physician Decision|0|||
144533138|NCT05953740|521154351|FG000|Period 2|Withdrawal by Subject|0|||
144533139|NCT05953740|521154352|FG001|Period 2|Withdrawal by Subject|1|||
144533140|NCT05953740|521154353|FG002|Period 2|Withdrawal by Subject|1|||
144533141|NCT05953740|521154354|FG003|Period 2|Withdrawal by Subject|0|||
144533142|NCT05953740|521154355|FG004|Period 2|Withdrawal by Subject|0|||
144533143|NCT05953740|521154356|FG005|Period 2|Withdrawal by Subject|0|||
144533144|NCT05953740|521154357|FG006|Period 2|Withdrawal by Subject|0|||
144533145|NCT05953740|521154358|FG007|Period 2|Withdrawal by Subject|0|||
144533146|NCT05890105|521154359|FG000|Overall Study|Adverse Event|1|||
144533147|NCT05890105|521154360|FG001|Overall Study|Adverse Event|0|||
144533148|NCT05890105|521154361|FG002|Overall Study|Adverse Event|0|||
144533149|NCT05890105|521154359|FG000|Overall Study|Other|1|||
144533150|NCT05890105|521154360|FG001|Overall Study|Other|2|||
144533151|NCT05890105|521154361|FG002|Overall Study|Other|0|||
144533152|NCT04505410|521154363|FG000|Overall Study|Adverse Event|2|||
144533153|NCT04505410|521154364|FG001|Overall Study|Adverse Event|0|||
144533154|NCT04505410|521154363|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
144533155|NCT04505410|521154364|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
144533156|NCT04505410|521154363|FG000|Overall Study|did not want to follow diet|1|||
144533157|NCT04505410|521154364|FG001|Overall Study|did not want to follow diet|0|||
144533158|NCT04505410|521154363|FG000|Overall Study|flare up of ulcerative colitis|0|||
144533159|NCT04505410|521154364|FG001|Overall Study|flare up of ulcerative colitis|1|||
144533160|NCT04505410|521154363|FG000|Overall Study|Lost to Follow-up|0|||
144533161|NCT04505410|521154364|FG001|Overall Study|Lost to Follow-up|2|||
144533162|NCT04505410|521154363|FG000|Overall Study|Lost to Follow-up|1|||
144533163|NCT04505410|521154364|FG001|Overall Study|Lost to Follow-up|0|||
144447283|NCT03221257|520836698|FG001|Overall Study|Withdrawal by Subject|1|||
144447284|NCT05402995|520836699|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
144533164|NCT04505410|521154363|FG000|Overall Study|initiated another diet on their own|0|||
144533165|NCT04505410|521154364|FG001|Overall Study|initiated another diet on their own|2|||
144533166|NCT05123027|521154369|FG000|Overall Study|Lost to Follow-up|17|||
144533167|NCT05123027|521154370|FG001|Overall Study|Lost to Follow-up|22|||
144447285|NCT05402995|520836700|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
144447286|NCT05402995|520836701|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
144447287|NCT05402995|520836702|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
144447288|NCT01071512|520836703|FG000|Overall Study|Adverse Event|1|||
144447289|NCT01071512|520836703|FG000|Overall Study|Development of antibodies to drug|2|||
144447290|NCT01071512|520836703|FG000|Overall Study|positive anti-JC virus antibody test|2|||
144447291|NCT02188485|520836708|FG000|Overall Study|Withdrawal by Subject|2|||
144447292|NCT02188485|520836709|FG001|Overall Study|Withdrawal by Subject|1|||
144447293|NCT02188485|520836708|FG000|Overall Study|PI withdrew, lack of capacity|0|||
144447294|NCT02188485|520836709|FG001|Overall Study|PI withdrew, lack of capacity|2|||
144447295|NCT01976845|520836712|FG000|Overall Study|Physician Decision|8|||
144447296|NCT01976845|520836713|FG001|Overall Study|Physician Decision|8|||
144447297|NCT01976845|520836714|FG002|Overall Study|Physician Decision|3|||
144447298|NCT00827372|520838950|FG000|Overall Study|Adverse Event|5|||
144447299|NCT00827372|520838950|FG000|Overall Study|Lack of Efficacy|3|||
144447300|NCT02293005|520838951|FG000|Overall Study|Adverse Event|2|||
144447301|NCT02293005|520838951|FG000|Overall Study|Death|4|||
144447302|NCT02293005|520838951|FG000|Overall Study|Lost to Follow-up|1|||
144447303|NCT02293005|520838951|FG000|Overall Study|Withdrawal by Subject|2|||
144447304|NCT02293005|520838951|FG000|Overall Study|Progression|17|||
144447305|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
144447306|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144447307|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144447308|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144447309|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144447310|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144447311|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
144447312|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144447313|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144447314|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144447315|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144447316|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144447317|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
144447318|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144447319|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144447320|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144447321|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144447322|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144447323|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
144447324|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144447325|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144447326|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144447327|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144447328|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144447329|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
144447330|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144447331|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144447332|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144447333|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144447334|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144447335|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
144447336|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
144447337|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
144447338|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
144447339|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
144447340|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
144447341|NCT02139644|520838952|FG000|Run-In Period (Pre-assignment)|Other|6|||
144447342|NCT02139644|520838953|FG001|Run-In Period (Pre-assignment)|Other|0|||
144447343|NCT02139644|520838954|FG002|Run-In Period (Pre-assignment)|Other|0|||
144447344|NCT02139644|520838955|FG003|Run-In Period (Pre-assignment)|Other|0|||
144447345|NCT02139644|520838956|FG004|Run-In Period (Pre-assignment)|Other|0|||
144447346|NCT02139644|520838957|FG005|Run-In Period (Pre-assignment)|Other|0|||
144447347|NCT02139644|520838952|FG000|Treatment Period|Adverse Event|0|||
144447348|NCT02139644|520838953|FG001|Treatment Period|Adverse Event|0|||
144533168|NCT05123027|521154369|FG000|Overall Study|Incarceration|3|||
144533169|NCT05123027|521154370|FG001|Overall Study|Incarceration|4|||
144533170|NCT05123027|521154369|FG000|Overall Study|Death|2|||
144533171|NCT05123027|521154370|FG001|Overall Study|Death|2|||
144533172|NCT05123027|521154369|FG000|Overall Study|Other|2|||
144533173|NCT05123027|521154370|FG001|Overall Study|Other|0|||
144533174|NCT02039401|521154372|FG000|Overall Study|Adverse Event|0|||
144447349|NCT02139644|520838954|FG002|Treatment Period|Adverse Event|3|||
144447350|NCT02139644|520838955|FG003|Treatment Period|Adverse Event|2|||
144447351|NCT02139644|520838956|FG004|Treatment Period|Adverse Event|1|||
144447352|NCT02139644|520838957|FG005|Treatment Period|Adverse Event|6|||
144447353|NCT02139644|520838952|FG000|Treatment Period|Withdrawal by Subject|0|||
144447354|NCT02139644|520838953|FG001|Treatment Period|Withdrawal by Subject|0|||
144447355|NCT02139644|520838954|FG002|Treatment Period|Withdrawal by Subject|2|||
144447356|NCT02139644|520838955|FG003|Treatment Period|Withdrawal by Subject|2|||
144447357|NCT02139644|520838956|FG004|Treatment Period|Withdrawal by Subject|3|||
144447358|NCT02139644|520838957|FG005|Treatment Period|Withdrawal by Subject|2|||
144447359|NCT02139644|520838952|FG000|Treatment Period|Non-compliance|0|||
144447360|NCT02139644|520838953|FG001|Treatment Period|Non-compliance|0|||
144447361|NCT02139644|520838954|FG002|Treatment Period|Non-compliance|0|||
144447362|NCT02139644|520838955|FG003|Treatment Period|Non-compliance|1|||
144447363|NCT02139644|520838956|FG004|Treatment Period|Non-compliance|0|||
144447364|NCT02139644|520838957|FG005|Treatment Period|Non-compliance|0|||
144447365|NCT02139644|520838952|FG000|Treatment Period|Protocol Violation|0|||
144447366|NCT02139644|520838953|FG001|Treatment Period|Protocol Violation|0|||
144447367|NCT02139644|520838954|FG002|Treatment Period|Protocol Violation|0|||
144447368|NCT02139644|520838955|FG003|Treatment Period|Protocol Violation|1|||
144447369|NCT02139644|520838956|FG004|Treatment Period|Protocol Violation|1|||
144447370|NCT02139644|520838957|FG005|Treatment Period|Protocol Violation|1|||
144447371|NCT02139644|520838952|FG000|Treatment Period|Disease progression|0|||
144447372|NCT02139644|520838953|FG001|Treatment Period|Disease progression|0|||
144447373|NCT02139644|520838954|FG002|Treatment Period|Disease progression|0|||
144447374|NCT02139644|520838955|FG003|Treatment Period|Disease progression|1|||
144447375|NCT02139644|520838956|FG004|Treatment Period|Disease progression|1|||
144447376|NCT02139644|520838957|FG005|Treatment Period|Disease progression|2|||
144447377|NCT02139644|520838952|FG000|Treatment Period|Lost to Follow-up|0|||
144447378|NCT02139644|520838953|FG001|Treatment Period|Lost to Follow-up|0|||
144447379|NCT02139644|520838954|FG002|Treatment Period|Lost to Follow-up|1|||
144447380|NCT02139644|520838955|FG003|Treatment Period|Lost to Follow-up|1|||
144447381|NCT02139644|520838956|FG004|Treatment Period|Lost to Follow-up|1|||
144447382|NCT02139644|520838957|FG005|Treatment Period|Lost to Follow-up|1|||
144447383|NCT02139644|520838952|FG000|Treatment Period|Lack of Efficacy|0|||
144447384|NCT02139644|520838953|FG001|Treatment Period|Lack of Efficacy|0|||
144447385|NCT02139644|520838954|FG002|Treatment Period|Lack of Efficacy|1|||
144447386|NCT02139644|520838955|FG003|Treatment Period|Lack of Efficacy|0|||
144447387|NCT02139644|520838956|FG004|Treatment Period|Lack of Efficacy|1|||
144447388|NCT02139644|520838957|FG005|Treatment Period|Lack of Efficacy|4|||
144447389|NCT02139644|520838952|FG000|Treatment Period|Other|0|||
144447390|NCT02139644|520838953|FG001|Treatment Period|Other|3|||
144447391|NCT02139644|520838954|FG002|Treatment Period|Other|1|||
144447392|NCT02139644|520838955|FG003|Treatment Period|Other|1|||
144447393|NCT02139644|520838956|FG004|Treatment Period|Other|0|||
144447394|NCT02139644|520838957|FG005|Treatment Period|Other|1|||
144447395|NCT03328897|520838958|FG000|Randomized-treatment Epoch|Adverse Event|4|||
144447396|NCT03328897|520838959|FG001|Randomized-treatment Epoch|Adverse Event|1|||
144447397|NCT03328897|520838960|FG002|Randomized-treatment Epoch|Adverse Event|1|||
144447398|NCT03328897|520838958|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
144447399|NCT03328897|520838959|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
144447400|NCT03328897|520838960|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
144447401|NCT03328897|520838958|FG000|Randomized-treatment Epoch|Pregnancy|3|||
144447402|NCT03328897|520838959|FG001|Randomized-treatment Epoch|Pregnancy|0|||
144447403|NCT03328897|520838960|FG002|Randomized-treatment Epoch|Pregnancy|0|||
144447404|NCT03328897|520838958|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
144447405|NCT03328897|520838959|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
144447406|NCT03328897|520838960|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
144447407|NCT03328897|520838958|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
144447408|NCT03328897|520838959|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
144447409|NCT03328897|520838960|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
144447410|NCT03328897|520838958|FG000|Follow-up Epoch|Adverse Event|4|||
144447411|NCT03328897|520838959|FG001|Follow-up Epoch|Adverse Event|0|||
144447412|NCT03328897|520838960|FG002|Follow-up Epoch|Adverse Event|1|||
144533175|NCT02039401|521154373|FG001|Overall Study|Adverse Event|1|||
144533176|NCT02865538|521154374|FG000|Overall Study|Withdrawal by Subject|0|||
144533177|NCT02865538|521154375|FG001|Overall Study|Withdrawal by Subject|0|||
144533178|NCT02865538|521154376|FG002|Overall Study|Withdrawal by Subject|1|||
144194110|NCT02119286|519906398|FG000|Overall Study|Lost to Follow-up|2|||
144447413|NCT03328897|520838958|FG000|Follow-up Epoch|Lack of Efficacy|1|||
144447414|NCT03328897|520838959|FG001|Follow-up Epoch|Lack of Efficacy|1|||
144447415|NCT03328897|520838960|FG002|Follow-up Epoch|Lack of Efficacy|1|||
144447416|NCT03328897|520838958|FG000|Follow-up Epoch|Lost to Follow-up|0|||
144447417|NCT03328897|520838959|FG001|Follow-up Epoch|Lost to Follow-up|1|||
144447418|NCT03328897|520838960|FG002|Follow-up Epoch|Lost to Follow-up|0|||
144447419|NCT03328897|520838958|FG000|Follow-up Epoch|Pregnancy|1|||
144447420|NCT03328897|520838959|FG001|Follow-up Epoch|Pregnancy|0|||
144194111|NCT02119286|519906399|FG001|Overall Study|Lost to Follow-up|0|||
144447421|NCT03328897|520838960|FG002|Follow-up Epoch|Pregnancy|0|||
144447422|NCT03328897|520838958|FG000|Follow-up Epoch|Patient/guardian decision|2|||
144447423|NCT03328897|520838959|FG001|Follow-up Epoch|Patient/guardian decision|1|||
144447424|NCT03328897|520838960|FG002|Follow-up Epoch|Patient/guardian decision|0|||
144447425|NCT00608829|520838962|FG000|Overall Study|Death|6|||
144447426|NCT00608829|520838962|FG000|Overall Study|Withdrawal by Subject|4|||
144447427|NCT00608829|520838962|FG000|Overall Study|Subject refuses to follow up or return.|5|||
144447428|NCT02766608|520838963|FG000|Overall Study|Adverse Event|27|||
144447429|NCT02766608|520838964|FG001|Overall Study|Adverse Event|22|||
144447430|NCT02766608|520838965|FG002|Overall Study|Adverse Event|17|||
144447431|NCT02766608|520838966|FG003|Overall Study|Adverse Event|13|||
144447432|NCT02766608|520838967|FG004|Overall Study|Adverse Event|12|||
144447433|NCT02766608|520838963|FG000|Overall Study|Withdrawal by Subject|21|||
144447434|NCT02766608|520838964|FG001|Overall Study|Withdrawal by Subject|20|||
144447435|NCT02766608|520838965|FG002|Overall Study|Withdrawal by Subject|24|||
144447436|NCT02766608|520838966|FG003|Overall Study|Withdrawal by Subject|13|||
144447437|NCT02766608|520838967|FG004|Overall Study|Withdrawal by Subject|10|||
144447438|NCT02766608|520838963|FG000|Overall Study|Lack of Efficacy|16|||
144447439|NCT02766608|520838964|FG001|Overall Study|Lack of Efficacy|15|||
144447440|NCT02766608|520838965|FG002|Overall Study|Lack of Efficacy|32|||
144447441|NCT02766608|520838966|FG003|Overall Study|Lack of Efficacy|8|||
144447442|NCT02766608|520838967|FG004|Overall Study|Lack of Efficacy|2|||
144447443|NCT02766608|520838963|FG000|Overall Study|Lost to Follow-up|6|||
144447444|NCT02766608|520838964|FG001|Overall Study|Lost to Follow-up|3|||
144447445|NCT02766608|520838965|FG002|Overall Study|Lost to Follow-up|5|||
144447446|NCT02766608|520838966|FG003|Overall Study|Lost to Follow-up|2|||
144447447|NCT02766608|520838967|FG004|Overall Study|Lost to Follow-up|2|||
144447448|NCT02766608|520838963|FG000|Overall Study|Physician Decision|3|||
144447449|NCT02766608|520838964|FG001|Overall Study|Physician Decision|2|||
144447450|NCT02766608|520838965|FG002|Overall Study|Physician Decision|3|||
144447451|NCT02766608|520838966|FG003|Overall Study|Physician Decision|1|||
144447452|NCT02766608|520838967|FG004|Overall Study|Physician Decision|2|||
144447453|NCT02766608|520838963|FG000|Overall Study|Protocol disc criteria|3|||
144447454|NCT02766608|520838964|FG001|Overall Study|Protocol disc criteria|3|||
144447455|NCT02766608|520838965|FG002|Overall Study|Protocol disc criteria|4|||
144447456|NCT02766608|520838966|FG003|Overall Study|Protocol disc criteria|0|||
144447457|NCT02766608|520838967|FG004|Overall Study|Protocol disc criteria|0|||
144447458|NCT02766608|520838963|FG000|Overall Study|Protocol Violation|0|||
144447459|NCT02766608|520838964|FG001|Overall Study|Protocol Violation|4|||
144447460|NCT02766608|520838965|FG002|Overall Study|Protocol Violation|4|||
144447461|NCT02766608|520838966|FG003|Overall Study|Protocol Violation|0|||
144447462|NCT02766608|520838967|FG004|Overall Study|Protocol Violation|1|||
144447463|NCT02766608|520838963|FG000|Overall Study|Administrative Reasons|3|||
144447464|NCT02766608|520838964|FG001|Overall Study|Administrative Reasons|1|||
144447465|NCT02766608|520838965|FG002|Overall Study|Administrative Reasons|1|||
144447466|NCT02766608|520838966|FG003|Overall Study|Administrative Reasons|0|||
144447467|NCT02766608|520838967|FG004|Overall Study|Administrative Reasons|0|||
144447468|NCT02080091|520838968|FG000|Overall Study|Study Terminated|22|||
144447469|NCT02080091|520838968|FG000|Overall Study|Death|1|||
144447470|NCT02080091|520838968|FG000|Overall Study|Withdrawal by Subject|1|||
144447471|NCT02080091|520838968|FG000|Overall Study|Other|1|||
144447472|NCT01265953|520838971|FG000|Overall Study|Non compliance|5|||
144447473|NCT01265953|520838972|FG001|Overall Study|Non compliance|3|||
144447474|NCT02648698|520838978|FG000|Overall Study|Protocol Violation|1|||
144447475|NCT02648698|520838979|FG001|Overall Study|Protocol Violation|5|||
144447476|NCT01640301|520838980|FG000|Overall Study|Death|0|||
144447477|NCT01640301|520838981|FG001|Overall Study|Death|8|||
144447478|NCT03143829|520838982|FG000|Overall Study|Withdrawal by Subject|2|||
144447479|NCT03143829|520838983|FG001|Overall Study|Withdrawal by Subject|5|||
144447480|NCT03143829|520838982|FG000|Overall Study|Lost to Follow-up|0|||
144606422|NCT01994382|521421006|FG013|Overall Study|Physician Decision|0|||
144606423|NCT01994382|521421007|FG014|Overall Study|Physician Decision|1|||
144606424|NCT01994382|521421008|FG015|Overall Study|Physician Decision|4|||
144606425|NCT01994382|521421009|FG016|Overall Study|Physician Decision|2|||
144194112|NCT02119286|519906400|FG002|Overall Study|Lost to Follow-up|1|||
144194113|NCT02119286|519906398|FG000|Overall Study|Withdrawal by Subject|4|||
144606426|NCT01994382|521420993|FG000|Overall Study|Death|0|||
144194114|NCT02119286|519906399|FG001|Overall Study|Withdrawal by Subject|1|||
144447481|NCT03143829|520838983|FG001|Overall Study|Lost to Follow-up|2|||
144447482|NCT03143829|520838982|FG000|Overall Study|Death|1|||
144447483|NCT03143829|520838983|FG001|Overall Study|Death|1|||
144447484|NCT03143829|520838982|FG000|Overall Study|changed treatment, no longer eligible|2|||
144447485|NCT03143829|520838983|FG001|Overall Study|changed treatment, no longer eligible|2|||
144447486|NCT00672477|520838985|FG000|Overall Study|Adverse Event|10|||
144447487|NCT00672477|520838986|FG001|Overall Study|Adverse Event|7|||
144447488|NCT00672477|520838985|FG000|Overall Study|Death|7|||
144447489|NCT00672477|520838986|FG001|Overall Study|Death|11|||
144447490|NCT00672477|520838985|FG000|Overall Study|Physician Decision|2|||
144606427|NCT01994382|521420994|FG001|Overall Study|Death|0|||
144447491|NCT00672477|520838986|FG001|Overall Study|Physician Decision|0|||
144447492|NCT00672477|520838985|FG000|Overall Study|Protocol Violation|1|||
144447493|NCT00672477|520838986|FG001|Overall Study|Protocol Violation|1|||
144447494|NCT00672477|520838985|FG000|Overall Study|Withdrawal by Subject|5|||
144447495|NCT00672477|520838986|FG001|Overall Study|Withdrawal by Subject|3|||
144447496|NCT00672477|520838985|FG000|Overall Study|Lack of Efficacy|1|||
144447497|NCT00672477|520838986|FG001|Overall Study|Lack of Efficacy|1|||
144447498|NCT00672477|520838985|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
144533179|NCT02865538|521154377|FG003|Overall Study|Withdrawal by Subject|0|||
144533180|NCT02865538|521154378|FG004|Overall Study|Withdrawal by Subject|0|||
144533181|NCT02865538|521154374|FG000|Overall Study|Lost to Follow-up|1|||
144533182|NCT02865538|521154375|FG001|Overall Study|Lost to Follow-up|0|||
144533183|NCT02865538|521154376|FG002|Overall Study|Lost to Follow-up|0|||
144533184|NCT02865538|521154377|FG003|Overall Study|Lost to Follow-up|0|||
144533185|NCT02865538|521154378|FG004|Overall Study|Lost to Follow-up|0|||
144533186|NCT04678856|521154379|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
144533187|NCT04678856|521154380|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
144533188|NCT04678856|521154379|FG000|Overall Study|Withdrawal by Subject|5|||
144533189|NCT04678856|521154380|FG001|Overall Study|Withdrawal by Subject|1|||
144533190|NCT05311176|521155359|FG000|Overall Study|Death|6|||
144533191|NCT05311176|521155359|FG000|Overall Study|Sponsor discontinued the study|1|||
144533192|NCT03505710|521155360|FG000|Overall Study|Progressive Disease|24|||
144533193|NCT03505710|521155361|FG001|Overall Study|Progressive Disease|17|||
144533194|NCT03505710|521155362|FG002|Overall Study|Progressive Disease|43|||
144533195|NCT03505710|521155360|FG000|Overall Study|Clinical Progression|6|||
144533196|NCT03505710|521155361|FG001|Overall Study|Clinical Progression|8|||
144533197|NCT03505710|521155362|FG002|Overall Study|Clinical Progression|3|||
144533198|NCT03505710|521155360|FG000|Overall Study|Adverse Event|12|||
144533199|NCT03505710|521155361|FG001|Overall Study|Adverse Event|6|||
144533200|NCT03505710|521155362|FG002|Overall Study|Adverse Event|28|||
144533201|NCT03505710|521155360|FG000|Overall Study|Withdrawal by Subject|1|||
144533202|NCT03505710|521155361|FG001|Overall Study|Withdrawal by Subject|3|||
144533203|NCT03505710|521155362|FG002|Overall Study|Withdrawal by Subject|7|||
144533204|NCT03505710|521155360|FG000|Overall Study|Physician Decision|1|||
144533205|NCT03505710|521155361|FG001|Overall Study|Physician Decision|1|||
144533206|NCT03505710|521155362|FG002|Overall Study|Physician Decision|2|||
144533207|NCT03505710|521155360|FG000|Overall Study|Death|4|||
144533208|NCT03505710|521155361|FG001|Overall Study|Death|5|||
144533209|NCT03505710|521155362|FG002|Overall Study|Death|6|||
144533210|NCT03505710|521155360|FG000|Overall Study|Other Reasons|1|||
144533211|NCT03505710|521155361|FG001|Overall Study|Other Reasons|1|||
144533212|NCT03505710|521155362|FG002|Overall Study|Other Reasons|1|||
144533213|NCT03505710|521155360|FG000|Overall Study|Study Terminated by Sponsor|0|||
144533214|NCT03505710|521155361|FG001|Overall Study|Study Terminated by Sponsor|0|||
144533215|NCT03505710|521155362|FG002|Overall Study|Study Terminated by Sponsor|1|||
144533216|NCT05552508|521155371|FG000|Overall Study|Adverse Event|3|||
144533217|NCT04605159|521155372|FG000|Overall Study|Adverse Event|6|||
144533218|NCT04605159|521155373|FG001|Overall Study|Adverse Event|3|||
144533219|NCT04605159|521155374|FG002|Overall Study|Adverse Event|21|||
144606428|NCT01994382|521420995|FG002|Overall Study|Death|0|||
144606429|NCT01994382|521420996|FG003|Overall Study|Death|0|||
144606430|NCT01994382|521420997|FG004|Overall Study|Death|1|||
144606431|NCT01994382|521420998|FG005|Overall Study|Death|0|||
144606432|NCT01994382|521420999|FG006|Overall Study|Death|0|||
144606433|NCT01994382|521421000|FG007|Overall Study|Death|0|||
144606434|NCT01994382|521421001|FG008|Overall Study|Death|1|||
144606435|NCT01994382|521421002|FG009|Overall Study|Death|1|||
144606436|NCT01994382|521421003|FG010|Overall Study|Death|0|||
144606437|NCT01994382|521421004|FG011|Overall Study|Death|0|||
144606438|NCT01994382|521421005|FG012|Overall Study|Death|0|||
144606439|NCT01994382|521421006|FG013|Overall Study|Death|0|||
144606440|NCT01994382|521421007|FG014|Overall Study|Death|0|||
144606441|NCT01994382|521421008|FG015|Overall Study|Death|1|||
144606442|NCT01994382|521421009|FG016|Overall Study|Death|0|||
144533220|NCT04605159|521155375|FG003|Overall Study|Adverse Event|4|||
144447499|NCT00672477|520838986|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
144447500|NCT01750268|520838988|FG000|Overall Study|Lost to Follow-up|0|||
144533221|NCT04605159|521155372|FG000|Overall Study|Lost to Follow-up|74|||
144533222|NCT04605159|521155373|FG001|Overall Study|Lost to Follow-up|45|||
144606443|NCT01994382|521420993|FG000|Overall Study|Adverse Event|0|||
144725252|NCT02581345|521851211|FG001|Part 1: up to Week 16|Physician Decision|4|||
144725253|NCT02581345|521851212|FG002|Part 1: up to Week 16|Physician Decision|0|||
144447501|NCT01750268|520838989|FG001|Overall Study|Lost to Follow-up|2|||
144533223|NCT04605159|521155374|FG002|Overall Study|Lost to Follow-up|119|||
144533224|NCT04605159|521155375|FG003|Overall Study|Lost to Follow-up|80|||
144533225|NCT04605159|521155372|FG000|Overall Study|Protocol Violation|4|||
144533226|NCT04605159|521155373|FG001|Overall Study|Protocol Violation|5|||
144533227|NCT04605159|521155374|FG002|Overall Study|Protocol Violation|2|||
144606444|NCT01994382|521420994|FG001|Overall Study|Adverse Event|1|||
144606445|NCT01994382|521420995|FG002|Overall Study|Adverse Event|2|||
144447502|NCT01750268|520838988|FG000|Overall Study|Physician Decision|0|||
144447503|NCT01750268|520838989|FG001|Overall Study|Physician Decision|3|||
144447504|NCT01750268|520838988|FG000|Overall Study|Withdrawal by Subject|2|||
144447505|NCT01750268|520838989|FG001|Overall Study|Withdrawal by Subject|0|||
144447506|NCT00966940|520838990|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
144447507|NCT00966940|520838991|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
144447508|NCT00966940|520838990|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
144447509|NCT00966940|520838991|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
144447510|NCT01529645|520838998|FG000|Overall Study|Lost to Follow-up|0|||
144447511|NCT01529645|520838999|FG001|Overall Study|Lost to Follow-up|1|||
144447512|NCT01529645|520839000|FG002|Overall Study|Lost to Follow-up|1|||
144447513|NCT01529645|520839001|FG003|Overall Study|Lost to Follow-up|1|||
144447514|NCT01529645|520839002|FG004|Overall Study|Lost to Follow-up|1|||
144447515|NCT01529645|520839003|FG005|Overall Study|Lost to Follow-up|0|||
144447516|NCT01529645|520839004|FG006|Overall Study|Lost to Follow-up|2|||
144447517|NCT01529645|520839005|FG007|Overall Study|Lost to Follow-up|0|||
144447518|NCT01529645|520839006|FG008|Overall Study|Lost to Follow-up|1|||
144447519|NCT01529645|520839007|FG009|Overall Study|Lost to Follow-up|0|||
144447520|NCT01529645|520838998|FG000|Overall Study|SAE - Premature contractions|0|||
144447521|NCT01529645|520838999|FG001|Overall Study|SAE - Premature contractions|0|||
144447522|NCT01529645|520839000|FG002|Overall Study|SAE - Premature contractions|1|||
144447523|NCT01529645|520839001|FG003|Overall Study|SAE - Premature contractions|0|||
144447524|NCT01529645|520839002|FG004|Overall Study|SAE - Premature contractions|0|||
144447525|NCT01529645|520839003|FG005|Overall Study|SAE - Premature contractions|0|||
144447526|NCT01529645|520839004|FG006|Overall Study|SAE - Premature contractions|0|||
144447527|NCT01529645|520839005|FG007|Overall Study|SAE - Premature contractions|0|||
144447528|NCT01529645|520839006|FG008|Overall Study|SAE - Premature contractions|0|||
144447529|NCT01529645|520839007|FG009|Overall Study|SAE - Premature contractions|0|||
144447530|NCT01529645|520838998|FG000|Overall Study|Withdrawal by Subject|2|||
144447531|NCT01529645|520838999|FG001|Overall Study|Withdrawal by Subject|0|||
144447532|NCT01529645|520839000|FG002|Overall Study|Withdrawal by Subject|0|||
144447533|NCT01529645|520839001|FG003|Overall Study|Withdrawal by Subject|1|||
144447534|NCT01529645|520839002|FG004|Overall Study|Withdrawal by Subject|1|||
144447535|NCT01529645|520839003|FG005|Overall Study|Withdrawal by Subject|1|||
144447536|NCT01529645|520839004|FG006|Overall Study|Withdrawal by Subject|0|||
144447537|NCT01529645|520839005|FG007|Overall Study|Withdrawal by Subject|0|||
144447538|NCT01529645|520839006|FG008|Overall Study|Withdrawal by Subject|0|||
144447539|NCT01529645|520839007|FG009|Overall Study|Withdrawal by Subject|0|||
144447540|NCT00274716|520839012|FG000|Phase A|Other non-reported reason|4|||
144447541|NCT00274716|520839013|FG001|Phase A|Other non-reported reason|2|||
144447542|NCT00274716|520839014|FG002|Phase A|Other non-reported reason|1|||
144447543|NCT00274716|520839015|FG003|Phase A|Other non-reported reason|2|||
144447544|NCT00274716|520839016|FG004|Phase A|Other non-reported reason|0|||
144447545|NCT00274716|520839017|FG005|Phase A|Other non-reported reason|1|||
144447546|NCT00274716|520839012|FG000|Phase A|Participant moved|0|||
144447547|NCT00274716|520839013|FG001|Phase A|Participant moved|0|||
144447548|NCT00274716|520839014|FG002|Phase A|Participant moved|1|||
144447549|NCT00274716|520839015|FG003|Phase A|Participant moved|0|||
144447550|NCT00274716|520839016|FG004|Phase A|Participant moved|0|||
144447551|NCT00274716|520839017|FG005|Phase A|Participant moved|1|||
144447552|NCT00274716|520839012|FG000|Phase A|Site Terminated|0|||
144447553|NCT00274716|520839013|FG001|Phase A|Site Terminated|0|||
144447554|NCT00274716|520839014|FG002|Phase A|Site Terminated|0|||
144447555|NCT00274716|520839015|FG003|Phase A|Site Terminated|1|||
144447556|NCT00274716|520839016|FG004|Phase A|Site Terminated|0|||
144447557|NCT00274716|520839017|FG005|Phase A|Site Terminated|0|||
144447558|NCT00274716|520839012|FG000|Phase A|Protocol Violation|1|||
144447559|NCT00274716|520839013|FG001|Phase A|Protocol Violation|0|||
144447560|NCT00274716|520839014|FG002|Phase A|Protocol Violation|0|||
144447561|NCT00274716|520839015|FG003|Phase A|Protocol Violation|1|||
144447562|NCT00274716|520839016|FG004|Phase A|Protocol Violation|0|||
144447563|NCT00274716|520839017|FG005|Phase A|Protocol Violation|0|||
144447564|NCT00274716|520839012|FG000|Phase A|Met criteria for discontinuation|1|||
144253735|NCT02499263|520130001|FG000|Overall Study|investigator's judgment|12|||
144447565|NCT00274716|520839013|FG001|Phase A|Met criteria for discontinuation|1|||
144447566|NCT00274716|520839014|FG002|Phase A|Met criteria for discontinuation|0|||
144447567|NCT00274716|520839015|FG003|Phase A|Met criteria for discontinuation|0|||
144447568|NCT00274716|520839016|FG004|Phase A|Met criteria for discontinuation|0|||
144447569|NCT00274716|520839017|FG005|Phase A|Met criteria for discontinuation|0|||
144447570|NCT00274716|520839012|FG000|Phase A|Withdrawal by Subject|2|||
144447571|NCT00274716|520839013|FG001|Phase A|Withdrawal by Subject|2|||
144447572|NCT00274716|520839014|FG002|Phase A|Withdrawal by Subject|1|||
144447573|NCT00274716|520839015|FG003|Phase A|Withdrawal by Subject|3|||
144447574|NCT00274716|520839016|FG004|Phase A|Withdrawal by Subject|0|||
144447575|NCT00274716|520839017|FG005|Phase A|Withdrawal by Subject|1|||
144447576|NCT00274716|520839012|FG000|Phase A|Adverse Event|2|||
144447577|NCT00274716|520839013|FG001|Phase A|Adverse Event|3|||
144447578|NCT00274716|520839014|FG002|Phase A|Adverse Event|3|||
144447579|NCT00274716|520839015|FG003|Phase A|Adverse Event|0|||
144447580|NCT00274716|520839016|FG004|Phase A|Adverse Event|2|||
144447581|NCT00274716|520839017|FG005|Phase A|Adverse Event|0|||
144447582|NCT00274716|520839012|FG000|Phase A|Completed but did not enter Phase B|1|||
144447583|NCT00274716|520839013|FG001|Phase A|Completed but did not enter Phase B|2|||
144447584|NCT00274716|520839014|FG002|Phase A|Completed but did not enter Phase B|2|||
144447585|NCT00274716|520839015|FG003|Phase A|Completed but did not enter Phase B|2|||
144447586|NCT00274716|520839016|FG004|Phase A|Completed but did not enter Phase B|1|||
144447587|NCT00274716|520839017|FG005|Phase A|Completed but did not enter Phase B|1|||
144447588|NCT00274716|520839012|FG000|Phase B|Adverse Event|0|||
144447589|NCT00274716|520839013|FG001|Phase B|Adverse Event|0|||
144447590|NCT00274716|520839014|FG002|Phase B|Adverse Event|2|||
144447591|NCT00274716|520839015|FG003|Phase B|Adverse Event|0|||
144447592|NCT00274716|520839016|FG004|Phase B|Adverse Event|0|||
144447593|NCT00274716|520839017|FG005|Phase B|Adverse Event|1|||
144606446|NCT01994382|521420996|FG003|Overall Study|Adverse Event|0|||
144447594|NCT00274716|520839012|FG000|Phase B|Protocol Violation|0|||
144447595|NCT00274716|520839013|FG001|Phase B|Protocol Violation|2|||
144447596|NCT00274716|520839014|FG002|Phase B|Protocol Violation|0|||
144447597|NCT00274716|520839015|FG003|Phase B|Protocol Violation|0|||
144447598|NCT00274716|520839016|FG004|Phase B|Protocol Violation|0|||
144447599|NCT00274716|520839017|FG005|Phase B|Protocol Violation|0|||
144447600|NCT00274716|520839012|FG000|Phase B|Withdrawal by Subject|0|||
144447601|NCT00274716|520839013|FG001|Phase B|Withdrawal by Subject|1|||
144447602|NCT00274716|520839014|FG002|Phase B|Withdrawal by Subject|0|||
144447603|NCT00274716|520839015|FG003|Phase B|Withdrawal by Subject|0|||
144447604|NCT00274716|520839016|FG004|Phase B|Withdrawal by Subject|0|||
144447605|NCT00274716|520839017|FG005|Phase B|Withdrawal by Subject|0|||
144447606|NCT00274716|520839012|FG000|Phase B|Participant moved|1|||
144447607|NCT00274716|520839013|FG001|Phase B|Participant moved|0|||
144447608|NCT00274716|520839014|FG002|Phase B|Participant moved|0|||
144447609|NCT00274716|520839015|FG003|Phase B|Participant moved|0|||
144447610|NCT00274716|520839016|FG004|Phase B|Participant moved|0|||
144447611|NCT00274716|520839017|FG005|Phase B|Participant moved|0|||
144447612|NCT00274716|520839012|FG000|Phase B|Other non-reported reason|0|||
144447613|NCT00274716|520839013|FG001|Phase B|Other non-reported reason|0|||
144447614|NCT00274716|520839014|FG002|Phase B|Other non-reported reason|1|||
144447615|NCT00274716|520839015|FG003|Phase B|Other non-reported reason|1|||
144447616|NCT00274716|520839016|FG004|Phase B|Other non-reported reason|0|||
144447617|NCT00274716|520839017|FG005|Phase B|Other non-reported reason|0|||
144447618|NCT00274716|520839012|FG000|Phase B|Lost to Follow-up|0|||
144447619|NCT00274716|520839013|FG001|Phase B|Lost to Follow-up|1|||
144447620|NCT00274716|520839014|FG002|Phase B|Lost to Follow-up|0|||
144606447|NCT01994382|521420997|FG004|Overall Study|Adverse Event|0|||
144606448|NCT01994382|521420998|FG005|Overall Study|Adverse Event|0|||
144606449|NCT01994382|521420999|FG006|Overall Study|Adverse Event|0|||
144606450|NCT01994382|521421000|FG007|Overall Study|Adverse Event|0|||
144606451|NCT01994382|521421001|FG008|Overall Study|Adverse Event|0|||
144606452|NCT01994382|521421002|FG009|Overall Study|Adverse Event|0|||
144606453|NCT01994382|521421003|FG010|Overall Study|Adverse Event|15|||
144606454|NCT01994382|521421004|FG011|Overall Study|Adverse Event|2|||
144606455|NCT01994382|521421005|FG012|Overall Study|Adverse Event|7|||
144606456|NCT01994382|521421006|FG013|Overall Study|Adverse Event|3|||
144606457|NCT01994382|521421007|FG014|Overall Study|Adverse Event|17|||
144606458|NCT01994382|521421008|FG015|Overall Study|Adverse Event|6|||
144606459|NCT01994382|521421009|FG016|Overall Study|Adverse Event|3|||
144606460|NCT01994382|521420993|FG000|Overall Study|Other than specified|0|||
144606461|NCT01994382|521420994|FG001|Overall Study|Other than specified|0|||
144606462|NCT01994382|521420995|FG002|Overall Study|Other than specified|0|||
144447621|NCT00274716|520839015|FG003|Phase B|Lost to Follow-up|0|||
144447622|NCT00274716|520839016|FG004|Phase B|Lost to Follow-up|0|||
144447623|NCT00274716|520839017|FG005|Phase B|Lost to Follow-up|0|||
144447624|NCT01774903|520839018|FG000|Overall Study|Adverse Event|7|||
144606463|NCT01994382|521420996|FG003|Overall Study|Other than specified|0|||
144606464|NCT01994382|521420997|FG004|Overall Study|Other than specified|0|||
144606465|NCT01994382|521420998|FG005|Overall Study|Other than specified|0|||
144606466|NCT01994382|521420999|FG006|Overall Study|Other than specified|0|||
144606467|NCT01994382|521421000|FG007|Overall Study|Other than specified|0|||
144606468|NCT01994382|521421001|FG008|Overall Study|Other than specified|0|||
144447625|NCT01774903|520839018|FG000|Overall Study|Withdrawal by Subject|2|||
144447626|NCT01774903|520839018|FG000|Overall Study|Lack of Efficacy|1|||
144447627|NCT01774903|520839018|FG000|Overall Study|Ineligible to continue the trial|1|||
144447628|NCT00924950|520839019|FG000|Overall Study|Lost to Follow-up|2|||
144447629|NCT01602315|520839020|FG000|Overall Study|Protocol Violation|0|||
144447630|NCT01602315|520839021|FG001|Overall Study|Protocol Violation|0|||
144447631|NCT01602315|520839022|FG002|Overall Study|Protocol Violation|0|||
144447632|NCT01602315|520839023|FG003|Overall Study|Protocol Violation|0|||
144447633|NCT01602315|520839024|FG004|Overall Study|Protocol Violation|0|||
144447634|NCT01602315|520839025|FG005|Overall Study|Protocol Violation|1|||
144447635|NCT01602315|520839026|FG006|Overall Study|Protocol Violation|0|||
144447636|NCT01602315|520839020|FG000|Overall Study|Physician Decision|2|||
144447637|NCT01602315|520839021|FG001|Overall Study|Physician Decision|0|||
144194115|NCT02119286|519906400|FG002|Overall Study|Withdrawal by Subject|0|||
144194116|NCT01996332|519906401|FG000|Overall Study|Adverse Event|117|||
144194117|NCT01996332|519906401|FG000|Overall Study|Lack of Efficacy|1245|||
144194118|NCT01996332|519906401|FG000|Overall Study|Death|264|||
144447638|NCT01602315|520839022|FG002|Overall Study|Physician Decision|0|||
144447639|NCT01602315|520839023|FG003|Overall Study|Physician Decision|0|||
144447640|NCT01602315|520839024|FG004|Overall Study|Physician Decision|2|||
144447641|NCT01602315|520839025|FG005|Overall Study|Physician Decision|1|||
144447642|NCT01602315|520839026|FG006|Overall Study|Physician Decision|1|||
144447643|NCT01602315|520839020|FG000|Overall Study|Disease progression|6|||
144447644|NCT01602315|520839021|FG001|Overall Study|Disease progression|3|||
144447645|NCT01602315|520839022|FG002|Overall Study|Disease progression|10|||
144447646|NCT01602315|520839023|FG003|Overall Study|Disease progression|1|||
144447647|NCT01602315|520839024|FG004|Overall Study|Disease progression|41|||
144447648|NCT01602315|520839025|FG005|Overall Study|Disease progression|12|||
144447649|NCT01602315|520839026|FG006|Overall Study|Disease progression|15|||
144447650|NCT01602315|520839020|FG000|Overall Study|Death|1|||
144447651|NCT01602315|520839021|FG001|Overall Study|Death|1|||
144447652|NCT01602315|520839022|FG002|Overall Study|Death|1|||
144447653|NCT01602315|520839023|FG003|Overall Study|Death|1|||
144447654|NCT01602315|520839024|FG004|Overall Study|Death|7|||
144447655|NCT01602315|520839025|FG005|Overall Study|Death|2|||
144447656|NCT01602315|520839026|FG006|Overall Study|Death|2|||
144447657|NCT01602315|520839020|FG000|Overall Study|Withdrawal by Subject|2|||
144447658|NCT01602315|520839021|FG001|Overall Study|Withdrawal by Subject|0|||
144447659|NCT01602315|520839022|FG002|Overall Study|Withdrawal by Subject|2|||
144447660|NCT01602315|520839023|FG003|Overall Study|Withdrawal by Subject|0|||
144447661|NCT01602315|520839024|FG004|Overall Study|Withdrawal by Subject|6|||
144447662|NCT01602315|520839025|FG005|Overall Study|Withdrawal by Subject|0|||
144447663|NCT01602315|520839026|FG006|Overall Study|Withdrawal by Subject|1|||
144447664|NCT01602315|520839020|FG000|Overall Study|Adverse Event|5|||
144447665|NCT01602315|520839021|FG001|Overall Study|Adverse Event|1|||
144447666|NCT01602315|520839022|FG002|Overall Study|Adverse Event|5|||
144447667|NCT01602315|520839023|FG003|Overall Study|Adverse Event|4|||
144447668|NCT01602315|520839024|FG004|Overall Study|Adverse Event|15|||
144447669|NCT01602315|520839025|FG005|Overall Study|Adverse Event|3|||
144447670|NCT01602315|520839026|FG006|Overall Study|Adverse Event|9|||
144447671|NCT01602315|520839020|FG000|Overall Study|Subject/guardian decision|0|||
144447672|NCT01602315|520839021|FG001|Overall Study|Subject/guardian decision|0|||
144447673|NCT01602315|520839022|FG002|Overall Study|Subject/guardian decision|0|||
144447674|NCT01602315|520839023|FG003|Overall Study|Subject/guardian decision|0|||
144447675|NCT01602315|520839024|FG004|Overall Study|Subject/guardian decision|0|||
144447676|NCT01602315|520839025|FG005|Overall Study|Subject/guardian decision|0|||
144447677|NCT01602315|520839026|FG006|Overall Study|Subject/guardian decision|1|||
144447678|NCT01602315|520839020|FG000|Overall Study|Cross-over patients to combo treatment|0|||
144447679|NCT01602315|520839021|FG001|Overall Study|Cross-over patients to combo treatment|0|||
144447680|NCT01602315|520839022|FG002|Overall Study|Cross-over patients to combo treatment|0|||
144447681|NCT01602315|520839023|FG003|Overall Study|Cross-over patients to combo treatment|0|||
144447682|NCT01602315|520839024|FG004|Overall Study|Cross-over patients to combo treatment|0|||
144447683|NCT01602315|520839025|FG005|Overall Study|Cross-over patients to combo treatment|16|||
144447684|NCT01602315|520839026|FG006|Overall Study|Cross-over patients to combo treatment|0|||
144447685|NCT04193202|520839027|FG000|Overall Study|Adverse Event|2|||
144447686|NCT04193202|520839028|FG001|Overall Study|Adverse Event|1|||
144447687|NCT04193202|520839027|FG000|Overall Study|Death|0|||
144447688|NCT04193202|520839028|FG001|Overall Study|Death|1|||
144447689|NCT04193202|520839027|FG000|Overall Study|Physician Decision|1|||
144447690|NCT04193202|520839028|FG001|Overall Study|Physician Decision|1|||
144447691|NCT04193202|520839027|FG000|Overall Study|Protocol Violation|2|||
144447692|NCT04193202|520839028|FG001|Overall Study|Protocol Violation|2|||
144447693|NCT04193202|520839027|FG000|Overall Study|Withdrawal by Subject|11|||
144447694|NCT04193202|520839028|FG001|Overall Study|Withdrawal by Subject|5|||
144447695|NCT01777997|520839033|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
144447696|NCT01777997|520839033|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
144447697|NCT01777997|520839033|FG000|Weeks 48 to 72/96 on ART|Death|1|||
144194119|NCT01996332|519906401|FG000|Overall Study|Protocol Violation|9|||
144447698|NCT01777997|520839033|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
144447699|NCT01694706|520839034|FG000|Overall Study|Adverse Event|0|||
144447700|NCT01694706|520839035|FG001|Overall Study|Adverse Event|1|||
144194120|NCT01996332|519906401|FG000|Overall Study|Withdrawal by Subject|71|||
144447701|NCT01694706|520839036|FG002|Overall Study|Adverse Event|0|||
144447702|NCT01694706|520839034|FG000|Overall Study|other reason not defined above|1|||
144447703|NCT01694706|520839035|FG001|Overall Study|other reason not defined above|0|||
144447704|NCT01694706|520839036|FG002|Overall Study|other reason not defined above|0|||
144447705|NCT00975975|520839041|FG000|Overall Study|Death|6|||
144447706|NCT00961259|520839042|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
144447707|NCT00961259|520839043|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
144194121|NCT01996332|519906401|FG000|Overall Study|Other|20|||
144194122|NCT01996332|519906401|FG000|Overall Study|Clinical Deterioration|28|||
144194123|NCT01996332|519906401|FG000|Overall Study|Physician Decision|17|||
144194124|NCT01996332|519906401|FG000|Overall Study|Lost to Follow-up|34|||
144194125|NCT02113189|519906402|FG000|Overall Study|Lost to follow up|2|||
144194126|NCT02113189|519906403|FG001|Overall Study|Lost to follow up|1|||
144194127|NCT02113189|519906404|FG002|Overall Study|Lost to follow up|3|||
144194128|NCT01304693|519906405|FG000|Overall Study|Adverse Event|0|||
144194129|NCT01304693|519906406|FG001|Overall Study|Adverse Event|0|||
144194130|NCT01304693|519906407|FG002|Overall Study|Adverse Event|0|||
144194131|NCT01304693|519906408|FG003|Overall Study|Adverse Event|0|||
144194132|NCT01304693|519906409|FG004|Overall Study|Adverse Event|1|||
144194133|NCT01304693|519906405|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
144194134|NCT01304693|519906406|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
144194135|NCT01304693|519906407|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
144194136|NCT01304693|519906408|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
144194137|NCT01304693|519906409|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
144194138|NCT03438396|519906411|FG000|Overall Study|Reason Not Specified|9|||
144194139|NCT03438396|519906411|FG000|Overall Study|Withdrawal by Subject|5|||
144194140|NCT03438396|519906411|FG000|Overall Study|Lost to Follow-up|2|||
144194141|NCT03438396|519906411|FG000|Overall Study|Death|85|||
144194142|NCT03438396|519906411|FG000|Overall Study|Not treated|1|||
144194143|NCT01744093|519906415|FG000|Overall Study|Withdrawal by Subject|6|||
144194144|NCT01744093|519906416|FG001|Overall Study|Withdrawal by Subject|1|||
144194145|NCT02006628|519906417|FG000|Overall Study|Adverse Event|1|||
144194146|NCT02006628|519906418|FG001|Overall Study|Adverse Event|1|||
144194147|NCT02006628|519906417|FG000|Overall Study|Withdrawal by Subject|2|||
144194148|NCT02006628|519906418|FG001|Overall Study|Withdrawal by Subject|1|||
144194149|NCT02384941|519906421|FG000|Overall Study|Adverse Event|11|||
144194150|NCT02384941|519906422|FG001|Overall Study|Adverse Event|13|||
144194151|NCT02384941|519906423|FG002|Overall Study|Adverse Event|17|||
144194152|NCT02384941|519906421|FG000|Overall Study|Lost to Follow-up|3|||
144194153|NCT02384941|519906422|FG001|Overall Study|Lost to Follow-up|2|||
144194154|NCT02384941|519906423|FG002|Overall Study|Lost to Follow-up|1|||
144194155|NCT02384941|519906421|FG000|Overall Study|Non-Compliance With Study Drug|2|||
144194156|NCT02384941|519906422|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144194157|NCT02384941|519906423|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144194158|NCT02384941|519906421|FG000|Overall Study|Physician Decision|1|||
144194159|NCT02384941|519906422|FG001|Overall Study|Physician Decision|1|||
144194160|NCT02384941|519906423|FG002|Overall Study|Physician Decision|0|||
144194161|NCT02384941|519906421|FG000|Overall Study|Protocol Violation|3|||
144194162|NCT02384941|519906422|FG001|Overall Study|Protocol Violation|0|||
144194163|NCT02384941|519906423|FG002|Overall Study|Protocol Violation|0|||
144194164|NCT02384941|519906421|FG000|Overall Study|Withdrawal by Subject|26|||
144194165|NCT02384941|519906422|FG001|Overall Study|Withdrawal by Subject|19|||
144194166|NCT02384941|519906423|FG002|Overall Study|Withdrawal by Subject|20|||
144194167|NCT02384941|519906421|FG000|Overall Study|Pregnancy|0|||
144194168|NCT02384941|519906422|FG001|Overall Study|Pregnancy|0|||
144194169|NCT02384941|519906423|FG002|Overall Study|Pregnancy|1|||
144194170|NCT02384941|519906421|FG000|Overall Study|Other than specified above|4|||
144194171|NCT02384941|519906422|FG001|Overall Study|Other than specified above|0|||
144194172|NCT02384941|519906423|FG002|Overall Study|Other than specified above|1|||
144194173|NCT02493777|519906424|FG000|Overall Study|Lost to Follow-up|0|||
144194174|NCT02493777|519906425|FG001|Overall Study|Lost to Follow-up|1|||
144447708|NCT00961259|520839044|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
144447709|NCT01252251|520839045|FG000|Overall Study|Withdrawal by Subject|1|||
144447710|NCT01324024|520839046|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
144447711|NCT01324024|520839047|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144447712|NCT01923181|520839048|FG000|Overall Study|Protocol Violation|2|||
144447713|NCT01923181|520839049|FG001|Overall Study|Protocol Violation|2|||
144447714|NCT01923181|520839050|FG002|Overall Study|Protocol Violation|0|||
144194175|NCT01705236|519906426|FG000|Overall Study|Lost to Follow-up|1|||
144447715|NCT01923181|520839051|FG003|Overall Study|Protocol Violation|2|||
144194176|NCT01705236|519906426|FG000|Overall Study|Administrative problems|2|||
144194177|NCT01705236|519906426|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
144194178|NCT01705236|519906426|FG000|Overall Study|Protocol Violation|3|||
144194179|NCT01705236|519906426|FG000|Overall Study|Abnormal test procedure result(s)|4|||
144194180|NCT01705236|519906426|FG000|Overall Study|Abnormal laboratory value(s)|4|||
144533228|NCT04605159|521155375|FG003|Overall Study|Protocol Violation|0|||
144194181|NCT01705236|519906426|FG000|Overall Study|Withdrawal by Subject|5|||
144194182|NCT01705236|519906426|FG000|Overall Study|Adverse Event|5|||
144194183|NCT03028740|519906427|FG000|Overall Study|Did not Receive Study Drug|4|||
144194184|NCT03028740|519906428|FG001|Overall Study|Did not Receive Study Drug|5|||
144194185|NCT03028740|519906427|FG000|Overall Study|Adverse Event|8|||
144194186|NCT03028740|519906428|FG001|Overall Study|Adverse Event|26|||
144253736|NCT02499263|520130001|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
144447716|NCT01923181|520839052|FG004|Overall Study|Protocol Violation|2|||
144725254|NCT02581345|521851213|FG003|Part 1: up to Week 16|Physician Decision|0|||
144194187|NCT03028740|519906427|FG000|Overall Study|Lack of Efficacy|0|||
144194188|NCT03028740|519906428|FG001|Overall Study|Lack of Efficacy|1|||
144194189|NCT03028740|519906427|FG000|Overall Study|Withdrawal by Subject|48|||
144194190|NCT03028740|519906428|FG001|Overall Study|Withdrawal by Subject|101|||
144194191|NCT03028740|519906427|FG000|Overall Study|Lost to Follow-up|30|||
144194192|NCT03028740|519906428|FG001|Overall Study|Lost to Follow-up|54|||
144194193|NCT03028740|519906427|FG000|Overall Study|Physician Decision|4|||
144194194|NCT03028740|519906428|FG001|Overall Study|Physician Decision|11|||
144194195|NCT03028740|519906427|FG000|Overall Study|Protocol Violation|4|||
144194196|NCT03028740|519906428|FG001|Overall Study|Protocol Violation|8|||
144194197|NCT03028740|519906427|FG000|Overall Study|Non-compliance with Study Drug|0|||
144194198|NCT03028740|519906428|FG001|Overall Study|Non-compliance with Study Drug|2|||
144194199|NCT03028740|519906427|FG000|Overall Study|Study Terminated by Sponsor|467|||
144194200|NCT03028740|519906428|FG001|Overall Study|Study Terminated by Sponsor|917|||
144194201|NCT03028740|519906427|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
144194202|NCT03028740|519906428|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
144194203|NCT03028740|519906427|FG000|Overall Study|Reason not Specified|1|||
144194204|NCT03028740|519906428|FG001|Overall Study|Reason not Specified|5|||
144194205|NCT00171301|519906429|FG000|Overall Study|Death|1|||
144447717|NCT01923181|520839053|FG005|Overall Study|Protocol Violation|1|||
144447718|NCT01923181|520839054|FG006|Overall Study|Protocol Violation|1|||
144447719|NCT01923181|520839055|FG007|Overall Study|Protocol Violation|2|||
144447720|NCT01923181|520839056|FG008|Overall Study|Protocol Violation|1|||
144447721|NCT01923181|520839048|FG000|Overall Study|Withdrawal by Subject|0|||
144447722|NCT01923181|520839049|FG001|Overall Study|Withdrawal by Subject|1|||
144447723|NCT01923181|520839050|FG002|Overall Study|Withdrawal by Subject|0|||
144447724|NCT01923181|520839051|FG003|Overall Study|Withdrawal by Subject|1|||
144447725|NCT01923181|520839052|FG004|Overall Study|Withdrawal by Subject|4|||
144447726|NCT01923181|520839053|FG005|Overall Study|Withdrawal by Subject|2|||
144447727|NCT01923181|520839054|FG006|Overall Study|Withdrawal by Subject|4|||
144447728|NCT01923181|520839055|FG007|Overall Study|Withdrawal by Subject|3|||
144447729|NCT01923181|520839056|FG008|Overall Study|Withdrawal by Subject|1|||
144447730|NCT01923181|520839048|FG000|Overall Study|Other|1|||
144447731|NCT01923181|520839049|FG001|Overall Study|Other|0|||
144447732|NCT01923181|520839050|FG002|Overall Study|Other|0|||
144447733|NCT01923181|520839051|FG003|Overall Study|Other|1|||
144447734|NCT01923181|520839052|FG004|Overall Study|Other|0|||
144447735|NCT01923181|520839053|FG005|Overall Study|Other|0|||
144447736|NCT01923181|520839054|FG006|Overall Study|Other|0|||
144447737|NCT01923181|520839055|FG007|Overall Study|Other|0|||
144447738|NCT01923181|520839056|FG008|Overall Study|Other|0|||
144447739|NCT01923181|520839048|FG000|Overall Study|Lost to Follow-up|0|||
144447740|NCT01923181|520839049|FG001|Overall Study|Lost to Follow-up|3|||
144447741|NCT01923181|520839050|FG002|Overall Study|Lost to Follow-up|2|||
144447742|NCT01923181|520839051|FG003|Overall Study|Lost to Follow-up|1|||
144447743|NCT01923181|520839052|FG004|Overall Study|Lost to Follow-up|2|||
144447744|NCT01923181|520839053|FG005|Overall Study|Lost to Follow-up|1|||
144447745|NCT01923181|520839054|FG006|Overall Study|Lost to Follow-up|3|||
144447746|NCT01923181|520839055|FG007|Overall Study|Lost to Follow-up|3|||
144447747|NCT01923181|520839056|FG008|Overall Study|Lost to Follow-up|1|||
144447748|NCT02691455|520839057|FG000|Overall Study|Withdrawal by Subject|1|||
144447749|NCT02691455|520839058|FG001|Overall Study|Withdrawal by Subject|2|||
144447750|NCT02691455|520839057|FG000|Overall Study|Lost to Follow-up|15|||
144447751|NCT02691455|520839058|FG001|Overall Study|Lost to Follow-up|15|||
144447752|NCT02057757|520839060|FG000|Overall Study|Withdrawal by Subject|3|||
144447753|NCT02057757|520839061|FG001|Overall Study|Withdrawal by Subject|5|||
144447754|NCT02057757|520839060|FG000|Overall Study|Death|2|||
144533229|NCT04605159|521155372|FG000|Overall Study|Withdrawal by Subject|66|||
144194206|NCT00171301|519906430|FG001|Overall Study|Death|2|||
144194207|NCT00171301|519906429|FG000|Overall Study|Adverse Event|1|||
144533230|NCT04605159|521155373|FG001|Overall Study|Withdrawal by Subject|37|||
144533231|NCT04605159|521155374|FG002|Overall Study|Withdrawal by Subject|68|||
144194208|NCT00171301|519906430|FG001|Overall Study|Adverse Event|2|||
144194209|NCT00171301|519906429|FG000|Overall Study|Lost to Follow-up|6|||
144194210|NCT00171301|519906430|FG001|Overall Study|Lost to Follow-up|2|||
144447755|NCT02057757|520839061|FG001|Overall Study|Death|0|||
144447756|NCT02057757|520839060|FG000|Overall Study|Lost to Follow-up|8|||
144447757|NCT02057757|520839061|FG001|Overall Study|Lost to Follow-up|3|||
144447758|NCT02057757|520839060|FG000|Overall Study|Non-compliance|1|||
144447759|NCT02057757|520839061|FG001|Overall Study|Non-compliance|0|||
144447760|NCT01158222|520839062|FG000|Overall Study|Not eligible for intermediate phase|17|||
144447761|NCT00111228|520839063|FG000|Overall Study|Withdrawal by Subject|5|||
144533232|NCT04605159|521155375|FG003|Overall Study|Withdrawal by Subject|50|||
144533233|NCT04605159|521155372|FG000|Overall Study|Migrated / moved from the study area|32|||
144194211|NCT00171301|519906429|FG000|Overall Study|Protocol Violation|0|||
144194212|NCT00171301|519906430|FG001|Overall Study|Protocol Violation|2|||
144447762|NCT00111228|520839064|FG001|Overall Study|Withdrawal by Subject|1|||
144447763|NCT00111228|520839065|FG002|Overall Study|Withdrawal by Subject|0|||
144447764|NCT00684424|520839068|FG000|Overall Study|Adverse Event|1|||
144447765|NCT00684424|520839068|FG000|Overall Study|Lost to Follow-up|2|||
144447766|NCT00684424|520839068|FG000|Overall Study|Other|2|||
144447767|NCT00205712|520839069|FG000|Overall Study|Lost to Follow-up|0|||
144447768|NCT00205712|520839070|FG001|Overall Study|Lost to Follow-up|1|||
144447769|NCT02296112|520839073|FG000|Overall Study|Disease progression|7|||
144447770|NCT02296112|520839073|FG000|Overall Study|Toxicity|1|||
144447771|NCT02296112|520839073|FG000|Overall Study|Began an alternate therapy|1|||
144447772|NCT02316717|520839074|FG000|Overall Study|Adverse Event|2|||
144447773|NCT02316717|520839075|FG001|Overall Study|Adverse Event|2|||
144447774|NCT02316717|520839076|FG002|Overall Study|Adverse Event|0|||
144447775|NCT02316717|520839074|FG000|Overall Study|Lost to Follow-up|1|||
144447776|NCT02316717|520839075|FG001|Overall Study|Lost to Follow-up|2|||
144447777|NCT02316717|520839076|FG002|Overall Study|Lost to Follow-up|1|||
144447778|NCT02316717|520839074|FG000|Overall Study|Non compliance|3|||
144447779|NCT02316717|520839075|FG001|Overall Study|Non compliance|1|||
144447780|NCT02316717|520839076|FG002|Overall Study|Non compliance|0|||
144447781|NCT02316717|520839074|FG000|Overall Study|Protocol Violation|2|||
144447782|NCT02316717|520839075|FG001|Overall Study|Protocol Violation|0|||
144447783|NCT02316717|520839076|FG002|Overall Study|Protocol Violation|0|||
144447784|NCT02316717|520839074|FG000|Overall Study|Withdrawal by Subject|2|||
144447785|NCT02316717|520839075|FG001|Overall Study|Withdrawal by Subject|1|||
144447786|NCT02316717|520839076|FG002|Overall Study|Withdrawal by Subject|1|||
144447787|NCT02316717|520839074|FG000|Overall Study|Death|0|||
144447788|NCT02316717|520839075|FG001|Overall Study|Death|0|||
144447789|NCT02316717|520839076|FG002|Overall Study|Death|1|||
144447790|NCT02316717|520839074|FG000|Overall Study|Physician Decision|0|||
144447791|NCT02316717|520839075|FG001|Overall Study|Physician Decision|1|||
144447792|NCT02316717|520839076|FG002|Overall Study|Physician Decision|0|||
144447793|NCT02316717|520839074|FG000|Overall Study|TBC|1|||
144447794|NCT02316717|520839075|FG001|Overall Study|TBC|0|||
144447795|NCT02316717|520839076|FG002|Overall Study|TBC|0|||
144447796|NCT01720069|520839077|FG000|Overall Study|Could not use e-diary correctly|0|||
144447797|NCT01720069|520839078|FG001|Overall Study|Could not use e-diary correctly|1|||
144447798|NCT01720069|520839079|FG002|Overall Study|Could not use e-diary correctly|1|||
144447799|NCT01720069|520839077|FG000|Overall Study|Randomised without baseline values|0|||
144447800|NCT01720069|520839078|FG001|Overall Study|Randomised without baseline values|0|||
144447801|NCT01720069|520839079|FG002|Overall Study|Randomised without baseline values|1|||
144447802|NCT01720069|520839077|FG000|Overall Study|Adverse Event|0|||
144447803|NCT01720069|520839078|FG001|Overall Study|Adverse Event|0|||
144447804|NCT01720069|520839079|FG002|Overall Study|Adverse Event|1|||
144447805|NCT01720069|520839077|FG000|Overall Study|Lack of Efficacy|0|||
144447806|NCT01720069|520839078|FG001|Overall Study|Lack of Efficacy|4|||
144447807|NCT01720069|520839079|FG002|Overall Study|Lack of Efficacy|0|||
144447808|NCT01720069|520839077|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
144725255|NCT02581345|521851210|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
144447809|NCT01720069|520839078|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
144447810|NCT01720069|520839079|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
144447811|NCT01720069|520839077|FG000|Overall Study|Withdrawal by Subject|0|||
144447812|NCT01720069|520839078|FG001|Overall Study|Withdrawal by Subject|2|||
144447813|NCT01720069|520839079|FG002|Overall Study|Withdrawal by Subject|1|||
144447814|NCT01720069|520839077|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
144447815|NCT01720069|520839078|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
144447816|NCT01720069|520839079|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
144447817|NCT01720069|520839077|FG000|Overall Study|Non-compliance on using e-diary|0|||
144447818|NCT01720069|520839078|FG001|Overall Study|Non-compliance on using e-diary|0|||
144447819|NCT01720069|520839079|FG002|Overall Study|Non-compliance on using e-diary|1|||
144725256|NCT02581345|521851211|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
144447820|NCT01720069|520839077|FG000|Overall Study|Lost to Follow-up|0|||
144447821|NCT01720069|520839078|FG001|Overall Study|Lost to Follow-up|0|||
144447822|NCT01720069|520839079|FG002|Overall Study|Lost to Follow-up|1|||
144447823|NCT00508742|520839080|FG000|Period 1: Infant Series|Adverse Event|5|||
144447824|NCT00508742|520839081|FG001|Period 1: Infant Series|Adverse Event|4|||
144447825|NCT00508742|520839080|FG000|Period 1: Infant Series|Protocol Violation|1|||
144447826|NCT00508742|520839081|FG001|Period 1: Infant Series|Protocol Violation|0|||
144447827|NCT00508742|520839080|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
144447828|NCT00508742|520839081|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
144447829|NCT00508742|520839080|FG000|Period 1: Infant Series|Physician Decision|1|||
144447830|NCT00508742|520839081|FG001|Period 1: Infant Series|Physician Decision|0|||
144447831|NCT00508742|520839080|FG000|Period 1: Infant Series|Other|4|||
144725257|NCT02581345|521851212|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
144725258|NCT02581345|521851213|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
144725259|NCT02581345|521851210|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
144447832|NCT00508742|520839081|FG001|Period 1: Infant Series|Other|1|||
144447833|NCT00508742|520839080|FG000|Period 2: After Infant Series|Adverse Event|2|||
144447834|NCT00508742|520839081|FG001|Period 2: After Infant Series|Adverse Event|6|||
144447835|NCT00508742|520839080|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
144533234|NCT04605159|521155373|FG001|Overall Study|Migrated / moved from the study area|22|||
144533235|NCT04605159|521155374|FG002|Overall Study|Migrated / moved from the study area|41|||
144533236|NCT04605159|521155375|FG003|Overall Study|Migrated / moved from the study area|21|||
144533237|NCT04605159|521155372|FG000|Overall Study|Other|1|||
144533238|NCT04605159|521155373|FG001|Overall Study|Other|2|||
144533239|NCT04605159|521155374|FG002|Overall Study|Other|7|||
144533240|NCT04605159|521155375|FG003|Overall Study|Other|3|||
144533241|NCT04804540|521155378|FG000|Overall Study|Adverse Event|26|||
144533242|NCT04804540|521155379|FG001|Overall Study|Adverse Event|13|||
144533243|NCT01828021|521155380|FG000|Overall Study|Adverse Event|5|||
144533244|NCT01828021|521155380|FG000|Overall Study|Lack of Efficacy|17|||
144533245|NCT01828021|521155380|FG000|Overall Study|Withdrawal by Subject|2|||
144533246|NCT01828021|521155380|FG000|Overall Study|Ileal obstruction, unrelated|1|||
144533247|NCT00942877|521155391|FG000|Overall Study|Refused further treatment|1|||
144533248|NCT00942877|521155392|FG001|Overall Study|Refused further treatment|1|||
144533249|NCT00942877|521155391|FG000|Overall Study|Patient was not treated|1|||
144533250|NCT00942877|521155392|FG001|Overall Study|Patient was not treated|0|||
144533251|NCT00942877|521155391|FG000|Overall Study|Adverse Event|1|||
144533252|NCT00942877|521155392|FG001|Overall Study|Adverse Event|0|||
144533253|NCT00942877|521155391|FG000|Overall Study|Progressive disease|42|||
144533254|NCT00942877|521155392|FG001|Overall Study|Progressive disease|3|||
144533255|NCT01385202|521155393|FG000|Overall Study|Lost to Follow-up|6|||
144533256|NCT01385202|521155393|FG000|Overall Study|Not Eligible|11|||
144533257|NCT01385202|521155393|FG000|Overall Study|Withdrawn|1|||
144533258|NCT04055012|521155394|FG000|Overall Study|Withdrawal by Subject|1|||
144533259|NCT04055012|521155395|FG001|Overall Study|Withdrawal by Subject|3|||
144533260|NCT04055012|521155396|FG002|Overall Study|Withdrawal by Subject|1|||
144533261|NCT04055012|521155397|FG003|Overall Study|Withdrawal by Subject|0|||
144533262|NCT04055012|521155394|FG000|Overall Study|Metformin Recall|1|||
144533263|NCT04055012|521155395|FG001|Overall Study|Metformin Recall|1|||
144533264|NCT04055012|521155396|FG002|Overall Study|Metformin Recall|1|||
144533265|NCT04055012|521155397|FG003|Overall Study|Metformin Recall|0|||
144533266|NCT03652272|521155400|FG000|3 Month|Withdrawal by Subject|1|||
144533267|NCT03652272|521155401|FG001|3 Month|Withdrawal by Subject|1|||
144533268|NCT03652272|521155400|FG000|3 Month|Lost to Follow-up|16|||
144533269|NCT03652272|521155401|FG001|3 Month|Lost to Follow-up|14|||
144533270|NCT02326974|521155402|FG000|Overall Study|Withdrawal by Subject|2|||
144533271|NCT02326974|521155402|FG000|Overall Study|failed heterogenity evaluation|5|||
144533272|NCT04924400|521155409|FG000|Overall Study|Lost to Follow-up|3|||
144533273|NCT04924400|521155410|FG001|Overall Study|Lost to Follow-up|0|||
144533274|NCT05070741|521155411|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
144533275|NCT03582033|521155412|FG000|Part A|Other|0|||
144533276|NCT03582033|521155413|FG001|Part A|Other|0|||
144533277|NCT03582033|521155414|FG002|Part A|Other|0|||
144533278|NCT03582033|521155415|FG003|Part A|Other|0|||
144533279|NCT03582033|521155416|FG004|Part A|Other|2|||
144533280|NCT03582033|521155417|FG005|Part A|Other|0|||
144533281|NCT03582033|521155418|FG006|Part A|Other|0|||
144533282|NCT03582033|521155419|FG007|Part A|Other|0|||
144533283|NCT03582033|521155420|FG008|Part A|Other|0|||
144533284|NCT03582033|521155421|FG009|Part A|Other|0|||
144533285|NCT03582033|521155412|FG000|Part A|Death|1|||
144533286|NCT03582033|521155413|FG001|Part A|Death|1|||
144533287|NCT03582033|521155414|FG002|Part A|Death|2|||
144533288|NCT03582033|521155415|FG003|Part A|Death|4|||
144533289|NCT03582033|521155416|FG004|Part A|Death|11|||
144533290|NCT03582033|521155417|FG005|Part A|Death|0|||
144533291|NCT03582033|521155418|FG006|Part A|Death|0|||
144533292|NCT03582033|521155419|FG007|Part A|Death|0|||
144533293|NCT03582033|521155420|FG008|Part A|Death|0|||
144606469|NCT01994382|521421002|FG009|Overall Study|Other than specified|0|||
144606470|NCT01994382|521421003|FG010|Overall Study|Other than specified|2|||
144533294|NCT03582033|521155421|FG009|Part A|Death|0|||
144533295|NCT03582033|521155412|FG000|Part A|Lost to Follow-up|0|||
144533296|NCT03582033|521155413|FG001|Part A|Lost to Follow-up|0|||
144533297|NCT03582033|521155414|FG002|Part A|Lost to Follow-up|0|||
144533298|NCT03582033|521155415|FG003|Part A|Lost to Follow-up|0|||
144533299|NCT03582033|521155416|FG004|Part A|Lost to Follow-up|1|||
144606471|NCT01994382|521421004|FG011|Overall Study|Other than specified|0|||
144533300|NCT03582033|521155417|FG005|Part A|Lost to Follow-up|0|||
144533301|NCT03582033|521155418|FG006|Part A|Lost to Follow-up|0|||
144533302|NCT03582033|521155419|FG007|Part A|Lost to Follow-up|0|||
144533303|NCT03582033|521155420|FG008|Part A|Lost to Follow-up|0|||
144533304|NCT03582033|521155421|FG009|Part A|Lost to Follow-up|0|||
144533305|NCT03582033|521155412|FG000|Part A|Study terminated by sponsor|0|||
144533306|NCT03582033|521155413|FG001|Part A|Study terminated by sponsor|0|||
144533307|NCT03582033|521155414|FG002|Part A|Study terminated by sponsor|0|||
144533308|NCT03582033|521155415|FG003|Part A|Study terminated by sponsor|2|||
144533309|NCT03582033|521155416|FG004|Part A|Study terminated by sponsor|1|||
144533310|NCT03582033|521155417|FG005|Part A|Study terminated by sponsor|0|||
144533311|NCT03582033|521155418|FG006|Part A|Study terminated by sponsor|0|||
144533312|NCT03582033|521155419|FG007|Part A|Study terminated by sponsor|0|||
144447836|NCT00508742|520839081|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
144447837|NCT00508742|520839080|FG000|Period 2: After Infant Series|Protocol Violation|1|||
144447838|NCT00508742|520839081|FG001|Period 2: After Infant Series|Protocol Violation|0|||
144194213|NCT00171301|519906429|FG000|Overall Study|Withdrawal by Subject|0|||
144194214|NCT00171301|519906430|FG001|Overall Study|Withdrawal by Subject|1|||
144194215|NCT02100319|519906432|FG000|Overall Study|Case Report Forms Uncollected|11|||
144194216|NCT02100319|519906432|FG000|Overall Study|Protocol Deviation|5|||
144194217|NCT02589522|519906433|FG000|Overall Study|Physician Decision|1|||
144194218|NCT02589522|519906434|FG001|Overall Study|Physician Decision|2|||
144194219|NCT02589522|519906435|FG002|Overall Study|Physician Decision|0|||
144194220|NCT02589522|519906433|FG000|Overall Study|Did not start treatment|1|||
144194221|NCT02589522|519906434|FG001|Overall Study|Did not start treatment|0|||
144447839|NCT00508742|520839080|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
144447840|NCT00508742|520839081|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
144447841|NCT00508742|520839080|FG000|Period 2: After Infant Series|Failed to Return|1|||
144447842|NCT00508742|520839081|FG001|Period 2: After Infant Series|Failed to Return|0|||
144447843|NCT00508742|520839080|FG000|Period 2: After Infant Series|Other|2|||
144447844|NCT00508742|520839081|FG001|Period 2: After Infant Series|Other|1|||
144447845|NCT00508742|520839080|FG000|Period 3: Toddler Dose|Adverse Event|1|||
144447846|NCT00508742|520839081|FG001|Period 3: Toddler Dose|Adverse Event|0|||
144447847|NCT00508742|520839080|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
144447848|NCT00508742|520839081|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
144447849|NCT00508742|520839080|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
144447850|NCT00508742|520839081|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
144447851|NCT00508742|520839080|FG000|Period 3: Toddler Dose|Other|5|||
144447852|NCT00508742|520839081|FG001|Period 3: Toddler Dose|Other|4|||
144447853|NCT04568122|520839082|FG000|Overall Study|Lost to Follow-up|48|||
144447854|NCT04568122|520839083|FG001|Overall Study|Lost to Follow-up|44|||
144447855|NCT04568122|520839084|FG002|Overall Study|Lost to Follow-up|4|||
144447856|NCT04568122|520839085|FG003|Overall Study|Lost to Follow-up|0|||
144447857|NCT04568122|520839086|FG004|Overall Study|Lost to Follow-up|0|||
144447858|NCT02460224|520839093|FG000|Overall Study|Adverse Event|0|||
144447859|NCT02460224|520839094|FG001|Overall Study|Adverse Event|0|||
144447860|NCT02460224|520839095|FG002|Overall Study|Adverse Event|0|||
144447861|NCT02460224|520839096|FG003|Overall Study|Adverse Event|0|||
144447862|NCT02460224|520839097|FG004|Overall Study|Adverse Event|0|||
144447863|NCT02460224|520839098|FG005|Overall Study|Adverse Event|0|||
144447864|NCT02460224|520839099|FG006|Overall Study|Adverse Event|1|||
144447865|NCT02460224|520839100|FG007|Overall Study|Adverse Event|0|||
144447866|NCT02460224|520839101|FG008|Overall Study|Adverse Event|0|||
144447867|NCT02460224|520839102|FG009|Overall Study|Adverse Event|0|||
144447868|NCT02460224|520839103|FG010|Overall Study|Adverse Event|0|||
144447869|NCT02460224|520839104|FG011|Overall Study|Adverse Event|0|||
144447870|NCT02460224|520839105|FG012|Overall Study|Adverse Event|1|||
144447871|NCT02460224|520839106|FG013|Overall Study|Adverse Event|0|||
144447872|NCT02460224|520839107|FG014|Overall Study|Adverse Event|0|||
144447873|NCT02460224|520839108|FG015|Overall Study|Adverse Event|0|||
144447874|NCT02460224|520839109|FG016|Overall Study|Adverse Event|1|||
144447875|NCT02460224|520839110|FG017|Overall Study|Adverse Event|0|||
144447876|NCT02460224|520839111|FG018|Overall Study|Adverse Event|1|||
144447877|NCT02460224|520839112|FG019|Overall Study|Adverse Event|0|||
144447878|NCT02460224|520839113|FG020|Overall Study|Adverse Event|1|||
144447879|NCT02460224|520839114|FG021|Overall Study|Adverse Event|1|||
144447880|NCT02460224|520839115|FG022|Overall Study|Adverse Event|1|||
144194222|NCT02589522|519906435|FG002|Overall Study|Did not start treatment|0|||
144447881|NCT02460224|520839116|FG023|Overall Study|Adverse Event|0|||
144447882|NCT02460224|520839117|FG024|Overall Study|Adverse Event|0|||
144447883|NCT02460224|520839118|FG025|Overall Study|Adverse Event|0|||
144447884|NCT02460224|520839119|FG026|Overall Study|Adverse Event|11|||
144447885|NCT02460224|520839120|FG027|Overall Study|Adverse Event|1|||
144447886|NCT02460224|520839121|FG028|Overall Study|Adverse Event|6|||
144533313|NCT03582033|521155420|FG008|Part A|Study terminated by sponsor|0|||
144533314|NCT03582033|521155421|FG009|Part A|Study terminated by sponsor|0|||
144533315|NCT03582033|521155412|FG000|Part A|Withdrawal by Subject|1|||
144533316|NCT03582033|521155413|FG001|Part A|Withdrawal by Subject|1|||
144533317|NCT03582033|521155414|FG002|Part A|Withdrawal by Subject|0|||
144533318|NCT03582033|521155415|FG003|Part A|Withdrawal by Subject|1|||
144533319|NCT03582033|521155416|FG004|Part A|Withdrawal by Subject|7|||
144533320|NCT03582033|521155417|FG005|Part A|Withdrawal by Subject|0|||
144533321|NCT03582033|521155418|FG006|Part A|Withdrawal by Subject|0|||
144606472|NCT01994382|521421005|FG012|Overall Study|Other than specified|2|||
144194223|NCT00754442|519906436|FG000|Overall Study|Withdrawal by Subject|5|||
144447887|NCT02460224|520839093|FG000|Overall Study|Death|0|||
144447888|NCT02460224|520839094|FG001|Overall Study|Death|0|||
144447889|NCT02460224|520839095|FG002|Overall Study|Death|0|||
144447890|NCT02460224|520839096|FG003|Overall Study|Death|0|||
144447891|NCT02460224|520839097|FG004|Overall Study|Death|0|||
144447892|NCT02460224|520839098|FG005|Overall Study|Death|2|||
144447893|NCT02460224|520839099|FG006|Overall Study|Death|1|||
144447894|NCT02460224|520839100|FG007|Overall Study|Death|0|||
144447895|NCT02460224|520839101|FG008|Overall Study|Death|0|||
144447896|NCT02460224|520839102|FG009|Overall Study|Death|1|||
144447897|NCT02460224|520839103|FG010|Overall Study|Death|0|||
144447898|NCT02460224|520839104|FG011|Overall Study|Death|0|||
144447899|NCT02460224|520839105|FG012|Overall Study|Death|0|||
144447900|NCT02460224|520839106|FG013|Overall Study|Death|1|||
144447901|NCT02460224|520839107|FG014|Overall Study|Death|0|||
144447902|NCT02460224|520839108|FG015|Overall Study|Death|0|||
144447903|NCT02460224|520839109|FG016|Overall Study|Death|2|||
144447904|NCT02460224|520839110|FG017|Overall Study|Death|1|||
144447905|NCT02460224|520839111|FG018|Overall Study|Death|0|||
144447906|NCT02460224|520839112|FG019|Overall Study|Death|2|||
144447907|NCT02460224|520839113|FG020|Overall Study|Death|0|||
144447908|NCT02460224|520839114|FG021|Overall Study|Death|0|||
144447909|NCT02460224|520839115|FG022|Overall Study|Death|0|||
144447910|NCT02460224|520839116|FG023|Overall Study|Death|0|||
144447911|NCT02460224|520839117|FG024|Overall Study|Death|1|||
144447912|NCT02460224|520839118|FG025|Overall Study|Death|1|||
144447913|NCT02460224|520839119|FG026|Overall Study|Death|5|||
144447914|NCT02460224|520839120|FG027|Overall Study|Death|0|||
144447915|NCT02460224|520839121|FG028|Overall Study|Death|1|||
144447916|NCT02460224|520839093|FG000|Overall Study|Lost to Follow-up|0|||
144447917|NCT02460224|520839094|FG001|Overall Study|Lost to Follow-up|0|||
144447918|NCT02460224|520839095|FG002|Overall Study|Lost to Follow-up|0|||
144447919|NCT02460224|520839096|FG003|Overall Study|Lost to Follow-up|0|||
144447920|NCT02460224|520839097|FG004|Overall Study|Lost to Follow-up|0|||
144447921|NCT02460224|520839098|FG005|Overall Study|Lost to Follow-up|0|||
144447922|NCT02460224|520839099|FG006|Overall Study|Lost to Follow-up|0|||
144447923|NCT02460224|520839100|FG007|Overall Study|Lost to Follow-up|0|||
144447924|NCT02460224|520839101|FG008|Overall Study|Lost to Follow-up|0|||
144447925|NCT02460224|520839102|FG009|Overall Study|Lost to Follow-up|0|||
144447926|NCT02460224|520839103|FG010|Overall Study|Lost to Follow-up|0|||
144447927|NCT02460224|520839104|FG011|Overall Study|Lost to Follow-up|0|||
144447928|NCT02460224|520839105|FG012|Overall Study|Lost to Follow-up|0|||
144447929|NCT02460224|520839106|FG013|Overall Study|Lost to Follow-up|0|||
144447930|NCT02460224|520839107|FG014|Overall Study|Lost to Follow-up|0|||
144447931|NCT02460224|520839108|FG015|Overall Study|Lost to Follow-up|0|||
144447932|NCT02460224|520839109|FG016|Overall Study|Lost to Follow-up|0|||
144447933|NCT02460224|520839110|FG017|Overall Study|Lost to Follow-up|0|||
144447934|NCT02460224|520839111|FG018|Overall Study|Lost to Follow-up|0|||
144447935|NCT02460224|520839112|FG019|Overall Study|Lost to Follow-up|0|||
144447936|NCT02460224|520839113|FG020|Overall Study|Lost to Follow-up|0|||
144447937|NCT02460224|520839114|FG021|Overall Study|Lost to Follow-up|0|||
144447938|NCT02460224|520839115|FG022|Overall Study|Lost to Follow-up|1|||
144447939|NCT02460224|520839116|FG023|Overall Study|Lost to Follow-up|0|||
144447940|NCT02460224|520839117|FG024|Overall Study|Lost to Follow-up|0|||
144447941|NCT02460224|520839118|FG025|Overall Study|Lost to Follow-up|0|||
144447942|NCT02460224|520839119|FG026|Overall Study|Lost to Follow-up|0|||
144606473|NCT01994382|521421006|FG013|Overall Study|Other than specified|0|||
144606474|NCT01994382|521421007|FG014|Overall Study|Other than specified|0|||
144606475|NCT01994382|521421008|FG015|Overall Study|Other than specified|4|||
144606476|NCT01994382|521421009|FG016|Overall Study|Other than specified|4|||
144606477|NCT01994382|521420993|FG000|Overall Study|Withdrawal by Subject|0|||
144606478|NCT01994382|521420994|FG001|Overall Study|Withdrawal by Subject|0|||
144606479|NCT01994382|521420995|FG002|Overall Study|Withdrawal by Subject|0|||
144606480|NCT01994382|521420996|FG003|Overall Study|Withdrawal by Subject|0|||
144606481|NCT01994382|521420997|FG004|Overall Study|Withdrawal by Subject|0|||
144725260|NCT02581345|521851211|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
144447943|NCT02460224|520839120|FG027|Overall Study|Lost to Follow-up|0|||
144447944|NCT02460224|520839121|FG028|Overall Study|Lost to Follow-up|0|||
144447945|NCT02460224|520839093|FG000|Overall Study|Physician Decision|0|||
144447946|NCT02460224|520839094|FG001|Overall Study|Physician Decision|1|||
144725261|NCT02581345|521851212|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
144725262|NCT02581345|521851213|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
144725263|NCT02581345|521851210|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
144447947|NCT02460224|520839095|FG002|Overall Study|Physician Decision|0|||
144447948|NCT02460224|520839096|FG003|Overall Study|Physician Decision|0|||
144447949|NCT02460224|520839097|FG004|Overall Study|Physician Decision|1|||
144447950|NCT02460224|520839098|FG005|Overall Study|Physician Decision|0|||
144447951|NCT02460224|520839099|FG006|Overall Study|Physician Decision|0|||
144447952|NCT02460224|520839100|FG007|Overall Study|Physician Decision|1|||
144447953|NCT02460224|520839101|FG008|Overall Study|Physician Decision|0|||
144447954|NCT02460224|520839102|FG009|Overall Study|Physician Decision|0|||
144447955|NCT02460224|520839103|FG010|Overall Study|Physician Decision|0|||
144447956|NCT02460224|520839104|FG011|Overall Study|Physician Decision|1|||
144447957|NCT02460224|520839105|FG012|Overall Study|Physician Decision|0|||
144447958|NCT02460224|520839106|FG013|Overall Study|Physician Decision|1|||
144447959|NCT02460224|520839107|FG014|Overall Study|Physician Decision|0|||
144447960|NCT02460224|520839108|FG015|Overall Study|Physician Decision|0|||
144447961|NCT02460224|520839109|FG016|Overall Study|Physician Decision|2|||
144447962|NCT02460224|520839110|FG017|Overall Study|Physician Decision|1|||
144447963|NCT02460224|520839111|FG018|Overall Study|Physician Decision|1|||
144447964|NCT02460224|520839112|FG019|Overall Study|Physician Decision|2|||
144447965|NCT02460224|520839113|FG020|Overall Study|Physician Decision|1|||
144447966|NCT02460224|520839114|FG021|Overall Study|Physician Decision|1|||
144447967|NCT02460224|520839115|FG022|Overall Study|Physician Decision|0|||
144447968|NCT02460224|520839116|FG023|Overall Study|Physician Decision|0|||
144447969|NCT02460224|520839117|FG024|Overall Study|Physician Decision|1|||
144447970|NCT02460224|520839118|FG025|Overall Study|Physician Decision|0|||
144447971|NCT02460224|520839119|FG026|Overall Study|Physician Decision|14|||
144447972|NCT02460224|520839120|FG027|Overall Study|Physician Decision|1|||
144447973|NCT02460224|520839121|FG028|Overall Study|Physician Decision|6|||
144447974|NCT02460224|520839093|FG000|Overall Study|Progressive disease|15|||
144447975|NCT02460224|520839094|FG001|Overall Study|Progressive disease|11|||
144447976|NCT02460224|520839095|FG002|Overall Study|Progressive disease|5|||
144447977|NCT02460224|520839096|FG003|Overall Study|Progressive disease|6|||
144447978|NCT02460224|520839097|FG004|Overall Study|Progressive disease|3|||
144447979|NCT02460224|520839098|FG005|Overall Study|Progressive disease|26|||
144447980|NCT02460224|520839099|FG006|Overall Study|Progressive disease|28|||
144447981|NCT02460224|520839100|FG007|Overall Study|Progressive disease|4|||
144447982|NCT02460224|520839101|FG008|Overall Study|Progressive disease|5|||
144447983|NCT02460224|520839102|FG009|Overall Study|Progressive disease|9|||
144447984|NCT02460224|520839103|FG010|Overall Study|Progressive disease|5|||
144447985|NCT02460224|520839104|FG011|Overall Study|Progressive disease|4|||
144447986|NCT02460224|520839105|FG012|Overall Study|Progressive disease|5|||
144447987|NCT02460224|520839106|FG013|Overall Study|Progressive disease|4|||
144447988|NCT02460224|520839107|FG014|Overall Study|Progressive disease|5|||
144447989|NCT02460224|520839108|FG015|Overall Study|Progressive disease|5|||
144447990|NCT02460224|520839109|FG016|Overall Study|Progressive disease|15|||
144447991|NCT02460224|520839110|FG017|Overall Study|Progressive disease|3|||
144447992|NCT02460224|520839111|FG018|Overall Study|Progressive disease|8|||
144447993|NCT02460224|520839112|FG019|Overall Study|Progressive disease|3|||
144447994|NCT02460224|520839113|FG020|Overall Study|Progressive disease|4|||
144447995|NCT02460224|520839114|FG021|Overall Study|Progressive disease|9|||
144447996|NCT02460224|520839115|FG022|Overall Study|Progressive disease|4|||
144447997|NCT02460224|520839116|FG023|Overall Study|Progressive disease|11|||
144447998|NCT02460224|520839117|FG024|Overall Study|Progressive disease|4|||
144447999|NCT02460224|520839118|FG025|Overall Study|Progressive disease|5|||
144448000|NCT02460224|520839119|FG026|Overall Study|Progressive disease|85|||
144448001|NCT02460224|520839120|FG027|Overall Study|Progressive disease|17|||
144448002|NCT02460224|520839121|FG028|Overall Study|Progressive disease|77|||
144448003|NCT02460224|520839093|FG000|Overall Study|Subject/guardian decision|2|||
144448004|NCT02460224|520839094|FG001|Overall Study|Subject/guardian decision|0|||
144448005|NCT02460224|520839095|FG002|Overall Study|Subject/guardian decision|1|||
144448006|NCT02460224|520839096|FG003|Overall Study|Subject/guardian decision|0|||
144448007|NCT02460224|520839097|FG004|Overall Study|Subject/guardian decision|2|||
144448008|NCT02460224|520839098|FG005|Overall Study|Subject/guardian decision|2|||
144448009|NCT02460224|520839099|FG006|Overall Study|Subject/guardian decision|0|||
144448010|NCT02460224|520839100|FG007|Overall Study|Subject/guardian decision|0|||
144448011|NCT02460224|520839101|FG008|Overall Study|Subject/guardian decision|1|||
144448012|NCT02460224|520839102|FG009|Overall Study|Subject/guardian decision|1|||
144448013|NCT02460224|520839103|FG010|Overall Study|Subject/guardian decision|0|||
144448014|NCT02460224|520839104|FG011|Overall Study|Subject/guardian decision|1|||
144448015|NCT02460224|520839105|FG012|Overall Study|Subject/guardian decision|0|||
144448016|NCT02460224|520839106|FG013|Overall Study|Subject/guardian decision|0|||
144448017|NCT02460224|520839107|FG014|Overall Study|Subject/guardian decision|0|||
144448018|NCT02460224|520839108|FG015|Overall Study|Subject/guardian decision|1|||
144448019|NCT02460224|520839109|FG016|Overall Study|Subject/guardian decision|0|||
144448020|NCT02460224|520839110|FG017|Overall Study|Subject/guardian decision|1|||
144533322|NCT03582033|521155419|FG007|Part A|Withdrawal by Subject|0|||
144253737|NCT02499263|520130001|FG000|Overall Study|Participant's decision|3|||
144253738|NCT02499263|520130001|FG000|Overall Study|Pregnancy|1|||
144253739|NCT04126317|520130020|FG000|Overall Study|Adverse Event|0|||
144253740|NCT04126317|520130021|FG001|Overall Study|Adverse Event|1|||
144448021|NCT02460224|520839111|FG018|Overall Study|Subject/guardian decision|2|||
144448022|NCT02460224|520839112|FG019|Overall Study|Subject/guardian decision|0|||
144448023|NCT02460224|520839113|FG020|Overall Study|Subject/guardian decision|0|||
144448024|NCT02460224|520839114|FG021|Overall Study|Subject/guardian decision|1|||
144533323|NCT03582033|521155420|FG008|Part A|Withdrawal by Subject|0|||
144253741|NCT04126317|520130020|FG000|Overall Study|Withdrawal by Subject|4|||
144448025|NCT02460224|520839115|FG022|Overall Study|Subject/guardian decision|0|||
144448026|NCT02460224|520839116|FG023|Overall Study|Subject/guardian decision|0|||
144448027|NCT02460224|520839117|FG024|Overall Study|Subject/guardian decision|0|||
144448028|NCT02460224|520839118|FG025|Overall Study|Subject/guardian decision|0|||
144533324|NCT03582033|521155421|FG009|Part A|Withdrawal by Subject|0|||
144448029|NCT02460224|520839119|FG026|Overall Study|Subject/guardian decision|6|||
144448030|NCT02460224|520839120|FG027|Overall Study|Subject/guardian decision|2|||
144448031|NCT02460224|520839121|FG028|Overall Study|Subject/guardian decision|3|||
144533325|NCT03582033|521155412|FG000|Part B|Death|0|||
144448032|NCT03146650|520839122|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
144448033|NCT03146650|520839122|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
144448034|NCT03146650|520839122|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
144448035|NCT03146650|520839122|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
144448036|NCT03146650|520839122|FG000|2 Year Follow-up|Death|11|||
144448037|NCT03146650|520839122|FG000|2 Year Follow-up|Still in follow-up|7|||
144448038|NCT03146650|520839122|FG000|2 Year Follow-up|Lost to Follow-up|1|||
144448039|NCT02517905|520839125|FG000|Overall Study|Lost to Follow-up|4|||
144448040|NCT02517905|520839126|FG001|Overall Study|Lost to Follow-up|0|||
144448041|NCT02517905|520839125|FG000|Overall Study|Withdrawal by Subject|4|||
144448042|NCT02517905|520839126|FG001|Overall Study|Withdrawal by Subject|0|||
144448043|NCT02517905|520839125|FG000|Overall Study|Screen failure|2|||
144448044|NCT02517905|520839126|FG001|Overall Study|Screen failure|2|||
144448045|NCT00459134|520839129|FG000|Overall Study|Physician Decision|1|||
144448046|NCT00459134|520839130|FG001|Overall Study|Physician Decision|1|||
144448047|NCT00459134|520839129|FG000|Overall Study|Withdrawal by Subject|8|||
144448048|NCT00459134|520839130|FG001|Overall Study|Withdrawal by Subject|7|||
144448049|NCT00459134|520839129|FG000|Overall Study|Lost to Follow-up|6|||
144448050|NCT00459134|520839130|FG001|Overall Study|Lost to Follow-up|7|||
144448051|NCT00459134|520839129|FG000|Overall Study|Surgery|1|||
144448052|NCT00459134|520839130|FG001|Overall Study|Surgery|2|||
144448053|NCT00459134|520839129|FG000|Overall Study|Toxicity|4|||
144448054|NCT00459134|520839130|FG001|Overall Study|Toxicity|5|||
144448055|NCT00459134|520839129|FG000|Overall Study|Progression|1|||
144448056|NCT00459134|520839130|FG001|Overall Study|Progression|0|||
144448057|NCT00459134|520839129|FG000|Overall Study|Multiple Reasons|2|||
144448058|NCT00459134|520839130|FG001|Overall Study|Multiple Reasons|3|||
144448059|NCT01755416|520839131|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
144448060|NCT01755416|520839132|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
144448061|NCT00441337|520839133|FG000|Overall Study|Disease Progression|6|||
144448062|NCT00441337|520839134|FG001|Overall Study|Disease Progression|6|||
144448063|NCT00441337|520839135|FG002|Overall Study|Disease Progression|4|||
144448064|NCT00441337|520839136|FG003|Overall Study|Disease Progression|18|||
144448065|NCT00441337|520839133|FG000|Overall Study|Lost to Follow-up|0|||
144448066|NCT00441337|520839134|FG001|Overall Study|Lost to Follow-up|0|||
144448067|NCT00441337|520839135|FG002|Overall Study|Lost to Follow-up|0|||
144448068|NCT00441337|520839136|FG003|Overall Study|Lost to Follow-up|1|||
144448069|NCT00441337|520839133|FG000|Overall Study|Sponsor Decision|0|||
144448070|NCT00441337|520839134|FG001|Overall Study|Sponsor Decision|0|||
144448071|NCT00441337|520839135|FG002|Overall Study|Sponsor Decision|1|||
144448072|NCT00441337|520839136|FG003|Overall Study|Sponsor Decision|2|||
144448073|NCT00441337|520839133|FG000|Overall Study|Did not meet inclusion criteria|0|||
144448074|NCT00441337|520839134|FG001|Overall Study|Did not meet inclusion criteria|0|||
144448075|NCT00441337|520839135|FG002|Overall Study|Did not meet inclusion criteria|1|||
144448076|NCT00441337|520839136|FG003|Overall Study|Did not meet inclusion criteria|0|||
144448077|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
144448078|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
144448079|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
144448080|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Death|1|||
144448081|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Death|0|||
144448082|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Death|0|||
144448083|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
144448084|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
144448085|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
144448086|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
144448087|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
144448088|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
144448089|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
144448090|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
144448091|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
144448092|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
144448093|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
144448094|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
144448095|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
144448096|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
144448097|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
144448098|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
144448099|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
144448100|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
144448101|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
144448102|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
144533326|NCT03582033|521155413|FG001|Part B|Death|0|||
144448103|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
144448104|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
144448105|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
144448106|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
144448107|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
144448108|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
144448109|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
144448110|NCT03655236|520839137|FG000|Subject Disposition in Part 1 Period|Other|0|||
144448111|NCT03655236|520839138|FG001|Subject Disposition in Part 1 Period|Other|2|||
144448112|NCT03655236|520839139|FG002|Subject Disposition in Part 1 Period|Other|2|||
144448113|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
144448114|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
144448115|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
144448116|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
144448117|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
144448118|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
144448119|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
144448120|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
144448121|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
144448122|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
144448123|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
144448124|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
144448125|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
144448126|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
144448127|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
144448128|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
144448129|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
144448130|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
144448131|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
144448132|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
144448133|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
144448134|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
144448135|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
144448136|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
144448137|NCT03655236|520839137|FG000|Subject Disposition in Part 2 Period|Other|1|||
144448138|NCT03655236|520839138|FG001|Subject Disposition in Part 2 Period|Other|0|||
144448139|NCT03655236|520839139|FG002|Subject Disposition in Part 2 Period|Other|0|||
144472216|NCT01889186|520926707|FG000|Overall Study|Progressive disease- Richter's|12|||
144472217|NCT01889186|520926708|FG001|Overall Study|Progressive disease- Richter's|7|||
144472218|NCT01889186|520926707|FG000|Overall Study|Progressive disease per protocol|46|||
144472219|NCT01889186|520926708|FG001|Overall Study|Progressive disease per protocol|17|||
144472220|NCT01889186|520926707|FG000|Overall Study|Stem cell transplant|2|||
144472221|NCT01889186|520926708|FG001|Overall Study|Stem cell transplant|1|||
144472222|NCT01889186|520926707|FG000|Overall Study|Withdrew consent|2|||
144472223|NCT01889186|520926708|FG001|Overall Study|Withdrew consent|3|||
144472224|NCT01889186|520926707|FG000|Overall Study|Other, not specified|18|||
144472225|NCT01889186|520926708|FG001|Overall Study|Other, not specified|15|||
144472226|NCT01281202|520926721|FG000|Overall Study|Adverse Event|2|||
144472227|NCT01281202|520926722|FG001|Overall Study|Adverse Event|0|||
144472228|NCT01281202|520926721|FG000|Overall Study|Withdrawal by Subject|2|||
144472229|NCT01281202|520926722|FG001|Overall Study|Withdrawal by Subject|2|||
144472230|NCT01281202|520926721|FG000|Overall Study|Protocol Violation|11|||
144472231|NCT01281202|520926722|FG001|Overall Study|Protocol Violation|10|||
144472232|NCT01281202|520926721|FG000|Overall Study|Administrative|2|||
144472233|NCT01281202|520926722|FG001|Overall Study|Administrative|8|||
144472234|NCT01281202|520926721|FG000|Overall Study|Lost to Follow-up|11|||
144472235|NCT01281202|520926722|FG001|Overall Study|Lost to Follow-up|13|||
144472236|NCT01281202|520926721|FG000|Overall Study|Incarceration|0|||
144472237|NCT01281202|520926722|FG001|Overall Study|Incarceration|3|||
144472238|NCT04711603|520926726|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
144472239|NCT04711603|520926727|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
144533327|NCT03582033|521155414|FG002|Part B|Death|0|||
144533328|NCT03582033|521155415|FG003|Part B|Death|0|||
144533329|NCT03582033|521155416|FG004|Part B|Death|0|||
144533330|NCT03582033|521155417|FG005|Part B|Death|2|||
144533331|NCT03582033|521155418|FG006|Part B|Death|0|||
144533332|NCT03582033|521155419|FG007|Part B|Death|0|||
144533333|NCT03582033|521155420|FG008|Part B|Death|0|||
144533334|NCT03582033|521155421|FG009|Part B|Death|0|||
144533335|NCT03582033|521155412|FG000|Part B|Study terminated by sponsor|0|||
144448140|NCT04258839|520840683|FG000|Overall Study|Adverse Event|2|||
144448141|NCT04258839|520840684|FG001|Overall Study|Adverse Event|4|||
144448142|NCT04258839|520840683|FG000|Overall Study|Lack of Efficacy|0|||
144448143|NCT04258839|520840684|FG001|Overall Study|Lack of Efficacy|2|||
144448144|NCT04258839|520840683|FG000|Overall Study|Lost to Follow-up|2|||
144448145|NCT04258839|520840684|FG001|Overall Study|Lost to Follow-up|0|||
144448146|NCT04258839|520840683|FG000|Overall Study|Withdrawal by Subject|1|||
144448147|NCT04258839|520840684|FG001|Overall Study|Withdrawal by Subject|2|||
144448148|NCT04258839|520840683|FG000|Overall Study|Withdrawal by Caregiver|5|||
144448149|NCT04258839|520840684|FG001|Overall Study|Withdrawal by Caregiver|6|||
144448150|NCT04258839|520840683|FG000|Overall Study|Reason not Specified|0|||
144448151|NCT04258839|520840684|FG001|Overall Study|Reason not Specified|1|||
144448152|NCT02805257|520840687|FG000|Overall Study|Lost to Follow-up|7|||
144448153|NCT02805257|520840688|FG001|Overall Study|Lost to Follow-up|6|||
144448154|NCT02805257|520840687|FG000|Overall Study|Death|0|||
144448155|NCT02805257|520840688|FG001|Overall Study|Death|1|||
144448156|NCT01627249|520840690|FG000|Overall Study|Death|3|||
144448157|NCT01627249|520840691|FG001|Overall Study|Death|5|||
144448158|NCT01627249|520840692|FG002|Overall Study|Death|3|||
144448159|NCT01627249|520840690|FG000|Overall Study|Withdrawal by Subject|12|||
144448160|NCT01627249|520840691|FG001|Overall Study|Withdrawal by Subject|6|||
144448161|NCT01627249|520840692|FG002|Overall Study|Withdrawal by Subject|9|||
144448162|NCT01627249|520840690|FG000|Overall Study|Missed Visit|1|||
144448163|NCT01627249|520840691|FG001|Overall Study|Missed Visit|1|||
144448164|NCT01627249|520840692|FG002|Overall Study|Missed Visit|0|||
144448165|NCT02886572|520840693|FG000|Overall Study|Death|8|||
144448166|NCT02932891|520840702|FG000|Overall Study|Lost to Follow-up|2|||
144448167|NCT02932891|520840702|FG000|Overall Study|HPA Suppress|2|||
144448168|NCT00563797|520840703|FG000|Overall Study|Lost to Follow-up|7|||
144448169|NCT00563797|520840704|FG001|Overall Study|Lost to Follow-up|2|||
144448170|NCT00530023|520840707|FG000|Overall Study|Withdrawal by Subject|0|||
144448171|NCT00530023|520840708|FG001|Overall Study|Withdrawal by Subject|1|||
144448172|NCT03095417|520840711|FG000|Overall Study|missed|1|||
144448173|NCT03095417|520840712|FG001|Overall Study|missed|2|||
144448174|NCT03095417|520840713|FG002|Overall Study|missed|0|||
144448175|NCT03095417|520840714|FG003|Overall Study|missed|1|||
144448176|NCT03095417|520840711|FG000|Overall Study|Lost to Follow-up|2|||
144448177|NCT03095417|520840712|FG001|Overall Study|Lost to Follow-up|2|||
144448178|NCT03095417|520840713|FG002|Overall Study|Lost to Follow-up|1|||
144448179|NCT03095417|520840714|FG003|Overall Study|Lost to Follow-up|0|||
144448180|NCT03095417|520840711|FG000|Overall Study|refusal|0|||
144448181|NCT03095417|520840712|FG001|Overall Study|refusal|1|||
144448182|NCT03095417|520840713|FG002|Overall Study|refusal|0|||
144448183|NCT03095417|520840714|FG003|Overall Study|refusal|1|||
144448184|NCT03095417|520840711|FG000|Overall Study|Withdrawal by Subject|8|||
144448185|NCT03095417|520840712|FG001|Overall Study|Withdrawal by Subject|2|||
144448186|NCT03095417|520840713|FG002|Overall Study|Withdrawal by Subject|5|||
144448187|NCT03095417|520840714|FG003|Overall Study|Withdrawal by Subject|4|||
144448188|NCT03095417|520840711|FG000|Overall Study|Physician Decision|1|||
144448189|NCT03095417|520840712|FG001|Overall Study|Physician Decision|2|||
144448190|NCT03095417|520840713|FG002|Overall Study|Physician Decision|2|||
144448191|NCT03095417|520840714|FG003|Overall Study|Physician Decision|2|||
144448192|NCT03095417|520840711|FG000|Overall Study|Death|1|||
144448193|NCT03095417|520840712|FG001|Overall Study|Death|2|||
144448194|NCT03095417|520840713|FG002|Overall Study|Death|1|||
144448195|NCT03095417|520840714|FG003|Overall Study|Death|3|||
144448196|NCT02571452|520840715|FG000|Overall Study Treatment|Protocol Violation|0|||
144448197|NCT02571452|520840716|FG001|Overall Study Treatment|Protocol Violation|1|||
144606482|NCT01994382|521420998|FG005|Overall Study|Withdrawal by Subject|0|||
144606483|NCT01994382|521420999|FG006|Overall Study|Withdrawal by Subject|0|||
144606484|NCT01994382|521421000|FG007|Overall Study|Withdrawal by Subject|0|||
144448198|NCT02571452|520840715|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
144448199|NCT02571452|520840716|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
144448200|NCT02571452|520840715|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
144448201|NCT02571452|520840716|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
144448202|NCT01877421|520840717|FG000|Phase 2|Lost to Follow-up|0|||
144448203|NCT01877421|520840718|FG001|Phase 2|Lost to Follow-up|0|||
144448204|NCT01877421|520840719|FG002|Phase 2|Lost to Follow-up|0|||
144448205|NCT01877421|520840720|FG003|Phase 2|Lost to Follow-up|0|||
144606485|NCT01994382|521421001|FG008|Overall Study|Withdrawal by Subject|0|||
144448206|NCT01877421|520840721|FG004|Phase 2|Lost to Follow-up|0|||
144448207|NCT01877421|520840722|FG005|Phase 2|Lost to Follow-up|0|||
144448208|NCT01877421|520840723|FG006|Phase 2|Lost to Follow-up|1|||
144448209|NCT01877421|520840724|FG007|Phase 2|Lost to Follow-up|0|||
144448210|NCT01877421|520840725|FG008|Phase 2|Lost to Follow-up|0|||
144448211|NCT01877421|520840726|FG009|Phase 2|Lost to Follow-up|0|||
144448212|NCT01877421|520840727|FG010|Phase 2|Lost to Follow-up|0|||
144448213|NCT01877421|520840728|FG011|Phase 2|Lost to Follow-up|0|||
144448214|NCT01877421|520840729|FG012|Phase 2|Lost to Follow-up|0|||
144448215|NCT01877421|520840730|FG013|Phase 2|Lost to Follow-up|0|||
144448216|NCT01877421|520840731|FG014|Phase 2|Lost to Follow-up|0|||
144533336|NCT03582033|521155413|FG001|Part B|Study terminated by sponsor|0|||
144253742|NCT04126317|520130021|FG001|Overall Study|Withdrawal by Subject|1|||
144253743|NCT00424593|520130024|FG000|Acute Double-Blind Period|Adverse Event|16|||
144253744|NCT00424593|520130025|FG001|Acute Double-Blind Period|Adverse Event|7|||
144253745|NCT00424593|520130024|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
144253746|NCT00424593|520130025|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
144253747|NCT00424593|520130024|FG000|Acute Double-Blind Period|Protocol Violation|2|||
144253748|NCT00424593|520130025|FG001|Acute Double-Blind Period|Protocol Violation|2|||
144253749|NCT00424593|520130024|FG000|Acute Double-Blind Period|Physician Decision|1|||
144253750|NCT00424593|520130025|FG001|Acute Double-Blind Period|Physician Decision|2|||
144253751|NCT00424593|520130024|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
144253752|NCT00424593|520130025|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
144253753|NCT00424593|520130024|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
144253754|NCT00424593|520130025|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
144253755|NCT00424593|520130024|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
144253756|NCT00424593|520130025|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
144253757|NCT00424593|520130024|FG000|Dose-Blind Extension Period|Adverse Event|18|||
144253758|NCT00424593|520130025|FG001|Dose-Blind Extension Period|Adverse Event|0|||
144253759|NCT00424593|520130024|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
144253760|NCT00424593|520130025|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
144253761|NCT00424593|520130024|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
144253762|NCT00424593|520130025|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
144253763|NCT00424593|520130024|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
144253764|NCT00424593|520130025|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
144253765|NCT00424593|520130024|FG000|Dose-Blind Extension Period|Physician Decision|3|||
144533337|NCT03582033|521155414|FG002|Part B|Study terminated by sponsor|0|||
144533338|NCT03582033|521155415|FG003|Part B|Study terminated by sponsor|0|||
144533339|NCT03582033|521155416|FG004|Part B|Study terminated by sponsor|0|||
144533340|NCT03582033|521155417|FG005|Part B|Study terminated by sponsor|12|||
144533341|NCT03582033|521155418|FG006|Part B|Study terminated by sponsor|0|||
144533342|NCT03582033|521155419|FG007|Part B|Study terminated by sponsor|0|||
144533343|NCT03582033|521155420|FG008|Part B|Study terminated by sponsor|0|||
144533344|NCT03582033|521155421|FG009|Part B|Study terminated by sponsor|0|||
144533345|NCT03582033|521155412|FG000|Part B|Withdrawal by Subject|0|||
144533346|NCT03582033|521155413|FG001|Part B|Withdrawal by Subject|0|||
144533347|NCT03582033|521155414|FG002|Part B|Withdrawal by Subject|0|||
144533348|NCT03582033|521155415|FG003|Part B|Withdrawal by Subject|0|||
144533349|NCT03582033|521155416|FG004|Part B|Withdrawal by Subject|0|||
144533350|NCT03582033|521155417|FG005|Part B|Withdrawal by Subject|6|||
144533351|NCT03582033|521155418|FG006|Part B|Withdrawal by Subject|0|||
144533352|NCT03582033|521155419|FG007|Part B|Withdrawal by Subject|0|||
144533353|NCT03582033|521155420|FG008|Part B|Withdrawal by Subject|0|||
144533354|NCT03582033|521155421|FG009|Part B|Withdrawal by Subject|0|||
144533355|NCT03582033|521155412|FG000|Part C|Other|0|||
144533356|NCT03582033|521155413|FG001|Part C|Other|0|||
144533357|NCT03582033|521155414|FG002|Part C|Other|0|||
144533358|NCT03582033|521155415|FG003|Part C|Other|0|||
144533359|NCT03582033|521155416|FG004|Part C|Other|0|||
144533360|NCT03582033|521155417|FG005|Part C|Other|0|||
144533361|NCT03582033|521155418|FG006|Part C|Other|2|||
144533362|NCT03582033|521155419|FG007|Part C|Other|0|||
144533363|NCT03582033|521155420|FG008|Part C|Other|0|||
144533364|NCT03582033|521155421|FG009|Part C|Other|0|||
144533365|NCT03582033|521155412|FG000|Part C|Death|0|||
144533366|NCT03582033|521155413|FG001|Part C|Death|0|||
144533367|NCT03582033|521155414|FG002|Part C|Death|0|||
144533368|NCT03582033|521155415|FG003|Part C|Death|0|||
144533369|NCT03582033|521155416|FG004|Part C|Death|0|||
144533370|NCT03582033|521155417|FG005|Part C|Death|0|||
144533371|NCT03582033|521155418|FG006|Part C|Death|6|||
144533372|NCT03582033|521155419|FG007|Part C|Death|1|||
144533373|NCT03582033|521155420|FG008|Part C|Death|2|||
144533374|NCT03582033|521155421|FG009|Part C|Death|0|||
144725264|NCT02581345|521851211|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
144253766|NCT00424593|520130025|FG001|Dose-Blind Extension Period|Physician Decision|0|||
144533375|NCT03582033|521155412|FG000|Part C|Study terminated by sponsor|0|||
144533376|NCT03582033|521155413|FG001|Part C|Study terminated by sponsor|0|||
144253767|NCT02985021|520130026|FG000|Overall Study|Inability to comply with study procedures|1|||
144253768|NCT02734862|520130028|FG000|Part A|Death|3|||
144253769|NCT02734862|520130029|FG001|Part A|Death|4|||
144253770|NCT02734862|520130030|FG002|Part A|Death|6|||
144253771|NCT02734862|520130028|FG000|Part A|Lost to Follow-up|2|||
144253772|NCT02734862|520130029|FG001|Part A|Lost to Follow-up|1|||
144533377|NCT03582033|521155414|FG002|Part C|Study terminated by sponsor|0|||
144533378|NCT03582033|521155415|FG003|Part C|Study terminated by sponsor|0|||
144253773|NCT02734862|520130030|FG002|Part A|Lost to Follow-up|1|||
144533379|NCT03582033|521155416|FG004|Part C|Study terminated by sponsor|0|||
144253774|NCT02734862|520130028|FG000|Part A|Withdrawal by Subject|1|||
144533380|NCT03582033|521155417|FG005|Part C|Study terminated by sponsor|0|||
144533381|NCT03582033|521155418|FG006|Part C|Study terminated by sponsor|3|||
144725265|NCT02581345|521851212|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
144725266|NCT02581345|521851213|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
144725267|NCT02581345|521851210|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
144725268|NCT02581345|521851211|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
144725269|NCT02581345|521851212|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
144725270|NCT02581345|521851213|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
144725271|NCT02581345|521851210|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
144725272|NCT02581345|521851211|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
144725273|NCT02581345|521851212|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
144725274|NCT02581345|521851213|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
144725275|NCT02581345|521851210|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
144725276|NCT02581345|521851211|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
144725277|NCT02581345|521851212|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
144725278|NCT02581345|521851213|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
144725279|NCT02581345|521851210|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
144725280|NCT02581345|521851211|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
144725281|NCT02581345|521851212|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
144725282|NCT02581345|521851213|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
144725283|NCT02581345|521851210|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
144725284|NCT02581345|521851211|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
144725285|NCT02581345|521851212|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
144194224|NCT00754442|519906437|FG001|Overall Study|Withdrawal by Subject|3|||
144194225|NCT04479475|519906438|FG000|Overall Study|Withdrawal by Subject|7|||
144194226|NCT00296491|519906439|FG000|Overall Study|Low Pollen Counts|18|||
144194227|NCT00296491|519906440|FG001|Overall Study|Low Pollen Counts|26|||
144448217|NCT01877421|520840732|FG015|Phase 2|Lost to Follow-up|0|||
144448218|NCT01877421|520840733|FG016|Phase 2|Lost to Follow-up|0|||
144448219|NCT01877421|520840734|FG017|Phase 2|Lost to Follow-up|0|||
144448220|NCT01877421|520840717|FG000|Phase 2|Withdrawal by Subject|0|||
144448221|NCT01877421|520840718|FG001|Phase 2|Withdrawal by Subject|0|||
144448222|NCT01877421|520840719|FG002|Phase 2|Withdrawal by Subject|0|||
144448223|NCT01877421|520840720|FG003|Phase 2|Withdrawal by Subject|0|||
144448224|NCT01877421|520840721|FG004|Phase 2|Withdrawal by Subject|0|||
144448225|NCT01877421|520840722|FG005|Phase 2|Withdrawal by Subject|0|||
144448226|NCT01877421|520840723|FG006|Phase 2|Withdrawal by Subject|0|||
144448227|NCT01877421|520840724|FG007|Phase 2|Withdrawal by Subject|0|||
144448228|NCT01877421|520840725|FG008|Phase 2|Withdrawal by Subject|1|||
144448229|NCT01877421|520840726|FG009|Phase 2|Withdrawal by Subject|0|||
144448230|NCT01877421|520840727|FG010|Phase 2|Withdrawal by Subject|1|||
144448231|NCT01877421|520840728|FG011|Phase 2|Withdrawal by Subject|0|||
144448232|NCT01877421|520840729|FG012|Phase 2|Withdrawal by Subject|1|||
144448233|NCT01877421|520840730|FG013|Phase 2|Withdrawal by Subject|0|||
144448234|NCT01877421|520840731|FG014|Phase 2|Withdrawal by Subject|0|||
144448235|NCT01877421|520840732|FG015|Phase 2|Withdrawal by Subject|1|||
144448236|NCT01877421|520840733|FG016|Phase 2|Withdrawal by Subject|0|||
144448237|NCT01877421|520840734|FG017|Phase 2|Withdrawal by Subject|0|||
144448238|NCT01877421|520840717|FG000|Phase 2|Protocol Violation|0|||
144448239|NCT01877421|520840718|FG001|Phase 2|Protocol Violation|0|||
144448240|NCT01877421|520840719|FG002|Phase 2|Protocol Violation|0|||
144448241|NCT01877421|520840720|FG003|Phase 2|Protocol Violation|0|||
144448242|NCT01877421|520840721|FG004|Phase 2|Protocol Violation|0|||
144448243|NCT01877421|520840722|FG005|Phase 2|Protocol Violation|0|||
144448244|NCT01877421|520840723|FG006|Phase 2|Protocol Violation|0|||
144448245|NCT01877421|520840724|FG007|Phase 2|Protocol Violation|0|||
144448246|NCT01877421|520840725|FG008|Phase 2|Protocol Violation|0|||
144448247|NCT01877421|520840726|FG009|Phase 2|Protocol Violation|0|||
144448248|NCT01877421|520840727|FG010|Phase 2|Protocol Violation|1|||
144448249|NCT01877421|520840728|FG011|Phase 2|Protocol Violation|0|||
144448250|NCT01877421|520840729|FG012|Phase 2|Protocol Violation|0|||
144448251|NCT01877421|520840730|FG013|Phase 2|Protocol Violation|0|||
144448252|NCT01877421|520840731|FG014|Phase 2|Protocol Violation|0|||
144448253|NCT01877421|520840732|FG015|Phase 2|Protocol Violation|0|||
144448254|NCT01877421|520840733|FG016|Phase 2|Protocol Violation|0|||
144448255|NCT01877421|520840734|FG017|Phase 2|Protocol Violation|0|||
144448256|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
144725286|NCT02581345|521851213|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
144725287|NCT02581345|521851210|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
144725288|NCT02581345|521851211|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
144725289|NCT02581345|521851212|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
144448257|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
144448258|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
144448259|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
144725290|NCT02581345|521851213|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
144448260|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
144448261|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
144448262|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
144194228|NCT00296491|519906441|FG002|Overall Study|Low Pollen Counts|25|||
144194229|NCT00296491|519906442|FG003|Overall Study|Low Pollen Counts|16|||
144194230|NCT00296491|519906439|FG000|Overall Study|Protocol Violation|4|||
144194231|NCT00296491|519906440|FG001|Overall Study|Protocol Violation|6|||
144194232|NCT00296491|519906441|FG002|Overall Study|Protocol Violation|2|||
144194233|NCT00296491|519906442|FG003|Overall Study|Protocol Violation|3|||
144194234|NCT00296491|519906439|FG000|Overall Study|Adverse Event|1|||
144194235|NCT00296491|519906440|FG001|Overall Study|Adverse Event|3|||
144194236|NCT00296491|519906441|FG002|Overall Study|Adverse Event|1|||
144194237|NCT00296491|519906442|FG003|Overall Study|Adverse Event|4|||
144194238|NCT00296491|519906439|FG000|Overall Study|Withdrawn due to Asthma|0|||
144194239|NCT00296491|519906440|FG001|Overall Study|Withdrawn due to Asthma|0|||
144194240|NCT00296491|519906441|FG002|Overall Study|Withdrawn due to Asthma|0|||
144194241|NCT00296491|519906442|FG003|Overall Study|Withdrawn due to Asthma|4|||
144194242|NCT00296491|519906439|FG000|Overall Study|Withdrawal by Subject|7|||
144194243|NCT00296491|519906440|FG001|Overall Study|Withdrawal by Subject|3|||
144194244|NCT00296491|519906441|FG002|Overall Study|Withdrawal by Subject|3|||
144194245|NCT00296491|519906442|FG003|Overall Study|Withdrawal by Subject|2|||
144194246|NCT00296491|519906439|FG000|Overall Study|Non-Compliance|12|||
144194247|NCT00296491|519906440|FG001|Overall Study|Non-Compliance|13|||
144194248|NCT00296491|519906441|FG002|Overall Study|Non-Compliance|10|||
144194249|NCT00296491|519906442|FG003|Overall Study|Non-Compliance|14|||
144194250|NCT00296491|519906439|FG000|Overall Study|Lost to Follow-up|0|||
144194251|NCT00296491|519906440|FG001|Overall Study|Lost to Follow-up|2|||
144194252|NCT00296491|519906441|FG002|Overall Study|Lost to Follow-up|2|||
144194253|NCT00296491|519906442|FG003|Overall Study|Lost to Follow-up|0|||
144194254|NCT06972251|519906445|FG000|Overall Study|Withdrawal by Subject|1|||
144194255|NCT06972251|519906446|FG001|Overall Study|Withdrawal by Subject|0|||
144194256|NCT06972251|519906445|FG000|Overall Study|Lost to Follow-up|10|||
144194257|NCT06972251|519906446|FG001|Overall Study|Lost to Follow-up|2|||
144194258|NCT04572243|519906447|FG000|Core Study: 14 Weeks|Adverse Event|1|||
144194259|NCT04572243|519906448|FG001|Core Study: 14 Weeks|Adverse Event|2|||
144194260|NCT04572243|519906449|FG002|Core Study: 14 Weeks|Adverse Event|0|||
144194261|NCT04572243|519906450|FG003|Core Study: 14 Weeks|Adverse Event|0|||
144194262|NCT04572243|519906447|FG000|Core Study: 14 Weeks|Subject choice|0|||
144194263|NCT04572243|519906448|FG001|Core Study: 14 Weeks|Subject choice|2|||
144194264|NCT04572243|519906449|FG002|Core Study: 14 Weeks|Subject choice|0|||
144194265|NCT04572243|519906450|FG003|Core Study: 14 Weeks|Subject choice|0|||
144194266|NCT04572243|519906447|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
144194267|NCT04572243|519906448|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
144194268|NCT04572243|519906449|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
144194269|NCT04572243|519906450|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
144194270|NCT04572243|519906447|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
144194271|NCT04572243|519906448|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
144194272|NCT04572243|519906449|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
144194273|NCT04572243|519906450|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
144448263|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
144448264|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
144448265|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
144448266|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
144448267|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
144448268|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
144448269|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
144448270|NCT02464969|520840735|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
144448271|NCT02464969|520840736|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
144448272|NCT02464969|520840735|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
144448273|NCT02464969|520840736|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
144448274|NCT02464969|520840735|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
144448275|NCT02464969|520840736|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
144448276|NCT02464969|520840735|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
144448277|NCT02464969|520840736|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
144448278|NCT00908960|520840739|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
144606486|NCT01994382|521421002|FG009|Overall Study|Withdrawal by Subject|0|||
144194274|NCT01661881|519906451|FG000|Overall Study|Disease Progression|1|||
144606487|NCT01994382|521421003|FG010|Overall Study|Withdrawal by Subject|6|||
144606488|NCT01994382|521421004|FG011|Overall Study|Withdrawal by Subject|0|||
144194275|NCT01231373|519906452|FG000|Overall Study|Withdrew consent prior to randomization|2|||
144194276|NCT01231373|519906453|FG001|Overall Study|Withdrew consent prior to randomization|1|||
144194277|NCT01231373|519906454|FG002|Overall Study|Withdrew consent prior to randomization|0|||
144606489|NCT01994382|521421005|FG012|Overall Study|Withdrawal by Subject|2|||
144253775|NCT02734862|520130029|FG001|Part A|Withdrawal by Subject|1|||
144253776|NCT02734862|520130030|FG002|Part A|Withdrawal by Subject|2|||
144194278|NCT01231373|519906455|FG003|Overall Study|Withdrew consent prior to randomization|0|||
144194279|NCT01231373|519906452|FG000|Overall Study|Lost to Follow-up|0|||
144448279|NCT00908960|520840740|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
144448280|NCT00908960|520840741|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
144448281|NCT02399085|520840742|FG000|Overall Study|Adverse Event|16|||
144448282|NCT02399085|520840742|FG000|Overall Study|Death|2|||
144448283|NCT02399085|520840742|FG000|Overall Study|Withdrawal by Subject|8|||
144448284|NCT02399085|520840742|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
144448285|NCT02399085|520840742|FG000|Overall Study|Physician Decision|5|||
144448286|NCT01158924|520840744|FG000|Overall Study|Withdrawal by Subject|1|||
144448287|NCT01158924|520840745|FG001|Overall Study|Withdrawal by Subject|2|||
144448288|NCT01158924|520840744|FG000|Overall Study|Lost to Follow-up|0|||
144448289|NCT01158924|520840745|FG001|Overall Study|Lost to Follow-up|1|||
144448290|NCT03795922|520840746|FG000|Overall Study|Adverse Event|2|||
144448291|NCT03795922|520840747|FG001|Overall Study|Adverse Event|1|||
144448292|NCT03795922|520840746|FG000|Overall Study|Withdrawal by Subject|5|||
144606490|NCT01994382|521421006|FG013|Overall Study|Withdrawal by Subject|0|||
144606491|NCT01994382|521421007|FG014|Overall Study|Withdrawal by Subject|4|||
144606492|NCT01994382|521421008|FG015|Overall Study|Withdrawal by Subject|3|||
144606493|NCT01994382|521421009|FG016|Overall Study|Withdrawal by Subject|0|||
144606494|NCT01994382|521420993|FG000|Overall Study|Lost to Follow-up|0|||
144606495|NCT01994382|521420994|FG001|Overall Study|Lost to Follow-up|0|||
144606496|NCT01994382|521420995|FG002|Overall Study|Lost to Follow-up|0|||
144606497|NCT01994382|521420996|FG003|Overall Study|Lost to Follow-up|0|||
144606498|NCT01994382|521420997|FG004|Overall Study|Lost to Follow-up|0|||
144606499|NCT01994382|521420998|FG005|Overall Study|Lost to Follow-up|0|||
144606500|NCT01994382|521420999|FG006|Overall Study|Lost to Follow-up|0|||
144606501|NCT01994382|521421000|FG007|Overall Study|Lost to Follow-up|0|||
144606502|NCT01994382|521421001|FG008|Overall Study|Lost to Follow-up|0|||
144606503|NCT01994382|521421002|FG009|Overall Study|Lost to Follow-up|0|||
144606504|NCT01994382|521421003|FG010|Overall Study|Lost to Follow-up|1|||
144448293|NCT03795922|520840747|FG001|Overall Study|Withdrawal by Subject|13|||
144448294|NCT03795922|520840746|FG000|Overall Study|Lost to Follow-up|2|||
144448295|NCT03795922|520840747|FG001|Overall Study|Lost to Follow-up|3|||
144448296|NCT03795922|520840746|FG000|Overall Study|Pregnancy|0|||
144448297|NCT03795922|520840747|FG001|Overall Study|Pregnancy|1|||
144448298|NCT03795922|520840746|FG000|Overall Study|Physician Decision|1|||
144448299|NCT03795922|520840747|FG001|Overall Study|Physician Decision|2|||
144448300|NCT03795922|520840746|FG000|Overall Study|Protocol Violation|0|||
144448301|NCT03795922|520840747|FG001|Overall Study|Protocol Violation|1|||
144448302|NCT03795922|520840746|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
144448303|NCT03795922|520840747|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
144448304|NCT02480621|520840753|FG000|Randomization|Withdrawal by Subject|1|||
144448305|NCT02480621|520840754|FG001|Randomization|Withdrawal by Subject|0|||
144448306|NCT02480621|520840753|FG000|Randomization|Surgeon did not give intervention|0|||
144448307|NCT02480621|520840754|FG001|Randomization|Surgeon did not give intervention|1|||
144448308|NCT02480621|520840753|FG000|Follow Up|Lost to Follow-up|4|||
144448309|NCT02480621|520840754|FG001|Follow Up|Lost to Follow-up|2|||
144448310|NCT02520531|520840759|FG000|Overall Study|Revision of study device components|2|||
144448311|NCT02520531|520840760|FG001|Overall Study|Revision of study device components|2|||
144606505|NCT01994382|521421004|FG011|Overall Study|Lost to Follow-up|0|||
144606506|NCT01994382|521421005|FG012|Overall Study|Lost to Follow-up|0|||
144606507|NCT01994382|521421006|FG013|Overall Study|Lost to Follow-up|0|||
144606508|NCT01994382|521421007|FG014|Overall Study|Lost to Follow-up|0|||
144606509|NCT01994382|521421008|FG015|Overall Study|Lost to Follow-up|0|||
144606510|NCT01994382|521421009|FG016|Overall Study|Lost to Follow-up|0|||
144194280|NCT01231373|519906453|FG001|Overall Study|Lost to Follow-up|0|||
144448312|NCT02520531|520840759|FG000|Overall Study|Death|1|||
144448313|NCT02520531|520840760|FG001|Overall Study|Death|2|||
144448314|NCT02520531|520840759|FG000|Overall Study|Lost to Follow-up|1|||
144448315|NCT02520531|520840760|FG001|Overall Study|Lost to Follow-up|1|||
144448316|NCT02520531|520840759|FG000|Overall Study|Meet exclusion criterion|0|||
144448317|NCT02520531|520840760|FG001|Overall Study|Meet exclusion criterion|1|||
144448318|NCT02520531|520840759|FG000|Overall Study|Withdrawal by Subject|1|||
144448319|NCT02520531|520840760|FG001|Overall Study|Withdrawal by Subject|0|||
144448320|NCT02520531|520840759|FG000|Overall Study|Not study device|1|||
144448321|NCT02520531|520840760|FG001|Overall Study|Not study device|0|||
144606511|NCT01994382|521420993|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606512|NCT01994382|521420994|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606513|NCT01994382|521420995|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606514|NCT01994382|521420996|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144448322|NCT01752933|520840771|FG000|Treatment|Disease Progression|3|||
144448323|NCT01752933|520840772|FG001|Treatment|Disease Progression|29|||
144448324|NCT01752933|520840771|FG000|Treatment|Withdrawal by Subject|0|||
144448325|NCT01752933|520840772|FG001|Treatment|Withdrawal by Subject|5|||
144448326|NCT01752933|520840771|FG000|Treatment|Adverse Event|1|||
144448327|NCT01752933|520840772|FG001|Treatment|Adverse Event|4|||
144448328|NCT01752933|520840771|FG000|Treatment|Physician Decision|0|||
144448329|NCT01752933|520840772|FG001|Treatment|Physician Decision|3|||
144448330|NCT01752933|520840771|FG000|Treatment|Death|0|||
144448331|NCT01752933|520840772|FG001|Treatment|Death|2|||
144448332|NCT01752933|520840771|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
144448333|NCT01752933|520840772|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
144448334|NCT01752933|520840771|FG000|Treatment|Patient noncompliant|0|||
144448335|NCT01752933|520840772|FG001|Treatment|Patient noncompliant|1|||
144448336|NCT01752933|520840771|FG000|Treatment|Patient unable to travel to appointments|0|||
144448337|NCT01752933|520840772|FG001|Treatment|Patient unable to travel to appointments|1|||
144448338|NCT01752933|520840771|FG000|Overall Study and Follow-up|Death|4|||
144448339|NCT01752933|520840772|FG001|Overall Study and Follow-up|Death|34|||
144448340|NCT01752933|520840771|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
144448341|NCT01752933|520840772|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
144448342|NCT01752933|520840771|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
144448343|NCT01752933|520840772|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
144448344|NCT01752933|520840771|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
144448345|NCT01752933|520840772|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
144448346|NCT01591681|520840773|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
144448347|NCT01591681|520840773|FG000|Overall Study|Failed to use system during run-in|1|||
144448348|NCT01649856|520840778|FG000|Overall Study|Withdrawal by Subject|14|||
144448349|NCT01649856|520840779|FG001|Overall Study|Withdrawal by Subject|14|||
144448350|NCT01649856|520840778|FG000|Overall Study|Protocol Violation|4|||
144448351|NCT01649856|520840779|FG001|Overall Study|Protocol Violation|4|||
144448352|NCT01649856|520840778|FG000|Overall Study|Treatment Failure|1|||
144448353|NCT01649856|520840779|FG001|Overall Study|Treatment Failure|1|||
144448354|NCT01649856|520840778|FG000|Overall Study|Death|69|||
144448355|NCT01649856|520840779|FG001|Overall Study|Death|34|||
144606515|NCT01994382|521420997|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606516|NCT01994382|521420998|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606517|NCT01994382|521420999|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606518|NCT01994382|521421000|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606519|NCT01994382|521421001|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606520|NCT01994382|521421002|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606521|NCT01994382|521421003|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
144606522|NCT01994382|521421004|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606523|NCT01994382|521421005|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
144606524|NCT01994382|521421006|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606525|NCT01994382|521421007|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
144606526|NCT01994382|521421008|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
144606527|NCT01994382|521421009|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
144606528|NCT01994382|521420993|FG000|Overall Study|Protocol violation/noncompliance|0|||
144606529|NCT01994382|521420994|FG001|Overall Study|Protocol violation/noncompliance|0|||
144606530|NCT01994382|521420995|FG002|Overall Study|Protocol violation/noncompliance|0|||
144448356|NCT01649856|520840778|FG000|Overall Study|Stable or Progressed Disease|5|||
144448357|NCT01649856|520840779|FG001|Overall Study|Stable or Progressed Disease|3|||
144448358|NCT01649856|520840778|FG000|Overall Study|Lost to Follow-up|20|||
144448359|NCT01649856|520840779|FG001|Overall Study|Lost to Follow-up|16|||
144448360|NCT01649856|520840778|FG000|Overall Study|Lack of Compliance|6|||
144448361|NCT01649856|520840779|FG001|Overall Study|Lack of Compliance|1|||
144448362|NCT01649856|520840778|FG000|Overall Study|Other|20|||
144606531|NCT01994382|521420996|FG003|Overall Study|Protocol violation/noncompliance|0|||
144606532|NCT01994382|521420997|FG004|Overall Study|Protocol violation/noncompliance|0|||
144606533|NCT01994382|521420998|FG005|Overall Study|Protocol violation/noncompliance|0|||
144606534|NCT01994382|521420999|FG006|Overall Study|Protocol violation/noncompliance|0|||
144606535|NCT01994382|521421000|FG007|Overall Study|Protocol violation/noncompliance|0|||
144606536|NCT01994382|521421001|FG008|Overall Study|Protocol violation/noncompliance|0|||
144606537|NCT01994382|521421002|FG009|Overall Study|Protocol violation/noncompliance|0|||
144194281|NCT01231373|519906454|FG002|Overall Study|Lost to Follow-up|0|||
144194282|NCT01231373|519906455|FG003|Overall Study|Lost to Follow-up|1|||
144194283|NCT01231373|519906452|FG000|Overall Study|Withdrew Consent|1|||
144194284|NCT01231373|519906453|FG001|Overall Study|Withdrew Consent|0|||
144194285|NCT01231373|519906454|FG002|Overall Study|Withdrew Consent|0|||
144194286|NCT01231373|519906455|FG003|Overall Study|Withdrew Consent|0|||
144194287|NCT00775606|519906460|FG000|Overall Study|Study sponsor terminated funding|3|||
144194288|NCT00775606|519906461|FG001|Overall Study|Study sponsor terminated funding|0|||
144194289|NCT03604341|519906462|FG000|Overall Study|Withdrawal by Subject|1|||
144194290|NCT03604341|519906463|FG001|Overall Study|Withdrawal by Subject|1|||
144194291|NCT03604341|519906462|FG000|Overall Study|Adverse Event|1|||
144194292|NCT03604341|519906463|FG001|Overall Study|Adverse Event|0|||
144194293|NCT03604341|519906462|FG000|Overall Study|Protocol Violation|0|||
144606538|NCT01994382|521421003|FG010|Overall Study|Protocol violation/noncompliance|0|||
144606539|NCT01994382|521421004|FG011|Overall Study|Protocol violation/noncompliance|1|||
144606540|NCT01994382|521421005|FG012|Overall Study|Protocol violation/noncompliance|0|||
144448363|NCT01649856|520840779|FG001|Overall Study|Other|5|||
144448364|NCT00179647|520840780|FG000|Overall Study|Adverse Event|294|||
144448365|NCT00179647|520840780|FG000|Overall Study|Lack of Efficacy|478|||
144448366|NCT00179647|520840780|FG000|Overall Study|Withdrawal by Subject|83|||
144448367|NCT00179647|520840780|FG000|Overall Study|Lost to Follow-up|4|||
144448368|NCT00179647|520840780|FG000|Overall Study|Death|94|||
144606541|NCT01994382|521421006|FG013|Overall Study|Protocol violation/noncompliance|0|||
144606542|NCT01994382|521421007|FG014|Overall Study|Protocol violation/noncompliance|0|||
144606543|NCT01994382|521421008|FG015|Overall Study|Protocol violation/noncompliance|0|||
144448369|NCT00179647|520840780|FG000|Overall Study|Other|960|||
144448370|NCT00622635|520840781|FG000|Treatment Period 1|Adverse Event|0|||
144448371|NCT00622635|520840782|FG001|Treatment Period 1|Adverse Event|0|||
144448372|NCT00622635|520840783|FG002|Treatment Period 1|Adverse Event|1|||
144448373|NCT00622635|520840784|FG003|Treatment Period 1|Adverse Event|0|||
144448374|NCT00622635|520840785|FG004|Treatment Period 1|Adverse Event|0|||
144448375|NCT00622635|520840786|FG005|Treatment Period 1|Adverse Event|0|||
144448376|NCT00622635|520840781|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144448377|NCT00622635|520840782|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144448378|NCT00622635|520840783|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144448379|NCT00622635|520840784|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144448380|NCT00622635|520840785|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144448381|NCT00622635|520840786|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144448382|NCT00622635|520840781|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
144448383|NCT00622635|520840782|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
144448384|NCT00622635|520840783|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
144448385|NCT00622635|520840784|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
144448386|NCT00622635|520840785|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
144448387|NCT00622635|520840786|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
144448388|NCT00622635|520840781|FG000|Treatment Period 2|Adverse Event|1|||
144448389|NCT00622635|520840782|FG001|Treatment Period 2|Adverse Event|0|||
144448390|NCT00622635|520840783|FG002|Treatment Period 2|Adverse Event|0|||
144448391|NCT00622635|520840784|FG003|Treatment Period 2|Adverse Event|0|||
144448392|NCT00622635|520840785|FG004|Treatment Period 2|Adverse Event|0|||
144448393|NCT00622635|520840786|FG005|Treatment Period 2|Adverse Event|0|||
144448394|NCT00622635|520840781|FG000|Treatment Period 3|Adverse Event|0|||
144448395|NCT00622635|520840782|FG001|Treatment Period 3|Adverse Event|0|||
144448396|NCT00622635|520840783|FG002|Treatment Period 3|Adverse Event|0|||
144448397|NCT00622635|520840784|FG003|Treatment Period 3|Adverse Event|2|||
144448398|NCT00622635|520840785|FG004|Treatment Period 3|Adverse Event|0|||
144448399|NCT00622635|520840786|FG005|Treatment Period 3|Adverse Event|0|||
144448400|NCT00622635|520840781|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144448401|NCT00622635|520840782|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144448402|NCT00622635|520840783|FG002|Treatment Period 3|Withdrawal by Subject|0|||
144448403|NCT00622635|520840784|FG003|Treatment Period 3|Withdrawal by Subject|1|||
144448404|NCT00622635|520840785|FG004|Treatment Period 3|Withdrawal by Subject|0|||
144448405|NCT00622635|520840786|FG005|Treatment Period 3|Withdrawal by Subject|0|||
144448406|NCT00835406|520840787|FG000|Period: First Intervention|Adverse Event|0|||
144448407|NCT00835406|520840788|FG001|Period: First Intervention|Adverse Event|1|||
144448408|NCT00835406|520840787|FG000|Period: First Intervention|Withdrawal by Subject|2|||
144448409|NCT00835406|520840788|FG001|Period: First Intervention|Withdrawal by Subject|0|||
144448410|NCT00835406|520840787|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
144448411|NCT00835406|520840788|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
144448412|NCT00281840|520840789|FG000|Overall Study|Adverse Event|12|||
144448413|NCT00281840|520840789|FG000|Overall Study|Physician Decision|6|||
144448414|NCT00281840|520840789|FG000|Overall Study|Withdrawal by Subject|3|||
144448415|NCT00281840|520840789|FG000|Overall Study|Disease Progression|2|||
144448416|NCT00281840|520840789|FG000|Overall Study|exceed maximum delay in treatment|1|||
144448417|NCT00281840|520840789|FG000|Overall Study|Complicating Disease|1|||
144448418|NCT02138214|520840792|FG000|Overall Study|Withdrawal by Subject|0|||
144448419|NCT02138214|520840793|FG001|Overall Study|Withdrawal by Subject|1|||
144448420|NCT02138214|520840794|FG002|Overall Study|Withdrawal by Subject|0|||
144448421|NCT02138214|520840792|FG000|Overall Study|Lost to Follow-up|0|||
144448422|NCT02138214|520840793|FG001|Overall Study|Lost to Follow-up|2|||
144448423|NCT02138214|520840794|FG002|Overall Study|Lost to Follow-up|4|||
144448424|NCT02138214|520840792|FG000|Overall Study|Screen Failure|0|||
144606544|NCT01994382|521421009|FG016|Overall Study|Protocol violation/noncompliance|2|||
144448425|NCT02138214|520840793|FG001|Overall Study|Screen Failure|1|||
144448426|NCT02138214|520840794|FG002|Overall Study|Screen Failure|0|||
144606545|NCT01994382|521420993|FG000|Overall Study|Rolled over to Phase 2a|0|||
144448427|NCT02185768|520840795|FG000|Overall Study|Patients were not treated|2|||
144448428|NCT03027466|520840800|FG000|Overall Study|Opting out of the app|1869|||
144448429|NCT03027466|520840801|FG001|Overall Study|Opting out of the app|1819|||
144448430|NCT03027466|520840802|FG002|Overall Study|Opting out of the app|1743|||
144448431|NCT03027466|520840803|FG003|Overall Study|Opting out of the app|1821|||
144448432|NCT02158039|520840804|FG000|Overall Study|Withdrawal by Subject|1|||
144448433|NCT02158039|520840804|FG000|Overall Study|Screen Failure|9|||
144448434|NCT03062891|520840816|FG000|Overall Study|Withdrawal by Subject|2|||
144448435|NCT03062891|520840817|FG001|Overall Study|Withdrawal by Subject|0|||
144448436|NCT03062891|520840816|FG000|Overall Study|Lost to Follow-up|50|||
144448437|NCT03062891|520840817|FG001|Overall Study|Lost to Follow-up|38|||
144448438|NCT01079234|520840823|FG000|Main: Week 0 to 26|Adverse Event|5|||
144448439|NCT01079234|520840824|FG001|Main: Week 0 to 26|Adverse Event|4|||
144448440|NCT01079234|520840825|FG002|Main: Week 0 to 26|Adverse Event|1|||
144253777|NCT02734862|520130028|FG000|Part A|Physician Decision|2|||
144533382|NCT03582033|521155419|FG007|Part C|Study terminated by sponsor|3|||
144533383|NCT03582033|521155420|FG008|Part C|Study terminated by sponsor|2|||
144533384|NCT03582033|521155421|FG009|Part C|Study terminated by sponsor|0|||
144533385|NCT03582033|521155412|FG000|Part C|Withdrawal by Subject|0|||
144533386|NCT03582033|521155413|FG001|Part C|Withdrawal by Subject|0|||
144533387|NCT03582033|521155414|FG002|Part C|Withdrawal by Subject|0|||
144533388|NCT03582033|521155415|FG003|Part C|Withdrawal by Subject|0|||
144533389|NCT03582033|521155416|FG004|Part C|Withdrawal by Subject|0|||
144533390|NCT03582033|521155417|FG005|Part C|Withdrawal by Subject|0|||
144533391|NCT03582033|521155418|FG006|Part C|Withdrawal by Subject|1|||
144533392|NCT03582033|521155419|FG007|Part C|Withdrawal by Subject|2|||
144533393|NCT03582033|521155420|FG008|Part C|Withdrawal by Subject|1|||
144533394|NCT03582033|521155421|FG009|Part C|Withdrawal by Subject|0|||
144533395|NCT03582033|521155412|FG000|Part D|Death|0|||
144533396|NCT03582033|521155413|FG001|Part D|Death|0|||
144533397|NCT03582033|521155414|FG002|Part D|Death|0|||
144533398|NCT03582033|521155415|FG003|Part D|Death|0|||
144533399|NCT03582033|521155416|FG004|Part D|Death|0|||
144533400|NCT03582033|521155417|FG005|Part D|Death|0|||
144533401|NCT03582033|521155418|FG006|Part D|Death|0|||
144533402|NCT03582033|521155419|FG007|Part D|Death|0|||
144533403|NCT03582033|521155420|FG008|Part D|Death|0|||
144533404|NCT03582033|521155421|FG009|Part D|Death|1|||
144533405|NCT03582033|521155412|FG000|Part D|Study terminated by sponsor|0|||
144533406|NCT03582033|521155413|FG001|Part D|Study terminated by sponsor|0|||
144533407|NCT03582033|521155414|FG002|Part D|Study terminated by sponsor|0|||
144533408|NCT03582033|521155415|FG003|Part D|Study terminated by sponsor|0|||
144533409|NCT03582033|521155416|FG004|Part D|Study terminated by sponsor|0|||
144533410|NCT03582033|521155417|FG005|Part D|Study terminated by sponsor|0|||
144533411|NCT03582033|521155418|FG006|Part D|Study terminated by sponsor|0|||
144533412|NCT03582033|521155419|FG007|Part D|Study terminated by sponsor|0|||
144533413|NCT03582033|521155420|FG008|Part D|Study terminated by sponsor|0|||
144533414|NCT03582033|521155421|FG009|Part D|Study terminated by sponsor|4|||
144533415|NCT06010836|521155422|FG000|Overall Study|Lost to Follow-up|2|||
144533416|NCT06010836|521155423|FG001|Overall Study|Lost to Follow-up|2|||
144533417|NCT06010836|521155422|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
144533418|NCT06010836|521155423|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
144533419|NCT06010836|521155422|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
144533420|NCT06010836|521155423|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
144533421|NCT06010836|521155422|FG000|Overall Study|Did not receive intervention discussion|0|||
144533422|NCT06010836|521155423|FG001|Overall Study|Did not receive intervention discussion|4|||
144533423|NCT05205161|521155424|FG000|Overall Study|Study terminated by sponsor|3|||
144533424|NCT05205161|521155425|FG001|Overall Study|Study terminated by sponsor|3|||
144533425|NCT05205161|521155426|FG002|Overall Study|Study terminated by sponsor|1|||
144533426|NCT05652010|521155427|FG000|First Intervention|Withdrawal by Subject|0|||
144533427|NCT05652010|521155428|FG001|First Intervention|Withdrawal by Subject|1|||
144253778|NCT02734862|520130029|FG001|Part A|Physician Decision|0|||
144448441|NCT01079234|520840826|FG003|Main: Week 0 to 26|Adverse Event|0|||
144448442|NCT01079234|520840823|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
144448443|NCT01079234|520840824|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
144533428|NCT05652010|521155427|FG000|Second Intervention|Withdrawal by Subject|1|||
144253779|NCT02734862|520130030|FG002|Part A|Physician Decision|1|||
144253780|NCT02734862|520130028|FG000|Part A|Adverse Event|2|||
144253781|NCT02734862|520130029|FG001|Part A|Adverse Event|0|||
144253782|NCT02734862|520130030|FG002|Part A|Adverse Event|1|||
144253783|NCT02734862|520130028|FG000|Part A|Noncompliance|1|||
144253784|NCT02734862|520130029|FG001|Part A|Noncompliance|1|||
144253785|NCT02734862|520130030|FG002|Part A|Noncompliance|0|||
144253786|NCT02734862|520130028|FG000|Part A|Other|1|||
144253787|NCT02734862|520130029|FG001|Part A|Other|1|||
144253788|NCT02734862|520130030|FG002|Part A|Other|3|||
144533429|NCT05652010|521155428|FG001|Second Intervention|Withdrawal by Subject|0|||
144253789|NCT02734862|520130028|FG000|Part B|Death|8|||
144448444|NCT01079234|520840825|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
144448445|NCT01079234|520840826|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
144448446|NCT01079234|520840823|FG000|Main: Week 0 to 26|Protocol Violation|6|||
144253790|NCT02734862|520130029|FG001|Part B|Death|3|||
144253791|NCT02734862|520130030|FG002|Part B|Death|5|||
144253792|NCT02734862|520130028|FG000|Part B|Lost to Follow-up|2|||
144448447|NCT01079234|520840824|FG001|Main: Week 0 to 26|Protocol Violation|2|||
144448448|NCT01079234|520840825|FG002|Main: Week 0 to 26|Protocol Violation|4|||
144448449|NCT01079234|520840826|FG003|Main: Week 0 to 26|Protocol Violation|0|||
144448450|NCT01079234|520840823|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
144448451|NCT01079234|520840824|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
144448452|NCT01079234|520840825|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
144448453|NCT01079234|520840826|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
144448454|NCT01079234|520840823|FG000|Main: Week 0 to 26|Unclassified|7|||
144448455|NCT01079234|520840824|FG001|Main: Week 0 to 26|Unclassified|13|||
144448456|NCT01079234|520840825|FG002|Main: Week 0 to 26|Unclassified|4|||
144448457|NCT01079234|520840826|FG003|Main: Week 0 to 26|Unclassified|0|||
144448458|NCT01079234|520840823|FG000|Extension: Week 27 to 52|Adverse Event|0|||
144448459|NCT01079234|520840824|FG001|Extension: Week 27 to 52|Adverse Event|0|||
144448460|NCT01079234|520840825|FG002|Extension: Week 27 to 52|Adverse Event|1|||
144448461|NCT01079234|520840826|FG003|Extension: Week 27 to 52|Adverse Event|0|||
144448462|NCT01079234|520840823|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
144448463|NCT01079234|520840824|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
144448464|NCT01079234|520840825|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
144448465|NCT01079234|520840826|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
144448466|NCT01079234|520840823|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
144448467|NCT01079234|520840824|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
144448468|NCT01079234|520840825|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
144448469|NCT01079234|520840826|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
144448470|NCT01079234|520840823|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
144448471|NCT01079234|520840824|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
144448472|NCT01079234|520840825|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
144448473|NCT01079234|520840826|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
144448474|NCT01079234|520840823|FG000|Extension: Week 27 to 52|Unclassified|0|||
144448475|NCT01079234|520840824|FG001|Extension: Week 27 to 52|Unclassified|0|||
144448476|NCT01079234|520840825|FG002|Extension: Week 27 to 52|Unclassified|4|||
144448477|NCT01079234|520840826|FG003|Extension: Week 27 to 52|Unclassified|7|||
144448478|NCT01334866|520840837|FG000|Overall Study|Withdrawal by Subject|10|||
144448479|NCT01334866|520840837|FG000|Overall Study|Lost to Follow-up|3|||
144448480|NCT01334866|520840837|FG000|Overall Study|Physician Decision|3|||
144448481|NCT01334866|520840837|FG000|Overall Study|medically necessary prior to procedure|2|||
144448482|NCT01334866|520840837|FG000|Overall Study|medically necessary post-procedure|1|||
144448483|NCT00958880|520840851|FG000|Overall Study|Lost to Follow-up|2|||
144448484|NCT00958880|520840852|FG001|Overall Study|Lost to Follow-up|2|||
144448485|NCT01516879|520840855|FG000|Overall Study|Withdrawal by Subject|9|||
144448486|NCT01516879|520840856|FG001|Overall Study|Withdrawal by Subject|11|||
144448487|NCT01516879|520840855|FG000|Overall Study|Death|0|||
144448488|NCT01516879|520840856|FG001|Overall Study|Death|2|||
144448489|NCT01516879|520840855|FG000|Overall Study|Lost to Follow-up|2|||
144448490|NCT01516879|520840856|FG001|Overall Study|Lost to Follow-up|11|||
144448491|NCT01516879|520840855|FG000|Overall Study|Other|5|||
144448492|NCT01516879|520840856|FG001|Overall Study|Other|10|||
144448493|NCT02047604|520840857|FG000|Overall Study|Withdrawal by Subject|0|||
144448494|NCT02047604|520840858|FG001|Overall Study|Withdrawal by Subject|0|||
144448495|NCT02047604|520840859|FG002|Overall Study|Withdrawal by Subject|0|||
144448496|NCT02047604|520840860|FG003|Overall Study|Withdrawal by Subject|0|||
144448497|NCT02047604|520840861|FG004|Overall Study|Withdrawal by Subject|1|||
144448498|NCT02047604|520840862|FG005|Overall Study|Withdrawal by Subject|1|||
144448499|NCT00829621|520840863|FG000|Overall Study|Death|1|||
144448500|NCT00829621|520840864|FG001|Overall Study|Death|0|||
144448501|NCT00829621|520840863|FG000|Overall Study|Lost to Follow-up|3|||
144448502|NCT00829621|520840864|FG001|Overall Study|Lost to Follow-up|4|||
144448503|NCT01818336|520842383|FG000|Overall Study|Declined retest visit|0|||
144448504|NCT01818336|520842384|FG001|Overall Study|Declined retest visit|11|||
144448505|NCT01818336|520842383|FG000|Overall Study|Lost to Follow-up|0|||
144448506|NCT01818336|520842384|FG001|Overall Study|Lost to Follow-up|1|||
144448507|NCT03042312|520842387|FG000|Overall Study|Administrative Reason|1|||
144448508|NCT03042312|520842388|FG001|Overall Study|Administrative Reason|1|||
144448509|NCT03042312|520842387|FG000|Overall Study|Adverse Event|0|||
144448510|NCT03042312|520842388|FG001|Overall Study|Adverse Event|1|||
144448511|NCT03042312|520842387|FG000|Overall Study|Lost to Follow-up|1|||
144448512|NCT03042312|520842388|FG001|Overall Study|Lost to Follow-up|3|||
144448513|NCT03042312|520842387|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
144448514|NCT03042312|520842388|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
144448515|NCT03042312|520842387|FG000|Overall Study|Withdrawal by Subject|4|||
144448516|NCT03042312|520842388|FG001|Overall Study|Withdrawal by Subject|5|||
144448517|NCT01043874|520842394|FG000|Overall Study|Adverse Event|3|||
144448518|NCT01043874|520842394|FG000|Overall Study|Withdrawal by Subject|1|||
144448519|NCT01043874|520842394|FG000|Overall Study|Lack of Efficacy|1|||
144448520|NCT01043874|520842394|FG000|Overall Study|Administrative Problems|1|||
144448521|NCT03266588|520842400|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
144194294|NCT03604341|519906463|FG001|Overall Study|Protocol Violation|1|||
144194295|NCT02408120|519906466|FG000|Overall Study|Withdrawal by Subject|0|||
144194296|NCT02408120|519906467|FG001|Overall Study|Withdrawal by Subject|1|||
144194297|NCT02408120|519906466|FG000|Overall Study|Treatment Refusal|1|||
144194298|NCT02408120|519906467|FG001|Overall Study|Treatment Refusal|0|||
144194299|NCT02408120|519906466|FG000|Overall Study|Received Steroids|1|||
144194300|NCT02408120|519906467|FG001|Overall Study|Received Steroids|1|||
144194301|NCT02408120|519906466|FG000|Overall Study|Discharged same day|1|||
144194302|NCT02408120|519906467|FG001|Overall Study|Discharged same day|1|||
144194303|NCT02408120|519906466|FG000|Overall Study|Did not receive insulin|1|||
144194304|NCT02408120|519906467|FG001|Overall Study|Did not receive insulin|2|||
144194305|NCT03739138|519906468|FG000|Overall Study|Death|0|||
144194306|NCT03739138|519906469|FG001|Overall Study|Death|7|||
144194307|NCT03739138|519906470|FG002|Overall Study|Death|4|||
144194308|NCT03739138|519906471|FG003|Overall Study|Death|13|||
144194309|NCT03739138|519906472|FG004|Overall Study|Death|0|||
144194310|NCT03739138|519906468|FG000|Overall Study|Lost to Follow-up|0|||
144194311|NCT03739138|519906469|FG001|Overall Study|Lost to Follow-up|0|||
144194312|NCT03739138|519906470|FG002|Overall Study|Lost to Follow-up|1|||
144194313|NCT03739138|519906471|FG003|Overall Study|Lost to Follow-up|0|||
144194314|NCT03739138|519906472|FG004|Overall Study|Lost to Follow-up|0|||
144194315|NCT03739138|519906468|FG000|Overall Study|Study Terminated By Sponsor|0|||
144194316|NCT03739138|519906469|FG001|Overall Study|Study Terminated By Sponsor|0|||
144194317|NCT03739138|519906470|FG002|Overall Study|Study Terminated By Sponsor|0|||
144194318|NCT03739138|519906471|FG003|Overall Study|Study Terminated By Sponsor|4|||
144194319|NCT03739138|519906472|FG004|Overall Study|Study Terminated By Sponsor|0|||
144194320|NCT03739138|519906468|FG000|Overall Study|Withdrawal by Subject|0|||
144194321|NCT03739138|519906469|FG001|Overall Study|Withdrawal by Subject|0|||
144194322|NCT03739138|519906470|FG002|Overall Study|Withdrawal by Subject|0|||
144194323|NCT03739138|519906471|FG003|Overall Study|Withdrawal by Subject|1|||
144194324|NCT03739138|519906472|FG004|Overall Study|Withdrawal by Subject|0|||
144194325|NCT00597116|519906476|FG000|Overall Study|Adverse Event|2|||
144194326|NCT00597116|519906477|FG001|Overall Study|Adverse Event|1|||
144194327|NCT00597116|519906476|FG000|Overall Study|Withdrawal by Subject|0|||
144194328|NCT00597116|519906477|FG001|Overall Study|Withdrawal by Subject|2|||
144194329|NCT00597116|519906476|FG000|Overall Study|Physician Decision|0|||
144194330|NCT00597116|519906477|FG001|Overall Study|Physician Decision|1|||
144194331|NCT00597116|519906476|FG000|Overall Study|Death|0|||
144194332|NCT00597116|519906477|FG001|Overall Study|Death|1|||
144194333|NCT00597116|519906476|FG000|Overall Study|Lost to Follow-up|1|||
144194334|NCT00597116|519906477|FG001|Overall Study|Lost to Follow-up|0|||
144448522|NCT03266588|520842401|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
144448523|NCT03266588|520842402|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
144448524|NCT03266588|520842400|FG000|Observational Period|Withdrawal by Subject|44|||
144448525|NCT03266588|520842401|FG001|Observational Period|Withdrawal by Subject|22|||
144448526|NCT03266588|520842402|FG002|Observational Period|Withdrawal by Subject|13|||
144448527|NCT03266588|520842400|FG000|Observational Period|Non-compliance|18|||
144448528|NCT03266588|520842401|FG001|Observational Period|Non-compliance|12|||
144448529|NCT03266588|520842402|FG002|Observational Period|Non-compliance|10|||
144448530|NCT03266588|520842400|FG000|Observational Period|Lost to Follow-up|8|||
144448531|NCT03266588|520842401|FG001|Observational Period|Lost to Follow-up|12|||
144448532|NCT03266588|520842402|FG002|Observational Period|Lost to Follow-up|4|||
144448533|NCT03266588|520842400|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
144448534|NCT03266588|520842401|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
144606546|NCT01994382|521420994|FG001|Overall Study|Rolled over to Phase 2a|0|||
144606547|NCT01994382|521420995|FG002|Overall Study|Rolled over to Phase 2a|1|||
144606548|NCT01994382|521420996|FG003|Overall Study|Rolled over to Phase 2a|0|||
144606549|NCT01994382|521420997|FG004|Overall Study|Rolled over to Phase 2a|0|||
144606550|NCT01994382|521420998|FG005|Overall Study|Rolled over to Phase 2a|0|||
144606551|NCT01994382|521420999|FG006|Overall Study|Rolled over to Phase 2a|0|||
144448535|NCT03266588|520842402|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
144448536|NCT03266588|520842400|FG000|Observational Period|Protocol Deviation|1|||
144448537|NCT03266588|520842401|FG001|Observational Period|Protocol Deviation|0|||
144606552|NCT01994382|521421000|FG007|Overall Study|Rolled over to Phase 2a|0|||
144448538|NCT03266588|520842402|FG002|Observational Period|Protocol Deviation|0|||
144606553|NCT01994382|521421001|FG008|Overall Study|Rolled over to Phase 2a|0|||
144606554|NCT01994382|521421002|FG009|Overall Study|Rolled over to Phase 2a|2|||
144606555|NCT01994382|521421003|FG010|Overall Study|Rolled over to Phase 2a|0|||
144194335|NCT00597116|519906476|FG000|Overall Study|Progressive disease|11|||
144194336|NCT00597116|519906477|FG001|Overall Study|Progressive disease|6|||
144194337|NCT00831623|519906491|FG000|Overall Study|Withdrawal by Subject|9|||
144606556|NCT01994382|521421004|FG011|Overall Study|Rolled over to Phase 2a|0|||
144194338|NCT00831623|519906491|FG000|Overall Study|Lost to Follow-up|1|||
144194339|NCT00831623|519906491|FG000|Overall Study|Not 2 years post-treatment|12|||
144194340|NCT01564459|519906496|FG000|Run-In|Adverse Event|7|||
144194341|NCT01564459|519906497|FG001|Run-In|Adverse Event|0|||
144194342|NCT01564459|519906498|FG002|Run-In|Adverse Event|0|||
144253793|NCT02734862|520130029|FG001|Part B|Lost to Follow-up|2|||
144253794|NCT02734862|520130030|FG002|Part B|Lost to Follow-up|0|||
144253795|NCT02734862|520130028|FG000|Part B|Withdrawal by Subject|3|||
144253796|NCT02734862|520130029|FG001|Part B|Withdrawal by Subject|1|||
144253797|NCT02734862|520130030|FG002|Part B|Withdrawal by Subject|0|||
144253798|NCT02734862|520130028|FG000|Part B|Other|0|||
144253799|NCT02734862|520130029|FG001|Part B|Other|1|||
144253800|NCT02734862|520130030|FG002|Part B|Other|0|||
144253801|NCT04854057|520130031|FG000|Overall Study|Adverse Event|0|||
144253802|NCT04854057|520130032|FG001|Overall Study|Adverse Event|1|||
144253803|NCT01951573|520130035|FG000|Washout Period|Adverse Event|0|||
144533430|NCT02510235|521155433|FG000|Overall Study|Withdrawal by Subject|1|||
144533431|NCT02510235|521155434|FG001|Overall Study|Withdrawal by Subject|0|||
144533432|NCT04206787|521155435|FG000|Overall Study|Other than listed|2|||
144533433|NCT04206787|521155435|FG000|Overall Study|Investigator decision|1|||
144533434|NCT04206787|521155435|FG000|Overall Study|Death|25|||
144533435|NCT04206787|521155435|FG000|Overall Study|Lost to Follow-up|9|||
144533436|NCT04206787|521155435|FG000|Overall Study|Withdrawal of consent|9|||
144533437|NCT03735979|521155439|FG000|Overall Study|Lost to Follow-up|1|||
144533438|NCT03735979|521155440|FG001|Overall Study|Lost to Follow-up|12|||
144533439|NCT03735979|521155441|FG002|Overall Study|Lost to Follow-up|14|||
144533440|NCT03735979|521155439|FG000|Overall Study|Withdrawal by Subject|1|||
144533441|NCT03735979|521155440|FG001|Overall Study|Withdrawal by Subject|5|||
144253804|NCT01951573|520130036|FG001|Washout Period|Adverse Event|1|||
144253805|NCT02087943|520130056|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
144253806|NCT02087943|520130057|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
144253807|NCT02087943|520130058|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
144253808|NCT02087943|520130059|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
144253809|NCT02087943|520130060|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
144253810|NCT02087943|520130056|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
144253811|NCT02087943|520130057|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
144253812|NCT02087943|520130058|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
144253813|NCT02087943|520130059|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
144253814|NCT02087943|520130060|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
144253815|NCT02087943|520130056|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
144253816|NCT02087943|520130057|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
144253817|NCT02087943|520130058|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
144253818|NCT02087943|520130059|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
144253819|NCT02087943|520130060|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
144253820|NCT02087943|520130056|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
144253821|NCT02087943|520130057|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
144253822|NCT02087943|520130058|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
144606557|NCT01994382|521421005|FG012|Overall Study|Rolled over to Phase 2a|0|||
144606558|NCT01994382|521421006|FG013|Overall Study|Rolled over to Phase 2a|0|||
144606559|NCT01994382|521421007|FG014|Overall Study|Rolled over to Phase 2a|0|||
144606560|NCT01994382|521421008|FG015|Overall Study|Rolled over to Phase 2a|0|||
144606561|NCT01994382|521421009|FG016|Overall Study|Rolled over to Phase 2a|0|||
144606562|NCT03023059|521421010|FG000|Overall Study|Withdrawal by Subject|5|||
144606563|NCT03781323|521421011|FG000|Overall Study|Withdrawal by Subject|1|||
144606564|NCT01303965|521421012|FG000|Overall Study|Adverse Event|1|||
144606565|NCT01303965|521421013|FG001|Overall Study|Adverse Event|1|||
144606566|NCT01303965|521421012|FG000|Overall Study|Death|0|||
144606567|NCT01303965|521421013|FG001|Overall Study|Death|3|||
144606568|NCT01303965|521421012|FG000|Overall Study|Withdrawal by Subject|1|||
144606569|NCT01303965|521421013|FG001|Overall Study|Withdrawal by Subject|0|||
144606570|NCT01303965|521421012|FG000|Overall Study|Disease Progression|1|||
144606571|NCT01303965|521421013|FG001|Overall Study|Disease Progression|6|||
144606572|NCT04534491|521421015|FG000|Overall Study|Not completed end-of-study interview|24|||
144606573|NCT04534491|521421015|FG000|Overall Study|Non-users|70|||
144606574|NCT04534491|521421015|FG000|Overall Study|Non-verifiable users|58|||
144253823|NCT02087943|520130059|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
144253824|NCT02087943|520130060|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
144253825|NCT02087943|520130056|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
144533442|NCT03735979|521155441|FG002|Overall Study|Withdrawal by Subject|2|||
144253826|NCT02087943|520130057|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
144253827|NCT02087943|520130058|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
144253828|NCT02087943|520130059|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
144606575|NCT02678416|521421020|FG000|Part 1|Withdrawal by Subject|1|||
144606576|NCT02678416|521421020|FG000|Part 2|Adverse Event|2|||
144606577|NCT02678416|521421020|FG000|Part 2|Withdrawal by Subject|1|||
144253829|NCT02087943|520130060|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
144253830|NCT02087943|520130056|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
144253831|NCT02087943|520130057|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
144253832|NCT02087943|520130058|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
144606578|NCT01848353|521421021|FG000|Phase 1|Withdrawal by Subject|3|||
144448539|NCT03266588|520842400|FG000|Observational Period|Other Reasons|3|||
144448540|NCT03266588|520842401|FG001|Observational Period|Other Reasons|0|||
144448541|NCT03266588|520842402|FG002|Observational Period|Other Reasons|1|||
144448542|NCT03266588|520842400|FG000|Long-term Treatment Period|Adverse Event|33|||
144194343|NCT01564459|519906496|FG000|Run-In|Lost to Follow-up|1|||
144448543|NCT03266588|520842401|FG001|Long-term Treatment Period|Adverse Event|17|||
144448544|NCT03266588|520842402|FG002|Long-term Treatment Period|Adverse Event|8|||
144448545|NCT03266588|520842400|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
144194344|NCT01564459|519906497|FG001|Run-In|Lost to Follow-up|0|||
144448546|NCT03266588|520842401|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
144448547|NCT03266588|520842402|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
144448548|NCT03266588|520842400|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
144448549|NCT03266588|520842401|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
144448550|NCT03266588|520842402|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
144448551|NCT03266588|520842400|FG000|Long-term Treatment Period|Non-Compliance|126|||
144448552|NCT03266588|520842401|FG001|Long-term Treatment Period|Non-Compliance|57|||
144448553|NCT03266588|520842402|FG002|Long-term Treatment Period|Non-Compliance|7|||
144448554|NCT03266588|520842400|FG000|Long-term Treatment Period|Pregnancy|11|||
144448555|NCT03266588|520842401|FG001|Long-term Treatment Period|Pregnancy|5|||
144448556|NCT03266588|520842402|FG002|Long-term Treatment Period|Pregnancy|0|||
144448557|NCT03266588|520842400|FG000|Long-term Treatment Period|Protocol Deviation|17|||
144448558|NCT03266588|520842401|FG001|Long-term Treatment Period|Protocol Deviation|10|||
144448559|NCT03266588|520842402|FG002|Long-term Treatment Period|Protocol Deviation|4|||
144448560|NCT03266588|520842400|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
144448561|NCT03266588|520842401|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
144448562|NCT03266588|520842402|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
144448563|NCT03266588|520842400|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
144448564|NCT03266588|520842401|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
144448565|NCT03266588|520842402|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
144448566|NCT03266588|520842400|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
144448567|NCT03266588|520842401|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
144448568|NCT03266588|520842402|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
144448569|NCT03266588|520842400|FG000|Long-term Treatment Period|Other Reasons|5|||
144448570|NCT03266588|520842401|FG001|Long-term Treatment Period|Other Reasons|0|||
144448571|NCT03266588|520842402|FG002|Long-term Treatment Period|Other Reasons|0|||
144448572|NCT03266588|520842400|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
144448573|NCT03266588|520842401|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
144448574|NCT03266588|520842402|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
144448575|NCT03087591|520842403|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
144448576|NCT03087591|520842403|FG000|Overall Study|Withdrawal by Subject|1|||
144448577|NCT00982319|520842409|FG000|Overall Study|Surgery date change|1|||
144448578|NCT00982319|520842410|FG001|Overall Study|Surgery date change|0|||
144448579|NCT00982319|520842409|FG000|Overall Study|Preop values out of acceptable range|1|||
144448580|NCT00982319|520842410|FG001|Overall Study|Preop values out of acceptable range|1|||
144448581|NCT00982319|520842409|FG000|Overall Study|Pregnancy|0|||
144448582|NCT00982319|520842410|FG001|Overall Study|Pregnancy|1|||
144448583|NCT01933334|520842411|FG000|Overall Study|Adverse Event|5|||
144448584|NCT01933334|520842412|FG001|Overall Study|Adverse Event|1|||
144448585|NCT01933334|520842411|FG000|Overall Study|Withdrawal by Subject|0|||
144448586|NCT01933334|520842412|FG001|Overall Study|Withdrawal by Subject|1|||
144448587|NCT01257204|520842413|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144448588|NCT01257204|520842414|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
144448589|NCT01257204|520842415|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
144448590|NCT01257204|520842413|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
144448591|NCT01257204|520842414|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
144448592|NCT01257204|520842415|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
144448593|NCT01257204|520842413|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
144448594|NCT01257204|520842414|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
144448595|NCT01257204|520842415|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
144448596|NCT01257204|520842413|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
144448597|NCT01257204|520842414|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
144448598|NCT01257204|520842415|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
144448599|NCT01257204|520842413|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
144448600|NCT01257204|520842414|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
144448601|NCT01257204|520842415|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
144448602|NCT01257204|520842413|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
144448603|NCT01257204|520842414|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
144194345|NCT01564459|519906498|FG002|Run-In|Lost to Follow-up|0|||
144194346|NCT01564459|519906496|FG000|Run-In|Non-compliance with study drug|2|||
144194347|NCT01564459|519906497|FG001|Run-In|Non-compliance with study drug|0|||
144448604|NCT01257204|520842415|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
144448605|NCT01257204|520842413|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
144448606|NCT01257204|520842414|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
144448607|NCT01257204|520842415|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
144448608|NCT01257204|520842413|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
144448609|NCT01257204|520842414|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
144448610|NCT01257204|520842415|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
144448611|NCT01257204|520842413|FG000|Follow-up Period (up to Week 48)|Other|0|||
144448612|NCT01257204|520842414|FG001|Follow-up Period (up to Week 48)|Other|0|||
144448613|NCT01257204|520842415|FG002|Follow-up Period (up to Week 48)|Other|5|||
144448614|NCT03614793|520842417|FG000|Overall Study|Lost to Follow-up|1|||
144448615|NCT03614793|520842418|FG001|Overall Study|Lost to Follow-up|2|||
144448616|NCT03614793|520842417|FG000|Overall Study|Lack of Efficacy|0|||
144448617|NCT03614793|520842418|FG001|Overall Study|Lack of Efficacy|5|||
144448618|NCT03614793|520842417|FG000|Overall Study|Withdrawal by Subject|0|||
144448619|NCT03614793|520842418|FG001|Overall Study|Withdrawal by Subject|1|||
144448620|NCT03614793|520842417|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
144448621|NCT03614793|520842418|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
144448622|NCT02082522|520842419|FG000|Overall Study|Sponsor termination|5|||
144448623|NCT02082522|520842420|FG001|Overall Study|Sponsor termination|3|||
144448624|NCT02082522|520842419|FG000|Overall Study|Withdrawal by Subject|2|||
144448625|NCT02082522|520842420|FG001|Overall Study|Withdrawal by Subject|4|||
144448626|NCT02082522|520842419|FG000|Overall Study|Death|1|||
144448627|NCT02082522|520842420|FG001|Overall Study|Death|0|||
144448628|NCT02082522|520842419|FG000|Overall Study|Lost to Follow-up|1|||
144448629|NCT02082522|520842420|FG001|Overall Study|Lost to Follow-up|0|||
144448630|NCT02082522|520842419|FG000|Overall Study|Physician Decision|3|||
144448631|NCT02082522|520842420|FG001|Overall Study|Physician Decision|1|||
144448632|NCT02082522|520842419|FG000|Overall Study|Disease progression|2|||
144448633|NCT02082522|520842420|FG001|Overall Study|Disease progression|2|||
144448634|NCT02082522|520842419|FG000|Overall Study|Chemotherapy change|1|||
144448635|NCT02082522|520842420|FG001|Overall Study|Chemotherapy change|3|||
144448636|NCT01863446|520842421|FG000|Overall Study|Withdrawal by Subject|1|||
144448637|NCT01863446|520842422|FG001|Overall Study|Withdrawal by Subject|0|||
144448638|NCT01863446|520842423|FG002|Overall Study|Withdrawal by Subject|1|||
144448639|NCT01863446|520842424|FG003|Overall Study|Withdrawal by Subject|2|||
144448640|NCT01863446|520842421|FG000|Overall Study|Physician Decision|0|||
144448641|NCT01863446|520842422|FG001|Overall Study|Physician Decision|0|||
144448642|NCT01863446|520842423|FG002|Overall Study|Physician Decision|1|||
144448643|NCT01863446|520842424|FG003|Overall Study|Physician Decision|0|||
144448644|NCT02496884|520842425|FG000|Overall Study|Counted twice as enrolled|2|||
144448645|NCT02496884|520842426|FG001|Overall Study|Counted twice as enrolled|0|||
144448646|NCT02496884|520842427|FG002|Overall Study|Counted twice as enrolled|0|||
144448647|NCT02496884|520842428|FG003|Overall Study|Counted twice as enrolled|0|||
144448648|NCT02496884|520842425|FG000|Overall Study|Withdrawal by Subject|0|||
144448649|NCT02496884|520842426|FG001|Overall Study|Withdrawal by Subject|3|||
144448650|NCT02496884|520842427|FG002|Overall Study|Withdrawal by Subject|0|||
144448651|NCT02496884|520842428|FG003|Overall Study|Withdrawal by Subject|0|||
144448652|NCT00097591|520842431|FG000|Overall Study|Withdrawal of consent|342|||
144448653|NCT00097591|520842432|FG001|Overall Study|Withdrawal of consent|323|||
144448654|NCT00097591|520842431|FG000|Overall Study|Less than 6 months on study drug|9|||
144448655|NCT00097591|520842432|FG001|Overall Study|Less than 6 months on study drug|7|||
144448656|NCT00097591|520842431|FG000|Overall Study|Unable to attend termination visit|53|||
144448657|NCT00097591|520842432|FG001|Overall Study|Unable to attend termination visit|51|||
144448658|NCT00097591|520842431|FG000|Overall Study|Lost to follow up|6|||
144448659|NCT00097591|520842432|FG001|Overall Study|Lost to follow up|10|||
144448660|NCT00097591|520842431|FG000|Overall Study|Other|0|||
144448661|NCT00097591|520842432|FG001|Overall Study|Other|3|||
144448662|NCT03603964|520842437|FG000|Overall Study|Death|9|||
144448663|NCT03603964|520842437|FG000|Overall Study|Withdrawal by participant|7|||
144448664|NCT03603964|520842437|FG000|Overall Study|Study terminated by Sponsor|19|||
144448665|NCT04317586|520842438|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
144448666|NCT04317586|520842438|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
144448667|NCT00807092|520842439|FG000|Overall Study|Adverse Event|0|||
144448668|NCT00807092|520842440|FG001|Overall Study|Adverse Event|1|||
144448669|NCT00807092|520842439|FG000|Overall Study|Protocol Violation|0|||
144448670|NCT00807092|520842440|FG001|Overall Study|Protocol Violation|2|||
144448671|NCT00807092|520842439|FG000|Overall Study|Withdrawal by Subject|1|||
144448672|NCT00807092|520842440|FG001|Overall Study|Withdrawal by Subject|0|||
144448673|NCT00807092|520842439|FG000|Overall Study|CGMS data collection failed|0|||
144448674|NCT00807092|520842440|FG001|Overall Study|CGMS data collection failed|1|||
144448675|NCT01794949|520842441|FG000|Overall Study|Lost to Follow-up|1|||
144448676|NCT01794949|520842442|FG001|Overall Study|Lost to Follow-up|0|||
144448677|NCT03003676|520842443|FG000|Overall Study|Lack of Efficacy|5|||
144448678|NCT03003676|520842444|FG001|Overall Study|Lack of Efficacy|7|||
144194348|NCT01564459|519906498|FG002|Run-In|Non-compliance with study drug|0|||
144194349|NCT01564459|519906496|FG000|Run-In|Protocol Violation|1|||
144194350|NCT01564459|519906497|FG001|Run-In|Protocol Violation|0|||
144194351|NCT01564459|519906498|FG002|Run-In|Protocol Violation|0|||
144194352|NCT01564459|519906496|FG000|Run-In|Withdrawal by Subject|1|||
144194353|NCT01564459|519906497|FG001|Run-In|Withdrawal by Subject|0|||
144194354|NCT01564459|519906498|FG002|Run-In|Withdrawal by Subject|0|||
144194355|NCT01564459|519906496|FG000|Double-blind Treatment|Adverse Event|0|||
144194356|NCT01564459|519906497|FG001|Double-blind Treatment|Adverse Event|0|||
144194357|NCT01564459|519906498|FG002|Double-blind Treatment|Adverse Event|1|||
144194358|NCT02080832|519906500|FG000|Overall Study|Excluded from analysis by MRI|9|||
144194359|NCT02080832|519906501|FG001|Overall Study|Excluded from analysis by MRI|10|||
144194360|NCT02080832|519906502|FG002|Overall Study|Excluded from analysis by MRI|14|||
144194361|NCT02080832|519906500|FG000|Overall Study|Lost to Follow-up|0|||
144448679|NCT03003676|520842443|FG000|Overall Study|Withdrawal by Subject|0|||
144194362|NCT02080832|519906501|FG001|Overall Study|Lost to Follow-up|2|||
144194363|NCT02080832|519906502|FG002|Overall Study|Lost to Follow-up|2|||
144194364|NCT01138111|519906506|FG000|Overall Study|Withdrawal by Subject|5|||
144194365|NCT01138111|519906506|FG000|Overall Study|Adverse Event|1|||
144194366|NCT01138111|519906506|FG000|Overall Study|Death|1|||
144194367|NCT01138111|519906506|FG000|Overall Study|Lost to Follow-up|2|||
144194368|NCT00560937|519906507|FG000|Overall Study|Withdrawal by Subject|0|||
144194369|NCT00560937|519906508|FG001|Overall Study|Withdrawal by Subject|1|||
144194370|NCT00560937|519906507|FG000|Overall Study|Physician Decision|1|||
144194371|NCT00560937|519906508|FG001|Overall Study|Physician Decision|1|||
144194372|NCT01118117|519906509|FG000|Overall Study|Death|8|||
144194373|NCT01118117|519906510|FG001|Overall Study|Death|0|||
144194374|NCT01118117|519906509|FG000|Overall Study|Lost to Follow-up|6|||
144194375|NCT01118117|519906510|FG001|Overall Study|Lost to Follow-up|0|||
144194376|NCT01118117|519906509|FG000|Overall Study|Missed 12 Month Visit|7|||
144448680|NCT03003676|520842444|FG001|Overall Study|Withdrawal by Subject|1|||
144448681|NCT03003676|520842443|FG000|Overall Study|Hepatitis B infection|1|||
144448682|NCT03003676|520842444|FG001|Overall Study|Hepatitis B infection|0|||
144448683|NCT01931839|520842454|FG000|Overall Study|Death|0|||
144725291|NCT02581345|521851210|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
144725292|NCT02581345|521851211|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
144725293|NCT02581345|521851212|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
144725294|NCT02581345|521851213|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
144725295|NCT03471078|521851217|FG000|Overall Study|Withdrawal by Subject|9|||
144725296|NCT03471078|521851218|FG001|Overall Study|Withdrawal by Subject|1|||
144725297|NCT03471078|521851217|FG000|Overall Study|Adverse Event|4|||
144725298|NCT03471078|521851218|FG001|Overall Study|Adverse Event|1|||
144725299|NCT03471078|521851217|FG000|Overall Study|Physician Decision|3|||
144725300|NCT03471078|521851218|FG001|Overall Study|Physician Decision|2|||
144725301|NCT03471078|521851217|FG000|Overall Study|Death|2|||
144725302|NCT03471078|521851218|FG001|Overall Study|Death|0|||
144725303|NCT03471078|521851217|FG000|Overall Study|Other|3|||
144725304|NCT03471078|521851218|FG001|Overall Study|Other|2|||
144725305|NCT00862979|521851228|FG000|Overall Study|Adverse Event|6|||
144725306|NCT00862979|521851229|FG001|Overall Study|Adverse Event|3|||
144725307|NCT00862979|521851228|FG000|Overall Study|Protocol Violation|0|||
144194377|NCT01118117|519906510|FG001|Overall Study|Missed 12 Month Visit|0|||
144194378|NCT00706992|519906511|FG000|Overall Study|Study termination|5|||
144194379|NCT00706992|519906512|FG001|Overall Study|Study termination|5|||
144194380|NCT00706992|519906513|FG002|Overall Study|Study termination|6|||
144194381|NCT00706992|519906514|FG003|Overall Study|Study termination|2|||
144194382|NCT00706992|519906515|FG004|Overall Study|Study termination|3|||
144194383|NCT00706992|519906516|FG005|Overall Study|Study termination|2|||
144448684|NCT01931839|520842455|FG001|Overall Study|Death|1|||
144448685|NCT01931839|520842456|FG002|Overall Study|Death|2|||
144725308|NCT00862979|521851229|FG001|Overall Study|Protocol Violation|1|||
144194384|NCT00706992|519906517|FG006|Overall Study|Study termination|3|||
144194385|NCT00706992|519906511|FG000|Overall Study|Disease progression before treatment|0|||
144194386|NCT00706992|519906512|FG001|Overall Study|Disease progression before treatment|0|||
144194387|NCT00706992|519906513|FG002|Overall Study|Disease progression before treatment|0|||
144194388|NCT00706992|519906514|FG003|Overall Study|Disease progression before treatment|0|||
144194389|NCT00706992|519906515|FG004|Overall Study|Disease progression before treatment|1|||
144194390|NCT00706992|519906516|FG005|Overall Study|Disease progression before treatment|0|||
144448686|NCT01931839|520842457|FG003|Overall Study|Death|0|||
144448687|NCT01931839|520842458|FG004|Overall Study|Death|0|||
144194391|NCT00706992|519906517|FG006|Overall Study|Disease progression before treatment|0|||
144194392|NCT01277718|519906518|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
144194393|NCT01277718|519906519|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
144194394|NCT01277718|519906518|FG000|Period 2 - Second Intervention|Physician Decision|0|||
144448688|NCT01931839|520842459|FG005|Overall Study|Death|0|||
144725309|NCT00862979|521851228|FG000|Overall Study|Patient withdrew consent|2|||
144725310|NCT00862979|521851229|FG001|Overall Study|Patient withdrew consent|1|||
144725311|NCT00862979|521851228|FG000|Overall Study|Administrative problems|0|||
144448689|NCT01931839|520842460|FG006|Overall Study|Death|0|||
144448690|NCT01931839|520842454|FG000|Overall Study|Physician Decision|1|||
144448691|NCT01931839|520842455|FG001|Overall Study|Physician Decision|0|||
144448692|NCT01931839|520842456|FG002|Overall Study|Physician Decision|1|||
144448693|NCT01931839|520842457|FG003|Overall Study|Physician Decision|0|||
144448694|NCT01931839|520842458|FG004|Overall Study|Physician Decision|0|||
144448695|NCT01931839|520842459|FG005|Overall Study|Physician Decision|0|||
144448696|NCT01931839|520842460|FG006|Overall Study|Physician Decision|1|||
144448697|NCT01931839|520842454|FG000|Overall Study|Withdrawal of consent|0|||
144448698|NCT01931839|520842455|FG001|Overall Study|Withdrawal of consent|0|||
144448699|NCT01931839|520842456|FG002|Overall Study|Withdrawal of consent|0|||
144448700|NCT01931839|520842457|FG003|Overall Study|Withdrawal of consent|0|||
144448701|NCT01931839|520842458|FG004|Overall Study|Withdrawal of consent|1|||
144448702|NCT01931839|520842459|FG005|Overall Study|Withdrawal of consent|0|||
144448703|NCT01931839|520842460|FG006|Overall Study|Withdrawal of consent|0|||
144448704|NCT01931839|520842454|FG000|Overall Study|Adverse Event|9|||
144448705|NCT01931839|520842455|FG001|Overall Study|Adverse Event|4|||
144448706|NCT01931839|520842456|FG002|Overall Study|Adverse Event|1|||
144448707|NCT01931839|520842457|FG003|Overall Study|Adverse Event|3|||
144448708|NCT01931839|520842458|FG004|Overall Study|Adverse Event|0|||
144448709|NCT01931839|520842459|FG005|Overall Study|Adverse Event|0|||
144448710|NCT01931839|520842460|FG006|Overall Study|Adverse Event|1|||
144448711|NCT01931839|520842454|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
144448712|NCT01931839|520842455|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
144448713|NCT01931839|520842456|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
144448714|NCT01931839|520842457|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
144448715|NCT01931839|520842458|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
144448716|NCT01931839|520842459|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
144448717|NCT01931839|520842460|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
144448718|NCT01931839|520842454|FG000|Overall Study|Other non-compliance|15|||
144448719|NCT01931839|520842455|FG001|Overall Study|Other non-compliance|9|||
144448720|NCT01931839|520842456|FG002|Overall Study|Other non-compliance|12|||
144448721|NCT01931839|520842457|FG003|Overall Study|Other non-compliance|3|||
144448722|NCT01931839|520842458|FG004|Overall Study|Other non-compliance|0|||
144448723|NCT01931839|520842459|FG005|Overall Study|Other non-compliance|3|||
144448724|NCT01931839|520842460|FG006|Overall Study|Other non-compliance|0|||
144448725|NCT01931839|520842454|FG000|Overall Study|Lost to Follow-up|1|||
144448726|NCT01931839|520842455|FG001|Overall Study|Lost to Follow-up|2|||
144448727|NCT01931839|520842456|FG002|Overall Study|Lost to Follow-up|4|||
144448728|NCT01931839|520842457|FG003|Overall Study|Lost to Follow-up|5|||
144448729|NCT01931839|520842458|FG004|Overall Study|Lost to Follow-up|0|||
144448730|NCT01931839|520842459|FG005|Overall Study|Lost to Follow-up|0|||
144448731|NCT01931839|520842460|FG006|Overall Study|Lost to Follow-up|0|||
144448732|NCT01931839|520842454|FG000|Overall Study|Other|4|||
144448733|NCT01931839|520842455|FG001|Overall Study|Other|2|||
144448734|NCT01931839|520842456|FG002|Overall Study|Other|6|||
144448735|NCT01931839|520842457|FG003|Overall Study|Other|0|||
144448736|NCT01931839|520842458|FG004|Overall Study|Other|0|||
144448737|NCT01931839|520842459|FG005|Overall Study|Other|0|||
144448738|NCT01931839|520842460|FG006|Overall Study|Other|0|||
144448739|NCT03224468|520842466|FG000|Overall Study|Did not obtain MM card|53|||
144448740|NCT03224468|520842467|FG001|Overall Study|Did not obtain MM card|0|||
144448741|NCT03224468|520842466|FG000|Overall Study|Lost to Follow-up|4|||
144448742|NCT03224468|520842467|FG001|Overall Study|Lost to Follow-up|11|||
144448743|NCT03224468|520842466|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
144448744|NCT03224468|520842467|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
144448745|NCT01978119|520842468|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
144448746|NCT01978119|520842469|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
144448747|NCT01978119|520842468|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
144448748|NCT01978119|520842469|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144448749|NCT01978119|520842468|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144253833|NCT02087943|520130059|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
144253834|NCT02087943|520130060|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
144253835|NCT02087943|520130056|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
144253836|NCT02087943|520130057|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
144253837|NCT02087943|520130058|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
144253838|NCT02087943|520130059|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
144448750|NCT01978119|520842469|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
144448751|NCT00812812|520842470|FG000|Overall Study|Adverse Event|2|||
144448752|NCT00812812|520842471|FG001|Overall Study|Adverse Event|1|||
144448753|NCT00812812|520842470|FG000|Overall Study|Lack of Efficacy|1|||
144448754|NCT00812812|520842471|FG001|Overall Study|Lack of Efficacy|0|||
144448755|NCT00812812|520842470|FG000|Overall Study|Lost to Follow-up|0|||
144448756|NCT00812812|520842471|FG001|Overall Study|Lost to Follow-up|1|||
144448757|NCT00812812|520842470|FG000|Overall Study|Withdrawal by Subject|0|||
144194395|NCT01277718|519906519|FG001|Period 2 - Second Intervention|Physician Decision|2|||
144194396|NCT02712333|519908407|FG000|First Period|Withdrawal by Subject|3|||
144194397|NCT02712333|519908408|FG001|First Period|Withdrawal by Subject|2|||
144448758|NCT00812812|520842471|FG001|Overall Study|Withdrawal by Subject|2|||
144448759|NCT01416805|520842484|FG000|Overall Study|Lost to Follow-up|4|||
144448760|NCT01416805|520842485|FG001|Overall Study|Lost to Follow-up|4|||
144448761|NCT03056690|520842486|FG000|Overall Study|Adverse Event|3|||
144448762|NCT03056690|520842487|FG001|Overall Study|Adverse Event|2|||
144448763|NCT03056690|520842486|FG000|Overall Study|Lack of Efficacy|1|||
144448764|NCT03056690|520842487|FG001|Overall Study|Lack of Efficacy|2|||
144448765|NCT03056690|520842486|FG000|Overall Study|Lost to Follow-up|3|||
144448766|NCT03056690|520842487|FG001|Overall Study|Lost to Follow-up|2|||
144448767|NCT03056690|520842486|FG000|Overall Study|Protocol Violation|2|||
144448768|NCT03056690|520842487|FG001|Overall Study|Protocol Violation|2|||
144448769|NCT03056690|520842486|FG000|Overall Study|Withdrawal by Subject|3|||
144448770|NCT03056690|520842487|FG001|Overall Study|Withdrawal by Subject|6|||
144448771|NCT03056690|520842486|FG000|Overall Study|Non-compliance with Study Drug|1|||
144448772|NCT03056690|520842487|FG001|Overall Study|Non-compliance with Study Drug|0|||
144448773|NCT03056690|520842486|FG000|Overall Study|Miscellaneous|1|||
144448774|NCT03056690|520842487|FG001|Overall Study|Miscellaneous|2|||
144448775|NCT01723904|520842488|FG000|Overall Study|Noncompliant|3|||
144448776|NCT01723904|520842488|FG000|Overall Study|Adverse Event|5|||
144448777|NCT01723904|520842488|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
144448778|NCT00887341|520842497|FG000|Overall Study|Refused treatment|1|||
144448779|NCT00887341|520842498|FG001|Overall Study|Refused treatment|0|||
144448780|NCT00887341|520842497|FG000|Overall Study|Withdrawal by Subject|1|||
144448781|NCT00887341|520842498|FG001|Overall Study|Withdrawal by Subject|1|||
144448782|NCT00887341|520842497|FG000|Overall Study|Adverse Event|0|||
144448783|NCT00887341|520842498|FG001|Overall Study|Adverse Event|1|||
144448784|NCT00887341|520842497|FG000|Overall Study|Lost to Follow-up|0|||
144448785|NCT00887341|520842498|FG001|Overall Study|Lost to Follow-up|1|||
144448786|NCT02127307|520842503|FG000|Overall Study|Protocol Violation|36|||
144448787|NCT02127307|520842503|FG000|Overall Study|Lost to Follow-up|2|||
144448788|NCT02127307|520842503|FG000|Overall Study|Death|101|||
144448789|NCT02127307|520842503|FG000|Overall Study|Other than specified above|169|||
144448790|NCT00235989|520842510|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
144448791|NCT00235989|520842511|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
144448792|NCT00235989|520842512|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
144448793|NCT00235989|520842513|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
144448794|NCT00235989|520842514|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
144448795|NCT00235989|520842515|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
144448796|NCT00235989|520842510|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
144448797|NCT00235989|520842511|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
144448798|NCT00235989|520842512|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
144448799|NCT00235989|520842513|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
144448800|NCT00235989|520842514|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
144448801|NCT00235989|520842515|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
144448802|NCT00235989|520842510|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
144448803|NCT00235989|520842511|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
144448804|NCT00235989|520842512|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
144448805|NCT00235989|520842513|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
144448806|NCT00235989|520842514|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
144448807|NCT00235989|520842515|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
144448808|NCT00235989|520842510|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
144448809|NCT00235989|520842511|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
144448810|NCT00235989|520842512|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
144448811|NCT00235989|520842513|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
144448812|NCT00235989|520842514|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
144448813|NCT00235989|520842515|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
144448814|NCT00235989|520842510|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
144448815|NCT00235989|520842511|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
144448816|NCT00235989|520842512|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
144606579|NCT01848353|521421022|FG001|Phase 1|Withdrawal by Subject|1|||
144194398|NCT02278718|519908409|FG000|Overall Study|Adverse Event|1|||
144194399|NCT02278718|519908410|FG001|Overall Study|Adverse Event|0|||
144194400|NCT02278718|519908409|FG000|Overall Study|Lost to Follow-up|2|||
144194401|NCT02278718|519908410|FG001|Overall Study|Lost to Follow-up|4|||
144194402|NCT02278718|519908409|FG000|Overall Study|Withdrawal by Subject|1|||
144194403|NCT02278718|519908410|FG001|Overall Study|Withdrawal by Subject|4|||
144194404|NCT02278718|519908409|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
144194405|NCT02278718|519908410|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
144194406|NCT02278718|519908409|FG000|Overall Study|Missing|0|||
144194407|NCT02278718|519908410|FG001|Overall Study|Missing|1|||
144199351|NCT00394524|519928876|FG001|Overall Study|Withdrawal by Subject|1|||
144448817|NCT00235989|520842513|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
144448818|NCT00235989|520842514|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
144448819|NCT00235989|520842515|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
144448820|NCT04187196|520842518|FG000|Overall Study|Screen Failure|2|||
144448821|NCT04187196|520842519|FG001|Overall Study|Screen Failure|0|||
144448822|NCT01687166|520842520|FG000|Overall Study|Attempt subject|2|||
144448823|NCT01687166|520842521|FG001|Overall Study|Attempt subject|3|||
144448824|NCT01687166|520842522|FG002|Overall Study|Attempt subject|2|||
144448825|NCT01687166|520842523|FG003|Overall Study|Attempt subject|0|||
144448826|NCT01687166|520842520|FG000|Overall Study|Did not meet eligibility criteria|4|||
144448827|NCT01687166|520842521|FG001|Overall Study|Did not meet eligibility criteria|6|||
144448828|NCT01687166|520842522|FG002|Overall Study|Did not meet eligibility criteria|1|||
144448829|NCT01687166|520842523|FG003|Overall Study|Did not meet eligibility criteria|1|||
144448830|NCT01687166|520842520|FG000|Overall Study|Adverse Event|2|||
144448831|NCT01687166|520842521|FG001|Overall Study|Adverse Event|1|||
144448832|NCT01687166|520842522|FG002|Overall Study|Adverse Event|0|||
144448833|NCT01687166|520842523|FG003|Overall Study|Adverse Event|0|||
144448834|NCT01687166|520842520|FG000|Overall Study|Physician Decision|3|||
144448835|NCT01687166|520842521|FG001|Overall Study|Physician Decision|2|||
144448836|NCT01687166|520842522|FG002|Overall Study|Physician Decision|1|||
144448837|NCT01687166|520842523|FG003|Overall Study|Physician Decision|0|||
144448838|NCT01687166|520842520|FG000|Overall Study|Withdrawal by Subject|11|||
144448839|NCT01687166|520842521|FG001|Overall Study|Withdrawal by Subject|4|||
144448840|NCT01687166|520842522|FG002|Overall Study|Withdrawal by Subject|3|||
144448841|NCT01687166|520842523|FG003|Overall Study|Withdrawal by Subject|0|||
144448842|NCT01687166|520842520|FG000|Overall Study|Lost to Follow-up|2|||
144448843|NCT01687166|520842521|FG001|Overall Study|Lost to Follow-up|5|||
144448844|NCT01687166|520842522|FG002|Overall Study|Lost to Follow-up|1|||
144448845|NCT01687166|520842523|FG003|Overall Study|Lost to Follow-up|0|||
144448846|NCT01687166|520842520|FG000|Overall Study|Equipment/Device Availability|0|||
144448847|NCT01687166|520842521|FG001|Overall Study|Equipment/Device Availability|1|||
144448848|NCT01687166|520842522|FG002|Overall Study|Equipment/Device Availability|0|||
144448849|NCT01687166|520842523|FG003|Overall Study|Equipment/Device Availability|0|||
144448850|NCT01687166|520842520|FG000|Overall Study|Death|1|||
144194408|NCT03212794|519908411|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
144448851|NCT01687166|520842521|FG001|Overall Study|Death|1|||
144448852|NCT01687166|520842522|FG002|Overall Study|Death|0|||
144448853|NCT01687166|520842523|FG003|Overall Study|Death|0|||
144448854|NCT01687166|520842520|FG000|Overall Study|Protocol Violation|1|||
144448855|NCT01687166|520842521|FG001|Overall Study|Protocol Violation|1|||
144448856|NCT01687166|520842522|FG002|Overall Study|Protocol Violation|1|||
144448857|NCT01687166|520842523|FG003|Overall Study|Protocol Violation|0|||
144448858|NCT01687166|520842520|FG000|Overall Study|Subject moved out of state|0|||
144448859|NCT01687166|520842521|FG001|Overall Study|Subject moved out of state|1|||
144448860|NCT01687166|520842522|FG002|Overall Study|Subject moved out of state|0|||
144448861|NCT01687166|520842523|FG003|Overall Study|Subject moved out of state|0|||
144448862|NCT01687166|520842520|FG000|Overall Study|Patient unable to be compliant|1|||
144448863|NCT01687166|520842521|FG001|Overall Study|Patient unable to be compliant|0|||
144448864|NCT01687166|520842522|FG002|Overall Study|Patient unable to be compliant|0|||
144448865|NCT01687166|520842523|FG003|Overall Study|Patient unable to be compliant|0|||
144448866|NCT01687166|520842520|FG000|Overall Study|Physician choice to use different device|1|||
144448867|NCT01687166|520842521|FG001|Overall Study|Physician choice to use different device|2|||
144448868|NCT01687166|520842522|FG002|Overall Study|Physician choice to use different device|4|||
144448869|NCT01687166|520842523|FG003|Overall Study|Physician choice to use different device|0|||
144448870|NCT01687166|520842520|FG000|Overall Study|Insurance|0|||
144448871|NCT01687166|520842521|FG001|Overall Study|Insurance|0|||
144448872|NCT01687166|520842522|FG002|Overall Study|Insurance|1|||
144448873|NCT01687166|520842523|FG003|Overall Study|Insurance|1|||
144448874|NCT02755831|520842524|FG000|Overall Study|Lost to Follow-up|3|||
144448875|NCT02755831|520842525|FG001|Overall Study|Lost to Follow-up|3|||
144194409|NCT03212794|519908412|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
144194410|NCT03212794|519908411|FG000|Overall Study|Lost to Follow-up|5|||
144194411|NCT03212794|519908412|FG001|Overall Study|Lost to Follow-up|6|||
144194412|NCT03212794|519908411|FG000|Overall Study|Incarcerated; unable to participate|2|||
144194413|NCT03212794|519908412|FG001|Overall Study|Incarcerated; unable to participate|0|||
144194414|NCT03212794|519908411|FG000|Overall Study|Withdrawal by Subject|1|||
144194415|NCT03212794|519908412|FG001|Overall Study|Withdrawal by Subject|0|||
144194416|NCT03212794|519908411|FG000|Overall Study|Death|0|||
144194417|NCT03212794|519908412|FG001|Overall Study|Death|1|||
144194418|NCT03212794|519908411|FG000|Overall Study|Found to be ineligible after allocation|0|||
144448876|NCT00183872|520842526|FG000|Overall Study|Death|3|||
144448877|NCT00183872|520842526|FG000|Overall Study|Adverse Event|9|||
144448878|NCT00183872|520842526|FG000|Overall Study|Withdrawal by Subject|2|||
144448879|NCT00183872|520842526|FG000|Overall Study|Drug delayed more than 28 days|2|||
144448880|NCT02797262|520842528|FG000|Overall Study|Withdrawal by Subject|5|||
144253839|NCT02087943|520130060|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
144253840|NCT02087943|520130056|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
144253841|NCT02087943|520130057|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
144253842|NCT02087943|520130058|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
144253843|NCT02087943|520130059|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
144253844|NCT02087943|520130060|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
144253845|NCT02087943|520130056|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
144253846|NCT02087943|520130057|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
144253847|NCT02087943|520130058|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
144253848|NCT02087943|520130059|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
144253849|NCT02087943|520130060|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
144253850|NCT02087943|520130056|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
144253851|NCT02087943|520130057|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
144253852|NCT02087943|520130058|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
144253853|NCT02087943|520130059|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
144253854|NCT02087943|520130060|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
144253855|NCT00329745|520130068|FG000|Overall Study|Protocol Violation|1|||
144253856|NCT00329745|520130069|FG001|Overall Study|Protocol Violation|0|||
144253857|NCT00329745|520130068|FG000|Overall Study|Withdrawal by Subject|0|||
144253858|NCT00329745|520130069|FG001|Overall Study|Withdrawal by Subject|1|||
144253859|NCT00329745|520130068|FG000|Overall Study|Lost to Follow-up|86|||
144253860|NCT00329745|520130069|FG001|Overall Study|Lost to Follow-up|101|||
144253861|NCT01808222|520130071|FG000|Overall Study|mpMR scan was not performed|1|||
144253862|NCT01146561|520130072|FG000|Overall Study|Withdrawal by Subject|1|||
144253863|NCT01146561|520130072|FG000|Overall Study|Lost to Follow-up|1|||
144606580|NCT01848353|521421023|FG002|Phase 1|Withdrawal by Subject|0|||
144606581|NCT01848353|521421024|FG003|Phase 1|Withdrawal by Subject|0|||
144606582|NCT01848353|521421021|FG000|Phase 2|Withdrawal by Subject|3|||
144606583|NCT01848353|521421022|FG001|Phase 2|Withdrawal by Subject|2|||
144606584|NCT01848353|521421023|FG002|Phase 2|Withdrawal by Subject|0|||
144606585|NCT01848353|521421024|FG003|Phase 2|Withdrawal by Subject|0|||
144606586|NCT01848353|521421021|FG000|Phase 3|Withdrawal by Subject|1|||
144606587|NCT01848353|521421022|FG001|Phase 3|Withdrawal by Subject|1|||
144606588|NCT01848353|521421023|FG002|Phase 3|Withdrawal by Subject|0|||
144606589|NCT01848353|521421024|FG003|Phase 3|Withdrawal by Subject|0|||
144606590|NCT00935272|521421025|FG000|Overall Study|Lost to Follow-up|10|||
144606591|NCT00935272|521421026|FG001|Overall Study|Lost to Follow-up|3|||
144194419|NCT03212794|519908412|FG001|Overall Study|Found to be ineligible after allocation|1|||
144194420|NCT03212794|519908411|FG000|Overall Study|Relocated out of area|2|||
144194421|NCT03212794|519908412|FG001|Overall Study|Relocated out of area|0|||
144194422|NCT00897949|519908413|FG000|Overall Study|Adverse Event|1|||
144194423|NCT00897949|519908414|FG001|Overall Study|Adverse Event|1|||
144194424|NCT00897949|519908415|FG002|Overall Study|Adverse Event|0|||
144606592|NCT00935272|521421025|FG000|Overall Study|Withdrawal by Subject|8|||
144606593|NCT00935272|521421026|FG001|Overall Study|Withdrawal by Subject|2|||
144606594|NCT00935272|521421025|FG000|Overall Study|Physician Decision|1|||
144606595|NCT00935272|521421026|FG001|Overall Study|Physician Decision|0|||
144606596|NCT00935272|521421025|FG000|Overall Study|Protocol Violation|0|||
144606597|NCT00935272|521421026|FG001|Overall Study|Protocol Violation|1|||
144606598|NCT01478360|521421032|FG000|Overall Study|Lost to Follow-up|1|||
144606599|NCT01478360|521421033|FG001|Overall Study|Lost to Follow-up|0|||
144606600|NCT01478360|521421032|FG000|Overall Study|Adverse Event|0|||
144606601|NCT01478360|521421033|FG001|Overall Study|Adverse Event|1|||
144606602|NCT01478360|521421032|FG000|Overall Study|Administrative problems|1|||
144606603|NCT01478360|521421033|FG001|Overall Study|Administrative problems|2|||
144606604|NCT02289352|521421034|FG000|Overall Study|Withdrawal by Subject|1|||
144606605|NCT02289352|521421035|FG001|Overall Study|Withdrawal by Subject|1|||
144606606|NCT02289352|521421036|FG002|Overall Study|Withdrawal by Subject|0|||
144194425|NCT00897949|519908413|FG000|Overall Study|Lost to Follow-up|0|||
144194426|NCT00897949|519908414|FG001|Overall Study|Lost to Follow-up|2|||
144194427|NCT00897949|519908415|FG002|Overall Study|Lost to Follow-up|1|||
144194428|NCT00897949|519908413|FG000|Overall Study|Protocol Violation|6|||
144253864|NCT02324699|520130073|FG000|Overall Study|study terminated|1|||
144253865|NCT03970200|520130074|FG000|Overall Study|Death|2|||
144253866|NCT03970200|520130075|FG001|Overall Study|Death|2|||
144253867|NCT03970200|520130076|FG002|Overall Study|Death|1|||
144253868|NCT03970200|520130074|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
144448881|NCT02797262|520842529|FG001|Overall Study|Withdrawal by Subject|1|||
144606607|NCT01390272|521421037|FG000|Overall Study|Death|3|||
144606608|NCT01390272|521421038|FG001|Overall Study|Death|2|||
144606609|NCT01390272|521421037|FG000|Overall Study|Withdrawal by Subject|9|||
144606610|NCT01390272|521421038|FG001|Overall Study|Withdrawal by Subject|5|||
144606611|NCT01390272|521421037|FG000|Overall Study|Patient moved, no longer eligible|5|||
144606612|NCT01390272|521421038|FG001|Overall Study|Patient moved, no longer eligible|8|||
144606613|NCT01177384|521421039|FG000|Overall Study|Adverse Event|6|||
144606614|NCT01177384|521421040|FG001|Overall Study|Adverse Event|4|||
144448882|NCT02797262|520842528|FG000|Overall Study|Lost to Follow-up|10|||
144448883|NCT02797262|520842529|FG001|Overall Study|Lost to Follow-up|7|||
144448884|NCT02797262|520842528|FG000|Overall Study|Death|1|||
144448885|NCT02797262|520842529|FG001|Overall Study|Death|2|||
144448886|NCT02797262|520842528|FG000|Overall Study|Adverse Event|1|||
144448887|NCT02797262|520842529|FG001|Overall Study|Adverse Event|0|||
144448888|NCT02797262|520842528|FG000|Overall Study|COVID-19|2|||
144448889|NCT02797262|520842529|FG001|Overall Study|COVID-19|1|||
144448890|NCT02797262|520842528|FG000|Overall Study|Out-of-country|1|||
144448891|NCT02797262|520842529|FG001|Overall Study|Out-of-country|0|||
144448892|NCT01600586|520842530|FG000|Overall Study|Physician Decision|3|||
144448893|NCT01600586|520842531|FG001|Overall Study|Physician Decision|3|||
144448894|NCT00965848|520842539|FG000|Overall Study|Protocol Violation|3|||
144448895|NCT00965848|520842540|FG001|Overall Study|Protocol Violation|0|||
144448896|NCT00965848|520842541|FG002|Overall Study|Protocol Violation|1|||
144448897|NCT00965848|520842539|FG000|Overall Study|Death|11|||
144448898|NCT00965848|520842540|FG001|Overall Study|Death|1|||
144448899|NCT00965848|520842541|FG002|Overall Study|Death|5|||
144448900|NCT00965848|520842539|FG000|Overall Study|Lost to Follow-up|0|||
144448901|NCT00965848|520842540|FG001|Overall Study|Lost to Follow-up|0|||
144448902|NCT00965848|520842541|FG002|Overall Study|Lost to Follow-up|1|||
144448903|NCT00965848|520842539|FG000|Overall Study|Withdrawal by Subject|1|||
144448904|NCT00965848|520842540|FG001|Overall Study|Withdrawal by Subject|0|||
144448905|NCT00965848|520842541|FG002|Overall Study|Withdrawal by Subject|0|||
144448906|NCT00965848|520842539|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
144448907|NCT00965848|520842540|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
144448908|NCT00965848|520842541|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
144448909|NCT00965848|520842539|FG000|Overall Study|Not Clinically Evaluable|7|||
144448910|NCT00965848|520842540|FG001|Overall Study|Not Clinically Evaluable|1|||
144448911|NCT00965848|520842541|FG002|Overall Study|Not Clinically Evaluable|1|||
144448912|NCT00965848|520842539|FG000|Overall Study|Other|5|||
144448913|NCT00965848|520842540|FG001|Overall Study|Other|0|||
144448914|NCT00965848|520842541|FG002|Overall Study|Other|1|||
144448915|NCT00813761|520842542|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
144448916|NCT00813761|520842543|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
144448917|NCT00813761|520842544|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
144448918|NCT00813761|520842545|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
144448919|NCT00813761|520842542|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
144448920|NCT00813761|520842543|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
144448921|NCT00813761|520842544|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
144448922|NCT00813761|520842545|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
144448923|NCT00813761|520842542|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
144448924|NCT00813761|520842543|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
144448925|NCT00813761|520842544|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
144448926|NCT00813761|520842545|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
144448927|NCT00813761|520842542|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
144448928|NCT00813761|520842543|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
144448929|NCT00813761|520842544|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
144448930|NCT00813761|520842545|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
144448931|NCT00813761|520842542|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
144448932|NCT00813761|520842543|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
144448933|NCT00813761|520842544|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
144448934|NCT00813761|520842545|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
144448935|NCT00813761|520842542|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
144448936|NCT00813761|520842543|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
144448937|NCT00813761|520842544|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
144448938|NCT00813761|520842545|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
144448939|NCT00813761|520842542|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
144448940|NCT00813761|520842543|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
144448941|NCT00813761|520842544|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
144448942|NCT00813761|520842545|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
144448943|NCT00813761|520842542|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
144448944|NCT00813761|520842543|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
144448945|NCT00813761|520842544|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
144448946|NCT00813761|520842545|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
144448947|NCT00813761|520842542|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
144448948|NCT00813761|520842543|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
144448949|NCT00813761|520842544|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
144448950|NCT00813761|520842545|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
144448951|NCT00813761|520842542|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
144725312|NCT00862979|521851229|FG001|Overall Study|Administrative problems|1|||
144448952|NCT00813761|520842543|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
144448953|NCT00813761|520842544|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
144448954|NCT00813761|520842545|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
144448955|NCT00813761|520842542|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
144448956|NCT00813761|520842543|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
144448957|NCT00813761|520842544|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
144448958|NCT00813761|520842545|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
144448959|NCT00813761|520842542|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
144448960|NCT00813761|520842543|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
144448961|NCT00813761|520842544|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
144448962|NCT00813761|520842545|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
144448963|NCT00691210|520842546|FG000|Overall Study|Progression of Disease|0|||
144448964|NCT00691210|520842547|FG001|Overall Study|Progression of Disease|0|||
144448965|NCT00691210|520842548|FG002|Overall Study|Progression of Disease|0|||
144448966|NCT00691210|520842549|FG003|Overall Study|Progression of Disease|2|||
144448967|NCT00691210|520842550|FG004|Overall Study|Progression of Disease|0|||
144725313|NCT00862979|521851228|FG000|Overall Study|Death|0|||
144725314|NCT00862979|521851229|FG001|Overall Study|Death|1|||
144725315|NCT02270736|521851230|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
144725316|NCT02270736|521851231|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
144725317|NCT02270736|521851232|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
144725318|NCT02270736|521851233|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
144725319|NCT02270736|521851234|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
144725320|NCT02270736|521851230|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
144725321|NCT02270736|521851231|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
144725322|NCT02270736|521851232|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
144725323|NCT02270736|521851233|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
144725324|NCT02270736|521851234|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
144725325|NCT02270736|521851230|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
144725326|NCT02270736|521851231|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
144725327|NCT02270736|521851232|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
144725328|NCT02270736|521851233|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
144725329|NCT02270736|521851234|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
144725330|NCT02270736|521851230|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
144725331|NCT02270736|521851231|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
144725332|NCT02270736|521851232|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
144725333|NCT02270736|521851233|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
144725334|NCT02270736|521851234|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
144725335|NCT02270736|521851230|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
144725336|NCT02270736|521851231|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
144725337|NCT02270736|521851232|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
144725338|NCT02270736|521851233|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
144725339|NCT02270736|521851234|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
144725340|NCT02270736|521851230|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
144725341|NCT02270736|521851231|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
144725342|NCT02270736|521851232|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
144725343|NCT02270736|521851233|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
144725344|NCT02270736|521851234|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
144725345|NCT02270736|521851230|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
144725346|NCT02270736|521851231|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
144725347|NCT02270736|521851232|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
144725348|NCT02270736|521851233|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
144725349|NCT02270736|521851234|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
144725350|NCT02270736|521851230|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
144194429|NCT00897949|519908414|FG001|Overall Study|Protocol Violation|3|||
144194430|NCT00897949|519908415|FG002|Overall Study|Protocol Violation|1|||
144194431|NCT00897949|519908413|FG000|Overall Study|Withdrawal by Subject|1|||
144194432|NCT00897949|519908414|FG001|Overall Study|Withdrawal by Subject|2|||
144194433|NCT00897949|519908415|FG002|Overall Study|Withdrawal by Subject|0|||
144448968|NCT00691210|520842551|FG005|Overall Study|Progression of Disease|0|||
144448969|NCT00691210|520842552|FG006|Overall Study|Progression of Disease|0|||
144448970|NCT00691210|520842553|FG007|Overall Study|Progression of Disease|0|||
144448971|NCT00691210|520842546|FG000|Overall Study|Lack of Efficacy|0|||
144448972|NCT00691210|520842547|FG001|Overall Study|Lack of Efficacy|0|||
144448973|NCT00691210|520842548|FG002|Overall Study|Lack of Efficacy|0|||
144448974|NCT00691210|520842549|FG003|Overall Study|Lack of Efficacy|1|||
144448975|NCT00691210|520842550|FG004|Overall Study|Lack of Efficacy|0|||
144448976|NCT00691210|520842551|FG005|Overall Study|Lack of Efficacy|1|||
144448977|NCT00691210|520842552|FG006|Overall Study|Lack of Efficacy|0|||
144448978|NCT00691210|520842553|FG007|Overall Study|Lack of Efficacy|0|||
144448979|NCT01208233|520842554|FG000|Overall Study|Adverse Event|0|||
144725351|NCT02270736|521851231|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
144725352|NCT02270736|521851232|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
144448980|NCT01208233|520842555|FG001|Overall Study|Adverse Event|1|||
144448981|NCT01208233|520842556|FG002|Overall Study|Adverse Event|2|||
144448982|NCT01208233|520842557|FG003|Overall Study|Adverse Event|0|||
144448983|NCT01208233|520842558|FG004|Overall Study|Adverse Event|3|||
144448984|NCT01208233|520842559|FG005|Overall Study|Adverse Event|5|||
144448985|NCT01208233|520842554|FG000|Overall Study|Death|0|||
144448986|NCT01208233|520842555|FG001|Overall Study|Death|0|||
144448987|NCT01208233|520842556|FG002|Overall Study|Death|0|||
144448988|NCT01208233|520842557|FG003|Overall Study|Death|0|||
144448989|NCT01208233|520842558|FG004|Overall Study|Death|3|||
144448990|NCT01208233|520842559|FG005|Overall Study|Death|5|||
144448991|NCT01208233|520842554|FG000|Overall Study|Did not meet entrance criteria|2|||
144448992|NCT01208233|520842555|FG001|Overall Study|Did not meet entrance criteria|1|||
144448993|NCT01208233|520842556|FG002|Overall Study|Did not meet entrance criteria|1|||
144448994|NCT01208233|520842557|FG003|Overall Study|Did not meet entrance criteria|0|||
144448995|NCT01208233|520842558|FG004|Overall Study|Did not meet entrance criteria|1|||
144448996|NCT01208233|520842559|FG005|Overall Study|Did not meet entrance criteria|0|||
144448997|NCT01208233|520842554|FG000|Overall Study|Medication error without adverse event|0|||
144448998|NCT01208233|520842555|FG001|Overall Study|Medication error without adverse event|0|||
144448999|NCT01208233|520842556|FG002|Overall Study|Medication error without adverse event|0|||
144449000|NCT01208233|520842557|FG003|Overall Study|Medication error without adverse event|0|||
144449001|NCT01208233|520842558|FG004|Overall Study|Medication error without adverse event|0|||
144449002|NCT01208233|520842559|FG005|Overall Study|Medication error without adverse event|1|||
144449003|NCT01208233|520842554|FG000|Overall Study|Study terminated by sponsor|0|||
144449004|NCT01208233|520842555|FG001|Overall Study|Study terminated by sponsor|0|||
144449005|NCT01208233|520842556|FG002|Overall Study|Study terminated by sponsor|0|||
144449006|NCT01208233|520842557|FG003|Overall Study|Study terminated by sponsor|0|||
144449007|NCT01208233|520842558|FG004|Overall Study|Study terminated by sponsor|10|||
144449008|NCT01208233|520842559|FG005|Overall Study|Study terminated by sponsor|7|||
144449009|NCT01208233|520842554|FG000|Overall Study|Protocol Violation|0|||
144449010|NCT01208233|520842555|FG001|Overall Study|Protocol Violation|0|||
144449011|NCT01208233|520842556|FG002|Overall Study|Protocol Violation|0|||
144449012|NCT01208233|520842557|FG003|Overall Study|Protocol Violation|0|||
144449013|NCT01208233|520842558|FG004|Overall Study|Protocol Violation|3|||
144449014|NCT01208233|520842559|FG005|Overall Study|Protocol Violation|0|||
144449015|NCT01208233|520842554|FG000|Overall Study|Other|2|||
144449016|NCT01208233|520842555|FG001|Overall Study|Other|1|||
144449017|NCT01208233|520842556|FG002|Overall Study|Other|0|||
144449018|NCT01208233|520842557|FG003|Overall Study|Other|0|||
144449019|NCT01208233|520842558|FG004|Overall Study|Other|0|||
144449020|NCT01208233|520842559|FG005|Overall Study|Other|1|||
144449021|NCT01208233|520842554|FG000|Overall Study|Withdrawal by Subject|1|||
144449022|NCT01208233|520842555|FG001|Overall Study|Withdrawal by Subject|0|||
144449023|NCT01208233|520842556|FG002|Overall Study|Withdrawal by Subject|1|||
144449024|NCT01208233|520842557|FG003|Overall Study|Withdrawal by Subject|1|||
144449025|NCT01208233|520842558|FG004|Overall Study|Withdrawal by Subject|4|||
144449026|NCT01208233|520842559|FG005|Overall Study|Withdrawal by Subject|2|||
144449027|NCT00983814|520842561|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
144449028|NCT00983814|520842562|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
144449029|NCT00983814|520842563|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
144449030|NCT00983814|520842561|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
144449031|NCT00983814|520842562|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
144449032|NCT00983814|520842563|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
144449033|NCT00983814|520842561|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
144449034|NCT00983814|520842562|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
144449035|NCT00983814|520842563|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
144449036|NCT00983814|520842561|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
144449037|NCT00983814|520842562|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
144449038|NCT00983814|520842563|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
144449039|NCT00983814|520842561|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
144449040|NCT00983814|520842562|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
144449041|NCT00983814|520842563|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
144449042|NCT01181895|520842566|FG000|Overall Study|Adverse Event|3|||
144449043|NCT01181895|520842567|FG001|Overall Study|Adverse Event|1|||
144449044|NCT01181895|520842568|FG002|Overall Study|Adverse Event|1|||
144449045|NCT01181895|520842566|FG000|Overall Study|Lack of Efficacy|8|||
144253869|NCT03970200|520130075|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
144449046|NCT01181895|520842567|FG001|Overall Study|Lack of Efficacy|9|||
144449047|NCT01181895|520842568|FG002|Overall Study|Lack of Efficacy|9|||
144449048|NCT01181895|520842566|FG000|Overall Study|Protocol Violation|2|||
144449049|NCT01181895|520842567|FG001|Overall Study|Protocol Violation|1|||
144449050|NCT01181895|520842568|FG002|Overall Study|Protocol Violation|0|||
144449051|NCT01181895|520842566|FG000|Overall Study|Lost to Follow-up|0|||
144449052|NCT01181895|520842567|FG001|Overall Study|Lost to Follow-up|1|||
144449053|NCT01181895|520842568|FG002|Overall Study|Lost to Follow-up|2|||
144449054|NCT01181895|520842566|FG000|Overall Study|Investigator Discretion|1|||
144253870|NCT03970200|520130076|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
144449055|NCT01181895|520842567|FG001|Overall Study|Investigator Discretion|2|||
144449056|NCT01181895|520842568|FG002|Overall Study|Investigator Discretion|1|||
144449057|NCT01181895|520842566|FG000|Overall Study|Withdrawal by Subject|3|||
144449058|NCT01181895|520842567|FG001|Overall Study|Withdrawal by Subject|0|||
144449059|NCT01181895|520842568|FG002|Overall Study|Withdrawal by Subject|5|||
144449060|NCT00555438|520842571|FG000|10 Days Post-operative|Death|4|||
144449061|NCT00555438|520842571|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
144449062|NCT05789875|520842574|FG000|Overall Study|Lost to Follow-up|6|||
144449063|NCT01994395|520842575|FG000|Overall Study|Withdrawal by Subject|1|||
144449064|NCT01994395|520842576|FG001|Overall Study|Withdrawal by Subject|2|||
144449065|NCT02447991|520842577|FG000|Overall Study|Withdrawn by subject - no data|0|||
144606615|NCT01177384|521421039|FG000|Overall Study|Lack of Efficacy|0|||
144606616|NCT01177384|521421040|FG001|Overall Study|Lack of Efficacy|1|||
144606617|NCT01177384|521421039|FG000|Overall Study|Lost to Follow-up|3|||
144606618|NCT01177384|521421040|FG001|Overall Study|Lost to Follow-up|4|||
144606619|NCT01177384|521421039|FG000|Overall Study|Physician Decision|0|||
144606620|NCT01177384|521421040|FG001|Overall Study|Physician Decision|3|||
144606621|NCT01177384|521421039|FG000|Overall Study|Protocol Violation|0|||
144606622|NCT01177384|521421040|FG001|Overall Study|Protocol Violation|2|||
144606623|NCT01177384|521421039|FG000|Overall Study|Withdrawal by Subject|5|||
144606624|NCT01177384|521421040|FG001|Overall Study|Withdrawal by Subject|12|||
144606625|NCT00590044|521421071|FG000|Overall Study|Withdrawal by Subject|2|||
144606626|NCT00590044|521421072|FG001|Overall Study|Withdrawal by Subject|2|||
144606627|NCT00590044|521421071|FG000|Overall Study|wrong insulin arm assigned|1|||
144606628|NCT00590044|521421072|FG001|Overall Study|wrong insulin arm assigned|0|||
144606629|NCT00590044|521421071|FG000|Overall Study|Protocol Violation|1|||
144606630|NCT00590044|521421072|FG001|Overall Study|Protocol Violation|0|||
144606631|NCT01514136|521421076|FG000|Test Period 1; Test A|Protocol Violation|1|||
144606632|NCT01514136|521421077|FG001|Test Period 1; Test A|Protocol Violation|0|||
144606633|NCT01514136|521421078|FG002|Test Period 1; Test A|Protocol Violation|0|||
144606634|NCT01514136|521421079|FG003|Test Period 1; Test A|Protocol Violation|0|||
144606635|NCT01514136|521421080|FG004|Test Period 1; Test A|Protocol Violation|0|||
144606636|NCT01514136|521421081|FG005|Test Period 1; Test A|Protocol Violation|0|||
144449066|NCT02447991|520842578|FG001|Overall Study|Withdrawn by subject - no data|2|||
144449067|NCT02447991|520842577|FG000|Overall Study|Withdrawn by Subject - with data|4|||
144449068|NCT02447991|520842578|FG001|Overall Study|Withdrawn by Subject - with data|4|||
144449069|NCT02447991|520842577|FG000|Overall Study|Lost to Follow-up - no data|3|||
144449070|NCT02447991|520842578|FG001|Overall Study|Lost to Follow-up - no data|6|||
144449071|NCT02447991|520842577|FG000|Overall Study|Lost to follow-up - with data|0|||
144449072|NCT02447991|520842578|FG001|Overall Study|Lost to follow-up - with data|3|||
144449073|NCT02447991|520842577|FG000|Overall Study|End of study - no treatment results|3|||
144449074|NCT02447991|520842578|FG001|Overall Study|End of study - no treatment results|6|||
144449075|NCT02447991|520842577|FG000|Overall Study|End of study - partial treatment results|0|||
144449076|NCT02447991|520842578|FG001|Overall Study|End of study - partial treatment results|9|||
144449077|NCT06748040|520842579|FG000|Overall Study|Death|3|||
144449078|NCT06748040|520842580|FG001|Overall Study|Death|4|||
144449079|NCT06748040|520842579|FG000|Overall Study|Lost to Follow-up|134|||
144449080|NCT06748040|520842580|FG001|Overall Study|Lost to Follow-up|132|||
144449081|NCT06748040|520842579|FG000|Overall Study|Withdrawal by Subject|3|||
144449082|NCT06748040|520842580|FG001|Overall Study|Withdrawal by Subject|5|||
144449083|NCT03136068|520844337|FG000|Overall Study|Lost to Follow-up|1|||
144449084|NCT03136068|520844338|FG001|Overall Study|Lost to Follow-up|1|||
144449085|NCT03136068|520844337|FG000|Overall Study|Protocol Violation|1|||
144449086|NCT03136068|520844338|FG001|Overall Study|Protocol Violation|0|||
144449087|NCT01040871|520844339|FG000|Overall Study|Adverse Event|6|||
144449088|NCT01040871|520844340|FG001|Overall Study|Adverse Event|2|||
144449089|NCT01040871|520844339|FG000|Overall Study|Withdrawal by Subject|2|||
144449090|NCT01040871|520844340|FG001|Overall Study|Withdrawal by Subject|0|||
144449091|NCT01040871|520844339|FG000|Overall Study|Death|1|||
144449092|NCT01040871|520844340|FG001|Overall Study|Death|3|||
144449093|NCT01040871|520844339|FG000|Overall Study|Lack of Efficacy|1|||
144449094|NCT01040871|520844340|FG001|Overall Study|Lack of Efficacy|1|||
144449095|NCT01040871|520844339|FG000|Overall Study|drug supply issue|1|||
144449096|NCT01040871|520844340|FG001|Overall Study|drug supply issue|0|||
144449097|NCT01040871|520844339|FG000|Overall Study|Randomized and Not Treated|2|||
144606637|NCT01514136|521421082|FG006|Test Period 1; Test A|Protocol Violation|0|||
144449098|NCT01040871|520844340|FG001|Overall Study|Randomized and Not Treated|1|||
144449099|NCT01073618|520844342|FG000|Overall Study|Death|208|||
144449100|NCT01073618|520844342|FG000|Overall Study|Adverse Event|19|||
144449101|NCT01073618|520844342|FG000|Overall Study|Other|80|||
144449102|NCT02044510|520844343|FG000|Overall Study|Adverse Event|1|||
144449103|NCT02044510|520844344|FG001|Overall Study|Adverse Event|2|||
144449104|NCT01175824|520844345|FG000|Overall Study|Adverse Event|2|||
144606638|NCT01514136|521421083|FG007|Test Period 1; Test A|Protocol Violation|0|||
144606639|NCT01514136|521421076|FG000|Test Period 1; Test A|Break from study holiday|2|||
144606640|NCT01514136|521421077|FG001|Test Period 1; Test A|Break from study holiday|0|||
144606641|NCT01514136|521421078|FG002|Test Period 1; Test A|Break from study holiday|0|||
144449105|NCT01175824|520844346|FG001|Overall Study|Adverse Event|1|||
144449106|NCT01175824|520844345|FG000|Overall Study|Lack of Efficacy|2|||
144449107|NCT01175824|520844346|FG001|Overall Study|Lack of Efficacy|0|||
144449108|NCT01175824|520844345|FG000|Overall Study|Lost to Follow-up|0|||
144449109|NCT01175824|520844346|FG001|Overall Study|Lost to Follow-up|1|||
144449110|NCT01175824|520844345|FG000|Overall Study|Physician Decision|0|||
144449111|NCT01175824|520844346|FG001|Overall Study|Physician Decision|4|||
144725353|NCT02270736|521851233|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
144725354|NCT02270736|521851234|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
144725355|NCT02270736|521851230|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
144725356|NCT02270736|521851231|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
144725357|NCT02270736|521851232|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
144725358|NCT02270736|521851233|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
144725359|NCT02270736|521851234|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
144725360|NCT00262600|521851235|FG000|Overall Study|Lost to Follow-up|17|||
144725361|NCT00262600|521851236|FG001|Overall Study|Lost to Follow-up|31|||
144725362|NCT00262600|521851237|FG002|Overall Study|Lost to Follow-up|41|||
144725363|NCT00262600|521851235|FG000|Overall Study|Withdrawal by Subject|128|||
144725364|NCT00262600|521851236|FG001|Overall Study|Withdrawal by Subject|145|||
144725365|NCT00262600|521851237|FG002|Overall Study|Withdrawal by Subject|139|||
144725366|NCT00262600|521851235|FG000|Overall Study|Not Treated|32|||
144725367|NCT00262600|521851236|FG001|Overall Study|Not Treated|17|||
144725368|NCT00262600|521851237|FG002|Overall Study|Not Treated|24|||
144725369|NCT00262600|521851235|FG000|Overall Study|Other|58|||
144725370|NCT00262600|521851236|FG001|Overall Study|Other|59|||
144725371|NCT00262600|521851237|FG002|Overall Study|Other|62|||
144449112|NCT01175824|520844345|FG000|Overall Study|Protocol Violation|2|||
144449113|NCT01175824|520844346|FG001|Overall Study|Protocol Violation|5|||
144725372|NCT02710123|521851240|FG000|Overall Study|Lost to Follow-up|3|||
144725373|NCT02710123|521851241|FG001|Overall Study|Lost to Follow-up|4|||
144725374|NCT02710123|521851240|FG000|Overall Study|Withdrawal by Subject|1|||
144725375|NCT02710123|521851241|FG001|Overall Study|Withdrawal by Subject|1|||
144725376|NCT02710123|521851240|FG000|Overall Study|Illness unrelated to study intervention|1|||
144725377|NCT02710123|521851241|FG001|Overall Study|Illness unrelated to study intervention|0|||
144725378|NCT05381948|521851242|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
144725379|NCT05381948|521851243|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
144725380|NCT05381948|521851244|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
144725381|NCT05381948|521851242|FG000|Overall Study|Adverse Event: Non-ocular|0|||
144725382|NCT05381948|521851243|FG001|Overall Study|Adverse Event: Non-ocular|1|||
144725383|NCT05381948|521851244|FG002|Overall Study|Adverse Event: Non-ocular|0|||
144725384|NCT05381948|521851242|FG000|Overall Study|Lost to Follow-up|1|||
144725385|NCT05381948|521851243|FG001|Overall Study|Lost to Follow-up|0|||
144725386|NCT05381948|521851244|FG002|Overall Study|Lost to Follow-up|0|||
144725387|NCT05381948|521851242|FG000|Overall Study|Protocol Deviation|0|||
144725388|NCT05381948|521851243|FG001|Overall Study|Protocol Deviation|2|||
144725389|NCT05381948|521851244|FG002|Overall Study|Protocol Deviation|0|||
144725390|NCT05381948|521851242|FG000|Overall Study|Withdrawal by Subject|1|||
144725391|NCT05381948|521851243|FG001|Overall Study|Withdrawal by Subject|0|||
144725392|NCT05381948|521851244|FG002|Overall Study|Withdrawal by Subject|1|||
144725393|NCT05381948|521851242|FG000|Overall Study|Death|0|||
144725394|NCT05381948|521851243|FG001|Overall Study|Death|2|||
144725395|NCT05381948|521851244|FG002|Overall Study|Death|0|||
144725396|NCT05381948|521851242|FG000|Overall Study|Discontinued study without receiving study drug|0|||
144725397|NCT05381948|521851243|FG001|Overall Study|Discontinued study without receiving study drug|0|||
144725398|NCT05381948|521851244|FG002|Overall Study|Discontinued study without receiving study drug|1|||
144725399|NCT04471207|521851245|FG000|Overall Study|Lost to Follow-up|4|||
144725400|NCT04471207|521851246|FG001|Overall Study|Lost to Follow-up|1|||
144725401|NCT04471207|521851245|FG000|Overall Study|Medication Contraindication|0|||
144725402|NCT04471207|521851246|FG001|Overall Study|Medication Contraindication|1|||
144725403|NCT04471207|521851245|FG000|Overall Study|Loss of Interest|2|||
144725404|NCT04471207|521851246|FG001|Overall Study|Loss of Interest|1|||
144449114|NCT01175824|520844345|FG000|Overall Study|Withdrawal by Subject|3|||
144449115|NCT01175824|520844346|FG001|Overall Study|Withdrawal by Subject|7|||
144449116|NCT01175824|520844345|FG000|Overall Study|Sponsor Decision|1|||
144449117|NCT01175824|520844346|FG001|Overall Study|Sponsor Decision|0|||
144449118|NCT01175824|520844345|FG000|Overall Study|Entry Criteria Not Met|6|||
144253871|NCT01607346|520130077|FG000|Overall Study|Adverse Event|3|||
144449119|NCT01175824|520844346|FG001|Overall Study|Entry Criteria Not Met|4|||
144725405|NCT04471207|521851245|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
144725406|NCT04471207|521851246|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
144725407|NCT04471207|521851245|FG000|Overall Study|Scheduling Conflicts|3|||
144725408|NCT04471207|521851246|FG001|Overall Study|Scheduling Conflicts|1|||
144725409|NCT04471207|521851245|FG000|Overall Study|Physician Decision|1|||
144725410|NCT04471207|521851246|FG001|Overall Study|Physician Decision|0|||
144725411|NCT04471207|521851245|FG000|Overall Study|Unwilling to Use System|0|||
144725412|NCT04471207|521851246|FG001|Overall Study|Unwilling to Use System|1|||
144725413|NCT00561730|521851249|FG000|Overall Study|Adverse Event|2|||
144725414|NCT00561730|521851249|FG000|Overall Study|Handling of the drug|1|||
144449120|NCT03455855|520844347|FG000|Overall Study|Lost to Follow-up|4|||
144449121|NCT03455855|520844348|FG001|Overall Study|Lost to Follow-up|2|||
144449122|NCT02979535|520844349|FG000|Overall Study|Non compliance with the protocol|78|||
144449123|NCT02979535|520844350|FG001|Overall Study|Non compliance with the protocol|82|||
144449124|NCT02979535|520844349|FG000|Overall Study|Consent withdrawn by participant|11|||
144449125|NCT02979535|520844350|FG001|Overall Study|Consent withdrawn by participant|18|||
144449126|NCT02979535|520844349|FG000|Overall Study|Lost to Follow-up|6|||
144449127|NCT02979535|520844350|FG001|Overall Study|Lost to Follow-up|1|||
144449128|NCT04820673|520844354|FG000|Overall Study|Adverse Event|6|||
144449129|NCT04820673|520844354|FG000|Overall Study|Due to Lack of Effectiveness|1|||
144449130|NCT04820673|520844354|FG000|Overall Study|Pregnancy|1|||
144449131|NCT04820673|520844354|FG000|Overall Study|Voluntary Withdrawal|20|||
144449132|NCT04820673|520844354|FG000|Overall Study|Lost to Follow-up|10|||
144449133|NCT00587587|520844355|FG000|Overall Study|Lost to Follow-up|6|||
144449134|NCT00587587|520844356|FG001|Overall Study|Lost to Follow-up|1|||
144449135|NCT00767000|520844362|FG000|54-week Study|Adverse Event|4|||
144449136|NCT00767000|520844363|FG001|54-week Study|Adverse Event|6|||
144449137|NCT00767000|520844364|FG002|54-week Study|Adverse Event|6|||
144449138|NCT00767000|520844365|FG003|54-week Study|Adverse Event|8|||
144449139|NCT00767000|520844366|FG004|54-week Study|Adverse Event|4|||
144449140|NCT00767000|520844362|FG000|54-week Study|Creaninine/creatinine clearance|2|||
144449141|NCT00767000|520844363|FG001|54-week Study|Creaninine/creatinine clearance|1|||
144449142|NCT00767000|520844364|FG002|54-week Study|Creaninine/creatinine clearance|2|||
144449143|NCT00767000|520844365|FG003|54-week Study|Creaninine/creatinine clearance|2|||
144449144|NCT00767000|520844366|FG004|54-week Study|Creaninine/creatinine clearance|4|||
144449145|NCT00767000|520844362|FG000|54-week Study|Hyperglycemia|0|||
144449146|NCT00767000|520844363|FG001|54-week Study|Hyperglycemia|0|||
144449147|NCT00767000|520844364|FG002|54-week Study|Hyperglycemia|1|||
144449148|NCT00767000|520844365|FG003|54-week Study|Hyperglycemia|0|||
144449149|NCT00767000|520844366|FG004|54-week Study|Hyperglycemia|1|||
144449150|NCT00767000|520844362|FG000|54-week Study|Hypoglycemia|0|||
144449151|NCT00767000|520844363|FG001|54-week Study|Hypoglycemia|1|||
144449152|NCT00767000|520844364|FG002|54-week Study|Hypoglycemia|0|||
144449153|NCT00767000|520844365|FG003|54-week Study|Hypoglycemia|0|||
144449154|NCT00767000|520844366|FG004|54-week Study|Hypoglycemia|0|||
144449155|NCT00767000|520844362|FG000|54-week Study|Interruption of study medication|0|||
144449156|NCT00767000|520844363|FG001|54-week Study|Interruption of study medication|0|||
144449157|NCT00767000|520844364|FG002|54-week Study|Interruption of study medication|1|||
144449158|NCT00767000|520844365|FG003|54-week Study|Interruption of study medication|0|||
144449159|NCT00767000|520844366|FG004|54-week Study|Interruption of study medication|0|||
144449160|NCT00767000|520844362|FG000|54-week Study|Lack of Efficacy|2|||
144449161|NCT00767000|520844363|FG001|54-week Study|Lack of Efficacy|0|||
144449162|NCT00767000|520844364|FG002|54-week Study|Lack of Efficacy|1|||
144449163|NCT00767000|520844365|FG003|54-week Study|Lack of Efficacy|0|||
144449164|NCT00767000|520844366|FG004|54-week Study|Lack of Efficacy|5|||
144449165|NCT00767000|520844362|FG000|54-week Study|Lost to Follow-up|4|||
144449166|NCT00767000|520844363|FG001|54-week Study|Lost to Follow-up|0|||
144449167|NCT00767000|520844364|FG002|54-week Study|Lost to Follow-up|1|||
144449168|NCT00767000|520844365|FG003|54-week Study|Lost to Follow-up|4|||
144449169|NCT00767000|520844366|FG004|54-week Study|Lost to Follow-up|2|||
144449170|NCT00767000|520844362|FG000|54-week Study|Physician Decision|4|||
144449171|NCT00767000|520844363|FG001|54-week Study|Physician Decision|0|||
144253872|NCT01098162|520130078|FG000|Overall Study|Adverse Event|37|||
144253873|NCT01098162|520130078|FG000|Overall Study|Lack of Efficacy|4|||
144253874|NCT01098162|520130078|FG000|Overall Study|Wish of Patient|7|||
144253875|NCT01098162|520130078|FG000|Overall Study|Lost to Follow-up|9|||
144253876|NCT01098162|520130078|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
144253877|NCT01098162|520130078|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
144253878|NCT01098162|520130078|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
144253879|NCT01098162|520130078|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
144253880|NCT01098162|520130078|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
144253881|NCT01098162|520130078|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
144253882|NCT01098162|520130078|FG000|Overall Study|Other Reason|1|||
144253883|NCT01098162|520130078|FG000|Overall Study|Reason Unknown|26|||
144253884|NCT01605825|520130079|FG000|Overall Study|Adverse Event|4|||
144253885|NCT01605825|520130080|FG001|Overall Study|Adverse Event|2|||
144253886|NCT01605825|520130079|FG000|Overall Study|Withdrawal by Subject|0|||
144253887|NCT01605825|520130080|FG001|Overall Study|Withdrawal by Subject|1|||
144253888|NCT01605825|520130079|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
144725415|NCT00561730|521851249|FG000|Overall Study|Lost to Follow-up|5|||
144253889|NCT01605825|520130080|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
144253890|NCT01605825|520130079|FG000|Overall Study|Non-Compliance with Protocol|3|||
144449172|NCT00767000|520844364|FG002|54-week Study|Physician Decision|1|||
144449173|NCT00767000|520844365|FG003|54-week Study|Physician Decision|1|||
144449174|NCT00767000|520844366|FG004|54-week Study|Physician Decision|1|||
144449175|NCT00767000|520844362|FG000|54-week Study|Progressive disease|0|||
144449176|NCT00767000|520844363|FG001|54-week Study|Progressive disease|0|||
144449177|NCT00767000|520844364|FG002|54-week Study|Progressive disease|1|||
144194434|NCT00897949|519908413|FG000|Overall Study|Patient Uncoorperative|0|||
144194435|NCT00897949|519908414|FG001|Overall Study|Patient Uncoorperative|2|||
144194436|NCT00897949|519908415|FG002|Overall Study|Patient Uncoorperative|1|||
144194437|NCT00897949|519908413|FG000|Overall Study|Lost to Follow-up|30|||
144194438|NCT00897949|519908414|FG001|Overall Study|Lost to Follow-up|23|||
144194439|NCT00897949|519908415|FG002|Overall Study|Lost to Follow-up|17|||
144194440|NCT00897949|519908413|FG000|Overall Study|Withdrawal by Subject|24|||
144194441|NCT00897949|519908414|FG001|Overall Study|Withdrawal by Subject|31|||
144194442|NCT00897949|519908415|FG002|Overall Study|Withdrawal by Subject|17|||
144194443|NCT00897949|519908413|FG000|Overall Study|Abnormal Prestudy Labs|2|||
144194444|NCT00897949|519908414|FG001|Overall Study|Abnormal Prestudy Labs|3|||
144194445|NCT00897949|519908415|FG002|Overall Study|Abnormal Prestudy Labs|4|||
144194446|NCT00897949|519908413|FG000|Overall Study|Abnormal Baseline ECG|2|||
144194447|NCT00897949|519908414|FG001|Overall Study|Abnormal Baseline ECG|2|||
144194448|NCT00897949|519908415|FG002|Overall Study|Abnormal Baseline ECG|4|||
144194449|NCT00897949|519908413|FG000|Overall Study|Need for Concom. Med.|0|||
144194450|NCT00897949|519908414|FG001|Overall Study|Need for Concom. Med.|1|||
144194451|NCT00897949|519908415|FG002|Overall Study|Need for Concom. Med.|1|||
144194452|NCT00897949|519908413|FG000|Overall Study|Lack of Migraine Attack|29|||
144194453|NCT00897949|519908414|FG001|Overall Study|Lack of Migraine Attack|30|||
144194454|NCT00897949|519908415|FG002|Overall Study|Lack of Migraine Attack|19|||
144194455|NCT00897949|519908413|FG000|Overall Study|Did not take study drug|9|||
144533443|NCT03735979|521155439|FG000|Overall Study|Not due to the above reasons|1|||
144533444|NCT03735979|521155440|FG001|Overall Study|Not due to the above reasons|0|||
144533445|NCT03735979|521155441|FG002|Overall Study|Not due to the above reasons|0|||
144533446|NCT00319111|521155444|FG000|Overall Study|Adverse Event|20|||
144533447|NCT00319111|521155444|FG000|Overall Study|Withdrawal of consent|11|||
144533448|NCT00319111|521155444|FG000|Overall Study|Death|9|||
144533449|NCT00319111|521155444|FG000|Overall Study|Lack of clinical improvement|4|||
144533450|NCT00319111|521155444|FG000|Overall Study|Administrative|2|||
144533451|NCT00319111|521155444|FG000|Overall Study|Treatment failure|1|||
144533452|NCT03165955|521155445|FG000|Treatment|Withdrawal by Subject|3|||
144533453|NCT03165955|521155445|FG000|Treatment|Death|1|||
144533454|NCT03165955|521155445|FG000|Treatment|Adverse Event|1|||
144533455|NCT03165955|521155445|FG000|Treatment|Progressive disease|3|||
144533456|NCT05525104|521155448|FG000|Overall Study|Failed caudal analgesia|1|||
144533457|NCT05525104|521155449|FG001|Overall Study|Failed caudal analgesia|3|||
144533458|NCT05525104|521155448|FG000|Overall Study|Premedication needed|0|||
144533459|NCT05525104|521155449|FG001|Overall Study|Premedication needed|1|||
144533460|NCT05525104|521155448|FG000|Overall Study|Protocol Violation|10|||
144533461|NCT05525104|521155449|FG001|Overall Study|Protocol Violation|0|||
144533462|NCT05525104|521155448|FG000|Overall Study|Cancelled operation|1|||
144533463|NCT05525104|521155449|FG001|Overall Study|Cancelled operation|0|||
144533464|NCT04427007|521156626|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
144533465|NCT04427007|521156627|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
144533466|NCT04389957|521156632|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
144533467|NCT04389957|521156633|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
144533468|NCT04389957|521156634|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
144533469|NCT04389957|521156635|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
144533470|NCT04389957|521156636|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
144533471|NCT05405985|521156639|FG000|Overall Study|Withdrawal by Subject|1|||
144533472|NCT05405985|521156640|FG001|Overall Study|Withdrawal by Subject|0|||
144533473|NCT01917084|521156641|FG000|Overall Study|Withdrawal by Subject|1|||
144533474|NCT03571386|521156642|FG000|Overall Study|scheduling conflict|4|||
144533475|NCT03571386|521156643|FG001|Overall Study|scheduling conflict|0|||
144533476|NCT03571386|521156642|FG000|Overall Study|Withdrawal by Subject|15|||
144194456|NCT00897949|519908414|FG001|Overall Study|Did not take study drug|3|||
144194457|NCT00897949|519908415|FG002|Overall Study|Did not take study drug|4|||
144194458|NCT01763918|519908416|FG000|Overall Study|Withdrawal by Subject|2|||
144194459|NCT01763918|519908417|FG001|Overall Study|Withdrawal by Subject|1|||
144194460|NCT01763918|519908418|FG002|Overall Study|Withdrawal by Subject|1|||
144194461|NCT01763918|519908419|FG003|Overall Study|Withdrawal by Subject|2|||
144194462|NCT01763918|519908416|FG000|Overall Study|Sponsor Decision|4|||
144194463|NCT01763918|519908417|FG001|Overall Study|Sponsor Decision|0|||
144194464|NCT01763918|519908418|FG002|Overall Study|Sponsor Decision|9|||
144194465|NCT01763918|519908419|FG003|Overall Study|Sponsor Decision|0|||
144194466|NCT01553747|519908420|FG000|Overall Study|Protocol Violation|0|||
144194467|NCT01553747|519908421|FG001|Overall Study|Protocol Violation|2|||
144194468|NCT01553747|519908422|FG002|Overall Study|Protocol Violation|0|||
144194469|NCT01553747|519908420|FG000|Overall Study|Voluntarily withdrew|70|||
144194470|NCT01553747|519908421|FG001|Overall Study|Voluntarily withdrew|66|||
144194471|NCT01553747|519908422|FG002|Overall Study|Voluntarily withdrew|74|||
144194472|NCT01553747|519908420|FG000|Overall Study|Adverse event or SAE|32|||
144194473|NCT01553747|519908421|FG001|Overall Study|Adverse event or SAE|28|||
144449178|NCT00767000|520844365|FG003|54-week Study|Progressive disease|0|||
144449179|NCT00767000|520844366|FG004|54-week Study|Progressive disease|0|||
144449180|NCT00767000|520844362|FG000|54-week Study|Protocol Violation|0|||
144449181|NCT00767000|520844363|FG001|54-week Study|Protocol Violation|0|||
144449182|NCT00767000|520844364|FG002|54-week Study|Protocol Violation|1|||
144449183|NCT00767000|520844365|FG003|54-week Study|Protocol Violation|2|||
144449184|NCT00767000|520844366|FG004|54-week Study|Protocol Violation|0|||
144449185|NCT00767000|520844362|FG000|54-week Study|Withdrawal by Subject|2|||
144449186|NCT00767000|520844363|FG001|54-week Study|Withdrawal by Subject|3|||
144194474|NCT01553747|519908422|FG002|Overall Study|Adverse event or SAE|19|||
144194475|NCT01553747|519908420|FG000|Overall Study|Physician decision: other|10|||
144194476|NCT01553747|519908421|FG001|Overall Study|Physician decision: other|8|||
144194477|NCT01553747|519908422|FG002|Overall Study|Physician decision: other|7|||
144194478|NCT01553747|519908420|FG000|Overall Study|Lost to Follow-up|11|||
144449187|NCT00767000|520844364|FG002|54-week Study|Withdrawal by Subject|5|||
144449188|NCT00767000|520844365|FG003|54-week Study|Withdrawal by Subject|11|||
144449189|NCT00767000|520844366|FG004|54-week Study|Withdrawal by Subject|13|||
144449190|NCT00767000|520844362|FG000|54-week Study|Study terminated by sponsor|90|||
144449191|NCT00767000|520844363|FG001|54-week Study|Study terminated by sponsor|102|||
144449192|NCT00767000|520844364|FG002|54-week Study|Study terminated by sponsor|89|||
144449193|NCT00767000|520844365|FG003|54-week Study|Study terminated by sponsor|196|||
144449194|NCT00767000|520844366|FG004|54-week Study|Study terminated by sponsor|194|||
144449195|NCT00767000|520844362|FG000|54-week Study|Reason not reported|0|||
144449196|NCT00767000|520844363|FG001|54-week Study|Reason not reported|0|||
144449197|NCT00767000|520844364|FG002|54-week Study|Reason not reported|0|||
144449198|NCT00767000|520844365|FG003|54-week Study|Reason not reported|1|||
144449199|NCT00767000|520844366|FG004|54-week Study|Reason not reported|0|||
144449200|NCT00767000|520844362|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
144449201|NCT00767000|520844363|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
144449202|NCT00767000|520844364|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
144449203|NCT00767000|520844365|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
144449204|NCT00767000|520844366|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
144533477|NCT03571386|521156643|FG001|Overall Study|Withdrawal by Subject|5|||
144533478|NCT04451772|521156650|FG000|Overall Study|Adverse Event|1|||
144533479|NCT04451772|521156651|FG001|Overall Study|Adverse Event|0|||
144533480|NCT04451772|521156652|FG002|Overall Study|Adverse Event|1|||
144533481|NCT04451772|521156653|FG003|Overall Study|Adverse Event|1|||
144533482|NCT04451772|521156654|FG004|Overall Study|Adverse Event|0|||
144533483|NCT04451772|521156655|FG005|Overall Study|Adverse Event|3|||
144533484|NCT04451772|521156650|FG000|Overall Study|Withdrawal by Subject|2|||
144533485|NCT04451772|521156651|FG001|Overall Study|Withdrawal by Subject|7|||
144533486|NCT04451772|521156652|FG002|Overall Study|Withdrawal by Subject|2|||
144194479|NCT01553747|519908421|FG001|Overall Study|Lost to Follow-up|5|||
144194480|NCT01553747|519908422|FG002|Overall Study|Lost to Follow-up|6|||
144194481|NCT01553747|519908420|FG000|Overall Study|Sponsor decision, specify|7|||
144194482|NCT01553747|519908421|FG001|Overall Study|Sponsor decision, specify|5|||
144194483|NCT01553747|519908422|FG002|Overall Study|Sponsor decision, specify|0|||
144194484|NCT01553747|519908420|FG000|Overall Study|Physician decision: lack of efficacy|1|||
144194485|NCT01553747|519908421|FG001|Overall Study|Physician decision: lack of efficacy|5|||
144194486|NCT01553747|519908422|FG002|Overall Study|Physician decision: lack of efficacy|3|||
144194487|NCT00102687|519908423|FG000|Initial Period|Withdrawal by Subject|6|||
144194488|NCT00102687|519908424|FG001|Initial Period|Withdrawal by Subject|3|||
144194489|NCT00102687|519908425|FG002|Initial Period|Withdrawal by Subject|5|||
144194490|NCT00102687|519908426|FG003|Initial Period|Withdrawal by Subject|0|||
144194491|NCT00102687|519908427|FG004|Initial Period|Withdrawal by Subject|0|||
144194492|NCT00102687|519908423|FG000|Initial Period|Adverse Event|4|||
144194493|NCT00102687|519908424|FG001|Initial Period|Adverse Event|7|||
144194494|NCT00102687|519908425|FG002|Initial Period|Adverse Event|9|||
144194495|NCT00102687|519908426|FG003|Initial Period|Adverse Event|0|||
144194496|NCT00102687|519908427|FG004|Initial Period|Adverse Event|0|||
144194497|NCT00102687|519908423|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
144194498|NCT00102687|519908424|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
144194499|NCT00102687|519908425|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
144194500|NCT00102687|519908426|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
144194501|NCT00102687|519908427|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
144194502|NCT00102687|519908423|FG000|Initial Period|Protocol Violation|0|||
144194503|NCT00102687|519908424|FG001|Initial Period|Protocol Violation|0|||
144194504|NCT00102687|519908425|FG002|Initial Period|Protocol Violation|2|||
144194505|NCT00102687|519908426|FG003|Initial Period|Protocol Violation|0|||
144449205|NCT00633984|520844368|FG000|Overall Study|Lost to Follow-up|0|||
144449206|NCT00633984|520844369|FG001|Overall Study|Lost to Follow-up|6|||
144449207|NCT00633984|520844368|FG000|Overall Study|Withdrawal by Subject|8|||
144449208|NCT00633984|520844369|FG001|Overall Study|Withdrawal by Subject|7|||
144533487|NCT04451772|521156653|FG003|Overall Study|Withdrawal by Subject|1|||
144194506|NCT00102687|519908427|FG004|Initial Period|Protocol Violation|0|||
144194507|NCT00102687|519908423|FG000|Initial Period|Physician Decision|2|||
144194508|NCT00102687|519908424|FG001|Initial Period|Physician Decision|9|||
144194509|NCT00102687|519908425|FG002|Initial Period|Physician Decision|6|||
144194510|NCT00102687|519908426|FG003|Initial Period|Physician Decision|0|||
144194511|NCT00102687|519908427|FG004|Initial Period|Physician Decision|0|||
144194512|NCT00102687|519908423|FG000|Initial Period|Sponsor's decision|0|||
144194513|NCT00102687|519908424|FG001|Initial Period|Sponsor's decision|1|||
144449209|NCT00633984|520844368|FG000|Overall Study|Hospitalized|1|||
144449210|NCT00633984|520844369|FG001|Overall Study|Hospitalized|0|||
144449211|NCT01168999|520844370|FG000|Overall Study|Lost to Follow-up|2|||
144449212|NCT01168999|520844371|FG001|Overall Study|Lost to Follow-up|1|||
144449213|NCT01168999|520844372|FG002|Overall Study|Lost to Follow-up|0|||
144449214|NCT01168999|520844373|FG003|Overall Study|Lost to Follow-up|0|||
144194514|NCT00102687|519908425|FG002|Initial Period|Sponsor's decision|1|||
144194515|NCT00102687|519908426|FG003|Initial Period|Sponsor's decision|0|||
144194516|NCT00102687|519908427|FG004|Initial Period|Sponsor's decision|0|||
144194517|NCT00102687|519908423|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
144194518|NCT00102687|519908424|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
144194519|NCT00102687|519908425|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
144194520|NCT00102687|519908426|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
144194521|NCT00102687|519908427|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
144194522|NCT00102687|519908423|FG000|Initial Period|Death|1|||
144194523|NCT00102687|519908424|FG001|Initial Period|Death|1|||
144194524|NCT00102687|519908425|FG002|Initial Period|Death|1|||
144194525|NCT00102687|519908426|FG003|Initial Period|Death|0|||
144449215|NCT01276327|520844374|FG000|Overall Study|Adverse Event|1|||
144449216|NCT01276327|520844375|FG001|Overall Study|Adverse Event|3|||
144449217|NCT01276327|520844374|FG000|Overall Study|Withdrawal by Subject|1|||
144449218|NCT01276327|520844375|FG001|Overall Study|Withdrawal by Subject|0|||
144449219|NCT03766646|520844376|FG000|Overall Study|Withdrawal by Subject|1|||
144449220|NCT03766646|520844377|FG001|Overall Study|Withdrawal by Subject|0|||
144449221|NCT03766646|520844376|FG000|Overall Study|Protocol Violation|0|||
144449222|NCT03766646|520844377|FG001|Overall Study|Protocol Violation|3|||
144449223|NCT00009737|520844380|FG000|Overall Study|Adverse Event|112|||
144194526|NCT00102687|519908427|FG004|Initial Period|Death|0|||
144194527|NCT00102687|519908423|FG000|Maintenance Period|Withdrawal by Subject|4|||
144194528|NCT00102687|519908424|FG001|Maintenance Period|Withdrawal by Subject|0|||
144194529|NCT00102687|519908425|FG002|Maintenance Period|Withdrawal by Subject|2|||
144194530|NCT00102687|519908426|FG003|Maintenance Period|Withdrawal by Subject|3|||
144194531|NCT00102687|519908427|FG004|Maintenance Period|Withdrawal by Subject|1|||
144449224|NCT00009737|520844381|FG001|Overall Study|Adverse Event|75|||
144449225|NCT00009737|520844380|FG000|Overall Study|Death|4|||
144449226|NCT00009737|520844381|FG001|Overall Study|Death|6|||
144449227|NCT00009737|520844380|FG000|Overall Study|Lack of Efficacy|17|||
144449228|NCT00009737|520844381|FG001|Overall Study|Lack of Efficacy|15|||
144449229|NCT00009737|520844380|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
144449230|NCT00009737|520844381|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
144449231|NCT00009737|520844380|FG000|Overall Study|Other Protocol Violation|1|||
144449232|NCT00009737|520844381|FG001|Overall Study|Other Protocol Violation|0|||
144449233|NCT00009737|520844380|FG000|Overall Study|Refused Treatment|15|||
144449234|NCT00009737|520844381|FG001|Overall Study|Refused Treatment|16|||
144449235|NCT00009737|520844380|FG000|Overall Study|Lost to Follow-up|1|||
144449236|NCT00009737|520844381|FG001|Overall Study|Lost to Follow-up|1|||
144533488|NCT04451772|521156654|FG004|Overall Study|Withdrawal by Subject|1|||
144533489|NCT04451772|521156655|FG005|Overall Study|Withdrawal by Subject|0|||
144533490|NCT04451772|521156650|FG000|Overall Study|Other, not specified|1|||
144533491|NCT04451772|521156651|FG001|Overall Study|Other, not specified|2|||
144533492|NCT04451772|521156652|FG002|Overall Study|Other, not specified|1|||
144533493|NCT04451772|521156653|FG003|Overall Study|Other, not specified|0|||
144533494|NCT04451772|521156654|FG004|Overall Study|Other, not specified|0|||
144533495|NCT04451772|521156655|FG005|Overall Study|Other, not specified|1|||
144533496|NCT04451772|521156650|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
144533497|NCT04451772|521156651|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
144533498|NCT04451772|521156652|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
144533499|NCT04451772|521156653|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
144533500|NCT04451772|521156654|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
144449237|NCT00009737|520844380|FG000|Overall Study|Administrative/Other Reasons|7|||
144449238|NCT00009737|520844381|FG001|Overall Study|Administrative/Other Reasons|1|||
144449239|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
144449240|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
144194532|NCT00102687|519908423|FG000|Maintenance Period|Adverse Event|1|||
144194533|NCT00102687|519908424|FG001|Maintenance Period|Adverse Event|0|||
144194534|NCT00102687|519908425|FG002|Maintenance Period|Adverse Event|0|||
144194535|NCT00102687|519908426|FG003|Maintenance Period|Adverse Event|1|||
144449241|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
144449242|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144449243|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144449244|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144449245|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144449246|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144449247|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144449248|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
144449249|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
144449250|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
144449251|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144449252|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144449253|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144449254|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144449255|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144449256|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144449257|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449258|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
144449259|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
144449260|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449261|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449262|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449263|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449264|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449265|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144449266|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
144449267|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
144449268|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
144449269|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144449270|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144449271|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144449272|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144449273|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144449274|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144449275|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
144449276|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
144449277|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
144449278|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
144449279|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
144449280|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
144449281|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
144194536|NCT00102687|519908427|FG004|Maintenance Period|Adverse Event|3|||
144194537|NCT00102687|519908423|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
144449282|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
144194538|NCT00102687|519908424|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
144449283|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
144449284|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
144449285|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449286|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449287|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449288|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449289|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449290|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449291|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449292|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144449293|NCT01172938|520844383|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449294|NCT01172938|520844384|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
144449295|NCT01172938|520844385|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
144449296|NCT01172938|520844386|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449297|NCT01172938|520844387|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449298|NCT01172938|520844388|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449299|NCT01172938|520844389|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449300|NCT01172938|520844390|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449301|NCT01172938|520844391|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
144449302|NCT01172938|520844383|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
144449303|NCT01172938|520844384|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
144449304|NCT01172938|520844385|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
144449305|NCT01172938|520844386|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
144449306|NCT01172938|520844387|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
144449307|NCT01172938|520844388|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
144449308|NCT01172938|520844389|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
144449309|NCT01172938|520844390|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
144449310|NCT01172938|520844391|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
144449311|NCT01172938|520844383|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
144449312|NCT01172938|520844384|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
144449313|NCT01172938|520844385|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
144449314|NCT01172938|520844386|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
144449315|NCT01172938|520844387|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
144449316|NCT01172938|520844388|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
144449317|NCT01172938|520844389|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
144449318|NCT01172938|520844390|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
144449319|NCT01172938|520844391|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
144449320|NCT01172938|520844383|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449321|NCT01172938|520844384|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449322|NCT01172938|520844385|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
144449323|NCT01172938|520844386|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449324|NCT01172938|520844387|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449325|NCT01172938|520844388|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449326|NCT01172938|520844389|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449327|NCT01172938|520844390|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449328|NCT01172938|520844391|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
144449329|NCT01172938|520844383|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
144449330|NCT01172938|520844384|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
144449331|NCT01172938|520844385|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
144449332|NCT01172938|520844386|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
144449333|NCT01172938|520844387|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
144449334|NCT01172938|520844388|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
144449335|NCT01172938|520844389|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
144449336|NCT01172938|520844390|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
144449337|NCT01172938|520844391|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
144449338|NCT01172938|520844383|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
144449339|NCT01172938|520844384|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
144449340|NCT01172938|520844385|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
144449341|NCT01172938|520844386|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
144449342|NCT01172938|520844387|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
144449343|NCT01172938|520844388|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
144449344|NCT01172938|520844389|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
144449345|NCT01172938|520844390|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
144194539|NCT00102687|519908425|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
144194540|NCT00102687|519908426|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
144194541|NCT00102687|519908427|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
144194542|NCT00102687|519908423|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
144194543|NCT00102687|519908424|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
144194544|NCT00102687|519908425|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
144194545|NCT00102687|519908426|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
144194546|NCT00102687|519908427|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
144194547|NCT00102687|519908423|FG000|Maintenance Period|Death|0|||
144194548|NCT00102687|519908424|FG001|Maintenance Period|Death|0|||
144194549|NCT00102687|519908425|FG002|Maintenance Period|Death|0|||
144194550|NCT00102687|519908426|FG003|Maintenance Period|Death|1|||
144194551|NCT00102687|519908427|FG004|Maintenance Period|Death|1|||
144194552|NCT00102687|519908423|FG000|Maintenance Period|Physician Decision|1|||
144194553|NCT00102687|519908424|FG001|Maintenance Period|Physician Decision|2|||
144194554|NCT00102687|519908425|FG002|Maintenance Period|Physician Decision|3|||
144194555|NCT00102687|519908426|FG003|Maintenance Period|Physician Decision|0|||
144194556|NCT00102687|519908427|FG004|Maintenance Period|Physician Decision|4|||
144194557|NCT02903238|519908439|FG000|Overall Study|Lost to Follow-up|4|||
144194558|NCT00700817|519908441|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
144194559|NCT00700817|519908442|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
144194560|NCT00700817|519908443|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
144194561|NCT00700817|519908444|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
144194562|NCT00700817|519908445|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
144194563|NCT00700817|519908441|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
144449346|NCT01172938|520844391|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
144449347|NCT01172938|520844383|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449348|NCT01172938|520844384|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449349|NCT01172938|520844385|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449350|NCT01172938|520844386|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449351|NCT01172938|520844387|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449352|NCT01172938|520844388|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
144449353|NCT01172938|520844389|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
144449354|NCT01172938|520844390|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449355|NCT01172938|520844391|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
144449356|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
144449357|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
144449358|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
144449359|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
144449360|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
144449361|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
144449362|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
144449363|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
144449364|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
144449365|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
144449366|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
144449367|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
144449368|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
144449369|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
144449370|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
144449371|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
144449372|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
144449373|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
144449374|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449375|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449376|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
144449377|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449378|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449379|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449380|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449381|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449382|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
144449383|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
144449384|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
144449385|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
144449386|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
144449387|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
144449388|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
144449389|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
144449390|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
144449391|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
144449392|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449393|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449394|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
144449395|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449396|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449397|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449398|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449399|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449400|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
144449401|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
144449402|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
144449403|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
144449404|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
144449405|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
144194564|NCT00700817|519908442|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
144194565|NCT00700817|519908443|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
144194566|NCT00700817|519908444|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
144449406|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
144725416|NCT00561730|521851249|FG000|Overall Study|Not specified reasons|1|||
144725417|NCT02446132|521851266|FG000|Overall Study|Adverse Event|10|||
144725418|NCT02446132|521851267|FG001|Overall Study|Adverse Event|27|||
144725419|NCT02446132|521851268|FG002|Overall Study|Adverse Event|27|||
144725420|NCT02446132|521851266|FG000|Overall Study|Death|2|||
144725421|NCT02446132|521851267|FG001|Overall Study|Death|13|||
144725422|NCT02446132|521851268|FG002|Overall Study|Death|10|||
144725423|NCT02446132|521851266|FG000|Overall Study|Lack of Efficacy|1|||
144194567|NCT00700817|519908445|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
144194568|NCT00700817|519908441|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
144725424|NCT02446132|521851267|FG001|Overall Study|Lack of Efficacy|10|||
144725425|NCT02446132|521851268|FG002|Overall Study|Lack of Efficacy|6|||
144194569|NCT00700817|519908442|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
144194570|NCT00700817|519908443|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
144194571|NCT00700817|519908444|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
144194572|NCT00700817|519908445|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
144194573|NCT00700817|519908441|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
144194574|NCT00700817|519908442|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
144194575|NCT00700817|519908443|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
144194576|NCT00700817|519908444|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
144194577|NCT00700817|519908445|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
144194578|NCT00700817|519908441|FG000|Week 0-26 (Main Period)|Unclassified|14|||
144194579|NCT00700817|519908442|FG001|Week 0-26 (Main Period)|Unclassified|4|||
144194580|NCT00700817|519908443|FG002|Week 0-26 (Main Period)|Unclassified|8|||
144194581|NCT00700817|519908444|FG003|Week 0-26 (Main Period)|Unclassified|0|||
144194582|NCT00700817|519908445|FG004|Week 0-26 (Main Period)|Unclassified|0|||
144194583|NCT00700817|519908441|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
144449407|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
144449408|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
144449409|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
144449410|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449411|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
144449412|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449413|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449414|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449415|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449416|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449417|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
144449418|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
144449419|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449420|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
144449421|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449422|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449423|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449424|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449425|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449426|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449427|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
144449428|NCT01172938|520844383|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449429|NCT01172938|520844384|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449430|NCT01172938|520844385|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449431|NCT01172938|520844386|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449432|NCT01172938|520844387|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449433|NCT01172938|520844388|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449434|NCT01172938|520844389|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449435|NCT01172938|520844390|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
144449436|NCT01172938|520844391|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
144449437|NCT01172938|520844383|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
144194584|NCT00700817|519908442|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
144194585|NCT00700817|519908443|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
144194586|NCT00700817|519908444|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
144194587|NCT00700817|519908445|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
144194588|NCT00700817|519908441|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
144194589|NCT00700817|519908442|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
144253891|NCT01605825|520130080|FG001|Overall Study|Non-Compliance with Protocol|0|||
144253892|NCT02155322|520130081|FG000|Overall Study|Adverse Event|1|||
144725426|NCT02446132|521851266|FG000|Overall Study|Lost to Follow-up|2|||
144725427|NCT02446132|521851267|FG001|Overall Study|Lost to Follow-up|4|||
144725428|NCT02446132|521851268|FG002|Overall Study|Lost to Follow-up|5|||
144725429|NCT02446132|521851266|FG000|Overall Study|Non-compliance With Study Drug|2|||
144194590|NCT00700817|519908443|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
144194591|NCT00700817|519908444|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
144194592|NCT00700817|519908445|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
144194593|NCT00700817|519908441|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
144194594|NCT00700817|519908442|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
144194595|NCT00700817|519908443|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
144449438|NCT01172938|520844384|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
144449439|NCT01172938|520844385|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
144449440|NCT01172938|520844386|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
144449441|NCT01172938|520844387|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
144449442|NCT01172938|520844388|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
144449443|NCT01172938|520844389|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
144449444|NCT01172938|520844390|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
144449445|NCT01172938|520844391|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
144449446|NCT01172938|520844383|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
144449447|NCT01172938|520844384|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
144449448|NCT01172938|520844385|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
144449449|NCT01172938|520844386|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
144449450|NCT01172938|520844387|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
144449451|NCT01172938|520844388|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
144449452|NCT01172938|520844389|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
144449453|NCT01172938|520844390|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
144449454|NCT01172938|520844391|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
144449455|NCT01172938|520844383|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449456|NCT01172938|520844384|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449457|NCT01172938|520844385|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449458|NCT01172938|520844386|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449459|NCT01172938|520844387|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449460|NCT01172938|520844388|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449461|NCT01172938|520844389|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449462|NCT01172938|520844390|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
144449463|NCT01172938|520844391|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
144449464|NCT01172938|520844383|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449465|NCT01172938|520844384|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
144449466|NCT01172938|520844385|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449467|NCT01172938|520844386|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449468|NCT01172938|520844387|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449469|NCT01172938|520844388|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449470|NCT01172938|520844389|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449471|NCT01172938|520844390|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449472|NCT01172938|520844391|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
144449473|NCT01172938|520844383|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449474|NCT01172938|520844384|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449475|NCT01172938|520844385|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
144449476|NCT01172938|520844386|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449477|NCT01172938|520844387|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449478|NCT01172938|520844388|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449479|NCT01172938|520844389|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449480|NCT01172938|520844390|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449481|NCT01172938|520844391|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
144449482|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
144449483|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
144449484|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
144449485|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
144449486|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
144449487|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
144449488|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
144449489|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
144449490|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
144449491|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
144449492|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
144449493|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
144449494|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
144449495|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
144194596|NCT00700817|519908444|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
144194597|NCT00700817|519908445|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
144449496|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
144449497|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
144449498|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
144449499|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
144449500|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
144194598|NCT00700817|519908441|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
144194599|NCT00700817|519908442|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
144449501|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
144449502|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
144449503|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
144449504|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
144449505|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
144449506|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
144449507|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
144449508|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
144449509|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449510|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449511|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
144449512|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449513|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449514|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449515|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449516|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
144449517|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
144449518|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449519|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449520|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449521|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449522|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449523|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449524|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449525|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
144449526|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
144449527|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
144449528|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
144449529|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
144449530|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
144449531|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
144449532|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
144449533|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
144449534|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
144449535|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
144449536|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449537|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144606642|NCT01514136|521421079|FG003|Test Period 1; Test A|Break from study holiday|0|||
144606643|NCT01514136|521421080|FG004|Test Period 1; Test A|Break from study holiday|0|||
144606644|NCT01514136|521421081|FG005|Test Period 1; Test A|Break from study holiday|0|||
144606645|NCT01514136|521421082|FG006|Test Period 1; Test A|Break from study holiday|0|||
144606646|NCT01514136|521421083|FG007|Test Period 1; Test A|Break from study holiday|0|||
144606647|NCT01514136|521421076|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
144606648|NCT01514136|521421077|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
144606649|NCT01514136|521421078|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
144606650|NCT01514136|521421079|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
144606651|NCT01514136|521421080|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
144606652|NCT01514136|521421081|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
144606653|NCT01514136|521421082|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
144606654|NCT01514136|521421083|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
144606655|NCT01514136|521421076|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
144606656|NCT01514136|521421077|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
144606657|NCT01514136|521421078|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
144606658|NCT01514136|521421079|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
144606659|NCT01514136|521421080|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
144606660|NCT01514136|521421081|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
144194600|NCT00700817|519908443|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
144194601|NCT00700817|519908444|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
144449538|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
144449539|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449540|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449541|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449542|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449543|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449544|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
144449545|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449546|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
144449547|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449548|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449549|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449550|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449551|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449552|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
144449553|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
144449554|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
144449555|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
144449556|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
144449557|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
144449558|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
144449559|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
144449560|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
144449561|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
144449562|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
144449563|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449564|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449565|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
144449566|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449567|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449568|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449569|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449570|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449571|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
144449572|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449573|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449574|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
144449575|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449576|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449577|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449578|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449579|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449580|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
144449581|NCT01172938|520844383|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449582|NCT01172938|520844384|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449583|NCT01172938|520844385|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449584|NCT01172938|520844386|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449585|NCT01172938|520844387|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449586|NCT01172938|520844388|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449587|NCT01172938|520844389|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449588|NCT01172938|520844390|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
144449589|NCT01172938|520844391|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
144449590|NCT02956629|520844392|FG000|Overall Study|Adverse Event|0|||
144449591|NCT02956629|520844393|FG001|Overall Study|Adverse Event|0|||
144449592|NCT02956629|520844394|FG002|Overall Study|Adverse Event|1|||
144449593|NCT02956629|520844395|FG003|Overall Study|Adverse Event|0|||
144449594|NCT02956629|520844396|FG004|Overall Study|Adverse Event|0|||
144449595|NCT02956629|520844397|FG005|Overall Study|Adverse Event|0|||
144449596|NCT02956629|520844392|FG000|Overall Study|Lost to Follow-up|2|||
144449597|NCT02956629|520844393|FG001|Overall Study|Lost to Follow-up|5|||
144449598|NCT02956629|520844394|FG002|Overall Study|Lost to Follow-up|3|||
144449599|NCT02956629|520844395|FG003|Overall Study|Lost to Follow-up|1|||
144449600|NCT02956629|520844396|FG004|Overall Study|Lost to Follow-up|0|||
144449601|NCT02956629|520844397|FG005|Overall Study|Lost to Follow-up|1|||
144449602|NCT02956629|520844392|FG000|Overall Study|Withdrawal by Subject|3|||
144449603|NCT02956629|520844393|FG001|Overall Study|Withdrawal by Subject|1|||
144449604|NCT02956629|520844394|FG002|Overall Study|Withdrawal by Subject|0|||
144449605|NCT02956629|520844395|FG003|Overall Study|Withdrawal by Subject|0|||
144449606|NCT02956629|520844396|FG004|Overall Study|Withdrawal by Subject|0|||
144449607|NCT02956629|520844397|FG005|Overall Study|Withdrawal by Subject|0|||
144449608|NCT00003498|520844398|FG000|Overall Study|Not evaluable.|4|||
144449609|NCT05282004|520844406|FG000|Overall Study|Adverse Event|2|||
144449610|NCT04808609|520844407|FG000|Overall Study|Lost to Follow-up|0|||
144449611|NCT04808609|520844408|FG001|Overall Study|Lost to Follow-up|2|||
144449612|NCT04808609|520844407|FG000|Overall Study|Administrative Withdrawal|0|||
144449613|NCT04808609|520844408|FG001|Overall Study|Administrative Withdrawal|1|||
144449614|NCT01993719|520844409|FG000|First Drug Administration|Not treated|1|||
144449615|NCT01993719|520844410|FG001|First Drug Administration|Not treated|0|||
144449616|NCT01993719|520844411|FG002|First Drug Administration|Not treated|0|||
144449617|NCT01993719|520844412|FG003|First Drug Administration|Not treated|0|||
144449618|NCT01993719|520844413|FG004|First Drug Administration|Not treated|0|||
144449619|NCT04067141|520844418|FG000|First Intervention|Withdrawal by Subject|0|||
144449620|NCT04067141|520844419|FG001|First Intervention|Withdrawal by Subject|1|||
144449621|NCT04067141|520844418|FG000|Second Intervention|Adverse Event|0|||
144449622|NCT04067141|520844419|FG001|Second Intervention|Adverse Event|2|||
144449623|NCT03295201|520844420|FG000|Overall Study|Lost to Follow-up|1|||
144449624|NCT03295201|520844421|FG001|Overall Study|Lost to Follow-up|1|||
144449625|NCT03295201|520844420|FG000|Overall Study|Hospital admission|0|||
144449626|NCT03295201|520844421|FG001|Overall Study|Hospital admission|1|||
144449627|NCT00572572|520844422|FG000|Overall Study|Withdrawal by Subject|3|||
144449628|NCT00572572|520844423|FG001|Overall Study|Withdrawal by Subject|6|||
144449629|NCT00889421|520844424|FG000|Overall Study|Lack of Efficacy|3|||
144449630|NCT01958918|520844425|FG000|Overall Study|Death|1|||
144449631|NCT01958918|520844426|FG001|Overall Study|Death|3|||
144449632|NCT01958918|520844425|FG000|Overall Study|Lost to Follow-up|4|||
144449633|NCT01958918|520844426|FG001|Overall Study|Lost to Follow-up|7|||
144449634|NCT01958918|520844425|FG000|Overall Study|Withdrawal by Subject|13|||
144449635|NCT01958918|520844426|FG001|Overall Study|Withdrawal by Subject|8|||
144449636|NCT01958918|520844425|FG000|Overall Study|Lack of Efficacy|13|||
144449637|NCT01958918|520844426|FG001|Overall Study|Lack of Efficacy|10|||
144449638|NCT01958918|520844425|FG000|Overall Study|Adverse Event|12|||
144449639|NCT01958918|520844426|FG001|Overall Study|Adverse Event|12|||
144449640|NCT01958918|520844425|FG000|Overall Study|administrative problems|0|||
144449641|NCT01958918|520844426|FG001|Overall Study|administrative problems|2|||
144449642|NCT02114892|520844430|FG000|Overall Study|Lost to Follow-up|1|||
144449643|NCT02114892|520844431|FG001|Overall Study|Lost to Follow-up|2|||
144449644|NCT00659269|520844435|FG000|Overall Study|Physician Decision|1|||
144449645|NCT00659269|520844436|FG001|Overall Study|Physician Decision|1|||
144449646|NCT00718042|520844438|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
144449647|NCT00718042|520844439|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
144449648|NCT00718042|520844440|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
144449649|NCT00718042|520844441|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
144449650|NCT00718042|520844442|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
144449651|NCT00718042|520844443|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
144449652|NCT00718042|520844438|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
144449653|NCT00718042|520844439|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
144449654|NCT00718042|520844440|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
144449655|NCT00718042|520844441|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
144449656|NCT00718042|520844442|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
144449657|NCT00718042|520844443|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
144449658|NCT00718042|520844438|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
144449659|NCT00718042|520844439|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
144449660|NCT00718042|520844440|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
144449661|NCT00718042|520844441|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
144449662|NCT00718042|520844442|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
144449663|NCT00718042|520844443|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
144449664|NCT00718042|520844438|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
144449665|NCT00718042|520844439|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
144449666|NCT00718042|520844440|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
144449667|NCT00718042|520844441|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
144449668|NCT00718042|520844442|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
144449669|NCT00718042|520844443|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
144449670|NCT00718042|520844438|FG000|Donor Follow-up|Lost to Follow-up|13|||
144449671|NCT00718042|520844439|FG001|Donor Follow-up|Lost to Follow-up|0|||
144449672|NCT00718042|520844440|FG002|Donor Follow-up|Lost to Follow-up|0|||
144449673|NCT00718042|520844441|FG003|Donor Follow-up|Lost to Follow-up|0|||
144449674|NCT00718042|520844442|FG004|Donor Follow-up|Lost to Follow-up|19|||
144449675|NCT00718042|520844443|FG005|Donor Follow-up|Lost to Follow-up|0|||
144449676|NCT04327934|520844444|FG000|Overall Study|Did not qualify|7|||
144449677|NCT04327934|520844445|FG001|Overall Study|Did not qualify|4|||
144449678|NCT04327934|520844444|FG000|Overall Study|Physician Decision|0|||
144449679|NCT04327934|520844445|FG001|Overall Study|Physician Decision|1|||
144449680|NCT02443298|520844446|FG000|Overall Study|Adverse Event|3|||
144449681|NCT02443298|520844447|FG001|Overall Study|Adverse Event|3|||
144449682|NCT02443298|520844446|FG000|Overall Study|Withdrawal by Subject|1|||
144449683|NCT02443298|520844447|FG001|Overall Study|Withdrawal by Subject|2|||
144449684|NCT01971346|520844449|FG000|Overall Study|Protocol Violation|3|||
144449685|NCT01971346|520844449|FG000|Overall Study|Lost to Follow-up|2|||
144449686|NCT01971346|520844449|FG000|Overall Study|Withdrawal by Subject|2|||
144449687|NCT01971346|520844449|FG000|Overall Study|Physician Decision|1|||
144449688|NCT00298831|520844450|FG000|Overall Study|Adverse Event|1|||
144449689|NCT00298831|520844450|FG000|Overall Study|Lost to Follow-up|3|||
144449690|NCT00298831|520844450|FG000|Overall Study|Withdrawal by Subject|1|||
144449691|NCT00298831|520844450|FG000|Overall Study|Participants did not receive treatment|27|||
144449692|NCT02052466|520844451|FG000|Overall Study|Withdrawal by Subject|1|||
144449693|NCT02052466|520844451|FG000|Overall Study|Acromial fracture|1|||
144449694|NCT00595582|520844453|FG000|Overall Study|Pilot study that PI terminated|2|||
144449695|NCT00595582|520844453|FG000|Overall Study|Lost to Follow-up|1|||
144449696|NCT00595582|520844453|FG000|Overall Study|Adverse Event|2|||
144449697|NCT00595582|520844453|FG000|Overall Study|Physician Decision|5|||
144449698|NCT01978184|520844454|FG000|Overall Study|Progressive disease|5|||
144449699|NCT01978184|520844455|FG001|Overall Study|Progressive disease|5|||
144449700|NCT01978184|520844454|FG000|Overall Study|Other than PDA|2|||
144449701|NCT01978184|520844455|FG001|Overall Study|Other than PDA|2|||
144449702|NCT01978184|520844454|FG000|Overall Study|Physician Decision|0|||
144449703|NCT01978184|520844455|FG001|Overall Study|Physician Decision|3|||
144449704|NCT01978184|520844454|FG000|Overall Study|Noncompliance|1|||
144449705|NCT01978184|520844455|FG001|Overall Study|Noncompliance|2|||
144449706|NCT01978184|520844454|FG000|Overall Study|Death|1|||
144449707|NCT01978184|520844455|FG001|Overall Study|Death|0|||
144449708|NCT01978184|520844454|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
144449709|NCT01978184|520844455|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
144449710|NCT02460198|520844457|FG000|Overall Study|Adverse Event|1|||
144449711|NCT02460198|520844458|FG001|Overall Study|Adverse Event|3|||
144449712|NCT02460198|520844457|FG000|Overall Study|Death|36|||
144449713|NCT02460198|520844458|FG001|Overall Study|Death|28|||
144449714|NCT02460198|520844457|FG000|Overall Study|Lost to Follow-up|1|||
144449715|NCT02460198|520844458|FG001|Overall Study|Lost to Follow-up|1|||
144449716|NCT02460198|520844457|FG000|Overall Study|Transferred to Extension Study|15|||
144449717|NCT02460198|520844458|FG001|Overall Study|Transferred to Extension Study|15|||
144449718|NCT02460198|520844457|FG000|Overall Study|Withdrawal by Subject|2|||
144449719|NCT02460198|520844458|FG001|Overall Study|Withdrawal by Subject|4|||
144449720|NCT02460198|520844457|FG000|Overall Study|Site Terminated By Sponsor|0|||
144449721|NCT02460198|520844458|FG001|Overall Study|Site Terminated By Sponsor|1|||
144449722|NCT02460198|520844457|FG000|Overall Study|Did Not Continue on Extension Study|6|||
144449723|NCT02460198|520844458|FG001|Overall Study|Did Not Continue on Extension Study|11|||
144449724|NCT00931307|520844459|FG000|Overall Study|Lack of Efficacy|12|||
144449725|NCT00931307|520844459|FG000|Overall Study|Biomicroscopy|1|||
144606661|NCT01514136|521421082|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
144606662|NCT01514136|521421083|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
144606663|NCT01514136|521421076|FG000|Test Period 2; Test A*|Adverse Event|0|||
144606664|NCT01514136|521421077|FG001|Test Period 2; Test A*|Adverse Event|0|||
144606665|NCT01514136|521421078|FG002|Test Period 2; Test A*|Adverse Event|0|||
144606666|NCT01514136|521421079|FG003|Test Period 2; Test A*|Adverse Event|0|||
144606667|NCT01514136|521421080|FG004|Test Period 2; Test A*|Adverse Event|1|||
144606668|NCT01514136|521421081|FG005|Test Period 2; Test A*|Adverse Event|0|||
144606669|NCT01514136|521421082|FG006|Test Period 2; Test A*|Adverse Event|0|||
144606670|NCT01514136|521421083|FG007|Test Period 2; Test A*|Adverse Event|0|||
144606671|NCT01514136|521421076|FG000|Test Period 2; Test A*|Holiday|0|||
144606672|NCT01514136|521421077|FG001|Test Period 2; Test A*|Holiday|0|||
144606673|NCT01514136|521421078|FG002|Test Period 2; Test A*|Holiday|0|||
144606674|NCT01514136|521421079|FG003|Test Period 2; Test A*|Holiday|0|||
144606675|NCT01514136|521421080|FG004|Test Period 2; Test A*|Holiday|1|||
144606676|NCT01514136|521421081|FG005|Test Period 2; Test A*|Holiday|0|||
144606677|NCT01514136|521421082|FG006|Test Period 2; Test A*|Holiday|0|||
144449726|NCT00023452|520844460|FG000|Overall Study|Ineligible for Study|163|||
144449727|NCT00023452|520844461|FG001|Overall Study|Ineligible for Study|159|||
144606678|NCT01514136|521421083|FG007|Test Period 2; Test A*|Holiday|0|||
144606679|NCT01514136|521421076|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
144606680|NCT01514136|521421077|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
144449728|NCT00023452|520844460|FG000|Overall Study|Out of Window|129|||
144449729|NCT00023452|520844461|FG001|Overall Study|Out of Window|69|||
144449730|NCT00023452|520844460|FG000|Overall Study|Death|2|||
144449731|NCT00023452|520844461|FG001|Overall Study|Death|0|||
144449732|NCT00023452|520844460|FG000|Overall Study|Withdrawal by Subject|66|||
144449733|NCT00023452|520844461|FG001|Overall Study|Withdrawal by Subject|54|||
144449734|NCT00023452|520844460|FG000|Overall Study|Adverse Event|139|||
144449735|NCT00023452|520844461|FG001|Overall Study|Adverse Event|196|||
144449736|NCT00023452|520844460|FG000|Overall Study|Lost to Follow-up|293|||
144449737|NCT00023452|520844461|FG001|Overall Study|Lost to Follow-up|60|||
144449738|NCT00023452|520844460|FG000|Overall Study|Physician Decision|49|||
144449739|NCT00023452|520844461|FG001|Overall Study|Physician Decision|21|||
144449740|NCT00023452|520844460|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
144449741|NCT00023452|520844461|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
144449742|NCT00023452|520844460|FG000|Overall Study|Pregnant|53|||
144449743|NCT00023452|520844461|FG001|Overall Study|Pregnant|20|||
144449744|NCT00023452|520844460|FG000|Overall Study|Other|204|||
144449745|NCT00023452|520844461|FG001|Overall Study|Other|69|||
144449746|NCT02770391|520844471|FG000|Overall Study|Lost to Follow-up|2|||
144449747|NCT02770391|520844471|FG000|Overall Study|Withdrawal by Subject|1|||
144449748|NCT02770391|520844471|FG000|Overall Study|Surgery delayed unevaluable|2|||
144449749|NCT02770391|520844471|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
144449750|NCT03333486|520844474|FG000|Overall Study|Withdrawal by Subject|1|||
144449751|NCT03333486|520844474|FG000|Overall Study|Lost to Follow-up|1|||
144449752|NCT03246529|520844483|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
144449753|NCT03246529|520844484|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
144449754|NCT03246529|520844485|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
144449755|NCT03246529|520844483|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
144449756|NCT03246529|520844484|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
144449757|NCT03246529|520844485|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
144449758|NCT03246529|520844483|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
144449759|NCT03246529|520844484|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
144449760|NCT03246529|520844485|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
144449761|NCT03246529|520844483|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
144449762|NCT03246529|520844484|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
144449763|NCT03246529|520844485|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
144449764|NCT03246529|520844483|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
144449765|NCT03246529|520844484|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
144449766|NCT03246529|520844485|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
144449767|NCT03246529|520844483|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
144449768|NCT03246529|520844484|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
144449769|NCT03246529|520844485|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
144449770|NCT03246529|520844483|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
144449771|NCT03246529|520844484|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
144449772|NCT03246529|520844485|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
144449773|NCT03246529|520844483|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
144449774|NCT03246529|520844484|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
144449775|NCT03246529|520844485|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
144449776|NCT03246529|520844483|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
144449777|NCT03246529|520844484|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
144449778|NCT03246529|520844485|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
144449779|NCT01337089|520846185|FG000|Overall Study|Adverse Event|237|||
144449780|NCT01337089|520846185|FG000|Overall Study|Withdrawal by Subject|129|||
144449781|NCT01337089|520846185|FG000|Overall Study|Withdrawal by Investigator|33|||
144449782|NCT01337089|520846185|FG000|Overall Study|Met Withdrawal Criteria|3|||
144449783|NCT01337089|520846185|FG000|Overall Study|Lost to Follow-up|2|||
144449784|NCT04419493|520846186|FG000|Wash-out After Period 1|Adverse Event|1|||
144449785|NCT04419493|520846187|FG001|Wash-out After Period 1|Adverse Event|2|||
144449786|NCT04419493|520846188|FG002|Wash-out After Period 1|Adverse Event|1|||
144449787|NCT04419493|520846189|FG003|Wash-out After Period 1|Adverse Event|0|||
144449788|NCT00524134|520846190|FG000|Overall Study|Withdrawal by Subject|1|||
144449789|NCT00524134|520846190|FG000|Overall Study|Physician Decision|1|||
144449790|NCT01782131|520846191|FG000|Overall Study|Death|93|||
144449791|NCT01782131|520846192|FG001|Overall Study|Death|96|||
144449792|NCT01782131|520846191|FG000|Overall Study|Lost to Follow-up|1|||
144449793|NCT01782131|520846192|FG001|Overall Study|Lost to Follow-up|3|||
144449794|NCT01782131|520846191|FG000|Overall Study|Withdrawal by Subject|10|||
144449795|NCT01782131|520846192|FG001|Overall Study|Withdrawal by Subject|10|||
144449796|NCT01782131|520846191|FG000|Overall Study|Randomized but not treated|5|||
144449797|NCT01782131|520846192|FG001|Overall Study|Randomized but not treated|5|||
144449798|NCT01782131|520846191|FG000|Overall Study|Reason not provided|0|||
144449799|NCT01782131|520846192|FG001|Overall Study|Reason not provided|1|||
144449800|NCT00796718|520846193|FG000|Overall Study|Adverse Event|2|||
144449801|NCT00796718|520846193|FG000|Overall Study|Exclusion Criteria|1|||
144449802|NCT00796718|520846193|FG000|Overall Study|Lost to Follow-up|5|||
144449803|NCT00796718|520846193|FG000|Overall Study|Withdrawal by Informed Consent|1|||
144449804|NCT02627677|520846195|FG000|Overall Study|Adverse event (not progressive disease)|1|||
144449805|NCT02627677|520846196|FG001|Overall Study|Adverse event (not progressive disease)|4|||
144449806|NCT02627677|520846197|FG002|Overall Study|Adverse event (not progressive disease)|1|||
144449807|NCT02627677|520846195|FG000|Overall Study|Progressive disease|1|||
144449808|NCT02627677|520846196|FG001|Overall Study|Progressive disease|3|||
144449809|NCT02627677|520846197|FG002|Overall Study|Progressive disease|0|||
144449810|NCT02627677|520846195|FG000|Overall Study|Lack of Efficacy|1|||
144449811|NCT02627677|520846196|FG001|Overall Study|Lack of Efficacy|2|||
144449812|NCT02627677|520846197|FG002|Overall Study|Lack of Efficacy|0|||
144449813|NCT02627677|520846195|FG000|Overall Study|Lost to Follow-up|0|||
144449814|NCT02627677|520846196|FG001|Overall Study|Lost to Follow-up|0|||
144449815|NCT02627677|520846197|FG002|Overall Study|Lost to Follow-up|1|||
144449816|NCT02627677|520846195|FG000|Overall Study|Pregnancy|0|||
144449817|NCT02627677|520846196|FG001|Overall Study|Pregnancy|1|||
144449818|NCT02627677|520846197|FG002|Overall Study|Pregnancy|0|||
144449819|NCT02627677|520846195|FG000|Overall Study|Study Terminated by Sponsor|5|||
144449820|NCT02627677|520846196|FG001|Overall Study|Study Terminated by Sponsor|10|||
144449821|NCT02627677|520846197|FG002|Overall Study|Study Terminated by Sponsor|6|||
144449822|NCT02627677|520846195|FG000|Overall Study|Physician Decision|0|||
144449823|NCT02627677|520846196|FG001|Overall Study|Physician Decision|0|||
144449824|NCT02627677|520846197|FG002|Overall Study|Physician Decision|2|||
144449825|NCT02627677|520846195|FG000|Overall Study|Withdrawal by Subject|2|||
144449826|NCT02627677|520846196|FG001|Overall Study|Withdrawal by Subject|1|||
144449827|NCT02627677|520846197|FG002|Overall Study|Withdrawal by Subject|1|||
144449828|NCT02627677|520846195|FG000|Overall Study|Reason not Specified|0|||
144449829|NCT02627677|520846196|FG001|Overall Study|Reason not Specified|0|||
144449830|NCT02627677|520846197|FG002|Overall Study|Reason not Specified|1|||
144449831|NCT02627677|520846195|FG000|Overall Study|Randomized but not Treated|1|||
144449832|NCT02627677|520846196|FG001|Overall Study|Randomized but not Treated|0|||
144449833|NCT02627677|520846197|FG002|Overall Study|Randomized but not Treated|0|||
144449834|NCT00317772|520846198|FG000|Overall Study|Adverse Event|0|||
144449835|NCT00317772|520846199|FG001|Overall Study|Adverse Event|0|||
144449836|NCT00317772|520846200|FG002|Overall Study|Adverse Event|0|||
144449837|NCT00317772|520846201|FG003|Overall Study|Adverse Event|2|||
144449838|NCT00317772|520846198|FG000|Overall Study|Disease Progression|2|||
144449839|NCT00317772|520846199|FG001|Overall Study|Disease Progression|2|||
144449840|NCT00317772|520846200|FG002|Overall Study|Disease Progression|1|||
144449841|NCT00317772|520846201|FG003|Overall Study|Disease Progression|7|||
144449842|NCT02696850|520846202|FG000|Overall Study|Withdrawal by Subject|3|||
144449843|NCT02696850|520846203|FG001|Overall Study|Withdrawal by Subject|3|||
144449844|NCT02696850|520846202|FG000|Overall Study|Lost to Follow-up|8|||
144449845|NCT02696850|520846203|FG001|Overall Study|Lost to Follow-up|5|||
144449846|NCT00673049|520846206|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
144449847|NCT00673049|520846207|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
144449848|NCT00673049|520846208|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
144449849|NCT00673049|520846209|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
144449850|NCT00673049|520846206|FG000|Before Progression on Erlotinib|Death|235|||
144449851|NCT00673049|520846207|FG001|Before Progression on Erlotinib|Death|167|||
144449852|NCT00673049|520846208|FG002|Before Progression on Erlotinib|Death|1|||
144449853|NCT00673049|520846209|FG003|Before Progression on Erlotinib|Death|0|||
144449854|NCT00673049|520846206|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
144449855|NCT00673049|520846207|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
144449856|NCT00673049|520846208|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
144449857|NCT00673049|520846209|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
144449858|NCT00673049|520846206|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
144449859|NCT00673049|520846207|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
144449860|NCT00673049|520846208|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
144449861|NCT00673049|520846209|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
144449862|NCT00673049|520846206|FG000|Before Progression on Erlotinib|Other|1|||
144449863|NCT00673049|520846207|FG001|Before Progression on Erlotinib|Other|2|||
144606681|NCT01514136|521421078|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
144606682|NCT01514136|521421079|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
144449864|NCT00673049|520846208|FG002|Before Progression on Erlotinib|Other|0|||
144449865|NCT00673049|520846209|FG003|Before Progression on Erlotinib|Other|0|||
144449866|NCT00673049|520846206|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
144449867|NCT00673049|520846207|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
144449868|NCT00673049|520846208|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
144449869|NCT00673049|520846209|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
144449870|NCT00673049|520846206|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
144449871|NCT00673049|520846207|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
144449872|NCT00673049|520846208|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
144449873|NCT00673049|520846209|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
144449874|NCT00673049|520846206|FG000|After Progression on Erlotinib|Death|0|||
144449875|NCT00673049|520846207|FG001|After Progression on Erlotinib|Death|0|||
144449876|NCT00673049|520846208|FG002|After Progression on Erlotinib|Death|0|||
144449877|NCT00673049|520846209|FG003|After Progression on Erlotinib|Death|71|||
144449878|NCT00673049|520846206|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
144606683|NCT01514136|521421080|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
144606684|NCT01514136|521421081|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
144449879|NCT00673049|520846207|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
144449880|NCT00673049|520846208|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
144449881|NCT00673049|520846209|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
144449882|NCT00673049|520846206|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
144449883|NCT00673049|520846207|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
144449884|NCT00673049|520846208|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
144449885|NCT00673049|520846209|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
144449886|NCT00673049|520846206|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
144449887|NCT00673049|520846207|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
144449888|NCT00673049|520846208|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
144449889|NCT00673049|520846209|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
144449890|NCT02621606|520846210|FG000|Overall Study|Withdrawal by Subject|0|||
144449891|NCT02621606|520846211|FG001|Overall Study|Withdrawal by Subject|1|||
144449892|NCT02621606|520846212|FG002|Overall Study|Withdrawal by Subject|0|||
144449893|NCT02039505|520846213|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
144449894|NCT02039505|520846214|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
144449895|NCT02039505|520846215|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
144449896|NCT02039505|520846216|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
144449897|NCT02039505|520846217|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
144449898|NCT02039505|520846218|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
144449899|NCT02039505|520846219|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
144449900|NCT02039505|520846213|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
144449901|NCT02039505|520846214|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
144449902|NCT02039505|520846215|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
144449903|NCT02039505|520846216|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
144449904|NCT02039505|520846217|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
144449905|NCT02039505|520846218|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
144449906|NCT02039505|520846219|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
144449907|NCT02039505|520846213|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
144449908|NCT02039505|520846214|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
144449909|NCT02039505|520846215|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
144449910|NCT02039505|520846216|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
144449911|NCT02039505|520846217|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
144449912|NCT02039505|520846218|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
144449913|NCT02039505|520846219|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
144449914|NCT02039505|520846213|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
144449915|NCT02039505|520846214|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
144449916|NCT02039505|520846215|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
144449917|NCT02039505|520846216|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
144449918|NCT02039505|520846217|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
144449919|NCT02039505|520846218|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
144449920|NCT02039505|520846219|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
144449921|NCT02039505|520846213|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
144449922|NCT02039505|520846214|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
144449923|NCT02039505|520846215|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
144449924|NCT02039505|520846216|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
144449925|NCT02039505|520846217|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
144449926|NCT02039505|520846218|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
144449927|NCT02039505|520846219|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
144449928|NCT02039505|520846213|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
144449929|NCT02039505|520846214|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
144449930|NCT02039505|520846215|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
144449931|NCT02039505|520846216|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
144449932|NCT02039505|520846217|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
144449933|NCT02039505|520846218|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
144449934|NCT02039505|520846219|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
144449935|NCT02039505|520846213|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
144533501|NCT04451772|521156655|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
144253893|NCT02155322|520130081|FG000|Overall Study|Physician Decision|1|||
144253894|NCT02155322|520130081|FG000|Overall Study|Relapse/Recurrence|8|||
144253895|NCT02155322|520130081|FG000|Overall Study|Withdrawal by Subject|4|||
144253896|NCT01926197|520130087|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
144253897|NCT01926197|520130088|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
144194602|NCT00700817|519908445|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
144194603|NCT00700817|519908441|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
144449936|NCT02039505|520846214|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
144449937|NCT02039505|520846215|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
144449938|NCT02039505|520846216|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
144449939|NCT02039505|520846217|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
144449940|NCT02039505|520846218|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
144449941|NCT02039505|520846219|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
144449942|NCT02039505|520846213|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
144449943|NCT02039505|520846214|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
144449944|NCT02039505|520846215|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
144449945|NCT02039505|520846216|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
144449946|NCT02039505|520846217|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
144449947|NCT02039505|520846218|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
144449948|NCT02039505|520846219|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
144449949|NCT02039505|520846213|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
144449950|NCT02039505|520846214|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
144449951|NCT02039505|520846215|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
144449952|NCT02039505|520846216|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
144449953|NCT02039505|520846217|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
144449954|NCT02039505|520846218|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
144449955|NCT02039505|520846219|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
144449956|NCT02039505|520846213|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
144449957|NCT02039505|520846214|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
144449958|NCT02039505|520846215|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
144449959|NCT02039505|520846216|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
144449960|NCT02039505|520846217|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
144449961|NCT02039505|520846218|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
144449962|NCT02039505|520846219|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
144449963|NCT02039505|520846213|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
144449964|NCT02039505|520846214|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
144449965|NCT02039505|520846215|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
144449966|NCT02039505|520846216|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
144449967|NCT02039505|520846217|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
144449968|NCT02039505|520846218|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
144449969|NCT02039505|520846219|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
144449970|NCT01163682|520846221|FG000|Overall Study|Lost to Follow-up|6|||
144449971|NCT01163682|520846222|FG001|Overall Study|Lost to Follow-up|9|||
144449972|NCT04713748|520846225|FG000|Overall Study|Not enough kits allocated|35|||
144449973|NCT02461589|520846226|FG000|Overall Study|Withdrawal by Subject|5|||
144449974|NCT02461589|520846227|FG001|Overall Study|Withdrawal by Subject|1|||
144449975|NCT02461589|520846228|FG002|Overall Study|Withdrawal by Subject|3|||
144449976|NCT02461589|520846229|FG003|Overall Study|Withdrawal by Subject|2|||
144449977|NCT02461589|520846230|FG004|Overall Study|Withdrawal by Subject|1|||
144449978|NCT02461589|520846231|FG005|Overall Study|Withdrawal by Subject|2|||
144449979|NCT02461589|520846232|FG006|Overall Study|Withdrawal by Subject|1|||
144449980|NCT02461589|520846233|FG007|Overall Study|Withdrawal by Subject|3|||
144449981|NCT02461589|520846234|FG008|Overall Study|Withdrawal by Subject|3|||
144449982|NCT02461589|520846235|FG009|Overall Study|Withdrawal by Subject|1|||
144449983|NCT02461589|520846226|FG000|Overall Study|Lost to Follow-up|0|||
144449984|NCT02461589|520846227|FG001|Overall Study|Lost to Follow-up|0|||
144449985|NCT02461589|520846228|FG002|Overall Study|Lost to Follow-up|2|||
144449986|NCT02461589|520846229|FG003|Overall Study|Lost to Follow-up|3|||
144449987|NCT02461589|520846230|FG004|Overall Study|Lost to Follow-up|1|||
144449988|NCT02461589|520846231|FG005|Overall Study|Lost to Follow-up|1|||
144449989|NCT02461589|520846232|FG006|Overall Study|Lost to Follow-up|3|||
144449990|NCT02461589|520846233|FG007|Overall Study|Lost to Follow-up|1|||
144449991|NCT02461589|520846234|FG008|Overall Study|Lost to Follow-up|3|||
144449992|NCT02461589|520846235|FG009|Overall Study|Lost to Follow-up|1|||
144449993|NCT02461589|520846226|FG000|Overall Study|Death|0|||
144449994|NCT02461589|520846227|FG001|Overall Study|Death|0|||
144449995|NCT02461589|520846228|FG002|Overall Study|Death|0|||
144194604|NCT00700817|519908442|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
144449996|NCT02461589|520846229|FG003|Overall Study|Death|0|||
144449997|NCT02461589|520846230|FG004|Overall Study|Death|0|||
144449998|NCT02461589|520846231|FG005|Overall Study|Death|0|||
144449999|NCT02461589|520846232|FG006|Overall Study|Death|0|||
144450000|NCT02461589|520846233|FG007|Overall Study|Death|1|||
144450001|NCT02461589|520846234|FG008|Overall Study|Death|0|||
144450002|NCT02461589|520846235|FG009|Overall Study|Death|0|||
144194605|NCT00700817|519908443|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
144450003|NCT02461589|520846226|FG000|Overall Study|Unclassified|0|||
144450004|NCT02461589|520846227|FG001|Overall Study|Unclassified|0|||
144450005|NCT02461589|520846228|FG002|Overall Study|Unclassified|0|||
144450006|NCT02461589|520846229|FG003|Overall Study|Unclassified|0|||
144450007|NCT02461589|520846230|FG004|Overall Study|Unclassified|0|||
144450008|NCT02461589|520846231|FG005|Overall Study|Unclassified|0|||
144450009|NCT02461589|520846232|FG006|Overall Study|Unclassified|1|||
144450010|NCT02461589|520846233|FG007|Overall Study|Unclassified|0|||
144450011|NCT02461589|520846234|FG008|Overall Study|Unclassified|0|||
144450012|NCT02461589|520846235|FG009|Overall Study|Unclassified|2|||
144450013|NCT02461589|520846226|FG000|Overall Study|Missing follow-up information|1|||
144450014|NCT02461589|520846227|FG001|Overall Study|Missing follow-up information|1|||
144450015|NCT02461589|520846228|FG002|Overall Study|Missing follow-up information|0|||
144450016|NCT02461589|520846229|FG003|Overall Study|Missing follow-up information|0|||
144450017|NCT02461589|520846230|FG004|Overall Study|Missing follow-up information|0|||
144450018|NCT02461589|520846231|FG005|Overall Study|Missing follow-up information|0|||
144450019|NCT02461589|520846232|FG006|Overall Study|Missing follow-up information|1|||
144450020|NCT02461589|520846233|FG007|Overall Study|Missing follow-up information|0|||
144450021|NCT02461589|520846234|FG008|Overall Study|Missing follow-up information|0|||
144450022|NCT02461589|520846235|FG009|Overall Study|Missing follow-up information|0|||
144450023|NCT02461589|520846226|FG000|Overall Study|Withdrawal from trial before exposure|0|||
144450024|NCT02461589|520846227|FG001|Overall Study|Withdrawal from trial before exposure|0|||
144450025|NCT02461589|520846228|FG002|Overall Study|Withdrawal from trial before exposure|0|||
144450026|NCT02461589|520846229|FG003|Overall Study|Withdrawal from trial before exposure|0|||
144450027|NCT02461589|520846230|FG004|Overall Study|Withdrawal from trial before exposure|0|||
144450028|NCT02461589|520846231|FG005|Overall Study|Withdrawal from trial before exposure|0|||
144450029|NCT02461589|520846232|FG006|Overall Study|Withdrawal from trial before exposure|0|||
144450030|NCT02461589|520846233|FG007|Overall Study|Withdrawal from trial before exposure|0|||
144450031|NCT02461589|520846234|FG008|Overall Study|Withdrawal from trial before exposure|0|||
144450032|NCT02461589|520846235|FG009|Overall Study|Withdrawal from trial before exposure|1|||
144450033|NCT00406029|520846236|FG000|Overall Study|Adverse Event|12|||
144450034|NCT00406029|520846237|FG001|Overall Study|Adverse Event|2|||
144450035|NCT00406029|520846238|FG002|Overall Study|Adverse Event|5|||
144450036|NCT00406029|520846239|FG003|Overall Study|Adverse Event|10|||
144450037|NCT00406029|520846240|FG004|Overall Study|Adverse Event|7|||
144450038|NCT00406029|520846236|FG000|Overall Study|Withdrawal by Subject|3|||
144450039|NCT00406029|520846237|FG001|Overall Study|Withdrawal by Subject|4|||
144450040|NCT00406029|520846238|FG002|Overall Study|Withdrawal by Subject|2|||
144450041|NCT00406029|520846239|FG003|Overall Study|Withdrawal by Subject|2|||
144450042|NCT00406029|520846240|FG004|Overall Study|Withdrawal by Subject|0|||
144450043|NCT00406029|520846236|FG000|Overall Study|Protocol Violation|1|||
144450044|NCT00406029|520846237|FG001|Overall Study|Protocol Violation|2|||
144450045|NCT00406029|520846238|FG002|Overall Study|Protocol Violation|0|||
144450046|NCT00406029|520846239|FG003|Overall Study|Protocol Violation|2|||
144450047|NCT00406029|520846240|FG004|Overall Study|Protocol Violation|0|||
144450048|NCT00406029|520846236|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
144450049|NCT00406029|520846237|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
144450050|NCT00406029|520846238|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
144450051|NCT00406029|520846239|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
144450052|NCT00406029|520846240|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
144450053|NCT00406029|520846236|FG000|Overall Study|Randomized in Error|0|||
144450054|NCT00406029|520846237|FG001|Overall Study|Randomized in Error|0|||
144450055|NCT00406029|520846238|FG002|Overall Study|Randomized in Error|2|||
144450056|NCT00406029|520846239|FG003|Overall Study|Randomized in Error|3|||
144450057|NCT00406029|520846240|FG004|Overall Study|Randomized in Error|1|||
144450058|NCT01557946|520846241|FG000|Overall Study|Adverse Event|3|||
144450059|NCT01557946|520846242|FG001|Overall Study|Adverse Event|0|||
144450060|NCT01038921|520846243|FG000|Overall Study|Withdrawal by Subject|1|||
144450061|NCT01038921|520846244|FG001|Overall Study|Withdrawal by Subject|0|||
144253898|NCT01926197|520130087|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
144253899|NCT01926197|520130088|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
144253900|NCT03628716|520130089|FG000|Overall Study|Adverse Event|1|||
144253901|NCT03628716|520130090|FG001|Overall Study|Adverse Event|1|||
144253902|NCT03628716|520130089|FG000|Overall Study|Death|1|||
144253903|NCT03628716|520130090|FG001|Overall Study|Death|0|||
144450062|NCT01038921|520846243|FG000|Overall Study|Physician Decision|1|||
144450063|NCT01038921|520846244|FG001|Overall Study|Physician Decision|0|||
144450064|NCT01831089|520846245|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
144253904|NCT03628716|520130089|FG000|Overall Study|Lack of Efficacy|15|||
144450065|NCT01831089|520846246|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
144450066|NCT01831089|520846247|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
144450067|NCT01831089|520846248|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
144450068|NCT01831089|520846249|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
144450069|NCT01831089|520846250|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
144450070|NCT01831089|520846245|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
144450071|NCT01831089|520846246|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
144450072|NCT01831089|520846247|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
144450073|NCT01831089|520846248|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
144450074|NCT01831089|520846249|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
144450075|NCT01831089|520846250|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
144450076|NCT01831089|520846245|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
144450077|NCT01831089|520846246|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
144450078|NCT01831089|520846247|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
144450079|NCT01831089|520846248|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
144450080|NCT01831089|520846249|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
144450081|NCT01831089|520846250|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
144450082|NCT01831089|520846245|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
144450083|NCT01831089|520846246|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
144450084|NCT01831089|520846247|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
144450085|NCT01831089|520846248|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
144450086|NCT01831089|520846249|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
144450087|NCT01831089|520846250|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
144450088|NCT01831089|520846245|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
144450089|NCT01831089|520846246|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
144450090|NCT01831089|520846247|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
144450091|NCT01831089|520846248|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
144450092|NCT01831089|520846249|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
144450093|NCT01831089|520846250|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
144450094|NCT01831089|520846245|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
144450095|NCT01831089|520846246|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
144450096|NCT01831089|520846247|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
144450097|NCT01831089|520846248|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
144450098|NCT01831089|520846249|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
144450099|NCT01831089|520846250|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
144450100|NCT01831089|520846245|FG000|Cohort III: Dose Level 3|Global end of study|0|||
144450101|NCT01831089|520846246|FG001|Cohort III: Dose Level 3|Global end of study|0|||
144450102|NCT01831089|520846247|FG002|Cohort III: Dose Level 3|Global end of study|1|||
144450103|NCT01831089|520846248|FG003|Cohort III: Dose Level 3|Global end of study|0|||
144450104|NCT01831089|520846249|FG004|Cohort III: Dose Level 3|Global end of study|0|||
144450105|NCT01831089|520846250|FG005|Cohort III: Dose Level 3|Global end of study|0|||
144450106|NCT01831089|520846245|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
144450107|NCT01831089|520846246|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
144450108|NCT01831089|520846247|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
144450109|NCT01831089|520846248|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
144450110|NCT01831089|520846249|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
144450111|NCT01831089|520846250|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
144450112|NCT01831089|520846245|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
144450113|NCT01831089|520846246|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
144450114|NCT01831089|520846247|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
144450115|NCT01831089|520846248|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
144450116|NCT01831089|520846249|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
144450117|NCT01831089|520846250|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
144450118|NCT01831089|520846245|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
144450119|NCT01831089|520846246|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
144450120|NCT01831089|520846247|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
144606685|NCT01514136|521421082|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
144606686|NCT01514136|521421083|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
144606687|NCT01514136|521421076|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606688|NCT01514136|521421077|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606689|NCT01514136|521421078|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606690|NCT01514136|521421079|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606691|NCT01514136|521421080|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606692|NCT01514136|521421081|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606693|NCT01514136|521421082|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
144606694|NCT01514136|521421083|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
144606695|NCT01514136|521421076|FG000|Test Period 2; Test C*|holiday|0|||
144606696|NCT01514136|521421077|FG001|Test Period 2; Test C*|holiday|0|||
144606697|NCT01514136|521421078|FG002|Test Period 2; Test C*|holiday|0|||
144450121|NCT01831089|520846248|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
144450122|NCT01831089|520846249|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
144450123|NCT01831089|520846250|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
144450124|NCT01831089|520846245|FG000|Cohort V: Dose Level 5|Death|0|||
144450125|NCT01831089|520846246|FG001|Cohort V: Dose Level 5|Death|0|||
144450126|NCT01831089|520846247|FG002|Cohort V: Dose Level 5|Death|0|||
144606698|NCT01514136|521421079|FG003|Test Period 2; Test C*|holiday|0|||
144450127|NCT01831089|520846248|FG003|Cohort V: Dose Level 5|Death|0|||
144450128|NCT01831089|520846249|FG004|Cohort V: Dose Level 5|Death|1|||
144450129|NCT01831089|520846250|FG005|Cohort V: Dose Level 5|Death|0|||
144450130|NCT01831089|520846245|FG000|Cohort V: Dose Level 5|Global end of study|0|||
144450131|NCT01831089|520846246|FG001|Cohort V: Dose Level 5|Global end of study|0|||
144450132|NCT01831089|520846247|FG002|Cohort V: Dose Level 5|Global end of study|0|||
144450133|NCT01831089|520846248|FG003|Cohort V: Dose Level 5|Global end of study|0|||
144450134|NCT01831089|520846249|FG004|Cohort V: Dose Level 5|Global end of study|2|||
144450135|NCT01831089|520846250|FG005|Cohort V: Dose Level 5|Global end of study|0|||
144450136|NCT01831089|520846245|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
144450137|NCT01831089|520846246|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
144450138|NCT01831089|520846247|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
144450139|NCT01831089|520846248|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
144450140|NCT01831089|520846249|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
144450141|NCT01831089|520846250|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
144450142|NCT01831089|520846245|FG000|Cohort B: Arm B|Progressive disease|0|||
144450143|NCT01831089|520846246|FG001|Cohort B: Arm B|Progressive disease|0|||
144450144|NCT01831089|520846247|FG002|Cohort B: Arm B|Progressive disease|0|||
144450145|NCT01831089|520846248|FG003|Cohort B: Arm B|Progressive disease|0|||
144450146|NCT01831089|520846249|FG004|Cohort B: Arm B|Progressive disease|0|||
144450147|NCT01831089|520846250|FG005|Cohort B: Arm B|Progressive disease|8|||
144450148|NCT01831089|520846245|FG000|Cohort B: Arm B|Physician Decision|0|||
144450149|NCT01831089|520846246|FG001|Cohort B: Arm B|Physician Decision|0|||
144450150|NCT01831089|520846247|FG002|Cohort B: Arm B|Physician Decision|0|||
144450151|NCT01831089|520846248|FG003|Cohort B: Arm B|Physician Decision|0|||
144450152|NCT01831089|520846249|FG004|Cohort B: Arm B|Physician Decision|0|||
144450153|NCT01831089|520846250|FG005|Cohort B: Arm B|Physician Decision|2|||
144450154|NCT01831089|520846245|FG000|Cohort B: Arm B|Never treated|0|||
144450155|NCT01831089|520846246|FG001|Cohort B: Arm B|Never treated|0|||
144450156|NCT01831089|520846247|FG002|Cohort B: Arm B|Never treated|0|||
144450157|NCT01831089|520846248|FG003|Cohort B: Arm B|Never treated|0|||
144450158|NCT01831089|520846249|FG004|Cohort B: Arm B|Never treated|0|||
144450159|NCT01831089|520846250|FG005|Cohort B: Arm B|Never treated|2|||
144450160|NCT01831089|520846245|FG000|Cohort B: Arm B|Adverse Event|0|||
144450161|NCT01831089|520846246|FG001|Cohort B: Arm B|Adverse Event|0|||
144450162|NCT01831089|520846247|FG002|Cohort B: Arm B|Adverse Event|0|||
144450163|NCT01831089|520846248|FG003|Cohort B: Arm B|Adverse Event|0|||
144450164|NCT01831089|520846249|FG004|Cohort B: Arm B|Adverse Event|0|||
144450165|NCT01831089|520846250|FG005|Cohort B: Arm B|Adverse Event|1|||
144450166|NCT01831089|520846245|FG000|Cohort B: Arm B|Global end of study|0|||
144450167|NCT01831089|520846246|FG001|Cohort B: Arm B|Global end of study|0|||
144450168|NCT01831089|520846247|FG002|Cohort B: Arm B|Global end of study|0|||
144450169|NCT01831089|520846248|FG003|Cohort B: Arm B|Global end of study|0|||
144450170|NCT01831089|520846249|FG004|Cohort B: Arm B|Global end of study|0|||
144450171|NCT01831089|520846250|FG005|Cohort B: Arm B|Global end of study|1|||
144450172|NCT02013765|520846251|FG000|Overall Study|Trial was terminated by sponsor|1|||
144450173|NCT01047683|520846256|FG000|Overall Study|Adverse Event|3|||
144450174|NCT01047683|520846257|FG001|Overall Study|Adverse Event|1|||
144450175|NCT01047683|520846258|FG002|Overall Study|Adverse Event|0|||
144450176|NCT01047683|520846256|FG000|Overall Study|Withdrew Consent|1|||
144450177|NCT01047683|520846257|FG001|Overall Study|Withdrew Consent|4|||
144450178|NCT01047683|520846258|FG002|Overall Study|Withdrew Consent|2|||
144450179|NCT01047683|520846256|FG000|Overall Study|Lost to Follow-up|0|||
144450180|NCT01047683|520846257|FG001|Overall Study|Lost to Follow-up|1|||
144450181|NCT01047683|520846258|FG002|Overall Study|Lost to Follow-up|0|||
144450182|NCT01047683|520846256|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
144450183|NCT01047683|520846257|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
144450184|NCT01047683|520846258|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
144450185|NCT00833924|520846262|FG000|Overall Study|Death|21|||
144450186|NCT00833924|520846262|FG000|Overall Study|Conversion|2|||
144450187|NCT00833924|520846262|FG000|Overall Study|Lost to Follow-up|2|||
144450188|NCT00833924|520846262|FG000|Overall Study|Withdrawal by Subject|13|||
144450189|NCT00833924|520846262|FG000|Overall Study|In study follow-up|71|||
144450190|NCT01485861|520846263|FG000|Phase Ib|Death|1|||
144450191|NCT01485861|520846264|FG001|Phase Ib|Death|0|||
144450192|NCT01485861|520846265|FG002|Phase Ib|Death|0|||
144450193|NCT01485861|520846266|FG003|Phase Ib|Death|0|||
144450194|NCT01485861|520846267|FG004|Phase Ib|Death|0|||
144450195|NCT01485861|520846268|FG005|Phase Ib|Death|0|||
144450196|NCT01485861|520846263|FG000|Phase Ib|Physician Decision|1|||
144450197|NCT01485861|520846264|FG001|Phase Ib|Physician Decision|1|||
144450198|NCT01485861|520846265|FG002|Phase Ib|Physician Decision|0|||
144450199|NCT01485861|520846266|FG003|Phase Ib|Physician Decision|0|||
144450200|NCT01485861|520846267|FG004|Phase Ib|Physician Decision|0|||
144450201|NCT01485861|520846268|FG005|Phase Ib|Physician Decision|0|||
144450202|NCT01485861|520846263|FG000|Phase Ib|Adverse Event|0|||
144450203|NCT01485861|520846264|FG001|Phase Ib|Adverse Event|4|||
144450204|NCT01485861|520846265|FG002|Phase Ib|Adverse Event|0|||
144450205|NCT01485861|520846266|FG003|Phase Ib|Adverse Event|0|||
144725430|NCT02446132|521851267|FG001|Overall Study|Non-compliance With Study Drug|2|||
144725431|NCT02446132|521851268|FG002|Overall Study|Non-compliance With Study Drug|3|||
144725432|NCT02446132|521851266|FG000|Overall Study|Physician Decision|1|||
144725433|NCT02446132|521851267|FG001|Overall Study|Physician Decision|8|||
144450206|NCT01485861|520846267|FG004|Phase Ib|Adverse Event|0|||
144450207|NCT01485861|520846268|FG005|Phase Ib|Adverse Event|0|||
144450208|NCT01485861|520846263|FG000|Phase Ib|Progression of disease|5|||
144450209|NCT01485861|520846264|FG001|Phase Ib|Progression of disease|0|||
144450210|NCT01485861|520846265|FG002|Phase Ib|Progression of disease|0|||
144450211|NCT01485861|520846266|FG003|Phase Ib|Progression of disease|0|||
144450212|NCT01485861|520846267|FG004|Phase Ib|Progression of disease|0|||
144450213|NCT01485861|520846268|FG005|Phase Ib|Progression of disease|0|||
144450214|NCT01485861|520846263|FG000|Phase Ib|Other|3|||
144450215|NCT01485861|520846264|FG001|Phase Ib|Other|0|||
144450216|NCT01485861|520846265|FG002|Phase Ib|Other|0|||
144450217|NCT01485861|520846266|FG003|Phase Ib|Other|0|||
144450218|NCT01485861|520846267|FG004|Phase Ib|Other|0|||
144450219|NCT01485861|520846268|FG005|Phase Ib|Other|0|||
144450220|NCT01485861|520846263|FG000|Phase Ib|Withdrawal by Subject|4|||
144450221|NCT01485861|520846264|FG001|Phase Ib|Withdrawal by Subject|1|||
144450222|NCT01485861|520846265|FG002|Phase Ib|Withdrawal by Subject|0|||
144450223|NCT01485861|520846266|FG003|Phase Ib|Withdrawal by Subject|0|||
144533502|NCT04311632|521156656|FG000|Overall Study|Withdrawal by Subject|0|||
144533503|NCT04311632|521156657|FG001|Overall Study|Withdrawal by Subject|0|||
144253905|NCT03628716|520130090|FG001|Overall Study|Lack of Efficacy|20|||
144253906|NCT03628716|520130089|FG000|Overall Study|Withdrawal by Subject|1|||
144253907|NCT03628716|520130090|FG001|Overall Study|Withdrawal by Subject|2|||
144253908|NCT03628716|520130089|FG000|Overall Study|Study Terminated by Sponsor|1|||
144253909|NCT03628716|520130090|FG001|Overall Study|Study Terminated by Sponsor|0|||
144253910|NCT00856843|520130091|FG000|Overall Study|Withdrawal by Subject|1|||
144253911|NCT00856843|520130092|FG001|Overall Study|Withdrawal by Subject|5|||
144253912|NCT00856843|520130091|FG000|Overall Study|Lack of Efficacy|1|||
144253913|NCT00856843|520130092|FG001|Overall Study|Lack of Efficacy|0|||
144253914|NCT02179749|520130093|FG000|Overall Study|Adverse Event|0|||
144253915|NCT02179749|520130094|FG001|Overall Study|Adverse Event|0|||
144253916|NCT02179749|520130095|FG002|Overall Study|Adverse Event|1|||
144253917|NCT02179749|520130093|FG000|Overall Study|Withdrawal by Subject|0|||
144253918|NCT02179749|520130094|FG001|Overall Study|Withdrawal by Subject|0|||
144253919|NCT02179749|520130095|FG002|Overall Study|Withdrawal by Subject|1|||
144253920|NCT01841567|520130096|FG000|Overall Study|Adverse Event|3|||
144253921|NCT01573754|520130101|FG000|Overall Study|Noncompliance or remission not achieved|3|||
144253922|NCT01573754|520130102|FG001|Overall Study|Noncompliance or remission not achieved|15|||
144253923|NCT00829829|520130103|FG000|Overall Study|Protocol Violation|0|||
144253924|NCT00829829|520130104|FG001|Overall Study|Protocol Violation|3|||
144253925|NCT00829829|520130105|FG002|Overall Study|Protocol Violation|0|||
144253926|NCT00829829|520130103|FG000|Overall Study|Adverse Event|4|||
144253927|NCT00829829|520130104|FG001|Overall Study|Adverse Event|4|||
144253928|NCT00829829|520130105|FG002|Overall Study|Adverse Event|3|||
144253929|NCT00829829|520130103|FG000|Overall Study|Withdrawal by Subject|8|||
144253930|NCT00829829|520130104|FG001|Overall Study|Withdrawal by Subject|4|||
144253931|NCT00829829|520130105|FG002|Overall Study|Withdrawal by Subject|2|||
144253932|NCT00829829|520130103|FG000|Overall Study|Decision by the Sponsor|1|||
144253933|NCT00829829|520130104|FG001|Overall Study|Decision by the Sponsor|0|||
144253934|NCT00829829|520130105|FG002|Overall Study|Decision by the Sponsor|2|||
144253935|NCT00829829|520130103|FG000|Overall Study|Lost to Follow-up|7|||
144253936|NCT00829829|520130104|FG001|Overall Study|Lost to Follow-up|3|||
144253937|NCT00829829|520130105|FG002|Overall Study|Lost to Follow-up|3|||
144253938|NCT00829829|520130103|FG000|Overall Study|Other than specified above|2|||
144533504|NCT04311632|521156658|FG002|Overall Study|Withdrawal by Subject|1|||
144533505|NCT04632225|521156659|FG000|Overall Study|Withdrawal by Subject|2|||
144606699|NCT01514136|521421080|FG004|Test Period 2; Test C*|holiday|0|||
144253939|NCT00829829|520130104|FG001|Overall Study|Other than specified above|2|||
144253940|NCT00829829|520130105|FG002|Overall Study|Other than specified above|1|||
144253941|NCT02984267|520130106|FG000|Overall Study|Protocol Violation|1|||
144253942|NCT02984267|520130107|FG001|Overall Study|Protocol Violation|0|||
144253943|NCT02984267|520130106|FG000|Overall Study|Withdrawal by Subject|0|||
144253944|NCT02984267|520130107|FG001|Overall Study|Withdrawal by Subject|1|||
144253945|NCT02685072|520130108|FG000|Treatment Period|Lost to Follow-up|12|||
144253946|NCT02685072|520130109|FG001|Treatment Period|Lost to Follow-up|6|||
144253947|NCT02685072|520130108|FG000|Treatment Period|Withdrawal by Subject|1|||
144253948|NCT02685072|520130109|FG001|Treatment Period|Withdrawal by Subject|3|||
144450224|NCT01485861|520846267|FG004|Phase Ib|Withdrawal by Subject|0|||
144450225|NCT01485861|520846268|FG005|Phase Ib|Withdrawal by Subject|0|||
144450226|NCT01485861|520846263|FG000|Phase II|Death|0|||
144450227|NCT01485861|520846264|FG001|Phase II|Death|0|||
144450228|NCT01485861|520846265|FG002|Phase II|Death|67|||
144450229|NCT01485861|520846266|FG003|Phase II|Death|71|||
144450230|NCT01485861|520846267|FG004|Phase II|Death|68|||
144450231|NCT01485861|520846268|FG005|Phase II|Death|0|||
144450232|NCT01485861|520846263|FG000|Phase II|Progression of Disease|0|||
144194606|NCT00700817|519908444|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
144194607|NCT00700817|519908445|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
144194608|NCT00700817|519908441|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
144194609|NCT00700817|519908442|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
144194610|NCT00700817|519908443|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
144194611|NCT00700817|519908444|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
144194612|NCT00700817|519908445|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
144194613|NCT00700817|519908441|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
144194614|NCT00700817|519908442|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
144194615|NCT00700817|519908443|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
144194616|NCT00700817|519908444|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
144194617|NCT00700817|519908445|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
144194618|NCT00700817|519908441|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
144194619|NCT00700817|519908442|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
144194620|NCT00700817|519908443|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
144194621|NCT00700817|519908444|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
144194622|NCT00700817|519908445|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
144194623|NCT00700817|519908441|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
144194624|NCT00700817|519908442|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
144194625|NCT00700817|519908443|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
144450233|NCT01485861|520846264|FG001|Phase II|Progression of Disease|0|||
144450234|NCT01485861|520846265|FG002|Phase II|Progression of Disease|1|||
144194626|NCT00700817|519908444|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
144450235|NCT01485861|520846266|FG003|Phase II|Progression of Disease|0|||
144450236|NCT01485861|520846267|FG004|Phase II|Progression of Disease|0|||
144450237|NCT01485861|520846268|FG005|Phase II|Progression of Disease|0|||
144450238|NCT01485861|520846263|FG000|Phase II|Other|0|||
144450239|NCT01485861|520846264|FG001|Phase II|Other|0|||
144450240|NCT01485861|520846265|FG002|Phase II|Other|0|||
144450241|NCT01485861|520846266|FG003|Phase II|Other|1|||
144450242|NCT01485861|520846267|FG004|Phase II|Other|0|||
144450243|NCT01485861|520846268|FG005|Phase II|Other|0|||
144450244|NCT01485861|520846263|FG000|Phase II|Withdrawal by Subject|0|||
144450245|NCT01485861|520846264|FG001|Phase II|Withdrawal by Subject|0|||
144450246|NCT01485861|520846265|FG002|Phase II|Withdrawal by Subject|6|||
144194627|NCT00700817|519908445|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
144450247|NCT01485861|520846266|FG003|Phase II|Withdrawal by Subject|3|||
144450248|NCT01485861|520846267|FG004|Phase II|Withdrawal by Subject|4|||
144450249|NCT01485861|520846268|FG005|Phase II|Withdrawal by Subject|0|||
144450250|NCT01485861|520846263|FG000|Phase II|Lost to Follow-up|0|||
144450251|NCT01485861|520846264|FG001|Phase II|Lost to Follow-up|0|||
144450252|NCT01485861|520846265|FG002|Phase II|Lost to Follow-up|2|||
144450253|NCT01485861|520846266|FG003|Phase II|Lost to Follow-up|3|||
144450254|NCT01485861|520846267|FG004|Phase II|Lost to Follow-up|5|||
144194628|NCT00700817|519908441|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
144194629|NCT00700817|519908442|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
144194630|NCT00700817|519908443|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
144194631|NCT00700817|519908444|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
144194632|NCT00700817|519908445|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
144194633|NCT00767520|519908448|FG000|Overall Study|Participants still on treatment|11|||
144194634|NCT00767520|519908449|FG001|Overall Study|Participants still on treatment|15|||
144194635|NCT00767520|519908448|FG000|Overall Study|Randomized in error and Never treated|0|||
144194636|NCT00767520|519908449|FG001|Overall Study|Randomized in error and Never treated|2|||
144194637|NCT00757848|519908450|FG000|Overall Study|Voluntary discontinuation|1|||
144194638|NCT00757848|519908451|FG001|Overall Study|Voluntary discontinuation|0|||
144194639|NCT00757848|519908450|FG000|Overall Study|Adverse Event|1|||
144194640|NCT00757848|519908451|FG001|Overall Study|Adverse Event|2|||
144194641|NCT00757848|519908450|FG000|Overall Study|Incorrect enrolment|1|||
144194642|NCT00757848|519908451|FG001|Overall Study|Incorrect enrolment|0|||
144194643|NCT01338987|519908452|FG000|Overall Study|enrolled on new protocol|0|||
144194644|NCT01338987|519908453|FG001|Overall Study|enrolled on new protocol|0|||
144194645|NCT01338987|519908454|FG002|Overall Study|enrolled on new protocol|1|||
144194646|NCT01338987|519908455|FG003|Overall Study|enrolled on new protocol|0|||
144194647|NCT01338987|519908456|FG004|Overall Study|enrolled on new protocol|0|||
144194648|NCT01338987|519908452|FG000|Overall Study|Disease progression on study|2|||
144194649|NCT01338987|519908453|FG001|Overall Study|Disease progression on study|1|||
144450255|NCT01485861|520846268|FG005|Phase II|Lost to Follow-up|0|||
144450256|NCT01485861|520846263|FG000|Phase II|Study Ended|0|||
144450257|NCT01485861|520846264|FG001|Phase II|Study Ended|0|||
144450258|NCT01485861|520846265|FG002|Phase II|Study Ended|7|||
144450259|NCT01485861|520846266|FG003|Phase II|Study Ended|8|||
144450260|NCT01485861|520846267|FG004|Phase II|Study Ended|6|||
144450261|NCT01485861|520846268|FG005|Phase II|Study Ended|0|||
144450262|NCT01485861|520846263|FG000|Safety Phase|Death|0|||
144450263|NCT01485861|520846264|FG001|Safety Phase|Death|0|||
144450264|NCT01485861|520846265|FG002|Safety Phase|Death|0|||
144450265|NCT01485861|520846266|FG003|Safety Phase|Death|0|||
144450266|NCT01485861|520846267|FG004|Safety Phase|Death|0|||
144450267|NCT01485861|520846268|FG005|Safety Phase|Death|2|||
144450268|NCT01485861|520846263|FG000|Safety Phase|Adverse Event|0|||
144450269|NCT01485861|520846264|FG001|Safety Phase|Adverse Event|0|||
144450270|NCT01485861|520846265|FG002|Safety Phase|Adverse Event|0|||
144450271|NCT01485861|520846266|FG003|Safety Phase|Adverse Event|0|||
144450272|NCT01485861|520846267|FG004|Safety Phase|Adverse Event|0|||
144450273|NCT01485861|520846268|FG005|Safety Phase|Adverse Event|1|||
144450274|NCT01485861|520846263|FG000|Safety Phase|Other|0|||
144450275|NCT01485861|520846264|FG001|Safety Phase|Other|0|||
144450276|NCT01485861|520846265|FG002|Safety Phase|Other|0|||
144450277|NCT01485861|520846266|FG003|Safety Phase|Other|0|||
144450278|NCT01485861|520846267|FG004|Safety Phase|Other|0|||
144450279|NCT01485861|520846268|FG005|Safety Phase|Other|5|||
144450280|NCT01485861|520846263|FG000|Safety Phase|Progression of Disease|0|||
144450281|NCT01485861|520846264|FG001|Safety Phase|Progression of Disease|0|||
144450282|NCT01485861|520846265|FG002|Safety Phase|Progression of Disease|0|||
144450283|NCT01485861|520846266|FG003|Safety Phase|Progression of Disease|0|||
144450284|NCT01485861|520846267|FG004|Safety Phase|Progression of Disease|0|||
144450285|NCT01485861|520846268|FG005|Safety Phase|Progression of Disease|9|||
144450286|NCT01485861|520846263|FG000|Safety Phase|Withdrawal by Subject|0|||
144450287|NCT01485861|520846264|FG001|Safety Phase|Withdrawal by Subject|0|||
144450288|NCT01485861|520846265|FG002|Safety Phase|Withdrawal by Subject|0|||
144450289|NCT01485861|520846266|FG003|Safety Phase|Withdrawal by Subject|0|||
144450290|NCT01485861|520846267|FG004|Safety Phase|Withdrawal by Subject|0|||
144450291|NCT01485861|520846268|FG005|Safety Phase|Withdrawal by Subject|6|||
144450292|NCT01485861|520846263|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
144450293|NCT01485861|520846264|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
144450294|NCT01485861|520846265|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
144450295|NCT01485861|520846266|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
144450296|NCT01485861|520846267|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
144450297|NCT01485861|520846268|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
144450298|NCT01260922|520846270|FG000|First Intervention|Withdrawal by Subject|0|||
144450299|NCT01260922|520846271|FG001|First Intervention|Withdrawal by Subject|1|||
144450300|NCT01260922|520846270|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
144450301|NCT01260922|520846271|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
144450302|NCT01260922|520846270|FG000|Second Intervention|Emesis|0|||
144450303|NCT01260922|520846271|FG001|Second Intervention|Emesis|2|||
144450304|NCT02822794|520846272|FG000|Overall Study|Withdrew Consent|1|||
144450305|NCT02822794|520846273|FG001|Overall Study|Withdrew Consent|0|||
144450306|NCT05101252|520846276|FG000|Overall Study|Unsatisfactory Test Article|1|||
144450307|NCT05101252|520846277|FG001|Overall Study|Unsatisfactory Test Article|0|||
144450308|NCT05101252|520846276|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144450309|NCT05101252|520846277|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
144450310|NCT05101252|520846276|FG000|Overall Study|Withdrew Consent during study|0|||
144450311|NCT05101252|520846277|FG001|Overall Study|Withdrew Consent during study|1|||
144450312|NCT05101252|520846276|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
144450313|NCT05101252|520846277|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
144450314|NCT02266381|520846278|FG000|Overall Study|Physician Decision|3|||
144533506|NCT04632225|521156660|FG001|Overall Study|Withdrawal by Subject|2|||
144533507|NCT02278211|521156661|FG000|Overall Study|Unable to analyse PET scan|2|||
144533508|NCT03858517|521156662|FG000|Overall Study|Adverse Event|1|||
144533509|NCT03858517|521156662|FG000|Overall Study|Lost to Follow-up|1|||
144253949|NCT02685072|520130108|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
144253950|NCT02685072|520130109|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
144253951|NCT02634710|520130110|FG000|Overall Study|Death|4|||
144253952|NCT01249833|520130111|FG000|Overall Study|Lost to Follow-up|0|||
144253953|NCT01249833|520130112|FG001|Overall Study|Lost to Follow-up|1|||
144253954|NCT00723697|520130116|FG000|Overall Study|Physician questionnaires not received|2|||
144253955|NCT00723697|520130116|FG000|Overall Study|Missing Informed Consent Form|10|||
144253956|NCT00723697|520130116|FG000|Overall Study|Other exclusion criteria applied|6|||
144450315|NCT02266381|520846279|FG001|Overall Study|Physician Decision|5|||
144450316|NCT02266381|520846280|FG002|Overall Study|Physician Decision|4|||
144450317|NCT03732248|520846281|FG000|Overall Study|Withdrawal by Subject|1|||
144450318|NCT03732248|520846282|FG001|Overall Study|Withdrawal by Subject|0|||
144450319|NCT00733824|520846283|FG000|Phase I|Withdrawal by Subject|1|||
144533510|NCT03858517|521156662|FG000|Overall Study|removed for being incarcerated|1|||
144533511|NCT03858517|521156662|FG000|Overall Study|Sponsor Closure|48|||
144533512|NCT06037668|521156663|FG000|Overall Study|Lost to Follow-up|1|||
144533513|NCT06037668|521156664|FG001|Overall Study|Lost to Follow-up|1|||
144450320|NCT00733824|520846284|FG001|Phase I|Withdrawal by Subject|0|||
144450321|NCT00733824|520846285|FG002|Phase I|Withdrawal by Subject|0|||
144450322|NCT00733824|520846286|FG003|Phase I|Withdrawal by Subject|0|||
144450323|NCT00733824|520846287|FG004|Phase I|Withdrawal by Subject|0|||
144450324|NCT01243944|520846296|FG000|Overall Study|Adverse Event|15|||
144725434|NCT02446132|521851268|FG002|Overall Study|Physician Decision|13|||
144725435|NCT02446132|521851266|FG000|Overall Study|Protocol Deviation|0|||
144725436|NCT02446132|521851267|FG001|Overall Study|Protocol Deviation|0|||
144725437|NCT02446132|521851268|FG002|Overall Study|Protocol Deviation|1|||
144725438|NCT02446132|521851266|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
144725439|NCT02446132|521851267|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
144725440|NCT02446132|521851268|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
144725441|NCT02446132|521851266|FG000|Overall Study|Study Terminated by Sponsor|4|||
144725442|NCT02446132|521851267|FG001|Overall Study|Study Terminated by Sponsor|35|||
144725443|NCT02446132|521851268|FG002|Overall Study|Study Terminated by Sponsor|58|||
144725444|NCT02446132|521851266|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
144725445|NCT02446132|521851267|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
144725446|NCT02446132|521851268|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
144725447|NCT02446132|521851266|FG000|Overall Study|Withdrawal by Subject|11|||
144725448|NCT02446132|521851267|FG001|Overall Study|Withdrawal by Subject|29|||
144725449|NCT02446132|521851268|FG002|Overall Study|Withdrawal by Subject|25|||
144725450|NCT02446132|521851266|FG000|Overall Study|Reason not Specified|4|||
144725451|NCT02446132|521851267|FG001|Overall Study|Reason not Specified|16|||
144725452|NCT02446132|521851268|FG002|Overall Study|Reason not Specified|10|||
144725453|NCT02446132|521851266|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
144725454|NCT02446132|521851267|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
144725455|NCT02446132|521851268|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
144725456|NCT05526248|521851269|FG000|Overall Study|Lost to Follow-up|1|||
144725457|NCT05526248|521851269|FG000|Overall Study|Adverse Event|2|||
144450325|NCT01243944|520846297|FG001|Overall Study|Adverse Event|13|||
144450326|NCT01243944|520846296|FG000|Overall Study|Lost to Follow-up|2|||
144450327|NCT01243944|520846297|FG001|Overall Study|Lost to Follow-up|1|||
144725458|NCT05526248|521851269|FG000|Overall Study|Withdrawal by Subject|1|||
144725459|NCT03444038|521851270|FG000|Overall Study|Adverse Event|12|||
144725460|NCT03444038|521851270|FG000|Overall Study|Withdrawal by Subject|7|||
144725461|NCT03444038|521851270|FG000|Overall Study|Lost to Follow-up|1|||
144450328|NCT01243944|520846296|FG000|Overall Study|Physician Decision|2|||
144450329|NCT01243944|520846297|FG001|Overall Study|Physician Decision|7|||
144450330|NCT01243944|520846296|FG000|Overall Study|Disease progression|12|||
144450331|NCT01243944|520846297|FG001|Overall Study|Disease progression|11|||
144450332|NCT01243944|520846296|FG000|Overall Study|Protocol deviation|1|||
144450333|NCT01243944|520846297|FG001|Overall Study|Protocol deviation|1|||
144450334|NCT01243944|520846296|FG000|Overall Study|Participant decision|10|||
144450335|NCT01243944|520846297|FG001|Overall Study|Participant decision|15|||
144450336|NCT01243944|520846296|FG000|Overall Study|Death|2|||
144450337|NCT01243944|520846297|FG001|Overall Study|Death|3|||
144450338|NCT01243944|520846296|FG000|Overall Study|Non-compliance with study treatment|1|||
144450339|NCT01243944|520846297|FG001|Overall Study|Non-compliance with study treatment|0|||
144450340|NCT01410110|520846301|FG000|Overall Study|Withdrawal by Subject|4|||
144450341|NCT01410110|520846302|FG001|Overall Study|Withdrawal by Subject|2|||
144450342|NCT03653429|520846309|FG000|Overall Study|Physician Decision|4|||
144450343|NCT03653429|520846310|FG001|Overall Study|Physician Decision|10|||
144450344|NCT00403546|520846311|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
144450345|NCT00403546|520846312|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
144450346|NCT00403546|520846313|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
144450347|NCT00403546|520846311|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
144450348|NCT00403546|520846312|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
144450349|NCT00403546|520846313|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
144450350|NCT00403546|520846311|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
144450351|NCT00403546|520846312|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
144450352|NCT00403546|520846313|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
144606700|NCT01514136|521421081|FG005|Test Period 2; Test C*|holiday|0|||
144725462|NCT03444038|521851270|FG000|Overall Study|Physician Decision|2|||
144725463|NCT03444038|521851270|FG000|Overall Study|Lack of Efficacy|7|||
144725464|NCT00977106|521851271|FG000|Overall Study|Adverse Event|5|||
144725465|NCT00977106|521851272|FG001|Overall Study|Adverse Event|6|||
144725466|NCT00977106|521851271|FG000|Overall Study|Withdrawal by Subject|2|||
144725467|NCT00977106|521851272|FG001|Overall Study|Withdrawal by Subject|2|||
144725468|NCT00977106|521851271|FG000|Overall Study|Lack of Efficacy|2|||
144725469|NCT00977106|521851272|FG001|Overall Study|Lack of Efficacy|2|||
144725470|NCT00977106|521851271|FG000|Overall Study|Protocol Violation|0|||
144450353|NCT00403546|520846311|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
144450354|NCT00403546|520846312|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
144450355|NCT00403546|520846313|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
144450356|NCT00403546|520846311|FG000|Screening Phase|Screening Failure|22|||
144450357|NCT00403546|520846312|FG001|Screening Phase|Screening Failure|0|||
144450358|NCT00403546|520846313|FG002|Screening Phase|Screening Failure|0|||
144450359|NCT00403546|520846311|FG000|Screening Phase|Adverse Event|1|||
144450360|NCT00403546|520846312|FG001|Screening Phase|Adverse Event|0|||
144725471|NCT00977106|521851272|FG001|Overall Study|Protocol Violation|1|||
144725472|NCT00977106|521851271|FG000|Overall Study|Other|1|||
144725473|NCT00977106|521851272|FG001|Overall Study|Other|0|||
144725474|NCT00436007|521851275|FG000|Overall Study|Withdrawal by Subject|5|||
144194650|NCT01338987|519908454|FG002|Overall Study|Disease progression on study|1|||
144194651|NCT01338987|519908455|FG003|Overall Study|Disease progression on study|0|||
144194652|NCT01338987|519908456|FG004|Overall Study|Disease progression on study|0|||
144194653|NCT00058214|519908459|FG000|Overall Study|Adverse Event|1|||
144194654|NCT00720226|519908467|FG000|Overall Study|Withdrawal by Subject|7|||
144194655|NCT00720226|519908468|FG001|Overall Study|Withdrawal by Subject|4|||
144194656|NCT00958126|519908469|FG000|Overall Study|Serious Adverse Event|0|||
144194657|NCT00958126|519908470|FG001|Overall Study|Serious Adverse Event|2|||
144194658|NCT00958126|519908471|FG002|Overall Study|Serious Adverse Event|0|||
144450361|NCT00403546|520846313|FG002|Screening Phase|Adverse Event|0|||
144450362|NCT00403546|520846311|FG000|Screening Phase|Terminated Prior to Randomization|5|||
144450363|NCT00403546|520846312|FG001|Screening Phase|Terminated Prior to Randomization|0|||
144450364|NCT00403546|520846313|FG002|Screening Phase|Terminated Prior to Randomization|0|||
144450365|NCT00403546|520846311|FG000|Randomized Trial|Early Terminations|0|||
144450366|NCT00403546|520846312|FG001|Randomized Trial|Early Terminations|17|||
144450367|NCT00403546|520846313|FG002|Randomized Trial|Early Terminations|16|||
144450368|NCT02604589|520846317|FG000|Overall Study|catheter dislodgement|0|||
144450369|NCT02604589|520846318|FG001|Overall Study|catheter dislodgement|0|||
144450370|NCT02604589|520846319|FG002|Overall Study|catheter dislodgement|1|||
144450371|NCT00793910|520846322|FG000|Overall Study|discarded study pills|0|||
144450372|NCT00793910|520846323|FG001|Overall Study|discarded study pills|1|||
144450373|NCT00793910|520846322|FG000|Overall Study|did not pick up medications|1|||
144450374|NCT00793910|520846323|FG001|Overall Study|did not pick up medications|1|||
144450375|NCT00793910|520846322|FG000|Overall Study|ineligible based on entry criteria|2|||
144450376|NCT00793910|520846323|FG001|Overall Study|ineligible based on entry criteria|3|||
144450377|NCT00793910|520846322|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
144450378|NCT00793910|520846323|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
144450379|NCT00793910|520846322|FG000|Overall Study|Withdrawal by Subject|0|||
144450380|NCT00793910|520846323|FG001|Overall Study|Withdrawal by Subject|1|||
144450381|NCT01700946|520846324|FG000|Overall Study|Lost to Follow-up|1|||
144450382|NCT01700946|520846325|FG001|Overall Study|Lost to Follow-up|0|||
144450383|NCT01700946|520846324|FG000|Overall Study|Physician Decision|7|||
144450384|NCT01700946|520846325|FG001|Overall Study|Physician Decision|12|||
144450385|NCT01700946|520846324|FG000|Overall Study|Withdrawal by Subject|0|||
144450386|NCT01700946|520846325|FG001|Overall Study|Withdrawal by Subject|2|||
144450387|NCT01700946|520846324|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
144450388|NCT01700946|520846325|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
144450389|NCT01700946|520846324|FG000|Overall Study|Relapse|2|||
144450390|NCT01700946|520846325|FG001|Overall Study|Relapse|1|||
144450391|NCT01700946|520846324|FG000|Overall Study|Unacceptable toxicity|1|||
144450392|NCT01700946|520846325|FG001|Overall Study|Unacceptable toxicity|0|||
144450393|NCT02799082|520846326|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
144450394|NCT02799082|520846327|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
144450395|NCT02799082|520846326|FG000|Overall Study|Protocol Violation|0|||
144450396|NCT02799082|520846327|FG001|Overall Study|Protocol Violation|1|||
144450397|NCT04496258|520846328|FG000|Overall Study|Withdrawal by Subject|2|||
144450398|NCT04496258|520846329|FG001|Overall Study|Withdrawal by Subject|1|||
144450399|NCT02610140|520846330|FG000|Randomization and Treatment Period|Radiological progression|23|||
144450400|NCT02610140|520846331|FG001|Randomization and Treatment Period|Radiological progression|15|||
144450401|NCT02610140|520846330|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
144450402|NCT02610140|520846331|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
144450403|NCT02610140|520846330|FG000|Randomization and Treatment Period|Protocol Violation|1|||
144450404|NCT02610140|520846331|FG001|Randomization and Treatment Period|Protocol Violation|0|||
144450405|NCT02610140|520846330|FG000|Randomization and Treatment Period|Physician Decision|0|||
144533514|NCT06037668|521156663|FG000|Overall Study|Protocol Violation|1|||
144194659|NCT00958126|519908472|FG003|Overall Study|Serious Adverse Event|0|||
144194660|NCT00958126|519908473|FG004|Overall Study|Serious Adverse Event|0|||
144194661|NCT00958126|519908474|FG005|Overall Study|Serious Adverse Event|0|||
144450406|NCT02610140|520846331|FG001|Randomization and Treatment Period|Physician Decision|1|||
144450407|NCT02610140|520846330|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
144450408|NCT02610140|520846331|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
144450409|NCT02610140|520846330|FG000|Randomization and Treatment Period|Death|7|||
144450410|NCT02610140|520846331|FG001|Randomization and Treatment Period|Death|1|||
144450411|NCT02610140|520846330|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
144450412|NCT02610140|520846331|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
144450413|NCT02610140|520846330|FG000|Randomization and Treatment Period|Adverse Event|44|||
144450414|NCT02610140|520846331|FG001|Randomization and Treatment Period|Adverse Event|13|||
144450415|NCT02610140|520846330|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
144450416|NCT02610140|520846331|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
144450417|NCT02610140|520846330|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
144450418|NCT02610140|520846331|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
144450419|NCT02610140|520846330|FG000|Randomization and Treatment Period|Not treated|3|||
144450420|NCT02610140|520846331|FG001|Randomization and Treatment Period|Not treated|10|||
144450421|NCT02610140|520846330|FG000|Safety Follow-up|Other|0|||
144450422|NCT02610140|520846331|FG001|Safety Follow-up|Other|2|||
144450423|NCT02610140|520846330|FG000|Safety Follow-up|Lost to Follow-up|1|||
144450424|NCT02610140|520846331|FG001|Safety Follow-up|Lost to Follow-up|0|||
144450425|NCT02610140|520846330|FG000|Safety Follow-up|No follow-up|5|||
144450426|NCT02610140|520846331|FG001|Safety Follow-up|No follow-up|3|||
144450427|NCT02610140|520846330|FG000|Safety Follow-up|Death|12|||
144450428|NCT02610140|520846331|FG001|Safety Follow-up|Death|2|||
144450429|NCT02610140|520846330|FG000|Safety Follow-up|Deterioration of general conditions|15|||
144450430|NCT02610140|520846331|FG001|Safety Follow-up|Deterioration of general conditions|5|||
144450431|NCT02610140|520846330|FG000|Safety Follow-up|Withdrawal by Subject|12|||
144450432|NCT02610140|520846331|FG001|Safety Follow-up|Withdrawal by Subject|12|||
144450433|NCT02610140|520846330|FG000|Active Follow-up|Progressive disease - radiological|30|||
144450434|NCT02610140|520846331|FG001|Active Follow-up|Progressive disease - radiological|22|||
144450435|NCT02610140|520846330|FG000|Active Follow-up|Death|8|||
144450436|NCT02610140|520846331|FG001|Active Follow-up|Death|1|||
144450437|NCT02610140|520846330|FG000|Active Follow-up|Withdrawal by Subject|4|||
144450438|NCT02610140|520846331|FG001|Active Follow-up|Withdrawal by Subject|0|||
144450439|NCT02610140|520846330|FG000|Active Follow-up|Progressive disease - clinical|1|||
144450440|NCT02610140|520846331|FG001|Active Follow-up|Progressive disease - clinical|2|||
144450441|NCT02610140|520846330|FG000|Active Follow-up|Deterioration of general conditions|1|||
144450442|NCT02610140|520846331|FG001|Active Follow-up|Deterioration of general conditions|0|||
144450443|NCT02610140|520846330|FG000|Active Follow-up|Ongoing but not completed|4|||
144450444|NCT02610140|520846331|FG001|Active Follow-up|Ongoing but not completed|1|||
144450445|NCT02610140|520846330|FG000|Long-term Follow-up|Death|86|||
144450446|NCT02610140|520846331|FG001|Long-term Follow-up|Death|44|||
144450447|NCT02610140|520846330|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
144450448|NCT02610140|520846331|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
144450449|NCT02610140|520846330|FG000|Long-term Follow-up|Lost to Follow-up|1|||
144450450|NCT02610140|520846331|FG001|Long-term Follow-up|Lost to Follow-up|2|||
144450451|NCT02610140|520846330|FG000|Long-term Follow-up|Ongoing but not completed|30|||
144450452|NCT02610140|520846331|FG001|Long-term Follow-up|Ongoing but not completed|17|||
144450453|NCT02617589|520846332|FG000|Randomization|Request to Discontinue Study Treatment|1|||
144450454|NCT02617589|520846333|FG001|Randomization|Request to Discontinue Study Treatment|3|||
144450455|NCT02617589|520846332|FG000|Randomization|Participant Withdrew Consent|1|||
144450456|NCT02617589|520846333|FG001|Randomization|Participant Withdrew Consent|2|||
144450457|NCT02617589|520846332|FG000|Treatment|Other Reasons|3|||
144450458|NCT02617589|520846333|FG001|Treatment|Other Reasons|3|||
144450459|NCT02617589|520846332|FG000|Treatment|Poor/Non Compliance|1|||
144450460|NCT02617589|520846333|FG001|Treatment|Poor/Non Compliance|1|||
144450461|NCT02617589|520846332|FG000|Treatment|Maximum Clinical Benefit|0|||
144450462|NCT02617589|520846333|FG001|Treatment|Maximum Clinical Benefit|2|||
144450463|NCT02617589|520846332|FG000|Treatment|Participant Withdrew Consent|2|||
144450464|NCT02617589|520846333|FG001|Treatment|Participant Withdrew Consent|6|||
144450465|NCT02617589|520846332|FG000|Treatment|Participant Request to Discontinue|12|||
144450466|NCT02617589|520846333|FG001|Treatment|Participant Request to Discontinue|21|||
144450467|NCT02617589|520846332|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
144450468|NCT02617589|520846333|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
144533515|NCT06037668|521156664|FG001|Overall Study|Protocol Violation|0|||
144533516|NCT06037668|521156663|FG000|Overall Study|Withdrawal by Subject|1|||
144533517|NCT06037668|521156664|FG001|Overall Study|Withdrawal by Subject|0|||
144725475|NCT00436007|521851276|FG001|Overall Study|Withdrawal by Subject|3|||
144725476|NCT00436007|521851277|FG002|Overall Study|Withdrawal by Subject|4|||
144450469|NCT02617589|520846332|FG000|Treatment|Death|1|||
144450470|NCT02617589|520846333|FG001|Treatment|Death|1|||
144450471|NCT02617589|520846332|FG000|Treatment|Study Drug Toxicity|27|||
144450472|NCT02617589|520846333|FG001|Treatment|Study Drug Toxicity|20|||
144450473|NCT02617589|520846332|FG000|Treatment|Disease Progression|216|||
144450474|NCT02617589|520846333|FG001|Treatment|Disease Progression|136|||
144450475|NCT00861341|520846336|FG000|Overall Study|Withdrawal by Subject|2|||
144450476|NCT01975389|520846339|FG000|Overall Study|Adverse Event|10|||
144450477|NCT01975389|520846340|FG001|Overall Study|Adverse Event|6|||
144450478|NCT01975389|520846339|FG000|Overall Study|Death|61|||
144450479|NCT01975389|520846340|FG001|Overall Study|Death|54|||
144450480|NCT01975389|520846339|FG000|Overall Study|Lost to Follow-up|81|||
144450481|NCT01975389|520846340|FG001|Overall Study|Lost to Follow-up|86|||
144450482|NCT01975389|520846339|FG000|Overall Study|Withdrawal by Subject|90|||
144450483|NCT01975389|520846340|FG001|Overall Study|Withdrawal by Subject|76|||
144450484|NCT01975389|520846339|FG000|Overall Study|Other|6|||
144450485|NCT01975389|520846340|FG001|Overall Study|Other|9|||
144450486|NCT01975389|520846339|FG000|Overall Study|Randomized, not treated|4|||
144450487|NCT01975389|520846340|FG001|Overall Study|Randomized, not treated|5|||
144450488|NCT01312961|520846341|FG000|Overall Study|Adverse Event|3|||
144450489|NCT01312961|520846342|FG001|Overall Study|Adverse Event|3|||
144450490|NCT01312961|520846341|FG000|Overall Study|Lack of Efficacy|11|||
144450491|NCT01312961|520846342|FG001|Overall Study|Lack of Efficacy|1|||
144450492|NCT01312961|520846341|FG000|Overall Study|Poor compliance to protocol|1|||
144450493|NCT01312961|520846342|FG001|Overall Study|Poor compliance to protocol|0|||
144450494|NCT01312961|520846341|FG000|Overall Study|Other than specified above|2|||
144450495|NCT01312961|520846342|FG001|Overall Study|Other than specified above|3|||
144450496|NCT04382612|520846351|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
144450497|NCT01328002|520846352|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
144450498|NCT01328002|520846353|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
144450499|NCT01328002|520846352|FG000|Open-Label Period|Adverse Event|8|||
144450500|NCT01328002|520846353|FG001|Open-Label Period|Adverse Event|0|||
144450501|NCT01328002|520846352|FG000|Open-Label Period|Lack of Efficacy|3|||
144450502|NCT01328002|520846353|FG001|Open-Label Period|Lack of Efficacy|0|||
144450503|NCT01328002|520846352|FG000|Open-Label Period|Protocol Violation|2|||
144450504|NCT01328002|520846353|FG001|Open-Label Period|Protocol Violation|0|||
144450505|NCT01328002|520846352|FG000|Open-Label Period|Withdrawal by Subject|9|||
144450506|NCT01328002|520846353|FG001|Open-Label Period|Withdrawal by Subject|0|||
144450507|NCT01328002|520846352|FG000|Open-Label Period|Lost to Follow-up|6|||
144450508|NCT01328002|520846353|FG001|Open-Label Period|Lost to Follow-up|0|||
144450509|NCT01328002|520846352|FG000|Open-Label Period|Other Reason|2|||
144450510|NCT01328002|520846353|FG001|Open-Label Period|Other Reason|0|||
144450511|NCT01328002|520846352|FG000|Double-Blind Period|Adverse Event|1|||
144450512|NCT01328002|520846353|FG001|Double-Blind Period|Adverse Event|0|||
144450513|NCT01328002|520846352|FG000|Double-Blind Period|Lack of Efficacy|1|||
144450514|NCT01328002|520846353|FG001|Double-Blind Period|Lack of Efficacy|0|||
144450515|NCT03149328|520846354|FG000|Overall Study|Withdrawal by Subject|30|||
144450516|NCT03149328|520846355|FG001|Overall Study|Withdrawal by Subject|26|||
144450517|NCT03149328|520846354|FG000|Overall Study|Changed Dialysis Modality|18|||
144450518|NCT03149328|520846355|FG001|Overall Study|Changed Dialysis Modality|1|||
144450519|NCT03149328|520846354|FG000|Overall Study|Transplant|9|||
144450520|NCT03149328|520846355|FG001|Overall Study|Transplant|1|||
144450521|NCT03149328|520846354|FG000|Overall Study|Lost to Follow-up|25|||
144450522|NCT03149328|520846355|FG001|Overall Study|Lost to Follow-up|16|||
144450523|NCT03149328|520846354|FG000|Overall Study|Left Study Site|1|||
144450524|NCT03149328|520846355|FG001|Overall Study|Left Study Site|2|||
144450525|NCT03149328|520846354|FG000|Overall Study|Language Barrier|1|||
144450526|NCT03149328|520846355|FG001|Overall Study|Language Barrier|0|||
144450527|NCT01306617|520846359|FG000|Overall Study|Adverse Event|1|||
144450528|NCT01306617|520846360|FG001|Overall Study|Adverse Event|0|||
144450529|NCT01306617|520846361|FG002|Overall Study|Adverse Event|0|||
144450530|NCT01306617|520846359|FG000|Overall Study|Virologic Failure|0|||
144450531|NCT01306617|520846360|FG001|Overall Study|Virologic Failure|0|||
144450532|NCT01306617|520846361|FG002|Overall Study|Virologic Failure|5|||
144450533|NCT01306617|520846359|FG000|Overall Study|Non-compliance|0|||
144450534|NCT01306617|520846360|FG001|Overall Study|Non-compliance|1|||
144450535|NCT01306617|520846361|FG002|Overall Study|Non-compliance|0|||
144450536|NCT01114516|520846363|FG000|Overall Study|Lost to Follow-up|2|||
144450537|NCT01114516|520846364|FG001|Overall Study|Lost to Follow-up|1|||
144450538|NCT02758236|520846366|FG000|Overall Study|Investigator discretion|43|||
144450539|NCT00898677|520846372|FG000|Overall Study|Adverse Event|0|||
144450540|NCT00898677|520846373|FG001|Overall Study|Adverse Event|0|||
144450541|NCT00898677|520846374|FG002|Overall Study|Adverse Event|1|||
144450542|NCT00898677|520846375|FG003|Overall Study|Adverse Event|0|||
144450543|NCT00898677|520846372|FG000|Overall Study|Lost to Follow-up|0|||
144450544|NCT00898677|520846373|FG001|Overall Study|Lost to Follow-up|0|||
144450545|NCT00898677|520846374|FG002|Overall Study|Lost to Follow-up|2|||
144450546|NCT00898677|520846375|FG003|Overall Study|Lost to Follow-up|0|||
144450547|NCT00898677|520846372|FG000|Overall Study|Protocol Violation|1|||
144450548|NCT00898677|520846373|FG001|Overall Study|Protocol Violation|1|||
144450549|NCT00898677|520846374|FG002|Overall Study|Protocol Violation|2|||
144606701|NCT01514136|521421082|FG006|Test Period 2; Test C*|holiday|1|||
144606702|NCT01514136|521421083|FG007|Test Period 2; Test C*|holiday|0|||
144606703|NCT01514136|521421076|FG000|Test Period 2; Test C*|Protocol Violation|0|||
144450550|NCT00898677|520846375|FG003|Overall Study|Protocol Violation|0|||
144450551|NCT00898677|520846372|FG000|Overall Study|Withdrawal by Subject|0|||
144450552|NCT00898677|520846373|FG001|Overall Study|Withdrawal by Subject|0|||
144450553|NCT00898677|520846374|FG002|Overall Study|Withdrawal by Subject|0|||
144450554|NCT00898677|520846375|FG003|Overall Study|Withdrawal by Subject|1|||
144450555|NCT00898677|520846372|FG000|Overall Study|Not Treated: Adverse Event|0|||
144450556|NCT00898677|520846373|FG001|Overall Study|Not Treated: Adverse Event|2|||
144450557|NCT00898677|520846374|FG002|Overall Study|Not Treated: Adverse Event|1|||
144450558|NCT00898677|520846375|FG003|Overall Study|Not Treated: Adverse Event|0|||
144450559|NCT00898677|520846372|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
144450560|NCT00898677|520846373|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
144450561|NCT00898677|520846374|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
144725477|NCT00436007|521851275|FG000|Overall Study|Lost to Follow-up|14|||
144725478|NCT00436007|521851276|FG001|Overall Study|Lost to Follow-up|10|||
144725479|NCT00436007|521851277|FG002|Overall Study|Lost to Follow-up|13|||
144725480|NCT00436007|521851275|FG000|Overall Study|Physician Decision|0|||
144725481|NCT00436007|521851276|FG001|Overall Study|Physician Decision|0|||
144725482|NCT00436007|521851277|FG002|Overall Study|Physician Decision|2|||
144725483|NCT00436007|521851275|FG000|Overall Study|Death|0|||
144725484|NCT00436007|521851276|FG001|Overall Study|Death|1|||
144725485|NCT00436007|521851277|FG002|Overall Study|Death|3|||
144725486|NCT00436007|521851275|FG000|Overall Study|Other|0|||
144725487|NCT00436007|521851276|FG001|Overall Study|Other|0|||
144725488|NCT00436007|521851277|FG002|Overall Study|Other|1|||
144725489|NCT01957488|521851278|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
144725490|NCT01957488|521851279|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
144725491|NCT01957488|521851280|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
144725492|NCT01957488|521851281|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
144450562|NCT00898677|520846375|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
144450563|NCT00898677|520846372|FG000|Overall Study|Not Treated: Pregnancy|0|||
144450564|NCT00898677|520846373|FG001|Overall Study|Not Treated: Pregnancy|0|||
144450565|NCT00898677|520846374|FG002|Overall Study|Not Treated: Pregnancy|1|||
144450566|NCT00898677|520846375|FG003|Overall Study|Not Treated: Pregnancy|0|||
144450567|NCT00898677|520846372|FG000|Overall Study|Not Treated: Protocol Violation|2|||
144450568|NCT00898677|520846373|FG001|Overall Study|Not Treated: Protocol Violation|0|||
144450569|NCT00898677|520846374|FG002|Overall Study|Not Treated: Protocol Violation|2|||
144450570|NCT00898677|520846375|FG003|Overall Study|Not Treated: Protocol Violation|0|||
144450571|NCT00898677|520846372|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
144450572|NCT00898677|520846373|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
144450573|NCT00898677|520846374|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
144450574|NCT00898677|520846375|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
144450575|NCT00898677|520846372|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
144450576|NCT00898677|520846373|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
144450577|NCT00898677|520846374|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
144450578|NCT00898677|520846375|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
144450579|NCT00898677|520846372|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
144450580|NCT00898677|520846373|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
144450581|NCT00898677|520846374|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
144450582|NCT00898677|520846375|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
144450583|NCT00898677|520846372|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
144450584|NCT00898677|520846373|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
144450585|NCT00898677|520846374|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
144450586|NCT00898677|520846375|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
144450587|NCT00898677|520846372|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
144450588|NCT00898677|520846373|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
144450589|NCT00898677|520846374|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
144450590|NCT00898677|520846375|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
144450591|NCT00898677|520846372|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
144450592|NCT00898677|520846373|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
144450593|NCT00898677|520846374|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
144450594|NCT00898677|520846375|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
144450595|NCT00898677|520846372|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
144450596|NCT00898677|520846373|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
144450597|NCT00898677|520846374|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
144450598|NCT00898677|520846375|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
144450599|NCT00836875|520846378|FG000|Overall Study|Death|3|||
144450600|NCT00836875|520846379|FG001|Overall Study|Death|2|||
144450601|NCT00836875|520846378|FG000|Overall Study|Withdrawal by Subject|0|||
144450602|NCT00836875|520846379|FG001|Overall Study|Withdrawal by Subject|1|||
144450603|NCT00432380|520848115|FG000|Overall Study|Migrated/moved from study area|3|||
144450604|NCT00432380|520848116|FG001|Overall Study|Migrated/moved from study area|4|||
144450605|NCT00432380|520848117|FG002|Overall Study|Migrated/moved from study area|1|||
144450606|NCT00432380|520848115|FG000|Overall Study|Adverse Event|1|||
144450607|NCT00432380|520848116|FG001|Overall Study|Adverse Event|0|||
144450608|NCT00432380|520848117|FG002|Overall Study|Adverse Event|0|||
144450609|NCT01071395|520848118|FG000|Overall Study|Withdrawal by Subject|2|||
144450610|NCT01071395|520848119|FG001|Overall Study|Withdrawal by Subject|1|||
144194662|NCT00958126|519908475|FG006|Overall Study|Serious Adverse Event|1|||
144450611|NCT01071395|520848118|FG000|Overall Study|Adverse Event|3|||
144450612|NCT01071395|520848119|FG001|Overall Study|Adverse Event|1|||
144194663|NCT00958126|519908476|FG007|Overall Study|Serious Adverse Event|0|||
144725493|NCT01957488|521851282|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
144725494|NCT01957488|521851283|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
144725495|NCT01957488|521851278|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
144725496|NCT01957488|521851279|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
144194664|NCT00958126|519908469|FG000|Overall Study|Withdrawal by Subject|0|||
144450613|NCT02032901|520848120|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
144450614|NCT02032901|520848121|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
144450615|NCT02032901|520848120|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
144450616|NCT02032901|520848121|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
144450617|NCT01722331|520848122|FG000|Part 1|Adverse Event|5|||
144450618|NCT01722331|520848123|FG001|Part 1|Adverse Event|0|||
144450619|NCT01722331|520848124|FG002|Part 1|Adverse Event|0|||
144450620|NCT01722331|520848125|FG003|Part 1|Adverse Event|0|||
144450621|NCT01722331|520848126|FG004|Part 1|Adverse Event|0|||
144450622|NCT01722331|520848127|FG005|Part 1|Adverse Event|0|||
144450623|NCT01722331|520848128|FG006|Part 1|Adverse Event|0|||
144450624|NCT01722331|520848122|FG000|Part 1|Lack of Efficacy|0|||
144450625|NCT01722331|520848123|FG001|Part 1|Lack of Efficacy|0|||
144450626|NCT01722331|520848124|FG002|Part 1|Lack of Efficacy|1|||
144450627|NCT01722331|520848125|FG003|Part 1|Lack of Efficacy|0|||
144450628|NCT01722331|520848126|FG004|Part 1|Lack of Efficacy|2|||
144450629|NCT01722331|520848127|FG005|Part 1|Lack of Efficacy|0|||
144450630|NCT01722331|520848128|FG006|Part 1|Lack of Efficacy|0|||
144450631|NCT01722331|520848122|FG000|Part 1|Lost to Follow-up|1|||
144450632|NCT01722331|520848123|FG001|Part 1|Lost to Follow-up|0|||
144450633|NCT01722331|520848124|FG002|Part 1|Lost to Follow-up|2|||
144450634|NCT01722331|520848125|FG003|Part 1|Lost to Follow-up|0|||
144450635|NCT01722331|520848126|FG004|Part 1|Lost to Follow-up|1|||
144450636|NCT01722331|520848127|FG005|Part 1|Lost to Follow-up|0|||
144194665|NCT00958126|519908470|FG001|Overall Study|Withdrawal by Subject|2|||
144194666|NCT00958126|519908471|FG002|Overall Study|Withdrawal by Subject|0|||
144194667|NCT00958126|519908472|FG003|Overall Study|Withdrawal by Subject|0|||
144194668|NCT00958126|519908473|FG004|Overall Study|Withdrawal by Subject|0|||
144194669|NCT00958126|519908474|FG005|Overall Study|Withdrawal by Subject|0|||
144194670|NCT00958126|519908475|FG006|Overall Study|Withdrawal by Subject|0|||
144194671|NCT00958126|519908476|FG007|Overall Study|Withdrawal by Subject|0|||
144194672|NCT00958126|519908469|FG000|Overall Study|Moved away from study area|0|||
144194673|NCT00958126|519908470|FG001|Overall Study|Moved away from study area|0|||
144194674|NCT00958126|519908471|FG002|Overall Study|Moved away from study area|1|||
144194675|NCT00958126|519908472|FG003|Overall Study|Moved away from study area|1|||
144194676|NCT00958126|519908473|FG004|Overall Study|Moved away from study area|0|||
144194677|NCT00958126|519908474|FG005|Overall Study|Moved away from study area|0|||
144194678|NCT00958126|519908475|FG006|Overall Study|Moved away from study area|0|||
144194679|NCT00958126|519908476|FG007|Overall Study|Moved away from study area|0|||
144606704|NCT01514136|521421077|FG001|Test Period 2; Test C*|Protocol Violation|0|||
144606705|NCT01514136|521421078|FG002|Test Period 2; Test C*|Protocol Violation|0|||
144450637|NCT01722331|520848128|FG006|Part 1|Lost to Follow-up|0|||
144606706|NCT01514136|521421079|FG003|Test Period 2; Test C*|Protocol Violation|0|||
144606707|NCT01514136|521421080|FG004|Test Period 2; Test C*|Protocol Violation|0|||
144606708|NCT01514136|521421081|FG005|Test Period 2; Test C*|Protocol Violation|0|||
144606709|NCT01514136|521421082|FG006|Test Period 2; Test C*|Protocol Violation|1|||
144606710|NCT01514136|521421083|FG007|Test Period 2; Test C*|Protocol Violation|0|||
144606711|NCT01010633|521421084|FG000|Overall Study|Adverse Event|1|||
144606712|NCT01010633|521421085|FG001|Overall Study|Adverse Event|1|||
144606713|NCT01010633|521421084|FG000|Overall Study|Protocol Violation|1|||
144606714|NCT01010633|521421085|FG001|Overall Study|Protocol Violation|2|||
144606715|NCT01010633|521421084|FG000|Overall Study|Withdrawal by Subject|2|||
144606716|NCT01010633|521421085|FG001|Overall Study|Withdrawal by Subject|1|||
144606717|NCT01010633|521421084|FG000|Overall Study|Investigator decision|0|||
144606718|NCT01010633|521421085|FG001|Overall Study|Investigator decision|1|||
144606719|NCT02941926|521421088|FG000|Core Phase|Progressive disease|1109|||
144606720|NCT02941926|521421088|FG000|Core Phase|Adverse Event|504|||
144606721|NCT02941926|521421088|FG000|Core Phase|Subject/guardian decision|127|||
144606722|NCT02941926|521421088|FG000|Core Phase|Physician Decision|112|||
144606723|NCT02941926|521421088|FG000|Core Phase|Death|46|||
144606724|NCT02941926|521421088|FG000|Core Phase|Protocol deviation|34|||
144606725|NCT02941926|521421088|FG000|Core Phase|Lost to Follow-up|8|||
144606726|NCT02941926|521421088|FG000|Core Phase|Technical problems|5|||
144606727|NCT02941926|521421088|FG000|Extension Phase|Physician Decision|155|||
144606728|NCT02941926|521421088|FG000|Extension Phase|Progressive disease|115|||
144606729|NCT02941926|521421088|FG000|Extension Phase|Adverse Event|13|||
144606730|NCT02941926|521421088|FG000|Extension Phase|Subject/Guardian decision|12|||
144194680|NCT00958126|519908469|FG000|Overall Study|Lost to Follow-up|1|||
144450638|NCT01722331|520848122|FG000|Part 1|Physician Decision|0|||
144450639|NCT01722331|520848123|FG001|Part 1|Physician Decision|0|||
144450640|NCT01722331|520848124|FG002|Part 1|Physician Decision|3|||
144450641|NCT01722331|520848125|FG003|Part 1|Physician Decision|0|||
144450642|NCT01722331|520848126|FG004|Part 1|Physician Decision|1|||
144606731|NCT02941926|521421088|FG000|Extension Phase|Death|6|||
144606732|NCT00888381|521421089|FG000|Overall Study|Lost to Follow-up|0|||
144194681|NCT00958126|519908470|FG001|Overall Study|Lost to Follow-up|5|||
144194682|NCT00958126|519908471|FG002|Overall Study|Lost to Follow-up|9|||
144194683|NCT00958126|519908472|FG003|Overall Study|Lost to Follow-up|8|||
144450643|NCT01722331|520848127|FG005|Part 1|Physician Decision|0|||
144450644|NCT01722331|520848128|FG006|Part 1|Physician Decision|0|||
144450645|NCT01722331|520848122|FG000|Part 1|Pregnancy|1|||
144194684|NCT00958126|519908473|FG004|Overall Study|Lost to Follow-up|0|||
144194685|NCT00958126|519908474|FG005|Overall Study|Lost to Follow-up|0|||
144194686|NCT00958126|519908475|FG006|Overall Study|Lost to Follow-up|0|||
144194687|NCT00958126|519908476|FG007|Overall Study|Lost to Follow-up|0|||
144194688|NCT00958126|519908469|FG000|Overall Study|Sponsor/Investigator decision|0|||
144194689|NCT00958126|519908470|FG001|Overall Study|Sponsor/Investigator decision|0|||
144194690|NCT00958126|519908471|FG002|Overall Study|Sponsor/Investigator decision|0|||
144194691|NCT00958126|519908472|FG003|Overall Study|Sponsor/Investigator decision|1|||
144194692|NCT00958126|519908473|FG004|Overall Study|Sponsor/Investigator decision|0|||
144194693|NCT00958126|519908474|FG005|Overall Study|Sponsor/Investigator decision|0|||
144194694|NCT00958126|519908475|FG006|Overall Study|Sponsor/Investigator decision|0|||
144194695|NCT00958126|519908476|FG007|Overall Study|Sponsor/Investigator decision|0|||
144194696|NCT00958126|519908469|FG000|Overall Study|Other Reason|0|||
144194697|NCT00958126|519908470|FG001|Overall Study|Other Reason|0|||
144194698|NCT00958126|519908471|FG002|Overall Study|Other Reason|0|||
144194699|NCT00958126|519908472|FG003|Overall Study|Other Reason|1|||
144194700|NCT00958126|519908473|FG004|Overall Study|Other Reason|0|||
144194701|NCT00958126|519908474|FG005|Overall Study|Other Reason|1|||
144194702|NCT00958126|519908475|FG006|Overall Study|Other Reason|0|||
144194703|NCT00958126|519908476|FG007|Overall Study|Other Reason|0|||
144194704|NCT00733369|519908477|FG000|Overall Study|Lost to Follow-up|2|||
144194705|NCT00733369|519908478|FG001|Overall Study|Lost to Follow-up|1|||
144194706|NCT00733369|519908477|FG000|Overall Study|Adverse Event|4|||
144194707|NCT00733369|519908478|FG001|Overall Study|Adverse Event|4|||
144194708|NCT00733369|519908477|FG000|Overall Study|Protocol Violation|4|||
144194709|NCT00733369|519908478|FG001|Overall Study|Protocol Violation|4|||
144194710|NCT01470612|519908482|FG000|Overall Study|Adverse Event|20|||
144194711|NCT01470612|519908483|FG001|Overall Study|Adverse Event|80|||
144194712|NCT01470612|519908482|FG000|Overall Study|Death|0|||
144450646|NCT01722331|520848123|FG001|Part 1|Pregnancy|0|||
144450647|NCT01722331|520848124|FG002|Part 1|Pregnancy|0|||
144450648|NCT01722331|520848125|FG003|Part 1|Pregnancy|0|||
144450649|NCT01722331|520848126|FG004|Part 1|Pregnancy|0|||
144450650|NCT01722331|520848127|FG005|Part 1|Pregnancy|0|||
144450651|NCT01722331|520848128|FG006|Part 1|Pregnancy|0|||
144450652|NCT01722331|520848122|FG000|Part 1|Progressive Disease|0|||
144450653|NCT01722331|520848123|FG001|Part 1|Progressive Disease|0|||
144450654|NCT01722331|520848124|FG002|Part 1|Progressive Disease|0|||
144450655|NCT01722331|520848125|FG003|Part 1|Progressive Disease|0|||
144450656|NCT01722331|520848126|FG004|Part 1|Progressive Disease|1|||
144450657|NCT01722331|520848127|FG005|Part 1|Progressive Disease|0|||
144450658|NCT01722331|520848128|FG006|Part 1|Progressive Disease|0|||
144450659|NCT01722331|520848122|FG000|Part 1|Protocol Violation|1|||
144450660|NCT01722331|520848123|FG001|Part 1|Protocol Violation|0|||
144450661|NCT01722331|520848124|FG002|Part 1|Protocol Violation|0|||
144450662|NCT01722331|520848125|FG003|Part 1|Protocol Violation|0|||
144450663|NCT01722331|520848126|FG004|Part 1|Protocol Violation|1|||
144450664|NCT01722331|520848127|FG005|Part 1|Protocol Violation|0|||
144450665|NCT01722331|520848128|FG006|Part 1|Protocol Violation|0|||
144450666|NCT01722331|520848122|FG000|Part 1|Withdrawal by Subject|2|||
144450667|NCT01722331|520848123|FG001|Part 1|Withdrawal by Subject|0|||
144450668|NCT01722331|520848124|FG002|Part 1|Withdrawal by Subject|3|||
144450669|NCT01722331|520848125|FG003|Part 1|Withdrawal by Subject|0|||
144450670|NCT01722331|520848126|FG004|Part 1|Withdrawal by Subject|3|||
144450671|NCT01722331|520848127|FG005|Part 1|Withdrawal by Subject|0|||
144450672|NCT01722331|520848128|FG006|Part 1|Withdrawal by Subject|0|||
144450673|NCT01722331|520848122|FG000|Part 2|Adverse Event|3|||
144450674|NCT01722331|520848123|FG001|Part 2|Adverse Event|0|||
144450675|NCT01722331|520848124|FG002|Part 2|Adverse Event|0|||
144450676|NCT01722331|520848125|FG003|Part 2|Adverse Event|0|||
144450677|NCT01722331|520848126|FG004|Part 2|Adverse Event|0|||
144533518|NCT06037668|521156663|FG000|Overall Study|Other Study Discontinuation Reason|1|||
144533519|NCT06037668|521156664|FG001|Overall Study|Other Study Discontinuation Reason|0|||
144533520|NCT05224544|521156665|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
144533521|NCT05224544|521156666|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
144533522|NCT05172232|521156667|FG000|Overall Study|Lost to Follow-up|3|||
144533523|NCT04881461|521156669|FG000|Overall Study|Adverse Event|2|||
144533524|NCT04881461|521156670|FG001|Overall Study|Adverse Event|4|||
144533525|NCT04881461|521156669|FG000|Overall Study|Withdrawal by Subject|19|||
144533526|NCT04881461|521156670|FG001|Overall Study|Withdrawal by Subject|19|||
144533527|NCT04881461|521156669|FG000|Overall Study|Lost to Follow-up|4|||
144533528|NCT04881461|521156670|FG001|Overall Study|Lost to Follow-up|4|||
144194713|NCT01470612|519908483|FG001|Overall Study|Death|1|||
144194714|NCT01470612|519908482|FG000|Overall Study|Lack of Efficacy|20|||
144194715|NCT01470612|519908483|FG001|Overall Study|Lack of Efficacy|326|||
144194716|NCT01470612|519908482|FG000|Overall Study|Lost to Follow-up|2|||
144194717|NCT01470612|519908483|FG001|Overall Study|Lost to Follow-up|5|||
144194718|NCT01470612|519908482|FG000|Overall Study|Did not meet entrance criteria|0|||
144450678|NCT01722331|520848127|FG005|Part 2|Adverse Event|1|||
144450679|NCT01722331|520848128|FG006|Part 2|Adverse Event|0|||
144450680|NCT01722331|520848122|FG000|Part 2|Lack of Efficacy|3|||
144450681|NCT01722331|520848123|FG001|Part 2|Lack of Efficacy|0|||
144450682|NCT01722331|520848124|FG002|Part 2|Lack of Efficacy|11|||
144450683|NCT01722331|520848125|FG003|Part 2|Lack of Efficacy|0|||
144450684|NCT01722331|520848126|FG004|Part 2|Lack of Efficacy|0|||
144450685|NCT01722331|520848127|FG005|Part 2|Lack of Efficacy|3|||
144450686|NCT01722331|520848128|FG006|Part 2|Lack of Efficacy|3|||
144450687|NCT01722331|520848122|FG000|Part 2|Lost to Follow-up|0|||
144450688|NCT01722331|520848123|FG001|Part 2|Lost to Follow-up|0|||
144450689|NCT01722331|520848124|FG002|Part 2|Lost to Follow-up|3|||
144450690|NCT01722331|520848125|FG003|Part 2|Lost to Follow-up|0|||
144450691|NCT01722331|520848126|FG004|Part 2|Lost to Follow-up|0|||
144450692|NCT01722331|520848127|FG005|Part 2|Lost to Follow-up|1|||
144450693|NCT01722331|520848128|FG006|Part 2|Lost to Follow-up|1|||
144450694|NCT01722331|520848122|FG000|Part 2|Non-Compliance with Study Drug|1|||
144450695|NCT01722331|520848123|FG001|Part 2|Non-Compliance with Study Drug|0|||
144450696|NCT01722331|520848124|FG002|Part 2|Non-Compliance with Study Drug|1|||
144450697|NCT01722331|520848125|FG003|Part 2|Non-Compliance with Study Drug|0|||
144450698|NCT01722331|520848126|FG004|Part 2|Non-Compliance with Study Drug|0|||
144450699|NCT01722331|520848127|FG005|Part 2|Non-Compliance with Study Drug|0|||
144450700|NCT01722331|520848128|FG006|Part 2|Non-Compliance with Study Drug|0|||
144450701|NCT01722331|520848122|FG000|Part 2|Physician Decision|0|||
144450702|NCT01722331|520848123|FG001|Part 2|Physician Decision|0|||
144450703|NCT01722331|520848124|FG002|Part 2|Physician Decision|2|||
144450704|NCT01722331|520848125|FG003|Part 2|Physician Decision|0|||
144450705|NCT01722331|520848126|FG004|Part 2|Physician Decision|0|||
144450706|NCT01722331|520848127|FG005|Part 2|Physician Decision|0|||
144450707|NCT01722331|520848128|FG006|Part 2|Physician Decision|0|||
144450708|NCT01722331|520848122|FG000|Part 2|Pregnancy|0|||
144450709|NCT01722331|520848123|FG001|Part 2|Pregnancy|0|||
144450710|NCT01722331|520848124|FG002|Part 2|Pregnancy|0|||
144450711|NCT01722331|520848125|FG003|Part 2|Pregnancy|0|||
144450712|NCT01722331|520848126|FG004|Part 2|Pregnancy|0|||
144450713|NCT01722331|520848127|FG005|Part 2|Pregnancy|1|||
144450714|NCT01722331|520848128|FG006|Part 2|Pregnancy|0|||
144450715|NCT01722331|520848122|FG000|Part 2|Progressive Disease|0|||
144450716|NCT01722331|520848123|FG001|Part 2|Progressive Disease|0|||
144450717|NCT01722331|520848124|FG002|Part 2|Progressive Disease|1|||
144450718|NCT01722331|520848125|FG003|Part 2|Progressive Disease|0|||
144450719|NCT01722331|520848126|FG004|Part 2|Progressive Disease|0|||
144450720|NCT01722331|520848127|FG005|Part 2|Progressive Disease|0|||
144450721|NCT01722331|520848128|FG006|Part 2|Progressive Disease|0|||
144450722|NCT01722331|520848122|FG000|Part 2|Protocol Violation|1|||
144450723|NCT01722331|520848123|FG001|Part 2|Protocol Violation|0|||
144450724|NCT01722331|520848124|FG002|Part 2|Protocol Violation|0|||
144450725|NCT01722331|520848125|FG003|Part 2|Protocol Violation|0|||
144450726|NCT01722331|520848126|FG004|Part 2|Protocol Violation|0|||
144450727|NCT01722331|520848127|FG005|Part 2|Protocol Violation|0|||
144450728|NCT01722331|520848128|FG006|Part 2|Protocol Violation|0|||
144450729|NCT01722331|520848122|FG000|Part 2|Withdrawal by Subject|5|||
144450730|NCT01722331|520848123|FG001|Part 2|Withdrawal by Subject|0|||
144450731|NCT01722331|520848124|FG002|Part 2|Withdrawal by Subject|3|||
144450732|NCT01722331|520848125|FG003|Part 2|Withdrawal by Subject|0|||
144450733|NCT01722331|520848126|FG004|Part 2|Withdrawal by Subject|0|||
144450734|NCT01722331|520848127|FG005|Part 2|Withdrawal by Subject|2|||
144450735|NCT01722331|520848128|FG006|Part 2|Withdrawal by Subject|2|||
144450736|NCT01722331|520848122|FG000|Part 2|Other Protocol Specified Criteria|6|||
144450737|NCT01722331|520848123|FG001|Part 2|Other Protocol Specified Criteria|0|||
144194719|NCT01470612|519908483|FG001|Overall Study|Did not meet entrance criteria|1|||
144450738|NCT01722331|520848124|FG002|Part 2|Other Protocol Specified Criteria|10|||
144450739|NCT01722331|520848125|FG003|Part 2|Other Protocol Specified Criteria|0|||
144450740|NCT01722331|520848126|FG004|Part 2|Other Protocol Specified Criteria|0|||
144450741|NCT01722331|520848127|FG005|Part 2|Other Protocol Specified Criteria|2|||
144450742|NCT01722331|520848128|FG006|Part 2|Other Protocol Specified Criteria|1|||
144450743|NCT01722331|520848122|FG000|Part 3|Adverse Event|2|||
144450744|NCT01722331|520848123|FG001|Part 3|Adverse Event|2|||
144450745|NCT01722331|520848124|FG002|Part 3|Adverse Event|0|||
144450746|NCT01722331|520848125|FG003|Part 3|Adverse Event|1|||
144450747|NCT01722331|520848126|FG004|Part 3|Adverse Event|0|||
144450748|NCT01722331|520848127|FG005|Part 3|Adverse Event|0|||
144450749|NCT01722331|520848128|FG006|Part 3|Adverse Event|0|||
144450750|NCT01722331|520848122|FG000|Part 3|Death|1|||
144450751|NCT01722331|520848123|FG001|Part 3|Death|0|||
144450752|NCT01722331|520848124|FG002|Part 3|Death|0|||
144450753|NCT01722331|520848125|FG003|Part 3|Death|0|||
144450754|NCT01722331|520848126|FG004|Part 3|Death|0|||
144450755|NCT01722331|520848127|FG005|Part 3|Death|0|||
144450756|NCT01722331|520848128|FG006|Part 3|Death|0|||
144450757|NCT01722331|520848122|FG000|Part 3|Lack of Efficacy|1|||
144450758|NCT01722331|520848123|FG001|Part 3|Lack of Efficacy|0|||
144450759|NCT01722331|520848124|FG002|Part 3|Lack of Efficacy|0|||
144450760|NCT01722331|520848125|FG003|Part 3|Lack of Efficacy|0|||
144450761|NCT01722331|520848126|FG004|Part 3|Lack of Efficacy|0|||
144450762|NCT01722331|520848127|FG005|Part 3|Lack of Efficacy|0|||
144450763|NCT01722331|520848128|FG006|Part 3|Lack of Efficacy|0|||
144450764|NCT01722331|520848122|FG000|Part 3|Lost to Follow-up|3|||
144450765|NCT01722331|520848123|FG001|Part 3|Lost to Follow-up|4|||
144450766|NCT01722331|520848124|FG002|Part 3|Lost to Follow-up|0|||
144450767|NCT01722331|520848125|FG003|Part 3|Lost to Follow-up|0|||
144450768|NCT01722331|520848126|FG004|Part 3|Lost to Follow-up|0|||
144450769|NCT01722331|520848127|FG005|Part 3|Lost to Follow-up|1|||
144450770|NCT01722331|520848128|FG006|Part 3|Lost to Follow-up|0|||
144450771|NCT01722331|520848122|FG000|Part 3|Non-Compliance with Study Drug|0|||
144450772|NCT01722331|520848123|FG001|Part 3|Non-Compliance with Study Drug|1|||
144450773|NCT01722331|520848124|FG002|Part 3|Non-Compliance with Study Drug|0|||
144450774|NCT01722331|520848125|FG003|Part 3|Non-Compliance with Study Drug|0|||
144450775|NCT01722331|520848126|FG004|Part 3|Non-Compliance with Study Drug|0|||
144450776|NCT01722331|520848127|FG005|Part 3|Non-Compliance with Study Drug|0|||
144450777|NCT01722331|520848128|FG006|Part 3|Non-Compliance with Study Drug|0|||
144450778|NCT01722331|520848122|FG000|Part 3|Physician Decision|1|||
144450779|NCT01722331|520848123|FG001|Part 3|Physician Decision|1|||
144450780|NCT01722331|520848124|FG002|Part 3|Physician Decision|0|||
144450781|NCT01722331|520848125|FG003|Part 3|Physician Decision|0|||
144450782|NCT01722331|520848126|FG004|Part 3|Physician Decision|0|||
144450783|NCT01722331|520848127|FG005|Part 3|Physician Decision|0|||
144450784|NCT01722331|520848128|FG006|Part 3|Physician Decision|1|||
144450785|NCT01722331|520848122|FG000|Part 3|Protocol Violation|2|||
144450786|NCT01722331|520848123|FG001|Part 3|Protocol Violation|1|||
144450787|NCT01722331|520848124|FG002|Part 3|Protocol Violation|0|||
144450788|NCT01722331|520848125|FG003|Part 3|Protocol Violation|0|||
144450789|NCT01722331|520848126|FG004|Part 3|Protocol Violation|0|||
144450790|NCT01722331|520848127|FG005|Part 3|Protocol Violation|0|||
144450791|NCT01722331|520848128|FG006|Part 3|Protocol Violation|0|||
144450792|NCT01722331|520848122|FG000|Part 3|Withdrawal by Subject|4|||
144450793|NCT01722331|520848123|FG001|Part 3|Withdrawal by Subject|7|||
144450794|NCT01722331|520848124|FG002|Part 3|Withdrawal by Subject|0|||
144450795|NCT01722331|520848125|FG003|Part 3|Withdrawal by Subject|0|||
144450796|NCT01722331|520848126|FG004|Part 3|Withdrawal by Subject|0|||
144450797|NCT01722331|520848127|FG005|Part 3|Withdrawal by Subject|2|||
144450798|NCT01722331|520848128|FG006|Part 3|Withdrawal by Subject|1|||
144450799|NCT01722331|520848122|FG000|Part 3|Other Protocol Specified Criteria|1|||
144450800|NCT01722331|520848123|FG001|Part 3|Other Protocol Specified Criteria|1|||
144450801|NCT01722331|520848124|FG002|Part 3|Other Protocol Specified Criteria|0|||
144450802|NCT01722331|520848125|FG003|Part 3|Other Protocol Specified Criteria|0|||
144450803|NCT01722331|520848126|FG004|Part 3|Other Protocol Specified Criteria|0|||
144450804|NCT01722331|520848127|FG005|Part 3|Other Protocol Specified Criteria|0|||
144450805|NCT01722331|520848128|FG006|Part 3|Other Protocol Specified Criteria|0|||
144450806|NCT01343082|520848131|FG000|The run-in Period|Not meeting criteria|3|||
144450807|NCT01343082|520848132|FG001|The run-in Period|Not meeting criteria|4|||
144450808|NCT01343082|520848133|FG002|The run-in Period|Not meeting criteria|5|||
144450809|NCT01343082|520848131|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
144450810|NCT01343082|520848132|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
144450811|NCT01343082|520848133|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
144450812|NCT01343082|520848131|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
144450813|NCT01343082|520848132|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
144450814|NCT01343082|520848133|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
144450815|NCT01343082|520848131|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
144450816|NCT01343082|520848132|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
144450817|NCT01343082|520848133|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
144450818|NCT01343082|520848131|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
144450819|NCT01343082|520848132|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
144450820|NCT01343082|520848133|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
144450821|NCT01154166|520848134|FG000|Overall Study|Adverse Event|14|||
144450822|NCT01154166|520848135|FG001|Overall Study|Adverse Event|9|||
144450823|NCT01154166|520848134|FG000|Overall Study|Lost to Follow-up|1|||
144450824|NCT01154166|520848135|FG001|Overall Study|Lost to Follow-up|1|||
144450825|NCT01154166|520848134|FG000|Overall Study|Protocol Violation|4|||
144450826|NCT01154166|520848135|FG001|Overall Study|Protocol Violation|1|||
144450827|NCT01154166|520848134|FG000|Overall Study|Withdrawal by Subject|10|||
144450828|NCT01154166|520848135|FG001|Overall Study|Withdrawal by Subject|1|||
144450829|NCT01154166|520848134|FG000|Overall Study|Lack of Efficacy|3|||
144450830|NCT01154166|520848135|FG001|Overall Study|Lack of Efficacy|0|||
144450831|NCT01154166|520848134|FG000|Overall Study|Disease Progression|1|||
144450832|NCT01154166|520848135|FG001|Overall Study|Disease Progression|0|||
144450833|NCT01154166|520848134|FG000|Overall Study|Poor Compliance|1|||
144450834|NCT01154166|520848135|FG001|Overall Study|Poor Compliance|0|||
144450835|NCT04265755|520848136|FG000|Overall Study|Withdrawal by Subject|39|||
144533529|NCT04881461|521156669|FG000|Overall Study|Lack of Efficacy|1|||
144450836|NCT04265755|520848136|FG000|Overall Study|Decision by sponsor|2|||
144450837|NCT04265755|520848136|FG000|Overall Study|Lost to Follow-up|11|||
144450838|NCT04265755|520848136|FG000|Overall Study|Death|1|||
144450839|NCT01375049|520848137|FG000|Overall Study|Adverse Event|2|||
144450840|NCT01375049|520848137|FG000|Overall Study|Lost to Follow-up|1|||
144450841|NCT01375049|520848137|FG000|Overall Study|Withdrawal by Subject|2|||
144450842|NCT01375049|520848137|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
144450843|NCT01575561|520848138|FG000|Overall Study|Adverse Event|9|||
144450844|NCT01575561|520848138|FG000|Overall Study|Lack of Efficacy|8|||
144450845|NCT01575561|520848138|FG000|Overall Study|Lost to Follow-up|6|||
144450846|NCT01575561|520848138|FG000|Overall Study|Protocol Violation|4|||
144450847|NCT01575561|520848138|FG000|Overall Study|Withdrawal by Subject|11|||
144450848|NCT01575561|520848138|FG000|Overall Study|administration|1|||
144450849|NCT02554773|520848139|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
144450850|NCT02554773|520848140|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
144450851|NCT02554773|520848139|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
144450852|NCT02554773|520848140|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
144450853|NCT02554773|520848139|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
144450854|NCT02554773|520848140|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
144450855|NCT02554773|520848139|FG000|Original Dose Regimen (SAS 1)|Death|1|||
144450856|NCT02554773|520848140|FG001|Original Dose Regimen (SAS 1)|Death|0|||
144450857|NCT02554773|520848139|FG000|Original Dose Regimen (SAS 1)|Other|4|||
144450858|NCT02554773|520848140|FG001|Original Dose Regimen (SAS 1)|Other|0|||
144450859|NCT02554773|520848139|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
144450860|NCT02554773|520848140|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
144450861|NCT02554773|520848139|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
144450862|NCT02554773|520848140|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
144450863|NCT02554773|520848139|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
144450864|NCT02554773|520848140|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
144450865|NCT02554773|520848139|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
144450866|NCT02554773|520848140|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
144450867|NCT02840877|520848141|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
144450868|NCT02840877|520848141|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
144450869|NCT02840877|520848141|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
144450870|NCT02840877|520848141|FG000|Baseline to 12 Weeks|Death|1|||
144450871|NCT02840877|520848141|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
144450872|NCT02840877|520848141|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
144450873|NCT02840877|520848141|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
144450874|NCT02840877|520848141|FG000|12 Weeks to 6 Months|Treatment failure|1|||
144450875|NCT02840877|520848141|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
144450876|NCT02840877|520848141|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
144450877|NCT02840877|520848141|FG000|12 Weeks to 6 Months|Death|1|||
144450878|NCT02840877|520848141|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
144450879|NCT02840877|520848141|FG000|6 Months to 18 Months|Treatment failure|7|||
144450880|NCT02840877|520848141|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
144533530|NCT04881461|521156670|FG001|Overall Study|Lack of Efficacy|0|||
144533531|NCT04881461|521156669|FG000|Overall Study|"Reason stated as other in CRF"|1|||
144533532|NCT04881461|521156670|FG001|Overall Study|"Reason stated as other in CRF"|2|||
144533533|NCT02997202|521156671|FG000|Overall Study|Miscellaneous|2|||
144533534|NCT02997202|521156672|FG001|Overall Study|Miscellaneous|2|||
144533535|NCT02997202|521156671|FG000|Overall Study|Withdrawal by Subject|8|||
144533536|NCT02997202|521156672|FG001|Overall Study|Withdrawal by Subject|12|||
144533537|NCT02997202|521156671|FG000|Overall Study|Lost to Follow-up|5|||
144533538|NCT02997202|521156672|FG001|Overall Study|Lost to Follow-up|3|||
144533539|NCT02997202|521156671|FG000|Overall Study|Death|41|||
144533540|NCT02997202|521156672|FG001|Overall Study|Death|45|||
144533541|NCT04158739|521156677|FG000|Overall Study|Adverse Event|1|||
144533542|NCT04158739|521156678|FG001|Overall Study|Adverse Event|0|||
144533543|NCT04158739|521156677|FG000|Overall Study|Death|0|||
144533544|NCT04158739|521156678|FG001|Overall Study|Death|1|||
144533545|NCT04158739|521156677|FG000|Overall Study|Lack of Efficacy|3|||
144533546|NCT04158739|521156678|FG001|Overall Study|Lack of Efficacy|7|||
144533547|NCT04158739|521156677|FG000|Overall Study|Physician Decision|0|||
144533548|NCT04158739|521156678|FG001|Overall Study|Physician Decision|1|||
144533549|NCT04158739|521156677|FG000|Overall Study|Withdrawal by Subject|3|||
144533550|NCT04158739|521156678|FG001|Overall Study|Withdrawal by Subject|0|||
144533551|NCT05422885|521156683|FG000|Overall Study|Lost to Follow-up|1|||
144533552|NCT05422885|521156683|FG000|Overall Study|Withdrawal by Subject|2|||
144533553|NCT03681262|521156684|FG000|Overall Study|Continuing on study|3|||
144533554|NCT03681262|521156685|FG001|Overall Study|Continuing on study|3|||
144450881|NCT02840877|520848141|FG000|6 Months to 18 Months|Moved/transferred out|6|||
144533555|NCT03681262|521156684|FG000|Overall Study|Lost to Follow-up|1|||
144533556|NCT03681262|521156685|FG001|Overall Study|Lost to Follow-up|0|||
144450882|NCT02840877|520848141|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
144450883|NCT02840877|520848141|FG000|6 Months to 18 Months|Death|4|||
144450884|NCT02840877|520848141|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
144450885|NCT02840877|520848141|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
144450886|NCT02840877|520848141|FG000|6 Months to 18 Months|Still in study.|14|||
144533557|NCT02782676|521156687|FG000|Overall Study|Lost to Follow-up|0|||
144533558|NCT02782676|521156688|FG001|Overall Study|Lost to Follow-up|1|||
144533559|NCT04214834|521156691|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
144450887|NCT02530619|520848151|FG000|Registered for Study|Withdrawal by Subject|2|||
144450888|NCT02530619|520848151|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
144450889|NCT02530619|520848151|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
144450890|NCT02530619|520848151|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
144450891|NCT02530619|520848151|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
144450892|NCT02530619|520848151|FG000|Follow-up Period (6 Months)|Death|4|||
144450893|NCT02530619|520848151|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
144450894|NCT02530619|520848151|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
144450895|NCT01854554|520848162|FG000|Overall Study|Denial of Insurance Coverage|12|||
144450896|NCT01854554|520848163|FG001|Overall Study|Denial of Insurance Coverage|0|||
144450897|NCT01854554|520848162|FG000|Overall Study|Decided to get treatment locally|1|||
144450898|NCT01854554|520848163|FG001|Overall Study|Decided to get treatment locally|5|||
144450899|NCT01854554|520848162|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
144450900|NCT01854554|520848163|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
144450901|NCT01854554|520848162|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
144450902|NCT01854554|520848163|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
144450903|NCT01854554|520848162|FG000|Overall Study|Progression|0|||
144450904|NCT01854554|520848163|FG001|Overall Study|Progression|1|||
144450905|NCT01854554|520848162|FG000|Overall Study|Lost to Follow-up|0|||
144450906|NCT01854554|520848163|FG001|Overall Study|Lost to Follow-up|1|||
144450907|NCT00359762|520848166|FG000|Period II|Adverse Event|17|||
144450908|NCT00359762|520848167|FG001|Period II|Adverse Event|0|||
144450909|NCT00359762|520848168|FG002|Period II|Adverse Event|0|||
144450910|NCT00359762|520848169|FG003|Period II|Adverse Event|0|||
144450911|NCT00359762|520848170|FG004|Period II|Adverse Event|49|||
144450912|NCT00359762|520848166|FG000|Period II|Protocol Violation|18|||
144450913|NCT00359762|520848167|FG001|Period II|Protocol Violation|0|||
144450914|NCT00359762|520848168|FG002|Period II|Protocol Violation|0|||
144450915|NCT00359762|520848169|FG003|Period II|Protocol Violation|0|||
144450916|NCT00359762|520848170|FG004|Period II|Protocol Violation|11|||
144450917|NCT00359762|520848166|FG000|Period II|Physician Decision|17|||
144450918|NCT00359762|520848167|FG001|Period II|Physician Decision|0|||
144450919|NCT00359762|520848168|FG002|Period II|Physician Decision|0|||
144450920|NCT00359762|520848169|FG003|Period II|Physician Decision|0|||
144450921|NCT00359762|520848170|FG004|Period II|Physician Decision|23|||
144450922|NCT00359762|520848166|FG000|Period II|Death|2|||
144450923|NCT00359762|520848167|FG001|Period II|Death|0|||
144450924|NCT00359762|520848168|FG002|Period II|Death|0|||
144450925|NCT00359762|520848169|FG003|Period II|Death|0|||
144450926|NCT00359762|520848170|FG004|Period II|Death|4|||
144450927|NCT00359762|520848166|FG000|Period II|Lack of Efficacy|11|||
144450928|NCT00359762|520848167|FG001|Period II|Lack of Efficacy|0|||
144450929|NCT00359762|520848168|FG002|Period II|Lack of Efficacy|0|||
144450930|NCT00359762|520848169|FG003|Period II|Lack of Efficacy|0|||
144450931|NCT00359762|520848170|FG004|Period II|Lack of Efficacy|8|||
144450932|NCT00359762|520848166|FG000|Period II|Lost to follow up|5|||
144450933|NCT00359762|520848167|FG001|Period II|Lost to follow up|0|||
144450934|NCT00359762|520848168|FG002|Period II|Lost to follow up|0|||
144533560|NCT04214834|521156692|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
144533561|NCT03812614|521156699|FG000|Intervention|Withdrawal by Subject|7|||
144533562|NCT03812614|521156700|FG001|Intervention|Withdrawal by Subject|2|||
144533563|NCT03812614|521156701|FG002|Intervention|Withdrawal by Subject|7|||
144533564|NCT03812614|521156702|FG003|Intervention|Withdrawal by Subject|2|||
144533565|NCT03812614|521156699|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
144533566|NCT03812614|521156700|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
144533567|NCT03812614|521156701|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
144606733|NCT00888381|521421090|FG001|Overall Study|Lost to Follow-up|1|||
144606734|NCT00097773|521421091|FG000|Overall Study|Lost to Follow-up|2|||
144253957|NCT02774005|520130117|FG000|Overall Study|Adverse Event|8|||
144253958|NCT02774005|520130117|FG000|Overall Study|Withdrawal by Subject|23|||
144253959|NCT02774005|520130117|FG000|Overall Study|Lost to Follow-up|7|||
144253960|NCT02774005|520130117|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
144253961|NCT02774005|520130117|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
144253962|NCT02774005|520130117|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
144450935|NCT00359762|520848169|FG003|Period II|Lost to follow up|0|||
144450936|NCT00359762|520848170|FG004|Period II|Lost to follow up|5|||
144450937|NCT00359762|520848166|FG000|Period II|Entry Criteria Not Met|8|||
144450938|NCT00359762|520848167|FG001|Period II|Entry Criteria Not Met|0|||
144450939|NCT00359762|520848168|FG002|Period II|Entry Criteria Not Met|0|||
144253963|NCT02774005|520130117|FG000|Overall Study|Death|1|||
144450940|NCT00359762|520848169|FG003|Period II|Entry Criteria Not Met|0|||
144450941|NCT00359762|520848170|FG004|Period II|Entry Criteria Not Met|4|||
144450942|NCT00359762|520848166|FG000|Period II|Subject Decision|50|||
144450943|NCT00359762|520848167|FG001|Period II|Subject Decision|0|||
144450944|NCT00359762|520848168|FG002|Period II|Subject Decision|0|||
144253964|NCT02774005|520130117|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
144450945|NCT00359762|520848169|FG003|Period II|Subject Decision|0|||
144450946|NCT00359762|520848170|FG004|Period II|Subject Decision|70|||
144450947|NCT00359762|520848166|FG000|Period III|Protocol Violation|0|||
144450948|NCT00359762|520848167|FG001|Period III|Protocol Violation|5|||
144450949|NCT00359762|520848168|FG002|Period III|Protocol Violation|3|||
144450950|NCT00359762|520848169|FG003|Period III|Protocol Violation|8|||
144450951|NCT00359762|520848170|FG004|Period III|Protocol Violation|0|||
144450952|NCT00359762|520848166|FG000|Period III|Adverse Event|0|||
144450953|NCT00359762|520848167|FG001|Period III|Adverse Event|3|||
144450954|NCT00359762|520848168|FG002|Period III|Adverse Event|4|||
144450955|NCT00359762|520848169|FG003|Period III|Adverse Event|10|||
144450956|NCT00359762|520848170|FG004|Period III|Adverse Event|0|||
144450957|NCT00359762|520848166|FG000|Period III|Physician Decision|0|||
144450958|NCT00359762|520848167|FG001|Period III|Physician Decision|5|||
144450959|NCT00359762|520848168|FG002|Period III|Physician Decision|9|||
144450960|NCT00359762|520848169|FG003|Period III|Physician Decision|15|||
144450961|NCT00359762|520848170|FG004|Period III|Physician Decision|0|||
144450962|NCT00359762|520848166|FG000|Period III|Lack of Efficacy|0|||
144450963|NCT00359762|520848167|FG001|Period III|Lack of Efficacy|7|||
144450964|NCT00359762|520848168|FG002|Period III|Lack of Efficacy|5|||
144450965|NCT00359762|520848169|FG003|Period III|Lack of Efficacy|9|||
144450966|NCT00359762|520848170|FG004|Period III|Lack of Efficacy|0|||
144450967|NCT00359762|520848166|FG000|Period III|Lost to follow up|0|||
144450968|NCT00359762|520848167|FG001|Period III|Lost to follow up|1|||
144253965|NCT02774005|520130117|FG000|Overall Study|Lack of compliance with study medication|4|||
144533568|NCT03812614|521156702|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
144533569|NCT03812614|521156699|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
144533570|NCT03812614|521156700|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
144533571|NCT03812614|521156701|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
144533572|NCT03812614|521156702|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
144533573|NCT03812614|521156699|FG000|6-month Follow-up|Lost to Follow-up|0|||
144533574|NCT03812614|521156700|FG001|6-month Follow-up|Lost to Follow-up|0|||
144533575|NCT03812614|521156701|FG002|6-month Follow-up|Lost to Follow-up|12|||
144253966|NCT02774005|520130117|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
144253967|NCT02774005|520130117|FG000|Overall Study|another study|1|||
144253968|NCT02774005|520130117|FG000|Overall Study|cardiologist imposed travel restriction|1|||
144253969|NCT01289574|520130118|FG000|Overall Study|Lack of Efficacy|4|||
144253970|NCT01289574|520130119|FG001|Overall Study|Lack of Efficacy|0|||
144253971|NCT01289574|520130120|FG002|Overall Study|Lack of Efficacy|1|||
144253972|NCT01289574|520130118|FG000|Overall Study|Lost to Follow-up|2|||
144253973|NCT01289574|520130119|FG001|Overall Study|Lost to Follow-up|0|||
144253974|NCT01289574|520130120|FG002|Overall Study|Lost to Follow-up|1|||
144253975|NCT01289574|520130118|FG000|Overall Study|Withdrawal by Subject|1|||
144253976|NCT01289574|520130119|FG001|Overall Study|Withdrawal by Subject|1|||
144253977|NCT01289574|520130120|FG002|Overall Study|Withdrawal by Subject|1|||
144253978|NCT01289574|520130118|FG000|Overall Study|Adverse Event|0|||
144253979|NCT01289574|520130119|FG001|Overall Study|Adverse Event|1|||
144253980|NCT01289574|520130120|FG002|Overall Study|Adverse Event|0|||
144253981|NCT01289574|520130118|FG000|Overall Study|Subject wanted alternate treatment|0|||
144253982|NCT01289574|520130119|FG001|Overall Study|Subject wanted alternate treatment|1|||
144253983|NCT01289574|520130120|FG002|Overall Study|Subject wanted alternate treatment|0|||
144253984|NCT00262002|520130121|FG000|Overall Study|Adverse Event|2|||
144253985|NCT00262002|520130122|FG001|Overall Study|Adverse Event|1|||
144253986|NCT00262002|520130123|FG002|Overall Study|Adverse Event|0|||
144253987|NCT00262002|520130124|FG003|Overall Study|Adverse Event|0|||
144253988|NCT00262002|520130125|FG004|Overall Study|Adverse Event|0|||
144253989|NCT00262002|520130126|FG005|Overall Study|Adverse Event|1|||
144253990|NCT00262002|520130127|FG006|Overall Study|Adverse Event|0|||
144253991|NCT00262002|520130121|FG000|Overall Study|Withdrawal by Subject|4|||
144253992|NCT00262002|520130122|FG001|Overall Study|Withdrawal by Subject|2|||
144253993|NCT00262002|520130123|FG002|Overall Study|Withdrawal by Subject|0|||
144253994|NCT00262002|520130124|FG003|Overall Study|Withdrawal by Subject|1|||
144450969|NCT00359762|520848168|FG002|Period III|Lost to follow up|1|||
144533576|NCT03812614|521156702|FG003|6-month Follow-up|Lost to Follow-up|8|||
144533577|NCT03812614|521156699|FG000|12-month Follow-up|Lost to Follow-up|18|||
144533578|NCT03812614|521156700|FG001|12-month Follow-up|Lost to Follow-up|17|||
144533579|NCT03812614|521156701|FG002|12-month Follow-up|Lost to Follow-up|5|||
144533580|NCT03812614|521156702|FG003|12-month Follow-up|Lost to Follow-up|2|||
144253995|NCT00262002|520130125|FG004|Overall Study|Withdrawal by Subject|2|||
144253996|NCT00262002|520130126|FG005|Overall Study|Withdrawal by Subject|2|||
144253997|NCT00262002|520130127|FG006|Overall Study|Withdrawal by Subject|2|||
144253998|NCT00262002|520130121|FG000|Overall Study|Lost to Follow-up|2|||
144450970|NCT00359762|520848169|FG003|Period III|Lost to follow up|2|||
144194720|NCT01470612|519908482|FG000|Overall Study|Pregnancy|2|||
144450971|NCT00359762|520848170|FG004|Period III|Lost to follow up|0|||
144450972|NCT00359762|520848166|FG000|Period III|Entry Criteria Not Met|0|||
144450973|NCT00359762|520848167|FG001|Period III|Entry Criteria Not Met|1|||
144450974|NCT00359762|520848168|FG002|Period III|Entry Criteria Not Met|0|||
144450975|NCT00359762|520848169|FG003|Period III|Entry Criteria Not Met|1|||
144450976|NCT00359762|520848170|FG004|Period III|Entry Criteria Not Met|0|||
144450977|NCT00359762|520848166|FG000|Period III|Subject Decision|0|||
144450978|NCT00359762|520848167|FG001|Period III|Subject Decision|7|||
144450979|NCT00359762|520848168|FG002|Period III|Subject Decision|8|||
144450980|NCT00359762|520848169|FG003|Period III|Subject Decision|20|||
144450981|NCT00359762|520848170|FG004|Period III|Subject Decision|0|||
144450982|NCT02819726|520848171|FG000|Part A (All Participants)|Lost to Follow-up|0|||
144450983|NCT02819726|520848172|FG001|Part A (All Participants)|Lost to Follow-up|1|||
144450984|NCT02819726|520848173|FG002|Part A (All Participants)|Lost to Follow-up|0|||
144450985|NCT02819726|520848174|FG003|Part A (All Participants)|Lost to Follow-up|0|||
144450986|NCT02819726|520848171|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
144450987|NCT02819726|520848172|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
144450988|NCT02819726|520848173|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
144450989|NCT02819726|520848174|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
144450990|NCT02819726|520848171|FG000|Part A (All Participants)|Protocol non-compliance|3|||
144450991|NCT02819726|520848172|FG001|Part A (All Participants)|Protocol non-compliance|4|||
144450992|NCT02819726|520848173|FG002|Part A (All Participants)|Protocol non-compliance|5|||
144450993|NCT02819726|520848174|FG003|Part A (All Participants)|Protocol non-compliance|0|||
144450994|NCT02819726|520848171|FG000|Part B (All Participants)|Lost to Follow-up|1|||
144450995|NCT02819726|520848172|FG001|Part B (All Participants)|Lost to Follow-up|1|||
144450996|NCT02819726|520848173|FG002|Part B (All Participants)|Lost to Follow-up|2|||
144450997|NCT02819726|520848174|FG003|Part B (All Participants)|Lost to Follow-up|2|||
144450998|NCT02819726|520848171|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
144450999|NCT02819726|520848172|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
144451000|NCT02819726|520848173|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
144451001|NCT02819726|520848174|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
144451002|NCT02819726|520848171|FG000|Part B (All Participants)|Protocol non-compliance|0|||
144451003|NCT02819726|520848172|FG001|Part B (All Participants)|Protocol non-compliance|0|||
144451004|NCT02819726|520848173|FG002|Part B (All Participants)|Protocol non-compliance|1|||
144451005|NCT02819726|520848174|FG003|Part B (All Participants)|Protocol non-compliance|0|||
144451006|NCT01033747|520848178|FG000|Overall Study|Adverse Event|9|||
144451007|NCT01033747|520848179|FG001|Overall Study|Adverse Event|4|||
144451008|NCT01033747|520848178|FG000|Overall Study|Abnormal Laboratory Value|1|||
144451009|NCT01033747|520848179|FG001|Overall Study|Abnormal Laboratory Value|0|||
144451010|NCT01033747|520848178|FG000|Overall Study|Abnormal test procedure|0|||
144451011|NCT01033747|520848179|FG001|Overall Study|Abnormal test procedure|1|||
144451012|NCT01033747|520848178|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
144451013|NCT01033747|520848179|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
144451014|NCT01033747|520848178|FG000|Overall Study|Protocol Violation|1|||
144451015|NCT01033747|520848179|FG001|Overall Study|Protocol Violation|0|||
144451016|NCT01033747|520848178|FG000|Overall Study|Withdrawal by Subject|9|||
144451017|NCT01033747|520848179|FG001|Overall Study|Withdrawal by Subject|6|||
144451018|NCT01033747|520848178|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
144451019|NCT01033747|520848179|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
144451020|NCT01033747|520848178|FG000|Overall Study|Stopped at end of Extension 1|2|||
144451021|NCT01033747|520848179|FG001|Overall Study|Stopped at end of Extension 1|0|||
144451022|NCT02613481|520848180|FG000|Overall Study|Lost to Follow-up|7|||
144451023|NCT02613481|520848180|FG000|Overall Study|Withdrawal by Subject|2|||
144451024|NCT02647658|520848181|FG000|Overall Study|Consent refusal|15|||
144451025|NCT02647658|520848182|FG001|Overall Study|Consent refusal|24|||
144451026|NCT00803023|520848183|FG000|Overall Study|Adverse Event|5|||
144451027|NCT00803023|520848184|FG001|Overall Study|Adverse Event|4|||
144451028|NCT00803023|520848185|FG002|Overall Study|Adverse Event|8|||
144451029|NCT00803023|520848186|FG003|Overall Study|Adverse Event|6|||
144451030|NCT00803023|520848183|FG000|Overall Study|Withdrawal by Subject|0|||
144451031|NCT00803023|520848184|FG001|Overall Study|Withdrawal by Subject|2|||
144451032|NCT00803023|520848185|FG002|Overall Study|Withdrawal by Subject|0|||
144451033|NCT00803023|520848186|FG003|Overall Study|Withdrawal by Subject|0|||
144451034|NCT00803023|520848183|FG000|Overall Study|Lost to Follow-up|0|||
144194721|NCT01470612|519908483|FG001|Overall Study|Pregnancy|10|||
144194722|NCT01470612|519908482|FG000|Overall Study|Protocol Violation|2|||
144194723|NCT01470612|519908483|FG001|Overall Study|Protocol Violation|7|||
144194724|NCT01470612|519908482|FG000|Overall Study|Withdrawal by Subject|24|||
144451035|NCT00803023|520848184|FG001|Overall Study|Lost to Follow-up|1|||
144451036|NCT00803023|520848185|FG002|Overall Study|Lost to Follow-up|2|||
144451037|NCT00803023|520848186|FG003|Overall Study|Lost to Follow-up|1|||
144451038|NCT00803023|520848183|FG000|Overall Study|Lack of Efficacy|0|||
144451039|NCT00803023|520848184|FG001|Overall Study|Lack of Efficacy|1|||
144451040|NCT00803023|520848185|FG002|Overall Study|Lack of Efficacy|1|||
144451041|NCT00803023|520848186|FG003|Overall Study|Lack of Efficacy|1|||
144194725|NCT01470612|519908483|FG001|Overall Study|Withdrawal by Subject|79|||
144194726|NCT01470612|519908482|FG000|Overall Study|Other|14|||
144194727|NCT01470612|519908483|FG001|Overall Study|Other|156|||
144194728|NCT03856593|519908487|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
144194729|NCT03856593|519908488|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
144194730|NCT01901874|519908489|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
144194731|NCT01901874|519908489|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
144194732|NCT01901874|519908489|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
144194733|NCT01901874|519908489|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
144194734|NCT01901874|519908489|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
144194735|NCT01901874|519908489|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
144194736|NCT01949116|519908490|FG000|Overall Study|Death|2|||
144194737|NCT01949116|519908491|FG001|Overall Study|Death|0|||
144194738|NCT01949116|519908490|FG000|Overall Study|Lost to Follow-up|1|||
144451042|NCT01542528|520848187|FG000|Overall Study|Lost to Follow-up|2|||
144451043|NCT01542528|520848188|FG001|Overall Study|Lost to Follow-up|1|||
144451044|NCT01542528|520848187|FG000|Overall Study|Physician Decision|1|||
144451045|NCT01542528|520848188|FG001|Overall Study|Physician Decision|0|||
144451046|NCT01542528|520848187|FG000|Overall Study|Withdrawal by Subject|9|||
144451047|NCT01542528|520848188|FG001|Overall Study|Withdrawal by Subject|6|||
144451048|NCT04382326|520848195|FG000|Overall Study|Adverse Event, not serious|1|||
144451049|NCT04382326|520848196|FG001|Overall Study|Adverse Event, not serious|2|||
144451050|NCT04382326|520848195|FG000|Overall Study|Other|1|||
144451051|NCT04382326|520848196|FG001|Overall Study|Other|0|||
144451052|NCT04382326|520848195|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
144451053|NCT04382326|520848196|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
144451054|NCT04382326|520848195|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
144451055|NCT04382326|520848196|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
144194739|NCT01949116|519908491|FG001|Overall Study|Lost to Follow-up|3|||
144194740|NCT01949116|519908490|FG000|Overall Study|Withdrawal by Subject|5|||
144194741|NCT01949116|519908491|FG001|Overall Study|Withdrawal by Subject|3|||
144194742|NCT02556307|519908501|FG000|Overall Study|Premature treatment interruption|11|||
144194743|NCT02556307|519908501|FG000|Overall Study|Lost to Follow-up|36|||
144194744|NCT02556307|519908501|FG000|Overall Study|Change to triple therapy|4|||
144194745|NCT02556307|519908501|FG000|Overall Study|Enrolled but not treated|2|||
144194746|NCT03078582|519908502|FG000|Overall Study|Adverse Event|0|||
144194747|NCT03078582|519908503|FG001|Overall Study|Adverse Event|8|||
144194748|NCT02039414|519908512|FG000|Overall Study|Delivered|1|||
144194749|NCT02039414|519908513|FG001|Overall Study|Delivered|1|||
144194750|NCT02039414|519908512|FG000|Overall Study|Lost to Follow-up|2|||
144194751|NCT02039414|519908513|FG001|Overall Study|Lost to Follow-up|0|||
144194752|NCT02039414|519908512|FG000|Overall Study|Protocol Violation|3|||
144194753|NCT02039414|519908513|FG001|Overall Study|Protocol Violation|1|||
144194754|NCT00653991|519908521|FG000|3 Month Follow-up|Participant would not respond|150|||
144606735|NCT00097773|521421092|FG001|Overall Study|Lost to Follow-up|2|||
144606736|NCT00097773|521421093|FG002|Overall Study|Lost to Follow-up|0|||
144606737|NCT00097773|521421094|FG003|Overall Study|Lost to Follow-up|1|||
144606738|NCT00097773|521421091|FG000|Overall Study|Physician Decision|2|||
144606739|NCT00097773|521421092|FG001|Overall Study|Physician Decision|2|||
144606740|NCT00097773|521421093|FG002|Overall Study|Physician Decision|3|||
144606741|NCT00097773|521421094|FG003|Overall Study|Physician Decision|1|||
144606742|NCT00097773|521421091|FG000|Overall Study|Withdrawal by Subject|3|||
144606743|NCT00097773|521421092|FG001|Overall Study|Withdrawal by Subject|3|||
144606744|NCT00097773|521421093|FG002|Overall Study|Withdrawal by Subject|3|||
144606745|NCT00097773|521421094|FG003|Overall Study|Withdrawal by Subject|1|||
144606746|NCT00097773|521421091|FG000|Overall Study|Adverse Event|0|||
144606747|NCT00097773|521421092|FG001|Overall Study|Adverse Event|1|||
144606748|NCT00097773|521421093|FG002|Overall Study|Adverse Event|0|||
144606749|NCT00097773|521421094|FG003|Overall Study|Adverse Event|0|||
144606750|NCT00097773|521421091|FG000|Overall Study|Other|1|||
144606751|NCT00097773|521421092|FG001|Overall Study|Other|0|||
144606752|NCT00097773|521421093|FG002|Overall Study|Other|2|||
144606753|NCT00097773|521421094|FG003|Overall Study|Other|0|||
144606754|NCT00175877|521421095|FG000|Overall Study|Adverse Event|136|||
144606755|NCT00175877|521421095|FG000|Overall Study|Withdrawal by Subject|141|||
144194755|NCT00653991|519908522|FG001|3 Month Follow-up|Participant would not respond|157|||
144194756|NCT00653991|519908521|FG000|6 Month Follow-up|Participant would not respond|133|||
144606756|NCT00175877|521421095|FG000|Overall Study|Lost to Follow-up|9|||
144606757|NCT00175877|521421095|FG000|Overall Study|Lack of Efficacy|26|||
144194757|NCT00653991|519908522|FG001|6 Month Follow-up|Participant would not respond|141|||
144194758|NCT02181296|519908523|FG000|Overall Study|Lost to Follow-up|7|||
144451056|NCT04382326|520848195|FG000|Overall Study|Protocol Violation|29|||
144451057|NCT04382326|520848196|FG001|Overall Study|Protocol Violation|23|||
144451058|NCT04382326|520848195|FG000|Overall Study|Physician Decision|0|||
144451059|NCT04382326|520848196|FG001|Overall Study|Physician Decision|1|||
144606758|NCT00175877|521421095|FG000|Overall Study|Protocol Violation|15|||
144725497|NCT01957488|521851280|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
144725498|NCT01957488|521851281|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
144725499|NCT01957488|521851282|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
144725500|NCT01957488|521851283|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
144725501|NCT01957488|521851278|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
144725502|NCT01957488|521851279|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
144194759|NCT02181296|519908524|FG001|Overall Study|Lost to Follow-up|6|||
144194760|NCT02939014|519908525|FG000|Overall Study|Lost to Follow-up|1|||
144451060|NCT04382326|520848195|FG000|Overall Study|Lost to Follow-up|48|||
144451061|NCT04382326|520848196|FG001|Overall Study|Lost to Follow-up|63|||
144451062|NCT04382326|520848195|FG000|Overall Study|Adverse Event, non-fatal|1|||
144451063|NCT04382326|520848196|FG001|Overall Study|Adverse Event, non-fatal|1|||
144451064|NCT01762761|520848197|FG000|Overall Study|Adverse Event|15|||
144451065|NCT01762761|520848198|FG001|Overall Study|Adverse Event|17|||
144451066|NCT01762761|520848197|FG000|Overall Study|Lack of Efficacy|9|||
144451067|NCT01762761|520848198|FG001|Overall Study|Lack of Efficacy|25|||
144451068|NCT01762761|520848197|FG000|Overall Study|Protocol Violation|1|||
144451069|NCT01762761|520848198|FG001|Overall Study|Protocol Violation|1|||
144451070|NCT01762761|520848197|FG000|Overall Study|Study closed/terminated|0|||
144451071|NCT01762761|520848198|FG001|Overall Study|Study closed/terminated|2|||
144451072|NCT01762761|520848197|FG000|Overall Study|Lost to Follow-up|3|||
144451073|NCT01762761|520848198|FG001|Overall Study|Lost to Follow-up|6|||
144451074|NCT01762761|520848197|FG000|Overall Study|Physician Decision|4|||
144451075|NCT01762761|520848198|FG001|Overall Study|Physician Decision|6|||
144451076|NCT01762761|520848197|FG000|Overall Study|Withdrawal by Subject|7|||
144451077|NCT01762761|520848198|FG001|Overall Study|Withdrawal by Subject|8|||
144451078|NCT01709227|520848204|FG000|Overall Study|Physician Decision|1|||
144451079|NCT01709227|520848205|FG001|Overall Study|Physician Decision|0|||
144451080|NCT01709227|520848204|FG000|Overall Study|Pleural Peritoneal communication|0|||
144451081|NCT01709227|520848205|FG001|Overall Study|Pleural Peritoneal communication|9|||
144451082|NCT01731171|520848209|FG000|Overall Study|Withdrawal by Subject|4|||
144451083|NCT01731171|520848210|FG001|Overall Study|Withdrawal by Subject|1|||
144451084|NCT01731171|520848209|FG000|Overall Study|Lost to Follow-up|3|||
144451085|NCT01731171|520848210|FG001|Overall Study|Lost to Follow-up|2|||
144451086|NCT01731171|520848209|FG000|Overall Study|Moved out of Area|0|||
144451087|NCT01731171|520848210|FG001|Overall Study|Moved out of Area|2|||
144451088|NCT01731171|520848209|FG000|Overall Study|Terminated for Lack of Adherence|0|||
144451089|NCT01731171|520848210|FG001|Overall Study|Terminated for Lack of Adherence|1|||
144451090|NCT01731171|520848209|FG000|Overall Study|Terminated for Safety Reasons|0|||
144725503|NCT01957488|521851280|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
144194761|NCT02939014|519908526|FG001|Overall Study|Lost to Follow-up|0|||
144194762|NCT02939014|519908525|FG000|Overall Study|Death|4|||
144194763|NCT02939014|519908526|FG001|Overall Study|Death|3|||
144194764|NCT01392326|519908537|FG000|Overall Study|Death|2|||
144194765|NCT01392326|519908538|FG001|Overall Study|Death|0|||
144194766|NCT01392326|519908539|FG002|Overall Study|Death|0|||
144194767|NCT01392326|519908537|FG000|Overall Study|Withdrawal by Subject|12|||
144194768|NCT01392326|519908538|FG001|Overall Study|Withdrawal by Subject|11|||
144194769|NCT01392326|519908539|FG002|Overall Study|Withdrawal by Subject|15|||
144194770|NCT01392326|519908537|FG000|Overall Study|Protocol Violation|2|||
144194771|NCT01392326|519908538|FG001|Overall Study|Protocol Violation|0|||
144451091|NCT01731171|520848210|FG001|Overall Study|Terminated for Safety Reasons|1|||
144451092|NCT05061446|520848220|FG000|Overall Study|Adverse Event|2|||
144451093|NCT05061446|520848221|FG001|Overall Study|Adverse Event|0|||
144451094|NCT05061446|520848222|FG002|Overall Study|Adverse Event|0|||
144451095|NCT05061446|520848220|FG000|Overall Study|Participant no longer available due to personal reason|0|||
144451096|NCT05061446|520848221|FG001|Overall Study|Participant no longer available due to personal reason|1|||
144725504|NCT01957488|521851281|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
144194772|NCT01392326|519908539|FG002|Overall Study|Protocol Violation|0|||
144451097|NCT05061446|520848222|FG002|Overall Study|Participant no longer available due to personal reason|0|||
144451098|NCT05857527|520848225|FG000|Overall Study|Withdrawal by Subject|0|||
144451099|NCT05857527|520848226|FG001|Overall Study|Withdrawal by Subject|1|||
144451100|NCT02543346|520848227|FG000|Second Priming Visit|Withdrawal by Subject|0|||
144451101|NCT02543346|520848228|FG001|Second Priming Visit|Withdrawal by Subject|2|||
144451102|NCT02543346|520848229|FG002|Second Priming Visit|Withdrawal by Subject|2|||
144194773|NCT01392326|519908537|FG000|Overall Study|Pregnancy|0|||
144194774|NCT01392326|519908538|FG001|Overall Study|Pregnancy|0|||
144194775|NCT01392326|519908539|FG002|Overall Study|Pregnancy|1|||
144451103|NCT02543346|520848230|FG003|Second Priming Visit|Withdrawal by Subject|2|||
144451104|NCT02543346|520848227|FG000|Second Priming Visit|Adverse Event|1|||
144451105|NCT02543346|520848228|FG001|Second Priming Visit|Adverse Event|0|||
144451106|NCT02543346|520848229|FG002|Second Priming Visit|Adverse Event|0|||
144451107|NCT02543346|520848230|FG003|Second Priming Visit|Adverse Event|0|||
144451108|NCT01748994|520848231|FG000|Overall Study|Lost to Follow-up|8|||
144451109|NCT01748994|520848232|FG001|Overall Study|Lost to Follow-up|6|||
144451110|NCT02141516|520848233|FG000|Overall Study|Adverse Event|0|||
144451111|NCT02141516|520848234|FG001|Overall Study|Adverse Event|1|||
144194776|NCT01392326|519908537|FG000|Overall Study|Physician Decision|7|||
144451112|NCT02141516|520848235|FG002|Overall Study|Adverse Event|0|||
144451113|NCT02141516|520848233|FG000|Overall Study|Lost to Follow-up|0|||
144451114|NCT02141516|520848234|FG001|Overall Study|Lost to Follow-up|1|||
144451115|NCT02141516|520848235|FG002|Overall Study|Lost to Follow-up|0|||
144606759|NCT00175877|521421095|FG000|Overall Study|Other Reason|20|||
144606760|NCT00175877|521421095|FG000|Overall Study|AE & Other|1|||
144606761|NCT00175877|521421095|FG000|Overall Study|Withdrawal by subject & Other|1|||
144606762|NCT02243865|521421100|FG000|Overall Study|Protocol Violation|1|||
144194777|NCT01392326|519908538|FG001|Overall Study|Physician Decision|5|||
144194778|NCT01392326|519908539|FG002|Overall Study|Physician Decision|2|||
144194779|NCT01392326|519908537|FG000|Overall Study|Lost to Follow-up|1|||
144194780|NCT01392326|519908538|FG001|Overall Study|Lost to Follow-up|3|||
144194781|NCT01392326|519908539|FG002|Overall Study|Lost to Follow-up|4|||
144194782|NCT01392326|519908537|FG000|Overall Study|Lack of Efficacy|14|||
144194783|NCT01392326|519908538|FG001|Overall Study|Lack of Efficacy|10|||
144194784|NCT01392326|519908539|FG002|Overall Study|Lack of Efficacy|15|||
144194785|NCT01392326|519908537|FG000|Overall Study|Adverse Event|9|||
144194786|NCT01392326|519908538|FG001|Overall Study|Adverse Event|6|||
144194787|NCT01392326|519908539|FG002|Overall Study|Adverse Event|11|||
144194788|NCT00518622|519908542|FG000|Overall Study|Lost to Follow-up|0|||
144194789|NCT00518622|519908543|FG001|Overall Study|Lost to Follow-up|0|||
144194790|NCT00518622|519908544|FG002|Overall Study|Lost to Follow-up|1|||
144194791|NCT00518622|519908545|FG003|Overall Study|Lost to Follow-up|0|||
144194792|NCT00518622|519908546|FG004|Overall Study|Lost to Follow-up|0|||
144194793|NCT00518622|519908547|FG005|Overall Study|Lost to Follow-up|0|||
144194794|NCT00518622|519908548|FG006|Overall Study|Lost to Follow-up|0|||
144194795|NCT00518622|519908549|FG007|Overall Study|Lost to Follow-up|0|||
144194796|NCT00518622|519908542|FG000|Overall Study|Study medication taken incorrectly|0|||
144194797|NCT00518622|519908543|FG001|Overall Study|Study medication taken incorrectly|1|||
144194798|NCT00518622|519908544|FG002|Overall Study|Study medication taken incorrectly|0|||
144194799|NCT00518622|519908545|FG003|Overall Study|Study medication taken incorrectly|0|||
144194800|NCT00518622|519908546|FG004|Overall Study|Study medication taken incorrectly|0|||
144194801|NCT00518622|519908547|FG005|Overall Study|Study medication taken incorrectly|0|||
144194802|NCT00518622|519908548|FG006|Overall Study|Study medication taken incorrectly|0|||
144194803|NCT00518622|519908549|FG007|Overall Study|Study medication taken incorrectly|0|||
144194804|NCT00094094|519908550|FG000|Overall Study|Death|2|||
144194805|NCT00094094|519908550|FG000|Overall Study|Lack of Efficacy|23|||
144194806|NCT00094094|519908550|FG000|Overall Study|Adverse Event|7|||
144194807|NCT01408563|519910312|FG000|Overall Study|Ineligible after consent/ registration|2|||
144194808|NCT03439852|519910314|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
144194809|NCT03439852|519910315|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
144194810|NCT03439852|519910314|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
144194811|NCT03439852|519910315|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
144194812|NCT03439852|519910314|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
144194813|NCT03439852|519910315|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
144194814|NCT02054130|519910319|FG000|Overall Study|Withdrawal by Subject|4|||
144194815|NCT02054130|519910320|FG001|Overall Study|Withdrawal by Subject|4|||
144194816|NCT02054130|519910321|FG002|Overall Study|Withdrawal by Subject|7|||
144194817|NCT02054130|519910322|FG003|Overall Study|Withdrawal by Subject|10|||
144194818|NCT02054130|519910319|FG000|Overall Study|Death|0|||
144194819|NCT02054130|519910320|FG001|Overall Study|Death|1|||
144194820|NCT02054130|519910321|FG002|Overall Study|Death|0|||
144194821|NCT02054130|519910322|FG003|Overall Study|Death|0|||
144194822|NCT02054130|519910319|FG000|Overall Study|Lost to Follow-up|0|||
144194823|NCT02054130|519910320|FG001|Overall Study|Lost to Follow-up|0|||
144194824|NCT02054130|519910321|FG002|Overall Study|Lost to Follow-up|1|||
144194825|NCT02054130|519910322|FG003|Overall Study|Lost to Follow-up|2|||
144194826|NCT02054130|519910319|FG000|Overall Study|Missed dose|4|||
144194827|NCT02054130|519910320|FG001|Overall Study|Missed dose|6|||
144194828|NCT02054130|519910321|FG002|Overall Study|Missed dose|7|||
144194829|NCT02054130|519910322|FG003|Overall Study|Missed dose|10|||
144194830|NCT03247517|519910323|FG000|Overall Study|Adverse Event|0|||
144194831|NCT03247517|519910324|FG001|Overall Study|Adverse Event|4|||
144194832|NCT03247517|519910325|FG002|Overall Study|Adverse Event|2|||
144194833|NCT03247517|519910323|FG000|Overall Study|Lost to Follow-up|2|||
144253999|NCT00262002|520130122|FG001|Overall Study|Lost to Follow-up|0|||
144194834|NCT03247517|519910324|FG001|Overall Study|Lost to Follow-up|6|||
144254000|NCT00262002|520130123|FG002|Overall Study|Lost to Follow-up|0|||
144451116|NCT02141516|520848233|FG000|Overall Study|Other|0|||
144194835|NCT03247517|519910325|FG002|Overall Study|Lost to Follow-up|4|||
144194836|NCT03247517|519910323|FG000|Overall Study|Consent withdrawn by caregiver|1|||
144194837|NCT03247517|519910324|FG001|Overall Study|Consent withdrawn by caregiver|4|||
144194838|NCT03247517|519910325|FG002|Overall Study|Consent withdrawn by caregiver|7|||
144194839|NCT03247517|519910323|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
144606763|NCT02243865|521421101|FG001|Overall Study|Protocol Violation|3|||
144194840|NCT03247517|519910324|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
144451117|NCT02141516|520848234|FG001|Overall Study|Other|3|||
144451118|NCT02141516|520848235|FG002|Overall Study|Other|0|||
144451119|NCT03251924|520848236|FG000|Overall Study|Disease Progression|6|||
144451120|NCT03251924|520848237|FG001|Overall Study|Disease Progression|6|||
144451121|NCT03251924|520848238|FG002|Overall Study|Disease Progression|7|||
144451122|NCT03251924|520848239|FG003|Overall Study|Disease Progression|8|||
144451123|NCT03251924|520848240|FG004|Overall Study|Disease Progression|8|||
144451124|NCT03251924|520848241|FG005|Overall Study|Disease Progression|7|||
144451125|NCT03251924|520848242|FG006|Overall Study|Disease Progression|6|||
144451126|NCT03251924|520848243|FG007|Overall Study|Disease Progression|10|||
144725505|NCT01957488|521851282|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
144725506|NCT01957488|521851283|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
144725507|NCT01957488|521851278|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
144725508|NCT01957488|521851279|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
144725509|NCT01957488|521851280|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
144725510|NCT01957488|521851281|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
144725511|NCT01957488|521851282|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
144725512|NCT01957488|521851283|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
144725513|NCT01957488|521851278|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
144725514|NCT01957488|521851279|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
144725515|NCT01957488|521851280|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
144725516|NCT01957488|521851281|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
144725517|NCT01957488|521851282|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
144725518|NCT01957488|521851283|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
144725519|NCT01957488|521851278|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
144725520|NCT01957488|521851279|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
144725521|NCT01957488|521851280|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
144725522|NCT01957488|521851281|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
144725523|NCT01957488|521851282|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
144725524|NCT01957488|521851283|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
144725525|NCT01957488|521851278|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
144725526|NCT01957488|521851279|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
144725527|NCT01957488|521851280|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
144725528|NCT01957488|521851281|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
144725529|NCT01957488|521851282|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
144725530|NCT01957488|521851283|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
144725531|NCT01957488|521851278|FG000|Test Period 2 (2 Weeks)|Other|1|||
144725532|NCT01957488|521851279|FG001|Test Period 2 (2 Weeks)|Other|0|||
144725533|NCT01957488|521851280|FG002|Test Period 2 (2 Weeks)|Other|0|||
144194841|NCT03247517|519910325|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
144194842|NCT03247517|519910323|FG000|Overall Study|Protocol Violation|0|||
144194843|NCT03247517|519910324|FG001|Overall Study|Protocol Violation|2|||
144194844|NCT03247517|519910325|FG002|Overall Study|Protocol Violation|0|||
144194845|NCT03247517|519910323|FG000|Overall Study|Multiple reasons|3|||
144194846|NCT03247517|519910324|FG001|Overall Study|Multiple reasons|1|||
144194847|NCT03247517|519910325|FG002|Overall Study|Multiple reasons|0|||
144194848|NCT00931268|519910326|FG000|Overall Study|Lost to Follow-up|6|||
144194849|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
144194850|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
144194851|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
144194852|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
144194853|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
144194854|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
144194855|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
144194856|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
144194857|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
144194858|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
144194859|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
144194860|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
144194861|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
144194862|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
144194863|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
144194864|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
144451127|NCT03251924|520848244|FG008|Overall Study|Disease Progression|6|||
144725534|NCT01957488|521851281|FG003|Test Period 2 (2 Weeks)|Other|0|||
144725535|NCT01957488|521851282|FG004|Test Period 2 (2 Weeks)|Other|0|||
144194865|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
144194866|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
144451128|NCT03251924|520848236|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
144451129|NCT03251924|520848237|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
144451130|NCT03251924|520848238|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
144451131|NCT03251924|520848239|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
144725536|NCT01957488|521851283|FG005|Test Period 2 (2 Weeks)|Other|0|||
144451132|NCT03251924|520848240|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
144451133|NCT03251924|520848241|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
144451134|NCT03251924|520848242|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
144451135|NCT03251924|520848243|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
144451136|NCT03251924|520848244|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
144451137|NCT03251924|520848236|FG000|Overall Study|Death|0|||
144451138|NCT03251924|520848237|FG001|Overall Study|Death|1|||
144451139|NCT03251924|520848238|FG002|Overall Study|Death|0|||
144451140|NCT03251924|520848239|FG003|Overall Study|Death|1|||
144451141|NCT03251924|520848240|FG004|Overall Study|Death|1|||
144451142|NCT03251924|520848241|FG005|Overall Study|Death|1|||
144451143|NCT03251924|520848242|FG006|Overall Study|Death|0|||
144451144|NCT03251924|520848243|FG007|Overall Study|Death|0|||
144451145|NCT03251924|520848244|FG008|Overall Study|Death|0|||
144451146|NCT03251924|520848236|FG000|Overall Study|Study Drug Toxicity|0|||
144451147|NCT03251924|520848237|FG001|Overall Study|Study Drug Toxicity|0|||
144451148|NCT03251924|520848238|FG002|Overall Study|Study Drug Toxicity|0|||
144451149|NCT03251924|520848239|FG003|Overall Study|Study Drug Toxicity|1|||
144451150|NCT03251924|520848240|FG004|Overall Study|Study Drug Toxicity|0|||
144451151|NCT03251924|520848241|FG005|Overall Study|Study Drug Toxicity|0|||
144451152|NCT03251924|520848242|FG006|Overall Study|Study Drug Toxicity|0|||
144451153|NCT03251924|520848243|FG007|Overall Study|Study Drug Toxicity|0|||
144451154|NCT03251924|520848244|FG008|Overall Study|Study Drug Toxicity|1|||
144451155|NCT03251924|520848236|FG000|Overall Study|Other Reasons|0|||
144451156|NCT03251924|520848237|FG001|Overall Study|Other Reasons|0|||
144451157|NCT03251924|520848238|FG002|Overall Study|Other Reasons|0|||
144451158|NCT03251924|520848239|FG003|Overall Study|Other Reasons|0|||
144451159|NCT03251924|520848240|FG004|Overall Study|Other Reasons|0|||
144451160|NCT03251924|520848241|FG005|Overall Study|Other Reasons|0|||
144451161|NCT03251924|520848242|FG006|Overall Study|Other Reasons|0|||
144451162|NCT03251924|520848243|FG007|Overall Study|Other Reasons|0|||
144451163|NCT03251924|520848244|FG008|Overall Study|Other Reasons|1|||
144451164|NCT03251924|520848236|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144451165|NCT03251924|520848237|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144451166|NCT03251924|520848238|FG002|Overall Study|Participant request to discontinue study treatment|0|||
144451167|NCT03251924|520848239|FG003|Overall Study|Participant request to discontinue study treatment|0|||
144451168|NCT03251924|520848240|FG004|Overall Study|Participant request to discontinue study treatment|0|||
144451169|NCT03251924|520848241|FG005|Overall Study|Participant request to discontinue study treatment|0|||
144451170|NCT03251924|520848242|FG006|Overall Study|Participant request to discontinue study treatment|0|||
144451171|NCT03251924|520848243|FG007|Overall Study|Participant request to discontinue study treatment|1|||
144451172|NCT03251924|520848244|FG008|Overall Study|Participant request to discontinue study treatment|0|||
144451173|NCT00153101|520848245|FG000|Overall Study|Lost to Follow-up|14|||
144451174|NCT00153101|520848246|FG001|Overall Study|Lost to Follow-up|14|||
144451175|NCT00153101|520848247|FG002|Overall Study|Lost to Follow-up|12|||
144451176|NCT00153101|520848248|FG003|Overall Study|Lost to Follow-up|5|||
144451177|NCT00153101|520848249|FG004|Overall Study|Lost to Follow-up|5|||
144451178|NCT00153101|520848245|FG000|Overall Study|Withdrawal by Subject|3|||
144451179|NCT00153101|520848246|FG001|Overall Study|Withdrawal by Subject|4|||
144451180|NCT00153101|520848247|FG002|Overall Study|Withdrawal by Subject|3|||
144451181|NCT00153101|520848248|FG003|Overall Study|Withdrawal by Subject|3|||
144451182|NCT00153101|520848249|FG004|Overall Study|Withdrawal by Subject|5|||
144451183|NCT03169153|520848250|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
144606764|NCT02243865|521421100|FG000|Overall Study|Lost to Follow-up|1|||
144606765|NCT02243865|521421101|FG001|Overall Study|Lost to Follow-up|1|||
144606766|NCT02243865|521421100|FG000|Overall Study|Withdrawal by Subject|1|||
144606767|NCT02243865|521421101|FG001|Overall Study|Withdrawal by Subject|0|||
144606768|NCT02243865|521421100|FG000|Overall Study|Adverse Event|1|||
144606769|NCT02243865|521421101|FG001|Overall Study|Adverse Event|1|||
144606770|NCT00955279|521421102|FG000|Overall Study|Other|0|||
144606771|NCT00955279|521421103|FG001|Overall Study|Other|0|||
144606772|NCT00955279|521421104|FG002|Overall Study|Other|3|||
144451184|NCT03169153|520848251|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
144451185|NCT03169153|520848250|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
144451186|NCT03169153|520848251|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
144606773|NCT00955279|521421102|FG000|Overall Study|Death|1|||
144606774|NCT00955279|521421103|FG001|Overall Study|Death|1|||
144606775|NCT00955279|521421104|FG002|Overall Study|Death|1|||
144451187|NCT03169153|520848250|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
144451188|NCT03169153|520848251|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
144451189|NCT03169153|520848250|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
144451190|NCT03169153|520848251|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
144451191|NCT03299192|520848252|FG000|Overall Study|Fell before classes started|1|||
144451192|NCT03299192|520848253|FG001|Overall Study|Fell before classes started|0|||
144451193|NCT03299192|520848254|FG002|Overall Study|Fell before classes started|0|||
144451194|NCT03299192|520848252|FG000|Overall Study|Other|0|||
144606776|NCT00955279|521421102|FG000|Overall Study|Lost to Follow-up|0|||
144451195|NCT03299192|520848253|FG001|Overall Study|Other|2|||
144451196|NCT03299192|520848254|FG002|Overall Study|Other|1|||
144451197|NCT00983580|520848256|FG000|Overall Study|Cancel Prior to treatment|1|||
144451198|NCT00983580|520848257|FG001|Overall Study|Cancel Prior to treatment|3|||
144451199|NCT00983580|520848256|FG000|Overall Study|Protocol Violation|1|||
144451200|NCT00983580|520848257|FG001|Overall Study|Protocol Violation|1|||
144451201|NCT00983580|520848256|FG000|Overall Study|Ineligible|3|||
144451202|NCT00983580|520848257|FG001|Overall Study|Ineligible|0|||
144451203|NCT00766415|520848258|FG000|Overall Study|Withdrawal by Subject|0|||
144451204|NCT00766415|520848259|FG001|Overall Study|Withdrawal by Subject|1|||
144451205|NCT00061048|520848260|FG000|Overall Study|Adverse Event|2|||
144451206|NCT00061048|520848260|FG000|Overall Study|disease progression|20|||
144451207|NCT01940705|520848261|FG000|Overall Study|Lost to Follow-up|1|||
144451208|NCT01940705|520848262|FG001|Overall Study|Lost to Follow-up|3|||
144451209|NCT01940705|520848263|FG002|Overall Study|Lost to Follow-up|2|||
144451210|NCT01940705|520848264|FG003|Overall Study|Lost to Follow-up|2|||
144451211|NCT01940705|520848261|FG000|Overall Study|Withdrawal by Subject|2|||
144451212|NCT01940705|520848262|FG001|Overall Study|Withdrawal by Subject|2|||
144451213|NCT01940705|520848263|FG002|Overall Study|Withdrawal by Subject|3|||
144451214|NCT01940705|520848264|FG003|Overall Study|Withdrawal by Subject|2|||
144451215|NCT01940705|520848261|FG000|Overall Study|Intervention not given|0|||
144451216|NCT01940705|520848262|FG001|Overall Study|Intervention not given|3|||
144451217|NCT01940705|520848263|FG002|Overall Study|Intervention not given|3|||
144451218|NCT01940705|520848264|FG003|Overall Study|Intervention not given|0|||
144451219|NCT01940705|520848261|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
144451220|NCT01940705|520848262|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
144451221|NCT01940705|520848263|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
144606777|NCT00955279|521421103|FG001|Overall Study|Lost to Follow-up|3|||
144606778|NCT00955279|521421104|FG002|Overall Study|Lost to Follow-up|1|||
144606779|NCT00955279|521421102|FG000|Overall Study|Withdrawal by Subject|2|||
144451222|NCT01940705|520848264|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
144451223|NCT00774995|520848268|FG000|Overall Study|Protocol Violation|0|||
144451224|NCT00774995|520848269|FG001|Overall Study|Protocol Violation|0|||
144451225|NCT00774995|520848270|FG002|Overall Study|Protocol Violation|1|||
144451226|NCT00774995|520848271|FG003|Overall Study|Protocol Violation|0|||
144451227|NCT03403634|520848276|FG000|Overall Study|Disease progression|3|||
144451228|NCT03403634|520848276|FG000|Overall Study|Did not meet eligibility criteria|4|||
144451229|NCT03964454|520848277|FG000|Overall Study|Lost to Follow-up|13|||
144451230|NCT03964454|520848278|FG001|Overall Study|Lost to Follow-up|7|||
144451231|NCT03964454|520848277|FG000|Overall Study|Withdrawal by Subject|4|||
144451232|NCT03964454|520848278|FG001|Overall Study|Withdrawal by Subject|11|||
144451233|NCT03422003|520850164|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
144451234|NCT03422003|520850165|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
144451235|NCT03422003|520850164|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
144451236|NCT03422003|520850165|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
144451237|NCT01404312|520850166|FG000|Overall Study|Death|21|||
144451238|NCT01404312|520850167|FG001|Overall Study|Death|27|||
144451239|NCT01404312|520850166|FG000|Overall Study|Withdrawal by Subject|15|||
144451240|NCT01404312|520850167|FG001|Overall Study|Withdrawal by Subject|18|||
144451241|NCT01404312|520850166|FG000|Overall Study|Participant Unable to get to clinic|93|||
144451242|NCT01404312|520850167|FG001|Overall Study|Participant Unable to get to clinic|103|||
144451243|NCT01404312|520850166|FG000|Overall Study|Lost to Follow-up|115|||
144451244|NCT01404312|520850167|FG001|Overall Study|Lost to Follow-up|111|||
144451245|NCT01404312|520850166|FG000|Overall Study|Site closed|22|||
144451246|NCT01404312|520850167|FG001|Overall Study|Site closed|21|||
144451247|NCT01404312|520850166|FG000|Overall Study|Participant not willing to adhere to req|31|||
144451248|NCT01404312|520850167|FG001|Overall Study|Participant not willing to adhere to req|29|||
144451249|NCT01404312|520850166|FG000|Overall Study|Severe debilitation, unable to continue|1|||
144451250|NCT01404312|520850167|FG001|Overall Study|Severe debilitation, unable to continue|2|||
144606780|NCT00955279|521421103|FG001|Overall Study|Withdrawal by Subject|0|||
144606781|NCT00955279|521421104|FG002|Overall Study|Withdrawal by Subject|3|||
144606782|NCT02003014|521421107|FG000|Overall Study|Case report forms uncollected|9|||
144606783|NCT02003014|521421107|FG000|Overall Study|Treatment started after contract period|1|||
144451251|NCT03794089|520850170|FG000|Overall Study|Lost to Follow-up|4|||
144451252|NCT03794089|520850171|FG001|Overall Study|Lost to Follow-up|1|||
144451253|NCT03794089|520850170|FG000|Overall Study|Withdrawal by Subject|2|||
144606784|NCT02003014|521421107|FG000|Overall Study|Patient did not visit the study site|5|||
144451254|NCT03794089|520850171|FG001|Overall Study|Withdrawal by Subject|0|||
144451255|NCT03985423|520850172|FG000|Overall Study|Adverse Event|1|||
144451256|NCT03985423|520850172|FG000|Overall Study|Death|2|||
144451257|NCT03985423|520850172|FG000|Overall Study|Physician Decision|1|||
144451258|NCT03985423|520850172|FG000|Overall Study|Withdrawal by Subject|2|||
144451259|NCT03985423|520850172|FG000|Overall Study|Lack of insurance and citizenship|1|||
144451260|NCT01045447|520850183|FG000|Overall Study|Adverse Event|0|||
144451261|NCT01045447|520850184|FG001|Overall Study|Adverse Event|1|||
144451262|NCT01045447|520850183|FG000|Overall Study|Lack of Efficacy|3|||
144451263|NCT01045447|520850184|FG001|Overall Study|Lack of Efficacy|1|||
144451264|NCT01045447|520850183|FG000|Overall Study|Protocol Violation|6|||
144451265|NCT01045447|520850184|FG001|Overall Study|Protocol Violation|3|||
144451266|NCT01045447|520850183|FG000|Overall Study|Withdrawal Criteria|10|||
144451267|NCT01045447|520850184|FG001|Overall Study|Withdrawal Criteria|10|||
144194867|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
144194868|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
144194869|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
144194870|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
144194871|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
144451268|NCT01045447|520850183|FG000|Overall Study|Unclassified|17|||
144451269|NCT01045447|520850184|FG001|Overall Study|Unclassified|13|||
144451270|NCT00129987|520850185|FG000|1st Educational Session|Withdrawal by Subject|141|||
144451271|NCT00129987|520850186|FG001|1st Educational Session|Withdrawal by Subject|109|||
144451272|NCT00129987|520850185|FG000|1 Year|Withdrawal by Subject|32|||
144451273|NCT00129987|520850186|FG001|1 Year|Withdrawal by Subject|21|||
144451274|NCT00116805|520850187|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
144451275|NCT00116805|520850188|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
144451276|NCT00116805|520850187|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
144451277|NCT00116805|520850188|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
144451278|NCT00116805|520850187|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
144451279|NCT00116805|520850188|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
144451280|NCT00116805|520850187|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
144451281|NCT00116805|520850188|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
144451282|NCT00116805|520850187|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
144451283|NCT00116805|520850188|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
144451284|NCT00116805|520850187|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
144451285|NCT00116805|520850188|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
144451286|NCT00116805|520850187|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
144451287|NCT00116805|520850188|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
144451288|NCT00116805|520850187|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
144451289|NCT00116805|520850188|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
144451290|NCT00116805|520850187|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
144451291|NCT00116805|520850188|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
144451292|NCT00116805|520850187|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
144451293|NCT00116805|520850188|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
144451294|NCT00116805|520850187|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
144451295|NCT00116805|520850188|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
144451296|NCT00116805|520850187|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
144451297|NCT00116805|520850188|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
144451298|NCT00116805|520850187|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
144451299|NCT00116805|520850188|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
144451300|NCT00116805|520850187|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
144451301|NCT00116805|520850188|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
144451302|NCT00116805|520850187|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
144451303|NCT00116805|520850188|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
144451304|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
144451305|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
144451306|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
144451307|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
144451308|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
144451309|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
144451310|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
144451311|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
144451312|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
144451313|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
144451314|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
144451315|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
144451316|NCT00116805|520850187|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
144451317|NCT00116805|520850188|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
144451318|NCT00116805|520850187|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
144194872|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
144194873|NCT01421342|519910327|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
144194874|NCT01421342|519910328|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
144194875|NCT01421342|519910329|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
144451319|NCT00116805|520850188|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
144533581|NCT05451693|521156704|FG000|Overall Study|Withdrawal by Subject|1|||
144533582|NCT05451693|521156705|FG001|Overall Study|Withdrawal by Subject|1|||
144533583|NCT05741294|521156706|FG000|Overall Study|Lost to Follow-up|3|||
144533584|NCT05741294|521156706|FG000|Overall Study|Protocol deviation|3|||
144533585|NCT05741294|521156706|FG000|Overall Study|Withdrawal by Subject|1|||
144533586|NCT04707768|521156719|FG000|Overall Study|Adverse Event|9|||
144533587|NCT04707768|521156720|FG001|Overall Study|Adverse Event|18|||
144533588|NCT04707768|521156721|FG002|Overall Study|Adverse Event|3|||
144533589|NCT04707768|521156719|FG000|Overall Study|Investigator's Discretion|8|||
144533590|NCT04707768|521156720|FG001|Overall Study|Investigator's Discretion|4|||
144533591|NCT04707768|521156721|FG002|Overall Study|Investigator's Discretion|3|||
144533592|NCT04707768|521156719|FG000|Overall Study|Withdrawal by Subject|6|||
144533593|NCT04707768|521156720|FG001|Overall Study|Withdrawal by Subject|8|||
144606785|NCT02003014|521421107|FG000|Overall Study|Investigator's transfer|4|||
144606786|NCT01660451|521421108|FG000|Overall Study|Protocol Violation|0|||
144606787|NCT01660451|521421109|FG001|Overall Study|Protocol Violation|1|||
144606788|NCT01660451|521421110|FG002|Overall Study|Protocol Violation|1|||
144606789|NCT01660451|521421108|FG000|Overall Study|AE not associated with clinical disease progression|13|||
144606790|NCT01660451|521421109|FG001|Overall Study|AE not associated with clinical disease progression|10|||
144606791|NCT01660451|521421110|FG002|Overall Study|AE not associated with clinical disease progression|40|||
144606792|NCT01660451|521421108|FG000|Overall Study|AE associated with clinical disease progression|1|||
144606793|NCT01660451|521421109|FG001|Overall Study|AE associated with clinical disease progression|3|||
144606794|NCT01660451|521421110|FG002|Overall Study|AE associated with clinical disease progression|11|||
144606795|NCT01660451|521421108|FG000|Overall Study|Sponsor Decision|0|||
144606796|NCT01660451|521421109|FG001|Overall Study|Sponsor Decision|0|||
144606797|NCT01660451|521421110|FG002|Overall Study|Sponsor Decision|1|||
144606798|NCT01660451|521421108|FG000|Overall Study|Protocol Deviation|0|||
144606799|NCT01660451|521421109|FG001|Overall Study|Protocol Deviation|0|||
144606800|NCT01660451|521421110|FG002|Overall Study|Protocol Deviation|1|||
144606801|NCT01660451|521421108|FG000|Overall Study|Physician Decision|1|||
144606802|NCT01660451|521421109|FG001|Overall Study|Physician Decision|2|||
144606803|NCT01660451|521421110|FG002|Overall Study|Physician Decision|5|||
144606804|NCT01660451|521421108|FG000|Overall Study|Withdrawal by Subject|1|||
144606805|NCT01660451|521421109|FG001|Overall Study|Withdrawal by Subject|1|||
144606806|NCT01660451|521421110|FG002|Overall Study|Withdrawal by Subject|20|||
144606807|NCT01660451|521421108|FG000|Overall Study|Trial closure.|0|||
144606808|NCT01660451|521421109|FG001|Overall Study|Trial closure.|0|||
144194876|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
144194877|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
144194878|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
144194879|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
144194880|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
144194881|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
144194882|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
144194883|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
144533594|NCT04707768|521156721|FG002|Overall Study|Withdrawal by Subject|2|||
144533595|NCT04707768|521156719|FG000|Overall Study|Lack of Efficacy|1|||
144533596|NCT04707768|521156720|FG001|Overall Study|Lack of Efficacy|3|||
144533597|NCT04707768|521156721|FG002|Overall Study|Lack of Efficacy|0|||
144533598|NCT04707768|521156719|FG000|Overall Study|Lost to Follow-up|0|||
144533599|NCT04707768|521156720|FG001|Overall Study|Lost to Follow-up|0|||
144533600|NCT04707768|521156721|FG002|Overall Study|Lost to Follow-up|3|||
144533601|NCT04707768|521156719|FG000|Overall Study|Death|13|||
144533602|NCT04707768|521156720|FG001|Overall Study|Death|11|||
144533603|NCT04707768|521156721|FG002|Overall Study|Death|13|||
144533604|NCT04707768|521156719|FG000|Overall Study|Protocol Violation|2|||
144533605|NCT04707768|521156720|FG001|Overall Study|Protocol Violation|1|||
144533606|NCT04707768|521156721|FG002|Overall Study|Protocol Violation|0|||
144533607|NCT04707768|521156719|FG000|Overall Study|Non Compliance with Study Drug|1|||
144533608|NCT04707768|521156720|FG001|Overall Study|Non Compliance with Study Drug|0|||
144533609|NCT04707768|521156721|FG002|Overall Study|Non Compliance with Study Drug|0|||
144533610|NCT04707768|521156719|FG000|Overall Study|Transplant|4|||
144533611|NCT04707768|521156720|FG001|Overall Study|Transplant|4|||
144533612|NCT04707768|521156721|FG002|Overall Study|Transplant|8|||
144533613|NCT04707768|521156719|FG000|Overall Study|Other|9|||
144533614|NCT04707768|521156720|FG001|Overall Study|Other|5|||
144533615|NCT04707768|521156721|FG002|Overall Study|Other|2|||
144533616|NCT04163991|521156722|FG000|Overall Study|Adverse Event|0|||
144533617|NCT04163991|521156723|FG001|Overall Study|Adverse Event|0|||
144533618|NCT04163991|521156724|FG002|Overall Study|Adverse Event|0|||
144533619|NCT04163991|521156725|FG003|Overall Study|Adverse Event|1|||
144533620|NCT04163991|521156726|FG004|Overall Study|Adverse Event|0|||
144533621|NCT04163991|521156722|FG000|Overall Study|Death|0|||
144533622|NCT04163991|521156723|FG001|Overall Study|Death|0|||
144606809|NCT01660451|521421110|FG002|Overall Study|Trial closure.|1|||
144194884|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
144194885|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
144194886|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
144194887|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
144194888|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
144194889|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
144194890|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
144194891|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
144451320|NCT00116805|520850187|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
144451321|NCT00116805|520850188|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
144451322|NCT00116805|520850187|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
144451323|NCT00116805|520850188|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
144451324|NCT00116805|520850187|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
144451325|NCT00116805|520850188|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
144451326|NCT00116805|520850187|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
144451327|NCT00116805|520850188|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
144451328|NCT00116805|520850187|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
144451329|NCT00116805|520850188|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
144451330|NCT00116805|520850187|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
144451331|NCT00116805|520850188|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
144451332|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
144451333|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
144451334|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
144451335|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
144451336|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
144451337|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
144451338|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
144451339|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
144451340|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
144451341|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
144451342|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
144194892|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
144194893|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
144194894|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
144194895|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
144194896|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
144194897|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
144194898|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
144194899|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
144194900|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
144194901|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
144194902|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
144194903|NCT01421342|519910327|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
144194904|NCT01421342|519910328|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
144194905|NCT01421342|519910329|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
144194906|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
144194907|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
144194908|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
144194909|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
144194910|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
144194911|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
144194912|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
144194913|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
144451343|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
144451344|NCT00116805|520850187|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
144451345|NCT00116805|520850188|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
144451346|NCT00116805|520850187|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
144451347|NCT00116805|520850188|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
144451348|NCT00116805|520850187|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
144451349|NCT00116805|520850188|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
144451350|NCT00116805|520850187|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
144451351|NCT00116805|520850188|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
144451352|NCT00116805|520850187|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
144533623|NCT04163991|521156724|FG002|Overall Study|Death|1|||
144533624|NCT04163991|521156725|FG003|Overall Study|Death|0|||
144451353|NCT00116805|520850188|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
144451354|NCT00116805|520850187|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
144194914|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
144194915|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
144194916|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
144194917|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
144194918|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
144194919|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
144194920|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
144194921|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
144194922|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
144194923|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
144194924|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
144194925|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
144194926|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
144194927|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
144194928|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
144194929|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
144194930|NCT01421342|519910327|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
144194931|NCT01421342|519910328|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
144194932|NCT01421342|519910329|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
144194933|NCT03463993|519910332|FG000|Overall Study|Lost to Follow-up|7|||
144194934|NCT03463993|519910333|FG001|Overall Study|Lost to Follow-up|8|||
144194935|NCT03463993|519910332|FG000|Overall Study|Withdrawal by Subject|2|||
144194936|NCT03463993|519910333|FG001|Overall Study|Withdrawal by Subject|0|||
144194937|NCT03463993|519910332|FG000|Overall Study|Protocol Violation|4|||
144194938|NCT03463993|519910333|FG001|Overall Study|Protocol Violation|1|||
144194939|NCT03463993|519910332|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
144194940|NCT03463993|519910333|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
144194941|NCT03463993|519910332|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
144194942|NCT03463993|519910333|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
144194943|NCT04440449|519910334|FG000|Overall Study|Lost to Follow-up|2|||
144194944|NCT04440449|519910335|FG001|Overall Study|Lost to Follow-up|0|||
144194945|NCT01621191|519910340|FG000|Overall Study|Adverse Event|9|||
144194946|NCT01621191|519910340|FG000|Overall Study|Withdrawal by Subject|8|||
144194947|NCT01621191|519910340|FG000|Overall Study|Lack of Efficacy|6|||
144194948|NCT01621191|519910340|FG000|Overall Study|Lost to Follow-up|1|||
144194949|NCT01621191|519910340|FG000|Overall Study|Site Removed From Study|1|||
144194950|NCT05420012|519910343|FG000|Overall Study|Lost to Follow-up|0|||
144194951|NCT05420012|519910344|FG001|Overall Study|Lost to Follow-up|1|||
144194952|NCT03253744|519910346|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
144194953|NCT03253744|519910347|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
144194954|NCT03253744|519910348|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
144194955|NCT03253744|519910349|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
144194956|NCT01134627|519910352|FG000|Overall Study|Adverse Event|47|||
144194957|NCT01134627|519910353|FG001|Overall Study|Adverse Event|31|||
144194958|NCT01134627|519910352|FG000|Overall Study|Lost to Follow-up|1|||
144194959|NCT01134627|519910353|FG001|Overall Study|Lost to Follow-up|2|||
144194960|NCT01134627|519910352|FG000|Overall Study|Protocol Violation|3|||
144194961|NCT01134627|519910353|FG001|Overall Study|Protocol Violation|5|||
144194962|NCT01134627|519910352|FG000|Overall Study|Lack of Efficacy|2|||
144194963|NCT01134627|519910353|FG001|Overall Study|Lack of Efficacy|12|||
144194964|NCT01134627|519910352|FG000|Overall Study|Withdrawal by Subject|4|||
144194965|NCT01134627|519910353|FG001|Overall Study|Withdrawal by Subject|3|||
144194966|NCT01134627|519910352|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
144194967|NCT01134627|519910353|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
144194968|NCT01134627|519910352|FG000|Overall Study|Other|11|||
144194969|NCT01134627|519910353|FG001|Overall Study|Other|14|||
144194970|NCT00977431|519910354|FG000|Overall Study|Other than listed|1|||
144194971|NCT00977431|519910355|FG001|Overall Study|Other than listed|0|||
144194972|NCT00977431|519910356|FG002|Overall Study|Other than listed|0|||
144194973|NCT00977431|519910357|FG003|Overall Study|Other than listed|0|||
144194974|NCT00977431|519910358|FG004|Overall Study|Other than listed|2|||
144194975|NCT00977431|519910354|FG000|Overall Study|Protocol Violation|0|||
144451355|NCT00116805|520850188|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
144451356|NCT00116805|520850187|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
144451357|NCT00116805|520850188|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
144451358|NCT00116805|520850187|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
144451359|NCT00116805|520850188|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
144533625|NCT04163991|521156726|FG004|Overall Study|Death|0|||
144194976|NCT00977431|519910355|FG001|Overall Study|Protocol Violation|0|||
144451360|NCT00116805|520850187|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
144451361|NCT00116805|520850188|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
144451362|NCT00116805|520850187|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
144451363|NCT00116805|520850188|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
144451364|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
144451365|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
144451366|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
144194977|NCT00977431|519910356|FG002|Overall Study|Protocol Violation|1|||
144194978|NCT00977431|519910357|FG003|Overall Study|Protocol Violation|0|||
144194979|NCT00977431|519910358|FG004|Overall Study|Protocol Violation|0|||
144194980|NCT00977431|519910354|FG000|Overall Study|Adverse Event|3|||
144194981|NCT00977431|519910355|FG001|Overall Study|Adverse Event|0|||
144194982|NCT00977431|519910356|FG002|Overall Study|Adverse Event|4|||
144194983|NCT00977431|519910357|FG003|Overall Study|Adverse Event|0|||
144194984|NCT00977431|519910358|FG004|Overall Study|Adverse Event|6|||
144194985|NCT00977431|519910354|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
144194986|NCT00977431|519910355|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
144194987|NCT00977431|519910356|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
144194988|NCT00977431|519910357|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
144194989|NCT00977431|519910358|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
144194990|NCT00977431|519910354|FG000|Overall Study|Progressive disease|2|||
144194991|NCT00977431|519910355|FG001|Overall Study|Progressive disease|6|||
144194992|NCT00977431|519910356|FG002|Overall Study|Progressive disease|1|||
144194993|NCT00977431|519910357|FG003|Overall Study|Progressive disease|3|||
144194994|NCT00977431|519910358|FG004|Overall Study|Progressive disease|5|||
144194995|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
144194996|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
144194997|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
144194998|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
144194999|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
144195000|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
144195001|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
144195002|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
144195003|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
144195004|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
144195005|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Subject decision|1|||
144195006|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Subject decision|1|||
144195007|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
144195008|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
144195009|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
144195010|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
144195011|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
144195012|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
144195013|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
144195014|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
144195015|NCT00518882|519910364|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
144195016|NCT00518882|519910365|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
144195017|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
144195018|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
144195019|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
144195020|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
144195021|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
144195022|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
144195023|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
144195024|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
144451367|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
144451368|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Adverse Event|5|||
144451369|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Adverse Event|3|||
144451370|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Adverse Event|4|||
144451371|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Adverse Event|10|||
144451372|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
144451373|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
144451374|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
144451375|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
144451376|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
144195025|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
144195026|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
144195027|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
144451377|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
144195028|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
144195029|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
144254001|NCT00262002|520130124|FG003|Overall Study|Lost to Follow-up|2|||
144254002|NCT00262002|520130125|FG004|Overall Study|Lost to Follow-up|0|||
144254003|NCT00262002|520130126|FG005|Overall Study|Lost to Follow-up|1|||
144254004|NCT00262002|520130127|FG006|Overall Study|Lost to Follow-up|0|||
144254005|NCT00262002|520130121|FG000|Overall Study|Inapropriate enrollment|0|||
144254006|NCT00262002|520130122|FG001|Overall Study|Inapropriate enrollment|1|||
144254007|NCT00262002|520130123|FG002|Overall Study|Inapropriate enrollment|0|||
144254008|NCT00262002|520130124|FG003|Overall Study|Inapropriate enrollment|0|||
144254009|NCT00262002|520130125|FG004|Overall Study|Inapropriate enrollment|0|||
144254010|NCT00262002|520130126|FG005|Overall Study|Inapropriate enrollment|0|||
144254011|NCT00262002|520130127|FG006|Overall Study|Inapropriate enrollment|0|||
144254012|NCT00262002|520130121|FG000|Overall Study|Protocol Violation|3|||
144254013|NCT00262002|520130122|FG001|Overall Study|Protocol Violation|2|||
144254014|NCT00262002|520130123|FG002|Overall Study|Protocol Violation|0|||
144254015|NCT00262002|520130124|FG003|Overall Study|Protocol Violation|2|||
144254016|NCT00262002|520130125|FG004|Overall Study|Protocol Violation|5|||
144254017|NCT00262002|520130126|FG005|Overall Study|Protocol Violation|3|||
144254018|NCT00262002|520130127|FG006|Overall Study|Protocol Violation|2|||
144254019|NCT00262002|520130121|FG000|Overall Study|Unable to classify|0|||
144254020|NCT00262002|520130122|FG001|Overall Study|Unable to classify|0|||
144254021|NCT00262002|520130123|FG002|Overall Study|Unable to classify|0|||
144254022|NCT00262002|520130124|FG003|Overall Study|Unable to classify|0|||
144254023|NCT00262002|520130125|FG004|Overall Study|Unable to classify|0|||
144254024|NCT00262002|520130126|FG005|Overall Study|Unable to classify|0|||
144254025|NCT00262002|520130127|FG006|Overall Study|Unable to classify|2|||
144254026|NCT02452554|520130128|FG000|Overall Study|Death|2|||
144254027|NCT02452554|520130129|FG001|Overall Study|Death|1|||
144254028|NCT02452554|520130130|FG002|Overall Study|Death|0|||
144254029|NCT02452554|520130131|FG003|Overall Study|Death|0|||
144254030|NCT02452554|520130132|FG004|Overall Study|Death|0|||
144254031|NCT02452554|520130133|FG005|Overall Study|Death|0|||
144254032|NCT02452554|520130128|FG000|Overall Study|Lack of Efficacy|13|||
144254033|NCT02452554|520130129|FG001|Overall Study|Lack of Efficacy|14|||
144254034|NCT02452554|520130130|FG002|Overall Study|Lack of Efficacy|9|||
144254035|NCT02452554|520130131|FG003|Overall Study|Lack of Efficacy|1|||
144254036|NCT02452554|520130132|FG004|Overall Study|Lack of Efficacy|5|||
144254037|NCT02452554|520130133|FG005|Overall Study|Lack of Efficacy|8|||
144254038|NCT02452554|520130128|FG000|Overall Study|Physician Decision|0|||
144254039|NCT02452554|520130129|FG001|Overall Study|Physician Decision|1|||
144254040|NCT02452554|520130130|FG002|Overall Study|Physician Decision|0|||
144254041|NCT02452554|520130131|FG003|Overall Study|Physician Decision|0|||
144254042|NCT02452554|520130132|FG004|Overall Study|Physician Decision|0|||
144254043|NCT02452554|520130133|FG005|Overall Study|Physician Decision|0|||
144254044|NCT02452554|520130128|FG000|Overall Study|Withdrawal by Subject|1|||
144254045|NCT02452554|520130129|FG001|Overall Study|Withdrawal by Subject|0|||
144254046|NCT02452554|520130130|FG002|Overall Study|Withdrawal by Subject|2|||
144254047|NCT02452554|520130131|FG003|Overall Study|Withdrawal by Subject|0|||
144725537|NCT01957488|521851278|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
144725538|NCT01957488|521851279|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
144254048|NCT02452554|520130132|FG004|Overall Study|Withdrawal by Subject|0|||
144725539|NCT01957488|521851280|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
144254049|NCT02452554|520130133|FG005|Overall Study|Withdrawal by Subject|1|||
144254050|NCT02452554|520130128|FG000|Overall Study|Ineligible|0|||
144254051|NCT02452554|520130129|FG001|Overall Study|Ineligible|1|||
144254052|NCT02452554|520130130|FG002|Overall Study|Ineligible|0|||
144254053|NCT02452554|520130131|FG003|Overall Study|Ineligible|0|||
144254054|NCT02452554|520130132|FG004|Overall Study|Ineligible|0|||
144254055|NCT02452554|520130133|FG005|Overall Study|Ineligible|0|||
144254056|NCT02452554|520130128|FG000|Overall Study|Never Received Treatment|1|||
144254057|NCT02452554|520130129|FG001|Overall Study|Never Received Treatment|0|||
144254058|NCT02452554|520130130|FG002|Overall Study|Never Received Treatment|0|||
144254059|NCT02452554|520130131|FG003|Overall Study|Never Received Treatment|0|||
144254060|NCT02452554|520130132|FG004|Overall Study|Never Received Treatment|0|||
144254061|NCT02452554|520130133|FG005|Overall Study|Never Received Treatment|0|||
144254062|NCT01085084|520130134|FG000|Overall Study|Withdrawal by Subject|1|||
144254063|NCT01085084|520130135|FG001|Overall Study|Withdrawal by Subject|0|||
144254064|NCT01085084|520130136|FG002|Overall Study|Withdrawal by Subject|0|||
144254065|NCT01085084|520130134|FG000|Overall Study|Lost to Follow-up|2|||
144725540|NCT01957488|521851281|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
144725541|NCT01957488|521851282|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
144254066|NCT01085084|520130135|FG001|Overall Study|Lost to Follow-up|1|||
144254067|NCT01085084|520130136|FG002|Overall Study|Lost to Follow-up|1|||
144254068|NCT01085084|520130134|FG000|Overall Study|Adverse Event|4|||
144254069|NCT01085084|520130135|FG001|Overall Study|Adverse Event|3|||
144254070|NCT01085084|520130136|FG002|Overall Study|Adverse Event|6|||
144254071|NCT01085084|520130134|FG000|Overall Study|Treatment Failure|0|||
144254072|NCT01085084|520130135|FG001|Overall Study|Treatment Failure|1|||
144254073|NCT01085084|520130136|FG002|Overall Study|Treatment Failure|2|||
144254074|NCT02749799|520130137|FG000|Overall Study|Adverse Event|2|||
144254075|NCT02749799|520130137|FG000|Overall Study|Lost to Follow-up|4|||
144254076|NCT02749799|520130137|FG000|Overall Study|Protocol Violation|1|||
144254077|NCT02749799|520130137|FG000|Overall Study|Withdrawal by Subject|1|||
144254078|NCT02070978|520130138|FG000|Overall Study|Adverse Event|6|||
144254079|NCT02070978|520130139|FG001|Overall Study|Adverse Event|2|||
144254080|NCT02070978|520130140|FG002|Overall Study|Adverse Event|0|||
144254081|NCT02070978|520130138|FG000|Overall Study|Lost to Follow-up|1|||
144254082|NCT02070978|520130139|FG001|Overall Study|Lost to Follow-up|3|||
144254083|NCT02070978|520130140|FG002|Overall Study|Lost to Follow-up|4|||
144254084|NCT02070978|520130138|FG000|Overall Study|Withdrawal by Subject|3|||
144254085|NCT02070978|520130139|FG001|Overall Study|Withdrawal by Subject|5|||
144254086|NCT02070978|520130140|FG002|Overall Study|Withdrawal by Subject|3|||
144254087|NCT02070978|520130138|FG000|Overall Study|Protocol Violation|1|||
144254088|NCT02070978|520130139|FG001|Overall Study|Protocol Violation|0|||
144254089|NCT02070978|520130140|FG002|Overall Study|Protocol Violation|3|||
144195030|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
144195031|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
144195032|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
144195033|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
144195034|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
144195035|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
144195036|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
144195037|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
144195038|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
144195039|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
144195040|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
144195041|NCT00518882|519910364|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
144195042|NCT00518882|519910365|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
144254090|NCT02070978|520130138|FG000|Overall Study|Lack of Efficacy|0|||
144254091|NCT02070978|520130139|FG001|Overall Study|Lack of Efficacy|1|||
144254092|NCT02070978|520130140|FG002|Overall Study|Lack of Efficacy|0|||
144254093|NCT02070978|520130138|FG000|Overall Study|Death|0|||
144254094|NCT02070978|520130139|FG001|Overall Study|Death|0|||
144254095|NCT02070978|520130140|FG002|Overall Study|Death|2|||
144254096|NCT02070978|520130138|FG000|Overall Study|Un-specified|3|||
144254097|NCT02070978|520130139|FG001|Overall Study|Un-specified|2|||
144254098|NCT02070978|520130140|FG002|Overall Study|Un-specified|2|||
144254099|NCT02070978|520130138|FG000|Overall Study|Terminated by Sponsor|33|||
144254100|NCT02070978|520130139|FG001|Overall Study|Terminated by Sponsor|40|||
144254101|NCT02070978|520130140|FG002|Overall Study|Terminated by Sponsor|39|||
144254102|NCT03951753|520130141|FG000|Overall Study|Adverse Event|1|||
144254103|NCT03951753|520130142|FG001|Overall Study|Adverse Event|0|||
144254104|NCT03951753|520130143|FG002|Overall Study|Adverse Event|3|||
144254105|NCT03951753|520130141|FG000|Overall Study|Withdrawal by Subject|3|||
144254106|NCT03951753|520130142|FG001|Overall Study|Withdrawal by Subject|1|||
144254107|NCT03951753|520130143|FG002|Overall Study|Withdrawal by Subject|0|||
144254108|NCT03951753|520130141|FG000|Overall Study|Lost to Follow-up|0|||
144254109|NCT03951753|520130142|FG001|Overall Study|Lost to Follow-up|0|||
144254110|NCT03951753|520130143|FG002|Overall Study|Lost to Follow-up|1|||
144254111|NCT02669043|520130148|FG000|Overall Study|Didn't meet I/E criteria|4|||
144254112|NCT00467558|520130151|FG000|Overall Study|Lost to Follow-up|2|||
144254113|NCT00467558|520130152|FG001|Overall Study|Lost to Follow-up|0|||
144254114|NCT02636439|520130154|FG000|Overall Study|Adverse Event|2|||
144254115|NCT02636439|520130155|FG001|Overall Study|Adverse Event|2|||
144254116|NCT02636439|520130154|FG000|Overall Study|Lost to Follow-up|1|||
144254117|NCT02636439|520130155|FG001|Overall Study|Lost to Follow-up|0|||
144254118|NCT02636439|520130154|FG000|Overall Study|Non-compliance|1|||
144254119|NCT02636439|520130155|FG001|Overall Study|Non-compliance|1|||
144254120|NCT02636439|520130154|FG000|Overall Study|Personal reasons|2|||
144254121|NCT02636439|520130155|FG001|Overall Study|Personal reasons|0|||
144254122|NCT00966355|520130158|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
144254123|NCT00966355|520130159|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
144254124|NCT00966355|520130160|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
144254125|NCT00966355|520130158|FG000|Overall Study|newly diagnosed advanced HCC|11|||
144254126|NCT00966355|520130159|FG001|Overall Study|newly diagnosed advanced HCC|12|||
144254127|NCT00966355|520130160|FG002|Overall Study|newly diagnosed advanced HCC|10|||
144254128|NCT00966355|520130158|FG000|Overall Study|Lost to Follow-up|5|||
144254129|NCT00966355|520130159|FG001|Overall Study|Lost to Follow-up|4|||
144254130|NCT00966355|520130160|FG002|Overall Study|Lost to Follow-up|3|||
144254131|NCT02552888|520130161|FG000|Overall Study|Lost to Follow-up|1|||
144254132|NCT02552888|520130162|FG001|Overall Study|Lost to Follow-up|1|||
144254133|NCT02155309|520131676|FG000|Overall Study|Protocol Violation|0|||
144254134|NCT02155309|520131677|FG001|Overall Study|Protocol Violation|0|||
144254135|NCT02155309|520131678|FG002|Overall Study|Protocol Violation|1|||
144254136|NCT04304508|520131681|FG000|Overall Study|Subject Decision|29|||
144254137|NCT04304508|520131682|FG001|Overall Study|Subject Decision|39|||
144254138|NCT04304508|520131683|FG002|Overall Study|Subject Decision|37|||
144451378|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
144451379|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
144451380|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Pregnancy|5|||
144451381|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Pregnancy|0|||
144451382|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Pregnancy|3|||
144451383|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Pregnancy|2|||
144451384|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Non-compliance|1|||
144451385|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Non-compliance|4|||
144451386|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Non-compliance|0|||
144451387|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Non-compliance|3|||
144451388|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Other|0|||
144725542|NCT01957488|521851283|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
144725543|NCT01957488|521851278|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
144195043|NCT02696031|519910366|FG000|Up to Week 24|Adverse Event|2|||
144195044|NCT02696031|519910367|FG001|Up to Week 24|Adverse Event|4|||
144195045|NCT02696031|519910368|FG002|Up to Week 24|Adverse Event|2|||
144195046|NCT02696031|519910369|FG003|Up to Week 24|Adverse Event|0|||
144195047|NCT02696031|519910370|FG004|Up to Week 24|Adverse Event|0|||
144195048|NCT02696031|519910371|FG005|Up to Week 24|Adverse Event|0|||
144195049|NCT02696031|519910366|FG000|Up to Week 24|Lack of Efficacy|2|||
144195050|NCT02696031|519910367|FG001|Up to Week 24|Lack of Efficacy|1|||
144195051|NCT02696031|519910368|FG002|Up to Week 24|Lack of Efficacy|2|||
144195052|NCT02696031|519910369|FG003|Up to Week 24|Lack of Efficacy|0|||
144195053|NCT02696031|519910370|FG004|Up to Week 24|Lack of Efficacy|0|||
144195054|NCT02696031|519910371|FG005|Up to Week 24|Lack of Efficacy|0|||
144195055|NCT02696031|519910366|FG000|Up to Week 24|Lost to Follow-up|0|||
144195056|NCT02696031|519910367|FG001|Up to Week 24|Lost to Follow-up|1|||
144195057|NCT02696031|519910368|FG002|Up to Week 24|Lost to Follow-up|1|||
144195058|NCT02696031|519910369|FG003|Up to Week 24|Lost to Follow-up|0|||
144195059|NCT02696031|519910370|FG004|Up to Week 24|Lost to Follow-up|0|||
144195060|NCT02696031|519910371|FG005|Up to Week 24|Lost to Follow-up|0|||
144195061|NCT02696031|519910366|FG000|Up to Week 24|Physician Decision|1|||
144195062|NCT02696031|519910367|FG001|Up to Week 24|Physician Decision|0|||
144195063|NCT02696031|519910368|FG002|Up to Week 24|Physician Decision|1|||
144195064|NCT02696031|519910369|FG003|Up to Week 24|Physician Decision|0|||
144195065|NCT02696031|519910370|FG004|Up to Week 24|Physician Decision|0|||
144195066|NCT02696031|519910371|FG005|Up to Week 24|Physician Decision|0|||
144195067|NCT02696031|519910366|FG000|Up to Week 24|Protocol Violation|1|||
144195068|NCT02696031|519910367|FG001|Up to Week 24|Protocol Violation|0|||
144195069|NCT02696031|519910368|FG002|Up to Week 24|Protocol Violation|0|||
144195070|NCT02696031|519910369|FG003|Up to Week 24|Protocol Violation|0|||
144195071|NCT02696031|519910370|FG004|Up to Week 24|Protocol Violation|0|||
144195072|NCT02696031|519910371|FG005|Up to Week 24|Protocol Violation|0|||
144195073|NCT02696031|519910366|FG000|Up to Week 24|Withdrawal by Subject|4|||
144195074|NCT02696031|519910367|FG001|Up to Week 24|Withdrawal by Subject|1|||
144195075|NCT02696031|519910368|FG002|Up to Week 24|Withdrawal by Subject|5|||
144195076|NCT02696031|519910369|FG003|Up to Week 24|Withdrawal by Subject|0|||
144195077|NCT02696031|519910370|FG004|Up to Week 24|Withdrawal by Subject|0|||
144195078|NCT02696031|519910371|FG005|Up to Week 24|Withdrawal by Subject|0|||
144195079|NCT02696031|519910366|FG000|Up to Week 52|Adverse Event|4|||
144195080|NCT02696031|519910367|FG001|Up to Week 52|Adverse Event|5|||
144195081|NCT02696031|519910368|FG002|Up to Week 52|Adverse Event|3|||
144195082|NCT02696031|519910369|FG003|Up to Week 52|Adverse Event|0|||
144195083|NCT02696031|519910370|FG004|Up to Week 52|Adverse Event|0|||
144195084|NCT02696031|519910371|FG005|Up to Week 52|Adverse Event|0|||
144195085|NCT02696031|519910366|FG000|Up to Week 52|Lack of Efficacy|10|||
144195086|NCT02696031|519910367|FG001|Up to Week 52|Lack of Efficacy|7|||
144195087|NCT02696031|519910368|FG002|Up to Week 52|Lack of Efficacy|11|||
144195088|NCT02696031|519910369|FG003|Up to Week 52|Lack of Efficacy|0|||
144195089|NCT02696031|519910370|FG004|Up to Week 52|Lack of Efficacy|0|||
144195090|NCT02696031|519910371|FG005|Up to Week 52|Lack of Efficacy|0|||
144195091|NCT02696031|519910366|FG000|Up to Week 52|Lost to Follow-up|1|||
144195092|NCT02696031|519910367|FG001|Up to Week 52|Lost to Follow-up|1|||
144195093|NCT02696031|519910368|FG002|Up to Week 52|Lost to Follow-up|1|||
144195094|NCT02696031|519910369|FG003|Up to Week 52|Lost to Follow-up|0|||
144195095|NCT02696031|519910370|FG004|Up to Week 52|Lost to Follow-up|0|||
144195096|NCT02696031|519910371|FG005|Up to Week 52|Lost to Follow-up|0|||
144195097|NCT02696031|519910366|FG000|Up to Week 52|Physician Decision|1|||
144195098|NCT02696031|519910367|FG001|Up to Week 52|Physician Decision|1|||
144195099|NCT02696031|519910368|FG002|Up to Week 52|Physician Decision|2|||
144195100|NCT02696031|519910369|FG003|Up to Week 52|Physician Decision|0|||
144195101|NCT02696031|519910370|FG004|Up to Week 52|Physician Decision|0|||
144451389|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Other|3|||
144451390|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Other|3|||
144725544|NCT01957488|521851279|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
144195102|NCT02696031|519910371|FG005|Up to Week 52|Physician Decision|0|||
144195103|NCT02696031|519910366|FG000|Up to Week 52|Pregnancy|0|||
144195104|NCT02696031|519910367|FG001|Up to Week 52|Pregnancy|2|||
144195105|NCT02696031|519910368|FG002|Up to Week 52|Pregnancy|0|||
144606810|NCT01660451|521421108|FG000|Overall Study|Switching to other therapy|0|||
144195106|NCT02696031|519910369|FG003|Up to Week 52|Pregnancy|0|||
144195107|NCT02696031|519910370|FG004|Up to Week 52|Pregnancy|0|||
144195108|NCT02696031|519910371|FG005|Up to Week 52|Pregnancy|0|||
144195109|NCT02696031|519910366|FG000|Up to Week 52|Protocol Violation|1|||
144195110|NCT02696031|519910367|FG001|Up to Week 52|Protocol Violation|0|||
144195111|NCT02696031|519910368|FG002|Up to Week 52|Protocol Violation|0|||
144195112|NCT02696031|519910369|FG003|Up to Week 52|Protocol Violation|0|||
144195113|NCT02696031|519910370|FG004|Up to Week 52|Protocol Violation|0|||
144195114|NCT02696031|519910371|FG005|Up to Week 52|Protocol Violation|0|||
144195115|NCT02696031|519910366|FG000|Up to Week 52|Withdrawal by Subject|12|||
144195116|NCT02696031|519910367|FG001|Up to Week 52|Withdrawal by Subject|3|||
144195117|NCT02696031|519910368|FG002|Up to Week 52|Withdrawal by Subject|9|||
144195118|NCT02696031|519910369|FG003|Up to Week 52|Withdrawal by Subject|0|||
144195119|NCT02696031|519910370|FG004|Up to Week 52|Withdrawal by Subject|0|||
144195120|NCT02696031|519910371|FG005|Up to Week 52|Withdrawal by Subject|0|||
144451391|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Other|1|||
144451392|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
144451393|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
144451394|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
144451395|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
144451396|NCT01760954|520850189|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
144451397|NCT01760954|520850190|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
144451398|NCT01760954|520850191|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
144451399|NCT01760954|520850192|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
144451400|NCT01760954|520850189|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
144451401|NCT01760954|520850190|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
144451402|NCT01760954|520850191|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
144451403|NCT01760954|520850192|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
144451404|NCT01760954|520850189|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
144451405|NCT01760954|520850190|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
144451406|NCT01760954|520850191|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
144451407|NCT01760954|520850192|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
144451408|NCT01760954|520850189|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
144451409|NCT01760954|520850190|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
144451410|NCT01760954|520850191|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
144451411|NCT01760954|520850192|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
144451412|NCT01760954|520850189|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
144451413|NCT01760954|520850190|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
144451414|NCT01760954|520850191|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
144451415|NCT01760954|520850192|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
144451416|NCT01760954|520850189|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
144451417|NCT01760954|520850190|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
144451418|NCT01760954|520850191|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
144451419|NCT01760954|520850192|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
144451420|NCT01760954|520850189|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
144451421|NCT01760954|520850190|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
144451422|NCT01760954|520850191|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
144451423|NCT01760954|520850192|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
144451424|NCT01159938|520850193|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
144451425|NCT01159938|520850194|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
144451426|NCT01159938|520850195|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
144451427|NCT01159938|520850196|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
144451428|NCT01159938|520850197|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
144451429|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Adverse Event|5|||
144451430|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Adverse Event|8|||
144451431|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Adverse Event|4|||
144451432|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Adverse Event|8|||
144451433|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
144451434|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
144451435|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
144451436|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
144451437|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
144451438|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
144195121|NCT02696031|519910366|FG000|Up to Week 104|Pregnancy|0|||
144195122|NCT02696031|519910367|FG001|Up to Week 104|Pregnancy|2|||
144195123|NCT02696031|519910368|FG002|Up to Week 104|Pregnancy|1|||
144195124|NCT02696031|519910369|FG003|Up to Week 104|Pregnancy|0|||
144195125|NCT02696031|519910370|FG004|Up to Week 104|Pregnancy|0|||
144195126|NCT02696031|519910371|FG005|Up to Week 104|Pregnancy|0|||
144195127|NCT02696031|519910366|FG000|Up to Week 104|Withdrawal by Subject|15|||
144195128|NCT02696031|519910367|FG001|Up to Week 104|Withdrawal by Subject|10|||
144195129|NCT02696031|519910368|FG002|Up to Week 104|Withdrawal by Subject|16|||
144195130|NCT02696031|519910369|FG003|Up to Week 104|Withdrawal by Subject|0|||
144195131|NCT02696031|519910370|FG004|Up to Week 104|Withdrawal by Subject|0|||
144195132|NCT02696031|519910371|FG005|Up to Week 104|Withdrawal by Subject|0|||
144195133|NCT02696031|519910366|FG000|Up to Week 104|Protocol Violation|1|||
144195134|NCT02696031|519910367|FG001|Up to Week 104|Protocol Violation|0|||
144195135|NCT02696031|519910368|FG002|Up to Week 104|Protocol Violation|0|||
144195136|NCT02696031|519910369|FG003|Up to Week 104|Protocol Violation|0|||
144195137|NCT02696031|519910370|FG004|Up to Week 104|Protocol Violation|0|||
144195138|NCT02696031|519910371|FG005|Up to Week 104|Protocol Violation|0|||
144195139|NCT02696031|519910366|FG000|Up to Week 104|Physician Decision|1|||
144195140|NCT02696031|519910367|FG001|Up to Week 104|Physician Decision|2|||
144195141|NCT02696031|519910368|FG002|Up to Week 104|Physician Decision|3|||
144195142|NCT02696031|519910369|FG003|Up to Week 104|Physician Decision|0|||
144195143|NCT02696031|519910370|FG004|Up to Week 104|Physician Decision|0|||
144195144|NCT02696031|519910371|FG005|Up to Week 104|Physician Decision|0|||
144195145|NCT02696031|519910366|FG000|Up to Week 104|Lost to Follow-up|2|||
144195146|NCT02696031|519910367|FG001|Up to Week 104|Lost to Follow-up|3|||
144195147|NCT02696031|519910368|FG002|Up to Week 104|Lost to Follow-up|1|||
144195148|NCT02696031|519910369|FG003|Up to Week 104|Lost to Follow-up|0|||
144195149|NCT02696031|519910370|FG004|Up to Week 104|Lost to Follow-up|0|||
144195150|NCT02696031|519910371|FG005|Up to Week 104|Lost to Follow-up|0|||
144195151|NCT02696031|519910366|FG000|Up to Week 104|Lack of Efficacy|13|||
144195152|NCT02696031|519910367|FG001|Up to Week 104|Lack of Efficacy|12|||
144195153|NCT02696031|519910368|FG002|Up to Week 104|Lack of Efficacy|11|||
144195154|NCT02696031|519910369|FG003|Up to Week 104|Lack of Efficacy|0|||
144195155|NCT02696031|519910370|FG004|Up to Week 104|Lack of Efficacy|0|||
144195156|NCT02696031|519910371|FG005|Up to Week 104|Lack of Efficacy|0|||
144195157|NCT02696031|519910366|FG000|Up to Week 104|Adverse Event|7|||
144195158|NCT02696031|519910367|FG001|Up to Week 104|Adverse Event|11|||
144195159|NCT02696031|519910368|FG002|Up to Week 104|Adverse Event|5|||
144254139|NCT04304508|520131684|FG003|Overall Study|Subject Decision|48|||
144254140|NCT04304508|520131681|FG000|Overall Study|Death|6|||
144254141|NCT04304508|520131682|FG001|Overall Study|Death|1|||
144254142|NCT04304508|520131683|FG002|Overall Study|Death|8|||
144254143|NCT04304508|520131684|FG003|Overall Study|Death|5|||
144254144|NCT04304508|520131681|FG000|Overall Study|Non-compliance With Study Drug|3|||
144254145|NCT04304508|520131682|FG001|Overall Study|Non-compliance With Study Drug|1|||
144254146|NCT04304508|520131683|FG002|Overall Study|Non-compliance With Study Drug|2|||
144254147|NCT04304508|520131684|FG003|Overall Study|Non-compliance With Study Drug|0|||
144254148|NCT04304508|520131681|FG000|Overall Study|Switching To Other Therapy|1|||
144254149|NCT04304508|520131682|FG001|Overall Study|Switching To Other Therapy|1|||
144254150|NCT04304508|520131683|FG002|Overall Study|Switching To Other Therapy|1|||
144254151|NCT04304508|520131684|FG003|Overall Study|Switching To Other Therapy|2|||
144254152|NCT04304508|520131681|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
144254153|NCT04304508|520131682|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
144254154|NCT04304508|520131683|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
144254155|NCT04304508|520131684|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
144254156|NCT04304508|520131681|FG000|Overall Study|Withdrawal by Subject|7|||
144254157|NCT04304508|520131682|FG001|Overall Study|Withdrawal by Subject|5|||
144254158|NCT04304508|520131683|FG002|Overall Study|Withdrawal by Subject|11|||
144254159|NCT04304508|520131684|FG003|Overall Study|Withdrawal by Subject|6|||
144254160|NCT04304508|520131681|FG000|Overall Study|Logistical Difficulties|2|||
144254161|NCT04304508|520131682|FG001|Overall Study|Logistical Difficulties|2|||
144254162|NCT04304508|520131683|FG002|Overall Study|Logistical Difficulties|3|||
144254163|NCT04304508|520131684|FG003|Overall Study|Logistical Difficulties|2|||
144254164|NCT04304508|520131681|FG000|Overall Study|Missing Information|1|||
144254165|NCT04304508|520131682|FG001|Overall Study|Missing Information|2|||
144606811|NCT01660451|521421109|FG001|Overall Study|Switching to other therapy|1|||
144606812|NCT01660451|521421110|FG002|Overall Study|Switching to other therapy|1|||
144195160|NCT02696031|519910369|FG003|Up to Week 104|Adverse Event|0|||
144195161|NCT02696031|519910370|FG004|Up to Week 104|Adverse Event|0|||
144195162|NCT02696031|519910371|FG005|Up to Week 104|Adverse Event|0|||
144195163|NCT02696031|519910366|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
144195164|NCT02696031|519910367|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
144195165|NCT02696031|519910368|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
144195166|NCT02696031|519910369|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
144195167|NCT02696031|519910370|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
144195168|NCT02696031|519910371|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
144254166|NCT04304508|520131683|FG002|Overall Study|Missing Information|1|||
144254167|NCT04304508|520131684|FG003|Overall Study|Missing Information|3|||
144606813|NCT01660451|521421108|FG000|Overall Study|Progressive disease - clinical progression|4|||
144195169|NCT02696031|519910366|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
144195170|NCT02696031|519910367|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
144195171|NCT02696031|519910368|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
144195172|NCT02696031|519910369|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
144195173|NCT02696031|519910370|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
144195174|NCT02696031|519910371|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
144195175|NCT02696031|519910366|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
144195176|NCT02696031|519910367|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
144195177|NCT02696031|519910368|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
144195178|NCT02696031|519910369|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
144195179|NCT02696031|519910370|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
144195180|NCT02696031|519910371|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
144195181|NCT02696031|519910366|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
144195182|NCT02696031|519910367|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
144195183|NCT02696031|519910368|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
144195184|NCT02696031|519910369|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
144195185|NCT02696031|519910370|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
144195186|NCT02696031|519910371|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
144195187|NCT02696031|519910366|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
144195188|NCT02696031|519910367|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
144195189|NCT02696031|519910368|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
144195190|NCT02696031|519910369|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
144195191|NCT02696031|519910370|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
144195192|NCT02696031|519910371|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
144195193|NCT02696031|519910366|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
144195194|NCT02696031|519910367|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
144195195|NCT02696031|519910368|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
144195196|NCT02696031|519910369|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
144195197|NCT02696031|519910370|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
144195198|NCT02696031|519910371|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
144195199|NCT02696031|519910366|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
144195200|NCT02696031|519910367|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
144195201|NCT02696031|519910368|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
144195202|NCT02696031|519910369|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
144195203|NCT02696031|519910370|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
144195204|NCT02696031|519910371|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
144195205|NCT02777918|519910372|FG000|Overall Study|Medical reasons|1|||
144195206|NCT02777918|519910373|FG001|Overall Study|Medical reasons|2|||
144195207|NCT02777918|519910372|FG000|Overall Study|Too busy / stressed|1|||
144451439|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
144451440|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
144451441|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Physician Decision|1|||
144451442|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Physician Decision|0|||
144451443|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Physician Decision|0|||
144451444|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Physician Decision|0|||
144451445|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
144451446|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
144451447|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
144451448|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
144451449|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Pregnancy|0|||
144451450|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Pregnancy|1|||
144451451|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Pregnancy|0|||
144451452|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Pregnancy|0|||
144451453|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
144451454|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
144451455|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
144451456|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
144451457|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Death|0|||
144451458|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Death|1|||
144451459|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Death|0|||
144451460|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Death|0|||
144451461|NCT00071487|520850202|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
144451462|NCT00071487|520850203|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
144451463|NCT00071487|520850204|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
144451464|NCT00071487|520850205|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
144195208|NCT02777918|519910373|FG001|Overall Study|Too busy / stressed|1|||
144451465|NCT00071487|520850202|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
144451466|NCT00071487|520850203|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
144254168|NCT04304508|520131681|FG000|Overall Study|Other|7|||
144254169|NCT04304508|520131682|FG001|Overall Study|Other|6|||
144254170|NCT04304508|520131683|FG002|Overall Study|Other|5|||
144254171|NCT04304508|520131684|FG003|Overall Study|Other|4|||
144254172|NCT04304508|520131681|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
144254173|NCT04304508|520131682|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
144254174|NCT04304508|520131683|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
144254175|NCT04304508|520131684|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
144254176|NCT04304508|520131681|FG000|Overall Study|Physician Decision|3|||
144254177|NCT04304508|520131682|FG001|Overall Study|Physician Decision|4|||
144254178|NCT04304508|520131683|FG002|Overall Study|Physician Decision|9|||
144254179|NCT04304508|520131684|FG003|Overall Study|Physician Decision|7|||
144451467|NCT00071487|520850204|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
144451468|NCT00071487|520850205|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
144451469|NCT00071487|520850202|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
144451470|NCT00071487|520850203|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
144451471|NCT00071487|520850204|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
144451472|NCT00071487|520850205|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
144451473|NCT00071487|520850202|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144451474|NCT00071487|520850203|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144451475|NCT00071487|520850204|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
144451476|NCT00071487|520850205|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
144451477|NCT00071487|520850202|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
144451478|NCT00071487|520850203|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
144451479|NCT00071487|520850204|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
144451480|NCT00071487|520850205|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
144451481|NCT00071487|520850202|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
144451482|NCT00071487|520850203|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
144451483|NCT00071487|520850204|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
144451484|NCT00071487|520850205|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
144451485|NCT00071487|520850202|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
144451486|NCT00071487|520850203|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
144451487|NCT00071487|520850204|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
144451488|NCT00071487|520850205|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
144451489|NCT02318329|520850208|FG000|Overall Study|Progressive Disease|2|||
144451490|NCT02318329|520850209|FG001|Overall Study|Progressive Disease|3|||
144451491|NCT02318329|520850210|FG002|Overall Study|Progressive Disease|2|||
144451492|NCT02318329|520850211|FG003|Overall Study|Progressive Disease|3|||
144451493|NCT02318329|520850212|FG004|Overall Study|Progressive Disease|3|||
144451494|NCT02318329|520850213|FG005|Overall Study|Progressive Disease|3|||
144451495|NCT02318329|520850214|FG006|Overall Study|Progressive Disease|1|||
144451496|NCT02318329|520850215|FG007|Overall Study|Progressive Disease|1|||
144451497|NCT02318329|520850216|FG008|Overall Study|Progressive Disease|5|||
144451498|NCT02318329|520850217|FG009|Overall Study|Progressive Disease|39|||
144451499|NCT02318329|520850208|FG000|Overall Study|Death|0|||
144451500|NCT02318329|520850209|FG001|Overall Study|Death|0|||
144451501|NCT02318329|520850210|FG002|Overall Study|Death|0|||
144451502|NCT02318329|520850211|FG003|Overall Study|Death|0|||
144451503|NCT02318329|520850212|FG004|Overall Study|Death|0|||
144451504|NCT02318329|520850213|FG005|Overall Study|Death|0|||
144451505|NCT02318329|520850214|FG006|Overall Study|Death|0|||
144451506|NCT02318329|520850215|FG007|Overall Study|Death|0|||
144451507|NCT02318329|520850216|FG008|Overall Study|Death|0|||
144451508|NCT02318329|520850217|FG009|Overall Study|Death|5|||
144451509|NCT02318329|520850208|FG000|Overall Study|Lost to Follow-up|0|||
144451510|NCT02318329|520850209|FG001|Overall Study|Lost to Follow-up|0|||
144451511|NCT02318329|520850210|FG002|Overall Study|Lost to Follow-up|0|||
144451512|NCT02318329|520850211|FG003|Overall Study|Lost to Follow-up|0|||
144451513|NCT02318329|520850212|FG004|Overall Study|Lost to Follow-up|0|||
144451514|NCT02318329|520850213|FG005|Overall Study|Lost to Follow-up|0|||
144451515|NCT02318329|520850214|FG006|Overall Study|Lost to Follow-up|0|||
144451516|NCT02318329|520850215|FG007|Overall Study|Lost to Follow-up|0|||
144451517|NCT02318329|520850216|FG008|Overall Study|Lost to Follow-up|0|||
144451518|NCT02318329|520850217|FG009|Overall Study|Lost to Follow-up|1|||
144606814|NCT01660451|521421109|FG001|Overall Study|Progressive disease - clinical progression|10|||
144451519|NCT02318329|520850208|FG000|Overall Study|Withdrawal by Subject|0|||
144451520|NCT02318329|520850209|FG001|Overall Study|Withdrawal by Subject|0|||
144451521|NCT02318329|520850210|FG002|Overall Study|Withdrawal by Subject|0|||
144606815|NCT01660451|521421110|FG002|Overall Study|Progressive disease - clinical progression|9|||
144606816|NCT01660451|521421108|FG000|Overall Study|Progressive disease - radiological progression|12|||
144254180|NCT04304508|520131681|FG000|Overall Study|Study drug never administered|10|||
144254181|NCT04304508|520131682|FG001|Overall Study|Study drug never administered|4|||
144451522|NCT02318329|520850211|FG003|Overall Study|Withdrawal by Subject|0|||
144451523|NCT02318329|520850212|FG004|Overall Study|Withdrawal by Subject|0|||
144451524|NCT02318329|520850213|FG005|Overall Study|Withdrawal by Subject|0|||
144195209|NCT02777918|519910372|FG000|Overall Study|Withdrawal by Subject|1|||
144195210|NCT02777918|519910373|FG001|Overall Study|Withdrawal by Subject|1|||
144195211|NCT03401073|519910374|FG000|Overall Study|Lost to Follow-up|1|||
144195212|NCT03401073|519910375|FG001|Overall Study|Lost to Follow-up|2|||
144195213|NCT03832738|519910382|FG000|Overall Study|Withdrawal by Subject|6|||
144195214|NCT03832738|519910383|FG001|Overall Study|Withdrawal by Subject|7|||
144195215|NCT03832738|519910384|FG002|Overall Study|Withdrawal by Subject|16|||
144195216|NCT03832738|519910382|FG000|Overall Study|Physician Decision|0|||
144195217|NCT03832738|519910383|FG001|Overall Study|Physician Decision|1|||
144195218|NCT03832738|519910384|FG002|Overall Study|Physician Decision|2|||
144195219|NCT03832738|519910382|FG000|Overall Study|Adverse Event|2|||
144195220|NCT03832738|519910383|FG001|Overall Study|Adverse Event|3|||
144195221|NCT03832738|519910384|FG002|Overall Study|Adverse Event|1|||
144195222|NCT03832738|519910382|FG000|Overall Study|Pregnancy|0|||
144195223|NCT03832738|519910383|FG001|Overall Study|Pregnancy|1|||
144195224|NCT03832738|519910384|FG002|Overall Study|Pregnancy|0|||
144195225|NCT03852459|519910385|FG000|Overall Study|Adverse Event|2|||
144195226|NCT03852459|519910386|FG001|Overall Study|Adverse Event|2|||
144195227|NCT03852459|519910385|FG000|Overall Study|Withdrawal by Subject|1|||
144195228|NCT03852459|519910386|FG001|Overall Study|Withdrawal by Subject|1|||
144195229|NCT00049842|519910387|FG000|Treatment Phase|Adverse Event|47|||
144195230|NCT00049842|519910388|FG001|Treatment Phase|Adverse Event|12|||
144195231|NCT00049842|519910387|FG000|Treatment Phase|Withdrawal by Subject|35|||
144195232|NCT00049842|519910388|FG001|Treatment Phase|Withdrawal by Subject|46|||
144195233|NCT00049842|519910387|FG000|Treatment Phase|Non-compliance with protocol|7|||
144195234|NCT00049842|519910388|FG001|Treatment Phase|Non-compliance with protocol|8|||
144195235|NCT00049842|519910387|FG000|Treatment Phase|Lost to Follow-up|4|||
144195236|NCT00049842|519910388|FG001|Treatment Phase|Lost to Follow-up|8|||
144195237|NCT00049842|519910387|FG000|Treatment Phase|Administrative|0|||
144195238|NCT00049842|519910388|FG001|Treatment Phase|Administrative|3|||
144195239|NCT00049842|519910387|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
144195240|NCT00049842|519910388|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
144195241|NCT00049842|519910387|FG000|Follow-up Phase|Adverse Event|6|||
144195242|NCT00049842|519910388|FG001|Follow-up Phase|Adverse Event|1|||
144195243|NCT00049842|519910387|FG000|Follow-up Phase|Other|1|||
144195244|NCT00049842|519910388|FG001|Follow-up Phase|Other|4|||
144195245|NCT03977701|519910389|FG000|Overall Study|COVID-19 pandemic|0|||
144195246|NCT03977701|519910390|FG001|Overall Study|COVID-19 pandemic|0|||
144195247|NCT03977701|519910391|FG002|Overall Study|COVID-19 pandemic|0|||
144195248|NCT03977701|519910392|FG003|Overall Study|COVID-19 pandemic|0|||
144195249|NCT03977701|519910393|FG004|Overall Study|COVID-19 pandemic|0|||
144254182|NCT04304508|520131683|FG002|Overall Study|Study drug never administered|4|||
144254183|NCT04304508|520131684|FG003|Overall Study|Study drug never administered|4|||
144254184|NCT04304508|520131681|FG000|Overall Study|Adverse Event|49|||
144254185|NCT04304508|520131682|FG001|Overall Study|Adverse Event|50|||
144254186|NCT04304508|520131683|FG002|Overall Study|Adverse Event|51|||
144254187|NCT04304508|520131684|FG003|Overall Study|Adverse Event|56|||
144254188|NCT04304508|520131681|FG000|Overall Study|Lost to Follow-up|1|||
144254189|NCT04304508|520131682|FG001|Overall Study|Lost to Follow-up|5|||
144254190|NCT04304508|520131683|FG002|Overall Study|Lost to Follow-up|2|||
144254191|NCT04304508|520131684|FG003|Overall Study|Lost to Follow-up|3|||
144254192|NCT02688764|520131691|FG000|Overall Study|Adverse Event|3|||
144254193|NCT02688764|520131692|FG001|Overall Study|Adverse Event|3|||
144254194|NCT02688764|520131691|FG000|Overall Study|AE/Kidney transplant|1|||
144254195|NCT02688764|520131692|FG001|Overall Study|AE/Kidney transplant|0|||
144254196|NCT02688764|520131691|FG000|Overall Study|AE/Lack of efficacy|1|||
144254197|NCT02688764|520131692|FG001|Overall Study|AE/Lack of efficacy|0|||
144254198|NCT02688764|520131691|FG000|Overall Study|AE/Non-compl.|1|||
144254199|NCT02688764|520131692|FG001|Overall Study|AE/Non-compl.|0|||
144195250|NCT03977701|519910394|FG005|Overall Study|COVID-19 pandemic|1|||
144195251|NCT03977701|519910395|FG006|Overall Study|COVID-19 pandemic|0|||
144195252|NCT03977701|519910396|FG007|Overall Study|COVID-19 pandemic|1|||
144195253|NCT03977701|519910397|FG008|Overall Study|COVID-19 pandemic|0|||
144195254|NCT03977701|519910398|FG009|Overall Study|COVID-19 pandemic|0|||
144195255|NCT01347866|519910399|FG000|Overall Study|Death|0|||
144254200|NCT02688764|520131691|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
144254201|NCT02688764|520131692|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
144254202|NCT02688764|520131691|FG000|Overall Study|AE/Other|0|||
144195256|NCT01347866|519910400|FG001|Overall Study|Death|0|||
144195257|NCT01347866|519910401|FG002|Overall Study|Death|0|||
144195258|NCT01347866|519910402|FG003|Overall Study|Death|1|||
144195259|NCT01347866|519910403|FG004|Overall Study|Death|2|||
144195260|NCT01347866|519910404|FG005|Overall Study|Death|2|||
144195261|NCT01347866|519910405|FG006|Overall Study|Death|1|||
144195262|NCT01347866|519910406|FG007|Overall Study|Death|0|||
144195263|NCT01347866|519910407|FG008|Overall Study|Death|4|||
144195264|NCT01347866|519910408|FG009|Overall Study|Death|1|||
144254203|NCT02688764|520131692|FG001|Overall Study|AE/Other|1|||
144254204|NCT02688764|520131691|FG000|Overall Study|AE/Physician decision|1|||
144254205|NCT02688764|520131692|FG001|Overall Study|AE/Physician decision|0|||
144254206|NCT02688764|520131691|FG000|Overall Study|AE/Withd. parent|3|||
144254207|NCT02688764|520131692|FG001|Overall Study|AE/Withd. parent|0|||
144254208|NCT02688764|520131691|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
144254209|NCT02688764|520131692|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
144254210|NCT02688764|520131691|FG000|Overall Study|AE/Withd. subject|1|||
144254211|NCT02688764|520131692|FG001|Overall Study|AE/Withd. subject|0|||
144254212|NCT02688764|520131691|FG000|Overall Study|Kidney transplant|10|||
144254213|NCT02688764|520131692|FG001|Overall Study|Kidney transplant|4|||
144254214|NCT02688764|520131691|FG000|Overall Study|Lack of Efficacy|3|||
144254215|NCT02688764|520131692|FG001|Overall Study|Lack of Efficacy|2|||
144254216|NCT02688764|520131691|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
144254217|NCT02688764|520131692|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
144254218|NCT02688764|520131691|FG000|Overall Study|Non-compliance with study drug|4|||
144254219|NCT02688764|520131692|FG001|Overall Study|Non-compliance with study drug|0|||
144254220|NCT02688764|520131691|FG000|Overall Study|Non-compl./Physician decision|2|||
144254221|NCT02688764|520131692|FG001|Overall Study|Non-compl./Physician decision|0|||
144254222|NCT02688764|520131691|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
144254223|NCT02688764|520131692|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
144254224|NCT02688764|520131691|FG000|Overall Study|Non-compl./Withd. subject|0|||
144254225|NCT02688764|520131692|FG001|Overall Study|Non-compl./Withd. subject|2|||
144254226|NCT02688764|520131691|FG000|Overall Study|Phosphorus level outside safe range|0|||
144195265|NCT01347866|519910409|FG010|Overall Study|Death|3|||
144195266|NCT01347866|519910410|FG011|Overall Study|Death|1|||
144195267|NCT01347866|519910411|FG012|Overall Study|Death|2|||
144195268|NCT01347866|519910412|FG013|Overall Study|Death|0|||
144195269|NCT01347866|519910413|FG014|Overall Study|Death|0|||
144195270|NCT01347866|519910414|FG015|Overall Study|Death|1|||
144195271|NCT01347866|519910415|FG016|Overall Study|Death|0|||
144195272|NCT01347866|519910399|FG000|Overall Study|Lost to Follow-up|0|||
144195273|NCT01347866|519910400|FG001|Overall Study|Lost to Follow-up|0|||
144195274|NCT01347866|519910401|FG002|Overall Study|Lost to Follow-up|0|||
144195275|NCT01347866|519910402|FG003|Overall Study|Lost to Follow-up|0|||
144195276|NCT01347866|519910403|FG004|Overall Study|Lost to Follow-up|0|||
144195277|NCT01347866|519910404|FG005|Overall Study|Lost to Follow-up|0|||
144195278|NCT01347866|519910405|FG006|Overall Study|Lost to Follow-up|0|||
144195279|NCT01347866|519910406|FG007|Overall Study|Lost to Follow-up|1|||
144195280|NCT01347866|519910407|FG008|Overall Study|Lost to Follow-up|1|||
144195281|NCT01347866|519910408|FG009|Overall Study|Lost to Follow-up|0|||
144195282|NCT01347866|519910409|FG010|Overall Study|Lost to Follow-up|0|||
144195283|NCT01347866|519910410|FG011|Overall Study|Lost to Follow-up|0|||
144195284|NCT01347866|519910411|FG012|Overall Study|Lost to Follow-up|0|||
144195285|NCT01347866|519910412|FG013|Overall Study|Lost to Follow-up|0|||
144195286|NCT01347866|519910413|FG014|Overall Study|Lost to Follow-up|0|||
144195287|NCT01347866|519910414|FG015|Overall Study|Lost to Follow-up|0|||
144195288|NCT01347866|519910415|FG016|Overall Study|Lost to Follow-up|0|||
144195289|NCT01347866|519910399|FG000|Overall Study|Other|3|||
144195290|NCT01347866|519910400|FG001|Overall Study|Other|1|||
144195291|NCT01347866|519910401|FG002|Overall Study|Other|1|||
144195292|NCT01347866|519910402|FG003|Overall Study|Other|4|||
144195293|NCT01347866|519910403|FG004|Overall Study|Other|5|||
144195294|NCT01347866|519910404|FG005|Overall Study|Other|0|||
144195295|NCT01347866|519910405|FG006|Overall Study|Other|5|||
144195296|NCT01347866|519910406|FG007|Overall Study|Other|3|||
144195297|NCT01347866|519910407|FG008|Overall Study|Other|22|||
144195298|NCT01347866|519910408|FG009|Overall Study|Other|5|||
144195299|NCT01347866|519910409|FG010|Overall Study|Other|0|||
144195300|NCT01347866|519910410|FG011|Overall Study|Other|3|||
144195301|NCT01347866|519910411|FG012|Overall Study|Other|4|||
144195302|NCT01347866|519910412|FG013|Overall Study|Other|4|||
144195303|NCT01347866|519910413|FG014|Overall Study|Other|2|||
144195304|NCT01347866|519910414|FG015|Overall Study|Other|3|||
144195305|NCT01347866|519910415|FG016|Overall Study|Other|0|||
144195306|NCT01347866|519910399|FG000|Overall Study|Subject refused further follow-up|2|||
144254227|NCT02688764|520131692|FG001|Overall Study|Phosphorus level outside safe range|1|||
144254228|NCT02688764|520131691|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
144254229|NCT02688764|520131692|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
144254230|NCT02688764|520131691|FG000|Overall Study|Study drug taste/Withd. parent|1|||
144254231|NCT02688764|520131692|FG001|Overall Study|Study drug taste/Withd. parent|0|||
144195307|NCT01347866|519910400|FG001|Overall Study|Subject refused further follow-up|0|||
144195308|NCT01347866|519910401|FG002|Overall Study|Subject refused further follow-up|0|||
144195309|NCT01347866|519910402|FG003|Overall Study|Subject refused further follow-up|2|||
144195310|NCT01347866|519910403|FG004|Overall Study|Subject refused further follow-up|0|||
144195311|NCT01347866|519910404|FG005|Overall Study|Subject refused further follow-up|1|||
144195312|NCT01347866|519910405|FG006|Overall Study|Subject refused further follow-up|0|||
144195313|NCT01347866|519910406|FG007|Overall Study|Subject refused further follow-up|0|||
144195314|NCT01347866|519910407|FG008|Overall Study|Subject refused further follow-up|4|||
144195315|NCT01347866|519910408|FG009|Overall Study|Subject refused further follow-up|1|||
144195316|NCT01347866|519910409|FG010|Overall Study|Subject refused further follow-up|0|||
144606817|NCT01660451|521421109|FG001|Overall Study|Progressive disease - radiological progression|23|||
144195317|NCT01347866|519910410|FG011|Overall Study|Subject refused further follow-up|0|||
144195318|NCT01347866|519910411|FG012|Overall Study|Subject refused further follow-up|1|||
144195319|NCT01347866|519910412|FG013|Overall Study|Subject refused further follow-up|3|||
144195320|NCT01347866|519910413|FG014|Overall Study|Subject refused further follow-up|1|||
144195321|NCT01347866|519910414|FG015|Overall Study|Subject refused further follow-up|0|||
144195322|NCT01347866|519910415|FG016|Overall Study|Subject refused further follow-up|2|||
144195323|NCT00430950|519910416|FG000|Overall Study|Adverse Event|7|||
144195324|NCT00430950|519910417|FG001|Overall Study|Adverse Event|6|||
144195325|NCT00430950|519910416|FG000|Overall Study|Withdrawal by Subject|1|||
144195326|NCT00430950|519910417|FG001|Overall Study|Withdrawal by Subject|0|||
144195327|NCT00430950|519910416|FG000|Overall Study|concomitant medication,etc.|5|||
144195328|NCT00430950|519910417|FG001|Overall Study|concomitant medication,etc.|7|||
144195329|NCT02429934|519910418|FG000|Overall Study|Withdrawal by Subject|0|||
144195330|NCT02429934|519910419|FG001|Overall Study|Withdrawal by Subject|2|||
144195331|NCT02429934|519910418|FG000|Overall Study|Adverse Event|2|||
144195332|NCT02429934|519910419|FG001|Overall Study|Adverse Event|0|||
144195333|NCT02429934|519910418|FG000|Overall Study|Lost to Follow-up|1|||
144195334|NCT02429934|519910419|FG001|Overall Study|Lost to Follow-up|1|||
144195335|NCT02429934|519910418|FG000|Overall Study|Physician Decision|1|||
144195336|NCT02429934|519910419|FG001|Overall Study|Physician Decision|0|||
144195337|NCT00869024|519910420|FG000|Overall Study|Death|2|||
144195338|NCT00869024|519910421|FG001|Overall Study|Death|3|||
144195339|NCT00869024|519910420|FG000|Overall Study|Lost to Follow-up|0|||
144195340|NCT00869024|519910421|FG001|Overall Study|Lost to Follow-up|1|||
144195341|NCT00869024|519910420|FG000|Overall Study|Protocol Violation|0|||
144195342|NCT00869024|519910421|FG001|Overall Study|Protocol Violation|1|||
144195343|NCT03545191|519910429|FG000|Overall Study|Death|1|||
144195344|NCT03545191|519910430|FG001|Overall Study|Death|0|||
144195345|NCT03545191|519910431|FG002|Overall Study|Death|0|||
144195346|NCT03545191|519910429|FG000|Overall Study|Adverse Event|4|||
144195347|NCT03545191|519910430|FG001|Overall Study|Adverse Event|2|||
144195348|NCT03545191|519910431|FG002|Overall Study|Adverse Event|7|||
144195349|NCT03545191|519910429|FG000|Overall Study|Other reasons|3|||
144195350|NCT03545191|519910430|FG001|Overall Study|Other reasons|11|||
144195351|NCT03545191|519910431|FG002|Overall Study|Other reasons|8|||
144195352|NCT03545191|519910429|FG000|Overall Study|Withdrawal by Subject|13|||
144195353|NCT03545191|519910430|FG001|Overall Study|Withdrawal by Subject|10|||
144195354|NCT03545191|519910431|FG002|Overall Study|Withdrawal by Subject|12|||
144195355|NCT03545191|519910429|FG000|Overall Study|Lost to Follow-up|1|||
144195356|NCT03545191|519910430|FG001|Overall Study|Lost to Follow-up|2|||
144195357|NCT03545191|519910431|FG002|Overall Study|Lost to Follow-up|3|||
144195358|NCT02025751|519910432|FG000|Overall Study|Lost to Follow-up|1|||
144195359|NCT02025751|519910433|FG001|Overall Study|Lost to Follow-up|0|||
144195360|NCT02025751|519910432|FG000|Overall Study|Adverse Event|0|||
144195361|NCT02025751|519910433|FG001|Overall Study|Adverse Event|1|||
144195362|NCT02025751|519910432|FG000|Overall Study|Physician Decision|0|||
144195363|NCT02025751|519910433|FG001|Overall Study|Physician Decision|1|||
144195364|NCT02025751|519910432|FG000|Overall Study|Withdrawal by Subject|0|||
144451525|NCT02318329|520850214|FG006|Overall Study|Withdrawal by Subject|0|||
144451526|NCT02318329|520850215|FG007|Overall Study|Withdrawal by Subject|0|||
144451527|NCT02318329|520850216|FG008|Overall Study|Withdrawal by Subject|0|||
144606818|NCT01660451|521421110|FG002|Overall Study|Progressive disease - radiological progression|50|||
144195365|NCT02025751|519910433|FG001|Overall Study|Withdrawal by Subject|1|||
144195366|NCT03351231|519910436|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
144451528|NCT02318329|520850217|FG009|Overall Study|Withdrawal by Subject|6|||
144451529|NCT02318329|520850208|FG000|Overall Study|Other|1|||
144451530|NCT02318329|520850209|FG001|Overall Study|Other|1|||
144451531|NCT02318329|520850210|FG002|Overall Study|Other|1|||
144451532|NCT02318329|520850211|FG003|Overall Study|Other|0|||
144451533|NCT02318329|520850212|FG004|Overall Study|Other|0|||
144451534|NCT02318329|520850213|FG005|Overall Study|Other|0|||
144451535|NCT02318329|520850214|FG006|Overall Study|Other|0|||
144451536|NCT02318329|520850215|FG007|Overall Study|Other|0|||
144451537|NCT02318329|520850216|FG008|Overall Study|Other|1|||
144451538|NCT02318329|520850217|FG009|Overall Study|Other|1|||
144451539|NCT00581945|520850220|FG000|Overall Study|Adverse Event|4|||
144451540|NCT00581945|520850221|FG001|Overall Study|Adverse Event|4|||
144451541|NCT00581945|520850220|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144451542|NCT00581945|520850221|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144451543|NCT00581945|520850220|FG000|Overall Study|Withdrawal by Subject|2|||
144195367|NCT03351231|519910436|FG000|Combination Therapy Period|Disease progression|2|||
144195368|NCT03351231|519910436|FG000|Combination Therapy Period|Study drug toxicity|1|||
144195369|NCT03351231|519910436|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
144195370|NCT03351231|519910436|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
144195371|NCT03351231|519910436|FG000|Safety Follow-Up Period|Other reason|2|||
144195372|NCT02340221|519910439|FG000|Overall Study|Death|100|||
144451544|NCT00581945|520850221|FG001|Overall Study|Withdrawal by Subject|6|||
144195373|NCT02340221|519910440|FG001|Overall Study|Death|197|||
144195374|NCT02340221|519910439|FG000|Overall Study|Withdrawal by Participant|24|||
144195375|NCT02340221|519910440|FG001|Overall Study|Withdrawal by Participant|37|||
144195376|NCT02340221|519910439|FG000|Overall Study|Lost to Follow-up|4|||
144195377|NCT02340221|519910440|FG001|Overall Study|Lost to Follow-up|15|||
144195378|NCT02340221|519910439|FG000|Overall Study|Reason Not Specified|85|||
144195379|NCT02340221|519910440|FG001|Overall Study|Reason Not Specified|165|||
144195380|NCT02340221|519910439|FG000|Overall Study|Study Terminated by Sponsor|1|||
144195381|NCT02340221|519910440|FG001|Overall Study|Study Terminated by Sponsor|3|||
144195382|NCT03487848|519910441|FG000|Overall Study|Lost to Follow-up|1|||
144195383|NCT03499119|519910442|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
144195384|NCT03499119|519910443|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
144195385|NCT03499119|519910444|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
144195386|NCT03499119|519910445|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
144195387|NCT03499119|519910442|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
144195388|NCT03499119|519910443|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
144195389|NCT03499119|519910444|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
144195390|NCT03499119|519910445|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
144195391|NCT03499119|519910442|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
144195392|NCT03499119|519910443|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
144195393|NCT03499119|519910444|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
144195394|NCT03499119|519910445|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
144195395|NCT03499119|519910442|FG000|Optional Extension Phase|Lost to Follow-up|0|||
144195396|NCT03499119|519910443|FG001|Optional Extension Phase|Lost to Follow-up|0|||
144195397|NCT03499119|519910444|FG002|Optional Extension Phase|Lost to Follow-up|0|||
144195398|NCT03499119|519910445|FG003|Optional Extension Phase|Lost to Follow-up|1|||
144195399|NCT03499119|519910442|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
144195400|NCT03499119|519910443|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
144195401|NCT03499119|519910444|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
144195402|NCT03499119|519910445|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
144195403|NCT03499119|519910442|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
144195404|NCT03499119|519910443|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
144195405|NCT03499119|519910444|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
144195406|NCT03499119|519910445|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
144195407|NCT02333487|519910446|FG000|Overall Study|Adverse Event|0|||
144195408|NCT02333487|519910447|FG001|Overall Study|Adverse Event|2|||
144195409|NCT02333487|519910448|FG002|Overall Study|Adverse Event|0|||
144195410|NCT06029959|519911932|FG000|Overall Study|Physician Decision|6|||
144195411|NCT00003138|519911933|FG000|Step 1|Reasons off treatment not documented|60|||
144195412|NCT00003138|519911934|FG001|Step 1|Reasons off treatment not documented|57|||
144195413|NCT00003138|519911933|FG000|Step 1|Never started treatment|1|||
144195414|NCT00003138|519911934|FG001|Step 1|Never started treatment|0|||
144195415|NCT00003138|519911933|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
144195416|NCT00003138|519911934|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
144195417|NCT00003138|519911933|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
144195418|NCT00003138|519911934|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
144195419|NCT00003138|519911933|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
144195420|NCT00003138|519911934|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
144195421|NCT00003138|519911933|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
144195422|NCT00003138|519911934|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
144195423|NCT04495283|519911935|FG000|Overall Study|Physician Decision|0|||
144195424|NCT04495283|519911936|FG001|Overall Study|Physician Decision|0|||
144195425|NCT04495283|519911937|FG002|Overall Study|Physician Decision|1|||
144195426|NCT04495283|519911935|FG000|Overall Study|Withdrawal by Subject|0|||
144195427|NCT04495283|519911936|FG001|Overall Study|Withdrawal by Subject|1|||
144195428|NCT04495283|519911937|FG002|Overall Study|Withdrawal by Subject|1|||
144195429|NCT04495283|519911935|FG000|Overall Study|Other|1|||
144195430|NCT04495283|519911936|FG001|Overall Study|Other|0|||
144195431|NCT04495283|519911937|FG002|Overall Study|Other|1|||
144195432|NCT02631876|519911938|FG000|Overall Study|Death|96|||
144195433|NCT02631876|519911939|FG001|Overall Study|Death|50|||
144451545|NCT00581945|520850220|FG000|Overall Study|Death|1|||
144451546|NCT00581945|520850221|FG001|Overall Study|Death|0|||
144195434|NCT02631876|519911938|FG000|Overall Study|Investigator's discretion|1|||
144195435|NCT02631876|519911939|FG001|Overall Study|Investigator's discretion|0|||
144195436|NCT02631876|519911938|FG000|Overall Study|Lost to Follow-up|2|||
144195437|NCT02631876|519911939|FG001|Overall Study|Lost to Follow-up|0|||
144195438|NCT02631876|519911938|FG000|Overall Study|Withdrawal by Subject|16|||
144195439|NCT02631876|519911939|FG001|Overall Study|Withdrawal by Subject|9|||
144195440|NCT02631876|519911938|FG000|Overall Study|Other than specified|4|||
144195441|NCT02631876|519911939|FG001|Overall Study|Other than specified|4|||
144195442|NCT01013649|519911942|FG000|First Step|Withdrawal by Subject|36|||
144195443|NCT01013649|519911943|FG001|First Step|Withdrawal by Subject|19|||
144195444|NCT01013649|519911944|FG002|First Step|Withdrawal by Subject|0|||
144195445|NCT01013649|519911945|FG003|First Step|Withdrawal by Subject|0|||
144195446|NCT01013649|519911942|FG000|First Step|Progression|58|||
144195447|NCT01013649|519911943|FG001|First Step|Progression|23|||
144195448|NCT01013649|519911944|FG002|First Step|Progression|0|||
144195449|NCT01013649|519911945|FG003|First Step|Progression|0|||
144195450|NCT01013649|519911942|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
144195451|NCT01013649|519911943|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
144195452|NCT01013649|519911944|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
144195453|NCT01013649|519911945|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
144195454|NCT01013649|519911942|FG000|First Step|Death|3|||
144195455|NCT01013649|519911943|FG001|First Step|Death|4|||
144195456|NCT01013649|519911944|FG002|First Step|Death|0|||
144195457|NCT01013649|519911945|FG003|First Step|Death|0|||
144195458|NCT01013649|519911942|FG000|First Step|Adverse Event|9|||
144195459|NCT01013649|519911943|FG001|First Step|Adverse Event|5|||
144195460|NCT01013649|519911944|FG002|First Step|Adverse Event|0|||
144195461|NCT01013649|519911945|FG003|First Step|Adverse Event|0|||
144195462|NCT01013649|519911942|FG000|First Step|Other|4|||
144195463|NCT01013649|519911943|FG001|First Step|Other|6|||
144195464|NCT01013649|519911944|FG002|First Step|Other|0|||
144195465|NCT01013649|519911945|FG003|First Step|Other|0|||
144195466|NCT02091141|519911946|FG000|Overall Study|Death|280|||
144195467|NCT02091141|519911947|FG001|Overall Study|Death|118|||
144451547|NCT01075321|520850228|FG000|Overall Study|Withdrawal by Subject|0|||
144451548|NCT01075321|520850229|FG001|Overall Study|Withdrawal by Subject|0|||
144451549|NCT01075321|520850230|FG002|Overall Study|Withdrawal by Subject|1|||
144451550|NCT01075321|520850231|FG003|Overall Study|Withdrawal by Subject|1|||
144451551|NCT01075321|520850228|FG000|Overall Study|Protocol Violation|0|||
144451552|NCT01075321|520850229|FG001|Overall Study|Protocol Violation|0|||
144451553|NCT01075321|520850230|FG002|Overall Study|Protocol Violation|1|||
144451554|NCT01075321|520850231|FG003|Overall Study|Protocol Violation|0|||
144451555|NCT01075321|520850228|FG000|Overall Study|Treatment Incomplete due to progression|1|||
144451556|NCT01075321|520850229|FG001|Overall Study|Treatment Incomplete due to progression|0|||
144451557|NCT01075321|520850230|FG002|Overall Study|Treatment Incomplete due to progression|0|||
144451558|NCT01075321|520850231|FG003|Overall Study|Treatment Incomplete due to progression|0|||
144451559|NCT01075321|520850228|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
144533626|NCT04163991|521156722|FG000|Overall Study|Lost to Follow-up|0|||
144533627|NCT04163991|521156723|FG001|Overall Study|Lost to Follow-up|1|||
144533628|NCT04163991|521156724|FG002|Overall Study|Lost to Follow-up|0|||
144533629|NCT04163991|521156725|FG003|Overall Study|Lost to Follow-up|0|||
144533630|NCT04163991|521156726|FG004|Overall Study|Lost to Follow-up|0|||
144533631|NCT04163991|521156722|FG000|Overall Study|Withdrawal by Subject|1|||
144533632|NCT04163991|521156723|FG001|Overall Study|Withdrawal by Subject|1|||
144533633|NCT04163991|521156724|FG002|Overall Study|Withdrawal by Subject|3|||
144533634|NCT04163991|521156725|FG003|Overall Study|Withdrawal by Subject|1|||
144533635|NCT04163991|521156726|FG004|Overall Study|Withdrawal by Subject|1|||
144533636|NCT04163991|521156722|FG000|Overall Study|Other, Not Specified|0|||
144533637|NCT04163991|521156723|FG001|Overall Study|Other, Not Specified|1|||
144533638|NCT04163991|521156724|FG002|Overall Study|Other, Not Specified|1|||
144533639|NCT04163991|521156725|FG003|Overall Study|Other, Not Specified|1|||
144533640|NCT04163991|521156726|FG004|Overall Study|Other, Not Specified|0|||
144533641|NCT03372057|521156727|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
144533642|NCT03372057|521156728|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
144533643|NCT03372057|521156729|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
144533644|NCT03372057|521156727|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
144533645|NCT03372057|521156728|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
144533646|NCT03372057|521156729|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
144533647|NCT03372057|521156727|FG000|Dose Optimization Phase|Death|16|||
144533648|NCT03372057|521156728|FG001|Dose Optimization Phase|Death|11|||
144533649|NCT03372057|521156729|FG002|Dose Optimization Phase|Death|0|||
144533650|NCT03372057|521156727|FG000|Expansion Phase|Withdrawal by Subject|0|||
144533651|NCT03372057|521156728|FG001|Expansion Phase|Withdrawal by Subject|0|||
144533652|NCT03372057|521156729|FG002|Expansion Phase|Withdrawal by Subject|4|||
144533653|NCT03372057|521156727|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
144533654|NCT03372057|521156728|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
144533655|NCT03372057|521156729|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
144533656|NCT03372057|521156727|FG000|Expansion Phase|Death|0|||
144533657|NCT03372057|521156728|FG001|Expansion Phase|Death|0|||
144533658|NCT03372057|521156729|FG002|Expansion Phase|Death|78|||
144533659|NCT03372057|521156727|FG000|Expansion Phase|Progressive Disease|0|||
144195468|NCT02091141|519911948|FG002|Overall Study|Death|46|||
144195469|NCT02091141|519911949|FG003|Overall Study|Death|13|||
144195470|NCT02091141|519911950|FG004|Overall Study|Death|31|||
144195471|NCT02091141|519911951|FG005|Overall Study|Death|16|||
144195472|NCT02091141|519911952|FG006|Overall Study|Death|12|||
144195473|NCT02091141|519911946|FG000|Overall Study|Withdrawal by Subject|21|||
144195474|NCT02091141|519911947|FG001|Overall Study|Withdrawal by Subject|13|||
144254232|NCT02688764|520131691|FG000|Overall Study|Subject moving out|2|||
144254233|NCT02688764|520131692|FG001|Overall Study|Subject moving out|0|||
144254234|NCT02688764|520131691|FG000|Overall Study|Subject taken off dialysis|1|||
144254235|NCT02688764|520131692|FG001|Overall Study|Subject taken off dialysis|0|||
144254236|NCT02688764|520131691|FG000|Overall Study|Withdrawal by parent|3|||
144254237|NCT02688764|520131692|FG001|Overall Study|Withdrawal by parent|0|||
144254238|NCT02113007|520131693|FG000|Overall Study|Progressive disease|2|||
144254239|NCT00885378|520131694|FG000|Overall Study|Lack of Efficacy|2|||
144254240|NCT00885378|520131695|FG001|Overall Study|Lack of Efficacy|2|||
144254241|NCT00885378|520131694|FG000|Overall Study|Withdrawal by Subject|1|||
144254242|NCT00885378|520131695|FG001|Overall Study|Withdrawal by Subject|2|||
144254243|NCT00885378|520131694|FG000|Overall Study|Lost to Follow-up|1|||
144254244|NCT00885378|520131695|FG001|Overall Study|Lost to Follow-up|2|||
144254245|NCT00885378|520131694|FG000|Overall Study|Poor/Noncompliance|2|||
144254246|NCT00885378|520131695|FG001|Overall Study|Poor/Noncompliance|2|||
144254247|NCT00885378|520131694|FG000|Overall Study|Protocol Violation|2|||
144254248|NCT00885378|520131695|FG001|Overall Study|Protocol Violation|0|||
144254249|NCT04750278|520131696|FG000|Overall Study|Death|9|||
144254250|NCT04750278|520131697|FG001|Overall Study|Death|10|||
144254251|NCT04750278|520131698|FG002|Overall Study|Death|10|||
144254252|NCT04750278|520131696|FG000|Overall Study|Withdrawal by Subject|4|||
144254253|NCT04750278|520131697|FG001|Overall Study|Withdrawal by Subject|1|||
144254254|NCT04750278|520131698|FG002|Overall Study|Withdrawal by Subject|2|||
144254255|NCT04750278|520131696|FG000|Overall Study|Lost to Follow-up|1|||
144254256|NCT04750278|520131697|FG001|Overall Study|Lost to Follow-up|1|||
144254257|NCT04750278|520131698|FG002|Overall Study|Lost to Follow-up|1|||
144254258|NCT04750278|520131696|FG000|Overall Study|Pregnancy|1|||
144254259|NCT04750278|520131697|FG001|Overall Study|Pregnancy|0|||
144254260|NCT04750278|520131698|FG002|Overall Study|Pregnancy|0|||
144254261|NCT04750278|520131696|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
144254262|NCT04750278|520131697|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
144254263|NCT04750278|520131698|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
144254264|NCT04750278|520131696|FG000|Overall Study|Non-compliance|0|||
144254265|NCT04750278|520131697|FG001|Overall Study|Non-compliance|0|||
144254266|NCT04750278|520131698|FG002|Overall Study|Non-compliance|1|||
144254267|NCT04750278|520131696|FG000|Overall Study|Transfer to Outside Facility|0|||
144254268|NCT04750278|520131697|FG001|Overall Study|Transfer to Outside Facility|2|||
144254269|NCT04750278|520131698|FG002|Overall Study|Transfer to Outside Facility|1|||
144254270|NCT04750278|520131696|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
144254271|NCT04750278|520131697|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
144254272|NCT04750278|520131698|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
144254273|NCT04750278|520131696|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
144451560|NCT01075321|520850229|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
144451561|NCT01075321|520850230|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
144451562|NCT01075321|520850231|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
144451563|NCT00982020|520850232|FG000|Overall Study|Adverse Event|19|||
144451564|NCT00982020|520850233|FG001|Overall Study|Adverse Event|15|||
144451565|NCT00982020|520850232|FG000|Overall Study|Withdrawal by Subject|11|||
144451566|NCT00982020|520850233|FG001|Overall Study|Withdrawal by Subject|14|||
144451567|NCT00982020|520850232|FG000|Overall Study|Lost to Follow-up|5|||
144451568|NCT00982020|520850233|FG001|Overall Study|Lost to Follow-up|11|||
144451569|NCT00982020|520850232|FG000|Overall Study|Lack of Efficacy|10|||
144451570|NCT00982020|520850233|FG001|Overall Study|Lack of Efficacy|4|||
144451571|NCT00982020|520850232|FG000|Overall Study|Parent/Caregiver Decision|5|||
144451572|NCT00982020|520850233|FG001|Overall Study|Parent/Caregiver Decision|5|||
144451573|NCT00982020|520850232|FG000|Overall Study|Treatment Non-compliance|3|||
144451574|NCT00982020|520850233|FG001|Overall Study|Treatment Non-compliance|6|||
144451575|NCT00982020|520850232|FG000|Overall Study|Physician Decision|2|||
144451576|NCT00982020|520850233|FG001|Overall Study|Physician Decision|5|||
144451577|NCT00982020|520850232|FG000|Overall Study|Entry Criteria Not Met|2|||
144451578|NCT00982020|520850233|FG001|Overall Study|Entry Criteria Not Met|1|||
144451579|NCT00982020|520850232|FG000|Overall Study|Protocol Violation|0|||
144451580|NCT00982020|520850233|FG001|Overall Study|Protocol Violation|2|||
144254274|NCT04750278|520131697|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
144259292|NCT01089127|520150359|FG005|Overall Study|Abnormal test procedure result(s)|0|||
144451581|NCT00982020|520850232|FG000|Overall Study|Clinical Relapse|0|||
144451582|NCT00982020|520850233|FG001|Overall Study|Clinical Relapse|1|||
144451583|NCT00353704|520850237|FG000|Overall Study|Protocol Violation|3|||
144451584|NCT00353704|520850238|FG001|Overall Study|Protocol Violation|1|||
144451585|NCT01181921|520850240|FG000|Overall Study|Lost to Follow-up|1|||
144533660|NCT03372057|521156728|FG001|Expansion Phase|Progressive Disease|0|||
144451586|NCT03669081|520850241|FG000|Overall Study|Data could not be validated|1|||
144533661|NCT03372057|521156729|FG002|Expansion Phase|Progressive Disease|1|||
144533662|NCT03372057|521156727|FG000|Expansion Phase|Adverse Event|0|||
144533663|NCT03372057|521156728|FG001|Expansion Phase|Adverse Event|0|||
144254275|NCT04750278|520131698|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
144254276|NCT01299896|520131699|FG000|Overall Study|Withdrawal by Subject|1|||
144254277|NCT01299896|520131700|FG001|Overall Study|Withdrawal by Subject|7|||
144254278|NCT01299896|520131699|FG000|Overall Study|Lost to Follow-up|0|||
144254279|NCT01299896|520131700|FG001|Overall Study|Lost to Follow-up|11|||
144254280|NCT01502956|520131705|FG000|Overall Study|Death|0|||
144254281|NCT01502956|520131706|FG001|Overall Study|Death|2|||
144254282|NCT01502956|520131705|FG000|Overall Study|Lost to Follow-up|14|||
144254283|NCT01502956|520131706|FG001|Overall Study|Lost to Follow-up|11|||
144254284|NCT01502956|520131705|FG000|Overall Study|Physician Decision|2|||
144254285|NCT01502956|520131706|FG001|Overall Study|Physician Decision|3|||
144451587|NCT03669081|520850242|FG001|Overall Study|Data could not be validated|1|||
144451588|NCT00389324|520850243|FG000|Run-In Phase|Adverse Event|1|||
144451589|NCT00389324|520850243|FG000|Run-In Phase|Lost to Follow-up|1|||
144451590|NCT00389324|520850243|FG000|Run-In Phase|Withdrawal by Subject|1|||
144451591|NCT00389324|520850243|FG000|Subcutaneous Phase|Adverse Event|2|||
144451592|NCT00389324|520850243|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
144451593|NCT00389324|520850243|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
144451594|NCT00389324|520850243|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
144451595|NCT02519504|520850244|FG000|Overall Study|Protocol Violation|6|||
144451596|NCT02519504|520850245|FG001|Overall Study|Protocol Violation|5|||
144451597|NCT02519504|520850244|FG000|Overall Study|Ineligible for direct testing|12|||
144451598|NCT02519504|520850245|FG001|Overall Study|Ineligible for direct testing|12|||
144451599|NCT02519504|520850244|FG000|Overall Study|Did not participate in direct testing|95|||
144451600|NCT02519504|520850245|FG001|Overall Study|Did not participate in direct testing|86|||
144451601|NCT01925183|520850248|FG000|Overall Study|Adverse Event|1|||
144451602|NCT01925183|520850249|FG001|Overall Study|Adverse Event|0|||
144451603|NCT02159482|520850250|FG000|Overall Study|Withdrawal by Subject|2|||
144451604|NCT02159482|520850250|FG000|Overall Study|Physician Decision|3|||
144451605|NCT04479618|520850253|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
144451606|NCT04479618|520850254|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
144451607|NCT04479618|520850255|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
144451608|NCT04479618|520850253|FG000|Overall Study|Lack of Efficacy|1|||
144451609|NCT04479618|520850254|FG001|Overall Study|Lack of Efficacy|0|||
144451610|NCT04479618|520850255|FG002|Overall Study|Lack of Efficacy|0|||
144451611|NCT04479618|520850253|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
144451612|NCT04479618|520850254|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
144451613|NCT04479618|520850255|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
144451614|NCT04479618|520850253|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
144451615|NCT04479618|520850254|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
144451616|NCT04479618|520850255|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
144451617|NCT04479618|520850253|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
144451618|NCT04479618|520850254|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
144451619|NCT04479618|520850255|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
144254286|NCT01502956|520131705|FG000|Overall Study|Withdrawal by Subject|8|||
144254287|NCT01502956|520131706|FG001|Overall Study|Withdrawal by Subject|10|||
144254288|NCT01616758|520131707|FG000|Overall Study|Adverse Event|1|||
144254289|NCT01616758|520131707|FG000|Overall Study|Withdrawal by Subject|2|||
144254290|NCT01616758|520131707|FG000|Overall Study|Disease progression|18|||
144254291|NCT01616758|520131707|FG000|Overall Study|Study termination by Sponsor|1|||
144254292|NCT03026283|520131708|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
144254293|NCT03026283|520131709|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
144254294|NCT03026283|520131710|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
144254295|NCT03026283|520131711|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
144254296|NCT03026283|520131712|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
144254297|NCT03026283|520131713|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
144254298|NCT03026283|520131714|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
144254299|NCT03026283|520131715|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
144451620|NCT04479618|520850253|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
144451621|NCT04479618|520850254|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
144451622|NCT04479618|520850255|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
144725545|NCT01957488|521851280|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
144254300|NCT03026283|520131708|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
144451623|NCT04443218|520850262|FG000|Overall Study|Exited study for other reasons|9|||
144725546|NCT01957488|521851281|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
144254301|NCT03026283|520131709|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
144254302|NCT03026283|520131710|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
144451624|NCT04443218|520850262|FG000|Overall Study|Withdrawal by Subject|1|||
144451625|NCT04443218|520850262|FG000|Overall Study|Lost to Follow-up|4|||
144451626|NCT04443218|520850262|FG000|Overall Study|Death|19|||
144451627|NCT04788147|520850276|FG000|Overall Study|Screen Failure|3|||
144451628|NCT04788147|520850277|FG001|Overall Study|Screen Failure|10|||
144451629|NCT04788147|520850276|FG000|Overall Study|Incomplete RMRS image session|2|||
144606819|NCT01660451|521421108|FG000|Overall Study|Death|1|||
144606820|NCT01660451|521421109|FG001|Overall Study|Death|0|||
144606821|NCT01660451|521421110|FG002|Overall Study|Death|1|||
144606822|NCT01660451|521421108|FG000|Overall Study|Other|0|||
144606823|NCT01660451|521421109|FG001|Overall Study|Other|0|||
144606824|NCT01660451|521421110|FG002|Overall Study|Other|1|||
144606825|NCT01159912|521421111|FG000|Overall Study|Adverse Event|2|||
144606826|NCT01159912|521421112|FG001|Overall Study|Adverse Event|2|||
144606827|NCT01159912|521421113|FG002|Overall Study|Adverse Event|3|||
144606828|NCT01159912|521421111|FG000|Overall Study|Lack of Efficacy|23|||
144606829|NCT01159912|521421112|FG001|Overall Study|Lack of Efficacy|15|||
144606830|NCT01159912|521421113|FG002|Overall Study|Lack of Efficacy|14|||
144195475|NCT02091141|519911948|FG002|Overall Study|Withdrawal by Subject|3|||
144195476|NCT02091141|519911949|FG003|Overall Study|Withdrawal by Subject|2|||
144195477|NCT02091141|519911950|FG004|Overall Study|Withdrawal by Subject|2|||
144195478|NCT02091141|519911951|FG005|Overall Study|Withdrawal by Subject|3|||
144195479|NCT02091141|519911952|FG006|Overall Study|Withdrawal by Subject|0|||
144195480|NCT02091141|519911946|FG000|Overall Study|Lost to Follow-up|21|||
144195481|NCT02091141|519911947|FG001|Overall Study|Lost to Follow-up|5|||
144195482|NCT02091141|519911948|FG002|Overall Study|Lost to Follow-up|1|||
144195483|NCT02091141|519911949|FG003|Overall Study|Lost to Follow-up|0|||
144195484|NCT02091141|519911950|FG004|Overall Study|Lost to Follow-up|1|||
144195485|NCT02091141|519911951|FG005|Overall Study|Lost to Follow-up|2|||
144195486|NCT02091141|519911952|FG006|Overall Study|Lost to Follow-up|0|||
144195487|NCT02091141|519911946|FG000|Overall Study|Reason Not Specified|6|||
144195488|NCT02091141|519911947|FG001|Overall Study|Reason Not Specified|5|||
144195489|NCT02091141|519911948|FG002|Overall Study|Reason Not Specified|2|||
144195490|NCT02091141|519911949|FG003|Overall Study|Reason Not Specified|0|||
144195491|NCT02091141|519911950|FG004|Overall Study|Reason Not Specified|0|||
144195492|NCT02091141|519911951|FG005|Overall Study|Reason Not Specified|0|||
144195493|NCT02091141|519911952|FG006|Overall Study|Reason Not Specified|1|||
144195494|NCT02091141|519911946|FG000|Overall Study|Study Ended by Sponsor|1|||
144195495|NCT02091141|519911947|FG001|Overall Study|Study Ended by Sponsor|9|||
144195496|NCT02091141|519911948|FG002|Overall Study|Study Ended by Sponsor|0|||
144195497|NCT02091141|519911949|FG003|Overall Study|Study Ended by Sponsor|0|||
144195498|NCT02091141|519911950|FG004|Overall Study|Study Ended by Sponsor|0|||
144195499|NCT02091141|519911951|FG005|Overall Study|Study Ended by Sponsor|0|||
144195500|NCT02091141|519911952|FG006|Overall Study|Study Ended by Sponsor|0|||
144195501|NCT02091141|519911946|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
144195502|NCT02091141|519911947|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
144195503|NCT02091141|519911948|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
144195504|NCT02091141|519911949|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
144195505|NCT02091141|519911950|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
144195506|NCT02091141|519911951|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
144195507|NCT02091141|519911952|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
144195508|NCT02246439|519911953|FG000|Overall Study|Adverse Event|3|||
144195509|NCT02246439|519911954|FG001|Overall Study|Adverse Event|0|||
144195510|NCT02246439|519911953|FG000|Overall Study|Lost to Follow-up|7|||
144195511|NCT02246439|519911954|FG001|Overall Study|Lost to Follow-up|5|||
144195512|NCT02246439|519911953|FG000|Overall Study|Protocol Violation|0|||
144195513|NCT02246439|519911954|FG001|Overall Study|Protocol Violation|2|||
144195514|NCT02246439|519911953|FG000|Overall Study|Physician Decision|0|||
144195515|NCT02246439|519911954|FG001|Overall Study|Physician Decision|1|||
144195516|NCT02246439|519911953|FG000|Overall Study|Unkonwn|1|||
144195517|NCT02246439|519911954|FG001|Overall Study|Unkonwn|3|||
144451630|NCT04788147|520850277|FG001|Overall Study|Incomplete RMRS image session|0|||
144195518|NCT02246439|519911953|FG000|Overall Study|Withdrawal by Subject|1|||
144451631|NCT03634579|520850278|FG000|Overall Study|study termination|9|||
144451632|NCT04111497|520850279|FG000|Overall Study|relapse of primary disease|1|||
144451633|NCT04111497|520850279|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
144451634|NCT01652716|520850283|FG000|Overall Study|Loss of glucose control|1|||
144451635|NCT01652716|520850284|FG001|Overall Study|Loss of glucose control|0|||
144606831|NCT01159912|521421111|FG000|Overall Study|Protocol Violation|1|||
144606832|NCT01159912|521421112|FG001|Overall Study|Protocol Violation|2|||
144195519|NCT02246439|519911954|FG001|Overall Study|Withdrawal by Subject|0|||
144195520|NCT03623386|519911955|FG000|Overall Study|Protocol Violation|3|||
144195521|NCT03623386|519911956|FG001|Overall Study|Protocol Violation|2|||
144195522|NCT03623386|519911957|FG002|Overall Study|Protocol Violation|0|||
144195523|NCT03623386|519911955|FG000|Overall Study|Physician Decision|1|||
144606833|NCT01159912|521421113|FG002|Overall Study|Protocol Violation|3|||
144606834|NCT01159912|521421111|FG000|Overall Study|Lost to Follow-up|4|||
144195524|NCT03623386|519911956|FG001|Overall Study|Physician Decision|1|||
144195525|NCT03623386|519911957|FG002|Overall Study|Physician Decision|0|||
144451636|NCT01652716|520850283|FG000|Overall Study|Administrative|0|||
144451637|NCT01652716|520850284|FG001|Overall Study|Administrative|2|||
144451638|NCT01652716|520850283|FG000|Overall Study|Investigator decision|1|||
144451639|NCT01652716|520850284|FG001|Overall Study|Investigator decision|4|||
144451640|NCT01652716|520850283|FG000|Overall Study|Lost to Follow-up|12|||
144451641|NCT01652716|520850284|FG001|Overall Study|Lost to Follow-up|11|||
144451642|NCT01652716|520850283|FG000|Overall Study|Protocol Violation|2|||
144451643|NCT01652716|520850284|FG001|Overall Study|Protocol Violation|1|||
144451644|NCT01652716|520850283|FG000|Overall Study|Adverse Event|7|||
144451645|NCT01652716|520850284|FG001|Overall Study|Adverse Event|10|||
144451646|NCT01652716|520850283|FG000|Overall Study|Withdrawal by Subject|33|||
144195526|NCT03623386|519911955|FG000|Overall Study|Lost to Follow-up|0|||
144195527|NCT03623386|519911956|FG001|Overall Study|Lost to Follow-up|2|||
144195528|NCT03623386|519911957|FG002|Overall Study|Lost to Follow-up|0|||
144195529|NCT03623386|519911955|FG000|Overall Study|COVID-19|0|||
144195530|NCT03623386|519911956|FG001|Overall Study|COVID-19|1|||
144195531|NCT03623386|519911957|FG002|Overall Study|COVID-19|0|||
144195532|NCT04271735|519911958|FG000|Overall Study|Physician Decision|2|||
144195533|NCT04271735|519911959|FG001|Overall Study|Physician Decision|0|||
144195534|NCT03197558|519911960|FG000|Overall Study|Tubes not placed|1|||
144195535|NCT02072148|519911965|FG000|Overall Study|withdrew prior to surgery|23|||
144195536|NCT02072148|519911966|FG001|Overall Study|withdrew prior to surgery|0|||
144195537|NCT02072148|519911967|FG002|Overall Study|withdrew prior to surgery|0|||
144195538|NCT02072148|519911965|FG000|Overall Study|Death|0|||
144195539|NCT02072148|519911966|FG001|Overall Study|Death|0|||
144195540|NCT02072148|519911967|FG002|Overall Study|Death|1|||
144195541|NCT02072148|519911965|FG000|Overall Study|Withdrawal by Subject|0|||
144195542|NCT02072148|519911966|FG001|Overall Study|Withdrawal by Subject|13|||
144195543|NCT02072148|519911967|FG002|Overall Study|Withdrawal by Subject|12|||
144195544|NCT00430495|519911968|FG000|Overall Study|Adverse Event|2|||
144195545|NCT00430495|519911969|FG001|Overall Study|Adverse Event|3|||
144195546|NCT00430495|519911970|FG002|Overall Study|Adverse Event|2|||
144195547|NCT00430495|519911971|FG003|Overall Study|Adverse Event|0|||
144195548|NCT00430495|519911968|FG000|Overall Study|Death|0|||
144451647|NCT01652716|520850284|FG001|Overall Study|Withdrawal by Subject|18|||
144451648|NCT01337297|520850287|FG000|Overall Study|They entered to single anodal tDCS|4|||
144451649|NCT01337297|520850288|FG001|Overall Study|They entered to single anodal tDCS|3|||
144451650|NCT01337297|520850287|FG000|Overall Study|Lost to Follow-up|1|||
144451651|NCT01337297|520850288|FG001|Overall Study|Lost to Follow-up|3|||
144451652|NCT02778204|520850289|FG000|Overall Study|Adverse Event|1|||
144451653|NCT02778204|520850290|FG001|Overall Study|Adverse Event|0|||
144451654|NCT02778204|520850291|FG002|Overall Study|Adverse Event|0|||
144451655|NCT02778204|520850292|FG003|Overall Study|Adverse Event|0|||
144451656|NCT02778204|520850289|FG000|Overall Study|Withdrawal by Subject|0|||
144451657|NCT02778204|520850290|FG001|Overall Study|Withdrawal by Subject|0|||
144451658|NCT02778204|520850291|FG002|Overall Study|Withdrawal by Subject|1|||
144451659|NCT02778204|520850292|FG003|Overall Study|Withdrawal by Subject|2|||
144451660|NCT02778204|520850289|FG000|Overall Study|Lost to Follow-up|1|||
144451661|NCT02778204|520850290|FG001|Overall Study|Lost to Follow-up|0|||
144451662|NCT02778204|520850291|FG002|Overall Study|Lost to Follow-up|2|||
144451663|NCT02778204|520850292|FG003|Overall Study|Lost to Follow-up|1|||
144451664|NCT02778204|520850289|FG000|Overall Study|Protocol Violation|0|||
144451665|NCT02778204|520850290|FG001|Overall Study|Protocol Violation|0|||
144451666|NCT02778204|520850291|FG002|Overall Study|Protocol Violation|1|||
144451667|NCT02778204|520850292|FG003|Overall Study|Protocol Violation|0|||
144451668|NCT02778204|520850289|FG000|Overall Study|Eligibility Violation|0|||
144451669|NCT02778204|520850290|FG001|Overall Study|Eligibility Violation|0|||
144451670|NCT02778204|520850291|FG002|Overall Study|Eligibility Violation|0|||
144451671|NCT02778204|520850292|FG003|Overall Study|Eligibility Violation|1|||
144451672|NCT04122443|520850293|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
144451673|NCT04122443|520850294|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
144451674|NCT04122443|520850295|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
144451675|NCT04122443|520850293|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
144451676|NCT04122443|520850294|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
144606835|NCT01159912|521421112|FG001|Overall Study|Lost to Follow-up|0|||
144195549|NCT00430495|519911969|FG001|Overall Study|Death|0|||
144195550|NCT00430495|519911970|FG002|Overall Study|Death|1|||
144195551|NCT00430495|519911971|FG003|Overall Study|Death|0|||
144195552|NCT00430495|519911968|FG000|Overall Study|Lost to Follow-up|0|||
144195553|NCT00430495|519911969|FG001|Overall Study|Lost to Follow-up|1|||
144195554|NCT00430495|519911970|FG002|Overall Study|Lost to Follow-up|4|||
144451677|NCT04122443|520850295|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
144451678|NCT01916304|520850296|FG000|Overall Study|Screening failure|17|||
144451679|NCT01898793|520850297|FG000|Overall Study|Death|2|||
144195555|NCT00430495|519911971|FG003|Overall Study|Lost to Follow-up|0|||
144451680|NCT01898793|520850298|FG001|Overall Study|Death|1|||
144254303|NCT03026283|520131711|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
144254304|NCT03026283|520131712|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
144254305|NCT03026283|520131713|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
144254306|NCT03026283|520131714|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
144254307|NCT03026283|520131715|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
144254308|NCT03026283|520131708|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144451681|NCT01898793|520850299|FG002|Overall Study|Death|4|||
144451682|NCT01898793|520850300|FG003|Overall Study|Death|0|||
144451683|NCT01898793|520850301|FG004|Overall Study|Death|0|||
144451684|NCT01898793|520850302|FG005|Overall Study|Death|0|||
144451685|NCT01898793|520850303|FG006|Overall Study|Death|0|||
144451686|NCT04666441|520850304|FG000|Overall Study|Lost to Follow-up|1|||
144451687|NCT04666441|520850305|FG001|Overall Study|Lost to Follow-up|4|||
144451688|NCT04666441|520850306|FG002|Overall Study|Lost to Follow-up|1|||
144451689|NCT04666441|520850307|FG003|Overall Study|Lost to Follow-up|3|||
144451690|NCT04666441|520850308|FG004|Overall Study|Lost to Follow-up|0|||
144451691|NCT04666441|520850309|FG005|Overall Study|Lost to Follow-up|2|||
144451692|NCT04666441|520850310|FG006|Overall Study|Lost to Follow-up|2|||
144451693|NCT04666441|520850311|FG007|Overall Study|Lost to Follow-up|2|||
144451694|NCT04666441|520850304|FG000|Overall Study|Subject Decision|1|||
144195556|NCT00430495|519911968|FG000|Overall Study|Protocol Violation|1|||
144195557|NCT00430495|519911969|FG001|Overall Study|Protocol Violation|0|||
144195558|NCT00430495|519911970|FG002|Overall Study|Protocol Violation|1|||
144195559|NCT00430495|519911971|FG003|Overall Study|Protocol Violation|0|||
144195560|NCT00430495|519911968|FG000|Overall Study|Disease Progression|1|||
144195561|NCT00430495|519911969|FG001|Overall Study|Disease Progression|1|||
144195562|NCT00430495|519911970|FG002|Overall Study|Disease Progression|0|||
144451695|NCT04666441|520850305|FG001|Overall Study|Subject Decision|1|||
144451696|NCT04666441|520850306|FG002|Overall Study|Subject Decision|3|||
144451697|NCT04666441|520850307|FG003|Overall Study|Subject Decision|1|||
144451698|NCT04666441|520850308|FG004|Overall Study|Subject Decision|0|||
144451699|NCT04666441|520850309|FG005|Overall Study|Subject Decision|1|||
144451700|NCT04666441|520850310|FG006|Overall Study|Subject Decision|3|||
144451701|NCT04666441|520850311|FG007|Overall Study|Subject Decision|2|||
144451702|NCT01578551|520850312|FG000|Overall Study|Adverse Event|1|||
144451703|NCT01578551|520850313|FG001|Overall Study|Adverse Event|0|||
144451704|NCT04028388|520850320|FG000|Overall Study|Evaluations missing|3|||
144451705|NCT04028388|520850321|FG001|Overall Study|Evaluations missing|6|||
144451706|NCT04028388|520850320|FG000|Overall Study|Not started|2|||
144451707|NCT04028388|520850321|FG001|Overall Study|Not started|0|||
144451708|NCT01312467|520850327|FG000|Overall Study|Adverse Event|4|||
144451709|NCT01312467|520850327|FG000|Overall Study|Lost to Follow-up|1|||
144451710|NCT01312467|520850327|FG000|Overall Study|Withdrawal by Subject|2|||
144451711|NCT01312467|520850327|FG000|Overall Study|Deported to country of origin|1|||
144451712|NCT01312467|520850327|FG000|Overall Study|Another medical condition|1|||
144451713|NCT01312467|520850327|FG000|Overall Study|Ineligible|4|||
144451714|NCT00129259|520850328|FG000|Overall Study|Lost to Follow-up|1|||
144451715|NCT00129259|520850329|FG001|Overall Study|Lost to Follow-up|1|||
144451716|NCT00129259|520850328|FG000|Overall Study|Withdrawal by Subject|2|||
144451717|NCT00129259|520850329|FG001|Overall Study|Withdrawal by Subject|1|||
144451718|NCT00129259|520850328|FG000|Overall Study|Only available minimal phone assessments|0|||
144451719|NCT00129259|520850329|FG001|Overall Study|Only available minimal phone assessments|1|||
144451720|NCT01632579|520850335|FG000|Washout Period|Adverse Event|1|||
144451721|NCT01632579|520850336|FG001|Washout Period|Adverse Event|0|||
144451722|NCT01632579|520850337|FG002|Washout Period|Adverse Event|0|||
144254309|NCT03026283|520131709|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
144451723|NCT01632579|520850338|FG003|Washout Period|Adverse Event|0|||
144451724|NCT01632579|520850339|FG004|Washout Period|Adverse Event|0|||
144451725|NCT01632579|520850340|FG005|Washout Period|Adverse Event|0|||
144451726|NCT01632579|520850341|FG006|Washout Period|Adverse Event|0|||
144451727|NCT01632579|520850342|FG007|Washout Period|Adverse Event|0|||
144451728|NCT01632579|520850343|FG008|Washout Period|Adverse Event|0|||
144451729|NCT01632579|520850335|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
144451730|NCT01632579|520850336|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
144451731|NCT01632579|520850337|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
144451732|NCT01632579|520850338|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
144451733|NCT01632579|520850339|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
144451734|NCT01632579|520850340|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
144451735|NCT01632579|520850341|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
144451736|NCT01632579|520850342|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
144606836|NCT01159912|521421113|FG002|Overall Study|Lost to Follow-up|0|||
144451737|NCT01632579|520850343|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
144451738|NCT03779841|520850344|FG000|Randomized Population|Did Not Receive Treatment|3|||
144451739|NCT03779841|520850345|FG001|Randomized Population|Did Not Receive Treatment|1|||
144451740|NCT03779841|520850346|FG002|Randomized Population|Did Not Receive Treatment|0|||
144451741|NCT03779841|520850344|FG000|Treated (Safety) Population|Adverse Event|1|||
144195563|NCT00430495|519911971|FG003|Overall Study|Disease Progression|0|||
144451742|NCT03779841|520850345|FG001|Treated (Safety) Population|Adverse Event|1|||
144254310|NCT03026283|520131710|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144254311|NCT03026283|520131711|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144254312|NCT03026283|520131712|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144254313|NCT03026283|520131713|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144254314|NCT03026283|520131714|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144254315|NCT03026283|520131715|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
144254316|NCT03026283|520131708|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254317|NCT03026283|520131709|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254318|NCT03026283|520131710|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
144254319|NCT03026283|520131711|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254320|NCT03026283|520131712|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254321|NCT03026283|520131713|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254322|NCT03026283|520131714|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254323|NCT03026283|520131715|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
144254324|NCT03026283|520131708|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
144254325|NCT03026283|520131709|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
144254326|NCT03026283|520131710|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
144254327|NCT03026283|520131711|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
144254328|NCT03026283|520131712|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
144254329|NCT03026283|520131713|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
144254330|NCT03026283|520131714|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
144254331|NCT03026283|520131715|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
144254332|NCT03026283|520131708|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
144254333|NCT03026283|520131709|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
144254334|NCT03026283|520131710|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
144254335|NCT03026283|520131711|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
144254336|NCT03026283|520131712|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
144451743|NCT03779841|520850346|FG002|Treated (Safety) Population|Adverse Event|0|||
144451744|NCT03779841|520850344|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
144451745|NCT03779841|520850345|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
144451746|NCT03779841|520850346|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
144254337|NCT03026283|520131713|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
144254338|NCT03026283|520131714|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
144254339|NCT03026283|520131715|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
144254340|NCT03026283|520131708|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
144254341|NCT03026283|520131709|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
144254342|NCT03026283|520131710|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
144451747|NCT03779841|520850344|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
144451748|NCT03779841|520850345|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
144451749|NCT03779841|520850346|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
144451750|NCT03779841|520850344|FG000|Treated (Safety) Population|Death|1|||
144451751|NCT03779841|520850345|FG001|Treated (Safety) Population|Death|0|||
144451752|NCT03779841|520850346|FG002|Treated (Safety) Population|Death|2|||
144451753|NCT00818441|520850347|FG000|Overall Study|Death|69|||
144451754|NCT00818441|520850348|FG001|Overall Study|Death|26|||
144451755|NCT00818441|520850347|FG000|Overall Study|Other|5|||
144451756|NCT00818441|520850348|FG001|Overall Study|Other|0|||
144451757|NCT00818441|520850347|FG000|Overall Study|Lost to Follow-up|2|||
144451758|NCT00818441|520850348|FG001|Overall Study|Lost to Follow-up|1|||
144451759|NCT00818441|520850347|FG000|Overall Study|Withdrawal by Subject|2|||
144451760|NCT00818441|520850348|FG001|Overall Study|Withdrawal by Subject|0|||
144451761|NCT00818441|520850347|FG000|Overall Study|Adverse Event|0|||
144451762|NCT00818441|520850348|FG001|Overall Study|Adverse Event|1|||
144451763|NCT00818441|520850347|FG000|Overall Study|Study terminated by sponsor|11|||
144725547|NCT01957488|521851282|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
144725548|NCT01957488|521851283|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
144725549|NCT01957488|521851278|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
144254343|NCT03026283|520131711|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
144254344|NCT03026283|520131712|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
144254345|NCT03026283|520131713|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
144254346|NCT03026283|520131714|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
144451764|NCT00818441|520850348|FG001|Overall Study|Study terminated by sponsor|2|||
144451765|NCT02199691|520850349|FG000|Overall Study|Protocol Violation|3|||
144451766|NCT02199691|520850350|FG001|Overall Study|Protocol Violation|3|||
144254347|NCT03026283|520131715|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
144451767|NCT02199691|520850351|FG002|Overall Study|Protocol Violation|6|||
144451768|NCT02199691|520850352|FG003|Overall Study|Protocol Violation|7|||
144451769|NCT02199691|520850349|FG000|Overall Study|Withdrawal by Subject|5|||
144451770|NCT02199691|520850350|FG001|Overall Study|Withdrawal by Subject|3|||
144725550|NCT01957488|521851279|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
144725551|NCT01957488|521851280|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
144725552|NCT01957488|521851281|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
144725553|NCT01957488|521851282|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
144725554|NCT01957488|521851283|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
144725555|NCT01957488|521851278|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
144725556|NCT01957488|521851279|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
144725557|NCT01957488|521851280|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
144725558|NCT01957488|521851281|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
144725559|NCT01957488|521851282|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
144725560|NCT01957488|521851283|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
144725561|NCT01957488|521851278|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
144725562|NCT01957488|521851279|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
144725563|NCT01957488|521851280|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
144725564|NCT01957488|521851281|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
144725565|NCT01957488|521851282|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
144725566|NCT01957488|521851283|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
144725567|NCT02419313|521851284|FG000|First Intervention|Lost to Follow-up|2|||
144725568|NCT02419313|521851285|FG001|First Intervention|Lost to Follow-up|0|||
144725569|NCT02419313|521851284|FG000|Second Intervention|Lost to Follow-up|1|||
144725570|NCT02419313|521851285|FG001|Second Intervention|Lost to Follow-up|0|||
144725571|NCT00442936|521851286|FG000|Overall Study|Protocol Violation|1|||
144725572|NCT00442936|521851287|FG001|Overall Study|Protocol Violation|0|||
144725573|NCT00442936|521851288|FG002|Overall Study|Protocol Violation|1|||
144725574|NCT00442936|521851289|FG003|Overall Study|Protocol Violation|1|||
144725575|NCT00524459|521851291|FG000|Overall Study|Withdrawal by Subject|1|||
144725576|NCT00524459|521851291|FG000|Overall Study|Other|1|||
144725577|NCT02428699|521851292|FG000|Washout Period 1|Screen Failure|1|||
144725578|NCT02428699|521851293|FG001|Washout Period 1|Screen Failure|2|||
144725579|NCT02433678|521851294|FG000|Overall Study|Lost to Follow-up|1|||
144725580|NCT02433678|521851295|FG001|Overall Study|Lost to Follow-up|2|||
144725581|NCT04424407|521851296|FG000|Overall Study|Withdrawal by Subject|2|||
144725582|NCT04424407|521851296|FG000|Overall Study|Lost to Follow-up|1|||
144725583|NCT01424722|521851299|FG000|Overall Study|Sponsor terminated investigation|2258|||
144725584|NCT02684578|521851300|FG000|Overall Study|Withdrawal by Subject|10|||
144725585|NCT02684578|521851301|FG001|Overall Study|Withdrawal by Subject|7|||
144725586|NCT02684578|521851300|FG000|Overall Study|Lost to Follow-up|0|||
144725587|NCT02684578|521851301|FG001|Overall Study|Lost to Follow-up|3|||
144725588|NCT02684578|521851300|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
144725589|NCT02684578|521851301|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
144195564|NCT00430495|519911968|FG000|Overall Study|Other|8|||
144195565|NCT00430495|519911969|FG001|Overall Study|Other|2|||
144195566|NCT00430495|519911970|FG002|Overall Study|Other|5|||
144195567|NCT00430495|519911971|FG003|Overall Study|Other|4|||
144195568|NCT00430495|519911968|FG000|Overall Study|Randomized but not Treated|2|||
144195569|NCT00430495|519911969|FG001|Overall Study|Randomized but not Treated|0|||
144195570|NCT00430495|519911970|FG002|Overall Study|Randomized but not Treated|0|||
144195571|NCT00430495|519911971|FG003|Overall Study|Randomized but not Treated|0|||
144195572|NCT00158756|519911972|FG000|Overall Study|Withdrawal by Subject|5|||
144195573|NCT00158756|519911973|FG001|Overall Study|Withdrawal by Subject|0|||
144195574|NCT00158756|519911974|FG002|Overall Study|Withdrawal by Subject|6|||
144195575|NCT00158756|519911975|FG003|Overall Study|Withdrawal by Subject|1|||
144195576|NCT00158756|519911976|FG004|Overall Study|Withdrawal by Subject|3|||
144195577|NCT00158756|519911972|FG000|Overall Study|Adverse Event|0|||
144195578|NCT00158756|519911973|FG001|Overall Study|Adverse Event|0|||
144195579|NCT00158756|519911974|FG002|Overall Study|Adverse Event|1|||
144195580|NCT00158756|519911975|FG003|Overall Study|Adverse Event|0|||
144195581|NCT00158756|519911976|FG004|Overall Study|Adverse Event|0|||
144195582|NCT00158756|519911972|FG000|Overall Study|Serious adverse event|0|||
144195583|NCT00158756|519911973|FG001|Overall Study|Serious adverse event|0|||
144195584|NCT00158756|519911974|FG002|Overall Study|Serious adverse event|1|||
144195585|NCT00158756|519911975|FG003|Overall Study|Serious adverse event|0|||
144195586|NCT00158756|519911976|FG004|Overall Study|Serious adverse event|0|||
144195587|NCT02400671|519911977|FG000|Overall Study|Death|5|||
144195588|NCT02400671|519911978|FG001|Overall Study|Death|3|||
144195589|NCT02400671|519911979|FG002|Overall Study|Death|4|||
144195590|NCT02400671|519911977|FG000|Overall Study|Lost to Follow-up|20|||
144195591|NCT02400671|519911978|FG001|Overall Study|Lost to Follow-up|27|||
144195592|NCT02400671|519911979|FG002|Overall Study|Lost to Follow-up|24|||
144195593|NCT02400671|519911977|FG000|Overall Study|Withdrawal by Subject|2|||
144195594|NCT02400671|519911978|FG001|Overall Study|Withdrawal by Subject|2|||
144195595|NCT02400671|519911979|FG002|Overall Study|Withdrawal by Subject|0|||
144195596|NCT01892657|519911980|FG000|Overall Study|Withdrawal by Subject|6|||
144725590|NCT02684578|521851300|FG000|Overall Study|Missing follow-up data|0|||
144725591|NCT02684578|521851301|FG001|Overall Study|Missing follow-up data|1|||
144725592|NCT01153984|521851302|FG000|Overall Study|Withdrawal by Subject|1|||
144195597|NCT01892657|519911980|FG000|Overall Study|Protocol Violation|12|||
144254348|NCT03026283|520131708|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254349|NCT03026283|520131709|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254350|NCT03026283|520131710|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254351|NCT03026283|520131711|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
144254352|NCT03026283|520131712|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254353|NCT03026283|520131713|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254354|NCT03026283|520131714|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254355|NCT03026283|520131715|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
144254356|NCT03026283|520131708|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
144254357|NCT03026283|520131709|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
144254358|NCT03026283|520131710|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
144254359|NCT03026283|520131711|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
144451771|NCT02199691|520850351|FG002|Overall Study|Withdrawal by Subject|12|||
144451772|NCT02199691|520850352|FG003|Overall Study|Withdrawal by Subject|13|||
144451773|NCT02199691|520850349|FG000|Overall Study|Lost to Follow-up|2|||
144451774|NCT02199691|520850350|FG001|Overall Study|Lost to Follow-up|1|||
144451775|NCT02199691|520850351|FG002|Overall Study|Lost to Follow-up|9|||
144451776|NCT02199691|520850352|FG003|Overall Study|Lost to Follow-up|10|||
144606837|NCT01159912|521421111|FG000|Overall Study|Physician Decision|0|||
144195598|NCT02566993|519911982|FG000|Overall Study|Randomized but not treated|5|||
144195599|NCT02566993|519911983|FG001|Overall Study|Randomized but not treated|16|||
144195600|NCT02566993|519911982|FG000|Overall Study|Progressive disease|213|||
144195601|NCT02566993|519911983|FG001|Overall Study|Progressive disease|152|||
144195602|NCT02566993|519911982|FG000|Overall Study|Withdrawal by Subject|12|||
144195603|NCT02566993|519911983|FG001|Overall Study|Withdrawal by Subject|28|||
144195604|NCT02566993|519911982|FG000|Overall Study|Death|17|||
144195605|NCT02566993|519911983|FG001|Overall Study|Death|23|||
144195606|NCT02566993|519911982|FG000|Overall Study|Physician Decision|10|||
144195607|NCT02566993|519911983|FG001|Overall Study|Physician Decision|17|||
144195608|NCT02566993|519911982|FG000|Overall Study|Study drug-related adverse event|20|||
144195609|NCT02566993|519911983|FG001|Overall Study|Study drug-related adverse event|41|||
144195610|NCT02566993|519911982|FG000|Overall Study|Non study drug-related adverse event|9|||
144195611|NCT02566993|519911983|FG001|Overall Study|Non study drug-related adverse event|9|||
144195612|NCT02566993|519911982|FG000|Overall Study|Symptomatic deterioration|9|||
144195613|NCT02566993|519911983|FG001|Overall Study|Symptomatic deterioration|16|||
144195614|NCT02566993|519911982|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
144195615|NCT02566993|519911983|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
144195616|NCT02566993|519911982|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
144195617|NCT02566993|519911983|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
144195618|NCT02566993|519911982|FG000|Overall Study|Screening failure|2|||
144195619|NCT02566993|519911983|FG001|Overall Study|Screening failure|0|||
144195620|NCT02566993|519911982|FG000|Overall Study|Lost to Follow-up|0|||
144195621|NCT02566993|519911983|FG001|Overall Study|Lost to Follow-up|1|||
144195622|NCT02566993|519911982|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
144195623|NCT02566993|519911983|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
144195624|NCT01546649|519911986|FG000|Overall Study|Adverse Event|4|||
144195625|NCT01546649|519911987|FG001|Overall Study|Adverse Event|5|||
144195626|NCT01546649|519911986|FG000|Overall Study|Protocol Violation|1|||
144195627|NCT01546649|519911987|FG001|Overall Study|Protocol Violation|0|||
144195628|NCT01546649|519911986|FG000|Overall Study|Lack of Efficacy|1|||
144195629|NCT01546649|519911987|FG001|Overall Study|Lack of Efficacy|0|||
144195630|NCT01546649|519911986|FG000|Overall Study|Recurrence|1|||
144195631|NCT01546649|519911987|FG001|Overall Study|Recurrence|1|||
144195632|NCT01546649|519911986|FG000|Overall Study|Discovery of secondary cancer|0|||
144195633|NCT01546649|519911987|FG001|Overall Study|Discovery of secondary cancer|1|||
144195634|NCT01546649|519911986|FG000|Overall Study|Withdrawal by Subject|1|||
144195635|NCT01546649|519911987|FG001|Overall Study|Withdrawal by Subject|2|||
144195636|NCT00942331|519911990|FG000|Overall Study|Did not start treatment|15|||
144195637|NCT00942331|519911991|FG001|Overall Study|Did not start treatment|22|||
144195638|NCT00567476|519911993|FG000|Overall Study|Adverse Event|2|||
144606838|NCT01159912|521421112|FG001|Overall Study|Physician Decision|0|||
144195639|NCT00567476|519911994|FG001|Overall Study|Adverse Event|0|||
144195640|NCT00567476|519911993|FG000|Overall Study|Pregnancy|1|||
144254360|NCT03026283|520131712|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
144451777|NCT01209624|520850358|FG000|Overall Study|Death|2|||
144451778|NCT01209624|520850358|FG000|Overall Study|Adverse Event|13|||
144195641|NCT00567476|519911994|FG001|Overall Study|Pregnancy|0|||
144195642|NCT00567476|519911993|FG000|Overall Study|Protocol Violation|4|||
144451779|NCT01209624|520850358|FG000|Overall Study|Lack of Efficacy|17|||
144195643|NCT00567476|519911994|FG001|Overall Study|Protocol Violation|1|||
144195644|NCT00567476|519911993|FG000|Overall Study|Lost to Follow-up|0|||
144254361|NCT03026283|520131713|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
144254362|NCT03026283|520131714|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
144254363|NCT03026283|520131715|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
144451780|NCT01209624|520850358|FG000|Overall Study|Lost to Follow-up|290|||
144451781|NCT01209624|520850358|FG000|Overall Study|Other|4|||
144254364|NCT03479008|520131720|FG000|Overall Study|Withdrawal by Subject|3|||
144254365|NCT01796301|520131721|FG000|Overall Study|Withdrawal by Subject|15|||
144451782|NCT01539291|520852512|FG000|Study GS-US-312-0116|Adverse Event|9|||
144451783|NCT01539291|520852513|FG001|Study GS-US-312-0116|Adverse Event|0|||
144451784|NCT01539291|520852514|FG002|Study GS-US-312-0116|Adverse Event|0|||
144451785|NCT01539291|520852515|FG003|Study GS-US-312-0116|Adverse Event|0|||
144451786|NCT01539291|520852512|FG000|Study GS-US-312-0116|Physician Decision|1|||
144451787|NCT01539291|520852513|FG001|Study GS-US-312-0116|Physician Decision|0|||
144254366|NCT01796301|520131722|FG001|Overall Study|Withdrawal by Subject|15|||
144254367|NCT01796301|520131721|FG000|Overall Study|Lost to Follow-up|3|||
144254368|NCT01796301|520131722|FG001|Overall Study|Lost to Follow-up|3|||
144254369|NCT01796301|520131721|FG000|Overall Study|Death|0|||
144254370|NCT01796301|520131722|FG001|Overall Study|Death|1|||
144254371|NCT01796301|520131721|FG000|Overall Study|Decision by Sponsor|0|||
144254372|NCT01796301|520131722|FG001|Overall Study|Decision by Sponsor|1|||
144254373|NCT01704755|520131723|FG000|Overall Study|Adverse Event|4|||
144254374|NCT01704755|520131724|FG001|Overall Study|Adverse Event|1|||
144254375|NCT01704755|520131723|FG000|Overall Study|Lost to Follow-up|3|||
144254376|NCT01704755|520131724|FG001|Overall Study|Lost to Follow-up|4|||
144451788|NCT01539291|520852514|FG002|Study GS-US-312-0116|Physician Decision|0|||
144451789|NCT01539291|520852515|FG003|Study GS-US-312-0116|Physician Decision|0|||
144254377|NCT01704755|520131723|FG000|Overall Study|Withdrew consent|1|||
144254378|NCT01704755|520131724|FG001|Overall Study|Withdrew consent|1|||
144254379|NCT01704755|520131723|FG000|Overall Study|Other (not specified)|3|||
144254380|NCT01704755|520131724|FG001|Overall Study|Other (not specified)|1|||
144254381|NCT01704755|520131723|FG000|Overall Study|Withdrew consent and personal issues|1|||
144254382|NCT01704755|520131724|FG001|Overall Study|Withdrew consent and personal issues|0|||
144254383|NCT00667563|520131725|FG000|Overall Study|Protocol Violation|24|||
144254384|NCT00264290|520131742|FG000|Intervention (8 Weeks)|Adverse Event|1|||
144254385|NCT00264290|520131743|FG001|Intervention (8 Weeks)|Adverse Event|0|||
144254386|NCT04472494|520131744|FG000|Pre-treatment|Other reasons|2|||
144254387|NCT04472494|520131745|FG001|Pre-treatment|Other reasons|0|||
144254388|NCT04472494|520131744|FG000|Treatment|Death|5|||
144451790|NCT01539291|520852512|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
144451791|NCT01539291|520852513|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
144451792|NCT01539291|520852514|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
144451793|NCT01539291|520852515|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
144451794|NCT01539291|520852512|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
144451795|NCT01539291|520852513|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
144451796|NCT01539291|520852514|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
144451797|NCT01539291|520852515|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
144451798|NCT01539291|520852512|FG000|Study GS-US-312-0116|Other|1|||
144451799|NCT01539291|520852513|FG001|Study GS-US-312-0116|Other|0|||
144451800|NCT01539291|520852514|FG002|Study GS-US-312-0116|Other|0|||
144451801|NCT01539291|520852515|FG003|Study GS-US-312-0116|Other|0|||
144451802|NCT01539291|520852512|FG000|Study GS-US-312-0117|Adverse Event|22|||
144451803|NCT01539291|520852513|FG001|Study GS-US-312-0117|Adverse Event|1|||
144451804|NCT01539291|520852514|FG002|Study GS-US-312-0117|Adverse Event|9|||
144451805|NCT01539291|520852515|FG003|Study GS-US-312-0117|Adverse Event|12|||
144451806|NCT01539291|520852512|FG000|Study GS-US-312-0117|Physician Decision|9|||
144451807|NCT01539291|520852513|FG001|Study GS-US-312-0117|Physician Decision|0|||
144451808|NCT01539291|520852514|FG002|Study GS-US-312-0117|Physician Decision|6|||
144451809|NCT01539291|520852515|FG003|Study GS-US-312-0117|Physician Decision|4|||
144451810|NCT01539291|520852512|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
144451811|NCT01539291|520852513|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
144451812|NCT01539291|520852514|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
144451813|NCT01539291|520852515|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
144451814|NCT01539291|520852512|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
144451815|NCT01539291|520852513|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
144451816|NCT01539291|520852514|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
144254389|NCT04472494|520131745|FG001|Treatment|Death|2|||
144451817|NCT01539291|520852515|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
144254390|NCT04472494|520131744|FG000|Treatment|Hospital discharge|1|||
144254391|NCT04472494|520131745|FG001|Treatment|Hospital discharge|1|||
144451818|NCT01539291|520852512|FG000|Study GS-US-312-0117|Other|2|||
144451819|NCT01539291|520852513|FG001|Study GS-US-312-0117|Other|1|||
144254392|NCT04399889|520131746|FG000|Overall Study|Death|5|||
144254393|NCT04399889|520131747|FG001|Overall Study|Death|1|||
144254394|NCT04399889|520131748|FG002|Overall Study|Death|1|||
144254395|NCT01152996|520131752|FG000|Overall Study|Withdrawal by Subject|142|||
144254396|NCT01152996|520131752|FG000|Overall Study|Adverse Event|115|||
144195645|NCT00567476|519911994|FG001|Overall Study|Lost to Follow-up|1|||
144195646|NCT00567476|519911993|FG000|Overall Study|Administrative issues|1|||
144195647|NCT00567476|519911994|FG001|Overall Study|Administrative issues|0|||
144451820|NCT01539291|520852514|FG002|Study GS-US-312-0117|Other|1|||
144451821|NCT01539291|520852515|FG003|Study GS-US-312-0117|Other|1|||
144451822|NCT04450264|520852516|FG000|Overall Study|Incomplete survey|13|||
144451823|NCT04450264|520852517|FG001|Overall Study|Incomplete survey|19|||
144451824|NCT03320070|520852518|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
144451825|NCT03320070|520852519|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
144451826|NCT03320070|520852518|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
144451827|NCT03320070|520852519|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
144451828|NCT03320070|520852518|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
144451829|NCT03320070|520852519|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
144451830|NCT03320070|520852518|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
144451831|NCT03320070|520852519|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
144451832|NCT03320070|520852518|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
144451833|NCT03320070|520852519|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
144451834|NCT03320070|520852518|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
144451835|NCT03320070|520852519|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
144451836|NCT00003457|520852525|FG000|Overall Study|Not evaluable|9|||
144451837|NCT00466193|520852526|FG000|Overall Study|Adverse Event|0|||
144451838|NCT00466193|520852527|FG001|Overall Study|Adverse Event|1|||
144451839|NCT00466193|520852526|FG000|Overall Study|Lost to Follow-up|2|||
144451840|NCT00466193|520852527|FG001|Overall Study|Lost to Follow-up|4|||
144451841|NCT00466193|520852526|FG000|Overall Study|Physician Decision|1|||
144451842|NCT00466193|520852527|FG001|Overall Study|Physician Decision|0|||
144451843|NCT00466193|520852526|FG000|Overall Study|Protocol Violation|1|||
144451844|NCT00466193|520852527|FG001|Overall Study|Protocol Violation|1|||
144451845|NCT00466193|520852526|FG000|Overall Study|Withdrawal by Subject|7|||
144451846|NCT00466193|520852527|FG001|Overall Study|Withdrawal by Subject|2|||
144451847|NCT00466193|520852526|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
144451848|NCT00466193|520852527|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
144451849|NCT02246998|520852528|FG000|Overall Study|Adverse Event|0|||
144451850|NCT02246998|520852529|FG001|Overall Study|Adverse Event|1|||
144451851|NCT02246998|520852530|FG002|Overall Study|Adverse Event|1|||
144451852|NCT02246998|520852531|FG003|Overall Study|Adverse Event|0|||
144451853|NCT02246998|520852528|FG000|Overall Study|Lost to Follow-up|1|||
144195648|NCT00567476|519911993|FG000|Overall Study|Medical Decision|0|||
144195649|NCT00567476|519911994|FG001|Overall Study|Medical Decision|1|||
144451854|NCT02246998|520852529|FG001|Overall Study|Lost to Follow-up|0|||
144606839|NCT01159912|521421113|FG002|Overall Study|Physician Decision|3|||
144606840|NCT01159912|521421111|FG000|Overall Study|Withdrawal by Subject|10|||
144606841|NCT01159912|521421112|FG001|Overall Study|Withdrawal by Subject|3|||
144195650|NCT00567476|519911993|FG000|Overall Study|Non-adherence to protocol|0|||
144451855|NCT02246998|520852530|FG002|Overall Study|Lost to Follow-up|0|||
144451856|NCT02246998|520852531|FG003|Overall Study|Lost to Follow-up|1|||
144451857|NCT02246998|520852528|FG000|Overall Study|Randomized but Never Dosed|1|||
144451858|NCT02246998|520852529|FG001|Overall Study|Randomized but Never Dosed|2|||
144451859|NCT02246998|520852530|FG002|Overall Study|Randomized but Never Dosed|2|||
144451860|NCT02246998|520852531|FG003|Overall Study|Randomized but Never Dosed|1|||
144451861|NCT02473614|520852541|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
144451862|NCT02473614|520852542|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
144451863|NCT02525133|520852543|FG000|Overall Study|Adverse Event|0|||
144451864|NCT02525133|520852544|FG001|Overall Study|Adverse Event|1|||
144451865|NCT02525133|520852543|FG000|Overall Study|Death|0|||
144451866|NCT02525133|520852544|FG001|Overall Study|Death|1|||
144451867|NCT02525133|520852543|FG000|Overall Study|did not meet randomization criteria|1|||
144451868|NCT02525133|520852544|FG001|Overall Study|did not meet randomization criteria|0|||
144451869|NCT02525133|520852543|FG000|Overall Study|Lost to Follow-up|5|||
144451870|NCT02525133|520852544|FG001|Overall Study|Lost to Follow-up|1|||
144451871|NCT02525133|520852543|FG000|Overall Study|randomized not enrolled|3|||
144451872|NCT02525133|520852544|FG001|Overall Study|randomized not enrolled|0|||
144451873|NCT02525133|520852543|FG000|Overall Study|Withdrawal by Subject|1|||
144451874|NCT02525133|520852544|FG001|Overall Study|Withdrawal by Subject|0|||
144451875|NCT01075074|520852545|FG000|Overall Study|Surgeon changed to open incisional case|1|||
144451876|NCT01075074|520852546|FG001|Overall Study|Surgeon changed to open incisional case|2|||
144451877|NCT01075074|520852547|FG002|Overall Study|Surgeon changed to open incisional case|2|||
144451878|NCT02416791|520852548|FG000|6 Months|Lost to Follow-up|0|||
144606842|NCT01159912|521421113|FG002|Overall Study|Withdrawal by Subject|3|||
144195651|NCT00567476|519911994|FG001|Overall Study|Non-adherence to protocol|1|||
144451879|NCT02416791|520852549|FG001|6 Months|Lost to Follow-up|0|||
144451880|NCT02416791|520852550|FG002|6 Months|Lost to Follow-up|1|||
144451881|NCT01054729|520852551|FG000|Overall Study|Randomized but Not Treated|0|||
144451882|NCT01054729|520852552|FG001|Overall Study|Randomized but Not Treated|1|||
144451883|NCT01054729|520852553|FG002|Overall Study|Randomized but Not Treated|0|||
144451884|NCT01054729|520852554|FG003|Overall Study|Randomized but Not Treated|0|||
144451885|NCT01054729|520852551|FG000|Overall Study|Adverse Event|1|||
144451886|NCT01054729|520852552|FG001|Overall Study|Adverse Event|1|||
144451887|NCT01054729|520852553|FG002|Overall Study|Adverse Event|2|||
144451888|NCT01054729|520852554|FG003|Overall Study|Adverse Event|1|||
144451889|NCT01054729|520852551|FG000|Overall Study|Withdrawal by Subject|1|||
144451890|NCT01054729|520852552|FG001|Overall Study|Withdrawal by Subject|0|||
144451891|NCT01054729|520852553|FG002|Overall Study|Withdrawal by Subject|1|||
144451892|NCT01054729|520852554|FG003|Overall Study|Withdrawal by Subject|0|||
144451893|NCT01054729|520852551|FG000|Overall Study|Lost to Follow-up|0|||
144451894|NCT01054729|520852552|FG001|Overall Study|Lost to Follow-up|1|||
144451895|NCT01054729|520852553|FG002|Overall Study|Lost to Follow-up|0|||
144451896|NCT01054729|520852554|FG003|Overall Study|Lost to Follow-up|0|||
144451897|NCT01054729|520852551|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
144451898|NCT01054729|520852552|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
144451899|NCT01054729|520852553|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
144451900|NCT01054729|520852554|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
144451901|NCT01054729|520852551|FG000|Overall Study|Non-responder|1|||
144451902|NCT01054729|520852552|FG001|Overall Study|Non-responder|0|||
144451903|NCT01054729|520852553|FG002|Overall Study|Non-responder|1|||
144451904|NCT01054729|520852554|FG003|Overall Study|Non-responder|1|||
144451905|NCT01054729|520852551|FG000|Overall Study|PEG/RBV Non-responder|1|||
144451906|NCT01054729|520852552|FG001|Overall Study|PEG/RBV Non-responder|0|||
144451907|NCT01054729|520852553|FG002|Overall Study|PEG/RBV Non-responder|1|||
144451908|NCT01054729|520852554|FG003|Overall Study|PEG/RBV Non-responder|0|||
144451909|NCT01054729|520852551|FG000|Overall Study|Personal/Obligations|0|||
144451910|NCT01054729|520852552|FG001|Overall Study|Personal/Obligations|1|||
144451911|NCT01054729|520852553|FG002|Overall Study|Personal/Obligations|0|||
144451912|NCT01054729|520852554|FG003|Overall Study|Personal/Obligations|0|||
144451913|NCT01054729|520852551|FG000|Overall Study|Subject moved|0|||
144451914|NCT01054729|520852552|FG001|Overall Study|Subject moved|0|||
144451915|NCT01054729|520852553|FG002|Overall Study|Subject moved|1|||
144451916|NCT01054729|520852554|FG003|Overall Study|Subject moved|0|||
144451917|NCT01054729|520852551|FG000|Overall Study|Lack of Efficacy|0|||
144451918|NCT01054729|520852552|FG001|Overall Study|Lack of Efficacy|0|||
144451919|NCT01054729|520852553|FG002|Overall Study|Lack of Efficacy|0|||
144451920|NCT01054729|520852554|FG003|Overall Study|Lack of Efficacy|1|||
144451921|NCT00562159|520852555|FG000|Overall Study|Adverse Event|11|||
144451922|NCT00562159|520852556|FG001|Overall Study|Adverse Event|8|||
144451923|NCT00562159|520852555|FG000|Overall Study|Lost to Follow-up|5|||
144451924|NCT00562159|520852556|FG001|Overall Study|Lost to Follow-up|4|||
144451925|NCT00562159|520852555|FG000|Overall Study|Withdrawal by Subject|9|||
144451926|NCT00562159|520852556|FG001|Overall Study|Withdrawal by Subject|8|||
144451927|NCT00562159|520852555|FG000|Overall Study|Protocol Violation|12|||
144451928|NCT00562159|520852556|FG001|Overall Study|Protocol Violation|12|||
144451929|NCT00562159|520852555|FG000|Overall Study|Did not meet protocol eligibility|1|||
144451930|NCT00562159|520852556|FG001|Overall Study|Did not meet protocol eligibility|1|||
144451931|NCT01992536|520852560|FG000|Overall Study|Administrative Reason|0|||
144451932|NCT01992536|520852561|FG001|Overall Study|Administrative Reason|0|||
144451933|NCT01992536|520852562|FG002|Overall Study|Administrative Reason|0|||
144451934|NCT01992536|520852563|FG003|Overall Study|Administrative Reason|0|||
144451935|NCT01992536|520852564|FG004|Overall Study|Administrative Reason|0|||
144451936|NCT01992536|520852565|FG005|Overall Study|Administrative Reason|0|||
144451937|NCT01992536|520852566|FG006|Overall Study|Administrative Reason|7|||
144451938|NCT01992536|520852567|FG007|Overall Study|Administrative Reason|0|||
144451939|NCT01992536|520852568|FG008|Overall Study|Administrative Reason|0|||
144451940|NCT01992536|520852569|FG009|Overall Study|Administrative Reason|0|||
144451941|NCT01992536|520852560|FG000|Overall Study|Lost to Follow-up|4|||
144451942|NCT01992536|520852561|FG001|Overall Study|Lost to Follow-up|2|||
144451943|NCT01992536|520852562|FG002|Overall Study|Lost to Follow-up|1|||
144451944|NCT01992536|520852563|FG003|Overall Study|Lost to Follow-up|0|||
144451945|NCT01992536|520852564|FG004|Overall Study|Lost to Follow-up|0|||
144451946|NCT01992536|520852565|FG005|Overall Study|Lost to Follow-up|1|||
144451947|NCT01992536|520852566|FG006|Overall Study|Lost to Follow-up|0|||
144451948|NCT01992536|520852567|FG007|Overall Study|Lost to Follow-up|0|||
144451949|NCT01992536|520852568|FG008|Overall Study|Lost to Follow-up|1|||
144451950|NCT01992536|520852569|FG009|Overall Study|Lost to Follow-up|1|||
144451951|NCT01992536|520852560|FG000|Overall Study|Withdrawal by Subject|0|||
144451952|NCT01992536|520852561|FG001|Overall Study|Withdrawal by Subject|1|||
144451953|NCT01992536|520852562|FG002|Overall Study|Withdrawal by Subject|0|||
144451954|NCT01992536|520852563|FG003|Overall Study|Withdrawal by Subject|2|||
144533664|NCT03372057|521156729|FG002|Expansion Phase|Adverse Event|1|||
144451955|NCT01992536|520852564|FG004|Overall Study|Withdrawal by Subject|0|||
144451956|NCT01992536|520852565|FG005|Overall Study|Withdrawal by Subject|0|||
144451957|NCT01992536|520852566|FG006|Overall Study|Withdrawal by Subject|0|||
144451958|NCT01992536|520852567|FG007|Overall Study|Withdrawal by Subject|0|||
144451959|NCT01992536|520852568|FG008|Overall Study|Withdrawal by Subject|0|||
144451960|NCT01992536|520852569|FG009|Overall Study|Withdrawal by Subject|0|||
144451961|NCT02317575|520852570|FG000|Period 1|Difficulty with venous cannulation|0|||
144451962|NCT02317575|520852571|FG001|Period 1|Difficulty with venous cannulation|1|||
144451963|NCT02317575|520852572|FG002|Period 1|Difficulty with venous cannulation|0|||
144254397|NCT01152996|520131752|FG000|Overall Study|Lost to Follow-up|112|||
144254398|NCT01152996|520131752|FG000|Overall Study|Lack of Efficacy|68|||
144254399|NCT01152996|520131752|FG000|Overall Study|Noncompliance|41|||
144254400|NCT01152996|520131752|FG000|Overall Study|Other|36|||
144254401|NCT01152996|520131752|FG000|Overall Study|Protocol Violation|22|||
144254402|NCT01152996|520131752|FG000|Overall Study|Elevated liver enzymes|1|||
144254403|NCT03077607|520131754|FG000|Period 1 (15 Days)|Adverse Event|1|||
144254404|NCT03077607|520131755|FG001|Period 1 (15 Days)|Adverse Event|0|||
144254405|NCT03077607|520131754|FG000|Period 1 (15 Days)|Death|1|||
144254406|NCT03077607|520131755|FG001|Period 1 (15 Days)|Death|0|||
144254407|NCT03077607|520131754|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
144254408|NCT03077607|520131755|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
144254409|NCT03077607|520131754|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
144254410|NCT03077607|520131755|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
144254411|NCT00460239|520131756|FG000|Overall Study|Physician Decision|0|||
144254412|NCT00460239|520131757|FG001|Overall Study|Physician Decision|1|||
144254413|NCT00460239|520131758|FG002|Overall Study|Physician Decision|0|||
144254414|NCT00460239|520131759|FG003|Overall Study|Physician Decision|0|||
144254415|NCT00460239|520131760|FG004|Overall Study|Physician Decision|0|||
144254416|NCT00460239|520131761|FG005|Overall Study|Physician Decision|2|||
144254417|NCT00460239|520131762|FG006|Overall Study|Physician Decision|0|||
144254418|NCT00460239|520131763|FG007|Overall Study|Physician Decision|0|||
144254419|NCT00460239|520131764|FG008|Overall Study|Physician Decision|0|||
144254420|NCT00460239|520131756|FG000|Overall Study|Withdrawal by Subject|0|||
144254421|NCT00460239|520131757|FG001|Overall Study|Withdrawal by Subject|0|||
144254422|NCT00460239|520131758|FG002|Overall Study|Withdrawal by Subject|0|||
144254423|NCT00460239|520131759|FG003|Overall Study|Withdrawal by Subject|0|||
144254424|NCT00460239|520131760|FG004|Overall Study|Withdrawal by Subject|0|||
144254425|NCT00460239|520131761|FG005|Overall Study|Withdrawal by Subject|1|||
144254426|NCT00460239|520131762|FG006|Overall Study|Withdrawal by Subject|0|||
144254427|NCT00460239|520131763|FG007|Overall Study|Withdrawal by Subject|0|||
144254428|NCT00460239|520131764|FG008|Overall Study|Withdrawal by Subject|0|||
144254429|NCT01005901|520131772|FG000|Overall Study|Withdrawal by Subject|38|||
144254430|NCT01005901|520131773|FG001|Overall Study|Withdrawal by Subject|14|||
144254431|NCT01005901|520131772|FG000|Overall Study|Adverse Event|30|||
144254432|NCT01005901|520131773|FG001|Overall Study|Adverse Event|16|||
144254433|NCT01005901|520131772|FG000|Overall Study|Administrative problems|21|||
144254434|NCT01005901|520131773|FG001|Overall Study|Administrative problems|13|||
144254435|NCT01005901|520131772|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
144254436|NCT01005901|520131773|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
144254437|NCT01005901|520131772|FG000|Overall Study|Protocol Violation|4|||
144254438|NCT01005901|520131773|FG001|Overall Study|Protocol Violation|3|||
144254439|NCT01005901|520131772|FG000|Overall Study|Death|2|||
144254440|NCT01005901|520131773|FG001|Overall Study|Death|3|||
144254441|NCT01005901|520131772|FG000|Overall Study|Lost to Follow-up|1|||
144254442|NCT01005901|520131773|FG001|Overall Study|Lost to Follow-up|2|||
144254443|NCT01005901|520131772|FG000|Overall Study|Patient's inability to use the device|1|||
144451964|NCT02317575|520852573|FG003|Period 1|Difficulty with venous cannulation|0|||
144451965|NCT02317575|520852574|FG004|Period 1|Difficulty with venous cannulation|0|||
144451966|NCT02317575|520852570|FG000|Period 1|Withdrawal by Subject|1|||
144451967|NCT02317575|520852571|FG001|Period 1|Withdrawal by Subject|0|||
144451968|NCT02317575|520852572|FG002|Period 1|Withdrawal by Subject|0|||
144451969|NCT02317575|520852573|FG003|Period 1|Withdrawal by Subject|0|||
144451970|NCT02317575|520852574|FG004|Period 1|Withdrawal by Subject|0|||
144451971|NCT03551938|520852577|FG000|3-Month Follow Up|Lost to Follow-up|39|||
144451972|NCT03551938|520852578|FG001|3-Month Follow Up|Lost to Follow-up|38|||
144451973|NCT03551938|520852577|FG000|6-Month Follow Up|Lost to Follow-up|46|||
144451974|NCT03551938|520852578|FG001|6-Month Follow Up|Lost to Follow-up|42|||
144451975|NCT03551938|520852577|FG000|9-Month Follow Up|Lost to Follow-up|44|||
144451976|NCT03551938|520852578|FG001|9-Month Follow Up|Lost to Follow-up|43|||
144451977|NCT04096560|520852579|FG000|Overall Study|Reason not Specified|1|||
144254444|NCT01005901|520131773|FG001|Overall Study|Patient's inability to use the device|1|||
144254445|NCT01005901|520131772|FG000|Overall Study|No longer requires study drug|0|||
144451978|NCT04096560|520852580|FG001|Overall Study|Reason not Specified|0|||
144254446|NCT01005901|520131773|FG001|Overall Study|No longer requires study drug|1|||
144254447|NCT00760487|520131774|FG000|Overall Study|Unilateral implantation|3|||
144254448|NCT04217317|520131779|FG000|Overall Study|Lack of Efficacy|4|||
144254449|NCT04217317|520131779|FG000|Overall Study|Physician Decision|1|||
144254450|NCT03836209|520131780|FG000|Overall Study|Adverse Event|5|||
144254451|NCT03836209|520131781|FG001|Overall Study|Adverse Event|2|||
144254452|NCT03836209|520131780|FG000|Overall Study|Death|4|||
144451979|NCT04096560|520852581|FG002|Overall Study|Reason not Specified|0|||
144451980|NCT04096560|520852582|FG003|Overall Study|Reason not Specified|0|||
144254453|NCT03836209|520131781|FG001|Overall Study|Death|1|||
144254454|NCT03836209|520131780|FG000|Overall Study|Lack of Efficacy|7|||
144254455|NCT03836209|520131781|FG001|Overall Study|Lack of Efficacy|10|||
144254456|NCT03836209|520131780|FG000|Overall Study|Physician Decision|7|||
144254457|NCT03836209|520131781|FG001|Overall Study|Physician Decision|11|||
144254458|NCT03836209|520131780|FG000|Overall Study|Protocol Violation|0|||
144254459|NCT03836209|520131781|FG001|Overall Study|Protocol Violation|3|||
144254460|NCT03836209|520131780|FG000|Overall Study|Withdrawal by Subject|2|||
144254461|NCT03836209|520131781|FG001|Overall Study|Withdrawal by Subject|10|||
144254462|NCT03836209|520131780|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
144254463|NCT03836209|520131781|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
144254464|NCT03739710|520131782|FG000|Overall Study|Screen Failed|81|||
144254465|NCT01753115|520131783|FG000|Overall Study|Lost to Follow-up|3|||
144254466|NCT01753115|520131784|FG001|Overall Study|Lost to Follow-up|6|||
144254467|NCT01753115|520131785|FG002|Overall Study|Lost to Follow-up|8|||
144254468|NCT01753115|520131783|FG000|Overall Study|Withdrawal by Subject|6|||
144254469|NCT01753115|520131784|FG001|Overall Study|Withdrawal by Subject|5|||
144254470|NCT01753115|520131785|FG002|Overall Study|Withdrawal by Subject|6|||
144254471|NCT01753115|520131783|FG000|Overall Study|Subject non-compliant|3|||
144254472|NCT01753115|520131784|FG001|Overall Study|Subject non-compliant|3|||
144254473|NCT01753115|520131785|FG002|Overall Study|Subject non-compliant|0|||
144254474|NCT01753115|520131783|FG000|Overall Study|Used excluded drug|0|||
144254475|NCT01753115|520131784|FG001|Overall Study|Used excluded drug|1|||
144254476|NCT01753115|520131785|FG002|Overall Study|Used excluded drug|0|||
144254477|NCT04313400|520131791|FG000|Overall Study|Withdrawal by Subject|0|||
144254478|NCT04313400|520131792|FG001|Overall Study|Withdrawal by Subject|0|||
144254479|NCT04313400|520131793|FG002|Overall Study|Withdrawal by Subject|0|||
144254480|NCT04313400|520131794|FG003|Overall Study|Withdrawal by Subject|0|||
144254481|NCT04313400|520131795|FG004|Overall Study|Withdrawal by Subject|0|||
144254482|NCT04313400|520131796|FG005|Overall Study|Withdrawal by Subject|4|||
144254483|NCT04313400|520131797|FG006|Overall Study|Withdrawal by Subject|1|||
144254484|NCT04313400|520131791|FG000|Overall Study|Adverse Event|0|||
144254485|NCT04313400|520131792|FG001|Overall Study|Adverse Event|0|||
144254486|NCT04313400|520131793|FG002|Overall Study|Adverse Event|0|||
144254487|NCT04313400|520131794|FG003|Overall Study|Adverse Event|0|||
144254488|NCT04313400|520131795|FG004|Overall Study|Adverse Event|0|||
144254489|NCT04313400|520131796|FG005|Overall Study|Adverse Event|1|||
144254490|NCT04313400|520131797|FG006|Overall Study|Adverse Event|0|||
144606843|NCT02374021|521421116|FG000|Overall Study|Adverse Event|1|||
144606844|NCT02374021|521421117|FG001|Overall Study|Adverse Event|0|||
144606845|NCT02374021|521421116|FG000|Overall Study|Lost to Follow-up|3|||
144606846|NCT02374021|521421117|FG001|Overall Study|Lost to Follow-up|2|||
144606847|NCT02374021|521421116|FG000|Overall Study|Physician Decision|0|||
144606848|NCT02374021|521421117|FG001|Overall Study|Physician Decision|3|||
144606849|NCT02374021|521421116|FG000|Overall Study|Withdrawal by Subject|6|||
144606850|NCT02374021|521421117|FG001|Overall Study|Withdrawal by Subject|5|||
144606851|NCT02374021|521421116|FG000|Overall Study|Poor Adherence|0|||
144606852|NCT02374021|521421117|FG001|Overall Study|Poor Adherence|1|||
144606853|NCT02374021|521421116|FG000|Overall Study|Scan protocol not followed|0|||
144606854|NCT02374021|521421117|FG001|Overall Study|Scan protocol not followed|1|||
144606855|NCT02374021|521421116|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
144606856|NCT02374021|521421117|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
144606857|NCT00074581|521421119|FG000|Overall Study|Death|15|||
144606858|NCT00074581|521421120|FG001|Overall Study|Death|16|||
144606859|NCT00074581|521421119|FG000|Overall Study|Withdrawal by Subject|50|||
144606860|NCT00074581|521421120|FG001|Overall Study|Withdrawal by Subject|49|||
144606861|NCT00074581|521421119|FG000|Overall Study|Unable to adhere to visit schedule|13|||
144606862|NCT00074581|521421120|FG001|Overall Study|Unable to adhere to visit schedule|14|||
144606863|NCT00074581|521421119|FG000|Overall Study|Relocated|14|||
144606864|NCT00074581|521421120|FG001|Overall Study|Relocated|9|||
144606865|NCT00074581|521421119|FG000|Overall Study|Were withdrawn by investigator|5|||
144606866|NCT00074581|521421120|FG001|Overall Study|Were withdrawn by investigator|2|||
144606867|NCT00074581|521421119|FG000|Overall Study|Lost to Follow-up|16|||
144606868|NCT00074581|521421120|FG001|Overall Study|Lost to Follow-up|11|||
144254491|NCT04313400|520131791|FG000|Overall Study|Lost to Follow-up|0|||
144606869|NCT00074581|521421119|FG000|Overall Study|Ended relationship w. index participant|117|||
144606870|NCT00074581|521421120|FG001|Overall Study|Ended relationship w. index participant|106|||
144254492|NCT04313400|520131792|FG001|Overall Study|Lost to Follow-up|0|||
144254493|NCT04313400|520131793|FG002|Overall Study|Lost to Follow-up|0|||
144254494|NCT04313400|520131794|FG003|Overall Study|Lost to Follow-up|0|||
144254495|NCT04313400|520131795|FG004|Overall Study|Lost to Follow-up|0|||
144606871|NCT00074581|521421119|FG000|Overall Study|Other|14|||
144606872|NCT00074581|521421120|FG001|Overall Study|Other|19|||
144254496|NCT04313400|520131796|FG005|Overall Study|Lost to Follow-up|1|||
144254497|NCT04313400|520131797|FG006|Overall Study|Lost to Follow-up|0|||
144725593|NCT01153984|521851302|FG000|Overall Study|Adverse Event|1|||
144254498|NCT03224624|520131802|FG000|Overall Study|Lost to Follow-up|9|||
144195652|NCT01491035|519911995|FG000|Overall Study|Lost to Follow-up|0|||
144195653|NCT01491035|519911996|FG001|Overall Study|Lost to Follow-up|0|||
144195654|NCT01491035|519911997|FG002|Overall Study|Lost to Follow-up|0|||
144195655|NCT01491035|519911998|FG003|Overall Study|Lost to Follow-up|0|||
144195656|NCT01491035|519911999|FG004|Overall Study|Lost to Follow-up|1|||
144195657|NCT01491035|519912000|FG005|Overall Study|Lost to Follow-up|0|||
144195658|NCT01491035|519912001|FG006|Overall Study|Lost to Follow-up|0|||
144451981|NCT04096560|520852583|FG004|Overall Study|Reason not Specified|1|||
144451982|NCT04096560|520852584|FG005|Overall Study|Reason not Specified|1|||
144451983|NCT04096560|520852585|FG006|Overall Study|Reason not Specified|1|||
144451984|NCT04096560|520852586|FG007|Overall Study|Reason not Specified|0|||
144451985|NCT04096560|520852579|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
144451986|NCT04096560|520852580|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
144725594|NCT02460159|521851303|FG000|Overall Study|Adverse Event|4|||
144195659|NCT01491035|519912002|FG007|Overall Study|Lost to Follow-up|0|||
144195660|NCT02999477|519912003|FG000|Overall Study|found ineligible after first dose|0|||
144195661|NCT02999477|519912004|FG001|Overall Study|found ineligible after first dose|1|||
144195662|NCT02999477|519912003|FG000|Overall Study|Withdrawal by Subject|1|||
144195663|NCT02999477|519912004|FG001|Overall Study|Withdrawal by Subject|1|||
144195664|NCT00891839|519912005|FG000|Overall Study|Adverse Event|2|||
144195665|NCT00891839|519912005|FG000|Overall Study|Withdrawal by Subject|2|||
144195666|NCT00891839|519912005|FG000|Overall Study|Disease progression|3|||
144195667|NCT01568866|519912009|FG000|Overall Study|Disease Progression|208|||
144195668|NCT01568866|519912010|FG001|Overall Study|Disease Progression|183|||
144195669|NCT01568866|519912009|FG000|Overall Study|Adverse Event|94|||
144195670|NCT01568866|519912010|FG001|Overall Study|Adverse Event|96|||
144195671|NCT01568866|519912009|FG000|Overall Study|Patient Request|55|||
144195672|NCT01568866|519912010|FG001|Overall Study|Patient Request|71|||
144195673|NCT01568866|519912009|FG000|Overall Study|Physician Decision|40|||
144195674|NCT01568866|519912010|FG001|Overall Study|Physician Decision|32|||
144195675|NCT01568866|519912009|FG000|Overall Study|Withdrawal by Subject|19|||
144195676|NCT01568866|519912010|FG001|Overall Study|Withdrawal by Subject|11|||
144195677|NCT01568866|519912009|FG000|Overall Study|Death|10|||
144195678|NCT01568866|519912010|FG001|Overall Study|Death|18|||
144195679|NCT01568866|519912009|FG000|Overall Study|Protocol Non-compliance|2|||
144195680|NCT01568866|519912010|FG001|Overall Study|Protocol Non-compliance|4|||
144195681|NCT01568866|519912009|FG000|Overall Study|Lost to Follow-up|1|||
144195682|NCT01568866|519912010|FG001|Overall Study|Lost to Follow-up|0|||
144195683|NCT01568866|519912009|FG000|Overall Study|Randomized but Not Dosed|9|||
144195684|NCT01568866|519912010|FG001|Overall Study|Randomized but Not Dosed|1|||
144195685|NCT00851643|519912011|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
144195686|NCT00851643|519912012|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
144195687|NCT00851643|519912013|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
144195688|NCT00851643|519912014|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
144195689|NCT00851643|519912015|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
144195690|NCT00851643|519912016|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
144195691|NCT00851643|519912011|FG000|Base Study (Up to 12 Months)|Other|0|||
144195692|NCT00851643|519912012|FG001|Base Study (Up to 12 Months)|Other|0|||
144195693|NCT00851643|519912013|FG002|Base Study (Up to 12 Months)|Other|0|||
144195694|NCT00851643|519912014|FG003|Base Study (Up to 12 Months)|Other|0|||
144195695|NCT00851643|519912015|FG004|Base Study (Up to 12 Months)|Other|0|||
144195696|NCT00851643|519912016|FG005|Base Study (Up to 12 Months)|Other|1|||
144195697|NCT00851643|519912011|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
144195698|NCT00851643|519912012|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
144195699|NCT00851643|519912013|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
144195700|NCT00851643|519912014|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
144195701|NCT00851643|519912015|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
144195702|NCT00851643|519912016|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
144195703|NCT00851643|519912011|FG000|Extension Study (Up to 36 Months)|Moved|0|||
144195704|NCT00851643|519912012|FG001|Extension Study (Up to 36 Months)|Moved|2|||
144195705|NCT00851643|519912013|FG002|Extension Study (Up to 36 Months)|Moved|1|||
144195706|NCT00851643|519912014|FG003|Extension Study (Up to 36 Months)|Moved|1|||
144195707|NCT00851643|519912015|FG004|Extension Study (Up to 36 Months)|Moved|0|||
144195708|NCT00851643|519912016|FG005|Extension Study (Up to 36 Months)|Moved|1|||
144195709|NCT01698775|519912017|FG000|Phase A|Adverse Event|2|||
144195710|NCT01698775|519912018|FG001|Phase A|Adverse Event|1|||
144195711|NCT01698775|519912017|FG000|Phase A|Death|1|||
144195712|NCT01698775|519912018|FG001|Phase A|Death|1|||
144195713|NCT01698775|519912017|FG000|Phase A|Lack of Efficacy|1|||
144195714|NCT01698775|519912018|FG001|Phase A|Lack of Efficacy|0|||
144195715|NCT01698775|519912017|FG000|Phase A|Lost to Follow-up|1|||
144195716|NCT01698775|519912018|FG001|Phase A|Lost to Follow-up|2|||
144451987|NCT04096560|520852581|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
144451988|NCT04096560|520852582|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
144451989|NCT04096560|520852583|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
144195717|NCT01698775|519912017|FG000|Phase A|Protocol Violation|1|||
144451990|NCT04096560|520852584|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
144451991|NCT04096560|520852585|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
144451992|NCT04096560|520852586|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
144451993|NCT04096560|520852579|FG000|Overall Study|Study Terminated by Sponsor|0|||
144451994|NCT04096560|520852580|FG001|Overall Study|Study Terminated by Sponsor|0|||
144451995|NCT04096560|520852581|FG002|Overall Study|Study Terminated by Sponsor|0|||
144451996|NCT04096560|520852582|FG003|Overall Study|Study Terminated by Sponsor|5|||
144451997|NCT04096560|520852583|FG004|Overall Study|Study Terminated by Sponsor|6|||
144451998|NCT04096560|520852584|FG005|Overall Study|Study Terminated by Sponsor|4|||
144451999|NCT04096560|520852585|FG006|Overall Study|Study Terminated by Sponsor|6|||
144452000|NCT04096560|520852586|FG007|Overall Study|Study Terminated by Sponsor|1|||
144452001|NCT04096560|520852579|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452002|NCT04096560|520852580|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452003|NCT04096560|520852581|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452004|NCT04096560|520852582|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452005|NCT04096560|520852583|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452006|NCT04096560|520852584|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452007|NCT04096560|520852585|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
144452008|NCT04096560|520852586|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
144452009|NCT00534352|520852587|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
144452010|NCT00534352|520852587|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
144452011|NCT00534352|520852587|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
144452012|NCT00534352|520852587|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
144254499|NCT03224624|520131803|FG001|Overall Study|Lost to Follow-up|4|||
144452013|NCT00534352|520852587|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
144452014|NCT00534352|520852587|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
144452015|NCT04079933|520852589|FG000|Overall Study|Withdrawal by Subject|3|||
144452016|NCT04079933|520852590|FG001|Overall Study|Withdrawal by Subject|4|||
144195718|NCT01698775|519912018|FG001|Phase A|Protocol Violation|0|||
144195719|NCT01698775|519912017|FG000|Phase A|Withdrawal by Subject|3|||
144195720|NCT01698775|519912018|FG001|Phase A|Withdrawal by Subject|4|||
144195721|NCT01698775|519912017|FG000|Phase A|Kidney [transplant]|0|||
144195722|NCT01698775|519912018|FG001|Phase A|Kidney [transplant]|1|||
144195723|NCT01698775|519912017|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
144195724|NCT01698775|519912018|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
144195725|NCT01698775|519912017|FG000|Phase B|Adverse Event|6|||
144195726|NCT01698775|519912018|FG001|Phase B|Adverse Event|3|||
144195727|NCT01698775|519912017|FG000|Phase B|Death|0|||
144195728|NCT01698775|519912018|FG001|Phase B|Death|1|||
144195729|NCT01698775|519912017|FG000|Phase B|Lack of Efficacy|0|||
144195730|NCT01698775|519912018|FG001|Phase B|Lack of Efficacy|1|||
144195731|NCT01698775|519912017|FG000|Phase B|Lost to Follow-up|0|||
144195732|NCT01698775|519912018|FG001|Phase B|Lost to Follow-up|1|||
144195733|NCT01698775|519912017|FG000|Phase B|Physician Decision|1|||
144195734|NCT01698775|519912018|FG001|Phase B|Physician Decision|1|||
144195735|NCT01698775|519912017|FG000|Phase B|Protocol Violation|1|||
144195736|NCT01698775|519912018|FG001|Phase B|Protocol Violation|1|||
144195737|NCT01698775|519912017|FG000|Phase B|Withdrawal by Subject|6|||
144195738|NCT01698775|519912018|FG001|Phase B|Withdrawal by Subject|2|||
144195739|NCT03864042|519912019|FG000|DDI Phase|Adverse Event|2|||
144195740|NCT03864042|519912020|FG001|DDI Phase|Adverse Event|0|||
144195741|NCT03864042|519912021|FG002|DDI Phase|Adverse Event|0|||
144195742|NCT03864042|519912019|FG000|DDI Phase|Physician Decision|1|||
144195743|NCT03864042|519912020|FG001|DDI Phase|Physician Decision|0|||
144195744|NCT03864042|519912021|FG002|DDI Phase|Physician Decision|0|||
144195745|NCT03864042|519912019|FG000|DDI Phase|Progressive Disease|1|||
144195746|NCT03864042|519912020|FG001|DDI Phase|Progressive Disease|0|||
144195747|NCT03864042|519912021|FG002|DDI Phase|Progressive Disease|0|||
144195748|NCT03864042|519912019|FG000|Post-DDI Phase|Adverse Event|5|||
144254500|NCT03224624|520131802|FG000|Overall Study|Death|1|||
144195749|NCT03864042|519912020|FG001|Post-DDI Phase|Adverse Event|3|||
144254501|NCT03224624|520131803|FG001|Overall Study|Death|0|||
144452017|NCT04079933|520852589|FG000|Overall Study|Lost to Follow-up|0|||
144452018|NCT04079933|520852590|FG001|Overall Study|Lost to Follow-up|1|||
144452019|NCT02401672|520852593|FG000|Overall Study|Withdrawal by Subject|1|||
144452020|NCT02401672|520852594|FG001|Overall Study|Withdrawal by Subject|3|||
144452021|NCT04796610|520852595|FG000|Overall Study|Withdrawal by Subject|1|||
144452022|NCT04796610|520852596|FG001|Overall Study|Withdrawal by Subject|0|||
144452023|NCT04796610|520852597|FG002|Overall Study|Withdrawal by Subject|0|||
144452024|NCT04796610|520852598|FG003|Overall Study|Withdrawal by Subject|0|||
144452025|NCT04796610|520852595|FG000|Overall Study|Lost to Follow-up|2|||
144452026|NCT04796610|520852596|FG001|Overall Study|Lost to Follow-up|0|||
144195750|NCT03864042|519912021|FG002|Post-DDI Phase|Adverse Event|2|||
144195751|NCT03864042|519912019|FG000|Post-DDI Phase|Progressive Disease|11|||
144254502|NCT01884545|520131804|FG000|Overall Study|Lost to Follow-up|6|||
144254503|NCT01884545|520131805|FG001|Overall Study|Lost to Follow-up|4|||
144254504|NCT01884545|520131806|FG002|Overall Study|Lost to Follow-up|9|||
144254505|NCT01884545|520131807|FG003|Overall Study|Lost to Follow-up|4|||
144254506|NCT01884545|520131804|FG000|Overall Study|Patient withdrawn|7|||
144254507|NCT01884545|520131805|FG001|Overall Study|Patient withdrawn|12|||
144254508|NCT01884545|520131806|FG002|Overall Study|Patient withdrawn|5|||
144254509|NCT01884545|520131807|FG003|Overall Study|Patient withdrawn|5|||
144254510|NCT01884545|520131804|FG000|Overall Study|Non-adherence|0|||
144254511|NCT01884545|520131805|FG001|Overall Study|Non-adherence|2|||
144254512|NCT01884545|520131806|FG002|Overall Study|Non-adherence|0|||
144254513|NCT01884545|520131807|FG003|Overall Study|Non-adherence|0|||
144254514|NCT01424241|520131808|FG000|Overall Study|Withdrawal by Subject|1|||
144254515|NCT01424241|520131808|FG000|Overall Study|Time constraints|2|||
144254516|NCT02782377|520131809|FG000|Overall Study|Physician Decision|5|||
144254517|NCT02347072|520131816|FG000|Overall Study|Adverse Event|2|||
144254518|NCT02347072|520131816|FG000|Overall Study|Withdrawal by Subject|6|||
144254519|NCT02347072|520131816|FG000|Overall Study|Physician Decision|1|||
144254520|NCT02347072|520131816|FG000|Overall Study|Lost to Follow-up|2|||
144254521|NCT02347072|520131816|FG000|Overall Study|Protocol Violation|1|||
144254522|NCT02347072|520131816|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
144254523|NCT04318132|520131819|FG000|Overall Study|Protocol Violation|0|||
144254524|NCT04318132|520131820|FG001|Overall Study|Protocol Violation|0|||
144254525|NCT04318132|520131821|FG002|Overall Study|Protocol Violation|3|||
144254526|NCT04318132|520131822|FG003|Overall Study|Protocol Violation|0|||
144452027|NCT04796610|520852597|FG002|Overall Study|Lost to Follow-up|1|||
144452028|NCT04796610|520852598|FG003|Overall Study|Lost to Follow-up|1|||
144452029|NCT01459796|520852599|FG000|Overall Study|Non compliance with protocol|2|||
144452030|NCT01459796|520852600|FG001|Overall Study|Non compliance with protocol|4|||
144452031|NCT01459796|520852599|FG000|Overall Study|Adverse Event|5|||
144452032|NCT01459796|520852600|FG001|Overall Study|Adverse Event|5|||
144452033|NCT01459796|520852599|FG000|Overall Study|Withdrawal by Subject|6|||
144452034|NCT01459796|520852600|FG001|Overall Study|Withdrawal by Subject|3|||
144452035|NCT01459796|520852599|FG000|Overall Study|Lost to Follow-up|5|||
144452036|NCT01459796|520852600|FG001|Overall Study|Lost to Follow-up|4|||
144452037|NCT01459796|520852599|FG000|Overall Study|Reason unspecified|1|||
144452038|NCT01459796|520852600|FG001|Overall Study|Reason unspecified|2|||
144452039|NCT01459796|520852599|FG000|Overall Study|Decision by the sponsor|75|||
144452040|NCT01459796|520852600|FG001|Overall Study|Decision by the sponsor|108|||
144254527|NCT00073008|520131823|FG000|Overall Study|Missing|6|||
144254528|NCT00073008|520131824|FG001|Overall Study|Missing|6|||
144254529|NCT00073008|520131823|FG000|Overall Study|Withdrawal by Subject|2|||
144254530|NCT00073008|520131824|FG001|Overall Study|Withdrawal by Subject|2|||
144254531|NCT00073008|520131823|FG000|Overall Study|Lost to Follow-up|1|||
144254532|NCT00073008|520131824|FG001|Overall Study|Lost to Follow-up|3|||
144254533|NCT00073008|520131823|FG000|Overall Study|Death|46|||
144254534|NCT00073008|520131824|FG001|Overall Study|Death|47|||
144254535|NCT00073008|520131823|FG000|Overall Study|"Other selected on Case Report Form"|7|||
144254536|NCT00073008|520131824|FG001|Overall Study|"Other selected on Case Report Form"|5|||
144254537|NCT00636961|520131834|FG000|Period 1|Administrative problems|1|||
144254538|NCT00636961|520131835|FG001|Period 1|Administrative problems|1|||
144254539|NCT00636961|520131834|FG000|Period 2|Adverse Event|1|||
144254540|NCT00636961|520131835|FG001|Period 2|Adverse Event|0|||
144452041|NCT00701051|520852601|FG000|Screening|Failed Screening|40|||
144452042|NCT00701051|520852602|FG001|Screening|Failed Screening|0|||
144452043|NCT00701051|520852603|FG002|Screening|Failed Screening|0|||
144452044|NCT00701051|520852601|FG000|Screening|Time conflicts|19|||
144452045|NCT00701051|520852602|FG001|Screening|Time conflicts|0|||
144452046|NCT00701051|520852603|FG002|Screening|Time conflicts|0|||
144606873|NCT04411628|521421122|FG000|Overall Study|Withdrawal by Subject|1|||
144606874|NCT04411628|521421123|FG001|Overall Study|Withdrawal by Subject|1|||
144606875|NCT04411628|521421124|FG002|Overall Study|Withdrawal by Subject|2|||
144606876|NCT04411628|521421125|FG003|Overall Study|Withdrawal by Subject|0|||
144606877|NCT04411628|521421122|FG000|Overall Study|Lost to Follow-up|0|||
144606878|NCT04411628|521421123|FG001|Overall Study|Lost to Follow-up|1|||
144254541|NCT00248833|520131836|FG000|Overall Study|Adverse Event|2|||
144254542|NCT00248833|520131837|FG001|Overall Study|Adverse Event|0|||
144452047|NCT00701051|520852601|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
144452048|NCT00701051|520852602|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
144452049|NCT00701051|520852603|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
144606879|NCT04411628|521421124|FG002|Overall Study|Lost to Follow-up|0|||
144254543|NCT00248833|520131838|FG002|Overall Study|Adverse Event|0|||
144254544|NCT00248833|520131836|FG000|Overall Study|Withdrawal by Subject|0|||
144254545|NCT00248833|520131837|FG001|Overall Study|Withdrawal by Subject|1|||
144254546|NCT00248833|520131838|FG002|Overall Study|Withdrawal by Subject|1|||
144452050|NCT02059148|520852604|FG000|Treatment 1|Protocol Violation|0|||
144452051|NCT02059148|520852605|FG001|Treatment 1|Protocol Violation|0|||
144452052|NCT02059148|520852606|FG002|Treatment 1|Protocol Violation|0|||
144452053|NCT02059148|520852607|FG003|Treatment 1|Protocol Violation|0|||
144606880|NCT04411628|521421125|FG003|Overall Study|Lost to Follow-up|0|||
144254547|NCT00248833|520131836|FG000|Overall Study|Lost to Follow-up|1|||
144254548|NCT00248833|520131837|FG001|Overall Study|Lost to Follow-up|1|||
144254549|NCT00248833|520131838|FG002|Overall Study|Lost to Follow-up|1|||
144254550|NCT00248833|520131836|FG000|Overall Study|Other|0|||
144254551|NCT00248833|520131837|FG001|Overall Study|Other|1|||
144195752|NCT03864042|519912020|FG001|Post-DDI Phase|Progressive Disease|6|||
144195753|NCT03864042|519912021|FG002|Post-DDI Phase|Progressive Disease|13|||
144195754|NCT03864042|519912019|FG000|Post-DDI Phase|Discretion of investigator|1|||
144195755|NCT03864042|519912020|FG001|Post-DDI Phase|Discretion of investigator|1|||
144195756|NCT03864042|519912021|FG002|Post-DDI Phase|Discretion of investigator|0|||
144195757|NCT03864042|519912019|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
144195758|NCT03864042|519912020|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
144195759|NCT03864042|519912021|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
144254552|NCT00248833|520131838|FG002|Overall Study|Other|0|||
144254553|NCT03885999|520131839|FG000|Overall Study|Adverse Event|1|||
144254554|NCT02494401|520131840|FG000|Overall Study|Lost to Follow-up|22|||
144254555|NCT02494401|520131841|FG001|Overall Study|Lost to Follow-up|25|||
144254556|NCT02494401|520131840|FG000|Overall Study|Withdrawal by Subject|3|||
144254557|NCT02494401|520131841|FG001|Overall Study|Withdrawal by Subject|2|||
144254558|NCT03630705|520133363|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
144254559|NCT03630705|520133364|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
144254560|NCT03630705|520133365|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
144254561|NCT03630705|520133366|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144254562|NCT03630705|520133363|FG000|Overall Study|Lost to Follow-up|1|||
144254563|NCT03630705|520133364|FG001|Overall Study|Lost to Follow-up|2|||
144254564|NCT03630705|520133365|FG002|Overall Study|Lost to Follow-up|0|||
144254565|NCT03630705|520133366|FG003|Overall Study|Lost to Follow-up|0|||
144254566|NCT03638466|520133367|FG000|Overall Study|Early Termination|0|||
144254567|NCT03638466|520133368|FG001|Overall Study|Early Termination|1|||
144254568|NCT01128400|520133369|FG000|Overall Study|Lost to Follow-up|1|||
144254569|NCT01128400|520133370|FG001|Overall Study|Lost to Follow-up|0|||
144254570|NCT01128400|520133371|FG002|Overall Study|Lost to Follow-up|1|||
144452054|NCT02059148|520852608|FG004|Treatment 1|Protocol Violation|0|||
144452055|NCT02059148|520852609|FG005|Treatment 1|Protocol Violation|1|||
144452056|NCT01525082|520852613|FG000|Overall Study|Death|1|||
144452057|NCT03321981|520852614|FG000|Overall Study|Progressive Disease (PD)|15|||
144452058|NCT03321981|520852615|FG001|Overall Study|Progressive Disease (PD)|30|||
144452059|NCT03321981|520852616|FG002|Overall Study|Progressive Disease (PD)|47|||
144452060|NCT03321981|520852614|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
144452061|NCT03321981|520852615|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
144452062|NCT03321981|520852616|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
144452063|NCT03321981|520852614|FG000|Overall Study|Adverse Event|0|||
144452064|NCT03321981|520852615|FG001|Overall Study|Adverse Event|0|||
144452065|NCT03321981|520852616|FG002|Overall Study|Adverse Event|2|||
144452066|NCT03321981|520852614|FG000|Overall Study|symptomatic deterioration|0|||
144452067|NCT03321981|520852615|FG001|Overall Study|symptomatic deterioration|1|||
144452068|NCT03321981|520852616|FG002|Overall Study|symptomatic deterioration|1|||
144452069|NCT03321981|520852614|FG000|Overall Study|Lack of compliance|0|||
144452070|NCT03321981|520852615|FG001|Overall Study|Lack of compliance|1|||
144452071|NCT03321981|520852616|FG002|Overall Study|Lack of compliance|0|||
144452072|NCT03321981|520852614|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
144452073|NCT03321981|520852615|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
144452074|NCT03321981|520852616|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
144452075|NCT03321981|520852614|FG000|Overall Study|Death|0|||
144452076|NCT03321981|520852615|FG001|Overall Study|Death|1|||
144452077|NCT03321981|520852616|FG002|Overall Study|Death|0|||
144452078|NCT03321981|520852614|FG000|Overall Study|Subject withdrawal of investigational product|0|||
144452079|NCT03321981|520852615|FG001|Overall Study|Subject withdrawal of investigational product|1|||
144452080|NCT03321981|520852616|FG002|Overall Study|Subject withdrawal of investigational product|0|||
144452081|NCT03321981|520852614|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
144452082|NCT03321981|520852615|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
144452083|NCT03321981|520852616|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
144452084|NCT03321981|520852614|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
144452085|NCT03321981|520852615|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
144472240|NCT04711603|520926728|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
144254571|NCT01128400|520133369|FG000|Overall Study|Screening failure|1|||
144254572|NCT01128400|520133370|FG001|Overall Study|Screening failure|0|||
144254573|NCT01128400|520133371|FG002|Overall Study|Screening failure|0|||
144254574|NCT01128400|520133369|FG000|Overall Study|were not invited to participate on taste|0|||
144254575|NCT01128400|520133370|FG001|Overall Study|were not invited to participate on taste|0|||
144472241|NCT04711603|520926729|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
144606881|NCT00682448|521422523|FG000|Overall Study|Adverse Event|1|||
144606882|NCT00682448|521422524|FG001|Overall Study|Adverse Event|2|||
144606883|NCT00682448|521422523|FG000|Overall Study|Lack of Efficacy|1|||
144606884|NCT00682448|521422524|FG001|Overall Study|Lack of Efficacy|0|||
144606885|NCT00682448|521422523|FG000|Overall Study|Lost to Follow-up|1|||
144606886|NCT00682448|521422524|FG001|Overall Study|Lost to Follow-up|3|||
144254576|NCT01128400|520133371|FG002|Overall Study|were not invited to participate on taste|15|||
144254577|NCT01128400|520133369|FG000|Overall Study|Excluded due to sinus problems|0|||
144606887|NCT00682448|521422523|FG000|Overall Study|Pregnancy|0|||
144606888|NCT00682448|521422524|FG001|Overall Study|Pregnancy|1|||
144606889|NCT00682448|521422523|FG000|Overall Study|Withdrawal by Subject|2|||
144606890|NCT00682448|521422524|FG001|Overall Study|Withdrawal by Subject|0|||
144606891|NCT00257166|521422528|FG000|Overall Study|Adverse Event|18|||
144606892|NCT00257166|521422529|FG001|Overall Study|Adverse Event|13|||
144254578|NCT01128400|520133370|FG001|Overall Study|Excluded due to sinus problems|1|||
144254579|NCT01128400|520133371|FG002|Overall Study|Excluded due to sinus problems|0|||
144452086|NCT03321981|520852616|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
144452087|NCT03880578|520852619|FG000|Overall Study|Withdrawal by Subject|0|||
144452088|NCT03880578|520852620|FG001|Overall Study|Withdrawal by Subject|3|||
144452089|NCT03880578|520852621|FG002|Overall Study|Withdrawal by Subject|1|||
144452090|NCT03880578|520852619|FG000|Overall Study|Death|0|||
144452091|NCT03880578|520852620|FG001|Overall Study|Death|1|||
144452092|NCT03880578|520852621|FG002|Overall Study|Death|0|||
144452093|NCT03105362|520852622|FG000|Overall Study|Withdrawal by Subject|1|||
144606893|NCT00257166|521422528|FG000|Overall Study|Laboratory abnormality|1|||
144606894|NCT00257166|521422529|FG001|Overall Study|Laboratory abnormality|0|||
144606895|NCT00257166|521422528|FG000|Overall Study|Lost to Follow-up|8|||
144606896|NCT00257166|521422529|FG001|Overall Study|Lost to Follow-up|1|||
144606897|NCT00257166|521422528|FG000|Overall Study|Withdrawal by Subject|9|||
144606898|NCT00257166|521422529|FG001|Overall Study|Withdrawal by Subject|2|||
144452094|NCT03105362|520852622|FG000|Overall Study|Lost to Follow-up|1|||
144452095|NCT01440946|520852623|FG000|Overall Study|Lost to Follow-up|1|||
144452096|NCT01440946|520852624|FG001|Overall Study|Lost to Follow-up|1|||
144452097|NCT01440946|520852623|FG000|Overall Study|Physician Decision|1|||
144452098|NCT01440946|520852624|FG001|Overall Study|Physician Decision|0|||
144725595|NCT02460159|521851304|FG001|Overall Study|Adverse Event|1|||
144725596|NCT02460159|521851303|FG000|Overall Study|Withdrawal by Subject|2|||
144725597|NCT02460159|521851304|FG001|Overall Study|Withdrawal by Subject|0|||
144195760|NCT03864042|519912019|FG000|Post-DDI Phase|Withdrawal of consent|1|||
144195761|NCT03864042|519912020|FG001|Post-DDI Phase|Withdrawal of consent|2|||
144452099|NCT01603875|520852628|FG000|Overall Study|Preexisting rabies antibody|3|||
144452100|NCT01603875|520852629|FG001|Overall Study|Preexisting rabies antibody|4|||
144452101|NCT01603875|520852630|FG002|Overall Study|Preexisting rabies antibody|3|||
144452102|NCT01603875|520852628|FG000|Overall Study|Lost to Follow-up|4|||
144452103|NCT01603875|520852629|FG001|Overall Study|Lost to Follow-up|3|||
144452104|NCT01603875|520852630|FG002|Overall Study|Lost to Follow-up|6|||
144452105|NCT01603875|520852628|FG000|Overall Study|Protocol Violation|0|||
144452106|NCT01603875|520852629|FG001|Overall Study|Protocol Violation|1|||
144452107|NCT01603875|520852630|FG002|Overall Study|Protocol Violation|0|||
144452108|NCT01072201|520852631|FG000|Overall Study|Lost to Follow-up|0|||
144452109|NCT01072201|520852632|FG001|Overall Study|Lost to Follow-up|1|||
144725598|NCT00973700|521851305|FG000|Overall Study|Withdrawal by Subject|2|||
144195762|NCT03864042|519912021|FG002|Post-DDI Phase|Withdrawal of consent|0|||
144195763|NCT00359788|519912022|FG000|Overall Study|Adverse Event|11|||
144195764|NCT00359788|519912023|FG001|Overall Study|Adverse Event|10|||
144195765|NCT00359788|519912022|FG000|Overall Study|Lack of Efficacy|1|||
144195766|NCT00359788|519912023|FG001|Overall Study|Lack of Efficacy|2|||
144195767|NCT00359788|519912022|FG000|Overall Study|Lost to Follow-up|3|||
144195768|NCT00359788|519912023|FG001|Overall Study|Lost to Follow-up|2|||
144195769|NCT00359788|519912022|FG000|Overall Study|Withdrawal by Subject|4|||
144254580|NCT02362425|520133372|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
144254581|NCT02362425|520133373|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
144254582|NCT02362425|520133374|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
144254583|NCT02362425|520133375|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
144452110|NCT00360334|520852633|FG000|Overall Study|Adverse Event|7|||
144452111|NCT00360334|520852634|FG001|Overall Study|Adverse Event|4|||
144452112|NCT00360334|520852633|FG000|Overall Study|Protocol Violation|1|||
144606899|NCT00257166|521422528|FG000|Overall Study|Other|16|||
144725599|NCT00973700|521851306|FG001|Overall Study|Withdrawal by Subject|2|||
144725600|NCT00973700|521851307|FG002|Overall Study|Withdrawal by Subject|8|||
144195770|NCT00359788|519912023|FG001|Overall Study|Withdrawal by Subject|1|||
144452113|NCT00360334|520852634|FG001|Overall Study|Protocol Violation|1|||
144452114|NCT00360334|520852633|FG000|Overall Study|Physician Decision|2|||
144452115|NCT00360334|520852634|FG001|Overall Study|Physician Decision|3|||
144452116|NCT00360334|520852633|FG000|Overall Study|Lack of Efficacy|0|||
144452117|NCT00360334|520852634|FG001|Overall Study|Lack of Efficacy|1|||
144452118|NCT00360334|520852633|FG000|Overall Study|Entry criterion not met|1|||
144606900|NCT00257166|521422529|FG001|Overall Study|Other|21|||
144195771|NCT00359788|519912022|FG000|Overall Study|Protocol Violation|4|||
144195772|NCT00359788|519912023|FG001|Overall Study|Protocol Violation|2|||
144195773|NCT02143583|519912028|FG000|Overall Study|Withdrawal by Subject|1|||
144195774|NCT02143583|519912029|FG001|Overall Study|Withdrawal by Subject|0|||
144195775|NCT02143583|519912030|FG002|Overall Study|Withdrawal by Subject|1|||
144195776|NCT02143583|519912028|FG000|Overall Study|husband illness|0|||
144195777|NCT02143583|519912029|FG001|Overall Study|husband illness|0|||
144254584|NCT02362425|520133372|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
144254585|NCT02362425|520133373|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
144254586|NCT02362425|520133374|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
144254587|NCT02362425|520133375|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
144254588|NCT02362425|520133372|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
144254589|NCT02362425|520133373|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
144254590|NCT02362425|520133374|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
144254591|NCT02362425|520133375|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
144254592|NCT02362425|520133372|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
144259293|NCT01089127|520150354|FG000|Overall Study|Lost to Follow-up|1|||
144452119|NCT00360334|520852634|FG001|Overall Study|Entry criterion not met|2|||
144452120|NCT00360334|520852633|FG000|Overall Study|Subject decision|8|||
144452121|NCT00360334|520852634|FG001|Overall Study|Subject decision|2|||
144452122|NCT05204134|520852636|FG000|Overall Study|Withdrawal by Subject|3|||
144452123|NCT05204134|520852636|FG000|Overall Study|Physician Decision|1|||
144452124|NCT02752048|520852640|FG000|Overall Study|Withdrawal by Subject|0|||
144452125|NCT02752048|520852641|FG001|Overall Study|Withdrawal by Subject|0|||
144452126|NCT02752048|520852642|FG002|Overall Study|Withdrawal by Subject|3|||
144452127|NCT01431508|520852643|FG000|Overall Study|Lack of Efficacy|1|||
144452128|NCT01431508|520852643|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
144452129|NCT00132769|520852644|FG000|Overall Study|Withdrawal by Subject|1|||
144606901|NCT00257166|521422528|FG000|Overall Study|Randomized, but not treated|1|||
144606902|NCT00257166|521422529|FG001|Overall Study|Randomized, but not treated|0|||
144606903|NCT00525044|521422532|FG000|Overall Study|Lost to Follow-up|0|||
144606904|NCT00525044|521422533|FG001|Overall Study|Lost to Follow-up|1|||
144606905|NCT01383096|521422534|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
144606906|NCT01383096|521422535|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
144606907|NCT01383096|521422536|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
144606908|NCT01383096|521422534|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
144606909|NCT01383096|521422535|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
144606910|NCT01383096|521422536|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
144606911|NCT01383096|521422534|FG000|Third Intervention (8 Days)|Elevated AST|0|||
144606912|NCT01383096|521422535|FG001|Third Intervention (8 Days)|Elevated AST|1|||
144606913|NCT01383096|521422536|FG002|Third Intervention (8 Days)|Elevated AST|0|||
144606914|NCT01383096|521422534|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
144606915|NCT01383096|521422535|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
144606916|NCT01383096|521422536|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
144606917|NCT01383096|521422534|FG000|Third Intervention (8 Days)|Adverse Event|1|||
144195778|NCT02143583|519912030|FG002|Overall Study|husband illness|1|||
144195779|NCT01244061|519912031|FG000|Overall Study|Death|1|||
144195780|NCT01244061|519912032|FG001|Overall Study|Death|0|||
144195781|NCT01244061|519912031|FG000|Overall Study|Did not meet entrance criteria|1|||
144195782|NCT01244061|519912032|FG001|Overall Study|Did not meet entrance criteria|0|||
144452130|NCT00132769|520852645|FG001|Overall Study|Withdrawal by Subject|3|||
144452131|NCT00132769|520852644|FG000|Overall Study|Lack of Efficacy|7|||
144452132|NCT00132769|520852645|FG001|Overall Study|Lack of Efficacy|6|||
144452133|NCT00132769|520852644|FG000|Overall Study|Adverse Event|2|||
144452134|NCT00132769|520852645|FG001|Overall Study|Adverse Event|1|||
144452135|NCT00132769|520852644|FG000|Overall Study|Protocol Violation|1|||
144452136|NCT00132769|520852645|FG001|Overall Study|Protocol Violation|1|||
144533665|NCT03817983|521156730|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
144195783|NCT01244061|519912031|FG000|Overall Study|Lack of Efficacy|1|||
144195784|NCT01244061|519912032|FG001|Overall Study|Lack of Efficacy|3|||
144452137|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452138|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144533666|NCT03817983|521156731|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
144533667|NCT03817983|521156732|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
144533668|NCT03744676|521156733|FG000|Pre-Treatment Phase|Disease related complications|2|||
144533669|NCT03744676|521156733|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
144533670|NCT03744676|521156733|FG000|Pre-Treatment Phase|Death|7|||
144533671|NCT03744676|521156733|FG000|Pre-Treatment Phase|Other Reasons|7|||
144533672|NCT03744676|521156733|FG000|Treatment Phase|Participant withdrew consent|8|||
144533673|NCT03744676|521156733|FG000|Treatment Phase|Death|33|||
144533674|NCT03744676|521156733|FG000|Treatment Phase|other reasons|6|||
144533675|NCT04078152|521156734|FG000|Overall Study|Other|83|||
144533676|NCT04078152|521156735|FG001|Overall Study|Other|22|||
144533677|NCT04078152|521156736|FG002|Overall Study|Other|25|||
144533678|NCT04078152|521156734|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
144533679|NCT04078152|521156735|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
144533680|NCT04078152|521156736|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
144533681|NCT04078152|521156734|FG000|Overall Study|Withdrawal by Subject|5|||
144533682|NCT04078152|521156735|FG001|Overall Study|Withdrawal by Subject|0|||
144533683|NCT04078152|521156736|FG002|Overall Study|Withdrawal by Subject|1|||
144533684|NCT04078152|521156734|FG000|Overall Study|Death|10|||
144533685|NCT04078152|521156735|FG001|Overall Study|Death|2|||
144533686|NCT04078152|521156736|FG002|Overall Study|Death|12|||
144533687|NCT04078152|521156734|FG000|Overall Study|Adverse Event|1|||
144533688|NCT04078152|521156735|FG001|Overall Study|Adverse Event|0|||
144533689|NCT04078152|521156736|FG002|Overall Study|Adverse Event|0|||
144533690|NCT00450216|521156738|FG000|Overall Study|Adverse Event|38|||
144533691|NCT00450216|521156739|FG001|Overall Study|Adverse Event|23|||
144533692|NCT00450216|521156738|FG000|Overall Study|Withdrawal by Subject|48|||
144533693|NCT00450216|521156739|FG001|Overall Study|Withdrawal by Subject|26|||
144533694|NCT00450216|521156738|FG000|Overall Study|Lost to Follow-up|16|||
144533695|NCT00450216|521156739|FG001|Overall Study|Lost to Follow-up|9|||
144533696|NCT00450216|521156738|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
144533697|NCT00450216|521156739|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
144533698|NCT00450216|521156738|FG000|Overall Study|misc|21|||
144195785|NCT01244061|519912031|FG000|Overall Study|Lost to Follow-up|34|||
144195786|NCT01244061|519912032|FG001|Overall Study|Lost to Follow-up|30|||
144195787|NCT01244061|519912031|FG000|Overall Study|Withdrawal by Subject|29|||
144195788|NCT01244061|519912032|FG001|Overall Study|Withdrawal by Subject|46|||
144195789|NCT01244061|519912031|FG000|Overall Study|Other|8|||
144195790|NCT01244061|519912032|FG001|Overall Study|Other|19|||
144195791|NCT01244061|519912031|FG000|Overall Study|Protocol Violation|1|||
144195792|NCT01244061|519912032|FG001|Overall Study|Protocol Violation|1|||
144195793|NCT01244061|519912031|FG000|Overall Study|Adverse Event|5|||
144195794|NCT01244061|519912032|FG001|Overall Study|Adverse Event|2|||
144195795|NCT01244061|519912031|FG000|Overall Study|Randomized but not treated|2|||
144195796|NCT01244061|519912032|FG001|Overall Study|Randomized but not treated|2|||
144195797|NCT01641133|519912033|FG000|Overall Study|Protocol Violation|0|||
144195798|NCT01641133|519912034|FG001|Overall Study|Protocol Violation|1|||
144195799|NCT01641133|519912035|FG002|Overall Study|Protocol Violation|1|||
144195800|NCT01641133|519912033|FG000|Overall Study|Migrated/moved from study area|5|||
144195801|NCT01641133|519912034|FG001|Overall Study|Migrated/moved from study area|3|||
144195802|NCT01641133|519912035|FG002|Overall Study|Migrated/moved from study area|1|||
144195803|NCT01641133|519912033|FG000|Overall Study|Adverse Event|0|||
144195804|NCT01641133|519912034|FG001|Overall Study|Adverse Event|0|||
144195805|NCT01641133|519912035|FG002|Overall Study|Adverse Event|1|||
144195806|NCT01641133|519912033|FG000|Overall Study|Withdrawal by Subject|5|||
144195807|NCT01641133|519912034|FG001|Overall Study|Withdrawal by Subject|3|||
144195808|NCT01641133|519912035|FG002|Overall Study|Withdrawal by Subject|3|||
144195809|NCT01641133|519912033|FG000|Overall Study|Lost to Follow-up|0|||
144195810|NCT01641133|519912034|FG001|Overall Study|Lost to Follow-up|2|||
144195811|NCT01641133|519912035|FG002|Overall Study|Lost to Follow-up|2|||
144195812|NCT00103402|519912036|FG000|Overall Study|Adverse Event|3|||
144195813|NCT00103402|519912037|FG001|Overall Study|Adverse Event|4|||
144195814|NCT00103402|519912036|FG000|Overall Study|Lost to Follow-up|8|||
144195815|NCT00103402|519912037|FG001|Overall Study|Lost to Follow-up|7|||
144195816|NCT00103402|519912036|FG000|Overall Study|Dissatisfied/No longer interested|6|||
144195817|NCT00103402|519912037|FG001|Overall Study|Dissatisfied/No longer interested|6|||
144195818|NCT00103402|519912036|FG000|Overall Study|Personal constraints/Other|5|||
144195819|NCT00103402|519912037|FG001|Overall Study|Personal constraints/Other|0|||
144195820|NCT01393730|519912038|FG000|Overall Study|Withdrawal by Subject|3|||
144195821|NCT01393730|519912038|FG000|Overall Study|Other|2|||
144195822|NCT01393730|519912038|FG000|Overall Study|Adverse Event|1|||
144195823|NCT02655016|519912041|FG000|Overall Study|Disease progression|6|||
144195824|NCT02655016|519912042|FG001|Overall Study|Disease progression|4|||
144195825|NCT02655016|519912041|FG000|Overall Study|Site closed|0|||
144195826|NCT02655016|519912042|FG001|Overall Study|Site closed|1|||
144195827|NCT02655016|519912041|FG000|Overall Study|Death|30|||
144195828|NCT02655016|519912042|FG001|Overall Study|Death|48|||
144195829|NCT02655016|519912041|FG000|Overall Study|Lost to Follow-up|1|||
144195830|NCT02655016|519912042|FG001|Overall Study|Lost to Follow-up|1|||
144195831|NCT02655016|519912041|FG000|Overall Study|Withdrawal by Subject|18|||
144195832|NCT02655016|519912042|FG001|Overall Study|Withdrawal by Subject|36|||
144195833|NCT04189445|519913627|FG000|Overall Study|Withdrawal of consent|8|||
144195834|NCT04189445|519913628|FG001|Overall Study|Withdrawal of consent|1|||
144195835|NCT04189445|519913629|FG002|Overall Study|Withdrawal of consent|0|||
144195836|NCT04189445|519913627|FG000|Overall Study|Study Terminated by Sponsor|25|||
144533699|NCT00450216|521156739|FG001|Overall Study|misc|20|||
144533700|NCT05008055|521156740|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
144533701|NCT05008055|521156741|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
144195837|NCT04189445|519913628|FG001|Overall Study|Study Terminated by Sponsor|3|||
144195838|NCT04189445|519913629|FG002|Overall Study|Study Terminated by Sponsor|0|||
144195839|NCT04189445|519913627|FG000|Overall Study|Death|54|||
144195840|NCT04189445|519913628|FG001|Overall Study|Death|24|||
144195841|NCT04189445|519913629|FG002|Overall Study|Death|0|||
144195842|NCT02960893|519913631|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
144195843|NCT02960893|519913632|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
144195844|NCT02960893|519913633|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
144195845|NCT02960893|519913634|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
144195846|NCT02960893|519913631|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
144195847|NCT02960893|519913632|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
144195848|NCT02960893|519913633|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
144195849|NCT02960893|519913634|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
144195850|NCT02960893|519913631|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
144195851|NCT02960893|519913632|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
144606918|NCT01383096|521422535|FG001|Third Intervention (8 Days)|Adverse Event|0|||
144606919|NCT01383096|521422536|FG002|Third Intervention (8 Days)|Adverse Event|0|||
144606920|NCT01383096|521422534|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
144606921|NCT01383096|521422535|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
144606922|NCT01383096|521422536|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
144606923|NCT01383096|521422534|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
144606924|NCT01383096|521422535|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
144606925|NCT01383096|521422536|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
144606926|NCT01383096|521422534|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
144606927|NCT01383096|521422535|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
144606928|NCT01383096|521422536|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
144606929|NCT01383096|521422534|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
144606930|NCT01383096|521422535|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
144606931|NCT01383096|521422536|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
144606932|NCT01383096|521422534|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
144606933|NCT01383096|521422535|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
144606934|NCT01383096|521422536|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
144606935|NCT01383096|521422534|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
144606936|NCT01383096|521422535|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
144606937|NCT01383096|521422536|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
144606938|NCT00549939|521422541|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
144195852|NCT02960893|519913633|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
144195853|NCT02960893|519913634|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
144195854|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
144606939|NCT00549939|521422542|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
144195855|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
144195856|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
144195857|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
144195858|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
144195859|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
144195860|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
144195861|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
144195862|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
144195863|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
144195864|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
144195865|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
144195866|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
144195867|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
144195868|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
144195869|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
144195870|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
144195871|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
144195872|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
144195873|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
144195874|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
144195875|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
144259294|NCT01089127|520150355|FG001|Overall Study|Lost to Follow-up|1|||
144452139|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452140|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452141|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
144452142|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452143|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144195876|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
144195877|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
144195878|NCT02960893|519913631|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
144195879|NCT02960893|519913632|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
144195880|NCT02960893|519913633|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
144195881|NCT02960893|519913634|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
144195882|NCT04285567|519913637|FG000|Overall Study|Death|3|||
144195883|NCT04285567|519913638|FG001|Overall Study|Death|3|||
144195884|NCT04285567|519913637|FG000|Overall Study|Lost to Follow-up|1|||
144195885|NCT04285567|519913638|FG001|Overall Study|Lost to Follow-up|1|||
144195886|NCT04285567|519913637|FG000|Overall Study|Reason Not Specified|1|||
144195887|NCT04285567|519913638|FG001|Overall Study|Reason Not Specified|1|||
144195888|NCT04285567|519913637|FG000|Overall Study|Physician Decision|2|||
144195889|NCT04285567|519913638|FG001|Overall Study|Physician Decision|1|||
144452144|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
144452145|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
144452146|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452147|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
144452148|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
144452149|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452150|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452151|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452152|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
144452153|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
144452154|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
144452155|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
144452156|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
144452157|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
144452158|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
144195890|NCT04285567|519913637|FG000|Overall Study|Withdrawal by Subject|2|||
144195891|NCT04285567|519913638|FG001|Overall Study|Withdrawal by Subject|6|||
144195892|NCT04285567|519913637|FG000|Overall Study|Adverse Event|1|||
144195893|NCT04285567|519913638|FG001|Overall Study|Adverse Event|0|||
144195894|NCT04285567|519913637|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
144195895|NCT04285567|519913638|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
144195896|NCT02177136|519913644|FG000|DB Phase|Withdrawal by Subject|2|||
144195897|NCT02177136|519913645|FG001|DB Phase|Withdrawal by Subject|0|||
144195898|NCT02177136|519913646|FG002|DB Phase|Withdrawal by Subject|0|||
144195899|NCT02177136|519913647|FG003|DB Phase|Withdrawal by Subject|0|||
144195900|NCT02177136|519913644|FG000|DB Phase|Discontinued Due to Pruritus|1|||
144195901|NCT02177136|519913645|FG001|DB Phase|Discontinued Due to Pruritus|3|||
144195902|NCT02177136|519913646|FG002|DB Phase|Discontinued Due to Pruritus|0|||
144195903|NCT02177136|519913647|FG003|DB Phase|Discontinued Due to Pruritus|0|||
144195904|NCT02177136|519913644|FG000|DB Phase|Adverse Event|3|||
144195905|NCT02177136|519913645|FG001|DB Phase|Adverse Event|2|||
144195906|NCT02177136|519913646|FG002|DB Phase|Adverse Event|3|||
144195907|NCT02177136|519913647|FG003|DB Phase|Adverse Event|0|||
144195908|NCT02177136|519913644|FG000|DB Phase|Protocol Violation|0|||
144195909|NCT02177136|519913645|FG001|DB Phase|Protocol Violation|0|||
144195910|NCT02177136|519913646|FG002|DB Phase|Protocol Violation|1|||
144195911|NCT02177136|519913647|FG003|DB Phase|Protocol Violation|0|||
144195912|NCT02177136|519913644|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
144195913|NCT02177136|519913645|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
144195914|NCT02177136|519913646|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
144195915|NCT02177136|519913647|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
144195916|NCT02177136|519913644|FG000|LTSE Phase|Withdrawal by Subject|0|||
144195917|NCT02177136|519913645|FG001|LTSE Phase|Withdrawal by Subject|0|||
144195918|NCT02177136|519913646|FG002|LTSE Phase|Withdrawal by Subject|0|||
144195919|NCT02177136|519913647|FG003|LTSE Phase|Withdrawal by Subject|6|||
144195920|NCT02177136|519913644|FG000|LTSE Phase|Adverse Event|0|||
144195921|NCT02177136|519913645|FG001|LTSE Phase|Adverse Event|0|||
144195922|NCT02177136|519913646|FG002|LTSE Phase|Adverse Event|0|||
144195923|NCT02177136|519913647|FG003|LTSE Phase|Adverse Event|10|||
144195924|NCT02177136|519913644|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
144195925|NCT02177136|519913645|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
144195926|NCT02177136|519913646|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
144195927|NCT02177136|519913647|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
144195928|NCT02177136|519913644|FG000|LTSE Phase|Physician Decision|0|||
144195929|NCT02177136|519913645|FG001|LTSE Phase|Physician Decision|0|||
144195930|NCT02177136|519913646|FG002|LTSE Phase|Physician Decision|0|||
144195931|NCT02177136|519913647|FG003|LTSE Phase|Physician Decision|2|||
144195932|NCT02177136|519913644|FG000|LTSE Phase|Lost to Follow-up|0|||
144254593|NCT02362425|520133373|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
144452159|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
144606940|NCT00549939|521422543|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
144606941|NCT00549939|521422541|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
144606942|NCT00549939|521422542|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
144606943|NCT00549939|521422543|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
144606944|NCT00549939|521422541|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
144606945|NCT00549939|521422542|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
144606946|NCT00549939|521422543|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
144606947|NCT00549939|521422541|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
144606948|NCT00549939|521422542|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
144606949|NCT00549939|521422543|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
144606950|NCT00549939|521422541|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
144606951|NCT00549939|521422542|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
144452160|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
144452161|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
144452162|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
144452163|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
144452164|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
144606952|NCT00549939|521422543|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
144606953|NCT00549939|521422541|FG000|40-week Open Label Treatment Period|Other|0|||
144606954|NCT00549939|521422542|FG001|40-week Open Label Treatment Period|Other|1|||
144606955|NCT00549939|521422543|FG002|40-week Open Label Treatment Period|Other|4|||
144606956|NCT03593850|521422546|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
144606957|NCT03593850|521422547|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
144606958|NCT00058552|521422552|FG000|Overall Study|Died prior to receiving treatment|4|||
144606959|NCT00058552|521422553|FG001|Overall Study|Died prior to receiving treatment|2|||
144606960|NCT00058552|521422552|FG000|Overall Study|Disease progression|52|||
144606961|NCT00058552|521422553|FG001|Overall Study|Disease progression|44|||
144606962|NCT00058552|521422552|FG000|Overall Study|Adverse Event|4|||
144606963|NCT00058552|521422553|FG001|Overall Study|Adverse Event|2|||
144606964|NCT00058552|521422552|FG000|Overall Study|Withdrawal by Subject|3|||
144725601|NCT00973700|521851308|FG003|Overall Study|Withdrawal by Subject|4|||
144725602|NCT00973700|521851309|FG004|Overall Study|Withdrawal by Subject|4|||
144725603|NCT00973700|521851305|FG000|Overall Study|Lost to Follow-up|5|||
144725604|NCT00973700|521851306|FG001|Overall Study|Lost to Follow-up|0|||
144195933|NCT02177136|519913645|FG001|LTSE Phase|Lost to Follow-up|0|||
144195934|NCT02177136|519913646|FG002|LTSE Phase|Lost to Follow-up|0|||
144195935|NCT02177136|519913647|FG003|LTSE Phase|Lost to Follow-up|1|||
144195936|NCT02177136|519913644|FG000|LTSE Phase|Participant Moved|0|||
144195937|NCT02177136|519913645|FG001|LTSE Phase|Participant Moved|0|||
144195938|NCT02177136|519913646|FG002|LTSE Phase|Participant Moved|0|||
144195939|NCT02177136|519913647|FG003|LTSE Phase|Participant Moved|1|||
144195940|NCT01386684|519913648|FG000|Overall Study|Lost to Follow-up|51|||
144195941|NCT01386684|519913648|FG000|Overall Study|Other|51|||
144195942|NCT01386684|519913648|FG000|Overall Study|Death|47|||
144195943|NCT01386684|519913648|FG000|Overall Study|Withdrawal of Consent|44|||
144195944|NCT01386684|519913648|FG000|Overall Study|Alternative Therapy Required|37|||
144195945|NCT01386684|519913648|FG000|Overall Study|Disease Progression|28|||
144195946|NCT01386684|519913648|FG000|Overall Study|Adverse Event|20|||
144195947|NCT01386684|519913648|FG000|Overall Study|Noncompliance|8|||
144195948|NCT01386684|519913648|FG000|Overall Study|Protocol Violation|4|||
144195949|NCT01386684|519913648|FG000|Overall Study|Missing|3|||
144195950|NCT00094458|519913649|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
144195951|NCT00094458|519913650|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
144195952|NCT00094458|519913651|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
144195953|NCT00094458|519913652|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
144195954|NCT00094458|519913653|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
144195955|NCT00094458|519913654|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
144195956|NCT00094458|519913649|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
144195957|NCT00094458|519913650|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
144195958|NCT00094458|519913651|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
144195959|NCT00094458|519913652|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
144195960|NCT00094458|519913653|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
144195961|NCT00094458|519913654|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
144195962|NCT00094458|519913649|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
144195963|NCT00094458|519913650|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
144195964|NCT00094458|519913651|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
144195965|NCT00094458|519913652|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
144195966|NCT00094458|519913653|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
144195967|NCT00094458|519913654|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
144452165|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
144195968|NCT00094458|519913649|FG000|Main Study: Through Week 30|Adverse Event|38|||
144195969|NCT00094458|519913650|FG001|Main Study: Through Week 30|Adverse Event|20|||
144195970|NCT00094458|519913651|FG002|Main Study: Through Week 30|Adverse Event|28|||
144195971|NCT00094458|519913652|FG003|Main Study: Through Week 30|Adverse Event|0|||
144195972|NCT00094458|519913653|FG004|Main Study: Through Week 30|Adverse Event|0|||
144195973|NCT00094458|519913654|FG005|Main Study: Through Week 30|Adverse Event|0|||
144195974|NCT00094458|519913649|FG000|Main Study: Through Week 30|Death|1|||
144195975|NCT00094458|519913650|FG001|Main Study: Through Week 30|Death|0|||
144195976|NCT00094458|519913651|FG002|Main Study: Through Week 30|Death|0|||
144195977|NCT00094458|519913652|FG003|Main Study: Through Week 30|Death|0|||
144195978|NCT00094458|519913653|FG004|Main Study: Through Week 30|Death|0|||
144195979|NCT00094458|519913654|FG005|Main Study: Through Week 30|Death|0|||
144195980|NCT00094458|519913649|FG000|Main Study: Through Week 30|Other|19|||
144195981|NCT00094458|519913650|FG001|Main Study: Through Week 30|Other|16|||
144195982|NCT00094458|519913651|FG002|Main Study: Through Week 30|Other|9|||
144195983|NCT00094458|519913652|FG003|Main Study: Through Week 30|Other|0|||
144195984|NCT00094458|519913653|FG004|Main Study: Through Week 30|Other|0|||
144195985|NCT00094458|519913654|FG005|Main Study: Through Week 30|Other|0|||
144195986|NCT00094458|519913649|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
144195987|NCT00094458|519913650|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
144195988|NCT00094458|519913651|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
144195989|NCT00094458|519913652|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
144195990|NCT00094458|519913653|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
144195991|NCT00094458|519913654|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
144195992|NCT00094458|519913649|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
144195993|NCT00094458|519913650|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
144195994|NCT00094458|519913651|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
144195995|NCT00094458|519913652|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
144195996|NCT00094458|519913653|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
144195997|NCT00094458|519913654|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
144195998|NCT00094458|519913649|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
144195999|NCT00094458|519913650|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
144196000|NCT00094458|519913651|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
144196001|NCT00094458|519913652|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
144196002|NCT00094458|519913653|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
144196003|NCT00094458|519913654|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
144196004|NCT00094458|519913649|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
144196005|NCT00094458|519913650|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
144196006|NCT00094458|519913651|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
144196007|NCT00094458|519913652|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
144196008|NCT00094458|519913653|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
144196009|NCT00094458|519913654|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
144196010|NCT00094458|519913649|FG000|OLE: Open-Label Extension|Adverse Event|0|||
144196011|NCT00094458|519913650|FG001|OLE: Open-Label Extension|Adverse Event|0|||
144196012|NCT00094458|519913651|FG002|OLE: Open-Label Extension|Adverse Event|0|||
144196013|NCT00094458|519913652|FG003|OLE: Open-Label Extension|Adverse Event|0|||
144196014|NCT00094458|519913653|FG004|OLE: Open-Label Extension|Adverse Event|3|||
144196015|NCT00094458|519913654|FG005|OLE: Open-Label Extension|Adverse Event|4|||
144196016|NCT00094458|519913649|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
144196017|NCT00094458|519913650|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
144196018|NCT00094458|519913651|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
144196019|NCT00094458|519913652|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
144196020|NCT00094458|519913653|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
144196021|NCT00094458|519913654|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
144196022|NCT00094458|519913649|FG000|OLE: Open-Label Extension|Patient decision|0|||
144196023|NCT00094458|519913650|FG001|OLE: Open-Label Extension|Patient decision|0|||
144196024|NCT00094458|519913651|FG002|OLE: Open-Label Extension|Patient decision|0|||
144196025|NCT00094458|519913652|FG003|OLE: Open-Label Extension|Patient decision|0|||
144196026|NCT00094458|519913653|FG004|OLE: Open-Label Extension|Patient decision|1|||
144196027|NCT00094458|519913654|FG005|OLE: Open-Label Extension|Patient decision|0|||
144196028|NCT03310411|519913661|FG000|Period 1|Adverse Event|0|||
144196029|NCT03310411|519913662|FG001|Period 1|Adverse Event|0|||
144196030|NCT03310411|519913663|FG002|Period 1|Adverse Event|0|||
144196031|NCT03310411|519913664|FG003|Period 1|Adverse Event|1|||
144196032|NCT00515541|519913667|FG000|Overall Study|Physician Decision|0|||
144196033|NCT00515541|519913668|FG001|Overall Study|Physician Decision|2|||
144196034|NCT00515541|519913669|FG002|Overall Study|Physician Decision|0|||
144452166|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
144452167|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
144452168|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
144452169|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452170|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452171|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452172|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452173|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452174|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
144452175|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
144452176|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452177|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452178|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
144452179|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
144452180|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
144452181|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452182|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452183|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452184|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
144452185|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452186|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452187|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452188|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452189|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452190|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
144254594|NCT02362425|520133374|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
144254595|NCT02362425|520133375|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
144254596|NCT02362425|520133372|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
144254597|NCT02362425|520133373|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
144254598|NCT02362425|520133374|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
144254599|NCT02362425|520133375|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
144254600|NCT02362425|520133372|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
144254601|NCT02362425|520133373|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
144254602|NCT02362425|520133374|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
144254603|NCT02362425|520133375|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
144254604|NCT02362425|520133372|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
144254605|NCT02362425|520133373|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
144254606|NCT02362425|520133374|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
144254607|NCT02362425|520133375|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
144254608|NCT02362425|520133372|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
144196035|NCT00515541|519913670|FG003|Overall Study|Physician Decision|1|||
144196036|NCT00515541|519913667|FG000|Overall Study|No show for appointments|0|||
144196037|NCT00515541|519913668|FG001|Overall Study|No show for appointments|1|||
144196038|NCT00515541|519913669|FG002|Overall Study|No show for appointments|0|||
144196039|NCT00515541|519913670|FG003|Overall Study|No show for appointments|2|||
144196040|NCT00515541|519913667|FG000|Overall Study|Withdrawal by Subject|0|||
144196041|NCT00515541|519913668|FG001|Overall Study|Withdrawal by Subject|2|||
144196042|NCT00515541|519913669|FG002|Overall Study|Withdrawal by Subject|0|||
144196043|NCT00515541|519913670|FG003|Overall Study|Withdrawal by Subject|2|||
144196044|NCT04268316|519913671|FG000|Overall Study|Withdrawal by Subject|2|||
144196045|NCT04268316|519913672|FG001|Overall Study|Withdrawal by Subject|1|||
144196046|NCT04268316|519913673|FG002|Overall Study|Withdrawal by Subject|0|||
144196047|NCT02132637|519913675|FG000|Study Period 1|Withdrawal by Subject|0|||
144196048|NCT02132637|519913676|FG001|Study Period 1|Withdrawal by Subject|4|||
144196049|NCT02132637|519913675|FG000|Study Period 1|Physician Decision|1|||
144196050|NCT02132637|519913676|FG001|Study Period 1|Physician Decision|0|||
144196051|NCT02132637|519913675|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
144196052|NCT02132637|519913676|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
144196053|NCT02132637|519913675|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
144196054|NCT02132637|519913676|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
144254609|NCT02362425|520133373|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
144254610|NCT02362425|520133374|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
144254611|NCT02362425|520133375|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
144254612|NCT00314808|520133381|FG000|Overall Study|Disease Progression without AE|4|||
144452191|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452192|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452193|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452194|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144254613|NCT00314808|520133381|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
144606965|NCT00058552|521422553|FG001|Overall Study|Withdrawal by Subject|5|||
144196055|NCT02072824|519913687|FG000|Overall Study|Insufficient clinical response|1|||
144196056|NCT02072824|519913688|FG001|Overall Study|Insufficient clinical response|0|||
144452195|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452196|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
144452197|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452198|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452199|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452200|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
144452201|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452202|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452203|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452204|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452205|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452206|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
144452207|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452208|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452209|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452210|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452211|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452212|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452213|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452214|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452215|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452216|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
144452217|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452218|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452219|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452220|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452221|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452222|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452223|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452224|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452225|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
144196057|NCT02072824|519913689|FG002|Overall Study|Insufficient clinical response|1|||
144196058|NCT02072824|519913687|FG000|Overall Study|No longer willing to participate|1|||
144196059|NCT02072824|519913688|FG001|Overall Study|No longer willing to participate|0|||
144196060|NCT02072824|519913689|FG002|Overall Study|No longer willing to participate|1|||
144196061|NCT02072824|519913687|FG000|Overall Study|Medication error|0|||
144196062|NCT02072824|519913688|FG001|Overall Study|Medication error|1|||
144196063|NCT02072824|519913689|FG002|Overall Study|Medication error|0|||
144196064|NCT02072824|519913687|FG000|Overall Study|Adverse Event|0|||
144196065|NCT02072824|519913688|FG001|Overall Study|Adverse Event|0|||
144196066|NCT02072824|519913689|FG002|Overall Study|Adverse Event|1|||
144196067|NCT02145026|519913693|FG000|Overall Study|Adverse Event|2|||
144196068|NCT02145026|519913693|FG000|Overall Study|Death|4|||
144196069|NCT02145026|519913693|FG000|Overall Study|Withdrawal by Subject|2|||
144196070|NCT02145026|519913693|FG000|Overall Study|Physician Decision|4|||
144196071|NCT03656874|519913694|FG000|Overall Study|Lost to Follow-up|3|||
144196072|NCT03656874|519913695|FG001|Overall Study|Lost to Follow-up|17|||
144196073|NCT03052322|519913697|FG000|Overall Study|Other un-specified|1|||
144196074|NCT03052322|519913698|FG001|Overall Study|Other un-specified|2|||
144196075|NCT03052322|519913697|FG000|Overall Study|Withdrawal by Subject|10|||
144196076|NCT03052322|519913698|FG001|Overall Study|Withdrawal by Subject|9|||
144196077|NCT03052322|519913697|FG000|Overall Study|Death|0|||
144196078|NCT03052322|519913698|FG001|Overall Study|Death|2|||
144196079|NCT03052322|519913697|FG000|Overall Study|Lack of Efficacy|1|||
144196080|NCT03052322|519913698|FG001|Overall Study|Lack of Efficacy|2|||
144196081|NCT03052322|519913697|FG000|Overall Study|Protocol Violation|1|||
144196082|NCT03052322|519913698|FG001|Overall Study|Protocol Violation|0|||
144196083|NCT03052322|519913697|FG000|Overall Study|Lost to Follow-up|2|||
144196084|NCT03052322|519913698|FG001|Overall Study|Lost to Follow-up|4|||
144452226|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452227|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144196085|NCT03052322|519913697|FG000|Overall Study|Adverse Event|6|||
144196086|NCT03052322|519913698|FG001|Overall Study|Adverse Event|13|||
144196087|NCT04920916|519913699|FG000|Phase IIa 60 Day Study|Death|2|||
144196088|NCT04920916|519913700|FG001|Phase IIa 60 Day Study|Death|5|||
144196089|NCT04920916|519913699|FG000|1 Year Follow up (Phone Call)|Death|1|||
144196090|NCT04920916|519913700|FG001|1 Year Follow up (Phone Call)|Death|3|||
144196091|NCT04920916|519913699|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
144196092|NCT04920916|519913700|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
144452228|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452229|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452230|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452231|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452232|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
144452233|NCT01609556|520852646|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
144452234|NCT01609556|520852647|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452235|NCT01609556|520852648|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452236|NCT01609556|520852649|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452237|NCT01609556|520852650|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452238|NCT01609556|520852651|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
144452239|NCT01609556|520852652|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452240|NCT01609556|520852653|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452241|NCT01609556|520852654|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452242|NCT01609556|520852655|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452243|NCT01609556|520852656|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
144452244|NCT01609556|520852657|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452245|NCT01609556|520852658|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452246|NCT01609556|520852659|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144452247|NCT01609556|520852660|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144196093|NCT00973765|519913701|FG000|Overall Study|Lost to Follow-up|8|||
144196094|NCT00973765|519913702|FG001|Overall Study|Lost to Follow-up|14|||
144196095|NCT02011113|519913703|FG000|Overall Study|Adverse Event|4|||
144196096|NCT02011113|519913703|FG000|Overall Study|Disease Progression (DP)|16|||
144196097|NCT02011113|519913703|FG000|Overall Study|Death|1|||
144196098|NCT02011113|519913703|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
144196099|NCT02011113|519913703|FG000|Overall Study|Investigator's judgement- DP|3|||
144196100|NCT02011113|519913703|FG000|Overall Study|Study terminated by sponsor|11|||
144196101|NCT05065983|519913710|FG000|Overall Study|Lost to Follow-up|2|||
144452248|NCT01609556|520852661|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
144606966|NCT00058552|521422552|FG000|Overall Study|Physician Decision|2|||
144196102|NCT00714493|519913711|FG000|Overall Study|Adverse Event|11|||
144196103|NCT00714493|519913711|FG000|Overall Study|Death|3|||
144196104|NCT00714493|519913711|FG000|Overall Study|Lack of Efficacy|10|||
144196105|NCT00714493|519913711|FG000|Overall Study|Lost to Follow-up|3|||
144196106|NCT00714493|519913711|FG000|Overall Study|Protocol Violation|12|||
144196107|NCT00714493|519913711|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
144196108|NCT00714493|519913711|FG000|Overall Study|OTHER|2|||
144196109|NCT00076804|519913712|FG000|Overall Study|Death|9|||
144196110|NCT00076804|519913713|FG001|Overall Study|Death|20|||
144196111|NCT00076804|519913712|FG000|Overall Study|Lost to Follow-up|9|||
144196112|NCT00076804|519913713|FG001|Overall Study|Lost to Follow-up|9|||
144196113|NCT00076804|519913712|FG000|Overall Study|Withdrawal by Subject|10|||
144196114|NCT00076804|519913713|FG001|Overall Study|Withdrawal by Subject|8|||
144196115|NCT00076804|519913712|FG000|Overall Study|Early study Closure|32|||
144196116|NCT00076804|519913713|FG001|Overall Study|Early study Closure|32|||
144196117|NCT00354341|519913714|FG000|Overall Study|Adverse Event|1|||
144196118|NCT00354341|519913715|FG001|Overall Study|Adverse Event|0|||
144196119|NCT00354341|519913714|FG000|Overall Study|Death|0|||
144196120|NCT00354341|519913715|FG001|Overall Study|Death|2|||
144196121|NCT00354341|519913714|FG000|Overall Study|Refused treatment|1|||
144196122|NCT00354341|519913715|FG001|Overall Study|Refused treatment|2|||
144196123|NCT00354341|519913714|FG000|Overall Study|Failure to return|0|||
144254614|NCT01775787|520133382|FG000|First 7-10 Days|Adverse Event|0|||
144254615|NCT01775787|520133383|FG001|First 7-10 Days|Adverse Event|1|||
144254616|NCT01775787|520133382|FG000|First 7-10 Days|family emergency|0|||
144606967|NCT00058552|521422553|FG001|Overall Study|Physician Decision|5|||
144606968|NCT00058552|521422552|FG000|Overall Study|Clinical disease progression|0|||
144606969|NCT00058552|521422553|FG001|Overall Study|Clinical disease progression|4|||
144606970|NCT02428855|521422554|FG000|Overall Study|Withdrawal by Subject|2|||
144606971|NCT03198520|521422557|FG000|Overall Study|Physician Decision|2|||
144606972|NCT03198520|521422557|FG000|Overall Study|Protocol Violation|2|||
144606973|NCT03198520|521422557|FG000|Overall Study|Withdrawal by Subject|1|||
144606974|NCT03198520|521422557|FG000|Overall Study|Study Ended|1|||
144254617|NCT01775787|520133383|FG001|First 7-10 Days|family emergency|1|||
144196124|NCT00354341|519913715|FG001|Overall Study|Failure to return|1|||
144196125|NCT00354341|519913714|FG000|Overall Study|Other|1|||
144254618|NCT01775787|520133382|FG000|First 7-10 Days|time commitment|0|||
144452249|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452250|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144606975|NCT01670539|521422558|FG000|Overall Study|Death|3|||
144196126|NCT00354341|519913715|FG001|Overall Study|Other|2|||
144196127|NCT04295135|519913716|FG000|Overall Study|Withdrawal by Subject|2|||
144196128|NCT04295135|519913717|FG001|Overall Study|Withdrawal by Subject|1|||
144196129|NCT04295135|519913716|FG000|Overall Study|Subject left organization|8|||
144254619|NCT01775787|520133383|FG001|First 7-10 Days|time commitment|2|||
144196130|NCT04295135|519913717|FG001|Overall Study|Subject left organization|4|||
144196131|NCT01732874|519913719|FG000|Overall Study|Withdrawal by Subject|5|||
144452251|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452252|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452253|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452254|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452255|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452256|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452257|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144196132|NCT01732874|519913720|FG001|Overall Study|Withdrawal by Subject|1|||
144196133|NCT01732874|519913719|FG000|Overall Study|Death of Infant|3|||
144196134|NCT01732874|519913720|FG001|Overall Study|Death of Infant|2|||
144196135|NCT00557076|519913721|FG000|Overall Study|Unblinding|0|||
144196136|NCT00557076|519913722|FG001|Overall Study|Unblinding|1|||
144196137|NCT04392583|519913724|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
144196138|NCT03484117|519913725|FG000|Overall Study|Lost to Follow-up|1|||
144196139|NCT03484117|519913726|FG001|Overall Study|Lost to Follow-up|3|||
144196140|NCT03484117|519913725|FG000|Overall Study|Declined participation in exit assess|1|||
144196141|NCT03484117|519913726|FG001|Overall Study|Declined participation in exit assess|1|||
144196142|NCT00136318|519913727|FG000|Overall Study|Adverse Event|5|||
144196143|NCT00136318|519913728|FG001|Overall Study|Adverse Event|5|||
144196144|NCT00136318|519913727|FG000|Overall Study|Withdrawal by Subject|2|||
144196145|NCT00136318|519913728|FG001|Overall Study|Withdrawal by Subject|2|||
144196146|NCT01846273|519913737|FG000|Overall Study|Adverse Event|9|||
144196147|NCT01846273|519913738|FG001|Overall Study|Adverse Event|7|||
144196148|NCT01846273|519913739|FG002|Overall Study|Adverse Event|0|||
144196149|NCT01846273|519913737|FG000|Overall Study|Subject withdrew consent|5|||
144196150|NCT01846273|519913738|FG001|Overall Study|Subject withdrew consent|8|||
144196151|NCT01846273|519913739|FG002|Overall Study|Subject withdrew consent|0|||
144196152|NCT01846273|519913737|FG000|Overall Study|Lost to Follow-up|2|||
144196153|NCT01846273|519913738|FG001|Overall Study|Lost to Follow-up|1|||
144196154|NCT01846273|519913739|FG002|Overall Study|Lost to Follow-up|0|||
144196155|NCT01846273|519913737|FG000|Overall Study|Administrative problems|1|||
144196156|NCT01846273|519913738|FG001|Overall Study|Administrative problems|0|||
144196157|NCT01846273|519913739|FG002|Overall Study|Administrative problems|0|||
144196158|NCT01846273|519913737|FG000|Overall Study|Death|2|||
144196159|NCT01846273|519913738|FG001|Overall Study|Death|1|||
144196160|NCT01846273|519913739|FG002|Overall Study|Death|0|||
144196161|NCT01846273|519913737|FG000|Overall Study|Disease Progression|0|||
144196162|NCT01846273|519913738|FG001|Overall Study|Disease Progression|4|||
144196163|NCT01846273|519913739|FG002|Overall Study|Disease Progression|0|||
144196164|NCT01846273|519913737|FG000|Overall Study|Protocol Deviation|2|||
144196165|NCT01846273|519913738|FG001|Overall Study|Protocol Deviation|3|||
144196166|NCT01846273|519913739|FG002|Overall Study|Protocol Deviation|0|||
144196167|NCT01846273|519913737|FG000|Overall Study|Physician Decision|1|||
144196168|NCT01846273|519913738|FG001|Overall Study|Physician Decision|2|||
144254620|NCT01775787|520133382|FG000|First 7-10 Days|concerns with using IV|1|||
144254621|NCT01775787|520133383|FG001|First 7-10 Days|concerns with using IV|2|||
144452258|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452259|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452260|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
144452261|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
144452262|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
144452263|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
144452264|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
144452265|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452266|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452267|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452268|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452269|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452270|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452271|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452272|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452273|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452274|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144196169|NCT01846273|519913739|FG002|Overall Study|Physician Decision|0|||
144196170|NCT02037165|519913742|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
144196171|NCT02037165|519913743|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
144196172|NCT02037165|519913744|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
144452275|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144452276|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
144196173|NCT02037165|519913745|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
144196174|NCT02037165|519913746|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
144196175|NCT02220725|519913747|FG000|Overall Study|Lost to Follow-up|0|||
144452277|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
144452278|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
144452279|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
144452280|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
144452281|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452282|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452283|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452284|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144196176|NCT02220725|519913748|FG001|Overall Study|Lost to Follow-up|0|||
144196177|NCT02220725|519913749|FG002|Overall Study|Lost to Follow-up|0|||
144196178|NCT02220725|519913750|FG003|Overall Study|Lost to Follow-up|1|||
144196179|NCT02220725|519913747|FG000|Overall Study|Withdrawal by Subject|0|||
144196180|NCT02220725|519913748|FG001|Overall Study|Withdrawal by Subject|0|||
144196181|NCT02220725|519913749|FG002|Overall Study|Withdrawal by Subject|0|||
144196182|NCT02220725|519913750|FG003|Overall Study|Withdrawal by Subject|1|||
144196183|NCT01297322|519913751|FG000|Overall Study|Lost to Follow-up|1|||
144196184|NCT01297322|519913752|FG001|Overall Study|Lost to Follow-up|0|||
144196185|NCT01297322|519913751|FG000|Overall Study|Withdrawal by Subject|0|||
144196186|NCT01297322|519913752|FG001|Overall Study|Withdrawal by Subject|1|||
144196187|NCT01297322|519913751|FG000|Overall Study|Protocol Violation|0|||
144196188|NCT01297322|519913752|FG001|Overall Study|Protocol Violation|3|||
144196189|NCT01583218|519913753|FG000|Overall Study|Withdrawal by Subject|43|||
144196190|NCT01583218|519913754|FG001|Overall Study|Withdrawal by Subject|29|||
144196191|NCT01583218|519913753|FG000|Overall Study|Death|206|||
144196192|NCT01583218|519913754|FG001|Overall Study|Death|211|||
144196193|NCT01583218|519913753|FG000|Overall Study|Lost to Follow-up|11|||
144196194|NCT01583218|519913754|FG001|Overall Study|Lost to Follow-up|17|||
144196195|NCT01583218|519913753|FG000|Overall Study|Adverse event or serious adverse event|3|||
144196196|NCT01583218|519913754|FG001|Overall Study|Adverse event or serious adverse event|3|||
144196197|NCT01583218|519913753|FG000|Overall Study|Patient /Family decision|3|||
144196198|NCT01583218|519913754|FG001|Overall Study|Patient /Family decision|0|||
144196199|NCT01583218|519913753|FG000|Overall Study|Cannot contact patient directly|1|||
144196200|NCT01583218|519913754|FG001|Overall Study|Cannot contact patient directly|2|||
144196201|NCT01583218|519913753|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
144196202|NCT01583218|519913754|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
144196203|NCT01583218|519913753|FG000|Overall Study|Patient did not wish to attend visits|0|||
144196204|NCT01583218|519913754|FG001|Overall Study|Patient did not wish to attend visits|1|||
144196205|NCT01583218|519913753|FG000|Overall Study|Patient randomized but not dosed|17|||
144196206|NCT01583218|519913754|FG001|Overall Study|Patient randomized but not dosed|16|||
144196207|NCT01583218|519913753|FG000|Overall Study|Patient was assessed via phone in person|1|||
144196208|NCT01583218|519913754|FG001|Overall Study|Patient was assessed via phone in person|0|||
144196209|NCT01583218|519913753|FG000|Overall Study|Patient deemed ineligible after random|2|||
144196210|NCT01583218|519913754|FG001|Overall Study|Patient deemed ineligible after random|0|||
144196211|NCT01583218|519913753|FG000|Overall Study|Patient was early terminated from study|0|||
144196212|NCT01583218|519913754|FG001|Overall Study|Patient was early terminated from study|1|||
144196213|NCT01583218|519913753|FG000|Overall Study|Patient was randomized due to mistake|1|||
144196214|NCT01583218|519913754|FG001|Overall Study|Patient was randomized due to mistake|0|||
144452285|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452286|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452287|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452288|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452289|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452290|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452291|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452292|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
144452293|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
144452294|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
144452295|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
144452296|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
144452297|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452298|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452299|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452300|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144254622|NCT01775787|520133382|FG000|Second 7-10 Days|time commitment|0|||
144254623|NCT01775787|520133383|FG001|Second 7-10 Days|time commitment|1|||
144196215|NCT01583218|519913753|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
144254624|NCT01775787|520133382|FG000|Second 7-10 Days|concerns with using IV|0|||
144254625|NCT01775787|520133383|FG001|Second 7-10 Days|concerns with using IV|1|||
144254626|NCT04076319|520133385|FG000|Overall Study|Withdrawal by Subject|2|||
144254627|NCT04076319|520133386|FG001|Overall Study|Withdrawal by Subject|0|||
144452301|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452302|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452303|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452304|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452305|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452306|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452307|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452308|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452309|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
144452310|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452311|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452312|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
144452313|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452314|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452315|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452316|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452317|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452318|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452319|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452320|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452321|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452322|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452323|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452324|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
144452325|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
144452326|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
144452327|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
144452328|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
144452329|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452330|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452331|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452332|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452333|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452334|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452335|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452336|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452337|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452338|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452339|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452340|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452341|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452342|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452343|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
144452344|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
144452345|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452346|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452347|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452348|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452349|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452350|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452351|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452352|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452353|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452354|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452355|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452356|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452357|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
144452358|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
144452359|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
144452360|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
144452361|NCT01609556|520852646|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452362|NCT01609556|520852647|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452363|NCT01609556|520852648|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452364|NCT01609556|520852649|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452365|NCT01609556|520852650|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452366|NCT01609556|520852651|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144254628|NCT04076319|520133385|FG000|Overall Study|Death|1|||
144452367|NCT01609556|520852652|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452368|NCT01609556|520852653|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452369|NCT01609556|520852654|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452370|NCT01609556|520852655|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452371|NCT01609556|520852656|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452372|NCT01609556|520852657|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452373|NCT01609556|520852658|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
144452374|NCT01609556|520852659|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452375|NCT01609556|520852660|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452376|NCT01609556|520852661|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
144452377|NCT04452344|520852662|FG000|Overall Study|Withdrawal by Subject|3|||
144452378|NCT04452344|520852663|FG001|Overall Study|Withdrawal by Subject|6|||
144452379|NCT04452344|520852662|FG000|Overall Study|Adverse Event|1|||
144452380|NCT04452344|520852663|FG001|Overall Study|Adverse Event|2|||
144452381|NCT04452344|520852662|FG000|Overall Study|Lost to Follow-up|2|||
144452382|NCT04452344|520852663|FG001|Overall Study|Lost to Follow-up|2|||
144452383|NCT04452344|520852662|FG000|Overall Study|No Post-Op Visit|6|||
144452384|NCT04452344|520852663|FG001|Overall Study|No Post-Op Visit|7|||
144452385|NCT00162136|520852665|FG000|Overall Study|Adverse Event|1|||
144452386|NCT00162136|520852665|FG000|Overall Study|Death|1|||
144452387|NCT00162136|520852665|FG000|Overall Study|Disease Progression/Relapse|23|||
144452388|NCT00162136|520852665|FG000|Overall Study|Investigator Request|5|||
144452389|NCT00162136|520852665|FG000|Overall Study|Study Drug Toxicity|4|||
144452390|NCT00162136|520852665|FG000|Overall Study|Withdrawal by Subject|1|||
144452391|NCT02788175|520852666|FG000|Overall Study|Protocol Violation|3|||
144452392|NCT02788175|520852666|FG000|Overall Study|Withdrawal by Subject|4|||
144452393|NCT02788175|520852666|FG000|Overall Study|Ineligible prior to study agent|6|||
144452394|NCT03930745|520852667|FG000|Overall Study|Lost to Follow-up|10|||
144452395|NCT03930745|520852668|FG001|Overall Study|Lost to Follow-up|5|||
144452396|NCT03930745|520852667|FG000|Overall Study|Withdrawal by Subject|1|||
144452397|NCT03930745|520852668|FG001|Overall Study|Withdrawal by Subject|2|||
144452398|NCT03930745|520852667|FG000|Overall Study|Protocol Violation|2|||
144452399|NCT03930745|520852668|FG001|Overall Study|Protocol Violation|2|||
144452400|NCT03930745|520852667|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
144452401|NCT03930745|520852668|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
144452402|NCT03930745|520852667|FG000|Overall Study|Adverse Event|0|||
144452403|NCT03930745|520852668|FG001|Overall Study|Adverse Event|1|||
144452404|NCT03930745|520852667|FG000|Overall Study|Pregnancy|0|||
144452405|NCT03930745|520852668|FG001|Overall Study|Pregnancy|1|||
144452406|NCT04095858|520852671|FG000|Overall Study|Death|1|||
144452407|NCT04095858|520852672|FG001|Overall Study|Death|0|||
144452408|NCT04095858|520852671|FG000|Overall Study|Study terminated by Sponsor|2|||
144452409|NCT04095858|520852672|FG001|Overall Study|Study terminated by Sponsor|4|||
144452410|NCT01344460|520852673|FG000|Overall Study|Withdrawal by Subject|1|||
144452411|NCT01344460|520852673|FG000|Overall Study|Lost to Follow-up|2|||
144452412|NCT03285477|520852675|FG000|Treatment and Response Assessment Period|Death|1|||
144452413|NCT03285477|520852676|FG001|Treatment and Response Assessment Period|Death|0|||
144452414|NCT03285477|520852675|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
144452415|NCT03285477|520852676|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
144452416|NCT03285477|520852675|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
144452417|NCT03285477|520852676|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
144452418|NCT03285477|520852675|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
144452419|NCT03285477|520852676|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
144452420|NCT03285477|520852675|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
144452421|NCT03285477|520852676|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
144452422|NCT03483623|520852677|FG000|Overall Study|43 complete sets achieved|1|||
144452423|NCT00852397|520852680|FG000|Overall Study|Adverse Event|4|||
144452424|NCT00852397|520852681|FG001|Overall Study|Adverse Event|6|||
144452425|NCT00852397|520852682|FG002|Overall Study|Adverse Event|4|||
144452426|NCT00852397|520852680|FG000|Overall Study|Death|0|||
144452427|NCT00852397|520852681|FG001|Overall Study|Death|0|||
144452428|NCT00852397|520852682|FG002|Overall Study|Death|1|||
144452429|NCT00852397|520852680|FG000|Overall Study|Withdrawal by Subject|4|||
144452430|NCT00852397|520852681|FG001|Overall Study|Withdrawal by Subject|1|||
144452431|NCT00852397|520852682|FG002|Overall Study|Withdrawal by Subject|2|||
144452432|NCT00852397|520852680|FG000|Overall Study|Study terminated by sponsor|2|||
144452433|NCT00852397|520852681|FG001|Overall Study|Study terminated by sponsor|1|||
144452434|NCT00852397|520852682|FG002|Overall Study|Study terminated by sponsor|6|||
144452435|NCT00852397|520852680|FG000|Overall Study|Difficulty in study site visit|1|||
144452436|NCT00852397|520852681|FG001|Overall Study|Difficulty in study site visit|0|||
144452437|NCT00852397|520852682|FG002|Overall Study|Difficulty in study site visit|0|||
144452438|NCT00852397|520852680|FG000|Overall Study|Protocol Violation|0|||
144452439|NCT00852397|520852681|FG001|Overall Study|Protocol Violation|0|||
144452440|NCT00852397|520852682|FG002|Overall Study|Protocol Violation|1|||
144452441|NCT01968434|520852686|FG000|Overall Study|Lost to Follow-up|3|||
144452442|NCT01968434|520852687|FG001|Overall Study|Lost to Follow-up|6|||
144452443|NCT00428610|520852690|FG000|Overall Study|Death Due to Adverse Event|3|||
144452444|NCT00428610|520852691|FG001|Overall Study|Death Due to Adverse Event|0|||
144452445|NCT00428610|520852692|FG002|Overall Study|Death Due to Adverse Event|5|||
144452446|NCT00428610|520852690|FG000|Overall Study|Death Due to Progressive Disease|0|||
144452447|NCT00428610|520852691|FG001|Overall Study|Death Due to Progressive Disease|0|||
144452448|NCT00428610|520852692|FG002|Overall Study|Death Due to Progressive Disease|2|||
144452449|NCT00428610|520852690|FG000|Overall Study|Adverse Event|2|||
144452450|NCT00428610|520852691|FG001|Overall Study|Adverse Event|3|||
144452451|NCT00428610|520852692|FG002|Overall Study|Adverse Event|2|||
144452452|NCT00428610|520852690|FG000|Overall Study|Investigator Decision|2|||
144452453|NCT00428610|520852691|FG001|Overall Study|Investigator Decision|1|||
144452454|NCT00428610|520852692|FG002|Overall Study|Investigator Decision|1|||
144452455|NCT00428610|520852690|FG000|Overall Study|Progressive Disease|42|||
144452456|NCT00428610|520852691|FG001|Overall Study|Progressive Disease|14|||
144452457|NCT00428610|520852692|FG002|Overall Study|Progressive Disease|22|||
144452458|NCT00428610|520852690|FG000|Overall Study|Withdrawal by Subject|4|||
144452459|NCT00428610|520852691|FG001|Overall Study|Withdrawal by Subject|0|||
144452460|NCT00428610|520852692|FG002|Overall Study|Withdrawal by Subject|0|||
144452461|NCT00262834|520854448|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
144452462|NCT00262834|520854449|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
144452463|NCT02352493|520854456|FG000|Overall Study|Pregnancy|0|||
144452464|NCT02352493|520854457|FG001|Overall Study|Pregnancy|0|||
144452465|NCT02352493|520854458|FG002|Overall Study|Pregnancy|0|||
144452466|NCT02352493|520854459|FG003|Overall Study|Pregnancy|0|||
144452467|NCT02352493|520854460|FG004|Overall Study|Pregnancy|0|||
144452468|NCT02352493|520854461|FG005|Overall Study|Pregnancy|0|||
144452469|NCT02352493|520854462|FG006|Overall Study|Pregnancy|1|||
144452470|NCT02352493|520854463|FG007|Overall Study|Pregnancy|0|||
144452471|NCT02352493|520854464|FG008|Overall Study|Pregnancy|1|||
144452472|NCT02352493|520854465|FG009|Overall Study|Pregnancy|0|||
144452473|NCT02352493|520854466|FG010|Overall Study|Pregnancy|0|||
144452474|NCT02352493|520854467|FG011|Overall Study|Pregnancy|0|||
144452475|NCT02352493|520854468|FG012|Overall Study|Pregnancy|0|||
144452476|NCT02352493|520854469|FG013|Overall Study|Pregnancy|0|||
144452477|NCT02352493|520854470|FG014|Overall Study|Pregnancy|0|||
144452478|NCT02352493|520854471|FG015|Overall Study|Pregnancy|0|||
144452479|NCT02352493|520854472|FG016|Overall Study|Pregnancy|0|||
144452480|NCT02352493|520854473|FG017|Overall Study|Pregnancy|0|||
144452481|NCT02352493|520854456|FG000|Overall Study|Withdrawal by Subject|0|||
144452482|NCT02352493|520854457|FG001|Overall Study|Withdrawal by Subject|0|||
144452483|NCT02352493|520854458|FG002|Overall Study|Withdrawal by Subject|0|||
144452484|NCT02352493|520854459|FG003|Overall Study|Withdrawal by Subject|0|||
144452485|NCT02352493|520854460|FG004|Overall Study|Withdrawal by Subject|0|||
144533702|NCT05008055|521156742|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
144533703|NCT03011034|521156747|FG000|Overall Study|Adverse Event|1|||
144533704|NCT03011034|521156748|FG001|Overall Study|Adverse Event|0|||
144533705|NCT05112900|521156749|FG000|Overall Study|Withdrawal by Subject|960|||
144533706|NCT05112900|521156750|FG001|Overall Study|Withdrawal by Subject|921|||
144533707|NCT05112900|521156751|FG002|Overall Study|Withdrawal by Subject|968|||
144254629|NCT04076319|520133386|FG001|Overall Study|Death|0|||
144254630|NCT01054222|520133387|FG000|Overall Study|Lack of Efficacy|1|||
144254631|NCT01054222|520133387|FG000|Overall Study|Lost to Follow-up|4|||
144533708|NCT04743973|521156753|FG000|Overall Study|Withdrawal by Subject|5|||
144533709|NCT04499521|521156756|FG000|Overall Study|Disease Progression|1|||
144533710|NCT04499521|521156757|FG001|Overall Study|Disease Progression|0|||
144533711|NCT03734029|521156758|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
144533712|NCT03734029|521156759|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
144254632|NCT01054222|520133387|FG000|Overall Study|Withdrawal by Subject|6|||
144254633|NCT00824655|520133388|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
144254634|NCT00824655|520133389|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
144452486|NCT02352493|520854461|FG005|Overall Study|Withdrawal by Subject|0|||
144452487|NCT02352493|520854462|FG006|Overall Study|Withdrawal by Subject|0|||
144452488|NCT02352493|520854463|FG007|Overall Study|Withdrawal by Subject|0|||
144452489|NCT02352493|520854464|FG008|Overall Study|Withdrawal by Subject|1|||
144452490|NCT02352493|520854465|FG009|Overall Study|Withdrawal by Subject|0|||
144452491|NCT02352493|520854466|FG010|Overall Study|Withdrawal by Subject|0|||
144452492|NCT02352493|520854467|FG011|Overall Study|Withdrawal by Subject|0|||
144452493|NCT02352493|520854468|FG012|Overall Study|Withdrawal by Subject|0|||
144452494|NCT02352493|520854469|FG013|Overall Study|Withdrawal by Subject|0|||
144452495|NCT02352493|520854470|FG014|Overall Study|Withdrawal by Subject|1|||
144452496|NCT02352493|520854471|FG015|Overall Study|Withdrawal by Subject|0|||
144452497|NCT02352493|520854472|FG016|Overall Study|Withdrawal by Subject|0|||
144452498|NCT02352493|520854473|FG017|Overall Study|Withdrawal by Subject|0|||
144452499|NCT02352493|520854456|FG000|Overall Study|Lost to Follow-up|0|||
144452500|NCT02352493|520854457|FG001|Overall Study|Lost to Follow-up|0|||
144533713|NCT03734029|521156758|FG000|Overall Study|Adverse Event|60|||
144452501|NCT02352493|520854458|FG002|Overall Study|Lost to Follow-up|0|||
144452502|NCT02352493|520854459|FG003|Overall Study|Lost to Follow-up|0|||
144452503|NCT02352493|520854460|FG004|Overall Study|Lost to Follow-up|0|||
144452504|NCT02352493|520854461|FG005|Overall Study|Lost to Follow-up|0|||
144725605|NCT00973700|521851307|FG002|Overall Study|Lost to Follow-up|1|||
144725606|NCT00973700|521851308|FG003|Overall Study|Lost to Follow-up|8|||
144725607|NCT00973700|521851309|FG004|Overall Study|Lost to Follow-up|5|||
144452505|NCT02352493|520854462|FG006|Overall Study|Lost to Follow-up|0|||
144452506|NCT02352493|520854463|FG007|Overall Study|Lost to Follow-up|0|||
144452507|NCT02352493|520854464|FG008|Overall Study|Lost to Follow-up|0|||
144452508|NCT02352493|520854465|FG009|Overall Study|Lost to Follow-up|1|||
144452509|NCT02352493|520854466|FG010|Overall Study|Lost to Follow-up|0|||
144452510|NCT02352493|520854467|FG011|Overall Study|Lost to Follow-up|0|||
144452511|NCT02352493|520854468|FG012|Overall Study|Lost to Follow-up|1|||
144452512|NCT02352493|520854469|FG013|Overall Study|Lost to Follow-up|2|||
144452513|NCT02352493|520854470|FG014|Overall Study|Lost to Follow-up|0|||
144452514|NCT02352493|520854471|FG015|Overall Study|Lost to Follow-up|0|||
144452515|NCT02352493|520854472|FG016|Overall Study|Lost to Follow-up|0|||
144452516|NCT02352493|520854473|FG017|Overall Study|Lost to Follow-up|0|||
144452517|NCT02162810|520854474|FG000|Overall Study|Protocol Violation|1|||
144452518|NCT02162810|520854475|FG001|Overall Study|Protocol Violation|0|||
144452519|NCT02162810|520854474|FG000|Overall Study|patients did not report compliance|4|||
144452520|NCT02162810|520854475|FG001|Overall Study|patients did not report compliance|1|||
144452521|NCT02546544|520854480|FG000|Overall Study|Disease Progression|14|||
144452522|NCT02546544|520854480|FG000|Overall Study|Adverse Event|1|||
144452523|NCT02546544|520854480|FG000|Overall Study|Withdrawal by Subject|1|||
144452524|NCT01921348|520854481|FG000|Overall Study|Withdrawal by Subject|1|||
144452525|NCT01921348|520854482|FG001|Overall Study|Withdrawal by Subject|0|||
144452526|NCT01921348|520854481|FG000|Overall Study|Lost to Follow-up|0|||
144452527|NCT01921348|520854482|FG001|Overall Study|Lost to Follow-up|2|||
144452528|NCT01465334|520854483|FG000|Overall Study|Disease Progression|1|||
144452529|NCT01465334|520854484|FG001|Overall Study|Disease Progression|0|||
144452530|NCT01465334|520854483|FG000|Overall Study|Adverse Event|1|||
144452531|NCT01465334|520854484|FG001|Overall Study|Adverse Event|0|||
144452532|NCT01465334|520854483|FG000|Overall Study|Richter's transformation|0|||
144452533|NCT01465334|520854484|FG001|Overall Study|Richter's transformation|3|||
144452534|NCT01465334|520854483|FG000|Overall Study|Refractory Disease|0|||
144452535|NCT01465334|520854484|FG001|Overall Study|Refractory Disease|3|||
144452536|NCT02548962|520854485|FG000|Overall Study|Withdrawal by Subject|1|||
144452537|NCT02548962|520854486|FG001|Overall Study|Withdrawal by Subject|0|||
144452538|NCT04831736|520854490|FG000|Overall Study|Withdrawal by Subject|0|||
144452539|NCT04831736|520854491|FG001|Overall Study|Withdrawal by Subject|1|||
144452540|NCT01046110|520854492|FG000|Overall Study|Adverse Event|9|||
144452541|NCT01046110|520854493|FG001|Overall Study|Adverse Event|2|||
144452542|NCT01046110|520854492|FG000|Overall Study|Lack of Efficacy|0|||
144452543|NCT01046110|520854493|FG001|Overall Study|Lack of Efficacy|1|||
144452544|NCT01046110|520854492|FG000|Overall Study|Protocol Violation|7|||
144452545|NCT01046110|520854493|FG001|Overall Study|Protocol Violation|12|||
144452546|NCT01046110|520854492|FG000|Overall Study|Withdrawal Criteria|3|||
144725608|NCT00973700|521851305|FG000|Overall Study|Inappropriate enrolment|0|||
144725609|NCT00973700|521851306|FG001|Overall Study|Inappropriate enrolment|0|||
144725610|NCT00973700|521851307|FG002|Overall Study|Inappropriate enrolment|0|||
144725611|NCT00973700|521851308|FG003|Overall Study|Inappropriate enrolment|4|||
144725612|NCT00973700|521851309|FG004|Overall Study|Inappropriate enrolment|0|||
144725613|NCT00973700|521851305|FG000|Overall Study|Unable to Classify|0|||
144725614|NCT00973700|521851306|FG001|Overall Study|Unable to Classify|0|||
144725615|NCT00973700|521851307|FG002|Overall Study|Unable to Classify|1|||
144725616|NCT00973700|521851308|FG003|Overall Study|Unable to Classify|2|||
144725617|NCT00973700|521851309|FG004|Overall Study|Unable to Classify|1|||
144452547|NCT01046110|520854493|FG001|Overall Study|Withdrawal Criteria|5|||
144725618|NCT03499964|521851310|FG000|Overall Study|Lack of Efficacy|6|||
144725619|NCT03499964|521851311|FG001|Overall Study|Lack of Efficacy|26|||
144725620|NCT03499964|521851310|FG000|Overall Study|Adverse Event|1|||
144452548|NCT01046110|520854492|FG000|Overall Study|Unclassified|36|||
144452549|NCT01046110|520854493|FG001|Overall Study|Unclassified|35|||
144452550|NCT01114646|520854494|FG000|Overall Study|Withdrawal by Subject|3|||
144725621|NCT03499964|521851311|FG001|Overall Study|Adverse Event|0|||
144725622|NCT03499964|521851310|FG000|Overall Study|Death|1|||
144725623|NCT03499964|521851311|FG001|Overall Study|Death|0|||
144452551|NCT01114646|520854495|FG001|Overall Study|Withdrawal by Subject|2|||
144452552|NCT01233817|520854496|FG000|Overall Study|Lost to Follow-up|1|||
144452553|NCT01233817|520854496|FG000|Overall Study|Withdrawal by Subject|2|||
144452554|NCT01202773|520854499|FG000|Overall Study|Adverse Event|4|||
144452555|NCT01202773|520854500|FG001|Overall Study|Adverse Event|5|||
144452556|NCT01202773|520854501|FG002|Overall Study|Adverse Event|5|||
144452557|NCT01202773|520854499|FG000|Overall Study|Lack of Efficacy|5|||
144452558|NCT01202773|520854500|FG001|Overall Study|Lack of Efficacy|4|||
144452559|NCT01202773|520854501|FG002|Overall Study|Lack of Efficacy|9|||
144452560|NCT01202773|520854499|FG000|Overall Study|Entry Criteria Not Met|2|||
144452561|NCT01202773|520854500|FG001|Overall Study|Entry Criteria Not Met|0|||
144452562|NCT01202773|520854501|FG002|Overall Study|Entry Criteria Not Met|1|||
144452563|NCT01202773|520854499|FG000|Overall Study|Lost to Follow-up|1|||
144452564|NCT01202773|520854500|FG001|Overall Study|Lost to Follow-up|2|||
144452565|NCT01202773|520854501|FG002|Overall Study|Lost to Follow-up|2|||
144452566|NCT01202773|520854499|FG000|Overall Study|Withdrawal by Subject|13|||
144452567|NCT01202773|520854500|FG001|Overall Study|Withdrawal by Subject|6|||
144452568|NCT01202773|520854501|FG002|Overall Study|Withdrawal by Subject|5|||
144452569|NCT01202773|520854499|FG000|Overall Study|Physician Decision|2|||
144452570|NCT01202773|520854500|FG001|Overall Study|Physician Decision|0|||
144452571|NCT01202773|520854501|FG002|Overall Study|Physician Decision|0|||
144452572|NCT01202773|520854499|FG000|Overall Study|Protocol Violation|11|||
144452573|NCT01202773|520854500|FG001|Overall Study|Protocol Violation|6|||
144452574|NCT01202773|520854501|FG002|Overall Study|Protocol Violation|10|||
144452575|NCT01202773|520854499|FG000|Overall Study|Sponsor Decision|19|||
144452576|NCT01202773|520854500|FG001|Overall Study|Sponsor Decision|20|||
144452577|NCT01202773|520854501|FG002|Overall Study|Sponsor Decision|23|||
144452578|NCT00575588|520854502|FG000|Overall Study|Adverse Event|11|||
144452579|NCT00575588|520854503|FG001|Overall Study|Adverse Event|13|||
144452580|NCT00575588|520854502|FG000|Overall Study|Withdrawal by Subject|27|||
144452581|NCT00575588|520854503|FG001|Overall Study|Withdrawal by Subject|31|||
144452582|NCT00575588|520854502|FG000|Overall Study|Lost to Follow-up|1|||
144452583|NCT00575588|520854503|FG001|Overall Study|Lost to Follow-up|3|||
144452584|NCT00575588|520854502|FG000|Overall Study|Death|4|||
144452585|NCT00575588|520854503|FG001|Overall Study|Death|2|||
144452586|NCT00575588|520854502|FG000|Overall Study|Incorrect enrollment|8|||
144452587|NCT00575588|520854503|FG001|Overall Study|Incorrect enrollment|4|||
144452588|NCT00575588|520854502|FG000|Overall Study|Study specific discontinuation criteria|203|||
144452589|NCT00575588|520854503|FG001|Overall Study|Study specific discontinuation criteria|218|||
144452590|NCT00575588|520854502|FG000|Overall Study|Severe non-compliance to protocol|5|||
144452591|NCT00575588|520854503|FG001|Overall Study|Severe non-compliance to protocol|7|||
144452592|NCT00575588|520854502|FG000|Overall Study|Safety reasons|2|||
144452593|NCT00575588|520854503|FG001|Overall Study|Safety reasons|1|||
144452594|NCT00575588|520854502|FG000|Overall Study|Elevated triglyceride|1|||
144452595|NCT00575588|520854503|FG001|Overall Study|Elevated triglyceride|0|||
144452596|NCT00575588|520854502|FG000|Overall Study|Patient moved|1|||
144452597|NCT00575588|520854503|FG001|Overall Study|Patient moved|3|||
144452598|NCT00575588|520854502|FG000|Overall Study|Impossible to determine HbA1c|0|||
144452599|NCT00575588|520854503|FG001|Overall Study|Impossible to determine HbA1c|1|||
144452600|NCT01430130|520854504|FG000|Overall Study|Lost to Follow-up|1|||
144452601|NCT01430130|520854504|FG000|Overall Study|Infection on Control Side of Incision|1|||
144452602|NCT03525834|520854505|FG000|Overall Study|Progressive disease|1|||
144452603|NCT02828111|520854509|FG000|Overall Study|Withdrawal by Subject|0|||
144452604|NCT02828111|520854510|FG001|Overall Study|Withdrawal by Subject|0|||
144452605|NCT02828111|520854511|FG002|Overall Study|Withdrawal by Subject|2|||
144452606|NCT02828111|520854512|FG003|Overall Study|Withdrawal by Subject|0|||
144452607|NCT02828111|520854513|FG004|Overall Study|Withdrawal by Subject|0|||
144452608|NCT02828111|520854509|FG000|Overall Study|Lost to Follow-up|0|||
144452609|NCT02828111|520854510|FG001|Overall Study|Lost to Follow-up|0|||
144452610|NCT02828111|520854511|FG002|Overall Study|Lost to Follow-up|0|||
144452611|NCT02828111|520854512|FG003|Overall Study|Lost to Follow-up|1|||
144452612|NCT02828111|520854513|FG004|Overall Study|Lost to Follow-up|1|||
144452613|NCT00614939|520854516|FG000|Overall Study|Withdrawal by Subject|10|||
144452614|NCT00614939|520854517|FG001|Overall Study|Withdrawal by Subject|17|||
144452615|NCT00614939|520854516|FG000|Overall Study|Study specific discontinuation criteris|13|||
144452616|NCT00614939|520854517|FG001|Overall Study|Study specific discontinuation criteris|16|||
144452617|NCT00614939|520854516|FG000|Overall Study|Adverse Event|2|||
144452618|NCT00614939|520854517|FG001|Overall Study|Adverse Event|5|||
144452619|NCT00614939|520854516|FG000|Overall Study|Incorrect enrollment|1|||
144452620|NCT00614939|520854517|FG001|Overall Study|Incorrect enrollment|2|||
144452621|NCT00614939|520854516|FG000|Overall Study|Death|4|||
144452622|NCT00614939|520854517|FG001|Overall Study|Death|3|||
144452623|NCT00614939|520854516|FG000|Overall Study|Poor/non-compliance|4|||
144452624|NCT00614939|520854517|FG001|Overall Study|Poor/non-compliance|0|||
144452625|NCT00614939|520854516|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
144452626|NCT00614939|520854517|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
144452627|NCT00840970|520854518|FG000|Overall Study|Adverse Event|0|||
144452628|NCT00840970|520854519|FG001|Overall Study|Adverse Event|0|||
144452629|NCT00840970|520854520|FG002|Overall Study|Adverse Event|1|||
144452630|NCT03465540|520854521|FG000|Overall Study|Withdrawal by Subject|0|||
144452631|NCT03465540|520854522|FG001|Overall Study|Withdrawal by Subject|0|||
144452632|NCT03465540|520854523|FG002|Overall Study|Withdrawal by Subject|1|||
144452633|NCT03465540|520854524|FG003|Overall Study|Withdrawal by Subject|1|||
144452634|NCT03465540|520854525|FG004|Overall Study|Withdrawal by Subject|1|||
144452635|NCT03465540|520854526|FG005|Overall Study|Withdrawal by Subject|0|||
144452636|NCT03465540|520854521|FG000|Overall Study|Lost to Follow-up|0|||
144452637|NCT03465540|520854522|FG001|Overall Study|Lost to Follow-up|1|||
144452638|NCT03465540|520854523|FG002|Overall Study|Lost to Follow-up|0|||
144452639|NCT03465540|520854524|FG003|Overall Study|Lost to Follow-up|0|||
144452640|NCT03465540|520854525|FG004|Overall Study|Lost to Follow-up|1|||
144452641|NCT03465540|520854526|FG005|Overall Study|Lost to Follow-up|0|||
144452642|NCT03465540|520854521|FG000|Overall Study|Death|1|||
144452643|NCT03465540|520854522|FG001|Overall Study|Death|1|||
144452644|NCT03465540|520854523|FG002|Overall Study|Death|0|||
144452645|NCT03465540|520854524|FG003|Overall Study|Death|2|||
144452646|NCT03465540|520854525|FG004|Overall Study|Death|0|||
144452647|NCT03465540|520854526|FG005|Overall Study|Death|2|||
144452648|NCT03465540|520854521|FG000|Overall Study|Protocol specified criteria|0|||
144452649|NCT03465540|520854522|FG001|Overall Study|Protocol specified criteria|2|||
144452650|NCT03465540|520854523|FG002|Overall Study|Protocol specified criteria|2|||
144452651|NCT03465540|520854524|FG003|Overall Study|Protocol specified criteria|0|||
144452652|NCT03465540|520854525|FG004|Overall Study|Protocol specified criteria|2|||
144452653|NCT03465540|520854526|FG005|Overall Study|Protocol specified criteria|0|||
144452654|NCT00504829|520854527|FG000|Overall Study|Protocol Violation|6|||
144452655|NCT00504829|520854528|FG001|Overall Study|Protocol Violation|4|||
144452656|NCT00504829|520854529|FG002|Overall Study|Protocol Violation|10|||
144452657|NCT01751568|520854534|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
144254635|NCT00824655|520133388|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
144254636|NCT00824655|520133389|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
144254637|NCT03782571|520133390|FG000|Period 1|Withdrawal by Subject|1|||
144254638|NCT03782571|520133391|FG001|Period 1|Withdrawal by Subject|0|||
144254639|NCT03782571|520133392|FG002|Period 1|Withdrawal by Subject|0|||
144254640|NCT03782571|520133393|FG003|Period 1|Withdrawal by Subject|0|||
144452658|NCT01751568|520854535|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
144452659|NCT01751568|520854536|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
144452660|NCT02660944|520854545|FG000|Overall Study|Adverse Event|3|||
144452661|NCT02660944|520854546|FG001|Overall Study|Adverse Event|4|||
144452662|NCT02660944|520854545|FG000|Overall Study|Physician Decision|3|||
144452663|NCT02660944|520854546|FG001|Overall Study|Physician Decision|1|||
144452664|NCT02660944|520854545|FG000|Overall Study|Withdrawal by Subject|5|||
144452665|NCT02660944|520854546|FG001|Overall Study|Withdrawal by Subject|3|||
144452666|NCT02660944|520854545|FG000|Overall Study|Lost to Follow-up|4|||
144452667|NCT02660944|520854546|FG001|Overall Study|Lost to Follow-up|1|||
144452668|NCT02660944|520854545|FG000|Overall Study|Subject schedule|0|||
144452669|NCT02660944|520854546|FG001|Overall Study|Subject schedule|1|||
144452670|NCT02660944|520854545|FG000|Overall Study|Exclusion criteria met|2|||
144452671|NCT02660944|520854546|FG001|Overall Study|Exclusion criteria met|0|||
144452672|NCT02843568|520854547|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
144452673|NCT02843568|520854548|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
144452674|NCT02843568|520854547|FG000|Overall Study|Death|3|||
144452675|NCT02843568|520854548|FG001|Overall Study|Death|3|||
144452676|NCT02843568|520854547|FG000|Overall Study|Withdrawal by Subject|1|||
144452677|NCT02843568|520854548|FG001|Overall Study|Withdrawal by Subject|1|||
144452678|NCT02843568|520854547|FG000|Overall Study|Lost to Follow-up|2|||
144452679|NCT02843568|520854548|FG001|Overall Study|Lost to Follow-up|0|||
144452680|NCT03586999|520854549|FG000|Overall Study|Lack of Efficacy|2|||
144452681|NCT01343407|520854550|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
144452682|NCT01343407|520854551|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
144452683|NCT01343407|520854552|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
144452684|NCT01343407|520854553|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
144452685|NCT01343407|520854554|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
144452686|NCT01343407|520854555|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
144452687|NCT01343407|520854550|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
144452688|NCT01343407|520854551|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
144452689|NCT01343407|520854552|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
144452690|NCT01343407|520854553|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
144452691|NCT01343407|520854554|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
144452692|NCT01343407|520854555|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
144452693|NCT00797667|520854563|FG000|Overall Study|Lack of Efficacy|0|||
144725624|NCT03499964|521851310|FG000|Overall Study|Withdrawal by Subject|2|||
144254641|NCT03782571|520133390|FG000|Period 3|Subject Unable to Attend V5|1|||
144452694|NCT00797667|520854564|FG001|Overall Study|Lack of Efficacy|1|||
144452695|NCT00797667|520854565|FG002|Overall Study|Lack of Efficacy|0|||
144452696|NCT00797667|520854563|FG000|Overall Study|Lost to Follow-up|8|||
144452697|NCT00797667|520854564|FG001|Overall Study|Lost to Follow-up|12|||
144452698|NCT00797667|520854565|FG002|Overall Study|Lost to Follow-up|2|||
144254642|NCT03782571|520133391|FG001|Period 3|Subject Unable to Attend V5|0|||
144254643|NCT03782571|520133392|FG002|Period 3|Subject Unable to Attend V5|0|||
144452699|NCT00797667|520854563|FG000|Overall Study|Physician Decision|3|||
144452700|NCT00797667|520854564|FG001|Overall Study|Physician Decision|1|||
144452701|NCT00797667|520854565|FG002|Overall Study|Physician Decision|0|||
144452702|NCT00797667|520854563|FG000|Overall Study|Pregnancy|2|||
144452703|NCT00797667|520854564|FG001|Overall Study|Pregnancy|0|||
144452704|NCT00797667|520854565|FG002|Overall Study|Pregnancy|0|||
144452705|NCT00797667|520854563|FG000|Overall Study|Protocol Violation|2|||
144452706|NCT00797667|520854564|FG001|Overall Study|Protocol Violation|7|||
144452707|NCT00797667|520854565|FG002|Overall Study|Protocol Violation|0|||
144452708|NCT00797667|520854563|FG000|Overall Study|Study Terminated by Sponsor|217|||
144452709|NCT00797667|520854564|FG001|Overall Study|Study Terminated by Sponsor|216|||
144452710|NCT00797667|520854565|FG002|Overall Study|Study Terminated by Sponsor|115|||
144452711|NCT00797667|520854563|FG000|Overall Study|Withdrawal by Subject|9|||
144452712|NCT00797667|520854564|FG001|Overall Study|Withdrawal by Subject|14|||
144452713|NCT00797667|520854565|FG002|Overall Study|Withdrawal by Subject|2|||
144452714|NCT00797667|520854563|FG000|Overall Study|Adverse Event|19|||
144452715|NCT00797667|520854564|FG001|Overall Study|Adverse Event|8|||
144452716|NCT00797667|520854565|FG002|Overall Study|Adverse Event|8|||
144452717|NCT01986829|520854570|FG000|Overall Study|Death|1|||
144452718|NCT02504866|520854571|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
144452719|NCT02504866|520854572|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
144452720|NCT02504866|520854573|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
144452721|NCT01229436|520854574|FG000|Overall Study|Withdrawal by Subject|2|||
144452722|NCT01229436|520854574|FG000|Overall Study|Lost to Follow-up|3|||
144452723|NCT00781326|520854577|FG000|Phase I|Adverse Event|1|||
144452724|NCT00781326|520854577|FG000|Phase I|Withdrawal by Subject|1|||
144452725|NCT00781326|520854577|FG000|Phase I|Physician Decision|2|||
144452726|NCT00096941|520854578|FG000|Overall Study|disease progression|3|||
144452727|NCT01775137|520854579|FG000|Overall Study|Death|1|||
144452728|NCT01775137|520854579|FG000|Overall Study|Protocol deviation|2|||
144452729|NCT01775137|520854579|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144452730|NCT01775137|520854579|FG000|Overall Study|Adverse Event|1|||
144452731|NCT01775137|520854579|FG000|Overall Study|Withdrawal by participants|5|||
144452732|NCT03231371|520854580|FG000|Overall Study|Withdrawal by Subject|1|||
144452733|NCT03231371|520854580|FG000|Overall Study|chose or were ineligible to have MRI|12|||
144452734|NCT02673697|520854583|FG000|Overall Study|Adverse Event|2|||
144452735|NCT02673697|520854584|FG001|Overall Study|Adverse Event|0|||
144452736|NCT02673697|520854583|FG000|Overall Study|Death|32|||
144452737|NCT02673697|520854584|FG001|Overall Study|Death|24|||
144452738|NCT02673697|520854583|FG000|Overall Study|Lost to Follow-up|5|||
144452739|NCT02673697|520854584|FG001|Overall Study|Lost to Follow-up|2|||
144452740|NCT02673697|520854583|FG000|Overall Study|Physician Decision|2|||
144452741|NCT02673697|520854584|FG001|Overall Study|Physician Decision|1|||
144452742|NCT02673697|520854583|FG000|Overall Study|Withdrawal by Subject|10|||
144452743|NCT02673697|520854584|FG001|Overall Study|Withdrawal by Subject|7|||
144452744|NCT02673697|520854583|FG000|Overall Study|Change subj medical status|1|||
144452745|NCT02673697|520854584|FG001|Overall Study|Change subj medical status|2|||
144452746|NCT02673697|520854583|FG000|Overall Study|Explant|10|||
144452747|NCT02673697|520854584|FG001|Overall Study|Explant|5|||
144452748|NCT02673697|520854583|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
144452749|NCT02673697|520854584|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
144452750|NCT03321019|520854593|FG000|Overall Study|Withdrawal by Subject|0|||
144452751|NCT03321019|520854594|FG001|Overall Study|Withdrawal by Subject|6|||
144452752|NCT03321019|520854593|FG000|Overall Study|Lost to Follow-up|0|||
144452753|NCT03321019|520854594|FG001|Overall Study|Lost to Follow-up|22|||
144452754|NCT04934670|520854595|FG000|Overall Study|Death|4|||
144452755|NCT04934670|520854596|FG001|Overall Study|Death|0|||
144452756|NCT04934670|520854595|FG000|Overall Study|Lost to Follow-up|1|||
144452757|NCT04934670|520854596|FG001|Overall Study|Lost to Follow-up|4|||
144452758|NCT03067441|520854599|FG000|Overall Study|Withdrawal by Subject|16|||
144452759|NCT03067441|520854600|FG001|Overall Study|Withdrawal by Subject|34|||
144452760|NCT03067441|520854599|FG000|Overall Study|Lost to Follow-up|7|||
144452761|NCT03067441|520854600|FG001|Overall Study|Lost to Follow-up|5|||
144452762|NCT03067441|520854599|FG000|Overall Study|Adverse Event|7|||
144452763|NCT03067441|520854600|FG001|Overall Study|Adverse Event|14|||
144452764|NCT03067441|520854599|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
144452765|NCT03067441|520854600|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
144452766|NCT03067441|520854599|FG000|Overall Study|Physician Decision|1|||
144452767|NCT03067441|520854600|FG001|Overall Study|Physician Decision|3|||
144452768|NCT03067441|520854599|FG000|Overall Study|Other|1|||
144452769|NCT03067441|520854600|FG001|Overall Study|Other|1|||
144452770|NCT01198600|520854609|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
144452771|NCT01198600|520854610|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
144452772|NCT01198600|520854611|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
144452773|NCT01198600|520854612|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
144452774|NCT01198600|520854609|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
144452775|NCT01198600|520854610|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
144452776|NCT01198600|520854611|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
144452777|NCT01198600|520854612|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
144472242|NCT04711603|520926726|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
144452778|NCT01198600|520854609|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
144452779|NCT01198600|520854610|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
144452780|NCT01198600|520854611|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
144452781|NCT01198600|520854612|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
144452782|NCT01198600|520854609|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
144452783|NCT01198600|520854610|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
144452784|NCT01198600|520854611|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
144452785|NCT01198600|520854612|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
144452786|NCT01198600|520854609|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
144452787|NCT01198600|520854610|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
144452788|NCT01198600|520854611|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
144452789|NCT01198600|520854612|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
144452790|NCT01198600|520854609|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
144452791|NCT01198600|520854610|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
144452792|NCT01198600|520854611|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
144452793|NCT01198600|520854612|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
144452794|NCT01198600|520854609|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
144452795|NCT01198600|520854610|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
144452796|NCT01198600|520854611|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
144452797|NCT01198600|520854612|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
144452798|NCT04177108|520854614|FG000|Overall Study|Withdrawal by Subject|4|||
144452799|NCT04177108|520854615|FG001|Overall Study|Withdrawal by Subject|8|||
144452800|NCT04177108|520854616|FG002|Overall Study|Withdrawal by Subject|9|||
144452801|NCT04177108|520854617|FG003|Overall Study|Withdrawal by Subject|11|||
144452802|NCT04177108|520854618|FG004|Overall Study|Withdrawal by Subject|13|||
144452803|NCT04177108|520854614|FG000|Overall Study|Physician Decision|23|||
144452804|NCT04177108|520854615|FG001|Overall Study|Physician Decision|15|||
144452805|NCT04177108|520854616|FG002|Overall Study|Physician Decision|18|||
144452806|NCT04177108|520854617|FG003|Overall Study|Physician Decision|29|||
144452807|NCT04177108|520854618|FG004|Overall Study|Physician Decision|23|||
144452808|NCT04177108|520854614|FG000|Overall Study|Reason Not Specified|0|||
144452809|NCT04177108|520854615|FG001|Overall Study|Reason Not Specified|1|||
144452810|NCT04177108|520854616|FG002|Overall Study|Reason Not Specified|0|||
144452811|NCT04177108|520854617|FG003|Overall Study|Reason Not Specified|0|||
144452812|NCT04177108|520854618|FG004|Overall Study|Reason Not Specified|2|||
144452813|NCT04177108|520854614|FG000|Overall Study|Lost to Follow-up|0|||
144452814|NCT04177108|520854615|FG001|Overall Study|Lost to Follow-up|0|||
144452815|NCT04177108|520854616|FG002|Overall Study|Lost to Follow-up|1|||
144452816|NCT04177108|520854617|FG003|Overall Study|Lost to Follow-up|1|||
144452817|NCT04177108|520854618|FG004|Overall Study|Lost to Follow-up|1|||
144452818|NCT04177108|520854614|FG000|Overall Study|Death|16|||
144452819|NCT04177108|520854615|FG001|Overall Study|Death|19|||
144452820|NCT04177108|520854616|FG002|Overall Study|Death|13|||
144606976|NCT01670539|521422559|FG001|Overall Study|Death|5|||
144606977|NCT01670539|521422558|FG000|Overall Study|Withdrawal by Subject|3|||
144606978|NCT01670539|521422559|FG001|Overall Study|Withdrawal by Subject|0|||
144606979|NCT04353596|521422560|FG000|Overall Study|Protocol Violation|4|||
144452821|NCT04177108|520854617|FG003|Overall Study|Death|17|||
144452822|NCT04177108|520854618|FG004|Overall Study|Death|18|||
144452823|NCT02041429|520854621|FG000|Overall Study|Progressive Disease|2|||
144452824|NCT02041429|520854622|FG001|Overall Study|Progressive Disease|2|||
144452825|NCT02041429|520854623|FG002|Overall Study|Progressive Disease|3|||
144452826|NCT02041429|520854624|FG003|Overall Study|Progressive Disease|2|||
144452827|NCT02041429|520854621|FG000|Overall Study|Toxicity|0|||
144452828|NCT02041429|520854622|FG001|Overall Study|Toxicity|1|||
144452829|NCT02041429|520854623|FG002|Overall Study|Toxicity|4|||
144452830|NCT02041429|520854624|FG003|Overall Study|Toxicity|2|||
144452831|NCT02041429|520854621|FG000|Overall Study|Withdrawal by Subject|0|||
144452832|NCT02041429|520854622|FG001|Overall Study|Withdrawal by Subject|1|||
144452833|NCT02041429|520854623|FG002|Overall Study|Withdrawal by Subject|0|||
144452834|NCT02041429|520854624|FG003|Overall Study|Withdrawal by Subject|0|||
144452835|NCT02041429|520854621|FG000|Overall Study|On Maintenance Therapy|1|||
144452836|NCT02041429|520854622|FG001|Overall Study|On Maintenance Therapy|0|||
144452837|NCT02041429|520854623|FG002|Overall Study|On Maintenance Therapy|0|||
144452838|NCT02041429|520854624|FG003|Overall Study|On Maintenance Therapy|2|||
144452839|NCT00784043|520854625|FG000|Overall Study|Withdrawal by Subject|8|||
144452840|NCT00784043|520854626|FG001|Overall Study|Withdrawal by Subject|5|||
144452841|NCT00784043|520854625|FG000|Overall Study|Protocol Terminated|23|||
144452842|NCT00784043|520854626|FG001|Overall Study|Protocol Terminated|1|||
144452843|NCT01143259|520854627|FG000|Overall Study|Withdrawal by Subject|3|||
144452844|NCT01143259|520854628|FG001|Overall Study|Withdrawal by Subject|2|||
144452845|NCT01143259|520854627|FG000|Overall Study|Protocol Violation|13|||
144452846|NCT01143259|520854628|FG001|Overall Study|Protocol Violation|9|||
144606980|NCT04353596|521422561|FG001|Overall Study|Protocol Violation|4|||
144452847|NCT01143259|520854627|FG000|Overall Study|Screen Failure|7|||
144452848|NCT01143259|520854628|FG001|Overall Study|Screen Failure|9|||
144452849|NCT00099983|520854629|FG000|Overall Study|Lost to Follow-up|2|||
144452850|NCT00099983|520854630|FG001|Overall Study|Lost to Follow-up|3|||
144452851|NCT00099983|520854629|FG000|Overall Study|Missing Source Documents|14|||
144452852|NCT00099983|520854630|FG001|Overall Study|Missing Source Documents|15|||
144452853|NCT00099983|520854629|FG000|Overall Study|Withdrawal by Subject|3|||
144452854|NCT00099983|520854630|FG001|Overall Study|Withdrawal by Subject|2|||
144452855|NCT00099983|520854629|FG000|Overall Study|Adverse Event|1|||
144452856|NCT00099983|520854630|FG001|Overall Study|Adverse Event|1|||
144452857|NCT00099983|520854629|FG000|Overall Study|Lack of Efficacy|0|||
144452858|NCT00099983|520854630|FG001|Overall Study|Lack of Efficacy|1|||
144452859|NCT00099983|520854629|FG000|Overall Study|Unable to return for appointments|1|||
144452860|NCT00099983|520854630|FG001|Overall Study|Unable to return for appointments|1|||
144452861|NCT00099983|520854629|FG000|Overall Study|Moved|1|||
144452862|NCT00099983|520854630|FG001|Overall Study|Moved|0|||
144452863|NCT00099983|520854629|FG000|Overall Study|Other psychiatric problem|1|||
144452864|NCT00099983|520854630|FG001|Overall Study|Other psychiatric problem|0|||
144452865|NCT00099983|520854629|FG000|Overall Study|Incarcerated|0|||
144452866|NCT00099983|520854630|FG001|Overall Study|Incarcerated|1|||
144452867|NCT00099983|520854629|FG000|Overall Study|Intolerant of burden of visits|0|||
144452868|NCT00099983|520854630|FG001|Overall Study|Intolerant of burden of visits|1|||
144452869|NCT00099983|520854629|FG000|Overall Study|Other issue|1|||
144452870|NCT00099983|520854630|FG001|Overall Study|Other issue|0|||
144452871|NCT03835533|520854635|FG000|Overall Study|Death|5|||
144452872|NCT03835533|520854636|FG001|Overall Study|Death|10|||
144452873|NCT03835533|520854637|FG002|Overall Study|Death|9|||
144452874|NCT03835533|520854635|FG000|Overall Study|Withdrawal by Subject|2|||
144452875|NCT03835533|520854636|FG001|Overall Study|Withdrawal by Subject|2|||
144452876|NCT03835533|520854637|FG002|Overall Study|Withdrawal by Subject|2|||
144452877|NCT03835533|520854635|FG000|Overall Study|Lost to Follow-up|1|||
144452878|NCT03835533|520854636|FG001|Overall Study|Lost to Follow-up|0|||
144452879|NCT03835533|520854637|FG002|Overall Study|Lost to Follow-up|0|||
144452880|NCT02207829|520854638|FG000|Overall Study|Adverse Event|10|||
144452881|NCT02207829|520854639|FG001|Overall Study|Adverse Event|9|||
144452882|NCT02207829|520854638|FG000|Overall Study|Lack of Efficacy|7|||
144452883|NCT02207829|520854639|FG001|Overall Study|Lack of Efficacy|5|||
144452884|NCT02207829|520854638|FG000|Overall Study|Lost to Follow-up|2|||
144452885|NCT02207829|520854639|FG001|Overall Study|Lost to Follow-up|2|||
144452886|NCT02207829|520854638|FG000|Overall Study|Protocol deviation|5|||
144452887|NCT02207829|520854639|FG001|Overall Study|Protocol deviation|4|||
144452888|NCT02207829|520854638|FG000|Overall Study|Withdrew consent|18|||
144452889|NCT02207829|520854639|FG001|Overall Study|Withdrew consent|14|||
144606981|NCT04353596|521422560|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
144606982|NCT04353596|521422561|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
144606983|NCT00823823|521422564|FG000|Overall Study|Lost to Follow-up|3|||
144606984|NCT00823823|521422565|FG001|Overall Study|Lost to Follow-up|1|||
144606985|NCT00823823|521422564|FG000|Overall Study|Protocol Violation|5|||
144606986|NCT00823823|521422565|FG001|Overall Study|Protocol Violation|5|||
144606987|NCT00536809|521422566|FG000|Phase II|Adverse Event|1|||
144606988|NCT00536809|521422566|FG000|Phase II|Referred for surgical resection|1|||
144606989|NCT02170779|521422582|FG000|Overall Study|Withdrawal by Subject|1|||
144606990|NCT02170779|521422583|FG001|Overall Study|Withdrawal by Subject|0|||
144606991|NCT02170779|521422582|FG000|Overall Study|Lost to Follow-up|0|||
144606992|NCT02170779|521422583|FG001|Overall Study|Lost to Follow-up|1|||
144606993|NCT00800683|521422584|FG000|Overall Study|Adverse Event|11|||
144606994|NCT00800683|521422585|FG001|Overall Study|Adverse Event|8|||
144606995|NCT00800683|521422584|FG000|Overall Study|Lost to Follow-up|3|||
144606996|NCT00800683|521422585|FG001|Overall Study|Lost to Follow-up|1|||
144606997|NCT00800683|521422584|FG000|Overall Study|Withdrawal by Subject|1|||
144606998|NCT00800683|521422585|FG001|Overall Study|Withdrawal by Subject|7|||
144606999|NCT00800683|521422584|FG000|Overall Study|Lack of Efficacy|1|||
144607000|NCT00800683|521422585|FG001|Overall Study|Lack of Efficacy|1|||
144452890|NCT00101101|520854640|FG000|Overall Study|never received vaccine|20|||
144607001|NCT00800683|521422584|FG000|Overall Study|Other|1|||
144607002|NCT00800683|521422585|FG001|Overall Study|Other|2|||
144607003|NCT03492554|521422590|FG000|Overall Study|Protocol Violation|0|||
144607004|NCT03492554|521422591|FG001|Overall Study|Protocol Violation|14|||
144452891|NCT01418209|520854641|FG000|Overall Study|Withdrawal by Subject|1|||
144452892|NCT01418209|520854642|FG001|Overall Study|Withdrawal by Subject|0|||
144452893|NCT01418209|520854643|FG002|Overall Study|Withdrawal by Subject|1|||
144452894|NCT01418209|520854641|FG000|Overall Study|Did not provide hot flash diary data|1|||
144452895|NCT01418209|520854642|FG001|Overall Study|Did not provide hot flash diary data|3|||
144607005|NCT00736034|521422592|FG000|Overall Study|Adverse Event|2|||
144607006|NCT03716050|521422598|FG000|Overall Study|Lost to Follow-up|0|||
144607007|NCT03716050|521422599|FG001|Overall Study|Lost to Follow-up|0|||
144607008|NCT03716050|521422600|FG002|Overall Study|Lost to Follow-up|1|||
144607009|NCT03716050|521422601|FG003|Overall Study|Lost to Follow-up|0|||
144452896|NCT01418209|520854643|FG002|Overall Study|Did not provide hot flash diary data|3|||
144452897|NCT02239510|520857072|FG000|Overall Study|Lost to Follow-up|2|||
144452898|NCT02239510|520857073|FG001|Overall Study|Lost to Follow-up|1|||
144452899|NCT00464542|520857076|FG000|Pre-treatment|Withdrawal by Subject|2|||
144452900|NCT03859323|520857077|FG000|Overall Study|Lost to Follow-up|0|||
144452901|NCT03859323|520857078|FG001|Overall Study|Lost to Follow-up|0|||
144452902|NCT03859323|520857079|FG002|Overall Study|Lost to Follow-up|0|||
144452903|NCT03859323|520857080|FG003|Overall Study|Lost to Follow-up|0|||
144452904|NCT03859323|520857081|FG004|Overall Study|Lost to Follow-up|0|||
144452905|NCT03859323|520857082|FG005|Overall Study|Lost to Follow-up|0|||
144452906|NCT03859323|520857083|FG006|Overall Study|Lost to Follow-up|1|||
144452907|NCT03859323|520857084|FG007|Overall Study|Lost to Follow-up|0|||
144452908|NCT03859323|520857085|FG008|Overall Study|Lost to Follow-up|0|||
144452909|NCT03859323|520857086|FG009|Overall Study|Lost to Follow-up|0|||
144452910|NCT03859323|520857087|FG010|Overall Study|Lost to Follow-up|0|||
144452911|NCT03859323|520857088|FG011|Overall Study|Lost to Follow-up|0|||
144452912|NCT03859323|520857089|FG012|Overall Study|Lost to Follow-up|0|||
144452913|NCT03859323|520857077|FG000|Overall Study|Withdrawal by Subject|0|||
144452914|NCT03859323|520857078|FG001|Overall Study|Withdrawal by Subject|0|||
144452915|NCT03859323|520857079|FG002|Overall Study|Withdrawal by Subject|1|||
144452916|NCT03859323|520857080|FG003|Overall Study|Withdrawal by Subject|0|||
144452917|NCT03859323|520857081|FG004|Overall Study|Withdrawal by Subject|0|||
144452918|NCT03859323|520857082|FG005|Overall Study|Withdrawal by Subject|1|||
144452919|NCT03859323|520857083|FG006|Overall Study|Withdrawal by Subject|0|||
144452920|NCT03859323|520857084|FG007|Overall Study|Withdrawal by Subject|0|||
144452921|NCT03859323|520857085|FG008|Overall Study|Withdrawal by Subject|0|||
144452922|NCT03859323|520857086|FG009|Overall Study|Withdrawal by Subject|1|||
144452923|NCT03859323|520857087|FG010|Overall Study|Withdrawal by Subject|1|||
144452924|NCT03859323|520857088|FG011|Overall Study|Withdrawal by Subject|2|||
144452925|NCT03859323|520857089|FG012|Overall Study|Withdrawal by Subject|1|||
144452926|NCT03859323|520857077|FG000|Overall Study|Pregnancy|0|||
144452927|NCT03859323|520857078|FG001|Overall Study|Pregnancy|0|||
144452928|NCT03859323|520857079|FG002|Overall Study|Pregnancy|0|||
144452929|NCT03859323|520857080|FG003|Overall Study|Pregnancy|0|||
144452930|NCT03859323|520857081|FG004|Overall Study|Pregnancy|0|||
144452931|NCT03859323|520857082|FG005|Overall Study|Pregnancy|0|||
144452932|NCT03859323|520857083|FG006|Overall Study|Pregnancy|0|||
144452933|NCT03859323|520857084|FG007|Overall Study|Pregnancy|0|||
144452934|NCT03859323|520857085|FG008|Overall Study|Pregnancy|0|||
144452935|NCT03859323|520857086|FG009|Overall Study|Pregnancy|1|||
144452936|NCT03859323|520857087|FG010|Overall Study|Pregnancy|0|||
144452937|NCT03859323|520857088|FG011|Overall Study|Pregnancy|0|||
144452938|NCT03859323|520857089|FG012|Overall Study|Pregnancy|0|||
144452939|NCT04401579|520857090|FG000|Overall Study|Death|23|||
144452940|NCT04401579|520857091|FG001|Overall Study|Death|36|||
144452941|NCT04401579|520857090|FG000|Overall Study|Lost to Follow-up|40|||
144452942|NCT04401579|520857091|FG001|Overall Study|Lost to Follow-up|41|||
144452943|NCT04401579|520857090|FG000|Overall Study|Withdrawal by Subject|8|||
144452944|NCT04401579|520857091|FG001|Overall Study|Withdrawal by Subject|16|||
144452945|NCT04401579|520857090|FG000|Overall Study|Physician Decision|1|||
144452946|NCT04401579|520857091|FG001|Overall Study|Physician Decision|2|||
144452947|NCT04401579|520857090|FG000|Overall Study|Became ineligible after enrollment|1|||
144452948|NCT04401579|520857091|FG001|Overall Study|Became ineligible after enrollment|1|||
144452949|NCT04401579|520857090|FG000|Overall Study|Enrolled but treatment not administered|7|||
144452950|NCT04401579|520857091|FG001|Overall Study|Enrolled but treatment not administered|9|||
144452951|NCT04401579|520857090|FG000|Overall Study|Adverse Event|2|||
144452952|NCT04401579|520857091|FG001|Overall Study|Adverse Event|1|||
144452953|NCT04401579|520857090|FG000|Overall Study|Scheduling error|1|||
144452954|NCT04401579|520857091|FG001|Overall Study|Scheduling error|2|||
144452955|NCT04401579|520857090|FG000|Overall Study|Transferred to another hospital|1|||
144452956|NCT04401579|520857091|FG001|Overall Study|Transferred to another hospital|2|||
144452957|NCT00489970|520857092|FG000|Persistence Year 9|Lost to Follow-up|2|||
144452958|NCT00489970|520857093|FG001|Persistence Year 9|Lost to Follow-up|2|||
144452959|NCT00489970|520857094|FG002|Persistence Year 9|Lost to Follow-up|3|||
144452960|NCT00489970|520857092|FG000|Persistence Year 9|Other|1|||
144452961|NCT00489970|520857093|FG001|Persistence Year 9|Other|0|||
144452962|NCT00489970|520857094|FG002|Persistence Year 9|Other|2|||
144452963|NCT01863680|520857095|FG000|Overall Study|Adverse Event|17|||
144452964|NCT01863680|520857095|FG000|Overall Study|Risk of OHSS|17|||
144452965|NCT01863680|520857095|FG000|Overall Study|Spontaneous pregnancy|2|||
144452966|NCT01863680|520857095|FG000|Overall Study|Withdrawal by Subject|1|||
144533714|NCT03734029|521156759|FG001|Overall Study|Adverse Event|14|||
144452967|NCT01863680|520857095|FG000|Overall Study|Did not undergo IVF/ET|14|||
144452968|NCT01863680|520857095|FG000|Overall Study|Other|6|||
144452969|NCT00566228|520857100|FG000|Overall Study|Withdrawal by Subject|1|||
144452970|NCT00566228|520857101|FG001|Overall Study|Withdrawal by Subject|0|||
144452971|NCT00566228|520857100|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
144452972|NCT00566228|520857101|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
144452973|NCT00566228|520857100|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
144452974|NCT00566228|520857101|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
144533715|NCT03734029|521156758|FG000|Overall Study|Withdrawal by Subject|12|||
144196216|NCT01583218|519913754|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
144196217|NCT01583218|519913753|FG000|Overall Study|Withdraw of consent on day of random|1|||
144196218|NCT01583218|519913754|FG001|Overall Study|Withdraw of consent on day of random|0|||
144196219|NCT02013375|519913757|FG000|Overall Study|Did not engraft|1|||
144196220|NCT02013375|519913757|FG000|Overall Study|Did not engraft|1|||
144452975|NCT00566228|520857100|FG000|Overall Study|progressed before infusion could occur|0|||
144452976|NCT00566228|520857101|FG001|Overall Study|progressed before infusion could occur|1|||
144452977|NCT02646423|520857104|FG000|Overall Study|Adverse Event|5|||
144452978|NCT02646423|520857105|FG001|Overall Study|Adverse Event|7|||
144452979|NCT02646423|520857104|FG000|Overall Study|Ineligible|2|||
144452980|NCT02646423|520857105|FG001|Overall Study|Ineligible|1|||
144452981|NCT00844194|520857109|FG000|Overall Study|Adverse Event|17|||
144452982|NCT00844194|520857110|FG001|Overall Study|Adverse Event|5|||
144452983|NCT00844194|520857109|FG000|Overall Study|Protocol Violation|1|||
144452984|NCT00844194|520857110|FG001|Overall Study|Protocol Violation|1|||
144452985|NCT00844194|520857109|FG000|Overall Study|Lost to Follow-up|1|||
144452986|NCT00844194|520857110|FG001|Overall Study|Lost to Follow-up|1|||
144452987|NCT00844194|520857109|FG000|Overall Study|Withdrawal by Subject|2|||
144452988|NCT00844194|520857110|FG001|Overall Study|Withdrawal by Subject|1|||
144452989|NCT00844194|520857109|FG000|Overall Study|Lack of Efficacy|3|||
144452990|NCT00844194|520857110|FG001|Overall Study|Lack of Efficacy|0|||
144452991|NCT00844194|520857109|FG000|Overall Study|Other reason (not specified)|1|||
144452992|NCT00844194|520857110|FG001|Overall Study|Other reason (not specified)|0|||
144452993|NCT00765245|520857111|FG000|Overall Study|disease progression|3|||
144452994|NCT00765245|520857112|FG001|Overall Study|disease progression|2|||
144452995|NCT00765245|520857111|FG000|Overall Study|Withdrawal by Subject|3|||
144452996|NCT00765245|520857112|FG001|Overall Study|Withdrawal by Subject|0|||
144452997|NCT00765245|520857111|FG000|Overall Study|Adverse Event|5|||
144452998|NCT00765245|520857112|FG001|Overall Study|Adverse Event|0|||
144607010|NCT03716050|521422602|FG004|Overall Study|Lost to Follow-up|0|||
144607011|NCT03716050|521422603|FG005|Overall Study|Lost to Follow-up|0|||
144607012|NCT03716050|521422604|FG006|Overall Study|Lost to Follow-up|0|||
144607013|NCT03716050|521422605|FG007|Overall Study|Lost to Follow-up|0|||
144607014|NCT03716050|521422598|FG000|Overall Study|Physician Decision|0|||
144607015|NCT03716050|521422599|FG001|Overall Study|Physician Decision|0|||
144607016|NCT03716050|521422600|FG002|Overall Study|Physician Decision|0|||
144607017|NCT03716050|521422601|FG003|Overall Study|Physician Decision|1|||
144607018|NCT03716050|521422602|FG004|Overall Study|Physician Decision|0|||
144607019|NCT03716050|521422603|FG005|Overall Study|Physician Decision|0|||
144607020|NCT03716050|521422604|FG006|Overall Study|Physician Decision|0|||
144607021|NCT03716050|521422605|FG007|Overall Study|Physician Decision|0|||
144607022|NCT03716050|521422598|FG000|Overall Study|Protocol Violation|0|||
144607023|NCT03716050|521422599|FG001|Overall Study|Protocol Violation|0|||
144607024|NCT03716050|521422600|FG002|Overall Study|Protocol Violation|0|||
144607025|NCT03716050|521422601|FG003|Overall Study|Protocol Violation|1|||
144607026|NCT03716050|521422602|FG004|Overall Study|Protocol Violation|0|||
144607027|NCT03716050|521422603|FG005|Overall Study|Protocol Violation|0|||
144607028|NCT03716050|521422604|FG006|Overall Study|Protocol Violation|0|||
144607029|NCT03716050|521422605|FG007|Overall Study|Protocol Violation|2|||
144607030|NCT03123250|521422606|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
144607031|NCT04340557|521422607|FG000|Overall Study|Transferred to ICU and/or death|1|||
144607032|NCT04340557|521422608|FG001|Overall Study|Transferred to ICU and/or death|2|||
144607033|NCT01221727|521422609|FG000|Overall Study|Physician Decision|2|||
144607034|NCT01221727|521422610|FG001|Overall Study|Physician Decision|0|||
144607035|NCT01221727|521422609|FG000|Overall Study|Withdrawal by Subject|1|||
144607036|NCT01221727|521422610|FG001|Overall Study|Withdrawal by Subject|1|||
144607037|NCT00529451|521422611|FG000|Overall Study|Subject withdrew consent|16|||
144607038|NCT00529451|521422612|FG001|Overall Study|Subject withdrew consent|21|||
144607039|NCT00529451|521422613|FG002|Overall Study|Subject withdrew consent|13|||
144607040|NCT00529451|521422614|FG003|Overall Study|Subject withdrew consent|12|||
144607041|NCT00529451|521422611|FG000|Overall Study|Adverse Event|9|||
144607042|NCT00529451|521422612|FG001|Overall Study|Adverse Event|16|||
144607043|NCT00529451|521422613|FG002|Overall Study|Adverse Event|14|||
144196221|NCT00712985|519913758|FG000|Overall Study|1 withdrew prior to start of drug|1|||
144607044|NCT00529451|521422614|FG003|Overall Study|Adverse Event|8|||
144607045|NCT00529451|521422611|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
144607046|NCT00529451|521422612|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
144607047|NCT00529451|521422613|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
144607048|NCT00529451|521422614|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
144607049|NCT00529451|521422611|FG000|Overall Study|Lost to Follow-up|4|||
144607050|NCT00529451|521422612|FG001|Overall Study|Lost to Follow-up|7|||
144196222|NCT00712985|519913758|FG000|Overall Study|1 patient moved out of state|1|||
144196223|NCT00712985|519913758|FG000|Overall Study|Lack of Efficacy|3|||
144452999|NCT00765245|520857111|FG000|Overall Study|Physician Decision|1|||
144453000|NCT00765245|520857112|FG001|Overall Study|Physician Decision|0|||
144453001|NCT00765245|520857111|FG000|Overall Study|Death|1|||
144453002|NCT00765245|520857112|FG001|Overall Study|Death|0|||
144453003|NCT02223390|520857113|FG000|Overall Study|Lost to Follow-up|9|||
144453004|NCT02223390|520857114|FG001|Overall Study|Lost to Follow-up|4|||
144453005|NCT00795600|520857116|FG000|Overall Study|Adverse Event|1|||
144453006|NCT00795600|520857117|FG001|Overall Study|Adverse Event|1|||
144453007|NCT00795600|520857116|FG000|Overall Study|Protocol Violation|1|||
144453008|NCT00795600|520857117|FG001|Overall Study|Protocol Violation|2|||
144453009|NCT00795600|520857116|FG000|Overall Study|Withdrawal by Subject|1|||
144453010|NCT00795600|520857117|FG001|Overall Study|Withdrawal by Subject|0|||
144453011|NCT00795600|520857116|FG000|Overall Study|Unclassified|1|||
144453012|NCT00795600|520857117|FG001|Overall Study|Unclassified|1|||
144453013|NCT03936244|520857121|FG000|Overall Study|Lost to Follow-up|5|||
144453014|NCT03936244|520857122|FG001|Overall Study|Lost to Follow-up|1|||
144453015|NCT03936244|520857121|FG000|Overall Study|Physician Decision|7|||
144453016|NCT03936244|520857122|FG001|Overall Study|Physician Decision|3|||
144453017|NCT01248884|520857127|FG000|Overall Study|Withdrawal by Subject|1|||
144453018|NCT01248884|520857128|FG001|Overall Study|Withdrawal by Subject|3|||
144453019|NCT01248884|520857129|FG002|Overall Study|Withdrawal by Subject|1|||
144453020|NCT01248884|520857127|FG000|Overall Study|Adverse Event|1|||
144453021|NCT01248884|520857128|FG001|Overall Study|Adverse Event|0|||
144453022|NCT01248884|520857129|FG002|Overall Study|Adverse Event|0|||
144453023|NCT02511431|520857130|FG000|Treatment|Lost to Follow-up|0|||
144453024|NCT02511431|520857131|FG001|Treatment|Lost to Follow-up|0|||
144453025|NCT02511431|520857132|FG002|Treatment|Lost to Follow-up|1|||
144453026|NCT02511431|520857133|FG003|Treatment|Lost to Follow-up|0|||
144453027|NCT02511431|520857134|FG004|Treatment|Lost to Follow-up|0|||
144453028|NCT02511431|520857135|FG005|Treatment|Lost to Follow-up|1|||
144453029|NCT01854827|520857136|FG000|Overall Study|Death|1|||
144453030|NCT00736996|520857137|FG000|Overall Study|Lost to Follow-up|1|||
144453031|NCT00736996|520857138|FG001|Overall Study|Lost to Follow-up|9|||
144453032|NCT00736996|520857139|FG002|Overall Study|Lost to Follow-up|2|||
144453033|NCT00462384|520857140|FG000|Overall Study|Adverse Event|2|||
144453034|NCT00462384|520857140|FG000|Overall Study|Death|2|||
144453035|NCT00462384|520857140|FG000|Overall Study|Withdrawal by Subject|1|||
144453036|NCT00462384|520857140|FG000|Overall Study|Other|4|||
144453037|NCT02667912|520857141|FG000|Overall Study|Death|3|||
144453038|NCT02667912|520857142|FG001|Overall Study|Death|1|||
144453039|NCT02667912|520857141|FG000|Overall Study|Withdrawal by Subject|1|||
144453040|NCT02667912|520857142|FG001|Overall Study|Withdrawal by Subject|2|||
144453041|NCT02667912|520857141|FG000|Overall Study|Withdrawal by Subject|1|||
144453042|NCT02667912|520857142|FG001|Overall Study|Withdrawal by Subject|0|||
144453043|NCT02079805|520857143|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144453044|NCT02079805|520857144|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
144453045|NCT02079805|520857143|FG000|Overall Study|Voluntary Withdrawal|0|||
144453046|NCT02079805|520857144|FG001|Overall Study|Voluntary Withdrawal|1|||
144453047|NCT00437489|520857145|FG000|Overall Study|Study terminated by sponsor|23|||
144453048|NCT00437489|520857146|FG001|Overall Study|Study terminated by sponsor|21|||
144453049|NCT00437489|520857145|FG000|Overall Study|Lost to Follow-up|0|||
144453050|NCT00437489|520857146|FG001|Overall Study|Lost to Follow-up|1|||
144453051|NCT00022516|520857147|FG000|Overall Study|Adverse Event|0|||
144453052|NCT00022516|520857148|FG001|Overall Study|Adverse Event|59|||
144453053|NCT00022516|520857147|FG000|Overall Study|Lack of Efficacy|0|||
144453054|NCT00022516|520857148|FG001|Overall Study|Lack of Efficacy|27|||
144453055|NCT00022516|520857147|FG000|Overall Study|Physician Decision|0|||
144453056|NCT00022516|520857148|FG001|Overall Study|Physician Decision|1|||
144453057|NCT00022516|520857147|FG000|Overall Study|Protocol Violation|1|||
144453058|NCT00022516|520857148|FG001|Overall Study|Protocol Violation|3|||
144453059|NCT00022516|520857147|FG000|Overall Study|Withdrawal by Subject|2|||
144453060|NCT00022516|520857148|FG001|Overall Study|Withdrawal by Subject|113|||
144453061|NCT00022516|520857147|FG000|Overall Study|Incomplete documentation|0|||
144453062|NCT00022516|520857148|FG001|Overall Study|Incomplete documentation|27|||
144453063|NCT03783923|520857150|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
144453064|NCT03783923|520857151|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
144453065|NCT03783923|520857150|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
144453066|NCT03783923|520857151|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
144453067|NCT03783923|520857150|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
144453068|NCT03783923|520857151|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
144453069|NCT03783923|520857150|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
144453070|NCT03783923|520857151|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
144453071|NCT03783923|520857150|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
144725625|NCT03499964|521851311|FG001|Overall Study|Withdrawal by Subject|1|||
144453072|NCT03783923|520857151|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
144453073|NCT01592708|520857152|FG000|Overall Study|Protocol Violation|3|||
144453074|NCT01592708|520857153|FG001|Overall Study|Protocol Violation|0|||
144453075|NCT02056301|520857158|FG000|Overall Study|Protocol Violation|1|||
144453076|NCT02056301|520857159|FG001|Overall Study|Protocol Violation|2|||
144453077|NCT02056301|520857158|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
144453078|NCT02056301|520857159|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
144453079|NCT02056301|520857158|FG000|Overall Study|Withdrawal by Subject|0|||
144533716|NCT03734029|521156759|FG001|Overall Study|Withdrawal by Subject|11|||
144533717|NCT03734029|521156758|FG000|Overall Study|Clinical progression by investigator|10|||
144533718|NCT03734029|521156759|FG001|Overall Study|Clinical progression by investigator|8|||
144533719|NCT03734029|521156758|FG000|Overall Study|Death|5|||
144533720|NCT03734029|521156759|FG001|Overall Study|Death|2|||
144453080|NCT02056301|520857159|FG001|Overall Study|Withdrawal by Subject|1|||
144533721|NCT03734029|521156758|FG000|Overall Study|Physician Decision|4|||
144533722|NCT03734029|521156759|FG001|Overall Study|Physician Decision|3|||
144533723|NCT03734029|521156758|FG000|Overall Study|Other|2|||
144533724|NCT03734029|521156759|FG001|Overall Study|Other|0|||
144533725|NCT03734029|521156758|FG000|Overall Study|Lost to Follow-up|0|||
144607051|NCT00529451|521422613|FG002|Overall Study|Lost to Follow-up|4|||
144607052|NCT00529451|521422614|FG003|Overall Study|Lost to Follow-up|4|||
144453081|NCT02056301|520857158|FG000|Overall Study|Issues with epidural|0|||
144453082|NCT02056301|520857159|FG001|Overall Study|Issues with epidural|3|||
144453083|NCT02328326|520857162|FG000|Overall Study|Withdrawal by Subject|10|||
144453084|NCT02328326|520857163|FG001|Overall Study|Withdrawal by Subject|3|||
144453085|NCT02328326|520857162|FG000|Overall Study|Death|2|||
144453086|NCT02328326|520857163|FG001|Overall Study|Death|1|||
144453087|NCT02328326|520857162|FG000|Overall Study|Lost to Follow-up|10|||
144453088|NCT02328326|520857163|FG001|Overall Study|Lost to Follow-up|4|||
144453089|NCT01767116|520857167|FG000|Overall Study|Lost to Follow-up|2|||
144453090|NCT01767116|520857168|FG001|Overall Study|Lost to Follow-up|2|||
144453091|NCT02209324|520857169|FG000|Overall Study|Adverse Event|2|||
144453092|NCT02209324|520857169|FG000|Overall Study|Lack of Efficacy|1|||
144453093|NCT02209324|520857169|FG000|Overall Study|Lost to Follow-up|1|||
144607053|NCT00529451|521422611|FG000|Overall Study|Protocol deviation|1|||
144607054|NCT00529451|521422612|FG001|Overall Study|Protocol deviation|1|||
144607055|NCT00529451|521422613|FG002|Overall Study|Protocol deviation|4|||
144607056|NCT00529451|521422614|FG003|Overall Study|Protocol deviation|1|||
144196224|NCT02674061|519913761|FG000|Overall Study|Death|229|||
144196225|NCT02674061|519913762|FG001|Overall Study|Death|77|||
144196226|NCT02674061|519913761|FG000|Overall Study|Lost to Follow-up|3|||
144196227|NCT02674061|519913762|FG001|Overall Study|Lost to Follow-up|3|||
144196228|NCT02674061|519913761|FG000|Overall Study|Withdrawal by Subject|9|||
144196229|NCT02674061|519913762|FG001|Overall Study|Withdrawal by Subject|1|||
144196230|NCT02674061|519913761|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
144196231|NCT02674061|519913762|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
144196232|NCT00123955|519913765|FG000|Overall Study|Adverse Event|1|||
144196233|NCT00123955|519913766|FG001|Overall Study|Adverse Event|0|||
144196234|NCT00123955|519913765|FG000|Overall Study|Withdrawal by Subject|4|||
144196235|NCT00123955|519913766|FG001|Overall Study|Withdrawal by Subject|3|||
144196236|NCT00123955|519913765|FG000|Overall Study|Death|0|||
144196237|NCT00123955|519913766|FG001|Overall Study|Death|1|||
144196238|NCT03334721|519913767|FG000|Overall Study|Withdrawal by Subject|1|||
144196239|NCT03334721|519913768|FG001|Overall Study|Withdrawal by Subject|0|||
144196240|NCT03334721|519913767|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
144196241|NCT03334721|519913768|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
144196242|NCT01558297|519913769|FG000|Overall Study|Withdrawal by Subject|2|||
144196243|NCT01558297|519913770|FG001|Overall Study|Withdrawal by Subject|2|||
144196244|NCT01558297|519913771|FG002|Overall Study|Withdrawal by Subject|1|||
144196245|NCT01663727|519913772|FG000|Overall Study|Death|161|||
144196246|NCT01663727|519913773|FG001|Overall Study|Death|155|||
144196247|NCT01663727|519913772|FG000|Overall Study|Lost to Follow-up|10|||
144196248|NCT01663727|519913773|FG001|Overall Study|Lost to Follow-up|8|||
144196249|NCT01663727|519913772|FG000|Overall Study|Withdrawal by Subject|18|||
144196250|NCT01663727|519913773|FG001|Overall Study|Withdrawal by Subject|25|||
144196251|NCT01663727|519913772|FG000|Overall Study|Study Terminated|51|||
144196252|NCT01663727|519913773|FG001|Overall Study|Study Terminated|50|||
144196253|NCT01663727|519913772|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
144196254|NCT01663727|519913773|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
144196255|NCT01663727|519913772|FG000|Overall Study|Withdrawal prior to dosing.|1|||
144196256|NCT01663727|519913773|FG001|Overall Study|Withdrawal prior to dosing.|0|||
144196257|NCT01902628|519913774|FG000|Overall Study|Withdrawal of participant's consent|7|||
144196258|NCT01902628|519913774|FG000|Overall Study|Adverse Event|41|||
144196259|NCT01902628|519913774|FG000|Overall Study|Lost to Follow-up|35|||
144196260|NCT01232491|519913775|FG000|Overall Study|Adverse Event|13|||
144196261|NCT01232491|519913776|FG001|Overall Study|Adverse Event|8|||
144196262|NCT01232491|519913775|FG000|Overall Study|Lack of Efficacy|1|||
144196263|NCT01232491|519913776|FG001|Overall Study|Lack of Efficacy|5|||
144196264|NCT01232491|519913775|FG000|Overall Study|Protocol Violation|13|||
144196265|NCT01232491|519913776|FG001|Overall Study|Protocol Violation|11|||
144196266|NCT01232491|519913775|FG000|Overall Study|Withdrawal Criteria|12|||
144196267|NCT01232491|519913776|FG001|Overall Study|Withdrawal Criteria|21|||
144196268|NCT01232491|519913775|FG000|Overall Study|Other|21|||
144453094|NCT02209324|520857169|FG000|Overall Study|Physician Decision|3|||
144533726|NCT03734029|521156759|FG001|Overall Study|Lost to Follow-up|1|||
144533727|NCT03734029|521156758|FG000|Overall Study|Randomized, but not treated|2|||
144725626|NCT03499964|521851310|FG000|Overall Study|Lost to Follow-up|1|||
144725627|NCT03499964|521851311|FG001|Overall Study|Lost to Follow-up|0|||
144725628|NCT01193608|521851313|FG000|Overall Study|Other|0|||
144725629|NCT01193608|521851314|FG001|Overall Study|Other|1|||
144725630|NCT01193608|521851315|FG002|Overall Study|Other|0|||
144725631|NCT01193608|521851316|FG003|Overall Study|Other|0|||
144725632|NCT01193608|521851317|FG004|Overall Study|Other|0|||
144725633|NCT01193608|521851318|FG005|Overall Study|Other|0|||
144725634|NCT01193608|521851313|FG000|Overall Study|Withdrawal by Subject|0|||
144725635|NCT01193608|521851314|FG001|Overall Study|Withdrawal by Subject|1|||
144725636|NCT01193608|521851315|FG002|Overall Study|Withdrawal by Subject|2|||
144725637|NCT01193608|521851316|FG003|Overall Study|Withdrawal by Subject|3|||
144725638|NCT01193608|521851317|FG004|Overall Study|Withdrawal by Subject|3|||
144725639|NCT01193608|521851318|FG005|Overall Study|Withdrawal by Subject|0|||
144725640|NCT01193608|521851313|FG000|Overall Study|Lost to Follow-up|0|||
144725641|NCT01193608|521851314|FG001|Overall Study|Lost to Follow-up|0|||
144725642|NCT01193608|521851315|FG002|Overall Study|Lost to Follow-up|0|||
144725643|NCT01193608|521851316|FG003|Overall Study|Lost to Follow-up|0|||
144725644|NCT01193608|521851317|FG004|Overall Study|Lost to Follow-up|1|||
144725645|NCT01193608|521851318|FG005|Overall Study|Lost to Follow-up|2|||
144725646|NCT01193608|521851313|FG000|Overall Study|Adverse Event|0|||
144725647|NCT01193608|521851314|FG001|Overall Study|Adverse Event|0|||
144725648|NCT01193608|521851315|FG002|Overall Study|Adverse Event|0|||
144725649|NCT01193608|521851316|FG003|Overall Study|Adverse Event|0|||
144725650|NCT01193608|521851317|FG004|Overall Study|Adverse Event|1|||
144725651|NCT01193608|521851318|FG005|Overall Study|Adverse Event|0|||
144725652|NCT00806156|521851322|FG000|Overall Study|Death|35|||
144725653|NCT00806156|521851323|FG001|Overall Study|Death|95|||
144725654|NCT00806156|521851322|FG000|Overall Study|Did not meet eligibility criteria|1|||
144453095|NCT02209324|520857169|FG000|Overall Study|Protocol Violation|14|||
144453096|NCT02209324|520857169|FG000|Overall Study|Withdrawal by Subject|8|||
144453097|NCT02209324|520857169|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
144453098|NCT02209324|520857169|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
144453099|NCT02209324|520857169|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
144453100|NCT03433456|520857170|FG000|Overall Study|Death|1|||
144453101|NCT03433456|520857171|FG001|Overall Study|Death|1|||
144453102|NCT03433456|520857170|FG000|Overall Study|Lost to Follow-up|14|||
144453103|NCT03433456|520857171|FG001|Overall Study|Lost to Follow-up|11|||
144453104|NCT03433456|520857170|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
144453105|NCT03433456|520857171|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
144453106|NCT01785602|520857175|FG000|Overall Study|Withdrawal by Subject|2|||
144453107|NCT01785602|520857176|FG001|Overall Study|Withdrawal by Subject|0|||
144453108|NCT01785602|520857175|FG000|Overall Study|Lost to Follow-up|1|||
144453109|NCT01785602|520857176|FG001|Overall Study|Lost to Follow-up|1|||
144453110|NCT01785602|520857175|FG000|Overall Study|Adverse Event|3|||
144453111|NCT01785602|520857176|FG001|Overall Study|Adverse Event|5|||
144453112|NCT01785602|520857175|FG000|Overall Study|Administrative problems|7|||
144453113|NCT01785602|520857176|FG001|Overall Study|Administrative problems|3|||
144453114|NCT01427712|520857177|FG000|Overall Study|Transfer to a different hospital|2|||
144453115|NCT01427712|520857177|FG000|Overall Study|Lost to Follow-up|1|||
144453116|NCT01427712|520857177|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
144453117|NCT01427712|520857177|FG000|Overall Study|Failure to visit|1|||
144453118|NCT00439777|520857178|FG000|Treatment Period|Death|29|||
144453119|NCT00439777|520857179|FG001|Treatment Period|Death|21|||
144453120|NCT00439777|520857178|FG000|Treatment Period|Study terminated by sponsor|125|||
144453121|NCT00439777|520857179|FG001|Treatment Period|Study terminated by sponsor|132|||
144725655|NCT00806156|521851323|FG001|Overall Study|Did not meet eligibility criteria|0|||
144725656|NCT00806156|521851322|FG000|Overall Study|Study terminated by Sponsor|2|||
144725657|NCT00806156|521851323|FG001|Overall Study|Study terminated by Sponsor|40|||
144725658|NCT00806156|521851322|FG000|Overall Study|Consent withdrawn by subject|1|||
144725659|NCT00806156|521851323|FG001|Overall Study|Consent withdrawn by subject|3|||
144196269|NCT01232491|519913776|FG001|Overall Study|Other|18|||
144196270|NCT02932228|519913779|FG000|Overall Study|Death|8|||
144196271|NCT02932228|519913780|FG001|Overall Study|Death|23|||
144196272|NCT02932228|519913779|FG000|Overall Study|not eligible upon chart review|2|||
144453122|NCT00439777|520857178|FG000|Treatment Period|Site closed by investigator|0|||
144453123|NCT00439777|520857179|FG001|Treatment Period|Site closed by investigator|1|||
144453124|NCT00439777|520857178|FG000|Treatment Period|Did not take study treatment|7|||
144453125|NCT00439777|520857179|FG001|Treatment Period|Did not take study treatment|8|||
144453126|NCT00439777|520857178|FG000|Treatment Period|Adverse Event|111|||
144725660|NCT00806156|521851322|FG000|Overall Study|Lost to Follow-up|0|||
144725661|NCT00806156|521851323|FG001|Overall Study|Lost to Follow-up|1|||
144725662|NCT01025037|521851324|FG000|Overall Study|Adverse Event|3|||
144725663|NCT01025037|521851324|FG000|Overall Study|Lost to Follow-up|7|||
144196273|NCT02932228|519913780|FG001|Overall Study|not eligible upon chart review|5|||
144196274|NCT01995266|519915076|FG000|Overall Study|Death|1|||
144725664|NCT01025037|521851324|FG000|Overall Study|Withdrawal by Subject|1|||
144725665|NCT02674334|521851325|FG000|Overall Study|Lost to Follow-up|5|||
144196275|NCT01995266|519915076|FG000|Overall Study|Lack of Efficacy|6|||
144196276|NCT01995266|519915076|FG000|Overall Study|Adverse Event|2|||
144196277|NCT00619112|519915077|FG000|Overall Study|Adverse Event|1|||
144196278|NCT00619112|519915078|FG001|Overall Study|Adverse Event|2|||
144196279|NCT00652028|519915083|FG000|Overall Study|Adverse Event|1|||
144196280|NCT00652028|519915084|FG001|Overall Study|Adverse Event|0|||
144196281|NCT00652028|519915085|FG002|Overall Study|Adverse Event|0|||
144196282|NCT00652028|519915086|FG003|Overall Study|Adverse Event|0|||
144453127|NCT00439777|520857179|FG001|Treatment Period|Adverse Event|92|||
144453128|NCT00439777|520857178|FG000|Treatment Period|Protocol Violation|23|||
144453129|NCT00439777|520857179|FG001|Treatment Period|Protocol Violation|30|||
144453130|NCT00439777|520857178|FG000|Treatment Period|Withdrawal by Subject|66|||
144453131|NCT00439777|520857179|FG001|Treatment Period|Withdrawal by Subject|118|||
144453132|NCT00439777|520857178|FG000|Treatment Period|Lack of Efficacy|1|||
144453133|NCT00439777|520857179|FG001|Treatment Period|Lack of Efficacy|4|||
144453134|NCT00439777|520857178|FG000|Treatment Period|Lost to Follow-up|8|||
144453135|NCT00439777|520857179|FG001|Treatment Period|Lost to Follow-up|10|||
144453136|NCT00439777|520857178|FG000|Treatment Period|Protocol driven decision point|1|||
144453137|NCT00439777|520857179|FG001|Treatment Period|Protocol driven decision point|3|||
144453138|NCT00439777|520857178|FG000|Treatment Period|Physician Decision|7|||
144453139|NCT00439777|520857179|FG001|Treatment Period|Physician Decision|18|||
144453140|NCT00439777|520857178|FG000|Treatment Period|Clinical endpoint reached|26|||
144453141|NCT00439777|520857179|FG001|Treatment Period|Clinical endpoint reached|13|||
144453142|NCT00439777|520857178|FG000|Treatment Period|Technical problems|3|||
144453143|NCT00439777|520857179|FG001|Treatment Period|Technical problems|1|||
144453144|NCT00439777|520857178|FG000|Treatment Period|Participant convenience|12|||
144453145|NCT00439777|520857179|FG001|Treatment Period|Participant convenience|8|||
144453146|NCT00439777|520857178|FG000|Observational Period|Protocol Violation|0|||
144453147|NCT00439777|520857179|FG001|Observational Period|Protocol Violation|2|||
144453148|NCT00439777|520857178|FG000|Observational Period|Withdrawal by Subject|9|||
144453149|NCT00439777|520857179|FG001|Observational Period|Withdrawal by Subject|5|||
144453150|NCT00439777|520857178|FG000|Observational Period|Lost to Follow-up|1|||
144453151|NCT00439777|520857179|FG001|Observational Period|Lost to Follow-up|11|||
144453152|NCT00439777|520857178|FG000|Observational Period|Death|27|||
144453153|NCT00439777|520857179|FG001|Observational Period|Death|20|||
144453154|NCT00439777|520857178|FG000|Observational Period|Study terminated by sponsor|3|||
144453155|NCT00439777|520857179|FG001|Observational Period|Study terminated by sponsor|1|||
144453156|NCT00439777|520857178|FG000|Observational Period|Protocol driven decision point|0|||
144453157|NCT00439777|520857179|FG001|Observational Period|Protocol driven decision point|1|||
144196283|NCT00652028|519915083|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
144196284|NCT00652028|519915084|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
144196285|NCT00652028|519915085|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
144196286|NCT00652028|519915086|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
144196287|NCT00652028|519915083|FG000|Overall Study|Physician Decision|0|||
144259295|NCT01089127|520150356|FG002|Overall Study|Lost to Follow-up|0|||
144453158|NCT00439777|520857178|FG000|Observational Period|Lack of Efficacy|1|||
144453159|NCT00439777|520857179|FG001|Observational Period|Lack of Efficacy|0|||
144453160|NCT00439777|520857178|FG000|Observational Period|Technical problems|0|||
144453161|NCT00439777|520857179|FG001|Observational Period|Technical problems|1|||
144453162|NCT00661492|520857180|FG000|Overall Study|Adverse Event|16|||
144453163|NCT00661492|520857181|FG001|Overall Study|Adverse Event|13|||
144453164|NCT00661492|520857180|FG000|Overall Study|Disease Progression|44|||
144453165|NCT00661492|520857181|FG001|Overall Study|Disease Progression|14|||
144607057|NCT00529451|521422611|FG000|Overall Study|Administrative problems|1|||
144607058|NCT00529451|521422612|FG001|Overall Study|Administrative problems|1|||
144607059|NCT00529451|521422613|FG002|Overall Study|Administrative problems|0|||
144607060|NCT00529451|521422614|FG003|Overall Study|Administrative problems|2|||
144607061|NCT00773136|521422615|FG000|Overall Study|Physician Decision|2|||
144607062|NCT02463071|521422618|FG000|Overall Study|Adverse Event|3|||
144607063|NCT02463071|521422619|FG001|Overall Study|Adverse Event|5|||
144607064|NCT02463071|521422620|FG002|Overall Study|Adverse Event|1|||
144607065|NCT02463071|521422618|FG000|Overall Study|Death|1|||
144607066|NCT02463071|521422619|FG001|Overall Study|Death|0|||
144607067|NCT02463071|521422620|FG002|Overall Study|Death|0|||
144607068|NCT02463071|521422618|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
144453166|NCT00661492|520857180|FG000|Overall Study|Patient Request|6|||
144607069|NCT02463071|521422619|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144196288|NCT00652028|519915084|FG001|Overall Study|Physician Decision|0|||
144453167|NCT00661492|520857181|FG001|Overall Study|Patient Request|1|||
144453168|NCT00661492|520857180|FG000|Overall Study|Investigator Request|1|||
144196289|NCT00652028|519915085|FG002|Overall Study|Physician Decision|1|||
144196290|NCT00652028|519915086|FG003|Overall Study|Physician Decision|0|||
144453169|NCT00661492|520857181|FG001|Overall Study|Investigator Request|0|||
144607070|NCT02463071|521422620|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
144453170|NCT00661492|520857180|FG000|Overall Study|Lost to Follow-up|0|||
144453171|NCT00661492|520857181|FG001|Overall Study|Lost to Follow-up|1|||
144453172|NCT00661492|520857180|FG000|Overall Study|Other|1|||
144453173|NCT00661492|520857181|FG001|Overall Study|Other|0|||
144453174|NCT01024387|520857182|FG000|Overall Study|Radiographic Progression|29|||
144453175|NCT01024387|520857182|FG000|Overall Study|Symptomatic Progression|10|||
144453176|NCT01024387|520857182|FG000|Overall Study|Physician Decision|5|||
144453177|NCT01024387|520857182|FG000|Overall Study|Withdrawal by Subject|5|||
144453178|NCT01024387|520857182|FG000|Overall Study|Death|2|||
144453179|NCT01024387|520857182|FG000|Overall Study|Prolonged Treatment Delay|1|||
144453180|NCT01024387|520857182|FG000|Overall Study|Adverse Event|3|||
144453181|NCT01024387|520857182|FG000|Overall Study|Other|5|||
144254644|NCT03782571|520133393|FG003|Period 3|Subject Unable to Attend V5|0|||
144254645|NCT03782571|520133390|FG000|Period 3|Adverse Event|1|||
144254646|NCT03782571|520133391|FG001|Period 3|Adverse Event|0|||
144254647|NCT03782571|520133392|FG002|Period 3|Adverse Event|0|||
144254648|NCT03782571|520133393|FG003|Period 3|Adverse Event|0|||
144254649|NCT03504189|520133394|FG000|Overall Study|Withdrawal by Subject|1|||
144254650|NCT03504189|520133394|FG000|Overall Study|Screening Failure|1|||
144254651|NCT03504189|520133394|FG000|Overall Study|Device Failure|2|||
144254652|NCT03091738|520133395|FG000|Overall Study|Adverse Event|1|||
144254653|NCT03091738|520133395|FG000|Overall Study|Lost to Follow-up|1|||
144254654|NCT00199849|520133406|FG000|Overall Study|Unrelated illness or complication|0|||
144254655|NCT00199849|520133407|FG001|Overall Study|Unrelated illness or complication|1|||
144254656|NCT00199849|520133408|FG002|Overall Study|Unrelated illness or complication|0|||
144254657|NCT00199849|520133406|FG000|Overall Study|Progressive disease requiring intervention|0|||
144254658|NCT00199849|520133407|FG001|Overall Study|Progressive disease requiring intervention|0|||
144254659|NCT00199849|520133408|FG002|Overall Study|Progressive disease requiring intervention|1|||
144254660|NCT00199849|520133406|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
144254661|NCT00199849|520133407|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
144453182|NCT03855189|520857183|FG000|Overall Study|Adverse Event|5|||
144453183|NCT03855189|520857184|FG001|Overall Study|Adverse Event|2|||
144453184|NCT03855189|520857185|FG002|Overall Study|Adverse Event|4|||
144453185|NCT03855189|520857183|FG000|Overall Study|Treatment Failure|1|||
144453186|NCT03855189|520857184|FG001|Overall Study|Treatment Failure|1|||
144453187|NCT03855189|520857185|FG002|Overall Study|Treatment Failure|2|||
144453188|NCT03855189|520857183|FG000|Overall Study|Noncompliance with Protocol|0|||
144453189|NCT03855189|520857184|FG001|Overall Study|Noncompliance with Protocol|1|||
144453190|NCT03855189|520857185|FG002|Overall Study|Noncompliance with Protocol|0|||
144453191|NCT03855189|520857183|FG000|Overall Study|Did Not Return|4|||
144453192|NCT03855189|520857184|FG001|Overall Study|Did Not Return|3|||
144453193|NCT03855189|520857185|FG002|Overall Study|Did Not Return|0|||
144453194|NCT02641080|520857186|FG000|Overall Study|Physician Decision|2|||
144453195|NCT02641080|520857187|FG001|Overall Study|Physician Decision|0|||
144453196|NCT02641080|520857186|FG000|Overall Study|Withdrawal by Subject|0|||
144453197|NCT02641080|520857187|FG001|Overall Study|Withdrawal by Subject|1|||
144453198|NCT02641080|520857186|FG000|Overall Study|Rehab Center denied use of pumps|0|||
144453199|NCT02641080|520857187|FG001|Overall Study|Rehab Center denied use of pumps|3|||
144453200|NCT02641080|520857186|FG000|Overall Study|Lost to Follow-up|0|||
144453201|NCT02641080|520857187|FG001|Overall Study|Lost to Follow-up|3|||
144453202|NCT00803634|520857188|FG000|Overall Study|Withdrew Consent|1|||
144453203|NCT00803634|520857189|FG001|Overall Study|Withdrew Consent|0|||
144453204|NCT00803634|520857188|FG000|Overall Study|Lost to Follow-up|2|||
144453205|NCT00803634|520857189|FG001|Overall Study|Lost to Follow-up|3|||
144453206|NCT00803634|520857188|FG000|Overall Study|Death|3|||
144453207|NCT00803634|520857189|FG001|Overall Study|Death|2|||
144453208|NCT04307186|520857190|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
144453209|NCT04307186|520857190|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
144453210|NCT04307186|520857190|FG000|Washout 3-14 Days|Progressive disease|1|||
144453211|NCT04307186|520857190|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
144453212|NCT04307186|520857190|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
144453213|NCT00586105|520857192|FG000|Overall Study|Adverse Event|4|||
144453214|NCT00586105|520857192|FG000|Overall Study|Death|2|||
144453215|NCT00586105|520857192|FG000|Overall Study|Protocol Violation|1|||
144453216|NCT00586105|520857192|FG000|Overall Study|Withdrawal by Subject|3|||
144453217|NCT00586105|520857192|FG000|Overall Study|Disease progression|19|||
144453218|NCT00586105|520857192|FG000|Overall Study|Switched to commercial drug|9|||
144453219|NCT00586105|520857192|FG000|Overall Study|Reason not reported|1|||
144453220|NCT03864900|520857197|FG000|Overall Study|Withdrawal by Subject|1|||
144453221|NCT03864900|520857198|FG001|Overall Study|Withdrawal by Subject|1|||
144725666|NCT02674334|521851326|FG001|Overall Study|Lost to Follow-up|3|||
144453222|NCT03864900|520857197|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
144453223|NCT03864900|520857198|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
144453224|NCT03238001|520857199|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
144453225|NCT03238001|520857199|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
144453226|NCT03238001|520857199|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
144453227|NCT03238001|520857199|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
144254662|NCT00199849|520133408|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
144453228|NCT03238001|520857199|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
144453229|NCT03238001|520857199|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
144453230|NCT03238001|520857199|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
144453231|NCT03238001|520857199|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
144453232|NCT03791398|520857203|FG000|Overall Study|Progression of Disease Under Study|2|||
144453233|NCT03791398|520857204|FG001|Overall Study|Progression of Disease Under Study|0|||
144453234|NCT03791398|520857205|FG002|Overall Study|Progression of Disease Under Study|0|||
144453235|NCT00766376|520857208|FG000|Overall Study|Withdrawal by Subject|27|||
144453236|NCT01800903|520857209|FG000|Second Test Period|unable to catheterise|1|||
144453237|NCT01800903|520857210|FG001|Second Test Period|unable to catheterise|0|||
144453238|NCT01800903|520857211|FG002|Second Test Period|unable to catheterise|0|||
144453239|NCT01800903|520857212|FG003|Second Test Period|unable to catheterise|0|||
144453240|NCT01800903|520857213|FG004|Second Test Period|unable to catheterise|0|||
144453241|NCT01800903|520857214|FG005|Second Test Period|unable to catheterise|0|||
144453242|NCT00080223|520857217|FG000|Overall Study|Adverse Event|23|||
144453243|NCT00080223|520857217|FG000|Overall Study|Death|21|||
144453244|NCT00080223|520857217|FG000|Overall Study|Withdrawal by Subject|13|||
144453245|NCT00080223|520857217|FG000|Overall Study|Lung Transplantation|9|||
144453246|NCT00080223|520857217|FG000|Overall Study|Non-compliance With Study Treatment|7|||
144453247|NCT00080223|520857217|FG000|Overall Study|Participant unwilling to continue|2|||
144453248|NCT00080223|520857217|FG000|Overall Study|Physician Decision|1|||
144453249|NCT03099382|520857224|FG000|Overall Study|Protocol Violation|2|||
144453250|NCT03099382|520857225|FG001|Overall Study|Protocol Violation|3|||
144453251|NCT01802411|520857226|FG000|Overall Study|Death|2|||
144453252|NCT01802411|520857227|FG001|Overall Study|Death|1|||
144453253|NCT01802411|520857226|FG000|Overall Study|Adverse Event|2|||
144453254|NCT01802411|520857227|FG001|Overall Study|Adverse Event|7|||
144453255|NCT01802411|520857226|FG000|Overall Study|Lack of Efficacy|8|||
144453256|NCT01802411|520857227|FG001|Overall Study|Lack of Efficacy|10|||
144453257|NCT01802411|520857226|FG000|Overall Study|Withdrawal by Subject|0|||
144453258|NCT01802411|520857227|FG001|Overall Study|Withdrawal by Subject|2|||
144453259|NCT01802411|520857226|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
144453260|NCT01802411|520857227|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
144453261|NCT01802411|520857226|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
144453262|NCT01802411|520857227|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
144453263|NCT01802411|520857226|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
144453264|NCT01802411|520857227|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
144453265|NCT00560833|520857240|FG000|Overall Study|Adverse Event|16|||
144453266|NCT00560833|520857241|FG001|Overall Study|Adverse Event|10|||
144453267|NCT00560833|520857242|FG002|Overall Study|Adverse Event|25|||
144453268|NCT00560833|520857243|FG003|Overall Study|Adverse Event|23|||
144453269|NCT00560833|520857244|FG004|Overall Study|Adverse Event|35|||
144453270|NCT00560833|520857240|FG000|Overall Study|Lost to Follow-up|0|||
144453271|NCT00560833|520857241|FG001|Overall Study|Lost to Follow-up|0|||
144453272|NCT00560833|520857242|FG002|Overall Study|Lost to Follow-up|1|||
144453273|NCT00560833|520857243|FG003|Overall Study|Lost to Follow-up|0|||
144453274|NCT00560833|520857244|FG004|Overall Study|Lost to Follow-up|0|||
144453275|NCT00560833|520857240|FG000|Overall Study|Lack of Efficacy|22|||
144453276|NCT00560833|520857241|FG001|Overall Study|Lack of Efficacy|9|||
144453277|NCT00560833|520857242|FG002|Overall Study|Lack of Efficacy|6|||
144196291|NCT00841906|519915087|FG000|Overall Study|Withdrawal by Subject|2|||
144196292|NCT00841906|519915088|FG001|Overall Study|Withdrawal by Subject|0|||
144196293|NCT02751359|519915093|FG000|Overall Study|Lost to Follow-up|1|||
144196294|NCT02667288|519915094|FG000|Overall Study|Protocol Violation|5|||
144196295|NCT02667288|519915094|FG000|Overall Study|Lost to Follow-up|3|||
144453278|NCT00560833|520857243|FG003|Overall Study|Lack of Efficacy|4|||
144453279|NCT00560833|520857244|FG004|Overall Study|Lack of Efficacy|4|||
144453280|NCT00560833|520857240|FG000|Overall Study|Participant uncooperative|5|||
144453281|NCT00560833|520857241|FG001|Overall Study|Participant uncooperative|5|||
144453282|NCT00560833|520857242|FG002|Overall Study|Participant uncooperative|4|||
144453283|NCT00560833|520857243|FG003|Overall Study|Participant uncooperative|4|||
144453284|NCT00560833|520857244|FG004|Overall Study|Participant uncooperative|2|||
144453285|NCT00560833|520857240|FG000|Overall Study|Other|1|||
144453286|NCT00560833|520857241|FG001|Overall Study|Other|1|||
144453287|NCT00560833|520857242|FG002|Overall Study|Other|3|||
144533728|NCT03734029|521156759|FG001|Overall Study|Randomized, but not treated|12|||
144533729|NCT05007080|521157769|FG000|Overall Study|Lost to Follow-up|0|||
144453288|NCT00560833|520857243|FG003|Overall Study|Other|0|||
144533730|NCT05007080|521157770|FG001|Overall Study|Lost to Follow-up|1|||
144533731|NCT05007080|521157771|FG002|Overall Study|Lost to Follow-up|0|||
144533732|NCT05007080|521157772|FG003|Overall Study|Lost to Follow-up|1|||
144533733|NCT05007080|521157773|FG004|Overall Study|Lost to Follow-up|1|||
144533734|NCT05007080|521157774|FG005|Overall Study|Lost to Follow-up|1|||
144533735|NCT05007080|521157769|FG000|Overall Study|Death|0|||
144453289|NCT00560833|520857244|FG004|Overall Study|Other|0|||
144453290|NCT00560833|520857240|FG000|Overall Study|Never received drug|0|||
144533736|NCT05007080|521157770|FG001|Overall Study|Death|1|||
144453291|NCT00560833|520857241|FG001|Overall Study|Never received drug|1|||
144453292|NCT00560833|520857242|FG002|Overall Study|Never received drug|0|||
144453293|NCT00560833|520857243|FG003|Overall Study|Never received drug|0|||
144453294|NCT00560833|520857244|FG004|Overall Study|Never received drug|1|||
144453295|NCT01059617|520857245|FG000|Overall Study|Other|7|||
144453296|NCT01059617|520857246|FG001|Overall Study|Other|1|||
144453297|NCT01059617|520857247|FG002|Overall Study|Other|8|||
144453298|NCT01059617|520857248|FG003|Overall Study|Other|6|||
144453299|NCT00612313|520857252|FG000|Overall Study|Withdrawal by Subject|6|||
144453300|NCT00612313|520857253|FG001|Overall Study|Withdrawal by Subject|9|||
144453301|NCT00612313|520857252|FG000|Overall Study|Lost to Follow-up|11|||
144196296|NCT02667288|519915094|FG000|Overall Study|Withdrawal by Subject|5|||
144196297|NCT01196078|519915095|FG000|Overall Study|Withdrawal by Subject|3|||
144453302|NCT00612313|520857253|FG001|Overall Study|Lost to Follow-up|4|||
144453303|NCT03864614|520857257|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
144453304|NCT03864614|520857258|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
144453305|NCT03864614|520857259|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
144453306|NCT03864614|520857260|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
144453307|NCT03864614|520857257|FG000|Overall Study|Withdrawal by Subject|72|||
144453308|NCT03864614|520857258|FG001|Overall Study|Withdrawal by Subject|100|||
144453309|NCT03864614|520857259|FG002|Overall Study|Withdrawal by Subject|1|||
144453310|NCT03864614|520857260|FG003|Overall Study|Withdrawal by Subject|21|||
144453311|NCT03864614|520857257|FG000|Overall Study|Lost to Follow-up|45|||
144453312|NCT03864614|520857258|FG001|Overall Study|Lost to Follow-up|54|||
144453313|NCT03864614|520857259|FG002|Overall Study|Lost to Follow-up|0|||
144453314|NCT03864614|520857260|FG003|Overall Study|Lost to Follow-up|9|||
144453315|NCT03864614|520857257|FG000|Overall Study|Adverse Event|42|||
144453316|NCT03864614|520857258|FG001|Overall Study|Adverse Event|30|||
144453317|NCT03864614|520857259|FG002|Overall Study|Adverse Event|1|||
144453318|NCT03864614|520857260|FG003|Overall Study|Adverse Event|9|||
144453319|NCT03864614|520857257|FG000|Overall Study|Protocol Deviation|6|||
144453320|NCT03864614|520857258|FG001|Overall Study|Protocol Deviation|26|||
144453321|NCT03864614|520857259|FG002|Overall Study|Protocol Deviation|0|||
144453322|NCT03864614|520857260|FG003|Overall Study|Protocol Deviation|1|||
144453323|NCT03864614|520857257|FG000|Overall Study|Physician Decision|7|||
144453324|NCT03864614|520857258|FG001|Overall Study|Physician Decision|10|||
144453325|NCT03864614|520857259|FG002|Overall Study|Physician Decision|1|||
144453326|NCT03864614|520857260|FG003|Overall Study|Physician Decision|5|||
144453327|NCT03864614|520857257|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
144453328|NCT03864614|520857258|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
144453329|NCT03864614|520857259|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
144453330|NCT03864614|520857260|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
144453331|NCT03864614|520857257|FG000|Overall Study|Sponsor Decision|1|||
144453332|NCT03864614|520857258|FG001|Overall Study|Sponsor Decision|2|||
144453333|NCT03864614|520857259|FG002|Overall Study|Sponsor Decision|0|||
144453334|NCT03864614|520857260|FG003|Overall Study|Sponsor Decision|0|||
144453335|NCT03864614|520857257|FG000|Overall Study|Pregnancy|0|||
144607071|NCT02463071|521422618|FG000|Overall Study|Reason not specified|7|||
144607072|NCT02463071|521422619|FG001|Overall Study|Reason not specified|9|||
144607073|NCT02463071|521422620|FG002|Overall Study|Reason not specified|4|||
144607074|NCT02463071|521422618|FG000|Overall Study|Protocol Violation|0|||
144607075|NCT02463071|521422619|FG001|Overall Study|Protocol Violation|2|||
144607076|NCT02463071|521422620|FG002|Overall Study|Protocol Violation|0|||
144607077|NCT02463071|521422618|FG000|Overall Study|Lost to Follow-up|0|||
144607078|NCT02463071|521422619|FG001|Overall Study|Lost to Follow-up|0|||
144607079|NCT02463071|521422620|FG002|Overall Study|Lost to Follow-up|1|||
144607080|NCT01009034|521422621|FG000|Overall Study|Lost to Follow-up|2|||
144607081|NCT01009034|521422621|FG000|Overall Study|Withdrawal by Subject|2|||
144607082|NCT01494350|521422622|FG000|Overall Study|Worsening of lesion|1|||
144725667|NCT02674334|521851325|FG000|Overall Study|participant difficulty breathing|1|||
144725668|NCT02674334|521851326|FG001|Overall Study|participant difficulty breathing|0|||
144725669|NCT02674334|521851325|FG000|Overall Study|NIRS not recording|1|||
144196298|NCT01196078|519915096|FG001|Overall Study|Withdrawal by Subject|5|||
144725670|NCT02674334|521851326|FG001|Overall Study|NIRS not recording|0|||
144725671|NCT01867242|521851329|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
144196299|NCT01196078|519915095|FG000|Overall Study|Adverse Event|4|||
144453336|NCT03864614|520857258|FG001|Overall Study|Pregnancy|1|||
144453337|NCT03864614|520857259|FG002|Overall Study|Pregnancy|0|||
144453338|NCT03864614|520857260|FG003|Overall Study|Pregnancy|0|||
144453339|NCT03864614|520857257|FG000|Overall Study|Other|7|||
144453340|NCT03864614|520857258|FG001|Overall Study|Other|9|||
144453341|NCT03864614|520857259|FG002|Overall Study|Other|1|||
144453342|NCT03864614|520857260|FG003|Overall Study|Other|4|||
144453343|NCT03864614|520857257|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
144453344|NCT03864614|520857258|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
144453345|NCT03864614|520857259|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
144607083|NCT04305275|521422623|FG000|Overall Study|Adverse Event|4|||
144196300|NCT01196078|519915096|FG001|Overall Study|Adverse Event|4|||
144453346|NCT03864614|520857260|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
144453347|NCT00136955|520858790|FG000|Overall Study|Adverse Event|8|||
144453348|NCT00136955|520858790|FG000|Overall Study|Lost to Follow-up|1|||
144453349|NCT00136955|520858790|FG000|Overall Study|Withdrawal by Subject|2|||
144453350|NCT00136955|520858790|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
144453351|NCT00074282|520858791|FG000|Step 1|Adverse Event|32|||
144453352|NCT00074282|520858792|FG001|Step 1|Adverse Event|0|||
144453353|NCT00074282|520858793|FG002|Step 1|Adverse Event|0|||
144453354|NCT00074282|520858791|FG000|Step 1|Death|6|||
144453355|NCT00074282|520858792|FG001|Step 1|Death|0|||
144453356|NCT00074282|520858793|FG002|Step 1|Death|0|||
144453357|NCT00074282|520858791|FG000|Step 1|Withdrawal by Subject|7|||
144453358|NCT00074282|520858792|FG001|Step 1|Withdrawal by Subject|0|||
144453359|NCT00074282|520858793|FG002|Step 1|Withdrawal by Subject|0|||
144453360|NCT00074282|520858791|FG000|Step 1|Disease progression|2|||
144453361|NCT00074282|520858792|FG001|Step 1|Disease progression|0|||
144453362|NCT00074282|520858793|FG002|Step 1|Disease progression|0|||
144453363|NCT00074282|520858791|FG000|Step 1|Alternative therapy|2|||
144453364|NCT00074282|520858792|FG001|Step 1|Alternative therapy|0|||
144453365|NCT00074282|520858793|FG002|Step 1|Alternative therapy|0|||
144453366|NCT00074282|520858791|FG000|Step 1|Other complicating disease|2|||
144453367|NCT00074282|520858792|FG001|Step 1|Other complicating disease|0|||
144453368|NCT00074282|520858793|FG002|Step 1|Other complicating disease|0|||
144453369|NCT00074282|520858791|FG000|Step 1|Physician Decision|1|||
144453370|NCT00074282|520858792|FG001|Step 1|Physician Decision|0|||
144453371|NCT00074282|520858793|FG002|Step 1|Physician Decision|0|||
144453372|NCT00074282|520858791|FG000|Step 1|Ineligible|4|||
144453373|NCT00074282|520858792|FG001|Step 1|Ineligible|0|||
144453374|NCT00074282|520858793|FG002|Step 1|Ineligible|0|||
144453375|NCT00074282|520858791|FG000|Step 1|Never started treatment|2|||
144453376|NCT00074282|520858792|FG001|Step 1|Never started treatment|0|||
144453377|NCT00074282|520858793|FG002|Step 1|Never started treatment|0|||
144453378|NCT00074282|520858791|FG000|Step 2|Adverse Event|0|||
144453379|NCT00074282|520858792|FG001|Step 2|Adverse Event|2|||
144453380|NCT00074282|520858793|FG002|Step 2|Adverse Event|12|||
144453381|NCT00074282|520858791|FG000|Step 2|Disease progression|0|||
144453382|NCT00074282|520858792|FG001|Step 2|Disease progression|0|||
144453383|NCT00074282|520858793|FG002|Step 2|Disease progression|5|||
144453384|NCT00074282|520858791|FG000|Step 2|Death|0|||
144453385|NCT00074282|520858792|FG001|Step 2|Death|0|||
144453386|NCT00074282|520858793|FG002|Step 2|Death|3|||
144453387|NCT00074282|520858791|FG000|Step 2|Withdrawal by Subject|0|||
144453388|NCT00074282|520858792|FG001|Step 2|Withdrawal by Subject|0|||
144453389|NCT00074282|520858793|FG002|Step 2|Withdrawal by Subject|2|||
144453390|NCT00074282|520858791|FG000|Step 2|Physician Decision|0|||
144453391|NCT00074282|520858792|FG001|Step 2|Physician Decision|0|||
144453392|NCT00074282|520858793|FG002|Step 2|Physician Decision|1|||
144453393|NCT00074282|520858791|FG000|Step 2|Ineligible|0|||
144453394|NCT00074282|520858792|FG001|Step 2|Ineligible|0|||
144453395|NCT00074282|520858793|FG002|Step 2|Ineligible|1|||
144453396|NCT01682460|520858795|FG000|Overall Study|Withdrawal by Subject|2|||
144453397|NCT01682460|520858795|FG000|Overall Study|Did not meet inclusion criteria|2|||
144453398|NCT02055352|520858799|FG000|Overall Study|Adverse Event|0|||
144453399|NCT02055352|520858800|FG001|Overall Study|Adverse Event|1|||
144453400|NCT02055352|520858799|FG000|Overall Study|Non-eligible|0|||
144607084|NCT04305275|521422624|FG001|Overall Study|Adverse Event|0|||
144607085|NCT04305275|521422623|FG000|Overall Study|Lost to Follow-up|1|||
144607086|NCT04305275|521422624|FG001|Overall Study|Lost to Follow-up|1|||
144607087|NCT04305275|521422623|FG000|Overall Study|Withdrawal by Participant|8|||
144607088|NCT04305275|521422624|FG001|Overall Study|Withdrawal by Participant|1|||
144607089|NCT00199836|521422626|FG000|Overall Study|Progressive Disease|5|||
144607090|NCT00199836|521422626|FG000|Overall Study|Death|1|||
144607091|NCT05093322|521422635|FG000|Overall Study|Death|6|||
144607092|NCT05093322|521422636|FG001|Overall Study|Death|2|||
144607093|NCT05093322|521422635|FG000|Overall Study|Other|4|||
144453401|NCT02055352|520858800|FG001|Overall Study|Non-eligible|1|||
144453402|NCT02055352|520858799|FG000|Overall Study|Poor compliance|1|||
144453403|NCT02055352|520858800|FG001|Overall Study|Poor compliance|1|||
144607094|NCT05093322|521422636|FG001|Overall Study|Other|1|||
144196301|NCT01196078|519915095|FG000|Overall Study|Protocol Violation|2|||
144196302|NCT01196078|519915096|FG001|Overall Study|Protocol Violation|1|||
144453404|NCT02055352|520858799|FG000|Overall Study|Death|1|||
144453405|NCT02055352|520858800|FG001|Overall Study|Death|2|||
144453406|NCT02055352|520858799|FG000|Overall Study|Patient decision|1|||
144453407|NCT02055352|520858800|FG001|Overall Study|Patient decision|1|||
144453408|NCT02055352|520858799|FG000|Overall Study|Use of prohibited treatment|0|||
144453409|NCT02055352|520858800|FG001|Overall Study|Use of prohibited treatment|3|||
144453410|NCT02055352|520858799|FG000|Overall Study|AE, study drug would be detrimental|1|||
144607095|NCT00617604|521422638|FG000|Overall Study|Death|2|||
144453411|NCT02055352|520858800|FG001|Overall Study|AE, study drug would be detrimental|3|||
144453412|NCT02055352|520858799|FG000|Overall Study|Withdrawal of informed consent|1|||
144453413|NCT02055352|520858800|FG001|Overall Study|Withdrawal of informed consent|0|||
144196303|NCT01196078|519915095|FG000|Overall Study|Lack of Efficacy|17|||
144196304|NCT01196078|519915096|FG001|Overall Study|Lack of Efficacy|23|||
144196305|NCT01196078|519915095|FG000|Overall Study|Lost to Follow-up|1|||
144196306|NCT01196078|519915096|FG001|Overall Study|Lost to Follow-up|0|||
144453414|NCT02055352|520858799|FG000|Overall Study|Reason unknown|1|||
144453415|NCT02055352|520858800|FG001|Overall Study|Reason unknown|5|||
144453416|NCT05349617|520858803|FG000|Overall Study|Death|1|||
144453417|NCT05349617|520858804|FG001|Overall Study|Death|1|||
144453418|NCT05349617|520858803|FG000|Overall Study|Lost to Follow-up|3|||
144453419|NCT05349617|520858804|FG001|Overall Study|Lost to Follow-up|8|||
144453420|NCT05349617|520858803|FG000|Overall Study|Withdrawal by Subject|2|||
144453421|NCT05349617|520858804|FG001|Overall Study|Withdrawal by Subject|10|||
144453422|NCT03811912|520858807|FG000|Overall Study|Withdrew Consent|4|||
144453423|NCT03811912|520858808|FG001|Overall Study|Withdrew Consent|2|||
144254663|NCT04727528|520133409|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
144196307|NCT01196078|519915095|FG000|Overall Study|Death|6|||
144196308|NCT01196078|519915096|FG001|Overall Study|Death|4|||
144254664|NCT04727528|520133410|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
144453424|NCT01438411|520858809|FG000|Overall Study|Adverse Event|8|||
144453425|NCT01438411|520858809|FG000|Overall Study|Lost to Follow-up|1|||
144254665|NCT04727528|520133409|FG000|Open-label Period|Randomized who did not receive treatment|1|||
144254666|NCT04727528|520133410|FG001|Open-label Period|Randomized who did not receive treatment|0|||
144254667|NCT04727528|520133409|FG000|Double-blind Treatment Phase|Adverse Event|0|||
144254668|NCT04727528|520133410|FG001|Double-blind Treatment Phase|Adverse Event|1|||
144254669|NCT04727528|520133409|FG000|Double-blind Treatment Phase|Death|0|||
144254670|NCT04727528|520133410|FG001|Double-blind Treatment Phase|Death|1|||
144254671|NCT04727528|520133409|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
144254672|NCT04727528|520133410|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
144254673|NCT04727528|520133409|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
144254674|NCT04727528|520133410|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
144254675|NCT04727528|520133409|FG000|Double-blind Treatment Phase|Physician Decision|0|||
144254676|NCT04727528|520133410|FG001|Double-blind Treatment Phase|Physician Decision|1|||
144254677|NCT04727528|520133409|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
144254678|NCT04727528|520133410|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144254679|NCT01826981|520133422|FG000|Overall Study|Lack of Efficacy|0|||
144254680|NCT01826981|520133423|FG001|Overall Study|Lack of Efficacy|1|||
144254681|NCT01826981|520133424|FG002|Overall Study|Lack of Efficacy|0|||
144254682|NCT01826981|520133425|FG003|Overall Study|Lack of Efficacy|0|||
144254683|NCT01826981|520133426|FG004|Overall Study|Lack of Efficacy|5|||
144254684|NCT01826981|520133427|FG005|Overall Study|Lack of Efficacy|0|||
144254685|NCT01826981|520133428|FG006|Overall Study|Lack of Efficacy|0|||
144254686|NCT01826981|520133429|FG007|Overall Study|Lack of Efficacy|8|||
144254687|NCT01826981|520133430|FG008|Overall Study|Lack of Efficacy|7|||
144254688|NCT01826981|520133431|FG009|Overall Study|Lack of Efficacy|0|||
144254689|NCT01826981|520133432|FG010|Overall Study|Lack of Efficacy|1|||
144254690|NCT01826981|520133433|FG011|Overall Study|Lack of Efficacy|0|||
144254691|NCT01826981|520133434|FG012|Overall Study|Lack of Efficacy|0|||
144254692|NCT01826981|520133435|FG013|Overall Study|Lack of Efficacy|3|||
144254693|NCT01826981|520133436|FG014|Overall Study|Lack of Efficacy|0|||
144254694|NCT01826981|520133422|FG000|Overall Study|Lost to Follow-up|0|||
144254695|NCT01826981|520133423|FG001|Overall Study|Lost to Follow-up|0|||
144254696|NCT01826981|520133424|FG002|Overall Study|Lost to Follow-up|0|||
144254697|NCT01826981|520133425|FG003|Overall Study|Lost to Follow-up|0|||
144254698|NCT01826981|520133426|FG004|Overall Study|Lost to Follow-up|1|||
144254699|NCT01826981|520133427|FG005|Overall Study|Lost to Follow-up|1|||
144254700|NCT01826981|520133428|FG006|Overall Study|Lost to Follow-up|0|||
144254701|NCT01826981|520133429|FG007|Overall Study|Lost to Follow-up|1|||
144254702|NCT01826981|520133430|FG008|Overall Study|Lost to Follow-up|0|||
144254703|NCT01826981|520133431|FG009|Overall Study|Lost to Follow-up|1|||
144254704|NCT01826981|520133432|FG010|Overall Study|Lost to Follow-up|1|||
144254705|NCT01826981|520133433|FG011|Overall Study|Lost to Follow-up|1|||
144453426|NCT01438411|520858809|FG000|Overall Study|Lack of Efficacy|1|||
144196309|NCT00127036|519915097|FG000|Overall Study|Insufficient Data for Analysis|6|||
144196310|NCT00127036|519915098|FG001|Overall Study|Insufficient Data for Analysis|11|||
144196311|NCT00127036|519915097|FG000|Overall Study|Screen Failure|2|||
144196312|NCT00127036|519915098|FG001|Overall Study|Screen Failure|0|||
144196313|NCT01797835|519915104|FG000|Overall Study|Lost to Follow-up|31|||
144196314|NCT01797835|519915105|FG001|Overall Study|Lost to Follow-up|27|||
144196315|NCT03001219|519915106|FG000|Proof of Concept|Study Termination by Sponsor|0|||
144196316|NCT03001219|519915107|FG001|Proof of Concept|Study Termination by Sponsor|1|||
144196317|NCT03001219|519915106|FG000|Proof of Concept|Withdrawal by Subject|0|||
144196318|NCT03001219|519915107|FG001|Proof of Concept|Withdrawal by Subject|4|||
144196319|NCT03001219|519915106|FG000|Proof of Concept|Protocol Deviation|0|||
144196320|NCT03001219|519915107|FG001|Proof of Concept|Protocol Deviation|1|||
144196321|NCT03001219|519915106|FG000|Proof of Concept|Adverse Event|1|||
144453427|NCT01438411|520858809|FG000|Overall Study|Withdrawal by Subject|3|||
144453428|NCT00618514|520858810|FG000|Overall Study|Lost to Follow-up|11|||
144453429|NCT00618514|520858811|FG001|Overall Study|Lost to Follow-up|12|||
144453430|NCT00618514|520858812|FG002|Overall Study|Lost to Follow-up|4|||
144453431|NCT02707055|520858813|FG000|Phase 1|Withdrawal by Subject|1|||
144453432|NCT02707055|520858814|FG001|Phase 1|Withdrawal by Subject|2|||
144453433|NCT02707055|520858813|FG000|Phase 1|Physician Decision|0|||
144453434|NCT02707055|520858814|FG001|Phase 1|Physician Decision|1|||
144453435|NCT02707055|520858813|FG000|Phase 2|Adverse Event|1|||
144453436|NCT02707055|520858814|FG001|Phase 2|Adverse Event|2|||
144453437|NCT00902304|520858815|FG000|Overall Study|Adverse Event|4|||
144453438|NCT00902304|520858816|FG001|Overall Study|Adverse Event|10|||
144453439|NCT00902304|520858817|FG002|Overall Study|Adverse Event|25|||
144453440|NCT00902304|520858815|FG000|Overall Study|Investigator discretion|3|||
144453441|NCT00902304|520858816|FG001|Overall Study|Investigator discretion|5|||
144453442|NCT00902304|520858817|FG002|Overall Study|Investigator discretion|13|||
144453443|NCT00902304|520858815|FG000|Overall Study|Lost to Follow-up|7|||
144453444|NCT00902304|520858816|FG001|Overall Study|Lost to Follow-up|7|||
144453445|NCT00902304|520858817|FG002|Overall Study|Lost to Follow-up|7|||
144453446|NCT00902304|520858815|FG000|Overall Study|Protocol Violation|9|||
144453447|NCT00902304|520858816|FG001|Overall Study|Protocol Violation|18|||
144453448|NCT00902304|520858817|FG002|Overall Study|Protocol Violation|20|||
144453449|NCT00902304|520858815|FG000|Overall Study|Withdrawal by Subject|32|||
144453450|NCT00902304|520858816|FG001|Overall Study|Withdrawal by Subject|22|||
144453451|NCT00902304|520858817|FG002|Overall Study|Withdrawal by Subject|43|||
144453452|NCT00902304|520858815|FG000|Overall Study|includes pregnancy|3|||
144607096|NCT00617604|521422639|FG001|Overall Study|Death|1|||
144607097|NCT00617604|521422638|FG000|Overall Study|Lost to Follow-up|1|||
144607098|NCT00617604|521422639|FG001|Overall Study|Lost to Follow-up|0|||
144607099|NCT00617604|521422638|FG000|Overall Study|Miscellaneous Reasons|8|||
144607100|NCT00617604|521422639|FG001|Overall Study|Miscellaneous Reasons|10|||
144607101|NCT00617604|521422638|FG000|Overall Study|Withdrawal by Subject|4|||
144607102|NCT00617604|521422639|FG001|Overall Study|Withdrawal by Subject|6|||
144607103|NCT00617604|521422638|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
144607104|NCT00617604|521422639|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
144607105|NCT00932425|521422645|FG000|Overall Study|Lost to Follow-up|0|||
144607106|NCT00932425|521422646|FG001|Overall Study|Lost to Follow-up|1|||
144607107|NCT00932425|521422645|FG000|Overall Study|Withdrawal by Subject|0|||
144607108|NCT00932425|521422646|FG001|Overall Study|Withdrawal by Subject|1|||
144607109|NCT05293743|521422649|FG000|Overall Study|Withdrawal by Subject|1|||
144607110|NCT05293743|521422650|FG001|Overall Study|Withdrawal by Subject|0|||
144607111|NCT02064920|521422651|FG000|Overall Study|Adverse Event|0|||
144607112|NCT02064920|521422652|FG001|Overall Study|Adverse Event|4|||
144607113|NCT02064920|521422651|FG000|Overall Study|Physician Decision|0|||
144725672|NCT01867242|521851330|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
144725673|NCT01867242|521851331|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
144453453|NCT00902304|520858816|FG001|Overall Study|includes pregnancy|9|||
144453454|NCT00902304|520858817|FG002|Overall Study|includes pregnancy|2|||
144254706|NCT01826981|520133434|FG012|Overall Study|Lost to Follow-up|1|||
144254707|NCT01826981|520133435|FG013|Overall Study|Lost to Follow-up|0|||
144254708|NCT01826981|520133436|FG014|Overall Study|Lost to Follow-up|0|||
144254709|NCT01826981|520133422|FG000|Overall Study|Withdrew Consent|0|||
144254710|NCT01826981|520133423|FG001|Overall Study|Withdrew Consent|0|||
144254711|NCT01826981|520133424|FG002|Overall Study|Withdrew Consent|0|||
144254712|NCT01826981|520133425|FG003|Overall Study|Withdrew Consent|0|||
144254713|NCT01826981|520133426|FG004|Overall Study|Withdrew Consent|0|||
144254714|NCT01826981|520133427|FG005|Overall Study|Withdrew Consent|0|||
144254715|NCT01826981|520133428|FG006|Overall Study|Withdrew Consent|1|||
144254716|NCT01826981|520133429|FG007|Overall Study|Withdrew Consent|1|||
144254717|NCT01826981|520133430|FG008|Overall Study|Withdrew Consent|0|||
144254718|NCT01826981|520133431|FG009|Overall Study|Withdrew Consent|0|||
144254719|NCT01826981|520133432|FG010|Overall Study|Withdrew Consent|0|||
144607114|NCT02064920|521422652|FG001|Overall Study|Physician Decision|1|||
144607115|NCT02064920|521422651|FG000|Overall Study|Technical Problems|0|||
144254720|NCT01826981|520133433|FG011|Overall Study|Withdrew Consent|1|||
144607116|NCT02064920|521422652|FG001|Overall Study|Technical Problems|1|||
144453455|NCT05706506|520858818|FG000|Overall Study|Adverse Event|1|||
144453456|NCT05706506|520858818|FG000|Overall Study|Withdrawal by Subject|4|||
144453457|NCT05706506|520858818|FG000|Overall Study|Lost to Follow-up|2|||
144254721|NCT01826981|520133434|FG012|Overall Study|Withdrew Consent|0|||
144254722|NCT01826981|520133435|FG013|Overall Study|Withdrew Consent|1|||
144453458|NCT05706506|520858818|FG000|Overall Study|Inadvertent Enrolment|12|||
144453459|NCT05706506|520858818|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
144725674|NCT05905783|521851334|FG000|Overall Study|Lost to Follow-up|12|||
144254723|NCT01826981|520133436|FG014|Overall Study|Withdrew Consent|0|||
144254724|NCT01826981|520133422|FG000|Overall Study|Adverse Event|0|||
144453460|NCT05706506|520858818|FG000|Overall Study|Participant Moved Out of State|1|||
144607117|NCT02064920|521422651|FG000|Overall Study|Withdrawal by Subject|1|||
144607118|NCT02064920|521422652|FG001|Overall Study|Withdrawal by Subject|3|||
144453461|NCT04837482|520858819|FG000|Period 2|Withdrawal by Subject|0|||
144453462|NCT04837482|520858820|FG001|Period 2|Withdrawal by Subject|1|||
144453463|NCT00086346|520858824|FG000|Randomization|Did not receive test article|4|||
144453464|NCT00086346|520858825|FG001|Randomization|Did not receive test article|4|||
144453465|NCT00086346|520858824|FG000|Patients Dosed With Test Article|Adverse Event|94|||
144453466|NCT00086346|520858825|FG001|Patients Dosed With Test Article|Adverse Event|11|||
144453467|NCT00086346|520858824|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
144453468|NCT00086346|520858825|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
144453469|NCT00086346|520858824|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
144453470|NCT00086346|520858825|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
144453471|NCT00086346|520858824|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
144453472|NCT00086346|520858825|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
144453473|NCT00086346|520858824|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
144453474|NCT00086346|520858825|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
144725675|NCT05905783|521851335|FG001|Overall Study|Lost to Follow-up|18|||
144254725|NCT01826981|520133423|FG001|Overall Study|Adverse Event|0|||
144254726|NCT01826981|520133424|FG002|Overall Study|Adverse Event|0|||
144254727|NCT01826981|520133425|FG003|Overall Study|Adverse Event|0|||
144254728|NCT01826981|520133426|FG004|Overall Study|Adverse Event|1|||
144254729|NCT01826981|520133427|FG005|Overall Study|Adverse Event|0|||
144254730|NCT01826981|520133428|FG006|Overall Study|Adverse Event|0|||
144254731|NCT01826981|520133429|FG007|Overall Study|Adverse Event|0|||
144254732|NCT01826981|520133430|FG008|Overall Study|Adverse Event|0|||
144254733|NCT01826981|520133431|FG009|Overall Study|Adverse Event|0|||
144254734|NCT01826981|520133432|FG010|Overall Study|Adverse Event|0|||
144254735|NCT01826981|520133433|FG011|Overall Study|Adverse Event|0|||
144254736|NCT01826981|520133434|FG012|Overall Study|Adverse Event|0|||
144254737|NCT01826981|520133435|FG013|Overall Study|Adverse Event|0|||
144254738|NCT01826981|520133436|FG014|Overall Study|Adverse Event|0|||
144254739|NCT01826981|520133422|FG000|Overall Study|Upper G-I Haemorrhage|0|||
144254740|NCT01826981|520133423|FG001|Overall Study|Upper G-I Haemorrhage|0|||
144254741|NCT01826981|520133424|FG002|Overall Study|Upper G-I Haemorrhage|0|||
144254742|NCT01826981|520133425|FG003|Overall Study|Upper G-I Haemorrhage|0|||
144254743|NCT01826981|520133426|FG004|Overall Study|Upper G-I Haemorrhage|0|||
144254744|NCT01826981|520133427|FG005|Overall Study|Upper G-I Haemorrhage|0|||
144254745|NCT01826981|520133428|FG006|Overall Study|Upper G-I Haemorrhage|0|||
144254746|NCT01826981|520133429|FG007|Overall Study|Upper G-I Haemorrhage|0|||
144254747|NCT01826981|520133430|FG008|Overall Study|Upper G-I Haemorrhage|0|||
144254748|NCT01826981|520133431|FG009|Overall Study|Upper G-I Haemorrhage|0|||
144254749|NCT01826981|520133432|FG010|Overall Study|Upper G-I Haemorrhage|0|||
144254750|NCT01826981|520133433|FG011|Overall Study|Upper G-I Haemorrhage|0|||
144254751|NCT01826981|520133434|FG012|Overall Study|Upper G-I Haemorrhage|0|||
144254752|NCT01826981|520133435|FG013|Overall Study|Upper G-I Haemorrhage|1|||
144254753|NCT01826981|520133436|FG014|Overall Study|Upper G-I Haemorrhage|0|||
144254754|NCT01826981|520133422|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254755|NCT01826981|520133423|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254756|NCT01826981|520133424|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254757|NCT01826981|520133425|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254758|NCT01826981|520133426|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254759|NCT01826981|520133427|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254760|NCT01826981|520133428|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254761|NCT01826981|520133429|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
144254762|NCT01826981|520133430|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254763|NCT01826981|520133431|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254764|NCT01826981|520133432|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254765|NCT01826981|520133433|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254766|NCT01826981|520133434|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254767|NCT01826981|520133435|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254768|NCT01826981|520133436|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
144254769|NCT00660595|520133443|FG000|Overall Study|Lost to Follow-up|0|||
144254770|NCT00660595|520133444|FG001|Overall Study|Lost to Follow-up|1|||
144254771|NCT00660595|520133443|FG000|Overall Study|Did not consent to participate in study|12|||
144254772|NCT00660595|520133444|FG001|Overall Study|Did not consent to participate in study|8|||
144254773|NCT00660595|520133443|FG000|Overall Study|Participant left hospital|1|||
144254774|NCT00660595|520133444|FG001|Overall Study|Participant left hospital|0|||
144254775|NCT00660595|520133443|FG000|Overall Study|Non Specified reasons|5|||
144254776|NCT00660595|520133444|FG001|Overall Study|Non Specified reasons|0|||
144254777|NCT01148459|520133445|FG000|Overall Study|Serious Adverse Event|5|||
144254778|NCT01148459|520133446|FG001|Overall Study|Serious Adverse Event|4|||
144254779|NCT01148459|520133445|FG000|Overall Study|Withdrawal by Subject|1|||
144254780|NCT01148459|520133446|FG001|Overall Study|Withdrawal by Subject|0|||
144254781|NCT01148459|520133445|FG000|Overall Study|Migrated/moved from study area|3|||
144254782|NCT01148459|520133446|FG001|Overall Study|Migrated/moved from study area|6|||
144254783|NCT01148459|520133445|FG000|Overall Study|Lost to Follow-up|2|||
144453475|NCT00086346|520858824|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
144453476|NCT00086346|520858825|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
144453477|NCT03727750|520858826|FG000|Overall Study|Death|45|||
144453478|NCT03727750|520858826|FG000|Overall Study|Withdrawal by Subject|2|||
144453479|NCT03727750|520858826|FG000|Overall Study|Lost to Follow-up|1|||
144453480|NCT03727750|520858826|FG000|Overall Study|Other|1|||
144453481|NCT01303627|520858827|FG000|Overall Study|the failure while performing URS|0|||
144453482|NCT01303627|520858828|FG001|Overall Study|the failure while performing URS|1|||
144453483|NCT00321919|520858831|FG000|Overall Study|Adverse Event|17|||
144453484|NCT00321919|520858832|FG001|Overall Study|Adverse Event|10|||
144453485|NCT00321919|520858831|FG000|Overall Study|Death|21|||
144453486|NCT00321919|520858832|FG001|Overall Study|Death|17|||
144453487|NCT00321919|520858831|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144453488|NCT00321919|520858832|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144453489|NCT00321919|520858831|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
144453490|NCT00321919|520858832|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
144453491|NCT00321919|520858831|FG000|Overall Study|Refused Treatment|23|||
144453492|NCT00321919|520858832|FG001|Overall Study|Refused Treatment|14|||
144453493|NCT00321919|520858831|FG000|Overall Study|Other Protocol Violation|2|||
144453494|NCT00321919|520858832|FG001|Overall Study|Other Protocol Violation|3|||
144453495|NCT00321919|520858831|FG000|Overall Study|Failure to Return|3|||
144453496|NCT00321919|520858832|FG001|Overall Study|Failure to Return|1|||
144453497|NCT00321919|520858831|FG000|Overall Study|Other withdrawal reason|7|||
144453498|NCT00321919|520858832|FG001|Overall Study|Other withdrawal reason|6|||
144453499|NCT01227889|520858833|FG000|Randomized Phase (RP)|Adverse Event|13|||
144453500|NCT01227889|520858834|FG001|Randomized Phase (RP)|Adverse Event|0|||
144453501|NCT01227889|520858833|FG000|Randomized Phase (RP)|Physician Decision|13|||
144453502|NCT01227889|520858834|FG001|Randomized Phase (RP)|Physician Decision|5|||
144453503|NCT01227889|520858833|FG000|Randomized Phase (RP)|Progressive Disease|135|||
144453504|NCT01227889|520858834|FG001|Randomized Phase (RP)|Progressive Disease|52|||
144453505|NCT01227889|520858833|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
144607119|NCT00916279|521422653|FG000|Overall Study|Death|2|||
144607120|NCT00916279|521422653|FG000|Overall Study|Lost to Follow-up|2|||
144196322|NCT03001219|519915107|FG001|Proof of Concept|Adverse Event|1|||
144196323|NCT03001219|519915106|FG000|Proof of Concept|Physician Decision|1|||
144196324|NCT03001219|519915107|FG001|Proof of Concept|Physician Decision|0|||
144196325|NCT03001219|519915106|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
144196326|NCT03001219|519915107|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
144196327|NCT03001219|519915106|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
144196328|NCT03001219|519915107|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
144196329|NCT03001219|519915106|FG000|Extension Period Analysis|Physician Decision|0|||
144196330|NCT03001219|519915107|FG001|Extension Period Analysis|Physician Decision|1|||
144196331|NCT03001219|519915106|FG000|Extension Period Analysis|Adverse Event|1|||
144196332|NCT03001219|519915107|FG001|Extension Period Analysis|Adverse Event|1|||
144196333|NCT03001219|519915106|FG000|Extension Period Analysis|Protocol Deviation|0|||
144196334|NCT03001219|519915107|FG001|Extension Period Analysis|Protocol Deviation|1|||
144196335|NCT03001219|519915106|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
144196336|NCT03001219|519915107|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
144196337|NCT01403064|519915108|FG000|Overall Study|Death|0|||
144196338|NCT01403064|519915109|FG001|Overall Study|Death|0|||
144196339|NCT01403064|519915110|FG002|Overall Study|Death|1|||
144196340|NCT01403064|519915111|FG003|Overall Study|Death|1|||
144196341|NCT01403064|519915108|FG000|Overall Study|Withdrawal by Subject|0|||
144196342|NCT01403064|519915109|FG001|Overall Study|Withdrawal by Subject|0|||
144196343|NCT01403064|519915110|FG002|Overall Study|Withdrawal by Subject|1|||
144196344|NCT01403064|519915111|FG003|Overall Study|Withdrawal by Subject|1|||
144607121|NCT02109562|521422654|FG000|Overall Study|Insufficient clinical response|2|||
144607122|NCT02109562|521422655|FG001|Overall Study|Insufficient clinical response|0|||
144607123|NCT02109562|521422656|FG002|Overall Study|Insufficient clinical response|4|||
144607124|NCT02109562|521422654|FG000|Overall Study|Adverse Event|0|||
144607125|NCT02109562|521422655|FG001|Overall Study|Adverse Event|2|||
144607126|NCT02109562|521422656|FG002|Overall Study|Adverse Event|3|||
144607127|NCT02109562|521422654|FG000|Overall Study|Lost to Follow-up|1|||
144196345|NCT01403064|519915108|FG000|Overall Study|Other|1|||
144453506|NCT01227889|520858834|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
144453507|NCT01227889|520858833|FG000|Randomized Phase (RP)|Missing|1|||
144453508|NCT01227889|520858834|FG001|Randomized Phase (RP)|Missing|3|||
144196346|NCT01403064|519915109|FG001|Overall Study|Other|0|||
144453509|NCT01227889|520858833|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
144453510|NCT01227889|520858834|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
144453511|NCT01227889|520858833|FG000|Crossover Phase|Adverse Event|0|||
144453512|NCT01227889|520858834|FG001|Crossover Phase|Adverse Event|1|||
144607128|NCT02109562|521422655|FG001|Overall Study|Lost to Follow-up|0|||
144607129|NCT02109562|521422656|FG002|Overall Study|Lost to Follow-up|1|||
144607130|NCT02109562|521422654|FG000|Overall Study|Protocol Violation|0|||
144196347|NCT01403064|519915110|FG002|Overall Study|Other|2|||
144453513|NCT01227889|520858833|FG000|Crossover Phase|Physician Decision|0|||
144453514|NCT01227889|520858834|FG001|Crossover Phase|Physician Decision|3|||
144453515|NCT01227889|520858833|FG000|Crossover Phase|Progressive Disease|0|||
144453516|NCT01227889|520858834|FG001|Crossover Phase|Progressive Disease|31|||
144453517|NCT01227889|520858833|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
144453518|NCT01227889|520858834|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
144453519|NCT01227889|520858833|FG000|Crossover Phase|Withdrawal by Subject|0|||
144453520|NCT01227889|520858834|FG001|Crossover Phase|Withdrawal by Subject|1|||
144453521|NCT04121962|520858837|FG000|Overall Study|Lost to Follow-up|42|||
144453522|NCT04121962|520858838|FG001|Overall Study|Lost to Follow-up|39|||
144196348|NCT01403064|519915111|FG003|Overall Study|Other|1|||
144254784|NCT01148459|520133446|FG001|Overall Study|Lost to Follow-up|0|||
144254785|NCT01148459|520133445|FG000|Overall Study|Refusal|1|||
144254786|NCT01148459|520133446|FG001|Overall Study|Refusal|0|||
144254787|NCT01148459|520133445|FG000|Overall Study|Failure to comply with study procedures|0|||
144254788|NCT01148459|520133446|FG001|Overall Study|Failure to comply with study procedures|1|||
144254789|NCT00707980|520133453|FG000|Overall Study|Adverse Event|49|||
144254790|NCT00707980|520133453|FG000|Overall Study|Lack of Efficacy|35|||
144254791|NCT00707980|520133453|FG000|Overall Study|Non-Compliance with Study Drug|28|||
144453523|NCT01175382|520858839|FG000|Overall Study|Lost to Follow-up|4|||
144196349|NCT02669940|519915114|FG000|Overall Study|Failure to return|0|||
144196350|NCT02669940|519915115|FG001|Overall Study|Failure to return|3|||
144196351|NCT02669940|519915114|FG000|Overall Study|Insufficient follow-up data|1|||
144196352|NCT02669940|519915115|FG001|Overall Study|Insufficient follow-up data|0|||
144196353|NCT00986180|519915118|FG000|Overall Study|Adverse Event|21|||
144196354|NCT00986180|519915119|FG001|Overall Study|Adverse Event|23|||
144196355|NCT00986180|519915118|FG000|Overall Study|Lack of Efficacy|4|||
144196356|NCT00986180|519915119|FG001|Overall Study|Lack of Efficacy|3|||
144196357|NCT00986180|519915118|FG000|Overall Study|Lost to Follow-up|5|||
144196358|NCT00986180|519915119|FG001|Overall Study|Lost to Follow-up|7|||
144196359|NCT00986180|519915118|FG000|Overall Study|Physician Decision|1|||
144196360|NCT00986180|519915119|FG001|Overall Study|Physician Decision|3|||
144196361|NCT00986180|519915118|FG000|Overall Study|Protocol Violation|2|||
144196362|NCT00986180|519915119|FG001|Overall Study|Protocol Violation|0|||
144196363|NCT00986180|519915118|FG000|Overall Study|Withdrawal by Subject|1|||
144196364|NCT00986180|519915119|FG001|Overall Study|Withdrawal by Subject|9|||
144196365|NCT00986180|519915118|FG000|Overall Study|Miscellanies|10|||
144196366|NCT00986180|519915119|FG001|Overall Study|Miscellanies|11|||
144196367|NCT01765582|519915120|FG000|Overall Study|Other|3|||
144196368|NCT01765582|519915121|FG001|Overall Study|Other|6|||
144196369|NCT01765582|519915122|FG002|Overall Study|Other|9|||
144196370|NCT01765582|519915120|FG000|Overall Study|Lost to Follow-up|2|||
144196371|NCT01765582|519915121|FG001|Overall Study|Lost to Follow-up|2|||
144196372|NCT01765582|519915122|FG002|Overall Study|Lost to Follow-up|1|||
144196373|NCT01765582|519915120|FG000|Overall Study|Death|31|||
144196374|NCT01765582|519915121|FG001|Overall Study|Death|36|||
144196375|NCT01765582|519915122|FG002|Overall Study|Death|33|||
144196376|NCT01765582|519915120|FG000|Overall Study|Sponsor Decision|46|||
144196377|NCT01765582|519915121|FG001|Overall Study|Sponsor Decision|42|||
144196378|NCT01765582|519915122|FG002|Overall Study|Sponsor Decision|42|||
144196379|NCT01765582|519915120|FG000|Overall Study|Withdrawal of Consent|11|||
144196380|NCT01765582|519915121|FG001|Overall Study|Withdrawal of Consent|6|||
144196381|NCT01765582|519915122|FG002|Overall Study|Withdrawal of Consent|10|||
144196382|NCT03251963|519915127|FG000|Overall Study|inappropriate Xa level timing|6|||
144196383|NCT03251963|519915128|FG001|Overall Study|inappropriate Xa level timing|3|||
144196384|NCT03251963|519915127|FG000|Overall Study|no peak Xa level drawn|2|||
144196385|NCT03251963|519915128|FG001|Overall Study|no peak Xa level drawn|0|||
144196386|NCT03251963|519915127|FG000|Overall Study|bled prior to Xa level|1|||
144196387|NCT03251963|519915128|FG001|Overall Study|bled prior to Xa level|2|||
144196388|NCT00616941|519915129|FG000|Overall Study|Progressive Disease|1|||
144196389|NCT00616941|519915130|FG001|Overall Study|Progressive Disease|2|||
144196390|NCT00616941|519915131|FG002|Overall Study|Progressive Disease|1|||
144196391|NCT00616941|519915129|FG000|Overall Study|Adverse Event|0|||
144196392|NCT00616941|519915130|FG001|Overall Study|Adverse Event|1|||
144196393|NCT00616941|519915131|FG002|Overall Study|Adverse Event|1|||
144196394|NCT00616941|519915129|FG000|Overall Study|Subject Non-compliance|0|||
144196395|NCT00616941|519915130|FG001|Overall Study|Subject Non-compliance|0|||
144196396|NCT00616941|519915131|FG002|Overall Study|Subject Non-compliance|1|||
144196397|NCT00616941|519915129|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
144196398|NCT00616941|519915130|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
144196399|NCT00616941|519915131|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
144196400|NCT00616941|519915129|FG000|Overall Study|Vaccination Suspended|0|||
144196401|NCT00616941|519915130|FG001|Overall Study|Vaccination Suspended|0|||
144196402|NCT00616941|519915131|FG002|Overall Study|Vaccination Suspended|3|||
144196403|NCT00688376|519915139|FG000|Double-Blind Phase|Adverse Event|4|||
144196404|NCT00688376|519915140|FG001|Double-Blind Phase|Adverse Event|4|||
144453524|NCT01175382|520858840|FG001|Overall Study|Lost to Follow-up|3|||
144453525|NCT01175382|520858841|FG002|Overall Study|Lost to Follow-up|1|||
144453526|NCT01175382|520858839|FG000|Overall Study|Physician Decision|0|||
144453527|NCT01175382|520858840|FG001|Overall Study|Physician Decision|1|||
144453528|NCT01175382|520858841|FG002|Overall Study|Physician Decision|0|||
144453529|NCT01175382|520858839|FG000|Overall Study|Withdrawal by Subject|0|||
144453530|NCT01175382|520858840|FG001|Overall Study|Withdrawal by Subject|0|||
144453531|NCT01175382|520858841|FG002|Overall Study|Withdrawal by Subject|1|||
144453532|NCT01175382|520858839|FG000|Overall Study|No longer having problem|1|||
144453533|NCT01175382|520858840|FG001|Overall Study|No longer having problem|0|||
144453534|NCT01175382|520858841|FG002|Overall Study|No longer having problem|1|||
144453535|NCT01175382|520858839|FG000|Overall Study|Unable/unwilling to attend visits|3|||
144453536|NCT01175382|520858840|FG001|Overall Study|Unable/unwilling to attend visits|1|||
144453537|NCT01175382|520858841|FG002|Overall Study|Unable/unwilling to attend visits|2|||
144453538|NCT01175382|520858839|FG000|Overall Study|Unwilling to follow protocol|0|||
144453539|NCT01175382|520858840|FG001|Overall Study|Unwilling to follow protocol|1|||
144453540|NCT01175382|520858841|FG002|Overall Study|Unwilling to follow protocol|0|||
144453541|NCT01175382|520858839|FG000|Overall Study|Unable to tolerate study meds|0|||
144453542|NCT01175382|520858840|FG001|Overall Study|Unable to tolerate study meds|1|||
144453543|NCT01175382|520858841|FG002|Overall Study|Unable to tolerate study meds|1|||
144453544|NCT00774787|520858842|FG000|Overall Study|Lost to Follow-up|1|||
144453545|NCT02019719|520858843|FG000|Overall Study|Adverse Event|1|||
144453546|NCT02019719|520858844|FG001|Overall Study|Adverse Event|0|||
144453547|NCT02019719|520858845|FG002|Overall Study|Adverse Event|0|||
144453548|NCT02019719|520858846|FG003|Overall Study|Adverse Event|1|||
144453549|NCT02019719|520858847|FG004|Overall Study|Adverse Event|1|||
144453550|NCT02019719|520858843|FG000|Overall Study|Protocol Violation|1|||
144453551|NCT02019719|520858844|FG001|Overall Study|Protocol Violation|1|||
144453552|NCT02019719|520858845|FG002|Overall Study|Protocol Violation|0|||
144453553|NCT02019719|520858846|FG003|Overall Study|Protocol Violation|0|||
144453554|NCT02019719|520858847|FG004|Overall Study|Protocol Violation|0|||
144453555|NCT02019719|520858843|FG000|Overall Study|Protocol defined stopping criteria|2|||
144453556|NCT02019719|520858844|FG001|Overall Study|Protocol defined stopping criteria|0|||
144453557|NCT02019719|520858845|FG002|Overall Study|Protocol defined stopping criteria|0|||
144453558|NCT02019719|520858846|FG003|Overall Study|Protocol defined stopping criteria|1|||
144453559|NCT02019719|520858847|FG004|Overall Study|Protocol defined stopping criteria|1|||
144453560|NCT02019719|520858843|FG000|Overall Study|Physician Decision|2|||
144453561|NCT02019719|520858844|FG001|Overall Study|Physician Decision|0|||
144453562|NCT02019719|520858845|FG002|Overall Study|Physician Decision|0|||
144453563|NCT02019719|520858846|FG003|Overall Study|Physician Decision|0|||
144453564|NCT02019719|520858847|FG004|Overall Study|Physician Decision|0|||
144453565|NCT02731131|520858851|FG000|Overall Study|Psychiatric Disorder|0|||
144453566|NCT02731131|520858852|FG001|Overall Study|Psychiatric Disorder|1|||
144453567|NCT02731131|520858851|FG000|Overall Study|Refused Therapy|0|||
144453568|NCT02731131|520858852|FG001|Overall Study|Refused Therapy|1|||
144453569|NCT01055639|520858857|FG000|Overall Study|Adverse Event|0|||
144453570|NCT01055639|520858858|FG001|Overall Study|Adverse Event|1|||
144725676|NCT05905783|521851334|FG000|Overall Study|Withdrawal by Subject|29|||
144725677|NCT05905783|521851335|FG001|Overall Study|Withdrawal by Subject|37|||
144725678|NCT05905783|521851334|FG000|Overall Study|Decision by sponsor|69|||
144725679|NCT05905783|521851335|FG001|Overall Study|Decision by sponsor|65|||
144725680|NCT02093689|521851336|FG000|Overall Study|Physician Decision|4|||
144725681|NCT02093689|521851337|FG001|Overall Study|Physician Decision|0|||
144196405|NCT00688376|519915139|FG000|Double-Blind Phase|Protocol Violation|1|||
144453571|NCT01055639|520858857|FG000|Overall Study|Lack of Efficacy|0|||
144453572|NCT01055639|520858858|FG001|Overall Study|Lack of Efficacy|1|||
144453573|NCT01055639|520858857|FG000|Overall Study|Lost to Follow-up|8|||
144453574|NCT01055639|520858858|FG001|Overall Study|Lost to Follow-up|11|||
144453575|NCT01055639|520858857|FG000|Overall Study|Protocol Violation|5|||
144453576|NCT01055639|520858858|FG001|Overall Study|Protocol Violation|5|||
144453577|NCT01055639|520858857|FG000|Overall Study|Withdrawal by Subject|8|||
144725682|NCT02093689|521851338|FG002|Overall Study|Physician Decision|0|||
144725683|NCT04947579|521851342|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
144453578|NCT01055639|520858858|FG001|Overall Study|Withdrawal by Subject|11|||
144453579|NCT01197950|520858862|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
144453580|NCT01197950|520858863|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
144453581|NCT01197950|520858864|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
144453582|NCT01659021|520858865|FG000|Main Study|Adverse Event|2|||
144453583|NCT01659021|520858866|FG001|Main Study|Adverse Event|3|||
144453584|NCT01659021|520858865|FG000|Main Study|Lost to Follow-up|1|||
144453585|NCT01659021|520858866|FG001|Main Study|Lost to Follow-up|0|||
144453586|NCT01659021|520858865|FG000|Main Study|Unknown Reasons|2|||
144453587|NCT01659021|520858866|FG001|Main Study|Unknown Reasons|1|||
144453588|NCT01659021|520858865|FG000|Main Study|Physician Decision|34|||
144453589|NCT01659021|520858866|FG001|Main Study|Physician Decision|16|||
144453590|NCT01659021|520858865|FG000|Main Study|Withdrawal by Subject|19|||
144453591|NCT01659021|520858866|FG001|Main Study|Withdrawal by Subject|16|||
144453592|NCT01659021|520858865|FG000|Main Study|Study Terminated by Sponsor|16|||
144453593|NCT01659021|520858866|FG001|Main Study|Study Terminated by Sponsor|1|||
144453594|NCT01659021|520858865|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
144453595|NCT01659021|520858866|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
144453596|NCT01659021|520858865|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
144453597|NCT01659021|520858866|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
144196406|NCT00688376|519915140|FG001|Double-Blind Phase|Protocol Violation|2|||
144196407|NCT00688376|519915139|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
144196408|NCT00688376|519915140|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
144196409|NCT00688376|519915139|FG000|Double-Blind Phase|Not treated|0|||
144196410|NCT00688376|519915140|FG001|Double-Blind Phase|Not treated|1|||
144196411|NCT00688376|519915139|FG000|Blinded Extension Phase|Adverse Event|3|||
144196412|NCT00688376|519915140|FG001|Blinded Extension Phase|Adverse Event|4|||
144196413|NCT00688376|519915139|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
144196414|NCT00688376|519915140|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
144196415|NCT00688376|519915139|FG000|Blinded Extension Phase|Physician Decision|1|||
144196416|NCT00688376|519915140|FG001|Blinded Extension Phase|Physician Decision|0|||
144196417|NCT00688376|519915139|FG000|Blinded Extension Phase|Other|1|||
144196418|NCT00688376|519915140|FG001|Blinded Extension Phase|Other|0|||
144196419|NCT02303041|519915141|FG000|Overall Study|Adverse Event|1|||
144196420|NCT02303041|519915142|FG001|Overall Study|Adverse Event|2|||
144196421|NCT01070771|519915143|FG000|Overall Study|Adverse Event|2|||
144196422|NCT01070771|519915143|FG000|Overall Study|Protocol Violation|1|||
144196423|NCT00289874|519915144|FG000|Overall Study|Adverse Event|1|||
144196424|NCT00289874|519915145|FG001|Overall Study|Adverse Event|5|||
144196425|NCT00289874|519915144|FG000|Overall Study|Lost to Follow-up|1|||
144196426|NCT00289874|519915145|FG001|Overall Study|Lost to Follow-up|1|||
144196427|NCT00289874|519915144|FG000|Overall Study|Protocol Violation|3|||
144196428|NCT00289874|519915145|FG001|Overall Study|Protocol Violation|2|||
144196429|NCT00289874|519915144|FG000|Overall Study|Did not meet eligibility|1|||
144196430|NCT00289874|519915145|FG001|Overall Study|Did not meet eligibility|0|||
144196431|NCT03835325|519915146|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
144196432|NCT03835325|519915146|FG000|Overall Study|Selection failure|1|||
144453598|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
144453599|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
144453600|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
144453601|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
144453602|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
144453603|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
144453604|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
144453605|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
144453606|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
144453607|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
144453608|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
144453609|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
144453610|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
144453611|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
144453612|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
144453613|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
144453614|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
144453615|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
144453616|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
144453617|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
144453618|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
144453619|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
144453620|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
144453621|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
144453622|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
144453623|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
144453624|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
144453625|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
144453626|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
144453627|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
144196433|NCT01370213|519915147|FG000|Overall Study|Early Death|1|||
144196434|NCT01370213|519915148|FG001|Overall Study|Early Death|0|||
144196435|NCT01370213|519915149|FG002|Overall Study|Early Death|0|||
144196436|NCT01370213|519915147|FG000|Overall Study|Not evaluable|0|||
144196437|NCT01370213|519915148|FG001|Overall Study|Not evaluable|2|||
144453628|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
144453629|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
144453630|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
144453631|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
144453632|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
144453633|NCT00383435|520858867|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
144453634|NCT00383435|520858868|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
144453635|NCT00383435|520858869|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
144453636|NCT00383435|520858870|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
144453637|NCT00383435|520858871|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
144453638|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
144453639|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
144453640|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
144453641|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
144453642|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
144453643|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
144453644|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
144453645|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
144453646|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
144453647|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
144453648|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
144453649|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
144453650|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
144453651|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
144453652|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
144453653|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
144453654|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
144453655|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
144453656|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
144453657|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
144453658|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
144453659|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
144453660|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
144453661|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
144453662|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
144453663|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
144453664|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
144453665|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
144453666|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
144453667|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
144453668|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
144453669|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
144453670|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
144453671|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
144453672|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
144453673|NCT00383435|520858867|FG000|26-Week Treatment Safety Extension|Administrative|1|||
144453674|NCT00383435|520858868|FG001|26-Week Treatment Safety Extension|Administrative|1|||
144453675|NCT00383435|520858869|FG002|26-Week Treatment Safety Extension|Administrative|0|||
144453676|NCT00383435|520858870|FG003|26-Week Treatment Safety Extension|Administrative|1|||
144453677|NCT00383435|520858871|FG004|26-Week Treatment Safety Extension|Administrative|0|||
144453678|NCT02682264|520858872|FG000|Overall Study|Withdrawal by Subject|56|||
144453679|NCT02682264|520858873|FG001|Overall Study|Withdrawal by Subject|45|||
144453680|NCT02682264|520858872|FG000|Overall Study|Lost to Follow-up|49|||
144453681|NCT02682264|520858873|FG001|Overall Study|Lost to Follow-up|41|||
144453682|NCT02682264|520858872|FG000|Overall Study|Lack of Efficacy|14|||
144453683|NCT02682264|520858873|FG001|Overall Study|Lack of Efficacy|16|||
144453684|NCT02682264|520858872|FG000|Overall Study|Withdrawal by Parent|6|||
144453685|NCT02682264|520858873|FG001|Overall Study|Withdrawal by Parent|7|||
144453686|NCT02682264|520858872|FG000|Overall Study|Adverse Event|9|||
144453687|NCT02682264|520858873|FG001|Overall Study|Adverse Event|0|||
144196438|NCT01370213|519915149|FG002|Overall Study|Not evaluable|0|||
144453688|NCT02682264|520858872|FG000|Overall Study|Noncompliance with study drug|1|||
144453689|NCT02682264|520858873|FG001|Overall Study|Noncompliance with study drug|4|||
144196439|NCT01550744|519915152|FG000|Open-Label|Lost to Follow-up|7|||
144196440|NCT01550744|519915153|FG001|Open-Label|Lost to Follow-up|0|||
144196441|NCT01550744|519915154|FG002|Open-Label|Lost to Follow-up|0|||
144453690|NCT02682264|520858872|FG000|Overall Study|Pregnancy|1|||
144453691|NCT02682264|520858873|FG001|Overall Study|Pregnancy|2|||
144453692|NCT02682264|520858872|FG000|Overall Study|Recovery|1|||
144453693|NCT02682264|520858873|FG001|Overall Study|Recovery|2|||
144453694|NCT02682264|520858872|FG000|Overall Study|Progressive Disease|1|||
144453695|NCT02682264|520858873|FG001|Overall Study|Progressive Disease|0|||
144453696|NCT02682264|520858872|FG000|Overall Study|Technical Problems|0|||
144453697|NCT02682264|520858873|FG001|Overall Study|Technical Problems|1|||
144453698|NCT02682264|520858872|FG000|Overall Study|Moved abroad and unable to continue|0|||
144453699|NCT02682264|520858873|FG001|Overall Study|Moved abroad and unable to continue|3|||
144453700|NCT02682264|520858872|FG000|Overall Study|Stopped test article application|0|||
144453701|NCT02682264|520858873|FG001|Overall Study|Stopped test article application|1|||
144453702|NCT03447769|520858875|FG000|Overall Study|Progressive disease|138|||
144453703|NCT03447769|520858876|FG001|Overall Study|Progressive disease|148|||
144453704|NCT03447769|520858875|FG000|Overall Study|Study terminated by Sponsor|60|||
144453705|NCT03447769|520858876|FG001|Overall Study|Study terminated by Sponsor|44|||
144453706|NCT03447769|520858875|FG000|Overall Study|Adverse Event|34|||
144453707|NCT03447769|520858876|FG001|Overall Study|Adverse Event|31|||
144453708|NCT03447769|520858875|FG000|Overall Study|Patient decision|27|||
144453709|NCT03447769|520858876|FG001|Overall Study|Patient decision|27|||
144453710|NCT03447769|520858875|FG000|Overall Study|Protocol deviation|4|||
144453711|NCT03447769|520858876|FG001|Overall Study|Protocol deviation|6|||
144453712|NCT03447769|520858875|FG000|Overall Study|Death|2|||
144453713|NCT03447769|520858876|FG001|Overall Study|Death|7|||
144453714|NCT03447769|520858875|FG000|Overall Study|Technical problems|1|||
144453715|NCT03447769|520858876|FG001|Overall Study|Technical problems|0|||
144453716|NCT03447769|520858875|FG000|Overall Study|Lost to Follow-up|0|||
144453717|NCT03447769|520858876|FG001|Overall Study|Lost to Follow-up|1|||
144453718|NCT03447769|520858875|FG000|Overall Study|Physician Decision|13|||
144453719|NCT03447769|520858876|FG001|Overall Study|Physician Decision|5|||
144453720|NCT01255358|520858878|FG000|Overall Study|Adverse Event|2|||
144453721|NCT01255358|520858878|FG000|Overall Study|Protocol Violation|2|||
144453722|NCT03950739|520858879|FG000|Treatment Phase|Adverse Event|2|||
144453723|NCT03950739|520858879|FG000|Optional Extension Phase|Death|1|||
144453724|NCT03950739|520858879|FG000|Optional Extension Phase|Progressive Disease|5|||
144453725|NCT03950739|520858879|FG000|Optional Extension Phase|Adverse Event|7|||
144453726|NCT03950739|520858879|FG000|Optional Extension Phase|Lost to Follow-up|2|||
144453727|NCT03950739|520858879|FG000|Optional Extension Phase|Site Closure|2|||
144453728|NCT03950739|520858879|FG000|Optional Extension Phase|Pregnancy|1|||
144453729|NCT03625570|520858881|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
144453730|NCT03625570|520858882|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
144453731|NCT03625570|520858881|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
144453732|NCT03625570|520858882|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
144453733|NCT03625570|520858881|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
144453734|NCT03625570|520858882|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
144453735|NCT00817089|520858884|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
144453736|NCT00817089|520858885|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
144453737|NCT00817089|520858886|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
144453738|NCT00817089|520858887|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
144453739|NCT00817089|520858884|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
144453740|NCT00817089|520858885|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
144453741|NCT00817089|520858886|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
144453742|NCT00817089|520858887|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
144453743|NCT00856583|520858891|FG000|Overall Study|Lack of Efficacy|389|||
144453744|NCT00856583|520858892|FG001|Overall Study|Lack of Efficacy|377|||
144453745|NCT00856583|520858891|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
144453746|NCT00856583|520858892|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
144453747|NCT00856583|520858891|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
144453748|NCT00856583|520858892|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
144453749|NCT00856583|520858891|FG000|Overall Study|Non-compliance|305|||
144453750|NCT00856583|520858892|FG001|Overall Study|Non-compliance|262|||
144453751|NCT00856583|520858891|FG000|Overall Study|Withdrawal by Subject|1092|||
144453752|NCT00856583|520858892|FG001|Overall Study|Withdrawal by Subject|919|||
144453753|NCT00856583|520858891|FG000|Overall Study|Physician Decision|59|||
144453754|NCT00856583|520858892|FG001|Overall Study|Physician Decision|82|||
144453755|NCT00856583|520858891|FG000|Overall Study|Pregnancy|14|||
144453756|NCT00856583|520858892|FG001|Overall Study|Pregnancy|5|||
144254792|NCT00707980|520133453|FG000|Overall Study|Protocol Deviations|19|||
144254793|NCT00707980|520133453|FG000|Overall Study|Withdrawal of Consent|81|||
144254794|NCT00707980|520133453|FG000|Overall Study|Lost to Follow-up|59|||
144254795|NCT00707980|520133453|FG000|Overall Study|Other|39|||
144453757|NCT00856583|520858891|FG000|Overall Study|Other|92|||
144453758|NCT00856583|520858892|FG001|Overall Study|Other|104|||
144453759|NCT00856583|520858891|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
144453760|NCT00856583|520858892|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
144453761|NCT01944046|520858893|FG000|Randomized to DB|Adverse Event|5|||
144453762|NCT01944046|520858894|FG001|Randomized to DB|Adverse Event|2|||
144453763|NCT01944046|520858893|FG000|Randomized to DB|Clinical Worsening|3|||
144453764|NCT01944046|520858894|FG001|Randomized to DB|Clinical Worsening|2|||
144453765|NCT01944046|520858893|FG000|Randomized to DB|Lost to Follow-up|3|||
144453766|NCT01944046|520858894|FG001|Randomized to DB|Lost to Follow-up|3|||
144453767|NCT01944046|520858893|FG000|Randomized to DB|Withdrawal by Subject|2|||
144453768|NCT01944046|520858894|FG001|Randomized to DB|Withdrawal by Subject|4|||
144453769|NCT01944046|520858893|FG000|Randomized to DB|Physician Decision|1|||
144453770|NCT01944046|520858894|FG001|Randomized to DB|Physician Decision|2|||
144453771|NCT01944046|520858893|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
144453772|NCT01944046|520858894|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
144453773|NCT01944046|520858893|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
144453774|NCT01944046|520858894|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
144453775|NCT01944046|520858893|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
144453776|NCT01944046|520858894|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
144453777|NCT01944046|520858893|FG000|Open Label Eligible and Consented|Adverse Event|6|||
144453778|NCT01944046|520858894|FG001|Open Label Eligible and Consented|Adverse Event|1|||
144453779|NCT01944046|520858893|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
144453780|NCT01944046|520858894|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
144453781|NCT01944046|520858893|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
144453782|NCT01944046|520858894|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
144453783|NCT01985126|520858902|FG000|Overall Study|Death|15|||
144453784|NCT01985126|520858903|FG001|Overall Study|Death|69|||
144453785|NCT01985126|520858902|FG000|Overall Study|Lost to Follow-up|0|||
144453786|NCT01985126|520858903|FG001|Overall Study|Lost to Follow-up|8|||
144453787|NCT01985126|520858902|FG000|Overall Study|Study Terminated By Sponsor|1|||
144453788|NCT01985126|520858903|FG001|Overall Study|Study Terminated By Sponsor|22|||
144453789|NCT01985126|520858902|FG000|Overall Study|Withdrawal by Subject|2|||
144453790|NCT01985126|520858903|FG001|Overall Study|Withdrawal by Subject|7|||
144453791|NCT05799495|520858906|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
144453792|NCT05799495|520858907|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
144453793|NCT05799495|520858908|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
144453794|NCT05799495|520858909|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
144453795|NCT05799495|520858906|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
144453796|NCT05799495|520858907|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
144453797|NCT05799495|520858908|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
144453798|NCT05799495|520858909|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
144453799|NCT05799495|520858906|FG000|Treatment (Up to 5 Days)|Other|0|||
144453800|NCT05799495|520858907|FG001|Treatment (Up to 5 Days)|Other|1|||
144453801|NCT05799495|520858908|FG002|Treatment (Up to 5 Days)|Other|0|||
144453802|NCT05799495|520858909|FG003|Treatment (Up to 5 Days)|Other|0|||
144453803|NCT05799495|520858906|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
144453804|NCT05799495|520858907|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
144453805|NCT05799495|520858908|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
144453806|NCT05799495|520858909|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
144453807|NCT05799495|520858906|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
144453808|NCT05799495|520858907|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
144453809|NCT05799495|520858908|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
144453810|NCT05799495|520858909|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
144453811|NCT05799495|520858906|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144453812|NCT05799495|520858907|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144453813|NCT05799495|520858908|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
144453814|NCT05799495|520858909|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144453815|NCT03694548|520858910|FG000|Part A Survey|Protocol Violation|3|||
144453816|NCT03694548|520858911|FG001|Part A Survey|Protocol Violation|3|||
144453817|NCT03694548|520858912|FG002|Part A Survey|Protocol Violation|0|||
144453818|NCT03694548|520858910|FG000|Part B Yoga Program|Protocol Violation|0|||
144453819|NCT03694548|520858911|FG001|Part B Yoga Program|Protocol Violation|0|||
144453820|NCT03694548|520858912|FG002|Part B Yoga Program|Protocol Violation|3|||
144254796|NCT02768792|520133456|FG000|Overall Study|Adverse Event|1|||
144254797|NCT04676724|520133457|FG000|Overall Study|Adverse Event|2|||
144254798|NCT04676724|520133458|FG001|Overall Study|Adverse Event|0|||
144254799|NCT04676724|520133457|FG000|Overall Study|Lost to Follow-up|1|||
144453821|NCT03694548|520858910|FG000|Part B Yoga Program|Did not attend intervention|0|||
144453822|NCT03694548|520858911|FG001|Part B Yoga Program|Did not attend intervention|0|||
144453823|NCT03694548|520858912|FG002|Part B Yoga Program|Did not attend intervention|8|||
144453824|NCT00305058|520858913|FG000|Overall Study|Participant too young|1|||
144453825|NCT00305058|520858914|FG001|Overall Study|Participant too young|0|||
144607131|NCT02109562|521422655|FG001|Overall Study|Protocol Violation|3|||
144607132|NCT02109562|521422656|FG002|Overall Study|Protocol Violation|1|||
144453826|NCT00305058|520858913|FG000|Overall Study|Missing data collection instrument|3|||
144607133|NCT02109562|521422654|FG000|Overall Study|Withdrawal by Subject|20|||
144254800|NCT04676724|520133458|FG001|Overall Study|Lost to Follow-up|0|||
144254801|NCT04676724|520133457|FG000|Overall Study|Physician Decision|0|||
144254802|NCT04676724|520133458|FG001|Overall Study|Physician Decision|1|||
144254803|NCT04676724|520133457|FG000|Overall Study|Withdrawal by Subject|3|||
144254804|NCT04676724|520133458|FG001|Overall Study|Withdrawal by Subject|2|||
144254805|NCT01188668|520133459|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
144254806|NCT01188668|520133459|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
144254807|NCT01188668|520133459|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
144254808|NCT00303472|520133460|FG000|Treatment Period|Adverse Event|0|||
144254809|NCT00303472|520133461|FG001|Treatment Period|Adverse Event|0|||
144254810|NCT00303472|520133462|FG002|Treatment Period|Adverse Event|0|||
144254811|NCT00303472|520133463|FG003|Treatment Period|Adverse Event|0|||
144254812|NCT00303472|520133464|FG004|Treatment Period|Adverse Event|1|||
144254813|NCT00303472|520133465|FG005|Treatment Period|Adverse Event|0|||
144254814|NCT00303472|520133466|FG006|Treatment Period|Adverse Event|0|||
144254815|NCT00303472|520133460|FG000|Treatment Period|Death|0|||
144254816|NCT00303472|520133461|FG001|Treatment Period|Death|0|||
144254817|NCT00303472|520133462|FG002|Treatment Period|Death|0|||
144254818|NCT00303472|520133463|FG003|Treatment Period|Death|1|||
144453827|NCT00305058|520858914|FG001|Overall Study|Missing data collection instrument|2|||
144453828|NCT00305058|520858913|FG000|Overall Study|Missing outcome data|3|||
144453829|NCT00305058|520858914|FG001|Overall Study|Missing outcome data|2|||
144453830|NCT01669343|520858915|FG000|Part A: All Patients|Withdrawal by Subject|7|||
144453831|NCT01669343|520858915|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
144453832|NCT01669343|520858915|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
144453833|NCT01669343|520858915|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
144453834|NCT01669343|520858915|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
144453835|NCT01866709|520858916|FG000|Overall Study|Adverse Event|1|||
144453836|NCT01866709|520858917|FG001|Overall Study|Adverse Event|0|||
144453837|NCT03191903|520858918|FG000|Overall Study|Withdrawal by Subject|6|||
144453838|NCT03191903|520858919|FG001|Overall Study|Withdrawal by Subject|5|||
144453839|NCT03191903|520858920|FG002|Overall Study|Withdrawal by Subject|4|||
144453840|NCT03191903|520858918|FG000|Overall Study|Adverse Event|1|||
144453841|NCT03191903|520858919|FG001|Overall Study|Adverse Event|0|||
144453842|NCT03191903|520858920|FG002|Overall Study|Adverse Event|0|||
144453843|NCT00503685|520858924|FG000|Overall Study|Adverse Event|0|||
144453844|NCT00503685|520858925|FG001|Overall Study|Adverse Event|0|||
144453845|NCT00503685|520858926|FG002|Overall Study|Adverse Event|2|||
144453846|NCT00503685|520858924|FG000|Overall Study|Withdrawal by Subject|0|||
144453847|NCT00503685|520858925|FG001|Overall Study|Withdrawal by Subject|1|||
144453848|NCT00503685|520858926|FG002|Overall Study|Withdrawal by Subject|0|||
144453849|NCT00503685|520858924|FG000|Overall Study|Protocol Violation|0|||
144453850|NCT00503685|520858925|FG001|Overall Study|Protocol Violation|1|||
144453851|NCT00503685|520858926|FG002|Overall Study|Protocol Violation|0|||
144453852|NCT00503685|520858924|FG000|Overall Study|Eligibility Criteria Not Met|0|||
144453853|NCT00503685|520858925|FG001|Overall Study|Eligibility Criteria Not Met|1|||
144453854|NCT00503685|520858926|FG002|Overall Study|Eligibility Criteria Not Met|0|||
144453855|NCT01110239|520858931|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
144453856|NCT01110239|520858932|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
144453857|NCT01110239|520858933|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
144453858|NCT01110239|520858934|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
144453859|NCT01110239|520858931|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
144453860|NCT01110239|520858932|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
144453861|NCT01110239|520858933|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
144453862|NCT01110239|520858934|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
144453863|NCT04369469|520858939|FG000|Overall Study|Lost to Follow-up|2|||
144453864|NCT04369469|520858940|FG001|Overall Study|Lost to Follow-up|4|||
144453865|NCT04369469|520858939|FG000|Overall Study|Physician Decision|2|||
144453866|NCT04369469|520858940|FG001|Overall Study|Physician Decision|1|||
144453867|NCT04369469|520858939|FG000|Overall Study|Withdrawal by Subject|2|||
144453868|NCT04369469|520858940|FG001|Overall Study|Withdrawal by Subject|3|||
144453869|NCT04369469|520858939|FG000|Overall Study|Adverse Event|1|||
144453870|NCT04369469|520858940|FG001|Overall Study|Adverse Event|0|||
144254819|NCT00303472|520133464|FG004|Treatment Period|Death|0|||
144254820|NCT00303472|520133465|FG005|Treatment Period|Death|0|||
144254821|NCT00303472|520133466|FG006|Treatment Period|Death|1|||
144254822|NCT00303472|520133460|FG000|Treatment Period|Withdrawal by Subject|0|||
144453871|NCT04369469|520858939|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
144453872|NCT04369469|520858940|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
144533737|NCT05007080|521157771|FG002|Overall Study|Death|0|||
144254823|NCT00303472|520133461|FG001|Treatment Period|Withdrawal by Subject|0|||
144254824|NCT00303472|520133462|FG002|Treatment Period|Withdrawal by Subject|0|||
144533738|NCT05007080|521157772|FG003|Overall Study|Death|0|||
144533739|NCT05007080|521157773|FG004|Overall Study|Death|0|||
144533740|NCT05007080|521157774|FG005|Overall Study|Death|0|||
144533741|NCT05007080|521157769|FG000|Overall Study|Withdrawal by Subject|1|||
144533742|NCT05007080|521157770|FG001|Overall Study|Withdrawal by Subject|2|||
144453873|NCT04369469|520858939|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
144453874|NCT04369469|520858940|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
144453875|NCT04369469|520858939|FG000|Overall Study|Unable to Provide Consent|0|||
144453876|NCT04369469|520858940|FG001|Overall Study|Unable to Provide Consent|1|||
144453877|NCT03135522|520858941|FG000|Overall Study|Adverse Event|1|||
144453878|NCT03135522|520858942|FG001|Overall Study|Adverse Event|0|||
144453879|NCT00499369|520858943|FG000|Overall Study|Adverse Event|2|||
144453880|NCT00499369|520858944|FG001|Overall Study|Adverse Event|2|||
144453881|NCT00499369|520858945|FG002|Overall Study|Adverse Event|3|||
144453882|NCT00499369|520858946|FG003|Overall Study|Adverse Event|1|||
144453883|NCT00499369|520858947|FG004|Overall Study|Adverse Event|2|||
144453884|NCT00499369|520858943|FG000|Overall Study|Withdrawal by Subject|0|||
144453885|NCT00499369|520858944|FG001|Overall Study|Withdrawal by Subject|1|||
144453886|NCT00499369|520858945|FG002|Overall Study|Withdrawal by Subject|1|||
144453887|NCT00499369|520858946|FG003|Overall Study|Withdrawal by Subject|0|||
144453888|NCT00499369|520858947|FG004|Overall Study|Withdrawal by Subject|0|||
144453889|NCT00499369|520858943|FG000|Overall Study|Progression|10|||
144453890|NCT00499369|520858944|FG001|Overall Study|Progression|12|||
144453891|NCT00499369|520858945|FG002|Overall Study|Progression|9|||
144453892|NCT00499369|520858946|FG003|Overall Study|Progression|6|||
144453893|NCT00499369|520858947|FG004|Overall Study|Progression|10|||
144453894|NCT00499369|520858943|FG000|Overall Study|Death|0|||
144453895|NCT00499369|520858944|FG001|Overall Study|Death|1|||
144453896|NCT00499369|520858945|FG002|Overall Study|Death|0|||
144453897|NCT00499369|520858946|FG003|Overall Study|Death|0|||
144453898|NCT00499369|520858947|FG004|Overall Study|Death|0|||
144453899|NCT00499369|520858943|FG000|Overall Study|Not protocol specified|2|||
144453900|NCT00499369|520858944|FG001|Overall Study|Not protocol specified|0|||
144453901|NCT00499369|520858945|FG002|Overall Study|Not protocol specified|3|||
144453902|NCT00499369|520858946|FG003|Overall Study|Not protocol specified|1|||
144453903|NCT00499369|520858947|FG004|Overall Study|Not protocol specified|0|||
144453904|NCT00499369|520858943|FG000|Overall Study|Ineligible|2|||
144453905|NCT00499369|520858944|FG001|Overall Study|Ineligible|2|||
144453906|NCT00499369|520858945|FG002|Overall Study|Ineligible|1|||
144453907|NCT00499369|520858946|FG003|Overall Study|Ineligible|1|||
144453908|NCT00499369|520858947|FG004|Overall Study|Ineligible|0|||
144453909|NCT01898195|520858948|FG000|Smoking Abstinence|Did not have good measurements|35|||
144453910|NCT01898195|520858949|FG001|Smoking Abstinence|Did not have good measurements|38|||
144453911|NCT01898195|520858950|FG002|Smoking Abstinence|Did not have good measurements|36|||
144453912|NCT01337245|520858951|FG000|Overall Study|Lost to Follow-up|1|||
144453913|NCT03283670|520858952|FG000|Placebo Gas|Withdrawal by Subject|2|||
144453914|NCT03283670|520858952|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
144453915|NCT03283670|520858952|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
144453916|NCT02280044|520860892|FG000|Overall Study|Planned alternate|0|||
144453917|NCT02280044|520860893|FG001|Overall Study|Planned alternate|2|||
144453918|NCT02105116|520860896|FG000|Overall Study|not eligible for step 2 of trial|5|||
144453919|NCT02105116|520860896|FG000|Overall Study|Death|1|||
144453920|NCT02492100|520860897|FG000|Overall Study|Death|1|||
144453921|NCT03832010|520860898|FG000|Overall Study|Withdrawal by Subject|2|||
144453922|NCT03832010|520860899|FG001|Overall Study|Withdrawal by Subject|1|||
144453923|NCT03832010|520860900|FG002|Overall Study|Withdrawal by Subject|0|||
144453924|NCT03832010|520860898|FG000|Overall Study|Lost to Follow-up|2|||
144453925|NCT03832010|520860899|FG001|Overall Study|Lost to Follow-up|1|||
144453926|NCT03832010|520860900|FG002|Overall Study|Lost to Follow-up|1|||
144453927|NCT00987467|520860901|FG000|Overall Study|Lost to Follow-up|2|||
144453928|NCT02348216|520860902|FG000|Overall Study|Death|5|||
144453929|NCT02348216|520860903|FG001|Overall Study|Death|53|||
144453930|NCT02348216|520860904|FG002|Overall Study|Death|11|||
144453931|NCT02348216|520860905|FG003|Overall Study|Death|20|||
144453932|NCT02348216|520860906|FG004|Overall Study|Death|16|||
144453933|NCT02348216|520860907|FG005|Overall Study|Death|32|||
144453934|NCT02348216|520860908|FG006|Overall Study|Death|17|||
144453935|NCT02348216|520860902|FG000|Overall Study|Full consent withdrawal|0|||
144453936|NCT02348216|520860903|FG001|Overall Study|Full consent withdrawal|0|||
144453937|NCT02348216|520860904|FG002|Overall Study|Full consent withdrawal|0|||
144453938|NCT02348216|520860905|FG003|Overall Study|Full consent withdrawal|1|||
144453939|NCT02348216|520860906|FG004|Overall Study|Full consent withdrawal|3|||
144453940|NCT02348216|520860907|FG005|Overall Study|Full consent withdrawal|0|||
144453941|NCT02348216|520860908|FG006|Overall Study|Full consent withdrawal|3|||
144453942|NCT02348216|520860902|FG000|Overall Study|Lost to Follow-up|0|||
144453943|NCT02348216|520860903|FG001|Overall Study|Lost to Follow-up|5|||
144254825|NCT00303472|520133463|FG003|Treatment Period|Withdrawal by Subject|1|||
144254826|NCT00303472|520133464|FG004|Treatment Period|Withdrawal by Subject|0|||
144453944|NCT02348216|520860904|FG002|Overall Study|Lost to Follow-up|2|||
144453945|NCT02348216|520860905|FG003|Overall Study|Lost to Follow-up|0|||
144453946|NCT02348216|520860906|FG004|Overall Study|Lost to Follow-up|1|||
144453947|NCT02348216|520860907|FG005|Overall Study|Lost to Follow-up|1|||
144453948|NCT02348216|520860908|FG006|Overall Study|Lost to Follow-up|1|||
144453949|NCT02348216|520860902|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
144453950|NCT02348216|520860903|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
144453951|NCT02348216|520860904|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
144453952|NCT02348216|520860905|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
144453953|NCT02348216|520860906|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
144453954|NCT02348216|520860907|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
144725684|NCT04947579|521851343|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
144725685|NCT04947579|521851344|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
144725686|NCT04947579|521851345|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
144725687|NCT04947579|521851346|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
144725688|NCT04947579|521851347|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
144725689|NCT04947579|521851342|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
144725690|NCT04947579|521851343|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
144196442|NCT01550744|519915152|FG000|Open-Label|Withdrawal by Subject|13|||
144196443|NCT01550744|519915153|FG001|Open-Label|Withdrawal by Subject|0|||
144196444|NCT01550744|519915154|FG002|Open-Label|Withdrawal by Subject|0|||
144196445|NCT01550744|519915152|FG000|Open-Label|Adverse Event|11|||
144453955|NCT02348216|520860908|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
144453956|NCT02348216|520860902|FG000|Overall Study|Reason not specified|2|||
144453957|NCT02348216|520860903|FG001|Overall Study|Reason not specified|19|||
144453958|NCT02348216|520860904|FG002|Overall Study|Reason not specified|11|||
144453959|NCT02348216|520860905|FG003|Overall Study|Reason not specified|17|||
144453960|NCT02348216|520860906|FG004|Overall Study|Reason not specified|21|||
144453961|NCT02348216|520860907|FG005|Overall Study|Reason not specified|17|||
144453962|NCT02348216|520860908|FG006|Overall Study|Reason not specified|19|||
144453963|NCT01666002|520860910|FG000|Overall Study|Lost to Follow-up|5|||
144453964|NCT01666002|520860911|FG001|Overall Study|Lost to Follow-up|0|||
144453965|NCT00346034|520860923|FG000|Overall Study|Adverse Event|34|||
144453966|NCT00346034|520860923|FG000|Overall Study|Lack of Efficacy|8|||
144453967|NCT00346034|520860923|FG000|Overall Study|Withdrawal by Subject|13|||
144453968|NCT00346034|520860923|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
144453969|NCT00346034|520860923|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
144453970|NCT04000165|520860924|FG000|Overall Study|Physician Decision|1|||
144453971|NCT04000165|520860924|FG000|Overall Study|Withdrawal by Subject|1|||
144453972|NCT00941603|520860925|FG000|Overall Study|Adverse Event|10|||
144453973|NCT00941603|520860926|FG001|Overall Study|Adverse Event|15|||
144453974|NCT00941603|520860927|FG002|Overall Study|Adverse Event|5|||
144453975|NCT00941603|520860928|FG003|Overall Study|Adverse Event|1|||
144453976|NCT00941603|520860929|FG004|Overall Study|Adverse Event|4|||
144453977|NCT00941603|520860930|FG005|Overall Study|Adverse Event|0|||
144453978|NCT00941603|520860925|FG000|Overall Study|Lost to Follow-up|0|||
144453979|NCT00941603|520860926|FG001|Overall Study|Lost to Follow-up|0|||
144453980|NCT00941603|520860927|FG002|Overall Study|Lost to Follow-up|0|||
144607134|NCT02109562|521422655|FG001|Overall Study|Withdrawal by Subject|25|||
144196446|NCT01550744|519915153|FG001|Open-Label|Adverse Event|0|||
144196447|NCT01550744|519915154|FG002|Open-Label|Adverse Event|0|||
144196448|NCT01550744|519915152|FG000|Open-Label|Lack of Efficacy|4|||
144196449|NCT01550744|519915153|FG001|Open-Label|Lack of Efficacy|0|||
144254827|NCT00303472|520133465|FG005|Treatment Period|Withdrawal by Subject|1|||
144254828|NCT00303472|520133466|FG006|Treatment Period|Withdrawal by Subject|0|||
144254829|NCT00303472|520133460|FG000|Treatment Period|Other|0|||
144453981|NCT00941603|520860928|FG003|Overall Study|Lost to Follow-up|1|||
144453982|NCT00941603|520860929|FG004|Overall Study|Lost to Follow-up|0|||
144607135|NCT02109562|521422656|FG002|Overall Study|Withdrawal by Subject|21|||
144607136|NCT02109562|521422654|FG000|Overall Study|Physician Decision|3|||
144607137|NCT02109562|521422655|FG001|Overall Study|Physician Decision|4|||
144607138|NCT02109562|521422656|FG002|Overall Study|Physician Decision|5|||
144254830|NCT00303472|520133461|FG001|Treatment Period|Other|0|||
144607139|NCT00310804|521422657|FG000|Overall Study|Lost to Follow-up|2|||
144607140|NCT00310804|521422658|FG001|Overall Study|Lost to Follow-up|0|||
144607141|NCT00310804|521422657|FG000|Overall Study|Withdrawal by Subject|3|||
144607142|NCT00310804|521422658|FG001|Overall Study|Withdrawal by Subject|0|||
144607143|NCT00688155|521422663|FG000|Overall Study|Withdrawal by Subject|2|||
144453983|NCT00941603|520860930|FG005|Overall Study|Lost to Follow-up|2|||
144453984|NCT00941603|520860925|FG000|Overall Study|Withdrawal by Subject|0|||
144453985|NCT00941603|520860926|FG001|Overall Study|Withdrawal by Subject|0|||
144453986|NCT00941603|520860927|FG002|Overall Study|Withdrawal by Subject|0|||
144453987|NCT00941603|520860928|FG003|Overall Study|Withdrawal by Subject|2|||
144196450|NCT01550744|519915154|FG002|Open-Label|Lack of Efficacy|0|||
144453988|NCT00941603|520860929|FG004|Overall Study|Withdrawal by Subject|0|||
144453989|NCT00941603|520860930|FG005|Overall Study|Withdrawal by Subject|1|||
144453990|NCT00941603|520860925|FG000|Overall Study|Protocol Violation|0|||
144196451|NCT01550744|519915152|FG000|Open-Label|Protocol Violation|4|||
144196452|NCT01550744|519915153|FG001|Open-Label|Protocol Violation|0|||
144196453|NCT01550744|519915154|FG002|Open-Label|Protocol Violation|0|||
144607144|NCT00688155|521422664|FG001|Overall Study|Withdrawal by Subject|2|||
144453991|NCT00941603|520860926|FG001|Overall Study|Protocol Violation|1|||
144453992|NCT00941603|520860927|FG002|Overall Study|Protocol Violation|0|||
144453993|NCT00941603|520860928|FG003|Overall Study|Protocol Violation|0|||
144453994|NCT00941603|520860929|FG004|Overall Study|Protocol Violation|0|||
144453995|NCT00941603|520860930|FG005|Overall Study|Protocol Violation|0|||
144453996|NCT00941603|520860925|FG000|Overall Study|Did not meet protocol eligibility|1|||
144453997|NCT00941603|520860926|FG001|Overall Study|Did not meet protocol eligibility|0|||
144453998|NCT00941603|520860927|FG002|Overall Study|Did not meet protocol eligibility|0|||
144453999|NCT00941603|520860928|FG003|Overall Study|Did not meet protocol eligibility|0|||
144454000|NCT00941603|520860929|FG004|Overall Study|Did not meet protocol eligibility|0|||
144454001|NCT00941603|520860930|FG005|Overall Study|Did not meet protocol eligibility|0|||
144454002|NCT00407537|520860931|FG000|Overall Study|Death|5|||
144454003|NCT00407537|520860932|FG001|Overall Study|Death|2|||
144454004|NCT00407537|520860931|FG000|Overall Study|Adverse Event|36|||
144454005|NCT00407537|520860932|FG001|Overall Study|Adverse Event|0|||
144454006|NCT00407537|520860931|FG000|Overall Study|Lost to Follow-up|12|||
144454007|NCT00407537|520860932|FG001|Overall Study|Lost to Follow-up|19|||
144454008|NCT00407537|520860931|FG000|Overall Study|Other|6|||
144454009|NCT00407537|520860932|FG001|Overall Study|Other|7|||
144454010|NCT00407537|520860931|FG000|Overall Study|Withdrawal by Subject|34|||
144607145|NCT00688155|521422665|FG002|Overall Study|Withdrawal by Subject|1|||
144454011|NCT00407537|520860932|FG001|Overall Study|Withdrawal by Subject|16|||
144454012|NCT01753193|520860933|FG000|Overall Study|Withdrawal by Subject|23|||
144607146|NCT00688155|521422666|FG003|Overall Study|Withdrawal by Subject|1|||
144607147|NCT03734016|521422667|FG000|Overall Study|Sponsor Ended Study|225|||
144607148|NCT03734016|521422668|FG001|Overall Study|Sponsor Ended Study|200|||
144607149|NCT03734016|521422667|FG000|Overall Study|Death|69|||
144607150|NCT03734016|521422668|FG001|Overall Study|Death|83|||
144607151|NCT03734016|521422667|FG000|Overall Study|Withdrawal by Subject|21|||
144607152|NCT03734016|521422668|FG001|Overall Study|Withdrawal by Subject|27|||
144607153|NCT03734016|521422667|FG000|Overall Study|Physician Decision|1|||
144607154|NCT03734016|521422668|FG001|Overall Study|Physician Decision|12|||
144607155|NCT03734016|521422667|FG000|Overall Study|Lost to Follow-up|6|||
144607156|NCT03734016|521422668|FG001|Overall Study|Lost to Follow-up|2|||
144607157|NCT03734016|521422667|FG000|Overall Study|Miscellaneous|5|||
144607158|NCT03734016|521422668|FG001|Overall Study|Miscellaneous|1|||
144607159|NCT01428661|521422671|FG000|Double-Masked Phase|Protocol Violation|9|||
144607160|NCT01428661|521422672|FG001|Double-Masked Phase|Protocol Violation|4|||
144607161|NCT01428661|521422673|FG002|Double-Masked Phase|Protocol Violation|0|||
144607162|NCT01428661|521422671|FG000|Double-Masked Phase|Adverse Event|13|||
144607163|NCT01428661|521422672|FG001|Double-Masked Phase|Adverse Event|4|||
144607164|NCT01428661|521422673|FG002|Double-Masked Phase|Adverse Event|0|||
144607165|NCT01428661|521422671|FG000|Double-Masked Phase|Lost to Follow-up|14|||
144607166|NCT01428661|521422672|FG001|Double-Masked Phase|Lost to Follow-up|14|||
144607167|NCT01428661|521422673|FG002|Double-Masked Phase|Lost to Follow-up|0|||
144607168|NCT01428661|521422671|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
144607169|NCT01428661|521422672|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
144607170|NCT01428661|521422673|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
144607171|NCT01428661|521422671|FG000|Double-Masked Phase|Lack of Efficacy|2|||
144607172|NCT01428661|521422672|FG001|Double-Masked Phase|Lack of Efficacy|1|||
144607173|NCT01428661|521422673|FG002|Double-Masked Phase|Lack of Efficacy|0|||
144607174|NCT01428661|521422671|FG000|Double-Masked Phase|*Various|1|||
144607175|NCT01428661|521422672|FG001|Double-Masked Phase|*Various|6|||
144607176|NCT01428661|521422673|FG002|Double-Masked Phase|*Various|0|||
144607177|NCT01428661|521422671|FG000|Open Label Extension|Protocol Violation|0|||
144607178|NCT01428661|521422672|FG001|Open Label Extension|Protocol Violation|0|||
144454013|NCT01753193|520860933|FG000|Overall Study|Lost to Follow-up|6|||
144454014|NCT01753193|520860933|FG000|Overall Study|Death|1|||
144454015|NCT01753193|520860933|FG000|Overall Study|Other|16|||
144454016|NCT00583557|520860934|FG000|Overall Study|Withdrawal by Subject|18|||
144454017|NCT00583557|520860934|FG000|Overall Study|Adverse Event|9|||
144607179|NCT01428661|521422673|FG002|Open Label Extension|Protocol Violation|9|||
144607180|NCT01428661|521422671|FG000|Open Label Extension|Adverse Event|0|||
144607181|NCT01428661|521422672|FG001|Open Label Extension|Adverse Event|0|||
144607182|NCT01428661|521422673|FG002|Open Label Extension|Adverse Event|15|||
144607183|NCT01428661|521422671|FG000|Open Label Extension|Lost to Follow-up|0|||
144725691|NCT04947579|521851344|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
144725692|NCT04947579|521851345|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
144454018|NCT00583557|520860934|FG000|Overall Study|Lack of Efficacy|31|||
144454019|NCT00583557|520860934|FG000|Overall Study|Lack of Compliance|5|||
144454020|NCT00583557|520860934|FG000|Overall Study|Other|5|||
144454021|NCT00583557|520860934|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
144454022|NCT01131312|520860935|FG000|Overall Study|Lost to Follow-up|425|||
144454023|NCT01131312|520860936|FG001|Overall Study|Lost to Follow-up|229|||
144607184|NCT01428661|521422672|FG001|Open Label Extension|Lost to Follow-up|0|||
144607185|NCT01428661|521422673|FG002|Open Label Extension|Lost to Follow-up|38|||
144607186|NCT01428661|521422671|FG000|Open Label Extension|Withdrawal by Subject|0|||
144607187|NCT01428661|521422672|FG001|Open Label Extension|Withdrawal by Subject|0|||
144725693|NCT04947579|521851346|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
144725694|NCT04947579|521851347|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
144725695|NCT04947579|521851342|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
144725696|NCT04947579|521851343|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
144725697|NCT04947579|521851344|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
144725698|NCT04947579|521851345|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
144725699|NCT04947579|521851346|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
144725700|NCT04947579|521851347|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
144725701|NCT04947579|521851342|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
144725702|NCT04947579|521851343|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
144254831|NCT00303472|520133462|FG002|Treatment Period|Other|0|||
144454024|NCT01131312|520860937|FG002|Overall Study|Lost to Follow-up|351|||
144725703|NCT04947579|521851344|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
144725704|NCT04947579|521851345|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
144725705|NCT04947579|521851346|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
144725706|NCT04947579|521851347|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
144725707|NCT04947579|521851342|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
144725708|NCT04947579|521851343|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
144254832|NCT00303472|520133463|FG003|Treatment Period|Other|0|||
144254833|NCT00303472|520133464|FG004|Treatment Period|Other|1|||
144454025|NCT02347761|520860938|FG000|All Collected|Death|1|||
144454026|NCT02347761|520860939|FG001|All Collected|Death|0|||
144454027|NCT02347761|520860940|FG002|All Collected|Death|0|||
144454028|NCT02347761|520860938|FG000|All Collected|Lost to Follow-up|3|||
144454029|NCT02347761|520860939|FG001|All Collected|Lost to Follow-up|2|||
144454030|NCT02347761|520860940|FG002|All Collected|Lost to Follow-up|3|||
144454031|NCT02347761|520860938|FG000|All Collected|Withdrawal by Subject|11|||
144454032|NCT02347761|520860939|FG001|All Collected|Withdrawal by Subject|11|||
144454033|NCT02347761|520860940|FG002|All Collected|Withdrawal by Subject|22|||
144454034|NCT02347761|520860938|FG000|All Collected|invetigator disretion|2|||
144454035|NCT02347761|520860939|FG001|All Collected|invetigator disretion|0|||
144454036|NCT02347761|520860940|FG002|All Collected|invetigator disretion|0|||
144454037|NCT02347761|520860938|FG000|All Collected|instillation site pain|0|||
144454038|NCT02347761|520860939|FG001|All Collected|instillation site pain|0|||
144454039|NCT02347761|520860940|FG002|All Collected|instillation site pain|1|||
144454040|NCT02347761|520860938|FG000|All Collected|exacerbation of COPD|0|||
144454041|NCT02347761|520860939|FG001|All Collected|exacerbation of COPD|0|||
144454042|NCT02347761|520860940|FG002|All Collected|exacerbation of COPD|1|||
144454043|NCT02347761|520860938|FG000|All Collected|moved/travel|0|||
144454044|NCT02347761|520860939|FG001|All Collected|moved/travel|1|||
144454045|NCT02347761|520860940|FG002|All Collected|moved/travel|0|||
144454046|NCT02347761|520860938|FG000|On Study Treatment|Lack of Efficacy|2|||
144454047|NCT02347761|520860939|FG001|On Study Treatment|Lack of Efficacy|3|||
144454048|NCT02347761|520860940|FG002|On Study Treatment|Lack of Efficacy|4|||
144454049|NCT02347761|520860938|FG000|On Study Treatment|non-compliance with study medication|0|||
144454050|NCT02347761|520860939|FG001|On Study Treatment|non-compliance with study medication|0|||
144454051|NCT02347761|520860940|FG002|On Study Treatment|non-compliance with study medication|2|||
144454052|NCT02347761|520860938|FG000|On Study Treatment|Withdrawal by Subject|7|||
144454053|NCT02347761|520860939|FG001|On Study Treatment|Withdrawal by Subject|3|||
144454054|NCT02347761|520860940|FG002|On Study Treatment|Withdrawal by Subject|5|||
144454055|NCT02347761|520860938|FG000|On Study Treatment|move/travel|2|||
144454056|NCT02347761|520860939|FG001|On Study Treatment|move/travel|6|||
144454057|NCT02347761|520860940|FG002|On Study Treatment|move/travel|5|||
144454058|NCT02347761|520860938|FG000|On Study Treatment|dissastisfaction with device|2|||
144454059|NCT02347761|520860939|FG001|On Study Treatment|dissastisfaction with device|1|||
144454060|NCT02347761|520860940|FG002|On Study Treatment|dissastisfaction with device|4|||
144454061|NCT02347761|520860938|FG000|On Study Treatment|Lost to Follow-up|2|||
144454062|NCT02347761|520860939|FG001|On Study Treatment|Lost to Follow-up|1|||
144454063|NCT02347761|520860940|FG002|On Study Treatment|Lost to Follow-up|1|||
144454064|NCT02347761|520860938|FG000|On Study Treatment|investigator discretion|2|||
144454065|NCT02347761|520860939|FG001|On Study Treatment|investigator discretion|0|||
144454066|NCT02347761|520860940|FG002|On Study Treatment|investigator discretion|0|||
144454067|NCT02347761|520860938|FG000|On Study Treatment|durg not working|0|||
144454068|NCT02347761|520860939|FG001|On Study Treatment|durg not working|1|||
144454069|NCT02347761|520860940|FG002|On Study Treatment|durg not working|1|||
144454070|NCT02347761|520860938|FG000|On Study Treatment|Adverse Event|10|||
144454071|NCT02347761|520860939|FG001|On Study Treatment|Adverse Event|8|||
144254834|NCT00303472|520133465|FG005|Treatment Period|Other|0|||
144254835|NCT00303472|520133466|FG006|Treatment Period|Other|1|||
144254836|NCT00303472|520133460|FG000|Treatment Period|Disease Progression (to AML)|0|||
144254837|NCT00303472|520133461|FG001|Treatment Period|Disease Progression (to AML)|0|||
144254838|NCT00303472|520133462|FG002|Treatment Period|Disease Progression (to AML)|0|||
144254839|NCT00303472|520133463|FG003|Treatment Period|Disease Progression (to AML)|0|||
144725709|NCT04947579|521851344|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
144725710|NCT04947579|521851345|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
144725711|NCT04947579|521851346|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
144725712|NCT04947579|521851347|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
144725713|NCT04947579|521851342|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
144725714|NCT04947579|521851343|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
144725715|NCT04947579|521851344|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
144725716|NCT04947579|521851345|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
144725717|NCT04947579|521851346|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
144725718|NCT04947579|521851347|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
144725719|NCT04947579|521851342|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
144725720|NCT04947579|521851343|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
144725721|NCT04947579|521851344|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
144725722|NCT04947579|521851345|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
144725723|NCT04947579|521851346|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
144725724|NCT04947579|521851347|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
144725725|NCT04947579|521851342|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
144725726|NCT04947579|521851343|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
144725727|NCT04947579|521851344|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
144725728|NCT04947579|521851345|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
144725729|NCT04947579|521851346|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
144725730|NCT04947579|521851347|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
144725731|NCT04947579|521851342|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
144725732|NCT04947579|521851343|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
144725733|NCT04947579|521851344|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
144725734|NCT04947579|521851345|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
144725735|NCT04947579|521851346|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
144454072|NCT02347761|520860940|FG002|On Study Treatment|Adverse Event|20|||
144454073|NCT03879798|520860941|FG000|Overall Study|Adverse Event|0|||
144454074|NCT03879798|520860942|FG001|Overall Study|Adverse Event|0|||
144454075|NCT03879798|520860943|FG002|Overall Study|Adverse Event|0|||
144454076|NCT03879798|520860944|FG003|Overall Study|Adverse Event|0|||
144454077|NCT03879798|520860945|FG004|Overall Study|Adverse Event|0|||
144454078|NCT03879798|520860946|FG005|Overall Study|Adverse Event|1|||
144454079|NCT03879798|520860941|FG000|Overall Study|Lack of Efficacy|0|||
144454080|NCT03879798|520860942|FG001|Overall Study|Lack of Efficacy|0|||
144454081|NCT03879798|520860943|FG002|Overall Study|Lack of Efficacy|0|||
144454082|NCT03879798|520860944|FG003|Overall Study|Lack of Efficacy|0|||
144454083|NCT03879798|520860945|FG004|Overall Study|Lack of Efficacy|0|||
144454084|NCT03879798|520860946|FG005|Overall Study|Lack of Efficacy|1|||
144454085|NCT03879798|520860941|FG000|Overall Study|Withdrawal by Subject|0|||
144454086|NCT03879798|520860942|FG001|Overall Study|Withdrawal by Subject|0|||
144454087|NCT03879798|520860943|FG002|Overall Study|Withdrawal by Subject|0|||
144454088|NCT03879798|520860944|FG003|Overall Study|Withdrawal by Subject|0|||
144454089|NCT03879798|520860945|FG004|Overall Study|Withdrawal by Subject|0|||
144454090|NCT03879798|520860946|FG005|Overall Study|Withdrawal by Subject|1|||
144454091|NCT03264989|520860947|FG000|Overall Study|Lost to Follow-up|1|||
144454092|NCT03264989|520860948|FG001|Overall Study|Lost to Follow-up|0|||
144454093|NCT03264989|520860947|FG000|Overall Study|New Therapy for study Indication|1|||
144454094|NCT03264989|520860948|FG001|Overall Study|New Therapy for study Indication|0|||
144454095|NCT03264989|520860947|FG000|Overall Study|Protocol Violation|0|||
144454096|NCT03264989|520860948|FG001|Overall Study|Protocol Violation|1|||
144454097|NCT03264989|520860947|FG000|Overall Study|Patient decision|13|||
144454098|NCT03264989|520860948|FG001|Overall Study|Patient decision|0|||
144454099|NCT03264989|520860947|FG000|Overall Study|Physician Decision|6|||
144454100|NCT03264989|520860948|FG001|Overall Study|Physician Decision|4|||
144454101|NCT03264989|520860947|FG000|Overall Study|Adverse Event|2|||
144454102|NCT03264989|520860948|FG001|Overall Study|Adverse Event|1|||
144454103|NCT03264989|520860947|FG000|Overall Study|Death|1|||
144454104|NCT03264989|520860948|FG001|Overall Study|Death|1|||
144454105|NCT03264989|520860947|FG000|Overall Study|Pregnancy|2|||
144454106|NCT03264989|520860948|FG001|Overall Study|Pregnancy|0|||
144454107|NCT03264989|520860947|FG000|Overall Study|End of Study|19|||
144725736|NCT04947579|521851347|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
144725737|NCT04947579|521851342|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
144725738|NCT04947579|521851343|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
144725739|NCT04947579|521851344|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
144454108|NCT03264989|520860948|FG001|Overall Study|End of Study|5|||
144454109|NCT01343056|520860951|FG000|Overall Study|Lost to Follow-up|7|||
144454110|NCT01343056|520860952|FG001|Overall Study|Lost to Follow-up|5|||
144454111|NCT01343056|520860953|FG002|Overall Study|Lost to Follow-up|3|||
144454112|NCT01343056|520860954|FG003|Overall Study|Lost to Follow-up|9|||
144454113|NCT00345579|520860958|FG000|Overall Study|Adverse Event|9|||
144454114|NCT00345579|520860959|FG001|Overall Study|Adverse Event|6|||
144454115|NCT00345579|520860958|FG000|Overall Study|Protocol Violation|14|||
144454116|NCT00345579|520860959|FG001|Overall Study|Protocol Violation|5|||
144454117|NCT00345579|520860958|FG000|Overall Study|Withdrawal by Subject|50|||
144454118|NCT00345579|520860959|FG001|Overall Study|Withdrawal by Subject|17|||
144454119|NCT00345579|520860958|FG000|Overall Study|Lost to Follow-up|82|||
144454120|NCT00345579|520860959|FG001|Overall Study|Lost to Follow-up|36|||
144454121|NCT00345579|520860958|FG000|Overall Study|Other|9|||
144454122|NCT00345579|520860959|FG001|Overall Study|Other|1|||
144454123|NCT00413413|520860960|FG000|Single-Blind|Adverse Event|0|||
144454124|NCT00413413|520860961|FG001|Single-Blind|Adverse Event|9|||
144454125|NCT00413413|520860962|FG002|Single-Blind|Adverse Event|0|||
144454126|NCT00413413|520860960|FG000|Single-Blind|Lack of Efficacy|0|||
144454127|NCT00413413|520860961|FG001|Single-Blind|Lack of Efficacy|5|||
144454128|NCT00413413|520860962|FG002|Single-Blind|Lack of Efficacy|0|||
144454129|NCT00413413|520860960|FG000|Single-Blind|Subject no longer requires study drug|0|||
144254840|NCT00303472|520133464|FG004|Treatment Period|Disease Progression (to AML)|1|||
144254841|NCT00303472|520133465|FG005|Treatment Period|Disease Progression (to AML)|0|||
144254842|NCT00303472|520133466|FG006|Treatment Period|Disease Progression (to AML)|0|||
144254843|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Adverse Event|1|||
144254844|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Adverse Event|0|||
144254845|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Adverse Event|1|||
144254846|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Adverse Event|0|||
144254847|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Adverse Event|0|||
144254848|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Adverse Event|0|||
144254849|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Adverse Event|0|||
144254850|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Death|2|||
144254851|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Death|0|||
144607188|NCT01428661|521422673|FG002|Open Label Extension|Withdrawal by Subject|49|||
144607189|NCT01428661|521422671|FG000|Open Label Extension|Lack of Efficacy|0|||
144254852|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Death|1|||
144454130|NCT00413413|520860961|FG001|Single-Blind|Subject no longer requires study drug|151|||
144454131|NCT00413413|520860962|FG002|Single-Blind|Subject no longer requires study drug|0|||
144454132|NCT00413413|520860960|FG000|Single-Blind|Protocol Violation|0|||
144454133|NCT00413413|520860961|FG001|Single-Blind|Protocol Violation|16|||
144454134|NCT00413413|520860962|FG002|Single-Blind|Protocol Violation|0|||
144454135|NCT00413413|520860960|FG000|Single-Blind|Withdrawal by Subject|0|||
144454136|NCT00413413|520860961|FG001|Single-Blind|Withdrawal by Subject|27|||
144454137|NCT00413413|520860962|FG002|Single-Blind|Withdrawal by Subject|0|||
144454138|NCT00413413|520860960|FG000|Single-Blind|Lost to Follow-up|0|||
144454139|NCT00413413|520860961|FG001|Single-Blind|Lost to Follow-up|8|||
144454140|NCT00413413|520860962|FG002|Single-Blind|Lost to Follow-up|0|||
144454141|NCT00413413|520860960|FG000|Double-Blind|Adverse Event|6|||
144454142|NCT00413413|520860961|FG001|Double-Blind|Adverse Event|0|||
144454143|NCT00413413|520860962|FG002|Double-Blind|Adverse Event|5|||
144454144|NCT00413413|520860960|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
144454145|NCT00413413|520860961|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
144454146|NCT00413413|520860962|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
144454147|NCT00413413|520860960|FG000|Double-Blind|Protocol deviation|1|||
144454148|NCT00413413|520860961|FG001|Double-Blind|Protocol deviation|2|||
144454149|NCT00413413|520860962|FG002|Double-Blind|Protocol deviation|1|||
144454150|NCT00413413|520860960|FG000|Double-Blind|Subject withdrew consent|4|||
144454151|NCT00413413|520860961|FG001|Double-Blind|Subject withdrew consent|6|||
144454152|NCT00413413|520860962|FG002|Double-Blind|Subject withdrew consent|9|||
144454153|NCT00413413|520860960|FG000|Double-Blind|Lost to Follow-up|3|||
144454154|NCT00413413|520860961|FG001|Double-Blind|Lost to Follow-up|4|||
144454155|NCT00413413|520860962|FG002|Double-Blind|Lost to Follow-up|2|||
144454156|NCT01040130|520860963|FG000|Overall Study|Adverse Event|1|||
144454157|NCT01040130|520860964|FG001|Overall Study|Adverse Event|1|||
144454158|NCT01040130|520860965|FG002|Overall Study|Adverse Event|0|||
144454159|NCT01040130|520860966|FG003|Overall Study|Adverse Event|5|||
144454160|NCT01040130|520860967|FG004|Overall Study|Adverse Event|0|||
144454161|NCT01040130|520860968|FG005|Overall Study|Adverse Event|3|||
144454162|NCT01040130|520860963|FG000|Overall Study|Protocol Violation|0|||
144607190|NCT01428661|521422672|FG001|Open Label Extension|Lack of Efficacy|0|||
144607191|NCT01428661|521422673|FG002|Open Label Extension|Lack of Efficacy|24|||
144454163|NCT01040130|520860964|FG001|Overall Study|Protocol Violation|0|||
144454164|NCT01040130|520860965|FG002|Overall Study|Protocol Violation|2|||
144454165|NCT01040130|520860966|FG003|Overall Study|Protocol Violation|0|||
144454166|NCT01040130|520860967|FG004|Overall Study|Protocol Violation|0|||
144454167|NCT01040130|520860968|FG005|Overall Study|Protocol Violation|0|||
144607192|NCT01428661|521422671|FG000|Open Label Extension|**Various|0|||
144607193|NCT01428661|521422672|FG001|Open Label Extension|**Various|0|||
144254853|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Death|0|||
144254854|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Death|0|||
144454168|NCT01040130|520860963|FG000|Overall Study|Withdrawal by Subject|0|||
144454169|NCT01040130|520860964|FG001|Overall Study|Withdrawal by Subject|2|||
144454170|NCT01040130|520860965|FG002|Overall Study|Withdrawal by Subject|0|||
144454171|NCT01040130|520860966|FG003|Overall Study|Withdrawal by Subject|0|||
144454172|NCT01040130|520860967|FG004|Overall Study|Withdrawal by Subject|0|||
144454173|NCT01040130|520860968|FG005|Overall Study|Withdrawal by Subject|1|||
144454174|NCT01040130|520860963|FG000|Overall Study|Other reasons not listed above|2|||
144454175|NCT01040130|520860964|FG001|Overall Study|Other reasons not listed above|0|||
144454176|NCT01040130|520860965|FG002|Overall Study|Other reasons not listed above|0|||
144454177|NCT01040130|520860966|FG003|Overall Study|Other reasons not listed above|0|||
144454178|NCT01040130|520860967|FG004|Overall Study|Other reasons not listed above|0|||
144454179|NCT01040130|520860968|FG005|Overall Study|Other reasons not listed above|0|||
144454180|NCT03029208|520860969|FG000|Overall Study|Withdrawal by Subject|2|||
144454181|NCT03029208|520860970|FG001|Overall Study|Withdrawal by Subject|3|||
144454182|NCT03029208|520860969|FG000|Overall Study|Lost to Follow-up|0|||
144454183|NCT03029208|520860970|FG001|Overall Study|Lost to Follow-up|1|||
144454184|NCT03207750|520860973|FG000|Overall Study|Adverse Event|3|||
144454185|NCT03207750|520860974|FG001|Overall Study|Adverse Event|2|||
144454186|NCT03207750|520860973|FG000|Overall Study|Lost to Follow-up|21|||
144454187|NCT03207750|520860974|FG001|Overall Study|Lost to Follow-up|29|||
144454188|NCT03207750|520860973|FG000|Overall Study|Protocol Violation|0|||
144454189|NCT03207750|520860974|FG001|Overall Study|Protocol Violation|1|||
144454190|NCT03207750|520860973|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
144454191|NCT03207750|520860974|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
144454192|NCT03207750|520860973|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
144454193|NCT03207750|520860974|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
144454194|NCT03207750|520860973|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
144454195|NCT03207750|520860974|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
144454196|NCT03207750|520860973|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
144454197|NCT03207750|520860974|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
144454198|NCT03207750|520860973|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
144454199|NCT03207750|520860974|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
144454200|NCT01732835|520860975|FG000|6-month Primary Endpoint|Did not receive device|19|||
144454201|NCT01732835|520860975|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
144454202|NCT01732835|520860975|FG000|6-month Primary Endpoint|Adverse Event|3|||
144454203|NCT01732835|520860975|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
144607194|NCT01428661|521422673|FG002|Open Label Extension|**Various|185|||
144607195|NCT00382720|521424329|FG000|Overall Study|Adverse Event|21|||
144607196|NCT00382720|521424330|FG001|Overall Study|Adverse Event|23|||
144607197|NCT00382720|521424331|FG002|Overall Study|Adverse Event|15|||
144607198|NCT00382720|521424329|FG000|Overall Study|Protocol Violation|2|||
144607199|NCT00382720|521424330|FG001|Overall Study|Protocol Violation|5|||
144607200|NCT00382720|521424331|FG002|Overall Study|Protocol Violation|1|||
144607201|NCT00382720|521424329|FG000|Overall Study|Death|0|||
144607202|NCT00382720|521424330|FG001|Overall Study|Death|1|||
144607203|NCT00382720|521424331|FG002|Overall Study|Death|2|||
144607204|NCT00382720|521424329|FG000|Overall Study|Progressive disease|37|||
144607205|NCT00382720|521424330|FG001|Overall Study|Progressive disease|28|||
144607206|NCT00382720|521424331|FG002|Overall Study|Progressive disease|38|||
144607207|NCT00382720|521424329|FG000|Overall Study|Withdrew consent|1|||
144607208|NCT00382720|521424330|FG001|Overall Study|Withdrew consent|1|||
144607209|NCT00382720|521424331|FG002|Overall Study|Withdrew consent|2|||
144607210|NCT00382720|521424329|FG000|Overall Study|Withdrawal by Subject|11|||
144607211|NCT00382720|521424330|FG001|Overall Study|Withdrawal by Subject|20|||
144607212|NCT00382720|521424331|FG002|Overall Study|Withdrawal by Subject|12|||
144607213|NCT00382720|521424329|FG000|Overall Study|Surgery|1|||
144607214|NCT00382720|521424330|FG001|Overall Study|Surgery|1|||
144607215|NCT00382720|521424331|FG002|Overall Study|Surgery|4|||
144607216|NCT00382720|521424329|FG000|Overall Study|Patient did not receive study medication|1|||
144607217|NCT00382720|521424330|FG001|Overall Study|Patient did not receive study medication|1|||
144607218|NCT00382720|521424331|FG002|Overall Study|Patient did not receive study medication|4|||
144607219|NCT00382720|521424329|FG000|Overall Study|Clinically progressive disease|0|||
144607220|NCT00382720|521424330|FG001|Overall Study|Clinically progressive disease|1|||
144607221|NCT00382720|521424331|FG002|Overall Study|Clinically progressive disease|0|||
144607222|NCT00382720|521424329|FG000|Overall Study|Good prognosis|0|||
144607223|NCT00382720|521424330|FG001|Overall Study|Good prognosis|1|||
144607224|NCT00382720|521424331|FG002|Overall Study|Good prognosis|0|||
144607225|NCT00382720|521424329|FG000|Overall Study|Investigator/Clinical decision|5|||
144607226|NCT00382720|521424330|FG001|Overall Study|Investigator/Clinical decision|6|||
144607227|NCT00382720|521424331|FG002|Overall Study|Investigator/Clinical decision|6|||
144607228|NCT00382720|521424329|FG000|Overall Study|Discontinued at end of study|0|||
144607229|NCT00382720|521424330|FG001|Overall Study|Discontinued at end of study|1|||
144454204|NCT01732835|520860975|FG000|2-year Extended Follow-up|Adverse Event|3|||
144454205|NCT01732835|520860975|FG000|2-year Extended Follow-up|Death|1|||
144454206|NCT02334748|520860976|FG000|Overall Study|Adverse Event|1|||
144607230|NCT00382720|521424331|FG002|Overall Study|Discontinued at end of study|2|||
144196454|NCT01550744|519915152|FG000|Open-Label|Not all 3 study drug injections received|2|||
144196455|NCT01550744|519915153|FG001|Open-Label|Not all 3 study drug injections received|0|||
144196456|NCT01550744|519915154|FG002|Open-Label|Not all 3 study drug injections received|0|||
144196457|NCT01550744|519915152|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
144196458|NCT01550744|519915153|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
144196459|NCT01550744|519915154|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
144196460|NCT01550744|519915152|FG000|Open-Label|Other|1|||
144196461|NCT01550744|519915153|FG001|Open-Label|Other|0|||
144254855|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Death|0|||
144254856|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Death|0|||
144254857|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
144254858|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
144254859|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
144254860|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
144254861|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
144254862|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
144254863|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
144254864|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Physician Decision|0|||
144254865|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Physician Decision|4|||
144254866|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Physician Decision|2|||
144254867|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Physician Decision|3|||
144254868|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Physician Decision|2|||
144254869|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Physician Decision|0|||
144254870|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Physician Decision|0|||
144254871|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
144254872|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
144254873|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
144254874|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
144254875|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
144254876|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
144254877|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
144254878|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Other|0|||
144254879|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Other|2|||
144254880|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Other|4|||
144254881|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Other|2|||
144254882|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Other|1|||
144254883|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Other|0|||
144254884|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Other|0|||
144254885|NCT00303472|520133460|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
144254886|NCT00303472|520133461|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
144254887|NCT00303472|520133462|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
144254888|NCT00303472|520133463|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
144254889|NCT00303472|520133464|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
144254890|NCT00303472|520133465|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
144254891|NCT00303472|520133466|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
144254892|NCT02937636|520133471|FG000|Overall Study|Other (Not specified)|3|||
144254893|NCT02937636|520133472|FG001|Overall Study|Other (Not specified)|2|||
144254894|NCT00770913|520133473|FG000|Overall Study|Adverse Event|1|||
144254895|NCT00770913|520133474|FG001|Overall Study|Adverse Event|3|||
144254896|NCT00770913|520133475|FG002|Overall Study|Adverse Event|6|||
144254897|NCT00770913|520133473|FG000|Overall Study|Refusal to continue participation|6|||
144254898|NCT00770913|520133474|FG001|Overall Study|Refusal to continue participation|4|||
144254899|NCT00770913|520133475|FG002|Overall Study|Refusal to continue participation|5|||
144254900|NCT00770913|520133473|FG000|Overall Study|Physician Decision|0|||
144254901|NCT00770913|520133474|FG001|Overall Study|Physician Decision|1|||
144254902|NCT00770913|520133475|FG002|Overall Study|Physician Decision|1|||
144254903|NCT00770913|520133473|FG000|Overall Study|Protocol Violation|3|||
144254904|NCT00770913|520133474|FG001|Overall Study|Protocol Violation|0|||
144254905|NCT00770913|520133475|FG002|Overall Study|Protocol Violation|1|||
144254906|NCT00770913|520133473|FG000|Overall Study|Incorrect drug was allocated|1|||
144254907|NCT00770913|520133474|FG001|Overall Study|Incorrect drug was allocated|0|||
144254908|NCT00770913|520133475|FG002|Overall Study|Incorrect drug was allocated|0|||
144254909|NCT00359294|520133480|FG000|Overall Study|Progressive disease|1|||
144254910|NCT00359294|520133481|FG001|Overall Study|Progressive disease|1|||
144254911|NCT00359294|520133482|FG002|Overall Study|Progressive disease|2|||
144254912|NCT00359294|520133483|FG003|Overall Study|Progressive disease|3|||
144254913|NCT00359294|520133484|FG004|Overall Study|Progressive disease|2|||
144254914|NCT00359294|520133480|FG000|Overall Study|Withdrawal by Subject|0|||
144254915|NCT00359294|520133481|FG001|Overall Study|Withdrawal by Subject|0|||
144454207|NCT02334748|520860976|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
144196462|NCT01550744|519915154|FG002|Open-Label|Other|0|||
144254916|NCT00359294|520133482|FG002|Overall Study|Withdrawal by Subject|0|||
144607231|NCT02737852|521424334|FG000|Overall Study|Withdrawal by Subject|2|||
144607232|NCT04042740|521424336|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
144607233|NCT04042740|521424336|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
144607234|NCT04490395|521424337|FG000|Overall Study|Lost to Follow-up|0|||
144607235|NCT04490395|521424338|FG001|Overall Study|Lost to Follow-up|1|||
144607236|NCT02163187|521424343|FG000|Overall Study|Device removed|1|||
144607237|NCT02163187|521424344|FG001|Overall Study|Device removed|0|||
144607238|NCT02163187|521424343|FG000|Overall Study|Progressive disease|1|||
144607239|NCT02163187|521424344|FG001|Overall Study|Progressive disease|0|||
144454208|NCT02334748|520860976|FG000|Overall Study|Patient no longer required study drug|2|||
144454209|NCT02334748|520860976|FG000|Overall Study|Lack of Efficacy|4|||
144454210|NCT02493361|520860977|FG000|Overall Study|Withdrawal by Subject|3|||
144454211|NCT01046643|520860978|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
144454212|NCT01046643|520860979|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
144454213|NCT01046643|520860980|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
144454214|NCT01046643|520860981|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
144454215|NCT03893448|520860988|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
144454216|NCT03893448|520860989|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
144454217|NCT03893448|520860988|FG000|Overall Study|Physician Decision|8|||
144454218|NCT03893448|520860989|FG001|Overall Study|Physician Decision|14|||
144454219|NCT03893448|520860988|FG000|Overall Study|Lost to Follow-up|34|||
144454220|NCT03893448|520860989|FG001|Overall Study|Lost to Follow-up|27|||
144454221|NCT03893448|520860988|FG000|Overall Study|Death|1|||
144454222|NCT03893448|520860989|FG001|Overall Study|Death|0|||
144454223|NCT04102501|520861002|FG000|Overall Study|Withdrawal by Subject|7|||
144454224|NCT04102501|520861003|FG001|Overall Study|Withdrawal by Subject|9|||
144454225|NCT04102501|520861002|FG000|Overall Study|Adverse Event|1|||
144454226|NCT04102501|520861003|FG001|Overall Study|Adverse Event|3|||
144454227|NCT02338362|520861004|FG000|Overall Study|Withdrawal by Subject|1|||
144454228|NCT02338362|520861005|FG001|Overall Study|Withdrawal by Subject|1|||
144454229|NCT04798586|520861007|FG000|Overall Study|Death|2|||
144607240|NCT03281668|521424345|FG000|Overall Study|Physician Decision|1|||
144607241|NCT03281668|521424345|FG000|Overall Study|scheduling conflict, family circumstance|2|||
144607242|NCT03281668|521424345|FG000|Overall Study|Withdrawal by Subject|4|||
144725740|NCT04947579|521851345|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
144725741|NCT04947579|521851346|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
144196463|NCT01550744|519915152|FG000|Double-Blind|Lost to Follow-up|0|||
144454230|NCT04433767|520861009|FG000|Overall Study|Adverse Event|1|||
144454231|NCT02371369|520861014|FG000|Part 1|Physician Decision|0|||
144454232|NCT02371369|520861015|FG001|Part 1|Physician Decision|3|||
144454233|NCT02371369|520861014|FG000|Part 1|Adverse Event|8|||
144196464|NCT01550744|519915153|FG001|Double-Blind|Lost to Follow-up|6|||
144196465|NCT01550744|519915154|FG002|Double-Blind|Lost to Follow-up|12|||
144196466|NCT01550744|519915152|FG000|Double-Blind|Withdrawal by Subject|0|||
144196467|NCT01550744|519915153|FG001|Double-Blind|Withdrawal by Subject|2|||
144196468|NCT01550744|519915154|FG002|Double-Blind|Withdrawal by Subject|15|||
144196469|NCT01550744|519915152|FG000|Double-Blind|Adverse Event|0|||
144196470|NCT01550744|519915153|FG001|Double-Blind|Adverse Event|4|||
144196471|NCT01550744|519915154|FG002|Double-Blind|Adverse Event|15|||
144196472|NCT01550744|519915152|FG000|Double-Blind|Death|0|||
144196473|NCT01550744|519915153|FG001|Double-Blind|Death|1|||
144196474|NCT01550744|519915154|FG002|Double-Blind|Death|0|||
144196475|NCT01550744|519915152|FG000|Double-Blind|Lack of Efficacy|0|||
144196476|NCT01550744|519915153|FG001|Double-Blind|Lack of Efficacy|2|||
144196477|NCT01550744|519915154|FG002|Double-Blind|Lack of Efficacy|8|||
144196478|NCT01550744|519915152|FG000|Double-Blind|Protocol Violation|0|||
144196479|NCT01550744|519915153|FG001|Double-Blind|Protocol Violation|0|||
144196480|NCT01550744|519915154|FG002|Double-Blind|Protocol Violation|4|||
144196481|NCT01550744|519915152|FG000|Double-Blind|Pregnancy|0|||
144196482|NCT01550744|519915153|FG001|Double-Blind|Pregnancy|0|||
144196483|NCT01550744|519915154|FG002|Double-Blind|Pregnancy|3|||
144196484|NCT01550744|519915152|FG000|Double-Blind|Other|0|||
144196485|NCT01550744|519915153|FG001|Double-Blind|Other|2|||
144196486|NCT01550744|519915154|FG002|Double-Blind|Other|10|||
144196487|NCT00706381|519915157|FG000|Overall Study|Lost to Follow-up|0|||
144196488|NCT00706381|519915158|FG001|Overall Study|Lost to Follow-up|1|||
144196489|NCT00706381|519915159|FG002|Overall Study|Lost to Follow-up|1|||
144196490|NCT00706381|519915160|FG003|Overall Study|Lost to Follow-up|0|||
144196491|NCT04355663|519915161|FG000|Overall Study|Physician Decision|2|||
144196492|NCT04355663|519915162|FG001|Overall Study|Physician Decision|7|||
144196493|NCT04355663|519915163|FG002|Overall Study|Physician Decision|0|||
144196494|NCT04355663|519915161|FG000|Overall Study|Adverse Event|0|||
144196495|NCT04355663|519915162|FG001|Overall Study|Adverse Event|0|||
144196496|NCT04355663|519915163|FG002|Overall Study|Adverse Event|1|||
144196497|NCT04355663|519915161|FG000|Overall Study|Withdrawal by Subject|0|||
144196498|NCT04355663|519915162|FG001|Overall Study|Withdrawal by Subject|8|||
144196499|NCT04355663|519915163|FG002|Overall Study|Withdrawal by Subject|3|||
144607243|NCT03281668|521424345|FG000|Overall Study|Lost to Follow-up|1|||
144607244|NCT00762892|521424352|FG000|Overall Study|Lost to Follow-up|2|||
144607245|NCT00762892|521424353|FG001|Overall Study|Lost to Follow-up|5|||
144454234|NCT02371369|520861015|FG001|Part 1|Adverse Event|0|||
144454235|NCT02371369|520861014|FG000|Part 1|Withdrawal by Subject|1|||
144454236|NCT02371369|520861015|FG001|Part 1|Withdrawal by Subject|6|||
144454237|NCT02371369|520861014|FG000|Part 1|Disease progression|0|||
144454238|NCT02371369|520861015|FG001|Part 1|Disease progression|1|||
144454239|NCT02371369|520861014|FG000|Part 1|Protocol Violation|0|||
144454240|NCT02371369|520861015|FG001|Part 1|Protocol Violation|1|||
144454241|NCT02371369|520861014|FG000|Part 2|Adverse Event|6|||
144454242|NCT02371369|520861015|FG001|Part 2|Adverse Event|5|||
144454243|NCT02371369|520861014|FG000|Part 2|Withdrawal by Subject|16|||
144454244|NCT02371369|520861015|FG001|Part 2|Withdrawal by Subject|6|||
144454245|NCT02371369|520861014|FG000|Part 2|Investigator decision|1|||
144454246|NCT02371369|520861015|FG001|Part 2|Investigator decision|2|||
144454247|NCT02371369|520861014|FG000|Part 2|Death|0|||
144454248|NCT02371369|520861015|FG001|Part 2|Death|1|||
144454249|NCT02371369|520861014|FG000|Part 2|Disease progression|1|||
144454250|NCT02371369|520861015|FG001|Part 2|Disease progression|0|||
144454251|NCT02371369|520861014|FG000|Part 2|Subject Noncompliance|1|||
144454252|NCT02371369|520861015|FG001|Part 2|Subject Noncompliance|0|||
144454253|NCT02371369|520861014|FG000|Part 2|Lost to Follow-up|1|||
144454254|NCT02371369|520861015|FG001|Part 2|Lost to Follow-up|1|||
144454255|NCT02371369|520861014|FG000|Part 2|Subject transitioned to commercial supply|6|||
144454256|NCT02371369|520861015|FG001|Part 2|Subject transitioned to commercial supply|4|||
144454257|NCT02371369|520861014|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
144454258|NCT02371369|520861015|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
144454259|NCT02371369|520861014|FG000|Part 2|Surgical resection of tumor|1|||
144454260|NCT02371369|520861015|FG001|Part 2|Surgical resection of tumor|1|||
144454261|NCT02371369|520861014|FG000|Part 2|Other|0|||
144454262|NCT02371369|520861015|FG001|Part 2|Other|1|||
144454263|NCT06281548|520861018|FG000|Overall Study|Lost to Follow-up|3|||
144454264|NCT01618838|520861019|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
144454265|NCT01764945|520861020|FG000|Overall Study|Adverse Event|0|||
144454266|NCT01764945|520861021|FG001|Overall Study|Adverse Event|1|||
144454267|NCT01764945|520861022|FG002|Overall Study|Adverse Event|0|||
144454268|NCT01764945|520861023|FG003|Overall Study|Adverse Event|0|||
144454269|NCT01764945|520861024|FG004|Overall Study|Adverse Event|0|||
144454270|NCT01764945|520861025|FG005|Overall Study|Adverse Event|0|||
144454271|NCT01764945|520861026|FG006|Overall Study|Adverse Event|1|||
144454272|NCT01764945|520861027|FG007|Overall Study|Adverse Event|0|||
144607246|NCT00762892|521424352|FG000|Overall Study|Withdrawal by Subject|0|||
144607247|NCT00762892|521424353|FG001|Overall Study|Withdrawal by Subject|1|||
144607248|NCT00762892|521424352|FG000|Overall Study|Death|1|||
144607249|NCT00762892|521424353|FG001|Overall Study|Death|0|||
144607250|NCT00762892|521424352|FG000|Overall Study|Pregnancy|1|||
144607251|NCT00762892|521424353|FG001|Overall Study|Pregnancy|0|||
144607252|NCT00762892|521424352|FG000|Overall Study|Incarceration|1|||
144607253|NCT00762892|521424353|FG001|Overall Study|Incarceration|0|||
144607254|NCT01841749|521424360|FG000|Overall Study|Protocol Violation|1|||
144607255|NCT02285920|521424361|FG000|Overall Study|Kidney transplantation|2|||
144607256|NCT02285920|521424362|FG001|Overall Study|Kidney transplantation|2|||
144607257|NCT02285920|521424363|FG002|Overall Study|Kidney transplantation|2|||
144607258|NCT02285920|521424364|FG003|Overall Study|Kidney transplantation|0|||
144607259|NCT02285920|521424361|FG000|Overall Study|Change to peritoneal dialysis|0|||
144607260|NCT02285920|521424362|FG001|Overall Study|Change to peritoneal dialysis|0|||
144607261|NCT02285920|521424363|FG002|Overall Study|Change to peritoneal dialysis|1|||
144607262|NCT02285920|521424364|FG003|Overall Study|Change to peritoneal dialysis|0|||
144607263|NCT02285920|521424361|FG000|Overall Study|Transfer to non-participating unit|0|||
144607264|NCT02285920|521424362|FG001|Overall Study|Transfer to non-participating unit|1|||
144607265|NCT02285920|521424363|FG002|Overall Study|Transfer to non-participating unit|0|||
144607266|NCT02285920|521424364|FG003|Overall Study|Transfer to non-participating unit|0|||
144607267|NCT02285920|521424361|FG000|Overall Study|Dialysis discontinuation|0|||
144607268|NCT02285920|521424362|FG001|Overall Study|Dialysis discontinuation|1|||
144607269|NCT02285920|521424363|FG002|Overall Study|Dialysis discontinuation|0|||
144454273|NCT01587651|520861030|FG000|Overall Study|Adverse Event|0|||
144454274|NCT01587651|520861031|FG001|Overall Study|Adverse Event|1|||
144607270|NCT02285920|521424364|FG003|Overall Study|Dialysis discontinuation|0|||
144454275|NCT01587651|520861032|FG002|Overall Study|Adverse Event|0|||
144454276|NCT01587651|520861030|FG000|Overall Study|Protocol Violation|0|||
144454277|NCT01587651|520861031|FG001|Overall Study|Protocol Violation|1|||
144454278|NCT01587651|520861032|FG002|Overall Study|Protocol Violation|1|||
144454279|NCT01587651|520861030|FG000|Overall Study|Withdrawal by Subject|0|||
144454280|NCT01587651|520861031|FG001|Overall Study|Withdrawal by Subject|1|||
144454281|NCT01587651|520861032|FG002|Overall Study|Withdrawal by Subject|0|||
144454282|NCT01136291|520861034|FG000|Overall Study|Lost to Follow-up|1|||
144454283|NCT01136291|520861035|FG001|Overall Study|Lost to Follow-up|1|||
144607271|NCT02285920|521424361|FG000|Overall Study|Death|2|||
144454284|NCT03165045|520861043|FG000|Visit 1|No registration after visit 1|9|||
144454285|NCT03165045|520861043|FG000|Visit 1|No treatment documented|10|||
144454286|NCT03165045|520861043|FG000|Visit 1|No visit 1|10|||
144454287|NCT03165045|520861043|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
144454288|NCT03165045|520861043|FG000|Visit 2|No available total CCQ score at all|29|||
144454289|NCT03165045|520861043|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
144454290|NCT00499889|520861047|FG000|Overall Study|Infection prior to treatment|1|||
144454291|NCT04782323|520861048|FG000|Overall Study|Death|1|||
144454292|NCT04782323|520861049|FG001|Overall Study|Death|0|||
144454293|NCT04782323|520861050|FG002|Overall Study|Death|0|||
144454294|NCT04782323|520861051|FG003|Overall Study|Death|0|||
144454295|NCT04782323|520861052|FG004|Overall Study|Death|1|||
144725742|NCT04947579|521851347|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
144725743|NCT04947579|521851342|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
144725744|NCT04947579|521851343|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
144725745|NCT04947579|521851344|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
144725746|NCT04947579|521851345|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
144725747|NCT04947579|521851346|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
144725748|NCT04947579|521851347|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
144725749|NCT00634179|521851350|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
144725750|NCT04272801|521851351|FG000|Overall Study|Withdrawal by Subject|4|||
144725751|NCT04272801|521851351|FG000|Overall Study|Lost to Follow-up|4|||
144725752|NCT04272801|521851351|FG000|Overall Study|Ineligible|1|||
144454296|NCT04782323|520861053|FG005|Overall Study|Death|1|||
144454297|NCT04782323|520861054|FG006|Overall Study|Death|1|||
144454298|NCT04782323|520861055|FG007|Overall Study|Death|0|||
144454299|NCT04782323|520861048|FG000|Overall Study|Withdrawal by Subject|0|||
144454300|NCT04782323|520861049|FG001|Overall Study|Withdrawal by Subject|0|||
144454301|NCT04782323|520861050|FG002|Overall Study|Withdrawal by Subject|1|||
144454302|NCT04782323|520861051|FG003|Overall Study|Withdrawal by Subject|0|||
144454303|NCT04782323|520861052|FG004|Overall Study|Withdrawal by Subject|0|||
144454304|NCT04782323|520861053|FG005|Overall Study|Withdrawal by Subject|1|||
144454305|NCT04782323|520861054|FG006|Overall Study|Withdrawal by Subject|0|||
144454306|NCT04782323|520861055|FG007|Overall Study|Withdrawal by Subject|1|||
144454307|NCT04782323|520861048|FG000|Overall Study|Lost to Follow-up|0|||
144454308|NCT04782323|520861049|FG001|Overall Study|Lost to Follow-up|1|||
144454309|NCT04782323|520861050|FG002|Overall Study|Lost to Follow-up|1|||
144454310|NCT04782323|520861051|FG003|Overall Study|Lost to Follow-up|0|||
144454311|NCT04782323|520861052|FG004|Overall Study|Lost to Follow-up|0|||
144725753|NCT00475020|521851352|FG000|Overall Study|Physician Decision|3|||
144725754|NCT00475020|521851352|FG000|Overall Study|Insurance Denial|1|||
144725755|NCT00475020|521851352|FG000|Overall Study|Donor not able to donate the last minute|1|||
144725756|NCT02456909|521851353|FG000|Overall Study|Did not receive allocated intervention|24|||
144725757|NCT02456909|521851354|FG001|Overall Study|Did not receive allocated intervention|26|||
144725758|NCT02456909|521851353|FG000|Overall Study|Did not complete the primary outcome|0|||
144725759|NCT02456909|521851354|FG001|Overall Study|Did not complete the primary outcome|1|||
144725760|NCT01575054|521851355|FG000|Overall Study|Other Reasons|5|||
144725761|NCT01575054|521851356|FG001|Overall Study|Other Reasons|3|||
144196500|NCT00038649|519915169|FG000|Overall Study|Adverse Event|9|||
144196501|NCT03395639|519915170|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
144196502|NCT03395639|519915171|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
144196503|NCT03395639|519915172|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
144196504|NCT03395639|519915170|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
144196505|NCT03395639|519915171|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
144196506|NCT03395639|519915172|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
144196507|NCT03395639|519915170|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
144454312|NCT04782323|520861053|FG005|Overall Study|Lost to Follow-up|1|||
144454313|NCT04782323|520861054|FG006|Overall Study|Lost to Follow-up|1|||
144454314|NCT04782323|520861055|FG007|Overall Study|Lost to Follow-up|2|||
144454315|NCT04782323|520861048|FG000|Overall Study|randomization in error|1|||
144725762|NCT01575054|521851355|FG000|Overall Study|Protocol Violation|2|||
144725763|NCT01575054|521851356|FG001|Overall Study|Protocol Violation|1|||
144725764|NCT01575054|521851355|FG000|Overall Study|Personal Reasons|10|||
144725765|NCT01575054|521851356|FG001|Overall Study|Personal Reasons|11|||
144454316|NCT04782323|520861049|FG001|Overall Study|randomization in error|0|||
144454317|NCT04782323|520861050|FG002|Overall Study|randomization in error|0|||
144454318|NCT04782323|520861051|FG003|Overall Study|randomization in error|0|||
144454319|NCT04782323|520861052|FG004|Overall Study|randomization in error|0|||
144454320|NCT04782323|520861053|FG005|Overall Study|randomization in error|0|||
144454321|NCT04782323|520861054|FG006|Overall Study|randomization in error|0|||
144725766|NCT01575054|521851355|FG000|Overall Study|Lost to Follow-up|3|||
144725767|NCT01575054|521851356|FG001|Overall Study|Lost to Follow-up|3|||
144725768|NCT01575054|521851355|FG000|Overall Study|Adverse Event|9|||
144725769|NCT01575054|521851356|FG001|Overall Study|Adverse Event|8|||
144196508|NCT03395639|519915171|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
144196509|NCT03395639|519915172|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
144196510|NCT03395639|519915170|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
144454322|NCT04782323|520861055|FG007|Overall Study|randomization in error|0|||
144454323|NCT00927927|520861058|FG000|Overall Study|Withdrawal by Subject|0|||
144454324|NCT00927927|520861059|FG001|Overall Study|Withdrawal by Subject|0|||
144454325|NCT00927927|520861060|FG002|Overall Study|Withdrawal by Subject|0|||
144454326|NCT00927927|520861061|FG003|Overall Study|Withdrawal by Subject|0|||
144454327|NCT00927927|520861062|FG004|Overall Study|Withdrawal by Subject|0|||
144454328|NCT00927927|520861063|FG005|Overall Study|Withdrawal by Subject|0|||
144454329|NCT00927927|520861064|FG006|Overall Study|Withdrawal by Subject|0|||
144454330|NCT00927927|520861065|FG007|Overall Study|Withdrawal by Subject|2|||
144454331|NCT00927927|520861066|FG008|Overall Study|Withdrawal by Subject|0|||
144454332|NCT00927927|520861067|FG009|Overall Study|Withdrawal by Subject|0|||
144454333|NCT00927927|520861068|FG010|Overall Study|Withdrawal by Subject|0|||
144454334|NCT00927927|520861069|FG011|Overall Study|Withdrawal by Subject|2|||
144454335|NCT00927927|520861070|FG012|Overall Study|Withdrawal by Subject|0|||
144454336|NCT00927927|520861071|FG013|Overall Study|Withdrawal by Subject|0|||
144454337|NCT00927927|520861072|FG014|Overall Study|Withdrawal by Subject|0|||
144454338|NCT01660906|520861073|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
144454339|NCT03478891|520861075|FG000|Overall Study|Enrolled, but product never administered|0|||
144454340|NCT03478891|520861076|FG001|Overall Study|Enrolled, but product never administered|0|||
144454341|NCT03478891|520861077|FG002|Overall Study|Enrolled, but product never administered|1|||
144454342|NCT03478891|520861075|FG000|Overall Study|Moved from area|0|||
144454343|NCT03478891|520861076|FG001|Overall Study|Moved from area|0|||
144454344|NCT03478891|520861077|FG002|Overall Study|Moved from area|1|||
144454345|NCT03478891|520861075|FG000|Overall Study|Lost to Follow-up|1|||
144454346|NCT03478891|520861076|FG001|Overall Study|Lost to Follow-up|0|||
144454347|NCT03478891|520861077|FG002|Overall Study|Lost to Follow-up|1|||
144454348|NCT03823651|520861080|FG000|Overall Study|Death|5|||
144454349|NCT03823651|520861081|FG001|Overall Study|Death|0|||
144454350|NCT03823651|520861080|FG000|Overall Study|Physician Decision|1|||
144454351|NCT03823651|520861081|FG001|Overall Study|Physician Decision|0|||
144454352|NCT03823651|520861080|FG000|Overall Study|Caregiver to patient who died|0|||
144454353|NCT03823651|520861081|FG001|Overall Study|Caregiver to patient who died|5|||
144454354|NCT03823651|520861080|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
144454355|NCT03823651|520861081|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
144454356|NCT01850004|520861082|FG000|Overall Study|Poor/Non-compliance|1|||
144454357|NCT01850004|520861082|FG000|Overall Study|Participant Withdrew Consent|9|||
144454358|NCT01850004|520861082|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
144454359|NCT01850004|520861082|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
144454360|NCT01850004|520861082|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
144454361|NCT01850004|520861082|FG000|Overall Study|Other Reasons|2|||
144454362|NCT01850004|520861082|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
144454363|NCT01850004|520861082|FG000|Overall Study|Maximum Clinical Benefit|4|||
144454364|NCT05350449|520861083|FG000|Overall Study|Withdrawal by Subject|4|||
144607272|NCT02285920|521424362|FG001|Overall Study|Death|0|||
144607273|NCT02285920|521424363|FG002|Overall Study|Death|2|||
144607274|NCT02285920|521424364|FG003|Overall Study|Death|1|||
144607275|NCT00677820|521424365|FG000|Overall Study|Lost to Follow-up|1|||
144607276|NCT00677820|521424366|FG001|Overall Study|Lost to Follow-up|0|||
144607277|NCT01641237|521424374|FG000|Period II|Withdrawal by Subject|1|||
144607278|NCT01641237|521424375|FG001|Period II|Withdrawal by Subject|0|||
144607279|NCT01641237|521424376|FG002|Period II|Withdrawal by Subject|0|||
144607280|NCT01641237|521424377|FG003|Period II|Withdrawal by Subject|0|||
144607281|NCT01641237|521424374|FG000|Period III|Lost to Follow-up|1|||
144607282|NCT01641237|521424375|FG001|Period III|Lost to Follow-up|0|||
144607283|NCT01641237|521424376|FG002|Period III|Lost to Follow-up|0|||
144607284|NCT01641237|521424377|FG003|Period III|Lost to Follow-up|0|||
144607285|NCT02716675|521424378|FG000|Overall Study|Death|2|||
144607286|NCT02716675|521424379|FG001|Overall Study|Death|3|||
144454365|NCT05350449|520861084|FG001|Overall Study|Withdrawal by Subject|8|||
144607287|NCT02716675|521424380|FG002|Overall Study|Death|0|||
144607288|NCT02716675|521424378|FG000|Overall Study|Physician Decision|2|||
144196511|NCT03395639|519915171|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
144196512|NCT03395639|519915172|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
144259296|NCT01089127|520150357|FG003|Overall Study|Lost to Follow-up|0|||
144454366|NCT00993447|520862902|FG000|Overall Study|Withdrawal by Subject|23|||
144454367|NCT00993447|520862903|FG001|Overall Study|Withdrawal by Subject|8|||
144454368|NCT00993447|520862902|FG000|Overall Study|Protocol Violation|12|||
144454369|NCT00993447|520862903|FG001|Overall Study|Protocol Violation|8|||
144454370|NCT00993447|520862902|FG000|Overall Study|Lost to Follow-up|1|||
144607289|NCT02716675|521424379|FG001|Overall Study|Physician Decision|1|||
144607290|NCT02716675|521424380|FG002|Overall Study|Physician Decision|1|||
144607291|NCT02716675|521424378|FG000|Overall Study|Lost to Follow-up|100|||
144533743|NCT05007080|521157771|FG002|Overall Study|Withdrawal by Subject|0|||
144533744|NCT05007080|521157772|FG003|Overall Study|Withdrawal by Subject|2|||
144533745|NCT05007080|521157773|FG004|Overall Study|Withdrawal by Subject|1|||
144725770|NCT03481309|521851357|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
144725771|NCT03481309|521851358|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
144725772|NCT03481309|521851359|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
144725773|NCT03481309|521851360|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
144725774|NCT03481309|521851361|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
144725775|NCT03481309|521851362|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
144725776|NCT01611090|521851365|FG000|Randomized Period|Lost to Follow-up|8|||
144725777|NCT01611090|521851366|FG001|Randomized Period|Lost to Follow-up|3|||
144725778|NCT01611090|521851367|FG002|Randomized Period|Lost to Follow-up|0|||
144725779|NCT01611090|521851365|FG000|Randomized Period|Withdrawal by Subject|22|||
144196513|NCT03395639|519915170|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
144196514|NCT03395639|519915171|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
144196515|NCT03395639|519915172|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
144196516|NCT00995085|519915176|FG000|Overall Study|Withdrawal by Subject|5|||
144196517|NCT02595008|519915180|FG000|Overall Study|Enrolled In Error|1|||
144196518|NCT02595008|519915181|FG001|Overall Study|Enrolled In Error|0|||
144196519|NCT03407118|519915182|FG000|Period 2|Withdrawal by Subject|1|||
144196520|NCT03407118|519915183|FG001|Period 2|Withdrawal by Subject|0|||
144196521|NCT04700280|519915186|FG000|Overall Study|Adverse Event|4|||
144196522|NCT04700280|519915187|FG001|Overall Study|Adverse Event|0|||
144196523|NCT04700280|519915186|FG000|Overall Study|Lack of Efficacy|1|||
144196524|NCT04700280|519915187|FG001|Overall Study|Lack of Efficacy|0|||
144196525|NCT04700280|519915186|FG000|Overall Study|Study terminated by sponsor|5|||
144196526|NCT04700280|519915187|FG001|Overall Study|Study terminated by sponsor|3|||
144196527|NCT04700280|519915186|FG000|Overall Study|Other than specified|1|||
144196528|NCT04700280|519915187|FG001|Overall Study|Other than specified|0|||
144196529|NCT02093221|519915190|FG000|Overall Study|Adverse Event|1|||
144196530|NCT02093221|519915191|FG001|Overall Study|Adverse Event|0|||
144196531|NCT02093221|519915192|FG002|Overall Study|Adverse Event|0|||
144196532|NCT02093221|519915193|FG003|Overall Study|Adverse Event|0|||
144196533|NCT02093221|519915194|FG004|Overall Study|Adverse Event|0|||
144196534|NCT02093221|519915190|FG000|Overall Study|Withdrawal by Subject|1|||
144196535|NCT02093221|519915191|FG001|Overall Study|Withdrawal by Subject|1|||
144196536|NCT02093221|519915192|FG002|Overall Study|Withdrawal by Subject|4|||
144196537|NCT02093221|519915193|FG003|Overall Study|Withdrawal by Subject|1|||
144196538|NCT02093221|519915194|FG004|Overall Study|Withdrawal by Subject|1|||
144196539|NCT02093221|519915190|FG000|Overall Study|Lost to Follow-up|2|||
144196540|NCT02093221|519915191|FG001|Overall Study|Lost to Follow-up|0|||
144196541|NCT02093221|519915192|FG002|Overall Study|Lost to Follow-up|1|||
144196542|NCT02093221|519915193|FG003|Overall Study|Lost to Follow-up|1|||
144196543|NCT02093221|519915194|FG004|Overall Study|Lost to Follow-up|0|||
144196544|NCT02093221|519915190|FG000|Overall Study|Death|0|||
144196545|NCT02093221|519915191|FG001|Overall Study|Death|1|||
144196546|NCT02093221|519915192|FG002|Overall Study|Death|0|||
144196547|NCT02093221|519915193|FG003|Overall Study|Death|0|||
144196548|NCT02093221|519915194|FG004|Overall Study|Death|0|||
144196549|NCT02093221|519915190|FG000|Overall Study|Protocol Violation|0|||
144196550|NCT02093221|519915191|FG001|Overall Study|Protocol Violation|1|||
144196551|NCT02093221|519915192|FG002|Overall Study|Protocol Violation|0|||
144196552|NCT02093221|519915193|FG003|Overall Study|Protocol Violation|0|||
144196553|NCT02093221|519915194|FG004|Overall Study|Protocol Violation|0|||
144196554|NCT02093221|519915190|FG000|Overall Study|Study termination|6|||
144196555|NCT02093221|519915191|FG001|Overall Study|Study termination|5|||
144196556|NCT02093221|519915192|FG002|Overall Study|Study termination|4|||
144196557|NCT02093221|519915193|FG003|Overall Study|Study termination|6|||
144196558|NCT02093221|519915194|FG004|Overall Study|Study termination|7|||
144196559|NCT00257920|519915195|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
144196560|NCT00257920|519915196|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
144196561|NCT00257920|519915195|FG000|Period: Second Intervention|Other|2|||
144196562|NCT00257920|519915196|FG001|Period: Second Intervention|Other|1|||
144196563|NCT00770692|519915197|FG000|Overall Study|Withdrawal by Subject|7|||
144196564|NCT00770692|519915198|FG001|Overall Study|Withdrawal by Subject|9|||
144196565|NCT00770692|519915199|FG002|Overall Study|Withdrawal by Subject|9|||
144533746|NCT05007080|521157774|FG005|Overall Study|Withdrawal by Subject|1|||
144196566|NCT00770692|519915200|FG003|Overall Study|Withdrawal by Subject|6|||
144196567|NCT00770692|519915197|FG000|Overall Study|Adverse Event|3|||
144196568|NCT00770692|519915198|FG001|Overall Study|Adverse Event|0|||
144196569|NCT00770692|519915199|FG002|Overall Study|Adverse Event|4|||
144196570|NCT00770692|519915200|FG003|Overall Study|Adverse Event|4|||
144196571|NCT00770692|519915197|FG000|Overall Study|Investigator judgment|2|||
144196572|NCT00770692|519915198|FG001|Overall Study|Investigator judgment|0|||
144196573|NCT00770692|519915199|FG002|Overall Study|Investigator judgment|1|||
144196574|NCT00770692|519915200|FG003|Overall Study|Investigator judgment|1|||
144196575|NCT03629028|519915201|FG000|Overall Study|Lost to Follow-up|26|||
144607292|NCT02716675|521424379|FG001|Overall Study|Lost to Follow-up|87|||
144607293|NCT02716675|521424380|FG002|Overall Study|Lost to Follow-up|99|||
144607294|NCT02716675|521424378|FG000|Overall Study|Withdrawal by Subject|22|||
144607295|NCT02716675|521424379|FG001|Overall Study|Withdrawal by Subject|25|||
144607296|NCT02716675|521424380|FG002|Overall Study|Withdrawal by Subject|20|||
144607297|NCT02716675|521424378|FG000|Overall Study|Protocol Violation|0|||
144607298|NCT02716675|521424379|FG001|Overall Study|Protocol Violation|3|||
144607299|NCT02716675|521424380|FG002|Overall Study|Protocol Violation|1|||
144454371|NCT00993447|520862903|FG001|Overall Study|Lost to Follow-up|3|||
144454372|NCT00993447|520862902|FG000|Overall Study|Adverse Event|1|||
144454373|NCT00993447|520862903|FG001|Overall Study|Adverse Event|0|||
144454374|NCT00970502|520862904|FG000|Overall Study|Withdrawal by Subject|1|||
144454375|NCT02041195|520862905|FG000|Overall Study|Adverse Event|1|||
144454376|NCT02041195|520862906|FG001|Overall Study|Adverse Event|2|||
144454377|NCT02041195|520862907|FG002|Overall Study|Adverse Event|0|||
144454378|NCT02041195|520862908|FG003|Overall Study|Adverse Event|0|||
144454379|NCT02041195|520862909|FG004|Overall Study|Adverse Event|0|||
144454380|NCT02041195|520862910|FG005|Overall Study|Adverse Event|0|||
144454381|NCT02041195|520862911|FG006|Overall Study|Adverse Event|3|||
144454382|NCT02041195|520862912|FG007|Overall Study|Adverse Event|0|||
144454383|NCT02041195|520862905|FG000|Overall Study|Withdrawal by Subject|1|||
144454384|NCT02041195|520862906|FG001|Overall Study|Withdrawal by Subject|0|||
144454385|NCT02041195|520862907|FG002|Overall Study|Withdrawal by Subject|0|||
144454386|NCT02041195|520862908|FG003|Overall Study|Withdrawal by Subject|0|||
144454387|NCT02041195|520862909|FG004|Overall Study|Withdrawal by Subject|0|||
144454388|NCT02041195|520862910|FG005|Overall Study|Withdrawal by Subject|0|||
144454389|NCT02041195|520862911|FG006|Overall Study|Withdrawal by Subject|4|||
144454390|NCT02041195|520862912|FG007|Overall Study|Withdrawal by Subject|3|||
144454391|NCT02041195|520862905|FG000|Overall Study|Unable to comply with study visits|0|||
144454392|NCT02041195|520862906|FG001|Overall Study|Unable to comply with study visits|1|||
144454393|NCT02041195|520862907|FG002|Overall Study|Unable to comply with study visits|0|||
144454394|NCT02041195|520862908|FG003|Overall Study|Unable to comply with study visits|0|||
144607300|NCT02716675|521424378|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
144607301|NCT02716675|521424379|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
144607302|NCT02716675|521424380|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
144607303|NCT02716675|521424378|FG000|Overall Study|Other|38|||
144607304|NCT02716675|521424379|FG001|Overall Study|Other|47|||
144607305|NCT02716675|521424380|FG002|Overall Study|Other|48|||
144607306|NCT00290290|521424383|FG000|Overall Study|Death|3|||
144607307|NCT00290290|521424384|FG001|Overall Study|Death|4|||
144607308|NCT00290290|521424383|FG000|Overall Study|Withdrawal by Subject|2|||
144607309|NCT00290290|521424384|FG001|Overall Study|Withdrawal by Subject|2|||
144607310|NCT00290290|521424383|FG000|Overall Study|Underwent clean surgical procedure|13|||
144607311|NCT00290290|521424384|FG001|Overall Study|Underwent clean surgical procedure|12|||
144607312|NCT00915772|521424385|FG000|Overall Study|Adverse Event|12|||
144607313|NCT00915772|521424386|FG001|Overall Study|Adverse Event|13|||
144607314|NCT00915772|521424387|FG002|Overall Study|Adverse Event|11|||
144607315|NCT00915772|521424385|FG000|Overall Study|Protocol Violation|4|||
144607316|NCT00915772|521424386|FG001|Overall Study|Protocol Violation|1|||
144607317|NCT00915772|521424387|FG002|Overall Study|Protocol Violation|2|||
144607318|NCT00915772|521424385|FG000|Overall Study|Lost to Follow-up|1|||
144607319|NCT00915772|521424386|FG001|Overall Study|Lost to Follow-up|2|||
144607320|NCT00915772|521424387|FG002|Overall Study|Lost to Follow-up|2|||
144196576|NCT03629028|519915202|FG001|Overall Study|Lost to Follow-up|23|||
144454395|NCT02041195|520862909|FG004|Overall Study|Unable to comply with study visits|1|||
144454396|NCT02041195|520862910|FG005|Overall Study|Unable to comply with study visits|0|||
144454397|NCT02041195|520862911|FG006|Overall Study|Unable to comply with study visits|0|||
144454398|NCT02041195|520862912|FG007|Overall Study|Unable to comply with study visits|0|||
144454399|NCT03564496|520862913|FG000|Overall Study|Withdrawal by Subject|1|||
144454400|NCT03564496|520862914|FG001|Overall Study|Withdrawal by Subject|1|||
144196577|NCT03629028|519915201|FG000|Overall Study|Pregnancy|4|||
144196578|NCT03629028|519915202|FG001|Overall Study|Pregnancy|2|||
144196579|NCT03629028|519915201|FG000|Overall Study|intolerance to examination|2|||
144607321|NCT00915772|521424385|FG000|Overall Study|Lack of Efficacy|9|||
144607322|NCT00915772|521424386|FG001|Overall Study|Lack of Efficacy|15|||
144607323|NCT00915772|521424387|FG002|Overall Study|Lack of Efficacy|3|||
144607324|NCT00915772|521424385|FG000|Overall Study|Refused to continue trial medication|6|||
144607325|NCT00915772|521424386|FG001|Overall Study|Refused to continue trial medication|8|||
144607326|NCT00915772|521424387|FG002|Overall Study|Refused to continue trial medication|4|||
144607327|NCT00915772|521424385|FG000|Overall Study|Any other reason|4|||
144196580|NCT03629028|519915202|FG001|Overall Study|intolerance to examination|0|||
144454401|NCT03564496|520862915|FG002|Overall Study|Withdrawal by Subject|0|||
144454402|NCT03564496|520862913|FG000|Overall Study|Screen failure|0|||
144454403|NCT03564496|520862914|FG001|Overall Study|Screen failure|3|||
144454404|NCT03564496|520862915|FG002|Overall Study|Screen failure|0|||
144454405|NCT00674986|520862916|FG000|Overall Study|Adverse Event|2|||
144454406|NCT00674986|520862917|FG001|Overall Study|Adverse Event|1|||
144607328|NCT00915772|521424386|FG001|Overall Study|Any other reason|7|||
144607329|NCT00915772|521424387|FG002|Overall Study|Any other reason|7|||
144607330|NCT03374995|521424388|FG000|Overall Study|Withdrawal by Subject|0|||
144196581|NCT02687360|519915203|FG000|Overall Study|Withdrawal by Subject|3|||
144196582|NCT02687360|519915204|FG001|Overall Study|Withdrawal by Subject|0|||
144196583|NCT04932941|519915205|FG000|Overall Study|Lost to Follow-up|3|||
144454407|NCT00674986|520862916|FG000|Overall Study|Subject withdrew consent|12|||
144454408|NCT00674986|520862917|FG001|Overall Study|Subject withdrew consent|19|||
144454409|NCT00674986|520862916|FG000|Overall Study|Lost to Follow-up|25|||
144454410|NCT00674986|520862917|FG001|Overall Study|Lost to Follow-up|53|||
144454411|NCT00674986|520862916|FG000|Overall Study|Other reasons|4|||
144454412|NCT00674986|520862917|FG001|Overall Study|Other reasons|8|||
144454413|NCT01880424|520862918|FG000|Overall Study|Adverse Event|7|||
144454414|NCT01880424|520862919|FG001|Overall Study|Adverse Event|6|||
144454415|NCT01880424|520862918|FG000|Overall Study|Lack of Efficacy|1|||
144454416|NCT01880424|520862919|FG001|Overall Study|Lack of Efficacy|4|||
144454417|NCT01880424|520862918|FG000|Overall Study|Lost to Follow-up|3|||
144454418|NCT01880424|520862919|FG001|Overall Study|Lost to Follow-up|2|||
144454419|NCT01880424|520862918|FG000|Overall Study|Protocol Violation|11|||
144454420|NCT01880424|520862919|FG001|Overall Study|Protocol Violation|13|||
144454421|NCT01880424|520862918|FG000|Overall Study|Withdrawal by Subject|10|||
144454422|NCT01880424|520862919|FG001|Overall Study|Withdrawal by Subject|30|||
144454423|NCT01880424|520862918|FG000|Overall Study|Other|1|||
144454424|NCT01880424|520862919|FG001|Overall Study|Other|0|||
144454425|NCT02053350|520862922|FG000|Overall Study|Withdrawal by Subject|1|||
144454426|NCT02053350|520862922|FG000|Overall Study|Adverse Event|4|||
144454427|NCT01747772|520862923|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
144454428|NCT02244944|520862924|FG000|Overall Study|Withdrawal by Subject|1|||
144454429|NCT02244944|520862924|FG000|Overall Study|Study Terminated|1|||
144454430|NCT02367911|520862927|FG000|Overall Study|Withdrawal by Subject|3|||
144454431|NCT02367911|520862928|FG001|Overall Study|Withdrawal by Subject|2|||
144454432|NCT02367911|520862927|FG000|Overall Study|Lost to Follow-up|2|||
144454433|NCT02367911|520862928|FG001|Overall Study|Lost to Follow-up|2|||
144454434|NCT00512135|520862929|FG000|Overall Study|Not Treated|5|||
144454435|NCT00512135|520862929|FG000|Overall Study|Lack of Efficacy|2|||
144454436|NCT00512135|520862929|FG000|Overall Study|Adverse Event|6|||
144454437|NCT00512135|520862929|FG000|Overall Study|Withdrawal by Subject|22|||
144454438|NCT00512135|520862929|FG000|Overall Study|Lost to Follow-up|27|||
144454439|NCT00512135|520862929|FG000|Overall Study|Other|22|||
144454440|NCT00377819|520862930|FG000|Overall Study|Adverse Event|2|||
144454441|NCT00377819|520862931|FG001|Overall Study|Adverse Event|3|||
144454442|NCT00377819|520862930|FG000|Overall Study|Withdrawal by Subject|10|||
144454443|NCT00377819|520862931|FG001|Overall Study|Withdrawal by Subject|4|||
144454444|NCT00377819|520862930|FG000|Overall Study|Death|0|||
144454445|NCT00377819|520862931|FG001|Overall Study|Death|1|||
144454446|NCT00377819|520862930|FG000|Overall Study|Lost to Follow-up|0|||
144454447|NCT00377819|520862931|FG001|Overall Study|Lost to Follow-up|1|||
144454448|NCT00377819|520862930|FG000|Overall Study|Protocol Violation|1|||
144454449|NCT00377819|520862931|FG001|Overall Study|Protocol Violation|1|||
144454450|NCT04495374|520862932|FG000|Overall Study|Protocol Violation|2|||
144454451|NCT04495374|520862933|FG001|Overall Study|Protocol Violation|1|||
144454452|NCT02807948|520862934|FG000|Overall Study|Physician Decision|1|||
144454453|NCT02807948|520862935|FG001|Overall Study|Physician Decision|0|||
144454454|NCT01054820|520862939|FG000|Overall Study|Withdrawal by Subject|2|||
144454455|NCT02624804|520862940|FG000|Overall Study|Screen Failure|5|||
144454456|NCT02590354|520862941|FG000|Phase 1|Active hepatitis B or C infection|1|||
144454457|NCT02590354|520862941|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
144454458|NCT02590354|520862941|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
144454459|NCT02590354|520862941|FG000|Phase 1|Subject does not want to participate|20|||
144454460|NCT02590354|520862941|FG000|Phase 1|Lost to Follow-up|1|||
144454461|NCT02590354|520862941|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
144454462|NCT00996996|520862945|FG000|Overall Study|Progressive Disease|10|||
144454463|NCT00996996|520862945|FG000|Overall Study|Non-compliance|8|||
144454464|NCT00996996|520862945|FG000|Overall Study|Lost to Follow-up|9|||
144454465|NCT00996996|520862945|FG000|Overall Study|Death|5|||
144454466|NCT00996996|520862945|FG000|Overall Study|Did Not Receive Study Medications|1|||
144454467|NCT00760929|520862946|FG000|Overall Study|Adverse Event|2|||
144454468|NCT00760929|520862947|FG001|Overall Study|Adverse Event|0|||
144454469|NCT00760929|520862948|FG002|Overall Study|Adverse Event|6|||
144454470|NCT00760929|520862949|FG003|Overall Study|Adverse Event|10|||
144454471|NCT00760929|520862946|FG000|Overall Study|Lack of Efficacy|0|||
144454472|NCT00760929|520862947|FG001|Overall Study|Lack of Efficacy|2|||
144454473|NCT00760929|520862948|FG002|Overall Study|Lack of Efficacy|1|||
144454474|NCT00760929|520862949|FG003|Overall Study|Lack of Efficacy|0|||
144454475|NCT00760929|520862946|FG000|Overall Study|Withdrawal by Subject|1|||
144454476|NCT00760929|520862947|FG001|Overall Study|Withdrawal by Subject|0|||
144454477|NCT00760929|520862948|FG002|Overall Study|Withdrawal by Subject|9|||
144454478|NCT00760929|520862949|FG003|Overall Study|Withdrawal by Subject|1|||
144454479|NCT00760929|520862946|FG000|Overall Study|Lost to Follow-up|0|||
144454480|NCT00760929|520862947|FG001|Overall Study|Lost to Follow-up|0|||
144454481|NCT00760929|520862948|FG002|Overall Study|Lost to Follow-up|1|||
144454482|NCT00760929|520862949|FG003|Overall Study|Lost to Follow-up|0|||
144454483|NCT00760929|520862946|FG000|Overall Study|Progression of Disease|21|||
144454484|NCT00760929|520862947|FG001|Overall Study|Progression of Disease|26|||
144454485|NCT00760929|520862948|FG002|Overall Study|Progression of Disease|38|||
144454486|NCT00760929|520862949|FG003|Overall Study|Progression of Disease|42|||
144454487|NCT00760929|520862946|FG000|Overall Study|Other|2|||
144454488|NCT00760929|520862947|FG001|Overall Study|Other|0|||
144454489|NCT00760929|520862948|FG002|Overall Study|Other|2|||
144454490|NCT00760929|520862949|FG003|Overall Study|Other|1|||
144454491|NCT00760929|520862946|FG000|Overall Study|Death|0|||
144454492|NCT00760929|520862947|FG001|Overall Study|Death|0|||
144454493|NCT00760929|520862948|FG002|Overall Study|Death|1|||
144454494|NCT00760929|520862949|FG003|Overall Study|Death|0|||
144454495|NCT00760929|520862946|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
144454496|NCT00760929|520862947|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
144454497|NCT00760929|520862948|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
144454498|NCT00760929|520862949|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
144454499|NCT02099838|520862950|FG000|Overall Study|Death|1|||
144454500|NCT02099838|520862951|FG001|Overall Study|Death|0|||
144454501|NCT02099838|520862950|FG000|Overall Study|Lost to Follow-up|3|||
144454502|NCT02099838|520862951|FG001|Overall Study|Lost to Follow-up|1|||
144454503|NCT02099838|520862950|FG000|Overall Study|Withdrawal by Subject|0|||
144454504|NCT02099838|520862951|FG001|Overall Study|Withdrawal by Subject|1|||
144454505|NCT04535037|520862952|FG000|Overall Study|Protocol Violation|1|||
144454506|NCT04535037|520862953|FG001|Overall Study|Protocol Violation|0|||
144454507|NCT04535037|520862952|FG000|Overall Study|Withdrawal by Subject|8|||
144454508|NCT04535037|520862953|FG001|Overall Study|Withdrawal by Subject|9|||
144454509|NCT04535037|520862952|FG000|Overall Study|Migrated / moved from the study area|1|||
144454510|NCT04535037|520862953|FG001|Overall Study|Migrated / moved from the study area|4|||
144454511|NCT04535037|520862952|FG000|Overall Study|Other|2|||
144454512|NCT04535037|520862953|FG001|Overall Study|Other|5|||
144454513|NCT01148810|520862954|FG000|Overall Study|Adverse Event|0|||
144454514|NCT01148810|520862955|FG001|Overall Study|Adverse Event|2|||
144454515|NCT01148810|520862954|FG000|Overall Study|Lack of Efficacy|0|||
144454516|NCT01148810|520862955|FG001|Overall Study|Lack of Efficacy|1|||
144454517|NCT01148810|520862954|FG000|Overall Study|Withdrawal by Subject|0|||
144454518|NCT01148810|520862955|FG001|Overall Study|Withdrawal by Subject|2|||
144454519|NCT01148810|520862954|FG000|Overall Study|Protocol Violation|1|||
144454520|NCT01148810|520862955|FG001|Overall Study|Protocol Violation|0|||
144454521|NCT02417246|520862961|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
144454522|NCT02417246|520862962|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
144454523|NCT02417246|520862961|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
144533747|NCT05007080|521157769|FG000|Overall Study|Other|1|||
144533748|NCT05007080|521157770|FG001|Overall Study|Other|0|||
144533749|NCT05007080|521157771|FG002|Overall Study|Other|1|||
144533750|NCT05007080|521157772|FG003|Overall Study|Other|1|||
144533751|NCT05007080|521157773|FG004|Overall Study|Other|0|||
144533752|NCT05007080|521157774|FG005|Overall Study|Other|2|||
144533753|NCT05007080|521157769|FG000|Overall Study|Randomized not vaccinated|0|||
144533754|NCT05007080|521157770|FG001|Overall Study|Randomized not vaccinated|0|||
144533755|NCT05007080|521157771|FG002|Overall Study|Randomized not vaccinated|0|||
144533756|NCT05007080|521157772|FG003|Overall Study|Randomized not vaccinated|0|||
144533757|NCT05007080|521157773|FG004|Overall Study|Randomized not vaccinated|0|||
144533758|NCT05007080|521157774|FG005|Overall Study|Randomized not vaccinated|1|||
144533759|NCT04173247|521157778|FG000|Overall Study|Withdrawal by Subject|0|||
144533760|NCT04173247|521157779|FG001|Overall Study|Withdrawal by Subject|2|||
144533761|NCT04173247|521157778|FG000|Overall Study|Death|1|||
144533762|NCT04173247|521157779|FG001|Overall Study|Death|0|||
144533763|NCT04173247|521157778|FG000|Overall Study|Physician Decision|1|||
144533764|NCT04173247|521157779|FG001|Overall Study|Physician Decision|0|||
144533765|NCT03884101|521157782|FG000|Overall Study|Participant Ongoing in Study|202|||
144533766|NCT03884101|521157783|FG001|Overall Study|Participant Ongoing in Study|186|||
144533767|NCT03884101|521157782|FG000|Overall Study|Death|212|||
144533768|NCT03884101|521157783|FG001|Overall Study|Death|224|||
144533769|NCT03884101|521157782|FG000|Overall Study|Lost to Follow-up|0|||
144533770|NCT03884101|521157783|FG001|Overall Study|Lost to Follow-up|1|||
144533771|NCT03884101|521157782|FG000|Overall Study|Withdrawal by Subject|6|||
144533772|NCT03884101|521157783|FG001|Overall Study|Withdrawal by Subject|11|||
144533773|NCT03370913|521157784|FG000|Overall Study|Death|1|||
144533774|NCT03370913|521157784|FG000|Overall Study|Lost to Follow-up|1|||
144533775|NCT04631016|521157788|FG000|Overall Study|Adverse Event|3|||
144533776|NCT04631016|521157789|FG001|Overall Study|Adverse Event|0|||
144533777|NCT04631016|521157788|FG000|Overall Study|Withdrawal by Subject|5|||
144533778|NCT04631016|521157789|FG001|Overall Study|Withdrawal by Subject|4|||
144533779|NCT04631016|521157788|FG000|Overall Study|Reason unspecified|1|||
144533780|NCT04631016|521157789|FG001|Overall Study|Reason unspecified|0|||
144454524|NCT02417246|520862962|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
144454525|NCT02417246|520862961|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
144454526|NCT02417246|520862962|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
144454527|NCT02417246|520862961|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
144454528|NCT02417246|520862962|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
144454529|NCT04408469|520862965|FG000|Overall Study|Lost to Follow-up|6|||
144454530|NCT04408469|520862966|FG001|Overall Study|Lost to Follow-up|9|||
144454531|NCT04408469|520862965|FG000|Overall Study|Withdrawal by Subject|6|||
144454532|NCT04408469|520862966|FG001|Overall Study|Withdrawal by Subject|1|||
144454533|NCT04408469|520862965|FG000|Overall Study|Dismissal due to ineligibility|0|||
144454534|NCT04408469|520862966|FG001|Overall Study|Dismissal due to ineligibility|1|||
144454535|NCT04321460|520862967|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
144454536|NCT04321460|520862968|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
144454537|NCT01308749|520862969|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
144454538|NCT01308749|520862970|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
144454539|NCT01308749|520862969|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
144454540|NCT01308749|520862970|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
144454541|NCT01308749|520862969|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
144454542|NCT01308749|520862970|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
144454543|NCT02553330|520862975|FG000|Overall Study|Study Terminated by Sponsor|2|||
144454544|NCT02553330|520862976|FG001|Overall Study|Study Terminated by Sponsor|13|||
144454545|NCT02553330|520862977|FG002|Overall Study|Study Terminated by Sponsor|12|||
144454546|NCT02553330|520862975|FG000|Overall Study|Withdrawal by Subject|3|||
144454547|NCT02553330|520862976|FG001|Overall Study|Withdrawal by Subject|19|||
144454548|NCT02553330|520862977|FG002|Overall Study|Withdrawal by Subject|21|||
144454549|NCT02553330|520862975|FG000|Overall Study|Other|0|||
144454550|NCT02553330|520862976|FG001|Overall Study|Other|1|||
144454551|NCT02553330|520862977|FG002|Overall Study|Other|0|||
144454552|NCT02553330|520862975|FG000|Overall Study|Non compliance to study treatment|0|||
144454553|NCT02553330|520862976|FG001|Overall Study|Non compliance to study treatment|1|||
144454554|NCT02553330|520862977|FG002|Overall Study|Non compliance to study treatment|0|||
144454555|NCT02553330|520862975|FG000|Overall Study|Adverse Event|0|||
144454556|NCT02553330|520862976|FG001|Overall Study|Adverse Event|1|||
144454557|NCT02553330|520862977|FG002|Overall Study|Adverse Event|0|||
144454558|NCT02553330|520862975|FG000|Overall Study|Lost to Follow-up|0|||
144254917|NCT00359294|520133483|FG003|Overall Study|Withdrawal by Subject|0|||
144254918|NCT00359294|520133484|FG004|Overall Study|Withdrawal by Subject|1|||
144254919|NCT00359294|520133480|FG000|Overall Study|Not treated|0|||
144254920|NCT00359294|520133481|FG001|Overall Study|Not treated|0|||
144254921|NCT00359294|520133482|FG002|Overall Study|Not treated|0|||
144254922|NCT00359294|520133483|FG003|Overall Study|Not treated|1|||
144254923|NCT00359294|520133484|FG004|Overall Study|Not treated|0|||
144254924|NCT00359294|520133480|FG000|Overall Study|Physician Decision|0|||
144254925|NCT00359294|520133481|FG001|Overall Study|Physician Decision|0|||
144254926|NCT00359294|520133482|FG002|Overall Study|Physician Decision|1|||
144254927|NCT00359294|520133483|FG003|Overall Study|Physician Decision|0|||
144254928|NCT00359294|520133484|FG004|Overall Study|Physician Decision|0|||
144254929|NCT03882957|520133487|FG000|Overall Study|Did not complete all three arms|1|||
144254930|NCT01134393|520133488|FG000|Overall Study|Adverse Event|18|||
144254931|NCT01134393|520133488|FG000|Overall Study|Lack of Efficacy|2|||
144254932|NCT01134393|520133488|FG000|Overall Study|Protocol Violation|12|||
144254933|NCT01134393|520133488|FG000|Overall Study|Lost to Follow-up|3|||
144254934|NCT01134393|520133488|FG000|Overall Study|Withdrawal by Subject|11|||
144254935|NCT01134393|520133488|FG000|Overall Study|Other|6|||
144254936|NCT01658904|520133489|FG000|Overall Study|Principal Investigator discretion|2|||
144254937|NCT01658904|520133490|FG001|Overall Study|Principal Investigator discretion|0|||
144254938|NCT01658904|520133491|FG002|Overall Study|Principal Investigator discretion|0|||
144254939|NCT00524680|520133493|FG000|Overall Study|progression|0|||
144254940|NCT00524680|520133494|FG001|Overall Study|progression|0|||
144254941|NCT00524680|520133495|FG002|Overall Study|progression|0|||
144254942|NCT00524680|520133496|FG003|Overall Study|progression|1|||
144254943|NCT00524680|520133493|FG000|Overall Study|Adverse Event|2|||
144254944|NCT00524680|520133494|FG001|Overall Study|Adverse Event|0|||
144254945|NCT00524680|520133495|FG002|Overall Study|Adverse Event|0|||
144254946|NCT00524680|520133496|FG003|Overall Study|Adverse Event|1|||
144254947|NCT00524680|520133493|FG000|Overall Study|Other|0|||
144254948|NCT00524680|520133494|FG001|Overall Study|Other|1|||
144254949|NCT00524680|520133495|FG002|Overall Study|Other|2|||
144254950|NCT00524680|520133496|FG003|Overall Study|Other|3|||
144254951|NCT00524680|520133493|FG000|Overall Study|Withdrawal by Subject|1|||
144254952|NCT00524680|520133494|FG001|Overall Study|Withdrawal by Subject|0|||
144254953|NCT00524680|520133495|FG002|Overall Study|Withdrawal by Subject|1|||
144254954|NCT00524680|520133496|FG003|Overall Study|Withdrawal by Subject|1|||
144254955|NCT04399538|520133500|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
144254956|NCT04399538|520133501|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
144254957|NCT04399538|520133502|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
144196584|NCT04932941|519915206|FG001|Overall Study|Lost to Follow-up|1|||
144196585|NCT04932941|519915205|FG000|Overall Study|Withdrawal by Subject|7|||
144196586|NCT04932941|519915206|FG001|Overall Study|Withdrawal by Subject|4|||
144454559|NCT02553330|520862976|FG001|Overall Study|Lost to Follow-up|4|||
144454560|NCT02553330|520862977|FG002|Overall Study|Lost to Follow-up|4|||
144454561|NCT04827212|520862985|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
144454562|NCT04827212|520862986|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
144454563|NCT04827212|520862985|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
144454564|NCT04827212|520862986|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
144454565|NCT00599326|520862991|FG000|Overall Study|Lost to Follow-up|1|||
144454566|NCT00599326|520862991|FG000|Overall Study|Noncompliant|1|||
144454567|NCT00784810|520862992|FG000|Overall Study|Adverse Event|32|||
144454568|NCT00784810|520862993|FG001|Overall Study|Adverse Event|20|||
144454569|NCT00784810|520862992|FG000|Overall Study|Lack of Efficacy|14|||
144454570|NCT00784810|520862993|FG001|Overall Study|Lack of Efficacy|11|||
144454571|NCT00784810|520862992|FG000|Overall Study|Withdrawal by Subject|11|||
144454572|NCT00784810|520862993|FG001|Overall Study|Withdrawal by Subject|9|||
144454573|NCT00784810|520862992|FG000|Overall Study|Administrative|5|||
144454574|NCT00784810|520862993|FG001|Overall Study|Administrative|8|||
144454575|NCT00784810|520862992|FG000|Overall Study|Lost to Follow-up|1|||
144454576|NCT00784810|520862993|FG001|Overall Study|Lost to Follow-up|1|||
144454577|NCT04137380|520862996|FG000|Overall Study|Physician Decision|0|||
144454578|NCT04137380|520862997|FG001|Overall Study|Physician Decision|0|||
144454579|NCT04137380|520862998|FG002|Overall Study|Physician Decision|0|||
144196587|NCT04932941|519915205|FG000|Overall Study|Other|4|||
144454580|NCT04137380|520862999|FG003|Overall Study|Physician Decision|1|||
144454581|NCT04137380|520863000|FG004|Overall Study|Physician Decision|0|||
144454582|NCT04137380|520863001|FG005|Overall Study|Physician Decision|0|||
144454583|NCT04137380|520863002|FG006|Overall Study|Physician Decision|0|||
144196588|NCT04932941|519915206|FG001|Overall Study|Other|2|||
144454584|NCT00563784|520863003|FG000|Overall Study|Withdrawal by Subject|2|||
144454585|NCT00563784|520863003|FG000|Overall Study|Screen Failures|20|||
144454586|NCT02265705|520863007|FG000|Treatment Period Week 0-24|Adverse Event|3|||
144454587|NCT02265705|520863008|FG001|Treatment Period Week 0-24|Adverse Event|2|||
144454588|NCT02265705|520863009|FG002|Treatment Period Week 0-24|Adverse Event|0|||
144454589|NCT02265705|520863010|FG003|Treatment Period Week 0-24|Adverse Event|0|||
144454590|NCT02265705|520863011|FG004|Treatment Period Week 0-24|Adverse Event|0|||
144454591|NCT02265705|520863012|FG005|Treatment Period Week 0-24|Adverse Event|0|||
144454592|NCT02265705|520863013|FG006|Treatment Period Week 0-24|Adverse Event|0|||
144454593|NCT02265705|520863007|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
144454594|NCT02265705|520863008|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
144196589|NCT05069155|519915207|FG000|Overall Study|Withdrawal by Subject|1|||
144454595|NCT02265705|520863009|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
144454596|NCT02265705|520863010|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
144454597|NCT02265705|520863011|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
144533781|NCT04631016|521157788|FG000|Overall Study|Failure to meet randomization criteria|2|||
144533782|NCT04631016|521157789|FG001|Overall Study|Failure to meet randomization criteria|1|||
144533783|NCT04967599|521157790|FG000|Overall Study|Lost to Follow-up|35|||
144533784|NCT04967599|521157791|FG001|Overall Study|Lost to Follow-up|19|||
144533785|NCT04967599|521157792|FG002|Overall Study|Lost to Follow-up|23|||
144533786|NCT04490109|521157795|FG000|Overall Study|Lost to Follow-up|3|||
144533787|NCT04490109|521157796|FG001|Overall Study|Lost to Follow-up|10|||
144533788|NCT04490109|521157797|FG002|Overall Study|Lost to Follow-up|4|||
144533789|NCT04490109|521157795|FG000|Overall Study|Withdrawal by Subject|8|||
144533790|NCT04490109|521157796|FG001|Overall Study|Withdrawal by Subject|6|||
144533791|NCT04490109|521157797|FG002|Overall Study|Withdrawal by Subject|9|||
144533792|NCT04490109|521157795|FG000|Overall Study|Physician Decision|0|||
144533793|NCT04490109|521157796|FG001|Overall Study|Physician Decision|2|||
144533794|NCT04490109|521157797|FG002|Overall Study|Physician Decision|3|||
144533795|NCT04490109|521157795|FG000|Overall Study|Adverse Event|2|||
144533796|NCT04490109|521157796|FG001|Overall Study|Adverse Event|1|||
144533797|NCT04490109|521157797|FG002|Overall Study|Adverse Event|0|||
144533798|NCT04490109|521157795|FG000|Overall Study|Significant Non-Compliance|2|||
144533799|NCT04490109|521157796|FG001|Overall Study|Significant Non-Compliance|4|||
144196590|NCT05069155|519915208|FG001|Overall Study|Withdrawal by Subject|3|||
144196591|NCT01366443|519915209|FG000|Overall Study|Lost to Follow-up|2|||
144196592|NCT01366443|519915209|FG000|Overall Study|Under 18 yo|1|||
144533800|NCT04490109|521157797|FG002|Overall Study|Significant Non-Compliance|4|||
144533801|NCT04490109|521157795|FG000|Overall Study|Significant Clinical Event|0|||
144259297|NCT01089127|520150358|FG004|Overall Study|Lost to Follow-up|1|||
144454598|NCT02265705|520863012|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
144454599|NCT02265705|520863013|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
144454600|NCT02265705|520863007|FG000|Treatment Period Week 0-24|Physician Decision|1|||
144533802|NCT04490109|521157796|FG001|Overall Study|Significant Clinical Event|1|||
144533803|NCT04490109|521157797|FG002|Overall Study|Significant Clinical Event|0|||
144196593|NCT00731549|519915210|FG000|Overall Study|Lost to Follow-up|19|||
144533804|NCT04490109|521157795|FG000|Overall Study|Other Reason|4|||
144454601|NCT02265705|520863008|FG001|Treatment Period Week 0-24|Physician Decision|0|||
144454602|NCT02265705|520863009|FG002|Treatment Period Week 0-24|Physician Decision|0|||
144454603|NCT02265705|520863010|FG003|Treatment Period Week 0-24|Physician Decision|0|||
144454604|NCT02265705|520863011|FG004|Treatment Period Week 0-24|Physician Decision|0|||
144454605|NCT02265705|520863012|FG005|Treatment Period Week 0-24|Physician Decision|0|||
144454606|NCT02265705|520863013|FG006|Treatment Period Week 0-24|Physician Decision|0|||
144454607|NCT02265705|520863007|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
144454608|NCT02265705|520863008|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
144454609|NCT02265705|520863009|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
144454610|NCT02265705|520863010|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
144454611|NCT02265705|520863011|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
144454612|NCT02265705|520863012|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
144454613|NCT02265705|520863013|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
144454614|NCT02265705|520863007|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
144454615|NCT02265705|520863008|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
144454616|NCT02265705|520863009|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
144454617|NCT02265705|520863010|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
144454618|NCT02265705|520863011|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
144454619|NCT02265705|520863012|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
144454620|NCT02265705|520863013|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
144454621|NCT02265705|520863007|FG000|Rescue Period|Withdrawal by Subject|0|||
144454622|NCT02265705|520863008|FG001|Rescue Period|Withdrawal by Subject|0|||
144454623|NCT02265705|520863009|FG002|Rescue Period|Withdrawal by Subject|1|||
144454624|NCT02265705|520863010|FG003|Rescue Period|Withdrawal by Subject|0|||
144454625|NCT02265705|520863011|FG004|Rescue Period|Withdrawal by Subject|0|||
144454626|NCT02265705|520863012|FG005|Rescue Period|Withdrawal by Subject|0|||
144454627|NCT02265705|520863013|FG006|Rescue Period|Withdrawal by Subject|0|||
144454628|NCT02265705|520863007|FG000|Rescue Period|Death|0|||
144454629|NCT02265705|520863008|FG001|Rescue Period|Death|0|||
144454630|NCT02265705|520863009|FG002|Rescue Period|Death|1|||
144454631|NCT02265705|520863010|FG003|Rescue Period|Death|0|||
144454632|NCT02265705|520863011|FG004|Rescue Period|Death|0|||
144454633|NCT02265705|520863012|FG005|Rescue Period|Death|0|||
144454634|NCT02265705|520863013|FG006|Rescue Period|Death|0|||
144454635|NCT02265705|520863007|FG000|Rescue Period|Lack of Efficacy|0|||
144454636|NCT02265705|520863008|FG001|Rescue Period|Lack of Efficacy|0|||
144454637|NCT02265705|520863009|FG002|Rescue Period|Lack of Efficacy|1|||
144454638|NCT02265705|520863010|FG003|Rescue Period|Lack of Efficacy|0|||
144454639|NCT02265705|520863011|FG004|Rescue Period|Lack of Efficacy|0|||
144454640|NCT02265705|520863012|FG005|Rescue Period|Lack of Efficacy|0|||
144454641|NCT02265705|520863013|FG006|Rescue Period|Lack of Efficacy|0|||
144454642|NCT02265705|520863007|FG000|Open Label Period|Adverse Event|0|||
144454643|NCT02265705|520863008|FG001|Open Label Period|Adverse Event|0|||
144454644|NCT02265705|520863009|FG002|Open Label Period|Adverse Event|0|||
144454645|NCT02265705|520863010|FG003|Open Label Period|Adverse Event|2|||
144454646|NCT02265705|520863011|FG004|Open Label Period|Adverse Event|2|||
144454647|NCT02265705|520863012|FG005|Open Label Period|Adverse Event|0|||
144454648|NCT02265705|520863013|FG006|Open Label Period|Adverse Event|0|||
144454649|NCT02265705|520863007|FG000|Open Label Period|Physician Decision|0|||
144454650|NCT02265705|520863008|FG001|Open Label Period|Physician Decision|0|||
144454651|NCT02265705|520863009|FG002|Open Label Period|Physician Decision|0|||
144454652|NCT02265705|520863010|FG003|Open Label Period|Physician Decision|0|||
144454653|NCT02265705|520863011|FG004|Open Label Period|Physician Decision|1|||
144454654|NCT02265705|520863012|FG005|Open Label Period|Physician Decision|0|||
144454655|NCT02265705|520863013|FG006|Open Label Period|Physician Decision|0|||
144454656|NCT02265705|520863007|FG000|Open Label Period|Withdrawal by Subject|0|||
144454657|NCT02265705|520863008|FG001|Open Label Period|Withdrawal by Subject|0|||
144454658|NCT02265705|520863009|FG002|Open Label Period|Withdrawal by Subject|0|||
144454659|NCT02265705|520863010|FG003|Open Label Period|Withdrawal by Subject|0|||
144454660|NCT02265705|520863011|FG004|Open Label Period|Withdrawal by Subject|2|||
144454661|NCT02265705|520863012|FG005|Open Label Period|Withdrawal by Subject|0|||
144454662|NCT02265705|520863013|FG006|Open Label Period|Withdrawal by Subject|0|||
144454663|NCT02265705|520863007|FG000|Follow-up Period|Sponsor Decision|0|||
144454664|NCT02265705|520863008|FG001|Follow-up Period|Sponsor Decision|0|||
144454665|NCT02265705|520863009|FG002|Follow-up Period|Sponsor Decision|0|||
144454666|NCT02265705|520863010|FG003|Follow-up Period|Sponsor Decision|0|||
144454667|NCT02265705|520863011|FG004|Follow-up Period|Sponsor Decision|0|||
144454668|NCT02265705|520863012|FG005|Follow-up Period|Sponsor Decision|1|||
144454669|NCT02265705|520863013|FG006|Follow-up Period|Sponsor Decision|6|||
144454670|NCT02265705|520863007|FG000|Follow-up Period|Adverse Event|0|||
144454671|NCT02265705|520863008|FG001|Follow-up Period|Adverse Event|0|||
144454672|NCT02265705|520863009|FG002|Follow-up Period|Adverse Event|0|||
144454673|NCT02265705|520863010|FG003|Follow-up Period|Adverse Event|0|||
144454674|NCT02265705|520863011|FG004|Follow-up Period|Adverse Event|0|||
144454675|NCT02265705|520863012|FG005|Follow-up Period|Adverse Event|0|||
144454676|NCT02265705|520863013|FG006|Follow-up Period|Adverse Event|3|||
144454677|NCT02265705|520863007|FG000|Follow-up Period|Physician Decision|0|||
144454678|NCT02265705|520863008|FG001|Follow-up Period|Physician Decision|0|||
144454679|NCT02265705|520863009|FG002|Follow-up Period|Physician Decision|0|||
144454680|NCT02265705|520863010|FG003|Follow-up Period|Physician Decision|0|||
144454681|NCT02265705|520863011|FG004|Follow-up Period|Physician Decision|0|||
144454682|NCT02265705|520863012|FG005|Follow-up Period|Physician Decision|0|||
144454683|NCT02265705|520863013|FG006|Follow-up Period|Physician Decision|1|||
144454684|NCT02265705|520863007|FG000|Follow-up Period|Withdrawal by Subject|0|||
144454685|NCT02265705|520863008|FG001|Follow-up Period|Withdrawal by Subject|0|||
144454686|NCT02265705|520863009|FG002|Follow-up Period|Withdrawal by Subject|0|||
144454687|NCT02265705|520863010|FG003|Follow-up Period|Withdrawal by Subject|0|||
144454688|NCT02265705|520863011|FG004|Follow-up Period|Withdrawal by Subject|0|||
144454689|NCT02265705|520863012|FG005|Follow-up Period|Withdrawal by Subject|0|||
144454690|NCT02265705|520863013|FG006|Follow-up Period|Withdrawal by Subject|1|||
144454691|NCT00779246|520863015|FG000|Overall Study|Missing sufficient data for analysis|33|||
144454692|NCT00779246|520863016|FG001|Overall Study|Missing sufficient data for analysis|53|||
144454693|NCT03579459|520863017|FG000|Overall Study|Adverse Event|7|||
144454694|NCT03579459|520863018|FG001|Overall Study|Adverse Event|6|||
144454695|NCT03579459|520863019|FG002|Overall Study|Adverse Event|2|||
144454696|NCT03579459|520863020|FG003|Overall Study|Adverse Event|6|||
144454697|NCT03579459|520863017|FG000|Overall Study|Death|1|||
144454698|NCT03579459|520863018|FG001|Overall Study|Death|0|||
144454699|NCT03579459|520863019|FG002|Overall Study|Death|1|||
144454700|NCT03579459|520863020|FG003|Overall Study|Death|2|||
144454701|NCT03579459|520863017|FG000|Overall Study|Lost to Follow-up|6|||
144454702|NCT03579459|520863018|FG001|Overall Study|Lost to Follow-up|2|||
144454703|NCT03579459|520863019|FG002|Overall Study|Lost to Follow-up|4|||
144454704|NCT03579459|520863020|FG003|Overall Study|Lost to Follow-up|1|||
144454705|NCT03579459|520863017|FG000|Overall Study|Physician Decision|0|||
144454706|NCT03579459|520863018|FG001|Overall Study|Physician Decision|1|||
144454707|NCT03579459|520863019|FG002|Overall Study|Physician Decision|0|||
144454708|NCT03579459|520863020|FG003|Overall Study|Physician Decision|1|||
144454709|NCT03579459|520863017|FG000|Overall Study|Protocol Violation|1|||
144454710|NCT03579459|520863018|FG001|Overall Study|Protocol Violation|2|||
144454711|NCT03579459|520863019|FG002|Overall Study|Protocol Violation|3|||
144454712|NCT03579459|520863020|FG003|Overall Study|Protocol Violation|5|||
144454713|NCT03579459|520863017|FG000|Overall Study|Withdrawal by Subject|12|||
144454714|NCT03579459|520863018|FG001|Overall Study|Withdrawal by Subject|8|||
144454715|NCT03579459|520863019|FG002|Overall Study|Withdrawal by Subject|11|||
144454716|NCT03579459|520863020|FG003|Overall Study|Withdrawal by Subject|8|||
144454717|NCT03579459|520863017|FG000|Overall Study|Medication error without associated adverse event|2|||
144454718|NCT03579459|520863018|FG001|Overall Study|Medication error without associated adverse event|1|||
144454719|NCT03579459|520863019|FG002|Overall Study|Medication error without associated adverse event|1|||
144454720|NCT03579459|520863020|FG003|Overall Study|Medication error without associated adverse event|0|||
144454721|NCT03579459|520863017|FG000|Overall Study|Other|0|||
144454722|NCT03579459|520863018|FG001|Overall Study|Other|1|||
144454723|NCT03579459|520863019|FG002|Overall Study|Other|1|||
144454724|NCT03579459|520863020|FG003|Overall Study|Other|0|||
144454725|NCT03579459|520863017|FG000|Overall Study|Randomized not vaccinated|0|||
144454726|NCT03579459|520863018|FG001|Overall Study|Randomized not vaccinated|2|||
144454727|NCT03579459|520863019|FG002|Overall Study|Randomized not vaccinated|0|||
144454728|NCT03579459|520863020|FG003|Overall Study|Randomized not vaccinated|1|||
144454729|NCT00148343|520863021|FG000|Overall Study|Withdrawal by Subject|12|||
144454730|NCT00148343|520863022|FG001|Overall Study|Withdrawal by Subject|7|||
144454731|NCT00148343|520863021|FG000|Overall Study|Physician Decision|3|||
144454732|NCT00148343|520863022|FG001|Overall Study|Physician Decision|4|||
144454733|NCT02844946|520863024|FG000|Overall Study|Lost to Follow-up|7|||
144454734|NCT02844946|520863025|FG001|Overall Study|Lost to Follow-up|0|||
144454735|NCT02806986|520863026|FG000|Treatment Stage 1|Adverse Event|1|||
144454736|NCT02806986|520863026|FG000|Treatment Stage 2|Adverse Event|3|||
144454737|NCT02806986|520863026|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
144454738|NCT02528214|520863027|FG000|Overall Study|Protocol Violation|0|||
144454739|NCT02528214|520863028|FG001|Overall Study|Protocol Violation|1|||
144454740|NCT02528214|520863027|FG000|Overall Study|Adverse Event|0|||
144454741|NCT02528214|520863028|FG001|Overall Study|Adverse Event|1|||
144454742|NCT02528214|520863027|FG000|Overall Study|Other than specified above|0|||
144454743|NCT02528214|520863028|FG001|Overall Study|Other than specified above|1|||
144454744|NCT01380327|520863032|FG000|Overall Study|Lost to Follow-up|0|||
144454745|NCT01380327|520863033|FG001|Overall Study|Lost to Follow-up|1|||
144454746|NCT01380327|520863034|FG002|Overall Study|Lost to Follow-up|1|||
144454747|NCT01380327|520863032|FG000|Overall Study|Protocol Violation|3|||
144454748|NCT01380327|520863033|FG001|Overall Study|Protocol Violation|2|||
144454749|NCT01380327|520863034|FG002|Overall Study|Protocol Violation|3|||
144454750|NCT01380327|520863032|FG000|Overall Study|Withdrawal by Subject|0|||
144454751|NCT01380327|520863033|FG001|Overall Study|Withdrawal by Subject|0|||
144454752|NCT01380327|520863034|FG002|Overall Study|Withdrawal by Subject|1|||
144454753|NCT01380327|520863032|FG000|Overall Study|Housing situation precluded ability to k|0|||
144454754|NCT01380327|520863033|FG001|Overall Study|Housing situation precluded ability to k|0|||
144454755|NCT01380327|520863034|FG002|Overall Study|Housing situation precluded ability to k|1|||
144454756|NCT01380327|520863032|FG000|Overall Study|Questionable onset of epilepsy|0|||
144454757|NCT01380327|520863033|FG001|Overall Study|Questionable onset of epilepsy|0|||
144454758|NCT01380327|520863034|FG002|Overall Study|Questionable onset of epilepsy|1|||
144454759|NCT01175668|520863035|FG000|Overall Study|Withdrawal by Subject|2|||
144454760|NCT01175668|520863036|FG001|Overall Study|Withdrawal by Subject|0|||
144454761|NCT00096135|520863037|FG000|Overall Study|Physician Decision|20|||
144454762|NCT00096135|520863038|FG001|Overall Study|Physician Decision|4|||
144454763|NCT00096135|520863037|FG000|Overall Study|Refusal of further protocol therapy|4|||
144454764|NCT00096135|520863038|FG001|Overall Study|Refusal of further protocol therapy|1|||
144454765|NCT00096135|520863037|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
144454766|NCT00096135|520863038|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
144454767|NCT00096135|520863037|FG000|Overall Study|Other, specify|15|||
144454768|NCT00096135|520863038|FG001|Overall Study|Other, specify|3|||
144454769|NCT00096135|520863037|FG000|Overall Study|Ineligible|2|||
144454770|NCT00096135|520863038|FG001|Overall Study|Ineligible|0|||
144454771|NCT01568047|520863039|FG000|Overall Study|Ineligibility|1|||
144454772|NCT01568047|520863040|FG001|Overall Study|Ineligibility|0|||
144454773|NCT01568047|520863041|FG002|Overall Study|Ineligibility|0|||
144454774|NCT01568047|520863042|FG003|Overall Study|Ineligibility|0|||
144454775|NCT01568047|520863039|FG000|Overall Study|Withdrawal by Subject|0|||
144454776|NCT01568047|520863040|FG001|Overall Study|Withdrawal by Subject|1|||
144454777|NCT01568047|520863041|FG002|Overall Study|Withdrawal by Subject|0|||
144454778|NCT01568047|520863042|FG003|Overall Study|Withdrawal by Subject|0|||
144454779|NCT01568047|520863039|FG000|Overall Study|Adverse Event|0|||
144454780|NCT01568047|520863040|FG001|Overall Study|Adverse Event|0|||
144454781|NCT01568047|520863041|FG002|Overall Study|Adverse Event|1|||
144454782|NCT01568047|520863042|FG003|Overall Study|Adverse Event|1|||
144454783|NCT00874029|520863043|FG000|Overall Study|Withdrawal by Subject|10|||
144454784|NCT00874029|520863043|FG000|Overall Study|Pregnancy|4|||
144454785|NCT00874029|520863043|FG000|Overall Study|Physician Decision|1|||
144454786|NCT00874029|520863043|FG000|Overall Study|Adverse Event|1|||
144454787|NCT00874029|520863043|FG000|Overall Study|Lost to Follow-up|5|||
144454788|NCT02937545|520863050|FG000|Overall Study|Withdrawal by Subject|1|||
144454789|NCT02937545|520863051|FG001|Overall Study|Withdrawal by Subject|2|||
144454790|NCT02937545|520863052|FG002|Overall Study|Withdrawal by Subject|6|||
144454791|NCT02937545|520863053|FG003|Overall Study|Withdrawal by Subject|7|||
144454792|NCT02937545|520863050|FG000|Overall Study|Lost to Follow-up|1|||
144454793|NCT02937545|520863051|FG001|Overall Study|Lost to Follow-up|0|||
144454794|NCT02937545|520863052|FG002|Overall Study|Lost to Follow-up|0|||
144454795|NCT02937545|520863053|FG003|Overall Study|Lost to Follow-up|0|||
144454796|NCT02007577|520863056|FG000|Overall Study|Adverse Event|1|||
144454797|NCT02007577|520863057|FG001|Overall Study|Adverse Event|0|||
144454798|NCT02007577|520863056|FG000|Overall Study|Withdrawal by Subject|0|||
144454799|NCT02007577|520863057|FG001|Overall Study|Withdrawal by Subject|1|||
144454800|NCT00968669|520863058|FG000|Overall Study|Lost to Follow-up|5|||
144454801|NCT00968669|520863059|FG001|Overall Study|Lost to Follow-up|2|||
144725780|NCT01611090|521851366|FG001|Randomized Period|Withdrawal by Subject|26|||
144254958|NCT04399538|520133503|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
144254959|NCT04399538|520133504|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
144254960|NCT04399538|520133500|FG000|Double-Blind Treatment|Adverse Event|0|||
144254961|NCT04399538|520133501|FG001|Double-Blind Treatment|Adverse Event|0|||
144254962|NCT04399538|520133502|FG002|Double-Blind Treatment|Adverse Event|0|||
144254963|NCT04399538|520133503|FG003|Double-Blind Treatment|Adverse Event|0|||
144254964|NCT04399538|520133504|FG004|Double-Blind Treatment|Adverse Event|1|||
144254965|NCT04399538|520133500|FG000|Follow-Up|Adverse Event|0|||
144254966|NCT04399538|520133501|FG001|Follow-Up|Adverse Event|0|||
144254967|NCT04399538|520133502|FG002|Follow-Up|Adverse Event|0|||
144254968|NCT04399538|520133503|FG003|Follow-Up|Adverse Event|0|||
144254969|NCT04399538|520133504|FG004|Follow-Up|Adverse Event|1|||
144254970|NCT04399538|520133500|FG000|Follow-Up|Withdrawal by Subject|0|||
144254971|NCT04399538|520133501|FG001|Follow-Up|Withdrawal by Subject|0|||
144254972|NCT04399538|520133502|FG002|Follow-Up|Withdrawal by Subject|0|||
144254973|NCT04399538|520133503|FG003|Follow-Up|Withdrawal by Subject|2|||
144254974|NCT04399538|520133504|FG004|Follow-Up|Withdrawal by Subject|0|||
144254975|NCT02756364|520133510|FG000|Overall Study|Site Terminated by Sponsor|24|||
144254976|NCT02756364|520133511|FG001|Overall Study|Site Terminated by Sponsor|30|||
144254977|NCT02756364|520133512|FG002|Overall Study|Site Terminated by Sponsor|21|||
144254978|NCT02756364|520133510|FG000|Overall Study|Death|20|||
144254979|NCT02756364|520133511|FG001|Overall Study|Death|15|||
144254980|NCT02756364|520133512|FG002|Overall Study|Death|18|||
144254981|NCT02756364|520133510|FG000|Overall Study|Withdrawal by Patient|2|||
144254982|NCT02756364|520133511|FG001|Overall Study|Withdrawal by Patient|1|||
144254983|NCT02756364|520133512|FG002|Overall Study|Withdrawal by Patient|8|||
144454802|NCT00968669|520863060|FG002|Overall Study|Lost to Follow-up|1|||
144254984|NCT02756364|520133510|FG000|Overall Study|Lost to Follow-up|0|||
144254985|NCT02756364|520133511|FG001|Overall Study|Lost to Follow-up|1|||
144254986|NCT02756364|520133512|FG002|Overall Study|Lost to Follow-up|1|||
144725781|NCT01611090|521851367|FG002|Randomized Period|Withdrawal by Subject|0|||
144725782|NCT01611090|521851365|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
144725783|NCT01611090|521851366|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
144725784|NCT01611090|521851367|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
144725785|NCT01611090|521851365|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
144725786|NCT01611090|521851366|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
144725787|NCT01611090|521851367|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
144725788|NCT05109234|521851368|FG000|Overall Study|Adverse Event|2|||
144725789|NCT05109234|521851369|FG001|Overall Study|Adverse Event|2|||
144725790|NCT05109234|521851368|FG000|Overall Study|Lack of Efficacy|5|||
144725791|NCT05109234|521851369|FG001|Overall Study|Lack of Efficacy|0|||
144196594|NCT00731549|519915210|FG000|Overall Study|Met withdrawal criteria|24|||
144196595|NCT00731549|519915210|FG000|Overall Study|Physician Decision|16|||
144196596|NCT00731549|519915210|FG000|Overall Study|Withdrawal by Subject|89|||
144196597|NCT00731549|519915210|FG000|Overall Study|Protocol deviation|1|||
144196598|NCT00731549|519915210|FG000|Overall Study|Adverse Event|31|||
144196599|NCT00731549|519915210|FG000|Overall Study|Lack of efficacy with AE|37|||
144196600|NCT00731549|519915210|FG000|Overall Study|Lack of efficacy without AE|6|||
144196601|NCT00588640|519915211|FG000|Overall Study|Physician Decision|1|||
144196602|NCT00588640|519915211|FG000|Overall Study|Ineligible Patient|1|||
144196603|NCT01673698|519915212|FG000|Overall Study|Lost to Follow-up|51|||
144196604|NCT01673698|519915213|FG001|Overall Study|Lost to Follow-up|13|||
144196605|NCT01111019|519915214|FG000|Overall Study|Withdrew Prematurely|2|||
144196606|NCT01111019|519915214|FG000|Overall Study|Other|1|||
144196607|NCT06204887|519916997|FG000|Overall Study|Lost to Follow-up|3|||
144196608|NCT06204887|519916998|FG001|Overall Study|Lost to Follow-up|4|||
144196609|NCT06204887|519916999|FG002|Overall Study|Lost to Follow-up|1|||
144196610|NCT06204887|519917000|FG003|Overall Study|Lost to Follow-up|6|||
144196611|NCT02522403|519917001|FG000|Overall Study|Lost to Follow-up|2|||
144196612|NCT02522403|519917002|FG001|Overall Study|Lost to Follow-up|2|||
144196613|NCT02522403|519917001|FG000|Overall Study|Withdrawal by Subject|2|||
144196614|NCT02522403|519917002|FG001|Overall Study|Withdrawal by Subject|4|||
144196615|NCT05142566|519917003|FG000|Overall Study|Protocol Violation|1|||
144196616|NCT04718194|519917006|FG000|Overall Study|Withdrawal by Subject|3|||
144196617|NCT04718194|519917007|FG001|Overall Study|Withdrawal by Subject|0|||
144454803|NCT00968669|520863061|FG003|Overall Study|Lost to Follow-up|4|||
144454804|NCT00968669|520863058|FG000|Overall Study|Withdrawal by Subject|9|||
144454805|NCT00968669|520863059|FG001|Overall Study|Withdrawal by Subject|7|||
144454806|NCT00968669|520863060|FG002|Overall Study|Withdrawal by Subject|5|||
144454807|NCT00968669|520863061|FG003|Overall Study|Withdrawal by Subject|3|||
144454808|NCT00968669|520863058|FG000|Overall Study|Pregnancy|0|||
144454809|NCT00968669|520863059|FG001|Overall Study|Pregnancy|0|||
144454810|NCT00968669|520863060|FG002|Overall Study|Pregnancy|2|||
144454811|NCT00968669|520863061|FG003|Overall Study|Pregnancy|0|||
144454812|NCT00968669|520863058|FG000|Overall Study|AE|1|||
144454813|NCT00968669|520863059|FG001|Overall Study|AE|0|||
144454814|NCT00968669|520863060|FG002|Overall Study|AE|0|||
144454815|NCT00968669|520863061|FG003|Overall Study|AE|0|||
144454816|NCT00968669|520863058|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
144454817|NCT00968669|520863059|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
144454818|NCT00968669|520863060|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
144454819|NCT00968669|520863061|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
144454820|NCT00968669|520863058|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
144454821|NCT00968669|520863059|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
144454822|NCT00968669|520863060|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
144454823|NCT00968669|520863061|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
144454824|NCT00968669|520863058|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
144454825|NCT00968669|520863059|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
144454826|NCT00968669|520863060|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
144454827|NCT00968669|520863061|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
144454828|NCT00968669|520863058|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
144454829|NCT00968669|520863059|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
144725792|NCT05109234|521851368|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
144725793|NCT05109234|521851369|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
144725794|NCT05109234|521851368|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
144196618|NCT04718194|519917006|FG000|Overall Study|Lost to Follow-up|3|||
144454830|NCT00968669|520863060|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
144454831|NCT00968669|520863061|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
144454832|NCT00968669|520863058|FG000|Overall Study|EARLY WITHDRAWAL|0|||
144196619|NCT04718194|519917007|FG001|Overall Study|Lost to Follow-up|0|||
144196620|NCT00856973|519917008|FG000|Overall Study|Adverse Event|5|||
144196621|NCT00856973|519917009|FG001|Overall Study|Adverse Event|5|||
144196622|NCT00856973|519917010|FG002|Overall Study|Adverse Event|3|||
144454833|NCT00968669|520863059|FG001|Overall Study|EARLY WITHDRAWAL|1|||
144196623|NCT00856973|519917008|FG000|Overall Study|Lost to Follow-up|6|||
144196624|NCT00856973|519917009|FG001|Overall Study|Lost to Follow-up|3|||
144454834|NCT00968669|520863060|FG002|Overall Study|EARLY WITHDRAWAL|0|||
144454835|NCT00968669|520863061|FG003|Overall Study|EARLY WITHDRAWAL|0|||
144454836|NCT00968669|520863058|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
144454837|NCT00968669|520863059|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
144454838|NCT00968669|520863060|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
144454839|NCT00968669|520863061|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
144454840|NCT00968669|520863058|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
144454841|NCT00968669|520863059|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
144454842|NCT00968669|520863060|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
144454843|NCT00968669|520863061|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
144454844|NCT00968669|520863058|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
144454845|NCT00968669|520863059|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
144454846|NCT00968669|520863060|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
144454847|NCT00968669|520863061|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
144454848|NCT00968669|520863058|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
144454849|NCT00968669|520863059|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
144454850|NCT00968669|520863060|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
144454851|NCT00968669|520863061|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
144454852|NCT00968669|520863058|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
144454853|NCT00968669|520863059|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
144454854|NCT00968669|520863060|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
144454855|NCT00968669|520863061|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
144454856|NCT00968669|520863058|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
144454857|NCT00968669|520863059|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
144454858|NCT00968669|520863060|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
144454859|NCT00968669|520863061|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
144454860|NCT00968669|520863058|FG000|Overall Study|SPONSOR DECISION|0|||
144454861|NCT00968669|520863059|FG001|Overall Study|SPONSOR DECISION|1|||
144454862|NCT00968669|520863060|FG002|Overall Study|SPONSOR DECISION|0|||
144454863|NCT00968669|520863061|FG003|Overall Study|SPONSOR DECISION|0|||
144454864|NCT00968669|520863058|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
144454865|NCT00968669|520863059|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
144454866|NCT00968669|520863060|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
144454867|NCT00968669|520863061|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
144454868|NCT00968669|520863058|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
144454869|NCT00968669|520863059|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
144454870|NCT00968669|520863060|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
144454871|NCT00968669|520863061|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
144454872|NCT00968669|520863058|FG000|Overall Study|SUBJECT INCARCERATED|0|||
144454873|NCT00968669|520863059|FG001|Overall Study|SUBJECT INCARCERATED|1|||
144454874|NCT00968669|520863060|FG002|Overall Study|SUBJECT INCARCERATED|0|||
144454875|NCT00968669|520863061|FG003|Overall Study|SUBJECT INCARCERATED|0|||
144454876|NCT00968669|520863058|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
144454877|NCT00968669|520863059|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
144454878|NCT00968669|520863060|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
144454879|NCT00968669|520863061|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
144454880|NCT00968669|520863058|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
144454881|NCT00968669|520863059|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
144454882|NCT00968669|520863060|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
144454883|NCT00968669|520863061|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
144454884|NCT00968617|520863065|FG000|Overall Study|Study terminated by sponsor|6|||
144454885|NCT00288587|520863069|FG000|Overall Study|Death|4|||
144454886|NCT00288587|520863070|FG001|Overall Study|Death|4|||
144454887|NCT00288587|520863069|FG000|Overall Study|Transplant|0|||
144454888|NCT00288587|520863070|FG001|Overall Study|Transplant|3|||
144454889|NCT00288587|520863069|FG000|Overall Study|Adverse Event|0|||
144454890|NCT00288587|520863070|FG001|Overall Study|Adverse Event|1|||
144454891|NCT00288587|520863069|FG000|Overall Study|Physician Decision|0|||
144454892|NCT00288587|520863070|FG001|Overall Study|Physician Decision|2|||
144454893|NCT00288587|520863069|FG000|Overall Study|Severe Aortic Stenosis|1|||
144196625|NCT00856973|519917010|FG002|Overall Study|Lost to Follow-up|5|||
144196626|NCT00856973|519917008|FG000|Overall Study|Physician Decision|0|||
144196627|NCT00856973|519917009|FG001|Overall Study|Physician Decision|3|||
144196628|NCT00856973|519917010|FG002|Overall Study|Physician Decision|1|||
144196629|NCT00856973|519917008|FG000|Overall Study|Protocol Violation|1|||
144196630|NCT00856973|519917009|FG001|Overall Study|Protocol Violation|2|||
144196631|NCT00856973|519917010|FG002|Overall Study|Protocol Violation|1|||
144454894|NCT00288587|520863070|FG001|Overall Study|Severe Aortic Stenosis|0|||
144196632|NCT00856973|519917008|FG000|Overall Study|Withdrawal by Subject|13|||
144196633|NCT00856973|519917009|FG001|Overall Study|Withdrawal by Subject|16|||
144533805|NCT04490109|521157796|FG001|Overall Study|Other Reason|1|||
144533806|NCT04490109|521157797|FG002|Overall Study|Other Reason|1|||
144196634|NCT00856973|519917010|FG002|Overall Study|Withdrawal by Subject|15|||
144454895|NCT01434602|520863071|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
144454896|NCT01434602|520863072|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
144454897|NCT01434602|520863073|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
144454898|NCT01434602|520863074|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
144454899|NCT01434602|520863075|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
144454900|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
144454901|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
144454902|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
144454903|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
144454904|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
144454905|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
144472243|NCT04711603|520926727|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
144254987|NCT02223364|520133513|FG000|Overall Study|Protocol Violation|3|||
144254988|NCT02223364|520133514|FG001|Overall Study|Protocol Violation|0|||
144254989|NCT02223364|520133515|FG002|Overall Study|Protocol Violation|3|||
144254990|NCT02223364|520133513|FG000|Overall Study|subject expired before surgery|1|||
144254991|NCT02223364|520133514|FG001|Overall Study|subject expired before surgery|0|||
144254992|NCT02223364|520133515|FG002|Overall Study|subject expired before surgery|0|||
144254993|NCT02223364|520133513|FG000|Overall Study|Physician Decision|1|||
144254994|NCT02223364|520133514|FG001|Overall Study|Physician Decision|0|||
144254995|NCT02223364|520133515|FG002|Overall Study|Physician Decision|0|||
144254996|NCT02772809|520133519|FG000|Overall Study|not completed some tasks|6|||
144254997|NCT02427802|520133520|FG000|Overall Study|Adverse Event|11|||
144254998|NCT02427802|520133521|FG001|Overall Study|Adverse Event|3|||
144254999|NCT02427802|520133522|FG002|Overall Study|Adverse Event|7|||
144255000|NCT02427802|520133520|FG000|Overall Study|Death|0|||
144255001|NCT02427802|520133521|FG001|Overall Study|Death|4|||
144255002|NCT02427802|520133522|FG002|Overall Study|Death|1|||
144255003|NCT02427802|520133520|FG000|Overall Study|Lost to Follow-up|13|||
144255004|NCT02427802|520133521|FG001|Overall Study|Lost to Follow-up|8|||
144255005|NCT02427802|520133522|FG002|Overall Study|Lost to Follow-up|8|||
144255006|NCT02427802|520133520|FG000|Overall Study|Physician Decision|4|||
144255007|NCT02427802|520133521|FG001|Overall Study|Physician Decision|2|||
144255008|NCT02427802|520133522|FG002|Overall Study|Physician Decision|4|||
144255009|NCT02427802|520133520|FG000|Overall Study|Withdrawal by Subject|10|||
144255010|NCT02427802|520133521|FG001|Overall Study|Withdrawal by Subject|5|||
144255011|NCT02427802|520133522|FG002|Overall Study|Withdrawal by Subject|11|||
144255012|NCT02427802|520133520|FG000|Overall Study|Protocol Violation|3|||
144255013|NCT02427802|520133521|FG001|Overall Study|Protocol Violation|1|||
144255014|NCT02427802|520133522|FG002|Overall Study|Protocol Violation|1|||
144255015|NCT02427802|520133520|FG000|Overall Study|protocol specific treatment unrelated|18|||
144255016|NCT02427802|520133521|FG001|Overall Study|protocol specific treatment unrelated|11|||
144255017|NCT02427802|520133522|FG002|Overall Study|protocol specific treatment unrelated|11|||
144255018|NCT05188729|520133523|FG000|Overall Study|Withdrawal by Subject|0|||
144255019|NCT05188729|520133524|FG001|Overall Study|Withdrawal by Subject|0|||
144255020|NCT05188729|520133525|FG002|Overall Study|Withdrawal by Subject|0|||
144255021|NCT05188729|520133526|FG003|Overall Study|Withdrawal by Subject|0|||
144255022|NCT05188729|520133527|FG004|Overall Study|Withdrawal by Subject|0|||
144255023|NCT05188729|520133528|FG005|Overall Study|Withdrawal by Subject|0|||
144255024|NCT05188729|520133529|FG006|Overall Study|Withdrawal by Subject|0|||
144255025|NCT05188729|520133530|FG007|Overall Study|Withdrawal by Subject|0|||
144255026|NCT05188729|520133531|FG008|Overall Study|Withdrawal by Subject|0|||
144255027|NCT05188729|520133532|FG009|Overall Study|Withdrawal by Subject|1|||
144255028|NCT05188729|520133533|FG010|Overall Study|Withdrawal by Subject|0|||
144255029|NCT05188729|520133534|FG011|Overall Study|Withdrawal by Subject|0|||
144255030|NCT05188729|520133535|FG012|Overall Study|Withdrawal by Subject|0|||
144255031|NCT05188729|520133523|FG000|Overall Study|Lost to Follow-up|0|||
144255032|NCT05188729|520133524|FG001|Overall Study|Lost to Follow-up|0|||
144255033|NCT05188729|520133525|FG002|Overall Study|Lost to Follow-up|0|||
144255034|NCT05188729|520133526|FG003|Overall Study|Lost to Follow-up|0|||
144255035|NCT05188729|520133527|FG004|Overall Study|Lost to Follow-up|0|||
144255036|NCT05188729|520133528|FG005|Overall Study|Lost to Follow-up|0|||
144255037|NCT05188729|520133529|FG006|Overall Study|Lost to Follow-up|0|||
144255038|NCT05188729|520133530|FG007|Overall Study|Lost to Follow-up|0|||
144255039|NCT05188729|520133531|FG008|Overall Study|Lost to Follow-up|0|||
144255040|NCT05188729|520133532|FG009|Overall Study|Lost to Follow-up|0|||
144255041|NCT05188729|520133533|FG010|Overall Study|Lost to Follow-up|1|||
144255042|NCT05188729|520133534|FG011|Overall Study|Lost to Follow-up|1|||
144255043|NCT05188729|520133535|FG012|Overall Study|Lost to Follow-up|0|||
144255044|NCT00398216|520136073|FG000|Overall Study|Adverse Event|4|||
144255045|NCT00398216|520136074|FG001|Overall Study|Adverse Event|2|||
144454906|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
144454907|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
144454908|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
144454909|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
144454910|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
144454911|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
144454912|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
144454913|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
144454914|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
144454915|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
144454916|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
144454917|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
144454918|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
144454919|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
144454920|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
144454921|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
144454922|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
144454923|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
144454924|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
144454925|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
144454926|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
144454927|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
144454928|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
144533807|NCT03880955|521157798|FG000|Overall Study|Adverse Event|1|||
144533808|NCT03880955|521157798|FG000|Overall Study|Death|1|||
144255046|NCT00398216|520136075|FG002|Overall Study|Adverse Event|5|||
144255047|NCT00398216|520136076|FG003|Overall Study|Adverse Event|7|||
144255048|NCT00398216|520136077|FG004|Overall Study|Adverse Event|2|||
144533809|NCT03880955|521157798|FG000|Overall Study|Lost to Follow-up|12|||
144533810|NCT03880955|521157798|FG000|Overall Study|Withdrawal by Subject|4|||
144533811|NCT03880955|521157798|FG000|Overall Study|Missing- Study Site Closed|27|||
144533812|NCT01438853|521157808|FG000|Overall Study|Death|0|||
144533813|NCT01438853|521157809|FG001|Overall Study|Death|0|||
144533814|NCT01438853|521157810|FG002|Overall Study|Death|0|||
144533815|NCT01438853|521157811|FG003|Overall Study|Death|1|||
144533816|NCT01438853|521157808|FG000|Overall Study|Withdrawal by Subject|0|||
144533817|NCT01438853|521157809|FG001|Overall Study|Withdrawal by Subject|0|||
144533818|NCT01438853|521157810|FG002|Overall Study|Withdrawal by Subject|1|||
144533819|NCT01438853|521157811|FG003|Overall Study|Withdrawal by Subject|0|||
144533820|NCT02919917|521157812|FG000|Overall Study|Withdrawal by Subject|4|||
144533821|NCT02919917|521157813|FG001|Overall Study|Withdrawal by Subject|8|||
144533822|NCT03279978|521157814|FG000|Overall Study|Withdrawal by Subject|0|||
144533823|NCT03279978|521157815|FG001|Overall Study|Withdrawal by Subject|1|||
144533824|NCT03279978|521157816|FG002|Overall Study|Withdrawal by Subject|0|||
144533825|NCT03279978|521157817|FG003|Overall Study|Withdrawal by Subject|0|||
144533826|NCT03279978|521157818|FG004|Overall Study|Withdrawal by Subject|0|||
144533827|NCT03279978|521157819|FG005|Overall Study|Withdrawal by Subject|0|||
144533828|NCT03279978|521157820|FG006|Overall Study|Withdrawal by Subject|0|||
144533829|NCT03279978|521157821|FG007|Overall Study|Withdrawal by Subject|0|||
144533830|NCT03279978|521157822|FG008|Overall Study|Withdrawal by Subject|0|||
144533831|NCT03279978|521157823|FG009|Overall Study|Withdrawal by Subject|1|||
144533832|NCT03279978|521157814|FG000|Overall Study|Lost to Follow-up|1|||
144533833|NCT03279978|521157815|FG001|Overall Study|Lost to Follow-up|0|||
144533834|NCT03279978|521157816|FG002|Overall Study|Lost to Follow-up|1|||
144533835|NCT03279978|521157817|FG003|Overall Study|Lost to Follow-up|0|||
144533836|NCT03279978|521157818|FG004|Overall Study|Lost to Follow-up|0|||
144533837|NCT03279978|521157819|FG005|Overall Study|Lost to Follow-up|0|||
144533838|NCT03279978|521157820|FG006|Overall Study|Lost to Follow-up|0|||
144533839|NCT03279978|521157821|FG007|Overall Study|Lost to Follow-up|0|||
144533840|NCT03279978|521157822|FG008|Overall Study|Lost to Follow-up|0|||
144533841|NCT03279978|521157823|FG009|Overall Study|Lost to Follow-up|0|||
144533842|NCT03279978|521157814|FG000|Overall Study|Other than stated above|0|||
144533843|NCT03279978|521157815|FG001|Overall Study|Other than stated above|0|||
144533844|NCT03279978|521157816|FG002|Overall Study|Other than stated above|0|||
144533845|NCT03279978|521157817|FG003|Overall Study|Other than stated above|0|||
144533846|NCT03279978|521157818|FG004|Overall Study|Other than stated above|0|||
144533847|NCT03279978|521157819|FG005|Overall Study|Other than stated above|0|||
144533848|NCT03279978|521157820|FG006|Overall Study|Other than stated above|1|||
144533849|NCT03279978|521157821|FG007|Overall Study|Other than stated above|0|||
144533850|NCT03279978|521157822|FG008|Overall Study|Other than stated above|0|||
144454929|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
144454930|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
144454931|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
144454932|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
144454933|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
144454934|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
144454935|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
144454936|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
144454937|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
144454938|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
144454939|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
144454940|NCT01434602|520863071|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
144454941|NCT01434602|520863072|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
144454942|NCT01434602|520863073|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
144454943|NCT01434602|520863074|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
144454944|NCT01434602|520863075|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
144454945|NCT05077267|520863081|FG000|Treatment Period|Lost to Follow-up|0|||
144454946|NCT05077267|520863082|FG001|Treatment Period|Lost to Follow-up|1|||
144454947|NCT05077267|520863083|FG002|Treatment Period|Lost to Follow-up|0|||
144454948|NCT05077267|520863081|FG000|Treatment Period|Withdrawal by Subject|0|||
144454949|NCT05077267|520863082|FG001|Treatment Period|Withdrawal by Subject|1|||
144454950|NCT05077267|520863083|FG002|Treatment Period|Withdrawal by Subject|0|||
144454951|NCT05077267|520863081|FG000|Follow-up Period|Lost to Follow-up|0|||
144454952|NCT05077267|520863082|FG001|Follow-up Period|Lost to Follow-up|5|||
144454953|NCT05077267|520863083|FG002|Follow-up Period|Lost to Follow-up|7|||
144454954|NCT05077267|520863081|FG000|Follow-up Period|Withdrawal by Subject|0|||
144454955|NCT05077267|520863082|FG001|Follow-up Period|Withdrawal by Subject|2|||
144454956|NCT05077267|520863083|FG002|Follow-up Period|Withdrawal by Subject|5|||
144454957|NCT05077267|520863081|FG000|Follow-up Period|Study terminated by sponsor|0|||
144454958|NCT05077267|520863082|FG001|Follow-up Period|Study terminated by sponsor|27|||
144454959|NCT05077267|520863083|FG002|Follow-up Period|Study terminated by sponsor|23|||
144454960|NCT05077267|520863081|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
144454961|NCT05077267|520863082|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
144454962|NCT05077267|520863083|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
144454963|NCT05077267|520863081|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
144454964|NCT05077267|520863082|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
144454965|NCT05077267|520863083|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
144454966|NCT02308033|520863084|FG000|Overall Study|Normal Gram stain at Baseline|13|||
144454967|NCT02308033|520863085|FG001|Overall Study|Normal Gram stain at Baseline|10|||
144454968|NCT02308033|520863084|FG000|Overall Study|Positive for STD at Baseline|7|||
144454969|NCT02308033|520863085|FG001|Overall Study|Positive for STD at Baseline|4|||
144454970|NCT02308033|520863084|FG000|Overall Study|Lost to Follow-up|6|||
144607331|NCT03374995|521424389|FG001|Overall Study|Withdrawal by Subject|1|||
144607332|NCT01211535|521424392|FG000|Overall Study|Adverse Event|0|||
144607333|NCT01211535|521424393|FG001|Overall Study|Adverse Event|1|||
144607334|NCT00003895|521424397|FG000|Overall Study|Adverse Event|4|||
144607335|NCT00003895|521424398|FG001|Overall Study|Adverse Event|0|||
144607336|NCT00003895|521424397|FG000|Overall Study|Lack of Efficacy|1|||
144607337|NCT00003895|521424398|FG001|Overall Study|Lack of Efficacy|1|||
144607338|NCT00003895|521424397|FG000|Overall Study|Patient Vacation|2|||
144607339|NCT00003895|521424398|FG001|Overall Study|Patient Vacation|0|||
144607340|NCT00003895|521424397|FG000|Overall Study|Withdrawal by Subject|0|||
144607341|NCT00003895|521424398|FG001|Overall Study|Withdrawal by Subject|3|||
144607342|NCT01735279|521424401|FG000|Overall Study|Lost to Follow-up|11|||
144607343|NCT01735279|521424402|FG001|Overall Study|Lost to Follow-up|8|||
144196635|NCT00856973|519917008|FG000|Overall Study|Other|11|||
144196636|NCT00856973|519917009|FG001|Overall Study|Other|12|||
144196637|NCT00856973|519917010|FG002|Overall Study|Other|13|||
144196638|NCT04556552|519917015|FG000|Overall Study|Lost to Follow-up|1|||
144196639|NCT04556552|519917016|FG001|Overall Study|Lost to Follow-up|0|||
144454971|NCT02308033|520863085|FG001|Overall Study|Lost to Follow-up|5|||
144454972|NCT01870843|520863089|FG000|Overall Study|Adverse Event|10|||
144454973|NCT01870843|520863089|FG000|Overall Study|Lost to Follow-up|24|||
144454974|NCT01870843|520863089|FG000|Overall Study|Death|1|||
144607344|NCT01380730|521424403|FG000|Overall Study|Death|0|||
144454975|NCT01870843|520863089|FG000|Overall Study|Withdrawal by Subject|18|||
144607345|NCT01380730|521424404|FG001|Overall Study|Death|0|||
144607346|NCT01380730|521424405|FG002|Overall Study|Death|0|||
144607347|NCT01380730|521424406|FG003|Overall Study|Death|0|||
144607348|NCT01380730|521424407|FG004|Overall Study|Death|1|||
144607349|NCT01380730|521424408|FG005|Overall Study|Death|0|||
144607350|NCT01380730|521424409|FG006|Overall Study|Death|0|||
144196640|NCT04556552|519917015|FG000|Overall Study|Claustrophobia|0|||
144454976|NCT00345397|520863090|FG000|Overall Study|Death|1|||
144454977|NCT03325712|520863091|FG000|Overall Study|Protocol Violation|0|||
144454978|NCT03325712|520863092|FG001|Overall Study|Protocol Violation|0|||
144454979|NCT03325712|520863093|FG002|Overall Study|Protocol Violation|0|||
144454980|NCT03325712|520863094|FG003|Overall Study|Protocol Violation|0|||
144454981|NCT03325712|520863095|FG004|Overall Study|Protocol Violation|1|||
144454982|NCT03325712|520863096|FG005|Overall Study|Protocol Violation|0|||
144454983|NCT03325712|520863097|FG006|Overall Study|Protocol Violation|0|||
144454984|NCT03325712|520863098|FG007|Overall Study|Protocol Violation|0|||
144454985|NCT03325712|520863091|FG000|Overall Study|Adverse Event|0|||
144454986|NCT03325712|520863092|FG001|Overall Study|Adverse Event|0|||
144454987|NCT03325712|520863093|FG002|Overall Study|Adverse Event|0|||
144454988|NCT03325712|520863094|FG003|Overall Study|Adverse Event|0|||
144454989|NCT03325712|520863095|FG004|Overall Study|Adverse Event|1|||
144454990|NCT03325712|520863096|FG005|Overall Study|Adverse Event|0|||
144454991|NCT03325712|520863097|FG006|Overall Study|Adverse Event|0|||
144454992|NCT03325712|520863098|FG007|Overall Study|Adverse Event|0|||
144454993|NCT01297062|520863100|FG000|Overall Study|Adverse Event|2|||
144454994|NCT01297062|520863101|FG001|Overall Study|Adverse Event|0|||
144454995|NCT01297062|520863102|FG002|Overall Study|Adverse Event|1|||
144454996|NCT01297062|520863103|FG003|Overall Study|Adverse Event|0|||
144454997|NCT01297062|520863104|FG004|Overall Study|Adverse Event|0|||
144454998|NCT01297062|520863105|FG005|Overall Study|Adverse Event|0|||
144454999|NCT01297062|520863106|FG006|Overall Study|Adverse Event|0|||
144455000|NCT01297062|520863100|FG000|Overall Study|Physician Decision|1|||
144455001|NCT01297062|520863101|FG001|Overall Study|Physician Decision|0|||
144455002|NCT01297062|520863102|FG002|Overall Study|Physician Decision|1|||
144455003|NCT01297062|520863103|FG003|Overall Study|Physician Decision|0|||
144455004|NCT01297062|520863104|FG004|Overall Study|Physician Decision|0|||
144455005|NCT01297062|520863105|FG005|Overall Study|Physician Decision|0|||
144607351|NCT01380730|521424410|FG007|Overall Study|Death|0|||
144607352|NCT02490475|521424411|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
144607353|NCT02490475|521424412|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
144607354|NCT02490475|521424413|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
144607355|NCT02490475|521424414|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
144607356|NCT02490475|521424411|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
144607357|NCT02490475|521424412|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
144607358|NCT02490475|521424413|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
144607359|NCT02490475|521424414|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
144607360|NCT02490475|521424411|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
144607361|NCT02490475|521424412|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
144607362|NCT02490475|521424413|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
144607363|NCT02490475|521424414|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
144607364|NCT02490475|521424411|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
144607365|NCT02490475|521424412|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
144607366|NCT02490475|521424413|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
144607367|NCT02490475|521424414|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
144607368|NCT02490475|521424411|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
144607369|NCT02490475|521424412|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
144607370|NCT02490475|521424413|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
144607371|NCT02490475|521424414|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
144607372|NCT02490475|521424411|FG000|Period 2: Extension Phase|Refused Treatment|0|||
144607373|NCT02490475|521424412|FG001|Period 2: Extension Phase|Refused Treatment|0|||
144607374|NCT02490475|521424413|FG002|Period 2: Extension Phase|Refused Treatment|0|||
144607375|NCT02490475|521424414|FG003|Period 2: Extension Phase|Refused Treatment|1|||
144607376|NCT02490475|521424411|FG000|Period 2: Extension Phase|Adverse Event|0|||
144607377|NCT02490475|521424412|FG001|Period 2: Extension Phase|Adverse Event|0|||
144607378|NCT02490475|521424413|FG002|Period 2: Extension Phase|Adverse Event|1|||
144455006|NCT01297062|520863106|FG006|Overall Study|Physician Decision|6|||
144455007|NCT01297062|520863100|FG000|Overall Study|Protocol Violation|0|||
144455008|NCT01297062|520863101|FG001|Overall Study|Protocol Violation|0|||
144455009|NCT01297062|520863102|FG002|Overall Study|Protocol Violation|0|||
144455010|NCT01297062|520863103|FG003|Overall Study|Protocol Violation|0|||
144607379|NCT02490475|521424414|FG003|Period 2: Extension Phase|Adverse Event|0|||
144607380|NCT01195090|521424419|FG000|Overall Study|Adverse Event|1|||
144455011|NCT01297062|520863104|FG004|Overall Study|Protocol Violation|1|||
144455012|NCT01297062|520863105|FG005|Overall Study|Protocol Violation|0|||
144455013|NCT01297062|520863106|FG006|Overall Study|Protocol Violation|0|||
144455014|NCT01297062|520863100|FG000|Overall Study|Subject Decision|1|||
144455015|NCT01297062|520863101|FG001|Overall Study|Subject Decision|1|||
144455016|NCT01297062|520863102|FG002|Overall Study|Subject Decision|0|||
144607381|NCT01195090|521424420|FG001|Overall Study|Adverse Event|2|||
144455017|NCT01297062|520863103|FG003|Overall Study|Subject Decision|1|||
144455018|NCT01297062|520863104|FG004|Overall Study|Subject Decision|1|||
144455019|NCT01297062|520863105|FG005|Overall Study|Subject Decision|1|||
144455020|NCT01297062|520863106|FG006|Overall Study|Subject Decision|2|||
144725795|NCT05109234|521851369|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
144725796|NCT05109234|521851368|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
144725797|NCT05109234|521851369|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
144725798|NCT05109234|521851368|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
144725799|NCT05109234|521851369|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
144725800|NCT03968224|521851370|FG000|Overall Study|Lost to Follow-up|11|||
144725801|NCT03968224|521851371|FG001|Overall Study|Lost to Follow-up|18|||
144725802|NCT00336024|521851372|FG000|Overall Study|Death|2|||
144725803|NCT00336024|521851373|FG001|Overall Study|Death|1|||
144725804|NCT00336024|521851372|FG000|Overall Study|Physician Decision|4|||
144725805|NCT00336024|521851373|FG001|Overall Study|Physician Decision|1|||
144725806|NCT00336024|521851372|FG000|Overall Study|Protocol Violation|1|||
144725807|NCT00336024|521851373|FG001|Overall Study|Protocol Violation|0|||
144196641|NCT04556552|519917016|FG001|Overall Study|Claustrophobia|1|||
144196642|NCT04556552|519917015|FG000|Overall Study|Inability to continue|0|||
144196643|NCT04556552|519917016|FG001|Overall Study|Inability to continue|1|||
144196644|NCT04551911|519917017|FG000|Overall Study|Lost to Follow-up|2|||
144196645|NCT04551911|519917018|FG001|Overall Study|Lost to Follow-up|1|||
144196646|NCT04551911|519917017|FG000|Overall Study|Withdrawal by Subject|10|||
144196647|NCT04551911|519917018|FG001|Overall Study|Withdrawal by Subject|10|||
144196648|NCT04551911|519917017|FG000|Overall Study|Did not receive the study drug|3|||
144196649|NCT04551911|519917018|FG001|Overall Study|Did not receive the study drug|4|||
144196650|NCT01215513|519917019|FG000|Overall Study|Not completed CS42|9|||
144196651|NCT01215513|519917019|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
144196652|NCT01215513|519917019|FG000|Overall Study|Adverse event (CS42A)|2|||
144196653|NCT01215513|519917019|FG000|Overall Study|Physician decision (CS42A)|6|||
144196654|NCT01215513|519917019|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
144196655|NCT01215513|519917019|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
144196656|NCT01553279|519917020|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
144196657|NCT01553279|519917021|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
144196658|NCT01553279|519917020|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
144196659|NCT01553279|519917021|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
144196660|NCT01553279|519917020|FG000|Interim Period|Withdrawal by Subject|2|||
144455021|NCT04295564|520864856|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
144455022|NCT04295564|520864857|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
144455023|NCT01773226|520864859|FG000|Overall Study|Withdrawal by Subject|1|||
144455024|NCT00724282|520864866|FG000|Overall Study|Withdrawal by Subject|3|||
144455025|NCT00724282|520864866|FG000|Overall Study|Physician Decision|1|||
144455026|NCT03521635|520864868|FG000|Overall Study|Adverse Event|1|||
144455027|NCT03521635|520864869|FG001|Overall Study|Adverse Event|1|||
144455028|NCT03521635|520864868|FG000|Overall Study|Refused to complete study visit|1|||
144455029|NCT03521635|520864869|FG001|Overall Study|Refused to complete study visit|0|||
144455030|NCT03521635|520864868|FG000|Overall Study|Refused to continue trial medication|2|||
144455031|NCT03521635|520864869|FG001|Overall Study|Refused to continue trial medication|2|||
144455032|NCT03521635|520864868|FG000|Overall Study|Lost to Follow-up|0|||
144455033|NCT03521635|520864869|FG001|Overall Study|Lost to Follow-up|1|||
144455034|NCT03521635|520864868|FG000|Overall Study|Meet exclusion criteria|0|||
144455035|NCT03521635|520864869|FG001|Overall Study|Meet exclusion criteria|1|||
144455036|NCT03521635|520864868|FG000|Overall Study|Patient not taken study medicine|0|||
144455037|NCT03521635|520864869|FG001|Overall Study|Patient not taken study medicine|1|||
144455038|NCT01928719|520864870|FG000|Overall Study|Lost to Follow-up|26|||
144455039|NCT01928719|520864871|FG001|Overall Study|Lost to Follow-up|11|||
144455040|NCT01928719|520864870|FG000|Overall Study|Withdrawal by Subject|22|||
144455041|NCT01928719|520864871|FG001|Overall Study|Withdrawal by Subject|7|||
144455042|NCT01928719|520864870|FG000|Overall Study|Protocol Violation|3|||
144455043|NCT01928719|520864871|FG001|Overall Study|Protocol Violation|1|||
144455044|NCT01928719|520864870|FG000|Overall Study|Adverse Event|1|||
144455045|NCT01928719|520864871|FG001|Overall Study|Adverse Event|0|||
144455046|NCT00263666|520864872|FG000|Overall Study|Adverse Event|6|||
144455047|NCT00263666|520864873|FG001|Overall Study|Adverse Event|8|||
144533851|NCT03279978|521157823|FG009|Overall Study|Other than stated above|0|||
144725808|NCT00336024|521851372|FG000|Overall Study|Withdrawal by Subject|1|||
144725809|NCT00336024|521851373|FG001|Overall Study|Withdrawal by Subject|2|||
144725810|NCT00336024|521851372|FG000|Overall Study|Failure to fulfill consolidation|1|||
144725811|NCT00336024|521851373|FG001|Overall Study|Failure to fulfill consolidation|1|||
144533852|NCT04330040|521157824|FG000|Overall Study|Other: Adverse event|5|||
144196661|NCT01553279|519917021|FG001|Interim Period|Withdrawal by Subject|2|||
144196662|NCT01553279|519917020|FG000|Interim Period|Lost to Follow-up|1|||
144196663|NCT01553279|519917021|FG001|Interim Period|Lost to Follow-up|0|||
144196664|NCT01553279|519917020|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
144455048|NCT00263666|520864872|FG000|Overall Study|Lost to Follow-up|1|||
144455049|NCT00263666|520864873|FG001|Overall Study|Lost to Follow-up|2|||
144455050|NCT00263666|520864872|FG000|Overall Study|Withdrawal by Subject|0|||
144455051|NCT00263666|520864873|FG001|Overall Study|Withdrawal by Subject|1|||
144455052|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
144455053|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
144455054|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
144455055|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
144455056|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
144455057|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
144455058|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
144455059|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
144455060|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
144455061|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
144455062|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
144455063|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
144455064|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
144455065|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
144455066|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
144455067|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
144455068|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
144455069|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
144455070|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
144455071|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
144455072|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
144455073|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
144455074|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
144455075|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
144455076|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455077|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455078|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455079|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455080|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455081|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455082|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455083|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455084|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455085|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455086|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455087|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455088|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455089|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455090|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455091|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
144455092|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455093|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455094|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
144455095|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
144455096|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
144455097|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455098|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455099|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455100|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455101|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455102|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144725812|NCT00336024|521851372|FG000|Overall Study|Progressive Disease|4|||
144725813|NCT00336024|521851373|FG001|Overall Study|Progressive Disease|7|||
144533853|NCT04330040|521157825|FG001|Overall Study|Other: Adverse event|0|||
144533854|NCT04330040|521157826|FG002|Overall Study|Other: Adverse event|0|||
144533855|NCT04330040|521157824|FG000|Overall Study|Disease progression|38|||
144533856|NCT04330040|521157825|FG001|Overall Study|Disease progression|10|||
144533857|NCT04330040|521157826|FG002|Overall Study|Disease progression|0|||
144533858|NCT04330040|521157824|FG000|Overall Study|Physician Decision|5|||
144533859|NCT04330040|521157825|FG001|Overall Study|Physician Decision|3|||
144533860|NCT04330040|521157826|FG002|Overall Study|Physician Decision|0|||
144533861|NCT04330040|521157824|FG000|Overall Study|Lost to Follow-up|1|||
144533862|NCT04330040|521157825|FG001|Overall Study|Lost to Follow-up|1|||
144533863|NCT04330040|521157826|FG002|Overall Study|Lost to Follow-up|0|||
144533864|NCT04330040|521157824|FG000|Overall Study|Death|2|||
144455103|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455104|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455105|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144533865|NCT04330040|521157825|FG001|Overall Study|Death|1|||
144533866|NCT04330040|521157826|FG002|Overall Study|Death|0|||
144725814|NCT00336024|521851372|FG000|Overall Study|Ineligible|7|||
144255049|NCT00398216|520136073|FG000|Overall Study|Protocol Violation|2|||
144455106|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455107|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455108|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455109|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455110|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455111|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
144455112|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
144455113|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
144455114|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
144455115|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
144455116|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
144455117|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
144455118|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
144455119|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
144455120|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
144455121|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
144455122|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
144455123|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
144455124|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
144455125|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
144455126|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
144455127|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
144455128|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
144455129|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
144455130|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
144455131|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
144455132|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
144455133|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455134|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455135|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455136|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455137|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455138|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455139|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455140|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455141|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455142|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455143|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455144|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455145|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455146|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455147|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455148|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455149|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455150|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455151|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
144455152|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
144455153|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
144455154|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455155|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
144455156|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
144455157|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455158|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455159|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455160|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455161|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455162|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455163|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455164|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455165|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455166|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455167|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455168|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455169|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455170|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144455171|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
144255050|NCT00398216|520136074|FG001|Overall Study|Protocol Violation|4|||
144455172|NCT01490632|520864874|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455173|NCT01490632|520864875|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455174|NCT01490632|520864876|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455175|NCT01490632|520864877|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455176|NCT01490632|520864878|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
144455177|NCT01490632|520864879|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455178|NCT01490632|520864880|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455179|NCT01490632|520864881|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455180|NCT01490632|520864882|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455181|NCT01490632|520864883|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455182|NCT01490632|520864884|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455183|NCT01490632|520864885|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455184|NCT01490632|520864886|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455185|NCT01490632|520864887|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455186|NCT01490632|520864888|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455187|NCT01490632|520864889|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455188|NCT01490632|520864890|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455189|NCT01490632|520864891|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455190|NCT01490632|520864892|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455191|NCT01490632|520864893|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
144455192|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455193|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455194|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455195|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455196|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455197|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
144455198|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
144455199|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455200|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455201|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
144455202|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
144455203|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
144455204|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455205|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455206|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455207|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455208|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455209|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455210|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455211|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
144455212|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455213|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455214|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455215|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455216|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455217|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455218|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
144455219|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455220|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
144455221|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
144455222|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
144533867|NCT04330040|521157824|FG000|Overall Study|Withdrawal by Subject|3|||
144533868|NCT04330040|521157825|FG001|Overall Study|Withdrawal by Subject|3|||
144533869|NCT04330040|521157826|FG002|Overall Study|Withdrawal by Subject|0|||
144533870|NCT04330040|521157824|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
144533871|NCT04330040|521157825|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
144533872|NCT04330040|521157826|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
144533873|NCT04330040|521157824|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
144533874|NCT04330040|521157825|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
144533875|NCT04330040|521157826|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
144533876|NCT04330040|521157824|FG000|Overall Study|Other: Disease progression|1|||
144533877|NCT04330040|521157825|FG001|Overall Study|Other: Disease progression|0|||
144607382|NCT01195090|521424419|FG000|Overall Study|Lost to Follow-up|2|||
144607383|NCT01195090|521424420|FG001|Overall Study|Lost to Follow-up|2|||
144607384|NCT01195090|521424419|FG000|Overall Study|Protocol Violation|3|||
144607385|NCT01195090|521424420|FG001|Overall Study|Protocol Violation|4|||
144455223|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455224|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455225|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455226|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455227|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455228|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455229|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455230|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455231|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
144455232|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455233|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455234|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455235|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455236|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455237|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455238|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
144455239|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455240|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455241|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
144455242|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455243|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455244|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455245|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455246|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455247|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455248|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455249|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455250|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455251|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
144455252|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455253|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455254|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455255|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455256|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455257|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455258|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
144455259|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455260|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
144533878|NCT04330040|521157826|FG002|Overall Study|Other: Disease progression|0|||
144533879|NCT04330040|521157824|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
144533880|NCT04330040|521157825|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
144533881|NCT04330040|521157826|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
144533882|NCT04330040|521157824|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
144533883|NCT04330040|521157825|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
144533884|NCT04330040|521157826|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
144533885|NCT04330040|521157824|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
144607386|NCT04912245|521424421|FG000|Overall Study|Withdrawal by Subject|21|||
144607387|NCT04912245|521424422|FG001|Overall Study|Withdrawal by Subject|4|||
144607388|NCT04912245|521424421|FG000|Overall Study|Lost to Follow-up|5|||
144607389|NCT04912245|521424422|FG001|Overall Study|Lost to Follow-up|11|||
144607390|NCT01205230|521424423|FG000|Overall Study|Adverse Event|4|||
144607391|NCT01205230|521424424|FG001|Overall Study|Adverse Event|0|||
144607392|NCT01205230|521424423|FG000|Overall Study|Physician Decision|1|||
144607393|NCT01205230|521424424|FG001|Overall Study|Physician Decision|0|||
144607394|NCT00922480|521424425|FG000|Main Study|Protocol Violation|3|||
144607395|NCT00922480|521424426|FG001|Main Study|Protocol Violation|6|||
144607396|NCT00922480|521424425|FG000|Main Study|Adverse Event|6|||
144607397|NCT00922480|521424426|FG001|Main Study|Adverse Event|7|||
144607398|NCT00922480|521424425|FG000|Main Study|Lack of Efficacy|3|||
144455261|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455262|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
144607399|NCT00922480|521424426|FG001|Main Study|Lack of Efficacy|0|||
144607400|NCT00922480|521424425|FG000|Main Study|Withdrawal by Subject|20|||
144607401|NCT00922480|521424426|FG001|Main Study|Withdrawal by Subject|15|||
144607402|NCT00922480|521424425|FG000|Main Study|Lost to Follow-up|5|||
144725815|NCT00336024|521851373|FG001|Overall Study|Ineligible|7|||
144196665|NCT01553279|519917021|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
144196666|NCT01553279|519917020|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
144455263|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455264|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455265|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455266|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455267|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455268|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455269|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455270|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455271|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
144455272|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455273|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455274|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455275|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455276|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455277|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
144455278|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455279|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455280|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455281|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455282|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455283|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455284|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455285|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455286|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455287|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455288|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455289|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455290|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455291|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
144455292|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455293|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455294|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455295|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455296|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455297|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455298|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
144455299|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455300|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
144455301|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455302|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
144455303|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
144455304|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455305|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455306|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455307|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455308|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455309|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455310|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455311|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
144455312|NCT01490632|520864874|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455313|NCT01490632|520864875|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455314|NCT01490632|520864876|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455315|NCT01490632|520864877|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144533886|NCT04330040|521157825|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
144533887|NCT04330040|521157826|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
144533888|NCT02461134|521157828|FG000|Overall Study|Adverse Event|1|||
144533889|NCT04761198|521157829|FG000|Overall Study|Progressive Disease|1|||
144533890|NCT04761198|521157830|FG001|Overall Study|Progressive Disease|0|||
144533891|NCT04761198|521157831|FG002|Overall Study|Progressive Disease|0|||
144533892|NCT04761198|521157832|FG003|Overall Study|Progressive Disease|1|||
144533893|NCT04761198|521157833|FG004|Overall Study|Progressive Disease|4|||
144725816|NCT02585258|521851374|FG000|Overall Study|Adverse Event|28|||
144196667|NCT01553279|519917021|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
144196668|NCT00605865|519917023|FG000|Overall Study|Protocol Violation|115|||
144196669|NCT03955471|519917024|FG000|Overall Study|Death|22|||
144533894|NCT04761198|521157834|FG005|Overall Study|Progressive Disease|1|||
144533895|NCT04761198|521157835|FG006|Overall Study|Progressive Disease|2|||
144533896|NCT04761198|521157829|FG000|Overall Study|Protocol Violation|0|||
144533897|NCT04761198|521157830|FG001|Overall Study|Protocol Violation|0|||
144533898|NCT04761198|521157831|FG002|Overall Study|Protocol Violation|0|||
144533899|NCT04761198|521157832|FG003|Overall Study|Protocol Violation|0|||
144533900|NCT04761198|521157833|FG004|Overall Study|Protocol Violation|1|||
144533901|NCT04761198|521157834|FG005|Overall Study|Protocol Violation|0|||
144533902|NCT04761198|521157835|FG006|Overall Study|Protocol Violation|0|||
144533903|NCT04761198|521157829|FG000|Overall Study|Death|2|||
144533904|NCT04761198|521157830|FG001|Overall Study|Death|1|||
144533905|NCT04761198|521157831|FG002|Overall Study|Death|2|||
144533906|NCT04761198|521157832|FG003|Overall Study|Death|5|||
144533907|NCT04761198|521157833|FG004|Overall Study|Death|14|||
144533908|NCT04761198|521157834|FG005|Overall Study|Death|2|||
144533909|NCT04761198|521157835|FG006|Overall Study|Death|5|||
144533910|NCT04761198|521157829|FG000|Overall Study|Lost to Follow-up|0|||
144533911|NCT04761198|521157830|FG001|Overall Study|Lost to Follow-up|0|||
144533912|NCT04761198|521157831|FG002|Overall Study|Lost to Follow-up|0|||
144533913|NCT04761198|521157832|FG003|Overall Study|Lost to Follow-up|0|||
144533914|NCT04761198|521157833|FG004|Overall Study|Lost to Follow-up|1|||
144533915|NCT04761198|521157834|FG005|Overall Study|Lost to Follow-up|0|||
144533916|NCT04761198|521157835|FG006|Overall Study|Lost to Follow-up|0|||
144533917|NCT04761198|521157829|FG000|Overall Study|Withdrawal by Subject|2|||
144533918|NCT04761198|521157830|FG001|Overall Study|Withdrawal by Subject|0|||
144533919|NCT04761198|521157831|FG002|Overall Study|Withdrawal by Subject|1|||
144533920|NCT04761198|521157832|FG003|Overall Study|Withdrawal by Subject|0|||
144533921|NCT04761198|521157833|FG004|Overall Study|Withdrawal by Subject|2|||
144533922|NCT04761198|521157834|FG005|Overall Study|Withdrawal by Subject|0|||
144533923|NCT04761198|521157835|FG006|Overall Study|Withdrawal by Subject|1|||
144533924|NCT04761198|521157829|FG000|Overall Study|Study Terminated by Sponsor|6|||
144533925|NCT04761198|521157830|FG001|Overall Study|Study Terminated by Sponsor|0|||
144533926|NCT04761198|521157831|FG002|Overall Study|Study Terminated by Sponsor|5|||
144533927|NCT04761198|521157832|FG003|Overall Study|Study Terminated by Sponsor|3|||
144533928|NCT04761198|521157833|FG004|Overall Study|Study Terminated by Sponsor|10|||
144533929|NCT04761198|521157834|FG005|Overall Study|Study Terminated by Sponsor|1|||
144533930|NCT04761198|521157835|FG006|Overall Study|Study Terminated by Sponsor|2|||
144533931|NCT02994927|521157836|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144533932|NCT02994927|521157837|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144533933|NCT02994927|521157836|FG000|Overall Study|Did not meet eligibility criteria|0|||
144533934|NCT02994927|521157837|FG001|Overall Study|Did not meet eligibility criteria|1|||
144533935|NCT02994927|521157836|FG000|Overall Study|Physician Decision|4|||
144533936|NCT02994927|521157837|FG001|Overall Study|Physician Decision|3|||
144533937|NCT02994927|521157836|FG000|Overall Study|Death|4|||
144533938|NCT02994927|521157837|FG001|Overall Study|Death|2|||
144533939|NCT02994927|521157836|FG000|Overall Study|Adverse Event|2|||
144533940|NCT02994927|521157837|FG001|Overall Study|Adverse Event|1|||
144533941|NCT02994927|521157836|FG000|Overall Study|Withdrawal by Subject|3|||
144533942|NCT02994927|521157837|FG001|Overall Study|Withdrawal by Subject|6|||
144533943|NCT02994927|521157836|FG000|Overall Study|Lost to Follow-up|2|||
144533944|NCT02994927|521157837|FG001|Overall Study|Lost to Follow-up|1|||
144533945|NCT00626795|521157838|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
144533946|NCT00626795|521157839|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
144533947|NCT00626795|521157840|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
144533948|NCT00626795|521157838|FG000|Blinded Treatment|Lack of Efficacy|2|||
144533949|NCT00626795|521157839|FG001|Blinded Treatment|Lack of Efficacy|0|||
144533950|NCT00626795|521157840|FG002|Blinded Treatment|Lack of Efficacy|0|||
144533951|NCT00626795|521157838|FG000|Blinded Treatment|Unacceptable adverse event|0|||
144533952|NCT00626795|521157839|FG001|Blinded Treatment|Unacceptable adverse event|0|||
144533953|NCT00626795|521157840|FG002|Blinded Treatment|Unacceptable adverse event|1|||
144533954|NCT00626795|521157838|FG000|Blinded Treatment|Protocol Violation|0|||
144533955|NCT00626795|521157839|FG001|Blinded Treatment|Protocol Violation|1|||
144533956|NCT00626795|521157840|FG002|Blinded Treatment|Protocol Violation|1|||
144533957|NCT00626795|521157838|FG000|Blinded Treatment|Withdrawal by Subject|1|||
144533958|NCT00626795|521157839|FG001|Blinded Treatment|Withdrawal by Subject|1|||
144533959|NCT00626795|521157840|FG002|Blinded Treatment|Withdrawal by Subject|0|||
144533960|NCT00626795|521157838|FG000|Blinded Treatment|Other reasons|2|||
144533961|NCT00626795|521157839|FG001|Blinded Treatment|Other reasons|0|||
144533962|NCT00626795|521157840|FG002|Blinded Treatment|Other reasons|2|||
144533963|NCT00626795|521157838|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
144533964|NCT00626795|521157839|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
144533965|NCT00626795|521157840|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
144533966|NCT03533257|521157848|FG000|Overall Study|Adverse Event|4|||
144533967|NCT03533257|521157849|FG001|Overall Study|Adverse Event|2|||
144533968|NCT03533257|521157848|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
144533969|NCT03533257|521157849|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
144455316|NCT01490632|520864878|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455317|NCT01490632|520864879|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
144455318|NCT01490632|520864880|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
144455319|NCT01490632|520864881|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
144455320|NCT01490632|520864882|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
144455321|NCT01490632|520864883|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
144455322|NCT01490632|520864884|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
144455323|NCT01490632|520864885|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
144196670|NCT03955471|519917024|FG000|Overall Study|Lost to Follow-up|1|||
144196671|NCT03955471|519917024|FG000|Overall Study|Withdrawal by Subject|6|||
144196672|NCT03955471|519917024|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
144196673|NCT01030341|519917027|FG000|Overall Study|Withdrawal by Subject|1|||
144455324|NCT01490632|520864886|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455325|NCT01490632|520864887|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455326|NCT01490632|520864888|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455327|NCT01490632|520864889|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455328|NCT01490632|520864890|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455329|NCT01490632|520864891|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455330|NCT01490632|520864892|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455331|NCT01490632|520864893|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
144455332|NCT01490632|520864874|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
144196674|NCT01030341|519917027|FG000|Overall Study|Lost to Follow-up|2|||
144196675|NCT00821873|519917028|FG000|Overall Study|Lost to Follow-up|4|||
144196676|NCT01884311|519917031|FG000|Overall Study|Withdrawal by Subject|3|||
144196677|NCT01884311|519917031|FG000|Overall Study|withdrew consent due to AEs|1|||
144455333|NCT01490632|520864875|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455334|NCT01490632|520864876|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455335|NCT01490632|520864877|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455336|NCT01490632|520864878|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455337|NCT01490632|520864879|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455338|NCT01490632|520864880|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455339|NCT01490632|520864881|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455340|NCT01490632|520864882|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455341|NCT01490632|520864883|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455342|NCT01490632|520864884|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455343|NCT01490632|520864885|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455344|NCT01490632|520864886|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455345|NCT01490632|520864887|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455346|NCT01490632|520864888|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
144455347|NCT01490632|520864889|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
144455348|NCT01490632|520864890|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455349|NCT01490632|520864891|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455350|NCT01490632|520864892|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455351|NCT01490632|520864893|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
144455352|NCT01490632|520864874|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455353|NCT01490632|520864875|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455354|NCT01490632|520864876|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455355|NCT01490632|520864877|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455356|NCT01490632|520864878|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455357|NCT01490632|520864879|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455358|NCT01490632|520864880|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455359|NCT01490632|520864881|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455360|NCT01490632|520864882|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455361|NCT01490632|520864883|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455362|NCT01490632|520864884|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455363|NCT01490632|520864885|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455364|NCT01490632|520864886|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455365|NCT01490632|520864887|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
144455366|NCT01490632|520864888|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455367|NCT01490632|520864889|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144533970|NCT04159519|521157850|FG000|Overall Study|Adverse Event|1|||
144533971|NCT04159519|521157851|FG001|Overall Study|Adverse Event|1|||
144196678|NCT01884311|519917031|FG000|Overall Study|Precautionary measure|1|||
144255051|NCT00398216|520136075|FG002|Overall Study|Protocol Violation|5|||
144196679|NCT00321828|519917034|FG000|Overall Study|Ineligible|3|||
144255052|NCT00398216|520136076|FG003|Overall Study|Protocol Violation|7|||
144196680|NCT00321828|519917034|FG000|Overall Study|No follow up data|1|||
144196681|NCT02307266|519917035|FG000|Overall Study|Adverse Event|3|||
144196682|NCT02307266|519917036|FG001|Overall Study|Adverse Event|1|||
144196683|NCT02307266|519917037|FG002|Overall Study|Adverse Event|5|||
144196684|NCT02307266|519917035|FG000|Overall Study|Withdrawal by Subject|2|||
144196685|NCT02307266|519917036|FG001|Overall Study|Withdrawal by Subject|0|||
144196686|NCT02307266|519917037|FG002|Overall Study|Withdrawal by Subject|1|||
144196687|NCT02307266|519917035|FG000|Overall Study|Lost to Follow-up|3|||
144196688|NCT02307266|519917036|FG001|Overall Study|Lost to Follow-up|0|||
144196689|NCT02307266|519917037|FG002|Overall Study|Lost to Follow-up|0|||
144196690|NCT02856880|519917039|FG000|Overall Study|Withdrawal of consent|1|||
144196691|NCT00793780|519917040|FG000|Overall Study|Withdrawal by Subject|2|||
144196692|NCT00793780|519917041|FG001|Overall Study|Withdrawal by Subject|1|||
144196693|NCT02858492|519917042|FG000|Overall Study|Withdrawal by Subject|0|||
144196694|NCT02858492|519917043|FG001|Overall Study|Withdrawal by Subject|1|||
144455368|NCT01490632|520864890|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455369|NCT01490632|520864891|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455370|NCT01490632|520864892|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455371|NCT01490632|520864893|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
144455372|NCT01490632|520864874|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455373|NCT01490632|520864875|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455374|NCT01490632|520864876|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455375|NCT01490632|520864877|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455376|NCT01490632|520864878|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455377|NCT01490632|520864879|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455378|NCT01490632|520864880|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455379|NCT01490632|520864881|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455380|NCT01490632|520864882|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455381|NCT01490632|520864883|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455382|NCT01490632|520864884|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455383|NCT01490632|520864885|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455384|NCT01490632|520864886|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455385|NCT01490632|520864887|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455386|NCT01490632|520864888|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
144455387|NCT01490632|520864889|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
144455388|NCT01490632|520864890|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455389|NCT01490632|520864891|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455390|NCT01490632|520864892|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455391|NCT01490632|520864893|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
144455392|NCT01490632|520864874|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455393|NCT01490632|520864875|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455394|NCT01490632|520864876|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455395|NCT01490632|520864877|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455396|NCT01490632|520864878|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455397|NCT01490632|520864879|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455398|NCT01490632|520864880|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455399|NCT01490632|520864881|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455400|NCT01490632|520864882|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455401|NCT01490632|520864883|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455402|NCT01490632|520864884|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455403|NCT01490632|520864885|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455404|NCT01490632|520864886|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
144455405|NCT01490632|520864887|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
144455406|NCT01490632|520864888|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
144455407|NCT01490632|520864889|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
144455408|NCT01490632|520864890|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455409|NCT01490632|520864891|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144533972|NCT04159519|521157850|FG000|Overall Study|Lack of Efficacy|1|||
144533973|NCT04159519|521157851|FG001|Overall Study|Lack of Efficacy|0|||
144533974|NCT04159519|521157850|FG000|Overall Study|Discontinued from study|1|||
144533975|NCT04159519|521157851|FG001|Overall Study|Discontinued from study|0|||
144533976|NCT04159519|521157850|FG000|Overall Study|Protocol Violation|1|||
144533977|NCT04159519|521157851|FG001|Overall Study|Protocol Violation|1|||
144196695|NCT02858492|519917044|FG002|Overall Study|Withdrawal by Subject|0|||
144196696|NCT02858492|519917045|FG003|Overall Study|Withdrawal by Subject|1|||
144455410|NCT01490632|520864892|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455411|NCT01490632|520864893|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
144455412|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
144455413|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
144455414|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
144455415|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
144455416|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
144455417|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
144455418|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
144455419|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
144455420|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
144455421|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
144455422|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
144455423|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
144196697|NCT02858492|519917042|FG000|Overall Study|Adverse Event|0|||
144196698|NCT02858492|519917043|FG001|Overall Study|Adverse Event|0|||
144455424|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
144455425|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
144455426|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
144455427|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
144455428|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
144455429|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
144455430|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
144455431|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
144455432|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Death|0|||
144455433|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Death|0|||
144455434|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Death|0|||
144455435|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Death|0|||
144455436|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Death|0|||
144455437|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Death|0|||
144455438|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Death|0|||
144455439|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Death|0|||
144455440|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Death|0|||
144455441|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Death|0|||
144455442|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Death|0|||
144455443|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Death|0|||
144455444|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Death|0|||
144455445|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Death|0|||
144455446|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Death|0|||
144455447|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Death|0|||
144455448|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Death|0|||
144455449|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Death|0|||
144196699|NCT02858492|519917044|FG002|Overall Study|Adverse Event|0|||
144196700|NCT02858492|519917045|FG003|Overall Study|Adverse Event|3|||
144196701|NCT02858492|519917042|FG000|Overall Study|Lack of Efficacy|0|||
144196702|NCT02858492|519917043|FG001|Overall Study|Lack of Efficacy|0|||
144196703|NCT02858492|519917044|FG002|Overall Study|Lack of Efficacy|0|||
144196704|NCT02858492|519917045|FG003|Overall Study|Lack of Efficacy|1|||
144196705|NCT02858492|519917042|FG000|Overall Study|Protocol defined stopping criteria|0|||
144196706|NCT02858492|519917043|FG001|Overall Study|Protocol defined stopping criteria|0|||
144196707|NCT02858492|519917044|FG002|Overall Study|Protocol defined stopping criteria|0|||
144196708|NCT02858492|519917045|FG003|Overall Study|Protocol defined stopping criteria|1|||
144196709|NCT00573157|519917046|FG000|Overall Study|Adverse Event|3|||
144196710|NCT00573157|519917047|FG001|Overall Study|Adverse Event|1|||
144196711|NCT00573157|519917046|FG000|Overall Study|Other|1|||
144455450|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Death|1|||
144455451|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Death|0|||
144455452|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455453|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455454|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455455|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455456|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144196712|NCT00573157|519917047|FG001|Overall Study|Other|1|||
144196713|NCT01032018|519917050|FG000|Overall Study|Lost to Follow-up|6|||
144196714|NCT01032018|519917051|FG001|Overall Study|Lost to Follow-up|5|||
144196715|NCT01032018|519917050|FG000|Overall Study|Death|0|||
144455457|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455458|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455459|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455460|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455461|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455462|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455463|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144196716|NCT01032018|519917051|FG001|Overall Study|Death|1|||
144196717|NCT00729248|519917055|FG000|Overall Study|Physician Decision|2|||
144196718|NCT03573505|519917056|FG000|Overall Study|Adverse Event|1|||
144455464|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455465|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455466|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455467|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455468|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
144455469|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
144455470|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
144455471|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
144455472|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455473|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455474|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455475|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455476|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455477|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455478|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455479|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455480|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455481|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455482|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455483|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455484|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144533978|NCT04159519|521157850|FG000|Overall Study|Withdrawal by Subject|4|||
144533979|NCT04159519|521157851|FG001|Overall Study|Withdrawal by Subject|4|||
144533980|NCT03493542|521157852|FG000|Base Study|Withdrawal by Subject|0|||
144533981|NCT03493542|521157853|FG001|Base Study|Withdrawal by Subject|4|||
144533982|NCT03493542|521157854|FG002|Base Study|Withdrawal by Subject|0|||
144533983|NCT03493542|521157852|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
144533984|NCT03493542|521157853|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
144533985|NCT03493542|521157854|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
144533986|NCT03493542|521157852|FG000|Extension Study|Withdrawal by Subject|0|||
144533987|NCT03493542|521157853|FG001|Extension Study|Withdrawal by Subject|0|||
144533988|NCT03493542|521157854|FG002|Extension Study|Withdrawal by Subject|25|||
144533989|NCT04244175|521158504|FG000|Overall Study|Adverse Event|3|||
144533990|NCT04244175|521158505|FG001|Overall Study|Adverse Event|2|||
144533991|NCT04244175|521158506|FG002|Overall Study|Adverse Event|5|||
144533992|NCT04244175|521158504|FG000|Overall Study|Lack of Efficacy|1|||
144533993|NCT04244175|521158505|FG001|Overall Study|Lack of Efficacy|0|||
144533994|NCT04244175|521158506|FG002|Overall Study|Lack of Efficacy|1|||
144533995|NCT04244175|521158504|FG000|Overall Study|Lost to Follow-up|1|||
144533996|NCT04244175|521158505|FG001|Overall Study|Lost to Follow-up|0|||
144533997|NCT04244175|521158506|FG002|Overall Study|Lost to Follow-up|0|||
144533998|NCT04244175|521158504|FG000|Overall Study|Non-compliance with study drug|1|||
144533999|NCT04244175|521158505|FG001|Overall Study|Non-compliance with study drug|0|||
144534000|NCT04244175|521158506|FG002|Overall Study|Non-compliance with study drug|1|||
144534001|NCT04244175|521158504|FG000|Overall Study|Protocol deviation|0|||
144534002|NCT04244175|521158505|FG001|Overall Study|Protocol deviation|1|||
144534003|NCT04244175|521158506|FG002|Overall Study|Protocol deviation|0|||
144534004|NCT04244175|521158504|FG000|Overall Study|Withdrawal by Subject|1|||
144534005|NCT04244175|521158505|FG001|Overall Study|Withdrawal by Subject|3|||
144534006|NCT04244175|521158506|FG002|Overall Study|Withdrawal by Subject|1|||
144534007|NCT04244175|521158504|FG000|Overall Study|Other, not specified|0|||
144534008|NCT04244175|521158505|FG001|Overall Study|Other, not specified|1|||
144534009|NCT04244175|521158506|FG002|Overall Study|Other, not specified|2|||
144534010|NCT04464564|521158514|FG000|Period A (Placebo lead-in)|Other|5|||
144534011|NCT04464564|521158515|FG001|Period A (Placebo lead-in)|Other|0|||
144534012|NCT04464564|521158516|FG002|Period A (Placebo lead-in)|Other|0|||
144534013|NCT04464564|521158517|FG003|Period A (Placebo lead-in)|Other|0|||
144534014|NCT04464564|521158514|FG000|Period B (Randomization Period)|Adverse Event|0|||
144534015|NCT04464564|521158515|FG001|Period B (Randomization Period)|Adverse Event|1|||
144534016|NCT04464564|521158516|FG002|Period B (Randomization Period)|Adverse Event|2|||
144534017|NCT04464564|521158517|FG003|Period B (Randomization Period)|Adverse Event|8|||
144534018|NCT04464564|521158514|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
144534019|NCT04464564|521158515|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
144534020|NCT04464564|521158516|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
144534021|NCT04464564|521158517|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
144455485|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455486|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455487|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144534022|NCT04464564|521158514|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
144534023|NCT04464564|521158515|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
144534024|NCT04464564|521158516|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
144534025|NCT04464564|521158517|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
144534026|NCT04464564|521158514|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
144196719|NCT03573505|519917057|FG001|Overall Study|Adverse Event|1|||
144196720|NCT03573505|519917056|FG000|Overall Study|Consent withdrawn|0|||
144196721|NCT03573505|519917057|FG001|Overall Study|Consent withdrawn|1|||
144455488|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455489|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455490|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
144455491|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
144455492|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
144455493|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
144455494|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
144455495|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
144455496|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
144455497|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
144455498|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
144455499|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
144455500|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
144455501|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
144455502|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
144455503|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
144455504|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
144455505|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
144455506|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
144455507|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
144455508|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
144455509|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
144455510|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
144455511|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
144455512|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
144455513|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
144455514|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
144455515|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
144455516|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
144455517|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
144455518|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
144455519|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
144455520|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
144455521|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
144455522|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
144455523|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
144455524|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
144455525|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
144455526|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
144455527|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
144455528|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
144455529|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
144455530|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
144455531|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
144455532|NCT01490632|520864874|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455533|NCT01490632|520864875|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455534|NCT01490632|520864876|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455535|NCT01490632|520864877|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455536|NCT01490632|520864878|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455537|NCT01490632|520864879|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455538|NCT01490632|520864880|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455539|NCT01490632|520864881|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455540|NCT01490632|520864882|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455541|NCT01490632|520864883|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455542|NCT01490632|520864884|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455543|NCT01490632|520864885|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455544|NCT01490632|520864886|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455545|NCT01490632|520864887|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455546|NCT01490632|520864888|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455547|NCT01490632|520864889|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144534027|NCT04464564|521158515|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
144534028|NCT04464564|521158516|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
144534029|NCT04464564|521158517|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
144534030|NCT04464564|521158514|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
144534031|NCT04464564|521158515|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
144534032|NCT04464564|521158516|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
144607403|NCT00922480|521424426|FG001|Main Study|Lost to Follow-up|0|||
144455548|NCT01490632|520864890|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
144455549|NCT01490632|520864891|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
144455550|NCT01490632|520864892|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
144455551|NCT01490632|520864893|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
144455552|NCT05732454|520864894|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
144455553|NCT05732454|520864895|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
144455554|NCT05732454|520864894|FG000|Part 1: DB Period|Adverse Event|1|||
144455555|NCT05732454|520864895|FG001|Part 1: DB Period|Adverse Event|0|||
144455556|NCT05732454|520864894|FG000|Part 1: DB Period|Lost to Follow-up|1|||
144455557|NCT05732454|520864895|FG001|Part 1: DB Period|Lost to Follow-up|0|||
144455558|NCT05732454|520864894|FG000|Part 1: DB Period|Protocol Violation|0|||
144455559|NCT05732454|520864895|FG001|Part 1: DB Period|Protocol Violation|1|||
144455560|NCT05732454|520864894|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
144455561|NCT05732454|520864895|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
144455562|NCT05732454|520864894|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
144455563|NCT05732454|520864895|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
144455564|NCT05732454|520864894|FG000|Part 1: OLE Period|Adverse Event|0|||
144455565|NCT05732454|520864895|FG001|Part 1: OLE Period|Adverse Event|1|||
144455566|NCT05732454|520864894|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
144455567|NCT05732454|520864895|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
144455568|NCT01153633|520864896|FG000|Overall Study|Protocol Violation|1|||
144455569|NCT01153633|520864897|FG001|Overall Study|Protocol Violation|1|||
144455570|NCT01153633|520864896|FG000|Overall Study|Therapeutic failure|3|||
144455571|NCT01153633|520864897|FG001|Overall Study|Therapeutic failure|3|||
144455572|NCT01003899|520864902|FG000|Overall Study|Other Adverse Event|8|||
144455573|NCT01003899|520864902|FG000|Overall Study|Not entered|4|||
144455574|NCT01003899|520864902|FG000|Overall Study|Not treated|1|||
144455575|NCT01003899|520864902|FG000|Overall Study|Progressive disease|34|||
144455576|NCT00352365|520864903|FG000|Induction Therapy|Adverse Event|7|||
144455577|NCT00352365|520864903|FG000|Induction Therapy|Progression/Relapse|8|||
144455578|NCT00352365|520864903|FG000|Induction Therapy|Death|7|||
144455579|NCT00352365|520864903|FG000|Induction Therapy|Not protocol specified|1|||
144455580|NCT00352365|520864903|FG000|Induction Therapy|Not eligible|3|||
144455581|NCT00352365|520864903|FG000|Induction Therapy|Death before starting protocol therapy|1|||
144455582|NCT00352365|520864903|FG000|Maintenance Therapy|Progression/Relapse|3|||
144455583|NCT00352365|520864903|FG000|Maintenance Therapy|Death|2|||
144455584|NCT00352365|520864903|FG000|Maintenance Therapy|Not protocol specified|3|||
144455585|NCT00352365|520864903|FG000|Maintenance Therapy|Not eligible|4|||
144455586|NCT01262651|520864904|FG000|Overall Study|Adverse Event|40|||
144455587|NCT01262651|520864905|FG001|Overall Study|Adverse Event|35|||
144455588|NCT01262651|520864904|FG000|Overall Study|Withdrawal by Subject|15|||
144455589|NCT01262651|520864905|FG001|Overall Study|Withdrawal by Subject|11|||
144455590|NCT01262651|520864904|FG000|Overall Study|Withdrawal by Investigator|2|||
144455591|NCT01262651|520864905|FG001|Overall Study|Withdrawal by Investigator|2|||
144455592|NCT01262651|520864904|FG000|Overall Study|Met Withdrawal Criteria|1|||
144455593|NCT01262651|520864905|FG001|Overall Study|Met Withdrawal Criteria|0|||
144455594|NCT04969783|520864906|FG000|Overall Study|Lost to Follow-up|2|||
144455595|NCT04969783|520864907|FG001|Overall Study|Lost to Follow-up|0|||
144455596|NCT04969783|520864906|FG000|Overall Study|Withdrawal by Subject|4|||
144455597|NCT04969783|520864907|FG001|Overall Study|Withdrawal by Subject|0|||
144455598|NCT04969783|520864906|FG000|Overall Study|Physician Decision|6|||
144455599|NCT04969783|520864907|FG001|Overall Study|Physician Decision|0|||
144455600|NCT03422250|520864908|FG000|Intervention|Adverse Event|0|||
144455601|NCT03422250|520864909|FG001|Intervention|Adverse Event|1|||
144455602|NCT03422250|520864910|FG002|Intervention|Adverse Event|0|||
144455603|NCT03422250|520864911|FG003|Intervention|Adverse Event|1|||
144455604|NCT03422250|520864908|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
144455605|NCT03422250|520864909|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
144455606|NCT03422250|520864910|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
144455607|NCT03422250|520864911|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
144455608|NCT03422250|520864908|FG000|Follow-up|Withdrawal by Subject|0|||
144455609|NCT03422250|520864909|FG001|Follow-up|Withdrawal by Subject|0|||
144455610|NCT03422250|520864910|FG002|Follow-up|Withdrawal by Subject|0|||
144455611|NCT03422250|520864911|FG003|Follow-up|Withdrawal by Subject|1|||
144455612|NCT03422250|520864908|FG000|Follow-up|Adverse Event|0|||
144455613|NCT03422250|520864909|FG001|Follow-up|Adverse Event|0|||
144455614|NCT03422250|520864910|FG002|Follow-up|Adverse Event|0|||
144455615|NCT03422250|520864911|FG003|Follow-up|Adverse Event|1|||
144455616|NCT02896855|520864921|FG000|Overall Study|Death|50|||
144455617|NCT02896855|520864922|FG001|Overall Study|Death|40|||
144455618|NCT02896855|520864921|FG000|Overall Study|Lost to Follow-up|15|||
144455619|NCT02896855|520864922|FG001|Overall Study|Lost to Follow-up|9|||
144455620|NCT02896855|520864921|FG000|Overall Study|Withdrawal by Subject|7|||
144455621|NCT02896855|520864922|FG001|Overall Study|Withdrawal by Subject|4|||
144455622|NCT01205685|520864923|FG000|Overall Study|Disease Progression|10|||
144455623|NCT01205685|520864923|FG000|Overall Study|Withdrawal by Subject|1|||
144455624|NCT02169674|520864924|FG000|Overall Study|Withdrawal by Subject|2|||
144455625|NCT02169674|520864925|FG001|Overall Study|Withdrawal by Subject|1|||
144455626|NCT02169674|520864924|FG000|Overall Study|Seroprotected|30|||
144455627|NCT02169674|520864925|FG001|Overall Study|Seroprotected|76|||
144455628|NCT02169674|520864924|FG000|Overall Study|Lost to Follow-up|0|||
144455629|NCT02169674|520864925|FG001|Overall Study|Lost to Follow-up|1|||
144455630|NCT03058679|520864926|FG000|Baseline to Week 6|Lost to Follow-up|3|||
144455631|NCT03058679|520864927|FG001|Baseline to Week 6|Lost to Follow-up|2|||
144455632|NCT03058679|520864926|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
144455633|NCT03058679|520864927|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
144455634|NCT03058679|520864926|FG000|Baseline to Week 6|Adverse Event|6|||
144455635|NCT03058679|520864927|FG001|Baseline to Week 6|Adverse Event|6|||
144455636|NCT03058679|520864926|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
144455637|NCT03058679|520864927|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
144455638|NCT03058679|520864926|FG000|Baseline to Week 6|Difficulty following the diet|0|||
144455639|NCT03058679|520864927|FG001|Baseline to Week 6|Difficulty following the diet|2|||
144455640|NCT03058679|520864926|FG000|Baseline to Week 6|Physician Decision|1|||
144455641|NCT03058679|520864927|FG001|Baseline to Week 6|Physician Decision|0|||
144455642|NCT03058679|520864926|FG000|Week 6 to Week 12|Change in medication|5|||
144455643|NCT03058679|520864927|FG001|Week 6 to Week 12|Change in medication|7|||
144455644|NCT03058679|520864926|FG000|Week 6 to Week 12|Adverse Event|4|||
144455645|NCT03058679|520864927|FG001|Week 6 to Week 12|Adverse Event|3|||
144455646|NCT03058679|520864926|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
144455647|NCT03058679|520864927|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
144455648|NCT03058679|520864926|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
144455649|NCT03058679|520864927|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
144455650|NCT02504294|520864930|FG000|Overall Study|Adverse Event|15|||
144455651|NCT02504294|520864931|FG001|Overall Study|Adverse Event|12|||
144455652|NCT02504294|520864930|FG000|Overall Study|Withdrawal by Subject|7|||
144455653|NCT02504294|520864931|FG001|Overall Study|Withdrawal by Subject|1|||
144455654|NCT02504294|520864930|FG000|Overall Study|Protocol Violation|27|||
144455655|NCT02504294|520864931|FG001|Overall Study|Protocol Violation|26|||
144455656|NCT02504294|520864930|FG000|Overall Study|Physician Decision|1|||
144455657|NCT02504294|520864931|FG001|Overall Study|Physician Decision|2|||
144455658|NCT02504294|520864930|FG000|Overall Study|Lost to Follow-up|6|||
144455659|NCT02504294|520864931|FG001|Overall Study|Lost to Follow-up|7|||
144455660|NCT01953926|520864932|FG000|Overall Study|Withdrawal by Subject|23|||
144455661|NCT01953926|520864933|FG001|Overall Study|Withdrawal by Subject|3|||
144455662|NCT01953926|520864934|FG002|Overall Study|Withdrawal by Subject|3|||
144455663|NCT01953926|520864935|FG003|Overall Study|Withdrawal by Subject|5|||
144455664|NCT01953926|520864936|FG004|Overall Study|Withdrawal by Subject|6|||
144455665|NCT01953926|520864937|FG005|Overall Study|Withdrawal by Subject|0|||
144455666|NCT01953926|520864938|FG006|Overall Study|Withdrawal by Subject|1|||
144455667|NCT01953926|520864932|FG000|Overall Study|Physician Decision|1|||
144455668|NCT01953926|520864933|FG001|Overall Study|Physician Decision|0|||
144455669|NCT01953926|520864934|FG002|Overall Study|Physician Decision|0|||
144455670|NCT01953926|520864935|FG003|Overall Study|Physician Decision|0|||
144455671|NCT01953926|520864936|FG004|Overall Study|Physician Decision|2|||
144455672|NCT01953926|520864937|FG005|Overall Study|Physician Decision|0|||
144455673|NCT01953926|520864938|FG006|Overall Study|Physician Decision|0|||
144455674|NCT01953926|520864932|FG000|Overall Study|Lost to Follow-up|18|||
144455675|NCT01953926|520864933|FG001|Overall Study|Lost to Follow-up|3|||
144455676|NCT01953926|520864934|FG002|Overall Study|Lost to Follow-up|0|||
144455677|NCT01953926|520864935|FG003|Overall Study|Lost to Follow-up|5|||
144455678|NCT01953926|520864936|FG004|Overall Study|Lost to Follow-up|3|||
144455679|NCT01953926|520864937|FG005|Overall Study|Lost to Follow-up|0|||
144455680|NCT01953926|520864938|FG006|Overall Study|Lost to Follow-up|0|||
144455681|NCT01953926|520864932|FG000|Overall Study|Protocol Violation|1|||
144455682|NCT01953926|520864933|FG001|Overall Study|Protocol Violation|0|||
144455683|NCT01953926|520864934|FG002|Overall Study|Protocol Violation|0|||
144455684|NCT01953926|520864935|FG003|Overall Study|Protocol Violation|0|||
144455685|NCT01953926|520864936|FG004|Overall Study|Protocol Violation|0|||
144725817|NCT02585258|521851375|FG001|Overall Study|Adverse Event|29|||
144455686|NCT01953926|520864937|FG005|Overall Study|Protocol Violation|0|||
144455687|NCT01953926|520864938|FG006|Overall Study|Protocol Violation|0|||
144455688|NCT01953926|520864932|FG000|Overall Study|Other, Disease progression|2|||
144455689|NCT01953926|520864933|FG001|Overall Study|Other, Disease progression|1|||
144455690|NCT01953926|520864934|FG002|Overall Study|Other, Disease progression|0|||
144455691|NCT01953926|520864935|FG003|Overall Study|Other, Disease progression|0|||
144455692|NCT01953926|520864936|FG004|Overall Study|Other, Disease progression|1|||
144455693|NCT01953926|520864937|FG005|Overall Study|Other, Disease progression|0|||
144455694|NCT01953926|520864938|FG006|Overall Study|Other, Disease progression|0|||
144455695|NCT01953926|520864932|FG000|Overall Study|Discontinuation of study by sponsor|41|||
144455696|NCT01953926|520864933|FG001|Overall Study|Discontinuation of study by sponsor|7|||
144455697|NCT01953926|520864934|FG002|Overall Study|Discontinuation of study by sponsor|5|||
144455698|NCT01953926|520864935|FG003|Overall Study|Discontinuation of study by sponsor|12|||
144455699|NCT01953926|520864936|FG004|Overall Study|Discontinuation of study by sponsor|46|||
144455700|NCT01953926|520864937|FG005|Overall Study|Discontinuation of study by sponsor|5|||
144455701|NCT01953926|520864938|FG006|Overall Study|Discontinuation of study by sponsor|6|||
144455702|NCT01953926|520864932|FG000|Overall Study|Not Treated|1|||
144455703|NCT01953926|520864933|FG001|Overall Study|Not Treated|0|||
144455704|NCT01953926|520864934|FG002|Overall Study|Not Treated|1|||
144455705|NCT01953926|520864935|FG003|Overall Study|Not Treated|0|||
144455706|NCT01953926|520864936|FG004|Overall Study|Not Treated|0|||
144455707|NCT01953926|520864937|FG005|Overall Study|Not Treated|0|||
144455708|NCT01953926|520864938|FG006|Overall Study|Not Treated|0|||
144455709|NCT01949480|520864939|FG000|Overall Study|Physician Decision|5|||
144455710|NCT01949480|520864940|FG001|Overall Study|Physician Decision|8|||
144455711|NCT00144339|520864941|FG000|Overall Study|Adverse Event|746|||
144455712|NCT00144339|520864942|FG001|Overall Study|Adverse Event|627|||
144455713|NCT00144339|520864941|FG000|Overall Study|Protocol Violation|75|||
144455714|NCT00144339|520864942|FG001|Overall Study|Protocol Violation|48|||
144455715|NCT00144339|520864941|FG000|Overall Study|Withdrawal by Subject|403|||
144455716|NCT00144339|520864942|FG001|Overall Study|Withdrawal by Subject|300|||
144455717|NCT00144339|520864941|FG000|Overall Study|Lost to Follow-up|76|||
144455718|NCT00144339|520864942|FG001|Overall Study|Lost to Follow-up|64|||
144455719|NCT00144339|520864941|FG000|Overall Study|Other|58|||
144455720|NCT00144339|520864942|FG001|Overall Study|Other|60|||
144455721|NCT00759109|520864948|FG000|Overall Study|Adverse Event|17|||
144455722|NCT00759109|520864949|FG001|Overall Study|Adverse Event|12|||
144455723|NCT00759109|520864948|FG000|Overall Study|Inability to comply|1|||
144455724|NCT00759109|520864949|FG001|Overall Study|Inability to comply|1|||
144455725|NCT00759109|520864948|FG000|Overall Study|Withdrawal by Subject|9|||
144455726|NCT00759109|520864949|FG001|Overall Study|Withdrawal by Subject|5|||
144455727|NCT00759109|520864948|FG000|Overall Study|Death|4|||
144455728|NCT00759109|520864949|FG001|Overall Study|Death|3|||
144455729|NCT00759109|520864948|FG000|Overall Study|Lost to Follow-up|4|||
144607404|NCT00922480|521424425|FG000|Main Study|Physician Decision|0|||
144455730|NCT00759109|520864949|FG001|Overall Study|Lost to Follow-up|6|||
144455731|NCT00759109|520864948|FG000|Overall Study|Started new therapy|2|||
144455732|NCT00759109|520864949|FG001|Overall Study|Started new therapy|6|||
144455733|NCT00759109|520864948|FG000|Overall Study|HCV RNA negative|1|||
144455734|NCT00759109|520864949|FG001|Overall Study|HCV RNA negative|0|||
144455735|NCT00759109|520864948|FG000|Overall Study|Participant moved to a different city|0|||
144455736|NCT00759109|520864949|FG001|Overall Study|Participant moved to a different city|1|||
144455737|NCT00759109|520864948|FG000|Overall Study|Participant had a liver transplant|0|||
144455738|NCT00759109|520864949|FG001|Overall Study|Participant had a liver transplant|1|||
144455739|NCT00759109|520864948|FG000|Overall Study|Lost during study|1|||
144455740|NCT00759109|520864949|FG001|Overall Study|Lost during study|0|||
144455741|NCT01827904|520864950|FG000|Main Study|Withdrawal by Subject|1|||
144455742|NCT01827904|520864951|FG001|Main Study|Withdrawal by Subject|0|||
144455743|NCT01827904|520864952|FG002|Main Study|Withdrawal by Subject|0|||
144455744|NCT01827904|520864950|FG000|Main Study|Adverse Event|1|||
144455745|NCT01827904|520864951|FG001|Main Study|Adverse Event|0|||
144455746|NCT01827904|520864952|FG002|Main Study|Adverse Event|0|||
144455747|NCT01827904|520864950|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
144455748|NCT01827904|520864951|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
144455749|NCT01827904|520864952|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
144455750|NCT01827904|520864950|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
144455751|NCT01827904|520864951|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
144455752|NCT01827904|520864952|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
144455753|NCT01827904|520864950|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
144455754|NCT01827904|520864951|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
144455755|NCT01827904|520864952|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
144455756|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
144455757|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
144455758|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
144455759|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
144455760|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
144455761|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
144455762|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
144455763|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
144455764|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
144455765|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
144455766|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
144455767|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
144455768|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Physician Decision|1|||
144455769|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Physician Decision|0|||
144455770|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Physician Decision|0|||
144455771|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
144455772|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
144607405|NCT00922480|521424426|FG001|Main Study|Physician Decision|1|||
144607406|NCT00922480|521424425|FG000|Extension Study|Protocol Violation|3|||
144607407|NCT00922480|521424426|FG001|Extension Study|Protocol Violation|0|||
144607408|NCT00922480|521424425|FG000|Extension Study|Adverse Event|1|||
144607409|NCT00922480|521424426|FG001|Extension Study|Adverse Event|1|||
144607410|NCT00922480|521424425|FG000|Extension Study|Withdrawal by Subject|1|||
144607411|NCT00922480|521424426|FG001|Extension Study|Withdrawal by Subject|1|||
144607412|NCT00922480|521424425|FG000|Extension Study|Others|0|||
144607413|NCT00922480|521424426|FG001|Extension Study|Others|1|||
144607414|NCT04784897|521424427|FG000|Overall Study|Death|4|||
144607415|NCT04784897|521424428|FG001|Overall Study|Death|2|||
144607416|NCT04784897|521424429|FG002|Overall Study|Death|1|||
144607417|NCT04784897|521424427|FG000|Overall Study|Withdrawal by Subject|0|||
144725818|NCT02585258|521851374|FG000|Overall Study|Death|3|||
144725819|NCT02585258|521851375|FG001|Overall Study|Death|2|||
144455773|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
144455774|NCT01827904|520864950|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
144455775|NCT01827904|520864951|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
144455776|NCT01827904|520864952|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
144455777|NCT00142909|520864953|FG000|Randomization|Various Reasons|7|||
144455778|NCT00142909|520864954|FG001|Randomization|Various Reasons|10|||
144455779|NCT00142909|520864953|FG000|Medications Begin|Protocol Violation|2|||
144455780|NCT00142909|520864954|FG001|Medications Begin|Protocol Violation|0|||
144455781|NCT00142909|520864953|FG000|Medications Begin|Withdrawal by Subject|5|||
144455782|NCT00142909|520864954|FG001|Medications Begin|Withdrawal by Subject|3|||
144455783|NCT00142909|520864953|FG000|Medications Begin|Withdrawal by Subject|2|||
144455784|NCT00142909|520864954|FG001|Medications Begin|Withdrawal by Subject|0|||
144455785|NCT02265237|520864956|FG000|As Treated (Overall Study)|Adverse Event|1|||
144455786|NCT02265237|520864957|FG001|As Treated (Overall Study)|Adverse Event|1|||
144455787|NCT02265237|520864958|FG002|As Treated (Overall Study)|Adverse Event|0|||
144455788|NCT02265237|520864959|FG003|As Treated (Overall Study)|Adverse Event|0|||
144455789|NCT02265237|520864956|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
144455790|NCT02265237|520864957|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
144455791|NCT02265237|520864958|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
144455792|NCT02265237|520864959|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
144455793|NCT02265237|520864956|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
144455794|NCT02265237|520864957|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
144455795|NCT02265237|520864958|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
144455796|NCT02265237|520864959|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
144455797|NCT02265237|520864956|FG000|As Treated (Overall Study)|Other|2|||
144455798|NCT02265237|520864957|FG001|As Treated (Overall Study)|Other|0|||
144455799|NCT02265237|520864958|FG002|As Treated (Overall Study)|Other|3|||
144455800|NCT02265237|520864959|FG003|As Treated (Overall Study)|Other|1|||
144455801|NCT01178853|520864961|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
144455802|NCT01178853|520864962|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
144455803|NCT01178853|520864961|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
144455804|NCT01178853|520864962|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
144455805|NCT01178853|520864961|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
144455806|NCT01178853|520864962|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
144455807|NCT01178853|520864961|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
144455808|NCT01178853|520864962|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
144455809|NCT01178853|520864961|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
144455810|NCT01178853|520864962|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
144455811|NCT03550313|520864963|FG000|Overall Study|Adverse Event|0|||
144455812|NCT03550313|520864964|FG001|Overall Study|Adverse Event|1|||
144455813|NCT03550313|520864965|FG002|Overall Study|Adverse Event|0|||
144455814|NCT03550313|520864963|FG000|Overall Study|Lost to Follow-up|5|||
144455815|NCT03550313|520864964|FG001|Overall Study|Lost to Follow-up|7|||
144455816|NCT03550313|520864965|FG002|Overall Study|Lost to Follow-up|12|||
144455817|NCT03550313|520864963|FG000|Overall Study|Study terminated by sponsor|44|||
144455818|NCT03550313|520864964|FG001|Overall Study|Study terminated by sponsor|37|||
144455819|NCT03550313|520864965|FG002|Overall Study|Study terminated by sponsor|48|||
144455820|NCT03550313|520864963|FG000|Overall Study|No longer met eligibility criteria|3|||
144455821|NCT03550313|520864964|FG001|Overall Study|No longer met eligibility criteria|5|||
144455822|NCT03550313|520864965|FG002|Overall Study|No longer met eligibility criteria|6|||
144455823|NCT03550313|520864963|FG000|Overall Study|Withdrawal by parent/guardian|20|||
144455824|NCT03550313|520864964|FG001|Overall Study|Withdrawal by parent/guardian|18|||
144725820|NCT02585258|521851374|FG000|Overall Study|Lack of Efficacy|7|||
144455825|NCT03550313|520864965|FG002|Overall Study|Withdrawal by parent/guardian|26|||
144455826|NCT03550313|520864963|FG000|Overall Study|Other|4|||
144455827|NCT03550313|520864964|FG001|Overall Study|Other|2|||
144455828|NCT03550313|520864965|FG002|Overall Study|Other|2|||
144607418|NCT04784897|521424428|FG001|Overall Study|Withdrawal by Subject|0|||
144607419|NCT04784897|521424429|FG002|Overall Study|Withdrawal by Subject|1|||
144607420|NCT03861936|521424430|FG000|Overall Study|Withdrawal by Subject|4|||
144607421|NCT03861936|521424431|FG001|Overall Study|Withdrawal by Subject|1|||
144455829|NCT03550313|520864963|FG000|Overall Study|Randomized but not vaccinated|3|||
144455830|NCT03550313|520864964|FG001|Overall Study|Randomized but not vaccinated|23|||
144455831|NCT03550313|520864965|FG002|Overall Study|Randomized but not vaccinated|2|||
144455832|NCT03550313|520864963|FG000|Overall Study|Sites terminated due to quality issues|18|||
144455833|NCT03550313|520864964|FG001|Overall Study|Sites terminated due to quality issues|17|||
144455834|NCT03550313|520864965|FG002|Overall Study|Sites terminated due to quality issues|18|||
144455835|NCT00839072|520864966|FG000|First Intervention Period|Withdrawal by Subject|1|||
144455836|NCT00839072|520864967|FG001|First Intervention Period|Withdrawal by Subject|0|||
144455837|NCT00839072|520864966|FG000|First Intervention Period|Adverse Event|1|||
144455838|NCT00839072|520864967|FG001|First Intervention Period|Adverse Event|1|||
144455839|NCT00839072|520864966|FG000|Second Intervention Period|Withdrawal by Subject|1|||
144455840|NCT00839072|520864967|FG001|Second Intervention Period|Withdrawal by Subject|0|||
144455841|NCT02720484|520864971|FG000|Treatment on Study|Adverse Event|1|||
144455842|NCT02720484|520864971|FG000|Treatment on Study|Withdrawal by Subject|1|||
144455843|NCT02720484|520864971|FG000|Treatment on Study|Progressive Disease|4|||
144455844|NCT02720484|520864971|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
144455845|NCT02720484|520864971|FG000|Follow Up for 2 Years|Death|3|||
144455846|NCT02720484|520864971|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
144455847|NCT05070897|520864975|FG000|Overall Study|Protocol Violation|123|||
144455848|NCT05070897|520864976|FG001|Overall Study|Protocol Violation|68|||
144455849|NCT01617629|520864979|FG000|Overall Study|Death|2|||
144455850|NCT01617629|520864979|FG000|Overall Study|Investigator's Clinical Judgement|1|||
144455851|NCT01617629|520864979|FG000|Overall Study|Reason Not Specified|1|||
144455852|NCT01617629|520864979|FG000|Overall Study|Participant Withdrew Consent|2|||
144455853|NCT01663636|520864980|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
144455854|NCT01663636|520864981|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
144455855|NCT02838017|520864983|FG000|Overall Study|Lost to Follow-up|14|||
144455856|NCT02838017|520864984|FG001|Overall Study|Lost to Follow-up|11|||
144455857|NCT01692197|520864985|FG000|Overall Study|Failed Screening|3|||
144455858|NCT02120924|520864986|FG000|Overall Study|Lack of Efficacy|1|||
144455859|NCT02120924|520864987|FG001|Overall Study|Lack of Efficacy|2|||
144455860|NCT02120924|520864988|FG002|Overall Study|Lack of Efficacy|3|||
144455861|NCT02120924|520864986|FG000|Overall Study|Adverse Event|0|||
144455862|NCT02120924|520864987|FG001|Overall Study|Adverse Event|1|||
144455863|NCT02120924|520864988|FG002|Overall Study|Adverse Event|3|||
144455864|NCT02120924|520864986|FG000|Overall Study|Withdrawal by Subject|16|||
144455865|NCT02120924|520864987|FG001|Overall Study|Withdrawal by Subject|20|||
144455866|NCT02120924|520864988|FG002|Overall Study|Withdrawal by Subject|8|||
144455867|NCT02120924|520864986|FG000|Overall Study|Lost to Follow-up|14|||
144455868|NCT02120924|520864987|FG001|Overall Study|Lost to Follow-up|14|||
144455869|NCT02120924|520864988|FG002|Overall Study|Lost to Follow-up|11|||
144455870|NCT02120924|520864986|FG000|Overall Study|Pregnancy|2|||
144455871|NCT02120924|520864987|FG001|Overall Study|Pregnancy|0|||
144455872|NCT02120924|520864988|FG002|Overall Study|Pregnancy|0|||
144455873|NCT02120924|520864986|FG000|Overall Study|Protocol Violation|3|||
144455874|NCT02120924|520864987|FG001|Overall Study|Protocol Violation|7|||
144455875|NCT02120924|520864988|FG002|Overall Study|Protocol Violation|2|||
144455876|NCT02120924|520864986|FG000|Overall Study|Physician Decision|0|||
144455877|NCT02120924|520864987|FG001|Overall Study|Physician Decision|1|||
144455878|NCT02120924|520864988|FG002|Overall Study|Physician Decision|1|||
144455879|NCT02120924|520864986|FG000|Overall Study|Death|1|||
144455880|NCT02120924|520864987|FG001|Overall Study|Death|0|||
144455881|NCT02120924|520864988|FG002|Overall Study|Death|0|||
144455882|NCT02120924|520864986|FG000|Overall Study|Compliance with IP|5|||
144455883|NCT02120924|520864987|FG001|Overall Study|Compliance with IP|1|||
144455884|NCT02120924|520864988|FG002|Overall Study|Compliance with IP|1|||
144455885|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
144455886|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
144455887|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
144455888|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
144455889|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
144455890|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
144455891|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
144455892|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
144455893|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
144455894|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
144455895|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
144455896|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
144455897|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
144455898|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
144455899|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
144455900|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
144455901|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
144455902|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
144455903|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
144455904|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
144455905|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
144455906|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
144455907|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
144455908|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
144455909|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
144455910|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
144455911|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
144455912|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
144455913|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
144455914|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
144455915|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
144455916|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
144455917|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
144455918|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
144455919|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
144455920|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
144455921|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
144455922|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
144455923|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
144455924|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
144534033|NCT04464564|521158517|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
144534034|NCT04464564|521158514|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
144534035|NCT04464564|521158515|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
144534036|NCT04464564|521158516|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
144534037|NCT04464564|521158517|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
144534038|NCT04464564|521158514|FG000|Period B (Randomization Period)|Reason not Specified|0|||
144534039|NCT04464564|521158515|FG001|Period B (Randomization Period)|Reason not Specified|3|||
144534040|NCT04464564|521158516|FG002|Period B (Randomization Period)|Reason not Specified|3|||
144534041|NCT04464564|521158517|FG003|Period B (Randomization Period)|Reason not Specified|3|||
144534042|NCT04282980|521158518|FG000|Overall Study|Remained on treatment|6|||
144534043|NCT04282980|521158518|FG000|Overall Study|Survival follow-up|11|||
144534044|NCT04282980|521158518|FG000|Overall Study|Withdrawal of informed consent|1|||
144534045|NCT04282980|521158518|FG000|Overall Study|Lost to Follow-up|1|||
144534046|NCT02095691|521158519|FG000|Overall Study|Physician Decision|1|||
144534047|NCT00887198|521158520|FG000|Randomized Period|Ongoing|42|||
144534048|NCT00887198|521158521|FG001|Randomized Period|Ongoing|0|||
144534049|NCT00887198|521158522|FG002|Randomized Period|Ongoing|0|||
144534050|NCT00887198|521158520|FG000|Randomized Period|Adverse Event|50|||
144534051|NCT00887198|521158521|FG001|Randomized Period|Adverse Event|33|||
144534052|NCT00887198|521158522|FG002|Randomized Period|Adverse Event|0|||
144534053|NCT00887198|521158520|FG000|Randomized Period|Lost to Follow-up|1|||
144534054|NCT00887198|521158521|FG001|Randomized Period|Lost to Follow-up|0|||
144534055|NCT00887198|521158522|FG002|Randomized Period|Lost to Follow-up|0|||
144534056|NCT00887198|521158520|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
144534057|NCT00887198|521158521|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
144534058|NCT00887198|521158522|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
144534059|NCT00887198|521158520|FG000|Randomized Period|Withdrawal by Subject|41|||
144534060|NCT00887198|521158521|FG001|Randomized Period|Withdrawal by Subject|56|||
144534061|NCT00887198|521158522|FG002|Randomized Period|Withdrawal by Subject|0|||
144534062|NCT00887198|521158520|FG000|Randomized Period|Progressive disease|366|||
144534063|NCT00887198|521158521|FG001|Randomized Period|Progressive disease|370|||
144534064|NCT00887198|521158522|FG002|Randomized Period|Progressive disease|0|||
144534065|NCT00887198|521158520|FG000|Randomized Period|Other|42|||
144534066|NCT00887198|521158521|FG001|Randomized Period|Other|30|||
144534067|NCT00887198|521158522|FG002|Randomized Period|Other|0|||
144534068|NCT00887198|521158520|FG000|Randomized Period|Randomized, Not treated|4|||
144534069|NCT00887198|521158521|FG001|Randomized Period|Randomized, Not treated|2|||
144534070|NCT00887198|521158522|FG002|Randomized Period|Randomized, Not treated|0|||
144534071|NCT00887198|521158520|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
144534072|NCT00887198|521158521|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
144534073|NCT00887198|521158522|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
144534074|NCT00887198|521158520|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
144534075|NCT00887198|521158521|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
144534076|NCT00887198|521158522|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
144534077|NCT00887198|521158520|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
144455925|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
144455926|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
144455927|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
144455928|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
144455929|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
144455930|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
144455931|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
144455932|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
144455933|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
144455934|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
144455935|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
144455936|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
144455937|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
144455938|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
144455939|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
144455940|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
144455941|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
144455942|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
144455943|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
144455944|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
144455945|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
144455946|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
144455947|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
144455948|NCT01884350|520864989|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
144455949|NCT01884350|520864990|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
144455950|NCT01884350|520864991|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
144455951|NCT03588572|520864998|FG000|Visitation 1|Lack of Efficacy|1|||
144455952|NCT03588572|520864999|FG001|Visitation 1|Lack of Efficacy|1|||
144455953|NCT03588572|520864998|FG000|Visitation 2|Lost to Follow-up|1|||
144455954|NCT03588572|520864999|FG001|Visitation 2|Lost to Follow-up|1|||
144455955|NCT03588572|520864998|FG000|Visitation 2|Lack of Efficacy|0|||
144455956|NCT03588572|520864999|FG001|Visitation 2|Lack of Efficacy|1|||
144534078|NCT00887198|521158521|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
144534079|NCT00887198|521158522|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
144534080|NCT00887198|521158520|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
144534081|NCT00887198|521158521|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
144534082|NCT00887198|521158522|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
144534083|NCT00887198|521158520|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
144534084|NCT00887198|521158521|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
144534085|NCT00887198|521158522|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
144534086|NCT00887198|521158520|FG000|Cross Over (Placebo to AA)|Other|0|||
144534087|NCT00887198|521158521|FG001|Cross Over (Placebo to AA)|Other|0|||
144534088|NCT00887198|521158522|FG002|Cross Over (Placebo to AA)|Other|19|||
144534089|NCT05830799|521158528|FG000|Overall Study|Withdrawal by Subject|1|||
144534090|NCT02624050|521158531|FG000|Overall Study|Physician Decision|4|||
144534091|NCT02624050|521158532|FG001|Overall Study|Physician Decision|0|||
144534092|NCT02624050|521158531|FG000|Overall Study|Protocol Violation|2|||
144534093|NCT02624050|521158532|FG001|Overall Study|Protocol Violation|0|||
144534094|NCT04157517|521158534|FG000|Overall Study|Death|1|||
144534095|NCT04157517|521158535|FG001|Overall Study|Death|2|||
144534096|NCT04157517|521158536|FG002|Overall Study|Death|2|||
144534097|NCT04157517|521158537|FG003|Overall Study|Death|3|||
144534098|NCT04157517|521158538|FG004|Overall Study|Death|3|||
144534099|NCT04157517|521158539|FG005|Overall Study|Death|4|||
144534100|NCT04157517|521158540|FG006|Overall Study|Death|1|||
144534101|NCT04157517|521158541|FG007|Overall Study|Death|2|||
144534102|NCT04157517|521158542|FG008|Overall Study|Death|4|||
144534103|NCT04157517|521158543|FG009|Overall Study|Death|0|||
144455957|NCT03588572|520864998|FG000|Visitation 2|Withdrawal by Subject|1|||
144455958|NCT03588572|520864999|FG001|Visitation 2|Withdrawal by Subject|0|||
144455959|NCT03588572|520864998|FG000|Visitation 3|Lost to Follow-up|1|||
144455960|NCT03588572|520864999|FG001|Visitation 3|Lost to Follow-up|1|||
144455961|NCT03588572|520864998|FG000|Visitation 3|Physician Decision|1|||
144455962|NCT03588572|520864999|FG001|Visitation 3|Physician Decision|1|||
144534104|NCT04157517|521158534|FG000|Overall Study|Withdrawal by Subject|1|||
144534105|NCT04157517|521158535|FG001|Overall Study|Withdrawal by Subject|1|||
144534106|NCT04157517|521158536|FG002|Overall Study|Withdrawal by Subject|1|||
144534107|NCT04157517|521158537|FG003|Overall Study|Withdrawal by Subject|0|||
144534108|NCT04157517|521158538|FG004|Overall Study|Withdrawal by Subject|0|||
144534109|NCT04157517|521158539|FG005|Overall Study|Withdrawal by Subject|1|||
144196722|NCT03573505|519917056|FG000|Overall Study|Disease progression|0|||
144607422|NCT03861936|521424432|FG002|Overall Study|Withdrawal by Subject|3|||
144607423|NCT03861936|521424430|FG000|Overall Study|Lost to Follow-up|5|||
144607424|NCT03861936|521424431|FG001|Overall Study|Lost to Follow-up|3|||
144607425|NCT03861936|521424432|FG002|Overall Study|Lost to Follow-up|3|||
144607426|NCT03861936|521424430|FG000|Overall Study|Physician Decision|0|||
144607427|NCT03861936|521424431|FG001|Overall Study|Physician Decision|1|||
144607428|NCT03861936|521424432|FG002|Overall Study|Physician Decision|0|||
144607429|NCT03861936|521424430|FG000|Overall Study|Protocol Deviation|0|||
144607430|NCT03861936|521424431|FG001|Overall Study|Protocol Deviation|0|||
144607431|NCT03861936|521424432|FG002|Overall Study|Protocol Deviation|1|||
144607432|NCT03861936|521424430|FG000|Overall Study|Reason not Specified|5|||
144607433|NCT03861936|521424431|FG001|Overall Study|Reason not Specified|5|||
144607434|NCT03861936|521424432|FG002|Overall Study|Reason not Specified|3|||
144607435|NCT02319668|521424433|FG000|Overall Study|Other (Not specified)|0|||
144607436|NCT02319668|521424434|FG001|Overall Study|Other (Not specified)|2|||
144607437|NCT01372150|521424439|FG000|Overall Study|Lack of Efficacy|3|||
144607438|NCT01372150|521424440|FG001|Overall Study|Lack of Efficacy|0|||
144607439|NCT01372150|521424441|FG002|Overall Study|Lack of Efficacy|1|||
144607440|NCT01372150|521424439|FG000|Overall Study|Lost to Follow-up|4|||
144607441|NCT01372150|521424440|FG001|Overall Study|Lost to Follow-up|5|||
144607442|NCT01372150|521424441|FG002|Overall Study|Lost to Follow-up|6|||
144607443|NCT01372150|521424439|FG000|Overall Study|Protocol Violation|1|||
144607444|NCT01372150|521424440|FG001|Overall Study|Protocol Violation|0|||
144607445|NCT01372150|521424441|FG002|Overall Study|Protocol Violation|3|||
144607446|NCT01372150|521424439|FG000|Overall Study|Withdrawal by Subject|2|||
144607447|NCT01372150|521424440|FG001|Overall Study|Withdrawal by Subject|7|||
144607448|NCT01372150|521424441|FG002|Overall Study|Withdrawal by Subject|2|||
144607449|NCT01372150|521424439|FG000|Overall Study|Other|1|||
144607450|NCT01372150|521424440|FG001|Overall Study|Other|0|||
144607451|NCT01372150|521424441|FG002|Overall Study|Other|2|||
144607452|NCT01372150|521424439|FG000|Overall Study|Adverse Event|2|||
144607453|NCT01372150|521424440|FG001|Overall Study|Adverse Event|1|||
144607454|NCT01372150|521424441|FG002|Overall Study|Adverse Event|2|||
144607455|NCT01372150|521424439|FG000|Overall Study|Randomized but not treated|0|||
144607456|NCT01372150|521424440|FG001|Overall Study|Randomized but not treated|1|||
144607457|NCT01372150|521424441|FG002|Overall Study|Randomized but not treated|0|||
144607458|NCT01236573|521424442|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607459|NCT01236573|521424443|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607460|NCT01236573|521424444|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607461|NCT01236573|521424445|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607462|NCT01236573|521424446|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607463|NCT01236573|521424447|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607464|NCT01236573|521424448|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
144607465|NCT01236573|521424449|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607466|NCT01236573|521424450|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
144607467|NCT01236573|521424451|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
144607468|NCT01236573|521424452|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
144607469|NCT01236573|521424442|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607470|NCT01236573|521424443|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144196723|NCT03573505|519917057|FG001|Overall Study|Disease progression|1|||
144196724|NCT03573505|519917056|FG000|Overall Study|Site Terminated by Sponsor|1|||
144196725|NCT03573505|519917057|FG001|Overall Study|Site Terminated by Sponsor|1|||
144455963|NCT03588572|520864998|FG000|Visitation 3|Withdrawal by Subject|1|||
144455964|NCT03588572|520864999|FG001|Visitation 3|Withdrawal by Subject|0|||
144455965|NCT01165281|520865000|FG000|Overall Study|Adverse Event|12|||
144455966|NCT01165281|520865001|FG001|Overall Study|Adverse Event|14|||
144455967|NCT01165281|520865000|FG000|Overall Study|Death|3|||
144455968|NCT01165281|520865001|FG001|Overall Study|Death|4|||
144455969|NCT01165281|520865000|FG000|Overall Study|Lack of Efficacy|4|||
144455970|NCT01165281|520865001|FG001|Overall Study|Lack of Efficacy|1|||
144455971|NCT01165281|520865000|FG000|Overall Study|Lost to Follow-up|0|||
144455972|NCT01165281|520865001|FG001|Overall Study|Lost to Follow-up|1|||
144455973|NCT01165281|520865000|FG000|Overall Study|Physician Decision|8|||
144455974|NCT01165281|520865001|FG001|Overall Study|Physician Decision|1|||
144455975|NCT01165281|520865000|FG000|Overall Study|Protocol Violation|6|||
144607471|NCT01236573|521424444|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607472|NCT01236573|521424445|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607473|NCT01236573|521424446|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607474|NCT01236573|521424447|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607475|NCT01236573|521424448|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607476|NCT01236573|521424449|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144255053|NCT00398216|520136077|FG004|Overall Study|Protocol Violation|5|||
144455976|NCT01165281|520865001|FG001|Overall Study|Protocol Violation|5|||
144455977|NCT01165281|520865000|FG000|Overall Study|Withdrawal by Subject|8|||
144607477|NCT01236573|521424450|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
144607478|NCT01236573|521424451|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607479|NCT01236573|521424452|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
144607480|NCT01236573|521424442|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607481|NCT01236573|521424443|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607482|NCT01236573|521424444|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607483|NCT01236573|521424445|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607484|NCT01236573|521424446|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607485|NCT01236573|521424447|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607486|NCT01236573|521424448|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607487|NCT01236573|521424449|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607488|NCT01236573|521424450|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607489|NCT01236573|521424451|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
144607490|NCT01236573|521424452|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
144607491|NCT02665052|521424453|FG000|Overall Study|Lost to Follow-up|1|||
144607492|NCT02665052|521424454|FG001|Overall Study|Lost to Follow-up|0|||
144607493|NCT02665052|521424455|FG002|Overall Study|Lost to Follow-up|0|||
144607494|NCT02665052|521424456|FG003|Overall Study|Lost to Follow-up|0|||
144607495|NCT02665052|521424453|FG000|Overall Study|Withdrawal by Subject|1|||
144607496|NCT02665052|521424454|FG001|Overall Study|Withdrawal by Subject|1|||
144607497|NCT02665052|521424455|FG002|Overall Study|Withdrawal by Subject|0|||
144607498|NCT02665052|521424456|FG003|Overall Study|Withdrawal by Subject|5|||
144607499|NCT02665052|521424453|FG000|Overall Study|Adverse Event|1|||
144607500|NCT02665052|521424454|FG001|Overall Study|Adverse Event|1|||
144607501|NCT02665052|521424455|FG002|Overall Study|Adverse Event|0|||
144607502|NCT02665052|521424456|FG003|Overall Study|Adverse Event|0|||
144607503|NCT02234284|521424457|FG000|Overall Study|Death|4|||
144607504|NCT02234284|521424458|FG001|Overall Study|Death|2|||
144607505|NCT02234284|521424457|FG000|Overall Study|Withdrawal by Subject|1|||
144607506|NCT02234284|521424458|FG001|Overall Study|Withdrawal by Subject|0|||
144607507|NCT02234284|521424457|FG000|Overall Study|Lost to Follow-up|20|||
144607508|NCT02234284|521424458|FG001|Overall Study|Lost to Follow-up|7|||
144607509|NCT04754802|521424460|FG000|Overall Study|Lost to Follow-up|0|||
144607510|NCT04754802|521424461|FG001|Overall Study|Lost to Follow-up|2|||
144607511|NCT04754802|521424460|FG000|Overall Study|Withdrawal by Subject|2|||
144607512|NCT04754802|521424461|FG001|Overall Study|Withdrawal by Subject|0|||
144607513|NCT04569032|521424462|FG000|Overall Study|Death|10|||
144607514|NCT04569032|521424463|FG001|Overall Study|Death|13|||
144607515|NCT04569032|521424462|FG000|Overall Study|Withdrawal by Subject|2|||
144607516|NCT04569032|521424463|FG001|Overall Study|Withdrawal by Subject|0|||
144607517|NCT04569032|521424462|FG000|Overall Study|Lost to Follow-up|0|||
144607518|NCT04569032|521424463|FG001|Overall Study|Lost to Follow-up|1|||
144607519|NCT04569032|521424462|FG000|Overall Study|In long term follow up|22|||
144607520|NCT04569032|521424463|FG001|Overall Study|In long term follow up|34|||
144607521|NCT00873366|521424464|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
144607522|NCT00873366|521424464|FG000|Overall Study|Off tamoxifen due to side effects|2|||
144607523|NCT00873366|521424464|FG000|Overall Study|Refused to continue DM-BT testing|3|||
144607524|NCT01970488|521424465|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
144607525|NCT01970488|521424466|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
144607526|NCT01970488|521424467|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
144196726|NCT03573505|519917056|FG000|Overall Study|Study terminated by sponsor|50|||
144196727|NCT03573505|519917057|FG001|Overall Study|Study terminated by sponsor|45|||
144196728|NCT03573505|519917056|FG000|Overall Study|Reason not specified|0|||
144196729|NCT03573505|519917057|FG001|Overall Study|Reason not specified|1|||
144196730|NCT03573505|519917056|FG000|Overall Study|Death|0|||
144607527|NCT01970488|521424468|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
144607528|NCT01970488|521424469|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
144607529|NCT01970488|521424465|FG000|Part 1: Through Week 16|Protocol Violation|1|||
144607530|NCT01970488|521424466|FG001|Part 1: Through Week 16|Protocol Violation|2|||
144607531|NCT01970488|521424467|FG002|Part 1: Through Week 16|Protocol Violation|0|||
144607532|NCT01970488|521424468|FG003|Part 1: Through Week 16|Protocol Violation|0|||
144607533|NCT01970488|521424469|FG004|Part 1: Through Week 16|Protocol Violation|0|||
144607534|NCT01970488|521424465|FG000|Part 1: Through Week 16|Adverse Event|6|||
144607535|NCT01970488|521424466|FG001|Part 1: Through Week 16|Adverse Event|5|||
144607536|NCT01970488|521424467|FG002|Part 1: Through Week 16|Adverse Event|0|||
144607537|NCT01970488|521424468|FG003|Part 1: Through Week 16|Adverse Event|0|||
144607538|NCT01970488|521424469|FG004|Part 1: Through Week 16|Adverse Event|0|||
144607539|NCT01970488|521424465|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
144607540|NCT01970488|521424466|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
144607541|NCT01970488|521424467|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
144607542|NCT01970488|521424468|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
144607543|NCT01970488|521424469|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
144607544|NCT01970488|521424465|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
144196731|NCT03573505|519917057|FG001|Overall Study|Death|4|||
144196732|NCT02040779|519917058|FG000|Overall Study|Adverse Event|1|||
144196733|NCT02040779|519917059|FG001|Overall Study|Adverse Event|0|||
144196734|NCT02040779|519917060|FG002|Overall Study|Adverse Event|0|||
144196735|NCT02040779|519917058|FG000|Overall Study|Withdrawal by Subject|4|||
144196736|NCT02040779|519917059|FG001|Overall Study|Withdrawal by Subject|1|||
144196737|NCT02040779|519917060|FG002|Overall Study|Withdrawal by Subject|3|||
144196738|NCT02040779|519917058|FG000|Overall Study|Non-compliance|0|||
144196739|NCT02040779|519917059|FG001|Overall Study|Non-compliance|1|||
144196740|NCT02040779|519917060|FG002|Overall Study|Non-compliance|0|||
144196741|NCT02040779|519917058|FG000|Overall Study|Protocol Violation|2|||
144455978|NCT01165281|520865001|FG001|Overall Study|Withdrawal by Subject|7|||
144455979|NCT01165281|520865000|FG000|Overall Study|Noncompliance with Study Drug|1|||
144455980|NCT01165281|520865001|FG001|Overall Study|Noncompliance with Study Drug|4|||
144455981|NCT01165281|520865000|FG000|Overall Study|Progressive Disease|10|||
144455982|NCT01165281|520865001|FG001|Overall Study|Progressive Disease|14|||
144455983|NCT01165281|520865000|FG000|Overall Study|Other|6|||
144455984|NCT01165281|520865001|FG001|Overall Study|Other|0|||
144455985|NCT02863991|520865002|FG000|Overall Study|Death|0|||
144455986|NCT02863991|520865003|FG001|Overall Study|Death|3|||
144455987|NCT02863991|520865002|FG000|Overall Study|Lack of Efficacy|0|||
144455988|NCT02863991|520865003|FG001|Overall Study|Lack of Efficacy|1|||
144455989|NCT02863991|520865002|FG000|Overall Study|Study Terminated|2|||
144455990|NCT02863991|520865003|FG001|Overall Study|Study Terminated|8|||
144455991|NCT00364858|520865008|FG000|Overall Study|Adverse Event|1|||
144455992|NCT00364858|520865009|FG001|Overall Study|Adverse Event|5|||
144455993|NCT00364858|520865008|FG000|Overall Study|Withdrawal by Subject|1|||
144455994|NCT00364858|520865009|FG001|Overall Study|Withdrawal by Subject|1|||
144455995|NCT00364858|520865008|FG000|Overall Study|Pregnancy|1|||
144455996|NCT00364858|520865009|FG001|Overall Study|Pregnancy|1|||
144455997|NCT00364858|520865008|FG000|Overall Study|Clinical failure|2|||
144455998|NCT00364858|520865009|FG001|Overall Study|Clinical failure|13|||
144455999|NCT00364858|520865008|FG000|Overall Study|Discontinuation at baseline|1|||
144456000|NCT00364858|520865009|FG001|Overall Study|Discontinuation at baseline|0|||
144456001|NCT00364858|520865008|FG000|Overall Study|Non-compliant|1|||
144456002|NCT00364858|520865009|FG001|Overall Study|Non-compliant|0|||
144456003|NCT00364858|520865008|FG000|Overall Study|Return to Q2 regimen|0|||
144456004|NCT00364858|520865009|FG001|Overall Study|Return to Q2 regimen|1|||
144456005|NCT00364858|520865008|FG000|Overall Study|Clinical baseline issue|0|||
144456006|NCT00364858|520865009|FG001|Overall Study|Clinical baseline issue|1|||
144456007|NCT01307501|520865010|FG000|Overall Study|Treatment Failure|1|||
144456008|NCT01307501|520865010|FG000|Overall Study|Death|20|||
144456009|NCT01307501|520865010|FG000|Overall Study|Lost to Follow-up|1|||
144456010|NCT01307501|520865010|FG000|Overall Study|Starting Hospice|1|||
144456011|NCT00363766|520865011|FG000|Overall Study|Progressive Disease|15|||
144456012|NCT00363766|520865012|FG001|Overall Study|Progressive Disease|9|||
144456013|NCT00363766|520865011|FG000|Overall Study|Adverse Event|10|||
144456014|NCT00363766|520865012|FG001|Overall Study|Adverse Event|2|||
144456015|NCT00363766|520865011|FG000|Overall Study|Disease Related Death|1|||
144456016|NCT00363766|520865012|FG001|Overall Study|Disease Related Death|3|||
144456017|NCT00363766|520865011|FG000|Overall Study|Not Disease Related Death|3|||
144456018|NCT00363766|520865012|FG001|Overall Study|Not Disease Related Death|4|||
144607545|NCT01970488|521424466|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
144607546|NCT01970488|521424467|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
144607547|NCT01970488|521424468|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
144607548|NCT01970488|521424469|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
144196742|NCT02040779|519917059|FG001|Overall Study|Protocol Violation|1|||
144196743|NCT02040779|519917060|FG002|Overall Study|Protocol Violation|0|||
144196744|NCT02040779|519917058|FG000|Overall Study|Lost to Follow-up|1|||
144196745|NCT02040779|519917059|FG001|Overall Study|Lost to Follow-up|2|||
144196746|NCT02040779|519917060|FG002|Overall Study|Lost to Follow-up|1|||
144456019|NCT00363766|520865011|FG000|Overall Study|Withdrawal by Subject|2|||
144456020|NCT00363766|520865012|FG001|Overall Study|Withdrawal by Subject|0|||
144456021|NCT00363766|520865011|FG000|Overall Study|Physician Decision|1|||
144456022|NCT00363766|520865012|FG001|Overall Study|Physician Decision|2|||
144456023|NCT00558285|520865013|FG000|Overall Study|Adverse Event|1|||
144456024|NCT00558285|520865014|FG001|Overall Study|Adverse Event|1|||
144456025|NCT00558285|520865015|FG002|Overall Study|Adverse Event|4|||
144456026|NCT00558285|520865016|FG003|Overall Study|Adverse Event|1|||
144456027|NCT00558285|520865017|FG004|Overall Study|Adverse Event|2|||
144456028|NCT00558285|520865013|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144196747|NCT02040779|519917058|FG000|Overall Study|Lack of Efficacy|4|||
144456029|NCT00558285|520865014|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144456030|NCT00558285|520865015|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144456031|NCT00558285|520865016|FG003|Overall Study|Abnormal test procedure result(s)|0|||
144607549|NCT01970488|521424465|FG000|Part 2: Post Week 16|Physician Decision|0|||
144196748|NCT02040779|519917059|FG001|Overall Study|Lack of Efficacy|2|||
144456032|NCT00558285|520865017|FG004|Overall Study|Abnormal test procedure result(s)|0|||
144456033|NCT00558285|520865013|FG000|Overall Study|Subject withdrew consent|2|||
144456034|NCT00558285|520865014|FG001|Overall Study|Subject withdrew consent|0|||
144456035|NCT00558285|520865015|FG002|Overall Study|Subject withdrew consent|1|||
144456036|NCT00558285|520865016|FG003|Overall Study|Subject withdrew consent|1|||
144456037|NCT00558285|520865017|FG004|Overall Study|Subject withdrew consent|1|||
144456038|NCT00558285|520865013|FG000|Overall Study|Lost to Follow-up|1|||
144456039|NCT00558285|520865014|FG001|Overall Study|Lost to Follow-up|1|||
144456040|NCT00558285|520865015|FG002|Overall Study|Lost to Follow-up|0|||
144456041|NCT00558285|520865016|FG003|Overall Study|Lost to Follow-up|0|||
144456042|NCT00558285|520865017|FG004|Overall Study|Lost to Follow-up|0|||
144456043|NCT00558285|520865013|FG000|Overall Study|Administrative problems|0|||
144456044|NCT00558285|520865014|FG001|Overall Study|Administrative problems|0|||
144456045|NCT00558285|520865015|FG002|Overall Study|Administrative problems|0|||
144456046|NCT00558285|520865016|FG003|Overall Study|Administrative problems|1|||
144456047|NCT00558285|520865017|FG004|Overall Study|Administrative problems|1|||
144456048|NCT00558285|520865013|FG000|Overall Study|Protocol deviation|1|||
144456049|NCT00558285|520865014|FG001|Overall Study|Protocol deviation|1|||
144456050|NCT00558285|520865015|FG002|Overall Study|Protocol deviation|0|||
144456051|NCT00558285|520865016|FG003|Overall Study|Protocol deviation|1|||
144456052|NCT00558285|520865017|FG004|Overall Study|Protocol deviation|0|||
144456053|NCT02345512|520865024|FG000|Overall Study|Adverse Event|1|||
144456054|NCT02345512|520865024|FG000|Overall Study|Withdrawal by Subject|1|||
144456055|NCT03712917|520865027|FG000|Overall Study|Pregnancy|0|||
144456056|NCT03712917|520865028|FG001|Overall Study|Pregnancy|0|||
144456057|NCT03712917|520865029|FG002|Overall Study|Pregnancy|1|||
144456058|NCT03712917|520865027|FG000|Overall Study|Adverse Event|0|||
144456059|NCT03712917|520865028|FG001|Overall Study|Adverse Event|4|||
144456060|NCT03712917|520865029|FG002|Overall Study|Adverse Event|3|||
144456061|NCT03712917|520865027|FG000|Overall Study|Lost to Follow-up|9|||
144456062|NCT03712917|520865028|FG001|Overall Study|Lost to Follow-up|4|||
144456063|NCT03712917|520865029|FG002|Overall Study|Lost to Follow-up|5|||
144456064|NCT04827576|520867065|FG000|Overall Study|Death|5|||
144456065|NCT04827576|520867066|FG001|Overall Study|Death|17|||
144456066|NCT04827576|520867067|FG002|Overall Study|Death|17|||
144456067|NCT04827576|520867068|FG003|Overall Study|Death|32|||
144456068|NCT04827576|520867065|FG000|Overall Study|Study Terminated by Sponsor|2|||
144456069|NCT04827576|520867066|FG001|Overall Study|Study Terminated by Sponsor|9|||
144456070|NCT04827576|520867067|FG002|Overall Study|Study Terminated by Sponsor|7|||
144456071|NCT04827576|520867068|FG003|Overall Study|Study Terminated by Sponsor|5|||
144456072|NCT04827576|520867065|FG000|Overall Study|Investigator's Discretion|1|||
144456073|NCT04827576|520867066|FG001|Overall Study|Investigator's Discretion|0|||
144456074|NCT04827576|520867067|FG002|Overall Study|Investigator's Discretion|2|||
144456075|NCT04827576|520867068|FG003|Overall Study|Investigator's Discretion|5|||
144456076|NCT04827576|520867065|FG000|Overall Study|Withdrew Consent|0|||
144456077|NCT04827576|520867066|FG001|Overall Study|Withdrew Consent|3|||
144456078|NCT04827576|520867067|FG002|Overall Study|Withdrew Consent|0|||
144456079|NCT04827576|520867068|FG003|Overall Study|Withdrew Consent|0|||
144456080|NCT04827576|520867065|FG000|Overall Study|Lost to Follow-up|1|||
144456081|NCT04827576|520867066|FG001|Overall Study|Lost to Follow-up|0|||
144534110|NCT04157517|521158540|FG006|Overall Study|Withdrawal by Subject|0|||
144534111|NCT04157517|521158541|FG007|Overall Study|Withdrawal by Subject|0|||
144534112|NCT04157517|521158542|FG008|Overall Study|Withdrawal by Subject|1|||
144534113|NCT04157517|521158543|FG009|Overall Study|Withdrawal by Subject|0|||
144534114|NCT04157517|521158534|FG000|Overall Study|Other|1|||
144534115|NCT04157517|521158535|FG001|Overall Study|Other|0|||
144534116|NCT04157517|521158536|FG002|Overall Study|Other|0|||
144534117|NCT04157517|521158537|FG003|Overall Study|Other|0|||
144534118|NCT04157517|521158538|FG004|Overall Study|Other|0|||
144534119|NCT04157517|521158539|FG005|Overall Study|Other|1|||
144534120|NCT04157517|521158540|FG006|Overall Study|Other|2|||
144534121|NCT04157517|521158541|FG007|Overall Study|Other|7|||
144534122|NCT04157517|521158542|FG008|Overall Study|Other|7|||
144534123|NCT04157517|521158543|FG009|Overall Study|Other|0|||
144534124|NCT01756300|521158547|FG000|Overall Study|Death|1|||
144534125|NCT01756300|521158547|FG000|Overall Study|Withdrawal by Subject|1|||
144534126|NCT02765412|521158548|FG000|Overall Study|Death|482|||
144456082|NCT04827576|520867067|FG002|Overall Study|Lost to Follow-up|0|||
144456083|NCT04827576|520867068|FG003|Overall Study|Lost to Follow-up|0|||
144534127|NCT02765412|521158549|FG001|Overall Study|Death|855|||
144456084|NCT04537923|520867069|FG000|Overall Study|Adverse Event|2|||
144534128|NCT04165213|521159069|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
144534129|NCT04165213|521159070|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
144456085|NCT04537923|520867070|FG001|Overall Study|Adverse Event|1|||
144456086|NCT04537923|520867071|FG002|Overall Study|Adverse Event|2|||
144456087|NCT04537923|520867072|FG003|Overall Study|Adverse Event|4|||
144456088|NCT04537923|520867069|FG000|Overall Study|Death|3|||
144534130|NCT04165213|521159069|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
144456089|NCT04537923|520867070|FG001|Overall Study|Death|3|||
144534131|NCT04165213|521159070|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
144534132|NCT04165213|521159069|FG000|Clinician Enrollment|Termination from site|0|||
144534133|NCT04165213|521159070|FG001|Clinician Enrollment|Termination from site|1|||
144534134|NCT04165213|521159069|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
144456090|NCT04537923|520867071|FG002|Overall Study|Death|1|||
144456091|NCT04537923|520867072|FG003|Overall Study|Death|11|||
144456092|NCT04537923|520867069|FG000|Overall Study|Lost to Follow-up|1|||
144456093|NCT04537923|520867070|FG001|Overall Study|Lost to Follow-up|2|||
144456094|NCT04537923|520867071|FG002|Overall Study|Lost to Follow-up|1|||
144456095|NCT04537923|520867072|FG003|Overall Study|Lost to Follow-up|6|||
144456096|NCT04537923|520867069|FG000|Overall Study|Physician Decision|1|||
144456097|NCT04537923|520867070|FG001|Overall Study|Physician Decision|0|||
144456098|NCT04537923|520867071|FG002|Overall Study|Physician Decision|2|||
144456099|NCT04537923|520867072|FG003|Overall Study|Physician Decision|5|||
144456100|NCT04537923|520867069|FG000|Overall Study|Pregnancy|1|||
144456101|NCT04537923|520867070|FG001|Overall Study|Pregnancy|0|||
144456102|NCT04537923|520867071|FG002|Overall Study|Pregnancy|0|||
144456103|NCT04537923|520867072|FG003|Overall Study|Pregnancy|0|||
144456104|NCT04537923|520867069|FG000|Overall Study|Withdrawal by Subject|4|||
144456105|NCT04537923|520867070|FG001|Overall Study|Withdrawal by Subject|4|||
144456106|NCT04537923|520867071|FG002|Overall Study|Withdrawal by Subject|4|||
144456107|NCT04537923|520867072|FG003|Overall Study|Withdrawal by Subject|58|||
144456108|NCT04537923|520867069|FG000|Overall Study|Missed study visits|2|||
144456109|NCT04537923|520867070|FG001|Overall Study|Missed study visits|0|||
144456110|NCT04537923|520867071|FG002|Overall Study|Missed study visits|0|||
144456111|NCT04537923|520867072|FG003|Overall Study|Missed study visits|3|||
144456112|NCT04537923|520867069|FG000|Overall Study|Sponsor's decision|0|||
144456113|NCT04537923|520867070|FG001|Overall Study|Sponsor's decision|0|||
144456114|NCT04537923|520867071|FG002|Overall Study|Sponsor's decision|1|||
144456115|NCT04537923|520867072|FG003|Overall Study|Sponsor's decision|1|||
144456116|NCT04537923|520867069|FG000|Overall Study|Safety reasons|1|||
144456117|NCT04537923|520867070|FG001|Overall Study|Safety reasons|0|||
144456118|NCT04537923|520867071|FG002|Overall Study|Safety reasons|0|||
144456119|NCT04537923|520867072|FG003|Overall Study|Safety reasons|0|||
144456120|NCT01261611|520867073|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
144456121|NCT01261611|520867074|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
144456122|NCT01261611|520867075|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
144456123|NCT01261611|520867073|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
144456124|NCT01261611|520867074|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
144456125|NCT01261611|520867075|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
144456126|NCT01261611|520867073|FG000|Treatment Cycle 1|Adverse Event|0|||
144456127|NCT01261611|520867074|FG001|Treatment Cycle 1|Adverse Event|1|||
144456128|NCT01261611|520867075|FG002|Treatment Cycle 1|Adverse Event|0|||
144456129|NCT01261611|520867073|FG000|Treatment Cycle 1|Protocol Violation|0|||
144456130|NCT01261611|520867074|FG001|Treatment Cycle 1|Protocol Violation|0|||
144456131|NCT01261611|520867075|FG002|Treatment Cycle 1|Protocol Violation|2|||
144456132|NCT01261611|520867073|FG000|Treatment Cycle 2|Completed study|4|||
144456133|NCT01261611|520867074|FG001|Treatment Cycle 2|Completed study|0|||
144456134|NCT01261611|520867075|FG002|Treatment Cycle 2|Completed study|0|||
144456135|NCT01261611|520867073|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
144456136|NCT01261611|520867074|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
144456137|NCT01261611|520867075|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
144456138|NCT01261611|520867073|FG000|Treatment Cycle 2|Adverse Event|1|||
144456139|NCT01261611|520867074|FG001|Treatment Cycle 2|Adverse Event|0|||
144456140|NCT01261611|520867075|FG002|Treatment Cycle 2|Adverse Event|0|||
144456141|NCT01261611|520867073|FG000|Treatment Cycle 2|Protocol Violation|2|||
144456142|NCT01261611|520867074|FG001|Treatment Cycle 2|Protocol Violation|0|||
144456143|NCT01261611|520867075|FG002|Treatment Cycle 2|Protocol Violation|0|||
144456144|NCT01261611|520867073|FG000|Treatment Cycle 2|Not otherwise specified|2|||
144456145|NCT01261611|520867074|FG001|Treatment Cycle 2|Not otherwise specified|0|||
144456146|NCT01261611|520867075|FG002|Treatment Cycle 2|Not otherwise specified|0|||
144456147|NCT01261611|520867073|FG000|Treatment Cycle 3|Completed study|24|||
144456148|NCT01261611|520867074|FG001|Treatment Cycle 3|Completed study|0|||
144456149|NCT01261611|520867075|FG002|Treatment Cycle 3|Completed study|0|||
144456150|NCT01261611|520867073|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
144456151|NCT01261611|520867074|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
144456152|NCT01261611|520867075|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
144456153|NCT01261611|520867073|FG000|Treatment Cycle 3|Adverse Event|1|||
144456154|NCT01261611|520867074|FG001|Treatment Cycle 3|Adverse Event|0|||
144456155|NCT01261611|520867075|FG002|Treatment Cycle 3|Adverse Event|0|||
144456156|NCT01261611|520867073|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
144456157|NCT01261611|520867074|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
144607550|NCT01970488|521424466|FG001|Part 2: Post Week 16|Physician Decision|0|||
144456158|NCT01261611|520867075|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
144456159|NCT01261611|520867073|FG000|Treatment Cycle 4|Completed study|87|||
144456160|NCT01261611|520867074|FG001|Treatment Cycle 4|Completed study|0|||
144456161|NCT01261611|520867075|FG002|Treatment Cycle 4|Completed study|0|||
144456162|NCT01261611|520867073|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
144456163|NCT01261611|520867074|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
144456164|NCT01261611|520867075|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
144456165|NCT01261611|520867073|FG000|Treatment Cycle 4|Adverse Event|1|||
144456166|NCT01261611|520867074|FG001|Treatment Cycle 4|Adverse Event|0|||
144456167|NCT01261611|520867075|FG002|Treatment Cycle 4|Adverse Event|0|||
144196749|NCT02040779|519917060|FG002|Overall Study|Lack of Efficacy|0|||
144196750|NCT00922272|519917061|FG000|Open-label Phase|Adverse Event|5|||
144196751|NCT00922272|519917062|FG001|Open-label Phase|Adverse Event|0|||
144196752|NCT00922272|519917061|FG000|Open-label Phase|Protocol Violation|1|||
144196753|NCT00922272|519917062|FG001|Open-label Phase|Protocol Violation|0|||
144196754|NCT00922272|519917061|FG000|Open-label Phase|Withdrawal by Subject|11|||
144196755|NCT00922272|519917062|FG001|Open-label Phase|Withdrawal by Subject|0|||
144196756|NCT00922272|519917061|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
144196757|NCT00922272|519917062|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
144196758|NCT00922272|519917061|FG000|Open-label Phase|Withdrawal criteria met|5|||
144196759|NCT00922272|519917062|FG001|Open-label Phase|Withdrawal criteria met|0|||
144196760|NCT00922272|519917061|FG000|Double-blind Phase|Adverse Event|1|||
144196761|NCT00922272|519917062|FG001|Double-blind Phase|Adverse Event|1|||
144196762|NCT00922272|519917061|FG000|Double-blind Phase|Withdrawal by Subject|1|||
144196763|NCT00922272|519917062|FG001|Double-blind Phase|Withdrawal by Subject|1|||
144456168|NCT01261611|520867073|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
144456169|NCT01261611|520867074|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
144456170|NCT01261611|520867075|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
144456171|NCT01261611|520867073|FG000|Treatment Cycle 4|Not otherwise specified|3|||
144456172|NCT01261611|520867074|FG001|Treatment Cycle 4|Not otherwise specified|0|||
144456173|NCT01261611|520867075|FG002|Treatment Cycle 4|Not otherwise specified|0|||
144456174|NCT01261611|520867073|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
144456175|NCT01261611|520867074|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
144456176|NCT01261611|520867075|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
144456177|NCT01261611|520867073|FG000|Treatment Cycle 5|Adverse Event|1|||
144456178|NCT01261611|520867074|FG001|Treatment Cycle 5|Adverse Event|0|||
144456179|NCT01261611|520867075|FG002|Treatment Cycle 5|Adverse Event|0|||
144456180|NCT01261611|520867073|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
144456181|NCT01261611|520867074|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
144456182|NCT01261611|520867075|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
144456183|NCT02527798|520867076|FG000|Overall Study|Physician Decision|1|||
144456184|NCT02527798|520867077|FG001|Overall Study|Physician Decision|0|||
144456185|NCT02527798|520867078|FG002|Overall Study|Physician Decision|1|||
144456186|NCT02527798|520867079|FG003|Overall Study|Physician Decision|1|||
144456187|NCT02527798|520867080|FG004|Overall Study|Physician Decision|0|||
144456188|NCT02527798|520867081|FG005|Overall Study|Physician Decision|0|||
144456189|NCT02527798|520867076|FG000|Overall Study|Death|0|||
144456190|NCT02527798|520867077|FG001|Overall Study|Death|0|||
144456191|NCT02527798|520867078|FG002|Overall Study|Death|1|||
144456192|NCT02527798|520867079|FG003|Overall Study|Death|0|||
144456193|NCT02527798|520867080|FG004|Overall Study|Death|0|||
144456194|NCT02527798|520867081|FG005|Overall Study|Death|0|||
144456195|NCT02527798|520867076|FG000|Overall Study|Withdrawal by Subject|0|||
144456196|NCT02527798|520867077|FG001|Overall Study|Withdrawal by Subject|1|||
144456197|NCT02527798|520867078|FG002|Overall Study|Withdrawal by Subject|2|||
144456198|NCT02527798|520867079|FG003|Overall Study|Withdrawal by Subject|0|||
144456199|NCT02527798|520867080|FG004|Overall Study|Withdrawal by Subject|0|||
144456200|NCT02527798|520867081|FG005|Overall Study|Withdrawal by Subject|0|||
144456201|NCT02527798|520867076|FG000|Overall Study|Reason undisclosed|1|||
144456202|NCT02527798|520867077|FG001|Overall Study|Reason undisclosed|0|||
144456203|NCT02527798|520867078|FG002|Overall Study|Reason undisclosed|1|||
144456204|NCT02527798|520867079|FG003|Overall Study|Reason undisclosed|0|||
144456205|NCT02527798|520867080|FG004|Overall Study|Reason undisclosed|0|||
144456206|NCT02527798|520867081|FG005|Overall Study|Reason undisclosed|0|||
144456207|NCT02527798|520867076|FG000|Overall Study|Did not receive intervention|1|||
144196764|NCT00922272|519917061|FG000|Double-blind Phase|Lost to Follow-up|2|||
144196765|NCT00922272|519917062|FG001|Double-blind Phase|Lost to Follow-up|1|||
144456208|NCT02527798|520867077|FG001|Overall Study|Did not receive intervention|1|||
144456209|NCT02527798|520867078|FG002|Overall Study|Did not receive intervention|0|||
144456210|NCT02527798|520867079|FG003|Overall Study|Did not receive intervention|0|||
144607551|NCT01970488|521424467|FG002|Part 2: Post Week 16|Physician Decision|0|||
144607552|NCT01970488|521424468|FG003|Part 2: Post Week 16|Physician Decision|0|||
144607553|NCT01970488|521424469|FG004|Part 2: Post Week 16|Physician Decision|1|||
144607554|NCT01970488|521424465|FG000|Part 2: Post Week 16|Non-compliance|0|||
144607555|NCT01970488|521424466|FG001|Part 2: Post Week 16|Non-compliance|0|||
144196766|NCT00922272|519917061|FG000|Double-blind Phase|Withdrawal criteria met|1|||
144456211|NCT02527798|520867080|FG004|Overall Study|Did not receive intervention|0|||
144456212|NCT02527798|520867081|FG005|Overall Study|Did not receive intervention|0|||
144456213|NCT04745169|520867083|FG000|Overall Study|Kidney transplantation|1|||
144456214|NCT04745169|520867083|FG000|Overall Study|Participant health problems|3|||
144456215|NCT04745169|520867083|FG000|Overall Study|Physician Decision|2|||
144456216|NCT01808690|520867084|FG000|Overall Study|Withdrawal by Subject|1|||
144456217|NCT01808690|520867085|FG001|Overall Study|Withdrawal by Subject|2|||
144607556|NCT01970488|521424467|FG002|Part 2: Post Week 16|Non-compliance|1|||
144607557|NCT01970488|521424468|FG003|Part 2: Post Week 16|Non-compliance|0|||
144607558|NCT01970488|521424469|FG004|Part 2: Post Week 16|Non-compliance|0|||
144607559|NCT01970488|521424465|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
144196767|NCT00922272|519917062|FG001|Double-blind Phase|Withdrawal criteria met|1|||
144196768|NCT00922272|519917061|FG000|Double-blind Phase|Noncompliance|1|||
144196769|NCT00922272|519917062|FG001|Double-blind Phase|Noncompliance|1|||
144456218|NCT03586648|520867088|FG000|Period 1|Withdrawal by Subject|0|||
144456219|NCT03586648|520867089|FG001|Period 1|Withdrawal by Subject|1|||
144456220|NCT03586648|520867088|FG000|Period 1|Lost to Follow-up|1|||
144456221|NCT03586648|520867089|FG001|Period 1|Lost to Follow-up|1|||
144456222|NCT03586648|520867088|FG000|Period 1|Adverse Event|1|||
144456223|NCT03586648|520867089|FG001|Period 1|Adverse Event|0|||
144456224|NCT03586648|520867088|FG000|Period 1|Study related symptoms or complaints|2|||
144456225|NCT03586648|520867089|FG001|Period 1|Study related symptoms or complaints|1|||
144456226|NCT03586648|520867088|FG000|Period 1|Physician Decision|0|||
144456227|NCT03586648|520867089|FG001|Period 1|Physician Decision|1|||
144456228|NCT03586648|520867088|FG000|Period 2|Adverse Event|1|||
144456229|NCT03586648|520867089|FG001|Period 2|Adverse Event|0|||
144456230|NCT02395120|520867090|FG000|Overall Study|Missed follow-up dental exam|57|||
144456231|NCT02395120|520867091|FG001|Overall Study|Missed follow-up dental exam|62|||
144456232|NCT02395120|520867092|FG002|Overall Study|Missed follow-up dental exam|6|||
144456233|NCT02395120|520867093|FG003|Overall Study|Missed follow-up dental exam|6|||
144456234|NCT02395120|520867094|FG004|Overall Study|Missed follow-up dental exam|51|||
144456235|NCT00377234|520867095|FG000|Overall Study|Adverse Event|14|||
144456236|NCT00377234|520867096|FG001|Overall Study|Adverse Event|17|||
144456237|NCT00377234|520867095|FG000|Overall Study|Withdrawal by Subject|11|||
144456238|NCT00377234|520867096|FG001|Overall Study|Withdrawal by Subject|9|||
144456239|NCT00377234|520867095|FG000|Overall Study|Lost to Follow-up|4|||
144456240|NCT00377234|520867096|FG001|Overall Study|Lost to Follow-up|2|||
144456241|NCT00377234|520867095|FG000|Overall Study|Administrative|2|||
144456242|NCT00377234|520867096|FG001|Overall Study|Administrative|1|||
144456243|NCT00377234|520867095|FG000|Overall Study|Not assigned|3|||
144456244|NCT00377234|520867096|FG001|Overall Study|Not assigned|2|||
144456245|NCT01159691|520867101|FG000|Overall Study|Lost to Follow-up|2|||
144456246|NCT01159691|520867101|FG000|Overall Study|Unknown reasons|1|||
144456247|NCT01159691|520867101|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
144456248|NCT01159691|520867101|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
144456249|NCT01159691|520867101|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
144456250|NCT01159691|520867101|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
144456251|NCT01159691|520867101|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
144456252|NCT01159691|520867101|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
144456253|NCT00896168|520867102|FG000|Overall Study|Adverse Event|4|||
144456254|NCT00896168|520867103|FG001|Overall Study|Adverse Event|7|||
144456255|NCT00896168|520867102|FG000|Overall Study|Treatment failure|8|||
144456256|NCT00896168|520867103|FG001|Overall Study|Treatment failure|10|||
144456257|NCT00896168|520867102|FG000|Overall Study|Lost to Follow-up|1|||
144456258|NCT00896168|520867103|FG001|Overall Study|Lost to Follow-up|1|||
144456259|NCT00896168|520867102|FG000|Overall Study|Other|1|||
144456260|NCT00896168|520867103|FG001|Overall Study|Other|1|||
144456261|NCT00384085|520867105|FG000|Overall Study|Adverse Event|5|||
144456262|NCT00384085|520867106|FG001|Overall Study|Adverse Event|5|||
144456263|NCT00384085|520867107|FG002|Overall Study|Adverse Event|4|||
144456264|NCT00384085|520867105|FG000|Overall Study|Lack of Efficacy|0|||
144456265|NCT00384085|520867106|FG001|Overall Study|Lack of Efficacy|3|||
144196770|NCT00922272|519917061|FG000|Double-blind Phase|Positive urine drug screen|1|||
144196771|NCT00922272|519917062|FG001|Double-blind Phase|Positive urine drug screen|1|||
144196772|NCT02588950|519917069|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
144196773|NCT02588950|519917070|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
144456266|NCT00384085|520867107|FG002|Overall Study|Lack of Efficacy|2|||
144456267|NCT00384085|520867105|FG000|Overall Study|No longer Requires Study Treatment|1|||
144456268|NCT00384085|520867106|FG001|Overall Study|No longer Requires Study Treatment|0|||
144456269|NCT00384085|520867107|FG002|Overall Study|No longer Requires Study Treatment|1|||
144456270|NCT00384085|520867105|FG000|Overall Study|Protocol Violation|2|||
144456271|NCT00384085|520867106|FG001|Overall Study|Protocol Violation|2|||
144456272|NCT00384085|520867107|FG002|Overall Study|Protocol Violation|2|||
144456273|NCT00384085|520867105|FG000|Overall Study|Lost to Follow-up|9|||
144456274|NCT00384085|520867106|FG001|Overall Study|Lost to Follow-up|9|||
144456275|NCT00384085|520867107|FG002|Overall Study|Lost to Follow-up|10|||
144456276|NCT00384085|520867105|FG000|Overall Study|Progressive Disease|0|||
144456277|NCT00384085|520867106|FG001|Overall Study|Progressive Disease|1|||
144456278|NCT00384085|520867107|FG002|Overall Study|Progressive Disease|0|||
144456279|NCT00384085|520867105|FG000|Overall Study|Withdrawal by Subject|14|||
144196774|NCT02588950|519917071|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
144456280|NCT00384085|520867106|FG001|Overall Study|Withdrawal by Subject|19|||
144456281|NCT00384085|520867107|FG002|Overall Study|Withdrawal by Subject|29|||
144456282|NCT00384085|520867105|FG000|Overall Study|Patient non-compliant|4|||
144456283|NCT00384085|520867106|FG001|Overall Study|Patient non-compliant|4|||
144456284|NCT00384085|520867107|FG002|Overall Study|Patient non-compliant|5|||
144456285|NCT00384085|520867105|FG000|Overall Study|Physician Decision|1|||
144456286|NCT00384085|520867106|FG001|Overall Study|Physician Decision|0|||
144456287|NCT00384085|520867107|FG002|Overall Study|Physician Decision|0|||
144456288|NCT00384085|520867105|FG000|Overall Study|Loss of site personnel|1|||
144456289|NCT00384085|520867106|FG001|Overall Study|Loss of site personnel|0|||
144456290|NCT00384085|520867107|FG002|Overall Study|Loss of site personnel|1|||
144456291|NCT00384085|520867105|FG000|Overall Study|Sponsor decision|1|||
144456292|NCT00384085|520867106|FG001|Overall Study|Sponsor decision|2|||
144456293|NCT00384085|520867107|FG002|Overall Study|Sponsor decision|1|||
144456294|NCT00384085|520867105|FG000|Overall Study|Patient moved|1|||
144456295|NCT00384085|520867106|FG001|Overall Study|Patient moved|0|||
144456296|NCT00384085|520867107|FG002|Overall Study|Patient moved|1|||
144456297|NCT00384085|520867105|FG000|Overall Study|Patient required surgery|0|||
144456298|NCT00384085|520867106|FG001|Overall Study|Patient required surgery|1|||
144456299|NCT00384085|520867107|FG002|Overall Study|Patient required surgery|0|||
144456300|NCT03725982|520867108|FG000|First Intervention|Withdrawal by Subject|0|||
144456301|NCT03725982|520867109|FG001|First Intervention|Withdrawal by Subject|1|||
144456302|NCT03725982|520867108|FG000|First Intervention|Physician Decision|1|||
144456303|NCT03725982|520867109|FG001|First Intervention|Physician Decision|1|||
144456304|NCT01944631|520867111|FG000|Overall Study|Adverse Event|1|||
144456305|NCT01944631|520867112|FG001|Overall Study|Adverse Event|0|||
144456306|NCT01944631|520867111|FG000|Overall Study|Lost to Follow-up|3|||
144456307|NCT01944631|520867112|FG001|Overall Study|Lost to Follow-up|1|||
144456308|NCT01944631|520867111|FG000|Overall Study|Withdrawal by Subject|0|||
144456309|NCT01944631|520867112|FG001|Overall Study|Withdrawal by Subject|1|||
144456310|NCT00838110|520867113|FG000|Overall Study|Death|0|||
144456311|NCT00838110|520867114|FG001|Overall Study|Death|0|||
144456312|NCT00838110|520867115|FG002|Overall Study|Death|1|||
144456313|NCT00838110|520867116|FG003|Overall Study|Death|2|||
144456314|NCT00838110|520867113|FG000|Overall Study|Adverse Event|11|||
144456315|NCT00838110|520867114|FG001|Overall Study|Adverse Event|10|||
144456316|NCT00838110|520867115|FG002|Overall Study|Adverse Event|8|||
144456317|NCT00838110|520867116|FG003|Overall Study|Adverse Event|7|||
144456318|NCT00838110|520867113|FG000|Overall Study|Withdrawal by Subject|5|||
144456319|NCT00838110|520867114|FG001|Overall Study|Withdrawal by Subject|6|||
144456320|NCT00838110|520867115|FG002|Overall Study|Withdrawal by Subject|3|||
144456321|NCT00838110|520867116|FG003|Overall Study|Withdrawal by Subject|4|||
144456322|NCT00838110|520867113|FG000|Overall Study|Other|3|||
144456323|NCT00838110|520867114|FG001|Overall Study|Other|3|||
144456324|NCT00838110|520867115|FG002|Overall Study|Other|3|||
144456325|NCT00838110|520867116|FG003|Overall Study|Other|2|||
144456326|NCT00838110|520867113|FG000|Overall Study|Protocol Violation|0|||
144456327|NCT00838110|520867114|FG001|Overall Study|Protocol Violation|2|||
144196775|NCT02588950|519917072|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
144196776|NCT02588950|519917069|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
144196777|NCT02588950|519917070|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
144456328|NCT00838110|520867115|FG002|Overall Study|Protocol Violation|1|||
144456329|NCT00838110|520867116|FG003|Overall Study|Protocol Violation|1|||
144456330|NCT00838110|520867113|FG000|Overall Study|Lost to Follow-up|3|||
144456331|NCT00838110|520867114|FG001|Overall Study|Lost to Follow-up|0|||
144607560|NCT01970488|521424466|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
144607561|NCT01970488|521424467|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
144607562|NCT01970488|521424468|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
144607563|NCT01970488|521424469|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
144607564|NCT01970488|521424465|FG000|Part 2: Post Week 16|Adverse Event|0|||
144607565|NCT01970488|521424466|FG001|Part 2: Post Week 16|Adverse Event|0|||
144196778|NCT02588950|519917071|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
144196779|NCT02588950|519917072|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
144456332|NCT00838110|520867115|FG002|Overall Study|Lost to Follow-up|0|||
144456333|NCT00838110|520867116|FG003|Overall Study|Lost to Follow-up|0|||
144456334|NCT00838110|520867113|FG000|Overall Study|Did not meet eligibility criteria|0|||
144456335|NCT00838110|520867114|FG001|Overall Study|Did not meet eligibility criteria|0|||
144456336|NCT00838110|520867115|FG002|Overall Study|Did not meet eligibility criteria|1|||
144456337|NCT00838110|520867116|FG003|Overall Study|Did not meet eligibility criteria|2|||
144456338|NCT00838110|520867113|FG000|Overall Study|Randomized but not treated|0|||
144607566|NCT01970488|521424467|FG002|Part 2: Post Week 16|Adverse Event|5|||
144607567|NCT01970488|521424468|FG003|Part 2: Post Week 16|Adverse Event|1|||
144607568|NCT01970488|521424469|FG004|Part 2: Post Week 16|Adverse Event|1|||
144607569|NCT01970488|521424465|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
144196780|NCT00866658|519917073|FG000|Overall Study|Adverse Event|5|||
144196781|NCT00866658|519917074|FG001|Overall Study|Adverse Event|14|||
144456339|NCT00838110|520867114|FG001|Overall Study|Randomized but not treated|1|||
144456340|NCT00838110|520867115|FG002|Overall Study|Randomized but not treated|0|||
144456341|NCT00838110|520867116|FG003|Overall Study|Randomized but not treated|0|||
144607570|NCT01970488|521424466|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
144725821|NCT02585258|521851375|FG001|Overall Study|Lack of Efficacy|9|||
144456342|NCT02811861|520867117|FG000|Overall Study|Radiological Disease Progression|123|||
144456343|NCT02811861|520867118|FG001|Overall Study|Radiological Disease Progression|97|||
144456344|NCT02811861|520867119|FG002|Overall Study|Radiological Disease Progression|174|||
144196782|NCT00866658|519917073|FG000|Overall Study|Lack of Efficacy|2|||
144196783|NCT00866658|519917074|FG001|Overall Study|Lack of Efficacy|1|||
144196784|NCT00866658|519917073|FG000|Overall Study|Withdrawal by Subject|1|||
144456345|NCT02811861|520867117|FG000|Overall Study|Clinical Disease Progression|20|||
144456346|NCT02811861|520867118|FG001|Overall Study|Clinical Disease Progression|19|||
144456347|NCT02811861|520867119|FG002|Overall Study|Clinical Disease Progression|22|||
144456348|NCT02811861|520867117|FG000|Overall Study|Adverse Event|63|||
144456349|NCT02811861|520867118|FG001|Overall Study|Adverse Event|60|||
144456350|NCT02811861|520867119|FG002|Overall Study|Adverse Event|41|||
144456351|NCT02811861|520867117|FG000|Overall Study|Lost to Follow-up|0|||
144456352|NCT02811861|520867118|FG001|Overall Study|Lost to Follow-up|0|||
144456353|NCT02811861|520867119|FG002|Overall Study|Lost to Follow-up|1|||
144456354|NCT02811861|520867117|FG000|Overall Study|Subject Choice|29|||
144456355|NCT02811861|520867118|FG001|Overall Study|Subject Choice|17|||
144456356|NCT02811861|520867119|FG002|Overall Study|Subject Choice|23|||
144456357|NCT02811861|520867117|FG000|Overall Study|Withdrawal by Subject|4|||
144456358|NCT02811861|520867118|FG001|Overall Study|Withdrawal by Subject|4|||
144456359|NCT02811861|520867119|FG002|Overall Study|Withdrawal by Subject|9|||
144456360|NCT02811861|520867117|FG000|Overall Study|Other|4|||
144456361|NCT02811861|520867118|FG001|Overall Study|Other|13|||
144456362|NCT02811861|520867119|FG002|Overall Study|Other|3|||
144456363|NCT02811861|520867117|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
144456364|NCT02811861|520867118|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
144456365|NCT02811861|520867119|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
144456366|NCT02811861|520867117|FG000|Overall Study|Randomized but not treated|2|||
144456367|NCT02811861|520867118|FG001|Overall Study|Randomized but not treated|3|||
144456368|NCT02811861|520867119|FG002|Overall Study|Randomized but not treated|17|||
144456369|NCT00467870|520867122|FG000|Overall Study|Adverse Event|13|||
144456370|NCT00467870|520867123|FG001|Overall Study|Adverse Event|9|||
144456371|NCT00467870|520867124|FG002|Overall Study|Adverse Event|1|||
144456372|NCT00467870|520867125|FG003|Overall Study|Adverse Event|15|||
144456373|NCT00467870|520867126|FG004|Overall Study|Adverse Event|15|||
144456374|NCT00467870|520867127|FG005|Overall Study|Adverse Event|1|||
144456375|NCT00467870|520867122|FG000|Overall Study|Protocol Violation|2|||
144456376|NCT00467870|520867123|FG001|Overall Study|Protocol Violation|1|||
144456377|NCT00467870|520867124|FG002|Overall Study|Protocol Violation|1|||
144456378|NCT00467870|520867125|FG003|Overall Study|Protocol Violation|2|||
144456379|NCT00467870|520867126|FG004|Overall Study|Protocol Violation|0|||
144456380|NCT00467870|520867127|FG005|Overall Study|Protocol Violation|0|||
144456381|NCT00467870|520867122|FG000|Overall Study|Withdrawal by Subject|14|||
144456382|NCT00467870|520867123|FG001|Overall Study|Withdrawal by Subject|21|||
144456383|NCT00467870|520867124|FG002|Overall Study|Withdrawal by Subject|0|||
144456384|NCT00467870|520867125|FG003|Overall Study|Withdrawal by Subject|9|||
144456385|NCT00467870|520867126|FG004|Overall Study|Withdrawal by Subject|10|||
144456386|NCT00467870|520867127|FG005|Overall Study|Withdrawal by Subject|1|||
144456387|NCT00467870|520867122|FG000|Overall Study|Lost to Follow-up|5|||
144456388|NCT00467870|520867123|FG001|Overall Study|Lost to Follow-up|3|||
144456389|NCT00467870|520867124|FG002|Overall Study|Lost to Follow-up|1|||
144456390|NCT00467870|520867125|FG003|Overall Study|Lost to Follow-up|1|||
144456391|NCT00467870|520867126|FG004|Overall Study|Lost to Follow-up|3|||
144456392|NCT00467870|520867127|FG005|Overall Study|Lost to Follow-up|0|||
144456393|NCT00467870|520867122|FG000|Overall Study|Subject Non-compliance|3|||
144534135|NCT04165213|521159070|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
144534136|NCT04165213|521159069|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
144534137|NCT04165213|521159070|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
144534138|NCT04165213|521159069|FG000|Caregiver Enrollment|Physician Decision|1|||
144534139|NCT04165213|521159070|FG001|Caregiver Enrollment|Physician Decision|0|||
144725822|NCT02585258|521851374|FG000|Overall Study|includes covid-related access problems|42|||
144196785|NCT00866658|519917074|FG001|Overall Study|Withdrawal by Subject|0|||
144196786|NCT00866658|519917073|FG000|Overall Study|Protocol Violation|1|||
144196787|NCT00866658|519917074|FG001|Overall Study|Protocol Violation|1|||
144456394|NCT00467870|520867123|FG001|Overall Study|Subject Non-compliance|4|||
144456395|NCT00467870|520867124|FG002|Overall Study|Subject Non-compliance|0|||
144456396|NCT00467870|520867125|FG003|Overall Study|Subject Non-compliance|1|||
144456397|NCT00467870|520867126|FG004|Overall Study|Subject Non-compliance|5|||
144456398|NCT00467870|520867127|FG005|Overall Study|Subject Non-compliance|0|||
144456399|NCT00467870|520867122|FG000|Overall Study|Other/Unknown|8|||
144456400|NCT00467870|520867123|FG001|Overall Study|Other/Unknown|5|||
144456401|NCT00467870|520867124|FG002|Overall Study|Other/Unknown|1|||
144456402|NCT00467870|520867125|FG003|Overall Study|Other/Unknown|5|||
144456403|NCT00467870|520867126|FG004|Overall Study|Other/Unknown|4|||
144456404|NCT00467870|520867127|FG005|Overall Study|Other/Unknown|0|||
144456405|NCT01917526|520867128|FG000|Overall Study|Protocol Violation|1|||
144456406|NCT01917526|520867129|FG001|Overall Study|Protocol Violation|1|||
144456407|NCT02261363|520867130|FG000|Overall Study|Lost to Follow-up|21|||
144456408|NCT01517802|520867131|FG000|Overall Study|Death|1|||
144534140|NCT04165213|521159069|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
144196788|NCT00866658|519917073|FG000|Overall Study|Familial and Personal Reasons|4|||
144607571|NCT01970488|521424467|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
144607572|NCT01970488|521424468|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
144607573|NCT01970488|521424469|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
144534141|NCT04165213|521159070|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
144534142|NCT04165213|521159069|FG000|Caregiver Enrollment|PLWD death|2|||
144534143|NCT04165213|521159070|FG001|Caregiver Enrollment|PLWD death|0|||
144534144|NCT04165213|521159069|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
144534145|NCT04165213|521159070|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
144534146|NCT04165213|521159069|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
144534147|NCT04165213|521159070|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
144534148|NCT04165213|521159069|FG000|PLWD Enrollment|Lost to Follow-up|1|||
144534149|NCT04165213|521159070|FG001|PLWD Enrollment|Lost to Follow-up|1|||
144534150|NCT04165213|521159069|FG000|PLWD Enrollment|Physician Decision|1|||
144534151|NCT04165213|521159070|FG001|PLWD Enrollment|Physician Decision|0|||
144534152|NCT04165213|521159069|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
144534153|NCT04165213|521159070|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
144534154|NCT04165213|521159069|FG000|PLWD Enrollment|Death|2|||
144534155|NCT04165213|521159070|FG001|PLWD Enrollment|Death|0|||
144534156|NCT04165213|521159069|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
144534157|NCT04165213|521159070|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
144534158|NCT05147584|521159071|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
144534159|NCT02163694|521159077|FG000|Overall Study|Adverse event- related to progression|4|||
144607574|NCT01970488|521424465|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
144607575|NCT01970488|521424466|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
144607576|NCT01970488|521424467|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
144607577|NCT01970488|521424468|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
144607578|NCT01970488|521424469|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
144607579|NCT00356889|521424475|FG000|Overall Study|Protocol Violation|2|||
144607580|NCT00356889|521424475|FG000|Overall Study|Adverse Event|1|||
144607581|NCT03098836|521424483|FG000|Overall Study|Adverse Event|1|||
144456409|NCT03268811|520867136|FG000|Overall Study|Adverse Event|0|||
144456410|NCT03268811|520867137|FG001|Overall Study|Adverse Event|1|||
144456411|NCT02031276|520867138|FG000|Period 1 Double-blind IV|Adverse Event|6|||
144456412|NCT02031276|520867139|FG001|Period 1 Double-blind IV|Adverse Event|5|||
144456413|NCT02031276|520867140|FG002|Period 1 Double-blind IV|Adverse Event|1|||
144456414|NCT02031276|520867138|FG000|Period 1 Double-blind IV|Other|0|||
144456415|NCT02031276|520867139|FG001|Period 1 Double-blind IV|Other|1|||
144456416|NCT02031276|520867140|FG002|Period 1 Double-blind IV|Other|0|||
144456417|NCT02031276|520867138|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
144456418|NCT02031276|520867139|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
144456419|NCT02031276|520867140|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
144456420|NCT02031276|520867138|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
144456421|NCT02031276|520867139|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
144456422|NCT02031276|520867140|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
144456423|NCT02031276|520867138|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
144456424|NCT02031276|520867139|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
144456425|NCT02031276|520867140|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
144456426|NCT02031276|520867138|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
144456427|NCT02031276|520867139|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
144456428|NCT02031276|520867140|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
144456429|NCT02031276|520867138|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
144456430|NCT02031276|520867139|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
144456431|NCT02031276|520867140|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
144456432|NCT02031276|520867138|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
144456433|NCT02031276|520867139|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
144456434|NCT02031276|520867140|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
144456435|NCT02031276|520867138|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
144534160|NCT02163694|521159078|FG001|Overall Study|Adverse event- related to progression|10|||
144534161|NCT02163694|521159077|FG000|Overall Study|Adverse event- not related to progression|7|||
144534162|NCT02163694|521159078|FG001|Overall Study|Adverse event- not related to progression|22|||
144607582|NCT03098836|521424484|FG001|Overall Study|Adverse Event|3|||
144456436|NCT02031276|520867139|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
144607583|NCT03098836|521424483|FG000|Overall Study|Lack of Efficacy|30|||
144456437|NCT02031276|520867140|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
144456438|NCT04726709|520867147|FG000|Overall Study|Withdrawal by Subject|2|||
144456439|NCT04726709|520867148|FG001|Overall Study|Withdrawal by Subject|2|||
144456440|NCT03073603|520867150|FG000|Overall Study|Noncompliance|3|||
144534163|NCT02163694|521159077|FG000|Overall Study|Withdrew consent|13|||
144534164|NCT02163694|521159078|FG001|Overall Study|Withdrew consent|28|||
144534165|NCT02163694|521159077|FG000|Overall Study|Lost to Follow-up|2|||
144607584|NCT03098836|521424484|FG001|Overall Study|Lack of Efficacy|15|||
144534166|NCT02163694|521159078|FG001|Overall Study|Lost to Follow-up|2|||
144607585|NCT03098836|521424483|FG000|Overall Study|Physician Decision|2|||
144196789|NCT00866658|519917074|FG001|Overall Study|Familial and Personal Reasons|5|||
144196790|NCT01248013|519917077|FG000|Overall Study|Withdrawal by Subject|14|||
144196791|NCT01388166|519917080|FG000|Overall Study|Adverse Event|16|||
144456441|NCT03073603|520867151|FG001|Overall Study|Noncompliance|1|||
144456442|NCT03073603|520867150|FG000|Overall Study|Adverse Event|5|||
144456443|NCT03073603|520867151|FG001|Overall Study|Adverse Event|3|||
144456444|NCT03073603|520867150|FG000|Overall Study|Physician Decision|1|||
144456445|NCT03073603|520867151|FG001|Overall Study|Physician Decision|2|||
144456446|NCT03073603|520867150|FG000|Overall Study|Required treatment not allowed by protocol|1|||
144456447|NCT03073603|520867151|FG001|Overall Study|Required treatment not allowed by protocol|0|||
144456448|NCT03073603|520867150|FG000|Overall Study|Financial or insurance-related|8|||
144456449|NCT03073603|520867151|FG001|Overall Study|Financial or insurance-related|0|||
144456450|NCT03073603|520867150|FG000|Overall Study|Withdrawal by Subject|0|||
144456451|NCT03073603|520867151|FG001|Overall Study|Withdrawal by Subject|1|||
144456452|NCT03073603|520867150|FG000|Overall Study|Discontinued DMT|4|||
144456453|NCT03073603|520867151|FG001|Overall Study|Discontinued DMT|0|||
144456454|NCT03073603|520867150|FG000|Overall Study|Restarted DMT|0|||
144456455|NCT03073603|520867151|FG001|Overall Study|Restarted DMT|1|||
144456456|NCT04757649|520867152|FG000|Overall Study|Withdrawal by Subject|1|||
144456457|NCT04757649|520867152|FG000|Overall Study|Adverse Event|1|||
144456458|NCT01286779|520867153|FG000|Overall Study|Withdrawal by Subject|9|||
144456459|NCT01286779|520867153|FG000|Overall Study|Protocol Violation|5|||
144456460|NCT01286779|520867153|FG000|Overall Study|Physician Decision|2|||
144456461|NCT01286779|520867153|FG000|Overall Study|Participant had scheduled surgery|1|||
144456462|NCT01286779|520867153|FG000|Overall Study|Participant moved to another country|1|||
144456463|NCT01286779|520867153|FG000|Overall Study|Discontinued by sponsor|1|||
144456464|NCT00574080|520867158|FG000|Overall Study|Death|10|||
144456465|NCT00574080|520867159|FG001|Overall Study|Death|10|||
144456466|NCT02862106|520867160|FG000|Overall Study|Adverse Event|4|||
144456467|NCT02862106|520867161|FG001|Overall Study|Adverse Event|0|||
144456468|NCT02862106|520867160|FG000|Overall Study|Protocol Violation|16|||
144456469|NCT02862106|520867161|FG001|Overall Study|Protocol Violation|1|||
144456470|NCT02862106|520867160|FG000|Overall Study|Lost to Follow-up|15|||
144456471|NCT02862106|520867161|FG001|Overall Study|Lost to Follow-up|5|||
144456472|NCT02862106|520867160|FG000|Overall Study|Withdrawal by Subject|2|||
144456473|NCT02862106|520867161|FG001|Overall Study|Withdrawal by Subject|0|||
144456474|NCT02862106|520867160|FG000|Overall Study|Subjects moved to other city|1|||
144456475|NCT02862106|520867161|FG001|Overall Study|Subjects moved to other city|0|||
144456476|NCT03434119|520867162|FG000|Overall Study|Randomized but not treated|1|||
144456477|NCT03434119|520867163|FG001|Overall Study|Randomized but not treated|0|||
144456478|NCT03434119|520867162|FG000|Overall Study|Adverse Event|1|||
144456479|NCT03434119|520867163|FG001|Overall Study|Adverse Event|0|||
144456480|NCT03434119|520867162|FG000|Overall Study|Poor Compliance to Protocol|0|||
144456481|NCT03434119|520867163|FG001|Overall Study|Poor Compliance to Protocol|1|||
144456482|NCT03434119|520867162|FG000|Overall Study|Study Terminated by Sponsor|91|||
144456483|NCT03434119|520867163|FG001|Overall Study|Study Terminated by Sponsor|102|||
144456484|NCT03434119|520867162|FG000|Overall Study|Withdrawal by Subject|7|||
144456485|NCT03434119|520867163|FG001|Overall Study|Withdrawal by Subject|5|||
144456486|NCT03434119|520867162|FG000|Overall Study|Other than specified|7|||
144456487|NCT03434119|520867163|FG001|Overall Study|Other than specified|5|||
144456488|NCT04360824|520867164|FG000|Overall Study|Withdrawal by Subject|2|||
144456489|NCT04360824|520867165|FG001|Overall Study|Withdrawal by Subject|1|||
144456490|NCT04360824|520867164|FG000|Overall Study|Did not receive assigned treatment|1|||
144456491|NCT04360824|520867165|FG001|Overall Study|Did not receive assigned treatment|3|||
144456492|NCT00304070|520867166|FG000|Overall Study|Death|0|||
144456493|NCT00304070|520867167|FG001|Overall Study|Death|0|||
144456494|NCT00304070|520867168|FG002|Overall Study|Death|3|||
144456495|NCT00304070|520867166|FG000|Overall Study|Lost to Follow-up|0|||
144456496|NCT00304070|520867167|FG001|Overall Study|Lost to Follow-up|0|||
144456497|NCT00304070|520867168|FG002|Overall Study|Lost to Follow-up|1|||
144196792|NCT01388166|519917080|FG000|Overall Study|Lost to Follow-up|30|||
144196793|NCT01388166|519917080|FG000|Overall Study|Others than specified above|13|||
144196794|NCT03760250|519917081|FG000|Overall Study|Withdrawal by Subject|1|||
144196795|NCT03760250|519917081|FG000|Overall Study|Physician Decision|1|||
144456498|NCT00304070|520867166|FG000|Overall Study|Physician Decision|0|||
144456499|NCT00304070|520867167|FG001|Overall Study|Physician Decision|0|||
144456500|NCT00304070|520867168|FG002|Overall Study|Physician Decision|3|||
144456501|NCT00304070|520867166|FG000|Overall Study|Withdrawal by Subject|0|||
144456502|NCT00304070|520867167|FG001|Overall Study|Withdrawal by Subject|0|||
144196796|NCT03733210|519917083|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
144456503|NCT00304070|520867168|FG002|Overall Study|Withdrawal by Subject|1|||
144456504|NCT00304070|520867166|FG000|Overall Study|Progressive Disease|3|||
144456505|NCT00304070|520867167|FG001|Overall Study|Progressive Disease|7|||
144456506|NCT00304070|520867168|FG002|Overall Study|Progressive Disease|4|||
144456507|NCT00320216|520867169|FG000|Overall Study|Adverse Event|0|||
144456508|NCT00320216|520867170|FG001|Overall Study|Adverse Event|6|||
144456509|NCT00320216|520867171|FG002|Overall Study|Adverse Event|0|||
144255054|NCT00398216|520136073|FG000|Overall Study|Lost to Follow-up|1|||
144456510|NCT00320216|520867172|FG003|Overall Study|Adverse Event|2|||
144456511|NCT00320216|520867173|FG004|Overall Study|Adverse Event|2|||
144456512|NCT00320216|520867169|FG000|Overall Study|Lack of Efficacy|6|||
144456513|NCT00320216|520867170|FG001|Overall Study|Lack of Efficacy|2|||
144456514|NCT00320216|520867171|FG002|Overall Study|Lack of Efficacy|1|||
144456515|NCT00320216|520867172|FG003|Overall Study|Lack of Efficacy|0|||
144456516|NCT00320216|520867173|FG004|Overall Study|Lack of Efficacy|1|||
144456517|NCT00320216|520867169|FG000|Overall Study|Lost to Follow-up|3|||
144456518|NCT00320216|520867170|FG001|Overall Study|Lost to Follow-up|0|||
144456519|NCT00320216|520867171|FG002|Overall Study|Lost to Follow-up|0|||
144456520|NCT00320216|520867172|FG003|Overall Study|Lost to Follow-up|0|||
144456521|NCT00320216|520867173|FG004|Overall Study|Lost to Follow-up|0|||
144456522|NCT00320216|520867169|FG000|Overall Study|Other|7|||
144456523|NCT00320216|520867170|FG001|Overall Study|Other|2|||
144456524|NCT00320216|520867171|FG002|Overall Study|Other|5|||
144456525|NCT00320216|520867172|FG003|Overall Study|Other|1|||
144456526|NCT00320216|520867173|FG004|Overall Study|Other|3|||
144456527|NCT00377676|520867174|FG000|Overall Study|Adverse Event|498|||
144456528|NCT00377676|520867175|FG001|Overall Study|Adverse Event|107|||
144456529|NCT00377676|520867174|FG000|Overall Study|Protocol Violation|33|||
144456530|NCT00377676|520867175|FG001|Overall Study|Protocol Violation|27|||
144456531|NCT00377676|520867174|FG000|Overall Study|Death|5|||
144456532|NCT00377676|520867175|FG001|Overall Study|Death|2|||
144456533|NCT00377676|520867174|FG000|Overall Study|Withdrawal by Subject|187|||
144456534|NCT00377676|520867175|FG001|Overall Study|Withdrawal by Subject|72|||
144456535|NCT00377676|520867174|FG000|Overall Study|Lost to Follow-up|120|||
144456536|NCT00377676|520867175|FG001|Overall Study|Lost to Follow-up|56|||
144456537|NCT00377676|520867174|FG000|Overall Study|Other|118|||
144456538|NCT00377676|520867175|FG001|Overall Study|Other|58|||
144456539|NCT06027216|520867186|FG000|Overall Study|Did not qualify|8|||
144456540|NCT05348681|520867187|FG000|Overall Study|Study terminated by Sponsor|8|||
144456541|NCT05348681|520867188|FG001|Overall Study|Study terminated by Sponsor|3|||
144456542|NCT05348681|520867187|FG000|Overall Study|Withdrawal by Subject|1|||
144456543|NCT05348681|520867188|FG001|Overall Study|Withdrawal by Subject|1|||
144456544|NCT05348681|520867187|FG000|Overall Study|Lost to Follow-up|1|||
144456545|NCT05348681|520867188|FG001|Overall Study|Lost to Follow-up|1|||
144456546|NCT05348681|520867187|FG000|Overall Study|Adverse Event|1|||
144456547|NCT05348681|520867188|FG001|Overall Study|Adverse Event|0|||
144456548|NCT05348681|520867187|FG000|Overall Study|Other|2|||
144456549|NCT05348681|520867188|FG001|Overall Study|Other|1|||
144456550|NCT03646513|520867192|FG000|Overall Study|Premature study termination|4|||
144456551|NCT00782340|520867193|FG000|Open Label Titration|Adverse Event|12|||
144456552|NCT00782340|520867194|FG001|Open Label Titration|Adverse Event|0|||
144456553|NCT00782340|520867195|FG002|Open Label Titration|Adverse Event|0|||
144456554|NCT00782340|520867193|FG000|Open Label Titration|Treatment failure|50|||
144456555|NCT00782340|520867194|FG001|Open Label Titration|Treatment failure|0|||
144456556|NCT00782340|520867195|FG002|Open Label Titration|Treatment failure|0|||
144456557|NCT00782340|520867193|FG000|Open Label Titration|Protocol Violation|5|||
144456558|NCT00782340|520867194|FG001|Open Label Titration|Protocol Violation|0|||
144456559|NCT00782340|520867195|FG002|Open Label Titration|Protocol Violation|0|||
144456560|NCT00782340|520867193|FG000|Open Label Titration|Withdrawal by Subject|5|||
144456561|NCT00782340|520867194|FG001|Open Label Titration|Withdrawal by Subject|0|||
144456562|NCT00782340|520867195|FG002|Open Label Titration|Withdrawal by Subject|0|||
144456563|NCT00782340|520867193|FG000|Open Label Titration|Enrollment capped|16|||
144456564|NCT00782340|520867194|FG001|Open Label Titration|Enrollment capped|0|||
144456565|NCT00782340|520867195|FG002|Open Label Titration|Enrollment capped|0|||
144456566|NCT00782340|520867193|FG000|Open Label Titration|Did not meet responder criteria|2|||
144456567|NCT00782340|520867194|FG001|Open Label Titration|Did not meet responder criteria|0|||
144456568|NCT00782340|520867195|FG002|Open Label Titration|Did not meet responder criteria|0|||
144456569|NCT00782340|520867193|FG000|Open Label Titration|Lost to Follow-up|5|||
144456570|NCT00782340|520867194|FG001|Open Label Titration|Lost to Follow-up|0|||
144456571|NCT00782340|520867195|FG002|Open Label Titration|Lost to Follow-up|0|||
144456572|NCT00782340|520867193|FG000|Open Label Titration|Randomized in error|6|||
144456573|NCT00782340|520867194|FG001|Open Label Titration|Randomized in error|0|||
144456574|NCT00782340|520867195|FG002|Open Label Titration|Randomized in error|0|||
144456575|NCT03538626|520867201|FG000|Overall Study|Withdrawal by Subject|0|||
144456576|NCT03538626|520867202|FG001|Overall Study|Withdrawal by Subject|1|||
144456577|NCT03538626|520867203|FG002|Overall Study|Withdrawal by Subject|0|||
144456578|NCT03538626|520867204|FG003|Overall Study|Withdrawal by Subject|0|||
144456579|NCT03538626|520867205|FG004|Overall Study|Withdrawal by Subject|0|||
144456580|NCT03538626|520867206|FG005|Overall Study|Withdrawal by Subject|0|||
144456581|NCT03538626|520867207|FG006|Overall Study|Withdrawal by Subject|0|||
144456582|NCT03538626|520867208|FG007|Overall Study|Withdrawal by Subject|0|||
144456583|NCT03538626|520867201|FG000|Overall Study|Lost to Follow-up|0|||
144456584|NCT03538626|520867202|FG001|Overall Study|Lost to Follow-up|0|||
144456585|NCT03538626|520867203|FG002|Overall Study|Lost to Follow-up|0|||
144456586|NCT03538626|520867204|FG003|Overall Study|Lost to Follow-up|0|||
144534167|NCT02163694|521159077|FG000|Overall Study|Sponsor discontinued study|3|||
144534168|NCT02163694|521159078|FG001|Overall Study|Sponsor discontinued study|29|||
144534169|NCT02163694|521159077|FG000|Overall Study|Progressive disease per protocol|125|||
144534170|NCT02163694|521159078|FG001|Overall Study|Progressive disease per protocol|224|||
144534171|NCT02163694|521159077|FG000|Overall Study|Other, not specified|17|||
144534172|NCT02163694|521159078|FG001|Overall Study|Other, not specified|22|||
144534173|NCT02163694|521159077|FG000|Overall Study|Randomized but Not Treated|1|||
144534174|NCT02163694|521159078|FG001|Overall Study|Randomized but Not Treated|0|||
144534175|NCT02163694|521159077|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
144534176|NCT02163694|521159078|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
144534177|NCT04560179|521159085|FG000|Overall Study|Physician Decision|1|||
144534178|NCT04560179|521159086|FG001|Overall Study|Physician Decision|0|||
144534179|NCT04560179|521159087|FG002|Overall Study|Physician Decision|0|||
144534180|NCT04560179|521159088|FG003|Overall Study|Physician Decision|0|||
144534181|NCT04560179|521159089|FG004|Overall Study|Physician Decision|0|||
144534182|NCT04560179|521159085|FG000|Overall Study|Adverse Event|0|||
144534183|NCT04560179|521159086|FG001|Overall Study|Adverse Event|0|||
144534184|NCT04560179|521159087|FG002|Overall Study|Adverse Event|0|||
144534185|NCT04560179|521159088|FG003|Overall Study|Adverse Event|1|||
144534186|NCT04560179|521159089|FG004|Overall Study|Adverse Event|0|||
144534187|NCT04369911|521159092|FG000|Overall Study|Lost to Follow-up|3|||
144534188|NCT04369911|521159093|FG001|Overall Study|Lost to Follow-up|3|||
144534189|NCT04369911|521159092|FG000|Overall Study|Withdrawal by Subject|1|||
144534190|NCT04369911|521159093|FG001|Overall Study|Withdrawal by Subject|2|||
144534191|NCT03662022|521159094|FG000|Year 1 2019|prevalent case|83|||
144534192|NCT03662022|521159095|FG001|Year 1 2019|prevalent case|116|||
144534193|NCT03662022|521159096|FG002|Year 1 2019|prevalent case|158|||
144534194|NCT03662022|521159097|FG003|Year 1 2019|prevalent case|99|||
144534195|NCT03662022|521159094|FG000|Year 2 2020|incident case|18|||
144534196|NCT03662022|521159095|FG001|Year 2 2020|incident case|18|||
144534197|NCT03662022|521159096|FG002|Year 2 2020|incident case|16|||
144534198|NCT03662022|521159097|FG003|Year 2 2020|incident case|26|||
144534199|NCT03662022|521159094|FG000|Year 2 2020|other case|18|||
144534200|NCT03662022|521159095|FG001|Year 2 2020|other case|16|||
144534201|NCT03662022|521159096|FG002|Year 2 2020|other case|16|||
144534202|NCT03662022|521159097|FG003|Year 2 2020|other case|24|||
144534203|NCT03662022|521159094|FG000|Year 2 2020|Lost to Follow-up|1633|||
144534204|NCT03662022|521159095|FG001|Year 2 2020|Lost to Follow-up|1183|||
144534205|NCT03662022|521159096|FG002|Year 2 2020|Lost to Follow-up|1381|||
144534206|NCT03662022|521159097|FG003|Year 2 2020|Lost to Follow-up|2858|||
144534207|NCT03662022|521159094|FG000|Year 3 2021|incident case|24|||
144534208|NCT03662022|521159095|FG001|Year 3 2021|incident case|27|||
144534209|NCT03662022|521159096|FG002|Year 3 2021|incident case|24|||
144534210|NCT03662022|521159097|FG003|Year 3 2021|incident case|11|||
144534211|NCT03662022|521159094|FG000|Year 3 2021|other case|4|||
144534212|NCT03662022|521159095|FG001|Year 3 2021|other case|15|||
144534213|NCT03662022|521159096|FG002|Year 3 2021|other case|10|||
144534214|NCT03662022|521159097|FG003|Year 3 2021|other case|14|||
144534215|NCT03662022|521159094|FG000|Year 3 2021|Lost to Follow-up|179|||
144534216|NCT03662022|521159095|FG001|Year 3 2021|Lost to Follow-up|244|||
144534217|NCT03662022|521159096|FG002|Year 3 2021|Lost to Follow-up|480|||
144534218|NCT03662022|521159097|FG003|Year 3 2021|Lost to Follow-up|477|||
144534219|NCT03662022|521159094|FG000|Year 4 2022|incident case|25|||
144534220|NCT03662022|521159095|FG001|Year 4 2022|incident case|41|||
144534221|NCT03662022|521159096|FG002|Year 4 2022|incident case|28|||
144534222|NCT03662022|521159097|FG003|Year 4 2022|incident case|7|||
144534223|NCT03662022|521159094|FG000|Year 4 2022|other case|8|||
144534224|NCT03662022|521159095|FG001|Year 4 2022|other case|19|||
144534225|NCT03662022|521159096|FG002|Year 4 2022|other case|13|||
144534226|NCT03662022|521159097|FG003|Year 4 2022|other case|7|||
144534227|NCT03662022|521159094|FG000|Year 4 2022|Lost to Follow-up|986|||
144534228|NCT03662022|521159095|FG001|Year 4 2022|Lost to Follow-up|1079|||
144534229|NCT03662022|521159096|FG002|Year 4 2022|Lost to Follow-up|1236|||
144534230|NCT03662022|521159097|FG003|Year 4 2022|Lost to Follow-up|1826|||
144534231|NCT04214418|521159098|FG000|Overall Study|Withdrawal by Subject|1|||
144534232|NCT04214418|521159099|FG001|Overall Study|Withdrawal by Subject|0|||
144534233|NCT04214418|521159100|FG002|Overall Study|Withdrawal by Subject|0|||
144534234|NCT04214418|521159101|FG003|Overall Study|Withdrawal by Subject|0|||
144534235|NCT04214418|521159102|FG004|Overall Study|Withdrawal by Subject|0|||
144534236|NCT04214418|521159103|FG005|Overall Study|Withdrawal by Subject|0|||
144725823|NCT02585258|521851375|FG001|Overall Study|includes covid-related access problems|46|||
144725824|NCT02585258|521851374|FG000|Overall Study|Lost to Follow-up|5|||
144534237|NCT04214418|521159098|FG000|Overall Study|Adverse Event|0|||
144534238|NCT04214418|521159099|FG001|Overall Study|Adverse Event|2|||
144534239|NCT04214418|521159100|FG002|Overall Study|Adverse Event|0|||
144534240|NCT04214418|521159101|FG003|Overall Study|Adverse Event|0|||
144534241|NCT04214418|521159102|FG004|Overall Study|Adverse Event|0|||
144534242|NCT04214418|521159103|FG005|Overall Study|Adverse Event|0|||
144534243|NCT04214418|521159098|FG000|Overall Study|Death|1|||
144534244|NCT04214418|521159099|FG001|Overall Study|Death|0|||
144456587|NCT03538626|520867205|FG004|Overall Study|Lost to Follow-up|0|||
144456588|NCT03538626|520867206|FG005|Overall Study|Lost to Follow-up|0|||
144456589|NCT03538626|520867207|FG006|Overall Study|Lost to Follow-up|1|||
144456590|NCT03538626|520867208|FG007|Overall Study|Lost to Follow-up|0|||
144456591|NCT02911948|520867210|FG000|Overall Study|Protocol Violation|0|||
144456592|NCT02911948|520867211|FG001|Overall Study|Protocol Violation|1|||
144456593|NCT02911948|520867210|FG000|Overall Study|Withdrawal by Subject|0|||
144456594|NCT02911948|520867211|FG001|Overall Study|Withdrawal by Subject|2|||
144456595|NCT02911948|520867210|FG000|Overall Study|Lack of Efficacy|0|||
144456596|NCT02911948|520867211|FG001|Overall Study|Lack of Efficacy|1|||
144456597|NCT02911948|520867210|FG000|Overall Study|Unclassified|0|||
144456598|NCT02911948|520867211|FG001|Overall Study|Unclassified|3|||
144456599|NCT01660763|520867222|FG000|Overall Study|Lack of Efficacy|45|||
144456600|NCT01660763|520867223|FG001|Overall Study|Lack of Efficacy|50|||
144456601|NCT01660763|520867222|FG000|Overall Study|Adverse Event|22|||
144456602|NCT01660763|520867223|FG001|Overall Study|Adverse Event|7|||
144456603|NCT01660763|520867222|FG000|Overall Study|Protocol Violation|1|||
144456604|NCT01660763|520867223|FG001|Overall Study|Protocol Violation|0|||
144456605|NCT01660763|520867222|FG000|Overall Study|Withdrawal by Subject|4|||
144456606|NCT01660763|520867223|FG001|Overall Study|Withdrawal by Subject|0|||
144456607|NCT01660763|520867222|FG000|Overall Study|Patient ready for early discharge|28|||
144456608|NCT01660763|520867223|FG001|Overall Study|Patient ready for early discharge|4|||
144456609|NCT01910519|520867224|FG000|Overall Study|Withdrawal by Subject|2|||
144456610|NCT01910519|520867225|FG001|Overall Study|Withdrawal by Subject|0|||
144456611|NCT01910519|520867224|FG000|Overall Study|Adverse Event|2|||
144456612|NCT01910519|520867225|FG001|Overall Study|Adverse Event|0|||
144456613|NCT04266028|520867226|FG000|Overall Study|Adverse Event|0|||
144456614|NCT04266028|520867227|FG001|Overall Study|Adverse Event|0|||
144456615|NCT04266028|520867228|FG002|Overall Study|Adverse Event|1|||
144456616|NCT04266028|520867229|FG003|Overall Study|Adverse Event|0|||
144456617|NCT04266028|520867230|FG004|Overall Study|Adverse Event|1|||
144456618|NCT04266028|520867231|FG005|Overall Study|Adverse Event|0|||
144456619|NCT04266028|520867232|FG006|Overall Study|Adverse Event|2|||
144456620|NCT04266028|520867233|FG007|Overall Study|Adverse Event|0|||
144456621|NCT04266028|520867226|FG000|Overall Study|temporary halt of the study|0|||
144456622|NCT04266028|520867227|FG001|Overall Study|temporary halt of the study|0|||
144456623|NCT04266028|520867228|FG002|Overall Study|temporary halt of the study|0|||
144456624|NCT04266028|520867229|FG003|Overall Study|temporary halt of the study|0|||
144456625|NCT04266028|520867230|FG004|Overall Study|temporary halt of the study|0|||
144456626|NCT04266028|520867231|FG005|Overall Study|temporary halt of the study|0|||
144456627|NCT04266028|520867232|FG006|Overall Study|temporary halt of the study|2|||
144456628|NCT04266028|520867233|FG007|Overall Study|temporary halt of the study|1|||
144456629|NCT04266028|520867226|FG000|Overall Study|Onset of birch pollen season|0|||
144456630|NCT04266028|520867227|FG001|Overall Study|Onset of birch pollen season|0|||
144456631|NCT04266028|520867228|FG002|Overall Study|Onset of birch pollen season|0|||
144456632|NCT04266028|520867229|FG003|Overall Study|Onset of birch pollen season|0|||
144456633|NCT04266028|520867230|FG004|Overall Study|Onset of birch pollen season|1|||
144456634|NCT04266028|520867231|FG005|Overall Study|Onset of birch pollen season|0|||
144456635|NCT04266028|520867232|FG006|Overall Study|Onset of birch pollen season|0|||
144456636|NCT04266028|520867233|FG007|Overall Study|Onset of birch pollen season|0|||
144456637|NCT01458574|520867234|FG000|Overall Study|Adverse Event|5|||
144456638|NCT01458574|520867235|FG001|Overall Study|Adverse Event|9|||
144456639|NCT01458574|520867236|FG002|Overall Study|Adverse Event|7|||
144456640|NCT01458574|520867234|FG000|Overall Study|Lack of Efficacy|70|||
144456641|NCT01458574|520867235|FG001|Overall Study|Lack of Efficacy|53|||
144456642|NCT01458574|520867236|FG002|Overall Study|Lack of Efficacy|132|||
144456643|NCT01458574|520867234|FG000|Overall Study|Lost to Follow-up|3|||
144456644|NCT01458574|520867235|FG001|Overall Study|Lost to Follow-up|2|||
144456645|NCT01458574|520867236|FG002|Overall Study|Lost to Follow-up|1|||
144456646|NCT01458574|520867234|FG000|Overall Study|Pregnancy|1|||
144456647|NCT01458574|520867235|FG001|Overall Study|Pregnancy|1|||
144456648|NCT01458574|520867236|FG002|Overall Study|Pregnancy|0|||
144456649|NCT01458574|520867234|FG000|Overall Study|Protocol Violation|0|||
144456650|NCT01458574|520867235|FG001|Overall Study|Protocol Violation|1|||
144456651|NCT01458574|520867236|FG002|Overall Study|Protocol Violation|0|||
144456652|NCT01458574|520867234|FG000|Overall Study|Withdrawal by Subject|6|||
144456653|NCT01458574|520867235|FG001|Overall Study|Withdrawal by Subject|3|||
144456654|NCT01458574|520867236|FG002|Overall Study|Withdrawal by Subject|5|||
144456655|NCT01458574|520867234|FG000|Overall Study|Other|2|||
144456656|NCT01458574|520867235|FG001|Overall Study|Other|1|||
144456657|NCT01458574|520867236|FG002|Overall Study|Other|0|||
144456658|NCT01458574|520867234|FG000|Overall Study|Randomized but not treated|0|||
144456659|NCT01458574|520867235|FG001|Overall Study|Randomized but not treated|1|||
144456660|NCT01458574|520867236|FG002|Overall Study|Randomized but not treated|0|||
144456661|NCT02125786|520867237|FG000|Overall Study|Still in Follow-up|3|||
144456662|NCT02125786|520867237|FG000|Overall Study|Screen Failure|2|||
144456663|NCT02125786|520867237|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
144456664|NCT02125786|520867237|FG000|Overall Study|Progressive Disease|44|||
144456665|NCT02125786|520867237|FG000|Overall Study|Death|8|||
144456666|NCT04964089|520867240|FG000|Overall Study|Adverse Event|8|||
144456667|NCT04964089|520867241|FG001|Overall Study|Adverse Event|6|||
144456668|NCT04964089|520867240|FG000|Overall Study|Non-compliance with study schedule|1|||
144456669|NCT04964089|520867241|FG001|Overall Study|Non-compliance with study schedule|0|||
144456670|NCT04964089|520867240|FG000|Overall Study|Withdrawal by Subject|6|||
144456671|NCT04964089|520867241|FG001|Overall Study|Withdrawal by Subject|5|||
144456672|NCT04964089|520867240|FG000|Overall Study|Lost to Follow-up|1|||
144456673|NCT04964089|520867241|FG001|Overall Study|Lost to Follow-up|1|||
144456674|NCT04964089|520867240|FG000|Overall Study|Progressive disease|4|||
144456675|NCT04964089|520867241|FG001|Overall Study|Progressive disease|0|||
144456676|NCT04964089|520867240|FG000|Overall Study|Physician Decision|1|||
144456677|NCT04964089|520867241|FG001|Overall Study|Physician Decision|0|||
144456678|NCT04964089|520867240|FG000|Overall Study|Participant did not want to continue study treatment|1|||
144456679|NCT04964089|520867241|FG001|Overall Study|Participant did not want to continue study treatment|0|||
144456680|NCT04964089|520867240|FG000|Overall Study|Participant moved to different state|1|||
144456681|NCT04964089|520867241|FG001|Overall Study|Participant moved to different state|0|||
144456682|NCT04964089|520867240|FG000|Overall Study|Participant decided to discontinue|0|||
144456683|NCT04964089|520867241|FG001|Overall Study|Participant decided to discontinue|1|||
144456684|NCT01682837|520867242|FG000|Baseline|Withdrawal by Subject|5|||
144456685|NCT01664078|520867245|FG000|Overall Study|Death|9|||
144456686|NCT01664078|520867245|FG000|Overall Study|Withdrawal by Subject|4|||
144456687|NCT01664078|520867245|FG000|Overall Study|Lost to Follow-up|2|||
144456688|NCT01664078|520867245|FG000|Overall Study|missed 5 year visit|1|||
144456689|NCT01664078|520867245|FG000|Overall Study|Other|53|||
144456690|NCT03832946|520867248|FG000|Overall Study|Adverse Event|3|||
144456691|NCT03832946|520867249|FG001|Overall Study|Adverse Event|1|||
144456692|NCT03832946|520867248|FG000|Overall Study|Lost to Follow-up|1|||
144456693|NCT03832946|520867249|FG001|Overall Study|Lost to Follow-up|0|||
144456694|NCT03832946|520867248|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
144456695|NCT03832946|520867249|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
144456696|NCT03832946|520867248|FG000|Overall Study|Lack of Efficacy|1|||
144456697|NCT03832946|520867249|FG001|Overall Study|Lack of Efficacy|0|||
144456698|NCT03832946|520867248|FG000|Overall Study|Withdrawal by Subject|12|||
144456699|NCT03832946|520867249|FG001|Overall Study|Withdrawal by Subject|9|||
144456700|NCT02715765|520867250|FG000|Overall Study|Study Termination|3|||
144456701|NCT02715765|520867251|FG001|Overall Study|Study Termination|0|||
144456702|NCT02715765|520867252|FG002|Overall Study|Study Termination|0|||
144456703|NCT02663817|520867253|FG000|Overall Study|Screen failure|2|||
144456704|NCT01308580|520867255|FG000|Overall Study|Lost to Follow-up|12|||
144456705|NCT01308580|520867256|FG001|Overall Study|Lost to Follow-up|7|||
144456706|NCT04743908|520869473|FG000|Overall Study|Death|1|||
144456707|NCT04743908|520869474|FG001|Overall Study|Death|0|||
144456708|NCT04743908|520869473|FG000|Overall Study|Lost to Follow-up|181|||
144456709|NCT04743908|520869474|FG001|Overall Study|Lost to Follow-up|180|||
144456710|NCT04743908|520869473|FG000|Overall Study|Withdrawal by Subject|1|||
144456711|NCT04743908|520869474|FG001|Overall Study|Withdrawal by Subject|2|||
144456712|NCT03822533|520869475|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
144456713|NCT03822533|520869476|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
144456714|NCT03822533|520869475|FG000|3 Month Follow-up|Lost to Follow-up|2|||
144534245|NCT04214418|521159100|FG002|Overall Study|Death|0|||
144534246|NCT04214418|521159101|FG003|Overall Study|Death|0|||
144534247|NCT04214418|521159102|FG004|Overall Study|Death|0|||
144534248|NCT04214418|521159103|FG005|Overall Study|Death|0|||
144534249|NCT04679389|521159106|FG000|Overall Study|Adverse Event|1|||
144534250|NCT04679389|521159107|FG001|Overall Study|Adverse Event|0|||
144534251|NCT04679389|521159106|FG000|Overall Study|Protocol Violation|2|||
144534252|NCT04679389|521159107|FG001|Overall Study|Protocol Violation|0|||
144534253|NCT04679389|521159106|FG000|Overall Study|Physician Decision|3|||
144534254|NCT04679389|521159107|FG001|Overall Study|Physician Decision|5|||
144607586|NCT03098836|521424484|FG001|Overall Study|Physician Decision|1|||
144607587|NCT03098836|521424483|FG000|Overall Study|Withdrawal by Subject|3|||
144456715|NCT03822533|520869476|FG001|3 Month Follow-up|Lost to Follow-up|2|||
144456716|NCT03822533|520869475|FG000|6 Month Follow-up|Lost to Follow-up|3|||
144456717|NCT03822533|520869476|FG001|6 Month Follow-up|Lost to Follow-up|0|||
144456718|NCT03822533|520869475|FG000|12 Month Follow-up|Lost to Follow-up|2|||
144456719|NCT03822533|520869476|FG001|12 Month Follow-up|Lost to Follow-up|3|||
144456720|NCT03822533|520869475|FG000|12 Month Follow-up|Pregnancy|0|||
144456721|NCT03822533|520869476|FG001|12 Month Follow-up|Pregnancy|1|||
144456722|NCT03822533|520869475|FG000|12 Month Follow-up|Surgery|2|||
144456723|NCT03822533|520869476|FG001|12 Month Follow-up|Surgery|0|||
144534255|NCT04679389|521159106|FG000|Overall Study|Withdrawal by Subject|5|||
144534256|NCT04679389|521159107|FG001|Overall Study|Withdrawal by Subject|7|||
144255055|NCT00398216|520136074|FG001|Overall Study|Lost to Follow-up|6|||
144456724|NCT03822533|520869475|FG000|12 Month Follow-up|Wrong address|1|||
144456725|NCT03822533|520869476|FG001|12 Month Follow-up|Wrong address|0|||
144534257|NCT05454514|521159115|FG000|Overall Study|Withdrawal by Subject|4|||
144725825|NCT02585258|521851375|FG001|Overall Study|Lost to Follow-up|2|||
144456726|NCT03822533|520869475|FG000|12 Month Follow-up|No symptoms|1|||
144456727|NCT03822533|520869476|FG001|12 Month Follow-up|No symptoms|0|||
144456728|NCT03822533|520869475|FG000|12 Month Follow-up|Changed primary care center|0|||
144456729|NCT03822533|520869476|FG001|12 Month Follow-up|Changed primary care center|1|||
144456730|NCT02489500|520869480|FG000|Overall Study|Death|1|||
144456731|NCT02489500|520869481|FG001|Overall Study|Death|1|||
144456732|NCT00328510|520869482|FG000|Overall Study|Gag disorder, could not use frame|4|||
144456733|NCT00328510|520869483|FG001|Overall Study|Gag disorder, could not use frame|0|||
144456734|NCT00328510|520869482|FG000|Overall Study|Dentition problems, could not use frame|1|||
144456735|NCT00328510|520869483|FG001|Overall Study|Dentition problems, could not use frame|0|||
144456736|NCT00328510|520869482|FG000|Overall Study|Withdrawal by Subject|4|||
144456737|NCT00328510|520869483|FG001|Overall Study|Withdrawal by Subject|2|||
144456738|NCT00328510|520869482|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
144456739|NCT00328510|520869483|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
144456740|NCT00328510|520869482|FG000|Overall Study|Treatment changed to a single fraction|1|||
144456741|NCT00328510|520869483|FG001|Overall Study|Treatment changed to a single fraction|1|||
144456742|NCT01990950|520869485|FG000|Overall Study|Death|3|||
144456743|NCT01990950|520869485|FG000|Overall Study|Lost to Follow-up|2|||
144456744|NCT01990950|520869485|FG000|Overall Study|Withdrawal by Subject|6|||
144456745|NCT02349295|520869486|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
144456746|NCT02349295|520869487|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
144456747|NCT02349295|520869488|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
144456748|NCT02349295|520869489|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456749|NCT02349295|520869490|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456750|NCT02349295|520869491|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456751|NCT02349295|520869492|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456752|NCT02349295|520869493|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456753|NCT02349295|520869494|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456754|NCT02349295|520869495|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456755|NCT02349295|520869496|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456756|NCT02349295|520869497|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456757|NCT02349295|520869498|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456758|NCT02349295|520869499|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
144456759|NCT02349295|520869486|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
144456760|NCT02349295|520869487|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
144456761|NCT02349295|520869488|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
144456762|NCT02349295|520869489|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456763|NCT02349295|520869490|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456764|NCT02349295|520869491|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456765|NCT02349295|520869492|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456766|NCT02349295|520869493|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456767|NCT02349295|520869494|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456768|NCT02349295|520869495|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456769|NCT02349295|520869496|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456770|NCT02349295|520869497|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456771|NCT02349295|520869498|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144456772|NCT02349295|520869499|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
144196797|NCT03733210|519917084|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
144196798|NCT04421586|519917091|FG000|Overall Study|Death|0|||
144196799|NCT04421586|519917092|FG001|Overall Study|Death|1|||
144196800|NCT04421586|519917091|FG000|Overall Study|Lost to Follow-up|2|||
144196801|NCT04421586|519917092|FG001|Overall Study|Lost to Follow-up|2|||
144196802|NCT04421586|519917091|FG000|Overall Study|Withdrawn by PI|1|||
144196803|NCT04421586|519917092|FG001|Overall Study|Withdrawn by PI|0|||
144196804|NCT04421586|519917091|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
144196805|NCT04421586|519917092|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
144456773|NCT02349295|520869486|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
144456774|NCT02349295|520869487|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
144456775|NCT02349295|520869488|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
144456776|NCT02349295|520869489|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456777|NCT02349295|520869490|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456778|NCT02349295|520869491|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456779|NCT02349295|520869492|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456780|NCT02349295|520869493|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456781|NCT02349295|520869494|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456782|NCT02349295|520869495|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456783|NCT02349295|520869496|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456784|NCT02349295|520869497|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456785|NCT02349295|520869498|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456786|NCT02349295|520869499|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
144456787|NCT02349295|520869486|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
144456788|NCT02349295|520869487|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
144456789|NCT02349295|520869488|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
144456790|NCT02349295|520869489|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456791|NCT02349295|520869490|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456792|NCT02349295|520869491|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456793|NCT02349295|520869492|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456794|NCT02349295|520869493|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456795|NCT02349295|520869494|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456796|NCT02349295|520869495|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456797|NCT02349295|520869496|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456798|NCT02349295|520869497|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456799|NCT02349295|520869498|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456800|NCT02349295|520869499|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
144456801|NCT02349295|520869486|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456802|NCT02349295|520869487|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
144456803|NCT02349295|520869488|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
144456804|NCT02349295|520869489|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456805|NCT02349295|520869490|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456806|NCT02349295|520869491|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456807|NCT02349295|520869492|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456808|NCT02349295|520869493|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456809|NCT02349295|520869494|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456810|NCT02349295|520869495|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456811|NCT02349295|520869496|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456812|NCT02349295|520869497|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456813|NCT02349295|520869498|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456814|NCT02349295|520869499|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
144456815|NCT02349295|520869486|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
144456816|NCT02349295|520869487|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
144456817|NCT02349295|520869488|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
144456818|NCT02349295|520869489|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
144456819|NCT02349295|520869490|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
144456820|NCT02349295|520869491|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
144456821|NCT02349295|520869492|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
144456822|NCT02349295|520869493|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
144456823|NCT02349295|520869494|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
144456824|NCT02349295|520869495|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
144456825|NCT02349295|520869496|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
144456826|NCT02349295|520869497|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
144456827|NCT02349295|520869498|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
144456828|NCT02349295|520869499|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
144456829|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456830|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456831|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456832|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456833|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456834|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456835|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456836|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
144196806|NCT04505293|519917093|FG000|Overall Study|Lost to Follow-up|2|||
144196807|NCT04505293|519917093|FG000|Overall Study|Withdrawal by Subject|6|||
144456837|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
144456838|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
144456839|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
144456840|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456841|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456842|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
144456843|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456844|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456845|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456846|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456847|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456848|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456849|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144196808|NCT04505293|519917093|FG000|Overall Study|CT scan unreadable|277|||
144456850|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
144456851|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
144456852|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
144456853|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
144456854|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456855|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456856|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
144456857|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456858|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456859|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456860|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456861|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456862|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456863|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456864|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
144456865|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456866|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
144456867|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456868|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456869|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456870|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
144456871|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
144456872|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
144456873|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
144456874|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
144456875|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
144456876|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
144456877|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
144456878|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
144456879|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
144456880|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
144456881|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
144456882|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
144456883|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
144456884|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
144456885|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456886|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456887|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456888|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144607588|NCT03098836|521424484|FG001|Overall Study|Withdrawal by Subject|2|||
144607589|NCT03986866|521424485|FG000|Overall Study|Withdrawal by Subject|0|||
144607590|NCT03986866|521424486|FG001|Overall Study|Withdrawal by Subject|3|||
144607591|NCT03986866|521424485|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
144607592|NCT03986866|521424486|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
144607593|NCT00898443|521424487|FG000|Overall Study|Withdrawal by Subject|1|||
144607594|NCT00898443|521424488|FG001|Overall Study|Withdrawal by Subject|0|||
144607595|NCT03250832|521424489|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
144607596|NCT03250832|521424490|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
144607597|NCT03250832|521424491|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
144607598|NCT03250832|521424492|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
144607599|NCT03250832|521424493|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
144607600|NCT03250832|521424494|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
144607601|NCT03250832|521424495|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
144607602|NCT03250832|521424496|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
144456889|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456890|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456891|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456892|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
144456893|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
144456894|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
144456895|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
144607603|NCT03250832|521424497|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
144607604|NCT03250832|521424498|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
144607605|NCT03250832|521424499|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
144725826|NCT03946449|521851376|FG000|Treatment Extension II|Rolled over to another study|0|||
144725827|NCT03946449|521851377|FG001|Treatment Extension II|Rolled over to another study|0|||
144456896|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456897|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456898|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
144456899|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456900|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456901|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456902|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456903|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456904|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456905|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456906|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
144456907|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
144456908|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456909|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456910|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456911|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456912|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
144456913|NCT02349295|520869486|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456914|NCT02349295|520869487|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456915|NCT02349295|520869488|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456916|NCT02349295|520869489|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456917|NCT02349295|520869490|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456918|NCT02349295|520869491|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456919|NCT02349295|520869492|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456920|NCT02349295|520869493|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
144456921|NCT02349295|520869494|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
144456922|NCT02349295|520869495|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456923|NCT02349295|520869496|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456924|NCT02349295|520869497|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456925|NCT02349295|520869498|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456926|NCT02349295|520869499|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
144456927|NCT02349295|520869486|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456928|NCT02349295|520869487|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456929|NCT02349295|520869488|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456930|NCT02349295|520869489|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456931|NCT02349295|520869490|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456932|NCT02349295|520869491|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456933|NCT02349295|520869492|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456934|NCT02349295|520869493|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456935|NCT02349295|520869494|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456936|NCT02349295|520869495|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456937|NCT02349295|520869496|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
144456938|NCT02349295|520869497|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
144456939|NCT02349295|520869498|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
144456940|NCT02349295|520869499|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
144456941|NCT02349295|520869486|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456942|NCT02349295|520869487|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456943|NCT02349295|520869488|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456944|NCT02349295|520869489|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456945|NCT02349295|520869490|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456946|NCT02349295|520869491|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456947|NCT02349295|520869492|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456948|NCT02349295|520869493|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456949|NCT02349295|520869494|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456950|NCT02349295|520869495|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456951|NCT02349295|520869496|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456952|NCT02349295|520869497|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
144534258|NCT05541484|521159118|FG000|Overall Study|Withdrawal by Subject|1|||
144534259|NCT05541484|521159119|FG001|Overall Study|Withdrawal by Subject|0|||
144534260|NCT05785130|521159123|FG000|Overall Study|Withdrawal by Subject|1|||
144534261|NCT05785130|521159124|FG001|Overall Study|Withdrawal by Subject|0|||
144456953|NCT02349295|520869498|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
144534262|NCT05785130|521159123|FG000|Overall Study|Lack of Efficacy|0|||
144456954|NCT02349295|520869499|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
144456955|NCT02349295|520869486|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456956|NCT02349295|520869487|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456957|NCT02349295|520869488|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456958|NCT02349295|520869489|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456959|NCT02349295|520869490|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456960|NCT02349295|520869491|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456961|NCT02349295|520869492|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456962|NCT02349295|520869493|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456963|NCT02349295|520869494|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456964|NCT02349295|520869495|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456965|NCT02349295|520869496|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456966|NCT02349295|520869497|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
144456967|NCT02349295|520869498|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
144456968|NCT02349295|520869499|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
144456969|NCT02349295|520869486|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456970|NCT02349295|520869487|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456971|NCT02349295|520869488|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456972|NCT02349295|520869489|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456973|NCT02349295|520869490|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456974|NCT02349295|520869491|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456975|NCT02349295|520869492|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456976|NCT02349295|520869493|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456977|NCT02349295|520869494|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456978|NCT02349295|520869495|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456979|NCT02349295|520869496|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456980|NCT02349295|520869497|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
144456981|NCT02349295|520869498|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456982|NCT02349295|520869499|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
144456983|NCT02349295|520869486|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456984|NCT02349295|520869487|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456985|NCT02349295|520869488|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456986|NCT02349295|520869489|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456987|NCT02349295|520869490|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456988|NCT02349295|520869491|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456989|NCT02349295|520869492|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456990|NCT02349295|520869493|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456991|NCT02349295|520869494|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144534263|NCT05785130|521159124|FG001|Overall Study|Lack of Efficacy|1|||
144534264|NCT01475786|521159129|FG000|Overall Study|Adverse Event|0|||
144534265|NCT01475786|521159130|FG001|Overall Study|Adverse Event|1|||
144534266|NCT01475786|521159131|FG002|Overall Study|Adverse Event|0|||
144534267|NCT01475786|521159129|FG000|Overall Study|Lost to Follow-up|1|||
144534268|NCT01475786|521159130|FG001|Overall Study|Lost to Follow-up|2|||
144534269|NCT01475786|521159131|FG002|Overall Study|Lost to Follow-up|1|||
144534270|NCT01475786|521159129|FG000|Overall Study|Withdrawal by Subject|0|||
144534271|NCT01475786|521159130|FG001|Overall Study|Withdrawal by Subject|1|||
144534272|NCT01475786|521159131|FG002|Overall Study|Withdrawal by Subject|1|||
144534273|NCT01475786|521159129|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
144534274|NCT01475786|521159130|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
144534275|NCT01475786|521159131|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
144534276|NCT01897441|521159132|FG000|Overall Study|Lost to Follow-up|0|||
144534277|NCT01897441|521159133|FG001|Overall Study|Lost to Follow-up|0|||
144534278|NCT01897441|521159134|FG002|Overall Study|Lost to Follow-up|1|||
144534279|NCT01897441|521159135|FG003|Overall Study|Lost to Follow-up|0|||
144534280|NCT01897441|521159136|FG004|Overall Study|Lost to Follow-up|0|||
144534281|NCT01897441|521159137|FG005|Overall Study|Lost to Follow-up|0|||
144534282|NCT01897441|521159132|FG000|Overall Study|Withdrawal by Subject|0|||
144534283|NCT01897441|521159133|FG001|Overall Study|Withdrawal by Subject|0|||
144534284|NCT01897441|521159134|FG002|Overall Study|Withdrawal by Subject|0|||
144534285|NCT01897441|521159135|FG003|Overall Study|Withdrawal by Subject|0|||
144534286|NCT01897441|521159136|FG004|Overall Study|Withdrawal by Subject|1|||
144255056|NCT00398216|520136075|FG002|Overall Study|Lost to Follow-up|4|||
144456992|NCT02349295|520869495|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456993|NCT02349295|520869496|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144534287|NCT01897441|521159137|FG005|Overall Study|Withdrawal by Subject|0|||
144534288|NCT01897441|521159132|FG000|Overall Study|Withdrawn by Provider|0|||
144534289|NCT01897441|521159133|FG001|Overall Study|Withdrawn by Provider|2|||
144534290|NCT01897441|521159134|FG002|Overall Study|Withdrawn by Provider|0|||
144534291|NCT01897441|521159135|FG003|Overall Study|Withdrawn by Provider|0|||
144456994|NCT02349295|520869497|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
144456995|NCT02349295|520869498|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456996|NCT02349295|520869499|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
144456997|NCT02863926|520869500|FG000|Overall Study|Physician Decision|1|||
144456998|NCT02863926|520869501|FG001|Overall Study|Physician Decision|0|||
144456999|NCT02863926|520869500|FG000|Overall Study|Lost to Follow-up|1|||
144457000|NCT02863926|520869501|FG001|Overall Study|Lost to Follow-up|1|||
144457001|NCT02014116|520869505|FG000|Overall Study|Progressive Disease|3|||
144457002|NCT02014116|520869506|FG001|Overall Study|Progressive Disease|4|||
144457003|NCT02014116|520869507|FG002|Overall Study|Progressive Disease|2|||
144457004|NCT02014116|520869508|FG003|Overall Study|Progressive Disease|6|||
144457005|NCT02014116|520869509|FG004|Overall Study|Progressive Disease|1|||
144457006|NCT02014116|520869510|FG005|Overall Study|Progressive Disease|13|||
144457007|NCT02014116|520869511|FG006|Overall Study|Progressive Disease|1|||
144457008|NCT02014116|520869512|FG007|Overall Study|Progressive Disease|3|||
144457009|NCT02014116|520869513|FG008|Overall Study|Progressive Disease|7|||
144457010|NCT02014116|520869505|FG000|Overall Study|Adverse Event|0|||
144457011|NCT02014116|520869506|FG001|Overall Study|Adverse Event|0|||
144457012|NCT02014116|520869507|FG002|Overall Study|Adverse Event|0|||
144457013|NCT02014116|520869508|FG003|Overall Study|Adverse Event|0|||
144457014|NCT02014116|520869509|FG004|Overall Study|Adverse Event|1|||
144457015|NCT02014116|520869510|FG005|Overall Study|Adverse Event|0|||
144457016|NCT02014116|520869511|FG006|Overall Study|Adverse Event|0|||
144457017|NCT02014116|520869512|FG007|Overall Study|Adverse Event|1|||
144457018|NCT02014116|520869513|FG008|Overall Study|Adverse Event|0|||
144457019|NCT02014116|520869505|FG000|Overall Study|Lost to Follow-up|0|||
144457020|NCT02014116|520869506|FG001|Overall Study|Lost to Follow-up|0|||
144457021|NCT02014116|520869507|FG002|Overall Study|Lost to Follow-up|0|||
144457022|NCT02014116|520869508|FG003|Overall Study|Lost to Follow-up|0|||
144457023|NCT02014116|520869509|FG004|Overall Study|Lost to Follow-up|0|||
144457024|NCT02014116|520869510|FG005|Overall Study|Lost to Follow-up|1|||
144457025|NCT02014116|520869511|FG006|Overall Study|Lost to Follow-up|0|||
144457026|NCT02014116|520869512|FG007|Overall Study|Lost to Follow-up|0|||
144457027|NCT02014116|520869513|FG008|Overall Study|Lost to Follow-up|1|||
144457028|NCT02014116|520869505|FG000|Overall Study|Death|0|||
144457029|NCT02014116|520869506|FG001|Overall Study|Death|0|||
144457030|NCT02014116|520869507|FG002|Overall Study|Death|0|||
144457031|NCT02014116|520869508|FG003|Overall Study|Death|0|||
144457032|NCT02014116|520869509|FG004|Overall Study|Death|0|||
144457033|NCT02014116|520869510|FG005|Overall Study|Death|0|||
144457034|NCT02014116|520869511|FG006|Overall Study|Death|0|||
144457035|NCT02014116|520869512|FG007|Overall Study|Death|1|||
144457036|NCT02014116|520869513|FG008|Overall Study|Death|1|||
144457037|NCT02014116|520869505|FG000|Overall Study|Withdrawal by Subject|0|||
144457038|NCT02014116|520869506|FG001|Overall Study|Withdrawal by Subject|0|||
144457039|NCT02014116|520869507|FG002|Overall Study|Withdrawal by Subject|1|||
144457040|NCT02014116|520869508|FG003|Overall Study|Withdrawal by Subject|1|||
144457041|NCT02014116|520869509|FG004|Overall Study|Withdrawal by Subject|0|||
144457042|NCT02014116|520869510|FG005|Overall Study|Withdrawal by Subject|1|||
144457043|NCT02014116|520869511|FG006|Overall Study|Withdrawal by Subject|0|||
144457044|NCT02014116|520869512|FG007|Overall Study|Withdrawal by Subject|0|||
144457045|NCT02014116|520869513|FG008|Overall Study|Withdrawal by Subject|0|||
144457046|NCT02014116|520869505|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
144457047|NCT02014116|520869506|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
144457048|NCT02014116|520869507|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
144457049|NCT02014116|520869508|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
144457050|NCT02014116|520869509|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
144457051|NCT02014116|520869510|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
144457052|NCT02014116|520869511|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
144457053|NCT02014116|520869512|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
144457054|NCT02014116|520869513|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
144457055|NCT02014116|520869505|FG000|Overall Study|Physician Decision|0|||
144457056|NCT02014116|520869506|FG001|Overall Study|Physician Decision|0|||
144457057|NCT02014116|520869507|FG002|Overall Study|Physician Decision|0|||
144457058|NCT02014116|520869508|FG003|Overall Study|Physician Decision|0|||
144607606|NCT03250832|521424500|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
144607607|NCT03250832|521424489|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
144457059|NCT02014116|520869509|FG004|Overall Study|Physician Decision|0|||
144457060|NCT02014116|520869510|FG005|Overall Study|Physician Decision|0|||
144457061|NCT02014116|520869511|FG006|Overall Study|Physician Decision|0|||
144457062|NCT02014116|520869512|FG007|Overall Study|Physician Decision|0|||
144457063|NCT02014116|520869513|FG008|Overall Study|Physician Decision|1|||
144457064|NCT01127178|520869514|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
144457065|NCT01127178|520869515|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
144457066|NCT01127178|520869514|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
144457067|NCT01127178|520869515|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
144457068|NCT01127178|520869514|FG000|Dose Escalation: Treatment Phase|Other|2|||
144457069|NCT01127178|520869515|FG001|Dose Escalation: Treatment Phase|Other|0|||
144457070|NCT01127178|520869514|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
144457071|NCT01127178|520869515|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
144457072|NCT01127178|520869514|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
144457073|NCT01127178|520869515|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
144457074|NCT01127178|520869514|FG000|Dose Escalation: Extension Phase|Other|1|||
144457075|NCT01127178|520869515|FG001|Dose Escalation: Extension Phase|Other|0|||
144457076|NCT04139317|520869516|FG000|Overall Study|Adverse Event|10|||
144457077|NCT04139317|520869517|FG001|Overall Study|Adverse Event|2|||
144457078|NCT04139317|520869516|FG000|Overall Study|Death|6|||
144457079|NCT04139317|520869517|FG001|Overall Study|Death|4|||
144457080|NCT04139317|520869516|FG000|Overall Study|Lost to Follow-up|1|||
144457081|NCT04139317|520869517|FG001|Overall Study|Lost to Follow-up|0|||
144457082|NCT04139317|520869516|FG000|Overall Study|Physician Decision|3|||
144457083|NCT04139317|520869517|FG001|Overall Study|Physician Decision|1|||
144457084|NCT04139317|520869516|FG000|Overall Study|Progressive Disease|19|||
144457085|NCT04139317|520869517|FG001|Overall Study|Progressive Disease|9|||
144457086|NCT04139317|520869516|FG000|Overall Study|Subject Decision|2|||
144457087|NCT04139317|520869517|FG001|Overall Study|Subject Decision|2|||
144457088|NCT00093145|520869526|FG000|Overall Study|Unacceptable Toxicity Only|2|||
144457089|NCT00093145|520869526|FG000|Overall Study|Physician Decision|5|||
144457090|NCT00093145|520869526|FG000|Overall Study|Withdrawal by Subject|9|||
144457091|NCT00093145|520869526|FG000|Overall Study|Other|1|||
144457092|NCT01310036|520869527|FG000|Overall Study|Administrative/other|10|||
144457093|NCT01310036|520869527|FG000|Overall Study|Withdrew Consent|11|||
144457094|NCT01310036|520869527|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
144457095|NCT01310036|520869527|FG000|Overall Study|Progression of Disease|164|||
144457096|NCT01310036|520869527|FG000|Overall Study|Death|1|||
144457097|NCT01310036|520869527|FG000|Overall Study|Adverse event or intercurrent illness|12|||
144457098|NCT00553267|520869528|FG000|Overall Study|Adverse Event|8|||
144457099|NCT00553267|520869529|FG001|Overall Study|Adverse Event|10|||
144457100|NCT00553267|520869530|FG002|Overall Study|Adverse Event|5|||
144457101|NCT00553267|520869528|FG000|Overall Study|Non compliant with protocol|3|||
144457102|NCT00553267|520869529|FG001|Overall Study|Non compliant with protocol|3|||
144457103|NCT00553267|520869530|FG002|Overall Study|Non compliant with protocol|2|||
144457104|NCT00553267|520869528|FG000|Overall Study|Lost to Follow-up|0|||
144457105|NCT00553267|520869529|FG001|Overall Study|Lost to Follow-up|0|||
144457106|NCT00553267|520869530|FG002|Overall Study|Lost to Follow-up|1|||
144457107|NCT00553267|520869528|FG000|Overall Study|Consent withdrawn|2|||
144457108|NCT00553267|520869529|FG001|Overall Study|Consent withdrawn|3|||
144457109|NCT00553267|520869530|FG002|Overall Study|Consent withdrawn|1|||
144457110|NCT00553267|520869528|FG000|Overall Study|Specified category|1|||
144457111|NCT00553267|520869529|FG001|Overall Study|Specified category|2|||
144457112|NCT00553267|520869530|FG002|Overall Study|Specified category|1|||
144457113|NCT04389840|520869531|FG000|Overall Study|Adverse Event|0|||
144457114|NCT04389840|520869532|FG001|Overall Study|Adverse Event|0|||
144457115|NCT04389840|520869533|FG002|Overall Study|Adverse Event|0|||
144457116|NCT04389840|520869534|FG003|Overall Study|Adverse Event|1|||
144457117|NCT04389840|520869535|FG004|Overall Study|Adverse Event|0|||
144457118|NCT04389840|520869536|FG005|Overall Study|Adverse Event|0|||
144457119|NCT04389840|520869531|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
144457120|NCT04389840|520869532|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
144457121|NCT04389840|520869533|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
144457122|NCT04389840|520869534|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
144457123|NCT04389840|520869535|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
144457124|NCT04389840|520869536|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
144457125|NCT04389840|520869531|FG000|Overall Study|Death|0|||
144457126|NCT04389840|520869532|FG001|Overall Study|Death|1|||
144457127|NCT04389840|520869533|FG002|Overall Study|Death|0|||
144457128|NCT04389840|520869534|FG003|Overall Study|Death|0|||
144457129|NCT04389840|520869535|FG004|Overall Study|Death|0|||
144534292|NCT01897441|521159136|FG004|Overall Study|Withdrawn by Provider|0|||
144457130|NCT04389840|520869536|FG005|Overall Study|Death|0|||
144534293|NCT01897441|521159137|FG005|Overall Study|Withdrawn by Provider|0|||
144534294|NCT01651000|521159141|FG000|Overall Study|Adverse Event|2|||
144457131|NCT02365467|520869542|FG000|Overall Study|Death|3|||
144457132|NCT00709722|520869543|FG000|Overall Study|Adverse Event|1|||
144457133|NCT02043782|520869544|FG000|Period 1|Adverse Event|0|||
144457134|NCT02043782|520869545|FG001|Period 1|Adverse Event|0|||
144457135|NCT02043782|520869546|FG002|Period 1|Adverse Event|1|||
144534295|NCT01651000|521159142|FG001|Overall Study|Adverse Event|8|||
144457136|NCT02043782|520869547|FG003|Period 1|Adverse Event|0|||
144457137|NCT02043782|520869548|FG004|Period 1|Adverse Event|0|||
144457138|NCT02043782|520869549|FG005|Period 1|Adverse Event|0|||
144534296|NCT01651000|521159141|FG000|Overall Study|Lost to Follow-up|3|||
144457139|NCT04667117|520869550|FG000|Investigational Period|Lost to Follow-up|0|||
144457140|NCT04667117|520869551|FG001|Investigational Period|Lost to Follow-up|0|||
144457141|NCT04667117|520869552|FG002|Investigational Period|Lost to Follow-up|1|||
144457142|NCT04667117|520869550|FG000|Investigational Period|Protocol Deviation|0|||
144457143|NCT04667117|520869551|FG001|Investigational Period|Protocol Deviation|1|||
144457144|NCT04667117|520869552|FG002|Investigational Period|Protocol Deviation|0|||
144457145|NCT04667117|520869550|FG000|Extension Period|Lost to Follow-up|1|||
144457146|NCT04667117|520869551|FG001|Extension Period|Lost to Follow-up|0|||
144457147|NCT04667117|520869552|FG002|Extension Period|Lost to Follow-up|0|||
144457148|NCT03359096|520869553|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
144457149|NCT03359096|520869554|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
144457150|NCT03359096|520869553|FG000|First Intervention (4 Weeks)|Death|1|||
144457151|NCT03359096|520869554|FG001|First Intervention (4 Weeks)|Death|0|||
144457152|NCT03359096|520869553|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
144457153|NCT03359096|520869554|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
144457154|NCT01306162|520869555|FG000|Period 1|Adverse Event|0|||
144457155|NCT01306162|520869556|FG001|Period 1|Adverse Event|0|||
144457156|NCT01306162|520869557|FG002|Period 1|Adverse Event|0|||
144457157|NCT01306162|520869558|FG003|Period 1|Adverse Event|1|||
144457158|NCT01306162|520869555|FG000|Washout 1|Non-compliance to protocol|0|||
144457159|NCT01306162|520869556|FG001|Washout 1|Non-compliance to protocol|1|||
144457160|NCT01306162|520869557|FG002|Washout 1|Non-compliance to protocol|0|||
144457161|NCT01306162|520869558|FG003|Washout 1|Non-compliance to protocol|0|||
144457162|NCT02252211|520869567|FG000|Overall Study|Adverse Event|0|||
144457163|NCT02252211|520869568|FG001|Overall Study|Adverse Event|1|||
144457164|NCT02252211|520869569|FG002|Overall Study|Adverse Event|0|||
144457165|NCT02252211|520869567|FG000|Overall Study|Progressive disease|3|||
144457166|NCT02252211|520869568|FG001|Overall Study|Progressive disease|2|||
144457167|NCT02252211|520869569|FG002|Overall Study|Progressive disease|0|||
144457168|NCT02252211|520869567|FG000|Overall Study|Withdrawal by Subject|1|||
144457169|NCT02252211|520869568|FG001|Overall Study|Withdrawal by Subject|0|||
144457170|NCT02252211|520869569|FG002|Overall Study|Withdrawal by Subject|0|||
144457171|NCT02252211|520869567|FG000|Overall Study|Serious Adverse Event During Screening|1|||
144457172|NCT02252211|520869568|FG001|Overall Study|Serious Adverse Event During Screening|0|||
144457173|NCT02252211|520869569|FG002|Overall Study|Serious Adverse Event During Screening|1|||
144457174|NCT00833989|520869574|FG000|Overall Study|Physician Decision|0|||
144457175|NCT00833989|520869575|FG001|Overall Study|Physician Decision|0|||
144457176|NCT00833989|520869576|FG002|Overall Study|Physician Decision|0|||
144457177|NCT00833989|520869577|FG003|Overall Study|Physician Decision|1|||
144457178|NCT00833989|520869574|FG000|Overall Study|Withdrawal by Subject|3|||
144457179|NCT00833989|520869575|FG001|Overall Study|Withdrawal by Subject|0|||
144457180|NCT00833989|520869576|FG002|Overall Study|Withdrawal by Subject|1|||
144457181|NCT00833989|520869577|FG003|Overall Study|Withdrawal by Subject|1|||
144457182|NCT01109992|520869578|FG000|Overall Study|Withdrawal by Subject|0|||
144457183|NCT01109992|520869579|FG001|Overall Study|Withdrawal by Subject|1|||
144457184|NCT01109992|520869578|FG000|Overall Study|Movement during rest scan.|0|||
144457185|NCT01109992|520869579|FG001|Overall Study|Movement during rest scan.|1|||
144457186|NCT00690755|520869582|FG000|Overall Study|Physician Decision|2|||
144457187|NCT00690755|520869583|FG001|Overall Study|Physician Decision|0|||
144457188|NCT00690755|520869584|FG002|Overall Study|Physician Decision|46|||
144457189|NCT00690755|520869585|FG003|Overall Study|Physician Decision|5|||
144457190|NCT00690755|520869586|FG004|Overall Study|Physician Decision|0|||
144457191|NCT00690755|520869587|FG005|Overall Study|Physician Decision|4|||
144457192|NCT00690755|520869588|FG006|Overall Study|Physician Decision|0|||
144457193|NCT00214136|520869591|FG000|Overall Study|Death|5|||
144457194|NCT04287920|520869592|FG000|Overall Study|Lost to Follow-up|1|||
144457195|NCT04287920|520869593|FG001|Overall Study|Lost to Follow-up|1|||
144457196|NCT04287920|520869592|FG000|Overall Study|Withdrawal by Subject|0|||
144725828|NCT03946449|521851378|FG002|Treatment Extension II|Rolled over to another study|2|||
144725829|NCT03946449|521851376|FG000|Treatment Extension II|Withdrawal by Subject|0|||
144725830|NCT03946449|521851377|FG001|Treatment Extension II|Withdrawal by Subject|0|||
144725831|NCT03946449|521851378|FG002|Treatment Extension II|Withdrawal by Subject|1|||
144457197|NCT04287920|520869593|FG001|Overall Study|Withdrawal by Subject|3|||
144457198|NCT02310750|520869594|FG000|HP Period 1|Lost to Follow-up|0|||
144457199|NCT02310750|520869595|FG001|HP Period 1|Lost to Follow-up|0|||
144457200|NCT02310750|520869596|FG002|HP Period 1|Lost to Follow-up|0|||
144457201|NCT02310750|520869597|FG003|HP Period 1|Lost to Follow-up|0|||
144457202|NCT02310750|520869598|FG004|HP Period 1|Lost to Follow-up|0|||
144457203|NCT02310750|520869599|FG005|HP Period 1|Lost to Follow-up|0|||
144457204|NCT02310750|520869600|FG006|HP Period 1|Lost to Follow-up|1|||
144457205|NCT02310750|520869601|FG007|HP Period 1|Lost to Follow-up|0|||
144457206|NCT02310750|520869602|FG008|HP Period 1|Lost to Follow-up|0|||
144457207|NCT02310750|520869603|FG009|HP Period 1|Lost to Follow-up|0|||
144457208|NCT02310750|520869604|FG010|HP Period 1|Lost to Follow-up|0|||
144457209|NCT02310750|520869605|FG011|HP Period 1|Lost to Follow-up|0|||
144457210|NCT02310750|520869606|FG012|HP Period 1|Lost to Follow-up|0|||
144457211|NCT02310750|520869607|FG013|HP Period 1|Lost to Follow-up|0|||
144457212|NCT02310750|520869608|FG014|HP Period 1|Lost to Follow-up|0|||
144457213|NCT02310750|520869609|FG015|HP Period 1|Lost to Follow-up|0|||
144457214|NCT02310750|520869594|FG000|HP Period 1|Withdrawal by Subject|1|||
144457215|NCT02310750|520869595|FG001|HP Period 1|Withdrawal by Subject|0|||
144457216|NCT02310750|520869596|FG002|HP Period 1|Withdrawal by Subject|0|||
144457217|NCT02310750|520869597|FG003|HP Period 1|Withdrawal by Subject|1|||
144457218|NCT02310750|520869598|FG004|HP Period 1|Withdrawal by Subject|0|||
144457219|NCT02310750|520869599|FG005|HP Period 1|Withdrawal by Subject|0|||
144457220|NCT02310750|520869600|FG006|HP Period 1|Withdrawal by Subject|0|||
144457221|NCT02310750|520869601|FG007|HP Period 1|Withdrawal by Subject|0|||
144457222|NCT02310750|520869602|FG008|HP Period 1|Withdrawal by Subject|0|||
144457223|NCT02310750|520869603|FG009|HP Period 1|Withdrawal by Subject|0|||
144457224|NCT02310750|520869604|FG010|HP Period 1|Withdrawal by Subject|0|||
144457225|NCT02310750|520869605|FG011|HP Period 1|Withdrawal by Subject|0|||
144457226|NCT02310750|520869606|FG012|HP Period 1|Withdrawal by Subject|0|||
144457227|NCT02310750|520869607|FG013|HP Period 1|Withdrawal by Subject|0|||
144457228|NCT02310750|520869608|FG014|HP Period 1|Withdrawal by Subject|0|||
144457229|NCT02310750|520869609|FG015|HP Period 1|Withdrawal by Subject|0|||
144457230|NCT02310750|520869594|FG000|HP Washout 1|Lost to Follow-up|0|||
144457231|NCT02310750|520869595|FG001|HP Washout 1|Lost to Follow-up|0|||
144457232|NCT02310750|520869596|FG002|HP Washout 1|Lost to Follow-up|1|||
144457233|NCT02310750|520869597|FG003|HP Washout 1|Lost to Follow-up|1|||
144457234|NCT02310750|520869598|FG004|HP Washout 1|Lost to Follow-up|2|||
144457235|NCT02310750|520869599|FG005|HP Washout 1|Lost to Follow-up|2|||
144457236|NCT02310750|520869600|FG006|HP Washout 1|Lost to Follow-up|3|||
144457237|NCT02310750|520869601|FG007|HP Washout 1|Lost to Follow-up|0|||
144457238|NCT02310750|520869602|FG008|HP Washout 1|Lost to Follow-up|0|||
144457239|NCT02310750|520869603|FG009|HP Washout 1|Lost to Follow-up|0|||
144457240|NCT02310750|520869604|FG010|HP Washout 1|Lost to Follow-up|0|||
144457241|NCT02310750|520869605|FG011|HP Washout 1|Lost to Follow-up|0|||
144457242|NCT02310750|520869606|FG012|HP Washout 1|Lost to Follow-up|0|||
144457243|NCT02310750|520869607|FG013|HP Washout 1|Lost to Follow-up|0|||
144457244|NCT02310750|520869608|FG014|HP Washout 1|Lost to Follow-up|0|||
144457245|NCT02310750|520869609|FG015|HP Washout 1|Lost to Follow-up|0|||
144457246|NCT02310750|520869594|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457247|NCT02310750|520869595|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457248|NCT02310750|520869596|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457249|NCT02310750|520869597|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
144457250|NCT02310750|520869598|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457251|NCT02310750|520869599|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
144457252|NCT02310750|520869600|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457253|NCT02310750|520869601|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457254|NCT02310750|520869602|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
144457255|NCT02310750|520869603|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
144457256|NCT02310750|520869604|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457257|NCT02310750|520869605|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457258|NCT02310750|520869606|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457259|NCT02310750|520869607|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457260|NCT02310750|520869608|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457261|NCT02310750|520869609|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
144457262|NCT02310750|520869594|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457263|NCT02310750|520869595|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457264|NCT02310750|520869596|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457265|NCT02310750|520869597|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457266|NCT02310750|520869598|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457267|NCT02310750|520869599|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457268|NCT02310750|520869600|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457269|NCT02310750|520869601|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457270|NCT02310750|520869602|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457271|NCT02310750|520869603|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
144457272|NCT02310750|520869604|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457273|NCT02310750|520869605|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457274|NCT02310750|520869606|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144534297|NCT01651000|521159142|FG001|Overall Study|Lost to Follow-up|2|||
144534298|NCT01651000|521159141|FG000|Overall Study|Protocol Violation|0|||
144534299|NCT01651000|521159142|FG001|Overall Study|Protocol Violation|3|||
144534300|NCT01651000|521159141|FG000|Overall Study|Withdrawal by Subject|2|||
144534301|NCT01651000|521159142|FG001|Overall Study|Withdrawal by Subject|10|||
144457275|NCT02310750|520869607|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457276|NCT02310750|520869608|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457277|NCT02310750|520869609|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
144457278|NCT02310750|520869594|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457279|NCT02310750|520869595|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457280|NCT02310750|520869596|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144534302|NCT01651000|521159141|FG000|Overall Study|Subject noncompliance|0|||
144534303|NCT01651000|521159142|FG001|Overall Study|Subject noncompliance|3|||
144534304|NCT01651000|521159141|FG000|Overall Study|Lack of Efficacy|1|||
144534305|NCT01651000|521159142|FG001|Overall Study|Lack of Efficacy|1|||
144534306|NCT01651000|521159141|FG000|Overall Study|Physician Decision|1|||
144457281|NCT02310750|520869597|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457282|NCT02310750|520869598|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457283|NCT02310750|520869599|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457284|NCT02310750|520869600|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457285|NCT02310750|520869601|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
144457286|NCT02310750|520869602|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
144457287|NCT02310750|520869603|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
144457288|NCT02310750|520869604|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457289|NCT02310750|520869605|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457290|NCT02310750|520869606|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457291|NCT02310750|520869607|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457292|NCT02310750|520869608|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457293|NCT02310750|520869609|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
144457294|NCT02310750|520869594|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457295|NCT02310750|520869595|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457296|NCT02310750|520869596|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457297|NCT02310750|520869597|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457298|NCT02310750|520869598|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457299|NCT02310750|520869599|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457300|NCT02310750|520869600|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457301|NCT02310750|520869601|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
144457302|NCT02310750|520869602|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
144457303|NCT02310750|520869603|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457304|NCT02310750|520869604|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457305|NCT02310750|520869605|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457306|NCT02310750|520869606|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457307|NCT02310750|520869607|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457308|NCT02310750|520869608|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457309|NCT02310750|520869609|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
144457310|NCT02310750|520869594|FG000|HP Washout 2|Lost to Follow-up|0|||
144457311|NCT02310750|520869595|FG001|HP Washout 2|Lost to Follow-up|0|||
144457312|NCT02310750|520869596|FG002|HP Washout 2|Lost to Follow-up|0|||
144457313|NCT02310750|520869597|FG003|HP Washout 2|Lost to Follow-up|0|||
144457314|NCT02310750|520869598|FG004|HP Washout 2|Lost to Follow-up|1|||
144457315|NCT02310750|520869599|FG005|HP Washout 2|Lost to Follow-up|0|||
144457316|NCT02310750|520869600|FG006|HP Washout 2|Lost to Follow-up|7|||
144457317|NCT02310750|520869601|FG007|HP Washout 2|Lost to Follow-up|0|||
144457318|NCT02310750|520869602|FG008|HP Washout 2|Lost to Follow-up|0|||
144457319|NCT02310750|520869603|FG009|HP Washout 2|Lost to Follow-up|0|||
144457320|NCT02310750|520869604|FG010|HP Washout 2|Lost to Follow-up|0|||
144457321|NCT02310750|520869605|FG011|HP Washout 2|Lost to Follow-up|0|||
144457322|NCT02310750|520869606|FG012|HP Washout 2|Lost to Follow-up|0|||
144457323|NCT02310750|520869607|FG013|HP Washout 2|Lost to Follow-up|0|||
144457324|NCT02310750|520869608|FG014|HP Washout 2|Lost to Follow-up|0|||
144457325|NCT02310750|520869609|FG015|HP Washout 2|Lost to Follow-up|0|||
144457326|NCT02952924|520869610|FG000|Overall Study|Protocol Violation|0|||
144457327|NCT02952924|520869611|FG001|Overall Study|Protocol Violation|0|||
144457328|NCT02952924|520869612|FG002|Overall Study|Protocol Violation|0|||
144457329|NCT02952924|520869613|FG003|Overall Study|Protocol Violation|0|||
144457330|NCT02952924|520869614|FG004|Overall Study|Protocol Violation|0|||
144457331|NCT02952924|520869615|FG005|Overall Study|Protocol Violation|0|||
144457332|NCT02952924|520869616|FG006|Overall Study|Protocol Violation|0|||
144457333|NCT02952924|520869617|FG007|Overall Study|Protocol Violation|0|||
144457334|NCT02952924|520869618|FG008|Overall Study|Protocol Violation|0|||
144457335|NCT02952924|520869619|FG009|Overall Study|Protocol Violation|0|||
144457336|NCT02952924|520869620|FG010|Overall Study|Protocol Violation|0|||
144457337|NCT02952924|520869621|FG011|Overall Study|Protocol Violation|0|||
144457338|NCT02952924|520869622|FG012|Overall Study|Protocol Violation|0|||
144457339|NCT02952924|520869623|FG013|Overall Study|Protocol Violation|0|||
144457340|NCT02952924|520869624|FG014|Overall Study|Protocol Violation|0|||
144607608|NCT03250832|521424490|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
144607609|NCT03250832|521424491|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
144457341|NCT02952924|520869625|FG015|Overall Study|Protocol Violation|0|||
144457342|NCT02952924|520869626|FG016|Overall Study|Protocol Violation|0|||
144457343|NCT02952924|520869627|FG017|Overall Study|Protocol Violation|0|||
144457344|NCT02952924|520869628|FG018|Overall Study|Protocol Violation|0|||
144457345|NCT02952924|520869629|FG019|Overall Study|Protocol Violation|1|||
144457346|NCT02952924|520869630|FG020|Overall Study|Protocol Violation|0|||
144457347|NCT02952924|520869631|FG021|Overall Study|Protocol Violation|0|||
144457348|NCT02952924|520869610|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
144457349|NCT02952924|520869611|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
144607610|NCT03250832|521424492|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
144457350|NCT02952924|520869612|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
144457351|NCT02952924|520869613|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
144457352|NCT02952924|520869614|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
144457353|NCT02952924|520869615|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
144457354|NCT02952924|520869616|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
144457355|NCT02952924|520869617|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
144457356|NCT02952924|520869618|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
144457357|NCT02952924|520869619|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
144457358|NCT02952924|520869620|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
144457359|NCT02952924|520869621|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
144457360|NCT02952924|520869622|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
144457361|NCT02952924|520869623|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
144457362|NCT02952924|520869624|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
144457363|NCT02952924|520869625|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
144457364|NCT02952924|520869626|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
144457365|NCT02952924|520869627|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
144457366|NCT02952924|520869628|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
144457367|NCT02952924|520869629|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
144457368|NCT02952924|520869630|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
144457369|NCT02952924|520869631|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
144457370|NCT02952924|520869610|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457371|NCT02952924|520869611|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457372|NCT02952924|520869612|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457373|NCT02952924|520869613|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457374|NCT02952924|520869614|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457375|NCT02952924|520869615|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457376|NCT02952924|520869616|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457377|NCT02952924|520869617|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457378|NCT02952924|520869618|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457379|NCT02952924|520869619|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457380|NCT02952924|520869620|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457381|NCT02952924|520869621|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457382|NCT02952924|520869622|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457383|NCT02952924|520869623|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457384|NCT02952924|520869624|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457385|NCT02952924|520869625|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457386|NCT02952924|520869626|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457387|NCT02952924|520869627|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457388|NCT02952924|520869628|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457389|NCT02952924|520869629|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457390|NCT02952924|520869630|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
144457391|NCT02952924|520869631|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
144457392|NCT02952924|520869610|FG000|Overall Study|Noncompliance with study drug|0|||
144457393|NCT02952924|520869611|FG001|Overall Study|Noncompliance with study drug|0|||
144457394|NCT02952924|520869612|FG002|Overall Study|Noncompliance with study drug|0|||
144457395|NCT02952924|520869613|FG003|Overall Study|Noncompliance with study drug|0|||
144457396|NCT02952924|520869614|FG004|Overall Study|Noncompliance with study drug|0|||
144457397|NCT02952924|520869615|FG005|Overall Study|Noncompliance with study drug|0|||
144457398|NCT02952924|520869616|FG006|Overall Study|Noncompliance with study drug|0|||
144457399|NCT02952924|520869617|FG007|Overall Study|Noncompliance with study drug|0|||
144457400|NCT02952924|520869618|FG008|Overall Study|Noncompliance with study drug|0|||
144457401|NCT02952924|520869619|FG009|Overall Study|Noncompliance with study drug|0|||
144457402|NCT02952924|520869620|FG010|Overall Study|Noncompliance with study drug|0|||
144196809|NCT01400919|519917097|FG000|Overall Study|Withdrawal by Subject|4|||
144196810|NCT01400919|519917097|FG000|Overall Study|Lost to Follow-up|2|||
144196811|NCT01400919|519917097|FG000|Overall Study|Missed visit|2|||
144196812|NCT02923674|519917098|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
144196813|NCT02923674|519917099|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
144196814|NCT02923674|519917100|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
144196815|NCT02923674|519917098|FG000|Overall Study|Lost to Follow-up|7|||
144196816|NCT02923674|519917099|FG001|Overall Study|Lost to Follow-up|12|||
144196817|NCT02923674|519917100|FG002|Overall Study|Lost to Follow-up|7|||
144196818|NCT02923674|519917098|FG000|Overall Study|Problem with intervention|2|||
144457403|NCT02952924|520869621|FG011|Overall Study|Noncompliance with study drug|0|||
144457404|NCT02952924|520869622|FG012|Overall Study|Noncompliance with study drug|0|||
144457405|NCT02952924|520869623|FG013|Overall Study|Noncompliance with study drug|0|||
144457406|NCT02952924|520869624|FG014|Overall Study|Noncompliance with study drug|0|||
144457407|NCT02952924|520869625|FG015|Overall Study|Noncompliance with study drug|0|||
144457408|NCT02952924|520869626|FG016|Overall Study|Noncompliance with study drug|0|||
144457409|NCT02952924|520869627|FG017|Overall Study|Noncompliance with study drug|0|||
144457410|NCT02952924|520869628|FG018|Overall Study|Noncompliance with study drug|0|||
144457411|NCT02952924|520869629|FG019|Overall Study|Noncompliance with study drug|0|||
144457412|NCT02952924|520869630|FG020|Overall Study|Noncompliance with study drug|0|||
144457413|NCT02952924|520869631|FG021|Overall Study|Noncompliance with study drug|1|||
144457414|NCT01226745|520869632|FG000|Overall Study|Did not complete schedule of assessments|8|||
144457415|NCT01226745|520869633|FG001|Overall Study|Did not complete schedule of assessments|3|||
144457416|NCT01226745|520869634|FG002|Overall Study|Did not complete schedule of assessments|6|||
144457417|NCT01226745|520869635|FG003|Overall Study|Did not complete schedule of assessments|0|||
144457418|NCT01226745|520869636|FG004|Overall Study|Did not complete schedule of assessments|0|||
144457419|NCT01226745|520869637|FG005|Overall Study|Did not complete schedule of assessments|1|||
144457420|NCT01226745|520869632|FG000|Overall Study|Lost to Follow-up|2|||
144457421|NCT01226745|520869633|FG001|Overall Study|Lost to Follow-up|6|||
144457422|NCT01226745|520869634|FG002|Overall Study|Lost to Follow-up|6|||
144457423|NCT01226745|520869635|FG003|Overall Study|Lost to Follow-up|1|||
144457424|NCT01226745|520869636|FG004|Overall Study|Lost to Follow-up|1|||
144457425|NCT01226745|520869637|FG005|Overall Study|Lost to Follow-up|2|||
144457426|NCT01226745|520869632|FG000|Overall Study|Death|1|||
144457427|NCT01226745|520869633|FG001|Overall Study|Death|0|||
144457428|NCT01226745|520869634|FG002|Overall Study|Death|0|||
144457429|NCT01226745|520869635|FG003|Overall Study|Death|0|||
144457430|NCT01226745|520869636|FG004|Overall Study|Death|0|||
144457431|NCT01226745|520869637|FG005|Overall Study|Death|1|||
144457432|NCT01226745|520869632|FG000|Overall Study|Other|6|||
144457433|NCT01226745|520869633|FG001|Overall Study|Other|7|||
144457434|NCT01226745|520869634|FG002|Overall Study|Other|8|||
144457435|NCT01226745|520869635|FG003|Overall Study|Other|4|||
144457436|NCT01226745|520869636|FG004|Overall Study|Other|3|||
144457437|NCT01226745|520869637|FG005|Overall Study|Other|1|||
144457438|NCT01934218|520869639|FG000|Double-blind Phase|Adverse Event|8|||
144457439|NCT01934218|520869640|FG001|Double-blind Phase|Adverse Event|8|||
144457440|NCT01934218|520869639|FG000|Double-blind Phase|Lack of Efficacy|6|||
144457441|NCT01934218|520869640|FG001|Double-blind Phase|Lack of Efficacy|7|||
144457442|NCT01934218|520869639|FG000|Double-blind Phase|Lost to Follow-up|7|||
144457443|NCT01934218|520869640|FG001|Double-blind Phase|Lost to Follow-up|14|||
144457444|NCT01934218|520869639|FG000|Double-blind Phase|Physician Decision|1|||
144457445|NCT01934218|520869640|FG001|Double-blind Phase|Physician Decision|2|||
144457446|NCT01934218|520869639|FG000|Double-blind Phase|Protocol Violation|4|||
144457447|NCT01934218|520869640|FG001|Double-blind Phase|Protocol Violation|0|||
144457448|NCT01934218|520869639|FG000|Double-blind Phase|Withdrawal by Subject|16|||
144457449|NCT01934218|520869640|FG001|Double-blind Phase|Withdrawal by Subject|13|||
144457450|NCT01934218|520869639|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
144457451|NCT01934218|520869640|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
144457452|NCT01934218|520869639|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
144457453|NCT01934218|520869640|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
144457454|NCT01934218|520869639|FG000|Open-Label Phase|Adverse Event|2|||
144457455|NCT01934218|520869640|FG001|Open-Label Phase|Adverse Event|4|||
144457456|NCT01934218|520869639|FG000|Open-Label Phase|Lack of Efficacy|1|||
144457457|NCT01934218|520869640|FG001|Open-Label Phase|Lack of Efficacy|4|||
144457458|NCT01934218|520869639|FG000|Open-Label Phase|Lost to Follow-up|4|||
144457459|NCT01934218|520869640|FG001|Open-Label Phase|Lost to Follow-up|2|||
144457460|NCT01934218|520869639|FG000|Open-Label Phase|Physician Decision|1|||
144457461|NCT01934218|520869640|FG001|Open-Label Phase|Physician Decision|0|||
144457462|NCT01934218|520869639|FG000|Open-Label Phase|Protocol Violation|1|||
144457463|NCT01934218|520869640|FG001|Open-Label Phase|Protocol Violation|0|||
144457464|NCT01934218|520869639|FG000|Open-Label Phase|Withdrawal by Subject|13|||
144457465|NCT01934218|520869640|FG001|Open-Label Phase|Withdrawal by Subject|11|||
144457466|NCT01934218|520869639|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
144457467|NCT01934218|520869640|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
144255057|NCT00398216|520136076|FG003|Overall Study|Lost to Follow-up|4|||
144457468|NCT01934218|520869639|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
144457469|NCT01934218|520869640|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
144457470|NCT02232893|520869646|FG000|Overall Study|Withdrawal by Subject|4|||
144457471|NCT02232893|520869647|FG001|Overall Study|Withdrawal by Subject|1|||
144457472|NCT02232893|520869646|FG000|Overall Study|Adverse Event|0|||
144457473|NCT02232893|520869647|FG001|Overall Study|Adverse Event|1|||
144457474|NCT02232893|520869646|FG000|Overall Study|Sponsor request early termination|0|||
144457475|NCT02232893|520869647|FG001|Overall Study|Sponsor request early termination|1|||
144725832|NCT02207231|521852630|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
144457476|NCT02232893|520869646|FG000|Overall Study|Developed exclusion criteria|0|||
144457477|NCT02232893|520869647|FG001|Overall Study|Developed exclusion criteria|1|||
144457478|NCT02232893|520869646|FG000|Overall Study|Other|0|||
144457479|NCT02232893|520869647|FG001|Overall Study|Other|3|||
144457480|NCT03867734|520869650|FG000|Overall Study|Lost to Follow-up|2|||
144457481|NCT03965052|520869651|FG000|Overall Study|Protocol Violation|1|||
144457482|NCT03965052|520869652|FG001|Overall Study|Protocol Violation|0|||
144457483|NCT00380068|520869658|FG000|Overall Study|Adverse Event|40|||
144457484|NCT00380068|520869658|FG000|Overall Study|Withdrawal by Subject|10|||
144457485|NCT00380068|520869658|FG000|Overall Study|Not compliant|6|||
144457486|NCT00380068|520869658|FG000|Overall Study|Lost to Follow-up|1|||
144457487|NCT00380068|520869658|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
144457488|NCT00380068|520869658|FG000|Overall Study|Lung transplant|3|||
144457489|NCT00380068|520869658|FG000|Overall Study|Physician Decision|2|||
144457490|NCT00380068|520869658|FG000|Overall Study|Partipant moved away|1|||
144457491|NCT00380068|520869658|FG000|Overall Study|Lack of Efficacy|5|||
144457492|NCT03351049|520869659|FG000|Overall Study|Withdrawal|26|||
144457493|NCT03351049|520869660|FG001|Overall Study|Withdrawal|22|||
144457494|NCT02730819|520869670|FG000|Overall Study|Lost to Follow-up|9|||
144457495|NCT02121847|520869671|FG000|Overall Study|Administrative Reasons|1|||
144457496|NCT02121847|520869671|FG000|Overall Study|Adverse Event|2|||
144457497|NCT01410448|520869677|FG000|Overall Study|No conversion to everolimus|0|||
144457498|NCT01410448|520869678|FG001|Overall Study|No conversion to everolimus|24|||
144457499|NCT01410448|520869677|FG000|Overall Study|Graft loss|4|||
144457500|NCT01410448|520869678|FG001|Overall Study|Graft loss|1|||
144457501|NCT01410448|520869677|FG000|Overall Study|Administrative issues|2|||
144457502|NCT01410448|520869678|FG001|Overall Study|Administrative issues|1|||
144457503|NCT01410448|520869677|FG000|Overall Study|Lost to Follow-up|1|||
144457504|NCT01410448|520869678|FG001|Overall Study|Lost to Follow-up|0|||
144457505|NCT01410448|520869677|FG000|Overall Study|Withdrawal by Subject|3|||
144457506|NCT01410448|520869678|FG001|Overall Study|Withdrawal by Subject|2|||
144457507|NCT01410448|520869677|FG000|Overall Study|Protocol Violation|0|||
144457508|NCT01410448|520869678|FG001|Overall Study|Protocol Violation|4|||
144457509|NCT01410448|520869677|FG000|Overall Study|Death|2|||
144457510|NCT01410448|520869678|FG001|Overall Study|Death|3|||
144457511|NCT00932893|520869681|FG000|Overall Study|Death|115|||
144457512|NCT00932893|520869682|FG001|Overall Study|Death|24|||
144457513|NCT00932893|520869681|FG000|Overall Study|Lost to Follow-up|8|||
144457514|NCT00932893|520869682|FG001|Overall Study|Lost to Follow-up|0|||
144457515|NCT00932893|520869681|FG000|Overall Study|Withdrawal by Subject|5|||
144457516|NCT00932893|520869682|FG001|Overall Study|Withdrawal by Subject|2|||
144457517|NCT00932893|520869681|FG000|Overall Study|Other|5|||
144457518|NCT00932893|520869682|FG001|Overall Study|Other|144|||
144457519|NCT02526693|520871512|FG000|Overall Study|Physician Decision|3|||
144457520|NCT02526693|520871513|FG001|Overall Study|Physician Decision|1|||
144457521|NCT01585103|520871515|FG000|Overall Study|Unable to swallow Cytosponge|6|||
144457522|NCT03581305|520871516|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
144457523|NCT03581305|520871517|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
144457524|NCT03581305|520871516|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
144457525|NCT03581305|520871517|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
144457526|NCT03581305|520871516|FG000|Serotonergic Study|Withdrawal by Subject|5|||
144457527|NCT03581305|520871517|FG001|Serotonergic Study|Withdrawal by Subject|1|||
144457528|NCT01798927|520871518|FG000|Overall Study|Withdrawal by Subject|1|||
144457529|NCT01914926|520871522|FG000|Overall Study|Adverse Event|1|||
144457530|NCT01914926|520871523|FG001|Overall Study|Adverse Event|0|||
144457531|NCT01914926|520871522|FG000|Overall Study|uncooperative, agitated and removed|0|||
144457532|NCT01914926|520871523|FG001|Overall Study|uncooperative, agitated and removed|1|||
144457533|NCT02301143|520871524|FG000|Induction Period|Enrolled But Not Treated|1|||
144457534|NCT02301143|520871525|FG001|Induction Period|Enrolled But Not Treated|0|||
144457535|NCT02301143|520871524|FG000|Induction Period|Death|1|||
144457536|NCT02301143|520871525|FG001|Induction Period|Death|0|||
144457537|NCT02301143|520871524|FG000|Induction Period|Adverse Event|22|||
144457538|NCT02301143|520871525|FG001|Induction Period|Adverse Event|0|||
144457539|NCT02301143|520871524|FG000|Induction Period|Progressive Disease|8|||
144457540|NCT02301143|520871525|FG001|Induction Period|Progressive Disease|0|||
144457541|NCT02301143|520871524|FG000|Induction Period|Withdrawal by Subject|3|||
144457542|NCT02301143|520871525|FG001|Induction Period|Withdrawal by Subject|0|||
144457543|NCT02301143|520871524|FG000|Induction Period|Noncompliance with Study Drug|1|||
144457544|NCT02301143|520871525|FG001|Induction Period|Noncompliance with Study Drug|0|||
144457545|NCT02301143|520871524|FG000|Induction Period|Physician Decision|4|||
144457546|NCT02301143|520871525|FG001|Induction Period|Physician Decision|0|||
144457547|NCT02301143|520871524|FG000|Induction Period|Symptomatic Deterioration|2|||
144457548|NCT02301143|520871525|FG001|Induction Period|Symptomatic Deterioration|0|||
144457549|NCT02301143|520871524|FG000|Induction Period|Protocol Violation|2|||
144457550|NCT02301143|520871525|FG001|Induction Period|Protocol Violation|0|||
144457551|NCT02301143|520871524|FG000|Induction Period|Other|1|||
144457552|NCT02301143|520871525|FG001|Induction Period|Other|0|||
144196819|NCT02923674|519917099|FG001|Overall Study|Problem with intervention|2|||
144607611|NCT03250832|521424493|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
144607612|NCT03250832|521424494|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
144607613|NCT03250832|521424495|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
144607614|NCT03250832|521424496|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
144607615|NCT03250832|521424497|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
144607616|NCT03250832|521424498|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
144607617|NCT03250832|521424499|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
144255058|NCT00398216|520136077|FG004|Overall Study|Lost to Follow-up|1|||
144255059|NCT00398216|520136073|FG000|Overall Study|Death|0|||
144255060|NCT00398216|520136074|FG001|Overall Study|Death|3|||
144255061|NCT00398216|520136075|FG002|Overall Study|Death|0|||
144255062|NCT00398216|520136076|FG003|Overall Study|Death|0|||
144255063|NCT00398216|520136077|FG004|Overall Study|Death|0|||
144255064|NCT00398216|520136073|FG000|Overall Study|Withdrawal by Subject|1|||
144255065|NCT00398216|520136074|FG001|Overall Study|Withdrawal by Subject|0|||
144255066|NCT00398216|520136075|FG002|Overall Study|Withdrawal by Subject|3|||
144255067|NCT00398216|520136076|FG003|Overall Study|Withdrawal by Subject|1|||
144255068|NCT00398216|520136077|FG004|Overall Study|Withdrawal by Subject|2|||
144255069|NCT00398216|520136073|FG000|Overall Study|administrative reasons|3|||
144255070|NCT00398216|520136074|FG001|Overall Study|administrative reasons|4|||
144255071|NCT00398216|520136075|FG002|Overall Study|administrative reasons|4|||
144255072|NCT00398216|520136076|FG003|Overall Study|administrative reasons|3|||
144255073|NCT00398216|520136077|FG004|Overall Study|administrative reasons|3|||
144255074|NCT00398216|520136073|FG000|Overall Study|entrance criteria|0|||
144255075|NCT00398216|520136074|FG001|Overall Study|entrance criteria|0|||
144255076|NCT00398216|520136075|FG002|Overall Study|entrance criteria|0|||
144255077|NCT00398216|520136076|FG003|Overall Study|entrance criteria|0|||
144255078|NCT00398216|520136077|FG004|Overall Study|entrance criteria|2|||
144255079|NCT04378569|520136079|FG000|Overall Study|Adverse Event|0|||
144255080|NCT04378569|520136080|FG001|Overall Study|Adverse Event|0|||
144255081|NCT04378569|520136081|FG002|Overall Study|Adverse Event|2|||
144255082|NCT04378569|520136082|FG003|Overall Study|Adverse Event|0|||
144255083|NCT04378569|520136083|FG004|Overall Study|Adverse Event|3|||
144255084|NCT04378569|520136084|FG005|Overall Study|Adverse Event|3|||
144255085|NCT04378569|520136079|FG000|Overall Study|Lost to Follow-up|0|||
144255086|NCT04378569|520136080|FG001|Overall Study|Lost to Follow-up|3|||
144255087|NCT04378569|520136081|FG002|Overall Study|Lost to Follow-up|1|||
144255088|NCT04378569|520136082|FG003|Overall Study|Lost to Follow-up|0|||
144255089|NCT04378569|520136083|FG004|Overall Study|Lost to Follow-up|1|||
144255090|NCT04378569|520136084|FG005|Overall Study|Lost to Follow-up|1|||
144255091|NCT04378569|520136079|FG000|Overall Study|Protocol Violation|0|||
144255092|NCT04378569|520136080|FG001|Overall Study|Protocol Violation|0|||
144255093|NCT04378569|520136081|FG002|Overall Study|Protocol Violation|0|||
144255094|NCT04378569|520136082|FG003|Overall Study|Protocol Violation|0|||
144255095|NCT04378569|520136083|FG004|Overall Study|Protocol Violation|0|||
144255096|NCT04378569|520136084|FG005|Overall Study|Protocol Violation|1|||
144255097|NCT04378569|520136079|FG000|Overall Study|Withdrawal by Subject|0|||
144255098|NCT04378569|520136080|FG001|Overall Study|Withdrawal by Subject|6|||
144255099|NCT04378569|520136081|FG002|Overall Study|Withdrawal by Subject|7|||
144255100|NCT04378569|520136082|FG003|Overall Study|Withdrawal by Subject|4|||
144255101|NCT04378569|520136083|FG004|Overall Study|Withdrawal by Subject|5|||
144255102|NCT04378569|520136084|FG005|Overall Study|Withdrawal by Subject|4|||
144255103|NCT04378569|520136079|FG000|Overall Study|Lack of response|0|||
144255104|NCT04378569|520136080|FG001|Overall Study|Lack of response|0|||
144255105|NCT04378569|520136081|FG002|Overall Study|Lack of response|1|||
144255106|NCT04378569|520136082|FG003|Overall Study|Lack of response|0|||
144255107|NCT04378569|520136083|FG004|Overall Study|Lack of response|1|||
144255108|NCT04378569|520136084|FG005|Overall Study|Lack of response|1|||
144255109|NCT01048944|520136085|FG000|Overall Study|Protocol Violation|8|||
144255110|NCT01048944|520136086|FG001|Overall Study|Protocol Violation|10|||
144255111|NCT01048944|520136087|FG002|Overall Study|Protocol Violation|10|||
144255112|NCT01048944|520136088|FG003|Overall Study|Protocol Violation|2|||
144255113|NCT00376532|520136089|FG000|Overall Study|Lack sufficient blood sample|6|||
144255114|NCT00376532|520136090|FG001|Overall Study|Lack sufficient blood sample|6|||
144255115|NCT01844817|520136091|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
144255116|NCT01844817|520136092|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
144255117|NCT01844817|520136091|FG000|Treatment|Progressive Disease|27|||
144255118|NCT01844817|520136092|FG001|Treatment|Progressive Disease|36|||
144255119|NCT01844817|520136091|FG000|Treatment|Adverse Event|17|||
144255120|NCT01844817|520136092|FG001|Treatment|Adverse Event|9|||
144255121|NCT01844817|520136091|FG000|Treatment|Withdrawal by Subject|10|||
144255122|NCT01844817|520136092|FG001|Treatment|Withdrawal by Subject|6|||
144255123|NCT01844817|520136091|FG000|Treatment|Death|10|||
144255124|NCT01844817|520136092|FG001|Treatment|Death|8|||
144255125|NCT01844817|520136091|FG000|Treatment|Lost to Follow-up|0|||
144255126|NCT01844817|520136092|FG001|Treatment|Lost to Follow-up|1|||
144255127|NCT01844817|520136091|FG000|Treatment|Other|0|||
144255128|NCT01844817|520136092|FG001|Treatment|Other|3|||
144457553|NCT02301143|520871524|FG000|Investigator's Choice|Adverse Event|0|||
144457554|NCT02301143|520871525|FG001|Investigator's Choice|Adverse Event|3|||
144457555|NCT02301143|520871524|FG000|Investigator's Choice|Progressive Disease|0|||
144457556|NCT02301143|520871525|FG001|Investigator's Choice|Progressive Disease|3|||
144457557|NCT02301143|520871524|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
144457558|NCT02301143|520871525|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
144457559|NCT02301143|520871524|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
144457560|NCT02301143|520871525|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
144457561|NCT02301143|520871524|FG000|Investigator's Choice|Other|0|||
144457562|NCT02301143|520871525|FG001|Investigator's Choice|Other|1|||
144457563|NCT02301143|520871524|FG000|Investigator's Choice|Unresectable Surgery|0|||
144457564|NCT02301143|520871525|FG001|Investigator's Choice|Unresectable Surgery|1|||
144457565|NCT04717596|520871526|FG000|Overall Study|Withdrawal by Subject|4|||
144457566|NCT00823719|520871527|FG000|Overall Study|Adverse Event|1|||
144457567|NCT00823719|520871528|FG001|Overall Study|Adverse Event|2|||
144457568|NCT00823719|520871527|FG000|Overall Study|Physician Decision|1|||
144457569|NCT00823719|520871528|FG001|Overall Study|Physician Decision|4|||
144457570|NCT00823719|520871527|FG000|Overall Study|Withdrawal by Subject|0|||
144457571|NCT00823719|520871528|FG001|Overall Study|Withdrawal by Subject|1|||
144457572|NCT00823719|520871527|FG000|Overall Study|Disease Progression|4|||
144457573|NCT00823719|520871528|FG001|Overall Study|Disease Progression|4|||
144457574|NCT04955639|520871529|FG000|Overall Study|Withdrawal by Subject|2|||
144457575|NCT04955639|520871530|FG001|Overall Study|Withdrawal by Subject|2|||
144457576|NCT04955639|520871529|FG000|Overall Study|Week 26 survey not completed|2|||
144457577|NCT04955639|520871530|FG001|Overall Study|Week 26 survey not completed|2|||
144457578|NCT01369342|520871531|FG000|Overall Study|Withdrawal by Subject|7|||
144457579|NCT01369342|520871532|FG001|Overall Study|Withdrawal by Subject|7|||
144457580|NCT01369342|520871533|FG002|Overall Study|Withdrawal by Subject|2|||
144457581|NCT01369342|520871531|FG000|Overall Study|Lost to Follow-up|5|||
144457582|NCT01369342|520871532|FG001|Overall Study|Lost to Follow-up|2|||
144457583|NCT01369342|520871533|FG002|Overall Study|Lost to Follow-up|1|||
144457584|NCT01369342|520871531|FG000|Overall Study|Not Treated|1|||
144457585|NCT01369342|520871532|FG001|Overall Study|Not Treated|0|||
144255129|NCT01133704|520136093|FG000|Overall Study|Death|44|||
144255130|NCT01133704|520136094|FG001|Overall Study|Death|26|||
144255131|NCT01133704|520136093|FG000|Overall Study|Patient refused to continue|4|||
144255132|NCT01133704|520136094|FG001|Overall Study|Patient refused to continue|0|||
144255133|NCT01133704|520136093|FG000|Overall Study|Study Closure|1|||
144255134|NCT01133704|520136094|FG001|Overall Study|Study Closure|0|||
144255135|NCT02207400|520136095|FG000|Overall Study|Adverse Event|1|||
144255136|NCT02207400|520136096|FG001|Overall Study|Adverse Event|1|||
144255137|NCT02207400|520136095|FG000|Overall Study|Lost to Follow-up|6|||
144255138|NCT02207400|520136096|FG001|Overall Study|Lost to Follow-up|7|||
144255139|NCT02207400|520136095|FG000|Overall Study|Protocol Violation|1|||
144255140|NCT02207400|520136096|FG001|Overall Study|Protocol Violation|1|||
144255141|NCT02207400|520136095|FG000|Overall Study|Withdrawal by Subject|8|||
144255142|NCT02207400|520136096|FG001|Overall Study|Withdrawal by Subject|4|||
144255143|NCT02207400|520136095|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
144255144|NCT02207400|520136096|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
144255145|NCT03396822|520136097|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
144534307|NCT01651000|521159142|FG001|Overall Study|Physician Decision|0|||
144534308|NCT01651000|521159141|FG000|Overall Study|Administrative reason|1|||
144534309|NCT01651000|521159142|FG001|Overall Study|Administrative reason|0|||
144534310|NCT01651000|521159141|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
144534311|NCT01651000|521159142|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
144534312|NCT03781089|521159940|FG000|Overall Study|Constipation|1|||
144457586|NCT01369342|520871533|FG002|Overall Study|Not Treated|0|||
144457587|NCT03204279|520871537|FG000|Overall Study|Withdrawal by Subject|0|||
144457588|NCT03204279|520871538|FG001|Overall Study|Withdrawal by Subject|1|||
144457589|NCT04969250|520871543|FG000|Overall Study|Protocol Violation|0|||
144457590|NCT04969250|520871544|FG001|Overall Study|Protocol Violation|2|||
144457591|NCT04969250|520871545|FG002|Overall Study|Protocol Violation|3|||
144457592|NCT04969250|520871546|FG003|Overall Study|Protocol Violation|8|||
144457593|NCT04969250|520871543|FG000|Overall Study|Withdrawal by Subject|0|||
144457594|NCT04969250|520871544|FG001|Overall Study|Withdrawal by Subject|1|||
144457595|NCT04969250|520871545|FG002|Overall Study|Withdrawal by Subject|0|||
144457596|NCT04969250|520871546|FG003|Overall Study|Withdrawal by Subject|0|||
144457597|NCT02119416|520871547|FG000|Overall Study|Protocol Violation|1|||
144534313|NCT03781089|521159941|FG001|Overall Study|Constipation|0|||
144534314|NCT03781089|521159940|FG000|Overall Study|Positive pregnancy test|0|||
144534315|NCT03781089|521159941|FG001|Overall Study|Positive pregnancy test|1|||
144534316|NCT03417284|521159942|FG000|Overall Study|Inadequate supply on study drug|1|||
144255146|NCT03396822|520136097|FG000|Overall Study|Physician Decision|1|||
144255147|NCT02849704|520136100|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
144255148|NCT02849704|520136101|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
144255149|NCT02849704|520136100|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
144457598|NCT02119416|520871548|FG001|Overall Study|Protocol Violation|1|||
144457599|NCT02119416|520871549|FG002|Overall Study|Protocol Violation|1|||
144457600|NCT02119416|520871547|FG000|Overall Study|wrong pubertal stage|1|||
144457601|NCT02119416|520871548|FG001|Overall Study|wrong pubertal stage|0|||
144457602|NCT02119416|520871549|FG002|Overall Study|wrong pubertal stage|1|||
144457603|NCT02278328|520871550|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
144457604|NCT02278328|520871551|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
144457605|NCT02278328|520871552|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
144457606|NCT02278328|520871550|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
144457607|NCT02278328|520871551|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
144457608|NCT02278328|520871552|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
144457609|NCT02278328|520871550|FG000|Neuropsych Screening|incomplete consent|0|||
144457610|NCT02278328|520871551|FG001|Neuropsych Screening|incomplete consent|0|||
144457611|NCT02278328|520871552|FG002|Neuropsych Screening|incomplete consent|2|||
144457612|NCT00130533|520871553|FG000|Overall Study|Withdrawal by Subject|33|||
144457613|NCT00130533|520871554|FG001|Overall Study|Withdrawal by Subject|6|||
144457614|NCT00130533|520871553|FG000|Overall Study|Adverse Event|34|||
144457615|NCT00130533|520871554|FG001|Overall Study|Adverse Event|1|||
144457616|NCT00130533|520871553|FG000|Overall Study|Disease relapse|9|||
144457617|NCT00130533|520871554|FG001|Overall Study|Disease relapse|13|||
144457618|NCT00130533|520871553|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
144457619|NCT00130533|520871554|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
144457620|NCT00130533|520871553|FG000|Overall Study|Death|4|||
144457621|NCT00130533|520871554|FG001|Overall Study|Death|2|||
144457622|NCT00130533|520871553|FG000|Overall Study|Protocol Violation|5|||
144457623|NCT00130533|520871554|FG001|Overall Study|Protocol Violation|1|||
144457624|NCT00130533|520871553|FG000|Overall Study|Lost to Follow-up|1|||
144457625|NCT00130533|520871554|FG001|Overall Study|Lost to Follow-up|1|||
144457626|NCT00130533|520871553|FG000|Overall Study|Sponsor´s decision|2|||
144457627|NCT00130533|520871554|FG001|Overall Study|Sponsor´s decision|0|||
144457628|NCT00130533|520871553|FG000|Overall Study|Second Primary Malignancy|0|||
144457629|NCT00130533|520871554|FG001|Overall Study|Second Primary Malignancy|1|||
144457630|NCT00130533|520871553|FG000|Overall Study|Other|12|||
144457631|NCT00130533|520871554|FG001|Overall Study|Other|5|||
144457632|NCT02384759|520871561|FG000|Overall Study|Patients not treated|3|||
144457633|NCT02384759|520871562|FG001|Overall Study|Patients not treated|2|||
144457634|NCT01605617|520871563|FG000|First Intervention|Adverse Event|0|||
144457635|NCT01605617|520871564|FG001|First Intervention|Adverse Event|1|||
144457636|NCT01605617|520871563|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
144457637|NCT01605617|520871564|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
144457638|NCT03043664|520871565|FG000|Overall Study|Lost to Follow-up|1|||
144457639|NCT03593655|520871566|FG000|First Product Use Period|Withdrawal by Subject|1|||
144457640|NCT03593655|520871567|FG001|First Product Use Period|Withdrawal by Subject|1|||
144457641|NCT03593655|520871566|FG000|First Product Use Period|Lost to Follow-up|1|||
144457642|NCT03593655|520871567|FG001|First Product Use Period|Lost to Follow-up|3|||
144457643|NCT03593655|520871566|FG000|Second Product Use Period|Withdrawal by Subject|1|||
144457644|NCT03593655|520871567|FG001|Second Product Use Period|Withdrawal by Subject|1|||
144457645|NCT03593655|520871566|FG000|Second Product Use Period|Lost to Follow-up|1|||
144457646|NCT03593655|520871567|FG001|Second Product Use Period|Lost to Follow-up|0|||
144457647|NCT03593655|520871566|FG000|Third Product Use Period|Lost to Follow-up|1|||
144457648|NCT03593655|520871567|FG001|Third Product Use Period|Lost to Follow-up|2|||
144457649|NCT03593655|520871566|FG000|Third Product Use Period|Physician Decision|0|||
144457650|NCT03593655|520871567|FG001|Third Product Use Period|Physician Decision|1|||
144457651|NCT03593655|520871566|FG000|Third Product Use Period|Withdrawal by Subject|0|||
144457652|NCT03593655|520871567|FG001|Third Product Use Period|Withdrawal by Subject|1|||
144457653|NCT05046795|520871568|FG000|Overall Study|Adverse Event|13|||
144457654|NCT05046795|520871569|FG001|Overall Study|Adverse Event|15|||
144457655|NCT05046795|520871568|FG000|Overall Study|Withdrawal by Subject|4|||
144457656|NCT05046795|520871569|FG001|Overall Study|Withdrawal by Subject|7|||
144457657|NCT05046795|520871568|FG000|Overall Study|Physician Decision|1|||
144457658|NCT05046795|520871569|FG001|Overall Study|Physician Decision|2|||
144457659|NCT05046795|520871568|FG000|Overall Study|Protocol Violation|1|||
144457660|NCT05046795|520871569|FG001|Overall Study|Protocol Violation|2|||
144457661|NCT05046795|520871568|FG000|Overall Study|Death|1|||
144457662|NCT05046795|520871569|FG001|Overall Study|Death|0|||
144457663|NCT05046795|520871568|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
144457664|NCT05046795|520871569|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
144457665|NCT01435577|520871572|FG000|Overall Study|Adverse Event|10|||
144457666|NCT01435577|520871573|FG001|Overall Study|Adverse Event|0|||
144457667|NCT01435577|520871572|FG000|Overall Study|Lack of Efficacy|7|||
144457668|NCT01435577|520871573|FG001|Overall Study|Lack of Efficacy|51|||
144255150|NCT02849704|520136101|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
144457669|NCT01435577|520871572|FG000|Overall Study|Alternative treatment started|0|||
144457670|NCT01435577|520871573|FG001|Overall Study|Alternative treatment started|1|||
144457671|NCT03585244|520871574|FG000|Overall Study|Withdrawal by Subject|15|||
144457672|NCT02105948|520871575|FG000|Overall Study|Adverse Event|10|||
144457673|NCT02105948|520871576|FG001|Overall Study|Adverse Event|7|||
144457674|NCT02105948|520871577|FG002|Overall Study|Adverse Event|11|||
144457675|NCT02105948|520871578|FG003|Overall Study|Adverse Event|11|||
144255151|NCT02849704|520136100|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
144255152|NCT02849704|520136101|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
144255153|NCT03251482|520136104|FG000|Overall Study|Withdrawal by Subject|0|||
144255154|NCT03251482|520136105|FG001|Overall Study|Withdrawal by Subject|1|||
144255155|NCT03251482|520136106|FG002|Overall Study|Withdrawal by Subject|0|||
144255156|NCT03251482|520136107|FG003|Overall Study|Withdrawal by Subject|0|||
144255157|NCT03251482|520136108|FG004|Overall Study|Withdrawal by Subject|0|||
144255158|NCT03746405|520136111|FG000|Overall Study|Withdrawal by Subject|3|||
144255159|NCT03746405|520136112|FG001|Overall Study|Withdrawal by Subject|0|||
144457676|NCT02105948|520871575|FG000|Overall Study|Lack of Efficacy|0|||
144457677|NCT02105948|520871576|FG001|Overall Study|Lack of Efficacy|1|||
144457678|NCT02105948|520871577|FG002|Overall Study|Lack of Efficacy|3|||
144457679|NCT02105948|520871578|FG003|Overall Study|Lack of Efficacy|2|||
144457680|NCT02105948|520871575|FG000|Overall Study|Lost to Follow-up|0|||
144457681|NCT02105948|520871576|FG001|Overall Study|Lost to Follow-up|0|||
144457682|NCT02105948|520871577|FG002|Overall Study|Lost to Follow-up|2|||
144457683|NCT02105948|520871578|FG003|Overall Study|Lost to Follow-up|1|||
144457684|NCT02105948|520871575|FG000|Overall Study|Physician Decision|2|||
144457685|NCT02105948|520871576|FG001|Overall Study|Physician Decision|2|||
144457686|NCT02105948|520871577|FG002|Overall Study|Physician Decision|2|||
144457687|NCT02105948|520871578|FG003|Overall Study|Physician Decision|2|||
144255160|NCT03746405|520136111|FG000|Overall Study|technical difficulties|0|||
144255161|NCT03746405|520136112|FG001|Overall Study|technical difficulties|2|||
144255162|NCT02753816|520136116|FG000|Overall Study|Protocol Violation|0|||
144255163|NCT02753816|520136117|FG001|Overall Study|Protocol Violation|1|||
144255164|NCT02753816|520136118|FG002|Overall Study|Protocol Violation|0|||
144255165|NCT03498313|520136119|FG000|Experimental Period 1|Adverse Event|1|||
144255166|NCT03498313|520136120|FG001|Experimental Period 1|Adverse Event|0|||
144255167|NCT03498313|520136121|FG002|Experimental Period 1|Adverse Event|0|||
144255168|NCT03498313|520136122|FG003|Experimental Period 1|Adverse Event|1|||
144255169|NCT03498313|520136123|FG004|Experimental Period 1|Adverse Event|0|||
144255170|NCT03498313|520136124|FG005|Experimental Period 1|Adverse Event|0|||
144255171|NCT03498313|520136119|FG000|Experimental Period 1|Withdrawal by Subject|0|||
144255172|NCT03498313|520136120|FG001|Experimental Period 1|Withdrawal by Subject|1|||
144255173|NCT03498313|520136121|FG002|Experimental Period 1|Withdrawal by Subject|0|||
144255174|NCT03498313|520136122|FG003|Experimental Period 1|Withdrawal by Subject|0|||
144255175|NCT03498313|520136123|FG004|Experimental Period 1|Withdrawal by Subject|0|||
144255176|NCT03498313|520136124|FG005|Experimental Period 1|Withdrawal by Subject|0|||
144255177|NCT03498313|520136119|FG000|Washout Period 1|Anovulation|1|||
144255178|NCT03498313|520136120|FG001|Washout Period 1|Anovulation|0|||
144255179|NCT03498313|520136121|FG002|Washout Period 1|Anovulation|0|||
144255180|NCT03498313|520136122|FG003|Washout Period 1|Anovulation|0|||
144457688|NCT02105948|520871575|FG000|Overall Study|Withdrawal by Subject|15|||
144457689|NCT02105948|520871576|FG001|Overall Study|Withdrawal by Subject|10|||
144457690|NCT02105948|520871577|FG002|Overall Study|Withdrawal by Subject|10|||
144534317|NCT03417284|521159943|FG001|Overall Study|Inadequate supply on study drug|0|||
144534318|NCT03417284|521159944|FG002|Overall Study|Inadequate supply on study drug|0|||
144534319|NCT03417284|521159945|FG003|Overall Study|Inadequate supply on study drug|0|||
144534320|NCT03417284|521159942|FG000|Overall Study|Disease Progression|0|||
144534321|NCT03417284|521159943|FG001|Overall Study|Disease Progression|0|||
144534322|NCT03417284|521159944|FG002|Overall Study|Disease Progression|1|||
144534323|NCT03417284|521159945|FG003|Overall Study|Disease Progression|0|||
144534324|NCT04633278|521159946|FG000|Overall Study|Adverse Event|1|||
144534325|NCT04633278|521159947|FG001|Overall Study|Adverse Event|0|||
144534326|NCT04633278|521159946|FG000|Overall Study|Withdrawal by Subject|1|||
144534327|NCT04633278|521159947|FG001|Overall Study|Withdrawal by Subject|0|||
144534328|NCT04633278|521159946|FG000|Overall Study|Death|11|||
144534329|NCT04633278|521159947|FG001|Overall Study|Death|7|||
144534330|NCT04633278|521159946|FG000|Overall Study|Sponsor Decision|3|||
144534331|NCT04633278|521159947|FG001|Overall Study|Sponsor Decision|0|||
144255181|NCT03498313|520136123|FG004|Washout Period 1|Anovulation|0|||
144255182|NCT03498313|520136124|FG005|Washout Period 1|Anovulation|0|||
144255183|NCT03498313|520136119|FG000|Washout Period 1|Withdrawal by Subject|0|||
144255184|NCT03498313|520136120|FG001|Washout Period 1|Withdrawal by Subject|3|||
144255185|NCT03498313|520136121|FG002|Washout Period 1|Withdrawal by Subject|0|||
144255186|NCT03498313|520136122|FG003|Washout Period 1|Withdrawal by Subject|1|||
144255187|NCT03498313|520136123|FG004|Washout Period 1|Withdrawal by Subject|0|||
144255188|NCT03498313|520136124|FG005|Washout Period 1|Withdrawal by Subject|1|||
144255189|NCT03498313|520136119|FG000|Experimental Period 2|Adverse Event|0|||
144457691|NCT02105948|520871578|FG003|Overall Study|Withdrawal by Subject|11|||
144457692|NCT01220557|520871580|FG000|Overall Study|Lost to Follow-up|5|||
144457693|NCT01220557|520871581|FG001|Overall Study|Lost to Follow-up|3|||
144457694|NCT01220557|520871580|FG000|Overall Study|attended less than 6 lessons|1|||
144457695|NCT01220557|520871581|FG001|Overall Study|attended less than 6 lessons|2|||
144457696|NCT01090453|520871584|FG000|Overall Study|Withdrawal by Subject|1|||
144457697|NCT01090453|520871585|FG001|Overall Study|Withdrawal by Subject|2|||
144457698|NCT01090453|520871584|FG000|Overall Study|Lost to Follow-up|7|||
144457699|NCT01090453|520871585|FG001|Overall Study|Lost to Follow-up|7|||
144457700|NCT01090453|520871584|FG000|Overall Study|Non serious AEs|1|||
144457701|NCT01090453|520871585|FG001|Overall Study|Non serious AEs|0|||
144457702|NCT01090453|520871584|FG000|Overall Study|Protocol Violation|2|||
144457703|NCT01090453|520871585|FG001|Overall Study|Protocol Violation|0|||
144457704|NCT01090453|520871584|FG000|Overall Study|Other|2|||
144457705|NCT01090453|520871585|FG001|Overall Study|Other|4|||
144457706|NCT01090453|520871584|FG000|Overall Study|Eligibility Criteria|0|||
144457707|NCT01090453|520871585|FG001|Overall Study|Eligibility Criteria|1|||
144457708|NCT04072159|520871586|FG000|Overall Study|Lost to Follow-up|6|||
144457709|NCT04072159|520871587|FG001|Overall Study|Lost to Follow-up|6|||
144457710|NCT04072159|520871586|FG000|Overall Study|Withdrawal by Subject|2|||
144457711|NCT04072159|520871587|FG001|Overall Study|Withdrawal by Subject|0|||
144457712|NCT00522275|520871588|FG000|Overall Study|Adverse Event|35|||
144457713|NCT00522275|520871588|FG000|Overall Study|Lack of Efficacy|80|||
144457714|NCT00522275|520871588|FG000|Overall Study|Subject withdrew consent|16|||
144457715|NCT00522275|520871588|FG000|Overall Study|Protocol deviation|1|||
144457716|NCT00522275|520871588|FG000|Overall Study|Unsatisfactory compliance|11|||
144457717|NCT00522275|520871588|FG000|Overall Study|Lost to Follow-up|8|||
144457718|NCT00522275|520871588|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
144457719|NCT00522275|520871588|FG000|Overall Study|Other: Subject is pregnant|2|||
144457720|NCT00522275|520871588|FG000|Overall Study|Other: Subject relocated|2|||
144457721|NCT00522275|520871588|FG000|Overall Study|Other: Subject arrested|1|||
144457722|NCT00522275|520871588|FG000|Overall Study|Other: Site / clinic closed|4|||
144457723|NCT00522275|520871588|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
144457724|NCT00522275|520871588|FG000|Overall Study|Other: Sponsor request|2|||
144457725|NCT00522275|520871588|FG000|Overall Study|Other: Subject ran out of medication|1|||
144457726|NCT00522275|520871588|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
144457727|NCT04323436|520871591|FG000|Overall Study|Adverse Event|7|||
144457728|NCT04323436|520871592|FG001|Overall Study|Adverse Event|0|||
144457729|NCT04323436|520871593|FG002|Overall Study|Adverse Event|0|||
144457730|NCT04323436|520871591|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
144457731|NCT04323436|520871592|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
144457732|NCT04323436|520871593|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
144457733|NCT04323436|520871591|FG000|Overall Study|Death|1|||
144457734|NCT04323436|520871592|FG001|Overall Study|Death|0|||
144457735|NCT04323436|520871593|FG002|Overall Study|Death|0|||
144457736|NCT04323436|520871591|FG000|Overall Study|Physician Decision|2|||
144457737|NCT04323436|520871592|FG001|Overall Study|Physician Decision|0|||
144457738|NCT04323436|520871593|FG002|Overall Study|Physician Decision|0|||
144457739|NCT04323436|520871591|FG000|Overall Study|Progressive disease|10|||
144457740|NCT04323436|520871592|FG001|Overall Study|Progressive disease|0|||
144457741|NCT04323436|520871593|FG002|Overall Study|Progressive disease|0|||
144457742|NCT04323436|520871591|FG000|Overall Study|Subject decision|3|||
144457743|NCT04323436|520871592|FG001|Overall Study|Subject decision|0|||
144457744|NCT04323436|520871593|FG002|Overall Study|Subject decision|0|||
144457745|NCT01196975|520871594|FG000|Overall Study|Adverse Event|2|||
144457746|NCT01196975|520871595|FG001|Overall Study|Adverse Event|2|||
144457747|NCT01196975|520871596|FG002|Overall Study|Adverse Event|0|||
144457748|NCT01196975|520871597|FG003|Overall Study|Adverse Event|0|||
144457749|NCT01196975|520871598|FG004|Overall Study|Adverse Event|2|||
144457750|NCT01196975|520871594|FG000|Overall Study|Withdrawal by Subject|2|||
144457751|NCT01196975|520871595|FG001|Overall Study|Withdrawal by Subject|1|||
144457752|NCT01196975|520871596|FG002|Overall Study|Withdrawal by Subject|0|||
144457753|NCT01196975|520871597|FG003|Overall Study|Withdrawal by Subject|1|||
144457754|NCT01196975|520871598|FG004|Overall Study|Withdrawal by Subject|0|||
144457755|NCT01196975|520871594|FG000|Overall Study|Lost to Follow-up|11|||
144534332|NCT04633278|521159946|FG000|Overall Study|Not Listed|1|||
144534333|NCT04633278|521159947|FG001|Overall Study|Not Listed|0|||
144534334|NCT03636490|521159948|FG000|Overall Study|Dropped out or incomplete data|141|||
144457756|NCT01196975|520871595|FG001|Overall Study|Lost to Follow-up|6|||
144457757|NCT01196975|520871596|FG002|Overall Study|Lost to Follow-up|5|||
144457758|NCT01196975|520871597|FG003|Overall Study|Lost to Follow-up|5|||
144457759|NCT01196975|520871598|FG004|Overall Study|Lost to Follow-up|11|||
144457760|NCT01365494|520871599|FG000|Overall Study|Adverse Event|1|||
144534335|NCT02246127|521159949|FG000|First Course Treatment|Adverse Event|9|||
144457761|NCT01365494|520871600|FG001|Overall Study|Adverse Event|0|||
144457762|NCT01365494|520871599|FG000|Overall Study|Withdrawal by Subject|0|||
144457763|NCT01365494|520871600|FG001|Overall Study|Withdrawal by Subject|1|||
144457764|NCT01365494|520871599|FG000|Overall Study|Lost to Follow-up|1|||
144457765|NCT01365494|520871600|FG001|Overall Study|Lost to Follow-up|2|||
144457766|NCT03021187|520871601|FG000|Overall Study|Death|0|||
144457767|NCT03021187|520871602|FG001|Overall Study|Death|0|||
144607618|NCT03250832|521424500|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
144607619|NCT03250832|521424489|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607620|NCT03250832|521424490|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144457768|NCT03021187|520871603|FG002|Overall Study|Death|3|||
144457769|NCT03021187|520871604|FG003|Overall Study|Death|0|||
144457770|NCT03021187|520871601|FG000|Overall Study|Withdrawal by Subject|0|||
144457771|NCT03021187|520871602|FG001|Overall Study|Withdrawal by Subject|6|||
144457772|NCT03021187|520871603|FG002|Overall Study|Withdrawal by Subject|2|||
144457773|NCT03021187|520871604|FG003|Overall Study|Withdrawal by Subject|5|||
144457774|NCT03021187|520871601|FG000|Overall Study|Lost to Follow-up|10|||
144457775|NCT03021187|520871602|FG001|Overall Study|Lost to Follow-up|3|||
144457776|NCT03021187|520871603|FG002|Overall Study|Lost to Follow-up|1|||
144457777|NCT03021187|520871604|FG003|Overall Study|Lost to Follow-up|4|||
144457778|NCT03832192|520871607|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
144457779|NCT03832192|520871608|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
144457780|NCT02663128|520871609|FG000|Period 2|Physician Decision|0|||
144457781|NCT02663128|520871610|FG001|Period 2|Physician Decision|0|||
144457782|NCT02663128|520871611|FG002|Period 2|Physician Decision|0|||
144457783|NCT02663128|520871612|FG003|Period 2|Physician Decision|0|||
144457784|NCT02663128|520871613|FG004|Period 2|Physician Decision|1|||
144457785|NCT02663128|520871614|FG005|Period 2|Physician Decision|0|||
144457786|NCT03394924|520871617|FG000|Overall Study|Adverse Event|0|||
144457787|NCT03394924|520871618|FG001|Overall Study|Adverse Event|5|||
144457788|NCT03394924|520871619|FG002|Overall Study|Adverse Event|0|||
144457789|NCT03394924|520871617|FG000|Overall Study|Withdrawal by Subject|2|||
144457790|NCT03394924|520871618|FG001|Overall Study|Withdrawal by Subject|0|||
144457791|NCT03394924|520871619|FG002|Overall Study|Withdrawal by Subject|0|||
144457792|NCT03394924|520871617|FG000|Overall Study|Lost to Follow-up|0|||
144457793|NCT03394924|520871618|FG001|Overall Study|Lost to Follow-up|1|||
144457794|NCT03394924|520871619|FG002|Overall Study|Lost to Follow-up|0|||
144457795|NCT03394924|520871617|FG000|Overall Study|Did not meet all inclusion criteria|1|||
144457796|NCT03394924|520871618|FG001|Overall Study|Did not meet all inclusion criteria|0|||
144457797|NCT03394924|520871619|FG002|Overall Study|Did not meet all inclusion criteria|0|||
144457798|NCT02276482|520871622|FG000|Overall Study|Adverse Event|1|||
144457799|NCT02276482|520871623|FG001|Overall Study|Adverse Event|0|||
144457800|NCT02276482|520871622|FG000|Overall Study|Withdrawal by Subject|1|||
144457801|NCT02276482|520871623|FG001|Overall Study|Withdrawal by Subject|0|||
144457802|NCT02276482|520871622|FG000|Overall Study|Gram-negative infection|1|||
144457803|NCT02276482|520871623|FG001|Overall Study|Gram-negative infection|0|||
144457804|NCT02276482|520871622|FG000|Overall Study|Reason not specified|0|||
144457805|NCT02276482|520871623|FG001|Overall Study|Reason not specified|1|||
144457806|NCT03277313|520871626|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
144457807|NCT03277313|520871627|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
144457808|NCT03277313|520871626|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
144457809|NCT03277313|520871627|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
144457810|NCT03277313|520871626|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
144457811|NCT03277313|520871627|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
144457812|NCT03277313|520871626|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
144457813|NCT03277313|520871627|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
144457814|NCT03277313|520871626|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
144457815|NCT03277313|520871627|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
144457816|NCT02005471|520871628|FG000|Main Study|Adverse Event|0|||
144457817|NCT02005471|520871629|FG001|Main Study|Adverse Event|1|||
144457818|NCT02005471|520871630|FG002|Main Study|Adverse Event|0|||
144457819|NCT02005471|520871631|FG003|Main Study|Adverse Event|0|||
144457820|NCT02005471|520871628|FG000|Main Study|Death|83|||
144457821|NCT02005471|520871629|FG001|Main Study|Death|52|||
144457822|NCT02005471|520871630|FG002|Main Study|Death|0|||
144457823|NCT02005471|520871631|FG003|Main Study|Death|0|||
144457824|NCT02005471|520871628|FG000|Main Study|Lost to Follow-up|4|||
144457825|NCT02005471|520871629|FG001|Main Study|Lost to Follow-up|5|||
144607621|NCT03250832|521424491|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
144607622|NCT03250832|521424492|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144255190|NCT03498313|520136120|FG001|Experimental Period 2|Adverse Event|0|||
144457826|NCT02005471|520871630|FG002|Main Study|Lost to Follow-up|0|||
144457827|NCT02005471|520871631|FG003|Main Study|Lost to Follow-up|0|||
144457828|NCT02005471|520871628|FG000|Main Study|Physician Decision|3|||
144457829|NCT02005471|520871629|FG001|Main Study|Physician Decision|1|||
144457830|NCT02005471|520871630|FG002|Main Study|Physician Decision|0|||
144457831|NCT02005471|520871631|FG003|Main Study|Physician Decision|0|||
144457832|NCT02005471|520871628|FG000|Main Study|Withdrawal by Subject|26|||
144457833|NCT02005471|520871629|FG001|Main Study|Withdrawal by Subject|11|||
144457834|NCT02005471|520871630|FG002|Main Study|Withdrawal by Subject|0|||
144457835|NCT02005471|520871631|FG003|Main Study|Withdrawal by Subject|0|||
144457836|NCT02005471|520871628|FG000|Main Study|Reason not Specified|0|||
144457837|NCT02005471|520871629|FG001|Main Study|Reason not Specified|6|||
144607623|NCT03250832|521424493|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607624|NCT03250832|521424494|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607625|NCT03250832|521424495|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607626|NCT03250832|521424496|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607627|NCT03250832|521424497|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607628|NCT03250832|521424498|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144457838|NCT02005471|520871630|FG002|Main Study|Reason not Specified|0|||
144457839|NCT02005471|520871631|FG003|Main Study|Reason not Specified|0|||
144457840|NCT02005471|520871628|FG000|Main Study|Randomized but not Dosed|8|||
144457841|NCT02005471|520871629|FG001|Main Study|Randomized but not Dosed|0|||
144457842|NCT02005471|520871630|FG002|Main Study|Randomized but not Dosed|0|||
144457843|NCT02005471|520871631|FG003|Main Study|Randomized but not Dosed|0|||
144457844|NCT02005471|520871628|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
144457845|NCT02005471|520871629|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
144457846|NCT02005471|520871630|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
144457847|NCT02005471|520871631|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
144457848|NCT02005471|520871628|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
144457849|NCT02005471|520871629|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
144457850|NCT02005471|520871630|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
144457851|NCT02005471|520871631|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
144457852|NCT02005471|520871628|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
144457853|NCT02005471|520871629|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
144457854|NCT02005471|520871630|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
144457855|NCT02005471|520871631|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
144457856|NCT00627705|520871633|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
144457857|NCT00627705|520871634|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
144457858|NCT00627705|520871633|FG000|Overall Study|Adverse Event|1|||
144457859|NCT00627705|520871634|FG001|Overall Study|Adverse Event|0|||
144457860|NCT00627705|520871633|FG000|Overall Study|Withdrawal by Subject|0|||
144457861|NCT00627705|520871634|FG001|Overall Study|Withdrawal by Subject|2|||
144457862|NCT00627705|520871633|FG000|Overall Study|Lost to Follow-up|0|||
144457863|NCT00627705|520871634|FG001|Overall Study|Lost to Follow-up|1|||
144457864|NCT00360529|520871635|FG000|Overall Study|Adverse Event|10|||
144457865|NCT00360529|520871636|FG001|Overall Study|Adverse Event|23|||
144457866|NCT00360529|520871637|FG002|Overall Study|Adverse Event|33|||
144457867|NCT00360529|520871635|FG000|Overall Study|Protocol Violation|3|||
144457868|NCT00360529|520871636|FG001|Overall Study|Protocol Violation|3|||
144457869|NCT00360529|520871637|FG002|Overall Study|Protocol Violation|11|||
144457870|NCT00360529|520871635|FG000|Overall Study|Lost to Follow-up|14|||
144457871|NCT00360529|520871636|FG001|Overall Study|Lost to Follow-up|10|||
144457872|NCT00360529|520871637|FG002|Overall Study|Lost to Follow-up|13|||
144457873|NCT00360529|520871635|FG000|Overall Study|Withdrawal by Subject|22|||
144457874|NCT00360529|520871636|FG001|Overall Study|Withdrawal by Subject|14|||
144457875|NCT00360529|520871637|FG002|Overall Study|Withdrawal by Subject|18|||
144457876|NCT00360529|520871635|FG000|Overall Study|Lack of Efficacy|8|||
144457877|NCT00360529|520871636|FG001|Overall Study|Lack of Efficacy|6|||
144457878|NCT00360529|520871637|FG002|Overall Study|Lack of Efficacy|5|||
144457879|NCT00360529|520871635|FG000|Overall Study|Reason discontinued not explained above|4|||
144457880|NCT00360529|520871636|FG001|Overall Study|Reason discontinued not explained above|9|||
144457881|NCT00360529|520871637|FG002|Overall Study|Reason discontinued not explained above|11|||
144457882|NCT02535065|520871638|FG000|Overall Study|Death|13|||
144457883|NCT02535065|520871638|FG000|Overall Study|Lost to Follow-up|1|||
144457884|NCT02535065|520871638|FG000|Overall Study|Withdrawal by Subject|6|||
144457885|NCT00110617|520871639|FG000|Overall Study|Adverse Event|2|||
144457886|NCT00110617|520871640|FG001|Overall Study|Adverse Event|4|||
144457887|NCT00110617|520871639|FG000|Overall Study|Abnormal Laboratory Value|4|||
144457888|NCT00110617|520871640|FG001|Overall Study|Abnormal Laboratory Value|2|||
144457889|NCT00110617|520871639|FG000|Overall Study|Lack of Efficacy|1|||
144457890|NCT00110617|520871640|FG001|Overall Study|Lack of Efficacy|0|||
144457891|NCT00110617|520871639|FG000|Overall Study|Patient no longer requires study drug|1|||
144607629|NCT03250832|521424499|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144607630|NCT03250832|521424500|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
144457892|NCT00110617|520871640|FG001|Overall Study|Patient no longer requires study drug|0|||
144457893|NCT00110617|520871639|FG000|Overall Study|Protocol Violation|5|||
144457894|NCT00110617|520871640|FG001|Overall Study|Protocol Violation|0|||
144457895|NCT00110617|520871639|FG000|Overall Study|Withdrawal by Subject|10|||
144457896|NCT00110617|520871640|FG001|Overall Study|Withdrawal by Subject|4|||
144457897|NCT00110617|520871639|FG000|Overall Study|Lost to Follow-up|9|||
144607631|NCT03250832|521424489|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
144607632|NCT03250832|521424490|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
144457898|NCT00110617|520871640|FG001|Overall Study|Lost to Follow-up|1|||
144457899|NCT00110617|520871639|FG000|Overall Study|Administrative problems|6|||
144607633|NCT03250832|521424491|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
144457900|NCT00110617|520871640|FG001|Overall Study|Administrative problems|5|||
144457901|NCT00110617|520871639|FG000|Overall Study|Death|1|||
144457902|NCT00110617|520871640|FG001|Overall Study|Death|1|||
144457903|NCT00110617|520871639|FG000|Overall Study|Did not receive study drug|0|||
144457904|NCT00110617|520871640|FG001|Overall Study|Did not receive study drug|12|||
144457905|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
144457906|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
144457907|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
144457908|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
144457909|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
144457910|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
144457911|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
144457912|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
144457913|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
144457914|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
144457915|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
144457916|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
144457917|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
144457918|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
144457919|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
144457920|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
144457921|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
144457922|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
144457923|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
144457924|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
144457925|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
144457926|NCT01781572|520871641|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
144457927|NCT01781572|520871642|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
144457928|NCT01781572|520871643|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
144457929|NCT01781572|520871641|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
144457930|NCT01781572|520871642|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
144457931|NCT01781572|520871643|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
144457932|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
144457933|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
144457934|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
144457935|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
144457936|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
144457937|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
144457938|NCT01781572|520871641|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
144457939|NCT01781572|520871642|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
144457940|NCT01781572|520871643|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
144457941|NCT01781572|520871641|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
144457942|NCT01781572|520871642|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
144457943|NCT01781572|520871643|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
144457944|NCT01781572|520871641|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
144457945|NCT01781572|520871642|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
144457946|NCT01781572|520871643|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
144457947|NCT01781572|520871641|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
144457948|NCT01781572|520871642|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
144457949|NCT01781572|520871643|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
144457950|NCT01781572|520871641|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
144457951|NCT01781572|520871642|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
144457952|NCT01781572|520871643|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
144457953|NCT01781572|520871641|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
144457954|NCT01781572|520871642|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
144457955|NCT01781572|520871643|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
144457956|NCT01781572|520871641|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
144457957|NCT01781572|520871642|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
144457958|NCT01781572|520871643|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
144457959|NCT00045110|520871644|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
144457960|NCT00045110|520871645|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
144457961|NCT00045110|520871646|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
144457962|NCT00045110|520871644|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
144457963|NCT00045110|520871645|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
144457964|NCT00045110|520871646|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
144457965|NCT00045110|520871644|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
144457966|NCT00045110|520871645|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
144457967|NCT00045110|520871646|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
144457968|NCT01438541|520871647|FG000|Overall Study|Physician Decision|1|||
144607634|NCT03250832|521424492|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
144457969|NCT01438541|520871647|FG000|Overall Study|Withdrawal by Subject|1|||
144457970|NCT01438541|520871647|FG000|Overall Study|discharge from the hospital|5|||
144457971|NCT02091167|520871648|FG000|Overall Study|Lost to Follow-up|0|||
144457972|NCT02091167|520871649|FG001|Overall Study|Lost to Follow-up|2|||
144457973|NCT03096782|520871650|FG000|Overall Study|Death|1|||
144457974|NCT03096782|520871650|FG000|Overall Study|Participant Relapsed|1|||
144457975|NCT03662750|520871651|FG000|Overall Study|Withdrawal by Subject|1|||
144457976|NCT03156023|520871652|FG000|Overall Study|Withdrawal by Subject|1|||
144457977|NCT03156023|520871653|FG001|Overall Study|Withdrawal by Subject|0|||
144457978|NCT03156023|520871654|FG002|Overall Study|Withdrawal by Subject|2|||
144457979|NCT03156023|520871655|FG003|Overall Study|Withdrawal by Subject|1|||
144457980|NCT03156023|520871656|FG004|Overall Study|Withdrawal by Subject|1|||
144457981|NCT03156023|520871652|FG000|Overall Study|Lost to Follow-up|0|||
144457982|NCT03156023|520871653|FG001|Overall Study|Lost to Follow-up|0|||
144457983|NCT03156023|520871654|FG002|Overall Study|Lost to Follow-up|0|||
144457984|NCT03156023|520871655|FG003|Overall Study|Lost to Follow-up|0|||
144457985|NCT03156023|520871656|FG004|Overall Study|Lost to Follow-up|1|||
144457986|NCT01625897|520873319|FG000|Overall Study|Adverse Event|27|||
144457987|NCT01625897|520873320|FG001|Overall Study|Adverse Event|10|||
144457988|NCT01625897|520873319|FG000|Overall Study|Physician Decision|0|||
144457989|NCT01625897|520873320|FG001|Overall Study|Physician Decision|1|||
144457990|NCT01625897|520873319|FG000|Overall Study|Withdrawal by Subject|25|||
144457991|NCT01625897|520873320|FG001|Overall Study|Withdrawal by Subject|3|||
144457992|NCT00156065|520873321|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
144457993|NCT00156065|520873322|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
144457994|NCT00156065|520873323|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
144457995|NCT00156065|520873321|FG000|Overall Study|Adverse Event|8|||
144457996|NCT00156065|520873322|FG001|Overall Study|Adverse Event|11|||
144457997|NCT00156065|520873323|FG002|Overall Study|Adverse Event|4|||
144457998|NCT00156065|520873321|FG000|Overall Study|Lack of Efficacy|2|||
144457999|NCT00156065|520873322|FG001|Overall Study|Lack of Efficacy|9|||
144458000|NCT00156065|520873323|FG002|Overall Study|Lack of Efficacy|3|||
144458001|NCT00156065|520873321|FG000|Overall Study|Withdrawal by Subject|13|||
144458002|NCT00156065|520873322|FG001|Overall Study|Withdrawal by Subject|26|||
144458003|NCT00156065|520873323|FG002|Overall Study|Withdrawal by Subject|16|||
144458004|NCT00156065|520873321|FG000|Overall Study|Lost to Follow-up|5|||
144458005|NCT00156065|520873322|FG001|Overall Study|Lost to Follow-up|7|||
144458006|NCT00156065|520873323|FG002|Overall Study|Lost to Follow-up|1|||
144458007|NCT00156065|520873321|FG000|Overall Study|Other|2|||
144458008|NCT00156065|520873322|FG001|Overall Study|Other|9|||
144458009|NCT00156065|520873323|FG002|Overall Study|Other|3|||
144534336|NCT02246127|521159950|FG001|First Course Treatment|Adverse Event|7|||
144534337|NCT02246127|521159949|FG000|First Course Treatment|Withdrawal by Subject|6|||
144534338|NCT02246127|521159950|FG001|First Course Treatment|Withdrawal by Subject|7|||
144534339|NCT02246127|521159949|FG000|First Course Treatment|Physician Decision|9|||
144534340|NCT02246127|521159950|FG001|First Course Treatment|Physician Decision|9|||
144534341|NCT02246127|521159949|FG000|First Course Treatment|Death|3|||
144534342|NCT02246127|521159950|FG001|First Course Treatment|Death|3|||
144534343|NCT02246127|521159949|FG000|First Course Treatment|Not reported reasons|6|||
144534344|NCT02246127|521159950|FG001|First Course Treatment|Not reported reasons|7|||
144255191|NCT03498313|520136121|FG002|Experimental Period 2|Adverse Event|0|||
144255192|NCT03498313|520136122|FG003|Experimental Period 2|Adverse Event|0|||
144255193|NCT03498313|520136123|FG004|Experimental Period 2|Adverse Event|1|||
144255194|NCT03498313|520136124|FG005|Experimental Period 2|Adverse Event|2|||
144255195|NCT03498313|520136119|FG000|Washout Period 2|Physician Decision|1|||
144255196|NCT03498313|520136120|FG001|Washout Period 2|Physician Decision|0|||
144255197|NCT03498313|520136121|FG002|Washout Period 2|Physician Decision|0|||
144255198|NCT03498313|520136122|FG003|Washout Period 2|Physician Decision|1|||
144255199|NCT03498313|520136123|FG004|Washout Period 2|Physician Decision|0|||
144255200|NCT03498313|520136124|FG005|Washout Period 2|Physician Decision|1|||
144255201|NCT03498313|520136119|FG000|Washout Period 2|Withdrawal by Subject|3|||
144255202|NCT03498313|520136120|FG001|Washout Period 2|Withdrawal by Subject|2|||
144255203|NCT03498313|520136121|FG002|Washout Period 2|Withdrawal by Subject|0|||
144255204|NCT03498313|520136122|FG003|Washout Period 2|Withdrawal by Subject|0|||
144255205|NCT03498313|520136123|FG004|Washout Period 2|Withdrawal by Subject|2|||
144255206|NCT03498313|520136124|FG005|Washout Period 2|Withdrawal by Subject|0|||
144255207|NCT03498313|520136119|FG000|Washout Period 2|Anovulation|0|||
144458010|NCT01432366|520873324|FG000|Overall Study|Non-Responder|7|||
144458011|NCT01432366|520873324|FG000|Overall Study|Adverse Event|8|||
144458012|NCT01432366|520873324|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
144458013|NCT01432366|520873324|FG000|Overall Study|Pregnancy|1|||
144458014|NCT01432366|520873324|FG000|Overall Study|Lost to Follow-up|13|||
144458015|NCT01432366|520873324|FG000|Overall Study|Lack of Efficacy|1|||
144534345|NCT02246127|521159949|FG000|First Course Treatment|Not treated|3|||
144255208|NCT03498313|520136120|FG001|Washout Period 2|Anovulation|0|||
144255209|NCT03498313|520136121|FG002|Washout Period 2|Anovulation|0|||
144255210|NCT03498313|520136122|FG003|Washout Period 2|Anovulation|0|||
144458016|NCT01432366|520873324|FG000|Overall Study|Site Closed|20|||
144458017|NCT01432366|520873324|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
144458018|NCT01432366|520873324|FG000|Overall Study|Other|14|||
144458019|NCT04546581|520873325|FG000|Overall Study|Adverse Event|9|||
144458020|NCT04546581|520873326|FG001|Overall Study|Adverse Event|3|||
144458021|NCT04546581|520873325|FG000|Overall Study|Physician Decision|0|||
144458022|NCT04546581|520873326|FG001|Overall Study|Physician Decision|1|||
144458023|NCT04546581|520873325|FG000|Overall Study|Protocol Violation|1|||
144458024|NCT04546581|520873326|FG001|Overall Study|Protocol Violation|2|||
144458025|NCT04546581|520873325|FG000|Overall Study|Withdrawal by Subject|3|||
144458026|NCT04546581|520873326|FG001|Overall Study|Withdrawal by Subject|7|||
144458027|NCT01275625|520873327|FG000|Overall Study|Death|1|||
144458028|NCT01275625|520873327|FG000|Overall Study|Lack of Efficacy|2|||
144458029|NCT01275625|520873327|FG000|Overall Study|Lost to Follow-up|1|||
144458030|NCT01275625|520873327|FG000|Overall Study|Withdrawal by Subject|3|||
144458031|NCT01275625|520873327|FG000|Overall Study|Protocol Violation|1|||
144458032|NCT01275625|520873327|FG000|Overall Study|Adverse Event|4|||
144458033|NCT01275625|520873327|FG000|Overall Study|Other|1|||
144458034|NCT01349569|520873328|FG000|Overall Study|Lack of Efficacy|4|||
144458035|NCT00626522|520873329|FG000|Overall Study|Protocol Violation|0|||
144458036|NCT00626522|520873330|FG001|Overall Study|Protocol Violation|0|||
144458037|NCT00626522|520873331|FG002|Overall Study|Protocol Violation|0|||
144458038|NCT00626522|520873332|FG003|Overall Study|Protocol Violation|0|||
144458039|NCT00626522|520873333|FG004|Overall Study|Protocol Violation|1|||
144458040|NCT00626522|520873334|FG005|Overall Study|Protocol Violation|0|||
144458041|NCT00626522|520873329|FG000|Overall Study|Adverse Event|2|||
144458042|NCT00626522|520873330|FG001|Overall Study|Adverse Event|1|||
144458043|NCT00626522|520873331|FG002|Overall Study|Adverse Event|2|||
144458044|NCT00626522|520873332|FG003|Overall Study|Adverse Event|0|||
144458045|NCT00626522|520873333|FG004|Overall Study|Adverse Event|1|||
144458046|NCT00626522|520873334|FG005|Overall Study|Adverse Event|1|||
144458047|NCT00626522|520873329|FG000|Overall Study|Withdrawal by Subject|2|||
144458048|NCT00626522|520873330|FG001|Overall Study|Withdrawal by Subject|5|||
144458049|NCT00626522|520873331|FG002|Overall Study|Withdrawal by Subject|5|||
144458050|NCT00626522|520873332|FG003|Overall Study|Withdrawal by Subject|0|||
144458051|NCT00626522|520873333|FG004|Overall Study|Withdrawal by Subject|4|||
144458052|NCT00626522|520873334|FG005|Overall Study|Withdrawal by Subject|1|||
144458053|NCT00626522|520873329|FG000|Overall Study|COPD exacerbation|0|||
144458054|NCT00626522|520873330|FG001|Overall Study|COPD exacerbation|0|||
144458055|NCT00626522|520873331|FG002|Overall Study|COPD exacerbation|0|||
144458056|NCT00626522|520873332|FG003|Overall Study|COPD exacerbation|1|||
144458057|NCT00626522|520873333|FG004|Overall Study|COPD exacerbation|1|||
144458058|NCT00626522|520873334|FG005|Overall Study|COPD exacerbation|0|||
144458059|NCT00626522|520873329|FG000|Overall Study|Lost to Follow-up|0|||
144458060|NCT00626522|520873330|FG001|Overall Study|Lost to Follow-up|1|||
144458061|NCT00626522|520873331|FG002|Overall Study|Lost to Follow-up|0|||
144458062|NCT00626522|520873332|FG003|Overall Study|Lost to Follow-up|0|||
144458063|NCT00626522|520873333|FG004|Overall Study|Lost to Follow-up|0|||
144458064|NCT00626522|520873334|FG005|Overall Study|Lost to Follow-up|0|||
144458065|NCT00626522|520873329|FG000|Overall Study|Inconsistent reason reported|1|||
144458066|NCT00626522|520873330|FG001|Overall Study|Inconsistent reason reported|0|||
144458067|NCT00626522|520873331|FG002|Overall Study|Inconsistent reason reported|0|||
144458068|NCT00626522|520873332|FG003|Overall Study|Inconsistent reason reported|0|||
144458069|NCT00626522|520873333|FG004|Overall Study|Inconsistent reason reported|0|||
144458070|NCT00626522|520873334|FG005|Overall Study|Inconsistent reason reported|0|||
144458071|NCT00626522|520873329|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
144458072|NCT00626522|520873330|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
144458073|NCT00626522|520873331|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
144607635|NCT03250832|521424493|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
144607636|NCT03250832|521424494|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
144607637|NCT03250832|521424495|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
144607638|NCT03250832|521424496|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
144607639|NCT03250832|521424497|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
144607640|NCT03250832|521424498|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
144458074|NCT00626522|520873332|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
144458075|NCT00626522|520873333|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
144458076|NCT00626522|520873334|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
144607641|NCT03250832|521424499|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
144458077|NCT01412944|520873342|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
144458078|NCT01412944|520873343|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
144458079|NCT01412944|520873344|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
144458080|NCT01412944|520873345|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
144607642|NCT03250832|521424500|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
144458081|NCT01412944|520873346|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
144607643|NCT03250832|521424489|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144458082|NCT01412944|520873347|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
144458083|NCT01412944|520873342|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
144458084|NCT01412944|520873343|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
144458085|NCT01412944|520873344|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
144458086|NCT01412944|520873345|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
144458087|NCT01412944|520873346|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
144458088|NCT01412944|520873347|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
144458089|NCT01412944|520873342|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
144458090|NCT01412944|520873343|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
144458091|NCT01412944|520873344|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
144458092|NCT01412944|520873345|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
144458093|NCT01412944|520873346|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
144458094|NCT01412944|520873347|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
144458095|NCT01412944|520873342|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
144458096|NCT01412944|520873343|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
144458097|NCT01412944|520873344|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
144458098|NCT01412944|520873345|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
144458099|NCT01412944|520873346|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
144458100|NCT01412944|520873347|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
144458101|NCT01412944|520873342|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
144458102|NCT01412944|520873343|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
144458103|NCT01412944|520873344|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
144458104|NCT01412944|520873345|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
144458105|NCT01412944|520873346|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
144458106|NCT01412944|520873347|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
144458107|NCT01412944|520873342|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
144458108|NCT01412944|520873343|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
144458109|NCT01412944|520873344|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
144458110|NCT01412944|520873345|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
144458111|NCT01412944|520873346|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
144458112|NCT01412944|520873347|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
144458113|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458114|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458115|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
144458116|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
144458117|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
144458118|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458119|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Adverse Event|0|||
144458120|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Adverse Event|0|||
144458121|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Adverse Event|0|||
144458122|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Adverse Event|0|||
144458123|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Adverse Event|1|||
144458124|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Adverse Event|0|||
144458125|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
144458126|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
144458127|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
144458128|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
144458129|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
144458130|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
144458131|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458132|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458133|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458134|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458135|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458136|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
144458137|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458138|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458139|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458140|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458141|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
144458142|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458143|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
144458144|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
144458145|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458146|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458147|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458148|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
144458149|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
144255211|NCT03498313|520136123|FG004|Washout Period 2|Anovulation|0|||
144255212|NCT03498313|520136124|FG005|Washout Period 2|Anovulation|1|||
144458150|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
144458151|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
144458152|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
144458153|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
144458154|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
144458155|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458156|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
144458157|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458158|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458159|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458160|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
144458161|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458162|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
144458163|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458164|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458165|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458166|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
144458167|NCT01412944|520873342|FG000|Entire: IV + Maintenance|Adverse Event|0|||
144458168|NCT01412944|520873343|FG001|Entire: IV + Maintenance|Adverse Event|1|||
144458169|NCT01412944|520873344|FG002|Entire: IV + Maintenance|Adverse Event|0|||
144458170|NCT01412944|520873345|FG003|Entire: IV + Maintenance|Adverse Event|0|||
144458171|NCT01412944|520873346|FG004|Entire: IV + Maintenance|Adverse Event|0|||
144458172|NCT01412944|520873347|FG005|Entire: IV + Maintenance|Adverse Event|0|||
144458173|NCT03240588|520873348|FG000|Overall Study|Death|3|||
144458174|NCT03240588|520873349|FG001|Overall Study|Death|0|||
144458175|NCT03240588|520873350|FG002|Overall Study|Death|0|||
144458176|NCT03240588|520873348|FG000|Overall Study|Adverse Event|5|||
144458177|NCT03240588|520873349|FG001|Overall Study|Adverse Event|4|||
144458178|NCT03240588|520873350|FG002|Overall Study|Adverse Event|0|||
144458179|NCT03240588|520873348|FG000|Overall Study|Lost to Follow-up|9|||
144458180|NCT03240588|520873349|FG001|Overall Study|Lost to Follow-up|4|||
144458181|NCT03240588|520873350|FG002|Overall Study|Lost to Follow-up|0|||
144458182|NCT03240588|520873348|FG000|Overall Study|Physician Decision|3|||
144458183|NCT03240588|520873349|FG001|Overall Study|Physician Decision|2|||
144458184|NCT03240588|520873350|FG002|Overall Study|Physician Decision|0|||
144458185|NCT03240588|520873348|FG000|Overall Study|Did not meet eligibility criteria|0|||
144458186|NCT03240588|520873349|FG001|Overall Study|Did not meet eligibility criteria|6|||
144458187|NCT03240588|520873350|FG002|Overall Study|Did not meet eligibility criteria|0|||
144458188|NCT03240588|520873348|FG000|Overall Study|No longer meets protocol criteria|12|||
144458189|NCT03240588|520873349|FG001|Overall Study|No longer meets protocol criteria|7|||
144458190|NCT03240588|520873350|FG002|Overall Study|No longer meets protocol criteria|0|||
144458191|NCT03240588|520873348|FG000|Overall Study|Withdrawal by Subject|60|||
144458192|NCT03240588|520873349|FG001|Overall Study|Withdrawal by Subject|52|||
144458193|NCT03240588|520873350|FG002|Overall Study|Withdrawal by Subject|7|||
144458194|NCT03240588|520873348|FG000|Overall Study|Other, additional details not available.|0|||
144458195|NCT03240588|520873349|FG001|Overall Study|Other, additional details not available.|12|||
144458196|NCT03240588|520873350|FG002|Overall Study|Other, additional details not available.|1|||
144458197|NCT03240588|520873348|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
144458198|NCT03240588|520873349|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
144255213|NCT02239640|520136128|FG000|Overall Study|Withdrawal by Subject|3|||
144255214|NCT02239640|520136128|FG000|Overall Study|Lost to Follow-up|72|||
144255215|NCT02239640|520136128|FG000|Overall Study|Death|142|||
144255216|NCT02372383|520136129|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
144534346|NCT02246127|521159950|FG001|First Course Treatment|Not treated|3|||
144255217|NCT02372383|520136130|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
144255218|NCT02372383|520136131|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
144255219|NCT00929994|520136132|FG000|Overall Study|Withdrawal by Subject|1|||
144255220|NCT00929994|520136132|FG000|Overall Study|medical issue unrelated to intervention|4|||
144255221|NCT00929994|520136132|FG000|Overall Study|employment|1|||
144458199|NCT03240588|520873350|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
144458200|NCT03240588|520873348|FG000|Overall Study|Closure of study|55|||
144458201|NCT03240588|520873349|FG001|Overall Study|Closure of study|3|||
144458202|NCT03240588|520873350|FG002|Overall Study|Closure of study|0|||
144458203|NCT03240588|520873348|FG000|Overall Study|Subject non-compliance|23|||
144458204|NCT03240588|520873349|FG001|Overall Study|Subject non-compliance|2|||
144458205|NCT03240588|520873350|FG002|Overall Study|Subject non-compliance|1|||
144458206|NCT03240588|520873348|FG000|Overall Study|Device Deficiency|1|||
144255222|NCT00206427|520136135|FG000|Overall Study|Adverse Event|2|||
144255223|NCT03130959|520136139|FG000|Overall Study|Disease progression|19|||
144458207|NCT03240588|520873349|FG001|Overall Study|Device Deficiency|0|||
144534347|NCT04496752|521159960|FG000|Second Assessment|Lost to Follow-up|3|||
144255224|NCT03130959|520136140|FG001|Overall Study|Disease progression|7|||
144255225|NCT03130959|520136141|FG002|Overall Study|Disease progression|12|||
144458208|NCT03240588|520873350|FG002|Overall Study|Device Deficiency|0|||
144458209|NCT03240588|520873348|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
144458210|NCT03240588|520873349|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
144458211|NCT03240588|520873350|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
144458212|NCT02091726|520873352|FG000|Overall Study|Lost to Follow-up|6|||
144458213|NCT06111742|520873359|FG000|Overall Study|Did not receive intervention|1|||
144458214|NCT06111742|520873360|FG001|Overall Study|Did not receive intervention|0|||
144458215|NCT06111742|520873361|FG002|Overall Study|Did not receive intervention|0|||
144458216|NCT06111742|520873359|FG000|Overall Study|Withdrawal by Subject|2|||
144458217|NCT06111742|520873360|FG001|Overall Study|Withdrawal by Subject|0|||
144458218|NCT06111742|520873361|FG002|Overall Study|Withdrawal by Subject|0|||
144458219|NCT03489304|520873362|FG000|Overall Study|Lost to Follow-up|4|||
144458220|NCT02239679|520873363|FG000|Overall Study|Lost to Follow-up|1|||
144458221|NCT02239679|520873364|FG001|Overall Study|Lost to Follow-up|0|||
144458222|NCT02239679|520873365|FG002|Overall Study|Lost to Follow-up|0|||
144458223|NCT02239679|520873363|FG000|Overall Study|Withdrawal by Subject|2|||
144458224|NCT02239679|520873364|FG001|Overall Study|Withdrawal by Subject|3|||
144458225|NCT02239679|520873365|FG002|Overall Study|Withdrawal by Subject|1|||
144458226|NCT02605954|520873367|FG000|Overall Study|Adverse Event|5|||
144458227|NCT02605954|520873368|FG001|Overall Study|Adverse Event|1|||
144458228|NCT02605954|520873367|FG000|Overall Study|Investigator's Discretion|1|||
144458229|NCT02605954|520873368|FG001|Overall Study|Investigator's Discretion|0|||
144458230|NCT02605954|520873367|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144458231|NCT02605954|520873368|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144458232|NCT02605954|520873367|FG000|Overall Study|Withdrew Consent|2|||
144458233|NCT02605954|520873368|FG001|Overall Study|Withdrew Consent|2|||
144458234|NCT02605954|520873367|FG000|Overall Study|Lost to Follow-up|3|||
144458235|NCT02605954|520873368|FG001|Overall Study|Lost to Follow-up|0|||
144458236|NCT02605954|520873367|FG000|Overall Study|Randomized but not treated|0|||
144458237|NCT02605954|520873368|FG001|Overall Study|Randomized but not treated|1|||
144458238|NCT03214367|520873369|FG000|Lead-in Period|Withdrawal by Subject|50|||
144458239|NCT03214367|520873370|FG001|Lead-in Period|Withdrawal by Subject|0|||
144458240|NCT03214367|520873371|FG002|Lead-in Period|Withdrawal by Subject|0|||
144458241|NCT03214367|520873372|FG003|Lead-in Period|Withdrawal by Subject|0|||
144458242|NCT03214367|520873373|FG004|Lead-in Period|Withdrawal by Subject|2|||
144607644|NCT03250832|521424490|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144458243|NCT03214367|520873374|FG005|Lead-in Period|Withdrawal by Subject|0|||
144458244|NCT03214367|520873375|FG006|Lead-in Period|Withdrawal by Subject|0|||
144458245|NCT03214367|520873376|FG007|Lead-in Period|Withdrawal by Subject|0|||
144458246|NCT03214367|520873369|FG000|Lead-in Period|Adverse Event|3|||
144458247|NCT03214367|520873370|FG001|Lead-in Period|Adverse Event|0|||
144458248|NCT03214367|520873371|FG002|Lead-in Period|Adverse Event|0|||
144458249|NCT03214367|520873372|FG003|Lead-in Period|Adverse Event|0|||
144458250|NCT03214367|520873373|FG004|Lead-in Period|Adverse Event|0|||
144458251|NCT03214367|520873374|FG005|Lead-in Period|Adverse Event|0|||
144458252|NCT03214367|520873375|FG006|Lead-in Period|Adverse Event|0|||
144458253|NCT03214367|520873376|FG007|Lead-in Period|Adverse Event|0|||
144458254|NCT03214367|520873369|FG000|Lead-in Period|Lost to Follow-up|12|||
144458255|NCT03214367|520873370|FG001|Lead-in Period|Lost to Follow-up|0|||
144458256|NCT03214367|520873371|FG002|Lead-in Period|Lost to Follow-up|0|||
144458257|NCT03214367|520873372|FG003|Lead-in Period|Lost to Follow-up|0|||
144458258|NCT03214367|520873373|FG004|Lead-in Period|Lost to Follow-up|0|||
144458259|NCT03214367|520873374|FG005|Lead-in Period|Lost to Follow-up|0|||
144458260|NCT03214367|520873375|FG006|Lead-in Period|Lost to Follow-up|0|||
144458261|NCT03214367|520873376|FG007|Lead-in Period|Lost to Follow-up|0|||
144458262|NCT03214367|520873369|FG000|Lead-in Period|Sponsor Decision|11|||
144458263|NCT03214367|520873370|FG001|Lead-in Period|Sponsor Decision|0|||
144458264|NCT03214367|520873371|FG002|Lead-in Period|Sponsor Decision|0|||
144458265|NCT03214367|520873372|FG003|Lead-in Period|Sponsor Decision|0|||
144458266|NCT03214367|520873373|FG004|Lead-in Period|Sponsor Decision|0|||
144458267|NCT03214367|520873374|FG005|Lead-in Period|Sponsor Decision|0|||
144255226|NCT03130959|520136142|FG003|Overall Study|Disease progression|7|||
144255227|NCT03130959|520136143|FG004|Overall Study|Disease progression|12|||
144255228|NCT03130959|520136144|FG005|Overall Study|Disease progression|3|||
144255229|NCT03130959|520136145|FG006|Overall Study|Disease progression|6|||
144458268|NCT03214367|520873375|FG006|Lead-in Period|Sponsor Decision|0|||
144458269|NCT03214367|520873376|FG007|Lead-in Period|Sponsor Decision|0|||
144458270|NCT03214367|520873369|FG000|Lead-in Period|Physician Decision|12|||
144458271|NCT03214367|520873370|FG001|Lead-in Period|Physician Decision|0|||
144458272|NCT03214367|520873371|FG002|Lead-in Period|Physician Decision|0|||
144458273|NCT03214367|520873372|FG003|Lead-in Period|Physician Decision|0|||
144458274|NCT03214367|520873373|FG004|Lead-in Period|Physician Decision|0|||
144458275|NCT03214367|520873374|FG005|Lead-in Period|Physician Decision|0|||
144458276|NCT03214367|520873375|FG006|Lead-in Period|Physician Decision|0|||
144458277|NCT03214367|520873376|FG007|Lead-in Period|Physician Decision|0|||
144458278|NCT03214367|520873369|FG000|Lead-in Period|Protocol Violation|5|||
144458279|NCT03214367|520873370|FG001|Lead-in Period|Protocol Violation|0|||
144458280|NCT03214367|520873371|FG002|Lead-in Period|Protocol Violation|0|||
144458281|NCT03214367|520873372|FG003|Lead-in Period|Protocol Violation|0|||
144458282|NCT03214367|520873373|FG004|Lead-in Period|Protocol Violation|0|||
144458283|NCT03214367|520873374|FG005|Lead-in Period|Protocol Violation|0|||
144458284|NCT03214367|520873375|FG006|Lead-in Period|Protocol Violation|0|||
144458285|NCT03214367|520873376|FG007|Lead-in Period|Protocol Violation|0|||
144458286|NCT03214367|520873369|FG000|Lead-in Period|Treatment Interruption|1|||
144458287|NCT03214367|520873370|FG001|Lead-in Period|Treatment Interruption|0|||
144458288|NCT03214367|520873371|FG002|Lead-in Period|Treatment Interruption|0|||
144458289|NCT03214367|520873372|FG003|Lead-in Period|Treatment Interruption|0|||
144458290|NCT03214367|520873373|FG004|Lead-in Period|Treatment Interruption|0|||
144458291|NCT03214367|520873374|FG005|Lead-in Period|Treatment Interruption|0|||
144458292|NCT03214367|520873375|FG006|Lead-in Period|Treatment Interruption|0|||
144458293|NCT03214367|520873376|FG007|Lead-in Period|Treatment Interruption|0|||
144458294|NCT03214367|520873369|FG000|Treatment Period|Adverse Event|0|||
144458295|NCT03214367|520873370|FG001|Treatment Period|Adverse Event|1|||
144458296|NCT03214367|520873371|FG002|Treatment Period|Adverse Event|4|||
144458297|NCT03214367|520873372|FG003|Treatment Period|Adverse Event|2|||
144458298|NCT03214367|520873373|FG004|Treatment Period|Adverse Event|0|||
144458299|NCT03214367|520873374|FG005|Treatment Period|Adverse Event|0|||
144458300|NCT03214367|520873375|FG006|Treatment Period|Adverse Event|0|||
144458301|NCT03214367|520873376|FG007|Treatment Period|Adverse Event|0|||
144458302|NCT03214367|520873369|FG000|Treatment Period|Death|0|||
144458303|NCT03214367|520873370|FG001|Treatment Period|Death|1|||
144458304|NCT03214367|520873371|FG002|Treatment Period|Death|1|||
144458305|NCT03214367|520873372|FG003|Treatment Period|Death|1|||
144458306|NCT03214367|520873373|FG004|Treatment Period|Death|0|||
144458307|NCT03214367|520873374|FG005|Treatment Period|Death|0|||
144458308|NCT03214367|520873375|FG006|Treatment Period|Death|0|||
144458309|NCT03214367|520873376|FG007|Treatment Period|Death|0|||
144458310|NCT03214367|520873369|FG000|Treatment Period|Lost to Follow-up|0|||
144458311|NCT03214367|520873370|FG001|Treatment Period|Lost to Follow-up|5|||
144458312|NCT03214367|520873371|FG002|Treatment Period|Lost to Follow-up|3|||
144458313|NCT03214367|520873372|FG003|Treatment Period|Lost to Follow-up|2|||
144458314|NCT03214367|520873373|FG004|Treatment Period|Lost to Follow-up|0|||
144458315|NCT03214367|520873374|FG005|Treatment Period|Lost to Follow-up|2|||
144458316|NCT03214367|520873375|FG006|Treatment Period|Lost to Follow-up|1|||
144458317|NCT03214367|520873376|FG007|Treatment Period|Lost to Follow-up|0|||
144458318|NCT03214367|520873369|FG000|Treatment Period|Sponsor Decision|0|||
144458319|NCT03214367|520873370|FG001|Treatment Period|Sponsor Decision|3|||
144458320|NCT03214367|520873371|FG002|Treatment Period|Sponsor Decision|0|||
144458321|NCT03214367|520873372|FG003|Treatment Period|Sponsor Decision|0|||
144458322|NCT03214367|520873373|FG004|Treatment Period|Sponsor Decision|0|||
144458323|NCT03214367|520873374|FG005|Treatment Period|Sponsor Decision|0|||
144458324|NCT03214367|520873375|FG006|Treatment Period|Sponsor Decision|0|||
144458325|NCT03214367|520873376|FG007|Treatment Period|Sponsor Decision|0|||
144458326|NCT03214367|520873369|FG000|Treatment Period|Physician Decision|0|||
144458327|NCT03214367|520873370|FG001|Treatment Period|Physician Decision|1|||
144458328|NCT03214367|520873371|FG002|Treatment Period|Physician Decision|2|||
144458329|NCT03214367|520873372|FG003|Treatment Period|Physician Decision|0|||
144458330|NCT03214367|520873373|FG004|Treatment Period|Physician Decision|0|||
144458331|NCT03214367|520873374|FG005|Treatment Period|Physician Decision|0|||
144458332|NCT03214367|520873375|FG006|Treatment Period|Physician Decision|0|||
144458333|NCT03214367|520873376|FG007|Treatment Period|Physician Decision|0|||
144458334|NCT03214367|520873369|FG000|Treatment Period|Protocol Violation|0|||
144458335|NCT03214367|520873370|FG001|Treatment Period|Protocol Violation|3|||
144607645|NCT03250832|521424491|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144458336|NCT03214367|520873371|FG002|Treatment Period|Protocol Violation|0|||
144458337|NCT03214367|520873372|FG003|Treatment Period|Protocol Violation|0|||
144458338|NCT03214367|520873373|FG004|Treatment Period|Protocol Violation|0|||
144458339|NCT03214367|520873374|FG005|Treatment Period|Protocol Violation|0|||
144458340|NCT03214367|520873375|FG006|Treatment Period|Protocol Violation|0|||
144458341|NCT03214367|520873376|FG007|Treatment Period|Protocol Violation|0|||
144458342|NCT03214367|520873369|FG000|Treatment Period|Withdrawal by Subject|0|||
144458343|NCT03214367|520873370|FG001|Treatment Period|Withdrawal by Subject|20|||
144458344|NCT03214367|520873371|FG002|Treatment Period|Withdrawal by Subject|23|||
144458345|NCT03214367|520873372|FG003|Treatment Period|Withdrawal by Subject|14|||
144458346|NCT03214367|520873373|FG004|Treatment Period|Withdrawal by Subject|0|||
144458347|NCT03214367|520873374|FG005|Treatment Period|Withdrawal by Subject|1|||
144458348|NCT03214367|520873375|FG006|Treatment Period|Withdrawal by Subject|1|||
144458349|NCT03214367|520873376|FG007|Treatment Period|Withdrawal by Subject|1|||
144458350|NCT03555396|520873377|FG000|Overall Study|Death|3|||
144458351|NCT03555396|520873378|FG001|Overall Study|Death|1|||
144458352|NCT03555396|520873377|FG000|Overall Study|Lost to Follow-up|0|||
144458353|NCT03555396|520873378|FG001|Overall Study|Lost to Follow-up|2|||
144458354|NCT02536508|520873379|FG000|Overall Study|Withdrawal by Subject|18|||
144458355|NCT02536508|520873380|FG001|Overall Study|Withdrawal by Subject|13|||
144458356|NCT02536508|520873381|FG002|Overall Study|Withdrawal by Subject|7|||
144458357|NCT02536508|520873379|FG000|Overall Study|Adverse Event|14|||
144458358|NCT02536508|520873380|FG001|Overall Study|Adverse Event|13|||
144458359|NCT02536508|520873381|FG002|Overall Study|Adverse Event|6|||
144458360|NCT02536508|520873379|FG000|Overall Study|Lost to Follow-up|12|||
144458361|NCT02536508|520873380|FG001|Overall Study|Lost to Follow-up|4|||
144458362|NCT02536508|520873381|FG002|Overall Study|Lost to Follow-up|0|||
144458363|NCT02536508|520873379|FG000|Overall Study|Lack of Efficacy|3|||
144458364|NCT02536508|520873380|FG001|Overall Study|Lack of Efficacy|5|||
144458365|NCT02536508|520873381|FG002|Overall Study|Lack of Efficacy|4|||
144458366|NCT02536508|520873379|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
144458367|NCT02536508|520873380|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
144458368|NCT02536508|520873381|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
144458369|NCT02536508|520873379|FG000|Overall Study|Physician Decision|0|||
144458370|NCT02536508|520873380|FG001|Overall Study|Physician Decision|4|||
144458371|NCT02536508|520873381|FG002|Overall Study|Physician Decision|2|||
144458372|NCT02536508|520873379|FG000|Overall Study|Major Protocol Deviation|2|||
144458373|NCT02536508|520873380|FG001|Overall Study|Major Protocol Deviation|2|||
144458374|NCT02536508|520873381|FG002|Overall Study|Major Protocol Deviation|2|||
144458375|NCT02536508|520873379|FG000|Overall Study|Administrative Reasons|0|||
144458376|NCT02536508|520873380|FG001|Overall Study|Administrative Reasons|1|||
144458377|NCT02536508|520873381|FG002|Overall Study|Administrative Reasons|0|||
144458378|NCT00434057|520873383|FG000|Overall Study|Withdrawal by Subject|1|||
144458379|NCT02473952|520873384|FG000|Overall Study|Adverse Event|2|||
144458380|NCT02473952|520873385|FG001|Overall Study|Adverse Event|2|||
144458381|NCT02473952|520873384|FG000|Overall Study|Withdrawal by Subject|0|||
144607646|NCT03250832|521424492|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607647|NCT03250832|521424493|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607648|NCT03250832|521424494|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144458382|NCT02473952|520873385|FG001|Overall Study|Withdrawal by Subject|6|||
144458383|NCT00455195|520873388|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
144458384|NCT00455195|520873389|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
144458385|NCT00455195|520873388|FG000|Double-blind Study AGLU02704|Death|1|||
144458386|NCT00455195|520873389|FG001|Double-blind Study AGLU02704|Death|0|||
144458387|NCT00455195|520873388|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
144458388|NCT00455195|520873389|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
144458389|NCT00455195|520873388|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
144458390|NCT00455195|520873389|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
144458391|NCT03732209|520873392|FG000|Overall Study|Lost to Follow-up|4|||
144458392|NCT03732209|520873393|FG001|Overall Study|Lost to Follow-up|4|||
144458393|NCT03732209|520873392|FG000|Overall Study|Withdrawal by Subject|8|||
144458394|NCT03732209|520873393|FG001|Overall Study|Withdrawal by Subject|9|||
144458395|NCT02864082|520873394|FG000|Overall Study|Adverse Event|1|||
144458396|NCT02864082|520873395|FG001|Overall Study|Adverse Event|1|||
144458397|NCT02864082|520873394|FG000|Overall Study|Lost to Follow-up|0|||
144458398|NCT02864082|520873395|FG001|Overall Study|Lost to Follow-up|1|||
144458399|NCT02864082|520873394|FG000|Overall Study|Withdrawal by Subject|2|||
144458400|NCT02864082|520873395|FG001|Overall Study|Withdrawal by Subject|2|||
144458401|NCT03621696|520873396|FG000|Overall Study|Not eligible|0|||
144458402|NCT03621696|520873397|FG001|Overall Study|Not eligible|0|||
144458403|NCT03621696|520873398|FG002|Overall Study|Not eligible|0|||
144458404|NCT03621696|520873399|FG003|Overall Study|Not eligible|5|||
144458405|NCT03621696|520873396|FG000|Overall Study|Withdrawal by Subject|1|||
144458406|NCT03621696|520873397|FG001|Overall Study|Withdrawal by Subject|1|||
144458407|NCT03621696|520873398|FG002|Overall Study|Withdrawal by Subject|1|||
144458408|NCT03621696|520873399|FG003|Overall Study|Withdrawal by Subject|0|||
144458409|NCT03621696|520873396|FG000|Overall Study|Physician Decision|0|||
144458410|NCT03621696|520873397|FG001|Overall Study|Physician Decision|0|||
144458411|NCT03621696|520873398|FG002|Overall Study|Physician Decision|1|||
144458412|NCT03621696|520873399|FG003|Overall Study|Physician Decision|0|||
144458413|NCT03273946|520873406|FG000|Overall Study|Withdrawal by Subject|5|||
144458414|NCT03273946|520873406|FG000|Overall Study|Unwillingness of the guardian|1|||
144458415|NCT03273946|520873406|FG000|Overall Study|Participant refused to use the drug|2|||
144458416|NCT03273946|520873406|FG000|Overall Study|Participant relative refused to use drug|1|||
144458417|NCT00718718|520873407|FG000|Prior to Week 12|Adverse Event|0|||
144458418|NCT00718718|520873408|FG001|Prior to Week 12|Adverse Event|0|||
144458419|NCT00718718|520873409|FG002|Prior to Week 12|Adverse Event|0|||
144458420|NCT00718718|520873410|FG003|Prior to Week 12|Adverse Event|0|||
144458421|NCT00718718|520873411|FG004|Prior to Week 12|Adverse Event|0|||
144458422|NCT00718718|520873412|FG005|Prior to Week 12|Adverse Event|0|||
144458423|NCT00718718|520873413|FG006|Prior to Week 12|Adverse Event|0|||
144458424|NCT00718718|520873414|FG007|Prior to Week 12|Adverse Event|1|||
144458425|NCT00718718|520873415|FG008|Prior to Week 12|Adverse Event|1|||
144458426|NCT00718718|520873416|FG009|Prior to Week 12|Adverse Event|0|||
144458427|NCT00718718|520873407|FG000|Prior to Week 12|Withdrawal by Subject|0|||
144458428|NCT00718718|520873408|FG001|Prior to Week 12|Withdrawal by Subject|0|||
144458429|NCT00718718|520873409|FG002|Prior to Week 12|Withdrawal by Subject|0|||
144725833|NCT02207231|521852631|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
144725834|NCT02207231|521852632|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
144458430|NCT00718718|520873410|FG003|Prior to Week 12|Withdrawal by Subject|0|||
144458431|NCT00718718|520873411|FG004|Prior to Week 12|Withdrawal by Subject|3|||
144458432|NCT00718718|520873412|FG005|Prior to Week 12|Withdrawal by Subject|0|||
144458433|NCT00718718|520873413|FG006|Prior to Week 12|Withdrawal by Subject|1|||
144458434|NCT00718718|520873414|FG007|Prior to Week 12|Withdrawal by Subject|1|||
144458435|NCT00718718|520873415|FG008|Prior to Week 12|Withdrawal by Subject|1|||
144458436|NCT00718718|520873416|FG009|Prior to Week 12|Withdrawal by Subject|0|||
144458437|NCT00718718|520873407|FG000|Prior to Week 12|Other|1|||
144458438|NCT00718718|520873408|FG001|Prior to Week 12|Other|0|||
144458439|NCT00718718|520873409|FG002|Prior to Week 12|Other|1|||
144458440|NCT00718718|520873410|FG003|Prior to Week 12|Other|0|||
144458441|NCT00718718|520873411|FG004|Prior to Week 12|Other|0|||
144458442|NCT00718718|520873412|FG005|Prior to Week 12|Other|0|||
144458443|NCT00718718|520873413|FG006|Prior to Week 12|Other|0|||
144458444|NCT00718718|520873414|FG007|Prior to Week 12|Other|0|||
144458445|NCT00718718|520873415|FG008|Prior to Week 12|Other|0|||
144458446|NCT00718718|520873416|FG009|Prior to Week 12|Other|0|||
144458447|NCT00718718|520873407|FG000|Week 12 to End of Study|Adverse Event|0|||
144458448|NCT00718718|520873408|FG001|Week 12 to End of Study|Adverse Event|0|||
144458449|NCT00718718|520873409|FG002|Week 12 to End of Study|Adverse Event|0|||
144458450|NCT00718718|520873410|FG003|Week 12 to End of Study|Adverse Event|0|||
144458451|NCT00718718|520873411|FG004|Week 12 to End of Study|Adverse Event|0|||
144458452|NCT00718718|520873412|FG005|Week 12 to End of Study|Adverse Event|0|||
144458453|NCT00718718|520873413|FG006|Week 12 to End of Study|Adverse Event|0|||
144458454|NCT00718718|520873414|FG007|Week 12 to End of Study|Adverse Event|1|||
144458455|NCT00718718|520873415|FG008|Week 12 to End of Study|Adverse Event|0|||
144458456|NCT00718718|520873416|FG009|Week 12 to End of Study|Adverse Event|0|||
144458457|NCT00718718|520873407|FG000|Week 12 to End of Study|Death|0|||
144458458|NCT00718718|520873408|FG001|Week 12 to End of Study|Death|0|||
144458459|NCT00718718|520873409|FG002|Week 12 to End of Study|Death|0|||
144458460|NCT00718718|520873410|FG003|Week 12 to End of Study|Death|0|||
144458461|NCT00718718|520873411|FG004|Week 12 to End of Study|Death|0|||
144458462|NCT00718718|520873412|FG005|Week 12 to End of Study|Death|1|||
144458463|NCT00718718|520873413|FG006|Week 12 to End of Study|Death|0|||
144458464|NCT00718718|520873414|FG007|Week 12 to End of Study|Death|0|||
144458465|NCT00718718|520873415|FG008|Week 12 to End of Study|Death|0|||
144458466|NCT00718718|520873416|FG009|Week 12 to End of Study|Death|0|||
144458467|NCT00718718|520873407|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
144458468|NCT00718718|520873408|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
144458469|NCT00718718|520873409|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
144458470|NCT00718718|520873410|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
144458471|NCT00718718|520873411|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
144458472|NCT00718718|520873412|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
144458473|NCT00718718|520873413|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
144458474|NCT00718718|520873414|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
144458475|NCT00718718|520873415|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
144458476|NCT00718718|520873416|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
144458477|NCT00718718|520873407|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
144458478|NCT00718718|520873408|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
144458479|NCT00718718|520873409|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
144458480|NCT00718718|520873410|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
144255230|NCT03130959|520136146|FG007|Overall Study|Disease progression|3|||
144255231|NCT03130959|520136147|FG008|Overall Study|Disease progression|15|||
144255232|NCT03130959|520136148|FG009|Overall Study|Disease progression|8|||
144255233|NCT03130959|520136139|FG000|Overall Study|Study drug toxicity|2|||
144255234|NCT03130959|520136140|FG001|Overall Study|Study drug toxicity|2|||
144255235|NCT03130959|520136141|FG002|Overall Study|Study drug toxicity|1|||
144255236|NCT03130959|520136142|FG003|Overall Study|Study drug toxicity|2|||
144255237|NCT03130959|520136143|FG004|Overall Study|Study drug toxicity|1|||
144458481|NCT00718718|520873411|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
144458482|NCT00718718|520873412|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
144458483|NCT00718718|520873413|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
144458484|NCT00718718|520873414|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
144255238|NCT03130959|520136144|FG005|Overall Study|Study drug toxicity|1|||
144255239|NCT03130959|520136145|FG006|Overall Study|Study drug toxicity|3|||
144458485|NCT00718718|520873415|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
144458486|NCT00718718|520873416|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
144458487|NCT00718718|520873407|FG000|Week 12 to End of Study|Other|0|||
144458488|NCT00718718|520873408|FG001|Week 12 to End of Study|Other|1|||
144458489|NCT00718718|520873409|FG002|Week 12 to End of Study|Other|0|||
144458490|NCT00718718|520873410|FG003|Week 12 to End of Study|Other|1|||
144458491|NCT00718718|520873411|FG004|Week 12 to End of Study|Other|0|||
144458492|NCT00718718|520873412|FG005|Week 12 to End of Study|Other|0|||
144255240|NCT03130959|520136146|FG007|Overall Study|Study drug toxicity|0|||
144255241|NCT03130959|520136147|FG008|Overall Study|Study drug toxicity|3|||
144458493|NCT00718718|520873413|FG006|Week 12 to End of Study|Other|1|||
144458494|NCT00718718|520873414|FG007|Week 12 to End of Study|Other|0|||
144458495|NCT00718718|520873415|FG008|Week 12 to End of Study|Other|0|||
144458496|NCT00718718|520873416|FG009|Week 12 to End of Study|Other|0|||
144458497|NCT03738150|520873417|FG000|Base Study|Withdrawal by Subject|1|||
144458498|NCT03738150|520873417|FG000|Extension Study|Withdrawal by Subject|1|||
144458499|NCT01358526|520873432|FG000|Open-label Titration Period|Adverse Event|95|||
144458500|NCT01358526|520873433|FG001|Open-label Titration Period|Adverse Event|0|||
144458501|NCT01358526|520873434|FG002|Open-label Titration Period|Adverse Event|0|||
144458502|NCT01358526|520873432|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
144458503|NCT01358526|520873433|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
144458504|NCT01358526|520873434|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
144458505|NCT01358526|520873432|FG000|Open-label Titration Period|Lost to Follow-up|25|||
144458506|NCT01358526|520873433|FG001|Open-label Titration Period|Lost to Follow-up|0|||
144458507|NCT01358526|520873434|FG002|Open-label Titration Period|Lost to Follow-up|0|||
144458508|NCT01358526|520873432|FG000|Open-label Titration Period|Lack of Efficacy|107|||
144458509|NCT01358526|520873433|FG001|Open-label Titration Period|Lack of Efficacy|0|||
144458510|NCT01358526|520873434|FG002|Open-label Titration Period|Lack of Efficacy|0|||
144458511|NCT01358526|520873432|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
144458512|NCT01358526|520873433|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
144458513|NCT01358526|520873434|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
144458514|NCT01358526|520873432|FG000|Open-label Titration Period|Administrative|8|||
144458515|NCT01358526|520873433|FG001|Open-label Titration Period|Administrative|0|||
144458516|NCT01358526|520873434|FG002|Open-label Titration Period|Administrative|0|||
144458517|NCT01358526|520873432|FG000|Open-label Titration Period|Did not qualify|178|||
144458518|NCT01358526|520873433|FG001|Open-label Titration Period|Did not qualify|0|||
144458519|NCT01358526|520873434|FG002|Open-label Titration Period|Did not qualify|0|||
144458520|NCT01358526|520873432|FG000|Double-blind Phase|Adverse Event|0|||
144458521|NCT01358526|520873433|FG001|Double-blind Phase|Adverse Event|24|||
144458522|NCT01358526|520873434|FG002|Double-blind Phase|Adverse Event|23|||
144458523|NCT01358526|520873432|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144458524|NCT01358526|520873433|FG001|Double-blind Phase|Withdrawal by Subject|10|||
144458525|NCT01358526|520873434|FG002|Double-blind Phase|Withdrawal by Subject|8|||
144458526|NCT01358526|520873432|FG000|Double-blind Phase|Lost to Follow-up|0|||
144458527|NCT01358526|520873433|FG001|Double-blind Phase|Lost to Follow-up|4|||
144458528|NCT01358526|520873434|FG002|Double-blind Phase|Lost to Follow-up|1|||
144458529|NCT01358526|520873432|FG000|Double-blind Phase|Lack of Efficacy|0|||
144458530|NCT01358526|520873433|FG001|Double-blind Phase|Lack of Efficacy|31|||
144458531|NCT01358526|520873434|FG002|Double-blind Phase|Lack of Efficacy|73|||
144458532|NCT01358526|520873432|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
144458533|NCT01358526|520873433|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
144458534|NCT01358526|520873434|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
144458535|NCT01358526|520873432|FG000|Double-blind Phase|Administrative|0|||
144458536|NCT01358526|520873433|FG001|Double-blind Phase|Administrative|6|||
144458537|NCT01358526|520873434|FG002|Double-blind Phase|Administrative|10|||
144255242|NCT03130959|520136148|FG009|Overall Study|Study drug toxicity|3|||
144255243|NCT03130959|520136139|FG000|Overall Study|Other reasons|0|||
144255244|NCT03130959|520136140|FG001|Overall Study|Other reasons|0|||
144255245|NCT03130959|520136141|FG002|Overall Study|Other reasons|0|||
144255246|NCT03130959|520136142|FG003|Overall Study|Other reasons|0|||
144255247|NCT03130959|520136143|FG004|Overall Study|Other reasons|0|||
144255248|NCT03130959|520136144|FG005|Overall Study|Other reasons|1|||
144255249|NCT03130959|520136145|FG006|Overall Study|Other reasons|1|||
144255250|NCT03130959|520136146|FG007|Overall Study|Other reasons|0|||
144255251|NCT03130959|520136147|FG008|Overall Study|Other reasons|0|||
144255252|NCT03130959|520136148|FG009|Overall Study|Other reasons|0|||
144255253|NCT03130959|520136139|FG000|Overall Study|Subject request to discontinue therapy|0|||
144255254|NCT03130959|520136140|FG001|Overall Study|Subject request to discontinue therapy|0|||
144255255|NCT03130959|520136141|FG002|Overall Study|Subject request to discontinue therapy|1|||
144255256|NCT03130959|520136142|FG003|Overall Study|Subject request to discontinue therapy|1|||
144255257|NCT03130959|520136143|FG004|Overall Study|Subject request to discontinue therapy|0|||
144255258|NCT03130959|520136144|FG005|Overall Study|Subject request to discontinue therapy|0|||
144458538|NCT04558346|520873435|FG000|Overall Study|Withdrawal by Subject|2|||
144458539|NCT04558346|520873436|FG001|Overall Study|Withdrawal by Subject|0|||
144458540|NCT04558346|520873435|FG000|Overall Study|Lost to Follow-up|0|||
144458541|NCT04558346|520873436|FG001|Overall Study|Lost to Follow-up|1|||
144255259|NCT03130959|520136145|FG006|Overall Study|Subject request to discontinue therapy|1|||
144255260|NCT03130959|520136146|FG007|Overall Study|Subject request to discontinue therapy|1|||
144534348|NCT04496752|521159961|FG001|Second Assessment|Lost to Follow-up|3|||
144534349|NCT04496752|521159960|FG000|Second Assessment|Adverse Event|2|||
144534350|NCT04496752|521159961|FG001|Second Assessment|Adverse Event|0|||
144458542|NCT04558346|520873435|FG000|Overall Study|Adverse Event|0|||
144458543|NCT04558346|520873436|FG001|Overall Study|Adverse Event|1|||
144255261|NCT03130959|520136147|FG008|Overall Study|Subject request to discontinue therapy|0|||
144458544|NCT01462344|520873437|FG000|Overall Study|Withdrawal by Subject|245|||
144458545|NCT01462344|520873438|FG001|Overall Study|Withdrawal by Subject|226|||
144458546|NCT01462344|520873437|FG000|Overall Study|Adverse Event|24|||
144458547|NCT01462344|520873438|FG001|Overall Study|Adverse Event|23|||
144458548|NCT01462344|520873437|FG000|Overall Study|Asthma Exacerbation|34|||
144458549|NCT01462344|520873438|FG001|Overall Study|Asthma Exacerbation|35|||
144458550|NCT01462344|520873437|FG000|Overall Study|Lack of Efficacy|5|||
144458551|NCT01462344|520873438|FG001|Overall Study|Lack of Efficacy|6|||
144458552|NCT01462344|520873437|FG000|Overall Study|Protocol Violation|68|||
144458553|NCT01462344|520873438|FG001|Overall Study|Protocol Violation|53|||
144458554|NCT01462344|520873437|FG000|Overall Study|Lost to Follow-up|7|||
144458555|NCT01462344|520873438|FG001|Overall Study|Lost to Follow-up|7|||
144458556|NCT01962974|520873441|FG000|Overall Study|Study termination|7|||
144458557|NCT03086447|520873442|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144458558|NCT03086447|520873443|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
144458559|NCT03086447|520873442|FG000|Overall Study|Lost Lens|2|||
144458560|NCT03086447|520873443|FG001|Overall Study|Lost Lens|5|||
144458561|NCT03086447|520873442|FG000|Overall Study|Product quality complaint|0|||
144458562|NCT03086447|520873443|FG001|Overall Study|Product quality complaint|1|||
144458563|NCT03086447|520873442|FG000|Overall Study|Lens Damage|1|||
144458564|NCT03086447|520873443|FG001|Overall Study|Lens Damage|6|||
144458565|NCT03086447|520873442|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
144458566|NCT03086447|520873443|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
144458567|NCT03086447|520873442|FG000|Overall Study|Test Article No Longer Available|1|||
144458568|NCT03086447|520873443|FG001|Overall Study|Test Article No Longer Available|0|||
144458569|NCT03086447|520873442|FG000|Overall Study|Protocol Violation|2|||
144458570|NCT03086447|520873443|FG001|Overall Study|Protocol Violation|4|||
144458571|NCT03086447|520873442|FG000|Overall Study|Lost to Follow-up|0|||
144458572|NCT03086447|520873443|FG001|Overall Study|Lost to Follow-up|1|||
144458573|NCT03086447|520873442|FG000|Overall Study|Adverse Event|3|||
144458574|NCT03086447|520873443|FG001|Overall Study|Adverse Event|0|||
144458575|NCT03086447|520873442|FG000|Overall Study|Lens Discomfort|2|||
144458576|NCT03086447|520873443|FG001|Overall Study|Lens Discomfort|1|||
144458577|NCT00809757|520873447|FG000|Overall Study|Adverse Event|2|||
144458578|NCT00809757|520873448|FG001|Overall Study|Adverse Event|3|||
144458579|NCT00809757|520873449|FG002|Overall Study|Adverse Event|3|||
144458580|NCT00809757|520873447|FG000|Overall Study|Lost to Follow-up|0|||
144458581|NCT00809757|520873448|FG001|Overall Study|Lost to Follow-up|0|||
144458582|NCT00809757|520873449|FG002|Overall Study|Lost to Follow-up|1|||
144458583|NCT00809757|520873447|FG000|Overall Study|Protocol Violation|1|||
144458584|NCT00809757|520873448|FG001|Overall Study|Protocol Violation|1|||
144458585|NCT00809757|520873449|FG002|Overall Study|Protocol Violation|1|||
144458586|NCT00809757|520873447|FG000|Overall Study|Withdrawal by Subject|2|||
144458587|NCT00809757|520873448|FG001|Overall Study|Withdrawal by Subject|1|||
144458588|NCT00809757|520873449|FG002|Overall Study|Withdrawal by Subject|3|||
144458589|NCT00809757|520873447|FG000|Overall Study|Subject Uncooperative|1|||
144458590|NCT00809757|520873448|FG001|Overall Study|Subject Uncooperative|0|||
144458591|NCT00809757|520873449|FG002|Overall Study|Subject Uncooperative|2|||
144458592|NCT00809757|520873447|FG000|Overall Study|Noncompliance with Medication|0|||
144458593|NCT00809757|520873448|FG001|Overall Study|Noncompliance with Medication|0|||
144458594|NCT00809757|520873449|FG002|Overall Study|Noncompliance with Medication|1|||
144458595|NCT00253864|520873450|FG000|Overall Study|Lost to Follow-up|5|||
144458596|NCT00253864|520873451|FG001|Overall Study|Lost to Follow-up|8|||
144458597|NCT00659334|520873452|FG000|Overall Study|Screen Failure|8|||
144458598|NCT00659334|520873453|FG001|Overall Study|Screen Failure|5|||
144458599|NCT00659334|520873454|FG002|Overall Study|Screen Failure|0|||
144458600|NCT00659334|520873455|FG003|Overall Study|Screen Failure|0|||
144458601|NCT00659334|520873456|FG004|Overall Study|Screen Failure|0|||
144458602|NCT00659334|520873457|FG005|Overall Study|Screen Failure|0|||
144458603|NCT00659334|520873458|FG006|Overall Study|Screen Failure|1|||
144458604|NCT01174342|520873459|FG000|Overall Study|Conversion to cesarean section|4|||
144458605|NCT01218438|520873467|FG000|Epoch 1|Physician Decision|2|||
144458606|NCT01218438|520873467|FG000|Epoch 1|Adverse Event|1|||
144458607|NCT01218438|520873467|FG000|Epoch 3|Withdrawal by Subject|3|||
144458608|NCT01218438|520873467|FG000|Epoch 3|Adverse Event|1|||
144458609|NCT01218438|520873467|FG000|Epoch 4|Physician Decision|1|||
144458610|NCT01218438|520873467|FG000|Epoch 4|Withdrawal by Subject|2|||
144458611|NCT04579757|520875991|FG000|Overall Study|Adverse Event|0|||
144458612|NCT04579757|520875992|FG001|Overall Study|Adverse Event|0|||
144458613|NCT04579757|520875993|FG002|Overall Study|Adverse Event|0|||
144458614|NCT04579757|520875994|FG003|Overall Study|Adverse Event|2|||
144458615|NCT04579757|520875995|FG004|Overall Study|Adverse Event|1|||
144458616|NCT04579757|520875996|FG005|Overall Study|Adverse Event|1|||
144458617|NCT04579757|520875997|FG006|Overall Study|Adverse Event|0|||
144458618|NCT04579757|520875998|FG007|Overall Study|Adverse Event|0|||
144458619|NCT04579757|520875999|FG008|Overall Study|Adverse Event|0|||
144458620|NCT04579757|520875991|FG000|Overall Study|Death|4|||
144458621|NCT04579757|520875992|FG001|Overall Study|Death|1|||
144458622|NCT04579757|520875993|FG002|Overall Study|Death|14|||
144458623|NCT04579757|520875994|FG003|Overall Study|Death|3|||
144458624|NCT04579757|520875995|FG004|Overall Study|Death|2|||
144458625|NCT04579757|520875996|FG005|Overall Study|Death|7|||
144458626|NCT04579757|520875997|FG006|Overall Study|Death|0|||
144458627|NCT04579757|520875998|FG007|Overall Study|Death|1|||
144458628|NCT04579757|520875999|FG008|Overall Study|Death|3|||
144458629|NCT04579757|520875991|FG000|Overall Study|Physician Decision|0|||
144458630|NCT04579757|520875992|FG001|Overall Study|Physician Decision|0|||
144458631|NCT04579757|520875993|FG002|Overall Study|Physician Decision|0|||
144458632|NCT04579757|520875994|FG003|Overall Study|Physician Decision|2|||
144458633|NCT04579757|520875995|FG004|Overall Study|Physician Decision|1|||
144458634|NCT04579757|520875996|FG005|Overall Study|Physician Decision|1|||
144458635|NCT04579757|520875997|FG006|Overall Study|Physician Decision|1|||
144458636|NCT04579757|520875998|FG007|Overall Study|Physician Decision|0|||
144458637|NCT04579757|520875999|FG008|Overall Study|Physician Decision|0|||
144458638|NCT04579757|520875991|FG000|Overall Study|Study Terminated By Sponsor|0|||
144458639|NCT04579757|520875992|FG001|Overall Study|Study Terminated By Sponsor|0|||
144458640|NCT04579757|520875993|FG002|Overall Study|Study Terminated By Sponsor|0|||
144458641|NCT04579757|520875994|FG003|Overall Study|Study Terminated By Sponsor|0|||
144458642|NCT04579757|520875995|FG004|Overall Study|Study Terminated By Sponsor|2|||
144458643|NCT04579757|520875996|FG005|Overall Study|Study Terminated By Sponsor|0|||
144458644|NCT04579757|520875997|FG006|Overall Study|Study Terminated By Sponsor|0|||
144458645|NCT04579757|520875998|FG007|Overall Study|Study Terminated By Sponsor|2|||
144458646|NCT04579757|520875999|FG008|Overall Study|Study Terminated By Sponsor|0|||
144458647|NCT04579757|520875991|FG000|Overall Study|Withdrawal by Subject|1|||
144458648|NCT04579757|520875992|FG001|Overall Study|Withdrawal by Subject|1|||
144458649|NCT04579757|520875993|FG002|Overall Study|Withdrawal by Subject|0|||
144458650|NCT04579757|520875994|FG003|Overall Study|Withdrawal by Subject|0|||
144458651|NCT04579757|520875995|FG004|Overall Study|Withdrawal by Subject|2|||
144458652|NCT04579757|520875996|FG005|Overall Study|Withdrawal by Subject|1|||
144458653|NCT04579757|520875997|FG006|Overall Study|Withdrawal by Subject|0|||
144458654|NCT04579757|520875998|FG007|Overall Study|Withdrawal by Subject|3|||
144458655|NCT04579757|520875999|FG008|Overall Study|Withdrawal by Subject|0|||
144458656|NCT04579757|520875991|FG000|Overall Study|Radiological or Clinical PD|1|||
144458657|NCT04579757|520875992|FG001|Overall Study|Radiological or Clinical PD|4|||
144458658|NCT04579757|520875993|FG002|Overall Study|Radiological or Clinical PD|1|||
144458659|NCT04579757|520875994|FG003|Overall Study|Radiological or Clinical PD|3|||
144458660|NCT04579757|520875995|FG004|Overall Study|Radiological or Clinical PD|9|||
144458661|NCT04579757|520875996|FG005|Overall Study|Radiological or Clinical PD|4|||
144458662|NCT04579757|520875997|FG006|Overall Study|Radiological or Clinical PD|2|||
144458663|NCT04579757|520875998|FG007|Overall Study|Radiological or Clinical PD|2|||
144458664|NCT04579757|520875999|FG008|Overall Study|Radiological or Clinical PD|0|||
144458665|NCT04579757|520875991|FG000|Overall Study|Start of New Therapy|0|||
144458666|NCT04579757|520875992|FG001|Overall Study|Start of New Therapy|0|||
144458667|NCT04579757|520875993|FG002|Overall Study|Start of New Therapy|0|||
144458668|NCT04579757|520875994|FG003|Overall Study|Start of New Therapy|0|||
144458669|NCT04579757|520875995|FG004|Overall Study|Start of New Therapy|2|||
144458670|NCT04579757|520875996|FG005|Overall Study|Start of New Therapy|1|||
144458671|NCT04579757|520875997|FG006|Overall Study|Start of New Therapy|0|||
144458672|NCT04579757|520875998|FG007|Overall Study|Start of New Therapy|0|||
144458673|NCT04579757|520875999|FG008|Overall Study|Start of New Therapy|0|||
144458674|NCT02207816|520876000|FG000|Overall Study|Serious Adverse Event|0|||
144458675|NCT02207816|520876001|FG001|Overall Study|Serious Adverse Event|5|||
144458676|NCT02207816|520876002|FG002|Overall Study|Serious Adverse Event|2|||
144458677|NCT02207816|520876000|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
144458678|NCT02207816|520876001|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
144458679|NCT02207816|520876002|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
144458680|NCT02207816|520876000|FG000|Overall Study|Withdrawal by Subject|4|||
144458681|NCT02207816|520876001|FG001|Overall Study|Withdrawal by Subject|9|||
144458682|NCT02207816|520876002|FG002|Overall Study|Withdrawal by Subject|7|||
144458683|NCT02207816|520876000|FG000|Overall Study|Migrated/Moved From Study Area|41|||
144458684|NCT02207816|520876001|FG001|Overall Study|Migrated/Moved From Study Area|60|||
144458685|NCT02207816|520876002|FG002|Overall Study|Migrated/Moved From Study Area|51|||
144458686|NCT02207816|520876000|FG000|Overall Study|Lost to Follow-up|3|||
144458687|NCT02207816|520876001|FG001|Overall Study|Lost to Follow-up|9|||
144458688|NCT02207816|520876002|FG002|Overall Study|Lost to Follow-up|1|||
144458689|NCT02207816|520876000|FG000|Overall Study|Other|1|||
144458690|NCT02207816|520876001|FG001|Overall Study|Other|2|||
144458691|NCT02207816|520876002|FG002|Overall Study|Other|4|||
144458692|NCT03508843|520876003|FG000|Overall Study|Withdrawal by Subject|1|||
144534351|NCT04675034|521159962|FG000|Overall Study|Lost to Follow-up|1|||
144458693|NCT03508843|520876003|FG000|Overall Study|technical difficulties|2|||
144458694|NCT04066114|520876004|FG000|Overall Study|Adverse Event|1|||
144458695|NCT04066114|520876005|FG001|Overall Study|Adverse Event|0|||
144458696|NCT04066114|520876006|FG002|Overall Study|Adverse Event|0|||
144458697|NCT04066114|520876004|FG000|Overall Study|Withdrawal by Subject|1|||
144458698|NCT04066114|520876005|FG001|Overall Study|Withdrawal by Subject|0|||
144458699|NCT04066114|520876006|FG002|Overall Study|Withdrawal by Subject|0|||
144458700|NCT04066114|520876004|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
144458701|NCT04066114|520876005|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
144458702|NCT04066114|520876006|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
144458703|NCT02148250|520876008|FG000|Screening|Withdrawal by Subject|5|||
144458704|NCT02148250|520876009|FG001|Screening|Withdrawal by Subject|0|||
144458705|NCT00922428|520876012|FG000|Overall Study|retrospective/extremely implausible data|2|||
144458706|NCT00922428|520876012|FG000|Overall Study|no medication use or questionable use|13|||
144458707|NCT03701555|520876024|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
144458708|NCT03701555|520876025|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
144458709|NCT03701555|520876026|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
144458710|NCT03701555|520876027|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
144458711|NCT03701555|520876028|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
144458712|NCT03701555|520876029|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
144458713|NCT03701555|520876030|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
144458714|NCT03701555|520876031|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
144458715|NCT03701555|520876032|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
144458716|NCT03701555|520876033|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
144458717|NCT03701555|520876034|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
144458718|NCT03701555|520876035|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
144458719|NCT03701555|520876036|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
144458720|NCT03701555|520876037|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
144458721|NCT03701555|520876038|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
144458722|NCT03701555|520876039|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
144458723|NCT03701555|520876040|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
144458724|NCT03701555|520876041|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
144458725|NCT03701555|520876042|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
144458726|NCT03701555|520876043|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
144458727|NCT03701555|520876044|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
144458728|NCT03701555|520876045|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
144458729|NCT03701555|520876046|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
144458730|NCT03701555|520876047|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
144458731|NCT03701555|520876048|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
144458732|NCT03701555|520876049|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
144458733|NCT03701555|520876050|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
144458734|NCT03701555|520876051|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
144458735|NCT03701555|520876052|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
144458736|NCT03701555|520876053|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
144458737|NCT03701555|520876054|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
144458738|NCT03701555|520876055|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
144458739|NCT03701555|520876056|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
144458740|NCT03701555|520876057|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
144534352|NCT04675034|521159963|FG001|Overall Study|Lost to Follow-up|1|||
144534353|NCT04675034|521159964|FG002|Overall Study|Lost to Follow-up|0|||
144534354|NCT04675034|521159965|FG003|Overall Study|Lost to Follow-up|2|||
144534355|NCT04675034|521159966|FG004|Overall Study|Lost to Follow-up|0|||
144534356|NCT04675034|521159962|FG000|Overall Study|Protocol Violation|1|||
144534357|NCT04675034|521159963|FG001|Overall Study|Protocol Violation|0|||
144534358|NCT04675034|521159964|FG002|Overall Study|Protocol Violation|0|||
144255262|NCT03130959|520136148|FG009|Overall Study|Subject request to discontinue therapy|0|||
144255263|NCT03130959|520136139|FG000|Overall Study|Not reported|0|||
144255264|NCT03130959|520136140|FG001|Overall Study|Not reported|0|||
144255265|NCT03130959|520136141|FG002|Overall Study|Not reported|0|||
144255266|NCT03130959|520136142|FG003|Overall Study|Not reported|1|||
144255267|NCT03130959|520136143|FG004|Overall Study|Not reported|0|||
144255268|NCT03130959|520136144|FG005|Overall Study|Not reported|1|||
144255269|NCT03130959|520136145|FG006|Overall Study|Not reported|0|||
144255270|NCT03130959|520136146|FG007|Overall Study|Not reported|0|||
144255271|NCT03130959|520136147|FG008|Overall Study|Not reported|0|||
144255272|NCT03130959|520136148|FG009|Overall Study|Not reported|1|||
144255273|NCT03130959|520136139|FG000|Overall Study|Adverse Event unrelated to drug|0|||
144255274|NCT03130959|520136140|FG001|Overall Study|Adverse Event unrelated to drug|0|||
144255275|NCT03130959|520136141|FG002|Overall Study|Adverse Event unrelated to drug|1|||
144255276|NCT03130959|520136142|FG003|Overall Study|Adverse Event unrelated to drug|1|||
144255277|NCT03130959|520136143|FG004|Overall Study|Adverse Event unrelated to drug|1|||
144255278|NCT03130959|520136144|FG005|Overall Study|Adverse Event unrelated to drug|0|||
144255279|NCT03130959|520136145|FG006|Overall Study|Adverse Event unrelated to drug|1|||
144255280|NCT03130959|520136146|FG007|Overall Study|Adverse Event unrelated to drug|0|||
144255281|NCT03130959|520136147|FG008|Overall Study|Adverse Event unrelated to drug|1|||
144458741|NCT03701555|520876058|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
144458742|NCT03701555|520876059|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
144458743|NCT03701555|520876024|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
144458744|NCT03701555|520876025|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
144534359|NCT04675034|521159965|FG003|Overall Study|Protocol Violation|1|||
144534360|NCT04675034|521159966|FG004|Overall Study|Protocol Violation|3|||
144255282|NCT03130959|520136148|FG009|Overall Study|Adverse Event unrelated to drug|1|||
144255283|NCT03130959|520136139|FG000|Overall Study|Participant withdrew consent|0|||
144255284|NCT03130959|520136140|FG001|Overall Study|Participant withdrew consent|1|||
144458745|NCT03701555|520876026|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
144607649|NCT03250832|521424495|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607650|NCT03250832|521424496|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
144607651|NCT03250832|521424497|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607652|NCT03250832|521424498|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607653|NCT03250832|521424499|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607654|NCT03250832|521424500|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
144607655|NCT03250832|521424489|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607656|NCT03250832|521424490|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144458746|NCT03701555|520876027|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
144458747|NCT03701555|520876028|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
144458748|NCT03701555|520876029|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
144458749|NCT03701555|520876030|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
144607657|NCT03250832|521424491|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607658|NCT03250832|521424492|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607659|NCT03250832|521424493|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607660|NCT03250832|521424494|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144458750|NCT03701555|520876031|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
144458751|NCT03701555|520876032|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
144458752|NCT03701555|520876033|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
144458753|NCT03701555|520876034|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
144458754|NCT03701555|520876035|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
144458755|NCT03701555|520876036|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
144458756|NCT03701555|520876037|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
144458757|NCT03701555|520876038|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
144458758|NCT03701555|520876039|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
144458759|NCT03701555|520876040|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
144458760|NCT03701555|520876041|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
144607661|NCT03250832|521424495|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144458761|NCT03701555|520876042|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
144458762|NCT03701555|520876043|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
144458763|NCT03701555|520876044|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
144458764|NCT03701555|520876045|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
144458765|NCT03701555|520876046|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
144458766|NCT03701555|520876047|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
144458767|NCT03701555|520876048|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
144458768|NCT03701555|520876049|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
144458769|NCT03701555|520876050|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
144458770|NCT03701555|520876051|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
144458771|NCT03701555|520876052|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
144458772|NCT03701555|520876053|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
144458773|NCT03701555|520876054|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
144458774|NCT03701555|520876055|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
144458775|NCT03701555|520876056|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
144607662|NCT03250832|521424496|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
144607663|NCT03250832|521424497|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607664|NCT03250832|521424498|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607665|NCT03250832|521424499|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144458776|NCT03701555|520876057|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
144458777|NCT03701555|520876058|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
144458778|NCT03701555|520876059|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
144458779|NCT03701555|520876024|FG000|Part 2 (Day 1)|Other|0|||
144458780|NCT03701555|520876025|FG001|Part 2 (Day 1)|Other|0|||
144458781|NCT03701555|520876026|FG002|Part 2 (Day 1)|Other|0|||
144458782|NCT03701555|520876027|FG003|Part 2 (Day 1)|Other|0|||
144458783|NCT03701555|520876028|FG004|Part 2 (Day 1)|Other|0|||
144458784|NCT03701555|520876029|FG005|Part 2 (Day 1)|Other|0|||
144458785|NCT03701555|520876030|FG006|Part 2 (Day 1)|Other|0|||
144458786|NCT03701555|520876031|FG007|Part 2 (Day 1)|Other|0|||
144458787|NCT03701555|520876032|FG008|Part 2 (Day 1)|Other|0|||
144458788|NCT03701555|520876033|FG009|Part 2 (Day 1)|Other|0|||
144458789|NCT03701555|520876034|FG010|Part 2 (Day 1)|Other|3|||
144458790|NCT03701555|520876035|FG011|Part 2 (Day 1)|Other|1|||
144607666|NCT03250832|521424500|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
144607667|NCT03250832|521424489|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607668|NCT03250832|521424490|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144458791|NCT03701555|520876036|FG012|Part 2 (Day 1)|Other|0|||
144458792|NCT03701555|520876037|FG013|Part 2 (Day 1)|Other|1|||
144458793|NCT03701555|520876038|FG014|Part 2 (Day 1)|Other|0|||
144458794|NCT03701555|520876039|FG015|Part 2 (Day 1)|Other|2|||
144458795|NCT03701555|520876040|FG016|Part 2 (Day 1)|Other|2|||
144458796|NCT03701555|520876041|FG017|Part 2 (Day 1)|Other|0|||
144458797|NCT03701555|520876042|FG018|Part 2 (Day 1)|Other|0|||
144458798|NCT03701555|520876043|FG019|Part 2 (Day 1)|Other|0|||
144458799|NCT03701555|520876044|FG020|Part 2 (Day 1)|Other|0|||
144255285|NCT03130959|520136141|FG002|Overall Study|Participant withdrew consent|0|||
144255286|NCT03130959|520136142|FG003|Overall Study|Participant withdrew consent|2|||
144255287|NCT03130959|520136143|FG004|Overall Study|Participant withdrew consent|1|||
144255288|NCT03130959|520136144|FG005|Overall Study|Participant withdrew consent|0|||
144255289|NCT03130959|520136145|FG006|Overall Study|Participant withdrew consent|0|||
144255290|NCT03130959|520136146|FG007|Overall Study|Participant withdrew consent|0|||
144255291|NCT03130959|520136147|FG008|Overall Study|Participant withdrew consent|0|||
144458800|NCT03701555|520876045|FG021|Part 2 (Day 1)|Other|0|||
144458801|NCT03701555|520876046|FG022|Part 2 (Day 1)|Other|0|||
144458802|NCT03701555|520876047|FG023|Part 2 (Day 1)|Other|0|||
144458803|NCT03701555|520876048|FG024|Part 2 (Day 1)|Other|0|||
144458804|NCT03701555|520876049|FG025|Part 2 (Day 1)|Other|0|||
144458805|NCT03701555|520876050|FG026|Part 2 (Day 1)|Other|0|||
144458806|NCT03701555|520876051|FG027|Part 2 (Day 1)|Other|0|||
144458807|NCT03701555|520876052|FG028|Part 2 (Day 1)|Other|0|||
144458808|NCT03701555|520876053|FG029|Part 2 (Day 1)|Other|0|||
144458809|NCT03701555|520876054|FG030|Part 2 (Day 1)|Other|0|||
144458810|NCT03701555|520876055|FG031|Part 2 (Day 1)|Other|0|||
144458811|NCT03701555|520876056|FG032|Part 2 (Day 1)|Other|0|||
144458812|NCT03701555|520876057|FG033|Part 2 (Day 1)|Other|0|||
144458813|NCT03701555|520876058|FG034|Part 2 (Day 1)|Other|0|||
144458814|NCT03701555|520876059|FG035|Part 2 (Day 1)|Other|0|||
144458815|NCT03701555|520876024|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
144458816|NCT03701555|520876025|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
144458817|NCT03701555|520876026|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
144458818|NCT03701555|520876027|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
144458819|NCT03701555|520876028|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
144458820|NCT03701555|520876029|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
144458821|NCT03701555|520876030|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
144458822|NCT03701555|520876031|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
144458823|NCT03701555|520876032|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
144458824|NCT03701555|520876033|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
144458825|NCT03701555|520876034|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
144255292|NCT03130959|520136148|FG009|Overall Study|Participant withdrew consent|2|||
144255293|NCT03130959|520136139|FG000|Overall Study|Administrative reason by sponsor|1|||
144255294|NCT03130959|520136140|FG001|Overall Study|Administrative reason by sponsor|0|||
144255295|NCT03130959|520136141|FG002|Overall Study|Administrative reason by sponsor|1|||
144255296|NCT03130959|520136142|FG003|Overall Study|Administrative reason by sponsor|0|||
144255297|NCT03130959|520136143|FG004|Overall Study|Administrative reason by sponsor|0|||
144255298|NCT03130959|520136144|FG005|Overall Study|Administrative reason by sponsor|0|||
144255299|NCT03130959|520136145|FG006|Overall Study|Administrative reason by sponsor|0|||
144255300|NCT03130959|520136146|FG007|Overall Study|Administrative reason by sponsor|0|||
144255301|NCT03130959|520136147|FG008|Overall Study|Administrative reason by sponsor|0|||
144255302|NCT03130959|520136148|FG009|Overall Study|Administrative reason by sponsor|0|||
144255303|NCT03130959|520136139|FG000|Overall Study|Lost to Follow-up|1|||
144255304|NCT03130959|520136140|FG001|Overall Study|Lost to Follow-up|0|||
144255305|NCT03130959|520136141|FG002|Overall Study|Lost to Follow-up|0|||
144255306|NCT03130959|520136142|FG003|Overall Study|Lost to Follow-up|0|||
144255307|NCT03130959|520136143|FG004|Overall Study|Lost to Follow-up|0|||
144255308|NCT03130959|520136144|FG005|Overall Study|Lost to Follow-up|0|||
144255309|NCT03130959|520136145|FG006|Overall Study|Lost to Follow-up|0|||
144255310|NCT03130959|520136146|FG007|Overall Study|Lost to Follow-up|0|||
144255311|NCT03130959|520136147|FG008|Overall Study|Lost to Follow-up|0|||
144255312|NCT03130959|520136148|FG009|Overall Study|Lost to Follow-up|0|||
144255313|NCT05205005|520136149|FG000|Overall Study|Withdrawal by Subject|1|||
144255314|NCT05205005|520136150|FG001|Overall Study|Withdrawal by Subject|0|||
144255315|NCT05205005|520136149|FG000|Overall Study|Adverse Event|1|||
144534361|NCT04675034|521159962|FG000|Overall Study|Withdrawal by Subject|9|||
144534362|NCT04675034|521159963|FG001|Overall Study|Withdrawal by Subject|3|||
144534363|NCT04675034|521159964|FG002|Overall Study|Withdrawal by Subject|4|||
144255316|NCT05205005|520136150|FG001|Overall Study|Adverse Event|0|||
144255317|NCT00694356|520136151|FG000|Overall Study|Adverse Event|1|||
144255318|NCT00694356|520136152|FG001|Overall Study|Adverse Event|0|||
144255319|NCT00694356|520136153|FG002|Overall Study|Adverse Event|0|||
144255320|NCT00694356|520136151|FG000|Overall Study|Progressive Disease|2|||
144458826|NCT03701555|520876035|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
144458827|NCT03701555|520876036|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
144458828|NCT03701555|520876037|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
144458829|NCT03701555|520876038|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
144458830|NCT03701555|520876039|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
144255321|NCT00694356|520136152|FG001|Overall Study|Progressive Disease|6|||
144255322|NCT00694356|520136153|FG002|Overall Study|Progressive Disease|6|||
144255323|NCT00741598|520136154|FG000|Overall Study|Lost to Follow-up|3|||
144255324|NCT00741598|520136155|FG001|Overall Study|Lost to Follow-up|4|||
144255325|NCT00741598|520136154|FG000|Overall Study|Lack of Efficacy|1|||
144255326|NCT00741598|520136155|FG001|Overall Study|Lack of Efficacy|2|||
144458831|NCT03701555|520876040|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
144534364|NCT04675034|521159965|FG003|Overall Study|Withdrawal by Subject|8|||
144458832|NCT03701555|520876041|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
144458833|NCT03701555|520876042|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
144458834|NCT03701555|520876043|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
144458835|NCT03701555|520876044|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
144458836|NCT03701555|520876045|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
144458837|NCT03701555|520876046|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
144458838|NCT03701555|520876047|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
144458839|NCT03701555|520876048|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
144458840|NCT03701555|520876049|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
144458841|NCT03701555|520876050|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
144458842|NCT03701555|520876051|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
144458843|NCT03701555|520876052|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
144458844|NCT03701555|520876053|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
144458845|NCT03701555|520876054|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
144458846|NCT03701555|520876055|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
144458847|NCT03701555|520876056|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
144458848|NCT03701555|520876057|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
144458849|NCT03701555|520876058|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
144458850|NCT03701555|520876059|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
144458851|NCT03701555|520876024|FG000|Part 3 (Day 1)|Subject Decision|0|||
144458852|NCT03701555|520876025|FG001|Part 3 (Day 1)|Subject Decision|0|||
144458853|NCT03701555|520876026|FG002|Part 3 (Day 1)|Subject Decision|0|||
144458854|NCT03701555|520876027|FG003|Part 3 (Day 1)|Subject Decision|0|||
144458855|NCT03701555|520876028|FG004|Part 3 (Day 1)|Subject Decision|0|||
144458856|NCT03701555|520876029|FG005|Part 3 (Day 1)|Subject Decision|0|||
144458857|NCT03701555|520876030|FG006|Part 3 (Day 1)|Subject Decision|0|||
144458858|NCT03701555|520876031|FG007|Part 3 (Day 1)|Subject Decision|0|||
144458859|NCT03701555|520876032|FG008|Part 3 (Day 1)|Subject Decision|0|||
144458860|NCT03701555|520876033|FG009|Part 3 (Day 1)|Subject Decision|0|||
144458861|NCT03701555|520876034|FG010|Part 3 (Day 1)|Subject Decision|0|||
144458862|NCT03701555|520876035|FG011|Part 3 (Day 1)|Subject Decision|0|||
144458863|NCT03701555|520876036|FG012|Part 3 (Day 1)|Subject Decision|0|||
144458864|NCT03701555|520876037|FG013|Part 3 (Day 1)|Subject Decision|0|||
144458865|NCT03701555|520876038|FG014|Part 3 (Day 1)|Subject Decision|0|||
144458866|NCT03701555|520876039|FG015|Part 3 (Day 1)|Subject Decision|0|||
144458867|NCT03701555|520876040|FG016|Part 3 (Day 1)|Subject Decision|0|||
144458868|NCT03701555|520876041|FG017|Part 3 (Day 1)|Subject Decision|0|||
144458869|NCT03701555|520876042|FG018|Part 3 (Day 1)|Subject Decision|0|||
144458870|NCT03701555|520876043|FG019|Part 3 (Day 1)|Subject Decision|0|||
144458871|NCT03701555|520876044|FG020|Part 3 (Day 1)|Subject Decision|0|||
144458872|NCT03701555|520876045|FG021|Part 3 (Day 1)|Subject Decision|0|||
144458873|NCT03701555|520876046|FG022|Part 3 (Day 1)|Subject Decision|0|||
144458874|NCT03701555|520876047|FG023|Part 3 (Day 1)|Subject Decision|0|||
144458875|NCT03701555|520876048|FG024|Part 3 (Day 1)|Subject Decision|0|||
144458876|NCT03701555|520876049|FG025|Part 3 (Day 1)|Subject Decision|0|||
144458877|NCT03701555|520876050|FG026|Part 3 (Day 1)|Subject Decision|1|||
144458878|NCT03701555|520876051|FG027|Part 3 (Day 1)|Subject Decision|0|||
144458879|NCT03701555|520876052|FG028|Part 3 (Day 1)|Subject Decision|0|||
144458880|NCT03701555|520876053|FG029|Part 3 (Day 1)|Subject Decision|0|||
144458881|NCT03701555|520876054|FG030|Part 3 (Day 1)|Subject Decision|0|||
144458882|NCT03701555|520876055|FG031|Part 3 (Day 1)|Subject Decision|2|||
144458883|NCT03701555|520876056|FG032|Part 3 (Day 1)|Subject Decision|1|||
144458884|NCT03701555|520876057|FG033|Part 3 (Day 1)|Subject Decision|1|||
144458885|NCT03701555|520876058|FG034|Part 3 (Day 1)|Subject Decision|0|||
144725835|NCT02207231|521852633|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
144255327|NCT00741598|520136154|FG000|Overall Study|Physician Decision|1|||
144458886|NCT03701555|520876059|FG035|Part 3 (Day 1)|Subject Decision|0|||
144458887|NCT03701555|520876024|FG000|Part 3 (Day 1)|Other|0|||
144458888|NCT03701555|520876025|FG001|Part 3 (Day 1)|Other|0|||
144458889|NCT03701555|520876026|FG002|Part 3 (Day 1)|Other|0|||
144458890|NCT03701555|520876027|FG003|Part 3 (Day 1)|Other|0|||
144458891|NCT03701555|520876028|FG004|Part 3 (Day 1)|Other|0|||
144458892|NCT03701555|520876029|FG005|Part 3 (Day 1)|Other|0|||
144458893|NCT03701555|520876030|FG006|Part 3 (Day 1)|Other|0|||
144458894|NCT03701555|520876031|FG007|Part 3 (Day 1)|Other|0|||
144458895|NCT03701555|520876032|FG008|Part 3 (Day 1)|Other|0|||
144534365|NCT04675034|521159966|FG004|Overall Study|Withdrawal by Subject|6|||
144534366|NCT03248479|521159967|FG000|Overall Study|Death|12|||
144534367|NCT03248479|521159968|FG001|Overall Study|Death|44|||
144534368|NCT03248479|521159969|FG002|Overall Study|Death|1|||
144534369|NCT03248479|521159970|FG003|Overall Study|Death|72|||
144534370|NCT03248479|521159971|FG004|Overall Study|Death|17|||
144534371|NCT03248479|521159972|FG005|Overall Study|Death|6|||
144534372|NCT03248479|521159973|FG006|Overall Study|Death|1|||
144534373|NCT03248479|521159974|FG007|Overall Study|Death|14|||
144255328|NCT00741598|520136155|FG001|Overall Study|Physician Decision|1|||
144458896|NCT03701555|520876033|FG009|Part 3 (Day 1)|Other|0|||
144458897|NCT03701555|520876034|FG010|Part 3 (Day 1)|Other|0|||
144458898|NCT03701555|520876035|FG011|Part 3 (Day 1)|Other|0|||
144458899|NCT03701555|520876036|FG012|Part 3 (Day 1)|Other|0|||
144534374|NCT03248479|521159975|FG008|Overall Study|Death|3|||
144458900|NCT03701555|520876037|FG013|Part 3 (Day 1)|Other|0|||
144458901|NCT03701555|520876038|FG014|Part 3 (Day 1)|Other|0|||
144458902|NCT03701555|520876039|FG015|Part 3 (Day 1)|Other|0|||
144458903|NCT03701555|520876040|FG016|Part 3 (Day 1)|Other|0|||
144458904|NCT03701555|520876041|FG017|Part 3 (Day 1)|Other|0|||
144458905|NCT03701555|520876042|FG018|Part 3 (Day 1)|Other|0|||
144458906|NCT03701555|520876043|FG019|Part 3 (Day 1)|Other|0|||
144458907|NCT03701555|520876044|FG020|Part 3 (Day 1)|Other|0|||
144458908|NCT03701555|520876045|FG021|Part 3 (Day 1)|Other|0|||
144458909|NCT03701555|520876046|FG022|Part 3 (Day 1)|Other|0|||
144458910|NCT03701555|520876047|FG023|Part 3 (Day 1)|Other|0|||
144458911|NCT03701555|520876048|FG024|Part 3 (Day 1)|Other|1|||
144458912|NCT03701555|520876049|FG025|Part 3 (Day 1)|Other|1|||
144458913|NCT03701555|520876050|FG026|Part 3 (Day 1)|Other|0|||
144458914|NCT03701555|520876051|FG027|Part 3 (Day 1)|Other|0|||
144458915|NCT03701555|520876052|FG028|Part 3 (Day 1)|Other|0|||
144458916|NCT03701555|520876053|FG029|Part 3 (Day 1)|Other|1|||
144458917|NCT03701555|520876054|FG030|Part 3 (Day 1)|Other|1|||
144458918|NCT03701555|520876055|FG031|Part 3 (Day 1)|Other|0|||
144458919|NCT03701555|520876056|FG032|Part 3 (Day 1)|Other|1|||
144458920|NCT03701555|520876057|FG033|Part 3 (Day 1)|Other|1|||
144458921|NCT03701555|520876058|FG034|Part 3 (Day 1)|Other|0|||
144458922|NCT03701555|520876059|FG035|Part 3 (Day 1)|Other|0|||
144458923|NCT02508311|520876065|FG000|Overall Study|Withdrawal by Subject|1|||
144458924|NCT02508311|520876066|FG001|Overall Study|Withdrawal by Subject|0|||
144458925|NCT00448539|520876067|FG000|Overall Study|Medication non-compliance|4|||
144458926|NCT00448539|520876068|FG001|Overall Study|Medication non-compliance|1|||
144458927|NCT00448539|520876067|FG000|Overall Study|Protocol Violation|1|||
144458928|NCT00448539|520876068|FG001|Overall Study|Protocol Violation|0|||
144458929|NCT00448539|520876067|FG000|Overall Study|Request of the investigator or sponsor|67|||
144458930|NCT00448539|520876068|FG001|Overall Study|Request of the investigator or sponsor|54|||
144458931|NCT00448539|520876067|FG000|Overall Study|Withdrawal by Subject|20|||
144458932|NCT00448539|520876068|FG001|Overall Study|Withdrawal by Subject|24|||
144458933|NCT00448539|520876067|FG000|Overall Study|Diary non-compliance|1|||
144458934|NCT00448539|520876068|FG001|Overall Study|Diary non-compliance|0|||
144458935|NCT00448539|520876067|FG000|Overall Study|Adverse Event|9|||
144458936|NCT00448539|520876068|FG001|Overall Study|Adverse Event|26|||
144458937|NCT00448539|520876067|FG000|Overall Study|Lack of Efficacy|27|||
144458938|NCT00448539|520876068|FG001|Overall Study|Lack of Efficacy|40|||
144458939|NCT00448539|520876067|FG000|Overall Study|Miscellaneous|2|||
144255329|NCT00741598|520136154|FG000|Overall Study|Pregnancy|1|||
144255330|NCT00741598|520136155|FG001|Overall Study|Pregnancy|0|||
144255331|NCT00741598|520136154|FG000|Overall Study|Withdrawal by Subject|3|||
144255332|NCT00741598|520136155|FG001|Overall Study|Withdrawal by Subject|2|||
144255333|NCT00313586|520136156|FG000|Overall Study|Disease progression|14|||
144255334|NCT00313586|520136157|FG001|Overall Study|Disease progression|19|||
144255335|NCT00313586|520136158|FG002|Overall Study|Disease progression|10|||
144458940|NCT00448539|520876068|FG001|Overall Study|Miscellaneous|1|||
144458941|NCT00448539|520876067|FG000|Overall Study|Change of meds|2|||
144458942|NCT00448539|520876068|FG001|Overall Study|Change of meds|3|||
144458943|NCT00448539|520876067|FG000|Overall Study|Lost to Follow-up|1|||
144458944|NCT00448539|520876068|FG001|Overall Study|Lost to Follow-up|3|||
144458945|NCT02103439|520876070|FG000|Overall Study|Adverse Event|0|||
144458946|NCT02103439|520876071|FG001|Overall Study|Adverse Event|2|||
144458947|NCT02103439|520876070|FG000|Overall Study|Withdrawal by Subject|3|||
144255336|NCT00313586|520136159|FG003|Overall Study|Disease progression|3|||
144255337|NCT00313586|520136156|FG000|Overall Study|Adverse Event|12|||
144458948|NCT02103439|520876071|FG001|Overall Study|Withdrawal by Subject|1|||
144458949|NCT02370602|520876072|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
144458950|NCT02370602|520876073|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
144534375|NCT03248479|521159976|FG009|Overall Study|Death|7|||
144534376|NCT03248479|521159977|FG010|Overall Study|Death|3|||
144534377|NCT03248479|521159978|FG011|Overall Study|Death|1|||
144534378|NCT03248479|521159979|FG012|Overall Study|Death|1|||
144534379|NCT03248479|521159967|FG000|Overall Study|Study terminated by sponsor|12|||
144534380|NCT03248479|521159968|FG001|Overall Study|Study terminated by sponsor|15|||
144534381|NCT03248479|521159969|FG002|Overall Study|Study terminated by sponsor|0|||
144534382|NCT03248479|521159970|FG003|Overall Study|Study terminated by sponsor|5|||
144534383|NCT03248479|521159971|FG004|Overall Study|Study terminated by sponsor|0|||
144534384|NCT03248479|521159972|FG005|Overall Study|Study terminated by sponsor|0|||
144534385|NCT03248479|521159973|FG006|Overall Study|Study terminated by sponsor|0|||
144534386|NCT03248479|521159974|FG007|Overall Study|Study terminated by sponsor|1|||
144534387|NCT03248479|521159975|FG008|Overall Study|Study terminated by sponsor|1|||
144534388|NCT03248479|521159976|FG009|Overall Study|Study terminated by sponsor|0|||
144534389|NCT03248479|521159977|FG010|Overall Study|Study terminated by sponsor|5|||
144534390|NCT03248479|521159978|FG011|Overall Study|Study terminated by sponsor|4|||
144534391|NCT03248479|521159979|FG012|Overall Study|Study terminated by sponsor|0|||
144534392|NCT03248479|521159967|FG000|Overall Study|Consent withdrawn|6|||
144534393|NCT03248479|521159968|FG001|Overall Study|Consent withdrawn|3|||
144534394|NCT03248479|521159969|FG002|Overall Study|Consent withdrawn|0|||
144458951|NCT02370602|520876074|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144458952|NCT02370602|520876075|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
144458953|NCT02370602|520876076|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
144458954|NCT02370602|520876077|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
144607669|NCT03250832|521424491|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607670|NCT03250832|521424492|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607671|NCT03250832|521424493|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607672|NCT03250832|521424494|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607673|NCT03250832|521424495|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144255338|NCT00313586|520136157|FG001|Overall Study|Adverse Event|18|||
144458955|NCT03349710|520876078|FG000|Treatment Period|Death|0|||
144458956|NCT03349710|520876079|FG001|Treatment Period|Death|0|||
144458957|NCT03349710|520876080|FG002|Treatment Period|Death|1|||
144458958|NCT03349710|520876081|FG003|Treatment Period|Death|0|||
144458959|NCT03349710|520876078|FG000|Treatment Period|Disease Progression|0|||
144458960|NCT03349710|520876079|FG001|Treatment Period|Disease Progression|2|||
144458961|NCT03349710|520876080|FG002|Treatment Period|Disease Progression|0|||
144458962|NCT03349710|520876081|FG003|Treatment Period|Disease Progression|1|||
144458963|NCT03349710|520876078|FG000|Treatment Period|Study Drug Toxicity|1|||
144458964|NCT03349710|520876079|FG001|Treatment Period|Study Drug Toxicity|0|||
144458965|NCT03349710|520876080|FG002|Treatment Period|Study Drug Toxicity|1|||
144458966|NCT03349710|520876081|FG003|Treatment Period|Study Drug Toxicity|1|||
144458967|NCT03349710|520876078|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
144458968|NCT03349710|520876079|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
144458969|NCT03349710|520876080|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
144458970|NCT03349710|520876081|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
144458971|NCT03349710|520876078|FG000|Treatment Period|admin reason by sponsor|0|||
144458972|NCT03349710|520876079|FG001|Treatment Period|admin reason by sponsor|7|||
144458973|NCT03349710|520876080|FG002|Treatment Period|admin reason by sponsor|0|||
144458974|NCT03349710|520876081|FG003|Treatment Period|admin reason by sponsor|19|||
144458975|NCT03349710|520876078|FG000|Treatment Period|Other Reason|2|||
144458976|NCT03349710|520876079|FG001|Treatment Period|Other Reason|0|||
144458977|NCT03349710|520876080|FG002|Treatment Period|Other Reason|2|||
144458978|NCT03349710|520876081|FG003|Treatment Period|Other Reason|1|||
144458979|NCT03349710|520876078|FG000|Treatment Period|completed|6|||
144458980|NCT03349710|520876079|FG001|Treatment Period|completed|0|||
144458981|NCT03349710|520876080|FG002|Treatment Period|completed|18|||
144458982|NCT03349710|520876081|FG003|Treatment Period|completed|1|||
144458983|NCT03349710|520876078|FG000|Treatment Period|participant request to discontinue|0|||
144458984|NCT03349710|520876079|FG001|Treatment Period|participant request to discontinue|0|||
144458985|NCT03349710|520876080|FG002|Treatment Period|participant request to discontinue|4|||
144458986|NCT03349710|520876081|FG003|Treatment Period|participant request to discontinue|0|||
144458987|NCT03349710|520876078|FG000|Treatment Period|participant withdrew consent|1|||
144458988|NCT03349710|520876079|FG001|Treatment Period|participant withdrew consent|0|||
144458989|NCT03349710|520876080|FG002|Treatment Period|participant withdrew consent|0|||
144458990|NCT03349710|520876081|FG003|Treatment Period|participant withdrew consent|0|||
144458991|NCT00695903|520876082|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
144458992|NCT00695903|520876083|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
144458993|NCT00695903|520876082|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
144458994|NCT00695903|520876083|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
144458995|NCT00695903|520876082|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
144458996|NCT00695903|520876083|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
144458997|NCT00695903|520876082|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
144458998|NCT00695903|520876083|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
144458999|NCT00695903|520876082|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
144459000|NCT00695903|520876083|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
144459001|NCT00695903|520876082|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
144459002|NCT00695903|520876083|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
144459003|NCT00695903|520876082|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
144459004|NCT00695903|520876083|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
144459005|NCT00695903|520876082|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
144459006|NCT00695903|520876083|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
144255339|NCT00313586|520136158|FG002|Overall Study|Adverse Event|3|||
144255340|NCT00313586|520136159|FG003|Overall Study|Adverse Event|10|||
144255341|NCT00313586|520136156|FG000|Overall Study|Death|11|||
144255342|NCT00313586|520136157|FG001|Overall Study|Death|8|||
144255343|NCT00313586|520136158|FG002|Overall Study|Death|1|||
144459007|NCT00695903|520876082|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
144459008|NCT00695903|520876083|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
144459009|NCT02696317|520876084|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
144255344|NCT00313586|520136159|FG003|Overall Study|Death|7|||
144255345|NCT00313586|520136156|FG000|Overall Study|Withdrawal by Subject|13|||
144255346|NCT00313586|520136157|FG001|Overall Study|Withdrawal by Subject|6|||
144255347|NCT00313586|520136158|FG002|Overall Study|Withdrawal by Subject|6|||
144255348|NCT00313586|520136159|FG003|Overall Study|Withdrawal by Subject|2|||
144255349|NCT00313586|520136156|FG000|Overall Study|Alternative therapy|3|||
144255350|NCT00313586|520136157|FG001|Overall Study|Alternative therapy|6|||
144255351|NCT00313586|520136158|FG002|Overall Study|Alternative therapy|2|||
144255352|NCT00313586|520136159|FG003|Overall Study|Alternative therapy|0|||
144255353|NCT00313586|520136156|FG000|Overall Study|Other complicating disease|2|||
144255354|NCT00313586|520136157|FG001|Overall Study|Other complicating disease|2|||
144255355|NCT00313586|520136158|FG002|Overall Study|Other complicating disease|0|||
144255356|NCT00313586|520136159|FG003|Overall Study|Other complicating disease|0|||
144255357|NCT00313586|520136156|FG000|Overall Study|Did not achieve HI-major/better response|10|||
144255358|NCT00313586|520136157|FG001|Overall Study|Did not achieve HI-major/better response|7|||
144255359|NCT00313586|520136158|FG002|Overall Study|Did not achieve HI-major/better response|2|||
144255360|NCT00313586|520136159|FG003|Overall Study|Did not achieve HI-major/better response|1|||
144255361|NCT00313586|520136156|FG000|Overall Study|Physician Decision|2|||
144255362|NCT00313586|520136157|FG001|Overall Study|Physician Decision|1|||
144255363|NCT00313586|520136158|FG002|Overall Study|Physician Decision|0|||
144255364|NCT00313586|520136159|FG003|Overall Study|Physician Decision|0|||
144255365|NCT00313586|520136156|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
144255366|NCT00313586|520136157|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
144255367|NCT00313586|520136158|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
144255368|NCT00313586|520136159|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
144255369|NCT00313586|520136156|FG000|Overall Study|Lost insurance|0|||
144255370|NCT00313586|520136157|FG001|Overall Study|Lost insurance|1|||
144255371|NCT00313586|520136158|FG002|Overall Study|Lost insurance|0|||
144255372|NCT00313586|520136159|FG003|Overall Study|Lost insurance|0|||
144255373|NCT00313586|520136156|FG000|Overall Study|Moved|0|||
144255374|NCT00313586|520136157|FG001|Overall Study|Moved|1|||
144255375|NCT00313586|520136158|FG002|Overall Study|Moved|0|||
144255376|NCT00313586|520136159|FG003|Overall Study|Moved|0|||
144255377|NCT00313586|520136156|FG000|Overall Study|Death before starting treatment|1|||
144255378|NCT00313586|520136157|FG001|Overall Study|Death before starting treatment|0|||
144255379|NCT00313586|520136158|FG002|Overall Study|Death before starting treatment|0|||
144255380|NCT00313586|520136159|FG003|Overall Study|Death before starting treatment|0|||
144255381|NCT01909973|520136164|FG000|Overall Study|Lost to Follow-up|1|||
144255382|NCT01909973|520136165|FG001|Overall Study|Lost to Follow-up|0|||
144255383|NCT00809094|520136166|FG000|Overall Study|Lost to Follow-up|0|||
144255384|NCT00809094|520136167|FG001|Overall Study|Lost to Follow-up|1|||
144255385|NCT01690299|520136169|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
144255386|NCT01690299|520136170|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
144255387|NCT01690299|520136171|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
144255388|NCT01690299|520136172|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
144255389|NCT01690299|520136173|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
144255390|NCT01690299|520136174|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
144255391|NCT01690299|520136169|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
144255392|NCT01690299|520136170|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144255393|NCT01690299|520136171|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144255394|NCT01690299|520136172|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144255395|NCT01690299|520136173|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144255396|NCT01690299|520136174|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144255397|NCT01690299|520136169|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
144255398|NCT01690299|520136170|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
144255399|NCT01690299|520136171|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144255400|NCT01690299|520136172|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144459010|NCT02696317|520876085|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
144459011|NCT02696317|520876084|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
144459012|NCT02696317|520876085|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
144459013|NCT01343368|520876086|FG000|Overall Study|Death|1|||
144459014|NCT01343368|520876087|FG001|Overall Study|Death|0|||
144459015|NCT01343368|520876086|FG000|Overall Study|Lost to Follow-up|1|||
144459016|NCT01343368|520876087|FG001|Overall Study|Lost to Follow-up|0|||
144459017|NCT01296568|520876090|FG000|Continued Access Phase|Lost to Follow-up|1|||
144459018|NCT01296568|520876090|FG000|Continued Access Phase|Withdrawal by Subject|1|||
144459019|NCT01296568|520876090|FG000|Continued Access Phase|Disease Progression|1|||
144255401|NCT01690299|520136173|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144255402|NCT01690299|520136174|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144255403|NCT01690299|520136169|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
144255404|NCT01690299|520136170|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
144255405|NCT01690299|520136171|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
144459020|NCT00237744|520876094|FG000|Overall Study|Withdrawal by Subject|3|||
144459021|NCT00237744|520876095|FG001|Overall Study|Withdrawal by Subject|1|||
144725836|NCT02207231|521852630|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
144255406|NCT01690299|520136172|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
144534395|NCT03248479|521159970|FG003|Overall Study|Consent withdrawn|9|||
144534396|NCT03248479|521159971|FG004|Overall Study|Consent withdrawn|1|||
144534397|NCT03248479|521159972|FG005|Overall Study|Consent withdrawn|0|||
144534398|NCT03248479|521159973|FG006|Overall Study|Consent withdrawn|0|||
144534399|NCT03248479|521159974|FG007|Overall Study|Consent withdrawn|1|||
144534400|NCT03248479|521159975|FG008|Overall Study|Consent withdrawn|0|||
144534401|NCT03248479|521159976|FG009|Overall Study|Consent withdrawn|3|||
144534402|NCT03248479|521159977|FG010|Overall Study|Consent withdrawn|1|||
144534403|NCT03248479|521159978|FG011|Overall Study|Consent withdrawn|0|||
144534404|NCT03248479|521159979|FG012|Overall Study|Consent withdrawn|1|||
144534405|NCT03248479|521159967|FG000|Overall Study|Lost to Follow-up|2|||
144534406|NCT03248479|521159968|FG001|Overall Study|Lost to Follow-up|1|||
144534407|NCT03248479|521159969|FG002|Overall Study|Lost to Follow-up|0|||
144534408|NCT03248479|521159970|FG003|Overall Study|Lost to Follow-up|0|||
144534409|NCT03248479|521159971|FG004|Overall Study|Lost to Follow-up|0|||
144534410|NCT03248479|521159972|FG005|Overall Study|Lost to Follow-up|0|||
144534411|NCT03248479|521159973|FG006|Overall Study|Lost to Follow-up|0|||
144534412|NCT03248479|521159974|FG007|Overall Study|Lost to Follow-up|0|||
144534413|NCT03248479|521159975|FG008|Overall Study|Lost to Follow-up|0|||
144534414|NCT03248479|521159976|FG009|Overall Study|Lost to Follow-up|0|||
144534415|NCT03248479|521159977|FG010|Overall Study|Lost to Follow-up|0|||
144534416|NCT03248479|521159978|FG011|Overall Study|Lost to Follow-up|0|||
144534417|NCT03248479|521159979|FG012|Overall Study|Lost to Follow-up|1|||
144534418|NCT03248479|521159967|FG000|Overall Study|Not reported|0|||
144534419|NCT03248479|521159968|FG001|Overall Study|Not reported|0|||
144534420|NCT03248479|521159969|FG002|Overall Study|Not reported|0|||
144534421|NCT03248479|521159970|FG003|Overall Study|Not reported|1|||
144534422|NCT03248479|521159971|FG004|Overall Study|Not reported|1|||
144534423|NCT03248479|521159972|FG005|Overall Study|Not reported|0|||
144534424|NCT03248479|521159973|FG006|Overall Study|Not reported|0|||
144534425|NCT03248479|521159974|FG007|Overall Study|Not reported|1|||
144534426|NCT03248479|521159975|FG008|Overall Study|Not reported|1|||
144534427|NCT03248479|521159976|FG009|Overall Study|Not reported|0|||
144534428|NCT03248479|521159977|FG010|Overall Study|Not reported|0|||
144534429|NCT03248479|521159978|FG011|Overall Study|Not reported|0|||
144534430|NCT03248479|521159979|FG012|Overall Study|Not reported|0|||
144534431|NCT03547271|521159986|FG000|Overall Study|Adverse Event|1|||
144534432|NCT03547271|521159987|FG001|Overall Study|Adverse Event|1|||
144534433|NCT03547271|521159988|FG002|Overall Study|Adverse Event|0|||
144534434|NCT03547271|521159989|FG003|Overall Study|Adverse Event|0|||
144534435|NCT03547271|521159986|FG000|Overall Study|Protocol deviation|5|||
144534436|NCT03547271|521159987|FG001|Overall Study|Protocol deviation|7|||
144196820|NCT02923674|519917100|FG002|Overall Study|Problem with intervention|1|||
144196821|NCT02923674|519917098|FG000|Overall Study|Adverse Event|3|||
144196822|NCT02923674|519917099|FG001|Overall Study|Adverse Event|1|||
144196823|NCT02923674|519917100|FG002|Overall Study|Adverse Event|1|||
144196824|NCT02923674|519917098|FG000|Overall Study|Withdrawal by Subject|2|||
144196825|NCT02923674|519917099|FG001|Overall Study|Withdrawal by Subject|2|||
144196826|NCT02923674|519917100|FG002|Overall Study|Withdrawal by Subject|2|||
144196827|NCT00846521|519917103|FG000|Overall Study|Withdrawal by Subject|5|||
144196828|NCT00846521|519917103|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
144196829|NCT00846521|519917103|FG000|Overall Study|Protocol Violation|1|||
144196830|NCT02408068|519917104|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
144196831|NCT02408068|519917105|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
144196832|NCT02408068|519917106|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
144196833|NCT02408068|519917107|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
144196834|NCT02408068|519917108|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
144196835|NCT02408068|519917109|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
144196836|NCT00003875|519917113|FG000|Overall Study|Screen Failed|1|||
144196837|NCT00886288|519917114|FG000|Overall Study|no respect of the 12 weeks period|657|||
144196838|NCT00886288|519917115|FG001|Overall Study|no respect of the 12 weeks period|227|||
144196839|NCT00886288|519917114|FG000|Overall Study|Lost to Follow-up|86|||
144196840|NCT00886288|519917115|FG001|Overall Study|Lost to Follow-up|0|||
144196841|NCT01194973|519917124|FG000|Screening Period|Screen Failure|3|||
144196842|NCT01194973|519917124|FG000|26 Week Treatment Period|Adverse Event|1|||
144196843|NCT01194973|519917124|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
144196844|NCT01194973|519917124|FG000|26 Week Treatment Period|Pregnancy|1|||
144196845|NCT01640873|519917125|FG000|Overall Study|Protocol Violation|2|||
144196846|NCT01640873|519917126|FG001|Overall Study|Protocol Violation|1|||
144196847|NCT01875471|519917129|FG000|Overall Study|Adverse Event|0|||
144196848|NCT01875471|519917130|FG001|Overall Study|Adverse Event|1|||
144534437|NCT03547271|521159988|FG002|Overall Study|Protocol deviation|3|||
144534438|NCT03547271|521159989|FG003|Overall Study|Protocol deviation|0|||
144534439|NCT03547271|521159986|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
144196849|NCT01875471|519917129|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
144196850|NCT01875471|519917130|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
144534440|NCT03547271|521159987|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
144725837|NCT02207231|521852631|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
144725838|NCT02207231|521852632|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
144255407|NCT01690299|520136173|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
144255408|NCT01690299|520136174|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
144255409|NCT01690299|520136169|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
144255410|NCT01690299|520136170|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
144255411|NCT01690299|520136171|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
144255412|NCT01690299|520136172|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
144255413|NCT01690299|520136173|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
144255414|NCT01690299|520136174|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
144255415|NCT01690299|520136169|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
144255416|NCT01690299|520136170|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
144255417|NCT01690299|520136171|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
144255418|NCT01690299|520136172|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
144459022|NCT00237744|520876096|FG002|Overall Study|Withdrawal by Subject|0|||
144459023|NCT04447404|520876099|FG000|Overall Study|Death|2|||
144459024|NCT04447404|520876100|FG001|Overall Study|Death|0|||
144459025|NCT00321854|520876101|FG000|Overall Study|Adverse Event|41|||
144459026|NCT00321854|520876102|FG001|Overall Study|Adverse Event|43|||
144459027|NCT00321854|520876101|FG000|Overall Study|Lack of Efficacy|9|||
144459028|NCT00321854|520876102|FG001|Overall Study|Lack of Efficacy|14|||
144459029|NCT00321854|520876101|FG000|Overall Study|Protocol Violation|6|||
144459030|NCT00321854|520876102|FG001|Overall Study|Protocol Violation|5|||
144459031|NCT00321854|520876101|FG000|Overall Study|Lost to Follow-up|0|||
144459032|NCT00321854|520876102|FG001|Overall Study|Lost to Follow-up|2|||
144459033|NCT00321854|520876101|FG000|Overall Study|Withdrawal by Subject|6|||
144459034|NCT00321854|520876102|FG001|Overall Study|Withdrawal by Subject|17|||
144459035|NCT00321854|520876101|FG000|Overall Study|Other|1|||
144459036|NCT00321854|520876102|FG001|Overall Study|Other|1|||
144459037|NCT04723576|520876103|FG000|Overall Study|Withdrawal by Subject|2133|||
144459038|NCT04723576|520876104|FG001|Overall Study|Withdrawal by Subject|3234|||
144459039|NCT00413153|520876105|FG000|Overall Study|Withdrawal by Subject|1|||
144459040|NCT00413153|520876106|FG001|Overall Study|Withdrawal by Subject|1|||
144459041|NCT00413153|520876105|FG000|Overall Study|Adverse Event|1|||
144459042|NCT00413153|520876106|FG001|Overall Study|Adverse Event|0|||
144459043|NCT01064739|520876107|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
144459044|NCT00454051|520876110|FG000|Overall Study|Adverse Event|1|||
144459045|NCT00454051|520876111|FG001|Overall Study|Adverse Event|2|||
144459046|NCT00454051|520876110|FG000|Overall Study|Withdrawal by Subject|1|||
144459047|NCT00454051|520876111|FG001|Overall Study|Withdrawal by Subject|0|||
144459048|NCT00454051|520876110|FG000|Overall Study|Protocol Violation|1|||
144459049|NCT00454051|520876111|FG001|Overall Study|Protocol Violation|1|||
144534441|NCT03547271|521159988|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
144534442|NCT03547271|521159989|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
144534443|NCT03547271|521159986|FG000|Overall Study|Lost to Follow-up|3|||
144534444|NCT03547271|521159987|FG001|Overall Study|Lost to Follow-up|3|||
144534445|NCT03547271|521159988|FG002|Overall Study|Lost to Follow-up|1|||
144534446|NCT03547271|521159989|FG003|Overall Study|Lost to Follow-up|0|||
144534447|NCT04795245|521159998|FG000|Overall Study|Unkown reason|7|||
144534448|NCT04795245|521159998|FG000|Overall Study|Death|17|||
144534449|NCT04795245|521159998|FG000|Overall Study|Other than listed|19|||
144534450|NCT04795245|521159998|FG000|Overall Study|Adverse Event|143|||
144534451|NCT04795245|521159998|FG000|Overall Study|Progressive disease|512|||
144534452|NCT04795245|521159998|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
144534453|NCT03904576|521159999|FG000|Washout Period|Protocol Violation|1|||
144534454|NCT03904576|521160000|FG001|Washout Period|Protocol Violation|1|||
144534455|NCT03418740|521160001|FG000|Overall Study|Lost to Follow-up|13|||
144534456|NCT03418740|521160001|FG000|Overall Study|Scheduling Issues|7|||
144534457|NCT03418740|521160001|FG000|Overall Study|Withdrawal by Subject|2|||
144534458|NCT03418740|521160001|FG000|Overall Study|Unable to Continue Consent|1|||
144255419|NCT01690299|520136173|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
144255420|NCT01690299|520136174|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
144255421|NCT01690299|520136169|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
144459050|NCT04258020|520876112|FG000|Overall Study|Withdrawal by Subject|1|||
144459051|NCT04258020|520876113|FG001|Overall Study|Withdrawal by Subject|0|||
144459052|NCT02097472|520876114|FG000|Received Vaccination 2|Adverse Event|0|||
144534459|NCT05215054|521160002|FG000|Overall Study|Lost to Follow-up|1|||
144534460|NCT05215054|521160003|FG001|Overall Study|Lost to Follow-up|1|||
144534461|NCT05215054|521160002|FG000|Overall Study|Protocol Violation|1|||
144534462|NCT05215054|521160003|FG001|Overall Study|Protocol Violation|1|||
144534463|NCT05215054|521160002|FG000|Overall Study|Withdrawal by Subject|4|||
144725839|NCT02207231|521852633|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
144459053|NCT02097472|520876115|FG001|Received Vaccination 2|Adverse Event|0|||
144459054|NCT02097472|520876116|FG002|Received Vaccination 2|Adverse Event|0|||
144459055|NCT02097472|520876117|FG003|Received Vaccination 2|Adverse Event|0|||
144607674|NCT03250832|521424496|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
144607675|NCT03250832|521424497|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607676|NCT03250832|521424498|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607677|NCT03250832|521424499|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607678|NCT03250832|521424500|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
144607679|NCT03250832|521424489|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607680|NCT03250832|521424490|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607681|NCT03250832|521424491|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607682|NCT03250832|521424492|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607683|NCT03250832|521424493|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607684|NCT03250832|521424494|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607685|NCT03250832|521424495|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607686|NCT03250832|521424496|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
144607687|NCT03250832|521424497|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607688|NCT03250832|521424498|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
144459056|NCT02097472|520876118|FG004|Received Vaccination 2|Adverse Event|0|||
144459057|NCT02097472|520876119|FG005|Received Vaccination 2|Adverse Event|0|||
144459058|NCT02097472|520876120|FG006|Received Vaccination 2|Adverse Event|1|||
144459059|NCT02097472|520876121|FG007|Received Vaccination 2|Adverse Event|0|||
144459060|NCT03966157|520876122|FG000|Overall Study|Physician Decision|1|||
144459061|NCT03966157|520876123|FG001|Overall Study|Physician Decision|0|||
144459062|NCT03305016|520876124|FG000|Overall Study|Withdrawal by Subject|2|||
144459063|NCT04004611|520876125|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459064|NCT04004611|520876126|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459065|NCT04004611|520876127|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459066|NCT04004611|520876128|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459067|NCT04004611|520876129|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459068|NCT04004611|520876130|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459069|NCT04004611|520876131|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459070|NCT04004611|520876132|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
144459071|NCT04004611|520876133|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
144459072|NCT04004611|520876125|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
144459073|NCT04004611|520876126|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
144459074|NCT04004611|520876127|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
144459075|NCT04004611|520876128|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
144459076|NCT04004611|520876129|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
144459077|NCT04004611|520876130|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
144459078|NCT04004611|520876131|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
144607689|NCT03250832|521424499|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607690|NCT03250832|521424500|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
144607691|NCT03250832|521424489|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607692|NCT03250832|521424490|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607693|NCT03250832|521424491|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607694|NCT03250832|521424492|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607695|NCT03250832|521424493|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607696|NCT03250832|521424494|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607697|NCT03250832|521424495|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607698|NCT03250832|521424496|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607699|NCT03250832|521424497|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
144607700|NCT03250832|521424498|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
144607701|NCT03250832|521424499|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607702|NCT03250832|521424500|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
144607703|NCT03250832|521424489|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607704|NCT03250832|521424490|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607705|NCT03250832|521424491|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607706|NCT03250832|521424492|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607707|NCT03250832|521424493|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607708|NCT03250832|521424494|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607709|NCT03250832|521424495|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607710|NCT03250832|521424496|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607711|NCT03250832|521424497|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
144607712|NCT03250832|521424498|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
144607713|NCT03250832|521424499|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144607714|NCT03250832|521424500|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
144459079|NCT04004611|520876132|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
144459080|NCT04004611|520876133|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
144459081|NCT04004611|520876125|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459082|NCT04004611|520876126|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144255422|NCT01690299|520136170|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
144459083|NCT04004611|520876127|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459084|NCT04004611|520876128|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459085|NCT04004611|520876129|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
144459086|NCT04004611|520876130|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459087|NCT04004611|520876131|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459088|NCT04004611|520876132|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459089|NCT04004611|520876133|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
144459090|NCT04004611|520876125|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
144459091|NCT04004611|520876126|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
144459092|NCT04004611|520876127|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
144459093|NCT04004611|520876128|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
144459094|NCT04004611|520876129|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
144459095|NCT04004611|520876130|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
144459096|NCT04004611|520876131|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
144459097|NCT04004611|520876132|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
144459098|NCT04004611|520876133|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
144459099|NCT04004611|520876125|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
144459100|NCT04004611|520876126|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459101|NCT04004611|520876127|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
144459102|NCT04004611|520876128|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459103|NCT04004611|520876129|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459104|NCT04004611|520876130|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459105|NCT04004611|520876131|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459106|NCT04004611|520876132|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459107|NCT04004611|520876133|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
144459108|NCT04004611|520876125|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459109|NCT04004611|520876126|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
144459110|NCT04004611|520876127|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459111|NCT04004611|520876128|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459112|NCT04004611|520876129|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459113|NCT04004611|520876130|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459114|NCT04004611|520876131|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459115|NCT04004611|520876132|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459116|NCT04004611|520876133|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
144459117|NCT03834779|520876136|FG000|Overall Study|Death|1|||
144459118|NCT03834779|520876137|FG001|Overall Study|Death|2|||
144459119|NCT03834779|520876136|FG000|Overall Study|Lost to Follow-up|6|||
144459120|NCT03834779|520876137|FG001|Overall Study|Lost to Follow-up|4|||
144459121|NCT01059565|520876142|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
144459122|NCT01059565|520876143|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
144534464|NCT05215054|521160003|FG001|Overall Study|Withdrawal by Subject|4|||
144534465|NCT04780581|521160005|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
144534466|NCT04780581|521160006|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
144534467|NCT04780581|521160005|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
144534468|NCT04780581|521160006|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
144534469|NCT05132400|521160888|FG000|Overall Study|Withdrawal by Subject|14|||
144534470|NCT05132400|521160889|FG001|Overall Study|Withdrawal by Subject|8|||
144534471|NCT05132400|521160888|FG000|Overall Study|Lost to Follow-up|132|||
144534472|NCT05132400|521160889|FG001|Overall Study|Lost to Follow-up|121|||
144534473|NCT03635567|521160891|FG000|Overall Study|Lost to Follow-up|4|||
144534474|NCT03635567|521160892|FG001|Overall Study|Lost to Follow-up|1|||
144534475|NCT03635567|521160891|FG000|Overall Study|Withdrawal by Subject|11|||
144534476|NCT03635567|521160892|FG001|Overall Study|Withdrawal by Subject|16|||
144534477|NCT03635567|521160891|FG000|Overall Study|Sponsor Decision|99|||
144534478|NCT03635567|521160892|FG001|Overall Study|Sponsor Decision|57|||
144534479|NCT03635567|521160891|FG000|Overall Study|Death|194|||
144534480|NCT03635567|521160892|FG001|Overall Study|Death|235|||
144534481|NCT02076009|521160893|FG000|Overall Study|Death|172|||
144534482|NCT02076009|521160894|FG001|Overall Study|Death|153|||
144534483|NCT02076009|521160893|FG000|Overall Study|Withdrawal by Subject|16|||
144534484|NCT02076009|521160894|FG001|Overall Study|Withdrawal by Subject|12|||
144534485|NCT02076009|521160893|FG000|Overall Study|Lost to Follow-up|4|||
144534486|NCT02076009|521160894|FG001|Overall Study|Lost to Follow-up|2|||
144534487|NCT02076009|521160893|FG000|Overall Study|Progressive Disease|1|||
144534488|NCT02076009|521160894|FG001|Overall Study|Progressive Disease|0|||
144534489|NCT02076009|521160893|FG000|Overall Study|Physician Decision|0|||
144534490|NCT02076009|521160894|FG001|Overall Study|Physician Decision|1|||
144534491|NCT02076009|521160893|FG000|Overall Study|End of data collection|90|||
144534492|NCT02076009|521160894|FG001|Overall Study|End of data collection|118|||
144459123|NCT01059565|520876142|FG000|24-Week Randomized Phase|Adverse Event|5|||
144459124|NCT01059565|520876143|FG001|24-Week Randomized Phase|Adverse Event|0|||
144459125|NCT01059565|520876142|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
144459126|NCT01059565|520876143|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
144459127|NCT01059565|520876142|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
144459128|NCT01059565|520876143|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
144459129|NCT01059565|520876142|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
144459130|NCT01059565|520876143|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
144459131|NCT01059565|520876142|FG000|24-Week Open-Label Phase|Adverse Event|2|||
144459132|NCT01059565|520876143|FG001|24-Week Open-Label Phase|Adverse Event|0|||
144459133|NCT01059565|520876142|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
144459134|NCT01059565|520876143|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
144459135|NCT01059565|520876142|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
144459136|NCT01059565|520876143|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
144459137|NCT01059565|520876142|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
144459138|NCT01059565|520876143|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
144459139|NCT01059565|520876142|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
144459140|NCT01059565|520876143|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
144459141|NCT01059565|520876142|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
144459142|NCT01059565|520876143|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
144459143|NCT03927950|520876144|FG000|Overall Study|Adverse Event|9|||
144459144|NCT03263429|520876145|FG000|Overall Study|Withdrawal by Subject|0|||
144459145|NCT03263429|520876146|FG001|Overall Study|Withdrawal by Subject|1|||
144459146|NCT03263429|520876147|FG002|Overall Study|Withdrawal by Subject|0|||
144459147|NCT03263429|520876145|FG000|Overall Study|Follow-Up Period Completed|0|||
144459148|NCT03263429|520876146|FG001|Overall Study|Follow-Up Period Completed|2|||
144459149|NCT03263429|520876147|FG002|Overall Study|Follow-Up Period Completed|0|||
144459150|NCT03263429|520876145|FG000|Overall Study|Death|3|||
144459151|NCT03263429|520876146|FG001|Overall Study|Death|5|||
144459152|NCT03263429|520876147|FG002|Overall Study|Death|16|||
144459153|NCT03263429|520876145|FG000|Overall Study|Participant unable to return|0|||
144459154|NCT03263429|520876146|FG001|Overall Study|Participant unable to return|0|||
144459155|NCT03263429|520876147|FG002|Overall Study|Participant unable to return|1|||
144459156|NCT03263429|520876145|FG000|Overall Study|Study Closed|0|||
144459157|NCT03263429|520876146|FG001|Overall Study|Study Closed|0|||
144459158|NCT03263429|520876147|FG002|Overall Study|Study Closed|1|||
144459159|NCT00121238|520876148|FG000|Overall Study|disease progression before intervention|1|||
144459160|NCT00121238|520876148|FG000|Overall Study|Protocol Violation|2|||
144459161|NCT01540851|520876149|FG000|Overall Study|Lost to Follow-up|14|||
144459162|NCT01540851|520876150|FG001|Overall Study|Lost to Follow-up|15|||
144459163|NCT01540851|520876149|FG000|Overall Study|Withdrawal by Subject|7|||
144459164|NCT01540851|520876150|FG001|Overall Study|Withdrawal by Subject|3|||
144459165|NCT00325468|520876151|FG000|Overall Study|Adverse Event|1|||
144255423|NCT01690299|520136171|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
144459166|NCT00325468|520876152|FG001|Overall Study|Adverse Event|1|||
144534493|NCT00942734|521160900|FG000|Overall Study|Adverse Event|2|||
144534494|NCT00942734|521160900|FG000|Overall Study|Protocol Violation|3|||
144534495|NCT00942734|521160900|FG000|Overall Study|Disease Progression|2|||
144534496|NCT00942734|521160900|FG000|Overall Study|Physician Decision|1|||
144534497|NCT06655818|521160901|FG000|Overall Study|Withdrawal by Subject|1|||
144534498|NCT00319046|521160902|FG000|Overall Study|withdrawal of subject's consent|7|||
144534499|NCT00319046|521160902|FG000|Overall Study|administrative reason|1|||
144534500|NCT00412607|521160911|FG000|Overall Study|Withdrawal by Subject|9|||
144534501|NCT00412607|521160911|FG000|Overall Study|Lost to Follow-up|19|||
144534502|NCT00412607|521160911|FG000|Overall Study|Death|61|||
144534503|NCT00412607|521160911|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
144534504|NCT03522298|521160920|FG000|Overall Study|Adverse Event|1|||
144534505|NCT03522298|521160921|FG001|Overall Study|Adverse Event|0|||
144534506|NCT03522298|521160922|FG002|Overall Study|Adverse Event|0|||
144534507|NCT03522298|521160923|FG003|Overall Study|Adverse Event|1|||
144534508|NCT03522298|521160920|FG000|Overall Study|Death|2|||
144534509|NCT03522298|521160921|FG001|Overall Study|Death|4|||
144534510|NCT03522298|521160922|FG002|Overall Study|Death|8|||
144534511|NCT03522298|521160923|FG003|Overall Study|Death|8|||
144459167|NCT00325468|520876153|FG002|Overall Study|Adverse Event|0|||
144459168|NCT00325468|520876154|FG003|Overall Study|Adverse Event|5|||
144459169|NCT00325468|520876155|FG004|Overall Study|Adverse Event|1|||
144459170|NCT00325468|520876151|FG000|Overall Study|Death|2|||
144459171|NCT00325468|520876152|FG001|Overall Study|Death|0|||
144459172|NCT00325468|520876153|FG002|Overall Study|Death|2|||
144534512|NCT03522298|521160920|FG000|Overall Study|Patient decision|0|||
144534513|NCT03522298|521160921|FG001|Overall Study|Patient decision|2|||
144459173|NCT00325468|520876154|FG003|Overall Study|Death|4|||
144534514|NCT03522298|521160922|FG002|Overall Study|Patient decision|2|||
144534515|NCT03522298|521160923|FG003|Overall Study|Patient decision|2|||
144534516|NCT05718687|521160924|FG000|Overall Study|Withdrawal by Subject|3|||
144607715|NCT03250832|521424489|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607716|NCT03250832|521424490|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607717|NCT03250832|521424491|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607718|NCT03250832|521424492|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607719|NCT03250832|521424493|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607720|NCT03250832|521424494|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607721|NCT03250832|521424495|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607722|NCT03250832|521424496|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607723|NCT03250832|521424497|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
144607724|NCT03250832|521424498|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
144607725|NCT03250832|521424499|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607726|NCT03250832|521424500|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
144607727|NCT03250832|521424489|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607728|NCT03250832|521424490|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607729|NCT03250832|521424491|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607730|NCT03250832|521424492|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607731|NCT03250832|521424493|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607732|NCT03250832|521424494|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607733|NCT03250832|521424495|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607734|NCT03250832|521424496|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607735|NCT03250832|521424497|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144196851|NCT01321008|519917131|FG000|Overall Study|Early Study Termination|1|||
144196852|NCT03978091|519917132|FG000|Overall Study|Lost to Follow-up|0|||
144196853|NCT03978091|519917133|FG001|Overall Study|Lost to Follow-up|0|||
144196854|NCT03978091|519917134|FG002|Overall Study|Lost to Follow-up|1|||
144196855|NCT03978091|519917135|FG003|Overall Study|Lost to Follow-up|0|||
144459174|NCT00325468|520876155|FG004|Overall Study|Death|0|||
144459175|NCT00325468|520876151|FG000|Overall Study|Lost to Follow-up|0|||
144459176|NCT00325468|520876152|FG001|Overall Study|Lost to Follow-up|0|||
144459177|NCT00325468|520876153|FG002|Overall Study|Lost to Follow-up|1|||
144459178|NCT00325468|520876154|FG003|Overall Study|Lost to Follow-up|2|||
144459179|NCT00325468|520876155|FG004|Overall Study|Lost to Follow-up|2|||
144459180|NCT00325468|520876151|FG000|Overall Study|Physician Decision|1|||
144459181|NCT00325468|520876152|FG001|Overall Study|Physician Decision|1|||
144459182|NCT00325468|520876153|FG002|Overall Study|Physician Decision|0|||
144459183|NCT00325468|520876154|FG003|Overall Study|Physician Decision|1|||
144459184|NCT00325468|520876155|FG004|Overall Study|Physician Decision|0|||
144459185|NCT00325468|520876151|FG000|Overall Study|Withdrawal by Subject|3|||
144459186|NCT00325468|520876152|FG001|Overall Study|Withdrawal by Subject|1|||
144459187|NCT00325468|520876153|FG002|Overall Study|Withdrawal by Subject|0|||
144459188|NCT00325468|520876154|FG003|Overall Study|Withdrawal by Subject|14|||
144459189|NCT00325468|520876155|FG004|Overall Study|Withdrawal by Subject|4|||
144196856|NCT03978091|519917136|FG004|Overall Study|Lost to Follow-up|0|||
144196857|NCT03978091|519917137|FG005|Overall Study|Lost to Follow-up|0|||
144196858|NCT03978091|519917132|FG000|Overall Study|Withdrawal by Subject|0|||
144196859|NCT03978091|519917133|FG001|Overall Study|Withdrawal by Subject|0|||
144196860|NCT03978091|519917134|FG002|Overall Study|Withdrawal by Subject|0|||
144196861|NCT03978091|519917135|FG003|Overall Study|Withdrawal by Subject|1|||
144196862|NCT03978091|519917136|FG004|Overall Study|Withdrawal by Subject|1|||
144196863|NCT03978091|519917137|FG005|Overall Study|Withdrawal by Subject|0|||
144196864|NCT01843348|519917138|FG000|Overall Study|Withdrawal by Subject|4|||
144196865|NCT01843348|519917139|FG001|Overall Study|Withdrawal by Subject|16|||
144196866|NCT01843348|519917140|FG002|Overall Study|Withdrawal by Subject|18|||
144196867|NCT01843348|519917138|FG000|Overall Study|Lost to Follow-up|5|||
144196868|NCT01843348|519917139|FG001|Overall Study|Lost to Follow-up|4|||
144196869|NCT01843348|519917140|FG002|Overall Study|Lost to Follow-up|2|||
144196870|NCT01843348|519917138|FG000|Overall Study|Death|5|||
144196871|NCT01843348|519917139|FG001|Overall Study|Death|3|||
144196872|NCT01843348|519917140|FG002|Overall Study|Death|4|||
144196873|NCT01843348|519917138|FG000|Overall Study|Graft loss/retransplantation|5|||
144196874|NCT01843348|519917139|FG001|Overall Study|Graft loss/retransplantation|8|||
144196875|NCT01843348|519917140|FG002|Overall Study|Graft loss/retransplantation|11|||
144196876|NCT01843348|519917138|FG000|Overall Study|Various reasons|4|||
144196877|NCT01843348|519917139|FG001|Overall Study|Various reasons|9|||
144196878|NCT01843348|519917140|FG002|Overall Study|Various reasons|6|||
144196879|NCT00679913|519917141|FG000|Overall Study|Protocol Violation|18|||
144196880|NCT00679913|519917142|FG001|Overall Study|Protocol Violation|13|||
144196881|NCT00062751|519917143|FG000|Overall Study|Disease progression|24|||
144196882|NCT00062751|519917144|FG001|Overall Study|Disease progression|17|||
144196883|NCT00062751|519917145|FG002|Overall Study|Disease progression|24|||
144196884|NCT00062751|519917146|FG003|Overall Study|Disease progression|2|||
144196885|NCT00062751|519917147|FG004|Overall Study|Disease progression|2|||
144725840|NCT02207231|521852630|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
144725841|NCT02207231|521852631|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
144725842|NCT02207231|521852632|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
144725843|NCT02207231|521852633|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
144725844|NCT02207231|521852630|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
144725845|NCT02207231|521852631|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
144725846|NCT02207231|521852632|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
144725847|NCT02207231|521852633|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
144725848|NCT02207231|521852630|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
144725849|NCT02207231|521852631|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
144725850|NCT02207231|521852632|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
144459190|NCT00325468|520876151|FG000|Overall Study|site closure etc|4|||
144459191|NCT00325468|520876152|FG001|Overall Study|site closure etc|2|||
144459192|NCT00325468|520876153|FG002|Overall Study|site closure etc|1|||
144459193|NCT00325468|520876154|FG003|Overall Study|site closure etc|8|||
144459194|NCT00325468|520876155|FG004|Overall Study|site closure etc|1|||
144459195|NCT03579563|520876159|FG000|Overall Study|Lost to Follow-up|0|||
144459196|NCT03579563|520876160|FG001|Overall Study|Lost to Follow-up|0|||
144459197|NCT03579563|520876161|FG002|Overall Study|Lost to Follow-up|0|||
144459198|NCT03579563|520876162|FG003|Overall Study|Lost to Follow-up|0|||
144459199|NCT03579563|520876163|FG004|Overall Study|Lost to Follow-up|1|||
144459200|NCT03579563|520876164|FG005|Overall Study|Lost to Follow-up|0|||
144459201|NCT03579563|520876159|FG000|Overall Study|Lack of Efficacy|1|||
144459202|NCT03579563|520876160|FG001|Overall Study|Lack of Efficacy|1|||
144459203|NCT03579563|520876161|FG002|Overall Study|Lack of Efficacy|4|||
144459204|NCT03579563|520876162|FG003|Overall Study|Lack of Efficacy|1|||
144459205|NCT03579563|520876163|FG004|Overall Study|Lack of Efficacy|2|||
144459206|NCT03579563|520876164|FG005|Overall Study|Lack of Efficacy|3|||
144459207|NCT03579563|520876159|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
144459208|NCT03579563|520876160|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
144534517|NCT01499368|521160929|FG000|Overall Study|Did not meet I/E criteria|8|||
144534518|NCT01499368|521160930|FG001|Overall Study|Did not meet I/E criteria|4|||
144534519|NCT01499368|521160931|FG002|Overall Study|Did not meet I/E criteria|4|||
144534520|NCT01499368|521160929|FG000|Overall Study|Prohibited Concomitant medication|1|||
144534521|NCT01499368|521160930|FG001|Overall Study|Prohibited Concomitant medication|1|||
144534522|NCT01499368|521160931|FG002|Overall Study|Prohibited Concomitant medication|0|||
144534523|NCT01499368|521160929|FG000|Overall Study|Withdrawal by Subject|11|||
144534524|NCT01499368|521160930|FG001|Overall Study|Withdrawal by Subject|10|||
144534525|NCT01499368|521160931|FG002|Overall Study|Withdrawal by Subject|8|||
144534526|NCT01499368|521160929|FG000|Overall Study|Lost to Follow-up|3|||
144534527|NCT01499368|521160930|FG001|Overall Study|Lost to Follow-up|2|||
144534528|NCT01499368|521160931|FG002|Overall Study|Lost to Follow-up|5|||
144534529|NCT01499368|521160929|FG000|Overall Study|Adverse Event|4|||
144534530|NCT01499368|521160930|FG001|Overall Study|Adverse Event|0|||
144534531|NCT01499368|521160931|FG002|Overall Study|Adverse Event|2|||
144534532|NCT01499368|521160929|FG000|Overall Study|Physician Decision|0|||
144534533|NCT01499368|521160930|FG001|Overall Study|Physician Decision|1|||
144534534|NCT01499368|521160931|FG002|Overall Study|Physician Decision|0|||
144534535|NCT01499368|521160929|FG000|Overall Study|Deviation from visit window|0|||
144534536|NCT01499368|521160930|FG001|Overall Study|Deviation from visit window|0|||
144534537|NCT01499368|521160931|FG002|Overall Study|Deviation from visit window|1|||
144534538|NCT01499368|521160929|FG000|Overall Study|Error of Prescriptions|0|||
144534539|NCT01499368|521160930|FG001|Overall Study|Error of Prescriptions|0|||
144534540|NCT01499368|521160931|FG002|Overall Study|Error of Prescriptions|1|||
144534541|NCT03982186|521160932|FG000|Overall Study|Lost to Follow-up|0|||
144534542|NCT03982186|521160933|FG001|Overall Study|Lost to Follow-up|1|||
144534543|NCT03982186|521160934|FG002|Overall Study|Lost to Follow-up|2|||
144534544|NCT03982186|521160935|FG003|Overall Study|Lost to Follow-up|1|||
144534545|NCT03982186|521160936|FG004|Overall Study|Lost to Follow-up|1|||
144534546|NCT03982186|521160937|FG005|Overall Study|Lost to Follow-up|0|||
144534547|NCT03982186|521160932|FG000|Overall Study|Physician Decision|0|||
144534548|NCT03982186|521160933|FG001|Overall Study|Physician Decision|1|||
144534549|NCT03982186|521160934|FG002|Overall Study|Physician Decision|0|||
144534550|NCT03982186|521160935|FG003|Overall Study|Physician Decision|0|||
144459209|NCT03579563|520876161|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
144459210|NCT03579563|520876162|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
144459211|NCT03579563|520876163|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
144534551|NCT03982186|521160936|FG004|Overall Study|Physician Decision|0|||
144534552|NCT03982186|521160937|FG005|Overall Study|Physician Decision|0|||
144534553|NCT03982186|521160932|FG000|Overall Study|Withdrawal by Subject|3|||
144534554|NCT03982186|521160933|FG001|Overall Study|Withdrawal by Subject|4|||
144534555|NCT03982186|521160934|FG002|Overall Study|Withdrawal by Subject|1|||
144534556|NCT03982186|521160935|FG003|Overall Study|Withdrawal by Subject|7|||
144534557|NCT03982186|521160936|FG004|Overall Study|Withdrawal by Subject|2|||
144607736|NCT03250832|521424498|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607737|NCT03250832|521424499|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
144607738|NCT03250832|521424500|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
144607739|NCT02303704|521424501|FG000|Overall Study|Protocol Violation|5|||
144607740|NCT02303704|521424502|FG001|Overall Study|Protocol Violation|9|||
144607741|NCT01034540|521424503|FG000|Overall Study|Adverse Event|0|||
144607742|NCT01034540|521424504|FG001|Overall Study|Adverse Event|1|||
144607743|NCT01721876|521424508|FG000|Overall Study|Not treated|1|||
144607744|NCT01721876|521424509|FG001|Overall Study|Not treated|4|||
144607745|NCT01721876|521424508|FG000|Overall Study|Disease progression / relapse|123|||
144607746|NCT01721876|521424509|FG001|Overall Study|Disease progression / relapse|156|||
144607747|NCT01721876|521424508|FG000|Overall Study|Death|6|||
144607748|NCT01721876|521424509|FG001|Overall Study|Death|13|||
144607749|NCT01721876|521424508|FG000|Overall Study|Adverse Event|41|||
144607750|NCT01721876|521424509|FG001|Overall Study|Adverse Event|165|||
144607751|NCT01721876|521424508|FG000|Overall Study|Protocol Violation|2|||
144607752|NCT01721876|521424509|FG001|Overall Study|Protocol Violation|1|||
144607753|NCT01721876|521424508|FG000|Overall Study|Withdrawal by Subject|15|||
144607754|NCT01721876|521424509|FG001|Overall Study|Withdrawal by Subject|38|||
144607755|NCT01721876|521424508|FG000|Overall Study|Reason not listed|34|||
144607756|NCT01721876|521424509|FG001|Overall Study|Reason not listed|63|||
144607757|NCT01721876|521424508|FG000|Overall Study|Sponsor terminated trial|0|||
144607758|NCT01721876|521424509|FG001|Overall Study|Sponsor terminated trial|4|||
144607759|NCT01979835|521424514|FG000|Primary Outcome SA Measurment|failed insertion|18|||
144607760|NCT01979835|521424514|FG000|Follow-up|Lost to Follow-up|32|||
144607761|NCT01717287|521426301|FG000|Overall Study|Lost to Follow-up|0|||
144607762|NCT01717287|521426302|FG001|Overall Study|Lost to Follow-up|2|||
144607763|NCT01717287|521426301|FG000|Overall Study|Protocol Violation|0|||
144607764|NCT01717287|521426302|FG001|Overall Study|Protocol Violation|1|||
144607765|NCT02369848|521426304|FG000|Overall Study|Death|1|||
144607766|NCT02369848|521426304|FG000|Overall Study|Withdrawal by Subject|2|||
144607767|NCT02369848|521426304|FG000|Overall Study|Lost to Follow-up|1|||
144607768|NCT03785925|521426305|FG000|Overall Study|Withdrawal by Subject|15|||
144607769|NCT03785925|521426305|FG000|Overall Study|Lost to Follow-up|1|||
144607770|NCT00957528|521426307|FG000|Overall Study|Protocol Violation|0|||
144607771|NCT00957528|521426308|FG001|Overall Study|Protocol Violation|1|||
144607772|NCT00957528|521426309|FG002|Overall Study|Protocol Violation|0|||
144607773|NCT00957528|521426307|FG000|Overall Study|Withdrawal by Subject|0|||
144607774|NCT00957528|521426308|FG001|Overall Study|Withdrawal by Subject|0|||
144607775|NCT00957528|521426309|FG002|Overall Study|Withdrawal by Subject|1|||
144607776|NCT01848288|521426310|FG000|Overall Study|Death|1|||
144607777|NCT01848288|521426310|FG000|Overall Study|Protocol Violation|1|||
144607778|NCT01848288|521426310|FG000|Overall Study|Withdrawal by Subject|1|||
144607779|NCT01490814|521426319|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
144607780|NCT01490814|521426320|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
144607781|NCT01490814|521426319|FG000|Overall Study|Physician Decision|1|||
144607782|NCT01490814|521426320|FG001|Overall Study|Physician Decision|0|||
144607783|NCT01490814|521426319|FG000|Overall Study|Withdrawal by Subject|0|||
144607784|NCT01490814|521426320|FG001|Overall Study|Withdrawal by Subject|5|||
144607785|NCT01537198|521426321|FG000|Overall Study|RSV infection|2|||
144607786|NCT01537198|521426321|FG000|Overall Study|Adverse Event|4|||
144607787|NCT01537198|521426321|FG000|Overall Study|No Further Visits to the Clinic|37|||
144607788|NCT01537198|521426321|FG000|Overall Study|Other|111|||
144607789|NCT00496730|521426322|FG000|Overall Study|Lost to Follow-up|4|||
144607790|NCT00496730|521426323|FG001|Overall Study|Lost to Follow-up|3|||
144607791|NCT00496730|521426322|FG000|Overall Study|Withdrawal by Subject|2|||
144607792|NCT00496730|521426323|FG001|Overall Study|Withdrawal by Subject|2|||
144607793|NCT00113074|521426324|FG000|Overall Study|Lost to Follow-up|10|||
144607794|NCT00113074|521426325|FG001|Overall Study|Lost to Follow-up|10|||
144607795|NCT00113074|521426326|FG002|Overall Study|Lost to Follow-up|14|||
144607796|NCT03680911|521426327|FG000|At Home Treatment|Study Termination|3|||
144607797|NCT03680911|521426328|FG001|At Home Treatment|Study Termination|0|||
144255424|NCT01690299|520136172|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
144255425|NCT01690299|520136173|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
144255426|NCT01690299|520136174|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
144255427|NCT01690299|520136169|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
144255428|NCT01690299|520136170|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
144255429|NCT01690299|520136171|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
144255430|NCT01690299|520136172|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
144255431|NCT01690299|520136173|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
144255432|NCT01690299|520136174|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
144255433|NCT01690299|520136169|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
144255434|NCT01690299|520136170|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
144255435|NCT01690299|520136171|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
144459212|NCT03579563|520876164|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
144459213|NCT03579563|520876159|FG000|Overall Study|Time/distance concern|0|||
144459214|NCT03579563|520876160|FG001|Overall Study|Time/distance concern|0|||
144459215|NCT03579563|520876161|FG002|Overall Study|Time/distance concern|1|||
144459216|NCT03579563|520876162|FG003|Overall Study|Time/distance concern|0|||
144459217|NCT03579563|520876163|FG004|Overall Study|Time/distance concern|0|||
144459218|NCT03579563|520876164|FG005|Overall Study|Time/distance concern|1|||
144459219|NCT03579563|520876159|FG000|Overall Study|COVID shutdown|2|||
144459220|NCT03579563|520876160|FG001|Overall Study|COVID shutdown|3|||
144459221|NCT03579563|520876161|FG002|Overall Study|COVID shutdown|4|||
144459222|NCT03579563|520876162|FG003|Overall Study|COVID shutdown|3|||
144459223|NCT03579563|520876163|FG004|Overall Study|COVID shutdown|1|||
144459224|NCT03579563|520876164|FG005|Overall Study|COVID shutdown|2|||
144459225|NCT03579563|520876159|FG000|Overall Study|Protocol administration error|1|||
144459226|NCT03579563|520876160|FG001|Overall Study|Protocol administration error|0|||
144459227|NCT03579563|520876161|FG002|Overall Study|Protocol administration error|1|||
144459228|NCT03579563|520876162|FG003|Overall Study|Protocol administration error|0|||
144459229|NCT03579563|520876163|FG004|Overall Study|Protocol administration error|1|||
144459230|NCT03579563|520876164|FG005|Overall Study|Protocol administration error|5|||
144459231|NCT04349553|520876168|FG000|Overall Study|Withdrawal by Subject|1|||
144459232|NCT04349553|520876169|FG001|Overall Study|Withdrawal by Subject|0|||
144459233|NCT04349553|520876170|FG002|Overall Study|Withdrawal by Subject|1|||
144459234|NCT04349553|520876171|FG003|Overall Study|Withdrawal by Subject|0|||
144459235|NCT03526250|520876172|FG000|Overall Study|Adverse Event|4|||
144459236|NCT03526250|520876172|FG000|Overall Study|Progressive Disease|16|||
144459237|NCT03526250|520876172|FG000|Overall Study|No Treatment|3|||
144459238|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
144459239|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
144459240|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
144459241|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
144459242|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
144459243|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
144459244|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
144459245|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
144459246|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
144459247|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
144459248|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
144459249|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
144459250|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
144459251|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
144459252|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
144459253|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
144459254|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
144459255|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
144459256|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
144459257|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
144459258|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
144459259|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
144459260|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
144459261|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
144459262|NCT01715805|520876173|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
144459263|NCT01715805|520876174|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
144459264|NCT01715805|520876175|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
144459265|NCT01715805|520876176|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
144459266|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
144459267|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
144459268|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
144459269|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
144459270|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
144459271|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
144459272|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
144459273|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
144459274|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
144459275|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
144459276|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
144459277|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
144534558|NCT03982186|521160937|FG005|Overall Study|Withdrawal by Subject|0|||
144534559|NCT03982186|521160932|FG000|Overall Study|Randomized and not treated|0|||
144534560|NCT03982186|521160933|FG001|Overall Study|Randomized and not treated|0|||
144459278|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
144459279|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
144459280|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
144459281|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
144459282|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
144459283|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
144459284|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
144459285|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
144534561|NCT03982186|521160934|FG002|Overall Study|Randomized and not treated|0|||
144534562|NCT03982186|521160935|FG003|Overall Study|Randomized and not treated|1|||
144534563|NCT03982186|521160936|FG004|Overall Study|Randomized and not treated|0|||
144534564|NCT03982186|521160937|FG005|Overall Study|Randomized and not treated|0|||
144534565|NCT01553149|521160938|FG000|Overall Study|Adverse Event|0|||
144534566|NCT01553149|521160939|FG001|Overall Study|Adverse Event|9|||
144534567|NCT01553149|521160938|FG000|Overall Study|Physician Decision|5|||
144534568|NCT01553149|521160939|FG001|Overall Study|Physician Decision|10|||
144534569|NCT01553149|521160938|FG000|Overall Study|Ineligible|0|||
144534570|NCT01553149|521160939|FG001|Overall Study|Ineligible|1|||
144534571|NCT02325154|521160940|FG000|Overall Study|Physician Decision|1|||
144534572|NCT01265537|521160941|FG000|Overall Study|Adverse Event|2|||
144534573|NCT01265537|521160942|FG001|Overall Study|Adverse Event|1|||
144534574|NCT01265537|521160941|FG000|Overall Study|Physician Decision|0|||
144534575|NCT01265537|521160942|FG001|Overall Study|Physician Decision|1|||
144534576|NCT05866926|521160943|FG000|Overall Study|Death|16|||
144534577|NCT05866926|521160944|FG001|Overall Study|Death|9|||
144534578|NCT05866926|521160943|FG000|Overall Study|Lost to Follow-up|0|||
144534579|NCT05866926|521160944|FG001|Overall Study|Lost to Follow-up|1|||
144534580|NCT05866926|521160943|FG000|Overall Study|Adverse Event|1|||
144534581|NCT05866926|521160944|FG001|Overall Study|Adverse Event|0|||
144534582|NCT05866926|521160943|FG000|Overall Study|Withdrawal by Subject|5|||
144534583|NCT05866926|521160944|FG001|Overall Study|Withdrawal by Subject|1|||
144534584|NCT05866926|521160943|FG000|Overall Study|Disease progression|1|||
144534585|NCT05866926|521160944|FG001|Overall Study|Disease progression|0|||
144534586|NCT05866926|521160943|FG000|Overall Study|other causes|2|||
144534587|NCT05866926|521160944|FG001|Overall Study|other causes|1|||
144534588|NCT03990883|521160945|FG000|Blinded Treatment Phase|Adverse Event|1|||
144534589|NCT03990883|521160946|FG001|Blinded Treatment Phase|Adverse Event|1|||
144607798|NCT03680911|521426327|FG000|At Home Treatment|Lost to Follow-up|0|||
144607799|NCT03680911|521426328|FG001|At Home Treatment|Lost to Follow-up|1|||
144607800|NCT03680911|521426327|FG000|At Home Treatment|Withdrawal by Subject|0|||
144607801|NCT03680911|521426328|FG001|At Home Treatment|Withdrawal by Subject|2|||
144607802|NCT03680911|521426327|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
144607803|NCT03680911|521426328|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
144607804|NCT03962738|521426331|FG000|Overall Study|Protocol Deviation|3|||
144607805|NCT03962738|521426332|FG001|Overall Study|Protocol Deviation|0|||
144607806|NCT03962738|521426333|FG002|Overall Study|Protocol Deviation|1|||
144607807|NCT03962738|521426334|FG003|Overall Study|Protocol Deviation|1|||
144607808|NCT03962738|521426331|FG000|Overall Study|Withdrawal by Subject|4|||
144607809|NCT03962738|521426332|FG001|Overall Study|Withdrawal by Subject|0|||
144607810|NCT03962738|521426333|FG002|Overall Study|Withdrawal by Subject|0|||
144607811|NCT03962738|521426334|FG003|Overall Study|Withdrawal by Subject|0|||
144607812|NCT03962738|521426331|FG000|Overall Study|Lost to Follow-up|0|||
144607813|NCT03962738|521426332|FG001|Overall Study|Lost to Follow-up|0|||
144607814|NCT03962738|521426333|FG002|Overall Study|Lost to Follow-up|1|||
144607815|NCT03962738|521426334|FG003|Overall Study|Lost to Follow-up|0|||
144607816|NCT00574288|521426335|FG000|Overall Study|Adverse Event|2|||
144607817|NCT00574288|521426336|FG001|Overall Study|Adverse Event|0|||
144607818|NCT00574288|521426337|FG002|Overall Study|Adverse Event|0|||
144607819|NCT00574288|521426338|FG003|Overall Study|Adverse Event|0|||
144607820|NCT00574288|521426339|FG004|Overall Study|Adverse Event|1|||
144607821|NCT00574288|521426340|FG005|Overall Study|Adverse Event|0|||
144607822|NCT00574288|521426341|FG006|Overall Study|Adverse Event|0|||
144607823|NCT00574288|521426335|FG000|Overall Study|Death|0|||
144607824|NCT00574288|521426336|FG001|Overall Study|Death|0|||
144607825|NCT00574288|521426337|FG002|Overall Study|Death|0|||
144534590|NCT03990883|521160947|FG002|Blinded Treatment Phase|Adverse Event|0|||
144534591|NCT03990883|521160945|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
144607826|NCT00574288|521426338|FG003|Overall Study|Death|0|||
144607827|NCT00574288|521426339|FG004|Overall Study|Death|0|||
144607828|NCT00574288|521426340|FG005|Overall Study|Death|25|||
144607829|NCT00574288|521426341|FG006|Overall Study|Death|21|||
144607830|NCT00574288|521426335|FG000|Overall Study|Lost to Follow-up|0|||
144459286|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
144534592|NCT03990883|521160946|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
144534593|NCT03990883|521160947|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
144534594|NCT03990883|521160945|FG000|Blinded Treatment Phase|Physician Decision|1|||
144607831|NCT00574288|521426336|FG001|Overall Study|Lost to Follow-up|0|||
144607832|NCT00574288|521426337|FG002|Overall Study|Lost to Follow-up|0|||
144459287|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
144459288|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
144459289|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
144459290|NCT01715805|520876173|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
144459291|NCT01715805|520876174|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
144459292|NCT01715805|520876175|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
144459293|NCT01715805|520876176|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
144459294|NCT02219932|520876179|FG000|Overall Study|Other|5|||
144459295|NCT02219932|520876180|FG001|Overall Study|Other|11|||
144459296|NCT02219932|520876179|FG000|Overall Study|Death|1|||
144459297|NCT02219932|520876180|FG001|Overall Study|Death|1|||
144459298|NCT02219932|520876179|FG000|Overall Study|Investigator Decision|0|||
144459299|NCT02219932|520876180|FG001|Overall Study|Investigator Decision|1|||
144459300|NCT02219932|520876179|FG000|Overall Study|Consent Withdrawn|11|||
144459301|NCT02219932|520876180|FG001|Overall Study|Consent Withdrawn|7|||
144459302|NCT02219932|520876179|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
144459303|NCT02219932|520876180|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
144459304|NCT02219932|520876179|FG000|Overall Study|Protocol Violation|10|||
144459305|NCT02219932|520876180|FG001|Overall Study|Protocol Violation|6|||
144459306|NCT02219932|520876179|FG000|Overall Study|Pregnancy|1|||
144459307|NCT02219932|520876180|FG001|Overall Study|Pregnancy|0|||
144459308|NCT02219932|520876179|FG000|Overall Study|Lost to Follow-up|4|||
144459309|NCT02219932|520876180|FG001|Overall Study|Lost to Follow-up|2|||
144459310|NCT02219932|520876179|FG000|Overall Study|Adverse Event|23|||
144459311|NCT02219932|520876180|FG001|Overall Study|Adverse Event|21|||
144459312|NCT01618864|520876181|FG000|Overall Study|Withdrawal by Subject|2|||
144459313|NCT01618864|520876181|FG000|Overall Study|Lost to Follow-up|2|||
144459314|NCT05177770|520876182|FG000|Overall Study|Death|4|||
144459315|NCT05177770|520876182|FG000|Overall Study|Withdrawal by Subject|1|||
144459316|NCT05177770|520876182|FG000|Overall Study|Adverse Event prior to dosing|1|||
144459317|NCT02372396|520876188|FG000|Overall Study|Lost to Follow-up|7|||
144459318|NCT02372396|520876189|FG001|Overall Study|Lost to Follow-up|9|||
144459319|NCT01272934|520876190|FG000|Overall Study|Adverse Event|0|||
144459320|NCT01272934|520876191|FG001|Overall Study|Adverse Event|1|||
144459321|NCT01272934|520876190|FG000|Overall Study|Abnormal Laboratory Value|0|||
144459322|NCT01272934|520876191|FG001|Overall Study|Abnormal Laboratory Value|1|||
144459323|NCT04313634|520876192|FG000|Overall Study|Adverse Event|2|||
144459324|NCT04313634|520876193|FG001|Overall Study|Adverse Event|2|||
144459325|NCT04313634|520876194|FG002|Overall Study|Adverse Event|0|||
144459326|NCT04313634|520876192|FG000|Overall Study|Withdrawal by Subject|1|||
144459327|NCT04313634|520876193|FG001|Overall Study|Withdrawal by Subject|0|||
144459328|NCT04313634|520876194|FG002|Overall Study|Withdrawal by Subject|1|||
144459329|NCT04313634|520876192|FG000|Overall Study|Protocol Violation|0|||
144459330|NCT04313634|520876193|FG001|Overall Study|Protocol Violation|0|||
144459331|NCT04313634|520876194|FG002|Overall Study|Protocol Violation|1|||
144534595|NCT03990883|521160946|FG001|Blinded Treatment Phase|Physician Decision|0|||
144534596|NCT03990883|521160947|FG002|Blinded Treatment Phase|Physician Decision|0|||
144534597|NCT03990883|521160945|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
144534598|NCT03990883|521160946|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
144534599|NCT03990883|521160947|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
144534600|NCT03990883|521160945|FG000|Blinded Treatment Phase|COVID-19|3|||
144534601|NCT03990883|521160946|FG001|Blinded Treatment Phase|COVID-19|2|||
144534602|NCT03990883|521160947|FG002|Blinded Treatment Phase|COVID-19|0|||
144534603|NCT03990883|521160945|FG000|Blinded Treatment Phase|Personal Reasons|6|||
144534604|NCT03990883|521160946|FG001|Blinded Treatment Phase|Personal Reasons|3|||
144534605|NCT03990883|521160947|FG002|Blinded Treatment Phase|Personal Reasons|0|||
144534606|NCT03990883|521160945|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
144534607|NCT03990883|521160946|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
144534608|NCT03990883|521160947|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
144534609|NCT03990883|521160945|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
144534610|NCT03990883|521160946|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
144534611|NCT03990883|521160947|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
144534612|NCT03990883|521160945|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
144534613|NCT03990883|521160946|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
144459332|NCT02199028|520876209|FG000|Week 1|Adverse Event|1|||
144534614|NCT03990883|521160947|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
144534615|NCT04595331|521161652|FG000|Overall Study|Withdrawal by Subject|0|||
144459333|NCT02199028|520876210|FG001|Week 1|Adverse Event|0|||
144534616|NCT04595331|521161653|FG001|Overall Study|Withdrawal by Subject|1|||
144459334|NCT02199028|520876209|FG000|Week 3|Adverse Event|1|||
144459335|NCT02199028|520876210|FG001|Week 3|Adverse Event|0|||
144459336|NCT01881126|520876211|FG000|Overall Study|Non-compliance|1|||
144459337|NCT01881126|520876212|FG001|Overall Study|Non-compliance|1|||
144459338|NCT01881126|520876211|FG000|Overall Study|Adverse Event|0|||
144459339|NCT01881126|520876212|FG001|Overall Study|Adverse Event|1|||
144607833|NCT00574288|521426338|FG003|Overall Study|Lost to Follow-up|0|||
144196886|NCT00062751|519917143|FG000|Overall Study|Adverse Event|4|||
144196887|NCT00062751|519917144|FG001|Overall Study|Adverse Event|7|||
144196888|NCT00062751|519917145|FG002|Overall Study|Adverse Event|2|||
144196889|NCT00062751|519917146|FG003|Overall Study|Adverse Event|2|||
144196890|NCT00062751|519917147|FG004|Overall Study|Adverse Event|2|||
144196891|NCT00062751|519917143|FG000|Overall Study|Other|2|||
144607834|NCT00574288|521426339|FG004|Overall Study|Lost to Follow-up|0|||
144607835|NCT00574288|521426340|FG005|Overall Study|Lost to Follow-up|1|||
144607836|NCT00574288|521426341|FG006|Overall Study|Lost to Follow-up|2|||
144607837|NCT00574288|521426335|FG000|Overall Study|Study Terminated By Sponsor|0|||
144607838|NCT00574288|521426336|FG001|Overall Study|Study Terminated By Sponsor|0|||
144607839|NCT00574288|521426337|FG002|Overall Study|Study Terminated By Sponsor|0|||
144607840|NCT00574288|521426338|FG003|Overall Study|Study Terminated By Sponsor|0|||
144607841|NCT00574288|521426339|FG004|Overall Study|Study Terminated By Sponsor|0|||
144607842|NCT00574288|521426340|FG005|Overall Study|Study Terminated By Sponsor|0|||
144607843|NCT00574288|521426341|FG006|Overall Study|Study Terminated By Sponsor|5|||
144607844|NCT00574288|521426335|FG000|Overall Study|Progressive Disease|17|||
144607845|NCT00574288|521426336|FG001|Overall Study|Progressive Disease|2|||
144607846|NCT00574288|521426337|FG002|Overall Study|Progressive Disease|3|||
144607847|NCT00574288|521426338|FG003|Overall Study|Progressive Disease|2|||
144607848|NCT00574288|521426339|FG004|Overall Study|Progressive Disease|1|||
144607849|NCT00574288|521426340|FG005|Overall Study|Progressive Disease|0|||
144607850|NCT00574288|521426341|FG006|Overall Study|Progressive Disease|0|||
144607851|NCT00574288|521426335|FG000|Overall Study|Other|1|||
144607852|NCT00574288|521426336|FG001|Overall Study|Other|1|||
144607853|NCT00574288|521426337|FG002|Overall Study|Other|0|||
144607854|NCT00574288|521426338|FG003|Overall Study|Other|0|||
144607855|NCT00574288|521426339|FG004|Overall Study|Other|0|||
144607856|NCT00574288|521426340|FG005|Overall Study|Other|0|||
144459340|NCT00695669|520876215|FG000|Overall Study|Adverse Event|0|||
144459341|NCT00695669|520876216|FG001|Overall Study|Adverse Event|0|||
144459342|NCT00695669|520876217|FG002|Overall Study|Adverse Event|2|||
144459343|NCT00695669|520876218|FG003|Overall Study|Adverse Event|0|||
144459344|NCT00695669|520876215|FG000|Overall Study|Lost to Follow-up|4|||
144459345|NCT00695669|520876216|FG001|Overall Study|Lost to Follow-up|4|||
144459346|NCT00695669|520876217|FG002|Overall Study|Lost to Follow-up|1|||
144459347|NCT00695669|520876218|FG003|Overall Study|Lost to Follow-up|4|||
144459348|NCT05045625|520876219|FG000|Overall Study|Lost to Follow-up|3|||
144459349|NCT00047879|520876220|FG000|Overall Study|Progressive disease|4|||
144459350|NCT00047879|520876221|FG001|Overall Study|Progressive disease|3|||
144459351|NCT02075593|520876224|FG000|Overall Study|Withdrawal by Subject|1|||
144459352|NCT03069482|520878403|FG000|Overall Study|Lost to Follow-up|0|||
144459353|NCT03069482|520878404|FG001|Overall Study|Lost to Follow-up|1|||
144725851|NCT02207231|521852633|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
144725852|NCT02207231|521852630|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
144725853|NCT02207231|521852631|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
144725854|NCT02207231|521852632|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
144725855|NCT02207231|521852633|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
144725856|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
144725857|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
144725858|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
144725859|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
144725860|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
144725861|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
144725862|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
144725863|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
144725864|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
144725865|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
144725866|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
144725867|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
144725868|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
144725869|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
144725870|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
144196892|NCT00062751|519917144|FG001|Overall Study|Other|3|||
144196893|NCT00062751|519917145|FG002|Overall Study|Other|1|||
144196894|NCT00062751|519917146|FG003|Overall Study|Other|0|||
144196895|NCT00062751|519917147|FG004|Overall Study|Other|1|||
144459354|NCT03069482|520878403|FG000|Overall Study|Physician Decision|1|||
144459355|NCT03069482|520878404|FG001|Overall Study|Physician Decision|0|||
144459356|NCT00791765|520878405|FG000|Weeks 1 to 12|Adverse Event|0|||
144459357|NCT00791765|520878406|FG001|Weeks 1 to 12|Adverse Event|1|||
144607857|NCT00574288|521426341|FG006|Overall Study|Other|0|||
144459358|NCT00791765|520878405|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
144196896|NCT00062751|519917143|FG000|Overall Study|Withdrawal by Subject|1|||
144607858|NCT00369785|521426353|FG000|Overall Study|Physician Decision|3|||
144607859|NCT00369785|521426354|FG001|Overall Study|Physician Decision|2|||
144607860|NCT00369785|521426353|FG000|Overall Study|Death|1|||
144607861|NCT00369785|521426354|FG001|Overall Study|Death|2|||
144607862|NCT00369785|521426353|FG000|Overall Study|Withdrawal by Subject|7|||
144607863|NCT00369785|521426354|FG001|Overall Study|Withdrawal by Subject|6|||
144607864|NCT00369785|521426353|FG000|Overall Study|Toxicity|6|||
144607865|NCT00369785|521426354|FG001|Overall Study|Toxicity|4|||
144607866|NCT00369785|521426353|FG000|Overall Study|Never started|0|||
144607867|NCT00369785|521426354|FG001|Overall Study|Never started|2|||
144607868|NCT00369785|521426353|FG000|Overall Study|Progression|4|||
144607869|NCT00369785|521426354|FG001|Overall Study|Progression|4|||
144607870|NCT00369785|521426353|FG000|Overall Study|Multiple reasons|6|||
144607871|NCT00369785|521426354|FG001|Overall Study|Multiple reasons|5|||
144607872|NCT02247960|521426358|FG000|Patient Consent and Randomization|Physician Decision|2|||
144607873|NCT02247960|521426359|FG001|Patient Consent and Randomization|Physician Decision|2|||
144607874|NCT02247960|521426358|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
144607875|NCT02247960|521426359|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
144607876|NCT02247960|521426358|FG000|Catheter Removed|Lost to Follow-up|7|||
144607877|NCT02247960|521426359|FG001|Catheter Removed|Lost to Follow-up|10|||
144607878|NCT00702325|521426360|FG000|Overall Study|Adverse Event|1|||
144607879|NCT00702325|521426361|FG001|Overall Study|Adverse Event|0|||
144607880|NCT00702325|521426360|FG000|Overall Study|Withdrawal by Subject|7|||
144607881|NCT00702325|521426361|FG001|Overall Study|Withdrawal by Subject|7|||
144607882|NCT00702325|521426360|FG000|Overall Study|Lost to Follow-up|3|||
144607883|NCT00702325|521426361|FG001|Overall Study|Lost to Follow-up|4|||
144607884|NCT00702325|521426360|FG000|Overall Study|Incorrect enrollment|5|||
144607885|NCT00702325|521426361|FG001|Overall Study|Incorrect enrollment|7|||
144607886|NCT00702325|521426360|FG000|Overall Study|Developed study discontinuation criteria|18|||
144607887|NCT00702325|521426361|FG001|Overall Study|Developed study discontinuation criteria|28|||
144607888|NCT00702325|521426360|FG000|Overall Study|Severe noncompliance to protocol|3|||
144607889|NCT00702325|521426361|FG001|Overall Study|Severe noncompliance to protocol|3|||
144607890|NCT00702325|521426360|FG000|Overall Study|Termination due to lab results|1|||
144607891|NCT00702325|521426361|FG001|Overall Study|Termination due to lab results|0|||
144607892|NCT00702325|521426360|FG000|Overall Study|Didn't follow study medication dosage|0|||
144607893|NCT00702325|521426361|FG001|Overall Study|Didn't follow study medication dosage|2|||
144607894|NCT00702325|521426360|FG000|Overall Study|Withdrew consent|0|||
144607895|NCT00702325|521426361|FG001|Overall Study|Withdrew consent|1|||
144607896|NCT00702325|521426360|FG000|Overall Study|Incorrectly Discontinued|0|||
144607897|NCT00702325|521426361|FG001|Overall Study|Incorrectly Discontinued|1|||
144607898|NCT04556136|521426365|FG000|Overall Study|Lost to Follow-up|6|||
144607899|NCT04556136|521426366|FG001|Overall Study|Lost to Follow-up|6|||
144607900|NCT04556136|521426365|FG000|Overall Study|Physician Decision|2|||
144607901|NCT04556136|521426366|FG001|Overall Study|Physician Decision|1|||
144607902|NCT04556136|521426365|FG000|Overall Study|Withdrawal by Subject|2|||
144607903|NCT04556136|521426366|FG001|Overall Study|Withdrawal by Subject|1|||
144607904|NCT01022502|521426369|FG000|Overall Study|Adverse Event|1|||
144607905|NCT01022502|521426369|FG000|Overall Study|employment related reasons|1|||
144607906|NCT01022502|521426369|FG000|Overall Study|Withdrawal by Subject|1|||
144607907|NCT02361944|521426370|FG000|Overall Study|surgery cancellation|0|||
144607908|NCT02361944|521426371|FG001|Overall Study|surgery cancellation|1|||
144607909|NCT02566577|521426372|FG000|Overall Study|Withdrawal by Subject|1|||
144607910|NCT02566577|521426373|FG001|Overall Study|Withdrawal by Subject|1|||
144607911|NCT02566577|521426372|FG000|Overall Study|Equipment failure|1|||
144459359|NCT00791765|520878406|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
144459360|NCT00791765|520878405|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
144459361|NCT00791765|520878406|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
144459362|NCT00791765|520878405|FG000|Weeks 1 to 12|Physician Decision|1|||
144459363|NCT00791765|520878406|FG001|Weeks 1 to 12|Physician Decision|0|||
144459364|NCT00791765|520878405|FG000|Weeks 1 to 12|Disease progression|3|||
144459365|NCT00791765|520878406|FG001|Weeks 1 to 12|Disease progression|0|||
144459366|NCT00791765|520878405|FG000|Weeks 1 to 12|Ineligibility determined|0|||
144607912|NCT02566577|521426373|FG001|Overall Study|Equipment failure|1|||
144607913|NCT02566577|521426372|FG000|Overall Study|Physical limitation|1|||
144607914|NCT02566577|521426373|FG001|Overall Study|Physical limitation|0|||
144607915|NCT00073528|521426384|FG000|Overall Study|Death|488|||
144607916|NCT00073528|521426385|FG001|Overall Study|Death|473|||
144607917|NCT00073528|521426384|FG000|Overall Study|Lost to Follow-up|52|||
144607918|NCT00073528|521426385|FG001|Overall Study|Lost to Follow-up|45|||
144607919|NCT00073528|521426384|FG000|Overall Study|Withdrawal by Subject|50|||
144459367|NCT00791765|520878406|FG001|Weeks 1 to 12|Ineligibility determined|3|||
144607920|NCT00073528|521426385|FG001|Overall Study|Withdrawal by Subject|45|||
144607921|NCT00073528|521426384|FG000|Overall Study|Study terminated by Sponsor|10|||
144607922|NCT00073528|521426385|FG001|Overall Study|Study terminated by Sponsor|29|||
144607923|NCT00073528|521426384|FG000|Overall Study|Other|18|||
144607924|NCT00073528|521426385|FG001|Overall Study|Other|19|||
144607925|NCT00073528|521426384|FG000|Overall Study|Other|9|||
144607926|NCT00073528|521426385|FG001|Overall Study|Other|12|||
144459368|NCT00791765|520878405|FG000|Weeks 13 to 24|Protocol deviation|2|||
144607927|NCT00073528|521426384|FG000|Overall Study|Protocol Violation|3|||
144255436|NCT01690299|520136172|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
144255437|NCT01690299|520136173|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
144255438|NCT01690299|520136174|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
144255439|NCT01690299|520136169|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
144255440|NCT01690299|520136170|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
144255441|NCT01690299|520136171|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
144255442|NCT01690299|520136172|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
144255443|NCT01690299|520136173|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
144255444|NCT01690299|520136174|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
144255445|NCT00551525|520136177|FG000|Overall Study|Protocol Violation|5|||
144255446|NCT02521792|520136183|FG000|Overall Study|Study Terminated|6|||
144255447|NCT00398047|520136184|FG000|Overall Study|all patient progressed before completion|3|||
144255448|NCT00237692|520136185|FG000|Overall Study|Lost to Follow-up|9|||
144255449|NCT00237692|520136186|FG001|Overall Study|Lost to Follow-up|3|||
144255450|NCT00237692|520136187|FG002|Overall Study|Lost to Follow-up|5|||
144255451|NCT00237692|520136188|FG003|Overall Study|Lost to Follow-up|3|||
144255452|NCT00237692|520136185|FG000|Overall Study|Death|1|||
144255453|NCT00237692|520136186|FG001|Overall Study|Death|2|||
144255454|NCT00237692|520136187|FG002|Overall Study|Death|2|||
144255455|NCT00237692|520136188|FG003|Overall Study|Death|3|||
144255456|NCT00237692|520136185|FG000|Overall Study|Excluded - did not meet criteria|4|||
144255457|NCT00237692|520136186|FG001|Overall Study|Excluded - did not meet criteria|3|||
144255458|NCT00237692|520136187|FG002|Overall Study|Excluded - did not meet criteria|5|||
144255459|NCT00237692|520136188|FG003|Overall Study|Excluded - did not meet criteria|9|||
144259298|NCT01089127|520150359|FG005|Overall Study|Lost to Follow-up|0|||
144459369|NCT00791765|520878406|FG001|Weeks 13 to 24|Protocol deviation|0|||
144459370|NCT00791765|520878405|FG000|Weeks 13 to 24|Adverse Event|0|||
144459371|NCT00791765|520878406|FG001|Weeks 13 to 24|Adverse Event|3|||
144459372|NCT00791765|520878405|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
144459373|NCT00791765|520878406|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
144459374|NCT00791765|520878405|FG000|Weeks 13 to 24|Disease progression|0|||
144459375|NCT00791765|520878406|FG001|Weeks 13 to 24|Disease progression|1|||
144459376|NCT00791765|520878405|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
144459377|NCT00791765|520878406|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
144459378|NCT00791765|520878405|FG000|Weeks 13 to 24|Other|0|||
144459379|NCT00791765|520878406|FG001|Weeks 13 to 24|Other|1|||
144459380|NCT00924287|520878408|FG000|Overall Study|Death|1|||
144459381|NCT02621931|520878413|FG000|Overall Study|Death|0|||
144534617|NCT04595331|521161652|FG000|Overall Study|Lost to Follow-up|0|||
144534618|NCT04595331|521161653|FG001|Overall Study|Lost to Follow-up|5|||
144534619|NCT04595331|521161652|FG000|Overall Study|Medical reason|0|||
144534620|NCT04595331|521161653|FG001|Overall Study|Medical reason|1|||
144534621|NCT05412004|521161655|FG000|Overall Study|Adverse Event|0|||
144534622|NCT05412004|521161656|FG001|Overall Study|Adverse Event|2|||
144534623|NCT05412004|521161657|FG002|Overall Study|Adverse Event|1|||
144534624|NCT05412004|521161658|FG003|Overall Study|Adverse Event|5|||
144534625|NCT05412004|521161655|FG000|Overall Study|Assigned Treatment by Mistake|5|||
144534626|NCT05412004|521161656|FG001|Overall Study|Assigned Treatment by Mistake|10|||
144534627|NCT05412004|521161657|FG002|Overall Study|Assigned Treatment by Mistake|2|||
144534628|NCT05412004|521161658|FG003|Overall Study|Assigned Treatment by Mistake|5|||
144534629|NCT05412004|521161655|FG000|Overall Study|Lost to Follow-up|3|||
144534630|NCT05412004|521161656|FG001|Overall Study|Lost to Follow-up|0|||
144534631|NCT05412004|521161657|FG002|Overall Study|Lost to Follow-up|0|||
144534632|NCT05412004|521161658|FG003|Overall Study|Lost to Follow-up|0|||
144534633|NCT05412004|521161655|FG000|Overall Study|Patient could not travel to site|0|||
144534634|NCT05412004|521161656|FG001|Overall Study|Patient could not travel to site|1|||
144534635|NCT05412004|521161657|FG002|Overall Study|Patient could not travel to site|0|||
144534636|NCT05412004|521161658|FG003|Overall Study|Patient could not travel to site|0|||
144534637|NCT05412004|521161655|FG000|Overall Study|Physician Decision|0|||
144534638|NCT05412004|521161656|FG001|Overall Study|Physician Decision|1|||
144534639|NCT05412004|521161657|FG002|Overall Study|Physician Decision|0|||
144534640|NCT05412004|521161658|FG003|Overall Study|Physician Decision|0|||
144534641|NCT05412004|521161655|FG000|Overall Study|Pregnancy|0|||
144534642|NCT05412004|521161656|FG001|Overall Study|Pregnancy|1|||
144534643|NCT05412004|521161657|FG002|Overall Study|Pregnancy|0|||
144534644|NCT05412004|521161658|FG003|Overall Study|Pregnancy|0|||
144534645|NCT05412004|521161655|FG000|Overall Study|Protocol Violation|1|||
144534646|NCT05412004|521161656|FG001|Overall Study|Protocol Violation|0|||
144534647|NCT05412004|521161657|FG002|Overall Study|Protocol Violation|0|||
144534648|NCT05412004|521161658|FG003|Overall Study|Protocol Violation|0|||
144534649|NCT05412004|521161655|FG000|Overall Study|Withdrawal by Subject|4|||
144534650|NCT05412004|521161656|FG001|Overall Study|Withdrawal by Subject|19|||
144534651|NCT05412004|521161657|FG002|Overall Study|Withdrawal by Subject|4|||
144534652|NCT05412004|521161658|FG003|Overall Study|Withdrawal by Subject|14|||
144534653|NCT05412004|521161655|FG000|Overall Study|Screen Failure|0|||
144534654|NCT05412004|521161656|FG001|Overall Study|Screen Failure|0|||
144607928|NCT00073528|521426385|FG001|Overall Study|Protocol Violation|5|||
144607929|NCT03086057|521426386|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
144607930|NCT03086057|521426387|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
144607931|NCT03086057|521426388|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
144607932|NCT03086057|521426389|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
144607933|NCT03086057|521426386|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
144607934|NCT03086057|521426387|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
144607935|NCT03086057|521426388|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
144459382|NCT02621931|520878414|FG001|Overall Study|Death|1|||
144459383|NCT02621931|520878415|FG002|Overall Study|Death|0|||
144459384|NCT02621931|520878413|FG000|Overall Study|Adverse Event|8|||
144459385|NCT02621931|520878414|FG001|Overall Study|Adverse Event|5|||
144459386|NCT02621931|520878415|FG002|Overall Study|Adverse Event|7|||
144459387|NCT02621931|520878413|FG000|Overall Study|Withdrawal by Subject|12|||
144459388|NCT02621931|520878414|FG001|Overall Study|Withdrawal by Subject|10|||
144459389|NCT02621931|520878415|FG002|Overall Study|Withdrawal by Subject|11|||
144459390|NCT02621931|520878413|FG000|Overall Study|Protocol Violation|2|||
144459391|NCT02621931|520878414|FG001|Overall Study|Protocol Violation|2|||
144459392|NCT02621931|520878415|FG002|Overall Study|Protocol Violation|2|||
144459393|NCT02621931|520878413|FG000|Overall Study|Pregnancy|2|||
144459394|NCT02621931|520878414|FG001|Overall Study|Pregnancy|0|||
144459395|NCT02621931|520878415|FG002|Overall Study|Pregnancy|0|||
144459396|NCT02621931|520878413|FG000|Overall Study|Noncompliance to study procedures|0|||
144607936|NCT03086057|521426389|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
144196897|NCT00062751|519917144|FG001|Overall Study|Withdrawal by Subject|2|||
144196898|NCT00062751|519917145|FG002|Overall Study|Withdrawal by Subject|2|||
144196899|NCT00062751|519917146|FG003|Overall Study|Withdrawal by Subject|1|||
144196900|NCT00062751|519917147|FG004|Overall Study|Withdrawal by Subject|0|||
144196901|NCT00062751|519917143|FG000|Overall Study|Symptomatic deterioration|1|||
144196902|NCT00062751|519917144|FG001|Overall Study|Symptomatic deterioration|1|||
144196903|NCT00062751|519917145|FG002|Overall Study|Symptomatic deterioration|0|||
144196904|NCT00062751|519917146|FG003|Overall Study|Symptomatic deterioration|0|||
144196905|NCT00062751|519917147|FG004|Overall Study|Symptomatic deterioration|1|||
144196906|NCT00062751|519917143|FG000|Overall Study|Death|1|||
144196907|NCT00062751|519917144|FG001|Overall Study|Death|0|||
144196908|NCT00062751|519917145|FG002|Overall Study|Death|1|||
144196909|NCT00062751|519917146|FG003|Overall Study|Death|0|||
144196910|NCT00062751|519917147|FG004|Overall Study|Death|0|||
144196911|NCT00858143|519918634|FG000|Overall Study|Adverse Event|16|||
144196912|NCT00858143|519918634|FG000|Overall Study|Lack of Efficacy|4|||
144196913|NCT00858143|519918634|FG000|Overall Study|Death|7|||
144459397|NCT02621931|520878414|FG001|Overall Study|Noncompliance to study procedures|1|||
144607937|NCT03086057|521426386|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
144607938|NCT03086057|521426387|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
144459398|NCT02621931|520878415|FG002|Overall Study|Noncompliance to study procedures|2|||
144459399|NCT02621931|520878413|FG000|Overall Study|Lost to Follow-up|8|||
144534655|NCT05412004|521161657|FG002|Overall Study|Screen Failure|0|||
144534656|NCT05412004|521161658|FG003|Overall Study|Screen Failure|1|||
144534657|NCT05412004|521161655|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
144534658|NCT05412004|521161656|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
144534659|NCT05412004|521161657|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
144534660|NCT05412004|521161658|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
144534661|NCT04644029|521161659|FG000|Overall Study|Death|1|||
144534662|NCT04644029|521161660|FG001|Overall Study|Death|0|||
144534663|NCT04644029|521161659|FG000|Overall Study|Physician Decision|1|||
144534664|NCT04644029|521161660|FG001|Overall Study|Physician Decision|2|||
144534665|NCT04644029|521161659|FG000|Overall Study|Withdrawal by Subject|21|||
144534666|NCT04644029|521161660|FG001|Overall Study|Withdrawal by Subject|19|||
144534667|NCT04644029|521161659|FG000|Overall Study|Lost to Follow-up|31|||
144534668|NCT04644029|521161660|FG001|Overall Study|Lost to Follow-up|34|||
144534669|NCT04644029|521161659|FG000|Overall Study|Study Terminated by Sponsor|308|||
144534670|NCT04644029|521161660|FG001|Overall Study|Study Terminated by Sponsor|309|||
144534671|NCT04644029|521161659|FG000|Overall Study|Randomized in Error|2|||
144534672|NCT04644029|521161660|FG001|Overall Study|Randomized in Error|1|||
144534673|NCT04644029|521161659|FG000|Overall Study|Other|0|||
144534674|NCT04644029|521161660|FG001|Overall Study|Other|1|||
144534675|NCT05020353|521161661|FG000|Overall Study|Protocol Violation|7|||
144534676|NCT05020353|521161661|FG000|Overall Study|Withdrawal by Subject|33|||
144534677|NCT04908930|521161670|FG000|Overall Study|Lost to Follow-up|1|||
144534678|NCT04908930|521161671|FG001|Overall Study|Lost to Follow-up|1|||
144534679|NCT04908930|521161672|FG002|Overall Study|Lost to Follow-up|0|||
144534680|NCT04908930|521161673|FG003|Overall Study|Lost to Follow-up|0|||
144534681|NCT04908930|521161674|FG004|Overall Study|Lost to Follow-up|0|||
144607939|NCT03086057|521426388|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
144607940|NCT03086057|521426389|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
144607941|NCT03086057|521426386|FG000|Stage 1: PrEP Uptake|Death|1|||
144607942|NCT03086057|521426387|FG001|Stage 1: PrEP Uptake|Death|0|||
144607943|NCT03086057|521426388|FG002|Stage 1: PrEP Uptake|Death|0|||
144607944|NCT03086057|521426389|FG003|Stage 1: PrEP Uptake|Death|0|||
144607945|NCT03086057|521426386|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
144607946|NCT03086057|521426387|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
144607947|NCT03086057|521426388|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
144607948|NCT03086057|521426389|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
144607949|NCT03086057|521426386|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
144607950|NCT03086057|521426387|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
144607951|NCT03086057|521426388|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
144607952|NCT03086057|521426389|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
144607953|NCT03086057|521426386|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
144607954|NCT03086057|521426387|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
144607955|NCT03086057|521426388|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
144607956|NCT03086057|521426389|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
144607957|NCT00003702|521426392|FG000|Overall Study|Ineligible cell types|2|||
144607958|NCT00003702|521426393|FG001|Overall Study|Ineligible cell types|2|||
144607959|NCT00003702|521426392|FG000|Overall Study|Did not meet criteria for persistence|8|||
144607960|NCT00003702|521426393|FG001|Overall Study|Did not meet criteria for persistence|5|||
144607961|NCT00003702|521426392|FG000|Overall Study|WHO score > 6|2|||
144607962|NCT00003702|521426393|FG001|Overall Study|WHO score > 6|1|||
144607963|NCT00003702|521426392|FG000|Overall Study|Inadequate documentation of disease|1|||
144607964|NCT00003702|521426393|FG001|Overall Study|Inadequate documentation of disease|3|||
144607965|NCT01786603|521426394|FG000|Overall Study|Death|5|||
144607966|NCT01786603|521426395|FG001|Overall Study|Death|1|||
144607967|NCT01786603|521426394|FG000|Overall Study|Adverse Event|6|||
144607968|NCT01786603|521426395|FG001|Overall Study|Adverse Event|2|||
144607969|NCT01786603|521426394|FG000|Overall Study|Physician decision to withdraw|6|||
144607970|NCT01786603|521426395|FG001|Overall Study|Physician decision to withdraw|7|||
144607971|NCT01786603|521426394|FG000|Overall Study|Lost to Follow-up|1|||
144607972|NCT01786603|521426395|FG001|Overall Study|Lost to Follow-up|2|||
144607973|NCT01226459|521426396|FG000|Overall Study|Adverse Event|2|||
144607974|NCT01226459|521426397|FG001|Overall Study|Adverse Event|8|||
144607975|NCT01226459|521426396|FG000|Overall Study|Protocol Violation|4|||
144607976|NCT01226459|521426397|FG001|Overall Study|Protocol Violation|3|||
144607977|NCT01226459|521426396|FG000|Overall Study|Withdrawal by Subject|10|||
144607978|NCT01226459|521426397|FG001|Overall Study|Withdrawal by Subject|13|||
144607979|NCT01226459|521426396|FG000|Overall Study|Lost to Follow-up|4|||
144607980|NCT01226459|521426397|FG001|Overall Study|Lost to Follow-up|8|||
144607981|NCT01226459|521426396|FG000|Overall Study|Pregnancy|1|||
144607982|NCT01226459|521426397|FG001|Overall Study|Pregnancy|0|||
144607983|NCT00474708|521426398|FG000|Overall Study|Lack of Efficacy|11|||
144607984|NCT00474708|521426399|FG001|Overall Study|Lack of Efficacy|5|||
144607985|NCT00474708|521426398|FG000|Overall Study|Suicide ideation/behavior|0|||
144607986|NCT00474708|521426399|FG001|Overall Study|Suicide ideation/behavior|1|||
144607987|NCT00474708|521426398|FG000|Overall Study|Withdrawal by Subject|7|||
144607988|NCT00474708|521426399|FG001|Overall Study|Withdrawal by Subject|0|||
144725871|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
144725872|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
144607989|NCT00474708|521426398|FG000|Overall Study|Lack of compliance|12|||
144607990|NCT00474708|521426399|FG001|Overall Study|Lack of compliance|4|||
144607991|NCT00474708|521426398|FG000|Overall Study|Lost to Follow-up|18|||
144607992|NCT00474708|521426399|FG001|Overall Study|Lost to Follow-up|9|||
144607993|NCT00474708|521426398|FG000|Overall Study|Physician Decision|9|||
144196914|NCT00858143|519918634|FG000|Overall Study|Other|23|||
144196915|NCT03853148|519918635|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
144607994|NCT00474708|521426399|FG001|Overall Study|Physician Decision|6|||
144607995|NCT01092143|521426400|FG000|Overall Study|Adverse Event|10|||
144607996|NCT01092143|521426401|FG001|Overall Study|Adverse Event|5|||
144607997|NCT01092143|521426402|FG002|Overall Study|Adverse Event|1|||
144607998|NCT01092143|521426403|FG003|Overall Study|Adverse Event|4|||
144607999|NCT01092143|521426404|FG004|Overall Study|Adverse Event|3|||
144608000|NCT01092143|521426400|FG000|Overall Study|Lost to Follow-up|1|||
144608001|NCT01092143|521426401|FG001|Overall Study|Lost to Follow-up|0|||
144608002|NCT01092143|521426402|FG002|Overall Study|Lost to Follow-up|1|||
144608003|NCT01092143|521426403|FG003|Overall Study|Lost to Follow-up|0|||
144608004|NCT01092143|521426404|FG004|Overall Study|Lost to Follow-up|0|||
144608005|NCT01092143|521426400|FG000|Overall Study|Consent withdrawn|2|||
144608006|NCT01092143|521426401|FG001|Overall Study|Consent withdrawn|1|||
144608007|NCT01092143|521426402|FG002|Overall Study|Consent withdrawn|0|||
144196916|NCT03853148|519918636|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
144608008|NCT01092143|521426403|FG003|Overall Study|Consent withdrawn|1|||
144608009|NCT01092143|521426404|FG004|Overall Study|Consent withdrawn|3|||
144608010|NCT01092143|521426400|FG000|Overall Study|Not treated|0|||
144608011|NCT01092143|521426401|FG001|Overall Study|Not treated|0|||
144608012|NCT01092143|521426402|FG002|Overall Study|Not treated|1|||
144608013|NCT01092143|521426403|FG003|Overall Study|Not treated|0|||
144608014|NCT01092143|521426404|FG004|Overall Study|Not treated|0|||
144608015|NCT01092143|521426400|FG000|Overall Study|did not reversibility criteria|0|||
144608016|NCT01092143|521426401|FG001|Overall Study|did not reversibility criteria|0|||
144608017|NCT01092143|521426402|FG002|Overall Study|did not reversibility criteria|1|||
144608018|NCT01092143|521426403|FG003|Overall Study|did not reversibility criteria|0|||
144608019|NCT01092143|521426404|FG004|Overall Study|did not reversibility criteria|0|||
144608020|NCT01092143|521426400|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
144608021|NCT01092143|521426401|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
144608022|NCT01092143|521426402|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
144608023|NCT01092143|521426403|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
144608024|NCT01092143|521426404|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
144608025|NCT01092143|521426400|FG000|Overall Study|Ineligible patient|1|||
144459400|NCT02621931|520878414|FG001|Overall Study|Lost to Follow-up|7|||
144459401|NCT02621931|520878415|FG002|Overall Study|Lost to Follow-up|10|||
144459402|NCT02621931|520878413|FG000|Overall Study|Lack of Efficacy|0|||
144459403|NCT02621931|520878414|FG001|Overall Study|Lack of Efficacy|0|||
144459404|NCT02621931|520878415|FG002|Overall Study|Lack of Efficacy|1|||
144459405|NCT02621931|520878413|FG000|Overall Study|Other|1|||
144608026|NCT01092143|521426401|FG001|Overall Study|Ineligible patient|0|||
144608027|NCT01092143|521426402|FG002|Overall Study|Ineligible patient|0|||
144608028|NCT01092143|521426403|FG003|Overall Study|Ineligible patient|0|||
144608029|NCT01092143|521426404|FG004|Overall Study|Ineligible patient|0|||
144608030|NCT01092143|521426400|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
144608031|NCT01092143|521426401|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
144608032|NCT01092143|521426402|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
144608033|NCT01092143|521426403|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
144608034|NCT01092143|521426404|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
144608035|NCT01092143|521426400|FG000|Overall Study|Patient travel|0|||
144608036|NCT01092143|521426401|FG001|Overall Study|Patient travel|0|||
144608037|NCT01092143|521426402|FG002|Overall Study|Patient travel|0|||
144608038|NCT01092143|521426403|FG003|Overall Study|Patient travel|0|||
144608039|NCT01092143|521426404|FG004|Overall Study|Patient travel|1|||
144608040|NCT01092143|521426400|FG000|Overall Study|Non compliance with study medication|0|||
144608041|NCT01092143|521426401|FG001|Overall Study|Non compliance with study medication|0|||
144608042|NCT01092143|521426402|FG002|Overall Study|Non compliance with study medication|0|||
144608043|NCT01092143|521426403|FG003|Overall Study|Non compliance with study medication|0|||
144608044|NCT01092143|521426404|FG004|Overall Study|Non compliance with study medication|1|||
144608045|NCT01092143|521426400|FG000|Overall Study|Randomized by mistake|0|||
144608046|NCT01092143|521426401|FG001|Overall Study|Randomized by mistake|0|||
144608047|NCT01092143|521426402|FG002|Overall Study|Randomized by mistake|0|||
144608048|NCT01092143|521426403|FG003|Overall Study|Randomized by mistake|1|||
144608049|NCT01092143|521426404|FG004|Overall Study|Randomized by mistake|0|||
144608050|NCT01092143|521426400|FG000|Overall Study|Pregnancy|0|||
144608051|NCT01092143|521426401|FG001|Overall Study|Pregnancy|0|||
144608052|NCT01092143|521426402|FG002|Overall Study|Pregnancy|0|||
144608053|NCT01092143|521426403|FG003|Overall Study|Pregnancy|1|||
144608054|NCT01092143|521426404|FG004|Overall Study|Pregnancy|0|||
144608055|NCT00117598|521426410|FG000|Prior to Treatment Cross Over|Death|40|||
144608056|NCT00117598|521426411|FG001|Prior to Treatment Cross Over|Death|41|||
144608057|NCT00117598|521426412|FG002|Prior to Treatment Cross Over|Death|37|||
144608058|NCT00117598|521426413|FG003|Prior to Treatment Cross Over|Death|0|||
144608059|NCT00117598|521426414|FG004|Prior to Treatment Cross Over|Death|0|||
144608060|NCT00117598|521426410|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
144608061|NCT00117598|521426411|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
144608062|NCT00117598|521426412|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
144608063|NCT00117598|521426413|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
144608064|NCT00117598|521426414|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
144608065|NCT00117598|521426410|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
144608066|NCT00117598|521426411|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
144608067|NCT00117598|521426412|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
144608068|NCT00117598|521426413|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
144259299|NCT01089127|520150354|FG000|Overall Study|Protocol deviation|0|||
144459406|NCT02621931|520878414|FG001|Overall Study|Other|1|||
144608069|NCT00117598|521426414|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
144608070|NCT00117598|521426410|FG000|Prior to Treatment Cross Over|Other|15|||
144608071|NCT00117598|521426411|FG001|Prior to Treatment Cross Over|Other|9|||
144608072|NCT00117598|521426412|FG002|Prior to Treatment Cross Over|Other|9|||
144608073|NCT00117598|521426413|FG003|Prior to Treatment Cross Over|Other|0|||
144608074|NCT00117598|521426414|FG004|Prior to Treatment Cross Over|Other|0|||
144459407|NCT02621931|520878415|FG002|Overall Study|Other|3|||
144459408|NCT02891187|520878416|FG000|Overall Study|Lost to Follow-up|1|||
144608075|NCT00117598|521426410|FG000|After Treament Cross Over|Death|0|||
144608076|NCT00117598|521426411|FG001|After Treament Cross Over|Death|0|||
144608077|NCT00117598|521426412|FG002|After Treament Cross Over|Death|0|||
144608078|NCT00117598|521426413|FG003|After Treament Cross Over|Death|1|||
144608079|NCT00117598|521426414|FG004|After Treament Cross Over|Death|2|||
144608080|NCT00117598|521426410|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
144608081|NCT00117598|521426411|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
144608082|NCT00117598|521426412|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
144608083|NCT00117598|521426413|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
144608084|NCT00117598|521426414|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
144608085|NCT00117598|521426410|FG000|After Treament Cross Over|Other|0|||
144608086|NCT00117598|521426411|FG001|After Treament Cross Over|Other|0|||
144608087|NCT00117598|521426412|FG002|After Treament Cross Over|Other|0|||
144608088|NCT00117598|521426413|FG003|After Treament Cross Over|Other|1|||
144608089|NCT00117598|521426414|FG004|After Treament Cross Over|Other|2|||
144608090|NCT00430482|521426419|FG000|Completed Treatment|Insufficient Treatment|7|||
144608091|NCT00430482|521426420|FG001|Completed Treatment|Insufficient Treatment|11|||
144608092|NCT00545402|521426421|FG000|Overall Study|Discontinuation of treatment|17|||
144608093|NCT00545402|521426422|FG001|Overall Study|Discontinuation of treatment|9|||
144608094|NCT00545402|521426421|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
144608095|NCT00545402|521426422|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
144608096|NCT00545402|521426421|FG000|Overall Study|Death|5|||
144608097|NCT00545402|521426422|FG001|Overall Study|Death|7|||
144608098|NCT00545402|521426421|FG000|Overall Study|Graft loss|2|||
144608099|NCT00545402|521426422|FG001|Overall Study|Graft loss|4|||
144608100|NCT00545402|521426421|FG000|Overall Study|Withdrawal by Subject|0|||
144608101|NCT00545402|521426422|FG001|Overall Study|Withdrawal by Subject|1|||
144608102|NCT00545402|521426421|FG000|Overall Study|Protocol Violation|1|||
144608103|NCT00545402|521426422|FG001|Overall Study|Protocol Violation|0|||
144608104|NCT00545402|521426421|FG000|Overall Study|Reason not specified|1|||
144608105|NCT00545402|521426422|FG001|Overall Study|Reason not specified|1|||
144608106|NCT00555477|521426423|FG000|Overall Study|Adverse Event|0|||
144608107|NCT00555477|521426424|FG001|Overall Study|Adverse Event|9|||
144608108|NCT00555477|521426423|FG000|Overall Study|Withdrawal by Subject|1|||
144608109|NCT00555477|521426424|FG001|Overall Study|Withdrawal by Subject|2|||
144608110|NCT00555477|521426423|FG000|Overall Study|Physician Decision|1|||
144608111|NCT00555477|521426424|FG001|Overall Study|Physician Decision|2|||
144608112|NCT00397033|521426425|FG000|Overall Study|Adverse Event|7|||
144608113|NCT00397033|521426426|FG001|Overall Study|Adverse Event|10|||
144608114|NCT00397033|521426427|FG002|Overall Study|Adverse Event|4|||
144608115|NCT00397033|521426425|FG000|Overall Study|Lack of Efficacy|22|||
144608116|NCT00397033|521426426|FG001|Overall Study|Lack of Efficacy|12|||
144608117|NCT00397033|521426427|FG002|Overall Study|Lack of Efficacy|9|||
144608118|NCT00397033|521426425|FG000|Overall Study|Lost to Follow-up|3|||
144608119|NCT00397033|521426426|FG001|Overall Study|Lost to Follow-up|3|||
144608120|NCT00397033|521426427|FG002|Overall Study|Lost to Follow-up|3|||
144608121|NCT00397033|521426425|FG000|Overall Study|Withdrawal by Subject|12|||
144608122|NCT00397033|521426426|FG001|Overall Study|Withdrawal by Subject|7|||
144608123|NCT00397033|521426427|FG002|Overall Study|Withdrawal by Subject|5|||
144608124|NCT00397033|521426425|FG000|Overall Study|Other|0|||
144608125|NCT00397033|521426426|FG001|Overall Study|Other|5|||
144608126|NCT00397033|521426427|FG002|Overall Study|Other|2|||
144608127|NCT03519867|521426428|FG000|Overall Study|Adverse Event|1|||
144608128|NCT03519867|521426429|FG001|Overall Study|Adverse Event|1|||
144608129|NCT03519867|521426430|FG002|Overall Study|Adverse Event|0|||
144608130|NCT03519867|521426431|FG003|Overall Study|Adverse Event|0|||
144608131|NCT03519867|521426432|FG004|Overall Study|Adverse Event|0|||
144608132|NCT03519867|521426433|FG005|Overall Study|Adverse Event|0|||
144608133|NCT03519867|521426434|FG006|Overall Study|Adverse Event|0|||
144608134|NCT03519867|521426435|FG007|Overall Study|Adverse Event|0|||
144608135|NCT03519867|521426436|FG008|Overall Study|Adverse Event|0|||
144608136|NCT03519867|521426437|FG009|Overall Study|Adverse Event|0|||
144608137|NCT03519867|521426428|FG000|Overall Study|Protocol Violation|0|||
144608138|NCT03519867|521426429|FG001|Overall Study|Protocol Violation|0|||
144725873|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
144459409|NCT02891187|520878417|FG001|Overall Study|Lost to Follow-up|2|||
144459410|NCT01912612|520878427|FG000|Overall Study|Adverse Event|4|||
144459411|NCT01912612|520878428|FG001|Overall Study|Adverse Event|0|||
144459412|NCT01912612|520878429|FG002|Overall Study|Adverse Event|0|||
144459413|NCT01912612|520878427|FG000|Overall Study|Withdrew consent|1|||
144459414|NCT01912612|520878428|FG001|Overall Study|Withdrew consent|0|||
144459415|NCT01912612|520878429|FG002|Overall Study|Withdrew consent|0|||
144608139|NCT03519867|521426430|FG002|Overall Study|Protocol Violation|0|||
144608140|NCT03519867|521426431|FG003|Overall Study|Protocol Violation|0|||
144608141|NCT03519867|521426432|FG004|Overall Study|Protocol Violation|0|||
144608142|NCT03519867|521426433|FG005|Overall Study|Protocol Violation|1|||
144608143|NCT03519867|521426434|FG006|Overall Study|Protocol Violation|0|||
144608144|NCT03519867|521426435|FG007|Overall Study|Protocol Violation|0|||
144608145|NCT03519867|521426436|FG008|Overall Study|Protocol Violation|0|||
144608146|NCT03519867|521426437|FG009|Overall Study|Protocol Violation|0|||
144608147|NCT03519867|521426428|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608148|NCT03519867|521426429|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608149|NCT03519867|521426430|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608150|NCT03519867|521426431|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608151|NCT03519867|521426432|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608152|NCT03519867|521426433|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608153|NCT03519867|521426434|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
144608154|NCT03519867|521426435|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608155|NCT03519867|521426436|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608156|NCT03519867|521426437|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
144608157|NCT03519867|521426428|FG000|Overall Study|Admin. of other reversal agent|1|||
144608158|NCT03519867|521426429|FG001|Overall Study|Admin. of other reversal agent|1|||
144608159|NCT03519867|521426430|FG002|Overall Study|Admin. of other reversal agent|0|||
144608160|NCT03519867|521426431|FG003|Overall Study|Admin. of other reversal agent|0|||
144608161|NCT03519867|521426432|FG004|Overall Study|Admin. of other reversal agent|0|||
144459416|NCT01912612|520878427|FG000|Overall Study|Study design change|0|||
144459417|NCT01912612|520878428|FG001|Overall Study|Study design change|0|||
144459418|NCT01912612|520878429|FG002|Overall Study|Study design change|3|||
144459419|NCT01588184|520878430|FG000|Overall Study|Death|1|||
144459420|NCT01588184|520878431|FG001|Overall Study|Death|0|||
144459421|NCT01588184|520878432|FG002|Overall Study|Death|0|||
144459422|NCT01588184|520878433|FG003|Overall Study|Death|1|||
144459423|NCT01588184|520878434|FG004|Overall Study|Death|1|||
144459424|NCT01588184|520878435|FG005|Overall Study|Death|1|||
144459425|NCT01588184|520878430|FG000|Overall Study|Withdrawal by Subject|2|||
144459426|NCT01588184|520878431|FG001|Overall Study|Withdrawal by Subject|4|||
144459427|NCT01588184|520878432|FG002|Overall Study|Withdrawal by Subject|0|||
144459428|NCT01588184|520878433|FG003|Overall Study|Withdrawal by Subject|1|||
144459429|NCT01588184|520878434|FG004|Overall Study|Withdrawal by Subject|0|||
144608162|NCT03519867|521426433|FG005|Overall Study|Admin. of other reversal agent|1|||
144608163|NCT03519867|521426434|FG006|Overall Study|Admin. of other reversal agent|0|||
144608164|NCT03519867|521426435|FG007|Overall Study|Admin. of other reversal agent|0|||
144608165|NCT03519867|521426436|FG008|Overall Study|Admin. of other reversal agent|0|||
144608166|NCT03519867|521426437|FG009|Overall Study|Admin. of other reversal agent|0|||
144608167|NCT03519867|521426428|FG000|Overall Study|Reason not provided|1|||
144608168|NCT03519867|521426429|FG001|Overall Study|Reason not provided|1|||
144608169|NCT03519867|521426430|FG002|Overall Study|Reason not provided|1|||
144608170|NCT03519867|521426431|FG003|Overall Study|Reason not provided|1|||
144608171|NCT03519867|521426432|FG004|Overall Study|Reason not provided|0|||
144608172|NCT03519867|521426433|FG005|Overall Study|Reason not provided|1|||
144608173|NCT03519867|521426434|FG006|Overall Study|Reason not provided|0|||
144608174|NCT03519867|521426435|FG007|Overall Study|Reason not provided|1|||
144608175|NCT03519867|521426436|FG008|Overall Study|Reason not provided|1|||
144608176|NCT03519867|521426437|FG009|Overall Study|Reason not provided|0|||
144608177|NCT01721057|521426438|FG000|Treatment Period|Withdrawal by Subject|11|||
144608178|NCT01721057|521426439|FG001|Treatment Period|Withdrawal by Subject|5|||
144608179|NCT01721057|521426440|FG002|Treatment Period|Withdrawal by Subject|8|||
144608180|NCT01721057|521426441|FG003|Treatment Period|Withdrawal by Subject|0|||
144608181|NCT01721057|521426442|FG004|Treatment Period|Withdrawal by Subject|0|||
144608182|NCT01721057|521426443|FG005|Treatment Period|Withdrawal by Subject|0|||
144608183|NCT01721057|521426444|FG006|Treatment Period|Withdrawal by Subject|0|||
144608184|NCT01721057|521426438|FG000|Treatment Period|Adverse Event|7|||
144608185|NCT01721057|521426439|FG001|Treatment Period|Adverse Event|10|||
144608186|NCT01721057|521426440|FG002|Treatment Period|Adverse Event|12|||
144608187|NCT01721057|521426441|FG003|Treatment Period|Adverse Event|0|||
144608188|NCT01721057|521426442|FG004|Treatment Period|Adverse Event|0|||
144608189|NCT01721057|521426443|FG005|Treatment Period|Adverse Event|0|||
144608190|NCT01721057|521426444|FG006|Treatment Period|Adverse Event|0|||
144608191|NCT01721057|521426438|FG000|Treatment Period|Lack of Efficacy|7|||
144608192|NCT01721057|521426439|FG001|Treatment Period|Lack of Efficacy|3|||
144608193|NCT01721057|521426440|FG002|Treatment Period|Lack of Efficacy|0|||
144608194|NCT01721057|521426441|FG003|Treatment Period|Lack of Efficacy|0|||
144608195|NCT01721057|521426442|FG004|Treatment Period|Lack of Efficacy|0|||
144608196|NCT01721057|521426443|FG005|Treatment Period|Lack of Efficacy|0|||
144608197|NCT01721057|521426444|FG006|Treatment Period|Lack of Efficacy|0|||
144608198|NCT01721057|521426438|FG000|Treatment Period|Lost to Follow-up|1|||
144608199|NCT01721057|521426439|FG001|Treatment Period|Lost to Follow-up|0|||
144608200|NCT01721057|521426440|FG002|Treatment Period|Lost to Follow-up|0|||
144608201|NCT01721057|521426441|FG003|Treatment Period|Lost to Follow-up|0|||
144608202|NCT01721057|521426442|FG004|Treatment Period|Lost to Follow-up|0|||
144608203|NCT01721057|521426443|FG005|Treatment Period|Lost to Follow-up|0|||
144608204|NCT01721057|521426444|FG006|Treatment Period|Lost to Follow-up|0|||
144608205|NCT01721057|521426438|FG000|Treatment Period|Physician Decision|0|||
144608206|NCT01721057|521426439|FG001|Treatment Period|Physician Decision|1|||
144459430|NCT01588184|520878435|FG005|Overall Study|Withdrawal by Subject|0|||
144459431|NCT01588184|520878430|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
144459432|NCT01588184|520878431|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
144459433|NCT01588184|520878432|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
144608207|NCT01721057|521426440|FG002|Treatment Period|Physician Decision|3|||
144608208|NCT01721057|521426441|FG003|Treatment Period|Physician Decision|0|||
144608209|NCT01721057|521426442|FG004|Treatment Period|Physician Decision|0|||
144608210|NCT01721057|521426443|FG005|Treatment Period|Physician Decision|0|||
144608211|NCT01721057|521426444|FG006|Treatment Period|Physician Decision|0|||
144608212|NCT01721057|521426438|FG000|Treatment Period|Death|2|||
144608213|NCT01721057|521426439|FG001|Treatment Period|Death|0|||
144608214|NCT01721057|521426440|FG002|Treatment Period|Death|0|||
144608215|NCT01721057|521426441|FG003|Treatment Period|Death|0|||
144608216|NCT01721057|521426442|FG004|Treatment Period|Death|0|||
144608217|NCT01721057|521426443|FG005|Treatment Period|Death|0|||
144608218|NCT01721057|521426444|FG006|Treatment Period|Death|0|||
144608219|NCT01721057|521426438|FG000|Rescue Period|Adverse Event|0|||
144608220|NCT01721057|521426439|FG001|Rescue Period|Adverse Event|0|||
144608221|NCT01721057|521426440|FG002|Rescue Period|Adverse Event|0|||
144608222|NCT01721057|521426441|FG003|Rescue Period|Adverse Event|1|||
144608223|NCT01721057|521426442|FG004|Rescue Period|Adverse Event|0|||
144608224|NCT01721057|521426443|FG005|Rescue Period|Adverse Event|0|||
144608225|NCT01721057|521426444|FG006|Rescue Period|Adverse Event|0|||
144608226|NCT01721057|521426438|FG000|Rescue Period|Lack of Efficacy|0|||
144608227|NCT01721057|521426439|FG001|Rescue Period|Lack of Efficacy|0|||
144608228|NCT01721057|521426440|FG002|Rescue Period|Lack of Efficacy|0|||
144608229|NCT01721057|521426441|FG003|Rescue Period|Lack of Efficacy|2|||
144608230|NCT01721057|521426442|FG004|Rescue Period|Lack of Efficacy|0|||
144608231|NCT01721057|521426443|FG005|Rescue Period|Lack of Efficacy|0|||
144608232|NCT01721057|521426444|FG006|Rescue Period|Lack of Efficacy|0|||
144608233|NCT01202279|521426447|FG000|Overall Study|Adverse Event|8|||
144608234|NCT01202279|521426448|FG001|Overall Study|Adverse Event|6|||
144608235|NCT01202279|521426447|FG000|Overall Study|Withdrawal by Subject|13|||
144608236|NCT01202279|521426448|FG001|Overall Study|Withdrawal by Subject|10|||
144608237|NCT01202279|521426447|FG000|Overall Study|Physician Decision|0|||
144608238|NCT01202279|521426448|FG001|Overall Study|Physician Decision|1|||
144608239|NCT01202279|521426447|FG000|Overall Study|Lost to Follow-up|10|||
144608240|NCT01202279|521426448|FG001|Overall Study|Lost to Follow-up|7|||
144608241|NCT01202279|521426447|FG000|Overall Study|Protocol Violation|1|||
144608242|NCT01202279|521426448|FG001|Overall Study|Protocol Violation|1|||
144608243|NCT01202279|521426447|FG000|Overall Study|study compliance|5|||
144608244|NCT01202279|521426448|FG001|Overall Study|study compliance|2|||
144608245|NCT03805750|521426449|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
144608246|NCT03805750|521426450|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
144608247|NCT01984164|521426451|FG000|Overall Study|Withdrawal by Subject|4|||
144608248|NCT01984164|521426452|FG001|Overall Study|Withdrawal by Subject|3|||
144608249|NCT01984164|521426451|FG000|Overall Study|Adverse Event|5|||
144608250|NCT01984164|521426452|FG001|Overall Study|Adverse Event|19|||
144608251|NCT01984164|521426451|FG000|Overall Study|Lost to Follow-up|1|||
144608252|NCT01984164|521426452|FG001|Overall Study|Lost to Follow-up|3|||
144608253|NCT02811549|521426453|FG000|Overall Study|Lost to Follow-up|1|||
144608254|NCT02811549|521426453|FG000|Overall Study|Withdrawal by Subject|3|||
144608255|NCT02811549|521426453|FG000|Overall Study|Subject screen failed|4|||
144608256|NCT02811549|521426453|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
144608257|NCT03472924|521426454|FG000|Overall Study|Adverse Event|1|||
144608258|NCT03472924|521426455|FG001|Overall Study|Adverse Event|0|||
144608259|NCT02546765|521426459|FG000|Overall Study|Withdrawal by Subject|0|||
144608260|NCT02546765|521426460|FG001|Overall Study|Withdrawal by Subject|1|||
144608261|NCT02546765|521426461|FG002|Overall Study|Withdrawal by Subject|0|||
144608262|NCT02546765|521426462|FG003|Overall Study|Withdrawal by Subject|0|||
144608263|NCT00475722|521426463|FG000|Overall Study|Withdrawal by Subject|12|||
144608264|NCT00475722|521426464|FG001|Overall Study|Withdrawal by Subject|12|||
144608265|NCT00475722|521426463|FG000|Overall Study|Protocol Violation|3|||
144608266|NCT00475722|521426464|FG001|Overall Study|Protocol Violation|0|||
144608267|NCT01889238|521426466|FG000|Overall Study|Death|1|||
144608268|NCT01889238|521426466|FG000|Overall Study|Withdrawal by Subject|1|||
144608269|NCT01889238|521426466|FG000|Overall Study|Adverse Event|6|||
144608270|NCT01889238|521426466|FG000|Overall Study|Disease Progression|104|||
144608271|NCT01889238|521426466|FG000|Overall Study|Other|6|||
144608272|NCT04136184|521426467|FG000|Overall Study|Lost to Follow-up|0|||
144608273|NCT04136184|521426468|FG001|Overall Study|Lost to Follow-up|3|||
144608274|NCT04136184|521426467|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
144608275|NCT04136184|521426468|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
144608276|NCT03318978|521426472|FG000|Overall Study|Withdrawal by Subject|1|||
144608277|NCT02844816|521426473|FG000|Overall Study|No protocol treatment received|5|||
144608278|NCT02844816|521426474|FG001|Overall Study|No protocol treatment received|1|||
144608279|NCT02844816|521426473|FG000|Overall Study|Ineligible|22|||
144608280|NCT02844816|521426474|FG001|Overall Study|Ineligible|15|||
144608281|NCT02844816|521426473|FG000|Overall Study|Participant refusal|5|||
144608282|NCT02844816|521426474|FG001|Overall Study|Participant refusal|5|||
144608283|NCT02844816|521426473|FG000|Overall Study|Adverse Event|5|||
144608284|NCT02844816|521426474|FG001|Overall Study|Adverse Event|4|||
144608285|NCT02844816|521426473|FG000|Overall Study|Death|0|||
144534682|NCT04908930|521161670|FG000|Overall Study|hardware in mouth|1|||
144534683|NCT04908930|521161671|FG001|Overall Study|hardware in mouth|1|||
144534684|NCT04908930|521161672|FG002|Overall Study|hardware in mouth|0|||
144534685|NCT04908930|521161673|FG003|Overall Study|hardware in mouth|0|||
144534686|NCT04908930|521161674|FG004|Overall Study|hardware in mouth|0|||
144534687|NCT04908930|521161670|FG000|Overall Study|wrong team|1|||
144459434|NCT01588184|520878433|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
144459435|NCT01588184|520878434|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
144459436|NCT01588184|520878435|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
144459437|NCT01588184|520878430|FG000|Overall Study|multiple reasons|0|||
144459438|NCT01588184|520878431|FG001|Overall Study|multiple reasons|3|||
144459439|NCT01588184|520878432|FG002|Overall Study|multiple reasons|0|||
144459440|NCT01588184|520878433|FG003|Overall Study|multiple reasons|1|||
144459441|NCT01588184|520878434|FG004|Overall Study|multiple reasons|0|||
144459442|NCT01588184|520878435|FG005|Overall Study|multiple reasons|0|||
144459443|NCT00907153|520878437|FG000|Overall Study|Lost to Follow-up|1|||
144459444|NCT00907153|520878438|FG001|Overall Study|Lost to Follow-up|1|||
144459445|NCT00907153|520878437|FG000|Overall Study|Withdrawal by Subject|1|||
144459446|NCT00907153|520878438|FG001|Overall Study|Withdrawal by Subject|3|||
144459447|NCT01983293|520878441|FG000|Overall Study|Withdrawal by Subject|29|||
144459448|NCT01983293|520878442|FG001|Overall Study|Withdrawal by Subject|15|||
144459449|NCT01983293|520878441|FG000|Overall Study|Missing 12-month visit|3|||
144459450|NCT01983293|520878442|FG001|Overall Study|Missing 12-month visit|3|||
144459451|NCT01983293|520878441|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
144459452|NCT01983293|520878442|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
144459453|NCT03147248|520878446|FG000|Overall Study|Adverse Event|0|||
144459454|NCT03147248|520878447|FG001|Overall Study|Adverse Event|2|||
144459455|NCT03147248|520878448|FG002|Overall Study|Adverse Event|2|||
144459456|NCT03147248|520878449|FG003|Overall Study|Adverse Event|2|||
144459457|NCT03147248|520878450|FG004|Overall Study|Adverse Event|6|||
144459458|NCT03147248|520878451|FG005|Overall Study|Adverse Event|11|||
144459459|NCT03147248|520878446|FG000|Overall Study|Disease progression|1|||
144459460|NCT03147248|520878447|FG001|Overall Study|Disease progression|0|||
144459461|NCT03147248|520878448|FG002|Overall Study|Disease progression|0|||
144459462|NCT03147248|520878449|FG003|Overall Study|Disease progression|0|||
144459463|NCT03147248|520878450|FG004|Overall Study|Disease progression|0|||
144459464|NCT03147248|520878451|FG005|Overall Study|Disease progression|2|||
144459465|NCT03147248|520878446|FG000|Overall Study|Withdrawal by Subject|0|||
144459466|NCT03147248|520878447|FG001|Overall Study|Withdrawal by Subject|0|||
144459467|NCT03147248|520878448|FG002|Overall Study|Withdrawal by Subject|0|||
144459468|NCT03147248|520878449|FG003|Overall Study|Withdrawal by Subject|0|||
144459469|NCT03147248|520878450|FG004|Overall Study|Withdrawal by Subject|12|||
144459470|NCT03147248|520878451|FG005|Overall Study|Withdrawal by Subject|9|||
144459471|NCT03147248|520878446|FG000|Overall Study|Protocol Violation|0|||
144459472|NCT03147248|520878447|FG001|Overall Study|Protocol Violation|0|||
144459473|NCT03147248|520878448|FG002|Overall Study|Protocol Violation|0|||
144459474|NCT03147248|520878449|FG003|Overall Study|Protocol Violation|0|||
144459475|NCT03147248|520878450|FG004|Overall Study|Protocol Violation|2|||
144459476|NCT03147248|520878451|FG005|Overall Study|Protocol Violation|0|||
144459477|NCT03147248|520878446|FG000|Overall Study|Lost to Follow-up|0|||
144459478|NCT03147248|520878447|FG001|Overall Study|Lost to Follow-up|0|||
144459479|NCT03147248|520878448|FG002|Overall Study|Lost to Follow-up|0|||
144459480|NCT03147248|520878449|FG003|Overall Study|Lost to Follow-up|0|||
144459481|NCT03147248|520878450|FG004|Overall Study|Lost to Follow-up|2|||
144459482|NCT03147248|520878451|FG005|Overall Study|Lost to Follow-up|0|||
144459483|NCT03147248|520878446|FG000|Overall Study|Pregnancy|0|||
144459484|NCT03147248|520878447|FG001|Overall Study|Pregnancy|0|||
144459485|NCT03147248|520878448|FG002|Overall Study|Pregnancy|0|||
144459486|NCT03147248|520878449|FG003|Overall Study|Pregnancy|0|||
144459487|NCT03147248|520878450|FG004|Overall Study|Pregnancy|1|||
144459488|NCT03147248|520878451|FG005|Overall Study|Pregnancy|0|||
144459489|NCT03147248|520878446|FG000|Overall Study|Death|0|||
144459490|NCT03147248|520878447|FG001|Overall Study|Death|0|||
144459491|NCT03147248|520878448|FG002|Overall Study|Death|0|||
144459492|NCT03147248|520878449|FG003|Overall Study|Death|0|||
144459493|NCT03147248|520878450|FG004|Overall Study|Death|0|||
144459494|NCT03147248|520878451|FG005|Overall Study|Death|4|||
144459495|NCT03147248|520878446|FG000|Overall Study|Physician Decision|0|||
144459496|NCT03147248|520878447|FG001|Overall Study|Physician Decision|0|||
144459497|NCT03147248|520878448|FG002|Overall Study|Physician Decision|0|||
144459498|NCT03147248|520878449|FG003|Overall Study|Physician Decision|0|||
144459499|NCT03147248|520878450|FG004|Overall Study|Physician Decision|2|||
144459500|NCT03147248|520878451|FG005|Overall Study|Physician Decision|4|||
144459501|NCT03147248|520878446|FG000|Overall Study|Prolonged Dosing Interval|0|||
144534688|NCT04908930|521161671|FG001|Overall Study|wrong team|0|||
144608286|NCT02844816|521426474|FG001|Overall Study|Death|1|||
144459502|NCT03147248|520878447|FG001|Overall Study|Prolonged Dosing Interval|0|||
144459503|NCT03147248|520878448|FG002|Overall Study|Prolonged Dosing Interval|0|||
144534689|NCT04908930|521161672|FG002|Overall Study|wrong team|0|||
144534690|NCT04908930|521161673|FG003|Overall Study|wrong team|0|||
144608287|NCT02844816|521426473|FG000|Overall Study|Disease progression/recurrence|50|||
144608288|NCT02844816|521426474|FG001|Overall Study|Disease progression/recurrence|24|||
144608289|NCT02844816|521426473|FG000|Overall Study|Physician Decision|1|||
144608290|NCT02844816|521426474|FG001|Overall Study|Physician Decision|1|||
144608291|NCT02717754|521426478|FG000|Overall Study|Incorrect Infusion Duration|0|||
144608292|NCT02717754|521426479|FG001|Overall Study|Incorrect Infusion Duration|0|||
144608293|NCT02717754|521426480|FG002|Overall Study|Incorrect Infusion Duration|0|||
144608294|NCT02717754|521426481|FG003|Overall Study|Incorrect Infusion Duration|10|||
144459504|NCT03147248|520878449|FG003|Overall Study|Prolonged Dosing Interval|0|||
144459505|NCT03147248|520878450|FG004|Overall Study|Prolonged Dosing Interval|1|||
144459506|NCT03147248|520878451|FG005|Overall Study|Prolonged Dosing Interval|1|||
144459507|NCT03750552|520878452|FG000|Overall Study|Adverse Event|5|||
144459508|NCT03750552|520878453|FG001|Overall Study|Adverse Event|1|||
144459509|NCT03750552|520878452|FG000|Overall Study|Withdrawal by Subject|1|||
144459510|NCT03750552|520878453|FG001|Overall Study|Withdrawal by Subject|1|||
144459511|NCT03750552|520878452|FG000|Overall Study|Other|2|||
144459512|NCT03750552|520878453|FG001|Overall Study|Other|0|||
144459513|NCT02062632|520878454|FG000|Overall Study|No treatment data|1|||
144459514|NCT00773968|520878457|FG000|Overall Study|Adverse Event|2|||
144459515|NCT00773968|520878457|FG000|Overall Study|Death|1|||
144459516|NCT00773968|520878457|FG000|Overall Study|Failure to Return|2|||
144459517|NCT00773968|520878457|FG000|Overall Study|Lack of Efficacy|3|||
144459518|NCT00773968|520878457|FG000|Overall Study|Protocol Violation|1|||
144459519|NCT00773968|520878457|FG000|Overall Study|Withdrawal by Subject|11|||
144459520|NCT00773968|520878457|FG000|Overall Study|Screen Failure|17|||
144459521|NCT00773968|520878457|FG000|Overall Study|Other|8|||
144459522|NCT02008890|520878465|FG000|Period 1|Withdrawal by Subject|7|||
144459523|NCT02008890|520878466|FG001|Period 1|Withdrawal by Subject|7|||
144459524|NCT02008890|520878467|FG002|Period 1|Withdrawal by Subject|5|||
144459525|NCT02008890|520878468|FG003|Period 1|Withdrawal by Subject|0|||
144459526|NCT02008890|520878469|FG004|Period 1|Withdrawal by Subject|0|||
144459527|NCT02008890|520878465|FG000|Period 1|Pregnancy|1|||
144608295|NCT02717754|521426482|FG004|Overall Study|Incorrect Infusion Duration|20|||
144608296|NCT02717754|521426483|FG005|Overall Study|Incorrect Infusion Duration|20|||
144608297|NCT01200238|521426484|FG000|Overall Study|Adverse Event|2|||
144608298|NCT01200238|521426485|FG001|Overall Study|Adverse Event|1|||
144608299|NCT01200238|521426484|FG000|Overall Study|Progressive Disease|5|||
144608300|NCT01200238|521426485|FG001|Overall Study|Progressive Disease|8|||
144608301|NCT01200238|521426484|FG000|Overall Study|Withdrawal by Subject|0|||
144608302|NCT01200238|521426485|FG001|Overall Study|Withdrawal by Subject|1|||
144608303|NCT00482703|521426486|FG000|Overall Study|Poor compliance|1|||
144608304|NCT00482703|521426487|FG001|Overall Study|Poor compliance|0|||
144608305|NCT00667823|521426489|FG000|Overall Study|Lost to Follow-up|5|||
144608306|NCT00667823|521426489|FG000|Overall Study|Adverse Event|7|||
144608307|NCT00667823|521426489|FG000|Overall Study|Death|182|||
144608308|NCT00667823|521426489|FG000|Overall Study|Withdrawal by Subject|12|||
144608309|NCT00667823|521426489|FG000|Overall Study|Other|8|||
144608310|NCT00667823|521426489|FG000|Overall Study|Missing (completion page missing)|2|||
144608311|NCT02592018|521426490|FG000|Overall Study|Adverse Event|1|||
144608312|NCT02592018|521426490|FG000|Overall Study|Lost to Follow-up|1|||
144608313|NCT03697720|521427781|FG000|Overall Study|Lost to Follow-up|7|||
144608314|NCT05050318|521427784|FG000|Overall Study|Protocol Deviation|1|||
144608315|NCT05050318|521427785|FG001|Overall Study|Protocol Deviation|0|||
144608316|NCT05050318|521427786|FG002|Overall Study|Protocol Deviation|0|||
144608317|NCT00766038|521427789|FG000|Overall Study|Lost to Follow-up|15|||
144608318|NCT00766038|521427790|FG001|Overall Study|Lost to Follow-up|14|||
144608319|NCT04183790|521427791|FG000|Overall Study|Participants did not rollover to Part B|12|||
144459528|NCT02008890|520878466|FG001|Period 1|Pregnancy|0|||
144459529|NCT02008890|520878467|FG002|Period 1|Pregnancy|0|||
144459530|NCT02008890|520878468|FG003|Period 1|Pregnancy|0|||
144459531|NCT02008890|520878469|FG004|Period 1|Pregnancy|0|||
144608320|NCT04183790|521427792|FG001|Overall Study|Participants did not rollover to Part B|0|||
144608321|NCT04183790|521427791|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
144608322|NCT04183790|521427792|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
144608323|NCT04183790|521427791|FG000|Overall Study|Commercial drug is available for participant|6|||
144608324|NCT04183790|521427792|FG001|Overall Study|Commercial drug is available for participant|0|||
144608325|NCT04183790|521427791|FG000|Overall Study|Adverse Event|1|||
144608326|NCT04183790|521427792|FG001|Overall Study|Adverse Event|0|||
144608327|NCT04183790|521427791|FG000|Overall Study|Not enrolled in 107 study|0|||
144608328|NCT04183790|521427792|FG001|Overall Study|Not enrolled in 107 study|2|||
144259300|NCT01089127|520150355|FG001|Overall Study|Protocol deviation|1|||
144459532|NCT02008890|520878465|FG000|Period 1|Physician Decision|1|||
144459533|NCT02008890|520878466|FG001|Period 1|Physician Decision|0|||
144459534|NCT02008890|520878467|FG002|Period 1|Physician Decision|1|||
144459535|NCT02008890|520878468|FG003|Period 1|Physician Decision|0|||
144459536|NCT02008890|520878469|FG004|Period 1|Physician Decision|0|||
144459537|NCT02008890|520878465|FG000|Period 1|Adverse Event|6|||
144459538|NCT02008890|520878466|FG001|Period 1|Adverse Event|8|||
144459539|NCT02008890|520878467|FG002|Period 1|Adverse Event|6|||
144608329|NCT01251653|521427793|FG000|Overall Study|Progressive Disease|1|||
144608330|NCT01251653|521427794|FG001|Overall Study|Progressive Disease|7|||
144608331|NCT01251653|521427795|FG002|Overall Study|Progressive Disease|16|||
144608332|NCT01251653|521427796|FG003|Overall Study|Progressive Disease|4|||
144608333|NCT01251653|521427797|FG004|Overall Study|Progressive Disease|0|||
144608334|NCT01251653|521427798|FG005|Overall Study|Progressive Disease|17|||
144608335|NCT01251653|521427799|FG006|Overall Study|Progressive Disease|14|||
144608336|NCT01251653|521427800|FG007|Overall Study|Progressive Disease|7|||
144608337|NCT01251653|521427801|FG008|Overall Study|Progressive Disease|5|||
144608338|NCT01251653|521427793|FG000|Overall Study|Dose-limiting toxicity|0|||
144608339|NCT01251653|521427794|FG001|Overall Study|Dose-limiting toxicity|1|||
144608340|NCT01251653|521427795|FG002|Overall Study|Dose-limiting toxicity|1|||
144608341|NCT01251653|521427796|FG003|Overall Study|Dose-limiting toxicity|1|||
144608342|NCT01251653|521427797|FG004|Overall Study|Dose-limiting toxicity|0|||
144608343|NCT01251653|521427798|FG005|Overall Study|Dose-limiting toxicity|0|||
144608344|NCT01251653|521427799|FG006|Overall Study|Dose-limiting toxicity|2|||
144608345|NCT01251653|521427800|FG007|Overall Study|Dose-limiting toxicity|0|||
144608346|NCT01251653|521427801|FG008|Overall Study|Dose-limiting toxicity|0|||
144608347|NCT01251653|521427793|FG000|Overall Study|Adverse Event|1|||
144608348|NCT01251653|521427794|FG001|Overall Study|Adverse Event|0|||
144608349|NCT01251653|521427795|FG002|Overall Study|Adverse Event|2|||
144608350|NCT01251653|521427796|FG003|Overall Study|Adverse Event|1|||
144608351|NCT01251653|521427797|FG004|Overall Study|Adverse Event|1|||
144608352|NCT01251653|521427798|FG005|Overall Study|Adverse Event|0|||
144608353|NCT01251653|521427799|FG006|Overall Study|Adverse Event|2|||
144608354|NCT01251653|521427800|FG007|Overall Study|Adverse Event|2|||
144608355|NCT01251653|521427801|FG008|Overall Study|Adverse Event|1|||
144608356|NCT01251653|521427793|FG000|Overall Study|Withdrawal by Subject|1|||
144608357|NCT01251653|521427794|FG001|Overall Study|Withdrawal by Subject|0|||
144608358|NCT01251653|521427795|FG002|Overall Study|Withdrawal by Subject|1|||
144608359|NCT01251653|521427796|FG003|Overall Study|Withdrawal by Subject|0|||
144608360|NCT01251653|521427797|FG004|Overall Study|Withdrawal by Subject|1|||
144608361|NCT01251653|521427798|FG005|Overall Study|Withdrawal by Subject|1|||
144608362|NCT01251653|521427799|FG006|Overall Study|Withdrawal by Subject|0|||
144608363|NCT01251653|521427800|FG007|Overall Study|Withdrawal by Subject|1|||
144608364|NCT01251653|521427801|FG008|Overall Study|Withdrawal by Subject|0|||
144608365|NCT01251653|521427793|FG000|Overall Study|Other reason not mentioned above|0|||
144608366|NCT01251653|521427794|FG001|Overall Study|Other reason not mentioned above|0|||
144608367|NCT01251653|521427795|FG002|Overall Study|Other reason not mentioned above|0|||
144608368|NCT01251653|521427796|FG003|Overall Study|Other reason not mentioned above|0|||
144608369|NCT01251653|521427797|FG004|Overall Study|Other reason not mentioned above|0|||
144608370|NCT01251653|521427798|FG005|Overall Study|Other reason not mentioned above|0|||
144459540|NCT02008890|520878468|FG003|Period 1|Adverse Event|0|||
144459541|NCT02008890|520878469|FG004|Period 1|Adverse Event|0|||
144459542|NCT02008890|520878465|FG000|Period 2|Adverse Event|12|||
144459543|NCT02008890|520878466|FG001|Period 2|Adverse Event|7|||
144459544|NCT02008890|520878467|FG002|Period 2|Adverse Event|0|||
144459545|NCT02008890|520878468|FG003|Period 2|Adverse Event|5|||
144459546|NCT02008890|520878469|FG004|Period 2|Adverse Event|5|||
144459547|NCT02008890|520878465|FG000|Period 2|Withdrawal by Subject|11|||
144459548|NCT02008890|520878466|FG001|Period 2|Withdrawal by Subject|8|||
144459549|NCT02008890|520878467|FG002|Period 2|Withdrawal by Subject|0|||
144459550|NCT02008890|520878468|FG003|Period 2|Withdrawal by Subject|7|||
144459551|NCT02008890|520878469|FG004|Period 2|Withdrawal by Subject|2|||
144459552|NCT02008890|520878465|FG000|Period 2|Physician Decision|4|||
144459553|NCT02008890|520878466|FG001|Period 2|Physician Decision|0|||
144459554|NCT02008890|520878467|FG002|Period 2|Physician Decision|0|||
144459555|NCT02008890|520878468|FG003|Period 2|Physician Decision|2|||
144459556|NCT02008890|520878469|FG004|Period 2|Physician Decision|1|||
144459557|NCT02008890|520878465|FG000|Period 2|Lost to Follow-up|0|||
144459558|NCT02008890|520878466|FG001|Period 2|Lost to Follow-up|0|||
144459559|NCT02008890|520878467|FG002|Period 2|Lost to Follow-up|1|||
144459560|NCT02008890|520878468|FG003|Period 2|Lost to Follow-up|0|||
144459561|NCT02008890|520878469|FG004|Period 2|Lost to Follow-up|0|||
144459562|NCT02008890|520878465|FG000|Extension Period|Withdrawal by Subject|3|||
144459563|NCT02008890|520878466|FG001|Extension Period|Withdrawal by Subject|2|||
144608371|NCT01251653|521427799|FG006|Overall Study|Other reason not mentioned above|0|||
144608372|NCT01251653|521427800|FG007|Overall Study|Other reason not mentioned above|2|||
144608373|NCT01251653|521427801|FG008|Overall Study|Other reason not mentioned above|0|||
144608374|NCT01183143|521427803|FG000|Overall Study|Protocol Violation|115|||
144608375|NCT01183143|521427803|FG000|Overall Study|Withdrawal by Subject|19|||
144459564|NCT02008890|520878467|FG002|Extension Period|Withdrawal by Subject|0|||
144459565|NCT02008890|520878468|FG003|Extension Period|Withdrawal by Subject|4|||
144459566|NCT02008890|520878469|FG004|Extension Period|Withdrawal by Subject|2|||
144459567|NCT02008890|520878465|FG000|Extension Period|Lost to Follow-up|1|||
144608376|NCT01183143|521427803|FG000|Overall Study|Subject Questionnaires not returned|5|||
144608377|NCT01183143|521427803|FG000|Overall Study|Subjects enrolled, but not treated|11|||
144608378|NCT04096274|521427804|FG000|Phase I|Lost to Follow-up|5|||
144608379|NCT04096274|521427805|FG001|Phase I|Lost to Follow-up|5|||
144608380|NCT04096274|521427804|FG000|Phase II|Lost to Follow-up|11|||
144608381|NCT04096274|521427805|FG001|Phase II|Lost to Follow-up|11|||
144608382|NCT00938717|521427807|FG000|Overall Study|Adverse Event|10|||
144608383|NCT00938717|521427808|FG001|Overall Study|Adverse Event|41|||
144608384|NCT00938717|521427807|FG000|Overall Study|Protocol Violation|11|||
144608385|NCT00938717|521427808|FG001|Overall Study|Protocol Violation|8|||
144608386|NCT00938717|521427807|FG000|Overall Study|Withdrawal by Subject|26|||
144608387|NCT00938717|521427808|FG001|Overall Study|Withdrawal by Subject|24|||
144608388|NCT00938717|521427807|FG000|Overall Study|Lost to Follow-up|13|||
144608389|NCT00938717|521427808|FG001|Overall Study|Lost to Follow-up|18|||
144608390|NCT00938717|521427807|FG000|Overall Study|Lack of Efficacy|33|||
144608391|NCT00938717|521427808|FG001|Overall Study|Lack of Efficacy|15|||
144608392|NCT00938717|521427807|FG000|Overall Study|Other reason|5|||
144608393|NCT00938717|521427808|FG001|Overall Study|Other reason|2|||
144608394|NCT00388505|521427811|FG000|Overall Study|Adverse Event or Death|43|||
144608395|NCT00388505|521427812|FG001|Overall Study|Adverse Event or Death|17|||
144608396|NCT00388505|521427811|FG000|Overall Study|Withdrawal by Subject|24|||
144608397|NCT00388505|521427812|FG001|Overall Study|Withdrawal by Subject|9|||
144608398|NCT00388505|521427811|FG000|Overall Study|Lost to Follow-up|5|||
144608399|NCT00388505|521427812|FG001|Overall Study|Lost to Follow-up|3|||
144608400|NCT00388505|521427811|FG000|Overall Study|Inappropriate Enrollment|0|||
144608401|NCT00388505|521427812|FG001|Overall Study|Inappropriate Enrollment|1|||
144608402|NCT00388505|521427811|FG000|Overall Study|Administrative Reason|1|||
144608403|NCT00388505|521427812|FG001|Overall Study|Administrative Reason|0|||
144608404|NCT00388505|521427811|FG000|Overall Study|Protocol Violation|6|||
144608405|NCT00388505|521427812|FG001|Overall Study|Protocol Violation|5|||
144608406|NCT00388505|521427811|FG000|Overall Study|Unable to classify|4|||
144608407|NCT00388505|521427812|FG001|Overall Study|Unable to classify|3|||
144608408|NCT05092919|521427813|FG000|Overall Study|Lost to Follow-up|7|||
144608409|NCT05092919|521427813|FG000|Overall Study|Withdrawal by Subject|2|||
144608410|NCT01942148|521427815|FG000|Overall Study|Adverse Event|4|||
144608411|NCT01942148|521427815|FG000|Overall Study|Lack of Efficacy|2|||
144608412|NCT01942148|521427815|FG000|Overall Study|Physician Decision|11|||
144608413|NCT01942148|521427815|FG000|Overall Study|Protocol Violation|1|||
144608414|NCT01942148|521427815|FG000|Overall Study|Withdrawal by Subject|8|||
144608415|NCT01942148|521427815|FG000|Overall Study|Use of the prohibition medicine|1|||
144608416|NCT02248259|521427816|FG000|Treatment Period 1|Adverse Event|0|||
144608417|NCT02248259|521427817|FG001|Treatment Period 1|Adverse Event|0|||
144608418|NCT02248259|521427818|FG002|Treatment Period 1|Adverse Event|1|||
144608419|NCT02248259|521427819|FG003|Treatment Period 1|Adverse Event|0|||
144608420|NCT00096785|521427825|FG000|Overall Study|Lost to Follow-up|1|||
144608421|NCT00096785|521427826|FG001|Overall Study|Lost to Follow-up|0|||
144608422|NCT00096785|521427825|FG000|Overall Study|Withdrawal by Subject|0|||
144608423|NCT00096785|521427826|FG001|Overall Study|Withdrawal by Subject|1|||
144608424|NCT00096785|521427825|FG000|Overall Study|Relocated|1|||
144608425|NCT00096785|521427826|FG001|Overall Study|Relocated|0|||
144608426|NCT00257725|521427827|FG000|Overall Study|Adverse Event|3|||
144608427|NCT02573870|521427828|FG000|Overall Study|Adverse Event|0|||
144608428|NCT02573870|521427829|FG001|Overall Study|Adverse Event|2|||
144608429|NCT02573870|521427828|FG000|Overall Study|Lack of Efficacy|0|||
144608430|NCT02573870|521427829|FG001|Overall Study|Lack of Efficacy|1|||
144608431|NCT02573870|521427828|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
144608432|NCT02573870|521427829|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
144608433|NCT02573870|521427828|FG000|Overall Study|Lost to Follow-up|0|||
144608434|NCT02573870|521427829|FG001|Overall Study|Lost to Follow-up|1|||
144608435|NCT02573870|521427828|FG000|Overall Study|Other: Fail to Meet Visit|0|||
144608436|NCT02573870|521427829|FG001|Overall Study|Other: Fail to Meet Visit|2|||
144608437|NCT01858532|521427830|FG000|Overall Study|Adverse Event|58|||
144608438|NCT01858532|521427831|FG001|Overall Study|Adverse Event|50|||
144608439|NCT01858532|521427832|FG002|Overall Study|Adverse Event|23|||
144608440|NCT01858532|521427833|FG003|Overall Study|Adverse Event|28|||
144608441|NCT01858532|521427830|FG000|Overall Study|Withdrew consent|71|||
144608442|NCT01858532|521427831|FG001|Overall Study|Withdrew consent|93|||
144608443|NCT01858532|521427832|FG002|Overall Study|Withdrew consent|46|||
144608444|NCT01858532|521427833|FG003|Overall Study|Withdrew consent|27|||
144608445|NCT01858532|521427830|FG000|Overall Study|Lost to Follow-up|17|||
144608446|NCT01858532|521427831|FG001|Overall Study|Lost to Follow-up|26|||
144259301|NCT01089127|520150356|FG002|Overall Study|Protocol deviation|0|||
144608447|NCT01858532|521427832|FG002|Overall Study|Lost to Follow-up|11|||
144608448|NCT01858532|521427833|FG003|Overall Study|Lost to Follow-up|14|||
144608449|NCT01858532|521427830|FG000|Overall Study|Deterioration of medical status|3|||
144608450|NCT01858532|521427831|FG001|Overall Study|Deterioration of medical status|4|||
144608451|NCT01858532|521427832|FG002|Overall Study|Deterioration of medical status|3|||
144608452|NCT01858532|521427833|FG003|Overall Study|Deterioration of medical status|7|||
144608453|NCT01858532|521427830|FG000|Overall Study|Investigator request|3|||
144608454|NCT01858532|521427831|FG001|Overall Study|Investigator request|4|||
144608455|NCT01858532|521427832|FG002|Overall Study|Investigator request|2|||
144608456|NCT01858532|521427833|FG003|Overall Study|Investigator request|6|||
144608457|NCT01858532|521427830|FG000|Overall Study|Other, not specified|29|||
144196917|NCT03853148|519918637|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
144196918|NCT03853148|519918638|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
144196919|NCT00059787|519918639|FG000|Overall Study|Adverse Event|13|||
144196920|NCT00059787|519918639|FG000|Overall Study|disease progression|2|||
144459568|NCT02008890|520878466|FG001|Extension Period|Lost to Follow-up|0|||
144459569|NCT02008890|520878467|FG002|Extension Period|Lost to Follow-up|0|||
144459570|NCT02008890|520878468|FG003|Extension Period|Lost to Follow-up|0|||
144459571|NCT02008890|520878469|FG004|Extension Period|Lost to Follow-up|0|||
144459572|NCT02008890|520878465|FG000|Extension Period|Adverse Event|1|||
144459573|NCT02008890|520878466|FG001|Extension Period|Adverse Event|3|||
144459574|NCT02008890|520878467|FG002|Extension Period|Adverse Event|0|||
144459575|NCT02008890|520878468|FG003|Extension Period|Adverse Event|0|||
144459576|NCT02008890|520878469|FG004|Extension Period|Adverse Event|2|||
144459577|NCT02332720|520878470|FG000|Part A and Part B|Lost to Follow-up|1|||
144459578|NCT02332720|520878471|FG001|Part A and Part B|Lost to Follow-up|0|||
144459579|NCT02332720|520878472|FG002|Part A and Part B|Lost to Follow-up|0|||
144459580|NCT02332720|520878473|FG003|Part A and Part B|Lost to Follow-up|0|||
144459581|NCT02332720|520878474|FG004|Part A and Part B|Lost to Follow-up|0|||
144459582|NCT02332720|520878475|FG005|Part A and Part B|Lost to Follow-up|2|||
144459583|NCT02332720|520878476|FG006|Part A and Part B|Lost to Follow-up|1|||
144459584|NCT02332720|520878477|FG007|Part A and Part B|Lost to Follow-up|1|||
144459585|NCT02332720|520878478|FG008|Part A and Part B|Lost to Follow-up|0|||
144459586|NCT02332720|520878479|FG009|Part A and Part B|Lost to Follow-up|0|||
144459587|NCT02332720|520878480|FG010|Part A and Part B|Lost to Follow-up|0|||
144459588|NCT02332720|520878481|FG011|Part A and Part B|Lost to Follow-up|0|||
144459589|NCT02332720|520878482|FG012|Part A and Part B|Lost to Follow-up|0|||
144459590|NCT02332720|520878483|FG013|Part A and Part B|Lost to Follow-up|0|||
144459591|NCT02332720|520878484|FG014|Part A and Part B|Lost to Follow-up|0|||
144459592|NCT02332720|520878485|FG015|Part A and Part B|Lost to Follow-up|1|||
144459593|NCT02332720|520878486|FG016|Part A and Part B|Lost to Follow-up|0|||
144459594|NCT02332720|520878487|FG017|Part A and Part B|Lost to Follow-up|0|||
144459595|NCT02332720|520878488|FG018|Part A and Part B|Lost to Follow-up|0|||
144459596|NCT02332720|520878489|FG019|Part A and Part B|Lost to Follow-up|0|||
144459597|NCT02332720|520878490|FG020|Part A and Part B|Lost to Follow-up|0|||
144459598|NCT02332720|520878491|FG021|Part A and Part B|Lost to Follow-up|0|||
144459599|NCT02332720|520878492|FG022|Part A and Part B|Lost to Follow-up|0|||
144459600|NCT02332720|520878470|FG000|Part A and Part B|Adverse Event|0|||
144459601|NCT02332720|520878471|FG001|Part A and Part B|Adverse Event|0|||
144459602|NCT02332720|520878472|FG002|Part A and Part B|Adverse Event|0|||
144459603|NCT02332720|520878473|FG003|Part A and Part B|Adverse Event|0|||
144459604|NCT02332720|520878474|FG004|Part A and Part B|Adverse Event|0|||
144459605|NCT02332720|520878475|FG005|Part A and Part B|Adverse Event|0|||
144459606|NCT02332720|520878476|FG006|Part A and Part B|Adverse Event|0|||
144459607|NCT02332720|520878477|FG007|Part A and Part B|Adverse Event|0|||
144459608|NCT02332720|520878478|FG008|Part A and Part B|Adverse Event|0|||
144459609|NCT02332720|520878479|FG009|Part A and Part B|Adverse Event|0|||
144459610|NCT02332720|520878480|FG010|Part A and Part B|Adverse Event|0|||
144459611|NCT02332720|520878481|FG011|Part A and Part B|Adverse Event|0|||
144459612|NCT02332720|520878482|FG012|Part A and Part B|Adverse Event|0|||
144459613|NCT02332720|520878483|FG013|Part A and Part B|Adverse Event|0|||
144459614|NCT02332720|520878484|FG014|Part A and Part B|Adverse Event|0|||
144459615|NCT02332720|520878485|FG015|Part A and Part B|Adverse Event|0|||
144459616|NCT02332720|520878486|FG016|Part A and Part B|Adverse Event|0|||
144459617|NCT02332720|520878487|FG017|Part A and Part B|Adverse Event|1|||
144459618|NCT02332720|520878488|FG018|Part A and Part B|Adverse Event|0|||
144459619|NCT02332720|520878489|FG019|Part A and Part B|Adverse Event|0|||
144459620|NCT02332720|520878490|FG020|Part A and Part B|Adverse Event|0|||
144459621|NCT02332720|520878491|FG021|Part A and Part B|Adverse Event|0|||
144459622|NCT02332720|520878492|FG022|Part A and Part B|Adverse Event|0|||
144459623|NCT02332720|520878470|FG000|Part A and Part B|Physician Decision|0|||
144459624|NCT02332720|520878471|FG001|Part A and Part B|Physician Decision|0|||
144459625|NCT02332720|520878472|FG002|Part A and Part B|Physician Decision|0|||
144459626|NCT02332720|520878473|FG003|Part A and Part B|Physician Decision|0|||
144459627|NCT02332720|520878474|FG004|Part A and Part B|Physician Decision|0|||
144459628|NCT02332720|520878475|FG005|Part A and Part B|Physician Decision|0|||
144459629|NCT02332720|520878476|FG006|Part A and Part B|Physician Decision|0|||
144459630|NCT02332720|520878477|FG007|Part A and Part B|Physician Decision|0|||
144459631|NCT02332720|520878478|FG008|Part A and Part B|Physician Decision|0|||
144459632|NCT02332720|520878479|FG009|Part A and Part B|Physician Decision|0|||
144459633|NCT02332720|520878480|FG010|Part A and Part B|Physician Decision|0|||
144459634|NCT02332720|520878481|FG011|Part A and Part B|Physician Decision|0|||
144459635|NCT02332720|520878482|FG012|Part A and Part B|Physician Decision|0|||
144459636|NCT02332720|520878483|FG013|Part A and Part B|Physician Decision|0|||
144459637|NCT02332720|520878484|FG014|Part A and Part B|Physician Decision|0|||
144608458|NCT01858532|521427831|FG001|Overall Study|Other, not specified|15|||
144608459|NCT01858532|521427832|FG002|Overall Study|Other, not specified|13|||
144608460|NCT01858532|521427833|FG003|Overall Study|Other, not specified|11|||
144608461|NCT00514514|521427834|FG000|Pre-phase|Death|10|||
144608462|NCT00514514|521427835|FG001|Pre-phase|Death|0|||
144608463|NCT00514514|521427836|FG002|Pre-phase|Death|0|||
144608464|NCT00514514|521427834|FG000|Pre-phase|administrative problems|2|||
144608465|NCT00514514|521427835|FG001|Pre-phase|administrative problems|0|||
144608466|NCT00514514|521427836|FG002|Pre-phase|administrative problems|0|||
144608467|NCT00514514|521427834|FG000|Pre-phase|Protocol Violation|6|||
144608468|NCT00514514|521427835|FG001|Pre-phase|Protocol Violation|0|||
144608469|NCT00514514|521427836|FG002|Pre-phase|Protocol Violation|0|||
144608470|NCT00514514|521427834|FG000|Pre-phase|condition no longer requires study drug|7|||
144608471|NCT00514514|521427835|FG001|Pre-phase|condition no longer requires study drug|0|||
144608472|NCT00514514|521427836|FG002|Pre-phase|condition no longer requires study drug|0|||
144608473|NCT00514514|521427834|FG000|Pre-phase|abnormal test procedure results|15|||
144608474|NCT00514514|521427835|FG001|Pre-phase|abnormal test procedure results|0|||
144608475|NCT00514514|521427836|FG002|Pre-phase|abnormal test procedure results|0|||
144608476|NCT00514514|521427834|FG000|Pre-phase|Lost to Follow-up|2|||
144608477|NCT00514514|521427835|FG001|Pre-phase|Lost to Follow-up|0|||
144608478|NCT00514514|521427836|FG002|Pre-phase|Lost to Follow-up|0|||
144608479|NCT00514514|521427834|FG000|Pre-phase|abnormal lab values|23|||
144608480|NCT00514514|521427835|FG001|Pre-phase|abnormal lab values|0|||
144608481|NCT00514514|521427836|FG002|Pre-phase|abnormal lab values|0|||
144608482|NCT00514514|521427834|FG000|Pre-phase|Lack of Efficacy|35|||
144608483|NCT00514514|521427835|FG001|Pre-phase|Lack of Efficacy|0|||
144608484|NCT00514514|521427836|FG002|Pre-phase|Lack of Efficacy|0|||
144608485|NCT00514514|521427834|FG000|Pre-phase|Adverse Event|137|||
144608486|NCT00514514|521427835|FG001|Pre-phase|Adverse Event|0|||
144608487|NCT00514514|521427836|FG002|Pre-phase|Adverse Event|0|||
144608488|NCT00514514|521427834|FG000|Pre-phase|Withdrawal by Subject|66|||
144608489|NCT00514514|521427835|FG001|Pre-phase|Withdrawal by Subject|0|||
144608490|NCT00514514|521427836|FG002|Pre-phase|Withdrawal by Subject|0|||
144608491|NCT00514514|521427834|FG000|Randomized - 9 Month|Death|3|||
144608492|NCT00514514|521427835|FG001|Randomized - 9 Month|Death|2|||
144608493|NCT00514514|521427836|FG002|Randomized - 9 Month|Death|2|||
144608494|NCT00514514|521427834|FG000|Randomized - 9 Month|Administrative problems|1|||
144608495|NCT00514514|521427835|FG001|Randomized - 9 Month|Administrative problems|1|||
144608496|NCT00514514|521427836|FG002|Randomized - 9 Month|Administrative problems|2|||
144608497|NCT00514514|521427834|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
144608498|NCT00514514|521427835|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
144608499|NCT00514514|521427836|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
144608500|NCT00514514|521427834|FG000|Randomized - 9 Month|Protocol Violation|1|||
144608501|NCT00514514|521427835|FG001|Randomized - 9 Month|Protocol Violation|1|||
144608502|NCT00514514|521427836|FG002|Randomized - 9 Month|Protocol Violation|0|||
144608503|NCT00514514|521427834|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
144608504|NCT00514514|521427835|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
144608505|NCT00514514|521427836|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
144608506|NCT00514514|521427834|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
144608507|NCT00514514|521427835|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
144608508|NCT00514514|521427836|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
144608509|NCT00514514|521427834|FG000|Randomized - 9 Month|Adverse Event|25|||
144608510|NCT00514514|521427835|FG001|Randomized - 9 Month|Adverse Event|44|||
144608511|NCT00514514|521427836|FG002|Randomized - 9 Month|Adverse Event|27|||
144608512|NCT00514514|521427834|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
144608513|NCT00514514|521427835|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
144608514|NCT00514514|521427836|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
144608515|NCT00514514|521427834|FG000|Extension - 4 Years|Lost to Follow-up|12|||
144608516|NCT00514514|521427835|FG001|Extension - 4 Years|Lost to Follow-up|10|||
144608517|NCT00514514|521427836|FG002|Extension - 4 Years|Lost to Follow-up|9|||
144608518|NCT00514514|521427834|FG000|Extension - 4 Years|Administrative problems|3|||
144608519|NCT00514514|521427835|FG001|Extension - 4 Years|Administrative problems|1|||
144608520|NCT00514514|521427836|FG002|Extension - 4 Years|Administrative problems|1|||
144608521|NCT00514514|521427834|FG000|Extension - 4 Years|Death|8|||
144608522|NCT00514514|521427835|FG001|Extension - 4 Years|Death|3|||
144608523|NCT00514514|521427836|FG002|Extension - 4 Years|Death|6|||
144608524|NCT00514514|521427834|FG000|Extension - 4 Years|Adverse Event|9|||
144608525|NCT00514514|521427835|FG001|Extension - 4 Years|Adverse Event|6|||
144608526|NCT00514514|521427836|FG002|Extension - 4 Years|Adverse Event|3|||
144608527|NCT01101438|521427841|FG000|Overall Study|Withdrawal by Subject|8|||
144196921|NCT00059787|519918639|FG000|Overall Study|ineligible|1|||
144608528|NCT01101438|521427842|FG001|Overall Study|Withdrawal by Subject|9|||
144608529|NCT01480284|521427843|FG000|Overall Study|Withdrawal by Subject|2|||
144608530|NCT01480284|521427844|FG001|Overall Study|Withdrawal by Subject|0|||
144608531|NCT01480284|521427843|FG000|Overall Study|Adverse Event|1|||
144608532|NCT01480284|521427844|FG001|Overall Study|Adverse Event|0|||
144608533|NCT01480284|521427843|FG000|Overall Study|Study closed/terminated|3|||
144608534|NCT01480284|521427844|FG001|Overall Study|Study closed/terminated|0|||
144608535|NCT01480284|521427843|FG000|Overall Study|Lost to Follow-up|1|||
144608536|NCT01480284|521427844|FG001|Overall Study|Lost to Follow-up|0|||
144608537|NCT01480284|521427843|FG000|Overall Study|Physician Decision|1|||
144608538|NCT01480284|521427844|FG001|Overall Study|Physician Decision|0|||
144608539|NCT00066742|521427845|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
144608540|NCT00066742|521427845|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
144608541|NCT00066742|521427845|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
144608542|NCT00066742|521427845|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
144608543|NCT00066742|521427845|FG000|Induction Chemoradiotherapy|Ineligible|3|||
144608544|NCT00066742|521427845|FG000|Consolidation Chemotherapy|not protocol specified|1|||
144608545|NCT00066742|521427845|FG000|Consolidation Chemotherapy|Ineligible|2|||
144608546|NCT03677596|521427852|FG000|Overall Study|Adverse Event|0|||
144608547|NCT03677596|521427853|FG001|Overall Study|Adverse Event|1|||
144608548|NCT03677596|521427852|FG000|Overall Study|Death|10|||
144608549|NCT03677596|521427853|FG001|Overall Study|Death|6|||
144608550|NCT03677596|521427852|FG000|Overall Study|Lost to Follow-up|0|||
144608551|NCT03677596|521427853|FG001|Overall Study|Lost to Follow-up|1|||
144608552|NCT03677596|521427852|FG000|Overall Study|Progressive Disease|8|||
144608553|NCT03677596|521427853|FG001|Overall Study|Progressive Disease|8|||
144608554|NCT03677596|521427852|FG000|Overall Study|Withdrawal by Subject|3|||
144608555|NCT03677596|521427853|FG001|Overall Study|Withdrawal by Subject|0|||
144608556|NCT03677596|521427852|FG000|Overall Study|Disease Relapse|2|||
144608557|NCT03677596|521427853|FG001|Overall Study|Disease Relapse|2|||
144608558|NCT03677596|521427852|FG000|Overall Study|Other|0|||
144608559|NCT03677596|521427853|FG001|Overall Study|Other|1|||
144608560|NCT00806195|521427854|FG000|Overall Study|Death|6|||
144608561|NCT00806195|521427855|FG001|Overall Study|Death|0|||
144608562|NCT00806195|521427856|FG002|Overall Study|Death|1|||
144608563|NCT00806195|521427857|FG003|Overall Study|Death|0|||
144608564|NCT00806195|521427854|FG000|Overall Study|Adverse Event|25|||
144608565|NCT00806195|521427855|FG001|Overall Study|Adverse Event|5|||
144608566|NCT00806195|521427856|FG002|Overall Study|Adverse Event|11|||
144608567|NCT00806195|521427857|FG003|Overall Study|Adverse Event|2|||
144608568|NCT00806195|521427854|FG000|Overall Study|Withdrawal by Subject|119|||
144608569|NCT00806195|521427855|FG001|Overall Study|Withdrawal by Subject|31|||
144196922|NCT00059787|519918639|FG000|Overall Study|Other|4|||
144196923|NCT04397445|519918642|FG000|Overall Study|Withdrawal by Subject|1|||
144608570|NCT00806195|521427856|FG002|Overall Study|Withdrawal by Subject|76|||
144608571|NCT00806195|521427857|FG003|Overall Study|Withdrawal by Subject|35|||
144608572|NCT00806195|521427854|FG000|Overall Study|Lost to Follow-up|217|||
144608573|NCT00806195|521427855|FG001|Overall Study|Lost to Follow-up|66|||
144608574|NCT00806195|521427856|FG002|Overall Study|Lost to Follow-up|90|||
144608575|NCT00806195|521427857|FG003|Overall Study|Lost to Follow-up|34|||
144608576|NCT00806195|521427854|FG000|Overall Study|Inappropriate Enrollment|0|||
144608577|NCT00806195|521427855|FG001|Overall Study|Inappropriate Enrollment|1|||
144608578|NCT00806195|521427856|FG002|Overall Study|Inappropriate Enrollment|0|||
144608579|NCT00806195|521427857|FG003|Overall Study|Inappropriate Enrollment|0|||
144608580|NCT00806195|521427854|FG000|Overall Study|Administrative Reason|113|||
144608581|NCT00806195|521427855|FG001|Overall Study|Administrative Reason|35|||
144608582|NCT00806195|521427856|FG002|Overall Study|Administrative Reason|66|||
144608583|NCT00806195|521427857|FG003|Overall Study|Administrative Reason|26|||
144608584|NCT00806195|521427854|FG000|Overall Study|Protocol Violation|34|||
144608585|NCT00806195|521427855|FG001|Overall Study|Protocol Violation|24|||
144608586|NCT00806195|521427856|FG002|Overall Study|Protocol Violation|26|||
144608587|NCT00806195|521427857|FG003|Overall Study|Protocol Violation|9|||
144608588|NCT02752035|521427858|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
144608589|NCT02752035|521427859|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
144608590|NCT02752035|521427860|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
144608591|NCT02752035|521427861|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
144608592|NCT02752035|521427858|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
144196924|NCT04397445|519918643|FG001|Overall Study|Withdrawal by Subject|0|||
144196925|NCT04397445|519918644|FG002|Overall Study|Withdrawal by Subject|0|||
144196926|NCT04397445|519918645|FG003|Overall Study|Withdrawal by Subject|0|||
144608593|NCT02752035|521427859|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
144608594|NCT02752035|521427860|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
144608595|NCT02752035|521427861|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
144608596|NCT02752035|521427858|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
144608597|NCT02752035|521427859|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
144608598|NCT02752035|521427860|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
144608599|NCT02752035|521427861|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
144608600|NCT02752035|521427858|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
144608601|NCT02752035|521427859|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
144608602|NCT02752035|521427860|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
144608603|NCT02752035|521427861|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
144608604|NCT02752035|521427858|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
144608605|NCT02752035|521427859|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
144608606|NCT02752035|521427860|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
144608607|NCT02752035|521427861|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
144608608|NCT02752035|521427858|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
144608609|NCT02752035|521427859|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
144608610|NCT02752035|521427860|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
144608611|NCT02752035|521427861|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
144608612|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
144608613|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
144608614|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
144608615|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
144608616|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
144608617|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
144608618|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
144608619|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
144608620|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
144608621|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
144608622|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
144608623|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
144608624|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
144608625|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
144608626|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
144608627|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
144608628|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
144608629|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
144608630|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
144608631|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
144608632|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Death|0|||
144608633|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Death|25|||
144608634|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Death|13|||
144608635|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Death|4|||
144608636|NCT02752035|521427858|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
144608637|NCT02752035|521427859|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
144608638|NCT02752035|521427860|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
144608639|NCT02752035|521427861|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
144608640|NCT02752035|521427858|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
144608641|NCT02752035|521427859|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
144608642|NCT02752035|521427860|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
144608643|NCT02752035|521427861|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
144459638|NCT02332720|520878485|FG015|Part A and Part B|Physician Decision|0|||
144459639|NCT02332720|520878486|FG016|Part A and Part B|Physician Decision|0|||
144459640|NCT02332720|520878487|FG017|Part A and Part B|Physician Decision|0|||
144608644|NCT02752035|521427858|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
144608645|NCT02752035|521427859|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
144608646|NCT02752035|521427860|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
144608647|NCT02752035|521427861|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
144608648|NCT02752035|521427858|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
144608649|NCT02752035|521427859|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
144608650|NCT02752035|521427860|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
144608651|NCT02752035|521427861|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
144608652|NCT02752035|521427858|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
144608653|NCT02752035|521427859|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
144608654|NCT02752035|521427860|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
144608655|NCT02752035|521427861|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
144608656|NCT01519934|521427866|FG000|Overall Study|Lost to Follow-up|3|||
144608657|NCT02161575|521427874|FG000|Overall Study|Protocol Violation|8|||
144608658|NCT02161575|521427874|FG000|Overall Study|Lack of Efficacy|1|||
144608659|NCT02161575|521427874|FG000|Overall Study|Adverse Event|2|||
144608660|NCT01231659|521427882|FG000|Overall Study|Adverse Event|9|||
144608661|NCT01231659|521427882|FG000|Overall Study|Disease Progression|48|||
144608662|NCT01231659|521427882|FG000|Overall Study|Death|2|||
144608663|NCT01231659|521427882|FG000|Overall Study|Patient refused to complete study visit|1|||
144608664|NCT01231659|521427882|FG000|Overall Study|Other protocol defined criteria|12|||
144608665|NCT01299376|521427883|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
144725874|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
144459641|NCT02332720|520878488|FG018|Part A and Part B|Physician Decision|1|||
144459642|NCT02332720|520878489|FG019|Part A and Part B|Physician Decision|0|||
144459643|NCT02332720|520878490|FG020|Part A and Part B|Physician Decision|0|||
144608666|NCT01299376|521427884|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
144725875|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
144725876|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
144725877|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
144725878|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
144725879|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
144725880|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
144725881|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
144725882|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
144725883|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
144534691|NCT04908930|521161674|FG004|Overall Study|wrong team|0|||
144534692|NCT04908930|521161670|FG000|Overall Study|quit team|2|||
144534693|NCT04908930|521161671|FG001|Overall Study|quit team|4|||
144534694|NCT04908930|521161672|FG002|Overall Study|quit team|0|||
144725884|NCT02207231|521852630|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
144725885|NCT02207231|521852631|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
144725886|NCT02207231|521852632|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
144725887|NCT02207231|521852633|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
144725888|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
144725889|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
144196927|NCT01429051|519918646|FG000|Titration Phase|Death|1|||
144196928|NCT01429051|519918646|FG000|Titration Phase|Withdrawal by Subject|7|||
144196929|NCT01429051|519918646|FG000|Titration Phase|Physician Decision|1|||
144196930|NCT01429051|519918646|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
144196931|NCT01429051|519918646|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
144196932|NCT01429051|519918646|FG000|Efficacy Phase|Adverse Event|1|||
144196933|NCT01429051|519918646|FG000|Efficacy Phase|Death|1|||
144534695|NCT04908930|521161673|FG003|Overall Study|quit team|0|||
144534696|NCT04908930|521161674|FG004|Overall Study|quit team|0|||
144534697|NCT04908930|521161670|FG000|Overall Study|Withdrawal by Subject|1|||
144534698|NCT04908930|521161671|FG001|Overall Study|Withdrawal by Subject|2|||
144534699|NCT04908930|521161672|FG002|Overall Study|Withdrawal by Subject|0|||
144534700|NCT04908930|521161673|FG003|Overall Study|Withdrawal by Subject|0|||
144534701|NCT04908930|521161674|FG004|Overall Study|Withdrawal by Subject|0|||
144534702|NCT04908930|521161670|FG000|Overall Study|parent not liking program|0|||
144534703|NCT04908930|521161671|FG001|Overall Study|parent not liking program|1|||
144534704|NCT04908930|521161672|FG002|Overall Study|parent not liking program|0|||
144608667|NCT01299376|521427883|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
144608668|NCT01299376|521427884|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
144608669|NCT01299376|521427883|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
144608670|NCT01299376|521427884|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
144608671|NCT01299376|521427883|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
144608672|NCT01299376|521427884|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
144608673|NCT01299376|521427883|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
144608674|NCT01299376|521427884|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
144608675|NCT01299376|521427883|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
144608676|NCT01299376|521427884|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
144608677|NCT01299376|521427883|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
144608678|NCT01299376|521427884|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
144608679|NCT01299376|521427883|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
144608680|NCT01299376|521427884|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
144608681|NCT01299376|521427883|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
144608682|NCT01299376|521427884|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
144608683|NCT01299376|521427883|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
144608684|NCT01299376|521427884|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
144608685|NCT01299376|521427883|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
144608686|NCT01299376|521427884|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
144608687|NCT02790138|521427887|FG000|Overall Study|Adverse Event|5|||
144608688|NCT02790138|521427888|FG001|Overall Study|Adverse Event|2|||
144608689|NCT02790138|521427887|FG000|Overall Study|Significant Protocol Deviation|0|||
144608690|NCT02790138|521427888|FG001|Overall Study|Significant Protocol Deviation|1|||
144608691|NCT02790138|521427887|FG000|Overall Study|Lost to Follow-up|1|||
144608692|NCT02790138|521427888|FG001|Overall Study|Lost to Follow-up|0|||
144608693|NCT02790138|521427887|FG000|Overall Study|Voluntary Withdrawal|8|||
144608694|NCT02790138|521427888|FG001|Overall Study|Voluntary Withdrawal|9|||
144608695|NCT02790138|521427887|FG000|Overall Study|Lack of Efficacy|6|||
144608696|NCT02790138|521427888|FG001|Overall Study|Lack of Efficacy|7|||
144196934|NCT01429051|519918646|FG000|Tolerability Phase|Death|5|||
144534705|NCT04908930|521161673|FG003|Overall Study|parent not liking program|0|||
144534706|NCT04908930|521161674|FG004|Overall Study|parent not liking program|0|||
144534707|NCT02777593|521161677|FG000|Overall Study|Still in study|1|||
144196935|NCT01429051|519918646|FG000|Tolerability Phase|Adverse Event|2|||
144534708|NCT02777593|521161678|FG001|Overall Study|Still in study|32|||
144608697|NCT02790138|521427887|FG000|Overall Study|Reason not Specified|1|||
144608698|NCT02790138|521427888|FG001|Overall Study|Reason not Specified|0|||
144608699|NCT03199040|521427889|FG000|Overall Study|Lack of Efficacy|2|||
144608700|NCT03199040|521427890|FG001|Overall Study|Lack of Efficacy|0|||
144608701|NCT03199040|521427889|FG000|Overall Study|Withdrawal by Subject|2|||
144608702|NCT03199040|521427890|FG001|Overall Study|Withdrawal by Subject|0|||
144608703|NCT03199040|521427889|FG000|Overall Study|Adverse Event|0|||
144608704|NCT03199040|521427890|FG001|Overall Study|Adverse Event|1|||
144608705|NCT03199040|521427889|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
144608706|NCT03199040|521427890|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
144608707|NCT03700320|521427891|FG000|Overall Study|Adverse Event|5|||
144608708|NCT03700320|521427892|FG001|Overall Study|Adverse Event|31|||
144608709|NCT03700320|521427891|FG000|Overall Study|Lack of Efficacy|2|||
144608710|NCT03700320|521427892|FG001|Overall Study|Lack of Efficacy|5|||
144608711|NCT03700320|521427891|FG000|Overall Study|Withdrawal by Subject|29|||
144608712|NCT03700320|521427892|FG001|Overall Study|Withdrawal by Subject|75|||
144608713|NCT03700320|521427891|FG000|Overall Study|Lost to Follow-up|16|||
144608714|NCT03700320|521427892|FG001|Overall Study|Lost to Follow-up|23|||
144608715|NCT03700320|521427891|FG000|Overall Study|Pregnancy|2|||
144608716|NCT03700320|521427892|FG001|Overall Study|Pregnancy|4|||
144608717|NCT03700320|521427891|FG000|Overall Study|Protocol Deviation|7|||
144608718|NCT03700320|521427892|FG001|Overall Study|Protocol Deviation|31|||
144608719|NCT03700320|521427891|FG000|Overall Study|Non-compliance with Study Drug|1|||
144608720|NCT03700320|521427892|FG001|Overall Study|Non-compliance with Study Drug|3|||
144608721|NCT03700320|521427891|FG000|Overall Study|Reason not Specified|0|||
144608722|NCT03700320|521427892|FG001|Overall Study|Reason not Specified|1|||
144608723|NCT03654976|521427895|FG000|Overall Study|Withdrawal by Subject|12|||
144608724|NCT03654976|521427896|FG001|Overall Study|Withdrawal by Subject|11|||
144608725|NCT03654976|521427895|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
144608726|NCT03654976|521427896|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
144608727|NCT03654976|521427895|FG000|Overall Study|Adverse Event|5|||
144608728|NCT03654976|521427896|FG001|Overall Study|Adverse Event|0|||
144196936|NCT01429051|519918646|FG000|Tolerability Phase|Withdrawal by Subject|5|||
144196937|NCT01429051|519918646|FG000|Tolerability Phase|Physician Decision|1|||
144608729|NCT03654976|521427895|FG000|Overall Study|Lost to Follow-up|2|||
144608730|NCT03654976|521427896|FG001|Overall Study|Lost to Follow-up|0|||
144608731|NCT03654976|521427895|FG000|Overall Study|Lack of Efficacy|0|||
144608732|NCT03654976|521427896|FG001|Overall Study|Lack of Efficacy|1|||
144608733|NCT02054325|521427897|FG000|Overall Study|Lost to Follow-up|8|||
144608734|NCT02054325|521427898|FG001|Overall Study|Lost to Follow-up|5|||
144608735|NCT01770912|521427899|FG000|Overall Study|Lost to Follow-up|2|||
144608736|NCT01770912|521427900|FG001|Overall Study|Lost to Follow-up|0|||
144608737|NCT01708291|521427901|FG000|Overall Study|fighting|2|||
144608738|NCT01708291|521427902|FG001|Overall Study|fighting|1|||
144608739|NCT01536951|521427904|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608740|NCT01536951|521427905|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608741|NCT01536951|521427906|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
144608742|NCT01536951|521427907|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608743|NCT01536951|521427908|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608744|NCT01536951|521427909|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608745|NCT01536951|521427910|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608746|NCT01536951|521427911|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608747|NCT01536951|521427912|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
144608748|NCT01536951|521427904|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
144608749|NCT01536951|521427905|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
144608750|NCT01536951|521427906|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
144608751|NCT01536951|521427907|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
144608752|NCT01536951|521427908|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
144608753|NCT01536951|521427909|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
144196938|NCT01429051|519918646|FG000|Tolerability Phase|Other|2|||
144196939|NCT03921151|519918647|FG000|Overall Study|Withdrawal by Subject|11|||
144196940|NCT03921151|519918648|FG001|Overall Study|Withdrawal by Subject|16|||
144196941|NCT00857792|519918650|FG000|Overall Study|inadequate image quality for analysis|12|||
144608754|NCT01536951|521427910|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
144608755|NCT01536951|521427911|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
144608756|NCT01536951|521427912|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
144196942|NCT02528123|519918654|FG000|Overall Study|Lost to Follow-up|1|||
144196943|NCT02963441|519918657|FG000|Overall Study|Protocol violation or withdrawn|8|||
144255460|NCT00237692|520136185|FG000|Overall Study|Withdrawal by Subject|4|||
144608757|NCT03496012|521429289|FG000|Overall Study|Withdrawal by Subject|2|||
144608758|NCT03496012|521429290|FG001|Overall Study|Withdrawal by Subject|0|||
144608759|NCT03496012|521429291|FG002|Overall Study|Withdrawal by Subject|2|||
144608760|NCT03496012|521429289|FG000|Overall Study|Adverse Event|0|||
144608761|NCT03496012|521429290|FG001|Overall Study|Adverse Event|0|||
144608762|NCT03496012|521429291|FG002|Overall Study|Adverse Event|1|||
144608763|NCT03496012|521429289|FG000|Overall Study|Reason Not Specified|2|||
144608764|NCT03496012|521429290|FG001|Overall Study|Reason Not Specified|0|||
144608765|NCT03496012|521429291|FG002|Overall Study|Reason Not Specified|1|||
144608766|NCT00574145|521429292|FG000|Overall Study|Withdrawal by Subject|2|||
144608767|NCT00574145|521429293|FG001|Overall Study|Withdrawal by Subject|1|||
144608768|NCT03227471|521429294|FG000|Overall Study|Withdrawal by Subject|0|||
144608769|NCT03227471|521429295|FG001|Overall Study|Withdrawal by Subject|0|||
144608770|NCT03227471|521429296|FG002|Overall Study|Withdrawal by Subject|0|||
144608771|NCT03227471|521429297|FG003|Overall Study|Withdrawal by Subject|0|||
144608772|NCT03227471|521429298|FG004|Overall Study|Withdrawal by Subject|1|||
144608773|NCT03227471|521429299|FG005|Overall Study|Withdrawal by Subject|0|||
144608774|NCT03227471|521429300|FG006|Overall Study|Withdrawal by Subject|0|||
144608775|NCT03227471|521429301|FG007|Overall Study|Withdrawal by Subject|0|||
144608776|NCT03227471|521429302|FG008|Overall Study|Withdrawal by Subject|0|||
144608777|NCT03227471|521429303|FG009|Overall Study|Withdrawal by Subject|0|||
144608778|NCT03227471|521429304|FG010|Overall Study|Withdrawal by Subject|0|||
144608779|NCT03227471|521429305|FG011|Overall Study|Withdrawal by Subject|0|||
144608780|NCT03227471|521429306|FG012|Overall Study|Withdrawal by Subject|1|||
144608781|NCT03227471|521429307|FG013|Overall Study|Withdrawal by Subject|0|||
144608782|NCT03227471|521429308|FG014|Overall Study|Withdrawal by Subject|0|||
144608783|NCT03227471|521429294|FG000|Overall Study|Randomized, Never Dosed|0|||
144608784|NCT03227471|521429295|FG001|Overall Study|Randomized, Never Dosed|0|||
144608785|NCT03227471|521429296|FG002|Overall Study|Randomized, Never Dosed|0|||
144608786|NCT03227471|521429297|FG003|Overall Study|Randomized, Never Dosed|0|||
144608787|NCT03227471|521429298|FG004|Overall Study|Randomized, Never Dosed|0|||
144608788|NCT03227471|521429299|FG005|Overall Study|Randomized, Never Dosed|0|||
144608789|NCT03227471|521429300|FG006|Overall Study|Randomized, Never Dosed|0|||
144608790|NCT03227471|521429301|FG007|Overall Study|Randomized, Never Dosed|0|||
144608791|NCT03227471|521429302|FG008|Overall Study|Randomized, Never Dosed|0|||
144608792|NCT03227471|521429303|FG009|Overall Study|Randomized, Never Dosed|0|||
144608793|NCT03227471|521429304|FG010|Overall Study|Randomized, Never Dosed|0|||
144608794|NCT03227471|521429305|FG011|Overall Study|Randomized, Never Dosed|0|||
144608795|NCT03227471|521429306|FG012|Overall Study|Randomized, Never Dosed|0|||
144608796|NCT03227471|521429307|FG013|Overall Study|Randomized, Never Dosed|0|||
144608797|NCT03227471|521429308|FG014|Overall Study|Randomized, Never Dosed|1|||
144608798|NCT02322125|521429309|FG000|Overall Study|Withdrawal by Subject|2|||
144608799|NCT00449670|521429315|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
144608800|NCT00449670|521429316|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
144608801|NCT00449670|521429315|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
144608802|NCT00449670|521429316|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
144608803|NCT00449670|521429315|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
144608804|NCT00449670|521429316|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
144608805|NCT00449670|521429315|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
144608806|NCT00449670|521429316|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
144608807|NCT00449670|521429315|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
144608808|NCT00449670|521429316|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
144608809|NCT00449670|521429315|FG000|Booster Phase (Study no.109873)|Other|0|||
144608810|NCT00449670|521429316|FG001|Booster Phase (Study no.109873)|Other|2|||
144608811|NCT01490450|521429319|FG000|Period 1|Lack of Efficacy|2|||
144608812|NCT01490450|521429320|FG001|Period 1|Lack of Efficacy|0|||
144608813|NCT01490450|521429321|FG002|Period 1|Lack of Efficacy|3|||
144608814|NCT01490450|521429322|FG003|Period 1|Lack of Efficacy|0|||
144196944|NCT02963441|519918657|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
144196945|NCT02963441|519918657|FG000|Overall Study|IDx-DR insufficient quality|33|||
144608815|NCT01490450|521429319|FG000|Period 1|Adverse Event|0|||
144608816|NCT01490450|521429320|FG001|Period 1|Adverse Event|0|||
144608817|NCT01490450|521429321|FG002|Period 1|Adverse Event|0|||
144608818|NCT01490450|521429322|FG003|Period 1|Adverse Event|5|||
144608819|NCT01490450|521429319|FG000|Period 1|Request to discontinue treatment|1|||
144608820|NCT01490450|521429320|FG001|Period 1|Request to discontinue treatment|0|||
144608821|NCT01490450|521429321|FG002|Period 1|Request to discontinue treatment|0|||
144608822|NCT01490450|521429322|FG003|Period 1|Request to discontinue treatment|0|||
144608823|NCT01490450|521429319|FG000|Period 1|Withdrawal by Subject|0|||
144608824|NCT01490450|521429320|FG001|Period 1|Withdrawal by Subject|0|||
144608825|NCT01490450|521429321|FG002|Period 1|Withdrawal by Subject|0|||
144608826|NCT01490450|521429322|FG003|Period 1|Withdrawal by Subject|3|||
144608827|NCT01490450|521429319|FG000|Period 1|No longer met study criteria|0|||
144608828|NCT01490450|521429320|FG001|Period 1|No longer met study criteria|1|||
144608829|NCT01490450|521429321|FG002|Period 1|No longer met study criteria|1|||
144608830|NCT01490450|521429322|FG003|Period 1|No longer met study criteria|0|||
144608831|NCT01490450|521429319|FG000|Period 2|Lack of Efficacy|0|||
144608832|NCT01490450|521429320|FG001|Period 2|Lack of Efficacy|0|||
144608833|NCT01490450|521429321|FG002|Period 2|Lack of Efficacy|0|||
144608834|NCT01490450|521429322|FG003|Period 2|Lack of Efficacy|1|||
144459644|NCT02332720|520878491|FG021|Part A and Part B|Physician Decision|0|||
144459645|NCT02332720|520878492|FG022|Part A and Part B|Physician Decision|0|||
144459646|NCT02332720|520878470|FG000|Part A and Part B|Withdrawal by Subject|0|||
144459647|NCT02332720|520878471|FG001|Part A and Part B|Withdrawal by Subject|0|||
144459648|NCT02332720|520878472|FG002|Part A and Part B|Withdrawal by Subject|0|||
144459649|NCT02332720|520878473|FG003|Part A and Part B|Withdrawal by Subject|0|||
144459650|NCT02332720|520878474|FG004|Part A and Part B|Withdrawal by Subject|0|||
144459651|NCT02332720|520878475|FG005|Part A and Part B|Withdrawal by Subject|1|||
144459652|NCT02332720|520878476|FG006|Part A and Part B|Withdrawal by Subject|0|||
144459653|NCT02332720|520878477|FG007|Part A and Part B|Withdrawal by Subject|0|||
144459654|NCT02332720|520878478|FG008|Part A and Part B|Withdrawal by Subject|0|||
144459655|NCT02332720|520878479|FG009|Part A and Part B|Withdrawal by Subject|0|||
144459656|NCT02332720|520878480|FG010|Part A and Part B|Withdrawal by Subject|0|||
144459657|NCT02332720|520878481|FG011|Part A and Part B|Withdrawal by Subject|0|||
144459658|NCT02332720|520878482|FG012|Part A and Part B|Withdrawal by Subject|0|||
144459659|NCT02332720|520878483|FG013|Part A and Part B|Withdrawal by Subject|0|||
144459660|NCT02332720|520878484|FG014|Part A and Part B|Withdrawal by Subject|0|||
144459661|NCT02332720|520878485|FG015|Part A and Part B|Withdrawal by Subject|0|||
144459662|NCT02332720|520878486|FG016|Part A and Part B|Withdrawal by Subject|0|||
144459663|NCT02332720|520878487|FG017|Part A and Part B|Withdrawal by Subject|0|||
144459664|NCT02332720|520878488|FG018|Part A and Part B|Withdrawal by Subject|0|||
144459665|NCT02332720|520878489|FG019|Part A and Part B|Withdrawal by Subject|1|||
144459666|NCT02332720|520878490|FG020|Part A and Part B|Withdrawal by Subject|0|||
144459667|NCT02332720|520878491|FG021|Part A and Part B|Withdrawal by Subject|0|||
144459668|NCT02332720|520878492|FG022|Part A and Part B|Withdrawal by Subject|0|||
144459669|NCT05912400|520878493|FG000|Overall Study|Lost to Follow-up|1|||
144459670|NCT05912400|520878494|FG001|Overall Study|Lost to Follow-up|0|||
144608835|NCT01490450|521429319|FG000|Period 2|Adverse Event|1|||
144459671|NCT05912400|520878493|FG000|Overall Study|Physician Decision|6|||
144459672|NCT05912400|520878494|FG001|Overall Study|Physician Decision|0|||
144459673|NCT05912400|520878493|FG000|Overall Study|Withdrawal by Subject|1|||
144459674|NCT05912400|520878494|FG001|Overall Study|Withdrawal by Subject|0|||
144459675|NCT02522494|520878497|FG000|Overall Study|Lost to Follow-up|6|||
144459676|NCT02522494|520878498|FG001|Overall Study|Lost to Follow-up|2|||
144459677|NCT02522494|520878497|FG000|Overall Study|Withdrawal by Subject|1|||
144459678|NCT02522494|520878498|FG001|Overall Study|Withdrawal by Subject|0|||
144459679|NCT02522494|520878497|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
144459680|NCT02522494|520878498|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
144459681|NCT02522494|520878497|FG000|Overall Study|Participant did not watch the video|1|||
144459682|NCT02522494|520878498|FG001|Overall Study|Participant did not watch the video|0|||
144459683|NCT02522494|520878497|FG000|Overall Study|Death|0|||
144459684|NCT02522494|520878498|FG001|Overall Study|Death|1|||
144459685|NCT01259713|520878503|FG000|Overall Study|Adverse Event|54|||
144459686|NCT01259713|520878504|FG001|Overall Study|Adverse Event|23|||
144459687|NCT01259713|520878503|FG000|Overall Study|Death Not Related to IFI|8|||
144459688|NCT01259713|520878504|FG001|Overall Study|Death Not Related to IFI|1|||
144459689|NCT01259713|520878503|FG000|Overall Study|Investigators Discretion|14|||
144459690|NCT01259713|520878504|FG001|Overall Study|Investigators Discretion|6|||
144459691|NCT01259713|520878503|FG000|Overall Study|Lack of Efficacy|2|||
144459692|NCT01259713|520878504|FG001|Overall Study|Lack of Efficacy|0|||
144459693|NCT01259713|520878503|FG000|Overall Study|Protocol Violation|5|||
144459694|NCT01259713|520878504|FG001|Overall Study|Protocol Violation|4|||
144459695|NCT01259713|520878503|FG000|Overall Study|Subject Withdrew Consent|12|||
144459696|NCT01259713|520878504|FG001|Overall Study|Subject Withdrew Consent|7|||
144459697|NCT02388724|520878505|FG000|Overall Study|Reason not Specified|0|||
144459698|NCT02388724|520878506|FG001|Overall Study|Reason not Specified|1|||
144459699|NCT02388724|520878505|FG000|Overall Study|Major Protocol Deviation|3|||
144459700|NCT02388724|520878506|FG001|Overall Study|Major Protocol Deviation|3|||
144459701|NCT02388724|520878505|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
144459702|NCT02388724|520878506|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
144459703|NCT02388724|520878505|FG000|Overall Study|Voluntary Withdrawal|6|||
144459704|NCT02388724|520878506|FG001|Overall Study|Voluntary Withdrawal|5|||
144459705|NCT02388724|520878505|FG000|Overall Study|Randomized but not Treated|0|||
144459706|NCT02388724|520878506|FG001|Overall Study|Randomized but not Treated|2|||
144459707|NCT03461003|520878507|FG000|Overall Study|Lost to Follow-up|2|||
144459708|NCT03461003|520878508|FG001|Overall Study|Lost to Follow-up|2|||
144459709|NCT03461003|520878507|FG000|Overall Study|Withdrawal by Subject|3|||
144459710|NCT03461003|520878508|FG001|Overall Study|Withdrawal by Subject|1|||
144459711|NCT01217073|520878514|FG000|Base Period|Adverse Event|1|||
144459712|NCT01217073|520878515|FG001|Base Period|Adverse Event|0|||
144459713|NCT01217073|520878516|FG002|Base Period|Adverse Event|1|||
144459714|NCT01217073|520878517|FG003|Base Period|Adverse Event|0|||
144608836|NCT01490450|521429320|FG001|Period 2|Adverse Event|1|||
144459715|NCT01217073|520878518|FG004|Base Period|Adverse Event|4|||
144459716|NCT01217073|520878519|FG005|Base Period|Adverse Event|1|||
144459717|NCT01217073|520878520|FG006|Base Period|Adverse Event|0|||
144459718|NCT01217073|520878521|FG007|Base Period|Adverse Event|0|||
144608837|NCT01490450|521429321|FG002|Period 2|Adverse Event|0|||
144608838|NCT01490450|521429322|FG003|Period 2|Adverse Event|1|||
144608839|NCT01490450|521429319|FG000|Period 2|Withdrawal by Subject|1|||
144608840|NCT01490450|521429320|FG001|Period 2|Withdrawal by Subject|0|||
144608841|NCT01490450|521429321|FG002|Period 2|Withdrawal by Subject|0|||
144608842|NCT01490450|521429322|FG003|Period 2|Withdrawal by Subject|0|||
144608843|NCT01490450|521429319|FG000|Period 2|Lost to Follow-up|0|||
144608844|NCT01490450|521429320|FG001|Period 2|Lost to Follow-up|0|||
144608845|NCT01490450|521429321|FG002|Period 2|Lost to Follow-up|0|||
144608846|NCT01490450|521429322|FG003|Period 2|Lost to Follow-up|2|||
144608847|NCT03197493|521429323|FG000|Overall Study|Withdrawal by Subject|5|||
144608848|NCT01462435|521429324|FG000|Overall Study|Lack of Efficacy|1|||
144608849|NCT01462435|521429325|FG001|Overall Study|Lack of Efficacy|0|||
144608850|NCT01462435|521429326|FG002|Overall Study|Lack of Efficacy|0|||
144608851|NCT01462435|521429327|FG003|Overall Study|Lack of Efficacy|3|||
144608852|NCT01462435|521429324|FG000|Overall Study|Physician Decision|0|||
144608853|NCT01462435|521429325|FG001|Overall Study|Physician Decision|0|||
144608854|NCT01462435|521429326|FG002|Overall Study|Physician Decision|1|||
144608855|NCT01462435|521429327|FG003|Overall Study|Physician Decision|0|||
144608856|NCT01462435|521429324|FG000|Overall Study|Withdrawal by Subject|0|||
144608857|NCT01462435|521429325|FG001|Overall Study|Withdrawal by Subject|0|||
144608858|NCT01462435|521429326|FG002|Overall Study|Withdrawal by Subject|0|||
144608859|NCT01462435|521429327|FG003|Overall Study|Withdrawal by Subject|1|||
144608860|NCT01462435|521429324|FG000|Overall Study|Lost to Follow-up|0|||
144608861|NCT01462435|521429325|FG001|Overall Study|Lost to Follow-up|0|||
144608862|NCT01462435|521429326|FG002|Overall Study|Lost to Follow-up|0|||
144459719|NCT01217073|520878514|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
144459720|NCT01217073|520878515|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459721|NCT01217073|520878516|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459722|NCT01217073|520878517|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459723|NCT01217073|520878518|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459724|NCT01217073|520878519|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459725|NCT01217073|520878520|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459726|NCT01217073|520878521|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
144459727|NCT01217073|520878514|FG000|Base Period|Excluded medication|0|||
144459728|NCT01217073|520878515|FG001|Base Period|Excluded medication|0|||
144459729|NCT01217073|520878516|FG002|Base Period|Excluded medication|0|||
144459730|NCT01217073|520878517|FG003|Base Period|Excluded medication|0|||
144459731|NCT01217073|520878518|FG004|Base Period|Excluded medication|1|||
144459732|NCT01217073|520878519|FG005|Base Period|Excluded medication|0|||
144459733|NCT01217073|520878520|FG006|Base Period|Excluded medication|0|||
144459734|NCT01217073|520878521|FG007|Base Period|Excluded medication|0|||
144459735|NCT01217073|520878514|FG000|Base Period|Lack of Efficacy|0|||
144459736|NCT01217073|520878515|FG001|Base Period|Lack of Efficacy|0|||
144459737|NCT01217073|520878516|FG002|Base Period|Lack of Efficacy|0|||
144608863|NCT01462435|521429327|FG003|Overall Study|Lost to Follow-up|1|||
144608864|NCT02807480|521429332|FG000|Overall Study|Withdrawal by Subject|14|||
144608865|NCT02807480|521429333|FG001|Overall Study|Withdrawal by Subject|10|||
144608866|NCT01543152|521429336|FG000|Overall Study|Withdrawal by Subject|0|||
144608867|NCT01543152|521429337|FG001|Overall Study|Withdrawal by Subject|2|||
144608868|NCT01543152|521429338|FG002|Overall Study|Withdrawal by Subject|0|||
144608869|NCT01543152|521429339|FG003|Overall Study|Withdrawal by Subject|0|||
144459738|NCT01217073|520878517|FG003|Base Period|Lack of Efficacy|0|||
144459739|NCT01217073|520878518|FG004|Base Period|Lack of Efficacy|0|||
144608870|NCT01543152|521429340|FG004|Overall Study|Withdrawal by Subject|0|||
144608871|NCT02053168|521429341|FG000|Overall Study|Withdrawal by Subject|1|||
144608872|NCT02053168|521429341|FG000|Overall Study|Physician Decision|1|||
144608873|NCT02053168|521429341|FG000|Overall Study|Lost to Follow-up|1|||
144608874|NCT00636675|521429345|FG000|Overall Study|Lost to Follow-up|121|||
144608875|NCT00636675|521429346|FG001|Overall Study|Lost to Follow-up|31|||
144459740|NCT01217073|520878519|FG005|Base Period|Lack of Efficacy|1|||
144459741|NCT01217073|520878520|FG006|Base Period|Lack of Efficacy|0|||
144459742|NCT01217073|520878521|FG007|Base Period|Lack of Efficacy|0|||
144459743|NCT01217073|520878514|FG000|Base Period|Lost to Follow-up|0|||
144459744|NCT01217073|520878515|FG001|Base Period|Lost to Follow-up|0|||
144459745|NCT01217073|520878516|FG002|Base Period|Lost to Follow-up|1|||
144459746|NCT01217073|520878517|FG003|Base Period|Lost to Follow-up|1|||
144608876|NCT00636675|521429345|FG000|Overall Study|Withdrawal by Subject|19|||
144608877|NCT00636675|521429346|FG001|Overall Study|Withdrawal by Subject|10|||
144608878|NCT02687542|521429347|FG000|Overall Study|Medication error without associated AEs|0|||
144608879|NCT02687542|521429348|FG001|Overall Study|Medication error without associated AEs|0|||
144608880|NCT02687542|521429349|FG002|Overall Study|Medication error without associated AEs|0|||
144608881|NCT02687542|521429350|FG003|Overall Study|Medication error without associated AEs|0|||
144459747|NCT01217073|520878518|FG004|Base Period|Lost to Follow-up|3|||
144608882|NCT02687542|521429351|FG004|Overall Study|Medication error without associated AEs|1|||
144608883|NCT02687542|521429347|FG000|Overall Study|Lost to Follow-up|0|||
144608884|NCT02687542|521429348|FG001|Overall Study|Lost to Follow-up|0|||
144608885|NCT02687542|521429349|FG002|Overall Study|Lost to Follow-up|0|||
144459748|NCT01217073|520878519|FG005|Base Period|Lost to Follow-up|0|||
144608886|NCT02687542|521429350|FG003|Overall Study|Lost to Follow-up|0|||
144608887|NCT02687542|521429351|FG004|Overall Study|Lost to Follow-up|1|||
144608888|NCT02687542|521429347|FG000|Overall Study|Protocol Violation|0|||
144608889|NCT02687542|521429348|FG001|Overall Study|Protocol Violation|1|||
144608890|NCT02687542|521429349|FG002|Overall Study|Protocol Violation|0|||
144608891|NCT02687542|521429350|FG003|Overall Study|Protocol Violation|0|||
144608892|NCT02687542|521429351|FG004|Overall Study|Protocol Violation|0|||
144608893|NCT02687542|521429347|FG000|Overall Study|Other|5|||
144608894|NCT02687542|521429348|FG001|Overall Study|Other|9|||
144608895|NCT02687542|521429349|FG002|Overall Study|Other|10|||
144608896|NCT02687542|521429350|FG003|Overall Study|Other|6|||
144608897|NCT02687542|521429351|FG004|Overall Study|Other|5|||
144608898|NCT02687542|521429347|FG000|Overall Study|Adverse Event|3|||
144608899|NCT02687542|521429348|FG001|Overall Study|Adverse Event|1|||
144608900|NCT02687542|521429349|FG002|Overall Study|Adverse Event|3|||
144608901|NCT02687542|521429350|FG003|Overall Study|Adverse Event|2|||
144608902|NCT02687542|521429351|FG004|Overall Study|Adverse Event|9|||
144608903|NCT02687542|521429347|FG000|Overall Study|Withdrawal by Subject|0|||
144608904|NCT02687542|521429348|FG001|Overall Study|Withdrawal by Subject|1|||
144608905|NCT02687542|521429349|FG002|Overall Study|Withdrawal by Subject|1|||
144608906|NCT02687542|521429350|FG003|Overall Study|Withdrawal by Subject|2|||
144608907|NCT02687542|521429351|FG004|Overall Study|Withdrawal by Subject|4|||
144608908|NCT01838616|521429352|FG000|Titration Period|Adverse Event|18|||
144608909|NCT01838616|521429353|FG001|Titration Period|Adverse Event|48|||
144608910|NCT01838616|521429352|FG000|Titration Period|Lack of Efficacy|5|||
144608911|NCT01838616|521429353|FG001|Titration Period|Lack of Efficacy|12|||
144459749|NCT01217073|520878520|FG006|Base Period|Lost to Follow-up|0|||
144608912|NCT01838616|521429352|FG000|Titration Period|Withdrawal by Subject|5|||
144608913|NCT01838616|521429353|FG001|Titration Period|Withdrawal by Subject|5|||
144608914|NCT01838616|521429352|FG000|Titration Period|Technical problems|1|||
144608915|NCT01838616|521429353|FG001|Titration Period|Technical problems|0|||
144608916|NCT01838616|521429352|FG000|Titration Period|Other|1|||
144608917|NCT01838616|521429353|FG001|Titration Period|Other|0|||
144608918|NCT01838616|521429352|FG000|Titration Period|Protocol Violation|0|||
144608919|NCT01838616|521429353|FG001|Titration Period|Protocol Violation|1|||
144608920|NCT01838616|521429352|FG000|Continuation Period|Lack of Efficacy|3|||
144608921|NCT01838616|521429353|FG001|Continuation Period|Lack of Efficacy|5|||
144608922|NCT01838616|521429352|FG000|Continuation Period|Adverse Event|8|||
144608923|NCT01838616|521429353|FG001|Continuation Period|Adverse Event|4|||
144608924|NCT01838616|521429352|FG000|Continuation Period|Protocol Violation|2|||
144608925|NCT01838616|521429353|FG001|Continuation Period|Protocol Violation|0|||
144608926|NCT01838616|521429352|FG000|Continuation Period|Lost to Follow-up|1|||
144608927|NCT01838616|521429353|FG001|Continuation Period|Lost to Follow-up|0|||
144608928|NCT01838616|521429352|FG000|Continuation Period|Withdrawal by Subject|0|||
144608929|NCT01838616|521429353|FG001|Continuation Period|Withdrawal by Subject|4|||
144608930|NCT01838616|521429352|FG000|Continuation Period|Technical problems|0|||
144608931|NCT01838616|521429353|FG001|Continuation Period|Technical problems|1|||
144608932|NCT01838616|521429352|FG000|Pick-up Arm|Lack of Efficacy|4|||
144608933|NCT01838616|521429353|FG001|Pick-up Arm|Lack of Efficacy|0|||
144608934|NCT01838616|521429352|FG000|Pick-up Arm|Adverse Event|9|||
144608935|NCT01838616|521429353|FG001|Pick-up Arm|Adverse Event|0|||
144608936|NCT01838616|521429352|FG000|Pick-up Arm|Withdrawal by Subject|1|||
144608937|NCT01838616|521429353|FG001|Pick-up Arm|Withdrawal by Subject|0|||
144608938|NCT01838616|521429352|FG000|Pick-up Arm|Technical problems|1|||
144608939|NCT01838616|521429353|FG001|Pick-up Arm|Technical problems|0|||
144608940|NCT02081534|521429358|FG000|Overall Study|Adverse Event|5|||
144608941|NCT02081534|521429359|FG001|Overall Study|Adverse Event|4|||
144459750|NCT01217073|520878521|FG007|Base Period|Lost to Follow-up|0|||
144608942|NCT02081534|521429360|FG002|Overall Study|Adverse Event|3|||
144608943|NCT02081534|521429361|FG003|Overall Study|Adverse Event|10|||
144608944|NCT02081534|521429362|FG004|Overall Study|Adverse Event|2|||
144608945|NCT02081534|521429363|FG005|Overall Study|Adverse Event|8|||
144608946|NCT02081534|521429364|FG006|Overall Study|Adverse Event|2|||
144608947|NCT02081534|521429358|FG000|Overall Study|Withdrawal by Subject|0|||
144608948|NCT02081534|521429359|FG001|Overall Study|Withdrawal by Subject|1|||
144608949|NCT02081534|521429360|FG002|Overall Study|Withdrawal by Subject|1|||
144608950|NCT02081534|521429361|FG003|Overall Study|Withdrawal by Subject|1|||
144608951|NCT02081534|521429362|FG004|Overall Study|Withdrawal by Subject|1|||
144608952|NCT02081534|521429363|FG005|Overall Study|Withdrawal by Subject|0|||
144608953|NCT02081534|521429364|FG006|Overall Study|Withdrawal by Subject|1|||
144608954|NCT02081534|521429358|FG000|Overall Study|Protocol Violation|0|||
144608955|NCT02081534|521429359|FG001|Overall Study|Protocol Violation|3|||
144608956|NCT02081534|521429360|FG002|Overall Study|Protocol Violation|0|||
144608957|NCT02081534|521429361|FG003|Overall Study|Protocol Violation|0|||
144608958|NCT02081534|521429362|FG004|Overall Study|Protocol Violation|0|||
144608959|NCT02081534|521429363|FG005|Overall Study|Protocol Violation|0|||
144608960|NCT02081534|521429364|FG006|Overall Study|Protocol Violation|1|||
144608961|NCT02081534|521429358|FG000|Overall Study|Lost to Follow-up|0|||
144608962|NCT02081534|521429359|FG001|Overall Study|Lost to Follow-up|0|||
144459751|NCT01217073|520878514|FG000|Base Period|Physician Decision|0|||
144459752|NCT01217073|520878515|FG001|Base Period|Physician Decision|0|||
144459753|NCT01217073|520878516|FG002|Base Period|Physician Decision|0|||
144459754|NCT01217073|520878517|FG003|Base Period|Physician Decision|0|||
144459755|NCT01217073|520878518|FG004|Base Period|Physician Decision|1|||
144459756|NCT01217073|520878519|FG005|Base Period|Physician Decision|0|||
144459757|NCT01217073|520878520|FG006|Base Period|Physician Decision|0|||
144459758|NCT01217073|520878521|FG007|Base Period|Physician Decision|0|||
144459759|NCT01217073|520878514|FG000|Base Period|Protocol Violation|1|||
144459760|NCT01217073|520878515|FG001|Base Period|Protocol Violation|0|||
144459761|NCT01217073|520878516|FG002|Base Period|Protocol Violation|0|||
144459762|NCT01217073|520878517|FG003|Base Period|Protocol Violation|0|||
144459763|NCT01217073|520878518|FG004|Base Period|Protocol Violation|1|||
144459764|NCT01217073|520878519|FG005|Base Period|Protocol Violation|2|||
144459765|NCT01217073|520878520|FG006|Base Period|Protocol Violation|0|||
144459766|NCT01217073|520878521|FG007|Base Period|Protocol Violation|0|||
144459767|NCT01217073|520878514|FG000|Base Period|Withdrawal by Subject|4|||
144459768|NCT01217073|520878515|FG001|Base Period|Withdrawal by Subject|5|||
144459769|NCT01217073|520878516|FG002|Base Period|Withdrawal by Subject|5|||
144459770|NCT01217073|520878517|FG003|Base Period|Withdrawal by Subject|1|||
144459771|NCT01217073|520878518|FG004|Base Period|Withdrawal by Subject|5|||
144459772|NCT01217073|520878519|FG005|Base Period|Withdrawal by Subject|5|||
144459773|NCT01217073|520878520|FG006|Base Period|Withdrawal by Subject|0|||
144459774|NCT01217073|520878521|FG007|Base Period|Withdrawal by Subject|0|||
144459775|NCT01217073|520878514|FG000|Extension Period|Adverse Event|0|||
144459776|NCT01217073|520878515|FG001|Extension Period|Adverse Event|0|||
144459777|NCT01217073|520878516|FG002|Extension Period|Adverse Event|0|||
144459778|NCT01217073|520878517|FG003|Extension Period|Adverse Event|0|||
144459779|NCT01217073|520878518|FG004|Extension Period|Adverse Event|0|||
144459780|NCT01217073|520878519|FG005|Extension Period|Adverse Event|0|||
144459781|NCT01217073|520878520|FG006|Extension Period|Adverse Event|19|||
144459782|NCT01217073|520878521|FG007|Extension Period|Adverse Event|5|||
144459783|NCT01217073|520878514|FG000|Extension Period|ALT/AST|0|||
144459784|NCT01217073|520878515|FG001|Extension Period|ALT/AST|0|||
144459785|NCT01217073|520878516|FG002|Extension Period|ALT/AST|0|||
144459786|NCT01217073|520878517|FG003|Extension Period|ALT/AST|0|||
144459787|NCT01217073|520878518|FG004|Extension Period|ALT/AST|0|||
144459788|NCT01217073|520878519|FG005|Extension Period|ALT/AST|0|||
144459789|NCT01217073|520878520|FG006|Extension Period|ALT/AST|2|||
144459790|NCT01217073|520878521|FG007|Extension Period|ALT/AST|0|||
144459791|NCT01217073|520878514|FG000|Extension Period|Contraindication to study medication|0|||
144459792|NCT01217073|520878515|FG001|Extension Period|Contraindication to study medication|0|||
144459793|NCT01217073|520878516|FG002|Extension Period|Contraindication to study medication|0|||
144459794|NCT01217073|520878517|FG003|Extension Period|Contraindication to study medication|0|||
144459795|NCT01217073|520878518|FG004|Extension Period|Contraindication to study medication|0|||
144459796|NCT01217073|520878519|FG005|Extension Period|Contraindication to study medication|0|||
144459797|NCT01217073|520878520|FG006|Extension Period|Contraindication to study medication|1|||
144459798|NCT01217073|520878521|FG007|Extension Period|Contraindication to study medication|0|||
144459799|NCT01217073|520878514|FG000|Extension Period|Creatinine/eGFR|0|||
144459800|NCT01217073|520878515|FG001|Extension Period|Creatinine/eGFR|0|||
144459801|NCT01217073|520878516|FG002|Extension Period|Creatinine/eGFR|0|||
144459802|NCT01217073|520878517|FG003|Extension Period|Creatinine/eGFR|0|||
144459803|NCT01217073|520878518|FG004|Extension Period|Creatinine/eGFR|0|||
144459804|NCT01217073|520878519|FG005|Extension Period|Creatinine/eGFR|0|||
144459805|NCT01217073|520878520|FG006|Extension Period|Creatinine/eGFR|11|||
144459806|NCT01217073|520878521|FG007|Extension Period|Creatinine/eGFR|1|||
144459807|NCT01217073|520878514|FG000|Extension Period|Death|0|||
144459808|NCT01217073|520878515|FG001|Extension Period|Death|0|||
144459809|NCT01217073|520878516|FG002|Extension Period|Death|0|||
144459810|NCT01217073|520878517|FG003|Extension Period|Death|0|||
144459811|NCT01217073|520878518|FG004|Extension Period|Death|0|||
144459812|NCT01217073|520878519|FG005|Extension Period|Death|0|||
144459813|NCT01217073|520878520|FG006|Extension Period|Death|1|||
144459814|NCT01217073|520878521|FG007|Extension Period|Death|0|||
144534709|NCT02777593|521161679|FG002|Overall Study|Still in study|3|||
144534710|NCT02777593|521161680|FG003|Overall Study|Still in study|6|||
144534711|NCT02777593|521161681|FG004|Overall Study|Still in study|5|||
144534712|NCT02777593|521161677|FG000|Overall Study|Death|21|||
144534713|NCT02777593|521161678|FG001|Overall Study|Death|28|||
144534714|NCT02777593|521161679|FG002|Overall Study|Death|0|||
144459815|NCT01217073|520878514|FG000|Extension Period|Excluded medication|0|||
144534715|NCT02777593|521161680|FG003|Overall Study|Death|5|||
144459816|NCT01217073|520878515|FG001|Extension Period|Excluded medication|0|||
144459817|NCT01217073|520878516|FG002|Extension Period|Excluded medication|0|||
144459818|NCT01217073|520878517|FG003|Extension Period|Excluded medication|0|||
144459819|NCT01217073|520878518|FG004|Extension Period|Excluded medication|0|||
144459820|NCT01217073|520878519|FG005|Extension Period|Excluded medication|0|||
144459821|NCT01217073|520878520|FG006|Extension Period|Excluded medication|2|||
144459822|NCT01217073|520878521|FG007|Extension Period|Excluded medication|0|||
144534716|NCT02777593|521161681|FG004|Overall Study|Death|0|||
144608963|NCT02081534|521429360|FG002|Overall Study|Lost to Follow-up|0|||
144608964|NCT02081534|521429361|FG003|Overall Study|Lost to Follow-up|2|||
144608965|NCT02081534|521429362|FG004|Overall Study|Lost to Follow-up|1|||
144608966|NCT02081534|521429363|FG005|Overall Study|Lost to Follow-up|1|||
144608967|NCT02081534|521429364|FG006|Overall Study|Lost to Follow-up|0|||
144608968|NCT02234479|521429365|FG000|Overall Study|Withdrawal by Subject|1|||
144608969|NCT02234479|521429366|FG001|Overall Study|Withdrawal by Subject|3|||
144608970|NCT01007032|521429367|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
144608971|NCT01007032|521429368|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
144608972|NCT01007032|521429369|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
144459823|NCT01217073|520878514|FG000|Extension Period|Lack of Efficacy|0|||
144459824|NCT01217073|520878515|FG001|Extension Period|Lack of Efficacy|0|||
144459825|NCT01217073|520878516|FG002|Extension Period|Lack of Efficacy|0|||
144459826|NCT01217073|520878517|FG003|Extension Period|Lack of Efficacy|0|||
144459827|NCT01217073|520878518|FG004|Extension Period|Lack of Efficacy|0|||
144608973|NCT01007032|521429370|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
144608974|NCT01007032|521429367|FG000|Overall Study|Withdrawal by Subject|0|||
144608975|NCT01007032|521429368|FG001|Overall Study|Withdrawal by Subject|0|||
144459828|NCT01217073|520878519|FG005|Extension Period|Lack of Efficacy|0|||
144459829|NCT01217073|520878520|FG006|Extension Period|Lack of Efficacy|3|||
144459830|NCT01217073|520878521|FG007|Extension Period|Lack of Efficacy|0|||
144459831|NCT01217073|520878514|FG000|Extension Period|Lost to Follow-up|0|||
144459832|NCT01217073|520878515|FG001|Extension Period|Lost to Follow-up|0|||
144459833|NCT01217073|520878516|FG002|Extension Period|Lost to Follow-up|0|||
144459834|NCT01217073|520878517|FG003|Extension Period|Lost to Follow-up|0|||
144459835|NCT01217073|520878518|FG004|Extension Period|Lost to Follow-up|0|||
144459836|NCT01217073|520878519|FG005|Extension Period|Lost to Follow-up|0|||
144459837|NCT01217073|520878520|FG006|Extension Period|Lost to Follow-up|9|||
144459838|NCT01217073|520878521|FG007|Extension Period|Lost to Follow-up|1|||
144459839|NCT01217073|520878514|FG000|Extension Period|Non-compliance with study drug|0|||
144459840|NCT01217073|520878515|FG001|Extension Period|Non-compliance with study drug|0|||
144459841|NCT01217073|520878516|FG002|Extension Period|Non-compliance with study drug|0|||
144459842|NCT01217073|520878517|FG003|Extension Period|Non-compliance with study drug|0|||
144459843|NCT01217073|520878518|FG004|Extension Period|Non-compliance with study drug|0|||
144459844|NCT01217073|520878519|FG005|Extension Period|Non-compliance with study drug|0|||
144534717|NCT02777593|521161677|FG000|Overall Study|Withdrawal by Subject|8|||
144534718|NCT02777593|521161678|FG001|Overall Study|Withdrawal by Subject|4|||
144534719|NCT02777593|521161679|FG002|Overall Study|Withdrawal by Subject|1|||
144608976|NCT01007032|521429369|FG002|Overall Study|Withdrawal by Subject|0|||
144608977|NCT01007032|521429370|FG003|Overall Study|Withdrawal by Subject|1|||
144608978|NCT03794583|521429371|FG000|Overall Study|Death|8|||
144608979|NCT03794583|521429371|FG000|Overall Study|Study Terminated by Sponsor|24|||
144608980|NCT03794583|521429371|FG000|Overall Study|Withdrawal by Subject|9|||
144608981|NCT01161043|521429377|FG000|Overall Study|Withdrawal by Subject|3|||
144608982|NCT02164929|521429378|FG000|Overall Study|Converted to open procedure|1|||
144608983|NCT02164929|521429379|FG001|Overall Study|Converted to open procedure|0|||
144608984|NCT02164929|521429380|FG002|Overall Study|Converted to open procedure|0|||
144608985|NCT02164929|521429381|FG003|Overall Study|Converted to open procedure|2|||
144608986|NCT02164929|521429378|FG000|Overall Study|Failed regional block|0|||
144608987|NCT02164929|521429379|FG001|Overall Study|Failed regional block|0|||
144608988|NCT02164929|521429380|FG002|Overall Study|Failed regional block|1|||
144608989|NCT02164929|521429381|FG003|Overall Study|Failed regional block|0|||
144608990|NCT00701090|521429389|FG000|Overall Study|Adverse Event|11|||
144608991|NCT00701090|521429390|FG001|Overall Study|Adverse Event|2|||
144608992|NCT00701090|521429389|FG000|Overall Study|Death|0|||
144608993|NCT00701090|521429390|FG001|Overall Study|Death|1|||
144534720|NCT02777593|521161680|FG003|Overall Study|Withdrawal by Subject|1|||
144534721|NCT02777593|521161681|FG004|Overall Study|Withdrawal by Subject|0|||
144534722|NCT02777593|521161677|FG000|Overall Study|Lost to Follow-up|8|||
144534723|NCT02777593|521161678|FG001|Overall Study|Lost to Follow-up|16|||
144534724|NCT02777593|521161679|FG002|Overall Study|Lost to Follow-up|5|||
144534725|NCT02777593|521161680|FG003|Overall Study|Lost to Follow-up|0|||
144534726|NCT02777593|521161681|FG004|Overall Study|Lost to Follow-up|1|||
144534727|NCT02777593|521161677|FG000|Overall Study|Physician Decision|2|||
144534728|NCT02777593|521161678|FG001|Overall Study|Physician Decision|2|||
144608994|NCT00701090|521429389|FG000|Overall Study|Lack of Efficacy|5|||
144608995|NCT00701090|521429390|FG001|Overall Study|Lack of Efficacy|4|||
144608996|NCT00701090|521429389|FG000|Overall Study|Lost to Follow-up|9|||
144534729|NCT02777593|521161679|FG002|Overall Study|Physician Decision|0|||
144608997|NCT00701090|521429390|FG001|Overall Study|Lost to Follow-up|9|||
144608998|NCT00701090|521429389|FG000|Overall Study|Physician Decision|3|||
144608999|NCT00701090|521429390|FG001|Overall Study|Physician Decision|4|||
144609000|NCT00701090|521429389|FG000|Overall Study|Protocol Violation|2|||
144609001|NCT00701090|521429390|FG001|Overall Study|Protocol Violation|3|||
144459845|NCT01217073|520878520|FG006|Extension Period|Non-compliance with study drug|0|||
144459846|NCT01217073|520878521|FG007|Extension Period|Non-compliance with study drug|1|||
144609002|NCT00701090|521429389|FG000|Overall Study|Withdrawal by Subject|11|||
144459847|NCT01217073|520878514|FG000|Extension Period|Physician Decision|0|||
144459848|NCT01217073|520878515|FG001|Extension Period|Physician Decision|0|||
144459849|NCT01217073|520878516|FG002|Extension Period|Physician Decision|0|||
144459850|NCT01217073|520878517|FG003|Extension Period|Physician Decision|0|||
144459851|NCT01217073|520878518|FG004|Extension Period|Physician Decision|0|||
144459852|NCT01217073|520878519|FG005|Extension Period|Physician Decision|0|||
144459853|NCT01217073|520878520|FG006|Extension Period|Physician Decision|4|||
144459854|NCT01217073|520878521|FG007|Extension Period|Physician Decision|1|||
144459855|NCT01217073|520878514|FG000|Extension Period|Protocol Violation|0|||
144459856|NCT01217073|520878515|FG001|Extension Period|Protocol Violation|0|||
144459857|NCT01217073|520878516|FG002|Extension Period|Protocol Violation|0|||
144459858|NCT01217073|520878517|FG003|Extension Period|Protocol Violation|0|||
144459859|NCT01217073|520878518|FG004|Extension Period|Protocol Violation|0|||
144459860|NCT01217073|520878519|FG005|Extension Period|Protocol Violation|0|||
144459861|NCT01217073|520878520|FG006|Extension Period|Protocol Violation|2|||
144459862|NCT01217073|520878521|FG007|Extension Period|Protocol Violation|1|||
144459863|NCT01217073|520878514|FG000|Extension Period|Site discontinued study participation|0|||
144459864|NCT01217073|520878515|FG001|Extension Period|Site discontinued study participation|0|||
144459865|NCT01217073|520878516|FG002|Extension Period|Site discontinued study participation|0|||
144459866|NCT01217073|520878517|FG003|Extension Period|Site discontinued study participation|0|||
144459867|NCT01217073|520878518|FG004|Extension Period|Site discontinued study participation|0|||
144459868|NCT01217073|520878519|FG005|Extension Period|Site discontinued study participation|0|||
144459869|NCT01217073|520878520|FG006|Extension Period|Site discontinued study participation|7|||
144459870|NCT01217073|520878521|FG007|Extension Period|Site discontinued study participation|2|||
144459871|NCT01217073|520878514|FG000|Extension Period|Withdrawal by Subject|0|||
144459872|NCT01217073|520878515|FG001|Extension Period|Withdrawal by Subject|0|||
144459873|NCT01217073|520878516|FG002|Extension Period|Withdrawal by Subject|0|||
144459874|NCT01217073|520878517|FG003|Extension Period|Withdrawal by Subject|0|||
144459875|NCT01217073|520878518|FG004|Extension Period|Withdrawal by Subject|0|||
144459876|NCT01217073|520878519|FG005|Extension Period|Withdrawal by Subject|0|||
144459877|NCT01217073|520878520|FG006|Extension Period|Withdrawal by Subject|30|||
144459878|NCT01217073|520878521|FG007|Extension Period|Withdrawal by Subject|8|||
144459879|NCT00620750|520878522|FG000|Overall Study|Lost to Follow-up|25|||
144459880|NCT04477187|520878523|FG000|Overall Study|Lost to Follow-up|2|||
144459881|NCT02047045|520878524|FG000|Baseline|Withdrawal by Subject|3|||
144459882|NCT02047045|520878525|FG001|Baseline|Withdrawal by Subject|2|||
144459883|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
144459884|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
144459885|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
144459886|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
144459887|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
144459888|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
144459889|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
144459890|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
144459891|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
144459892|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
144459893|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
144459894|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
144459895|NCT02047045|520878524|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
144459896|NCT02047045|520878525|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
144459897|NCT02047045|520878524|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
144459898|NCT02047045|520878525|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
144459899|NCT00765843|520878526|FG000|Overall Study|Lost to Follow-up|1|||
144459900|NCT00765843|520878527|FG001|Overall Study|Lost to Follow-up|3|||
144459901|NCT00765843|520878528|FG002|Overall Study|Lost to Follow-up|2|||
144459902|NCT00765843|520878526|FG000|Overall Study|did not return to receive intervention|0|||
144459903|NCT00765843|520878527|FG001|Overall Study|did not return to receive intervention|1|||
144459904|NCT00765843|520878528|FG002|Overall Study|did not return to receive intervention|0|||
144459905|NCT00765843|520878526|FG000|Overall Study|Adverse Event|0|||
144459906|NCT00765843|520878527|FG001|Overall Study|Adverse Event|0|||
144459907|NCT00765843|520878528|FG002|Overall Study|Adverse Event|1|||
144459908|NCT02460991|520878529|FG000|Overall Study|Withdrawal by Subject|0|||
144459909|NCT02460991|520878530|FG001|Overall Study|Withdrawal by Subject|2|||
144459910|NCT00856856|520878531|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
144459911|NCT00856856|520878531|FG000|4-year Clinical Follow-up|Missed visit|1|||
144459912|NCT02117570|520878534|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
144459913|NCT02117570|520878535|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
144459914|NCT02117570|520878536|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
144459915|NCT02117570|520878534|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
144459916|NCT02117570|520878535|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
144459917|NCT02117570|520878536|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
144534730|NCT02777593|521161680|FG003|Overall Study|Physician Decision|0|||
144459918|NCT02117570|520878534|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
144459919|NCT02117570|520878535|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
144459920|NCT02117570|520878536|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
144459921|NCT02117570|520878534|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
144459922|NCT02117570|520878535|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
144459923|NCT02117570|520878536|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
144459924|NCT02117570|520878534|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
144459925|NCT02117570|520878535|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
144459926|NCT02117570|520878536|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
144459927|NCT02117570|520878534|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
144459928|NCT02117570|520878535|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
144459929|NCT02117570|520878536|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
144459930|NCT02117570|520878534|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
144459931|NCT02117570|520878535|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
144459932|NCT02117570|520878536|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
144459933|NCT04862143|520878537|FG000|Overall Study|Adverse Event|1|||
144459934|NCT04862143|520878537|FG000|Overall Study|Study terminated by sponsor|1|||
144459935|NCT01571362|520878538|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
144534731|NCT02777593|521161681|FG004|Overall Study|Physician Decision|0|||
144534732|NCT02777593|521161677|FG000|Overall Study|Discontinued due to Other|1|||
144534733|NCT02777593|521161678|FG001|Overall Study|Discontinued due to Other|0|||
144534734|NCT02777593|521161679|FG002|Overall Study|Discontinued due to Other|0|||
144534735|NCT02777593|521161680|FG003|Overall Study|Discontinued due to Other|0|||
144534736|NCT02777593|521161681|FG004|Overall Study|Discontinued due to Other|0|||
144534737|NCT03884439|521161682|FG000|Overall Study|No informed consent for publication of study results|38|||
144534738|NCT03884439|521161682|FG000|Overall Study|Contract violation/deficiency|7|||
144534739|NCT06065735|521161688|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
144534740|NCT06065735|521161689|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
144534741|NCT06065735|521161690|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
144534742|NCT06065735|521161688|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
144534743|NCT06065735|521161689|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
144534744|NCT06065735|521161690|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
144534745|NCT06065735|521161688|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
144534746|NCT06065735|521161689|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
144534747|NCT06065735|521161690|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
144534748|NCT06065735|521161688|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
144534749|NCT06065735|521161689|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
144534750|NCT06065735|521161690|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
144534751|NCT06065735|521161688|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
144534752|NCT06065735|521161689|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
144534753|NCT06065735|521161690|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
144534754|NCT02532621|521161691|FG000|Overall Study|Death|3|||
144534755|NCT02532621|521161691|FG000|Overall Study|Lost to Follow-up|3|||
144534756|NCT02532621|521161691|FG000|Overall Study|Withdrawal by Subject|6|||
144534757|NCT02532621|521161691|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
144534758|NCT02532621|521161691|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
144534759|NCT02933489|521161696|FG000|Overall Study|Ineligible|3|||
144534760|NCT02933489|521161697|FG001|Overall Study|Ineligible|3|||
144534761|NCT02933489|521161696|FG000|Overall Study|Withdrawal by Subject|27|||
144534762|NCT02933489|521161697|FG001|Overall Study|Withdrawal by Subject|18|||
144534763|NCT02933489|521161696|FG000|Overall Study|Unable to complete exams (other)|14|||
144534764|NCT02933489|521161697|FG001|Overall Study|Unable to complete exams (other)|7|||
144534765|NCT05485935|521161698|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
144534766|NCT05485935|521161699|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
144534767|NCT05485935|521161698|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
144534768|NCT05485935|521161699|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
144534769|NCT05485935|521161698|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
144534770|NCT05485935|521161699|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
144534771|NCT05485935|521161698|FG000|Period 2 (T2 and V3)|loss of contact|0|||
144459936|NCT01571362|520878539|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
144459937|NCT01571362|520878540|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
144459938|NCT01571362|520878538|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
144534772|NCT05485935|521161699|FG001|Period 2 (T2 and V3)|loss of contact|1|||
144534773|NCT04093869|521161701|FG000|Overall Study|Death|0|||
144534774|NCT04093869|521161702|FG001|Overall Study|Death|1|||
144534775|NCT04093869|521161701|FG000|Overall Study|Withdrawal by Subject|1|||
144534776|NCT04093869|521161702|FG001|Overall Study|Withdrawal by Subject|0|||
144534777|NCT02806726|521161703|FG000|Overall Study|Lost to Follow-up|1|||
144534778|NCT03250676|521161704|FG000|Overall Study|Adverse Event|0|||
144609003|NCT00701090|521429390|FG001|Overall Study|Withdrawal by Subject|16|||
144609004|NCT00701090|521429389|FG000|Overall Study|Other|7|||
144609005|NCT00701090|521429390|FG001|Overall Study|Other|12|||
144609006|NCT00509067|521429394|FG000|Overall Study|Lost to Follow-up|1|||
144609007|NCT00509067|521429395|FG001|Overall Study|Lost to Follow-up|1|||
144609008|NCT00509067|521429394|FG000|Overall Study|Adverse Event|3|||
144609009|NCT00509067|521429395|FG001|Overall Study|Adverse Event|1|||
144609010|NCT00509067|521429394|FG000|Overall Study|Protocol Violation|0|||
144609011|NCT00509067|521429395|FG001|Overall Study|Protocol Violation|3|||
144609012|NCT01854645|521429403|FG000|Overall Study|Protocol-Specified Criteria|13|||
144609013|NCT01854645|521429404|FG001|Overall Study|Protocol-Specified Criteria|10|||
144609014|NCT01854645|521429405|FG002|Overall Study|Protocol-Specified Criteria|8|||
144609015|NCT01854645|521429406|FG003|Overall Study|Protocol-Specified Criteria|5|||
144609016|NCT01854645|521429407|FG004|Overall Study|Protocol-Specified Criteria|7|||
144609017|NCT01854645|521429403|FG000|Overall Study|Administrative Reasons / Missing|0|||
144609018|NCT01854645|521429404|FG001|Overall Study|Administrative Reasons / Missing|0|||
144609019|NCT01854645|521429405|FG002|Overall Study|Administrative Reasons / Missing|0|||
144609020|NCT01854645|521429406|FG003|Overall Study|Administrative Reasons / Missing|1|||
144609021|NCT01854645|521429407|FG004|Overall Study|Administrative Reasons / Missing|1|||
144609022|NCT01854645|521429403|FG000|Overall Study|Protocol Violation|3|||
144609023|NCT01854645|521429404|FG001|Overall Study|Protocol Violation|0|||
144609024|NCT01854645|521429405|FG002|Overall Study|Protocol Violation|5|||
144609025|NCT01854645|521429406|FG003|Overall Study|Protocol Violation|4|||
144609026|NCT01854645|521429407|FG004|Overall Study|Protocol Violation|1|||
144609027|NCT01854645|521429403|FG000|Overall Study|Lost to Follow-up|10|||
144609028|NCT01854645|521429404|FG001|Overall Study|Lost to Follow-up|7|||
144609029|NCT01854645|521429405|FG002|Overall Study|Lost to Follow-up|8|||
144609030|NCT01854645|521429406|FG003|Overall Study|Lost to Follow-up|5|||
144609031|NCT01854645|521429407|FG004|Overall Study|Lost to Follow-up|0|||
144609032|NCT01854645|521429403|FG000|Overall Study|Physician Decision|1|||
144609033|NCT01854645|521429404|FG001|Overall Study|Physician Decision|5|||
144609034|NCT01854645|521429405|FG002|Overall Study|Physician Decision|3|||
144609035|NCT01854645|521429406|FG003|Overall Study|Physician Decision|3|||
144609036|NCT01854645|521429407|FG004|Overall Study|Physician Decision|7|||
144609037|NCT01854645|521429403|FG000|Overall Study|Withdrawal by Subject|31|||
144609038|NCT01854645|521429404|FG001|Overall Study|Withdrawal by Subject|41|||
144459939|NCT01571362|520878539|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
144459940|NCT01571362|520878540|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
144459941|NCT01571362|520878538|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
144459942|NCT01571362|520878539|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
144459943|NCT01571362|520878540|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
144459944|NCT01571362|520878538|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
144459945|NCT01571362|520878539|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
144459946|NCT01571362|520878540|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
144609039|NCT01854645|521429405|FG002|Overall Study|Withdrawal by Subject|30|||
144609040|NCT01854645|521429406|FG003|Overall Study|Withdrawal by Subject|21|||
144609041|NCT01854645|521429407|FG004|Overall Study|Withdrawal by Subject|24|||
144459947|NCT01571362|520878538|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
144459948|NCT01571362|520878539|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
144459949|NCT01571362|520878540|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
144459950|NCT01571362|520878538|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
144459951|NCT01571362|520878539|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
144459952|NCT01571362|520878540|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
144459953|NCT01571362|520878538|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144459954|NCT01571362|520878539|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
144609042|NCT01854645|521429403|FG000|Overall Study|Lack of Efficacy|7|||
144609043|NCT01854645|521429404|FG001|Overall Study|Lack of Efficacy|12|||
144459955|NCT01571362|520878540|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
144609044|NCT01854645|521429405|FG002|Overall Study|Lack of Efficacy|9|||
144609045|NCT01854645|521429406|FG003|Overall Study|Lack of Efficacy|3|||
144609046|NCT01854645|521429407|FG004|Overall Study|Lack of Efficacy|9|||
144609047|NCT01854645|521429403|FG000|Overall Study|Adverse Event|33|||
144609048|NCT01854645|521429404|FG001|Overall Study|Adverse Event|31|||
144609049|NCT01854645|521429405|FG002|Overall Study|Adverse Event|19|||
144609050|NCT01854645|521429406|FG003|Overall Study|Adverse Event|20|||
144609051|NCT01854645|521429407|FG004|Overall Study|Adverse Event|11|||
144609052|NCT01817751|521429410|FG000|Overall Study|Physician Decision|1|||
144609053|NCT00382018|521429411|FG000|Overall Study|Progression|0|||
144609054|NCT00382018|521429412|FG001|Overall Study|Progression|136|||
144609055|NCT00382018|521429413|FG002|Overall Study|Progression|51|||
144609056|NCT00382018|521429414|FG003|Overall Study|Progression|43|||
144609057|NCT00382018|521429411|FG000|Overall Study|Death|0|||
144609058|NCT00382018|521429412|FG001|Overall Study|Death|9|||
144609059|NCT00382018|521429413|FG002|Overall Study|Death|7|||
144609060|NCT00382018|521429414|FG003|Overall Study|Death|11|||
144609061|NCT00382018|521429411|FG000|Overall Study|Withdrawal by Subject|0|||
144609062|NCT00382018|521429412|FG001|Overall Study|Withdrawal by Subject|4|||
144609063|NCT00382018|521429413|FG002|Overall Study|Withdrawal by Subject|3|||
144609064|NCT00382018|521429414|FG003|Overall Study|Withdrawal by Subject|4|||
144609065|NCT00382018|521429411|FG000|Overall Study|Other, not protocol specified|0|||
144609066|NCT00382018|521429412|FG001|Overall Study|Other, not protocol specified|16|||
144609067|NCT00382018|521429413|FG002|Overall Study|Other, not protocol specified|3|||
144609068|NCT00382018|521429414|FG003|Overall Study|Other, not protocol specified|1|||
144609069|NCT01252810|521429415|FG000|Overall Study|Withdrawal by Subject|4|||
144609070|NCT01252810|521429416|FG001|Overall Study|Withdrawal by Subject|1|||
144609071|NCT01252810|521429415|FG000|Overall Study|Lost to Follow-up|0|||
144609072|NCT01252810|521429416|FG001|Overall Study|Lost to Follow-up|1|||
144609073|NCT01252810|521429415|FG000|Overall Study|Physician Decision|2|||
144609074|NCT01252810|521429416|FG001|Overall Study|Physician Decision|1|||
144609075|NCT01252810|521429415|FG000|Overall Study|Various reasons|8|||
144609076|NCT01252810|521429416|FG001|Overall Study|Various reasons|0|||
144609077|NCT01846624|521429417|FG000|Overall Study|Died during induction, no midostaurin|1|||
144609078|NCT00427349|521429421|FG000|Overall Study|Lack of Efficacy|23|||
144609079|NCT00427349|521429421|FG000|Overall Study|Adverse Event|14|||
144459956|NCT01571362|520878538|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
144459957|NCT01571362|520878539|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
144459958|NCT01571362|520878540|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
144459959|NCT01571362|520878538|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144459960|NCT01571362|520878539|FG001|Double-Blind Treatment Period|Adverse Event|9|||
144459961|NCT01571362|520878540|FG002|Double-Blind Treatment Period|Adverse Event|14|||
144459962|NCT01571362|520878538|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144459963|NCT01571362|520878539|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
144459964|NCT01571362|520878540|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
144459965|NCT01571362|520878538|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
144459966|NCT01571362|520878539|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
144459967|NCT01571362|520878540|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
144459968|NCT01571362|520878538|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
144459969|NCT01571362|520878539|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
144459970|NCT01571362|520878540|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
144459971|NCT03117738|520878541|FG000|Overall Study|Withdrawal by Subject|3|||
144459972|NCT03117738|520878542|FG001|Overall Study|Withdrawal by Subject|1|||
144459973|NCT03117738|520878541|FG000|Overall Study|Lost to Follow-up|1|||
144459974|NCT03117738|520878542|FG001|Overall Study|Lost to Follow-up|4|||
144459975|NCT01669629|520878543|FG000|Period 1|protocol deviation|1|||
144459976|NCT01669629|520878544|FG001|Period 1|protocol deviation|2|||
144459977|NCT01221597|520878545|FG000|Overall Study|Adverse Event|4|||
144459978|NCT01221597|520878546|FG001|Overall Study|Adverse Event|1|||
144459979|NCT01221597|520878545|FG000|Overall Study|Withdrawal by Subject|20|||
144459980|NCT01221597|520878546|FG001|Overall Study|Withdrawal by Subject|6|||
144459981|NCT01221597|520878545|FG000|Overall Study|Lost to Follow-up|6|||
144459982|NCT01221597|520878546|FG001|Overall Study|Lost to Follow-up|5|||
144459983|NCT01221597|520878545|FG000|Overall Study|Protocol Violation|1|||
144459984|NCT01221597|520878546|FG001|Overall Study|Protocol Violation|0|||
144459985|NCT01221597|520878545|FG000|Overall Study|Other|3|||
144459986|NCT01221597|520878546|FG001|Overall Study|Other|4|||
144459987|NCT01221597|520878545|FG000|Overall Study|Death|2|||
144459988|NCT01221597|520878546|FG001|Overall Study|Death|0|||
144459989|NCT04420689|520878548|FG000|Overall Study|COVID-19 related hospitalization|0|||
144459990|NCT04420689|520878549|FG001|Overall Study|COVID-19 related hospitalization|0|||
144459991|NCT04420689|520878550|FG002|Overall Study|COVID-19 related hospitalization|0|||
144459992|NCT04420689|520878551|FG003|Overall Study|COVID-19 related hospitalization|0|||
144459993|NCT04420689|520878552|FG004|Overall Study|COVID-19 related hospitalization|1|||
144459994|NCT04420689|520878553|FG005|Overall Study|COVID-19 related hospitalization|0|||
144459995|NCT04420689|520878554|FG006|Overall Study|COVID-19 related hospitalization|0|||
144459996|NCT04420689|520878548|FG000|Overall Study|Physician Decision|0|||
144459997|NCT04420689|520878549|FG001|Overall Study|Physician Decision|0|||
144459998|NCT04420689|520878550|FG002|Overall Study|Physician Decision|0|||
144459999|NCT04420689|520878551|FG003|Overall Study|Physician Decision|0|||
144460000|NCT04420689|520878552|FG004|Overall Study|Physician Decision|0|||
144460001|NCT04420689|520878553|FG005|Overall Study|Physician Decision|1|||
144460002|NCT04420689|520878554|FG006|Overall Study|Physician Decision|0|||
144609080|NCT00427349|521429421|FG000|Overall Study|Death|1|||
144609081|NCT00427349|521429421|FG000|Overall Study|Withdrawal by Subject|3|||
144725890|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
144725891|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
144609082|NCT00427349|521429421|FG000|Overall Study|Alternative therapy|1|||
144725892|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
144460003|NCT01292928|520878564|FG000|Overall Study|Death|8|||
144460004|NCT01292928|520878564|FG000|Overall Study|Withdrawal by Subject|8|||
144460005|NCT01292928|520878564|FG000|Overall Study|Lost to Follow-up|6|||
144460006|NCT01292928|520878564|FG000|Overall Study|Physician Decision|2|||
144460007|NCT01519206|520878565|FG000|Overall Study|Lost to Follow-up|3|||
144460008|NCT01519206|520878565|FG000|Overall Study|Missed Visit|2|||
144460009|NCT04420221|520878566|FG000|Overall Study|Withdrawal by Subject|0|||
144725893|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
144725894|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
144725895|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
144460010|NCT04420221|520878567|FG001|Overall Study|Withdrawal by Subject|0|||
144460011|NCT04420221|520878568|FG002|Overall Study|Withdrawal by Subject|0|||
144460012|NCT04420221|520878569|FG003|Overall Study|Withdrawal by Subject|0|||
144460013|NCT04420221|520878570|FG004|Overall Study|Withdrawal by Subject|0|||
144460014|NCT04420221|520878571|FG005|Overall Study|Withdrawal by Subject|20|||
144460015|NCT04420221|520878572|FG006|Overall Study|Withdrawal by Subject|5|||
144460016|NCT04420221|520878566|FG000|Overall Study|Other|0|||
144460017|NCT04420221|520878567|FG001|Overall Study|Other|0|||
144460018|NCT04420221|520878568|FG002|Overall Study|Other|0|||
144460019|NCT04420221|520878569|FG003|Overall Study|Other|0|||
144460020|NCT04420221|520878570|FG004|Overall Study|Other|0|||
144460021|NCT04420221|520878571|FG005|Overall Study|Other|1|||
144460022|NCT04420221|520878572|FG006|Overall Study|Other|1|||
144460023|NCT04420221|520878566|FG000|Overall Study|Lost to Follow-up|0|||
144534779|NCT03250676|521161705|FG001|Overall Study|Adverse Event|0|||
144534780|NCT03250676|521161706|FG002|Overall Study|Adverse Event|0|||
144534781|NCT03250676|521161707|FG003|Overall Study|Adverse Event|1|||
144534782|NCT03250676|521161708|FG004|Overall Study|Adverse Event|2|||
144534783|NCT03250676|521161709|FG005|Overall Study|Adverse Event|9|||
144534784|NCT03250676|521161704|FG000|Overall Study|Withdrawal by Subject|1|||
144534785|NCT03250676|521161705|FG001|Overall Study|Withdrawal by Subject|0|||
144534786|NCT03250676|521161706|FG002|Overall Study|Withdrawal by Subject|0|||
144534787|NCT03250676|521161707|FG003|Overall Study|Withdrawal by Subject|1|||
144534788|NCT03250676|521161708|FG004|Overall Study|Withdrawal by Subject|1|||
144534789|NCT03250676|521161709|FG005|Overall Study|Withdrawal by Subject|2|||
144534790|NCT03250676|521161704|FG000|Overall Study|Physician Decision|0|||
144534791|NCT03250676|521161705|FG001|Overall Study|Physician Decision|0|||
144534792|NCT03250676|521161706|FG002|Overall Study|Physician Decision|0|||
144534793|NCT03250676|521161707|FG003|Overall Study|Physician Decision|2|||
144534794|NCT03250676|521161708|FG004|Overall Study|Physician Decision|0|||
144534795|NCT03250676|521161709|FG005|Overall Study|Physician Decision|3|||
144534796|NCT03250676|521161704|FG000|Overall Study|Withdrawal of consent|0|||
144534797|NCT03250676|521161705|FG001|Overall Study|Withdrawal of consent|0|||
144534798|NCT03250676|521161706|FG002|Overall Study|Withdrawal of consent|2|||
144534799|NCT03250676|521161707|FG003|Overall Study|Withdrawal of consent|0|||
144534800|NCT03250676|521161708|FG004|Overall Study|Withdrawal of consent|0|||
144534801|NCT03250676|521161709|FG005|Overall Study|Withdrawal of consent|2|||
144534802|NCT03250676|521161704|FG000|Overall Study|Other|1|||
144534803|NCT03250676|521161705|FG001|Overall Study|Other|0|||
144534804|NCT03250676|521161706|FG002|Overall Study|Other|0|||
144534805|NCT03250676|521161707|FG003|Overall Study|Other|0|||
144534806|NCT03250676|521161708|FG004|Overall Study|Other|0|||
144534807|NCT03250676|521161709|FG005|Overall Study|Other|0|||
144534808|NCT03250676|521161704|FG000|Overall Study|Disease progression|4|||
144534809|NCT03250676|521161705|FG001|Overall Study|Disease progression|12|||
144534810|NCT03250676|521161706|FG002|Overall Study|Disease progression|9|||
144534811|NCT03250676|521161707|FG003|Overall Study|Disease progression|7|||
144534812|NCT03250676|521161708|FG004|Overall Study|Disease progression|4|||
144534813|NCT03250676|521161709|FG005|Overall Study|Disease progression|88|||
144534814|NCT05129501|521161712|FG000|Overall Study|Lost to Follow-up|54|||
144534815|NCT05129501|521161713|FG001|Overall Study|Lost to Follow-up|41|||
144534816|NCT03092674|521161714|FG000|Overall Study|Adverse Event or Side Effects|1|||
144534817|NCT03092674|521161715|FG001|Overall Study|Adverse Event or Side Effects|4|||
144534818|NCT03092674|521161716|FG002|Overall Study|Adverse Event or Side Effects|4|||
144534819|NCT03092674|521161714|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
144534820|NCT03092674|521161715|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
144534821|NCT03092674|521161716|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
144534822|NCT03092674|521161714|FG000|Overall Study|Progression/Relapse|5|||
144534823|NCT03092674|521161715|FG001|Overall Study|Progression/Relapse|4|||
144534824|NCT03092674|521161716|FG002|Overall Study|Progression/Relapse|8|||
144534825|NCT03092674|521161714|FG000|Overall Study|Death|4|||
144534826|NCT03092674|521161715|FG001|Overall Study|Death|8|||
144534827|NCT03092674|521161716|FG002|Overall Study|Death|2|||
144534828|NCT03092674|521161714|FG000|Overall Study|Other - Not Protocol Specified|11|||
144534829|NCT03092674|521161715|FG001|Overall Study|Other - Not Protocol Specified|8|||
144534830|NCT03092674|521161716|FG002|Overall Study|Other - Not Protocol Specified|8|||
144534831|NCT01527188|521161717|FG000|Overall Study|Adverse Event|5|||
144534832|NCT01527188|521161718|FG001|Overall Study|Adverse Event|5|||
144534833|NCT01527188|521161719|FG002|Overall Study|Adverse Event|11|||
144534834|NCT01527188|521161720|FG003|Overall Study|Adverse Event|0|||
144534835|NCT01527188|521161717|FG000|Overall Study|Withdrawal by Subject|3|||
144534836|NCT01527188|521161718|FG001|Overall Study|Withdrawal by Subject|6|||
144534837|NCT01527188|521161719|FG002|Overall Study|Withdrawal by Subject|4|||
144534838|NCT01527188|521161720|FG003|Overall Study|Withdrawal by Subject|4|||
144534839|NCT01527188|521161717|FG000|Overall Study|Any other reason not above-mentioned|6|||
144534840|NCT01527188|521161718|FG001|Overall Study|Any other reason not above-mentioned|7|||
144534841|NCT01527188|521161719|FG002|Overall Study|Any other reason not above-mentioned|8|||
144534842|NCT01527188|521161720|FG003|Overall Study|Any other reason not above-mentioned|8|||
144534843|NCT04626427|521161723|FG000|Overall Study|Death|1|||
144534844|NCT04626427|521161723|FG000|Overall Study|Withdrawal by Subject|1|||
144534845|NCT04626427|521161723|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
144534846|NCT04626427|521161723|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
144534847|NCT05267639|521162535|FG000|Overall Study|Withdrawal by Subject|1|||
144534848|NCT05267639|521162536|FG001|Overall Study|Withdrawal by Subject|0|||
144534849|NCT03512301|521162545|FG000|Overall Study|Protocol Violation|2|||
144534850|NCT03512301|521162545|FG000|Overall Study|Did Not Qualify|3|||
144534851|NCT03512301|521162545|FG000|Overall Study|Age-ineligible|1|||
144534852|NCT03512301|521162545|FG000|Overall Study|Inadequate fluency with the English language|3|||
144534853|NCT02611687|521162548|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
144534854|NCT02611687|521162549|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
144534855|NCT05157841|521162554|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
144534856|NCT05157841|521162555|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
144534857|NCT05157841|521162556|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
144534858|NCT05157841|521162554|FG000|Part A (14 Days)|Adverse Event|1|||
144534859|NCT05157841|521162555|FG001|Part A (14 Days)|Adverse Event|0|||
144534860|NCT05157841|521162556|FG002|Part A (14 Days)|Adverse Event|0|||
144534861|NCT05157841|521162554|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
144534862|NCT05157841|521162555|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
144534863|NCT05157841|521162556|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
144534864|NCT04933474|521162557|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
144534865|NCT04933474|521162558|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
144534866|NCT04933474|521162557|FG000|Overall Study|Lost to Follow-up|19|||
144534867|NCT04933474|521162558|FG001|Overall Study|Lost to Follow-up|9|||
144534868|NCT04933474|521162557|FG000|Overall Study|Life Burden - unable to participate|6|||
144534869|NCT04933474|521162558|FG001|Overall Study|Life Burden - unable to participate|2|||
144534870|NCT04933474|521162557|FG000|Overall Study|Disease Burden - unable to participate|4|||
144534871|NCT04933474|521162558|FG001|Overall Study|Disease Burden - unable to participate|1|||
144534872|NCT04933474|521162557|FG000|Overall Study|Surgery/Hospitalization|1|||
144534873|NCT04933474|521162558|FG001|Overall Study|Surgery/Hospitalization|2|||
144534874|NCT04933474|521162557|FG000|Overall Study|Dissatisfied with Intervention|1|||
144534875|NCT04933474|521162558|FG001|Overall Study|Dissatisfied with Intervention|1|||
144534876|NCT04933474|521162557|FG000|Overall Study|Withdrew interest in participation|1|||
144534877|NCT04933474|521162558|FG001|Overall Study|Withdrew interest in participation|0|||
144534878|NCT04933474|521162557|FG000|Overall Study|Had previously enrolled in the study|0|||
144534879|NCT04933474|521162558|FG001|Overall Study|Had previously enrolled in the study|1|||
144534880|NCT04772534|521162563|FG000|Overall Study|Physician Decision|1|||
144534881|NCT04772534|521162564|FG001|Overall Study|Physician Decision|0|||
144534882|NCT04772534|521162565|FG002|Overall Study|Physician Decision|0|||
144534883|NCT04772534|521162563|FG000|Overall Study|Withdrawal by Subject|3|||
144534884|NCT04772534|521162564|FG001|Overall Study|Withdrawal by Subject|0|||
144534885|NCT04772534|521162565|FG002|Overall Study|Withdrawal by Subject|1|||
144534886|NCT03786926|521162574|FG000|Overall Study|Adverse Event|0|||
144534887|NCT03786926|521162575|FG001|Overall Study|Adverse Event|0|||
144534888|NCT03786926|521162576|FG002|Overall Study|Adverse Event|0|||
144534889|NCT03786926|521162577|FG003|Overall Study|Adverse Event|0|||
144534890|NCT03786926|521162578|FG004|Overall Study|Adverse Event|0|||
144534891|NCT03786926|521162579|FG005|Overall Study|Adverse Event|0|||
144534892|NCT03786926|521162580|FG006|Overall Study|Adverse Event|0|||
144534893|NCT03786926|521162581|FG007|Overall Study|Adverse Event|1|||
144534894|NCT03786926|521162582|FG008|Overall Study|Adverse Event|1|||
144534895|NCT03786926|521162583|FG009|Overall Study|Adverse Event|0|||
144534896|NCT03786926|521162584|FG010|Overall Study|Adverse Event|1|||
144534897|NCT03786926|521162574|FG000|Overall Study|Progressive disease|3|||
144534898|NCT03786926|521162575|FG001|Overall Study|Progressive disease|0|||
144534899|NCT03786926|521162576|FG002|Overall Study|Progressive disease|3|||
144534900|NCT03786926|521162577|FG003|Overall Study|Progressive disease|1|||
144534901|NCT03786926|521162578|FG004|Overall Study|Progressive disease|2|||
144534902|NCT03786926|521162579|FG005|Overall Study|Progressive disease|2|||
144725896|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
144534903|NCT03786926|521162580|FG006|Overall Study|Progressive disease|1|||
144534904|NCT03786926|521162581|FG007|Overall Study|Progressive disease|6|||
144534905|NCT03786926|521162582|FG008|Overall Study|Progressive disease|1|||
144534906|NCT03786926|521162583|FG009|Overall Study|Progressive disease|1|||
144534907|NCT03786926|521162584|FG010|Overall Study|Progressive disease|1|||
144534908|NCT03786926|521162574|FG000|Overall Study|Death|0|||
144534909|NCT03786926|521162575|FG001|Overall Study|Death|1|||
144534910|NCT03786926|521162576|FG002|Overall Study|Death|1|||
144460024|NCT04420221|520878567|FG001|Overall Study|Lost to Follow-up|0|||
144460025|NCT04420221|520878568|FG002|Overall Study|Lost to Follow-up|0|||
144460026|NCT04420221|520878569|FG003|Overall Study|Lost to Follow-up|0|||
144460027|NCT04420221|520878570|FG004|Overall Study|Lost to Follow-up|0|||
144460028|NCT04420221|520878571|FG005|Overall Study|Lost to Follow-up|3|||
144460029|NCT04420221|520878572|FG006|Overall Study|Lost to Follow-up|2|||
144460030|NCT04420221|520878566|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
144460031|NCT04420221|520878567|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
144460032|NCT04420221|520878568|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
144460033|NCT04420221|520878569|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
144460034|NCT04420221|520878570|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
144460035|NCT04420221|520878571|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
144460036|NCT04420221|520878572|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
144460037|NCT02647359|520878573|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
144460038|NCT02647359|520878574|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
144460039|NCT02647359|520878573|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
144460040|NCT02647359|520878574|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
144460041|NCT02647359|520878573|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
144460042|NCT02647359|520878574|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
144460043|NCT02647359|520878573|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
144460044|NCT02647359|520878574|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
144460045|NCT02647359|520878573|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
144460046|NCT02647359|520878574|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
144460047|NCT02647359|520878573|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
144460048|NCT02647359|520878574|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
144460049|NCT04642638|520878575|FG000|Overall Study|Withdrawal by Subject|23|||
144460050|NCT04642638|520878576|FG001|Overall Study|Withdrawal by Subject|29|||
144460051|NCT04642638|520878577|FG002|Overall Study|Withdrawal by Subject|9|||
144460052|NCT04642638|520878578|FG003|Overall Study|Withdrawal by Subject|7|||
144460053|NCT04642638|520878579|FG004|Overall Study|Withdrawal by Subject|61|||
144460054|NCT04642638|520878580|FG005|Overall Study|Withdrawal by Subject|27|||
144460055|NCT04642638|520878575|FG000|Overall Study|Lost to Follow-up|17|||
144460056|NCT04642638|520878576|FG001|Overall Study|Lost to Follow-up|18|||
144460057|NCT04642638|520878577|FG002|Overall Study|Lost to Follow-up|5|||
144460058|NCT04642638|520878578|FG003|Overall Study|Lost to Follow-up|5|||
144460059|NCT04642638|520878579|FG004|Overall Study|Lost to Follow-up|6|||
144460060|NCT04642638|520878580|FG005|Overall Study|Lost to Follow-up|3|||
144460061|NCT04642638|520878575|FG000|Overall Study|Adverse Event|0|||
144460062|NCT04642638|520878576|FG001|Overall Study|Adverse Event|0|||
144460063|NCT04642638|520878577|FG002|Overall Study|Adverse Event|1|||
144460064|NCT04642638|520878578|FG003|Overall Study|Adverse Event|0|||
144460065|NCT04642638|520878579|FG004|Overall Study|Adverse Event|10|||
144460066|NCT04642638|520878580|FG005|Overall Study|Adverse Event|3|||
144460067|NCT04642638|520878575|FG000|Overall Study|Reason Not Specified|1|||
144460068|NCT04642638|520878576|FG001|Overall Study|Reason Not Specified|4|||
144460069|NCT04642638|520878577|FG002|Overall Study|Reason Not Specified|0|||
144460070|NCT04642638|520878578|FG003|Overall Study|Reason Not Specified|0|||
144460071|NCT04642638|520878579|FG004|Overall Study|Reason Not Specified|38|||
144460072|NCT04642638|520878580|FG005|Overall Study|Reason Not Specified|16|||
144460073|NCT04642638|520878575|FG000|Overall Study|Physician Decision|0|||
144460074|NCT04642638|520878576|FG001|Overall Study|Physician Decision|0|||
144460075|NCT04642638|520878577|FG002|Overall Study|Physician Decision|0|||
144460076|NCT04642638|520878578|FG003|Overall Study|Physician Decision|0|||
144460077|NCT04642638|520878579|FG004|Overall Study|Physician Decision|2|||
144460078|NCT04642638|520878580|FG005|Overall Study|Physician Decision|1|||
144460079|NCT04642638|520878575|FG000|Overall Study|Protocol Deviation|0|||
144460080|NCT04642638|520878576|FG001|Overall Study|Protocol Deviation|0|||
144460081|NCT04642638|520878577|FG002|Overall Study|Protocol Deviation|0|||
144460082|NCT04642638|520878578|FG003|Overall Study|Protocol Deviation|0|||
144460083|NCT04642638|520878579|FG004|Overall Study|Protocol Deviation|1|||
144460084|NCT04642638|520878580|FG005|Overall Study|Protocol Deviation|3|||
144460085|NCT04642638|520878575|FG000|Overall Study|Study Terminated|0|||
144460086|NCT04642638|520878576|FG001|Overall Study|Study Terminated|0|||
144460087|NCT04642638|520878577|FG002|Overall Study|Study Terminated|0|||
144460088|NCT04642638|520878578|FG003|Overall Study|Study Terminated|0|||
144460089|NCT04642638|520878579|FG004|Overall Study|Study Terminated|484|||
144460090|NCT04642638|520878580|FG005|Overall Study|Study Terminated|250|||
144460091|NCT04642638|520878575|FG000|Overall Study|Pregnancy|0|||
144460092|NCT04642638|520878576|FG001|Overall Study|Pregnancy|0|||
144460093|NCT04642638|520878577|FG002|Overall Study|Pregnancy|0|||
144534911|NCT03786926|521162577|FG003|Overall Study|Death|0|||
144534912|NCT03786926|521162578|FG004|Overall Study|Death|0|||
144460094|NCT04642638|520878578|FG003|Overall Study|Pregnancy|0|||
144460095|NCT04642638|520878579|FG004|Overall Study|Pregnancy|1|||
144460096|NCT04642638|520878580|FG005|Overall Study|Pregnancy|0|||
144534913|NCT03786926|521162579|FG005|Overall Study|Death|0|||
144609083|NCT00427349|521429421|FG000|Overall Study|Other|2|||
144609084|NCT00427349|521429421|FG000|Overall Study|Ineligible|1|||
144609085|NCT00427349|521429421|FG000|Overall Study|Never started therapy|1|||
144609086|NCT00698997|521429422|FG000|Overall Study|Lost to Follow-up|3|||
144609087|NCT00698997|521429423|FG001|Overall Study|Lost to Follow-up|0|||
144609088|NCT00698997|521429422|FG000|Overall Study|Withdrawal by Subject|7|||
144609089|NCT00698997|521429423|FG001|Overall Study|Withdrawal by Subject|27|||
144609090|NCT05082376|521429424|FG000|Overall Study|Lost to Follow-up|2|||
144609091|NCT00493220|521429425|FG000|Third Intervention|Withdrawal by Subject|1|||
144609092|NCT00493220|521429426|FG001|Third Intervention|Withdrawal by Subject|0|||
144609093|NCT00493220|521429427|FG002|Third Intervention|Withdrawal by Subject|0|||
144609094|NCT00493220|521429428|FG003|Third Intervention|Withdrawal by Subject|0|||
144609095|NCT00493220|521429429|FG004|Third Intervention|Withdrawal by Subject|0|||
144609096|NCT00493220|521429430|FG005|Third Intervention|Withdrawal by Subject|0|||
144609097|NCT02625233|521429431|FG000|Overall Study|Adverse Event|2|||
144609098|NCT02625233|521429432|FG001|Overall Study|Adverse Event|0|||
144609099|NCT04425720|521429438|FG000|Overall Study|Withdrawal by Subject|0|||
144609100|NCT04425720|521429439|FG001|Overall Study|Withdrawal by Subject|20|||
144609101|NCT00445224|521429440|FG000|Specific Exercises|Withdrawal by Subject|3|||
144609102|NCT00445224|521429441|FG001|Specific Exercises|Withdrawal by Subject|3|||
144609103|NCT00445224|521429440|FG000|Specific Exercises|Withdrawal by Subject|1|||
144609104|NCT00445224|521429441|FG001|Specific Exercises|Withdrawal by Subject|0|||
144609105|NCT01524198|521431000|FG000|Overall Study|Protocol Violation|8|||
144609106|NCT01524198|521431001|FG001|Overall Study|Protocol Violation|6|||
144609107|NCT01524198|521431000|FG000|Overall Study|Withdrawal by Subject|15|||
144725897|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
144725898|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
144725899|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
144725900|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
144725901|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
144725902|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
144725903|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
144725904|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
144725905|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
144725906|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
144725907|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
144725908|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
144725909|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
144725910|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
144725911|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
144725912|NCT02207231|521852630|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
144725913|NCT02207231|521852631|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
144725914|NCT02207231|521852632|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
144725915|NCT02207231|521852633|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
144725916|NCT01644500|521852634|FG000|Overall Study|Adverse Event|6|||
144725917|NCT01644500|521852635|FG001|Overall Study|Adverse Event|1|||
144725918|NCT01644500|521852636|FG002|Overall Study|Adverse Event|2|||
144725919|NCT01644500|521852634|FG000|Overall Study|Death|0|||
144725920|NCT01644500|521852635|FG001|Overall Study|Death|1|||
144725921|NCT01644500|521852636|FG002|Overall Study|Death|0|||
144725922|NCT01644500|521852634|FG000|Overall Study|Lost to Follow-up|3|||
144725923|NCT01644500|521852635|FG001|Overall Study|Lost to Follow-up|8|||
144725924|NCT01644500|521852636|FG002|Overall Study|Lost to Follow-up|0|||
144725925|NCT01644500|521852634|FG000|Overall Study|Protocol Violation|1|||
144725926|NCT01644500|521852635|FG001|Overall Study|Protocol Violation|1|||
144725927|NCT01644500|521852636|FG002|Overall Study|Protocol Violation|0|||
144725928|NCT01644500|521852634|FG000|Overall Study|Withdrawal by Subject|11|||
144725929|NCT01644500|521852635|FG001|Overall Study|Withdrawal by Subject|12|||
144725930|NCT01644500|521852636|FG002|Overall Study|Withdrawal by Subject|12|||
144725931|NCT01644500|521852634|FG000|Overall Study|Physician Decision|1|||
144609108|NCT01524198|521431001|FG001|Overall Study|Withdrawal by Subject|10|||
144609109|NCT02232802|521431002|FG000|Period 1|Sponsor request|1|||
144609110|NCT02232802|521431003|FG001|Period 1|Sponsor request|0|||
144609111|NCT02232802|521431002|FG000|Period 1|Adverse Event|1|||
144725932|NCT01644500|521852635|FG001|Overall Study|Physician Decision|1|||
144609112|NCT02232802|521431003|FG001|Period 1|Adverse Event|1|||
144609113|NCT00885703|521431005|FG000|Overall Study|Death|9|||
144609114|NCT00885703|521431006|FG001|Overall Study|Death|7|||
144609115|NCT00885703|521431007|FG002|Overall Study|Death|8|||
144609116|NCT00885703|521431008|FG003|Overall Study|Death|7|||
144609117|NCT00885703|521431009|FG004|Overall Study|Death|7|||
144609118|NCT00885703|521431010|FG005|Overall Study|Death|8|||
144609119|NCT00885703|521431011|FG006|Overall Study|Death|4|||
144609120|NCT00885703|521431005|FG000|Overall Study|Lost to Follow-up|0|||
144725933|NCT01644500|521852636|FG002|Overall Study|Physician Decision|1|||
144609121|NCT00885703|521431006|FG001|Overall Study|Lost to Follow-up|0|||
144609122|NCT00885703|521431007|FG002|Overall Study|Lost to Follow-up|1|||
144609123|NCT00885703|521431008|FG003|Overall Study|Lost to Follow-up|0|||
144609124|NCT00885703|521431009|FG004|Overall Study|Lost to Follow-up|0|||
144609125|NCT00885703|521431010|FG005|Overall Study|Lost to Follow-up|1|||
144609126|NCT00885703|521431011|FG006|Overall Study|Lost to Follow-up|0|||
144534914|NCT03786926|521162580|FG006|Overall Study|Death|0|||
144534915|NCT03786926|521162581|FG007|Overall Study|Death|0|||
144534916|NCT03786926|521162582|FG008|Overall Study|Death|0|||
144534917|NCT03786926|521162583|FG009|Overall Study|Death|1|||
144534918|NCT03786926|521162584|FG010|Overall Study|Death|2|||
144534919|NCT03786926|521162574|FG000|Overall Study|Physician Decision|0|||
144534920|NCT03786926|521162575|FG001|Overall Study|Physician Decision|1|||
144534921|NCT03786926|521162576|FG002|Overall Study|Physician Decision|0|||
144534922|NCT03786926|521162577|FG003|Overall Study|Physician Decision|1|||
144534923|NCT03786926|521162578|FG004|Overall Study|Physician Decision|2|||
144534924|NCT03786926|521162579|FG005|Overall Study|Physician Decision|0|||
144534925|NCT03786926|521162580|FG006|Overall Study|Physician Decision|0|||
144534926|NCT03786926|521162581|FG007|Overall Study|Physician Decision|2|||
144534927|NCT03786926|521162582|FG008|Overall Study|Physician Decision|1|||
144534928|NCT03786926|521162583|FG009|Overall Study|Physician Decision|1|||
144534929|NCT03786926|521162584|FG010|Overall Study|Physician Decision|0|||
144534930|NCT03786926|521162574|FG000|Overall Study|Withdrawal by Subject|0|||
144534931|NCT03786926|521162575|FG001|Overall Study|Withdrawal by Subject|1|||
144534932|NCT03786926|521162576|FG002|Overall Study|Withdrawal by Subject|1|||
144534933|NCT03786926|521162577|FG003|Overall Study|Withdrawal by Subject|0|||
144534934|NCT03786926|521162578|FG004|Overall Study|Withdrawal by Subject|0|||
144534935|NCT03786926|521162579|FG005|Overall Study|Withdrawal by Subject|0|||
144534936|NCT03786926|521162580|FG006|Overall Study|Withdrawal by Subject|1|||
144534937|NCT03786926|521162581|FG007|Overall Study|Withdrawal by Subject|0|||
144534938|NCT03786926|521162582|FG008|Overall Study|Withdrawal by Subject|1|||
144534939|NCT03786926|521162583|FG009|Overall Study|Withdrawal by Subject|0|||
144534940|NCT03786926|521162584|FG010|Overall Study|Withdrawal by Subject|1|||
144534941|NCT03786926|521162574|FG000|Overall Study|Study terminated by Sponsor|0|||
144534942|NCT03786926|521162575|FG001|Overall Study|Study terminated by Sponsor|0|||
144534943|NCT03786926|521162576|FG002|Overall Study|Study terminated by Sponsor|0|||
144534944|NCT03786926|521162577|FG003|Overall Study|Study terminated by Sponsor|0|||
144534945|NCT03786926|521162578|FG004|Overall Study|Study terminated by Sponsor|1|||
144534946|NCT03786926|521162579|FG005|Overall Study|Study terminated by Sponsor|0|||
144534947|NCT03786926|521162580|FG006|Overall Study|Study terminated by Sponsor|0|||
144534948|NCT03786926|521162581|FG007|Overall Study|Study terminated by Sponsor|4|||
144534949|NCT03786926|521162582|FG008|Overall Study|Study terminated by Sponsor|0|||
144534950|NCT03786926|521162583|FG009|Overall Study|Study terminated by Sponsor|0|||
144534951|NCT03786926|521162584|FG010|Overall Study|Study terminated by Sponsor|0|||
144534952|NCT03786926|521162574|FG000|Overall Study|Anti-neoplasm treatment|0|||
144534953|NCT03786926|521162575|FG001|Overall Study|Anti-neoplasm treatment|0|||
144534954|NCT03786926|521162576|FG002|Overall Study|Anti-neoplasm treatment|0|||
144534955|NCT03786926|521162577|FG003|Overall Study|Anti-neoplasm treatment|0|||
144534956|NCT03786926|521162578|FG004|Overall Study|Anti-neoplasm treatment|1|||
144534957|NCT03786926|521162579|FG005|Overall Study|Anti-neoplasm treatment|0|||
144534958|NCT03786926|521162580|FG006|Overall Study|Anti-neoplasm treatment|1|||
144534959|NCT03786926|521162581|FG007|Overall Study|Anti-neoplasm treatment|0|||
144534960|NCT03786926|521162582|FG008|Overall Study|Anti-neoplasm treatment|0|||
144534961|NCT03786926|521162583|FG009|Overall Study|Anti-neoplasm treatment|0|||
144534962|NCT03786926|521162584|FG010|Overall Study|Anti-neoplasm treatment|0|||
144534963|NCT03786926|521162574|FG000|Overall Study|Other|0|||
144534964|NCT03786926|521162575|FG001|Overall Study|Other|0|||
144534965|NCT03786926|521162576|FG002|Overall Study|Other|0|||
144534966|NCT03786926|521162577|FG003|Overall Study|Other|1|||
144534967|NCT03786926|521162578|FG004|Overall Study|Other|0|||
144534968|NCT03786926|521162579|FG005|Overall Study|Other|1|||
144534969|NCT03786926|521162580|FG006|Overall Study|Other|0|||
144534970|NCT03786926|521162581|FG007|Overall Study|Other|0|||
144534971|NCT03786926|521162582|FG008|Overall Study|Other|2|||
144534972|NCT03786926|521162583|FG009|Overall Study|Other|0|||
144534973|NCT03786926|521162584|FG010|Overall Study|Other|0|||
144534974|NCT05875701|521162592|FG000|Overall Study|Lost to Follow-up|2|||
144534975|NCT05875701|521162593|FG001|Overall Study|Lost to Follow-up|0|||
144534976|NCT05875701|521162592|FG000|Overall Study|Withdrawal by Subject|1|||
144534977|NCT05875701|521162593|FG001|Overall Study|Withdrawal by Subject|1|||
144534978|NCT05988398|521162597|FG000|Overall Study|Lack of time|21|||
144534979|NCT05988398|521162598|FG001|Overall Study|Lack of time|0|||
144534980|NCT05988398|521162597|FG000|Overall Study|Absent from school|0|||
144609127|NCT00885703|521431005|FG000|Overall Study|Withdrawal by Subject|0|||
144534981|NCT05988398|521162598|FG001|Overall Study|Absent from school|38|||
144534982|NCT05988398|521162597|FG000|Overall Study|Chose not to participate|0|||
144534983|NCT05988398|521162598|FG001|Overall Study|Chose not to participate|42|||
144609128|NCT00885703|521431006|FG001|Overall Study|Withdrawal by Subject|0|||
144534984|NCT05988398|521162597|FG000|Overall Study|Other commitments (e.g., sports)|0|||
144534985|NCT05988398|521162598|FG001|Overall Study|Other commitments (e.g., sports)|25|||
144609129|NCT00885703|521431007|FG002|Overall Study|Withdrawal by Subject|0|||
144609130|NCT00885703|521431008|FG003|Overall Study|Withdrawal by Subject|1|||
144609131|NCT00885703|521431009|FG004|Overall Study|Withdrawal by Subject|3|||
144609132|NCT00885703|521431010|FG005|Overall Study|Withdrawal by Subject|1|||
144609133|NCT00885703|521431011|FG006|Overall Study|Withdrawal by Subject|1|||
144609134|NCT00885703|521431005|FG000|Overall Study|Ineligible (no CM)|1|||
144609135|NCT00885703|521431006|FG001|Overall Study|Ineligible (no CM)|3|||
144609136|NCT00885703|521431007|FG002|Overall Study|Ineligible (no CM)|2|||
144609137|NCT00885703|521431008|FG003|Overall Study|Ineligible (no CM)|1|||
144609138|NCT00885703|521431009|FG004|Overall Study|Ineligible (no CM)|2|||
144609139|NCT00885703|521431010|FG005|Overall Study|Ineligible (no CM)|3|||
144609140|NCT00885703|521431011|FG006|Overall Study|Ineligible (no CM)|1|||
144609141|NCT00176605|521431013|FG000|Overall Study|Withdrawal by Subject|2|||
144609142|NCT01321710|521431014|FG000|Overall Study|Lost to Follow-up|4|||
144609143|NCT01321710|521431015|FG001|Overall Study|Lost to Follow-up|5|||
144609144|NCT01321710|521431016|FG002|Overall Study|Lost to Follow-up|0|||
144609145|NCT00833053|521431018|FG000|Overall Study|Adverse Event|4|||
144609146|NCT00833053|521431019|FG001|Overall Study|Adverse Event|0|||
144609147|NCT00833053|521431018|FG000|Overall Study|Treatment Failure|3|||
144609148|NCT00833053|521431019|FG001|Overall Study|Treatment Failure|1|||
144609149|NCT00833053|521431018|FG000|Overall Study|Withdrawal by Subject|0|||
144609150|NCT00833053|521431019|FG001|Overall Study|Withdrawal by Subject|1|||
144609151|NCT00833053|521431018|FG000|Overall Study|Protocol Violation|2|||
144609152|NCT00833053|521431019|FG001|Overall Study|Protocol Violation|1|||
144609153|NCT02187471|521431020|FG000|Overall Study|Protocol Violation|4|||
144609154|NCT02187471|521431021|FG001|Overall Study|Protocol Violation|5|||
144609155|NCT02187471|521431022|FG002|Overall Study|Protocol Violation|4|||
144609156|NCT02187471|521431023|FG003|Overall Study|Protocol Violation|4|||
144609157|NCT02187471|521431020|FG000|Overall Study|Missing|0|||
144609158|NCT02187471|521431021|FG001|Overall Study|Missing|0|||
144609159|NCT02187471|521431022|FG002|Overall Study|Missing|0|||
144609160|NCT02187471|521431023|FG003|Overall Study|Missing|1|||
144609161|NCT02187471|521431020|FG000|Overall Study|Lack of Efficacy|18|||
144609162|NCT02187471|521431021|FG001|Overall Study|Lack of Efficacy|9|||
144609163|NCT02187471|521431022|FG002|Overall Study|Lack of Efficacy|13|||
144609164|NCT02187471|521431023|FG003|Overall Study|Lack of Efficacy|11|||
144609165|NCT02187471|521431020|FG000|Overall Study|Adverse Event|24|||
144609166|NCT02187471|521431021|FG001|Overall Study|Adverse Event|34|||
144609167|NCT02187471|521431022|FG002|Overall Study|Adverse Event|44|||
144609168|NCT02187471|521431023|FG003|Overall Study|Adverse Event|36|||
144609169|NCT02187471|521431020|FG000|Overall Study|Withdrawal by Subject|23|||
144609170|NCT02187471|521431021|FG001|Overall Study|Withdrawal by Subject|29|||
144609171|NCT02187471|521431022|FG002|Overall Study|Withdrawal by Subject|22|||
144609172|NCT02187471|521431023|FG003|Overall Study|Withdrawal by Subject|24|||
144609173|NCT02187471|521431020|FG000|Overall Study|Other|7|||
144609174|NCT02187471|521431021|FG001|Overall Study|Other|5|||
144609175|NCT02187471|521431022|FG002|Overall Study|Other|3|||
144609176|NCT02187471|521431023|FG003|Overall Study|Other|4|||
144609177|NCT02236520|521431024|FG000|Overall Study|Physician Decision|0|||
144609178|NCT02236520|521431025|FG001|Overall Study|Physician Decision|5|||
144609179|NCT02236520|521431026|FG002|Overall Study|Physician Decision|0|||
144609180|NCT02236520|521431027|FG003|Overall Study|Physician Decision|0|||
144460097|NCT00511004|520878581|FG000|Overall Study|Lost to Follow-up|0|||
144460098|NCT00511004|520878582|FG001|Overall Study|Lost to Follow-up|0|||
144460099|NCT00511004|520878583|FG002|Overall Study|Lost to Follow-up|4|||
144460100|NCT00990652|520878584|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
144460101|NCT00990652|520878584|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
144460102|NCT01003249|520878589|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144460103|NCT01003249|520878590|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144460104|NCT01003249|520878589|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
144460105|NCT01003249|520878590|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
144460106|NCT01003249|520878589|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
144460107|NCT01003249|520878590|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144460108|NCT01003249|520878589|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
144460109|NCT01003249|520878590|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
144460110|NCT03387852|520878594|FG000|Overall Study|Adverse event (AE)|3|||
144460111|NCT03387852|520878595|FG001|Overall Study|Adverse event (AE)|0|||
144460112|NCT03387852|520878596|FG002|Overall Study|Adverse event (AE)|2|||
144460113|NCT03387852|520878597|FG003|Overall Study|Adverse event (AE)|0|||
144460114|NCT03387852|520878594|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
144609181|NCT02236520|521431024|FG000|Overall Study|Withdrawal by Subject|1|||
144609182|NCT02236520|521431025|FG001|Overall Study|Withdrawal by Subject|0|||
144609183|NCT02236520|521431026|FG002|Overall Study|Withdrawal by Subject|0|||
144609184|NCT02236520|521431027|FG003|Overall Study|Withdrawal by Subject|1|||
144460115|NCT03387852|520878595|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
144460116|NCT03387852|520878596|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
144609185|NCT02236520|521431024|FG000|Overall Study|Pregnancy|1|||
144609186|NCT02236520|521431025|FG001|Overall Study|Pregnancy|0|||
144460117|NCT03387852|520878597|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
144460118|NCT03387852|520878594|FG000|Overall Study|Withdrawal by participant|1|||
144460119|NCT03387852|520878595|FG001|Overall Study|Withdrawal by participant|1|||
144609187|NCT02236520|521431026|FG002|Overall Study|Pregnancy|0|||
144460120|NCT03387852|520878596|FG002|Overall Study|Withdrawal by participant|3|||
144460121|NCT03387852|520878597|FG003|Overall Study|Withdrawal by participant|2|||
144460122|NCT03387852|520878594|FG000|Overall Study|Other- Unspecified|1|||
144460123|NCT03387852|520878595|FG001|Overall Study|Other- Unspecified|1|||
144460124|NCT03387852|520878596|FG002|Overall Study|Other- Unspecified|2|||
144460125|NCT03387852|520878597|FG003|Overall Study|Other- Unspecified|1|||
144460126|NCT03387852|520878594|FG000|Overall Study|Poor compliance to protocol|0|||
144460127|NCT03387852|520878595|FG001|Overall Study|Poor compliance to protocol|0|||
144460128|NCT03387852|520878596|FG002|Overall Study|Poor compliance to protocol|0|||
144460129|NCT03387852|520878597|FG003|Overall Study|Poor compliance to protocol|1|||
144460130|NCT03387852|520878594|FG000|Overall Study|Randomized and not treated|0|||
144460131|NCT03387852|520878595|FG001|Overall Study|Randomized and not treated|0|||
144460132|NCT03387852|520878596|FG002|Overall Study|Randomized and not treated|0|||
144609188|NCT02236520|521431027|FG003|Overall Study|Pregnancy|0|||
144609189|NCT01785160|521431028|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
144609190|NCT01785160|521431028|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
144609191|NCT02318667|521431029|FG000|Overall Study|Adverse Event|1|||
144609192|NCT02318667|521431029|FG000|Overall Study|Lack of Efficacy|6|||
144609193|NCT02318667|521431029|FG000|Overall Study|Protocol Violation|2|||
144609194|NCT01033734|521431030|FG000|Overall Study|Withdrawal by Subject|1|||
144609195|NCT00139776|521431039|FG000|Period I|Did not enter Period II|575|||
144609196|NCT00139776|521431040|FG001|Period I|Did not enter Period II|0|||
144609197|NCT00139776|521431041|FG002|Period I|Did not enter Period II|0|||
144609198|NCT00139776|521431042|FG003|Period I|Did not enter Period II|0|||
144609199|NCT00139776|521431039|FG000|Period II|Not Randomized into Period III|0|||
144609200|NCT00139776|521431040|FG001|Period II|Not Randomized into Period III|322|||
144609201|NCT00139776|521431041|FG002|Period II|Not Randomized into Period III|0|||
144609202|NCT00139776|521431042|FG003|Period II|Not Randomized into Period III|0|||
144609203|NCT00139776|521431039|FG000|Period III|Adverse Event|0|||
144609204|NCT00139776|521431040|FG001|Period III|Adverse Event|0|||
144609205|NCT00139776|521431041|FG002|Period III|Adverse Event|22|||
144609206|NCT00139776|521431042|FG003|Period III|Adverse Event|23|||
144609207|NCT00139776|521431039|FG000|Period III|Other|0|||
144609208|NCT00139776|521431040|FG001|Period III|Other|0|||
144609209|NCT00139776|521431041|FG002|Period III|Other|23|||
144609210|NCT00139776|521431042|FG003|Period III|Other|34|||
144609211|NCT00139776|521431039|FG000|Period III|Lack of Efficacy|0|||
144609212|NCT00139776|521431040|FG001|Period III|Lack of Efficacy|0|||
144609213|NCT00139776|521431041|FG002|Period III|Lack of Efficacy|10|||
144609214|NCT00139776|521431042|FG003|Period III|Lack of Efficacy|24|||
144609215|NCT00139776|521431039|FG000|Period III|Lost to Follow-up|0|||
144609216|NCT00139776|521431040|FG001|Period III|Lost to Follow-up|0|||
144609217|NCT00139776|521431041|FG002|Period III|Lost to Follow-up|5|||
144609218|NCT00139776|521431042|FG003|Period III|Lost to Follow-up|4|||
144609219|NCT00139776|521431039|FG000|Period III|Withdrawal by Subject|0|||
144609220|NCT00139776|521431040|FG001|Period III|Withdrawal by Subject|0|||
144609221|NCT00139776|521431041|FG002|Period III|Withdrawal by Subject|16|||
144609222|NCT00139776|521431042|FG003|Period III|Withdrawal by Subject|21|||
144609223|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
144609224|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
144609225|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
144609226|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
144609227|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
144609228|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
144460133|NCT03387852|520878597|FG003|Overall Study|Randomized and not treated|1|||
144460134|NCT01218646|520878599|FG000|Overall Study|Adverse Event|0|||
144609229|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
144609230|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
144609231|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
144609232|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
144609233|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
144609234|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
144609235|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
144609236|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
144609237|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
144609238|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
144609239|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
144460135|NCT01218646|520878600|FG001|Overall Study|Adverse Event|0|||
144609240|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
144609241|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
144460136|NCT01218646|520878601|FG002|Overall Study|Adverse Event|1|||
144460137|NCT01218646|520878602|FG003|Overall Study|Adverse Event|0|||
144460138|NCT01218646|520878599|FG000|Overall Study|Lost to Follow-up|1|||
144460139|NCT01218646|520878600|FG001|Overall Study|Lost to Follow-up|0|||
144460140|NCT01218646|520878601|FG002|Overall Study|Lost to Follow-up|0|||
144196946|NCT04688931|519918658|FG000|Overall Study|Adverse Event|4|||
144196947|NCT04688931|519918659|FG001|Overall Study|Adverse Event|1|||
144196948|NCT04688931|519918658|FG000|Overall Study|Withdrawal by Subject|5|||
144196949|NCT04688931|519918659|FG001|Overall Study|Withdrawal by Subject|16|||
144196950|NCT04688931|519918658|FG000|Overall Study|Physician Decision|3|||
144196951|NCT04688931|519918659|FG001|Overall Study|Physician Decision|5|||
144196952|NCT04688931|519918658|FG000|Overall Study|Noncompliance|0|||
144196953|NCT04688931|519918659|FG001|Overall Study|Noncompliance|1|||
144196954|NCT04688931|519918658|FG000|Overall Study|Lost to Follow-up|1|||
144196955|NCT04688931|519918659|FG001|Overall Study|Lost to Follow-up|3|||
144196956|NCT04688931|519918658|FG000|Overall Study|Randomization Error|3|||
144196957|NCT04688931|519918659|FG001|Overall Study|Randomization Error|0|||
144196958|NCT04688931|519918658|FG000|Overall Study|Not Eligible|1|||
144196959|NCT04688931|519918659|FG001|Overall Study|Not Eligible|3|||
144196960|NCT04688931|519918658|FG000|Overall Study|Disease Progression|0|||
144196961|NCT04688931|519918659|FG001|Overall Study|Disease Progression|2|||
144196962|NCT04688931|519918658|FG000|Overall Study|Sponsor Requirement|1|||
144196963|NCT04688931|519918659|FG001|Overall Study|Sponsor Requirement|1|||
144196964|NCT04688931|519918658|FG000|Overall Study|Other Reason|1|||
144196965|NCT04688931|519918659|FG001|Overall Study|Other Reason|2|||
144196966|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Adverse Event|9|||
144196967|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Adverse Event|4|||
144196968|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Adverse Event|5|||
144460141|NCT01218646|520878602|FG003|Overall Study|Lost to Follow-up|0|||
144460142|NCT01218646|520878599|FG000|Overall Study|Protocol Violation|0|||
144460143|NCT01218646|520878600|FG001|Overall Study|Protocol Violation|0|||
144460144|NCT01218646|520878601|FG002|Overall Study|Protocol Violation|1|||
144460145|NCT01218646|520878602|FG003|Overall Study|Protocol Violation|1|||
144460146|NCT00722761|520878603|FG000|Overall Study|Lost to Follow-up|1|||
144460147|NCT00722761|520878604|FG001|Overall Study|Lost to Follow-up|4|||
144460148|NCT00722761|520878603|FG000|Overall Study|Withdrawal by Subject|5|||
144460149|NCT00722761|520878604|FG001|Overall Study|Withdrawal by Subject|2|||
144460150|NCT04414696|520878607|FG000|3-month Follow up|Withdrawal by Subject|1|||
144460151|NCT04414696|520878608|FG001|3-month Follow up|Withdrawal by Subject|0|||
144460152|NCT04414696|520878607|FG000|3-month Follow up|Lost to Follow-up|22|||
144460153|NCT04414696|520878608|FG001|3-month Follow up|Lost to Follow-up|23|||
144460154|NCT04414696|520878607|FG000|6-month Follow up|Withdrawal by Subject|1|||
144460155|NCT04414696|520878608|FG001|6-month Follow up|Withdrawal by Subject|2|||
144460156|NCT04414696|520878607|FG000|6-month Follow up|Lost to Follow-up|5|||
144460157|NCT04414696|520878608|FG001|6-month Follow up|Lost to Follow-up|2|||
144460158|NCT05819749|520878609|FG000|Overall Study|Lost to Follow-up|1|||
144460159|NCT00726752|520878610|FG000|Overall Study|Lack of Efficacy|6|||
144460160|NCT01877408|520880803|FG000|Overall Study|Lost to Follow-up|0|||
144460161|NCT01877408|520880804|FG001|Overall Study|Lost to Follow-up|2|||
144460162|NCT00920426|520880805|FG000|ITZ111451|Adverse Event|1|||
144460163|NCT00920426|520880806|FG001|ITZ111451|Adverse Event|0|||
144460164|NCT00920426|520880807|FG002|ITZ111451|Adverse Event|0|||
144460165|NCT00920426|520880808|FG003|ITZ111451|Adverse Event|0|||
144460166|NCT01292603|520880809|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
144460167|NCT01292603|520880810|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
144460168|NCT01292603|520880811|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
144460169|NCT01292603|520880812|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
144460170|NCT01292603|520880813|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
144460171|NCT01292603|520880814|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
144460172|NCT01292603|520880809|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
144460173|NCT01292603|520880810|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
144460174|NCT01292603|520880811|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
144460175|NCT01292603|520880812|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
144460176|NCT01292603|520880813|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
144196969|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Adverse Event|9|||
144534986|NCT04408755|521162599|FG000|Period A (Placebo lead-in)|Other|11|||
144534987|NCT04408755|521162600|FG001|Period A (Placebo lead-in)|Other|0|||
144534988|NCT04408755|521162601|FG002|Period A (Placebo lead-in)|Other|0|||
144534989|NCT04408755|521162602|FG003|Period A (Placebo lead-in)|Other|0|||
144534990|NCT04408755|521162599|FG000|Period B (Randomization Period)|Adverse Event|0|||
144534991|NCT04408755|521162600|FG001|Period B (Randomization Period)|Adverse Event|3|||
144196970|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Adverse Event|8|||
144196971|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Adverse Event|0|||
144460177|NCT01292603|520880814|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
144460178|NCT01292603|520880809|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
144460179|NCT01292603|520880810|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
144460180|NCT01292603|520880811|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
144196972|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Adverse Event|0|||
144460181|NCT01292603|520880812|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
144534992|NCT04408755|521162601|FG002|Period B (Randomization Period)|Adverse Event|0|||
144609242|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
144609243|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
144609244|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
144609245|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
144609246|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
144609247|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
144609248|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
144609249|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
144609250|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
144609251|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
144609252|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
144609253|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609254|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
144609255|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
144609256|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
144609257|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609258|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
144609259|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
144609260|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
144609261|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
144609262|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
144609263|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
144609264|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
144609265|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
144609266|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
144609267|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
144609268|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
144609269|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
144609270|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
144609271|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
144609272|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
144609273|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
144609274|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
144609275|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
144609276|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
144609277|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
144609278|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
144609279|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
144609280|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
144609281|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
144609282|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
144609283|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
144609284|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
144609285|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
144609286|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
144609287|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
144609288|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
144609289|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
144609290|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
144609291|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
144609292|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
144609293|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
144609294|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
144609295|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
144609296|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
144609297|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
144460182|NCT01292603|520880813|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
144460183|NCT01292603|520880814|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
144460184|NCT01292603|520880809|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
144460185|NCT01292603|520880810|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
144460186|NCT01292603|520880811|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
144460187|NCT01292603|520880812|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
144609298|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
144609299|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
144609300|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
144609301|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
144609302|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
144609303|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
144609304|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
144609305|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
144609306|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
144609307|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
144609308|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
144609309|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
144609310|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
144609311|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
144609312|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
144609313|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
144609314|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
144460188|NCT01292603|520880813|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
144460189|NCT01292603|520880814|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
144460190|NCT01292603|520880809|FG000|Part 1: Regular Follow-Up Period|Death|3|||
144460191|NCT01292603|520880810|FG001|Part 1: Regular Follow-Up Period|Death|1|||
144609315|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
144609316|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
144609317|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
144609318|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
144609319|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
144609320|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
144609321|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
144609322|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
144609323|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
144609324|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
144609325|NCT00111800|521431047|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
144609326|NCT00111800|521431048|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
144609327|NCT00111800|521431049|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
144609328|NCT00111800|521431050|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
144609329|NCT00111800|521431051|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
144609330|NCT00111800|521431052|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
144609331|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
144609332|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
144609333|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
144609334|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
144609335|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
144609336|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
144609337|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
144609338|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
144609339|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
144725934|NCT01439165|521852643|FG000|Overall Study|Protocol Violation|3|||
144196973|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
144196974|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
144196975|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
144196976|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
144196977|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
144196978|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
144196979|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
144196980|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Death|1|||
144196981|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Death|1|||
144196982|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Death|1|||
144196983|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Death|1|||
144196984|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Death|0|||
144196985|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Death|0|||
144196986|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Death|0|||
144196987|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
144196988|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
144196989|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
144255461|NCT00237692|520136186|FG001|Overall Study|Withdrawal by Subject|6|||
144196990|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
144196991|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
144196992|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
144196993|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
144460192|NCT01292603|520880811|FG002|Part 1: Regular Follow-Up Period|Death|3|||
144460193|NCT01292603|520880812|FG003|Part 1: Regular Follow-Up Period|Death|1|||
144460194|NCT01292603|520880813|FG004|Part 1: Regular Follow-Up Period|Death|0|||
144460195|NCT01292603|520880814|FG005|Part 1: Regular Follow-Up Period|Death|0|||
144460196|NCT01292603|520880809|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
144460197|NCT01292603|520880810|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
144460198|NCT01292603|520880811|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
144196994|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
144196995|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
144259302|NCT01089127|520150357|FG003|Overall Study|Protocol deviation|0|||
144460199|NCT01292603|520880812|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
144460200|NCT01292603|520880813|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
144460201|NCT01292603|520880814|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
144460202|NCT01292603|520880809|FG000|Part 2: Dose Confirmation Period|Death|0|||
144460203|NCT01292603|520880810|FG001|Part 2: Dose Confirmation Period|Death|0|||
144460204|NCT01292603|520880811|FG002|Part 2: Dose Confirmation Period|Death|0|||
144460205|NCT01292603|520880812|FG003|Part 2: Dose Confirmation Period|Death|0|||
144460206|NCT01292603|520880813|FG004|Part 2: Dose Confirmation Period|Death|1|||
144460207|NCT01292603|520880814|FG005|Part 2: Dose Confirmation Period|Death|0|||
144460208|NCT01292603|520880809|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
144460209|NCT01292603|520880810|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
144460210|NCT01292603|520880811|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
144460211|NCT01292603|520880812|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
144460212|NCT01292603|520880813|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
144460213|NCT01292603|520880814|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
144460214|NCT01292603|520880809|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
144460215|NCT01292603|520880810|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
144460216|NCT01292603|520880811|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
144460217|NCT01292603|520880812|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
144460218|NCT01292603|520880813|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
144460219|NCT01292603|520880814|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
144460220|NCT01292603|520880809|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
144460221|NCT01292603|520880810|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
144460222|NCT01292603|520880811|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
144460223|NCT01292603|520880812|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
144460224|NCT01292603|520880813|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
144460225|NCT01292603|520880814|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
144460226|NCT01292603|520880809|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
144460227|NCT01292603|520880810|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
144460228|NCT01292603|520880811|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
144460229|NCT01292603|520880812|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
144460230|NCT01292603|520880813|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
144460231|NCT01292603|520880814|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
144460232|NCT01292603|520880809|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
144460233|NCT01292603|520880810|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
144460234|NCT01292603|520880811|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
144460235|NCT01292603|520880812|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
144460236|NCT01292603|520880813|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
144460237|NCT01292603|520880814|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
144460238|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Death|0|||
144460239|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Death|0|||
144460240|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Death|0|||
144460241|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Death|0|||
144460242|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Death|6|||
144460243|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Death|3|||
144460244|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
144460245|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
144460246|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
144460247|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
144460248|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
144460249|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
144460250|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
144460251|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
144460252|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
144460253|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
144460254|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
144196996|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
144196997|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
144196998|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
144196999|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
144197000|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
144197001|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
144197002|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
144197003|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
144197004|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
144197005|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
144460255|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
144460256|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
144460257|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
144460258|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
144460259|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
144460260|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
144460261|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
144460262|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
144460263|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
144460264|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
144460265|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
144460266|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
144460267|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
144460268|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
144460269|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
144460270|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
144460271|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
144460272|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
144460273|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
144460274|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
144460275|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
144460276|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
144460277|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
144460278|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
144460279|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
144460280|NCT01292603|520880809|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
144460281|NCT01292603|520880810|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
144460282|NCT01292603|520880811|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
144460283|NCT01292603|520880812|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
144460284|NCT01292603|520880813|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
144460285|NCT01292603|520880814|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
144460286|NCT01292603|520880809|FG000|Overall Survival Status|Death|3|||
144460287|NCT01292603|520880810|FG001|Overall Survival Status|Death|1|||
144460288|NCT01292603|520880811|FG002|Overall Survival Status|Death|3|||
144460289|NCT01292603|520880812|FG003|Overall Survival Status|Death|1|||
144460290|NCT01292603|520880813|FG004|Overall Survival Status|Death|16|||
144460291|NCT01292603|520880814|FG005|Overall Survival Status|Death|10|||
144460292|NCT03870763|520880817|FG000|Overall Study|Study terminated by sponsor|0|||
144460293|NCT03870763|520880818|FG001|Overall Study|Study terminated by sponsor|2|||
144460294|NCT03870763|520880819|FG002|Overall Study|Study terminated by sponsor|0|||
144460295|NCT03870763|520880817|FG000|Overall Study|Withdrawal by Subject|0|||
144460296|NCT03870763|520880818|FG001|Overall Study|Withdrawal by Subject|1|||
144460297|NCT03870763|520880819|FG002|Overall Study|Withdrawal by Subject|0|||
144460298|NCT03870763|520880817|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
144460299|NCT03870763|520880818|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
144460300|NCT03870763|520880819|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
144460301|NCT01559844|520880821|FG000|Overall Study|Consent Withdrawn|7|||
144460302|NCT01559844|520880821|FG000|Overall Study|Death|5|||
144460303|NCT01559844|520880821|FG000|Overall Study|Efficacy Failure|10|||
144460304|NCT01559844|520880821|FG000|Overall Study|No Longer A Transplant Candidate|3|||
144460305|NCT02564523|520880824|FG000|Overall Study|Withdrawal by Subject|3|||
144460306|NCT02564523|520880825|FG001|Overall Study|Withdrawal by Subject|0|||
144460307|NCT02564523|520880826|FG002|Overall Study|Withdrawal by Subject|1|||
144460308|NCT02564523|520880827|FG003|Overall Study|Withdrawal by Subject|0|||
144460309|NCT02564523|520880828|FG004|Overall Study|Withdrawal by Subject|1|||
144460310|NCT02564523|520880829|FG005|Overall Study|Withdrawal by Subject|0|||
144725935|NCT01439165|521852644|FG001|Overall Study|Protocol Violation|0|||
144197006|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
144255462|NCT00237692|520136187|FG002|Overall Study|Withdrawal by Subject|10|||
144460311|NCT02564523|520880830|FG006|Overall Study|Withdrawal by Subject|1|||
144460312|NCT02564523|520880831|FG007|Overall Study|Withdrawal by Subject|0|||
144460313|NCT02564523|520880832|FG008|Overall Study|Withdrawal by Subject|0|||
144725936|NCT01439165|521852643|FG000|Overall Study|Lost to Follow-up|11|||
144725937|NCT01439165|521852644|FG001|Overall Study|Lost to Follow-up|1|||
144725938|NCT01439165|521852643|FG000|Overall Study|Withdrawal by Subject|7|||
144725939|NCT01439165|521852644|FG001|Overall Study|Withdrawal by Subject|1|||
144197007|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
144197008|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Other|2|||
144197009|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Other|9|||
144197010|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Other|9|||
144197011|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Other|3|||
144197012|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Other|2|||
144197013|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Other|0|||
144197014|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Other|0|||
144197015|NCT00361335|519918660|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
144197016|NCT00361335|519918661|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
144197017|NCT00361335|519918662|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
144197018|NCT00361335|519918663|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
144460314|NCT02564523|520880833|FG009|Overall Study|Withdrawal by Subject|0|||
144460315|NCT02564523|520880834|FG010|Overall Study|Withdrawal by Subject|1|||
144460316|NCT02564523|520880835|FG011|Overall Study|Withdrawal by Subject|0|||
144460317|NCT02564523|520880836|FG012|Overall Study|Withdrawal by Subject|1|||
144460318|NCT02564523|520880837|FG013|Overall Study|Withdrawal by Subject|0|||
144460319|NCT02564523|520880838|FG014|Overall Study|Withdrawal by Subject|0|||
144460320|NCT02564523|520880839|FG015|Overall Study|Withdrawal by Subject|0|||
144460321|NCT02564523|520880840|FG016|Overall Study|Withdrawal by Subject|0|||
144460322|NCT02564523|520880841|FG017|Overall Study|Withdrawal by Subject|0|||
144460323|NCT02564523|520880824|FG000|Overall Study|Adverse Event|0|||
144460324|NCT02564523|520880825|FG001|Overall Study|Adverse Event|0|||
144460325|NCT02564523|520880826|FG002|Overall Study|Adverse Event|0|||
144460326|NCT02564523|520880827|FG003|Overall Study|Adverse Event|0|||
144197019|NCT00361335|519918664|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
144460327|NCT02564523|520880828|FG004|Overall Study|Adverse Event|0|||
144460328|NCT02564523|520880829|FG005|Overall Study|Adverse Event|0|||
144460329|NCT02564523|520880830|FG006|Overall Study|Adverse Event|0|||
144460330|NCT02564523|520880831|FG007|Overall Study|Adverse Event|0|||
144460331|NCT02564523|520880832|FG008|Overall Study|Adverse Event|0|||
144460332|NCT02564523|520880833|FG009|Overall Study|Adverse Event|0|||
144460333|NCT02564523|520880834|FG010|Overall Study|Adverse Event|0|||
144460334|NCT02564523|520880835|FG011|Overall Study|Adverse Event|0|||
144460335|NCT02564523|520880836|FG012|Overall Study|Adverse Event|0|||
144460336|NCT02564523|520880837|FG013|Overall Study|Adverse Event|0|||
144460337|NCT02564523|520880838|FG014|Overall Study|Adverse Event|0|||
144460338|NCT02564523|520880839|FG015|Overall Study|Adverse Event|0|||
144460339|NCT02564523|520880840|FG016|Overall Study|Adverse Event|0|||
144460340|NCT02564523|520880841|FG017|Overall Study|Adverse Event|1|||
144460341|NCT02564523|520880824|FG000|Overall Study|Death|0|||
144460342|NCT02564523|520880825|FG001|Overall Study|Death|0|||
144460343|NCT02564523|520880826|FG002|Overall Study|Death|0|||
144460344|NCT02564523|520880827|FG003|Overall Study|Death|0|||
144460345|NCT02564523|520880828|FG004|Overall Study|Death|0|||
144460346|NCT02564523|520880829|FG005|Overall Study|Death|0|||
144460347|NCT02564523|520880830|FG006|Overall Study|Death|1|||
144460348|NCT02564523|520880831|FG007|Overall Study|Death|0|||
144460349|NCT02564523|520880832|FG008|Overall Study|Death|0|||
144460350|NCT02564523|520880833|FG009|Overall Study|Death|0|||
144460351|NCT02564523|520880834|FG010|Overall Study|Death|1|||
144460352|NCT02564523|520880835|FG011|Overall Study|Death|0|||
144460353|NCT02564523|520880836|FG012|Overall Study|Death|0|||
144460354|NCT02564523|520880837|FG013|Overall Study|Death|0|||
144460355|NCT02564523|520880838|FG014|Overall Study|Death|0|||
144460356|NCT02564523|520880839|FG015|Overall Study|Death|0|||
144460357|NCT02564523|520880840|FG016|Overall Study|Death|0|||
144460358|NCT02564523|520880841|FG017|Overall Study|Death|0|||
144460359|NCT02564523|520880824|FG000|Overall Study|Lost to Follow-up|2|||
144460360|NCT02564523|520880825|FG001|Overall Study|Lost to Follow-up|1|||
144460361|NCT02564523|520880826|FG002|Overall Study|Lost to Follow-up|4|||
144197020|NCT00361335|519918665|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
144460362|NCT02564523|520880827|FG003|Overall Study|Lost to Follow-up|0|||
144460363|NCT02564523|520880828|FG004|Overall Study|Lost to Follow-up|1|||
144460364|NCT02564523|520880829|FG005|Overall Study|Lost to Follow-up|0|||
144460365|NCT02564523|520880830|FG006|Overall Study|Lost to Follow-up|1|||
144197021|NCT00361335|519918666|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
144197022|NCT00361335|519918660|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
144460366|NCT02564523|520880831|FG007|Overall Study|Lost to Follow-up|0|||
144460367|NCT02564523|520880832|FG008|Overall Study|Lost to Follow-up|0|||
144460368|NCT02564523|520880833|FG009|Overall Study|Lost to Follow-up|0|||
144197023|NCT00361335|519918661|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
144460369|NCT02564523|520880834|FG010|Overall Study|Lost to Follow-up|0|||
144460370|NCT02564523|520880835|FG011|Overall Study|Lost to Follow-up|1|||
144460371|NCT02564523|520880836|FG012|Overall Study|Lost to Follow-up|1|||
144460372|NCT02564523|520880837|FG013|Overall Study|Lost to Follow-up|0|||
144460373|NCT02564523|520880838|FG014|Overall Study|Lost to Follow-up|0|||
144460374|NCT02564523|520880839|FG015|Overall Study|Lost to Follow-up|0|||
144460375|NCT02564523|520880840|FG016|Overall Study|Lost to Follow-up|0|||
144460376|NCT02564523|520880841|FG017|Overall Study|Lost to Follow-up|0|||
144460377|NCT02564523|520880824|FG000|Overall Study|Physician Decision|0|||
144460378|NCT02564523|520880825|FG001|Overall Study|Physician Decision|0|||
144460379|NCT02564523|520880826|FG002|Overall Study|Physician Decision|0|||
144460380|NCT02564523|520880827|FG003|Overall Study|Physician Decision|0|||
144460381|NCT02564523|520880828|FG004|Overall Study|Physician Decision|1|||
144460382|NCT02564523|520880829|FG005|Overall Study|Physician Decision|0|||
144460383|NCT02564523|520880830|FG006|Overall Study|Physician Decision|0|||
144460384|NCT02564523|520880831|FG007|Overall Study|Physician Decision|0|||
144460385|NCT02564523|520880832|FG008|Overall Study|Physician Decision|0|||
144460386|NCT02564523|520880833|FG009|Overall Study|Physician Decision|0|||
144460387|NCT02564523|520880834|FG010|Overall Study|Physician Decision|1|||
144460388|NCT02564523|520880835|FG011|Overall Study|Physician Decision|0|||
144460389|NCT02564523|520880836|FG012|Overall Study|Physician Decision|0|||
144460390|NCT02564523|520880837|FG013|Overall Study|Physician Decision|0|||
144460391|NCT02564523|520880838|FG014|Overall Study|Physician Decision|0|||
144460392|NCT02564523|520880839|FG015|Overall Study|Physician Decision|0|||
144460393|NCT02564523|520880840|FG016|Overall Study|Physician Decision|0|||
144460394|NCT02564523|520880841|FG017|Overall Study|Physician Decision|0|||
144460395|NCT02564523|520880824|FG000|Overall Study|Protocol Violation|2|||
144460396|NCT02564523|520880825|FG001|Overall Study|Protocol Violation|2|||
144460397|NCT02564523|520880826|FG002|Overall Study|Protocol Violation|5|||
144460398|NCT02564523|520880827|FG003|Overall Study|Protocol Violation|0|||
144460399|NCT02564523|520880828|FG004|Overall Study|Protocol Violation|1|||
144460400|NCT02564523|520880829|FG005|Overall Study|Protocol Violation|0|||
144460401|NCT02564523|520880830|FG006|Overall Study|Protocol Violation|0|||
144460402|NCT02564523|520880831|FG007|Overall Study|Protocol Violation|0|||
144460403|NCT02564523|520880832|FG008|Overall Study|Protocol Violation|0|||
144460404|NCT02564523|520880833|FG009|Overall Study|Protocol Violation|0|||
144460405|NCT02564523|520880834|FG010|Overall Study|Protocol Violation|0|||
144460406|NCT02564523|520880835|FG011|Overall Study|Protocol Violation|0|||
144460407|NCT02564523|520880836|FG012|Overall Study|Protocol Violation|0|||
144534993|NCT04408755|521162602|FG003|Period B (Randomization Period)|Adverse Event|1|||
144197024|NCT00361335|519918662|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
144197025|NCT00361335|519918663|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
144197026|NCT00361335|519918664|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
144197027|NCT00361335|519918665|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
144197028|NCT00361335|519918666|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
144534994|NCT04408755|521162599|FG000|Period B (Randomization Period)|Death|0|||
144534995|NCT04408755|521162600|FG001|Period B (Randomization Period)|Death|0|||
144534996|NCT04408755|521162601|FG002|Period B (Randomization Period)|Death|1|||
144534997|NCT04408755|521162602|FG003|Period B (Randomization Period)|Death|0|||
144534998|NCT04408755|521162599|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
144534999|NCT04408755|521162600|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
144535000|NCT04408755|521162601|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
144535001|NCT04408755|521162602|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
144535002|NCT04408755|521162599|FG000|Period B (Randomization Period)|Physician Decision|0|||
144535003|NCT04408755|521162600|FG001|Period B (Randomization Period)|Physician Decision|0|||
144535004|NCT04408755|521162601|FG002|Period B (Randomization Period)|Physician Decision|1|||
144535005|NCT04408755|521162602|FG003|Period B (Randomization Period)|Physician Decision|0|||
144535006|NCT04408755|521162599|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
144535007|NCT04408755|521162600|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
144535008|NCT04408755|521162601|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
144535009|NCT04408755|521162602|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
144535010|NCT04408755|521162599|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
144535011|NCT04408755|521162600|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
144535012|NCT04408755|521162601|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
144535013|NCT04408755|521162602|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
144535014|NCT04408755|521162599|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
144535015|NCT04408755|521162600|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
144535016|NCT04408755|521162601|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
144197029|NCT00361335|519918660|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
144197030|NCT00361335|519918661|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
144259303|NCT01089127|520150358|FG004|Overall Study|Protocol deviation|1|||
144460408|NCT02564523|520880837|FG013|Overall Study|Protocol Violation|0|||
144460409|NCT02564523|520880838|FG014|Overall Study|Protocol Violation|0|||
144460410|NCT02564523|520880839|FG015|Overall Study|Protocol Violation|0|||
144460411|NCT02564523|520880840|FG016|Overall Study|Protocol Violation|0|||
144460412|NCT02564523|520880841|FG017|Overall Study|Protocol Violation|0|||
144460413|NCT02564523|520880824|FG000|Overall Study|Other|3|||
144460414|NCT02564523|520880825|FG001|Overall Study|Other|0|||
144460415|NCT02564523|520880826|FG002|Overall Study|Other|0|||
144460416|NCT02564523|520880827|FG003|Overall Study|Other|1|||
144460417|NCT02564523|520880828|FG004|Overall Study|Other|0|||
144460418|NCT02564523|520880829|FG005|Overall Study|Other|0|||
144460419|NCT02564523|520880830|FG006|Overall Study|Other|0|||
144460420|NCT02564523|520880831|FG007|Overall Study|Other|0|||
144460421|NCT02564523|520880832|FG008|Overall Study|Other|0|||
144460422|NCT02564523|520880833|FG009|Overall Study|Other|0|||
144460423|NCT02564523|520880834|FG010|Overall Study|Other|0|||
144460424|NCT02564523|520880835|FG011|Overall Study|Other|0|||
144460425|NCT02564523|520880836|FG012|Overall Study|Other|0|||
144460426|NCT02564523|520880837|FG013|Overall Study|Other|0|||
144460427|NCT02564523|520880838|FG014|Overall Study|Other|0|||
144460428|NCT02564523|520880839|FG015|Overall Study|Other|0|||
144460429|NCT02564523|520880840|FG016|Overall Study|Other|0|||
144460430|NCT02564523|520880841|FG017|Overall Study|Other|0|||
144460431|NCT01816594|520880844|FG000|Overall Study|Local Progress|0|||
144460432|NCT01816594|520880845|FG001|Overall Study|Local Progress|2|||
144460433|NCT01816594|520880844|FG000|Overall Study|Adverse Event|9|||
144460434|NCT01816594|520880845|FG001|Overall Study|Adverse Event|0|||
144460435|NCT01816594|520880844|FG000|Overall Study|Withdrawal by Subject|1|||
144460436|NCT01816594|520880845|FG001|Overall Study|Withdrawal by Subject|0|||
144460437|NCT01816594|520880844|FG000|Overall Study|Physician Decision|1|||
144460438|NCT01816594|520880845|FG001|Overall Study|Physician Decision|0|||
144460439|NCT03905655|520880846|FG000|Overall Study|Adverse Event|1|||
144460440|NCT03905655|520880847|FG001|Overall Study|Adverse Event|0|||
144460441|NCT03905655|520880848|FG002|Overall Study|Adverse Event|1|||
144460442|NCT03905655|520880849|FG003|Overall Study|Adverse Event|1|||
144460443|NCT02566031|520880850|FG000|Overall Study|Patient/guardian decision|14|||
144460444|NCT02566031|520880851|FG001|Overall Study|Patient/guardian decision|7|||
144460445|NCT02566031|520880850|FG000|Overall Study|Protocol deviation|2|||
144460446|NCT02566031|520880851|FG001|Overall Study|Protocol deviation|3|||
144460447|NCT02566031|520880850|FG000|Overall Study|Adverse Event|3|||
144460448|NCT02566031|520880851|FG001|Overall Study|Adverse Event|1|||
144460449|NCT02566031|520880850|FG000|Overall Study|Lost to Follow-up|1|||
144460450|NCT02566031|520880851|FG001|Overall Study|Lost to Follow-up|1|||
144460451|NCT00515502|520880852|FG000|Treatment Period 1|Adverse Event|0|||
144460452|NCT00515502|520880853|FG001|Treatment Period 1|Adverse Event|0|||
144460453|NCT00515502|520880854|FG002|Treatment Period 1|Adverse Event|0|||
144460454|NCT00515502|520880855|FG003|Treatment Period 1|Adverse Event|0|||
144460455|NCT00515502|520880856|FG004|Treatment Period 1|Adverse Event|0|||
144460456|NCT00515502|520880857|FG005|Treatment Period 1|Adverse Event|0|||
144460457|NCT00515502|520880858|FG006|Treatment Period 1|Adverse Event|1|||
144460458|NCT00515502|520880859|FG007|Treatment Period 1|Adverse Event|0|||
144460459|NCT00515502|520880860|FG008|Treatment Period 1|Adverse Event|1|||
144460460|NCT00515502|520880861|FG009|Treatment Period 1|Adverse Event|0|||
144460461|NCT00515502|520880862|FG010|Treatment Period 1|Adverse Event|0|||
144460462|NCT00515502|520880863|FG011|Treatment Period 1|Adverse Event|1|||
144460463|NCT00515502|520880852|FG000|Treatment Period 2|Adverse Event|0|||
144460464|NCT00515502|520880853|FG001|Treatment Period 2|Adverse Event|1|||
144460465|NCT00515502|520880854|FG002|Treatment Period 2|Adverse Event|0|||
144460466|NCT00515502|520880855|FG003|Treatment Period 2|Adverse Event|0|||
144460467|NCT00515502|520880856|FG004|Treatment Period 2|Adverse Event|0|||
144460468|NCT00515502|520880857|FG005|Treatment Period 2|Adverse Event|0|||
144460469|NCT00515502|520880858|FG006|Treatment Period 2|Adverse Event|0|||
144460470|NCT00515502|520880859|FG007|Treatment Period 2|Adverse Event|0|||
144460471|NCT00515502|520880860|FG008|Treatment Period 2|Adverse Event|0|||
144460472|NCT00515502|520880861|FG009|Treatment Period 2|Adverse Event|0|||
144460473|NCT00515502|520880862|FG010|Treatment Period 2|Adverse Event|0|||
144460474|NCT00515502|520880863|FG011|Treatment Period 2|Adverse Event|0|||
144460475|NCT02732938|520880867|FG000|Overall Study|Death|0|||
144460476|NCT02732938|520880868|FG001|Overall Study|Death|11|||
144460477|NCT02732938|520880869|FG002|Overall Study|Death|0|||
144460478|NCT02732938|520880867|FG000|Overall Study|Randomized but did not receive treatment|0|||
144460479|NCT02732938|520880868|FG001|Overall Study|Randomized but did not receive treatment|1|||
144460480|NCT02732938|520880869|FG002|Overall Study|Randomized but did not receive treatment|0|||
144460481|NCT02732938|520880867|FG000|Overall Study|Refused further follow-up|1|||
144535017|NCT04408755|521162602|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
144460482|NCT02732938|520880868|FG001|Overall Study|Refused further follow-up|0|||
144460483|NCT02732938|520880869|FG002|Overall Study|Refused further follow-up|0|||
144460484|NCT02732938|520880867|FG000|Overall Study|Study terminated by sponsor|3|||
144460485|NCT02732938|520880868|FG001|Overall Study|Study terminated by sponsor|6|||
144460486|NCT02732938|520880869|FG002|Overall Study|Study terminated by sponsor|0|||
144535018|NCT04408755|521162599|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
144460487|NCT04530448|520880870|FG000|Overall Study|Physician Decision|3|||
144460488|NCT04530448|520880871|FG001|Overall Study|Physician Decision|0|||
144725940|NCT03331042|521852648|FG000|Overall Study|Protocol Violation|1|||
144460489|NCT01613248|520880872|FG000|Overall Study|Adverse Event|0|||
144460490|NCT01613248|520880873|FG001|Overall Study|Adverse Event|0|||
144460491|NCT01613248|520880874|FG002|Overall Study|Adverse Event|0|||
144460492|NCT01613248|520880875|FG003|Overall Study|Adverse Event|1|||
144609340|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
144609341|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
144609342|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
144609343|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
144460493|NCT01613248|520880876|FG004|Overall Study|Adverse Event|0|||
144460494|NCT01613248|520880877|FG005|Overall Study|Adverse Event|0|||
144460495|NCT01613248|520880872|FG000|Overall Study|Withdrawal by Subject|3|||
144460496|NCT01613248|520880873|FG001|Overall Study|Withdrawal by Subject|2|||
144460497|NCT01613248|520880874|FG002|Overall Study|Withdrawal by Subject|2|||
144460498|NCT01613248|520880875|FG003|Overall Study|Withdrawal by Subject|5|||
144460499|NCT01613248|520880876|FG004|Overall Study|Withdrawal by Subject|0|||
144460500|NCT01613248|520880877|FG005|Overall Study|Withdrawal by Subject|1|||
144460501|NCT01613248|520880872|FG000|Overall Study|Lost to Follow-up|5|||
144460502|NCT01613248|520880873|FG001|Overall Study|Lost to Follow-up|7|||
144460503|NCT01613248|520880874|FG002|Overall Study|Lost to Follow-up|4|||
144460504|NCT01613248|520880875|FG003|Overall Study|Lost to Follow-up|8|||
144460505|NCT01613248|520880876|FG004|Overall Study|Lost to Follow-up|4|||
144460506|NCT01613248|520880877|FG005|Overall Study|Lost to Follow-up|2|||
144460507|NCT01613248|520880872|FG000|Overall Study|Study Terminated by Sponsor|4|||
144460508|NCT01613248|520880873|FG001|Overall Study|Study Terminated by Sponsor|6|||
144460509|NCT01613248|520880874|FG002|Overall Study|Study Terminated by Sponsor|8|||
144460510|NCT01613248|520880875|FG003|Overall Study|Study Terminated by Sponsor|8|||
144460511|NCT01613248|520880876|FG004|Overall Study|Study Terminated by Sponsor|9|||
144460512|NCT01613248|520880877|FG005|Overall Study|Study Terminated by Sponsor|11|||
144460513|NCT01613248|520880872|FG000|Overall Study|Physician Decision|8|||
144460514|NCT01613248|520880873|FG001|Overall Study|Physician Decision|8|||
144460515|NCT01613248|520880874|FG002|Overall Study|Physician Decision|9|||
144460516|NCT01613248|520880875|FG003|Overall Study|Physician Decision|4|||
144535019|NCT04408755|521162600|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
144535020|NCT04408755|521162601|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
144535021|NCT04408755|521162602|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
144535022|NCT04408755|521162599|FG000|Period B (Randomization Period)|Reason not Specified|0|||
144535023|NCT04408755|521162600|FG001|Period B (Randomization Period)|Reason not Specified|1|||
144535024|NCT04408755|521162601|FG002|Period B (Randomization Period)|Reason not Specified|0|||
144535025|NCT04408755|521162602|FG003|Period B (Randomization Period)|Reason not Specified|2|||
144535026|NCT00308997|521162603|FG000|Overall Study|Subject feigned clinical data|0|||
144535027|NCT00308997|521162604|FG001|Overall Study|Subject feigned clinical data|1|||
144535028|NCT00308997|521162603|FG000|Overall Study|Unable to tolerate intervention|1|||
144535029|NCT00308997|521162604|FG001|Overall Study|Unable to tolerate intervention|0|||
144535030|NCT04490356|521162606|FG000|Overall Study|Lost to Follow-up|1|||
144535031|NCT03733626|521162612|FG000|Overall Study|Physician Decision|4|||
144535032|NCT03733626|521162613|FG001|Overall Study|Physician Decision|4|||
144535033|NCT03816397|521162620|FG000|Overall Study|Censored at interim analysis date.|13|||
144535034|NCT03816397|521162621|FG001|Overall Study|Censored at interim analysis date.|6|||
144535035|NCT03816397|521162620|FG000|Overall Study|Withdrawal by Subject|1|||
144535036|NCT03816397|521162621|FG001|Overall Study|Withdrawal by Subject|1|||
144535037|NCT05836012|521162630|FG000|Overall Study|Lost to Follow-up|1|||
144535038|NCT05836012|521162631|FG001|Overall Study|Lost to Follow-up|0|||
144535039|NCT05836012|521162630|FG000|Overall Study|Withdrawal by Subject|1|||
144535040|NCT05836012|521162631|FG001|Overall Study|Withdrawal by Subject|3|||
144535041|NCT05836012|521162630|FG000|Overall Study|Reason not included in pre-specified categories|2|||
144535042|NCT05836012|521162631|FG001|Overall Study|Reason not included in pre-specified categories|1|||
144535043|NCT05985395|521162632|FG000|Overall Study|Physician Decision|2|||
144535044|NCT05985395|521162633|FG001|Overall Study|Physician Decision|1|||
144535045|NCT05985395|521162632|FG000|Overall Study|Withdrawal by Subject|1|||
144535046|NCT05985395|521162633|FG001|Overall Study|Withdrawal by Subject|0|||
144535047|NCT03934931|521163126|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
144535048|NCT03934931|521163127|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
144535049|NCT03934931|521163128|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
144535050|NCT00447980|521163129|FG000|Overall Study|Withdrawal by Subject|1|||
144535051|NCT00447980|521163130|FG001|Overall Study|Withdrawal by Subject|1|||
144535052|NCT00447980|521163131|FG002|Overall Study|Withdrawal by Subject|4|||
144609344|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
144609345|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
144460517|NCT01613248|520880876|FG004|Overall Study|Physician Decision|7|||
144535053|NCT00447980|521163132|FG003|Overall Study|Withdrawal by Subject|4|||
144535054|NCT00447980|521163129|FG000|Overall Study|Lost to Follow-up|1|||
144535055|NCT00447980|521163130|FG001|Overall Study|Lost to Follow-up|1|||
144535056|NCT00447980|521163131|FG002|Overall Study|Lost to Follow-up|0|||
144725941|NCT03331042|521852649|FG001|Overall Study|Protocol Violation|0|||
144460518|NCT01613248|520880877|FG005|Overall Study|Physician Decision|6|||
144460519|NCT01613248|520880872|FG000|Overall Study|Lack of Qualifying Event|9|||
144460520|NCT01613248|520880873|FG001|Overall Study|Lack of Qualifying Event|11|||
144460521|NCT01613248|520880874|FG002|Overall Study|Lack of Qualifying Event|10|||
144609346|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
144609347|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
144609348|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
144609349|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
144609350|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
144609351|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
144609352|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
144609353|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
144609354|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
144609355|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609356|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609357|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
144609358|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609359|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609360|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
144609361|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
144609362|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
144609363|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
144609364|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
144609365|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
144609366|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
144609367|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
144609368|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
144609369|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
144609370|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
144609371|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
144609372|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
144609373|NCT00111800|521431047|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
144609374|NCT00111800|521431048|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
144609375|NCT00111800|521431049|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
144609376|NCT00111800|521431050|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
144609377|NCT00111800|521431051|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
144609378|NCT00111800|521431052|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
144609379|NCT00914927|521431054|FG000|Overall Study|Adverse Event|0|||
144609380|NCT00914927|521431055|FG001|Overall Study|Adverse Event|0|||
144609381|NCT00914927|521431056|FG002|Overall Study|Adverse Event|0|||
144609382|NCT00914927|521431057|FG003|Overall Study|Adverse Event|0|||
144609383|NCT00914927|521431058|FG004|Overall Study|Adverse Event|1|||
144609384|NCT00914927|521431059|FG005|Overall Study|Adverse Event|0|||
144609385|NCT00914927|521431060|FG006|Overall Study|Adverse Event|0|||
144609386|NCT00914927|521431054|FG000|Overall Study|Withdrawal by Subject|0|||
144609387|NCT00914927|521431055|FG001|Overall Study|Withdrawal by Subject|1|||
144255463|NCT00237692|520136188|FG003|Overall Study|Withdrawal by Subject|4|||
144255464|NCT00902746|520136189|FG000|Overall Study|Protocol Violation|7|||
144460522|NCT01613248|520880875|FG003|Overall Study|Lack of Qualifying Event|11|||
144609388|NCT00914927|521431056|FG002|Overall Study|Withdrawal by Subject|0|||
144609389|NCT00914927|521431057|FG003|Overall Study|Withdrawal by Subject|1|||
144609390|NCT00914927|521431058|FG004|Overall Study|Withdrawal by Subject|0|||
144255465|NCT00902746|520136189|FG000|Overall Study|Withdrawal by Subject|16|||
144255466|NCT00902746|520136189|FG000|Overall Study|Adverse Event|8|||
144255467|NCT00902746|520136189|FG000|Overall Study|Lost to Follow-up|3|||
144460523|NCT01613248|520880876|FG004|Overall Study|Lack of Qualifying Event|15|||
144460524|NCT01613248|520880877|FG005|Overall Study|Lack of Qualifying Event|18|||
144460525|NCT01613248|520880872|FG000|Overall Study|Pregnancy|0|||
144460526|NCT01613248|520880873|FG001|Overall Study|Pregnancy|0|||
144460527|NCT01613248|520880874|FG002|Overall Study|Pregnancy|0|||
144460528|NCT01613248|520880875|FG003|Overall Study|Pregnancy|1|||
144460529|NCT01613248|520880876|FG004|Overall Study|Pregnancy|0|||
144460530|NCT01613248|520880877|FG005|Overall Study|Pregnancy|0|||
144460531|NCT01491854|520880878|FG000|Overall Study|mainly due to premature termination|93|||
144460532|NCT01491854|520880878|FG000|Overall Study|Death|1|||
144460533|NCT01491854|520880878|FG000|Overall Study|Withdrawal by Subject|3|||
144460534|NCT01491854|520880878|FG000|Overall Study|Lost to Follow-up|33|||
144460535|NCT01672801|520880887|FG000|Overall Study|Screen Failure|0|||
144609391|NCT00914927|521431059|FG005|Overall Study|Withdrawal by Subject|0|||
144460536|NCT01672801|520880888|FG001|Overall Study|Screen Failure|1|||
144609392|NCT00914927|521431060|FG006|Overall Study|Withdrawal by Subject|0|||
144609393|NCT00914927|521431054|FG000|Overall Study|Lost to Follow-up|0|||
144460537|NCT02384954|520880898|FG000|Phase 1|Progressive Disease|2|||
144460538|NCT02384954|520880899|FG001|Phase 1|Progressive Disease|0|||
144460539|NCT02384954|520880900|FG002|Phase 1|Progressive Disease|1|||
144460540|NCT02384954|520880901|FG003|Phase 1|Progressive Disease|1|||
144460541|NCT02384954|520880902|FG004|Phase 1|Progressive Disease|0|||
144460542|NCT02384954|520880903|FG005|Phase 1|Progressive Disease|0|||
144460543|NCT02384954|520880904|FG006|Phase 1|Progressive Disease|0|||
144460544|NCT02384954|520880905|FG007|Phase 1|Progressive Disease|0|||
144460545|NCT02384954|520880906|FG008|Phase 1|Progressive Disease|0|||
144460546|NCT02384954|520880898|FG000|Phase 1|Adverse Event|0|||
144460547|NCT02384954|520880899|FG001|Phase 1|Adverse Event|0|||
144460548|NCT02384954|520880900|FG002|Phase 1|Adverse Event|1|||
144460549|NCT02384954|520880901|FG003|Phase 1|Adverse Event|0|||
144460550|NCT02384954|520880902|FG004|Phase 1|Adverse Event|0|||
144460551|NCT02384954|520880903|FG005|Phase 1|Adverse Event|0|||
144460552|NCT02384954|520880904|FG006|Phase 1|Adverse Event|0|||
144460553|NCT02384954|520880905|FG007|Phase 1|Adverse Event|0|||
144460554|NCT02384954|520880906|FG008|Phase 1|Adverse Event|0|||
144460555|NCT02384954|520880898|FG000|Phase 2|Progressive Disease|0|||
144460556|NCT02384954|520880899|FG001|Phase 2|Progressive Disease|0|||
144460557|NCT02384954|520880900|FG002|Phase 2|Progressive Disease|0|||
144460558|NCT02384954|520880901|FG003|Phase 2|Progressive Disease|0|||
144460559|NCT02384954|520880902|FG004|Phase 2|Progressive Disease|0|||
144460560|NCT02384954|520880903|FG005|Phase 2|Progressive Disease|0|||
144460561|NCT02384954|520880904|FG006|Phase 2|Progressive Disease|0|||
144460562|NCT02384954|520880905|FG007|Phase 2|Progressive Disease|1|||
144460563|NCT02384954|520880906|FG008|Phase 2|Progressive Disease|2|||
144460564|NCT02384954|520880898|FG000|Phase 2|Adverse Event|0|||
144460565|NCT02384954|520880899|FG001|Phase 2|Adverse Event|0|||
144535057|NCT00447980|521163132|FG003|Overall Study|Lost to Follow-up|0|||
144535058|NCT00447980|521163129|FG000|Overall Study|Did not proceed with surgery|3|||
144535059|NCT00447980|521163130|FG001|Overall Study|Did not proceed with surgery|3|||
144535060|NCT00447980|521163131|FG002|Overall Study|Did not proceed with surgery|2|||
144535061|NCT00447980|521163132|FG003|Overall Study|Did not proceed with surgery|2|||
144535062|NCT02075554|521163135|FG000|Overall Study|Lost to Follow-up|7|||
144535063|NCT02075554|521163135|FG000|Overall Study|Withdrawal by Subject|5|||
144535064|NCT02075554|521163135|FG000|Overall Study|Physician Decision|3|||
144535065|NCT04281498|521163158|FG000|Overall Study|Progression of disease|1|||
144535066|NCT04281498|521163158|FG000|Overall Study|Planned SCT|1|||
144535067|NCT04281498|521163158|FG000|Overall Study|Alternative Treatment|1|||
144535068|NCT03587805|521163159|FG000|Overall Study|Adverse Event|72|||
144535069|NCT03587805|521163159|FG000|Overall Study|Death|1|||
144535070|NCT03587805|521163159|FG000|Overall Study|Lost to Follow-up|78|||
144535071|NCT03587805|521163159|FG000|Overall Study|Withdrawal by Subject|105|||
144535072|NCT03587805|521163159|FG000|Overall Study|Lack of Efficacy|119|||
144535073|NCT03587805|521163159|FG000|Overall Study|Reason unknown|26|||
144535074|NCT03587805|521163159|FG000|Overall Study|COVID_19 pandemic|4|||
144535075|NCT03587805|521163159|FG000|Overall Study|Various reasons|121|||
144535076|NCT03587805|521163159|FG000|Overall Study|Withdrawal by parent/guardian|3|||
144535077|NCT01220531|521163160|FG000|Overall Study|Death|7|||
144535078|NCT01220531|521163160|FG000|Overall Study|Lost to Follow-up|1|||
144535079|NCT00709956|521163161|FG000|Overall Study|Withdrawal by Subject|1|||
144535080|NCT00709956|521163162|FG001|Overall Study|Withdrawal by Subject|1|||
144535081|NCT00709956|521163161|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
144535082|NCT00709956|521163162|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
144535083|NCT01105091|521163163|FG000|Overall Study|Death|2|||
144535084|NCT01105091|521163164|FG001|Overall Study|Death|0|||
144535085|NCT03008382|521163165|FG000|Overall Study|Withdrawal by Subject|2|||
144535086|NCT03008382|521163166|FG001|Overall Study|Withdrawal by Subject|5|||
144535087|NCT03008382|521163167|FG002|Overall Study|Withdrawal by Subject|2|||
144535088|NCT03008382|521163168|FG003|Overall Study|Withdrawal by Subject|0|||
144535089|NCT03008382|521163165|FG000|Overall Study|Protocol Violation|1|||
144535090|NCT03008382|521163166|FG001|Overall Study|Protocol Violation|0|||
144535091|NCT03008382|521163167|FG002|Overall Study|Protocol Violation|0|||
144535092|NCT03008382|521163168|FG003|Overall Study|Protocol Violation|0|||
144725942|NCT03331042|521852650|FG002|Overall Study|Protocol Violation|0|||
144197031|NCT00361335|519918662|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
144460566|NCT02384954|520880900|FG002|Phase 2|Adverse Event|0|||
144460567|NCT02384954|520880901|FG003|Phase 2|Adverse Event|0|||
144460568|NCT02384954|520880902|FG004|Phase 2|Adverse Event|0|||
144460569|NCT02384954|520880903|FG005|Phase 2|Adverse Event|0|||
144460570|NCT02384954|520880904|FG006|Phase 2|Adverse Event|0|||
144460571|NCT02384954|520880905|FG007|Phase 2|Adverse Event|1|||
144460572|NCT02384954|520880906|FG008|Phase 2|Adverse Event|1|||
144460573|NCT02384954|520880898|FG000|Phase 2|Failure to meet continuation criteria|0|||
144535093|NCT03008382|521163165|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
144535094|NCT03008382|521163166|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
144535095|NCT03008382|521163167|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
144535096|NCT03008382|521163168|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
144535097|NCT03008382|521163165|FG000|Overall Study|Lost to Follow-up|0|||
144460574|NCT02384954|520880899|FG001|Phase 2|Failure to meet continuation criteria|0|||
144460575|NCT02384954|520880900|FG002|Phase 2|Failure to meet continuation criteria|0|||
144460576|NCT02384954|520880901|FG003|Phase 2|Failure to meet continuation criteria|0|||
144460577|NCT02384954|520880902|FG004|Phase 2|Failure to meet continuation criteria|0|||
144460578|NCT02384954|520880903|FG005|Phase 2|Failure to meet continuation criteria|0|||
144460579|NCT02384954|520880904|FG006|Phase 2|Failure to meet continuation criteria|0|||
144460580|NCT02384954|520880905|FG007|Phase 2|Failure to meet continuation criteria|1|||
144460581|NCT02384954|520880906|FG008|Phase 2|Failure to meet continuation criteria|0|||
144460582|NCT03449030|520880918|FG000|Overall Study|Withdrawal by Subject|0|||
144460583|NCT03449030|520880919|FG001|Overall Study|Withdrawal by Subject|0|||
144460584|NCT03449030|520880920|FG002|Overall Study|Withdrawal by Subject|0|||
144460585|NCT03449030|520880921|FG003|Overall Study|Withdrawal by Subject|1|||
144460586|NCT03449030|520880922|FG004|Overall Study|Withdrawal by Subject|1|||
144460587|NCT03449030|520880923|FG005|Overall Study|Withdrawal by Subject|1|||
144460588|NCT03449030|520880924|FG006|Overall Study|Withdrawal by Subject|1|||
144460589|NCT03449030|520880925|FG007|Overall Study|Withdrawal by Subject|2|||
144460590|NCT03449030|520880926|FG008|Overall Study|Withdrawal by Subject|0|||
144460591|NCT03449030|520880927|FG009|Overall Study|Withdrawal by Subject|0|||
144460592|NCT03449030|520880918|FG000|Overall Study|Symptomatic Deterioration|0|||
144460593|NCT03449030|520880919|FG001|Overall Study|Symptomatic Deterioration|1|||
144460594|NCT03449030|520880920|FG002|Overall Study|Symptomatic Deterioration|0|||
144460595|NCT03449030|520880921|FG003|Overall Study|Symptomatic Deterioration|0|||
144460596|NCT03449030|520880922|FG004|Overall Study|Symptomatic Deterioration|0|||
144460597|NCT03449030|520880923|FG005|Overall Study|Symptomatic Deterioration|1|||
144460598|NCT03449030|520880924|FG006|Overall Study|Symptomatic Deterioration|1|||
144460599|NCT03449030|520880925|FG007|Overall Study|Symptomatic Deterioration|0|||
144460600|NCT03449030|520880926|FG008|Overall Study|Symptomatic Deterioration|2|||
144460601|NCT03449030|520880927|FG009|Overall Study|Symptomatic Deterioration|0|||
144460602|NCT03449030|520880918|FG000|Overall Study|Progressive Disease|1|||
144460603|NCT03449030|520880919|FG001|Overall Study|Progressive Disease|0|||
144535098|NCT03008382|521163166|FG001|Overall Study|Lost to Follow-up|0|||
144535099|NCT03008382|521163167|FG002|Overall Study|Lost to Follow-up|1|||
144535100|NCT03008382|521163168|FG003|Overall Study|Lost to Follow-up|0|||
144535101|NCT03008382|521163165|FG000|Overall Study|Screenfail|0|||
144535102|NCT03008382|521163166|FG001|Overall Study|Screenfail|0|||
144535103|NCT03008382|521163167|FG002|Overall Study|Screenfail|2|||
144535104|NCT03008382|521163168|FG003|Overall Study|Screenfail|0|||
144535105|NCT03215706|521163169|FG000|Randomization|Adverse Event unrelated to study drug|1|||
144535106|NCT03215706|521163170|FG001|Randomization|Adverse Event unrelated to study drug|0|||
144535107|NCT03215706|521163169|FG000|Randomization|participant withdrew consent|1|||
144535108|NCT03215706|521163170|FG001|Randomization|participant withdrew consent|3|||
144535109|NCT03215706|521163169|FG000|Randomization|no longer meets study criteria|1|||
144535110|NCT03215706|521163170|FG001|Randomization|no longer meets study criteria|4|||
144535111|NCT03215706|521163169|FG000|Randomization|other reasons|0|||
144535112|NCT03215706|521163170|FG001|Randomization|other reasons|2|||
144535113|NCT03215706|521163169|FG000|Treatment Period|Disease Progression|150|||
144535114|NCT03215706|521163170|FG001|Treatment Period|Disease Progression|142|||
144535115|NCT03215706|521163169|FG000|Treatment Period|Study Drug Toxicity|53|||
144535116|NCT03215706|521163170|FG001|Treatment Period|Study Drug Toxicity|21|||
144535117|NCT03215706|521163169|FG000|Treatment Period|Death|2|||
144535118|NCT03215706|521163170|FG001|Treatment Period|Death|1|||
144535119|NCT03215706|521163169|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
144535120|NCT03215706|521163170|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
144535121|NCT03215706|521163169|FG000|Treatment Period|Request to D/C treatment|1|||
144535122|NCT03215706|521163170|FG001|Treatment Period|Request to D/C treatment|6|||
144535123|NCT03215706|521163169|FG000|Treatment Period|Participant withdrew consent|3|||
144535124|NCT03215706|521163170|FG001|Treatment Period|Participant withdrew consent|4|||
144535125|NCT03215706|521163169|FG000|Treatment Period|Lost to Follow-up|0|||
144535126|NCT03215706|521163170|FG001|Treatment Period|Lost to Follow-up|1|||
144535127|NCT03215706|521163169|FG000|Treatment Period|Other Reasons|4|||
144535128|NCT03215706|521163170|FG001|Treatment Period|Other Reasons|5|||
144535129|NCT03215706|521163169|FG000|Treatment Period|Ongoing in the treatment period|105|||
144535130|NCT03215706|521163170|FG001|Treatment Period|Ongoing in the treatment period|43|||
144535131|NCT00945724|521163171|FG000|Overall Study|Withdrawal by Subject|2|||
144535132|NCT00945724|521163171|FG000|Overall Study|Physician Decision|1|||
144460604|NCT03449030|520880920|FG002|Overall Study|Progressive Disease|1|||
144460605|NCT03449030|520880921|FG003|Overall Study|Progressive Disease|4|||
144460606|NCT03449030|520880922|FG004|Overall Study|Progressive Disease|5|||
144460607|NCT03449030|520880923|FG005|Overall Study|Progressive Disease|3|||
144535133|NCT00945724|521163171|FG000|Overall Study|Adverse Event|5|||
144535134|NCT00945724|521163171|FG000|Overall Study|Second malignancy|1|||
144535135|NCT03705793|521163997|FG000|Overall Study|Lost to Follow-up|3|||
144535136|NCT03705793|521163998|FG001|Overall Study|Lost to Follow-up|4|||
144535137|NCT03705793|521163997|FG000|Overall Study|Withdrawal by Subject|2|||
144535138|NCT03705793|521163998|FG001|Overall Study|Withdrawal by Subject|1|||
144535139|NCT02720068|521163999|FG000|Overall Study|Adverse Event|0|||
144460608|NCT03449030|520880924|FG006|Overall Study|Progressive Disease|0|||
144609394|NCT00914927|521431055|FG001|Overall Study|Lost to Follow-up|0|||
144609395|NCT00914927|521431056|FG002|Overall Study|Lost to Follow-up|0|||
144460609|NCT03449030|520880925|FG007|Overall Study|Progressive Disease|1|||
144460610|NCT03449030|520880926|FG008|Overall Study|Progressive Disease|1|||
144460611|NCT03449030|520880927|FG009|Overall Study|Progressive Disease|1|||
144460612|NCT03449030|520880918|FG000|Overall Study|Adverse Event|0|||
144460613|NCT03449030|520880919|FG001|Overall Study|Adverse Event|0|||
144460614|NCT03449030|520880920|FG002|Overall Study|Adverse Event|0|||
144460615|NCT03449030|520880921|FG003|Overall Study|Adverse Event|0|||
144460616|NCT03449030|520880922|FG004|Overall Study|Adverse Event|0|||
144460617|NCT03449030|520880923|FG005|Overall Study|Adverse Event|2|||
144460618|NCT03449030|520880924|FG006|Overall Study|Adverse Event|0|||
144460619|NCT03449030|520880925|FG007|Overall Study|Adverse Event|0|||
144460620|NCT03449030|520880926|FG008|Overall Study|Adverse Event|0|||
144460621|NCT03449030|520880927|FG009|Overall Study|Adverse Event|0|||
144460622|NCT03449030|520880918|FG000|Overall Study|Death|0|||
144460623|NCT03449030|520880919|FG001|Overall Study|Death|0|||
144460624|NCT03449030|520880920|FG002|Overall Study|Death|0|||
144460625|NCT03449030|520880921|FG003|Overall Study|Death|0|||
144460626|NCT03449030|520880922|FG004|Overall Study|Death|1|||
144460627|NCT03449030|520880923|FG005|Overall Study|Death|0|||
144460628|NCT03449030|520880924|FG006|Overall Study|Death|0|||
144460629|NCT03449030|520880925|FG007|Overall Study|Death|0|||
144460630|NCT03449030|520880926|FG008|Overall Study|Death|0|||
144460631|NCT03449030|520880927|FG009|Overall Study|Death|0|||
144460632|NCT03595904|520880929|FG000|Overall Study|Protocol Violation|3|||
144460633|NCT03595904|520880930|FG001|Overall Study|Protocol Violation|1|||
144460634|NCT03595904|520880929|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
144460635|NCT03595904|520880930|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
144460636|NCT03595904|520880929|FG000|Overall Study|Insurance complications|1|||
144460637|NCT03595904|520880930|FG001|Overall Study|Insurance complications|0|||
144460638|NCT03595904|520880929|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
144460639|NCT03595904|520880930|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
144460640|NCT00700401|520880938|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
144460641|NCT00700401|520880938|FG000|Overall Study|Adverse Event|5|||
144460642|NCT00700401|520880938|FG000|Overall Study|Refused Treatment|2|||
144460643|NCT00700401|520880938|FG000|Overall Study|Lost to Follow-up|1|||
144460644|NCT00700401|520880938|FG000|Overall Study|Treatment never started|1|||
144460645|NCT00700401|520880938|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
144460646|NCT00700401|520880938|FG000|Overall Study|Withdrawal by Subject|2|||
144460647|NCT00295750|520880939|FG000|Overall Study|Adverse Event|19|||
144460648|NCT00295750|520880940|FG001|Overall Study|Adverse Event|15|||
144460649|NCT00295750|520880941|FG002|Overall Study|Adverse Event|12|||
144460650|NCT00295750|520880939|FG000|Overall Study|Lack of Efficacy|1|||
144460651|NCT00295750|520880940|FG001|Overall Study|Lack of Efficacy|1|||
144460652|NCT00295750|520880941|FG002|Overall Study|Lack of Efficacy|0|||
144460653|NCT00295750|520880939|FG000|Overall Study|Lost to Follow-up|1|||
144460654|NCT00295750|520880940|FG001|Overall Study|Lost to Follow-up|4|||
144460655|NCT00295750|520880941|FG002|Overall Study|Lost to Follow-up|1|||
144460656|NCT00295750|520880939|FG000|Overall Study|Taking prohibited therapy|2|||
144460657|NCT00295750|520880940|FG001|Overall Study|Taking prohibited therapy|3|||
144460658|NCT00295750|520880941|FG002|Overall Study|Taking prohibited therapy|2|||
144535140|NCT02720068|521164000|FG001|Overall Study|Adverse Event|0|||
144535141|NCT02720068|521164001|FG002|Overall Study|Adverse Event|0|||
144535142|NCT02720068|521164002|FG003|Overall Study|Adverse Event|0|||
144535143|NCT02720068|521164003|FG004|Overall Study|Adverse Event|0|||
144535144|NCT02720068|521164004|FG005|Overall Study|Adverse Event|0|||
144535145|NCT02720068|521164005|FG006|Overall Study|Adverse Event|0|||
144535146|NCT02720068|521164006|FG007|Overall Study|Adverse Event|0|||
144535147|NCT02720068|521164007|FG008|Overall Study|Adverse Event|0|||
144535148|NCT02720068|521164008|FG009|Overall Study|Adverse Event|0|||
144535149|NCT02720068|521164009|FG010|Overall Study|Adverse Event|0|||
144535150|NCT02720068|521164010|FG011|Overall Study|Adverse Event|1|||
144535151|NCT02720068|521164011|FG012|Overall Study|Adverse Event|0|||
144460659|NCT00295750|520880939|FG000|Overall Study|Administrative errors|2|||
144460660|NCT00295750|520880940|FG001|Overall Study|Administrative errors|4|||
144460661|NCT00295750|520880941|FG002|Overall Study|Administrative errors|5|||
144460662|NCT00295750|520880939|FG000|Overall Study|Trial drug errors|1|||
144460663|NCT00295750|520880940|FG001|Overall Study|Trial drug errors|1|||
144460664|NCT00295750|520880941|FG002|Overall Study|Trial drug errors|0|||
144460665|NCT00295750|520880939|FG000|Overall Study|Disease progression|2|||
144460666|NCT00295750|520880940|FG001|Overall Study|Disease progression|1|||
144460667|NCT00295750|520880941|FG002|Overall Study|Disease progression|0|||
144460668|NCT00295750|520880939|FG000|Overall Study|Personal reasons|0|||
144535152|NCT02720068|521164012|FG013|Overall Study|Adverse Event|0|||
144535153|NCT02720068|521164013|FG014|Overall Study|Adverse Event|0|||
144535154|NCT02720068|521164014|FG015|Overall Study|Adverse Event|0|||
144535155|NCT02720068|521164015|FG016|Overall Study|Adverse Event|0|||
144609396|NCT00914927|521431057|FG003|Overall Study|Lost to Follow-up|1|||
144609397|NCT00914927|521431058|FG004|Overall Study|Lost to Follow-up|0|||
144609398|NCT00914927|521431059|FG005|Overall Study|Lost to Follow-up|0|||
144609399|NCT00914927|521431060|FG006|Overall Study|Lost to Follow-up|0|||
144609400|NCT00914927|521431054|FG000|Overall Study|Administrative/Other|2|||
144609401|NCT00914927|521431055|FG001|Overall Study|Administrative/Other|1|||
144609402|NCT00914927|521431056|FG002|Overall Study|Administrative/Other|0|||
144609403|NCT00914927|521431057|FG003|Overall Study|Administrative/Other|0|||
144609404|NCT00914927|521431058|FG004|Overall Study|Administrative/Other|1|||
144609405|NCT00914927|521431059|FG005|Overall Study|Administrative/Other|0|||
144609406|NCT00914927|521431060|FG006|Overall Study|Administrative/Other|0|||
144609407|NCT00971178|521431065|FG000|Overall Study|Lost to Follow-up|2|||
144609408|NCT00971178|521431066|FG001|Overall Study|Lost to Follow-up|2|||
144609409|NCT00971178|521431067|FG002|Overall Study|Lost to Follow-up|2|||
144609410|NCT00365456|521431068|FG000|Trial Period I (12 Months)|Adverse Event|84|||
144609411|NCT00365456|521431069|FG001|Trial Period I (12 Months)|Adverse Event|0|||
144609412|NCT00365456|521431068|FG000|Trial Period I (12 Months)|Non-compliance|3|||
144609413|NCT00365456|521431069|FG001|Trial Period I (12 Months)|Non-compliance|0|||
144609414|NCT00365456|521431068|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
144609415|NCT00365456|521431069|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
144609416|NCT00365456|521431068|FG000|Trial Period I (12 Months)|Other|11|||
144255468|NCT00902746|520136189|FG000|Overall Study|Physician Decision|2|||
144255469|NCT01151345|520136196|FG000|First Intervention Period|Protocol Violation|0|||
144255470|NCT01151345|520136197|FG001|First Intervention Period|Protocol Violation|1|||
144255471|NCT04208412|520136198|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
144255472|NCT04208412|520136199|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
144255473|NCT04208412|520136198|FG000|Overall Study|Withdrawal by Subject|1|||
144609417|NCT00365456|521431069|FG001|Trial Period I (12 Months)|Other|0|||
144609418|NCT00365456|521431068|FG000|Trial Period II (12 Months)|Adverse Event|0|||
144609419|NCT00365456|521431069|FG001|Trial Period II (12 Months)|Adverse Event|6|||
144609420|NCT00365456|521431068|FG000|Trial Period II (12 Months)|Non-compliance|0|||
144609421|NCT00365456|521431069|FG001|Trial Period II (12 Months)|Non-compliance|2|||
144609422|NCT00365456|521431068|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
144609423|NCT00365456|521431069|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
144609424|NCT00365456|521431068|FG000|Trial Period II (12 Months)|Other|0|||
144609425|NCT00365456|521431069|FG001|Trial Period II (12 Months)|Other|1|||
144609426|NCT00365456|521431068|FG000|Trial Period III (12 Months)|Adverse Event|13|||
144609427|NCT00365456|521431069|FG001|Trial Period III (12 Months)|Adverse Event|3|||
144609428|NCT00365456|521431068|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
144609429|NCT00365456|521431069|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
144609430|NCT00365456|521431068|FG000|Trial Period III (12 Months)|Other|1|||
144609431|NCT00365456|521431069|FG001|Trial Period III (12 Months)|Other|1|||
144609432|NCT00424749|521431070|FG000|Overall Study|Withdrawal by Subject|1|||
144609433|NCT00714285|521431071|FG000|Overall Study|Lost to Follow-up|0|||
144609434|NCT00714285|521431072|FG001|Overall Study|Lost to Follow-up|2|||
144609435|NCT00714285|521431073|FG002|Overall Study|Lost to Follow-up|0|||
144609436|NCT00714285|521431074|FG003|Overall Study|Lost to Follow-up|1|||
144609437|NCT00714285|521431071|FG000|Overall Study|Migrated/moved from study area|0|||
144609438|NCT00714285|521431072|FG001|Overall Study|Migrated/moved from study area|1|||
144609439|NCT00714285|521431073|FG002|Overall Study|Migrated/moved from study area|0|||
144609440|NCT00714285|521431074|FG003|Overall Study|Migrated/moved from study area|0|||
144609441|NCT01131676|521431075|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
144609442|NCT01131676|521431076|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
144609443|NCT01131676|521431077|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
144609444|NCT01131676|521431075|FG000|Discontinuation From Treatment|Not treated|4|||
144609445|NCT01131676|521431076|FG001|Discontinuation From Treatment|Not treated|2|||
144609446|NCT01131676|521431077|FG002|Discontinuation From Treatment|Not treated|2|||
144609447|NCT01131676|521431075|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
144609448|NCT01131676|521431076|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
144609449|NCT01131676|521431077|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
144609450|NCT01131676|521431075|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
144609451|NCT01131676|521431076|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
144609452|NCT01131676|521431077|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
144609453|NCT01131676|521431075|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
144255474|NCT04208412|520136199|FG001|Overall Study|Withdrawal by Subject|0|||
144609454|NCT01131676|521431076|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
144609455|NCT01131676|521431077|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
144609456|NCT01131676|521431075|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
144609457|NCT01131676|521431076|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
144609458|NCT01131676|521431077|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
144609459|NCT01131676|521431075|FG000|Discontinuation From Treatment|Other than those specified|162|||
144609460|NCT01131676|521431076|FG001|Discontinuation From Treatment|Other than those specified|142|||
144609461|NCT01131676|521431077|FG002|Discontinuation From Treatment|Other than those specified|125|||
144609462|NCT01131676|521431075|FG000|Discontinuation From Treatment|Adverse Event|303|||
144609463|NCT01131676|521431076|FG001|Discontinuation From Treatment|Adverse Event|267|||
144609464|NCT01131676|521431077|FG002|Discontinuation From Treatment|Adverse Event|273|||
144609465|NCT01131676|521431075|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
144609466|NCT01131676|521431076|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
144609467|NCT01131676|521431077|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
144609468|NCT01131676|521431075|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
144609469|NCT01131676|521431076|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
144609470|NCT01131676|521431077|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
144609471|NCT01131676|521431075|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
144609472|NCT01131676|521431076|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
144609473|NCT01131676|521431077|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
144609474|NCT01131676|521431075|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
144609475|NCT01131676|521431076|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
144609476|NCT01131676|521431077|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
144609477|NCT01131676|521431075|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
144609478|NCT01131676|521431076|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
144609479|NCT01131676|521431077|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
144609480|NCT01131676|521431075|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
144609481|NCT01131676|521431076|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
144609482|NCT01131676|521431077|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
144609483|NCT04109222|521431078|FG000|Overall Study|Adverse Event|1|||
144609484|NCT04109222|521431079|FG001|Overall Study|Adverse Event|0|||
144609485|NCT04109222|521431080|FG002|Overall Study|Adverse Event|0|||
144609486|NCT02577406|521431081|FG000|Randomized Period|Death|1|||
144609487|NCT02577406|521431082|FG001|Randomized Period|Death|0|||
144609488|NCT02577406|521431081|FG000|Randomized Period|Other reasons|0|||
144609489|NCT02577406|521431082|FG001|Randomized Period|Other reasons|20|||
144609490|NCT02577406|521431081|FG000|Treatment Period|Death|38|||
144609491|NCT02577406|521431082|FG001|Treatment Period|Death|23|||
144609492|NCT02577406|521431081|FG000|Treatment Period|Adverse Event|17|||
144609493|NCT02577406|521431082|FG001|Treatment Period|Adverse Event|12|||
144609494|NCT02577406|521431081|FG000|Treatment Period|Progressive Disease|53|||
144609495|NCT02577406|521431082|FG001|Treatment Period|Progressive Disease|37|||
144609496|NCT02577406|521431081|FG000|Treatment Period|Withdrawal by Subject|10|||
144609497|NCT02577406|521431082|FG001|Treatment Period|Withdrawal by Subject|24|||
144609498|NCT02577406|521431081|FG000|Treatment Period|Lost to Follow-up|0|||
144609499|NCT02577406|521431082|FG001|Treatment Period|Lost to Follow-up|1|||
144609500|NCT02577406|521431081|FG000|Treatment Period|Transition to commercially available treatment|1|||
144609501|NCT02577406|521431082|FG001|Treatment Period|Transition to commercially available treatment|1|||
144609502|NCT02577406|521431081|FG000|Treatment Period|Physician Decision|1|||
144609503|NCT02577406|521431082|FG001|Treatment Period|Physician Decision|0|||
144609504|NCT02577406|521431081|FG000|Treatment Period|Disease Relapse|28|||
144609505|NCT02577406|521431082|FG001|Treatment Period|Disease Relapse|1|||
144609506|NCT02577406|521431081|FG000|Treatment Period|Protocol Violation|0|||
144609507|NCT02577406|521431082|FG001|Treatment Period|Protocol Violation|1|||
144609508|NCT02577406|521431081|FG000|Treatment Period|Other Reasons|3|||
144609509|NCT02577406|521431082|FG001|Treatment Period|Other Reasons|39|||
144609510|NCT02577406|521431081|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
144460669|NCT00295750|520880940|FG001|Overall Study|Personal reasons|1|||
144460670|NCT00295750|520880941|FG002|Overall Study|Personal reasons|0|||
144609511|NCT02577406|521431082|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
144609512|NCT02138617|521431083|FG000|Overall Study|Death|1|||
144609513|NCT02138617|521431084|FG001|Overall Study|Death|2|||
144609514|NCT02138617|521431085|FG002|Overall Study|Death|2|||
144609515|NCT02138617|521431083|FG000|Overall Study|Adverse Event|8|||
144609516|NCT02138617|521431084|FG001|Overall Study|Adverse Event|5|||
144609517|NCT02138617|521431085|FG002|Overall Study|Adverse Event|2|||
144609518|NCT02138617|521431083|FG000|Overall Study|Disease Progression|20|||
144609519|NCT02138617|521431084|FG001|Overall Study|Disease Progression|13|||
144609520|NCT02138617|521431085|FG002|Overall Study|Disease Progression|4|||
144609521|NCT02138617|521431083|FG000|Overall Study|Withdrawal by Subject|7|||
144609522|NCT02138617|521431084|FG001|Overall Study|Withdrawal by Subject|10|||
144609523|NCT02138617|521431085|FG002|Overall Study|Withdrawal by Subject|2|||
144609524|NCT02138617|521431083|FG000|Overall Study|other complicating disease|0|||
144609525|NCT02138617|521431084|FG001|Overall Study|other complicating disease|2|||
144609526|NCT02138617|521431085|FG002|Overall Study|other complicating disease|0|||
144609527|NCT02138617|521431083|FG000|Overall Study|Protocol Violation|1|||
144460671|NCT00295750|520880939|FG000|Overall Study|Randomized but never received trial drug|4|||
144460672|NCT00295750|520880940|FG001|Overall Study|Randomized but never received trial drug|3|||
144460673|NCT00295750|520880941|FG002|Overall Study|Randomized but never received trial drug|3|||
144460674|NCT00295750|520880939|FG000|Overall Study|Withdrawal by Subject|9|||
144460675|NCT00295750|520880940|FG001|Overall Study|Withdrawal by Subject|4|||
144460676|NCT00295750|520880941|FG002|Overall Study|Withdrawal by Subject|7|||
144609528|NCT02138617|521431084|FG001|Overall Study|Protocol Violation|0|||
144609529|NCT02138617|521431085|FG002|Overall Study|Protocol Violation|0|||
144609530|NCT02138617|521431083|FG000|Overall Study|Physician Decision|7|||
144609531|NCT02138617|521431084|FG001|Overall Study|Physician Decision|6|||
144609532|NCT02138617|521431085|FG002|Overall Study|Physician Decision|0|||
144609533|NCT02138617|521431083|FG000|Overall Study|financial reason|0|||
144609534|NCT02138617|521431084|FG001|Overall Study|financial reason|1|||
144609535|NCT02138617|521431085|FG002|Overall Study|financial reason|0|||
144609536|NCT02138617|521431083|FG000|Overall Study|other therapy|3|||
144609537|NCT02138617|521431084|FG001|Overall Study|other therapy|4|||
144609538|NCT02138617|521431085|FG002|Overall Study|other therapy|0|||
144609539|NCT05525689|521431089|FG000|Overall Study|Lost to Follow-up|1|||
144609540|NCT05525689|521431090|FG001|Overall Study|Lost to Follow-up|0|||
144609541|NCT03000179|521431093|FG000|Overall Study|Lost to Follow-up|2|||
144609542|NCT04688775|521431096|FG000|Placebo-controlled Period|Randomized, not treated|1|||
144609543|NCT04688775|521431097|FG001|Placebo-controlled Period|Randomized, not treated|1|||
144609544|NCT04688775|521431098|FG002|Placebo-controlled Period|Randomized, not treated|0|||
144609545|NCT04688775|521431099|FG003|Placebo-controlled Period|Randomized, not treated|0|||
144609546|NCT04688775|521431096|FG000|Placebo-controlled Period|Adverse Event|2|||
144609547|NCT04688775|521431097|FG001|Placebo-controlled Period|Adverse Event|0|||
144609548|NCT04688775|521431098|FG002|Placebo-controlled Period|Adverse Event|0|||
144609549|NCT04688775|521431099|FG003|Placebo-controlled Period|Adverse Event|0|||
144609550|NCT04688775|521431096|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
144609551|NCT04688775|521431097|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
144609552|NCT04688775|521431098|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
144609553|NCT04688775|521431099|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
144609554|NCT04688775|521431096|FG000|Placebo-controlled Period|Protocol Violation|0|||
144609555|NCT04688775|521431097|FG001|Placebo-controlled Period|Protocol Violation|1|||
144609556|NCT04688775|521431098|FG002|Placebo-controlled Period|Protocol Violation|0|||
144609557|NCT04688775|521431099|FG003|Placebo-controlled Period|Protocol Violation|0|||
144609558|NCT04688775|521431096|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
144609559|NCT04688775|521431097|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
144609560|NCT04688775|521431098|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
144609561|NCT04688775|521431099|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
144609562|NCT04688775|521431096|FG000|Placebo-controlled Period|Other reasons|0|||
144609563|NCT04688775|521431097|FG001|Placebo-controlled Period|Other reasons|1|||
144609564|NCT04688775|521431098|FG002|Placebo-controlled Period|Other reasons|0|||
144609565|NCT04688775|521431099|FG003|Placebo-controlled Period|Other reasons|0|||
144609566|NCT04688775|521431096|FG000|Delayed Start Period|Adverse Event|0|||
144460677|NCT00295750|520880939|FG000|Overall Study|Protocol Violation|2|||
144460678|NCT00295750|520880940|FG001|Overall Study|Protocol Violation|4|||
144460679|NCT00295750|520880941|FG002|Overall Study|Protocol Violation|2|||
144460680|NCT01650259|520880942|FG000|Overall Study|Improvement|105|||
144460681|NCT01650259|520880943|FG001|Overall Study|Improvement|0|||
144460682|NCT01650259|520880942|FG000|Overall Study|Adverse Event|127|||
144460683|NCT01650259|520880943|FG001|Overall Study|Adverse Event|0|||
144460684|NCT01650259|520880942|FG000|Overall Study|Lack of Efficacy|143|||
144460685|NCT01650259|520880943|FG001|Overall Study|Lack of Efficacy|0|||
144460686|NCT01650259|520880942|FG000|Overall Study|Lost to Follow-up|435|||
144460687|NCT01650259|520880943|FG001|Overall Study|Lost to Follow-up|0|||
144460688|NCT01650259|520880942|FG000|Overall Study|Patients had no visit after entry|70|||
144460689|NCT01650259|520880943|FG001|Overall Study|Patients had no visit after entry|0|||
144460690|NCT01650259|520880942|FG000|Overall Study|CRF not collected|98|||
144460691|NCT01650259|520880943|FG001|Overall Study|CRF not collected|82|||
144460692|NCT01650259|520880942|FG000|Overall Study|Not treated|1|||
144460693|NCT01650259|520880943|FG001|Overall Study|Not treated|7|||
144460694|NCT01650259|520880942|FG000|Overall Study|Other than listed|64|||
144460695|NCT01650259|520880943|FG001|Overall Study|Other than listed|146|||
144609567|NCT04688775|521431097|FG001|Delayed Start Period|Adverse Event|0|||
144609568|NCT04688775|521431098|FG002|Delayed Start Period|Adverse Event|1|||
144609569|NCT04688775|521431099|FG003|Delayed Start Period|Adverse Event|0|||
144609570|NCT04688775|521431096|FG000|Delayed Start Period|Lack of Efficacy|0|||
144609571|NCT04688775|521431097|FG001|Delayed Start Period|Lack of Efficacy|0|||
144609572|NCT04688775|521431098|FG002|Delayed Start Period|Lack of Efficacy|0|||
144609573|NCT04688775|521431099|FG003|Delayed Start Period|Lack of Efficacy|3|||
144609574|NCT04688775|521431096|FG000|Delayed Start Period|Withdrawal by Subject|0|||
144609575|NCT04688775|521431097|FG001|Delayed Start Period|Withdrawal by Subject|0|||
144460696|NCT00355082|520880949|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
144460697|NCT00355082|520880950|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
144460698|NCT00355082|520880951|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
144460699|NCT00355082|520880949|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
144460700|NCT00355082|520880950|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
144460701|NCT00355082|520880951|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
144460702|NCT00355082|520880949|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
144460703|NCT00355082|520880950|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
144460704|NCT00355082|520880951|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
144460705|NCT00355082|520880949|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
144460706|NCT00355082|520880950|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
144460707|NCT00355082|520880951|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
144460708|NCT00355082|520880949|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
144460709|NCT00355082|520880950|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
144460710|NCT00355082|520880951|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
144460711|NCT00355082|520880949|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
144460712|NCT00355082|520880950|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
144460713|NCT00355082|520880951|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
144460714|NCT00355082|520880949|FG000|Continuation Phase|Adverse Event|2|||
144460715|NCT00355082|520880950|FG001|Continuation Phase|Adverse Event|0|||
144460716|NCT00355082|520880951|FG002|Continuation Phase|Adverse Event|1|||
144460717|NCT00355082|520880949|FG000|Continuation Phase|Lost to Follow-up|2|||
144460718|NCT00355082|520880950|FG001|Continuation Phase|Lost to Follow-up|0|||
144460719|NCT00355082|520880951|FG002|Continuation Phase|Lost to Follow-up|1|||
144460720|NCT00355082|520880949|FG000|Continuation Phase|Protocol Violation|1|||
144460721|NCT00355082|520880950|FG001|Continuation Phase|Protocol Violation|0|||
144460722|NCT00355082|520880951|FG002|Continuation Phase|Protocol Violation|1|||
144460723|NCT00355082|520880949|FG000|Continuation Phase|Withdrawal by Subject|4|||
144460724|NCT00355082|520880950|FG001|Continuation Phase|Withdrawal by Subject|0|||
144460725|NCT00355082|520880951|FG002|Continuation Phase|Withdrawal by Subject|0|||
144460726|NCT00355082|520880949|FG000|Continuation Phase|Lack of Efficacy|5|||
144460727|NCT00355082|520880950|FG001|Continuation Phase|Lack of Efficacy|0|||
144460728|NCT00355082|520880951|FG002|Continuation Phase|Lack of Efficacy|0|||
144460729|NCT00355082|520880949|FG000|Continuation Phase|Site Closed by Sponsor|8|||
144460730|NCT00355082|520880950|FG001|Continuation Phase|Site Closed by Sponsor|0|||
144460731|NCT00355082|520880951|FG002|Continuation Phase|Site Closed by Sponsor|0|||
144460732|NCT00355082|520880949|FG000|Continuation Phase|Scheduling Error|1|||
144460733|NCT00355082|520880950|FG001|Continuation Phase|Scheduling Error|0|||
144460734|NCT00355082|520880951|FG002|Continuation Phase|Scheduling Error|0|||
144460735|NCT00355082|520880949|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
144460736|NCT00355082|520880950|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
144460737|NCT00355082|520880951|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
144460738|NCT00724971|520880957|FG000|Overall Study|Adverse Event|5|||
144460739|NCT00724971|520880957|FG000|Overall Study|Withdrawal by Subject|1|||
144460740|NCT02132611|520880959|FG000|Overall Study|Death|2|||
144460741|NCT02194621|520880967|FG000|Overall Study|6 withdrew prior to randomization|2|||
144460742|NCT02194621|520880968|FG001|Overall Study|6 withdrew prior to randomization|2|||
144460743|NCT02194621|520880969|FG002|Overall Study|6 withdrew prior to randomization|2|||
144460744|NCT02194621|520880967|FG000|Overall Study|Withdrawal by Subject|4|||
144460745|NCT02194621|520880968|FG001|Overall Study|Withdrawal by Subject|4|||
144460746|NCT02194621|520880969|FG002|Overall Study|Withdrawal by Subject|7|||
144460747|NCT02763384|520880970|FG000|Overall Study|Physician Decision|1|||
144460748|NCT02763384|520880970|FG000|Overall Study|Rapid decline - went on hospice|1|||
144460749|NCT02493127|520880971|FG000|Overall Study|Lost to Follow-up|1|||
144460750|NCT02493127|520880972|FG001|Overall Study|Lost to Follow-up|1|||
144460751|NCT02096900|520880973|FG000|Overall Study|Did not receive medication|3|||
144460752|NCT02096900|520880974|FG001|Overall Study|Did not receive medication|1|||
144460753|NCT02096900|520880973|FG000|Overall Study|Surgery cancelled- medication received|1|||
144460754|NCT02096900|520880974|FG001|Overall Study|Surgery cancelled- medication received|1|||
144460755|NCT04177758|520880975|FG000|Overall Study|Lost to Follow-up|19|||
144460756|NCT04177758|520880976|FG001|Overall Study|Lost to Follow-up|11|||
144460757|NCT03826667|520880980|FG000|Overall Study|Protocol deviation|21|||
144460758|NCT00808808|520880981|FG000|Overall Study|Vaccinated; survey not completed|131|||
144460759|NCT00808808|520880982|FG001|Overall Study|Vaccinated; survey not completed|169|||
144460760|NCT00808808|520880983|FG002|Overall Study|Vaccinated; survey not completed|302|||
144460761|NCT00808808|520880981|FG000|Overall Study|Employee was not vaccinated.|2686|||
144460762|NCT00808808|520880982|FG001|Overall Study|Employee was not vaccinated.|2268|||
144460763|NCT00808808|520880983|FG002|Overall Study|Employee was not vaccinated.|2255|||
144460764|NCT02298192|520880984|FG000|Overall Study|Unclassified|3|||
144460765|NCT02298192|520880985|FG001|Overall Study|Unclassified|2|||
144460766|NCT02298192|520880984|FG000|Overall Study|Withdrawal criteria|2|||
144460767|NCT02298192|520880985|FG001|Overall Study|Withdrawal criteria|0|||
144460768|NCT02298192|520880984|FG000|Overall Study|Withdrawal by Subject|6|||
144460769|NCT02298192|520880985|FG001|Overall Study|Withdrawal by Subject|1|||
144460770|NCT02298192|520880984|FG000|Overall Study|Lost to Follow-up|2|||
144535156|NCT02720068|521164016|FG017|Overall Study|Adverse Event|0|||
144460771|NCT02298192|520880985|FG001|Overall Study|Lost to Follow-up|1|||
144460772|NCT02298192|520880984|FG000|Overall Study|Adverse Event|6|||
144460773|NCT02298192|520880985|FG001|Overall Study|Adverse Event|2|||
144460774|NCT04764396|520880988|FG000|Overall Study|Physician Decision|1|||
144460775|NCT04764396|520880989|FG001|Overall Study|Physician Decision|0|||
144460776|NCT02653482|520880991|FG000|Overall Study|Death|1|||
144460777|NCT02653482|520880992|FG001|Overall Study|Death|1|||
144460778|NCT02693665|520880995|FG000|Overall Study|Death|3|||
144460779|NCT02693665|520880996|FG001|Overall Study|Death|2|||
144460780|NCT02693665|520880995|FG000|Overall Study|Lost to Follow-up|7|||
144460781|NCT02693665|520880996|FG001|Overall Study|Lost to Follow-up|3|||
144460782|NCT02693665|520880995|FG000|Overall Study|Protocol Violation|1|||
144460783|NCT02693665|520880996|FG001|Overall Study|Protocol Violation|0|||
144460784|NCT02693665|520880995|FG000|Overall Study|Withdrawal by Subject|2|||
144460785|NCT02693665|520880996|FG001|Overall Study|Withdrawal by Subject|0|||
144460786|NCT02693665|520880995|FG000|Overall Study|patient wanted to leave it behind|1|||
144460787|NCT02693665|520880996|FG001|Overall Study|patient wanted to leave it behind|0|||
144460788|NCT02693665|520880995|FG000|Overall Study|anxiety|1|||
144460789|NCT02693665|520880996|FG001|Overall Study|anxiety|0|||
144460790|NCT02693665|520880995|FG000|Overall Study|family issues|1|||
144460791|NCT02693665|520880996|FG001|Overall Study|family issues|0|||
144460792|NCT02693665|520880995|FG000|Overall Study|no reason given|1|||
144460793|NCT02693665|520880996|FG001|Overall Study|no reason given|0|||
144460794|NCT06167031|520880998|FG000|Overall Study|Lost to Follow-up|5|||
144460795|NCT06167031|520880999|FG001|Overall Study|Lost to Follow-up|1|||
144460796|NCT00844857|520883486|FG000|Overall Study|Adverse Event|24|||
144460797|NCT00844857|520883487|FG001|Overall Study|Adverse Event|5|||
144460798|NCT00844857|520883486|FG000|Overall Study|Sponsor Decision|1|||
144460799|NCT00844857|520883487|FG001|Overall Study|Sponsor Decision|1|||
144460800|NCT00844857|520883486|FG000|Overall Study|Physician Decision|2|||
144460801|NCT00844857|520883487|FG001|Overall Study|Physician Decision|0|||
144460802|NCT00844857|520883486|FG000|Overall Study|Parent/Caregiver Decision|6|||
144460803|NCT00844857|520883487|FG001|Overall Study|Parent/Caregiver Decision|2|||
144460804|NCT00844857|520883486|FG000|Overall Study|Withdrawal by Subject|8|||
144460805|NCT00844857|520883487|FG001|Overall Study|Withdrawal by Subject|7|||
144460806|NCT00844857|520883486|FG000|Overall Study|Protocol Violation|6|||
144460807|NCT00844857|520883487|FG001|Overall Study|Protocol Violation|0|||
144460808|NCT00844857|520883486|FG000|Overall Study|Lack of Efficacy|5|||
144460809|NCT00844857|520883487|FG001|Overall Study|Lack of Efficacy|5|||
144460810|NCT00844857|520883486|FG000|Overall Study|Clinical Relapse|0|||
144460811|NCT00844857|520883487|FG001|Overall Study|Clinical Relapse|1|||
144460812|NCT00844857|520883486|FG000|Overall Study|Entry Criteria Not Met|0|||
144460813|NCT00844857|520883487|FG001|Overall Study|Entry Criteria Not Met|1|||
144460814|NCT00844857|520883486|FG000|Overall Study|Lost to Follow-up|2|||
144460815|NCT00844857|520883487|FG001|Overall Study|Lost to Follow-up|3|||
144460816|NCT00844857|520883486|FG000|Overall Study|Did Not Take Study Drug|3|||
144460817|NCT00844857|520883487|FG001|Overall Study|Did Not Take Study Drug|1|||
144460818|NCT00844857|520883486|FG000|Overall Study|Good Clinical Practice Violations|21|||
144460819|NCT00844857|520883487|FG001|Overall Study|Good Clinical Practice Violations|11|||
144460820|NCT00570674|520883488|FG000|Overall Study|Withdrawal by Subject|0|||
144460821|NCT00570674|520883489|FG001|Overall Study|Withdrawal by Subject|0|||
144460822|NCT00570674|520883490|FG002|Overall Study|Withdrawal by Subject|1|||
144460823|NCT00570674|520883491|FG003|Overall Study|Withdrawal by Subject|0|||
144460824|NCT00570674|520883492|FG004|Overall Study|Withdrawal by Subject|0|||
144460825|NCT00570674|520883493|FG005|Overall Study|Withdrawal by Subject|0|||
144460826|NCT00570674|520883494|FG006|Overall Study|Withdrawal by Subject|0|||
144460827|NCT02985866|520883500|FG000|Overall Study|Poor CGM data|1|||
144460828|NCT02985866|520883501|FG001|Overall Study|Poor CGM data|1|||
144460829|NCT02120027|520883504|FG000|Overall Study|Adverse Event|4|||
144460830|NCT02120027|520883505|FG001|Overall Study|Adverse Event|5|||
144460831|NCT02120027|520883504|FG000|Overall Study|Lack of Efficacy|3|||
144460832|NCT02120027|520883505|FG001|Overall Study|Lack of Efficacy|5|||
144725943|NCT03331042|521852651|FG003|Overall Study|Protocol Violation|0|||
144725944|NCT03331042|521852648|FG000|Overall Study|Physician Decision|0|||
144725945|NCT03331042|521852649|FG001|Overall Study|Physician Decision|0|||
144460833|NCT02120027|520883504|FG000|Overall Study|Lost to Follow-up|5|||
144460834|NCT02120027|520883505|FG001|Overall Study|Lost to Follow-up|13|||
144460835|NCT02120027|520883504|FG000|Overall Study|Other|4|||
144725946|NCT03331042|521852650|FG002|Overall Study|Physician Decision|1|||
144460836|NCT02120027|520883505|FG001|Overall Study|Other|0|||
144460837|NCT02120027|520883504|FG000|Overall Study|Physician Decision|4|||
144460838|NCT02120027|520883505|FG001|Overall Study|Physician Decision|3|||
144460839|NCT02120027|520883504|FG000|Overall Study|Protocol Violation|18|||
144460840|NCT02120027|520883505|FG001|Overall Study|Protocol Violation|21|||
144460841|NCT02120027|520883504|FG000|Overall Study|Study terminated by Sponsor|45|||
144460842|NCT02120027|520883505|FG001|Overall Study|Study terminated by Sponsor|47|||
144460843|NCT02120027|520883504|FG000|Overall Study|Withdrawal by Subject|33|||
144460844|NCT02120027|520883505|FG001|Overall Study|Withdrawal by Subject|25|||
144725947|NCT03331042|521852651|FG003|Overall Study|Physician Decision|0|||
144725948|NCT03331042|521852648|FG000|Overall Study|Lost to Follow-up|0|||
144460845|NCT03393000|520883508|FG000|Overall Study|Death|11|||
144460846|NCT03393000|520883508|FG000|Overall Study|Withdrawal by Subject|2|||
144460847|NCT03393000|520883508|FG000|Overall Study|Physician Decision|1|||
144460848|NCT01773070|520883509|FG000|Overall Study|Withdrawal by Subject|24|||
144460849|NCT01773070|520883509|FG000|Overall Study|Lost to Follow-up|39|||
144460850|NCT01773070|520883509|FG000|Overall Study|Other|15|||
144460851|NCT01773070|520883509|FG000|Overall Study|Death (unrelated to study procedures)|3|||
144460852|NCT01843192|520883510|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
144460853|NCT01843192|520883511|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
144460854|NCT01843192|520883512|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
144460855|NCT01471054|520883513|FG000|Overall Study|Study terminated prematurely|4|||
144460856|NCT01471054|520883514|FG001|Overall Study|Study terminated prematurely|0|||
144460857|NCT02181803|520883515|FG000|Overall Study|Withdrawal by Subject|0|||
144460858|NCT02181803|520883516|FG001|Overall Study|Withdrawal by Subject|2|||
144460859|NCT02181803|520883517|FG002|Overall Study|Withdrawal by Subject|0|||
144460860|NCT02181803|520883518|FG003|Overall Study|Withdrawal by Subject|0|||
144460861|NCT02181803|520883519|FG004|Overall Study|Withdrawal by Subject|0|||
144460862|NCT02181803|520883520|FG005|Overall Study|Withdrawal by Subject|0|||
144460863|NCT02181803|520883521|FG006|Overall Study|Withdrawal by Subject|0|||
144460864|NCT02181803|520883522|FG007|Overall Study|Withdrawal by Subject|0|||
144460865|NCT02181803|520883523|FG008|Overall Study|Withdrawal by Subject|0|||
144460866|NCT02181803|520883515|FG000|Overall Study|Physician Decision|0|||
144460867|NCT02181803|520883516|FG001|Overall Study|Physician Decision|0|||
144460868|NCT02181803|520883517|FG002|Overall Study|Physician Decision|0|||
144460869|NCT02181803|520883518|FG003|Overall Study|Physician Decision|1|||
144460870|NCT02181803|520883519|FG004|Overall Study|Physician Decision|0|||
144460871|NCT02181803|520883520|FG005|Overall Study|Physician Decision|0|||
144460872|NCT02181803|520883521|FG006|Overall Study|Physician Decision|0|||
144460873|NCT02181803|520883522|FG007|Overall Study|Physician Decision|1|||
144460874|NCT02181803|520883523|FG008|Overall Study|Physician Decision|0|||
144460875|NCT02181803|520883515|FG000|Overall Study|Adverse Event|0|||
144460876|NCT02181803|520883516|FG001|Overall Study|Adverse Event|2|||
144460877|NCT02181803|520883517|FG002|Overall Study|Adverse Event|0|||
144460878|NCT02181803|520883518|FG003|Overall Study|Adverse Event|1|||
144460879|NCT02181803|520883519|FG004|Overall Study|Adverse Event|0|||
144460880|NCT02181803|520883520|FG005|Overall Study|Adverse Event|0|||
144460881|NCT02181803|520883521|FG006|Overall Study|Adverse Event|1|||
144460882|NCT02181803|520883522|FG007|Overall Study|Adverse Event|0|||
144460883|NCT02181803|520883523|FG008|Overall Study|Adverse Event|0|||
144460884|NCT00951041|520883524|FG000|Overall Study|Withdrawal by Subject|1|||
144460885|NCT00951041|520883525|FG001|Overall Study|Withdrawal by Subject|1|||
144460886|NCT00951041|520883524|FG000|Overall Study|Lost to Follow-up|1|||
144460887|NCT00951041|520883525|FG001|Overall Study|Lost to Follow-up|0|||
144460888|NCT00951041|520883524|FG000|Overall Study|Other|3|||
144460889|NCT00951041|520883525|FG001|Overall Study|Other|0|||
144460890|NCT02277106|520883526|FG000|Stage 2|Adverse Event|0|||
144460891|NCT02277106|520883527|FG001|Stage 2|Adverse Event|0|||
144460892|NCT02277106|520883528|FG002|Stage 2|Adverse Event|1|||
144460893|NCT03031938|520883529|FG000|Overall Study|Death|1|||
144460894|NCT03031938|520883530|FG001|Overall Study|Death|0|||
144460895|NCT02479412|520883533|FG000|Overall Study|Adverse Event|0|||
144460896|NCT02479412|520883534|FG001|Overall Study|Adverse Event|0|||
144460897|NCT02479412|520883535|FG002|Overall Study|Adverse Event|1|||
144460898|NCT02479412|520883536|FG003|Overall Study|Adverse Event|0|||
144460899|NCT02479412|520883537|FG004|Overall Study|Adverse Event|0|||
144460900|NCT02479412|520883538|FG005|Overall Study|Adverse Event|0|||
144460901|NCT02479412|520883539|FG006|Overall Study|Adverse Event|0|||
144460902|NCT02479412|520883540|FG007|Overall Study|Adverse Event|0|||
144460903|NCT02479412|520883541|FG008|Overall Study|Adverse Event|0|||
144460904|NCT02479412|520883533|FG000|Overall Study|Study-specific withdrawal criteria|0|||
144460905|NCT02479412|520883534|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144460906|NCT02479412|520883535|FG002|Overall Study|Study-specific withdrawal criteria|1|||
144460907|NCT02479412|520883536|FG003|Overall Study|Study-specific withdrawal criteria|1|||
144460908|NCT02479412|520883537|FG004|Overall Study|Study-specific withdrawal criteria|0|||
144460909|NCT02479412|520883538|FG005|Overall Study|Study-specific withdrawal criteria|0|||
144460910|NCT02479412|520883539|FG006|Overall Study|Study-specific withdrawal criteria|0|||
144460911|NCT02479412|520883540|FG007|Overall Study|Study-specific withdrawal criteria|1|||
144460912|NCT02479412|520883541|FG008|Overall Study|Study-specific withdrawal criteria|1|||
144460913|NCT02479412|520883533|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
144460914|NCT02479412|520883534|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
144460915|NCT02479412|520883535|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
144535157|NCT02720068|521163999|FG000|Overall Study|Death|1|||
144535158|NCT02720068|521164000|FG001|Overall Study|Death|3|||
144535159|NCT02720068|521164001|FG002|Overall Study|Death|2|||
144460916|NCT02479412|520883536|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
144535160|NCT02720068|521164002|FG003|Overall Study|Death|1|||
144535161|NCT02720068|521164003|FG004|Overall Study|Death|2|||
144535162|NCT02720068|521164004|FG005|Overall Study|Death|1|||
144460917|NCT02479412|520883537|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
144460918|NCT02479412|520883538|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
144460919|NCT02479412|520883539|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
144460920|NCT02479412|520883540|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
144460921|NCT02479412|520883541|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
144460922|NCT01026974|520883552|FG000|Overall Study|Withdrawal by Subject|0|||
144460923|NCT01026974|520883553|FG001|Overall Study|Withdrawal by Subject|1|||
144460924|NCT01026974|520883554|FG002|Overall Study|Withdrawal by Subject|7|||
144460925|NCT01026974|520883555|FG003|Overall Study|Withdrawal by Subject|2|||
144460926|NCT01026974|520883552|FG000|Overall Study|Lost to Follow-up|1|||
144460927|NCT01026974|520883553|FG001|Overall Study|Lost to Follow-up|1|||
144460928|NCT01026974|520883554|FG002|Overall Study|Lost to Follow-up|4|||
144460929|NCT01026974|520883555|FG003|Overall Study|Lost to Follow-up|0|||
144460930|NCT01026974|520883552|FG000|Overall Study|Adverse Event|0|||
144460931|NCT01026974|520883553|FG001|Overall Study|Adverse Event|0|||
144460932|NCT01026974|520883554|FG002|Overall Study|Adverse Event|0|||
144460933|NCT01026974|520883555|FG003|Overall Study|Adverse Event|1|||
144460934|NCT01026974|520883552|FG000|Overall Study|Inappropriate enrollment|0|||
144460935|NCT01026974|520883553|FG001|Overall Study|Inappropriate enrollment|0|||
144460936|NCT01026974|520883554|FG002|Overall Study|Inappropriate enrollment|1|||
144460937|NCT01026974|520883555|FG003|Overall Study|Inappropriate enrollment|0|||
144460938|NCT03280121|520883557|FG000|Overall Study|Physician Decision|1|||
144460939|NCT03280121|520883557|FG000|Overall Study|Lost to Follow-up|1|||
144460940|NCT03280121|520883557|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
144460941|NCT03638141|520883567|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
144460942|NCT03759873|520883568|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
144460943|NCT03759873|520883569|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
144460944|NCT03759873|520883570|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
144460945|NCT03759873|520883571|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
144460946|NCT03759873|520883568|FG000|Overall Study|Moved outside eligible area|0|||
144460947|NCT03759873|520883569|FG001|Overall Study|Moved outside eligible area|2|||
144460948|NCT03759873|520883570|FG002|Overall Study|Moved outside eligible area|0|||
144460949|NCT03759873|520883571|FG003|Overall Study|Moved outside eligible area|0|||
144460950|NCT03759873|520883568|FG000|Overall Study|Withdrawal by Subject|0|||
144460951|NCT03759873|520883569|FG001|Overall Study|Withdrawal by Subject|0|||
144460952|NCT03759873|520883570|FG002|Overall Study|Withdrawal by Subject|1|||
144460953|NCT03759873|520883571|FG003|Overall Study|Withdrawal by Subject|0|||
144460954|NCT01362140|520883574|FG000|Overall Study|Noncompliance|1|||
144460955|NCT01362140|520883575|FG001|Overall Study|Noncompliance|0|||
144460956|NCT01362140|520883574|FG000|Overall Study|Adverse Event|2|||
144460957|NCT01362140|520883575|FG001|Overall Study|Adverse Event|2|||
144460958|NCT01362140|520883574|FG000|Overall Study|Withdrawal by Subject|3|||
144460959|NCT01362140|520883575|FG001|Overall Study|Withdrawal by Subject|3|||
144460960|NCT01362140|520883574|FG000|Overall Study|Administrative Decision|0|||
144460961|NCT01362140|520883575|FG001|Overall Study|Administrative Decision|1|||
144460962|NCT01362140|520883574|FG000|Overall Study|Death|2|||
144460963|NCT01362140|520883575|FG001|Overall Study|Death|1|||
144460964|NCT01362140|520883574|FG000|Overall Study|Other|1|||
144460965|NCT01362140|520883575|FG001|Overall Study|Other|1|||
144460966|NCT01362140|520883574|FG000|Overall Study|Protocol-specified Criteria|1|||
144460967|NCT01362140|520883575|FG001|Overall Study|Protocol-specified Criteria|2|||
144460968|NCT01362140|520883574|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
144460969|NCT01362140|520883575|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
144460970|NCT06476366|520883576|FG000|Overall Study|Lost to Follow-up|1|||
144460971|NCT06476366|520883577|FG001|Overall Study|Lost to Follow-up|3|||
144460972|NCT06476366|520883576|FG000|Overall Study|Adverse Event|1|||
144460973|NCT06476366|520883577|FG001|Overall Study|Adverse Event|0|||
144460974|NCT01910129|520883578|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
144460975|NCT01910129|520883579|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
144460976|NCT01910129|520883580|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
144460977|NCT01910129|520883578|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
144460978|NCT01910129|520883579|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
144460979|NCT01910129|520883580|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
144460980|NCT00965523|520883581|FG000|Study 221|Progressive Disease|4|||
144460981|NCT00965523|520883581|FG000|Study 221|Physician Decision|3|||
144460982|NCT00965523|520883581|FG000|Study 224|Progressive Disease|5|||
144460983|NCT00965523|520883581|FG000|Study 224|Physician Decision|1|||
144460984|NCT02415400|520883582|FG000|Overall Study|Adverse Event|0|||
144460985|NCT02415400|520883583|FG001|Overall Study|Adverse Event|1|||
144460986|NCT02415400|520883584|FG002|Overall Study|Adverse Event|1|||
144460987|NCT02415400|520883585|FG003|Overall Study|Adverse Event|2|||
144460988|NCT02415400|520883582|FG000|Overall Study|Participant request to stop therapy|4|||
144460989|NCT02415400|520883583|FG001|Overall Study|Participant request to stop therapy|3|||
144460990|NCT02415400|520883584|FG002|Overall Study|Participant request to stop therapy|8|||
144460991|NCT02415400|520883585|FG003|Overall Study|Participant request to stop therapy|6|||
144460992|NCT02415400|520883582|FG000|Overall Study|Participant withdrew consent|14|||
144460993|NCT02415400|520883583|FG001|Overall Study|Participant withdrew consent|12|||
144460994|NCT02415400|520883584|FG002|Overall Study|Participant withdrew consent|30|||
144460995|NCT02415400|520883585|FG003|Overall Study|Participant withdrew consent|21|||
144460996|NCT02415400|520883582|FG000|Overall Study|Death|39|||
144460997|NCT02415400|520883583|FG001|Overall Study|Death|41|||
144460998|NCT02415400|520883584|FG002|Overall Study|Death|35|||
144460999|NCT02415400|520883585|FG003|Overall Study|Death|42|||
144255475|NCT04208412|520136198|FG000|Overall Study|Lost to Follow-up|0|||
144255476|NCT04208412|520136199|FG001|Overall Study|Lost to Follow-up|1|||
144255477|NCT02588092|520136202|FG000|Overall Study|Death|4|||
144255478|NCT02588092|520136203|FG001|Overall Study|Death|3|||
144255479|NCT02588092|520136204|FG002|Overall Study|Death|3|||
144255480|NCT02588092|520136205|FG003|Overall Study|Death|3|||
144255481|NCT02588092|520136206|FG004|Overall Study|Death|2|||
144255482|NCT02588092|520136207|FG005|Overall Study|Death|2|||
144461000|NCT02415400|520883582|FG000|Overall Study|Lost to Follow-up|3|||
144461001|NCT02415400|520883583|FG001|Overall Study|Lost to Follow-up|3|||
144461002|NCT02415400|520883584|FG002|Overall Study|Lost to Follow-up|2|||
144461003|NCT02415400|520883585|FG003|Overall Study|Lost to Follow-up|5|||
144461004|NCT02415400|520883582|FG000|Overall Study|Poor/Non-Compliance|0|||
144461005|NCT02415400|520883583|FG001|Overall Study|Poor/Non-Compliance|1|||
144255483|NCT02588092|520136208|FG006|Overall Study|Death|2|||
144255484|NCT02588092|520136209|FG007|Overall Study|Death|1|||
144255485|NCT02588092|520136210|FG008|Overall Study|Death|5|||
144255486|NCT02588092|520136211|FG009|Overall Study|Death|2|||
144255487|NCT02588092|520136202|FG000|Overall Study|Withdrawal by Subject|0|||
144461006|NCT02415400|520883584|FG002|Overall Study|Poor/Non-Compliance|3|||
144461007|NCT02415400|520883585|FG003|Overall Study|Poor/Non-Compliance|4|||
144461008|NCT02415400|520883582|FG000|Overall Study|Participant no longer meets criteria|2|||
144461009|NCT02415400|520883583|FG001|Overall Study|Participant no longer meets criteria|0|||
144461010|NCT02415400|520883584|FG002|Overall Study|Participant no longer meets criteria|0|||
144461011|NCT02415400|520883585|FG003|Overall Study|Participant no longer meets criteria|1|||
144461012|NCT02415400|520883582|FG000|Overall Study|Participant doesn't answer phone|1|||
144461013|NCT02415400|520883583|FG001|Overall Study|Participant doesn't answer phone|0|||
144461014|NCT02415400|520883584|FG002|Overall Study|Participant doesn't answer phone|0|||
144461015|NCT02415400|520883585|FG003|Overall Study|Participant doesn't answer phone|0|||
144461016|NCT02415400|520883582|FG000|Overall Study|Participant wanted home visits|1|||
144461017|NCT02415400|520883583|FG001|Overall Study|Participant wanted home visits|0|||
144461018|NCT02415400|520883584|FG002|Overall Study|Participant wanted home visits|0|||
144461019|NCT02415400|520883585|FG003|Overall Study|Participant wanted home visits|0|||
144461020|NCT02415400|520883582|FG000|Overall Study|Randomized in error|2|||
144461021|NCT02415400|520883583|FG001|Overall Study|Randomized in error|0|||
144461022|NCT02415400|520883584|FG002|Overall Study|Randomized in error|0|||
144461023|NCT02415400|520883585|FG003|Overall Study|Randomized in error|0|||
144461024|NCT02415400|520883582|FG000|Overall Study|No study drug on site|0|||
144461025|NCT02415400|520883583|FG001|Overall Study|No study drug on site|1|||
144461026|NCT02415400|520883584|FG002|Overall Study|No study drug on site|0|||
144461027|NCT02415400|520883585|FG003|Overall Study|No study drug on site|0|||
144461028|NCT02415400|520883582|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
144461029|NCT02415400|520883583|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
144461030|NCT02415400|520883584|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
144461031|NCT02415400|520883585|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
144461032|NCT02415400|520883582|FG000|Overall Study|Coagulation values cannot be set|0|||
144461033|NCT02415400|520883583|FG001|Overall Study|Coagulation values cannot be set|0|||
144461034|NCT02415400|520883584|FG002|Overall Study|Coagulation values cannot be set|1|||
144461035|NCT02415400|520883585|FG003|Overall Study|Coagulation values cannot be set|0|||
144461036|NCT02415400|520883582|FG000|Overall Study|State regulations prevent participation|0|||
144535163|NCT02720068|521164005|FG006|Overall Study|Death|2|||
144461037|NCT02415400|520883583|FG001|Overall Study|State regulations prevent participation|0|||
144535164|NCT02720068|521164006|FG007|Overall Study|Death|2|||
144535165|NCT02720068|521164007|FG008|Overall Study|Death|3|||
144255488|NCT02588092|520136203|FG001|Overall Study|Withdrawal by Subject|0|||
144255489|NCT02588092|520136204|FG002|Overall Study|Withdrawal by Subject|0|||
144461038|NCT02415400|520883584|FG002|Overall Study|State regulations prevent participation|1|||
144461039|NCT02415400|520883585|FG003|Overall Study|State regulations prevent participation|0|||
144461040|NCT02415400|520883582|FG000|Overall Study|Poor treatment monitoring|0|||
144461041|NCT02415400|520883583|FG001|Overall Study|Poor treatment monitoring|0|||
144461042|NCT02415400|520883584|FG002|Overall Study|Poor treatment monitoring|1|||
144461043|NCT02415400|520883585|FG003|Overall Study|Poor treatment monitoring|0|||
144461044|NCT02415400|520883582|FG000|Overall Study|Participant in jail|0|||
144535166|NCT02720068|521164008|FG009|Overall Study|Death|1|||
144255490|NCT02588092|520136205|FG003|Overall Study|Withdrawal by Subject|0|||
144255491|NCT02588092|520136206|FG004|Overall Study|Withdrawal by Subject|0|||
144255492|NCT02588092|520136207|FG005|Overall Study|Withdrawal by Subject|1|||
144255493|NCT02588092|520136208|FG006|Overall Study|Withdrawal by Subject|1|||
144461045|NCT02415400|520883583|FG001|Overall Study|Participant in jail|0|||
144461046|NCT02415400|520883584|FG002|Overall Study|Participant in jail|1|||
144461047|NCT02415400|520883585|FG003|Overall Study|Participant in jail|0|||
144461048|NCT02415400|520883582|FG000|Overall Study|Investigator decision|0|||
144461049|NCT02415400|520883583|FG001|Overall Study|Investigator decision|0|||
144461050|NCT02415400|520883584|FG002|Overall Study|Investigator decision|1|||
144461051|NCT02415400|520883585|FG003|Overall Study|Investigator decision|1|||
144461052|NCT02415400|520883582|FG000|Overall Study|Site closure; participant won't transfer|0|||
144461053|NCT02415400|520883583|FG001|Overall Study|Site closure; participant won't transfer|0|||
144461054|NCT02415400|520883584|FG002|Overall Study|Site closure; participant won't transfer|0|||
144461055|NCT02415400|520883585|FG003|Overall Study|Site closure; participant won't transfer|1|||
144461056|NCT01581281|520883588|FG000|Overall Study|Early Study Closure|15|||
144461057|NCT01581281|520883589|FG001|Overall Study|Early Study Closure|6|||
144461058|NCT01581281|520883590|FG002|Overall Study|Early Study Closure|12|||
144461059|NCT02081846|520883591|FG000|Overall Study|Withdrawal by Subject|1|||
144461060|NCT02081846|520883592|FG001|Overall Study|Withdrawal by Subject|0|||
144461061|NCT02081846|520883591|FG000|Overall Study|invalid consent|1|||
144461062|NCT02081846|520883592|FG001|Overall Study|invalid consent|0|||
144461063|NCT00092131|520883600|FG000|Treatment Period I|Adverse Event|1|||
144461064|NCT00092131|520883601|FG001|Treatment Period I|Adverse Event|0|||
144461065|NCT00092131|520883600|FG000|Treatment Period II|Adverse Event|0|||
144461066|NCT00092131|520883601|FG001|Treatment Period II|Adverse Event|1|||
144461067|NCT02576067|520883602|FG000|Overall Study|Death|0|||
144461068|NCT02576067|520883603|FG001|Overall Study|Death|1|||
144461069|NCT02576067|520883602|FG000|Overall Study|Lack of Efficacy|1|||
144461070|NCT02576067|520883603|FG001|Overall Study|Lack of Efficacy|0|||
144461071|NCT02576067|520883602|FG000|Overall Study|Lost to Follow-up|11|||
144461072|NCT02576067|520883603|FG001|Overall Study|Lost to Follow-up|0|||
144461073|NCT02576067|520883602|FG000|Overall Study|Withdrawal by Subject|11|||
144461074|NCT02576067|520883603|FG001|Overall Study|Withdrawal by Subject|2|||
144461075|NCT02576067|520883602|FG000|Overall Study|study closure of main CIRT trial)|0|||
144461076|NCT02576067|520883603|FG001|Overall Study|study closure of main CIRT trial)|8|||
144461077|NCT02576067|520883602|FG000|Overall Study|not randomized, failed run-in|7|||
144461078|NCT02576067|520883603|FG001|Overall Study|not randomized, failed run-in|0|||
144461079|NCT02576067|520883602|FG000|Overall Study|screen failure/ re-enrolled|0|||
144461080|NCT02576067|520883603|FG001|Overall Study|screen failure/ re-enrolled|25|||
144461081|NCT02576067|520883602|FG000|Overall Study|Physician Decision|4|||
144461082|NCT02576067|520883603|FG001|Overall Study|Physician Decision|0|||
144461083|NCT02372409|520883606|FG000|Overall Study|Lost to Follow-up|1|||
144461084|NCT02372409|520883607|FG001|Overall Study|Lost to Follow-up|0|||
144461085|NCT02372409|520883606|FG000|Overall Study|Disease progression|1|||
144461086|NCT02372409|520883607|FG001|Overall Study|Disease progression|1|||
144461087|NCT01808313|520883608|FG000|Overall Study|Adverse Event|5|||
144461088|NCT01808313|520883608|FG000|Overall Study|Protocol Violation|2|||
144461089|NCT01808313|520883608|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144461090|NCT01808313|520883608|FG000|Overall Study|Lost to Follow-up|1|||
144461091|NCT01808313|520883608|FG000|Overall Study|Physician Decision|1|||
144461092|NCT03346759|520883613|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
144461093|NCT03346759|520883614|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
144461094|NCT03346759|520883613|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
144461095|NCT03346759|520883614|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
144461096|NCT03346759|520883613|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
144461097|NCT03346759|520883614|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
144461098|NCT03943095|520883615|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
144461099|NCT03943095|520883616|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
144461100|NCT03943095|520883615|FG000|Overall Study|Withdrawal by Subject|1|||
144461101|NCT03943095|520883616|FG001|Overall Study|Withdrawal by Subject|0|||
144461102|NCT03674177|520883617|FG000|Overall Study|Lost to Follow-up|2|||
144535167|NCT02720068|521164009|FG010|Overall Study|Death|20|||
144535168|NCT02720068|521164010|FG011|Overall Study|Death|166|||
144535169|NCT02720068|521164011|FG012|Overall Study|Death|34|||
144461103|NCT03674177|520883618|FG001|Overall Study|Lost to Follow-up|1|||
144461104|NCT03674177|520883619|FG002|Overall Study|Lost to Follow-up|0|||
144461105|NCT03674177|520883620|FG003|Overall Study|Lost to Follow-up|2|||
144535170|NCT02720068|521164012|FG013|Overall Study|Death|30|||
144535171|NCT02720068|521164013|FG014|Overall Study|Death|45|||
144535172|NCT02720068|521164014|FG015|Overall Study|Death|16|||
144535173|NCT02720068|521164015|FG016|Overall Study|Death|20|||
144461106|NCT00714168|520883621|FG000|Overall Study|Pregnancy|5|||
144461107|NCT00714168|520883622|FG001|Overall Study|Pregnancy|4|||
144461108|NCT00714168|520883621|FG000|Overall Study|Lost to Follow-up|32|||
144461109|NCT00714168|520883622|FG001|Overall Study|Lost to Follow-up|50|||
144461110|NCT00714168|520883621|FG000|Overall Study|Relocation|4|||
144461111|NCT00714168|520883622|FG001|Overall Study|Relocation|3|||
144535174|NCT02720068|521164016|FG017|Overall Study|Death|28|||
144535175|NCT02720068|521163999|FG000|Overall Study|Lost to Follow-up|0|||
144535176|NCT02720068|521164000|FG001|Overall Study|Lost to Follow-up|0|||
144535177|NCT02720068|521164001|FG002|Overall Study|Lost to Follow-up|0|||
144255494|NCT02588092|520136209|FG007|Overall Study|Withdrawal by Subject|2|||
144255495|NCT02588092|520136210|FG008|Overall Study|Withdrawal by Subject|0|||
144255496|NCT02588092|520136211|FG009|Overall Study|Withdrawal by Subject|0|||
144255497|NCT02588092|520136202|FG000|Overall Study|Started Another Treatment|0|||
144255498|NCT02588092|520136203|FG001|Overall Study|Started Another Treatment|0|||
144255499|NCT02588092|520136204|FG002|Overall Study|Started Another Treatment|0|||
144461112|NCT00714168|520883621|FG000|Overall Study|Non-study medical condition|3|||
144461113|NCT00714168|520883622|FG001|Overall Study|Non-study medical condition|2|||
144461114|NCT04988308|520883624|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
144461115|NCT04988308|520883625|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
144461116|NCT04988308|520883626|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
144461117|NCT04988308|520883627|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
144461118|NCT04988308|520883628|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
144461119|NCT04988308|520883629|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
144461120|NCT04988308|520883624|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
144461121|NCT04988308|520883625|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
144461122|NCT04988308|520883626|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
144461123|NCT04988308|520883627|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
144461124|NCT04988308|520883628|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
144461125|NCT04988308|520883629|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
144461126|NCT04988308|520883624|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
144461127|NCT04988308|520883625|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
144461128|NCT04988308|520883626|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
144461129|NCT04988308|520883627|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
144461130|NCT04988308|520883628|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
144461131|NCT04988308|520883629|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
144461132|NCT04988308|520883624|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
144461133|NCT04988308|520883625|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
144461134|NCT04988308|520883626|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
144461135|NCT04988308|520883627|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
144461136|NCT04988308|520883628|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
144461137|NCT04988308|520883629|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
144461138|NCT04988308|520883624|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
144461139|NCT04988308|520883625|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
144461140|NCT04988308|520883626|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
144461141|NCT04988308|520883627|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
144461142|NCT04988308|520883628|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
144461143|NCT04988308|520883629|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
144461144|NCT04988308|520883624|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
144461145|NCT04988308|520883625|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
144461146|NCT04988308|520883626|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
144461147|NCT04988308|520883627|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
144461148|NCT04988308|520883628|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
144461149|NCT04988308|520883629|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
144461150|NCT04988308|520883624|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
144461151|NCT04988308|520883625|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
144535178|NCT02720068|521164002|FG003|Overall Study|Lost to Follow-up|0|||
144535179|NCT02720068|521164003|FG004|Overall Study|Lost to Follow-up|0|||
144535180|NCT02720068|521164004|FG005|Overall Study|Lost to Follow-up|0|||
144535181|NCT02720068|521164005|FG006|Overall Study|Lost to Follow-up|0|||
144535182|NCT02720068|521164006|FG007|Overall Study|Lost to Follow-up|0|||
144535183|NCT02720068|521164007|FG008|Overall Study|Lost to Follow-up|0|||
144535184|NCT02720068|521164008|FG009|Overall Study|Lost to Follow-up|0|||
144535185|NCT02720068|521164009|FG010|Overall Study|Lost to Follow-up|0|||
144535186|NCT02720068|521164010|FG011|Overall Study|Lost to Follow-up|1|||
144535187|NCT02720068|521164011|FG012|Overall Study|Lost to Follow-up|0|||
144535188|NCT02720068|521164012|FG013|Overall Study|Lost to Follow-up|1|||
144535189|NCT02720068|521164013|FG014|Overall Study|Lost to Follow-up|2|||
144535190|NCT02720068|521164014|FG015|Overall Study|Lost to Follow-up|0|||
144535191|NCT02720068|521164015|FG016|Overall Study|Lost to Follow-up|0|||
144535192|NCT02720068|521164016|FG017|Overall Study|Lost to Follow-up|1|||
144535193|NCT02720068|521163999|FG000|Overall Study|Physician Decision|0|||
144535194|NCT02720068|521164000|FG001|Overall Study|Physician Decision|0|||
144535195|NCT02720068|521164001|FG002|Overall Study|Physician Decision|0|||
144535196|NCT02720068|521164002|FG003|Overall Study|Physician Decision|1|||
144535197|NCT02720068|521164003|FG004|Overall Study|Physician Decision|0|||
144535198|NCT02720068|521164004|FG005|Overall Study|Physician Decision|0|||
144535199|NCT02720068|521164005|FG006|Overall Study|Physician Decision|0|||
144535200|NCT02720068|521164006|FG007|Overall Study|Physician Decision|0|||
144255500|NCT02588092|520136205|FG003|Overall Study|Started Another Treatment|0|||
144535201|NCT02720068|521164007|FG008|Overall Study|Physician Decision|0|||
144535202|NCT02720068|521164008|FG009|Overall Study|Physician Decision|0|||
144535203|NCT02720068|521164009|FG010|Overall Study|Physician Decision|0|||
144535204|NCT02720068|521164010|FG011|Overall Study|Physician Decision|1|||
144535205|NCT02720068|521164011|FG012|Overall Study|Physician Decision|0|||
144535206|NCT02720068|521164012|FG013|Overall Study|Physician Decision|0|||
144535207|NCT02720068|521164013|FG014|Overall Study|Physician Decision|0|||
144535208|NCT02720068|521164014|FG015|Overall Study|Physician Decision|0|||
144535209|NCT02720068|521164015|FG016|Overall Study|Physician Decision|0|||
144535210|NCT02720068|521164016|FG017|Overall Study|Physician Decision|1|||
144535211|NCT02720068|521163999|FG000|Overall Study|Progressive Disease|2|||
144535212|NCT02720068|521164000|FG001|Overall Study|Progressive Disease|3|||
144535213|NCT02720068|521164001|FG002|Overall Study|Progressive Disease|1|||
144535214|NCT02720068|521164002|FG003|Overall Study|Progressive Disease|1|||
144535215|NCT02720068|521164003|FG004|Overall Study|Progressive Disease|1|||
144535216|NCT02720068|521164004|FG005|Overall Study|Progressive Disease|2|||
144535217|NCT02720068|521164005|FG006|Overall Study|Progressive Disease|1|||
144535218|NCT02720068|521164006|FG007|Overall Study|Progressive Disease|1|||
144535219|NCT02720068|521164007|FG008|Overall Study|Progressive Disease|0|||
144535220|NCT02720068|521164008|FG009|Overall Study|Progressive Disease|1|||
144535221|NCT02720068|521164009|FG010|Overall Study|Progressive Disease|0|||
144535222|NCT02720068|521164010|FG011|Overall Study|Progressive Disease|4|||
144535223|NCT02720068|521164011|FG012|Overall Study|Progressive Disease|1|||
144535224|NCT02720068|521164012|FG013|Overall Study|Progressive Disease|0|||
144535225|NCT02720068|521164013|FG014|Overall Study|Progressive Disease|0|||
144535226|NCT02720068|521164014|FG015|Overall Study|Progressive Disease|0|||
144535227|NCT02720068|521164015|FG016|Overall Study|Progressive Disease|0|||
144535228|NCT02720068|521164016|FG017|Overall Study|Progressive Disease|0|||
144535229|NCT02720068|521163999|FG000|Overall Study|Sponsor Decision|0|||
144535230|NCT02720068|521164000|FG001|Overall Study|Sponsor Decision|0|||
144535231|NCT02720068|521164001|FG002|Overall Study|Sponsor Decision|0|||
144535232|NCT02720068|521164002|FG003|Overall Study|Sponsor Decision|0|||
144535233|NCT02720068|521164003|FG004|Overall Study|Sponsor Decision|0|||
144535234|NCT02720068|521164004|FG005|Overall Study|Sponsor Decision|0|||
144535235|NCT02720068|521164005|FG006|Overall Study|Sponsor Decision|0|||
144535236|NCT02720068|521164006|FG007|Overall Study|Sponsor Decision|0|||
144535237|NCT02720068|521164007|FG008|Overall Study|Sponsor Decision|0|||
144535238|NCT02720068|521164008|FG009|Overall Study|Sponsor Decision|0|||
144535239|NCT02720068|521164009|FG010|Overall Study|Sponsor Decision|0|||
144535240|NCT02720068|521164010|FG011|Overall Study|Sponsor Decision|6|||
144535241|NCT02720068|521164011|FG012|Overall Study|Sponsor Decision|3|||
144535242|NCT02720068|521164012|FG013|Overall Study|Sponsor Decision|2|||
144609576|NCT04688775|521431098|FG002|Delayed Start Period|Withdrawal by Subject|2|||
144609577|NCT04688775|521431099|FG003|Delayed Start Period|Withdrawal by Subject|4|||
144609578|NCT04688775|521431096|FG000|Delayed Start Period|Lost to Follow-up|0|||
144461152|NCT04988308|520883626|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
144461153|NCT04988308|520883627|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
144461154|NCT04988308|520883628|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
144461155|NCT04988308|520883629|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
144461156|NCT04988308|520883624|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144461157|NCT04988308|520883625|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144461158|NCT04988308|520883626|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
144461159|NCT04988308|520883627|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
144461160|NCT04988308|520883628|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
144461161|NCT04988308|520883629|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
144461162|NCT04988308|520883624|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
144461163|NCT04988308|520883625|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
144461164|NCT04988308|520883626|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
144461165|NCT04988308|520883627|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
144461166|NCT04988308|520883628|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
144461167|NCT04988308|520883629|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
144535243|NCT02720068|521164013|FG014|Overall Study|Sponsor Decision|4|||
144609579|NCT04688775|521431097|FG001|Delayed Start Period|Lost to Follow-up|0|||
144535244|NCT02720068|521164014|FG015|Overall Study|Sponsor Decision|4|||
144535245|NCT02720068|521164015|FG016|Overall Study|Sponsor Decision|0|||
144535246|NCT02720068|521164016|FG017|Overall Study|Sponsor Decision|8|||
144535247|NCT02720068|521163999|FG000|Overall Study|Withdrawal by Subject|0|||
144535248|NCT02720068|521164000|FG001|Overall Study|Withdrawal by Subject|0|||
144535249|NCT02720068|521164001|FG002|Overall Study|Withdrawal by Subject|0|||
144535250|NCT02720068|521164002|FG003|Overall Study|Withdrawal by Subject|0|||
144535251|NCT02720068|521164003|FG004|Overall Study|Withdrawal by Subject|0|||
144461168|NCT03034577|520883639|FG000|Overall Study|Withdrawal by Subject|6|||
144535252|NCT02720068|521164004|FG005|Overall Study|Withdrawal by Subject|0|||
144535253|NCT02720068|521164005|FG006|Overall Study|Withdrawal by Subject|0|||
144535254|NCT02720068|521164006|FG007|Overall Study|Withdrawal by Subject|0|||
144461169|NCT03034577|520883640|FG001|Overall Study|Withdrawal by Subject|9|||
144461170|NCT03034577|520883639|FG000|Overall Study|Lost to Follow-up|25|||
144461171|NCT03034577|520883640|FG001|Overall Study|Lost to Follow-up|26|||
144461172|NCT02625623|520883641|FG000|Overall Study|Participants randomized but not treated|9|||
144461173|NCT02625623|520883642|FG001|Overall Study|Participants randomized but not treated|1|||
144461174|NCT02352948|520883646|FG000|Overall Study|Death|47|||
144461175|NCT02352948|520883647|FG001|Overall Study|Death|48|||
144461176|NCT02352948|520883648|FG002|Overall Study|Death|114|||
144461177|NCT02352948|520883649|FG003|Overall Study|Death|74|||
144461178|NCT02352948|520883650|FG004|Overall Study|Death|77|||
144461179|NCT02352948|520883651|FG005|Overall Study|Death|44|||
144461180|NCT02352948|520883646|FG000|Overall Study|Lost to Follow-up|1|||
144461181|NCT02352948|520883647|FG001|Overall Study|Lost to Follow-up|0|||
144461182|NCT02352948|520883648|FG002|Overall Study|Lost to Follow-up|2|||
144461183|NCT02352948|520883649|FG003|Overall Study|Lost to Follow-up|1|||
144461184|NCT02352948|520883650|FG004|Overall Study|Lost to Follow-up|2|||
144461185|NCT02352948|520883651|FG005|Overall Study|Lost to Follow-up|1|||
144609580|NCT04688775|521431098|FG002|Delayed Start Period|Lost to Follow-up|2|||
144609581|NCT04688775|521431099|FG003|Delayed Start Period|Lost to Follow-up|1|||
144461186|NCT02352948|520883646|FG000|Overall Study|Withdrawal by Subject|1|||
144461187|NCT02352948|520883647|FG001|Overall Study|Withdrawal by Subject|10|||
144461188|NCT02352948|520883648|FG002|Overall Study|Withdrawal by Subject|11|||
144461189|NCT02352948|520883649|FG003|Overall Study|Withdrawal by Subject|23|||
144461190|NCT02352948|520883650|FG004|Overall Study|Withdrawal by Subject|9|||
144461191|NCT02352948|520883651|FG005|Overall Study|Withdrawal by Subject|4|||
144461192|NCT02352948|520883646|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144461193|NCT02352948|520883647|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144461194|NCT02352948|520883648|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
144461195|NCT02352948|520883649|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
144461196|NCT02352948|520883650|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
144461197|NCT02352948|520883651|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
144461198|NCT02352948|520883646|FG000|Overall Study|Other|0|||
144461199|NCT02352948|520883647|FG001|Overall Study|Other|0|||
144461200|NCT02352948|520883648|FG002|Overall Study|Other|2|||
144461201|NCT02352948|520883649|FG003|Overall Study|Other|0|||
144461202|NCT02352948|520883650|FG004|Overall Study|Other|0|||
144461203|NCT02352948|520883651|FG005|Overall Study|Other|0|||
144461204|NCT00679939|520883653|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
144461205|NCT00679939|520883654|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
144461206|NCT00679939|520883653|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
144461207|NCT00679939|520883654|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
144461208|NCT00679939|520883653|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
144461209|NCT00679939|520883654|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
144461210|NCT00679939|520883653|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
144461211|NCT00679939|520883654|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
144461212|NCT00679939|520883653|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
144461213|NCT00679939|520883654|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
144461214|NCT00679939|520883653|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
144461215|NCT00679939|520883654|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
144461216|NCT00679939|520883653|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
144461217|NCT00679939|520883654|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
144461218|NCT00679939|520883653|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
144461219|NCT00679939|520883654|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
144461220|NCT00679939|520883653|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
144461221|NCT00679939|520883654|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
144461222|NCT00679939|520883653|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
144461223|NCT00679939|520883654|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
144461224|NCT03230916|520883658|FG000|Overall Study|Withdrawal by Subject|0|||
144461225|NCT03230916|520883659|FG001|Overall Study|Withdrawal by Subject|0|||
144461226|NCT03230916|520883660|FG002|Overall Study|Withdrawal by Subject|0|||
144461227|NCT03230916|520883661|FG003|Overall Study|Withdrawal by Subject|0|||
144461228|NCT03230916|520883662|FG004|Overall Study|Withdrawal by Subject|0|||
144461229|NCT03230916|520883663|FG005|Overall Study|Withdrawal by Subject|1|||
144609582|NCT04688775|521431096|FG000|Delayed Start Period|other reasons|0|||
144609583|NCT04688775|521431097|FG001|Delayed Start Period|other reasons|0|||
144461230|NCT03230916|520883664|FG006|Overall Study|Withdrawal by Subject|0|||
144461231|NCT03230916|520883665|FG007|Overall Study|Withdrawal by Subject|0|||
144609584|NCT04688775|521431098|FG002|Delayed Start Period|other reasons|1|||
144609585|NCT04688775|521431099|FG003|Delayed Start Period|other reasons|0|||
144609586|NCT01843972|521431100|FG000|Overall Study|Withdrawal by Subject|0|||
144461232|NCT03230916|520883666|FG008|Overall Study|Withdrawal by Subject|0|||
144461233|NCT03230916|520883667|FG009|Overall Study|Withdrawal by Subject|0|||
144609587|NCT01843972|521431101|FG001|Overall Study|Withdrawal by Subject|0|||
144609588|NCT01843972|521431102|FG002|Overall Study|Withdrawal by Subject|0|||
144461234|NCT03230916|520883668|FG010|Overall Study|Withdrawal by Subject|0|||
144461235|NCT01128413|520883669|FG000|Overall Study|Withdrawal by Subject|1|||
144461236|NCT01128413|520883670|FG001|Overall Study|Withdrawal by Subject|0|||
144461237|NCT01128413|520883669|FG000|Overall Study|NICOM Monitor Problems|2|||
144461238|NCT01128413|520883670|FG001|Overall Study|NICOM Monitor Problems|1|||
144461239|NCT01128413|520883669|FG000|Overall Study|Pt made DNR|1|||
144461240|NCT01128413|520883670|FG001|Overall Study|Pt made DNR|0|||
144461241|NCT06273774|520883671|FG000|Overall Study|Participant was out of state.|0|||
144461242|NCT06273774|520883672|FG001|Overall Study|Participant was out of state.|0|||
144461243|NCT06273774|520883673|FG002|Overall Study|Participant was out of state.|0|||
144461244|NCT06273774|520883674|FG003|Overall Study|Participant was out of state.|0|||
144461245|NCT06273774|520883675|FG004|Overall Study|Participant was out of state.|0|||
144461246|NCT06273774|520883676|FG005|Overall Study|Participant was out of state.|1|||
144461247|NCT06273774|520883671|FG000|Overall Study|Lost to Follow-up|0|||
144461248|NCT06273774|520883672|FG001|Overall Study|Lost to Follow-up|0|||
144461249|NCT06273774|520883673|FG002|Overall Study|Lost to Follow-up|0|||
144461250|NCT06273774|520883674|FG003|Overall Study|Lost to Follow-up|0|||
144461251|NCT06273774|520883675|FG004|Overall Study|Lost to Follow-up|1|||
144461252|NCT06273774|520883676|FG005|Overall Study|Lost to Follow-up|0|||
144461253|NCT02010060|520883677|FG000|Overall Study|Lost to Follow-up|1|||
144461254|NCT02010060|520883678|FG001|Overall Study|Lost to Follow-up|2|||
144461255|NCT02010060|520883679|FG002|Overall Study|Lost to Follow-up|2|||
144461256|NCT02010060|520883677|FG000|Overall Study|Injury|0|||
144461257|NCT02010060|520883678|FG001|Overall Study|Injury|1|||
144461258|NCT02010060|520883679|FG002|Overall Study|Injury|0|||
144461259|NCT00660010|520883682|FG000|Overall Study|Withdrawal by Subject|2|||
144461260|NCT00660010|520883682|FG000|Overall Study|Lost to Follow-up|3|||
144461261|NCT00660010|520883682|FG000|Overall Study|Adverse Event|1|||
144461262|NCT00660010|520883682|FG000|Overall Study|Noncompliance with visit schedule|3|||
144461263|NCT02979639|520885945|FG000|Overall Study|Withdrawal based on medical judgement|1|||
144461264|NCT02979639|520885945|FG000|Overall Study|Lost to Follow-up|8|||
144461265|NCT02979639|520885945|FG000|Overall Study|Withdrawal by Subject|3|||
144461266|NCT02979639|520885945|FG000|Overall Study|Adverse Event|2|||
144461267|NCT03667053|520885947|FG000|Overall Study|Withdrawal by Subject|1|||
144461268|NCT03667053|520885948|FG001|Overall Study|Withdrawal by Subject|0|||
144461269|NCT03667053|520885949|FG002|Overall Study|Withdrawal by Subject|0|||
144461270|NCT03647501|520885950|FG000|Overall Study|Lost to Follow-up|1|||
144461271|NCT03647501|520885951|FG001|Overall Study|Lost to Follow-up|1|||
144461272|NCT03647501|520885950|FG000|Overall Study|Withdrawal by Subject|0|||
144461273|NCT03647501|520885951|FG001|Overall Study|Withdrawal by Subject|1|||
144461274|NCT01324271|520885952|FG000|Overall Study|Lost to Follow-up|3|||
144461275|NCT01324271|520885953|FG001|Overall Study|Lost to Follow-up|0|||
144461276|NCT01324271|520885952|FG000|Overall Study|Physician Decision|1|||
144461277|NCT01324271|520885953|FG001|Overall Study|Physician Decision|0|||
144461278|NCT03996473|520885954|FG000|Treatment Assignment|Withdrawal by Subject|1|||
144461279|NCT03996473|520885954|FG000|Treatment Assignment|Progressive disease|6|||
144461280|NCT03996473|520885954|FG000|Treatment Assignment|Study drug never administered|1|||
144461281|NCT03996473|520885954|FG000|Active Follow-up|Death|1|||
144461282|NCT03996473|520885954|FG000|Long-term Follow-up|Death|5|||
144461283|NCT06116591|520885955|FG000|Overall Study|No longer met eligibility criteria|0|||
144461284|NCT06116591|520885956|FG001|Overall Study|No longer met eligibility criteria|1|||
144609589|NCT01843972|521431103|FG003|Overall Study|Withdrawal by Subject|0|||
144609590|NCT01843972|521431104|FG004|Overall Study|Withdrawal by Subject|1|||
144609591|NCT01843972|521431105|FG005|Overall Study|Withdrawal by Subject|0|||
144609592|NCT01843972|521431106|FG006|Overall Study|Withdrawal by Subject|0|||
144609593|NCT01843972|521431107|FG007|Overall Study|Withdrawal by Subject|0|||
144609594|NCT01843972|521431108|FG008|Overall Study|Withdrawal by Subject|0|||
144461285|NCT06116591|520885955|FG000|Overall Study|Other: Change in life situation|0|||
144461286|NCT06116591|520885956|FG001|Overall Study|Other: Change in life situation|1|||
144461287|NCT05585307|520885957|FG000|Overall Study|Lost to Follow-up|0|||
144461288|NCT05585307|520885958|FG001|Overall Study|Lost to Follow-up|0|||
144461289|NCT05585307|520885959|FG002|Overall Study|Lost to Follow-up|0|||
144461290|NCT05585307|520885960|FG003|Overall Study|Lost to Follow-up|0|||
144197032|NCT00361335|519918663|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
144197033|NCT00361335|519918664|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
144197034|NCT00361335|519918665|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
144197035|NCT00361335|519918666|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
144197036|NCT00361335|519918660|FG000|SC Period: Week E0 to Week E24|Death|0|||
144197037|NCT00361335|519918661|FG001|SC Period: Week E0 to Week E24|Death|0|||
144461291|NCT05585307|520885961|FG004|Overall Study|Lost to Follow-up|0|||
144461292|NCT05585307|520885962|FG005|Overall Study|Lost to Follow-up|0|||
144461293|NCT05585307|520885963|FG006|Overall Study|Lost to Follow-up|1|||
144461294|NCT05585307|520885964|FG007|Overall Study|Lost to Follow-up|0|||
144461295|NCT01869491|520885965|FG000|Overall Study|Adverse Event|3|||
144461296|NCT01869491|520885966|FG001|Overall Study|Adverse Event|5|||
144461297|NCT01869491|520885965|FG000|Overall Study|Lack of Efficacy|0|||
144461298|NCT01869491|520885966|FG001|Overall Study|Lack of Efficacy|3|||
144461299|NCT01869491|520885965|FG000|Overall Study|Withdrawal by Subject|6|||
144461300|NCT01869491|520885966|FG001|Overall Study|Withdrawal by Subject|7|||
144461301|NCT01869491|520885965|FG000|Overall Study|Lost to Follow-up|11|||
144461302|NCT01869491|520885966|FG001|Overall Study|Lost to Follow-up|9|||
144461303|NCT01869491|520885965|FG000|Overall Study|No further need of investigational product|1|||
144461304|NCT01869491|520885966|FG001|Overall Study|No further need of investigational product|0|||
144461305|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
144461306|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
144461307|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
144461308|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
144461309|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
144461310|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
144461311|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
144461312|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
144461313|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
144461314|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
144461315|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
144461316|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
144461317|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
144461318|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
144461319|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
144461320|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
144461321|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
144461322|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
144461323|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
144461324|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
144461325|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
144461326|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
144461327|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
144461328|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
144461329|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
144461330|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
144461331|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
144461332|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
144461333|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
144461334|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
144461335|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
144461336|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
144461337|NCT04818346|520885967|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
144461338|NCT04818346|520885968|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
144461339|NCT04818346|520885969|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
144461340|NCT04818346|520885970|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
144461341|NCT04818346|520885967|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
144461342|NCT04818346|520885968|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
144461343|NCT04818346|520885969|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
144461344|NCT04818346|520885970|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
144461345|NCT04818346|520885967|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
144461346|NCT04818346|520885968|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
144461347|NCT04818346|520885969|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
144461348|NCT04818346|520885970|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
144461349|NCT04818346|520885967|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
144461350|NCT04818346|520885968|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
144461351|NCT04818346|520885969|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
144461352|NCT04818346|520885970|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
144461353|NCT04818346|520885967|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
144461354|NCT04818346|520885968|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
144461355|NCT04818346|520885969|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
144461356|NCT04818346|520885970|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
144461357|NCT04818346|520885967|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
144461358|NCT04818346|520885968|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
144461359|NCT04818346|520885969|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
144461360|NCT04818346|520885970|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
144461361|NCT04818346|520885967|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
144461362|NCT04818346|520885968|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
144461363|NCT04818346|520885969|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
144461364|NCT04818346|520885970|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
144461365|NCT00492284|520885971|FG000|Overall Study|Adverse Event|0|||
144461366|NCT00492284|520885972|FG001|Overall Study|Adverse Event|1|||
144461367|NCT00492284|520885973|FG002|Overall Study|Adverse Event|1|||
144461368|NCT00492284|520885974|FG003|Overall Study|Adverse Event|2|||
144461369|NCT00492284|520885971|FG000|Overall Study|Lost to Follow-up|0|||
144461370|NCT00492284|520885972|FG001|Overall Study|Lost to Follow-up|0|||
144461371|NCT00492284|520885973|FG002|Overall Study|Lost to Follow-up|3|||
144461372|NCT00492284|520885974|FG003|Overall Study|Lost to Follow-up|1|||
144461373|NCT00492284|520885971|FG000|Overall Study|Death|0|||
144461374|NCT00492284|520885972|FG001|Overall Study|Death|3|||
144461375|NCT00492284|520885973|FG002|Overall Study|Death|2|||
144461376|NCT00492284|520885974|FG003|Overall Study|Death|5|||
144461377|NCT00492284|520885971|FG000|Overall Study|Withdrawal by Subject|1|||
144461378|NCT00492284|520885972|FG001|Overall Study|Withdrawal by Subject|0|||
144461379|NCT00492284|520885973|FG002|Overall Study|Withdrawal by Subject|0|||
144461380|NCT00492284|520885974|FG003|Overall Study|Withdrawal by Subject|2|||
144461381|NCT03695172|520885975|FG000|Overall Study|Withdrawal by Subject|1|||
144461382|NCT03695172|520885976|FG001|Overall Study|Withdrawal by Subject|1|||
144461383|NCT03695172|520885977|FG002|Overall Study|Withdrawal by Subject|0|||
144461384|NCT02734212|520885978|FG000|Overall Study|Lost to Follow-up|5|||
144461385|NCT02734212|520885979|FG001|Overall Study|Lost to Follow-up|10|||
144461386|NCT04313881|520885982|FG000|Overall Study|Death|138|||
144461387|NCT04313881|520885983|FG001|Overall Study|Death|126|||
144461388|NCT04313881|520885982|FG000|Overall Study|Study terminated by sponsor|108|||
144461389|NCT04313881|520885983|FG001|Overall Study|Study terminated by sponsor|129|||
144461390|NCT04313881|520885982|FG000|Overall Study|Consent withdrawn|19|||
144461391|NCT04313881|520885983|FG001|Overall Study|Consent withdrawn|15|||
144461392|NCT04313881|520885982|FG000|Overall Study|Reason not Specified|3|||
144461393|NCT04313881|520885983|FG001|Overall Study|Reason not Specified|1|||
144461394|NCT00727272|520885984|FG000|Washout Period A|Adverse Event|0|||
144461395|NCT00727272|520885985|FG001|Washout Period A|Adverse Event|0|||
144461396|NCT00727272|520885986|FG002|Washout Period A|Adverse Event|1|||
144461397|NCT00727272|520885984|FG000|Washout Period B|Withdrawal by Subject|0|||
144461398|NCT00727272|520885985|FG001|Washout Period B|Withdrawal by Subject|0|||
144461399|NCT00727272|520885986|FG002|Washout Period B|Withdrawal by Subject|1|||
144461400|NCT00651664|520885987|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
144461401|NCT00651664|520885988|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
144461402|NCT00651664|520885989|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
144461403|NCT00651664|520885990|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
144461404|NCT00651664|520885991|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
144461405|NCT00651664|520885992|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
144461406|NCT00651664|520885993|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
144461407|NCT00651664|520885994|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
144461408|NCT00651664|520885995|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
144461409|NCT00651664|520885996|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
144461410|NCT00651664|520885987|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
144461411|NCT00651664|520885988|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
144461412|NCT00651664|520885989|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
144461413|NCT00651664|520885990|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
144461414|NCT00651664|520885991|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
144461415|NCT00651664|520885992|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
144461416|NCT00651664|520885993|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
144461417|NCT00651664|520885994|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
144461418|NCT00651664|520885995|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
144461419|NCT00651664|520885996|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
144461420|NCT00651664|520885987|FG000|Overall Study|Progressive Disease|3|||
144461421|NCT00651664|520885988|FG001|Overall Study|Progressive Disease|3|||
144461422|NCT00651664|520885989|FG002|Overall Study|Progressive Disease|3|||
144461423|NCT00651664|520885990|FG003|Overall Study|Progressive Disease|12|||
144461424|NCT00651664|520885991|FG004|Overall Study|Progressive Disease|4|||
144461425|NCT00651664|520885992|FG005|Overall Study|Progressive Disease|1|||
144461426|NCT00651664|520885993|FG006|Overall Study|Progressive Disease|3|||
144461427|NCT00651664|520885994|FG007|Overall Study|Progressive Disease|6|||
144461428|NCT00651664|520885995|FG008|Overall Study|Progressive Disease|5|||
144461429|NCT00651664|520885996|FG009|Overall Study|Progressive Disease|5|||
144461430|NCT00651664|520885987|FG000|Overall Study|Patient Declined Further Treatment|0|||
144461431|NCT00651664|520885988|FG001|Overall Study|Patient Declined Further Treatment|0|||
144461432|NCT00651664|520885989|FG002|Overall Study|Patient Declined Further Treatment|0|||
144461433|NCT00651664|520885990|FG003|Overall Study|Patient Declined Further Treatment|1|||
144461434|NCT00651664|520885991|FG004|Overall Study|Patient Declined Further Treatment|1|||
144461435|NCT00651664|520885992|FG005|Overall Study|Patient Declined Further Treatment|1|||
144461436|NCT00651664|520885993|FG006|Overall Study|Patient Declined Further Treatment|0|||
144461437|NCT00651664|520885994|FG007|Overall Study|Patient Declined Further Treatment|0|||
144461438|NCT00651664|520885995|FG008|Overall Study|Patient Declined Further Treatment|0|||
144461439|NCT00651664|520885996|FG009|Overall Study|Patient Declined Further Treatment|1|||
144461440|NCT00651664|520885987|FG000|Overall Study|Symptomatic Deterioration|0|||
144461441|NCT00651664|520885988|FG001|Overall Study|Symptomatic Deterioration|0|||
144461442|NCT00651664|520885989|FG002|Overall Study|Symptomatic Deterioration|0|||
144461443|NCT00651664|520885990|FG003|Overall Study|Symptomatic Deterioration|1|||
144461444|NCT00651664|520885991|FG004|Overall Study|Symptomatic Deterioration|0|||
144461445|NCT00651664|520885992|FG005|Overall Study|Symptomatic Deterioration|0|||
144461446|NCT00651664|520885993|FG006|Overall Study|Symptomatic Deterioration|1|||
144461447|NCT00651664|520885994|FG007|Overall Study|Symptomatic Deterioration|0|||
144461448|NCT00651664|520885995|FG008|Overall Study|Symptomatic Deterioration|1|||
144461449|NCT00651664|520885996|FG009|Overall Study|Symptomatic Deterioration|0|||
144461450|NCT00651664|520885987|FG000|Overall Study|Reason not Specified|0|||
144461451|NCT00651664|520885988|FG001|Overall Study|Reason not Specified|0|||
144461452|NCT00651664|520885989|FG002|Overall Study|Reason not Specified|0|||
144461453|NCT00651664|520885990|FG003|Overall Study|Reason not Specified|0|||
144461454|NCT00651664|520885991|FG004|Overall Study|Reason not Specified|0|||
144461455|NCT00651664|520885992|FG005|Overall Study|Reason not Specified|0|||
144461456|NCT00651664|520885993|FG006|Overall Study|Reason not Specified|1|||
144461457|NCT00651664|520885994|FG007|Overall Study|Reason not Specified|0|||
144461458|NCT00651664|520885995|FG008|Overall Study|Reason not Specified|0|||
144461459|NCT00651664|520885996|FG009|Overall Study|Reason not Specified|0|||
144461460|NCT00688636|520885997|FG000|Overall Study|Adverse Event|2|||
144461461|NCT00688636|520885998|FG001|Overall Study|Adverse Event|1|||
144461462|NCT01572727|520885999|FG000|Overall Study|Adverse Event|43|||
144461463|NCT01572727|520886000|FG001|Overall Study|Adverse Event|15|||
144461464|NCT01572727|520885999|FG000|Overall Study|Lost to Follow-up|1|||
144461465|NCT01572727|520886000|FG001|Overall Study|Lost to Follow-up|1|||
144461466|NCT01572727|520885999|FG000|Overall Study|Physician Decision|23|||
144461467|NCT01572727|520886000|FG001|Overall Study|Physician Decision|9|||
144461468|NCT01572727|520885999|FG000|Overall Study|Progressive disease|59|||
144461469|NCT01572727|520886000|FG001|Overall Study|Progressive disease|82|||
144461470|NCT01572727|520885999|FG000|Overall Study|Protocol Violation|0|||
144461471|NCT01572727|520886000|FG001|Overall Study|Protocol Violation|1|||
144461472|NCT01572727|520885999|FG000|Overall Study|Study terminated by sponsor|61|||
144461473|NCT01572727|520886000|FG001|Overall Study|Study terminated by sponsor|83|||
144461474|NCT01572727|520885999|FG000|Overall Study|Parent/guardian decision|14|||
144461475|NCT01572727|520886000|FG001|Overall Study|Parent/guardian decision|9|||
144461476|NCT01572727|520885999|FG000|Overall Study|Death|2|||
144461477|NCT01572727|520886000|FG001|Overall Study|Death|2|||
144461478|NCT01572727|520885999|FG000|Overall Study|Untreated|4|||
144461479|NCT01572727|520886000|FG001|Overall Study|Untreated|7|||
144461480|NCT04053764|520886001|FG000|Overall Study|Withdrawal by Subject|6|||
144461481|NCT04053764|520886002|FG001|Overall Study|Withdrawal by Subject|2|||
144461482|NCT04053764|520886001|FG000|Overall Study|Physician Decision|2|||
144461483|NCT04053764|520886002|FG001|Overall Study|Physician Decision|1|||
144461484|NCT04053764|520886001|FG000|Overall Study|Adverse Event|1|||
144461485|NCT04053764|520886002|FG001|Overall Study|Adverse Event|0|||
144461486|NCT04053764|520886001|FG000|Overall Study|Pregnancy|1|||
144461487|NCT04053764|520886002|FG001|Overall Study|Pregnancy|0|||
144535255|NCT02720068|521164007|FG008|Overall Study|Withdrawal by Subject|0|||
144535256|NCT02720068|521164008|FG009|Overall Study|Withdrawal by Subject|1|||
144535257|NCT02720068|521164009|FG010|Overall Study|Withdrawal by Subject|0|||
144535258|NCT02720068|521164010|FG011|Overall Study|Withdrawal by Subject|27|||
144461488|NCT04732286|520886003|FG000|Overall Study|Progressive Disease|2|||
144461489|NCT04732286|520886003|FG000|Overall Study|Physician Decision|1|||
144461490|NCT04732286|520886003|FG000|Overall Study|Study Terminated by Sponsor|31|||
144535259|NCT02720068|521164011|FG012|Overall Study|Withdrawal by Subject|2|||
144535260|NCT02720068|521164012|FG013|Overall Study|Withdrawal by Subject|8|||
144535261|NCT02720068|521164013|FG014|Overall Study|Withdrawal by Subject|7|||
144535262|NCT02720068|521164014|FG015|Overall Study|Withdrawal by Subject|0|||
144535263|NCT02720068|521164015|FG016|Overall Study|Withdrawal by Subject|0|||
144535264|NCT02720068|521164016|FG017|Overall Study|Withdrawal by Subject|2|||
144461491|NCT04732286|520886003|FG000|Overall Study|Withdrawal by Subject|10|||
144461492|NCT04732286|520886003|FG000|Overall Study|Non-compliance With Study Drug|1|||
144461493|NCT04732286|520886003|FG000|Overall Study|Lost to Follow-up|4|||
144461494|NCT04732286|520886003|FG000|Overall Study|Death|51|||
144461495|NCT01474681|520886004|FG000|Overall Study|Death|0|||
144461496|NCT01474681|520886005|FG001|Overall Study|Death|3|||
144535265|NCT02720068|521163999|FG000|Overall Study|Protocol Violation|0|||
144535266|NCT02720068|521164000|FG001|Overall Study|Protocol Violation|0|||
144461497|NCT01474681|520886006|FG002|Overall Study|Death|2|||
144461498|NCT01474681|520886007|FG003|Overall Study|Death|6|||
144461499|NCT02195986|520886010|FG000|Overall Study|Adverse Event|3|||
144461500|NCT02195986|520886011|FG001|Overall Study|Adverse Event|0|||
144461501|NCT02195986|520886012|FG002|Overall Study|Adverse Event|0|||
144461502|NCT02195986|520886010|FG000|Overall Study|Withdrawal by Subject|0|||
144461503|NCT02195986|520886011|FG001|Overall Study|Withdrawal by Subject|3|||
144461504|NCT02195986|520886012|FG002|Overall Study|Withdrawal by Subject|0|||
144461505|NCT02195986|520886010|FG000|Overall Study|Family Emergency|0|||
144461506|NCT02195986|520886011|FG001|Overall Study|Family Emergency|0|||
144461507|NCT02195986|520886012|FG002|Overall Study|Family Emergency|1|||
144461508|NCT02195986|520886010|FG000|Overall Study|Protocol Violation|0|||
144461509|NCT02195986|520886011|FG001|Overall Study|Protocol Violation|1|||
144461510|NCT02195986|520886012|FG002|Overall Study|Protocol Violation|1|||
144461511|NCT02195986|520886010|FG000|Overall Study|Non-compliance|0|||
144461512|NCT02195986|520886011|FG001|Overall Study|Non-compliance|1|||
144461513|NCT02195986|520886012|FG002|Overall Study|Non-compliance|0|||
144461514|NCT00319098|520886015|FG000|Overall Study|Serious adverse event|3|||
144461515|NCT00319098|520886016|FG001|Overall Study|Serious adverse event|0|||
144461516|NCT00319098|520886015|FG000|Overall Study|Adverse Event|20|||
144461517|NCT00319098|520886016|FG001|Overall Study|Adverse Event|1|||
144461518|NCT00319098|520886015|FG000|Overall Study|Withdrawal by Subject|37|||
144461519|NCT00319098|520886016|FG001|Overall Study|Withdrawal by Subject|8|||
144461520|NCT00319098|520886015|FG000|Overall Study|Migrated/moved from study area|2|||
144461521|NCT00319098|520886016|FG001|Overall Study|Migrated/moved from study area|1|||
144461522|NCT00319098|520886015|FG000|Overall Study|Lost to Follow-up|37|||
144461523|NCT00319098|520886016|FG001|Overall Study|Lost to Follow-up|13|||
144461524|NCT00319098|520886015|FG000|Overall Study|Others|33|||
144461525|NCT00319098|520886016|FG001|Overall Study|Others|8|||
144461526|NCT00319098|520886015|FG000|Overall Study|Protocol Violation|3|||
144461527|NCT00319098|520886016|FG001|Overall Study|Protocol Violation|1|||
144461528|NCT02834780|520886017|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
144461529|NCT02834780|520886018|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
144461530|NCT02834780|520886019|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
144461531|NCT02834780|520886020|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
144461532|NCT02834780|520886021|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
144461533|NCT02834780|520886022|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
144461534|NCT02834780|520886023|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
144461535|NCT02834780|520886024|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
144461536|NCT02834780|520886025|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
144461537|NCT02834780|520886026|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
144461538|NCT02834780|520886027|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
144461539|NCT02834780|520886028|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
144461540|NCT02834780|520886029|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
144461541|NCT02834780|520886017|FG000|Overall Study|Withdrawal by Subject|0|||
144461542|NCT02834780|520886018|FG001|Overall Study|Withdrawal by Subject|0|||
144461543|NCT02834780|520886019|FG002|Overall Study|Withdrawal by Subject|1|||
144461544|NCT02834780|520886020|FG003|Overall Study|Withdrawal by Subject|0|||
144461545|NCT02834780|520886021|FG004|Overall Study|Withdrawal by Subject|0|||
144461546|NCT02834780|520886022|FG005|Overall Study|Withdrawal by Subject|0|||
144461547|NCT02834780|520886023|FG006|Overall Study|Withdrawal by Subject|0|||
144461548|NCT02834780|520886024|FG007|Overall Study|Withdrawal by Subject|0|||
144461549|NCT02834780|520886025|FG008|Overall Study|Withdrawal by Subject|0|||
144461550|NCT02834780|520886026|FG009|Overall Study|Withdrawal by Subject|0|||
144461551|NCT02834780|520886027|FG010|Overall Study|Withdrawal by Subject|1|||
144461552|NCT02834780|520886028|FG011|Overall Study|Withdrawal by Subject|0|||
144461553|NCT02834780|520886029|FG012|Overall Study|Withdrawal by Subject|0|||
144461554|NCT02834780|520886017|FG000|Overall Study|Adverse Event|0|||
144461555|NCT02834780|520886018|FG001|Overall Study|Adverse Event|0|||
144461556|NCT02834780|520886019|FG002|Overall Study|Adverse Event|0|||
144461557|NCT02834780|520886020|FG003|Overall Study|Adverse Event|0|||
144461558|NCT02834780|520886021|FG004|Overall Study|Adverse Event|1|||
144461559|NCT02834780|520886022|FG005|Overall Study|Adverse Event|0|||
144461560|NCT02834780|520886023|FG006|Overall Study|Adverse Event|1|||
144461561|NCT02834780|520886024|FG007|Overall Study|Adverse Event|1|||
144461562|NCT02834780|520886025|FG008|Overall Study|Adverse Event|0|||
144461563|NCT02834780|520886026|FG009|Overall Study|Adverse Event|2|||
144461564|NCT02834780|520886027|FG010|Overall Study|Adverse Event|0|||
144461565|NCT02834780|520886028|FG011|Overall Study|Adverse Event|3|||
144461566|NCT02834780|520886029|FG012|Overall Study|Adverse Event|2|||
144461567|NCT02834780|520886017|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
144461568|NCT02834780|520886018|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
144461569|NCT02834780|520886019|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
144535267|NCT02720068|521164001|FG002|Overall Study|Protocol Violation|0|||
144535268|NCT02720068|521164002|FG003|Overall Study|Protocol Violation|0|||
144535269|NCT02720068|521164003|FG004|Overall Study|Protocol Violation|0|||
144461570|NCT02834780|520886020|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
144461571|NCT02834780|520886021|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
144461572|NCT02834780|520886022|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
144535270|NCT02720068|521164004|FG005|Overall Study|Protocol Violation|0|||
144535271|NCT02720068|521164005|FG006|Overall Study|Protocol Violation|0|||
144535272|NCT02720068|521164006|FG007|Overall Study|Protocol Violation|0|||
144535273|NCT02720068|521164007|FG008|Overall Study|Protocol Violation|0|||
144535274|NCT02720068|521164008|FG009|Overall Study|Protocol Violation|0|||
144535275|NCT02720068|521164009|FG010|Overall Study|Protocol Violation|1|||
144535276|NCT02720068|521164010|FG011|Overall Study|Protocol Violation|0|||
144535277|NCT02720068|521164011|FG012|Overall Study|Protocol Violation|0|||
144461573|NCT02834780|520886023|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
144461574|NCT02834780|520886024|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
144461575|NCT02834780|520886025|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
144461576|NCT02834780|520886026|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
144461577|NCT02834780|520886027|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
144461578|NCT02834780|520886028|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
144461579|NCT02834780|520886029|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
144461580|NCT02834780|520886017|FG000|Overall Study|Other|1|||
144461581|NCT02834780|520886018|FG001|Overall Study|Other|0|||
144461582|NCT02834780|520886019|FG002|Overall Study|Other|1|||
144461583|NCT02834780|520886020|FG003|Overall Study|Other|2|||
144535278|NCT02720068|521164012|FG013|Overall Study|Protocol Violation|0|||
144461584|NCT02834780|520886021|FG004|Overall Study|Other|0|||
144461585|NCT02834780|520886022|FG005|Overall Study|Other|0|||
144461586|NCT02834780|520886023|FG006|Overall Study|Other|0|||
144461587|NCT02834780|520886024|FG007|Overall Study|Other|0|||
144461588|NCT02834780|520886025|FG008|Overall Study|Other|0|||
144461589|NCT02834780|520886026|FG009|Overall Study|Other|0|||
144461590|NCT02834780|520886027|FG010|Overall Study|Other|0|||
144461591|NCT02834780|520886028|FG011|Overall Study|Other|0|||
144461592|NCT02834780|520886029|FG012|Overall Study|Other|1|||
144461593|NCT03150056|520886030|FG000|Overall Study|Withdrawal by Subject|0|||
144461594|NCT03150056|520886031|FG001|Overall Study|Withdrawal by Subject|0|||
144461595|NCT03150056|520886032|FG002|Overall Study|Withdrawal by Subject|0|||
144461596|NCT03150056|520886033|FG003|Overall Study|Withdrawal by Subject|0|||
144535279|NCT02720068|521164013|FG014|Overall Study|Protocol Violation|1|||
144535280|NCT02720068|521164014|FG015|Overall Study|Protocol Violation|0|||
144535281|NCT02720068|521164015|FG016|Overall Study|Protocol Violation|1|||
144535282|NCT02720068|521164016|FG017|Overall Study|Protocol Violation|0|||
144535283|NCT02467270|521164029|FG000|Overall Study|Participants Never Treated|0|||
144535284|NCT02467270|521164030|FG001|Overall Study|Participants Never Treated|1|||
144535285|NCT02467270|521164031|FG002|Overall Study|Participants Never Treated|0|||
144535286|NCT02467270|521164029|FG000|Overall Study|Ongoing|50|||
144535287|NCT02467270|521164030|FG001|Overall Study|Ongoing|41|||
144725949|NCT03331042|521852649|FG001|Overall Study|Lost to Follow-up|0|||
144725950|NCT03331042|521852650|FG002|Overall Study|Lost to Follow-up|0|||
144725951|NCT03331042|521852651|FG003|Overall Study|Lost to Follow-up|1|||
144197038|NCT00361335|519918662|FG002|SC Period: Week E0 to Week E24|Death|0|||
144197039|NCT00361335|519918663|FG003|SC Period: Week E0 to Week E24|Death|0|||
144461597|NCT03150056|520886034|FG004|Overall Study|Withdrawal by Subject|0|||
144461598|NCT03150056|520886035|FG005|Overall Study|Withdrawal by Subject|2|||
144461599|NCT03150056|520886030|FG000|Overall Study|Study terminated by Sponsor|1|||
144461600|NCT03150056|520886031|FG001|Overall Study|Study terminated by Sponsor|3|||
144461601|NCT03150056|520886032|FG002|Overall Study|Study terminated by Sponsor|1|||
144461602|NCT03150056|520886033|FG003|Overall Study|Study terminated by Sponsor|1|||
144461603|NCT03150056|520886034|FG004|Overall Study|Study terminated by Sponsor|5|||
144461604|NCT03150056|520886035|FG005|Overall Study|Study terminated by Sponsor|6|||
144461605|NCT03150056|520886030|FG000|Overall Study|Death|9|||
144461606|NCT03150056|520886031|FG001|Overall Study|Death|2|||
144461607|NCT03150056|520886032|FG002|Overall Study|Death|2|||
144535288|NCT02467270|521164031|FG002|Overall Study|Ongoing|43|||
144197040|NCT00361335|519918664|FG004|SC Period: Week E0 to Week E24|Death|0|||
144197041|NCT00361335|519918665|FG005|SC Period: Week E0 to Week E24|Death|0|||
144461608|NCT03150056|520886033|FG003|Overall Study|Death|7|||
144535289|NCT02467270|521164029|FG000|Overall Study|Adverse Event|16|||
144535290|NCT02467270|521164030|FG001|Overall Study|Adverse Event|15|||
144535291|NCT02467270|521164031|FG002|Overall Study|Adverse Event|14|||
144535292|NCT02467270|521164029|FG000|Overall Study|Progressive Disease|7|||
144725952|NCT00322491|521852652|FG000|Overall Study|Adverse Event|1|||
144725953|NCT00322491|521852653|FG001|Overall Study|Adverse Event|0|||
144461609|NCT03150056|520886034|FG004|Overall Study|Death|8|||
144461610|NCT03150056|520886035|FG005|Overall Study|Death|10|||
144461611|NCT02270450|520886038|FG000|Overall Study|Refusal unrelated to adverse event|3|||
144461612|NCT02270450|520886039|FG001|Overall Study|Refusal unrelated to adverse event|1|||
144461613|NCT02270450|520886040|FG002|Overall Study|Refusal unrelated to adverse event|5|||
144461614|NCT02270450|520886041|FG003|Overall Study|Refusal unrelated to adverse event|14|||
144461615|NCT02270450|520886038|FG000|Overall Study|Progression/relapse|1|||
144461616|NCT02270450|520886039|FG001|Overall Study|Progression/relapse|2|||
144461617|NCT02270450|520886040|FG002|Overall Study|Progression/relapse|4|||
144461618|NCT02270450|520886041|FG003|Overall Study|Progression/relapse|9|||
144535293|NCT02467270|521164030|FG001|Overall Study|Progressive Disease|7|||
144461619|NCT02270450|520886038|FG000|Overall Study|Death|19|||
144461620|NCT02270450|520886039|FG001|Overall Study|Death|19|||
144461621|NCT02270450|520886040|FG002|Overall Study|Death|31|||
144461622|NCT02270450|520886041|FG003|Overall Study|Death|59|||
144461623|NCT02363738|520886043|FG000|Overall Study|Adverse Event|5|||
144461624|NCT02363738|520886044|FG001|Overall Study|Adverse Event|2|||
144461625|NCT02363738|520886043|FG000|Overall Study|Lack of Efficacy|1|||
144461626|NCT02363738|520886044|FG001|Overall Study|Lack of Efficacy|2|||
144461627|NCT02363738|520886043|FG000|Overall Study|Lost to Follow-up|2|||
144461628|NCT02363738|520886044|FG001|Overall Study|Lost to Follow-up|1|||
144461629|NCT02187991|520886048|FG000|Overall Study|Adverse Event|13|||
144461630|NCT02187991|520886049|FG001|Overall Study|Adverse Event|14|||
144461631|NCT02187991|520886050|FG002|Overall Study|Adverse Event|3|||
144461632|NCT02187991|520886051|FG003|Overall Study|Adverse Event|2|||
144461633|NCT02187991|520886048|FG000|Overall Study|Withdrawal by Subject|9|||
144461634|NCT02187991|520886049|FG001|Overall Study|Withdrawal by Subject|6|||
144461635|NCT02187991|520886050|FG002|Overall Study|Withdrawal by Subject|3|||
144461636|NCT02187991|520886051|FG003|Overall Study|Withdrawal by Subject|2|||
144461637|NCT02187991|520886048|FG000|Overall Study|Physician Decision|4|||
144461638|NCT02187991|520886049|FG001|Overall Study|Physician Decision|4|||
144461639|NCT02187991|520886050|FG002|Overall Study|Physician Decision|0|||
144461640|NCT02187991|520886051|FG003|Overall Study|Physician Decision|2|||
144461641|NCT02187991|520886048|FG000|Overall Study|Other, unrelated complication|7|||
144461642|NCT02187991|520886049|FG001|Overall Study|Other, unrelated complication|1|||
144461643|NCT02187991|520886050|FG002|Overall Study|Other, unrelated complication|1|||
144461644|NCT02187991|520886051|FG003|Overall Study|Other, unrelated complication|2|||
144461645|NCT02187991|520886048|FG000|Overall Study|Death|1|||
144461646|NCT02187991|520886049|FG001|Overall Study|Death|3|||
144461647|NCT02187991|520886050|FG002|Overall Study|Death|0|||
144461648|NCT02187991|520886051|FG003|Overall Study|Death|0|||
144461649|NCT01392560|520886052|FG000|Overall Study|Adverse Event|2|||
144461650|NCT01392560|520886052|FG000|Overall Study|not entered|8|||
144461651|NCT01392560|520886052|FG000|Overall Study|discontinued during placebo run-in|2|||
144461652|NCT01939028|520886055|FG000|Overall Study|Withdrawal by Subject|5|||
144461653|NCT01939028|520886055|FG000|Overall Study|Physician Decision|7|||
144461654|NCT00322348|520886056|FG000|Overall Study|Adverse Event|0|||
144461655|NCT00322348|520886057|FG001|Overall Study|Adverse Event|1|||
144461656|NCT00322348|520886056|FG000|Overall Study|Withdrawal by Subject|1|||
144461657|NCT00322348|520886057|FG001|Overall Study|Withdrawal by Subject|4|||
144255501|NCT02588092|520136206|FG004|Overall Study|Started Another Treatment|1|||
144255502|NCT02588092|520136207|FG005|Overall Study|Started Another Treatment|0|||
144255503|NCT02588092|520136208|FG006|Overall Study|Started Another Treatment|0|||
144255504|NCT02588092|520136209|FG007|Overall Study|Started Another Treatment|1|||
144255505|NCT02588092|520136210|FG008|Overall Study|Started Another Treatment|0|||
144255506|NCT02588092|520136211|FG009|Overall Study|Started Another Treatment|0|||
144255507|NCT02588092|520136202|FG000|Overall Study|Sponsor Decision|0|||
144255508|NCT02588092|520136203|FG001|Overall Study|Sponsor Decision|0|||
144255509|NCT02588092|520136204|FG002|Overall Study|Sponsor Decision|0|||
144255510|NCT02588092|520136205|FG003|Overall Study|Sponsor Decision|0|||
144255511|NCT02588092|520136206|FG004|Overall Study|Sponsor Decision|0|||
144255512|NCT02588092|520136207|FG005|Overall Study|Sponsor Decision|0|||
144255513|NCT02588092|520136208|FG006|Overall Study|Sponsor Decision|0|||
144255514|NCT02588092|520136209|FG007|Overall Study|Sponsor Decision|0|||
144255515|NCT02588092|520136210|FG008|Overall Study|Sponsor Decision|1|||
144255516|NCT02588092|520136211|FG009|Overall Study|Sponsor Decision|1|||
144255517|NCT01348100|520136212|FG000|Overall Study|Subject Withdrew Consent|0|||
144255518|NCT01348100|520136213|FG001|Overall Study|Subject Withdrew Consent|0|||
144255519|NCT01348100|520136214|FG002|Overall Study|Subject Withdrew Consent|2|||
144255520|NCT01348100|520136215|FG003|Overall Study|Subject Withdrew Consent|0|||
144255521|NCT01348100|520136216|FG004|Overall Study|Subject Withdrew Consent|1|||
144255522|NCT01348100|520136217|FG005|Overall Study|Subject Withdrew Consent|0|||
144255523|NCT01348100|520136218|FG006|Overall Study|Subject Withdrew Consent|1|||
144255524|NCT01348100|520136212|FG000|Overall Study|Protocol Deviation|0|||
144255525|NCT01348100|520136213|FG001|Overall Study|Protocol Deviation|0|||
144255526|NCT01348100|520136214|FG002|Overall Study|Protocol Deviation|0|||
144255527|NCT01348100|520136215|FG003|Overall Study|Protocol Deviation|1|||
144255528|NCT01348100|520136216|FG004|Overall Study|Protocol Deviation|0|||
144255529|NCT01348100|520136217|FG005|Overall Study|Protocol Deviation|0|||
144461658|NCT00322348|520886056|FG000|Overall Study|Lost to Follow-up|1|||
144461659|NCT00322348|520886057|FG001|Overall Study|Lost to Follow-up|0|||
144461660|NCT00322348|520886056|FG000|Overall Study|Death|0|||
144461661|NCT00322348|520886057|FG001|Overall Study|Death|2|||
144461662|NCT00322348|520886056|FG000|Overall Study|Disease Progression|30|||
144461663|NCT00322348|520886057|FG001|Overall Study|Disease Progression|25|||
144461664|NCT00322348|520886056|FG000|Overall Study|Reasons not specified|5|||
144461665|NCT00322348|520886057|FG001|Overall Study|Reasons not specified|1|||
144461666|NCT00936858|520886058|FG000|Overall Study|Death|3|||
144461667|NCT00936858|520886058|FG000|Overall Study|Progression|29|||
144461668|NCT00936858|520886058|FG000|Overall Study|Withdrawal by Subject|5|||
144461669|NCT00936858|520886058|FG000|Overall Study|Adverse Event|1|||
144255530|NCT01348100|520136218|FG006|Overall Study|Protocol Deviation|0|||
144255531|NCT01348100|520136212|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144255532|NCT01348100|520136213|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144255533|NCT01348100|520136214|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144255534|NCT01348100|520136215|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144255535|NCT01348100|520136216|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144255536|NCT01348100|520136217|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
144255537|NCT01348100|520136218|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144255538|NCT01348100|520136212|FG000|Overall Study|Lost to Follow-up|0|||
144255539|NCT01348100|520136213|FG001|Overall Study|Lost to Follow-up|0|||
144255540|NCT01348100|520136214|FG002|Overall Study|Lost to Follow-up|0|||
144255541|NCT01348100|520136215|FG003|Overall Study|Lost to Follow-up|0|||
144255542|NCT01348100|520136216|FG004|Overall Study|Lost to Follow-up|0|||
144255543|NCT01348100|520136217|FG005|Overall Study|Lost to Follow-up|0|||
144255544|NCT01348100|520136218|FG006|Overall Study|Lost to Follow-up|1|||
144255545|NCT01348100|520136212|FG000|Overall Study|Administrative Problems|0|||
144255546|NCT01348100|520136213|FG001|Overall Study|Administrative Problems|0|||
144255547|NCT01348100|520136214|FG002|Overall Study|Administrative Problems|0|||
144255548|NCT01348100|520136215|FG003|Overall Study|Administrative Problems|0|||
144255549|NCT01348100|520136216|FG004|Overall Study|Administrative Problems|0|||
144255550|NCT01348100|520136217|FG005|Overall Study|Administrative Problems|1|||
144255551|NCT01348100|520136218|FG006|Overall Study|Administrative Problems|1|||
144255552|NCT03853291|520136219|FG000|Overall Study|Lost to Follow-up|1|||
144255553|NCT03853291|520136220|FG001|Overall Study|Lost to Follow-up|2|||
144255554|NCT03853291|520136221|FG002|Overall Study|Lost to Follow-up|0|||
144255555|NCT03853291|520136222|FG003|Overall Study|Lost to Follow-up|0|||
144255556|NCT03853291|520136223|FG004|Overall Study|Lost to Follow-up|0|||
144255557|NCT03853291|520136224|FG005|Overall Study|Lost to Follow-up|0|||
144255558|NCT03853291|520136219|FG000|Overall Study|Determined to be ineligible|1|||
144255559|NCT03853291|520136220|FG001|Overall Study|Determined to be ineligible|1|||
144255560|NCT03853291|520136221|FG002|Overall Study|Determined to be ineligible|0|||
144255561|NCT03853291|520136222|FG003|Overall Study|Determined to be ineligible|0|||
144255562|NCT03853291|520136223|FG004|Overall Study|Determined to be ineligible|0|||
144255563|NCT03853291|520136224|FG005|Overall Study|Determined to be ineligible|0|||
144255564|NCT03883477|520136225|FG000|Overall Study|Death|1|||
144255565|NCT03883477|520136226|FG001|Overall Study|Death|0|||
144255566|NCT03883477|520136225|FG000|Overall Study|Protocol Violation|0|||
144255567|NCT03883477|520136226|FG001|Overall Study|Protocol Violation|1|||
144255568|NCT03762681|520136235|FG000|Part 1|Withdrawal by Subject|0|||
144255569|NCT03762681|520136236|FG001|Part 1|Withdrawal by Subject|0|||
144255570|NCT03762681|520136237|FG002|Part 1|Withdrawal by Subject|0|||
144255571|NCT03762681|520136238|FG003|Part 1|Withdrawal by Subject|1|||
144255572|NCT03762681|520136239|FG004|Part 1|Withdrawal by Subject|0|||
144255573|NCT03762681|520136240|FG005|Part 1|Withdrawal by Subject|0|||
144255574|NCT03762681|520136241|FG006|Part 1|Withdrawal by Subject|0|||
144255575|NCT03762681|520136242|FG007|Part 1|Withdrawal by Subject|0|||
144255576|NCT03762681|520136235|FG000|Part 2a|Pandemic Travel Restrictions|0|||
144255577|NCT03762681|520136236|FG001|Part 2a|Pandemic Travel Restrictions|0|||
144255578|NCT03762681|520136237|FG002|Part 2a|Pandemic Travel Restrictions|0|||
144255579|NCT03762681|520136238|FG003|Part 2a|Pandemic Travel Restrictions|0|||
144255580|NCT03762681|520136239|FG004|Part 2a|Pandemic Travel Restrictions|0|||
144255581|NCT03762681|520136240|FG005|Part 2a|Pandemic Travel Restrictions|0|||
144255582|NCT03762681|520136241|FG006|Part 2a|Pandemic Travel Restrictions|0|||
144255583|NCT03762681|520136242|FG007|Part 2a|Pandemic Travel Restrictions|1|||
144255584|NCT03162328|520136243|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
144255585|NCT03162328|520136244|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
144255586|NCT03162328|520136245|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
144255587|NCT03162328|520136243|FG000|Screening Period|Withdrawal by Subject|1|||
144255588|NCT03162328|520136244|FG001|Screening Period|Withdrawal by Subject|0|||
144255589|NCT03162328|520136245|FG002|Screening Period|Withdrawal by Subject|0|||
144255590|NCT03162328|520136243|FG000|Study Period|Withdrawal by Subject|0|||
144255591|NCT03162328|520136244|FG001|Study Period|Withdrawal by Subject|0|||
144255592|NCT03162328|520136245|FG002|Study Period|Withdrawal by Subject|1|||
144255593|NCT03301831|520136246|FG000|Overall Study|Lost to Follow-up|5|||
144255594|NCT03301831|520136247|FG001|Overall Study|Lost to Follow-up|3|||
144255595|NCT03301831|520136246|FG000|Overall Study|Protocol Violation|4|||
144255596|NCT03301831|520136247|FG001|Overall Study|Protocol Violation|0|||
144255597|NCT03301831|520136246|FG000|Overall Study|Withdrawal by Subject|11|||
144255598|NCT03301831|520136247|FG001|Overall Study|Withdrawal by Subject|0|||
144255599|NCT00913770|520136252|FG000|Overall Study|Unable to contact|24|||
144255600|NCT00913770|520136253|FG001|Overall Study|Unable to contact|19|||
144255601|NCT00913770|520136254|FG002|Overall Study|Unable to contact|13|||
144255602|NCT00913770|520136252|FG000|Overall Study|Refused|11|||
144255603|NCT00913770|520136253|FG001|Overall Study|Refused|10|||
144255604|NCT00913770|520136254|FG002|Overall Study|Refused|8|||
144255605|NCT03337048|520136255|FG000|Overall Study|Withdrawal by Subject|2|||
144255606|NCT03337048|520136256|FG001|Overall Study|Withdrawal by Subject|0|||
144259304|NCT01089127|520150359|FG005|Overall Study|Protocol deviation|0|||
144255607|NCT03337048|520136257|FG002|Overall Study|Withdrawal by Subject|0|||
144255608|NCT02348008|520136258|FG000|Overall Study|Adverse Event|2|||
144255609|NCT02348008|520136259|FG001|Overall Study|Adverse Event|3|||
144255610|NCT02348008|520136260|FG002|Overall Study|Adverse Event|3|||
144255611|NCT02348008|520136258|FG000|Overall Study|Disease Progression|1|||
144255612|NCT02348008|520136259|FG001|Overall Study|Disease Progression|5|||
144255613|NCT02348008|520136260|FG002|Overall Study|Disease Progression|16|||
144255614|NCT02348008|520136258|FG000|Overall Study|Withdrawal by Subject|0|||
144255615|NCT02348008|520136259|FG001|Overall Study|Withdrawal by Subject|1|||
144255616|NCT02348008|520136260|FG002|Overall Study|Withdrawal by Subject|0|||
144255617|NCT02348008|520136258|FG000|Overall Study|Symptomatic Deterioration|0|||
144255618|NCT02348008|520136259|FG001|Overall Study|Symptomatic Deterioration|1|||
144255619|NCT02348008|520136260|FG002|Overall Study|Symptomatic Deterioration|0|||
144255620|NCT01416155|520136261|FG000|Overall Study|Adverse Event|8|||
144255621|NCT01416155|520136261|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
144255622|NCT01416155|520136261|FG000|Overall Study|Withdrawal by Subject|33|||
144255623|NCT01416155|520136261|FG000|Overall Study|Investigator decision|8|||
144255624|NCT01416155|520136261|FG000|Overall Study|Other|7|||
144255625|NCT03597139|520136262|FG000|Overall Study|Adverse Event|3|||
144255626|NCT03597139|520136263|FG001|Overall Study|Adverse Event|0|||
144255627|NCT03597139|520136262|FG000|Overall Study|Protocol Non-compliance|1|||
144255628|NCT03597139|520136263|FG001|Overall Study|Protocol Non-compliance|0|||
144255629|NCT04811664|520136266|FG000|Overall Study|Lost to Follow-up|78|||
144255630|NCT04811664|520136267|FG001|Overall Study|Lost to Follow-up|125|||
144255631|NCT04811664|520136268|FG002|Overall Study|Lost to Follow-up|46|||
144255632|NCT04811664|520136266|FG000|Overall Study|Withdrawal by Subject|39|||
144255633|NCT04811664|520136267|FG001|Overall Study|Withdrawal by Subject|76|||
144255634|NCT04811664|520136268|FG002|Overall Study|Withdrawal by Subject|12|||
144255635|NCT04811664|520136266|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
144255636|NCT04811664|520136267|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
144255637|NCT04811664|520136268|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
144255638|NCT04811664|520136266|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
144255639|NCT04811664|520136267|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
144255640|NCT04811664|520136268|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
144255641|NCT04811664|520136266|FG000|Overall Study|Protocol Violation|0|||
144255642|NCT04811664|520136267|FG001|Overall Study|Protocol Violation|5|||
144255643|NCT04811664|520136268|FG002|Overall Study|Protocol Violation|11|||
144255644|NCT04811664|520136266|FG000|Overall Study|Study Terminated by Sponsor|4|||
144255645|NCT04811664|520136267|FG001|Overall Study|Study Terminated by Sponsor|3|||
144255646|NCT04811664|520136268|FG002|Overall Study|Study Terminated by Sponsor|34|||
144255647|NCT04811664|520136266|FG000|Overall Study|Early Study Closure|3|||
144255648|NCT04811664|520136267|FG001|Overall Study|Early Study Closure|7|||
144255649|NCT04811664|520136268|FG002|Overall Study|Early Study Closure|79|||
144255650|NCT04811664|520136266|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
144255651|NCT04811664|520136267|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
144255652|NCT04811664|520136268|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
144255653|NCT05052697|520136269|FG000|Substudy A|Lost to Follow-up|0|||
144255654|NCT05052697|520136270|FG001|Substudy A|Lost to Follow-up|0|||
144255655|NCT05052697|520136271|FG002|Substudy A|Lost to Follow-up|0|||
144255656|NCT05052697|520136272|FG003|Substudy A|Lost to Follow-up|0|||
144255657|NCT05052697|520136273|FG004|Substudy A|Lost to Follow-up|0|||
144255658|NCT05052697|520136274|FG005|Substudy A|Lost to Follow-up|1|||
144255659|NCT05052697|520136275|FG006|Substudy A|Lost to Follow-up|0|||
144255660|NCT05052697|520136276|FG007|Substudy A|Lost to Follow-up|0|||
144255661|NCT05052697|520136277|FG008|Substudy A|Lost to Follow-up|0|||
144255662|NCT05052697|520136278|FG009|Substudy A|Lost to Follow-up|0|||
144255663|NCT05052697|520136279|FG010|Substudy A|Lost to Follow-up|0|||
144255664|NCT05052697|520136280|FG011|Substudy A|Lost to Follow-up|0|||
144255665|NCT05052697|520136281|FG012|Substudy A|Lost to Follow-up|0|||
144255666|NCT05052697|520136282|FG013|Substudy A|Lost to Follow-up|0|||
144255667|NCT05052697|520136283|FG014|Substudy A|Lost to Follow-up|0|||
144255668|NCT05052697|520136284|FG015|Substudy A|Lost to Follow-up|2|||
144255669|NCT05052697|520136285|FG016|Substudy A|Lost to Follow-up|0|||
144255670|NCT05052697|520136286|FG017|Substudy A|Lost to Follow-up|0|||
144255671|NCT05052697|520136287|FG018|Substudy A|Lost to Follow-up|0|||
144255672|NCT05052697|520136288|FG019|Substudy A|Lost to Follow-up|0|||
144255673|NCT05052697|520136289|FG020|Substudy A|Lost to Follow-up|0|||
144255674|NCT05052697|520136290|FG021|Substudy A|Lost to Follow-up|0|||
144255675|NCT05052697|520136291|FG022|Substudy A|Lost to Follow-up|0|||
144255676|NCT05052697|520136292|FG023|Substudy A|Lost to Follow-up|0|||
144255677|NCT05052697|520136293|FG024|Substudy A|Lost to Follow-up|0|||
144255678|NCT05052697|520136294|FG025|Substudy A|Lost to Follow-up|0|||
144255679|NCT05052697|520136295|FG026|Substudy A|Lost to Follow-up|0|||
144255680|NCT05052697|520136296|FG027|Substudy A|Lost to Follow-up|0|||
144255681|NCT05052697|520136297|FG028|Substudy A|Lost to Follow-up|0|||
144255682|NCT05052697|520136298|FG029|Substudy A|Lost to Follow-up|0|||
144461670|NCT00936858|520886058|FG000|Overall Study|Physician Decision|7|||
144461671|NCT00936858|520886058|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
144461672|NCT00936858|520886058|FG000|Overall Study|Lost to Follow-up|1|||
144461673|NCT00989287|520886070|FG000|Overall Study|Adverse Event|1|||
144461674|NCT00989287|520886071|FG001|Overall Study|Adverse Event|0|||
144461675|NCT00989287|520886070|FG000|Overall Study|Lost to Follow-up|0|||
144461676|NCT00989287|520886071|FG001|Overall Study|Lost to Follow-up|1|||
144461677|NCT02341417|520886072|FG000|Overall Study|Withdrawal by Subject|0|||
144461678|NCT02341417|520886073|FG001|Overall Study|Withdrawal by Subject|2|||
144461679|NCT02341417|520886074|FG002|Overall Study|Withdrawal by Subject|0|||
144461680|NCT02341417|520886072|FG000|Overall Study|Decision by sponsor|2|||
144461681|NCT02341417|520886073|FG001|Overall Study|Decision by sponsor|0|||
144461682|NCT02341417|520886074|FG002|Overall Study|Decision by sponsor|0|||
144461683|NCT02341417|520886072|FG000|Overall Study|Death|0|||
144461684|NCT02341417|520886073|FG001|Overall Study|Death|0|||
144461685|NCT02341417|520886074|FG002|Overall Study|Death|1|||
144461686|NCT01857531|520886088|FG000|Overall Study|Withdrawal by Subject|4|||
144461687|NCT03570619|520886089|FG000|Overall Study|Adverse Event|2|||
144461688|NCT03570619|520886090|FG001|Overall Study|Adverse Event|0|||
144461689|NCT03570619|520886091|FG002|Overall Study|Adverse Event|1|||
144461690|NCT03570619|520886089|FG000|Overall Study|new diagnosis of new malignancy|1|||
144461691|NCT03570619|520886090|FG001|Overall Study|new diagnosis of new malignancy|0|||
144461692|NCT03570619|520886091|FG002|Overall Study|new diagnosis of new malignancy|0|||
144461693|NCT03570619|520886089|FG000|Overall Study|Physician Decision|1|||
144461694|NCT03570619|520886090|FG001|Overall Study|Physician Decision|1|||
144197042|NCT00361335|519918666|FG006|SC Period: Week E0 to Week E24|Death|1|||
144197043|NCT00361335|519918660|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
144255683|NCT05052697|520136299|FG030|Substudy A|Lost to Follow-up|0|||
144461695|NCT03570619|520886091|FG002|Overall Study|Physician Decision|0|||
144461696|NCT03570619|520886089|FG000|Overall Study|Withdrawal by Subject|0|||
144461697|NCT03570619|520886090|FG001|Overall Study|Withdrawal by Subject|2|||
144461698|NCT03570619|520886091|FG002|Overall Study|Withdrawal by Subject|0|||
144535294|NCT02467270|521164031|FG002|Overall Study|Progressive Disease|4|||
144535295|NCT02467270|521164029|FG000|Overall Study|Death|2|||
144535296|NCT02467270|521164030|FG001|Overall Study|Death|0|||
144535297|NCT02467270|521164031|FG002|Overall Study|Death|2|||
144535298|NCT02467270|521164029|FG000|Overall Study|Lack of Efficacy|12|||
144535299|NCT02467270|521164030|FG001|Overall Study|Lack of Efficacy|18|||
144535300|NCT02467270|521164031|FG002|Overall Study|Lack of Efficacy|23|||
144535301|NCT02467270|521164029|FG000|Overall Study|Non-compliance With Study Drug|0|||
144535302|NCT02467270|521164030|FG001|Overall Study|Non-compliance With Study Drug|2|||
144535303|NCT02467270|521164031|FG002|Overall Study|Non-compliance With Study Drug|1|||
144535304|NCT02467270|521164029|FG000|Overall Study|Lost to Follow-up|2|||
144535305|NCT02467270|521164030|FG001|Overall Study|Lost to Follow-up|1|||
144535306|NCT02467270|521164031|FG002|Overall Study|Lost to Follow-up|0|||
144535307|NCT02467270|521164029|FG000|Overall Study|Pregnancy|0|||
144535308|NCT02467270|521164030|FG001|Overall Study|Pregnancy|1|||
144535309|NCT02467270|521164031|FG002|Overall Study|Pregnancy|0|||
144535310|NCT02467270|521164029|FG000|Overall Study|Physician Decision|0|||
144535311|NCT02467270|521164030|FG001|Overall Study|Physician Decision|4|||
144535312|NCT02467270|521164031|FG002|Overall Study|Physician Decision|1|||
144535313|NCT02467270|521164029|FG000|Overall Study|Withdrawal by Subject|4|||
144535314|NCT02467270|521164030|FG001|Overall Study|Withdrawal by Subject|3|||
144535315|NCT02467270|521164031|FG002|Overall Study|Withdrawal by Subject|5|||
144535316|NCT02467270|521164029|FG000|Overall Study|Reason not Specified|1|||
144535317|NCT02467270|521164030|FG001|Overall Study|Reason not Specified|2|||
144535318|NCT02467270|521164031|FG002|Overall Study|Reason not Specified|1|||
144535319|NCT00739908|521164032|FG000|Overall Study|Adverse Event|5|||
144535320|NCT00739908|521164033|FG001|Overall Study|Adverse Event|6|||
144535321|NCT00739908|521164032|FG000|Overall Study|Withdrawal by Subject|4|||
144535322|NCT00739908|521164033|FG001|Overall Study|Withdrawal by Subject|2|||
144535323|NCT00739908|521164032|FG000|Overall Study|Lost to Follow-up|14|||
144535324|NCT00739908|521164033|FG001|Overall Study|Lost to Follow-up|9|||
144535325|NCT00739908|521164032|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
144535326|NCT00739908|521164033|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
144535327|NCT00739908|521164032|FG000|Overall Study|Non-Compliance With Study Medication|0|||
144535328|NCT00739908|521164033|FG001|Overall Study|Non-Compliance With Study Medication|3|||
144461699|NCT04773587|520886092|FG000|Overall Study|Lost to Follow-up|11|||
144461700|NCT04773587|520886093|FG001|Overall Study|Lost to Follow-up|3|||
144461701|NCT04773587|520886092|FG000|Overall Study|Adverse Event|6|||
144461702|NCT04773587|520886093|FG001|Overall Study|Adverse Event|3|||
144461703|NCT04773587|520886092|FG000|Overall Study|Lack of Efficacy|5|||
144535329|NCT00739908|521164032|FG000|Overall Study|Lack of Efficacy|0|||
144535330|NCT00739908|521164033|FG001|Overall Study|Lack of Efficacy|1|||
144535331|NCT00739908|521164032|FG000|Overall Study|Relocation|0|||
144535332|NCT00739908|521164033|FG001|Overall Study|Relocation|1|||
144535333|NCT01773993|521164038|FG000|Overall Study|No Visit After Treatment|35|||
144535334|NCT04993677|521164039|FG000|Overall Study|Lost to Follow-up|1|||
144461704|NCT04773587|520886093|FG001|Overall Study|Lack of Efficacy|2|||
144461705|NCT04773587|520886092|FG000|Overall Study|Withdrawal by Subject|4|||
144461706|NCT04773587|520886093|FG001|Overall Study|Withdrawal by Subject|5|||
144725954|NCT00322491|521852652|FG000|Overall Study|Death|1|||
144725955|NCT00322491|521852653|FG001|Overall Study|Death|2|||
144609595|NCT01843972|521431109|FG009|Overall Study|Withdrawal by Subject|0|||
144609596|NCT04702737|521431112|FG000|Overall Study|Decision by Sponsor|1|||
144609597|NCT04702737|521431112|FG000|Overall Study|Withdrawal of Consent from Study|3|||
144609598|NCT04702737|521431112|FG000|Overall Study|Lost to Follow-up|1|||
144609599|NCT04702737|521431112|FG000|Overall Study|Death|35|||
144609600|NCT01177683|521431113|FG000|Study Treatment|Disease Progressions during treatment|2|||
144609601|NCT01177683|521431114|FG001|Study Treatment|Disease Progressions during treatment|0|||
144609602|NCT01177683|521431115|FG002|Study Treatment|Disease Progressions during treatment|3|||
144609603|NCT01177683|521431113|FG000|Study Treatment|Adverse Event|0|||
144609604|NCT01177683|521431114|FG001|Study Treatment|Adverse Event|1|||
144609605|NCT01177683|521431115|FG002|Study Treatment|Adverse Event|12|||
144609606|NCT01177683|521431113|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
144609607|NCT01177683|521431114|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
144609608|NCT01177683|521431115|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
144609609|NCT01177683|521431113|FG000|Study Treatment|Alternative therapy|0|||
144197044|NCT00361335|519918661|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
144197045|NCT00361335|519918662|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
144197046|NCT00361335|519918663|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
144197047|NCT00361335|519918664|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
144197048|NCT00361335|519918665|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
144197049|NCT00361335|519918666|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
144197050|NCT00361335|519918660|FG000|SC Period: Week E0 to Week E24|Other|1|||
144197051|NCT00361335|519918661|FG001|SC Period: Week E0 to Week E24|Other|0|||
144197052|NCT00361335|519918662|FG002|SC Period: Week E0 to Week E24|Other|0|||
144197053|NCT00361335|519918663|FG003|SC Period: Week E0 to Week E24|Other|1|||
144197054|NCT00361335|519918664|FG004|SC Period: Week E0 to Week E24|Other|0|||
144197055|NCT00361335|519918665|FG005|SC Period: Week E0 to Week E24|Other|1|||
144197056|NCT00361335|519918666|FG006|SC Period: Week E0 to Week E24|Other|2|||
144197057|NCT00361335|519918660|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
144197058|NCT00361335|519918661|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
144197059|NCT00361335|519918662|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
144197060|NCT00361335|519918663|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
144197061|NCT00361335|519918664|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
144197062|NCT00361335|519918665|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
144197063|NCT00361335|519918666|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
144197064|NCT00506129|519918667|FG000|Overall Study|Disease Progression/Relapse|15|||
144197065|NCT00506129|519918667|FG000|Overall Study|Death|7|||
144197066|NCT01968694|519918668|FG000|Washout (1 Month)|Lost to Follow-up|0|||
144197067|NCT01968694|519918669|FG001|Washout (1 Month)|Lost to Follow-up|1|||
144609610|NCT01177683|521431114|FG001|Study Treatment|Alternative therapy|0|||
144609611|NCT01177683|521431115|FG002|Study Treatment|Alternative therapy|4|||
144609612|NCT01177683|521431113|FG000|Study Treatment|Physician Decision|1|||
144609613|NCT01177683|521431114|FG001|Study Treatment|Physician Decision|0|||
144609614|NCT01177683|521431115|FG002|Study Treatment|Physician Decision|1|||
144609615|NCT01177683|521431113|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
144609616|NCT01177683|521431114|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
144609617|NCT01177683|521431115|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
144197068|NCT00251719|519918670|FG000|Overall Study|Adverse Event|14|||
144197069|NCT00251719|519918671|FG001|Overall Study|Adverse Event|8|||
144197070|NCT00251719|519918672|FG002|Overall Study|Adverse Event|7|||
144197071|NCT00251719|519918670|FG000|Overall Study|Protocol Violation|1|||
144197072|NCT00251719|519918671|FG001|Overall Study|Protocol Violation|1|||
144197073|NCT00251719|519918672|FG002|Overall Study|Protocol Violation|1|||
144197074|NCT00251719|519918670|FG000|Overall Study|Lost to Follow-up|5|||
144197075|NCT00251719|519918671|FG001|Overall Study|Lost to Follow-up|11|||
144197076|NCT00251719|519918672|FG002|Overall Study|Lost to Follow-up|8|||
144197077|NCT00251719|519918670|FG000|Overall Study|Withdrawal by Subject|14|||
144461707|NCT04773587|520886092|FG000|Overall Study|Noncompliance|1|||
144197078|NCT00251719|519918671|FG001|Overall Study|Withdrawal by Subject|12|||
144197079|NCT00251719|519918672|FG002|Overall Study|Withdrawal by Subject|11|||
144197080|NCT00251719|519918670|FG000|Overall Study|Lack of Efficacy|2|||
144197081|NCT00251719|519918671|FG001|Overall Study|Lack of Efficacy|1|||
144197082|NCT00251719|519918672|FG002|Overall Study|Lack of Efficacy|0|||
144609618|NCT01177683|521431113|FG000|Study Treatment|Symptomatic Deterioration|0|||
144609619|NCT01177683|521431114|FG001|Study Treatment|Symptomatic Deterioration|0|||
144609620|NCT01177683|521431115|FG002|Study Treatment|Symptomatic Deterioration|1|||
144725956|NCT00688064|521852654|FG000|Overall Study|Protocol Violation|0|||
144725957|NCT00688064|521852655|FG001|Overall Study|Protocol Violation|1|||
144197083|NCT00251719|519918670|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
144197084|NCT00251719|519918671|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
144461708|NCT04773587|520886093|FG001|Overall Study|Noncompliance|0|||
144461709|NCT04773587|520886092|FG000|Overall Study|Protocol Violation|1|||
144461710|NCT04773587|520886093|FG001|Overall Study|Protocol Violation|0|||
144461711|NCT04773587|520886092|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
144461712|NCT04773587|520886093|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
144461713|NCT04656847|520886094|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
144461714|NCT03301051|520886095|FG000|Overall Study|Adverse Event|0|||
144461715|NCT03301051|520886096|FG001|Overall Study|Adverse Event|4|||
144461716|NCT03301051|520886095|FG000|Overall Study|Withdrawal by Subject|59|||
144461717|NCT03301051|520886096|FG001|Overall Study|Withdrawal by Subject|65|||
144461718|NCT03301051|520886095|FG000|Overall Study|Lost to Follow-up|263|||
144461719|NCT03301051|520886096|FG001|Overall Study|Lost to Follow-up|282|||
144461720|NCT03301051|520886095|FG000|Overall Study|Protocol Violation|1|||
144461721|NCT03301051|520886096|FG001|Overall Study|Protocol Violation|3|||
144461722|NCT03301051|520886095|FG000|Overall Study|Physician Decision|1|||
144461723|NCT03301051|520886096|FG001|Overall Study|Physician Decision|3|||
144461724|NCT03301051|520886095|FG000|Overall Study|Death|1|||
144461725|NCT03301051|520886096|FG001|Overall Study|Death|1|||
144461726|NCT03301051|520886095|FG000|Overall Study|Miscellaneous|8|||
144461727|NCT03301051|520886096|FG001|Overall Study|Miscellaneous|4|||
144461728|NCT03301051|520886095|FG000|Overall Study|Randomized, not vaccinated|13|||
144461729|NCT03301051|520886096|FG001|Overall Study|Randomized, not vaccinated|10|||
144461730|NCT00622167|520886097|FG000|Overall Study|Did not meet angiographic criteria|20|||
144461731|NCT04598152|520886098|FG000|Overall Study|Lost to Follow-up|0|||
144461732|NCT04598152|520886099|FG001|Overall Study|Lost to Follow-up|1|||
144461733|NCT01954017|520886100|FG000|Overall Study|Adverse Event|0|||
144461734|NCT01954017|520886101|FG001|Overall Study|Adverse Event|0|||
144461735|NCT01954017|520886102|FG002|Overall Study|Adverse Event|1|||
144461736|NCT01954017|520886100|FG000|Overall Study|Death|2|||
144255684|NCT05052697|520136300|FG031|Substudy A|Lost to Follow-up|0|||
144255685|NCT05052697|520136301|FG032|Substudy A|Lost to Follow-up|0|||
144461737|NCT01954017|520886101|FG001|Overall Study|Death|1|||
144461738|NCT01954017|520886102|FG002|Overall Study|Death|1|||
144461739|NCT01954017|520886100|FG000|Overall Study|Withdrawal by Subject|0|||
144461740|NCT01954017|520886101|FG001|Overall Study|Withdrawal by Subject|1|||
144461741|NCT01954017|520886102|FG002|Overall Study|Withdrawal by Subject|0|||
144461742|NCT01954017|520886100|FG000|Overall Study|Protocol Violation|0|||
144461743|NCT01954017|520886101|FG001|Overall Study|Protocol Violation|3|||
144461744|NCT01954017|520886102|FG002|Overall Study|Protocol Violation|2|||
144461745|NCT01954017|520886100|FG000|Overall Study|Necrotizing enterocolitis|1|||
144461746|NCT01954017|520886101|FG001|Overall Study|Necrotizing enterocolitis|0|||
144461747|NCT01954017|520886102|FG002|Overall Study|Necrotizing enterocolitis|1|||
144461748|NCT01954017|520886100|FG000|Overall Study|Enteral intake stopped >7 days|0|||
144461749|NCT01954017|520886101|FG001|Overall Study|Enteral intake stopped >7 days|1|||
144461750|NCT01954017|520886102|FG002|Overall Study|Enteral intake stopped >7 days|1|||
144461751|NCT01954017|520886100|FG000|Overall Study|All other reasons|2|||
144461752|NCT01954017|520886101|FG001|Overall Study|All other reasons|2|||
144461753|NCT01954017|520886102|FG002|Overall Study|All other reasons|7|||
144461754|NCT00435370|520886104|FG000|Overall Study|Adverse Event|8|||
144461755|NCT00435370|520886105|FG001|Overall Study|Adverse Event|8|||
144461756|NCT00435370|520886104|FG000|Overall Study|Withdrawal by Subject|10|||
144461757|NCT00435370|520886105|FG001|Overall Study|Withdrawal by Subject|10|||
144461758|NCT00435370|520886104|FG000|Overall Study|Antipsychotic medication changed|4|||
144461759|NCT00435370|520886105|FG001|Overall Study|Antipsychotic medication changed|2|||
144461760|NCT01965834|520886106|FG000|Overall Study|Lack of Efficacy|4|||
144461761|NCT01453595|520886107|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
144461762|NCT01453595|520886108|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144461763|NCT01453595|520886109|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
144461764|NCT00983073|520886110|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
144461765|NCT00983073|520886110|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
144461766|NCT00983073|520886110|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
144535335|NCT04993677|521164040|FG001|Overall Study|Lost to Follow-up|0|||
144535336|NCT04993677|521164041|FG002|Overall Study|Lost to Follow-up|0|||
144535337|NCT04993677|521164042|FG003|Overall Study|Lost to Follow-up|0|||
144535338|NCT04993677|521164039|FG000|Overall Study|Death|11|||
144535339|NCT04993677|521164040|FG001|Overall Study|Death|8|||
144255686|NCT05052697|520136302|FG033|Substudy A|Lost to Follow-up|0|||
144255687|NCT05052697|520136269|FG000|Substudy A|No longer met eligibility criteria|0|||
144461767|NCT00983073|520886110|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
144461768|NCT00983073|520886110|FG000|Titration and Optimal Dose Period|Other reason|4|||
144461769|NCT00983073|520886110|FG000|Maintenance Period|Adverse Event|5|||
144461770|NCT00983073|520886110|FG000|Maintenance Period|Withdrawal by Subject|2|||
144461771|NCT00983073|520886110|FG000|Maintenance Period|Lack of Efficacy|2|||
144461772|NCT00983073|520886110|FG000|Maintenance Period|Other Reason|7|||
144461773|NCT01864564|520886114|FG000|Overall Study|Lost to Follow-up|17|||
144461774|NCT01864564|520886115|FG001|Overall Study|Lost to Follow-up|23|||
144461775|NCT01864564|520886114|FG000|Overall Study|Withdrawal by Subject|20|||
144461776|NCT01864564|520886115|FG001|Overall Study|Withdrawal by Subject|11|||
144461777|NCT01864564|520886114|FG000|Overall Study|Protocol Violation|0|||
144461778|NCT01864564|520886115|FG001|Overall Study|Protocol Violation|27|||
144461779|NCT01864564|520886114|FG000|Overall Study|not reported|0|||
144461780|NCT01864564|520886115|FG001|Overall Study|not reported|34|||
144461781|NCT02269670|520886116|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
144461782|NCT04370054|520886117|FG000|Treatment Phase|Lost to Follow-up|1|||
144461783|NCT04370054|520886117|FG000|Treatment Phase|Withdrawal by Subject|1|||
144461784|NCT04370054|520886117|FG000|Follow-Up Phase|Ongoing|75|||
144461785|NCT04657211|520886118|FG000|Overall Study|Withdrawal by Subject|21|||
144461786|NCT04657211|520886118|FG000|Overall Study|Lost to Follow-up|113|||
144461787|NCT04657211|520886118|FG000|Overall Study|Death|47|||
144461788|NCT04657211|520886118|FG000|Overall Study|Transfer to another institution|21|||
144461789|NCT04657211|520886118|FG000|Overall Study|Other|29|||
144461790|NCT05557942|520886120|FG000|Overall Study|Death|0|||
144461791|NCT05557942|520886121|FG001|Overall Study|Death|0|||
144535340|NCT04993677|521164041|FG002|Overall Study|Death|3|||
144535341|NCT04993677|521164042|FG003|Overall Study|Death|1|||
144535342|NCT04993677|521164039|FG000|Overall Study|Subject withdrawal of consent|4|||
144535343|NCT04993677|521164040|FG001|Overall Study|Subject withdrawal of consent|3|||
144535344|NCT04993677|521164041|FG002|Overall Study|Subject withdrawal of consent|0|||
144535345|NCT04993677|521164042|FG003|Overall Study|Subject withdrawal of consent|2|||
144535346|NCT04993677|521164039|FG000|Overall Study|Study termination by sponsor|3|||
144535347|NCT04993677|521164040|FG001|Overall Study|Study termination by sponsor|25|||
144535348|NCT04993677|521164041|FG002|Overall Study|Study termination by sponsor|3|||
144535349|NCT04993677|521164042|FG003|Overall Study|Study termination by sponsor|3|||
144535350|NCT04993677|521164039|FG000|Overall Study|Other|2|||
144535351|NCT04993677|521164040|FG001|Overall Study|Other|3|||
144535352|NCT04993677|521164041|FG002|Overall Study|Other|3|||
144197085|NCT00251719|519918672|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
144197086|NCT00251719|519918670|FG000|Overall Study|Investigator decision|1|||
144197087|NCT00251719|519918671|FG001|Overall Study|Investigator decision|1|||
144197088|NCT00251719|519918672|FG002|Overall Study|Investigator decision|0|||
144197089|NCT00251719|519918670|FG000|Overall Study|Noncompliance|2|||
144197090|NCT00251719|519918671|FG001|Overall Study|Noncompliance|3|||
144197091|NCT00251719|519918672|FG002|Overall Study|Noncompliance|1|||
144461792|NCT05557942|520886122|FG002|Overall Study|Death|0|||
144461793|NCT05557942|520886123|FG003|Overall Study|Death|2|||
144461794|NCT05557942|520886124|FG004|Overall Study|Death|1|||
144535353|NCT04993677|521164042|FG003|Overall Study|Other|2|||
144535354|NCT04174170|521164043|FG000|Placebo Run-in Period|Not Randomized|38|||
144535355|NCT04174170|521164044|FG001|Placebo Run-in Period|Not Randomized|0|||
144535356|NCT04174170|521164045|FG002|Placebo Run-in Period|Not Randomized|0|||
144535357|NCT04174170|521164046|FG003|Placebo Run-in Period|Not Randomized|0|||
144535358|NCT04174170|521164043|FG000|Double Blind Treatment Period|Adverse Event|0|||
144535359|NCT04174170|521164044|FG001|Double Blind Treatment Period|Adverse Event|9|||
144535360|NCT04174170|521164045|FG002|Double Blind Treatment Period|Adverse Event|9|||
144535361|NCT04174170|521164046|FG003|Double Blind Treatment Period|Adverse Event|8|||
144535362|NCT04174170|521164043|FG000|Double Blind Treatment Period|Death|0|||
144535363|NCT04174170|521164044|FG001|Double Blind Treatment Period|Death|1|||
144535364|NCT04174170|521164045|FG002|Double Blind Treatment Period|Death|0|||
144535365|NCT04174170|521164046|FG003|Double Blind Treatment Period|Death|0|||
144535366|NCT04174170|521164043|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
144535367|NCT04174170|521164044|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
144535368|NCT04174170|521164045|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
144535369|NCT04174170|521164046|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
144535370|NCT04174170|521164043|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
144535371|NCT04174170|521164044|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
144535372|NCT04174170|521164045|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
144535373|NCT04174170|521164046|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
144535374|NCT04174170|521164043|FG000|Double Blind Treatment Period|Physician Decision|0|||
144535375|NCT04174170|521164044|FG001|Double Blind Treatment Period|Physician Decision|1|||
144535376|NCT04174170|521164045|FG002|Double Blind Treatment Period|Physician Decision|0|||
144535377|NCT04174170|521164046|FG003|Double Blind Treatment Period|Physician Decision|1|||
144535378|NCT04174170|521164043|FG000|Double Blind Treatment Period|Pregnancy|0|||
144535379|NCT04174170|521164044|FG001|Double Blind Treatment Period|Pregnancy|1|||
144535380|NCT04174170|521164045|FG002|Double Blind Treatment Period|Pregnancy|0|||
144535381|NCT04174170|521164046|FG003|Double Blind Treatment Period|Pregnancy|1|||
144535382|NCT04174170|521164043|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
144535383|NCT04174170|521164044|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
144535384|NCT04174170|521164045|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
144535385|NCT04174170|521164046|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
144535386|NCT04174170|521164043|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
144725958|NCT00688064|521852654|FG000|Overall Study|Adverse Event|2|||
144255688|NCT05052697|520136270|FG001|Substudy A|No longer met eligibility criteria|0|||
144255689|NCT05052697|520136271|FG002|Substudy A|No longer met eligibility criteria|0|||
144255690|NCT05052697|520136272|FG003|Substudy A|No longer met eligibility criteria|0|||
144255691|NCT05052697|520136273|FG004|Substudy A|No longer met eligibility criteria|0|||
144255692|NCT05052697|520136274|FG005|Substudy A|No longer met eligibility criteria|0|||
144255693|NCT05052697|520136275|FG006|Substudy A|No longer met eligibility criteria|0|||
144255694|NCT05052697|520136276|FG007|Substudy A|No longer met eligibility criteria|0|||
144255695|NCT05052697|520136277|FG008|Substudy A|No longer met eligibility criteria|0|||
144255696|NCT05052697|520136278|FG009|Substudy A|No longer met eligibility criteria|0|||
144255697|NCT05052697|520136279|FG010|Substudy A|No longer met eligibility criteria|0|||
144255698|NCT05052697|520136280|FG011|Substudy A|No longer met eligibility criteria|0|||
144255699|NCT05052697|520136281|FG012|Substudy A|No longer met eligibility criteria|0|||
144255700|NCT05052697|520136282|FG013|Substudy A|No longer met eligibility criteria|1|||
144255701|NCT05052697|520136283|FG014|Substudy A|No longer met eligibility criteria|0|||
144255702|NCT05052697|520136284|FG015|Substudy A|No longer met eligibility criteria|0|||
144255703|NCT05052697|520136285|FG016|Substudy A|No longer met eligibility criteria|0|||
144255704|NCT05052697|520136286|FG017|Substudy A|No longer met eligibility criteria|0|||
144255705|NCT05052697|520136287|FG018|Substudy A|No longer met eligibility criteria|0|||
144255706|NCT05052697|520136288|FG019|Substudy A|No longer met eligibility criteria|0|||
144255707|NCT05052697|520136289|FG020|Substudy A|No longer met eligibility criteria|0|||
144255708|NCT05052697|520136290|FG021|Substudy A|No longer met eligibility criteria|0|||
144255709|NCT05052697|520136291|FG022|Substudy A|No longer met eligibility criteria|0|||
144255710|NCT05052697|520136292|FG023|Substudy A|No longer met eligibility criteria|0|||
144255711|NCT05052697|520136293|FG024|Substudy A|No longer met eligibility criteria|0|||
144255712|NCT05052697|520136294|FG025|Substudy A|No longer met eligibility criteria|0|||
144255713|NCT05052697|520136295|FG026|Substudy A|No longer met eligibility criteria|0|||
144255714|NCT05052697|520136296|FG027|Substudy A|No longer met eligibility criteria|0|||
144255715|NCT05052697|520136297|FG028|Substudy A|No longer met eligibility criteria|0|||
144255716|NCT05052697|520136298|FG029|Substudy A|No longer met eligibility criteria|0|||
144255717|NCT05052697|520136299|FG030|Substudy A|No longer met eligibility criteria|0|||
144255718|NCT05052697|520136300|FG031|Substudy A|No longer met eligibility criteria|0|||
144255719|NCT05052697|520136301|FG032|Substudy A|No longer met eligibility criteria|0|||
144255720|NCT05052697|520136302|FG033|Substudy A|No longer met eligibility criteria|0|||
144255721|NCT05052697|520136269|FG000|Substudy A|Not vaccinated|0|||
144255722|NCT05052697|520136270|FG001|Substudy A|Not vaccinated|0|||
144255723|NCT05052697|520136271|FG002|Substudy A|Not vaccinated|0|||
144255724|NCT05052697|520136272|FG003|Substudy A|Not vaccinated|1|||
144255725|NCT05052697|520136273|FG004|Substudy A|Not vaccinated|0|||
144255726|NCT05052697|520136274|FG005|Substudy A|Not vaccinated|0|||
144255727|NCT05052697|520136275|FG006|Substudy A|Not vaccinated|0|||
144255728|NCT05052697|520136276|FG007|Substudy A|Not vaccinated|0|||
144255729|NCT05052697|520136277|FG008|Substudy A|Not vaccinated|1|||
144255730|NCT05052697|520136278|FG009|Substudy A|Not vaccinated|0|||
144255731|NCT05052697|520136279|FG010|Substudy A|Not vaccinated|0|||
144255732|NCT05052697|520136280|FG011|Substudy A|Not vaccinated|0|||
144255733|NCT05052697|520136281|FG012|Substudy A|Not vaccinated|0|||
144255734|NCT05052697|520136282|FG013|Substudy A|Not vaccinated|0|||
144255735|NCT05052697|520136283|FG014|Substudy A|Not vaccinated|0|||
144255736|NCT05052697|520136284|FG015|Substudy A|Not vaccinated|0|||
144255737|NCT05052697|520136285|FG016|Substudy A|Not vaccinated|0|||
144255738|NCT05052697|520136286|FG017|Substudy A|Not vaccinated|0|||
144255739|NCT05052697|520136287|FG018|Substudy A|Not vaccinated|0|||
144255740|NCT05052697|520136288|FG019|Substudy A|Not vaccinated|0|||
144255741|NCT05052697|520136289|FG020|Substudy A|Not vaccinated|0|||
144255742|NCT05052697|520136290|FG021|Substudy A|Not vaccinated|0|||
144255743|NCT05052697|520136291|FG022|Substudy A|Not vaccinated|0|||
144255744|NCT05052697|520136292|FG023|Substudy A|Not vaccinated|0|||
144255745|NCT05052697|520136293|FG024|Substudy A|Not vaccinated|0|||
144255746|NCT05052697|520136294|FG025|Substudy A|Not vaccinated|0|||
144255747|NCT05052697|520136295|FG026|Substudy A|Not vaccinated|0|||
144255748|NCT05052697|520136296|FG027|Substudy A|Not vaccinated|0|||
144461795|NCT05557942|520886125|FG005|Overall Study|Death|1|||
144461796|NCT05557942|520886120|FG000|Overall Study|Physician Decision|1|||
144461797|NCT05557942|520886121|FG001|Overall Study|Physician Decision|1|||
144461798|NCT05557942|520886122|FG002|Overall Study|Physician Decision|2|||
144461799|NCT05557942|520886123|FG003|Overall Study|Physician Decision|3|||
144461800|NCT05557942|520886124|FG004|Overall Study|Physician Decision|0|||
144461801|NCT05557942|520886125|FG005|Overall Study|Physician Decision|2|||
144461802|NCT05557942|520886120|FG000|Overall Study|Study terminated by sponsor|17|||
144461803|NCT05557942|520886121|FG001|Overall Study|Study terminated by sponsor|17|||
144461804|NCT05557942|520886122|FG002|Overall Study|Study terminated by sponsor|14|||
144255749|NCT05052697|520136297|FG028|Substudy A|Not vaccinated|0|||
144255750|NCT05052697|520136298|FG029|Substudy A|Not vaccinated|0|||
144255751|NCT05052697|520136299|FG030|Substudy A|Not vaccinated|0|||
144255752|NCT05052697|520136300|FG031|Substudy A|Not vaccinated|0|||
144255753|NCT05052697|520136301|FG032|Substudy A|Not vaccinated|0|||
144255754|NCT05052697|520136302|FG033|Substudy A|Not vaccinated|0|||
144255755|NCT05052697|520136269|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144609621|NCT01177683|521431113|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
144609622|NCT01177683|521431114|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
144609623|NCT01177683|521431115|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
144609624|NCT01177683|521431113|FG000|Follow up|Patient lost to follow up|0|||
144609625|NCT01177683|521431114|FG001|Follow up|Patient lost to follow up|0|||
144609626|NCT01177683|521431115|FG002|Follow up|Patient lost to follow up|2|||
144609627|NCT01177683|521431113|FG000|Follow up|Death|2|||
144609628|NCT01177683|521431114|FG001|Follow up|Death|1|||
144609629|NCT01177683|521431115|FG002|Follow up|Death|7|||
144609630|NCT01177683|521431113|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
144609631|NCT01177683|521431114|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
144609632|NCT01177683|521431115|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
144609633|NCT01977820|521431118|FG000|Overall Study|Sponsor terminated the study|1|||
144609634|NCT01977820|521431119|FG001|Overall Study|Sponsor terminated the study|1|||
144609635|NCT02568475|521431123|FG000|Overall Study|Lost to Follow-up|40|||
144609636|NCT02568475|521431124|FG001|Overall Study|Lost to Follow-up|39|||
144609637|NCT02568475|521431123|FG000|Overall Study|Withdrawal by Subject|2|||
144609638|NCT02568475|521431124|FG001|Overall Study|Withdrawal by Subject|0|||
144609639|NCT02568475|521431123|FG000|Overall Study|Discharged home|4|||
144609640|NCT02568475|521431124|FG001|Overall Study|Discharged home|4|||
144609641|NCT02568475|521431123|FG000|Overall Study|Short-term: Discharge location unknown|4|||
144609642|NCT02568475|521431124|FG001|Overall Study|Short-term: Discharge location unknown|0|||
144609643|NCT02568475|521431123|FG000|Overall Study|Transferred to another facility|1|||
144609644|NCT02568475|521431124|FG001|Overall Study|Transferred to another facility|0|||
144609645|NCT00290186|521431129|FG000|Overall Study|Adverse Event|1|||
144609646|NCT00290186|521431130|FG001|Overall Study|Adverse Event|1|||
144609647|NCT00290186|521431129|FG000|Overall Study|Lost to Follow-up|3|||
144609648|NCT00290186|521431130|FG001|Overall Study|Lost to Follow-up|2|||
144609649|NCT00290186|521431129|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
144609650|NCT00290186|521431130|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
144609651|NCT00290186|521431129|FG000|Overall Study|Withdrawal by Subject|0|||
144609652|NCT00290186|521431130|FG001|Overall Study|Withdrawal by Subject|1|||
144609653|NCT03184077|521431133|FG000|Overall Study|Lost to Follow-up|21|||
144609654|NCT03184077|521431134|FG001|Overall Study|Lost to Follow-up|21|||
144609655|NCT03159091|521431135|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
144609656|NCT03159091|521431136|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
144609657|NCT03159091|521431135|FG000|Overall Study|Patient has taken no dose of study drug|0|||
144609658|NCT03159091|521431136|FG001|Overall Study|Patient has taken no dose of study drug|1|||
144609659|NCT00262522|521431137|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
144609660|NCT00262522|521431138|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
144609661|NCT00262522|521431139|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
144609662|NCT00262522|521431140|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
144609663|NCT00262522|521431137|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
144609664|NCT00262522|521431138|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
144609665|NCT00262522|521431139|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
144609666|NCT00262522|521431140|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
144609667|NCT00262522|521431137|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
144609668|NCT00262522|521431138|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
144609669|NCT00262522|521431139|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
144609670|NCT00262522|521431140|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
144609671|NCT00262522|521431137|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
144609672|NCT00262522|521431138|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
144609673|NCT00262522|521431139|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
144609674|NCT00262522|521431140|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
144609675|NCT00262522|521431137|FG000|Study Start Through 8 Weeks|Death|1|||
144609676|NCT00262522|521431138|FG001|Study Start Through 8 Weeks|Death|0|||
144609677|NCT00262522|521431139|FG002|Study Start Through 8 Weeks|Death|0|||
144609678|NCT00262522|521431140|FG003|Study Start Through 8 Weeks|Death|0|||
144609679|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
144609680|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
144609681|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
144609682|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
144609683|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
144609684|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
144725959|NCT00688064|521852655|FG001|Overall Study|Adverse Event|4|||
144609685|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
144609686|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
144609687|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
144609688|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
144609689|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
144609690|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
144609691|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
144255756|NCT05052697|520136270|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255757|NCT05052697|520136271|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255758|NCT05052697|520136272|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255759|NCT05052697|520136273|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255760|NCT05052697|520136274|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255761|NCT05052697|520136275|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144461805|NCT05557942|520886123|FG003|Overall Study|Study terminated by sponsor|40|||
144461806|NCT05557942|520886124|FG004|Overall Study|Study terminated by sponsor|45|||
144461807|NCT05557942|520886125|FG005|Overall Study|Study terminated by sponsor|37|||
144255762|NCT05052697|520136276|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255763|NCT05052697|520136277|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255764|NCT05052697|520136278|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255765|NCT05052697|520136279|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255766|NCT05052697|520136280|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255767|NCT05052697|520136281|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255768|NCT05052697|520136282|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255769|NCT05052697|520136283|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255770|NCT05052697|520136284|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255771|NCT05052697|520136285|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255772|NCT05052697|520136286|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255773|NCT05052697|520136287|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
144255774|NCT05052697|520136288|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
144255775|NCT05052697|520136289|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255776|NCT05052697|520136290|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
144255777|NCT05052697|520136291|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
144255778|NCT05052697|520136292|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255779|NCT05052697|520136293|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255780|NCT05052697|520136294|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255781|NCT05052697|520136295|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255782|NCT05052697|520136296|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255783|NCT05052697|520136297|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255784|NCT05052697|520136298|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255785|NCT05052697|520136299|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255786|NCT05052697|520136300|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255787|NCT05052697|520136301|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144255788|NCT05052697|520136302|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
144461808|NCT05557942|520886120|FG000|Overall Study|Protocol Violation|0|||
144461809|NCT05557942|520886121|FG001|Overall Study|Protocol Violation|0|||
144461810|NCT05557942|520886122|FG002|Overall Study|Protocol Violation|0|||
144461811|NCT05557942|520886123|FG003|Overall Study|Protocol Violation|0|||
144461812|NCT05557942|520886124|FG004|Overall Study|Protocol Violation|0|||
144535387|NCT04174170|521164044|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
144255789|NCT05052697|520136269|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255790|NCT05052697|520136270|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255791|NCT05052697|520136271|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255792|NCT05052697|520136272|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255793|NCT05052697|520136273|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255794|NCT05052697|520136274|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255795|NCT05052697|520136275|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255796|NCT05052697|520136276|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255797|NCT05052697|520136277|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255798|NCT05052697|520136278|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255799|NCT05052697|520136279|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255800|NCT05052697|520136280|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255801|NCT05052697|520136281|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255802|NCT05052697|520136282|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255803|NCT05052697|520136283|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255804|NCT05052697|520136284|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255805|NCT05052697|520136285|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255806|NCT05052697|520136286|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
144535388|NCT04174170|521164045|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
144535389|NCT04174170|521164046|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
144535390|NCT04174170|521164043|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
144255807|NCT05052697|520136287|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255808|NCT05052697|520136288|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255809|NCT05052697|520136289|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255810|NCT05052697|520136290|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
144461813|NCT05557942|520886125|FG005|Overall Study|Protocol Violation|1|||
144609692|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
144609693|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
144609694|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
144609695|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Death|2|||
144609696|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Death|0|||
144609697|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Death|1|||
144609698|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Death|0|||
144609699|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
144609700|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
144609701|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
144609702|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
144609703|NCT00262522|521431137|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
144609704|NCT00262522|521431138|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
144609705|NCT00262522|521431139|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
144609706|NCT00262522|521431140|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
144609707|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
144609708|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
144609709|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
144609710|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
144609711|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
144609712|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
144609713|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
144609714|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
144609715|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
144609716|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
144609717|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
144609718|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
144609719|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
144609720|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
144609721|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
144609722|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
144609723|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Death|2|||
144609724|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Death|0|||
144609725|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Death|2|||
144609726|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Death|0|||
144609727|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
144609728|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
144609729|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
144609730|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
144609731|NCT00262522|521431137|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
144609732|NCT00262522|521431138|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
144609733|NCT00262522|521431139|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
144609734|NCT00262522|521431140|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
144609735|NCT02044133|521431141|FG000|Overall Study|Lost to Follow-up|1|||
144609736|NCT02044133|521431142|FG001|Overall Study|Lost to Follow-up|1|||
144609737|NCT02044133|521431141|FG000|Overall Study|Death|1|||
144609738|NCT02044133|521431142|FG001|Overall Study|Death|0|||
144609739|NCT02044133|521431141|FG000|Overall Study|Release|3|||
144609740|NCT02044133|521431142|FG001|Overall Study|Release|4|||
144609741|NCT02044133|521431141|FG000|Overall Study|Transfer|1|||
144609742|NCT02044133|521431142|FG001|Overall Study|Transfer|0|||
144609743|NCT02044133|521431141|FG000|Overall Study|refusal of blood sampling|0|||
144609744|NCT02044133|521431142|FG001|Overall Study|refusal of blood sampling|1|||
144609745|NCT04085523|521431143|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
144609746|NCT04085523|521431144|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
144609747|NCT04085523|521431145|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
144609748|NCT04085523|521431146|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
144609749|NCT04085523|521431147|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
144609750|NCT04085523|521431148|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
144609751|NCT00943579|521431150|FG000|Overall Study|Adverse Event|4|||
144609752|NCT00943579|521431151|FG001|Overall Study|Adverse Event|3|||
144609753|NCT00943579|521431150|FG000|Overall Study|Lack of Efficacy|2|||
144609754|NCT00943579|521431151|FG001|Overall Study|Lack of Efficacy|2|||
144609755|NCT02710136|521431152|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
144609756|NCT02710136|521431153|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
144609757|NCT00418665|521431154|FG000|Treatment Period|Ineligibility determined|1|||
144609758|NCT00418665|521431155|FG001|Treatment Period|Ineligibility determined|1|||
144609759|NCT00418665|521431156|FG002|Treatment Period|Ineligibility determined|0|||
144609760|NCT00418665|521431154|FG000|Treatment Period|Adverse Event|2|||
144609761|NCT00418665|521431155|FG001|Treatment Period|Adverse Event|2|||
144609762|NCT00418665|521431156|FG002|Treatment Period|Adverse Event|0|||
144255811|NCT05052697|520136291|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255812|NCT05052697|520136292|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255813|NCT05052697|520136293|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255814|NCT05052697|520136294|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255815|NCT05052697|520136295|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255816|NCT05052697|520136296|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
144461814|NCT05557942|520886120|FG000|Overall Study|Withdrawal by Subject|0|||
144461815|NCT05557942|520886121|FG001|Overall Study|Withdrawal by Subject|0|||
144461816|NCT05557942|520886122|FG002|Overall Study|Withdrawal by Subject|0|||
144461817|NCT05557942|520886123|FG003|Overall Study|Withdrawal by Subject|0|||
144461818|NCT05557942|520886124|FG004|Overall Study|Withdrawal by Subject|2|||
144255817|NCT05052697|520136297|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255818|NCT05052697|520136298|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255819|NCT05052697|520136299|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255820|NCT05052697|520136300|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255821|NCT05052697|520136301|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
144255822|NCT05052697|520136302|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
144461819|NCT05557942|520886125|FG005|Overall Study|Withdrawal by Subject|0|||
144609763|NCT00418665|521431154|FG000|Treatment Period|Withdrawal by Subject|0|||
144255823|NCT05052697|520136269|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255824|NCT05052697|520136270|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255825|NCT05052697|520136271|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255826|NCT05052697|520136272|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144461820|NCT00710424|520886128|FG000|Overall Study|Adverse Event|30|||
144609764|NCT00418665|521431155|FG001|Treatment Period|Withdrawal by Subject|3|||
144609765|NCT00418665|521431156|FG002|Treatment Period|Withdrawal by Subject|1|||
144609766|NCT00418665|521431154|FG000|Treatment Period|Requirement for alternative therapy|1|||
144609767|NCT00418665|521431155|FG001|Treatment Period|Requirement for alternative therapy|0|||
144609768|NCT00418665|521431156|FG002|Treatment Period|Requirement for alternative therapy|0|||
144609769|NCT00418665|521431154|FG000|Treatment Period|Physician Decision|1|||
144609770|NCT00418665|521431155|FG001|Treatment Period|Physician Decision|0|||
144609771|NCT00418665|521431156|FG002|Treatment Period|Physician Decision|3|||
144609772|NCT00418665|521431154|FG000|Treatment Extension|Adverse Event|1|||
144609773|NCT00418665|521431155|FG001|Treatment Extension|Adverse Event|0|||
144609774|NCT00418665|521431156|FG002|Treatment Extension|Adverse Event|0|||
144609775|NCT00418665|521431154|FG000|Treatment Extension|Withdrawal by Subject|1|||
144609776|NCT00418665|521431155|FG001|Treatment Extension|Withdrawal by Subject|0|||
144609777|NCT00418665|521431156|FG002|Treatment Extension|Withdrawal by Subject|0|||
144609778|NCT00418665|521431154|FG000|Treatment Extension|Requirement for alternative therapy|2|||
144609779|NCT00418665|521431155|FG001|Treatment Extension|Requirement for alternative therapy|2|||
144609780|NCT00418665|521431156|FG002|Treatment Extension|Requirement for alternative therapy|0|||
144609781|NCT00418665|521431154|FG000|Treatment Extension|Physician Decision|2|||
144609782|NCT00418665|521431155|FG001|Treatment Extension|Physician Decision|2|||
144609783|NCT00418665|521431156|FG002|Treatment Extension|Physician Decision|1|||
144609784|NCT00418665|521431154|FG000|Treatment Extension|Death|0|||
144609785|NCT00418665|521431155|FG001|Treatment Extension|Death|0|||
144609786|NCT00418665|521431156|FG002|Treatment Extension|Death|1|||
144609787|NCT01133379|521431157|FG000|Overall Study|Withdrawal by Subject|0|||
144609788|NCT01133379|521431158|FG001|Overall Study|Withdrawal by Subject|1|||
144609789|NCT01133379|521431159|FG002|Overall Study|Withdrawal by Subject|1|||
144609790|NCT01133379|521431157|FG000|Overall Study|Lost to Follow-up|1|||
144609791|NCT01133379|521431158|FG001|Overall Study|Lost to Follow-up|1|||
144609792|NCT01133379|521431159|FG002|Overall Study|Lost to Follow-up|1|||
144609793|NCT06156215|521431168|FG000|Overall Study|Withdrawal by Subject|2|||
144609794|NCT06156215|521431169|FG001|Overall Study|Withdrawal by Subject|4|||
144609795|NCT06156215|521431170|FG002|Overall Study|Withdrawal by Subject|4|||
144609796|NCT06156215|521431171|FG003|Overall Study|Withdrawal by Subject|0|||
144609797|NCT06156215|521431172|FG004|Overall Study|Withdrawal by Subject|2|||
144609798|NCT06156215|521431173|FG005|Overall Study|Withdrawal by Subject|2|||
144609799|NCT06156215|521431168|FG000|Overall Study|Left ED without completing study|9|||
144609800|NCT06156215|521431169|FG001|Overall Study|Left ED without completing study|3|||
144609801|NCT06156215|521431170|FG002|Overall Study|Left ED without completing study|9|||
144609802|NCT06156215|521431171|FG003|Overall Study|Left ED without completing study|0|||
144609803|NCT06156215|521431172|FG004|Overall Study|Left ED without completing study|8|||
144609804|NCT06156215|521431173|FG005|Overall Study|Left ED without completing study|16|||
144609805|NCT06156215|521431168|FG000|Overall Study|Physician Decision|1|||
144609806|NCT06156215|521431169|FG001|Overall Study|Physician Decision|0|||
144609807|NCT06156215|521431170|FG002|Overall Study|Physician Decision|0|||
144609808|NCT06156215|521431171|FG003|Overall Study|Physician Decision|0|||
144461821|NCT00710424|520886129|FG001|Overall Study|Adverse Event|12|||
144609809|NCT06156215|521431172|FG004|Overall Study|Physician Decision|0|||
144609810|NCT06156215|521431173|FG005|Overall Study|Physician Decision|0|||
144609811|NCT06156215|521431168|FG000|Overall Study|Became or found ineligible|2|||
144609812|NCT06156215|521431169|FG001|Overall Study|Became or found ineligible|0|||
144255827|NCT05052697|520136273|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255828|NCT05052697|520136274|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255829|NCT05052697|520136275|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255830|NCT05052697|520136276|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255831|NCT05052697|520136277|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144461822|NCT00710424|520886128|FG000|Overall Study|Lack of Efficacy|4|||
144461823|NCT00710424|520886129|FG001|Overall Study|Lack of Efficacy|5|||
144461824|NCT00710424|520886128|FG000|Overall Study|Withdrawal by Subject|5|||
144461825|NCT00710424|520886129|FG001|Overall Study|Withdrawal by Subject|3|||
144461826|NCT00710424|520886128|FG000|Overall Study|Lost to Follow-up|0|||
144461827|NCT00710424|520886129|FG001|Overall Study|Lost to Follow-up|1|||
144461828|NCT00710424|520886128|FG000|Overall Study|Refused medication, no side effects|1|||
144461829|NCT00710424|520886129|FG001|Overall Study|Refused medication, no side effects|0|||
144461830|NCT00710424|520886128|FG000|Overall Study|Non-compliance with stable analgesia|1|||
144461831|NCT00710424|520886129|FG001|Overall Study|Non-compliance with stable analgesia|0|||
144255832|NCT05052697|520136278|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255833|NCT05052697|520136279|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255834|NCT05052697|520136280|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255835|NCT05052697|520136281|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144461832|NCT00710424|520886128|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
144461833|NCT00710424|520886129|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
144535391|NCT04174170|521164044|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
144255836|NCT05052697|520136282|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255837|NCT05052697|520136283|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255838|NCT05052697|520136284|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255839|NCT05052697|520136285|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255840|NCT05052697|520136286|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255841|NCT05052697|520136287|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255842|NCT05052697|520136288|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
144255843|NCT05052697|520136289|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255844|NCT05052697|520136290|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255845|NCT05052697|520136291|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255846|NCT05052697|520136292|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255847|NCT05052697|520136293|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255848|NCT05052697|520136294|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255849|NCT05052697|520136295|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255850|NCT05052697|520136296|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255851|NCT05052697|520136297|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255852|NCT05052697|520136298|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144461834|NCT00710424|520886128|FG000|Overall Study|Subject thought medication changed|1|||
144461835|NCT00710424|520886129|FG001|Overall Study|Subject thought medication changed|0|||
144535392|NCT04174170|521164045|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
144535393|NCT04174170|521164046|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
144535394|NCT04664881|521164047|FG000|Overall Study|Withdrawal by Subject|1|||
144535395|NCT04664881|521164048|FG001|Overall Study|Withdrawal by Subject|8|||
144535396|NCT04664881|521164047|FG000|Overall Study|Physician Decision|0|||
144535397|NCT04664881|521164048|FG001|Overall Study|Physician Decision|5|||
144535398|NCT04664881|521164047|FG000|Overall Study|Lost to Follow-up|1|||
144535399|NCT04664881|521164048|FG001|Overall Study|Lost to Follow-up|0|||
144535400|NCT02231749|521164056|FG000|Overall Study|Disease progression|229|||
144535401|NCT02231749|521164057|FG001|Overall Study|Disease progression|297|||
144535402|NCT02231749|521164056|FG000|Overall Study|Study Drug Toxicity|134|||
144535403|NCT02231749|521164057|FG001|Overall Study|Study Drug Toxicity|63|||
144535404|NCT02231749|521164056|FG000|Overall Study|Death|1|||
144535405|NCT02231749|521164057|FG001|Overall Study|Death|1|||
144535406|NCT02231749|521164056|FG000|Overall Study|AE unrelated to Study drug|32|||
144535407|NCT02231749|521164057|FG001|Overall Study|AE unrelated to Study drug|31|||
144535408|NCT02231749|521164056|FG000|Overall Study|Participant's request to discontinue|10|||
144535409|NCT02231749|521164057|FG001|Overall Study|Participant's request to discontinue|21|||
144535410|NCT02231749|521164056|FG000|Overall Study|Participant withdrew Consent|8|||
144535411|NCT02231749|521164057|FG001|Overall Study|Participant withdrew Consent|15|||
144535412|NCT02231749|521164056|FG000|Overall Study|Lost to Follow-up|1|||
144535413|NCT02231749|521164057|FG001|Overall Study|Lost to Follow-up|2|||
144535414|NCT02231749|521164056|FG000|Overall Study|Maximum Clinical Benefit|5|||
144535415|NCT02231749|521164057|FG001|Overall Study|Maximum Clinical Benefit|8|||
144535416|NCT02231749|521164056|FG000|Overall Study|Poor/Non-Compliance|0|||
144535417|NCT02231749|521164057|FG001|Overall Study|Poor/Non-Compliance|3|||
144535418|NCT02231749|521164056|FG000|Overall Study|Pregnancy|1|||
144535419|NCT02231749|521164057|FG001|Overall Study|Pregnancy|0|||
144535420|NCT02231749|521164056|FG000|Overall Study|other|0|||
144535421|NCT02231749|521164057|FG001|Overall Study|other|8|||
144535422|NCT02231749|521164056|FG000|Overall Study|No longer meets Study Criteria|1|||
144535423|NCT02231749|521164057|FG001|Overall Study|No longer meets Study Criteria|0|||
144255853|NCT05052697|520136299|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255854|NCT05052697|520136300|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255855|NCT05052697|520136301|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255856|NCT05052697|520136302|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
144255857|NCT05052697|520136269|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255858|NCT05052697|520136270|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255859|NCT05052697|520136271|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255860|NCT05052697|520136272|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255861|NCT05052697|520136273|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255862|NCT05052697|520136274|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255863|NCT05052697|520136275|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255864|NCT05052697|520136276|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144609813|NCT06156215|521431170|FG002|Overall Study|Became or found ineligible|2|||
144609814|NCT06156215|521431171|FG003|Overall Study|Became or found ineligible|0|||
144609815|NCT06156215|521431172|FG004|Overall Study|Became or found ineligible|1|||
144609816|NCT06156215|521431173|FG005|Overall Study|Became or found ineligible|2|||
144609817|NCT00736255|521432548|FG000|Overall Study|Adverse Event|1|||
144609818|NCT00736255|521432549|FG001|Overall Study|Adverse Event|0|||
144609819|NCT00736255|521432548|FG000|Overall Study|Physician Decision|1|||
144609820|NCT00736255|521432549|FG001|Overall Study|Physician Decision|0|||
144609821|NCT00736255|521432548|FG000|Overall Study|Non-compliance|1|||
144609822|NCT00736255|521432549|FG001|Overall Study|Non-compliance|1|||
144609823|NCT02833974|521432550|FG000|Overall Study|Lost to Follow-up|1|||
144609824|NCT02833974|521432551|FG001|Overall Study|Lost to Follow-up|0|||
144609825|NCT02833974|521432550|FG000|Overall Study|Adverse Event|0|||
144609826|NCT02833974|521432551|FG001|Overall Study|Adverse Event|3|||
144609827|NCT01502709|521432556|FG000|Overall Study|Lost to Follow-up|4|||
144609828|NCT01502709|521432557|FG001|Overall Study|Lost to Follow-up|0|||
144609829|NCT00307151|521432558|FG000|Overall Study|Death|4|||
144609830|NCT00307151|521432559|FG001|Overall Study|Death|3|||
144609831|NCT00307151|521432560|FG002|Overall Study|Death|10|||
144609832|NCT00307151|521432561|FG003|Overall Study|Death|3|||
144609833|NCT00307151|521432558|FG000|Overall Study|Severe debilitation, unable to continue|1|||
144609834|NCT00307151|521432559|FG001|Overall Study|Severe debilitation, unable to continue|0|||
144609835|NCT00307151|521432560|FG002|Overall Study|Severe debilitation, unable to continue|0|||
144609836|NCT00307151|521432561|FG003|Overall Study|Severe debilitation, unable to continue|0|||
144609837|NCT00307151|521432558|FG000|Overall Study|Subject unable to get to clinic|1|||
144609838|NCT00307151|521432559|FG001|Overall Study|Subject unable to get to clinic|0|||
144609839|NCT00307151|521432560|FG002|Overall Study|Subject unable to get to clinic|6|||
144609840|NCT00307151|521432561|FG003|Overall Study|Subject unable to get to clinic|2|||
144609841|NCT00307151|521432558|FG000|Overall Study|Withdrew consent|0|||
144609842|NCT00307151|521432559|FG001|Overall Study|Withdrew consent|1|||
144609843|NCT00307151|521432560|FG002|Overall Study|Withdrew consent|1|||
144609844|NCT00307151|521432561|FG003|Overall Study|Withdrew consent|3|||
144609845|NCT00307151|521432558|FG000|Overall Study|Not willing to adhere to study reqs|2|||
144609846|NCT00307151|521432559|FG001|Overall Study|Not willing to adhere to study reqs|0|||
144609847|NCT00307151|521432560|FG002|Overall Study|Not willing to adhere to study reqs|2|||
144609848|NCT00307151|521432561|FG003|Overall Study|Not willing to adhere to study reqs|2|||
144609849|NCT00307151|521432558|FG000|Overall Study|Clinic unable to contact subject|3|||
144609850|NCT00307151|521432559|FG001|Overall Study|Clinic unable to contact subject|3|||
144609851|NCT00307151|521432560|FG002|Overall Study|Clinic unable to contact subject|1|||
144609852|NCT00307151|521432561|FG003|Overall Study|Clinic unable to contact subject|1|||
144609853|NCT02966509|521432565|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
144609854|NCT02966509|521432566|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
144609855|NCT02966509|521432565|FG000|Baseline Satisfaction Survey|Death|0|||
144609856|NCT02966509|521432566|FG001|Baseline Satisfaction Survey|Death|1|||
144609857|NCT02966509|521432565|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
144609858|NCT02966509|521432566|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
144255865|NCT05052697|520136277|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255866|NCT05052697|520136278|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255867|NCT05052697|520136279|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144609859|NCT02966509|521432565|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
144255868|NCT05052697|520136280|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144609860|NCT02966509|521432566|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
144609861|NCT02966509|521432565|FG000|6 Month Satisfaction Decision Survey|Death|22|||
144609862|NCT02966509|521432566|FG001|6 Month Satisfaction Decision Survey|Death|25|||
144609863|NCT02966509|521432565|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
144609864|NCT02966509|521432566|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
144255869|NCT05052697|520136281|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255870|NCT05052697|520136282|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144609865|NCT02966509|521432565|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
144609866|NCT02966509|521432566|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
144255871|NCT05052697|520136283|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255872|NCT05052697|520136284|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255873|NCT05052697|520136285|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255874|NCT05052697|520136286|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
144255875|NCT05052697|520136287|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255876|NCT05052697|520136288|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255877|NCT05052697|520136289|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255878|NCT05052697|520136290|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255879|NCT05052697|520136291|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255880|NCT05052697|520136292|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255881|NCT05052697|520136293|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255882|NCT05052697|520136294|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
144255883|NCT05052697|520136295|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144609867|NCT02966509|521432565|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
144609868|NCT02966509|521432566|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
144609869|NCT02966509|521432565|FG000|6 Month Satisfaction Survey|Death|36|||
144609870|NCT02966509|521432566|FG001|6 Month Satisfaction Survey|Death|33|||
144609871|NCT02966509|521432565|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
144609872|NCT02966509|521432566|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
144609873|NCT02966509|521432565|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
144609874|NCT02966509|521432566|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
144609875|NCT02966509|521432565|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
144609876|NCT02966509|521432566|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
144609877|NCT02966509|521432565|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
144609878|NCT02966509|521432566|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
144609879|NCT02966509|521432565|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
144609880|NCT02966509|521432566|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
144609881|NCT00404820|521432567|FG000|Overall Study|Adverse Event|4|||
144609882|NCT00404820|521432568|FG001|Overall Study|Adverse Event|16|||
144609883|NCT00404820|521432567|FG000|Overall Study|Withdrawal by Subject|5|||
144609884|NCT00404820|521432568|FG001|Overall Study|Withdrawal by Subject|3|||
144609885|NCT00404820|521432567|FG000|Overall Study|Lost to Follow-up|7|||
144609886|NCT00404820|521432568|FG001|Overall Study|Lost to Follow-up|3|||
144609887|NCT00404820|521432567|FG000|Overall Study|Administrative problems|2|||
144609888|NCT00404820|521432568|FG001|Overall Study|Administrative problems|0|||
144609889|NCT00404820|521432567|FG000|Overall Study|Death|1|||
144609890|NCT00404820|521432568|FG001|Overall Study|Death|0|||
144609891|NCT00404820|521432567|FG000|Overall Study|Other|0|||
144609892|NCT00404820|521432568|FG001|Overall Study|Other|2|||
144609893|NCT01566773|521432569|FG000|Overall Study|Protocol specified criteria|4|||
144609894|NCT01566773|521432569|FG000|Overall Study|Protocol Violation|4|||
144609895|NCT01566773|521432569|FG000|Overall Study|Withdrawal by Subject|9|||
144609896|NCT01566773|521432569|FG000|Overall Study|Administrative reason|1|||
144609897|NCT01566773|521432569|FG000|Overall Study|Adverse Event|10|||
144609898|NCT01566773|521432569|FG000|Overall Study|Physician Decision|2|||
144609899|NCT00003535|521432570|FG000|Overall Study|Not evaluable|5|||
144609900|NCT02289742|521432575|FG000|First Wear Period|Adverse event prior to treatment|0|||
144609901|NCT02289742|521432576|FG001|First Wear Period|Adverse event prior to treatment|1|||
144609902|NCT02289742|521432577|FG002|First Wear Period|Adverse event prior to treatment|0|||
144609903|NCT02289742|521432578|FG003|First Wear Period|Adverse event prior to treatment|0|||
144609904|NCT02289742|521432575|FG000|First Wear Period|Adverse Event|0|||
144609905|NCT02289742|521432576|FG001|First Wear Period|Adverse Event|0|||
144609906|NCT02289742|521432577|FG002|First Wear Period|Adverse Event|1|||
144609907|NCT02289742|521432578|FG003|First Wear Period|Adverse Event|0|||
144609908|NCT02289742|521432575|FG000|First Wear Period|Other prior to treatment|0|||
144609909|NCT02289742|521432576|FG001|First Wear Period|Other prior to treatment|0|||
144255884|NCT05052697|520136296|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
144255885|NCT05052697|520136297|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144461836|NCT00710424|520886128|FG000|Overall Study|Ceased treatment due to travel|1|||
144461837|NCT00710424|520886129|FG001|Overall Study|Ceased treatment due to travel|0|||
144461838|NCT00710424|520886128|FG000|Overall Study|Subject preferred paracetamol|0|||
144461839|NCT00710424|520886129|FG001|Overall Study|Subject preferred paracetamol|1|||
144461840|NCT00710424|520886128|FG000|Overall Study|Felt good so stopped treatment|0|||
144461841|NCT00710424|520886129|FG001|Overall Study|Felt good so stopped treatment|1|||
144461842|NCT01962493|520886130|FG000|Overall Study|Adverse Event|1|||
144461843|NCT01962493|520886131|FG001|Overall Study|Adverse Event|2|||
144609910|NCT02289742|521432577|FG002|First Wear Period|Other prior to treatment|0|||
144609911|NCT02289742|521432578|FG003|First Wear Period|Other prior to treatment|1|||
144609912|NCT02289742|521432575|FG000|Third Wear Period|Adverse Event|0|||
144609913|NCT02289742|521432576|FG001|Third Wear Period|Adverse Event|1|||
144609914|NCT02289742|521432577|FG002|Third Wear Period|Adverse Event|0|||
144609915|NCT02289742|521432578|FG003|Third Wear Period|Adverse Event|0|||
144609916|NCT02289742|521432575|FG000|Third Wear Period|Reason not given|0|||
144461844|NCT01962493|520886130|FG000|Overall Study|Protocol Violation|0|||
144461845|NCT01962493|520886131|FG001|Overall Study|Protocol Violation|1|||
144461846|NCT01962493|520886130|FG000|Overall Study|Withdrawal by Subject|4|||
144461847|NCT01962493|520886131|FG001|Overall Study|Withdrawal by Subject|2|||
144461848|NCT03776136|520886132|FG000|Overall Study|Death|85|||
144461849|NCT03776136|520886132|FG000|Overall Study|Withdrawal by Subject|3|||
144609917|NCT02289742|521432576|FG001|Third Wear Period|Reason not given|0|||
144609918|NCT02289742|521432577|FG002|Third Wear Period|Reason not given|0|||
144609919|NCT02289742|521432578|FG003|Third Wear Period|Reason not given|1|||
144609920|NCT02865018|521432579|FG000|Overall Study|Withdrawal by Subject|1|||
144609921|NCT01365039|521432580|FG000|Overall Study|Study related symptoms and complaints|1|||
144609922|NCT01365039|521432581|FG001|Overall Study|Study related symptoms and complaints|0|||
144609923|NCT03807349|521432582|FG000|Overall Study|Early Study Termination|9|||
144609924|NCT00294060|521432583|FG000|Overall Study|Death|225|||
144609925|NCT00294060|521432583|FG000|Overall Study|Other|59|||
144609926|NCT00294060|521432583|FG000|Overall Study|Lost to Follow-up|55|||
144609927|NCT00294060|521432583|FG000|Overall Study|Withdrawal by Subject|11|||
144609928|NCT00294060|521432583|FG000|Overall Study|Physician Decision|797|||
144197092|NCT00251719|519918670|FG000|Overall Study|Barrett's esophagus|2|||
144197093|NCT00251719|519918671|FG001|Overall Study|Barrett's esophagus|2|||
144197094|NCT00251719|519918672|FG002|Overall Study|Barrett's esophagus|0|||
144197095|NCT02792959|519918675|FG000|Overall Study|Protocol Violation|1|||
144197096|NCT01780987|519918682|FG000|Overall Study|Adverse Event|0|||
144197097|NCT01780987|519918683|FG001|Overall Study|Adverse Event|4|||
144197098|NCT01780987|519918682|FG000|Overall Study|Withdrawal by Subject|2|||
144197099|NCT01780987|519918683|FG001|Overall Study|Withdrawal by Subject|0|||
144197100|NCT01780987|519918682|FG000|Overall Study|Request of Changing Hospital|0|||
144197101|NCT01780987|519918683|FG001|Overall Study|Request of Changing Hospital|1|||
144197102|NCT01780987|519918682|FG000|Overall Study|Changing Residence|1|||
144197103|NCT01780987|519918683|FG001|Overall Study|Changing Residence|0|||
144197104|NCT01780987|519918682|FG000|Overall Study|Not Receiving any Study Medication|0|||
144197105|NCT01780987|519918683|FG001|Overall Study|Not Receiving any Study Medication|1|||
144197106|NCT04168190|519918684|FG000|Overall Study|Lost to Follow-up|0|||
144197107|NCT04168190|519918685|FG001|Overall Study|Lost to Follow-up|1|||
144197108|NCT04168190|519918686|FG002|Overall Study|Lost to Follow-up|0|||
144197109|NCT04168190|519918687|FG003|Overall Study|Lost to Follow-up|7|||
144197110|NCT04168190|519918688|FG004|Overall Study|Lost to Follow-up|5|||
144197111|NCT04168190|519918684|FG000|Overall Study|Withdrawal by Subject|1|||
144197112|NCT04168190|519918685|FG001|Overall Study|Withdrawal by Subject|0|||
144197113|NCT04168190|519918686|FG002|Overall Study|Withdrawal by Subject|0|||
144197114|NCT04168190|519918687|FG003|Overall Study|Withdrawal by Subject|2|||
144197115|NCT04168190|519918688|FG004|Overall Study|Withdrawal by Subject|4|||
144197116|NCT04168190|519918684|FG000|Overall Study|Death|0|||
144197117|NCT04168190|519918685|FG001|Overall Study|Death|0|||
144197118|NCT04168190|519918686|FG002|Overall Study|Death|0|||
144197119|NCT04168190|519918687|FG003|Overall Study|Death|1|||
144197120|NCT04168190|519918688|FG004|Overall Study|Death|0|||
144197121|NCT02335983|519918689|FG000|Overall Study|Sponsor Decision|0|||
144197122|NCT02335983|519918690|FG001|Overall Study|Sponsor Decision|0|||
144197123|NCT02335983|519918691|FG002|Overall Study|Sponsor Decision|1|||
144197124|NCT02335983|519918692|FG003|Overall Study|Sponsor Decision|1|||
144197125|NCT02335983|519918693|FG004|Overall Study|Sponsor Decision|0|||
144197126|NCT02335983|519918694|FG005|Overall Study|Sponsor Decision|1|||
144197127|NCT02335983|519918689|FG000|Overall Study|Withdrawal by Subject|3|||
144197128|NCT02335983|519918690|FG001|Overall Study|Withdrawal by Subject|2|||
144197129|NCT02335983|519918691|FG002|Overall Study|Withdrawal by Subject|2|||
144197130|NCT02335983|519918692|FG003|Overall Study|Withdrawal by Subject|1|||
144197131|NCT02335983|519918693|FG004|Overall Study|Withdrawal by Subject|3|||
144197132|NCT02335983|519918694|FG005|Overall Study|Withdrawal by Subject|9|||
144197133|NCT02335983|519918689|FG000|Overall Study|Death|0|||
144197134|NCT02335983|519918690|FG001|Overall Study|Death|0|||
144197135|NCT02335983|519918691|FG002|Overall Study|Death|2|||
144197136|NCT02335983|519918692|FG003|Overall Study|Death|0|||
144197137|NCT02335983|519918693|FG004|Overall Study|Death|0|||
144197138|NCT02335983|519918694|FG005|Overall Study|Death|0|||
144197139|NCT02335983|519918689|FG000|Overall Study|Lost to Follow-up|0|||
144197140|NCT02335983|519918690|FG001|Overall Study|Lost to Follow-up|0|||
144197141|NCT02335983|519918691|FG002|Overall Study|Lost to Follow-up|0|||
144197142|NCT02335983|519918692|FG003|Overall Study|Lost to Follow-up|0|||
144197143|NCT02335983|519918693|FG004|Overall Study|Lost to Follow-up|0|||
144197144|NCT02335983|519918694|FG005|Overall Study|Lost to Follow-up|1|||
144197145|NCT02335983|519918689|FG000|Overall Study|Protocol Specified Criteria|5|||
144197146|NCT02335983|519918690|FG001|Overall Study|Protocol Specified Criteria|7|||
144197147|NCT02335983|519918691|FG002|Overall Study|Protocol Specified Criteria|27|||
144197148|NCT02335983|519918692|FG003|Overall Study|Protocol Specified Criteria|7|||
144197149|NCT02335983|519918693|FG004|Overall Study|Protocol Specified Criteria|5|||
144255886|NCT05052697|520136298|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144609929|NCT00294060|521432583|FG000|Overall Study|Medical condition|3|||
144609930|NCT00294060|521432583|FG000|Overall Study|Device explanted/not replaced|23|||
144255887|NCT05052697|520136299|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255888|NCT05052697|520136300|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255889|NCT05052697|520136301|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255890|NCT05052697|520136302|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
144255891|NCT05052697|520136269|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255892|NCT05052697|520136270|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255893|NCT05052697|520136271|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255894|NCT05052697|520136272|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255895|NCT05052697|520136273|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255896|NCT05052697|520136274|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255897|NCT05052697|520136275|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255898|NCT05052697|520136276|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255899|NCT05052697|520136277|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255900|NCT05052697|520136278|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255901|NCT05052697|520136279|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255902|NCT05052697|520136280|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255903|NCT05052697|520136281|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255904|NCT05052697|520136282|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255905|NCT05052697|520136283|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255906|NCT05052697|520136284|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255907|NCT05052697|520136285|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255908|NCT05052697|520136286|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255909|NCT05052697|520136287|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255910|NCT05052697|520136288|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255911|NCT05052697|520136289|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255912|NCT05052697|520136290|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255913|NCT05052697|520136291|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255914|NCT05052697|520136292|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255915|NCT05052697|520136293|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255916|NCT05052697|520136294|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255917|NCT05052697|520136295|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255918|NCT05052697|520136296|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255919|NCT05052697|520136297|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
144255920|NCT05052697|520136298|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255921|NCT05052697|520136299|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
144255922|NCT05052697|520136300|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
144255923|NCT05052697|520136301|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
144255924|NCT05052697|520136302|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
144255925|NCT05052697|520136269|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255926|NCT05052697|520136270|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255927|NCT05052697|520136271|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255928|NCT05052697|520136272|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255929|NCT05052697|520136273|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255930|NCT05052697|520136274|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255931|NCT05052697|520136275|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255932|NCT05052697|520136276|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255933|NCT05052697|520136277|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255934|NCT05052697|520136278|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255935|NCT05052697|520136279|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255936|NCT05052697|520136280|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255937|NCT05052697|520136281|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255938|NCT05052697|520136282|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255939|NCT05052697|520136283|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255940|NCT05052697|520136284|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255941|NCT05052697|520136285|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255942|NCT05052697|520136286|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255943|NCT05052697|520136287|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255944|NCT05052697|520136288|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255945|NCT05052697|520136289|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255946|NCT05052697|520136290|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255947|NCT05052697|520136291|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144535424|NCT04194450|521164058|FG000|Overall Study|not eligible|1|||
144535425|NCT04194450|521164059|FG001|Overall Study|not eligible|0|||
144255948|NCT05052697|520136292|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255949|NCT05052697|520136293|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255950|NCT05052697|520136294|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255951|NCT05052697|520136295|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144535426|NCT04757753|521164060|FG000|Overall Study|Lost to Follow-up|7|||
144255952|NCT05052697|520136296|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255953|NCT05052697|520136297|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
144255954|NCT05052697|520136298|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
144255955|NCT05052697|520136299|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
144255956|NCT05052697|520136300|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
144255957|NCT05052697|520136301|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
144255958|NCT05052697|520136302|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
144255959|NCT05052697|520136269|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255960|NCT05052697|520136270|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255961|NCT05052697|520136271|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255962|NCT05052697|520136272|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255963|NCT05052697|520136273|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255964|NCT05052697|520136274|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255965|NCT05052697|520136275|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255966|NCT05052697|520136276|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255967|NCT05052697|520136277|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255968|NCT05052697|520136278|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255969|NCT05052697|520136279|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255970|NCT05052697|520136280|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255971|NCT05052697|520136281|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255972|NCT05052697|520136282|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255973|NCT05052697|520136283|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255974|NCT05052697|520136284|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255975|NCT05052697|520136285|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255976|NCT05052697|520136286|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255977|NCT05052697|520136287|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255978|NCT05052697|520136288|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255979|NCT05052697|520136289|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255980|NCT05052697|520136290|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255981|NCT05052697|520136291|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255982|NCT05052697|520136292|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255983|NCT05052697|520136293|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255984|NCT05052697|520136294|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255985|NCT05052697|520136295|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255986|NCT05052697|520136296|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255987|NCT05052697|520136297|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255988|NCT05052697|520136298|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255989|NCT05052697|520136299|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255990|NCT05052697|520136300|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255991|NCT05052697|520136301|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
144255992|NCT05052697|520136302|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
144255993|NCT05052697|520136269|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144255994|NCT05052697|520136270|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144255995|NCT05052697|520136271|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144255996|NCT05052697|520136272|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144255997|NCT05052697|520136273|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144255998|NCT05052697|520136274|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144255999|NCT05052697|520136275|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256000|NCT05052697|520136276|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256001|NCT05052697|520136277|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256002|NCT05052697|520136278|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256003|NCT05052697|520136279|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256004|NCT05052697|520136280|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256005|NCT05052697|520136281|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256006|NCT05052697|520136282|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256007|NCT05052697|520136283|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256008|NCT05052697|520136284|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256009|NCT05052697|520136285|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256010|NCT05052697|520136286|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256011|NCT05052697|520136287|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256012|NCT05052697|520136288|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256013|NCT05052697|520136289|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256014|NCT05052697|520136290|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256015|NCT05052697|520136291|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256016|NCT05052697|520136292|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256017|NCT05052697|520136293|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256018|NCT05052697|520136294|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256019|NCT05052697|520136295|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256020|NCT05052697|520136296|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256021|NCT05052697|520136297|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
144256022|NCT05052697|520136298|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
144256023|NCT05052697|520136299|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
144256024|NCT05052697|520136300|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256025|NCT05052697|520136301|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256026|NCT05052697|520136302|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
144256027|NCT01900899|520136305|FG000|Overall Study|Withdrawal by Subject|7|||
144256028|NCT01900899|520136306|FG001|Overall Study|Withdrawal by Subject|1|||
144256029|NCT01900899|520136305|FG000|Overall Study|Migrated from study area|2|||
144256030|NCT01900899|520136306|FG001|Overall Study|Migrated from study area|0|||
144256031|NCT00534105|520136309|FG000|Overall Study|Lost to Follow-up|23|||
144256032|NCT00534105|520136310|FG001|Overall Study|Lost to Follow-up|39|||
144256033|NCT00978341|520136311|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
144256034|NCT00978341|520136312|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
144256035|NCT01402986|520136313|FG000|Overall Study|Withdrawal by Subject|7|||
144256036|NCT01402986|520136314|FG001|Overall Study|Withdrawal by Subject|10|||
144256037|NCT01402986|520136315|FG002|Overall Study|Withdrawal by Subject|7|||
144256038|NCT01402986|520136316|FG003|Overall Study|Withdrawal by Subject|13|||
144256039|NCT01402986|520136313|FG000|Overall Study|Death|0|||
144256040|NCT01402986|520136314|FG001|Overall Study|Death|0|||
144256041|NCT01402986|520136315|FG002|Overall Study|Death|0|||
144256042|NCT01402986|520136316|FG003|Overall Study|Death|2|||
144256043|NCT01402986|520136313|FG000|Overall Study|Lost to Follow-up|0|||
144256044|NCT01402986|520136314|FG001|Overall Study|Lost to Follow-up|0|||
144256045|NCT01402986|520136315|FG002|Overall Study|Lost to Follow-up|0|||
144256046|NCT01402986|520136316|FG003|Overall Study|Lost to Follow-up|1|||
144256047|NCT01402986|520136313|FG000|Overall Study|Other|2|||
144256048|NCT01402986|520136314|FG001|Overall Study|Other|5|||
144256049|NCT01402986|520136315|FG002|Overall Study|Other|1|||
144256050|NCT01402986|520136316|FG003|Overall Study|Other|6|||
144256051|NCT03749109|520136317|FG000|Overall Study|Adverse Event|2|||
144256052|NCT03749109|520136318|FG001|Overall Study|Adverse Event|0|||
144256053|NCT02634983|520136319|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
144256054|NCT02634983|520136320|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
144256055|NCT03178851|520136321|FG000|Overall Study|Death|48|||
144256056|NCT03178851|520136322|FG001|Overall Study|Death|2|||
144256057|NCT03178851|520136323|FG002|Overall Study|Death|25|||
144256058|NCT03178851|520136321|FG000|Overall Study|Withdrawal by Subject|8|||
144256059|NCT03178851|520136322|FG001|Overall Study|Withdrawal by Subject|0|||
144256060|NCT03178851|520136323|FG002|Overall Study|Withdrawal by Subject|0|||
144256061|NCT03178851|520136321|FG000|Overall Study|Lost to Follow-up|5|||
144256062|NCT03178851|520136322|FG001|Overall Study|Lost to Follow-up|2|||
144256063|NCT03178851|520136323|FG002|Overall Study|Lost to Follow-up|0|||
144256064|NCT03178851|520136321|FG000|Overall Study|Adverse Event|0|||
144256065|NCT03178851|520136322|FG001|Overall Study|Adverse Event|0|||
144256066|NCT03178851|520136323|FG002|Overall Study|Adverse Event|1|||
144256067|NCT03178851|520136321|FG000|Overall Study|Study Termination by Sponsor|31|||
144256068|NCT03178851|520136322|FG001|Overall Study|Study Termination by Sponsor|7|||
144256069|NCT03178851|520136323|FG002|Overall Study|Study Termination by Sponsor|26|||
144256070|NCT02226120|520136324|FG000|Overall Study|Adverse Event|60|||
144256071|NCT02226120|520136324|FG000|Overall Study|Death|172|||
144256072|NCT02226120|520136324|FG000|Overall Study|Study terminated by sponsor|1|||
144256073|NCT02226120|520136324|FG000|Overall Study|Technical problems|4|||
144256074|NCT02226120|520136324|FG000|Overall Study|Lost to Follow-up|13|||
144256075|NCT02226120|520136324|FG000|Overall Study|Physician Decision|21|||
144256076|NCT02226120|520136324|FG000|Overall Study|Withdrawal by parent/guardian|36|||
144256077|NCT02226120|520136324|FG000|Overall Study|Non-compliance with study drug|10|||
144256078|NCT02226120|520136324|FG000|Overall Study|Protocol deviation|1|||
144256079|NCT02226120|520136324|FG000|Overall Study|missing treatment disposition pages|2|||
144535427|NCT04757753|521164061|FG001|Overall Study|Lost to Follow-up|7|||
144256080|NCT00520767|520136328|FG000|Overall Study|Death|2|||
144256081|NCT02447328|520139368|FG000|Overall Study|Withdrawal by Subject|1|||
144535428|NCT04757753|521164060|FG000|Overall Study|Withdrawal by Subject|0|||
144535429|NCT04757753|521164061|FG001|Overall Study|Withdrawal by Subject|3|||
144256082|NCT00802672|520139372|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
144256083|NCT00802672|520139373|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
144256084|NCT00802672|520139374|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
144256085|NCT00802672|520139372|FG000|Overall Study|Adverse Event|1|||
144256086|NCT00802672|520139373|FG001|Overall Study|Adverse Event|1|||
144535430|NCT04757753|521164060|FG000|Overall Study|Endodontic treatment failure|1|||
144256087|NCT00802672|520139374|FG002|Overall Study|Adverse Event|1|||
144256088|NCT00802672|520139372|FG000|Overall Study|Protocol Violation|2|||
144256089|NCT00802672|520139373|FG001|Overall Study|Protocol Violation|1|||
144256090|NCT00802672|520139374|FG002|Overall Study|Protocol Violation|1|||
144256091|NCT00802672|520139372|FG000|Overall Study|Lost to Follow-up|5|||
144256092|NCT00802672|520139373|FG001|Overall Study|Lost to Follow-up|5|||
144256093|NCT00802672|520139374|FG002|Overall Study|Lost to Follow-up|3|||
144256094|NCT00802672|520139372|FG000|Overall Study|Withdrawal by Subject|1|||
144256095|NCT00802672|520139373|FG001|Overall Study|Withdrawal by Subject|1|||
144535431|NCT04757753|521164061|FG001|Overall Study|Endodontic treatment failure|2|||
144535432|NCT04757753|521164060|FG000|Overall Study|Tooth fracture/extraction|3|||
144535433|NCT04757753|521164061|FG001|Overall Study|Tooth fracture/extraction|0|||
144535434|NCT03201939|521164064|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
144535435|NCT03201939|521164065|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
144535436|NCT03333915|521164066|FG000|Overall Study|Lost to Follow-up|0|||
144535437|NCT03333915|521164067|FG001|Overall Study|Lost to Follow-up|0|||
144535438|NCT03333915|521164068|FG002|Overall Study|Lost to Follow-up|1|||
144535439|NCT03333915|521164069|FG003|Overall Study|Lost to Follow-up|0|||
144535440|NCT03333915|521164070|FG004|Overall Study|Lost to Follow-up|0|||
144535441|NCT03333915|521164066|FG000|Overall Study|Disease Progression|0|||
144535442|NCT03333915|521164067|FG001|Overall Study|Disease Progression|1|||
144535443|NCT03333915|521164068|FG002|Overall Study|Disease Progression|0|||
144535444|NCT03333915|521164069|FG003|Overall Study|Disease Progression|0|||
144535445|NCT03333915|521164070|FG004|Overall Study|Disease Progression|0|||
144535446|NCT03333915|521164066|FG000|Overall Study|Death|0|||
144535447|NCT03333915|521164067|FG001|Overall Study|Death|0|||
144535448|NCT03333915|521164068|FG002|Overall Study|Death|0|||
144535449|NCT03333915|521164069|FG003|Overall Study|Death|37|||
144535450|NCT03333915|521164070|FG004|Overall Study|Death|18|||
144535451|NCT03333915|521164066|FG000|Overall Study|Sponsor's Decision|0|||
144535452|NCT03333915|521164067|FG001|Overall Study|Sponsor's Decision|0|||
144535453|NCT03333915|521164068|FG002|Overall Study|Sponsor's Decision|0|||
144535454|NCT03333915|521164069|FG003|Overall Study|Sponsor's Decision|48|||
144535455|NCT03333915|521164070|FG004|Overall Study|Sponsor's Decision|4|||
144535456|NCT03333915|521164066|FG000|Overall Study|Withdrawal by Subject|0|||
144535457|NCT03333915|521164067|FG001|Overall Study|Withdrawal by Subject|0|||
144535458|NCT03333915|521164068|FG002|Overall Study|Withdrawal by Subject|0|||
144535459|NCT03333915|521164069|FG003|Overall Study|Withdrawal by Subject|5|||
144535460|NCT03333915|521164070|FG004|Overall Study|Withdrawal by Subject|1|||
144535461|NCT02206828|521164089|FG000|Overall Study|Lost to Follow-up|7|||
144535462|NCT05180539|521164765|FG000|Overall Study|Lost to Follow-up|27|||
144535463|NCT05180539|521164766|FG001|Overall Study|Lost to Follow-up|30|||
144535464|NCT00994643|521164769|FG000|Overall Study|Withdrawal by Subject|1|||
144535465|NCT04518943|521164771|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
144535466|NCT04518943|521164772|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
144535467|NCT04518943|521164773|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
144535468|NCT04518943|521164774|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
144535469|NCT04518943|521164775|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
144535470|NCT04518943|521164776|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
144535471|NCT04518943|521164777|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
144535472|NCT04518943|521164778|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
144535473|NCT04518943|521164779|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
144535474|NCT04518943|521164780|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
144535475|NCT04518943|521164781|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
144535476|NCT04518943|521164782|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
144535477|NCT04518943|521164783|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
144535478|NCT04518943|521164784|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
144535479|NCT04518943|521164785|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
144535480|NCT04518943|521164786|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
144535481|NCT00968149|521164787|FG000|Overall Study|Adverse Event|5|||
144535482|NCT00968149|521164788|FG001|Overall Study|Adverse Event|1|||
144535483|NCT00968149|521164787|FG000|Overall Study|Lack of Efficacy|0|||
144535484|NCT00968149|521164788|FG001|Overall Study|Lack of Efficacy|4|||
144535485|NCT00968149|521164787|FG000|Overall Study|Lost to Follow-up|0|||
144535486|NCT00968149|521164788|FG001|Overall Study|Lost to Follow-up|1|||
144535487|NCT00968149|521164787|FG000|Overall Study|Protocol Violation|4|||
144535488|NCT00968149|521164788|FG001|Overall Study|Protocol Violation|0|||
144535489|NCT00968149|521164787|FG000|Overall Study|Withdrawal by Subject|2|||
144535490|NCT00968149|521164788|FG001|Overall Study|Withdrawal by Subject|0|||
144535491|NCT00113360|521164789|FG000|Overall Study|Adverse Event|3|||
144535492|NCT00113360|521164789|FG000|Overall Study|Subject required surgery|1|||
144535493|NCT00113360|521164789|FG000|Overall Study|Did not meet eligibility criteria|3|||
144535494|NCT00328783|521164792|FG000|Overall Study|Could not tolerate ABC|21|||
144535495|NCT00328783|521164792|FG000|Overall Study|No heart in RT field|4|||
144535496|NCT00328783|521164792|FG000|Overall Study|Withdrawal by Subject|1|||
144535497|NCT03660930|521164794|FG000|Overall Study|Adverse Event|0|||
144535498|NCT03660930|521164795|FG001|Overall Study|Adverse Event|0|||
144535499|NCT03660930|521164796|FG002|Overall Study|Adverse Event|0|||
144535500|NCT03660930|521164797|FG003|Overall Study|Adverse Event|2|||
144535501|NCT03660930|521164798|FG004|Overall Study|Adverse Event|0|||
144535502|NCT03660930|521164799|FG005|Overall Study|Adverse Event|1|||
144609931|NCT01360554|521432584|FG000|Overall Study|Death|359|||
144609932|NCT01360554|521432585|FG001|Overall Study|Death|371|||
144609933|NCT01360554|521432584|FG000|Overall Study|Lost to Follow-up|4|||
144609934|NCT01360554|521432585|FG001|Overall Study|Lost to Follow-up|4|||
144609935|NCT01360554|521432584|FG000|Overall Study|Withdrawal by Subject|23|||
144609936|NCT01360554|521432585|FG001|Overall Study|Withdrawal by Subject|24|||
144609937|NCT01360554|521432584|FG000|Overall Study|Study terminated by sponsor|49|||
144609938|NCT01360554|521432585|FG001|Overall Study|Study terminated by sponsor|37|||
144609939|NCT01360554|521432584|FG000|Overall Study|Other, not specified|1|||
144609940|NCT01360554|521432585|FG001|Overall Study|Other, not specified|0|||
144609941|NCT01360554|521432584|FG000|Overall Study|Randomized but not treated.|3|||
144609942|NCT01360554|521432585|FG001|Overall Study|Randomized but not treated.|3|||
144609943|NCT00187096|521432586|FG000|Overall Study|unacceptable toxicity|0|||
144609944|NCT00187096|521432587|FG001|Overall Study|unacceptable toxicity|0|||
144609945|NCT00187096|521432588|FG002|Overall Study|unacceptable toxicity|1|||
144609946|NCT03668600|521432595|FG000|Overall Study|Study Terminated by the Sponsor|157|||
144609947|NCT03668600|521432595|FG000|Overall Study|Protocol Violation|1|||
144609948|NCT03668600|521432595|FG000|Overall Study|Pregnancy|1|||
144609949|NCT03668600|521432595|FG000|Overall Study|Lost to Follow-up|7|||
144609950|NCT03668600|521432595|FG000|Overall Study|Withdrawal by Subject|56|||
144609951|NCT03668600|521432595|FG000|Overall Study|Lack of Efficacy|7|||
144609952|NCT03668600|521432595|FG000|Overall Study|Adverse Event|1|||
144609953|NCT01263483|521432597|FG000|Overall Study|Adverse Event|4|||
144609954|NCT01263483|521432598|FG001|Overall Study|Adverse Event|0|||
144609955|NCT01263483|521432599|FG002|Overall Study|Adverse Event|3|||
144609956|NCT01263483|521432597|FG000|Overall Study|Withdrawal by Subject|1|||
144609957|NCT01263483|521432598|FG001|Overall Study|Withdrawal by Subject|0|||
144609958|NCT01263483|521432599|FG002|Overall Study|Withdrawal by Subject|0|||
144609959|NCT01263483|521432597|FG000|Overall Study|Lack of Efficacy|2|||
144609960|NCT01263483|521432598|FG001|Overall Study|Lack of Efficacy|0|||
144609961|NCT01263483|521432599|FG002|Overall Study|Lack of Efficacy|0|||
144609962|NCT01263483|521432597|FG000|Overall Study|Protocol Violation|0|||
144609963|NCT01263483|521432598|FG001|Overall Study|Protocol Violation|1|||
144609964|NCT01263483|521432599|FG002|Overall Study|Protocol Violation|1|||
144609965|NCT01263483|521432597|FG000|Overall Study|Participant Unavailability|0|||
144609966|NCT01263483|521432598|FG001|Overall Study|Participant Unavailability|1|||
144609967|NCT01263483|521432599|FG002|Overall Study|Participant Unavailability|1|||
144609968|NCT00326209|521432600|FG000|Overall Study|Adverse Event|28|||
144609969|NCT00326209|521432600|FG000|Overall Study|Withdrawal by Subject|22|||
144609970|NCT00326209|521432600|FG000|Overall Study|Lack of Efficacy|31|||
144609971|NCT00326209|521432600|FG000|Overall Study|Lost to Follow-up|18|||
144609972|NCT00326209|521432600|FG000|Overall Study|Participant non-compliant|6|||
144609973|NCT00326209|521432600|FG000|Overall Study|Sponsor closed study|173|||
144609974|NCT00326209|521432600|FG000|Overall Study|Prohibited medication use|1|||
144609975|NCT00326209|521432600|FG000|Overall Study|Violation of entry criteria|1|||
144609976|NCT00326209|521432600|FG000|Overall Study|Withdrawn in error|1|||
144609977|NCT00326209|521432600|FG000|Overall Study|Pregnancy|1|||
144609978|NCT01111851|521432603|FG000|Overall Study|All planned PET scans were not obtained.|2|||
144609979|NCT01111851|521432604|FG001|Overall Study|All planned PET scans were not obtained.|0|||
144609980|NCT05500274|521432605|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
144609981|NCT05500274|521432606|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
144609982|NCT05500274|521432605|FG000|Overall Study|Lost to Follow-up|76|||
144609983|NCT05500274|521432606|FG001|Overall Study|Lost to Follow-up|51|||
144609984|NCT05807464|521432609|FG000|Overall Study|Adverse Event|1|||
144609985|NCT04451161|521432610|FG000|Overall Study|Lost to Follow-up|28|||
144609986|NCT04451161|521432611|FG001|Overall Study|Lost to Follow-up|37|||
144609987|NCT04451161|521432612|FG002|Overall Study|Lost to Follow-up|22|||
144609988|NCT04451161|521432613|FG003|Overall Study|Lost to Follow-up|13|||
144609989|NCT04451161|521432614|FG004|Overall Study|Lost to Follow-up|11|||
144609990|NCT04451161|521432615|FG005|Overall Study|Lost to Follow-up|14|||
144609991|NCT04451161|521432610|FG000|Overall Study|Withdrawal by Subject|3|||
144609992|NCT04451161|521432611|FG001|Overall Study|Withdrawal by Subject|0|||
144609993|NCT04451161|521432612|FG002|Overall Study|Withdrawal by Subject|0|||
144609994|NCT04451161|521432613|FG003|Overall Study|Withdrawal by Subject|0|||
144609995|NCT04451161|521432614|FG004|Overall Study|Withdrawal by Subject|2|||
144609996|NCT04451161|521432615|FG005|Overall Study|Withdrawal by Subject|4|||
144609997|NCT03596866|521432617|FG000|Overall Study|Site terminated by Sponsor|64|||
144609998|NCT03596866|521432618|FG001|Overall Study|Site terminated by Sponsor|65|||
144609999|NCT03596866|521432617|FG000|Overall Study|Death|37|||
144610000|NCT03596866|521432618|FG001|Overall Study|Death|24|||
144610001|NCT03596866|521432617|FG000|Overall Study|Withdrawal by Subject|4|||
144610002|NCT03596866|521432618|FG001|Overall Study|Withdrawal by Subject|6|||
144610003|NCT03596866|521432617|FG000|Overall Study|Missing|0|||
144610004|NCT03596866|521432618|FG001|Overall Study|Missing|6|||
144610005|NCT03596866|521432617|FG000|Overall Study|Lost to Follow-up|2|||
144610006|NCT03596866|521432618|FG001|Overall Study|Lost to Follow-up|3|||
144610007|NCT03596866|521432617|FG000|Overall Study|Protocol Violation|1|||
144610008|NCT03596866|521432618|FG001|Overall Study|Protocol Violation|0|||
144256096|NCT00802672|520139374|FG002|Overall Study|Withdrawal by Subject|2|||
144256097|NCT00802672|520139372|FG000|Overall Study|other|3|||
144256098|NCT00802672|520139373|FG001|Overall Study|other|1|||
144256099|NCT00802672|520139374|FG002|Overall Study|other|2|||
144256100|NCT04336475|520139378|FG000|Overall Study|pain|1|||
144256101|NCT04336475|520139379|FG001|Overall Study|pain|0|||
144256102|NCT04336475|520139378|FG000|Overall Study|upper respiratory infection|1|||
144256103|NCT04336475|520139379|FG001|Overall Study|upper respiratory infection|0|||
144256104|NCT04336475|520139378|FG000|Overall Study|Lost to Follow-up|0|||
144256105|NCT04336475|520139379|FG001|Overall Study|Lost to Follow-up|2|||
144256106|NCT01990573|520139382|FG000|Overall Study|Physician Decision|0|||
144256107|NCT01990573|520139383|FG001|Overall Study|Physician Decision|0|||
144256108|NCT01990573|520139384|FG002|Overall Study|Physician Decision|1|||
144256109|NCT01763827|520139389|FG000|Overall Study|Withdrawal by Subject|1|||
144256110|NCT01763827|520139390|FG001|Overall Study|Withdrawal by Subject|0|||
144256111|NCT01763827|520139391|FG002|Overall Study|Withdrawal by Subject|0|||
144256112|NCT01763827|520139392|FG003|Overall Study|Withdrawal by Subject|0|||
144256113|NCT01763827|520139393|FG004|Overall Study|Withdrawal by Subject|2|||
144256114|NCT01763827|520139394|FG005|Overall Study|Withdrawal by Subject|0|||
144256115|NCT01763827|520139389|FG000|Overall Study|Decision by sponsor|2|||
144256116|NCT01763827|520139390|FG001|Overall Study|Decision by sponsor|0|||
144256117|NCT01763827|520139391|FG002|Overall Study|Decision by sponsor|3|||
144256118|NCT01763827|520139392|FG003|Overall Study|Decision by sponsor|0|||
144256119|NCT01763827|520139393|FG004|Overall Study|Decision by sponsor|2|||
144256120|NCT01763827|520139394|FG005|Overall Study|Decision by sponsor|1|||
144256121|NCT01763827|520139389|FG000|Overall Study|Lost to Follow-up|0|||
144256122|NCT01763827|520139390|FG001|Overall Study|Lost to Follow-up|1|||
144256123|NCT01763827|520139391|FG002|Overall Study|Lost to Follow-up|1|||
144256124|NCT01763827|520139392|FG003|Overall Study|Lost to Follow-up|1|||
144256125|NCT01763827|520139393|FG004|Overall Study|Lost to Follow-up|2|||
144256126|NCT01763827|520139394|FG005|Overall Study|Lost to Follow-up|1|||
144256127|NCT02030119|520139395|FG000|Overall Study|Withdrawal by Subject|3|||
144256128|NCT02030119|520139396|FG001|Overall Study|Withdrawal by Subject|1|||
144256129|NCT02030119|520139397|FG002|Overall Study|Withdrawal by Subject|5|||
144256130|NCT02030119|520139398|FG003|Overall Study|Withdrawal by Subject|3|||
144256131|NCT02030119|520139395|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
144256132|NCT02030119|520139396|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
144256133|NCT02030119|520139397|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
144256134|NCT02030119|520139398|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
144256135|NCT00759655|520139399|FG000|Overall Study|Termination of the study by sponsor|1|||
144256136|NCT00412932|520139402|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
144256137|NCT00412932|520139402|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
144256138|NCT00412932|520139402|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
144256139|NCT00412932|520139402|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
144256140|NCT00412932|520139402|FG000|Olmesartan (Olm) 20 mg|Other|1|||
144256141|NCT00412932|520139402|FG000|Olmesartan 40 mg|Adverse Event|4|||
144256142|NCT00412932|520139402|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
144256143|NCT00412932|520139402|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
144256144|NCT00412932|520139402|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
144256145|NCT00412932|520139402|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
144256146|NCT00412932|520139402|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
144256147|NCT00412932|520139402|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
144256148|NCT01310127|520139403|FG000|Overall Study|Protocol Violation|1|||
144256149|NCT01310127|520139404|FG001|Overall Study|Protocol Violation|1|||
144256150|NCT01310127|520139403|FG000|Overall Study|advanced psc cataract outlier|1|||
144256151|NCT01310127|520139404|FG001|Overall Study|advanced psc cataract outlier|0|||
144256152|NCT01025284|520139406|FG000|Overall Study|Investigator Decision|0|||
144256153|NCT01025284|520139407|FG001|Overall Study|Investigator Decision|1|||
144256154|NCT01025284|520139408|FG002|Overall Study|Investigator Decision|0|||
144256155|NCT01025284|520139406|FG000|Overall Study|Withdrawal by Subject|0|||
144256156|NCT01025284|520139407|FG001|Overall Study|Withdrawal by Subject|1|||
144256157|NCT01025284|520139408|FG002|Overall Study|Withdrawal by Subject|0|||
144256158|NCT00905567|520139409|FG000|Washout|Withdrawal by Subject|0|||
144256159|NCT00905567|520139410|FG001|Washout|Withdrawal by Subject|1|||
144256160|NCT00547248|520139415|FG000|Overall Study|Protocol Violation|0|||
144256161|NCT00547248|520139416|FG001|Overall Study|Protocol Violation|0|||
144256162|NCT00547248|520139417|FG002|Overall Study|Protocol Violation|1|||
144256163|NCT00547248|520139418|FG003|Overall Study|Protocol Violation|1|||
144256164|NCT00547248|520139415|FG000|Overall Study|Migrated/moved from study area|0|||
144256165|NCT00547248|520139416|FG001|Overall Study|Migrated/moved from study area|0|||
144256166|NCT00547248|520139417|FG002|Overall Study|Migrated/moved from study area|2|||
144256167|NCT00547248|520139418|FG003|Overall Study|Migrated/moved from study area|0|||
144256168|NCT00547248|520139415|FG000|Overall Study|Withdrawal by Subject|0|||
144256169|NCT00547248|520139416|FG001|Overall Study|Withdrawal by Subject|0|||
144256170|NCT00547248|520139417|FG002|Overall Study|Withdrawal by Subject|7|||
144256171|NCT00547248|520139418|FG003|Overall Study|Withdrawal by Subject|1|||
144610009|NCT03596866|521432617|FG000|Overall Study|Reason Not Specified|14|||
144610010|NCT03596866|521432618|FG001|Overall Study|Reason Not Specified|13|||
144610011|NCT01961349|521432619|FG000|Overall Study|Withdrawal by Subject|1|||
144610012|NCT01961349|521432620|FG001|Overall Study|Withdrawal by Subject|4|||
144610013|NCT01961349|521432621|FG002|Overall Study|Withdrawal by Subject|0|||
144610014|NCT01961349|521432619|FG000|Overall Study|Adverse Event|0|||
144610015|NCT01961349|521432620|FG001|Overall Study|Adverse Event|0|||
144610016|NCT01961349|521432621|FG002|Overall Study|Adverse Event|1|||
144610017|NCT01961349|521432619|FG000|Overall Study|registration error, personal reason etc|2|||
144610018|NCT01961349|521432620|FG001|Overall Study|registration error, personal reason etc|2|||
144610019|NCT01961349|521432621|FG002|Overall Study|registration error, personal reason etc|1|||
144610020|NCT00596947|521432622|FG000|Overall Study|study halted due to low enrollment|5|||
144610021|NCT00596947|521432623|FG001|Overall Study|study halted due to low enrollment|3|||
144610022|NCT00596947|521432622|FG000|Overall Study|Lost to Follow-up|1|||
144610023|NCT00596947|521432623|FG001|Overall Study|Lost to Follow-up|0|||
144610024|NCT00829179|521432624|FG000|Overall Study|Withdrawal by Subject|1|||
144610025|NCT02343159|521432625|FG000|Overall Study|Early Study Termination|16|||
144610026|NCT02343159|521432626|FG001|Overall Study|Early Study Termination|19|||
144610027|NCT02343159|521432627|FG002|Overall Study|Early Study Termination|23|||
144610028|NCT02343159|521432625|FG000|Overall Study|Physician Decision|2|||
144610029|NCT02343159|521432626|FG001|Overall Study|Physician Decision|0|||
144610030|NCT02343159|521432627|FG002|Overall Study|Physician Decision|1|||
144610031|NCT02343159|521432625|FG000|Overall Study|Withdrawal by Subject|3|||
144610032|NCT02343159|521432626|FG001|Overall Study|Withdrawal by Subject|0|||
144610033|NCT02343159|521432627|FG002|Overall Study|Withdrawal by Subject|2|||
144610034|NCT02343159|521432625|FG000|Overall Study|Lost to Follow-up|0|||
144610035|NCT02343159|521432626|FG001|Overall Study|Lost to Follow-up|2|||
144610036|NCT02343159|521432627|FG002|Overall Study|Lost to Follow-up|2|||
144610037|NCT02343159|521432625|FG000|Overall Study|Adverse Event|4|||
144610038|NCT02343159|521432626|FG001|Overall Study|Adverse Event|4|||
144610039|NCT02343159|521432627|FG002|Overall Study|Adverse Event|2|||
144610040|NCT02343159|521432625|FG000|Overall Study|Sponsor Decision|0|||
144610041|NCT02343159|521432626|FG001|Overall Study|Sponsor Decision|1|||
144610042|NCT02343159|521432627|FG002|Overall Study|Sponsor Decision|0|||
144610043|NCT02343159|521432625|FG000|Overall Study|Enrollment Error|1|||
144610044|NCT02343159|521432626|FG001|Overall Study|Enrollment Error|0|||
144610045|NCT02343159|521432627|FG002|Overall Study|Enrollment Error|0|||
144610046|NCT00545064|521432628|FG000|Overall Study|Lost to Follow-up|3|||
144610047|NCT00545064|521432628|FG000|Overall Study|Withdrawal by Subject|2|||
144610048|NCT00545064|521432628|FG000|Overall Study|did not complete course of treatment|1|||
144610049|NCT00545064|521432628|FG000|Overall Study|cancel all appointments, no rebooking|1|||
144610050|NCT00545064|521432628|FG000|Overall Study|inclement weather|1|||
144610051|NCT01506960|521432631|FG000|Overall Study|Did not meet angiographic criteria|47|||
144610052|NCT00789880|521432634|FG000|Overall Study|Adverse Event|0|||
144610053|NCT00789880|521432635|FG001|Overall Study|Adverse Event|0|||
144610054|NCT00789880|521432636|FG002|Overall Study|Adverse Event|0|||
144610055|NCT00789880|521432637|FG003|Overall Study|Adverse Event|0|||
144610056|NCT00789880|521432638|FG004|Overall Study|Adverse Event|1|||
144610057|NCT00789880|521432639|FG005|Overall Study|Adverse Event|0|||
144610058|NCT00789880|521432634|FG000|Overall Study|Protocol Violation|0|||
144610059|NCT00789880|521432635|FG001|Overall Study|Protocol Violation|1|||
144610060|NCT00789880|521432636|FG002|Overall Study|Protocol Violation|0|||
144610061|NCT00789880|521432637|FG003|Overall Study|Protocol Violation|1|||
144610062|NCT00789880|521432638|FG004|Overall Study|Protocol Violation|0|||
144610063|NCT00789880|521432639|FG005|Overall Study|Protocol Violation|0|||
144610064|NCT00789880|521432634|FG000|Overall Study|Withdrawal by Subject|1|||
144610065|NCT00789880|521432635|FG001|Overall Study|Withdrawal by Subject|0|||
144610066|NCT00789880|521432636|FG002|Overall Study|Withdrawal by Subject|0|||
144610067|NCT00789880|521432637|FG003|Overall Study|Withdrawal by Subject|0|||
144610068|NCT00789880|521432638|FG004|Overall Study|Withdrawal by Subject|2|||
144610069|NCT00789880|521432639|FG005|Overall Study|Withdrawal by Subject|0|||
144610070|NCT00609986|521432641|FG000|Overall Study|Did not receive transplant or treatment|8|||
144610071|NCT00609986|521432642|FG001|Overall Study|Did not receive transplant or treatment|3|||
144610072|NCT04814823|521432643|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
144610073|NCT05318937|521432648|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144610074|NCT05318937|521432649|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144610075|NCT05318937|521432648|FG000|Overall Study|Lost to Follow-up|0|||
144610076|NCT05318937|521432649|FG001|Overall Study|Lost to Follow-up|1|||
144610077|NCT05318937|521432648|FG000|Overall Study|Withdrawal by Subject|0|||
144610078|NCT05318937|521432649|FG001|Overall Study|Withdrawal by Subject|2|||
144610079|NCT05318937|521432648|FG000|Overall Study|Protocol Violation|0|||
144610080|NCT05318937|521432649|FG001|Overall Study|Protocol Violation|1|||
144461850|NCT03776136|520886132|FG000|Overall Study|Sponsor Decision|15|||
144610081|NCT04722042|521432650|FG000|Overall Study|Withdrawal by Subject|2|||
144610082|NCT04722042|521432651|FG001|Overall Study|Withdrawal by Subject|1|||
144610083|NCT04722042|521432652|FG002|Overall Study|Withdrawal by Subject|0|||
144256172|NCT00534248|520139419|FG000|Overall Study|Adverse Event|19|||
144256173|NCT00534248|520139420|FG001|Overall Study|Adverse Event|29|||
144256174|NCT00534248|520139419|FG000|Overall Study|Lost to Follow-up|353|||
144256175|NCT00534248|520139420|FG001|Overall Study|Lost to Follow-up|375|||
144256176|NCT00534248|520139419|FG000|Overall Study|Other protocol specified criteria|13|||
144256177|NCT00534248|520139420|FG001|Overall Study|Other protocol specified criteria|3|||
144256178|NCT00534248|520139419|FG000|Overall Study|Physician Decision|10|||
144256179|NCT00534248|520139420|FG001|Overall Study|Physician Decision|7|||
144256180|NCT00534248|520139419|FG000|Overall Study|Protocol Violation|3|||
144256181|NCT00534248|520139420|FG001|Overall Study|Protocol Violation|4|||
144256182|NCT00534248|520139419|FG000|Overall Study|Withdrawal by Subject|263|||
144256183|NCT00534248|520139420|FG001|Overall Study|Withdrawal by Subject|255|||
144256184|NCT02259400|520139425|FG000|Overall Study|Death|0|||
144256185|NCT02259400|520139426|FG001|Overall Study|Death|2|||
144256186|NCT00697593|520139428|FG000|Overall Study|Adverse Event|3|||
144256187|NCT00697593|520139428|FG000|Overall Study|Protocol Violation|1|||
144256188|NCT00697593|520139428|FG000|Overall Study|Lack of Efficacy|3|||
144256189|NCT00697593|520139428|FG000|Overall Study|Suspension of the study by sponsor|12|||
144256190|NCT02630563|520139431|FG000|Overall Study|Administrative|1|||
144256191|NCT02061813|520139434|FG000|Overall Study|Withdrawal by Subject|1|||
144256192|NCT02061813|520139434|FG000|Overall Study|Protocol Violation|2|||
144256193|NCT02075008|520139437|FG000|Overall Study|Technical problems|1|||
144256194|NCT02075008|520139437|FG000|Overall Study|Pregnancy|1|||
144256195|NCT02075008|520139437|FG000|Overall Study|Physician Decision|1|||
144256196|NCT02075008|520139437|FG000|Overall Study|Lost to Follow-up|1|||
144256197|NCT02075008|520139437|FG000|Overall Study|Lack of Efficacy|1|||
144256198|NCT02075008|520139437|FG000|Overall Study|Death|1|||
144256199|NCT02075008|520139437|FG000|Overall Study|Adverse Event|5|||
144256200|NCT02075008|520139437|FG000|Overall Study|Withdrawal by Subject|6|||
144610084|NCT04490018|521432660|FG000|Overall Study|Protocol Violation|0|||
144256201|NCT02075008|520139437|FG000|Overall Study|Study terminated by Sponsor|159|||
144256202|NCT03042910|520139440|FG000|Overall Study|Adverse Event|1|||
144256203|NCT03042910|520139440|FG000|Overall Study|Disease Progression|2|||
144610085|NCT04490018|521432661|FG001|Overall Study|Protocol Violation|2|||
144610086|NCT04490018|521432662|FG002|Overall Study|Protocol Violation|1|||
144610087|NCT04490018|521432660|FG000|Overall Study|Lost to Follow-up|2|||
144610088|NCT04490018|521432661|FG001|Overall Study|Lost to Follow-up|2|||
144610089|NCT04490018|521432662|FG002|Overall Study|Lost to Follow-up|0|||
144610090|NCT04490018|521432660|FG000|Overall Study|Withdrawal by Subject|2|||
144610091|NCT04490018|521432661|FG001|Overall Study|Withdrawal by Subject|1|||
144610092|NCT04490018|521432662|FG002|Overall Study|Withdrawal by Subject|0|||
144610093|NCT04490018|521432660|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144610094|NCT04490018|521432661|FG001|Overall Study|Withdrawal by parent/guardian|3|||
144610095|NCT04490018|521432662|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144610096|NCT02269787|521432665|FG000|Overall Study|Lost to Follow-up|20|||
144610097|NCT02269787|521432666|FG001|Overall Study|Lost to Follow-up|6|||
144610098|NCT02269787|521432665|FG000|Overall Study|Death|2|||
144610099|NCT02269787|521432666|FG001|Overall Study|Death|3|||
144610100|NCT02269787|521432665|FG000|Overall Study|Incapacitated|0|||
144610101|NCT02269787|521432666|FG001|Overall Study|Incapacitated|1|||
144610102|NCT00798135|521432667|FG000|Overall Study|Disease progression, relapse|11|||
144610103|NCT00798135|521432667|FG000|Overall Study|Disease progression, refractory|1|||
144610104|NCT00798135|521432667|FG000|Overall Study|Physician Decision|1|||
144610105|NCT00687440|521432668|FG000|Overall Study|Adverse Event|3|||
144610106|NCT00687440|521432668|FG000|Overall Study|Lost to Follow-up|3|||
144610107|NCT00687440|521432668|FG000|Overall Study|Lack of Efficacy|2|||
144610108|NCT00687440|521432668|FG000|Overall Study|Death|2|||
144610109|NCT00687440|521432668|FG000|Overall Study|Other|1|||
144610110|NCT00687440|521432668|FG000|Overall Study|Missing|1|||
144610111|NCT02228720|521432669|FG000|Open Label - Day 30|Lost to Follow-up|1|||
144610112|NCT03337542|521432670|FG000|Overall Study|Withdrew Consent|17|||
144610113|NCT03337542|521432670|FG000|Overall Study|Allergic Adverse Event|1|||
144610114|NCT03337542|521432670|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
144610115|NCT03337542|521432670|FG000|Overall Study|Lost to Follow-up|1|||
144610116|NCT03337542|521432670|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
144610117|NCT01401842|521432671|FG000|Overall Study|Withdrawal by Subject|3|||
144725960|NCT00688064|521852654|FG000|Overall Study|Withdrawal by Subject|7|||
144256204|NCT03042910|520139440|FG000|Overall Study|Withdrawal by Subject|3|||
144256205|NCT03042910|520139440|FG000|Overall Study|Enrolled but not treated|1|||
144610118|NCT01401842|521432672|FG001|Overall Study|Withdrawal by Subject|2|||
144610119|NCT01401842|521432671|FG000|Overall Study|academic reason|4|||
144725961|NCT00688064|521852655|FG001|Overall Study|Withdrawal by Subject|7|||
144610120|NCT01401842|521432672|FG001|Overall Study|academic reason|1|||
144610121|NCT01401842|521432671|FG000|Overall Study|changed companies|20|||
144256206|NCT02187861|520139441|FG000|Overall Study|Adverse Event|2|||
144256207|NCT02187861|520139442|FG001|Overall Study|Adverse Event|1|||
144256208|NCT02187861|520139443|FG002|Overall Study|Adverse Event|2|||
144610122|NCT01401842|521432672|FG001|Overall Study|changed companies|34|||
144610123|NCT01401842|521432671|FG000|Overall Study|discharged from US Army|3|||
144256209|NCT02187861|520139444|FG003|Overall Study|Adverse Event|1|||
144256210|NCT02187861|520139441|FG000|Overall Study|Death|0|||
144256211|NCT02187861|520139442|FG001|Overall Study|Death|3|||
144256212|NCT02187861|520139443|FG002|Overall Study|Death|1|||
144256213|NCT02187861|520139444|FG003|Overall Study|Death|2|||
144256214|NCT02187861|520139441|FG000|Overall Study|Physician Decision|0|||
144256215|NCT02187861|520139442|FG001|Overall Study|Physician Decision|1|||
144256216|NCT02187861|520139443|FG002|Overall Study|Physician Decision|0|||
144256217|NCT02187861|520139444|FG003|Overall Study|Physician Decision|3|||
144256218|NCT02187861|520139441|FG000|Overall Study|Progressive Disease|4|||
144256219|NCT02187861|520139442|FG001|Overall Study|Progressive Disease|42|||
144256220|NCT02187861|520139443|FG002|Overall Study|Progressive Disease|19|||
144256221|NCT02187861|520139444|FG003|Overall Study|Progressive Disease|22|||
144256222|NCT02187861|520139441|FG000|Overall Study|Withdrawal by Subject|0|||
144256223|NCT02187861|520139442|FG001|Overall Study|Withdrawal by Subject|0|||
144256224|NCT02187861|520139443|FG002|Overall Study|Withdrawal by Subject|3|||
144256225|NCT02187861|520139444|FG003|Overall Study|Withdrawal by Subject|3|||
144256226|NCT02187861|520139441|FG000|Overall Study|Other|0|||
144256227|NCT02187861|520139442|FG001|Overall Study|Other|1|||
144256228|NCT02187861|520139443|FG002|Overall Study|Other|7|||
144256229|NCT02187861|520139444|FG003|Overall Study|Other|1|||
144256230|NCT04105842|520139445|FG000|Overall Study|Withdrawal by Subject|2|||
144256231|NCT01301079|520139446|FG000|Overall Study|Lost to Follow-up|2|||
144256232|NCT01301079|520139447|FG001|Overall Study|Lost to Follow-up|2|||
144256233|NCT01639703|520139450|FG000|Overall Study|Withdrawal by Subject|5|||
144256234|NCT01639703|520139450|FG000|Overall Study|Other reason|7|||
144256235|NCT02087670|520139451|FG000|Overall Study|Withdrawal by Subject|3|||
144256236|NCT02087670|520139452|FG001|Overall Study|Withdrawal by Subject|2|||
144256237|NCT01308463|520139454|FG000|Overall Study|Study Discontinued|23|||
144256238|NCT01308463|520139454|FG000|Overall Study|Death|4|||
144256239|NCT01308463|520139454|FG000|Overall Study|Revision|2|||
144256240|NCT03519919|520139455|FG000|Overall Study|Withdrawal by Subject|1|||
144256241|NCT03519919|520139455|FG000|Overall Study|Lack of Efficacy|1|||
144256242|NCT03519919|520139455|FG000|Overall Study|Screen Failure|1|||
144256243|NCT03117361|520139456|FG000|Overall Study|Progressive disease|5|||
144256244|NCT03117361|520139456|FG000|Overall Study|Death|1|||
144256245|NCT03117361|520139456|FG000|Overall Study|Physician Decision|2|||
144256246|NCT03117361|520139456|FG000|Overall Study|On study treatment at the end of study|1|||
144256247|NCT03117361|520139456|FG000|Overall Study|Treatment-related adverse event|1|||
144256248|NCT02144077|520139457|FG000|Overall Study|Withdrawal by Subject|3|||
144256249|NCT02144077|520139458|FG001|Overall Study|Withdrawal by Subject|3|||
144256250|NCT02144077|520139457|FG000|Overall Study|Adverse Event|2|||
144256251|NCT02144077|520139458|FG001|Overall Study|Adverse Event|3|||
144256252|NCT02144077|520139457|FG000|Overall Study|Lost to Follow-up|2|||
144256253|NCT02144077|520139458|FG001|Overall Study|Lost to Follow-up|2|||
144256254|NCT02144077|520139457|FG000|Overall Study|Protocol Violation|1|||
144256255|NCT02144077|520139458|FG001|Overall Study|Protocol Violation|2|||
144256256|NCT02144077|520139457|FG000|Overall Study|Death|0|||
144256257|NCT02144077|520139458|FG001|Overall Study|Death|1|||
144256258|NCT02144077|520139457|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
144256259|NCT02144077|520139458|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
144256260|NCT02072941|520139459|FG000|Overall Study|Withdrawal by Subject|29|||
144256261|NCT02072941|520139460|FG001|Overall Study|Withdrawal by Subject|21|||
144256262|NCT02072941|520139459|FG000|Overall Study|Lost to Follow-up|4|||
144256263|NCT02072941|520139460|FG001|Overall Study|Lost to Follow-up|4|||
144256264|NCT02072941|520139459|FG000|Overall Study|Death|3|||
144256265|NCT02072941|520139460|FG001|Overall Study|Death|2|||
144256266|NCT02072941|520139459|FG000|Overall Study|Removed by Study Staff|2|||
144256267|NCT02072941|520139460|FG001|Overall Study|Removed by Study Staff|2|||
144256268|NCT01247350|520139461|FG000|Overall Study|Adverse Event|0|||
144256269|NCT01247350|520139462|FG001|Overall Study|Adverse Event|0|||
144256270|NCT01247350|520139463|FG002|Overall Study|Adverse Event|1|||
144256271|NCT01247350|520139464|FG003|Overall Study|Adverse Event|0|||
144256272|NCT01247350|520139465|FG004|Overall Study|Adverse Event|0|||
144256273|NCT01247350|520139461|FG000|Overall Study|Withdrawal by Subject|0|||
144256274|NCT01247350|520139462|FG001|Overall Study|Withdrawal by Subject|0|||
144256275|NCT01247350|520139463|FG002|Overall Study|Withdrawal by Subject|0|||
144256276|NCT01247350|520139464|FG003|Overall Study|Withdrawal by Subject|1|||
144256277|NCT01247350|520139465|FG004|Overall Study|Withdrawal by Subject|0|||
144256278|NCT01247350|520139461|FG000|Overall Study|Entry criteria not met|0|||
144256279|NCT01247350|520139462|FG001|Overall Study|Entry criteria not met|0|||
144535503|NCT03660930|521164800|FG006|Overall Study|Adverse Event|0|||
144535504|NCT03660930|521164801|FG007|Overall Study|Adverse Event|0|||
144256280|NCT01247350|520139463|FG002|Overall Study|Entry criteria not met|0|||
144256281|NCT01247350|520139464|FG003|Overall Study|Entry criteria not met|0|||
144256282|NCT01247350|520139465|FG004|Overall Study|Entry criteria not met|1|||
144256283|NCT02020889|520139466|FG000|Overall Study|Adverse Event|0|||
144256284|NCT02020889|520139467|FG001|Overall Study|Adverse Event|1|||
144256285|NCT02020889|520139466|FG000|Overall Study|Lack of Efficacy|1|||
144725962|NCT00688064|521852654|FG000|Overall Study|Lost to Follow-up|10|||
144256286|NCT02020889|520139467|FG001|Overall Study|Lack of Efficacy|0|||
144256287|NCT02020889|520139466|FG000|Overall Study|Lost to Follow-up|1|||
144256288|NCT02020889|520139467|FG001|Overall Study|Lost to Follow-up|0|||
144256289|NCT02020889|520139466|FG000|Overall Study|Physician Decision|2|||
144256290|NCT02020889|520139467|FG001|Overall Study|Physician Decision|0|||
144256291|NCT02020889|520139466|FG000|Overall Study|Withdrawal by Subject|3|||
144256292|NCT02020889|520139467|FG001|Overall Study|Withdrawal by Subject|2|||
144256293|NCT02260817|520139469|FG000|Overall Study|Lost to Follow-up|0|||
144256294|NCT02260817|520139470|FG001|Overall Study|Lost to Follow-up|14|||
144256295|NCT02260817|520139469|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
144256296|NCT02260817|520139470|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
144256297|NCT02260817|520139469|FG000|Overall Study|Observation, no biopsy|0|||
144256298|NCT02260817|520139470|FG001|Overall Study|Observation, no biopsy|1|||
144256299|NCT02260817|520139469|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
144256300|NCT02260817|520139470|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
144256301|NCT02260817|520139469|FG000|Overall Study|Protocol Violation|0|||
144256302|NCT02260817|520139470|FG001|Overall Study|Protocol Violation|14|||
144256303|NCT01882803|520139473|FG000|Overall Study|Disease Progression|1|||
144256304|NCT01882803|520139473|FG000|Overall Study|Withdrawal by Subject|9|||
144256305|NCT01882803|520139473|FG000|Overall Study|Death|68|||
144256306|NCT01882803|520139473|FG000|Overall Study|Physician Decision|3|||
144256307|NCT01882803|520139473|FG000|Overall Study|Lost to Follow-up|3|||
144256308|NCT01882803|520139473|FG000|Overall Study|Follow-up Completed|39|||
144256309|NCT01882803|520139473|FG000|Overall Study|Study Terminated by the Sponsor|6|||
144256310|NCT02081001|520139474|FG000|Overall Study|Adverse Event|0|||
144256311|NCT02081001|520139475|FG001|Overall Study|Adverse Event|0|||
144256312|NCT02081001|520139476|FG002|Overall Study|Adverse Event|0|||
144256313|NCT02081001|520139477|FG003|Overall Study|Adverse Event|0|||
144256314|NCT02081001|520139478|FG004|Overall Study|Adverse Event|1|||
144256315|NCT02081001|520139479|FG005|Overall Study|Adverse Event|0|||
144256316|NCT02081001|520139480|FG006|Overall Study|Adverse Event|0|||
144256317|NCT02081001|520139481|FG007|Overall Study|Adverse Event|0|||
144256318|NCT02081001|520139482|FG008|Overall Study|Adverse Event|0|||
144256319|NCT02081001|520139483|FG009|Overall Study|Adverse Event|0|||
144256320|NCT02081001|520139484|FG010|Overall Study|Adverse Event|0|||
144256321|NCT02081001|520139485|FG011|Overall Study|Adverse Event|0|||
144256322|NCT01765569|520139486|FG000|Period B|Withdrawal by Subject|1|||
144256323|NCT01765569|520139486|FG000|Period C|Death|1|||
144256324|NCT01030718|520139487|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
144256325|NCT01030718|520139488|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
144256326|NCT01030718|520139489|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
144256327|NCT01030718|520139487|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
144256328|NCT01030718|520139488|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
144256329|NCT01030718|520139489|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
144256330|NCT01030718|520139487|FG000|Studies CA180-031 and -036 Combined|Death|0|||
144256331|NCT01030718|520139488|FG001|Studies CA180-031 and -036 Combined|Death|1|||
144256332|NCT01030718|520139489|FG002|Studies CA180-031 and -036 Combined|Death|0|||
144256333|NCT01030718|520139487|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
144256334|NCT01030718|520139488|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
144256335|NCT01030718|520139489|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
144256336|NCT01030718|520139487|FG000|Study CA180-036 Only|insufficient effect|1|||
144256337|NCT01030718|520139488|FG001|Study CA180-036 Only|insufficient effect|1|||
144256338|NCT01030718|520139489|FG002|Study CA180-036 Only|insufficient effect|5|||
144256339|NCT01030718|520139487|FG000|Study CA180-036 Only|Adverse Event|2|||
144256340|NCT01030718|520139488|FG001|Study CA180-036 Only|Adverse Event|3|||
144256341|NCT01030718|520139489|FG002|Study CA180-036 Only|Adverse Event|0|||
144256342|NCT01030718|520139487|FG000|Study CA180-036 Only|Death|0|||
144256343|NCT01030718|520139488|FG001|Study CA180-036 Only|Death|1|||
144256344|NCT01030718|520139489|FG002|Study CA180-036 Only|Death|0|||
144610124|NCT01401842|521432672|FG001|Overall Study|discharged from US Army|4|||
144610125|NCT01401842|521432671|FG000|Overall Study|invalid follow-up strength data|1|||
144256345|NCT01030718|520139487|FG000|Study CA180-036 Only|Other Reasons|0|||
144256346|NCT01030718|520139488|FG001|Study CA180-036 Only|Other Reasons|2|||
144256347|NCT01030718|520139489|FG002|Study CA180-036 Only|Other Reasons|0|||
144256348|NCT00423813|520139490|FG000|Overall Study|Adverse Event|11|||
144256349|NCT00423813|520139491|FG001|Overall Study|Adverse Event|30|||
144256350|NCT00423813|520139492|FG002|Overall Study|Adverse Event|40|||
144256351|NCT00423813|520139490|FG000|Overall Study|Withdrawal by Subject|6|||
144256352|NCT00423813|520139491|FG001|Overall Study|Withdrawal by Subject|8|||
144256353|NCT00423813|520139492|FG002|Overall Study|Withdrawal by Subject|5|||
144256354|NCT00423813|520139490|FG000|Overall Study|Lost to Follow-up|5|||
144256355|NCT00423813|520139491|FG001|Overall Study|Lost to Follow-up|4|||
144256356|NCT00423813|520139492|FG002|Overall Study|Lost to Follow-up|4|||
144256357|NCT00423813|520139490|FG000|Overall Study|Lack of Efficacy|23|||
144256358|NCT00423813|520139491|FG001|Overall Study|Lack of Efficacy|18|||
144256359|NCT00423813|520139492|FG002|Overall Study|Lack of Efficacy|19|||
144610126|NCT01401842|521432672|FG001|Overall Study|invalid follow-up strength data|4|||
144256360|NCT00423813|520139490|FG000|Overall Study|Physician Decision|2|||
144256361|NCT00423813|520139491|FG001|Overall Study|Physician Decision|0|||
144256362|NCT00423813|520139492|FG002|Overall Study|Physician Decision|0|||
144256363|NCT00423813|520139490|FG000|Overall Study|Sponsor Decision|0|||
144256364|NCT00423813|520139491|FG001|Overall Study|Sponsor Decision|1|||
144256365|NCT00423813|520139492|FG002|Overall Study|Sponsor Decision|0|||
144256366|NCT00423813|520139490|FG000|Overall Study|Protocol Violation|9|||
144256367|NCT00423813|520139491|FG001|Overall Study|Protocol Violation|4|||
144256368|NCT00423813|520139492|FG002|Overall Study|Protocol Violation|4|||
144256369|NCT00423813|520139490|FG000|Overall Study|Pregnancy|0|||
144256370|NCT00423813|520139491|FG001|Overall Study|Pregnancy|0|||
144256371|NCT00423813|520139492|FG002|Overall Study|Pregnancy|1|||
144256372|NCT00423813|520139490|FG000|Overall Study|Subject started night shift work|1|||
144256373|NCT00423813|520139491|FG001|Overall Study|Subject started night shift work|0|||
144256374|NCT00423813|520139492|FG002|Overall Study|Subject started night shift work|0|||
144256375|NCT00423813|520139490|FG000|Overall Study|Will start exclusionary medications|0|||
144256376|NCT00423813|520139491|FG001|Overall Study|Will start exclusionary medications|1|||
144256377|NCT00423813|520139492|FG002|Overall Study|Will start exclusionary medications|0|||
144256378|NCT00423813|520139490|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
144256379|NCT00423813|520139491|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
144256380|NCT00423813|520139492|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
144256381|NCT01386944|520139493|FG000|Overall Study|Adverse Event|26|||
144256382|NCT01386944|520139493|FG000|Overall Study|Lack of Efficacy|14|||
144256383|NCT01386944|520139493|FG000|Overall Study|Lost to Follow-up|8|||
144256384|NCT01386944|520139493|FG000|Overall Study|Unspecified reason|8|||
144256385|NCT04186221|520139495|FG000|Overall Study|Death|1|||
144256386|NCT01904032|520139504|FG000|Overall Study|Adverse Event|3|||
144256387|NCT01904032|520139505|FG001|Overall Study|Adverse Event|1|||
144256388|NCT01904032|520139504|FG000|Overall Study|Lost to Follow-up|4|||
144256389|NCT01904032|520139505|FG001|Overall Study|Lost to Follow-up|2|||
144256390|NCT00531947|520139506|FG000|Overall Study|Adverse Event|5|||
144256391|NCT00531947|520139507|FG001|Overall Study|Adverse Event|10|||
144256392|NCT00531947|520139506|FG000|Overall Study|Lost to Follow-up|12|||
144256393|NCT00531947|520139507|FG001|Overall Study|Lost to Follow-up|9|||
144256394|NCT00531947|520139506|FG000|Overall Study|Withdrawal by Subject|14|||
144256395|NCT00531947|520139507|FG001|Overall Study|Withdrawal by Subject|19|||
144256396|NCT00531947|520139506|FG000|Overall Study|Protocol Violation|2|||
144256397|NCT00531947|520139507|FG001|Overall Study|Protocol Violation|1|||
144256398|NCT00531947|520139506|FG000|Overall Study|Non-Compliance|4|||
144256399|NCT00531947|520139507|FG001|Overall Study|Non-Compliance|7|||
144256400|NCT00531947|520139506|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
144256401|NCT00531947|520139507|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
144256402|NCT03148067|520139514|FG000|Overall Study|Lost to Follow-up|3|||
144256403|NCT03148067|520139514|FG000|Overall Study|Death|1|||
144256404|NCT02383355|520139519|FG000|Overall Study|Adverse Event|2|||
144256405|NCT02383355|520139520|FG001|Overall Study|Adverse Event|0|||
144256406|NCT04074330|520139526|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
144256407|NCT04074330|520139527|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
144256408|NCT04074330|520139528|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
144256409|NCT04074330|520139529|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
144256410|NCT04074330|520139530|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
144256411|NCT04074330|520139531|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
144256412|NCT04074330|520139532|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
144256413|NCT04074330|520139533|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
144256414|NCT04074330|520139534|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
144256415|NCT04074330|520139535|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
144256416|NCT04074330|520139526|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
144256417|NCT04074330|520139527|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
144256418|NCT04074330|520139528|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
144256419|NCT04074330|520139529|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
144256420|NCT04074330|520139530|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
144256421|NCT04074330|520139531|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
144256422|NCT04074330|520139532|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
144535505|NCT03660930|521164794|FG000|Overall Study|Withdrawal by Subject|0|||
144256423|NCT04074330|520139533|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
144256424|NCT04074330|520139534|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
144256425|NCT04074330|520139535|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
144256426|NCT04074330|520139526|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256427|NCT04074330|520139527|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256428|NCT04074330|520139528|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
144256429|NCT04074330|520139529|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256430|NCT04074330|520139530|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256431|NCT04074330|520139531|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256432|NCT04074330|520139532|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256433|NCT04074330|520139533|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256434|NCT04074330|520139534|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256435|NCT04074330|520139535|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
144256436|NCT04074330|520139526|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256437|NCT04074330|520139527|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256438|NCT04074330|520139528|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256439|NCT04074330|520139529|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256440|NCT04074330|520139530|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256441|NCT04074330|520139531|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
144256442|NCT04074330|520139532|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256443|NCT04074330|520139533|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
144256444|NCT04074330|520139534|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256445|NCT04074330|520139535|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
144256446|NCT04074330|520139526|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
144256447|NCT04074330|520139527|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
144256448|NCT04074330|520139528|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
144256449|NCT04074330|520139529|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
144256450|NCT04074330|520139530|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
144256451|NCT04074330|520139531|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
144256452|NCT04074330|520139532|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
144256453|NCT04074330|520139533|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
144256454|NCT04074330|520139534|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
144256455|NCT04074330|520139535|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
144256456|NCT04074330|520139526|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
144256457|NCT04074330|520139527|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
144256458|NCT04074330|520139528|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
144256459|NCT04074330|520139529|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
144256460|NCT04074330|520139530|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
144256461|NCT04074330|520139531|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
144256462|NCT04074330|520139532|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
144256463|NCT04074330|520139533|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
144256464|NCT04074330|520139534|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
144256465|NCT04074330|520139535|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
144256466|NCT04074330|520139526|FG000|Dose Expansion (up to 42 Months)|Death|0|||
144256467|NCT04074330|520139527|FG001|Dose Expansion (up to 42 Months)|Death|0|||
144256468|NCT04074330|520139528|FG002|Dose Expansion (up to 42 Months)|Death|0|||
144256469|NCT04074330|520139529|FG003|Dose Expansion (up to 42 Months)|Death|0|||
144256470|NCT04074330|520139530|FG004|Dose Expansion (up to 42 Months)|Death|0|||
144256471|NCT04074330|520139531|FG005|Dose Expansion (up to 42 Months)|Death|0|||
144256472|NCT04074330|520139532|FG006|Dose Expansion (up to 42 Months)|Death|0|||
144256473|NCT04074330|520139533|FG007|Dose Expansion (up to 42 Months)|Death|0|||
144256474|NCT04074330|520139534|FG008|Dose Expansion (up to 42 Months)|Death|1|||
144256475|NCT04074330|520139535|FG009|Dose Expansion (up to 42 Months)|Death|0|||
144256476|NCT04074330|520139526|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256477|NCT04074330|520139527|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256478|NCT04074330|520139528|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256479|NCT04074330|520139529|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256480|NCT04074330|520139530|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256481|NCT04074330|520139531|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256482|NCT04074330|520139532|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256483|NCT04074330|520139533|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
144256484|NCT04074330|520139534|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
144256485|NCT04074330|520139535|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
144256486|NCT03124537|520139536|FG000|Overall Study|Lost to Follow-up|3|||
144256487|NCT03124537|520139537|FG001|Overall Study|Lost to Follow-up|5|||
144256488|NCT03124537|520139536|FG000|Overall Study|App Crash, Incomplete Data|7|||
144256489|NCT03124537|520139537|FG001|Overall Study|App Crash, Incomplete Data|8|||
144256490|NCT03681184|520139538|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
144256491|NCT03681184|520139539|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
144256492|NCT02787083|520139540|FG000|Overall Study|Adverse Event|1|||
144256493|NCT02787083|520139541|FG001|Overall Study|Adverse Event|0|||
144256494|NCT02787083|520139540|FG000|Overall Study|Withdrawal by Subject|2|||
144461851|NCT00955357|520887581|FG000|Titration Phase|Adverse Event|9|||
144461852|NCT00955357|520887582|FG001|Titration Phase|Adverse Event|46|||
144461853|NCT00955357|520887581|FG000|Titration Phase|Lack of Efficacy|0|||
144256495|NCT02787083|520139541|FG001|Overall Study|Withdrawal by Subject|2|||
144256496|NCT00893971|520139542|FG000|Overall Study|Physician Decision|3|||
144256497|NCT03268005|520139543|FG000|Overall Study|Death|2|||
144256498|NCT03268005|520139544|FG001|Overall Study|Death|1|||
144256499|NCT03268005|520139543|FG000|Overall Study|Lost to Follow-up|2|||
144256500|NCT03268005|520139544|FG001|Overall Study|Lost to Follow-up|2|||
144256501|NCT03268005|520139543|FG000|Overall Study|Withdrawal by Subject|11|||
144256502|NCT03268005|520139544|FG001|Overall Study|Withdrawal by Subject|11|||
144256503|NCT00492232|520139545|FG000|Placebo Run-in|Adverse Event|0|||
144256504|NCT00492232|520139546|FG001|Placebo Run-in|Adverse Event|2|||
144256505|NCT00492232|520139545|FG000|Placebo Run-in|Protocol Violation|0|||
144256506|NCT00492232|520139546|FG001|Placebo Run-in|Protocol Violation|3|||
144256507|NCT00492232|520139545|FG000|Placebo Run-in|Lost to Follow-up|0|||
144256508|NCT00492232|520139546|FG001|Placebo Run-in|Lost to Follow-up|3|||
144256509|NCT00492232|520139545|FG000|Placebo Run-in|Withdrawal by Subject|0|||
144256510|NCT00492232|520139546|FG001|Placebo Run-in|Withdrawal by Subject|8|||
144256511|NCT00492232|520139545|FG000|Placebo Run-in|Pregnancy|0|||
144256512|NCT00492232|520139546|FG001|Placebo Run-in|Pregnancy|1|||
144256513|NCT00492232|520139545|FG000|Placebo Run-in|Entrance criteria not met|0|||
144256514|NCT00492232|520139546|FG001|Placebo Run-in|Entrance criteria not met|45|||
144256515|NCT00492232|520139545|FG000|Placebo Run-in|Other|0|||
144256516|NCT00492232|520139546|FG001|Placebo Run-in|Other|6|||
144256517|NCT00492232|520139545|FG000|Placebo Run-in|Missing|0|||
144256518|NCT00492232|520139546|FG001|Placebo Run-in|Missing|2|||
144256519|NCT00492232|520139545|FG000|Double-Blind Treatment|Adverse Event|1|||
144256520|NCT00492232|520139546|FG001|Double-Blind Treatment|Adverse Event|2|||
144256521|NCT00492232|520139545|FG000|Double-Blind Treatment|Protocol Violation|3|||
144256522|NCT00492232|520139546|FG001|Double-Blind Treatment|Protocol Violation|7|||
144256523|NCT00492232|520139545|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
144256524|NCT00492232|520139546|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
144256525|NCT00492232|520139545|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
144256526|NCT00492232|520139546|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
144256527|NCT00492232|520139545|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
144256528|NCT00492232|520139546|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
144256529|NCT00492232|520139545|FG000|Double-Blind Treatment|Other|6|||
144256530|NCT00492232|520139546|FG001|Double-Blind Treatment|Other|5|||
144256531|NCT00492232|520139545|FG000|Double-Blind Treatment|Randomized not treated|1|||
144256532|NCT00492232|520139546|FG001|Double-Blind Treatment|Randomized not treated|0|||
144256533|NCT00492232|520139545|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
144256534|NCT00492232|520139546|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
144256535|NCT00382109|520139548|FG000|Overall Study|Adverse Event|3|||
144256536|NCT00382109|520139549|FG001|Overall Study|Adverse Event|0|||
144256537|NCT00382109|520139548|FG000|Overall Study|Physician Decision|6|||
144256538|NCT00382109|520139549|FG001|Overall Study|Physician Decision|1|||
144256539|NCT00382109|520139548|FG000|Overall Study|Withdrawal by Subject|1|||
144256540|NCT00382109|520139549|FG001|Overall Study|Withdrawal by Subject|0|||
144256541|NCT00382109|520139548|FG000|Overall Study|ineligible|2|||
144256542|NCT00382109|520139549|FG001|Overall Study|ineligible|0|||
144256543|NCT00382109|520139548|FG000|Overall Study|Other|0|||
144256544|NCT00382109|520139549|FG001|Overall Study|Other|2|||
144256545|NCT00382109|520139548|FG000|Overall Study|consent withdrawal|0|||
144256546|NCT00382109|520139549|FG001|Overall Study|consent withdrawal|1|||
144256547|NCT02717442|520139550|FG000|Overall Study|Study Terminated by Sponsor|31|||
144256548|NCT02717442|520139551|FG001|Overall Study|Study Terminated by Sponsor|29|||
144256549|NCT02717442|520139550|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
144256550|NCT02717442|520139551|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
144256551|NCT02717442|520139550|FG000|Overall Study|Other - Not Specified|2|||
144256552|NCT02717442|520139551|FG001|Overall Study|Other - Not Specified|0|||
144256553|NCT03275389|520139552|FG000|Overall Study|Lost to Follow-up|10|||
144256554|NCT03275389|520139553|FG001|Overall Study|Lost to Follow-up|10|||
144256555|NCT03275389|520139554|FG002|Overall Study|Lost to Follow-up|19|||
144256556|NCT03275389|520139555|FG003|Overall Study|Lost to Follow-up|12|||
144256557|NCT03275389|520139556|FG004|Overall Study|Lost to Follow-up|11|||
144256558|NCT03275389|520139557|FG005|Overall Study|Lost to Follow-up|12|||
144256559|NCT03275389|520139558|FG006|Overall Study|Lost to Follow-up|21|||
144256560|NCT03275389|520139559|FG007|Overall Study|Lost to Follow-up|15|||
144256561|NCT03275389|520139560|FG008|Overall Study|Lost to Follow-up|12|||
144256562|NCT03275389|520139561|FG009|Overall Study|Lost to Follow-up|14|||
144256563|NCT03275389|520139552|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256564|NCT03275389|520139553|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256565|NCT03275389|520139554|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256566|NCT03275389|520139555|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256567|NCT03275389|520139556|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256568|NCT03275389|520139557|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
144256569|NCT03275389|520139558|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256570|NCT03275389|520139559|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144256571|NCT03275389|520139560|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
144610127|NCT01401842|521432671|FG000|Overall Study|on profile|9|||
144610128|NCT01401842|521432672|FG001|Overall Study|on profile|5|||
144610129|NCT01401842|521432671|FG000|Overall Study|other/unknown|28|||
144610130|NCT01401842|521432672|FG001|Overall Study|other/unknown|17|||
144610131|NCT00583024|521432681|FG000|Overall Study|Lost to Follow-up|4|||
144610132|NCT03977974|521432684|FG000|Period 2|Adverse Event|0|||
144610133|NCT03977974|521432685|FG001|Period 2|Adverse Event|0|||
144610134|NCT03977974|521432686|FG002|Period 2|Adverse Event|0|||
144610135|NCT03977974|521432687|FG003|Period 2|Adverse Event|0|||
144610136|NCT03977974|521432688|FG004|Period 2|Adverse Event|1|||
144610137|NCT03977974|521432689|FG005|Period 2|Adverse Event|0|||
144610138|NCT03977974|521432690|FG006|Period 2|Adverse Event|0|||
144610139|NCT03977974|521432691|FG007|Period 2|Adverse Event|0|||
144610140|NCT03977974|521432692|FG008|Period 2|Adverse Event|0|||
144610141|NCT03977974|521432693|FG009|Period 2|Adverse Event|0|||
144610142|NCT03977974|521432694|FG010|Period 2|Adverse Event|0|||
144610143|NCT03977974|521432695|FG011|Period 2|Adverse Event|0|||
144610144|NCT03977974|521432696|FG012|Period 2|Adverse Event|0|||
144610145|NCT04360551|521434209|FG000|Overall Study|Withdrawal by Subject|1|||
144610146|NCT04360551|521434210|FG001|Overall Study|Withdrawal by Subject|0|||
144610147|NCT00847145|521434221|FG000|Overall Study|AE or Death|0|||
144610148|NCT00847145|521434222|FG001|Overall Study|AE or Death|1|||
144610149|NCT00847145|521434223|FG002|Overall Study|AE or Death|1|||
144610150|NCT00847145|521434224|FG003|Overall Study|AE or Death|0|||
144610151|NCT00847145|521434225|FG004|Overall Study|AE or Death|0|||
144610152|NCT00847145|521434226|FG005|Overall Study|AE or Death|0|||
144610153|NCT00847145|521434227|FG006|Overall Study|AE or Death|0|||
144610154|NCT00847145|521434228|FG007|Overall Study|AE or Death|0|||
144610155|NCT00847145|521434221|FG000|Overall Study|Withdrawal by Subject|3|||
144610156|NCT00847145|521434222|FG001|Overall Study|Withdrawal by Subject|4|||
144610157|NCT00847145|521434223|FG002|Overall Study|Withdrawal by Subject|6|||
144610158|NCT00847145|521434224|FG003|Overall Study|Withdrawal by Subject|1|||
144610159|NCT00847145|521434225|FG004|Overall Study|Withdrawal by Subject|0|||
144610160|NCT00847145|521434226|FG005|Overall Study|Withdrawal by Subject|0|||
144610161|NCT00847145|521434227|FG006|Overall Study|Withdrawal by Subject|1|||
144610162|NCT00847145|521434228|FG007|Overall Study|Withdrawal by Subject|1|||
144610163|NCT00847145|521434221|FG000|Overall Study|Lost to Follow-up|3|||
144610164|NCT00847145|521434222|FG001|Overall Study|Lost to Follow-up|1|||
144610165|NCT00847145|521434223|FG002|Overall Study|Lost to Follow-up|1|||
144610166|NCT00847145|521434224|FG003|Overall Study|Lost to Follow-up|0|||
144610167|NCT00847145|521434225|FG004|Overall Study|Lost to Follow-up|4|||
144610168|NCT00847145|521434226|FG005|Overall Study|Lost to Follow-up|4|||
144197150|NCT02335983|519918694|FG005|Overall Study|Protocol Specified Criteria|21|||
144197151|NCT00629265|519918695|FG000|Overall Study|Lost to Follow-up|4|||
144197152|NCT00629265|519918696|FG001|Overall Study|Lost to Follow-up|5|||
144197153|NCT00629265|519918695|FG000|Overall Study|Withdrawal by Subject|11|||
144197154|NCT00629265|519918696|FG001|Overall Study|Withdrawal by Subject|8|||
144197155|NCT00629265|519918695|FG000|Overall Study|Death|1|||
144197156|NCT00629265|519918696|FG001|Overall Study|Death|0|||
144197157|NCT00629265|519918695|FG000|Overall Study|Adverse Event|2|||
144197158|NCT00629265|519918696|FG001|Overall Study|Adverse Event|0|||
144197159|NCT00629265|519918695|FG000|Overall Study|HNC Recurrence|4|||
144197160|NCT00629265|519918696|FG001|Overall Study|HNC Recurrence|0|||
144197161|NCT00629265|519918695|FG000|Overall Study|Other CA Requiring Treatment|1|||
144197162|NCT00629265|519918696|FG001|Overall Study|Other CA Requiring Treatment|3|||
144197163|NCT00629265|519918695|FG000|Overall Study|Needed Esophageal Dilation|4|||
144197164|NCT00629265|519918696|FG001|Overall Study|Needed Esophageal Dilation|1|||
144197165|NCT00629265|519918695|FG000|Overall Study|Unrelated Medical Complications|3|||
144197166|NCT00629265|519918696|FG001|Overall Study|Unrelated Medical Complications|1|||
144197167|NCT00629265|519918695|FG000|Overall Study|Unknown Reason|2|||
144197168|NCT00629265|519918696|FG001|Overall Study|Unknown Reason|2|||
144197169|NCT03127644|519918697|FG000|Overall Study|Study-specific withdrawal criteria|0|||
144197170|NCT03127644|519918698|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144197171|NCT03127644|519918699|FG002|Overall Study|Study-specific withdrawal criteria|2|||
144197172|NCT00160641|519918705|FG000|Overall Study|Adverse Event|102|||
144610169|NCT00847145|521434227|FG006|Overall Study|Lost to Follow-up|8|||
144610170|NCT00847145|521434228|FG007|Overall Study|Lost to Follow-up|2|||
144610171|NCT00847145|521434221|FG000|Overall Study|Inappropriate enrollment|0|||
144610172|NCT00847145|521434222|FG001|Overall Study|Inappropriate enrollment|0|||
144610173|NCT00847145|521434223|FG002|Overall Study|Inappropriate enrollment|0|||
144610174|NCT00847145|521434224|FG003|Overall Study|Inappropriate enrollment|0|||
144610175|NCT00847145|521434225|FG004|Overall Study|Inappropriate enrollment|1|||
144610176|NCT00847145|521434226|FG005|Overall Study|Inappropriate enrollment|0|||
144197173|NCT00160641|519918705|FG000|Overall Study|Withdrawal by Subject|87|||
144197174|NCT00160641|519918705|FG000|Overall Study|Lost to Follow-up|8|||
144197175|NCT00160641|519918705|FG000|Overall Study|Lack of Efficacy|12|||
144610177|NCT00847145|521434227|FG006|Overall Study|Inappropriate enrollment|0|||
144610178|NCT00847145|521434228|FG007|Overall Study|Inappropriate enrollment|0|||
144610179|NCT00847145|521434221|FG000|Overall Study|Protocol Violation|0|||
144610180|NCT00847145|521434222|FG001|Overall Study|Protocol Violation|0|||
144256572|NCT03275389|520139561|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
144256573|NCT03275389|520139552|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
144256574|NCT03275389|520139553|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144256575|NCT03275389|520139554|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144256576|NCT03275389|520139555|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
144256577|NCT03275389|520139556|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
144256578|NCT03275389|520139557|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
144256579|NCT03275389|520139558|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
144256580|NCT03275389|520139559|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
144256581|NCT03275389|520139560|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
144256582|NCT03275389|520139561|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
144256583|NCT03275389|520139552|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256584|NCT03275389|520139553|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
144256585|NCT03275389|520139554|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256586|NCT03275389|520139555|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
144256587|NCT03275389|520139556|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256588|NCT03275389|520139557|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256589|NCT03275389|520139558|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144256590|NCT03275389|520139559|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256591|NCT03275389|520139560|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256592|NCT03275389|520139561|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144256593|NCT03275389|520139552|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256594|NCT03275389|520139553|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256595|NCT03275389|520139554|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
144256596|NCT03275389|520139555|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256597|NCT03275389|520139556|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256598|NCT03275389|520139557|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256599|NCT03275389|520139558|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256600|NCT03275389|520139559|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256601|NCT03275389|520139560|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144256602|NCT03275389|520139561|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
144256603|NCT03275389|520139552|FG000|Overall Study|Other|0|||
144256604|NCT03275389|520139553|FG001|Overall Study|Other|4|||
144256605|NCT03275389|520139554|FG002|Overall Study|Other|3|||
144256606|NCT03275389|520139555|FG003|Overall Study|Other|2|||
144256607|NCT03275389|520139556|FG004|Overall Study|Other|2|||
144256608|NCT03275389|520139557|FG005|Overall Study|Other|2|||
144256609|NCT03275389|520139558|FG006|Overall Study|Other|0|||
144256610|NCT03275389|520139559|FG007|Overall Study|Other|0|||
144256611|NCT03275389|520139560|FG008|Overall Study|Other|1|||
144256612|NCT03275389|520139561|FG009|Overall Study|Other|0|||
144256613|NCT03035916|520139562|FG000|Overall Study|Puncture failed|0|||
144256614|NCT03035916|520139563|FG001|Overall Study|Puncture failed|2|||
144256615|NCT03035916|520139564|FG002|Overall Study|Puncture failed|0|||
144256616|NCT01451554|520139565|FG000|Overall Study|Withdrawal by Subject|14|||
144256617|NCT01451554|520139566|FG001|Overall Study|Withdrawal by Subject|9|||
144256618|NCT00401193|520141604|FG000|Overall Study|Adverse Event|1|||
144256619|NCT00401193|520141605|FG001|Overall Study|Adverse Event|3|||
144256620|NCT00401193|520141606|FG002|Overall Study|Adverse Event|1|||
144256621|NCT00401193|520141604|FG000|Overall Study|Protocol Violation|3|||
144256622|NCT00401193|520141605|FG001|Overall Study|Protocol Violation|1|||
144256623|NCT00401193|520141606|FG002|Overall Study|Protocol Violation|1|||
144256624|NCT00401193|520141604|FG000|Overall Study|Lost to Follow-up|6|||
144256625|NCT00401193|520141605|FG001|Overall Study|Lost to Follow-up|5|||
144256626|NCT00401193|520141606|FG002|Overall Study|Lost to Follow-up|1|||
144256627|NCT00401193|520141604|FG000|Overall Study|Withdrawal by Subject|2|||
144256628|NCT00401193|520141605|FG001|Overall Study|Withdrawal by Subject|0|||
144256629|NCT00401193|520141606|FG002|Overall Study|Withdrawal by Subject|1|||
144256630|NCT00401193|520141604|FG000|Overall Study|Other Event|3|||
144256631|NCT00401193|520141605|FG001|Overall Study|Other Event|2|||
144610181|NCT00847145|521434223|FG002|Overall Study|Protocol Violation|3|||
144256632|NCT00401193|520141606|FG002|Overall Study|Other Event|2|||
144256633|NCT02526160|520141607|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
144256634|NCT02526160|520141608|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
144256635|NCT02526160|520141607|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
144256636|NCT02526160|520141608|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
144610182|NCT00847145|521434224|FG003|Overall Study|Protocol Violation|0|||
144610183|NCT00847145|521434225|FG004|Overall Study|Protocol Violation|1|||
144256637|NCT02526160|520141607|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
144256638|NCT02526160|520141608|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
144256639|NCT02526160|520141607|FG000|Open-Label Treatment Extension Period I|Death|0|||
144256640|NCT02526160|520141608|FG001|Open-Label Treatment Extension Period I|Death|1|||
144256641|NCT02526160|520141607|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
144256642|NCT02526160|520141608|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
144256643|NCT02526160|520141607|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
144256644|NCT02526160|520141608|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
144256645|NCT02526160|520141607|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
144256646|NCT02526160|520141608|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
144256647|NCT02526160|520141607|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
144610184|NCT00847145|521434226|FG005|Overall Study|Protocol Violation|0|||
144610185|NCT00847145|521434227|FG006|Overall Study|Protocol Violation|0|||
144610186|NCT00847145|521434228|FG007|Overall Study|Protocol Violation|1|||
144610187|NCT02181816|521434236|FG000|Overall Study|Case Report Forms Uncollected|38|||
144610188|NCT02181816|521434236|FG000|Overall Study|Protocol Deviation|21|||
144610189|NCT00253643|521434239|FG000|Overall Study|Withdrawal by Subject|0|||
144610190|NCT00253643|521434240|FG001|Overall Study|Withdrawal by Subject|0|||
144610191|NCT00253643|521434241|FG002|Overall Study|Withdrawal by Subject|1|||
144610192|NCT00253643|521434242|FG003|Overall Study|Withdrawal by Subject|1|||
144610193|NCT00253643|521434239|FG000|Overall Study|Non-Compliance|0|||
144610194|NCT00253643|521434240|FG001|Overall Study|Non-Compliance|0|||
144610195|NCT00253643|521434241|FG002|Overall Study|Non-Compliance|0|||
144610196|NCT00253643|521434242|FG003|Overall Study|Non-Compliance|2|||
144610197|NCT01368536|521434243|FG000|Overall Study|Adverse Event|5|||
144610198|NCT01368536|521434244|FG001|Overall Study|Adverse Event|6|||
144610199|NCT01368536|521434245|FG002|Overall Study|Adverse Event|8|||
144610200|NCT01368536|521434243|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144610201|NCT01368536|521434244|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144610202|NCT01368536|521434245|FG002|Overall Study|Abnormal laboratory value(s)|2|||
144610203|NCT01368536|521434243|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144610204|NCT01368536|521434244|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144610205|NCT01368536|521434245|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144610206|NCT01368536|521434243|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
144610207|NCT01368536|521434244|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144610208|NCT01368536|521434245|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144610209|NCT01368536|521434243|FG000|Overall Study|No longer required study medication|0|||
144610210|NCT01368536|521434244|FG001|Overall Study|No longer required study medication|0|||
144610211|NCT01368536|521434245|FG002|Overall Study|No longer required study medication|1|||
144610212|NCT01368536|521434243|FG000|Overall Study|Withdrawal by Subject|2|||
144610213|NCT01368536|521434244|FG001|Overall Study|Withdrawal by Subject|5|||
144610214|NCT01368536|521434245|FG002|Overall Study|Withdrawal by Subject|4|||
144610215|NCT01368536|521434243|FG000|Overall Study|Lost to Follow-up|3|||
144610216|NCT01368536|521434244|FG001|Overall Study|Lost to Follow-up|3|||
144610217|NCT01368536|521434245|FG002|Overall Study|Lost to Follow-up|5|||
144610218|NCT01368536|521434243|FG000|Overall Study|Administrative problems|34|||
144610219|NCT01368536|521434244|FG001|Overall Study|Administrative problems|39|||
144610220|NCT01368536|521434245|FG002|Overall Study|Administrative problems|35|||
144610221|NCT01368536|521434243|FG000|Overall Study|Protocol deviation|0|||
144610222|NCT01368536|521434244|FG001|Overall Study|Protocol deviation|3|||
144610223|NCT01368536|521434245|FG002|Overall Study|Protocol deviation|1|||
144610224|NCT02636582|521434246|FG000|Overall Study|Surgical Pathology|1|||
144610225|NCT02636582|521434247|FG001|Overall Study|Surgical Pathology|0|||
144610226|NCT01555151|521434248|FG000|Overall Study|Withdrawal by Subject|6|||
144610227|NCT01555151|521434249|FG001|Overall Study|Withdrawal by Subject|2|||
144610228|NCT01555151|521434250|FG002|Overall Study|Withdrawal by Subject|0|||
144610229|NCT01555151|521434251|FG003|Overall Study|Withdrawal by Subject|2|||
144610230|NCT01555151|521434248|FG000|Overall Study|Administrative|3|||
144610231|NCT01555151|521434249|FG001|Overall Study|Administrative|1|||
144610232|NCT01555151|521434250|FG002|Overall Study|Administrative|2|||
144610233|NCT01555151|521434251|FG003|Overall Study|Administrative|0|||
144610234|NCT01555151|521434248|FG000|Overall Study|Protocol Violation|3|||
144610235|NCT01555151|521434249|FG001|Overall Study|Protocol Violation|3|||
144535506|NCT03660930|521164795|FG001|Overall Study|Withdrawal by Subject|0|||
144610236|NCT01555151|521434250|FG002|Overall Study|Protocol Violation|3|||
144535507|NCT03660930|521164796|FG002|Overall Study|Withdrawal by Subject|0|||
144535508|NCT03660930|521164797|FG003|Overall Study|Withdrawal by Subject|0|||
144535509|NCT03660930|521164798|FG004|Overall Study|Withdrawal by Subject|0|||
144535510|NCT03660930|521164799|FG005|Overall Study|Withdrawal by Subject|1|||
144535511|NCT03660930|521164800|FG006|Overall Study|Withdrawal by Subject|0|||
144535512|NCT03660930|521164801|FG007|Overall Study|Withdrawal by Subject|0|||
144535513|NCT02656706|521164804|FG000|Overall Study|Insurance Denial|1|||
144535514|NCT03725332|521164805|FG000|Overall Study|Adverse Event|5|||
144610237|NCT01555151|521434251|FG003|Overall Study|Protocol Violation|5|||
144610238|NCT01555151|521434248|FG000|Overall Study|Adverse Event|1|||
144610239|NCT01555151|521434249|FG001|Overall Study|Adverse Event|2|||
144610240|NCT01555151|521434250|FG002|Overall Study|Adverse Event|1|||
144610241|NCT01555151|521434251|FG003|Overall Study|Adverse Event|2|||
144610242|NCT01555151|521434248|FG000|Overall Study|Lost to Follow-up|0|||
144256648|NCT02526160|520141608|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
144256649|NCT01962948|520141611|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
144256650|NCT01962948|520141612|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
144256651|NCT01962948|520141613|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
144256652|NCT01962948|520141614|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
144256653|NCT02576977|520141616|FG000|Overall Study|Adverse Event|13|||
144256654|NCT02576977|520141617|FG001|Overall Study|Adverse Event|2|||
144256655|NCT02576977|520141616|FG000|Overall Study|Death|73|||
144256656|NCT02576977|520141617|FG001|Overall Study|Death|60|||
144256657|NCT02576977|520141616|FG000|Overall Study|Screen failure|1|||
144256658|NCT02576977|520141617|FG001|Overall Study|Screen failure|0|||
144256659|NCT02576977|520141616|FG000|Overall Study|Study Terminated at Selected Sites|27|||
144256660|NCT02576977|520141617|FG001|Overall Study|Study Terminated at Selected Sites|50|||
144256661|NCT02576977|520141616|FG000|Overall Study|Withdrawal by Subject|11|||
144256662|NCT02576977|520141617|FG001|Overall Study|Withdrawal by Subject|11|||
144256663|NCT02576977|520141616|FG000|Overall Study|Final Disposition Unknown|0|||
144256664|NCT02576977|520141617|FG001|Overall Study|Final Disposition Unknown|1|||
144256665|NCT02576977|520141616|FG000|Overall Study|Lost to Follow-up|1|||
144256666|NCT02576977|520141617|FG001|Overall Study|Lost to Follow-up|0|||
144256667|NCT02576977|520141616|FG000|Overall Study|Progressive Disease|0|||
144256668|NCT02576977|520141617|FG001|Overall Study|Progressive Disease|1|||
144256669|NCT02579382|520141622|FG000|Main Study Phase|Lost to Follow-up|0|||
144256670|NCT02579382|520141623|FG001|Main Study Phase|Lost to Follow-up|0|||
144256671|NCT02579382|520141624|FG002|Main Study Phase|Lost to Follow-up|2|||
144256672|NCT02579382|520141625|FG003|Main Study Phase|Lost to Follow-up|0|||
144256673|NCT02579382|520141622|FG000|Main Study Phase|Withdrew Consent|0|||
144256674|NCT02579382|520141623|FG001|Main Study Phase|Withdrew Consent|0|||
144256675|NCT02579382|520141624|FG002|Main Study Phase|Withdrew Consent|0|||
144256676|NCT02579382|520141625|FG003|Main Study Phase|Withdrew Consent|2|||
144256677|NCT02579382|520141622|FG000|Main Study Phase|Lack of Efficacy|0|||
144256678|NCT02579382|520141623|FG001|Main Study Phase|Lack of Efficacy|0|||
144256679|NCT02579382|520141624|FG002|Main Study Phase|Lack of Efficacy|0|||
144256680|NCT02579382|520141625|FG003|Main Study Phase|Lack of Efficacy|1|||
144256681|NCT02579382|520141622|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
144256682|NCT02579382|520141623|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
144256683|NCT02579382|520141624|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
144256684|NCT02579382|520141625|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
144256685|NCT02579382|520141622|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
144256686|NCT02579382|520141623|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
144256687|NCT02579382|520141624|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
144256688|NCT02579382|520141625|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
144256689|NCT02579382|520141622|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
144256690|NCT02579382|520141623|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
144256691|NCT02579382|520141624|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
144256692|NCT02579382|520141625|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
144256693|NCT02579382|520141622|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
144256694|NCT02579382|520141623|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
144256695|NCT02579382|520141624|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
144256696|NCT02579382|520141625|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
144256697|NCT02579382|520141622|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
144256698|NCT02579382|520141623|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
144256699|NCT02579382|520141624|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
144256700|NCT02579382|520141625|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
144256701|NCT02579382|520141622|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
144256702|NCT02579382|520141623|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
144256703|NCT02579382|520141624|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
144256704|NCT02579382|520141625|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
144256705|NCT00667992|520141626|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
144256706|NCT00667992|520141627|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
144256707|NCT00667992|520141626|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
144256708|NCT00667992|520141627|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
144256709|NCT00667992|520141626|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
144256710|NCT00667992|520141627|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
144256711|NCT00667992|520141626|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
144256712|NCT00667992|520141627|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
144256713|NCT00667992|520141626|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
144256714|NCT00667992|520141627|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
144256715|NCT00667992|520141626|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
144256716|NCT00667992|520141627|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
144256717|NCT00667992|520141626|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
144256718|NCT00667992|520141627|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
144256719|NCT00667992|520141626|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
144256720|NCT00667992|520141627|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
144256721|NCT00667992|520141626|FG000|Wash-out|Not within one doubling dilution|4|||
144256722|NCT00667992|520141627|FG001|Wash-out|Not within one doubling dilution|3|||
144256723|NCT00667992|520141626|FG000|Wash-out|Failure to wash-out|2|||
144256724|NCT00667992|520141627|FG001|Wash-out|Failure to wash-out|2|||
144256725|NCT00667992|520141626|FG000|Wash-out|Withdrawal by Subject|1|||
144256726|NCT00667992|520141627|FG001|Wash-out|Withdrawal by Subject|0|||
144256727|NCT00667992|520141626|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
144256728|NCT00667992|520141627|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
144256729|NCT00667992|520141626|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
144256730|NCT00667992|520141627|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
144256731|NCT02906579|520141635|FG000|Overall Study|Adverse Event|1|||
144256732|NCT02906579|520141635|FG000|Overall Study|Physician Decision|1|||
144256733|NCT02793947|520141636|FG000|Overall Study|Death|1|||
144256734|NCT02793947|520141637|FG001|Overall Study|Death|0|||
144256735|NCT02793947|520141636|FG000|Overall Study|Physician Decision|1|||
144256736|NCT02793947|520141637|FG001|Overall Study|Physician Decision|5|||
144256737|NCT02213380|520141640|FG000|Underwent Randomization|Withdrawal by Subject|2|||
144256738|NCT02213380|520141641|FG001|Underwent Randomization|Withdrawal by Subject|0|||
144256739|NCT02213380|520141640|FG000|Underwent Randomization|Not treated|3|||
144256740|NCT02213380|520141641|FG001|Underwent Randomization|Not treated|3|||
144256741|NCT02213380|520141640|FG000|Per-protocol Analysis|Protocol Violation|32|||
144256742|NCT02213380|520141641|FG001|Per-protocol Analysis|Protocol Violation|36|||
144256743|NCT01490840|520141645|FG000|Phase 1|Lost to Follow-up|1|||
144256744|NCT01490840|520141646|FG001|Phase 1|Lost to Follow-up|0|||
144256745|NCT01490840|520141645|FG000|Phase 1|Adverse Event|2|||
144256746|NCT01490840|520141646|FG001|Phase 1|Adverse Event|1|||
144256747|NCT01490840|520141645|FG000|Phase 1|Withdrawal by Subject|6|||
144256748|NCT01490840|520141646|FG001|Phase 1|Withdrawal by Subject|5|||
144256749|NCT01490840|520141645|FG000|Phase 1|Visit 6a omitted|1|||
144256750|NCT01490840|520141646|FG001|Phase 1|Visit 6a omitted|0|||
144256751|NCT01490840|520141645|FG000|Phase 2|Withdrawal by Subject|4|||
144256752|NCT01490840|520141646|FG001|Phase 2|Withdrawal by Subject|3|||
144256753|NCT01490840|520141645|FG000|Phase 2|Permanent interruption of fingolimod|0|||
144256754|NCT01490840|520141646|FG001|Phase 2|Permanent interruption of fingolimod|1|||
144256755|NCT01490840|520141645|FG000|Phase 2|Lost to Follow-up|1|||
144256756|NCT01490840|520141646|FG001|Phase 2|Lost to Follow-up|1|||
144256757|NCT01490840|520141645|FG000|Phase 2|Adverse Event|1|||
144256758|NCT01490840|520141646|FG001|Phase 2|Adverse Event|1|||
144256759|NCT01465230|520141650|FG000|Overall Study|Withdrawal by Subject|2|||
144256760|NCT02542397|520141652|FG000|Overall Study|Death|2|||
144256761|NCT02542397|520141652|FG000|Overall Study|Physician Decision|6|||
144256762|NCT02542397|520141652|FG000|Overall Study|Withdrawal by Subject|6|||
144256763|NCT02542397|520141652|FG000|Overall Study|Lost to Follow-up|2|||
144461854|NCT00955357|520887582|FG001|Titration Phase|Lack of Efficacy|2|||
144461855|NCT00955357|520887581|FG000|Titration Phase|Protocol Violation|3|||
144461856|NCT00955357|520887582|FG001|Titration Phase|Protocol Violation|7|||
144461857|NCT00955357|520887581|FG000|Titration Phase|Lost to Follow-up|1|||
144461858|NCT00955357|520887582|FG001|Titration Phase|Lost to Follow-up|3|||
144461859|NCT00955357|520887581|FG000|Titration Phase|Withdrawal by Subject|3|||
144256764|NCT01738919|520141654|FG000|Overall Study|Lost to Follow-up|1|||
144256765|NCT01738919|520141655|FG001|Overall Study|Lost to Follow-up|0|||
144256766|NCT01738919|520141654|FG000|Overall Study|Immigrated|0|||
144461860|NCT00955357|520887582|FG001|Titration Phase|Withdrawal by Subject|5|||
144461861|NCT00955357|520887581|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
144461862|NCT00955357|520887582|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
144461863|NCT00955357|520887581|FG000|Titration Phase|Study medication not tolerated|0|||
144461864|NCT00955357|520887582|FG001|Titration Phase|Study medication not tolerated|1|||
144461865|NCT00955357|520887581|FG000|Titration Phase|Non compliance to study procedures|0|||
144461866|NCT00955357|520887582|FG001|Titration Phase|Non compliance to study procedures|1|||
144461867|NCT00955357|520887581|FG000|Maintenance Phase|Adverse Event|3|||
144461868|NCT00955357|520887582|FG001|Maintenance Phase|Adverse Event|23|||
144461869|NCT00955357|520887581|FG000|Maintenance Phase|Lack of Efficacy|0|||
144461870|NCT00955357|520887582|FG001|Maintenance Phase|Lack of Efficacy|4|||
144610243|NCT01555151|521434249|FG001|Overall Study|Lost to Follow-up|0|||
144256767|NCT01738919|520141655|FG001|Overall Study|Immigrated|1|||
144256768|NCT01738919|520141654|FG000|Overall Study|Withdrawal by Subject|0|||
144256769|NCT01738919|520141655|FG001|Overall Study|Withdrawal by Subject|1|||
144256770|NCT01738919|520141654|FG000|Overall Study|Not treated in accordance to guidelines|0|||
144256771|NCT01738919|520141655|FG001|Overall Study|Not treated in accordance to guidelines|1|||
144256772|NCT01473940|520141659|FG000|Induction Therapy|Death|0|||
144256773|NCT01473940|520141660|FG001|Induction Therapy|Death|0|||
144461871|NCT00955357|520887581|FG000|Maintenance Phase|Protocol Violation|2|||
144461872|NCT00955357|520887582|FG001|Maintenance Phase|Protocol Violation|6|||
144461873|NCT00955357|520887581|FG000|Maintenance Phase|Lost to Follow-up|2|||
144461874|NCT00955357|520887582|FG001|Maintenance Phase|Lost to Follow-up|7|||
144461875|NCT00955357|520887581|FG000|Maintenance Phase|Withdrawal by Subject|4|||
144461876|NCT00955357|520887582|FG001|Maintenance Phase|Withdrawal by Subject|4|||
144461877|NCT00955357|520887581|FG000|Maintenance Phase|Patient moving out of area|0|||
144461878|NCT00955357|520887582|FG001|Maintenance Phase|Patient moving out of area|1|||
144461879|NCT00955357|520887581|FG000|Maintenance Phase|Non compliance to study procedures|1|||
144461880|NCT00955357|520887582|FG001|Maintenance Phase|Non compliance to study procedures|0|||
144461881|NCT01258608|520887583|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
144461882|NCT01258608|520887584|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
144461883|NCT01258608|520887583|FG000|Overall Study|Clinical progression|1|||
144461884|NCT01258608|520887584|FG001|Overall Study|Clinical progression|0|||
144461885|NCT01258608|520887583|FG000|Overall Study|Sponsor decision|0|||
144461886|NCT01258608|520887584|FG001|Overall Study|Sponsor decision|1|||
144256774|NCT01473940|520141661|FG002|Induction Therapy|Death|1|||
144256775|NCT01473940|520141662|FG003|Induction Therapy|Death|1|||
144256776|NCT01473940|520141659|FG000|Induction Therapy|Progressive Disease|0|||
144256777|NCT01473940|520141660|FG001|Induction Therapy|Progressive Disease|1|||
144256778|NCT01473940|520141661|FG002|Induction Therapy|Progressive Disease|1|||
144256779|NCT01473940|520141662|FG003|Induction Therapy|Progressive Disease|0|||
144256780|NCT01473940|520141659|FG000|Maintenance Therapy|Progressive Disease|1|||
144256781|NCT01473940|520141660|FG001|Maintenance Therapy|Progressive Disease|2|||
144256782|NCT01473940|520141661|FG002|Maintenance Therapy|Progressive Disease|1|||
144256783|NCT01473940|520141662|FG003|Maintenance Therapy|Progressive Disease|4|||
144256784|NCT02849171|520141663|FG000|Overall Study|Withdrawal by Subject|1|||
144256785|NCT02849171|520141663|FG000|Overall Study|Not treated|1|||
144256786|NCT02532257|520141664|FG000|Overall Study|Adverse Event|2|||
144256787|NCT02532257|520141664|FG000|Overall Study|Physician Decision|4|||
144461887|NCT01258608|520887583|FG000|Overall Study|Physician Decision|6|||
144461888|NCT01258608|520887584|FG001|Overall Study|Physician Decision|1|||
144461889|NCT01258608|520887583|FG000|Overall Study|Lost to Follow-up|0|||
144461890|NCT01258608|520887584|FG001|Overall Study|Lost to Follow-up|1|||
144461891|NCT01258608|520887583|FG000|Overall Study|Lack of compliance|1|||
144461892|NCT01258608|520887584|FG001|Overall Study|Lack of compliance|0|||
144461893|NCT01258608|520887583|FG000|Overall Study|Lack of Efficacy|0|||
144461894|NCT01258608|520887584|FG001|Overall Study|Lack of Efficacy|1|||
144461895|NCT01258608|520887583|FG000|Overall Study|Adverse Event|6|||
144461896|NCT01258608|520887584|FG001|Overall Study|Adverse Event|10|||
144461897|NCT01258608|520887583|FG000|Overall Study|Withdrawal by Subject|6|||
144461898|NCT01258608|520887584|FG001|Overall Study|Withdrawal by Subject|5|||
144461899|NCT02943408|520887594|FG000|Overall Study|Lost to Follow-up|7|||
144461900|NCT02943408|520887595|FG001|Overall Study|Lost to Follow-up|1|||
144461901|NCT02943408|520887594|FG000|Overall Study|Withdrawal by Subject|0|||
144461902|NCT02943408|520887595|FG001|Overall Study|Withdrawal by Subject|1|||
144461903|NCT01621126|520887598|FG000|Overall Study|Physician Decision|6|||
144461904|NCT01949311|520887599|FG000|Overall Study|Lost to Follow-up|73|||
144461905|NCT01949311|520887599|FG000|Overall Study|Terminated by Sponsor|708|||
144461906|NCT01949311|520887599|FG000|Overall Study|Withdrawal by Subject|375|||
144461907|NCT01949311|520887599|FG000|Overall Study|Lack of Efficacy|50|||
144461908|NCT01949311|520887599|FG000|Overall Study|Protocol Deviation|34|||
144461909|NCT01949311|520887599|FG000|Overall Study|Pregnancy|20|||
144461910|NCT01949311|520887599|FG000|Overall Study|Physician Decision|9|||
144461911|NCT01949311|520887599|FG000|Overall Study|Other|4|||
144461912|NCT01949311|520887599|FG000|Overall Study|Adverse Event|107|||
144461913|NCT02925455|520887600|FG000|Overall Study|Withdrawal by Subject|2|||
144461914|NCT02925455|520887601|FG001|Overall Study|Withdrawal by Subject|0|||
144256788|NCT02532257|520141664|FG000|Overall Study|Withdrawal by Subject|3|||
144256789|NCT02532257|520141664|FG000|Overall Study|Progressive Disease|10|||
144256790|NCT02090283|520141665|FG000|Overall Study|Withdrawal by Subject|6|||
144256791|NCT02090283|520141666|FG001|Overall Study|Withdrawal by Subject|6|||
144256792|NCT02090283|520141667|FG002|Overall Study|Withdrawal by Subject|6|||
144256793|NCT02090283|520141665|FG000|Overall Study|Sponsor Terminated Study|6|||
144256794|NCT02090283|520141666|FG001|Overall Study|Sponsor Terminated Study|6|||
144461915|NCT00360308|520887602|FG000|Overall Study|Adverse Event|15|||
144461916|NCT00360308|520887603|FG001|Overall Study|Adverse Event|14|||
144461917|NCT00360308|520887604|FG002|Overall Study|Adverse Event|25|||
144461918|NCT00360308|520887602|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
144461919|NCT00360308|520887603|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
144461920|NCT00360308|520887604|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
144535515|NCT03725332|521164806|FG001|Overall Study|Adverse Event|10|||
144256795|NCT02090283|520141667|FG002|Overall Study|Sponsor Terminated Study|1|||
144256796|NCT02090283|520141665|FG000|Overall Study|Lost to Follow-up|2|||
144461921|NCT00360308|520887602|FG000|Overall Study|Protocol Violation|2|||
144461922|NCT00360308|520887603|FG001|Overall Study|Protocol Violation|1|||
144256797|NCT02090283|520141666|FG001|Overall Study|Lost to Follow-up|2|||
144256798|NCT02090283|520141667|FG002|Overall Study|Lost to Follow-up|3|||
144256799|NCT02090283|520141665|FG000|Overall Study|Adverse Event|1|||
144256800|NCT02090283|520141666|FG001|Overall Study|Adverse Event|1|||
144256801|NCT02090283|520141667|FG002|Overall Study|Adverse Event|0|||
144256802|NCT02090283|520141665|FG000|Overall Study|Protocol Violation|2|||
144256803|NCT02090283|520141666|FG001|Overall Study|Protocol Violation|0|||
144256804|NCT02090283|520141667|FG002|Overall Study|Protocol Violation|0|||
144256805|NCT02964338|520141671|FG000|Overall Study|Sponsor terminated study for futility|12|||
144256806|NCT02964338|520141672|FG001|Overall Study|Sponsor terminated study for futility|15|||
144256807|NCT02964338|520141673|FG002|Overall Study|Sponsor terminated study for futility|14|||
144256808|NCT02964338|520141671|FG000|Overall Study|Lack of Efficacy|0|||
144256809|NCT02964338|520141672|FG001|Overall Study|Lack of Efficacy|3|||
144256810|NCT02964338|520141673|FG002|Overall Study|Lack of Efficacy|0|||
144256811|NCT02964338|520141671|FG000|Overall Study|Lost to Follow-up|1|||
144256812|NCT02964338|520141672|FG001|Overall Study|Lost to Follow-up|0|||
144256813|NCT02964338|520141673|FG002|Overall Study|Lost to Follow-up|3|||
144256814|NCT02964338|520141671|FG000|Overall Study|Protocol Violation|0|||
144256815|NCT02964338|520141672|FG001|Overall Study|Protocol Violation|1|||
144256816|NCT02964338|520141673|FG002|Overall Study|Protocol Violation|0|||
144256817|NCT02964338|520141671|FG000|Overall Study|Withdrawal by Subject|1|||
144256818|NCT02964338|520141672|FG001|Overall Study|Withdrawal by Subject|3|||
144256819|NCT02964338|520141673|FG002|Overall Study|Withdrawal by Subject|1|||
144256820|NCT02964338|520141671|FG000|Overall Study|Adverse Event|2|||
144256821|NCT02964338|520141672|FG001|Overall Study|Adverse Event|1|||
144256822|NCT02964338|520141673|FG002|Overall Study|Adverse Event|1|||
144256823|NCT02964338|520141671|FG000|Overall Study|Non-compliant with e-diary|0|||
144256824|NCT02964338|520141672|FG001|Overall Study|Non-compliant with e-diary|1|||
144256825|NCT02964338|520141673|FG002|Overall Study|Non-compliant with e-diary|0|||
144256826|NCT02964338|520141671|FG000|Overall Study|Did not meet criteria|1|||
144256827|NCT02964338|520141672|FG001|Overall Study|Did not meet criteria|0|||
144256828|NCT02964338|520141673|FG002|Overall Study|Did not meet criteria|0|||
144256829|NCT00184002|520141674|FG000|Overall Study|Adverse Event|9|||
144256830|NCT00184002|520141674|FG000|Overall Study|Death|3|||
144256831|NCT00184002|520141674|FG000|Overall Study|Physician Decision|1|||
144256832|NCT00184002|520141674|FG000|Overall Study|Withdrawal by Subject|4|||
144256833|NCT00572455|520141682|FG000|Stage I (14 Days)|Adverse Event|0|||
144256834|NCT00572455|520141683|FG001|Stage I (14 Days)|Adverse Event|0|||
144256835|NCT00572455|520141684|FG002|Stage I (14 Days)|Adverse Event|0|||
144256836|NCT00572455|520141685|FG003|Stage I (14 Days)|Adverse Event|0|||
144256837|NCT00572455|520141686|FG004|Stage I (14 Days)|Adverse Event|0|||
144256838|NCT00572455|520141687|FG005|Stage I (14 Days)|Adverse Event|3|||
144256839|NCT00572455|520141688|FG006|Stage I (14 Days)|Adverse Event|0|||
144256840|NCT00572455|520141689|FG007|Stage I (14 Days)|Adverse Event|0|||
144256841|NCT00572455|520141690|FG008|Stage I (14 Days)|Adverse Event|0|||
144256842|NCT00572455|520141691|FG009|Stage I (14 Days)|Adverse Event|0|||
144256843|NCT00572455|520141692|FG010|Stage I (14 Days)|Adverse Event|0|||
144256844|NCT00572455|520141693|FG011|Stage I (14 Days)|Adverse Event|0|||
144256845|NCT00572455|520141694|FG012|Stage I (14 Days)|Adverse Event|0|||
144256846|NCT00572455|520141695|FG013|Stage I (14 Days)|Adverse Event|0|||
144256847|NCT00572455|520141682|FG000|Stage I (14 Days)|Other|0|||
144256848|NCT00572455|520141683|FG001|Stage I (14 Days)|Other|0|||
144256849|NCT00572455|520141684|FG002|Stage I (14 Days)|Other|0|||
144256850|NCT00572455|520141685|FG003|Stage I (14 Days)|Other|0|||
144256851|NCT00572455|520141686|FG004|Stage I (14 Days)|Other|1|||
144256852|NCT00572455|520141687|FG005|Stage I (14 Days)|Other|0|||
144256853|NCT00572455|520141688|FG006|Stage I (14 Days)|Other|0|||
144256854|NCT00572455|520141689|FG007|Stage I (14 Days)|Other|0|||
144256855|NCT00572455|520141690|FG008|Stage I (14 Days)|Other|0|||
144256856|NCT00572455|520141691|FG009|Stage I (14 Days)|Other|0|||
144256857|NCT00572455|520141692|FG010|Stage I (14 Days)|Other|0|||
144256858|NCT00572455|520141693|FG011|Stage I (14 Days)|Other|0|||
144256859|NCT00572455|520141694|FG012|Stage I (14 Days)|Other|0|||
144461923|NCT00360308|520887604|FG002|Overall Study|Protocol Violation|2|||
144256860|NCT00572455|520141695|FG013|Stage I (14 Days)|Other|0|||
144256861|NCT00572455|520141682|FG000|Stage II (28 Days)|Adverse Event|0|||
144256862|NCT00572455|520141683|FG001|Stage II (28 Days)|Adverse Event|0|||
144256863|NCT00572455|520141684|FG002|Stage II (28 Days)|Adverse Event|0|||
144256864|NCT00572455|520141685|FG003|Stage II (28 Days)|Adverse Event|0|||
144256865|NCT00572455|520141686|FG004|Stage II (28 Days)|Adverse Event|0|||
144256866|NCT00572455|520141687|FG005|Stage II (28 Days)|Adverse Event|0|||
144256867|NCT00572455|520141688|FG006|Stage II (28 Days)|Adverse Event|0|||
144256868|NCT00572455|520141689|FG007|Stage II (28 Days)|Adverse Event|0|||
144256869|NCT00572455|520141690|FG008|Stage II (28 Days)|Adverse Event|1|||
144256870|NCT00572455|520141691|FG009|Stage II (28 Days)|Adverse Event|3|||
144256871|NCT00572455|520141692|FG010|Stage II (28 Days)|Adverse Event|3|||
144256872|NCT00572455|520141693|FG011|Stage II (28 Days)|Adverse Event|4|||
144256873|NCT00572455|520141694|FG012|Stage II (28 Days)|Adverse Event|5|||
144256874|NCT00572455|520141695|FG013|Stage II (28 Days)|Adverse Event|1|||
144256875|NCT00572455|520141682|FG000|Stage II (28 Days)|Death|0|||
144256876|NCT00572455|520141683|FG001|Stage II (28 Days)|Death|0|||
144256877|NCT00572455|520141684|FG002|Stage II (28 Days)|Death|0|||
144256878|NCT00572455|520141685|FG003|Stage II (28 Days)|Death|0|||
144256879|NCT00572455|520141686|FG004|Stage II (28 Days)|Death|0|||
144256880|NCT00572455|520141687|FG005|Stage II (28 Days)|Death|0|||
144256881|NCT00572455|520141688|FG006|Stage II (28 Days)|Death|0|||
144256882|NCT00572455|520141689|FG007|Stage II (28 Days)|Death|0|||
144461924|NCT00360308|520887602|FG000|Overall Study|Withdrawal by Subject|11|||
144461925|NCT00360308|520887603|FG001|Overall Study|Withdrawal by Subject|7|||
144256883|NCT00572455|520141690|FG008|Stage II (28 Days)|Death|1|||
144256884|NCT00572455|520141691|FG009|Stage II (28 Days)|Death|0|||
144256885|NCT00572455|520141692|FG010|Stage II (28 Days)|Death|0|||
144256886|NCT00572455|520141693|FG011|Stage II (28 Days)|Death|0|||
144256887|NCT00572455|520141694|FG012|Stage II (28 Days)|Death|0|||
144256888|NCT00572455|520141695|FG013|Stage II (28 Days)|Death|0|||
144461926|NCT00360308|520887604|FG002|Overall Study|Withdrawal by Subject|14|||
144461927|NCT00360308|520887602|FG000|Overall Study|Lack of Efficacy|3|||
144461928|NCT00360308|520887603|FG001|Overall Study|Lack of Efficacy|0|||
144461929|NCT00360308|520887604|FG002|Overall Study|Lack of Efficacy|2|||
144461930|NCT00360308|520887602|FG000|Overall Study|Other|2|||
144461931|NCT00360308|520887603|FG001|Overall Study|Other|1|||
144461932|NCT00360308|520887604|FG002|Overall Study|Other|1|||
144461933|NCT00360308|520887602|FG000|Overall Study|Study termination by sponsor|43|||
144461934|NCT00360308|520887603|FG001|Overall Study|Study termination by sponsor|55|||
144461935|NCT00360308|520887604|FG002|Overall Study|Study termination by sponsor|44|||
144461936|NCT03137303|520887605|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
144461937|NCT03137303|520887606|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
144461938|NCT03137303|520887605|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
144461939|NCT03137303|520887606|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
144461940|NCT03137303|520887605|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
144461941|NCT03137303|520887606|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
144461942|NCT03137303|520887605|FG000|T3: 9-month Follow-up|Death|1|||
144461943|NCT03137303|520887606|FG001|T3: 9-month Follow-up|Death|0|||
144461944|NCT03137303|520887605|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
144461945|NCT03137303|520887606|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
144461946|NCT03137303|520887605|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
144461947|NCT03137303|520887606|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
144461948|NCT03137303|520887605|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
144461949|NCT03137303|520887606|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
144461950|NCT04402866|520887613|FG000|Overall Study|Discontinued Prior to Treatment|0|||
144461951|NCT04402866|520887614|FG001|Overall Study|Discontinued Prior to Treatment|0|||
144461952|NCT04402866|520887615|FG002|Overall Study|Discontinued Prior to Treatment|0|||
144461953|NCT04402866|520887616|FG003|Overall Study|Discontinued Prior to Treatment|0|||
144461954|NCT04402866|520887617|FG004|Overall Study|Discontinued Prior to Treatment|2|||
144461955|NCT04402866|520887618|FG005|Overall Study|Discontinued Prior to Treatment|3|||
144461956|NCT04402866|520887613|FG000|Overall Study|Adverse Event|2|||
144461957|NCT04402866|520887614|FG001|Overall Study|Adverse Event|1|||
144461958|NCT04402866|520887615|FG002|Overall Study|Adverse Event|0|||
144461959|NCT04402866|520887616|FG003|Overall Study|Adverse Event|0|||
144461960|NCT04402866|520887617|FG004|Overall Study|Adverse Event|13|||
144461961|NCT04402866|520887618|FG005|Overall Study|Adverse Event|8|||
144461962|NCT04402866|520887613|FG000|Overall Study|Miscellaneous|0|||
144461963|NCT04402866|520887614|FG001|Overall Study|Miscellaneous|0|||
144461964|NCT04402866|520887615|FG002|Overall Study|Miscellaneous|1|||
144461965|NCT04402866|520887616|FG003|Overall Study|Miscellaneous|0|||
144461966|NCT04402866|520887617|FG004|Overall Study|Miscellaneous|0|||
144461967|NCT04402866|520887618|FG005|Overall Study|Miscellaneous|0|||
144461968|NCT04402866|520887613|FG000|Overall Study|Lost to Follow-up|0|||
144461969|NCT04402866|520887614|FG001|Overall Study|Lost to Follow-up|0|||
144461970|NCT04402866|520887615|FG002|Overall Study|Lost to Follow-up|0|||
144461971|NCT04402866|520887616|FG003|Overall Study|Lost to Follow-up|0|||
144256889|NCT00572455|520141682|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
144256890|NCT00572455|520141683|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
144256891|NCT00572455|520141684|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
144256892|NCT00572455|520141685|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
144461972|NCT04402866|520887617|FG004|Overall Study|Lost to Follow-up|0|||
144461973|NCT04402866|520887618|FG005|Overall Study|Lost to Follow-up|1|||
144461974|NCT04402866|520887613|FG000|Overall Study|Withdrawal by Subject|0|||
144461975|NCT04402866|520887614|FG001|Overall Study|Withdrawal by Subject|0|||
144461976|NCT04402866|520887615|FG002|Overall Study|Withdrawal by Subject|0|||
144461977|NCT04402866|520887616|FG003|Overall Study|Withdrawal by Subject|0|||
144461978|NCT04402866|520887617|FG004|Overall Study|Withdrawal by Subject|0|||
144461979|NCT04402866|520887618|FG005|Overall Study|Withdrawal by Subject|2|||
144256893|NCT00572455|520141686|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
144256894|NCT00572455|520141687|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
144256895|NCT00572455|520141688|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
144256896|NCT00572455|520141689|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
144256897|NCT00572455|520141690|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
144256898|NCT00572455|520141691|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
144256899|NCT00572455|520141692|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
144256900|NCT00572455|520141693|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
144461980|NCT02015676|520887619|FG000|Overall Study|Adverse Event|2|||
144461981|NCT02015676|520887620|FG001|Overall Study|Adverse Event|18|||
144461982|NCT02015676|520887621|FG002|Overall Study|Adverse Event|0|||
144461983|NCT02015676|520887619|FG000|Overall Study|Lack of Efficacy|2|||
144461984|NCT02015676|520887620|FG001|Overall Study|Lack of Efficacy|4|||
144461985|NCT02015676|520887621|FG002|Overall Study|Lack of Efficacy|0|||
144461986|NCT02015676|520887619|FG000|Overall Study|Protocol Violation|1|||
144256901|NCT00572455|520141694|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
144256902|NCT00572455|520141695|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
144256903|NCT00572455|520141682|FG000|Stage II (28 Days)|Other|0|||
144256904|NCT00572455|520141683|FG001|Stage II (28 Days)|Other|0|||
144256905|NCT00572455|520141684|FG002|Stage II (28 Days)|Other|0|||
144256906|NCT00572455|520141685|FG003|Stage II (28 Days)|Other|0|||
144256907|NCT00572455|520141686|FG004|Stage II (28 Days)|Other|0|||
144256908|NCT00572455|520141687|FG005|Stage II (28 Days)|Other|0|||
144256909|NCT00572455|520141688|FG006|Stage II (28 Days)|Other|0|||
144256910|NCT00572455|520141689|FG007|Stage II (28 Days)|Other|0|||
144256911|NCT00572455|520141690|FG008|Stage II (28 Days)|Other|1|||
144256912|NCT00572455|520141691|FG009|Stage II (28 Days)|Other|0|||
144256913|NCT00572455|520141692|FG010|Stage II (28 Days)|Other|0|||
144256914|NCT00572455|520141693|FG011|Stage II (28 Days)|Other|0|||
144256915|NCT00572455|520141694|FG012|Stage II (28 Days)|Other|0|||
144256916|NCT00572455|520141695|FG013|Stage II (28 Days)|Other|0|||
144256917|NCT00572455|520141682|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
144256918|NCT00572455|520141683|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
144256919|NCT00572455|520141684|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
144461987|NCT02015676|520887620|FG001|Overall Study|Protocol Violation|0|||
144461988|NCT02015676|520887621|FG002|Overall Study|Protocol Violation|0|||
144461989|NCT02015676|520887619|FG000|Overall Study|Withdrawal by Subject|1|||
144461990|NCT02015676|520887620|FG001|Overall Study|Withdrawal by Subject|7|||
144461991|NCT02015676|520887621|FG002|Overall Study|Withdrawal by Subject|1|||
144461992|NCT02015676|520887619|FG000|Overall Study|Administrative reasons|0|||
144461993|NCT02015676|520887620|FG001|Overall Study|Administrative reasons|3|||
144461994|NCT02015676|520887621|FG002|Overall Study|Administrative reasons|1|||
144461995|NCT02015676|520887619|FG000|Overall Study|Death|0|||
144535516|NCT03725332|521164805|FG000|Overall Study|Death|1|||
144535517|NCT03725332|521164806|FG001|Overall Study|Death|3|||
144535518|NCT03725332|521164805|FG000|Overall Study|Lost to Follow-up|43|||
144535519|NCT03725332|521164806|FG001|Overall Study|Lost to Follow-up|122|||
144535520|NCT03725332|521164805|FG000|Overall Study|Withdrawal by Subject|0|||
144535521|NCT03725332|521164806|FG001|Overall Study|Withdrawal by Subject|1|||
144535522|NCT03725332|521164805|FG000|Overall Study|Duplicate enrollment|0|||
144535523|NCT03725332|521164806|FG001|Overall Study|Duplicate enrollment|1|||
144535524|NCT03725332|521164805|FG000|Overall Study|Did not consent|0|||
144535525|NCT03725332|521164806|FG001|Overall Study|Did not consent|1|||
144535526|NCT03242915|521164809|FG000|Overall Study|Adverse Event|5|||
144535527|NCT03242915|521164810|FG001|Overall Study|Adverse Event|1|||
144535528|NCT03242915|521164809|FG000|Overall Study|Withdrawal by Subject|0|||
144535529|NCT03242915|521164810|FG001|Overall Study|Withdrawal by Subject|2|||
144535530|NCT03242915|521164809|FG000|Overall Study|Physician Decision|4|||
144535531|NCT03242915|521164810|FG001|Overall Study|Physician Decision|1|||
144535532|NCT03142009|521164812|FG000|Overall Study|Lost to Follow-up|45|||
144535533|NCT03142009|521164813|FG001|Overall Study|Lost to Follow-up|30|||
144535534|NCT03872466|521164814|FG000|Overall Study|Withdrawal by Subject|1|||
144535535|NCT03872466|521164815|FG001|Overall Study|Withdrawal by Subject|0|||
144535536|NCT03872466|521164814|FG000|Overall Study|Physician Decision|2|||
144535537|NCT03872466|521164815|FG001|Overall Study|Physician Decision|0|||
144535538|NCT01778686|521164816|FG000|Overall Study|Adverse Event|0|||
144535539|NCT01778686|521164817|FG001|Overall Study|Adverse Event|0|||
144535540|NCT01778686|521164818|FG002|Overall Study|Adverse Event|1|||
144535541|NCT04012567|521164819|FG000|Overall Study|Lost to Follow-up|0|||
144535542|NCT04012567|521164820|FG001|Overall Study|Lost to Follow-up|1|||
144535543|NCT04012567|521164819|FG000|Overall Study|Withdrawal by Subject|1|||
144535544|NCT04012567|521164820|FG001|Overall Study|Withdrawal by Subject|0|||
144535545|NCT06059443|521164821|FG000|Overall Study|Withdrawal by Subject|2|||
144535546|NCT06059443|521164822|FG001|Overall Study|Withdrawal by Subject|0|||
144535547|NCT06059443|521164821|FG000|Overall Study|Lost to Follow-up|2|||
144535548|NCT06059443|521164822|FG001|Overall Study|Lost to Follow-up|2|||
144535549|NCT05771467|521164824|FG000|Overall Study|Lost to Follow-up|6|||
144535550|NCT05771467|521164825|FG001|Overall Study|Lost to Follow-up|3|||
144535551|NCT04940624|521164829|FG000|Overall Study|Adverse Event|4|||
144535552|NCT04940624|521164830|FG001|Overall Study|Adverse Event|11|||
144256920|NCT00572455|520141685|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
144256921|NCT00572455|520141686|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
144256922|NCT00572455|520141687|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
144256923|NCT00572455|520141688|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
144256924|NCT00572455|520141689|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
144610244|NCT01555151|521434250|FG002|Overall Study|Lost to Follow-up|0|||
144725963|NCT00688064|521852655|FG001|Overall Study|Lost to Follow-up|10|||
144725964|NCT00688064|521852654|FG000|Overall Study|Lack of Efficacy|0|||
144610245|NCT01555151|521434251|FG003|Overall Study|Lost to Follow-up|1|||
144610246|NCT01816061|521434252|FG000|Overall Study|Lost to Follow-up|13|||
144610247|NCT01816061|521434253|FG001|Overall Study|Lost to Follow-up|24|||
144610248|NCT01671111|521434255|FG000|Overall Study|Adverse Event|2|||
144610249|NCT01671111|521434255|FG000|Overall Study|Lack of Efficacy|1|||
144610250|NCT01671111|521434255|FG000|Overall Study|Withdrawal by Subject|2|||
144610251|NCT01671111|521434255|FG000|Overall Study|Physician Decision|1|||
144610252|NCT01671111|521434255|FG000|Overall Study|Other|24|||
144610253|NCT02114268|521434258|FG000|Overall Study|Lost to Follow-up|4|||
144610254|NCT02114268|521434259|FG001|Overall Study|Lost to Follow-up|1|||
144610255|NCT02114268|521434260|FG002|Overall Study|Lost to Follow-up|1|||
144610256|NCT02114268|521434261|FG003|Overall Study|Lost to Follow-up|0|||
144610257|NCT02114268|521434262|FG004|Overall Study|Lost to Follow-up|0|||
144610258|NCT02114268|521434263|FG005|Overall Study|Lost to Follow-up|2|||
144610259|NCT02114268|521434258|FG000|Overall Study|Withdrawal by Subject|1|||
144610260|NCT02114268|521434259|FG001|Overall Study|Withdrawal by Subject|0|||
144610261|NCT02114268|521434260|FG002|Overall Study|Withdrawal by Subject|0|||
144610262|NCT02114268|521434261|FG003|Overall Study|Withdrawal by Subject|0|||
144610263|NCT02114268|521434262|FG004|Overall Study|Withdrawal by Subject|0|||
144610264|NCT02114268|521434263|FG005|Overall Study|Withdrawal by Subject|1|||
144610265|NCT02114268|521434258|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
144610266|NCT02114268|521434259|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
144610267|NCT02114268|521434260|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
144610268|NCT02114268|521434261|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
144610269|NCT02114268|521434262|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
144610270|NCT02114268|521434263|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
144610271|NCT01075412|521434270|FG000|Overall Study|Withdrawal by Subject|0|||
144610272|NCT01075412|521434271|FG001|Overall Study|Withdrawal by Subject|1|||
144610273|NCT00865904|521434273|FG000|Overall Study|Randomized but not Treated|2|||
144610274|NCT00865904|521434274|FG001|Overall Study|Randomized but not Treated|0|||
144610275|NCT00865904|521434275|FG002|Overall Study|Randomized but not Treated|0|||
144610276|NCT00865904|521434276|FG003|Overall Study|Randomized but not Treated|1|||
144610277|NCT00865904|521434277|FG004|Overall Study|Randomized but not Treated|1|||
144610278|NCT01431274|521434278|FG000|Overall Study|Adverse Event|51|||
144610279|NCT01431274|521434279|FG001|Overall Study|Adverse Event|37|||
144610280|NCT01431274|521434280|FG002|Overall Study|Adverse Event|43|||
144610281|NCT01431274|521434281|FG003|Overall Study|Adverse Event|30|||
144610282|NCT01431274|521434282|FG004|Overall Study|Adverse Event|37|||
144610283|NCT01431274|521434278|FG000|Overall Study|Consent withdrawn not due to AE|29|||
144610284|NCT01431274|521434279|FG001|Overall Study|Consent withdrawn not due to AE|20|||
144610285|NCT01431274|521434280|FG002|Overall Study|Consent withdrawn not due to AE|17|||
144610286|NCT01431274|521434281|FG003|Overall Study|Consent withdrawn not due to AE|20|||
144610287|NCT01431274|521434282|FG004|Overall Study|Consent withdrawn not due to AE|11|||
144610288|NCT01431274|521434278|FG000|Overall Study|Non compliant with protocol|5|||
144610289|NCT01431274|521434279|FG001|Overall Study|Non compliant with protocol|8|||
144610290|NCT01431274|521434280|FG002|Overall Study|Non compliant with protocol|4|||
144610291|NCT01431274|521434281|FG003|Overall Study|Non compliant with protocol|4|||
144610292|NCT01431274|521434282|FG004|Overall Study|Non compliant with protocol|4|||
144610293|NCT01431274|521434278|FG000|Overall Study|Lost to Follow-up|6|||
144610294|NCT01431274|521434279|FG001|Overall Study|Lost to Follow-up|7|||
144610295|NCT01431274|521434280|FG002|Overall Study|Lost to Follow-up|1|||
144610296|NCT01431274|521434281|FG003|Overall Study|Lost to Follow-up|4|||
144610297|NCT01431274|521434282|FG004|Overall Study|Lost to Follow-up|0|||
144610298|NCT01431274|521434278|FG000|Overall Study|Other reason not stated above|6|||
144610299|NCT01431274|521434279|FG001|Overall Study|Other reason not stated above|5|||
144610300|NCT01431274|521434280|FG002|Overall Study|Other reason not stated above|7|||
144610301|NCT01431274|521434281|FG003|Overall Study|Other reason not stated above|2|||
144610302|NCT01431274|521434282|FG004|Overall Study|Other reason not stated above|4|||
144610303|NCT00133991|521434285|FG000|Overall Study|Death|4|||
144610304|NCT01378858|521434286|FG000|Overall Study|Withdrawal by Subject|4|||
144610305|NCT01378858|521434287|FG001|Overall Study|Withdrawal by Subject|4|||
144610306|NCT02664272|521434288|FG000|Overall Study|Fluoroscopic images not made available|2|||
144610307|NCT03073980|521434289|FG000|Overall Study|Lost to Follow-up|10|||
144610308|NCT03073980|521434290|FG001|Overall Study|Lost to Follow-up|2|||
144610309|NCT03073980|521434291|FG002|Overall Study|Lost to Follow-up|9|||
144610310|NCT03073980|521434289|FG000|Overall Study|No post-procedure data|0|||
144610311|NCT03073980|521434290|FG001|Overall Study|No post-procedure data|0|||
144610312|NCT03073980|521434291|FG002|Overall Study|No post-procedure data|2|||
144610313|NCT01358760|521434292|FG000|Overall Study|Adverse Event|3|||
144610314|NCT01358760|521434293|FG001|Overall Study|Adverse Event|4|||
144610315|NCT01358760|521434294|FG002|Overall Study|Adverse Event|3|||
144610316|NCT01358760|521434292|FG000|Overall Study|Lost to Follow-up|1|||
144610317|NCT01358760|521434293|FG001|Overall Study|Lost to Follow-up|1|||
144610318|NCT01358760|521434294|FG002|Overall Study|Lost to Follow-up|3|||
144256925|NCT00572455|520141690|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
144256926|NCT00572455|520141691|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
144256927|NCT00572455|520141692|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
144256928|NCT00572455|520141693|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
144256929|NCT00572455|520141694|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
144256930|NCT00572455|520141695|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
144256931|NCT02384538|520141696|FG000|Overall Study|Adverse Event|1|||
144256932|NCT02384538|520141697|FG001|Overall Study|Adverse Event|4|||
144256933|NCT02384538|520141696|FG000|Overall Study|Lack of Efficacy|4|||
144256934|NCT02384538|520141697|FG001|Overall Study|Lack of Efficacy|4|||
144256935|NCT02384538|520141696|FG000|Overall Study|Withdrew Consent|0|||
144256936|NCT02384538|520141697|FG001|Overall Study|Withdrew Consent|4|||
144256937|NCT02384538|520141696|FG000|Overall Study|Other|1|||
144256938|NCT02384538|520141697|FG001|Overall Study|Other|3|||
144610319|NCT01358760|521434292|FG000|Overall Study|Withdrawal by Subject|5|||
144610320|NCT01358760|521434293|FG001|Overall Study|Withdrawal by Subject|3|||
144610321|NCT01358760|521434294|FG002|Overall Study|Withdrawal by Subject|2|||
144610322|NCT01358760|521434292|FG000|Overall Study|Physician Decision|1|||
144610323|NCT01358760|521434293|FG001|Overall Study|Physician Decision|0|||
144610324|NCT01358760|521434294|FG002|Overall Study|Physician Decision|1|||
144610325|NCT01358760|521434292|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
144610326|NCT01358760|521434293|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
144610327|NCT01358760|521434294|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
144610328|NCT00450723|521434296|FG000|Overall Study|Physician Decision|5|||
144610329|NCT02047253|521434299|FG000|Overall Study|Lost to Follow-up|8|||
144610330|NCT03574753|521434300|FG000|Overall Study|Adverse Event|3|||
144610331|NCT03574753|521434300|FG000|Overall Study|Progression/relapse|19|||
144610332|NCT03574753|521434300|FG000|Overall Study|Death|1|||
144610333|NCT01877915|521434301|FG000|Overall Study|Lost to Follow-up|10|||
144610334|NCT01877915|521434302|FG001|Overall Study|Lost to Follow-up|9|||
144610335|NCT01877915|521434301|FG000|Overall Study|Withdrawal by Subject|42|||
144610336|NCT01877915|521434302|FG001|Overall Study|Withdrawal by Subject|55|||
144610337|NCT01877915|521434301|FG000|Overall Study|Other|2|||
144610338|NCT01877915|521434302|FG001|Overall Study|Other|4|||
144610339|NCT05678257|521434307|FG000|Overall Study|Withdrawal by Subject|2|||
144610340|NCT05678257|521434308|FG001|Overall Study|Withdrawal by Subject|0|||
144610341|NCT05678257|521434309|FG002|Overall Study|Withdrawal by Subject|5|||
144610342|NCT05678257|521434307|FG000|Overall Study|Physician Decision|1|||
144610343|NCT05678257|521434308|FG001|Overall Study|Physician Decision|0|||
144610344|NCT05678257|521434309|FG002|Overall Study|Physician Decision|1|||
144610345|NCT05678257|521434307|FG000|Overall Study|Adverse Event|1|||
144610346|NCT05678257|521434308|FG001|Overall Study|Adverse Event|3|||
144610347|NCT05678257|521434309|FG002|Overall Study|Adverse Event|1|||
144610348|NCT05678257|521434307|FG000|Overall Study|Progressive disease|11|||
144610349|NCT05678257|521434308|FG001|Overall Study|Progressive disease|18|||
144610350|NCT05678257|521434309|FG002|Overall Study|Progressive disease|7|||
144610351|NCT05678257|521434307|FG000|Overall Study|No longer clinically benefitting|2|||
144610352|NCT05678257|521434308|FG001|Overall Study|No longer clinically benefitting|1|||
144610353|NCT05678257|521434309|FG002|Overall Study|No longer clinically benefitting|0|||
144610354|NCT05678257|521434307|FG000|Overall Study|Sponsor decision|5|||
144610355|NCT05678257|521434308|FG001|Overall Study|Sponsor decision|9|||
144610356|NCT05678257|521434309|FG002|Overall Study|Sponsor decision|8|||
144610357|NCT05678257|521434307|FG000|Overall Study|Protocol Violation|0|||
144610358|NCT05678257|521434308|FG001|Overall Study|Protocol Violation|0|||
144610359|NCT05678257|521434309|FG002|Overall Study|Protocol Violation|1|||
144610360|NCT05678257|521434307|FG000|Overall Study|Patient non-compliance|0|||
144256939|NCT04446429|520141698|FG000|Overall Study|Lost to Follow-up|6|||
144256940|NCT04446429|520141699|FG001|Overall Study|Lost to Follow-up|0|||
144256941|NCT02187029|520141703|FG000|Overall Study|Adverse Event|0|||
144256942|NCT02187029|520141704|FG001|Overall Study|Adverse Event|1|||
144461996|NCT02015676|520887620|FG001|Overall Study|Death|1|||
144461997|NCT02015676|520887621|FG002|Overall Study|Death|0|||
144461998|NCT02015676|520887619|FG000|Overall Study|Disease progression|3|||
144461999|NCT02015676|520887620|FG001|Overall Study|Disease progression|1|||
144462000|NCT02015676|520887621|FG002|Overall Study|Disease progression|1|||
144610361|NCT05678257|521434308|FG001|Overall Study|Patient non-compliance|0|||
144610362|NCT05678257|521434309|FG002|Overall Study|Patient non-compliance|3|||
144610363|NCT02046096|521434310|FG000|Overall Study|Death|28|||
144610364|NCT02046096|521434311|FG001|Overall Study|Death|45|||
144610365|NCT02046096|521434310|FG000|Overall Study|Lost to Follow-up|9|||
144610366|NCT02046096|521434311|FG001|Overall Study|Lost to Follow-up|20|||
144610367|NCT02046096|521434310|FG000|Overall Study|Withdrawal by Subject|5|||
144610368|NCT02046096|521434311|FG001|Overall Study|Withdrawal by Subject|17|||
144610369|NCT02046096|521434310|FG000|Overall Study|Other endpoint|2|||
144610370|NCT02046096|521434311|FG001|Overall Study|Other endpoint|19|||
144256943|NCT02187029|520141705|FG002|Overall Study|Adverse Event|1|||
144256944|NCT02187029|520141706|FG003|Overall Study|Adverse Event|0|||
144256945|NCT02187029|520141703|FG000|Overall Study|Study Terminated by Sponsor|0|||
144610371|NCT03520959|521434312|FG000|Overall Study|Study terminated by Sponsor|0|||
144610372|NCT03520959|521434313|FG001|Overall Study|Study terminated by Sponsor|1|||
144610373|NCT01449461|521434314|FG000|Overall Study|Adverse Event|0|||
144610374|NCT01449461|521434315|FG001|Overall Study|Adverse Event|3|||
144610375|NCT01449461|521434316|FG002|Overall Study|Adverse Event|2|||
144610376|NCT01449461|521434317|FG003|Overall Study|Adverse Event|3|||
144610377|NCT01449461|521434318|FG004|Overall Study|Adverse Event|4|||
144610378|NCT01449461|521434319|FG005|Overall Study|Adverse Event|4|||
144610379|NCT01449461|521434314|FG000|Overall Study|Death|0|||
144610380|NCT01449461|521434315|FG001|Overall Study|Death|2|||
144610381|NCT01449461|521434316|FG002|Overall Study|Death|0|||
144610382|NCT01449461|521434317|FG003|Overall Study|Death|0|||
144610383|NCT01449461|521434318|FG004|Overall Study|Death|7|||
144610384|NCT01449461|521434319|FG005|Overall Study|Death|1|||
144610385|NCT01449461|521434314|FG000|Overall Study|Physician Decision|0|||
144610386|NCT01449461|521434315|FG001|Overall Study|Physician Decision|1|||
144610387|NCT01449461|521434316|FG002|Overall Study|Physician Decision|0|||
144610388|NCT01449461|521434317|FG003|Overall Study|Physician Decision|4|||
144610389|NCT01449461|521434318|FG004|Overall Study|Physician Decision|1|||
144610390|NCT01449461|521434319|FG005|Overall Study|Physician Decision|0|||
144610391|NCT01449461|521434314|FG000|Overall Study|Documented Progressive Disease|4|||
144610392|NCT01449461|521434315|FG001|Overall Study|Documented Progressive Disease|7|||
144610393|NCT01449461|521434316|FG002|Overall Study|Documented Progressive Disease|14|||
144610394|NCT01449461|521434317|FG003|Overall Study|Documented Progressive Disease|15|||
144610395|NCT01449461|521434318|FG004|Overall Study|Documented Progressive Disease|24|||
144610396|NCT01449461|521434319|FG005|Overall Study|Documented Progressive Disease|5|||
144610397|NCT01449461|521434314|FG000|Overall Study|Clinical Progressive Disease|2|||
144610398|NCT01449461|521434315|FG001|Overall Study|Clinical Progressive Disease|2|||
144610399|NCT01449461|521434316|FG002|Overall Study|Clinical Progressive Disease|0|||
144610400|NCT01449461|521434317|FG003|Overall Study|Clinical Progressive Disease|3|||
144610401|NCT01449461|521434318|FG004|Overall Study|Clinical Progressive Disease|4|||
144610402|NCT01449461|521434319|FG005|Overall Study|Clinical Progressive Disease|2|||
144610403|NCT01449461|521434314|FG000|Overall Study|Protocol Violation|0|||
144610404|NCT01449461|521434315|FG001|Overall Study|Protocol Violation|0|||
144610405|NCT01449461|521434316|FG002|Overall Study|Protocol Violation|0|||
144610406|NCT01449461|521434317|FG003|Overall Study|Protocol Violation|1|||
144610407|NCT01449461|521434318|FG004|Overall Study|Protocol Violation|0|||
144610408|NCT01449461|521434319|FG005|Overall Study|Protocol Violation|0|||
144610409|NCT01449461|521434314|FG000|Overall Study|Site Terminated by Sponsor|0|||
144610410|NCT01449461|521434315|FG001|Overall Study|Site Terminated by Sponsor|1|||
144610411|NCT01449461|521434316|FG002|Overall Study|Site Terminated by Sponsor|2|||
144610412|NCT01449461|521434317|FG003|Overall Study|Site Terminated by Sponsor|3|||
144610413|NCT01449461|521434318|FG004|Overall Study|Site Terminated by Sponsor|4|||
144610414|NCT01449461|521434319|FG005|Overall Study|Site Terminated by Sponsor|1|||
144610415|NCT01449461|521434314|FG000|Overall Study|Withdrawal by Subject|0|||
144610416|NCT01449461|521434315|FG001|Overall Study|Withdrawal by Subject|1|||
144610417|NCT01449461|521434316|FG002|Overall Study|Withdrawal by Subject|0|||
144610418|NCT01449461|521434317|FG003|Overall Study|Withdrawal by Subject|0|||
144610419|NCT01449461|521434318|FG004|Overall Study|Withdrawal by Subject|2|||
144610420|NCT01449461|521434319|FG005|Overall Study|Withdrawal by Subject|1|||
144610421|NCT01449461|521434314|FG000|Overall Study|Reason not Specified|0|||
144610422|NCT01449461|521434315|FG001|Overall Study|Reason not Specified|1|||
144610423|NCT01449461|521434316|FG002|Overall Study|Reason not Specified|0|||
144610424|NCT01449461|521434317|FG003|Overall Study|Reason not Specified|3|||
144610425|NCT01449461|521434318|FG004|Overall Study|Reason not Specified|2|||
144610426|NCT01449461|521434319|FG005|Overall Study|Reason not Specified|1|||
144610427|NCT05314517|521434321|FG000|Double-blind Period|Adverse Event|4|||
144610428|NCT05314517|521434322|FG001|Double-blind Period|Adverse Event|0|||
144610429|NCT05314517|521434323|FG002|Double-blind Period|Adverse Event|0|||
144610430|NCT05314517|521434324|FG003|Double-blind Period|Adverse Event|0|||
144610431|NCT05314517|521434321|FG000|Double-blind Period|Noncompliance|0|||
144610432|NCT05314517|521434322|FG001|Double-blind Period|Noncompliance|1|||
144610433|NCT05314517|521434323|FG002|Double-blind Period|Noncompliance|0|||
144610434|NCT05314517|521434324|FG003|Double-blind Period|Noncompliance|0|||
144610435|NCT05314517|521434321|FG000|Double-blind Period|Randomized, not treated|1|||
144610436|NCT05314517|521434322|FG001|Double-blind Period|Randomized, not treated|0|||
144610437|NCT05314517|521434323|FG002|Double-blind Period|Randomized, not treated|0|||
144610438|NCT05314517|521434324|FG003|Double-blind Period|Randomized, not treated|0|||
144610439|NCT05314517|521434321|FG000|Open-label Extension|Adverse Event|0|||
144610440|NCT05314517|521434322|FG001|Open-label Extension|Adverse Event|0|||
144610441|NCT05314517|521434323|FG002|Open-label Extension|Adverse Event|1|||
144610442|NCT05314517|521434324|FG003|Open-label Extension|Adverse Event|2|||
144610443|NCT05314517|521434321|FG000|Open-label Extension|Investigator decision|0|||
144610444|NCT05314517|521434322|FG001|Open-label Extension|Investigator decision|0|||
144610445|NCT05314517|521434323|FG002|Open-label Extension|Investigator decision|1|||
144610446|NCT05314517|521434324|FG003|Open-label Extension|Investigator decision|0|||
144610447|NCT05314517|521434321|FG000|Open-label Extension|Lost to Follow-up|0|||
144725965|NCT00688064|521852655|FG001|Overall Study|Lack of Efficacy|1|||
144462001|NCT03321396|520887630|FG000|Overall Study|Physician Decision|1|||
144462002|NCT01654549|520887631|FG000|Overall Study|H.pylori eradication not successful|0|||
144462003|NCT01654549|520887632|FG001|Overall Study|H.pylori eradication not successful|1|||
144462004|NCT01972841|520887633|FG000|Overall Study|Randomized but Never Received Treatment|2|||
144462005|NCT01972841|520887634|FG001|Overall Study|Randomized but Never Received Treatment|5|||
144462006|NCT01972841|520887635|FG002|Overall Study|Randomized but Never Received Treatment|4|||
144462007|NCT01972841|520887636|FG003|Overall Study|Randomized but Never Received Treatment|2|||
144462008|NCT01972841|520887637|FG004|Overall Study|Randomized but Never Received Treatment|6|||
144462009|NCT01972841|520887638|FG005|Overall Study|Randomized but Never Received Treatment|13|||
144462010|NCT01972841|520887633|FG000|Overall Study|Adverse Event|13|||
144462011|NCT01972841|520887634|FG001|Overall Study|Adverse Event|8|||
144462012|NCT01972841|520887635|FG002|Overall Study|Adverse Event|12|||
144462013|NCT01972841|520887636|FG003|Overall Study|Adverse Event|9|||
144462014|NCT01972841|520887637|FG004|Overall Study|Adverse Event|21|||
144462015|NCT01972841|520887638|FG005|Overall Study|Adverse Event|26|||
144462016|NCT01972841|520887633|FG000|Overall Study|Lack of Efficacy|1|||
144462017|NCT01972841|520887634|FG001|Overall Study|Lack of Efficacy|0|||
144462018|NCT01972841|520887635|FG002|Overall Study|Lack of Efficacy|0|||
144462019|NCT01972841|520887636|FG003|Overall Study|Lack of Efficacy|2|||
144462020|NCT01972841|520887637|FG004|Overall Study|Lack of Efficacy|4|||
144462021|NCT01972841|520887638|FG005|Overall Study|Lack of Efficacy|1|||
144462022|NCT01972841|520887633|FG000|Overall Study|Lost to Follow-up|4|||
144462023|NCT01972841|520887634|FG001|Overall Study|Lost to Follow-up|2|||
144462024|NCT01972841|520887635|FG002|Overall Study|Lost to Follow-up|4|||
144462025|NCT01972841|520887636|FG003|Overall Study|Lost to Follow-up|2|||
144462026|NCT01972841|520887637|FG004|Overall Study|Lost to Follow-up|9|||
144462027|NCT01972841|520887638|FG005|Overall Study|Lost to Follow-up|3|||
144462028|NCT01972841|520887633|FG000|Overall Study|Protocol Violation|2|||
144462029|NCT01972841|520887634|FG001|Overall Study|Protocol Violation|2|||
144462030|NCT01972841|520887635|FG002|Overall Study|Protocol Violation|3|||
144462031|NCT01972841|520887636|FG003|Overall Study|Protocol Violation|5|||
144462032|NCT01972841|520887637|FG004|Overall Study|Protocol Violation|9|||
144462033|NCT01972841|520887638|FG005|Overall Study|Protocol Violation|4|||
144462034|NCT01972841|520887633|FG000|Overall Study|Withdrawal by participants|21|||
144462035|NCT01972841|520887634|FG001|Overall Study|Withdrawal by participants|27|||
144462036|NCT01972841|520887635|FG002|Overall Study|Withdrawal by participants|23|||
144462037|NCT01972841|520887636|FG003|Overall Study|Withdrawal by participants|16|||
144462038|NCT01972841|520887637|FG004|Overall Study|Withdrawal by participants|33|||
144462039|NCT01972841|520887638|FG005|Overall Study|Withdrawal by participants|34|||
144462040|NCT01972841|520887633|FG000|Overall Study|Miscellaneous|0|||
144462041|NCT01972841|520887634|FG001|Overall Study|Miscellaneous|0|||
144462042|NCT01972841|520887635|FG002|Overall Study|Miscellaneous|4|||
144462043|NCT01972841|520887636|FG003|Overall Study|Miscellaneous|1|||
144462044|NCT01972841|520887637|FG004|Overall Study|Miscellaneous|0|||
144462045|NCT01972841|520887638|FG005|Overall Study|Miscellaneous|4|||
144462046|NCT01972841|520887633|FG000|Overall Study|Did not have end of treatment page|0|||
144462047|NCT01972841|520887634|FG001|Overall Study|Did not have end of treatment page|0|||
144462048|NCT01972841|520887635|FG002|Overall Study|Did not have end of treatment page|0|||
144462049|NCT01972841|520887636|FG003|Overall Study|Did not have end of treatment page|0|||
144610448|NCT05314517|521434322|FG001|Open-label Extension|Lost to Follow-up|0|||
144725966|NCT00688064|521852654|FG000|Overall Study|Pregnancy|1|||
144610449|NCT05314517|521434323|FG002|Open-label Extension|Lost to Follow-up|0|||
144610450|NCT05314517|521434324|FG003|Open-label Extension|Lost to Follow-up|1|||
144610451|NCT05314517|521434321|FG000|Open-label Extension|Withdrawal by Subject|0|||
144610452|NCT05314517|521434322|FG001|Open-label Extension|Withdrawal by Subject|0|||
144610453|NCT05314517|521434323|FG002|Open-label Extension|Withdrawal by Subject|1|||
144610454|NCT05314517|521434324|FG003|Open-label Extension|Withdrawal by Subject|2|||
144610455|NCT05314517|521434321|FG000|Open-label Extension|Use of prohibited medication|0|||
144610456|NCT05314517|521434322|FG001|Open-label Extension|Use of prohibited medication|0|||
144610457|NCT05314517|521434323|FG002|Open-label Extension|Use of prohibited medication|1|||
144610458|NCT05314517|521434324|FG003|Open-label Extension|Use of prohibited medication|0|||
144610459|NCT05314517|521434321|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
144462050|NCT01972841|520887637|FG004|Overall Study|Did not have end of treatment page|1|||
144462051|NCT01972841|520887638|FG005|Overall Study|Did not have end of treatment page|0|||
144462052|NCT04969198|520887641|FG000|Overall Study|Withdrawal by Subject|20|||
144462053|NCT04969198|520887641|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
144462054|NCT04969198|520887641|FG000|Overall Study|Lost to Follow-up|20|||
144462055|NCT04009291|520887642|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
144462056|NCT04009291|520887643|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
144462057|NCT04009291|520887644|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
144462058|NCT04009291|520887645|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
144462059|NCT04009291|520887646|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
144462060|NCT04009291|520887642|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
144462061|NCT04009291|520887643|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
144725967|NCT00688064|521852655|FG001|Overall Study|Pregnancy|0|||
144725968|NCT00688064|521852654|FG000|Overall Study|Any other reasons|1|||
144725969|NCT00688064|521852655|FG001|Overall Study|Any other reasons|3|||
144725970|NCT02497781|521852656|FG000|Overall Study|Withdrawal by Subject|2|||
144725971|NCT02497781|521852657|FG001|Overall Study|Withdrawal by Subject|0|||
144462062|NCT04009291|520887644|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
144462063|NCT04009291|520887645|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
144462064|NCT04009291|520887646|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
144462065|NCT01270347|520887647|FG000|Core Phase|Adverse Event|1|||
144462066|NCT01270347|520887648|FG001|Core Phase|Adverse Event|6|||
144462067|NCT01270347|520887647|FG000|Core Phase|Withdrawal by Subject|1|||
144462068|NCT01270347|520887648|FG001|Core Phase|Withdrawal by Subject|2|||
144462069|NCT01270347|520887647|FG000|Core Phase|Lost to Follow-up|0|||
144462070|NCT01270347|520887648|FG001|Core Phase|Lost to Follow-up|1|||
144462071|NCT01270347|520887647|FG000|Core Phase|Miscellaneous|8|||
144462072|NCT01270347|520887648|FG001|Core Phase|Miscellaneous|14|||
144725972|NCT02497781|521852656|FG000|Overall Study|Lack of Efficacy|0|||
144725973|NCT02497781|521852657|FG001|Overall Study|Lack of Efficacy|1|||
144725974|NCT02497781|521852656|FG000|Overall Study|Randomised but not treated|1|||
144725975|NCT02497781|521852657|FG001|Overall Study|Randomised but not treated|1|||
144725976|NCT02497781|521852656|FG000|Overall Study|Lost to Follow-up|1|||
144725977|NCT02497781|521852657|FG001|Overall Study|Lost to Follow-up|1|||
144725978|NCT02236130|521852658|FG000|Overall Study|Lost to Follow-up|7|||
144725979|NCT02236130|521852659|FG001|Overall Study|Lost to Follow-up|12|||
144725980|NCT00525590|521852660|FG000|Overall Study|Adverse Event|3|||
144725981|NCT00525590|521852660|FG000|Overall Study|Physician Decision|3|||
144725982|NCT00525590|521852660|FG000|Overall Study|Withdrawal by Subject|16|||
144725983|NCT00525590|521852660|FG000|Overall Study|Lost to Follow-up|1|||
144725984|NCT00525590|521852660|FG000|Overall Study|Death|9|||
144725985|NCT00525590|521852660|FG000|Overall Study|Other|13|||
144725986|NCT01345019|521852669|FG000|Blinded Treatment Phase|Death|147|||
144725987|NCT01345019|521852670|FG001|Blinded Treatment Phase|Death|137|||
144725988|NCT01345019|521852669|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
144725989|NCT01345019|521852670|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
144725990|NCT01345019|521852669|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
144725991|NCT01345019|521852670|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
144725992|NCT01345019|521852669|FG000|Blinded Treatment Phase|Disease Progression|12|||
144725993|NCT01345019|521852670|FG001|Blinded Treatment Phase|Disease Progression|10|||
144725994|NCT01345019|521852669|FG000|Blinded Treatment Phase|Adverse Event|6|||
144725995|NCT01345019|521852670|FG001|Blinded Treatment Phase|Adverse Event|13|||
144725996|NCT01345019|521852669|FG000|Blinded Treatment Phase|Administrative Decision|10|||
144725997|NCT01345019|521852670|FG001|Blinded Treatment Phase|Administrative Decision|8|||
144725998|NCT01345019|521852669|FG000|Blinded Treatment Phase|Noncompliance|5|||
144725999|NCT01345019|521852670|FG001|Blinded Treatment Phase|Noncompliance|3|||
144726000|NCT01345019|521852669|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
144726001|NCT01345019|521852670|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
144726002|NCT01345019|521852669|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
144726003|NCT01345019|521852670|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
144726004|NCT01345019|521852669|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
144726005|NCT01345019|521852670|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
144726006|NCT01345019|521852669|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
144610460|NCT05314517|521434322|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
144610461|NCT05314517|521434323|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
144610462|NCT05314517|521434324|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
144610463|NCT04969276|521434325|FG000|Overall Study|Protocol Deviation|0|||
144610464|NCT04969276|521434326|FG001|Overall Study|Protocol Deviation|1|||
144610465|NCT04969276|521434327|FG002|Overall Study|Protocol Deviation|0|||
144610466|NCT04969276|521434325|FG000|Overall Study|Withdrawal by Subject|1|||
144610467|NCT04969276|521434326|FG001|Overall Study|Withdrawal by Subject|10|||
144610468|NCT04969276|521434327|FG002|Overall Study|Withdrawal by Subject|0|||
144610469|NCT04969276|521434325|FG000|Overall Study|Lost to Follow-up|0|||
144610470|NCT04969276|521434326|FG001|Overall Study|Lost to Follow-up|1|||
144610471|NCT04969276|521434327|FG002|Overall Study|Lost to Follow-up|0|||
144610472|NCT05248295|521434331|FG000|Overall Study|found ineligible|4|||
144726007|NCT01345019|521852670|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
144462073|NCT01270347|520887647|FG000|Extension Phase|Adverse Event|1|||
144462074|NCT01270347|520887648|FG001|Extension Phase|Adverse Event|3|||
144462075|NCT01270347|520887647|FG000|Extension Phase|Withdrawal by Subject|3|||
144462076|NCT01270347|520887648|FG001|Extension Phase|Withdrawal by Subject|4|||
144462077|NCT01270347|520887647|FG000|Extension Phase|Miscellaneous|2|||
144610473|NCT05248295|521434332|FG001|Overall Study|found ineligible|1|||
144610474|NCT05248295|521434331|FG000|Overall Study|Withdrawal by Subject|0|||
144726008|NCT01345019|521852669|FG000|Open Label Treatment Phase|Death|49|||
144726009|NCT01345019|521852670|FG001|Open Label Treatment Phase|Death|48|||
144726010|NCT01345019|521852669|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
144462078|NCT01270347|520887648|FG001|Extension Phase|Miscellaneous|2|||
144462079|NCT01556438|520887651|FG000|Overall Study|Adverse Event|4|||
144462080|NCT01556438|520887652|FG001|Overall Study|Adverse Event|2|||
144462081|NCT01556438|520887651|FG000|Overall Study|Sponsor Decision|0|||
144462082|NCT01556438|520887652|FG001|Overall Study|Sponsor Decision|2|||
144462083|NCT01556438|520887651|FG000|Overall Study|Progressive Disease|0|||
144462084|NCT01556438|520887652|FG001|Overall Study|Progressive Disease|6|||
144462085|NCT01556438|520887651|FG000|Overall Study|Death|0|||
144462086|NCT01556438|520887652|FG001|Overall Study|Death|1|||
144462087|NCT03282227|520887654|FG000|Overall Study|Exposure Goals Achieved|60|||
144462088|NCT03282227|520887654|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
144462089|NCT03282227|520887654|FG000|Overall Study|Adverse Event|15|||
144462090|NCT03282227|520887654|FG000|Overall Study|Lost to Follow-up|21|||
144256946|NCT02187029|520141704|FG001|Overall Study|Study Terminated by Sponsor|0|||
144256947|NCT02187029|520141705|FG002|Overall Study|Study Terminated by Sponsor|10|||
144256948|NCT02187029|520141706|FG003|Overall Study|Study Terminated by Sponsor|3|||
144256949|NCT02187029|520141703|FG000|Overall Study|Withdrawal by Subject|1|||
144256950|NCT02187029|520141704|FG001|Overall Study|Withdrawal by Subject|0|||
144256951|NCT02187029|520141705|FG002|Overall Study|Withdrawal by Subject|0|||
144462091|NCT03282227|520887654|FG000|Overall Study|Withdrawal by Subject|20|||
144462092|NCT03282227|520887654|FG000|Overall Study|Lack of Efficacy|12|||
144462093|NCT03282227|520887654|FG000|Overall Study|Sponsor decision|3|||
144462094|NCT03282227|520887654|FG000|Overall Study|Physician Decision|2|||
144462095|NCT03282227|520887654|FG000|Overall Study|Pregnancy|2|||
144256952|NCT02187029|520141706|FG003|Overall Study|Withdrawal by Subject|0|||
144256953|NCT01763203|520141713|FG000|Overall Study|Death|4|||
144256954|NCT01763203|520141714|FG001|Overall Study|Death|7|||
144256955|NCT01763203|520141713|FG000|Overall Study|Lost to Follow-up|12|||
144256956|NCT01763203|520141714|FG001|Overall Study|Lost to Follow-up|12|||
144256957|NCT01763203|520141713|FG000|Overall Study|Withdrawal by Subject|8|||
144256958|NCT01763203|520141714|FG001|Overall Study|Withdrawal by Subject|12|||
144256959|NCT01763203|520141713|FG000|Overall Study|Moved out of study region|7|||
144256960|NCT01763203|520141714|FG001|Overall Study|Moved out of study region|10|||
144256961|NCT01763203|520141713|FG000|Overall Study|Physician Decision|2|||
144256962|NCT01763203|520141714|FG001|Overall Study|Physician Decision|1|||
144256963|NCT02756819|520141718|FG000|Overall Study|Lost for observation|23|||
144256964|NCT02756819|520141718|FG000|Overall Study|Patient's unwillingness|16|||
144256965|NCT02756819|520141718|FG000|Overall Study|Insufficient efficacy|2|||
144256966|NCT02756819|520141718|FG000|Overall Study|Adverse Event|2|||
144256967|NCT02756819|520141718|FG000|Overall Study|Reason not Specified|9|||
144256968|NCT01491841|520141720|FG000|Overall Study|Screen Failure|10|||
144256969|NCT01491841|520141720|FG000|Overall Study|Withdrawal by Subject|1|||
144256970|NCT02933528|520141721|FG000|Overall Study|Lost to Follow-up|2|||
144256971|NCT01042392|520141722|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
144256972|NCT01042392|520141723|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
144256973|NCT01042392|520141724|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
144256974|NCT01042392|520141725|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
144256975|NCT01042392|520141722|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
144256976|NCT01042392|520141723|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
144256977|NCT01042392|520141724|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
144256978|NCT01042392|520141725|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
144256979|NCT01042392|520141722|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
144256980|NCT01042392|520141723|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
144256981|NCT01042392|520141724|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
144256982|NCT01042392|520141725|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
144256983|NCT01042392|520141722|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
144256984|NCT01042392|520141723|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
144256985|NCT01042392|520141724|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
144256986|NCT01042392|520141725|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
144256987|NCT01042392|520141722|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
144256988|NCT01042392|520141723|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
144256989|NCT01042392|520141724|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
144256990|NCT01042392|520141725|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
144256991|NCT01042392|520141722|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
144256992|NCT01042392|520141723|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
144256993|NCT01042392|520141724|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
144256994|NCT01042392|520141725|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
144462096|NCT03282227|520887654|FG000|Overall Study|Other|1|||
144462097|NCT02491671|520887655|FG000|Overall Study|Adverse Event|6|||
144462098|NCT02491671|520887656|FG001|Overall Study|Adverse Event|8|||
144462099|NCT02491671|520887655|FG000|Overall Study|Death|0|||
144462100|NCT02491671|520887656|FG001|Overall Study|Death|2|||
144462101|NCT02491671|520887655|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
144535553|NCT04940624|521164829|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144256995|NCT01042392|520141722|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
144462102|NCT02491671|520887656|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
144462103|NCT02251990|520887657|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
144462104|NCT02251990|520887658|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
144462105|NCT02251990|520887657|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
144462106|NCT02251990|520887658|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
144256996|NCT01042392|520141723|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
144256997|NCT01042392|520141724|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
144256998|NCT01042392|520141725|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
144256999|NCT01042392|520141722|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
144257000|NCT01042392|520141723|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
144257001|NCT01042392|520141724|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
144257002|NCT01042392|520141725|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
144257003|NCT01042392|520141722|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
144257004|NCT01042392|520141723|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
144257005|NCT01042392|520141724|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
144257006|NCT01042392|520141725|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
144257007|NCT03076996|520141726|FG000|Overall Study|Withdrawal by Subject|2|||
144257008|NCT03076996|520141726|FG000|Overall Study|Lost to Follow-up|3|||
144257009|NCT03076996|520141726|FG000|Overall Study|Literacy precluded participation|1|||
144257010|NCT00587795|520141727|FG000|Overall Study|Withdrawal by Subject|1|||
144257011|NCT00587795|520141728|FG001|Overall Study|Withdrawal by Subject|0|||
144257012|NCT00943592|520141729|FG000|Overall Study|Death|3|||
144257013|NCT00169104|520141730|FG000|Overall Study|Withdrawal by Subject|2|||
144257014|NCT00169104|520141731|FG001|Overall Study|Withdrawal by Subject|0|||
144257015|NCT00169104|520141730|FG000|Overall Study|Protocol Violation|0|||
144257016|NCT00169104|520141731|FG001|Overall Study|Protocol Violation|1|||
144257017|NCT00169104|520141730|FG000|Overall Study|Physician Decision|0|||
144257018|NCT00169104|520141731|FG001|Overall Study|Physician Decision|1|||
144257019|NCT00715299|520141737|FG000|Overall Study|Withdrawal by Subject|1|||
144462107|NCT02251990|520887657|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
144462108|NCT02251990|520887658|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
144462109|NCT02251990|520887657|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
144462110|NCT02251990|520887658|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
144462111|NCT02251990|520887657|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
144462112|NCT02251990|520887658|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
144462113|NCT02251990|520887657|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
144462114|NCT02251990|520887658|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
144610475|NCT05248295|521434332|FG001|Overall Study|Withdrawal by Subject|1|||
144610476|NCT05248295|521434331|FG000|Overall Study|Data loss: audio recording error|1|||
144610477|NCT05248295|521434332|FG001|Overall Study|Data loss: audio recording error|1|||
144610478|NCT04655144|521434333|FG000|Overall Study|Consumed THC|1|||
144610479|NCT04655144|521434334|FG001|Overall Study|Consumed THC|0|||
144610480|NCT04655144|521434333|FG000|Overall Study|Unilateral embolization|0|||
144610481|NCT04655144|521434334|FG001|Overall Study|Unilateral embolization|1|||
144610482|NCT01484977|521434337|FG000|Overall Study|Adverse Event|8|||
144610483|NCT01484977|521434337|FG000|Overall Study|Lack of Efficacy|4|||
144610484|NCT01484977|521434337|FG000|Overall Study|Protocol Violation|6|||
144610485|NCT01484977|521434337|FG000|Overall Study|Lost to Follow-up|1|||
144610486|NCT01484977|521434337|FG000|Overall Study|Withdrawal by Subject|4|||
144610487|NCT01484977|521434337|FG000|Overall Study|Subject Protocol Non-compliant|1|||
144610488|NCT01484977|521434337|FG000|Overall Study|Moving Overseas|1|||
144610489|NCT01484977|521434337|FG000|Overall Study|Low White Blood Cell Count|1|||
144610490|NCT01484977|521434337|FG000|Overall Study|Lack of Compliance|1|||
144610491|NCT00591214|521434342|FG000|Overall Study|Physician Decision|7|||
144462115|NCT03265600|520887659|FG000|Overall Study|Lost to Follow-up|17|||
144462116|NCT03265600|520887660|FG001|Overall Study|Lost to Follow-up|5|||
144462117|NCT03265600|520887659|FG000|Overall Study|Withdrawal by Subject|4|||
144610492|NCT00591214|521434342|FG000|Overall Study|Withdrawal by Subject|1|||
144257020|NCT00715299|520141737|FG000|Overall Study|Adverse Event|3|||
144257021|NCT00715299|520141737|FG000|Overall Study|failed the pre-screen exercise test|2|||
144257022|NCT01540981|520141738|FG000|Overall Study|Withdrawal by Subject|1|||
144257023|NCT01540981|520141739|FG001|Overall Study|Withdrawal by Subject|0|||
144257024|NCT01535443|520141740|FG000|Overall Study|Physician Decision|3|||
144257025|NCT00232557|520141741|FG000|Overall Study|Lost to Follow-up|3|||
144610493|NCT04857996|521434343|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
144257026|NCT00232557|520141742|FG001|Overall Study|Lost to Follow-up|5|||
144257027|NCT02438280|520141745|FG000|Overall Study|Physician Decision|1|||
144610494|NCT04857996|521434344|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
144610495|NCT04857996|521434343|FG000|Overall Study|Lost to Follow-up|1|||
144257028|NCT02438280|520141746|FG001|Overall Study|Physician Decision|0|||
144257029|NCT04435808|520141747|FG000|Overall Study|Study stopped by DSMB|0|||
144257030|NCT04435808|520141748|FG001|Overall Study|Study stopped by DSMB|1|||
144257031|NCT03299101|520141749|FG000|Overall Study|Lost to Follow-up|1|||
144257032|NCT03299101|520141749|FG000|Overall Study|Withdrawal by Subject|5|||
144257033|NCT03299101|520141749|FG000|Overall Study|Surgery was changed|3|||
144257034|NCT03299101|520141749|FG000|Overall Study|Not enough time to complete prehab|1|||
144257035|NCT02982863|520141750|FG000|Overall Study|Not eligible patients|809|||
144257036|NCT02982863|520141751|FG001|Overall Study|Not eligible patients|4261|||
144257037|NCT02982863|520141752|FG002|Overall Study|Not eligible patients|1852|||
144257038|NCT02982863|520141753|FG003|Overall Study|Not eligible patients|1400|||
144257039|NCT02982863|520141754|FG004|Overall Study|Not eligible patients|492|||
144257040|NCT02457195|520141755|FG000|Overall Study|Adverse Event|3|||
144257041|NCT02457195|520141755|FG000|Overall Study|Protocol Violation|2|||
144257042|NCT02457195|520141755|FG000|Overall Study|Withdrawal by Subject|4|||
144257043|NCT05359952|520141756|FG000|Overall Study|Lost to Follow-up|1|||
144257044|NCT05359952|520141757|FG001|Overall Study|Lost to Follow-up|0|||
144257045|NCT05980013|520141758|FG000|Overall Study|Withdrawal by Subject|0|||
144257046|NCT05980013|520141759|FG001|Overall Study|Withdrawal by Subject|1|||
144257047|NCT05980013|520141758|FG000|Overall Study|Device Error|0|||
144257048|NCT05980013|520141759|FG001|Overall Study|Device Error|1|||
144257049|NCT01563913|520141760|FG000|Overall Study|Physician Decision|1|||
144257050|NCT01563913|520141761|FG001|Overall Study|Physician Decision|0|||
144257051|NCT01563913|520141760|FG000|Overall Study|Spouse Passed Away|1|||
144257052|NCT01563913|520141761|FG001|Overall Study|Spouse Passed Away|0|||
144257053|NCT03066778|520141762|FG000|Overall Study|Death|195|||
144257054|NCT03066778|520141763|FG001|Overall Study|Death|205|||
144257055|NCT03066778|520141762|FG000|Overall Study|Withdrawal by Subject|5|||
144257056|NCT03066778|520141763|FG001|Overall Study|Withdrawal by Subject|7|||
144257057|NCT02091414|520141764|FG000|Overall Study|Withdrawal by Subject|2|||
144257058|NCT02091414|520141764|FG000|Overall Study|Death|2|||
144726011|NCT01345019|521852670|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
144726012|NCT01345019|521852669|FG000|Open Label Treatment Phase|Adverse Event|30|||
144257059|NCT00435461|520141765|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
144257060|NCT00435461|520141766|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
144257061|NCT00435461|520141767|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
144257062|NCT00435461|520141765|FG000|Overall Study|Protocol Violation|6|||
144257063|NCT00435461|520141766|FG001|Overall Study|Protocol Violation|9|||
144257064|NCT00435461|520141767|FG002|Overall Study|Protocol Violation|10|||
144257065|NCT00435461|520141765|FG000|Overall Study|Participant randomized(inadequate score)|1|||
144257066|NCT00435461|520141766|FG001|Overall Study|Participant randomized(inadequate score)|0|||
144257067|NCT00435461|520141767|FG002|Overall Study|Participant randomized(inadequate score)|0|||
144257068|NCT00435461|520141765|FG000|Overall Study|Compliance less than 80 percent|1|||
144257069|NCT00435461|520141766|FG001|Overall Study|Compliance less than 80 percent|0|||
144257070|NCT00435461|520141767|FG002|Overall Study|Compliance less than 80 percent|0|||
144257071|NCT00435461|520141765|FG000|Overall Study|In error, two study medications switched|1|||
144257072|NCT00435461|520141766|FG001|Overall Study|In error, two study medications switched|0|||
144257073|NCT00435461|520141767|FG002|Overall Study|In error, two study medications switched|0|||
144257074|NCT00435461|520141765|FG000|Overall Study|Lack of Efficacy|2|||
144257075|NCT00435461|520141766|FG001|Overall Study|Lack of Efficacy|1|||
144257076|NCT00435461|520141767|FG002|Overall Study|Lack of Efficacy|0|||
144257077|NCT00435461|520141765|FG000|Overall Study|Withdrawal by Subject|1|||
144257078|NCT00435461|520141766|FG001|Overall Study|Withdrawal by Subject|0|||
144257079|NCT00435461|520141767|FG002|Overall Study|Withdrawal by Subject|2|||
144257080|NCT00435461|520141765|FG000|Overall Study|Randomized in error|1|||
144257081|NCT00435461|520141766|FG001|Overall Study|Randomized in error|0|||
144257082|NCT00435461|520141767|FG002|Overall Study|Randomized in error|0|||
144257083|NCT00435461|520141765|FG000|Overall Study|Participant could not tolerate symptoms|0|||
144257084|NCT00435461|520141766|FG001|Overall Study|Participant could not tolerate symptoms|0|||
144257085|NCT00435461|520141767|FG002|Overall Study|Participant could not tolerate symptoms|1|||
144257086|NCT00435461|520141765|FG000|Overall Study|Participant could not swallow capsule|0|||
144726013|NCT01345019|521852670|FG001|Open Label Treatment Phase|Adverse Event|51|||
144257087|NCT00435461|520141766|FG001|Overall Study|Participant could not swallow capsule|0|||
144257088|NCT00435461|520141767|FG002|Overall Study|Participant could not swallow capsule|1|||
144257089|NCT00435461|520141765|FG000|Overall Study|Pregnancy|2|||
144257090|NCT00435461|520141766|FG001|Overall Study|Pregnancy|0|||
144257091|NCT00435461|520141767|FG002|Overall Study|Pregnancy|0|||
144462118|NCT03265600|520887660|FG001|Overall Study|Withdrawal by Subject|2|||
144462119|NCT03265600|520887659|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
144257092|NCT00435461|520141765|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
144257093|NCT00435461|520141766|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
144257094|NCT00435461|520141767|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
144257095|NCT00435461|520141765|FG000|Overall Study|Participant ended study one day early|1|||
144462120|NCT03265600|520887660|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
144726014|NCT01345019|521852669|FG000|Open Label Treatment Phase|Administrative Decision|30|||
144257096|NCT00435461|520141766|FG001|Overall Study|Participant ended study one day early|0|||
144257097|NCT00435461|520141767|FG002|Overall Study|Participant ended study one day early|0|||
144257098|NCT00435461|520141765|FG000|Overall Study|Noncompliance with study requirements|1|||
144257099|NCT00435461|520141766|FG001|Overall Study|Noncompliance with study requirements|1|||
144257100|NCT00435461|520141767|FG002|Overall Study|Noncompliance with study requirements|1|||
144257101|NCT00435461|520141765|FG000|Overall Study|Adverse Event|1|||
144257102|NCT00435461|520141766|FG001|Overall Study|Adverse Event|2|||
144462121|NCT00535730|520887661|FG000|Overall Study|Adverse Event|1|||
144462122|NCT00535730|520887662|FG001|Overall Study|Adverse Event|1|||
144462123|NCT00535730|520887661|FG000|Overall Study|Lost to Follow-up|0|||
144462124|NCT00535730|520887662|FG001|Overall Study|Lost to Follow-up|1|||
144257103|NCT00435461|520141767|FG002|Overall Study|Adverse Event|6|||
144257104|NCT00435461|520141765|FG000|Overall Study|Non-Compliance of diary|2|||
144257105|NCT00435461|520141766|FG001|Overall Study|Non-Compliance of diary|0|||
144257106|NCT00435461|520141767|FG002|Overall Study|Non-Compliance of diary|1|||
144257107|NCT00435461|520141765|FG000|Overall Study|Lost to Follow-up|1|||
144257108|NCT00435461|520141766|FG001|Overall Study|Lost to Follow-up|1|||
144462125|NCT00535730|520887661|FG000|Overall Study|Physician Decision|0|||
144462126|NCT00535730|520887662|FG001|Overall Study|Physician Decision|1|||
144462127|NCT00535730|520887661|FG000|Overall Study|Protocol Violation|1|||
144462128|NCT00535730|520887662|FG001|Overall Study|Protocol Violation|0|||
144462129|NCT00535730|520887661|FG000|Overall Study|Withdrawal by Subject|0|||
144462130|NCT00535730|520887662|FG001|Overall Study|Withdrawal by Subject|4|||
144462131|NCT04330638|520887663|FG000|Overall Study|Adverse Event|9|||
144462132|NCT04330638|520887664|FG001|Overall Study|Adverse Event|10|||
144462133|NCT04330638|520887665|FG002|Overall Study|Adverse Event|15|||
144462134|NCT04330638|520887666|FG003|Overall Study|Adverse Event|6|||
144462135|NCT04330638|520887667|FG004|Overall Study|Adverse Event|10|||
144462136|NCT04330638|520887668|FG005|Overall Study|Adverse Event|5|||
144462137|NCT04330638|520887663|FG000|Overall Study|Other|2|||
144462138|NCT04330638|520887664|FG001|Overall Study|Other|2|||
144462139|NCT04330638|520887665|FG002|Overall Study|Other|5|||
144462140|NCT04330638|520887666|FG003|Overall Study|Other|1|||
144462141|NCT04330638|520887667|FG004|Overall Study|Other|3|||
144257109|NCT00435461|520141767|FG002|Overall Study|Lost to Follow-up|2|||
144257110|NCT01768559|520141768|FG000|Overall Study|Randomized but not treated|0|||
144257111|NCT01768559|520141769|FG001|Overall Study|Randomized but not treated|0|||
144257112|NCT01768559|520141770|FG002|Overall Study|Randomized but not treated|1|||
144257113|NCT01768559|520141768|FG000|Overall Study|Adverse Event|15|||
144257114|NCT01768559|520141769|FG001|Overall Study|Adverse Event|2|||
144257115|NCT01768559|520141770|FG002|Overall Study|Adverse Event|5|||
144257116|NCT01768559|520141768|FG000|Overall Study|Lack of Efficacy|6|||
144257117|NCT01768559|520141769|FG001|Overall Study|Lack of Efficacy|4|||
144257118|NCT01768559|520141770|FG002|Overall Study|Lack of Efficacy|0|||
144257119|NCT01768559|520141768|FG000|Overall Study|Poor compliance to protocol|0|||
144257120|NCT01768559|520141769|FG001|Overall Study|Poor compliance to protocol|3|||
144462142|NCT04330638|520887668|FG005|Overall Study|Other|2|||
144462143|NCT04330638|520887663|FG000|Overall Study|Withdrawal by Subject|4|||
144462144|NCT04330638|520887664|FG001|Overall Study|Withdrawal by Subject|0|||
144462145|NCT04330638|520887665|FG002|Overall Study|Withdrawal by Subject|0|||
144462146|NCT04330638|520887666|FG003|Overall Study|Withdrawal by Subject|0|||
144462147|NCT04330638|520887667|FG004|Overall Study|Withdrawal by Subject|0|||
144462148|NCT04330638|520887668|FG005|Overall Study|Withdrawal by Subject|0|||
144462149|NCT04330638|520887663|FG000|Overall Study|Lost to Follow-up|3|||
144610496|NCT04857996|521434344|FG001|Overall Study|Lost to Follow-up|3|||
144610497|NCT04857996|521434343|FG000|Overall Study|Site Closure|1|||
144610498|NCT04857996|521434344|FG001|Overall Study|Site Closure|0|||
144610499|NCT04857996|521434343|FG000|Overall Study|Withdrawal by Subject|1|||
144610500|NCT04857996|521434344|FG001|Overall Study|Withdrawal by Subject|0|||
144610501|NCT01129921|521434345|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
144610502|NCT01129921|521434346|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
144610503|NCT01129921|521434345|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
144462150|NCT04330638|520887664|FG001|Overall Study|Lost to Follow-up|2|||
144462151|NCT04330638|520887665|FG002|Overall Study|Lost to Follow-up|3|||
144462152|NCT04330638|520887666|FG003|Overall Study|Lost to Follow-up|2|||
144610504|NCT01129921|521434346|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
144610505|NCT01129921|521434345|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
144610506|NCT01129921|521434346|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
144610507|NCT01129921|521434345|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
144257121|NCT01768559|520141770|FG002|Overall Study|Poor compliance to protocol|2|||
144257122|NCT01768559|520141768|FG000|Overall Study|Other than specified|9|||
144257123|NCT01768559|520141769|FG001|Overall Study|Other than specified|8|||
144257124|NCT01768559|520141770|FG002|Overall Study|Other than specified|5|||
144462153|NCT04330638|520887667|FG004|Overall Study|Lost to Follow-up|3|||
144462154|NCT04330638|520887668|FG005|Overall Study|Lost to Follow-up|0|||
144462155|NCT02293538|520887669|FG000|Overall Study|Adverse Event|0|||
144462156|NCT02293538|520887670|FG001|Overall Study|Adverse Event|1|||
144462157|NCT02293538|520887669|FG000|Overall Study|Lost to Follow-up|1|||
144462158|NCT02293538|520887670|FG001|Overall Study|Lost to Follow-up|0|||
144462159|NCT02293538|520887669|FG000|Overall Study|Withdrawal by Subject|0|||
144462160|NCT02293538|520887670|FG001|Overall Study|Withdrawal by Subject|1|||
144462161|NCT03336619|520887672|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
144462162|NCT03336619|520887673|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
144610508|NCT01129921|521434346|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
144610509|NCT00282295|521434349|FG000|Overall Study|Adverse Event|0|||
144610510|NCT00282295|521434350|FG001|Overall Study|Adverse Event|1|||
144610511|NCT00282295|521434351|FG002|Overall Study|Adverse Event|0|||
144610512|NCT00282295|521434349|FG000|Overall Study|Serious Adverse Events|0|||
144610513|NCT00282295|521434350|FG001|Overall Study|Serious Adverse Events|0|||
144610514|NCT00282295|521434351|FG002|Overall Study|Serious Adverse Events|1|||
144610515|NCT00282295|521434349|FG000|Overall Study|Protocol Violation|0|||
144610516|NCT00282295|521434350|FG001|Overall Study|Protocol Violation|2|||
144610517|NCT00282295|521434351|FG002|Overall Study|Protocol Violation|1|||
144610518|NCT00282295|521434349|FG000|Overall Study|Withdrawal by Subject|2|||
144610519|NCT00282295|521434350|FG001|Overall Study|Withdrawal by Subject|6|||
144610520|NCT00282295|521434351|FG002|Overall Study|Withdrawal by Subject|4|||
144610521|NCT00282295|521434349|FG000|Overall Study|Lost to Follow-up|1|||
144610522|NCT00282295|521434350|FG001|Overall Study|Lost to Follow-up|7|||
144610523|NCT00282295|521434351|FG002|Overall Study|Lost to Follow-up|2|||
144610524|NCT00282295|521434349|FG000|Overall Study|Other|0|||
144610525|NCT00282295|521434350|FG001|Overall Study|Other|1|||
144610526|NCT00282295|521434351|FG002|Overall Study|Other|0|||
144610527|NCT01392677|521434354|FG000|Overall Study|Adverse Event|3|||
144610528|NCT01392677|521434355|FG001|Overall Study|Adverse Event|1|||
144610529|NCT01392677|521434354|FG000|Overall Study|Withdrawal by Subject|0|||
144610530|NCT01392677|521434355|FG001|Overall Study|Withdrawal by Subject|2|||
144610531|NCT01392677|521434354|FG000|Overall Study|Incorrect enrollment|2|||
144610532|NCT01392677|521434355|FG001|Overall Study|Incorrect enrollment|3|||
144610533|NCT01392677|521434354|FG000|Overall Study|Other reason|3|||
144610534|NCT01392677|521434355|FG001|Overall Study|Other reason|2|||
144610535|NCT00121108|521434356|FG000|Overall Study|Lost to Follow-up|10|||
144610536|NCT00121108|521434357|FG001|Overall Study|Lost to Follow-up|22|||
144610537|NCT00121108|521434356|FG000|Overall Study|Withdrawal by Subject|106|||
144610538|NCT00121108|521434357|FG001|Overall Study|Withdrawal by Subject|195|||
144610539|NCT00121108|521434356|FG000|Overall Study|Death|5|||
144610540|NCT00121108|521434357|FG001|Overall Study|Death|8|||
144610541|NCT01380379|521434360|FG000|Overall Study|Pregnancy|1|||
144610542|NCT01357577|521434363|FG000|Overall Study|Lost to Follow-up|20|||
144610543|NCT01357577|521434364|FG001|Overall Study|Lost to Follow-up|16|||
144610544|NCT01357577|521434363|FG000|Overall Study|Withdrawal by Subject|16|||
144610545|NCT01357577|521434364|FG001|Overall Study|Withdrawal by Subject|8|||
144610546|NCT01357577|521434363|FG000|Overall Study|look at data in database?|1|||
144610547|NCT01357577|521434364|FG001|Overall Study|look at data in database?|2|||
144610548|NCT04419610|521435475|FG000|Overall Study|Withdrawal by Subject|3|||
144610549|NCT04419610|521435476|FG001|Overall Study|Withdrawal by Subject|1|||
144610550|NCT04419610|521435475|FG000|Overall Study|Adverse Event|1|||
144610551|NCT04419610|521435476|FG001|Overall Study|Adverse Event|0|||
144610552|NCT04419610|521435475|FG000|Overall Study|discharged early|1|||
144610553|NCT04419610|521435476|FG001|Overall Study|discharged early|1|||
144610554|NCT01439282|521435477|FG000|Overall Study|Adverse Event|5|||
144610555|NCT01439282|521435478|FG001|Overall Study|Adverse Event|0|||
144610556|NCT01439282|521435477|FG000|Overall Study|Withdrawal by Subject|2|||
144610557|NCT01439282|521435478|FG001|Overall Study|Withdrawal by Subject|0|||
144610558|NCT01439282|521435477|FG000|Overall Study|Other|1|||
144610559|NCT01439282|521435478|FG001|Overall Study|Other|1|||
144610560|NCT00346073|521435482|FG000|Overall Study|Serious Adverse Event|2|||
144610561|NCT00346073|521435483|FG001|Overall Study|Serious Adverse Event|0|||
144610562|NCT00346073|521435482|FG000|Overall Study|Lost to Follow-up|39|||
144610563|NCT00346073|521435483|FG001|Overall Study|Lost to Follow-up|24|||
144462163|NCT03336619|520887672|FG000|Overall Study|Withdrawal by Subject|17|||
144462164|NCT03336619|520887673|FG001|Overall Study|Withdrawal by Subject|16|||
144610564|NCT00980200|521435485|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
144610565|NCT00980200|521435486|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
144610566|NCT00980200|521435487|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
144610567|NCT00980200|521435488|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
144610568|NCT00980200|521435489|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
144610569|NCT00980200|521435485|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
144610570|NCT00980200|521435486|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
144610571|NCT00980200|521435487|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
144610572|NCT00980200|521435488|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
144610573|NCT00980200|521435489|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
144610574|NCT04179734|521435493|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
144610575|NCT04179734|521435494|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
144462165|NCT03336619|520887672|FG000|Overall Study|Adverse Event|2|||
144462166|NCT03336619|520887673|FG001|Overall Study|Adverse Event|5|||
144462167|NCT03336619|520887672|FG000|Overall Study|Physician Decision|3|||
144462168|NCT03336619|520887673|FG001|Overall Study|Physician Decision|0|||
144462169|NCT02820623|520887674|FG000|Overall Study|Withdrawal by Subject|1|||
144462170|NCT02820623|520887675|FG001|Overall Study|Withdrawal by Subject|3|||
144462171|NCT02820623|520887676|FG002|Overall Study|Withdrawal by Subject|3|||
144462172|NCT02820623|520887674|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
144462173|NCT02820623|520887675|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
144462174|NCT02820623|520887676|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
144462175|NCT02820623|520887674|FG000|Overall Study|Therapist unable to enroll clients|1|||
144197176|NCT00160641|519918705|FG000|Overall Study|Protocol Violation|3|||
144462176|NCT02820623|520887675|FG001|Overall Study|Therapist unable to enroll clients|1|||
144462177|NCT02820623|520887676|FG002|Overall Study|Therapist unable to enroll clients|3|||
144535554|NCT04940624|521164830|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
144535555|NCT04940624|521164829|FG000|Overall Study|Physician Decision|1|||
144535556|NCT04940624|521164830|FG001|Overall Study|Physician Decision|0|||
144535557|NCT04940624|521164829|FG000|Overall Study|Lost to Follow-up|1|||
144535558|NCT04940624|521164830|FG001|Overall Study|Lost to Follow-up|0|||
144535559|NCT04940624|521164829|FG000|Overall Study|Reason Not Specified|1|||
144535560|NCT04940624|521164830|FG001|Overall Study|Reason Not Specified|0|||
144535561|NCT03782116|521164831|FG000|Completed Intervetion|Lost to Follow-up|11|||
144535562|NCT03782116|521164832|FG001|Completed Intervetion|Lost to Follow-up|7|||
144535563|NCT03782116|521164831|FG000|Completed Intervetion|Withdrawal by Subject|6|||
144535564|NCT03782116|521164832|FG001|Completed Intervetion|Withdrawal by Subject|5|||
144535565|NCT03782116|521164831|FG000|Included in Analysis|Protocol Violation|5|||
144535566|NCT03782116|521164832|FG001|Included in Analysis|Protocol Violation|5|||
144535567|NCT02726386|521165210|FG000|Overall Study|Adverse Event|17|||
144535568|NCT02726386|521165211|FG001|Overall Study|Adverse Event|20|||
144535569|NCT02726386|521165210|FG000|Overall Study|Withdrawal by Subject|14|||
144535570|NCT02726386|521165211|FG001|Overall Study|Withdrawal by Subject|28|||
144535571|NCT02726386|521165210|FG000|Overall Study|Other reasons|7|||
144535572|NCT02726386|521165211|FG001|Overall Study|Other reasons|8|||
144535573|NCT05424718|521165232|FG000|Overall Study|Lost to Follow-up|5|||
144535574|NCT05424718|521165233|FG001|Overall Study|Lost to Follow-up|4|||
144535575|NCT04899674|521165237|FG000|Test|Adverse Event|1|||
144535576|NCT03774472|521165238|FG000|Overall Study|Physician Decision|1|||
144535577|NCT03774472|521165239|FG001|Overall Study|Physician Decision|0|||
144535578|NCT03774472|521165240|FG002|Overall Study|Physician Decision|0|||
144535579|NCT03774472|521165238|FG000|Overall Study|Progression prior to 4 weeks|0|||
144535580|NCT03774472|521165239|FG001|Overall Study|Progression prior to 4 weeks|1|||
144535581|NCT03774472|521165240|FG002|Overall Study|Progression prior to 4 weeks|0|||
144535582|NCT03774472|521165238|FG000|Overall Study|Withdrawal by Subject|0|||
144535583|NCT03774472|521165239|FG001|Overall Study|Withdrawal by Subject|1|||
144535584|NCT03774472|521165240|FG002|Overall Study|Withdrawal by Subject|0|||
144535585|NCT03150862|521165241|FG000|Overall Study|Death|2|||
144535586|NCT03150862|521165242|FG001|Overall Study|Death|7|||
144535587|NCT03150862|521165243|FG002|Overall Study|Death|8|||
144535588|NCT03150862|521165244|FG003|Overall Study|Death|27|||
144535589|NCT03150862|521165245|FG004|Overall Study|Death|4|||
144535590|NCT03150862|521165246|FG005|Overall Study|Death|8|||
144535591|NCT03150862|521165247|FG006|Overall Study|Death|6|||
144535592|NCT03150862|521165248|FG007|Overall Study|Death|21|||
144535593|NCT03150862|521165241|FG000|Overall Study|Withdrawal by Subject|1|||
144535594|NCT03150862|521165242|FG001|Overall Study|Withdrawal by Subject|1|||
144535595|NCT03150862|521165243|FG002|Overall Study|Withdrawal by Subject|0|||
144535596|NCT03150862|521165244|FG003|Overall Study|Withdrawal by Subject|3|||
144535597|NCT03150862|521165245|FG004|Overall Study|Withdrawal by Subject|1|||
144535598|NCT03150862|521165246|FG005|Overall Study|Withdrawal by Subject|1|||
144535599|NCT03150862|521165247|FG006|Overall Study|Withdrawal by Subject|1|||
144535600|NCT03150862|521165248|FG007|Overall Study|Withdrawal by Subject|3|||
144535601|NCT03150862|521165241|FG000|Overall Study|Lost to Follow-up|0|||
144535602|NCT03150862|521165242|FG001|Overall Study|Lost to Follow-up|0|||
144535603|NCT03150862|521165243|FG002|Overall Study|Lost to Follow-up|1|||
144535604|NCT03150862|521165244|FG003|Overall Study|Lost to Follow-up|0|||
144535605|NCT03150862|521165245|FG004|Overall Study|Lost to Follow-up|0|||
144535606|NCT03150862|521165246|FG005|Overall Study|Lost to Follow-up|0|||
144535607|NCT03150862|521165247|FG006|Overall Study|Lost to Follow-up|0|||
144535608|NCT03150862|521165248|FG007|Overall Study|Lost to Follow-up|2|||
144535609|NCT03150862|521165241|FG000|Overall Study|Sponsor's decision|0|||
144535610|NCT03150862|521165242|FG001|Overall Study|Sponsor's decision|0|||
144535611|NCT03150862|521165243|FG002|Overall Study|Sponsor's decision|0|||
144535612|NCT03150862|521165244|FG003|Overall Study|Sponsor's decision|10|||
144535613|NCT03150862|521165245|FG004|Overall Study|Sponsor's decision|3|||
144535614|NCT03150862|521165246|FG005|Overall Study|Sponsor's decision|0|||
144535615|NCT03150862|521165247|FG006|Overall Study|Sponsor's decision|1|||
144535616|NCT03150862|521165248|FG007|Overall Study|Sponsor's decision|1|||
144535617|NCT03150862|521165241|FG000|Overall Study|Change in Methylation status|0|||
144726015|NCT01345019|521852670|FG001|Open Label Treatment Phase|Administrative Decision|15|||
144726016|NCT01345019|521852669|FG000|Open Label Treatment Phase|Disease Progression|17|||
144726017|NCT01345019|521852670|FG001|Open Label Treatment Phase|Disease Progression|18|||
144726018|NCT01345019|521852669|FG000|Open Label Treatment Phase|Noncompliance|5|||
144726019|NCT01345019|521852670|FG001|Open Label Treatment Phase|Noncompliance|4|||
144726020|NCT01345019|521852669|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
144726021|NCT01345019|521852670|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
144197177|NCT00160641|519918705|FG000|Overall Study|Other|9|||
144610576|NCT04179734|521435493|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
144610577|NCT04179734|521435494|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
144610578|NCT00937937|521435495|FG000|Overall Study|Adverse Event|6|||
144610579|NCT00937937|521435495|FG000|Overall Study|Withdrawal by Subject|2|||
144610580|NCT00937937|521435495|FG000|Overall Study|Progression/relapse|61|||
144610581|NCT00937937|521435495|FG000|Overall Study|Death|1|||
144610582|NCT00937937|521435495|FG000|Overall Study|Other|2|||
144610583|NCT00054704|521435496|FG000|Overall Study|Lack of Efficacy|2|||
144610584|NCT00054704|521435497|FG001|Overall Study|Lack of Efficacy|3|||
144610585|NCT00054704|521435496|FG000|Overall Study|Adverse Event|3|||
144610586|NCT00054704|521435497|FG001|Overall Study|Adverse Event|1|||
144610587|NCT00054704|521435496|FG000|Overall Study|Lost to Follow-up|0|||
144610588|NCT00054704|521435497|FG001|Overall Study|Lost to Follow-up|1|||
144610589|NCT00362414|521435498|FG000|Overall Study|Death|2|||
144610590|NCT00362414|521435498|FG000|Overall Study|Adverse Event|1|||
144610591|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
144610592|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
144610593|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
144610594|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
144610595|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
144610596|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
144610597|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Death|2|||
144610598|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Death|0|||
144610599|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
144610600|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
144610601|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
144610602|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
144610603|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
144610604|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
144610605|NCT02603120|521435499|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
144610606|NCT02603120|521435500|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
144610607|NCT02603120|521435499|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
144610608|NCT02603120|521435500|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
144610609|NCT02603120|521435499|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
144610610|NCT02603120|521435500|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
144610611|NCT02603120|521435499|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
144610612|NCT02603120|521435500|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
144610613|NCT02603120|521435499|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
144610614|NCT02603120|521435500|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
144610615|NCT02603120|521435499|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
144610616|NCT02603120|521435500|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
144610617|NCT02603120|521435499|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
144610618|NCT02603120|521435500|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
144610619|NCT01469182|521435503|FG000|Overall Study|Adverse Event|21|||
144610620|NCT01469182|521435504|FG001|Overall Study|Adverse Event|3|||
144610621|NCT01469182|521435503|FG000|Overall Study|Lost to Follow-up|3|||
144610622|NCT01469182|521435504|FG001|Overall Study|Lost to Follow-up|0|||
144610623|NCT01469182|521435503|FG000|Overall Study|Withdrawal by Subject|4|||
144610624|NCT01469182|521435504|FG001|Overall Study|Withdrawal by Subject|1|||
144610625|NCT01469182|521435503|FG000|Overall Study|Protocol Violation|4|||
144610626|NCT01469182|521435504|FG001|Overall Study|Protocol Violation|2|||
144610627|NCT01469182|521435503|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
144610628|NCT01469182|521435504|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
144610629|NCT01761292|521435505|FG000|Part 1|Adverse Event|1|||
144610630|NCT01761292|521435505|FG000|Part 1|not receiving treatment in Part 1|1|||
144610631|NCT01761292|521435505|FG000|Extension 1|Withdrawal by Subject|1|||
144610632|NCT00383084|521435506|FG000|Overall Study|Withdrawal by Subject|12|||
144610633|NCT00383084|521435507|FG001|Overall Study|Withdrawal by Subject|10|||
144610634|NCT02113436|521435508|FG000|Period 1: 8 Weeks|Adverse Event|1|||
144610635|NCT02113436|521435509|FG001|Period 1: 8 Weeks|Adverse Event|0|||
144610636|NCT02113436|521435510|FG002|Period 1: 8 Weeks|Adverse Event|0|||
144610637|NCT02113436|521435511|FG003|Period 1: 8 Weeks|Adverse Event|0|||
144610638|NCT02113436|521435508|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
144610639|NCT02113436|521435509|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
144726022|NCT01345019|521852669|FG000|Open Label Treatment Phase|Pregnancy|1|||
144257125|NCT03146741|520141771|FG000|Overall Study|Txp with non-HCV+ heart|4|||
144257126|NCT03146741|520141771|FG000|Overall Study|Listeted for MOT|2|||
144462178|NCT02820623|520887674|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
144462179|NCT02820623|520887675|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
144462180|NCT02820623|520887676|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
144462181|NCT00744653|520887694|FG000|Overall Study|antineoplastic treatment|11|||
144462182|NCT00744653|520887694|FG000|Overall Study|Death|1|||
144462183|NCT00744653|520887694|FG000|Overall Study|Lost to Follow-up|1|||
144462184|NCT00744653|520887694|FG000|Overall Study|Physician Decision|3|||
144462185|NCT03077724|520887701|FG000|Overall Study|Lost to Follow-up|5|||
144462186|NCT03077724|520887702|FG001|Overall Study|Lost to Follow-up|1|||
144462187|NCT03077724|520887701|FG000|Overall Study|Withdrawal by Subject|3|||
144462188|NCT03077724|520887702|FG001|Overall Study|Withdrawal by Subject|1|||
144462189|NCT00234065|520887703|FG000|Overall Study|Adverse Event|268|||
144462190|NCT00234065|520887704|FG001|Overall Study|Adverse Event|166|||
144462191|NCT00234065|520887703|FG000|Overall Study|Withdrawal by Subject|73|||
144462192|NCT00234065|520887704|FG001|Overall Study|Withdrawal by Subject|56|||
144462193|NCT00234065|520887703|FG000|Overall Study|Physician Decision|23|||
144462194|NCT00234065|520887704|FG001|Overall Study|Physician Decision|22|||
144462195|NCT00234065|520887703|FG000|Overall Study|Not Classified|111|||
144462196|NCT00234065|520887704|FG001|Overall Study|Not Classified|112|||
144462197|NCT02313428|520887705|FG000|Overall Study|Lost to Follow-up|1|||
144462198|NCT02313428|520887706|FG001|Overall Study|Lost to Follow-up|1|||
144462199|NCT05374421|520887707|FG000|Overall Study|Withdrawal by Subject|3|||
144462200|NCT05374421|520887708|FG001|Overall Study|Withdrawal by Subject|4|||
144462201|NCT02057874|520889428|FG000|Overall Study|participant did not return for scan|1|||
144462202|NCT01738984|520889429|FG000|Overall Study|Pregnancy|4|||
144462203|NCT01738984|520889430|FG001|Overall Study|Pregnancy|0|||
144462204|NCT01738984|520889429|FG000|Overall Study|Withdrawal by Subject|1|||
144462205|NCT01738984|520889430|FG001|Overall Study|Withdrawal by Subject|0|||
144462206|NCT01738984|520889429|FG000|Overall Study|Lost to Follow-up|59|||
144462207|NCT01738984|520889430|FG001|Overall Study|Lost to Follow-up|39|||
144462208|NCT04205630|520889435|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
144462209|NCT04205630|520889435|FG000|Overall Study|Disease clinical progression|7|||
144462210|NCT04205630|520889435|FG000|Overall Study|Withdrawal by Subject|2|||
144535618|NCT03150862|521165242|FG001|Overall Study|Change in Methylation status|0|||
144535619|NCT03150862|521165243|FG002|Overall Study|Change in Methylation status|0|||
144535620|NCT03150862|521165244|FG003|Overall Study|Change in Methylation status|0|||
144535621|NCT03150862|521165245|FG004|Overall Study|Change in Methylation status|1|||
144257127|NCT03146741|520141771|FG000|Overall Study|Physician Decision|2|||
144257128|NCT03146741|520141771|FG000|Overall Study|Awaiting txp|2|||
144257129|NCT02504320|520141772|FG000|Treatment Period 1|Positive Drug Screen|0|||
144257130|NCT02504320|520141773|FG001|Treatment Period 1|Positive Drug Screen|0|||
144257131|NCT02504320|520141774|FG002|Treatment Period 1|Positive Drug Screen|1|||
144257132|NCT02504320|520141775|FG003|Treatment Period 1|Positive Drug Screen|0|||
144257133|NCT02504320|520141772|FG000|Treatment Period 2|Positive Drug Screen|0|||
144257134|NCT02504320|520141773|FG001|Treatment Period 2|Positive Drug Screen|1|||
144257135|NCT02504320|520141774|FG002|Treatment Period 2|Positive Drug Screen|0|||
144257136|NCT02504320|520141775|FG003|Treatment Period 2|Positive Drug Screen|0|||
144257137|NCT02504320|520141772|FG000|Treatment Period 3|Positive Drug Screen|0|||
144257138|NCT02504320|520141773|FG001|Treatment Period 3|Positive Drug Screen|0|||
144257139|NCT02504320|520141774|FG002|Treatment Period 3|Positive Drug Screen|0|||
144257140|NCT02504320|520141775|FG003|Treatment Period 3|Positive Drug Screen|1|||
144257141|NCT02504320|520141772|FG000|Treatment Period 3|Adverse Event|0|||
144257142|NCT02504320|520141773|FG001|Treatment Period 3|Adverse Event|0|||
144257143|NCT02504320|520141774|FG002|Treatment Period 3|Adverse Event|1|||
144257144|NCT02504320|520141775|FG003|Treatment Period 3|Adverse Event|0|||
144257145|NCT00685360|520141779|FG000|Overall Study|Lost to Follow-up|0|||
144257146|NCT00685360|520141780|FG001|Overall Study|Lost to Follow-up|1|||
144257147|NCT00685360|520141781|FG002|Overall Study|Lost to Follow-up|2|||
144257148|NCT00685360|520141779|FG000|Overall Study|Adverse Event|4|||
144257149|NCT00685360|520141780|FG001|Overall Study|Adverse Event|6|||
144257150|NCT00685360|520141781|FG002|Overall Study|Adverse Event|4|||
144257151|NCT00685360|520141779|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
144257152|NCT00685360|520141780|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
144257153|NCT00685360|520141781|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
144257154|NCT00685360|520141779|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
144257155|NCT00685360|520141780|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
144257156|NCT00685360|520141781|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
144462211|NCT04205630|520889435|FG000|Overall Study|Adverse Event|17|||
144462212|NCT04205630|520889435|FG000|Overall Study|Other|1|||
144462213|NCT00886340|520889439|FG000|Overall Study|Withdrawal by Subject|0|||
144462214|NCT00886340|520889440|FG001|Overall Study|Withdrawal by Subject|7|||
144462215|NCT02338154|520889441|FG000|Overall Study|Death|46|||
144462216|NCT02338154|520889441|FG000|Overall Study|Valve Implant Failure|17|||
144257157|NCT00685360|520141779|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
144257158|NCT00685360|520141780|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
144257159|NCT00685360|520141781|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
144257160|NCT00685360|520141779|FG000|Overall Study|Protocol Deviation|0|||
144257161|NCT00685360|520141780|FG001|Overall Study|Protocol Deviation|1|||
144257162|NCT00685360|520141781|FG002|Overall Study|Protocol Deviation|1|||
144257163|NCT03293394|520141782|FG000|Follow-up (6 Months)|Adverse Event|4|||
144257164|NCT03293394|520141783|FG001|Follow-up (6 Months)|Adverse Event|2|||
144257165|NCT02823470|520143333|FG000|Overall Study|Adverse Event|1|||
144257166|NCT02823470|520143334|FG001|Overall Study|Adverse Event|0|||
144257167|NCT02823470|520143333|FG000|Overall Study|Study terminated by sponsor|8|||
144257168|NCT02823470|520143334|FG001|Overall Study|Study terminated by sponsor|15|||
144257169|NCT00621257|520143338|FG000|Overall Study|Lost to Follow-up|4|||
144257170|NCT00621257|520143339|FG001|Overall Study|Lost to Follow-up|0|||
144257171|NCT00621257|520143340|FG002|Overall Study|Lost to Follow-up|2|||
144257172|NCT00621257|520143341|FG003|Overall Study|Lost to Follow-up|4|||
144257173|NCT00621257|520143342|FG004|Overall Study|Lost to Follow-up|7|||
144257174|NCT00621257|520143338|FG000|Overall Study|Adverse Event|0|||
144257175|NCT00621257|520143339|FG001|Overall Study|Adverse Event|1|||
144257176|NCT00621257|520143340|FG002|Overall Study|Adverse Event|1|||
144257177|NCT00621257|520143341|FG003|Overall Study|Adverse Event|0|||
144257178|NCT00621257|520143342|FG004|Overall Study|Adverse Event|0|||
144257179|NCT00621257|520143338|FG000|Overall Study|Physician Decision|0|||
144257180|NCT00621257|520143339|FG001|Overall Study|Physician Decision|2|||
144257181|NCT00621257|520143340|FG002|Overall Study|Physician Decision|0|||
144257182|NCT00621257|520143341|FG003|Overall Study|Physician Decision|1|||
144257183|NCT00621257|520143342|FG004|Overall Study|Physician Decision|1|||
144257184|NCT00621257|520143338|FG000|Overall Study|Withdrawal by Subject|0|||
144257185|NCT00621257|520143339|FG001|Overall Study|Withdrawal by Subject|0|||
144257186|NCT00621257|520143340|FG002|Overall Study|Withdrawal by Subject|0|||
144257187|NCT00621257|520143341|FG003|Overall Study|Withdrawal by Subject|1|||
144257188|NCT00621257|520143342|FG004|Overall Study|Withdrawal by Subject|1|||
144257189|NCT01255904|520143346|FG000|Overall Study|Physician Decision|1|||
144257190|NCT01255904|520143347|FG001|Overall Study|Physician Decision|4|||
144257191|NCT00281697|520143352|FG000|Overall Study|> 60 days since last dose of study drug|4|||
144257192|NCT00281697|520143353|FG001|Overall Study|> 60 days since last dose of study drug|4|||
144257193|NCT00281697|520143352|FG000|Overall Study|Adverse Event|54|||
144257194|NCT00281697|520143353|FG001|Overall Study|Adverse Event|15|||
144257195|NCT00281697|520143352|FG000|Overall Study|Death|8|||
144257196|NCT00281697|520143353|FG001|Overall Study|Death|3|||
144257197|NCT00281697|520143352|FG000|Overall Study|Disease progression|279|||
144257198|NCT00281697|520143353|FG001|Overall Study|Disease progression|149|||
144257199|NCT00281697|520143352|FG000|Overall Study|Other|5|||
144257200|NCT00281697|520143353|FG001|Overall Study|Other|6|||
144257201|NCT00281697|520143352|FG000|Overall Study|Physician's decision to withdraw|15|||
144257202|NCT00281697|520143353|FG001|Overall Study|Physician's decision to withdraw|12|||
144257203|NCT00281697|520143352|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
144257204|NCT00281697|520143353|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
144257205|NCT00281697|520143352|FG000|Overall Study|Did not receive study drug|3|||
144257206|NCT00281697|520143353|FG001|Overall Study|Did not receive study drug|2|||
144257207|NCT00632125|520143354|FG000|Overall Study|Death|82|||
144257208|NCT00632125|520143354|FG000|Overall Study|Withdrawal by Subject|44|||
144257209|NCT00632125|520143354|FG000|Overall Study|Adverse Event|36|||
144257210|NCT00632125|520143354|FG000|Overall Study|Renal transplantation|17|||
144257211|NCT00632125|520143354|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
144257212|NCT00632125|520143354|FG000|Overall Study|Non-compliance|8|||
144257213|NCT00632125|520143354|FG000|Overall Study|Development of uncontrolled hypertension|5|||
144257214|NCT00632125|520143354|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
144257215|NCT02821416|520143355|FG000|Overall Study|Adverse Event|0|||
144257216|NCT02821416|520143356|FG001|Overall Study|Adverse Event|1|||
144257217|NCT02821416|520143355|FG000|Overall Study|Withdrawal by Subject|2|||
144257218|NCT02821416|520143356|FG001|Overall Study|Withdrawal by Subject|0|||
144257219|NCT02821416|520143355|FG000|Overall Study|Lost to Follow-up|1|||
144535622|NCT03150862|521165246|FG005|Overall Study|Change in Methylation status|0|||
144535623|NCT03150862|521165247|FG006|Overall Study|Change in Methylation status|0|||
144257220|NCT02821416|520143356|FG001|Overall Study|Lost to Follow-up|0|||
144257221|NCT02256917|520143357|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
144257222|NCT02256917|520143357|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
144257223|NCT02256917|520143357|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
144257224|NCT02256917|520143357|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
144257225|NCT02256917|520143357|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
144257226|NCT01737879|520143361|FG000|Overall Study|Death|1|||
144257227|NCT01737879|520143361|FG000|Overall Study|Sponsor decision|40|||
144257228|NCT00784719|520143364|FG000|Overall Study|Adverse Event|0|||
144257229|NCT00784719|520143365|FG001|Overall Study|Adverse Event|2|||
144535624|NCT03150862|521165248|FG007|Overall Study|Change in Methylation status|0|||
144535625|NCT03150862|521165241|FG000|Overall Study|Roll over in to Long Term Extension|0|||
144535626|NCT03150862|521165242|FG001|Overall Study|Roll over in to Long Term Extension|0|||
144535627|NCT03150862|521165243|FG002|Overall Study|Roll over in to Long Term Extension|0|||
144535628|NCT03150862|521165244|FG003|Overall Study|Roll over in to Long Term Extension|0|||
144535629|NCT03150862|521165245|FG004|Overall Study|Roll over in to Long Term Extension|0|||
144535630|NCT03150862|521165246|FG005|Overall Study|Roll over in to Long Term Extension|0|||
144535631|NCT03150862|521165247|FG006|Overall Study|Roll over in to Long Term Extension|0|||
144535632|NCT03150862|521165248|FG007|Overall Study|Roll over in to Long Term Extension|1|||
144535633|NCT03150862|521165241|FG000|Overall Study|Progressive Disease|0|||
144535634|NCT03150862|521165242|FG001|Overall Study|Progressive Disease|0|||
144535635|NCT03150862|521165243|FG002|Overall Study|Progressive Disease|0|||
144535636|NCT03150862|521165244|FG003|Overall Study|Progressive Disease|0|||
144535637|NCT03150862|521165245|FG004|Overall Study|Progressive Disease|0|||
144535638|NCT03150862|521165246|FG005|Overall Study|Progressive Disease|0|||
144535639|NCT03150862|521165247|FG006|Overall Study|Progressive Disease|0|||
144535640|NCT03150862|521165248|FG007|Overall Study|Progressive Disease|2|||
144535641|NCT05039021|521166061|FG000|Overall Study|Death|1|||
144535642|NCT05039021|521166061|FG000|Overall Study|Lost to Follow-up|3|||
144535643|NCT02566889|521166064|FG000|Overall Study|Withdrawal by Subject|3|||
144535644|NCT02566889|521166065|FG001|Overall Study|Withdrawal by Subject|1|||
144535645|NCT02566889|521166064|FG000|Overall Study|Adverse Event|4|||
144535646|NCT02566889|521166065|FG001|Overall Study|Adverse Event|2|||
144535647|NCT02566889|521166064|FG000|Overall Study|Other|6|||
144535648|NCT02566889|521166065|FG001|Overall Study|Other|2|||
144535649|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|Other|0|||
144535650|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|Other|2|||
144535651|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|Other|1|||
144535652|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|Other|2|||
144535653|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|Other|2|||
144535654|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|Other|0|||
144535655|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|Other|0|||
144535656|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|Other|0|||
144535657|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|Other|0|||
144535658|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|Other|0|||
144535659|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|Other|0|||
144535660|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|Other|0|||
144535661|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|Other|0|||
144535662|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|Other|0|||
144535663|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|Other|0|||
144535664|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|Other|0|||
144535665|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|Other|0|||
144535666|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
144535667|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
144535668|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
144535669|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
144535670|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
144535671|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
144535672|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535673|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535674|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535675|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535676|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535677|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535678|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535679|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535680|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535681|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535682|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
144535683|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535684|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
144535685|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
144535686|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535687|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
144535688|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
144197178|NCT02787408|519918706|FG000|Overall Study|Death|16|||
144535689|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535690|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535691|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535692|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535693|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535694|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535695|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535696|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535697|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535698|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144535699|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
144610640|NCT02113436|521435510|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
144610641|NCT02113436|521435511|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
144610642|NCT02113436|521435508|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
144610643|NCT02113436|521435509|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
144610644|NCT02113436|521435510|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
144610645|NCT02113436|521435511|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
144610646|NCT02113436|521435508|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
144610647|NCT02113436|521435509|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
144610648|NCT02113436|521435510|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
144610649|NCT02113436|521435511|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
144610650|NCT02113436|521435508|FG000|Period 2: 16 Weeks|Adverse Event|0|||
144610651|NCT02113436|521435509|FG001|Period 2: 16 Weeks|Adverse Event|0|||
144610652|NCT02113436|521435510|FG002|Period 2: 16 Weeks|Adverse Event|4|||
144610653|NCT02113436|521435511|FG003|Period 2: 16 Weeks|Adverse Event|5|||
144610654|NCT02113436|521435508|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
144610655|NCT02113436|521435509|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
144610656|NCT02113436|521435510|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
144610657|NCT02113436|521435511|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
144610658|NCT02113436|521435508|FG000|Period 2: 16 Weeks|Physician Decision|0|||
144610659|NCT02113436|521435509|FG001|Period 2: 16 Weeks|Physician Decision|0|||
144610660|NCT02113436|521435510|FG002|Period 2: 16 Weeks|Physician Decision|2|||
144610661|NCT02113436|521435511|FG003|Period 2: 16 Weeks|Physician Decision|0|||
144610662|NCT02113436|521435508|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
144610663|NCT02113436|521435509|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
144610664|NCT02113436|521435510|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
144610665|NCT02113436|521435511|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
144610666|NCT01648790|521435512|FG000|Treatment 3|Withdrawal by Subject|0|||
144610667|NCT01648790|521435513|FG001|Treatment 3|Withdrawal by Subject|0|||
144610668|NCT01648790|521435514|FG002|Treatment 3|Withdrawal by Subject|0|||
144610669|NCT01648790|521435515|FG003|Treatment 3|Withdrawal by Subject|1|||
144610670|NCT01648790|521435516|FG004|Treatment 3|Withdrawal by Subject|0|||
144610671|NCT02159729|521435517|FG000|Overall Study|Adverse Event|0|||
144610672|NCT02159729|521435518|FG001|Overall Study|Adverse Event|1|||
144197179|NCT02787408|519918706|FG000|Overall Study|Withdrawal by Subject|1|||
144197180|NCT02787408|519918706|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
144197181|NCT01782482|519918707|FG000|Overall Study|Adverse Event|2|||
144197182|NCT01782482|519918708|FG001|Overall Study|Adverse Event|1|||
144197183|NCT01782482|519918707|FG000|Overall Study|Lost to Follow-up|2|||
144197184|NCT01782482|519918708|FG001|Overall Study|Lost to Follow-up|3|||
144197185|NCT01782482|519918707|FG000|Overall Study|Physician Decision|1|||
144197186|NCT01782482|519918708|FG001|Overall Study|Physician Decision|0|||
144197187|NCT01782482|519918707|FG000|Overall Study|Protocol Violation|1|||
144197188|NCT01782482|519918708|FG001|Overall Study|Protocol Violation|0|||
144197189|NCT01782482|519918707|FG000|Overall Study|Withdrawal by Subject|2|||
144197190|NCT01782482|519918708|FG001|Overall Study|Withdrawal by Subject|3|||
144197191|NCT01782482|519918707|FG000|Overall Study|Randomized in Error|2|||
144197192|NCT01782482|519918708|FG001|Overall Study|Randomized in Error|2|||
144197193|NCT01782482|519918707|FG000|Overall Study|Habitually wearing toric lens OS|0|||
144197194|NCT01782482|519918708|FG001|Overall Study|Habitually wearing toric lens OS|1|||
144197195|NCT00985712|519918710|FG000|Overall Study|Adverse Event|0|||
144197196|NCT00985712|519918711|FG001|Overall Study|Adverse Event|1|||
144197197|NCT00985712|519918710|FG000|Overall Study|Lost to Follow-up|2|||
144197198|NCT00985712|519918711|FG001|Overall Study|Lost to Follow-up|2|||
144197199|NCT00985712|519918710|FG000|Overall Study|Protocol Violation|0|||
144197200|NCT00985712|519918711|FG001|Overall Study|Protocol Violation|1|||
144197201|NCT00985712|519918710|FG000|Overall Study|Withdrawal by Subject|4|||
144197202|NCT00985712|519918711|FG001|Overall Study|Withdrawal by Subject|1|||
144197203|NCT00985712|519918710|FG000|Overall Study|Sponsor decision|0|||
144197204|NCT00985712|519918711|FG001|Overall Study|Sponsor decision|2|||
144197205|NCT03096847|519918712|FG000|Overall Study|Other|2|||
144197206|NCT03096847|519918713|FG001|Overall Study|Other|1|||
144197207|NCT03096847|519918714|FG002|Overall Study|Other|2|||
144197208|NCT03096847|519918712|FG000|Overall Study|Lost to Follow-up|1|||
144197209|NCT03096847|519918713|FG001|Overall Study|Lost to Follow-up|0|||
144197210|NCT03096847|519918714|FG002|Overall Study|Lost to Follow-up|1|||
144197211|NCT03096847|519918712|FG000|Overall Study|Death|6|||
144197212|NCT03096847|519918713|FG001|Overall Study|Death|0|||
144197213|NCT03096847|519918714|FG002|Overall Study|Death|2|||
144197214|NCT03096847|519918712|FG000|Overall Study|Protocol Violation|3|||
144197215|NCT03096847|519918713|FG001|Overall Study|Protocol Violation|0|||
144197216|NCT03096847|519918714|FG002|Overall Study|Protocol Violation|6|||
144197217|NCT03096847|519918712|FG000|Overall Study|Physician Decision|12|||
144197218|NCT03096847|519918713|FG001|Overall Study|Physician Decision|2|||
144197219|NCT03096847|519918714|FG002|Overall Study|Physician Decision|8|||
144197220|NCT03096847|519918712|FG000|Overall Study|Withdrawal by Subject|24|||
144197221|NCT03096847|519918713|FG001|Overall Study|Withdrawal by Subject|1|||
144610673|NCT02159729|521435517|FG000|Overall Study|Subject's Request|13|||
144610674|NCT02159729|521435518|FG001|Overall Study|Subject's Request|10|||
144257230|NCT00784719|520143366|FG002|Overall Study|Adverse Event|0|||
144257231|NCT00784719|520143367|FG003|Overall Study|Adverse Event|0|||
144257232|NCT00784719|520143368|FG004|Overall Study|Adverse Event|1|||
144257233|NCT00784719|520143369|FG005|Overall Study|Adverse Event|1|||
144257234|NCT00784719|520143370|FG006|Overall Study|Adverse Event|1|||
144257235|NCT00784719|520143364|FG000|Overall Study|Lost to Follow-up|0|||
144257236|NCT00784719|520143365|FG001|Overall Study|Lost to Follow-up|0|||
144257237|NCT00784719|520143366|FG002|Overall Study|Lost to Follow-up|0|||
144257238|NCT00784719|520143367|FG003|Overall Study|Lost to Follow-up|0|||
144257239|NCT00784719|520143368|FG004|Overall Study|Lost to Follow-up|1|||
144257240|NCT00784719|520143369|FG005|Overall Study|Lost to Follow-up|1|||
144257241|NCT00784719|520143370|FG006|Overall Study|Lost to Follow-up|0|||
144257242|NCT00784719|520143364|FG000|Overall Study|Other|2|||
144257243|NCT00784719|520143365|FG001|Overall Study|Other|1|||
144257244|NCT00784719|520143366|FG002|Overall Study|Other|1|||
144257245|NCT00784719|520143367|FG003|Overall Study|Other|0|||
144257246|NCT00784719|520143368|FG004|Overall Study|Other|2|||
144257247|NCT00784719|520143369|FG005|Overall Study|Other|1|||
144257248|NCT00784719|520143370|FG006|Overall Study|Other|3|||
144257249|NCT00784719|520143364|FG000|Overall Study|Withdrawal by Subject|1|||
144257250|NCT00784719|520143365|FG001|Overall Study|Withdrawal by Subject|0|||
144257251|NCT00784719|520143366|FG002|Overall Study|Withdrawal by Subject|0|||
144257252|NCT00784719|520143367|FG003|Overall Study|Withdrawal by Subject|0|||
144257253|NCT00784719|520143368|FG004|Overall Study|Withdrawal by Subject|2|||
144257254|NCT00784719|520143369|FG005|Overall Study|Withdrawal by Subject|0|||
144257255|NCT00784719|520143370|FG006|Overall Study|Withdrawal by Subject|1|||
144257256|NCT02497404|520143371|FG000|Overall Study|Adverse Event|1|||
144257257|NCT01408901|520143374|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
144257258|NCT01408901|520143375|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
144257259|NCT01408901|520143376|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
144257260|NCT01408901|520143377|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
144257261|NCT01408901|520143374|FG000|6-Week Follow-Up|Death|1|||
144257262|NCT01408901|520143375|FG001|6-Week Follow-Up|Death|0|||
144257263|NCT01408901|520143376|FG002|6-Week Follow-Up|Death|0|||
144257264|NCT01408901|520143377|FG003|6-Week Follow-Up|Death|0|||
144257265|NCT01408901|520143374|FG000|6-Week Follow-Up|Cancelled visit|0|||
144257266|NCT01408901|520143375|FG001|6-Week Follow-Up|Cancelled visit|1|||
144257267|NCT01408901|520143376|FG002|6-Week Follow-Up|Cancelled visit|0|||
144257268|NCT01408901|520143377|FG003|6-Week Follow-Up|Cancelled visit|2|||
144257269|NCT01408901|520143374|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
144257270|NCT01408901|520143375|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
144257271|NCT01408901|520143376|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
144257272|NCT01408901|520143377|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
144257273|NCT01408901|520143374|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
144257274|NCT01408901|520143375|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
144257275|NCT01408901|520143376|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
144257276|NCT01408901|520143377|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
144257277|NCT01408901|520143374|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
144257278|NCT01408901|520143375|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
144257279|NCT01408901|520143376|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
144257280|NCT01408901|520143377|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
144257281|NCT01408901|520143374|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
144257282|NCT01408901|520143375|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
144257283|NCT01408901|520143376|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
144257284|NCT01408901|520143377|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
144257285|NCT01408901|520143374|FG000|26-Week Follow-Up|Death|0|||
144257286|NCT01408901|520143375|FG001|26-Week Follow-Up|Death|1|||
144257287|NCT01408901|520143376|FG002|26-Week Follow-Up|Death|0|||
144257288|NCT01408901|520143377|FG003|26-Week Follow-Up|Death|0|||
144257289|NCT04865419|520143378|FG000|Overall Study|Other|1|||
144257290|NCT04865419|520143379|FG001|Overall Study|Other|2|||
144257291|NCT04865419|520143380|FG002|Overall Study|Other|2|||
144257292|NCT04865419|520143381|FG003|Overall Study|Other|1|||
144257293|NCT04865419|520143382|FG004|Overall Study|Other|3|||
144257294|NCT04865419|520143383|FG005|Overall Study|Other|0|||
144257295|NCT04865419|520143384|FG006|Overall Study|Other|0|||
144257296|NCT04865419|520143385|FG007|Overall Study|Other|1|||
144257297|NCT04865419|520143386|FG008|Overall Study|Other|0|||
144257298|NCT04865419|520143387|FG009|Overall Study|Other|0|||
144257299|NCT04865419|520143388|FG010|Overall Study|Other|0|||
144257300|NCT04865419|520143378|FG000|Overall Study|Withdrawal by Subject|0|||
144257301|NCT04865419|520143379|FG001|Overall Study|Withdrawal by Subject|1|||
144257302|NCT04865419|520143380|FG002|Overall Study|Withdrawal by Subject|1|||
144462217|NCT02338154|520889441|FG000|Overall Study|Valve Explant|11|||
144257303|NCT04865419|520143381|FG003|Overall Study|Withdrawal by Subject|0|||
144257304|NCT04865419|520143382|FG004|Overall Study|Withdrawal by Subject|0|||
144610675|NCT02159729|521435517|FG000|Overall Study|Lost to Follow-up|24|||
144257305|NCT04865419|520143383|FG005|Overall Study|Withdrawal by Subject|0|||
144257306|NCT04865419|520143384|FG006|Overall Study|Withdrawal by Subject|0|||
144257307|NCT04865419|520143385|FG007|Overall Study|Withdrawal by Subject|1|||
144257308|NCT04865419|520143386|FG008|Overall Study|Withdrawal by Subject|2|||
144257309|NCT04865419|520143387|FG009|Overall Study|Withdrawal by Subject|1|||
144257310|NCT04865419|520143388|FG010|Overall Study|Withdrawal by Subject|0|||
144257311|NCT04865419|520143378|FG000|Overall Study|Study terminated by Sponsor|0|||
144257312|NCT04865419|520143379|FG001|Overall Study|Study terminated by Sponsor|0|||
144257313|NCT04865419|520143380|FG002|Overall Study|Study terminated by Sponsor|0|||
144257314|NCT04865419|520143381|FG003|Overall Study|Study terminated by Sponsor|2|||
144257315|NCT04865419|520143382|FG004|Overall Study|Study terminated by Sponsor|2|||
144257316|NCT04865419|520143383|FG005|Overall Study|Study terminated by Sponsor|0|||
144257317|NCT04865419|520143384|FG006|Overall Study|Study terminated by Sponsor|0|||
144257318|NCT04865419|520143385|FG007|Overall Study|Study terminated by Sponsor|0|||
144257319|NCT04865419|520143386|FG008|Overall Study|Study terminated by Sponsor|0|||
144257320|NCT04865419|520143387|FG009|Overall Study|Study terminated by Sponsor|0|||
144257321|NCT04865419|520143388|FG010|Overall Study|Study terminated by Sponsor|1|||
144257322|NCT04865419|520143378|FG000|Overall Study|Death|3|||
144257323|NCT04865419|520143379|FG001|Overall Study|Death|1|||
144257324|NCT04865419|520143380|FG002|Overall Study|Death|4|||
144257325|NCT04865419|520143381|FG003|Overall Study|Death|2|||
144257326|NCT04865419|520143382|FG004|Overall Study|Death|5|||
144257327|NCT04865419|520143383|FG005|Overall Study|Death|2|||
144257328|NCT04865419|520143384|FG006|Overall Study|Death|1|||
144257329|NCT04865419|520143385|FG007|Overall Study|Death|1|||
144257330|NCT04865419|520143386|FG008|Overall Study|Death|2|||
144257331|NCT04865419|520143387|FG009|Overall Study|Death|2|||
144257332|NCT04865419|520143388|FG010|Overall Study|Death|1|||
144257333|NCT04865419|520143378|FG000|Overall Study|Lost to Follow-up|0|||
144257334|NCT04865419|520143379|FG001|Overall Study|Lost to Follow-up|0|||
144257335|NCT04865419|520143380|FG002|Overall Study|Lost to Follow-up|0|||
144257336|NCT04865419|520143381|FG003|Overall Study|Lost to Follow-up|0|||
144257337|NCT04865419|520143382|FG004|Overall Study|Lost to Follow-up|0|||
144257338|NCT04865419|520143383|FG005|Overall Study|Lost to Follow-up|0|||
144257339|NCT04865419|520143384|FG006|Overall Study|Lost to Follow-up|0|||
144257340|NCT04865419|520143385|FG007|Overall Study|Lost to Follow-up|0|||
144257341|NCT04865419|520143386|FG008|Overall Study|Lost to Follow-up|0|||
144257342|NCT04865419|520143387|FG009|Overall Study|Lost to Follow-up|1|||
144257343|NCT04865419|520143388|FG010|Overall Study|Lost to Follow-up|0|||
144257344|NCT00547157|520143389|FG000|Overall Study|Other|1|||
144257345|NCT00547157|520143390|FG001|Overall Study|Other|0|||
144257346|NCT00547157|520143389|FG000|Overall Study|Death|38|||
144257347|NCT00547157|520143390|FG001|Overall Study|Death|18|||
144257348|NCT00547157|520143389|FG000|Overall Study|Withdrawal by Subject|3|||
144257349|NCT00547157|520143390|FG001|Overall Study|Withdrawal by Subject|1|||
144257350|NCT00547157|520143389|FG000|Overall Study|Administrative decision|3|||
144257351|NCT00547157|520143390|FG001|Overall Study|Administrative decision|2|||
144257352|NCT00547157|520143389|FG000|Overall Study|Lost to Follow-up|4|||
144257353|NCT00547157|520143390|FG001|Overall Study|Lost to Follow-up|2|||
144257354|NCT01087203|520143399|FG000|Overall Study|Lost to Follow-up|2|||
144257355|NCT01087203|520143400|FG001|Overall Study|Lost to Follow-up|0|||
144257356|NCT01087203|520143399|FG000|Overall Study|Withdrawal by Subject|2|||
144257357|NCT01087203|520143400|FG001|Overall Study|Withdrawal by Subject|6|||
144257358|NCT01087203|520143399|FG000|Overall Study|Lack of Efficacy|1|||
144257359|NCT01087203|520143400|FG001|Overall Study|Lack of Efficacy|2|||
144257360|NCT01087203|520143399|FG000|Overall Study|Study terminated by sponsor|27|||
144257361|NCT01087203|520143400|FG001|Overall Study|Study terminated by sponsor|27|||
144257362|NCT02559570|520143401|FG000|Overall Study|Adverse Event|0|||
144257363|NCT02559570|520143402|FG001|Overall Study|Adverse Event|2|||
144257364|NCT02559570|520143403|FG002|Overall Study|Adverse Event|0|||
144257365|NCT02559570|520143404|FG003|Overall Study|Adverse Event|1|||
144257366|NCT02559570|520143405|FG004|Overall Study|Adverse Event|0|||
144257367|NCT02559570|520143401|FG000|Overall Study|Withdrawal of Consent|0|||
144257368|NCT02559570|520143402|FG001|Overall Study|Withdrawal of Consent|0|||
144257369|NCT02559570|520143403|FG002|Overall Study|Withdrawal of Consent|1|||
144257370|NCT02559570|520143404|FG003|Overall Study|Withdrawal of Consent|2|||
144257371|NCT02559570|520143405|FG004|Overall Study|Withdrawal of Consent|1|||
144257372|NCT02559570|520143401|FG000|Overall Study|Lost to Follow-up|1|||
144257373|NCT02559570|520143402|FG001|Overall Study|Lost to Follow-up|0|||
144257374|NCT02559570|520143403|FG002|Overall Study|Lost to Follow-up|0|||
144257375|NCT02559570|520143404|FG003|Overall Study|Lost to Follow-up|0|||
144257376|NCT02559570|520143405|FG004|Overall Study|Lost to Follow-up|0|||
144257377|NCT02559570|520143401|FG000|Overall Study|Protocol Violation|1|||
144257378|NCT02559570|520143402|FG001|Overall Study|Protocol Violation|0|||
144257379|NCT02559570|520143403|FG002|Overall Study|Protocol Violation|0|||
144257380|NCT02559570|520143404|FG003|Overall Study|Protocol Violation|0|||
144257381|NCT02559570|520143405|FG004|Overall Study|Protocol Violation|1|||
144257382|NCT02559570|520143401|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144257383|NCT02559570|520143402|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144257384|NCT02559570|520143403|FG002|Overall Study|Other Miscellaneous Reasons|1|||
144257385|NCT02559570|520143404|FG003|Overall Study|Other Miscellaneous Reasons|0|||
144257386|NCT02559570|520143405|FG004|Overall Study|Other Miscellaneous Reasons|0|||
144257387|NCT05095311|520143414|FG000|Overall Study|Lost to Follow-up|7|||
144257388|NCT05095311|520143415|FG001|Overall Study|Lost to Follow-up|0|||
144257389|NCT05095311|520143416|FG002|Overall Study|Lost to Follow-up|0|||
144257390|NCT00972283|520143417|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
144257391|NCT00972283|520143418|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
144257392|NCT00972283|520143417|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
144257393|NCT00972283|520143418|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
144257394|NCT00972283|520143417|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
144257395|NCT00972283|520143418|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
144257396|NCT00972283|520143417|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
144257397|NCT00972283|520143418|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
144257398|NCT00972283|520143417|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
144257399|NCT00972283|520143418|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
144257400|NCT00972283|520143417|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
144257401|NCT00972283|520143418|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
144257402|NCT00972283|520143417|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
144257403|NCT00972283|520143418|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
144257404|NCT00972283|520143417|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
144257405|NCT00972283|520143418|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
144257406|NCT00972283|520143417|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
144257407|NCT00972283|520143418|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
144257408|NCT00972283|520143417|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
144257409|NCT00972283|520143418|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
144257410|NCT00334295|520143423|FG000|Overall Study|Patients received fewer than 3 injection|5|||
144257411|NCT00792116|520143426|FG000|Overall Study|Lost to Follow-up|0|||
144257412|NCT00792116|520143427|FG001|Overall Study|Lost to Follow-up|1|||
144257413|NCT00792116|520143426|FG000|Overall Study|Discontnued intervention|1|||
144257414|NCT00792116|520143427|FG001|Overall Study|Discontnued intervention|0|||
144257415|NCT02453256|520143428|FG000|Double Blind Period|Death|1|||
144257416|NCT02453256|520143429|FG001|Double Blind Period|Death|1|||
144257417|NCT02453256|520143428|FG000|Double Blind Period|Adverse Event|3|||
144257418|NCT02453256|520143429|FG001|Double Blind Period|Adverse Event|2|||
144257419|NCT02453256|520143428|FG000|Double Blind Period|Withdrawal by Subject|9|||
144257420|NCT02453256|520143429|FG001|Double Blind Period|Withdrawal by Subject|5|||
144257421|NCT02453256|520143428|FG000|Double Blind Period|Other|0|||
144257422|NCT02453256|520143429|FG001|Double Blind Period|Other|1|||
144257423|NCT02453256|520143428|FG000|Open Label Period|Adverse Event|1|||
144257424|NCT02453256|520143429|FG001|Open Label Period|Adverse Event|3|||
144257425|NCT02453256|520143428|FG000|Open Label Period|Death|0|||
144257426|NCT02453256|520143429|FG001|Open Label Period|Death|1|||
144257427|NCT02453256|520143428|FG000|Open Label Period|Lost to Follow-up|1|||
144257428|NCT02453256|520143429|FG001|Open Label Period|Lost to Follow-up|0|||
144257429|NCT02453256|520143428|FG000|Open Label Period|Other|0|||
144257430|NCT02453256|520143429|FG001|Open Label Period|Other|2|||
144257431|NCT02453256|520143428|FG000|Open Label Period|Withdrawal by Subject|5|||
144257432|NCT02453256|520143429|FG001|Open Label Period|Withdrawal by Subject|1|||
144257433|NCT00980655|520143430|FG000|Overall Study|Adverse Event|13|||
144257434|NCT00980655|520143431|FG001|Overall Study|Adverse Event|31|||
144257435|NCT00980655|520143430|FG000|Overall Study|Death|0|||
144257436|NCT00980655|520143431|FG001|Overall Study|Death|7|||
144257437|NCT00980655|520143430|FG000|Overall Study|Protocol Violation|2|||
144257438|NCT00980655|520143431|FG001|Overall Study|Protocol Violation|7|||
144257439|NCT00980655|520143430|FG000|Overall Study|Withdrawal by Subject|0|||
144257440|NCT00980655|520143431|FG001|Overall Study|Withdrawal by Subject|4|||
144257441|NCT00980655|520143430|FG000|Overall Study|Lost to Follow-up|0|||
144257442|NCT00980655|520143431|FG001|Overall Study|Lost to Follow-up|1|||
144257443|NCT00980655|520143430|FG000|Overall Study|Parent/legal guardian request|1|||
144257444|NCT00980655|520143431|FG001|Overall Study|Parent/legal guardian request|0|||
144257445|NCT00980655|520143430|FG000|Overall Study|Other|0|||
144257446|NCT00980655|520143431|FG001|Overall Study|Other|1|||
144257447|NCT00845676|520143437|FG000|Overall Study|Virologic breakthrough at week 20|1|||
144257448|NCT00845676|520143437|FG000|Overall Study|Adverse Event|1|||
144257449|NCT03373461|520143438|FG000|Part 2|Adverse Event|0|||
144257450|NCT03373461|520143439|FG001|Part 2|Adverse Event|1|||
144257451|NCT03373461|520143440|FG002|Part 2|Adverse Event|0|||
144257452|NCT03373461|520143441|FG003|Part 2|Adverse Event|0|||
144257453|NCT03373461|520143442|FG004|Part 2|Adverse Event|1|||
144257454|NCT00481767|520143443|FG000|Overall Study|Withdrawal by Subject|16|||
144257455|NCT00481767|520143444|FG001|Overall Study|Withdrawal by Subject|11|||
144257456|NCT00481767|520143443|FG000|Overall Study|Lost to Follow-up|16|||
144257457|NCT00481767|520143444|FG001|Overall Study|Lost to Follow-up|10|||
144257458|NCT01790516|520143445|FG000|Overall Study|Physician Decision|1|||
144257459|NCT01790516|520143446|FG001|Overall Study|Physician Decision|0|||
144257460|NCT03034135|520143447|FG000|Overall Study|Withdrawal by Subject|2|||
144257461|NCT01972464|520143450|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
144257462|NCT01972464|520143451|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
144610676|NCT02159729|521435518|FG001|Overall Study|Lost to Follow-up|9|||
144610677|NCT02159729|521435517|FG000|Overall Study|Non compliance|2|||
144610678|NCT02159729|521435518|FG001|Overall Study|Non compliance|0|||
144610679|NCT02159729|521435517|FG000|Overall Study|Other Unspecified|3|||
144610680|NCT02159729|521435518|FG001|Overall Study|Other Unspecified|1|||
144610681|NCT02953340|521435519|FG000|Overall Study|Death|0|||
144610682|NCT02953340|521435520|FG001|Overall Study|Death|1|||
144610683|NCT02953340|521435519|FG000|Overall Study|Investigator Decision|3|||
144610684|NCT02953340|521435520|FG001|Overall Study|Investigator Decision|3|||
144610685|NCT02953340|521435519|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
144610686|NCT02953340|521435520|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
144610687|NCT02953340|521435519|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
144610688|NCT02953340|521435520|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
144610689|NCT02953340|521435519|FG000|Overall Study|Withdrawal by Subject|9|||
144610690|NCT02953340|521435520|FG001|Overall Study|Withdrawal by Subject|9|||
144610691|NCT02953340|521435519|FG000|Overall Study|Sponsor decision|0|||
144610692|NCT02953340|521435520|FG001|Overall Study|Sponsor decision|2|||
144610693|NCT02953340|521435519|FG000|Overall Study|Lost to Follow-up|3|||
144610694|NCT02953340|521435520|FG001|Overall Study|Lost to Follow-up|2|||
144610695|NCT02953340|521435519|FG000|Overall Study|Reason not specified|2|||
144610696|NCT02953340|521435520|FG001|Overall Study|Reason not specified|2|||
144610697|NCT04712110|521435521|FG000|Overall Study|Lost to Follow-up|0|||
144610698|NCT04712110|521435522|FG001|Overall Study|Lost to Follow-up|1|||
144610699|NCT04712110|521435521|FG000|Overall Study|Withdrawal by Subject|0|||
144610700|NCT04712110|521435522|FG001|Overall Study|Withdrawal by Subject|4|||
144610701|NCT04712110|521435521|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
144610702|NCT04712110|521435522|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
144610703|NCT01197521|521435523|FG000|Overall Study|Not reported|24|||
144610704|NCT01197521|521435524|FG001|Overall Study|Not reported|25|||
144610705|NCT01197521|521435525|FG002|Overall Study|Not reported|21|||
144610706|NCT01197521|521435523|FG000|Overall Study|Enrolment in long term extension|42|||
144610707|NCT01197521|521435524|FG001|Overall Study|Enrolment in long term extension|36|||
144610708|NCT01197521|521435525|FG002|Overall Study|Enrolment in long term extension|87|||
144610709|NCT01197521|521435523|FG000|Overall Study|Severe non-compliance to protocol|1|||
144610710|NCT01197521|521435524|FG001|Overall Study|Severe non-compliance to protocol|3|||
144610711|NCT01197521|521435525|FG002|Overall Study|Severe non-compliance to protocol|3|||
144610712|NCT01197521|521435523|FG000|Overall Study|Lack of therapeutic response|2|||
144610713|NCT01197521|521435524|FG001|Overall Study|Lack of therapeutic response|3|||
144610714|NCT01197521|521435525|FG002|Overall Study|Lack of therapeutic response|4|||
144610715|NCT01197521|521435523|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
144610716|NCT01197521|521435524|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
144610717|NCT01197521|521435525|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
144610718|NCT01197521|521435523|FG000|Overall Study|Lost to Follow-up|3|||
144610719|NCT01197521|521435524|FG001|Overall Study|Lost to Follow-up|2|||
144610720|NCT01197521|521435525|FG002|Overall Study|Lost to Follow-up|2|||
144610721|NCT01197521|521435523|FG000|Overall Study|Adverse Event|25|||
144610722|NCT01197521|521435524|FG001|Overall Study|Adverse Event|28|||
144610723|NCT01197521|521435525|FG002|Overall Study|Adverse Event|24|||
144610724|NCT04707157|521435532|FG000|Overall Study|Adverse Event|12|||
144610725|NCT04707157|521435533|FG001|Overall Study|Adverse Event|3|||
144610726|NCT04707157|521435532|FG000|Overall Study|Lost to Follow-up|2|||
144610727|NCT04707157|521435533|FG001|Overall Study|Lost to Follow-up|0|||
144610728|NCT04707157|521435532|FG000|Overall Study|Sponsor's decision|1|||
144610729|NCT04707157|521435533|FG001|Overall Study|Sponsor's decision|0|||
144610730|NCT04707157|521435532|FG000|Overall Study|Physician Decision|8|||
144610731|NCT04707157|521435533|FG001|Overall Study|Physician Decision|5|||
144610732|NCT04707157|521435532|FG000|Overall Study|Protocol Deviation|1|||
144610733|NCT04707157|521435533|FG001|Overall Study|Protocol Deviation|0|||
144610734|NCT04707157|521435532|FG000|Overall Study|Withdrawal by Subject|1|||
144610735|NCT04707157|521435533|FG001|Overall Study|Withdrawal by Subject|1|||
144610736|NCT03625687|521435540|FG000|Overall Study|Death|1|||
144610737|NCT05879107|521435543|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
144610738|NCT05879107|521435544|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
144610739|NCT05879107|521435543|FG000|Overall Study|Migrated / moved from the study area|1|||
144610740|NCT05879107|521435544|FG001|Overall Study|Migrated / moved from the study area|1|||
144610741|NCT05879107|521435543|FG000|Overall Study|Lost to Follow-up|8|||
144610742|NCT05879107|521435544|FG001|Overall Study|Lost to Follow-up|13|||
144610743|NCT05879107|521435543|FG000|Overall Study|Death|0|||
144610744|NCT05879107|521435544|FG001|Overall Study|Death|2|||
144610745|NCT05879107|521435543|FG000|Overall Study|Other|0|||
144610746|NCT05879107|521435544|FG001|Overall Study|Other|3|||
144610747|NCT00589420|521435547|FG000|Overall Study|screen failure|1|||
144610748|NCT00243386|521435548|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
144610749|NCT00243386|521435549|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
144610750|NCT00243386|521435550|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
144257463|NCT01972464|520143450|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
144257464|NCT01972464|520143451|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
144257465|NCT01972464|520143450|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
144257466|NCT01972464|520143451|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
144257467|NCT01972464|520143450|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
144257468|NCT01972464|520143451|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
144257469|NCT01073163|520144883|FG000|Overall Study|Adverse Event|1|||
144257470|NCT01073163|520144883|FG000|Overall Study|Disease Progression|1|||
144257471|NCT01073163|520144883|FG000|Overall Study|Early termination|1|||
144257472|NCT00703677|520144884|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
144257473|NCT04441788|520144885|FG000|Overall Study|Voluntary Withdrawl|0|||
144257474|NCT04441788|520144886|FG001|Overall Study|Voluntary Withdrawl|1|||
144257475|NCT04441788|520144887|FG002|Overall Study|Voluntary Withdrawl|0|||
144257476|NCT04441788|520144885|FG000|Overall Study|Ineligibility|1|||
144257477|NCT04441788|520144886|FG001|Overall Study|Ineligibility|0|||
144257478|NCT04441788|520144887|FG002|Overall Study|Ineligibility|0|||
144257479|NCT04441788|520144885|FG000|Overall Study|Adverse Event|0|||
144257480|NCT04441788|520144886|FG001|Overall Study|Adverse Event|0|||
144257481|NCT04441788|520144887|FG002|Overall Study|Adverse Event|4|||
144257482|NCT04441788|520144885|FG000|Overall Study|Study Terminated by Sponsor|16|||
144257483|NCT04441788|520144886|FG001|Overall Study|Study Terminated by Sponsor|16|||
144257484|NCT04441788|520144887|FG002|Overall Study|Study Terminated by Sponsor|12|||
144257485|NCT03859648|520144894|FG000|Overall Study|Lost to Follow-up|1|||
144257486|NCT03859648|520144894|FG000|Overall Study|Adverse Event|1|||
144257487|NCT02315664|520144895|FG000|Overall Study|Lost to Follow-up|1|||
144257488|NCT02315664|520144896|FG001|Overall Study|Lost to Follow-up|1|||
144257489|NCT02315664|520144895|FG000|Overall Study|Withdrawal by Subject|0|||
144257490|NCT02315664|520144896|FG001|Overall Study|Withdrawal by Subject|3|||
144257491|NCT01677182|520144897|FG000|Overall Study|Adverse Event|2|||
144257492|NCT01677182|520144898|FG001|Overall Study|Adverse Event|1|||
144257493|NCT01677182|520144899|FG002|Overall Study|Adverse Event|8|||
144257494|NCT01677182|520144897|FG000|Overall Study|Protocol Violation|5|||
144257495|NCT01677182|520144898|FG001|Overall Study|Protocol Violation|1|||
144257496|NCT01677182|520144899|FG002|Overall Study|Protocol Violation|4|||
144257497|NCT01677182|520144897|FG000|Overall Study|Lost to Follow-up|4|||
144257498|NCT01677182|520144898|FG001|Overall Study|Lost to Follow-up|0|||
144257499|NCT01677182|520144899|FG002|Overall Study|Lost to Follow-up|3|||
144257500|NCT01677182|520144897|FG000|Overall Study|Withdrawal by Subject|7|||
144257501|NCT01677182|520144898|FG001|Overall Study|Withdrawal by Subject|12|||
144257502|NCT01677182|520144899|FG002|Overall Study|Withdrawal by Subject|10|||
144257503|NCT01677182|520144897|FG000|Overall Study|Study termination|12|||
144257504|NCT01677182|520144898|FG001|Overall Study|Study termination|9|||
144257505|NCT01677182|520144899|FG002|Overall Study|Study termination|11|||
144257506|NCT01677182|520144897|FG000|Overall Study|Lack of Efficacy|3|||
144257507|NCT01677182|520144898|FG001|Overall Study|Lack of Efficacy|0|||
144257508|NCT01677182|520144899|FG002|Overall Study|Lack of Efficacy|1|||
144257509|NCT01677182|520144897|FG000|Overall Study|Other reasons|1|||
144257510|NCT01677182|520144898|FG001|Overall Study|Other reasons|5|||
144257511|NCT01677182|520144899|FG002|Overall Study|Other reasons|2|||
144257512|NCT02501161|520144900|FG000|Overall Study|Adverse Event|2|||
144257513|NCT02501161|520144901|FG001|Overall Study|Adverse Event|6|||
144257514|NCT02501161|520144900|FG000|Overall Study|Lost to Follow-up|7|||
144257515|NCT02501161|520144901|FG001|Overall Study|Lost to Follow-up|4|||
144257516|NCT02501161|520144900|FG000|Overall Study|Withdrawal by Subject|10|||
144257517|NCT02501161|520144901|FG001|Overall Study|Withdrawal by Subject|15|||
144257518|NCT02501161|520144900|FG000|Overall Study|Other|3|||
144257519|NCT02501161|520144901|FG001|Overall Study|Other|0|||
144257520|NCT00762762|520144906|FG000|Overall Study|Did not return for appointments|6|||
144257521|NCT00762762|520144907|FG001|Overall Study|Did not return for appointments|8|||
144257522|NCT02489448|520144908|FG000|Overall Study|Death|3|||
144257523|NCT02489448|520144908|FG000|Overall Study|Withdrawal by Subject|2|||
144257524|NCT02171429|520144916|FG000|Overall Study|Other|0|||
144257525|NCT02171429|520144917|FG001|Overall Study|Other|1|||
144257526|NCT02171429|520144918|FG002|Overall Study|Other|1|||
144257527|NCT02171429|520144916|FG000|Overall Study|Non-Compliance|0|||
144257528|NCT02171429|520144917|FG001|Overall Study|Non-Compliance|0|||
144257529|NCT02171429|520144918|FG002|Overall Study|Non-Compliance|1|||
144257530|NCT02171429|520144916|FG000|Overall Study|Physician Decision|0|||
144257531|NCT02171429|520144917|FG001|Overall Study|Physician Decision|0|||
144257532|NCT02171429|520144918|FG002|Overall Study|Physician Decision|1|||
144257533|NCT02171429|520144916|FG000|Overall Study|Withdrawal by Subject|1|||
144257534|NCT02171429|520144917|FG001|Overall Study|Withdrawal by Subject|1|||
144257535|NCT02171429|520144918|FG002|Overall Study|Withdrawal by Subject|1|||
144257536|NCT02171429|520144916|FG000|Overall Study|Lost to Follow-up|0|||
144257537|NCT02171429|520144917|FG001|Overall Study|Lost to Follow-up|1|||
144257538|NCT02171429|520144918|FG002|Overall Study|Lost to Follow-up|0|||
144257539|NCT02171429|520144916|FG000|Overall Study|Death|0|||
144257540|NCT02171429|520144917|FG001|Overall Study|Death|0|||
144257541|NCT02171429|520144918|FG002|Overall Study|Death|1|||
144257542|NCT01724177|520144921|FG000|Overall Study|Adverse Event|8|||
144257543|NCT01724177|520144921|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
144257544|NCT01724177|520144921|FG000|Overall Study|Nervous participant|1|||
144257545|NCT01724177|520144921|FG000|Overall Study|Serious Adverse Event Related|1|||
144257546|NCT01705080|520144922|FG000|Overall Study|Missed visit|10|||
144257547|NCT01705080|520144923|FG001|Overall Study|Missed visit|4|||
144257548|NCT01705080|520144924|FG002|Overall Study|Missed visit|1|||
144257549|NCT01705080|520144922|FG000|Overall Study|Death|4|||
144257550|NCT01705080|520144923|FG001|Overall Study|Death|4|||
144257551|NCT01705080|520144924|FG002|Overall Study|Death|6|||
144257552|NCT01705080|520144922|FG000|Overall Study|Withdrawal by Subject|61|||
144257553|NCT01705080|520144923|FG001|Overall Study|Withdrawal by Subject|44|||
144257554|NCT01705080|520144924|FG002|Overall Study|Withdrawal by Subject|9|||
144257555|NCT04152083|520144931|FG000|Overall Study|Lost to Follow-up|2|||
144257556|NCT04152083|520144932|FG001|Overall Study|Lost to Follow-up|1|||
144257557|NCT04152083|520144931|FG000|Overall Study|Adverse Event|1|||
144257558|NCT04152083|520144932|FG001|Overall Study|Adverse Event|0|||
144257559|NCT04152083|520144931|FG000|Overall Study|Randomized but not treated|3|||
144257560|NCT04152083|520144932|FG001|Overall Study|Randomized but not treated|2|||
144257561|NCT02609386|520144933|FG000|Overall Study|Withdrawal by Subject|6|||
144257562|NCT02609386|520144934|FG001|Overall Study|Withdrawal by Subject|1|||
144257563|NCT02609386|520144933|FG000|Overall Study|Lost to Follow-up|3|||
144257564|NCT02609386|520144934|FG001|Overall Study|Lost to Follow-up|5|||
144257565|NCT02609386|520144933|FG000|Overall Study|Death|19|||
144257566|NCT02609386|520144934|FG001|Overall Study|Death|9|||
144257567|NCT02609386|520144933|FG000|Overall Study|Physician Decision|0|||
144257568|NCT02609386|520144934|FG001|Overall Study|Physician Decision|2|||
144257569|NCT00540644|520144935|FG000|Overall Study|Adverse Event|3|||
144257570|NCT00540644|520144936|FG001|Overall Study|Adverse Event|1|||
144257571|NCT00540644|520144935|FG000|Overall Study|Disease Progression|3|||
144257572|NCT00540644|520144936|FG001|Overall Study|Disease Progression|1|||
144257573|NCT00540644|520144935|FG000|Overall Study|Physician Decision|0|||
144257574|NCT00540644|520144936|FG001|Overall Study|Physician Decision|5|||
144257575|NCT00540644|520144935|FG000|Overall Study|Withdrawal by Subject|2|||
144257576|NCT00540644|520144936|FG001|Overall Study|Withdrawal by Subject|2|||
144257577|NCT00540644|520144935|FG000|Overall Study|Noncomplilance|1|||
144257578|NCT00540644|520144936|FG001|Overall Study|Noncomplilance|0|||
144257579|NCT03280056|520144937|FG000|Overall Study|Withdrawal by Subject|12|||
144257580|NCT03280056|520144938|FG001|Overall Study|Withdrawal by Subject|14|||
144257581|NCT03280056|520144937|FG000|Overall Study|Death|9|||
144257582|NCT03280056|520144938|FG001|Overall Study|Death|2|||
144257583|NCT03280056|520144937|FG000|Overall Study|Adverse Event|1|||
144257584|NCT03280056|520144938|FG001|Overall Study|Adverse Event|3|||
144257585|NCT03280056|520144937|FG000|Overall Study|Lost to Follow-up|1|||
144257586|NCT03280056|520144938|FG001|Overall Study|Lost to Follow-up|1|||
144257587|NCT03280056|520144937|FG000|Overall Study|Physician Decision|0|||
144257588|NCT03280056|520144938|FG001|Overall Study|Physician Decision|1|||
144257589|NCT03280056|520144937|FG000|Overall Study|Early Discontinuation|1|||
144257590|NCT03280056|520144938|FG001|Overall Study|Early Discontinuation|0|||
144257591|NCT01869777|520144939|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
144257592|NCT01135524|520144946|FG000|Overall Study|Withdrawal by Subject|14|||
144257593|NCT01135524|520144946|FG000|Overall Study|Adverse Event|20|||
144257594|NCT01135524|520144946|FG000|Overall Study|Lost to Follow-up|3|||
144257595|NCT01135524|520144946|FG000|Overall Study|Administrative|151|||
144257596|NCT01135524|520144946|FG000|Overall Study|Lack of Efficacy|8|||
144257597|NCT03318003|520144947|FG000|Overall Study|Withdrawal by Subject|1|||
144257598|NCT03318003|520144948|FG001|Overall Study|Withdrawal by Subject|1|||
144257599|NCT03318003|520144947|FG000|Overall Study|fetal loss|0|||
144257600|NCT03318003|520144948|FG001|Overall Study|fetal loss|1|||
144257601|NCT00397189|520144949|FG000|3 Weeks Period|Lost to Follow-up|5|||
144257602|NCT00397189|520144950|FG001|3 Weeks Period|Lost to Follow-up|4|||
144257603|NCT00397189|520144949|FG000|3 Weeks Period|Adverse Event|3|||
144257604|NCT00397189|520144950|FG001|3 Weeks Period|Adverse Event|2|||
144257605|NCT00397189|520144949|FG000|3 Weeks Period|Withdrawal by Subject|13|||
144535700|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|Death|2|||
144257606|NCT00397189|520144950|FG001|3 Weeks Period|Withdrawal by Subject|9|||
144257607|NCT00397189|520144949|FG000|3 Weeks Period|Physician Decision|0|||
144257608|NCT00397189|520144950|FG001|3 Weeks Period|Physician Decision|2|||
144257609|NCT00397189|520144949|FG000|3 Weeks Period|Protocol Violation|0|||
144257610|NCT00397189|520144950|FG001|3 Weeks Period|Protocol Violation|3|||
144257611|NCT00397189|520144949|FG000|3 Weeks Period|Other|0|||
144257612|NCT00397189|520144950|FG001|3 Weeks Period|Other|2|||
144257613|NCT04819438|520144953|FG000|Overall Study|Withdrawal by Subject|1|||
144257614|NCT04819438|520144954|FG001|Overall Study|Withdrawal by Subject|0|||
144257615|NCT04819438|520144953|FG000|Overall Study|Adverse Event|0|||
144257616|NCT04819438|520144954|FG001|Overall Study|Adverse Event|1|||
144257617|NCT04819438|520144953|FG000|Overall Study|Protocol Violation|0|||
144257618|NCT04819438|520144954|FG001|Overall Study|Protocol Violation|1|||
144257619|NCT02869893|520144955|FG000|Overall Study|participant aversion to IV|5|||
144257620|NCT02869893|520144955|FG000|Overall Study|participant fear of MRI scanner|2|||
144257621|NCT02328937|520144956|FG000|Period 1|Lost to Follow-up|0|||
144257622|NCT02328937|520144957|FG001|Period 1|Lost to Follow-up|0|||
144257623|NCT02328937|520144958|FG002|Period 1|Lost to Follow-up|0|||
144257624|NCT02328937|520144959|FG003|Period 1|Lost to Follow-up|1|||
144257625|NCT02328937|520144960|FG004|Period 1|Lost to Follow-up|0|||
144257626|NCT02328937|520144961|FG005|Period 1|Lost to Follow-up|0|||
144257627|NCT02328937|520144956|FG000|Period 2|Adverse Event|0|||
144257628|NCT02328937|520144957|FG001|Period 2|Adverse Event|0|||
144257629|NCT02328937|520144958|FG002|Period 2|Adverse Event|1|||
144257630|NCT02328937|520144959|FG003|Period 2|Adverse Event|0|||
144257631|NCT02328937|520144960|FG004|Period 2|Adverse Event|0|||
144257632|NCT02328937|520144961|FG005|Period 2|Adverse Event|0|||
144257633|NCT03665077|520144964|FG000|Overall Study|Lost to Follow-up|2|||
144257634|NCT03665077|520144964|FG000|Overall Study|Physician Decision|2|||
144257635|NCT00837967|520144967|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
144257636|NCT00837967|520144968|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
144535701|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|Death|1|||
144535702|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|Death|1|||
144535703|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|Death|0|||
144535704|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|Death|0|||
144535705|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|Death|0|||
144535706|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|Death|0|||
144257643|NCT02609984|520144981|FG000|Overall Study|Death|29|||
144257644|NCT02609984|520144982|FG001|Overall Study|Death|26|||
144257645|NCT02609984|520144981|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
144257646|NCT02609984|520144982|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
144257647|NCT02609984|520144981|FG000|Overall Study|Lost to Follow-up|1|||
144257648|NCT02609984|520144982|FG001|Overall Study|Lost to Follow-up|2|||
144257649|NCT02609984|520144981|FG000|Overall Study|Withdrawal by Subject|0|||
144257650|NCT02609984|520144982|FG001|Overall Study|Withdrawal by Subject|1|||
144257651|NCT02609984|520144981|FG000|Overall Study|Disease Progression|2|||
144257652|NCT02609984|520144982|FG001|Overall Study|Disease Progression|0|||
144257653|NCT02306850|520144983|FG000|Overall Study|Lack of Efficacy|2|||
144257654|NCT02420262|520144984|FG000|Overall Study|Adverse Event|1|||
144257655|NCT02420262|520144985|FG001|Overall Study|Adverse Event|0|||
144257656|NCT02420262|520144984|FG000|Overall Study|Withdrawal by Subject|1|||
144257657|NCT02420262|520144985|FG001|Overall Study|Withdrawal by Subject|4|||
144257658|NCT02420262|520144984|FG000|Overall Study|Unclassified|0|||
144257659|NCT02420262|520144985|FG001|Overall Study|Unclassified|1|||
144257660|NCT01210222|520144986|FG000|Overall Study|Ineligible|2|||
144257661|NCT01210222|520144986|FG000|Overall Study|Never treated|1|||
144257662|NCT00941304|520144987|FG000|Overall Study|Lost to Follow-up|1|||
144257663|NCT00941304|520144988|FG001|Overall Study|Lost to Follow-up|0|||
144257664|NCT00941304|520144989|FG002|Overall Study|Lost to Follow-up|0|||
144257665|NCT00941304|520144990|FG003|Overall Study|Lost to Follow-up|0|||
144257666|NCT00941304|520144991|FG004|Overall Study|Lost to Follow-up|0|||
144535707|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|Death|0|||
144535708|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|Death|0|||
144535709|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|Death|0|||
144535710|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|Death|0|||
144535711|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|Death|0|||
144535712|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|Death|0|||
144535713|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|Death|0|||
144535714|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|Death|0|||
144535715|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|Death|0|||
144535716|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|Death|0|||
144535717|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535718|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
144535719|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535720|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535721|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
144535722|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
144535723|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535724|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535725|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535726|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535727|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535728|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535729|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535730|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535731|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535732|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535733|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
144535734|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535735|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535736|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535737|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
144257667|NCT04978337|520144992|FG000|Overall Study|Withdrawal by Subject|0|||
144257668|NCT04978337|520144993|FG001|Overall Study|Withdrawal by Subject|1|||
144257669|NCT01436227|520144997|FG000|Overall Study|Adverse Event|7|||
144257670|NCT01436227|520144997|FG000|Overall Study|Death|1|||
144257671|NCT01436227|520144997|FG000|Overall Study|Lack of Efficacy|1|||
144257672|NCT01436227|520144997|FG000|Overall Study|Lost to Follow-up|3|||
144257673|NCT01436227|520144997|FG000|Overall Study|Physician Decision|1|||
144257674|NCT01436227|520144997|FG000|Overall Study|Withdrawal by Subject|7|||
144257675|NCT01436227|520144997|FG000|Overall Study|Disease progression, relapse|6|||
144257676|NCT05446142|520145000|FG000|Period 2|Adverse Event|1|||
144257677|NCT05446142|520145001|FG001|Period 2|Adverse Event|0|||
144257678|NCT05446142|520145002|FG002|Period 2|Adverse Event|0|||
144610751|NCT00243386|521435548|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
144610752|NCT00243386|521435549|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
144610753|NCT00243386|521435550|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
144610754|NCT00243386|521435548|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
144610755|NCT00243386|521435549|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
144610756|NCT00243386|521435550|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
144610757|NCT00243386|521435548|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
144610758|NCT00243386|521435549|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
144610759|NCT00243386|521435550|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
144610760|NCT00243386|521435548|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
144610761|NCT00243386|521435549|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
144610762|NCT00243386|521435550|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
144610763|NCT00243386|521435548|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
144610764|NCT00243386|521435549|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
144610765|NCT00243386|521435550|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
144610766|NCT00243386|521435548|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
144610767|NCT00243386|521435549|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
144610768|NCT00243386|521435550|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
144610769|NCT00243386|521435548|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
144610770|NCT00243386|521435549|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
144610771|NCT00243386|521435550|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
144610772|NCT04037748|521435551|FG000|Treatment Period 1|Withdrawal by Subject|3|||
144610773|NCT04037748|521435552|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144610774|NCT04037748|521435551|FG000|Treatment Period 1|Adverse Event|1|||
144610775|NCT04037748|521435552|FG001|Treatment Period 1|Adverse Event|1|||
144610776|NCT04037748|521435551|FG000|Treatment Period 1|Protocol Violation|4|||
144610777|NCT04037748|521435552|FG001|Treatment Period 1|Protocol Violation|5|||
144610778|NCT04037748|521435551|FG000|Treatment Period 2|Adverse Event|0|||
144610779|NCT04037748|521435552|FG001|Treatment Period 2|Adverse Event|1|||
144610780|NCT04037748|521435551|FG000|Treatment Period 2|Protocol Violation|2|||
144610781|NCT04037748|521435552|FG001|Treatment Period 2|Protocol Violation|0|||
144610782|NCT04695392|521435556|FG000|Overall Study|Withdrawn by parent/guardian|0|||
144610783|NCT04695392|521435557|FG001|Overall Study|Withdrawn by parent/guardian|1|||
144610784|NCT04695392|521435556|FG000|Overall Study|Withdrawn by physician|0|||
144610785|NCT04695392|521435557|FG001|Overall Study|Withdrawn by physician|1|||
144610786|NCT03710486|521435558|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
144610787|NCT03710486|521435559|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
144610788|NCT03710486|521435558|FG000|Overall Study|Missing|0|||
144610789|NCT03710486|521435559|FG001|Overall Study|Missing|2|||
144610790|NCT01987960|521435560|FG000|Period 1|Adverse Event|24|||
144610791|NCT01987960|521435561|FG001|Period 1|Adverse Event|0|||
144610792|NCT01987960|521435562|FG002|Period 1|Adverse Event|0|||
144610793|NCT01987960|521435563|FG003|Period 1|Adverse Event|0|||
144610794|NCT01987960|521435560|FG000|Period 1|Lack of Efficacy|4|||
144610795|NCT01987960|521435561|FG001|Period 1|Lack of Efficacy|0|||
144610796|NCT01987960|521435562|FG002|Period 1|Lack of Efficacy|0|||
144610797|NCT01987960|521435563|FG003|Period 1|Lack of Efficacy|0|||
144610798|NCT01987960|521435560|FG000|Period 1|Non-compliance with IMP|6|||
144610799|NCT01987960|521435561|FG001|Period 1|Non-compliance with IMP|0|||
144610800|NCT01987960|521435562|FG002|Period 1|Non-compliance with IMP|0|||
144610801|NCT01987960|521435563|FG003|Period 1|Non-compliance with IMP|0|||
144257679|NCT05446142|520145003|FG003|Period 2|Adverse Event|0|||
144257680|NCT05446142|520145004|FG004|Period 2|Adverse Event|0|||
144257681|NCT05446142|520145005|FG005|Period 2|Adverse Event|0|||
144610802|NCT01987960|521435560|FG000|Period 1|Protocol Violation|12|||
144257682|NCT02098395|520145010|FG000|Overall Study|Protocol Violation|2|||
144610803|NCT01987960|521435561|FG001|Period 1|Protocol Violation|0|||
144610804|NCT01987960|521435562|FG002|Period 1|Protocol Violation|0|||
144610805|NCT01987960|521435563|FG003|Period 1|Protocol Violation|0|||
144610806|NCT01987960|521435560|FG000|Period 1|Withdrawal by Subject|21|||
144610807|NCT01987960|521435561|FG001|Period 1|Withdrawal by Subject|0|||
144257683|NCT02098395|520145011|FG001|Overall Study|Protocol Violation|2|||
144257684|NCT02098395|520145012|FG002|Overall Study|Protocol Violation|0|||
144257685|NCT02098395|520145013|FG003|Overall Study|Protocol Violation|7|||
144257686|NCT02098395|520145010|FG000|Overall Study|Withdrawal by Subject|10|||
144257687|NCT02098395|520145011|FG001|Overall Study|Withdrawal by Subject|10|||
144257688|NCT02098395|520145012|FG002|Overall Study|Withdrawal by Subject|5|||
144257689|NCT02098395|520145013|FG003|Overall Study|Withdrawal by Subject|13|||
144257690|NCT02098395|520145010|FG000|Overall Study|Adverse Event|12|||
144257691|NCT02098395|520145011|FG001|Overall Study|Adverse Event|19|||
144257692|NCT02098395|520145012|FG002|Overall Study|Adverse Event|34|||
144257693|NCT02098395|520145013|FG003|Overall Study|Adverse Event|2|||
144257694|NCT02098395|520145010|FG000|Overall Study|Lost to Follow-up|2|||
144257695|NCT02098395|520145011|FG001|Overall Study|Lost to Follow-up|1|||
144257696|NCT02098395|520145012|FG002|Overall Study|Lost to Follow-up|0|||
144257697|NCT02098395|520145013|FG003|Overall Study|Lost to Follow-up|3|||
144257698|NCT02098395|520145010|FG000|Overall Study|Unclassified|0|||
144257699|NCT02098395|520145011|FG001|Overall Study|Unclassified|0|||
144257700|NCT02098395|520145012|FG002|Overall Study|Unclassified|3|||
144257701|NCT02098395|520145013|FG003|Overall Study|Unclassified|2|||
144257702|NCT04633226|520145019|FG000|Overall Study|Withdrawal by parent/guardian|4|||
144257703|NCT04633226|520145019|FG000|Overall Study|Randomized by mistake without study treatment|1|||
144257704|NCT05415462|520145021|FG000|Overall Study|Death|18|||
144257705|NCT05415462|520145022|FG001|Overall Study|Death|10|||
144257706|NCT05415462|520145021|FG000|Overall Study|Lost to Follow-up|72|||
144257707|NCT05415462|520145022|FG001|Overall Study|Lost to Follow-up|64|||
144257708|NCT05415462|520145021|FG000|Overall Study|Physician Decision|5|||
144257709|NCT05415462|520145022|FG001|Overall Study|Physician Decision|5|||
144726023|NCT01345019|521852670|FG001|Open Label Treatment Phase|Pregnancy|0|||
144610808|NCT01987960|521435562|FG002|Period 1|Withdrawal by Subject|0|||
144610809|NCT01987960|521435563|FG003|Period 1|Withdrawal by Subject|0|||
144610810|NCT01987960|521435560|FG000|Period 1|Lost to Follow-up|40|||
144610811|NCT01987960|521435561|FG001|Period 1|Lost to Follow-up|0|||
144610812|NCT01987960|521435562|FG002|Period 1|Lost to Follow-up|0|||
144610813|NCT01987960|521435563|FG003|Period 1|Lost to Follow-up|0|||
144610814|NCT01987960|521435560|FG000|Period 1|administrative or other reason|75|||
144610815|NCT01987960|521435561|FG001|Period 1|administrative or other reason|0|||
144610816|NCT01987960|521435562|FG002|Period 1|administrative or other reason|0|||
144610817|NCT01987960|521435563|FG003|Period 1|administrative or other reason|0|||
144610818|NCT01987960|521435560|FG000|Period 1|Withdrawal of consent before treatment|4|||
144610819|NCT01987960|521435561|FG001|Period 1|Withdrawal of consent before treatment|0|||
144610820|NCT01987960|521435562|FG002|Period 1|Withdrawal of consent before treatment|0|||
144610821|NCT01987960|521435563|FG003|Period 1|Withdrawal of consent before treatment|0|||
144610822|NCT01987960|521435560|FG000|Period 2|Adverse Event|0|||
144610823|NCT01987960|521435561|FG001|Period 2|Adverse Event|0|||
144610824|NCT01987960|521435562|FG002|Period 2|Adverse Event|1|||
144610825|NCT01987960|521435563|FG003|Period 2|Adverse Event|0|||
144610826|NCT01987960|521435560|FG000|Period 2|Withdrawal by Subject|0|||
144610827|NCT01987960|521435561|FG001|Period 2|Withdrawal by Subject|0|||
144610828|NCT01987960|521435562|FG002|Period 2|Withdrawal by Subject|1|||
144610829|NCT01987960|521435563|FG003|Period 2|Withdrawal by Subject|0|||
144610830|NCT01987960|521435560|FG000|Period 2|Administrative or other reason|0|||
144610831|NCT01987960|521435561|FG001|Period 2|Administrative or other reason|5|||
144610832|NCT01987960|521435562|FG002|Period 2|Administrative or other reason|7|||
144610833|NCT01987960|521435563|FG003|Period 2|Administrative or other reason|0|||
144610834|NCT01987960|521435560|FG000|Period 3|Adverse Event|0|||
144610835|NCT01987960|521435561|FG001|Period 3|Adverse Event|0|||
144610836|NCT01987960|521435562|FG002|Period 3|Adverse Event|0|||
144610837|NCT01987960|521435563|FG003|Period 3|Adverse Event|7|||
144610838|NCT01987960|521435560|FG000|Period 3|Non-compliance with IMP|0|||
144610839|NCT01987960|521435561|FG001|Period 3|Non-compliance with IMP|0|||
144610840|NCT01987960|521435562|FG002|Period 3|Non-compliance with IMP|0|||
144610841|NCT01987960|521435563|FG003|Period 3|Non-compliance with IMP|1|||
144610842|NCT01987960|521435560|FG000|Period 3|Protocol Violation|0|||
144610843|NCT01987960|521435561|FG001|Period 3|Protocol Violation|0|||
144257710|NCT05415462|520145021|FG000|Overall Study|Protocol Deviation|1|||
144257711|NCT05415462|520145022|FG001|Overall Study|Protocol Deviation|0|||
144257712|NCT05415462|520145021|FG000|Overall Study|Withdrawal by Subject|129|||
144257713|NCT05415462|520145022|FG001|Overall Study|Withdrawal by Subject|101|||
144257714|NCT05415462|520145021|FG000|Overall Study|Other Than Specified|8|||
144610844|NCT01987960|521435562|FG002|Period 3|Protocol Violation|0|||
144610845|NCT01987960|521435563|FG003|Period 3|Protocol Violation|6|||
144610846|NCT01987960|521435560|FG000|Period 3|Withdrawal by Subject|0|||
144610847|NCT01987960|521435561|FG001|Period 3|Withdrawal by Subject|0|||
144610848|NCT01987960|521435562|FG002|Period 3|Withdrawal by Subject|0|||
144257715|NCT05415462|520145022|FG001|Overall Study|Other Than Specified|8|||
144257716|NCT02588664|520145029|FG000|Overall Study|Death|56|||
144257717|NCT02588664|520145030|FG001|Overall Study|Death|55|||
144610849|NCT01987960|521435563|FG003|Period 3|Withdrawal by Subject|9|||
144610850|NCT01987960|521435560|FG000|Period 3|Lost to Follow-up|0|||
144610851|NCT01987960|521435561|FG001|Period 3|Lost to Follow-up|0|||
144610852|NCT01987960|521435562|FG002|Period 3|Lost to Follow-up|0|||
144257718|NCT02588664|520145029|FG000|Overall Study|Lost to Follow-up|1305|||
144257719|NCT02588664|520145030|FG001|Overall Study|Lost to Follow-up|990|||
144257720|NCT00524173|520145031|FG000|Overall Study|Lost to Follow-up|0|||
144610853|NCT01987960|521435563|FG003|Period 3|Lost to Follow-up|5|||
144610854|NCT01987960|521435560|FG000|Period 3|Administrative or other reason|0|||
144610855|NCT01987960|521435561|FG001|Period 3|Administrative or other reason|0|||
144610856|NCT01987960|521435562|FG002|Period 3|Administrative or other reason|0|||
144610857|NCT01987960|521435563|FG003|Period 3|Administrative or other reason|43|||
144610858|NCT01279850|521435568|FG000|Overall Study|Protocol Violation|50|||
144610859|NCT01279850|521435568|FG000|Overall Study|No Drug Administration Information|7|||
144610860|NCT01279850|521435568|FG000|Overall Study|No Visit After Treatment|34|||
144610861|NCT01131520|521435569|FG000|Overall Study|Computer problem|1|||
144610862|NCT01131520|521435570|FG001|Overall Study|Computer problem|0|||
144610863|NCT01131520|521435569|FG000|Overall Study|Counselor not available|0|||
144610864|NCT01131520|521435570|FG001|Overall Study|Counselor not available|3|||
144610865|NCT01131520|521435569|FG000|Overall Study|Subject changed history after enrollment|0|||
144610866|NCT01131520|521435570|FG001|Overall Study|Subject changed history after enrollment|1|||
144610867|NCT01436084|521435573|FG000|Overall Study|Disease Progression|2|||
144610868|NCT01436084|521435573|FG000|Overall Study|Withdrawal by Subject|1|||
144610869|NCT01436084|521435573|FG000|Overall Study|Early Closure of Study|1|||
144610870|NCT01744665|521435574|FG000|Monitoring Phase|Adverse Event|4|||
144610871|NCT01744665|521435574|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
144610872|NCT01744665|521435574|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
144610873|NCT01744665|521435574|FG000|Monitoring Phase|Withdrawal by Subject|5|||
144610874|NCT01744665|521435574|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
144610875|NCT01744665|521435574|FG000|Consolidation Phase|Adverse Event|2|||
144610876|NCT01744665|521435574|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
144610877|NCT01744665|521435574|FG000|Consolidation Phase|Withdrawal by Subject|4|||
144257721|NCT00524173|520145032|FG001|Overall Study|Lost to Follow-up|1|||
144257722|NCT00524173|520145031|FG000|Overall Study|Death|1|||
144257723|NCT00524173|520145032|FG001|Overall Study|Death|0|||
144257724|NCT00524173|520145031|FG000|Overall Study|Had not reached endpoint at study close|4|||
144257725|NCT00524173|520145032|FG001|Overall Study|Had not reached endpoint at study close|1|||
144535738|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
144535739|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
144535740|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535741|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535742|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535743|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535744|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535745|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535746|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535747|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535748|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535749|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535750|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
144535751|NCT02719574|521166066|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535752|NCT02719574|521166067|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535753|NCT02719574|521166068|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
144535754|NCT02719574|521166069|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535755|NCT02719574|521166070|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535756|NCT02719574|521166071|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535757|NCT02719574|521166072|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535758|NCT02719574|521166073|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535759|NCT02719574|521166074|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535760|NCT02719574|521166075|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535761|NCT02719574|521166076|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535762|NCT02719574|521166077|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535763|NCT02719574|521166078|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535764|NCT02719574|521166079|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535765|NCT02719574|521166080|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535766|NCT02719574|521166081|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535767|NCT02719574|521166082|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144535768|NCT02719574|521166066|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535769|NCT02719574|521166067|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535770|NCT02719574|521166068|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535771|NCT02719574|521166069|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535772|NCT02719574|521166070|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535773|NCT02719574|521166071|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535774|NCT02719574|521166072|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
144535775|NCT02719574|521166073|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
144535776|NCT02719574|521166074|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
144257726|NCT04530838|520146867|FG000|Overall Study|Other|2|||
144257727|NCT04530838|520146868|FG001|Overall Study|Other|1|||
144257728|NCT04530838|520146869|FG002|Overall Study|Other|0|||
144257729|NCT04530838|520146867|FG000|Overall Study|Physician Decision|0|||
144257730|NCT04530838|520146868|FG001|Overall Study|Physician Decision|0|||
144257731|NCT04530838|520146869|FG002|Overall Study|Physician Decision|1|||
144257732|NCT04530838|520146867|FG000|Overall Study|Death|0|||
144257733|NCT04530838|520146868|FG001|Overall Study|Death|0|||
144257734|NCT04530838|520146869|FG002|Overall Study|Death|1|||
144257735|NCT04530838|520146867|FG000|Overall Study|Adverse Event|0|||
144257736|NCT04530838|520146868|FG001|Overall Study|Adverse Event|1|||
144257737|NCT04530838|520146869|FG002|Overall Study|Adverse Event|0|||
144257738|NCT04530838|520146867|FG000|Overall Study|No longer meets eligibility criteria|1|||
144257739|NCT04530838|520146868|FG001|Overall Study|No longer meets eligibility criteria|0|||
144257740|NCT04530838|520146869|FG002|Overall Study|No longer meets eligibility criteria|2|||
144462218|NCT02338154|520889441|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
144462219|NCT02338154|520889441|FG000|Overall Study|Lost to Follow-up|8|||
144462220|NCT02338154|520889441|FG000|Overall Study|Other Reason|3|||
144462221|NCT02338154|520889441|FG000|Overall Study|Patients Without Exit Form|47|||
144462222|NCT02338154|520889441|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
144462223|NCT04279314|520889442|FG000|Overall Study|Adverse Event|55|||
144462224|NCT04279314|520889442|FG000|Overall Study|Withdrawal by Subject|5|||
144462225|NCT04279314|520889442|FG000|Overall Study|Lack of Efficacy|5|||
144462226|NCT04279314|520889442|FG000|Overall Study|Protocol Violation|3|||
144462227|NCT04279314|520889442|FG000|Overall Study|Other (not COVID-19 related)|2|||
144462228|NCT02481310|520889443|FG000|Follow up|Still in follow up|0|||
144462229|NCT02481310|520889444|FG001|Follow up|Still in follow up|3|||
144462230|NCT02481310|520889445|FG002|Follow up|Still in follow up|0|||
144462231|NCT00686166|520889451|FG000|Overall Study|Adverse Event|7|||
144462232|NCT00686166|520889451|FG000|Overall Study|Withdrawal by Subject|1|||
144462233|NCT00686166|520889451|FG000|Overall Study|Progression/Relapse|1|||
144462234|NCT00686166|520889451|FG000|Overall Study|Death|1|||
144462235|NCT00686166|520889451|FG000|Overall Study|Not Protocol Specified|1|||
144462236|NCT00686166|520889451|FG000|Overall Study|Ineligible|5|||
144462237|NCT00686166|520889451|FG000|Overall Study|Did not begin protocol therapy|4|||
144462238|NCT01514448|520889452|FG000|Overall Study|Death|7|||
144462239|NCT01514448|520889453|FG001|Overall Study|Death|8|||
144462240|NCT01514448|520889452|FG000|Overall Study|Withdrawal by Subject|2|||
144462241|NCT01514448|520889453|FG001|Overall Study|Withdrawal by Subject|0|||
144462242|NCT01514448|520889452|FG000|Overall Study|Lost to Follow-up|2|||
144462243|NCT01514448|520889453|FG001|Overall Study|Lost to Follow-up|0|||
144462244|NCT01514448|520889452|FG000|Overall Study|New Cancer Therapy|1|||
144257741|NCT04530838|520146867|FG000|Overall Study|Withdrawal by parent/guardian|5|||
144257742|NCT04530838|520146868|FG001|Overall Study|Withdrawal by parent/guardian|2|||
144257743|NCT04530838|520146869|FG002|Overall Study|Withdrawal by parent/guardian|2|||
144257744|NCT00803712|520146870|FG000|Overall Study|Noncompliance|3|||
144257745|NCT00803712|520146871|FG001|Overall Study|Noncompliance|0|||
144257746|NCT00803712|520146870|FG000|Overall Study|Adverse Event|5|||
144257747|NCT00803712|520146871|FG001|Overall Study|Adverse Event|0|||
144257748|NCT00803712|520146870|FG000|Overall Study|Death|8|||
144257749|NCT00803712|520146871|FG001|Overall Study|Death|7|||
144257750|NCT00803712|520146870|FG000|Overall Study|Lost to Follow-up|3|||
144257751|NCT00803712|520146871|FG001|Overall Study|Lost to Follow-up|1|||
144257752|NCT00803712|520146870|FG000|Overall Study|Withdrawal by Subject|2|||
144257753|NCT00803712|520146871|FG001|Overall Study|Withdrawal by Subject|4|||
144257754|NCT00803712|520146870|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
144257755|NCT00803712|520146871|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
144257756|NCT00803712|520146870|FG000|Overall Study|Protocol criteria (other)|0|||
144257757|NCT00803712|520146871|FG001|Overall Study|Protocol criteria (other)|2|||
144257758|NCT00803712|520146870|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
144462245|NCT01514448|520889453|FG001|Overall Study|New Cancer Therapy|0|||
144462246|NCT02314624|520889454|FG000|Overall Study|No participating patient|16|||
144462247|NCT02314624|520889455|FG001|Overall Study|No participating patient|13|||
144462248|NCT02314624|520889454|FG000|Overall Study|Participant withdrew|7|||
144462249|NCT02314624|520889455|FG001|Overall Study|Participant withdrew|2|||
144610878|NCT01744665|521435574|FG000|Consolidation Phase|Administrative problems|9|||
144610879|NCT01744665|521435574|FG000|Re-initiation Phase|Administrative problems|10|||
144610880|NCT01744665|521435574|FG000|Re-initiation Phase|Adverse Event|1|||
144610881|NCT01744665|521435574|FG000|Re-initiation Phase|No longer required treatment|1|||
144257759|NCT00803712|520146871|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
144257760|NCT00803712|520146870|FG000|Overall Study|Administrative decision|2|||
144257761|NCT00803712|520146871|FG001|Overall Study|Administrative decision|3|||
144462250|NCT02314624|520889454|FG000|Overall Study|Lost to Follow-up|2|||
144462251|NCT02314624|520889455|FG001|Overall Study|Lost to Follow-up|5|||
144462252|NCT02314624|520889454|FG000|Overall Study|Dropped/Excluded by PI|6|||
144257762|NCT00803712|520146870|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
144257763|NCT00803712|520146871|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
144462253|NCT02314624|520889455|FG001|Overall Study|Dropped/Excluded by PI|6|||
144462254|NCT03912259|520889456|FG000|Overall Study|Adverse Event (AE)|2|||
144462255|NCT03912259|520889457|FG001|Overall Study|Adverse Event (AE)|4|||
144462256|NCT03912259|520889456|FG000|Overall Study|Lack of Efficacy|4|||
144462257|NCT03912259|520889457|FG001|Overall Study|Lack of Efficacy|1|||
144462258|NCT03912259|520889456|FG000|Overall Study|Withdrawal by Subject|11|||
144610882|NCT01744665|521435574|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
144610883|NCT00807742|521435575|FG000|Overall Study|Death|9|||
144610884|NCT00807742|521435576|FG001|Overall Study|Death|2|||
144610885|NCT00807742|521435575|FG000|Overall Study|Withdrawal by Subject|2|||
144610886|NCT00807742|521435576|FG001|Overall Study|Withdrawal by Subject|1|||
144610887|NCT00807742|521435575|FG000|Overall Study|Lost to Follow-up|35|||
144610888|NCT00807742|521435576|FG001|Overall Study|Lost to Follow-up|51|||
144610889|NCT03080883|521435577|FG000|Overall Study|Withdrawal by Subject|11|||
144610890|NCT03080883|521435578|FG001|Overall Study|Withdrawal by Subject|15|||
144610891|NCT03080883|521435577|FG000|Overall Study|Adverse Event|22|||
144610892|NCT03080883|521435578|FG001|Overall Study|Adverse Event|22|||
144610893|NCT03080883|521435577|FG000|Overall Study|Alternative Therapy|0|||
144610894|NCT03080883|521435578|FG001|Overall Study|Alternative Therapy|3|||
144610895|NCT03080883|521435577|FG000|Overall Study|Other Complicating Disease|9|||
144610896|NCT03080883|521435578|FG001|Overall Study|Other Complicating Disease|5|||
144610897|NCT03080883|521435577|FG000|Overall Study|Death|21|||
144610898|NCT03080883|521435578|FG001|Overall Study|Death|16|||
144610899|NCT03080883|521435577|FG000|Overall Study|Physician Decision|2|||
144610900|NCT03080883|521435578|FG001|Overall Study|Physician Decision|2|||
144610901|NCT03080883|521435577|FG000|Overall Study|Disease Progression|2|||
144610902|NCT03080883|521435578|FG001|Overall Study|Disease Progression|8|||
144610903|NCT03080883|521435577|FG000|Overall Study|Lost to Follow-up|1|||
144610904|NCT03080883|521435578|FG001|Overall Study|Lost to Follow-up|1|||
144610905|NCT01227187|521437162|FG000|Overall Study|Physician Decision|0|||
144610906|NCT01227187|521437163|FG001|Overall Study|Physician Decision|0|||
144610907|NCT01227187|521437164|FG002|Overall Study|Physician Decision|0|||
144610908|NCT01227187|521437165|FG003|Overall Study|Physician Decision|1|||
144610909|NCT00840086|521437166|FG000|Overall Study|Adverse Event|1|||
144610910|NCT00840086|521437166|FG000|Overall Study|Protocol Violation|2|||
144610911|NCT00840086|521437166|FG000|Overall Study|Lost to Follow-up|1|||
144610912|NCT03332498|521437167|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
144610913|NCT03332498|521437168|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
144610914|NCT03332498|521437169|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
144610915|NCT02830880|521437170|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
144610916|NCT02830880|521437170|FG000|Overall Study|Death|1|||
144610917|NCT02830880|521437170|FG000|Overall Study|Physician Decision|1|||
144610918|NCT02349048|521437175|FG000|Overall Study|Withdrawal by Subject|4|||
144610919|NCT02349048|521437176|FG001|Overall Study|Withdrawal by Subject|0|||
144610920|NCT02349048|521437175|FG000|Overall Study|Lost to Follow-up|1|||
144610921|NCT02349048|521437176|FG001|Overall Study|Lost to Follow-up|0|||
144610922|NCT00122681|521437185|FG000|Overall Study|Adverse Event|20|||
144610923|NCT00122681|521437186|FG001|Overall Study|Adverse Event|16|||
144610924|NCT00122681|521437185|FG000|Overall Study|Lost to Follow-up|1080|||
144610925|NCT00122681|521437186|FG001|Overall Study|Lost to Follow-up|1097|||
144610926|NCT00122681|521437185|FG000|Overall Study|Protocol Violation|7|||
144610927|NCT00122681|521437186|FG001|Overall Study|Protocol Violation|10|||
144610928|NCT00122681|521437185|FG000|Overall Study|Withdrawal by Subject|257|||
144610929|NCT00122681|521437186|FG001|Overall Study|Withdrawal by Subject|251|||
144610930|NCT00122681|521437185|FG000|Overall Study|Personal reasons|150|||
144610931|NCT00122681|521437186|FG001|Overall Study|Personal reasons|147|||
144610932|NCT00573430|521437196|FG000|Overall Study|Incorrect enrollment of randomization|0|||
144610933|NCT00573430|521437197|FG001|Overall Study|Incorrect enrollment of randomization|4|||
144610934|NCT00573430|521437198|FG002|Overall Study|Incorrect enrollment of randomization|3|||
144610935|NCT00573430|521437196|FG000|Overall Study|Adverse Event|0|||
144462259|NCT03912259|520889457|FG001|Overall Study|Withdrawal by Subject|1|||
144462260|NCT04786444|520889458|FG000|Overall Study|Withdrawal by Subject|4|||
144610936|NCT00573430|521437197|FG001|Overall Study|Adverse Event|0|||
144610937|NCT00573430|521437198|FG002|Overall Study|Adverse Event|2|||
144610938|NCT00573430|521437196|FG000|Overall Study|Withdrawal by Subject|1|||
144610939|NCT00573430|521437197|FG001|Overall Study|Withdrawal by Subject|0|||
144610940|NCT00573430|521437198|FG002|Overall Study|Withdrawal by Subject|1|||
144610941|NCT00573430|521437196|FG000|Overall Study|Protocol Violation|0|||
144610942|NCT00573430|521437197|FG001|Overall Study|Protocol Violation|1|||
144610943|NCT00573430|521437198|FG002|Overall Study|Protocol Violation|1|||
144610944|NCT00573430|521437196|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144462261|NCT04786444|520889459|FG001|Overall Study|Withdrawal by Subject|7|||
144610945|NCT00573430|521437197|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144610946|NCT00573430|521437198|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
144610947|NCT03719690|521437199|FG000|Overall Study|Withdrawal by Subject|5|||
144610948|NCT03719690|521437200|FG001|Overall Study|Withdrawal by Subject|10|||
144610949|NCT03719690|521437199|FG000|Overall Study|Death|40|||
144610950|NCT03719690|521437200|FG001|Overall Study|Death|149|||
144257764|NCT03410992|520146872|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257765|NCT03410992|520146873|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
144257766|NCT03410992|520146874|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257767|NCT03410992|520146875|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257768|NCT03410992|520146876|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257769|NCT03410992|520146877|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257770|NCT03410992|520146878|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257771|NCT03410992|520146879|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257772|NCT03410992|520146880|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257773|NCT03410992|520146881|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257774|NCT03410992|520146882|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
144257775|NCT03410992|520146872|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
144257776|NCT03410992|520146873|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
144257777|NCT03410992|520146874|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257778|NCT03410992|520146875|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257779|NCT03410992|520146876|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257780|NCT03410992|520146877|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257781|NCT03410992|520146878|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257782|NCT03410992|520146879|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257783|NCT03410992|520146880|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257784|NCT03410992|520146881|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257785|NCT03410992|520146882|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
144257786|NCT03410992|520146872|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
144257787|NCT03410992|520146873|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
144257788|NCT03410992|520146874|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257789|NCT03410992|520146875|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257790|NCT03410992|520146876|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257791|NCT03410992|520146877|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257792|NCT03410992|520146878|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257793|NCT03410992|520146879|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257794|NCT03410992|520146880|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257795|NCT03410992|520146881|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257796|NCT03410992|520146882|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
144257797|NCT03410992|520146872|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
144462262|NCT04786444|520889460|FG002|Overall Study|Withdrawal by Subject|2|||
144462263|NCT04786444|520889458|FG000|Overall Study|Lost to Follow-up|11|||
144462264|NCT04786444|520889459|FG001|Overall Study|Lost to Follow-up|9|||
144462265|NCT04786444|520889460|FG002|Overall Study|Lost to Follow-up|10|||
144462266|NCT04786444|520889458|FG000|Overall Study|Subject would like to become pregnant|0|||
144462267|NCT04786444|520889459|FG001|Overall Study|Subject would like to become pregnant|1|||
144462268|NCT04786444|520889460|FG002|Overall Study|Subject would like to become pregnant|0|||
144462269|NCT03166618|520889461|FG000|Overall Study|Study was Terminated|0|||
144462270|NCT03166618|520889462|FG001|Overall Study|Study was Terminated|1|||
144462271|NCT01925950|520889463|FG000|Part 2|Withdrawal by Subject|1|||
144462272|NCT01925950|520889464|FG001|Part 2|Withdrawal by Subject|0|||
144462273|NCT03561090|520889466|FG000|Overall Study|Adverse Event|11|||
144462274|NCT03561090|520889467|FG001|Overall Study|Adverse Event|7|||
144462275|NCT03561090|520889466|FG000|Overall Study|Non-Compliance With Study Drug|2|||
144462276|NCT03561090|520889467|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144462277|NCT03561090|520889466|FG000|Overall Study|Protocol Violation|2|||
144462278|NCT03561090|520889467|FG001|Overall Study|Protocol Violation|2|||
144462279|NCT03561090|520889466|FG000|Overall Study|Withdrawal by Subject|7|||
144462280|NCT03561090|520889467|FG001|Overall Study|Withdrawal by Subject|7|||
144462281|NCT03561090|520889466|FG000|Overall Study|Lost to Follow-up|7|||
144462282|NCT03561090|520889467|FG001|Overall Study|Lost to Follow-up|2|||
144462283|NCT03561090|520889466|FG000|Overall Study|Study Terminated by Sponsor|10|||
144462284|NCT03561090|520889467|FG001|Overall Study|Study Terminated by Sponsor|15|||
144462285|NCT03561090|520889466|FG000|Overall Study|Randomized by Mistake|1|||
144462286|NCT03561090|520889467|FG001|Overall Study|Randomized by Mistake|1|||
144462287|NCT03561090|520889466|FG000|Overall Study|Other Not Specified|0|||
144462288|NCT03561090|520889467|FG001|Overall Study|Other Not Specified|2|||
144462289|NCT04162769|520889474|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
144462290|NCT04162769|520889475|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
144462291|NCT04162769|520889476|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
144535777|NCT02719574|521166075|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535778|NCT02719574|521166076|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535779|NCT02719574|521166077|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535780|NCT02719574|521166078|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535781|NCT02719574|521166079|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144535782|NCT02719574|521166080|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144462292|NCT04162769|520889477|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
144462293|NCT04162769|520889474|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
144462294|NCT04162769|520889475|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
144462295|NCT04162769|520889476|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
144462296|NCT04162769|520889477|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
144462297|NCT04162769|520889474|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
144462298|NCT04162769|520889475|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
144462299|NCT04162769|520889476|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
144462300|NCT04162769|520889477|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
144462301|NCT04162769|520889474|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
144462302|NCT04162769|520889475|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
144462303|NCT04162769|520889476|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
144462304|NCT04162769|520889477|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
144462305|NCT04162769|520889474|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
144462306|NCT04162769|520889475|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
144462307|NCT04162769|520889476|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
144462308|NCT04162769|520889477|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
144462309|NCT04162769|520889474|FG000|Double-blind Treatment (12-Week)|Other|0|||
144462310|NCT04162769|520889475|FG001|Double-blind Treatment (12-Week)|Other|1|||
144462311|NCT04162769|520889476|FG002|Double-blind Treatment (12-Week)|Other|1|||
144257798|NCT03410992|520146873|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144462312|NCT04162769|520889477|FG003|Double-blind Treatment (12-Week)|Other|0|||
144462313|NCT04162769|520889474|FG000|OLE Period (52-Week)|Adverse Event|0|||
144462314|NCT04162769|520889475|FG001|OLE Period (52-Week)|Adverse Event|0|||
144462315|NCT04162769|520889476|FG002|OLE Period (52-Week)|Adverse Event|0|||
144462316|NCT04162769|520889477|FG003|OLE Period (52-Week)|Adverse Event|5|||
144462317|NCT04162769|520889474|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
144462318|NCT04162769|520889475|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
144462319|NCT04162769|520889476|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
144462320|NCT04162769|520889477|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
144462321|NCT04162769|520889474|FG000|OLE Period (52-Week)|Physician Decision|0|||
144462322|NCT04162769|520889475|FG001|OLE Period (52-Week)|Physician Decision|0|||
144462323|NCT04162769|520889476|FG002|OLE Period (52-Week)|Physician Decision|0|||
144462324|NCT04162769|520889477|FG003|OLE Period (52-Week)|Physician Decision|1|||
144462325|NCT04162769|520889474|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
144462326|NCT04162769|520889475|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
144462327|NCT04162769|520889476|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
144462328|NCT04162769|520889477|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
144462329|NCT04162769|520889474|FG000|OLE Period (52-Week)|Protocol deviation|0|||
144462330|NCT04162769|520889475|FG001|OLE Period (52-Week)|Protocol deviation|0|||
144462331|NCT04162769|520889476|FG002|OLE Period (52-Week)|Protocol deviation|0|||
144462332|NCT04162769|520889477|FG003|OLE Period (52-Week)|Protocol deviation|2|||
144462333|NCT00713648|520889480|FG000|Overall Study|Adverse Event|1|||
144462334|NCT00713648|520889480|FG000|Overall Study|Unclassified|2|||
144462335|NCT00713648|520889480|FG000|Overall Study|According to Protocol|2|||
144462336|NCT00713648|520889480|FG000|Overall Study|Development of antibodies|3|||
144462337|NCT00082173|520889481|FG000|Overall Study|Withdrawal by Subject|3|||
144462338|NCT00082173|520889482|FG001|Overall Study|Withdrawal by Subject|5|||
144462339|NCT00082173|520889481|FG000|Overall Study|Lost to Follow-up|1|||
144462340|NCT00082173|520889482|FG001|Overall Study|Lost to Follow-up|0|||
144462341|NCT00082173|520889481|FG000|Overall Study|Adverse Event|1|||
144257799|NCT03410992|520146874|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257800|NCT03410992|520146875|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144462342|NCT00082173|520889482|FG001|Overall Study|Adverse Event|0|||
144462343|NCT00082173|520889481|FG000|Overall Study|Culture negative or resistant at baselin|5|||
144462344|NCT00082173|520889482|FG001|Overall Study|Culture negative or resistant at baselin|6|||
144462345|NCT00746590|520889483|FG000|Overall Study|Death|1|||
144462346|NCT00464815|520889486|FG000|Overall Study|Withdrawal by Subject|6|||
144462347|NCT00464815|520889487|FG001|Overall Study|Withdrawal by Subject|3|||
144462348|NCT00254982|520889490|FG000|Overall Study|Other|2|||
144462349|NCT00254982|520889491|FG001|Overall Study|Other|1|||
144462350|NCT00254982|520889490|FG000|Overall Study|Lack of Efficacy|5|||
144462351|NCT00254982|520889491|FG001|Overall Study|Lack of Efficacy|3|||
144462352|NCT00254982|520889490|FG000|Overall Study|Lost to Follow-up|5|||
144462353|NCT00254982|520889491|FG001|Overall Study|Lost to Follow-up|3|||
144462354|NCT00254982|520889490|FG000|Overall Study|Adverse Event|18|||
144462355|NCT00254982|520889491|FG001|Overall Study|Adverse Event|16|||
144462356|NCT00254982|520889490|FG000|Overall Study|Withdrawal by Subject|1|||
144462357|NCT00254982|520889491|FG001|Overall Study|Withdrawal by Subject|1|||
144462358|NCT00254982|520889490|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
144462359|NCT00254982|520889491|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
144462360|NCT00254982|520889490|FG000|Overall Study|Protocol deviation|1|||
144462361|NCT00254982|520889491|FG001|Overall Study|Protocol deviation|1|||
144257801|NCT03410992|520146876|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257802|NCT03410992|520146877|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257803|NCT03410992|520146878|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257804|NCT03410992|520146879|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257805|NCT03410992|520146880|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257806|NCT03410992|520146881|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257807|NCT03410992|520146882|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
144257808|NCT03410992|520146872|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
144257809|NCT03410992|520146873|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
144257810|NCT03410992|520146874|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257811|NCT03410992|520146875|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257812|NCT03410992|520146876|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257813|NCT03410992|520146877|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257814|NCT03410992|520146878|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257815|NCT03410992|520146879|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257816|NCT03410992|520146880|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257817|NCT03410992|520146881|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257818|NCT03410992|520146882|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
144257819|NCT03410992|520146872|FG000|Week 16 Assessment|Incorrect escapers|0|||
144257820|NCT03410992|520146873|FG001|Week 16 Assessment|Incorrect escapers|6|||
144257821|NCT03410992|520146874|FG002|Week 16 Assessment|Incorrect escapers|0|||
144257822|NCT03410992|520146875|FG003|Week 16 Assessment|Incorrect escapers|0|||
144257823|NCT03410992|520146876|FG004|Week 16 Assessment|Incorrect escapers|0|||
144257824|NCT03410992|520146877|FG005|Week 16 Assessment|Incorrect escapers|0|||
144257825|NCT03410992|520146878|FG006|Week 16 Assessment|Incorrect escapers|0|||
144257826|NCT03410992|520146879|FG007|Week 16 Assessment|Incorrect escapers|0|||
144257827|NCT03410992|520146880|FG008|Week 16 Assessment|Incorrect escapers|0|||
144257828|NCT03410992|520146881|FG009|Week 16 Assessment|Incorrect escapers|0|||
144257829|NCT03410992|520146882|FG010|Week 16 Assessment|Incorrect escapers|0|||
144462362|NCT00254982|520889490|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
144462363|NCT00254982|520889491|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
144462364|NCT00254982|520889490|FG000|Overall Study|Malignancy|0|||
144462365|NCT00254982|520889491|FG001|Overall Study|Malignancy|2|||
144462366|NCT00254982|520889490|FG000|Overall Study|Opportunistic infection|1|||
144462367|NCT00254982|520889491|FG001|Overall Study|Opportunistic infection|0|||
144462368|NCT00254982|520889490|FG000|Overall Study|Abnormal liver function tests|2|||
144462369|NCT00254982|520889491|FG001|Overall Study|Abnormal liver function tests|1|||
144462370|NCT03643952|520889495|FG000|Overall Study|Lack of Efficacy|1|||
144462371|NCT00487162|520889496|FG000|Overall Study|Adverse Event|0|||
144462372|NCT00487162|520889497|FG001|Overall Study|Adverse Event|1|||
144462373|NCT00487162|520889496|FG000|Overall Study|Physician Decision|0|||
144462374|NCT00487162|520889497|FG001|Overall Study|Physician Decision|1|||
144462375|NCT00487162|520889496|FG000|Overall Study|Withdrawal by Subject|2|||
144462376|NCT00487162|520889497|FG001|Overall Study|Withdrawal by Subject|3|||
144462377|NCT00815295|520889500|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
144462378|NCT00815295|520889501|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
144462379|NCT00815295|520889502|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
144462380|NCT01433354|520889507|FG000|Overall Study|Adverse Event|6|||
144462381|NCT01433354|520889507|FG000|Overall Study|Lost to Follow-up|1|||
144462382|NCT01433354|520889507|FG000|Overall Study|Administrative problems|90|||
144462383|NCT01433354|520889507|FG000|Overall Study|Protocol Violation|2|||
144462384|NCT01433354|520889507|FG000|Overall Study|Lack of Efficacy|17|||
144462385|NCT01433354|520889507|FG000|Overall Study|Subject Withdrew Consent|3|||
144462386|NCT00937924|520889515|FG000|Overall Study|Lost to Follow-up|44|||
144462387|NCT00937924|520889516|FG001|Overall Study|Lost to Follow-up|44|||
144462388|NCT00937924|520889517|FG002|Overall Study|Lost to Follow-up|41|||
144462389|NCT02633137|520889536|FG000|Overall Study|Adverse Event|1|||
144462390|NCT02633137|520889536|FG000|Overall Study|Lack of Efficacy|2|||
144462391|NCT02633137|520889536|FG000|Overall Study|Withdrawal by Subject|1|||
144462392|NCT03152526|520889537|FG000|Overall Study|Withdrawal by Subject|0|||
144462393|NCT03152526|520889538|FG001|Overall Study|Withdrawal by Subject|1|||
144462394|NCT04307004|520889539|FG000|Randomization 1|Withdrawal by Subject|25|||
144462395|NCT04307004|520889540|FG001|Randomization 1|Withdrawal by Subject|26|||
144726024|NCT01345019|521852669|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
144257830|NCT03410992|520146872|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257831|NCT03410992|520146873|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257832|NCT03410992|520146874|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257833|NCT03410992|520146875|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
144462396|NCT04307004|520889541|FG002|Randomization 1|Withdrawal by Subject|0|||
144462397|NCT04307004|520889542|FG003|Randomization 1|Withdrawal by Subject|0|||
144462398|NCT04307004|520889539|FG000|Randomization 2|Withdrawal by Subject|0|||
144462399|NCT04307004|520889540|FG001|Randomization 2|Withdrawal by Subject|0|||
144462400|NCT04307004|520889541|FG002|Randomization 2|Withdrawal by Subject|28|||
144462401|NCT04307004|520889542|FG003|Randomization 2|Withdrawal by Subject|23|||
144462402|NCT05545072|520889545|FG000|Overall Study|Lost to Follow-up|1|||
144462403|NCT05545072|520889546|FG001|Overall Study|Lost to Follow-up|0|||
144462404|NCT05545072|520889545|FG000|Overall Study|Study ended prematurely due to funding|2|||
144462405|NCT05545072|520889546|FG001|Overall Study|Study ended prematurely due to funding|2|||
144462406|NCT02395042|520889547|FG000|Treatment 1 Period|Adverse Event|1|||
144462407|NCT02395042|520889548|FG001|Treatment 1 Period|Adverse Event|3|||
144462408|NCT02395042|520889549|FG002|Treatment 1 Period|Adverse Event|1|||
144462409|NCT02395042|520889547|FG000|Treatment 1 Period|Lack of Efficacy|1|||
144462410|NCT02395042|520889548|FG001|Treatment 1 Period|Lack of Efficacy|1|||
144462411|NCT02395042|520889549|FG002|Treatment 1 Period|Lack of Efficacy|0|||
144462412|NCT02395042|520889547|FG000|Treatment 1 Period|Lost to Follow-up|1|||
144462413|NCT02395042|520889548|FG001|Treatment 1 Period|Lost to Follow-up|0|||
144462414|NCT02395042|520889549|FG002|Treatment 1 Period|Lost to Follow-up|0|||
144462415|NCT02395042|520889547|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
144462416|NCT02395042|520889548|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
144462417|NCT02395042|520889549|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
144462418|NCT02395042|520889547|FG000|Treatment 2 Period|Lack of Efficacy|1|||
144462419|NCT02395042|520889548|FG001|Treatment 2 Period|Lack of Efficacy|1|||
144462420|NCT02395042|520889549|FG002|Treatment 2 Period|Lack of Efficacy|0|||
144462421|NCT05130970|520889550|FG000|Overall Study|Adverse Event|1|||
144462422|NCT05130970|520889551|FG001|Overall Study|Adverse Event|1|||
144462423|NCT05130970|520889550|FG000|Overall Study|Death|0|||
144462424|NCT05130970|520889551|FG001|Overall Study|Death|1|||
144462425|NCT05130970|520889550|FG000|Overall Study|Lost to Follow-up|0|||
144462426|NCT05130970|520889551|FG001|Overall Study|Lost to Follow-up|1|||
144462427|NCT05130970|520889550|FG000|Overall Study|Physician Decision|0|||
144462428|NCT05130970|520889551|FG001|Overall Study|Physician Decision|1|||
144462429|NCT05130970|520889550|FG000|Overall Study|Withdrawal by Subject|1|||
144462430|NCT05130970|520889551|FG001|Overall Study|Withdrawal by Subject|1|||
144462431|NCT02807558|520889552|FG000|Overall Study|Consent withdrawn by participant|4|||
144462432|NCT02807558|520889553|FG001|Overall Study|Consent withdrawn by participant|0|||
144462433|NCT02807558|520889554|FG002|Overall Study|Consent withdrawn by participant|4|||
144462434|NCT02807558|520889555|FG003|Overall Study|Consent withdrawn by participant|2|||
144462435|NCT02807558|520889556|FG004|Overall Study|Consent withdrawn by participant|1|||
144462436|NCT02807558|520889557|FG005|Overall Study|Consent withdrawn by participant|0|||
144462437|NCT02807558|520889552|FG000|Overall Study|Non-compliance with Study Drug|0|||
144462438|NCT02807558|520889553|FG001|Overall Study|Non-compliance with Study Drug|0|||
144462439|NCT02807558|520889554|FG002|Overall Study|Non-compliance with Study Drug|1|||
144462440|NCT02807558|520889555|FG003|Overall Study|Non-compliance with Study Drug|0|||
144462441|NCT02807558|520889556|FG004|Overall Study|Non-compliance with Study Drug|0|||
144462442|NCT02807558|520889557|FG005|Overall Study|Non-compliance with Study Drug|0|||
144462443|NCT02807558|520889552|FG000|Overall Study|Adverse Event|0|||
144462444|NCT02807558|520889553|FG001|Overall Study|Adverse Event|0|||
144462445|NCT02807558|520889554|FG002|Overall Study|Adverse Event|9|||
144462446|NCT02807558|520889555|FG003|Overall Study|Adverse Event|0|||
144462447|NCT02807558|520889556|FG004|Overall Study|Adverse Event|0|||
144462448|NCT02807558|520889557|FG005|Overall Study|Adverse Event|0|||
144462449|NCT02807558|520889552|FG000|Overall Study|Death|23|||
144462450|NCT02807558|520889553|FG001|Overall Study|Death|2|||
144462451|NCT02807558|520889554|FG002|Overall Study|Death|3|||
144462452|NCT02807558|520889555|FG003|Overall Study|Death|43|||
144462453|NCT02807558|520889556|FG004|Overall Study|Death|24|||
144462454|NCT02807558|520889557|FG005|Overall Study|Death|15|||
144462455|NCT02807558|520889552|FG000|Overall Study|Progressive Disease|0|||
144462456|NCT02807558|520889553|FG001|Overall Study|Progressive Disease|0|||
144462457|NCT02807558|520889554|FG002|Overall Study|Progressive Disease|1|||
144462458|NCT02807558|520889555|FG003|Overall Study|Progressive Disease|0|||
144462459|NCT02807558|520889556|FG004|Overall Study|Progressive Disease|0|||
144462460|NCT02807558|520889557|FG005|Overall Study|Progressive Disease|0|||
144462461|NCT02807558|520889552|FG000|Overall Study|Other than specified|1|||
144462462|NCT02807558|520889553|FG001|Overall Study|Other than specified|0|||
144462463|NCT02807558|520889554|FG002|Overall Study|Other than specified|2|||
144462464|NCT02807558|520889555|FG003|Overall Study|Other than specified|0|||
144462465|NCT02807558|520889556|FG004|Overall Study|Other than specified|1|||
144462466|NCT02807558|520889557|FG005|Overall Study|Other than specified|1|||
144462467|NCT02807558|520889552|FG000|Overall Study|Lack of Efficacy|0|||
144462468|NCT02807558|520889553|FG001|Overall Study|Lack of Efficacy|0|||
144462469|NCT02807558|520889554|FG002|Overall Study|Lack of Efficacy|9|||
144462470|NCT02807558|520889555|FG003|Overall Study|Lack of Efficacy|0|||
144462471|NCT02807558|520889556|FG004|Overall Study|Lack of Efficacy|0|||
144462472|NCT02807558|520889557|FG005|Overall Study|Lack of Efficacy|0|||
144462473|NCT02273141|520889558|FG000|Overall Study|Adverse Event|0|||
144462474|NCT02273141|520889559|FG001|Overall Study|Adverse Event|1|||
144462475|NCT02273141|520889558|FG000|Overall Study|Lost to Follow-up|1|||
144462476|NCT02273141|520889559|FG001|Overall Study|Lost to Follow-up|3|||
144462477|NCT02273141|520889558|FG000|Overall Study|Withdrawal by Subject|10|||
144462478|NCT02273141|520889559|FG001|Overall Study|Withdrawal by Subject|15|||
144462479|NCT02273141|520889558|FG000|Overall Study|Various|6|||
144462480|NCT02273141|520889559|FG001|Overall Study|Various|6|||
144462481|NCT00529399|520889560|FG000|Overall Study|Lost to Follow-up|1|||
144462482|NCT00529399|520889561|FG001|Overall Study|Lost to Follow-up|0|||
144462483|NCT00529399|520889562|FG002|Overall Study|Lost to Follow-up|1|||
144462484|NCT00529399|520889560|FG000|Overall Study|Withdrawal by Subject|1|||
144462485|NCT00529399|520889561|FG001|Overall Study|Withdrawal by Subject|0|||
144462486|NCT00529399|520889562|FG002|Overall Study|Withdrawal by Subject|1|||
144462487|NCT00529399|520889560|FG000|Overall Study|Non-compliant|0|||
144462488|NCT00529399|520889561|FG001|Overall Study|Non-compliant|1|||
144462489|NCT00529399|520889562|FG002|Overall Study|Non-compliant|0|||
144462490|NCT02576678|520889573|FG000|Overall Study|Adverse Event|0|||
144462491|NCT02576678|520889574|FG001|Overall Study|Adverse Event|0|||
144462492|NCT02576678|520889575|FG002|Overall Study|Adverse Event|2|||
144462493|NCT02576678|520889573|FG000|Overall Study|Withdrawal by Subject|3|||
144462494|NCT02576678|520889574|FG001|Overall Study|Withdrawal by Subject|1|||
144462495|NCT02576678|520889575|FG002|Overall Study|Withdrawal by Subject|2|||
144462496|NCT02576678|520889573|FG000|Overall Study|Lost to Follow-up|0|||
144462497|NCT02576678|520889574|FG001|Overall Study|Lost to Follow-up|0|||
144462498|NCT02576678|520889575|FG002|Overall Study|Lost to Follow-up|1|||
144462499|NCT02576678|520889573|FG000|Overall Study|Miscellaneous|2|||
144462500|NCT02576678|520889574|FG001|Overall Study|Miscellaneous|0|||
144462501|NCT02576678|520889575|FG002|Overall Study|Miscellaneous|0|||
144462502|NCT01454583|520889578|FG000|1st Year|Lost to Follow-up|1057|||
144462503|NCT01454583|520889579|FG001|1st Year|Lost to Follow-up|318|||
144462504|NCT01454583|520889580|FG002|1st Year|Lost to Follow-up|180|||
144462505|NCT01454583|520889578|FG000|2nd Year|Lost to Follow-up|3965|||
144462506|NCT01454583|520889579|FG001|2nd Year|Lost to Follow-up|1049|||
144462507|NCT01454583|520889580|FG002|2nd Year|Lost to Follow-up|737|||
144462508|NCT01454583|520889578|FG000|3rd Year|Lost to Follow-up|1959|||
144462509|NCT01454583|520889579|FG001|3rd Year|Lost to Follow-up|512|||
144462510|NCT01454583|520889580|FG002|3rd Year|Lost to Follow-up|297|||
144462511|NCT00584727|520889581|FG000|First Intervention|Discontinuation|0|||
144462512|NCT00584727|520889582|FG001|First Intervention|Discontinuation|0|||
144462513|NCT00584727|520889583|FG002|First Intervention|Discontinuation|1|||
144462514|NCT00584727|520889584|FG003|First Intervention|Discontinuation|0|||
144462515|NCT00584727|520889585|FG004|First Intervention|Discontinuation|0|||
144462516|NCT00584727|520889586|FG005|First Intervention|Discontinuation|0|||
144462517|NCT00584727|520889581|FG000|Third Intervention|Protocol Violation|0|||
144462518|NCT00584727|520889582|FG001|Third Intervention|Protocol Violation|0|||
144462519|NCT00584727|520889583|FG002|Third Intervention|Protocol Violation|1|||
144257834|NCT03410992|520146876|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
144257835|NCT03410992|520146877|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257836|NCT03410992|520146878|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257837|NCT03410992|520146879|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257838|NCT03410992|520146880|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257839|NCT03410992|520146881|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257840|NCT03410992|520146882|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
144257841|NCT03410992|520146872|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257842|NCT03410992|520146873|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257843|NCT03410992|520146874|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257844|NCT03410992|520146875|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
144257845|NCT03410992|520146876|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
144462520|NCT00584727|520889584|FG003|Third Intervention|Protocol Violation|0|||
144462521|NCT00584727|520889585|FG004|Third Intervention|Protocol Violation|4|||
144462522|NCT00584727|520889586|FG005|Third Intervention|Protocol Violation|2|||
144462523|NCT00729833|520889589|FG000|Overall Study|Death|5|||
144462524|NCT00729833|520889590|FG001|Overall Study|Death|1|||
144462525|NCT00729833|520889591|FG002|Overall Study|Death|3|||
144462526|NCT00729833|520889592|FG003|Overall Study|Death|5|||
144462527|NCT00729833|520889589|FG000|Overall Study|Study Terminated by Sponsor|0|||
144462528|NCT00729833|520889590|FG001|Overall Study|Study Terminated by Sponsor|0|||
144462529|NCT00729833|520889591|FG002|Overall Study|Study Terminated by Sponsor|1|||
144462530|NCT00729833|520889592|FG003|Overall Study|Study Terminated by Sponsor|0|||
144462531|NCT00729833|520889589|FG000|Overall Study|Lost to Follow-up|1|||
144462532|NCT00729833|520889590|FG001|Overall Study|Lost to Follow-up|0|||
144462533|NCT00729833|520889591|FG002|Overall Study|Lost to Follow-up|0|||
144462534|NCT00729833|520889592|FG003|Overall Study|Lost to Follow-up|0|||
144462535|NCT00729833|520889589|FG000|Overall Study|Withdrawal by Subject|3|||
144462536|NCT00729833|520889590|FG001|Overall Study|Withdrawal by Subject|1|||
144535783|NCT02719574|521166081|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144462537|NCT00729833|520889591|FG002|Overall Study|Withdrawal by Subject|3|||
144462538|NCT00729833|520889592|FG003|Overall Study|Withdrawal by Subject|0|||
144462539|NCT00729833|520889589|FG000|Overall Study|Unspecified Reasons|11|||
144462540|NCT00729833|520889590|FG001|Overall Study|Unspecified Reasons|5|||
144257846|NCT03410992|520146877|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
144257847|NCT03410992|520146878|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257848|NCT03410992|520146879|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257849|NCT03410992|520146880|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257850|NCT03410992|520146881|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257851|NCT03410992|520146882|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
144257852|NCT03410992|520146872|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257853|NCT03410992|520146873|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257854|NCT03410992|520146874|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257855|NCT03410992|520146875|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144462541|NCT00729833|520889591|FG002|Overall Study|Unspecified Reasons|5|||
144462542|NCT00729833|520889592|FG003|Overall Study|Unspecified Reasons|1|||
144462543|NCT03152552|520889593|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
144462544|NCT03152552|520889594|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
144462545|NCT03152552|520889595|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
144462546|NCT03152552|520889596|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
144462547|NCT03152552|520889597|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
144462548|NCT03152552|520889593|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
144462549|NCT03152552|520889594|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
144535784|NCT02719574|521166082|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
144257856|NCT03410992|520146876|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257857|NCT03410992|520146877|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
144257858|NCT03410992|520146878|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257859|NCT03410992|520146879|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257860|NCT03410992|520146880|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257861|NCT03410992|520146881|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257862|NCT03410992|520146882|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
144257863|NCT03410992|520146872|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257864|NCT03410992|520146873|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257865|NCT03410992|520146874|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257866|NCT03410992|520146875|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
144257867|NCT03410992|520146876|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
144257868|NCT03410992|520146877|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
144257869|NCT03410992|520146878|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257870|NCT03410992|520146879|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257871|NCT03410992|520146880|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257872|NCT03410992|520146881|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257873|NCT03410992|520146882|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
144257874|NCT03410992|520146872|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257875|NCT03410992|520146873|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257876|NCT03410992|520146874|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257877|NCT03410992|520146875|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257878|NCT03410992|520146876|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257879|NCT03410992|520146877|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257880|NCT03410992|520146878|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257881|NCT03410992|520146879|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
144257882|NCT03410992|520146880|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257883|NCT03410992|520146881|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257884|NCT03410992|520146882|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
144257885|NCT03410992|520146872|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257886|NCT03410992|520146873|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257887|NCT03410992|520146874|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257888|NCT03410992|520146875|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257889|NCT03410992|520146876|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257890|NCT03410992|520146877|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257891|NCT03410992|520146878|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257892|NCT03410992|520146879|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144257893|NCT03410992|520146880|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
144257894|NCT03410992|520146881|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144462550|NCT03152552|520889595|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
144462551|NCT03152552|520889596|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
144462552|NCT03152552|520889597|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
144535785|NCT02719574|521166066|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535786|NCT02719574|521166067|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535787|NCT02719574|521166068|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144462553|NCT03152552|520889593|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
144535788|NCT02719574|521166069|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144462554|NCT03152552|520889594|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
144462555|NCT03152552|520889595|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
144462556|NCT03152552|520889596|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
144462557|NCT03152552|520889597|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
144462558|NCT03152552|520889593|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144462559|NCT03152552|520889594|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144462560|NCT03152552|520889595|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144462561|NCT03152552|520889596|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144462562|NCT03152552|520889597|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144462563|NCT03152552|520889593|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
144462564|NCT03152552|520889594|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
144462565|NCT03152552|520889595|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
144462566|NCT03152552|520889596|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
144462567|NCT03152552|520889597|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
144462568|NCT03152552|520889593|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
144462569|NCT03152552|520889594|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
144462570|NCT03152552|520889595|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
144462571|NCT03152552|520889596|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
144257895|NCT03410992|520146882|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
144462572|NCT03152552|520889597|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
144462573|NCT03152552|520889593|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
144462574|NCT03152552|520889594|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
144462575|NCT03152552|520889595|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
144462576|NCT03152552|520889596|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
144462577|NCT03152552|520889597|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
144257896|NCT02620787|520146883|FG000|Overall Study|Adverse Event|1|||
144257897|NCT02620787|520146884|FG001|Overall Study|Adverse Event|0|||
144257898|NCT02620787|520146883|FG000|Overall Study|Eligibility Criteria Not Met|1|||
144462578|NCT01300546|520889600|FG000|Overall Study|Withdrawal by Subject|1|||
144462579|NCT01300546|520889601|FG001|Overall Study|Withdrawal by Subject|0|||
144462580|NCT01300546|520889600|FG000|Overall Study|Lost to Follow-up|0|||
144462581|NCT01300546|520889601|FG001|Overall Study|Lost to Follow-up|2|||
144462582|NCT01300546|520889600|FG000|Overall Study|Lack of Efficacy|0|||
144462583|NCT01300546|520889601|FG001|Overall Study|Lack of Efficacy|3|||
144462584|NCT01300546|520889600|FG000|Overall Study|Adverse Event|0|||
144462585|NCT01300546|520889601|FG001|Overall Study|Adverse Event|1|||
144462586|NCT05245864|520889606|FG000|Overall Study|Withdrawal by Subject|1|||
144462587|NCT05245864|520889607|FG001|Overall Study|Withdrawal by Subject|1|||
144462588|NCT01986881|520891686|FG000|Overall Study|Death|228|||
144462589|NCT01986881|520891687|FG001|Overall Study|Death|233|||
144462590|NCT01986881|520891688|FG002|Overall Study|Death|247|||
144462591|NCT01986881|520891686|FG000|Overall Study|Lost to Follow-up|51|||
144462592|NCT01986881|520891687|FG001|Overall Study|Lost to Follow-up|44|||
144462593|NCT01986881|520891688|FG002|Overall Study|Lost to Follow-up|55|||
144462594|NCT01986881|520891686|FG000|Overall Study|Physician Decision|7|||
144462595|NCT01986881|520891687|FG001|Overall Study|Physician Decision|4|||
144462596|NCT01986881|520891688|FG002|Overall Study|Physician Decision|6|||
144462597|NCT01986881|520891686|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
144462598|NCT01986881|520891687|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
144535789|NCT02719574|521166070|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535790|NCT02719574|521166071|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535791|NCT02719574|521166072|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
144535792|NCT02719574|521166073|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
144535793|NCT02719574|521166074|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535794|NCT02719574|521166075|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144257899|NCT02620787|520146884|FG001|Overall Study|Eligibility Criteria Not Met|0|||
144257900|NCT01896193|520146886|FG000|Overall Study|Lack of Efficacy|20|||
144462599|NCT01986881|520891688|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
144462600|NCT01986881|520891686|FG000|Overall Study|Withdrawal by Subject|41|||
144462601|NCT01986881|520891687|FG001|Overall Study|Withdrawal by Subject|60|||
144462602|NCT01986881|520891688|FG002|Overall Study|Withdrawal by Subject|45|||
144462603|NCT01986881|520891686|FG000|Overall Study|Subject Moved|0|||
144462604|NCT01986881|520891687|FG001|Overall Study|Subject Moved|1|||
144462605|NCT01986881|520891688|FG002|Overall Study|Subject Moved|0|||
144462606|NCT01986881|520891686|FG000|Overall Study|Other|1|||
144462607|NCT01986881|520891687|FG001|Overall Study|Other|2|||
144462608|NCT01986881|520891688|FG002|Overall Study|Other|2|||
144462609|NCT01549613|520891694|FG000|Overall Study|Lost to Follow-up|11|||
144462610|NCT01549613|520891695|FG001|Overall Study|Lost to Follow-up|11|||
144462611|NCT02216123|520891696|FG000|Overall Study|Lost to Follow-up|4|||
144462612|NCT02216123|520891697|FG001|Overall Study|Lost to Follow-up|2|||
144535795|NCT02719574|521166076|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144610951|NCT03719690|521437199|FG000|Overall Study|Miscellaneous|12|||
144257901|NCT01896193|520146887|FG001|Overall Study|Lack of Efficacy|11|||
144462613|NCT02216123|520891696|FG000|Overall Study|Withdrawal by Subject|2|||
144462614|NCT02216123|520891697|FG001|Overall Study|Withdrawal by Subject|0|||
144462615|NCT02131272|520891698|FG000|Overall Study|Withdrawal by parent|0|||
144462616|NCT02131272|520891699|FG001|Overall Study|Withdrawal by parent|1|||
144462617|NCT02131272|520891698|FG000|Overall Study|Withdrawal by Subject|0|||
144462618|NCT02131272|520891699|FG001|Overall Study|Withdrawal by Subject|1|||
144462619|NCT02131272|520891698|FG000|Overall Study|Withdrawal Criteria|1|||
144462620|NCT02131272|520891699|FG001|Overall Study|Withdrawal Criteria|0|||
144462621|NCT00381940|520891700|FG000|Overall Study|Lack of Efficacy|3|||
144462622|NCT00381940|520891700|FG000|Overall Study|Protocol Violation|1|||
144462623|NCT00381940|520891700|FG000|Overall Study|Ineligible|1|||
144462624|NCT03162224|520891701|FG000|Overall Study|Death|4|||
144462625|NCT03162224|520891702|FG001|Overall Study|Death|5|||
144462626|NCT03162224|520891703|FG002|Overall Study|Death|8|||
144462627|NCT03162224|520891701|FG000|Overall Study|Withdrawal by Subject|1|||
144462628|NCT03162224|520891702|FG001|Overall Study|Withdrawal by Subject|0|||
144462629|NCT03162224|520891703|FG002|Overall Study|Withdrawal by Subject|1|||
144462630|NCT03162224|520891701|FG000|Overall Study|Lost to Follow-up|0|||
144462631|NCT03162224|520891702|FG001|Overall Study|Lost to Follow-up|1|||
144462632|NCT03162224|520891703|FG002|Overall Study|Lost to Follow-up|0|||
144462633|NCT03162224|520891701|FG000|Overall Study|Other|6|||
144462634|NCT03162224|520891702|FG001|Overall Study|Other|2|||
144462635|NCT03162224|520891703|FG002|Overall Study|Other|1|||
144462636|NCT05159622|520891704|FG000|Overall Study|Lost to Follow-up|4|||
144462637|NCT05159622|520891705|FG001|Overall Study|Lost to Follow-up|5|||
144462638|NCT00725452|520891707|FG000|Overall Study|Adverse Event|3|||
144462639|NCT00725452|520891707|FG000|Overall Study|Lack of Efficacy|2|||
144462640|NCT00725452|520891707|FG000|Overall Study|Reason not specified|1|||
144462641|NCT00725452|520891707|FG000|Overall Study|Physician Decision|1|||
144462642|NCT00725452|520891707|FG000|Overall Study|Withdrawal by Subject|3|||
144462643|NCT00725452|520891707|FG000|Overall Study|Lost to Follow-up|1|||
144462644|NCT02163733|520891708|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
144462645|NCT02163733|520891709|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
144462646|NCT02163733|520891710|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
144462647|NCT02163733|520891708|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
144462648|NCT02163733|520891709|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
144462649|NCT02163733|520891710|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
144462650|NCT02723864|520891711|FG000|Overall Study|Refused further treatment|1|||
144462651|NCT02723864|520891712|FG001|Overall Study|Refused further treatment|0|||
144462652|NCT02723864|520891713|FG002|Overall Study|Refused further treatment|0|||
144462653|NCT02723864|520891714|FG003|Overall Study|Refused further treatment|0|||
144462654|NCT02723864|520891715|FG004|Overall Study|Refused further treatment|1|||
144462655|NCT02723864|520891716|FG005|Overall Study|Refused further treatment|2|||
144462656|NCT02723864|520891717|FG006|Overall Study|Refused further treatment|0|||
144462657|NCT02723864|520891711|FG000|Overall Study|Exceed treatment hold time|0|||
144462658|NCT02723864|520891712|FG001|Overall Study|Exceed treatment hold time|1|||
144462659|NCT02723864|520891713|FG002|Overall Study|Exceed treatment hold time|0|||
144462660|NCT02723864|520891714|FG003|Overall Study|Exceed treatment hold time|0|||
144462661|NCT02723864|520891715|FG004|Overall Study|Exceed treatment hold time|0|||
144462662|NCT02723864|520891716|FG005|Overall Study|Exceed treatment hold time|0|||
144462663|NCT02723864|520891717|FG006|Overall Study|Exceed treatment hold time|0|||
144462664|NCT02723864|520891711|FG000|Overall Study|Clinical progression|0|||
144462665|NCT02723864|520891712|FG001|Overall Study|Clinical progression|0|||
144462666|NCT02723864|520891713|FG002|Overall Study|Clinical progression|1|||
144462667|NCT02723864|520891714|FG003|Overall Study|Clinical progression|0|||
144462668|NCT02723864|520891715|FG004|Overall Study|Clinical progression|0|||
144462669|NCT02723864|520891716|FG005|Overall Study|Clinical progression|3|||
144462670|NCT02723864|520891717|FG006|Overall Study|Clinical progression|1|||
144462671|NCT02723864|520891711|FG000|Overall Study|Physician Decision|0|||
144462672|NCT02723864|520891712|FG001|Overall Study|Physician Decision|0|||
144462673|NCT02723864|520891713|FG002|Overall Study|Physician Decision|0|||
144462674|NCT02723864|520891714|FG003|Overall Study|Physician Decision|0|||
144462675|NCT02723864|520891715|FG004|Overall Study|Physician Decision|0|||
144462676|NCT02723864|520891716|FG005|Overall Study|Physician Decision|0|||
144462677|NCT02723864|520891717|FG006|Overall Study|Physician Decision|1|||
144462678|NCT02723864|520891711|FG000|Overall Study|Changes in patient condition|0|||
144462679|NCT02723864|520891712|FG001|Overall Study|Changes in patient condition|0|||
144462680|NCT02723864|520891713|FG002|Overall Study|Changes in patient condition|0|||
144462681|NCT02723864|520891714|FG003|Overall Study|Changes in patient condition|0|||
144462682|NCT02723864|520891715|FG004|Overall Study|Changes in patient condition|0|||
144462683|NCT02723864|520891716|FG005|Overall Study|Changes in patient condition|1|||
144462684|NCT02723864|520891717|FG006|Overall Study|Changes in patient condition|0|||
144462685|NCT02723864|520891711|FG000|Overall Study|Patient choice|0|||
144462686|NCT02723864|520891712|FG001|Overall Study|Patient choice|0|||
144462687|NCT02723864|520891713|FG002|Overall Study|Patient choice|0|||
144462688|NCT02723864|520891714|FG003|Overall Study|Patient choice|0|||
144462689|NCT02723864|520891715|FG004|Overall Study|Patient choice|0|||
144462690|NCT02723864|520891716|FG005|Overall Study|Patient choice|1|||
144462691|NCT02723864|520891717|FG006|Overall Study|Patient choice|0|||
144462692|NCT02723864|520891711|FG000|Overall Study|Adverse Event|0|||
144462693|NCT02723864|520891712|FG001|Overall Study|Adverse Event|0|||
144462694|NCT02723864|520891713|FG002|Overall Study|Adverse Event|0|||
144462695|NCT02723864|520891714|FG003|Overall Study|Adverse Event|0|||
144462696|NCT02723864|520891715|FG004|Overall Study|Adverse Event|0|||
144462697|NCT02723864|520891716|FG005|Overall Study|Adverse Event|1|||
144462698|NCT02723864|520891717|FG006|Overall Study|Adverse Event|0|||
144462699|NCT02723864|520891711|FG000|Overall Study|Started new treatment|0|||
144462700|NCT02723864|520891712|FG001|Overall Study|Started new treatment|0|||
144462701|NCT02723864|520891713|FG002|Overall Study|Started new treatment|0|||
144462702|NCT02723864|520891714|FG003|Overall Study|Started new treatment|0|||
144462703|NCT02723864|520891715|FG004|Overall Study|Started new treatment|0|||
144462704|NCT02723864|520891716|FG005|Overall Study|Started new treatment|1|||
144462705|NCT02723864|520891717|FG006|Overall Study|Started new treatment|0|||
144462706|NCT02723864|520891711|FG000|Overall Study|Switched to alternative treatment|0|||
144462707|NCT02723864|520891712|FG001|Overall Study|Switched to alternative treatment|0|||
144462708|NCT02723864|520891713|FG002|Overall Study|Switched to alternative treatment|0|||
144462709|NCT02723864|520891714|FG003|Overall Study|Switched to alternative treatment|0|||
144462710|NCT02723864|520891715|FG004|Overall Study|Switched to alternative treatment|0|||
144462711|NCT02723864|520891716|FG005|Overall Study|Switched to alternative treatment|1|||
144462712|NCT02723864|520891717|FG006|Overall Study|Switched to alternative treatment|0|||
144462713|NCT02723864|520891711|FG000|Overall Study|Late determination of ineligibility|0|||
144462714|NCT02723864|520891712|FG001|Overall Study|Late determination of ineligibility|0|||
144462715|NCT02723864|520891713|FG002|Overall Study|Late determination of ineligibility|0|||
144462716|NCT02723864|520891714|FG003|Overall Study|Late determination of ineligibility|0|||
144462717|NCT02723864|520891715|FG004|Overall Study|Late determination of ineligibility|0|||
144462718|NCT02723864|520891716|FG005|Overall Study|Late determination of ineligibility|1|||
144726025|NCT01345019|521852670|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
144462719|NCT02723864|520891717|FG006|Overall Study|Late determination of ineligibility|0|||
144462720|NCT02633800|520891722|FG000|Overall Study|Death|3|||
144462721|NCT02633800|520891723|FG001|Overall Study|Death|3|||
144462722|NCT02633800|520891722|FG000|Overall Study|Reason not provided|1|||
144462723|NCT02633800|520891723|FG001|Overall Study|Reason not provided|0|||
144610952|NCT03719690|521437200|FG001|Overall Study|Miscellaneous|56|||
144610953|NCT03719690|521437199|FG000|Overall Study|Lost to Follow-up|2|||
144610954|NCT03719690|521437200|FG001|Overall Study|Lost to Follow-up|18|||
144610955|NCT03719690|521437199|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
144610956|NCT03719690|521437200|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
144610957|NCT01278745|521437201|FG000|Overall Study|Death|2|||
144610958|NCT01278745|521437202|FG001|Overall Study|Death|5|||
144610959|NCT01278745|521437203|FG002|Overall Study|Death|7|||
144610960|NCT01278745|521437204|FG003|Overall Study|Death|0|||
144610961|NCT01278745|521437201|FG000|Overall Study|Physician Decision|1|||
144610962|NCT01278745|521437202|FG001|Overall Study|Physician Decision|0|||
144610963|NCT01278745|521437203|FG002|Overall Study|Physician Decision|0|||
144610964|NCT01278745|521437204|FG003|Overall Study|Physician Decision|9|||
144610965|NCT01278745|521437201|FG000|Overall Study|Withdrawal by Subject|1|||
144610966|NCT01278745|521437202|FG001|Overall Study|Withdrawal by Subject|1|||
144610967|NCT01278745|521437203|FG002|Overall Study|Withdrawal by Subject|5|||
144610968|NCT01278745|521437204|FG003|Overall Study|Withdrawal by Subject|1|||
144610969|NCT01278745|521437201|FG000|Overall Study|Sponsor Decision|1|||
144610970|NCT01278745|521437202|FG001|Overall Study|Sponsor Decision|0|||
144610971|NCT01278745|521437203|FG002|Overall Study|Sponsor Decision|62|||
144610972|NCT01278745|521437204|FG003|Overall Study|Sponsor Decision|6|||
144610973|NCT01278745|521437201|FG000|Overall Study|Ineligible|0|||
144610974|NCT01278745|521437202|FG001|Overall Study|Ineligible|0|||
144610975|NCT01278745|521437203|FG002|Overall Study|Ineligible|42|||
144610976|NCT01278745|521437204|FG003|Overall Study|Ineligible|61|||
144610977|NCT01278745|521437201|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
144610978|NCT01278745|521437202|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
144610979|NCT01278745|521437203|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
144610980|NCT01278745|521437204|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
144610981|NCT01148537|521437205|FG000|Overall Study|Withdrawal by Subject|1|||
144610982|NCT01148537|521437206|FG001|Overall Study|Withdrawal by Subject|0|||
144610983|NCT01148537|521437207|FG002|Overall Study|Withdrawal by Subject|2|||
144462724|NCT02633800|520891722|FG000|Overall Study|Radiologic(al) progression|23|||
144462725|NCT02633800|520891723|FG001|Overall Study|Radiologic(al) progression|23|||
144462726|NCT02633800|520891722|FG000|Overall Study|Clinical progression|3|||
144462727|NCT02633800|520891723|FG001|Overall Study|Clinical progression|6|||
144462728|NCT02633800|520891722|FG000|Overall Study|Study terminated by sponsor|6|||
144462729|NCT02633800|520891723|FG001|Overall Study|Study terminated by sponsor|5|||
144610984|NCT01148537|521437205|FG000|Overall Study|Adverse Event|2|||
144610985|NCT01148537|521437206|FG001|Overall Study|Adverse Event|0|||
144610986|NCT01148537|521437207|FG002|Overall Study|Adverse Event|1|||
144610987|NCT01471015|521437208|FG000|Overall Study|Death|0|||
144462730|NCT02633800|520891722|FG000|Overall Study|Adverse event, non-fatal|7|||
144462731|NCT02633800|520891723|FG001|Overall Study|Adverse event, non-fatal|2|||
144462732|NCT02633800|520891722|FG000|Overall Study|Withdrawal by Subject|0|||
144462733|NCT02633800|520891723|FG001|Overall Study|Withdrawal by Subject|3|||
144462734|NCT02633800|520891722|FG000|Overall Study|Patient Request|1|||
144462735|NCT02633800|520891723|FG001|Overall Study|Patient Request|1|||
144462736|NCT01733732|520891724|FG000|Overall Study|Adverse Event|1|||
144462737|NCT01733732|520891725|FG001|Overall Study|Adverse Event|0|||
144462738|NCT01733732|520891724|FG000|Overall Study|Did not attend all study visits|1|||
144462739|NCT01733732|520891725|FG001|Overall Study|Did not attend all study visits|0|||
144462740|NCT01358968|520891728|FG000|Period 2|Adverse Event|0|||
144462741|NCT01358968|520891729|FG001|Period 2|Adverse Event|1|||
144462742|NCT01358968|520891730|FG002|Period 2|Adverse Event|0|||
144462743|NCT01358968|520891731|FG003|Period 2|Adverse Event|0|||
144462744|NCT01358968|520891728|FG000|Continued Access Phase|Progression of Disease|0|||
144462745|NCT01358968|520891729|FG001|Continued Access Phase|Progression of Disease|0|||
144610988|NCT01471015|521437209|FG001|Overall Study|Death|1|||
144610989|NCT01471015|521437210|FG002|Overall Study|Death|1|||
144610990|NCT01843842|521437216|FG000|Overall Study|Do not meet inclusion criteria|1|||
144610991|NCT01843842|521437217|FG001|Overall Study|Do not meet inclusion criteria|1|||
144610992|NCT01376778|521437218|FG000|Overall Study|Lost to Follow-up|3|||
144610993|NCT01376778|521437219|FG001|Overall Study|Lost to Follow-up|2|||
144610994|NCT00454857|521437221|FG000|Overall Study|Withdrawal by Subject|15|||
144610995|NCT00454857|521437221|FG000|Overall Study|Lost to Follow-up|16|||
144610996|NCT00454857|521437221|FG000|Overall Study|Noncompliance|6|||
144610997|NCT00454857|521437221|FG000|Overall Study|Death|5|||
144610998|NCT00454857|521437221|FG000|Overall Study|Other|11|||
144610999|NCT00454857|521437221|FG000|Overall Study|Reason unknown|1|||
144611000|NCT00632099|521437224|FG000|Overall Study|Lost to Follow-up|3|||
144611001|NCT00632099|521437225|FG001|Overall Study|Lost to Follow-up|3|||
144611002|NCT04206605|521437240|FG000|Overall Study|Adverse Event|0|||
144611003|NCT04206605|521437241|FG001|Overall Study|Adverse Event|1|||
144611004|NCT04206605|521437240|FG000|Overall Study|Withdrawal by Subject|1|||
144611005|NCT04206605|521437241|FG001|Overall Study|Withdrawal by Subject|0|||
144611006|NCT00827606|521437242|FG000|Overall Study|Protocol Violation|4|||
144611007|NCT00827606|521437243|FG001|Overall Study|Protocol Violation|3|||
144611008|NCT00827606|521437242|FG000|Overall Study|Lost to Follow-up|3|||
144611009|NCT00827606|521437243|FG001|Overall Study|Lost to Follow-up|1|||
144611010|NCT00827606|521437242|FG000|Overall Study|Withdrawal by Subject|7|||
144611011|NCT00827606|521437243|FG001|Overall Study|Withdrawal by Subject|6|||
144611012|NCT00827606|521437242|FG000|Overall Study|Pregnancy|0|||
144611013|NCT00827606|521437243|FG001|Overall Study|Pregnancy|1|||
144611014|NCT00827606|521437242|FG000|Overall Study|Other|5|||
144611015|NCT00827606|521437243|FG001|Overall Study|Other|13|||
144611016|NCT00827606|521437242|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
144611017|NCT00827606|521437243|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
144611018|NCT00827606|521437242|FG000|Overall Study|Adverse Event|4|||
144611019|NCT00827606|521437243|FG001|Overall Study|Adverse Event|2|||
144611020|NCT04995055|521437246|FG000|Period 1|COVID-19 Related|1|||
144611021|NCT04995055|521437247|FG001|Period 1|COVID-19 Related|0|||
144611022|NCT04995055|521437246|FG000|Period 1|Withdrawal by Subject|0|||
144611023|NCT04995055|521437247|FG001|Period 1|Withdrawal by Subject|1|||
144611024|NCT04995055|521437246|FG000|Period 1|Subject discontinued due to timing|4|||
144611025|NCT04995055|521437247|FG001|Period 1|Subject discontinued due to timing|4|||
144611026|NCT00942175|521437249|FG000|Overall Study|Adverse Event|2|||
144611027|NCT00942175|521437250|FG001|Overall Study|Adverse Event|1|||
144611028|NCT00942175|521437251|FG002|Overall Study|Adverse Event|0|||
144611029|NCT00942175|521437252|FG003|Overall Study|Adverse Event|0|||
144611030|NCT00942175|521437249|FG000|Overall Study|Protocol Violation|0|||
144611031|NCT00942175|521437250|FG001|Overall Study|Protocol Violation|1|||
144611032|NCT00942175|521437251|FG002|Overall Study|Protocol Violation|2|||
144462746|NCT01358968|520891730|FG002|Continued Access Phase|Progression of Disease|8|||
144611033|NCT00942175|521437252|FG003|Overall Study|Protocol Violation|0|||
144611034|NCT00942175|521437249|FG000|Overall Study|Pregnancy|0|||
144611035|NCT00942175|521437250|FG001|Overall Study|Pregnancy|0|||
144611036|NCT00942175|521437251|FG002|Overall Study|Pregnancy|0|||
144611037|NCT00942175|521437252|FG003|Overall Study|Pregnancy|1|||
144611038|NCT00942175|521437249|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
144611039|NCT00942175|521437250|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
144611040|NCT00942175|521437251|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
144611041|NCT00942175|521437252|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
144611042|NCT00942175|521437249|FG000|Overall Study|Low Platelet Count|0|||
144611043|NCT00942175|521437250|FG001|Overall Study|Low Platelet Count|2|||
144197222|NCT03096847|519918714|FG002|Overall Study|Withdrawal by Subject|12|||
144611044|NCT00942175|521437251|FG002|Overall Study|Low Platelet Count|0|||
144462747|NCT01358968|520891731|FG003|Continued Access Phase|Progression of Disease|4|||
144462748|NCT01358968|520891728|FG000|Continued Access Phase|Protocol Violation|0|||
144611045|NCT00942175|521437252|FG003|Overall Study|Low Platelet Count|0|||
144611046|NCT01066585|521437253|FG000|Overall Study|Protocol Violation|1|||
144462749|NCT01358968|520891729|FG001|Continued Access Phase|Protocol Violation|0|||
144462750|NCT01358968|520891730|FG002|Continued Access Phase|Protocol Violation|0|||
144462751|NCT01358968|520891731|FG003|Continued Access Phase|Protocol Violation|2|||
144462752|NCT01358968|520891728|FG000|Continued Access Phase|Withdrawal by Subject|0|||
144462753|NCT01358968|520891729|FG001|Continued Access Phase|Withdrawal by Subject|0|||
144462754|NCT01358968|520891730|FG002|Continued Access Phase|Withdrawal by Subject|3|||
144462755|NCT01358968|520891731|FG003|Continued Access Phase|Withdrawal by Subject|0|||
144462756|NCT01358968|520891728|FG000|Continued Access Phase|Death|0|||
144462757|NCT01358968|520891729|FG001|Continued Access Phase|Death|0|||
144462758|NCT01358968|520891730|FG002|Continued Access Phase|Death|1|||
144462759|NCT01358968|520891731|FG003|Continued Access Phase|Death|1|||
144462760|NCT04052204|520891734|FG000|Overall Study|Death|1|||
144462761|NCT04052204|520891735|FG001|Overall Study|Death|0|||
144462762|NCT04052204|520891736|FG002|Overall Study|Death|0|||
144462763|NCT04052204|520891734|FG000|Overall Study|Progressive disease|1|||
144462764|NCT04052204|520891735|FG001|Overall Study|Progressive disease|0|||
144462765|NCT04052204|520891736|FG002|Overall Study|Progressive disease|0|||
144462766|NCT04052204|520891734|FG000|Overall Study|Other|1|||
144462767|NCT04052204|520891735|FG001|Overall Study|Other|0|||
144462768|NCT04052204|520891736|FG002|Overall Study|Other|0|||
144462769|NCT04794803|520891755|FG000|Overall Study|Death|1|||
144462770|NCT04794803|520891756|FG001|Overall Study|Death|3|||
144462771|NCT04794803|520891755|FG000|Overall Study|Lost to Follow-up|2|||
144462772|NCT04794803|520891756|FG001|Overall Study|Lost to Follow-up|2|||
144462773|NCT04794803|520891755|FG000|Overall Study|Withdrawal by Subject|1|||
144462774|NCT04794803|520891756|FG001|Overall Study|Withdrawal by Subject|0|||
144462775|NCT04794803|520891755|FG000|Overall Study|Physician Decision|1|||
144257902|NCT01896193|520146886|FG000|Overall Study|Protocol Violation|0|||
144257903|NCT01896193|520146887|FG001|Overall Study|Protocol Violation|1|||
144257904|NCT01896193|520146886|FG000|Overall Study|Withdrew Consent|1|||
144257905|NCT01896193|520146887|FG001|Overall Study|Withdrew Consent|0|||
144257906|NCT00807612|520146889|FG000|Overall Study|Death|8|||
144257907|NCT00807612|520146889|FG000|Overall Study|Study early termination|5|||
144257908|NCT00807612|520146889|FG000|Overall Study|Withdrawal by Subject|1|||
144257909|NCT04607135|520146891|FG000|Overall Study|Physician Decision|1|||
144462776|NCT04794803|520891756|FG001|Overall Study|Physician Decision|1|||
144462777|NCT04794803|520891755|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
144462778|NCT04794803|520891756|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
144462779|NCT04794803|520891755|FG000|Overall Study|Refused to continue the treatment|1|||
144462780|NCT04794803|520891756|FG001|Overall Study|Refused to continue the treatment|0|||
144462781|NCT04794803|520891755|FG000|Overall Study|Patient admitted to ICU|0|||
144462782|NCT04794803|520891756|FG001|Overall Study|Patient admitted to ICU|1|||
144462783|NCT00476476|520891757|FG000|Overall Study|Adverse Event|2|||
144462784|NCT00476476|520891758|FG001|Overall Study|Adverse Event|7|||
144462785|NCT00476476|520891757|FG000|Overall Study|Progressive Disease|0|||
144462786|NCT00476476|520891758|FG001|Overall Study|Progressive Disease|17|||
144462787|NCT01618162|520891759|FG000|Overall Study|Protocol Violation|13|||
144462788|NCT01618162|520891760|FG001|Overall Study|Protocol Violation|10|||
144462789|NCT01618162|520891759|FG000|Overall Study|Adverse Event|9|||
144462790|NCT01618162|520891760|FG001|Overall Study|Adverse Event|2|||
144462791|NCT01618162|520891759|FG000|Overall Study|Withdrawal Criteria|2|||
144462792|NCT01618162|520891760|FG001|Overall Study|Withdrawal Criteria|10|||
144462793|NCT01618162|520891759|FG000|Overall Study|Unclassified|14|||
144462794|NCT01618162|520891760|FG001|Overall Study|Unclassified|13|||
144462795|NCT04124926|520891761|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
144462796|NCT04124926|520891762|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
144462797|NCT04124926|520891763|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
144462798|NCT04124926|520891764|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
144462799|NCT04124926|520891765|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
144462800|NCT04124926|520891761|FG000|Healing Phase|Protocol Violation|0|||
144462801|NCT04124926|520891762|FG001|Healing Phase|Protocol Violation|1|||
144462802|NCT04124926|520891763|FG002|Healing Phase|Protocol Violation|0|||
144462803|NCT04124926|520891764|FG003|Healing Phase|Protocol Violation|0|||
144462804|NCT04124926|520891765|FG004|Healing Phase|Protocol Violation|0|||
144535796|NCT02719574|521166077|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535797|NCT02719574|521166078|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535798|NCT02719574|521166079|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535799|NCT02719574|521166080|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535800|NCT02719574|521166081|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144535801|NCT02719574|521166082|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
144257910|NCT04607135|520146891|FG000|Overall Study|Withdrawal by Subject|1|||
144462805|NCT04124926|520891761|FG000|Healing Phase|Lost to Follow-up|5|||
144462806|NCT04124926|520891762|FG001|Healing Phase|Lost to Follow-up|4|||
144462807|NCT04124926|520891763|FG002|Healing Phase|Lost to Follow-up|0|||
144462808|NCT04124926|520891764|FG003|Healing Phase|Lost to Follow-up|0|||
144462809|NCT04124926|520891765|FG004|Healing Phase|Lost to Follow-up|0|||
144257911|NCT04607135|520146891|FG000|Overall Study|Equipment not working|3|||
144462810|NCT04124926|520891761|FG000|Healing Phase|Voluntary Withdrawal|10|||
144462811|NCT04124926|520891762|FG001|Healing Phase|Voluntary Withdrawal|7|||
144462812|NCT04124926|520891763|FG002|Healing Phase|Voluntary Withdrawal|0|||
144462813|NCT04124926|520891764|FG003|Healing Phase|Voluntary Withdrawal|0|||
144462814|NCT04124926|520891765|FG004|Healing Phase|Voluntary Withdrawal|0|||
144462815|NCT04124926|520891761|FG000|Healing Phase|Withdrawal of Consent|5|||
144462816|NCT04124926|520891762|FG001|Healing Phase|Withdrawal of Consent|3|||
144462817|NCT04124926|520891763|FG002|Healing Phase|Withdrawal of Consent|0|||
144462818|NCT04124926|520891764|FG003|Healing Phase|Withdrawal of Consent|0|||
144462819|NCT04124926|520891765|FG004|Healing Phase|Withdrawal of Consent|0|||
144462820|NCT04124926|520891761|FG000|Healing Phase|Miscellaneous|8|||
144462821|NCT04124926|520891762|FG001|Healing Phase|Miscellaneous|7|||
144462822|NCT04124926|520891763|FG002|Healing Phase|Miscellaneous|0|||
144462823|NCT04124926|520891764|FG003|Healing Phase|Miscellaneous|0|||
144462824|NCT04124926|520891765|FG004|Healing Phase|Miscellaneous|0|||
144462825|NCT04124926|520891761|FG000|Healing Phase|Randomized but not Treated|0|||
144462826|NCT04124926|520891762|FG001|Healing Phase|Randomized but not Treated|3|||
144462827|NCT04124926|520891763|FG002|Healing Phase|Randomized but not Treated|0|||
144462828|NCT04124926|520891764|FG003|Healing Phase|Randomized but not Treated|0|||
144462829|NCT04124926|520891765|FG004|Healing Phase|Randomized but not Treated|0|||
144462830|NCT04124926|520891761|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
144462831|NCT04124926|520891762|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
144462832|NCT04124926|520891763|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
144462833|NCT04124926|520891764|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
144462834|NCT04124926|520891765|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
144462835|NCT04124926|520891761|FG000|Maintenance Phase|Protocol Violation|0|||
144462836|NCT04124926|520891762|FG001|Maintenance Phase|Protocol Violation|0|||
144462837|NCT04124926|520891763|FG002|Maintenance Phase|Protocol Violation|3|||
144462838|NCT04124926|520891764|FG003|Maintenance Phase|Protocol Violation|0|||
144462839|NCT04124926|520891765|FG004|Maintenance Phase|Protocol Violation|0|||
144462840|NCT04124926|520891761|FG000|Maintenance Phase|Lost to Follow-up|0|||
144462841|NCT04124926|520891762|FG001|Maintenance Phase|Lost to Follow-up|0|||
144462842|NCT04124926|520891763|FG002|Maintenance Phase|Lost to Follow-up|7|||
144462843|NCT04124926|520891764|FG003|Maintenance Phase|Lost to Follow-up|8|||
144462844|NCT04124926|520891765|FG004|Maintenance Phase|Lost to Follow-up|9|||
144462845|NCT04124926|520891761|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
144462846|NCT04124926|520891762|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
144462847|NCT04124926|520891763|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
144462848|NCT04124926|520891764|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
144462849|NCT04124926|520891765|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
144462850|NCT04124926|520891761|FG000|Maintenance Phase|Pregnancy|0|||
144462851|NCT04124926|520891762|FG001|Maintenance Phase|Pregnancy|0|||
144462852|NCT04124926|520891763|FG002|Maintenance Phase|Pregnancy|0|||
144462853|NCT04124926|520891764|FG003|Maintenance Phase|Pregnancy|1|||
144462854|NCT04124926|520891765|FG004|Maintenance Phase|Pregnancy|0|||
144462855|NCT04124926|520891761|FG000|Maintenance Phase|Lack of Efficacy|0|||
144462856|NCT04124926|520891762|FG001|Maintenance Phase|Lack of Efficacy|0|||
144462857|NCT04124926|520891763|FG002|Maintenance Phase|Lack of Efficacy|0|||
144462858|NCT04124926|520891764|FG003|Maintenance Phase|Lack of Efficacy|0|||
144462859|NCT04124926|520891765|FG004|Maintenance Phase|Lack of Efficacy|1|||
144462860|NCT04124926|520891761|FG000|Maintenance Phase|Withdrawal of Consent|0|||
144462861|NCT04124926|520891762|FG001|Maintenance Phase|Withdrawal of Consent|0|||
144462862|NCT04124926|520891763|FG002|Maintenance Phase|Withdrawal of Consent|5|||
144462863|NCT04124926|520891764|FG003|Maintenance Phase|Withdrawal of Consent|5|||
144462864|NCT04124926|520891765|FG004|Maintenance Phase|Withdrawal of Consent|5|||
144462865|NCT04124926|520891761|FG000|Maintenance Phase|Miscellaneous|0|||
144462866|NCT04124926|520891762|FG001|Maintenance Phase|Miscellaneous|0|||
144462867|NCT04124926|520891763|FG002|Maintenance Phase|Miscellaneous|1|||
144462868|NCT04124926|520891764|FG003|Maintenance Phase|Miscellaneous|2|||
144462869|NCT04124926|520891765|FG004|Maintenance Phase|Miscellaneous|4|||
144462870|NCT04124926|520891761|FG000|Maintenance Phase|Randomized but not Treated|0|||
144462871|NCT04124926|520891762|FG001|Maintenance Phase|Randomized but not Treated|0|||
144462872|NCT04124926|520891763|FG002|Maintenance Phase|Randomized but not Treated|2|||
144611047|NCT01066585|521437254|FG001|Overall Study|Protocol Violation|0|||
144462873|NCT04124926|520891764|FG003|Maintenance Phase|Randomized but not Treated|2|||
144462874|NCT04124926|520891765|FG004|Maintenance Phase|Randomized but not Treated|0|||
144462875|NCT00971048|520891769|FG000|Overall Study|Protocol Violation|1|||
144462876|NCT00971048|520891770|FG001|Overall Study|Protocol Violation|2|||
144462877|NCT00971048|520891771|FG002|Overall Study|Protocol Violation|0|||
144462878|NCT00971048|520891772|FG003|Overall Study|Protocol Violation|1|||
144462879|NCT00971048|520891769|FG000|Overall Study|Adverse Event|0|||
144462880|NCT00971048|520891770|FG001|Overall Study|Adverse Event|0|||
144462881|NCT00971048|520891771|FG002|Overall Study|Adverse Event|1|||
144611048|NCT01066585|521437253|FG000|Overall Study|Withdrawal by Subject|0|||
144611049|NCT01066585|521437254|FG001|Overall Study|Withdrawal by Subject|3|||
144197223|NCT03096847|519918712|FG000|Overall Study|Adverse Event|72|||
144462882|NCT00971048|520891772|FG003|Overall Study|Adverse Event|0|||
144462883|NCT00971048|520891769|FG000|Overall Study|Physician Decision|0|||
144462884|NCT00971048|520891770|FG001|Overall Study|Physician Decision|0|||
144462885|NCT00971048|520891771|FG002|Overall Study|Physician Decision|0|||
144462886|NCT00971048|520891772|FG003|Overall Study|Physician Decision|1|||
144462887|NCT02013622|520891780|FG000|Overall Study|Lost to Follow-up|10|||
144462888|NCT02013622|520891780|FG000|Overall Study|Adverse Event|3|||
144462889|NCT02013622|520891780|FG000|Overall Study|Met Withdrawal Criteria|3|||
144462890|NCT02013622|520891780|FG000|Overall Study|Withdrawal by Subject|6|||
144462891|NCT02013622|520891780|FG000|Overall Study|Protocol Deviation|1|||
144462892|NCT02013622|520891780|FG000|Overall Study|Lack of Efficacy|1|||
144462893|NCT03644186|520891781|FG000|Overall Study|Withdrawal by Subject|1|||
144462894|NCT03644186|520891782|FG001|Overall Study|Withdrawal by Subject|1|||
144462895|NCT02701985|520891785|FG000|Overall Study|Withdrawal by Subject|1|||
144462896|NCT02701985|520891786|FG001|Overall Study|Withdrawal by Subject|1|||
144462897|NCT02701985|520891785|FG000|Overall Study|Lost to Follow-up|1|||
144462898|NCT02701985|520891786|FG001|Overall Study|Lost to Follow-up|0|||
144462899|NCT02701985|520891785|FG000|Overall Study|Death|1|||
144462900|NCT02701985|520891786|FG001|Overall Study|Death|0|||
144462901|NCT02701985|520891785|FG000|Overall Study|Adverse Event|0|||
144462902|NCT02701985|520891786|FG001|Overall Study|Adverse Event|5|||
144462903|NCT04391023|520891787|FG000|Overall Study|Withdrawal by Subject|2|||
144462904|NCT04391023|520891788|FG001|Overall Study|Withdrawal by Subject|2|||
144462905|NCT02085408|520891792|FG000|Step 1: Induction|Disease Progression|19|||
144462906|NCT02085408|520891793|FG001|Step 1: Induction|Disease Progression|19|||
144462907|NCT02085408|520891792|FG000|Step 1: Induction|Adverse Event|18|||
144462908|NCT02085408|520891793|FG001|Step 1: Induction|Adverse Event|17|||
144462909|NCT02085408|520891792|FG000|Step 1: Induction|Death|33|||
144462910|NCT02085408|520891793|FG001|Step 1: Induction|Death|30|||
144462911|NCT02085408|520891792|FG000|Step 1: Induction|Withdrawal by Subject|16|||
144462912|NCT02085408|520891793|FG001|Step 1: Induction|Withdrawal by Subject|8|||
144462913|NCT02085408|520891792|FG000|Step 1: Induction|Alternative Therapy|15|||
144462914|NCT02085408|520891793|FG001|Step 1: Induction|Alternative Therapy|19|||
144462915|NCT02085408|520891792|FG000|Step 1: Induction|Complicating Disease|2|||
144462916|NCT02085408|520891793|FG001|Step 1: Induction|Complicating Disease|3|||
144462917|NCT02085408|520891792|FG000|Step 1: Induction|Other|27|||
144462918|NCT02085408|520891793|FG001|Step 1: Induction|Other|39|||
144462919|NCT02085408|520891792|FG000|Step 1: Induction|Never started treatment|6|||
144462920|NCT02085408|520891793|FG001|Step 1: Induction|Never started treatment|4|||
144462921|NCT02085408|520891792|FG000|Step 2: Consolidation|Disease Progression|5|||
144462922|NCT02085408|520891793|FG001|Step 2: Consolidation|Disease Progression|20|||
144462923|NCT02085408|520891792|FG000|Step 2: Consolidation|Adverse Event|9|||
144462924|NCT02085408|520891793|FG001|Step 2: Consolidation|Adverse Event|8|||
144462925|NCT02085408|520891792|FG000|Step 2: Consolidation|Death|4|||
144462926|NCT02085408|520891793|FG001|Step 2: Consolidation|Death|3|||
144462927|NCT02085408|520891792|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
144462928|NCT02085408|520891793|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
144462929|NCT02085408|520891792|FG000|Step 2: Consolidation|Alternative Therapy|9|||
144462930|NCT02085408|520891793|FG001|Step 2: Consolidation|Alternative Therapy|3|||
144462931|NCT02085408|520891792|FG000|Step 2: Consolidation|Complicating Disease|0|||
144462932|NCT02085408|520891793|FG001|Step 2: Consolidation|Complicating Disease|2|||
144462933|NCT02085408|520891792|FG000|Step 2: Consolidation|Other|6|||
144462934|NCT02085408|520891793|FG001|Step 2: Consolidation|Other|6|||
144462935|NCT02085408|520891792|FG000|Step 2: Consolidation|Never started treatment|4|||
144611050|NCT00884273|521437257|FG000|Overall Study|Adverse Event|0|||
144611051|NCT00884273|521437258|FG001|Overall Study|Adverse Event|2|||
144611052|NCT00884273|521437257|FG000|Overall Study|Protocol Violation|1|||
144611053|NCT00884273|521437258|FG001|Overall Study|Protocol Violation|3|||
144611054|NCT00884273|521437257|FG000|Overall Study|Practical reasons|1|||
144197224|NCT03096847|519918713|FG001|Overall Study|Adverse Event|6|||
144197225|NCT03096847|519918714|FG002|Overall Study|Adverse Event|28|||
144197226|NCT03096847|519918712|FG000|Overall Study|Progressive disease|97|||
144197227|NCT03096847|519918713|FG001|Overall Study|Progressive disease|10|||
144197228|NCT03096847|519918714|FG002|Overall Study|Progressive disease|78|||
144197229|NCT03096847|519918712|FG000|Overall Study|Non-compliance with study medication|1|||
144197230|NCT03096847|519918713|FG001|Overall Study|Non-compliance with study medication|0|||
144197231|NCT03096847|519918714|FG002|Overall Study|Non-compliance with study medication|0|||
144197232|NCT03096847|519918712|FG000|Overall Study|New therapy for study indication|1|||
144197233|NCT03096847|519918713|FG001|Overall Study|New therapy for study indication|0|||
144462936|NCT02085408|520891793|FG001|Step 2: Consolidation|Never started treatment|3|||
144462937|NCT02085408|520891792|FG000|Step 3: Maintenance|Disease Progression|13|||
144462938|NCT02085408|520891793|FG001|Step 3: Maintenance|Disease Progression|11|||
144462939|NCT02085408|520891792|FG000|Step 3: Maintenance|Adverse Event|2|||
144462940|NCT02085408|520891793|FG001|Step 3: Maintenance|Adverse Event|4|||
144197234|NCT03096847|519918714|FG002|Overall Study|New therapy for study indication|1|||
144197235|NCT01000493|519918715|FG000|Overall Study|Adverse Event|3|||
144462941|NCT02085408|520891792|FG000|Step 3: Maintenance|Death|1|||
144462942|NCT02085408|520891793|FG001|Step 3: Maintenance|Death|2|||
144462943|NCT02085408|520891792|FG000|Step 3: Maintenance|Alternative Therapy|1|||
144462944|NCT02085408|520891793|FG001|Step 3: Maintenance|Alternative Therapy|1|||
144462945|NCT02085408|520891792|FG000|Step 3: Maintenance|Complicating Disease|0|||
144462946|NCT02085408|520891793|FG001|Step 3: Maintenance|Complicating Disease|1|||
144462947|NCT02085408|520891792|FG000|Step 3: Maintenance|Other|3|||
144611055|NCT00884273|521437258|FG001|Overall Study|Practical reasons|0|||
144611056|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
144462948|NCT02085408|520891793|FG001|Step 3: Maintenance|Other|2|||
144462949|NCT02085408|520891792|FG000|Step 3: Maintenance|Never started treatment|5|||
144462950|NCT02085408|520891793|FG001|Step 3: Maintenance|Never started treatment|1|||
144462951|NCT02189798|520891794|FG000|Extended Use Phase|Withdrawal by Subject|0|||
144462952|NCT02189798|520891795|FG001|Extended Use Phase|Withdrawal by Subject|4|||
144462953|NCT02189798|520891794|FG000|Extended Use Phase|Physician Decision|1|||
144462954|NCT02189798|520891795|FG001|Extended Use Phase|Physician Decision|0|||
144462955|NCT02189798|520891794|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
144462956|NCT02189798|520891795|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
144462957|NCT02189798|520891794|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
144462958|NCT02189798|520891795|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
144462959|NCT02189798|520891794|FG000|Extended Use Phase|Travel Issues|2|||
144462960|NCT02189798|520891795|FG001|Extended Use Phase|Travel Issues|1|||
144462961|NCT02189798|520891794|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
144462962|NCT02189798|520891795|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
144462963|NCT05553808|520891798|FG000|Overall Study|Death|25|||
144462964|NCT05553808|520891799|FG001|Overall Study|Death|62|||
144462965|NCT05553808|520891798|FG000|Overall Study|Site Closed|6|||
144462966|NCT05553808|520891799|FG001|Overall Study|Site Closed|6|||
144462967|NCT05553808|520891798|FG000|Overall Study|Lost to Follow-up|1|||
144462968|NCT05553808|520891799|FG001|Overall Study|Lost to Follow-up|0|||
144462969|NCT05553808|520891798|FG000|Overall Study|Withdrawal by Subject|3|||
144462970|NCT05553808|520891799|FG001|Overall Study|Withdrawal by Subject|2|||
144462971|NCT01388816|520891803|FG000|Overall Study|Adverse Event|0|||
144462972|NCT01388816|520891804|FG001|Overall Study|Adverse Event|2|||
144462973|NCT01388816|520891805|FG002|Overall Study|Adverse Event|0|||
144462974|NCT01388816|520891806|FG003|Overall Study|Adverse Event|0|||
144462975|NCT01388816|520891803|FG000|Overall Study|Lost to Follow-up|0|||
144462976|NCT01388816|520891804|FG001|Overall Study|Lost to Follow-up|1|||
144462977|NCT01388816|520891805|FG002|Overall Study|Lost to Follow-up|0|||
144462978|NCT01388816|520891806|FG003|Overall Study|Lost to Follow-up|0|||
144462979|NCT01388816|520891803|FG000|Overall Study|Withdrawal by Subject|2|||
144462980|NCT01388816|520891804|FG001|Overall Study|Withdrawal by Subject|1|||
144462981|NCT01388816|520891805|FG002|Overall Study|Withdrawal by Subject|1|||
144462982|NCT01388816|520891806|FG003|Overall Study|Withdrawal by Subject|0|||
144535802|NCT02719574|521166066|FG000|Phase 1 (Dose Expansion)|Death|0|||
144535803|NCT02719574|521166067|FG001|Phase 1 (Dose Expansion)|Death|0|||
144535804|NCT02719574|521166068|FG002|Phase 1 (Dose Expansion)|Death|0|||
144535805|NCT02719574|521166069|FG003|Phase 1 (Dose Expansion)|Death|0|||
144535806|NCT02719574|521166070|FG004|Phase 1 (Dose Expansion)|Death|0|||
144535807|NCT02719574|521166071|FG005|Phase 1 (Dose Expansion)|Death|0|||
144535808|NCT02719574|521166072|FG006|Phase 1 (Dose Expansion)|Death|1|||
144535809|NCT02719574|521166073|FG007|Phase 1 (Dose Expansion)|Death|6|||
144535810|NCT02719574|521166074|FG008|Phase 1 (Dose Expansion)|Death|0|||
144535811|NCT02719574|521166075|FG009|Phase 1 (Dose Expansion)|Death|0|||
144535812|NCT02719574|521166076|FG010|Phase 1 (Dose Expansion)|Death|0|||
144535813|NCT02719574|521166077|FG011|Phase 1 (Dose Expansion)|Death|0|||
144535814|NCT02719574|521166078|FG012|Phase 1 (Dose Expansion)|Death|0|||
144535815|NCT02719574|521166079|FG013|Phase 1 (Dose Expansion)|Death|0|||
144535816|NCT02719574|521166080|FG014|Phase 1 (Dose Expansion)|Death|0|||
144535817|NCT02719574|521166081|FG015|Phase 1 (Dose Expansion)|Death|0|||
144535818|NCT02719574|521166082|FG016|Phase 1 (Dose Expansion)|Death|0|||
144535819|NCT02719574|521166066|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
144462983|NCT01388816|520891803|FG000|Overall Study|Protocol Violation|0|||
144462984|NCT01388816|520891804|FG001|Overall Study|Protocol Violation|0|||
144462985|NCT01388816|520891805|FG002|Overall Study|Protocol Violation|2|||
144462986|NCT01388816|520891806|FG003|Overall Study|Protocol Violation|0|||
144462987|NCT03206203|520891810|FG000|Treatment|Death|38|||
144462988|NCT03206203|520891811|FG001|Treatment|Death|26|||
144462989|NCT03206203|520891812|FG002|Treatment|Death|0|||
144462990|NCT03206203|520891810|FG000|Treatment|Withdrawal by Subject|1|||
144462991|NCT03206203|520891811|FG001|Treatment|Withdrawal by Subject|0|||
144462992|NCT03206203|520891812|FG002|Treatment|Withdrawal by Subject|0|||
144462993|NCT03206203|520891810|FG000|Treatment|Lost to Follow-up|4|||
144462994|NCT03206203|520891811|FG001|Treatment|Lost to Follow-up|0|||
144535820|NCT02719574|521166067|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535821|NCT02719574|521166068|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535822|NCT02719574|521166069|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535823|NCT02719574|521166070|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
144611057|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
144257912|NCT03465709|520146892|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
144257913|NCT03465709|520146892|FG000|Overall Study|Withdrawal by Subject|3|||
144257914|NCT04892446|520146893|FG000|Overall Study|Death|4|||
144257915|NCT04892446|520146894|FG001|Overall Study|Death|4|||
144257916|NCT04892446|520146895|FG002|Overall Study|Death|0|||
144257917|NCT04892446|520146893|FG000|Overall Study|Withdrew consent|3|||
144257918|NCT04892446|520146894|FG001|Overall Study|Withdrew consent|0|||
144257919|NCT04892446|520146895|FG002|Overall Study|Withdrew consent|1|||
144257920|NCT04892446|520146893|FG000|Overall Study|Investigator's discretion|1|||
144257921|NCT04892446|520146894|FG001|Overall Study|Investigator's discretion|1|||
144257922|NCT04892446|520146895|FG002|Overall Study|Investigator's discretion|0|||
144257923|NCT04892446|520146893|FG000|Overall Study|Study terminated by sponsor|0|||
144257924|NCT04892446|520146894|FG001|Overall Study|Study terminated by sponsor|0|||
144257925|NCT04892446|520146895|FG002|Overall Study|Study terminated by sponsor|2|||
144257926|NCT03193047|520146897|FG000|Overall Study|Physician Decision|1|||
144257927|NCT03193047|520146898|FG001|Overall Study|Physician Decision|0|||
144257928|NCT03193047|520146897|FG000|Overall Study|Participant Left State|1|||
144257929|NCT03193047|520146898|FG001|Overall Study|Participant Left State|0|||
144257930|NCT00705341|520146899|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
144257931|NCT00705341|520146900|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
144257932|NCT00705341|520146901|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
144257933|NCT00705341|520146902|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
144257934|NCT00705341|520146899|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
144257935|NCT00705341|520146900|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
144257936|NCT00705341|520146901|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
144257937|NCT00705341|520146902|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
144257938|NCT02585713|520146906|FG000|Overall Study|Withdrew prior to treatment|2|||
144257939|NCT02585713|520146907|FG001|Overall Study|Withdrew prior to treatment|7|||
144257940|NCT02585713|520146906|FG000|Overall Study|Other|3|||
144257941|NCT02585713|520146907|FG001|Overall Study|Other|1|||
144257942|NCT03173456|520146908|FG000|Baseline|Medication dispensing system malfunction'|0|||
144257943|NCT03173456|520146909|FG001|Baseline|Medication dispensing system malfunction'|1|||
144257944|NCT03173456|520146910|FG002|Baseline|Medication dispensing system malfunction'|0|||
144257945|NCT03173456|520146911|FG003|Baseline|Medication dispensing system malfunction'|0|||
144257946|NCT03173456|520146912|FG004|Baseline|Medication dispensing system malfunction'|2|||
144257947|NCT03173456|520146908|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
144257948|NCT03173456|520146909|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
144257949|NCT03173456|520146910|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
144257950|NCT03173456|520146911|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
144257951|NCT03173456|520146912|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
144257952|NCT01733121|520146913|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
144257953|NCT01733121|520146914|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
144257954|NCT01733121|520146913|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
144257955|NCT01733121|520146914|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
144257956|NCT01733121|520146913|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
144257957|NCT01733121|520146914|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
144462995|NCT03206203|520891812|FG002|Treatment|Lost to Follow-up|0|||
144462996|NCT03206203|520891810|FG000|Treatment|N/A in Follow-Up|8|||
144462997|NCT03206203|520891811|FG001|Treatment|N/A in Follow-Up|1|||
144462998|NCT03206203|520891812|FG002|Treatment|N/A in Follow-Up|0|||
144462999|NCT03206203|520891810|FG000|Treatment|Disease progression|0|||
144463000|NCT03206203|520891811|FG001|Treatment|Disease progression|1|||
144463001|NCT03206203|520891812|FG002|Treatment|Disease progression|0|||
144463002|NCT03206203|520891810|FG000|Treatment|Refused follow-up|0|||
144535824|NCT02719574|521166071|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535825|NCT02719574|521166072|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
144535826|NCT02719574|521166073|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
144535827|NCT02719574|521166074|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535828|NCT02719574|521166075|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535829|NCT02719574|521166076|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535830|NCT02719574|521166077|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535831|NCT02719574|521166078|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535832|NCT02719574|521166079|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535833|NCT02719574|521166080|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
144535834|NCT02719574|521166081|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
144257958|NCT01733121|520146913|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
144463003|NCT03206203|520891811|FG001|Treatment|Refused follow-up|1|||
144463004|NCT03206203|520891812|FG002|Treatment|Refused follow-up|0|||
144535835|NCT02719574|521166082|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
144257959|NCT01733121|520146914|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
144257960|NCT03061188|520146917|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
144257961|NCT03061188|520146918|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
144257962|NCT03061188|520146919|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
144463005|NCT03206203|520891810|FG000|Treatment|Cross over to Arm 1|0|||
144611058|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
144611059|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
144463006|NCT03206203|520891811|FG001|Treatment|Cross over to Arm 1|19|||
144463007|NCT03206203|520891812|FG002|Treatment|Cross over to Arm 1|0|||
144463008|NCT03206203|520891810|FG000|Optional Cross-Over|Death|0|||
144463009|NCT03206203|520891811|FG001|Optional Cross-Over|Death|0|||
144463010|NCT03206203|520891812|FG002|Optional Cross-Over|Death|14|||
144463011|NCT03206203|520891810|FG000|Optional Cross-Over|Refused follow-up|0|||
144463012|NCT03206203|520891811|FG001|Optional Cross-Over|Refused follow-up|0|||
144463013|NCT03206203|520891812|FG002|Optional Cross-Over|Refused follow-up|2|||
144463014|NCT03998618|520891813|FG000|Overall Study|Death|7|||
144463015|NCT03998618|520891814|FG001|Overall Study|Death|11|||
144463016|NCT03998618|520891813|FG000|Overall Study|hospice enrollment|3|||
144463017|NCT03998618|520891814|FG001|Overall Study|hospice enrollment|3|||
144463018|NCT03998618|520891813|FG000|Overall Study|Not feeling well/health problems|3|||
144463019|NCT03998618|520891814|FG001|Overall Study|Not feeling well/health problems|5|||
144463020|NCT03998618|520891813|FG000|Overall Study|Lost to Follow-up|6|||
144463021|NCT03998618|520891814|FG001|Overall Study|Lost to Follow-up|6|||
144463022|NCT03998618|520891813|FG000|Overall Study|Withdrawal by Subject|0|||
144463023|NCT03998618|520891814|FG001|Overall Study|Withdrawal by Subject|4|||
144463024|NCT01483924|520891815|FG000|Overall Study|Withdrawal by Subject|2|||
144463025|NCT01483924|520891816|FG001|Overall Study|Withdrawal by Subject|0|||
144463026|NCT01483924|520891817|FG002|Overall Study|Withdrawal by Subject|0|||
144463027|NCT01483924|520891818|FG003|Overall Study|Withdrawal by Subject|1|||
144463028|NCT01483924|520891819|FG004|Overall Study|Withdrawal by Subject|1|||
144463029|NCT01483924|520891815|FG000|Overall Study|Adverse Event|0|||
144463030|NCT01483924|520891816|FG001|Overall Study|Adverse Event|0|||
144463031|NCT01483924|520891817|FG002|Overall Study|Adverse Event|1|||
144463032|NCT01483924|520891818|FG003|Overall Study|Adverse Event|1|||
144463033|NCT01483924|520891819|FG004|Overall Study|Adverse Event|0|||
144463034|NCT01483924|520891815|FG000|Overall Study|Non-compliance|0|||
144463035|NCT01483924|520891816|FG001|Overall Study|Non-compliance|0|||
144463036|NCT01483924|520891817|FG002|Overall Study|Non-compliance|0|||
144463037|NCT01483924|520891818|FG003|Overall Study|Non-compliance|1|||
144463038|NCT01483924|520891819|FG004|Overall Study|Non-compliance|1|||
144463039|NCT01483924|520891815|FG000|Overall Study|Sponsor concern over ECG result|0|||
144463040|NCT01483924|520891816|FG001|Overall Study|Sponsor concern over ECG result|0|||
144463041|NCT01483924|520891817|FG002|Overall Study|Sponsor concern over ECG result|0|||
144463042|NCT01483924|520891818|FG003|Overall Study|Sponsor concern over ECG result|1|||
144463043|NCT01483924|520891819|FG004|Overall Study|Sponsor concern over ECG result|0|||
144463044|NCT00003298|520891820|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
144463045|NCT00003298|520891820|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
144463046|NCT00003298|520891820|FG000|Surgery|Unresectable at surgery|3|||
144463047|NCT00003298|520891820|FG000|Surgery|Progression before surgery|2|||
144463048|NCT00003298|520891820|FG000|Surgery|Unevaluable and off study|2|||
144463049|NCT00003298|520891820|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
144463050|NCT00003298|520891820|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
144463051|NCT00003298|520891820|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
144463052|NCT00003298|520891820|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
144463053|NCT00003298|520891820|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
144463054|NCT00003298|520891820|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
144611060|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
144463055|NCT00003298|520891820|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
144463056|NCT00003298|520891820|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
144463057|NCT00003298|520891820|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
144463058|NCT00003298|520891820|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
144463059|NCT00335322|520891822|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
144463060|NCT00335322|520891823|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
144463061|NCT00335322|520891824|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
144463062|NCT02308748|520891827|FG000|Period 1|Withdrawal by Subject|0|||
144463063|NCT02308748|520891828|FG001|Period 1|Withdrawal by Subject|0|||
144463064|NCT02308748|520891829|FG002|Period 1|Withdrawal by Subject|1|||
144463065|NCT02308748|520891830|FG003|Period 1|Withdrawal by Subject|0|||
144463066|NCT02308748|520891831|FG004|Period 1|Withdrawal by Subject|0|||
144463067|NCT02308748|520891832|FG005|Period 1|Withdrawal by Subject|0|||
144463068|NCT02308748|520891833|FG006|Period 1|Withdrawal by Subject|0|||
144463069|NCT02308748|520891834|FG007|Period 1|Withdrawal by Subject|0|||
144463070|NCT02308748|520891835|FG008|Period 1|Withdrawal by Subject|0|||
144463071|NCT02308748|520891836|FG009|Period 1|Withdrawal by Subject|0|||
144463072|NCT02308748|520891827|FG000|Period 2|Adverse Event|0|||
144463073|NCT02308748|520891828|FG001|Period 2|Adverse Event|0|||
144197236|NCT01000493|519918716|FG001|Overall Study|Adverse Event|6|||
144463074|NCT02308748|520891829|FG002|Period 2|Adverse Event|0|||
144463075|NCT02308748|520891830|FG003|Period 2|Adverse Event|0|||
144463076|NCT02308748|520891831|FG004|Period 2|Adverse Event|0|||
144197237|NCT01000493|519918715|FG000|Overall Study|Lack of Efficacy|1|||
144611061|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
144611062|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
144611063|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
144611064|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
144611065|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
144611066|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
144611067|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
144611068|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
144611069|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
144611070|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
144611071|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
144611072|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
144611073|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
144611074|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
144611075|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
144611076|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
144611077|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
144611078|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
144611079|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
144611080|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Death|2|||
144611081|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Death|1|||
144611082|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Death|0|||
144611083|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Death|0|||
144611084|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
144611085|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
144611086|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
144611087|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
144611088|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
144611089|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
144611090|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
144611091|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
144611092|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
144611093|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
144611094|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
144463077|NCT02308748|520891832|FG005|Period 2|Adverse Event|0|||
144463078|NCT02308748|520891833|FG006|Period 2|Adverse Event|0|||
144463079|NCT02308748|520891834|FG007|Period 2|Adverse Event|1|||
144463080|NCT02308748|520891835|FG008|Period 2|Adverse Event|0|||
144463081|NCT02308748|520891836|FG009|Period 2|Adverse Event|0|||
144463082|NCT02308748|520891827|FG000|Period 3|Protocol Violation|0|||
144463083|NCT02308748|520891828|FG001|Period 3|Protocol Violation|0|||
144463084|NCT02308748|520891829|FG002|Period 3|Protocol Violation|0|||
144463085|NCT02308748|520891830|FG003|Period 3|Protocol Violation|0|||
144463086|NCT02308748|520891831|FG004|Period 3|Protocol Violation|0|||
144463087|NCT02308748|520891832|FG005|Period 3|Protocol Violation|0|||
144463088|NCT02308748|520891833|FG006|Period 3|Protocol Violation|0|||
144463089|NCT02308748|520891834|FG007|Period 3|Protocol Violation|0|||
144463090|NCT02308748|520891835|FG008|Period 3|Protocol Violation|0|||
144463091|NCT02308748|520891836|FG009|Period 3|Protocol Violation|1|||
144463092|NCT02308748|520891827|FG000|Period 5|Adverse Event|1|||
144463093|NCT02308748|520891828|FG001|Period 5|Adverse Event|0|||
144463094|NCT02308748|520891829|FG002|Period 5|Adverse Event|0|||
144463095|NCT02308748|520891830|FG003|Period 5|Adverse Event|0|||
144611095|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
144611096|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
144611097|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
144611098|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
144611099|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
144611100|NCT01940471|521437259|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
144611101|NCT01940471|521437260|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
144611102|NCT01940471|521437261|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
144611103|NCT01940471|521437262|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
144611104|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
144611105|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
144611106|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
144257963|NCT03061188|520146920|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
144463096|NCT02308748|520891831|FG004|Period 5|Adverse Event|0|||
144463097|NCT02308748|520891832|FG005|Period 5|Adverse Event|0|||
144463098|NCT02308748|520891833|FG006|Period 5|Adverse Event|0|||
144463099|NCT02308748|520891834|FG007|Period 5|Adverse Event|0|||
144463100|NCT02308748|520891835|FG008|Period 5|Adverse Event|1|||
144463101|NCT02308748|520891836|FG009|Period 5|Adverse Event|0|||
144463102|NCT01994954|520891841|FG000|Overall Study|Death|1|||
144463103|NCT01994954|520891842|FG001|Overall Study|Death|0|||
144463104|NCT01994954|520891841|FG000|Overall Study|Withdrawal by Subject|9|||
144463105|NCT01994954|520891842|FG001|Overall Study|Withdrawal by Subject|14|||
144463106|NCT01994954|520891841|FG000|Overall Study|Physician Decision|2|||
144463107|NCT01994954|520891842|FG001|Overall Study|Physician Decision|2|||
144463108|NCT01994954|520891841|FG000|Overall Study|Lost to Follow-up|8|||
144463109|NCT01994954|520891842|FG001|Overall Study|Lost to Follow-up|10|||
144463110|NCT01994954|520891841|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
144463111|NCT01994954|520891842|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
144463112|NCT00417079|520891843|FG000|Overall Study|Disease progression|267|||
144463113|NCT00417079|520891844|FG001|Overall Study|Disease progression|180|||
144463114|NCT00417079|520891843|FG000|Overall Study|Adverse Event|32|||
144463115|NCT00417079|520891844|FG001|Overall Study|Adverse Event|67|||
144463116|NCT00417079|520891843|FG000|Overall Study|Non-compliance to protocol|0|||
144463117|NCT00417079|520891844|FG001|Overall Study|Non-compliance to protocol|1|||
144463118|NCT00417079|520891843|FG000|Overall Study|Lost to Follow-up|2|||
144463119|NCT00417079|520891844|FG001|Overall Study|Lost to Follow-up|0|||
144463120|NCT00417079|520891843|FG000|Overall Study|Withdrawal by Subject|17|||
144463121|NCT00417079|520891844|FG001|Overall Study|Withdrawal by Subject|8|||
144463122|NCT00417079|520891843|FG000|Overall Study|Not treated|6|||
144463123|NCT00417079|520891844|FG001|Overall Study|Not treated|7|||
144463124|NCT00417079|520891843|FG000|Overall Study|Screened failure|2|||
144463125|NCT00417079|520891844|FG001|Overall Study|Screened failure|1|||
144463126|NCT00417079|520891843|FG000|Overall Study|Investigator's decision|1|||
144463127|NCT00417079|520891844|FG001|Overall Study|Investigator's decision|4|||
144463128|NCT00417079|520891843|FG000|Overall Study|Non-confirmed Disease progression|1|||
144463129|NCT00417079|520891844|FG001|Overall Study|Non-confirmed Disease progression|1|||
144463130|NCT00417079|520891843|FG000|Overall Study|Clinical deterioration|1|||
144463131|NCT00417079|520891844|FG001|Overall Study|Clinical deterioration|0|||
144463132|NCT00417079|520891843|FG000|Overall Study|Screening error|2|||
144463133|NCT00417079|520891844|FG001|Overall Study|Screening error|1|||
144463134|NCT00417079|520891843|FG000|Overall Study|Withdrawal by subject's family|0|||
144463135|NCT00417079|520891844|FG001|Overall Study|Withdrawal by subject's family|1|||
144463136|NCT00417079|520891843|FG000|Overall Study|Patient unable to come to the clinic|0|||
144463137|NCT00417079|520891844|FG001|Overall Study|Patient unable to come to the clinic|1|||
144463138|NCT00417079|520891843|FG000|Overall Study|abnormal liver function tests|0|||
144463139|NCT00417079|520891844|FG001|Overall Study|abnormal liver function tests|1|||
144463140|NCT01022762|520891845|FG000|Overall Study|Adverse Event|3|||
144463141|NCT01022762|520891846|FG001|Overall Study|Adverse Event|1|||
144463142|NCT01022762|520891845|FG000|Overall Study|Lack of Efficacy|0|||
144463143|NCT01022762|520891846|FG001|Overall Study|Lack of Efficacy|1|||
144463144|NCT01022762|520891845|FG000|Overall Study|Protocol Violation|7|||
144463145|NCT01022762|520891846|FG001|Overall Study|Protocol Violation|6|||
144463146|NCT01022762|520891845|FG000|Overall Study|Unclassified|12|||
144463147|NCT01022762|520891846|FG001|Overall Study|Unclassified|20|||
144463148|NCT04084314|520891847|FG000|Overall Study|Subject/guardian decision|91|||
144463149|NCT04084314|520891847|FG000|Overall Study|Adverse Event|24|||
144463150|NCT04084314|520891847|FG000|Overall Study|Lost to Follow-up|19|||
144463151|NCT04084314|520891847|FG000|Overall Study|New therapy for study indication|9|||
144463152|NCT04084314|520891847|FG000|Overall Study|Pregnancy|9|||
144463153|NCT04084314|520891847|FG000|Overall Study|Withdrawal of informed consent|8|||
144463154|NCT04084314|520891847|FG000|Overall Study|Physician Decision|4|||
144463155|NCT04084314|520891847|FG000|Overall Study|Protocol Deviation|3|||
144463156|NCT01565707|520891848|FG000|Overall Study|Adverse Event|1|||
144463157|NCT01565707|520891849|FG001|Overall Study|Adverse Event|6|||
144463158|NCT01565707|520891850|FG002|Overall Study|Adverse Event|2|||
144611107|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
144611108|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
144611109|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
144463159|NCT01565707|520891851|FG003|Overall Study|Adverse Event|1|||
144463160|NCT01565707|520891848|FG000|Overall Study|Lost to Follow-up|1|||
144463161|NCT01565707|520891849|FG001|Overall Study|Lost to Follow-up|0|||
144463162|NCT01565707|520891850|FG002|Overall Study|Lost to Follow-up|0|||
144463163|NCT01565707|520891851|FG003|Overall Study|Lost to Follow-up|0|||
144463164|NCT01565707|520891848|FG000|Overall Study|Protocol Violation|1|||
144463165|NCT01565707|520891849|FG001|Overall Study|Protocol Violation|0|||
144611110|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
144463166|NCT01565707|520891850|FG002|Overall Study|Protocol Violation|0|||
144611111|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
144463167|NCT01565707|520891851|FG003|Overall Study|Protocol Violation|1|||
144463168|NCT01565707|520891848|FG000|Overall Study|Withdrawal by Subject|3|||
144463169|NCT01565707|520891849|FG001|Overall Study|Withdrawal by Subject|1|||
144463170|NCT01565707|520891850|FG002|Overall Study|Withdrawal by Subject|1|||
144463171|NCT01565707|520891851|FG003|Overall Study|Withdrawal by Subject|1|||
144463172|NCT01565707|520891848|FG000|Overall Study|Randomized but not evaluable|2|||
144726026|NCT01345019|521852669|FG000|Open Label Treatment Phase|Protocol Violation|0|||
144726027|NCT01345019|521852670|FG001|Open Label Treatment Phase|Protocol Violation|1|||
144726028|NCT03830164|521852672|FG000|Overall Study|Adverse Event|0|||
144257964|NCT03061188|520146917|FG000|On Follow-up for 3 Years|Death|0|||
144257965|NCT03061188|520146918|FG001|On Follow-up for 3 Years|Death|3|||
144463173|NCT01565707|520891849|FG001|Overall Study|Randomized but not evaluable|0|||
144463174|NCT01565707|520891850|FG002|Overall Study|Randomized but not evaluable|0|||
144463175|NCT01565707|520891851|FG003|Overall Study|Randomized but not evaluable|0|||
144463176|NCT01565707|520891848|FG000|Overall Study|Miscellaneous|1|||
144463177|NCT01565707|520891849|FG001|Overall Study|Miscellaneous|1|||
144463178|NCT01565707|520891850|FG002|Overall Study|Miscellaneous|0|||
144463179|NCT01565707|520891851|FG003|Overall Study|Miscellaneous|2|||
144463180|NCT00127608|520891852|FG000|Overall Study|VZV DNA negative|1|||
144463181|NCT01329029|520891855|FG000|Overall Study|Withdrawal by Subject|117|||
144463182|NCT01329029|520891856|FG001|Overall Study|Withdrawal by Subject|87|||
144463183|NCT01329029|520891855|FG000|Overall Study|Adverse Event|82|||
144463184|NCT01329029|520891856|FG001|Overall Study|Adverse Event|29|||
144463185|NCT01329029|520891855|FG000|Overall Study|Death|16|||
144463186|NCT01329029|520891856|FG001|Overall Study|Death|19|||
144463187|NCT01329029|520891855|FG000|Overall Study|Other|14|||
144463188|NCT01329029|520891856|FG001|Overall Study|Other|20|||
144463189|NCT01329029|520891855|FG000|Overall Study|COPD Exacerbation|11|||
144463190|NCT01329029|520891856|FG001|Overall Study|COPD Exacerbation|18|||
144463191|NCT01329029|520891855|FG000|Overall Study|Physician Decision|16|||
144463192|NCT01329029|520891856|FG001|Overall Study|Physician Decision|13|||
144463193|NCT01329029|520891855|FG000|Overall Study|Lost to Follow-up|8|||
144463194|NCT01329029|520891856|FG001|Overall Study|Lost to Follow-up|5|||
144463195|NCT01329029|520891855|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
144463196|NCT01329029|520891856|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
144463197|NCT00680407|520891862|FG000|Overall Study|Lost to Follow-up|3|||
144463198|NCT00680407|520891863|FG001|Overall Study|Lost to Follow-up|3|||
144463199|NCT00680407|520891864|FG002|Overall Study|Lost to Follow-up|1|||
144463200|NCT00680407|520891862|FG000|Overall Study|Withdrawal by Subject|5|||
144726029|NCT03830164|521852673|FG001|Overall Study|Adverse Event|2|||
144257966|NCT03061188|520146919|FG002|On Follow-up for 3 Years|Death|5|||
144463201|NCT00680407|520891863|FG001|Overall Study|Withdrawal by Subject|2|||
144463202|NCT00680407|520891864|FG002|Overall Study|Withdrawal by Subject|2|||
144463203|NCT00506493|520891865|FG000|Overall Study|Death|6|||
144463204|NCT00506493|520891865|FG000|Overall Study|Withdrawal by Subject|5|||
144463205|NCT00003508|520893400|FG000|Overall Study|Not evaluable|5|||
144463206|NCT02160314|520893401|FG000|Overall Study|Adverse Event|0|||
144463207|NCT02160314|520893402|FG001|Overall Study|Adverse Event|6|||
144463208|NCT02160314|520893401|FG000|Overall Study|Protocol Violation|0|||
144463209|NCT02160314|520893402|FG001|Overall Study|Protocol Violation|4|||
144463210|NCT02160314|520893401|FG000|Overall Study|Withdrawal by Subject|1|||
144463211|NCT02160314|520893402|FG001|Overall Study|Withdrawal by Subject|2|||
144463212|NCT02160314|520893401|FG000|Overall Study|Lost to Follow-up|0|||
144463213|NCT02160314|520893402|FG001|Overall Study|Lost to Follow-up|1|||
144463214|NCT00593567|520893403|FG000|Overall Study|Adverse Event|2|||
144463215|NCT00593567|520893404|FG001|Overall Study|Adverse Event|0|||
144463216|NCT00593567|520893403|FG000|Overall Study|Physician Decision|2|||
144463217|NCT00593567|520893404|FG001|Overall Study|Physician Decision|0|||
144463218|NCT00593567|520893403|FG000|Overall Study|Protocol Violation|13|||
144463219|NCT00593567|520893404|FG001|Overall Study|Protocol Violation|7|||
144463220|NCT00593567|520893403|FG000|Overall Study|Lack of Efficacy|2|||
144463221|NCT00593567|520893404|FG001|Overall Study|Lack of Efficacy|1|||
144463222|NCT00593567|520893403|FG000|Overall Study|Withdrawal by Subject|1|||
144463223|NCT00593567|520893404|FG001|Overall Study|Withdrawal by Subject|2|||
144463224|NCT03576768|520893410|FG000|Overall Study|Lost to Follow-up|3|||
144463225|NCT03576768|520893411|FG001|Overall Study|Lost to Follow-up|3|||
144463226|NCT03576768|520893412|FG002|Overall Study|Lost to Follow-up|0|||
144463227|NCT03576768|520893413|FG003|Overall Study|Lost to Follow-up|0|||
144463228|NCT00590902|520893414|FG000|Overall Study|Death|1|||
144463229|NCT00785291|520893415|FG000|Overall Study|Never began treatment|8|||
144463230|NCT00785291|520893416|FG001|Overall Study|Never began treatment|4|||
144463231|NCT00785291|520893417|FG002|Overall Study|Never began treatment|4|||
144463232|NCT00785291|520893415|FG000|Overall Study|Adverse Event|39|||
144463233|NCT00785291|520893416|FG001|Overall Study|Adverse Event|70|||
144463234|NCT00785291|520893417|FG002|Overall Study|Adverse Event|56|||
144463235|NCT00785291|520893415|FG000|Overall Study|Death|7|||
144463236|NCT00785291|520893416|FG001|Overall Study|Death|4|||
144463237|NCT00785291|520893417|FG002|Overall Study|Death|3|||
144463238|NCT00785291|520893415|FG000|Overall Study|Withdrawal by Subject|35|||
144463239|NCT00785291|520893416|FG001|Overall Study|Withdrawal by Subject|36|||
144463240|NCT00785291|520893417|FG002|Overall Study|Withdrawal by Subject|17|||
144463241|NCT00785291|520893415|FG000|Overall Study|Alternative Therapy|12|||
144463242|NCT00785291|520893416|FG001|Overall Study|Alternative Therapy|6|||
144463243|NCT00785291|520893417|FG002|Overall Study|Alternative Therapy|7|||
144611112|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
144611113|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
144611114|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
144611115|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
144611116|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
144611117|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
144463244|NCT00785291|520893415|FG000|Overall Study|Complicating illness|6|||
144463245|NCT00785291|520893416|FG001|Overall Study|Complicating illness|4|||
144463246|NCT00785291|520893417|FG002|Overall Study|Complicating illness|4|||
144463247|NCT00785291|520893415|FG000|Overall Study|Other Medical Reasons|29|||
144463248|NCT00785291|520893416|FG001|Overall Study|Other Medical Reasons|25|||
144463249|NCT00785291|520893417|FG002|Overall Study|Other Medical Reasons|15|||
144463250|NCT02119260|520893418|FG000|Overall Study|Adverse Event|1|||
144463251|NCT02119260|520893419|FG001|Overall Study|Adverse Event|0|||
144463252|NCT02119260|520893420|FG002|Overall Study|Adverse Event|0|||
144463253|NCT02119260|520893421|FG003|Overall Study|Adverse Event|0|||
144463254|NCT02119260|520893422|FG004|Overall Study|Adverse Event|0|||
144463255|NCT02119260|520893423|FG005|Overall Study|Adverse Event|0|||
144463256|NCT02119260|520893424|FG006|Overall Study|Adverse Event|0|||
144463257|NCT02119260|520893418|FG000|Overall Study|Withdrew consent|0|||
144463258|NCT02119260|520893419|FG001|Overall Study|Withdrew consent|1|||
144463259|NCT02119260|520893420|FG002|Overall Study|Withdrew consent|1|||
144463260|NCT02119260|520893421|FG003|Overall Study|Withdrew consent|0|||
144463261|NCT02119260|520893422|FG004|Overall Study|Withdrew consent|0|||
144463262|NCT02119260|520893423|FG005|Overall Study|Withdrew consent|0|||
144463263|NCT02119260|520893424|FG006|Overall Study|Withdrew consent|0|||
144463264|NCT03224182|520893432|FG000|Overall Study|Study Drug Not Instilled|6|||
144463265|NCT03224182|520893433|FG001|Overall Study|Study Drug Not Instilled|1|||
144463266|NCT03224182|520893432|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
144463267|NCT03224182|520893433|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
144463268|NCT03224182|520893432|FG000|Overall Study|Withdrew of Consent|4|||
144463269|NCT03224182|520893433|FG001|Overall Study|Withdrew of Consent|2|||
144463270|NCT03224182|520893432|FG000|Overall Study|Investigator Decision|3|||
144463271|NCT03224182|520893433|FG001|Overall Study|Investigator Decision|1|||
144463272|NCT03224182|520893432|FG000|Overall Study|Sponsor Decision|26|||
144463273|NCT03224182|520893433|FG001|Overall Study|Sponsor Decision|12|||
144463274|NCT03224182|520893432|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
144463275|NCT03224182|520893433|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
144463276|NCT03224182|520893432|FG000|Overall Study|Lost to Follow-up|1|||
144463277|NCT03224182|520893433|FG001|Overall Study|Lost to Follow-up|0|||
144463278|NCT03224182|520893432|FG000|Overall Study|Participant Had Recurrence|11|||
144463279|NCT03224182|520893433|FG001|Overall Study|Participant Had Recurrence|5|||
144463280|NCT03224182|520893432|FG000|Overall Study|Death|0|||
144463281|NCT03224182|520893433|FG001|Overall Study|Death|1|||
144463282|NCT03224182|520893432|FG000|Overall Study|Reason not Specified|3|||
144463283|NCT03224182|520893433|FG001|Overall Study|Reason not Specified|3|||
144463284|NCT03224182|520893432|FG000|Overall Study|Other|1|||
144463285|NCT03224182|520893433|FG001|Overall Study|Other|0|||
144463286|NCT02822222|520893437|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
144463287|NCT02822222|520893438|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
144463288|NCT00643916|520893439|FG000|Overall Study|Protocol Violation|0|||
144463289|NCT00643916|520893440|FG001|Overall Study|Protocol Violation|1|||
144463290|NCT00643916|520893441|FG002|Overall Study|Protocol Violation|1|||
144463291|NCT00643916|520893442|FG003|Overall Study|Protocol Violation|1|||
144463292|NCT00643916|520893443|FG004|Overall Study|Protocol Violation|0|||
144463293|NCT00643916|520893444|FG005|Overall Study|Protocol Violation|0|||
144463294|NCT00643916|520893439|FG000|Overall Study|Lost to Follow-up|0|||
144463295|NCT00643916|520893440|FG001|Overall Study|Lost to Follow-up|1|||
144463296|NCT00643916|520893441|FG002|Overall Study|Lost to Follow-up|0|||
144463297|NCT00643916|520893442|FG003|Overall Study|Lost to Follow-up|0|||
144463298|NCT00643916|520893443|FG004|Overall Study|Lost to Follow-up|0|||
144463299|NCT00643916|520893444|FG005|Overall Study|Lost to Follow-up|0|||
144463300|NCT00643916|520893439|FG000|Overall Study|Withdrawal by Subject|2|||
144611118|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
144197238|NCT01000493|519918716|FG001|Overall Study|Lack of Efficacy|1|||
144726030|NCT03830164|521852674|FG002|Overall Study|Adverse Event|0|||
144197239|NCT01000493|519918715|FG000|Overall Study|Protocol Violation|1|||
144463301|NCT00643916|520893440|FG001|Overall Study|Withdrawal by Subject|2|||
144463302|NCT00643916|520893441|FG002|Overall Study|Withdrawal by Subject|2|||
144463303|NCT00643916|520893442|FG003|Overall Study|Withdrawal by Subject|1|||
144463304|NCT00643916|520893443|FG004|Overall Study|Withdrawal by Subject|0|||
144463305|NCT00643916|520893444|FG005|Overall Study|Withdrawal by Subject|1|||
144463306|NCT00643916|520893439|FG000|Overall Study|Not Vaccinated|2|||
144463307|NCT00643916|520893440|FG001|Overall Study|Not Vaccinated|2|||
144463308|NCT00643916|520893441|FG002|Overall Study|Not Vaccinated|3|||
144257967|NCT03061188|520146920|FG003|On Follow-up for 3 Years|Death|4|||
144257968|NCT03061188|520146917|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
144257969|NCT03061188|520146918|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
144257970|NCT03061188|520146919|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
144257971|NCT03061188|520146920|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
144257972|NCT00436826|520146925|FG000|Double Blind Period (DBP)|Adverse Event|2|||
144611119|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
144257973|NCT00436826|520146926|FG001|Double Blind Period (DBP)|Adverse Event|0|||
144257974|NCT00436826|520146927|FG002|Double Blind Period (DBP)|Adverse Event|0|||
144257975|NCT00436826|520146928|FG003|Double Blind Period (DBP)|Adverse Event|0|||
144257976|NCT00436826|520146929|FG004|Double Blind Period (DBP)|Adverse Event|0|||
144257977|NCT00436826|520146930|FG005|Double Blind Period (DBP)|Adverse Event|0|||
144257978|NCT00436826|520146925|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
144257979|NCT00436826|520146926|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
144257980|NCT00436826|520146927|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
144257981|NCT00436826|520146928|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
144257982|NCT00436826|520146929|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
144257983|NCT00436826|520146930|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
144257984|NCT00436826|520146925|FG000|Double Blind Period (DBP)|Other|10|||
144257985|NCT00436826|520146926|FG001|Double Blind Period (DBP)|Other|11|||
144257986|NCT00436826|520146927|FG002|Double Blind Period (DBP)|Other|0|||
144257987|NCT00436826|520146928|FG003|Double Blind Period (DBP)|Other|0|||
144257988|NCT00436826|520146929|FG004|Double Blind Period (DBP)|Other|0|||
144257989|NCT00436826|520146930|FG005|Double Blind Period (DBP)|Other|0|||
144257990|NCT00436826|520146925|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
144257991|NCT00436826|520146926|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
144257992|NCT00436826|520146927|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
144257993|NCT00436826|520146928|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
144257994|NCT00436826|520146929|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
144257995|NCT00436826|520146930|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
144257996|NCT00436826|520146925|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
144257997|NCT00436826|520146926|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
144257998|NCT00436826|520146927|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
144257999|NCT00436826|520146928|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
144258000|NCT00436826|520146929|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
144258001|NCT00436826|520146930|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
144258002|NCT00436826|520146925|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
144611120|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
144611121|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
144611122|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
144611123|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
144611124|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
144611125|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
144611126|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
144611127|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
144611128|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
144611129|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
144611130|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
144611131|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
144611132|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
144611133|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
144611134|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
144611135|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
144611136|NCT01940471|521437259|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
144611137|NCT01940471|521437260|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
144611138|NCT01940471|521437261|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
144611139|NCT01940471|521437262|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
144611140|NCT00258674|521437263|FG000|Overall Study|Death|32|||
144611141|NCT00258674|521437264|FG001|Overall Study|Death|53|||
144611142|NCT00258674|521437265|FG002|Overall Study|Death|34|||
144258003|NCT00436826|520146926|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
144611143|NCT03715153|521437266|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
144611144|NCT03715153|521437267|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
144726031|NCT03830164|521852672|FG000|Overall Study|Lack of Efficacy|1|||
144258004|NCT00436826|520146927|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
144258005|NCT00436826|520146928|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
144258006|NCT00436826|520146929|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
144611145|NCT03715153|521437266|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
144611146|NCT03715153|521437267|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
144611147|NCT03715153|521437266|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
144611148|NCT03715153|521437267|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
144611149|NCT03715153|521437266|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
144611150|NCT03715153|521437267|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
144611151|NCT03715153|521437266|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
144611152|NCT03715153|521437267|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
144611153|NCT03715153|521437266|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
144611154|NCT03715153|521437267|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
144611155|NCT02973087|521437270|FG000|Overall Study|Withdrawal by Subject|2|||
144611156|NCT02973087|521437271|FG001|Overall Study|Withdrawal by Subject|1|||
144611157|NCT02973087|521437270|FG000|Overall Study|Adverse Event|1|||
144611158|NCT02973087|521437271|FG001|Overall Study|Adverse Event|0|||
144611159|NCT02973087|521437270|FG000|Overall Study|other|1|||
144611160|NCT02973087|521437271|FG001|Overall Study|other|1|||
144611161|NCT02090413|521437282|FG000|Overall Study|Adverse Event|11|||
144611162|NCT02090413|521437283|FG001|Overall Study|Adverse Event|15|||
144611163|NCT02090413|521437284|FG002|Overall Study|Adverse Event|20|||
144611164|NCT02090413|521437282|FG000|Overall Study|Flushing event|2|||
144611165|NCT02090413|521437283|FG001|Overall Study|Flushing event|0|||
144611166|NCT02090413|521437284|FG002|Overall Study|Flushing event|1|||
144611167|NCT02090413|521437282|FG000|Overall Study|Withdrawal by Subject|2|||
144611168|NCT02090413|521437283|FG001|Overall Study|Withdrawal by Subject|2|||
144611169|NCT02090413|521437284|FG002|Overall Study|Withdrawal by Subject|2|||
144611170|NCT02090413|521437282|FG000|Overall Study|Investigator Decision|1|||
144611171|NCT02090413|521437283|FG001|Overall Study|Investigator Decision|1|||
144611172|NCT02090413|521437284|FG002|Overall Study|Investigator Decision|0|||
144611173|NCT02090413|521437282|FG000|Overall Study|Other|2|||
144611174|NCT02090413|521437283|FG001|Overall Study|Other|1|||
144611175|NCT02090413|521437284|FG002|Overall Study|Other|0|||
144611176|NCT02090413|521437282|FG000|Overall Study|Lost to Follow-up|1|||
144611177|NCT02090413|521437283|FG001|Overall Study|Lost to Follow-up|1|||
144611178|NCT02090413|521437284|FG002|Overall Study|Lost to Follow-up|0|||
144611179|NCT05419128|521437285|FG000|Overall Study|Withdrawal by Subject|1|||
144611180|NCT05419128|521437286|FG001|Overall Study|Withdrawal by Subject|1|||
144611181|NCT05419128|521437287|FG002|Overall Study|Withdrawal by Subject|0|||
144611182|NCT05419128|521437288|FG003|Overall Study|Withdrawal by Subject|1|||
144611183|NCT05419128|521437289|FG004|Overall Study|Withdrawal by Subject|1|||
144611184|NCT05419128|521437290|FG005|Overall Study|Withdrawal by Subject|0|||
144611185|NCT05419128|521437285|FG000|Overall Study|Lost to Follow-up|0|||
144611186|NCT05419128|521437286|FG001|Overall Study|Lost to Follow-up|0|||
144611187|NCT05419128|521437287|FG002|Overall Study|Lost to Follow-up|1|||
144611188|NCT05419128|521437288|FG003|Overall Study|Lost to Follow-up|0|||
144611189|NCT05419128|521437289|FG004|Overall Study|Lost to Follow-up|0|||
144611190|NCT05419128|521437290|FG005|Overall Study|Lost to Follow-up|1|||
144611191|NCT03834519|521437291|FG000|Overall Study|Lost to Follow-up|2|||
144611192|NCT03834519|521437292|FG001|Overall Study|Lost to Follow-up|1|||
144611193|NCT03834519|521437291|FG000|Overall Study|Withdrawal by Subject|5|||
144611194|NCT03834519|521437292|FG001|Overall Study|Withdrawal by Subject|8|||
144611195|NCT03834519|521437291|FG000|Overall Study|Death|368|||
144611196|NCT03834519|521437292|FG001|Overall Study|Death|174|||
144463309|NCT00643916|520893442|FG003|Overall Study|Not Vaccinated|0|||
144463310|NCT00643916|520893443|FG004|Overall Study|Not Vaccinated|2|||
144463311|NCT00643916|520893444|FG005|Overall Study|Not Vaccinated|0|||
144463312|NCT00440531|520893449|FG000|Overall Study|Adverse Event|1|||
144463313|NCT00440531|520893450|FG001|Overall Study|Adverse Event|0|||
144463314|NCT00440531|520893451|FG002|Overall Study|Adverse Event|2|||
144463315|NCT00440531|520893449|FG000|Overall Study|Withdrawal by Subject|2|||
144463316|NCT00440531|520893450|FG001|Overall Study|Withdrawal by Subject|0|||
144463317|NCT00440531|520893451|FG002|Overall Study|Withdrawal by Subject|0|||
144611197|NCT03834519|521437291|FG000|Overall Study|Physician Decision|5|||
144611198|NCT03834519|521437292|FG001|Overall Study|Physician Decision|1|||
144611199|NCT03834519|521437291|FG000|Overall Study|Sponsor decision|149|||
144611200|NCT03834519|521437292|FG001|Overall Study|Sponsor decision|80|||
144611201|NCT00853749|521437293|FG000|Overall Study|Lost to Follow-up|0|||
144611202|NCT00853749|521437294|FG001|Overall Study|Lost to Follow-up|1|||
144611203|NCT03996876|521437297|FG000|Overall Study|Incomplete Data|2|||
144611204|NCT03996876|521437298|FG001|Overall Study|Incomplete Data|4|||
144611205|NCT01538628|521437301|FG000|Overall Study|Withdrawal by Subject|1|||
144611206|NCT01538628|521437302|FG001|Overall Study|Withdrawal by Subject|1|||
144611207|NCT01538628|521437301|FG000|Overall Study|Lost to Follow-up|0|||
144611208|NCT01538628|521437302|FG001|Overall Study|Lost to Follow-up|1|||
144611209|NCT01617460|521438853|FG000|Overall Study|Adverse Event|10|||
144611210|NCT01617460|521438853|FG000|Overall Study|Physician Decision|16|||
144611211|NCT01617460|521438853|FG000|Overall Study|Protocol Violation|5|||
144611212|NCT01617460|521438853|FG000|Overall Study|Withdrawal by Subject|9|||
144197240|NCT01000493|519918716|FG001|Overall Study|Protocol Violation|8|||
144463318|NCT00440531|520893449|FG000|Overall Study|Protocol Violation|1|||
144463319|NCT00440531|520893450|FG001|Overall Study|Protocol Violation|2|||
144463320|NCT00440531|520893451|FG002|Overall Study|Protocol Violation|0|||
144726032|NCT03830164|521852673|FG001|Overall Study|Lack of Efficacy|5|||
144726033|NCT03830164|521852674|FG002|Overall Study|Lack of Efficacy|0|||
144463321|NCT00440531|520893449|FG000|Overall Study|Lost to Follow-up|4|||
144611213|NCT03703882|521438854|FG000|Overall Study|Adverse Event|1|||
144611214|NCT03703882|521438855|FG001|Overall Study|Adverse Event|0|||
144611215|NCT03703882|521438854|FG000|Overall Study|Lost to Follow-up|0|||
144611216|NCT03703882|521438855|FG001|Overall Study|Lost to Follow-up|2|||
144611217|NCT03703882|521438854|FG000|Overall Study|Non-compliance with study drug|0|||
144611218|NCT03703882|521438855|FG001|Overall Study|Non-compliance with study drug|1|||
144611219|NCT03703882|521438854|FG000|Overall Study|Physician Decision|0|||
144611220|NCT03703882|521438855|FG001|Overall Study|Physician Decision|1|||
144611221|NCT03703882|521438854|FG000|Overall Study|Progressive disease|1|||
144611222|NCT03703882|521438855|FG001|Overall Study|Progressive disease|0|||
144611223|NCT03703882|521438854|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144611224|NCT03703882|521438855|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144611225|NCT03703882|521438854|FG000|Overall Study|Starting another treatment|0|||
144611226|NCT03703882|521438855|FG001|Overall Study|Starting another treatment|1|||
144611227|NCT03703882|521438854|FG000|Overall Study|noncompliance with study procedures|0|||
144611228|NCT03703882|521438855|FG001|Overall Study|noncompliance with study procedures|1|||
144611229|NCT00457015|521438859|FG000|Overall Study|Left study site against medical advice|0|||
144611230|NCT00457015|521438860|FG001|Overall Study|Left study site against medical advice|1|||
144611231|NCT00075023|521438861|FG000|Pilot Study|Physician Decision|1|||
144611232|NCT00075023|521438862|FG001|Pilot Study|Physician Decision|2|||
144611233|NCT00075023|521438861|FG000|Pilot Study|Withdrawal by Subject|1|||
144611234|NCT00075023|521438862|FG001|Pilot Study|Withdrawal by Subject|0|||
144463322|NCT00440531|520893450|FG001|Overall Study|Lost to Follow-up|3|||
144463323|NCT00440531|520893451|FG002|Overall Study|Lost to Follow-up|5|||
144463324|NCT00440531|520893449|FG000|Overall Study|see pre-assignment details|2|||
144463325|NCT00440531|520893450|FG001|Overall Study|see pre-assignment details|0|||
144463326|NCT00440531|520893451|FG002|Overall Study|see pre-assignment details|0|||
144463327|NCT00447057|520893452|FG000|Overall Study|Adverse Event|4|||
144463328|NCT00447057|520893453|FG001|Overall Study|Adverse Event|10|||
144463329|NCT00447057|520893454|FG002|Overall Study|Adverse Event|0|||
144463330|NCT00447057|520893455|FG003|Overall Study|Adverse Event|3|||
144463331|NCT00447057|520893452|FG000|Overall Study|Death due to study disease|6|||
144463332|NCT00447057|520893453|FG001|Overall Study|Death due to study disease|4|||
144463333|NCT00447057|520893454|FG002|Overall Study|Death due to study disease|1|||
144463334|NCT00447057|520893455|FG003|Overall Study|Death due to study disease|1|||
144463335|NCT00447057|520893452|FG000|Overall Study|Lost to Follow-up|0|||
144463336|NCT00447057|520893453|FG001|Overall Study|Lost to Follow-up|1|||
144463337|NCT00447057|520893454|FG002|Overall Study|Lost to Follow-up|0|||
144463338|NCT00447057|520893455|FG003|Overall Study|Lost to Follow-up|0|||
144463339|NCT00447057|520893452|FG000|Overall Study|Entry criteria not met|1|||
144463340|NCT00447057|520893453|FG001|Overall Study|Entry criteria not met|1|||
144463341|NCT00447057|520893454|FG002|Overall Study|Entry criteria not met|0|||
144463342|NCT00447057|520893455|FG003|Overall Study|Entry criteria not met|0|||
144463343|NCT00447057|520893452|FG000|Overall Study|Protocol Violation|0|||
144463344|NCT00447057|520893453|FG001|Overall Study|Protocol Violation|1|||
144463345|NCT00447057|520893454|FG002|Overall Study|Protocol Violation|0|||
144463346|NCT00447057|520893455|FG003|Overall Study|Protocol Violation|0|||
144463347|NCT00447057|520893452|FG000|Overall Study|Withdrawal by Subject|4|||
144535836|NCT02719574|521166066|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535837|NCT02719574|521166067|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535838|NCT02719574|521166068|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535839|NCT02719574|521166069|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535840|NCT02719574|521166070|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535841|NCT02719574|521166071|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535842|NCT02719574|521166072|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
144535843|NCT02719574|521166073|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
144535844|NCT02719574|521166074|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535845|NCT02719574|521166075|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535846|NCT02719574|521166076|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535847|NCT02719574|521166077|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535848|NCT02719574|521166078|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
144611235|NCT03670953|521438863|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
144611236|NCT03670953|521438864|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
144463348|NCT00447057|520893453|FG001|Overall Study|Withdrawal by Subject|5|||
144463349|NCT00447057|520893454|FG002|Overall Study|Withdrawal by Subject|1|||
144535849|NCT02719574|521166079|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535850|NCT02719574|521166080|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535851|NCT02719574|521166081|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
144726034|NCT03830164|521852672|FG000|Overall Study|Lost to Follow-up|0|||
144726035|NCT03830164|521852673|FG001|Overall Study|Lost to Follow-up|1|||
144535852|NCT02719574|521166082|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
144535853|NCT02719574|521166066|FG000|Phase 1 (Dose Expansion)|Other|0|||
144535854|NCT02719574|521166067|FG001|Phase 1 (Dose Expansion)|Other|0|||
144535855|NCT02719574|521166068|FG002|Phase 1 (Dose Expansion)|Other|0|||
144535856|NCT02719574|521166069|FG003|Phase 1 (Dose Expansion)|Other|0|||
144535857|NCT02719574|521166070|FG004|Phase 1 (Dose Expansion)|Other|0|||
144535858|NCT02719574|521166071|FG005|Phase 1 (Dose Expansion)|Other|0|||
144535859|NCT02719574|521166072|FG006|Phase 1 (Dose Expansion)|Other|1|||
144535860|NCT02719574|521166073|FG007|Phase 1 (Dose Expansion)|Other|7|||
144535861|NCT02719574|521166074|FG008|Phase 1 (Dose Expansion)|Other|0|||
144535862|NCT02719574|521166075|FG009|Phase 1 (Dose Expansion)|Other|0|||
144535863|NCT02719574|521166076|FG010|Phase 1 (Dose Expansion)|Other|0|||
144535864|NCT02719574|521166077|FG011|Phase 1 (Dose Expansion)|Other|0|||
144535865|NCT02719574|521166078|FG012|Phase 1 (Dose Expansion)|Other|0|||
144535866|NCT02719574|521166079|FG013|Phase 1 (Dose Expansion)|Other|0|||
144611237|NCT03670953|521438865|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
144611238|NCT03670953|521438866|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
144611239|NCT03670953|521438863|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
144611240|NCT03670953|521438864|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
144611241|NCT03670953|521438865|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
144611242|NCT03670953|521438866|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
144611243|NCT03670953|521438863|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
144611244|NCT03670953|521438864|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
144611245|NCT03670953|521438865|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
144611246|NCT03670953|521438866|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
144611247|NCT03670953|521438863|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
144611248|NCT03670953|521438864|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
144611249|NCT03670953|521438865|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
144611250|NCT03670953|521438866|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
144611251|NCT03670953|521438863|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
144611252|NCT03670953|521438864|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
144611253|NCT03670953|521438865|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
144611254|NCT03670953|521438866|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
144611255|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
144611256|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
144611257|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
144611258|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
144611259|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
144611260|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
144611261|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
144611262|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
144611263|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
144611264|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
144611265|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
144611266|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
144611267|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
144611268|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
144611269|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
144611270|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
144535867|NCT02719574|521166080|FG014|Phase 1 (Dose Expansion)|Other|0|||
144535868|NCT02719574|521166081|FG015|Phase 1 (Dose Expansion)|Other|0|||
144535869|NCT02719574|521166082|FG016|Phase 1 (Dose Expansion)|Other|0|||
144535870|NCT02719574|521166066|FG000|Phase 2|Protocol Defined Disease Progression|0|||
144535871|NCT02719574|521166067|FG001|Phase 2|Protocol Defined Disease Progression|0|||
144535872|NCT02719574|521166068|FG002|Phase 2|Protocol Defined Disease Progression|0|||
144535873|NCT02719574|521166069|FG003|Phase 2|Protocol Defined Disease Progression|0|||
144611271|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
144611272|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
144611273|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
144611274|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
144611275|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
144611276|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
144611277|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
144611278|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
144611279|NCT03670953|521438863|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
144611280|NCT03670953|521438864|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
144611281|NCT03670953|521438865|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
144611282|NCT03670953|521438866|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
144611283|NCT03670953|521438863|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
144535874|NCT02719574|521166070|FG004|Phase 2|Protocol Defined Disease Progression|0|||
144535875|NCT02719574|521166071|FG005|Phase 2|Protocol Defined Disease Progression|0|||
144535876|NCT02719574|521166072|FG006|Phase 2|Protocol Defined Disease Progression|0|||
144611284|NCT03670953|521438864|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
144611285|NCT03670953|521438865|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
144611286|NCT03670953|521438866|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
144611287|NCT03670953|521438863|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
144611288|NCT03670953|521438864|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
144611289|NCT03670953|521438865|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
144535877|NCT02719574|521166073|FG007|Phase 2|Protocol Defined Disease Progression|0|||
144611290|NCT03670953|521438866|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
144611291|NCT03670953|521438863|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
144611292|NCT03670953|521438864|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
144611293|NCT03670953|521438865|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
144611294|NCT03670953|521438866|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
144611295|NCT03670953|521438863|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
144611296|NCT03670953|521438864|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
144611297|NCT03670953|521438865|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
144611298|NCT03670953|521438866|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
144611299|NCT03670953|521438863|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
144611300|NCT03670953|521438864|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
144611301|NCT03670953|521438865|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
144611302|NCT03670953|521438866|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
144611303|NCT03670953|521438863|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
144611304|NCT03670953|521438864|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
144611305|NCT03670953|521438865|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
144611306|NCT03670953|521438866|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
144611307|NCT02982954|521438869|FG000|Overall Study|Death|55|||
144611308|NCT02982954|521438870|FG001|Overall Study|Death|29|||
144611309|NCT02982954|521438871|FG002|Overall Study|Death|15|||
144535878|NCT02719574|521166074|FG008|Phase 2|Protocol Defined Disease Progression|0|||
144535879|NCT02719574|521166075|FG009|Phase 2|Protocol Defined Disease Progression|65|||
144535880|NCT02719574|521166076|FG010|Phase 2|Protocol Defined Disease Progression|8|||
144535881|NCT02719574|521166077|FG011|Phase 2|Protocol Defined Disease Progression|2|||
144535882|NCT02719574|521166078|FG012|Phase 2|Protocol Defined Disease Progression|4|||
144535883|NCT02719574|521166079|FG013|Phase 2|Protocol Defined Disease Progression|9|||
144535884|NCT02719574|521166080|FG014|Phase 2|Protocol Defined Disease Progression|11|||
144535885|NCT02719574|521166081|FG015|Phase 2|Protocol Defined Disease Progression|3|||
144535886|NCT02719574|521166082|FG016|Phase 2|Protocol Defined Disease Progression|4|||
144535887|NCT02719574|521166066|FG000|Phase 2|Adverse Event|0|||
144535888|NCT02719574|521166067|FG001|Phase 2|Adverse Event|0|||
144535889|NCT02719574|521166068|FG002|Phase 2|Adverse Event|0|||
144535890|NCT02719574|521166069|FG003|Phase 2|Adverse Event|0|||
144535891|NCT02719574|521166070|FG004|Phase 2|Adverse Event|0|||
144535892|NCT02719574|521166071|FG005|Phase 2|Adverse Event|0|||
144535893|NCT02719574|521166072|FG006|Phase 2|Adverse Event|0|||
144535894|NCT02719574|521166073|FG007|Phase 2|Adverse Event|0|||
144535895|NCT02719574|521166074|FG008|Phase 2|Adverse Event|0|||
144535896|NCT02719574|521166075|FG009|Phase 2|Adverse Event|27|||
144535897|NCT02719574|521166076|FG010|Phase 2|Adverse Event|0|||
144535898|NCT02719574|521166077|FG011|Phase 2|Adverse Event|1|||
144535899|NCT02719574|521166078|FG012|Phase 2|Adverse Event|1|||
144535900|NCT02719574|521166079|FG013|Phase 2|Adverse Event|1|||
144535901|NCT02719574|521166080|FG014|Phase 2|Adverse Event|2|||
144535902|NCT02719574|521166081|FG015|Phase 2|Adverse Event|2|||
144535903|NCT02719574|521166082|FG016|Phase 2|Adverse Event|3|||
144535904|NCT02719574|521166066|FG000|Phase 2|Other|0|||
144535905|NCT02719574|521166067|FG001|Phase 2|Other|0|||
144535906|NCT02719574|521166068|FG002|Phase 2|Other|0|||
144535907|NCT02719574|521166069|FG003|Phase 2|Other|0|||
144535908|NCT02719574|521166070|FG004|Phase 2|Other|0|||
144535909|NCT02719574|521166071|FG005|Phase 2|Other|0|||
144535910|NCT02719574|521166072|FG006|Phase 2|Other|0|||
144535911|NCT02719574|521166073|FG007|Phase 2|Other|0|||
144535912|NCT02719574|521166074|FG008|Phase 2|Other|0|||
144535913|NCT02719574|521166075|FG009|Phase 2|Other|20|||
144535914|NCT02719574|521166076|FG010|Phase 2|Other|7|||
144535915|NCT02719574|521166077|FG011|Phase 2|Other|0|||
144535916|NCT02719574|521166078|FG012|Phase 2|Other|5|||
144535917|NCT02719574|521166079|FG013|Phase 2|Other|7|||
144535918|NCT02719574|521166080|FG014|Phase 2|Other|0|||
144535919|NCT02719574|521166081|FG015|Phase 2|Other|1|||
144535920|NCT02719574|521166082|FG016|Phase 2|Other|4|||
144535921|NCT02719574|521166066|FG000|Phase 2|Transplant|0|||
144535922|NCT02719574|521166067|FG001|Phase 2|Transplant|0|||
144535923|NCT02719574|521166068|FG002|Phase 2|Transplant|0|||
144535924|NCT02719574|521166069|FG003|Phase 2|Transplant|0|||
144535925|NCT02719574|521166070|FG004|Phase 2|Transplant|0|||
144535926|NCT02719574|521166071|FG005|Phase 2|Transplant|0|||
144535927|NCT02719574|521166072|FG006|Phase 2|Transplant|0|||
144535928|NCT02719574|521166073|FG007|Phase 2|Transplant|0|||
144463350|NCT00447057|520893455|FG003|Overall Study|Withdrawal by Subject|1|||
144611310|NCT02982954|521438872|FG003|Overall Study|Death|20|||
144611311|NCT02982954|521438869|FG000|Overall Study|Lost to Follow-up|2|||
144611312|NCT02982954|521438870|FG001|Overall Study|Lost to Follow-up|1|||
144611313|NCT02982954|521438871|FG002|Overall Study|Lost to Follow-up|0|||
144611314|NCT02982954|521438872|FG003|Overall Study|Lost to Follow-up|0|||
144611315|NCT02982954|521438869|FG000|Overall Study|Participant withdrew consent|7|||
144611316|NCT02982954|521438870|FG001|Overall Study|Participant withdrew consent|5|||
144611317|NCT02982954|521438871|FG002|Overall Study|Participant withdrew consent|1|||
144611318|NCT02982954|521438872|FG003|Overall Study|Participant withdrew consent|1|||
144611319|NCT02982954|521438869|FG000|Overall Study|Other reasons|42|||
144611320|NCT02982954|521438870|FG001|Overall Study|Other reasons|17|||
144611321|NCT02982954|521438871|FG002|Overall Study|Other reasons|12|||
144611322|NCT02982954|521438872|FG003|Overall Study|Other reasons|3|||
144611323|NCT02982954|521438869|FG000|Overall Study|Premature site closure|0|||
144611324|NCT02982954|521438870|FG001|Overall Study|Premature site closure|0|||
144611325|NCT02982954|521438871|FG002|Overall Study|Premature site closure|0|||
144611326|NCT02982954|521438872|FG003|Overall Study|Premature site closure|1|||
144611327|NCT00516048|521438873|FG000|Overall Study|Death|0|||
144611328|NCT00516048|521438874|FG001|Overall Study|Death|0|||
144611329|NCT00516048|521438875|FG002|Overall Study|Death|1|||
144611330|NCT00516048|521438873|FG000|Overall Study|Subject Decision|0|||
144611331|NCT00516048|521438874|FG001|Overall Study|Subject Decision|2|||
144611332|NCT00516048|521438875|FG002|Overall Study|Subject Decision|0|||
144611333|NCT02263079|521438876|FG000|Overall Study|Physician Decision|1|||
144611334|NCT02263079|521438877|FG001|Overall Study|Physician Decision|0|||
144611335|NCT02263079|521438878|FG002|Overall Study|Physician Decision|0|||
144611336|NCT02263079|521438876|FG000|Overall Study|Withdrawal by Subject|2|||
144611337|NCT02263079|521438877|FG001|Overall Study|Withdrawal by Subject|8|||
144611338|NCT02263079|521438878|FG002|Overall Study|Withdrawal by Subject|0|||
144611339|NCT02554019|521438879|FG000|Overall Study|Withdrawal by Subject|1|||
144611340|NCT02554019|521438880|FG001|Overall Study|Withdrawal by Subject|0|||
144611341|NCT02554019|521438881|FG002|Overall Study|Withdrawal by Subject|2|||
144611342|NCT02554019|521438879|FG000|Overall Study|Adverse Event|1|||
144611343|NCT02554019|521438880|FG001|Overall Study|Adverse Event|0|||
144611344|NCT02554019|521438881|FG002|Overall Study|Adverse Event|0|||
144611345|NCT02463409|521438882|FG000|Overall Study|Withdrawal by Subject|1|||
144611346|NCT02463409|521438882|FG000|Overall Study|Screen failure|1|||
144611347|NCT00916357|521438883|FG000|Period 1|Withdrawal by Subject|1|||
144611348|NCT00916357|521438884|FG001|Period 1|Withdrawal by Subject|0|||
144611349|NCT00916357|521438885|FG002|Period 1|Withdrawal by Subject|0|||
144611350|NCT00916357|521438886|FG003|Period 1|Withdrawal by Subject|0|||
144611351|NCT00916357|521438887|FG004|Period 1|Withdrawal by Subject|0|||
144611352|NCT00916357|521438888|FG005|Period 1|Withdrawal by Subject|0|||
144611353|NCT00916357|521438883|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
144611354|NCT00916357|521438884|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
144611355|NCT00916357|521438885|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
144611356|NCT00916357|521438886|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
144611357|NCT00916357|521438887|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
144611358|NCT00916357|521438888|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
144611359|NCT03577730|521438889|FG000|Overall Study|Physician Decision|3|||
144611360|NCT03577730|521438890|FG001|Overall Study|Physician Decision|1|||
144611361|NCT03577730|521438889|FG000|Overall Study|Did not receive allocated intervention|1|||
144611362|NCT03577730|521438890|FG001|Overall Study|Did not receive allocated intervention|0|||
144611363|NCT02634151|521438892|FG000|Overall Study|Withdrawal by Subject|1|||
144611364|NCT02634151|521438893|FG001|Overall Study|Withdrawal by Subject|0|||
144611365|NCT02634151|521438892|FG000|Overall Study|Non-Compliance|0|||
144611366|NCT02634151|521438893|FG001|Overall Study|Non-Compliance|1|||
144611367|NCT02634151|521438892|FG000|Overall Study|Other|0|||
144611368|NCT02634151|521438893|FG001|Overall Study|Other|1|||
144611369|NCT02535715|521438894|FG000|Overall Study|Withdrawal by Subject|0|||
144611370|NCT02535715|521438895|FG001|Overall Study|Withdrawal by Subject|0|||
144611371|NCT02535715|521438896|FG002|Overall Study|Withdrawal by Subject|1|||
144611372|NCT00909181|521438897|FG000|Overall Study|Lost to Follow-up|39|||
144611373|NCT00909181|521438898|FG001|Overall Study|Lost to Follow-up|18|||
144611374|NCT00909181|521438899|FG002|Overall Study|Lost to Follow-up|33|||
144463351|NCT00447057|520893452|FG000|Overall Study|Physician Decision|9|||
144463352|NCT00447057|520893453|FG001|Overall Study|Physician Decision|6|||
144611375|NCT04353284|521438900|FG000|Overall Study|Adverse Event|1|||
144611376|NCT04353284|521438901|FG001|Overall Study|Adverse Event|1|||
144611377|NCT04353284|521438900|FG000|Overall Study|Lost to Follow-up|1|||
144611378|NCT04353284|521438901|FG001|Overall Study|Lost to Follow-up|0|||
144611379|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
144611380|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
144611381|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
144611382|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
144611383|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
144611384|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
144611385|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
144611386|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
144611387|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
144611388|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
144611389|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
144611390|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
144611391|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
144611392|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
144611393|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
144611394|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
144611395|NCT00094770|521438903|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
144258007|NCT00436826|520146930|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
144258008|NCT00110357|520146936|FG000|Overall Study|Deterioration without progression|2|||
144258009|NCT00110357|520146937|FG001|Overall Study|Deterioration without progression|0|||
144258010|NCT00110357|520146936|FG000|Overall Study|Disease progression/relapse|20|||
144258011|NCT00110357|520146937|FG001|Overall Study|Disease progression/relapse|15|||
144258012|NCT00110357|520146936|FG000|Overall Study|Study Closure|1|||
144611396|NCT00094770|521438904|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
144611397|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
144611398|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
144611399|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
144258013|NCT00110357|520146937|FG001|Overall Study|Study Closure|0|||
144463353|NCT00447057|520893454|FG002|Overall Study|Physician Decision|3|||
144611400|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
144611401|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
144611402|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
144611403|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
144611404|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
144611405|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
144611406|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
144611407|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
144611408|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
144611409|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
144611410|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
144611411|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
144611412|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
144611413|NCT00094770|521438903|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
144611414|NCT00094770|521438904|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
144611415|NCT01911442|521438905|FG000|Overall Study|Adverse Event|2|||
144258014|NCT00110357|520146936|FG000|Overall Study|Study Drug Toxicity|1|||
144463354|NCT00447057|520893455|FG003|Overall Study|Physician Decision|1|||
144463355|NCT00447057|520893452|FG000|Overall Study|Sponsor decision|1|||
144463356|NCT00447057|520893453|FG001|Overall Study|Sponsor decision|1|||
144463357|NCT00447057|520893454|FG002|Overall Study|Sponsor decision|0|||
144463358|NCT00447057|520893455|FG003|Overall Study|Sponsor decision|0|||
144463359|NCT00447057|520893452|FG000|Overall Study|Progressive disease|58|||
144463360|NCT00447057|520893453|FG001|Overall Study|Progressive disease|43|||
144463361|NCT00447057|520893454|FG002|Overall Study|Progressive disease|13|||
144463362|NCT00447057|520893455|FG003|Overall Study|Progressive disease|18|||
144463363|NCT00447057|520893452|FG000|Overall Study|Death due to adverse event|0|||
144463364|NCT00447057|520893453|FG001|Overall Study|Death due to adverse event|0|||
144463365|NCT00447057|520893454|FG002|Overall Study|Death due to adverse event|1|||
144463366|NCT00447057|520893455|FG003|Overall Study|Death due to adverse event|2|||
144463367|NCT00447057|520893452|FG000|Overall Study|Death, study drug related|0|||
144463368|NCT00447057|520893453|FG001|Overall Study|Death, study drug related|1|||
144463369|NCT00447057|520893454|FG002|Overall Study|Death, study drug related|0|||
144463370|NCT00447057|520893455|FG003|Overall Study|Death, study drug related|0|||
144463371|NCT00743366|520893467|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
144463372|NCT00743366|520893468|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
144463373|NCT01328574|520893469|FG000|Overall Study|Refused further treatment|1|||
144463374|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
144463375|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
144611416|NCT01911442|521438906|FG001|Overall Study|Adverse Event|2|||
144611417|NCT01911442|521438907|FG002|Overall Study|Adverse Event|4|||
144611418|NCT01911442|521438905|FG000|Overall Study|Lack of Efficacy|1|||
144611419|NCT01911442|521438906|FG001|Overall Study|Lack of Efficacy|1|||
144611420|NCT01911442|521438907|FG002|Overall Study|Lack of Efficacy|1|||
144611421|NCT01911442|521438905|FG000|Overall Study|Lost to Follow-up|2|||
144463376|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|disease progression|58|||
144611422|NCT01911442|521438906|FG001|Overall Study|Lost to Follow-up|0|||
144258015|NCT00110357|520146937|FG001|Overall Study|Study Drug Toxicity|3|||
144463377|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|disease progression|47|||
144463378|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|Death|3|||
144463379|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|Death|6|||
144611423|NCT01911442|521438907|FG002|Overall Study|Lost to Follow-up|1|||
144611424|NCT01911442|521438905|FG000|Overall Study|Withdrawal by Subject|1|||
144611425|NCT01911442|521438906|FG001|Overall Study|Withdrawal by Subject|0|||
144611426|NCT01911442|521438907|FG002|Overall Study|Withdrawal by Subject|6|||
144611427|NCT01911442|521438905|FG000|Overall Study|Mother's Work Schedule|0|||
144611428|NCT01911442|521438906|FG001|Overall Study|Mother's Work Schedule|1|||
144611429|NCT01911442|521438907|FG002|Overall Study|Mother's Work Schedule|0|||
144611430|NCT01549275|521438910|FG000|Overall Study|Lost to Follow-up|1|||
144611431|NCT01549275|521438911|FG001|Overall Study|Lost to Follow-up|0|||
144611432|NCT01040351|521438912|FG000|Overall Study|poor ovarian response|1|||
144611433|NCT01040351|521438913|FG001|Overall Study|poor ovarian response|2|||
144611434|NCT04773106|521438917|FG000|Overall Study|Withdrawal by Subject|3|||
144611435|NCT04773106|521438917|FG000|Overall Study|Death|1|||
144611436|NCT02819635|521438918|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
144611437|NCT02819635|521438919|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
144258016|NCT00110357|520146936|FG000|Overall Study|Withdrawal by Subject|3|||
144258017|NCT00110357|520146937|FG001|Overall Study|Withdrawal by Subject|1|||
144463380|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
144463381|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
144463382|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
144463383|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
144463384|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
144463385|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
144463386|NCT02472964|520893476|FG000|Part 1 (up to Week 24)|Other|2|||
144463387|NCT02472964|520893477|FG001|Part 1 (up to Week 24)|Other|1|||
144463388|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
144463389|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
144463390|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
144463391|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
144463392|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Death|0|||
144463393|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Death|1|||
144463394|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
144463395|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
144463396|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
144463397|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
144463398|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
144463399|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
144463400|NCT02472964|520893476|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
144463401|NCT02472964|520893477|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
144463402|NCT01967732|520893484|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
144463403|NCT01967732|520893485|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
144463404|NCT01967732|520893486|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
144463405|NCT01967732|520893487|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
144463406|NCT01967732|520893484|FG000|First Intervention (Day 1)|Poor venous access|0|||
144463407|NCT01967732|520893485|FG001|First Intervention (Day 1)|Poor venous access|1|||
144463408|NCT01967732|520893486|FG002|First Intervention (Day 1)|Poor venous access|0|||
144463409|NCT01967732|520893487|FG003|First Intervention (Day 1)|Poor venous access|0|||
144535929|NCT02719574|521166074|FG008|Phase 2|Transplant|0|||
144535930|NCT02719574|521166075|FG009|Phase 2|Transplant|15|||
144535931|NCT02719574|521166076|FG010|Phase 2|Transplant|2|||
144535932|NCT02719574|521166077|FG011|Phase 2|Transplant|0|||
144535933|NCT02719574|521166078|FG012|Phase 2|Transplant|6|||
144535934|NCT02719574|521166079|FG013|Phase 2|Transplant|1|||
144535935|NCT02719574|521166080|FG014|Phase 2|Transplant|1|||
144535936|NCT02719574|521166081|FG015|Phase 2|Transplant|0|||
144535937|NCT02719574|521166082|FG016|Phase 2|Transplant|0|||
144535938|NCT02719574|521166066|FG000|Phase 2|Death|0|||
144535939|NCT02719574|521166067|FG001|Phase 2|Death|0|||
144535940|NCT02719574|521166068|FG002|Phase 2|Death|0|||
144535941|NCT02719574|521166069|FG003|Phase 2|Death|0|||
144535942|NCT02719574|521166070|FG004|Phase 2|Death|0|||
144535943|NCT02719574|521166071|FG005|Phase 2|Death|0|||
144535944|NCT02719574|521166072|FG006|Phase 2|Death|0|||
144535945|NCT02719574|521166073|FG007|Phase 2|Death|0|||
144535946|NCT02719574|521166074|FG008|Phase 2|Death|0|||
144535947|NCT02719574|521166075|FG009|Phase 2|Death|14|||
144463410|NCT00113568|520893501|FG000|Overall Study|Adverse Event|97|||
144535948|NCT02719574|521166076|FG010|Phase 2|Death|0|||
144535949|NCT02719574|521166077|FG011|Phase 2|Death|0|||
144535950|NCT02719574|521166078|FG012|Phase 2|Death|1|||
144535951|NCT02719574|521166079|FG013|Phase 2|Death|1|||
144535952|NCT02719574|521166080|FG014|Phase 2|Death|2|||
144611438|NCT02819635|521438920|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
144611439|NCT02819635|521438921|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
144611440|NCT02819635|521438922|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
144611441|NCT02819635|521438923|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
144535953|NCT02719574|521166081|FG015|Phase 2|Death|0|||
144535954|NCT02719574|521166082|FG016|Phase 2|Death|0|||
144535955|NCT02719574|521166066|FG000|Phase 2|Investigator Decision|0|||
144463411|NCT00113568|520893501|FG000|Overall Study|Death|1|||
144463412|NCT00113568|520893501|FG000|Overall Study|Lack of Efficacy|30|||
144463413|NCT00113568|520893501|FG000|Overall Study|Lost to Follow-up|156|||
144463414|NCT00113568|520893501|FG000|Overall Study|Protocol Violation|32|||
144463415|NCT00113568|520893501|FG000|Overall Study|Withdrawal by Subject|117|||
144463416|NCT00113568|520893501|FG000|Overall Study|Other|112|||
144463417|NCT01988779|520893504|FG000|Overall Study|Withdrawal by Subject|2|||
144463418|NCT01988779|520893505|FG001|Overall Study|Withdrawal by Subject|2|||
144463419|NCT01988779|520893504|FG000|Overall Study|Protocol Violation|1|||
144463420|NCT01988779|520893505|FG001|Overall Study|Protocol Violation|0|||
144463421|NCT00377403|520893506|FG000|Overall Study|Unable to contact for telephone intervie|4|||
144463422|NCT00377403|520893507|FG001|Overall Study|Unable to contact for telephone intervie|7|||
144463423|NCT01041638|520893508|FG000|Overall Study|Adverse Event|4|||
144463424|NCT01041638|520893508|FG000|Overall Study|Death|1|||
144463425|NCT01041638|520893508|FG000|Overall Study|Lack of Efficacy|7|||
144463426|NCT01041638|520893508|FG000|Overall Study|Physician Decision|4|||
144463427|NCT01041638|520893508|FG000|Overall Study|Withdrawal by Subject|11|||
144463428|NCT01687257|520893512|FG000|Overall Study|Efficacy Failure|6|||
144463429|NCT01687257|520893513|FG001|Overall Study|Efficacy Failure|0|||
144463430|NCT01687257|520893514|FG002|Overall Study|Efficacy Failure|5|||
144463431|NCT01687257|520893512|FG000|Overall Study|Subject Withdrew Consent|1|||
144463432|NCT01687257|520893513|FG001|Overall Study|Subject Withdrew Consent|1|||
144463433|NCT01687257|520893514|FG002|Overall Study|Subject Withdrew Consent|1|||
144463434|NCT01687257|520893512|FG000|Overall Study|Adverse Event|1|||
144463435|NCT01687257|520893513|FG001|Overall Study|Adverse Event|0|||
144463436|NCT01687257|520893514|FG002|Overall Study|Adverse Event|0|||
144463437|NCT01687257|520893512|FG000|Overall Study|Investigator's Discretion|0|||
144463438|NCT01687257|520893513|FG001|Overall Study|Investigator's Discretion|3|||
144463439|NCT01687257|520893514|FG002|Overall Study|Investigator's Discretion|0|||
144463440|NCT04403698|520893515|FG000|Overall Study|Adverse Event|1|||
144463441|NCT04403698|520893516|FG001|Overall Study|Adverse Event|1|||
144463442|NCT04403698|520893515|FG000|Overall Study|Lost to Follow-up|1|||
144463443|NCT04403698|520893516|FG001|Overall Study|Lost to Follow-up|0|||
144463444|NCT04403698|520893515|FG000|Overall Study|Protocol Violation|0|||
144463445|NCT04403698|520893516|FG001|Overall Study|Protocol Violation|1|||
144463446|NCT01922076|520893517|FG000|Overall Study|Adverse Event|0|||
144463447|NCT01922076|520893518|FG001|Overall Study|Adverse Event|0|||
144463448|NCT01922076|520893519|FG002|Overall Study|Adverse Event|0|||
144463449|NCT01922076|520893520|FG003|Overall Study|Adverse Event|0|||
144463450|NCT01922076|520893521|FG004|Overall Study|Adverse Event|1|||
144463451|NCT01922076|520893522|FG005|Overall Study|Adverse Event|0|||
144463452|NCT01922076|520893523|FG006|Overall Study|Adverse Event|0|||
144463453|NCT01922076|520893517|FG000|Overall Study|Physician Decision|0|||
144463454|NCT01922076|520893518|FG001|Overall Study|Physician Decision|0|||
144463455|NCT01922076|520893519|FG002|Overall Study|Physician Decision|1|||
144463456|NCT01922076|520893520|FG003|Overall Study|Physician Decision|0|||
144463457|NCT01922076|520893521|FG004|Overall Study|Physician Decision|0|||
144463458|NCT01922076|520893522|FG005|Overall Study|Physician Decision|0|||
144463459|NCT01922076|520893523|FG006|Overall Study|Physician Decision|0|||
144463460|NCT01922076|520893517|FG000|Overall Study|Withdrawal by Subject|0|||
144463461|NCT01922076|520893518|FG001|Overall Study|Withdrawal by Subject|0|||
144463462|NCT01922076|520893519|FG002|Overall Study|Withdrawal by Subject|0|||
144463463|NCT01922076|520893520|FG003|Overall Study|Withdrawal by Subject|1|||
144463464|NCT01922076|520893521|FG004|Overall Study|Withdrawal by Subject|0|||
144463465|NCT01922076|520893522|FG005|Overall Study|Withdrawal by Subject|1|||
144463466|NCT01922076|520893523|FG006|Overall Study|Withdrawal by Subject|1|||
144463467|NCT04899349|520893524|FG000|Overall Study|Study terminated by Sponsor|2|||
144463468|NCT04899349|520893525|FG001|Overall Study|Study terminated by Sponsor|0|||
144463469|NCT01018394|520893526|FG000|Overall Study|Withdrawal by Subject|5|||
144463470|NCT01018394|520893527|FG001|Overall Study|Withdrawal by Subject|5|||
144611442|NCT02819635|521438924|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
144611443|NCT02819635|521438925|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
144611444|NCT02819635|521438926|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
144611445|NCT02819635|521438927|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
144463471|NCT01018394|520893526|FG000|Overall Study|Lost to Follow-up|4|||
144463472|NCT01018394|520893527|FG001|Overall Study|Lost to Follow-up|3|||
144463473|NCT00683644|520893528|FG000|Overall Study|Withdrawal by Subject|4|||
144463474|NCT00683644|520893529|FG001|Overall Study|Withdrawal by Subject|2|||
144463475|NCT00683644|520893528|FG000|Overall Study|Lost to Follow-up|1|||
144463476|NCT00683644|520893529|FG001|Overall Study|Lost to Follow-up|4|||
144463477|NCT00683644|520893528|FG000|Overall Study|Adverse Event|1|||
144463478|NCT00683644|520893529|FG001|Overall Study|Adverse Event|2|||
144463479|NCT00683644|520893528|FG000|Overall Study|Low copper, other health problems,|7|||
144463480|NCT00683644|520893529|FG001|Overall Study|Low copper, other health problems,|6|||
144463481|NCT03085485|520893530|FG000|Overall Study|Death|1|||
144463482|NCT03085485|520893531|FG001|Overall Study|Death|0|||
144463483|NCT03085485|520893530|FG000|Overall Study|Lost to Follow-up|1|||
144463484|NCT03085485|520893531|FG001|Overall Study|Lost to Follow-up|0|||
144611446|NCT02819635|521438928|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
144611447|NCT02819635|521438929|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
144463485|NCT01302119|520893532|FG000|Overall Study|Withdrawal by Subject|30|||
144463486|NCT01302119|520893533|FG001|Overall Study|Withdrawal by Subject|20|||
144463487|NCT01302119|520893532|FG000|Overall Study|Lost to Follow-up|10|||
144463488|NCT01302119|520893533|FG001|Overall Study|Lost to Follow-up|4|||
144463489|NCT01302119|520893532|FG000|Overall Study|Adverse Event|2|||
144463490|NCT01302119|520893533|FG001|Overall Study|Adverse Event|1|||
144463491|NCT01302119|520893532|FG000|Overall Study|Non-compliance|4|||
144463492|NCT01302119|520893533|FG001|Overall Study|Non-compliance|2|||
144463493|NCT01302119|520893532|FG000|Overall Study|Non-specific|4|||
144463494|NCT01302119|520893533|FG001|Overall Study|Non-specific|1|||
144463495|NCT01775904|520893537|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
144463496|NCT01775904|520893537|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
144463497|NCT01261338|520893543|FG000|Overall Study|Withdrawal by Subject|3|||
144463498|NCT01261338|520893544|FG001|Overall Study|Withdrawal by Subject|2|||
144463499|NCT00126438|520893545|FG000|Overall Study|Withdrawal due to adverse event|1|||
144463500|NCT00126438|520893546|FG001|Overall Study|Withdrawal due to adverse event|0|||
144463501|NCT00126438|520893545|FG000|Overall Study|Lost to Follow-up|22|||
144463502|NCT00126438|520893546|FG001|Overall Study|Lost to Follow-up|0|||
144463503|NCT00126438|520893545|FG000|Overall Study|Protocol Violation|8|||
144463504|NCT00126438|520893546|FG001|Overall Study|Protocol Violation|8|||
144463505|NCT00126438|520893545|FG000|Overall Study|Withdrawal by Subject|3|||
144463506|NCT00126438|520893546|FG001|Overall Study|Withdrawal by Subject|2|||
144463507|NCT02899728|520893547|FG000|Overall Study|Withdrawal by Subject|1|||
144463508|NCT02899728|520893548|FG001|Overall Study|Withdrawal by Subject|1|||
144463509|NCT01951625|520893549|FG000|Treatment Period|Protocol Violation|2|||
144463510|NCT01951625|520893550|FG001|Treatment Period|Protocol Violation|0|||
144463511|NCT01951625|520893551|FG002|Treatment Period|Protocol Violation|1|||
144463512|NCT01951625|520893552|FG003|Treatment Period|Protocol Violation|3|||
144463513|NCT01951625|520893553|FG004|Treatment Period|Protocol Violation|2|||
144463514|NCT01951625|520893549|FG000|Treatment Period|Physician Decision|0|||
144535956|NCT02719574|521166067|FG001|Phase 2|Investigator Decision|0|||
144535957|NCT02719574|521166068|FG002|Phase 2|Investigator Decision|0|||
144535958|NCT02719574|521166069|FG003|Phase 2|Investigator Decision|0|||
144535959|NCT02719574|521166070|FG004|Phase 2|Investigator Decision|0|||
144535960|NCT02719574|521166071|FG005|Phase 2|Investigator Decision|0|||
144535961|NCT02719574|521166072|FG006|Phase 2|Investigator Decision|0|||
144535962|NCT02719574|521166073|FG007|Phase 2|Investigator Decision|0|||
144535963|NCT02719574|521166074|FG008|Phase 2|Investigator Decision|0|||
144535964|NCT02719574|521166075|FG009|Phase 2|Investigator Decision|6|||
144535965|NCT02719574|521166076|FG010|Phase 2|Investigator Decision|1|||
144535966|NCT02719574|521166077|FG011|Phase 2|Investigator Decision|2|||
144535967|NCT02719574|521166078|FG012|Phase 2|Investigator Decision|3|||
144535968|NCT02719574|521166079|FG013|Phase 2|Investigator Decision|1|||
144535969|NCT02719574|521166080|FG014|Phase 2|Investigator Decision|3|||
144535970|NCT02719574|521166081|FG015|Phase 2|Investigator Decision|2|||
144535971|NCT02719574|521166082|FG016|Phase 2|Investigator Decision|0|||
144535972|NCT02719574|521166066|FG000|Phase 2|Withdrawal by Subject|0|||
144535973|NCT02719574|521166067|FG001|Phase 2|Withdrawal by Subject|0|||
144535974|NCT02719574|521166068|FG002|Phase 2|Withdrawal by Subject|0|||
144535975|NCT02719574|521166069|FG003|Phase 2|Withdrawal by Subject|0|||
144535976|NCT02719574|521166070|FG004|Phase 2|Withdrawal by Subject|0|||
144535977|NCT02719574|521166071|FG005|Phase 2|Withdrawal by Subject|0|||
144535978|NCT02719574|521166072|FG006|Phase 2|Withdrawal by Subject|0|||
144535979|NCT02719574|521166073|FG007|Phase 2|Withdrawal by Subject|0|||
144535980|NCT02719574|521166074|FG008|Phase 2|Withdrawal by Subject|0|||
144535981|NCT02719574|521166075|FG009|Phase 2|Withdrawal by Subject|5|||
144535982|NCT02719574|521166076|FG010|Phase 2|Withdrawal by Subject|0|||
144535983|NCT02719574|521166077|FG011|Phase 2|Withdrawal by Subject|0|||
144463515|NCT01951625|520893550|FG001|Treatment Period|Physician Decision|0|||
144463516|NCT01951625|520893551|FG002|Treatment Period|Physician Decision|0|||
144463517|NCT01951625|520893552|FG003|Treatment Period|Physician Decision|0|||
144463518|NCT01951625|520893553|FG004|Treatment Period|Physician Decision|1|||
144535984|NCT02719574|521166078|FG012|Phase 2|Withdrawal by Subject|0|||
144535985|NCT02719574|521166079|FG013|Phase 2|Withdrawal by Subject|1|||
144535986|NCT02719574|521166080|FG014|Phase 2|Withdrawal by Subject|1|||
144535987|NCT02719574|521166081|FG015|Phase 2|Withdrawal by Subject|2|||
144535988|NCT02719574|521166082|FG016|Phase 2|Withdrawal by Subject|0|||
144535989|NCT02719574|521166066|FG000|Phase 2|Protocol Violation|0|||
144535990|NCT02719574|521166067|FG001|Phase 2|Protocol Violation|0|||
144535991|NCT02719574|521166068|FG002|Phase 2|Protocol Violation|0|||
144535992|NCT02719574|521166069|FG003|Phase 2|Protocol Violation|0|||
144535993|NCT02719574|521166070|FG004|Phase 2|Protocol Violation|0|||
144535994|NCT02719574|521166071|FG005|Phase 2|Protocol Violation|0|||
144463519|NCT01951625|520893549|FG000|Treatment Period|Protocol driven decision point|0|||
144535995|NCT02719574|521166072|FG006|Phase 2|Protocol Violation|0|||
144535996|NCT02719574|521166073|FG007|Phase 2|Protocol Violation|0|||
144535997|NCT02719574|521166074|FG008|Phase 2|Protocol Violation|0|||
144463520|NCT01951625|520893550|FG001|Treatment Period|Protocol driven decision point|5|||
144463521|NCT01951625|520893551|FG002|Treatment Period|Protocol driven decision point|0|||
144463522|NCT01951625|520893552|FG003|Treatment Period|Protocol driven decision point|2|||
144463523|NCT01951625|520893553|FG004|Treatment Period|Protocol driven decision point|1|||
144463524|NCT01951625|520893549|FG000|Treatment Period|Non compliance with study drug|1|||
144463525|NCT01951625|520893550|FG001|Treatment Period|Non compliance with study drug|2|||
144463526|NCT01951625|520893551|FG002|Treatment Period|Non compliance with study drug|2|||
144463527|NCT01951625|520893552|FG003|Treatment Period|Non compliance with study drug|0|||
144463528|NCT01951625|520893553|FG004|Treatment Period|Non compliance with study drug|0|||
144463529|NCT01951625|520893549|FG000|Treatment Period|Death|3|||
144463530|NCT01951625|520893550|FG001|Treatment Period|Death|2|||
144463531|NCT01951625|520893551|FG002|Treatment Period|Death|2|||
144463532|NCT01951625|520893552|FG003|Treatment Period|Death|1|||
144463533|NCT01951625|520893553|FG004|Treatment Period|Death|2|||
144463534|NCT01951625|520893549|FG000|Treatment Period|Adverse Event|7|||
144463535|NCT01951625|520893550|FG001|Treatment Period|Adverse Event|10|||
144463536|NCT01951625|520893551|FG002|Treatment Period|Adverse Event|9|||
144463537|NCT01951625|520893552|FG003|Treatment Period|Adverse Event|8|||
144463538|NCT01951625|520893553|FG004|Treatment Period|Adverse Event|8|||
144463539|NCT01951625|520893549|FG000|Treatment Period|Withdrawal by Subject|5|||
144463540|NCT01951625|520893550|FG001|Treatment Period|Withdrawal by Subject|2|||
144463541|NCT01951625|520893551|FG002|Treatment Period|Withdrawal by Subject|1|||
144463542|NCT01951625|520893552|FG003|Treatment Period|Withdrawal by Subject|7|||
144463543|NCT01951625|520893553|FG004|Treatment Period|Withdrawal by Subject|3|||
144463544|NCT01951625|520893549|FG000|Treatment Period|Lost to Follow-up|1|||
144463545|NCT01951625|520893550|FG001|Treatment Period|Lost to Follow-up|0|||
144463546|NCT01951625|520893551|FG002|Treatment Period|Lost to Follow-up|0|||
144463547|NCT01951625|520893552|FG003|Treatment Period|Lost to Follow-up|1|||
144463548|NCT01951625|520893553|FG004|Treatment Period|Lost to Follow-up|0|||
144463549|NCT01951625|520893549|FG000|Follow Up Period|Non-compliance with study drug|1|||
144463550|NCT01951625|520893550|FG001|Follow Up Period|Non-compliance with study drug|0|||
144463551|NCT01951625|520893551|FG002|Follow Up Period|Non-compliance with study drug|0|||
144463552|NCT01951625|520893552|FG003|Follow Up Period|Non-compliance with study drug|0|||
144463553|NCT01951625|520893553|FG004|Follow Up Period|Non-compliance with study drug|0|||
144463554|NCT01951625|520893549|FG000|Follow Up Period|Death|1|||
144463555|NCT01951625|520893550|FG001|Follow Up Period|Death|3|||
144463556|NCT01951625|520893551|FG002|Follow Up Period|Death|2|||
144463557|NCT01951625|520893552|FG003|Follow Up Period|Death|2|||
144463558|NCT01951625|520893553|FG004|Follow Up Period|Death|1|||
144463559|NCT01951625|520893549|FG000|Follow Up Period|Logistical difficulties|1|||
144463560|NCT01951625|520893550|FG001|Follow Up Period|Logistical difficulties|2|||
144463561|NCT01951625|520893551|FG002|Follow Up Period|Logistical difficulties|0|||
144463562|NCT01951625|520893552|FG003|Follow Up Period|Logistical difficulties|0|||
144463563|NCT01951625|520893553|FG004|Follow Up Period|Logistical difficulties|0|||
144463564|NCT01951625|520893549|FG000|Follow Up Period|Adverse Event|0|||
144463565|NCT01951625|520893550|FG001|Follow Up Period|Adverse Event|3|||
144463566|NCT01951625|520893551|FG002|Follow Up Period|Adverse Event|2|||
144463567|NCT01951625|520893552|FG003|Follow Up Period|Adverse Event|3|||
144463568|NCT01951625|520893553|FG004|Follow Up Period|Adverse Event|5|||
144463569|NCT01951625|520893549|FG000|Follow Up Period|Withdrawal by Subject|4|||
144463570|NCT01951625|520893550|FG001|Follow Up Period|Withdrawal by Subject|1|||
144463571|NCT01951625|520893551|FG002|Follow Up Period|Withdrawal by Subject|0|||
144463572|NCT01951625|520893552|FG003|Follow Up Period|Withdrawal by Subject|5|||
144463573|NCT01951625|520893553|FG004|Follow Up Period|Withdrawal by Subject|3|||
144463574|NCT01951625|520893549|FG000|Follow Up Period|Lost to Follow-up|1|||
144463575|NCT01951625|520893550|FG001|Follow Up Period|Lost to Follow-up|0|||
144463576|NCT01951625|520893551|FG002|Follow Up Period|Lost to Follow-up|0|||
144258018|NCT04004260|520146938|FG000|Overall Study|Withdrawal by Subject|7|||
144463577|NCT01951625|520893552|FG003|Follow Up Period|Lost to Follow-up|1|||
144463578|NCT01951625|520893553|FG004|Follow Up Period|Lost to Follow-up|1|||
144463579|NCT00613951|520893555|FG000|Overall Study|Adverse Event|1|||
144463580|NCT00613951|520893556|FG001|Overall Study|Adverse Event|0|||
144463581|NCT00613951|520893557|FG002|Overall Study|Adverse Event|1|||
144463582|NCT00613951|520893555|FG000|Overall Study|Lack of Efficacy|0|||
144463583|NCT00613951|520893556|FG001|Overall Study|Lack of Efficacy|1|||
144463584|NCT00613951|520893557|FG002|Overall Study|Lack of Efficacy|1|||
144463585|NCT00613951|520893555|FG000|Overall Study|Protocol Violation|1|||
144463586|NCT00613951|520893556|FG001|Overall Study|Protocol Violation|1|||
144463587|NCT00613951|520893557|FG002|Overall Study|Protocol Violation|1|||
144463588|NCT00613951|520893555|FG000|Overall Study|Unclassified|5|||
144463589|NCT00613951|520893556|FG001|Overall Study|Unclassified|3|||
144463590|NCT00613951|520893557|FG002|Overall Study|Unclassified|2|||
144463591|NCT05540522|520893558|FG000|Overall Study|Adverse Event|1|||
144463592|NCT05540522|520893559|FG001|Overall Study|Adverse Event|0|||
144463593|NCT05540522|520893560|FG002|Overall Study|Adverse Event|2|||
144463594|NCT05540522|520893561|FG003|Overall Study|Adverse Event|5|||
144463595|NCT05540522|520893558|FG000|Overall Study|Lost to Follow-up|487|||
144463596|NCT05540522|520893559|FG001|Overall Study|Lost to Follow-up|427|||
144463597|NCT05540522|520893560|FG002|Overall Study|Lost to Follow-up|146|||
144463598|NCT05540522|520893561|FG003|Overall Study|Lost to Follow-up|166|||
144463599|NCT05540522|520893558|FG000|Overall Study|Physician Decision|11|||
144463600|NCT05540522|520893559|FG001|Overall Study|Physician Decision|19|||
144463601|NCT05540522|520893560|FG002|Overall Study|Physician Decision|8|||
144463602|NCT05540522|520893561|FG003|Overall Study|Physician Decision|13|||
144463603|NCT05540522|520893558|FG000|Overall Study|Pregnancy|1|||
144463604|NCT05540522|520893559|FG001|Overall Study|Pregnancy|0|||
144463605|NCT05540522|520893560|FG002|Overall Study|Pregnancy|0|||
144463606|NCT05540522|520893561|FG003|Overall Study|Pregnancy|0|||
144463607|NCT05540522|520893558|FG000|Overall Study|Protocol Violation|3|||
144463608|NCT05540522|520893559|FG001|Overall Study|Protocol Violation|1|||
144463609|NCT05540522|520893560|FG002|Overall Study|Protocol Violation|9|||
144463610|NCT05540522|520893561|FG003|Overall Study|Protocol Violation|7|||
144463611|NCT05540522|520893558|FG000|Overall Study|Withdrawal by Subject|168|||
144463612|NCT05540522|520893559|FG001|Overall Study|Withdrawal by Subject|134|||
144463613|NCT05540522|520893560|FG002|Overall Study|Withdrawal by Subject|331|||
144463614|NCT05540522|520893561|FG003|Overall Study|Withdrawal by Subject|322|||
144463615|NCT05540522|520893558|FG000|Overall Study|Death|7|||
144463616|NCT05540522|520893559|FG001|Overall Study|Death|9|||
144463617|NCT05540522|520893560|FG002|Overall Study|Death|49|||
144463618|NCT05540522|520893561|FG003|Overall Study|Death|46|||
144463619|NCT05540522|520893558|FG000|Overall Study|Not vaccinated|34|||
144463620|NCT05540522|520893559|FG001|Overall Study|Not vaccinated|53|||
144463621|NCT05540522|520893560|FG002|Overall Study|Not vaccinated|57|||
144463622|NCT05540522|520893561|FG003|Overall Study|Not vaccinated|50|||
144463623|NCT05540522|520893558|FG000|Overall Study|No longer meets eligibility criteria|0|||
144463624|NCT05540522|520893559|FG001|Overall Study|No longer meets eligibility criteria|0|||
144463625|NCT05540522|520893560|FG002|Overall Study|No longer meets eligibility criteria|3|||
144463626|NCT05540522|520893561|FG003|Overall Study|No longer meets eligibility criteria|2|||
144463627|NCT05540522|520893558|FG000|Overall Study|Other (Unspecified)|8|||
144463628|NCT05540522|520893559|FG001|Overall Study|Other (Unspecified)|10|||
144463629|NCT05540522|520893560|FG002|Overall Study|Other (Unspecified)|4|||
144463630|NCT05540522|520893561|FG003|Overall Study|Other (Unspecified)|2|||
144463631|NCT03754803|520893562|FG000|Overall Study|Withdrawal by Subject|2|||
144463632|NCT04348604|520893565|FG000|Week 8|Withdrawal by Subject|1|||
144463633|NCT04348604|520893566|FG001|Week 8|Withdrawal by Subject|1|||
144463634|NCT04348604|520893565|FG000|Week 8|Lost to Follow-up|1|||
144463635|NCT04348604|520893566|FG001|Week 8|Lost to Follow-up|2|||
144463636|NCT04348604|520893565|FG000|Week 8|Suspended|0|||
144463637|NCT04348604|520893566|FG001|Week 8|Suspended|1|||
144463638|NCT04348604|520893565|FG000|Week 12|Lost to Follow-up|1|||
144463639|NCT04348604|520893566|FG001|Week 12|Lost to Follow-up|2|||
144463640|NCT04348604|520893565|FG000|Week 12|Withdrawal by Subject|1|||
144463641|NCT04348604|520893566|FG001|Week 12|Withdrawal by Subject|0|||
144463642|NCT04348604|520893565|FG000|Week 24|Lost to Follow-up|2|||
144463643|NCT04348604|520893566|FG001|Week 24|Lost to Follow-up|1|||
144463644|NCT02097108|520893567|FG000|Overall Study|Adverse Event|1|||
144463645|NCT02097108|520893567|FG000|Overall Study|patient was abroad for 6 months|1|||
144463646|NCT04918784|520895228|FG000|Overall Study|Amputation - no longer eligible|1|||
144463647|NCT04918784|520895229|FG001|Overall Study|Amputation - no longer eligible|2|||
144463648|NCT04918784|520895228|FG000|Overall Study|Death|1|||
144463649|NCT04918784|520895229|FG001|Overall Study|Death|0|||
144463650|NCT04918784|520895228|FG000|Overall Study|patient non-compliance|3|||
144463651|NCT04918784|520895229|FG001|Overall Study|patient non-compliance|1|||
144463652|NCT04918784|520895228|FG000|Overall Study|Adverse Event|1|||
144463653|NCT04918784|520895229|FG001|Overall Study|Adverse Event|0|||
144463654|NCT01712009|520895230|FG000|Overall Study|Withdrawal by Subject|24|||
144463655|NCT01712009|520895231|FG001|Overall Study|Withdrawal by Subject|15|||
144463656|NCT01712009|520895232|FG002|Overall Study|Withdrawal by Subject|8|||
144463657|NCT01712009|520895230|FG000|Overall Study|Lost to Follow-up|2|||
144463658|NCT01712009|520895231|FG001|Overall Study|Lost to Follow-up|0|||
144463659|NCT01712009|520895232|FG002|Overall Study|Lost to Follow-up|1|||
144463660|NCT01712009|520895230|FG000|Overall Study|Decision by Sponsor|12|||
144463661|NCT01712009|520895231|FG001|Overall Study|Decision by Sponsor|14|||
144463662|NCT01712009|520895232|FG002|Overall Study|Decision by Sponsor|12|||
144463663|NCT04050865|520895240|FG000|Overall Study|Adverse Event|1|||
144463664|NCT04050865|520895241|FG001|Overall Study|Adverse Event|0|||
144463665|NCT04050865|520895240|FG000|Overall Study|no insert|1|||
144463666|NCT04050865|520895241|FG001|Overall Study|no insert|0|||
144463667|NCT04050865|520895240|FG000|Overall Study|Only 1 insert|2|||
144463668|NCT04050865|520895241|FG001|Overall Study|Only 1 insert|3|||
144463669|NCT04050865|520895240|FG000|Overall Study|Physician Decision|0|||
144463670|NCT04050865|520895241|FG001|Overall Study|Physician Decision|1|||
144535998|NCT02719574|521166075|FG009|Phase 2|Protocol Violation|1|||
144535999|NCT02719574|521166076|FG010|Phase 2|Protocol Violation|0|||
144536000|NCT02719574|521166077|FG011|Phase 2|Protocol Violation|0|||
144536001|NCT02719574|521166078|FG012|Phase 2|Protocol Violation|0|||
144536002|NCT02719574|521166079|FG013|Phase 2|Protocol Violation|0|||
144536003|NCT02719574|521166080|FG014|Phase 2|Protocol Violation|0|||
144463671|NCT04050865|520895240|FG000|Overall Study|Withdrawal by Subject|0|||
144463672|NCT04050865|520895241|FG001|Overall Study|Withdrawal by Subject|1|||
144463673|NCT00857207|520895242|FG000|Overall Study|Withdrawal by Subject|13|||
144463674|NCT00857207|520895243|FG001|Overall Study|Withdrawal by Subject|0|||
144463675|NCT00857207|520895242|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
144463676|NCT00857207|520895243|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
144463677|NCT00857207|520895242|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
144463678|NCT00857207|520895243|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
144463679|NCT00677833|520895244|FG000|Overall Study|Withdrawal by Subject|4|||
144463680|NCT00677833|520895245|FG001|Overall Study|Withdrawal by Subject|0|||
144463681|NCT00677833|520895246|FG002|Overall Study|Withdrawal by Subject|1|||
144463682|NCT00677833|520895247|FG003|Overall Study|Withdrawal by Subject|3|||
144463683|NCT00677833|520895244|FG000|Overall Study|Lost to Follow-up|0|||
144463684|NCT00677833|520895245|FG001|Overall Study|Lost to Follow-up|0|||
144463685|NCT00677833|520895246|FG002|Overall Study|Lost to Follow-up|1|||
144463686|NCT00677833|520895247|FG003|Overall Study|Lost to Follow-up|0|||
144463687|NCT02184611|520895248|FG000|Overall Study|Lack of Efficacy|11|||
144463688|NCT02184611|520895249|FG001|Overall Study|Lack of Efficacy|15|||
144463689|NCT02184611|520895248|FG000|Overall Study|Withdrawal by Subject|5|||
144463690|NCT02184611|520895249|FG001|Overall Study|Withdrawal by Subject|6|||
144463691|NCT02184611|520895248|FG000|Overall Study|Adverse Event|4|||
144463692|NCT02184611|520895249|FG001|Overall Study|Adverse Event|5|||
144463693|NCT02184611|520895248|FG000|Overall Study|Protocol Violation|1|||
144463694|NCT02184611|520895249|FG001|Overall Study|Protocol Violation|1|||
144463695|NCT02184611|520895248|FG000|Overall Study|Protocol defined stopping criteria|0|||
144463696|NCT02184611|520895249|FG001|Overall Study|Protocol defined stopping criteria|1|||
144463697|NCT00160680|520895250|FG000|Overall Study|Adverse Event|0|||
144463698|NCT00160680|520895251|FG001|Overall Study|Adverse Event|1|||
144463699|NCT00160680|520895250|FG000|Overall Study|Lack of Efficacy|2|||
144463700|NCT00160680|520895251|FG001|Overall Study|Lack of Efficacy|1|||
144463701|NCT00160680|520895250|FG000|Overall Study|Lost to Follow-up|3|||
144463702|NCT00160680|520895251|FG001|Overall Study|Lost to Follow-up|2|||
144463703|NCT00160680|520895250|FG000|Overall Study|Withdrawal by Subject|4|||
144463704|NCT00160680|520895251|FG001|Overall Study|Withdrawal by Subject|9|||
144463705|NCT04493216|520895252|FG000|Overall Study|Study terminated by sponsor|30|||
144463706|NCT04493216|520895253|FG001|Overall Study|Study terminated by sponsor|33|||
144463707|NCT04493216|520895254|FG002|Overall Study|Study terminated by sponsor|28|||
144463708|NCT04493216|520895255|FG003|Overall Study|Study terminated by sponsor|27|||
144463709|NCT04493216|520895252|FG000|Overall Study|Withdrawal by Subject|2|||
144463710|NCT04493216|520895253|FG001|Overall Study|Withdrawal by Subject|1|||
144463711|NCT04493216|520895254|FG002|Overall Study|Withdrawal by Subject|1|||
144463712|NCT04493216|520895255|FG003|Overall Study|Withdrawal by Subject|2|||
144463713|NCT04493216|520895252|FG000|Overall Study|Protocol Violation|1|||
144463714|NCT04493216|520895253|FG001|Overall Study|Protocol Violation|2|||
144463715|NCT04493216|520895254|FG002|Overall Study|Protocol Violation|0|||
144463716|NCT04493216|520895255|FG003|Overall Study|Protocol Violation|2|||
144463717|NCT04493216|520895252|FG000|Overall Study|Physician Decision|0|||
144463718|NCT04493216|520895253|FG001|Overall Study|Physician Decision|0|||
144463719|NCT04493216|520895254|FG002|Overall Study|Physician Decision|1|||
144463720|NCT04493216|520895255|FG003|Overall Study|Physician Decision|0|||
144463721|NCT04493216|520895252|FG000|Overall Study|Lost to Follow-up|2|||
144463722|NCT04493216|520895253|FG001|Overall Study|Lost to Follow-up|1|||
144463723|NCT04493216|520895254|FG002|Overall Study|Lost to Follow-up|0|||
144463724|NCT04493216|520895255|FG003|Overall Study|Lost to Follow-up|1|||
144463725|NCT04493216|520895252|FG000|Overall Study|Adverse Event|1|||
144463726|NCT04493216|520895253|FG001|Overall Study|Adverse Event|4|||
144463727|NCT04493216|520895254|FG002|Overall Study|Adverse Event|5|||
144463728|NCT04493216|520895255|FG003|Overall Study|Adverse Event|2|||
144463729|NCT04493216|520895252|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
144463730|NCT04493216|520895253|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
144463731|NCT04493216|520895254|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
144536004|NCT02719574|521166081|FG015|Phase 2|Protocol Violation|0|||
144536005|NCT02719574|521166082|FG016|Phase 2|Protocol Violation|0|||
144536006|NCT00495677|521166086|FG000|Stage 1 (25 Days)|Adverse Event|0|||
144536007|NCT00495677|521166087|FG001|Stage 1 (25 Days)|Adverse Event|0|||
144536008|NCT00495677|521166088|FG002|Stage 1 (25 Days)|Adverse Event|1|||
144536009|NCT00495677|521166089|FG003|Stage 1 (25 Days)|Adverse Event|0|||
144463732|NCT04493216|520895255|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
144463733|NCT00985725|520895256|FG000|Overall Study|Adverse Event|4|||
144536010|NCT00495677|521166090|FG004|Stage 1 (25 Days)|Adverse Event|0|||
144536011|NCT00495677|521166091|FG005|Stage 1 (25 Days)|Adverse Event|0|||
144536012|NCT00495677|521166092|FG006|Stage 1 (25 Days)|Adverse Event|0|||
144536013|NCT04129164|521166100|FG000|Overall Study|Non-compliance with procedures|0|||
144536014|NCT04129164|521166101|FG001|Overall Study|Non-compliance with procedures|0|||
144536015|NCT04129164|521166102|FG002|Overall Study|Non-compliance with procedures|2|||
144611448|NCT02819635|521438918|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144463734|NCT00985725|520895257|FG001|Overall Study|Adverse Event|1|||
144463735|NCT00985725|520895256|FG000|Overall Study|Protocol Violation|1|||
144463736|NCT00985725|520895257|FG001|Overall Study|Protocol Violation|3|||
144463737|NCT00985725|520895256|FG000|Overall Study|Withdrawal by Subject|4|||
144463738|NCT00985725|520895257|FG001|Overall Study|Withdrawal by Subject|4|||
144463739|NCT00985725|520895256|FG000|Overall Study|Lost to Follow-up|1|||
144463740|NCT00985725|520895257|FG001|Overall Study|Lost to Follow-up|1|||
144463741|NCT00985725|520895256|FG000|Overall Study|Lack of Efficacy|0|||
144463742|NCT00985725|520895257|FG001|Overall Study|Lack of Efficacy|1|||
144463743|NCT00985725|520895256|FG000|Overall Study|Non-compliance|1|||
144463744|NCT00985725|520895257|FG001|Overall Study|Non-compliance|2|||
144463745|NCT00985725|520895256|FG000|Overall Study|Out-of-window visits|0|||
144463746|NCT00985725|520895257|FG001|Overall Study|Out-of-window visits|1|||
144463747|NCT03151005|520895258|FG000|Overall Study|Lost to Follow-up|5|||
144463748|NCT03151005|520895259|FG001|Overall Study|Lost to Follow-up|5|||
144463749|NCT02794285|520895262|FG000|Overall Study|Adverse Event|11|||
144463750|NCT02794285|520895263|FG001|Overall Study|Adverse Event|4|||
144463751|NCT02794285|520895264|FG002|Overall Study|Adverse Event|5|||
144463752|NCT02794285|520895265|FG003|Overall Study|Adverse Event|8|||
144463753|NCT02794285|520895262|FG000|Overall Study|Condition Under Investigation Improved|1|||
144463754|NCT02794285|520895263|FG001|Overall Study|Condition Under Investigation Improved|0|||
144463755|NCT02794285|520895264|FG002|Overall Study|Condition Under Investigation Improved|0|||
144463756|NCT02794285|520895265|FG003|Overall Study|Condition Under Investigation Improved|0|||
144463757|NCT02794285|520895262|FG000|Overall Study|Condition Under Investigation Worsened|0|||
144463758|NCT02794285|520895263|FG001|Overall Study|Condition Under Investigation Worsened|2|||
144463759|NCT02794285|520895264|FG002|Overall Study|Condition Under Investigation Worsened|1|||
144463760|NCT02794285|520895265|FG003|Overall Study|Condition Under Investigation Worsened|0|||
144463761|NCT02794285|520895262|FG000|Overall Study|Death|2|||
144463762|NCT02794285|520895263|FG001|Overall Study|Death|1|||
144463763|NCT02794285|520895264|FG002|Overall Study|Death|2|||
144463764|NCT02794285|520895265|FG003|Overall Study|Death|0|||
144463765|NCT02794285|520895262|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
144463766|NCT02794285|520895263|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
144463767|NCT02794285|520895264|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
144463768|NCT02794285|520895265|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
144463769|NCT02794285|520895262|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
144463770|NCT02794285|520895263|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
144463771|NCT02794285|520895264|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
144463772|NCT02794285|520895265|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
144463773|NCT02794285|520895262|FG000|Overall Study|Lack of Efficacy|10|||
144463774|NCT02794285|520895263|FG001|Overall Study|Lack of Efficacy|6|||
144463775|NCT02794285|520895264|FG002|Overall Study|Lack of Efficacy|3|||
144463776|NCT02794285|520895265|FG003|Overall Study|Lack of Efficacy|3|||
144463777|NCT02794285|520895262|FG000|Overall Study|Lost to Follow-up|5|||
144463778|NCT02794285|520895263|FG001|Overall Study|Lost to Follow-up|6|||
144463779|NCT02794285|520895264|FG002|Overall Study|Lost to Follow-up|3|||
144463780|NCT02794285|520895265|FG003|Overall Study|Lost to Follow-up|1|||
144463781|NCT02794285|520895262|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
144463782|NCT02794285|520895263|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
144463783|NCT02794285|520895264|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
144463784|NCT02794285|520895265|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
144463785|NCT02794285|520895262|FG000|Overall Study|Withdrawal by Subject|38|||
144463786|NCT02794285|520895263|FG001|Overall Study|Withdrawal by Subject|29|||
144463787|NCT02794285|520895264|FG002|Overall Study|Withdrawal by Subject|20|||
144463788|NCT02794285|520895265|FG003|Overall Study|Withdrawal by Subject|12|||
144463789|NCT02794285|520895262|FG000|Overall Study|Missing|1|||
144463790|NCT02794285|520895263|FG001|Overall Study|Missing|0|||
144463791|NCT02794285|520895264|FG002|Overall Study|Missing|0|||
144463792|NCT02794285|520895265|FG003|Overall Study|Missing|0|||
144463793|NCT02794285|520895262|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
144463794|NCT02794285|520895263|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
144463795|NCT02794285|520895264|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
144463796|NCT02794285|520895265|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
144463797|NCT02794285|520895262|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
144463798|NCT02794285|520895263|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
144463799|NCT02794285|520895264|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
144463800|NCT02794285|520895265|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
144463801|NCT03252587|520895266|FG000|Overall Study|Adverse Event|3|||
144463802|NCT03252587|520895267|FG001|Overall Study|Adverse Event|8|||
144463803|NCT03252587|520895268|FG002|Overall Study|Adverse Event|6|||
144463804|NCT03252587|520895269|FG003|Overall Study|Adverse Event|12|||
144463805|NCT03252587|520895266|FG000|Overall Study|Lack of Efficacy|7|||
144463806|NCT03252587|520895267|FG001|Overall Study|Lack of Efficacy|2|||
144463807|NCT03252587|520895268|FG002|Overall Study|Lack of Efficacy|2|||
144463808|NCT03252587|520895269|FG003|Overall Study|Lack of Efficacy|4|||
144463809|NCT03252587|520895266|FG000|Overall Study|Lost to Follow-up|2|||
144463810|NCT03252587|520895267|FG001|Overall Study|Lost to Follow-up|0|||
144463811|NCT03252587|520895268|FG002|Overall Study|Lost to Follow-up|0|||
144463812|NCT03252587|520895269|FG003|Overall Study|Lost to Follow-up|2|||
144463813|NCT03252587|520895266|FG000|Overall Study|Pregnancy|2|||
144463814|NCT03252587|520895267|FG001|Overall Study|Pregnancy|1|||
144463815|NCT03252587|520895268|FG002|Overall Study|Pregnancy|0|||
144463816|NCT03252587|520895269|FG003|Overall Study|Pregnancy|1|||
144463817|NCT03252587|520895266|FG000|Overall Study|Withdrawal by Subject|8|||
144463818|NCT03252587|520895267|FG001|Overall Study|Withdrawal by Subject|4|||
144463819|NCT03252587|520895268|FG002|Overall Study|Withdrawal by Subject|4|||
144463820|NCT03252587|520895269|FG003|Overall Study|Withdrawal by Subject|4|||
144463821|NCT03252587|520895266|FG000|Overall Study|Other Reasons|2|||
144463822|NCT03252587|520895267|FG001|Overall Study|Other Reasons|5|||
144463823|NCT03252587|520895268|FG002|Overall Study|Other Reasons|5|||
144463824|NCT03252587|520895269|FG003|Overall Study|Other Reasons|4|||
144463825|NCT03945188|520895270|FG000|Overall Study|Protocol Violation|1|||
144463826|NCT03945188|520895271|FG001|Overall Study|Protocol Violation|0|||
144463827|NCT03945188|520895270|FG000|Overall Study|Disease worsening|79|||
144463828|NCT03945188|520895271|FG001|Overall Study|Disease worsening|73|||
144463829|NCT03945188|520895270|FG000|Overall Study|Physician Decision|2|||
144463830|NCT03945188|520895271|FG001|Overall Study|Physician Decision|2|||
144463831|NCT03945188|520895270|FG000|Overall Study|Lack of Efficacy|7|||
144463832|NCT03945188|520895271|FG001|Overall Study|Lack of Efficacy|4|||
144463833|NCT03945188|520895270|FG000|Overall Study|Pregnancy|2|||
144463834|NCT03945188|520895271|FG001|Overall Study|Pregnancy|0|||
144463835|NCT03945188|520895270|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
144463836|NCT03945188|520895271|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
144463837|NCT03945188|520895270|FG000|Overall Study|Adverse Event|10|||
144463838|NCT03945188|520895271|FG001|Overall Study|Adverse Event|5|||
144463839|NCT03945188|520895270|FG000|Overall Study|Other|2|||
144463840|NCT03945188|520895271|FG001|Overall Study|Other|2|||
144463841|NCT03945188|520895270|FG000|Overall Study|Lost to Follow-up|1|||
144463842|NCT03945188|520895271|FG001|Overall Study|Lost to Follow-up|2|||
144463843|NCT00423176|520895286|FG000|Overall Study|Adverse Event|4|||
144463844|NCT00423176|520895287|FG001|Overall Study|Adverse Event|6|||
144463845|NCT00423176|520895286|FG000|Overall Study|Treatment Failure|1|||
144463846|NCT00423176|520895287|FG001|Overall Study|Treatment Failure|6|||
144463847|NCT00423176|520895286|FG000|Overall Study|Lost to Follow-up|4|||
144463848|NCT00423176|520895287|FG001|Overall Study|Lost to Follow-up|7|||
144463849|NCT00423176|520895286|FG000|Overall Study|Withdrawal by Subject|4|||
144463850|NCT00423176|520895287|FG001|Overall Study|Withdrawal by Subject|3|||
144463851|NCT00423176|520895286|FG000|Overall Study|Protocol Violation|1|||
144463852|NCT00423176|520895287|FG001|Overall Study|Protocol Violation|3|||
144463853|NCT00423176|520895286|FG000|Overall Study|Did not meet protocol eligibility|2|||
144463854|NCT00423176|520895287|FG001|Overall Study|Did not meet protocol eligibility|4|||
144463855|NCT05072080|520895290|FG000|Overall Study|Death|0|||
144463856|NCT05072080|520895291|FG001|Overall Study|Death|0|||
144463857|NCT05072080|520895292|FG002|Overall Study|Death|1|||
144463858|NCT05072080|520895293|FG003|Overall Study|Death|0|||
144463859|NCT05072080|520895290|FG000|Overall Study|Lost to Follow-up|65|||
144463860|NCT05072080|520895291|FG001|Overall Study|Lost to Follow-up|70|||
144463861|NCT05072080|520895292|FG002|Overall Study|Lost to Follow-up|58|||
144463862|NCT05072080|520895293|FG003|Overall Study|Lost to Follow-up|23|||
144463863|NCT05072080|520895290|FG000|Overall Study|Physician Decision|2|||
144463864|NCT05072080|520895291|FG001|Overall Study|Physician Decision|1|||
144463865|NCT05072080|520895292|FG002|Overall Study|Physician Decision|1|||
144611449|NCT02819635|521438919|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144611450|NCT02819635|521438920|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144611451|NCT02819635|521438921|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144463866|NCT05072080|520895293|FG003|Overall Study|Physician Decision|0|||
144463867|NCT05072080|520895290|FG000|Overall Study|Withdrawal by Subject|45|||
144463868|NCT05072080|520895291|FG001|Overall Study|Withdrawal by Subject|30|||
144611452|NCT02819635|521438922|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
144611453|NCT02819635|521438923|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
144463869|NCT05072080|520895292|FG002|Overall Study|Withdrawal by Subject|27|||
144463870|NCT05072080|520895293|FG003|Overall Study|Withdrawal by Subject|7|||
144463871|NCT05072080|520895290|FG000|Overall Study|Sponsor Decision|0|||
144463872|NCT05072080|520895291|FG001|Overall Study|Sponsor Decision|1|||
144463873|NCT05072080|520895292|FG002|Overall Study|Sponsor Decision|0|||
144463874|NCT05072080|520895293|FG003|Overall Study|Sponsor Decision|0|||
144463875|NCT05072080|520895290|FG000|Overall Study|Subject moved|1|||
144463876|NCT05072080|520895291|FG001|Overall Study|Subject moved|3|||
144463877|NCT05072080|520895292|FG002|Overall Study|Subject moved|5|||
144463878|NCT05072080|520895293|FG003|Overall Study|Subject moved|2|||
144463879|NCT05072080|520895290|FG000|Overall Study|Withdrawal by parent|0|||
144463880|NCT05072080|520895291|FG001|Overall Study|Withdrawal by parent|0|||
144463881|NCT05072080|520895292|FG002|Overall Study|Withdrawal by parent|1|||
144463882|NCT05072080|520895293|FG003|Overall Study|Withdrawal by parent|0|||
144463883|NCT05072080|520895290|FG000|Overall Study|Subject was deployed|0|||
144463884|NCT05072080|520895291|FG001|Overall Study|Subject was deployed|1|||
144463885|NCT05072080|520895292|FG002|Overall Study|Subject was deployed|0|||
144463886|NCT05072080|520895293|FG003|Overall Study|Subject was deployed|0|||
144463887|NCT05072080|520895290|FG000|Overall Study|Subject left site without receiving dose|0|||
144463888|NCT05072080|520895291|FG001|Overall Study|Subject left site without receiving dose|1|||
144463889|NCT05072080|520895292|FG002|Overall Study|Subject left site without receiving dose|0|||
144463890|NCT05072080|520895293|FG003|Overall Study|Subject left site without receiving dose|0|||
144463891|NCT05072080|520895290|FG000|Overall Study|Subject incarcerated|0|||
144463892|NCT05072080|520895291|FG001|Overall Study|Subject incarcerated|1|||
144463893|NCT05072080|520895292|FG002|Overall Study|Subject incarcerated|0|||
144463894|NCT05072080|520895293|FG003|Overall Study|Subject incarcerated|1|||
144463895|NCT05072080|520895290|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
144463896|NCT05072080|520895291|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
144463897|NCT05072080|520895292|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
144463898|NCT05072080|520895293|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
144463899|NCT05072080|520895290|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
144463900|NCT05072080|520895291|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
144463901|NCT05072080|520895292|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
144463902|NCT05072080|520895293|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
144463903|NCT01640808|520895295|FG000|Overall Study|Unable to continue dynamic CT|14|||
144463904|NCT01640808|520895296|FG001|Overall Study|Unable to continue dynamic CT|4|||
144463905|NCT01640808|520895295|FG000|Overall Study|Withdrawal by Subject|12|||
144463906|NCT01640808|520895296|FG001|Overall Study|Withdrawal by Subject|4|||
144463907|NCT01640808|520895295|FG000|Overall Study|Lost to Follow-up|4|||
144463908|NCT01640808|520895296|FG001|Overall Study|Lost to Follow-up|0|||
144463909|NCT01640808|520895295|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
144463910|NCT01640808|520895296|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
144463911|NCT01640808|520895295|FG000|Overall Study|Administration of anticancer drugs|2|||
144463912|NCT01640808|520895296|FG001|Overall Study|Administration of anticancer drugs|1|||
144463913|NCT01640808|520895295|FG000|Overall Study|Physician Decision|19|||
144463914|NCT01640808|520895296|FG001|Overall Study|Physician Decision|5|||
144463915|NCT01640808|520895295|FG000|Overall Study|Randomized but not treated|4|||
144463916|NCT01640808|520895296|FG001|Overall Study|Randomized but not treated|2|||
144463917|NCT02477111|520895297|FG000|Overall Study|Death|28|||
144463918|NCT02477111|520895297|FG000|Overall Study|Withdrawal by Subject|19|||
144463919|NCT02477111|520895297|FG000|Overall Study|Lost to Follow-up|4|||
144463920|NCT02192502|520895299|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
144463921|NCT02192502|520895300|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
144463922|NCT02192502|520895299|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
144463923|NCT02192502|520895300|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
144463924|NCT02192502|520895299|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
144463925|NCT02192502|520895300|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
144463926|NCT01381692|520895301|FG000|Overall Study|Adverse Event|1|||
144463927|NCT01381692|520895302|FG001|Overall Study|Adverse Event|0|||
144463928|NCT01381692|520895303|FG002|Overall Study|Adverse Event|0|||
144463929|NCT01381692|520895304|FG003|Overall Study|Adverse Event|0|||
144536016|NCT04129164|521166103|FG003|Overall Study|Non-compliance with procedures|0|||
144536017|NCT04129164|521166100|FG000|Overall Study|Adverse Event|0|||
144536018|NCT04129164|521166101|FG001|Overall Study|Adverse Event|0|||
144536019|NCT04129164|521166102|FG002|Overall Study|Adverse Event|2|||
144536020|NCT04129164|521166103|FG003|Overall Study|Adverse Event|0|||
144536021|NCT04129164|521166100|FG000|Overall Study|Pregnancy|0|||
144536022|NCT04129164|521166101|FG001|Overall Study|Pregnancy|0|||
144463930|NCT01381692|520895305|FG004|Overall Study|Adverse Event|0|||
144463931|NCT01381692|520895306|FG005|Overall Study|Adverse Event|0|||
144463932|NCT03896035|520895308|FG000|Overall Study|Lost to Follow-up|2|||
144463933|NCT03896035|520895309|FG001|Overall Study|Lost to Follow-up|6|||
144463934|NCT03896035|520895308|FG000|Overall Study|Withdrawal by Subject|0|||
144463935|NCT03896035|520895309|FG001|Overall Study|Withdrawal by Subject|1|||
144463936|NCT03896035|520895308|FG000|Overall Study|Health/family health issues during COVID|0|||
144463937|NCT03896035|520895309|FG001|Overall Study|Health/family health issues during COVID|4|||
144463938|NCT01506193|520895312|FG000|Overall Study|Protocol Violation|1|||
144463939|NCT01506193|520895313|FG001|Overall Study|Protocol Violation|0|||
144463940|NCT01506193|520895314|FG002|Overall Study|Protocol Violation|1|||
144463941|NCT01506193|520895312|FG000|Overall Study|Migrated/moved from study area|0|||
144463942|NCT01506193|520895313|FG001|Overall Study|Migrated/moved from study area|0|||
144536023|NCT04129164|521166102|FG002|Overall Study|Pregnancy|0|||
144463943|NCT01506193|520895314|FG002|Overall Study|Migrated/moved from study area|1|||
144463944|NCT01506193|520895312|FG000|Overall Study|Adverse event, non-fatal|0|||
144463945|NCT01506193|520895313|FG001|Overall Study|Adverse event, non-fatal|0|||
144463946|NCT01506193|520895314|FG002|Overall Study|Adverse event, non-fatal|1|||
144463947|NCT01506193|520895312|FG000|Overall Study|Withdrawal by Subject|5|||
144463948|NCT01506193|520895313|FG001|Overall Study|Withdrawal by Subject|1|||
144463949|NCT01506193|520895314|FG002|Overall Study|Withdrawal by Subject|8|||
144463950|NCT01506193|520895312|FG000|Overall Study|Lost to Follow-up|8|||
144463951|NCT01506193|520895313|FG001|Overall Study|Lost to Follow-up|3|||
144463952|NCT01506193|520895314|FG002|Overall Study|Lost to Follow-up|3|||
144463953|NCT01152580|520895318|FG000|Overall Study|Withdrawal by Subject|0|||
144463954|NCT01152580|520895319|FG001|Overall Study|Withdrawal by Subject|1|||
144463955|NCT00449176|520895321|FG000|Overall Study|Withdrawal by Subject|39|||
144463956|NCT00449176|520895322|FG001|Overall Study|Withdrawal by Subject|43|||
144463957|NCT00449176|520895323|FG002|Overall Study|Withdrawal by Subject|59|||
144463958|NCT00449176|520895321|FG000|Overall Study|Lost to Follow-up|13|||
144463959|NCT00449176|520895322|FG001|Overall Study|Lost to Follow-up|8|||
144463960|NCT00449176|520895323|FG002|Overall Study|Lost to Follow-up|12|||
144463961|NCT00449176|520895321|FG000|Overall Study|Adverse Event|51|||
144463962|NCT00449176|520895322|FG001|Overall Study|Adverse Event|107|||
144463963|NCT00449176|520895323|FG002|Overall Study|Adverse Event|15|||
144463964|NCT00449176|520895321|FG000|Overall Study|Lack of Efficacy|13|||
144463965|NCT00449176|520895322|FG001|Overall Study|Lack of Efficacy|7|||
144463966|NCT00449176|520895323|FG002|Overall Study|Lack of Efficacy|50|||
144463967|NCT00449176|520895321|FG000|Overall Study|Study drug non-compliant|14|||
144463968|NCT00449176|520895322|FG001|Overall Study|Study drug non-compliant|11|||
144463969|NCT00449176|520895323|FG002|Overall Study|Study drug non-compliant|11|||
144463970|NCT00449176|520895321|FG000|Overall Study|all other|22|||
144463971|NCT00449176|520895322|FG001|Overall Study|all other|19|||
144463972|NCT00449176|520895323|FG002|Overall Study|all other|20|||
144463973|NCT00675766|520895324|FG000|Overall Study|Lost to Follow-up|6|||
144463974|NCT00675766|520895325|FG001|Overall Study|Lost to Follow-up|5|||
144463975|NCT00675766|520895326|FG002|Overall Study|Lost to Follow-up|21|||
144463976|NCT00675766|520895327|FG003|Overall Study|Lost to Follow-up|26|||
144463977|NCT01749982|520895328|FG000|Overall Study|Physician Decision|0|||
144463978|NCT01749982|520895329|FG001|Overall Study|Physician Decision|0|||
144463979|NCT01749982|520895330|FG002|Overall Study|Physician Decision|0|||
144463980|NCT01749982|520895331|FG003|Overall Study|Physician Decision|1|||
144463981|NCT01749982|520895328|FG000|Overall Study|Lost to Follow-up|0|||
144463982|NCT01749982|520895329|FG001|Overall Study|Lost to Follow-up|0|||
144463983|NCT01749982|520895330|FG002|Overall Study|Lost to Follow-up|0|||
144463984|NCT01749982|520895331|FG003|Overall Study|Lost to Follow-up|1|||
144463985|NCT01749982|520895328|FG000|Overall Study|Withdrawal by Subject|0|||
144463986|NCT01749982|520895329|FG001|Overall Study|Withdrawal by Subject|0|||
144463987|NCT01749982|520895330|FG002|Overall Study|Withdrawal by Subject|0|||
144463988|NCT01749982|520895331|FG003|Overall Study|Withdrawal by Subject|1|||
144463989|NCT00736645|520895332|FG000|Overall Study|Adverse Event|0|||
144463990|NCT00736645|520895333|FG001|Overall Study|Adverse Event|2|||
144463991|NCT00736645|520895334|FG002|Overall Study|Adverse Event|0|||
144463992|NCT00736645|520895335|FG003|Overall Study|Adverse Event|0|||
144463993|NCT03792126|520895338|FG000|Overall Study|Adverse Event|1|||
144463994|NCT03792126|520895339|FG001|Overall Study|Adverse Event|2|||
144463995|NCT03792126|520895338|FG000|Overall Study|Death|0|||
144463996|NCT03792126|520895339|FG001|Overall Study|Death|1|||
144463997|NCT03792126|520895338|FG000|Overall Study|Lost to Follow-up|1|||
144463998|NCT03792126|520895339|FG001|Overall Study|Lost to Follow-up|0|||
144463999|NCT03792126|520895338|FG000|Overall Study|Withdrawal by Subject|0|||
144464000|NCT03792126|520895339|FG001|Overall Study|Withdrawal by Subject|1|||
144464001|NCT03792126|520895338|FG000|Overall Study|COVID-19 Restrictions|1|||
144536024|NCT04129164|521166103|FG003|Overall Study|Pregnancy|1|||
144536025|NCT04129164|521166100|FG000|Overall Study|Withdrawal by Subject|3|||
144536026|NCT04129164|521166101|FG001|Overall Study|Withdrawal by Subject|2|||
144536027|NCT04129164|521166102|FG002|Overall Study|Withdrawal by Subject|4|||
144536028|NCT04129164|521166103|FG003|Overall Study|Withdrawal by Subject|6|||
144536029|NCT04129164|521166100|FG000|Overall Study|Death|0|||
144536030|NCT04129164|521166101|FG001|Overall Study|Death|1|||
144536031|NCT04129164|521166102|FG002|Overall Study|Death|0|||
144464002|NCT03792126|520895339|FG001|Overall Study|COVID-19 Restrictions|3|||
144464003|NCT03792126|520895338|FG000|Overall Study|Symptoms resolved|0|||
144464004|NCT03792126|520895339|FG001|Overall Study|Symptoms resolved|3|||
144536032|NCT04129164|521166103|FG003|Overall Study|Death|0|||
144464005|NCT00441090|520895341|FG000|Overall Study|Adverse Event|0|||
144464006|NCT00441090|520895342|FG001|Overall Study|Adverse Event|1|||
144464007|NCT00441090|520895343|FG002|Overall Study|Adverse Event|1|||
144464008|NCT00441090|520895344|FG003|Overall Study|Adverse Event|0|||
144464009|NCT00441090|520895345|FG004|Overall Study|Adverse Event|0|||
144464010|NCT00441090|520895341|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
144464011|NCT00441090|520895342|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
144464012|NCT00441090|520895343|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
144464013|NCT00441090|520895344|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
144464014|NCT00441090|520895345|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
144536033|NCT04129164|521166100|FG000|Overall Study|Lost to Follow-up|0|||
144464015|NCT00441090|520895341|FG000|Overall Study|Withdrawal by Subject|1|||
144464016|NCT00441090|520895342|FG001|Overall Study|Withdrawal by Subject|0|||
144464017|NCT00441090|520895343|FG002|Overall Study|Withdrawal by Subject|1|||
144464018|NCT00441090|520895344|FG003|Overall Study|Withdrawal by Subject|0|||
144464019|NCT00441090|520895345|FG004|Overall Study|Withdrawal by Subject|0|||
144464020|NCT00441090|520895341|FG000|Overall Study|Lack of Efficacy|1|||
144464021|NCT00441090|520895342|FG001|Overall Study|Lack of Efficacy|0|||
144464022|NCT00441090|520895343|FG002|Overall Study|Lack of Efficacy|0|||
144464023|NCT00441090|520895344|FG003|Overall Study|Lack of Efficacy|0|||
144464024|NCT00441090|520895345|FG004|Overall Study|Lack of Efficacy|0|||
144464025|NCT00518115|520895346|FG000|Overall Study|Adverse Event|6|||
144464026|NCT00518115|520895347|FG001|Overall Study|Adverse Event|1|||
144464027|NCT00518115|520895348|FG002|Overall Study|Adverse Event|5|||
144464028|NCT00518115|520895349|FG003|Overall Study|Adverse Event|6|||
144464029|NCT00518115|520895350|FG004|Overall Study|Adverse Event|5|||
144464030|NCT00518115|520895351|FG005|Overall Study|Adverse Event|5|||
144464031|NCT00518115|520895352|FG006|Overall Study|Adverse Event|5|||
144464032|NCT00518115|520895353|FG007|Overall Study|Adverse Event|10|||
144464033|NCT00518115|520895354|FG008|Overall Study|Adverse Event|2|||
144464034|NCT00518115|520895355|FG009|Overall Study|Adverse Event|9|||
144464035|NCT00518115|520895346|FG000|Overall Study|Lost to Follow-up|0|||
144464036|NCT00518115|520895347|FG001|Overall Study|Lost to Follow-up|0|||
144464037|NCT00518115|520895348|FG002|Overall Study|Lost to Follow-up|2|||
144464038|NCT00518115|520895349|FG003|Overall Study|Lost to Follow-up|3|||
144464039|NCT00518115|520895350|FG004|Overall Study|Lost to Follow-up|1|||
144464040|NCT00518115|520895351|FG005|Overall Study|Lost to Follow-up|3|||
144464041|NCT00518115|520895352|FG006|Overall Study|Lost to Follow-up|0|||
144464042|NCT00518115|520895353|FG007|Overall Study|Lost to Follow-up|1|||
144464043|NCT00518115|520895354|FG008|Overall Study|Lost to Follow-up|1|||
144464044|NCT00518115|520895355|FG009|Overall Study|Lost to Follow-up|1|||
144464045|NCT00518115|520895346|FG000|Overall Study|Protocol Violation|1|||
144464046|NCT00518115|520895347|FG001|Overall Study|Protocol Violation|3|||
144464047|NCT00518115|520895348|FG002|Overall Study|Protocol Violation|1|||
144464048|NCT00518115|520895349|FG003|Overall Study|Protocol Violation|0|||
144464049|NCT00518115|520895350|FG004|Overall Study|Protocol Violation|0|||
144464050|NCT00518115|520895351|FG005|Overall Study|Protocol Violation|0|||
144464051|NCT00518115|520895352|FG006|Overall Study|Protocol Violation|0|||
144464052|NCT00518115|520895353|FG007|Overall Study|Protocol Violation|0|||
144464053|NCT00518115|520895354|FG008|Overall Study|Protocol Violation|0|||
144464054|NCT00518115|520895355|FG009|Overall Study|Protocol Violation|0|||
144464055|NCT00518115|520895346|FG000|Overall Study|Withdrawal by Subject|1|||
144464056|NCT00518115|520895347|FG001|Overall Study|Withdrawal by Subject|1|||
144464057|NCT00518115|520895348|FG002|Overall Study|Withdrawal by Subject|5|||
144464058|NCT00518115|520895349|FG003|Overall Study|Withdrawal by Subject|0|||
144464059|NCT00518115|520895350|FG004|Overall Study|Withdrawal by Subject|2|||
144464060|NCT00518115|520895351|FG005|Overall Study|Withdrawal by Subject|1|||
144464061|NCT00518115|520895352|FG006|Overall Study|Withdrawal by Subject|0|||
144464062|NCT00518115|520895353|FG007|Overall Study|Withdrawal by Subject|2|||
144464063|NCT00518115|520895354|FG008|Overall Study|Withdrawal by Subject|1|||
144464064|NCT00518115|520895355|FG009|Overall Study|Withdrawal by Subject|3|||
144464065|NCT00518115|520895346|FG000|Overall Study|Lack of Efficacy|1|||
144464066|NCT00518115|520895347|FG001|Overall Study|Lack of Efficacy|0|||
144464067|NCT00518115|520895348|FG002|Overall Study|Lack of Efficacy|1|||
144464068|NCT00518115|520895349|FG003|Overall Study|Lack of Efficacy|1|||
144464069|NCT00518115|520895350|FG004|Overall Study|Lack of Efficacy|0|||
144464070|NCT00518115|520895351|FG005|Overall Study|Lack of Efficacy|0|||
144464071|NCT00518115|520895352|FG006|Overall Study|Lack of Efficacy|0|||
144464072|NCT00518115|520895353|FG007|Overall Study|Lack of Efficacy|1|||
144464073|NCT00518115|520895354|FG008|Overall Study|Lack of Efficacy|0|||
144464074|NCT00518115|520895355|FG009|Overall Study|Lack of Efficacy|0|||
144464075|NCT00518115|520895346|FG000|Overall Study|Non-Compliance|1|||
144464076|NCT00518115|520895347|FG001|Overall Study|Non-Compliance|0|||
144464077|NCT00518115|520895348|FG002|Overall Study|Non-Compliance|1|||
144464078|NCT00518115|520895349|FG003|Overall Study|Non-Compliance|0|||
144464079|NCT00518115|520895350|FG004|Overall Study|Non-Compliance|1|||
144464080|NCT00518115|520895351|FG005|Overall Study|Non-Compliance|1|||
144464081|NCT00518115|520895352|FG006|Overall Study|Non-Compliance|1|||
144464082|NCT00518115|520895353|FG007|Overall Study|Non-Compliance|1|||
144464083|NCT00518115|520895354|FG008|Overall Study|Non-Compliance|0|||
144464084|NCT00518115|520895355|FG009|Overall Study|Non-Compliance|1|||
144464085|NCT00518115|520895346|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
144464086|NCT00518115|520895347|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
144536034|NCT04129164|521166101|FG001|Overall Study|Lost to Follow-up|1|||
144536035|NCT04129164|521166102|FG002|Overall Study|Lost to Follow-up|0|||
144536036|NCT04129164|521166103|FG003|Overall Study|Lost to Follow-up|0|||
144536037|NCT03653364|521166106|FG000|Overall Study|Withdrawal by Subject|1|||
144536038|NCT03653364|521166106|FG000|Overall Study|Enrolled in Error|1|||
144536039|NCT03653364|521166106|FG000|Overall Study|Death|1|||
144536040|NCT03983382|521166109|FG000|Overall Study|Death|1|||
144536041|NCT03983382|521166109|FG000|Overall Study|Lost to Follow-up|3|||
144536042|NCT03983382|521166109|FG000|Overall Study|Physician Decision|2|||
144536043|NCT03983382|521166109|FG000|Overall Study|Withdrawal by Subject|10|||
144536044|NCT03983382|521166109|FG000|Overall Study|Change in cancer treatment|2|||
144536045|NCT03705390|521166117|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
144536046|NCT03705390|521166117|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
144536047|NCT02989662|521166119|FG000|Overall Study|Lost to Follow-up|0|||
144536048|NCT02989662|521166120|FG001|Overall Study|Lost to Follow-up|0|||
144536049|NCT02989662|521166121|FG002|Overall Study|Lost to Follow-up|0|||
144536050|NCT02989662|521166122|FG003|Overall Study|Lost to Follow-up|2|||
144536051|NCT02989662|521166119|FG000|Overall Study|Physician Decision|3|||
144536052|NCT02989662|521166120|FG001|Overall Study|Physician Decision|0|||
144536053|NCT02989662|521166121|FG002|Overall Study|Physician Decision|0|||
144536054|NCT02989662|521166122|FG003|Overall Study|Physician Decision|0|||
144536055|NCT02989662|521166119|FG000|Overall Study|Withdrawal by Subject|1|||
144536056|NCT02989662|521166120|FG001|Overall Study|Withdrawal by Subject|0|||
144536057|NCT02989662|521166121|FG002|Overall Study|Withdrawal by Subject|0|||
144536058|NCT02989662|521166122|FG003|Overall Study|Withdrawal by Subject|0|||
144536059|NCT00357682|521166123|FG000|Overall Study|Did not receive allocated Treatment|10|||
144536060|NCT00357682|521166124|FG001|Overall Study|Did not receive allocated Treatment|9|||
144536061|NCT00357682|521166125|FG002|Overall Study|Did not receive allocated Treatment|9|||
144536062|NCT00357682|521166126|FG003|Overall Study|Did not receive allocated Treatment|10|||
144536063|NCT00357682|521166123|FG000|Overall Study|Withdrew consent|6|||
144536064|NCT00357682|521166124|FG001|Overall Study|Withdrew consent|6|||
144536065|NCT00357682|521166125|FG002|Overall Study|Withdrew consent|5|||
144536066|NCT00357682|521166126|FG003|Overall Study|Withdrew consent|5|||
144536067|NCT00357682|521166123|FG000|Overall Study|Lost to Follow-up|39|||
144536068|NCT00357682|521166124|FG001|Overall Study|Lost to Follow-up|33|||
144536069|NCT00357682|521166125|FG002|Overall Study|Lost to Follow-up|26|||
144536070|NCT00357682|521166126|FG003|Overall Study|Lost to Follow-up|35|||
144536071|NCT00357682|521166123|FG000|Overall Study|Adverse Event|24|||
144536072|NCT00357682|521166124|FG001|Overall Study|Adverse Event|32|||
144536073|NCT00357682|521166125|FG002|Overall Study|Adverse Event|22|||
144536074|NCT00357682|521166126|FG003|Overall Study|Adverse Event|27|||
144536075|NCT00357682|521166123|FG000|Overall Study|Physician Decision|32|||
144536076|NCT00357682|521166124|FG001|Overall Study|Physician Decision|20|||
144536077|NCT00357682|521166125|FG002|Overall Study|Physician Decision|24|||
144536078|NCT00357682|521166126|FG003|Overall Study|Physician Decision|30|||
144536079|NCT00357682|521166123|FG000|Overall Study|Patient decision|73|||
144536080|NCT00357682|521166124|FG001|Overall Study|Patient decision|80|||
144536081|NCT00357682|521166125|FG002|Overall Study|Patient decision|51|||
144536082|NCT00357682|521166126|FG003|Overall Study|Patient decision|59|||
144536083|NCT00357682|521166123|FG000|Overall Study|Other reason|157|||
144536084|NCT00357682|521166124|FG001|Overall Study|Other reason|130|||
144536085|NCT00357682|521166125|FG002|Overall Study|Other reason|114|||
144536086|NCT00357682|521166126|FG003|Overall Study|Other reason|99|||
144536087|NCT04174560|521166131|FG000|Overall Study|Lost to Follow-up|1|||
144536088|NCT04174560|521166132|FG001|Overall Study|Lost to Follow-up|0|||
144536089|NCT04174560|521166133|FG002|Overall Study|Lost to Follow-up|0|||
144536090|NCT04174560|521166134|FG003|Overall Study|Lost to Follow-up|0|||
144536091|NCT04174560|521166131|FG000|Overall Study|Withdrawal by Subject|0|||
144536092|NCT04174560|521166132|FG001|Overall Study|Withdrawal by Subject|0|||
144536093|NCT04174560|521166133|FG002|Overall Study|Withdrawal by Subject|2|||
144536094|NCT04174560|521166134|FG003|Overall Study|Withdrawal by Subject|0|||
144536095|NCT04046549|521166136|FG000|Overall Study|Adverse Event|1|||
144536096|NCT04046549|521166136|FG000|Overall Study|Physician Decision|1|||
144536097|NCT04046549|521166136|FG000|Overall Study|Withdrawal by Subject|3|||
144536098|NCT04046549|521166136|FG000|Overall Study|Other, Not Specified|5|||
144536099|NCT05934292|521166139|FG000|Overall Study|Lost to Follow-up|0|||
144536100|NCT05934292|521166140|FG001|Overall Study|Lost to Follow-up|0|||
144536101|NCT05934292|521166141|FG002|Overall Study|Lost to Follow-up|1|||
144536102|NCT05934292|521166142|FG003|Overall Study|Lost to Follow-up|0|||
144536103|NCT04479787|521166143|FG000|Through 6 Months|Withdrawal by Subject|16|||
144536104|NCT04479787|521166144|FG001|Through 6 Months|Withdrawal by Subject|14|||
144611454|NCT02819635|521438924|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
144536105|NCT04479787|521166143|FG000|Through 6 Months|Unsuccessful Trial|17|||
144611455|NCT02819635|521438925|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144611456|NCT02819635|521438926|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144611457|NCT02819635|521438927|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144611458|NCT02819635|521438928|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144536106|NCT04479787|521166144|FG001|Through 6 Months|Unsuccessful Trial|0|||
144536107|NCT04479787|521166143|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
144536108|NCT04479787|521166144|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
144536109|NCT04479787|521166143|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
144536110|NCT04479787|521166144|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
144536111|NCT04479787|521166143|FG000|Through 6 Months|Lost to Follow-up|3|||
144536112|NCT04479787|521166144|FG001|Through 6 Months|Lost to Follow-up|2|||
144611459|NCT02819635|521438929|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
144464087|NCT00518115|520895348|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464088|NCT00518115|520895349|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464089|NCT00518115|520895350|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464090|NCT00518115|520895351|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
144464091|NCT00518115|520895352|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464092|NCT00518115|520895353|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464093|NCT00518115|520895354|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464094|NCT00518115|520895355|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
144464095|NCT00518115|520895346|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
144464096|NCT00518115|520895347|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464097|NCT00518115|520895348|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464098|NCT00518115|520895349|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464099|NCT00518115|520895350|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464100|NCT00518115|520895351|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464101|NCT00518115|520895352|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464102|NCT00518115|520895353|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464103|NCT00518115|520895354|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464104|NCT00518115|520895355|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
144464105|NCT00518115|520895346|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464106|NCT00518115|520895347|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464107|NCT00518115|520895348|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
144464108|NCT00518115|520895349|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464109|NCT00518115|520895350|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464110|NCT00518115|520895351|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464111|NCT00518115|520895352|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464112|NCT00518115|520895353|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464113|NCT00518115|520895354|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
144464114|NCT00518115|520895355|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
144464115|NCT00518115|520895346|FG000|Overall Study|Wrong Monotherapy Administered|0|||
144464116|NCT00518115|520895347|FG001|Overall Study|Wrong Monotherapy Administered|0|||
144464117|NCT00518115|520895348|FG002|Overall Study|Wrong Monotherapy Administered|1|||
144464118|NCT00518115|520895349|FG003|Overall Study|Wrong Monotherapy Administered|0|||
144464119|NCT00518115|520895350|FG004|Overall Study|Wrong Monotherapy Administered|0|||
144464120|NCT00518115|520895351|FG005|Overall Study|Wrong Monotherapy Administered|0|||
144464121|NCT00518115|520895352|FG006|Overall Study|Wrong Monotherapy Administered|1|||
144464122|NCT00518115|520895353|FG007|Overall Study|Wrong Monotherapy Administered|0|||
144464123|NCT00518115|520895354|FG008|Overall Study|Wrong Monotherapy Administered|0|||
144464124|NCT00518115|520895355|FG009|Overall Study|Wrong Monotherapy Administered|0|||
144464125|NCT00518115|520895346|FG000|Overall Study|Violation of Exclusion Criteria|0|||
144464126|NCT00518115|520895347|FG001|Overall Study|Violation of Exclusion Criteria|0|||
144464127|NCT00518115|520895348|FG002|Overall Study|Violation of Exclusion Criteria|0|||
144464128|NCT00518115|520895349|FG003|Overall Study|Violation of Exclusion Criteria|1|||
144464129|NCT00518115|520895350|FG004|Overall Study|Violation of Exclusion Criteria|0|||
144464130|NCT00518115|520895351|FG005|Overall Study|Violation of Exclusion Criteria|0|||
144464131|NCT00518115|520895352|FG006|Overall Study|Violation of Exclusion Criteria|1|||
144464132|NCT00518115|520895353|FG007|Overall Study|Violation of Exclusion Criteria|0|||
144464133|NCT00518115|520895354|FG008|Overall Study|Violation of Exclusion Criteria|0|||
144464134|NCT00518115|520895355|FG009|Overall Study|Violation of Exclusion Criteria|0|||
144464135|NCT00518115|520895346|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
144464136|NCT00518115|520895347|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
144464137|NCT00518115|520895348|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
144464138|NCT00518115|520895349|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
144464139|NCT00518115|520895350|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
144464140|NCT00518115|520895351|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
144464141|NCT00518115|520895352|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
144464142|NCT00518115|520895353|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
144464143|NCT00518115|520895354|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
144464144|NCT00518115|520895355|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
144464145|NCT00518115|520895346|FG000|Overall Study|Withdrew Consent|0|||
144464146|NCT00518115|520895347|FG001|Overall Study|Withdrew Consent|0|||
144611460|NCT02819635|521438918|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611461|NCT02819635|521438919|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144464147|NCT00518115|520895348|FG002|Overall Study|Withdrew Consent|0|||
144464148|NCT00518115|520895349|FG003|Overall Study|Withdrew Consent|0|||
144464149|NCT00518115|520895350|FG004|Overall Study|Withdrew Consent|0|||
144464150|NCT00518115|520895351|FG005|Overall Study|Withdrew Consent|1|||
144611462|NCT02819635|521438920|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144464151|NCT00518115|520895352|FG006|Overall Study|Withdrew Consent|0|||
144611463|NCT02819635|521438921|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611464|NCT02819635|521438922|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611465|NCT02819635|521438923|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
144611466|NCT02819635|521438924|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
144464152|NCT00518115|520895353|FG007|Overall Study|Withdrew Consent|0|||
144464153|NCT00518115|520895354|FG008|Overall Study|Withdrew Consent|0|||
144464154|NCT00518115|520895355|FG009|Overall Study|Withdrew Consent|0|||
144464155|NCT00518115|520895346|FG000|Overall Study|Moved Out of State|0|||
144464156|NCT00518115|520895347|FG001|Overall Study|Moved Out of State|0|||
144464157|NCT00518115|520895348|FG002|Overall Study|Moved Out of State|0|||
144464158|NCT00518115|520895349|FG003|Overall Study|Moved Out of State|0|||
144464159|NCT00518115|520895350|FG004|Overall Study|Moved Out of State|0|||
144464160|NCT00518115|520895351|FG005|Overall Study|Moved Out of State|0|||
144464161|NCT00518115|520895352|FG006|Overall Study|Moved Out of State|0|||
144464162|NCT00518115|520895353|FG007|Overall Study|Moved Out of State|0|||
144464163|NCT00518115|520895354|FG008|Overall Study|Moved Out of State|0|||
144464164|NCT00518115|520895355|FG009|Overall Study|Moved Out of State|1|||
144464165|NCT04891419|520895356|FG000|Overall Study|Withdrawal by Subject|4|||
144464166|NCT04891419|520895357|FG001|Overall Study|Withdrawal by Subject|0|||
144464167|NCT04891419|520895356|FG000|Overall Study|Lost to Follow-up|1|||
144464168|NCT04891419|520895357|FG001|Overall Study|Lost to Follow-up|3|||
144464169|NCT00827918|520895358|FG000|Overall Study|Adverse Event|4|||
144464170|NCT00827918|520895359|FG001|Overall Study|Adverse Event|0|||
144464171|NCT00827918|520895360|FG002|Overall Study|Adverse Event|0|||
144464172|NCT00827918|520895358|FG000|Overall Study|Lack of Efficacy|16|||
144464173|NCT00827918|520895359|FG001|Overall Study|Lack of Efficacy|4|||
144464174|NCT00827918|520895360|FG002|Overall Study|Lack of Efficacy|15|||
144464175|NCT00827918|520895358|FG000|Overall Study|Physician Decision|1|||
144464176|NCT00827918|520895359|FG001|Overall Study|Physician Decision|0|||
144464177|NCT00827918|520895360|FG002|Overall Study|Physician Decision|0|||
144464178|NCT00827918|520895358|FG000|Overall Study|Pregnancy|0|||
144464179|NCT00827918|520895359|FG001|Overall Study|Pregnancy|1|||
144464180|NCT00827918|520895360|FG002|Overall Study|Pregnancy|0|||
144464181|NCT00827918|520895358|FG000|Overall Study|Progressive Disease|1|||
144464182|NCT00827918|520895359|FG001|Overall Study|Progressive Disease|1|||
144464183|NCT00827918|520895360|FG002|Overall Study|Progressive Disease|0|||
144464184|NCT00827918|520895358|FG000|Overall Study|Protocol Violation|0|||
144464185|NCT00827918|520895359|FG001|Overall Study|Protocol Violation|1|||
144464186|NCT00827918|520895360|FG002|Overall Study|Protocol Violation|0|||
144464187|NCT00827918|520895358|FG000|Overall Study|Withdrawal by Subject|6|||
144464188|NCT00827918|520895359|FG001|Overall Study|Withdrawal by Subject|2|||
144464189|NCT00827918|520895360|FG002|Overall Study|Withdrawal by Subject|6|||
144464190|NCT00802074|520895361|FG000|Overall Study|Adverse Event|1|||
144464191|NCT00802074|520895362|FG001|Overall Study|Adverse Event|1|||
144464192|NCT00802074|520895363|FG002|Overall Study|Adverse Event|1|||
144464193|NCT00802074|520895364|FG003|Overall Study|Adverse Event|0|||
144464194|NCT00802074|520895365|FG004|Overall Study|Adverse Event|0|||
144464195|NCT00802074|520895366|FG005|Overall Study|Adverse Event|0|||
144464196|NCT00802074|520895361|FG000|Overall Study|Withdrawal by Subject|1|||
144464197|NCT00802074|520895362|FG001|Overall Study|Withdrawal by Subject|0|||
144464198|NCT00802074|520895363|FG002|Overall Study|Withdrawal by Subject|0|||
144536113|NCT04479787|521166143|FG000|Through 6 Months|Death|3|||
144536114|NCT04479787|521166144|FG001|Through 6 Months|Death|0|||
144536115|NCT04479787|521166143|FG000|Through 6 Months|Inclusion/Exclusion|2|||
144536116|NCT04479787|521166144|FG001|Through 6 Months|Inclusion/Exclusion|1|||
144536117|NCT04479787|521166143|FG000|Through 6 Months|Subject Became Pregnant|1|||
144536118|NCT04479787|521166144|FG001|Through 6 Months|Subject Became Pregnant|1|||
144536119|NCT04479787|521166143|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
144536120|NCT04479787|521166144|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
144536121|NCT04479787|521166143|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
144536122|NCT04479787|521166144|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
144536123|NCT04479787|521166143|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
144536124|NCT04479787|521166144|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
144536125|NCT04479787|521166143|FG000|After 6 Months|Withdrawal by Subject|3|||
144536126|NCT04479787|521166144|FG001|After 6 Months|Withdrawal by Subject|13|||
144536127|NCT04479787|521166143|FG000|After 6 Months|Unsuccessful Trial|0|||
144726036|NCT03830164|521852674|FG002|Overall Study|Lost to Follow-up|0|||
144464199|NCT00802074|520895364|FG003|Overall Study|Withdrawal by Subject|0|||
144464200|NCT00802074|520895365|FG004|Overall Study|Withdrawal by Subject|0|||
144464201|NCT00802074|520895366|FG005|Overall Study|Withdrawal by Subject|0|||
144464202|NCT00843167|520895369|FG000|Treatment Period|Adverse Event|1|||
144464203|NCT00843167|520895370|FG001|Treatment Period|Adverse Event|5|||
144464204|NCT00843167|520895369|FG000|Treatment Period|Withdrawal by Subject|2|||
144464205|NCT00843167|520895370|FG001|Treatment Period|Withdrawal by Subject|3|||
144464206|NCT03743038|520895371|FG000|Overall Study|Physician Decision|1|||
144464207|NCT05207813|520895373|FG000|Overall Study|Lost to Follow-up|2|||
144464208|NCT00617344|520895374|FG000|Overall Study|Serious adverse event|1|||
144536128|NCT04479787|521166144|FG001|After 6 Months|Unsuccessful Trial|7|||
144536129|NCT04479787|521166143|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
144536130|NCT04479787|521166144|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
144536131|NCT04479787|521166143|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
144536132|NCT04479787|521166144|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
144536133|NCT04479787|521166143|FG000|After 6 Months|Death|2|||
144536134|NCT04479787|521166144|FG001|After 6 Months|Death|0|||
144536135|NCT04479787|521166143|FG000|After 6 Months|Lost to Follow-up|1|||
144536136|NCT04479787|521166144|FG001|After 6 Months|Lost to Follow-up|1|||
144536137|NCT04479787|521166143|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
144536138|NCT04479787|521166144|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
144536139|NCT04479787|521166143|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
144536140|NCT04479787|521166144|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
144536141|NCT04479787|521166143|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
144536142|NCT04479787|521166144|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
144536143|NCT04479787|521166143|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
144536144|NCT04479787|521166144|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
144536145|NCT04039113|521166150|FG000|Overall Study|Withdrawal by Subject|8|||
144536146|NCT04039113|521166151|FG001|Overall Study|Withdrawal by Subject|11|||
144536147|NCT04039113|521166150|FG000|Overall Study|Lost to Follow-up|1|||
144536148|NCT04039113|521166151|FG001|Overall Study|Lost to Follow-up|1|||
144536149|NCT04039113|521166150|FG000|Overall Study|Adverse Event|2|||
144536150|NCT04039113|521166151|FG001|Overall Study|Adverse Event|2|||
144536151|NCT04039113|521166150|FG000|Overall Study|Death|2|||
144536152|NCT04039113|521166151|FG001|Overall Study|Death|4|||
144536153|NCT04039113|521166150|FG000|Overall Study|Site Closure|6|||
144536154|NCT04039113|521166151|FG001|Overall Study|Site Closure|0|||
144536155|NCT04039113|521166150|FG000|Overall Study|Failure to meet randomisation criteria|4|||
144611467|NCT02819635|521438925|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611468|NCT02819635|521438926|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611469|NCT02819635|521438927|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611470|NCT02819635|521438928|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611471|NCT02819635|521438929|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
144611472|NCT02819635|521438918|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611473|NCT02819635|521438919|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611474|NCT02819635|521438920|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611475|NCT02819635|521438921|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611476|NCT02819635|521438922|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611477|NCT02819635|521438923|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611478|NCT02819635|521438924|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
144611479|NCT02819635|521438925|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611480|NCT02819635|521438926|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611481|NCT02819635|521438927|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611482|NCT02819635|521438928|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611483|NCT02819635|521438929|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
144611484|NCT02819635|521438918|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
144611485|NCT02819635|521438919|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
144611486|NCT02819635|521438920|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
144611487|NCT02819635|521438921|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
144611488|NCT02819635|521438922|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
144611489|NCT02819635|521438923|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
144611490|NCT02819635|521438924|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
144611491|NCT02819635|521438925|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
144611492|NCT02819635|521438926|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
144611493|NCT02819635|521438927|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
144611494|NCT02819635|521438928|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
144611495|NCT02819635|521438929|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
144611496|NCT02819635|521438918|FG000|Substudy 2, Part 2|Adverse Event|0|||
144611497|NCT02819635|521438919|FG001|Substudy 2, Part 2|Adverse Event|0|||
144611498|NCT02819635|521438920|FG002|Substudy 2, Part 2|Adverse Event|0|||
144611499|NCT02819635|521438921|FG003|Substudy 2, Part 2|Adverse Event|0|||
144611500|NCT02819635|521438922|FG004|Substudy 2, Part 2|Adverse Event|0|||
144611501|NCT02819635|521438923|FG005|Substudy 2, Part 2|Adverse Event|4|||
144611502|NCT02819635|521438924|FG006|Substudy 2, Part 2|Adverse Event|0|||
144611503|NCT02819635|521438925|FG007|Substudy 2, Part 2|Adverse Event|0|||
144611504|NCT02819635|521438926|FG008|Substudy 2, Part 2|Adverse Event|0|||
144536156|NCT04039113|521166151|FG001|Overall Study|Failure to meet randomisation criteria|0|||
144536157|NCT00353496|521166152|FG000|Overall Study|Adverse Event|1|||
144464209|NCT00617344|520895375|FG001|Overall Study|Serious adverse event|0|||
144464210|NCT00617344|520895376|FG002|Overall Study|Serious adverse event|0|||
144464211|NCT00617344|520895374|FG000|Overall Study|Other Adverse Event|1|||
144726037|NCT03830164|521852672|FG000|Overall Study|Withdrawal by Subject|1|||
144726038|NCT03830164|521852673|FG001|Overall Study|Withdrawal by Subject|0|||
144726039|NCT03830164|521852674|FG002|Overall Study|Withdrawal by Subject|0|||
144726040|NCT00995553|521852679|FG000|Overall Study|Withdrawal by Subject|2|||
144726041|NCT00995553|521852680|FG001|Overall Study|Withdrawal by Subject|6|||
144726042|NCT00950807|521852685|FG000|Treatment Period 1|Lack of Efficacy|1|||
144611505|NCT02819635|521438927|FG009|Substudy 2, Part 2|Adverse Event|0|||
144611506|NCT02819635|521438928|FG010|Substudy 2, Part 2|Adverse Event|0|||
144611507|NCT02819635|521438929|FG011|Substudy 2, Part 2|Adverse Event|0|||
144611508|NCT02819635|521438918|FG000|Substudy 2, Part 2|Withdrew consent|0|||
144464212|NCT00617344|520895375|FG001|Overall Study|Other Adverse Event|1|||
144464213|NCT00617344|520895376|FG002|Overall Study|Other Adverse Event|0|||
144464214|NCT00617344|520895374|FG000|Overall Study|Protocol Violation|10|||
144464215|NCT00617344|520895375|FG001|Overall Study|Protocol Violation|8|||
144464216|NCT00617344|520895376|FG002|Overall Study|Protocol Violation|5|||
144464217|NCT00617344|520895374|FG000|Overall Study|Lost to Follow-up|5|||
144464218|NCT00617344|520895375|FG001|Overall Study|Lost to Follow-up|4|||
144464219|NCT00617344|520895376|FG002|Overall Study|Lost to Follow-up|1|||
144464220|NCT00617344|520895374|FG000|Overall Study|Withdrawal by Subject|8|||
144464221|NCT00617344|520895375|FG001|Overall Study|Withdrawal by Subject|9|||
144464222|NCT00617344|520895376|FG002|Overall Study|Withdrawal by Subject|2|||
144464223|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
144464224|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
144464225|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
144464226|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
144464227|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
144611509|NCT02819635|521438919|FG001|Substudy 2, Part 2|Withdrew consent|0|||
144611510|NCT02819635|521438920|FG002|Substudy 2, Part 2|Withdrew consent|0|||
144611511|NCT02819635|521438921|FG003|Substudy 2, Part 2|Withdrew consent|0|||
144611512|NCT02819635|521438922|FG004|Substudy 2, Part 2|Withdrew consent|0|||
144611513|NCT02819635|521438923|FG005|Substudy 2, Part 2|Withdrew consent|3|||
144611514|NCT02819635|521438924|FG006|Substudy 2, Part 2|Withdrew consent|1|||
144611515|NCT02819635|521438925|FG007|Substudy 2, Part 2|Withdrew consent|0|||
144611516|NCT02819635|521438926|FG008|Substudy 2, Part 2|Withdrew consent|0|||
144611517|NCT02819635|521438927|FG009|Substudy 2, Part 2|Withdrew consent|0|||
144611518|NCT02819635|521438928|FG010|Substudy 2, Part 2|Withdrew consent|0|||
144611519|NCT02819635|521438929|FG011|Substudy 2, Part 2|Withdrew consent|0|||
144611520|NCT02819635|521438918|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
144611521|NCT02819635|521438919|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
144611522|NCT02819635|521438920|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
144611523|NCT02819635|521438921|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
144611524|NCT02819635|521438922|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
144611525|NCT02819635|521438923|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
144611526|NCT02819635|521438924|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
144611527|NCT02819635|521438925|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
144464228|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
144464229|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
144611528|NCT02819635|521438926|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
144611529|NCT02819635|521438927|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
144611530|NCT02819635|521438928|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
144611531|NCT02819635|521438929|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
144611532|NCT02819635|521438918|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144726043|NCT00950807|521852686|FG001|Treatment Period 1|Lack of Efficacy|0|||
144726044|NCT00950807|521852687|FG002|Treatment Period 1|Lack of Efficacy|0|||
144464230|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
144464231|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
144464232|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
144464233|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
144464234|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
144464235|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
144464236|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
144464237|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
144464238|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
144464239|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
144464240|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
144464241|NCT00833638|520895378|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
144464242|NCT00833638|520895379|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
144464243|NCT00833638|520895380|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
144464244|NCT00833638|520895378|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
144258019|NCT04004260|520146939|FG001|Overall Study|Withdrawal by Subject|3|||
144258020|NCT04004260|520146938|FG000|Overall Study|Lost to Follow-up|22|||
144258021|NCT04004260|520146939|FG001|Overall Study|Lost to Follow-up|12|||
144258022|NCT04004260|520146938|FG000|Overall Study|Did not engage in intervention|13|||
144258023|NCT04004260|520146939|FG001|Overall Study|Did not engage in intervention|17|||
144258024|NCT03382418|520146940|FG000|Overall Study|Withdrawal by Subject|1|||
144258025|NCT03382418|520146941|FG001|Overall Study|Withdrawal by Subject|0|||
144258026|NCT03382418|520146942|FG002|Overall Study|Withdrawal by Subject|0|||
144258027|NCT03382418|520146940|FG000|Overall Study|Lost to Follow-up|2|||
144258028|NCT03382418|520146941|FG001|Overall Study|Lost to Follow-up|3|||
144258029|NCT03382418|520146942|FG002|Overall Study|Lost to Follow-up|0|||
144258030|NCT02360280|520146943|FG000|Overall Study|Withdrawal by Subject|2|||
144258031|NCT02360280|520146944|FG001|Overall Study|Withdrawal by Subject|0|||
144258032|NCT02360280|520146943|FG000|Overall Study|Adverse Event|0|||
144258033|NCT02360280|520146944|FG001|Overall Study|Adverse Event|1|||
144258034|NCT02360280|520146943|FG000|Overall Study|Lost to Follow-up|1|||
144258035|NCT02360280|520146944|FG001|Overall Study|Lost to Follow-up|0|||
144258036|NCT00320788|520146945|FG000|Overall Study|Adverse Event|0|||
144258037|NCT00320788|520146946|FG001|Overall Study|Adverse Event|0|||
144258038|NCT00320788|520146947|FG002|Overall Study|Adverse Event|0|||
144258039|NCT00320788|520146948|FG003|Overall Study|Adverse Event|1|||
144258040|NCT00320788|520146949|FG004|Overall Study|Adverse Event|0|||
144258041|NCT00320788|520146945|FG000|Overall Study|Death|0|||
144258042|NCT00320788|520146946|FG001|Overall Study|Death|0|||
144611533|NCT02819635|521438919|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144611534|NCT02819635|521438920|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144258043|NCT00320788|520146947|FG002|Overall Study|Death|1|||
144258044|NCT00320788|520146948|FG003|Overall Study|Death|0|||
144258045|NCT00320788|520146949|FG004|Overall Study|Death|1|||
144536158|NCT00353496|521166153|FG001|Overall Study|Adverse Event|0|||
144611535|NCT02819635|521438921|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144536159|NCT00353496|521166152|FG000|Overall Study|Protocol Violation|2|||
144611536|NCT02819635|521438922|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144611537|NCT02819635|521438923|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144536160|NCT00353496|521166153|FG001|Overall Study|Protocol Violation|2|||
144536161|NCT00353496|521166152|FG000|Overall Study|Withdrawal by Subject|3|||
144536162|NCT00353496|521166153|FG001|Overall Study|Withdrawal by Subject|4|||
144536163|NCT00353496|521166152|FG000|Overall Study|Physician Decision|6|||
144536164|NCT00353496|521166153|FG001|Overall Study|Physician Decision|9|||
144536165|NCT00353496|521166152|FG000|Overall Study|Not otherwise specified|4|||
144536166|NCT00353496|521166153|FG001|Overall Study|Not otherwise specified|2|||
144536167|NCT02111096|521166649|FG000|Overall Study|Adverse Event|4|||
144536168|NCT02111096|521166650|FG001|Overall Study|Adverse Event|1|||
144536169|NCT02111096|521166651|FG002|Overall Study|Adverse Event|2|||
144536170|NCT02111096|521166649|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144536171|NCT02111096|521166650|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144536172|NCT02111096|521166651|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144536173|NCT02111096|521166649|FG000|Overall Study|Lost to Follow Up|1|||
144536174|NCT02111096|521166650|FG001|Overall Study|Lost to Follow Up|1|||
144536175|NCT02111096|521166651|FG002|Overall Study|Lost to Follow Up|1|||
144536176|NCT02111096|521166649|FG000|Overall Study|Physician Decision|0|||
144536177|NCT02111096|521166650|FG001|Overall Study|Physician Decision|1|||
144536178|NCT02111096|521166651|FG002|Overall Study|Physician Decision|0|||
144536179|NCT02111096|521166649|FG000|Overall Study|Protocol Violation|1|||
144536180|NCT02111096|521166650|FG001|Overall Study|Protocol Violation|0|||
144536181|NCT02111096|521166651|FG002|Overall Study|Protocol Violation|1|||
144536182|NCT02111096|521166649|FG000|Overall Study|Terminated by Sponsor|53|||
144536183|NCT02111096|521166650|FG001|Overall Study|Terminated by Sponsor|35|||
144536184|NCT02111096|521166651|FG002|Overall Study|Terminated by Sponsor|54|||
144536185|NCT02111096|521166649|FG000|Overall Study|Withdrawal by Subject|4|||
144536186|NCT02111096|521166650|FG001|Overall Study|Withdrawal by Subject|2|||
144536187|NCT02111096|521166651|FG002|Overall Study|Withdrawal by Subject|8|||
144536188|NCT00686595|521166652|FG000|Overall Study|Adverse Event|3|||
144611538|NCT02819635|521438924|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
144536189|NCT00686595|521166652|FG000|Overall Study|Protocol Violation|1|||
144611539|NCT02819635|521438925|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144258046|NCT00320788|520146945|FG000|Overall Study|Lost to Follow-up|0|||
144536190|NCT00686595|521166652|FG000|Overall Study|Lost to Follow-up|1|||
144536191|NCT00686595|521166652|FG000|Overall Study|Lack of Efficacy|1|||
144536192|NCT00686595|521166652|FG000|Overall Study|Poor Compliance|1|||
144536193|NCT03286114|521166655|FG000|Overall Study|Adverse Event|6|||
144536194|NCT03286114|521166655|FG000|Overall Study|Death|3|||
144258047|NCT00320788|520146946|FG001|Overall Study|Lost to Follow-up|2|||
144258048|NCT00320788|520146947|FG002|Overall Study|Lost to Follow-up|1|||
144258049|NCT00320788|520146948|FG003|Overall Study|Lost to Follow-up|0|||
144258050|NCT00320788|520146949|FG004|Overall Study|Lost to Follow-up|0|||
144258051|NCT00320788|520146945|FG000|Overall Study|Decision by the Sponsor|1|||
144611540|NCT02819635|521438926|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144611541|NCT02819635|521438927|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144611542|NCT02819635|521438928|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144464245|NCT00833638|520895379|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
144464246|NCT00833638|520895380|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
144464247|NCT00833638|520895378|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
144464248|NCT00833638|520895379|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
144464249|NCT00833638|520895380|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
144464250|NCT00490646|520895381|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
144464251|NCT00490646|520895382|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
144464252|NCT00490646|520895381|FG000|Overall Study|Never Treated (had an adverse event)|1|||
144464253|NCT00490646|520895382|FG001|Overall Study|Never Treated (had an adverse event)|0|||
144464254|NCT00490646|520895381|FG000|Overall Study|Never Treated (withdrew consent)|0|||
144464255|NCT00490646|520895382|FG001|Overall Study|Never Treated (withdrew consent)|1|||
144464256|NCT01178086|520895383|FG000|Overall Study|Participant refusal|7|||
144464257|NCT01178086|520895383|FG000|Overall Study|Physician Decision|44|||
144464258|NCT01178086|520895383|FG000|Overall Study|Switch to other CLL therapy|113|||
144464259|NCT01178086|520895383|FG000|Overall Study|Death|59|||
144464260|NCT01178086|520895383|FG000|Overall Study|Other unspecified|89|||
144464261|NCT01178086|520895383|FG000|Overall Study|Excluded from EAS|20|||
144464262|NCT02962908|520895386|FG000|Overall Study|Lost to Follow-up|0|||
144464263|NCT02962908|520895387|FG001|Overall Study|Lost to Follow-up|3|||
144536195|NCT01260896|521166658|FG000|First Intervention|Withdrawn Due to Emesis|2|||
144536196|NCT01260896|521166659|FG001|First Intervention|Withdrawn Due to Emesis|0|||
144536197|NCT00003222|521166662|FG000|Overall Study|Physician Decision|0|||
144536198|NCT00003222|521166663|FG001|Overall Study|Physician Decision|1|||
144536199|NCT03248492|521166672|FG000|Overall Study|Progressive Disease|24|||
144536200|NCT03248492|521166673|FG001|Overall Study|Progressive Disease|23|||
144536201|NCT03248492|521166674|FG002|Overall Study|Progressive Disease|11|||
144536202|NCT03248492|521166675|FG003|Overall Study|Progressive Disease|66|||
144536203|NCT03248492|521166676|FG004|Overall Study|Progressive Disease|1|||
144536204|NCT03248492|521166672|FG000|Overall Study|Adverse Event|14|||
144536205|NCT03248492|521166673|FG001|Overall Study|Adverse Event|13|||
144536206|NCT03248492|521166674|FG002|Overall Study|Adverse Event|9|||
144536207|NCT03248492|521166675|FG003|Overall Study|Adverse Event|22|||
144536208|NCT03248492|521166676|FG004|Overall Study|Adverse Event|2|||
144536209|NCT03248492|521166672|FG000|Overall Study|Withdrawal by Subject|5|||
144536210|NCT03248492|521166673|FG001|Overall Study|Withdrawal by Subject|4|||
144536211|NCT03248492|521166674|FG002|Overall Study|Withdrawal by Subject|0|||
144536212|NCT03248492|521166675|FG003|Overall Study|Withdrawal by Subject|8|||
144536213|NCT03248492|521166676|FG004|Overall Study|Withdrawal by Subject|1|||
144536214|NCT03248492|521166672|FG000|Overall Study|Physician Decision|1|||
144536215|NCT03248492|521166673|FG001|Overall Study|Physician Decision|1|||
144536216|NCT03248492|521166674|FG002|Overall Study|Physician Decision|1|||
144536217|NCT03248492|521166675|FG003|Overall Study|Physician Decision|7|||
144536218|NCT03248492|521166676|FG004|Overall Study|Physician Decision|0|||
144536219|NCT03248492|521166672|FG000|Overall Study|Death|1|||
144536220|NCT03248492|521166673|FG001|Overall Study|Death|1|||
144536221|NCT03248492|521166674|FG002|Overall Study|Death|0|||
144536222|NCT03248492|521166675|FG003|Overall Study|Death|6|||
144536223|NCT03248492|521166676|FG004|Overall Study|Death|0|||
144536224|NCT03248492|521166672|FG000|Overall Study|Study Terminated by Sponsor|3|||
144536225|NCT03248492|521166673|FG001|Overall Study|Study Terminated by Sponsor|1|||
144536226|NCT03248492|521166674|FG002|Overall Study|Study Terminated by Sponsor|0|||
144536227|NCT03248492|521166675|FG003|Overall Study|Study Terminated by Sponsor|7|||
144536228|NCT03248492|521166676|FG004|Overall Study|Study Terminated by Sponsor|0|||
144536229|NCT03248492|521166672|FG000|Overall Study|Other|2|||
144536230|NCT03248492|521166673|FG001|Overall Study|Other|5|||
144536231|NCT03248492|521166674|FG002|Overall Study|Other|0|||
144536232|NCT03248492|521166675|FG003|Overall Study|Other|14|||
144536233|NCT03248492|521166676|FG004|Overall Study|Other|0|||
144536234|NCT03767335|521166680|FG000|Overall Study|Physician Decision|1|||
144536235|NCT03767335|521166681|FG001|Overall Study|Physician Decision|1|||
144536236|NCT03767335|521166682|FG002|Overall Study|Physician Decision|0|||
144536237|NCT03767335|521166680|FG000|Overall Study|Withdrawal by Subject|0|||
144536238|NCT03767335|521166681|FG001|Overall Study|Withdrawal by Subject|0|||
144536239|NCT03767335|521166682|FG002|Overall Study|Withdrawal by Subject|6|||
144536240|NCT03767335|521166680|FG000|Overall Study|Participant excluded from efficacy population|0|||
144536241|NCT03767335|521166681|FG001|Overall Study|Participant excluded from efficacy population|0|||
144536242|NCT03767335|521166682|FG002|Overall Study|Participant excluded from efficacy population|1|||
144536243|NCT03767335|521166680|FG000|Overall Study|Death|0|||
144536244|NCT03767335|521166681|FG001|Overall Study|Death|0|||
144536245|NCT03767335|521166682|FG002|Overall Study|Death|2|||
144464264|NCT02962908|520895388|FG002|Overall Study|Lost to Follow-up|0|||
144464265|NCT02962908|520895389|FG003|Overall Study|Lost to Follow-up|1|||
144536246|NCT03767335|521166680|FG000|Overall Study|Progressive Disease|2|||
144536247|NCT03767335|521166681|FG001|Overall Study|Progressive Disease|2|||
144464266|NCT02962908|520895386|FG000|Overall Study|Withdrawal by Subject|0|||
144464267|NCT02962908|520895387|FG001|Overall Study|Withdrawal by Subject|3|||
144464268|NCT02962908|520895388|FG002|Overall Study|Withdrawal by Subject|0|||
144464269|NCT02962908|520895389|FG003|Overall Study|Withdrawal by Subject|2|||
144464270|NCT02962908|520895386|FG000|Overall Study|Protocol Violation|0|||
144464271|NCT02962908|520895387|FG001|Overall Study|Protocol Violation|1|||
144464272|NCT02962908|520895388|FG002|Overall Study|Protocol Violation|0|||
144464273|NCT02962908|520895389|FG003|Overall Study|Protocol Violation|0|||
144464274|NCT02962908|520895386|FG000|Overall Study|Physician Decision|0|||
144464275|NCT02962908|520895387|FG001|Overall Study|Physician Decision|1|||
144464276|NCT02962908|520895388|FG002|Overall Study|Physician Decision|0|||
144464277|NCT02962908|520895389|FG003|Overall Study|Physician Decision|0|||
144464278|NCT02626780|520895394|FG000|Overall Study|Withdrawal by Subject|3|||
144464279|NCT04304833|520895395|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
144464280|NCT04304833|520895396|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
144464281|NCT01266850|520897646|FG000|Overall Study|Lost to Follow-up|19|||
144464282|NCT01266850|520897647|FG001|Overall Study|Lost to Follow-up|19|||
144464283|NCT01266850|520897648|FG002|Overall Study|Lost to Follow-up|13|||
144464284|NCT01266850|520897649|FG003|Overall Study|Lost to Follow-up|13|||
144464285|NCT01266850|520897650|FG004|Overall Study|Lost to Follow-up|12|||
144464286|NCT01266850|520897646|FG000|Overall Study|Withdrawal by Subject|8|||
144464287|NCT01266850|520897647|FG001|Overall Study|Withdrawal by Subject|9|||
144464288|NCT01266850|520897648|FG002|Overall Study|Withdrawal by Subject|6|||
144464289|NCT01266850|520897649|FG003|Overall Study|Withdrawal by Subject|9|||
144464290|NCT01266850|520897650|FG004|Overall Study|Withdrawal by Subject|12|||
144464291|NCT01266850|520897646|FG000|Overall Study|Physician Decision|3|||
144464292|NCT01266850|520897647|FG001|Overall Study|Physician Decision|6|||
144464293|NCT01266850|520897648|FG002|Overall Study|Physician Decision|4|||
144464294|NCT01266850|520897649|FG003|Overall Study|Physician Decision|4|||
144464295|NCT01266850|520897650|FG004|Overall Study|Physician Decision|3|||
144464296|NCT01266850|520897646|FG000|Overall Study|Protocol Violation|0|||
144464297|NCT01266850|520897647|FG001|Overall Study|Protocol Violation|1|||
144464298|NCT01266850|520897648|FG002|Overall Study|Protocol Violation|0|||
144464299|NCT01266850|520897649|FG003|Overall Study|Protocol Violation|1|||
144464300|NCT01266850|520897650|FG004|Overall Study|Protocol Violation|2|||
144464301|NCT01266850|520897646|FG000|Overall Study|Adverse Event|0|||
144464302|NCT01266850|520897647|FG001|Overall Study|Adverse Event|0|||
144464303|NCT01266850|520897648|FG002|Overall Study|Adverse Event|0|||
144464304|NCT01266850|520897649|FG003|Overall Study|Adverse Event|0|||
144464305|NCT01266850|520897650|FG004|Overall Study|Adverse Event|1|||
144464306|NCT01266850|520897646|FG000|Overall Study|Site Closure|0|||
144464307|NCT01266850|520897647|FG001|Overall Study|Site Closure|1|||
144464308|NCT01266850|520897648|FG002|Overall Study|Site Closure|1|||
144464309|NCT01266850|520897649|FG003|Overall Study|Site Closure|1|||
144464310|NCT01266850|520897650|FG004|Overall Study|Site Closure|0|||
144464311|NCT00499031|520897651|FG000|Overall Study|Improper pre-protocol treatment|1|||
144464312|NCT00499031|520897651|FG000|Overall Study|Required test not done|1|||
144464313|NCT00499031|520897651|FG000|Overall Study|Never treated|1|||
144464314|NCT00428090|520897654|FG000|Overall Study|Adverse Event|10|||
144611543|NCT02819635|521438929|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
144611544|NCT02819635|521438918|FG000|Substudy 2, Part 2|Other, not specified|0|||
144464315|NCT00428090|520897655|FG001|Overall Study|Adverse Event|8|||
144464316|NCT00428090|520897656|FG002|Overall Study|Adverse Event|10|||
144464317|NCT00428090|520897657|FG003|Overall Study|Adverse Event|11|||
144464318|NCT00428090|520897654|FG000|Overall Study|Lost to Follow-up|3|||
144464319|NCT00428090|520897655|FG001|Overall Study|Lost to Follow-up|6|||
144464320|NCT00428090|520897656|FG002|Overall Study|Lost to Follow-up|1|||
144464321|NCT00428090|520897657|FG003|Overall Study|Lost to Follow-up|4|||
144464322|NCT00428090|520897654|FG000|Overall Study|Protocol Violation|3|||
144464323|NCT00428090|520897655|FG001|Overall Study|Protocol Violation|1|||
144464324|NCT00428090|520897656|FG002|Overall Study|Protocol Violation|3|||
144464325|NCT00428090|520897657|FG003|Overall Study|Protocol Violation|3|||
144464326|NCT00428090|520897654|FG000|Overall Study|Withdrawal by Subject|10|||
144464327|NCT00428090|520897655|FG001|Overall Study|Withdrawal by Subject|12|||
144464328|NCT00428090|520897656|FG002|Overall Study|Withdrawal by Subject|15|||
144464329|NCT00428090|520897657|FG003|Overall Study|Withdrawal by Subject|5|||
144464330|NCT00428090|520897654|FG000|Overall Study|Sponsor terminated study|0|||
144464331|NCT00428090|520897655|FG001|Overall Study|Sponsor terminated study|1|||
144464332|NCT00428090|520897656|FG002|Overall Study|Sponsor terminated study|0|||
144464333|NCT00428090|520897657|FG003|Overall Study|Sponsor terminated study|0|||
144464334|NCT00428090|520897654|FG000|Overall Study|Non-compliance|4|||
144464335|NCT00428090|520897655|FG001|Overall Study|Non-compliance|0|||
144464336|NCT00428090|520897656|FG002|Overall Study|Non-compliance|1|||
144464337|NCT00428090|520897657|FG003|Overall Study|Non-compliance|3|||
144464338|NCT00428090|520897654|FG000|Overall Study|Par. did not returned to visit|1|||
144464339|NCT00428090|520897655|FG001|Overall Study|Par. did not returned to visit|0|||
144464340|NCT00428090|520897656|FG002|Overall Study|Par. did not returned to visit|0|||
144464341|NCT00428090|520897657|FG003|Overall Study|Par. did not returned to visit|1|||
144464342|NCT00428090|520897654|FG000|Overall Study|Follow-Up visit not possible|1|||
144464343|NCT00428090|520897655|FG001|Overall Study|Follow-Up visit not possible|0|||
144464344|NCT00428090|520897656|FG002|Overall Study|Follow-Up visit not possible|0|||
144464345|NCT00428090|520897657|FG003|Overall Study|Follow-Up visit not possible|0|||
144464346|NCT00428090|520897654|FG000|Overall Study|Prohibited medication used for SAE|1|||
144464347|NCT00428090|520897655|FG001|Overall Study|Prohibited medication used for SAE|0|||
144464348|NCT00428090|520897656|FG002|Overall Study|Prohibited medication used for SAE|0|||
144464349|NCT00428090|520897657|FG003|Overall Study|Prohibited medication used for SAE|0|||
144464350|NCT00428090|520897654|FG000|Overall Study|Death of par.|1|||
144464351|NCT00428090|520897655|FG001|Overall Study|Death of par.|0|||
144464352|NCT00428090|520897656|FG002|Overall Study|Death of par.|1|||
144464353|NCT00428090|520897657|FG003|Overall Study|Death of par.|0|||
144464354|NCT00428090|520897654|FG000|Overall Study|Visit 7 exceed the visit window|0|||
144464355|NCT00428090|520897655|FG001|Overall Study|Visit 7 exceed the visit window|1|||
144464356|NCT00428090|520897656|FG002|Overall Study|Visit 7 exceed the visit window|0|||
144464357|NCT00428090|520897657|FG003|Overall Study|Visit 7 exceed the visit window|0|||
144464358|NCT00428090|520897654|FG000|Overall Study|Medical monitor terminated par.|0|||
144464359|NCT00428090|520897655|FG001|Overall Study|Medical monitor terminated par.|1|||
144464360|NCT00428090|520897656|FG002|Overall Study|Medical monitor terminated par.|0|||
144464361|NCT00428090|520897657|FG003|Overall Study|Medical monitor terminated par.|0|||
144464362|NCT00428090|520897654|FG000|Overall Study|Mental status of par. was|0|||
144464363|NCT00428090|520897655|FG001|Overall Study|Mental status of par. was|1|||
144464364|NCT00428090|520897656|FG002|Overall Study|Mental status of par. was|0|||
144464365|NCT00428090|520897657|FG003|Overall Study|Mental status of par. was|0|||
144464366|NCT00428090|520897654|FG000|Overall Study|Worsening of AD|0|||
144464367|NCT00428090|520897655|FG001|Overall Study|Worsening of AD|0|||
144464368|NCT00428090|520897656|FG002|Overall Study|Worsening of AD|1|||
144464369|NCT00428090|520897657|FG003|Overall Study|Worsening of AD|0|||
144464370|NCT00428090|520897654|FG000|Overall Study|Excluded for concerning QTc value|0|||
144464371|NCT00428090|520897655|FG001|Overall Study|Excluded for concerning QTc value|0|||
144464372|NCT00428090|520897656|FG002|Overall Study|Excluded for concerning QTc value|1|||
144464373|NCT00428090|520897657|FG003|Overall Study|Excluded for concerning QTc value|0|||
144464374|NCT00428090|520897654|FG000|Overall Study|Insufficient AD documentation|0|||
144464375|NCT00428090|520897655|FG001|Overall Study|Insufficient AD documentation|0|||
144464376|NCT00428090|520897656|FG002|Overall Study|Insufficient AD documentation|1|||
144464377|NCT00428090|520897657|FG003|Overall Study|Insufficient AD documentation|0|||
144464378|NCT00428090|520897654|FG000|Overall Study|High MMSE scores|0|||
144464379|NCT00428090|520897655|FG001|Overall Study|High MMSE scores|0|||
144464380|NCT00428090|520897656|FG002|Overall Study|High MMSE scores|1|||
144464381|NCT00428090|520897657|FG003|Overall Study|High MMSE scores|0|||
144464382|NCT00428090|520897654|FG000|Overall Study|Deterioration of cognitive status|0|||
144464383|NCT00428090|520897655|FG001|Overall Study|Deterioration of cognitive status|0|||
144464384|NCT00428090|520897656|FG002|Overall Study|Deterioration of cognitive status|1|||
144464385|NCT00428090|520897657|FG003|Overall Study|Deterioration of cognitive status|0|||
144464386|NCT00428090|520897654|FG000|Overall Study|Serious adverse event|0|||
144464387|NCT00428090|520897655|FG001|Overall Study|Serious adverse event|0|||
144464388|NCT00428090|520897656|FG002|Overall Study|Serious adverse event|1|||
144464389|NCT00428090|520897657|FG003|Overall Study|Serious adverse event|0|||
144464390|NCT00428090|520897654|FG000|Overall Study|Excluded for heart insufficiency|0|||
144464391|NCT00428090|520897655|FG001|Overall Study|Excluded for heart insufficiency|0|||
144464392|NCT00428090|520897656|FG002|Overall Study|Excluded for heart insufficiency|1|||
144464393|NCT00428090|520897657|FG003|Overall Study|Excluded for heart insufficiency|0|||
144464394|NCT00428090|520897654|FG000|Overall Study|Raised Creatinine Value|0|||
144464395|NCT00428090|520897655|FG001|Overall Study|Raised Creatinine Value|0|||
144464396|NCT00428090|520897656|FG002|Overall Study|Raised Creatinine Value|0|||
144464397|NCT00428090|520897657|FG003|Overall Study|Raised Creatinine Value|1|||
144464398|NCT03409666|520897658|FG000|Overall Study|Physician Decision|0|||
144464399|NCT03409666|520897659|FG001|Overall Study|Physician Decision|1|||
144464400|NCT03409666|520897658|FG000|Overall Study|Protocol Violation|0|||
144536248|NCT03767335|521166682|FG002|Overall Study|Progressive Disease|2|||
144536249|NCT03767335|521166680|FG000|Overall Study|Disease progression needing additional medication|0|||
144464401|NCT03409666|520897659|FG001|Overall Study|Protocol Violation|3|||
144726045|NCT00950807|521852688|FG003|Treatment Period 1|Lack of Efficacy|0|||
144464402|NCT02606279|520897667|FG000|Overall Study|Lost to Follow-up|0|||
144464403|NCT02606279|520897668|FG001|Overall Study|Lost to Follow-up|1|||
144464404|NCT03563716|520897672|FG000|Overall Study|Death|20|||
144464405|NCT03563716|520897673|FG001|Overall Study|Death|14|||
144464406|NCT03563716|520897672|FG000|Overall Study|Withdrawal by Subject|3|||
144464407|NCT03563716|520897673|FG001|Overall Study|Withdrawal by Subject|3|||
144464408|NCT03563716|520897672|FG000|Overall Study|Still on Study|45|||
144464409|NCT03563716|520897673|FG001|Overall Study|Still on Study|50|||
144464410|NCT04605978|520897674|FG000|Overall Study|Adverse Event|2|||
144464411|NCT04605978|520897675|FG001|Overall Study|Adverse Event|1|||
144464412|NCT04605978|520897674|FG000|Overall Study|Withdrawal nonmedical reason|1|||
144611545|NCT02819635|521438919|FG001|Substudy 2, Part 2|Other, not specified|0|||
144611546|NCT02819635|521438920|FG002|Substudy 2, Part 2|Other, not specified|0|||
144611547|NCT02819635|521438921|FG003|Substudy 2, Part 2|Other, not specified|0|||
144258052|NCT00320788|520146946|FG001|Overall Study|Decision by the Sponsor|1|||
144258053|NCT00320788|520146947|FG002|Overall Study|Decision by the Sponsor|0|||
144258054|NCT00320788|520146948|FG003|Overall Study|Decision by the Sponsor|0|||
144464413|NCT04605978|520897675|FG001|Overall Study|Withdrawal nonmedical reason|1|||
144464414|NCT02583425|520897676|FG000|Screening|Did not meet entry criteria|12|||
144611548|NCT02819635|521438922|FG004|Substudy 2, Part 2|Other, not specified|0|||
144611549|NCT02819635|521438923|FG005|Substudy 2, Part 2|Other, not specified|4|||
144464415|NCT02583425|520897676|FG000|Baseline|Did not meet continued criteria|5|||
144464416|NCT02583425|520897676|FG000|Treatment Period|Adverse Event|1|||
144464417|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
144464418|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
144258055|NCT00320788|520146949|FG004|Overall Study|Decision by the Sponsor|1|||
144258056|NCT00320788|520146945|FG000|Overall Study|Other|1|||
144258057|NCT00320788|520146946|FG001|Overall Study|Other|2|||
144258058|NCT00320788|520146947|FG002|Overall Study|Other|1|||
144258059|NCT00320788|520146948|FG003|Overall Study|Other|1|||
144258060|NCT00320788|520146949|FG004|Overall Study|Other|1|||
144258061|NCT00320788|520146945|FG000|Overall Study|Physician Decision|1|||
144258062|NCT00320788|520146946|FG001|Overall Study|Physician Decision|1|||
144258063|NCT00320788|520146947|FG002|Overall Study|Physician Decision|0|||
144258064|NCT00320788|520146948|FG003|Overall Study|Physician Decision|0|||
144258065|NCT00320788|520146949|FG004|Overall Study|Physician Decision|0|||
144258066|NCT00320788|520146945|FG000|Overall Study|Protocol Violation|0|||
144258067|NCT00320788|520146946|FG001|Overall Study|Protocol Violation|0|||
144258068|NCT00320788|520146947|FG002|Overall Study|Protocol Violation|0|||
144258069|NCT00320788|520146948|FG003|Overall Study|Protocol Violation|0|||
144258070|NCT00320788|520146949|FG004|Overall Study|Protocol Violation|1|||
144258071|NCT00320788|520146945|FG000|Overall Study|Withdrawal by Subject|3|||
144258072|NCT00320788|520146946|FG001|Overall Study|Withdrawal by Subject|0|||
144258073|NCT00320788|520146947|FG002|Overall Study|Withdrawal by Subject|0|||
144258074|NCT00320788|520146948|FG003|Overall Study|Withdrawal by Subject|3|||
144258075|NCT00320788|520146949|FG004|Overall Study|Withdrawal by Subject|1|||
144258076|NCT02137226|520146953|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
144258077|NCT02137226|520146954|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
144258078|NCT02137226|520146955|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
144258079|NCT02137226|520146956|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
144258080|NCT02137226|520146957|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
144258081|NCT02137226|520146953|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
144258082|NCT02137226|520146954|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
144258083|NCT02137226|520146955|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
144258084|NCT02137226|520146956|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
144258085|NCT02137226|520146957|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
144258086|NCT02137226|520146953|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
144464419|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
144464420|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
144464421|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
144464422|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
144464423|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
144464424|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
144464425|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
144464426|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
144464427|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
144464428|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
144464429|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Death|6|||
144464430|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Death|3|||
144464431|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Death|0|||
144464432|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Death|1|||
144464433|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Death|1|||
144611550|NCT02819635|521438924|FG006|Substudy 2, Part 2|Other, not specified|8|||
144611551|NCT02819635|521438925|FG007|Substudy 2, Part 2|Other, not specified|0|||
144464434|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Death|0|||
144611552|NCT02819635|521438926|FG008|Substudy 2, Part 2|Other, not specified|0|||
144464435|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
144611553|NCT02819635|521438927|FG009|Substudy 2, Part 2|Other, not specified|0|||
144611554|NCT02819635|521438928|FG010|Substudy 2, Part 2|Other, not specified|0|||
144258087|NCT02137226|520146954|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
144258088|NCT02137226|520146955|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
144258089|NCT02137226|520146956|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
144464436|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
144464437|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
144464438|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
144611555|NCT02819635|521438929|FG011|Substudy 2, Part 2|Other, not specified|0|||
144611556|NCT02819635|521438918|FG000|Substudy 3|Adverse Event|0|||
144611557|NCT02819635|521438919|FG001|Substudy 3|Adverse Event|0|||
144611558|NCT02819635|521438920|FG002|Substudy 3|Adverse Event|0|||
144611559|NCT02819635|521438921|FG003|Substudy 3|Adverse Event|0|||
144464439|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
144464440|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
144464441|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
144464442|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
144464443|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
144611560|NCT02819635|521438922|FG004|Substudy 3|Adverse Event|0|||
144611561|NCT02819635|521438923|FG005|Substudy 3|Adverse Event|0|||
144611562|NCT02819635|521438924|FG006|Substudy 3|Adverse Event|0|||
144611563|NCT02819635|521438925|FG007|Substudy 3|Adverse Event|0|||
144611564|NCT02819635|521438926|FG008|Substudy 3|Adverse Event|32|||
144611565|NCT02819635|521438927|FG009|Substudy 3|Adverse Event|3|||
144611566|NCT02819635|521438928|FG010|Substudy 3|Adverse Event|12|||
144611567|NCT02819635|521438929|FG011|Substudy 3|Adverse Event|18|||
144611568|NCT02819635|521438918|FG000|Substudy 3|Withdrew consent|0|||
144611569|NCT02819635|521438919|FG001|Substudy 3|Withdrew consent|0|||
144611570|NCT02819635|521438920|FG002|Substudy 3|Withdrew consent|0|||
144611571|NCT02819635|521438921|FG003|Substudy 3|Withdrew consent|0|||
144611572|NCT02819635|521438922|FG004|Substudy 3|Withdrew consent|0|||
144611573|NCT02819635|521438923|FG005|Substudy 3|Withdrew consent|0|||
144611574|NCT02819635|521438924|FG006|Substudy 3|Withdrew consent|0|||
144611575|NCT02819635|521438925|FG007|Substudy 3|Withdrew consent|0|||
144611576|NCT02819635|521438926|FG008|Substudy 3|Withdrew consent|11|||
144611577|NCT02819635|521438927|FG009|Substudy 3|Withdrew consent|1|||
144611578|NCT02819635|521438928|FG010|Substudy 3|Withdrew consent|4|||
144611579|NCT02819635|521438929|FG011|Substudy 3|Withdrew consent|9|||
144611580|NCT02819635|521438918|FG000|Substudy 3|Lost to Follow-up|0|||
144611581|NCT02819635|521438919|FG001|Substudy 3|Lost to Follow-up|0|||
144611582|NCT02819635|521438920|FG002|Substudy 3|Lost to Follow-up|0|||
144611583|NCT02819635|521438921|FG003|Substudy 3|Lost to Follow-up|0|||
144611584|NCT02819635|521438922|FG004|Substudy 3|Lost to Follow-up|0|||
144611585|NCT02819635|521438923|FG005|Substudy 3|Lost to Follow-up|0|||
144611586|NCT02819635|521438924|FG006|Substudy 3|Lost to Follow-up|0|||
144611587|NCT02819635|521438925|FG007|Substudy 3|Lost to Follow-up|0|||
144611588|NCT02819635|521438926|FG008|Substudy 3|Lost to Follow-up|1|||
144611589|NCT02819635|521438927|FG009|Substudy 3|Lost to Follow-up|0|||
144611590|NCT02819635|521438928|FG010|Substudy 3|Lost to Follow-up|1|||
144611591|NCT02819635|521438929|FG011|Substudy 3|Lost to Follow-up|1|||
144611592|NCT02819635|521438918|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611593|NCT02819635|521438919|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611594|NCT02819635|521438920|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611595|NCT02819635|521438921|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611596|NCT02819635|521438922|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611597|NCT02819635|521438923|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611598|NCT02819635|521438924|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611599|NCT02819635|521438925|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611600|NCT02819635|521438926|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611601|NCT02819635|521438927|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
144464444|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
144464445|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
144464446|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
144464447|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
144464448|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
144611602|NCT02819635|521438928|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
144611603|NCT02819635|521438929|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
144611604|NCT02819635|521438918|FG000|Substudy 3|Other, not specified|0|||
144611605|NCT02819635|521438919|FG001|Substudy 3|Other, not specified|0|||
144611606|NCT02819635|521438920|FG002|Substudy 3|Other, not specified|0|||
144611607|NCT02819635|521438921|FG003|Substudy 3|Other, not specified|0|||
144611608|NCT02819635|521438922|FG004|Substudy 3|Other, not specified|0|||
144611609|NCT02819635|521438923|FG005|Substudy 3|Other, not specified|0|||
144611610|NCT02819635|521438924|FG006|Substudy 3|Other, not specified|0|||
144464449|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
144464450|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
144611611|NCT02819635|521438925|FG007|Substudy 3|Other, not specified|0|||
144611612|NCT02819635|521438926|FG008|Substudy 3|Other, not specified|202|||
144611613|NCT02819635|521438927|FG009|Substudy 3|Other, not specified|5|||
144611614|NCT02819635|521438928|FG010|Substudy 3|Other, not specified|89|||
144611615|NCT02819635|521438929|FG011|Substudy 3|Other, not specified|39|||
144611616|NCT03179891|521438931|FG000|First Intervention|Withdrawal by Subject|1|||
144611617|NCT03179891|521438932|FG001|First Intervention|Withdrawal by Subject|1|||
144611618|NCT03179891|521438931|FG000|First Intervention|Unspecified reason|1|||
144611619|NCT03179891|521438932|FG001|First Intervention|Unspecified reason|0|||
144611620|NCT03179891|521438931|FG000|First Intervention|Protocol Violation|0|||
144464451|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
144464452|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
144464453|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
144464454|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
144464455|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
144464456|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
144464457|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
144464458|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
144464459|NCT03104699|520897677|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
144464460|NCT03104699|520897678|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
144464461|NCT03104699|520897679|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
144464462|NCT03104699|520897680|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
144464463|NCT03104699|520897681|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
144464464|NCT03104699|520897682|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
144464465|NCT03104699|520897677|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144464466|NCT03104699|520897678|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144464467|NCT03104699|520897679|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144464468|NCT03104699|520897680|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144464469|NCT03104699|520897681|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
144464470|NCT03104699|520897682|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
144464471|NCT03104699|520897677|FG000|Phase 2: Dose Expansion|Death|0|||
144464472|NCT03104699|520897678|FG001|Phase 2: Dose Expansion|Death|0|||
144464473|NCT03104699|520897679|FG002|Phase 2: Dose Expansion|Death|0|||
144464474|NCT03104699|520897680|FG003|Phase 2: Dose Expansion|Death|0|||
144464475|NCT03104699|520897681|FG004|Phase 2: Dose Expansion|Death|0|||
144464476|NCT03104699|520897682|FG005|Phase 2: Dose Expansion|Death|107|||
144464477|NCT03104699|520897677|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
144464478|NCT03104699|520897678|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
144464479|NCT03104699|520897679|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
144464480|NCT03104699|520897680|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
144464481|NCT03104699|520897681|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
144464482|NCT03104699|520897682|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
144464483|NCT03104699|520897677|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
144464484|NCT03104699|520897678|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
144464485|NCT03104699|520897679|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
144464486|NCT03104699|520897680|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
144464487|NCT03104699|520897681|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
144464488|NCT03104699|520897682|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
144464489|NCT03104699|520897677|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144464490|NCT03104699|520897678|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144464491|NCT03104699|520897679|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144464492|NCT03104699|520897680|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144464493|NCT03104699|520897681|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
144464494|NCT03104699|520897682|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
144464495|NCT03104699|520897677|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
144464496|NCT03104699|520897678|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
144464497|NCT03104699|520897679|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
144464498|NCT03104699|520897680|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
144464499|NCT03104699|520897681|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
144464500|NCT03104699|520897682|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
144464501|NCT01644734|520897683|FG000|Overall Study|Adverse Event|4|||
144464502|NCT01644734|520897683|FG000|Overall Study|Lost to Follow-up|17|||
144464503|NCT01644734|520897683|FG000|Overall Study|Reasons other than stated above|7|||
144464504|NCT01644734|520897683|FG000|Overall Study|Missing documentation|238|||
144536250|NCT03767335|521166681|FG001|Overall Study|Disease progression needing additional medication|0|||
144536251|NCT03767335|521166682|FG002|Overall Study|Disease progression needing additional medication|17|||
144536252|NCT03767335|521166680|FG000|Overall Study|Sponsor decision|0|||
144536253|NCT03767335|521166681|FG001|Overall Study|Sponsor decision|0|||
144536254|NCT03767335|521166682|FG002|Overall Study|Sponsor decision|2|||
144536255|NCT03767335|521166680|FG000|Overall Study|Other Medical Reasons|0|||
144536256|NCT03767335|521166681|FG001|Overall Study|Other Medical Reasons|0|||
144536257|NCT03767335|521166682|FG002|Overall Study|Other Medical Reasons|3|||
144536258|NCT01315132|521166683|FG000|Overall Study|not treated due to disease progression|1|||
144536259|NCT01313559|521166684|FG000|Overall Study|Withdrawal by Subject|1|||
144464505|NCT03318523|520897688|FG000|PC Period: Up to Year 1|Adverse Event|1|||
144464506|NCT03318523|520897689|FG001|PC Period: Up to Year 1|Adverse Event|0|||
144464507|NCT03318523|520897690|FG002|PC Period: Up to Year 1|Adverse Event|2|||
144464508|NCT03318523|520897691|FG003|PC Period: Up to Year 1|Adverse Event|0|||
144464509|NCT03318523|520897692|FG004|PC Period: Up to Year 1|Adverse Event|0|||
144464510|NCT03318523|520897693|FG005|PC Period: Up to Year 1|Adverse Event|0|||
144536260|NCT01313559|521166685|FG001|Overall Study|Withdrawal by Subject|2|||
144464511|NCT03318523|520897694|FG006|PC Period: Up to Year 1|Adverse Event|0|||
144464512|NCT03318523|520897695|FG007|PC Period: Up to Year 1|Adverse Event|0|||
144464513|NCT03318523|520897696|FG008|PC Period: Up to Year 1|Adverse Event|0|||
144464514|NCT03318523|520897697|FG009|PC Period: Up to Year 1|Adverse Event|0|||
144464515|NCT03318523|520897688|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
144464516|NCT03318523|520897689|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
144464517|NCT03318523|520897690|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464518|NCT03318523|520897691|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
144464519|NCT03318523|520897692|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464520|NCT03318523|520897693|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464521|NCT03318523|520897694|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464522|NCT03318523|520897695|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464523|NCT03318523|520897696|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464524|NCT03318523|520897697|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
144464525|NCT03318523|520897688|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464526|NCT03318523|520897689|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464527|NCT03318523|520897690|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464528|NCT03318523|520897691|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464529|NCT03318523|520897692|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
144464530|NCT03318523|520897693|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464531|NCT03318523|520897694|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464532|NCT03318523|520897695|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
144464533|NCT03318523|520897696|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
144464534|NCT03318523|520897697|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
144464535|NCT03318523|520897688|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
144464536|NCT03318523|520897689|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
144464537|NCT03318523|520897690|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
144464538|NCT03318523|520897691|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
144464539|NCT03318523|520897692|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
144464540|NCT03318523|520897693|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
144464541|NCT03318523|520897694|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
144464542|NCT03318523|520897695|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
144464543|NCT03318523|520897696|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
144464544|NCT03318523|520897697|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
144464545|NCT03318523|520897688|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464546|NCT03318523|520897689|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464547|NCT03318523|520897690|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464548|NCT03318523|520897691|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464549|NCT03318523|520897692|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464550|NCT03318523|520897693|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
144464551|NCT03318523|520897694|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464552|NCT03318523|520897695|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464553|NCT03318523|520897696|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464554|NCT03318523|520897697|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
144464555|NCT03318523|520897688|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464556|NCT03318523|520897689|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464557|NCT03318523|520897690|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464558|NCT03318523|520897691|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464559|NCT03318523|520897692|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464560|NCT03318523|520897693|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464561|NCT03318523|520897694|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464562|NCT03318523|520897695|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464563|NCT03318523|520897696|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
144464564|NCT03318523|520897697|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
144464565|NCT03318523|520897688|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
144464566|NCT03318523|520897689|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
144464567|NCT03318523|520897690|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
144464568|NCT03318523|520897691|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
144464569|NCT03318523|520897692|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
144464570|NCT03318523|520897693|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
144464571|NCT03318523|520897694|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
144464572|NCT03318523|520897695|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
144536261|NCT01313559|521166684|FG000|Overall Study|Disease progression|1|||
144536262|NCT01313559|521166685|FG001|Overall Study|Disease progression|0|||
144536263|NCT01313559|521166684|FG000|Overall Study|Rising PSA|2|||
144536264|NCT01313559|521166685|FG001|Overall Study|Rising PSA|0|||
144536265|NCT04908514|521166686|FG000|Overall Study|Lost to Follow-up|2|||
144611621|NCT03179891|521438932|FG001|First Intervention|Protocol Violation|1|||
144611622|NCT00530894|521438933|FG000|Overall Study|Death|84|||
144258090|NCT02137226|520146957|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
144258091|NCT02137226|520146953|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
144258092|NCT02137226|520146954|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
144258093|NCT02137226|520146955|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
144464573|NCT03318523|520897696|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
144464574|NCT03318523|520897697|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
144464575|NCT03318523|520897688|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464576|NCT03318523|520897689|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464577|NCT03318523|520897690|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464578|NCT03318523|520897691|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464579|NCT03318523|520897692|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
144464580|NCT03318523|520897693|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464581|NCT03318523|520897694|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464582|NCT03318523|520897695|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
144464583|NCT03318523|520897696|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
144464584|NCT03318523|520897697|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
144464585|NCT03232983|520897700|FG000|Period 1|Physician Decision|0|||
144464586|NCT03232983|520897701|FG001|Period 1|Physician Decision|0|||
144464587|NCT03232983|520897702|FG002|Period 1|Physician Decision|1|||
144464588|NCT03232983|520897703|FG003|Period 1|Physician Decision|0|||
144464589|NCT03232983|520897700|FG000|Washout Period 2|Physician Decision|0|||
144464590|NCT03232983|520897701|FG001|Washout Period 2|Physician Decision|0|||
144464591|NCT03232983|520897702|FG002|Washout Period 2|Physician Decision|1|||
144464592|NCT03232983|520897703|FG003|Washout Period 2|Physician Decision|0|||
144464593|NCT03232983|520897700|FG000|Washout Period 2|Withdrawal by Subject|0|||
144464594|NCT03232983|520897701|FG001|Washout Period 2|Withdrawal by Subject|0|||
144464595|NCT03232983|520897702|FG002|Washout Period 2|Withdrawal by Subject|0|||
144464596|NCT03232983|520897703|FG003|Washout Period 2|Withdrawal by Subject|1|||
144464597|NCT03232983|520897700|FG000|Period 4|Withdrawal by Subject|1|||
144464598|NCT03232983|520897701|FG001|Period 4|Withdrawal by Subject|0|||
144464599|NCT03232983|520897702|FG002|Period 4|Withdrawal by Subject|0|||
144464600|NCT03232983|520897703|FG003|Period 4|Withdrawal by Subject|0|||
144464601|NCT01615328|520897704|FG000|Overall Study|Lost to Follow-up|3|||
144464602|NCT01615328|520897705|FG001|Overall Study|Lost to Follow-up|5|||
144464603|NCT00863655|520897706|FG000|Overall Study|Protocol Violation|4|||
144464604|NCT00863655|520897707|FG001|Overall Study|Protocol Violation|0|||
144464605|NCT00863655|520897706|FG000|Overall Study|Adverse Event|52|||
144464606|NCT00863655|520897707|FG001|Overall Study|Adverse Event|8|||
144464607|NCT00863655|520897706|FG000|Overall Study|Withdrawal by Subject|47|||
144464608|NCT00863655|520897707|FG001|Overall Study|Withdrawal by Subject|7|||
144464609|NCT00863655|520897706|FG000|Overall Study|Administrative problems|1|||
144464610|NCT00863655|520897707|FG001|Overall Study|Administrative problems|0|||
144464611|NCT00863655|520897706|FG000|Overall Study|Death|7|||
144464612|NCT00863655|520897707|FG001|Overall Study|Death|1|||
144464613|NCT00863655|520897706|FG000|Overall Study|New cancer therapy|5|||
144464614|NCT00863655|520897707|FG001|Overall Study|New cancer therapy|1|||
144464615|NCT00863655|520897706|FG000|Overall Study|Disease progression|364|||
144611623|NCT00530894|521438934|FG001|Overall Study|Death|89|||
144611624|NCT00530894|521438935|FG002|Overall Study|Death|55|||
144611625|NCT00530894|521438936|FG003|Overall Study|Death|89|||
144611626|NCT00530894|521438933|FG000|Overall Study|Lost to Follow-up|1|||
144611627|NCT00530894|521438934|FG001|Overall Study|Lost to Follow-up|3|||
144611628|NCT00530894|521438935|FG002|Overall Study|Lost to Follow-up|0|||
144611629|NCT00530894|521438936|FG003|Overall Study|Lost to Follow-up|0|||
144611630|NCT00530894|521438933|FG000|Overall Study|Withdrawal by Subject|1|||
144611631|NCT00530894|521438934|FG001|Overall Study|Withdrawal by Subject|23|||
144611632|NCT00530894|521438935|FG002|Overall Study|Withdrawal by Subject|0|||
144611633|NCT00530894|521438936|FG003|Overall Study|Withdrawal by Subject|5|||
144611634|NCT00530894|521438933|FG000|Overall Study|Alive and censored prior to 1 year|2|||
144464616|NCT00863655|520897707|FG001|Overall Study|Disease progression|221|||
144464617|NCT00863655|520897706|FG000|Overall Study|Treatment completed as per protocol|5|||
144464618|NCT00863655|520897707|FG001|Overall Study|Treatment completed as per protocol|1|||
144464619|NCT02548455|520897709|FG000|Overall Study|Withdrawal by Subject|27|||
144464620|NCT02548455|520897709|FG000|Overall Study|Death|26|||
144464621|NCT02548455|520897709|FG000|Overall Study|Lost to Follow-up|14|||
144464622|NCT02548455|520897709|FG000|Overall Study|Visit not completed|173|||
144464623|NCT02261493|520897710|FG000|Overall Study|Noncompliance|0|||
144464624|NCT02261493|520897711|FG001|Overall Study|Noncompliance|0|||
144464625|NCT02261493|520897712|FG002|Overall Study|Noncompliance|2|||
144464626|NCT02261493|520897710|FG000|Overall Study|Physician Decision|0|||
144464627|NCT02261493|520897711|FG001|Overall Study|Physician Decision|1|||
144464628|NCT02261493|520897712|FG002|Overall Study|Physician Decision|0|||
144464629|NCT02261493|520897710|FG000|Overall Study|Undisclosed alcohol abuse|0|||
144726046|NCT00950807|521852689|FG004|Treatment Period 1|Lack of Efficacy|0|||
144611635|NCT00530894|521438934|FG001|Overall Study|Alive and censored prior to 1 year|0|||
144611636|NCT00530894|521438935|FG002|Overall Study|Alive and censored prior to 1 year|0|||
144464630|NCT02261493|520897711|FG001|Overall Study|Undisclosed alcohol abuse|1|||
144464631|NCT02261493|520897712|FG002|Overall Study|Undisclosed alcohol abuse|0|||
144464632|NCT02261493|520897710|FG000|Overall Study|Protocol Violation|1|||
144464633|NCT02261493|520897711|FG001|Overall Study|Protocol Violation|0|||
144464634|NCT02261493|520897712|FG002|Overall Study|Protocol Violation|0|||
144464635|NCT02261493|520897710|FG000|Overall Study|Personal Reasons|14|||
144464636|NCT02261493|520897711|FG001|Overall Study|Personal Reasons|14|||
144464637|NCT02261493|520897712|FG002|Overall Study|Personal Reasons|16|||
144464638|NCT02261493|520897710|FG000|Overall Study|Lost to Follow-up|14|||
144464639|NCT02261493|520897711|FG001|Overall Study|Lost to Follow-up|27|||
144464640|NCT02261493|520897712|FG002|Overall Study|Lost to Follow-up|8|||
144464641|NCT02261493|520897710|FG000|Overall Study|Pregnancy|1|||
144464642|NCT02261493|520897711|FG001|Overall Study|Pregnancy|2|||
144464643|NCT02261493|520897712|FG002|Overall Study|Pregnancy|0|||
144464644|NCT02261493|520897710|FG000|Overall Study|Lack of Efficacy|0|||
144464645|NCT02261493|520897711|FG001|Overall Study|Lack of Efficacy|1|||
144464646|NCT02261493|520897712|FG002|Overall Study|Lack of Efficacy|0|||
144464647|NCT02261493|520897710|FG000|Overall Study|Adverse Event|0|||
144464648|NCT02261493|520897711|FG001|Overall Study|Adverse Event|1|||
144464649|NCT02261493|520897712|FG002|Overall Study|Adverse Event|0|||
144464650|NCT01597050|520897713|FG000|Overall Study|Withdrawal by Subject|1|||
144464651|NCT01597050|520897714|FG001|Overall Study|Withdrawal by Subject|0|||
144464652|NCT00483184|520897715|FG000|Overall Study|Withdrawal by Subject|2|||
144464653|NCT00483184|520897716|FG001|Overall Study|Withdrawal by Subject|2|||
144464654|NCT00483184|520897717|FG002|Overall Study|Withdrawal by Subject|0|||
144464655|NCT00483184|520897715|FG000|Overall Study|Lost to Follow-up|1|||
144464656|NCT00483184|520897716|FG001|Overall Study|Lost to Follow-up|0|||
144464657|NCT00483184|520897717|FG002|Overall Study|Lost to Follow-up|0|||
144464658|NCT00483184|520897715|FG000|Overall Study|Adverse Event|1|||
144464659|NCT00483184|520897716|FG001|Overall Study|Adverse Event|2|||
144464660|NCT00483184|520897717|FG002|Overall Study|Adverse Event|2|||
144464661|NCT00483184|520897715|FG000|Overall Study|Protocol Violation|1|||
144464662|NCT00483184|520897716|FG001|Overall Study|Protocol Violation|0|||
144464663|NCT00483184|520897717|FG002|Overall Study|Protocol Violation|1|||
144464664|NCT02065336|520897721|FG000|Extension Phase|Study Terminated by Sponsor|0|||
144464665|NCT02065336|520897722|FG001|Extension Phase|Study Terminated by Sponsor|0|||
144464666|NCT02065336|520897723|FG002|Extension Phase|Study Terminated by Sponsor|0|||
144464667|NCT02065336|520897724|FG003|Extension Phase|Study Terminated by Sponsor|0|||
144464668|NCT02065336|520897725|FG004|Extension Phase|Study Terminated by Sponsor|0|||
144464669|NCT02065336|520897726|FG005|Extension Phase|Study Terminated by Sponsor|0|||
144464670|NCT02065336|520897727|FG006|Extension Phase|Study Terminated by Sponsor|0|||
144464671|NCT02065336|520897728|FG007|Extension Phase|Study Terminated by Sponsor|0|||
144464672|NCT02065336|520897729|FG008|Extension Phase|Study Terminated by Sponsor|2|||
144464673|NCT02065336|520897730|FG009|Extension Phase|Study Terminated by Sponsor|8|||
144464674|NCT00530855|520897731|FG000|Overall Study|Lack of Efficacy|20|||
144536266|NCT04908514|521166686|FG000|Overall Study|Withdrawal by Subject|1|||
144536267|NCT05714059|521166688|FG000|Overall Study|Withdrawal by Subject|2|||
144536268|NCT05714059|521166689|FG001|Overall Study|Withdrawal by Subject|2|||
144536269|NCT05714059|521166688|FG000|Overall Study|Adverse Event|0|||
144536270|NCT05714059|521166689|FG001|Overall Study|Adverse Event|1|||
144611637|NCT00530894|521438936|FG003|Overall Study|Alive and censored prior to 1 year|0|||
144611638|NCT02969187|521438939|FG000|Overall Study|Physician Decision|12|||
144611639|NCT02969187|521438940|FG001|Overall Study|Physician Decision|13|||
144611640|NCT01486927|521438941|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
144536271|NCT05714059|521166688|FG000|Overall Study|Lost to Follow-up|0|||
144536272|NCT05714059|521166689|FG001|Overall Study|Lost to Follow-up|1|||
144536273|NCT05714059|521166688|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
144536274|NCT05714059|521166689|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
144536275|NCT05714059|521166688|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
144611641|NCT01486927|521438941|FG000|Overall Study|Physician Decision|1|||
144464675|NCT00530855|520897731|FG000|Overall Study|Withdrawal by Subject|30|||
144464676|NCT00530855|520897731|FG000|Overall Study|Fatal Serious AE|3|||
144464677|NCT00530855|520897731|FG000|Overall Study|Non Fatal Serious AE|7|||
144464678|NCT00530855|520897731|FG000|Overall Study|Non Fatal Non Serious AE|12|||
144464679|NCT00530855|520897731|FG000|Overall Study|Protocol Violation|3|||
144464680|NCT00530855|520897731|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
144464681|NCT00530855|520897731|FG000|Overall Study|Lost to Follow-up|9|||
144536276|NCT05714059|521166689|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
144536277|NCT03473223|521166691|FG000|Overall Study|Lost to Follow-up|1|||
144536278|NCT03473223|521166692|FG001|Overall Study|Lost to Follow-up|1|||
144536279|NCT03473223|521166691|FG000|Overall Study|Withdrawal by Subject|47|||
144611642|NCT01486927|521438941|FG000|Overall Study|50 Exposure days not reached|2|||
144464682|NCT00530855|520897731|FG000|Overall Study|Other reason for premature termination|17|||
144464683|NCT01292876|520897732|FG000|Overall Study|Physician Decision|4|||
144611643|NCT01486927|521438941|FG000|Overall Study|Withdrawal by Subject|8|||
144726047|NCT00950807|521852690|FG005|Treatment Period 1|Lack of Efficacy|1|||
144726048|NCT00950807|521852691|FG006|Treatment Period 1|Lack of Efficacy|0|||
144464684|NCT01627327|520897733|FG000|Overall Study|Adverse Event|6|||
144464685|NCT01627327|520897734|FG001|Overall Study|Adverse Event|12|||
144464686|NCT01627327|520897733|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
144464687|NCT01627327|520897734|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
144464688|NCT01627327|520897733|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
144464689|NCT01627327|520897734|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
144464690|NCT01627327|520897733|FG000|Overall Study|Protocol Violation|4|||
144464691|NCT01627327|520897734|FG001|Overall Study|Protocol Violation|10|||
144464692|NCT01627327|520897733|FG000|Overall Study|Lost to Follow-up|1|||
144464693|NCT01627327|520897734|FG001|Overall Study|Lost to Follow-up|3|||
144464694|NCT01627327|520897733|FG000|Overall Study|Physician Decision|1|||
144464695|NCT01627327|520897734|FG001|Overall Study|Physician Decision|0|||
144464696|NCT01627327|520897733|FG000|Overall Study|Withdrawal by Subject|3|||
144464697|NCT01627327|520897734|FG001|Overall Study|Withdrawal by Subject|3|||
144464698|NCT04528069|520897740|FG000|Overall Study|Adverse Event|1|||
144464699|NCT04528069|520897740|FG000|Overall Study|Lost to Follow-up|1|||
144464700|NCT04528069|520897740|FG000|Overall Study|Patient Unable to Come|1|||
144464701|NCT04528069|520897740|FG000|Overall Study|Patient Unable to Attend|1|||
144464702|NCT01137474|520897741|FG000|Overall Study|Adverse Event|3|||
144464703|NCT01137474|520897742|FG001|Overall Study|Adverse Event|5|||
144464704|NCT01137474|520897743|FG002|Overall Study|Adverse Event|1|||
144464705|NCT01137474|520897744|FG003|Overall Study|Adverse Event|3|||
144464706|NCT01137474|520897741|FG000|Overall Study|Withdrawal by Subject|7|||
144464707|NCT01137474|520897742|FG001|Overall Study|Withdrawal by Subject|2|||
144464708|NCT01137474|520897743|FG002|Overall Study|Withdrawal by Subject|6|||
144464709|NCT01137474|520897744|FG003|Overall Study|Withdrawal by Subject|9|||
144464710|NCT01137474|520897741|FG000|Overall Study|No longer met study criteria|6|||
144464711|NCT01137474|520897742|FG001|Overall Study|No longer met study criteria|1|||
144464712|NCT01137474|520897743|FG002|Overall Study|No longer met study criteria|0|||
144464713|NCT01137474|520897744|FG003|Overall Study|No longer met study criteria|5|||
144464714|NCT01137474|520897741|FG000|Overall Study|Lost to Follow-up|5|||
144464715|NCT01137474|520897742|FG001|Overall Study|Lost to Follow-up|1|||
144464716|NCT01137474|520897743|FG002|Overall Study|Lost to Follow-up|0|||
144464717|NCT01137474|520897744|FG003|Overall Study|Lost to Follow-up|2|||
144464718|NCT01137474|520897741|FG000|Overall Study|Lack of Efficacy|0|||
144464719|NCT01137474|520897742|FG001|Overall Study|Lack of Efficacy|0|||
144464720|NCT01137474|520897743|FG002|Overall Study|Lack of Efficacy|0|||
144464721|NCT01137474|520897744|FG003|Overall Study|Lack of Efficacy|2|||
144464722|NCT01137474|520897741|FG000|Overall Study|Other|3|||
144464723|NCT01137474|520897742|FG001|Overall Study|Other|1|||
144464724|NCT01137474|520897743|FG002|Overall Study|Other|0|||
144464725|NCT01137474|520897744|FG003|Overall Study|Other|0|||
144464726|NCT01137474|520897741|FG000|Overall Study|Pregnancy|0|||
144464727|NCT01137474|520897742|FG001|Overall Study|Pregnancy|1|||
144464728|NCT01137474|520897743|FG002|Overall Study|Pregnancy|0|||
144464729|NCT01137474|520897744|FG003|Overall Study|Pregnancy|0|||
144464730|NCT01137474|520897741|FG000|Overall Study|Administrative reason by sponsor|0|||
144464731|NCT01137474|520897742|FG001|Overall Study|Administrative reason by sponsor|1|||
144464732|NCT01137474|520897743|FG002|Overall Study|Administrative reason by sponsor|0|||
144464733|NCT01137474|520897744|FG003|Overall Study|Administrative reason by sponsor|0|||
144464734|NCT02525874|520897745|FG000|Overall Study|Other|1|||
144464735|NCT02525874|520897745|FG000|Overall Study|Investigator Decision|1|||
144464736|NCT02525874|520897745|FG000|Overall Study|Consent withdrawn|22|||
144464737|NCT02525874|520897745|FG000|Overall Study|Non-compliance with study drug|3|||
144464738|NCT02525874|520897745|FG000|Overall Study|Adverse Event|17|||
144464739|NCT02525874|520897745|FG000|Overall Study|Lost to Follow-up|7|||
144464740|NCT02525874|520897745|FG000|Overall Study|Disease progression, defined by protocol|2|||
144464741|NCT02525874|520897745|FG000|Overall Study|Disease relapse|4|||
144464742|NCT02525874|520897745|FG000|Overall Study|Alternative Treatment for MS|2|||
144464743|NCT02525874|520897745|FG000|Overall Study|New lesions in Brain|1|||
144464744|NCT01814371|520897746|FG000|Overall Study|Lost to Follow-up|30|||
144464745|NCT01814371|520897747|FG001|Overall Study|Lost to Follow-up|27|||
144464746|NCT01692782|520897748|FG000|Overall Study|Adverse Event|12|||
144464747|NCT01692782|520897749|FG001|Overall Study|Adverse Event|32|||
144464748|NCT01692782|520897750|FG002|Overall Study|Adverse Event|2|||
144464749|NCT01692782|520897748|FG000|Overall Study|Lack of Efficacy|1|||
144464750|NCT01692782|520897749|FG001|Overall Study|Lack of Efficacy|2|||
144464751|NCT01692782|520897750|FG002|Overall Study|Lack of Efficacy|0|||
144464752|NCT01692782|520897748|FG000|Overall Study|Lost to Follow-up|2|||
144464753|NCT01692782|520897749|FG001|Overall Study|Lost to Follow-up|7|||
144464754|NCT01692782|520897750|FG002|Overall Study|Lost to Follow-up|1|||
144464755|NCT01692782|520897748|FG000|Overall Study|Pregnancy|1|||
144464756|NCT01692782|520897749|FG001|Overall Study|Pregnancy|0|||
144464757|NCT01692782|520897750|FG002|Overall Study|Pregnancy|0|||
144464758|NCT01692782|520897748|FG000|Overall Study|Protocol Violation|1|||
144464759|NCT01692782|520897749|FG001|Overall Study|Protocol Violation|0|||
144464760|NCT01692782|520897750|FG002|Overall Study|Protocol Violation|2|||
144611644|NCT01486927|521438941|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
144611645|NCT01923285|521438945|FG000|Overall Study|Withdrawal by Subject|7|||
144611646|NCT01923285|521438946|FG001|Overall Study|Withdrawal by Subject|6|||
144611647|NCT03374189|521438947|FG000|Overall Study|Lost to Follow-up|1|||
144611648|NCT03374189|521438948|FG001|Overall Study|Lost to Follow-up|0|||
144611649|NCT02375724|521438949|FG000|Overall Study|Lack of Efficacy|1|||
144611650|NCT02375724|521438950|FG001|Overall Study|Lack of Efficacy|1|||
144611651|NCT02375724|521438949|FG000|Overall Study|Withdrawal by Subject|1|||
144611652|NCT02375724|521438950|FG001|Overall Study|Withdrawal by Subject|1|||
144611653|NCT02375724|521438949|FG000|Overall Study|Lost to Follow-up|1|||
144611654|NCT02375724|521438950|FG001|Overall Study|Lost to Follow-up|0|||
144611655|NCT02375724|521438949|FG000|Overall Study|Protocol Violation|1|||
144611656|NCT02375724|521438950|FG001|Overall Study|Protocol Violation|0|||
144611657|NCT02375724|521438949|FG000|Overall Study|Adverse Event|2|||
144611658|NCT02375724|521438950|FG001|Overall Study|Adverse Event|4|||
144611659|NCT01517893|521438953|FG000|Overall Study|Withdrawal by Subject|3|||
144611660|NCT01517893|521438954|FG001|Overall Study|Withdrawal by Subject|0|||
144611661|NCT03462576|521438955|FG000|Overall Study|Protocol Violation|5|||
144611662|NCT03462576|521438956|FG001|Overall Study|Protocol Violation|11|||
144611663|NCT03462576|521438957|FG002|Overall Study|Protocol Violation|7|||
144611664|NCT03462576|521438955|FG000|Overall Study|Device Malfunction|0|||
144611665|NCT03462576|521438956|FG001|Overall Study|Device Malfunction|0|||
144611666|NCT03462576|521438957|FG002|Overall Study|Device Malfunction|1|||
144611667|NCT02285777|521438958|FG000|Overall Study|Withdrawal by Subject|1|||
144611668|NCT02285777|521438959|FG001|Overall Study|Withdrawal by Subject|1|||
144611669|NCT02285777|521438958|FG000|Overall Study|Lost to Follow-up|4|||
144611670|NCT02285777|521438959|FG001|Overall Study|Lost to Follow-up|2|||
144611671|NCT03962101|521438960|FG000|Overall Study|Adverse Event|1|||
144611672|NCT03962101|521438960|FG000|Overall Study|Physician Decision|2|||
144611673|NCT03962101|521438960|FG000|Overall Study|Not related to medical events|1|||
144611674|NCT00271596|521438961|FG000|Overall Study|Protocol Violation|1|||
144611675|NCT00271596|521438962|FG001|Overall Study|Protocol Violation|0|||
144611676|NCT00271596|521438961|FG000|Overall Study|Withdrawal by Subject|0|||
144611677|NCT00271596|521438962|FG001|Overall Study|Withdrawal by Subject|1|||
144611678|NCT01543828|521438963|FG000|Treatment 2|Lost to Follow-up|1|||
144611679|NCT01543828|521438964|FG001|Treatment 2|Lost to Follow-up|0|||
144611680|NCT01069172|521438965|FG000|Overall Study|Withdrawal by Subject|1|||
144611681|NCT01069172|521438966|FG001|Overall Study|Withdrawal by Subject|0|||
144611682|NCT00711425|521438970|FG000|Overall Study|Protocol Violation|1|||
144611683|NCT00711425|521438970|FG000|Overall Study|Death|2|||
144611684|NCT00711425|521438970|FG000|Overall Study|Lost to Follow-up|1|||
144611685|NCT03901079|521438973|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
144611686|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
144611687|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
144611688|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Death|0|||
144611689|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Death|1|||
144611690|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
144464761|NCT01692782|520897748|FG000|Overall Study|Non-complance with study drug|0|||
144464762|NCT01692782|520897749|FG001|Overall Study|Non-complance with study drug|4|||
144464763|NCT01692782|520897750|FG002|Overall Study|Non-complance with study drug|1|||
144464764|NCT01692782|520897748|FG000|Overall Study|Non-compliant with study visits|0|||
144464765|NCT01692782|520897749|FG001|Overall Study|Non-compliant with study visits|0|||
144464766|NCT01692782|520897750|FG002|Overall Study|Non-compliant with study visits|1|||
144464767|NCT01692782|520897748|FG000|Overall Study|SAE not related to study drug|0|||
144464768|NCT01692782|520897749|FG001|Overall Study|SAE not related to study drug|1|||
144464769|NCT01692782|520897750|FG002|Overall Study|SAE not related to study drug|0|||
144464770|NCT01692782|520897748|FG000|Overall Study|Withdrawal by Subject|3|||
144464771|NCT01692782|520897749|FG001|Overall Study|Withdrawal by Subject|10|||
144464772|NCT01692782|520897750|FG002|Overall Study|Withdrawal by Subject|3|||
144464773|NCT00868439|520897756|FG000|Overall Study|Adverse Event|4|||
144464774|NCT00868439|520897757|FG001|Overall Study|Adverse Event|3|||
144464775|NCT00868439|520897756|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
144464776|NCT00868439|520897757|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
144464777|NCT00868439|520897756|FG000|Overall Study|Death|0|||
144464778|NCT00868439|520897757|FG001|Overall Study|Death|1|||
144611691|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
144611692|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
144611693|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
144611694|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
144611695|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
144611696|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
144611697|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
144611698|NCT00843518|521438974|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
144611699|NCT00843518|521438975|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
144258094|NCT02137226|520146956|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
144258095|NCT02137226|520146957|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
144258096|NCT02137226|520146953|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
144258097|NCT02137226|520146954|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
144258098|NCT02137226|520146955|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
144258099|NCT02137226|520146956|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
144258100|NCT02137226|520146957|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
144258101|NCT02137226|520146953|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
144258102|NCT02137226|520146954|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
144258103|NCT02137226|520146955|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
144258104|NCT02137226|520146956|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
144258105|NCT02137226|520146957|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
144258106|NCT02137226|520146953|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
144258107|NCT02137226|520146954|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
144258108|NCT02137226|520146955|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
144258109|NCT02137226|520146956|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
144258110|NCT02137226|520146957|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
144258111|NCT02137226|520146953|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
144258112|NCT02137226|520146954|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
144258113|NCT02137226|520146955|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
144258114|NCT02137226|520146956|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
144258115|NCT02137226|520146957|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
144258116|NCT02137226|520146953|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
144258117|NCT02137226|520146954|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
144258118|NCT02137226|520146955|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
144258119|NCT02137226|520146956|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
144258120|NCT02137226|520146957|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
144258121|NCT02137226|520146953|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
144258122|NCT02137226|520146954|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
144258123|NCT02137226|520146955|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
144258124|NCT02137226|520146956|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
144258125|NCT02137226|520146957|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
144258126|NCT02137226|520146953|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
144258127|NCT02137226|520146954|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
144258128|NCT02137226|520146955|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
144258129|NCT02137226|520146956|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
144258130|NCT02137226|520146957|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
144258131|NCT02137226|520146953|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
144258132|NCT02137226|520146954|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
144258133|NCT02137226|520146955|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
144258134|NCT02137226|520146956|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
144258135|NCT02137226|520146957|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
144258136|NCT01398358|520146960|FG000|Overall Study|Lost to Follow-up|11|||
144258137|NCT01398358|520146961|FG001|Overall Study|Lost to Follow-up|21|||
144258138|NCT01398358|520146962|FG002|Overall Study|Lost to Follow-up|18|||
144258139|NCT01398358|520146960|FG000|Overall Study|Withdrawal by Subject|3|||
144258140|NCT01398358|520146961|FG001|Overall Study|Withdrawal by Subject|2|||
144258141|NCT01398358|520146962|FG002|Overall Study|Withdrawal by Subject|2|||
144258142|NCT01398358|520146960|FG000|Overall Study|no longer eligible|1|||
144258143|NCT01398358|520146961|FG001|Overall Study|no longer eligible|0|||
144464779|NCT00868439|520897756|FG000|Overall Study|Protocol Violation|1|||
144464780|NCT00868439|520897757|FG001|Overall Study|Protocol Violation|1|||
144464781|NCT00868439|520897756|FG000|Overall Study|Physician Decision|1|||
144464782|NCT00868439|520897757|FG001|Overall Study|Physician Decision|0|||
144464783|NCT00868439|520897756|FG000|Overall Study|Withdrawal by Subject|0|||
144464784|NCT00868439|520897757|FG001|Overall Study|Withdrawal by Subject|1|||
144464785|NCT00224874|520897758|FG000|Overall Study|Withdrawal by Subject|0|||
144258144|NCT01398358|520146962|FG002|Overall Study|no longer eligible|1|||
144258145|NCT00003896|520146963|FG000|Overall Study|Adverse Event|16|||
144258146|NCT00003896|520146963|FG000|Overall Study|Withdrawal by Subject|1|||
144258147|NCT00003896|520146963|FG000|Overall Study|Lack of Efficacy|1|||
144258148|NCT00003896|520146963|FG000|Overall Study|Death|3|||
144258149|NCT00003896|520146963|FG000|Overall Study|not protocol specified|3|||
144258150|NCT00003896|520146963|FG000|Overall Study|ineligible|5|||
144258151|NCT00985686|520146964|FG000|Overall Study|Lost to Follow-up|1|||
144258152|NCT00985686|520146965|FG001|Overall Study|Lost to Follow-up|1|||
144258153|NCT00985686|520146966|FG002|Overall Study|Lost to Follow-up|0|||
144258154|NCT00985686|520146967|FG003|Overall Study|Lost to Follow-up|2|||
144258155|NCT03134911|520146968|FG000|Overall Study|Screen failure|31|||
144464786|NCT00224874|520897759|FG001|Overall Study|Withdrawal by Subject|0|||
144464787|NCT00224874|520897760|FG002|Overall Study|Withdrawal by Subject|1|||
144464788|NCT00224874|520897761|FG003|Overall Study|Withdrawal by Subject|0|||
144464789|NCT00911534|520897762|FG000|Overall Study|Adverse Event|4|||
144464790|NCT00911534|520897763|FG001|Overall Study|Adverse Event|4|||
144464791|NCT00911534|520897762|FG000|Overall Study|Lost to Follow-up|2|||
144464792|NCT00911534|520897763|FG001|Overall Study|Lost to Follow-up|4|||
144464793|NCT00911534|520897762|FG000|Overall Study|Withdrawal by Subject|2|||
144464794|NCT00911534|520897763|FG001|Overall Study|Withdrawal by Subject|1|||
144464795|NCT00911534|520897762|FG000|Overall Study|Lack of Efficacy|4|||
144464796|NCT00911534|520897763|FG001|Overall Study|Lack of Efficacy|1|||
144464797|NCT00911534|520897762|FG000|Overall Study|Withdrawal of consent|1|||
144464798|NCT00911534|520897763|FG001|Overall Study|Withdrawal of consent|4|||
144464799|NCT00911534|520897762|FG000|Overall Study|Other|2|||
144464800|NCT00911534|520897763|FG001|Overall Study|Other|2|||
144464801|NCT04867369|520897764|FG000|Overall Study|Withdrawal by Subject|1|||
144464802|NCT04867369|520897765|FG001|Overall Study|Withdrawal by Subject|0|||
144464803|NCT05554237|520897766|FG000|Part 2 (7 Days)|Adverse Event|0|||
144464804|NCT05554237|520897767|FG001|Part 2 (7 Days)|Adverse Event|0|||
144464805|NCT05554237|520897768|FG002|Part 2 (7 Days)|Adverse Event|0|||
144464806|NCT05554237|520897769|FG003|Part 2 (7 Days)|Adverse Event|0|||
144464807|NCT05554237|520897770|FG004|Part 2 (7 Days)|Adverse Event|2|||
144464808|NCT05554237|520897771|FG005|Part 2 (7 Days)|Adverse Event|0|||
144464809|NCT05554237|520897772|FG006|Part 2 (7 Days)|Adverse Event|0|||
144464810|NCT05554237|520897773|FG007|Part 2 (7 Days)|Adverse Event|0|||
144464811|NCT05554237|520897774|FG008|Part 2 (7 Days)|Adverse Event|0|||
144464812|NCT05554237|520897775|FG009|Part 2 (7 Days)|Adverse Event|1|||
144464813|NCT05554237|520897776|FG010|Part 2 (7 Days)|Adverse Event|0|||
144464814|NCT05554237|520897777|FG011|Part 2 (7 Days)|Adverse Event|0|||
144464815|NCT05554237|520897778|FG012|Part 2 (7 Days)|Adverse Event|1|||
144464816|NCT05554237|520897779|FG013|Part 2 (7 Days)|Adverse Event|0|||
144464817|NCT02677116|520897780|FG000|Overall Study|Adverse Event|0|||
144464818|NCT02677116|520897781|FG001|Overall Study|Adverse Event|1|||
144464819|NCT02677116|520897782|FG002|Overall Study|Adverse Event|0|||
144464820|NCT02677116|520897783|FG003|Overall Study|Adverse Event|0|||
144464821|NCT02677116|520897784|FG004|Overall Study|Adverse Event|0|||
144464822|NCT02677116|520897785|FG005|Overall Study|Adverse Event|1|||
144464823|NCT02677116|520897786|FG006|Overall Study|Adverse Event|1|||
144464824|NCT02677116|520897787|FG007|Overall Study|Adverse Event|0|||
144464825|NCT02677116|520897788|FG008|Overall Study|Adverse Event|0|||
144464826|NCT02677116|520897780|FG000|Overall Study|Physician Decision|0|||
144464827|NCT02677116|520897781|FG001|Overall Study|Physician Decision|2|||
144464828|NCT02677116|520897782|FG002|Overall Study|Physician Decision|3|||
144464829|NCT02677116|520897783|FG003|Overall Study|Physician Decision|2|||
144258156|NCT03134911|520146968|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
144258157|NCT00420628|520146976|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
144258158|NCT00420628|520146977|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
144258159|NCT00420628|520146976|FG000|Overall Study|Lost to Follow-up|3|||
144258160|NCT00420628|520146977|FG001|Overall Study|Lost to Follow-up|2|||
144258161|NCT00420628|520146976|FG000|Overall Study|Adverse Event|1|||
144258162|NCT00420628|520146977|FG001|Overall Study|Adverse Event|0|||
144258163|NCT00184093|520146982|FG000|Overall Study|Adverse Event|3|||
144258164|NCT00184093|520146982|FG000|Overall Study|Lost to Follow-up|3|||
144258165|NCT00184093|520146982|FG000|Overall Study|Physician Decision|1|||
144258166|NCT00184093|520146982|FG000|Overall Study|Withdrawal by Subject|2|||
144258167|NCT00805129|520146989|FG000|Overall Study|Not treated|1|||
144258168|NCT01868165|520146990|FG000|Overall Study|Withdrawal by Subject|36|||
144258169|NCT01868165|520146990|FG000|Overall Study|Physician Decision|2|||
144258170|NCT01868165|520146990|FG000|Overall Study|Lost to Follow-up|3|||
144258171|NCT01868165|520146990|FG000|Overall Study|Death|4|||
144258172|NCT00571662|520146991|FG000|Overall Study|Withdrawal by Subject|2|||
144258173|NCT00571662|520146991|FG000|Overall Study|psychiatric instability|1|||
144258174|NCT00571662|520146991|FG000|Overall Study|Adverse Event|5|||
144258175|NCT01429298|520146992|FG000|Overall Study|Protocol Violation|4|||
144464830|NCT02677116|520897784|FG004|Overall Study|Physician Decision|1|||
144464831|NCT02677116|520897785|FG005|Overall Study|Physician Decision|3|||
144464832|NCT02677116|520897786|FG006|Overall Study|Physician Decision|1|||
144611700|NCT04607148|521438978|FG000|Overall Study|Withdrawal by Subject|0|||
144258176|NCT01429298|520146993|FG001|Overall Study|Protocol Violation|6|||
144258177|NCT00396383|520146994|FG000|Overall Study|Death|2|||
144464833|NCT02677116|520897787|FG007|Overall Study|Physician Decision|1|||
144464834|NCT02677116|520897788|FG008|Overall Study|Physician Decision|2|||
144464835|NCT02677116|520897780|FG000|Overall Study|Withdrawal by parent or guardian|2|||
144464836|NCT02677116|520897781|FG001|Overall Study|Withdrawal by parent or guardian|1|||
144464837|NCT02677116|520897782|FG002|Overall Study|Withdrawal by parent or guardian|0|||
144464838|NCT02677116|520897783|FG003|Overall Study|Withdrawal by parent or guardian|1|||
144464839|NCT02677116|520897784|FG004|Overall Study|Withdrawal by parent or guardian|0|||
144258178|NCT00396383|520146994|FG000|Overall Study|Lost to Follow-up|1|||
144258179|NCT01839916|520146995|FG000|Overall Study|Death|9|||
144464840|NCT02677116|520897785|FG005|Overall Study|Withdrawal by parent or guardian|0|||
144464841|NCT02677116|520897786|FG006|Overall Study|Withdrawal by parent or guardian|2|||
144611701|NCT04607148|521438979|FG001|Overall Study|Withdrawal by Subject|4|||
144464842|NCT02677116|520897787|FG007|Overall Study|Withdrawal by parent or guardian|1|||
144611702|NCT04607148|521438980|FG002|Overall Study|Withdrawal by Subject|2|||
144611703|NCT04607148|521438981|FG003|Overall Study|Withdrawal by Subject|8|||
144611704|NCT04607148|521438978|FG000|Overall Study|Study Terminated by Sponsor|14|||
144611705|NCT04607148|521438979|FG001|Overall Study|Study Terminated by Sponsor|59|||
144611706|NCT04607148|521438980|FG002|Overall Study|Study Terminated by Sponsor|9|||
144611707|NCT04607148|521438981|FG003|Overall Study|Study Terminated by Sponsor|39|||
144611708|NCT04607148|521438978|FG000|Overall Study|Sponsor Decision|0|||
144611709|NCT04607148|521438979|FG001|Overall Study|Sponsor Decision|0|||
144611710|NCT04607148|521438980|FG002|Overall Study|Sponsor Decision|1|||
144611711|NCT04607148|521438981|FG003|Overall Study|Sponsor Decision|0|||
144611712|NCT04607148|521438978|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144611713|NCT04607148|521438979|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144611714|NCT04607148|521438980|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144611715|NCT04607148|521438981|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144611716|NCT04607148|521438978|FG000|Overall Study|Lost to Follow-up|0|||
144611717|NCT04607148|521438979|FG001|Overall Study|Lost to Follow-up|2|||
144611718|NCT04607148|521438980|FG002|Overall Study|Lost to Follow-up|0|||
144611719|NCT04607148|521438981|FG003|Overall Study|Lost to Follow-up|0|||
144611720|NCT04607148|521438978|FG000|Overall Study|Death|0|||
144611721|NCT04607148|521438979|FG001|Overall Study|Death|3|||
144611722|NCT04607148|521438980|FG002|Overall Study|Death|0|||
144611723|NCT04607148|521438981|FG003|Overall Study|Death|1|||
144611724|NCT04607148|521438978|FG000|Overall Study|Adverse Event|0|||
144611725|NCT04607148|521438979|FG001|Overall Study|Adverse Event|1|||
144611726|NCT04607148|521438980|FG002|Overall Study|Adverse Event|0|||
144611727|NCT04607148|521438981|FG003|Overall Study|Adverse Event|0|||
144611728|NCT00916149|521438984|FG000|Overall Study|Lost to Follow-up|3|||
144611729|NCT00916149|521438985|FG001|Overall Study|Lost to Follow-up|2|||
144611730|NCT00916149|521438986|FG002|Overall Study|Lost to Follow-up|0|||
144611731|NCT00916149|521438984|FG000|Overall Study|Unable to place scalp EEG leads|1|||
144611732|NCT00916149|521438985|FG001|Overall Study|Unable to place scalp EEG leads|0|||
144611733|NCT00916149|521438986|FG002|Overall Study|Unable to place scalp EEG leads|0|||
144611734|NCT00912028|521438987|FG000|Overall Study|Lost to Follow-up|2|||
144611735|NCT00912028|521438988|FG001|Overall Study|Lost to Follow-up|3|||
144611736|NCT00912028|521438989|FG002|Overall Study|Lost to Follow-up|0|||
144611737|NCT00912028|521438990|FG003|Overall Study|Lost to Follow-up|1|||
144611738|NCT00912028|521438991|FG004|Overall Study|Lost to Follow-up|3|||
144611739|NCT00912028|521438987|FG000|Overall Study|Withdrawal by Subject|3|||
144611740|NCT00912028|521438988|FG001|Overall Study|Withdrawal by Subject|0|||
144611741|NCT00912028|521438989|FG002|Overall Study|Withdrawal by Subject|0|||
144611742|NCT00912028|521438990|FG003|Overall Study|Withdrawal by Subject|0|||
144611743|NCT00912028|521438991|FG004|Overall Study|Withdrawal by Subject|0|||
144611744|NCT03002155|521438992|FG000|Overall Study|Lost to Follow-up|1|||
144611745|NCT03002155|521438993|FG001|Overall Study|Lost to Follow-up|2|||
144611746|NCT03002155|521438992|FG000|Overall Study|Withdrawal by Subject|1|||
144611747|NCT03002155|521438993|FG001|Overall Study|Withdrawal by Subject|0|||
144611748|NCT03002155|521438992|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
144611749|NCT03002155|521438993|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
144611750|NCT03451084|521438996|FG000|Overall Study|Withdrawal by Subject|2|||
144611751|NCT03451084|521438997|FG001|Overall Study|Withdrawal by Subject|1|||
144611752|NCT03451084|521438998|FG002|Overall Study|Withdrawal by Subject|2|||
144611753|NCT03451084|521438999|FG003|Overall Study|Withdrawal by Subject|1|||
144611754|NCT03451084|521438996|FG000|Overall Study|Disease recurrence|0|||
144611755|NCT03451084|521438997|FG001|Overall Study|Disease recurrence|2|||
144611756|NCT03451084|521438998|FG002|Overall Study|Disease recurrence|0|||
144611757|NCT03451084|521438999|FG003|Overall Study|Disease recurrence|0|||
144611758|NCT03451084|521438996|FG000|Overall Study|Lack of Efficacy|0|||
144611759|NCT03451084|521438997|FG001|Overall Study|Lack of Efficacy|3|||
144611760|NCT03451084|521438998|FG002|Overall Study|Lack of Efficacy|0|||
144611761|NCT03451084|521438999|FG003|Overall Study|Lack of Efficacy|1|||
144611762|NCT03451084|521438996|FG000|Overall Study|Death|1|||
144611763|NCT03451084|521438997|FG001|Overall Study|Death|0|||
144611764|NCT03451084|521438998|FG002|Overall Study|Death|2|||
144611765|NCT03451084|521438999|FG003|Overall Study|Death|0|||
144611766|NCT03451084|521438996|FG000|Overall Study|Physician Decision|0|||
144611767|NCT03451084|521438997|FG001|Overall Study|Physician Decision|0|||
144611768|NCT03451084|521438998|FG002|Overall Study|Physician Decision|2|||
144611769|NCT03451084|521438999|FG003|Overall Study|Physician Decision|2|||
144611770|NCT03451084|521438996|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
144611771|NCT03451084|521438997|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
144611772|NCT03451084|521438998|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
144611773|NCT03451084|521438999|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
144611774|NCT03418129|521439000|FG000|Overall Study|Lost to Follow-up|11|||
144611775|NCT03418129|521439001|FG001|Overall Study|Lost to Follow-up|20|||
144611776|NCT03418129|521439002|FG002|Overall Study|Lost to Follow-up|15|||
144611777|NCT03418129|521439000|FG000|Overall Study|Withdrawal by Subject|3|||
144611778|NCT03418129|521439001|FG001|Overall Study|Withdrawal by Subject|6|||
144611779|NCT03418129|521439002|FG002|Overall Study|Withdrawal by Subject|4|||
144611780|NCT01617070|521439008|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
144611781|NCT05289570|521439009|FG000|Overall Study|Physician Decision|1|||
144611782|NCT04544475|521439015|FG000|Overall Study|Withdrawal by Subject|1|||
144611783|NCT04544475|521439016|FG001|Overall Study|Withdrawal by Subject|3|||
144611784|NCT00808236|521439017|FG000|Overall Study|Was not resuscitated|50|||
144611785|NCT00808236|521439018|FG001|Overall Study|Was not resuscitated|56|||
144611786|NCT00808236|521439017|FG000|Overall Study|Pre-defined exclusion|13|||
144611787|NCT00808236|521439018|FG001|Overall Study|Pre-defined exclusion|3|||
144611788|NCT00808236|521439017|FG000|Overall Study|Lost to Follow-up|1|||
144611789|NCT00808236|521439018|FG001|Overall Study|Lost to Follow-up|1|||
144611790|NCT00808236|521439017|FG000|Overall Study|Physician Decision|0|||
144611791|NCT00808236|521439018|FG001|Overall Study|Physician Decision|1|||
144611792|NCT00808236|521439017|FG000|Overall Study|Death|18|||
144611793|NCT00808236|521439018|FG001|Overall Study|Death|30|||
144611794|NCT01147744|521439019|FG000|Overall Study|Protocol Violation|1|||
144611795|NCT01147744|521439020|FG001|Overall Study|Protocol Violation|0|||
144611796|NCT01147744|521439021|FG002|Overall Study|Protocol Violation|1|||
144611797|NCT01147744|521439022|FG003|Overall Study|Protocol Violation|0|||
144611798|NCT01147744|521439023|FG004|Overall Study|Protocol Violation|1|||
144611799|NCT01147744|521439024|FG005|Overall Study|Protocol Violation|3|||
144611800|NCT01147744|521439025|FG006|Overall Study|Protocol Violation|1|||
144611801|NCT01147744|521439019|FG000|Overall Study|Physician Decision|0|||
144611802|NCT01147744|521439020|FG001|Overall Study|Physician Decision|1|||
144611803|NCT01147744|521439021|FG002|Overall Study|Physician Decision|1|||
144611804|NCT01147744|521439022|FG003|Overall Study|Physician Decision|0|||
144611805|NCT01147744|521439023|FG004|Overall Study|Physician Decision|0|||
144611806|NCT01147744|521439024|FG005|Overall Study|Physician Decision|0|||
144611807|NCT01147744|521439025|FG006|Overall Study|Physician Decision|1|||
144611808|NCT01147744|521439019|FG000|Overall Study|Lack of Efficacy|11|||
144611809|NCT01147744|521439020|FG001|Overall Study|Lack of Efficacy|11|||
144611810|NCT01147744|521439021|FG002|Overall Study|Lack of Efficacy|9|||
144611811|NCT01147744|521439022|FG003|Overall Study|Lack of Efficacy|11|||
144611812|NCT01147744|521439023|FG004|Overall Study|Lack of Efficacy|13|||
144611813|NCT01147744|521439024|FG005|Overall Study|Lack of Efficacy|8|||
144611814|NCT01147744|521439025|FG006|Overall Study|Lack of Efficacy|7|||
144611815|NCT01147744|521439019|FG000|Overall Study|Adverse Event|1|||
144611816|NCT01147744|521439020|FG001|Overall Study|Adverse Event|2|||
144611817|NCT01147744|521439021|FG002|Overall Study|Adverse Event|3|||
144611818|NCT01147744|521439022|FG003|Overall Study|Adverse Event|0|||
144611819|NCT01147744|521439023|FG004|Overall Study|Adverse Event|2|||
144611820|NCT01147744|521439024|FG005|Overall Study|Adverse Event|1|||
144611821|NCT01147744|521439025|FG006|Overall Study|Adverse Event|2|||
144611822|NCT01147744|521439019|FG000|Overall Study|Withdrawal by Subject|8|||
144611823|NCT01147744|521439020|FG001|Overall Study|Withdrawal by Subject|4|||
144611824|NCT01147744|521439021|FG002|Overall Study|Withdrawal by Subject|2|||
144611825|NCT01147744|521439022|FG003|Overall Study|Withdrawal by Subject|2|||
144611826|NCT01147744|521439023|FG004|Overall Study|Withdrawal by Subject|2|||
144611827|NCT01147744|521439024|FG005|Overall Study|Withdrawal by Subject|5|||
144611828|NCT01147744|521439025|FG006|Overall Study|Withdrawal by Subject|2|||
144611829|NCT01147744|521439019|FG000|Overall Study|Lost to Follow-up|0|||
144611830|NCT01147744|521439020|FG001|Overall Study|Lost to Follow-up|1|||
144611831|NCT01147744|521439021|FG002|Overall Study|Lost to Follow-up|0|||
144611832|NCT01147744|521439022|FG003|Overall Study|Lost to Follow-up|0|||
144611833|NCT01147744|521439023|FG004|Overall Study|Lost to Follow-up|0|||
144611834|NCT01147744|521439024|FG005|Overall Study|Lost to Follow-up|0|||
144611835|NCT01147744|521439025|FG006|Overall Study|Lost to Follow-up|0|||
144611836|NCT01147744|521439019|FG000|Overall Study|Sponsor decision to amend protocol|7|||
144611837|NCT01147744|521439020|FG001|Overall Study|Sponsor decision to amend protocol|4|||
144611838|NCT01147744|521439021|FG002|Overall Study|Sponsor decision to amend protocol|2|||
144611839|NCT01147744|521439022|FG003|Overall Study|Sponsor decision to amend protocol|5|||
144611840|NCT01147744|521439023|FG004|Overall Study|Sponsor decision to amend protocol|7|||
144611841|NCT01147744|521439024|FG005|Overall Study|Sponsor decision to amend protocol|2|||
144611842|NCT01147744|521439025|FG006|Overall Study|Sponsor decision to amend protocol|6|||
144611843|NCT01147744|521439019|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144611844|NCT01147744|521439020|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144611845|NCT01147744|521439021|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144611846|NCT01147744|521439022|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144611847|NCT01147744|521439023|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144611848|NCT01147744|521439024|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144611849|NCT01147744|521439025|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144611850|NCT01342484|521439027|FG000|Overall Study|Other Reasons|1|||
144611851|NCT01342484|521439028|FG001|Overall Study|Other Reasons|0|||
144611852|NCT01342484|521439029|FG002|Overall Study|Other Reasons|0|||
144611853|NCT01342484|521439027|FG000|Overall Study|Protocol Violation|0|||
144611854|NCT01342484|521439028|FG001|Overall Study|Protocol Violation|0|||
144611855|NCT01342484|521439029|FG002|Overall Study|Protocol Violation|1|||
144611856|NCT01342484|521439027|FG000|Overall Study|Withdrawal by Subject|1|||
144611857|NCT01342484|521439028|FG001|Overall Study|Withdrawal by Subject|0|||
144611858|NCT01342484|521439029|FG002|Overall Study|Withdrawal by Subject|0|||
144611859|NCT01293968|521439030|FG000|Overall Study|non-cooperation|3|||
144611860|NCT01293968|521439031|FG001|Overall Study|non-cooperation|3|||
144611861|NCT00597753|521439033|FG000|Overall Study|Adverse Event|6|||
144611862|NCT00597753|521439034|FG001|Overall Study|Adverse Event|2|||
144611863|NCT00597753|521439033|FG000|Overall Study|Death|55|||
144611864|NCT00597753|521439034|FG001|Overall Study|Death|29|||
144611865|NCT00597753|521439033|FG000|Overall Study|Lack of Efficacy|2|||
144611866|NCT00597753|521439034|FG001|Overall Study|Lack of Efficacy|0|||
144611867|NCT00597753|521439033|FG000|Overall Study|Lost to Follow-up|10|||
144611868|NCT00597753|521439034|FG001|Overall Study|Lost to Follow-up|3|||
144611869|NCT00597753|521439033|FG000|Overall Study|Physician Decision|5|||
144611870|NCT00597753|521439034|FG001|Overall Study|Physician Decision|1|||
144464843|NCT02677116|520897788|FG008|Overall Study|Withdrawal by parent or guardian|0|||
144464844|NCT02677116|520897780|FG000|Overall Study|Withdrawal by Subject|1|||
144464845|NCT02677116|520897781|FG001|Overall Study|Withdrawal by Subject|0|||
144464846|NCT02677116|520897782|FG002|Overall Study|Withdrawal by Subject|0|||
144611871|NCT00597753|521439033|FG000|Overall Study|Pregnancy|1|||
144611872|NCT00597753|521439034|FG001|Overall Study|Pregnancy|0|||
144464847|NCT02677116|520897783|FG003|Overall Study|Withdrawal by Subject|0|||
144464848|NCT02677116|520897784|FG004|Overall Study|Withdrawal by Subject|0|||
144464849|NCT02677116|520897785|FG005|Overall Study|Withdrawal by Subject|0|||
144464850|NCT02677116|520897786|FG006|Overall Study|Withdrawal by Subject|0|||
144464851|NCT02677116|520897787|FG007|Overall Study|Withdrawal by Subject|0|||
144464852|NCT02677116|520897788|FG008|Overall Study|Withdrawal by Subject|0|||
144611873|NCT00597753|521439033|FG000|Overall Study|Withdrawal by Subject|35|||
144611874|NCT00597753|521439034|FG001|Overall Study|Withdrawal by Subject|12|||
144611875|NCT00597753|521439033|FG000|Overall Study|Discontinued Dialysis|0|||
144611876|NCT00597753|521439034|FG001|Overall Study|Discontinued Dialysis|1|||
144611877|NCT00597753|521439033|FG000|Overall Study|Never dosed|2|||
144611878|NCT00597753|521439034|FG001|Overall Study|Never dosed|0|||
144611879|NCT00597753|521439033|FG000|Overall Study|Noncompliance|2|||
144611880|NCT00597753|521439034|FG001|Overall Study|Noncompliance|1|||
144611881|NCT00597753|521439033|FG000|Overall Study|Relocation|17|||
144611882|NCT00597753|521439034|FG001|Overall Study|Relocation|6|||
144611883|NCT00597753|521439033|FG000|Overall Study|Renal transplant|10|||
144611884|NCT00597753|521439034|FG001|Overall Study|Renal transplant|3|||
144611885|NCT00597753|521439033|FG000|Overall Study|Site closed by sponsor|19|||
144611886|NCT00597753|521439034|FG001|Overall Study|Site closed by sponsor|7|||
144611887|NCT00597753|521439033|FG000|Overall Study|Site elected to close|2|||
144611888|NCT00597753|521439034|FG001|Overall Study|Site elected to close|4|||
144611889|NCT00388973|521440882|FG000|Overall Study|Adverse Event|16|||
144611890|NCT00388973|521440883|FG001|Overall Study|Adverse Event|6|||
144611891|NCT00388973|521440882|FG000|Overall Study|Lack of Efficacy|1|||
144611892|NCT00388973|521440883|FG001|Overall Study|Lack of Efficacy|12|||
144611893|NCT00388973|521440882|FG000|Overall Study|Protocol Violation|3|||
144611894|NCT00388973|521440883|FG001|Overall Study|Protocol Violation|0|||
144611895|NCT00388973|521440882|FG000|Overall Study|Withdrawal by Subject|14|||
144611896|NCT00388973|521440883|FG001|Overall Study|Withdrawal by Subject|17|||
144611897|NCT00388973|521440882|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
144611898|NCT00388973|521440883|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
144611899|NCT00388973|521440882|FG000|Overall Study|Did not complete 61 days of treatment|5|||
144611900|NCT00388973|521440883|FG001|Overall Study|Did not complete 61 days of treatment|4|||
144611901|NCT00388973|521440882|FG000|Overall Study|Left region|0|||
144611902|NCT00388973|521440883|FG001|Overall Study|Left region|1|||
144611903|NCT00388973|521440882|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
144611904|NCT00388973|521440883|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
144611905|NCT04342871|521440893|FG000|Overall Study|Death|4|||
144611906|NCT04342871|521440893|FG000|Overall Study|Clinical deterioration/illness progression|2|||
144611907|NCT04342871|521440893|FG000|Overall Study|Did not complete baseline assessments|5|||
144611908|NCT04342871|521440893|FG000|Overall Study|Lost to Follow-up|13|||
144611909|NCT00666458|521440894|FG000|Overall Study|Adverse Event|8|||
144611910|NCT00666458|521440895|FG001|Overall Study|Adverse Event|7|||
144611911|NCT00666458|521440894|FG000|Overall Study|Withdrawal by Subject|5|||
144611912|NCT00666458|521440895|FG001|Overall Study|Withdrawal by Subject|4|||
144611913|NCT00666458|521440894|FG000|Overall Study|Lost to Follow-up|0|||
144611914|NCT00666458|521440895|FG001|Overall Study|Lost to Follow-up|3|||
144611915|NCT00666458|521440894|FG000|Overall Study|Administrative reason by sponsor|1|||
144611916|NCT00666458|521440895|FG001|Overall Study|Administrative reason by sponsor|1|||
144611917|NCT00666458|521440894|FG000|Overall Study|Incorrect enrollment|7|||
144611918|NCT00666458|521440895|FG001|Overall Study|Incorrect enrollment|1|||
144464853|NCT01569438|520897789|FG000|Overall Study|Lack of Efficacy|1|||
144611919|NCT00666458|521440894|FG000|Overall Study|Study specific discontinuation criteria|14|||
144611920|NCT00666458|521440895|FG001|Overall Study|Study specific discontinuation criteria|7|||
144258180|NCT01839916|520146995|FG000|Overall Study|Physician Decision|17|||
144464854|NCT01569438|520897790|FG001|Overall Study|Lack of Efficacy|2|||
144258181|NCT01839916|520146995|FG000|Overall Study|Relapse|12|||
144464855|NCT01569438|520897789|FG000|Overall Study|Withdrawal by Subject|0|||
144464856|NCT01569438|520897790|FG001|Overall Study|Withdrawal by Subject|3|||
144464857|NCT01569438|520897789|FG000|Overall Study|Adverse Event|2|||
144464858|NCT01569438|520897790|FG001|Overall Study|Adverse Event|15|||
144464859|NCT01569438|520897789|FG000|Overall Study|Protocol Violation|2|||
144464860|NCT01569438|520897790|FG001|Overall Study|Protocol Violation|0|||
144464861|NCT01569438|520897789|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
144464862|NCT01569438|520897790|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
144464863|NCT01569438|520897789|FG000|Overall Study|Sponsor/Physician decision|1|||
144464864|NCT01569438|520897790|FG001|Overall Study|Sponsor/Physician decision|1|||
144464865|NCT01569438|520897789|FG000|Overall Study|Unable to adhere to study schedule|0|||
144464866|NCT01569438|520897790|FG001|Overall Study|Unable to adhere to study schedule|1|||
144464867|NCT01207102|520897791|FG000|Overall Study|Withdrawal by Subject|5|||
144464868|NCT01207102|520897791|FG000|Overall Study|Adverse Event|2|||
144464869|NCT01207102|520897791|FG000|Overall Study|progression|2|||
144464870|NCT01207102|520897791|FG000|Overall Study|Withdrawal by Treating Physician|1|||
144464871|NCT01693068|520897792|FG000|Randomization Period|On-study|2|||
144464872|NCT01693068|520897793|FG001|Randomization Period|On-study|5|||
144464873|NCT01693068|520897794|FG002|Randomization Period|On-study|0|||
144464874|NCT01693068|520897792|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
144464875|NCT01693068|520897793|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
144464876|NCT01693068|520897794|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
144464877|NCT00295022|520897795|FG000|Overall Study|Adverse Event|1|||
144464878|NCT00295022|520897796|FG001|Overall Study|Adverse Event|1|||
144464879|NCT00295022|520897797|FG002|Overall Study|Adverse Event|2|||
144464880|NCT00295022|520897795|FG000|Overall Study|Lost to Follow-up|0|||
144464881|NCT00295022|520897796|FG001|Overall Study|Lost to Follow-up|0|||
144464882|NCT00295022|520897797|FG002|Overall Study|Lost to Follow-up|1|||
144464883|NCT00295022|520897795|FG000|Overall Study|Withdrawal by Subject|0|||
144464884|NCT00295022|520897796|FG001|Overall Study|Withdrawal by Subject|0|||
144464885|NCT00295022|520897797|FG002|Overall Study|Withdrawal by Subject|2|||
144464886|NCT01239030|520897798|FG000|Double Blind|Adverse Event|0|||
144464887|NCT01239030|520897799|FG001|Double Blind|Adverse Event|1|||
144464888|NCT01239030|520897800|FG002|Double Blind|Adverse Event|0|||
144464889|NCT01239030|520897801|FG003|Double Blind|Adverse Event|2|||
144464890|NCT01239030|520897802|FG004|Double Blind|Adverse Event|0|||
144464891|NCT01239030|520897798|FG000|Double Blind|Withdrawal by Subject|0|||
144464892|NCT01239030|520897799|FG001|Double Blind|Withdrawal by Subject|1|||
144464893|NCT01239030|520897800|FG002|Double Blind|Withdrawal by Subject|1|||
144464894|NCT01239030|520897801|FG003|Double Blind|Withdrawal by Subject|0|||
144464895|NCT01239030|520897802|FG004|Double Blind|Withdrawal by Subject|1|||
144464896|NCT01239030|520897798|FG000|Double Blind|Lost to Follow-up|1|||
144464897|NCT01239030|520897799|FG001|Double Blind|Lost to Follow-up|1|||
144464898|NCT01239030|520897800|FG002|Double Blind|Lost to Follow-up|0|||
144464899|NCT01239030|520897801|FG003|Double Blind|Lost to Follow-up|0|||
144464900|NCT01239030|520897802|FG004|Double Blind|Lost to Follow-up|0|||
144464901|NCT01239030|520897798|FG000|Double Blind|Physician Decision|0|||
144464902|NCT01239030|520897799|FG001|Double Blind|Physician Decision|1|||
144464903|NCT01239030|520897800|FG002|Double Blind|Physician Decision|0|||
144464904|NCT01239030|520897801|FG003|Double Blind|Physician Decision|0|||
144464905|NCT01239030|520897802|FG004|Double Blind|Physician Decision|0|||
144464906|NCT01239030|520897798|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
144464907|NCT01239030|520897799|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
144464908|NCT01239030|520897800|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
144464909|NCT01239030|520897801|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
144464910|NCT01239030|520897802|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
144464911|NCT01239030|520897798|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
144258182|NCT01839916|520146995|FG000|Overall Study|GVHD|2|||
144258183|NCT01839916|520146995|FG000|Overall Study|Graft Failure|1|||
144258184|NCT00534638|520146998|FG000|Overall Study|Withdrawal by Subject|3|||
144464912|NCT01239030|520897799|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
144464913|NCT01239030|520897800|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
144464914|NCT01239030|520897801|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
144464915|NCT01239030|520897802|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
144464916|NCT01239030|520897798|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
144464917|NCT01239030|520897799|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
144464918|NCT01239030|520897800|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
144464919|NCT01239030|520897801|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
144464920|NCT01239030|520897802|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
144464921|NCT01239030|520897798|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
144464922|NCT01239030|520897799|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
144464923|NCT01239030|520897800|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
144464924|NCT01239030|520897801|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
144464925|NCT01239030|520897802|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
144464926|NCT03240692|520897813|FG000|Overall Study|Physician Decision|1|||
144464927|NCT03240692|520897813|FG000|Overall Study|Withdrawal by Subject|1|||
144464928|NCT02300220|520897814|FG000|Overall Study|Lost to Follow-up|1|||
144464929|NCT02300220|520897815|FG001|Overall Study|Lost to Follow-up|2|||
144464930|NCT02300220|520897814|FG000|Overall Study|Death|1|||
144464931|NCT02300220|520897815|FG001|Overall Study|Death|1|||
144464932|NCT02300220|520897814|FG000|Overall Study|Adverse Event|1|||
144464933|NCT02300220|520897815|FG001|Overall Study|Adverse Event|1|||
144464934|NCT02300220|520897814|FG000|Overall Study|Protocol Violation|1|||
144464935|NCT02300220|520897815|FG001|Overall Study|Protocol Violation|0|||
144464936|NCT02300220|520897814|FG000|Overall Study|Withdrawal by Subject|0|||
144464937|NCT02300220|520897815|FG001|Overall Study|Withdrawal by Subject|2|||
144464938|NCT02300220|520897814|FG000|Overall Study|Did not tolerate IMP|0|||
144464939|NCT02300220|520897815|FG001|Overall Study|Did not tolerate IMP|1|||
144464940|NCT04322682|520897816|FG000|Overall Study|Withdrawal by Subject|33|||
144464941|NCT04322682|520897817|FG001|Overall Study|Withdrawal by Subject|47|||
144464942|NCT04322682|520897816|FG000|Overall Study|Death|5|||
144464943|NCT04322682|520897817|FG001|Overall Study|Death|9|||
144464944|NCT04322682|520897816|FG000|Overall Study|Lost to Follow-up|4|||
144464945|NCT04322682|520897817|FG001|Overall Study|Lost to Follow-up|8|||
144464946|NCT04322682|520897816|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
144464947|NCT04322682|520897817|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
144464948|NCT04123067|520897818|FG000|Overall Study|Lost to Follow-up|0|||
144464949|NCT04123067|520897819|FG001|Overall Study|Lost to Follow-up|1|||
144464950|NCT02238379|520897820|FG000|Overall Study|Lost to Follow-up|1|||
144464951|NCT02238379|520897821|FG001|Overall Study|Lost to Follow-up|0|||
144464952|NCT01441102|520897822|FG000|Overall Study|Adverse Event|1|||
144464953|NCT01441102|520897822|FG000|Overall Study|Withdrawal by Subject|2|||
144464954|NCT00605280|520897823|FG000|Year 1|Protocol Violation|0|||
144464955|NCT00605280|520897824|FG001|Year 1|Protocol Violation|0|||
144464956|NCT00605280|520897825|FG002|Year 1|Protocol Violation|0|||
144464957|NCT00605280|520897826|FG003|Year 1|Protocol Violation|1|||
144464958|NCT00605280|520897823|FG000|Year 1|Adverse Event|3|||
144464959|NCT00605280|520897824|FG001|Year 1|Adverse Event|1|||
144464960|NCT00605280|520897825|FG002|Year 1|Adverse Event|1|||
144464961|NCT00605280|520897826|FG003|Year 1|Adverse Event|5|||
144464962|NCT00605280|520897823|FG000|Year 1|Physician Decision|7|||
144464963|NCT00605280|520897824|FG001|Year 1|Physician Decision|4|||
144464964|NCT00605280|520897825|FG002|Year 1|Physician Decision|0|||
144464965|NCT00605280|520897826|FG003|Year 1|Physician Decision|6|||
144464966|NCT00605280|520897823|FG000|Year 1|Withdrawal by Subject|2|||
144464967|NCT00605280|520897824|FG001|Year 1|Withdrawal by Subject|4|||
144464968|NCT00605280|520897825|FG002|Year 1|Withdrawal by Subject|0|||
144464969|NCT00605280|520897826|FG003|Year 1|Withdrawal by Subject|4|||
144464970|NCT00605280|520897823|FG000|Year 1|Other|2|||
144464971|NCT00605280|520897824|FG001|Year 1|Other|1|||
144464972|NCT00605280|520897825|FG002|Year 1|Other|0|||
144464973|NCT00605280|520897826|FG003|Year 1|Other|1|||
144464974|NCT00605280|520897823|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
144464975|NCT00605280|520897824|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
144464976|NCT00605280|520897825|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
144464977|NCT00605280|520897826|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
144536280|NCT03473223|521166692|FG001|Overall Study|Withdrawal by Subject|42|||
144536281|NCT03473223|521166691|FG000|Overall Study|Indirect contact|32|||
144536282|NCT03473223|521166692|FG001|Overall Study|Indirect contact|29|||
144536283|NCT03473223|521166691|FG000|Overall Study|Other (Not specified)|32|||
144536284|NCT03473223|521166692|FG001|Overall Study|Other (Not specified)|20|||
144536285|NCT04755595|521166693|FG000|Overall Study|Lost to Follow-up|1|||
144536286|NCT00655499|521167358|FG000|Overall Study|not eligible|4|||
144536287|NCT03140670|521167359|FG000|Overall Study|Withdrawal by Subject|2|||
144536288|NCT03140670|521167359|FG000|Overall Study|Lost to Follow-up|1|||
144536289|NCT03140670|521167359|FG000|Overall Study|Physician Decision|1|||
144536290|NCT00220805|521167360|FG000|Overall Study|Adverse Event|1|||
144536291|NCT00220805|521167361|FG001|Overall Study|Adverse Event|3|||
144464978|NCT00605280|520897823|FG000|Year 2|Adverse Event|4|||
144464979|NCT00605280|520897824|FG001|Year 2|Adverse Event|0|||
144464980|NCT00605280|520897825|FG002|Year 2|Adverse Event|2|||
144464981|NCT00605280|520897826|FG003|Year 2|Adverse Event|4|||
144464982|NCT00605280|520897823|FG000|Year 2|Physician Decision|11|||
144464983|NCT00605280|520897824|FG001|Year 2|Physician Decision|6|||
144464984|NCT00605280|520897825|FG002|Year 2|Physician Decision|4|||
144464985|NCT00605280|520897826|FG003|Year 2|Physician Decision|11|||
144464986|NCT00605280|520897823|FG000|Year 2|Withdrawal by Subject|4|||
144464987|NCT00605280|520897824|FG001|Year 2|Withdrawal by Subject|0|||
144464988|NCT00605280|520897825|FG002|Year 2|Withdrawal by Subject|0|||
144464989|NCT00605280|520897826|FG003|Year 2|Withdrawal by Subject|4|||
144464990|NCT00605280|520897823|FG000|Year 2|Other|1|||
144464991|NCT00605280|520897824|FG001|Year 2|Other|0|||
144536292|NCT00220805|521167360|FG000|Overall Study|Withdrawal by Subject|3|||
144464992|NCT00605280|520897825|FG002|Year 2|Other|0|||
144464993|NCT00605280|520897826|FG003|Year 2|Other|1|||
144464994|NCT00605280|520897823|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
144464995|NCT00605280|520897824|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
144464996|NCT00605280|520897825|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
144464997|NCT00605280|520897826|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
144464998|NCT00605280|520897823|FG000|Year 3 Extension|Adverse Event|2|||
144464999|NCT00605280|520897824|FG001|Year 3 Extension|Adverse Event|0|||
144465000|NCT00605280|520897825|FG002|Year 3 Extension|Adverse Event|0|||
144465001|NCT00605280|520897826|FG003|Year 3 Extension|Adverse Event|2|||
144465002|NCT00605280|520897823|FG000|Year 3 Extension|Physician Decision|0|||
144465003|NCT00605280|520897824|FG001|Year 3 Extension|Physician Decision|0|||
144465004|NCT00605280|520897825|FG002|Year 3 Extension|Physician Decision|0|||
144465005|NCT00605280|520897826|FG003|Year 3 Extension|Physician Decision|2|||
144465006|NCT00605280|520897823|FG000|Year 3 Extension|Withdrawal by Subject|2|||
144465007|NCT00605280|520897824|FG001|Year 3 Extension|Withdrawal by Subject|0|||
144465008|NCT00605280|520897825|FG002|Year 3 Extension|Withdrawal by Subject|0|||
144465009|NCT00605280|520897826|FG003|Year 3 Extension|Withdrawal by Subject|5|||
144465010|NCT00605280|520897823|FG000|Year 3 Extension|Other|2|||
144465011|NCT00605280|520897824|FG001|Year 3 Extension|Other|0|||
144611921|NCT00666458|521440894|FG000|Overall Study|Severe non-compliance to the protocol|1|||
144611922|NCT00666458|521440895|FG001|Overall Study|Severe non-compliance to the protocol|1|||
144611923|NCT00666458|521440894|FG000|Overall Study|Safety reasons|1|||
144611924|NCT00666458|521440895|FG001|Overall Study|Safety reasons|0|||
144611925|NCT00666458|521440894|FG000|Overall Study|Medical history of anemia|1|||
144465012|NCT00605280|520897825|FG002|Year 3 Extension|Other|0|||
144465013|NCT00605280|520897826|FG003|Year 3 Extension|Other|0|||
144465014|NCT00605280|520897823|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
144465015|NCT00605280|520897824|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
144465016|NCT00605280|520897825|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
144536293|NCT00220805|521167361|FG001|Overall Study|Withdrawal by Subject|0|||
144611926|NCT00666458|521440895|FG001|Overall Study|Medical history of anemia|0|||
144536294|NCT00220805|521167360|FG000|Overall Study|Lack of Efficacy|1|||
144611927|NCT02222207|521440896|FG000|Overall Study|Death|1|||
144611928|NCT02222207|521440896|FG000|Overall Study|Other reasons|2|||
144611929|NCT02222207|521440896|FG000|Overall Study|Adverse Event|1|||
144611930|NCT01429584|521440900|FG000|Overall Study|Withdrawal by Subject|1|||
144611931|NCT01429584|521440901|FG001|Overall Study|Withdrawal by Subject|0|||
144611932|NCT01429584|521440900|FG000|Overall Study|Protocol Violation|0|||
144611933|NCT01429584|521440901|FG001|Overall Study|Protocol Violation|1|||
144611934|NCT00747643|521440902|FG000|Overall Study|Withdrawal by Subject|36|||
144611935|NCT00747643|521440903|FG001|Overall Study|Withdrawal by Subject|27|||
144611936|NCT00750698|521440904|FG000|Overall Study|Withdrawal by Subject|1|||
144611937|NCT00750698|521440905|FG001|Overall Study|Withdrawal by Subject|0|||
144611938|NCT00750698|521440904|FG000|Overall Study|Progressive disease|5|||
144611939|NCT00750698|521440905|FG001|Overall Study|Progressive disease|2|||
144611940|NCT00402649|521440906|FG000|Overall Study|Lost to Follow-up|1|||
144611941|NCT00402649|521440906|FG000|Overall Study|Withdrawal by Subject|1|||
144611942|NCT01999465|521440907|FG000|Overall Study|Lost to Follow-up|0|||
144611943|NCT01999465|521440908|FG001|Overall Study|Lost to Follow-up|2|||
144611944|NCT01999465|521440907|FG000|Overall Study|Protocol Violation|0|||
144611945|NCT01999465|521440908|FG001|Overall Study|Protocol Violation|1|||
144611946|NCT01308008|521440916|FG000|4 Weeks|Illness, disinterest, time|9|||
144611947|NCT01308008|521440917|FG001|4 Weeks|Illness, disinterest, time|2|||
144465017|NCT00605280|520897826|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
144465018|NCT02137369|520897829|FG000|Overall Study|Withdrawal by Subject|3|||
144465019|NCT02137369|520897830|FG001|Overall Study|Withdrawal by Subject|2|||
144536295|NCT00220805|521167361|FG001|Overall Study|Lack of Efficacy|0|||
144536296|NCT00220805|521167360|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
144536297|NCT00220805|521167361|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
144536298|NCT03699163|521167362|FG000|Overall Study|Physician Decision|12|||
144536299|NCT03699163|521167363|FG001|Overall Study|Physician Decision|0|||
144536300|NCT03699163|521167362|FG000|Overall Study|failed QC measures|205|||
144536301|NCT03699163|521167363|FG001|Overall Study|failed QC measures|206|||
144536302|NCT01596972|521167368|FG000|Overall Study|Physician Decision|1|||
144465020|NCT02137369|520897829|FG000|Overall Study|Adverse Event|2|||
144465021|NCT02137369|520897830|FG001|Overall Study|Adverse Event|0|||
144536303|NCT01596972|521167369|FG001|Overall Study|Physician Decision|9|||
144611948|NCT01417195|521440918|FG000|Overall Study|Stimulation failure|1|||
144611949|NCT01417195|521440919|FG001|Overall Study|Stimulation failure|0|||
144611950|NCT01417195|521440918|FG000|Overall Study|No embryos for transfer|0|||
144611951|NCT01417195|521440919|FG001|Overall Study|No embryos for transfer|1|||
144611952|NCT01417195|521440918|FG000|Overall Study|No transfer due to risk of OHSS|1|||
144465022|NCT02137369|520897829|FG000|Overall Study|Lost to Follow-up|1|||
144465023|NCT02137369|520897830|FG001|Overall Study|Lost to Follow-up|0|||
144465024|NCT02137369|520897829|FG000|Overall Study|Moved away|2|||
144536304|NCT01596972|521167368|FG000|Overall Study|Lost to Follow-up|0|||
144611953|NCT01417195|521440919|FG001|Overall Study|No transfer due to risk of OHSS|0|||
144611954|NCT01417195|521440918|FG000|Overall Study|No transfer due to elevated progesterone|1|||
144465025|NCT02137369|520897830|FG001|Overall Study|Moved away|0|||
144465026|NCT05608629|520897831|FG000|Overall Study|Lost to Follow-up|2|||
144465027|NCT03969719|520897832|FG000|Overall Study|Other reasons not specified|1|||
144465028|NCT03969719|520897833|FG001|Overall Study|Other reasons not specified|1|||
144465029|NCT03969719|520897834|FG002|Overall Study|Other reasons not specified|3|||
144465030|NCT03969719|520897832|FG000|Overall Study|Withdrawal by Subject|2|||
144465031|NCT03969719|520897833|FG001|Overall Study|Withdrawal by Subject|3|||
144465032|NCT03969719|520897834|FG002|Overall Study|Withdrawal by Subject|2|||
144465033|NCT03969719|520897832|FG000|Overall Study|Protocol Violation|1|||
144465034|NCT03969719|520897833|FG001|Overall Study|Protocol Violation|2|||
144465035|NCT03969719|520897834|FG002|Overall Study|Protocol Violation|0|||
144465036|NCT03969719|520897832|FG000|Overall Study|Adverse Event|0|||
144465037|NCT03969719|520897833|FG001|Overall Study|Adverse Event|2|||
144465038|NCT03969719|520897834|FG002|Overall Study|Adverse Event|0|||
144465039|NCT03969719|520897832|FG000|Overall Study|Lost to Follow-up|0|||
144465040|NCT03969719|520897833|FG001|Overall Study|Lost to Follow-up|1|||
144465041|NCT03969719|520897834|FG002|Overall Study|Lost to Follow-up|0|||
144465042|NCT01669122|520897836|FG000|Period I|Lost to Follow-up|1|||
144465043|NCT01669122|520897836|FG000|Washout Period II|Protocol Violation|2|||
144465044|NCT03762473|520897837|FG000|Overall Study|Death|1|||
144465045|NCT03762473|520897838|FG001|Overall Study|Death|0|||
144465046|NCT00829387|520897839|FG000|Overall Study|Withdrawal by Subject|2|||
144465047|NCT00829387|520897840|FG001|Overall Study|Withdrawal by Subject|3|||
144465048|NCT00829387|520897839|FG000|Overall Study|Disqualified by PI|1|||
144465049|NCT00829387|520897840|FG001|Overall Study|Disqualified by PI|0|||
144465050|NCT03543254|520897841|FG000|Overall Study|Lost to Follow-up|1|||
144465051|NCT02077166|520897842|FG000|Overall Study|Death|6|||
144611955|NCT01417195|521440919|FG001|Overall Study|No transfer due to elevated progesterone|0|||
144611956|NCT03357731|521440920|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
144465052|NCT02077166|520897843|FG001|Overall Study|Death|7|||
144465053|NCT02077166|520897844|FG002|Overall Study|Death|5|||
144465054|NCT02077166|520897845|FG003|Overall Study|Death|6|||
144465055|NCT02077166|520897846|FG004|Overall Study|Death|4|||
144465056|NCT02077166|520897847|FG005|Overall Study|Death|32|||
144465057|NCT02077166|520897848|FG006|Overall Study|Death|22|||
144465058|NCT02077166|520897842|FG000|Overall Study|Study Closure by Sponsor|3|||
144465059|NCT02077166|520897843|FG001|Overall Study|Study Closure by Sponsor|0|||
144465060|NCT02077166|520897844|FG002|Overall Study|Study Closure by Sponsor|2|||
144465061|NCT02077166|520897845|FG003|Overall Study|Study Closure by Sponsor|2|||
144465062|NCT02077166|520897846|FG004|Overall Study|Study Closure by Sponsor|2|||
144465063|NCT02077166|520897847|FG005|Overall Study|Study Closure by Sponsor|12|||
144465064|NCT02077166|520897848|FG006|Overall Study|Study Closure by Sponsor|4|||
144465065|NCT02077166|520897842|FG000|Overall Study|Lost to Follow-up|0|||
144465066|NCT02077166|520897843|FG001|Overall Study|Lost to Follow-up|0|||
144465067|NCT02077166|520897844|FG002|Overall Study|Lost to Follow-up|0|||
144465068|NCT02077166|520897845|FG003|Overall Study|Lost to Follow-up|0|||
144465069|NCT02077166|520897846|FG004|Overall Study|Lost to Follow-up|0|||
144465070|NCT02077166|520897847|FG005|Overall Study|Lost to Follow-up|1|||
144465071|NCT02077166|520897848|FG006|Overall Study|Lost to Follow-up|0|||
144465072|NCT02077166|520897842|FG000|Overall Study|Withdrawal by Subject|3|||
144465073|NCT02077166|520897843|FG001|Overall Study|Withdrawal by Subject|0|||
144465074|NCT02077166|520897844|FG002|Overall Study|Withdrawal by Subject|1|||
144465075|NCT02077166|520897845|FG003|Overall Study|Withdrawal by Subject|1|||
144465076|NCT02077166|520897846|FG004|Overall Study|Withdrawal by Subject|1|||
144465077|NCT02077166|520897847|FG005|Overall Study|Withdrawal by Subject|3|||
144465078|NCT02077166|520897848|FG006|Overall Study|Withdrawal by Subject|0|||
144465079|NCT02077166|520897842|FG000|Overall Study|Other, Not Specified|0|||
144465080|NCT02077166|520897843|FG001|Overall Study|Other, Not Specified|0|||
144465081|NCT02077166|520897844|FG002|Overall Study|Other, Not Specified|1|||
144465082|NCT02077166|520897845|FG003|Overall Study|Other, Not Specified|0|||
144465083|NCT02077166|520897846|FG004|Overall Study|Other, Not Specified|1|||
144465084|NCT02077166|520897847|FG005|Overall Study|Other, Not Specified|7|||
144465085|NCT02077166|520897848|FG006|Overall Study|Other, Not Specified|8|||
144465086|NCT03519854|520897849|FG000|Overall Study|Technical Error|0|||
144465087|NCT03519854|520897850|FG001|Overall Study|Technical Error|0|||
144465088|NCT03519854|520897851|FG002|Overall Study|Technical Error|1|||
144465089|NCT03519854|520897852|FG003|Overall Study|Technical Error|0|||
144465090|NCT03519854|520897853|FG004|Overall Study|Technical Error|0|||
144465091|NCT03519854|520897854|FG005|Overall Study|Technical Error|0|||
144465092|NCT03519854|520897855|FG006|Overall Study|Technical Error|0|||
144465093|NCT03519854|520897856|FG007|Overall Study|Technical Error|0|||
144465094|NCT03519854|520897857|FG008|Overall Study|Technical Error|0|||
144465095|NCT03519854|520897858|FG009|Overall Study|Technical Error|0|||
144465096|NCT03519854|520897859|FG010|Overall Study|Technical Error|0|||
144465097|NCT03519854|520897860|FG011|Overall Study|Technical Error|0|||
144465098|NCT03519854|520897861|FG012|Overall Study|Technical Error|0|||
144465099|NCT03519854|520897862|FG013|Overall Study|Technical Error|0|||
144611957|NCT03357731|521440921|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
144611958|NCT03357731|521440922|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
144611959|NCT03357731|521440923|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
144611960|NCT03357731|521440924|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
144611961|NCT03357731|521440925|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
144611962|NCT03357731|521440920|FG000|Overall Study|Acute bradycardia and hypotension|0|||
144611963|NCT03357731|521440921|FG001|Overall Study|Acute bradycardia and hypotension|0|||
144611964|NCT03357731|521440922|FG002|Overall Study|Acute bradycardia and hypotension|0|||
144611965|NCT03357731|521440923|FG003|Overall Study|Acute bradycardia and hypotension|1|||
144611966|NCT03357731|521440924|FG004|Overall Study|Acute bradycardia and hypotension|0|||
144611967|NCT03357731|521440925|FG005|Overall Study|Acute bradycardia and hypotension|0|||
144611968|NCT03357731|521440920|FG000|Overall Study|Adverse Event|0|||
144611969|NCT03357731|521440921|FG001|Overall Study|Adverse Event|0|||
144611970|NCT03357731|521440922|FG002|Overall Study|Adverse Event|0|||
144611971|NCT03357731|521440923|FG003|Overall Study|Adverse Event|0|||
144611972|NCT03357731|521440924|FG004|Overall Study|Adverse Event|0|||
144611973|NCT03357731|521440925|FG005|Overall Study|Adverse Event|1|||
144611974|NCT03357731|521440920|FG000|Overall Study|Hypotension|0|||
144611975|NCT03357731|521440921|FG001|Overall Study|Hypotension|0|||
144611976|NCT03357731|521440922|FG002|Overall Study|Hypotension|1|||
144611977|NCT03357731|521440923|FG003|Overall Study|Hypotension|1|||
144611978|NCT03357731|521440924|FG004|Overall Study|Hypotension|0|||
144611979|NCT03357731|521440925|FG005|Overall Study|Hypotension|0|||
144611980|NCT03357731|521440920|FG000|Overall Study|Lost to Follow-up|0|||
144611981|NCT03357731|521440921|FG001|Overall Study|Lost to Follow-up|0|||
144611982|NCT03357731|521440922|FG002|Overall Study|Lost to Follow-up|0|||
144611983|NCT03357731|521440923|FG003|Overall Study|Lost to Follow-up|1|||
144611984|NCT03357731|521440924|FG004|Overall Study|Lost to Follow-up|0|||
144611985|NCT03357731|521440925|FG005|Overall Study|Lost to Follow-up|0|||
144611986|NCT02325219|521440926|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
144611987|NCT02325219|521440927|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
144611988|NCT02325219|521440928|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
144611989|NCT02325219|521440929|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
144611990|NCT02325219|521440930|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
144611991|NCT02325219|521440926|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
144611992|NCT02325219|521440927|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
144611993|NCT02325219|521440928|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144611994|NCT02325219|521440929|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144611995|NCT02325219|521440930|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
144611996|NCT02325219|521440926|FG000|Controlled Period (Week 0 - 16)|Other|0|||
144611997|NCT02325219|521440927|FG001|Controlled Period (Week 0 - 16)|Other|0|||
144611998|NCT02325219|521440928|FG002|Controlled Period (Week 0 - 16)|Other|1|||
144611999|NCT02325219|521440929|FG003|Controlled Period (Week 0 - 16)|Other|0|||
144612000|NCT02325219|521440930|FG004|Controlled Period (Week 0 - 16)|Other|0|||
144612001|NCT02325219|521440926|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
144612002|NCT02325219|521440927|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
144612003|NCT02325219|521440928|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
144612004|NCT02325219|521440929|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
144612005|NCT02325219|521440930|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
144612006|NCT02325219|521440926|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
144612007|NCT02325219|521440927|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
144612008|NCT02325219|521440928|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
144612009|NCT02325219|521440929|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
144612010|NCT02325219|521440930|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
144612011|NCT02325219|521440926|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144612012|NCT02325219|521440927|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
144612013|NCT02325219|521440928|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144612014|NCT02325219|521440929|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144612015|NCT02325219|521440930|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
144612016|NCT04036708|521440931|FG000|Overall Study|Lost to Follow-up|14|||
144612017|NCT04036708|521440932|FG001|Overall Study|Lost to Follow-up|4|||
144612018|NCT04036708|521440933|FG002|Overall Study|Lost to Follow-up|14|||
144612019|NCT04036708|521440934|FG003|Overall Study|Lost to Follow-up|4|||
144612020|NCT04766021|521440935|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
144612021|NCT04766021|521440935|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
144612022|NCT02347098|521440938|FG000|Overall Study|Death|1|||
144612023|NCT02347098|521440939|FG001|Overall Study|Death|0|||
144612024|NCT02347098|521440938|FG000|Overall Study|Withdrawal by Subject|1|||
144612025|NCT02347098|521440939|FG001|Overall Study|Withdrawal by Subject|0|||
144612026|NCT02347098|521440938|FG000|Overall Study|Lost to Follow-up|2|||
144612027|NCT02347098|521440939|FG001|Overall Study|Lost to Follow-up|2|||
144612028|NCT02347098|521440938|FG000|Overall Study|Refuse Follow-up Visit|1|||
144612029|NCT02347098|521440939|FG001|Overall Study|Refuse Follow-up Visit|5|||
144612030|NCT02347098|521440938|FG000|Overall Study|no visit due to illness|2|||
144612031|NCT02347098|521440939|FG001|Overall Study|no visit due to illness|1|||
144612032|NCT01444742|521440940|FG000|Overall Study|Death|1|||
144612033|NCT02187172|521440941|FG000|Overall Study|Lost to Follow-up|1|||
144612034|NCT02187172|521440942|FG001|Overall Study|Lost to Follow-up|2|||
144612035|NCT02187172|521440941|FG000|Overall Study|Lack of Efficacy|1|||
144612036|NCT02187172|521440942|FG001|Overall Study|Lack of Efficacy|2|||
144612037|NCT02187172|521440941|FG000|Overall Study|Adverse Event|0|||
144612038|NCT02187172|521440942|FG001|Overall Study|Adverse Event|1|||
144612039|NCT02187172|521440941|FG000|Overall Study|Physician Decision|1|||
144612040|NCT02187172|521440942|FG001|Overall Study|Physician Decision|1|||
144612041|NCT04640272|521440943|FG000|Overall Study|Subject moved out of area|1|||
144612042|NCT01349465|521440953|FG000|Overall Study|Adverse Event|1|||
144612043|NCT01349465|521440954|FG001|Overall Study|Adverse Event|0|||
144612044|NCT01349465|521440953|FG000|Overall Study|Death|3|||
144612045|NCT01349465|521440954|FG001|Overall Study|Death|0|||
144612046|NCT01349465|521440953|FG000|Overall Study|Lost to Follow-up|10|||
144612047|NCT01349465|521440954|FG001|Overall Study|Lost to Follow-up|1|||
144612048|NCT01349465|521440953|FG000|Overall Study|Withdrawal by Subject|4|||
144612049|NCT01349465|521440954|FG001|Overall Study|Withdrawal by Subject|2|||
144612050|NCT01349465|521440953|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
144612051|NCT01349465|521440954|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
144612052|NCT03370120|521440960|FG000|Overall Study|Adverse event, non-fatal|24|||
144612053|NCT03370120|521440960|FG000|Overall Study|Withdrawal by Subject|6|||
144612054|NCT03370120|521440960|FG000|Overall Study|Lost to Follow-up|1|||
144612055|NCT03370120|521440960|FG000|Overall Study|Lack of Efficacy|37|||
144612056|NCT03370120|521440960|FG000|Overall Study|Per sponsor's instructions|1|||
144612057|NCT03370120|521440960|FG000|Overall Study|Study was terminated by parent company UCB|2|||
144612058|NCT03370120|521440960|FG000|Overall Study|The study was ended by the promoter|3|||
144612059|NCT03370120|521440960|FG000|Overall Study|Discontinuation of drug development|3|||
144612060|NCT03370120|521440960|FG000|Overall Study|End of project|2|||
144612061|NCT03370120|521440960|FG000|Overall Study|Premature study closure|2|||
144612062|NCT03370120|521440960|FG000|Overall Study|Premature program termination|1|||
144612063|NCT03370120|521440960|FG000|Overall Study|Premature study termination|7|||
144612064|NCT03370120|521440960|FG000|Overall Study|Trial terminated by sponsor|2|||
144612065|NCT03370120|521440960|FG000|Overall Study|Trial discontinued by sponsor|2|||
144612066|NCT03370120|521440960|FG000|Overall Study|Study ended|15|||
144612067|NCT03370120|521440960|FG000|Overall Study|Clinical trial has been cancelled|1|||
144612068|NCT03370120|521440960|FG000|Overall Study|End of study per sponsor decision|2|||
144612069|NCT03370120|521440960|FG000|Overall Study|Promoter's decision|2|||
144612070|NCT03370120|521440960|FG000|Overall Study|The trial has been suspended|3|||
144612071|NCT03370120|521440960|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
144612072|NCT03370120|521440960|FG000|Overall Study|Early termination by order of sponsor|2|||
144612073|NCT03370120|521440960|FG000|Overall Study|Discontinuation of the study|5|||
144612074|NCT03370120|521440960|FG000|Overall Study|End of clinical trial discontinuation|1|||
144612075|NCT03370120|521440960|FG000|Overall Study|Because the clinical trial ended halfway|4|||
144612076|NCT03370120|521440960|FG000|Overall Study|Development discontinued|5|||
144612077|NCT03370120|521440960|FG000|Overall Study|Padsenovil program closed|3|||
144612078|NCT03370120|521440960|FG000|Overall Study|End of project|2|||
144612079|NCT03370120|521440960|FG000|Overall Study|Termination of project|1|||
144612080|NCT03370120|521440960|FG000|Overall Study|The study was interrupted by sponsor|4|||
144612081|NCT03370120|521440960|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
144612082|NCT03370120|521440960|FG000|Overall Study|End of sponsor decision|1|||
144612083|NCT03370120|521440960|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
144612084|NCT03370120|521440960|FG000|Overall Study|Early termination of studies|5|||
144612085|NCT03370120|521440960|FG000|Overall Study|This study is ended early|1|||
144612086|NCT03370120|521440960|FG000|Overall Study|End of padsevonil program|2|||
144612087|NCT03370120|521440960|FG000|Overall Study|Decision of sponsor|6|||
144612088|NCT03370120|521440960|FG000|Overall Study|Asked by the sponsor|3|||
144612089|NCT03370120|521440960|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
144612090|NCT03370120|521440960|FG000|Overall Study|PI decision poor compliance from participant|1|||
144612091|NCT03370120|521440960|FG000|Overall Study|Promoter ended the study|3|||
144612092|NCT03370120|521440960|FG000|Overall Study|Premature study close by sponsor's decision|4|||
144612093|NCT03370120|521440960|FG000|Overall Study|Study terminated by sponsor|33|||
144612094|NCT03370120|521440960|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
144612095|NCT03370120|521440960|FG000|Overall Study|Sponsor decision to terminate study|63|||
144612096|NCT03370120|521440960|FG000|Overall Study|Program closure|3|||
144612097|NCT03370120|521440960|FG000|Overall Study|Study ended prematurely|1|||
144612098|NCT03370120|521440960|FG000|Overall Study|Study stopped by sponsor|2|||
144612099|NCT03370120|521440960|FG000|Overall Study|Program termination|55|||
144612100|NCT03370120|521440960|FG000|Overall Study|Sponsor decision|62|||
144612101|NCT03370120|521440960|FG000|Overall Study|Sponsor study closure|10|||
144612102|NCT00928889|521440961|FG000|Overall Study|Lost to Follow-up|3|||
144612103|NCT00928889|521440962|FG001|Overall Study|Lost to Follow-up|1|||
144612104|NCT00928889|521440961|FG000|Overall Study|Protocol Violation|0|||
144612105|NCT00928889|521440962|FG001|Overall Study|Protocol Violation|1|||
144612106|NCT00928889|521440961|FG000|Overall Study|Adverse Event|1|||
144612107|NCT00928889|521440962|FG001|Overall Study|Adverse Event|0|||
144612108|NCT00928889|521440961|FG000|Overall Study|Other|1|||
144612109|NCT00928889|521440962|FG001|Overall Study|Other|0|||
144612110|NCT01309659|521440963|FG000|Overall Study|Protocol Violation|0|||
144612111|NCT01309659|521440964|FG001|Overall Study|Protocol Violation|1|||
144612112|NCT03972969|521440968|FG000|3-month Follow-up|Death|1|||
144612113|NCT03972969|521440969|FG001|3-month Follow-up|Death|1|||
144612114|NCT03972969|521440970|FG002|3-month Follow-up|Death|0|||
144612115|NCT03972969|521440968|FG000|6-month Follow-up|Death|1|||
144612116|NCT03972969|521440969|FG001|6-month Follow-up|Death|1|||
144612117|NCT03972969|521440970|FG002|6-month Follow-up|Death|1|||
144612118|NCT03972969|521440968|FG000|6-month Follow-up|Lost to Follow-up|2|||
144612119|NCT03972969|521440969|FG001|6-month Follow-up|Lost to Follow-up|2|||
144612120|NCT03972969|521440970|FG002|6-month Follow-up|Lost to Follow-up|2|||
144612121|NCT01399788|521440974|FG000|First Intervention Period|Adverse Event|1|||
144612122|NCT01399788|521440975|FG001|First Intervention Period|Adverse Event|0|||
144612123|NCT03699007|521440976|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
144612124|NCT03699007|521440977|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
144726049|NCT00950807|521852692|FG007|Treatment Period 1|Lack of Efficacy|0|||
144726050|NCT00950807|521852693|FG008|Treatment Period 1|Lack of Efficacy|0|||
144726051|NCT00950807|521852694|FG009|Treatment Period 1|Lack of Efficacy|0|||
144465100|NCT03519854|520897863|FG014|Overall Study|Technical Error|0|||
144465101|NCT03519854|520897864|FG015|Overall Study|Technical Error|0|||
144465102|NCT03519854|520897865|FG016|Overall Study|Technical Error|0|||
144465103|NCT03519854|520897866|FG017|Overall Study|Technical Error|0|||
144465104|NCT00941330|520897867|FG000|Overall Study|Other|1|||
144465105|NCT00941330|520897868|FG001|Overall Study|Other|0|||
144465106|NCT00941330|520897867|FG000|Overall Study|Physician Decision|0|||
144465107|NCT00941330|520897868|FG001|Overall Study|Physician Decision|2|||
144465108|NCT02747238|520897869|FG000|Overall Study|Lack of Efficacy|0|||
144465109|NCT02747238|520897870|FG001|Overall Study|Lack of Efficacy|1|||
144465110|NCT02747238|520897869|FG000|Overall Study|Data lost|3|||
144465111|NCT02747238|520897870|FG001|Overall Study|Data lost|5|||
144465112|NCT05132699|520897871|FG000|Overall Study|Withdrawal by Subject|3|||
144465113|NCT05132699|520897872|FG001|Overall Study|Withdrawal by Subject|0|||
144465114|NCT02030015|520899793|FG000|Overall Study|Withdrawal by Subject|3|||
144465115|NCT02030015|520899793|FG000|Overall Study|Death|13|||
144465116|NCT00833560|520899794|FG000|Overall Study|Toxicity|13|||
144465117|NCT00833560|520899794|FG000|Overall Study|Adverse Event|11|||
144465118|NCT00833560|520899794|FG000|Overall Study|Protocol Violation|6|||
144465119|NCT00833560|520899794|FG000|Overall Study|Lack of Efficacy|4|||
144465120|NCT00833560|520899794|FG000|Overall Study|Death|2|||
144465121|NCT00833560|520899794|FG000|Overall Study|Pregression of other disease|1|||
144465122|NCT00833560|520899794|FG000|Overall Study|Other|5|||
144465123|NCT00512148|520899801|FG000|Primay Study Period|Withdrawal by Subject|1|||
144465124|NCT02690974|520899806|FG000|Overall Study|Adverse Event|16|||
144465125|NCT02690974|520899806|FG000|Overall Study|Death|9|||
144465126|NCT02690974|520899806|FG000|Overall Study|Subject/guardian decision|4|||
144465127|NCT02690974|520899806|FG000|Overall Study|Lost to Follow-up|3|||
144465128|NCT02690974|520899806|FG000|Overall Study|Withdrawal of Informed Consent|3|||
144465129|NCT02690974|520899806|FG000|Overall Study|Physician Decision|2|||
144465130|NCT02690974|520899806|FG000|Overall Study|Non-compliance with study treatment|1|||
144465131|NCT02690974|520899806|FG000|Overall Study|Protocol-defined stopping criteria|1|||
144465132|NCT02690974|520899806|FG000|Overall Study|Protocol Deviation|1|||
144465133|NCT01666951|520899813|FG000|Overall Study|Not dosed|1|||
144726052|NCT00950807|521852685|FG000|Treatment Period 1|Protocol Violation|1|||
144465134|NCT01666951|520899814|FG001|Overall Study|Not dosed|1|||
144465135|NCT02623322|520899818|FG000|Overall Study|Lost to Follow-up|2|||
144465136|NCT02623322|520899819|FG001|Overall Study|Lost to Follow-up|1|||
144465137|NCT02623322|520899820|FG002|Overall Study|Lost to Follow-up|0|||
144465138|NCT03284788|520899821|FG000|Overall Study|Withdrawal by Subject|2|||
144612125|NCT03699007|521440976|FG000|6-month Follow Up|Lost to Follow-up|2|||
144612126|NCT03699007|521440977|FG001|6-month Follow Up|Lost to Follow-up|3|||
144726053|NCT00950807|521852686|FG001|Treatment Period 1|Protocol Violation|0|||
144726054|NCT00950807|521852687|FG002|Treatment Period 1|Protocol Violation|0|||
144465139|NCT01690130|520899825|FG000|Overall Study|Subject have cancelled visit.|1|||
144465140|NCT01690130|520899826|FG001|Overall Study|Subject have cancelled visit.|0|||
144465141|NCT02462876|520899827|FG000|Overall Study|Death|3|||
144465142|NCT02462876|520899827|FG000|Overall Study|Lost to Follow-up|7|||
144465143|NCT02462876|520899827|FG000|Overall Study|Surgical Bypass|9|||
144465144|NCT02462876|520899827|FG000|Overall Study|Amputation Above the Metatarsals|1|||
144465145|NCT02462876|520899827|FG000|Overall Study|36 months follow-up visit missed|1|||
144465146|NCT02462876|520899827|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
144612127|NCT04251910|521440980|FG000|Overall Study|Covid 19 lockdown|0|||
144612128|NCT04251910|521440981|FG001|Overall Study|Covid 19 lockdown|5|||
144612129|NCT04251910|521440982|FG002|Overall Study|Covid 19 lockdown|0|||
144612130|NCT04251910|521440983|FG003|Overall Study|Covid 19 lockdown|4|||
144612131|NCT04251910|521440984|FG004|Overall Study|Covid 19 lockdown|0|||
144612132|NCT04251910|521440985|FG005|Overall Study|Covid 19 lockdown|0|||
144612133|NCT04251910|521440980|FG000|Overall Study|Assisted living facility was closed|0|||
144612134|NCT04251910|521440981|FG001|Overall Study|Assisted living facility was closed|0|||
144612135|NCT04251910|521440982|FG002|Overall Study|Assisted living facility was closed|0|||
144612136|NCT04251910|521440983|FG003|Overall Study|Assisted living facility was closed|0|||
144612137|NCT04251910|521440984|FG004|Overall Study|Assisted living facility was closed|1|||
144612138|NCT04251910|521440985|FG005|Overall Study|Assisted living facility was closed|0|||
144612139|NCT00804570|521440986|FG000|Overall Study|Adverse Event|14|||
144612140|NCT00804570|521440987|FG001|Overall Study|Adverse Event|7|||
144612141|NCT00804570|521440986|FG000|Overall Study|Lack of Efficacy|0|||
144612142|NCT00804570|521440987|FG001|Overall Study|Lack of Efficacy|1|||
144612143|NCT00804570|521440986|FG000|Overall Study|Lost to Follow-up|18|||
144612144|NCT00804570|521440987|FG001|Overall Study|Lost to Follow-up|21|||
144612145|NCT00804570|521440986|FG000|Overall Study|Entry criteria not met|5|||
144612146|NCT00804570|521440987|FG001|Overall Study|Entry criteria not met|5|||
144465147|NCT02462876|520899827|FG000|Overall Study|Patient did not come back to the vascular department|1|||
144465148|NCT02462876|520899827|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
144465149|NCT02462876|520899827|FG000|Overall Study|Patient refused to come back|1|||
144465150|NCT02462876|520899827|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
144465151|NCT02462876|520899827|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
144465152|NCT01786512|520899828|FG000|Overall Study|Lost to Follow-up|0|||
144465153|NCT01786512|520899829|FG001|Overall Study|Lost to Follow-up|0|||
144465154|NCT01786512|520899830|FG002|Overall Study|Lost to Follow-up|0|||
144465155|NCT01786512|520899831|FG003|Overall Study|Lost to Follow-up|0|||
144465156|NCT01786512|520899832|FG004|Overall Study|Lost to Follow-up|0|||
144465157|NCT01786512|520899833|FG005|Overall Study|Lost to Follow-up|0|||
144465158|NCT01786512|520899834|FG006|Overall Study|Lost to Follow-up|0|||
144465159|NCT01786512|520899835|FG007|Overall Study|Lost to Follow-up|0|||
144465160|NCT01786512|520899836|FG008|Overall Study|Lost to Follow-up|0|||
144465161|NCT01786512|520899837|FG009|Overall Study|Lost to Follow-up|1|||
144465162|NCT01786512|520899838|FG010|Overall Study|Lost to Follow-up|0|||
144465163|NCT01786512|520899828|FG000|Overall Study|Decision by sponsor|0|||
144465164|NCT01786512|520899829|FG001|Overall Study|Decision by sponsor|0|||
144465165|NCT01786512|520899830|FG002|Overall Study|Decision by sponsor|0|||
144465166|NCT01786512|520899831|FG003|Overall Study|Decision by sponsor|0|||
144465167|NCT01786512|520899832|FG004|Overall Study|Decision by sponsor|0|||
144465168|NCT01786512|520899833|FG005|Overall Study|Decision by sponsor|0|||
144465169|NCT01786512|520899834|FG006|Overall Study|Decision by sponsor|0|||
144465170|NCT01786512|520899835|FG007|Overall Study|Decision by sponsor|0|||
144465171|NCT01786512|520899836|FG008|Overall Study|Decision by sponsor|0|||
144465172|NCT01786512|520899837|FG009|Overall Study|Decision by sponsor|0|||
144465173|NCT01786512|520899838|FG010|Overall Study|Decision by sponsor|2|||
144465174|NCT01786512|520899828|FG000|Overall Study|Withdrawal by Subject|0|||
144465175|NCT01786512|520899829|FG001|Overall Study|Withdrawal by Subject|1|||
144465176|NCT01786512|520899830|FG002|Overall Study|Withdrawal by Subject|0|||
144465177|NCT01786512|520899831|FG003|Overall Study|Withdrawal by Subject|0|||
144465178|NCT01786512|520899832|FG004|Overall Study|Withdrawal by Subject|0|||
144465179|NCT01786512|520899833|FG005|Overall Study|Withdrawal by Subject|0|||
144465180|NCT01786512|520899834|FG006|Overall Study|Withdrawal by Subject|1|||
144465181|NCT01786512|520899835|FG007|Overall Study|Withdrawal by Subject|0|||
144465182|NCT01786512|520899836|FG008|Overall Study|Withdrawal by Subject|0|||
144465183|NCT01786512|520899837|FG009|Overall Study|Withdrawal by Subject|3|||
144465184|NCT01786512|520899838|FG010|Overall Study|Withdrawal by Subject|7|||
144465185|NCT01786512|520899828|FG000|Overall Study|Death|0|||
144465186|NCT01786512|520899829|FG001|Overall Study|Death|0|||
144465187|NCT01786512|520899830|FG002|Overall Study|Death|0|||
144465188|NCT01786512|520899831|FG003|Overall Study|Death|0|||
144465189|NCT01786512|520899832|FG004|Overall Study|Death|0|||
144465190|NCT01786512|520899833|FG005|Overall Study|Death|0|||
144465191|NCT01786512|520899834|FG006|Overall Study|Death|0|||
144465192|NCT01786512|520899835|FG007|Overall Study|Death|0|||
144465193|NCT01786512|520899836|FG008|Overall Study|Death|4|||
144465194|NCT01786512|520899837|FG009|Overall Study|Death|1|||
144612147|NCT00804570|521440986|FG000|Overall Study|Protocol Violation|12|||
144612148|NCT00804570|521440987|FG001|Overall Study|Protocol Violation|16|||
144197241|NCT01000493|519918715|FG000|Overall Study|Study closed/terminated|25|||
144465195|NCT01786512|520899838|FG010|Overall Study|Death|3|||
144465196|NCT02450331|520899839|FG000|Overall Study|Death|162|||
144465197|NCT02450331|520899840|FG001|Overall Study|Death|171|||
144465198|NCT02450331|520899839|FG000|Overall Study|Lost to Follow-up|14|||
144465199|NCT02450331|520899840|FG001|Overall Study|Lost to Follow-up|12|||
144465200|NCT02450331|520899839|FG000|Overall Study|Withdrawal by Subject|55|||
144465201|NCT02450331|520899840|FG001|Overall Study|Withdrawal by Subject|44|||
144465202|NCT02450331|520899839|FG000|Overall Study|Non-specified other|1|||
144465203|NCT02450331|520899840|FG001|Overall Study|Non-specified other|1|||
144612149|NCT00804570|521440986|FG000|Overall Study|Physician Decision|1|||
144612150|NCT00804570|521440987|FG001|Overall Study|Physician Decision|2|||
144612151|NCT00804570|521440986|FG000|Overall Study|Sponsor decision|1|||
144612152|NCT00804570|521440987|FG001|Overall Study|Sponsor decision|4|||
144612153|NCT00804570|521440986|FG000|Overall Study|Withdrawal by Subject|21|||
144612154|NCT00804570|521440987|FG001|Overall Study|Withdrawal by Subject|38|||
144612155|NCT00290342|521440988|FG000|Overall Study|Other|0|||
144612156|NCT00290342|521440989|FG001|Overall Study|Other|1|||
144612157|NCT00290342|521440988|FG000|Overall Study|Withdrawal by Subject|6|||
144612158|NCT00290342|521440989|FG001|Overall Study|Withdrawal by Subject|4|||
144612159|NCT00290342|521440988|FG000|Overall Study|Lost to Follow-up|1|||
144612160|NCT00290342|521440989|FG001|Overall Study|Lost to Follow-up|0|||
144612161|NCT01056510|521440992|FG000|Overall Study|Dropout Before Start of Treatment|1|||
144612162|NCT01056510|521440993|FG001|Overall Study|Dropout Before Start of Treatment|1|||
144612163|NCT01056510|521440992|FG000|Overall Study|Withdrawal by Subject|4|||
144612164|NCT01056510|521440993|FG001|Overall Study|Withdrawal by Subject|2|||
144612165|NCT01056510|521440992|FG000|Overall Study|Death|29|||
144612166|NCT01056510|521440993|FG001|Overall Study|Death|34|||
144612167|NCT01056510|521440992|FG000|Overall Study|Noncompliance|1|||
144612168|NCT01056510|521440993|FG001|Overall Study|Noncompliance|3|||
144612169|NCT01056510|521440992|FG000|Overall Study|Physician Decision|4|||
144612170|NCT01056510|521440993|FG001|Overall Study|Physician Decision|5|||
144612171|NCT01056510|521440992|FG000|Overall Study|Lost to Follow-up|5|||
144612172|NCT01056510|521440993|FG001|Overall Study|Lost to Follow-up|6|||
144612173|NCT01056510|521440992|FG000|Overall Study|Other|10|||
144612174|NCT01056510|521440993|FG001|Overall Study|Other|12|||
144612175|NCT01056510|521440992|FG000|Overall Study|Missing|0|||
144612176|NCT01056510|521440993|FG001|Overall Study|Missing|1|||
144612177|NCT02285998|521440996|FG000|Overall Study|Adverse Event|9|||
144612178|NCT02285998|521440997|FG001|Overall Study|Adverse Event|8|||
144612179|NCT02285998|521440996|FG000|Overall Study|Physician Decision|1|||
144612180|NCT02285998|521440997|FG001|Overall Study|Physician Decision|2|||
144465204|NCT03581981|520899841|FG000|Overall Study|Withdrawal by Subject|12|||
144465205|NCT03581981|520899842|FG001|Overall Study|Withdrawal by Subject|13|||
144465206|NCT03581981|520899841|FG000|Overall Study|Physician Decision|1|||
144465207|NCT03581981|520899842|FG001|Overall Study|Physician Decision|2|||
144465208|NCT03581981|520899841|FG000|Overall Study|Lost to Follow-up|0|||
144465209|NCT03581981|520899842|FG001|Overall Study|Lost to Follow-up|4|||
144465210|NCT02157779|520899847|FG000|Overall Study|Logistical|9|||
144465211|NCT02157779|520899848|FG001|Overall Study|Logistical|3|||
144465212|NCT02157779|520899847|FG000|Overall Study|Stopped attending, reason unknown|11|||
144465213|NCT02157779|520899848|FG001|Overall Study|Stopped attending, reason unknown|7|||
144465214|NCT02157779|520899847|FG000|Overall Study|No response to outreach after Baseline|1|||
144465215|NCT02157779|520899848|FG001|Overall Study|No response to outreach after Baseline|1|||
144465216|NCT02157779|520899847|FG000|Overall Study|Moved|1|||
144465217|NCT02157779|520899848|FG001|Overall Study|Moved|0|||
144465218|NCT02157779|520899847|FG000|Overall Study|Medical|1|||
144465219|NCT02157779|520899848|FG001|Overall Study|Medical|0|||
144465220|NCT02157779|520899847|FG000|Overall Study|Legal issue|1|||
144465221|NCT02157779|520899848|FG001|Overall Study|Legal issue|0|||
144465222|NCT00002558|520899852|FG000|Overall Study|Withdrawal by Subject|0|||
144465223|NCT00002558|520899853|FG001|Overall Study|Withdrawal by Subject|1|||
144465224|NCT01260350|520899854|FG000|Overall Study|Lack of Efficacy|0|||
144465225|NCT01260350|520899855|FG001|Overall Study|Lack of Efficacy|0|||
144465226|NCT01260350|520899856|FG002|Overall Study|Lack of Efficacy|0|||
144465227|NCT01260350|520899857|FG003|Overall Study|Lack of Efficacy|0|||
144465228|NCT01260350|520899858|FG004|Overall Study|Lack of Efficacy|0|||
144465229|NCT01260350|520899859|FG005|Overall Study|Lack of Efficacy|0|||
144465230|NCT01260350|520899860|FG006|Overall Study|Lack of Efficacy|0|||
144465231|NCT01260350|520899861|FG007|Overall Study|Lack of Efficacy|0|||
144465232|NCT01260350|520899862|FG008|Overall Study|Lack of Efficacy|0|||
144465233|NCT01260350|520899863|FG009|Overall Study|Lack of Efficacy|0|||
144465234|NCT01260350|520899864|FG010|Overall Study|Lack of Efficacy|0|||
144465235|NCT01260350|520899865|FG011|Overall Study|Lack of Efficacy|0|||
144465236|NCT01260350|520899866|FG012|Overall Study|Lack of Efficacy|0|||
144465237|NCT01260350|520899867|FG013|Overall Study|Lack of Efficacy|0|||
144465238|NCT01260350|520899868|FG014|Overall Study|Lack of Efficacy|0|||
144612181|NCT02285998|521440996|FG000|Overall Study|Lost to Follow-up|176|||
144612182|NCT02285998|521440997|FG001|Overall Study|Lost to Follow-up|172|||
144612183|NCT02285998|521440996|FG000|Overall Study|Withdrawal by Subject|53|||
144612184|NCT02285998|521440997|FG001|Overall Study|Withdrawal by Subject|61|||
144465239|NCT01260350|520899869|FG015|Overall Study|Lack of Efficacy|0|||
144612185|NCT02285998|521440996|FG000|Overall Study|Other Reasons|7|||
144612186|NCT02285998|521440997|FG001|Overall Study|Other Reasons|10|||
144197242|NCT01000493|519918716|FG001|Overall Study|Study closed/terminated|23|||
144197243|NCT01000493|519918715|FG000|Overall Study|Lost to Follow-up|5|||
144465240|NCT01260350|520899870|FG016|Overall Study|Lack of Efficacy|0|||
144465241|NCT01260350|520899871|FG017|Overall Study|Lack of Efficacy|1|||
144465242|NCT01260350|520899872|FG018|Overall Study|Lack of Efficacy|0|||
144612187|NCT00841568|521440998|FG000|Overall Study|Adverse Event|1|||
144612188|NCT00841568|521440998|FG000|Overall Study|Death|1|||
144258185|NCT00534638|520146999|FG001|Overall Study|Withdrawal by Subject|4|||
144258186|NCT00534638|520146998|FG000|Overall Study|Migrated/moved from study area|13|||
144258187|NCT00534638|520146999|FG001|Overall Study|Migrated/moved from study area|11|||
144258188|NCT00534638|520146998|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
144258189|NCT00534638|520146999|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
144258190|NCT00534638|520146998|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
144258191|NCT00534638|520146999|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
144258192|NCT00534638|520146998|FG000|Overall Study|Other|1685|||
144258193|NCT00534638|520146999|FG001|Overall Study|Other|902|||
144258194|NCT02903420|520147002|FG000|Overall Study|Death|3|||
144258195|NCT02500719|520147005|FG000|Overall Study|Lost to Follow-up|2|||
144258196|NCT02500719|520147006|FG001|Overall Study|Lost to Follow-up|3|||
144258197|NCT02500719|520147005|FG000|Overall Study|Trauma history|1|||
144258198|NCT02500719|520147006|FG001|Overall Study|Trauma history|0|||
144258199|NCT02500719|520147005|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
144258200|NCT02500719|520147006|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
144258201|NCT02500719|520147005|FG000|Overall Study|Did not meet criteria for PTSD|0|||
144258202|NCT02500719|520147006|FG001|Overall Study|Did not meet criteria for PTSD|1|||
144258203|NCT02500719|520147005|FG000|Overall Study|Claustrophobia|0|||
144258204|NCT02500719|520147006|FG001|Overall Study|Claustrophobia|1|||
144258205|NCT02500719|520147005|FG000|Overall Study|History of head trauma|0|||
144258206|NCT02500719|520147006|FG001|Overall Study|History of head trauma|1|||
144258207|NCT00181883|520147009|FG000|Overall Study|Lack of Efficacy|2|||
144258208|NCT00181883|520147009|FG000|Overall Study|Treatment Limiting AEs|3|||
144258209|NCT00181883|520147009|FG000|Overall Study|Withdrawal by Subject|4|||
144258210|NCT00181883|520147009|FG000|Overall Study|Lost to Follow-up|1|||
144258211|NCT02710084|520147010|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
144258212|NCT02710084|520147011|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
144258213|NCT05305989|520147012|FG000|Overall Study|Other|3|||
144258214|NCT05305989|520147013|FG001|Overall Study|Other|2|||
144258215|NCT05305989|520147014|FG002|Overall Study|Other|0|||
144258216|NCT05305989|520147012|FG000|Overall Study|Sponsor decision|2|||
144258217|NCT05305989|520147013|FG001|Overall Study|Sponsor decision|1|||
144258218|NCT05305989|520147014|FG002|Overall Study|Sponsor decision|0|||
144258219|NCT05305989|520147012|FG000|Overall Study|Protocol Violation|0|||
144258220|NCT05305989|520147013|FG001|Overall Study|Protocol Violation|1|||
144258221|NCT05305989|520147014|FG002|Overall Study|Protocol Violation|0|||
144258222|NCT05305989|520147012|FG000|Overall Study|Investigator decision|1|||
144258223|NCT05305989|520147013|FG001|Overall Study|Investigator decision|2|||
144258224|NCT05305989|520147014|FG002|Overall Study|Investigator decision|0|||
144258225|NCT05305989|520147012|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
144258226|NCT05305989|520147013|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
144258227|NCT05305989|520147014|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
144258228|NCT05305989|520147012|FG000|Overall Study|Adverse Event|1|||
144258229|NCT05305989|520147013|FG001|Overall Study|Adverse Event|1|||
144258230|NCT05305989|520147014|FG002|Overall Study|Adverse Event|0|||
144258231|NCT05305989|520147012|FG000|Overall Study|Enrolled but never dosed|3|||
144258232|NCT05305989|520147013|FG001|Overall Study|Enrolled but never dosed|2|||
144258233|NCT05305989|520147014|FG002|Overall Study|Enrolled but never dosed|1|||
144258234|NCT00282152|520147015|FG000|Overall Study|Withdrawal by Subject|1|||
144258235|NCT00282152|520147016|FG001|Overall Study|Withdrawal by Subject|0|||
144258236|NCT00585325|520147017|FG000|Overall Study|Withdrawal by Subject|1|||
144258237|NCT00585325|520147018|FG001|Overall Study|Withdrawal by Subject|1|||
144258238|NCT03092791|520147019|FG000|Overall Study|Lost to Follow-up|0|||
144258239|NCT03092791|520147020|FG001|Overall Study|Lost to Follow-up|0|||
144258240|NCT03092791|520147021|FG002|Overall Study|Lost to Follow-up|0|||
144258241|NCT03092791|520147022|FG003|Overall Study|Lost to Follow-up|0|||
144258242|NCT03092791|520147023|FG004|Overall Study|Lost to Follow-up|0|||
144258243|NCT03092791|520147024|FG005|Overall Study|Lost to Follow-up|0|||
144258244|NCT03092791|520147025|FG006|Overall Study|Lost to Follow-up|1|||
144258245|NCT03092791|520147026|FG007|Overall Study|Lost to Follow-up|0|||
144258246|NCT03092791|520147019|FG000|Overall Study|Withdrawal of Consent|0|||
144258247|NCT03092791|520147020|FG001|Overall Study|Withdrawal of Consent|0|||
144465243|NCT01260350|520899873|FG019|Overall Study|Lack of Efficacy|0|||
144465244|NCT01260350|520899874|FG020|Overall Study|Lack of Efficacy|3|||
144465245|NCT01260350|520899875|FG021|Overall Study|Lack of Efficacy|0|||
144465246|NCT01260350|520899854|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465247|NCT01260350|520899855|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465248|NCT01260350|520899856|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465249|NCT01260350|520899857|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465250|NCT01260350|520899858|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465251|NCT01260350|520899859|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465252|NCT01260350|520899860|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465253|NCT01260350|520899861|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465254|NCT01260350|520899862|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
144465255|NCT01260350|520899863|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465256|NCT01260350|520899864|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465257|NCT01260350|520899865|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465258|NCT01260350|520899866|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465259|NCT01260350|520899867|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144612189|NCT00841568|521440998|FG000|Overall Study|Withdrawal by Subject|2|||
144612190|NCT00841568|521440998|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
144612191|NCT00978029|521440999|FG000|Overall Study|Adverse Event|1|||
144612192|NCT00978029|521441000|FG001|Overall Study|Adverse Event|2|||
144612193|NCT00978029|521441001|FG002|Overall Study|Adverse Event|5|||
144612194|NCT00978029|521440999|FG000|Overall Study|Withdrawal by Subject|0|||
144612195|NCT00978029|521441000|FG001|Overall Study|Withdrawal by Subject|0|||
144612196|NCT00978029|521441001|FG002|Overall Study|Withdrawal by Subject|1|||
144612197|NCT00978029|521440999|FG000|Overall Study|Protocol Violation|0|||
144612198|NCT00978029|521441000|FG001|Overall Study|Protocol Violation|1|||
144612199|NCT00978029|521441001|FG002|Overall Study|Protocol Violation|0|||
144612200|NCT00545298|521441002|FG000|Overall Study|Issues with Standard of Care|2|||
144612201|NCT00545298|521441003|FG001|Overall Study|Issues with Standard of Care|0|||
144612202|NCT00545298|521441004|FG002|Overall Study|Issues with Standard of Care|1|||
144612203|NCT01793142|521441007|FG000|Overall Study|Randomized not treated|7|||
144612204|NCT01840579|521441008|FG000|Overall Study|Status not recorded|0|||
144612205|NCT01840579|521441009|FG001|Overall Study|Status not recorded|0|||
144465260|NCT01260350|520899868|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144536305|NCT01596972|521167369|FG001|Overall Study|Lost to Follow-up|4|||
144536306|NCT01596972|521167368|FG000|Overall Study|Withdrawal by Subject|0|||
144536307|NCT01596972|521167369|FG001|Overall Study|Withdrawal by Subject|1|||
144536308|NCT01639131|521167371|FG000|Overall Study|Disease Progression|6|||
144536309|NCT01964300|521167373|FG000|Overall Study|Ineligible after enrollment|0|||
144536310|NCT01964300|521167374|FG001|Overall Study|Ineligible after enrollment|1|||
144536311|NCT01964300|521167373|FG000|Overall Study|Adverse Event|1|||
144536312|NCT01964300|521167374|FG001|Overall Study|Adverse Event|1|||
144536313|NCT01964300|521167373|FG000|Overall Study|Lack of Efficacy|3|||
144536314|NCT01964300|521167374|FG001|Overall Study|Lack of Efficacy|5|||
144536315|NCT01964300|521167373|FG000|Overall Study|Withdrawal by Subject|0|||
144536316|NCT01964300|521167374|FG001|Overall Study|Withdrawal by Subject|1|||
144536317|NCT01964300|521167373|FG000|Overall Study|To receive alternative therapy|1|||
144536318|NCT01964300|521167374|FG001|Overall Study|To receive alternative therapy|2|||
144536319|NCT01964300|521167373|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
144536320|NCT01964300|521167374|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
144536321|NCT01964300|521167373|FG000|Overall Study|Weight criteria not met|0|||
144536322|NCT01964300|521167374|FG001|Overall Study|Weight criteria not met|1|||
144536323|NCT00557492|521167375|FG000|Overall Study|Change in health insurance|1|||
144536324|NCT03621735|521167377|FG000|Overall Study|Withdrawal by Subject|13|||
144536325|NCT03621735|521167378|FG001|Overall Study|Withdrawal by Subject|13|||
144536326|NCT03875313|521167382|FG000|Overall Study|Withdrawal by Subject|1|||
144536327|NCT03875313|521167383|FG001|Overall Study|Withdrawal by Subject|3|||
144536328|NCT03875313|521167384|FG002|Overall Study|Withdrawal by Subject|0|||
144536329|NCT03875313|521167385|FG003|Overall Study|Withdrawal by Subject|0|||
144536330|NCT03875313|521167386|FG004|Overall Study|Withdrawal by Subject|0|||
144536331|NCT03875313|521167382|FG000|Overall Study|Death|0|||
144536332|NCT03875313|521167383|FG001|Overall Study|Death|0|||
144536333|NCT03875313|521167384|FG002|Overall Study|Death|0|||
144536334|NCT03875313|521167385|FG003|Overall Study|Death|0|||
144536335|NCT03875313|521167386|FG004|Overall Study|Death|1|||
144536336|NCT03875313|521167382|FG000|Overall Study|Lost to Follow-up|0|||
144536337|NCT03875313|521167383|FG001|Overall Study|Lost to Follow-up|0|||
144536338|NCT03875313|521167384|FG002|Overall Study|Lost to Follow-up|0|||
144536339|NCT03875313|521167385|FG003|Overall Study|Lost to Follow-up|0|||
144536340|NCT03875313|521167386|FG004|Overall Study|Lost to Follow-up|1|||
144536341|NCT03875313|521167382|FG000|Overall Study|Study Termination by Sponsor|0|||
144536342|NCT03875313|521167383|FG001|Overall Study|Study Termination by Sponsor|1|||
144536343|NCT03875313|521167384|FG002|Overall Study|Study Termination by Sponsor|1|||
144536344|NCT03875313|521167385|FG003|Overall Study|Study Termination by Sponsor|0|||
144536345|NCT03875313|521167386|FG004|Overall Study|Study Termination by Sponsor|1|||
144536346|NCT03875313|521167382|FG000|Overall Study|New Anticancer Treatment|0|||
144536347|NCT03875313|521167383|FG001|Overall Study|New Anticancer Treatment|1|||
144536348|NCT03875313|521167384|FG002|Overall Study|New Anticancer Treatment|2|||
144536349|NCT03875313|521167385|FG003|Overall Study|New Anticancer Treatment|1|||
144536350|NCT03875313|521167386|FG004|Overall Study|New Anticancer Treatment|0|||
144536351|NCT03875313|521167382|FG000|Overall Study|Other, Not Specified|2|||
144536352|NCT03875313|521167383|FG001|Overall Study|Other, Not Specified|11|||
144536353|NCT03875313|521167384|FG002|Overall Study|Other, Not Specified|3|||
144536354|NCT03875313|521167385|FG003|Overall Study|Other, Not Specified|3|||
144612206|NCT01840579|521441010|FG002|Overall Study|Status not recorded|2|||
144612207|NCT01840579|521441011|FG003|Overall Study|Status not recorded|3|||
144612208|NCT01840579|521441012|FG004|Overall Study|Status not recorded|4|||
144612209|NCT01840579|521441013|FG005|Overall Study|Status not recorded|3|||
144612210|NCT01840579|521441014|FG006|Overall Study|Status not recorded|0|||
144612211|NCT01840579|521441015|FG007|Overall Study|Status not recorded|3|||
144465261|NCT01260350|520899869|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465262|NCT01260350|520899870|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465263|NCT01260350|520899871|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465264|NCT01260350|520899872|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465265|NCT01260350|520899873|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465266|NCT01260350|520899874|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465267|NCT01260350|520899875|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
144465268|NCT00626028|520899876|FG000|Overall Study|Adverse Event|1|||
144465269|NCT00626028|520899877|FG001|Overall Study|Adverse Event|1|||
144465270|NCT00626028|520899876|FG000|Overall Study|Device Failure|0|||
144465271|NCT00626028|520899877|FG001|Overall Study|Device Failure|1|||
144465272|NCT00626028|520899876|FG000|Overall Study|Physician Decision|2|||
144465273|NCT00626028|520899877|FG001|Overall Study|Physician Decision|1|||
144465274|NCT00626028|520899876|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
144465275|NCT00626028|520899877|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
144465276|NCT05224050|520899878|FG000|Overall Study|Withdrawal by Subject|9|||
144465277|NCT05224050|520899878|FG000|Overall Study|Lost to Follow-up|3|||
144465278|NCT02436330|520899879|FG000|Cohort 1|Lost to Follow-up|5|||
144465279|NCT02436330|520899880|FG001|Cohort 1|Lost to Follow-up|2|||
144465280|NCT02436330|520899879|FG000|Cohort 1|Withdrawal by Subject|0|||
144465281|NCT02436330|520899880|FG001|Cohort 1|Withdrawal by Subject|1|||
144465282|NCT02436330|520899879|FG000|Cohort 2|Lost to Follow-up|2|||
144465283|NCT02436330|520899880|FG001|Cohort 2|Lost to Follow-up|0|||
144465284|NCT02436330|520899879|FG000|Cohort 2|Withdrawal by Subject|2|||
144465285|NCT02436330|520899880|FG001|Cohort 2|Withdrawal by Subject|3|||
144465286|NCT02436330|520899879|FG000|Cohort 3|Lost to Follow-up|1|||
144465287|NCT02436330|520899880|FG001|Cohort 3|Lost to Follow-up|0|||
144465288|NCT02436330|520899879|FG000|Cohort 3|Withdrawal by Subject|4|||
144536355|NCT03875313|521167386|FG004|Overall Study|Other, Not Specified|1|||
144536356|NCT04121546|521167387|FG000|Overall Study|Lost to Follow-up|1|||
144536357|NCT04121546|521167388|FG001|Overall Study|Lost to Follow-up|3|||
144536358|NCT04495621|521167399|FG000|Overall Study|Withdrawal by Subject|0|||
144536359|NCT04495621|521167400|FG001|Overall Study|Withdrawal by Subject|3|||
144536360|NCT04495621|521167399|FG000|Overall Study|Death|7|||
144536361|NCT04495621|521167400|FG001|Overall Study|Death|11|||
144536362|NCT04495621|521167399|FG000|Overall Study|Investigator Decision|0|||
144536363|NCT04495621|521167400|FG001|Overall Study|Investigator Decision|7|||
144536364|NCT04495621|521167399|FG000|Overall Study|Lost to Follow-up|0|||
144536365|NCT04495621|521167400|FG001|Overall Study|Lost to Follow-up|1|||
144536366|NCT02754596|521167406|FG000|Overall Study|Withdrawal by Subject|3|||
144536367|NCT02754596|521167407|FG001|Overall Study|Withdrawal by Subject|4|||
144536368|NCT02754596|521167408|FG002|Overall Study|Withdrawal by Subject|0|||
144536369|NCT02754596|521167406|FG000|Overall Study|Physician Decision|1|||
144536370|NCT02754596|521167407|FG001|Overall Study|Physician Decision|1|||
144536371|NCT02754596|521167408|FG002|Overall Study|Physician Decision|1|||
144536372|NCT02754596|521167406|FG000|Overall Study|Lost to Follow-up|1|||
144536373|NCT02754596|521167407|FG001|Overall Study|Lost to Follow-up|1|||
144612212|NCT01840579|521441016|FG008|Overall Study|Status not recorded|3|||
144612213|NCT01840579|521441017|FG009|Overall Study|Status not recorded|3|||
144612214|NCT01840579|521441008|FG000|Overall Study|Progressive disease|3|||
144612215|NCT01840579|521441009|FG001|Overall Study|Progressive disease|5|||
144612216|NCT01840579|521441010|FG002|Overall Study|Progressive disease|0|||
144612217|NCT01840579|521441011|FG003|Overall Study|Progressive disease|0|||
144612218|NCT01840579|521441012|FG004|Overall Study|Progressive disease|0|||
144612219|NCT01840579|521441013|FG005|Overall Study|Progressive disease|0|||
144612220|NCT01840579|521441014|FG006|Overall Study|Progressive disease|0|||
144612221|NCT01840579|521441015|FG007|Overall Study|Progressive disease|0|||
144612222|NCT01840579|521441016|FG008|Overall Study|Progressive disease|0|||
144612223|NCT01840579|521441017|FG009|Overall Study|Progressive disease|0|||
144612224|NCT01840579|521441008|FG000|Overall Study|Ongoing in study|0|||
144612225|NCT01840579|521441009|FG001|Overall Study|Ongoing in study|1|||
144612226|NCT01840579|521441010|FG002|Overall Study|Ongoing in study|0|||
144612227|NCT01840579|521441011|FG003|Overall Study|Ongoing in study|0|||
144612228|NCT01840579|521441012|FG004|Overall Study|Ongoing in study|0|||
144465289|NCT02436330|520899880|FG001|Cohort 3|Withdrawal by Subject|0|||
144536374|NCT02754596|521167408|FG002|Overall Study|Lost to Follow-up|2|||
144536375|NCT02754596|521167406|FG000|Overall Study|Death|0|||
144536376|NCT02754596|521167407|FG001|Overall Study|Death|2|||
144536377|NCT02754596|521167408|FG002|Overall Study|Death|0|||
144536378|NCT02754596|521167406|FG000|Overall Study|Adverse Event|1|||
144536379|NCT02754596|521167407|FG001|Overall Study|Adverse Event|0|||
144612229|NCT01840579|521441013|FG005|Overall Study|Ongoing in study|0|||
144612230|NCT01840579|521441014|FG006|Overall Study|Ongoing in study|0|||
144726055|NCT00950807|521852688|FG003|Treatment Period 1|Protocol Violation|0|||
144726056|NCT00950807|521852689|FG004|Treatment Period 1|Protocol Violation|0|||
144726057|NCT00950807|521852690|FG005|Treatment Period 1|Protocol Violation|0|||
144612231|NCT01840579|521441015|FG007|Overall Study|Ongoing in study|0|||
144612232|NCT01840579|521441016|FG008|Overall Study|Ongoing in study|0|||
144612233|NCT01840579|521441017|FG009|Overall Study|Ongoing in study|0|||
144465290|NCT02436330|520899879|FG000|Cohort 4|Lost to Follow-up|1|||
144465291|NCT02436330|520899880|FG001|Cohort 4|Lost to Follow-up|0|||
144465292|NCT02436330|520899879|FG000|Cohort 4|Withdrawal by Subject|1|||
144465293|NCT02436330|520899880|FG001|Cohort 4|Withdrawal by Subject|0|||
144465294|NCT02436330|520899879|FG000|Cohort 5|Lost to Follow-up|3|||
144465295|NCT02436330|520899880|FG001|Cohort 5|Lost to Follow-up|2|||
144465296|NCT02436330|520899879|FG000|Cohort 5|Withdrawal by Subject|3|||
144465297|NCT02436330|520899880|FG001|Cohort 5|Withdrawal by Subject|2|||
144465298|NCT02436330|520899879|FG000|Cohort 6|Lost to Follow-up|2|||
144465299|NCT02436330|520899880|FG001|Cohort 6|Lost to Follow-up|0|||
144465300|NCT02436330|520899879|FG000|Cohort 6|Withdrawal by Subject|1|||
144465301|NCT02436330|520899880|FG001|Cohort 6|Withdrawal by Subject|1|||
144465302|NCT04575467|520899885|FG000|Overall Study|Adverse Event|0|||
144465303|NCT04575467|520899886|FG001|Overall Study|Adverse Event|1|||
144465304|NCT04575467|520899887|FG002|Overall Study|Adverse Event|0|||
144465305|NCT04575467|520899888|FG003|Overall Study|Adverse Event|0|||
144465306|NCT03182868|520899891|FG000|Overall Study|Protocol Violation|3|||
144465307|NCT03182868|520899892|FG001|Overall Study|Protocol Violation|0|||
144465308|NCT03182868|520899893|FG002|Overall Study|Protocol Violation|4|||
144465309|NCT03182868|520899894|FG003|Overall Study|Protocol Violation|1|||
144465310|NCT03182868|520899895|FG004|Overall Study|Protocol Violation|8|||
144465311|NCT03213158|520899902|FG000|Overall Study|Withdrawal by Subject|1|||
144465312|NCT03213158|520899902|FG000|Overall Study|Physician Decision|2|||
144465313|NCT03649230|520899910|FG000|Overall Study|Adverse Event|12|||
144465314|NCT03649230|520899910|FG000|Overall Study|Death|8|||
144465315|NCT03649230|520899910|FG000|Overall Study|Withdrawal by Subject|6|||
144465316|NCT03649230|520899910|FG000|Overall Study|Physician Decision|5|||
144465317|NCT03649230|520899910|FG000|Overall Study|Disease progression|5|||
144465318|NCT03649230|520899910|FG000|Overall Study|Switched to non-HEC|5|||
144465319|NCT03649230|520899910|FG000|Overall Study|Chemotherapy discontinued|4|||
144465320|NCT03649230|520899910|FG000|Overall Study|Received only 3 HEC cycles|4|||
144465321|NCT03649230|520899910|FG000|Overall Study|Screen Failure|3|||
144465322|NCT03649230|520899910|FG000|Overall Study|Patient stopped treatment|2|||
144465323|NCT03649230|520899910|FG000|Overall Study|Protocol Violation|1|||
144465324|NCT03649230|520899910|FG000|Overall Study|Non-compliance|1|||
144465325|NCT03649230|520899910|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
144465326|NCT00734630|520899915|FG000|Overall Study|Lack of Efficacy|4|||
144465327|NCT00734630|520899916|FG001|Overall Study|Lack of Efficacy|4|||
144465328|NCT00734630|520899915|FG000|Overall Study|Withdrawal by Subject|7|||
144465329|NCT00734630|520899916|FG001|Overall Study|Withdrawal by Subject|9|||
144465330|NCT00734630|520899915|FG000|Overall Study|Lost to Follow-up|13|||
144465331|NCT00734630|520899916|FG001|Overall Study|Lost to Follow-up|7|||
144465332|NCT00734630|520899915|FG000|Overall Study|Protocol Violation|0|||
144465333|NCT00734630|520899916|FG001|Overall Study|Protocol Violation|3|||
144465334|NCT00734630|520899915|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
144465335|NCT00734630|520899916|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
144465336|NCT00734630|520899915|FG000|Overall Study|Adverse Event|3|||
144465337|NCT00734630|520899916|FG001|Overall Study|Adverse Event|6|||
144612234|NCT01840579|521441008|FG000|Overall Study|Death|0|||
144612235|NCT01840579|521441009|FG001|Overall Study|Death|0|||
144612236|NCT01840579|521441010|FG002|Overall Study|Death|0|||
144726058|NCT00950807|521852691|FG006|Treatment Period 1|Protocol Violation|0|||
144726059|NCT00950807|521852692|FG007|Treatment Period 1|Protocol Violation|0|||
144612237|NCT01840579|521441011|FG003|Overall Study|Death|0|||
144612238|NCT01840579|521441012|FG004|Overall Study|Death|0|||
144612239|NCT01840579|521441013|FG005|Overall Study|Death|1|||
144612240|NCT01840579|521441014|FG006|Overall Study|Death|0|||
144612241|NCT01840579|521441015|FG007|Overall Study|Death|0|||
144612242|NCT01840579|521441016|FG008|Overall Study|Death|0|||
144612243|NCT01840579|521441017|FG009|Overall Study|Death|0|||
144465338|NCT00734630|520899915|FG000|Overall Study|Randomized in Error|0|||
144465339|NCT00734630|520899916|FG001|Overall Study|Randomized in Error|1|||
144465340|NCT00734630|520899915|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
144465341|NCT00734630|520899916|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
144465342|NCT00734630|520899915|FG000|Overall Study|Poor Compliance|1|||
144465343|NCT00734630|520899916|FG001|Overall Study|Poor Compliance|1|||
144465344|NCT00977665|520899917|FG000|Overall Study|Withdrawal by Subject|1|||
144465345|NCT00977665|520899918|FG001|Overall Study|Withdrawal by Subject|3|||
144465346|NCT00977665|520899917|FG000|Overall Study|Physician Decision|2|||
144465347|NCT00977665|520899918|FG001|Overall Study|Physician Decision|1|||
144465348|NCT00977665|520899917|FG000|Overall Study|Sponsor requested withdrawal|0|||
144612244|NCT01840579|521441008|FG000|Overall Study|Adverse Event|0|||
144612245|NCT01840579|521441009|FG001|Overall Study|Adverse Event|1|||
144465349|NCT00977665|520899918|FG001|Overall Study|Sponsor requested withdrawal|1|||
144465350|NCT00977665|520899917|FG000|Overall Study|Lost to Follow-up|1|||
144465351|NCT00977665|520899918|FG001|Overall Study|Lost to Follow-up|0|||
144465352|NCT00977665|520899917|FG000|Overall Study|Death|3|||
144465353|NCT00977665|520899918|FG001|Overall Study|Death|2|||
144465354|NCT00977665|520899917|FG000|Overall Study|Adverse Event|14|||
144465355|NCT00977665|520899918|FG001|Overall Study|Adverse Event|7|||
144465356|NCT00977665|520899917|FG000|Overall Study|Treatment failure|0|||
144465357|NCT00977665|520899918|FG001|Overall Study|Treatment failure|1|||
144465358|NCT01330433|520899919|FG000|Overall Study|Death|1|||
144465359|NCT01330433|520899920|FG001|Overall Study|Death|3|||
144465360|NCT01330433|520899919|FG000|Overall Study|Lost to Follow-up|1|||
144465361|NCT01330433|520899920|FG001|Overall Study|Lost to Follow-up|0|||
144465362|NCT00127101|520899921|FG000|Base Protocol|Adverse Event|0|||
144465363|NCT00127101|520899922|FG001|Base Protocol|Adverse Event|2|||
144465364|NCT00127101|520899923|FG002|Base Protocol|Adverse Event|1|||
144465365|NCT00127101|520899924|FG003|Base Protocol|Adverse Event|0|||
144536380|NCT02754596|521167408|FG002|Overall Study|Adverse Event|1|||
144536381|NCT02754596|521167406|FG000|Overall Study|Other|1|||
144536382|NCT02754596|521167407|FG001|Overall Study|Other|0|||
144536383|NCT02754596|521167408|FG002|Overall Study|Other|0|||
144536384|NCT05707351|521167410|FG000|Overall Study|Withdrawal by Subject|2|||
144536385|NCT05707351|521167410|FG000|Overall Study|Reason Not Specified|1|||
144536386|NCT04059406|521167421|FG000|Overall Study|Early Treatment Termination|5|||
144536387|NCT04059406|521167422|FG001|Overall Study|Early Treatment Termination|5|||
144536388|NCT04059406|521167423|FG002|Overall Study|Early Treatment Termination|15|||
144536389|NCT00319696|521167424|FG000|Overall Study|Adverse Event|36|||
144536390|NCT00319696|521167424|FG000|Overall Study|withdrawal of consent|14|||
144536391|NCT00319696|521167424|FG000|Overall Study|administrative|7|||
144536392|NCT00319696|521167424|FG000|Overall Study|Lost to Follow-up|3|||
144536393|NCT02500576|521167425|FG000|Overall Study|Adverse Event|0|||
144726060|NCT00950807|521852693|FG008|Treatment Period 1|Protocol Violation|0|||
144258248|NCT03092791|520147021|FG002|Overall Study|Withdrawal of Consent|0|||
144258249|NCT03092791|520147022|FG003|Overall Study|Withdrawal of Consent|0|||
144258250|NCT03092791|520147023|FG004|Overall Study|Withdrawal of Consent|4|||
144726061|NCT00950807|521852694|FG009|Treatment Period 1|Protocol Violation|0|||
144726062|NCT00950807|521852685|FG000|Treatment Period 1|Lost to Follow-up|0|||
144726063|NCT00950807|521852686|FG001|Treatment Period 1|Lost to Follow-up|0|||
144726064|NCT00950807|521852687|FG002|Treatment Period 1|Lost to Follow-up|1|||
144726065|NCT00950807|521852688|FG003|Treatment Period 1|Lost to Follow-up|0|||
144726066|NCT00950807|521852689|FG004|Treatment Period 1|Lost to Follow-up|0|||
144726067|NCT00950807|521852690|FG005|Treatment Period 1|Lost to Follow-up|0|||
144726068|NCT00950807|521852691|FG006|Treatment Period 1|Lost to Follow-up|0|||
144726069|NCT00950807|521852692|FG007|Treatment Period 1|Lost to Follow-up|0|||
144726070|NCT00950807|521852693|FG008|Treatment Period 1|Lost to Follow-up|0|||
144726071|NCT00950807|521852694|FG009|Treatment Period 1|Lost to Follow-up|0|||
144726072|NCT00950807|521852685|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144726073|NCT00950807|521852686|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144726074|NCT00950807|521852687|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144726075|NCT00950807|521852688|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144726076|NCT00950807|521852689|FG004|Treatment Period 1|Withdrawal by Subject|1|||
144726077|NCT00950807|521852690|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144726078|NCT00950807|521852691|FG006|Treatment Period 1|Withdrawal by Subject|0|||
144726079|NCT00950807|521852692|FG007|Treatment Period 1|Withdrawal by Subject|0|||
144726080|NCT00950807|521852693|FG008|Treatment Period 1|Withdrawal by Subject|1|||
144726081|NCT00950807|521852694|FG009|Treatment Period 1|Withdrawal by Subject|0|||
144726082|NCT00950807|521852685|FG000|Treatment Period 1|Adverse Event|0|||
144258251|NCT03092791|520147024|FG005|Overall Study|Withdrawal of Consent|12|||
144258252|NCT03092791|520147025|FG006|Overall Study|Withdrawal of Consent|6|||
144465366|NCT00127101|520899925|FG004|Base Protocol|Adverse Event|0|||
144465367|NCT00127101|520899926|FG005|Base Protocol|Adverse Event|0|||
144465368|NCT00127101|520899921|FG000|Base Protocol|Lack of Efficacy|1|||
144258253|NCT03092791|520147026|FG007|Overall Study|Withdrawal of Consent|4|||
144258254|NCT03092791|520147019|FG000|Overall Study|Study Termination|0|||
144465369|NCT00127101|520899922|FG001|Base Protocol|Lack of Efficacy|0|||
144536394|NCT02500576|521167426|FG001|Overall Study|Adverse Event|1|||
144536395|NCT02500576|521167425|FG000|Overall Study|Death|2|||
144536396|NCT02500576|521167426|FG001|Overall Study|Death|1|||
144726083|NCT00950807|521852686|FG001|Treatment Period 1|Adverse Event|0|||
144726084|NCT00950807|521852687|FG002|Treatment Period 1|Adverse Event|0|||
144726085|NCT00950807|521852688|FG003|Treatment Period 1|Adverse Event|0|||
144726086|NCT00950807|521852689|FG004|Treatment Period 1|Adverse Event|0|||
144726087|NCT00950807|521852690|FG005|Treatment Period 1|Adverse Event|1|||
144258255|NCT03092791|520147020|FG001|Overall Study|Study Termination|0|||
144258256|NCT03092791|520147021|FG002|Overall Study|Study Termination|0|||
144465370|NCT00127101|520899923|FG002|Base Protocol|Lack of Efficacy|0|||
144465371|NCT00127101|520899924|FG003|Base Protocol|Lack of Efficacy|0|||
144465372|NCT00127101|520899925|FG004|Base Protocol|Lack of Efficacy|2|||
144536397|NCT02500576|521167425|FG000|Overall Study|Lack of Efficacy|5|||
144612246|NCT01840579|521441010|FG002|Overall Study|Adverse Event|0|||
144612247|NCT01840579|521441011|FG003|Overall Study|Adverse Event|0|||
144465373|NCT00127101|520899926|FG005|Base Protocol|Lack of Efficacy|0|||
144465374|NCT00127101|520899921|FG000|Base Protocol|Withdrawal by Subject|1|||
144465375|NCT00127101|520899922|FG001|Base Protocol|Withdrawal by Subject|2|||
144465376|NCT00127101|520899923|FG002|Base Protocol|Withdrawal by Subject|1|||
144465377|NCT00127101|520899924|FG003|Base Protocol|Withdrawal by Subject|0|||
144465378|NCT00127101|520899925|FG004|Base Protocol|Withdrawal by Subject|0|||
144465379|NCT00127101|520899926|FG005|Base Protocol|Withdrawal by Subject|1|||
144465380|NCT00127101|520899921|FG000|Continuation Phase|Adverse Event|0|||
144465381|NCT00127101|520899922|FG001|Continuation Phase|Adverse Event|0|||
144465382|NCT00127101|520899923|FG002|Continuation Phase|Adverse Event|0|||
144465383|NCT00127101|520899924|FG003|Continuation Phase|Adverse Event|0|||
144465384|NCT00127101|520899925|FG004|Continuation Phase|Adverse Event|1|||
144465385|NCT00127101|520899926|FG005|Continuation Phase|Adverse Event|1|||
144465386|NCT00127101|520899921|FG000|Continuation Phase|Lack of Efficacy|0|||
144465387|NCT00127101|520899922|FG001|Continuation Phase|Lack of Efficacy|0|||
144465388|NCT00127101|520899923|FG002|Continuation Phase|Lack of Efficacy|0|||
144465389|NCT00127101|520899924|FG003|Continuation Phase|Lack of Efficacy|0|||
144465390|NCT00127101|520899925|FG004|Continuation Phase|Lack of Efficacy|0|||
144612248|NCT01840579|521441012|FG004|Overall Study|Adverse Event|0|||
144612249|NCT01840579|521441013|FG005|Overall Study|Adverse Event|0|||
144612250|NCT01840579|521441014|FG006|Overall Study|Adverse Event|0|||
144612251|NCT01840579|521441015|FG007|Overall Study|Adverse Event|0|||
144612252|NCT01840579|521441016|FG008|Overall Study|Adverse Event|0|||
144612253|NCT01840579|521441017|FG009|Overall Study|Adverse Event|0|||
144612254|NCT01840579|521441008|FG000|Overall Study|Follow-up ended by Sponsor|0|||
144612255|NCT01840579|521441009|FG001|Overall Study|Follow-up ended by Sponsor|0|||
144612256|NCT01840579|521441010|FG002|Overall Study|Follow-up ended by Sponsor|0|||
144612257|NCT01840579|521441011|FG003|Overall Study|Follow-up ended by Sponsor|0|||
144612258|NCT01840579|521441012|FG004|Overall Study|Follow-up ended by Sponsor|0|||
144612259|NCT01840579|521441013|FG005|Overall Study|Follow-up ended by Sponsor|0|||
144612260|NCT01840579|521441014|FG006|Overall Study|Follow-up ended by Sponsor|2|||
144612261|NCT01840579|521441015|FG007|Overall Study|Follow-up ended by Sponsor|0|||
144612262|NCT01840579|521441016|FG008|Overall Study|Follow-up ended by Sponsor|0|||
144612263|NCT01840579|521441017|FG009|Overall Study|Follow-up ended by Sponsor|0|||
144612264|NCT03302975|521441019|FG000|Overall Study|Lost to Follow-up|4|||
144612265|NCT05003622|521441021|FG000|Overall Study|Progressive disease|2|||
144612266|NCT05003622|521441021|FG000|Overall Study|Withdrawal by Subject|1|||
144612267|NCT01045798|521441025|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
144612268|NCT01045798|521441026|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
144612269|NCT01045798|521441025|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
144465391|NCT00127101|520899926|FG005|Continuation Phase|Lack of Efficacy|1|||
144612270|NCT01045798|521441026|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
144612271|NCT01045798|521441025|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
144612272|NCT01045798|521441026|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
144612273|NCT01045798|521441025|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
144612274|NCT01045798|521441026|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
144612275|NCT04066491|521441027|FG000|Overall Study|Randomized, not treated|0|||
144465392|NCT00127101|520899921|FG000|Continuation Phase|Withdrawal by Subject|0|||
144465393|NCT00127101|520899922|FG001|Continuation Phase|Withdrawal by Subject|0|||
144612276|NCT04066491|521441028|FG001|Overall Study|Randomized, not treated|0|||
144612277|NCT04066491|521441029|FG002|Overall Study|Randomized, not treated|2|||
144612278|NCT04506086|521441030|FG000|Overall Study|Withdrawal by Subject|2|||
144612279|NCT02321930|521441038|FG000|Overall Study|Lost to Follow-up|1|||
144612280|NCT05885737|521441039|FG000|DB Period|Adverse Event|4|||
144612281|NCT05885737|521441040|FG001|DB Period|Adverse Event|4|||
144612282|NCT05885737|521441039|FG000|DB Period|Lost to Follow-up|0|||
144612283|NCT05885737|521441040|FG001|DB Period|Lost to Follow-up|1|||
144612284|NCT05885737|521441039|FG000|DB Period|Physician Decision|2|||
144612285|NCT05885737|521441040|FG001|DB Period|Physician Decision|0|||
144612286|NCT05885737|521441039|FG000|DB Period|Withdrawal by Subject|12|||
144612287|NCT05885737|521441040|FG001|DB Period|Withdrawal by Subject|6|||
144465394|NCT00127101|520899923|FG002|Continuation Phase|Withdrawal by Subject|1|||
144465395|NCT00127101|520899924|FG003|Continuation Phase|Withdrawal by Subject|0|||
144612288|NCT05885737|521441039|FG000|DB Period|Other: Unspecified|2|||
144612289|NCT05885737|521441040|FG001|DB Period|Other: Unspecified|2|||
144612290|NCT05885737|521441039|FG000|OLE Period|Adverse Event|3|||
144612291|NCT05885737|521441040|FG001|OLE Period|Adverse Event|2|||
144612292|NCT05885737|521441039|FG000|OLE Period|Physician Decision|1|||
144612293|NCT05885737|521441040|FG001|OLE Period|Physician Decision|0|||
144612294|NCT05885737|521441039|FG000|OLE Period|Withdrawal by Subject|5|||
144612295|NCT05885737|521441040|FG001|OLE Period|Withdrawal by Subject|5|||
144612296|NCT05885737|521441039|FG000|OLE Period|Other: Unspecified|2|||
144612297|NCT05885737|521441040|FG001|OLE Period|Other: Unspecified|1|||
144612298|NCT01652885|521442671|FG000|Overall Study|Adverse Event|1|||
144465396|NCT00127101|520899925|FG004|Continuation Phase|Withdrawal by Subject|2|||
144465397|NCT00127101|520899926|FG005|Continuation Phase|Withdrawal by Subject|1|||
144465398|NCT02291614|520899927|FG000|Overall Study|Lost to Follow-up|0|||
144465399|NCT02291614|520899928|FG001|Overall Study|Lost to Follow-up|0|||
144465400|NCT02291614|520899929|FG002|Overall Study|Lost to Follow-up|0|||
144465401|NCT02291614|520899930|FG003|Overall Study|Lost to Follow-up|0|||
144465402|NCT02291614|520899931|FG004|Overall Study|Lost to Follow-up|0|||
144465403|NCT02291614|520899932|FG005|Overall Study|Lost to Follow-up|0|||
144465404|NCT02291614|520899933|FG006|Overall Study|Lost to Follow-up|0|||
144465405|NCT02291614|520899934|FG007|Overall Study|Lost to Follow-up|1|||
144465406|NCT02291614|520899935|FG008|Overall Study|Lost to Follow-up|0|||
144465407|NCT02291614|520899936|FG009|Overall Study|Lost to Follow-up|0|||
144465408|NCT02291614|520899937|FG010|Overall Study|Lost to Follow-up|0|||
144465409|NCT02291614|520899927|FG000|Overall Study|Withdrawal by Subject|0|||
144465410|NCT02291614|520899928|FG001|Overall Study|Withdrawal by Subject|1|||
144465411|NCT02291614|520899929|FG002|Overall Study|Withdrawal by Subject|0|||
144465412|NCT02291614|520899930|FG003|Overall Study|Withdrawal by Subject|0|||
144465413|NCT02291614|520899931|FG004|Overall Study|Withdrawal by Subject|0|||
144465414|NCT02291614|520899932|FG005|Overall Study|Withdrawal by Subject|0|||
144465415|NCT02291614|520899933|FG006|Overall Study|Withdrawal by Subject|0|||
144465416|NCT02291614|520899934|FG007|Overall Study|Withdrawal by Subject|0|||
144465417|NCT02291614|520899935|FG008|Overall Study|Withdrawal by Subject|0|||
144465418|NCT02291614|520899936|FG009|Overall Study|Withdrawal by Subject|2|||
144465419|NCT02291614|520899937|FG010|Overall Study|Withdrawal by Subject|2|||
144465420|NCT02291614|520899927|FG000|Overall Study|Decision by sponsor|0|||
144465421|NCT02291614|520899928|FG001|Overall Study|Decision by sponsor|0|||
144465422|NCT02291614|520899929|FG002|Overall Study|Decision by sponsor|0|||
144465423|NCT02291614|520899930|FG003|Overall Study|Decision by sponsor|1|||
144465424|NCT02291614|520899931|FG004|Overall Study|Decision by sponsor|0|||
144465425|NCT02291614|520899932|FG005|Overall Study|Decision by sponsor|0|||
144465426|NCT02291614|520899933|FG006|Overall Study|Decision by sponsor|0|||
144465427|NCT02291614|520899934|FG007|Overall Study|Decision by sponsor|0|||
144465428|NCT02291614|520899935|FG008|Overall Study|Decision by sponsor|0|||
144465429|NCT02291614|520899936|FG009|Overall Study|Decision by sponsor|0|||
144465430|NCT02291614|520899937|FG010|Overall Study|Decision by sponsor|0|||
144465431|NCT02291614|520899927|FG000|Overall Study|Death|0|||
144465432|NCT02291614|520899928|FG001|Overall Study|Death|0|||
144465433|NCT02291614|520899929|FG002|Overall Study|Death|1|||
144465434|NCT02291614|520899930|FG003|Overall Study|Death|0|||
144465435|NCT02291614|520899931|FG004|Overall Study|Death|1|||
144465436|NCT02291614|520899932|FG005|Overall Study|Death|1|||
144465437|NCT02291614|520899933|FG006|Overall Study|Death|1|||
144465438|NCT02291614|520899934|FG007|Overall Study|Death|0|||
144465439|NCT02291614|520899935|FG008|Overall Study|Death|0|||
144465440|NCT02291614|520899936|FG009|Overall Study|Death|0|||
144465441|NCT02291614|520899937|FG010|Overall Study|Death|0|||
144465442|NCT01662310|520899938|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
144465443|NCT01662310|520899939|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
144612299|NCT00075400|521442672|FG000|Overall Study|Ineligible: wrong primary|1|||
144612300|NCT00075400|521442672|FG000|Overall Study|Never treated|2|||
144612301|NCT03723707|521442673|FG000|Overall Study|Death|32|||
144612302|NCT03723707|521442674|FG001|Overall Study|Death|32|||
144612303|NCT03723707|521442673|FG000|Overall Study|Admitted to long term care|12|||
144612304|NCT03723707|521442674|FG001|Overall Study|Admitted to long term care|12|||
144612305|NCT03723707|521442673|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
144612306|NCT03723707|521442674|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
144612307|NCT03723707|521442673|FG000|Overall Study|Lost to Follow-up|40|||
144612308|NCT03723707|521442674|FG001|Overall Study|Lost to Follow-up|22|||
144612309|NCT03723707|521442673|FG000|Overall Study|Discontinued after study closure|24|||
144612310|NCT03723707|521442674|FG001|Overall Study|Discontinued after study closure|12|||
144612311|NCT04682405|521442676|FG000|Overall Study|Adverse Event|0|||
144612312|NCT04682405|521442677|FG001|Overall Study|Adverse Event|1|||
144612313|NCT03557281|521442678|FG000|Overall Study|Investigator discretion|0|||
144612314|NCT03557281|521442679|FG001|Overall Study|Investigator discretion|0|||
144612315|NCT03557281|521442680|FG002|Overall Study|Investigator discretion|1|||
144612316|NCT03557281|521442681|FG003|Overall Study|Investigator discretion|0|||
144612317|NCT03557281|521442682|FG004|Overall Study|Investigator discretion|0|||
144612318|NCT03557281|521442678|FG000|Overall Study|Withdrawal by Subject|0|||
144612319|NCT03557281|521442679|FG001|Overall Study|Withdrawal by Subject|1|||
144612320|NCT03557281|521442680|FG002|Overall Study|Withdrawal by Subject|1|||
144258257|NCT03092791|520147022|FG003|Overall Study|Study Termination|0|||
144258258|NCT03092791|520147023|FG004|Overall Study|Study Termination|55|||
144465444|NCT01662310|520899940|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
144465445|NCT01662310|520899941|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
144465446|NCT01662310|520899942|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
144465447|NCT01662310|520899938|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
144465448|NCT01662310|520899939|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
144465449|NCT01662310|520899940|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
144465450|NCT01662310|520899941|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
144465451|NCT01662310|520899942|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
144465452|NCT01662310|520899938|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
144465453|NCT01662310|520899939|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
144612321|NCT03557281|521442681|FG003|Overall Study|Withdrawal by Subject|1|||
144612322|NCT03557281|521442682|FG004|Overall Study|Withdrawal by Subject|2|||
144465454|NCT01662310|520899940|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
144465455|NCT01662310|520899941|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
144465456|NCT01662310|520899942|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
144465457|NCT01662310|520899938|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
144465458|NCT01662310|520899939|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
144465459|NCT01662310|520899940|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
144465460|NCT01662310|520899941|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
144465461|NCT01662310|520899942|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
144465462|NCT01662310|520899938|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
144465463|NCT01662310|520899939|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
144465464|NCT01662310|520899940|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
144465465|NCT01662310|520899941|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
144465466|NCT01662310|520899942|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
144465467|NCT01662310|520899938|FG000|Run-In or Stabilization Phase|Other|1|||
144465468|NCT01662310|520899939|FG001|Run-In or Stabilization Phase|Other|0|||
144465469|NCT01662310|520899940|FG002|Run-In or Stabilization Phase|Other|0|||
144612323|NCT03557281|521442678|FG000|Overall Study|Randomized, but did not receive treatment|0|||
144612324|NCT03557281|521442679|FG001|Overall Study|Randomized, but did not receive treatment|0|||
144612325|NCT03557281|521442680|FG002|Overall Study|Randomized, but did not receive treatment|0|||
144612326|NCT03557281|521442681|FG003|Overall Study|Randomized, but did not receive treatment|0|||
144612327|NCT03557281|521442682|FG004|Overall Study|Randomized, but did not receive treatment|1|||
144612328|NCT01199042|521442683|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
144612329|NCT01199042|521442683|FG000|At Home (3 Months)|Lost to Follow-up|1|||
144612330|NCT00390546|521442687|FG000|Overall Study|Renal impairment|1|||
144612331|NCT00390546|521442688|FG001|Overall Study|Renal impairment|0|||
144612332|NCT00390546|521442687|FG000|Overall Study|Physician Decision|5|||
144612333|NCT00390546|521442688|FG001|Overall Study|Physician Decision|5|||
144612334|NCT01773109|521442689|FG000|Overall Study|Symptomatic Progression|2|||
144612335|NCT01773109|521442689|FG000|Overall Study|Death|1|||
144612336|NCT01239342|521442690|FG000|Overall Study|Adverse Event|1|||
144612337|NCT01239342|521442691|FG001|Overall Study|Adverse Event|0|||
144612338|NCT01239342|521442690|FG000|Overall Study|Withdrawal by Subject|1|||
144612339|NCT01239342|521442691|FG001|Overall Study|Withdrawal by Subject|5|||
144612340|NCT01239342|521442690|FG000|Overall Study|Reason Unknown|1|||
144612341|NCT01239342|521442691|FG001|Overall Study|Reason Unknown|1|||
144612342|NCT02918864|521442694|FG000|Overall Study|Withdrawal by Subject|1|||
144612343|NCT02918864|521442695|FG001|Overall Study|Withdrawal by Subject|1|||
144612344|NCT02918864|521442694|FG000|Overall Study|Lost to Follow-up|3|||
144612345|NCT02918864|521442695|FG001|Overall Study|Lost to Follow-up|2|||
144612346|NCT02257372|521442701|FG000|Overall Study|Adverse Event|3|||
144612347|NCT02257372|521442702|FG001|Overall Study|Adverse Event|7|||
144612348|NCT02257372|521442701|FG000|Overall Study|Lack of Efficacy|2|||
144612349|NCT02257372|521442702|FG001|Overall Study|Lack of Efficacy|1|||
144612350|NCT02257372|521442701|FG000|Overall Study|Protocol Violation|1|||
144612351|NCT02257372|521442702|FG001|Overall Study|Protocol Violation|1|||
144612352|NCT02257372|521442701|FG000|Overall Study|Lost to Follow-up|0|||
144612353|NCT02257372|521442702|FG001|Overall Study|Lost to Follow-up|1|||
144612354|NCT02257372|521442701|FG000|Overall Study|Withdrew consent|1|||
144612355|NCT02257372|521442702|FG001|Overall Study|Withdrew consent|0|||
144612356|NCT01849874|521442704|FG000|Overall Study|Death|89|||
144612357|NCT01849874|521442705|FG001|Overall Study|Death|42|||
144612358|NCT01849874|521442704|FG000|Overall Study|Withdrawal by Subject|17|||
144465470|NCT01662310|520899941|FG003|Run-In or Stabilization Phase|Other|0|||
144465471|NCT01662310|520899942|FG004|Run-In or Stabilization Phase|Other|0|||
144465472|NCT01662310|520899938|FG000|Double-Blind Phase|Adverse Event|0|||
144612359|NCT01849874|521442705|FG001|Overall Study|Withdrawal by Subject|16|||
144612360|NCT01849874|521442704|FG000|Overall Study|Lost to Follow-up|3|||
144465473|NCT01662310|520899939|FG001|Double-Blind Phase|Adverse Event|0|||
144465474|NCT01662310|520899940|FG002|Double-Blind Phase|Adverse Event|1|||
144465475|NCT01662310|520899941|FG003|Double-Blind Phase|Adverse Event|0|||
144465476|NCT01662310|520899942|FG004|Double-Blind Phase|Adverse Event|0|||
144465477|NCT01662310|520899938|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144612361|NCT01849874|521442705|FG001|Overall Study|Lost to Follow-up|2|||
144612362|NCT01849874|521442704|FG000|Overall Study|Study Termination By Sponsor|93|||
144612363|NCT01849874|521442705|FG001|Overall Study|Study Termination By Sponsor|48|||
144612364|NCT01849874|521442704|FG000|Overall Study|Completed as per protocol amendment 6|3|||
144612365|NCT01849874|521442705|FG001|Overall Study|Completed as per protocol amendment 6|0|||
144465478|NCT01662310|520899939|FG001|Double-Blind Phase|Lost to Follow-up|3|||
144612366|NCT01849874|521442704|FG000|Overall Study|Physician Decision|7|||
144465479|NCT01662310|520899940|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144258259|NCT03092791|520147024|FG005|Overall Study|Study Termination|46|||
144258260|NCT03092791|520147025|FG006|Overall Study|Study Termination|53|||
144258261|NCT03092791|520147026|FG007|Overall Study|Study Termination|55|||
144258262|NCT03092791|520147019|FG000|Overall Study|Death|0|||
144258263|NCT03092791|520147020|FG001|Overall Study|Death|0|||
144258264|NCT03092791|520147021|FG002|Overall Study|Death|0|||
144258265|NCT03092791|520147022|FG003|Overall Study|Death|0|||
144258266|NCT03092791|520147023|FG004|Overall Study|Death|0|||
144258267|NCT03092791|520147024|FG005|Overall Study|Death|1|||
144258268|NCT03092791|520147025|FG006|Overall Study|Death|0|||
144258269|NCT03092791|520147026|FG007|Overall Study|Death|1|||
144258270|NCT03092791|520147019|FG000|Overall Study|Reason Not Specified|0|||
144258271|NCT03092791|520147020|FG001|Overall Study|Reason Not Specified|0|||
144258272|NCT03092791|520147021|FG002|Overall Study|Reason Not Specified|0|||
144258273|NCT03092791|520147022|FG003|Overall Study|Reason Not Specified|0|||
144258274|NCT03092791|520147023|FG004|Overall Study|Reason Not Specified|1|||
144258275|NCT03092791|520147024|FG005|Overall Study|Reason Not Specified|1|||
144258276|NCT03092791|520147025|FG006|Overall Study|Reason Not Specified|0|||
144258277|NCT03092791|520147026|FG007|Overall Study|Reason Not Specified|0|||
144258278|NCT02182830|520147027|FG000|Overall Study|Not Treated|1|||
144258279|NCT02182830|520147028|FG001|Overall Study|Not Treated|1|||
144258280|NCT02182830|520147027|FG000|Overall Study|Trial stopped, reason missing|3|||
144258281|NCT02182830|520147028|FG001|Overall Study|Trial stopped, reason missing|3|||
144258282|NCT02182830|520147027|FG000|Overall Study|Consent withdrawn|8|||
144258283|NCT02182830|520147028|FG001|Overall Study|Consent withdrawn|8|||
144258284|NCT02182830|520147027|FG000|Overall Study|Lost to Follow-up|3|||
144258285|NCT02182830|520147028|FG001|Overall Study|Lost to Follow-up|3|||
144258286|NCT01990768|520147029|FG000|Intervention Started|Found to be ineligible|14|||
144258287|NCT01990768|520147030|FG001|Intervention Started|Found to be ineligible|13|||
144258288|NCT01990768|520147031|FG002|Intervention Started|Found to be ineligible|11|||
144258289|NCT01990768|520147029|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
144258290|NCT01990768|520147030|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
144258291|NCT01990768|520147031|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
144258292|NCT01990768|520147029|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
144258293|NCT01990768|520147030|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
144258294|NCT01990768|520147031|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
144258295|NCT01990768|520147029|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
144258296|NCT01990768|520147030|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
144258297|NCT01990768|520147031|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
144258298|NCT01990768|520147029|FG000|Intervention Started|Patient care priority|1|||
144258299|NCT01990768|520147030|FG001|Intervention Started|Patient care priority|2|||
144258300|NCT01990768|520147031|FG002|Intervention Started|Patient care priority|3|||
144258301|NCT01990768|520147029|FG000|Intervention Started|IV lost|2|||
144258302|NCT01990768|520147030|FG001|Intervention Started|IV lost|2|||
144258303|NCT01990768|520147031|FG002|Intervention Started|IV lost|2|||
144258304|NCT01990768|520147029|FG000|Intervention Started|Required CPR|1|||
144258305|NCT01990768|520147030|FG001|Intervention Started|Required CPR|1|||
144258306|NCT01990768|520147031|FG002|Intervention Started|Required CPR|0|||
144258307|NCT01990768|520147029|FG000|Intervention Started|Seizure or hx of seizure|0|||
144258308|NCT01990768|520147030|FG001|Intervention Started|Seizure or hx of seizure|0|||
144258309|NCT01990768|520147031|FG002|Intervention Started|Seizure or hx of seizure|2|||
144258310|NCT01990768|520147029|FG000|Intervention Started|Discovered to be pregnant|0|||
144258311|NCT01990768|520147030|FG001|Intervention Started|Discovered to be pregnant|1|||
144536398|NCT02500576|521167426|FG001|Overall Study|Lack of Efficacy|5|||
144536399|NCT02500576|521167425|FG000|Overall Study|Withdrawal by Subject|1|||
144536400|NCT02500576|521167426|FG001|Overall Study|Withdrawal by Subject|1|||
144536401|NCT04977583|521168404|FG000|Overall Study|Lost to Follow-up|8|||
144536402|NCT04977583|521168405|FG001|Overall Study|Lost to Follow-up|4|||
144536403|NCT04977583|521168406|FG002|Overall Study|Lost to Follow-up|13|||
144536404|NCT04977583|521168404|FG000|Overall Study|Withdrawal by Subject|3|||
144536405|NCT04977583|521168405|FG001|Overall Study|Withdrawal by Subject|2|||
144536406|NCT04977583|521168406|FG002|Overall Study|Withdrawal by Subject|1|||
144536407|NCT02325466|521168407|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
144536408|NCT02325466|521168408|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
144536409|NCT02325466|521168409|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
144536410|NCT02325466|521168407|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
144536411|NCT02325466|521168408|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
144536412|NCT02325466|521168409|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
144536413|NCT02325466|521168407|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
144536414|NCT02325466|521168408|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
144536415|NCT02325466|521168409|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
144536416|NCT02325466|521168407|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
144536417|NCT02325466|521168408|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
144465480|NCT01662310|520899941|FG003|Double-Blind Phase|Lost to Follow-up|0|||
144465481|NCT01662310|520899942|FG004|Double-Blind Phase|Lost to Follow-up|0|||
144612367|NCT01849874|521442705|FG001|Overall Study|Physician Decision|1|||
144726088|NCT00950807|521852691|FG006|Treatment Period 1|Adverse Event|0|||
144726089|NCT00950807|521852692|FG007|Treatment Period 1|Adverse Event|0|||
144726090|NCT00950807|521852693|FG008|Treatment Period 1|Adverse Event|0|||
144726091|NCT00950807|521852694|FG009|Treatment Period 1|Adverse Event|0|||
144726092|NCT00950807|521852685|FG000|Washout Period 1|Lack of Efficacy|0|||
144726093|NCT00950807|521852686|FG001|Washout Period 1|Lack of Efficacy|0|||
144726094|NCT00950807|521852687|FG002|Washout Period 1|Lack of Efficacy|0|||
144726095|NCT00950807|521852688|FG003|Washout Period 1|Lack of Efficacy|0|||
144726096|NCT00950807|521852689|FG004|Washout Period 1|Lack of Efficacy|0|||
144726097|NCT00950807|521852690|FG005|Washout Period 1|Lack of Efficacy|0|||
144726098|NCT00950807|521852691|FG006|Washout Period 1|Lack of Efficacy|1|||
144726099|NCT00950807|521852692|FG007|Washout Period 1|Lack of Efficacy|0|||
144726100|NCT00950807|521852693|FG008|Washout Period 1|Lack of Efficacy|0|||
144726101|NCT00950807|521852694|FG009|Washout Period 1|Lack of Efficacy|0|||
144726102|NCT00950807|521852685|FG000|Washout Period 1|Withdrawal by Subject|0|||
144726103|NCT00950807|521852686|FG001|Washout Period 1|Withdrawal by Subject|0|||
144726104|NCT00950807|521852687|FG002|Washout Period 1|Withdrawal by Subject|0|||
144726105|NCT00950807|521852688|FG003|Washout Period 1|Withdrawal by Subject|0|||
144726106|NCT00950807|521852689|FG004|Washout Period 1|Withdrawal by Subject|0|||
144726107|NCT00950807|521852690|FG005|Washout Period 1|Withdrawal by Subject|0|||
144726108|NCT00950807|521852691|FG006|Washout Period 1|Withdrawal by Subject|0|||
144726109|NCT00950807|521852692|FG007|Washout Period 1|Withdrawal by Subject|0|||
144726110|NCT00950807|521852693|FG008|Washout Period 1|Withdrawal by Subject|1|||
144726111|NCT00950807|521852694|FG009|Washout Period 1|Withdrawal by Subject|0|||
144726112|NCT00950807|521852685|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
144726113|NCT00950807|521852686|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144612368|NCT01849874|521442704|FG000|Overall Study|Other|16|||
144612369|NCT01849874|521442705|FG001|Overall Study|Other|4|||
144612370|NCT02104583|521442706|FG000|Overall Study|New ICD or CRT-D implanted|2|||
144612371|NCT02104583|521442707|FG001|Overall Study|New ICD or CRT-D implanted|0|||
144612372|NCT02104583|521442708|FG002|Overall Study|New ICD or CRT-D implanted|1|||
144612373|NCT02104583|521442709|FG003|Overall Study|New ICD or CRT-D implanted|0|||
144612374|NCT02104583|521442710|FG004|Overall Study|New ICD or CRT-D implanted|0|||
144612375|NCT02104583|521442706|FG000|Overall Study|Death|2|||
144612376|NCT02104583|521442707|FG001|Overall Study|Death|1|||
144612377|NCT02104583|521442708|FG002|Overall Study|Death|3|||
144612378|NCT02104583|521442709|FG003|Overall Study|Death|3|||
144612379|NCT02104583|521442710|FG004|Overall Study|Death|5|||
144612380|NCT02104583|521442706|FG000|Overall Study|Subject required cardiac ablation|6|||
144612381|NCT02104583|521442707|FG001|Overall Study|Subject required cardiac ablation|4|||
144612382|NCT02104583|521442708|FG002|Overall Study|Subject required cardiac ablation|4|||
144612383|NCT02104583|521442709|FG003|Overall Study|Subject required cardiac ablation|5|||
144612384|NCT02104583|521442710|FG004|Overall Study|Subject required cardiac ablation|4|||
144612385|NCT02104583|521442706|FG000|Overall Study|Subject required prohibited medication|0|||
144612386|NCT02104583|521442707|FG001|Overall Study|Subject required prohibited medication|1|||
144612387|NCT02104583|521442708|FG002|Overall Study|Subject required prohibited medication|1|||
144612388|NCT02104583|521442709|FG003|Overall Study|Subject required prohibited medication|0|||
144612389|NCT02104583|521442710|FG004|Overall Study|Subject required prohibited medication|1|||
144612390|NCT02104583|521442706|FG000|Overall Study|Withdrew Consent|3|||
144612391|NCT02104583|521442707|FG001|Overall Study|Withdrew Consent|2|||
144612392|NCT02104583|521442708|FG002|Overall Study|Withdrew Consent|0|||
144612393|NCT02104583|521442709|FG003|Overall Study|Withdrew Consent|2|||
144612394|NCT02104583|521442710|FG004|Overall Study|Withdrew Consent|1|||
144612395|NCT02104583|521442706|FG000|Overall Study|Investigator's Discretion|1|||
144612396|NCT02104583|521442707|FG001|Overall Study|Investigator's Discretion|0|||
144612397|NCT02104583|521442708|FG002|Overall Study|Investigator's Discretion|0|||
144612398|NCT02104583|521442709|FG003|Overall Study|Investigator's Discretion|0|||
144612399|NCT02104583|521442710|FG004|Overall Study|Investigator's Discretion|0|||
144612400|NCT02104583|521442706|FG000|Overall Study|Protocol Violation|0|||
144612401|NCT02104583|521442707|FG001|Overall Study|Protocol Violation|0|||
144612402|NCT02104583|521442708|FG002|Overall Study|Protocol Violation|1|||
144612403|NCT02104583|521442709|FG003|Overall Study|Protocol Violation|0|||
144726114|NCT00950807|521852687|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144726115|NCT00950807|521852688|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144726116|NCT00950807|521852689|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144726117|NCT00950807|521852690|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144465482|NCT01662310|520899938|FG000|Double-Blind Phase|Pregnancy|0|||
144612404|NCT02104583|521442710|FG004|Overall Study|Protocol Violation|0|||
144612405|NCT02104583|521442706|FG000|Overall Study|Adverse Event|3|||
144612406|NCT02104583|521442707|FG001|Overall Study|Adverse Event|3|||
144612407|NCT02104583|521442708|FG002|Overall Study|Adverse Event|6|||
144612408|NCT02104583|521442709|FG003|Overall Study|Adverse Event|6|||
144612409|NCT02104583|521442710|FG004|Overall Study|Adverse Event|1|||
144612410|NCT02104583|521442706|FG000|Overall Study|Lost to Follow-up|1|||
144465483|NCT01662310|520899939|FG001|Double-Blind Phase|Pregnancy|2|||
144465484|NCT01662310|520899940|FG002|Double-Blind Phase|Pregnancy|0|||
144465485|NCT01662310|520899941|FG003|Double-Blind Phase|Pregnancy|0|||
144465486|NCT01662310|520899942|FG004|Double-Blind Phase|Pregnancy|0|||
144465487|NCT01662310|520899938|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
144465488|NCT01662310|520899939|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
144465489|NCT01662310|520899940|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
144465490|NCT01662310|520899941|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144465491|NCT01662310|520899942|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
144465492|NCT01662310|520899938|FG000|Double-Blind Phase|Other|0|||
144465493|NCT01662310|520899939|FG001|Double-Blind Phase|Other|0|||
144465494|NCT01662310|520899940|FG002|Double-Blind Phase|Other|1|||
144465495|NCT01662310|520899941|FG003|Double-Blind Phase|Other|0|||
144465496|NCT01662310|520899942|FG004|Double-Blind Phase|Other|0|||
144465497|NCT01662310|520899938|FG000|Double-Blind Phase|Randomized but not treated|0|||
144465498|NCT01662310|520899939|FG001|Double-Blind Phase|Randomized but not treated|1|||
144465499|NCT01662310|520899940|FG002|Double-Blind Phase|Randomized but not treated|0|||
144465500|NCT01662310|520899941|FG003|Double-Blind Phase|Randomized but not treated|0|||
144465501|NCT01662310|520899942|FG004|Double-Blind Phase|Randomized but not treated|0|||
144465502|NCT01662310|520899938|FG000|Open-Label Extension Phase|Adverse Event|0|||
144465503|NCT01662310|520899939|FG001|Open-Label Extension Phase|Adverse Event|0|||
144612411|NCT02104583|521442707|FG001|Overall Study|Lost to Follow-up|0|||
144726118|NCT00950807|521852691|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
144612412|NCT02104583|521442708|FG002|Overall Study|Lost to Follow-up|0|||
144612413|NCT02104583|521442709|FG003|Overall Study|Lost to Follow-up|0|||
144612414|NCT02104583|521442710|FG004|Overall Study|Lost to Follow-up|0|||
144612415|NCT02104583|521442706|FG000|Overall Study|Randomized but Never Treated|0|||
144612416|NCT02104583|521442707|FG001|Overall Study|Randomized but Never Treated|0|||
144612417|NCT02104583|521442708|FG002|Overall Study|Randomized but Never Treated|0|||
144612418|NCT02104583|521442709|FG003|Overall Study|Randomized but Never Treated|1|||
144612419|NCT02104583|521442710|FG004|Overall Study|Randomized but Never Treated|0|||
144612420|NCT04329702|521442713|FG000|Overall Study|illness|3|||
144612421|NCT04329702|521442714|FG001|Overall Study|illness|4|||
144612422|NCT04329702|521442715|FG002|Overall Study|illness|0|||
144612423|NCT04329702|521442713|FG000|Overall Study|Lost to Follow-up|0|||
144612424|NCT04329702|521442714|FG001|Overall Study|Lost to Follow-up|0|||
144612425|NCT04329702|521442715|FG002|Overall Study|Lost to Follow-up|2|||
144612426|NCT04329702|521442713|FG000|Overall Study|Death|0|||
144612427|NCT04329702|521442714|FG001|Overall Study|Death|2|||
144612428|NCT04329702|521442715|FG002|Overall Study|Death|0|||
144612429|NCT01438489|521442716|FG000|Overall Study|Lost to Follow-up|4|||
144612430|NCT01438489|521442717|FG001|Overall Study|Lost to Follow-up|2|||
144612431|NCT01438489|521442718|FG002|Overall Study|Lost to Follow-up|2|||
144612432|NCT01438489|521442716|FG000|Overall Study|Withdrawal by Subject|11|||
144612433|NCT01438489|521442717|FG001|Overall Study|Withdrawal by Subject|3|||
144612434|NCT01438489|521442718|FG002|Overall Study|Withdrawal by Subject|8|||
144612435|NCT01438489|521442716|FG000|Overall Study|Death|0|||
144612436|NCT01438489|521442717|FG001|Overall Study|Death|0|||
144612437|NCT01438489|521442718|FG002|Overall Study|Death|1|||
144612438|NCT01438489|521442716|FG000|Overall Study|Sponsor decision|4|||
144612439|NCT01438489|521442717|FG001|Overall Study|Sponsor decision|1|||
144612440|NCT01438489|521442718|FG002|Overall Study|Sponsor decision|4|||
144612441|NCT01438489|521442716|FG000|Overall Study|Subject choice/Subject moved|2|||
144612442|NCT01438489|521442717|FG001|Overall Study|Subject choice/Subject moved|1|||
144612443|NCT01438489|521442718|FG002|Overall Study|Subject choice/Subject moved|1|||
144612444|NCT01438489|521442716|FG000|Overall Study|Investigator decision|0|||
144612445|NCT01438489|521442717|FG001|Overall Study|Investigator decision|1|||
144612446|NCT01438489|521442718|FG002|Overall Study|Investigator decision|0|||
144612447|NCT01438489|521442716|FG000|Overall Study|AE/SAEs|2|||
144612448|NCT01438489|521442717|FG001|Overall Study|AE/SAEs|1|||
144612449|NCT01438489|521442718|FG002|Overall Study|AE/SAEs|1|||
144612450|NCT01438489|521442716|FG000|Overall Study|Received prohibited medication|1|||
144612451|NCT01438489|521442717|FG001|Overall Study|Received prohibited medication|0|||
144612452|NCT01438489|521442718|FG002|Overall Study|Received prohibited medication|0|||
144612453|NCT01438489|521442716|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
144612454|NCT01438489|521442717|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
144612455|NCT01438489|521442718|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
144465504|NCT01662310|520899940|FG002|Open-Label Extension Phase|Adverse Event|0|||
144465505|NCT01662310|520899941|FG003|Open-Label Extension Phase|Adverse Event|3|||
144465506|NCT01662310|520899942|FG004|Open-Label Extension Phase|Adverse Event|0|||
144612456|NCT01438489|521442716|FG000|Overall Study|Inadequate venous access|0|||
144612457|NCT01438489|521442717|FG001|Overall Study|Inadequate venous access|2|||
144612458|NCT01438489|521442718|FG002|Overall Study|Inadequate venous access|0|||
144465507|NCT01662310|520899938|FG000|Open-Label Extension Phase|Death|0|||
144465508|NCT01662310|520899939|FG001|Open-Label Extension Phase|Death|0|||
144465509|NCT01662310|520899940|FG002|Open-Label Extension Phase|Death|0|||
144258312|NCT01990768|520147031|FG002|Intervention Started|Discovered to be pregnant|0|||
144258313|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
144258314|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
144465510|NCT01662310|520899941|FG003|Open-Label Extension Phase|Death|1|||
144465511|NCT01662310|520899942|FG004|Open-Label Extension Phase|Death|0|||
144465512|NCT01662310|520899938|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
144465513|NCT01662310|520899939|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
144465514|NCT01662310|520899940|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
144465515|NCT01662310|520899941|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
144465516|NCT01662310|520899942|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
144465517|NCT01662310|520899938|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
144465518|NCT01662310|520899939|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
144465519|NCT01662310|520899940|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
144465520|NCT01662310|520899941|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
144465521|NCT01662310|520899942|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
144465522|NCT01662310|520899938|FG000|Open-Label Extension Phase|Pregnancy|0|||
144465523|NCT01662310|520899939|FG001|Open-Label Extension Phase|Pregnancy|0|||
144465524|NCT01662310|520899940|FG002|Open-Label Extension Phase|Pregnancy|0|||
144465525|NCT01662310|520899941|FG003|Open-Label Extension Phase|Pregnancy|1|||
144465526|NCT01662310|520899942|FG004|Open-Label Extension Phase|Pregnancy|0|||
144465527|NCT01662310|520899938|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
144465528|NCT01662310|520899939|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
144465529|NCT01662310|520899940|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
144465530|NCT01662310|520899941|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
144465531|NCT01662310|520899942|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
144465532|NCT02432105|520899943|FG000|Overall Study|Lost to Follow-up|1|||
144465533|NCT02432105|520899944|FG001|Overall Study|Lost to Follow-up|1|||
144465534|NCT02432105|520899945|FG002|Overall Study|Lost to Follow-up|0|||
144465535|NCT02432105|520899943|FG000|Overall Study|Withdrawal by Subject|1|||
144465536|NCT02432105|520899944|FG001|Overall Study|Withdrawal by Subject|0|||
144465537|NCT02432105|520899945|FG002|Overall Study|Withdrawal by Subject|1|||
144465538|NCT02432105|520899943|FG000|Overall Study|Culture positive for yeast|0|||
144465539|NCT02432105|520899944|FG001|Overall Study|Culture positive for yeast|1|||
144465540|NCT02432105|520899945|FG002|Overall Study|Culture positive for yeast|0|||
144465541|NCT02432105|520899943|FG000|Overall Study|Randomized in error|0|||
144465542|NCT02432105|520899944|FG001|Overall Study|Randomized in error|0|||
144465543|NCT02432105|520899945|FG002|Overall Study|Randomized in error|2|||
144465544|NCT04302350|520899948|FG000|Overall Study|Physician Decision|1|||
144465545|NCT04302350|520899949|FG001|Overall Study|Physician Decision|1|||
144465546|NCT04302350|520899950|FG002|Overall Study|Physician Decision|2|||
144465547|NCT04302350|520899948|FG000|Overall Study|Lack of Efficacy|1|||
144465548|NCT04302350|520899949|FG001|Overall Study|Lack of Efficacy|1|||
144465549|NCT04302350|520899950|FG002|Overall Study|Lack of Efficacy|4|||
144465550|NCT04302350|520899948|FG000|Overall Study|Adverse Event|0|||
144465551|NCT04302350|520899949|FG001|Overall Study|Adverse Event|1|||
144465552|NCT04302350|520899950|FG002|Overall Study|Adverse Event|2|||
144465553|NCT02012491|520899953|FG000|Overall Study|Lost to Follow-up|1|||
144465554|NCT02012491|520899954|FG001|Overall Study|Lost to Follow-up|0|||
144465555|NCT02012491|520899953|FG000|Overall Study|Protocol Violation|0|||
144465556|NCT02012491|520899954|FG001|Overall Study|Protocol Violation|1|||
144465557|NCT02012491|520899953|FG000|Overall Study|Withdrawal by Subject|1|||
144465558|NCT02012491|520899954|FG001|Overall Study|Withdrawal by Subject|0|||
144465559|NCT01400503|520899965|FG000|Overall Study|Withdrawal by Subject|1|||
144465560|NCT01400503|520899965|FG000|Overall Study|Study Terminated by Sponsor|58|||
144465561|NCT01400503|520899965|FG000|Overall Study|Other|1|||
144465562|NCT01212770|520899966|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
144465563|NCT01212770|520899967|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
144258315|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
144258316|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
144258317|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
144258318|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
144465564|NCT01212770|520899968|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
144465565|NCT01212770|520899969|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144465566|NCT01212770|520899970|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144465567|NCT01212770|520899971|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144465568|NCT01212770|520899972|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144465569|NCT01212770|520899973|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144465570|NCT01212770|520899974|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144465571|NCT01212770|520899966|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
144465572|NCT01212770|520899967|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
144465573|NCT01212770|520899968|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
144465574|NCT01212770|520899969|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144612459|NCT00766532|521442719|FG000|Overall Study|Protocol Violation|2|||
144612460|NCT01476475|521442721|FG000|Overall Study|Adverse Event|6|||
144612461|NCT01476475|521442722|FG001|Overall Study|Adverse Event|0|||
144612462|NCT01476475|521442721|FG000|Overall Study|Poor compliance to protocol|1|||
144612463|NCT01476475|521442722|FG001|Overall Study|Poor compliance to protocol|1|||
144612464|NCT01476475|521442721|FG000|Overall Study|Other reasons|4|||
144612465|NCT01476475|521442722|FG001|Overall Study|Other reasons|2|||
144612466|NCT00751400|521442725|FG000|Overall Study|Lost to Follow-up|10|||
144612467|NCT01372384|521442729|FG000|Overall Study|Progression of disease|3|||
144612468|NCT00661531|521442735|FG000|Overall Study|Withdrawal by Subject|3|||
144612469|NCT03134599|521442736|FG000|Week 1|Lost to Follow-up|0|||
144726119|NCT00950807|521852692|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
144612470|NCT03134599|521442737|FG001|Week 1|Lost to Follow-up|0|||
144612471|NCT03134599|521442738|FG002|Week 1|Lost to Follow-up|0|||
144612472|NCT03134599|521442739|FG003|Week 1|Lost to Follow-up|0|||
144612473|NCT03134599|521442740|FG004|Week 1|Lost to Follow-up|1|||
144612474|NCT03134599|521442741|FG005|Week 1|Lost to Follow-up|0|||
144612475|NCT03134599|521442736|FG000|Week 2|Lost to Follow-up|1|||
144612476|NCT03134599|521442737|FG001|Week 2|Lost to Follow-up|0|||
144612477|NCT03134599|521442738|FG002|Week 2|Lost to Follow-up|0|||
144726120|NCT00950807|521852693|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144726121|NCT00950807|521852694|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
144726122|NCT00950807|521852685|FG000|Washout Period 1|Adverse Event|2|||
144726123|NCT00950807|521852686|FG001|Washout Period 1|Adverse Event|0|||
144726124|NCT00950807|521852687|FG002|Washout Period 1|Adverse Event|0|||
144612478|NCT03134599|521442739|FG003|Week 2|Lost to Follow-up|1|||
144612479|NCT03134599|521442740|FG004|Week 2|Lost to Follow-up|1|||
144612480|NCT03134599|521442741|FG005|Week 2|Lost to Follow-up|0|||
144612481|NCT03134599|521442736|FG000|Week 3|Lost to Follow-up|0|||
144612482|NCT03134599|521442737|FG001|Week 3|Lost to Follow-up|0|||
144612483|NCT03134599|521442738|FG002|Week 3|Lost to Follow-up|0|||
144612484|NCT03134599|521442739|FG003|Week 3|Lost to Follow-up|1|||
144612485|NCT03134599|521442740|FG004|Week 3|Lost to Follow-up|0|||
144612486|NCT03134599|521442741|FG005|Week 3|Lost to Follow-up|1|||
144612487|NCT01265615|521442742|FG000|Overall Study|Protocol Violation|2|||
144612488|NCT01265615|521442743|FG001|Overall Study|Protocol Violation|2|||
144612489|NCT01265615|521442744|FG002|Overall Study|Protocol Violation|4|||
144612490|NCT01265615|521442745|FG003|Overall Study|Protocol Violation|3|||
144612491|NCT02576444|521442746|FG000|Overall Study|Death|1|||
144612492|NCT02576444|521442747|FG001|Overall Study|Death|1|||
144612493|NCT02576444|521442748|FG002|Overall Study|Death|0|||
144612494|NCT02576444|521442749|FG003|Overall Study|Death|0|||
144726125|NCT00950807|521852688|FG003|Washout Period 1|Adverse Event|1|||
144726126|NCT00950807|521852689|FG004|Washout Period 1|Adverse Event|1|||
144612495|NCT02576444|521442746|FG000|Overall Study|Withdrawal by Subject|0|||
144612496|NCT02576444|521442747|FG001|Overall Study|Withdrawal by Subject|0|||
144612497|NCT02576444|521442748|FG002|Overall Study|Withdrawal by Subject|2|||
144612498|NCT02576444|521442749|FG003|Overall Study|Withdrawal by Subject|0|||
144612499|NCT02576444|521442746|FG000|Overall Study|Adverse Event|0|||
144612500|NCT02576444|521442747|FG001|Overall Study|Adverse Event|0|||
144612501|NCT02576444|521442748|FG002|Overall Study|Adverse Event|1|||
144612502|NCT02576444|521442749|FG003|Overall Study|Adverse Event|0|||
144612503|NCT02576444|521442746|FG000|Overall Study|Physician Decision|0|||
144612504|NCT02576444|521442747|FG001|Overall Study|Physician Decision|0|||
144726127|NCT00950807|521852690|FG005|Washout Period 1|Adverse Event|0|||
144726128|NCT00950807|521852691|FG006|Washout Period 1|Adverse Event|0|||
144726129|NCT00950807|521852692|FG007|Washout Period 1|Adverse Event|0|||
144197244|NCT01000493|519918716|FG001|Overall Study|Lost to Follow-up|9|||
144197245|NCT01000493|519918715|FG000|Overall Study|Physician Decision|1|||
144197246|NCT01000493|519918716|FG001|Overall Study|Physician Decision|1|||
144197247|NCT01000493|519918715|FG000|Overall Study|Withdrawal by Subject|3|||
144197248|NCT01000493|519918716|FG001|Overall Study|Withdrawal by Subject|7|||
144197249|NCT03097588|519918725|FG000|Overall Study|Adverse Event|1|||
144197250|NCT01144364|519918728|FG000|Induction Phase|Disease progression|14|||
144197251|NCT01144364|519918729|FG001|Induction Phase|Disease progression|0|||
144197252|NCT01144364|519918730|FG002|Induction Phase|Disease progression|0|||
144197253|NCT01144364|519918728|FG000|Induction Phase|Adverse Event|9|||
144197254|NCT01144364|519918729|FG001|Induction Phase|Adverse Event|0|||
144197255|NCT01144364|519918730|FG002|Induction Phase|Adverse Event|0|||
144197256|NCT01144364|519918728|FG000|Induction Phase|Death|1|||
144197257|NCT01144364|519918729|FG001|Induction Phase|Death|0|||
144197258|NCT01144364|519918730|FG002|Induction Phase|Death|0|||
144197259|NCT01144364|519918728|FG000|Induction Phase|Withdrawal by Subject|1|||
144197260|NCT01144364|519918729|FG001|Induction Phase|Withdrawal by Subject|0|||
144197261|NCT01144364|519918730|FG002|Induction Phase|Withdrawal by Subject|0|||
144197262|NCT01144364|519918728|FG000|Induction Phase|Lost to Follow-up|2|||
144197263|NCT01144364|519918729|FG001|Induction Phase|Lost to Follow-up|0|||
144197264|NCT01144364|519918730|FG002|Induction Phase|Lost to Follow-up|0|||
144197265|NCT01144364|519918728|FG000|Induction Phase|Physician Decision|1|||
144197266|NCT01144364|519918729|FG001|Induction Phase|Physician Decision|0|||
144197267|NCT01144364|519918730|FG002|Induction Phase|Physician Decision|0|||
144258319|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
144258320|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
144258321|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
144258322|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
144258323|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
144258324|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
144258325|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Death|3|||
144258326|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Death|1|||
144258327|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Death|1|||
144258328|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Discharged|2|||
144258329|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Discharged|1|||
144258330|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Discharged|0|||
144258331|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
144258332|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
144258333|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
144258334|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
144258335|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
144258336|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
144258337|NCT01990768|520147029|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
144258338|NCT01990768|520147030|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
144258339|NCT01990768|520147031|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
144258340|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
144258341|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
144258342|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
144258343|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
144258344|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
144258345|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
144258346|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
144258347|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
144258348|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
144258349|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
144258350|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
144258351|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
144612505|NCT02576444|521442748|FG002|Overall Study|Physician Decision|1|||
144612506|NCT02576444|521442749|FG003|Overall Study|Physician Decision|0|||
144612507|NCT04206020|521442752|FG000|Overall Study|Adverse Event|1|||
144612508|NCT04206020|521442753|FG001|Overall Study|Adverse Event|4|||
144612509|NCT04206020|521442752|FG000|Overall Study|Protocol Violation|2|||
144612510|NCT04206020|521442753|FG001|Overall Study|Protocol Violation|0|||
144612511|NCT04206020|521442752|FG000|Overall Study|Withdrawal by Subject|2|||
144612512|NCT04206020|521442753|FG001|Overall Study|Withdrawal by Subject|0|||
144612513|NCT04206020|521442752|FG000|Overall Study|Lost to Follow-up|2|||
144612514|NCT04206020|521442753|FG001|Overall Study|Lost to Follow-up|0|||
144197268|NCT01144364|519918728|FG000|Induction Phase|Stable disease|2|||
144197269|NCT01144364|519918729|FG001|Induction Phase|Stable disease|0|||
144197270|NCT01144364|519918730|FG002|Induction Phase|Stable disease|0|||
144197271|NCT01144364|519918728|FG000|Induction Phase|Secondary neoplasia|1|||
144197272|NCT01144364|519918729|FG001|Induction Phase|Secondary neoplasia|0|||
144197273|NCT01144364|519918730|FG002|Induction Phase|Secondary neoplasia|0|||
144197274|NCT01144364|519918728|FG000|Induction Phase|Protocol Violation|1|||
144197275|NCT01144364|519918729|FG001|Induction Phase|Protocol Violation|0|||
144197276|NCT01144364|519918730|FG002|Induction Phase|Protocol Violation|0|||
144197277|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
144197278|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
144197279|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
144197280|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
144197281|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
144197282|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
144197283|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Death|0|||
144197284|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Death|2|||
144197285|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Death|0|||
144197286|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
144258352|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
144258353|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
144258354|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
144612515|NCT04206020|521442752|FG000|Overall Study|Pregnancy|0|||
144612516|NCT04206020|521442753|FG001|Overall Study|Pregnancy|1|||
144612517|NCT04206020|521442752|FG000|Overall Study|Unable to attend visits|1|||
144612518|NCT04206020|521442753|FG001|Overall Study|Unable to attend visits|2|||
144612519|NCT02700412|521442754|FG000|Overall Study|Adverse Event|6|||
144197287|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
144197288|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
144612520|NCT02700412|521442754|FG000|Overall Study|Death|1|||
144612521|NCT02700412|521442754|FG000|Overall Study|Lack of Efficacy|19|||
144612522|NCT02700412|521442754|FG000|Overall Study|Protocol Violation|5|||
144612523|NCT02700412|521442754|FG000|Overall Study|Withdrawal by Subject|2|||
144612524|NCT04416555|521442755|FG000|Overall Study|Withdrawal by Subject|0|||
144612525|NCT04416555|521442756|FG001|Overall Study|Withdrawal by Subject|3|||
144612526|NCT01356407|521442763|FG000|Overall Study|Lost to Follow-up|2|||
144612527|NCT01356407|521442764|FG001|Overall Study|Lost to Follow-up|0|||
144612528|NCT01356407|521442763|FG000|Overall Study|Patient Withdrew Consent|2|||
144612529|NCT01356407|521442764|FG001|Overall Study|Patient Withdrew Consent|1|||
144612530|NCT01356407|521442763|FG000|Overall Study|Could not afford IMP administration|0|||
144612531|NCT01356407|521442764|FG001|Overall Study|Could not afford IMP administration|1|||
144612532|NCT01356407|521442763|FG000|Overall Study|Not complete Endoscopy|2|||
144612533|NCT01356407|521442764|FG001|Overall Study|Not complete Endoscopy|2|||
144612534|NCT02018822|521442765|FG000|Overall Study|filling replaced by crown|0|||
144612535|NCT02018822|521442766|FG001|Overall Study|filling replaced by crown|1|||
144612536|NCT02018822|521442767|FG002|Overall Study|filling replaced by crown|0|||
144612537|NCT02018822|521442765|FG000|Overall Study|Physician Decision|0|||
144612538|NCT02018822|521442766|FG001|Overall Study|Physician Decision|1|||
144612539|NCT02018822|521442767|FG002|Overall Study|Physician Decision|1|||
144612540|NCT02018822|521442765|FG000|Overall Study|Lost to Follow-up|6|||
144612541|NCT02018822|521442766|FG001|Overall Study|Lost to Follow-up|6|||
144612542|NCT02018822|521442767|FG002|Overall Study|Lost to Follow-up|5|||
144612543|NCT03201458|521442768|FG000|Overall Study|No longer eligible|2|||
144612544|NCT03201458|521442769|FG001|Overall Study|No longer eligible|5|||
144197289|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
144197290|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
144197291|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
144197292|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
144612545|NCT03201458|521442768|FG000|Overall Study|Health event before starting|1|||
144612546|NCT03201458|521442769|FG001|Overall Study|Health event before starting|0|||
144197293|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
144197294|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
144197295|NCT01144364|519918728|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
144197296|NCT01144364|519918729|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
144197297|NCT01144364|519918730|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
144197298|NCT03456960|519918731|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144197299|NCT03456960|519918732|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144197300|NCT03456960|519918733|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
144197301|NCT03456960|519918734|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
144197302|NCT03456960|519918735|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144197303|NCT03456960|519918736|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
144197304|NCT03456960|519918731|FG000|Period 2 (1 Day)|Adverse Event|1|||
144197305|NCT03456960|519918732|FG001|Period 2 (1 Day)|Adverse Event|0|||
144197306|NCT03456960|519918733|FG002|Period 2 (1 Day)|Adverse Event|0|||
144197307|NCT03456960|519918734|FG003|Period 2 (1 Day)|Adverse Event|1|||
144197308|NCT03456960|519918735|FG004|Period 2 (1 Day)|Adverse Event|0|||
144197309|NCT03456960|519918736|FG005|Period 2 (1 Day)|Adverse Event|0|||
144197310|NCT02989168|519918737|FG000|Overall Study|Withdrawal by Subject|2|||
144197311|NCT02989168|519918738|FG001|Overall Study|Withdrawal by Subject|0|||
144197312|NCT02989168|519918737|FG000|Overall Study|Physician Decision|0|||
144197313|NCT02989168|519918738|FG001|Overall Study|Physician Decision|1|||
144197314|NCT02989168|519918737|FG000|Overall Study|Adverse Event|1|||
144197315|NCT02989168|519918738|FG001|Overall Study|Adverse Event|2|||
144197316|NCT02989168|519918737|FG000|Overall Study|Sponsor stopped study.|1|||
144197317|NCT02989168|519918738|FG001|Overall Study|Sponsor stopped study.|0|||
144197318|NCT03828448|519918741|FG000|Overall Study|Sponsor's Discretion|34|||
144197319|NCT00532935|519918742|FG000|Overall Study|Adverse Event|11|||
144197320|NCT00532935|519918743|FG001|Overall Study|Adverse Event|12|||
144197321|NCT00532935|519918742|FG000|Overall Study|Lack of Efficacy|0|||
144197322|NCT00532935|519918743|FG001|Overall Study|Lack of Efficacy|3|||
144197323|NCT00532935|519918742|FG000|Overall Study|Lost to Follow-up|10|||
144197324|NCT00532935|519918743|FG001|Overall Study|Lost to Follow-up|6|||
144612547|NCT03201458|521442768|FG000|Overall Study|Physician Decision|1|||
144197325|NCT00532935|519918742|FG000|Overall Study|Physician Decision|4|||
144197326|NCT00532935|519918743|FG001|Overall Study|Physician Decision|5|||
144197327|NCT00532935|519918742|FG000|Overall Study|Pregnancy|1|||
144197328|NCT00532935|519918743|FG001|Overall Study|Pregnancy|0|||
144258355|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
144197329|NCT00532935|519918742|FG000|Overall Study|Protocol Violation|4|||
144197330|NCT00532935|519918743|FG001|Overall Study|Protocol Violation|2|||
144197331|NCT00532935|519918742|FG000|Overall Study|Withdrawal by Subject|10|||
144197332|NCT00532935|519918743|FG001|Overall Study|Withdrawal by Subject|9|||
144612548|NCT03201458|521442769|FG001|Overall Study|Physician Decision|0|||
144612549|NCT00715026|521442770|FG000|Overall Study|Withdrawal by Subject|5|||
144612550|NCT00715026|521442770|FG000|Overall Study|Lost to Follow-up|3|||
144465575|NCT01212770|520899970|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144465576|NCT01212770|520899971|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144465577|NCT01212770|520899972|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144465578|NCT01212770|520899973|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144465579|NCT01212770|520899974|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144465580|NCT01212770|520899966|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
144465581|NCT01212770|520899967|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
144465582|NCT01212770|520899968|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
144465583|NCT01212770|520899969|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144465584|NCT01212770|520899970|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144465585|NCT01212770|520899971|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144465586|NCT01212770|520899972|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144465587|NCT01212770|520899973|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144465588|NCT01212770|520899974|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144465589|NCT01212770|520899966|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
144465590|NCT01212770|520899967|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465591|NCT01212770|520899968|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
144465592|NCT01212770|520899969|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465593|NCT01212770|520899970|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465594|NCT01212770|520899971|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465595|NCT01212770|520899972|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465596|NCT01212770|520899973|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465597|NCT01212770|520899974|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144465598|NCT01212770|520899966|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465599|NCT01212770|520899967|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465600|NCT01212770|520899968|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
144465601|NCT01212770|520899969|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465602|NCT01212770|520899970|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465603|NCT01212770|520899971|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465604|NCT01212770|520899972|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465605|NCT01212770|520899973|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465606|NCT01212770|520899974|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144465607|NCT01212770|520899966|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
144465608|NCT01212770|520899967|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
144465609|NCT01212770|520899968|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
144465610|NCT01212770|520899969|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
144465611|NCT01212770|520899970|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
144465612|NCT01212770|520899971|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
144465613|NCT01212770|520899972|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
144465614|NCT01212770|520899973|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
144465615|NCT01212770|520899974|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
144612551|NCT00715026|521442770|FG000|Overall Study|Protocol Violation|1|||
144612552|NCT00715026|521442770|FG000|Overall Study|Surgery done on non-study consented hip|1|||
144612553|NCT02614859|521442771|FG000|Overall Study|Physician Decision|0|||
144612554|NCT02614859|521442772|FG001|Overall Study|Physician Decision|1|||
144612555|NCT03259074|521442774|FG000|Overall Study|Adverse Event|9|||
144612556|NCT03259074|521442775|FG001|Overall Study|Adverse Event|12|||
144612557|NCT03259074|521442776|FG002|Overall Study|Adverse Event|8|||
144612558|NCT03259074|521442774|FG000|Overall Study|Death|1|||
144612559|NCT03259074|521442775|FG001|Overall Study|Death|1|||
144612560|NCT03259074|521442776|FG002|Overall Study|Death|3|||
144612561|NCT03259074|521442774|FG000|Overall Study|Lost to Follow-up|2|||
144612562|NCT03259074|521442775|FG001|Overall Study|Lost to Follow-up|4|||
144612563|NCT03259074|521442776|FG002|Overall Study|Lost to Follow-up|3|||
144612564|NCT03259074|521442774|FG000|Overall Study|New Therapy For Study Indication|1|||
144612565|NCT03259074|521442775|FG001|Overall Study|New Therapy For Study Indication|2|||
144612566|NCT03259074|521442776|FG002|Overall Study|New Therapy For Study Indication|2|||
144612567|NCT03259074|521442774|FG000|Overall Study|Physician Decision|4|||
144612568|NCT03259074|521442775|FG001|Overall Study|Physician Decision|12|||
144612569|NCT03259074|521442776|FG002|Overall Study|Physician Decision|10|||
144465616|NCT01212770|520899966|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
144465617|NCT01212770|520899967|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
144465618|NCT01212770|520899968|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
144465619|NCT01212770|520899969|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
144612570|NCT03259074|521442774|FG000|Overall Study|Pregnancy|1|||
144612571|NCT03259074|521442775|FG001|Overall Study|Pregnancy|1|||
144612572|NCT03259074|521442776|FG002|Overall Study|Pregnancy|0|||
144612573|NCT03259074|521442774|FG000|Overall Study|Progressive Disease|1|||
144612574|NCT03259074|521442775|FG001|Overall Study|Progressive Disease|0|||
144465620|NCT01212770|520899970|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
144465621|NCT01212770|520899971|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
144465622|NCT01212770|520899972|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
144465623|NCT01212770|520899973|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
144465624|NCT01212770|520899974|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
144465625|NCT01212770|520899966|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
144465626|NCT01212770|520899967|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
144465627|NCT01212770|520899968|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
144465628|NCT01212770|520899969|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
144465629|NCT01212770|520899970|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
144465630|NCT01212770|520899971|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
144465631|NCT01212770|520899972|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
144465632|NCT01212770|520899973|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
144465633|NCT01212770|520899974|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
144465634|NCT01212770|520899966|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
144465635|NCT01212770|520899967|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
144465636|NCT01212770|520899968|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
144465637|NCT01212770|520899969|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
144465638|NCT01212770|520899970|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
144465639|NCT01212770|520899971|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
144465640|NCT01212770|520899972|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
144465641|NCT01212770|520899973|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
144465642|NCT01212770|520899974|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
144465643|NCT01212770|520899966|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465644|NCT01212770|520899967|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465645|NCT01212770|520899968|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
144465646|NCT01212770|520899969|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465647|NCT01212770|520899970|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465648|NCT01212770|520899971|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465649|NCT01212770|520899972|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465650|NCT01212770|520899973|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465651|NCT01212770|520899974|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
144465652|NCT01212770|520899966|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465653|NCT01212770|520899967|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465654|NCT01212770|520899968|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465655|NCT01212770|520899969|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
144465656|NCT01212770|520899970|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465657|NCT01212770|520899971|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465658|NCT01212770|520899972|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465659|NCT01212770|520899973|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465660|NCT01212770|520899974|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
144465661|NCT01212770|520899966|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465662|NCT01212770|520899967|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465663|NCT01212770|520899968|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
144465664|NCT01212770|520899969|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
144465665|NCT01212770|520899970|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465666|NCT01212770|520899971|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465667|NCT01212770|520899972|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465668|NCT01212770|520899973|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465669|NCT01212770|520899974|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
144465670|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144465671|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
144465672|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
144465673|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144465674|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144465675|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144465676|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144465677|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144536418|NCT02325466|521168409|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
144536419|NCT02325466|521168407|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
144536420|NCT02325466|521168408|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
144536421|NCT02325466|521168409|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
144536422|NCT02325466|521168407|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
144536423|NCT02325466|521168408|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
144536424|NCT02325466|521168409|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
144465678|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
144465679|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144465680|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
144465681|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
144465682|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144465683|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144465684|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144465685|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144465686|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
144465687|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
144465688|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465689|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
144465690|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465691|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465692|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465693|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465694|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465695|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465696|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
144465697|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144465698|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
144465699|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
144465700|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144465701|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144465702|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144465703|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144465704|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
144465705|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
144465706|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
144465707|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
144465708|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
144465709|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
144465710|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
144465711|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
144465712|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
144465713|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
144465714|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
144465715|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144465716|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
144465717|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
144465718|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144465719|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144465720|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144465721|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144465722|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144465723|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
144465724|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144465725|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
144465726|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
144465727|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144465728|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144465729|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144465730|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144465731|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
144465732|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
144465733|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144465734|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
144465735|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
144465736|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144465737|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144465738|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144465739|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144465740|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
144465741|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
144465742|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144465743|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
144465744|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
144612575|NCT03259074|521442776|FG002|Overall Study|Progressive Disease|0|||
144197333|NCT00532935|519918742|FG000|Overall Study|Protocol Specific Criteria|11|||
144197334|NCT00532935|519918743|FG001|Overall Study|Protocol Specific Criteria|15|||
144197335|NCT00456495|519918744|FG000|Overall Study|Physician Decision|2|||
144197336|NCT00673933|519918745|FG000|Overall Study|Withdrawal by Subject|2|||
144197337|NCT00673933|519918745|FG000|Overall Study|Lost to Follow-up|1|||
144197338|NCT02206620|519918746|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
144197339|NCT02206620|519918747|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
144197340|NCT02206620|519918746|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
144197341|NCT02206620|519918747|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
144612576|NCT03259074|521442774|FG000|Overall Study|Protocol Deviation|1|||
144612577|NCT03259074|521442775|FG001|Overall Study|Protocol Deviation|1|||
144612578|NCT03259074|521442776|FG002|Overall Study|Protocol Deviation|3|||
144612579|NCT03259074|521442774|FG000|Overall Study|Subject/Guardian Decision|13|||
144612580|NCT03259074|521442775|FG001|Overall Study|Subject/Guardian Decision|16|||
144612581|NCT03259074|521442776|FG002|Overall Study|Subject/Guardian Decision|14|||
144612582|NCT00705783|521442777|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
144612583|NCT00705783|521442778|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
144612584|NCT00705783|521442779|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
144612585|NCT00705783|521442777|FG000|Conversion Phase|Lost to Follow-up|13|||
144612586|NCT00705783|521442778|FG001|Conversion Phase|Lost to Follow-up|0|||
144612587|NCT00705783|521442779|FG002|Conversion Phase|Lost to Follow-up|0|||
144612588|NCT00705783|521442777|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
144612589|NCT00705783|521442778|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
144612590|NCT00705783|521442779|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
144612591|NCT00705783|521442777|FG000|Conversion Phase|Withdrawn by Investigator|4|||
144612592|NCT00705783|521442778|FG001|Conversion Phase|Withdrawn by Investigator|0|||
144612593|NCT00705783|521442779|FG002|Conversion Phase|Withdrawn by Investigator|0|||
144612594|NCT00705783|521442777|FG000|Conversion Phase|Withdrew Consent|24|||
144612595|NCT00705783|521442778|FG001|Conversion Phase|Withdrew Consent|0|||
144612596|NCT00705783|521442779|FG002|Conversion Phase|Withdrew Consent|0|||
144612597|NCT00705783|521442777|FG000|Conversion Phase|Protocol Deviation|2|||
144612598|NCT00705783|521442778|FG001|Conversion Phase|Protocol Deviation|0|||
144612599|NCT00705783|521442779|FG002|Conversion Phase|Protocol Deviation|0|||
144612600|NCT00705783|521442777|FG000|Conversion Phase|Adverse Event|11|||
144612601|NCT00705783|521442778|FG001|Conversion Phase|Adverse Event|0|||
144612602|NCT00705783|521442779|FG002|Conversion Phase|Adverse Event|0|||
144612603|NCT00705783|521442777|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
144612604|NCT00705783|521442778|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
144612605|NCT00705783|521442779|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
144612606|NCT00705783|521442777|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
144612607|NCT00705783|521442778|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
144612608|NCT00705783|521442779|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
144612609|NCT00705783|521442777|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
144612610|NCT00705783|521442778|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
144612611|NCT00705783|521442779|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
144612612|NCT00705783|521442777|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
144612613|NCT00705783|521442778|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
144612614|NCT00705783|521442779|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
144612615|NCT00705783|521442777|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
144612616|NCT00705783|521442778|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
144612617|NCT00705783|521442779|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
144612618|NCT00705783|521442777|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
144612619|NCT00705783|521442778|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
144612620|NCT00705783|521442779|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
144612621|NCT00705783|521442777|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
144612622|NCT00705783|521442778|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
144612623|NCT00705783|521442779|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
144612624|NCT00705783|521442777|FG000|Oral Stabilization Phase|Adverse Event|14|||
144612625|NCT00705783|521442778|FG001|Oral Stabilization Phase|Adverse Event|0|||
144612626|NCT00705783|521442779|FG002|Oral Stabilization Phase|Adverse Event|0|||
144612627|NCT00705783|521442777|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
144612628|NCT00705783|521442778|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144612629|NCT00705783|521442779|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144612630|NCT00705783|521442777|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
144612631|NCT00705783|521442778|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144612632|NCT00705783|521442779|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144726130|NCT00950807|521852693|FG008|Washout Period 1|Adverse Event|0|||
144612633|NCT00705783|521442777|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
144612634|NCT00705783|521442778|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
144726131|NCT00950807|521852694|FG009|Washout Period 1|Adverse Event|0|||
144197342|NCT01346774|519918748|FG000|Overall Study|Did not take a single dose|6|||
144726132|NCT00950807|521852685|FG000|Treatment Period 2|Lack of Efficacy|1|||
144726133|NCT00950807|521852686|FG001|Treatment Period 2|Lack of Efficacy|0|||
144726134|NCT00950807|521852687|FG002|Treatment Period 2|Lack of Efficacy|0|||
144726135|NCT00950807|521852688|FG003|Treatment Period 2|Lack of Efficacy|0|||
144197343|NCT01346774|519918749|FG001|Overall Study|Did not take a single dose|4|||
144726136|NCT00950807|521852689|FG004|Treatment Period 2|Lack of Efficacy|0|||
144726137|NCT00950807|521852690|FG005|Treatment Period 2|Lack of Efficacy|0|||
144726138|NCT00950807|521852691|FG006|Treatment Period 2|Lack of Efficacy|0|||
144726139|NCT00950807|521852692|FG007|Treatment Period 2|Lack of Efficacy|0|||
144726140|NCT00950807|521852693|FG008|Treatment Period 2|Lack of Efficacy|0|||
144726141|NCT00950807|521852694|FG009|Treatment Period 2|Lack of Efficacy|0|||
144726142|NCT00950807|521852685|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144726143|NCT00950807|521852686|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144726144|NCT00950807|521852687|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144726145|NCT00950807|521852688|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144726146|NCT00950807|521852689|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144726147|NCT00950807|521852690|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144726148|NCT00950807|521852691|FG006|Treatment Period 2|Withdrawal by Subject|1|||
144726149|NCT00950807|521852692|FG007|Treatment Period 2|Withdrawal by Subject|2|||
144612635|NCT00705783|521442779|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
144612636|NCT00705783|521442777|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
144612637|NCT00705783|521442778|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
144612638|NCT00705783|521442779|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
144612639|NCT00705783|521442777|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
144612640|NCT00705783|521442778|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
144612641|NCT00705783|521442779|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
144612642|NCT00705783|521442777|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
144726150|NCT00950807|521852693|FG008|Treatment Period 2|Withdrawal by Subject|0|||
144726151|NCT00950807|521852694|FG009|Treatment Period 2|Withdrawal by Subject|0|||
144726152|NCT00950807|521852685|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
144726153|NCT00950807|521852686|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726154|NCT00950807|521852687|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144197344|NCT01346774|519918748|FG000|Overall Study|Lost to Follow-up|3|||
144197345|NCT01346774|519918749|FG001|Overall Study|Lost to Follow-up|4|||
144197346|NCT01346774|519918748|FG000|Overall Study|Withdrawal by Subject|1|||
144197347|NCT01346774|519918749|FG001|Overall Study|Withdrawal by Subject|4|||
144197348|NCT01346774|519918748|FG000|Overall Study|Protocol Violation|2|||
144197349|NCT01346774|519918749|FG001|Overall Study|Protocol Violation|3|||
144197350|NCT01346774|519918748|FG000|Overall Study|Adverse Event|1|||
144197351|NCT01346774|519918749|FG001|Overall Study|Adverse Event|2|||
144197352|NCT01929031|519918752|FG000|Overall Study|Adverse Event|3|||
144197353|NCT01929031|519918753|FG001|Overall Study|Adverse Event|1|||
144197354|NCT01929031|519918754|FG002|Overall Study|Adverse Event|1|||
144197355|NCT01929031|519918755|FG003|Overall Study|Adverse Event|0|||
144197356|NCT01929031|519918756|FG004|Overall Study|Adverse Event|0|||
144197357|NCT01929031|519918757|FG005|Overall Study|Adverse Event|0|||
144197358|NCT01929031|519918752|FG000|Overall Study|Protocol Violation|1|||
144197359|NCT01929031|519918753|FG001|Overall Study|Protocol Violation|0|||
144197360|NCT01929031|519918754|FG002|Overall Study|Protocol Violation|0|||
144197361|NCT01929031|519918755|FG003|Overall Study|Protocol Violation|0|||
144197362|NCT01929031|519918756|FG004|Overall Study|Protocol Violation|0|||
144197363|NCT01929031|519918757|FG005|Overall Study|Protocol Violation|1|||
144197364|NCT01929031|519918752|FG000|Overall Study|Reason other than specified above|0|||
144197365|NCT01929031|519918753|FG001|Overall Study|Reason other than specified above|1|||
144197366|NCT01929031|519918754|FG002|Overall Study|Reason other than specified above|0|||
144197367|NCT01929031|519918755|FG003|Overall Study|Reason other than specified above|0|||
144197368|NCT01929031|519918756|FG004|Overall Study|Reason other than specified above|1|||
144197369|NCT01929031|519918757|FG005|Overall Study|Reason other than specified above|0|||
144197370|NCT05816200|519918758|FG000|Overall Study|Lost to Follow-up|2|||
144465745|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144465746|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144465747|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144197371|NCT05816200|519918759|FG001|Overall Study|Lost to Follow-up|1|||
144197372|NCT02394730|519918760|FG000|Overall Study|Lost to Follow-up|1|||
144465748|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144465749|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
144465750|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
144465751|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465752|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
144726155|NCT00950807|521852688|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726156|NCT00950807|521852689|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726157|NCT00950807|521852690|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144197373|NCT02394730|519918761|FG001|Overall Study|Lost to Follow-up|0|||
144726158|NCT00950807|521852691|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726159|NCT00950807|521852692|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726160|NCT00950807|521852693|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726161|NCT00950807|521852694|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
144726162|NCT00950807|521852685|FG000|Treatment Period 2|Adverse Event|0|||
144726163|NCT00950807|521852686|FG001|Treatment Period 2|Adverse Event|1|||
144726164|NCT00950807|521852687|FG002|Treatment Period 2|Adverse Event|0|||
144726165|NCT00950807|521852688|FG003|Treatment Period 2|Adverse Event|1|||
144726166|NCT00950807|521852689|FG004|Treatment Period 2|Adverse Event|0|||
144726167|NCT00950807|521852690|FG005|Treatment Period 2|Adverse Event|1|||
144726168|NCT00950807|521852691|FG006|Treatment Period 2|Adverse Event|0|||
144726169|NCT00950807|521852692|FG007|Treatment Period 2|Adverse Event|1|||
144197374|NCT02394730|519918760|FG000|Overall Study|Withdrawal by Subject|0|||
144536425|NCT02325466|521168407|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
144726170|NCT00950807|521852693|FG008|Treatment Period 2|Adverse Event|0|||
144197375|NCT02394730|519918761|FG001|Overall Study|Withdrawal by Subject|1|||
144197376|NCT00507546|519918762|FG000|Overall Study|Withdrawal by Subject|1|||
144536426|NCT02325466|521168408|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
144536427|NCT02325466|521168409|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
144536428|NCT02325466|521168407|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
144536429|NCT02325466|521168408|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
144536430|NCT02325466|521168409|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
144536431|NCT02325466|521168407|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
144536432|NCT02325466|521168408|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
144536433|NCT02325466|521168409|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
144536434|NCT01288443|521168413|FG000|Overall Study|Adverse Event|0|||
144536435|NCT01288443|521168414|FG001|Overall Study|Adverse Event|0|||
144536436|NCT01288443|521168415|FG002|Overall Study|Adverse Event|1|||
144536437|NCT01288443|521168416|FG003|Overall Study|Adverse Event|1|||
144536438|NCT01288443|521168417|FG004|Overall Study|Adverse Event|3|||
144536439|NCT01288443|521168418|FG005|Overall Study|Adverse Event|1|||
144536440|NCT01288443|521168413|FG000|Overall Study|Poor compliance to protocol|0|||
144536441|NCT01288443|521168414|FG001|Overall Study|Poor compliance to protocol|0|||
144536442|NCT01288443|521168415|FG002|Overall Study|Poor compliance to protocol|0|||
144536443|NCT01288443|521168416|FG003|Overall Study|Poor compliance to protocol|0|||
144536444|NCT01288443|521168417|FG004|Overall Study|Poor compliance to protocol|0|||
144536445|NCT01288443|521168418|FG005|Overall Study|Poor compliance to protocol|1|||
144536446|NCT01288443|521168413|FG000|Overall Study|Participant Moved|0|||
144536447|NCT01288443|521168414|FG001|Overall Study|Participant Moved|0|||
144536448|NCT01288443|521168415|FG002|Overall Study|Participant Moved|0|||
144536449|NCT01288443|521168416|FG003|Overall Study|Participant Moved|1|||
144536450|NCT01288443|521168417|FG004|Overall Study|Participant Moved|2|||
144536451|NCT01288443|521168418|FG005|Overall Study|Participant Moved|1|||
144536452|NCT01288443|521168413|FG000|Overall Study|Consent withdrawn by Participant|0|||
144536453|NCT01288443|521168414|FG001|Overall Study|Consent withdrawn by Participant|0|||
144536454|NCT01288443|521168415|FG002|Overall Study|Consent withdrawn by Participant|0|||
144536455|NCT01288443|521168416|FG003|Overall Study|Consent withdrawn by Participant|0|||
144536456|NCT01288443|521168417|FG004|Overall Study|Consent withdrawn by Participant|0|||
144536457|NCT01288443|521168418|FG005|Overall Study|Consent withdrawn by Participant|1|||
144536458|NCT01288443|521168413|FG000|Overall Study|Lost to Follow-up|0|||
144536459|NCT01288443|521168414|FG001|Overall Study|Lost to Follow-up|1|||
144536460|NCT01288443|521168415|FG002|Overall Study|Lost to Follow-up|0|||
144536461|NCT01288443|521168416|FG003|Overall Study|Lost to Follow-up|0|||
144536462|NCT01288443|521168417|FG004|Overall Study|Lost to Follow-up|0|||
144536463|NCT01288443|521168418|FG005|Overall Study|Lost to Follow-up|0|||
144536464|NCT01288443|521168413|FG000|Overall Study|Study drug auto-injector administration|0|||
144536465|NCT01288443|521168414|FG001|Overall Study|Study drug auto-injector administration|0|||
144536466|NCT01288443|521168415|FG002|Overall Study|Study drug auto-injector administration|0|||
144536467|NCT01288443|521168416|FG003|Overall Study|Study drug auto-injector administration|0|||
144536468|NCT01288443|521168417|FG004|Overall Study|Study drug auto-injector administration|1|||
144536469|NCT01288443|521168418|FG005|Overall Study|Study drug auto-injector administration|1|||
144536470|NCT01288443|521168413|FG000|Overall Study|Other than above|0|||
144536471|NCT01288443|521168414|FG001|Overall Study|Other than above|0|||
144536472|NCT01288443|521168415|FG002|Overall Study|Other than above|0|||
144536473|NCT01288443|521168416|FG003|Overall Study|Other than above|2|||
144536474|NCT01288443|521168417|FG004|Overall Study|Other than above|1|||
144536475|NCT01288443|521168418|FG005|Overall Study|Other than above|0|||
144536476|NCT00982644|521168419|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
144536477|NCT00982644|521168420|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
144536478|NCT00982644|521168419|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
144536479|NCT00982644|521168420|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
144536480|NCT00982644|521168419|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
144536481|NCT00982644|521168420|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
144726171|NCT00950807|521852694|FG009|Treatment Period 2|Adverse Event|0|||
144465753|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465754|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465755|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465756|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465757|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465758|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465759|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144465760|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465761|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465762|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465763|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465764|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465765|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465766|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465767|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
144465768|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
144465769|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144465770|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
144465771|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
144465772|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144465773|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144465774|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144465775|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144465776|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
144465777|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
144465778|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144465779|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
144465780|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
144465781|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144465782|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144465783|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144465784|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144465785|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144465786|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
144465787|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144465788|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
144465789|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
144465790|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144465791|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144465792|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144465793|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144465794|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
144465795|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144465796|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
144465797|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
144465798|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
144465799|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
144465800|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
144465801|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
144465802|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
144465803|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
144465804|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
144465805|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144465806|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
144465807|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
144465808|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144726172|NCT00950807|521852685|FG000|Washout Period 2|Lack of Efficacy|1|||
144726173|NCT00950807|521852686|FG001|Washout Period 2|Lack of Efficacy|0|||
144726174|NCT00950807|521852687|FG002|Washout Period 2|Lack of Efficacy|0|||
144726175|NCT00950807|521852688|FG003|Washout Period 2|Lack of Efficacy|0|||
144726176|NCT00950807|521852689|FG004|Washout Period 2|Lack of Efficacy|0|||
144465809|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144465810|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144726177|NCT00950807|521852690|FG005|Washout Period 2|Lack of Efficacy|0|||
144726178|NCT00950807|521852691|FG006|Washout Period 2|Lack of Efficacy|0|||
144726179|NCT00950807|521852692|FG007|Washout Period 2|Lack of Efficacy|0|||
144726180|NCT00950807|521852693|FG008|Washout Period 2|Lack of Efficacy|0|||
144726181|NCT00950807|521852694|FG009|Washout Period 2|Lack of Efficacy|0|||
144726182|NCT00950807|521852685|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
144197377|NCT00507546|519918763|FG001|Overall Study|Withdrawal by Subject|0|||
144197378|NCT00507546|519918762|FG000|Overall Study|Protocol Violation|1|||
144197379|NCT00507546|519918763|FG001|Overall Study|Protocol Violation|0|||
144197380|NCT00507546|519918762|FG000|Overall Study|Physician Decision|0|||
144197381|NCT00507546|519918763|FG001|Overall Study|Physician Decision|1|||
144197382|NCT02384850|519918764|FG000|Overall Study|Withdrawal by Subject|2|||
144197383|NCT02384850|519918765|FG001|Overall Study|Withdrawal by Subject|2|||
144197384|NCT01334710|519918768|FG000|Overall Study|Trial was terminated|3|||
144197385|NCT04969861|519918770|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
144197386|NCT04969861|519918771|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
144197387|NCT04062448|519920247|FG000|Overall Study|Lost to Follow-up|1|||
144197388|NCT04062448|519920247|FG000|Overall Study|Withdrawal by Subject|2|||
144197389|NCT04319718|519920248|FG000|Overall Study|Adverse Event|0|||
144197390|NCT04319718|519920249|FG001|Overall Study|Adverse Event|2|||
144197391|NCT04319718|519920248|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
144197392|NCT04319718|519920249|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
144197393|NCT01293539|519920250|FG000|Overall Study|Physician Decision|1|||
144197394|NCT00292188|519920251|FG000|Single-Blind|Adverse Event|14|||
144197395|NCT00292188|519920252|FG001|Single-Blind|Adverse Event|0|||
144197396|NCT00292188|519920253|FG002|Single-Blind|Adverse Event|0|||
144197397|NCT00292188|519920251|FG000|Single-Blind|Lack of Efficacy|2|||
144197398|NCT00292188|519920252|FG001|Single-Blind|Lack of Efficacy|0|||
144197399|NCT00292188|519920253|FG002|Single-Blind|Lack of Efficacy|0|||
144197400|NCT00292188|519920251|FG000|Single-Blind|Laboratory Abnormality|5|||
144197401|NCT00292188|519920252|FG001|Single-Blind|Laboratory Abnormality|0|||
144197402|NCT00292188|519920253|FG002|Single-Blind|Laboratory Abnormality|0|||
144197403|NCT00292188|519920251|FG000|Single-Blind|Lost to Follow-up|3|||
144465811|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144465812|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144465813|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144465814|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465815|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465816|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
144465817|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465818|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465819|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465820|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465821|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465822|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144465823|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465824|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
144465825|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465826|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465827|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465828|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465829|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465830|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144465831|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
144465832|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
144465833|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
144465834|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
144465835|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
144465836|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
144465837|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
144465838|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
144465839|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
144465840|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
144465841|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465842|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465843|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
144465844|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465845|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465846|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465847|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465848|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144465849|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144197404|NCT00292188|519920252|FG001|Single-Blind|Lost to Follow-up|0|||
144197405|NCT00292188|519920253|FG002|Single-Blind|Lost to Follow-up|0|||
144197406|NCT00292188|519920251|FG000|Single-Blind|Other|77|||
144197407|NCT00292188|519920252|FG001|Single-Blind|Other|0|||
144197408|NCT00292188|519920253|FG002|Single-Blind|Other|0|||
144197409|NCT00292188|519920251|FG000|Single-Blind|Withdrawal by Subject|12|||
144726183|NCT00950807|521852686|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
144465850|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465851|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465852|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
144465853|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465854|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465855|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465856|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465857|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144465858|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
144465859|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465860|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465861|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
144465862|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465863|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465864|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465865|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465866|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465867|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144465868|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144465869|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
144465870|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
144465871|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144465872|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144465873|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144465874|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144465875|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
144465876|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144465877|NCT01212770|520899966|FG000|Long-term Safety Phase (Year 5)|Death|0|||
144465878|NCT01212770|520899967|FG001|Long-term Safety Phase (Year 5)|Death|0|||
144465879|NCT01212770|520899968|FG002|Long-term Safety Phase (Year 5)|Death|0|||
144465880|NCT01212770|520899969|FG003|Long-term Safety Phase (Year 5)|Death|0|||
144465881|NCT01212770|520899970|FG004|Long-term Safety Phase (Year 5)|Death|0|||
144465882|NCT01212770|520899971|FG005|Long-term Safety Phase (Year 5)|Death|0|||
144465883|NCT01212770|520899972|FG006|Long-term Safety Phase (Year 5)|Death|0|||
144465884|NCT01212770|520899973|FG007|Long-term Safety Phase (Year 5)|Death|1|||
144465885|NCT01212770|520899974|FG008|Long-term Safety Phase (Year 5)|Death|0|||
144465886|NCT00951275|520899979|FG000|Overall Study|Administrative Reason|1|||
144465887|NCT00951275|520899979|FG000|Overall Study|Adverse Event|7|||
144465888|NCT00951275|520899979|FG000|Overall Study|Withdrawal by Subject|4|||
144465889|NCT00951275|520899979|FG000|Overall Study|Protocol Violation|1|||
144465890|NCT00655980|520899980|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
144465891|NCT00655980|520899981|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
144465892|NCT00655980|520899982|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
144465893|NCT02858895|520899984|FG000|Overall Study|Disease progression|31|||
144465894|NCT02858895|520899984|FG000|Overall Study|Death|2|||
144465895|NCT02858895|520899984|FG000|Overall Study|Adverse Event|1|||
144465896|NCT02858895|520899984|FG000|Overall Study|Withdrawal by Subject|3|||
144465897|NCT02858895|520899984|FG000|Overall Study|hospice,|1|||
144465898|NCT02858895|520899984|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
144465899|NCT05338333|520899987|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
144465900|NCT05338333|520899988|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
144465901|NCT01475136|520899989|FG000|Overall Study|Sponsor Decision|0|||
144612643|NCT00705783|521442778|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
144612644|NCT00705783|521442779|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
144612645|NCT00705783|521442777|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
144612646|NCT00705783|521442778|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
144612647|NCT00705783|521442779|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
144612648|NCT00705783|521442777|FG000|Depot Stabilization Phase|Adverse Event|17|||
144612649|NCT00705783|521442778|FG001|Depot Stabilization Phase|Adverse Event|0|||
144612650|NCT00705783|521442779|FG002|Depot Stabilization Phase|Adverse Event|0|||
144612651|NCT00705783|521442777|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
144612652|NCT00705783|521442778|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144612653|NCT00705783|521442779|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144612654|NCT00705783|521442777|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
144612655|NCT00705783|521442778|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144612656|NCT00705783|521442779|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144612657|NCT00705783|521442777|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
144726184|NCT00950807|521852687|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
144726185|NCT00950807|521852688|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
144465902|NCT01475136|520899990|FG001|Overall Study|Sponsor Decision|1|||
144465903|NCT01475136|520899991|FG002|Overall Study|Sponsor Decision|0|||
144465904|NCT01475136|520899992|FG003|Overall Study|Sponsor Decision|0|||
144465905|NCT01475136|520899989|FG000|Overall Study|Entry Criteria Not Met|0|||
144465906|NCT01475136|520899990|FG001|Overall Study|Entry Criteria Not Met|2|||
144465907|NCT01475136|520899991|FG002|Overall Study|Entry Criteria Not Met|3|||
144465908|NCT01475136|520899992|FG003|Overall Study|Entry Criteria Not Met|1|||
144465909|NCT01475136|520899989|FG000|Overall Study|Withdrawal by Subject|0|||
144465910|NCT01475136|520899990|FG001|Overall Study|Withdrawal by Subject|0|||
144465911|NCT01475136|520899991|FG002|Overall Study|Withdrawal by Subject|0|||
144465912|NCT01475136|520899992|FG003|Overall Study|Withdrawal by Subject|2|||
144465913|NCT01475136|520899989|FG000|Overall Study|Adverse Event|1|||
144465914|NCT01475136|520899990|FG001|Overall Study|Adverse Event|0|||
144465915|NCT01475136|520899991|FG002|Overall Study|Adverse Event|0|||
144465916|NCT01475136|520899992|FG003|Overall Study|Adverse Event|1|||
144465917|NCT01475136|520899989|FG000|Overall Study|Death|0|||
144465918|NCT01475136|520899990|FG001|Overall Study|Death|0|||
144465919|NCT01475136|520899991|FG002|Overall Study|Death|0|||
144465920|NCT01475136|520899992|FG003|Overall Study|Death|1|||
144465921|NCT01266642|520900000|FG000|Overall Study|Protocol Violation|0|||
144465922|NCT01266642|520900001|FG001|Overall Study|Protocol Violation|1|||
144465923|NCT01323530|520901774|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
144465924|NCT01323530|520901775|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144465925|NCT01323530|520901776|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144465926|NCT01323530|520901777|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144465927|NCT01323530|520901778|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144465928|NCT01323530|520901779|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
144465929|NCT01323530|520901780|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
144465930|NCT01323530|520901774|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
144465931|NCT01323530|520901775|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
144465932|NCT01323530|520901776|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
144465933|NCT01323530|520901777|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144465934|NCT01323530|520901778|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
144465935|NCT01323530|520901779|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144465936|NCT01323530|520901780|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
144465937|NCT01323530|520901774|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
144465938|NCT01323530|520901775|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
144465939|NCT01323530|520901776|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
144465940|NCT01323530|520901777|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
144465941|NCT01323530|520901778|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
144465942|NCT01323530|520901779|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
144465943|NCT01323530|520901780|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
144465944|NCT01323530|520901774|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
144465945|NCT01323530|520901775|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
144465946|NCT01323530|520901776|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
144465947|NCT01323530|520901777|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
144465948|NCT01323530|520901778|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
144465949|NCT01323530|520901779|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
144465950|NCT01323530|520901780|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
144465951|NCT01323530|520901774|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
144465952|NCT01323530|520901775|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
144465953|NCT01323530|520901776|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
144465954|NCT01323530|520901777|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
144465955|NCT01323530|520901778|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
144465956|NCT01323530|520901779|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
144465957|NCT01323530|520901780|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
144465958|NCT01323530|520901774|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
144465959|NCT01323530|520901775|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
144465960|NCT01323530|520901776|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
144465961|NCT01323530|520901777|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
144465962|NCT01323530|520901778|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
144465963|NCT01323530|520901779|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
144465964|NCT01323530|520901780|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
144465965|NCT01323530|520901774|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
144465966|NCT01323530|520901775|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
144465967|NCT01323530|520901776|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
144465968|NCT01323530|520901777|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
144465969|NCT01323530|520901778|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
144465970|NCT01323530|520901779|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
144465971|NCT01323530|520901780|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
144465972|NCT01323530|520901774|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
144465973|NCT01323530|520901775|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
144465974|NCT01323530|520901776|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
144465975|NCT01323530|520901777|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
144465976|NCT01323530|520901778|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
144465977|NCT01323530|520901779|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
144465978|NCT01323530|520901780|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
144465979|NCT01194570|520901781|FG000|Overall Study|Adverse Event|22|||
144465980|NCT01194570|520901782|FG001|Overall Study|Adverse Event|40|||
144465981|NCT01194570|520901781|FG000|Overall Study|Death|6|||
144465982|NCT01194570|520901782|FG001|Overall Study|Death|20|||
144465983|NCT01194570|520901781|FG000|Overall Study|Lack of Efficacy|32|||
144465984|NCT01194570|520901782|FG001|Overall Study|Lack of Efficacy|33|||
144465985|NCT01194570|520901781|FG000|Overall Study|Lost to Follow-up|4|||
144465986|NCT01194570|520901782|FG001|Overall Study|Lost to Follow-up|15|||
144465987|NCT01194570|520901781|FG000|Overall Study|Non-Compliance|2|||
144465988|NCT01194570|520901782|FG001|Overall Study|Non-Compliance|2|||
144465989|NCT01194570|520901781|FG000|Overall Study|Non-Compliance With Study Drug|2|||
144465990|NCT01194570|520901782|FG001|Overall Study|Non-Compliance With Study Drug|2|||
144465991|NCT01194570|520901781|FG000|Overall Study|Other|18|||
144465992|NCT01194570|520901782|FG001|Overall Study|Other|47|||
144465993|NCT01194570|520901781|FG000|Overall Study|Physician Decision|10|||
144465994|NCT01194570|520901782|FG001|Overall Study|Physician Decision|25|||
144465995|NCT01194570|520901781|FG000|Overall Study|Protocol Violation|1|||
144465996|NCT01194570|520901782|FG001|Overall Study|Protocol Violation|2|||
144465997|NCT01194570|520901781|FG000|Overall Study|Study Terminated By Sponsor|0|||
144465998|NCT01194570|520901782|FG001|Overall Study|Study Terminated By Sponsor|1|||
144465999|NCT01194570|520901781|FG000|Overall Study|Withdrawal by Subject|57|||
144466000|NCT01194570|520901782|FG001|Overall Study|Withdrawal by Subject|82|||
144466001|NCT01194570|520901781|FG000|Overall Study|Pregnancy|1|||
144466002|NCT01194570|520901782|FG001|Overall Study|Pregnancy|1|||
144466003|NCT01377480|520901783|FG000|Overall Study|Protocol Violation|0|||
144466004|NCT01377480|520901784|FG001|Overall Study|Protocol Violation|0|||
144466005|NCT01377480|520901785|FG002|Overall Study|Protocol Violation|0|||
144466006|NCT01377480|520901786|FG003|Overall Study|Protocol Violation|4|||
144466007|NCT01377480|520901783|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
144466008|NCT01377480|520901784|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
144466009|NCT01377480|520901785|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
144466010|NCT01377480|520901786|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
144466011|NCT01377480|520901783|FG000|Overall Study|Withdrawal by Subject|0|||
144466012|NCT01377480|520901784|FG001|Overall Study|Withdrawal by Subject|0|||
144466013|NCT01377480|520901785|FG002|Overall Study|Withdrawal by Subject|1|||
144466014|NCT01377480|520901786|FG003|Overall Study|Withdrawal by Subject|0|||
144466015|NCT01377480|520901783|FG000|Overall Study|Serious adverse event|0|||
144466016|NCT01377480|520901784|FG001|Overall Study|Serious adverse event|0|||
144466017|NCT01377480|520901785|FG002|Overall Study|Serious adverse event|1|||
144466018|NCT01377480|520901786|FG003|Overall Study|Serious adverse event|1|||
144466019|NCT01377480|520901783|FG000|Overall Study|Other|0|||
144466020|NCT01377480|520901784|FG001|Overall Study|Other|0|||
144466021|NCT01377480|520901785|FG002|Overall Study|Other|7|||
144466022|NCT01377480|520901786|FG003|Overall Study|Other|6|||
144466023|NCT01735201|520901791|FG000|Overall Study|Adverse Event|1|||
144466024|NCT01735201|520901792|FG001|Overall Study|Adverse Event|1|||
144612658|NCT00705783|521442778|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
144612659|NCT00705783|521442779|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
144612660|NCT00705783|521442777|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
144612661|NCT00705783|521442778|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
144612662|NCT00705783|521442779|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
144612663|NCT00705783|521442777|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
144612664|NCT00705783|521442778|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
144612665|NCT00705783|521442779|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
144612666|NCT00705783|521442777|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
144612667|NCT00705783|521442778|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
144197410|NCT00292188|519920252|FG001|Single-Blind|Withdrawal by Subject|0|||
144197411|NCT00292188|519920253|FG002|Single-Blind|Withdrawal by Subject|0|||
144466025|NCT01735201|520901793|FG002|Overall Study|Adverse Event|0|||
144466026|NCT01735201|520901794|FG003|Overall Study|Adverse Event|1|||
144466027|NCT01735201|520901795|FG004|Overall Study|Adverse Event|1|||
144466028|NCT01735201|520901796|FG005|Overall Study|Adverse Event|3|||
144466029|NCT01735201|520901797|FG006|Overall Study|Adverse Event|2|||
144466030|NCT01735201|520901798|FG007|Overall Study|Adverse Event|1|||
144466031|NCT01735201|520901791|FG000|Overall Study|Personal Reasons|1|||
144466032|NCT01735201|520901792|FG001|Overall Study|Personal Reasons|0|||
144466033|NCT01735201|520901793|FG002|Overall Study|Personal Reasons|0|||
144612668|NCT00705783|521442779|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
144466034|NCT01735201|520901794|FG003|Overall Study|Personal Reasons|0|||
144466035|NCT01735201|520901795|FG004|Overall Study|Personal Reasons|0|||
144466036|NCT01735201|520901796|FG005|Overall Study|Personal Reasons|0|||
144466037|NCT01735201|520901797|FG006|Overall Study|Personal Reasons|0|||
144466038|NCT01735201|520901798|FG007|Overall Study|Personal Reasons|0|||
144466039|NCT01735201|520901791|FG000|Overall Study|Protocol Violation|1|||
144466040|NCT01735201|520901792|FG001|Overall Study|Protocol Violation|0|||
144466041|NCT01735201|520901793|FG002|Overall Study|Protocol Violation|0|||
144466042|NCT01735201|520901794|FG003|Overall Study|Protocol Violation|0|||
144466043|NCT01735201|520901795|FG004|Overall Study|Protocol Violation|0|||
144466044|NCT01735201|520901796|FG005|Overall Study|Protocol Violation|0|||
144466045|NCT01735201|520901797|FG006|Overall Study|Protocol Violation|0|||
144466046|NCT01735201|520901798|FG007|Overall Study|Protocol Violation|0|||
144466047|NCT01735201|520901791|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144466048|NCT01735201|520901792|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144466049|NCT01735201|520901793|FG002|Overall Study|Other Miscellaneous Reasons|0|||
144466050|NCT01735201|520901794|FG003|Overall Study|Other Miscellaneous Reasons|1|||
144466051|NCT01735201|520901795|FG004|Overall Study|Other Miscellaneous Reasons|0|||
144466052|NCT01735201|520901796|FG005|Overall Study|Other Miscellaneous Reasons|2|||
144466053|NCT01735201|520901797|FG006|Overall Study|Other Miscellaneous Reasons|1|||
144466054|NCT01735201|520901798|FG007|Overall Study|Other Miscellaneous Reasons|1|||
144466055|NCT00289887|520901801|FG000|Overall Study|Adverse Event|3|||
144466056|NCT00289887|520901802|FG001|Overall Study|Adverse Event|3|||
144466057|NCT00289887|520901801|FG000|Overall Study|Lack of Efficacy|3|||
144466058|NCT00289887|520901802|FG001|Overall Study|Lack of Efficacy|11|||
144466059|NCT00289887|520901801|FG000|Overall Study|Lost to Follow-up|3|||
144466060|NCT00289887|520901802|FG001|Overall Study|Lost to Follow-up|3|||
144466061|NCT00289887|520901801|FG000|Overall Study|Protocol Violation|3|||
144466062|NCT00289887|520901802|FG001|Overall Study|Protocol Violation|1|||
144466063|NCT00289887|520901801|FG000|Overall Study|Withdrawal by Subject|3|||
144466064|NCT00289887|520901802|FG001|Overall Study|Withdrawal by Subject|8|||
144466065|NCT00289887|520901801|FG000|Overall Study|Other|7|||
144466066|NCT00289887|520901802|FG001|Overall Study|Other|3|||
144466067|NCT04128293|520901804|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
144466068|NCT04128293|520901805|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
144466069|NCT04128293|520901806|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
144466070|NCT04128293|520901807|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
144466071|NCT02035332|520901808|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
144466072|NCT00420199|520901815|FG000|Overall Study|Participant no longer met study criteria|1|||
144466073|NCT00420199|520901816|FG001|Overall Study|Participant no longer met study criteria|0|||
144466074|NCT00558428|520901823|FG000|Overall Study|Adverse Event|6|||
144466075|NCT00558428|520901824|FG001|Overall Study|Adverse Event|22|||
144466076|NCT00558428|520901825|FG002|Overall Study|Adverse Event|3|||
144466077|NCT00558428|520901826|FG003|Overall Study|Adverse Event|4|||
144466078|NCT00558428|520901823|FG000|Overall Study|Lost to Follow-up|0|||
144466079|NCT00558428|520901824|FG001|Overall Study|Lost to Follow-up|1|||
144466080|NCT00558428|520901825|FG002|Overall Study|Lost to Follow-up|0|||
144466081|NCT00558428|520901826|FG003|Overall Study|Lost to Follow-up|0|||
144466082|NCT00558428|520901823|FG000|Overall Study|Lack of Efficacy|0|||
144466083|NCT00558428|520901824|FG001|Overall Study|Lack of Efficacy|0|||
144466084|NCT00558428|520901825|FG002|Overall Study|Lack of Efficacy|1|||
144466085|NCT00558428|520901826|FG003|Overall Study|Lack of Efficacy|2|||
144612669|NCT00705783|521442777|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
144612670|NCT00705783|521442778|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
144612671|NCT00705783|521442779|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
144612672|NCT00705783|521442777|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
144197412|NCT00292188|519920251|FG000|Single-Blind|Did not receive treatment|1|||
144612673|NCT00705783|521442778|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
144612674|NCT00705783|521442779|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
144612675|NCT00705783|521442777|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
144612676|NCT00705783|521442778|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
144612677|NCT00705783|521442779|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
144466086|NCT00558428|520901823|FG000|Overall Study|Non compliant with protocol|1|||
144466087|NCT00558428|520901824|FG001|Overall Study|Non compliant with protocol|0|||
144612678|NCT00705783|521442777|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
144197413|NCT00292188|519920252|FG001|Single-Blind|Did not receive treatment|0|||
144466088|NCT00558428|520901825|FG002|Overall Study|Non compliant with protocol|0|||
144466089|NCT00558428|520901826|FG003|Overall Study|Non compliant with protocol|3|||
144466090|NCT00558428|520901823|FG000|Overall Study|Consent withdrawn|2|||
144466091|NCT00558428|520901824|FG001|Overall Study|Consent withdrawn|1|||
144466092|NCT00558428|520901825|FG002|Overall Study|Consent withdrawn|0|||
144466093|NCT00558428|520901826|FG003|Overall Study|Consent withdrawn|1|||
144466094|NCT00558428|520901823|FG000|Overall Study|Other|3|||
144466095|NCT00558428|520901824|FG001|Overall Study|Other|0|||
144197414|NCT00292188|519920253|FG002|Single-Blind|Did not receive treatment|0|||
144466096|NCT00558428|520901825|FG002|Overall Study|Other|0|||
144466097|NCT00558428|520901826|FG003|Overall Study|Other|1|||
144466098|NCT02219048|520901827|FG000|Overall Study|Adverse Event|2|||
144612679|NCT00705783|521442778|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
144612680|NCT00705783|521442779|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
144612681|NCT00705783|521442777|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
144612682|NCT00705783|521442778|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
144612683|NCT00705783|521442779|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
144612684|NCT02830776|521442780|FG000|Overall Study|Lost to Follow-up|1|||
144612685|NCT01820364|521442781|FG000|Part I: LGX818|Death|1|||
144612686|NCT01820364|521442782|FG001|Part I: LGX818|Death|0|||
144466099|NCT02219048|520901828|FG001|Overall Study|Adverse Event|5|||
144466100|NCT02219048|520901827|FG000|Overall Study|No longer meets eligibility criteria|1|||
144466101|NCT02219048|520901828|FG001|Overall Study|No longer meets eligibility criteria|0|||
144466102|NCT02219048|520901827|FG000|Overall Study|Study terminated by sponsor|16|||
144466103|NCT02219048|520901828|FG001|Overall Study|Study terminated by sponsor|15|||
144466104|NCT02219048|520901827|FG000|Overall Study|Withdrawal by Subject|2|||
144466105|NCT02219048|520901828|FG001|Overall Study|Withdrawal by Subject|0|||
144466106|NCT02219048|520901827|FG000|Overall Study|Other|0|||
144466107|NCT02219048|520901828|FG001|Overall Study|Other|1|||
144466108|NCT00338884|520901829|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
144466109|NCT00338884|520901829|FG000|Overall Study|Adverse Event|14|||
144612687|NCT01820364|521442781|FG000|Part I: LGX818|Administrative Problems|3|||
144612688|NCT01820364|521442782|FG001|Part I: LGX818|Administrative Problems|0|||
144612689|NCT01820364|521442781|FG000|Part I: LGX818|Adverse Event|6|||
144612690|NCT01820364|521442782|FG001|Part I: LGX818|Adverse Event|0|||
144612691|NCT01820364|521442781|FG000|Part I: LGX818|Disease Progression|4|||
144466110|NCT00338884|520901829|FG000|Overall Study|Death|8|||
144466111|NCT00338884|520901829|FG000|Overall Study|Other|4|||
144466112|NCT00338884|520901829|FG000|Overall Study|Global Deterioration of Health Status|3|||
144466113|NCT00338884|520901829|FG000|Overall Study|Withdrawal by Subject|3|||
144466114|NCT00338884|520901829|FG000|Overall Study|Lost to Follow-up|1|||
144466115|NCT00338884|520901829|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
144466116|NCT02355002|520901830|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
144466117|NCT02355002|520901831|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
144466118|NCT02355002|520901830|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
144466119|NCT02355002|520901831|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
144466120|NCT02355002|520901830|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
144466121|NCT02355002|520901831|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
144466122|NCT02355002|520901830|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
144466123|NCT02355002|520901831|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
144466124|NCT02355002|520901830|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
144466125|NCT02355002|520901831|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
144466126|NCT02355002|520901830|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
144466127|NCT02355002|520901831|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
144466128|NCT02355002|520901830|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
144466129|NCT02355002|520901831|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
144466130|NCT05711641|520901832|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
144466131|NCT05711641|520901833|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
144466132|NCT05711641|520901832|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
144612692|NCT01820364|521442782|FG001|Part I: LGX818|Disease Progression|0|||
144612693|NCT01820364|521442781|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
144612694|NCT01820364|521442782|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
144612695|NCT01087775|521442786|FG000|Overall Study|failed inclusion criteria|2|||
144612696|NCT01553188|521442789|FG000|Overall Study|Patient choice|1|||
144612697|NCT01553188|521442790|FG001|Overall Study|Patient choice|0|||
144612698|NCT01553188|521442791|FG002|Overall Study|Patient choice|0|||
144612699|NCT01553188|521442792|FG003|Overall Study|Patient choice|0|||
144612700|NCT01553188|521442789|FG000|Overall Study|Intercurrent illness and adverse event|0|||
144197415|NCT00292188|519920251|FG000|Double-Blind|Adverse Event|0|||
144612701|NCT01553188|521442790|FG001|Overall Study|Intercurrent illness and adverse event|1|||
144612702|NCT01553188|521442791|FG002|Overall Study|Intercurrent illness and adverse event|2|||
144612703|NCT01553188|521442792|FG003|Overall Study|Intercurrent illness and adverse event|0|||
144612704|NCT04744207|521442794|FG000|Treatment|Withdrawal by Subject|2|||
144612705|NCT04744207|521442795|FG001|Treatment|Withdrawal by Subject|0|||
144612706|NCT04744207|521442794|FG000|Treatment|Adverse Event|1|||
144466133|NCT05711641|520901833|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
144466134|NCT03342638|520901838|FG000|Overall Study|Withdrawal by Subject|1|||
144612707|NCT04744207|521442795|FG001|Treatment|Adverse Event|2|||
144612708|NCT00777101|521442803|FG000|Overall Study|Death|48|||
144197416|NCT00292188|519920252|FG001|Double-Blind|Adverse Event|25|||
144197417|NCT00292188|519920253|FG002|Double-Blind|Adverse Event|9|||
144466135|NCT03342638|520901839|FG001|Overall Study|Withdrawal by Subject|0|||
144466136|NCT03342638|520901838|FG000|Overall Study|Physician Decision|0|||
144466137|NCT03342638|520901839|FG001|Overall Study|Physician Decision|1|||
144466138|NCT01292239|520901840|FG000|Overall Study|Other|1|||
144466139|NCT01292239|520901841|FG001|Overall Study|Other|1|||
144466140|NCT01292239|520901840|FG000|Overall Study|Withdrawal by Subject|3|||
144466141|NCT01292239|520901841|FG001|Overall Study|Withdrawal by Subject|6|||
144466142|NCT00262821|520901842|FG000|Overall Study|Ineligible - wrong stage|0|||
144466143|NCT00262821|520901843|FG001|Overall Study|Ineligible - wrong stage|3|||
144466144|NCT00262821|520901842|FG000|Overall Study|Ineligible - wrong cell type|2|||
144466145|NCT00262821|520901843|FG001|Overall Study|Ineligible - wrong cell type|2|||
144466146|NCT00262821|520901842|FG000|Overall Study|Ineligible - wrong primary|0|||
144466147|NCT00262821|520901843|FG001|Overall Study|Ineligible - wrong primary|1|||
144466148|NCT00262821|520901842|FG000|Overall Study|Ineligible - inadequate pathology|1|||
144466149|NCT00262821|520901843|FG001|Overall Study|Ineligible - inadequate pathology|3|||
144466150|NCT00262821|520901842|FG000|Overall Study|Ineligible - elevated creatinine|0|||
144466151|NCT00262821|520901843|FG001|Overall Study|Ineligible - elevated creatinine|2|||
144466152|NCT00262821|520901842|FG000|Overall Study|Ineligible - required test not done|1|||
144466153|NCT00262821|520901843|FG001|Overall Study|Ineligible - required test not done|4|||
144466154|NCT00262821|520901842|FG000|Overall Study|Inevaluable - inadequate data|0|||
144466155|NCT00262821|520901843|FG001|Overall Study|Inevaluable - inadequate data|4|||
144466156|NCT02275065|520901844|FG000|Overall Study|Randomized but not treated|1|||
144466157|NCT02275065|520901845|FG001|Overall Study|Randomized but not treated|0|||
144466158|NCT02275065|520901846|FG002|Overall Study|Randomized but not treated|1|||
144466159|NCT02275065|520901847|FG003|Overall Study|Randomized but not treated|1|||
144466160|NCT02275065|520901848|FG004|Overall Study|Randomized but not treated|0|||
144466161|NCT01995461|520901849|FG000|Overall Study|Death|1|||
144466162|NCT01995461|520901849|FG000|Overall Study|Lost to Follow-up|2|||
144466163|NCT01995461|520901849|FG000|Overall Study|Withdrawal by Subject|2|||
144466164|NCT00587964|520901850|FG000|Overall Study|Withdrawal by Subject|1|||
144466165|NCT00587964|520901850|FG000|Overall Study|Lost to Follow-up|1|||
144466166|NCT00587964|520901850|FG000|Overall Study|Patient found to be ineligible|1|||
144466167|NCT00587964|520901850|FG000|Overall Study|Patient did not receive intervention|5|||
144466168|NCT00587964|520901850|FG000|Overall Study|Progression of Disease|4|||
144466169|NCT00540124|520901851|FG000|Overall Study|Adverse Event|0|||
144466170|NCT00540124|520901852|FG001|Overall Study|Adverse Event|2|||
144466171|NCT00540124|520901853|FG002|Overall Study|Adverse Event|1|||
144466172|NCT00540124|520901851|FG000|Overall Study|Entry Criteria Not Met|2|||
144466173|NCT00540124|520901852|FG001|Overall Study|Entry Criteria Not Met|0|||
144466174|NCT00540124|520901853|FG002|Overall Study|Entry Criteria Not Met|0|||
144466175|NCT00540124|520901851|FG000|Overall Study|Lack of Efficacy|1|||
144466176|NCT00540124|520901852|FG001|Overall Study|Lack of Efficacy|0|||
144466177|NCT00540124|520901853|FG002|Overall Study|Lack of Efficacy|0|||
144466178|NCT00540124|520901851|FG000|Overall Study|Withdrawal by Subject|1|||
144466179|NCT00540124|520901852|FG001|Overall Study|Withdrawal by Subject|1|||
144466180|NCT00540124|520901853|FG002|Overall Study|Withdrawal by Subject|0|||
144466181|NCT01302847|520901861|FG000|Overall Study|Death|0|||
144466182|NCT01302847|520901862|FG001|Overall Study|Death|1|||
144466183|NCT01302847|520901863|FG002|Overall Study|Death|0|||
144466184|NCT01302847|520901864|FG003|Overall Study|Death|0|||
144466185|NCT01302847|520901865|FG004|Overall Study|Death|0|||
144466186|NCT01302847|520901866|FG005|Overall Study|Death|1|||
144466187|NCT01302847|520901867|FG006|Overall Study|Death|1|||
144466188|NCT01302847|520901868|FG007|Overall Study|Death|0|||
144466189|NCT01302847|520901861|FG000|Overall Study|Pregnancy|2|||
144466190|NCT01302847|520901862|FG001|Overall Study|Pregnancy|0|||
144466191|NCT01302847|520901863|FG002|Overall Study|Pregnancy|0|||
144466192|NCT01302847|520901864|FG003|Overall Study|Pregnancy|0|||
144612709|NCT00777101|521442804|FG001|Overall Study|Death|43|||
144612710|NCT00777101|521442803|FG000|Overall Study|Withdrawal by Subject|11|||
144612711|NCT00777101|521442804|FG001|Overall Study|Withdrawal by Subject|6|||
144612712|NCT00777101|521442803|FG000|Overall Study|Lost to Follow-up|2|||
144466193|NCT01302847|520901865|FG004|Overall Study|Pregnancy|0|||
144466194|NCT01302847|520901866|FG005|Overall Study|Pregnancy|0|||
144466195|NCT01302847|520901867|FG006|Overall Study|Pregnancy|0|||
144466196|NCT01302847|520901868|FG007|Overall Study|Pregnancy|0|||
144466197|NCT01302847|520901861|FG000|Overall Study|Virologic failure|0|||
144466198|NCT01302847|520901862|FG001|Overall Study|Virologic failure|2|||
144466199|NCT01302847|520901863|FG002|Overall Study|Virologic failure|0|||
144466200|NCT01302847|520901864|FG003|Overall Study|Virologic failure|2|||
144466201|NCT01302847|520901865|FG004|Overall Study|Virologic failure|1|||
144466202|NCT01302847|520901866|FG005|Overall Study|Virologic failure|3|||
144466203|NCT01302847|520901867|FG006|Overall Study|Virologic failure|1|||
144466204|NCT01302847|520901868|FG007|Overall Study|Virologic failure|2|||
144466205|NCT01302847|520901861|FG000|Overall Study|Severe debilitation, unable to continue|0|||
144466206|NCT01302847|520901862|FG001|Overall Study|Severe debilitation, unable to continue|0|||
144466207|NCT01302847|520901863|FG002|Overall Study|Severe debilitation, unable to continue|0|||
144466208|NCT01302847|520901864|FG003|Overall Study|Severe debilitation, unable to continue|0|||
144466209|NCT01302847|520901865|FG004|Overall Study|Severe debilitation, unable to continue|0|||
144466210|NCT01302847|520901866|FG005|Overall Study|Severe debilitation, unable to continue|1|||
144466211|NCT01302847|520901867|FG006|Overall Study|Severe debilitation, unable to continue|1|||
144466212|NCT01302847|520901868|FG007|Overall Study|Severe debilitation, unable to continue|0|||
144466213|NCT01302847|520901861|FG000|Overall Study|Not able to get to clinic|1|||
144466214|NCT01302847|520901862|FG001|Overall Study|Not able to get to clinic|1|||
144466215|NCT01302847|520901863|FG002|Overall Study|Not able to get to clinic|0|||
144466216|NCT01302847|520901864|FG003|Overall Study|Not able to get to clinic|0|||
144466217|NCT01302847|520901865|FG004|Overall Study|Not able to get to clinic|0|||
144466218|NCT01302847|520901866|FG005|Overall Study|Not able to get to clinic|0|||
144466219|NCT01302847|520901867|FG006|Overall Study|Not able to get to clinic|0|||
144466220|NCT01302847|520901868|FG007|Overall Study|Not able to get to clinic|0|||
144466221|NCT01302847|520901861|FG000|Overall Study|Site closing|2|||
144466222|NCT01302847|520901862|FG001|Overall Study|Site closing|2|||
144466223|NCT01302847|520901863|FG002|Overall Study|Site closing|0|||
144466224|NCT01302847|520901864|FG003|Overall Study|Site closing|0|||
144466225|NCT01302847|520901865|FG004|Overall Study|Site closing|0|||
144612713|NCT00777101|521442804|FG001|Overall Study|Lost to Follow-up|1|||
144612714|NCT00777101|521442803|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
144612715|NCT00777101|521442804|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
144612716|NCT00777101|521442803|FG000|Overall Study|Failed to Return|0|||
144612717|NCT00777101|521442804|FG001|Overall Study|Failed to Return|1|||
144612718|NCT00961220|521442805|FG000|Overall Study|Adverse Event|3|||
144612719|NCT00961220|521442805|FG000|Overall Study|Lack of Efficacy|1|||
144612720|NCT00961220|521442805|FG000|Overall Study|No IV access for O6BG|1|||
144612721|NCT00961220|521442805|FG000|Overall Study|O6BG no longer supplied|1|||
144612722|NCT00961220|521442805|FG000|Overall Study|Complete Response prior to 12 courses|1|||
144612723|NCT05376215|521442806|FG000|Overall Study|Withdrawal by Subject|2|||
144612724|NCT05376215|521442807|FG001|Overall Study|Withdrawal by Subject|1|||
144612725|NCT05376215|521442806|FG000|Overall Study|Lost to Follow-up|0|||
144612726|NCT05376215|521442807|FG001|Overall Study|Lost to Follow-up|1|||
144612727|NCT01301950|521442815|FG000|Overall Study|Surgery was cancelled by patient|0|||
144612728|NCT01301950|521442816|FG001|Overall Study|Surgery was cancelled by patient|1|||
144612729|NCT04041284|521442819|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
144612730|NCT04041284|521442820|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
144612731|NCT04041284|521442819|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
144612732|NCT04041284|521442820|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
144612733|NCT04041284|521442819|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
144612734|NCT04041284|521442820|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
144612735|NCT04041284|521442819|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
144612736|NCT04041284|521442820|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
144612737|NCT04041284|521442819|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
144612738|NCT04041284|521442820|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
144612739|NCT04041284|521442819|FG000|DB Phase (12 Weeks)|Other than specified|1|||
144612740|NCT04041284|521442820|FG001|DB Phase (12 Weeks)|Other than specified|0|||
144612741|NCT04041284|521442819|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
144612742|NCT04041284|521442820|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
144612743|NCT04041284|521442819|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
144612744|NCT04041284|521442820|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
144612745|NCT04041284|521442819|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
144612746|NCT04041284|521442820|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
144612747|NCT04041284|521442819|FG000|OL Phase (12 Weeks)|Other than specified|6|||
144612748|NCT04041284|521442820|FG001|OL Phase (12 Weeks)|Other than specified|2|||
144612749|NCT00825162|521442821|FG000|Overall Study|Withdrawal by Subject|11|||
144612750|NCT00825162|521442822|FG001|Overall Study|Withdrawal by Subject|13|||
144612751|NCT00825162|521442823|FG002|Overall Study|Withdrawal by Subject|3|||
144612752|NCT00825162|521442821|FG000|Overall Study|Lost to Follow-up|9|||
144612753|NCT00825162|521442822|FG001|Overall Study|Lost to Follow-up|6|||
144612754|NCT00825162|521442823|FG002|Overall Study|Lost to Follow-up|3|||
144466226|NCT01302847|520901866|FG005|Overall Study|Site closing|0|||
144466227|NCT01302847|520901867|FG006|Overall Study|Site closing|0|||
144466228|NCT01302847|520901868|FG007|Overall Study|Site closing|0|||
144466229|NCT01302847|520901861|FG000|Overall Study|Withdrawal by Subject|1|||
144466230|NCT01302847|520901862|FG001|Overall Study|Withdrawal by Subject|0|||
144466231|NCT01302847|520901863|FG002|Overall Study|Withdrawal by Subject|0|||
144466232|NCT01302847|520901864|FG003|Overall Study|Withdrawal by Subject|0|||
144466233|NCT01302847|520901865|FG004|Overall Study|Withdrawal by Subject|1|||
144466234|NCT01302847|520901866|FG005|Overall Study|Withdrawal by Subject|0|||
144466235|NCT01302847|520901867|FG006|Overall Study|Withdrawal by Subject|0|||
144466236|NCT01302847|520901868|FG007|Overall Study|Withdrawal by Subject|1|||
144612755|NCT00825162|521442821|FG000|Overall Study|Physician Decision|2|||
144612756|NCT00825162|521442822|FG001|Overall Study|Physician Decision|0|||
144612757|NCT00825162|521442823|FG002|Overall Study|Physician Decision|0|||
144726186|NCT00950807|521852689|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
144612758|NCT00825162|521442821|FG000|Overall Study|Move away from the study area|1|||
144612759|NCT00825162|521442822|FG001|Overall Study|Move away from the study area|0|||
144612760|NCT00825162|521442823|FG002|Overall Study|Move away from the study area|0|||
144612761|NCT00825162|521442821|FG000|Overall Study|Unable to attend the study visit|5|||
144612762|NCT00825162|521442822|FG001|Overall Study|Unable to attend the study visit|2|||
144612763|NCT00825162|521442823|FG002|Overall Study|Unable to attend the study visit|0|||
144466237|NCT01302847|520901861|FG000|Overall Study|Not willing to adhere to requirements|5|||
144466238|NCT01302847|520901862|FG001|Overall Study|Not willing to adhere to requirements|0|||
144466239|NCT01302847|520901863|FG002|Overall Study|Not willing to adhere to requirements|1|||
144466240|NCT01302847|520901864|FG003|Overall Study|Not willing to adhere to requirements|0|||
144466241|NCT01302847|520901865|FG004|Overall Study|Not willing to adhere to requirements|0|||
144466242|NCT01302847|520901866|FG005|Overall Study|Not willing to adhere to requirements|0|||
144466243|NCT01302847|520901867|FG006|Overall Study|Not willing to adhere to requirements|0|||
144466244|NCT01302847|520901868|FG007|Overall Study|Not willing to adhere to requirements|2|||
144466245|NCT01302847|520901861|FG000|Overall Study|Site unable to contact participant|2|||
144466246|NCT01302847|520901862|FG001|Overall Study|Site unable to contact participant|1|||
144466247|NCT01302847|520901863|FG002|Overall Study|Site unable to contact participant|0|||
144466248|NCT01302847|520901864|FG003|Overall Study|Site unable to contact participant|0|||
144466249|NCT01302847|520901865|FG004|Overall Study|Site unable to contact participant|0|||
144466250|NCT01302847|520901866|FG005|Overall Study|Site unable to contact participant|0|||
144466251|NCT01302847|520901867|FG006|Overall Study|Site unable to contact participant|2|||
144466252|NCT01302847|520901868|FG007|Overall Study|Site unable to contact participant|0|||
144466253|NCT01371851|520901870|FG000|Overall Study|Lost to Follow-up|5|||
144466254|NCT01371851|520901871|FG001|Overall Study|Lost to Follow-up|8|||
144466255|NCT01371851|520901870|FG000|Overall Study|was arrested and put in jail|0|||
144466256|NCT01371851|520901871|FG001|Overall Study|was arrested and put in jail|1|||
144466257|NCT01371851|520901870|FG000|Overall Study|non study related adverse event|1|||
144466258|NCT01371851|520901871|FG001|Overall Study|non study related adverse event|0|||
144466259|NCT01371851|520901870|FG000|Overall Study|Blood Pressure outside study parameters|2|||
144466260|NCT01371851|520901871|FG001|Overall Study|Blood Pressure outside study parameters|0|||
144466261|NCT00374322|520901872|FG000|Overall Study|Lost to Follow-up|92|||
144466262|NCT00374322|520901873|FG001|Overall Study|Lost to Follow-up|90|||
144466263|NCT00374322|520901872|FG000|Overall Study|Protocol Violation|8|||
144466264|NCT00374322|520901873|FG001|Overall Study|Protocol Violation|3|||
144466265|NCT00374322|520901872|FG000|Overall Study|Withdrawal by Subject|235|||
144466266|NCT00374322|520901873|FG001|Overall Study|Withdrawal by Subject|167|||
144466267|NCT00374322|520901872|FG000|Overall Study|Sponsor Terminated Study|866|||
144466268|NCT00374322|520901873|FG001|Overall Study|Sponsor Terminated Study|990|||
144466269|NCT00374322|520901872|FG000|Overall Study|Physician Decision|36|||
144466270|NCT00374322|520901873|FG001|Overall Study|Physician Decision|32|||
144466271|NCT00374322|520901872|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
144466272|NCT00374322|520901873|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
144466273|NCT00374322|520901872|FG000|Overall Study|Sponsor Decision|2|||
144466274|NCT00374322|520901873|FG001|Overall Study|Sponsor Decision|3|||
144466275|NCT00374322|520901872|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
144466276|NCT00374322|520901873|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
144466277|NCT00374322|520901872|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
144466278|NCT00374322|520901873|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
144466279|NCT00374322|520901872|FG000|Overall Study|Severe Toxicity|1|||
144466280|NCT00374322|520901873|FG001|Overall Study|Severe Toxicity|0|||
144466281|NCT00374322|520901872|FG000|Overall Study|Site Closed|2|||
144466282|NCT00374322|520901873|FG001|Overall Study|Site Closed|2|||
144466283|NCT00374322|520901872|FG000|Overall Study|Participant Changed Physician|1|||
144466284|NCT00374322|520901873|FG001|Overall Study|Participant Changed Physician|0|||
144466285|NCT00374322|520901872|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
144466286|NCT00374322|520901873|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
144466287|NCT00374322|520901872|FG000|Overall Study|Noncompliance with Study Requirements|0|||
144466288|NCT00374322|520901873|FG001|Overall Study|Noncompliance with Study Requirements|1|||
144466289|NCT00374322|520901872|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
144466290|NCT00374322|520901873|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
144612764|NCT00964743|521442824|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
144612765|NCT01549002|521442828|FG000|Overall Study|Excessive pain|0|||
144466291|NCT00374322|520901872|FG000|Overall Study|Did Not Receive Study Medication|8|||
144466292|NCT00374322|520901873|FG001|Overall Study|Did Not Receive Study Medication|6|||
144466293|NCT00450411|520901874|FG000|Overall Study|Protocol Violation|6|||
144466294|NCT00450411|520901874|FG000|Overall Study|No protocol treatment|2|||
144466295|NCT02130193|520901875|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
144466296|NCT02130193|520901876|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
144466297|NCT02130193|520901877|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
144466298|NCT02130193|520901875|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
144466299|NCT02130193|520901876|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
144612766|NCT01549002|521442829|FG001|Overall Study|Excessive pain|2|||
144612767|NCT01549002|521442828|FG000|Overall Study|Moderate sedation required|0|||
144726187|NCT00950807|521852690|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
144726188|NCT00950807|521852691|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
144726189|NCT00950807|521852692|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
144726190|NCT00950807|521852693|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
144726191|NCT00950807|521852694|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
144726192|NCT00950807|521852685|FG000|Washout Period 2|Adverse Event|3|||
144726193|NCT00950807|521852686|FG001|Washout Period 2|Adverse Event|0|||
144726194|NCT00950807|521852687|FG002|Washout Period 2|Adverse Event|0|||
144726195|NCT00950807|521852688|FG003|Washout Period 2|Adverse Event|1|||
144726196|NCT00950807|521852689|FG004|Washout Period 2|Adverse Event|0|||
144726197|NCT00950807|521852690|FG005|Washout Period 2|Adverse Event|0|||
144726198|NCT00950807|521852691|FG006|Washout Period 2|Adverse Event|0|||
144726199|NCT00950807|521852692|FG007|Washout Period 2|Adverse Event|0|||
144726200|NCT00950807|521852693|FG008|Washout Period 2|Adverse Event|0|||
144726201|NCT00950807|521852694|FG009|Washout Period 2|Adverse Event|0|||
144726202|NCT00950807|521852685|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144726203|NCT00950807|521852686|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144726204|NCT00950807|521852687|FG002|Treatment Period 3|Withdrawal by Subject|0|||
144726205|NCT00950807|521852688|FG003|Treatment Period 3|Withdrawal by Subject|0|||
144726206|NCT00950807|521852689|FG004|Treatment Period 3|Withdrawal by Subject|0|||
144726207|NCT00950807|521852690|FG005|Treatment Period 3|Withdrawal by Subject|0|||
144726208|NCT00950807|521852691|FG006|Treatment Period 3|Withdrawal by Subject|0|||
144726209|NCT00950807|521852692|FG007|Treatment Period 3|Withdrawal by Subject|0|||
144726210|NCT00950807|521852693|FG008|Treatment Period 3|Withdrawal by Subject|0|||
144726211|NCT00950807|521852694|FG009|Treatment Period 3|Withdrawal by Subject|1|||
144726212|NCT00950807|521852685|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
144726213|NCT00950807|521852686|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144612768|NCT01549002|521442829|FG001|Overall Study|Moderate sedation required|2|||
144612769|NCT00492752|521442830|FG000|Double Blind Treatment|Death|13|||
144612770|NCT00492752|521442831|FG001|Double Blind Treatment|Death|0|||
144612771|NCT00492752|521442832|FG002|Double Blind Treatment|Death|2|||
144612772|NCT00492752|521442833|FG003|Double Blind Treatment|Death|0|||
144612773|NCT00492752|521442830|FG000|Double Blind Treatment|Adverse Event|1|||
144612774|NCT00492752|521442831|FG001|Double Blind Treatment|Adverse Event|0|||
144612775|NCT00492752|521442832|FG002|Double Blind Treatment|Adverse Event|0|||
144612776|NCT00492752|521442833|FG003|Double Blind Treatment|Adverse Event|0|||
144612777|NCT00492752|521442830|FG000|Double Blind Treatment|Protocol Violation|0|||
144726214|NCT00950807|521852687|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726215|NCT00950807|521852688|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726216|NCT00950807|521852689|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726217|NCT00950807|521852690|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726218|NCT00950807|521852691|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726219|NCT00950807|521852692|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
144726220|NCT00950807|521852693|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726221|NCT00950807|521852694|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
144726222|NCT00950807|521852685|FG000|Treatment Period 3|Adverse Event|0|||
144726223|NCT00950807|521852686|FG001|Treatment Period 3|Adverse Event|0|||
144726224|NCT00950807|521852687|FG002|Treatment Period 3|Adverse Event|0|||
144726225|NCT00950807|521852688|FG003|Treatment Period 3|Adverse Event|0|||
144726226|NCT00950807|521852689|FG004|Treatment Period 3|Adverse Event|0|||
144726227|NCT00950807|521852690|FG005|Treatment Period 3|Adverse Event|0|||
144726228|NCT00950807|521852691|FG006|Treatment Period 3|Adverse Event|1|||
144726229|NCT00950807|521852692|FG007|Treatment Period 3|Adverse Event|0|||
144726230|NCT00950807|521852693|FG008|Treatment Period 3|Adverse Event|0|||
144466300|NCT02130193|520901877|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
144466301|NCT02130193|520901875|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
144466302|NCT02130193|520901876|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
144466303|NCT02130193|520901877|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
144466304|NCT02130193|520901875|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
144612778|NCT00492752|521442831|FG001|Double Blind Treatment|Protocol Violation|0|||
144466305|NCT02130193|520901876|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
144466306|NCT02130193|520901877|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
144612779|NCT00492752|521442832|FG002|Double Blind Treatment|Protocol Violation|1|||
144612780|NCT00492752|521442833|FG003|Double Blind Treatment|Protocol Violation|0|||
144612781|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
144612782|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
144726231|NCT00950807|521852694|FG009|Treatment Period 3|Adverse Event|0|||
144726232|NCT00337077|521852695|FG000|Overall Study|Progressive disease|25|||
144726233|NCT00337077|521852696|FG001|Overall Study|Progressive disease|37|||
144726234|NCT00337077|521852697|FG002|Overall Study|Progressive disease|19|||
144726235|NCT00337077|521852695|FG000|Overall Study|Adverse Event|7|||
144726236|NCT00337077|521852696|FG001|Overall Study|Adverse Event|7|||
144726237|NCT00337077|521852697|FG002|Overall Study|Adverse Event|1|||
144726238|NCT00337077|521852695|FG000|Overall Study|Death|0|||
144466307|NCT01297959|520901880|FG000|Overall Study|Adverse Event|0|||
144466308|NCT01297959|520901881|FG001|Overall Study|Adverse Event|1|||
144466309|NCT01297959|520901880|FG000|Overall Study|Protocol Violation|2|||
144466310|NCT01297959|520901881|FG001|Overall Study|Protocol Violation|1|||
144466311|NCT01297959|520901880|FG000|Overall Study|Withdrawal by Subject|5|||
144466312|NCT01297959|520901881|FG001|Overall Study|Withdrawal by Subject|4|||
144466313|NCT01297959|520901880|FG000|Overall Study|Physician Decision|0|||
144466314|NCT01297959|520901881|FG001|Overall Study|Physician Decision|1|||
144466315|NCT01297959|520901880|FG000|Overall Study|Unrelated medical illness / complication|0|||
144466316|NCT01297959|520901881|FG001|Overall Study|Unrelated medical illness / complication|2|||
144466317|NCT01297959|520901880|FG000|Overall Study|Other|13|||
144466318|NCT01297959|520901881|FG001|Overall Study|Other|7|||
144466319|NCT01667432|520901882|FG000|Overall Study|Premature Study Termination|26|||
144466320|NCT01667432|520901882|FG000|Overall Study|Failure to Return|10|||
144466321|NCT01667432|520901882|FG000|Overall Study|Moved to Another Center|3|||
144466322|NCT01667432|520901882|FG000|Overall Study|Lost to Follow-up|3|||
144466323|NCT01667432|520901882|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
144466324|NCT01667432|520901882|FG000|Overall Study|Insufficient Therapeutic Response|4|||
144466325|NCT01667432|520901882|FG000|Overall Study|Adverse Event|1|||
144466326|NCT01667432|520901882|FG000|Overall Study|Protocol Deviation|2|||
144466327|NCT01667432|520901882|FG000|Overall Study|Principal Investigator Decision|1|||
144466328|NCT01667432|520901882|FG000|Overall Study|Reason Not Specified|2|||
144466329|NCT01667432|520901882|FG000|Overall Study|Missing Information|4|||
144466330|NCT00344461|520901883|FG000|Overall Study|Adverse Event|6|||
144466331|NCT00344461|520901883|FG000|Overall Study|Death|1|||
144466332|NCT00344461|520901883|FG000|Overall Study|Lack of Efficacy|2|||
144466333|NCT00344461|520901883|FG000|Overall Study|Lost to Follow-up|2|||
144466334|NCT00344461|520901883|FG000|Overall Study|Physician Decision|2|||
144466335|NCT00344461|520901883|FG000|Overall Study|Protocol Violation|6|||
144466336|NCT00344461|520901883|FG000|Overall Study|Withdrawal by Subject|2|||
144466337|NCT00707031|520901893|FG000|Overall Study|Adverse Event|45|||
144466338|NCT00707031|520901894|FG001|Overall Study|Adverse Event|45|||
144466339|NCT00707031|520901893|FG000|Overall Study|Lack of Efficacy|19|||
144466340|NCT00707031|520901894|FG001|Overall Study|Lack of Efficacy|6|||
144466341|NCT00707031|520901893|FG000|Overall Study|Lost to Follow-up|2|||
144466342|NCT00707031|520901894|FG001|Overall Study|Lost to Follow-up|1|||
144466343|NCT00707031|520901893|FG000|Overall Study|Protocol Violation|1|||
144466344|NCT00707031|520901894|FG001|Overall Study|Protocol Violation|0|||
144466345|NCT00707031|520901893|FG000|Overall Study|Withdrawal by Subject|7|||
144466346|NCT00707031|520901894|FG001|Overall Study|Withdrawal by Subject|8|||
144466347|NCT00707031|520901893|FG000|Overall Study|Poor Compliance to Protocol|7|||
144466348|NCT00707031|520901894|FG001|Overall Study|Poor Compliance to Protocol|13|||
144466349|NCT00707031|520901893|FG000|Overall Study|Familial or Personal Reasons|12|||
144466350|NCT00707031|520901894|FG001|Overall Study|Familial or Personal Reasons|15|||
144466351|NCT00707031|520901893|FG000|Overall Study|Serious Noncompliance|2|||
144466352|NCT00707031|520901894|FG001|Overall Study|Serious Noncompliance|3|||
144466353|NCT00707031|520901893|FG000|Overall Study|Sponsor Decision|9|||
144466354|NCT00707031|520901894|FG001|Overall Study|Sponsor Decision|8|||
144466355|NCT03645759|520901900|FG000|Overall Study|Lost to Follow-up|3|||
144466356|NCT03645759|520901901|FG001|Overall Study|Lost to Follow-up|2|||
144466357|NCT00818753|520901902|FG000|Overall Study|Protocol Violation|1|||
144466358|NCT00818753|520901903|FG001|Overall Study|Protocol Violation|0|||
144466359|NCT00818753|520901904|FG002|Overall Study|Protocol Violation|0|||
144466360|NCT00818753|520901902|FG000|Overall Study|Other reason (not specified)|0|||
144466361|NCT00818753|520901903|FG001|Overall Study|Other reason (not specified)|0|||
144466362|NCT00818753|520901904|FG002|Overall Study|Other reason (not specified)|1|||
144466363|NCT00818753|520901902|FG000|Overall Study|Randomised and not treated|2|||
144466364|NCT00818753|520901903|FG001|Overall Study|Randomised and not treated|0|||
144466365|NCT00818753|520901904|FG002|Overall Study|Randomised and not treated|0|||
144466366|NCT01389973|520901905|FG000|Overall Study|Lost to Follow-up|1|||
144466367|NCT01389973|520901905|FG000|Overall Study|Trial Stopped by Sponsor|9|||
144466368|NCT01389973|520901905|FG000|Overall Study|Other|10|||
144466369|NCT00725296|520901906|FG000|Overall Study|Adverse Event|11|||
144466370|NCT00725296|520901906|FG000|Overall Study|Lack of Efficacy|7|||
144466371|NCT00725296|520901906|FG000|Overall Study|Withdrawal by Subject|3|||
144466372|NCT00725296|520901906|FG000|Overall Study|Non-Compliance|2|||
144466373|NCT00725296|520901906|FG000|Overall Study|Lost to Follow-up|1|||
144466374|NCT00725296|520901906|FG000|Overall Study|Other|38|||
144466375|NCT02693743|520901907|FG000|Overall Study|Physician Decision|1|||
144466376|NCT02693743|520901908|FG001|Overall Study|Physician Decision|0|||
144612783|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
144466377|NCT03360942|520901909|FG000|Overall Study|Device explanted|2|||
144466378|NCT03360942|520901909|FG000|Overall Study|Study closure|1|||
144466379|NCT03360942|520901909|FG000|Overall Study|Withdrawal by Subject|2|||
144466380|NCT02459574|520901915|FG000|Overall Study|Withdrawal by Subject|6|||
144612784|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
144466381|NCT02459574|520901916|FG001|Overall Study|Withdrawal by Subject|6|||
144466382|NCT02459574|520901917|FG002|Overall Study|Withdrawal by Subject|2|||
144197418|NCT00292188|519920251|FG000|Double-Blind|Lack of Efficacy|0|||
144466383|NCT02459574|520901915|FG000|Overall Study|Lost to Follow-up|1|||
144466384|NCT02459574|520901916|FG001|Overall Study|Lost to Follow-up|1|||
144466385|NCT02459574|520901917|FG002|Overall Study|Lost to Follow-up|0|||
144466386|NCT02459574|520901915|FG000|Overall Study|Death|0|||
144466387|NCT02459574|520901916|FG001|Overall Study|Death|1|||
144466388|NCT02459574|520901917|FG002|Overall Study|Death|0|||
144466389|NCT00251745|520901919|FG000|Overall Study|Adverse Event|7|||
144466390|NCT00251745|520901920|FG001|Overall Study|Adverse Event|9|||
144466391|NCT00251745|520901921|FG002|Overall Study|Adverse Event|11|||
144466392|NCT00251745|520901919|FG000|Overall Study|Lost to Follow-up|4|||
144466393|NCT00251745|520901920|FG001|Overall Study|Lost to Follow-up|2|||
144466394|NCT00251745|520901921|FG002|Overall Study|Lost to Follow-up|5|||
144466395|NCT00251745|520901919|FG000|Overall Study|Withdrawal by Subject|13|||
144466396|NCT00251745|520901920|FG001|Overall Study|Withdrawal by Subject|7|||
144466397|NCT00251745|520901921|FG002|Overall Study|Withdrawal by Subject|3|||
144466398|NCT00251745|520901919|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
144466399|NCT00251745|520901920|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
144466400|NCT00251745|520901921|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
144466401|NCT00251745|520901919|FG000|Overall Study|Lack of Efficacy|3|||
144466402|NCT00251745|520901920|FG001|Overall Study|Lack of Efficacy|0|||
144466403|NCT00251745|520901921|FG002|Overall Study|Lack of Efficacy|0|||
144466404|NCT00251745|520901919|FG000|Overall Study|Noncompliant|0|||
144466405|NCT00251745|520901920|FG001|Overall Study|Noncompliant|2|||
144466406|NCT00251745|520901921|FG002|Overall Study|Noncompliant|2|||
144466407|NCT00251745|520901919|FG000|Overall Study|Pregnancy|0|||
144466408|NCT00251745|520901920|FG001|Overall Study|Pregnancy|1|||
144466409|NCT00251745|520901921|FG002|Overall Study|Pregnancy|0|||
144466410|NCT00251745|520901919|FG000|Overall Study|Per Subject Request|0|||
144466411|NCT00251745|520901920|FG001|Overall Study|Per Subject Request|0|||
144466412|NCT00251745|520901921|FG002|Overall Study|Per Subject Request|1|||
144466413|NCT00251745|520901919|FG000|Overall Study|Per Investigator Request|1|||
144466414|NCT00251745|520901920|FG001|Overall Study|Per Investigator Request|0|||
144466415|NCT00251745|520901921|FG002|Overall Study|Per Investigator Request|0|||
144466416|NCT04508699|520901926|FG000|Overall Study|Lack of Efficacy|2|||
144466417|NCT04508699|520901927|FG001|Overall Study|Lack of Efficacy|15|||
144466418|NCT04508699|520901926|FG000|Overall Study|Withdrawal by Subject|0|||
144466419|NCT04508699|520901927|FG001|Overall Study|Withdrawal by Subject|2|||
144466420|NCT04866017|520901928|FG000|Overall Study|Study Terminated by Sponsor|13|||
144466421|NCT04866017|520901929|FG001|Overall Study|Study Terminated by Sponsor|14|||
144466422|NCT04866017|520901930|FG002|Overall Study|Study Terminated by Sponsor|13|||
144466423|NCT04866017|520901928|FG000|Overall Study|Death|8|||
144726239|NCT00337077|521852696|FG001|Overall Study|Death|1|||
144466424|NCT04866017|520901929|FG001|Overall Study|Death|4|||
144466425|NCT04866017|520901930|FG002|Overall Study|Death|8|||
144466426|NCT04866017|520901928|FG000|Overall Study|Withdrawal by Subject|1|||
144466427|NCT04866017|520901929|FG001|Overall Study|Withdrawal by Subject|0|||
144466428|NCT04866017|520901930|FG002|Overall Study|Withdrawal by Subject|1|||
144466429|NCT04866017|520901928|FG000|Overall Study|Physician Decision|0|||
144466430|NCT04866017|520901929|FG001|Overall Study|Physician Decision|1|||
144466431|NCT04866017|520901930|FG002|Overall Study|Physician Decision|0|||
144466432|NCT03355326|520901931|FG000|Overall Study|Protocol Violation|3|||
144466433|NCT03355326|520901932|FG001|Overall Study|Protocol Violation|3|||
144466434|NCT01111123|520903733|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
144466435|NCT01111123|520903734|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
144466436|NCT01111123|520903733|FG000|Maintenance Phase|Lost to Follow-up|0|||
144466437|NCT01111123|520903734|FG001|Maintenance Phase|Lost to Follow-up|2|||
144466438|NCT01203930|520903739|FG000|Overall Study|Disease Progression|0|||
144466439|NCT01203930|520903740|FG001|Overall Study|Disease Progression|4|||
144466440|NCT01203930|520903739|FG000|Overall Study|Death|3|||
144466441|NCT01203930|520903740|FG001|Overall Study|Death|1|||
144466442|NCT01203930|520903739|FG000|Overall Study|Withdrew Consent|1|||
144466443|NCT01203930|520903740|FG001|Overall Study|Withdrew Consent|10|||
144466444|NCT01203930|520903739|FG000|Overall Study|Investigator Request|0|||
144466445|NCT01203930|520903740|FG001|Overall Study|Investigator Request|8|||
144466446|NCT01203930|520903739|FG000|Overall Study|Study Terminated by Sponsor|0|||
144466447|NCT01203930|520903740|FG001|Overall Study|Study Terminated by Sponsor|12|||
144466448|NCT01203930|520903739|FG000|Overall Study|Poor tolerance of study drug|0|||
144466449|NCT01203930|520903740|FG001|Overall Study|Poor tolerance of study drug|1|||
144466450|NCT01203930|520903739|FG000|Overall Study|Adverse Event|17|||
144466451|NCT01203930|520903740|FG001|Overall Study|Adverse Event|5|||
144466452|NCT03014674|520903744|FG000|Overall Study|Withdrawal by Subject|1|||
144466453|NCT03014674|520903745|FG001|Overall Study|Withdrawal by Subject|0|||
144466454|NCT03014674|520903746|FG002|Overall Study|Withdrawal by Subject|0|||
144466455|NCT01332227|520903747|FG000|Overall Study|Adverse Event|4|||
144466456|NCT01332227|520903748|FG001|Overall Study|Adverse Event|1|||
144726240|NCT00337077|521852697|FG002|Overall Study|Death|0|||
144466457|NCT01332227|520903747|FG000|Overall Study|Withdrawal by Subject|5|||
144466458|NCT01332227|520903748|FG001|Overall Study|Withdrawal by Subject|1|||
144726241|NCT00337077|521852695|FG000|Overall Study|Withdrawal by Subject|7|||
144726242|NCT00337077|521852696|FG001|Overall Study|Withdrawal by Subject|2|||
144726243|NCT00337077|521852697|FG002|Overall Study|Withdrawal by Subject|2|||
144726244|NCT00337077|521852695|FG000|Overall Study|Alternative therapy|1|||
144726245|NCT00337077|521852696|FG001|Overall Study|Alternative therapy|0|||
144726246|NCT00337077|521852697|FG002|Overall Study|Alternative therapy|0|||
144726247|NCT00337077|521852695|FG000|Overall Study|Physician Decision|1|||
144726248|NCT00337077|521852696|FG001|Overall Study|Physician Decision|4|||
144726249|NCT00337077|521852697|FG002|Overall Study|Physician Decision|2|||
144726250|NCT00337077|521852695|FG000|Overall Study|Never started treatment|1|||
144726251|NCT00337077|521852696|FG001|Overall Study|Never started treatment|1|||
144726252|NCT00337077|521852697|FG002|Overall Study|Never started treatment|0|||
144726253|NCT00337077|521852695|FG000|Overall Study|Ineligible|1|||
144726254|NCT00337077|521852696|FG001|Overall Study|Ineligible|1|||
144726255|NCT00337077|521852697|FG002|Overall Study|Ineligible|1|||
144726256|NCT01492400|521852702|FG000|Overall Study|Miscellaneous Reasons|2|||
144726257|NCT01492400|521852703|FG001|Overall Study|Miscellaneous Reasons|3|||
144726258|NCT01492400|521852702|FG000|Overall Study|Personal Reasons|0|||
144726259|NCT01492400|521852703|FG001|Overall Study|Personal Reasons|5|||
144726260|NCT01492400|521852702|FG000|Overall Study|Lost to Follow-up|3|||
144726261|NCT01492400|521852703|FG001|Overall Study|Lost to Follow-up|1|||
144726262|NCT01492400|521852702|FG000|Overall Study|Pregnancy|0|||
144726263|NCT01492400|521852703|FG001|Overall Study|Pregnancy|1|||
144726264|NCT01492400|521852702|FG000|Overall Study|Lack of Efficacy|1|||
144726265|NCT01492400|521852703|FG001|Overall Study|Lack of Efficacy|1|||
144726266|NCT01492400|521852702|FG000|Overall Study|Adverse Event|10|||
144726267|NCT01492400|521852703|FG001|Overall Study|Adverse Event|5|||
144726268|NCT00659607|521852704|FG000|Overall Study|No blood pressure recorded|147|||
144726269|NCT00659607|521852704|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
144726270|NCT00659607|521852704|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
144726271|NCT00659607|521852704|FG000|Overall Study|No recorded efficacy data|15|||
144726272|NCT00659607|521852704|FG000|Overall Study|Inconsistent BP measuring date|2|||
144726273|NCT02899338|521852706|FG000|Overall Study|Adverse Event|1|||
144726274|NCT02899338|521852707|FG001|Overall Study|Adverse Event|2|||
144726275|NCT02899338|521852706|FG000|Overall Study|Withdrawal by Subject|2|||
144726276|NCT02899338|521852707|FG001|Overall Study|Withdrawal by Subject|0|||
144726277|NCT06179108|521852708|FG000|Overall Study|Withdrawal by Subject|16|||
144726278|NCT06179108|521852709|FG001|Overall Study|Withdrawal by Subject|19|||
144726279|NCT06179108|521852710|FG002|Overall Study|Withdrawal by Subject|10|||
144726280|NCT06179108|521852711|FG003|Overall Study|Withdrawal by Subject|11|||
144726281|NCT06179108|521852708|FG000|Overall Study|Lost to Follow-up|12|||
144726282|NCT06179108|521852709|FG001|Overall Study|Lost to Follow-up|4|||
144726283|NCT06179108|521852710|FG002|Overall Study|Lost to Follow-up|1|||
144726284|NCT06179108|521852711|FG003|Overall Study|Lost to Follow-up|9|||
144726285|NCT06179108|521852708|FG000|Overall Study|Adverse Event|2|||
144726286|NCT06179108|521852709|FG001|Overall Study|Adverse Event|3|||
144726287|NCT06179108|521852710|FG002|Overall Study|Adverse Event|3|||
144726288|NCT06179108|521852711|FG003|Overall Study|Adverse Event|2|||
144726289|NCT06179108|521852708|FG000|Overall Study|Protocol Violation|0|||
144726290|NCT06179108|521852709|FG001|Overall Study|Protocol Violation|1|||
144726291|NCT06179108|521852710|FG002|Overall Study|Protocol Violation|0|||
144726292|NCT06179108|521852711|FG003|Overall Study|Protocol Violation|1|||
144726293|NCT06179108|521852708|FG000|Overall Study|Physician Decision|1|||
144726294|NCT06179108|521852709|FG001|Overall Study|Physician Decision|1|||
144726295|NCT06179108|521852710|FG002|Overall Study|Physician Decision|0|||
144726296|NCT06179108|521852711|FG003|Overall Study|Physician Decision|0|||
144726297|NCT06179108|521852708|FG000|Overall Study|Lack of Efficacy|0|||
144726298|NCT06179108|521852709|FG001|Overall Study|Lack of Efficacy|0|||
144612785|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
144612786|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
144612787|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
144612788|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
144612789|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
144612790|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
144612791|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
144612792|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
144726299|NCT06179108|521852710|FG002|Overall Study|Lack of Efficacy|0|||
144726300|NCT06179108|521852711|FG003|Overall Study|Lack of Efficacy|1|||
144726301|NCT06179108|521852708|FG000|Overall Study|Death|0|||
144726302|NCT06179108|521852709|FG001|Overall Study|Death|0|||
144726303|NCT06179108|521852710|FG002|Overall Study|Death|0|||
144726304|NCT06179108|521852711|FG003|Overall Study|Death|1|||
144726305|NCT01370408|521852712|FG000|Overall Study|treatment failure|9|||
144726306|NCT05014412|521852714|FG000|Overall Study|Death|11|||
144726307|NCT05014412|521852715|FG001|Overall Study|Death|7|||
144726308|NCT05014412|521852716|FG002|Overall Study|Death|4|||
144726309|NCT05014412|521852717|FG003|Overall Study|Death|7|||
144726310|NCT05014412|521852714|FG000|Overall Study|Withdrawal by Subject|1|||
144726311|NCT05014412|521852715|FG001|Overall Study|Withdrawal by Subject|1|||
144536482|NCT00982644|521168419|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
144536483|NCT00982644|521168420|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
144536484|NCT00982644|521168419|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
144536485|NCT00982644|521168420|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
144536486|NCT00982644|521168419|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
144536487|NCT00982644|521168420|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
144536488|NCT00982644|521168419|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
144536489|NCT00982644|521168420|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
144536490|NCT00982644|521168419|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
144536491|NCT00982644|521168420|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
144536492|NCT00982644|521168419|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
144536493|NCT00982644|521168420|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
144536494|NCT00982644|521168419|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
144536495|NCT00982644|521168420|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
144536496|NCT00943917|521168421|FG000|Stage I|Adverse Event|1|||
144536497|NCT00943917|521168422|FG001|Stage I|Adverse Event|2|||
144536498|NCT00943917|521168423|FG002|Stage I|Adverse Event|2|||
144536499|NCT00943917|521168424|FG003|Stage I|Adverse Event|0|||
144536500|NCT00943917|521168425|FG004|Stage I|Adverse Event|0|||
144536501|NCT00943917|521168426|FG005|Stage I|Adverse Event|0|||
144536502|NCT00943917|521168427|FG006|Stage I|Adverse Event|0|||
144536503|NCT00943917|521168428|FG007|Stage I|Adverse Event|0|||
144536504|NCT00943917|521168429|FG008|Stage I|Adverse Event|0|||
144536505|NCT00943917|521168430|FG009|Stage I|Adverse Event|0|||
144536506|NCT00943917|521168431|FG010|Stage I|Adverse Event|0|||
144536507|NCT00943917|521168432|FG011|Stage I|Adverse Event|0|||
144536508|NCT00943917|521168433|FG012|Stage I|Adverse Event|0|||
144536509|NCT00943917|521168434|FG013|Stage I|Adverse Event|0|||
144536510|NCT00943917|521168435|FG014|Stage I|Adverse Event|0|||
144536511|NCT00943917|521168421|FG000|Stage I|Lost to Follow-up|0|||
144536512|NCT00943917|521168422|FG001|Stage I|Lost to Follow-up|0|||
144536513|NCT00943917|521168423|FG002|Stage I|Lost to Follow-up|1|||
144536514|NCT00943917|521168424|FG003|Stage I|Lost to Follow-up|0|||
144536515|NCT00943917|521168425|FG004|Stage I|Lost to Follow-up|0|||
144536516|NCT00943917|521168426|FG005|Stage I|Lost to Follow-up|0|||
144536517|NCT00943917|521168427|FG006|Stage I|Lost to Follow-up|0|||
144536518|NCT00943917|521168428|FG007|Stage I|Lost to Follow-up|0|||
144536519|NCT00943917|521168429|FG008|Stage I|Lost to Follow-up|0|||
144536520|NCT00943917|521168430|FG009|Stage I|Lost to Follow-up|0|||
144536521|NCT00943917|521168431|FG010|Stage I|Lost to Follow-up|0|||
144536522|NCT00943917|521168432|FG011|Stage I|Lost to Follow-up|0|||
144536523|NCT00943917|521168433|FG012|Stage I|Lost to Follow-up|0|||
144536524|NCT00943917|521168434|FG013|Stage I|Lost to Follow-up|0|||
144536525|NCT00943917|521168435|FG014|Stage I|Lost to Follow-up|0|||
144536526|NCT00943917|521168421|FG000|Stage I|hyperglycemia|0|||
144536527|NCT00943917|521168422|FG001|Stage I|hyperglycemia|0|||
144536528|NCT00943917|521168423|FG002|Stage I|hyperglycemia|1|||
144536529|NCT00943917|521168424|FG003|Stage I|hyperglycemia|0|||
144536530|NCT00943917|521168425|FG004|Stage I|hyperglycemia|0|||
144536531|NCT00943917|521168426|FG005|Stage I|hyperglycemia|0|||
144536532|NCT00943917|521168427|FG006|Stage I|hyperglycemia|0|||
144536533|NCT00943917|521168428|FG007|Stage I|hyperglycemia|0|||
144536534|NCT00943917|521168429|FG008|Stage I|hyperglycemia|0|||
144536535|NCT00943917|521168430|FG009|Stage I|hyperglycemia|0|||
144536536|NCT00943917|521168431|FG010|Stage I|hyperglycemia|0|||
144536537|NCT00943917|521168432|FG011|Stage I|hyperglycemia|0|||
144536538|NCT00943917|521168433|FG012|Stage I|hyperglycemia|0|||
144536539|NCT00943917|521168434|FG013|Stage I|hyperglycemia|0|||
144536540|NCT00943917|521168435|FG014|Stage I|hyperglycemia|0|||
144536541|NCT00943917|521168421|FG000|Stage I|A1C elevation|1|||
144536542|NCT00943917|521168422|FG001|Stage I|A1C elevation|0|||
144536543|NCT00943917|521168423|FG002|Stage I|A1C elevation|0|||
144536544|NCT00943917|521168424|FG003|Stage I|A1C elevation|0|||
144536545|NCT00943917|521168425|FG004|Stage I|A1C elevation|0|||
144536546|NCT00943917|521168426|FG005|Stage I|A1C elevation|0|||
144536547|NCT00943917|521168427|FG006|Stage I|A1C elevation|0|||
144536548|NCT00943917|521168428|FG007|Stage I|A1C elevation|0|||
144536549|NCT00943917|521168429|FG008|Stage I|A1C elevation|0|||
144536550|NCT00943917|521168430|FG009|Stage I|A1C elevation|0|||
144536551|NCT00943917|521168431|FG010|Stage I|A1C elevation|0|||
144536552|NCT00943917|521168432|FG011|Stage I|A1C elevation|0|||
144536553|NCT00943917|521168433|FG012|Stage I|A1C elevation|0|||
144536554|NCT00943917|521168434|FG013|Stage I|A1C elevation|0|||
144536555|NCT00943917|521168435|FG014|Stage I|A1C elevation|0|||
144536556|NCT00943917|521168421|FG000|Stage I|Withdrawal by Subject|2|||
144536557|NCT00943917|521168422|FG001|Stage I|Withdrawal by Subject|1|||
144536558|NCT00943917|521168423|FG002|Stage I|Withdrawal by Subject|2|||
144536559|NCT00943917|521168424|FG003|Stage I|Withdrawal by Subject|0|||
144536560|NCT00943917|521168425|FG004|Stage I|Withdrawal by Subject|0|||
144536561|NCT00943917|521168426|FG005|Stage I|Withdrawal by Subject|0|||
144536562|NCT00943917|521168427|FG006|Stage I|Withdrawal by Subject|0|||
144536563|NCT00943917|521168428|FG007|Stage I|Withdrawal by Subject|0|||
144466459|NCT01332227|520903747|FG000|Overall Study|Lost to Follow-up|2|||
144466460|NCT01332227|520903748|FG001|Overall Study|Lost to Follow-up|0|||
144466461|NCT01332227|520903747|FG000|Overall Study|Lack of Efficacy|3|||
144466462|NCT01332227|520903748|FG001|Overall Study|Lack of Efficacy|1|||
144466463|NCT01332227|520903747|FG000|Overall Study|Poor compliance/noncompliance|1|||
144466464|NCT01332227|520903748|FG001|Overall Study|Poor compliance/noncompliance|1|||
144466465|NCT01332227|520903747|FG000|Overall Study|Patient moved from area|1|||
144466466|NCT01332227|520903748|FG001|Overall Study|Patient moved from area|0|||
144466467|NCT01332227|520903747|FG000|Overall Study|Patient began prohibited medication|0|||
144466468|NCT01332227|520903748|FG001|Overall Study|Patient began prohibited medication|1|||
144466469|NCT00514943|520903749|FG000|Stage 1|Progressive disease|4|||
144466470|NCT00514943|520903750|FG001|Stage 1|Progressive disease|8|||
144466471|NCT00514943|520903749|FG000|Stage 1|Other Adverse Event|16|||
144466472|NCT00514943|520903750|FG001|Stage 1|Other Adverse Event|6|||
144466473|NCT00514943|520903749|FG000|Stage 1|Not treated|1|||
144466474|NCT00514943|520903750|FG001|Stage 1|Not treated|2|||
144466475|NCT00514943|520903749|FG000|Stage 1|Patient refused to continue study meds|8|||
144466476|NCT00514943|520903750|FG001|Stage 1|Patient refused to continue study meds|3|||
144466477|NCT00514943|520903749|FG000|Stage 1|Other than stated above|1|||
144466478|NCT00514943|520903750|FG001|Stage 1|Other than stated above|7|||
144466479|NCT00514943|520903749|FG000|Stage 2|Progressive disease|27|||
144466480|NCT00514943|520903750|FG001|Stage 2|Progressive disease|24|||
144466481|NCT00514943|520903749|FG000|Stage 2|Other Adverse Event|3|||
144466482|NCT00514943|520903750|FG001|Stage 2|Other Adverse Event|10|||
144466483|NCT00514943|520903749|FG000|Stage 2|Patient refused to continue study meds|2|||
144466484|NCT00514943|520903750|FG001|Stage 2|Patient refused to continue study meds|0|||
144466485|NCT00514943|520903749|FG000|Stage 2|Other than stated above|0|||
144466486|NCT00514943|520903750|FG001|Stage 2|Other than stated above|2|||
144466487|NCT03751631|520903756|FG000|Overall Study|Withdrawal by Subject|0|||
144466488|NCT03751631|520903757|FG001|Overall Study|Withdrawal by Subject|0|||
144466489|NCT03751631|520903758|FG002|Overall Study|Withdrawal by Subject|1|||
144466490|NCT03751631|520903759|FG003|Overall Study|Withdrawal by Subject|1|||
144466491|NCT03751631|520903760|FG004|Overall Study|Withdrawal by Subject|0|||
144466492|NCT03751631|520903761|FG005|Overall Study|Withdrawal by Subject|0|||
144466493|NCT03382782|520903762|FG000|Cohort 1|Withdrawal by Subject|11|||
144466494|NCT03382782|520903763|FG001|Cohort 1|Withdrawal by Subject|5|||
144466495|NCT03382782|520903764|FG002|Cohort 1|Withdrawal by Subject|0|||
144466496|NCT03382782|520903762|FG000|Cohort 2|Withdrawal by Subject|1|||
144466497|NCT03382782|520903763|FG001|Cohort 2|Withdrawal by Subject|1|||
144466498|NCT03382782|520903764|FG002|Cohort 2|Withdrawal by Subject|0|||
144466499|NCT03382782|520903762|FG000|Cohort 3|Withdrawal by Subject|1|||
144466500|NCT03382782|520903763|FG001|Cohort 3|Withdrawal by Subject|2|||
144466501|NCT03382782|520903764|FG002|Cohort 3|Withdrawal by Subject|0|||
144466502|NCT01791725|520903765|FG000|Overall Study|Withdrawal by Subject|0|||
144466503|NCT01791725|520903766|FG001|Overall Study|Withdrawal by Subject|1|||
144466504|NCT01791725|520903767|FG002|Overall Study|Withdrawal by Subject|0|||
144466505|NCT02366910|520903768|FG000|Overall Study|Withdrawal by Subject|2|||
144466506|NCT02366910|520903768|FG000|Overall Study|Screen Failure|3|||
144466507|NCT03813238|520903769|FG000|Overall Study|Adverse Event|0|||
144466508|NCT03813238|520903770|FG001|Overall Study|Adverse Event|6|||
144466509|NCT03813238|520903769|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144466510|NCT03813238|520903770|FG001|Overall Study|Withdrawal by parent/guardian|2|||
144466511|NCT03813238|520903769|FG000|Overall Study|Lost to Follow-up|0|||
144466512|NCT03813238|520903770|FG001|Overall Study|Lost to Follow-up|1|||
144466513|NCT03813238|520903769|FG000|Overall Study|Other than specified|1|||
144466514|NCT03813238|520903770|FG001|Overall Study|Other than specified|2|||
144466515|NCT00605293|520903771|FG000|Overall Study|Death|2|||
144466516|NCT00605293|520903772|FG001|Overall Study|Death|1|||
144466517|NCT00605293|520903771|FG000|Overall Study|Insufficient Therapeutic Response|2|||
144466518|NCT00605293|520903772|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144466519|NCT00605293|520903771|FG000|Overall Study|Adverse Event|1|||
144466520|NCT00605293|520903772|FG001|Overall Study|Adverse Event|0|||
144466521|NCT00605293|520903771|FG000|Overall Study|Holidays Dialysis Out|1|||
144466522|NCT00605293|520903772|FG001|Overall Study|Holidays Dialysis Out|0|||
144466523|NCT00605293|520903771|FG000|Overall Study|Blood Transfusion|7|||
144466524|NCT00605293|520903772|FG001|Overall Study|Blood Transfusion|1|||
144466525|NCT00605293|520903771|FG000|Overall Study|Renal Transplantation|3|||
144612793|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
144612794|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
144612795|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
144612796|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
144612797|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
144612798|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
144466526|NCT00605293|520903772|FG001|Overall Study|Renal Transplantation|1|||
144466527|NCT00605293|520903771|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
144466528|NCT00605293|520903772|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
144466529|NCT00605293|520903771|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
144466530|NCT00605293|520903772|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
144466531|NCT00605293|520903771|FG000|Overall Study|Principal Investigator Decision|0|||
144466532|NCT00605293|520903772|FG001|Overall Study|Principal Investigator Decision|1|||
144466533|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
144466534|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
144466535|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
144466536|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
144466537|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
144466538|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
144466539|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
144466540|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
144466541|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Other|18|||
144466542|NCT02565914|520903773|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
144466543|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
144466544|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Other|1|||
144466545|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
144466546|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
144466547|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
144466548|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
144466549|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
144466550|NCT02565914|520903773|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
144466551|NCT02565914|520903773|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
144466552|NCT02565914|520903773|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
144466553|NCT02565914|520903773|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
144466554|NCT02565914|520903773|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
144466555|NCT02565914|520903773|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
144466556|NCT02565914|520903773|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
144466557|NCT02080871|520903777|FG000|Overall Study|Death|1|||
144466558|NCT02080871|520903777|FG000|Overall Study|Lost to Follow-up|1|||
144466559|NCT00234052|520903778|FG000|Treatment|Withdrawal by Subject|3|||
144466560|NCT00234052|520903778|FG000|Treatment|Adverse Event|5|||
144466561|NCT00234052|520903778|FG000|Treatment|Death|2|||
144466562|NCT00234052|520903778|FG000|Treatment|Progressive Disease|11|||
144466563|NCT00234052|520903778|FG000|Follow-up for 5 Years|Death|41|||
144466564|NCT00234052|520903778|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
144466565|NCT00234052|520903778|FG000|Follow-up for 5 Years|Other|7|||
144466566|NCT01410474|520903779|FG000|Overall Study|Withdrawal by Subject|0|||
144466567|NCT01410474|520903780|FG001|Overall Study|Withdrawal by Subject|1|||
144466568|NCT02428296|520903781|FG000|Overall Study|Adverse Event|7|||
144466569|NCT02428296|520903781|FG000|Overall Study|Withdrawal by Subject|2|||
144466570|NCT00828984|520903782|FG000|Overall Study|Adverse Event|2|||
144466571|NCT00828984|520903783|FG001|Overall Study|Adverse Event|3|||
144466572|NCT00828984|520903784|FG002|Overall Study|Adverse Event|0|||
144466573|NCT00828984|520903782|FG000|Overall Study|Lost to Follow-up|5|||
144466574|NCT00828984|520903783|FG001|Overall Study|Lost to Follow-up|3|||
144466575|NCT00828984|520903784|FG002|Overall Study|Lost to Follow-up|1|||
144466576|NCT00828984|520903782|FG000|Overall Study|Withdrawal by Subject|4|||
144466577|NCT00828984|520903783|FG001|Overall Study|Withdrawal by Subject|4|||
144466578|NCT00828984|520903784|FG002|Overall Study|Withdrawal by Subject|4|||
144466579|NCT00828984|520903782|FG000|Overall Study|Ineligable|1|||
144466580|NCT00828984|520903783|FG001|Overall Study|Ineligable|2|||
144466581|NCT00828984|520903784|FG002|Overall Study|Ineligable|0|||
144466582|NCT00828984|520903782|FG000|Overall Study|Medical Contraindication|0|||
144466583|NCT00828984|520903783|FG001|Overall Study|Medical Contraindication|1|||
144466584|NCT00828984|520903784|FG002|Overall Study|Medical Contraindication|0|||
144466585|NCT00828984|520903782|FG000|Overall Study|Noncompliant|1|||
144466586|NCT00828984|520903783|FG001|Overall Study|Noncompliant|2|||
144466587|NCT00828984|520903784|FG002|Overall Study|Noncompliant|3|||
144466588|NCT00828984|520903782|FG000|Overall Study|ConMed|1|||
144466589|NCT00828984|520903783|FG001|Overall Study|ConMed|1|||
144466590|NCT00828984|520903784|FG002|Overall Study|ConMed|1|||
144466591|NCT00831779|520903790|FG000|Overall Study|Lost to Follow-up|1|||
144466592|NCT00831779|520903791|FG001|Overall Study|Lost to Follow-up|0|||
144612799|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
144612800|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
144612801|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
144612802|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
144466593|NCT00831779|520903790|FG000|Overall Study|No longer met criteria|0|||
144466594|NCT00831779|520903791|FG001|Overall Study|No longer met criteria|1|||
144466595|NCT02054806|520903792|FG000|Overall Study|Sponsor Decision|31|||
144466596|NCT02054806|520903792|FG000|Overall Study|Withdrawal by Subject|43|||
144726312|NCT05014412|521852716|FG002|Overall Study|Withdrawal by Subject|1|||
144726313|NCT05014412|521852717|FG003|Overall Study|Withdrawal by Subject|2|||
144726314|NCT05014412|521852714|FG000|Overall Study|Ongoing|21|||
144726315|NCT05014412|521852715|FG001|Overall Study|Ongoing|4|||
144726316|NCT05014412|521852716|FG002|Overall Study|Ongoing|6|||
144726317|NCT05014412|521852717|FG003|Overall Study|Ongoing|20|||
144726318|NCT02353169|521852718|FG000|Overall Study|QTc > 450 msec|1|||
144726319|NCT02353169|521852719|FG001|Overall Study|QTc > 450 msec|1|||
144726320|NCT02353169|521852720|FG002|Overall Study|QTc > 450 msec|1|||
144726321|NCT02353169|521852721|FG003|Overall Study|QTc > 450 msec|1|||
144726322|NCT02353169|521852718|FG000|Overall Study|OR team declined|2|||
144726323|NCT02353169|521852719|FG001|Overall Study|OR team declined|0|||
144726324|NCT02353169|521852720|FG002|Overall Study|OR team declined|0|||
144466597|NCT02054806|520903792|FG000|Overall Study|Protocol Violation|2|||
144466598|NCT02054806|520903792|FG000|Overall Study|Lost to Follow-up|10|||
144466599|NCT02054806|520903792|FG000|Overall Study|Death|391|||
144466600|NCT00952367|520903793|FG000|Overall Study|Withdrawal by Subject|2|||
144466601|NCT00952367|520903793|FG000|Overall Study|Noncoordination|1|||
144466602|NCT00952367|520903793|FG000|Overall Study|Protocol Violation|3|||
144466603|NCT02230956|520903794|FG000|Overall Study|Adverse Event|1|||
144466604|NCT02230956|520903795|FG001|Overall Study|Adverse Event|1|||
144466605|NCT02230956|520903796|FG002|Overall Study|Adverse Event|0|||
144466606|NCT02230956|520903794|FG000|Overall Study|Lack of Efficacy|1|||
144466607|NCT02230956|520903795|FG001|Overall Study|Lack of Efficacy|1|||
144466608|NCT02230956|520903796|FG002|Overall Study|Lack of Efficacy|1|||
144466609|NCT02230956|520903794|FG000|Overall Study|Lost to Follow-up|1|||
144466610|NCT02230956|520903795|FG001|Overall Study|Lost to Follow-up|1|||
144466611|NCT02230956|520903796|FG002|Overall Study|Lost to Follow-up|2|||
144466612|NCT02230956|520903794|FG000|Overall Study|Personal Reasons|2|||
144466613|NCT02230956|520903795|FG001|Overall Study|Personal Reasons|1|||
144466614|NCT02230956|520903796|FG002|Overall Study|Personal Reasons|1|||
144466615|NCT02230956|520903794|FG000|Overall Study|Protocol Violation|0|||
144466616|NCT02230956|520903795|FG001|Overall Study|Protocol Violation|1|||
144466617|NCT02230956|520903796|FG002|Overall Study|Protocol Violation|1|||
144466618|NCT02230956|520903794|FG000|Overall Study|Other Miscellaneous Reason|0|||
144466619|NCT02230956|520903795|FG001|Overall Study|Other Miscellaneous Reason|1|||
144466620|NCT02230956|520903796|FG002|Overall Study|Other Miscellaneous Reason|2|||
144466621|NCT04535947|520903797|FG000|Overall Study|Adverse Event|1|||
144466622|NCT04535947|520903798|FG001|Overall Study|Adverse Event|4|||
144466623|NCT04535947|520903797|FG000|Overall Study|Other reasons not specified|2|||
144466624|NCT04535947|520903798|FG001|Overall Study|Other reasons not specified|0|||
144466625|NCT04535947|520903797|FG000|Overall Study|Withdrawal by Subject|1|||
144466626|NCT04535947|520903798|FG001|Overall Study|Withdrawal by Subject|1|||
144466627|NCT03205371|520903803|FG000|Overall Study|Withdrawal by Subject|4|||
144466628|NCT03205371|520903804|FG001|Overall Study|Withdrawal by Subject|1|||
144466629|NCT03205371|520903805|FG002|Overall Study|Withdrawal by Subject|0|||
144466630|NCT03205371|520903806|FG003|Overall Study|Withdrawal by Subject|0|||
144466631|NCT03205371|520903807|FG004|Overall Study|Withdrawal by Subject|0|||
144466632|NCT03205371|520903808|FG005|Overall Study|Withdrawal by Subject|0|||
144466633|NCT03205371|520903809|FG006|Overall Study|Withdrawal by Subject|4|||
144466634|NCT03205371|520903810|FG007|Overall Study|Withdrawal by Subject|0|||
144466635|NCT03205371|520903811|FG008|Overall Study|Withdrawal by Subject|2|||
144466636|NCT03205371|520903812|FG009|Overall Study|Withdrawal by Subject|0|||
144466637|NCT03205371|520903813|FG010|Overall Study|Withdrawal by Subject|0|||
144466638|NCT03205371|520903814|FG011|Overall Study|Withdrawal by Subject|1|||
144466639|NCT03205371|520903803|FG000|Overall Study|Lost to Follow-up|0|||
144466640|NCT03205371|520903804|FG001|Overall Study|Lost to Follow-up|0|||
144466641|NCT03205371|520903805|FG002|Overall Study|Lost to Follow-up|0|||
144466642|NCT03205371|520903806|FG003|Overall Study|Lost to Follow-up|0|||
144466643|NCT03205371|520903807|FG004|Overall Study|Lost to Follow-up|0|||
144466644|NCT03205371|520903808|FG005|Overall Study|Lost to Follow-up|0|||
144726325|NCT02353169|521852721|FG003|Overall Study|OR team declined|0|||
144466645|NCT03205371|520903809|FG006|Overall Study|Lost to Follow-up|5|||
144466646|NCT03205371|520903810|FG007|Overall Study|Lost to Follow-up|2|||
144726326|NCT02353169|521852718|FG000|Overall Study|Inhalational induction|0|||
144466647|NCT03205371|520903811|FG008|Overall Study|Lost to Follow-up|3|||
144466648|NCT03205371|520903812|FG009|Overall Study|Lost to Follow-up|0|||
144466649|NCT03205371|520903813|FG010|Overall Study|Lost to Follow-up|0|||
144466650|NCT03205371|520903814|FG011|Overall Study|Lost to Follow-up|0|||
144466651|NCT03205371|520903803|FG000|Overall Study|Protocol Violation|0|||
144466652|NCT03205371|520903804|FG001|Overall Study|Protocol Violation|0|||
144726327|NCT02353169|521852719|FG001|Overall Study|Inhalational induction|2|||
144726328|NCT02353169|521852720|FG002|Overall Study|Inhalational induction|0|||
144466653|NCT03205371|520903805|FG002|Overall Study|Protocol Violation|0|||
144466654|NCT03205371|520903806|FG003|Overall Study|Protocol Violation|0|||
144466655|NCT03205371|520903807|FG004|Overall Study|Protocol Violation|0|||
144466656|NCT03205371|520903808|FG005|Overall Study|Protocol Violation|0|||
144466657|NCT03205371|520903809|FG006|Overall Study|Protocol Violation|1|||
144466658|NCT03205371|520903810|FG007|Overall Study|Protocol Violation|0|||
144726329|NCT02353169|521852721|FG003|Overall Study|Inhalational induction|0|||
144466659|NCT03205371|520903811|FG008|Overall Study|Protocol Violation|0|||
144466660|NCT03205371|520903812|FG009|Overall Study|Protocol Violation|0|||
144466661|NCT03205371|520903813|FG010|Overall Study|Protocol Violation|0|||
144466662|NCT03205371|520903814|FG011|Overall Study|Protocol Violation|0|||
144466663|NCT03205371|520903803|FG000|Overall Study|Adverse Event|0|||
144466664|NCT03205371|520903804|FG001|Overall Study|Adverse Event|0|||
144466665|NCT03205371|520903805|FG002|Overall Study|Adverse Event|0|||
144466666|NCT03205371|520903806|FG003|Overall Study|Adverse Event|0|||
144466667|NCT03205371|520903807|FG004|Overall Study|Adverse Event|0|||
144466668|NCT03205371|520903808|FG005|Overall Study|Adverse Event|0|||
144466669|NCT03205371|520903809|FG006|Overall Study|Adverse Event|0|||
144466670|NCT03205371|520903810|FG007|Overall Study|Adverse Event|1|||
144466671|NCT03205371|520903811|FG008|Overall Study|Adverse Event|0|||
144466672|NCT03205371|520903812|FG009|Overall Study|Adverse Event|0|||
144466673|NCT03205371|520903813|FG010|Overall Study|Adverse Event|0|||
144466674|NCT03205371|520903814|FG011|Overall Study|Adverse Event|0|||
144466675|NCT03575325|520903815|FG000|Overall Study|Death|1|||
144466676|NCT04575051|520903816|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
144466677|NCT04575051|520903817|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
144466678|NCT04575051|520903818|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
144466679|NCT04575051|520903819|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
144466680|NCT04575051|520903820|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
144466681|NCT04575051|520903816|FG000|Time Period 1|Missing follow up|1|||
144466682|NCT04575051|520903817|FG001|Time Period 1|Missing follow up|3|||
144466683|NCT04575051|520903818|FG002|Time Period 1|Missing follow up|1|||
144466684|NCT04575051|520903819|FG003|Time Period 1|Missing follow up|3|||
144466685|NCT04575051|520903820|FG004|Time Period 1|Missing follow up|2|||
144466686|NCT04575051|520903816|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
144466687|NCT04575051|520903817|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
144466688|NCT04575051|520903818|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
144466689|NCT04575051|520903819|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
144466690|NCT04575051|520903820|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
144466691|NCT04575051|520903816|FG000|Time Period 2|Missing follow up|1|||
144466692|NCT04575051|520903817|FG001|Time Period 2|Missing follow up|8|||
144466693|NCT04575051|520903818|FG002|Time Period 2|Missing follow up|7|||
144466694|NCT04575051|520903819|FG003|Time Period 2|Missing follow up|0|||
144466695|NCT04575051|520903820|FG004|Time Period 2|Missing follow up|1|||
144466696|NCT04575051|520903816|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
144466697|NCT04575051|520903817|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
144466698|NCT04575051|520903818|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
144466699|NCT04575051|520903819|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
144466700|NCT04575051|520903820|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
144466701|NCT04575051|520903816|FG000|Time Period 3|Missing follow up|8|||
144466702|NCT04575051|520903817|FG001|Time Period 3|Missing follow up|6|||
144466703|NCT04575051|520903818|FG002|Time Period 3|Missing follow up|4|||
144466704|NCT04575051|520903819|FG003|Time Period 3|Missing follow up|3|||
144466705|NCT04575051|520903820|FG004|Time Period 3|Missing follow up|0|||
144466706|NCT04575051|520903816|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
144466707|NCT04575051|520903817|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
144466708|NCT04575051|520903818|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
144466709|NCT04575051|520903819|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
144466710|NCT04575051|520903820|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
144466711|NCT04575051|520903816|FG000|Time Period 4|Missing follow up|17|||
144466712|NCT04575051|520903817|FG001|Time Period 4|Missing follow up|3|||
144466713|NCT04575051|520903818|FG002|Time Period 4|Missing follow up|4|||
144466714|NCT04575051|520903819|FG003|Time Period 4|Missing follow up|2|||
144466715|NCT04575051|520903820|FG004|Time Period 4|Missing follow up|1|||
144466716|NCT04575051|520903816|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
144466717|NCT04575051|520903817|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
144466718|NCT04575051|520903818|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
144466719|NCT04575051|520903819|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
144466720|NCT04575051|520903820|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
144466721|NCT04575051|520903816|FG000|Time Period 5|Missing follow up|11|||
144466722|NCT04575051|520903817|FG001|Time Period 5|Missing follow up|8|||
144466723|NCT04575051|520903818|FG002|Time Period 5|Missing follow up|12|||
144466724|NCT04575051|520903819|FG003|Time Period 5|Missing follow up|3|||
144612803|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
144612804|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
144612805|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
144612806|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
144466725|NCT04575051|520903820|FG004|Time Period 5|Missing follow up|11|||
144466726|NCT03178266|520903821|FG000|Overall Study|Death|0|||
144466727|NCT03178266|520903822|FG001|Overall Study|Death|1|||
144466728|NCT03178266|520903821|FG000|Overall Study|Disont. Early|0|||
144466729|NCT03178266|520903822|FG001|Overall Study|Disont. Early|1|||
144466730|NCT03178266|520903821|FG000|Overall Study|Withdrawal by Subject|0|||
144466731|NCT03178266|520903822|FG001|Overall Study|Withdrawal by Subject|2|||
144466732|NCT02363946|520903823|FG000|Overall Study|Lost to Follow-up|0|||
144466733|NCT02363946|520903824|FG001|Overall Study|Lost to Follow-up|0|||
144466734|NCT02363946|520903825|FG002|Overall Study|Lost to Follow-up|0|||
144466735|NCT02363946|520903826|FG003|Overall Study|Lost to Follow-up|0|||
144466736|NCT02363946|520903827|FG004|Overall Study|Lost to Follow-up|0|||
144612807|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
144612808|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
144612809|NCT00492752|521442830|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
144612810|NCT00492752|521442831|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
144612811|NCT00492752|521442832|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
144612812|NCT00492752|521442833|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
144612813|NCT00219284|521442834|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
144612814|NCT00219284|521442835|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
144612815|NCT00219284|521442834|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
144612816|NCT00219284|521442835|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
144612817|NCT00219284|521442834|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
144612818|NCT00219284|521442835|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
144612819|NCT00219284|521442834|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
144612820|NCT00219284|521442835|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
144612821|NCT00219284|521442834|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
144612822|NCT00219284|521442835|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
144612823|NCT00219284|521442834|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
144612824|NCT00219284|521442835|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
144612825|NCT00219284|521442834|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
144612826|NCT00219284|521442835|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
144612827|NCT00219284|521442834|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
144612828|NCT00219284|521442835|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
144612829|NCT00219284|521442834|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
144612830|NCT00219284|521442835|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
144612831|NCT01357655|521442836|FG000|Overall Study|Administrative Reason by Sponsor|45|||
144612832|NCT01357655|521442837|FG001|Overall Study|Administrative Reason by Sponsor|0|||
144612833|NCT01357655|521442836|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
144612834|NCT01357655|521442837|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144612835|NCT01357655|521442836|FG000|Overall Study|Disease Progression|1|||
144612836|NCT01357655|521442837|FG001|Overall Study|Disease Progression|0|||
144612837|NCT01357655|521442836|FG000|Overall Study|Lost to Follow-up|2|||
144612838|NCT01357655|521442837|FG001|Overall Study|Lost to Follow-up|0|||
144612839|NCT01357655|521442836|FG000|Overall Study|Maximum Clinical Benefit|2|||
144466737|NCT02363946|520903828|FG005|Overall Study|Lost to Follow-up|0|||
144466738|NCT02363946|520903829|FG006|Overall Study|Lost to Follow-up|0|||
144466739|NCT02363946|520903830|FG007|Overall Study|Lost to Follow-up|1|||
144466740|NCT02363946|520903831|FG008|Overall Study|Lost to Follow-up|0|||
144612840|NCT01357655|521442837|FG001|Overall Study|Maximum Clinical Benefit|0|||
144612841|NCT01357655|521442836|FG000|Overall Study|Reason Unspecified|1|||
144612842|NCT01357655|521442837|FG001|Overall Study|Reason Unspecified|0|||
144612843|NCT01357655|521442836|FG000|Overall Study|Study Drug Toxicity|11|||
144612844|NCT01357655|521442837|FG001|Overall Study|Study Drug Toxicity|0|||
144612845|NCT01357655|521442836|FG000|Overall Study|Subject Withdrew Consent|1|||
144612846|NCT01357655|521442837|FG001|Overall Study|Subject Withdrew Consent|0|||
144612847|NCT00880399|521443945|FG000|Overall Study|Adverse Event|4|||
144612848|NCT00880399|521443946|FG001|Overall Study|Adverse Event|6|||
144612849|NCT00880399|521443947|FG002|Overall Study|Adverse Event|5|||
144612850|NCT00880399|521443945|FG000|Overall Study|Lack of Efficacy|1|||
144612851|NCT00880399|521443946|FG001|Overall Study|Lack of Efficacy|4|||
144612852|NCT00880399|521443947|FG002|Overall Study|Lack of Efficacy|2|||
144612853|NCT00880399|521443945|FG000|Overall Study|Protocol Violation|4|||
144612854|NCT00880399|521443946|FG001|Overall Study|Protocol Violation|4|||
144612855|NCT00880399|521443947|FG002|Overall Study|Protocol Violation|6|||
144612856|NCT00880399|521443945|FG000|Overall Study|Study closed/terminated|3|||
144612857|NCT00880399|521443946|FG001|Overall Study|Study closed/terminated|7|||
144726330|NCT02353169|521852718|FG000|Overall Study|ECG data error|0|||
144726331|NCT02353169|521852719|FG001|Overall Study|ECG data error|3|||
144612858|NCT00880399|521443947|FG002|Overall Study|Study closed/terminated|4|||
144612859|NCT00880399|521443945|FG000|Overall Study|Lost to Follow-up|8|||
144466741|NCT02363946|520903832|FG009|Overall Study|Lost to Follow-up|0|||
144466742|NCT02363946|520903833|FG010|Overall Study|Lost to Follow-up|0|||
144466743|NCT02363946|520903834|FG011|Overall Study|Lost to Follow-up|0|||
144466744|NCT02363946|520903835|FG012|Overall Study|Lost to Follow-up|0|||
144466745|NCT00316082|520903842|FG000|Overall Study|Lack of Efficacy|2|||
144466746|NCT00316082|520903843|FG001|Overall Study|Lack of Efficacy|3|||
144466747|NCT00316082|520903844|FG002|Overall Study|Lack of Efficacy|3|||
144466748|NCT00316082|520903845|FG003|Overall Study|Lack of Efficacy|4|||
144466749|NCT00316082|520903846|FG004|Overall Study|Lack of Efficacy|6|||
144466750|NCT00316082|520903842|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
144466751|NCT00316082|520903843|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
144466752|NCT00316082|520903844|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
144466753|NCT00316082|520903845|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
144466754|NCT00316082|520903846|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
144466755|NCT00316082|520903842|FG000|Overall Study|Lost to Follow-up|7|||
144466756|NCT00316082|520903843|FG001|Overall Study|Lost to Follow-up|6|||
144466757|NCT00316082|520903844|FG002|Overall Study|Lost to Follow-up|7|||
144466758|NCT00316082|520903845|FG003|Overall Study|Lost to Follow-up|8|||
144466759|NCT00316082|520903846|FG004|Overall Study|Lost to Follow-up|6|||
144466760|NCT00316082|520903842|FG000|Overall Study|Poor/noncompliance|6|||
144466761|NCT00316082|520903843|FG001|Overall Study|Poor/noncompliance|1|||
144466762|NCT00316082|520903844|FG002|Overall Study|Poor/noncompliance|4|||
144466763|NCT00316082|520903845|FG003|Overall Study|Poor/noncompliance|1|||
144466764|NCT00316082|520903846|FG004|Overall Study|Poor/noncompliance|4|||
144466765|NCT00316082|520903842|FG000|Overall Study|Adverse Event|4|||
144466766|NCT00316082|520903843|FG001|Overall Study|Adverse Event|2|||
144466767|NCT00316082|520903844|FG002|Overall Study|Adverse Event|5|||
144466768|NCT00316082|520903845|FG003|Overall Study|Adverse Event|1|||
144466769|NCT00316082|520903846|FG004|Overall Study|Adverse Event|3|||
144466770|NCT00316082|520903842|FG000|Overall Study|Subject no longer meets study criteria|3|||
144466771|NCT00316082|520903843|FG001|Overall Study|Subject no longer meets study criteria|1|||
144466772|NCT00316082|520903844|FG002|Overall Study|Subject no longer meets study criteria|2|||
144466773|NCT00316082|520903845|FG003|Overall Study|Subject no longer meets study criteria|2|||
144466774|NCT00316082|520903846|FG004|Overall Study|Subject no longer meets study criteria|1|||
144466775|NCT00316082|520903842|FG000|Overall Study|Physician Decision|1|||
144466776|NCT00316082|520903843|FG001|Overall Study|Physician Decision|1|||
144466777|NCT00316082|520903844|FG002|Overall Study|Physician Decision|2|||
144466778|NCT00316082|520903845|FG003|Overall Study|Physician Decision|1|||
144466779|NCT00316082|520903846|FG004|Overall Study|Physician Decision|1|||
144466780|NCT00316082|520903842|FG000|Overall Study|Death|0|||
144466781|NCT00316082|520903843|FG001|Overall Study|Death|0|||
144466782|NCT00316082|520903844|FG002|Overall Study|Death|1|||
144466783|NCT00316082|520903845|FG003|Overall Study|Death|0|||
144466784|NCT00316082|520903846|FG004|Overall Study|Death|0|||
144466785|NCT00316082|520903842|FG000|Overall Study|Administrative reason by sponsor|0|||
144466786|NCT00316082|520903843|FG001|Overall Study|Administrative reason by sponsor|0|||
144466787|NCT00316082|520903844|FG002|Overall Study|Administrative reason by sponsor|1|||
144466788|NCT00316082|520903845|FG003|Overall Study|Administrative reason by sponsor|0|||
144466789|NCT00316082|520903846|FG004|Overall Study|Administrative reason by sponsor|0|||
144466790|NCT00528775|520903847|FG000|Overall Study|Other not specified|1|||
144466791|NCT01777854|520903856|FG000|Overall Study|Physician Decision|3|||
144466792|NCT01777854|520903857|FG001|Overall Study|Physician Decision|3|||
144466793|NCT03311373|520903860|FG000|Overall Study|Adverse Event|1|||
144466794|NCT03311373|520903860|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
144466795|NCT03311373|520903860|FG000|Overall Study|Lost to Follow-up|1|||
144466796|NCT03311373|520903860|FG000|Overall Study|Physician Decision|1|||
144726332|NCT02353169|521852720|FG002|Overall Study|ECG data error|2|||
144726333|NCT02353169|521852721|FG003|Overall Study|ECG data error|2|||
144466797|NCT03311373|520903860|FG000|Overall Study|Withdrawal by Subject|3|||
144466798|NCT01830127|520903863|FG000|Overall Study|Adverse Event|1|||
144466799|NCT01830127|520903864|FG001|Overall Study|Adverse Event|6|||
144466800|NCT01830127|520903863|FG000|Overall Study|Lack of Efficacy|3|||
144466801|NCT01830127|520903864|FG001|Overall Study|Lack of Efficacy|0|||
144466802|NCT01830127|520903863|FG000|Overall Study|Withdrawal by Subject|1|||
144466803|NCT01830127|520903864|FG001|Overall Study|Withdrawal by Subject|1|||
144466804|NCT01830127|520903863|FG000|Overall Study|Other reason not defined above|0|||
144466805|NCT01830127|520903864|FG001|Overall Study|Other reason not defined above|2|||
144466806|NCT00541450|520903865|FG000|Phase A|Adverse Event|3|||
144466807|NCT00541450|520903866|FG001|Phase A|Adverse Event|0|||
144466808|NCT00541450|520903865|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
144466809|NCT00541450|520903866|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
144466810|NCT00541450|520903865|FG000|Phase A|Hyperglycemia|0|||
144466811|NCT00541450|520903866|FG001|Phase A|Hyperglycemia|1|||
144466812|NCT00541450|520903865|FG000|Phase A|Lost to Follow-up|6|||
144466813|NCT00541450|520903866|FG001|Phase A|Lost to Follow-up|4|||
144466814|NCT00541450|520903865|FG000|Phase A|Physician Decision|2|||
144466815|NCT00541450|520903866|FG001|Phase A|Physician Decision|0|||
144466816|NCT00541450|520903865|FG000|Phase A|Protocol Violation|2|||
144466817|NCT00541450|520903866|FG001|Phase A|Protocol Violation|3|||
144466818|NCT00541450|520903865|FG000|Phase A|Withdrawal by Subject|7|||
144466819|NCT00541450|520903866|FG001|Phase A|Withdrawal by Subject|7|||
144466820|NCT00541450|520903865|FG000|Phase B|Adverse Event|6|||
144466821|NCT00541450|520903866|FG001|Phase B|Adverse Event|6|||
144466822|NCT00541450|520903865|FG000|Phase B|Hyperglycemia|10|||
144466823|NCT00541450|520903866|FG001|Phase B|Hyperglycemia|9|||
144466824|NCT00541450|520903865|FG000|Phase B|Lost to Follow-up|6|||
144466825|NCT00541450|520903866|FG001|Phase B|Lost to Follow-up|4|||
144466826|NCT00541450|520903865|FG000|Phase B|Physician Decision|4|||
144466827|NCT00541450|520903866|FG001|Phase B|Physician Decision|2|||
144466828|NCT00541450|520903865|FG000|Phase B|Pregnancy|0|||
144466829|NCT00541450|520903866|FG001|Phase B|Pregnancy|1|||
144466830|NCT00541450|520903865|FG000|Phase B|Protocol Violation|3|||
144466831|NCT00541450|520903866|FG001|Phase B|Protocol Violation|3|||
144612860|NCT00880399|521443946|FG001|Overall Study|Lost to Follow-up|5|||
144612861|NCT00880399|521443947|FG002|Overall Study|Lost to Follow-up|3|||
144612862|NCT00880399|521443945|FG000|Overall Study|Physician Decision|5|||
144612863|NCT00880399|521443946|FG001|Overall Study|Physician Decision|0|||
144612864|NCT00880399|521443947|FG002|Overall Study|Physician Decision|3|||
144612865|NCT00880399|521443945|FG000|Overall Study|Withdrawal by Subject|6|||
144612866|NCT00880399|521443946|FG001|Overall Study|Withdrawal by Subject|3|||
144612867|NCT00880399|521443947|FG002|Overall Study|Withdrawal by Subject|3|||
144612868|NCT01230307|521443948|FG000|Overall Study|LVAD Placement|0|||
144612869|NCT01230307|521443949|FG001|Overall Study|LVAD Placement|2|||
144612870|NCT02256540|521443953|FG000|Overall Study|Withdrawal by Subject|0|||
144612871|NCT02256540|521443954|FG001|Overall Study|Withdrawal by Subject|1|||
144612872|NCT02256540|521443955|FG002|Overall Study|Withdrawal by Subject|1|||
144612873|NCT02256540|521443953|FG000|Overall Study|Back pain preventing exercise|0|||
144612874|NCT02256540|521443954|FG001|Overall Study|Back pain preventing exercise|0|||
144612875|NCT02256540|521443955|FG002|Overall Study|Back pain preventing exercise|1|||
144612876|NCT01230242|521443956|FG000|Overall Study|Physician Decision|2|||
144612877|NCT01230242|521443956|FG000|Overall Study|Withdrawal by Subject|1|||
144612878|NCT03923426|521443957|FG000|Overall Study|Other|19|||
144612879|NCT03923426|521443957|FG000|Overall Study|Lost to Follow-up|16|||
144612880|NCT03923426|521443957|FG000|Overall Study|Death|107|||
144612881|NCT03923426|521443957|FG000|Overall Study|Incomplete response to question|13|||
144612882|NCT01918007|521443958|FG000|Overall Study|Baseline oximetry not acceptable|11|||
144612883|NCT01918007|521443959|FG001|Overall Study|Baseline oximetry not acceptable|7|||
144612884|NCT01918007|521443958|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
144612885|NCT01918007|521443959|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
144612886|NCT01918007|521443958|FG000|Overall Study|Lost to Follow-up|4|||
144612887|NCT01918007|521443959|FG001|Overall Study|Lost to Follow-up|7|||
144612888|NCT01140451|521443961|FG000|Overall Study|Withdrawal by Subject|26|||
144612889|NCT01140451|521443962|FG001|Overall Study|Withdrawal by Subject|33|||
144612890|NCT01140451|521443961|FG000|Overall Study|Adverse Event|2|||
144612891|NCT01140451|521443962|FG001|Overall Study|Adverse Event|6|||
144612892|NCT01140451|521443961|FG000|Overall Study|Physician Decision|5|||
144612893|NCT01140451|521443962|FG001|Overall Study|Physician Decision|3|||
144612894|NCT01140451|521443961|FG000|Overall Study|Lost to Follow-up|2|||
144612895|NCT01140451|521443962|FG001|Overall Study|Lost to Follow-up|0|||
144612896|NCT01140451|521443961|FG000|Overall Study|Participants Planning Pregnancy|3|||
144612897|NCT01140451|521443962|FG001|Overall Study|Participants Planning Pregnancy|0|||
144612898|NCT00441974|521443963|FG000|Overall Study|Adverse Event|6|||
144612899|NCT00441974|521443963|FG000|Overall Study|Consent Withdrawn|35|||
144612900|NCT00441974|521443963|FG000|Overall Study|Lost to Follow-up|80|||
144612901|NCT00441974|521443963|FG000|Overall Study|Protocol Violation|7|||
144612902|NCT04962022|521443970|FG000|Period 1|Withdrawal by Subject|1|||
144612903|NCT04962022|521443971|FG001|Period 1|Withdrawal by Subject|0|||
144612904|NCT00530270|521443974|FG000|Overall Study|Protocol Violation|1|||
144612905|NCT00530270|521443975|FG001|Overall Study|Protocol Violation|0|||
144612906|NCT02004262|521443978|FG000|Overall Study|Death|67|||
144612907|NCT02004262|521443979|FG001|Overall Study|Death|64|||
144612908|NCT02004262|521443980|FG002|Overall Study|Death|66|||
144612909|NCT02004262|521443981|FG003|Overall Study|Death|28|||
144612910|NCT02004262|521443982|FG004|Overall Study|Death|29|||
144466832|NCT00541450|520903865|FG000|Phase B|Withdrawal by Subject|8|||
144466833|NCT00541450|520903866|FG001|Phase B|Withdrawal by Subject|6|||
144466834|NCT02048072|520903867|FG000|Overall Study|Adverse Event|3|||
144466835|NCT02048072|520903867|FG000|Overall Study|Lost to Follow-up|1|||
144466836|NCT01112579|520903868|FG000|Overall Study|Missed Visit|1|||
144466837|NCT01112579|520903869|FG001|Overall Study|Missed Visit|1|||
144612911|NCT02004262|521443983|FG005|Overall Study|Death|22|||
144612912|NCT02004262|521443978|FG000|Overall Study|Withdrawal by Subject|1|||
144612913|NCT02004262|521443979|FG001|Overall Study|Withdrawal by Subject|0|||
144612914|NCT02004262|521443980|FG002|Overall Study|Withdrawal by Subject|4|||
144612915|NCT02004262|521443981|FG003|Overall Study|Withdrawal by Subject|0|||
144612916|NCT02004262|521443982|FG004|Overall Study|Withdrawal by Subject|1|||
144466838|NCT01112579|520903868|FG000|Overall Study|Death|0|||
144466839|NCT01112579|520903869|FG001|Overall Study|Death|2|||
144466840|NCT01648270|520903870|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
144466841|NCT00902694|520903871|FG000|Overall Study|Death|1|||
144466842|NCT00902694|520903872|FG001|Overall Study|Death|3|||
144612917|NCT02004262|521443983|FG005|Overall Study|Withdrawal by Subject|3|||
144197419|NCT00292188|519920252|FG001|Double-Blind|Lack of Efficacy|2|||
144197420|NCT00292188|519920253|FG002|Double-Blind|Lack of Efficacy|12|||
144197421|NCT00292188|519920251|FG000|Double-Blind|Lost to Follow-up|0|||
144197422|NCT00292188|519920252|FG001|Double-Blind|Lost to Follow-up|1|||
144197423|NCT00292188|519920253|FG002|Double-Blind|Lost to Follow-up|0|||
144197424|NCT00292188|519920251|FG000|Double-Blind|Other|0|||
144197425|NCT00292188|519920252|FG001|Double-Blind|Other|3|||
144197426|NCT00292188|519920253|FG002|Double-Blind|Other|4|||
144197427|NCT00292188|519920251|FG000|Double-Blind|Withdrawal by Subject|0|||
144197428|NCT00292188|519920252|FG001|Double-Blind|Withdrawal by Subject|0|||
144197429|NCT00292188|519920253|FG002|Double-Blind|Withdrawal by Subject|3|||
144197430|NCT00292188|519920251|FG000|Double-Blind|Laboratory Abnormality|0|||
144197431|NCT00292188|519920252|FG001|Double-Blind|Laboratory Abnormality|0|||
144466843|NCT00902694|520903871|FG000|Overall Study|Lost to Follow-up|1|||
144612918|NCT02004262|521443978|FG000|Overall Study|Lost to Follow-up|1|||
144612919|NCT02004262|521443979|FG001|Overall Study|Lost to Follow-up|1|||
144612920|NCT02004262|521443980|FG002|Overall Study|Lost to Follow-up|0|||
144612921|NCT02004262|521443981|FG003|Overall Study|Lost to Follow-up|0|||
144612922|NCT02004262|521443982|FG004|Overall Study|Lost to Follow-up|0|||
144612923|NCT02004262|521443983|FG005|Overall Study|Lost to Follow-up|0|||
144612924|NCT02004262|521443978|FG000|Overall Study|Study Terminated by Sponsor|4|||
144612925|NCT02004262|521443979|FG001|Overall Study|Study Terminated by Sponsor|3|||
144612926|NCT02004262|521443980|FG002|Overall Study|Study Terminated by Sponsor|2|||
144612927|NCT02004262|521443981|FG003|Overall Study|Study Terminated by Sponsor|1|||
144612928|NCT02004262|521443982|FG004|Overall Study|Study Terminated by Sponsor|1|||
144612929|NCT02004262|521443983|FG005|Overall Study|Study Terminated by Sponsor|5|||
144612930|NCT00552175|521443986|FG000|Overall Study|Lack of Efficacy|2|||
144612931|NCT00552175|521443987|FG001|Overall Study|Lack of Efficacy|0|||
144612932|NCT00552175|521443988|FG002|Overall Study|Lack of Efficacy|1|||
144612933|NCT00552175|521443986|FG000|Overall Study|Adverse Event|9|||
144612934|NCT00552175|521443987|FG001|Overall Study|Adverse Event|9|||
144612935|NCT00552175|521443988|FG002|Overall Study|Adverse Event|10|||
144612936|NCT00552175|521443986|FG000|Overall Study|Withdrawal by Subject|2|||
144612937|NCT00552175|521443987|FG001|Overall Study|Withdrawal by Subject|2|||
144612938|NCT00552175|521443988|FG002|Overall Study|Withdrawal by Subject|1|||
144612939|NCT00552175|521443986|FG000|Overall Study|Lost to Follow-up|0|||
144612940|NCT00552175|521443987|FG001|Overall Study|Lost to Follow-up|0|||
144612941|NCT00552175|521443988|FG002|Overall Study|Lost to Follow-up|1|||
144612942|NCT00552175|521443986|FG000|Overall Study|Entry Criteria Not Met|1|||
144612943|NCT00552175|521443987|FG001|Overall Study|Entry Criteria Not Met|1|||
144612944|NCT00552175|521443988|FG002|Overall Study|Entry Criteria Not Met|0|||
144612945|NCT00552175|521443986|FG000|Overall Study|Reason Not Specified|3|||
144612946|NCT00552175|521443987|FG001|Overall Study|Reason Not Specified|1|||
144612947|NCT00552175|521443988|FG002|Overall Study|Reason Not Specified|1|||
144612948|NCT00750737|521443989|FG000|Overall Study|Withdrawal by Subject|3|||
144612949|NCT00750737|521443990|FG001|Overall Study|Withdrawal by Subject|3|||
144612950|NCT02919436|521443991|FG000|Overall Study|Did not undergo surgery|16|||
144612951|NCT02919436|521443992|FG001|Overall Study|Did not undergo surgery|20|||
144612952|NCT02919436|521443991|FG000|Overall Study|Enrolled before trial registration|44|||
144612953|NCT02919436|521443992|FG001|Overall Study|Enrolled before trial registration|33|||
144612954|NCT01389752|521443993|FG000|Study Period 1|Sponsor decision|0|||
144612955|NCT01389752|521443994|FG001|Study Period 1|Sponsor decision|2|||
144612956|NCT01389752|521443993|FG000|Study Period 2|Sponsor decision|1|||
144612957|NCT01389752|521443994|FG001|Study Period 2|Sponsor decision|0|||
144612958|NCT00053417|521444005|FG000|Overall Study|Adverse Event|1|||
144612959|NCT00053417|521444006|FG001|Overall Study|Adverse Event|0|||
144612960|NCT00053417|521444007|FG002|Overall Study|Adverse Event|1|||
144612961|NCT00053417|521444008|FG003|Overall Study|Adverse Event|5|||
144612962|NCT00053417|521444005|FG000|Overall Study|Non-Compliance|0|||
144612963|NCT00053417|521444006|FG001|Overall Study|Non-Compliance|0|||
144612964|NCT00053417|521444007|FG002|Overall Study|Non-Compliance|0|||
144612965|NCT00053417|521444008|FG003|Overall Study|Non-Compliance|1|||
144612966|NCT00053417|521444005|FG000|Overall Study|Withdrawal by Subject|0|||
144612967|NCT00053417|521444006|FG001|Overall Study|Withdrawal by Subject|1|||
144612968|NCT00053417|521444007|FG002|Overall Study|Withdrawal by Subject|0|||
144612969|NCT00053417|521444008|FG003|Overall Study|Withdrawal by Subject|0|||
144612970|NCT00053417|521444005|FG000|Overall Study|Lost to Follow-up|1|||
144612971|NCT00053417|521444006|FG001|Overall Study|Lost to Follow-up|1|||
144612972|NCT00053417|521444007|FG002|Overall Study|Lost to Follow-up|0|||
144197432|NCT00292188|519920253|FG002|Double-Blind|Laboratory Abnormality|1|||
144466844|NCT00902694|520903872|FG001|Overall Study|Lost to Follow-up|0|||
144612973|NCT00053417|521444008|FG003|Overall Study|Lost to Follow-up|0|||
144612974|NCT02409290|521444009|FG000|Overall Study|Protocol Violation|3|||
144612975|NCT02409290|521444010|FG001|Overall Study|Protocol Violation|6|||
144612976|NCT02409290|521444011|FG002|Overall Study|Protocol Violation|9|||
144612977|NCT02409290|521444012|FG003|Overall Study|Protocol Violation|4|||
144612978|NCT02409290|521444009|FG000|Overall Study|No positive culture/no baseline sample|3|||
144612979|NCT02409290|521444010|FG001|Overall Study|No positive culture/no baseline sample|9|||
144612980|NCT02409290|521444011|FG002|Overall Study|No positive culture/no baseline sample|6|||
144612981|NCT02409290|521444012|FG003|Overall Study|No positive culture/no baseline sample|5|||
144612982|NCT02409290|521444009|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
144612983|NCT02409290|521444010|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
144612984|NCT02409290|521444011|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
144612985|NCT02409290|521444012|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
144197433|NCT04322149|519920254|FG000|Overall Study|Adverse Event|1|||
144197434|NCT04322149|519920255|FG001|Overall Study|Adverse Event|1|||
144197435|NCT04322149|519920256|FG002|Overall Study|Adverse Event|0|||
144612986|NCT02230384|521444016|FG000|Phase 1|Lost to Follow-up|1|||
144612987|NCT02230384|521444017|FG001|Phase 1|Lost to Follow-up|0|||
144612988|NCT02230384|521444016|FG000|Phase 1|Physician Decision|0|||
144612989|NCT02230384|521444017|FG001|Phase 1|Physician Decision|1|||
144197436|NCT04322149|519920257|FG003|Overall Study|Adverse Event|0|||
144197437|NCT04322149|519920254|FG000|Overall Study|Withdrawal by Subject|0|||
144197438|NCT04322149|519920255|FG001|Overall Study|Withdrawal by Subject|0|||
144197439|NCT04322149|519920256|FG002|Overall Study|Withdrawal by Subject|0|||
144197440|NCT04322149|519920257|FG003|Overall Study|Withdrawal by Subject|2|||
144197441|NCT04322149|519920254|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
144197442|NCT04322149|519920255|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
144197443|NCT04322149|519920256|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
144612990|NCT02230384|521444016|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
144612991|NCT02230384|521444017|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
144612992|NCT02230384|521444016|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
144612993|NCT02230384|521444017|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
144612994|NCT02230384|521444016|FG000|Phase 2 - Switch|Adverse Event|2|||
144612995|NCT02230384|521444017|FG001|Phase 2 - Switch|Adverse Event|0|||
144612996|NCT00282334|521444019|FG000|Overall Study|Withdrawal by Subject|8|||
144612997|NCT00282334|521444020|FG001|Overall Study|Withdrawal by Subject|5|||
144612998|NCT00781911|521444027|FG000|Overall Study|Adverse Event|4|||
144612999|NCT00781911|521444028|FG001|Overall Study|Adverse Event|4|||
144613000|NCT00781911|521444027|FG000|Overall Study|Withdrawal by Subject|1|||
144613001|NCT00781911|521444028|FG001|Overall Study|Withdrawal by Subject|2|||
144613002|NCT00781911|521444027|FG000|Overall Study|Physician Decision|0|||
144613003|NCT00781911|521444028|FG001|Overall Study|Physician Decision|2|||
144613004|NCT00781911|521444027|FG000|Overall Study|Sponsor Decision|1|||
144197444|NCT04322149|519920257|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
144197445|NCT01700049|519920264|FG000|Overall Study|Withdrawal by Subject|1|||
144197446|NCT03084367|519920267|FG000|Overall Study|Lost to Follow-up|32|||
144197447|NCT03084367|519920267|FG000|Overall Study|Withdrawal by Subject|4|||
144197448|NCT03084367|519920267|FG000|Overall Study|Other|1|||
144197449|NCT01206101|519920268|FG000|Overall Study|Adverse Event|1|||
144197450|NCT01206101|519920269|FG001|Overall Study|Adverse Event|0|||
144197451|NCT01206101|519920268|FG000|Overall Study|Physician Decision|0|||
144466845|NCT00902694|520903871|FG000|Overall Study|Censored per protocol|3|||
144466846|NCT00902694|520903872|FG001|Overall Study|Censored per protocol|1|||
144466847|NCT00902694|520903871|FG000|Overall Study|Pregnancy|1|||
144466848|NCT00902694|520903872|FG001|Overall Study|Pregnancy|1|||
144466849|NCT00902694|520903871|FG000|Overall Study|Incarceration|1|||
144466850|NCT00902694|520903872|FG001|Overall Study|Incarceration|0|||
144466851|NCT04969263|520903873|FG000|Overall Study|Death|1|||
144466852|NCT04969263|520903873|FG000|Overall Study|Lost to Follow-up|2|||
144466853|NCT04969263|520903873|FG000|Overall Study|Withdrawal by Subject|5|||
144466854|NCT04969263|520903873|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
144466855|NCT03456700|520903874|FG000|Overall Study|Withdrawal by Subject|1|||
144466856|NCT04154787|520903875|FG000|Overall Study|Adverse Event|0|||
144466857|NCT04154787|520903876|FG001|Overall Study|Adverse Event|1|||
144466858|NCT04154787|520903877|FG002|Overall Study|Adverse Event|0|||
144466859|NCT04154787|520903875|FG000|Overall Study|Patient Requires Other Treatment|0|||
144466860|NCT04154787|520903876|FG001|Overall Study|Patient Requires Other Treatment|1|||
144466861|NCT04154787|520903877|FG002|Overall Study|Patient Requires Other Treatment|0|||
144466862|NCT04154787|520903875|FG000|Overall Study|Study Terminated By Sponsor|0|||
144466863|NCT04154787|520903876|FG001|Overall Study|Study Terminated By Sponsor|6|||
144613005|NCT00781911|521444028|FG001|Overall Study|Sponsor Decision|0|||
144613006|NCT03317795|521444033|FG000|Overall Study|IUD Expulsion|1|||
144613007|NCT03317795|521444034|FG001|Overall Study|IUD Expulsion|0|||
144613008|NCT03317795|521444033|FG000|Overall Study|Lost to Follow-up|1|||
144613009|NCT03317795|521444034|FG001|Overall Study|Lost to Follow-up|3|||
144613010|NCT03317795|521444033|FG000|Overall Study|Treatment change|0|||
144613011|NCT03317795|521444034|FG001|Overall Study|Treatment change|3|||
144613012|NCT03317795|521444033|FG000|Overall Study|Intolerance of medication|0|||
144466864|NCT04154787|520903877|FG002|Overall Study|Study Terminated By Sponsor|1|||
144466865|NCT04154787|520903875|FG000|Overall Study|Subject Decision|0|||
144466866|NCT04154787|520903876|FG001|Overall Study|Subject Decision|1|||
144466867|NCT04154787|520903877|FG002|Overall Study|Subject Decision|0|||
144466868|NCT04154787|520903875|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
144466869|NCT04154787|520903876|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
144466870|NCT04154787|520903877|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
144466871|NCT03053050|520903878|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
144466872|NCT03053050|520903879|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
144466873|NCT03053050|520903880|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
144466874|NCT03053050|520903881|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
144466875|NCT03053050|520903878|FG000|Randomized Phase|Withdrew Consent|16|||
144466876|NCT03053050|520903879|FG001|Randomized Phase|Withdrew Consent|8|||
144466877|NCT03053050|520903880|FG002|Randomized Phase|Withdrew Consent|9|||
144466878|NCT03053050|520903881|FG003|Randomized Phase|Withdrew Consent|0|||
144466879|NCT03053050|520903878|FG000|Randomized Phase|Investigator's Discretion|6|||
144466880|NCT03053050|520903879|FG001|Randomized Phase|Investigator's Discretion|6|||
144466881|NCT03053050|520903880|FG002|Randomized Phase|Investigator's Discretion|3|||
144466882|NCT03053050|520903881|FG003|Randomized Phase|Investigator's Discretion|0|||
144466883|NCT03053050|520903878|FG000|Randomized Phase|Lost to Follow-up|5|||
144466884|NCT03053050|520903879|FG001|Randomized Phase|Lost to Follow-up|1|||
144466885|NCT03053050|520903880|FG002|Randomized Phase|Lost to Follow-up|1|||
144466886|NCT03053050|520903881|FG003|Randomized Phase|Lost to Follow-up|0|||
144466887|NCT03053050|520903878|FG000|Randomized Phase|Adverse Event|0|||
144466888|NCT03053050|520903879|FG001|Randomized Phase|Adverse Event|1|||
144466889|NCT03053050|520903880|FG002|Randomized Phase|Adverse Event|0|||
144466890|NCT03053050|520903881|FG003|Randomized Phase|Adverse Event|0|||
144466891|NCT03053050|520903878|FG000|Randomized Phase|Randomized but Never Treated|2|||
144466892|NCT03053050|520903879|FG001|Randomized Phase|Randomized but Never Treated|2|||
144466893|NCT03053050|520903880|FG002|Randomized Phase|Randomized but Never Treated|2|||
144466894|NCT03053050|520903881|FG003|Randomized Phase|Randomized but Never Treated|0|||
144466895|NCT03053050|520903878|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
144466896|NCT03053050|520903879|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
144466897|NCT03053050|520903880|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
144466898|NCT03053050|520903881|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
144466899|NCT03053050|520903878|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
144466900|NCT03053050|520903879|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
144466901|NCT03053050|520903880|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
144466902|NCT03053050|520903881|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
144466903|NCT03053050|520903878|FG000|Open-label Phase|Withdrew Consent|0|||
144466904|NCT03053050|520903879|FG001|Open-label Phase|Withdrew Consent|0|||
144466905|NCT03053050|520903880|FG002|Open-label Phase|Withdrew Consent|0|||
144466906|NCT03053050|520903881|FG003|Open-label Phase|Withdrew Consent|6|||
144466907|NCT03053050|520903878|FG000|Open-label Phase|Investigator's Discretion|0|||
144466908|NCT03053050|520903879|FG001|Open-label Phase|Investigator's Discretion|0|||
144466909|NCT03053050|520903880|FG002|Open-label Phase|Investigator's Discretion|0|||
144466910|NCT03053050|520903881|FG003|Open-label Phase|Investigator's Discretion|4|||
144466911|NCT03703466|520903882|FG000|Overall Study|Death|2|||
144466912|NCT03703466|520903883|FG001|Overall Study|Death|1|||
144466913|NCT03703466|520903884|FG002|Overall Study|Death|0|||
144466914|NCT03703466|520903882|FG000|Overall Study|Withdrawal by Subject|0|||
144466915|NCT03703466|520903883|FG001|Overall Study|Withdrawal by Subject|3|||
144466916|NCT03703466|520903884|FG002|Overall Study|Withdrawal by Subject|0|||
144466917|NCT03703466|520903882|FG000|Overall Study|Completed < 3 Cycles|2|||
144466918|NCT03703466|520903883|FG001|Overall Study|Completed < 3 Cycles|2|||
144466919|NCT03703466|520903884|FG002|Overall Study|Completed < 3 Cycles|2|||
144466920|NCT01553318|520905552|FG000|Overall Study|Protocol Violation|3|||
144466921|NCT01553318|520905553|FG001|Overall Study|Protocol Violation|2|||
144466922|NCT02178059|520905555|FG000|Washout|Physician Decision|1|||
144466923|NCT02178059|520905556|FG001|Washout|Physician Decision|0|||
144466924|NCT02586025|520905557|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
144466925|NCT02586025|520905558|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
144466926|NCT02586025|520905557|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
144466927|NCT02586025|520905558|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
144466928|NCT02586025|520905557|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
144466929|NCT02586025|520905558|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
144466930|NCT02586025|520905557|FG000|Neoadjuvant Treatment|Death|1|||
144258356|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
144466931|NCT02586025|520905558|FG001|Neoadjuvant Treatment|Death|0|||
144466932|NCT02586025|520905557|FG000|Neoadjuvant Treatment|Adverse Event|1|||
144466933|NCT02586025|520905558|FG001|Neoadjuvant Treatment|Adverse Event|0|||
144466934|NCT02586025|520905557|FG000|Neoadjuvant Treatment|Physician Decision|2|||
144466935|NCT02586025|520905558|FG001|Neoadjuvant Treatment|Physician Decision|1|||
144466936|NCT02586025|520905557|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
144466937|NCT02586025|520905558|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
144466938|NCT02586025|520905557|FG000|Adjuvant Treatment|Recurrent Disease|4|||
144466939|NCT02586025|520905558|FG001|Adjuvant Treatment|Recurrent Disease|5|||
144726334|NCT02353169|521852718|FG000|Overall Study|Pre-op medication|0|||
144726335|NCT02353169|521852719|FG001|Overall Study|Pre-op medication|0|||
144726336|NCT02353169|521852720|FG002|Overall Study|Pre-op medication|1|||
144726337|NCT02353169|521852721|FG003|Overall Study|Pre-op medication|0|||
144726338|NCT00486837|521852724|FG000|Overall Study|Withdrawal by Subject|1|||
144726339|NCT00486837|521852725|FG001|Overall Study|Withdrawal by Subject|0|||
144726340|NCT00486837|521852724|FG000|Overall Study|Adverse Event|1|||
144726341|NCT00486837|521852725|FG001|Overall Study|Adverse Event|1|||
144726342|NCT00486837|521852724|FG000|Overall Study|Protocol Violation|4|||
144726343|NCT00486837|521852725|FG001|Overall Study|Protocol Violation|2|||
144726344|NCT00486837|521852724|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
144726345|NCT00486837|521852725|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
144726346|NCT02468778|521852726|FG000|Overall Study|Death|2|||
144726347|NCT02468778|521852727|FG001|Overall Study|Death|1|||
144726348|NCT02468778|521852728|FG002|Overall Study|Death|0|||
144726349|NCT02468778|521852726|FG000|Overall Study|Lost to Follow-up|1|||
144726350|NCT02468778|521852727|FG001|Overall Study|Lost to Follow-up|2|||
144726351|NCT02468778|521852728|FG002|Overall Study|Lost to Follow-up|2|||
144726352|NCT02468778|521852726|FG000|Overall Study|Withdrawal by Subject|0|||
144726353|NCT02468778|521852727|FG001|Overall Study|Withdrawal by Subject|1|||
144726354|NCT02468778|521852728|FG002|Overall Study|Withdrawal by Subject|1|||
144726355|NCT00414765|521852729|FG000|Overall Study|Adverse Event|5|||
144726356|NCT00414765|521852730|FG001|Overall Study|Adverse Event|9|||
144726357|NCT00414765|521852729|FG000|Overall Study|Withdrawal by Subject|1|||
144726358|NCT00414765|521852730|FG001|Overall Study|Withdrawal by Subject|1|||
144466940|NCT02586025|520905557|FG000|Adjuvant Treatment|Physician Decision|0|||
144466941|NCT02586025|520905558|FG001|Adjuvant Treatment|Physician Decision|1|||
144466942|NCT02586025|520905557|FG000|Adjuvant Treatment|Pregnancy|1|||
144466943|NCT02586025|520905558|FG001|Adjuvant Treatment|Pregnancy|0|||
144466944|NCT02586025|520905557|FG000|Treatment-Free Follow-Up|Death|11|||
144466945|NCT02586025|520905558|FG001|Treatment-Free Follow-Up|Death|11|||
144466946|NCT02586025|520905557|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
144466947|NCT02586025|520905558|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
144466948|NCT02586025|520905557|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
144466949|NCT02586025|520905558|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
144466950|NCT02586025|520905557|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
144466951|NCT02586025|520905558|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
144466952|NCT02586025|520905557|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
144466953|NCT02586025|520905558|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
144466954|NCT00175825|520905559|FG000|Overall Study|Adverse Event|3|||
144466955|NCT00175825|520905560|FG001|Overall Study|Adverse Event|2|||
144466956|NCT00175825|520905561|FG002|Overall Study|Adverse Event|1|||
144466957|NCT00175825|520905562|FG003|Overall Study|Adverse Event|1|||
144466958|NCT00175825|520905559|FG000|Overall Study|Lost to Follow-up|1|||
144466959|NCT00175825|520905560|FG001|Overall Study|Lost to Follow-up|2|||
144466960|NCT00175825|520905561|FG002|Overall Study|Lost to Follow-up|0|||
144466961|NCT00175825|520905562|FG003|Overall Study|Lost to Follow-up|0|||
144466962|NCT00175825|520905559|FG000|Overall Study|Withdrawal by Subject|1|||
144466963|NCT00175825|520905560|FG001|Overall Study|Withdrawal by Subject|0|||
144466964|NCT00175825|520905561|FG002|Overall Study|Withdrawal by Subject|0|||
144466965|NCT00175825|520905562|FG003|Overall Study|Withdrawal by Subject|0|||
144466966|NCT00999466|520905565|FG000|Main Part|Withdrawal by Subject|0|||
144466967|NCT00999466|520905566|FG001|Main Part|Withdrawal by Subject|0|||
144466968|NCT00999466|520905567|FG002|Main Part|Withdrawal by Subject|2|||
144466969|NCT00999466|520905565|FG000|Main Part|Adverse Event|0|||
144466970|NCT00999466|520905566|FG001|Main Part|Adverse Event|4|||
144466971|NCT00999466|520905567|FG002|Main Part|Adverse Event|2|||
144466972|NCT03255824|520905568|FG000|Overall Study|Under-sedation|2|||
144466973|NCT03255824|520905569|FG001|Overall Study|Under-sedation|1|||
144466974|NCT02001194|520905571|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
144466975|NCT02001194|520905572|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
144466976|NCT02001194|520905573|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
144726359|NCT00414765|521852729|FG000|Overall Study|Disease Progression|0|||
144466977|NCT02001194|520905574|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
144466978|NCT02001194|520905571|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
144466979|NCT02001194|520905572|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
144466980|NCT02001194|520905573|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
144536564|NCT00943917|521168429|FG008|Stage I|Withdrawal by Subject|0|||
144726360|NCT00414765|521852730|FG001|Overall Study|Disease Progression|1|||
144726361|NCT05295953|521852732|FG000|Overall Study|Withdrawal by Subject|0|||
144726362|NCT05295953|521852733|FG001|Overall Study|Withdrawal by Subject|1|||
144726363|NCT05694013|521852735|FG000|Overall Study|Death|6|||
144466981|NCT02001194|520905574|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
144466982|NCT03432364|520905576|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
144466983|NCT00522301|520905577|FG000|Overall Study|Withdrawal by Subject|1|||
144466984|NCT00522301|520905577|FG000|Overall Study|Adverse Event|5|||
144466985|NCT03040713|520905578|FG000|Overall Study|Positive amyloid scan|3|||
144613013|NCT03317795|521444034|FG001|Overall Study|Intolerance of medication|1|||
144613014|NCT00939783|521444036|FG000|Overall Study|Death|6|||
144466986|NCT00337272|520905579|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
144466987|NCT00337272|520905580|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
144466988|NCT00337272|520905579|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
144466989|NCT00337272|520905580|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
144466990|NCT00337272|520905579|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
144466991|NCT00337272|520905580|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
144466992|NCT00337272|520905579|FG000|Treatment Period|Non-compliance|1|||
144466993|NCT00337272|520905580|FG001|Treatment Period|Non-compliance|1|||
144466994|NCT00337272|520905579|FG000|Treatment Period|Withdrawal by Subject|0|||
144466995|NCT00337272|520905580|FG001|Treatment Period|Withdrawal by Subject|1|||
144466996|NCT00337272|520905579|FG000|Withdrawal Period|Non-compliance|0|||
144466997|NCT00337272|520905580|FG001|Withdrawal Period|Non-compliance|1|||
144466998|NCT02570126|520905590|FG000|Overall Study|Lost to Follow-up|2|||
144466999|NCT02570126|520905591|FG001|Overall Study|Lost to Follow-up|0|||
144467000|NCT02570126|520905590|FG000|Overall Study|Unable To Arrange Visit 3|1|||
144467001|NCT02570126|520905591|FG001|Overall Study|Unable To Arrange Visit 3|0|||
144467002|NCT02570126|520905590|FG000|Overall Study|Violation Of Procedures GSK|0|||
144467003|NCT02570126|520905591|FG001|Overall Study|Violation Of Procedures GSK|1|||
144467004|NCT02570126|520905590|FG000|Overall Study|Protocol Violation|0|||
144467005|NCT02570126|520905591|FG001|Overall Study|Protocol Violation|1|||
144467006|NCT02570126|520905590|FG000|Overall Study|Withdrawal by Subject|3|||
144467007|NCT02570126|520905591|FG001|Overall Study|Withdrawal by Subject|7|||
144467008|NCT01113502|520905592|FG000|Overall Study|Withdrawal by Subject|1|||
144467009|NCT01113502|520905593|FG001|Overall Study|Withdrawal by Subject|0|||
144467010|NCT01113502|520905594|FG002|Overall Study|Withdrawal by Subject|1|||
144467011|NCT01113502|520905595|FG003|Overall Study|Withdrawal by Subject|1|||
144467012|NCT01113502|520905596|FG004|Overall Study|Withdrawal by Subject|0|||
144467013|NCT01113502|520905592|FG000|Overall Study|Adverse Event|0|||
144467014|NCT01113502|520905593|FG001|Overall Study|Adverse Event|0|||
144467015|NCT01113502|520905594|FG002|Overall Study|Adverse Event|3|||
144467016|NCT01113502|520905595|FG003|Overall Study|Adverse Event|2|||
144467017|NCT01113502|520905596|FG004|Overall Study|Adverse Event|0|||
144467018|NCT00781391|520905599|FG000|Overall Study|never received study drug|24|||
144467019|NCT00781391|520905600|FG001|Overall Study|never received study drug|23|||
144467020|NCT00781391|520905601|FG002|Overall Study|never received study drug|32|||
144467021|NCT00781391|520905599|FG000|Overall Study|Protocol Violation|19|||
144467022|NCT00781391|520905600|FG001|Overall Study|Protocol Violation|17|||
144467023|NCT00781391|520905601|FG002|Overall Study|Protocol Violation|20|||
144467024|NCT00781391|520905599|FG000|Overall Study|Death|789|||
144467025|NCT00781391|520905600|FG001|Overall Study|Death|730|||
144467026|NCT00781391|520905601|FG002|Overall Study|Death|706|||
144467027|NCT00781391|520905599|FG000|Overall Study|Withdrawal by Subject|47|||
144467028|NCT00781391|520905600|FG001|Overall Study|Withdrawal by Subject|37|||
144467029|NCT00781391|520905601|FG002|Overall Study|Withdrawal by Subject|25|||
144467030|NCT00781391|520905599|FG000|Overall Study|Lost to Follow-up|0|||
144467031|NCT00781391|520905600|FG001|Overall Study|Lost to Follow-up|0|||
144467032|NCT00781391|520905601|FG002|Overall Study|Lost to Follow-up|1|||
144467033|NCT01970982|520905612|FG000|Overall Study|Withdrawal by Subject|0|||
144467034|NCT01970982|520905613|FG001|Overall Study|Withdrawal by Subject|0|||
144467035|NCT01970982|520905614|FG002|Overall Study|Withdrawal by Subject|2|||
144467036|NCT00708916|520905617|FG000|Overall Study|Subject Noncompliance|2|||
144467037|NCT00708916|520905617|FG000|Overall Study|Adverse Event|2|||
144467038|NCT01362439|520905618|FG000|Overall Study|Adverse Event|1|||
144467039|NCT01362439|520905618|FG000|Overall Study|Lack of Efficacy|3|||
144467040|NCT01362439|520905618|FG000|Overall Study|Lost to Follow-up|2|||
144467041|NCT01362439|520905618|FG000|Overall Study|Study medication non-compliant|1|||
144467042|NCT01362439|520905618|FG000|Overall Study|Participant who withdrew consent|8|||
144467043|NCT01984684|520905621|FG000|Overall Study|Lost to Follow-up|25|||
144536565|NCT00943917|521168430|FG009|Stage I|Withdrawal by Subject|0|||
144536566|NCT00943917|521168431|FG010|Stage I|Withdrawal by Subject|0|||
144536567|NCT00943917|521168432|FG011|Stage I|Withdrawal by Subject|0|||
144536568|NCT00943917|521168433|FG012|Stage I|Withdrawal by Subject|0|||
144536569|NCT00943917|521168434|FG013|Stage I|Withdrawal by Subject|0|||
144536570|NCT00943917|521168435|FG014|Stage I|Withdrawal by Subject|0|||
144536571|NCT00943917|521168421|FG000|Stage II|Adverse Event|0|||
144536572|NCT00943917|521168422|FG001|Stage II|Adverse Event|0|||
144613015|NCT00939783|521444036|FG000|Overall Study|Adverse Event|39|||
144467044|NCT01984684|520905622|FG001|Overall Study|Lost to Follow-up|24|||
144613016|NCT00939783|521444036|FG000|Overall Study|Study Terminated by Sponsor|498|||
144467045|NCT01984684|520905621|FG000|Overall Study|Adverse Event|8|||
144467046|NCT01984684|520905622|FG001|Overall Study|Adverse Event|12|||
144536573|NCT00943917|521168423|FG002|Stage II|Adverse Event|0|||
144536574|NCT00943917|521168424|FG003|Stage II|Adverse Event|0|||
144613017|NCT00939783|521444036|FG000|Overall Study|Withdrawal by Subject|78|||
144613018|NCT00939783|521444036|FG000|Overall Study|Other|16|||
144536575|NCT00943917|521168425|FG004|Stage II|Adverse Event|0|||
144467047|NCT01984684|520905621|FG000|Overall Study|Withdrawal by Subject|9|||
144467048|NCT01984684|520905622|FG001|Overall Study|Withdrawal by Subject|9|||
144467049|NCT01984684|520905621|FG000|Overall Study|Lack of Efficacy|3|||
144467050|NCT01984684|520905622|FG001|Overall Study|Lack of Efficacy|6|||
144467051|NCT01984684|520905621|FG000|Overall Study|Physician Decision|4|||
144467052|NCT01984684|520905622|FG001|Overall Study|Physician Decision|2|||
144467053|NCT01984684|520905621|FG000|Overall Study|Protocol Violation|4|||
144467054|NCT01984684|520905622|FG001|Overall Study|Protocol Violation|2|||
144467055|NCT01984684|520905621|FG000|Overall Study|Death|0|||
144467056|NCT01984684|520905622|FG001|Overall Study|Death|1|||
144467057|NCT01984684|520905621|FG000|Overall Study|Noncompliance with study drug|2|||
144467058|NCT01984684|520905622|FG001|Overall Study|Noncompliance with study drug|1|||
144467059|NCT01984684|520905621|FG000|Overall Study|Subject incarcerated|1|||
144467060|NCT01984684|520905622|FG001|Overall Study|Subject incarcerated|0|||
144467061|NCT01984684|520905621|FG000|Overall Study|Study drug not available at site|1|||
144467062|NCT01984684|520905622|FG001|Overall Study|Study drug not available at site|1|||
144467063|NCT01984684|520905621|FG000|Overall Study|Subject had inadequate IV access|0|||
144467064|NCT01984684|520905622|FG001|Overall Study|Subject had inadequate IV access|1|||
144467065|NCT03574597|520905628|FG000|Overall Study|Withdrawal by Subject|67|||
144467066|NCT03574597|520905629|FG001|Overall Study|Withdrawal by Subject|96|||
144467067|NCT03574597|520905628|FG000|Overall Study|Lost to Follow-up|192|||
144467068|NCT03574597|520905629|FG001|Overall Study|Lost to Follow-up|188|||
144467069|NCT02355743|520905630|FG000|Overall Study|Withdrawal by Subject|1|||
144467070|NCT02355743|520905630|FG000|Overall Study|Lost to Follow-up|1|||
144467071|NCT03492281|520905634|FG000|Overall Study|Withdrawal by Subject|21|||
144467072|NCT03492281|520905635|FG001|Overall Study|Withdrawal by Subject|14|||
144467073|NCT03492281|520905636|FG002|Overall Study|Withdrawal by Subject|13|||
144467074|NCT03492281|520905634|FG000|Overall Study|Lost to Follow-up|14|||
144467075|NCT03492281|520905635|FG001|Overall Study|Lost to Follow-up|15|||
144467076|NCT03492281|520905636|FG002|Overall Study|Lost to Follow-up|10|||
144467077|NCT03492281|520905634|FG000|Overall Study|Adverse Event|6|||
144467078|NCT03492281|520905635|FG001|Overall Study|Adverse Event|8|||
144467079|NCT03492281|520905636|FG002|Overall Study|Adverse Event|13|||
144467080|NCT03492281|520905634|FG000|Overall Study|Lack of Efficacy|3|||
144467081|NCT03492281|520905635|FG001|Overall Study|Lack of Efficacy|0|||
144467082|NCT03492281|520905636|FG002|Overall Study|Lack of Efficacy|1|||
144467083|NCT03492281|520905634|FG000|Overall Study|Physician Decision|1|||
144536576|NCT00943917|521168426|FG005|Stage II|Adverse Event|1|||
144536577|NCT00943917|521168427|FG006|Stage II|Adverse Event|3|||
144536578|NCT00943917|521168428|FG007|Stage II|Adverse Event|0|||
144536579|NCT00943917|521168429|FG008|Stage II|Adverse Event|1|||
144536580|NCT00943917|521168430|FG009|Stage II|Adverse Event|0|||
144536581|NCT00943917|521168431|FG010|Stage II|Adverse Event|0|||
144536582|NCT00943917|521168432|FG011|Stage II|Adverse Event|0|||
144536583|NCT00943917|521168433|FG012|Stage II|Adverse Event|0|||
144536584|NCT00943917|521168434|FG013|Stage II|Adverse Event|0|||
144536585|NCT00943917|521168435|FG014|Stage II|Adverse Event|0|||
144536586|NCT00943917|521168421|FG000|Stage II|Withdrawal by Subject|0|||
144536587|NCT00943917|521168422|FG001|Stage II|Withdrawal by Subject|0|||
144536588|NCT00943917|521168423|FG002|Stage II|Withdrawal by Subject|0|||
144536589|NCT00943917|521168424|FG003|Stage II|Withdrawal by Subject|0|||
144536590|NCT00943917|521168425|FG004|Stage II|Withdrawal by Subject|0|||
144536591|NCT00943917|521168426|FG005|Stage II|Withdrawal by Subject|1|||
144536592|NCT00943917|521168427|FG006|Stage II|Withdrawal by Subject|0|||
144536593|NCT00943917|521168428|FG007|Stage II|Withdrawal by Subject|0|||
144536594|NCT00943917|521168429|FG008|Stage II|Withdrawal by Subject|0|||
144536595|NCT00943917|521168430|FG009|Stage II|Withdrawal by Subject|0|||
144536596|NCT00943917|521168431|FG010|Stage II|Withdrawal by Subject|0|||
144536597|NCT00943917|521168432|FG011|Stage II|Withdrawal by Subject|0|||
144536598|NCT00943917|521168433|FG012|Stage II|Withdrawal by Subject|0|||
144197452|NCT01206101|519920269|FG001|Overall Study|Physician Decision|1|||
144467084|NCT03492281|520905635|FG001|Overall Study|Physician Decision|0|||
144467085|NCT03492281|520905636|FG002|Overall Study|Physician Decision|3|||
144467086|NCT03492281|520905634|FG000|Overall Study|Protocol Violation|0|||
144467087|NCT03492281|520905635|FG001|Overall Study|Protocol Violation|2|||
144467088|NCT03492281|520905636|FG002|Overall Study|Protocol Violation|1|||
144467089|NCT03492281|520905634|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
144467090|NCT03492281|520905635|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
144467091|NCT03492281|520905636|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
144467092|NCT03492281|520905634|FG000|Overall Study|Death|0|||
144536599|NCT00943917|521168434|FG013|Stage II|Withdrawal by Subject|0|||
144536600|NCT00943917|521168435|FG014|Stage II|Withdrawal by Subject|0|||
144536601|NCT00943917|521168421|FG000|Stage II|Pregnancy|0|||
144536602|NCT00943917|521168422|FG001|Stage II|Pregnancy|0|||
144536603|NCT00943917|521168423|FG002|Stage II|Pregnancy|0|||
144467093|NCT03492281|520905635|FG001|Overall Study|Death|0|||
144536604|NCT00943917|521168424|FG003|Stage II|Pregnancy|0|||
144536605|NCT00943917|521168425|FG004|Stage II|Pregnancy|0|||
144536606|NCT00943917|521168426|FG005|Stage II|Pregnancy|1|||
144536607|NCT00943917|521168427|FG006|Stage II|Pregnancy|0|||
144536608|NCT00943917|521168428|FG007|Stage II|Pregnancy|0|||
144467094|NCT03492281|520905636|FG002|Overall Study|Death|1|||
144467095|NCT03492281|520905634|FG000|Overall Study|Captured as Other in Database|8|||
144467096|NCT03492281|520905635|FG001|Overall Study|Captured as Other in Database|6|||
144467097|NCT03492281|520905636|FG002|Overall Study|Captured as Other in Database|3|||
144467098|NCT03624504|520905637|FG000|Overall Study|Unsuccessful Implant|1|||
144467099|NCT02862457|520905638|FG000|Overall Study|Death|1|||
144467100|NCT02862457|520905639|FG001|Overall Study|Death|3|||
144467101|NCT02862457|520905640|FG002|Overall Study|Death|2|||
144613019|NCT00939783|521444036|FG000|Overall Study|Lost to Follow-up|8|||
144467102|NCT02862457|520905641|FG003|Overall Study|Death|3|||
144467103|NCT02862457|520905642|FG004|Overall Study|Death|0|||
144467104|NCT02862457|520905643|FG005|Overall Study|Death|2|||
144467105|NCT02862457|520905644|FG006|Overall Study|Death|1|||
144467106|NCT02862457|520905638|FG000|Overall Study|Lost to Follow-up|1|||
144467107|NCT02862457|520905639|FG001|Overall Study|Lost to Follow-up|0|||
144467108|NCT02862457|520905640|FG002|Overall Study|Lost to Follow-up|0|||
144467109|NCT02862457|520905641|FG003|Overall Study|Lost to Follow-up|1|||
144467110|NCT02862457|520905642|FG004|Overall Study|Lost to Follow-up|0|||
144467111|NCT02862457|520905643|FG005|Overall Study|Lost to Follow-up|0|||
144467112|NCT02862457|520905644|FG006|Overall Study|Lost to Follow-up|0|||
144467113|NCT02862457|520905638|FG000|Overall Study|Withdrawal by Subject|0|||
144467114|NCT02862457|520905639|FG001|Overall Study|Withdrawal by Subject|0|||
144467115|NCT02862457|520905640|FG002|Overall Study|Withdrawal by Subject|1|||
144467116|NCT02862457|520905641|FG003|Overall Study|Withdrawal by Subject|0|||
144467117|NCT02862457|520905642|FG004|Overall Study|Withdrawal by Subject|0|||
144467118|NCT02862457|520905643|FG005|Overall Study|Withdrawal by Subject|1|||
144467119|NCT02862457|520905644|FG006|Overall Study|Withdrawal by Subject|0|||
144467120|NCT00951483|520905647|FG000|Overall Study|Physician Decision|4|||
144467121|NCT00951483|520905648|FG001|Overall Study|Physician Decision|0|||
144467122|NCT00951483|520905647|FG000|Overall Study|Withdrawal by Subject|15|||
144467123|NCT00951483|520905648|FG001|Overall Study|Withdrawal by Subject|0|||
144467124|NCT03565887|520905649|FG000|Overall Study|Adverse Event|1|||
144467125|NCT03565887|520905650|FG001|Overall Study|Adverse Event|0|||
144467126|NCT03565887|520905649|FG000|Overall Study|Withdrawal by Subject|0|||
144467127|NCT03565887|520905650|FG001|Overall Study|Withdrawal by Subject|2|||
144467128|NCT03364751|520905651|FG000|Overall Study|Withdrawal by Subject|1|||
144467129|NCT03364751|520905652|FG001|Overall Study|Withdrawal by Subject|0|||
144467130|NCT03364751|520905653|FG002|Overall Study|Withdrawal by Subject|0|||
144467131|NCT03364751|520905654|FG003|Overall Study|Withdrawal by Subject|0|||
144467132|NCT03364751|520905651|FG000|Overall Study|Lost to Follow-up|0|||
144467133|NCT03364751|520905652|FG001|Overall Study|Lost to Follow-up|1|||
144467134|NCT03364751|520905653|FG002|Overall Study|Lost to Follow-up|0|||
144467135|NCT03364751|520905654|FG003|Overall Study|Lost to Follow-up|0|||
144467136|NCT02975973|520905655|FG000|Overall Study|Adverse Event|1|||
144467137|NCT02975973|520905656|FG001|Overall Study|Adverse Event|1|||
144467138|NCT02975973|520905657|FG002|Overall Study|Adverse Event|1|||
144467139|NCT02975973|520905658|FG003|Overall Study|Adverse Event|0|||
144467140|NCT03804710|520905660|FG000|Overall Study|Adverse Event|0|||
144467141|NCT03804710|520905661|FG001|Overall Study|Adverse Event|3|||
144467142|NCT03804710|520905660|FG000|Overall Study|Withdrawal by Subject|2|||
144467143|NCT03804710|520905661|FG001|Overall Study|Withdrawal by Subject|1|||
144467144|NCT03804710|520905660|FG000|Overall Study|Other|0|||
144467145|NCT03804710|520905661|FG001|Overall Study|Other|1|||
144467146|NCT04542018|520905662|FG000|Overall Study|Withdrawal by Subject|0|||
144467147|NCT04542018|520905663|FG001|Overall Study|Withdrawal by Subject|0|||
144467148|NCT04542018|520905664|FG002|Overall Study|Withdrawal by Subject|4|||
144467149|NCT04542018|520905662|FG000|Overall Study|Protocol Violation|0|||
144467150|NCT04542018|520905663|FG001|Overall Study|Protocol Violation|0|||
144467151|NCT04542018|520905664|FG002|Overall Study|Protocol Violation|2|||
144467152|NCT03583554|520905665|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
144467153|NCT03583554|520905666|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
144467154|NCT03583554|520905667|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
144613020|NCT00939783|521444036|FG000|Overall Study|Protocol Violation|3|||
144613021|NCT00939783|521444036|FG000|Overall Study|Enrolled but not treated|1|||
144613022|NCT00501007|521444039|FG000|Overall Study|Inclusion criteria not met.|29|||
144613023|NCT00501007|521444040|FG001|Overall Study|Inclusion criteria not met.|25|||
144613024|NCT00135668|521444041|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
144613025|NCT00135668|521444042|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
144613026|NCT00135668|521444043|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
144613027|NCT00135668|521444044|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
144613028|NCT01892163|521444049|FG000|Overall Study|Death|1|||
144467155|NCT03923933|520905676|FG000|Overall Study|Lost to Follow-up|1|||
144467156|NCT03923933|520905677|FG001|Overall Study|Lost to Follow-up|0|||
144467157|NCT03923933|520905676|FG000|Overall Study|Withdrawal by Subject|0|||
144467158|NCT03923933|520905677|FG001|Overall Study|Withdrawal by Subject|1|||
144467159|NCT00419263|520905678|FG000|Overall Study|Lost to Follow-up|2|||
144467160|NCT00419263|520905679|FG001|Overall Study|Lost to Follow-up|1|||
144467161|NCT00419263|520905680|FG002|Overall Study|Lost to Follow-up|1|||
144467162|NCT00419263|520905678|FG000|Overall Study|Randomized in Error, Not Treated|1|||
144467163|NCT00419263|520905679|FG001|Overall Study|Randomized in Error, Not Treated|1|||
144467164|NCT00419263|520905680|FG002|Overall Study|Randomized in Error, Not Treated|0|||
144467165|NCT00419263|520905678|FG000|Overall Study|Adverse Event|0|||
144467166|NCT00419263|520905679|FG001|Overall Study|Adverse Event|0|||
144467167|NCT00419263|520905680|FG002|Overall Study|Adverse Event|1|||
144467168|NCT00419263|520905678|FG000|Overall Study|Withdrawal by Subject|0|||
144467169|NCT00419263|520905679|FG001|Overall Study|Withdrawal by Subject|0|||
144467170|NCT00419263|520905680|FG002|Overall Study|Withdrawal by Subject|1|||
144467171|NCT02342886|520905681|FG000|Overall Study|Treatment non-compliance|1|||
144467172|NCT02342886|520905682|FG001|Overall Study|Treatment non-compliance|0|||
144467173|NCT02342886|520905683|FG002|Overall Study|Treatment non-compliance|0|||
144467174|NCT02342886|520905684|FG003|Overall Study|Treatment non-compliance|1|||
144467175|NCT02342886|520905685|FG004|Overall Study|Treatment non-compliance|0|||
144467176|NCT02342886|520905681|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
144467177|NCT02342886|520905682|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
144467178|NCT02342886|520905683|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
144467179|NCT02342886|520905684|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
144467180|NCT02342886|520905685|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
144467181|NCT02342886|520905681|FG000|Overall Study|Adverse event/specific toxicity|4|||
144467182|NCT02342886|520905682|FG001|Overall Study|Adverse event/specific toxicity|3|||
144613029|NCT01892163|521444050|FG001|Overall Study|Death|1|||
144467183|NCT02342886|520905683|FG002|Overall Study|Adverse event/specific toxicity|11|||
144467184|NCT02342886|520905684|FG003|Overall Study|Adverse event/specific toxicity|2|||
144467185|NCT02342886|520905685|FG004|Overall Study|Adverse event/specific toxicity|1|||
144467186|NCT02342886|520905681|FG000|Overall Study|Lost to Follow-up|1|||
144467187|NCT02342886|520905682|FG001|Overall Study|Lost to Follow-up|0|||
144467188|NCT02342886|520905683|FG002|Overall Study|Lost to Follow-up|0|||
144467189|NCT02342886|520905684|FG003|Overall Study|Lost to Follow-up|0|||
144467190|NCT02342886|520905685|FG004|Overall Study|Lost to Follow-up|0|||
144467191|NCT02342886|520905681|FG000|Overall Study|Death|1|||
144467192|NCT02342886|520905682|FG001|Overall Study|Death|2|||
144467193|NCT02342886|520905683|FG002|Overall Study|Death|1|||
144467194|NCT02342886|520905684|FG003|Overall Study|Death|0|||
144467195|NCT02342886|520905685|FG004|Overall Study|Death|1|||
144467196|NCT02342886|520905681|FG000|Overall Study|Withdrawal by Subject|0|||
144467197|NCT02342886|520905682|FG001|Overall Study|Withdrawal by Subject|1|||
144467198|NCT02342886|520905683|FG002|Overall Study|Withdrawal by Subject|0|||
144467199|NCT02342886|520905684|FG003|Overall Study|Withdrawal by Subject|1|||
144467200|NCT02342886|520905685|FG004|Overall Study|Withdrawal by Subject|0|||
144467201|NCT02342886|520905681|FG000|Overall Study|Investigator/sponsor decision|0|||
144467202|NCT02342886|520905682|FG001|Overall Study|Investigator/sponsor decision|2|||
144467203|NCT02342886|520905683|FG002|Overall Study|Investigator/sponsor decision|0|||
144467204|NCT02342886|520905684|FG003|Overall Study|Investigator/sponsor decision|3|||
144467205|NCT02342886|520905685|FG004|Overall Study|Investigator/sponsor decision|1|||
144467206|NCT02342886|520905681|FG000|Overall Study|Pregnancy|0|||
144467207|NCT02342886|520905682|FG001|Overall Study|Pregnancy|0|||
144467208|NCT02342886|520905683|FG002|Overall Study|Pregnancy|2|||
144467209|NCT02342886|520905684|FG003|Overall Study|Pregnancy|0|||
144467210|NCT02342886|520905685|FG004|Overall Study|Pregnancy|0|||
144467211|NCT02342886|520905681|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
144467212|NCT02342886|520905682|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
144467213|NCT02342886|520905683|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
144467214|NCT02342886|520905684|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
144467215|NCT02342886|520905685|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
144467216|NCT02342886|520905681|FG000|Overall Study|Protocol Violation|0|||
144467217|NCT02342886|520905682|FG001|Overall Study|Protocol Violation|0|||
144467218|NCT02342886|520905683|FG002|Overall Study|Protocol Violation|0|||
144467219|NCT02342886|520905684|FG003|Overall Study|Protocol Violation|2|||
144613030|NCT01892163|521444049|FG000|Overall Study|Lost to Follow-up|1|||
144258357|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
144467220|NCT02342886|520905685|FG004|Overall Study|Protocol Violation|0|||
144467221|NCT01328080|520905686|FG000|Overall Study|Lost to Follow-up|5|||
144467222|NCT00862134|520905687|FG000|Overall Study|Death|1|||
144467223|NCT00862134|520905688|FG001|Overall Study|Death|0|||
144467224|NCT00862134|520905687|FG000|Overall Study|Physician Decision|0|||
144467225|NCT00862134|520905688|FG001|Overall Study|Physician Decision|1|||
144467226|NCT00862134|520905687|FG000|Overall Study|Withdrawal by Subject|1|||
144467227|NCT00862134|520905688|FG001|Overall Study|Withdrawal by Subject|2|||
144467228|NCT00862134|520905687|FG000|Overall Study|Sponsor terminated study|5|||
144467229|NCT00862134|520905688|FG001|Overall Study|Sponsor terminated study|7|||
144467230|NCT00862134|520905687|FG000|Overall Study|Adverse Event|2|||
144467231|NCT00862134|520905688|FG001|Overall Study|Adverse Event|2|||
144467232|NCT00862134|520905687|FG000|Overall Study|Withdrew prior to dosing|2|||
144613031|NCT01892163|521444050|FG001|Overall Study|Lost to Follow-up|0|||
144613032|NCT01924182|521444051|FG000|Overall Study|Withdrawal by Subject|1|||
144613033|NCT01924182|521444052|FG001|Overall Study|Withdrawal by Subject|0|||
144536609|NCT00943917|521168429|FG008|Stage II|Pregnancy|0|||
144536610|NCT00943917|521168430|FG009|Stage II|Pregnancy|0|||
144536611|NCT00943917|521168431|FG010|Stage II|Pregnancy|0|||
144536612|NCT00943917|521168432|FG011|Stage II|Pregnancy|0|||
144536613|NCT00943917|521168433|FG012|Stage II|Pregnancy|0|||
144536614|NCT00943917|521168434|FG013|Stage II|Pregnancy|0|||
144613034|NCT00432042|521444055|FG000|Overall Study|Protocol Violation|2|||
144536615|NCT00943917|521168435|FG014|Stage II|Pregnancy|0|||
144536616|NCT00943917|521168421|FG000|Stage II Continuation|Adverse Event|0|||
144536617|NCT00943917|521168422|FG001|Stage II Continuation|Adverse Event|0|||
144536618|NCT00943917|521168423|FG002|Stage II Continuation|Adverse Event|0|||
144536619|NCT00943917|521168424|FG003|Stage II Continuation|Adverse Event|0|||
144536620|NCT00943917|521168425|FG004|Stage II Continuation|Adverse Event|0|||
144536621|NCT00943917|521168426|FG005|Stage II Continuation|Adverse Event|0|||
144613035|NCT00432042|521444056|FG001|Overall Study|Protocol Violation|0|||
144613036|NCT00432042|521444057|FG002|Overall Study|Protocol Violation|0|||
144613037|NCT00432042|521444055|FG000|Overall Study|Withdrawal by Subject|0|||
144613038|NCT00432042|521444056|FG001|Overall Study|Withdrawal by Subject|0|||
144613039|NCT00432042|521444057|FG002|Overall Study|Withdrawal by Subject|2|||
144613040|NCT00432042|521444055|FG000|Overall Study|Lost to Follow-up|5|||
144613041|NCT00432042|521444056|FG001|Overall Study|Lost to Follow-up|1|||
144613042|NCT00432042|521444057|FG002|Overall Study|Lost to Follow-up|0|||
144613043|NCT03803059|521444059|FG000|Overall Study|Protocol Violation|2|||
144613044|NCT03803059|521444059|FG000|Overall Study|Lost to Follow-up|1|||
144613045|NCT05264740|521444067|FG000|Baseline|Withdrawal by Subject|0|||
144613046|NCT05264740|521444068|FG001|Baseline|Withdrawal by Subject|1|||
144613047|NCT05264740|521444067|FG000|Follow Up 1|Lost to Follow-up|1|||
144613048|NCT05264740|521444068|FG001|Follow Up 1|Lost to Follow-up|1|||
144613049|NCT05264740|521444067|FG000|Follow Up 1|Withdrawal by Subject|0|||
144613050|NCT05264740|521444068|FG001|Follow Up 1|Withdrawal by Subject|1|||
144613051|NCT05264740|521444067|FG000|Follow Up 2|Lost to Follow-up|1|||
144613052|NCT05264740|521444068|FG001|Follow Up 2|Lost to Follow-up|4|||
144613053|NCT05264740|521444067|FG000|Follow Up 3|Lost to Follow-up|7|||
144613054|NCT05264740|521444068|FG001|Follow Up 3|Lost to Follow-up|4|||
144613055|NCT02663453|521444070|FG000|Overall Study|Death|4|||
144613056|NCT02663453|521444071|FG001|Overall Study|Death|4|||
144613057|NCT02663453|521444070|FG000|Overall Study|Withdrawal by Subject|1|||
144613058|NCT02663453|521444071|FG001|Overall Study|Withdrawal by Subject|0|||
144613059|NCT03709654|521445420|FG000|Overall Study|Lost to Follow-up|1|||
144613060|NCT03709654|521445421|FG001|Overall Study|Lost to Follow-up|1|||
144613061|NCT03709654|521445420|FG000|Overall Study|Withdrawal by Subject|1|||
144613062|NCT03709654|521445421|FG001|Overall Study|Withdrawal by Subject|1|||
144613063|NCT03709654|521445420|FG000|Overall Study|Adverse Event|1|||
144613064|NCT03709654|521445421|FG001|Overall Study|Adverse Event|0|||
144613065|NCT01902966|521445422|FG000|Overall Study|Death|1|||
144613066|NCT01902966|521445422|FG000|Overall Study|Physician Decision|1|||
144613067|NCT01902966|521445422|FG000|Overall Study|Withdrawal by Subject|1|||
144613068|NCT02037295|521445423|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
144613069|NCT02037295|521445424|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
144613070|NCT02037295|521445425|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
144613071|NCT02037295|521445426|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
144613072|NCT01146873|521445433|FG000|Overall Study|Transfer out|0|||
144613073|NCT01146873|521445434|FG001|Overall Study|Transfer out|6|||
144613074|NCT01967628|521445435|FG000|Overall Study|Withdrawal by Subject|2|||
144613075|NCT01967628|521445436|FG001|Overall Study|Withdrawal by Subject|0|||
144613076|NCT01967628|521445435|FG000|Overall Study|Unable to complete bronchoscopy|4|||
144613077|NCT01967628|521445436|FG001|Overall Study|Unable to complete bronchoscopy|6|||
144613078|NCT01967628|521445435|FG000|Overall Study|Lost to Follow-up|1|||
144613079|NCT01967628|521445436|FG001|Overall Study|Lost to Follow-up|0|||
144613080|NCT01967628|521445435|FG000|Overall Study|Low protein concentration in sample|20|||
144613081|NCT01967628|521445436|FG001|Overall Study|Low protein concentration in sample|25|||
144613082|NCT00838331|521445437|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
144613083|NCT03200366|521445440|FG000|Patient Navigation Intervention Given|Death|0|||
144536622|NCT00943917|521168427|FG006|Stage II Continuation|Adverse Event|0|||
144536623|NCT00943917|521168428|FG007|Stage II Continuation|Adverse Event|0|||
144536624|NCT00943917|521168429|FG008|Stage II Continuation|Adverse Event|0|||
144536625|NCT00943917|521168430|FG009|Stage II Continuation|Adverse Event|0|||
144536626|NCT00943917|521168431|FG010|Stage II Continuation|Adverse Event|0|||
144197453|NCT01206101|519920268|FG000|Overall Study|Unclassified|1|||
144536627|NCT00943917|521168432|FG011|Stage II Continuation|Adverse Event|1|||
144536628|NCT00943917|521168433|FG012|Stage II Continuation|Adverse Event|2|||
144613084|NCT03200366|521445441|FG001|Patient Navigation Intervention Given|Death|2|||
144613085|NCT03200366|521445442|FG002|Patient Navigation Intervention Given|Death|0|||
144613086|NCT03200366|521445440|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
144613087|NCT03200366|521445441|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
144613088|NCT03200366|521445442|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
144613089|NCT03200366|521445440|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
144613090|NCT03200366|521445441|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
144613091|NCT03200366|521445442|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
144613092|NCT03200366|521445440|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
144613093|NCT03200366|521445441|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
144613094|NCT03200366|521445442|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
144613095|NCT03200366|521445440|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
144613096|NCT03200366|521445441|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
144613097|NCT03200366|521445442|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
144613098|NCT03200366|521445440|FG000|6 Month Post-Baseline Interview|Death|1|||
144613099|NCT03200366|521445441|FG001|6 Month Post-Baseline Interview|Death|1|||
144613100|NCT03200366|521445442|FG002|6 Month Post-Baseline Interview|Death|1|||
144613101|NCT03200366|521445440|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
144613102|NCT03200366|521445441|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
144613103|NCT03200366|521445442|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
144613104|NCT03200366|521445440|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
144613105|NCT03200366|521445441|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
144613106|NCT03200366|521445442|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
144613107|NCT03200366|521445440|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
144613108|NCT03200366|521445441|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
144613109|NCT03200366|521445442|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
144613110|NCT03200366|521445440|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
144613111|NCT03200366|521445441|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
144613112|NCT03200366|521445442|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
144613113|NCT03200366|521445440|FG000|9 Month Post-Baseline Interview|Death|1|||
144613114|NCT03200366|521445441|FG001|9 Month Post-Baseline Interview|Death|1|||
144613115|NCT03200366|521445442|FG002|9 Month Post-Baseline Interview|Death|1|||
144613116|NCT03200366|521445440|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
144613117|NCT03200366|521445441|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
144613118|NCT03200366|521445442|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
144613119|NCT03200366|521445440|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
144613120|NCT03200366|521445441|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
144613121|NCT03200366|521445442|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
144613122|NCT03200366|521445440|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
144613123|NCT03200366|521445441|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
144613124|NCT03200366|521445442|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
144613125|NCT04677959|521445443|FG000|Overall Study|Adverse Event|1|||
144613126|NCT04677959|521445444|FG001|Overall Study|Adverse Event|9|||
144613127|NCT04677959|521445443|FG000|Overall Study|Withdrawal by Subject|2|||
144613128|NCT04677959|521445444|FG001|Overall Study|Withdrawal by Subject|15|||
144613129|NCT04677959|521445443|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144613130|NCT04677959|521445444|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144613131|NCT04677959|521445443|FG000|Overall Study|Non-compliance with study drug|0|||
144613132|NCT04677959|521445444|FG001|Overall Study|Non-compliance with study drug|2|||
144613133|NCT04677959|521445443|FG000|Overall Study|Protocol deviation|0|||
144613134|NCT04677959|521445444|FG001|Overall Study|Protocol deviation|11|||
144613135|NCT04677959|521445443|FG000|Overall Study|Lost to Follow-up|9|||
144613136|NCT04677959|521445444|FG001|Overall Study|Lost to Follow-up|13|||
144613137|NCT04677959|521445443|FG000|Overall Study|Other than specified|0|||
144613138|NCT04677959|521445444|FG001|Overall Study|Other than specified|8|||
144613139|NCT01074190|521445445|FG000|Overall Study|Emergency Cesarean Delivery|1|||
144613140|NCT01074190|521445446|FG001|Overall Study|Emergency Cesarean Delivery|2|||
144613141|NCT01074190|521445447|FG002|Overall Study|Emergency Cesarean Delivery|1|||
144613142|NCT01074190|521445445|FG000|Overall Study|Protocol Violation|2|||
144613143|NCT01074190|521445446|FG001|Overall Study|Protocol Violation|1|||
144613144|NCT01074190|521445447|FG002|Overall Study|Protocol Violation|0|||
144613145|NCT01074190|521445445|FG000|Overall Study|Delivered in under 90 minutes|0|||
144613146|NCT01074190|521445446|FG001|Overall Study|Delivered in under 90 minutes|2|||
144613147|NCT01074190|521445447|FG002|Overall Study|Delivered in under 90 minutes|1|||
144613148|NCT01074190|521445445|FG000|Overall Study|Subject withdrew consent|1|||
144613149|NCT01074190|521445446|FG001|Overall Study|Subject withdrew consent|1|||
144613150|NCT01074190|521445447|FG002|Overall Study|Subject withdrew consent|1|||
144613151|NCT00732303|521445448|FG000|Overall Study|Study Terminated|2|||
144613152|NCT00264875|521445449|FG000|Overall Study|Adverse Event|6|||
144613153|NCT00264875|521445449|FG000|Overall Study|Lost to Follow-up|6|||
144613154|NCT00264875|521445449|FG000|Overall Study|Protocol Violation|11|||
144613155|NCT00264875|521445449|FG000|Overall Study|Withdrawal by Subject|7|||
144613156|NCT01500278|521445456|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
144467233|NCT00862134|520905688|FG001|Overall Study|Withdrew prior to dosing|0|||
144467234|NCT02191267|520905689|FG000|Overall Study|Withdrawal by Subject|1|||
144467235|NCT02191267|520905690|FG001|Overall Study|Withdrawal by Subject|0|||
144467236|NCT02191267|520905691|FG002|Overall Study|Withdrawal by Subject|0|||
144467237|NCT00765674|520905692|FG000|Overall Study|Adverse Event|7|||
144467238|NCT00765674|520905693|FG001|Overall Study|Adverse Event|2|||
144467239|NCT00765674|520905694|FG002|Overall Study|Adverse Event|8|||
144467240|NCT00765674|520905695|FG003|Overall Study|Adverse Event|11|||
144467241|NCT00765674|520905692|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
144467242|NCT00765674|520905693|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
144467243|NCT00765674|520905694|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
144467244|NCT00765674|520905695|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
144467245|NCT00765674|520905692|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
144467246|NCT00765674|520905693|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
144467247|NCT00765674|520905694|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
144467248|NCT00765674|520905695|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
144467249|NCT00765674|520905692|FG000|Overall Study|Lack of Efficacy|2|||
144467250|NCT00765674|520905693|FG001|Overall Study|Lack of Efficacy|3|||
144467251|NCT00765674|520905694|FG002|Overall Study|Lack of Efficacy|1|||
144467252|NCT00765674|520905695|FG003|Overall Study|Lack of Efficacy|2|||
144467253|NCT00765674|520905692|FG000|Overall Study|Protocol Violation|2|||
144467254|NCT00765674|520905693|FG001|Overall Study|Protocol Violation|0|||
144467255|NCT00765674|520905694|FG002|Overall Study|Protocol Violation|1|||
144467256|NCT00765674|520905695|FG003|Overall Study|Protocol Violation|0|||
144467257|NCT00765674|520905692|FG000|Overall Study|Withdrawal by Subject|5|||
144467258|NCT00765674|520905693|FG001|Overall Study|Withdrawal by Subject|7|||
144467259|NCT00765674|520905694|FG002|Overall Study|Withdrawal by Subject|3|||
144467260|NCT00765674|520905695|FG003|Overall Study|Withdrawal by Subject|8|||
144467261|NCT00765674|520905692|FG000|Overall Study|Lost to Follow-up|4|||
144467262|NCT00765674|520905693|FG001|Overall Study|Lost to Follow-up|6|||
144467263|NCT00765674|520905694|FG002|Overall Study|Lost to Follow-up|2|||
144467264|NCT00765674|520905695|FG003|Overall Study|Lost to Follow-up|1|||
144467265|NCT00765674|520905692|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
144467266|NCT00765674|520905693|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
144467267|NCT00765674|520905694|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
144467268|NCT00765674|520905695|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
144467269|NCT01813474|520905696|FG000|Overall Study|Withdrawal by Subject|0|||
144467270|NCT01813474|520905697|FG001|Overall Study|Withdrawal by Subject|0|||
144467271|NCT01813474|520905698|FG002|Overall Study|Withdrawal by Subject|1|||
144467272|NCT01813474|520905696|FG000|Overall Study|Adverse Event|1|||
144467273|NCT01813474|520905697|FG001|Overall Study|Adverse Event|1|||
144467274|NCT01813474|520905698|FG002|Overall Study|Adverse Event|0|||
144467275|NCT01813474|520905696|FG000|Overall Study|Lack of Efficacy|2|||
144467276|NCT01813474|520905697|FG001|Overall Study|Lack of Efficacy|6|||
144467277|NCT01813474|520905698|FG002|Overall Study|Lack of Efficacy|9|||
144467278|NCT01813474|520905696|FG000|Overall Study|Death|0|||
144467279|NCT01813474|520905697|FG001|Overall Study|Death|0|||
144467280|NCT01813474|520905698|FG002|Overall Study|Death|1|||
144467281|NCT03015402|520905699|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
144467282|NCT03015402|520905700|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
144467283|NCT03015402|520905699|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
144467284|NCT03015402|520905700|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
144467285|NCT00538590|520905703|FG000|Overall Study|Death|1|||
144467286|NCT00538590|520905704|FG001|Overall Study|Death|0|||
144467287|NCT00567190|520905705|FG000|Overall Study|Death|235|||
144467288|NCT00567190|520905706|FG001|Overall Study|Death|280|||
144467289|NCT00567190|520905705|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
144467290|NCT00567190|520905706|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
144467291|NCT00636610|520905707|FG000|Overall Study|Adverse Event|4|||
144467292|NCT00636610|520905708|FG001|Overall Study|Adverse Event|4|||
144467293|NCT00636610|520905707|FG000|Overall Study|Death|6|||
144467294|NCT00636610|520905708|FG001|Overall Study|Death|3|||
144467295|NCT00636610|520905707|FG000|Overall Study|Physician decision to withdraw patient|15|||
144467296|NCT00636610|520905708|FG001|Overall Study|Physician decision to withdraw patient|9|||
144467297|NCT00636610|520905707|FG000|Overall Study|Subject decision to withdraw|15|||
144467298|NCT00636610|520905708|FG001|Overall Study|Subject decision to withdraw|11|||
144467299|NCT00636610|520905707|FG000|Overall Study|Disease progression - radiographic|41|||
144467300|NCT00636610|520905708|FG001|Overall Study|Disease progression - radiographic|51|||
144467301|NCT00636610|520905707|FG000|Overall Study|Disease progression - clinical|8|||
144467302|NCT00636610|520905708|FG001|Overall Study|Disease progression - clinical|3|||
144467303|NCT00636610|520905707|FG000|Overall Study|Reason for discontinuation not available|3|||
144467304|NCT00636610|520905708|FG001|Overall Study|Reason for discontinuation not available|2|||
144467305|NCT00553696|520905713|FG000|Overall Study|Adverse Event|2|||
144467306|NCT00553696|520905714|FG001|Overall Study|Adverse Event|4|||
144467307|NCT00553696|520905715|FG002|Overall Study|Adverse Event|0|||
144467308|NCT00553696|520905716|FG003|Overall Study|Adverse Event|1|||
144467309|NCT00553696|520905713|FG000|Overall Study|Global deterioration of health status|0|||
144467310|NCT00553696|520905714|FG001|Overall Study|Global deterioration of health status|2|||
144467311|NCT00553696|520905715|FG002|Overall Study|Global deterioration of health status|0|||
144467312|NCT00553696|520905716|FG003|Overall Study|Global deterioration of health status|0|||
144467313|NCT00553696|520905713|FG000|Overall Study|Objective progression or relapse|2|||
144467314|NCT00553696|520905714|FG001|Overall Study|Objective progression or relapse|9|||
144467315|NCT00553696|520905715|FG002|Overall Study|Objective progression or relapse|6|||
144467316|NCT00553696|520905716|FG003|Overall Study|Objective progression or relapse|0|||
144467317|NCT00553696|520905713|FG000|Overall Study|Withdrawal by Subject|0|||
144467318|NCT00553696|520905714|FG001|Overall Study|Withdrawal by Subject|1|||
144467319|NCT00553696|520905715|FG002|Overall Study|Withdrawal by Subject|0|||
144467320|NCT00553696|520905716|FG003|Overall Study|Withdrawal by Subject|0|||
144467321|NCT02085252|520905719|FG000|Overall Study|Withdrawal of Consent|1|||
144467322|NCT02085252|520905720|FG001|Overall Study|Withdrawal of Consent|0|||
144467323|NCT02085252|520905719|FG000|Overall Study|Adverse Event|0|||
144467324|NCT02085252|520905720|FG001|Overall Study|Adverse Event|1|||
144467325|NCT02085252|520905719|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
144467326|NCT02085252|520905720|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
144467327|NCT02085252|520905719|FG000|Overall Study|Reason Not Specified|0|||
144467328|NCT02085252|520905720|FG001|Overall Study|Reason Not Specified|1|||
144467329|NCT02085252|520905719|FG000|Overall Study|Reason Unknown|0|||
144467330|NCT02085252|520905720|FG001|Overall Study|Reason Unknown|1|||
144467331|NCT00671931|520905721|FG000|Overall Study|Physician Decision|1|||
144467332|NCT00671931|520905722|FG001|Overall Study|Physician Decision|0|||
144467333|NCT00671931|520905723|FG002|Overall Study|Physician Decision|0|||
144467334|NCT00671931|520905724|FG003|Overall Study|Physician Decision|2|||
144467335|NCT00671931|520905725|FG004|Overall Study|Physician Decision|1|||
144467336|NCT02543658|520907109|FG000|Overall Study|Lack of Efficacy|0|||
144467337|NCT02543658|520907110|FG001|Overall Study|Lack of Efficacy|4|||
144467338|NCT00437645|520907117|FG000|Overall Study|Adverse Event|15|||
144467339|NCT00437645|520907118|FG001|Overall Study|Adverse Event|84|||
144467340|NCT00437645|520907117|FG000|Overall Study|Withdrawal by Subject|10|||
144467341|NCT00437645|520907118|FG001|Overall Study|Withdrawal by Subject|22|||
144467342|NCT00437645|520907117|FG000|Overall Study|Protocol Violation|3|||
144467343|NCT00437645|520907118|FG001|Overall Study|Protocol Violation|3|||
144467344|NCT00437645|520907117|FG000|Overall Study|Lost to Follow-up|2|||
144467345|NCT00437645|520907118|FG001|Overall Study|Lost to Follow-up|3|||
144467346|NCT00437645|520907117|FG000|Overall Study|Administrative problems|2|||
144467347|NCT00437645|520907118|FG001|Overall Study|Administrative problems|1|||
144467348|NCT00437645|520907117|FG000|Overall Study|Lack of Efficacy|2|||
144467349|NCT00437645|520907118|FG001|Overall Study|Lack of Efficacy|1|||
144467350|NCT00437645|520907117|FG000|Overall Study|Condition no longer requires study drug|1|||
144467351|NCT00437645|520907118|FG001|Overall Study|Condition no longer requires study drug|1|||
144467352|NCT03966053|520907119|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
144467353|NCT01699022|520907124|FG000|Overall Study|Early discontinuation from the study|3|||
144467354|NCT02066402|520907125|FG000|Overall Study|Adverse Event|1|||
144467355|NCT02066402|520907126|FG001|Overall Study|Adverse Event|2|||
144467356|NCT02066402|520907125|FG000|Overall Study|Lost to Follow-up|11|||
144467357|NCT02066402|520907126|FG001|Overall Study|Lost to Follow-up|8|||
144467358|NCT02066402|520907125|FG000|Overall Study|Withdrawal by Subject|14|||
144467359|NCT02066402|520907126|FG001|Overall Study|Withdrawal by Subject|11|||
144467360|NCT02066402|520907125|FG000|Overall Study|Progressive disease-clinical progression|0|||
144467361|NCT02066402|520907126|FG001|Overall Study|Progressive disease-clinical progression|1|||
144467362|NCT02066402|520907125|FG000|Overall Study|Protocol driven decision point|0|||
144467363|NCT02066402|520907126|FG001|Overall Study|Protocol driven decision point|1|||
144467364|NCT00152464|520907127|FG000|Overall Study|Adverse Event|3|||
144467365|NCT00152464|520907128|FG001|Overall Study|Adverse Event|6|||
144536629|NCT00943917|521168434|FG013|Stage II Continuation|Adverse Event|1|||
144536630|NCT00943917|521168435|FG014|Stage II Continuation|Adverse Event|1|||
144536631|NCT00943917|521168421|FG000|Stage II Continuation|Withdrawal by Subject|0|||
144536632|NCT00943917|521168422|FG001|Stage II Continuation|Withdrawal by Subject|0|||
144536633|NCT00943917|521168423|FG002|Stage II Continuation|Withdrawal by Subject|0|||
144536634|NCT00943917|521168424|FG003|Stage II Continuation|Withdrawal by Subject|0|||
144536635|NCT00943917|521168425|FG004|Stage II Continuation|Withdrawal by Subject|0|||
144536636|NCT00943917|521168426|FG005|Stage II Continuation|Withdrawal by Subject|0|||
144467366|NCT00152464|520907127|FG000|Overall Study|Lost to Follow-up|8|||
144467367|NCT00152464|520907128|FG001|Overall Study|Lost to Follow-up|4|||
144467368|NCT00152464|520907127|FG000|Overall Study|Protocol Violation|3|||
144467369|NCT00152464|520907128|FG001|Overall Study|Protocol Violation|1|||
144467370|NCT00152464|520907127|FG000|Overall Study|Withdrawal by Subject|21|||
144536637|NCT00943917|521168427|FG006|Stage II Continuation|Withdrawal by Subject|0|||
144536638|NCT00943917|521168428|FG007|Stage II Continuation|Withdrawal by Subject|0|||
144536639|NCT00943917|521168429|FG008|Stage II Continuation|Withdrawal by Subject|0|||
144536640|NCT00943917|521168430|FG009|Stage II Continuation|Withdrawal by Subject|0|||
144467371|NCT00152464|520907128|FG001|Overall Study|Withdrawal by Subject|22|||
144467372|NCT00152464|520907127|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
144467373|NCT00152464|520907128|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
144467374|NCT00152464|520907127|FG000|Overall Study|Eczema deterioration|0|||
144467375|NCT00152464|520907128|FG001|Overall Study|Eczema deterioration|1|||
144467376|NCT00152464|520907127|FG000|Overall Study|Parent decision|1|||
144467377|NCT00152464|520907128|FG001|Overall Study|Parent decision|1|||
144467378|NCT00152464|520907127|FG000|Overall Study|Investigator decision|1|||
144467379|NCT00152464|520907128|FG001|Overall Study|Investigator decision|0|||
144467380|NCT00152464|520907127|FG000|Overall Study|Lack of Efficacy|1|||
144467381|NCT00152464|520907128|FG001|Overall Study|Lack of Efficacy|0|||
144467382|NCT00152464|520907127|FG000|Overall Study|Eczema poorly controlled|1|||
144467383|NCT00152464|520907128|FG001|Overall Study|Eczema poorly controlled|0|||
144467384|NCT00152464|520907127|FG000|Overall Study|Patient relocated|1|||
144467385|NCT00152464|520907128|FG001|Overall Study|Patient relocated|0|||
144467386|NCT04465357|520907130|FG000|Overall Study|Adverse Event|2|||
144467387|NCT04465357|520907130|FG000|Overall Study|Lack of Efficacy|1|||
144467388|NCT04465357|520907130|FG000|Overall Study|Lost to Follow-up|2|||
144467389|NCT04465357|520907130|FG000|Overall Study|Withdrawal by Subject|6|||
144467390|NCT04465357|520907130|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
144467391|NCT01754467|520907132|FG000|Overall Study|Lost to Follow-up|1|||
144467392|NCT01970462|520907133|FG000|Overall Study|Lost to Follow-up|0|||
144467393|NCT01970462|520907134|FG001|Overall Study|Lost to Follow-up|2|||
144467394|NCT00917579|520907135|FG000|Washout >= 2 Weeks|Adverse Event|1|||
144467395|NCT00917579|520907136|FG001|Washout >= 2 Weeks|Adverse Event|0|||
144467396|NCT00917579|520907135|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
144467397|NCT00917579|520907136|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
144467398|NCT00754338|520907137|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
144467399|NCT00754338|520907138|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
144467400|NCT00754338|520907139|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
144467401|NCT00754338|520907140|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
144467402|NCT00754338|520907137|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
144467403|NCT00754338|520907138|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
144467404|NCT00754338|520907139|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
144467405|NCT00754338|520907140|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
144467406|NCT04020341|520907143|FG000|Overall Study|Adverse Event|8|||
144467407|NCT04020341|520907144|FG001|Overall Study|Adverse Event|6|||
144467408|NCT04020341|520907143|FG000|Overall Study|Lost to Follow-up|8|||
144467409|NCT04020341|520907144|FG001|Overall Study|Lost to Follow-up|2|||
144467410|NCT04020341|520907143|FG000|Overall Study|Withdrawal by Subject|16|||
144467411|NCT04020341|520907144|FG001|Overall Study|Withdrawal by Subject|16|||
144467412|NCT04020341|520907143|FG000|Overall Study|Participant not able to swallow the tablet|1|||
144467413|NCT04020341|520907144|FG001|Overall Study|Participant not able to swallow the tablet|0|||
144467414|NCT04020341|520907143|FG000|Overall Study|Physician Decision|0|||
144467415|NCT04020341|520907144|FG001|Overall Study|Physician Decision|2|||
144467416|NCT04020341|520907143|FG000|Overall Study|Protocol Deviation|0|||
144467417|NCT04020341|520907144|FG001|Overall Study|Protocol Deviation|2|||
144467418|NCT05763628|520907145|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
144467419|NCT05763628|520907146|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
144467420|NCT05763628|520907145|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
144467421|NCT05763628|520907146|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
144467422|NCT05763628|520907145|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
144467423|NCT05763628|520907146|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
144467424|NCT04683926|520907154|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
144467425|NCT04683926|520907155|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
144467426|NCT04683926|520907156|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
144467427|NCT04683926|520907157|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
144467428|NCT04385368|520907159|FG000|Overall Study|Death|5|||
144467429|NCT04385368|520907160|FG001|Overall Study|Death|5|||
144467430|NCT04385368|520907159|FG000|Overall Study|Physician Decision|3|||
144467431|NCT04385368|520907160|FG001|Overall Study|Physician Decision|0|||
144467432|NCT04385368|520907159|FG000|Overall Study|Withdrawal by Subject|4|||
144467433|NCT04385368|520907160|FG001|Overall Study|Withdrawal by Subject|3|||
144467434|NCT02123108|520907163|FG000|Overall Study|Death|2|||
144467435|NCT02123108|520907164|FG001|Overall Study|Death|3|||
144467436|NCT00716092|520907165|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
144467437|NCT00716092|520907166|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
144467438|NCT00716092|520907167|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
144467439|NCT01132326|520907168|FG000|Overall Study|Lack of Efficacy|25|||
144467440|NCT01132326|520907168|FG000|Overall Study|Adverse Event|37|||
144467441|NCT01132326|520907168|FG000|Overall Study|Protocol Violation|1|||
144467442|NCT01132326|520907168|FG000|Overall Study|Lost to Follow-up|16|||
144613157|NCT01500278|521445457|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
144613158|NCT01500278|521445456|FG000|Week 0 - Week 12|Protocol Violation|10|||
144467443|NCT01132326|520907168|FG000|Overall Study|Withdrawal by Subject|40|||
144467444|NCT01132326|520907168|FG000|Overall Study|Physician Decision|10|||
144467445|NCT01132326|520907168|FG000|Overall Study|Study Termination|80|||
144467446|NCT01132326|520907168|FG000|Overall Study|Declining Health|1|||
144467447|NCT01132326|520907168|FG000|Overall Study|Pregnancy|1|||
144467448|NCT01132326|520907168|FG000|Overall Study|Caregiver Withdrew Consent|1|||
144467449|NCT01132326|520907168|FG000|Overall Study|Death|5|||
144467450|NCT01132326|520907168|FG000|Overall Study|Subject Unable to Come To Visits|1|||
144467451|NCT00677235|520907169|FG000|Overall Study|Withdrawal by Subject|1|||
144467452|NCT00677235|520907170|FG001|Overall Study|Withdrawal by Subject|1|||
144467453|NCT00677235|520907169|FG000|Overall Study|Lost to Follow-up|2|||
144467454|NCT00677235|520907170|FG001|Overall Study|Lost to Follow-up|1|||
144467455|NCT00677235|520907169|FG000|Overall Study|Death|37|||
144467456|NCT00677235|520907170|FG001|Overall Study|Death|36|||
144467457|NCT00677235|520907169|FG000|Overall Study|Adverse Experience|1|||
144467458|NCT00677235|520907170|FG001|Overall Study|Adverse Experience|0|||
144467459|NCT01040260|520907171|FG000|Overall Study|Withdrawal by Subject|12|||
144467460|NCT01040260|520907172|FG001|Overall Study|Withdrawal by Subject|6|||
144467461|NCT01040260|520907171|FG000|Overall Study|Lost to Follow-up|3|||
144467462|NCT01040260|520907172|FG001|Overall Study|Lost to Follow-up|5|||
144467463|NCT00689221|520907176|FG000|Overall Study|Ongoing at cut-off date|39|||
144467464|NCT00689221|520907177|FG001|Overall Study|Ongoing at cut-off date|36|||
144467465|NCT01812655|520907181|FG000|Overall Study|Protocol Violation|1|||
144467466|NCT01812655|520907182|FG001|Overall Study|Protocol Violation|1|||
144467467|NCT01812655|520907183|FG002|Overall Study|Protocol Violation|0|||
144467468|NCT01428076|520907185|FG000|Overall Study|Adverse Event|0|||
144467469|NCT01428076|520907186|FG001|Overall Study|Adverse Event|1|||
144467470|NCT04435665|520907187|FG000|Overall Study|Lost to Follow-up|0|||
144467471|NCT04435665|520907188|FG001|Overall Study|Lost to Follow-up|0|||
144467472|NCT04435665|520907189|FG002|Overall Study|Lost to Follow-up|0|||
144467473|NCT04435665|520907190|FG003|Overall Study|Lost to Follow-up|1|||
144467474|NCT00765388|520907191|FG000|Period 1|Lack of Efficacy|1|||
144467475|NCT00765388|520907192|FG001|Period 1|Lack of Efficacy|2|||
144467476|NCT00765388|520907191|FG000|Period 1|Lost to Follow-up|0|||
144467477|NCT00765388|520907192|FG001|Period 1|Lost to Follow-up|1|||
144467478|NCT00765388|520907191|FG000|Period 1|Herpes Zoster|0|||
144467479|NCT00765388|520907192|FG001|Period 1|Herpes Zoster|1|||
144467480|NCT00765388|520907191|FG000|Period 1|Hip operation|0|||
144467481|NCT00765388|520907192|FG001|Period 1|Hip operation|1|||
144467482|NCT02216773|520907193|FG000|Overall Study|Disease progression|4|||
144467483|NCT02216773|520907194|FG001|Overall Study|Disease progression|2|||
144467484|NCT02216773|520907193|FG000|Overall Study|Insufficient FLRV|4|||
144467485|NCT02216773|520907194|FG001|Overall Study|Insufficient FLRV|0|||
144467486|NCT02216773|520907193|FG000|Overall Study|Abandoned|4|||
144467487|NCT02216773|520907194|FG001|Overall Study|Abandoned|3|||
144467488|NCT02124265|520907198|FG000|Overall Study|Adverse Event|1|||
144467489|NCT04510675|520907201|FG000|Overall Study|Withdrawal by Subject|5|||
144467490|NCT00810264|520907202|FG000|Overall Study|Lost to Follow-up|191|||
144467491|NCT00810264|520907202|FG000|Overall Study|Withdrawal by subject or physician|721|||
144467492|NCT00810264|520907202|FG000|Overall Study|Death|641|||
144467493|NCT01563536|520907213|FG000|Overall Study|Withdrawal by Subject|0|||
144467494|NCT01563536|520907214|FG001|Overall Study|Withdrawal by Subject|2|||
144467495|NCT01563536|520907213|FG000|Overall Study|Lost to Follow-up|1|||
144467496|NCT01563536|520907214|FG001|Overall Study|Lost to Follow-up|0|||
144467497|NCT00058123|520907224|FG000|Overall Study|Wrong histology|9|||
144467498|NCT00058123|520907224|FG000|Overall Study|Received >3 prior treatments|1|||
144467499|NCT00686881|520907225|FG000|Overall Study|Withdrawal by Subject|11|||
144467500|NCT00686881|520907226|FG001|Overall Study|Withdrawal by Subject|18|||
144467501|NCT00686881|520907225|FG000|Overall Study|Lost to Follow-up|0|||
144467502|NCT00686881|520907226|FG001|Overall Study|Lost to Follow-up|1|||
144467503|NCT00686881|520907225|FG000|Overall Study|Treatment-related adverse event|10|||
144467504|NCT00686881|520907226|FG001|Overall Study|Treatment-related adverse event|9|||
144467505|NCT00686881|520907225|FG000|Overall Study|Met discontinuation criteria|5|||
144467506|NCT00686881|520907226|FG001|Overall Study|Met discontinuation criteria|0|||
144467507|NCT00686881|520907225|FG000|Overall Study|Onset of malignant tumor|11|||
144467508|NCT00686881|520907226|FG001|Overall Study|Onset of malignant tumor|11|||
144467509|NCT00686881|520907225|FG000|Overall Study|Lack of Efficacy|4|||
144467510|NCT00686881|520907226|FG001|Overall Study|Lack of Efficacy|3|||
144467511|NCT00686881|520907225|FG000|Overall Study|Physician Decision|1|||
144467512|NCT00686881|520907226|FG001|Overall Study|Physician Decision|0|||
144467513|NCT00686881|520907225|FG000|Overall Study|Circumstances of site|1|||
144467514|NCT00686881|520907226|FG001|Overall Study|Circumstances of site|1|||
144467515|NCT00686881|520907225|FG000|Overall Study|Did not meet protocol eligibility|1|||
144467516|NCT00686881|520907226|FG001|Overall Study|Did not meet protocol eligibility|0|||
144467517|NCT00686881|520907225|FG000|Overall Study|Irregular visits|1|||
144467518|NCT00686881|520907226|FG001|Overall Study|Irregular visits|0|||
144467519|NCT00686881|520907225|FG000|Overall Study|Study discontinuation|35|||
144467520|NCT00686881|520907226|FG001|Overall Study|Study discontinuation|32|||
144467521|NCT00686881|520907225|FG000|Overall Study|Never received study drug|2|||
144726364|NCT05694013|521852736|FG001|Overall Study|Death|2|||
144726365|NCT05694013|521852735|FG000|Overall Study|Participant Decision|0|||
144726366|NCT05694013|521852736|FG001|Overall Study|Participant Decision|1|||
144726367|NCT05694013|521852735|FG000|Overall Study|Physician Decision|1|||
144726368|NCT05694013|521852736|FG001|Overall Study|Physician Decision|0|||
144726369|NCT05694013|521852735|FG000|Overall Study|Progressive Disease|0|||
144726370|NCT05694013|521852736|FG001|Overall Study|Progressive Disease|1|||
144726371|NCT05694013|521852735|FG000|Overall Study|Study Terminated by Sponsor|12|||
144726372|NCT05694013|521852736|FG001|Overall Study|Study Terminated by Sponsor|17|||
144613159|NCT01500278|521445457|FG001|Week 0 - Week 12|Protocol Violation|16|||
144613160|NCT01500278|521445456|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
144613161|NCT01500278|521445457|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
144613162|NCT01500278|521445456|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
144613163|NCT01500278|521445457|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
144613164|NCT01500278|521445456|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
144613165|NCT01500278|521445457|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
144613166|NCT01500278|521445456|FG000|Week 0 - Week 12|Patient decision|1|||
144613167|NCT01500278|521445457|FG001|Week 0 - Week 12|Patient decision|0|||
144613168|NCT01500278|521445456|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
144613169|NCT01500278|521445457|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
144613170|NCT01500278|521445456|FG000|Week 0 - Week 12|Investigator decision|1|||
144467522|NCT00686881|520907226|FG001|Overall Study|Never received study drug|6|||
144467523|NCT02925676|520907230|FG000|Overall Study|Withdrawal by Subject|1|||
144467524|NCT02151266|520907231|FG000|Overall Study|Lost to Follow-up|1|||
144467525|NCT02151266|520907232|FG001|Overall Study|Lost to Follow-up|4|||
144467526|NCT02151266|520907233|FG002|Overall Study|Lost to Follow-up|1|||
144467527|NCT02151266|520907231|FG000|Overall Study|Did NOT receive intervention|3|||
144467528|NCT02151266|520907232|FG001|Overall Study|Did NOT receive intervention|6|||
144467529|NCT02151266|520907233|FG002|Overall Study|Did NOT receive intervention|2|||
144467530|NCT02151266|520907231|FG000|Overall Study|Not able to exercise|4|||
144467531|NCT02151266|520907232|FG001|Overall Study|Not able to exercise|5|||
144467532|NCT02151266|520907233|FG002|Overall Study|Not able to exercise|4|||
144467533|NCT04839965|520907235|FG000|Overall Study|Death|6|||
144467534|NCT04839965|520907236|FG001|Overall Study|Death|6|||
144467535|NCT04839965|520907235|FG000|Overall Study|Lost to Follow-up|1|||
144467536|NCT04839965|520907236|FG001|Overall Study|Lost to Follow-up|0|||
144467537|NCT00981084|520907237|FG000|Post Intervention (Data Analysis)|poor effort|1|||
144467538|NCT00981084|520907238|FG001|Post Intervention (Data Analysis)|poor effort|1|||
144467539|NCT00981084|520907237|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
144467540|NCT00981084|520907238|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
144467541|NCT02291679|520907239|FG000|Overall Study|Adverse Event|2|||
144467542|NCT02291679|520907240|FG001|Overall Study|Adverse Event|12|||
144467543|NCT02291679|520907241|FG002|Overall Study|Adverse Event|19|||
144613171|NCT01500278|521445457|FG001|Week 0 - Week 12|Investigator decision|0|||
144613172|NCT01500278|521445456|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
144613173|NCT01500278|521445457|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
144613174|NCT01500278|521445456|FG000|Week 0 - Week 12|Sponsor decision|1|||
144613175|NCT01500278|521445457|FG001|Week 0 - Week 12|Sponsor decision|0|||
144613176|NCT01500278|521445456|FG000|Week 0 - Week 12|Personal reason|0|||
144613177|NCT01500278|521445457|FG001|Week 0 - Week 12|Personal reason|1|||
144613178|NCT01500278|521445456|FG000|Week 0 - Week 12|Other serious disease|0|||
144613179|NCT01500278|521445457|FG001|Week 0 - Week 12|Other serious disease|1|||
144613180|NCT01500278|521445456|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
144613181|NCT01500278|521445457|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
144467544|NCT02291679|520907239|FG000|Overall Study|Protocol Violation|5|||
144467545|NCT02291679|520907240|FG001|Overall Study|Protocol Violation|1|||
144467546|NCT02291679|520907241|FG002|Overall Study|Protocol Violation|7|||
144467547|NCT02291679|520907239|FG000|Overall Study|Withdrew Consent|18|||
144467548|NCT02291679|520907240|FG001|Overall Study|Withdrew Consent|10|||
144467549|NCT02291679|520907241|FG002|Overall Study|Withdrew Consent|15|||
144467550|NCT02291679|520907239|FG000|Overall Study|Lost to Follow-up|12|||
144467551|NCT02291679|520907240|FG001|Overall Study|Lost to Follow-up|10|||
144467552|NCT02291679|520907241|FG002|Overall Study|Lost to Follow-up|9|||
144467553|NCT02291679|520907239|FG000|Overall Study|Insufficient Therapeutic Response|5|||
144467554|NCT02291679|520907240|FG001|Overall Study|Insufficient Therapeutic Response|5|||
144467555|NCT02291679|520907241|FG002|Overall Study|Insufficient Therapeutic Response|7|||
144613182|NCT01500278|521445456|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
144726373|NCT05694013|521852735|FG000|Overall Study|Withdrawal by Subject|3|||
144726374|NCT05694013|521852736|FG001|Overall Study|Withdrawal by Subject|0|||
144726375|NCT04817891|521852737|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
144467556|NCT02291679|520907239|FG000|Overall Study|Other|2|||
144467557|NCT02291679|520907240|FG001|Overall Study|Other|4|||
144467558|NCT02291679|520907241|FG002|Overall Study|Other|2|||
144467559|NCT02276222|520907242|FG000|Overall Study|Adverse Event|62|||
144467560|NCT02276222|520907243|FG001|Overall Study|Adverse Event|11|||
144467561|NCT02276222|520907242|FG000|Overall Study|Death|3|||
144613183|NCT01500278|521445457|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
144613184|NCT01500278|521445456|FG000|Week 13 - Week 104|Protocol Violation|6|||
144613185|NCT01500278|521445457|FG001|Week 13 - Week 104|Protocol Violation|6|||
144613186|NCT01500278|521445456|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
144613187|NCT01500278|521445457|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
144613188|NCT01500278|521445456|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
144613189|NCT01500278|521445457|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
144467562|NCT02276222|520907243|FG001|Overall Study|Death|4|||
144467563|NCT02276222|520907242|FG000|Overall Study|Lack of Efficacy|13|||
144467564|NCT02276222|520907243|FG001|Overall Study|Lack of Efficacy|3|||
144467565|NCT02276222|520907242|FG000|Overall Study|Protocol Violation|3|||
144467566|NCT02276222|520907243|FG001|Overall Study|Protocol Violation|2|||
144467567|NCT02276222|520907242|FG000|Overall Study|Withdrawal by Subject|79|||
144467568|NCT02276222|520907243|FG001|Overall Study|Withdrawal by Subject|33|||
144467569|NCT02276222|520907242|FG000|Overall Study|non compliance with study medication|6|||
144467570|NCT02276222|520907243|FG001|Overall Study|non compliance with study medication|2|||
144467571|NCT02276222|520907242|FG000|Overall Study|sponsor decision|0|||
144467572|NCT02276222|520907243|FG001|Overall Study|sponsor decision|3|||
144467573|NCT02276222|520907242|FG000|Overall Study|Lost to Follow-up|15|||
144467574|NCT02276222|520907243|FG001|Overall Study|Lost to Follow-up|5|||
144467575|NCT02276222|520907242|FG000|Overall Study|Physician Decision|2|||
144467576|NCT02276222|520907243|FG001|Overall Study|Physician Decision|1|||
144467577|NCT02276222|520907242|FG000|Overall Study|sheduling conflict|1|||
144467578|NCT02276222|520907243|FG001|Overall Study|sheduling conflict|0|||
144467579|NCT02276222|520907242|FG000|Overall Study|subject withdrew after randomization|1|||
144467580|NCT02276222|520907243|FG001|Overall Study|subject withdrew after randomization|0|||
144467581|NCT02170025|520907244|FG000|Overall Study|Adverse Event|2|||
144467582|NCT02170025|520907245|FG001|Overall Study|Adverse Event|0|||
144467583|NCT00572195|520907246|FG000|Overall Study|Withdrawal by Subject|50|||
144467584|NCT00572195|520907246|FG000|Overall Study|Death|9|||
144467585|NCT00572195|520907246|FG000|Overall Study|Adverse Event|4|||
144467586|NCT00572195|520907246|FG000|Overall Study|Lost to Follow-up|5|||
144467587|NCT01525602|520907247|FG000|Overall Study|Adverse Event|1|||
144467588|NCT01525602|520907248|FG001|Overall Study|Adverse Event|0|||
144467589|NCT01525602|520907249|FG002|Overall Study|Adverse Event|1|||
144467590|NCT01525602|520907250|FG003|Overall Study|Adverse Event|1|||
144467591|NCT01525602|520907251|FG004|Overall Study|Adverse Event|3|||
144467592|NCT01525602|520907252|FG005|Overall Study|Adverse Event|3|||
144467593|NCT01525602|520907253|FG006|Overall Study|Adverse Event|0|||
144467594|NCT01525602|520907254|FG007|Overall Study|Adverse Event|1|||
144467595|NCT01525602|520907247|FG000|Overall Study|Disease progression|6|||
144467596|NCT01525602|520907248|FG001|Overall Study|Disease progression|3|||
144467597|NCT01525602|520907249|FG002|Overall Study|Disease progression|2|||
144467598|NCT01525602|520907250|FG003|Overall Study|Disease progression|5|||
144467599|NCT01525602|520907251|FG004|Overall Study|Disease progression|22|||
144467600|NCT01525602|520907252|FG005|Overall Study|Disease progression|2|||
144467601|NCT01525602|520907253|FG006|Overall Study|Disease progression|3|||
144467602|NCT01525602|520907254|FG007|Overall Study|Disease progression|3|||
144467603|NCT01525602|520907247|FG000|Overall Study|Clinical progression|2|||
144467604|NCT01525602|520907248|FG001|Overall Study|Clinical progression|0|||
144467605|NCT01525602|520907249|FG002|Overall Study|Clinical progression|0|||
144613190|NCT01500278|521445456|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
144613191|NCT01500278|521445457|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
144613192|NCT01500278|521445456|FG000|Week 13 - Week 104|Non/bad compliance|7|||
144613193|NCT01500278|521445457|FG001|Week 13 - Week 104|Non/bad compliance|5|||
144467606|NCT01525602|520907250|FG003|Overall Study|Clinical progression|0|||
144467607|NCT01525602|520907251|FG004|Overall Study|Clinical progression|0|||
144467608|NCT01525602|520907252|FG005|Overall Study|Clinical progression|0|||
144467609|NCT01525602|520907253|FG006|Overall Study|Clinical progression|1|||
144467610|NCT01525602|520907254|FG007|Overall Study|Clinical progression|1|||
144467611|NCT01525602|520907247|FG000|Overall Study|Non-compliance|0|||
144467612|NCT01525602|520907248|FG001|Overall Study|Non-compliance|0|||
144613194|NCT01500278|521445456|FG000|Week 13 - Week 104|Recurrent infections|1|||
144613195|NCT01500278|521445457|FG001|Week 13 - Week 104|Recurrent infections|0|||
144613196|NCT01500278|521445456|FG000|Week 13 - Week 104|False positive test|1|||
144467613|NCT01525602|520907249|FG002|Overall Study|Non-compliance|0|||
144467614|NCT01525602|520907250|FG003|Overall Study|Non-compliance|0|||
144467615|NCT01525602|520907251|FG004|Overall Study|Non-compliance|1|||
144467616|NCT01525602|520907252|FG005|Overall Study|Non-compliance|0|||
144467617|NCT01525602|520907253|FG006|Overall Study|Non-compliance|0|||
144467618|NCT01525602|520907254|FG007|Overall Study|Non-compliance|0|||
144613197|NCT01500278|521445457|FG001|Week 13 - Week 104|False positive test|2|||
144613198|NCT01500278|521445456|FG000|Week 13 - Week 104|Sponsor request|4|||
144613199|NCT01500278|521445457|FG001|Week 13 - Week 104|Sponsor request|0|||
144613200|NCT01500278|521445456|FG000|Week 13 - Week 104|Withdrawn in error|1|||
144467619|NCT01525602|520907247|FG000|Overall Study|Withdrawal by Subject|0|||
144467620|NCT01525602|520907248|FG001|Overall Study|Withdrawal by Subject|0|||
144467621|NCT01525602|520907249|FG002|Overall Study|Withdrawal by Subject|0|||
144467622|NCT01525602|520907250|FG003|Overall Study|Withdrawal by Subject|0|||
144467623|NCT01525602|520907251|FG004|Overall Study|Withdrawal by Subject|3|||
144467624|NCT01525602|520907252|FG005|Overall Study|Withdrawal by Subject|1|||
144467625|NCT01525602|520907253|FG006|Overall Study|Withdrawal by Subject|0|||
144467626|NCT01525602|520907254|FG007|Overall Study|Withdrawal by Subject|1|||
144467627|NCT01525602|520907247|FG000|Overall Study|Physician Decision|0|||
144467628|NCT01525602|520907248|FG001|Overall Study|Physician Decision|0|||
144467629|NCT01525602|520907249|FG002|Overall Study|Physician Decision|0|||
144467630|NCT01525602|520907250|FG003|Overall Study|Physician Decision|0|||
144467631|NCT01525602|520907251|FG004|Overall Study|Physician Decision|3|||
144467632|NCT01525602|520907252|FG005|Overall Study|Physician Decision|0|||
144467633|NCT01525602|520907253|FG006|Overall Study|Physician Decision|1|||
144467634|NCT01525602|520907254|FG007|Overall Study|Physician Decision|0|||
144467635|NCT01525602|520907247|FG000|Overall Study|Death|0|||
144467636|NCT01525602|520907248|FG001|Overall Study|Death|0|||
144467637|NCT01525602|520907249|FG002|Overall Study|Death|0|||
144467638|NCT01525602|520907250|FG003|Overall Study|Death|0|||
144467639|NCT01525602|520907251|FG004|Overall Study|Death|1|||
144467640|NCT01525602|520907252|FG005|Overall Study|Death|1|||
144467641|NCT01525602|520907253|FG006|Overall Study|Death|0|||
144467642|NCT01525602|520907254|FG007|Overall Study|Death|0|||
144467643|NCT01525602|520907247|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
144467644|NCT01525602|520907248|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
144467645|NCT01525602|520907249|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
144467646|NCT01525602|520907250|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
144467647|NCT01525602|520907251|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
144467648|NCT01525602|520907252|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
144467649|NCT01525602|520907253|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
144467650|NCT01525602|520907254|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
144467651|NCT01024608|520907257|FG000|Overall Study|Adverse Event|1|||
144467652|NCT01024608|520907258|FG001|Overall Study|Adverse Event|0|||
144467653|NCT01024608|520907257|FG000|Overall Study|Withdrawal by Subject|1|||
144467654|NCT01024608|520907258|FG001|Overall Study|Withdrawal by Subject|0|||
144467655|NCT01024608|520907257|FG000|Overall Study|Lost to Follow-up|0|||
144467656|NCT01024608|520907258|FG001|Overall Study|Lost to Follow-up|1|||
144467657|NCT01024608|520907257|FG000|Overall Study|Protocol Violation|0|||
144467658|NCT01024608|520907258|FG001|Overall Study|Protocol Violation|3|||
144467659|NCT01024608|520907257|FG000|Overall Study|Never received study treatment|2|||
144467660|NCT01024608|520907258|FG001|Overall Study|Never received study treatment|0|||
144467661|NCT04586569|520909386|FG000|Overall Study|Withdrawal by Subject|0|||
144467662|NCT04586569|520909387|FG001|Overall Study|Withdrawal by Subject|2|||
144467663|NCT04586569|520909386|FG000|Overall Study|No longer eligible|2|||
144467664|NCT04586569|520909387|FG001|Overall Study|No longer eligible|3|||
144467665|NCT04586569|520909386|FG000|Overall Study|Physician Decision|1|||
144467666|NCT04586569|520909387|FG001|Overall Study|Physician Decision|0|||
144467667|NCT04098406|520909389|FG000|Overall Study|Adverse Event|2|||
144467668|NCT04098406|520909390|FG001|Overall Study|Adverse Event|1|||
144467669|NCT04098406|520909389|FG000|Overall Study|Withdrawal by Subject|1|||
144467670|NCT04098406|520909390|FG001|Overall Study|Withdrawal by Subject|0|||
144467671|NCT03597568|520909391|FG000|Overall Study|Withdrawal by Subject|1|||
144467672|NCT03597568|520909392|FG001|Overall Study|Withdrawal by Subject|1|||
144467673|NCT03597568|520909391|FG000|Overall Study|Unable to analyze vascular data|1|||
144467674|NCT03597568|520909392|FG001|Overall Study|Unable to analyze vascular data|1|||
144467675|NCT03548207|520909393|FG000|Overall Study|Death|10|||
144467676|NCT03548207|520909394|FG001|Overall Study|Death|23|||
144467677|NCT03548207|520909395|FG002|Overall Study|Death|3|||
144467678|NCT03548207|520909393|FG000|Overall Study|Lost to Follow-up|0|||
144467679|NCT03548207|520909394|FG001|Overall Study|Lost to Follow-up|2|||
144467680|NCT03548207|520909395|FG002|Overall Study|Lost to Follow-up|0|||
144467681|NCT03548207|520909393|FG000|Overall Study|Withdrawal by Subject|0|||
144467682|NCT03548207|520909394|FG001|Overall Study|Withdrawal by Subject|3|||
144467683|NCT03548207|520909395|FG002|Overall Study|Withdrawal by Subject|0|||
144613201|NCT01500278|521445457|FG001|Week 13 - Week 104|Withdrawn in error|0|||
144613202|NCT01500278|521445456|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
144613203|NCT01500278|521445457|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
144613204|NCT01500278|521445456|FG000|Week 13 - Week 104|Protocol deviation|1|||
144467684|NCT03548207|520909393|FG000|Overall Study|Sponsor decision|19|||
144467685|NCT03548207|520909394|FG001|Overall Study|Sponsor decision|40|||
144467686|NCT03548207|520909395|FG002|Overall Study|Sponsor decision|6|||
144467687|NCT03548207|520909393|FG000|Overall Study|Randomized but not treated|6|||
144467688|NCT03548207|520909394|FG001|Overall Study|Randomized but not treated|10|||
144467689|NCT03548207|520909395|FG002|Overall Study|Randomized but not treated|4|||
144467690|NCT01357616|520909397|FG000|Overall Study|Adverse Event|1|||
144467691|NCT01357616|520909398|FG001|Overall Study|Adverse Event|1|||
144467692|NCT01357616|520909397|FG000|Overall Study|Lost to Follow-up|4|||
144467693|NCT01357616|520909398|FG001|Overall Study|Lost to Follow-up|3|||
144467694|NCT01357616|520909397|FG000|Overall Study|Protocol Violation|0|||
144467695|NCT01357616|520909398|FG001|Overall Study|Protocol Violation|2|||
144467696|NCT01357616|520909397|FG000|Overall Study|Inadequate Control of IOP|1|||
144467697|NCT01357616|520909398|FG001|Overall Study|Inadequate Control of IOP|2|||
144467698|NCT01357616|520909397|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
144467699|NCT01357616|520909398|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
144467700|NCT01357616|520909397|FG000|Overall Study|Withdrawal by Subject|1|||
144467701|NCT01357616|520909398|FG001|Overall Study|Withdrawal by Subject|0|||
144467702|NCT03320018|520909402|FG000|Treatment Period|Withdrawal by Subject|1|||
144467703|NCT03320018|520909403|FG001|Treatment Period|Withdrawal by Subject|0|||
144467704|NCT03320018|520909402|FG000|Day 90 Follow up|Death|0|||
144467705|NCT03320018|520909403|FG001|Day 90 Follow up|Death|1|||
144467706|NCT02691182|520909404|FG000|Overall Study|Withdrawal by Subject|4|||
144467707|NCT02691182|520909405|FG001|Overall Study|Withdrawal by Subject|7|||
144467708|NCT02691182|520909406|FG002|Overall Study|Withdrawal by Subject|6|||
144467709|NCT02691182|520909407|FG003|Overall Study|Withdrawal by Subject|8|||
144467710|NCT02691182|520909404|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
144467711|NCT02691182|520909405|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
144467712|NCT02691182|520909406|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
144467713|NCT02691182|520909407|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
144467714|NCT02691182|520909404|FG000|Overall Study|Lost to Follow-up|8|||
144467715|NCT02691182|520909405|FG001|Overall Study|Lost to Follow-up|33|||
144467716|NCT02691182|520909406|FG002|Overall Study|Lost to Follow-up|19|||
144467717|NCT02691182|520909407|FG003|Overall Study|Lost to Follow-up|22|||
144467718|NCT02691182|520909404|FG000|Overall Study|Adverse Event|3|||
144467719|NCT02691182|520909405|FG001|Overall Study|Adverse Event|10|||
144467720|NCT02691182|520909406|FG002|Overall Study|Adverse Event|10|||
144467721|NCT02691182|520909407|FG003|Overall Study|Adverse Event|11|||
144467722|NCT02691182|520909404|FG000|Overall Study|Physician Decision|3|||
144467723|NCT02691182|520909405|FG001|Overall Study|Physician Decision|7|||
144467724|NCT02691182|520909406|FG002|Overall Study|Physician Decision|14|||
144467725|NCT02691182|520909407|FG003|Overall Study|Physician Decision|8|||
144467726|NCT02691182|520909404|FG000|Overall Study|Lack of Efficacy|0|||
144467727|NCT02691182|520909405|FG001|Overall Study|Lack of Efficacy|0|||
144467728|NCT02691182|520909406|FG002|Overall Study|Lack of Efficacy|0|||
144467729|NCT02691182|520909407|FG003|Overall Study|Lack of Efficacy|4|||
144467730|NCT02691182|520909404|FG000|Overall Study|Protocol Violation|2|||
144467731|NCT02691182|520909405|FG001|Overall Study|Protocol Violation|6|||
144467732|NCT02691182|520909406|FG002|Overall Study|Protocol Violation|6|||
144467733|NCT02691182|520909407|FG003|Overall Study|Protocol Violation|8|||
144467734|NCT02691182|520909404|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
144467735|NCT02691182|520909405|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
144467736|NCT02691182|520909406|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
144467737|NCT02691182|520909407|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
144467738|NCT02691182|520909404|FG000|Overall Study|Missing|0|||
144467739|NCT02691182|520909405|FG001|Overall Study|Missing|5|||
144467740|NCT02691182|520909406|FG002|Overall Study|Missing|1|||
144467741|NCT02691182|520909407|FG003|Overall Study|Missing|5|||
144467742|NCT05906368|520909410|FG000|Overall Study|Withdrawal by Subject|1|||
144467743|NCT05906368|520909411|FG001|Overall Study|Withdrawal by Subject|1|||
144467744|NCT05906368|520909410|FG000|Overall Study|Ineligibility criteria identified|2|||
144467745|NCT05906368|520909411|FG001|Overall Study|Ineligibility criteria identified|0|||
144467746|NCT04493931|520909412|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
144467747|NCT04493931|520909413|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
144467748|NCT04493931|520909414|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
144536641|NCT00943917|521168431|FG010|Stage II Continuation|Withdrawal by Subject|0|||
144536642|NCT00943917|521168432|FG011|Stage II Continuation|Withdrawal by Subject|0|||
144536643|NCT00943917|521168433|FG012|Stage II Continuation|Withdrawal by Subject|0|||
144536644|NCT00943917|521168434|FG013|Stage II Continuation|Withdrawal by Subject|1|||
144536645|NCT00943917|521168435|FG014|Stage II Continuation|Withdrawal by Subject|3|||
144536646|NCT00943917|521168421|FG000|Stage II Continuation|Protocol Violation|0|||
144536647|NCT00943917|521168422|FG001|Stage II Continuation|Protocol Violation|0|||
144536648|NCT00943917|521168423|FG002|Stage II Continuation|Protocol Violation|0|||
144613205|NCT01500278|521445457|FG001|Week 13 - Week 104|Protocol deviation|0|||
144613206|NCT01500278|521445456|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
144467749|NCT04493931|520909415|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
144536649|NCT00943917|521168424|FG003|Stage II Continuation|Protocol Violation|0|||
144536650|NCT00943917|521168425|FG004|Stage II Continuation|Protocol Violation|0|||
144536651|NCT00943917|521168426|FG005|Stage II Continuation|Protocol Violation|0|||
144613207|NCT01500278|521445457|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
144467750|NCT04493931|520909416|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
144467751|NCT04493931|520909417|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
144467752|NCT04493931|520909418|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
144726376|NCT04817891|521852737|FG000|Overall Study|Adverse Event|1|||
144467753|NCT04493931|520909412|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
144467754|NCT04493931|520909413|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
144467755|NCT04493931|520909414|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
144467756|NCT04493931|520909415|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
144467757|NCT04493931|520909416|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
144467758|NCT04493931|520909417|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
144467759|NCT04493931|520909418|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
144467760|NCT04493931|520909412|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
144467761|NCT04493931|520909413|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
144467762|NCT04493931|520909414|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
144467763|NCT04493931|520909415|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
144467764|NCT04493931|520909416|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
144467765|NCT04493931|520909417|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
144467766|NCT04493931|520909418|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
144467767|NCT04493931|520909412|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
144467768|NCT04493931|520909413|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
144467769|NCT04493931|520909414|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
144467770|NCT04493931|520909415|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
144467771|NCT04493931|520909416|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
144467772|NCT04493931|520909417|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
144467773|NCT04493931|520909418|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
144467774|NCT03338894|520909419|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
144467775|NCT01127646|520909420|FG000|Overall Study|Entry Criteria Not Met|1|||
144467776|NCT01127646|520909421|FG001|Overall Study|Entry Criteria Not Met|0|||
144467777|NCT01127646|520909420|FG000|Overall Study|Protocol Violation|0|||
144467778|NCT01127646|520909421|FG001|Overall Study|Protocol Violation|1|||
144467779|NCT03466086|520909422|FG000|Period 1|Sponsor decision due to study timeline|1|||
144467780|NCT03466086|520909423|FG001|Period 1|Sponsor decision due to study timeline|0|||
144467781|NCT03466086|520909422|FG000|Period 1|Withdrawal by Subject|1|||
144467782|NCT03466086|520909423|FG001|Period 1|Withdrawal by Subject|0|||
144467783|NCT04721925|520909427|FG000|2-Month Assessment|Lost to Follow-up|5|||
144467784|NCT04721925|520909428|FG001|2-Month Assessment|Lost to Follow-up|3|||
144467785|NCT04721925|520909427|FG000|4-Month Assessment|Lost to Follow-up|3|||
144467786|NCT04721925|520909428|FG001|4-Month Assessment|Lost to Follow-up|6|||
144467787|NCT04570436|520909432|FG000|Overall Study|Adverse Event|0|||
144467788|NCT04570436|520909433|FG001|Overall Study|Adverse Event|0|||
144467789|NCT04570436|520909434|FG002|Overall Study|Adverse Event|1|||
144467790|NCT04570436|520909435|FG003|Overall Study|Adverse Event|0|||
144467791|NCT04570436|520909436|FG004|Overall Study|Adverse Event|0|||
144467792|NCT04570436|520909437|FG005|Overall Study|Adverse Event|0|||
144467793|NCT04570436|520909438|FG006|Overall Study|Adverse Event|0|||
144467794|NCT04570436|520909439|FG007|Overall Study|Adverse Event|0|||
144467795|NCT04570436|520909440|FG008|Overall Study|Adverse Event|0|||
144467796|NCT04570436|520909441|FG009|Overall Study|Adverse Event|0|||
144467797|NCT04570436|520909432|FG000|Overall Study|Physician Decision|1|||
144467798|NCT04570436|520909433|FG001|Overall Study|Physician Decision|0|||
144467799|NCT04570436|520909434|FG002|Overall Study|Physician Decision|0|||
144467800|NCT04570436|520909435|FG003|Overall Study|Physician Decision|0|||
144467801|NCT04570436|520909436|FG004|Overall Study|Physician Decision|0|||
144467802|NCT04570436|520909437|FG005|Overall Study|Physician Decision|0|||
144467803|NCT04570436|520909438|FG006|Overall Study|Physician Decision|0|||
144467804|NCT04570436|520909439|FG007|Overall Study|Physician Decision|0|||
144467805|NCT04570436|520909440|FG008|Overall Study|Physician Decision|0|||
144467806|NCT04570436|520909441|FG009|Overall Study|Physician Decision|0|||
144467807|NCT03002610|520909442|FG000|Overall Study|Withdrawal by Subject|6|||
144467808|NCT03002610|520909443|FG001|Overall Study|Withdrawal by Subject|25|||
144467809|NCT03002610|520909444|FG002|Overall Study|Withdrawal by Subject|13|||
144467810|NCT03802123|520909445|FG000|Overall Study|Withdrawal by Subject|3|||
144467811|NCT03802123|520909445|FG000|Overall Study|Physician Decision|1|||
144467812|NCT03802123|520909445|FG000|Overall Study|Subject moved to hospice care|1|||
144467813|NCT03802123|520909445|FG000|Overall Study|technician error|1|||
144467814|NCT03802123|520909445|FG000|Overall Study|Death|3|||
144467815|NCT04860518|520909446|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
144467816|NCT04860518|520909447|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
144467817|NCT00594854|520909448|FG000|Overall Study|Study terminated|7|||
144467818|NCT00594854|520909449|FG001|Overall Study|Study terminated|10|||
144467819|NCT03172702|520909450|FG000|Overall Study|Adverse Event|9|||
144467820|NCT03172702|520909450|FG000|Overall Study|Death|2|||
144467821|NCT03172702|520909450|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
144536652|NCT00943917|521168427|FG006|Stage II Continuation|Protocol Violation|0|||
144536653|NCT00943917|521168428|FG007|Stage II Continuation|Protocol Violation|0|||
144536654|NCT00943917|521168429|FG008|Stage II Continuation|Protocol Violation|0|||
144467822|NCT03172702|520909450|FG000|Overall Study|Withdrawal by Subject|5|||
144467823|NCT03172702|520909450|FG000|Overall Study|Other|2|||
144467824|NCT02835339|520909451|FG000|Overall Study|Did not receive allocated intervention|13|||
144467825|NCT02835339|520909452|FG001|Overall Study|Did not receive allocated intervention|16|||
144467826|NCT01077544|520909453|FG000|Overall Study|New Cancer Therapy|3|||
144467827|NCT01077544|520909454|FG001|Overall Study|New Cancer Therapy|3|||
144467828|NCT01077544|520909453|FG000|Overall Study|Adverse Event|0|||
144467829|NCT01077544|520909454|FG001|Overall Study|Adverse Event|1|||
144467830|NCT01077544|520909453|FG000|Overall Study|Disease Progression|0|||
144467831|NCT01077544|520909454|FG001|Overall Study|Disease Progression|1|||
144467832|NCT03923959|520909463|FG000|Overall Study|Death|16|||
144467833|NCT03923959|520909464|FG001|Overall Study|Death|12|||
144467834|NCT03923959|520909463|FG000|Overall Study|Lost to Follow-up|56|||
144467835|NCT03923959|520909464|FG001|Overall Study|Lost to Follow-up|56|||
144467836|NCT03923959|520909463|FG000|Overall Study|Withdrawal by Subject|1|||
144467837|NCT03923959|520909464|FG001|Overall Study|Withdrawal by Subject|1|||
144467838|NCT03923959|520909463|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
144467839|NCT03923959|520909464|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
144467840|NCT04918147|520909465|FG000|Overall Study|Disease flare as defined in protocol|0|||
144467841|NCT04918147|520909466|FG001|Overall Study|Disease flare as defined in protocol|2|||
144467842|NCT02954354|520909468|FG000|Overall Study|Adverse Event|2|||
144467843|NCT02954354|520909469|FG001|Overall Study|Adverse Event|2|||
144467844|NCT02954354|520909470|FG002|Overall Study|Adverse Event|4|||
144467845|NCT02954354|520909468|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
144467846|NCT02954354|520909469|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
144467847|NCT02954354|520909470|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
144467848|NCT02954354|520909468|FG000|Overall Study|Lack of Efficacy|0|||
144467849|NCT02954354|520909469|FG001|Overall Study|Lack of Efficacy|2|||
144467850|NCT02954354|520909470|FG002|Overall Study|Lack of Efficacy|0|||
144467851|NCT02954354|520909468|FG000|Overall Study|Withdrawal by Subject|17|||
144467852|NCT02954354|520909469|FG001|Overall Study|Withdrawal by Subject|9|||
144467853|NCT02954354|520909470|FG002|Overall Study|Withdrawal by Subject|11|||
144467854|NCT02954354|520909468|FG000|Overall Study|Lost to Follow-up|12|||
144467855|NCT02954354|520909469|FG001|Overall Study|Lost to Follow-up|5|||
144467856|NCT02954354|520909470|FG002|Overall Study|Lost to Follow-up|0|||
144467857|NCT02954354|520909468|FG000|Overall Study|Miscellaneous|2|||
144467858|NCT02954354|520909469|FG001|Overall Study|Miscellaneous|2|||
144467859|NCT02954354|520909470|FG002|Overall Study|Miscellaneous|1|||
144467860|NCT06134180|520909473|FG000|Overall Study|Lost to Follow-up|4|||
144467861|NCT04642898|520909478|FG000|Overall Study|Withdrawal by Subject|2|||
144467862|NCT04642898|520909479|FG001|Overall Study|Withdrawal by Subject|4|||
144467863|NCT04642898|520909480|FG002|Overall Study|Withdrawal by Subject|4|||
144467864|NCT04642898|520909481|FG003|Overall Study|Withdrawal by Subject|6|||
144467865|NCT04642898|520909482|FG004|Overall Study|Withdrawal by Subject|2|||
144467866|NCT04642898|520909483|FG005|Overall Study|Withdrawal by Subject|6|||
144467867|NCT04642898|520909478|FG000|Overall Study|Lost to Follow-up|0|||
144467868|NCT04642898|520909479|FG001|Overall Study|Lost to Follow-up|0|||
144467869|NCT04642898|520909480|FG002|Overall Study|Lost to Follow-up|0|||
144467870|NCT04642898|520909481|FG003|Overall Study|Lost to Follow-up|2|||
144467871|NCT04642898|520909482|FG004|Overall Study|Lost to Follow-up|0|||
144467872|NCT04642898|520909483|FG005|Overall Study|Lost to Follow-up|1|||
144467873|NCT04642898|520909478|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
144467874|NCT04642898|520909479|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
144467875|NCT04642898|520909480|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
144467876|NCT04642898|520909481|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
144467877|NCT04642898|520909482|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
144536655|NCT00943917|521168430|FG009|Stage II Continuation|Protocol Violation|1|||
144536656|NCT00943917|521168431|FG010|Stage II Continuation|Protocol Violation|0|||
144536657|NCT00943917|521168432|FG011|Stage II Continuation|Protocol Violation|1|||
144536658|NCT00943917|521168433|FG012|Stage II Continuation|Protocol Violation|0|||
144536659|NCT00943917|521168434|FG013|Stage II Continuation|Protocol Violation|0|||
144536660|NCT00943917|521168435|FG014|Stage II Continuation|Protocol Violation|0|||
144536661|NCT00943917|521168421|FG000|Stage II Continuation|hypoglycemia|0|||
144536662|NCT00943917|521168422|FG001|Stage II Continuation|hypoglycemia|0|||
144536663|NCT00943917|521168423|FG002|Stage II Continuation|hypoglycemia|0|||
144536664|NCT00943917|521168424|FG003|Stage II Continuation|hypoglycemia|0|||
144467878|NCT04642898|520909483|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
144467879|NCT04642898|520909478|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
144467880|NCT04642898|520909479|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
144467881|NCT04642898|520909480|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
144467882|NCT04642898|520909481|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
144467883|NCT04642898|520909482|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
144259305|NCT01468454|520150360|FG000|Overall Study|Did not have surgery after PET|9|||
144467884|NCT04642898|520909483|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
144467885|NCT04495179|520909484|FG000|Overall Study|Lost to Follow-up|0|||
144467886|NCT04495179|520909485|FG001|Overall Study|Lost to Follow-up|1|||
144467887|NCT04495179|520909484|FG000|Overall Study|Withdrawal by Subject|2|||
144467888|NCT04495179|520909485|FG001|Overall Study|Withdrawal by Subject|4|||
144467889|NCT04495179|520909484|FG000|Overall Study|Study terminated by sponsor|0|||
144467890|NCT04495179|520909485|FG001|Overall Study|Study terminated by sponsor|18|||
144467891|NCT04495179|520909484|FG000|Overall Study|Death|0|||
144467892|NCT04495179|520909485|FG001|Overall Study|Death|4|||
144467893|NCT04495179|520909484|FG000|Overall Study|Adverse Event|0|||
144467894|NCT04495179|520909485|FG001|Overall Study|Adverse Event|1|||
144467895|NCT00162370|520909486|FG000|Efficacy Population|Lost to Follow-up|51|||
144467896|NCT00569582|520909500|FG000|Overall Study|Withdrawal by Subject|5|||
144467897|NCT00569582|520909500|FG000|Overall Study|Death|2|||
144467898|NCT00569582|520909500|FG000|Overall Study|Adverse Event|7|||
144467899|NCT00569582|520909500|FG000|Overall Study|Subject was too ill to travel.|1|||
144467900|NCT00569582|520909500|FG000|Overall Study|Subject was non-compliant.|1|||
144467901|NCT04040751|520909501|FG000|Overall Study|Withdrawal by Subject|2|||
144467902|NCT04040751|520909502|FG001|Overall Study|Withdrawal by Subject|0|||
144467903|NCT04040751|520909503|FG002|Overall Study|Withdrawal by Subject|2|||
144467904|NCT04040751|520909504|FG003|Overall Study|Withdrawal by Subject|0|||
144467905|NCT04212091|520909507|FG000|Overall Study|Lost to Follow-up|0|||
144467906|NCT04212091|520909508|FG001|Overall Study|Lost to Follow-up|0|||
144467907|NCT04212091|520909509|FG002|Overall Study|Lost to Follow-up|0|||
144467908|NCT04212091|520909510|FG003|Overall Study|Lost to Follow-up|0|||
144467909|NCT04212091|520909511|FG004|Overall Study|Lost to Follow-up|1|||
144467910|NCT04212091|520909512|FG005|Overall Study|Lost to Follow-up|1|||
144467911|NCT04212091|520909507|FG000|Overall Study|Participant unable to adhere to visit|0|||
144467912|NCT04212091|520909508|FG001|Overall Study|Participant unable to adhere to visit|0|||
144467913|NCT04212091|520909509|FG002|Overall Study|Participant unable to adhere to visit|0|||
144467914|NCT04212091|520909510|FG003|Overall Study|Participant unable to adhere to visit|0|||
144467915|NCT04212091|520909511|FG004|Overall Study|Participant unable to adhere to visit|1|||
144467916|NCT04212091|520909512|FG005|Overall Study|Participant unable to adhere to visit|0|||
144467917|NCT02612311|520909513|FG000|Overall Study|Adverse Event|16|||
144467918|NCT02612311|520909514|FG001|Overall Study|Adverse Event|12|||
144467919|NCT02612311|520909515|FG002|Overall Study|Adverse Event|7|||
144467920|NCT02612311|520909516|FG003|Overall Study|Adverse Event|13|||
144467921|NCT02612311|520909513|FG000|Overall Study|Death|29|||
144467922|NCT02612311|520909514|FG001|Overall Study|Death|10|||
144467923|NCT02612311|520909515|FG002|Overall Study|Death|11|||
144467924|NCT02612311|520909516|FG003|Overall Study|Death|11|||
144467925|NCT02612311|520909513|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
144467926|NCT02612311|520909514|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
144467927|NCT02612311|520909515|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
144467928|NCT02612311|520909516|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
144467929|NCT02612311|520909513|FG000|Overall Study|Investigator's Decision|11|||
144467930|NCT02612311|520909514|FG001|Overall Study|Investigator's Decision|15|||
144467931|NCT02612311|520909515|FG002|Overall Study|Investigator's Decision|6|||
144467932|NCT02612311|520909516|FG003|Overall Study|Investigator's Decision|6|||
144467933|NCT02612311|520909513|FG000|Overall Study|Lack of Efficacy|0|||
144467934|NCT02612311|520909514|FG001|Overall Study|Lack of Efficacy|0|||
144467935|NCT02612311|520909515|FG002|Overall Study|Lack of Efficacy|1|||
144467936|NCT02612311|520909516|FG003|Overall Study|Lack of Efficacy|1|||
144467937|NCT02612311|520909513|FG000|Overall Study|Lost to Follow-up|2|||
144467938|NCT02612311|520909514|FG001|Overall Study|Lost to Follow-up|2|||
144467939|NCT02612311|520909515|FG002|Overall Study|Lost to Follow-up|1|||
144467940|NCT02612311|520909516|FG003|Overall Study|Lost to Follow-up|2|||
144467941|NCT02612311|520909513|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
144467942|NCT02612311|520909514|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
144467943|NCT02612311|520909515|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
144467944|NCT02612311|520909516|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
144467945|NCT02612311|520909513|FG000|Overall Study|Site Terminated by Sponsor|29|||
144467946|NCT02612311|520909514|FG001|Overall Study|Site Terminated by Sponsor|12|||
144467947|NCT02612311|520909515|FG002|Overall Study|Site Terminated by Sponsor|13|||
144467948|NCT02612311|520909516|FG003|Overall Study|Site Terminated by Sponsor|5|||
144467949|NCT02612311|520909513|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
144467950|NCT02612311|520909514|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
144467951|NCT02612311|520909515|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
144467952|NCT02612311|520909516|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
144467953|NCT02612311|520909513|FG000|Overall Study|Reason Not Specified|3|||
144467954|NCT02612311|520909514|FG001|Overall Study|Reason Not Specified|7|||
144467955|NCT02612311|520909515|FG002|Overall Study|Reason Not Specified|4|||
144467956|NCT02612311|520909516|FG003|Overall Study|Reason Not Specified|5|||
144613208|NCT01500278|521445456|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
144467957|NCT02612311|520909513|FG000|Overall Study|Unknown/Missing|10|||
144467958|NCT02612311|520909514|FG001|Overall Study|Unknown/Missing|13|||
144467959|NCT02612311|520909515|FG002|Overall Study|Unknown/Missing|4|||
144467960|NCT02612311|520909516|FG003|Overall Study|Unknown/Missing|0|||
144467961|NCT02612311|520909513|FG000|Overall Study|Non-Compliance with Study|1|||
144467962|NCT02612311|520909514|FG001|Overall Study|Non-Compliance with Study|0|||
144467963|NCT02612311|520909515|FG002|Overall Study|Non-Compliance with Study|0|||
144467964|NCT02612311|520909516|FG003|Overall Study|Non-Compliance with Study|0|||
144467965|NCT04085328|520909517|FG000|Overall Study|Witihdrew Consent|16|||
144467966|NCT04085328|520909518|FG001|Overall Study|Witihdrew Consent|16|||
144467967|NCT04085328|520909517|FG000|Overall Study|Adverse Event|8|||
144467968|NCT04085328|520909518|FG001|Overall Study|Adverse Event|7|||
144467969|NCT04085328|520909517|FG000|Overall Study|Lost to Follow-up|7|||
144467970|NCT04085328|520909518|FG001|Overall Study|Lost to Follow-up|2|||
144467971|NCT04085328|520909517|FG000|Overall Study|Physician Decision|0|||
144467972|NCT04085328|520909518|FG001|Overall Study|Physician Decision|1|||
144467973|NCT04085328|520909517|FG000|Overall Study|Pregnancy|0|||
144467974|NCT04085328|520909518|FG001|Overall Study|Pregnancy|1|||
144467975|NCT04085328|520909517|FG000|Overall Study|Reasons Related to COVID-19|5|||
144467976|NCT04085328|520909518|FG001|Overall Study|Reasons Related to COVID-19|8|||
144467977|NCT04085328|520909517|FG000|Overall Study|Did not meet inclusion criteria|1|||
144467978|NCT04085328|520909518|FG001|Overall Study|Did not meet inclusion criteria|1|||
144467979|NCT04085328|520909517|FG000|Overall Study|Early termination|1|||
144467980|NCT04085328|520909518|FG001|Overall Study|Early termination|0|||
144467981|NCT01596582|520909519|FG000|Overall Study|Deemed ineligible after study visit|3|||
144467982|NCT01596582|520909520|FG001|Overall Study|Deemed ineligible after study visit|6|||
144467983|NCT01596582|520909519|FG000|Overall Study|Missing all outcome data|1|||
144467984|NCT01596582|520909520|FG001|Overall Study|Missing all outcome data|1|||
144467985|NCT00313820|520909522|FG000|Assigned to Treatment|Other|1|||
144467986|NCT00313820|520909523|FG001|Assigned to Treatment|Other|0|||
144467987|NCT00313820|520909522|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
144467988|NCT00313820|520909523|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
144467989|NCT00313820|520909522|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
144467990|NCT00313820|520909523|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
144467991|NCT00313820|520909522|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
144467992|NCT00313820|520909523|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
144467993|NCT00313820|520909522|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
144467994|NCT00313820|520909523|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
144467995|NCT00313820|520909522|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
144467996|NCT00313820|520909523|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
144467997|NCT03260868|520909525|FG000|Overall Study|Poor Compliance to Protocol|0|||
144467998|NCT03260868|520909526|FG001|Overall Study|Poor Compliance to Protocol|2|||
144467999|NCT03260868|520909525|FG000|Overall Study|Study Terminated By Sponsor|2|||
144468000|NCT03260868|520909526|FG001|Overall Study|Study Terminated By Sponsor|1|||
144468001|NCT03260868|520909525|FG000|Overall Study|Other than specified above|1|||
144468002|NCT03260868|520909526|FG001|Overall Study|Other than specified above|0|||
144468003|NCT01298999|520909527|FG000|Overall Study|Physician Decision|0|||
144468004|NCT01298999|520909528|FG001|Overall Study|Physician Decision|1|||
144468005|NCT01298999|520909527|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
144468006|NCT01298999|520909528|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
144468007|NCT01169675|520909531|FG000|Overall Study|Progressive disease|13|||
144468008|NCT01169675|520909532|FG001|Overall Study|Progressive disease|2|||
144468009|NCT01169675|520909533|FG002|Overall Study|Progressive disease|5|||
144468010|NCT01169675|520909534|FG003|Overall Study|Progressive disease|15|||
144468011|NCT01169675|520909535|FG004|Overall Study|Progressive disease|1|||
144468012|NCT01169675|520909531|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144468013|NCT01169675|520909532|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144468014|NCT01169675|520909533|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144468015|NCT01169675|520909534|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144613209|NCT01500278|521445457|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
144468016|NCT01169675|520909535|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
144468017|NCT01169675|520909531|FG000|Overall Study|Adverse Event|5|||
144468018|NCT01169675|520909532|FG001|Overall Study|Adverse Event|1|||
144468019|NCT01169675|520909533|FG002|Overall Study|Adverse Event|2|||
144613210|NCT01500278|521445456|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
144613211|NCT01500278|521445457|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
144468020|NCT01169675|520909534|FG003|Overall Study|Adverse Event|0|||
144468021|NCT01169675|520909535|FG004|Overall Study|Adverse Event|0|||
144468022|NCT01169675|520909531|FG000|Overall Study|Withdrawal by Subject|1|||
144468023|NCT01169675|520909532|FG001|Overall Study|Withdrawal by Subject|0|||
144468024|NCT01169675|520909533|FG002|Overall Study|Withdrawal by Subject|0|||
144468025|NCT01169675|520909534|FG003|Overall Study|Withdrawal by Subject|1|||
144613212|NCT01500278|521445456|FG000|Week 13 - Week 104|Relocation|0|||
144468026|NCT01169675|520909535|FG004|Overall Study|Withdrawal by Subject|2|||
144468027|NCT01169675|520909531|FG000|Overall Study|Other Reason Not Defined Above|0|||
144468028|NCT01169675|520909532|FG001|Overall Study|Other Reason Not Defined Above|0|||
144468029|NCT01169675|520909533|FG002|Overall Study|Other Reason Not Defined Above|0|||
144468030|NCT01169675|520909534|FG003|Overall Study|Other Reason Not Defined Above|1|||
144468031|NCT01169675|520909535|FG004|Overall Study|Other Reason Not Defined Above|1|||
144468032|NCT02816138|520909538|FG000|Overall Study|Adverse Event|1|||
144468033|NCT02355028|520909539|FG000|Overall Study|Adverse Event|2|||
144468034|NCT02355028|520909540|FG001|Overall Study|Adverse Event|0|||
144468035|NCT02355028|520909539|FG000|Overall Study|Withdrawal by Subject|1|||
144468036|NCT02355028|520909540|FG001|Overall Study|Withdrawal by Subject|1|||
144468037|NCT02355028|520909539|FG000|Overall Study|Deemed ineligible after randomization|8|||
144468038|NCT02355028|520909540|FG001|Overall Study|Deemed ineligible after randomization|4|||
144468039|NCT04102579|520909541|FG000|Overall Study|Withdrawal by Subject|3|||
144468040|NCT04102579|520909542|FG001|Overall Study|Withdrawal by Subject|4|||
144468041|NCT04102579|520909541|FG000|Overall Study|Lost to Follow-up|0|||
144468042|NCT04102579|520909542|FG001|Overall Study|Lost to Follow-up|1|||
144468043|NCT04102579|520909541|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
144468044|NCT04102579|520909542|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
144468045|NCT04102579|520909541|FG000|Overall Study|Other than Specified|1|||
144468046|NCT04102579|520909542|FG001|Overall Study|Other than Specified|0|||
144468047|NCT04102579|520909541|FG000|Overall Study|Not Dosed with Study Drug|0|||
144468048|NCT04102579|520909542|FG001|Overall Study|Not Dosed with Study Drug|1|||
144468049|NCT02412137|520909549|FG000|Overall Study|Withdrawal by Subject|2|||
144468050|NCT02412137|520909550|FG001|Overall Study|Withdrawal by Subject|0|||
144468051|NCT02412137|520909549|FG000|Overall Study|Lost to Follow-up|21|||
144468052|NCT02412137|520909550|FG001|Overall Study|Lost to Follow-up|14|||
144468053|NCT02412137|520909549|FG000|Overall Study|Physician Decision|28|||
144468054|NCT02412137|520909550|FG001|Overall Study|Physician Decision|9|||
144468055|NCT00608582|520909554|FG000|Overall Study|Lost to Follow-up|2|||
144468056|NCT00608582|520909555|FG001|Overall Study|Lost to Follow-up|0|||
144468057|NCT00608582|520909554|FG000|Overall Study|No Best Response in Phase 1 located|1|||
144468058|NCT00608582|520909555|FG001|Overall Study|No Best Response in Phase 1 located|1|||
144468059|NCT00608582|520909554|FG000|Overall Study|Illicit Drug Use|1|||
144468060|NCT00608582|520909555|FG001|Overall Study|Illicit Drug Use|0|||
144468061|NCT00608582|520909554|FG000|Overall Study|Early stage Design Change|0|||
144468062|NCT00608582|520909555|FG001|Overall Study|Early stage Design Change|3|||
144468063|NCT00415610|520911324|FG000|Overall Study|Death|3|||
144468064|NCT00415610|520911325|FG001|Overall Study|Death|2|||
144468065|NCT00415610|520911326|FG002|Overall Study|Death|5|||
144468066|NCT05453110|520911330|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
144468067|NCT05453110|520911331|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
144468068|NCT05453110|520911332|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
144468069|NCT00266825|520911339|FG000|Completed Follow-Up|Lost to Follow-up|14|||
144468070|NCT00266825|520911340|FG001|Completed Follow-Up|Lost to Follow-up|19|||
144468071|NCT00266825|520911339|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
144468072|NCT00266825|520911340|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
144468073|NCT00430248|520911341|FG000|Overall Study|Adverse Event|49|||
144468074|NCT00430248|520911342|FG001|Overall Study|Adverse Event|61|||
144468075|NCT00430248|520911343|FG002|Overall Study|Adverse Event|64|||
144468076|NCT00430248|520911341|FG000|Overall Study|Protocol Violation|10|||
144468077|NCT00430248|520911342|FG001|Overall Study|Protocol Violation|2|||
144468078|NCT00430248|520911343|FG002|Overall Study|Protocol Violation|4|||
144468079|NCT00430248|520911341|FG000|Overall Study|Personal Reasons|12|||
144468080|NCT00430248|520911342|FG001|Overall Study|Personal Reasons|24|||
144536665|NCT00943917|521168425|FG004|Stage II Continuation|hypoglycemia|0|||
144536666|NCT00943917|521168426|FG005|Stage II Continuation|hypoglycemia|0|||
144536667|NCT00943917|521168427|FG006|Stage II Continuation|hypoglycemia|0|||
144536668|NCT00943917|521168428|FG007|Stage II Continuation|hypoglycemia|0|||
144536669|NCT00943917|521168429|FG008|Stage II Continuation|hypoglycemia|0|||
144536670|NCT00943917|521168430|FG009|Stage II Continuation|hypoglycemia|0|||
144536671|NCT00943917|521168431|FG010|Stage II Continuation|hypoglycemia|0|||
144536672|NCT00943917|521168432|FG011|Stage II Continuation|hypoglycemia|0|||
144536673|NCT00943917|521168433|FG012|Stage II Continuation|hypoglycemia|1|||
144536674|NCT00943917|521168434|FG013|Stage II Continuation|hypoglycemia|0|||
144536675|NCT00943917|521168435|FG014|Stage II Continuation|hypoglycemia|0|||
144536676|NCT00943917|521168421|FG000|Stage II Continuation|A1C elevation|0|||
144536677|NCT00943917|521168422|FG001|Stage II Continuation|A1C elevation|0|||
144468081|NCT00430248|520911343|FG002|Overall Study|Personal Reasons|9|||
144468082|NCT00430248|520911341|FG000|Overall Study|Lost to Follow-up|28|||
144468083|NCT00430248|520911342|FG001|Overall Study|Lost to Follow-up|33|||
144536678|NCT00943917|521168423|FG002|Stage II Continuation|A1C elevation|0|||
144536679|NCT00943917|521168424|FG003|Stage II Continuation|A1C elevation|0|||
144613213|NCT01500278|521445457|FG001|Week 13 - Week 104|Relocation|1|||
144613214|NCT01500278|521445456|FG000|Week 13 - Week 104|Sponsor decision|0|||
144468084|NCT00430248|520911343|FG002|Overall Study|Lost to Follow-up|28|||
144468085|NCT00430248|520911341|FG000|Overall Study|Therapeutic Failure|1|||
144468086|NCT00430248|520911342|FG001|Overall Study|Therapeutic Failure|1|||
144468087|NCT00430248|520911343|FG002|Overall Study|Therapeutic Failure|1|||
144468088|NCT00430248|520911341|FG000|Overall Study|Withdrawal by Subject|14|||
144468089|NCT00430248|520911342|FG001|Overall Study|Withdrawal by Subject|20|||
144468090|NCT00430248|520911343|FG002|Overall Study|Withdrawal by Subject|16|||
144468091|NCT00430248|520911341|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144468092|NCT00430248|520911342|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
144468093|NCT00430248|520911343|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144468094|NCT00430248|520911341|FG000|Overall Study|Gout Flare|3|||
144468095|NCT00430248|520911342|FG001|Overall Study|Gout Flare|7|||
144468096|NCT00430248|520911343|FG002|Overall Study|Gout Flare|2|||
144468097|NCT00430248|520911341|FG000|Overall Study|Reason Not Specified|8|||
144468098|NCT00430248|520911342|FG001|Overall Study|Reason Not Specified|8|||
144468099|NCT00430248|520911343|FG002|Overall Study|Reason Not Specified|11|||
144468100|NCT02799784|520911346|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
144468101|NCT02799784|520911347|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
144468102|NCT02799784|520911346|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
144468103|NCT02799784|520911347|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
144468104|NCT02799784|520911346|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
144468105|NCT02799784|520911347|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
144468106|NCT02799784|520911346|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
144468107|NCT02799784|520911347|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
144468108|NCT02799784|520911346|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
144468109|NCT02799784|520911347|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
144468110|NCT02799784|520911346|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
144468111|NCT02799784|520911347|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
144468112|NCT00658567|520911349|FG000|Overall Study|Adverse Event|5|||
144468113|NCT00658567|520911350|FG001|Overall Study|Adverse Event|2|||
144468114|NCT00658567|520911351|FG002|Overall Study|Adverse Event|3|||
144468115|NCT00658567|520911349|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
144468116|NCT00658567|520911350|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
144468117|NCT00658567|520911351|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
144468118|NCT00658567|520911349|FG000|Overall Study|Physician Decision|0|||
144468119|NCT00658567|520911350|FG001|Overall Study|Physician Decision|1|||
144468120|NCT00658567|520911351|FG002|Overall Study|Physician Decision|0|||
144468121|NCT00658567|520911349|FG000|Overall Study|At Discretion of Sponsor|1|||
144468122|NCT00658567|520911350|FG001|Overall Study|At Discretion of Sponsor|1|||
144468123|NCT00658567|520911351|FG002|Overall Study|At Discretion of Sponsor|1|||
144468124|NCT01281644|520911352|FG000|Overall Study|Lost to Follow-up|3|||
144468125|NCT01281644|520911352|FG000|Overall Study|Withdrawal by Subject|2|||
144468126|NCT00691938|520911353|FG000|Overall Study|QTc prolongation|1|||
144468127|NCT00691938|520911354|FG001|Overall Study|QTc prolongation|0|||
144468128|NCT00691938|520911355|FG002|Overall Study|QTc prolongation|0|||
144468129|NCT00691938|520911356|FG003|Overall Study|QTc prolongation|0|||
144468130|NCT00691938|520911357|FG004|Overall Study|QTc prolongation|0|||
144468131|NCT00691938|520911358|FG005|Overall Study|QTc prolongation|0|||
144468132|NCT00691938|520911359|FG006|Overall Study|QTc prolongation|0|||
144468133|NCT04555096|520911364|FG000|Overall Study|Death|4|||
144468134|NCT04555096|520911365|FG001|Overall Study|Death|4|||
144468135|NCT04555096|520911364|FG000|Overall Study|Withdrawal by Subject|1|||
144468136|NCT04555096|520911365|FG001|Overall Study|Withdrawal by Subject|0|||
144468137|NCT04555096|520911364|FG000|Overall Study|Other|0|||
144468138|NCT04555096|520911365|FG001|Overall Study|Other|1|||
144468139|NCT03292146|520911372|FG000|Baseline to 12 months|Relocation|1|||
144468140|NCT03292146|520911373|FG001|Baseline to 12 months|Relocation|0|||
144468141|NCT03292146|520911372|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
144468142|NCT03292146|520911373|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
144468143|NCT03292146|520911372|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
144468144|NCT03292146|520911373|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
144468145|NCT03292146|520911372|FG000|12 months to 24 months|Planning pregnancy|2|||
144468146|NCT03292146|520911373|FG001|12 months to 24 months|Planning pregnancy|2|||
144468147|NCT03292146|520911372|FG000|12 months to 24 months|Personal reasons|1|||
144536680|NCT00943917|521168425|FG004|Stage II Continuation|A1C elevation|0|||
144468148|NCT03292146|520911373|FG001|12 months to 24 months|Personal reasons|0|||
144468149|NCT03292146|520911372|FG000|12 months to 24 months|Lost to Follow-up|0|||
144468150|NCT03292146|520911373|FG001|12 months to 24 months|Lost to Follow-up|1|||
144468151|NCT03039023|520911374|FG000|Overall Study|Withdrawal by Subject|1|||
144536681|NCT00943917|521168426|FG005|Stage II Continuation|A1C elevation|0|||
144536682|NCT00943917|521168427|FG006|Stage II Continuation|A1C elevation|0|||
144468152|NCT03039023|520911375|FG001|Overall Study|Withdrawal by Subject|0|||
144468153|NCT03039023|520911376|FG002|Overall Study|Withdrawal by Subject|1|||
144468154|NCT03039023|520911377|FG003|Overall Study|Withdrawal by Subject|1|||
144468155|NCT03039023|520911378|FG004|Overall Study|Withdrawal by Subject|0|||
144468156|NCT03039023|520911374|FG000|Overall Study|Physician Decision|0|||
144468157|NCT03039023|520911375|FG001|Overall Study|Physician Decision|0|||
144468158|NCT03039023|520911376|FG002|Overall Study|Physician Decision|0|||
144468159|NCT03039023|520911377|FG003|Overall Study|Physician Decision|1|||
144468160|NCT03039023|520911378|FG004|Overall Study|Physician Decision|0|||
144468161|NCT03701399|520911381|FG000|Overall Study|Adverse Event|3|||
144468162|NCT03701399|520911382|FG001|Overall Study|Adverse Event|5|||
144468163|NCT03701399|520911381|FG000|Overall Study|Withdrawal by Subject|6|||
144468164|NCT03701399|520911382|FG001|Overall Study|Withdrawal by Subject|3|||
144468165|NCT03701399|520911381|FG000|Overall Study|Investigators decision|1|||
144468166|NCT03701399|520911382|FG001|Overall Study|Investigators decision|2|||
144468167|NCT03701399|520911381|FG000|Overall Study|Lost to Follow-up|1|||
144468168|NCT03701399|520911382|FG001|Overall Study|Lost to Follow-up|2|||
144468169|NCT03701399|520911381|FG000|Overall Study|Death|1|||
144468170|NCT03701399|520911382|FG001|Overall Study|Death|1|||
144468171|NCT03701399|520911381|FG000|Overall Study|Randomized but not treated|1|||
144468172|NCT03701399|520911382|FG001|Overall Study|Randomized but not treated|0|||
144468173|NCT04280562|520911383|FG000|Study|Adverse Event|2|||
144468174|NCT04280562|520911384|FG001|Study|Adverse Event|0|||
144468175|NCT04280562|520911383|FG000|Study|Lost to Follow-up|3|||
144468176|NCT04280562|520911384|FG001|Study|Lost to Follow-up|3|||
144468177|NCT02618967|520911388|FG000|Overall Study|Lost to Follow-up|0|||
144468178|NCT02618967|520911389|FG001|Overall Study|Lost to Follow-up|0|||
144468179|NCT02618967|520911390|FG002|Overall Study|Lost to Follow-up|1|||
144468180|NCT02618967|520911391|FG003|Overall Study|Lost to Follow-up|0|||
144468181|NCT02618967|520911392|FG004|Overall Study|Lost to Follow-up|2|||
144468182|NCT02618967|520911393|FG005|Overall Study|Lost to Follow-up|0|||
144468183|NCT02618967|520911394|FG006|Overall Study|Lost to Follow-up|0|||
144468184|NCT02618967|520911395|FG007|Overall Study|Lost to Follow-up|0|||
144468185|NCT02618967|520911388|FG000|Overall Study|Withdrawal by Subject|1|||
144468186|NCT02618967|520911389|FG001|Overall Study|Withdrawal by Subject|0|||
144468187|NCT02618967|520911390|FG002|Overall Study|Withdrawal by Subject|0|||
144468188|NCT02618967|520911391|FG003|Overall Study|Withdrawal by Subject|0|||
144468189|NCT02618967|520911392|FG004|Overall Study|Withdrawal by Subject|0|||
144468190|NCT02618967|520911393|FG005|Overall Study|Withdrawal by Subject|0|||
144468191|NCT02618967|520911394|FG006|Overall Study|Withdrawal by Subject|0|||
144468192|NCT02618967|520911395|FG007|Overall Study|Withdrawal by Subject|0|||
144468193|NCT01368965|520911396|FG000|Overall Study|Lost to Follow-up|12|||
144468194|NCT04559568|520911397|FG000|Overall Study|Physician Decision|0|||
144468195|NCT04559568|520911398|FG001|Overall Study|Physician Decision|0|||
144468196|NCT04559568|520911399|FG002|Overall Study|Physician Decision|0|||
144468197|NCT04559568|520911400|FG003|Overall Study|Physician Decision|0|||
144468198|NCT04559568|520911401|FG004|Overall Study|Physician Decision|0|||
144468199|NCT04559568|520911402|FG005|Overall Study|Physician Decision|0|||
144468200|NCT04559568|520911403|FG006|Overall Study|Physician Decision|0|||
144468201|NCT04559568|520911404|FG007|Overall Study|Physician Decision|0|||
144536683|NCT00943917|521168428|FG007|Stage II Continuation|A1C elevation|0|||
144536684|NCT00943917|521168429|FG008|Stage II Continuation|A1C elevation|0|||
144536685|NCT00943917|521168430|FG009|Stage II Continuation|A1C elevation|0|||
144536686|NCT00943917|521168431|FG010|Stage II Continuation|A1C elevation|0|||
144536687|NCT00943917|521168432|FG011|Stage II Continuation|A1C elevation|0|||
144536688|NCT00943917|521168433|FG012|Stage II Continuation|A1C elevation|0|||
144536689|NCT00943917|521168434|FG013|Stage II Continuation|A1C elevation|1|||
144536690|NCT00943917|521168435|FG014|Stage II Continuation|A1C elevation|0|||
144536691|NCT01171976|521168436|FG000|Overall Study|Protocol Violation|0|||
144536692|NCT01171976|521168437|FG001|Overall Study|Protocol Violation|0|||
144536693|NCT01171976|521168438|FG002|Overall Study|Protocol Violation|1|||
144536694|NCT01171976|521168436|FG000|Overall Study|Death|2|||
144536695|NCT01171976|521168437|FG001|Overall Study|Death|4|||
144536696|NCT01171976|521168438|FG002|Overall Study|Death|1|||
144536697|NCT01171976|521168436|FG000|Overall Study|Lost to Follow-up|4|||
144536698|NCT01171976|521168437|FG001|Overall Study|Lost to Follow-up|0|||
144536699|NCT01171976|521168438|FG002|Overall Study|Lost to Follow-up|2|||
144536700|NCT01171976|521168436|FG000|Overall Study|Withdrawal by Subject|1|||
144536701|NCT01171976|521168437|FG001|Overall Study|Withdrawal by Subject|5|||
144468202|NCT04559568|520911405|FG008|Overall Study|Physician Decision|0|||
144468203|NCT04559568|520911406|FG009|Overall Study|Physician Decision|1|||
144468204|NCT04559568|520911407|FG010|Overall Study|Physician Decision|0|||
144468205|NCT04559568|520911397|FG000|Overall Study|Withdrawal by Subject|0|||
144468206|NCT04559568|520911398|FG001|Overall Study|Withdrawal by Subject|0|||
144468207|NCT04559568|520911399|FG002|Overall Study|Withdrawal by Subject|0|||
144468208|NCT04559568|520911400|FG003|Overall Study|Withdrawal by Subject|0|||
144468209|NCT04559568|520911401|FG004|Overall Study|Withdrawal by Subject|0|||
144468210|NCT04559568|520911402|FG005|Overall Study|Withdrawal by Subject|0|||
144468211|NCT04559568|520911403|FG006|Overall Study|Withdrawal by Subject|0|||
144468212|NCT04559568|520911404|FG007|Overall Study|Withdrawal by Subject|0|||
144468213|NCT04559568|520911405|FG008|Overall Study|Withdrawal by Subject|0|||
144536702|NCT01171976|521168438|FG002|Overall Study|Withdrawal by Subject|6|||
144468214|NCT04559568|520911406|FG009|Overall Study|Withdrawal by Subject|0|||
144468215|NCT04559568|520911407|FG010|Overall Study|Withdrawal by Subject|1|||
144468216|NCT02712905|520911410|FG000|Monotherapy|Death|2|||
144468217|NCT02712905|520911411|FG001|Monotherapy|Death|5|||
144468218|NCT02712905|520911412|FG002|Monotherapy|Death|0|||
144468219|NCT02712905|520911413|FG003|Monotherapy|Death|3|||
144468220|NCT02712905|520911414|FG004|Monotherapy|Death|15|||
144468221|NCT02712905|520911415|FG005|Monotherapy|Death|1|||
144468222|NCT02712905|520911416|FG006|Monotherapy|Death|3|||
144468223|NCT02712905|520911417|FG007|Monotherapy|Death|3|||
144468224|NCT02712905|520911418|FG008|Monotherapy|Death|0|||
144468225|NCT02712905|520911419|FG009|Monotherapy|Death|27|||
144468226|NCT02712905|520911420|FG010|Monotherapy|Death|2|||
144468227|NCT02712905|520911421|FG011|Monotherapy|Death|5|||
144468228|NCT02712905|520911422|FG012|Monotherapy|Death|0|||
144468229|NCT02712905|520911423|FG013|Monotherapy|Death|0|||
144468230|NCT02712905|520911424|FG014|Monotherapy|Death|0|||
144468231|NCT02712905|520911425|FG015|Monotherapy|Death|0|||
144468232|NCT02712905|520911426|FG016|Monotherapy|Death|0|||
144468233|NCT02712905|520911427|FG017|Monotherapy|Death|0|||
144613215|NCT01500278|521445457|FG001|Week 13 - Week 104|Sponsor decision|2|||
144613216|NCT01500278|521445456|FG000|Week 13 - Week 104|Medical monitor decision|0|||
144613217|NCT01500278|521445457|FG001|Week 13 - Week 104|Medical monitor decision|2|||
144613218|NCT01500278|521445456|FG000|Week 13 - Week 104|Personal reason|0|||
144613219|NCT01500278|521445457|FG001|Week 13 - Week 104|Personal reason|1|||
144613220|NCT01500278|521445456|FG000|Week 13 - Week 104|Not completed|0|||
144613221|NCT01500278|521445457|FG001|Week 13 - Week 104|Not completed|1|||
144613222|NCT01500278|521445456|FG000|Week 13 - Week 104|Death|2|||
144613223|NCT01500278|521445457|FG001|Week 13 - Week 104|Death|4|||
144613224|NCT01500278|521445456|FG000|Week 13 - Week 104|Adverse Event|54|||
144613225|NCT01500278|521445457|FG001|Week 13 - Week 104|Adverse Event|54|||
144613226|NCT00283595|521445458|FG000|Overall Study|Withdrawal by Subject|1|||
144726377|NCT04817891|521852737|FG000|Overall Study|Withdrawal by Subject|1|||
144726378|NCT03257462|521852740|FG000|Cohort A|Lost to Follow-up|1|||
144468234|NCT02712905|520911410|FG000|Monotherapy|Lost to Follow-up|0|||
144468235|NCT02712905|520911411|FG001|Monotherapy|Lost to Follow-up|1|||
144468236|NCT02712905|520911412|FG002|Monotherapy|Lost to Follow-up|0|||
144468237|NCT02712905|520911413|FG003|Monotherapy|Lost to Follow-up|1|||
144468238|NCT02712905|520911414|FG004|Monotherapy|Lost to Follow-up|0|||
144468239|NCT02712905|520911415|FG005|Monotherapy|Lost to Follow-up|0|||
144468240|NCT02712905|520911416|FG006|Monotherapy|Lost to Follow-up|0|||
144468241|NCT02712905|520911417|FG007|Monotherapy|Lost to Follow-up|0|||
144468242|NCT02712905|520911418|FG008|Monotherapy|Lost to Follow-up|0|||
144468243|NCT02712905|520911419|FG009|Monotherapy|Lost to Follow-up|2|||
144468244|NCT02712905|520911420|FG010|Monotherapy|Lost to Follow-up|0|||
144468245|NCT02712905|520911421|FG011|Monotherapy|Lost to Follow-up|0|||
144468246|NCT02712905|520911422|FG012|Monotherapy|Lost to Follow-up|0|||
144468247|NCT02712905|520911423|FG013|Monotherapy|Lost to Follow-up|0|||
144468248|NCT02712905|520911424|FG014|Monotherapy|Lost to Follow-up|0|||
144468249|NCT02712905|520911425|FG015|Monotherapy|Lost to Follow-up|0|||
144468250|NCT02712905|520911426|FG016|Monotherapy|Lost to Follow-up|0|||
144468251|NCT02712905|520911427|FG017|Monotherapy|Lost to Follow-up|0|||
144468252|NCT02712905|520911410|FG000|Monotherapy|Physician Decision|1|||
144468253|NCT02712905|520911411|FG001|Monotherapy|Physician Decision|0|||
144468254|NCT02712905|520911412|FG002|Monotherapy|Physician Decision|0|||
144468255|NCT02712905|520911413|FG003|Monotherapy|Physician Decision|1|||
144468256|NCT02712905|520911414|FG004|Monotherapy|Physician Decision|0|||
144468257|NCT02712905|520911415|FG005|Monotherapy|Physician Decision|0|||
144468258|NCT02712905|520911416|FG006|Monotherapy|Physician Decision|0|||
144468259|NCT02712905|520911417|FG007|Monotherapy|Physician Decision|0|||
144468260|NCT02712905|520911418|FG008|Monotherapy|Physician Decision|0|||
144468261|NCT02712905|520911419|FG009|Monotherapy|Physician Decision|1|||
144468262|NCT02712905|520911420|FG010|Monotherapy|Physician Decision|0|||
144468263|NCT02712905|520911421|FG011|Monotherapy|Physician Decision|0|||
144468264|NCT02712905|520911422|FG012|Monotherapy|Physician Decision|0|||
144468265|NCT02712905|520911423|FG013|Monotherapy|Physician Decision|0|||
144468266|NCT02712905|520911424|FG014|Monotherapy|Physician Decision|0|||
144468267|NCT02712905|520911425|FG015|Monotherapy|Physician Decision|0|||
144726379|NCT03257462|521852741|FG001|Cohort A|Lost to Follow-up|0|||
144468268|NCT02712905|520911426|FG016|Monotherapy|Physician Decision|0|||
144468269|NCT02712905|520911427|FG017|Monotherapy|Physician Decision|0|||
144468270|NCT02712905|520911410|FG000|Monotherapy|Study Terminated by Sponsor|0|||
144468271|NCT02712905|520911411|FG001|Monotherapy|Study Terminated by Sponsor|0|||
144468272|NCT02712905|520911412|FG002|Monotherapy|Study Terminated by Sponsor|0|||
144468273|NCT02712905|520911413|FG003|Monotherapy|Study Terminated by Sponsor|0|||
144468274|NCT02712905|520911414|FG004|Monotherapy|Study Terminated by Sponsor|1|||
144468275|NCT02712905|520911415|FG005|Monotherapy|Study Terminated by Sponsor|0|||
144468276|NCT02712905|520911416|FG006|Monotherapy|Study Terminated by Sponsor|0|||
144468277|NCT02712905|520911417|FG007|Monotherapy|Study Terminated by Sponsor|0|||
144468278|NCT02712905|520911418|FG008|Monotherapy|Study Terminated by Sponsor|0|||
144468279|NCT02712905|520911419|FG009|Monotherapy|Study Terminated by Sponsor|2|||
144613227|NCT00283595|521445459|FG001|Overall Study|Withdrawal by Subject|2|||
144613228|NCT04718974|521445463|FG000|Overall Study|Death|0|||
144468280|NCT02712905|520911420|FG010|Monotherapy|Study Terminated by Sponsor|0|||
144468281|NCT02712905|520911421|FG011|Monotherapy|Study Terminated by Sponsor|0|||
144468282|NCT02712905|520911422|FG012|Monotherapy|Study Terminated by Sponsor|0|||
144468283|NCT02712905|520911423|FG013|Monotherapy|Study Terminated by Sponsor|0|||
144468284|NCT02712905|520911424|FG014|Monotherapy|Study Terminated by Sponsor|0|||
144468285|NCT02712905|520911425|FG015|Monotherapy|Study Terminated by Sponsor|0|||
144468286|NCT02712905|520911426|FG016|Monotherapy|Study Terminated by Sponsor|0|||
144468287|NCT02712905|520911427|FG017|Monotherapy|Study Terminated by Sponsor|0|||
144468288|NCT02712905|520911410|FG000|Monotherapy|Withdrawal by Subject|0|||
144468289|NCT02712905|520911411|FG001|Monotherapy|Withdrawal by Subject|0|||
144468290|NCT02712905|520911412|FG002|Monotherapy|Withdrawal by Subject|1|||
144468291|NCT02712905|520911413|FG003|Monotherapy|Withdrawal by Subject|0|||
144468292|NCT02712905|520911414|FG004|Monotherapy|Withdrawal by Subject|2|||
144468293|NCT02712905|520911415|FG005|Monotherapy|Withdrawal by Subject|0|||
144468294|NCT02712905|520911416|FG006|Monotherapy|Withdrawal by Subject|0|||
144468295|NCT02712905|520911417|FG007|Monotherapy|Withdrawal by Subject|0|||
144468296|NCT02712905|520911418|FG008|Monotherapy|Withdrawal by Subject|0|||
144468297|NCT02712905|520911419|FG009|Monotherapy|Withdrawal by Subject|4|||
144468298|NCT02712905|520911420|FG010|Monotherapy|Withdrawal by Subject|1|||
144468299|NCT02712905|520911421|FG011|Monotherapy|Withdrawal by Subject|2|||
144468300|NCT02712905|520911422|FG012|Monotherapy|Withdrawal by Subject|0|||
144468301|NCT02712905|520911423|FG013|Monotherapy|Withdrawal by Subject|0|||
144468302|NCT02712905|520911424|FG014|Monotherapy|Withdrawal by Subject|0|||
144468303|NCT02712905|520911425|FG015|Monotherapy|Withdrawal by Subject|0|||
144468304|NCT02712905|520911426|FG016|Monotherapy|Withdrawal by Subject|0|||
144468305|NCT02712905|520911427|FG017|Monotherapy|Withdrawal by Subject|0|||
144468306|NCT02712905|520911410|FG000|Monotherapy|Started New Cancer Drug|0|||
144468307|NCT02712905|520911411|FG001|Monotherapy|Started New Cancer Drug|0|||
144468308|NCT02712905|520911412|FG002|Monotherapy|Started New Cancer Drug|0|||
144468309|NCT02712905|520911413|FG003|Monotherapy|Started New Cancer Drug|0|||
144468310|NCT02712905|520911414|FG004|Monotherapy|Started New Cancer Drug|0|||
144468311|NCT02712905|520911415|FG005|Monotherapy|Started New Cancer Drug|1|||
144468312|NCT02712905|520911416|FG006|Monotherapy|Started New Cancer Drug|0|||
144468313|NCT02712905|520911417|FG007|Monotherapy|Started New Cancer Drug|0|||
144468314|NCT02712905|520911418|FG008|Monotherapy|Started New Cancer Drug|0|||
144468315|NCT02712905|520911419|FG009|Monotherapy|Started New Cancer Drug|0|||
144468316|NCT02712905|520911420|FG010|Monotherapy|Started New Cancer Drug|0|||
144468317|NCT02712905|520911421|FG011|Monotherapy|Started New Cancer Drug|0|||
144468318|NCT02712905|520911422|FG012|Monotherapy|Started New Cancer Drug|0|||
144468319|NCT02712905|520911423|FG013|Monotherapy|Started New Cancer Drug|0|||
144468320|NCT02712905|520911424|FG014|Monotherapy|Started New Cancer Drug|0|||
144468321|NCT02712905|520911425|FG015|Monotherapy|Started New Cancer Drug|0|||
144468322|NCT02712905|520911426|FG016|Monotherapy|Started New Cancer Drug|0|||
144468323|NCT02712905|520911427|FG017|Monotherapy|Started New Cancer Drug|0|||
144468324|NCT02712905|520911410|FG000|Monotherapy|Adverse Event|0|||
144468325|NCT02712905|520911411|FG001|Monotherapy|Adverse Event|0|||
144468326|NCT02712905|520911412|FG002|Monotherapy|Adverse Event|0|||
144468327|NCT02712905|520911413|FG003|Monotherapy|Adverse Event|0|||
144468328|NCT02712905|520911414|FG004|Monotherapy|Adverse Event|0|||
144468329|NCT02712905|520911415|FG005|Monotherapy|Adverse Event|0|||
144468330|NCT02712905|520911416|FG006|Monotherapy|Adverse Event|0|||
144468331|NCT02712905|520911417|FG007|Monotherapy|Adverse Event|0|||
144468332|NCT02712905|520911418|FG008|Monotherapy|Adverse Event|1|||
144468333|NCT02712905|520911419|FG009|Monotherapy|Adverse Event|0|||
144468334|NCT02712905|520911420|FG010|Monotherapy|Adverse Event|0|||
144468335|NCT02712905|520911421|FG011|Monotherapy|Adverse Event|0|||
144468336|NCT02712905|520911422|FG012|Monotherapy|Adverse Event|0|||
144468337|NCT02712905|520911423|FG013|Monotherapy|Adverse Event|0|||
144468338|NCT02712905|520911424|FG014|Monotherapy|Adverse Event|0|||
144468339|NCT02712905|520911425|FG015|Monotherapy|Adverse Event|0|||
144468340|NCT02712905|520911426|FG016|Monotherapy|Adverse Event|0|||
144468341|NCT02712905|520911427|FG017|Monotherapy|Adverse Event|0|||
144468342|NCT02712905|520911410|FG000|Combination Therapy|Death|0|||
144613229|NCT04718974|521445464|FG001|Overall Study|Death|2|||
144613230|NCT04718974|521445463|FG000|Overall Study|Lost to Follow-up|10|||
144613231|NCT04718974|521445464|FG001|Overall Study|Lost to Follow-up|20|||
144613232|NCT04718974|521445463|FG000|Overall Study|Transferred out|2|||
144613233|NCT04718974|521445464|FG001|Overall Study|Transferred out|4|||
144613234|NCT01709435|521445465|FG000|Overall Study|Adverse Event|1|||
144613235|NCT01709435|521445466|FG001|Overall Study|Adverse Event|1|||
144613236|NCT01709435|521445467|FG002|Overall Study|Adverse Event|1|||
144468343|NCT02712905|520911411|FG001|Combination Therapy|Death|0|||
144468344|NCT02712905|520911412|FG002|Combination Therapy|Death|0|||
144613237|NCT01709435|521445468|FG003|Overall Study|Adverse Event|0|||
144613238|NCT01709435|521445469|FG004|Overall Study|Adverse Event|0|||
144468345|NCT02712905|520911413|FG003|Combination Therapy|Death|0|||
144468346|NCT02712905|520911414|FG004|Combination Therapy|Death|0|||
144468347|NCT02712905|520911415|FG005|Combination Therapy|Death|0|||
144468348|NCT02712905|520911416|FG006|Combination Therapy|Death|0|||
144613239|NCT01709435|521445470|FG005|Overall Study|Adverse Event|1|||
144468349|NCT02712905|520911417|FG007|Combination Therapy|Death|0|||
144468350|NCT02712905|520911418|FG008|Combination Therapy|Death|0|||
144468351|NCT02712905|520911419|FG009|Combination Therapy|Death|0|||
144468352|NCT02712905|520911420|FG010|Combination Therapy|Death|0|||
144468353|NCT02712905|520911421|FG011|Combination Therapy|Death|0|||
144468354|NCT02712905|520911422|FG012|Combination Therapy|Death|5|||
144468355|NCT02712905|520911423|FG013|Combination Therapy|Death|6|||
144468356|NCT02712905|520911424|FG014|Combination Therapy|Death|1|||
144468357|NCT02712905|520911425|FG015|Combination Therapy|Death|3|||
144468358|NCT02712905|520911426|FG016|Combination Therapy|Death|1|||
144468359|NCT02712905|520911427|FG017|Combination Therapy|Death|3|||
144468360|NCT02712905|520911410|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
144468361|NCT02712905|520911411|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
144468362|NCT02712905|520911412|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
144468363|NCT02712905|520911413|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
144468364|NCT02712905|520911414|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
144468365|NCT02712905|520911415|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
144468366|NCT02712905|520911416|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
144468367|NCT02712905|520911417|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
144468368|NCT02712905|520911418|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
144468369|NCT02712905|520911419|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
144468370|NCT02712905|520911420|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
144468371|NCT02712905|520911421|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
144468372|NCT02712905|520911422|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
144468373|NCT02712905|520911423|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
144468374|NCT02712905|520911424|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
144468375|NCT02712905|520911425|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
144468376|NCT02712905|520911426|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
144468377|NCT02712905|520911427|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
144468378|NCT02712905|520911410|FG000|Combination Therapy|Withdrawal by Subject|0|||
144468379|NCT02712905|520911411|FG001|Combination Therapy|Withdrawal by Subject|0|||
144468380|NCT02712905|520911412|FG002|Combination Therapy|Withdrawal by Subject|0|||
144468381|NCT02712905|520911413|FG003|Combination Therapy|Withdrawal by Subject|0|||
144468382|NCT02712905|520911414|FG004|Combination Therapy|Withdrawal by Subject|0|||
144468383|NCT02712905|520911415|FG005|Combination Therapy|Withdrawal by Subject|0|||
144468384|NCT02712905|520911416|FG006|Combination Therapy|Withdrawal by Subject|0|||
144468385|NCT02712905|520911417|FG007|Combination Therapy|Withdrawal by Subject|0|||
144468386|NCT02712905|520911418|FG008|Combination Therapy|Withdrawal by Subject|0|||
144468387|NCT02712905|520911419|FG009|Combination Therapy|Withdrawal by Subject|0|||
144468388|NCT02712905|520911420|FG010|Combination Therapy|Withdrawal by Subject|0|||
144468389|NCT02712905|520911421|FG011|Combination Therapy|Withdrawal by Subject|0|||
144468390|NCT02712905|520911422|FG012|Combination Therapy|Withdrawal by Subject|0|||
144468391|NCT02712905|520911423|FG013|Combination Therapy|Withdrawal by Subject|0|||
144468392|NCT02712905|520911424|FG014|Combination Therapy|Withdrawal by Subject|0|||
144468393|NCT02712905|520911425|FG015|Combination Therapy|Withdrawal by Subject|1|||
144468394|NCT02712905|520911426|FG016|Combination Therapy|Withdrawal by Subject|0|||
144468395|NCT02712905|520911427|FG017|Combination Therapy|Withdrawal by Subject|2|||
144468396|NCT02712905|520911410|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468397|NCT02712905|520911411|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468398|NCT02712905|520911412|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468399|NCT02712905|520911413|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468400|NCT02712905|520911414|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468401|NCT02712905|520911415|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468402|NCT02712905|520911416|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468403|NCT02712905|520911417|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468404|NCT02712905|520911418|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468405|NCT02712905|520911419|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468406|NCT02712905|520911420|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468407|NCT02712905|520911421|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468408|NCT02712905|520911422|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468409|NCT02712905|520911423|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468410|NCT02712905|520911424|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468411|NCT02712905|520911425|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
144468412|NCT02712905|520911426|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468413|NCT02712905|520911427|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
144468414|NCT03721965|520911428|FG000|Overall Study|Death|1|||
144468415|NCT03721965|520911428|FG000|Overall Study|Study Terminated by Sponsor|1|||
144536703|NCT01171976|521168436|FG000|Overall Study|Abnormal test result|1|||
144536704|NCT01171976|521168437|FG001|Overall Study|Abnormal test result|0|||
144536705|NCT01171976|521168438|FG002|Overall Study|Abnormal test result|0|||
144726380|NCT03257462|521852742|FG002|Cohort A|Lost to Follow-up|0|||
144726381|NCT03257462|521852743|FG003|Cohort A|Lost to Follow-up|0|||
144726382|NCT03257462|521852740|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
144468416|NCT02454101|520911429|FG000|Overall Study|Adverse Event|2|||
144468417|NCT02454101|520911430|FG001|Overall Study|Adverse Event|3|||
144536706|NCT01171976|521168436|FG000|Overall Study|Adverse Event|6|||
144536707|NCT01171976|521168437|FG001|Overall Study|Adverse Event|2|||
144536708|NCT01171976|521168438|FG002|Overall Study|Adverse Event|5|||
144536709|NCT03213457|521168444|FG000|Screening Period|Withdrawal by Subject|0|||
144536710|NCT03213457|521168445|FG001|Screening Period|Withdrawal by Subject|1|||
144536711|NCT03213457|521168446|FG002|Screening Period|Withdrawal by Subject|0|||
144536712|NCT03213457|521168444|FG000|Screening Period|Other|1|||
144536713|NCT03213457|521168445|FG001|Screening Period|Other|0|||
144468418|NCT02454101|520911429|FG000|Overall Study|Lost to Follow-up|3|||
144468419|NCT02454101|520911430|FG001|Overall Study|Lost to Follow-up|4|||
144468420|NCT00045305|520911437|FG000|Overall Study|Lack of Efficacy|6|||
144468421|NCT00045305|520911437|FG000|Overall Study|Adverse Event|3|||
144468422|NCT00045305|520911437|FG000|Overall Study|Death|3|||
144468423|NCT00045305|520911437|FG000|Overall Study|site error|2|||
144468424|NCT04274894|520911438|FG000|Overall Study|Adverse Event|7|||
144468425|NCT04274894|520911438|FG000|Overall Study|Withdrew consent|5|||
144468426|NCT04274894|520911438|FG000|Overall Study|Lost to Follow-up|9|||
144468427|NCT04274894|520911438|FG000|Overall Study|COVID-19 infection|1|||
144468428|NCT04274894|520911438|FG000|Overall Study|Other, not specified|20|||
144468429|NCT01936857|520911439|FG000|Overall Study|Sent to prison or 06 center|11|||
144468430|NCT01936857|520911440|FG001|Overall Study|Sent to prison or 06 center|12|||
144468431|NCT01936857|520911439|FG000|Overall Study|Lost to Follow-up|10|||
144536714|NCT03213457|521168446|FG002|Screening Period|Other|0|||
144536715|NCT03213457|521168444|FG000|Double-Blind Period|Adverse Event|3|||
144536716|NCT03213457|521168445|FG001|Double-Blind Period|Adverse Event|2|||
144536717|NCT03213457|521168446|FG002|Double-Blind Period|Adverse Event|7|||
144536718|NCT03213457|521168444|FG000|Double-Blind Period|Withdrawal by Subject|14|||
144536719|NCT03213457|521168445|FG001|Double-Blind Period|Withdrawal by Subject|2|||
144536720|NCT03213457|521168446|FG002|Double-Blind Period|Withdrawal by Subject|14|||
144536721|NCT03213457|521168444|FG000|Double-Blind Period|Lost to Follow-up|2|||
144536722|NCT03213457|521168445|FG001|Double-Blind Period|Lost to Follow-up|3|||
144536723|NCT03213457|521168446|FG002|Double-Blind Period|Lost to Follow-up|9|||
144536724|NCT03213457|521168444|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
144536725|NCT03213457|521168445|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
144536726|NCT03213457|521168446|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
144536727|NCT03213457|521168444|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
144536728|NCT03213457|521168445|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
144536729|NCT03213457|521168446|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
144536730|NCT03213457|521168444|FG000|Double-Blind Period|Pregnancy|5|||
144536731|NCT03213457|521168445|FG001|Double-Blind Period|Pregnancy|0|||
144536732|NCT03213457|521168446|FG002|Double-Blind Period|Pregnancy|0|||
144536733|NCT03213457|521168444|FG000|Double-Blind Period|Other|10|||
144536734|NCT03213457|521168445|FG001|Double-Blind Period|Other|3|||
144536735|NCT03213457|521168446|FG002|Double-Blind Period|Other|17|||
144536736|NCT03213457|521168444|FG000|Open-Label Period|Adverse Event|1|||
144536737|NCT03213457|521168445|FG001|Open-Label Period|Adverse Event|2|||
144536738|NCT03213457|521168446|FG002|Open-Label Period|Adverse Event|2|||
144536739|NCT03213457|521168444|FG000|Open-Label Period|Withdrawal by Subject|12|||
144536740|NCT03213457|521168445|FG001|Open-Label Period|Withdrawal by Subject|5|||
144536741|NCT03213457|521168446|FG002|Open-Label Period|Withdrawal by Subject|24|||
144536742|NCT03213457|521168444|FG000|Open-Label Period|Lost to Follow-up|1|||
144536743|NCT03213457|521168445|FG001|Open-Label Period|Lost to Follow-up|2|||
144536744|NCT03213457|521168446|FG002|Open-Label Period|Lost to Follow-up|8|||
144536745|NCT03213457|521168444|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
144536746|NCT03213457|521168445|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
144536747|NCT03213457|521168446|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
144536748|NCT03213457|521168444|FG000|Open-Label Period|Non-compliance with study procedures|1|||
144536749|NCT03213457|521168445|FG001|Open-Label Period|Non-compliance with study procedures|1|||
144536750|NCT03213457|521168446|FG002|Open-Label Period|Non-compliance with study procedures|2|||
144536751|NCT03213457|521168444|FG000|Open-Label Period|Exclusionary medications|0|||
144536752|NCT03213457|521168445|FG001|Open-Label Period|Exclusionary medications|0|||
144536753|NCT03213457|521168446|FG002|Open-Label Period|Exclusionary medications|1|||
144536754|NCT03213457|521168444|FG000|Open-Label Period|Other|1|||
144536755|NCT03213457|521168445|FG001|Open-Label Period|Other|1|||
144536756|NCT03213457|521168446|FG002|Open-Label Period|Other|6|||
144468432|NCT01936857|520911440|FG001|Overall Study|Lost to Follow-up|7|||
144536757|NCT03213457|521168444|FG000|Follow-Up Period|Adverse Event|16|||
144536758|NCT03213457|521168445|FG001|Follow-Up Period|Adverse Event|8|||
144726383|NCT03257462|521852741|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
144726384|NCT03257462|521852742|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
144726385|NCT03257462|521852743|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
144726386|NCT00368277|521852744|FG000|Overall Study|Adverse Event|33|||
144726387|NCT00368277|521852745|FG001|Overall Study|Adverse Event|49|||
144726388|NCT00368277|521852744|FG000|Overall Study|Death|2|||
144726389|NCT00368277|521852745|FG001|Overall Study|Death|1|||
144726390|NCT00368277|521852744|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
144726391|NCT00368277|521852745|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
144726392|NCT00368277|521852744|FG000|Overall Study|Protocol deviation|7|||
144726393|NCT00368277|521852745|FG001|Overall Study|Protocol deviation|0|||
144726394|NCT00368277|521852744|FG000|Overall Study|Patient withdrew consent|32|||
144726395|NCT00368277|521852745|FG001|Overall Study|Patient withdrew consent|28|||
144726396|NCT00368277|521852744|FG000|Overall Study|Lost to Follow-up|8|||
144726397|NCT00368277|521852745|FG001|Overall Study|Lost to Follow-up|6|||
144726398|NCT04347239|521852746|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
144726399|NCT04347239|521852747|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
144726400|NCT04347239|521852748|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
144726401|NCT04347239|521852746|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
144726402|NCT04347239|521852747|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
144726403|NCT04347239|521852748|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
144726404|NCT00918567|521852749|FG000|Overall Study|Lack of Efficacy|3|||
144726405|NCT00918567|521852750|FG001|Overall Study|Lack of Efficacy|1|||
144726406|NCT00918567|521852749|FG000|Overall Study|Withdrawal by Subject|1|||
144726407|NCT00918567|521852750|FG001|Overall Study|Withdrawal by Subject|1|||
144726408|NCT00918567|521852749|FG000|Overall Study|Adverse Event|1|||
144726409|NCT00918567|521852750|FG001|Overall Study|Adverse Event|0|||
144726410|NCT03283709|521852753|FG000|Overall Study|trial terminated|0|||
144726411|NCT03283709|521852754|FG001|Overall Study|trial terminated|1|||
144726412|NCT05275998|521852755|FG000|Overall Study|Adverse Event|0|||
144726413|NCT05275998|521852756|FG001|Overall Study|Adverse Event|0|||
144726414|NCT05275998|521852757|FG002|Overall Study|Adverse Event|0|||
144726415|NCT05275998|521852758|FG003|Overall Study|Adverse Event|1|||
144726416|NCT05275998|521852755|FG000|Overall Study|Withdrawal by Subject|0|||
144726417|NCT05275998|521852756|FG001|Overall Study|Withdrawal by Subject|0|||
144726418|NCT05275998|521852757|FG002|Overall Study|Withdrawal by Subject|0|||
144726419|NCT05275998|521852758|FG003|Overall Study|Withdrawal by Subject|1|||
144726420|NCT05275998|521852755|FG000|Overall Study|Physician Decision|0|||
144726421|NCT05275998|521852756|FG001|Overall Study|Physician Decision|0|||
144726422|NCT05275998|521852757|FG002|Overall Study|Physician Decision|0|||
144726423|NCT05275998|521852758|FG003|Overall Study|Physician Decision|1|||
144726424|NCT05275998|521852755|FG000|Overall Study|Protocol Violation|0|||
144726425|NCT05275998|521852756|FG001|Overall Study|Protocol Violation|0|||
144726426|NCT05275998|521852757|FG002|Overall Study|Protocol Violation|1|||
144726427|NCT05275998|521852758|FG003|Overall Study|Protocol Violation|0|||
144726428|NCT00264810|521852759|FG000|Baseline|Withdrawal by Subject|10|||
144726429|NCT00264810|521852760|FG001|Baseline|Withdrawal by Subject|10|||
144726430|NCT00264810|521852759|FG000|Baseline|Physician Decision|7|||
144726431|NCT00264810|521852760|FG001|Baseline|Physician Decision|8|||
144726432|NCT00264810|521852759|FG000|Baseline|Subject Compliance Failure|3|||
144726433|NCT00264810|521852760|FG001|Baseline|Subject Compliance Failure|3|||
144536759|NCT03213457|521168446|FG002|Follow-Up Period|Adverse Event|37|||
144536760|NCT03213457|521168444|FG000|Follow-Up Period|Withdrawal by Subject|18|||
144536761|NCT03213457|521168445|FG001|Follow-Up Period|Withdrawal by Subject|11|||
144536762|NCT03213457|521168446|FG002|Follow-Up Period|Withdrawal by Subject|55|||
144536763|NCT03213457|521168444|FG000|Follow-Up Period|Lost to Follow-up|28|||
144536764|NCT03213457|521168445|FG001|Follow-Up Period|Lost to Follow-up|15|||
144536765|NCT03213457|521168446|FG002|Follow-Up Period|Lost to Follow-up|50|||
144726434|NCT00264810|521852759|FG000|Baseline|Insufficient Seizure Frequency|2|||
144726435|NCT00264810|521852760|FG001|Baseline|Insufficient Seizure Frequency|2|||
144726436|NCT00264810|521852759|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
144726437|NCT00264810|521852760|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
144726438|NCT00264810|521852759|FG000|Baseline|Other|0|||
144726439|NCT00264810|521852760|FG001|Baseline|Other|1|||
144197454|NCT01206101|519920269|FG001|Overall Study|Unclassified|0|||
144536766|NCT03213457|521168444|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
144613240|NCT01709435|521445465|FG000|Overall Study|Lack of Efficacy|5|||
144726440|NCT00264810|521852759|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
144726441|NCT00264810|521852760|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
144726442|NCT00264810|521852759|FG000|Stimulation Optimization Period|Death|0|||
144726443|NCT00264810|521852760|FG001|Stimulation Optimization Period|Death|1|||
144726444|NCT00264810|521852759|FG000|Blinded Evaluation Period|Explant due to infection|1|||
144468433|NCT01936857|520911439|FG000|Overall Study|Death|7|||
144468434|NCT01936857|520911440|FG001|Overall Study|Death|3|||
144468435|NCT01936857|520911439|FG000|Overall Study|Moved|2|||
144468436|NCT01936857|520911440|FG001|Overall Study|Moved|1|||
144468437|NCT01936857|520911439|FG000|Overall Study|Withdrawal by Subject|1|||
144468438|NCT01936857|520911440|FG001|Overall Study|Withdrawal by Subject|0|||
144468439|NCT01936857|520911439|FG000|Overall Study|Side effect of medication|1|||
144468440|NCT01936857|520911440|FG001|Overall Study|Side effect of medication|0|||
144468441|NCT01936857|520911439|FG000|Overall Study|Other|2|||
144468442|NCT01936857|520911440|FG001|Overall Study|Other|2|||
144468443|NCT02279043|520911441|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
144468444|NCT02279043|520911442|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
144468445|NCT02279043|520911443|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
144468446|NCT02279043|520911441|FG000|Overall Study|Lost to Follow-up|46|||
144468447|NCT02279043|520911442|FG001|Overall Study|Lost to Follow-up|88|||
144468448|NCT02279043|520911443|FG002|Overall Study|Lost to Follow-up|0|||
144468449|NCT01939548|520911444|FG000|Overall Study|Non compliance|0|||
144468450|NCT01939548|520911445|FG001|Overall Study|Non compliance|2|||
144468451|NCT01939548|520911446|FG002|Overall Study|Non compliance|0|||
144468452|NCT01939548|520911444|FG000|Overall Study|Study Terminated by Sponsor|17|||
144468453|NCT01939548|520911445|FG001|Overall Study|Study Terminated by Sponsor|19|||
144468454|NCT01939548|520911446|FG002|Overall Study|Study Terminated by Sponsor|12|||
144468455|NCT01939548|520911444|FG000|Overall Study|Insufficient Clinical Response|1|||
144468456|NCT01939548|520911445|FG001|Overall Study|Insufficient Clinical Response|0|||
144468457|NCT01939548|520911446|FG002|Overall Study|Insufficient Clinical Response|0|||
144468458|NCT01939548|520911444|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
144468459|NCT01939548|520911445|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
144468460|NCT01939548|520911446|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
144468461|NCT01939548|520911444|FG000|Overall Study|Withdrawal by Subject|4|||
144468462|NCT01939548|520911445|FG001|Overall Study|Withdrawal by Subject|4|||
144468463|NCT01939548|520911446|FG002|Overall Study|Withdrawal by Subject|1|||
144468464|NCT01939548|520911444|FG000|Overall Study|Protocol Violation|7|||
144468465|NCT01939548|520911445|FG001|Overall Study|Protocol Violation|6|||
144468466|NCT01939548|520911446|FG002|Overall Study|Protocol Violation|5|||
144468467|NCT01939548|520911444|FG000|Overall Study|Lost to Follow-up|5|||
144468468|NCT01939548|520911445|FG001|Overall Study|Lost to Follow-up|5|||
144468469|NCT01939548|520911446|FG002|Overall Study|Lost to Follow-up|3|||
144468470|NCT01939548|520911444|FG000|Overall Study|Adverse Event|2|||
144468471|NCT01939548|520911445|FG001|Overall Study|Adverse Event|9|||
144468472|NCT01939548|520911446|FG002|Overall Study|Adverse Event|7|||
144468473|NCT01939548|520911444|FG000|Overall Study|Death|0|||
144468474|NCT01939548|520911445|FG001|Overall Study|Death|0|||
144468475|NCT01939548|520911446|FG002|Overall Study|Death|1|||
144468476|NCT01939548|520911444|FG000|Overall Study|Participant dropped|0|||
144468477|NCT01939548|520911445|FG001|Overall Study|Participant dropped|0|||
144468478|NCT01939548|520911446|FG002|Overall Study|Participant dropped|1|||
144468479|NCT01939548|520911444|FG000|Overall Study|Participant unwilling to continue|0|||
144468480|NCT01939548|520911445|FG001|Overall Study|Participant unwilling to continue|1|||
144468481|NCT01939548|520911446|FG002|Overall Study|Participant unwilling to continue|0|||
144468482|NCT01939548|520911444|FG000|Overall Study|Participant withdrew consent|0|||
144468483|NCT01939548|520911445|FG001|Overall Study|Participant withdrew consent|2|||
144468484|NCT01939548|520911446|FG002|Overall Study|Participant withdrew consent|0|||
144468485|NCT01939548|520911444|FG000|Overall Study|Did not complete follow-up|0|||
144468486|NCT01939548|520911445|FG001|Overall Study|Did not complete follow-up|1|||
144468487|NCT01939548|520911446|FG002|Overall Study|Did not complete follow-up|0|||
144468488|NCT00490282|520911447|FG000|Overall Study|Withdrawal by Subject|3|||
144536767|NCT03213457|521168445|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
144536768|NCT03213457|521168446|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
144536769|NCT03213457|521168444|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
144536770|NCT03213457|521168445|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
144536771|NCT03213457|521168446|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
144536772|NCT03213457|521168444|FG000|Follow-Up Period|Pregnancy|7|||
144536773|NCT03213457|521168445|FG001|Follow-Up Period|Pregnancy|0|||
144536774|NCT03213457|521168446|FG002|Follow-Up Period|Pregnancy|18|||
144468489|NCT04198805|520911451|FG000|Overall Study|Death|0|||
144468490|NCT04198805|520911452|FG001|Overall Study|Death|0|||
144468491|NCT04198805|520911453|FG002|Overall Study|Death|0|||
144468492|NCT04198805|520911454|FG003|Overall Study|Death|1|||
144468493|NCT04198805|520911451|FG000|Overall Study|Early Termination|8|||
144468494|NCT04198805|520911452|FG001|Overall Study|Early Termination|4|||
144468495|NCT04198805|520911453|FG002|Overall Study|Early Termination|6|||
144613241|NCT01709435|521445466|FG001|Overall Study|Lack of Efficacy|7|||
144468496|NCT04198805|520911454|FG003|Overall Study|Early Termination|9|||
144468497|NCT01494584|520911459|FG000|Overall Study|Study Closed/Terminated|1|||
144468498|NCT01499082|520911460|FG000|Overall Study|Randomized but not Treated|0|||
144468499|NCT01499082|520911461|FG001|Overall Study|Randomized but not Treated|1|||
144468500|NCT01499082|520911460|FG000|Overall Study|Adverse Event|12|||
144613242|NCT01709435|521445467|FG002|Overall Study|Lack of Efficacy|2|||
144613243|NCT01709435|521445468|FG003|Overall Study|Lack of Efficacy|2|||
144613244|NCT01709435|521445469|FG004|Overall Study|Lack of Efficacy|6|||
144613245|NCT01709435|521445470|FG005|Overall Study|Lack of Efficacy|3|||
144613246|NCT01709435|521445465|FG000|Overall Study|Physician Decision|0|||
144613247|NCT01709435|521445466|FG001|Overall Study|Physician Decision|1|||
144613248|NCT01709435|521445467|FG002|Overall Study|Physician Decision|0|||
144468501|NCT01499082|520911461|FG001|Overall Study|Adverse Event|16|||
144468502|NCT01499082|520911460|FG000|Overall Study|Lack of Efficacy|1|||
144468503|NCT01499082|520911461|FG001|Overall Study|Lack of Efficacy|1|||
144468504|NCT01499082|520911460|FG000|Overall Study|Protocol Violation|6|||
144468505|NCT01499082|520911461|FG001|Overall Study|Protocol Violation|8|||
144468506|NCT01499082|520911460|FG000|Overall Study|Diverse Reasons|18|||
144468507|NCT01499082|520911461|FG001|Overall Study|Diverse Reasons|14|||
144468508|NCT01499082|520911460|FG000|Overall Study|Site Closure for Noncompliance|5|||
144468509|NCT01499082|520911461|FG001|Overall Study|Site Closure for Noncompliance|2|||
144468510|NCT01499082|520911460|FG000|Overall Study|Hypoglycemia|2|||
144468511|NCT01499082|520911461|FG001|Overall Study|Hypoglycemia|3|||
144613249|NCT01709435|521445468|FG003|Overall Study|Physician Decision|1|||
144613250|NCT01709435|521445469|FG004|Overall Study|Physician Decision|2|||
144613251|NCT01709435|521445470|FG005|Overall Study|Physician Decision|0|||
144613252|NCT01709435|521445465|FG000|Overall Study|Withdrawal by Subject|0|||
144468512|NCT01499082|520911460|FG000|Overall Study|Lost to Follow-up|1|||
144468513|NCT01499082|520911461|FG001|Overall Study|Lost to Follow-up|3|||
144468514|NCT03599349|520911462|FG000|Overall Study|Lost to Follow-up|1|||
144468515|NCT05380947|520911468|FG000|Washout Period 1|Not attend visit|1|||
144468516|NCT05380947|520911469|FG001|Washout Period 1|Not attend visit|0|||
144468517|NCT05380947|520911470|FG002|Washout Period 1|Not attend visit|0|||
144468518|NCT05380947|520911471|FG003|Washout Period 1|Not attend visit|0|||
144468519|NCT05380947|520911468|FG000|Washout Period 2|Adverse Event|1|||
144468520|NCT05380947|520911469|FG001|Washout Period 2|Adverse Event|0|||
144468521|NCT05380947|520911470|FG002|Washout Period 2|Adverse Event|0|||
144468522|NCT05380947|520911471|FG003|Washout Period 2|Adverse Event|0|||
144468523|NCT05380947|520911468|FG000|Washout Period 3|Adverse Event|0|||
144468524|NCT05380947|520911469|FG001|Washout Period 3|Adverse Event|1|||
144468525|NCT05380947|520911470|FG002|Washout Period 3|Adverse Event|0|||
144468526|NCT05380947|520911471|FG003|Washout Period 3|Adverse Event|0|||
144468527|NCT05380947|520911468|FG000|Washout Period 3|Not attend visit|0|||
144613253|NCT01709435|521445466|FG001|Overall Study|Withdrawal by Subject|0|||
144613254|NCT01709435|521445467|FG002|Overall Study|Withdrawal by Subject|3|||
144613255|NCT01709435|521445468|FG003|Overall Study|Withdrawal by Subject|0|||
144613256|NCT01709435|521445469|FG004|Overall Study|Withdrawal by Subject|2|||
144613257|NCT01709435|521445470|FG005|Overall Study|Withdrawal by Subject|2|||
144613258|NCT02184195|521445473|FG000|Overall Study|Patient decision|5|||
144613259|NCT02184195|521445474|FG001|Overall Study|Patient decision|2|||
144613260|NCT02184195|521445473|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144613261|NCT02184195|521445474|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144613262|NCT02184195|521445473|FG000|Overall Study|Death|67|||
144613263|NCT02184195|521445474|FG001|Overall Study|Death|44|||
144613264|NCT02184195|521445473|FG000|Overall Study|Lost to Follow-up|1|||
144613265|NCT02184195|521445474|FG001|Overall Study|Lost to Follow-up|5|||
144613266|NCT02184195|521445473|FG000|Overall Study|Other|0|||
144613267|NCT02184195|521445474|FG001|Overall Study|Other|3|||
144613268|NCT03029143|521445475|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
144613269|NCT03029143|521445476|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
144613270|NCT03029143|521445477|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
144613271|NCT03029143|521445475|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
144613272|NCT03029143|521445476|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
144613273|NCT03029143|521445477|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
144613274|NCT03029143|521445475|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
144613275|NCT03029143|521445476|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
144613276|NCT03029143|521445477|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
144613277|NCT03029143|521445475|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
144258358|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
144258359|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
144468528|NCT05380947|520911469|FG001|Washout Period 3|Not attend visit|1|||
144468529|NCT05380947|520911470|FG002|Washout Period 3|Not attend visit|0|||
144613278|NCT03029143|521445476|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
144613279|NCT03029143|521445477|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
144613280|NCT03029143|521445475|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
144468530|NCT05380947|520911471|FG003|Washout Period 3|Not attend visit|1|||
144468531|NCT06213701|520911472|FG000|Overall Study|Withdrawal by Subject|2|||
144468532|NCT06213701|520911473|FG001|Overall Study|Withdrawal by Subject|1|||
144468533|NCT06213701|520911474|FG002|Overall Study|Withdrawal by Subject|0|||
144468534|NCT01256567|520911476|FG000|Overall Study|Withdrawal by Subject|1|||
144468535|NCT02453685|520911489|FG000|Overall Study|Adverse Event|0|||
144468536|NCT02453685|520911490|FG001|Overall Study|Adverse Event|1|||
144468537|NCT02453685|520911489|FG000|Overall Study|Protocol Violation|7|||
144468538|NCT02453685|520911490|FG001|Overall Study|Protocol Violation|4|||
144468539|NCT02453685|520911489|FG000|Overall Study|Lost to Follow-up|0|||
144468540|NCT02453685|520911490|FG001|Overall Study|Lost to Follow-up|1|||
144468541|NCT02453685|520911489|FG000|Overall Study|Withdrawal by Subject|8|||
144468542|NCT02453685|520911490|FG001|Overall Study|Withdrawal by Subject|4|||
144468543|NCT02453685|520911489|FG000|Overall Study|Unclassified|4|||
144468544|NCT02453685|520911490|FG001|Overall Study|Unclassified|2|||
144468545|NCT00522626|520911495|FG000|Overall Study|Lost to Follow-up|7|||
144468546|NCT00803452|520911496|FG000|Overall Study|Adverse Event|0|||
144468547|NCT00803452|520911497|FG001|Overall Study|Adverse Event|2|||
144468548|NCT00803452|520911496|FG000|Overall Study|Lost to Follow-up|0|||
144468549|NCT00803452|520911497|FG001|Overall Study|Lost to Follow-up|3|||
144468550|NCT05899686|520911498|FG000|Overall Study|Protocol Violation|1|||
144468551|NCT02532179|520913201|FG000|Overall Study|Lost to Follow-up|1|||
144468552|NCT02532179|520913201|FG000|Overall Study|Pregnancy|1|||
144468553|NCT02532179|520913201|FG000|Overall Study|Subject received depot steroid injection|1|||
144468554|NCT01337674|520913207|FG000|Treatment Period 1|Adverse Event|0|||
144468555|NCT01337674|520913208|FG001|Treatment Period 1|Adverse Event|1|||
144468556|NCT01337674|520913209|FG002|Treatment Period 1|Adverse Event|0|||
144613281|NCT03029143|521445476|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
144613282|NCT03029143|521445477|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
144613283|NCT03029143|521445475|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
144468557|NCT01337674|520913210|FG003|Treatment Period 1|Adverse Event|0|||
144468558|NCT01337674|520913207|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
144468559|NCT01337674|520913208|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
144468560|NCT01337674|520913209|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
144468561|NCT01337674|520913210|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
144468562|NCT01337674|520913207|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144468563|NCT01337674|520913208|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144468564|NCT01337674|520913209|FG002|Treatment Period 2|Withdrawal by Subject|1|||
144468565|NCT01337674|520913210|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144468566|NCT03076970|520913211|FG000|Washout Period 2|Adverse Event|0|||
144468567|NCT03076970|520913212|FG001|Washout Period 2|Adverse Event|0|||
144468568|NCT03076970|520913213|FG002|Washout Period 2|Adverse Event|0|||
144468569|NCT03076970|520913214|FG003|Washout Period 2|Adverse Event|0|||
144468570|NCT03076970|520913215|FG004|Washout Period 2|Adverse Event|1|||
144468571|NCT03076970|520913216|FG005|Washout Period 2|Adverse Event|0|||
144468572|NCT03076970|520913211|FG000|Period 3|Withdrawal by Subject|0|||
144468573|NCT03076970|520913212|FG001|Period 3|Withdrawal by Subject|0|||
144468574|NCT03076970|520913213|FG002|Period 3|Withdrawal by Subject|0|||
144468575|NCT03076970|520913214|FG003|Period 3|Withdrawal by Subject|0|||
144468576|NCT03076970|520913215|FG004|Period 3|Withdrawal by Subject|0|||
144468577|NCT03076970|520913216|FG005|Period 3|Withdrawal by Subject|1|||
144468578|NCT03076970|520913211|FG000|Period 3|Failure to meet I/E criteria|0|||
144468579|NCT03076970|520913212|FG001|Period 3|Failure to meet I/E criteria|0|||
144468580|NCT03076970|520913213|FG002|Period 3|Failure to meet I/E criteria|0|||
144468581|NCT03076970|520913214|FG003|Period 3|Failure to meet I/E criteria|0|||
144468582|NCT03076970|520913215|FG004|Period 3|Failure to meet I/E criteria|1|||
144468583|NCT03076970|520913216|FG005|Period 3|Failure to meet I/E criteria|0|||
144468584|NCT00789815|520913217|FG000|Overall Study|Protocol Violation|6|||
144468585|NCT00789815|520913218|FG001|Overall Study|Protocol Violation|1|||
144468586|NCT00789815|520913217|FG000|Overall Study|Intubation due to massive bleeding|1|||
144468587|NCT00789815|520913218|FG001|Overall Study|Intubation due to massive bleeding|0|||
144468588|NCT00119405|520913219|FG000|Overall Study|Withdrawal by Subject|1|||
144468589|NCT04958785|520913223|FG000|Overall Study|Study Terminated by Sponsor|4|||
144468590|NCT04958785|520913224|FG001|Overall Study|Study Terminated by Sponsor|10|||
144468591|NCT04958785|520913225|FG002|Overall Study|Study Terminated by Sponsor|7|||
144468592|NCT04958785|520913226|FG003|Overall Study|Study Terminated by Sponsor|6|||
144468593|NCT04958785|520913227|FG004|Overall Study|Study Terminated by Sponsor|34|||
144468594|NCT04958785|520913223|FG000|Overall Study|Death|2|||
144613284|NCT03029143|521445476|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
144468595|NCT04958785|520913224|FG001|Overall Study|Death|3|||
144468596|NCT04958785|520913225|FG002|Overall Study|Death|4|||
144468597|NCT04958785|520913226|FG003|Overall Study|Death|5|||
144468598|NCT04958785|520913227|FG004|Overall Study|Death|5|||
144468599|NCT04958785|520913223|FG000|Overall Study|Withdrew consent|2|||
144468600|NCT04958785|520913224|FG001|Overall Study|Withdrew consent|0|||
144468601|NCT04958785|520913225|FG002|Overall Study|Withdrew consent|3|||
144468602|NCT04958785|520913226|FG003|Overall Study|Withdrew consent|1|||
144468603|NCT04958785|520913227|FG004|Overall Study|Withdrew consent|0|||
144468604|NCT04958785|520913223|FG000|Overall Study|Investigator's discretion|0|||
144468605|NCT04958785|520913224|FG001|Overall Study|Investigator's discretion|1|||
144468606|NCT04958785|520913225|FG002|Overall Study|Investigator's discretion|0|||
144468607|NCT04958785|520913226|FG003|Overall Study|Investigator's discretion|1|||
144468608|NCT04958785|520913227|FG004|Overall Study|Investigator's discretion|2|||
144258360|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
144258361|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
144258362|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
144258363|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
144258364|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
144258365|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
144258366|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
144258367|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
144536775|NCT03213457|521168444|FG000|Follow-Up Period|Exclusionary medications|1|||
144536776|NCT03213457|521168445|FG001|Follow-Up Period|Exclusionary medications|1|||
144536777|NCT03213457|521168446|FG002|Follow-Up Period|Exclusionary medications|5|||
144536778|NCT03213457|521168444|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
144536779|NCT03213457|521168445|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
144536780|NCT03213457|521168446|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
144536781|NCT03213457|521168444|FG000|Follow-Up Period|Other|14|||
144536782|NCT03213457|521168445|FG001|Follow-Up Period|Other|10|||
144536783|NCT03213457|521168446|FG002|Follow-Up Period|Other|31|||
144536784|NCT02951052|521168447|FG000|Overall Study|Adverse Event|13|||
144536785|NCT02951052|521168448|FG001|Overall Study|Adverse Event|5|||
144536786|NCT02951052|521168447|FG000|Overall Study|Withdrawal by Subject|1|||
144536787|NCT02951052|521168448|FG001|Overall Study|Withdrawal by Subject|5|||
144536788|NCT02951052|521168447|FG000|Overall Study|Physician Decision|2|||
144536789|NCT02951052|521168448|FG001|Overall Study|Physician Decision|0|||
144536790|NCT02951052|521168447|FG000|Overall Study|Lost to Follow-up|1|||
144536791|NCT02951052|521168448|FG001|Overall Study|Lost to Follow-up|1|||
144536792|NCT02951052|521168447|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
144536793|NCT02951052|521168448|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
144536794|NCT02951052|521168447|FG000|Overall Study|Protocol Violation|5|||
144613285|NCT03029143|521445477|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
144613286|NCT03029143|521445475|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
144613287|NCT03029143|521445476|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
144613288|NCT03029143|521445477|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
144613289|NCT03029143|521445475|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144613290|NCT03029143|521445476|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144613291|NCT03029143|521445477|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
144613292|NCT03029143|521445475|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
144613293|NCT03029143|521445476|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
144613294|NCT03029143|521445477|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
144613295|NCT03029143|521445475|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144613296|NCT03029143|521445476|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
144613297|NCT03029143|521445477|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
144613298|NCT03029143|521445475|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
144613299|NCT03029143|521445476|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
144613300|NCT03029143|521445477|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
144613301|NCT00974675|521445478|FG000|Overall Study|Adverse Event|2|||
144613302|NCT00974675|521445479|FG001|Overall Study|Adverse Event|1|||
144613303|NCT00974675|521445480|FG002|Overall Study|Adverse Event|1|||
144613304|NCT00974675|521445481|FG003|Overall Study|Adverse Event|1|||
144613305|NCT00974675|521445478|FG000|Overall Study|Physician Decision|0|||
144613306|NCT00974675|521445479|FG001|Overall Study|Physician Decision|0|||
144613307|NCT00974675|521445480|FG002|Overall Study|Physician Decision|1|||
144613308|NCT00974675|521445481|FG003|Overall Study|Physician Decision|0|||
144613309|NCT00974675|521445478|FG000|Overall Study|Participant on holiday; unable to attend|0|||
144613310|NCT00974675|521445479|FG001|Overall Study|Participant on holiday; unable to attend|0|||
144613311|NCT00974675|521445480|FG002|Overall Study|Participant on holiday; unable to attend|0|||
144613312|NCT00974675|521445481|FG003|Overall Study|Participant on holiday; unable to attend|1|||
144613313|NCT02121262|521445482|FG000|Overall Study|Adverse Event|6|||
144613314|NCT02121262|521445483|FG001|Overall Study|Adverse Event|3|||
144613315|NCT02121262|521445482|FG000|Overall Study|Lack of Efficacy|3|||
144613316|NCT02121262|521445483|FG001|Overall Study|Lack of Efficacy|0|||
144613317|NCT02121262|521445482|FG000|Overall Study|Personal Reasons|19|||
144613318|NCT02121262|521445483|FG001|Overall Study|Personal Reasons|5|||
144613319|NCT02121262|521445482|FG000|Overall Study|Protocol Violation|1|||
144613320|NCT02121262|521445483|FG001|Overall Study|Protocol Violation|1|||
144613321|NCT02121262|521445482|FG000|Overall Study|Participant Dropped-out|0|||
144259306|NCT00511810|520150363|FG000|Overall Study|Lost to Follow-up|1|||
144536795|NCT02951052|521168448|FG001|Overall Study|Protocol Violation|3|||
144536796|NCT02951052|521168447|FG000|Overall Study|Lack of Efficacy|3|||
144613322|NCT02121262|521445483|FG001|Overall Study|Participant Dropped-out|1|||
144613323|NCT02121262|521445482|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
144536797|NCT02951052|521168448|FG001|Overall Study|Lack of Efficacy|4|||
144536798|NCT02951052|521168447|FG000|Overall Study|Ongoing|1|||
144726445|NCT00264810|521852760|FG001|Blinded Evaluation Period|Explant due to infection|1|||
144726446|NCT00264810|521852759|FG000|Open Label Evaluation Period|Explant due to infection|1|||
144726447|NCT00264810|521852760|FG001|Open Label Evaluation Period|Explant due to infection|1|||
144726448|NCT00264810|521852759|FG000|Open Label Evaluation Period|Death|3|||
144726449|NCT00264810|521852760|FG001|Open Label Evaluation Period|Death|2|||
144726450|NCT00264810|521852759|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
144726451|NCT00264810|521852760|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
144726452|NCT02199509|521852761|FG000|Overall Study|Suicidal Ideation|0|||
144726453|NCT02199509|521852762|FG001|Overall Study|Suicidal Ideation|1|||
144726454|NCT02199509|521852761|FG000|Overall Study|Misunderstood titration schedule|1|||
144726455|NCT02199509|521852762|FG001|Overall Study|Misunderstood titration schedule|0|||
144726456|NCT01658943|521852763|FG000|Overall Study|Adverse Event|6|||
144726457|NCT01658943|521852764|FG001|Overall Study|Adverse Event|13|||
144726458|NCT01658943|521852763|FG000|Overall Study|Withdrawal by Subject|9|||
144726459|NCT01658943|521852764|FG001|Overall Study|Withdrawal by Subject|2|||
144726460|NCT01658943|521852763|FG000|Overall Study|Progression/Relapse|39|||
144726461|NCT01658943|521852764|FG001|Overall Study|Progression/Relapse|40|||
144726462|NCT01658943|521852763|FG000|Overall Study|Death|4|||
144726463|NCT01658943|521852764|FG001|Overall Study|Death|2|||
144726464|NCT01658943|521852763|FG000|Overall Study|not protocol specified|4|||
144726465|NCT01658943|521852764|FG001|Overall Study|not protocol specified|1|||
144726466|NCT01658943|521852763|FG000|Overall Study|Not eligible|7|||
144726467|NCT01658943|521852764|FG001|Overall Study|Not eligible|9|||
144726468|NCT01658943|521852763|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
144726469|NCT01658943|521852764|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
144726470|NCT03309956|521852765|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
144726471|NCT02768298|521852766|FG000|Overall Study|Adverse Event|1|||
144613324|NCT02121262|521445483|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
144613325|NCT02121262|521445482|FG000|Overall Study|Consent Withdrawn|1|||
144613326|NCT02121262|521445483|FG001|Overall Study|Consent Withdrawn|0|||
144613327|NCT01394627|521445485|FG000|First Intervention (1 Day)|poor intravenous access|0|||
144613328|NCT01394627|521445486|FG001|First Intervention (1 Day)|poor intravenous access|1|||
144468609|NCT04958785|520913223|FG000|Overall Study|Adverse Event|0|||
144468610|NCT04958785|520913224|FG001|Overall Study|Adverse Event|0|||
144468611|NCT04958785|520913225|FG002|Overall Study|Adverse Event|0|||
144468612|NCT04958785|520913226|FG003|Overall Study|Adverse Event|0|||
144468613|NCT04958785|520913227|FG004|Overall Study|Adverse Event|1|||
144613329|NCT01394627|521445485|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
144613330|NCT01394627|521445486|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
144613331|NCT03223428|521445487|FG000|Overall Study|No longer taking Xermelo|27|||
144613332|NCT03223428|521445487|FG000|Overall Study|Declined Consent|1|||
144613333|NCT03223428|521445487|FG000|Overall Study|Non-responders|56|||
144613334|NCT03223428|521445487|FG000|Overall Study|Withdrawal by Subject|14|||
144613335|NCT03917823|521445489|FG000|Overall Study|Lost to Follow-up|1|||
144613336|NCT03917823|521445490|FG001|Overall Study|Lost to Follow-up|1|||
144613337|NCT03917823|521445489|FG000|Overall Study|Withdrawal by Subject|0|||
144613338|NCT03917823|521445490|FG001|Overall Study|Withdrawal by Subject|1|||
144613339|NCT02424253|521445493|FG000|Overall Study|Other, unspecified|1|||
144613340|NCT02424253|521445494|FG001|Overall Study|Other, unspecified|0|||
144613341|NCT02424253|521445493|FG000|Overall Study|Compliance problems|1|||
144613342|NCT02424253|521445494|FG001|Overall Study|Compliance problems|0|||
144613343|NCT02424253|521445493|FG000|Overall Study|Physician Decision|2|||
144613344|NCT02424253|521445494|FG001|Overall Study|Physician Decision|0|||
144613345|NCT02424253|521445493|FG000|Overall Study|Lack of Efficacy|0|||
144613346|NCT02424253|521445494|FG001|Overall Study|Lack of Efficacy|7|||
144613347|NCT02424253|521445493|FG000|Overall Study|Adverse Event|2|||
144613348|NCT02424253|521445494|FG001|Overall Study|Adverse Event|0|||
144613349|NCT02424253|521445493|FG000|Overall Study|Consent withdrawn by subject|4|||
144613350|NCT02424253|521445494|FG001|Overall Study|Consent withdrawn by subject|1|||
144613351|NCT02424253|521445493|FG000|Overall Study|Lost to Follow-up|1|||
144613352|NCT02424253|521445494|FG001|Overall Study|Lost to Follow-up|1|||
144613353|NCT02290873|521445497|FG000|Overall Study|Withdrawal by Subject|0|||
144613354|NCT02290873|521445498|FG001|Overall Study|Withdrawal by Subject|1|||
144613355|NCT02290873|521445499|FG002|Overall Study|Withdrawal by Subject|1|||
144613356|NCT02290873|521445497|FG000|Overall Study|Nellcor device error|1|||
144613357|NCT02290873|521445498|FG001|Overall Study|Nellcor device error|0|||
144613358|NCT02290873|521445499|FG002|Overall Study|Nellcor device error|0|||
144726472|NCT02768298|521852767|FG001|Overall Study|Adverse Event|4|||
144726473|NCT02768298|521852766|FG000|Overall Study|Death|2|||
144726474|NCT02768298|521852767|FG001|Overall Study|Death|1|||
144468614|NCT04958785|520913223|FG000|Overall Study|Lost to Follow-up|0|||
144613359|NCT02290873|521445497|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
144613360|NCT02290873|521445498|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
144613361|NCT02290873|521445499|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
144468615|NCT04958785|520913224|FG001|Overall Study|Lost to Follow-up|0|||
144613362|NCT02290873|521445497|FG000|Overall Study|Protocol Violation|0|||
144613363|NCT02290873|521445498|FG001|Overall Study|Protocol Violation|0|||
144613364|NCT02290873|521445499|FG002|Overall Study|Protocol Violation|1|||
144613365|NCT02700997|521445502|FG000|Overall Study|Did not undergo CT imaging|1|||
144613366|NCT02700997|521445502|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
144613367|NCT00078325|521445505|FG000|Overall Study|Adverse Event|15|||
144613368|NCT00078325|521445506|FG001|Overall Study|Adverse Event|10|||
144613369|NCT00078325|521445507|FG002|Overall Study|Adverse Event|5|||
144613370|NCT00078325|521445505|FG000|Overall Study|Protocol Violation|2|||
144613371|NCT00078325|521445506|FG001|Overall Study|Protocol Violation|2|||
144613372|NCT00078325|521445507|FG002|Overall Study|Protocol Violation|0|||
144613373|NCT00078325|521445505|FG000|Overall Study|Withdrawal by Subject|1|||
144613374|NCT00078325|521445506|FG001|Overall Study|Withdrawal by Subject|5|||
144613375|NCT00078325|521445507|FG002|Overall Study|Withdrawal by Subject|3|||
144613376|NCT00078325|521445505|FG000|Overall Study|Lost to Follow-up|0|||
144613377|NCT00078325|521445506|FG001|Overall Study|Lost to Follow-up|1|||
144613378|NCT00078325|521445507|FG002|Overall Study|Lost to Follow-up|1|||
144613379|NCT00078325|521445505|FG000|Overall Study|Physician Decision|2|||
144613380|NCT00078325|521445506|FG001|Overall Study|Physician Decision|0|||
144613381|NCT00078325|521445507|FG002|Overall Study|Physician Decision|1|||
144613382|NCT00078325|521445505|FG000|Overall Study|Miscellaneous|1|||
144613383|NCT00078325|521445506|FG001|Overall Study|Miscellaneous|1|||
144613384|NCT00078325|521445507|FG002|Overall Study|Miscellaneous|1|||
144613385|NCT04126083|521445511|FG000|Overall Study|Withdrawal by Subject|1|||
144613386|NCT00578136|521445512|FG000|Overall Study|Not given intervention|1|||
144613387|NCT00578136|521445513|FG001|Overall Study|Not given intervention|1|||
144613388|NCT00932360|521445515|FG000|Washout (One Week)|Withdrawal by Subject|0|||
144613389|NCT00932360|521445516|FG001|Washout (One Week)|Withdrawal by Subject|0|||
144613390|NCT00932360|521445517|FG002|Washout (One Week)|Withdrawal by Subject|0|||
144613391|NCT00932360|521445518|FG003|Washout (One Week)|Withdrawal by Subject|0|||
144613392|NCT00932360|521445519|FG004|Washout (One Week)|Withdrawal by Subject|2|||
144613393|NCT00932360|521445520|FG005|Washout (One Week)|Withdrawal by Subject|0|||
144613394|NCT02536313|521445521|FG000|Overall Study|Lack of Efficacy|0|||
144613395|NCT02536313|521445522|FG001|Overall Study|Lack of Efficacy|1|||
144613396|NCT01585272|521445526|FG000|Overall Study|Adverse Event|22|||
144613397|NCT01585272|521445526|FG000|Overall Study|Protocol Violation|7|||
144613398|NCT01585272|521445526|FG000|Overall Study|Withdrawal by Subject|10|||
144613399|NCT00645593|521445527|FG000|Overall Study|Later found to be ineligible|1|||
144613400|NCT00645593|521445528|FG001|Overall Study|Later found to be ineligible|0|||
144468616|NCT04958785|520913225|FG002|Overall Study|Lost to Follow-up|0|||
144468617|NCT04958785|520913226|FG003|Overall Study|Lost to Follow-up|0|||
144468618|NCT04958785|520913227|FG004|Overall Study|Lost to Follow-up|1|||
144468619|NCT01224925|520913228|FG000|Overall Study|Lost to Follow-up|3|||
144468620|NCT01224925|520913229|FG001|Overall Study|Lost to Follow-up|2|||
144468621|NCT00245102|520913232|FG000|Overall Study|Not Treated|1|||
144468622|NCT00245102|520913233|FG001|Overall Study|Not Treated|0|||
144468623|NCT00245102|520913234|FG002|Overall Study|Not Treated|1|||
144468624|NCT00245102|520913235|FG003|Overall Study|Not Treated|0|||
144468625|NCT00245102|520913236|FG004|Overall Study|Not Treated|0|||
144468626|NCT00245102|520913237|FG005|Overall Study|Not Treated|0|||
144468627|NCT00245102|520913232|FG000|Overall Study|Protocol Violation|1|||
144468628|NCT00245102|520913233|FG001|Overall Study|Protocol Violation|0|||
144468629|NCT00245102|520913234|FG002|Overall Study|Protocol Violation|0|||
144468630|NCT00245102|520913235|FG003|Overall Study|Protocol Violation|0|||
144468631|NCT00245102|520913236|FG004|Overall Study|Protocol Violation|0|||
144468632|NCT00245102|520913237|FG005|Overall Study|Protocol Violation|0|||
144468633|NCT00245102|520913232|FG000|Overall Study|Death|0|||
144468634|NCT00245102|520913233|FG001|Overall Study|Death|0|||
144468635|NCT00245102|520913234|FG002|Overall Study|Death|0|||
144468636|NCT00245102|520913235|FG003|Overall Study|Death|1|||
144468637|NCT00245102|520913236|FG004|Overall Study|Death|0|||
144468638|NCT00245102|520913237|FG005|Overall Study|Death|0|||
144468639|NCT00245102|520913232|FG000|Overall Study|Adverse Event|4|||
144468640|NCT00245102|520913233|FG001|Overall Study|Adverse Event|2|||
144613401|NCT00993265|521445533|FG000|Overall Study|Adverse Event|1|||
144613402|NCT00993265|521445534|FG001|Overall Study|Adverse Event|0|||
144613403|NCT00993265|521445533|FG000|Overall Study|Changed dose of concomitant drug|2|||
144613404|NCT00993265|521445534|FG001|Overall Study|Changed dose of concomitant drug|0|||
144613405|NCT00993265|521445533|FG000|Overall Study|Non-compliant with study medication|1|||
144613406|NCT00993265|521445534|FG001|Overall Study|Non-compliant with study medication|0|||
144613407|NCT00517751|521445536|FG000|Overall Study|Death|3|||
144613408|NCT00517751|521445536|FG000|Overall Study|Withdrawal by Subject|37|||
144613409|NCT00517751|521445536|FG000|Overall Study|Lost to Follow-up|4|||
144613410|NCT00517751|521445536|FG000|Overall Study|patient not over due|6|||
144613411|NCT00517751|521445536|FG000|Overall Study|Patient not due for visit|76|||
144468641|NCT00245102|520913234|FG002|Overall Study|Adverse Event|5|||
144468642|NCT00245102|520913235|FG003|Overall Study|Adverse Event|1|||
144468643|NCT00245102|520913236|FG004|Overall Study|Adverse Event|0|||
144468644|NCT00245102|520913237|FG005|Overall Study|Adverse Event|2|||
144468645|NCT00245102|520913232|FG000|Overall Study|Decline in performance|0|||
144613412|NCT00517751|521445536|FG000|Overall Study|Missing|3|||
144613413|NCT03021499|521445537|FG000|Overall Study|Adverse Event|1|||
144613414|NCT03021499|521445538|FG001|Overall Study|Adverse Event|0|||
144468646|NCT00245102|520913233|FG001|Overall Study|Decline in performance|2|||
144468647|NCT00245102|520913234|FG002|Overall Study|Decline in performance|0|||
144468648|NCT00245102|520913235|FG003|Overall Study|Decline in performance|1|||
144468649|NCT00245102|520913236|FG004|Overall Study|Decline in performance|0|||
144468650|NCT00245102|520913237|FG005|Overall Study|Decline in performance|2|||
144468651|NCT00245102|520913232|FG000|Overall Study|Participant needed surgery|0|||
144468652|NCT00245102|520913233|FG001|Overall Study|Participant needed surgery|0|||
144468653|NCT00245102|520913234|FG002|Overall Study|Participant needed surgery|1|||
144468654|NCT00245102|520913235|FG003|Overall Study|Participant needed surgery|0|||
144468655|NCT00245102|520913236|FG004|Overall Study|Participant needed surgery|0|||
144468656|NCT00245102|520913237|FG005|Overall Study|Participant needed surgery|0|||
144468657|NCT00245102|520913232|FG000|Overall Study|Clinical progression|1|||
144468658|NCT00245102|520913233|FG001|Overall Study|Clinical progression|0|||
144468659|NCT00245102|520913234|FG002|Overall Study|Clinical progression|0|||
144468660|NCT00245102|520913235|FG003|Overall Study|Clinical progression|0|||
144468661|NCT00245102|520913236|FG004|Overall Study|Clinical progression|0|||
144468662|NCT00245102|520913237|FG005|Overall Study|Clinical progression|0|||
144468663|NCT02293395|520913244|FG000|Overall Study|Lost to Follow-up|1|||
144468664|NCT02293395|520913245|FG001|Overall Study|Lost to Follow-up|0|||
144468665|NCT02293395|520913244|FG000|Overall Study|Withdrawal by Subject|8|||
144468666|NCT02293395|520913245|FG001|Overall Study|Withdrawal by Subject|7|||
144468667|NCT00224770|520913251|FG000|Overall Study|Lost to Follow-up|4|||
144468668|NCT00224770|520913252|FG001|Overall Study|Lost to Follow-up|2|||
144468669|NCT00224770|520913253|FG002|Overall Study|Lost to Follow-up|0|||
144468670|NCT01106430|520913254|FG000|Overall Study|Adverse Event|8|||
144468671|NCT01106430|520913255|FG001|Overall Study|Adverse Event|10|||
144468672|NCT01106430|520913254|FG000|Overall Study|Lack of Efficacy|2|||
144468673|NCT01106430|520913255|FG001|Overall Study|Lack of Efficacy|13|||
144468674|NCT01106430|520913254|FG000|Overall Study|Lost to Follow-up|5|||
144468675|NCT01106430|520913255|FG001|Overall Study|Lost to Follow-up|1|||
144468676|NCT01106430|520913254|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
144468677|NCT01106430|520913255|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
144468678|NCT01106430|520913254|FG000|Overall Study|Moved Out Of State|0|||
144468679|NCT01106430|520913255|FG001|Overall Study|Moved Out Of State|1|||
144468680|NCT01106430|520913254|FG000|Overall Study|Refused To Take Medication|0|||
144468681|NCT01106430|520913255|FG001|Overall Study|Refused To Take Medication|1|||
144468682|NCT01106430|520913254|FG000|Overall Study|Noncompliance|0|||
144468683|NCT01106430|520913255|FG001|Overall Study|Noncompliance|1|||
144468684|NCT01106430|520913254|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
144468685|NCT01106430|520913255|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
144468686|NCT01106430|520913254|FG000|Overall Study|Previous Use Of Marijuana|1|||
144468687|NCT01106430|520913255|FG001|Overall Study|Previous Use Of Marijuana|0|||
144536799|NCT02951052|521168448|FG001|Overall Study|Ongoing|0|||
144536800|NCT05155306|521168458|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
144536801|NCT05155306|521168459|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
144536802|NCT05155306|521168460|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
144536803|NCT05155306|521168461|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
144536804|NCT05155306|521168458|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
144536805|NCT05155306|521168459|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
144536806|NCT05155306|521168460|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
144536807|NCT05155306|521168461|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
144536808|NCT04158141|521168465|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
144536809|NCT04158141|521168466|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
144536810|NCT04158141|521168467|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
144536811|NCT04158141|521168465|FG000|Step 1: Registration|Adverse Event|1|||
144536812|NCT04158141|521168466|FG001|Step 1: Registration|Adverse Event|0|||
144536813|NCT04158141|521168467|FG002|Step 1: Registration|Adverse Event|0|||
144536814|NCT04158141|521168465|FG000|Step 1: Registration|Withdrawal by Subject|1|||
144536815|NCT04158141|521168466|FG001|Step 1: Registration|Withdrawal by Subject|0|||
144536816|NCT04158141|521168467|FG002|Step 1: Registration|Withdrawal by Subject|0|||
144468688|NCT01106430|520913254|FG000|Overall Study|Protocol Violation|7|||
144468689|NCT01106430|520913255|FG001|Overall Study|Protocol Violation|2|||
144468690|NCT01106430|520913254|FG000|Overall Study|Withdrawal by Subject|8|||
144468691|NCT01106430|520913255|FG001|Overall Study|Withdrawal by Subject|4|||
144468692|NCT02127372|520913258|FG000|Overall Study|Withdrawal by Subject|1|||
144468693|NCT02127372|520913259|FG001|Overall Study|Withdrawal by Subject|0|||
144468694|NCT03837509|520913260|FG000|Phase 1|Death|5|||
144468695|NCT03837509|520913261|FG001|Phase 1|Death|2|||
144536817|NCT04158141|521168465|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
144613415|NCT03021499|521445537|FG000|Overall Study|Death|1|||
144613416|NCT03021499|521445538|FG001|Overall Study|Death|5|||
144468696|NCT03837509|520913262|FG002|Phase 1|Death|0|||
144468697|NCT03837509|520913263|FG003|Phase 1|Death|0|||
144536818|NCT04158141|521168466|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
144536819|NCT04158141|521168467|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
144536820|NCT04121741|521168468|FG000|Overall Study|Protocol Violation|1|||
144536821|NCT04121741|521168469|FG001|Overall Study|Protocol Violation|0|||
144536822|NCT04121741|521168470|FG002|Overall Study|Protocol Violation|0|||
144536823|NCT04121741|521168471|FG003|Overall Study|Protocol Violation|0|||
144536824|NCT04121741|521168472|FG004|Overall Study|Protocol Violation|0|||
144536825|NCT04121741|521168473|FG005|Overall Study|Protocol Violation|0|||
144536826|NCT01084863|521168474|FG000|Main Study Treatment Period|Disease progression|11|||
144536827|NCT01084863|521168475|FG001|Main Study Treatment Period|Disease progression|7|||
144536828|NCT01084863|521168474|FG000|Main Study Treatment Period|Adverse Event|5|||
144536829|NCT01084863|521168475|FG001|Main Study Treatment Period|Adverse Event|3|||
144536830|NCT01084863|521168474|FG000|Main Study Treatment Period|Other Reason|0|||
144536831|NCT01084863|521168475|FG001|Main Study Treatment Period|Other Reason|1|||
144536832|NCT01084863|521168474|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
144536833|NCT01084863|521168475|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
144536834|NCT01084863|521168474|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
144536835|NCT01084863|521168475|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
144536836|NCT01084863|521168474|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
144536837|NCT01084863|521168475|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
144536838|NCT01084863|521168474|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
144536839|NCT01084863|521168475|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
144536840|NCT01084863|521168474|FG000|Treatment Period Beyond Cycle 8|Other|0|||
144536841|NCT01084863|521168475|FG001|Treatment Period Beyond Cycle 8|Other|1|||
144536842|NCT01084863|521168474|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
144536843|NCT01084863|521168475|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
144536844|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
144536845|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
144536846|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
144536847|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
144536848|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
144726475|NCT02768298|521852766|FG000|Overall Study|Non-compliance with study treatment|0|||
144726476|NCT02768298|521852767|FG001|Overall Study|Non-compliance with study treatment|1|||
144726477|NCT02768298|521852766|FG000|Overall Study|Subject/guardian decision|1|||
144536849|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
144536850|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
144536851|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
144536852|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
144536853|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
144536854|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
144536855|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
144536856|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
144536857|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
144536858|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
144536859|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
144536860|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
144536861|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
144536862|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
144536863|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
144536864|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
144536865|NCT04505722|521168476|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
144536866|NCT04505722|521168477|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
144536867|NCT04505722|521168478|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
144536868|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
144536869|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
144536870|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
144536871|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
144536872|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
144536873|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
144536874|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
144726478|NCT02768298|521852767|FG001|Overall Study|Subject/guardian decision|0|||
144726479|NCT02768298|521852766|FG000|Overall Study|Withdrawal of informed consent|0|||
144536875|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
144536876|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
144536877|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
144536878|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
144613417|NCT03021499|521445537|FG000|Overall Study|Lack of Efficacy|0|||
144197455|NCT04709835|519920272|FG000|Overall Study|Withdrawal by Subject|0|||
144197456|NCT04709835|519920273|FG001|Overall Study|Withdrawal by Subject|1|||
144197457|NCT04709835|519920274|FG002|Overall Study|Withdrawal by Subject|0|||
144468698|NCT03837509|520913264|FG004|Phase 1|Death|0|||
144468699|NCT03837509|520913260|FG000|Phase 2|Death|0|||
144468700|NCT03837509|520913261|FG001|Phase 2|Death|0|||
144468701|NCT03837509|520913262|FG002|Phase 2|Death|0|||
144468702|NCT03837509|520913263|FG003|Phase 2|Death|1|||
144468703|NCT03837509|520913264|FG004|Phase 2|Death|1|||
144468704|NCT02173548|520913265|FG000|Overall Study|Lost to Follow-up|0|||
144468705|NCT02173548|520913266|FG001|Overall Study|Lost to Follow-up|2|||
144468706|NCT02173548|520913265|FG000|Overall Study|Withdrawal by Subject|1|||
144468707|NCT02173548|520913266|FG001|Overall Study|Withdrawal by Subject|0|||
144468708|NCT01756352|520913269|FG000|Overall Study|moved away and lost to followup|1|||
144468709|NCT03822117|520913270|FG000|Overall Study|Death|18|||
144468710|NCT03822117|520913271|FG001|Overall Study|Death|17|||
144468711|NCT03822117|520913272|FG002|Overall Study|Death|12|||
144468712|NCT03822117|520913273|FG003|Overall Study|Death|4|||
144468713|NCT03822117|520913270|FG000|Overall Study|Lost to Follow-up|1|||
144468714|NCT03822117|520913271|FG001|Overall Study|Lost to Follow-up|2|||
144468715|NCT03822117|520913272|FG002|Overall Study|Lost to Follow-up|3|||
144468716|NCT03822117|520913273|FG003|Overall Study|Lost to Follow-up|0|||
144468717|NCT03822117|520913270|FG000|Overall Study|Study Terminated by Sponsor|25|||
144468718|NCT03822117|520913271|FG001|Overall Study|Study Terminated by Sponsor|11|||
144468719|NCT03822117|520913272|FG002|Overall Study|Study Terminated by Sponsor|6|||
144468720|NCT03822117|520913273|FG003|Overall Study|Study Terminated by Sponsor|0|||
144468721|NCT03822117|520913270|FG000|Overall Study|Withdrawal by Subject|4|||
144468722|NCT03822117|520913271|FG001|Overall Study|Withdrawal by Subject|0|||
144468723|NCT03822117|520913272|FG002|Overall Study|Withdrawal by Subject|3|||
144468724|NCT03822117|520913273|FG003|Overall Study|Withdrawal by Subject|0|||
144468725|NCT03822117|520913270|FG000|Overall Study|Disease Progression|1|||
144468726|NCT03822117|520913271|FG001|Overall Study|Disease Progression|2|||
144536879|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
144536880|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
144536881|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
144536882|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
144536883|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
144536884|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
144536885|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
144536886|NCT04505722|521168476|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
144536887|NCT04505722|521168477|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
144536888|NCT04505722|521168478|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
144536889|NCT03275285|521168479|FG000|Overall Study|Ongoing|45|||
144536890|NCT03275285|521168480|FG001|Overall Study|Ongoing|69|||
144536891|NCT05827068|521168489|FG000|Overall Study|Lost to Follow-up|1|||
144536892|NCT05827068|521168490|FG001|Overall Study|Lost to Follow-up|4|||
144536893|NCT05827068|521168491|FG002|Overall Study|Lost to Follow-up|1|||
144536894|NCT05827068|521168492|FG003|Overall Study|Lost to Follow-up|1|||
144536895|NCT05827068|521168493|FG004|Overall Study|Lost to Follow-up|2|||
144536896|NCT05827068|521168494|FG005|Overall Study|Lost to Follow-up|4|||
144536897|NCT05827068|521168495|FG006|Overall Study|Lost to Follow-up|1|||
144536898|NCT05827068|521168489|FG000|Overall Study|Withdrawal by Subject|4|||
144536899|NCT05827068|521168490|FG001|Overall Study|Withdrawal by Subject|0|||
144536900|NCT05827068|521168491|FG002|Overall Study|Withdrawal by Subject|1|||
144536901|NCT05827068|521168492|FG003|Overall Study|Withdrawal by Subject|2|||
144536902|NCT05827068|521168493|FG004|Overall Study|Withdrawal by Subject|3|||
144536903|NCT05827068|521168494|FG005|Overall Study|Withdrawal by Subject|0|||
144536904|NCT05827068|521168495|FG006|Overall Study|Withdrawal by Subject|1|||
144536905|NCT05827068|521168489|FG000|Overall Study|Physician Decision|0|||
144536906|NCT05827068|521168490|FG001|Overall Study|Physician Decision|0|||
144536907|NCT05827068|521168491|FG002|Overall Study|Physician Decision|0|||
144536908|NCT05827068|521168492|FG003|Overall Study|Physician Decision|0|||
144536909|NCT05827068|521168493|FG004|Overall Study|Physician Decision|1|||
144536910|NCT05827068|521168494|FG005|Overall Study|Physician Decision|0|||
144536911|NCT05827068|521168495|FG006|Overall Study|Physician Decision|1|||
144536912|NCT05827068|521168489|FG000|Overall Study|Other Than Specified|0|||
144536913|NCT05827068|521168490|FG001|Overall Study|Other Than Specified|1|||
144536914|NCT05827068|521168491|FG002|Overall Study|Other Than Specified|0|||
144536915|NCT05827068|521168492|FG003|Overall Study|Other Than Specified|0|||
144536916|NCT05827068|521168493|FG004|Overall Study|Other Than Specified|0|||
144536917|NCT05827068|521168494|FG005|Overall Study|Other Than Specified|0|||
144536918|NCT05827068|521168495|FG006|Overall Study|Other Than Specified|0|||
144536919|NCT02285270|521169153|FG000|Overall Study|Lost to Follow-up|1|||
144468727|NCT03822117|520913272|FG002|Overall Study|Disease Progression|1|||
144468728|NCT03822117|520913273|FG003|Overall Study|Disease Progression|0|||
144468729|NCT03822117|520913270|FG000|Overall Study|Never Returned to Hospital|0|||
144468730|NCT03822117|520913271|FG001|Overall Study|Never Returned to Hospital|0|||
144468731|NCT03822117|520913272|FG002|Overall Study|Never Returned to Hospital|1|||
144468732|NCT03822117|520913273|FG003|Overall Study|Never Returned to Hospital|0|||
144468733|NCT05131165|520913274|FG000|Overall Study|Death|1|||
144468734|NCT05131165|520913275|FG001|Overall Study|Death|1|||
144613418|NCT03021499|521445538|FG001|Overall Study|Lack of Efficacy|1|||
144613419|NCT03021499|521445537|FG000|Overall Study|Lost to Follow-up|1|||
144468735|NCT05131165|520913276|FG002|Overall Study|Death|0|||
144468736|NCT05131165|520913274|FG000|Overall Study|Lost to Follow-up|2|||
144468737|NCT05131165|520913275|FG001|Overall Study|Lost to Follow-up|2|||
144613420|NCT03021499|521445538|FG001|Overall Study|Lost to Follow-up|3|||
144613421|NCT03021499|521445537|FG000|Overall Study|Physician Decision|2|||
144613422|NCT03021499|521445538|FG001|Overall Study|Physician Decision|3|||
144613423|NCT03021499|521445537|FG000|Overall Study|Pregnancy|1|||
144613424|NCT03021499|521445538|FG001|Overall Study|Pregnancy|0|||
144613425|NCT03021499|521445537|FG000|Overall Study|Withdrawal by Subject|7|||
144613426|NCT03021499|521445538|FG001|Overall Study|Withdrawal by Subject|14|||
144613427|NCT03021499|521445537|FG000|Overall Study|Prohibited medication required|1|||
144613428|NCT03021499|521445538|FG001|Overall Study|Prohibited medication required|0|||
144613429|NCT03021499|521445537|FG000|Overall Study|Protocol non-compliance|1|||
144613430|NCT03021499|521445538|FG001|Overall Study|Protocol non-compliance|1|||
144613431|NCT03021499|521445537|FG000|Overall Study|None of the above|0|||
144613432|NCT03021499|521445538|FG001|Overall Study|None of the above|4|||
144613433|NCT03021499|521445537|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
144613434|NCT03021499|521445538|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
144613435|NCT01210690|521445539|FG000|Overall Study|Adverse Event|7|||
144613436|NCT01210690|521445539|FG000|Overall Study|Lack of Efficacy|12|||
144613437|NCT01210690|521445539|FG000|Overall Study|Lost to Follow-up|3|||
144613438|NCT01210690|521445539|FG000|Overall Study|Disease Remission|1|||
144613439|NCT01210690|521445539|FG000|Overall Study|Withdrawal by Subject|1|||
144613440|NCT01210690|521445539|FG000|Overall Study|Patient refused to swallow|1|||
144613441|NCT01210690|521445539|FG000|Overall Study|Patient could not take glucose|1|||
144613442|NCT00495820|521445540|FG000|Overall Study|Adverse Event|1|||
144613443|NCT00495820|521445541|FG001|Overall Study|Adverse Event|1|||
144613444|NCT00470054|521445542|FG000|Overall Study|Ineligible|1|||
144613445|NCT00820950|521445543|FG000|Overall Study|Scheduling Conflict|0|||
144258368|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
144468738|NCT05131165|520913276|FG002|Overall Study|Lost to Follow-up|5|||
144468739|NCT05131165|520913274|FG000|Overall Study|Transferred out of clinic|1|||
144468740|NCT05131165|520913275|FG001|Overall Study|Transferred out of clinic|0|||
144468741|NCT05131165|520913276|FG002|Overall Study|Transferred out of clinic|3|||
144468742|NCT05131165|520913274|FG000|Overall Study|Dropped out|1|||
144536920|NCT02285270|521169153|FG000|Overall Study|Physician Decision|3|||
144536921|NCT02285270|521169153|FG000|Overall Study|Determined to be ineligible|1|||
144536922|NCT02284113|521169155|FG000|Overall Study|Adverse Event|1|||
144536923|NCT02284113|521169156|FG001|Overall Study|Adverse Event|0|||
144536924|NCT02284113|521169155|FG000|Overall Study|non-compliance|0|||
144613446|NCT00820950|521445544|FG001|Overall Study|Scheduling Conflict|0|||
144613447|NCT00820950|521445545|FG002|Overall Study|Scheduling Conflict|0|||
144613448|NCT00820950|521445546|FG003|Overall Study|Scheduling Conflict|0|||
144613449|NCT00820950|521445547|FG004|Overall Study|Scheduling Conflict|0|||
144613450|NCT00820950|521445548|FG005|Overall Study|Scheduling Conflict|0|||
144613451|NCT00820950|521445549|FG006|Overall Study|Scheduling Conflict|1|||
144613452|NCT00820950|521445550|FG007|Overall Study|Scheduling Conflict|1|||
144613453|NCT00820950|521445551|FG008|Overall Study|Scheduling Conflict|0|||
144613454|NCT00820950|521445552|FG009|Overall Study|Scheduling Conflict|0|||
144613455|NCT00820950|521445543|FG000|Overall Study|Protocol Violation|1|||
144613456|NCT00820950|521445544|FG001|Overall Study|Protocol Violation|1|||
144613457|NCT00820950|521445545|FG002|Overall Study|Protocol Violation|0|||
144613458|NCT00820950|521445546|FG003|Overall Study|Protocol Violation|0|||
144613459|NCT00820950|521445547|FG004|Overall Study|Protocol Violation|0|||
144613460|NCT00820950|521445548|FG005|Overall Study|Protocol Violation|0|||
144613461|NCT00820950|521445549|FG006|Overall Study|Protocol Violation|0|||
144613462|NCT00820950|521445550|FG007|Overall Study|Protocol Violation|0|||
144536925|NCT02284113|521169156|FG001|Overall Study|non-compliance|1|||
144613463|NCT00820950|521445551|FG008|Overall Study|Protocol Violation|0|||
144613464|NCT00820950|521445552|FG009|Overall Study|Protocol Violation|0|||
144613465|NCT00528021|521445558|FG000|Overall Study|Lack of Efficacy|17|||
144613466|NCT00528021|521445559|FG001|Overall Study|Lack of Efficacy|13|||
144613467|NCT00528021|521445560|FG002|Overall Study|Lack of Efficacy|7|||
144613468|NCT00528021|521445561|FG003|Overall Study|Lack of Efficacy|9|||
144536926|NCT02284113|521169155|FG000|Overall Study|Withdrawal by Subject|0|||
144536927|NCT02284113|521169156|FG001|Overall Study|Withdrawal by Subject|1|||
144536928|NCT02284113|521169155|FG000|Overall Study|not provided|0|||
144468743|NCT05131165|520913275|FG001|Overall Study|Dropped out|2|||
144468744|NCT05131165|520913276|FG002|Overall Study|Dropped out|0|||
144468745|NCT04539821|520913284|FG000|Overall Study|Withdrawal by Subject|2|||
144468746|NCT04539821|520913284|FG000|Overall Study|continued care with their physician|20|||
144536929|NCT02284113|521169156|FG001|Overall Study|not provided|1|||
144613469|NCT04050982|521445562|FG000|Overall Study|Did not meet eligibility criteria|0|||
144613470|NCT04050982|521445563|FG001|Overall Study|Did not meet eligibility criteria|1|||
144613471|NCT04050982|521445564|FG002|Overall Study|Did not meet eligibility criteria|0|||
144468747|NCT04539821|520913284|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
144613472|NCT04050982|521445562|FG000|Overall Study|Withdrawal by Subject|1|||
144613473|NCT04050982|521445563|FG001|Overall Study|Withdrawal by Subject|0|||
144613474|NCT04050982|521445564|FG002|Overall Study|Withdrawal by Subject|0|||
144613475|NCT04050982|521445562|FG000|Overall Study|Unable to enroll on platform|1|||
144613476|NCT04050982|521445563|FG001|Overall Study|Unable to enroll on platform|0|||
144613477|NCT04050982|521445564|FG002|Overall Study|Unable to enroll on platform|0|||
144613478|NCT01246583|521445565|FG000|Overall Study|Lost to Follow-up|0|||
144613479|NCT01246583|521445566|FG001|Overall Study|Lost to Follow-up|0|||
144613480|NCT01246583|521445567|FG002|Overall Study|Lost to Follow-up|0|||
144613481|NCT01246583|521445568|FG003|Overall Study|Lost to Follow-up|1|||
144613482|NCT01246583|521445565|FG000|Overall Study|Protocol Violation|0|||
144613483|NCT01246583|521445566|FG001|Overall Study|Protocol Violation|0|||
144613484|NCT01246583|521445567|FG002|Overall Study|Protocol Violation|1|||
144613485|NCT01246583|521445568|FG003|Overall Study|Protocol Violation|0|||
144613486|NCT01246583|521445565|FG000|Overall Study|Withdrawal by Subject|1|||
144613487|NCT01246583|521445566|FG001|Overall Study|Withdrawal by Subject|0|||
144613488|NCT01246583|521445567|FG002|Overall Study|Withdrawal by Subject|0|||
144613489|NCT01246583|521445568|FG003|Overall Study|Withdrawal by Subject|0|||
144613490|NCT02116777|521445569|FG000|Overall Study|Adverse Event|0|||
144613491|NCT02116777|521445570|FG001|Overall Study|Adverse Event|0|||
144468748|NCT02563002|520913287|FG000|Overall Study|Death|72|||
144468749|NCT02563002|520913288|FG001|Overall Study|Death|87|||
144468750|NCT02563002|520913287|FG000|Overall Study|Lost to Follow-up|5|||
144468751|NCT02563002|520913288|FG001|Overall Study|Lost to Follow-up|0|||
144468752|NCT02563002|520913287|FG000|Overall Study|Physician Decision|0|||
144468753|NCT02563002|520913288|FG001|Overall Study|Physician Decision|2|||
144468754|NCT02563002|520913287|FG000|Overall Study|Withdrawal by Subject|2|||
144468755|NCT02563002|520913288|FG001|Overall Study|Withdrawal by Subject|10|||
144468756|NCT02563002|520913287|FG000|Overall Study|Sponsor decision|74|||
144468757|NCT02563002|520913288|FG001|Overall Study|Sponsor decision|55|||
144468758|NCT01804816|520913300|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
144468759|NCT01804816|520913300|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
144468760|NCT01256411|520913303|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
144468761|NCT01256411|520913304|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
144468762|NCT01256411|520913305|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
144468763|NCT01256411|520913306|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
144468764|NCT01256411|520913307|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
144468765|NCT01256411|520913308|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
144468766|NCT01256411|520913303|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
144468767|NCT01256411|520913304|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
144468768|NCT01256411|520913305|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
144468769|NCT01256411|520913306|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
144468770|NCT01256411|520913307|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
144468771|NCT01256411|520913308|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
144468772|NCT01256411|520913303|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
144468773|NCT01256411|520913304|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
144468774|NCT01256411|520913305|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
144468775|NCT01256411|520913306|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
144468776|NCT01256411|520913307|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
144468777|NCT01256411|520913308|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
144468778|NCT01256411|520913303|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
144468779|NCT01256411|520913304|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
144468780|NCT01256411|520913305|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
144468781|NCT01256411|520913306|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
144468782|NCT01256411|520913307|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
144613492|NCT02116777|521445571|FG002|Overall Study|Adverse Event|0|||
144613493|NCT02116777|521445572|FG003|Overall Study|Adverse Event|0|||
144613494|NCT02116777|521445573|FG004|Overall Study|Adverse Event|2|||
144613495|NCT02116777|521445574|FG005|Overall Study|Adverse Event|2|||
144613496|NCT02116777|521445575|FG006|Overall Study|Adverse Event|0|||
144613497|NCT02116777|521445569|FG000|Overall Study|Death|0|||
144613498|NCT02116777|521445570|FG001|Overall Study|Death|0|||
144613499|NCT02116777|521445571|FG002|Overall Study|Death|0|||
144613500|NCT02116777|521445572|FG003|Overall Study|Death|1|||
144468783|NCT01256411|520913308|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
144468784|NCT01256411|520913303|FG000|Extension by Maximum Treatment|Adverse Event|4|||
144468785|NCT01256411|520913304|FG001|Extension by Maximum Treatment|Adverse Event|2|||
144613501|NCT02116777|521445573|FG004|Overall Study|Death|0|||
144613502|NCT02116777|521445574|FG005|Overall Study|Death|0|||
144613503|NCT02116777|521445575|FG006|Overall Study|Death|0|||
144613504|NCT02116777|521445569|FG000|Overall Study|Lack of Efficacy|3|||
144613505|NCT02116777|521445570|FG001|Overall Study|Lack of Efficacy|3|||
144613506|NCT02116777|521445571|FG002|Overall Study|Lack of Efficacy|3|||
144613507|NCT02116777|521445572|FG003|Overall Study|Lack of Efficacy|8|||
144613508|NCT02116777|521445573|FG004|Overall Study|Lack of Efficacy|4|||
144613509|NCT02116777|521445574|FG005|Overall Study|Lack of Efficacy|1|||
144613510|NCT02116777|521445575|FG006|Overall Study|Lack of Efficacy|9|||
144613511|NCT02116777|521445569|FG000|Overall Study|Physician Decision|0|||
144613512|NCT02116777|521445570|FG001|Overall Study|Physician Decision|0|||
144613513|NCT02116777|521445571|FG002|Overall Study|Physician Decision|0|||
144613514|NCT02116777|521445572|FG003|Overall Study|Physician Decision|2|||
144613515|NCT02116777|521445573|FG004|Overall Study|Physician Decision|0|||
144613516|NCT02116777|521445574|FG005|Overall Study|Physician Decision|0|||
144468786|NCT01256411|520913305|FG002|Extension by Maximum Treatment|Adverse Event|1|||
144468787|NCT01256411|520913306|FG003|Extension by Maximum Treatment|Adverse Event|0|||
144468788|NCT01256411|520913307|FG004|Extension by Maximum Treatment|Adverse Event|0|||
144468789|NCT01256411|520913308|FG005|Extension by Maximum Treatment|Adverse Event|0|||
144468790|NCT01256411|520913303|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
144468791|NCT01256411|520913304|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
144468792|NCT01256411|520913305|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
144468793|NCT01256411|520913306|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
144468794|NCT01256411|520913307|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
144468795|NCT01256411|520913308|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
144468796|NCT01256411|520913303|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
144468797|NCT01256411|520913304|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
144468798|NCT01256411|520913305|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
144468799|NCT01256411|520913306|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
144468800|NCT01256411|520913307|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
144468801|NCT01256411|520913308|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
144468802|NCT01256411|520913303|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
144468803|NCT01256411|520913304|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
144468804|NCT01256411|520913305|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
144468805|NCT01256411|520913306|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
144468806|NCT01256411|520913307|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
144468807|NCT01256411|520913308|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
144468808|NCT01256411|520913303|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
144468809|NCT01256411|520913304|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
144468810|NCT01256411|520913305|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
144468811|NCT01256411|520913306|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
144468812|NCT01256411|520913307|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
144468813|NCT01256411|520913308|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
144468814|NCT01256411|520913303|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
144468815|NCT01256411|520913304|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
144468816|NCT01256411|520913305|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
144468817|NCT01256411|520913306|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
144468818|NCT01256411|520913307|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
144468819|NCT01256411|520913308|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
144468820|NCT00929162|520913309|FG000|Overall Study|Adverse Event|8|||
144468821|NCT00929162|520913310|FG001|Overall Study|Adverse Event|5|||
144468822|NCT00929162|520913309|FG000|Overall Study|Withdrawal by Subject|3|||
144468823|NCT00929162|520913310|FG001|Overall Study|Withdrawal by Subject|1|||
144468824|NCT00929162|520913309|FG000|Overall Study|Protocol Violation|32|||
144468825|NCT00929162|520913310|FG001|Overall Study|Protocol Violation|30|||
144468826|NCT00929162|520913309|FG000|Overall Study|Other termination reason|5|||
144468827|NCT00929162|520913310|FG001|Overall Study|Other termination reason|6|||
144468828|NCT01822587|520913311|FG000|Overall Study|Lost to Follow-up|7|||
144468829|NCT01822587|520913312|FG001|Overall Study|Lost to Follow-up|9|||
144468830|NCT01822587|520913313|FG002|Overall Study|Lost to Follow-up|12|||
144468831|NCT01822587|520913311|FG000|Overall Study|Physician Decision|9|||
144468832|NCT01822587|520913312|FG001|Overall Study|Physician Decision|6|||
144468833|NCT01822587|520913313|FG002|Overall Study|Physician Decision|6|||
144468834|NCT01274182|520913314|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
144468835|NCT01274182|520913315|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144468836|NCT01274182|520913316|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
144468837|NCT01274182|520913314|FG000|Overall Study|Adverse Event|4|||
144468838|NCT01274182|520913315|FG001|Overall Study|Adverse Event|5|||
144468839|NCT01274182|520913316|FG002|Overall Study|Adverse Event|3|||
144468840|NCT01274182|520913314|FG000|Overall Study|Withdrawal by Subject|5|||
144468841|NCT01274182|520913315|FG001|Overall Study|Withdrawal by Subject|5|||
144468842|NCT01274182|520913316|FG002|Overall Study|Withdrawal by Subject|3|||
144468843|NCT01274182|520913314|FG000|Overall Study|Lost to Follow-up|2|||
144468844|NCT01274182|520913315|FG001|Overall Study|Lost to Follow-up|3|||
144468845|NCT01274182|520913316|FG002|Overall Study|Lost to Follow-up|1|||
144468846|NCT01274182|520913314|FG000|Overall Study|Protocol Violation|3|||
144468847|NCT01274182|520913315|FG001|Overall Study|Protocol Violation|2|||
144613517|NCT02116777|521445575|FG006|Overall Study|Physician Decision|0|||
144613518|NCT02116777|521445569|FG000|Overall Study|Protocol Violation|0|||
144468848|NCT01274182|520913316|FG002|Overall Study|Protocol Violation|0|||
144468849|NCT01274182|520913314|FG000|Overall Study|Death|1|||
144468850|NCT01274182|520913315|FG001|Overall Study|Death|0|||
144468851|NCT01274182|520913316|FG002|Overall Study|Death|1|||
144468852|NCT00117676|520913317|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
144468853|NCT00117676|520913318|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
144468854|NCT00117676|520913317|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
144468855|NCT00117676|520913318|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
144468856|NCT00117676|520913317|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
144468857|NCT00117676|520913318|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
144468858|NCT00117676|520913317|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
144468859|NCT00117676|520913318|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
144468860|NCT00117676|520913317|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
144468861|NCT00117676|520913318|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
144468862|NCT00117676|520913317|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
144468863|NCT00117676|520913318|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
144468864|NCT00117676|520913317|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
144468865|NCT00117676|520913318|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
144468866|NCT00117676|520913317|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
144468867|NCT00117676|520913318|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
144468868|NCT00117676|520913317|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
144468869|NCT00117676|520913318|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
144468870|NCT00117676|520913317|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
144468871|NCT00117676|520913318|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
144468872|NCT00117676|520913317|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
144468873|NCT00117676|520913318|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
144468874|NCT00117676|520913317|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
144468875|NCT00117676|520913318|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
144468876|NCT00117676|520913317|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
144468877|NCT00117676|520913318|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
144468878|NCT00117676|520913317|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
144468879|NCT00117676|520913318|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
144468880|NCT00117676|520913317|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
144468881|NCT00117676|520913318|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
144468882|NCT00117676|520913317|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
144468883|NCT00117676|520913318|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
144468884|NCT00117676|520913317|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
144468885|NCT00117676|520913318|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
144468886|NCT00117676|520913317|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
144468887|NCT00117676|520913318|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
144468888|NCT00117676|520913317|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
144468889|NCT00117676|520913318|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
144468890|NCT00117676|520913317|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
144468891|NCT00117676|520913318|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
144468892|NCT00117676|520913317|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
144468893|NCT00117676|520913318|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
144468894|NCT00117676|520913317|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
144468895|NCT00117676|520913318|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
144468896|NCT00117676|520913317|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
144468897|NCT00117676|520913318|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
144468898|NCT00117676|520913317|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
144468899|NCT00117676|520913318|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
144468900|NCT00117676|520913317|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
144468901|NCT00117676|520913318|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
144468902|NCT00117676|520913317|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
144468903|NCT00117676|520913318|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
144468904|NCT00117676|520913317|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
144468905|NCT00117676|520913318|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
144468906|NCT00117676|520913317|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
144468907|NCT00117676|520913318|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
144468908|NCT00117676|520913317|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
144468909|NCT00117676|520913318|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
144468910|NCT00117676|520913317|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
144468911|NCT00117676|520913318|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
144468912|NCT00117676|520913317|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
144468913|NCT00117676|520913318|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
144468914|NCT00117676|520913317|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
144468915|NCT00117676|520913318|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
144468916|NCT00117676|520913317|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
144468917|NCT00117676|520913318|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
144468918|NCT00117676|520913317|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
144468919|NCT00117676|520913318|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
144468920|NCT00117676|520913317|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
144468921|NCT00117676|520913318|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
144468922|NCT00952822|520913319|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
144468923|NCT00952822|520913320|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
144468924|NCT00952822|520913321|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
144468925|NCT00952822|520913322|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
144468926|NCT00952822|520913319|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
144468927|NCT00952822|520913320|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
144468928|NCT00952822|520913321|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
144468929|NCT00952822|520913322|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
144468930|NCT03440372|520913325|FG000|Treatment|Adverse Event|16|||
144468931|NCT03440372|520913326|FG001|Treatment|Adverse Event|8|||
144468932|NCT03440372|520913325|FG000|Treatment|Lack of Efficacy|4|||
144468933|NCT03440372|520913326|FG001|Treatment|Lack of Efficacy|2|||
144468934|NCT03440372|520913325|FG000|Treatment|Withdrawal by Subject|12|||
144468935|NCT03440372|520913326|FG001|Treatment|Withdrawal by Subject|8|||
144468936|NCT03440372|520913325|FG000|Treatment|Lost to Follow-up|1|||
144468937|NCT03440372|520913326|FG001|Treatment|Lost to Follow-up|0|||
144468938|NCT03440372|520913325|FG000|Treatment|Pregnancy|1|||
144468939|NCT03440372|520913326|FG001|Treatment|Pregnancy|0|||
144468940|NCT03440372|520913325|FG000|Treatment|Study Terminated by Sponsor|2|||
144468941|NCT03440372|520913326|FG001|Treatment|Study Terminated by Sponsor|1|||
144468942|NCT03440372|520913325|FG000|Treatment|Other Reason|2|||
144468943|NCT03440372|520913326|FG001|Treatment|Other Reason|3|||
144468944|NCT00448448|520913327|FG000|Overall Study|Withdrawal by Subject|13|||
144468945|NCT00448448|520913328|FG001|Overall Study|Withdrawal by Subject|2|||
144468946|NCT00448448|520913327|FG000|Overall Study|On protocol when study ended|83|||
144468947|NCT00448448|520913328|FG001|Overall Study|On protocol when study ended|36|||
144468948|NCT00448448|520913327|FG000|Overall Study|Lost to Follow-up|2|||
144468949|NCT00448448|520913328|FG001|Overall Study|Lost to Follow-up|1|||
144468950|NCT00448448|520913327|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
144468951|NCT00448448|520913328|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
144468952|NCT00448448|520913327|FG000|Overall Study|Signed consent lost|0|||
144468953|NCT00448448|520913328|FG001|Overall Study|Signed consent lost|1|||
144468954|NCT02660827|520913331|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
144468955|NCT02660827|520913331|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
144468956|NCT02660827|520913331|FG000|From Study to End of Continued Access|Adverse Event|3|||
144468957|NCT02660827|520913331|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
144468958|NCT02660827|520913331|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
144468959|NCT02660827|520913331|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
144468960|NCT02660827|520913331|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
144468961|NCT02660827|520913331|FG000|Period 2: Continued Access Period|Adverse Event|3|||
144468962|NCT01422408|520913332|FG000|Overall Study|Adverse Event|1|||
144468963|NCT01422408|520913332|FG000|Overall Study|Withdrawal by Subject|3|||
144468964|NCT04672941|520913333|FG000|Overall Study|Investigator decision|1|||
144468965|NCT04672941|520913333|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
144468966|NCT04672941|520913333|FG000|Overall Study|COVID-19 related but no adverse event|1|||
144468967|NCT04672941|520913333|FG000|Overall Study|Adverse Event|2|||
144468968|NCT04672941|520913333|FG000|Overall Study|Lost to Follow-up|2|||
144468969|NCT02953938|520913334|FG000|Overall Study|Adverse Event|0|||
144536930|NCT02284113|521169155|FG000|Overall Study|surgery cancelled|2|||
144536931|NCT02284113|521169156|FG001|Overall Study|surgery cancelled|0|||
144468970|NCT02953938|520913335|FG001|Overall Study|Adverse Event|1|||
144468971|NCT02953938|520913334|FG000|Overall Study|Withdrawal by Subject|1|||
144468972|NCT02953938|520913335|FG001|Overall Study|Withdrawal by Subject|1|||
144468973|NCT00453986|520913336|FG000|Overall Study|Lost to Follow-up|6|||
144468974|NCT00453986|520913337|FG001|Overall Study|Lost to Follow-up|5|||
144468975|NCT00453986|520913338|FG002|Overall Study|Lost to Follow-up|6|||
144468976|NCT00453986|520913339|FG003|Overall Study|Lost to Follow-up|2|||
144468977|NCT00453986|520913340|FG004|Overall Study|Lost to Follow-up|0|||
144536932|NCT04191824|521169157|FG000|Overall Study|Death|13|||
144197458|NCT01859130|519920275|FG000|Overall Study|Death|4|||
144468978|NCT01659151|520913341|FG000|Overall Study|Inadequate TIL growth|1|||
144468979|NCT06223373|520913345|FG000|Overall Study|Lost to Follow-up|1|||
144536933|NCT04191824|521169158|FG001|Overall Study|Death|12|||
144536934|NCT04191824|521169157|FG000|Overall Study|Lost to Follow-up|456|||
144536935|NCT04191824|521169158|FG001|Overall Study|Lost to Follow-up|435|||
144536936|NCT04191824|521169157|FG000|Overall Study|Physician Decision|2|||
144536937|NCT04191824|521169158|FG001|Overall Study|Physician Decision|1|||
144536938|NCT04191824|521169157|FG000|Overall Study|Protocol Violation|0|||
144536939|NCT04191824|521169158|FG001|Overall Study|Protocol Violation|2|||
144536940|NCT04191824|521169157|FG000|Overall Study|Withdrawal by Subject|16|||
144536941|NCT04191824|521169158|FG001|Overall Study|Withdrawal by Subject|18|||
144536942|NCT04191824|521169157|FG000|Overall Study|Early site closure|24|||
144536943|NCT04191824|521169158|FG001|Overall Study|Early site closure|22|||
144536944|NCT01218009|521169159|FG000|Overall Study|Protocol Violation|2|||
144536945|NCT01218009|521169160|FG001|Overall Study|Protocol Violation|1|||
144536946|NCT01218009|521169159|FG000|Overall Study|Withdrawal by Subject|3|||
144536947|NCT01218009|521169160|FG001|Overall Study|Withdrawal by Subject|1|||
144536948|NCT01218009|521169159|FG000|Overall Study|Sponsor terminated study|161|||
144536949|NCT01218009|521169160|FG001|Overall Study|Sponsor terminated study|163|||
144536950|NCT01324310|521169161|FG000|Overall Study|Adverse Event|1|||
144536951|NCT01324310|521169161|FG000|Overall Study|Disease Progression|1|||
144536952|NCT03170882|521169162|FG000|Overall Study|Death|17|||
144536953|NCT03170882|521169163|FG001|Overall Study|Death|29|||
144536954|NCT03170882|521169162|FG000|Overall Study|Lost to Follow-up|0|||
144536955|NCT03170882|521169163|FG001|Overall Study|Lost to Follow-up|1|||
144536956|NCT03170882|521169162|FG000|Overall Study|Withdrawal by Subject|4|||
144536957|NCT03170882|521169163|FG001|Overall Study|Withdrawal by Subject|7|||
144536958|NCT03170882|521169162|FG000|Overall Study|Reason not Specified|28|||
144536959|NCT03170882|521169163|FG001|Overall Study|Reason not Specified|36|||
144536960|NCT00087685|521169164|FG000|Overall Study|Adverse Event|5|||
144536961|NCT00087685|521169164|FG000|Overall Study|Non-Compliance|1|||
144536962|NCT00087685|521169164|FG000|Overall Study|Progressive Disease|5|||
144536963|NCT00087685|521169164|FG000|Overall Study|Withdrawal by Subject|3|||
144536964|NCT01830595|521169165|FG000|First Period|Withdrawal by Subject|1|||
144536965|NCT01830595|521169166|FG001|First Period|Withdrawal by Subject|3|||
144536966|NCT01830595|521169165|FG000|Washout|Withdrawal by Subject|2|||
144536967|NCT01830595|521169166|FG001|Washout|Withdrawal by Subject|2|||
144536968|NCT04018495|521169167|FG000|Overall Study|Physician Decision|1|||
144536969|NCT05116774|521169168|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
144536970|NCT05116774|521169169|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
144536971|NCT05116774|521169168|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
144536972|NCT05116774|521169169|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
144536973|NCT05116774|521169168|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
144536974|NCT05116774|521169169|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
144536975|NCT05116774|521169168|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
144536976|NCT05116774|521169169|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
144536977|NCT04305327|521169170|FG000|Overall Study|Study early termination|2|||
144536978|NCT04305327|521169171|FG001|Overall Study|Study early termination|5|||
144536979|NCT04305327|521169172|FG002|Overall Study|Study early termination|2|||
144536980|NCT04305327|521169173|FG003|Overall Study|Study early termination|2|||
144536981|NCT04305327|521169170|FG000|Overall Study|Withdrawal by Subject|0|||
144536982|NCT04305327|521169171|FG001|Overall Study|Withdrawal by Subject|1|||
144536983|NCT04305327|521169172|FG002|Overall Study|Withdrawal by Subject|0|||
144536984|NCT04305327|521169173|FG003|Overall Study|Withdrawal by Subject|0|||
144536985|NCT00115934|521169174|FG000|Overall Study|Lost to Follow-up|1|||
144536986|NCT00115934|521169175|FG001|Overall Study|Lost to Follow-up|0|||
144536987|NCT00115934|521169174|FG000|Overall Study|Did not receive intervention|3|||
144536988|NCT00115934|521169175|FG001|Overall Study|Did not receive intervention|2|||
144536989|NCT00747565|521169176|FG000|Overall Study|Withdrawal by Subject|10|||
144536990|NCT00747565|521169177|FG001|Overall Study|Withdrawal by Subject|6|||
144536991|NCT00747565|521169176|FG000|Overall Study|Lost to Follow-up|4|||
144536992|NCT00747565|521169177|FG001|Overall Study|Lost to Follow-up|1|||
144536993|NCT01983683|521169178|FG000|Overall Study|Withdrawal by Subject|14|||
144536994|NCT01983683|521169179|FG001|Overall Study|Withdrawal by Subject|18|||
144536995|NCT01983683|521169178|FG000|Overall Study|Death|11|||
144536996|NCT01983683|521169179|FG001|Overall Study|Death|15|||
144536997|NCT01983683|521169178|FG000|Overall Study|Physician Decision|8|||
144536998|NCT01983683|521169179|FG001|Overall Study|Physician Decision|9|||
144536999|NCT01983683|521169178|FG000|Overall Study|Lost to Follow-up|4|||
144537000|NCT01983683|521169179|FG001|Overall Study|Lost to Follow-up|8|||
144537001|NCT01983683|521169178|FG000|Overall Study|Sponsor Decision|1|||
144537002|NCT01983683|521169179|FG001|Overall Study|Sponsor Decision|1|||
144537003|NCT04882917|521169187|FG000|Overall Study|Adverse Event|0|||
144537004|NCT04882917|521169188|FG001|Overall Study|Adverse Event|1|||
144537005|NCT04882917|521169189|FG002|Overall Study|Adverse Event|2|||
144537006|NCT04882917|521169190|FG003|Overall Study|Adverse Event|2|||
144537007|NCT04882917|521169187|FG000|Overall Study|Withdrawal by Subject|1|||
144537008|NCT04882917|521169188|FG001|Overall Study|Withdrawal by Subject|0|||
144537009|NCT04882917|521169189|FG002|Overall Study|Withdrawal by Subject|2|||
144537010|NCT04882917|521169190|FG003|Overall Study|Withdrawal by Subject|1|||
144537011|NCT04882917|521169187|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
144468980|NCT06223373|520913346|FG001|Overall Study|Lost to Follow-up|2|||
144468981|NCT04981678|520913348|FG000|Overall Study|Lost to Follow-up|0|||
144468982|NCT04981678|520913349|FG001|Overall Study|Lost to Follow-up|1|||
144468983|NCT03421808|520913350|FG000|Overall Study|COVID related problems|2|||
144468984|NCT03421808|520913351|FG001|Overall Study|COVID related problems|0|||
144468985|NCT03421808|520913350|FG000|Overall Study|Withdrawal by Subject|1|||
144468986|NCT03421808|520913351|FG001|Overall Study|Withdrawal by Subject|0|||
144468987|NCT03421808|520913350|FG000|Overall Study|Protocol Violation|0|||
144468988|NCT03421808|520913351|FG001|Overall Study|Protocol Violation|1|||
144468989|NCT03764774|520913352|FG000|Overall Study|Withdrawal by Subject|0|||
144468990|NCT03764774|520913353|FG001|Overall Study|Withdrawal by Subject|0|||
144468991|NCT03764774|520913354|FG002|Overall Study|Withdrawal by Subject|0|||
144468992|NCT03764774|520913355|FG003|Overall Study|Withdrawal by Subject|0|||
144468993|NCT03764774|520913356|FG004|Overall Study|Withdrawal by Subject|0|||
144468994|NCT03764774|520913357|FG005|Overall Study|Withdrawal by Subject|0|||
144468995|NCT03764774|520913358|FG006|Overall Study|Withdrawal by Subject|0|||
144468996|NCT03764774|520913359|FG007|Overall Study|Withdrawal by Subject|0|||
144468997|NCT03764774|520913360|FG008|Overall Study|Withdrawal by Subject|0|||
144468998|NCT03764774|520913361|FG009|Overall Study|Withdrawal by Subject|0|||
144468999|NCT03764774|520913362|FG010|Overall Study|Withdrawal by Subject|1|||
144469000|NCT03764774|520913363|FG011|Overall Study|Withdrawal by Subject|0|||
144469001|NCT03764774|520913364|FG012|Overall Study|Withdrawal by Subject|0|||
144469002|NCT03764774|520913365|FG013|Overall Study|Withdrawal by Subject|0|||
144469003|NCT03764774|520913352|FG000|Overall Study|Adverse Event|0|||
144469004|NCT03764774|520913353|FG001|Overall Study|Adverse Event|0|||
144469005|NCT03764774|520913354|FG002|Overall Study|Adverse Event|0|||
144469006|NCT03764774|520913355|FG003|Overall Study|Adverse Event|0|||
144469007|NCT03764774|520913356|FG004|Overall Study|Adverse Event|0|||
144469008|NCT03764774|520913357|FG005|Overall Study|Adverse Event|0|||
144469009|NCT03764774|520913358|FG006|Overall Study|Adverse Event|0|||
144469010|NCT03764774|520913359|FG007|Overall Study|Adverse Event|0|||
144469011|NCT03764774|520913360|FG008|Overall Study|Adverse Event|0|||
144469012|NCT03764774|520913361|FG009|Overall Study|Adverse Event|0|||
144469013|NCT03764774|520913362|FG010|Overall Study|Adverse Event|0|||
144469014|NCT03764774|520913363|FG011|Overall Study|Adverse Event|0|||
144469015|NCT03764774|520913364|FG012|Overall Study|Adverse Event|2|||
144469016|NCT03764774|520913365|FG013|Overall Study|Adverse Event|0|||
144469017|NCT03764774|520913352|FG000|Overall Study|Lost to Follow-up|0|||
144469018|NCT03764774|520913353|FG001|Overall Study|Lost to Follow-up|0|||
144469019|NCT03764774|520913354|FG002|Overall Study|Lost to Follow-up|0|||
144469020|NCT03764774|520913355|FG003|Overall Study|Lost to Follow-up|0|||
144469021|NCT03764774|520913356|FG004|Overall Study|Lost to Follow-up|0|||
144469022|NCT03764774|520913357|FG005|Overall Study|Lost to Follow-up|0|||
144469023|NCT03764774|520913358|FG006|Overall Study|Lost to Follow-up|0|||
144469024|NCT03764774|520913359|FG007|Overall Study|Lost to Follow-up|0|||
144469025|NCT03764774|520913360|FG008|Overall Study|Lost to Follow-up|0|||
144469026|NCT03764774|520913361|FG009|Overall Study|Lost to Follow-up|0|||
144469027|NCT03764774|520913362|FG010|Overall Study|Lost to Follow-up|0|||
144469028|NCT03764774|520913363|FG011|Overall Study|Lost to Follow-up|0|||
144469029|NCT03764774|520913364|FG012|Overall Study|Lost to Follow-up|0|||
144469030|NCT03764774|520913365|FG013|Overall Study|Lost to Follow-up|1|||
144469031|NCT03764774|520913352|FG000|Overall Study|Physician Decision|0|||
144469032|NCT03764774|520913353|FG001|Overall Study|Physician Decision|0|||
144469033|NCT03764774|520913354|FG002|Overall Study|Physician Decision|0|||
144469034|NCT03764774|520913355|FG003|Overall Study|Physician Decision|0|||
144469035|NCT03764774|520913356|FG004|Overall Study|Physician Decision|0|||
144469036|NCT03764774|520913357|FG005|Overall Study|Physician Decision|0|||
144469037|NCT03764774|520913358|FG006|Overall Study|Physician Decision|0|||
144469038|NCT03764774|520913359|FG007|Overall Study|Physician Decision|0|||
144469039|NCT03764774|520913360|FG008|Overall Study|Physician Decision|0|||
144469040|NCT03764774|520913361|FG009|Overall Study|Physician Decision|4|||
144258369|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
144258370|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
144469041|NCT03764774|520913362|FG010|Overall Study|Physician Decision|1|||
144469042|NCT03764774|520913363|FG011|Overall Study|Physician Decision|4|||
144469043|NCT03764774|520913364|FG012|Overall Study|Physician Decision|9|||
144469044|NCT03764774|520913365|FG013|Overall Study|Physician Decision|0|||
144469045|NCT03764774|520913352|FG000|Overall Study|Study Termination|0|||
144469046|NCT03764774|520913353|FG001|Overall Study|Study Termination|0|||
144469047|NCT03764774|520913354|FG002|Overall Study|Study Termination|0|||
144469048|NCT03764774|520913355|FG003|Overall Study|Study Termination|0|||
144469049|NCT03764774|520913356|FG004|Overall Study|Study Termination|0|||
144469050|NCT03764774|520913357|FG005|Overall Study|Study Termination|0|||
144469051|NCT03764774|520913358|FG006|Overall Study|Study Termination|0|||
144469052|NCT03764774|520913359|FG007|Overall Study|Study Termination|0|||
144469053|NCT03764774|520913360|FG008|Overall Study|Study Termination|0|||
144469054|NCT03764774|520913361|FG009|Overall Study|Study Termination|1|||
144469055|NCT03764774|520913362|FG010|Overall Study|Study Termination|0|||
144469056|NCT03764774|520913363|FG011|Overall Study|Study Termination|0|||
144469057|NCT03764774|520913364|FG012|Overall Study|Study Termination|0|||
144469058|NCT03764774|520913365|FG013|Overall Study|Study Termination|2|||
144469059|NCT04922554|520913369|FG000|Overall Study|Adverse Event|4|||
144469060|NCT04922554|520913370|FG001|Overall Study|Adverse Event|0|||
144469061|NCT04922554|520913369|FG000|Overall Study|Withdrawal by Subject|1|||
144469062|NCT04922554|520913370|FG001|Overall Study|Withdrawal by Subject|0|||
144469063|NCT04233372|520915003|FG000|Overall Study|Lost to Follow-up|104|||
144469064|NCT04233372|520915003|FG000|Overall Study|Adverse Event|8|||
144469065|NCT04233372|520915003|FG000|Overall Study|Withdrawal by Subject|2|||
144469066|NCT01090310|520915004|FG000|Core Study|Adverse Event|2|||
144469067|NCT01090310|520915005|FG001|Core Study|Adverse Event|2|||
144469068|NCT01090310|520915006|FG002|Core Study|Adverse Event|1|||
144469069|NCT01090310|520915007|FG003|Core Study|Adverse Event|1|||
144469070|NCT01090310|520915004|FG000|Core Study|Subject withdrew consent|0|||
144469071|NCT01090310|520915005|FG001|Core Study|Subject withdrew consent|3|||
144469072|NCT01090310|520915006|FG002|Core Study|Subject withdrew consent|1|||
144469073|NCT01090310|520915007|FG003|Core Study|Subject withdrew consent|1|||
144469074|NCT01090310|520915004|FG000|Core Study|Abnormal test procedure result|0|||
144469075|NCT01090310|520915005|FG001|Core Study|Abnormal test procedure result|0|||
144469076|NCT01090310|520915006|FG002|Core Study|Abnormal test procedure result|1|||
144469077|NCT01090310|520915007|FG003|Core Study|Abnormal test procedure result|0|||
144469078|NCT01090310|520915004|FG000|Core Study|Administrative reasons|5|||
144469079|NCT01090310|520915005|FG001|Core Study|Administrative reasons|6|||
144469080|NCT01090310|520915006|FG002|Core Study|Administrative reasons|4|||
144469081|NCT01090310|520915007|FG003|Core Study|Administrative reasons|4|||
144469082|NCT01090310|520915004|FG000|Core Study|Protocol deviation|1|||
144469083|NCT01090310|520915005|FG001|Core Study|Protocol deviation|0|||
144469084|NCT01090310|520915006|FG002|Core Study|Protocol deviation|0|||
144469085|NCT01090310|520915007|FG003|Core Study|Protocol deviation|1|||
144469086|NCT01090310|520915004|FG000|Extension Study|Aministrative problems|13|||
144469087|NCT01090310|520915005|FG001|Extension Study|Aministrative problems|15|||
144469088|NCT01090310|520915006|FG002|Extension Study|Aministrative problems|14|||
144469089|NCT01090310|520915007|FG003|Extension Study|Aministrative problems|18|||
144469090|NCT01090310|520915004|FG000|Extension Study|Adverse Event|0|||
144469091|NCT01090310|520915005|FG001|Extension Study|Adverse Event|0|||
144469092|NCT01090310|520915006|FG002|Extension Study|Adverse Event|0|||
144469093|NCT01090310|520915007|FG003|Extension Study|Adverse Event|1|||
144469094|NCT01090310|520915004|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
144469095|NCT01090310|520915005|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
144469096|NCT01090310|520915006|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
144469097|NCT01090310|520915007|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
144469098|NCT01090310|520915004|FG000|Extension Study|Subject withdrew consent|0|||
144469099|NCT01090310|520915005|FG001|Extension Study|Subject withdrew consent|1|||
144469100|NCT01090310|520915006|FG002|Extension Study|Subject withdrew consent|0|||
144469101|NCT01090310|520915007|FG003|Extension Study|Subject withdrew consent|0|||
144469102|NCT00695786|520915008|FG000|Overall Study|Adverse Event|0|||
144469103|NCT00695786|520915009|FG001|Overall Study|Adverse Event|3|||
144469104|NCT00695786|520915010|FG002|Overall Study|Adverse Event|4|||
144469105|NCT00695786|520915011|FG003|Overall Study|Adverse Event|2|||
144469106|NCT00695786|520915008|FG000|Overall Study|Lost to Follow-up|0|||
144469107|NCT00695786|520915009|FG001|Overall Study|Lost to Follow-up|5|||
144469108|NCT00695786|520915010|FG002|Overall Study|Lost to Follow-up|1|||
144469109|NCT00695786|520915011|FG003|Overall Study|Lost to Follow-up|1|||
144469110|NCT00695786|520915008|FG000|Overall Study|Withdrawal by Subject|0|||
144613519|NCT02116777|521445570|FG001|Overall Study|Protocol Violation|0|||
144613520|NCT02116777|521445571|FG002|Overall Study|Protocol Violation|0|||
144613521|NCT02116777|521445572|FG003|Overall Study|Protocol Violation|1|||
144613522|NCT02116777|521445573|FG004|Overall Study|Protocol Violation|0|||
144469111|NCT00695786|520915009|FG001|Overall Study|Withdrawal by Subject|4|||
144469112|NCT00695786|520915010|FG002|Overall Study|Withdrawal by Subject|3|||
144469113|NCT00695786|520915011|FG003|Overall Study|Withdrawal by Subject|1|||
144469114|NCT00695786|520915008|FG000|Overall Study|Deemed Ineligible|1|||
144469115|NCT00695786|520915009|FG001|Overall Study|Deemed Ineligible|0|||
144469116|NCT00695786|520915010|FG002|Overall Study|Deemed Ineligible|0|||
144469117|NCT00695786|520915011|FG003|Overall Study|Deemed Ineligible|0|||
144469118|NCT00695786|520915008|FG000|Overall Study|Lack of Efficacy|0|||
144469119|NCT00695786|520915009|FG001|Overall Study|Lack of Efficacy|0|||
144469120|NCT00695786|520915010|FG002|Overall Study|Lack of Efficacy|0|||
144469121|NCT00695786|520915011|FG003|Overall Study|Lack of Efficacy|4|||
144469122|NCT01364922|520915017|FG000|Open-label (OL) Period|Adverse Event|7|||
144469123|NCT01364922|520915018|FG001|Open-label (OL) Period|Adverse Event|0|||
144197459|NCT01859130|519920275|FG000|Overall Study|Lost to Follow-up|16|||
144469124|NCT01364922|520915019|FG002|Open-label (OL) Period|Adverse Event|0|||
144469125|NCT01364922|520915017|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
144469126|NCT01364922|520915018|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
144469127|NCT01364922|520915019|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
144469128|NCT01364922|520915017|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
144613523|NCT02116777|521445574|FG005|Overall Study|Protocol Violation|0|||
144469129|NCT01364922|520915018|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
144469130|NCT01364922|520915019|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
144469131|NCT01364922|520915017|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
144469132|NCT01364922|520915018|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
144469133|NCT01364922|520915019|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
144469134|NCT01364922|520915017|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
144469135|NCT01364922|520915018|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
144469136|NCT01364922|520915019|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
144469137|NCT01364922|520915017|FG000|Open-label (OL) Period|Other, Unspecified|1|||
144469138|NCT01364922|520915018|FG001|Open-label (OL) Period|Other, Unspecified|0|||
144469139|NCT01364922|520915019|FG002|Open-label (OL) Period|Other, Unspecified|0|||
144469140|NCT01364922|520915017|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
144469141|NCT01364922|520915018|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
144469142|NCT01364922|520915019|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
144469143|NCT01364922|520915017|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
144469144|NCT01364922|520915018|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
144469145|NCT01364922|520915019|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
144469146|NCT01364922|520915017|FG000|Double-Blind (DB) Period|Adverse Event|0|||
144469147|NCT01364922|520915018|FG001|Double-Blind (DB) Period|Adverse Event|0|||
144469148|NCT01364922|520915019|FG002|Double-Blind (DB) Period|Adverse Event|1|||
144469149|NCT01364922|520915017|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
144469150|NCT01364922|520915018|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
144469151|NCT01364922|520915019|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
144469152|NCT04244396|520915022|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
144469153|NCT04244396|520915022|FG000|Overall Study|Withdrawal by Subject|2|||
144469154|NCT04244396|520915022|FG000|Overall Study|Study termination|37|||
144469155|NCT01787097|520915023|FG000|Overall Study|Withdrawal by Subject|1|||
144469156|NCT01787097|520915024|FG001|Overall Study|Withdrawal by Subject|0|||
144469157|NCT01787097|520915025|FG002|Overall Study|Withdrawal by Subject|0|||
144469158|NCT01787097|520915026|FG003|Overall Study|Withdrawal by Subject|0|||
144469159|NCT05178121|520915027|FG000|Overall Study|Other|4|||
144469160|NCT05178121|520915027|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
144469161|NCT00949884|520915028|FG000|Overall Study|Adverse Event|14|||
144469162|NCT00949884|520915029|FG001|Overall Study|Adverse Event|3|||
144469163|NCT00949884|520915030|FG002|Overall Study|Adverse Event|12|||
144469164|NCT00949884|520915028|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
144469165|NCT00949884|520915029|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
144469166|NCT00949884|520915030|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
144469167|NCT00949884|520915028|FG000|Overall Study|Lost to Follow-up|7|||
144469168|NCT00949884|520915029|FG001|Overall Study|Lost to Follow-up|5|||
144469169|NCT00949884|520915030|FG002|Overall Study|Lost to Follow-up|5|||
144469170|NCT00949884|520915028|FG000|Overall Study|Physician Decision|5|||
144469171|NCT00949884|520915029|FG001|Overall Study|Physician Decision|0|||
144469172|NCT00949884|520915030|FG002|Overall Study|Physician Decision|6|||
144469173|NCT00949884|520915028|FG000|Overall Study|Treatment non-compliance|5|||
144469174|NCT00949884|520915029|FG001|Overall Study|Treatment non-compliance|0|||
144469175|NCT00949884|520915030|FG002|Overall Study|Treatment non-compliance|8|||
144469176|NCT00949884|520915028|FG000|Overall Study|Withdrawal by Subject|13|||
144469177|NCT00949884|520915029|FG001|Overall Study|Withdrawal by Subject|4|||
144469178|NCT00949884|520915030|FG002|Overall Study|Withdrawal by Subject|16|||
144469179|NCT00949884|520915028|FG000|Overall Study|Lack of Efficacy|4|||
144469180|NCT00949884|520915029|FG001|Overall Study|Lack of Efficacy|2|||
144469181|NCT00949884|520915030|FG002|Overall Study|Lack of Efficacy|7|||
144469182|NCT00949884|520915028|FG000|Overall Study|Study terminated by sponsor|0|||
144469183|NCT00949884|520915029|FG001|Overall Study|Study terminated by sponsor|0|||
144469184|NCT00949884|520915030|FG002|Overall Study|Study terminated by sponsor|1|||
144469185|NCT01953003|520915031|FG000|Overall Study|Not treated|0|||
144469186|NCT01953003|520915032|FG001|Overall Study|Not treated|1|||
144469187|NCT01953003|520915031|FG000|Overall Study|Progressive disease|35|||
144469188|NCT01953003|520915032|FG001|Overall Study|Progressive disease|45|||
144469189|NCT01953003|520915031|FG000|Overall Study|Related Adverse events|7|||
144469190|NCT01953003|520915032|FG001|Overall Study|Related Adverse events|2|||
144469191|NCT01953003|520915031|FG000|Overall Study|Non-related adverse events|0|||
144469192|NCT01953003|520915032|FG001|Overall Study|Non-related adverse events|2|||
144469193|NCT01953003|520915031|FG000|Overall Study|Protocol Violation|0|||
144469194|NCT01953003|520915032|FG001|Overall Study|Protocol Violation|1|||
144469195|NCT01953003|520915031|FG000|Overall Study|Withdrawal by Subject|14|||
144469196|NCT01953003|520915032|FG001|Overall Study|Withdrawal by Subject|4|||
144469197|NCT03391765|520915038|FG000|Overall Study|Adverse Event|2|||
144537012|NCT04882917|521169188|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
144469198|NCT03391765|520915039|FG001|Overall Study|Adverse Event|0|||
144469199|NCT03391765|520915040|FG002|Overall Study|Adverse Event|0|||
144537013|NCT04882917|521169189|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
144613524|NCT02116777|521445575|FG006|Overall Study|Protocol Violation|0|||
144469200|NCT03391765|520915041|FG003|Overall Study|Adverse Event|2|||
144469201|NCT03391765|520915038|FG000|Overall Study|Withdrew consent|5|||
144469202|NCT03391765|520915039|FG001|Overall Study|Withdrew consent|7|||
144469203|NCT03391765|520915040|FG002|Overall Study|Withdrew consent|2|||
144469204|NCT03391765|520915041|FG003|Overall Study|Withdrew consent|5|||
144469205|NCT03391765|520915038|FG000|Overall Study|Other, not specified|44|||
144469206|NCT03391765|520915039|FG001|Overall Study|Other, not specified|38|||
144469207|NCT03391765|520915040|FG002|Overall Study|Other, not specified|21|||
144469208|NCT03391765|520915041|FG003|Overall Study|Other, not specified|16|||
144469209|NCT00944658|520915042|FG000|Treatment 12 Weeks|Adverse Event|0|||
144469210|NCT00944658|520915043|FG001|Treatment 12 Weeks|Adverse Event|2|||
144469211|NCT00662857|520915047|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
144469212|NCT00662857|520915048|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
144469213|NCT00662857|520915047|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
144469214|NCT00662857|520915048|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
144469215|NCT00662857|520915047|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
144469216|NCT00662857|520915048|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
144469217|NCT00838682|520915051|FG000|Overall Study|Lost to Follow-up|21|||
144469218|NCT00838682|520915052|FG001|Overall Study|Lost to Follow-up|14|||
144469219|NCT00838682|520915051|FG000|Overall Study|detection of exclusion criteria|4|||
144469220|NCT00838682|520915052|FG001|Overall Study|detection of exclusion criteria|3|||
144469221|NCT00838682|520915051|FG000|Overall Study|Protocol Violation|0|||
144469222|NCT00838682|520915052|FG001|Overall Study|Protocol Violation|1|||
144469223|NCT00838682|520915051|FG000|Overall Study|Withdrawal by Subject|0|||
144469224|NCT00838682|520915052|FG001|Overall Study|Withdrawal by Subject|1|||
144469225|NCT00989092|520915057|FG000|Overall Study|Physician Decision|9|||
144469226|NCT00989092|520915058|FG001|Overall Study|Physician Decision|6|||
144469227|NCT00989092|520915057|FG000|Overall Study|Adverse Event|20|||
144469228|NCT00989092|520915058|FG001|Overall Study|Adverse Event|1|||
144469229|NCT00989092|520915057|FG000|Overall Study|Chemotherapy initiated|12|||
144469230|NCT00989092|520915058|FG001|Overall Study|Chemotherapy initiated|4|||
144469231|NCT00989092|520915057|FG000|Overall Study|Withdrawal by Subject|17|||
144469232|NCT00989092|520915058|FG001|Overall Study|Withdrawal by Subject|9|||
144469233|NCT00989092|520915057|FG000|Overall Study|Death|14|||
144469234|NCT00989092|520915058|FG001|Overall Study|Death|2|||
144469235|NCT00989092|520915057|FG000|Overall Study|Ineligibility determined|3|||
144469236|NCT00989092|520915058|FG001|Overall Study|Ineligibility determined|3|||
144469237|NCT00989092|520915057|FG000|Overall Study|Lost to Follow-up|6|||
144469238|NCT00989092|520915058|FG001|Overall Study|Lost to Follow-up|2|||
144469239|NCT00989092|520915057|FG000|Overall Study|Other|3|||
144469240|NCT00989092|520915058|FG001|Overall Study|Other|1|||
144469241|NCT00989092|520915057|FG000|Overall Study|Protocol deviation|2|||
144469242|NCT00989092|520915058|FG001|Overall Study|Protocol deviation|0|||
144469243|NCT00989092|520915057|FG000|Overall Study|Erythropoietin therapy initiated|2|||
144469244|NCT00989092|520915058|FG001|Overall Study|Erythropoietin therapy initiated|0|||
144469245|NCT00989092|520915057|FG000|Overall Study|Did not receive study drug|2|||
144469246|NCT00989092|520915058|FG001|Overall Study|Did not receive study drug|0|||
144469247|NCT02832622|520915060|FG000|Overall Study|MPP not programmed|1259|||
144469248|NCT02832622|520915060|FG000|Overall Study|Withdrawal by Subject|123|||
144469249|NCT02832622|520915060|FG000|Overall Study|Death|119|||
144469250|NCT02832622|520915060|FG000|Overall Study|Unsuccessful CRT implant|93|||
144469251|NCT02832622|520915060|FG000|Overall Study|Lost to Follow-up|45|||
144469252|NCT02832622|520915060|FG000|Overall Study|Patient non-compliance|42|||
144469253|NCT02832622|520915060|FG000|Overall Study|Withdrawal by other reasons|25|||
144469254|NCT02832622|520915060|FG000|Overall Study|System explant|24|||
144469255|NCT02832622|520915060|FG000|Overall Study|Physician Decision|6|||
144469256|NCT02472652|520915062|FG000|Overall Study|Lost to Follow-up|1|||
144469257|NCT00998400|520915067|FG000|Overall Study|Lack of interest/motivation|1|||
144469258|NCT00998400|520915068|FG001|Overall Study|Lack of interest/motivation|2|||
144469259|NCT00998400|520915067|FG000|Overall Study|Logistical problems|1|||
144726480|NCT02768298|521852767|FG001|Overall Study|Withdrawal of informed consent|1|||
144726481|NCT04603937|521852768|FG000|Overall Study|Adverse Event|9|||
144726482|NCT04603937|521852769|FG001|Overall Study|Adverse Event|10|||
144726483|NCT04603937|521852768|FG000|Overall Study|Withdrawal by Subject|7|||
144726484|NCT04603937|521852769|FG001|Overall Study|Withdrawal by Subject|6|||
144726485|NCT04603937|521852768|FG000|Overall Study|Lost to Follow-up|5|||
144469260|NCT00998400|520915068|FG001|Overall Study|Logistical problems|0|||
144469261|NCT03704584|520915069|FG000|Overall Study|Withdrawal by Subject|1|||
144469262|NCT03704584|520915070|FG001|Overall Study|Withdrawal by Subject|0|||
144469263|NCT03185832|520915071|FG000|Overall Study|Death|9|||
144469264|NCT03185832|520915072|FG001|Overall Study|Death|14|||
144469265|NCT03185832|520915073|FG002|Overall Study|Death|9|||
144726486|NCT04603937|521852769|FG001|Overall Study|Lost to Follow-up|6|||
144726487|NCT04603937|521852768|FG000|Overall Study|Physician Decision|0|||
144469266|NCT03185832|520915074|FG003|Overall Study|Death|7|||
144469267|NCT03185832|520915071|FG000|Overall Study|Withdrawn - vital status available|0|||
144469268|NCT03185832|520915072|FG001|Overall Study|Withdrawn - vital status available|1|||
144469269|NCT03185832|520915073|FG002|Overall Study|Withdrawn - vital status available|1|||
144469270|NCT03185832|520915074|FG003|Overall Study|Withdrawn - vital status available|4|||
144726488|NCT04603937|521852769|FG001|Overall Study|Physician Decision|1|||
144469271|NCT01083641|520915076|FG000|Overall Study|Withdrawal by Subject|2|||
144469272|NCT03439189|520915077|FG000|Overall Study|Protocol Violation|19|||
144469273|NCT03439189|520915077|FG000|Overall Study|Lack of Efficacy|63|||
144469274|NCT03412812|520915078|FG000|Level 1|Death|3|||
144469275|NCT03412812|520915079|FG001|Level 1|Death|0|||
144469276|NCT03412812|520915078|FG000|Level 1|Adverse Event|0|||
144469277|NCT03412812|520915079|FG001|Level 1|Adverse Event|1|||
144469278|NCT01777321|520915080|FG000|Overall Study|Withdrawal by Subject|0|||
144469279|NCT01777321|520915081|FG001|Overall Study|Withdrawal by Subject|1|||
144469280|NCT03315143|520915087|FG000|Overall Study|Death|240|||
144469281|NCT03315143|520915088|FG001|Overall Study|Death|246|||
144469282|NCT03315143|520915087|FG000|Overall Study|Withdrawal by Subject|57|||
144469283|NCT03315143|520915088|FG001|Overall Study|Withdrawal by Subject|68|||
144469284|NCT03315143|520915087|FG000|Overall Study|Site Terminated by Sponsor|256|||
144469285|NCT03315143|520915088|FG001|Overall Study|Site Terminated by Sponsor|282|||
144469286|NCT03315143|520915087|FG000|Overall Study|Study Terminated by Sponsor|4723|||
144469287|NCT03315143|520915088|FG001|Overall Study|Study Terminated by Sponsor|4664|||
144469288|NCT03315143|520915087|FG000|Overall Study|Reason not Specified|16|||
144469289|NCT03315143|520915088|FG001|Overall Study|Reason not Specified|32|||
144469290|NCT02052310|520915089|FG000|Overall Study|Death|64|||
144469291|NCT02052310|520915090|FG001|Overall Study|Death|54|||
144469292|NCT02052310|520915089|FG000|Overall Study|Withdrawal by Subject|37|||
144469293|NCT02052310|520915090|FG001|Overall Study|Withdrawal by Subject|49|||
144469294|NCT02052310|520915089|FG000|Overall Study|Other than specified|32|||
144469295|NCT02052310|520915090|FG001|Overall Study|Other than specified|29|||
144469296|NCT02052310|520915089|FG000|Overall Study|Adverse Event|29|||
144469297|NCT02052310|520915090|FG001|Overall Study|Adverse Event|22|||
144469298|NCT02052310|520915089|FG000|Overall Study|Kidney Transplant|23|||
144469299|NCT02052310|520915090|FG001|Overall Study|Kidney Transplant|29|||
144469300|NCT02052310|520915089|FG000|Overall Study|Physician Decision|14|||
144469301|NCT02052310|520915090|FG001|Overall Study|Physician Decision|7|||
144469302|NCT02052310|520915089|FG000|Overall Study|Lack of Efficacy|6|||
144613525|NCT02116777|521445569|FG000|Overall Study|Withdrawal by Subject|0|||
144613526|NCT02116777|521445570|FG001|Overall Study|Withdrawal by Subject|0|||
144613527|NCT02116777|521445571|FG002|Overall Study|Withdrawal by Subject|0|||
144613528|NCT02116777|521445572|FG003|Overall Study|Withdrawal by Subject|1|||
144613529|NCT02116777|521445573|FG004|Overall Study|Withdrawal by Subject|0|||
144613530|NCT02116777|521445574|FG005|Overall Study|Withdrawal by Subject|0|||
144613531|NCT02116777|521445575|FG006|Overall Study|Withdrawal by Subject|0|||
144613532|NCT01423851|521445577|FG000|Whole Study|Disease progression|2|||
144613533|NCT01423851|521445578|FG001|Whole Study|Disease progression|1|||
144613534|NCT01423851|521445579|FG002|Whole Study|Disease progression|1|||
144613535|NCT01423851|521445580|FG003|Whole Study|Disease progression|4|||
144613536|NCT01423851|521445581|FG004|Whole Study|Disease progression|1|||
144613537|NCT01423851|521445582|FG005|Whole Study|Disease progression|3|||
144613538|NCT01423851|521445583|FG006|Whole Study|Disease progression|1|||
144613539|NCT01423851|521445584|FG007|Whole Study|Disease progression|4|||
144613540|NCT01423851|521445585|FG008|Whole Study|Disease progression|0|||
144613541|NCT01423851|521445586|FG009|Whole Study|Disease progression|2|||
144613542|NCT01423851|521445587|FG010|Whole Study|Disease progression|10|||
144613543|NCT01423851|521445577|FG000|Whole Study|Physician Decision|0|||
144613544|NCT01423851|521445578|FG001|Whole Study|Physician Decision|1|||
144613545|NCT01423851|521445579|FG002|Whole Study|Physician Decision|2|||
144613546|NCT01423851|521445580|FG003|Whole Study|Physician Decision|0|||
144613547|NCT01423851|521445581|FG004|Whole Study|Physician Decision|2|||
144613548|NCT01423851|521445582|FG005|Whole Study|Physician Decision|0|||
144613549|NCT01423851|521445583|FG006|Whole Study|Physician Decision|2|||
144613550|NCT01423851|521445584|FG007|Whole Study|Physician Decision|1|||
144613551|NCT01423851|521445585|FG008|Whole Study|Physician Decision|3|||
144613552|NCT01423851|521445586|FG009|Whole Study|Physician Decision|4|||
144613553|NCT01423851|521445587|FG010|Whole Study|Physician Decision|12|||
144613554|NCT01423851|521445577|FG000|Whole Study|Withdrawal by Subject|1|||
144258371|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
144469303|NCT02052310|520915090|FG001|Overall Study|Lack of Efficacy|1|||
144469304|NCT02052310|520915089|FG000|Overall Study|Site Terminated by Sponsor|5|||
144613555|NCT01423851|521445578|FG001|Whole Study|Withdrawal by Subject|1|||
144258372|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
144469305|NCT02052310|520915090|FG001|Overall Study|Site Terminated by Sponsor|13|||
144469306|NCT02052310|520915089|FG000|Overall Study|Lost to Follow-up|4|||
144469307|NCT02052310|520915090|FG001|Overall Study|Lost to Follow-up|2|||
144469308|NCT02052310|520915089|FG000|Overall Study|Protocol Violation|1|||
144613556|NCT01423851|521445579|FG002|Whole Study|Withdrawal by Subject|0|||
144613557|NCT01423851|521445580|FG003|Whole Study|Withdrawal by Subject|0|||
144469309|NCT02052310|520915090|FG001|Overall Study|Protocol Violation|6|||
144469310|NCT04452877|520915091|FG000|Overall Study|Adverse Event|5|||
144469311|NCT04452877|520915091|FG000|Overall Study|Lost to Follow-up|1|||
144613558|NCT01423851|521445581|FG004|Whole Study|Withdrawal by Subject|0|||
144613559|NCT01423851|521445582|FG005|Whole Study|Withdrawal by Subject|0|||
144613560|NCT01423851|521445583|FG006|Whole Study|Withdrawal by Subject|0|||
144613561|NCT01423851|521445584|FG007|Whole Study|Withdrawal by Subject|0|||
144537014|NCT04882917|521169190|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
144537015|NCT00319020|521169191|FG000|Overall Study|Death|2|||
144537016|NCT00319020|521169192|FG001|Overall Study|Death|2|||
144537017|NCT00319020|521169191|FG000|Overall Study|Withdrawal by Subject|4|||
144537018|NCT00319020|521169192|FG001|Overall Study|Withdrawal by Subject|1|||
144537019|NCT00319020|521169191|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
144537020|NCT00319020|521169192|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
144537021|NCT00319020|521169191|FG000|Overall Study|Administrative reason|0|||
144469312|NCT04452877|520915091|FG000|Overall Study|Physician Decision|4|||
144469313|NCT04452877|520915091|FG000|Overall Study|Progressive Disease|18|||
144469314|NCT04452877|520915091|FG000|Overall Study|Withdrawal by Subject|3|||
144469315|NCT01505387|520915092|FG000|Overall Study|Protocol Violation|1|||
144469316|NCT01505387|520915093|FG001|Overall Study|Protocol Violation|0|||
144469317|NCT01505387|520915092|FG000|Overall Study|Withdrawal by Subject|1|||
144469318|NCT01505387|520915093|FG001|Overall Study|Withdrawal by Subject|1|||
144469319|NCT00595504|520915094|FG000|Overall Study|Withdrawal by Subject|1|||
144469320|NCT00595504|520915095|FG001|Overall Study|Withdrawal by Subject|3|||
144469321|NCT00595504|520915094|FG000|Overall Study|Physician Decision|1|||
144469322|NCT00595504|520915095|FG001|Overall Study|Physician Decision|0|||
144469323|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
144469324|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
144469325|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
144469326|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
144469327|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
144469328|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
144469329|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
144469330|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
144469331|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
144469332|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
144469333|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
144469334|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
144469335|NCT00293267|520915096|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
144469336|NCT00293267|520915097|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
144469337|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
144469338|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
144469339|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
144469340|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
144469341|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
144469342|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
144469343|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
144469344|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
144469345|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Death|3|||
144469346|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Death|0|||
144469347|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
144469348|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
144469349|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
144469350|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
144469351|NCT00293267|520915096|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
144469352|NCT00293267|520915097|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
144469353|NCT00293267|520915096|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
144469354|NCT00293267|520915097|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
144537022|NCT00319020|521169192|FG001|Overall Study|Administrative reason|5|||
144537023|NCT00319020|521169191|FG000|Overall Study|Disease progression|0|||
144537024|NCT00319020|521169192|FG001|Overall Study|Disease progression|2|||
144537025|NCT00319020|521169191|FG000|Overall Study|Transplant|0|||
144537026|NCT00319020|521169192|FG001|Overall Study|Transplant|1|||
144537027|NCT00319020|521169191|FG000|Overall Study|Treatment failure|0|||
144537028|NCT00319020|521169192|FG001|Overall Study|Treatment failure|1|||
144537029|NCT00319020|521169191|FG000|Overall Study|Adverse Event|0|||
144537030|NCT00319020|521169192|FG001|Overall Study|Adverse Event|1|||
144537031|NCT04926740|521169198|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
144537032|NCT04926740|521169199|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
144537033|NCT04926740|521169198|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
144537034|NCT04926740|521169199|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
144537035|NCT04980300|521169200|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
144613562|NCT01423851|521445585|FG008|Whole Study|Withdrawal by Subject|2|||
144613563|NCT01423851|521445586|FG009|Whole Study|Withdrawal by Subject|0|||
144469355|NCT00293267|520915096|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
144469356|NCT00293267|520915097|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
144469357|NCT00293267|520915096|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
144469358|NCT00293267|520915097|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
144469359|NCT00293267|520915096|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
144469360|NCT00293267|520915097|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
144469361|NCT00293267|520915096|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
144469362|NCT00293267|520915097|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
144469363|NCT00293267|520915096|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
144469364|NCT00293267|520915097|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
144469365|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
144469366|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
144469367|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
144469368|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
144469369|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
144469370|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
144469371|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
144469372|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
144469373|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
144469374|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
144469375|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
144469376|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
144469377|NCT00293267|520915096|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
144469378|NCT00293267|520915097|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
144469379|NCT01050816|520915098|FG000|Overall Study|Lost to Follow-up|2|||
144469380|NCT01050816|520915098|FG000|Overall Study|patient's refusal|2|||
144469381|NCT03086330|520915099|FG000|Overall Study|Withdrawal by Subject|3|||
144469382|NCT03086330|520915100|FG001|Overall Study|Withdrawal by Subject|2|||
144469383|NCT03086330|520915099|FG000|Overall Study|Lost to Follow-up|1|||
144469384|NCT03086330|520915100|FG001|Overall Study|Lost to Follow-up|2|||
144469385|NCT01445652|520915101|FG000|Overall Study|Not comfortable in lenses|5|||
144469386|NCT01445652|520915102|FG001|Overall Study|Not comfortable in lenses|0|||
144469387|NCT01445652|520915101|FG000|Overall Study|Failed to attend scheduled visit|2|||
144469388|NCT01445652|520915102|FG001|Overall Study|Failed to attend scheduled visit|3|||
144469389|NCT01445652|520915101|FG000|Overall Study|Failed teach session|2|||
144469390|NCT01445652|520915102|FG001|Overall Study|Failed teach session|0|||
144469391|NCT01445652|520915101|FG000|Overall Study|Adverse Event|1|||
144469392|NCT01445652|520915102|FG001|Overall Study|Adverse Event|0|||
144469393|NCT01755702|520915105|FG000|Wash Out Period I|Other Reason|3|||
144469394|NCT01755702|520915105|FG000|Washout Period II|Other Reason|5|||
144469395|NCT03945292|520915109|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
144469396|NCT03945292|520915110|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
144469397|NCT03945292|520915111|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
144469398|NCT03945292|520915112|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
144469399|NCT03945292|520915113|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
144469400|NCT03945292|520915114|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
144469401|NCT03945292|520915115|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
144469402|NCT03945292|520915116|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
144469403|NCT03945292|520915109|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469404|NCT03945292|520915110|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469405|NCT03945292|520915111|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
144469406|NCT03945292|520915112|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469407|NCT03945292|520915113|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469408|NCT03945292|520915114|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469409|NCT03945292|520915115|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469410|NCT03945292|520915116|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
144469411|NCT03945292|520915109|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469412|NCT03945292|520915110|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469413|NCT03945292|520915111|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469414|NCT03945292|520915112|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469415|NCT03945292|520915113|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469416|NCT03945292|520915114|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469417|NCT03945292|520915115|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
144469418|NCT03945292|520915116|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
144469419|NCT02684006|520915117|FG000|Overall Study|Other|18|||
144469420|NCT02684006|520915118|FG001|Overall Study|Other|6|||
144613564|NCT01423851|521445587|FG010|Whole Study|Withdrawal by Subject|4|||
144469421|NCT02684006|520915117|FG000|Overall Study|Protocol Violation|2|||
144469422|NCT02684006|520915118|FG001|Overall Study|Protocol Violation|1|||
144469423|NCT02684006|520915117|FG000|Overall Study|Non-compliance with study drug|1|||
144469424|NCT02684006|520915118|FG001|Overall Study|Non-compliance with study drug|1|||
144613565|NCT01423851|521445577|FG000|Whole Study|Adverse Event|0|||
144613566|NCT01423851|521445578|FG001|Whole Study|Adverse Event|0|||
144469425|NCT02684006|520915117|FG000|Overall Study|No longer met eligibility criteria|6|||
144469426|NCT02684006|520915118|FG001|Overall Study|No longer met eligibility criteria|2|||
144469427|NCT02684006|520915117|FG000|Overall Study|Lost to Follow-up|0|||
144469428|NCT02684006|520915118|FG001|Overall Study|Lost to Follow-up|1|||
144469429|NCT02684006|520915117|FG000|Overall Study|Death|25|||
144469430|NCT02684006|520915118|FG001|Overall Study|Death|22|||
144469431|NCT02684006|520915117|FG000|Overall Study|Global deterioration of health status|18|||
144469432|NCT02684006|520915118|FG001|Overall Study|Global deterioration of health status|20|||
144469433|NCT02684006|520915117|FG000|Overall Study|Physician Decision|15|||
144469434|NCT02684006|520915118|FG001|Overall Study|Physician Decision|8|||
144469435|NCT02684006|520915117|FG000|Overall Study|Adverse Event|86|||
144469436|NCT02684006|520915118|FG001|Overall Study|Adverse Event|65|||
144469437|NCT02684006|520915117|FG000|Overall Study|Withdrawal by Subject|29|||
144469438|NCT02684006|520915118|FG001|Overall Study|Withdrawal by Subject|43|||
144469439|NCT02684006|520915117|FG000|Overall Study|Progressive disease|236|||
144469440|NCT02684006|520915118|FG001|Overall Study|Progressive disease|266|||
144469441|NCT02684006|520915117|FG000|Overall Study|Participation terminated by sponsor|6|||
144469442|NCT02684006|520915118|FG001|Overall Study|Participation terminated by sponsor|9|||
144469443|NCT05103384|520915119|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
144469444|NCT05608499|520915120|FG000|Overall Study|Lack of Efficacy|1|||
144469445|NCT05608499|520915121|FG001|Overall Study|Lack of Efficacy|0|||
144469446|NCT05608499|520915120|FG000|Overall Study|Lost to Follow-up|0|||
144469447|NCT05608499|520915121|FG001|Overall Study|Lost to Follow-up|1|||
144469448|NCT00514735|520915122|FG000|Overall Study|Withdrawal by Subject|13|||
144469449|NCT00514735|520915123|FG001|Overall Study|Withdrawal by Subject|5|||
144469450|NCT00514735|520915122|FG000|Overall Study|Death|1|||
144469451|NCT00514735|520915123|FG001|Overall Study|Death|0|||
144469452|NCT00514735|520915122|FG000|Overall Study|Lost to Follow-up|0|||
144469453|NCT00514735|520915123|FG001|Overall Study|Lost to Follow-up|1|||
144469454|NCT04393441|520915129|FG000|Overall Study|Adverse Event|0|||
144469455|NCT04393441|520915130|FG001|Overall Study|Adverse Event|3|||
144469456|NCT04393441|520915129|FG000|Overall Study|Withdrawal by Subject|5|||
144469457|NCT04393441|520915130|FG001|Overall Study|Withdrawal by Subject|7|||
144469458|NCT04393441|520915129|FG000|Overall Study|Lost to Follow-up|0|||
144469459|NCT04393441|520915130|FG001|Overall Study|Lost to Follow-up|2|||
144469460|NCT04393441|520915129|FG000|Overall Study|Protocol Deviation|2|||
144469461|NCT04393441|520915130|FG001|Overall Study|Protocol Deviation|1|||
144469462|NCT04393441|520915129|FG000|Overall Study|Reason not Specified|1|||
144469463|NCT04393441|520915130|FG001|Overall Study|Reason not Specified|1|||
144469464|NCT02782169|520915131|FG000|Overall Study|Lost to Follow-up|1|||
144469465|NCT02782169|520915132|FG001|Overall Study|Lost to Follow-up|2|||
144469466|NCT04003610|520915133|FG000|Overall Study|Lost to Follow-up|0|||
144469467|NCT04003610|520915134|FG001|Overall Study|Lost to Follow-up|1|||
144469468|NCT04003610|520915135|FG002|Overall Study|Lost to Follow-up|0|||
144469469|NCT04003610|520915133|FG000|Overall Study|Death|0|||
144469470|NCT04003610|520915134|FG001|Overall Study|Death|0|||
144469471|NCT04003610|520915135|FG002|Overall Study|Death|3|||
144469472|NCT04003610|520915133|FG000|Overall Study|Study Terminated by Sponsor|0|||
144469473|NCT04003610|520915134|FG001|Overall Study|Study Terminated by Sponsor|0|||
144469474|NCT04003610|520915135|FG002|Overall Study|Study Terminated by Sponsor|3|||
144469475|NCT00771810|520915136|FG000|Overall Study|Adverse Event|3|||
144469476|NCT00771810|520915137|FG001|Overall Study|Adverse Event|0|||
144469477|NCT00771810|520915138|FG002|Overall Study|Adverse Event|2|||
144469478|NCT00771810|520915136|FG000|Overall Study|Lost to Follow-up|0|||
144469479|NCT00771810|520915137|FG001|Overall Study|Lost to Follow-up|0|||
144469480|NCT00771810|520915138|FG002|Overall Study|Lost to Follow-up|1|||
144469481|NCT00771810|520915136|FG000|Overall Study|Physician Decision|1|||
144469482|NCT00771810|520915137|FG001|Overall Study|Physician Decision|2|||
144469483|NCT00771810|520915138|FG002|Overall Study|Physician Decision|2|||
144469484|NCT00771810|520915136|FG000|Overall Study|Protocol Violation|0|||
144469485|NCT00771810|520915137|FG001|Overall Study|Protocol Violation|1|||
144469486|NCT00771810|520915138|FG002|Overall Study|Protocol Violation|1|||
144469487|NCT00771810|520915136|FG000|Overall Study|Withdrawal by Subject|1|||
144469488|NCT00771810|520915137|FG001|Overall Study|Withdrawal by Subject|2|||
144469489|NCT00771810|520915138|FG002|Overall Study|Withdrawal by Subject|0|||
144469490|NCT00771810|520915136|FG000|Overall Study|Other|0|||
144469491|NCT00771810|520915137|FG001|Overall Study|Other|0|||
144469492|NCT00771810|520915138|FG002|Overall Study|Other|1|||
144469493|NCT04751942|520915144|FG000|Overall Study|Lost to Follow-up|9|||
144469494|NCT04751942|520915145|FG001|Overall Study|Lost to Follow-up|6|||
144469495|NCT00724152|520915147|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
144469496|NCT00724152|520915148|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
144469497|NCT00724152|520915149|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
144469498|NCT00724152|520915147|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
144469499|NCT00724152|520915148|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
144469500|NCT00724152|520915149|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
144613567|NCT01423851|521445579|FG002|Whole Study|Adverse Event|0|||
144613568|NCT01423851|521445580|FG003|Whole Study|Adverse Event|2|||
144613569|NCT01423851|521445581|FG004|Whole Study|Adverse Event|0|||
144613570|NCT01423851|521445582|FG005|Whole Study|Adverse Event|0|||
144469501|NCT03266770|520915150|FG000|Overall Study|Physician Decision|3|||
144469502|NCT03266770|520915150|FG000|Overall Study|Insufficient study supplies|1|||
144469503|NCT03266770|520915150|FG000|Overall Study|Adverse Event|1|||
144469504|NCT03848403|520915152|FG000|Period 2 (Day 8)|Adverse Event|1|||
144469505|NCT03848403|520915153|FG001|Period 2 (Day 8)|Adverse Event|2|||
144469506|NCT03848403|520915154|FG002|Period 2 (Day 8)|Adverse Event|2|||
144469507|NCT03848403|520915152|FG000|Period 2 (Day 8)|Physician Decision|0|||
144469508|NCT03848403|520915153|FG001|Period 2 (Day 8)|Physician Decision|1|||
144469509|NCT03848403|520915154|FG002|Period 2 (Day 8)|Physician Decision|0|||
144469510|NCT03848403|520915152|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
144469511|NCT03848403|520915153|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
144469512|NCT03848403|520915154|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
144469513|NCT00168038|520915155|FG000|Overall Study|Adverse Event|1|||
144469514|NCT00168038|520915155|FG000|Overall Study|Therapy failure|1|||
144469515|NCT02657031|520915158|FG000|Overall Study|Adverse Event|1|||
144469516|NCT02657031|520915159|FG001|Overall Study|Adverse Event|2|||
144469517|NCT02638948|520915164|FG000|Overall Study|Withdrawal by Subject|4|||
144469518|NCT02638948|520915165|FG001|Overall Study|Withdrawal by Subject|5|||
144469519|NCT02638948|520915166|FG002|Overall Study|Withdrawal by Subject|3|||
144469520|NCT02638948|520915167|FG003|Overall Study|Withdrawal by Subject|1|||
144469521|NCT02638948|520915164|FG000|Overall Study|Administrative Reason by Sponsor|0|||
144469522|NCT02638948|520915165|FG001|Overall Study|Administrative Reason by Sponsor|1|||
144469523|NCT02638948|520915166|FG002|Overall Study|Administrative Reason by Sponsor|0|||
144469524|NCT02638948|520915167|FG003|Overall Study|Administrative Reason by Sponsor|4|||
144469525|NCT02638948|520915164|FG000|Overall Study|Adverse Event|0|||
144469526|NCT02638948|520915165|FG001|Overall Study|Adverse Event|0|||
144469527|NCT02638948|520915166|FG002|Overall Study|Adverse Event|1|||
144469528|NCT02638948|520915167|FG003|Overall Study|Adverse Event|1|||
144469529|NCT02638948|520915164|FG000|Overall Study|Lack of Efficacy|1|||
144469530|NCT02638948|520915165|FG001|Overall Study|Lack of Efficacy|1|||
144469531|NCT02638948|520915166|FG002|Overall Study|Lack of Efficacy|0|||
144469532|NCT02638948|520915167|FG003|Overall Study|Lack of Efficacy|0|||
144469533|NCT02638948|520915164|FG000|Overall Study|Lost to Follow-up|0|||
144469534|NCT02638948|520915165|FG001|Overall Study|Lost to Follow-up|0|||
144469535|NCT02638948|520915166|FG002|Overall Study|Lost to Follow-up|1|||
144469536|NCT02638948|520915167|FG003|Overall Study|Lost to Follow-up|1|||
144469537|NCT02638948|520915164|FG000|Overall Study|Poor/Non-Compliance|0|||
144469538|NCT02638948|520915165|FG001|Overall Study|Poor/Non-Compliance|2|||
144469539|NCT02638948|520915166|FG002|Overall Study|Poor/Non-Compliance|1|||
144469540|NCT02638948|520915167|FG003|Overall Study|Poor/Non-Compliance|0|||
144469541|NCT02638948|520915164|FG000|Overall Study|Participant no longer met study criteria|0|||
144469542|NCT02638948|520915165|FG001|Overall Study|Participant no longer met study criteria|1|||
144469543|NCT02638948|520915166|FG002|Overall Study|Participant no longer met study criteria|0|||
144613571|NCT01423851|521445583|FG006|Whole Study|Adverse Event|0|||
144613572|NCT01423851|521445584|FG007|Whole Study|Adverse Event|3|||
144613573|NCT01423851|521445585|FG008|Whole Study|Adverse Event|3|||
144613574|NCT01423851|521445586|FG009|Whole Study|Adverse Event|2|||
144613575|NCT01423851|521445587|FG010|Whole Study|Adverse Event|3|||
144613576|NCT00733954|521445591|FG000|Overall Study|Lost to Follow-up|5|||
144613577|NCT00733954|521445592|FG001|Overall Study|Lost to Follow-up|2|||
144469544|NCT02638948|520915167|FG003|Overall Study|Participant no longer met study criteria|0|||
144469545|NCT02638948|520915164|FG000|Overall Study|Other than specified above|4|||
144469546|NCT02638948|520915165|FG001|Overall Study|Other than specified above|1|||
144469547|NCT02638948|520915166|FG002|Overall Study|Other than specified above|1|||
144469548|NCT02638948|520915167|FG003|Overall Study|Other than specified above|1|||
144469549|NCT05007392|520915168|FG000|Overall Study|Randomized but not treated|1|||
144469550|NCT05007392|520915169|FG001|Overall Study|Randomized but not treated|2|||
144469551|NCT05007392|520915168|FG000|Overall Study|Other|5|||
144469552|NCT05007392|520915169|FG001|Overall Study|Other|4|||
144469553|NCT05007392|520915168|FG000|Overall Study|Lost to Follow-up|1|||
144469554|NCT05007392|520915169|FG001|Overall Study|Lost to Follow-up|2|||
144469555|NCT05007392|520915168|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
144613578|NCT00733954|521445591|FG000|Overall Study|Protocol Violation|1|||
144613579|NCT00733954|521445592|FG001|Overall Study|Protocol Violation|0|||
144613580|NCT00733954|521445591|FG000|Overall Study|Withdrawal by Subject|2|||
144197460|NCT01859130|519920275|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
144469556|NCT05007392|520915169|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
144469557|NCT05007392|520915168|FG000|Overall Study|Use of prohibited concomitant drug|1|||
144469558|NCT05007392|520915169|FG001|Overall Study|Use of prohibited concomitant drug|1|||
144469559|NCT05007392|520915168|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
144469560|NCT05007392|520915169|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
144613581|NCT00733954|521445592|FG001|Overall Study|Withdrawal by Subject|0|||
144469561|NCT05007392|520915168|FG000|Overall Study|Adverse Event|10|||
144469562|NCT05007392|520915169|FG001|Overall Study|Adverse Event|6|||
144469563|NCT05007392|520915168|FG000|Overall Study|Participant choice|5|||
144469564|NCT05007392|520915169|FG001|Overall Study|Participant choice|10|||
144469565|NCT05007392|520915168|FG000|Overall Study|Withdrawal of consent|5|||
144469566|NCT05007392|520915169|FG001|Overall Study|Withdrawal of consent|4|||
144469567|NCT01218126|520915172|FG000|Overall Study|Adverse Event|8|||
144469568|NCT01218126|520915173|FG001|Overall Study|Adverse Event|10|||
144469569|NCT01218126|520915174|FG002|Overall Study|Adverse Event|12|||
144469570|NCT01218126|520915175|FG003|Overall Study|Adverse Event|16|||
144469571|NCT01218126|520915172|FG000|Overall Study|Lack of Efficacy|7|||
144469572|NCT01218126|520915173|FG001|Overall Study|Lack of Efficacy|2|||
144469573|NCT01218126|520915174|FG002|Overall Study|Lack of Efficacy|2|||
144469574|NCT01218126|520915175|FG003|Overall Study|Lack of Efficacy|6|||
144469575|NCT01218126|520915172|FG000|Overall Study|Protocol Violation|5|||
144469576|NCT01218126|520915173|FG001|Overall Study|Protocol Violation|2|||
144469577|NCT01218126|520915174|FG002|Overall Study|Protocol Violation|2|||
144469578|NCT01218126|520915175|FG003|Overall Study|Protocol Violation|3|||
144469579|NCT01218126|520915172|FG000|Overall Study|Protocol-defined stopping criteria|1|||
144469580|NCT01218126|520915173|FG001|Overall Study|Protocol-defined stopping criteria|1|||
144469581|NCT01218126|520915174|FG002|Overall Study|Protocol-defined stopping criteria|0|||
144469582|NCT01218126|520915175|FG003|Overall Study|Protocol-defined stopping criteria|0|||
144469583|NCT01218126|520915172|FG000|Overall Study|Lost to Follow-up|0|||
144469584|NCT01218126|520915173|FG001|Overall Study|Lost to Follow-up|0|||
144469585|NCT01218126|520915174|FG002|Overall Study|Lost to Follow-up|0|||
144469586|NCT01218126|520915175|FG003|Overall Study|Lost to Follow-up|2|||
144469587|NCT01218126|520915172|FG000|Overall Study|Physician Decision|1|||
144469588|NCT01218126|520915173|FG001|Overall Study|Physician Decision|2|||
144469589|NCT01218126|520915174|FG002|Overall Study|Physician Decision|4|||
144469590|NCT01218126|520915175|FG003|Overall Study|Physician Decision|2|||
144469591|NCT01218126|520915172|FG000|Overall Study|Withdrawal by Subject|2|||
144613582|NCT03416153|521445593|FG000|Overall Study|Physician Decision|1|||
144613583|NCT03416153|521445594|FG001|Overall Study|Physician Decision|1|||
144613584|NCT03416153|521445593|FG000|Overall Study|Withdrawal by Subject|1|||
144613585|NCT03416153|521445594|FG001|Overall Study|Withdrawal by Subject|0|||
144613586|NCT00490568|521446987|FG000|Overall Study|Adverse Event|116|||
144613587|NCT00490568|521446987|FG000|Overall Study|Lost to Follow-up|13|||
144613588|NCT00490568|521446987|FG000|Overall Study|Protocol Violation|45|||
144613589|NCT00490568|521446987|FG000|Overall Study|Withdrawal by Subject|135|||
144613590|NCT00490568|521446987|FG000|Overall Study|Still in the study at termination|974|||
144613591|NCT00490568|521446987|FG000|Overall Study|Other|1|||
144613592|NCT00490568|521446987|FG000|Overall Study|Exclusion criteria met|1|||
144613593|NCT00490568|521446987|FG000|Overall Study|Caregiver related|20|||
144613594|NCT00490568|521446987|FG000|Overall Study|Abnormal ECG|25|||
144613595|NCT00490568|521446987|FG000|Overall Study|Participant refused follow-up|9|||
144613596|NCT00490568|521446987|FG000|Overall Study|Legal representative withdrew consent|1|||
144613597|NCT00490568|521446987|FG000|Overall Study|Disease progression|4|||
144613598|NCT00490568|521446987|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
144613599|NCT00490568|521446987|FG000|Overall Study|Investigator decision|3|||
144613600|NCT00490568|521446987|FG000|Overall Study|Non-Compliance|7|||
144469592|NCT01218126|520915173|FG001|Overall Study|Withdrawal by Subject|5|||
144469593|NCT01218126|520915174|FG002|Overall Study|Withdrawal by Subject|4|||
144469594|NCT01218126|520915175|FG003|Overall Study|Withdrawal by Subject|6|||
144469595|NCT00657618|520915178|FG000|Overall Study|Adverse Event|32|||
144469596|NCT00657618|520915178|FG000|Overall Study|Withdrawal by Subject|8|||
144469597|NCT00657618|520915178|FG000|Overall Study|negative for leishmaniasis|2|||
144469598|NCT00657618|520915178|FG000|Overall Study|didn't start due to schedule conflicts|1|||
144469599|NCT05809596|520915179|FG000|Overall Study|Death|16|||
144613601|NCT00490568|521446987|FG000|Overall Study|Efficacy related|3|||
144613602|NCT00490568|521446987|FG000|Overall Study|Participant died|1|||
144613603|NCT00490568|521446987|FG000|Overall Study|Participant withdrawal due to surgery|1|||
144613604|NCT00105443|521446988|FG000|Double-Blind Treatment|Adverse Event|1|||
144613605|NCT00105443|521446989|FG001|Double-Blind Treatment|Adverse Event|0|||
144613606|NCT00105443|521446990|FG002|Double-Blind Treatment|Adverse Event|0|||
144613607|NCT00105443|521446991|FG003|Double-Blind Treatment|Adverse Event|0|||
144613608|NCT00105443|521446988|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
144613609|NCT00105443|521446989|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
144613610|NCT00105443|521446990|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
144613611|NCT00105443|521446991|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
144469600|NCT05809596|520915179|FG000|Overall Study|Withdrawal by Subject|4|||
144469601|NCT05809596|520915179|FG000|Overall Study|Physician Decision|1|||
144469602|NCT05809596|520915179|FG000|Overall Study|Missed Visit|2|||
144469603|NCT05809596|520915179|FG000|Overall Study|Other|3|||
144469604|NCT02240108|520916198|FG000|Overall Study|Other than specified|8|||
144469605|NCT02240108|520916199|FG001|Overall Study|Other than specified|6|||
144469606|NCT02240108|520916198|FG000|Overall Study|Adverse Event|1|||
144469607|NCT02240108|520916199|FG001|Overall Study|Adverse Event|9|||
144537036|NCT04980300|521169201|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
144537037|NCT04980300|521169200|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
144537038|NCT04980300|521169201|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
144537039|NCT04980300|521169200|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
144537040|NCT04980300|521169201|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
144537041|NCT04980300|521169200|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
144537042|NCT04980300|521169201|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
144537043|NCT05864209|521169908|FG000|Overall Study|Lost to Follow-up|2|||
144537044|NCT05864209|521169909|FG001|Overall Study|Lost to Follow-up|3|||
144537045|NCT04530487|521169910|FG000|Overall Study|Death|1|||
144537046|NCT02422615|521169916|FG000|Treatment Period|Progressive disease|314|||
144537047|NCT02422615|521169917|FG001|Treatment Period|Progressive disease|200|||
144537048|NCT02422615|521169916|FG000|Treatment Period|Adverse Event|51|||
144537049|NCT02422615|521169917|FG001|Treatment Period|Adverse Event|9|||
144537050|NCT02422615|521169916|FG000|Treatment Period|Physician Decision|32|||
144537051|NCT02422615|521169917|FG001|Treatment Period|Physician Decision|8|||
144537052|NCT02422615|521169916|FG000|Treatment Period|Subject/guardian decision|38|||
144537053|NCT02422615|521169917|FG001|Treatment Period|Subject/guardian decision|8|||
144537054|NCT02422615|521169916|FG000|Treatment Period|Death|2|||
144537055|NCT02422615|521169917|FG001|Treatment Period|Death|1|||
144537056|NCT02422615|521169916|FG000|Treatment Period|Technical problems|0|||
144537057|NCT02422615|521169917|FG001|Treatment Period|Technical problems|1|||
144537058|NCT02422615|521169916|FG000|Treatment Period|Protocol deviation|1|||
144537059|NCT02422615|521169917|FG001|Treatment Period|Protocol deviation|1|||
144537060|NCT02422615|521169916|FG000|Treatment Period|Study terminated as per protocol|46|||
144537061|NCT02422615|521169917|FG001|Treatment Period|Study terminated as per protocol|14|||
144537062|NCT02422615|521169916|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
144537063|NCT02422615|521169917|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144537064|NCT02422615|521169916|FG000|Post-treatment Efficacy Follow-up|Death|2|||
144537065|NCT02422615|521169917|FG001|Post-treatment Efficacy Follow-up|Death|1|||
144537066|NCT02422615|521169916|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
144537067|NCT02422615|521169917|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144537068|NCT02422615|521169916|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
144537069|NCT02422615|521169917|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
144537070|NCT02422615|521169916|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
144537071|NCT02422615|521169917|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
144537072|NCT02422615|521169916|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
144537073|NCT02422615|521169917|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
144537074|NCT00439270|521169920|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
144537075|NCT00439270|521169921|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
144537076|NCT00439270|521169922|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
144537077|NCT00439270|521169923|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
144537078|NCT00439270|521169924|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
144537079|NCT00439270|521169920|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
144537080|NCT00439270|521169921|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
144537081|NCT00439270|521169922|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
144537082|NCT00439270|521169923|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
144537083|NCT00439270|521169924|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
144537084|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
144537085|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
144537086|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
144537087|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
144537088|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
144537089|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
144537090|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
144537091|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
144537092|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
144537093|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
144537094|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
144537095|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
144537096|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
144537097|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
144537098|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
144537099|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
144537100|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
144537101|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
144537102|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
144537103|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
144537104|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
144537105|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
144537106|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
144537107|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
144613612|NCT00105443|521446988|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
144613613|NCT00105443|521446989|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
144613614|NCT00105443|521446990|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
144613615|NCT00105443|521446991|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
144613616|NCT00105443|521446988|FG000|Double-Blind Treatment|Physician Decision|1|||
144613617|NCT00105443|521446989|FG001|Double-Blind Treatment|Physician Decision|0|||
144613618|NCT00105443|521446990|FG002|Double-Blind Treatment|Physician Decision|2|||
144613619|NCT00105443|521446991|FG003|Double-Blind Treatment|Physician Decision|0|||
144613620|NCT00105443|521446988|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
144613621|NCT00105443|521446989|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
144613622|NCT00105443|521446990|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
144613623|NCT00105443|521446991|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
144613624|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
144613625|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
144613626|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
144613627|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
144613628|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
144613629|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
144613630|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
144613631|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
144613632|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
144613633|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
144613634|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
144613635|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
144613636|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
144613637|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
144613638|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
144613639|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
144613640|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
144613641|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
144613642|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
144613643|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
144613644|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
144613645|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
144613646|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
144613647|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
144613648|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
144613649|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
144613650|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
144613651|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
144613652|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
144613653|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
144613654|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
144613655|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
144613656|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
144613657|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
144613658|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
144613659|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
144613660|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
144613661|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
144613662|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
144613663|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
144613664|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
144613665|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
144613666|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
144613667|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
144613668|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
144613669|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
144613670|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
144613671|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
144613672|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
144613673|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
144613674|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
144469608|NCT02240108|520916198|FG000|Overall Study|Pregnancy|1|||
144469609|NCT02240108|520916199|FG001|Overall Study|Pregnancy|0|||
144469610|NCT02240108|520916198|FG000|Overall Study|Withdrawal by Subject|4|||
144469611|NCT02240108|520916199|FG001|Overall Study|Withdrawal by Subject|9|||
144469612|NCT02240108|520916198|FG000|Overall Study|StudyTerminated by Sponsor|0|||
144469613|NCT02240108|520916199|FG001|Overall Study|StudyTerminated by Sponsor|1|||
144469614|NCT02182973|520916201|FG000|Overall Study|Withdrawal by Subject|3|||
144469615|NCT02182973|520916202|FG001|Overall Study|Withdrawal by Subject|0|||
144469616|NCT01235546|520916203|FG000|Overall Study|Staff error, medication not administered|1|||
144469617|NCT01235546|520916204|FG001|Overall Study|Staff error, medication not administered|0|||
144469618|NCT01235546|520916203|FG000|Overall Study|Protocol Violation|1|||
144469619|NCT01235546|520916204|FG001|Overall Study|Protocol Violation|1|||
144469620|NCT01123382|520916205|FG000|Overall Study|Withdrawal by Subject|1|||
144469621|NCT01123382|520916206|FG001|Overall Study|Withdrawal by Subject|4|||
144469622|NCT01123382|520916205|FG000|Overall Study|Lost to Follow-up|1|||
144469623|NCT01123382|520916206|FG001|Overall Study|Lost to Follow-up|2|||
144469624|NCT02740049|520916207|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
144469625|NCT02274857|520916208|FG000|Overall Study|Adverse Event|1|||
144469626|NCT02274857|520916209|FG001|Overall Study|Adverse Event|0|||
144469627|NCT02274857|520916208|FG000|Overall Study|Death|1|||
144469628|NCT02274857|520916209|FG001|Overall Study|Death|2|||
144469629|NCT02274857|520916208|FG000|Overall Study|Lost to Follow-up|3|||
144469630|NCT02274857|520916209|FG001|Overall Study|Lost to Follow-up|0|||
144469631|NCT02274857|520916208|FG000|Overall Study|Physician Decision|2|||
144469632|NCT02274857|520916209|FG001|Overall Study|Physician Decision|0|||
144469633|NCT02274857|520916208|FG000|Overall Study|Trial screen failure|0|||
144469634|NCT02274857|520916209|FG001|Overall Study|Trial screen failure|2|||
144469635|NCT02274857|520916208|FG000|Overall Study|Withdrawal by Subject|11|||
144469636|NCT02274857|520916209|FG001|Overall Study|Withdrawal by Subject|2|||
144469637|NCT02274857|520916208|FG000|Overall Study|Other|2|||
144469638|NCT02274857|520916209|FG001|Overall Study|Other|0|||
144469639|NCT03338829|520916214|FG000|Overall Study|Lost to Follow-up|4|||
144469640|NCT03338829|520916215|FG001|Overall Study|Lost to Follow-up|2|||
144469641|NCT03338829|520916216|FG002|Overall Study|Lost to Follow-up|4|||
144469642|NCT03338829|520916214|FG000|Overall Study|Pregnancy loss|1|||
144469643|NCT03338829|520916215|FG001|Overall Study|Pregnancy loss|1|||
144469644|NCT03338829|520916216|FG002|Overall Study|Pregnancy loss|0|||
144469645|NCT03338829|520916214|FG000|Overall Study|Protocol Violation|0|||
144469646|NCT03338829|520916215|FG001|Overall Study|Protocol Violation|1|||
144469647|NCT03338829|520916216|FG002|Overall Study|Protocol Violation|0|||
144469648|NCT02340026|520916217|FG000|Treatment Phase|Withdrawal by Subject|2|||
144469649|NCT02340026|520916218|FG001|Treatment Phase|Withdrawal by Subject|2|||
144469650|NCT02340026|520916217|FG000|Follow-up Phase|Lost to Follow-up|1|||
144469651|NCT02340026|520916218|FG001|Follow-up Phase|Lost to Follow-up|0|||
144469652|NCT03078816|520916229|FG000|Overall Study|Withdrawal by Subject|1|||
144469653|NCT02114151|520916230|FG000|Overall Study|Death|1|||
144469654|NCT02114151|520916230|FG000|Overall Study|Lost to Follow-up|1|||
144469655|NCT02114151|520916230|FG000|Overall Study|Withdrawal by Subject|5|||
144469656|NCT01666808|520916231|FG000|Overall Study|Lost to Follow-up|9|||
144537108|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
144537109|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
144537110|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
144537111|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
144537112|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
144537113|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
144537114|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
144537115|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
144537116|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
144537117|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
144537118|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
144537119|NCT00439270|521169920|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
144537120|NCT00439270|521169921|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
144537121|NCT00439270|521169922|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
144537122|NCT00439270|521169923|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
144537123|NCT00439270|521169924|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
144537124|NCT01268306|521169925|FG000|Overall Study|Lost to Follow-up|1|||
144537125|NCT04334317|521169926|FG000|Overall Study|Adverse Event|1|||
144537126|NCT04334317|521169927|FG001|Overall Study|Adverse Event|2|||
144537127|NCT04334317|521169928|FG002|Overall Study|Adverse Event|0|||
144537128|NCT04334317|521169929|FG003|Overall Study|Adverse Event|0|||
144537129|NCT04334317|521169926|FG000|Overall Study|Protocol Deviation|0|||
144537130|NCT04334317|521169927|FG001|Overall Study|Protocol Deviation|1|||
144537131|NCT04334317|521169928|FG002|Overall Study|Protocol Deviation|0|||
144537132|NCT04334317|521169929|FG003|Overall Study|Protocol Deviation|0|||
144537133|NCT04334317|521169926|FG000|Overall Study|Withdrawal by Subject|2|||
144259307|NCT00511810|520150364|FG001|Overall Study|Lost to Follow-up|2|||
144469657|NCT01666808|520916232|FG001|Overall Study|Lost to Follow-up|15|||
144469658|NCT01666808|520916231|FG000|Overall Study|Withdrawal by Subject|3|||
144469659|NCT01666808|520916232|FG001|Overall Study|Withdrawal by Subject|1|||
144469660|NCT01666808|520916231|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
144469661|NCT01666808|520916232|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
144469662|NCT03933826|520916233|FG000|Overall Study|Withdrawal by Subject|8|||
144469663|NCT03933826|520916234|FG001|Overall Study|Withdrawal by Subject|1|||
144469664|NCT03933826|520916233|FG000|Overall Study|Death|19|||
144469665|NCT03933826|520916234|FG001|Overall Study|Death|11|||
144469666|NCT03933826|520916233|FG000|Overall Study|Lost to Follow-up|41|||
144469667|NCT03933826|520916234|FG001|Overall Study|Lost to Follow-up|13|||
144469668|NCT01860703|520916237|FG000|Overall Study|Adverse Event|1|||
144469669|NCT01860703|520916238|FG001|Overall Study|Adverse Event|4|||
144469670|NCT01860703|520916239|FG002|Overall Study|Adverse Event|0|||
144469671|NCT01860703|520916240|FG003|Overall Study|Adverse Event|2|||
144469672|NCT01860703|520916237|FG000|Overall Study|Withdrawal by Subject|0|||
144469673|NCT01860703|520916238|FG001|Overall Study|Withdrawal by Subject|1|||
144469674|NCT01860703|520916239|FG002|Overall Study|Withdrawal by Subject|0|||
144469675|NCT01860703|520916240|FG003|Overall Study|Withdrawal by Subject|0|||
144469676|NCT01860703|520916237|FG000|Overall Study|Personal reason|1|||
144469677|NCT01860703|520916238|FG001|Overall Study|Personal reason|0|||
144469678|NCT01860703|520916239|FG002|Overall Study|Personal reason|1|||
144469679|NCT01860703|520916240|FG003|Overall Study|Personal reason|0|||
144469680|NCT00696410|520916242|FG000|Overall Study|Lost to Follow-up|2|||
144469681|NCT00696410|520916243|FG001|Overall Study|Lost to Follow-up|0|||
144469682|NCT00696410|520916242|FG000|Overall Study|Withdrawal by Subject|8|||
144469683|NCT00696410|520916243|FG001|Overall Study|Withdrawal by Subject|0|||
144469684|NCT00696410|520916242|FG000|Overall Study|Physician Decision|3|||
144469685|NCT00696410|520916243|FG001|Overall Study|Physician Decision|0|||
144469686|NCT03184792|520916247|FG000|Overall Study|Pandemic|2|||
144469687|NCT03184792|520916248|FG001|Overall Study|Pandemic|2|||
144469688|NCT00265889|520916250|FG000|Overall Study|Physician Decision|1|||
144469689|NCT00265889|520916250|FG000|Overall Study|Protocol Violation|1|||
144469690|NCT00265889|520916250|FG000|Overall Study|Insurance denied the request|3|||
144469691|NCT02134587|520916251|FG000|Overall Study|Did not completed all meetings|30|||
144469692|NCT01515748|520916259|FG000|Overall Study|Withdrawal by Subject|32|||
144469693|NCT01515748|520916260|FG001|Overall Study|Withdrawal by Subject|41|||
144469694|NCT01515748|520916259|FG000|Overall Study|Lost to Follow-up|2|||
144469695|NCT01515748|520916260|FG001|Overall Study|Lost to Follow-up|4|||
144469696|NCT01515748|520916259|FG000|Overall Study|Other than specified above|5|||
144469697|NCT01515748|520916260|FG001|Overall Study|Other than specified above|10|||
144469698|NCT03221387|520916261|FG000|Overall Study|Lost to Follow-up|1|||
144469699|NCT03221387|520916261|FG000|Overall Study|Lung transplant|1|||
144537134|NCT04334317|521169927|FG001|Overall Study|Withdrawal by Subject|2|||
144537135|NCT04334317|521169928|FG002|Overall Study|Withdrawal by Subject|0|||
144537136|NCT04334317|521169929|FG003|Overall Study|Withdrawal by Subject|0|||
144537137|NCT03709706|521169930|FG000|Overall Study|Adverse Event|0|||
144537138|NCT03709706|521169931|FG001|Overall Study|Adverse Event|1|||
144537139|NCT03709706|521169930|FG000|Overall Study|Physician Decision|14|||
144537140|NCT03709706|521169931|FG001|Overall Study|Physician Decision|8|||
144537141|NCT03709706|521169930|FG000|Overall Study|Withdrawal by Subject|2|||
144537142|NCT03709706|521169931|FG001|Overall Study|Withdrawal by Subject|1|||
144537143|NCT03709706|521169930|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
144537144|NCT03709706|521169931|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
144537145|NCT01105975|521169932|FG000|Overall Study|Adverse Event|2|||
144537146|NCT01105975|521169933|FG001|Overall Study|Adverse Event|1|||
144537147|NCT01105975|521169934|FG002|Overall Study|Adverse Event|5|||
144537148|NCT01105975|521169935|FG003|Overall Study|Adverse Event|1|||
144537149|NCT01105975|521169936|FG004|Overall Study|Adverse Event|0|||
144537150|NCT01105975|521169937|FG005|Overall Study|Adverse Event|1|||
144537151|NCT01105975|521169938|FG006|Overall Study|Adverse Event|2|||
144537152|NCT01105975|521169939|FG007|Overall Study|Adverse Event|4|||
144537153|NCT01105975|521169940|FG008|Overall Study|Adverse Event|1|||
144537154|NCT01105975|521169941|FG009|Overall Study|Adverse Event|4|||
144537155|NCT01105975|521169932|FG000|Overall Study|Withdrawal by Subject|2|||
144537156|NCT01105975|521169933|FG001|Overall Study|Withdrawal by Subject|2|||
144537157|NCT01105975|521169934|FG002|Overall Study|Withdrawal by Subject|2|||
144537158|NCT01105975|521169935|FG003|Overall Study|Withdrawal by Subject|0|||
144537159|NCT01105975|521169936|FG004|Overall Study|Withdrawal by Subject|4|||
144537160|NCT01105975|521169937|FG005|Overall Study|Withdrawal by Subject|1|||
144537161|NCT01105975|521169938|FG006|Overall Study|Withdrawal by Subject|2|||
144469700|NCT02365519|520916262|FG000|Randomized and Treated|Adverse Event|0|||
144469701|NCT02365519|520916263|FG001|Randomized and Treated|Adverse Event|1|||
144469702|NCT02365519|520916264|FG002|Randomized and Treated|Adverse Event|0|||
144469703|NCT02365519|520916262|FG000|Randomized and Treated|Withdrawal by Subject|0|||
144469704|NCT02365519|520916263|FG001|Randomized and Treated|Withdrawal by Subject|1|||
144613675|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
144613676|NCT00105443|521446988|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
144613677|NCT00105443|521446989|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
144613678|NCT00105443|521446990|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
144613679|NCT00105443|521446991|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
144613680|NCT01157078|521446992|FG000|Overall Study|Withdrawal by Subject|12|||
144613681|NCT01157078|521446993|FG001|Overall Study|Withdrawal by Subject|14|||
144613682|NCT01157078|521446992|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144613683|NCT01157078|521446993|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144613684|NCT01157078|521446992|FG000|Overall Study|Adverse Event|6|||
144613685|NCT01157078|521446993|FG001|Overall Study|Adverse Event|6|||
144613686|NCT01157078|521446992|FG000|Overall Study|Severe non-compliance to protocol|2|||
144613687|NCT01157078|521446993|FG001|Overall Study|Severe non-compliance to protocol|4|||
144613688|NCT01157078|521446992|FG000|Overall Study|Condition under investigation worsened|0|||
144613689|NCT01157078|521446993|FG001|Overall Study|Condition under investigation worsened|1|||
144613690|NCT01157078|521446992|FG000|Overall Study|Lack of Efficacy|2|||
144613691|NCT01157078|521446993|FG001|Overall Study|Lack of Efficacy|0|||
144613692|NCT01157078|521446992|FG000|Overall Study|Study-specific withdrawal criteria|2|||
144613693|NCT01157078|521446993|FG001|Overall Study|Study-specific withdrawal criteria|2|||
144613694|NCT01157078|521446992|FG000|Overall Study|Lost to Follow-up|7|||
144613695|NCT01157078|521446993|FG001|Overall Study|Lost to Follow-up|5|||
144613696|NCT01157078|521446992|FG000|Overall Study|Other|2|||
144613697|NCT01157078|521446993|FG001|Overall Study|Other|4|||
144613698|NCT02055820|521446994|FG000|Phase I: Dose-Finding|Death|1|||
144613699|NCT02055820|521446995|FG001|Phase I: Dose-Finding|Death|0|||
144613700|NCT02055820|521446996|FG002|Phase I: Dose-Finding|Death|1|||
144613701|NCT02055820|521446997|FG003|Phase I: Dose-Finding|Death|2|||
144613702|NCT02055820|521446998|FG004|Phase I: Dose-Finding|Death|0|||
144613703|NCT02055820|521446999|FG005|Phase I: Dose-Finding|Death|1|||
144613704|NCT02055820|521447000|FG006|Phase I: Dose-Finding|Death|1|||
144613705|NCT02055820|521447001|FG007|Phase I: Dose-Finding|Death|0|||
144613706|NCT02055820|521447002|FG008|Phase I: Dose-Finding|Death|0|||
144613707|NCT02055820|521447003|FG009|Phase I: Dose-Finding|Death|0|||
144613708|NCT02055820|521446994|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613709|NCT02055820|521446995|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613710|NCT02055820|521446996|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613711|NCT02055820|521446997|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613712|NCT02055820|521446998|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613713|NCT02055820|521446999|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
144613714|NCT02055820|521447000|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613715|NCT02055820|521447001|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613716|NCT02055820|521447002|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613717|NCT02055820|521447003|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
144613718|NCT02055820|521446994|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613719|NCT02055820|521446995|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613720|NCT02055820|521446996|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613721|NCT02055820|521446997|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
144613722|NCT02055820|521446998|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613723|NCT02055820|521446999|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613724|NCT02055820|521447000|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
144613725|NCT02055820|521447001|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613726|NCT02055820|521447002|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613727|NCT02055820|521447003|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
144613728|NCT02055820|521446994|FG000|Phase II: Expansion|Death|0|||
144613729|NCT02055820|521446995|FG001|Phase II: Expansion|Death|0|||
144613730|NCT02055820|521446996|FG002|Phase II: Expansion|Death|0|||
144613731|NCT02055820|521446997|FG003|Phase II: Expansion|Death|0|||
144613732|NCT02055820|521446998|FG004|Phase II: Expansion|Death|33|||
144613733|NCT02055820|521446999|FG005|Phase II: Expansion|Death|0|||
144613734|NCT02055820|521447000|FG006|Phase II: Expansion|Death|0|||
144613735|NCT02055820|521447001|FG007|Phase II: Expansion|Death|0|||
144613736|NCT02055820|521447002|FG008|Phase II: Expansion|Death|0|||
144613737|NCT02055820|521447003|FG009|Phase II: Expansion|Death|0|||
144613738|NCT02055820|521446994|FG000|Phase II: Expansion|Lost to Follow-up|0|||
144613739|NCT02055820|521446995|FG001|Phase II: Expansion|Lost to Follow-up|0|||
144613740|NCT02055820|521446996|FG002|Phase II: Expansion|Lost to Follow-up|0|||
144613741|NCT02055820|521446997|FG003|Phase II: Expansion|Lost to Follow-up|0|||
144613742|NCT02055820|521446998|FG004|Phase II: Expansion|Lost to Follow-up|4|||
144613743|NCT02055820|521446999|FG005|Phase II: Expansion|Lost to Follow-up|0|||
144613744|NCT02055820|521447000|FG006|Phase II: Expansion|Lost to Follow-up|0|||
144613745|NCT02055820|521447001|FG007|Phase II: Expansion|Lost to Follow-up|0|||
144613746|NCT02055820|521447002|FG008|Phase II: Expansion|Lost to Follow-up|0|||
144613747|NCT02055820|521447003|FG009|Phase II: Expansion|Lost to Follow-up|0|||
144613748|NCT02055820|521446994|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
144613749|NCT02055820|521446995|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
144613750|NCT02055820|521446996|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
144537162|NCT01105975|521169939|FG007|Overall Study|Withdrawal by Subject|1|||
144537163|NCT01105975|521169940|FG008|Overall Study|Withdrawal by Subject|0|||
144537164|NCT01105975|521169941|FG009|Overall Study|Withdrawal by Subject|3|||
144537165|NCT01105975|521169932|FG000|Overall Study|Lost to Follow-up|1|||
144537166|NCT01105975|521169933|FG001|Overall Study|Lost to Follow-up|0|||
144537167|NCT01105975|521169934|FG002|Overall Study|Lost to Follow-up|0|||
144537168|NCT01105975|521169935|FG003|Overall Study|Lost to Follow-up|1|||
144537169|NCT01105975|521169936|FG004|Overall Study|Lost to Follow-up|1|||
144537170|NCT01105975|521169937|FG005|Overall Study|Lost to Follow-up|0|||
144537171|NCT01105975|521169938|FG006|Overall Study|Lost to Follow-up|0|||
144537172|NCT01105975|521169939|FG007|Overall Study|Lost to Follow-up|0|||
144537173|NCT01105975|521169940|FG008|Overall Study|Lost to Follow-up|1|||
144537174|NCT01105975|521169941|FG009|Overall Study|Lost to Follow-up|0|||
144537175|NCT01105975|521169932|FG000|Overall Study|Physician Decision|0|||
144537176|NCT01105975|521169933|FG001|Overall Study|Physician Decision|0|||
144537177|NCT01105975|521169934|FG002|Overall Study|Physician Decision|0|||
144537178|NCT01105975|521169935|FG003|Overall Study|Physician Decision|0|||
144537179|NCT01105975|521169936|FG004|Overall Study|Physician Decision|0|||
144537180|NCT01105975|521169937|FG005|Overall Study|Physician Decision|0|||
144537181|NCT01105975|521169938|FG006|Overall Study|Physician Decision|2|||
144537182|NCT01105975|521169939|FG007|Overall Study|Physician Decision|0|||
144537183|NCT01105975|521169940|FG008|Overall Study|Physician Decision|0|||
144537184|NCT01105975|521169941|FG009|Overall Study|Physician Decision|0|||
144537185|NCT01105975|521169932|FG000|Overall Study|Protocol Violation|0|||
144537186|NCT01105975|521169933|FG001|Overall Study|Protocol Violation|2|||
144537187|NCT01105975|521169934|FG002|Overall Study|Protocol Violation|2|||
144537188|NCT01105975|521169935|FG003|Overall Study|Protocol Violation|0|||
144537189|NCT01105975|521169936|FG004|Overall Study|Protocol Violation|1|||
144537190|NCT01105975|521169937|FG005|Overall Study|Protocol Violation|1|||
144537191|NCT01105975|521169938|FG006|Overall Study|Protocol Violation|1|||
144537192|NCT01105975|521169939|FG007|Overall Study|Protocol Violation|1|||
144537193|NCT01105975|521169940|FG008|Overall Study|Protocol Violation|2|||
144537194|NCT01105975|521169941|FG009|Overall Study|Protocol Violation|2|||
144537195|NCT01105975|521169932|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144537196|NCT01105975|521169933|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144537197|NCT01105975|521169934|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
144537198|NCT01105975|521169935|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144537199|NCT01105975|521169936|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144537200|NCT01105975|521169937|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
144537201|NCT01105975|521169938|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
144537202|NCT01105975|521169939|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
144537203|NCT01105975|521169940|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
144537204|NCT01105975|521169941|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
144537205|NCT04868617|521169942|FG000|Overall Study|Death|1|||
144537206|NCT04868617|521169943|FG001|Overall Study|Death|0|||
144537207|NCT04868617|521169942|FG000|Overall Study|Adverse Event|1|||
144537208|NCT04868617|521169943|FG001|Overall Study|Adverse Event|0|||
144537209|NCT04868617|521169942|FG000|Overall Study|Withdrawal by Subject|1|||
144537210|NCT04868617|521169943|FG001|Overall Study|Withdrawal by Subject|0|||
144537211|NCT04868617|521169942|FG000|Overall Study|Device deficiency|1|||
144537212|NCT04868617|521169943|FG001|Overall Study|Device deficiency|0|||
144537213|NCT03183050|521169944|FG000|Overall Study|Lost to Follow-up|23|||
144537214|NCT02797132|521169945|FG000|Part A (15 Days)|Adverse Event|1|||
144537215|NCT02797132|521169945|FG000|Part B (24 Weeks)|Adverse Event|3|||
144537216|NCT01371994|521169948|FG000|Overall Study|Adverse Event|3|||
144537217|NCT01371994|521169949|FG001|Overall Study|Adverse Event|6|||
144537218|NCT01371994|521169948|FG000|Overall Study|Lack of Efficacy|3|||
144537219|NCT01371994|521169949|FG001|Overall Study|Lack of Efficacy|0|||
144537220|NCT01371994|521169948|FG000|Overall Study|Withdrawal by Subject|13|||
144537221|NCT01371994|521169949|FG001|Overall Study|Withdrawal by Subject|7|||
144537222|NCT01371994|521169948|FG000|Overall Study|Lost to Follow-up|1|||
144537223|NCT01371994|521169949|FG001|Overall Study|Lost to Follow-up|1|||
144537224|NCT01371994|521169948|FG000|Overall Study|Protocol Violation|24|||
144537225|NCT01371994|521169949|FG001|Overall Study|Protocol Violation|17|||
144537226|NCT01371994|521169948|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
144537227|NCT01371994|521169949|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
144537228|NCT01371994|521169948|FG000|Overall Study|Physician Decision|1|||
144537229|NCT01371994|521169949|FG001|Overall Study|Physician Decision|1|||
144537230|NCT01371994|521169948|FG000|Overall Study|Miscellaneous Reasons|6|||
144537231|NCT01371994|521169949|FG001|Overall Study|Miscellaneous Reasons|4|||
144537232|NCT05018143|521169950|FG000|Overall Study|Lost to Follow-up|5|||
144537233|NCT05018143|521169951|FG001|Overall Study|Lost to Follow-up|4|||
144537234|NCT05018143|521169950|FG000|Overall Study|Withdrawal by Subject|0|||
144537235|NCT05018143|521169951|FG001|Overall Study|Withdrawal by Subject|1|||
144537236|NCT05601882|521169952|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
144537237|NCT05601882|521169953|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
144537238|NCT05601882|521169954|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
144613751|NCT02055820|521446997|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
144259308|NCT00511810|520150363|FG000|Overall Study|Lack of Efficacy|0|||
144469705|NCT02365519|520916264|FG002|Randomized and Treated|Withdrawal by Subject|1|||
144469706|NCT01971723|520916265|FG000|Overall Study|Withdrawal by Subject|1|||
144469707|NCT01971723|520916266|FG001|Overall Study|Withdrawal by Subject|1|||
144469708|NCT01971723|520916265|FG000|Overall Study|Protocol Violation|1|||
144469709|NCT01971723|520916266|FG001|Overall Study|Protocol Violation|2|||
144469710|NCT03188055|520916270|FG000|Overall Study|Unavailable for training|0|||
144469711|NCT03188055|520916271|FG001|Overall Study|Unavailable for training|0|||
144469712|NCT03188055|520916272|FG002|Overall Study|Unavailable for training|19|||
144469713|NCT03188055|520916273|FG003|Overall Study|Unavailable for training|0|||
144469714|NCT03188055|520916274|FG004|Overall Study|Unavailable for training|0|||
144469715|NCT03188055|520916275|FG005|Overall Study|Unavailable for training|0|||
144469716|NCT03188055|520916270|FG000|Overall Study|Lost to Follow-up|0|||
144469717|NCT03188055|520916271|FG001|Overall Study|Lost to Follow-up|18|||
144469718|NCT03188055|520916272|FG002|Overall Study|Lost to Follow-up|0|||
144469719|NCT03188055|520916273|FG003|Overall Study|Lost to Follow-up|11|||
144469720|NCT03188055|520916274|FG004|Overall Study|Lost to Follow-up|0|||
144469721|NCT03188055|520916275|FG005|Overall Study|Lost to Follow-up|0|||
144469722|NCT03188055|520916270|FG000|Overall Study|Withdrawal by Subject|0|||
144469723|NCT03188055|520916271|FG001|Overall Study|Withdrawal by Subject|1|||
144469724|NCT03188055|520916272|FG002|Overall Study|Withdrawal by Subject|0|||
144469725|NCT03188055|520916273|FG003|Overall Study|Withdrawal by Subject|1|||
144469726|NCT03188055|520916274|FG004|Overall Study|Withdrawal by Subject|0|||
144469727|NCT03188055|520916275|FG005|Overall Study|Withdrawal by Subject|0|||
144469728|NCT03657277|520916276|FG000|Overall Study|Physician Decision|2|||
144469729|NCT03657277|520916276|FG000|Overall Study|Lost to Follow-up|1|||
144469730|NCT03657277|520916276|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
144469731|NCT02286089|520916279|FG000|Overall Study|Ongoing in Study|1|||
144469732|NCT02286089|520916280|FG001|Overall Study|Ongoing in Study|1|||
144469733|NCT02286089|520916281|FG002|Overall Study|Ongoing in Study|4|||
144469734|NCT02286089|520916282|FG003|Overall Study|Ongoing in Study|10|||
144469735|NCT02286089|520916279|FG000|Overall Study|Withdrawal by Subject|0|||
144469736|NCT02286089|520916280|FG001|Overall Study|Withdrawal by Subject|0|||
144469737|NCT02286089|520916281|FG002|Overall Study|Withdrawal by Subject|2|||
144469738|NCT02286089|520916282|FG003|Overall Study|Withdrawal by Subject|2|||
144469739|NCT05774197|520916283|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
144469740|NCT05073133|520916285|FG000|Overall Study|Death|2|||
144469741|NCT05002218|520916286|FG000|Overall Study|Lost to Follow-up|5|||
144469742|NCT05002218|520916287|FG001|Overall Study|Lost to Follow-up|6|||
144469743|NCT04120233|520916288|FG000|Overall Study|Adverse Event|0|||
144469744|NCT04120233|520916289|FG001|Overall Study|Adverse Event|0|||
144469745|NCT04120233|520916290|FG002|Overall Study|Adverse Event|0|||
144469746|NCT04120233|520916291|FG003|Overall Study|Adverse Event|0|||
144469747|NCT04120233|520916292|FG004|Overall Study|Adverse Event|1|||
144469748|NCT04120233|520916293|FG005|Overall Study|Adverse Event|0|||
144469749|NCT02553460|520916296|FG000|Overall Study|Death|3|||
144469750|NCT02553460|520916296|FG000|Overall Study|Withdrawal by Subject|1|||
144469751|NCT02553460|520916296|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
144469752|NCT02553460|520916296|FG000|Overall Study|Relapse or Transplant|14|||
144469753|NCT02553460|520916296|FG000|Overall Study|No response to treatment|2|||
144469754|NCT02553460|520916296|FG000|Overall Study|CAR T cells|2|||
144469755|NCT03770494|520916297|FG000|Overall Study|Lost to Follow-up|0|||
144469756|NCT03770494|520916298|FG001|Overall Study|Lost to Follow-up|0|||
144469757|NCT03770494|520916299|FG002|Overall Study|Lost to Follow-up|1|||
144469758|NCT03770494|520916300|FG003|Overall Study|Lost to Follow-up|1|||
144469759|NCT03770494|520916301|FG004|Overall Study|Lost to Follow-up|1|||
144469760|NCT03770494|520916302|FG005|Overall Study|Lost to Follow-up|0|||
144469761|NCT03770494|520916303|FG006|Overall Study|Lost to Follow-up|0|||
144469762|NCT03770494|520916304|FG007|Overall Study|Lost to Follow-up|0|||
144469763|NCT03770494|520916305|FG008|Overall Study|Lost to Follow-up|0|||
144469764|NCT03770494|520916306|FG009|Overall Study|Lost to Follow-up|0|||
144469765|NCT03770494|520916307|FG010|Overall Study|Lost to Follow-up|0|||
144469766|NCT03770494|520916308|FG011|Overall Study|Lost to Follow-up|0|||
144469767|NCT03770494|520916309|FG012|Overall Study|Lost to Follow-up|0|||
144469768|NCT03770494|520916310|FG013|Overall Study|Lost to Follow-up|0|||
144469769|NCT03770494|520916297|FG000|Overall Study|Study terminated by sponsor|1|||
144469770|NCT03770494|520916298|FG001|Overall Study|Study terminated by sponsor|2|||
144469771|NCT03770494|520916299|FG002|Overall Study|Study terminated by sponsor|1|||
144469772|NCT03770494|520916300|FG003|Overall Study|Study terminated by sponsor|1|||
144469773|NCT03770494|520916301|FG004|Overall Study|Study terminated by sponsor|1|||
144469774|NCT03770494|520916302|FG005|Overall Study|Study terminated by sponsor|2|||
144469775|NCT03770494|520916303|FG006|Overall Study|Study terminated by sponsor|1|||
144469776|NCT03770494|520916304|FG007|Overall Study|Study terminated by sponsor|2|||
144469777|NCT03770494|520916305|FG008|Overall Study|Study terminated by sponsor|1|||
144469778|NCT03770494|520916306|FG009|Overall Study|Study terminated by sponsor|2|||
144469779|NCT03770494|520916307|FG010|Overall Study|Study terminated by sponsor|1|||
144613752|NCT02055820|521446998|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
144613753|NCT02055820|521446999|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
144613754|NCT02055820|521447000|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
144613755|NCT02055820|521447001|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
144613756|NCT02055820|521447002|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
144613757|NCT02055820|521447003|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
144613758|NCT00930761|521447004|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
144613759|NCT00930761|521447005|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
144613760|NCT00930761|521447004|FG000|Overall Study|less than 3 music therapy sessions|0|||
144613761|NCT00930761|521447005|FG001|Overall Study|less than 3 music therapy sessions|3|||
144613762|NCT03571646|521447007|FG000|Overall Study|Adverse Event|1|||
144613763|NCT03571646|521447008|FG001|Overall Study|Adverse Event|0|||
144613764|NCT03571646|521447007|FG000|Overall Study|Withdrawal by Subject|1|||
144613765|NCT03571646|521447008|FG001|Overall Study|Withdrawal by Subject|1|||
144613766|NCT03548935|521447009|FG000|Overall Study|Withdrawal by Subject|26|||
144613767|NCT03548935|521447010|FG001|Overall Study|Withdrawal by Subject|17|||
144613768|NCT03548935|521447009|FG000|Overall Study|Lost to Follow-up|39|||
144613769|NCT03548935|521447010|FG001|Overall Study|Lost to Follow-up|28|||
144613770|NCT03548935|521447009|FG000|Overall Study|Death|1|||
144613771|NCT03548935|521447010|FG001|Overall Study|Death|1|||
144613772|NCT01970995|521447011|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
144613773|NCT01970995|521447012|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
144613774|NCT01970995|521447013|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
144613775|NCT01970995|521447011|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
144613776|NCT01970995|521447012|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
144613777|NCT01970995|521447013|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
144613778|NCT01157364|521447016|FG000|Overall Study|Other Reasons|1|||
144613779|NCT01157364|521447017|FG001|Overall Study|Other Reasons|1|||
144613780|NCT01157364|521447018|FG002|Overall Study|Other Reasons|2|||
144613781|NCT01157364|521447019|FG003|Overall Study|Other Reasons|1|||
144613782|NCT01157364|521447020|FG004|Overall Study|Other Reasons|0|||
144613783|NCT01157364|521447021|FG005|Overall Study|Other Reasons|0|||
144613784|NCT01157364|521447016|FG000|Overall Study|Personal Reasons|0|||
144613785|NCT01157364|521447017|FG001|Overall Study|Personal Reasons|2|||
144613786|NCT01157364|521447018|FG002|Overall Study|Personal Reasons|0|||
144613787|NCT01157364|521447019|FG003|Overall Study|Personal Reasons|0|||
144613788|NCT01157364|521447020|FG004|Overall Study|Personal Reasons|1|||
144613789|NCT01157364|521447021|FG005|Overall Study|Personal Reasons|1|||
144613790|NCT01157364|521447016|FG000|Overall Study|Lost to Follow-up|1|||
144613791|NCT01157364|521447017|FG001|Overall Study|Lost to Follow-up|0|||
144613792|NCT01157364|521447018|FG002|Overall Study|Lost to Follow-up|1|||
144613793|NCT01157364|521447019|FG003|Overall Study|Lost to Follow-up|0|||
144613794|NCT01157364|521447020|FG004|Overall Study|Lost to Follow-up|0|||
144613795|NCT01157364|521447021|FG005|Overall Study|Lost to Follow-up|0|||
144613796|NCT01157364|521447016|FG000|Overall Study|Lack of Efficacy|0|||
144613797|NCT01157364|521447017|FG001|Overall Study|Lack of Efficacy|0|||
144613798|NCT01157364|521447018|FG002|Overall Study|Lack of Efficacy|0|||
144613799|NCT01157364|521447019|FG003|Overall Study|Lack of Efficacy|1|||
144613800|NCT01157364|521447020|FG004|Overall Study|Lack of Efficacy|0|||
144613801|NCT01157364|521447021|FG005|Overall Study|Lack of Efficacy|0|||
144613802|NCT01157364|521447016|FG000|Overall Study|Adverse Event|0|||
144613803|NCT01157364|521447017|FG001|Overall Study|Adverse Event|1|||
144613804|NCT01157364|521447018|FG002|Overall Study|Adverse Event|1|||
144613805|NCT01157364|521447019|FG003|Overall Study|Adverse Event|0|||
144613806|NCT01157364|521447020|FG004|Overall Study|Adverse Event|1|||
144613807|NCT01157364|521447021|FG005|Overall Study|Adverse Event|0|||
144613808|NCT01780662|521447022|FG000|Overall Study|Adverse Event|1|||
144613809|NCT01780662|521447023|FG001|Overall Study|Adverse Event|0|||
144613810|NCT01780662|521447024|FG002|Overall Study|Adverse Event|2|||
144613811|NCT01780662|521447022|FG000|Overall Study|Physician Decision|0|||
144613812|NCT01780662|521447023|FG001|Overall Study|Physician Decision|5|||
144613813|NCT01780662|521447024|FG002|Overall Study|Physician Decision|7|||
144613814|NCT01780662|521447022|FG000|Overall Study|Protocol Violation|0|||
144613815|NCT01780662|521447023|FG001|Overall Study|Protocol Violation|1|||
144613816|NCT01780662|521447024|FG002|Overall Study|Protocol Violation|0|||
144613817|NCT01780662|521447022|FG000|Overall Study|Ineligible|0|||
144613818|NCT01780662|521447023|FG001|Overall Study|Ineligible|0|||
144613819|NCT01780662|521447024|FG002|Overall Study|Ineligible|1|||
144613820|NCT01263639|521447025|FG000|Overall Study|Lost to Follow-up|66|||
144613821|NCT01263639|521447026|FG001|Overall Study|Lost to Follow-up|70|||
144613822|NCT01263639|521447025|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
144613823|NCT01263639|521447026|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
144613824|NCT02025907|521447027|FG000|Overall Study|Lack of Efficacy|1|||
144613825|NCT02025907|521447028|FG001|Overall Study|Lack of Efficacy|0|||
144613826|NCT02025907|521447027|FG000|Overall Study|Withdrawal by Subject|15|||
144613827|NCT02025907|521447028|FG001|Overall Study|Withdrawal by Subject|8|||
144613828|NCT02025907|521447027|FG000|Overall Study|Protocol Violation|2|||
144613829|NCT02025907|521447028|FG001|Overall Study|Protocol Violation|0|||
144613830|NCT02025907|521447027|FG000|Overall Study|Physician Decision|2|||
144613831|NCT02025907|521447028|FG001|Overall Study|Physician Decision|0|||
144613832|NCT02025907|521447027|FG000|Overall Study|Lost to Follow-up|2|||
144613833|NCT02025907|521447028|FG001|Overall Study|Lost to Follow-up|2|||
144613834|NCT02025907|521447027|FG000|Overall Study|Adverse Event|3|||
144613835|NCT02025907|521447028|FG001|Overall Study|Adverse Event|1|||
144469780|NCT03770494|520916308|FG011|Overall Study|Study terminated by sponsor|2|||
144469781|NCT03770494|520916309|FG012|Overall Study|Study terminated by sponsor|0|||
144469782|NCT03770494|520916310|FG013|Overall Study|Study terminated by sponsor|0|||
144469783|NCT03770494|520916297|FG000|Overall Study|Withdrawal by Subject|1|||
144469784|NCT03770494|520916298|FG001|Overall Study|Withdrawal by Subject|1|||
144469785|NCT03770494|520916299|FG002|Overall Study|Withdrawal by Subject|0|||
144469786|NCT03770494|520916300|FG003|Overall Study|Withdrawal by Subject|0|||
144469787|NCT03770494|520916301|FG004|Overall Study|Withdrawal by Subject|2|||
144469788|NCT03770494|520916302|FG005|Overall Study|Withdrawal by Subject|2|||
144469789|NCT03770494|520916303|FG006|Overall Study|Withdrawal by Subject|2|||
144469790|NCT03770494|520916304|FG007|Overall Study|Withdrawal by Subject|0|||
144469791|NCT03770494|520916305|FG008|Overall Study|Withdrawal by Subject|2|||
144469792|NCT03770494|520916306|FG009|Overall Study|Withdrawal by Subject|3|||
144469793|NCT03770494|520916307|FG010|Overall Study|Withdrawal by Subject|1|||
144469794|NCT03770494|520916308|FG011|Overall Study|Withdrawal by Subject|0|||
144469795|NCT03770494|520916309|FG012|Overall Study|Withdrawal by Subject|0|||
144469796|NCT03770494|520916310|FG013|Overall Study|Withdrawal by Subject|0|||
144613836|NCT02025907|521447027|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
144613837|NCT02025907|521447028|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
144613838|NCT02411539|521447032|FG000|Overall Study|Lost to Follow-up|2|||
144613839|NCT02411539|521447033|FG001|Overall Study|Lost to Follow-up|0|||
144613840|NCT02411539|521447032|FG000|Overall Study|Confounding medical condition|0|||
144613841|NCT02411539|521447033|FG001|Overall Study|Confounding medical condition|1|||
144613842|NCT03631732|521447041|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
144613843|NCT03631732|521447042|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
144613844|NCT03631732|521447041|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
144613845|NCT03631732|521447042|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
144613846|NCT03631732|521447041|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
144613847|NCT03631732|521447042|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
144613848|NCT03631732|521447041|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
144613849|NCT03631732|521447042|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
144613850|NCT03631732|521447041|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
144613851|NCT03631732|521447042|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
144613852|NCT03631732|521447041|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
144613853|NCT03631732|521447042|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
144613854|NCT03631732|521447041|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
144613855|NCT03631732|521447042|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
144613856|NCT03631732|521447041|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
144613857|NCT03631732|521447042|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
144613858|NCT03631732|521447041|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
144613859|NCT03631732|521447042|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
144613860|NCT03631732|521447041|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
144613861|NCT03631732|521447042|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
144613862|NCT00886600|521447043|FG000|Double-blind Monotherapy|Adverse Event|1|||
144613863|NCT00886600|521447044|FG001|Double-blind Monotherapy|Adverse Event|1|||
144613864|NCT00886600|521447045|FG002|Double-blind Monotherapy|Adverse Event|1|||
144469797|NCT01345630|520917986|FG000|Overall Study|Adverse Event|22|||
144469798|NCT01345630|520917987|FG001|Overall Study|Adverse Event|23|||
144469799|NCT01345630|520917986|FG000|Overall Study|Lost to Follow-up|17|||
144469800|NCT01345630|520917987|FG001|Overall Study|Lost to Follow-up|16|||
144469801|NCT01345630|520917986|FG000|Overall Study|Protocol Violation|4|||
144469802|NCT01345630|520917987|FG001|Overall Study|Protocol Violation|1|||
144613865|NCT00886600|521447046|FG003|Double-blind Monotherapy|Adverse Event|1|||
144613866|NCT00886600|521447043|FG000|Double-blind Monotherapy|Protocol Violation|0|||
144613867|NCT00886600|521447044|FG001|Double-blind Monotherapy|Protocol Violation|0|||
144613868|NCT00886600|521447045|FG002|Double-blind Monotherapy|Protocol Violation|0|||
144613869|NCT00886600|521447046|FG003|Double-blind Monotherapy|Protocol Violation|1|||
144613870|NCT00886600|521447043|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
144613871|NCT00886600|521447044|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
144613872|NCT00886600|521447045|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
144613873|NCT00886600|521447046|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
144613874|NCT00886600|521447043|FG000|Combination Therapy Period|Adverse Event|0|||
144613875|NCT00886600|521447044|FG001|Combination Therapy Period|Adverse Event|0|||
144613876|NCT00886600|521447045|FG002|Combination Therapy Period|Adverse Event|1|||
144613877|NCT00886600|521447046|FG003|Combination Therapy Period|Adverse Event|0|||
144613878|NCT00886600|521447043|FG000|Combination Therapy Period|Protocol Violation|0|||
144613879|NCT00886600|521447044|FG001|Combination Therapy Period|Protocol Violation|0|||
144613880|NCT00886600|521447045|FG002|Combination Therapy Period|Protocol Violation|1|||
144469803|NCT01345630|520917986|FG000|Overall Study|Medication error without associated AE|0|||
144469804|NCT01345630|520917987|FG001|Overall Study|Medication error without associated AE|1|||
144469805|NCT01345630|520917986|FG000|Overall Study|Study terminated by sponsor|254|||
144469806|NCT01345630|520917987|FG001|Overall Study|Study terminated by sponsor|285|||
144613881|NCT00886600|521447046|FG003|Combination Therapy Period|Protocol Violation|0|||
144613882|NCT01251367|521447047|FG000|Overall Study|Protocol Violation|1|||
144613883|NCT01251367|521447047|FG000|Overall Study|Lack of Efficacy|2|||
144613884|NCT01251367|521447047|FG000|Overall Study|Adverse Event|19|||
144613885|NCT01251367|521447047|FG000|Overall Study|Withdrawal by Subject|36|||
144613886|NCT01251367|521447047|FG000|Overall Study|Lost to Follow-up|5|||
144613887|NCT01251367|521447047|FG000|Overall Study|Subject Required Alternative Treatment|7|||
144613888|NCT01251367|521447047|FG000|Overall Study|No Study Drug Available|1|||
144613889|NCT01251367|521447047|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
144613890|NCT01251367|521447047|FG000|Overall Study|End of Study Visit Performed in Error|1|||
144613891|NCT02016820|521447050|FG000|Overall Study|Lost to Follow-up|2|||
144613892|NCT02016820|521447051|FG001|Overall Study|Lost to Follow-up|4|||
144613893|NCT00473343|521447052|FG000|Overall Study|Adverse Event|9|||
144613894|NCT00473343|521447052|FG000|Overall Study|Lost to Follow-up|8|||
144613895|NCT00473343|521447052|FG000|Overall Study|Treatment failure|27|||
144613896|NCT00473343|521447052|FG000|Overall Study|Withdrew consent|3|||
144613897|NCT00473343|521447052|FG000|Overall Study|Other un-specified reason|3|||
144613898|NCT02370615|521447053|FG000|Overall Study|Adverse Event|1|||
144613899|NCT02370615|521447054|FG001|Overall Study|Adverse Event|0|||
144613900|NCT01378104|521447055|FG000|Overall Study|Adverse Event|8|||
144613901|NCT01378104|521447056|FG001|Overall Study|Adverse Event|8|||
144613902|NCT01378104|521447055|FG000|Overall Study|Lack of Efficacy|7|||
144613903|NCT01378104|521447056|FG001|Overall Study|Lack of Efficacy|5|||
144469807|NCT01345630|520917986|FG000|Overall Study|Other reasons|6|||
144469808|NCT01345630|520917987|FG001|Overall Study|Other reasons|8|||
144469809|NCT01345630|520917986|FG000|Overall Study|Withdrawn due to pregnancy|1|||
144469810|NCT01345630|520917987|FG001|Overall Study|Withdrawn due to pregnancy|2|||
144469811|NCT01345630|520917986|FG000|Overall Study|No longer willing to participate|9|||
144469812|NCT01345630|520917987|FG001|Overall Study|No longer willing to participate|12|||
144469813|NCT01345630|520917986|FG000|Overall Study|Insufficient clinical response|48|||
144469814|NCT01345630|520917987|FG001|Overall Study|Insufficient clinical response|11|||
144469815|NCT00939484|520917988|FG000|Overall Study|Progression/Relapse|8|||
144469816|NCT00939484|520917989|FG001|Overall Study|Progression/Relapse|20|||
144469817|NCT00939484|520917990|FG002|Overall Study|Progression/Relapse|3|||
144469818|NCT03938454|520917991|FG000|Overall Study|Protocol Violation|1|||
144469819|NCT03938454|520917991|FG000|Overall Study|Withdrawal by Subject|2|||
144469820|NCT03938454|520917991|FG000|Overall Study|Lost to Follow-up|3|||
144469821|NCT03092375|520917998|FG000|Overall Study|Lack of Efficacy|0|||
144469822|NCT03092375|520917999|FG001|Overall Study|Lack of Efficacy|1|||
144469823|NCT03092375|520918000|FG002|Overall Study|Lack of Efficacy|1|||
144469824|NCT03092375|520918001|FG003|Overall Study|Lack of Efficacy|0|||
144469825|NCT00553501|520918002|FG000|Overall Study|Adverse Event|2|||
144469826|NCT00553501|520918002|FG000|Overall Study|Death|1|||
144469827|NCT00553501|520918002|FG000|Overall Study|Progression|1|||
144469828|NCT01464021|520918003|FG000|Overall Study|Withdrawal by Subject|13|||
144469829|NCT01464021|520918003|FG000|Overall Study|Lost to Follow-up|1|||
144469830|NCT01464021|520918003|FG000|Overall Study|Lack of Efficacy|1|||
144469831|NCT01464021|520918003|FG000|Overall Study|various|11|||
144469832|NCT00949715|520918004|FG000|Overall Study|Physician Decision|1|||
144613904|NCT01378104|521447055|FG000|Overall Study|Withdrawal by Subject|12|||
144469833|NCT00949715|520918005|FG001|Overall Study|Physician Decision|0|||
144469834|NCT00949715|520918004|FG000|Overall Study|Lost to Follow-up|1|||
144469835|NCT00949715|520918005|FG001|Overall Study|Lost to Follow-up|0|||
144469836|NCT00949715|520918004|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
144469837|NCT00949715|520918005|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
144613905|NCT01378104|521447056|FG001|Overall Study|Withdrawal by Subject|13|||
144613906|NCT00455013|521447058|FG000|Short Term Period|Adverse Event|2|||
144613907|NCT00455013|521447059|FG001|Short Term Period|Adverse Event|5|||
144469838|NCT00861614|520918007|FG000|Overall Study|Disease Progression|182|||
144469839|NCT00861614|520918008|FG001|Overall Study|Disease Progression|263|||
144613908|NCT00455013|521447060|FG002|Short Term Period|Adverse Event|0|||
144613909|NCT00455013|521447058|FG000|Short Term Period|Withdrawal by Subject|0|||
144613910|NCT00455013|521447059|FG001|Short Term Period|Withdrawal by Subject|0|||
144197461|NCT01859130|519920275|FG000|Overall Study|Physician Decision|6|||
144469840|NCT00861614|520918007|FG000|Overall Study|Study Drug Toxicity|79|||
144469841|NCT00861614|520918008|FG001|Overall Study|Study Drug Toxicity|6|||
144469842|NCT00861614|520918007|FG000|Overall Study|Death|32|||
144469843|NCT00861614|520918008|FG001|Overall Study|Death|19|||
144469844|NCT00861614|520918007|FG000|Overall Study|Adverse Event|27|||
144469845|NCT00861614|520918008|FG001|Overall Study|Adverse Event|23|||
144613911|NCT00455013|521447060|FG002|Short Term Period|Withdrawal by Subject|1|||
144613912|NCT00455013|521447058|FG000|Short Term Period|Lack of Efficacy|4|||
144469846|NCT00861614|520918007|FG000|Overall Study|Withdrawal by Subject|34|||
144469847|NCT00861614|520918008|FG001|Overall Study|Withdrawal by Subject|35|||
144469848|NCT00861614|520918007|FG000|Overall Study|Other|17|||
144469849|NCT00861614|520918008|FG001|Overall Study|Other|22|||
144469850|NCT01255592|520918009|FG000|Overall Study|Adverse Event|5|||
144469851|NCT01255592|520918010|FG001|Overall Study|Adverse Event|0|||
144469852|NCT01255592|520918009|FG000|Overall Study|Withdrawal by Subject|1|||
144469853|NCT01255592|520918010|FG001|Overall Study|Withdrawal by Subject|0|||
144469854|NCT01255592|520918009|FG000|Overall Study|Other|0|||
144469855|NCT01255592|520918010|FG001|Overall Study|Other|1|||
144469856|NCT01289418|520918011|FG000|Day 8 Survey|email address invalid|283|||
144469857|NCT01289418|520918011|FG000|Day 8 Survey|participants did not complete the survey|1935|||
144469858|NCT01289418|520918011|FG000|Day 29 Survey|email address invalid|283|||
144469859|NCT01289418|520918011|FG000|Day 29 Survey|participants did not complete the survey|2185|||
144469860|NCT01352585|520918013|FG000|Overall Study|Adverse Event|2|||
144469861|NCT01352585|520918014|FG001|Overall Study|Adverse Event|1|||
144469862|NCT01352585|520918013|FG000|Overall Study|Lost to Follow-up|1|||
144469863|NCT01352585|520918014|FG001|Overall Study|Lost to Follow-up|0|||
144469864|NCT01352585|520918013|FG000|Overall Study|Other|5|||
144469865|NCT01352585|520918014|FG001|Overall Study|Other|2|||
144469866|NCT02243280|520918017|FG000|Treated|Adverse Event|1|||
144469867|NCT02243280|520918018|FG001|Treated|Adverse Event|0|||
144469868|NCT02243280|520918019|FG002|Treated|Adverse Event|0|||
144469869|NCT02243280|520918020|FG003|Treated|Adverse Event|0|||
144469870|NCT02243280|520918021|FG004|Treated|Adverse Event|0|||
144469871|NCT02243280|520918022|FG005|Treated|Adverse Event|0|||
144469872|NCT02243280|520918023|FG006|Treated|Adverse Event|0|||
144469873|NCT02243280|520918024|FG007|Treated|Adverse Event|0|||
144469874|NCT02243280|520918025|FG008|Treated|Adverse Event|0|||
144469875|NCT02243280|520918026|FG009|Treated|Adverse Event|0|||
144469876|NCT02243280|520918027|FG010|Treated|Adverse Event|1|||
144469877|NCT02243280|520918017|FG000|Treated|Lost to Follow-up|0|||
144469878|NCT02243280|520918018|FG001|Treated|Lost to Follow-up|0|||
144469879|NCT02243280|520918019|FG002|Treated|Lost to Follow-up|0|||
144469880|NCT02243280|520918020|FG003|Treated|Lost to Follow-up|0|||
144469881|NCT02243280|520918021|FG004|Treated|Lost to Follow-up|0|||
144469882|NCT02243280|520918022|FG005|Treated|Lost to Follow-up|0|||
144469883|NCT02243280|520918023|FG006|Treated|Lost to Follow-up|0|||
144469884|NCT02243280|520918024|FG007|Treated|Lost to Follow-up|0|||
144469885|NCT02243280|520918025|FG008|Treated|Lost to Follow-up|1|||
144469886|NCT02243280|520918026|FG009|Treated|Lost to Follow-up|0|||
144469887|NCT02243280|520918027|FG010|Treated|Lost to Follow-up|2|||
144469888|NCT01807156|520918038|FG000|Overall Study|Physician Decision|1|||
144469889|NCT03928028|520918039|FG000|Overall Study|Physician Decision|9|||
144469890|NCT03928028|520918040|FG001|Overall Study|Physician Decision|6|||
144469891|NCT03928028|520918041|FG002|Overall Study|Physician Decision|3|||
144469892|NCT03928028|520918039|FG000|Overall Study|Withdrawal by Subject|12|||
144469893|NCT03928028|520918040|FG001|Overall Study|Withdrawal by Subject|3|||
144469894|NCT03928028|520918041|FG002|Overall Study|Withdrawal by Subject|3|||
144469895|NCT04525547|520918047|FG000|Overall Study|Not treated with Ofev|2|||
144469896|NCT04525547|520918047|FG000|Overall Study|Off-label use|2|||
144469897|NCT04525547|520918047|FG000|Overall Study|Lost to Follow-up|1|||
144469898|NCT00800202|520918048|FG000|Overall Study|Adverse Event|7|||
144469899|NCT00800202|520918049|FG001|Overall Study|Adverse Event|6|||
144469900|NCT00800202|520918048|FG000|Overall Study|Death|1|||
144469901|NCT00800202|520918049|FG001|Overall Study|Death|0|||
144469902|NCT00800202|520918048|FG000|Overall Study|Other|5|||
144469903|NCT00800202|520918049|FG001|Overall Study|Other|0|||
144469904|NCT00800202|520918048|FG000|Overall Study|Disease Progression|54|||
144469905|NCT00800202|520918049|FG001|Overall Study|Disease Progression|18|||
144469906|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
144469907|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
144469908|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
144469909|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
144469910|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
144469911|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
144469912|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
144469913|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
144469914|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
144469915|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
144469916|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
144469917|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
144469918|NCT01493687|520918059|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
144469919|NCT01493687|520918060|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
144469920|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
144469921|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
144469922|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
144469923|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
144469924|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
144469925|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
144469926|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
144469927|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
144469928|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
144469929|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
144469930|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
144469931|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
144469932|NCT01493687|520918059|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
144469933|NCT01493687|520918060|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
144469934|NCT01493687|520918059|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
144469935|NCT01493687|520918060|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
144469936|NCT02323646|520918064|FG000|Treatment Course 1|Adverse Event|1|||
144469937|NCT02323646|520918065|FG001|Treatment Course 1|Adverse Event|0|||
144469938|NCT02323646|520918066|FG002|Treatment Course 1|Adverse Event|1|||
144469939|NCT02323646|520918064|FG000|Treatment Course 1|Heavy Bleeding|1|||
144469940|NCT02323646|520918065|FG001|Treatment Course 1|Heavy Bleeding|1|||
144469941|NCT02323646|520918066|FG002|Treatment Course 1|Heavy Bleeding|0|||
144469942|NCT02323646|520918064|FG000|Treatment Course 1|Lost to Follow-up|1|||
144469943|NCT02323646|520918065|FG001|Treatment Course 1|Lost to Follow-up|0|||
144469944|NCT02323646|520918066|FG002|Treatment Course 1|Lost to Follow-up|2|||
144469945|NCT02323646|520918064|FG000|Treatment Course 1|Withdrawal by Subject|0|||
144469946|NCT02323646|520918065|FG001|Treatment Course 1|Withdrawal by Subject|2|||
144469947|NCT02323646|520918066|FG002|Treatment Course 1|Withdrawal by Subject|0|||
144469948|NCT02323646|520918064|FG000|Treatment Course 2|Adverse Event|1|||
144469949|NCT02323646|520918065|FG001|Treatment Course 2|Adverse Event|0|||
144469950|NCT02323646|520918066|FG002|Treatment Course 2|Adverse Event|1|||
144469951|NCT02323646|520918064|FG000|Treatment Course 2|Lost to Follow-up|0|||
144537239|NCT05601882|521169955|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
144537240|NCT05601882|521169952|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
144537241|NCT05601882|521169953|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
144537242|NCT05601882|521169954|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
144537243|NCT05601882|521169955|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
144537244|NCT05601882|521169952|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
144537245|NCT05601882|521169953|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
144537246|NCT05601882|521169954|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
144537247|NCT05601882|521169955|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
144537248|NCT05601882|521169952|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
144537249|NCT05601882|521169953|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
144537250|NCT05601882|521169954|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
144537251|NCT05601882|521169955|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
144537252|NCT05601882|521169952|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
144537253|NCT05601882|521169953|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
144537254|NCT05601882|521169954|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
144537255|NCT05601882|521169955|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
144537256|NCT05601882|521169952|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
144537257|NCT05601882|521169953|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
144537258|NCT05601882|521169954|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
144537259|NCT05601882|521169955|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
144537260|NCT05521516|521169961|FG000|Overall Study|Withdrawal by Subject|1|||
144537261|NCT05521516|521169962|FG001|Overall Study|Withdrawal by Subject|1|||
144537262|NCT03891758|521169963|FG000|Overall Study|Adverse Event|2|||
144537263|NCT03891758|521169964|FG001|Overall Study|Adverse Event|0|||
144537264|NCT03891758|521169963|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144537265|NCT03891758|521169964|FG001|Overall Study|Withdrawal by parent/guardian|2|||
144537266|NCT00227266|521169965|FG000|Overall Study|Withdrawal by Subject|0|||
144537267|NCT00227266|521169966|FG001|Overall Study|Withdrawal by Subject|0|||
144537268|NCT00227266|521169967|FG002|Overall Study|Withdrawal by Subject|1|||
144537269|NCT00227266|521169965|FG000|Overall Study|Protocol Violation|1|||
144537270|NCT00227266|521169966|FG001|Overall Study|Protocol Violation|0|||
144537271|NCT00227266|521169967|FG002|Overall Study|Protocol Violation|1|||
144537272|NCT00227266|521169965|FG000|Overall Study|Excessive weight gain|0|||
144537273|NCT00227266|521169966|FG001|Overall Study|Excessive weight gain|0|||
144537274|NCT00227266|521169967|FG002|Overall Study|Excessive weight gain|2|||
144537275|NCT01470144|521169969|FG000|Overall Study|Adverse Event|2|||
144537276|NCT01470144|521169969|FG000|Overall Study|Death|1|||
144537277|NCT01470144|521169969|FG000|Overall Study|Lung transplant|6|||
144469952|NCT02323646|520918065|FG001|Treatment Course 2|Lost to Follow-up|0|||
144469953|NCT02323646|520918066|FG002|Treatment Course 2|Lost to Follow-up|1|||
144537278|NCT01470144|521169969|FG000|Overall Study|Patient's and investigator's decision|1|||
144537279|NCT03876457|521170919|FG000|Overall Study|Lost to Follow-up|1|||
144537280|NCT03876457|521170920|FG001|Overall Study|Lost to Follow-up|3|||
144469954|NCT02323646|520918064|FG000|Treatment Course 2|Non-compliance|0|||
144469955|NCT02323646|520918065|FG001|Treatment Course 2|Non-compliance|1|||
144469956|NCT02323646|520918066|FG002|Treatment Course 2|Non-compliance|1|||
144469957|NCT00521144|520918067|FG000|Overall Study|Not Treated|0|||
144469958|NCT00521144|520918068|FG001|Overall Study|Not Treated|0|||
144469959|NCT00521144|520918069|FG002|Overall Study|Not Treated|0|||
144469960|NCT00521144|520918070|FG003|Overall Study|Not Treated|1|||
144469961|NCT00521144|520918071|FG004|Overall Study|Not Treated|0|||
144469962|NCT00521144|520918067|FG000|Overall Study|Adverse Event|0|||
144469963|NCT00521144|520918068|FG001|Overall Study|Adverse Event|1|||
144469964|NCT00521144|520918069|FG002|Overall Study|Adverse Event|0|||
144469965|NCT00521144|520918070|FG003|Overall Study|Adverse Event|0|||
144469966|NCT00521144|520918071|FG004|Overall Study|Adverse Event|1|||
144469967|NCT00521144|520918067|FG000|Overall Study|Progressive Disease|4|||
144469968|NCT00521144|520918068|FG001|Overall Study|Progressive Disease|2|||
144469969|NCT00521144|520918069|FG002|Overall Study|Progressive Disease|2|||
144469970|NCT00521144|520918070|FG003|Overall Study|Progressive Disease|0|||
144469971|NCT00521144|520918071|FG004|Overall Study|Progressive Disease|6|||
144469972|NCT01370525|520918072|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
144469973|NCT01370525|520918073|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
144469974|NCT01370525|520918072|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144469975|NCT01370525|520918073|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144469976|NCT01370525|520918072|FG000|Overall Study|Adverse Event|0|||
144469977|NCT01370525|520918073|FG001|Overall Study|Adverse Event|1|||
144469978|NCT01370525|520918072|FG000|Overall Study|Protocol Violation|2|||
144469979|NCT01370525|520918073|FG001|Overall Study|Protocol Violation|1|||
144469980|NCT01370525|520918072|FG000|Overall Study|Lost to follow up|2|||
144469981|NCT01370525|520918073|FG001|Overall Study|Lost to follow up|6|||
144469982|NCT04791761|520918076|FG000|Overall Study|Lost to Follow-up|8|||
144469983|NCT04791761|520918077|FG001|Overall Study|Lost to Follow-up|6|||
144469984|NCT04791761|520918078|FG002|Overall Study|Lost to Follow-up|10|||
144469985|NCT04791761|520918076|FG000|Overall Study|Withdrawal by Subject|0|||
144537281|NCT01036724|521170921|FG000|Overall Study|Adverse Event|1|||
144537282|NCT01036724|521170922|FG001|Overall Study|Adverse Event|2|||
144537283|NCT01036724|521170921|FG000|Overall Study|Lack of Efficacy|1|||
144537284|NCT01036724|521170922|FG001|Overall Study|Lack of Efficacy|1|||
144537285|NCT01036724|521170921|FG000|Overall Study|Protocol Violation|4|||
144537286|NCT01036724|521170922|FG001|Overall Study|Protocol Violation|5|||
144537287|NCT01574716|521170925|FG000|Part 1|Death|3|||
144537288|NCT01574716|521170926|FG001|Part 1|Death|1|||
144537289|NCT01574716|521170927|FG002|Part 1|Death|8|||
144537290|NCT01574716|521170928|FG003|Part 1|Death|0|||
144537291|NCT01574716|521170929|FG004|Part 1|Death|0|||
144537292|NCT01574716|521170925|FG000|Part 1|Discontinuation of study by sponsor|0|||
144537293|NCT01574716|521170926|FG001|Part 1|Discontinuation of study by sponsor|0|||
144537294|NCT01574716|521170927|FG002|Part 1|Discontinuation of study by sponsor|1|||
144537295|NCT01574716|521170928|FG003|Part 1|Discontinuation of study by sponsor|0|||
144537296|NCT01574716|521170929|FG004|Part 1|Discontinuation of study by sponsor|0|||
144537297|NCT01574716|521170925|FG000|Part 1|Withdrawal by Subject|0|||
144537298|NCT01574716|521170926|FG001|Part 1|Withdrawal by Subject|2|||
144537299|NCT01574716|521170927|FG002|Part 1|Withdrawal by Subject|0|||
144537300|NCT01574716|521170928|FG003|Part 1|Withdrawal by Subject|0|||
144537301|NCT01574716|521170929|FG004|Part 1|Withdrawal by Subject|0|||
144537302|NCT01574716|521170925|FG000|Part 1|Lost to Follow-up|0|||
144537303|NCT01574716|521170926|FG001|Part 1|Lost to Follow-up|1|||
144537304|NCT01574716|521170927|FG002|Part 1|Lost to Follow-up|0|||
144537305|NCT01574716|521170928|FG003|Part 1|Lost to Follow-up|0|||
144537306|NCT01574716|521170929|FG004|Part 1|Lost to Follow-up|0|||
144537307|NCT01574716|521170925|FG000|Part 2|Progressive disease|0|||
144537308|NCT01574716|521170926|FG001|Part 2|Progressive disease|0|||
144537309|NCT01574716|521170927|FG002|Part 2|Progressive disease|0|||
144537310|NCT01574716|521170928|FG003|Part 2|Progressive disease|1|||
144537311|NCT01574716|521170929|FG004|Part 2|Progressive disease|0|||
144537312|NCT01574716|521170925|FG000|Part 2|Death|0|||
144537313|NCT01574716|521170926|FG001|Part 2|Death|0|||
144613913|NCT00455013|521447059|FG001|Short Term Period|Lack of Efficacy|0|||
144613914|NCT00455013|521447060|FG002|Short Term Period|Lack of Efficacy|0|||
144469986|NCT04791761|520918077|FG001|Overall Study|Withdrawal by Subject|1|||
144469987|NCT04791761|520918078|FG002|Overall Study|Withdrawal by Subject|1|||
144469988|NCT04791761|520918076|FG000|Overall Study|Protocol Violation|0|||
144469989|NCT04791761|520918077|FG001|Overall Study|Protocol Violation|1|||
144469990|NCT04791761|520918078|FG002|Overall Study|Protocol Violation|1|||
144469991|NCT00180479|520918081|FG000|Overall Study|Death|4|||
144469992|NCT00180479|520918082|FG001|Overall Study|Death|2|||
144537314|NCT01574716|521170927|FG002|Part 2|Death|0|||
144537315|NCT01574716|521170928|FG003|Part 2|Death|76|||
144537316|NCT01574716|521170929|FG004|Part 2|Death|35|||
144537317|NCT01574716|521170925|FG000|Part 2|Discontinuation of study by sponsor|0|||
144537318|NCT01574716|521170926|FG001|Part 2|Discontinuation of study by sponsor|0|||
144537319|NCT01574716|521170927|FG002|Part 2|Discontinuation of study by sponsor|0|||
144537320|NCT01574716|521170928|FG003|Part 2|Discontinuation of study by sponsor|51|||
144469993|NCT00180479|520918081|FG000|Overall Study|Lost to Follow-up|9|||
144469994|NCT00180479|520918082|FG001|Overall Study|Lost to Follow-up|7|||
144469995|NCT00180479|520918081|FG000|Overall Study|Withdrawal by Subject|3|||
144469996|NCT00180479|520918082|FG001|Overall Study|Withdrawal by Subject|3|||
144469997|NCT00180479|520918081|FG000|Overall Study|Informed consent not signed|0|||
144469998|NCT00180479|520918082|FG001|Overall Study|Informed consent not signed|1|||
144469999|NCT02459262|520918087|FG000|Overall Study|Withdrawal by Subject|0|||
144470000|NCT02459262|520918088|FG001|Overall Study|Withdrawal by Subject|0|||
144470001|NCT02459262|520918089|FG002|Overall Study|Withdrawal by Subject|0|||
144470002|NCT02459262|520918090|FG003|Overall Study|Withdrawal by Subject|0|||
144470003|NCT02459262|520918091|FG004|Overall Study|Withdrawal by Subject|0|||
144470004|NCT02459262|520918092|FG005|Overall Study|Withdrawal by Subject|0|||
144470005|NCT02459262|520918093|FG006|Overall Study|Withdrawal by Subject|0|||
144470006|NCT02459262|520918094|FG007|Overall Study|Withdrawal by Subject|0|||
144470007|NCT02459262|520918095|FG008|Overall Study|Withdrawal by Subject|0|||
144470008|NCT02459262|520918096|FG009|Overall Study|Withdrawal by Subject|1|||
144470009|NCT02459262|520918097|FG010|Overall Study|Withdrawal by Subject|0|||
144470010|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
144470011|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
144470012|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
144470013|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
144470014|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
144470015|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
144470016|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
144470017|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
144470018|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
144470019|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
144470020|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
144470021|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
144470022|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
144470023|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
144470024|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
144470025|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
144470026|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
144537321|NCT01574716|521170929|FG004|Part 2|Discontinuation of study by sponsor|31|||
144537322|NCT01574716|521170925|FG000|Part 2|Withdrawal by Subject|0|||
144537323|NCT01574716|521170926|FG001|Part 2|Withdrawal by Subject|0|||
144537324|NCT01574716|521170927|FG002|Part 2|Withdrawal by Subject|0|||
144537325|NCT01574716|521170928|FG003|Part 2|Withdrawal by Subject|5|||
144537326|NCT01574716|521170929|FG004|Part 2|Withdrawal by Subject|4|||
144537327|NCT01574716|521170925|FG000|Part 2|Brain metastases|0|||
144537328|NCT01574716|521170926|FG001|Part 2|Brain metastases|0|||
144537329|NCT01574716|521170927|FG002|Part 2|Brain metastases|0|||
144537330|NCT01574716|521170928|FG003|Part 2|Brain metastases|1|||
144537331|NCT01574716|521170929|FG004|Part 2|Brain metastases|0|||
144537332|NCT01574716|521170925|FG000|Part 2|Lost to Follow-up|0|||
144537333|NCT01574716|521170926|FG001|Part 2|Lost to Follow-up|0|||
144613915|NCT00455013|521447058|FG000|Short Term Period|Other|0|||
144613916|NCT00455013|521447059|FG001|Short Term Period|Other|0|||
144537334|NCT01574716|521170927|FG002|Part 2|Lost to Follow-up|0|||
144537335|NCT01574716|521170928|FG003|Part 2|Lost to Follow-up|3|||
144537336|NCT01574716|521170929|FG004|Part 2|Lost to Follow-up|0|||
144537337|NCT02438137|521170930|FG000|Overall Study|Lost to Follow-up|3|||
144613917|NCT00455013|521447060|FG002|Short Term Period|Other|1|||
144613918|NCT00455013|521447058|FG000|Long Term Extension (LTE)|Adverse Event|0|||
144613919|NCT00455013|521447059|FG001|Long Term Extension (LTE)|Adverse Event|1|||
144613920|NCT00455013|521447060|FG002|Long Term Extension (LTE)|Adverse Event|1|||
144613921|NCT00455013|521447058|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
144537338|NCT02438137|521170931|FG001|Overall Study|Lost to Follow-up|2|||
144613922|NCT00455013|521447059|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
144613923|NCT00455013|521447060|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
144613924|NCT00455013|521447058|FG000|Long Term Extension (LTE)|Death|1|||
144613925|NCT00455013|521447059|FG001|Long Term Extension (LTE)|Death|1|||
144613926|NCT00455013|521447060|FG002|Long Term Extension (LTE)|Death|0|||
144613927|NCT00455013|521447058|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
144613928|NCT00455013|521447059|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
144613929|NCT00455013|521447060|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
144613930|NCT00455013|521447058|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
144613931|NCT00455013|521447059|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
144613932|NCT00455013|521447060|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
144613933|NCT00455013|521447058|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
144613934|NCT00455013|521447059|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
144613935|NCT00455013|521447060|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
144470027|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
144470028|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
144470029|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
144470030|NCT00549757|520918104|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
144470031|NCT00549757|520918105|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
144470032|NCT00549757|520918104|FG000|Extension Period (in Average 9 Months)|Death|143|||
144470033|NCT00549757|520918105|FG001|Extension Period (in Average 9 Months)|Death|136|||
144470034|NCT00549757|520918104|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
144470035|NCT00549757|520918105|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
144470036|NCT00549757|520918104|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
144470037|NCT00549757|520918105|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
144470038|NCT00549757|520918104|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
144470039|NCT00549757|520918105|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
144470040|NCT02641392|520918108|FG000|Overall Study|Lost to Follow-up|0|||
144470041|NCT02641392|520918109|FG001|Overall Study|Lost to Follow-up|0|||
144470042|NCT02641392|520918110|FG002|Overall Study|Lost to Follow-up|2|||
144470043|NCT02641392|520918108|FG000|Overall Study|Withdrawal by Subject|0|||
144470044|NCT02641392|520918109|FG001|Overall Study|Withdrawal by Subject|0|||
144470045|NCT02641392|520918110|FG002|Overall Study|Withdrawal by Subject|17|||
144470046|NCT02641392|520918108|FG000|Overall Study|Adverse Event|0|||
144470047|NCT02641392|520918109|FG001|Overall Study|Adverse Event|1|||
144470048|NCT02641392|520918110|FG002|Overall Study|Adverse Event|25|||
144470049|NCT02641392|520918108|FG000|Overall Study|Study Terminated by Sponsor|4|||
144470050|NCT02641392|520918109|FG001|Overall Study|Study Terminated by Sponsor|12|||
144470051|NCT02641392|520918110|FG002|Overall Study|Study Terminated by Sponsor|144|||
144470052|NCT02641392|520918108|FG000|Overall Study|Lack of Efficacy|0|||
144470053|NCT02641392|520918109|FG001|Overall Study|Lack of Efficacy|0|||
144470054|NCT02641392|520918110|FG002|Overall Study|Lack of Efficacy|101|||
144470055|NCT02641392|520918108|FG000|Overall Study|Miscellaneous|0|||
144470056|NCT02641392|520918109|FG001|Overall Study|Miscellaneous|0|||
144470057|NCT02641392|520918110|FG002|Overall Study|Miscellaneous|3|||
144470058|NCT02641392|520918108|FG000|Overall Study|Death|0|||
144470059|NCT02641392|520918109|FG001|Overall Study|Death|0|||
144470060|NCT02641392|520918110|FG002|Overall Study|Death|1|||
144470061|NCT03518125|520918113|FG000|Overall Study|Lost to Follow-up|0|||
144470062|NCT03518125|520918114|FG001|Overall Study|Lost to Follow-up|2|||
144470063|NCT03518125|520918115|FG002|Overall Study|Lost to Follow-up|0|||
144470064|NCT03518125|520918116|FG003|Overall Study|Lost to Follow-up|0|||
144470065|NCT03518125|520918117|FG004|Overall Study|Lost to Follow-up|3|||
144470066|NCT03518125|520918118|FG005|Overall Study|Lost to Follow-up|5|||
144470067|NCT03518125|520918113|FG000|Overall Study|Physician Decision|0|||
144470068|NCT03518125|520918114|FG001|Overall Study|Physician Decision|1|||
144470069|NCT03518125|520918115|FG002|Overall Study|Physician Decision|0|||
144470070|NCT03518125|520918116|FG003|Overall Study|Physician Decision|0|||
144470071|NCT03518125|520918117|FG004|Overall Study|Physician Decision|0|||
144470072|NCT03518125|520918118|FG005|Overall Study|Physician Decision|0|||
144470073|NCT03518125|520918113|FG000|Overall Study|Withdrawal by Subject|1|||
144470074|NCT03518125|520918114|FG001|Overall Study|Withdrawal by Subject|1|||
144470075|NCT03518125|520918115|FG002|Overall Study|Withdrawal by Subject|0|||
144470076|NCT03518125|520918116|FG003|Overall Study|Withdrawal by Subject|1|||
144470077|NCT03518125|520918117|FG004|Overall Study|Withdrawal by Subject|1|||
144470078|NCT03518125|520918118|FG005|Overall Study|Withdrawal by Subject|3|||
144470079|NCT03518125|520918113|FG000|Overall Study|Missed Day 394 Visit|1|||
144470080|NCT03518125|520918114|FG001|Overall Study|Missed Day 394 Visit|0|||
144470081|NCT03518125|520918115|FG002|Overall Study|Missed Day 394 Visit|0|||
144470082|NCT03518125|520918116|FG003|Overall Study|Missed Day 394 Visit|0|||
144537339|NCT02438137|521170930|FG000|Overall Study|Adverse Event|1|||
144537340|NCT02438137|521170931|FG001|Overall Study|Adverse Event|0|||
144537341|NCT02438137|521170930|FG000|Overall Study|Withdrawal by Subject|4|||
144537342|NCT02438137|521170931|FG001|Overall Study|Withdrawal by Subject|3|||
144537343|NCT02438137|521170930|FG000|Overall Study|Physician Decision|0|||
144537344|NCT02438137|521170931|FG001|Overall Study|Physician Decision|1|||
144537345|NCT02502526|521170936|FG000|Overall Study|Lost to Follow-up|2|||
144537346|NCT02502526|521170937|FG001|Overall Study|Lost to Follow-up|2|||
144613936|NCT00455013|521447058|FG000|Long Term Extension (LTE)|non-specified|0|||
144613937|NCT00455013|521447059|FG001|Long Term Extension (LTE)|non-specified|0|||
144470083|NCT03518125|520918117|FG004|Overall Study|Missed Day 394 Visit|0|||
144470084|NCT03518125|520918118|FG005|Overall Study|Missed Day 394 Visit|0|||
144470085|NCT01197508|520918120|FG000|Overall Study|Withdrawal by Subject|8|||
144470086|NCT01197508|520918121|FG001|Overall Study|Withdrawal by Subject|7|||
144470087|NCT01197508|520918122|FG002|Overall Study|Withdrawal by Subject|15|||
144470088|NCT01197508|520918123|FG003|Overall Study|Withdrawal by Subject|4|||
144537347|NCT02502526|521170938|FG002|Overall Study|Lost to Follow-up|3|||
144537348|NCT02502526|521170936|FG000|Overall Study|Withdrawal by Subject|0|||
144613938|NCT00455013|521447060|FG002|Long Term Extension (LTE)|non-specified|1|||
144613939|NCT01445951|521447061|FG000|Overall Study|Adverse Event|16|||
144470089|NCT01197508|520918120|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
144470090|NCT01197508|520918121|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
144470091|NCT01197508|520918122|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
144470092|NCT01197508|520918123|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
144470093|NCT01197508|520918120|FG000|Overall Study|Adverse Event|10|||
144470094|NCT01197508|520918121|FG001|Overall Study|Adverse Event|13|||
144470095|NCT01197508|520918122|FG002|Overall Study|Adverse Event|23|||
144470096|NCT01197508|520918123|FG003|Overall Study|Adverse Event|3|||
144470097|NCT01197508|520918120|FG000|Overall Study|Severe non-compliance to protocol|0|||
144470098|NCT01197508|520918121|FG001|Overall Study|Severe non-compliance to protocol|3|||
144470099|NCT01197508|520918122|FG002|Overall Study|Severe non-compliance to protocol|1|||
144470100|NCT01197508|520918123|FG003|Overall Study|Severe non-compliance to protocol|3|||
144470101|NCT01197508|520918120|FG000|Overall Study|Condition under investigation worsened|1|||
144470102|NCT01197508|520918121|FG001|Overall Study|Condition under investigation worsened|1|||
144470103|NCT01197508|520918122|FG002|Overall Study|Condition under investigation worsened|1|||
144470104|NCT01197508|520918123|FG003|Overall Study|Condition under investigation worsened|1|||
144470105|NCT01197508|520918120|FG000|Overall Study|Lack of Efficacy|1|||
144470106|NCT01197508|520918121|FG001|Overall Study|Lack of Efficacy|2|||
144470107|NCT01197508|520918122|FG002|Overall Study|Lack of Efficacy|2|||
144470108|NCT01197508|520918123|FG003|Overall Study|Lack of Efficacy|1|||
144470109|NCT01197508|520918120|FG000|Overall Study|Study-specific withdrawal criteria|0|||
144470110|NCT01197508|520918121|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144470111|NCT01197508|520918122|FG002|Overall Study|Study-specific withdrawal criteria|1|||
144470112|NCT01197508|520918123|FG003|Overall Study|Study-specific withdrawal criteria|2|||
144470113|NCT01197508|520918120|FG000|Overall Study|Lost to Follow-up|1|||
144470114|NCT01197508|520918121|FG001|Overall Study|Lost to Follow-up|1|||
144470115|NCT01197508|520918122|FG002|Overall Study|Lost to Follow-up|2|||
144470116|NCT01197508|520918123|FG003|Overall Study|Lost to Follow-up|0|||
144470117|NCT01197508|520918120|FG000|Overall Study|Other|2|||
144470118|NCT01197508|520918121|FG001|Overall Study|Other|3|||
144470119|NCT01197508|520918122|FG002|Overall Study|Other|2|||
144470120|NCT01197508|520918123|FG003|Overall Study|Other|2|||
144470121|NCT01119768|520918124|FG000|Treatment Period|Lack of Efficacy|18|||
144470122|NCT01119768|520918125|FG001|Treatment Period|Lack of Efficacy|25|||
144470123|NCT01301391|520918126|FG000|Overall Study|Death|13|||
144470124|NCT01301391|520918126|FG000|Overall Study|Lost to Follow-up|3|||
144470125|NCT01301391|520918126|FG000|Overall Study|Physician Decision|2|||
144470126|NCT01301391|520918126|FG000|Overall Study|Sponsor's decision|8|||
144470127|NCT01662063|520918129|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
144470128|NCT01662063|520918130|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
144470129|NCT01662063|520918131|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
144470130|NCT01662063|520918129|FG000|Overall Study|Lack of Efficacy|1|||
144470131|NCT01662063|520918130|FG001|Overall Study|Lack of Efficacy|6|||
144470132|NCT01662063|520918131|FG002|Overall Study|Lack of Efficacy|0|||
144470133|NCT01662063|520918129|FG000|Overall Study|Lost to Follow-up|0|||
144470134|NCT01662063|520918130|FG001|Overall Study|Lost to Follow-up|4|||
144470135|NCT01662063|520918131|FG002|Overall Study|Lost to Follow-up|0|||
144470136|NCT01662063|520918129|FG000|Overall Study|Protocol Violation|1|||
144470137|NCT01662063|520918130|FG001|Overall Study|Protocol Violation|0|||
144470138|NCT01662063|520918131|FG002|Overall Study|Protocol Violation|0|||
144470139|NCT01662063|520918129|FG000|Overall Study|Withdrawal by Subject|2|||
144613940|NCT01445951|521447062|FG001|Overall Study|Adverse Event|9|||
144613941|NCT01445951|521447063|FG002|Overall Study|Adverse Event|0|||
144613942|NCT01445951|521447061|FG000|Overall Study|Protocol Violation|2|||
144613943|NCT01445951|521447062|FG001|Overall Study|Protocol Violation|2|||
144613944|NCT01445951|521447063|FG002|Overall Study|Protocol Violation|2|||
144613945|NCT01445951|521447061|FG000|Overall Study|Withdrawal by Subject|21|||
144613946|NCT01445951|521447062|FG001|Overall Study|Withdrawal by Subject|16|||
144613947|NCT01445951|521447063|FG002|Overall Study|Withdrawal by Subject|8|||
144613948|NCT01445951|521447061|FG000|Overall Study|Physician Decision|3|||
144613949|NCT01445951|521447062|FG001|Overall Study|Physician Decision|1|||
144613950|NCT01445951|521447063|FG002|Overall Study|Physician Decision|0|||
144613951|NCT01445951|521447061|FG000|Overall Study|Lost to Follow-up|1|||
144470140|NCT01662063|520918130|FG001|Overall Study|Withdrawal by Subject|4|||
144470141|NCT01662063|520918131|FG002|Overall Study|Withdrawal by Subject|1|||
144470142|NCT01662063|520918129|FG000|Overall Study|Physician Decision|0|||
144613952|NCT01445951|521447062|FG001|Overall Study|Lost to Follow-up|2|||
144613953|NCT01445951|521447063|FG002|Overall Study|Lost to Follow-up|4|||
144613954|NCT01445951|521447061|FG000|Overall Study|Pregnancy|0|||
144613955|NCT01445951|521447062|FG001|Overall Study|Pregnancy|1|||
144613956|NCT01445951|521447063|FG002|Overall Study|Pregnancy|4|||
144613957|NCT01445951|521447061|FG000|Overall Study|Death|0|||
144470143|NCT01662063|520918130|FG001|Overall Study|Physician Decision|2|||
144470144|NCT01662063|520918131|FG002|Overall Study|Physician Decision|0|||
144470145|NCT01662063|520918129|FG000|Overall Study|Other|0|||
144470146|NCT01662063|520918130|FG001|Overall Study|Other|1|||
144470147|NCT01662063|520918131|FG002|Overall Study|Other|0|||
144470148|NCT01949870|520918138|FG000|Overall Study|Lack of Efficacy|2|||
144470149|NCT01949870|520918138|FG000|Overall Study|Adverse Event|1|||
144470150|NCT01949870|520918138|FG000|Overall Study|Study termination|1|||
144470151|NCT01949870|520918138|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
144470152|NCT01477853|520918139|FG000|Phase A|Adverse Event|1|||
144470153|NCT01477853|520918140|FG001|Phase A|Adverse Event|2|||
144470154|NCT01477853|520918141|FG002|Phase A|Adverse Event|2|||
144470155|NCT01477853|520918139|FG000|Phase A|Lost to Follow-up|4|||
144470156|NCT01477853|520918140|FG001|Phase A|Lost to Follow-up|3|||
144470157|NCT01477853|520918141|FG002|Phase A|Lost to Follow-up|2|||
144470158|NCT01477853|520918139|FG000|Phase A|Physician Decision|1|||
144470159|NCT01477853|520918140|FG001|Phase A|Physician Decision|0|||
144470160|NCT01477853|520918141|FG002|Phase A|Physician Decision|1|||
144470161|NCT01477853|520918139|FG000|Phase A|Study terminated by sponsor|37|||
144470162|NCT01477853|520918140|FG001|Phase A|Study terminated by sponsor|40|||
144470163|NCT01477853|520918141|FG002|Phase A|Study terminated by sponsor|39|||
144470164|NCT01477853|520918139|FG000|Phase B|Lost to Follow-up|0|||
144470165|NCT01477853|520918140|FG001|Phase B|Lost to Follow-up|1|||
144470166|NCT01477853|520918141|FG002|Phase B|Lost to Follow-up|0|||
144470167|NCT01477853|520918139|FG000|Phase B|Study terminated by sponsor|12|||
144470168|NCT01477853|520918140|FG001|Phase B|Study terminated by sponsor|10|||
144470169|NCT01477853|520918141|FG002|Phase B|Study terminated by sponsor|11|||
144470170|NCT00677352|520918144|FG000|Treatment Phase|Adverse Event|14|||
144470171|NCT00677352|520918145|FG001|Treatment Phase|Adverse Event|22|||
144470172|NCT00677352|520918144|FG000|Treatment Phase|Lack of Efficacy|2|||
144470173|NCT00677352|520918145|FG001|Treatment Phase|Lack of Efficacy|3|||
144470174|NCT00677352|520918144|FG000|Treatment Phase|Lost to Follow-up|0|||
144470175|NCT00677352|520918145|FG001|Treatment Phase|Lost to Follow-up|1|||
144470176|NCT00677352|520918144|FG000|Treatment Phase|Withdrawal by Subject|7|||
144470177|NCT00677352|520918145|FG001|Treatment Phase|Withdrawal by Subject|7|||
144470178|NCT00677352|520918144|FG000|Treatment Phase|Physician Decision|1|||
144470179|NCT00677352|520918145|FG001|Treatment Phase|Physician Decision|0|||
144470180|NCT00677352|520918144|FG000|Treatment Phase|Pregnancy|0|||
144470181|NCT00677352|520918145|FG001|Treatment Phase|Pregnancy|1|||
144470182|NCT00677352|520918144|FG000|Treatment Phase|Protocol Violation|1|||
144470183|NCT00677352|520918145|FG001|Treatment Phase|Protocol Violation|1|||
144470184|NCT00677352|520918144|FG000|Treatment Phase|Transference or work related matter|0|||
144470185|NCT00677352|520918145|FG001|Treatment Phase|Transference or work related matter|5|||
144470186|NCT00677352|520918144|FG000|Treatment Phase|Not treated|0|||
144470187|NCT00677352|520918145|FG001|Treatment Phase|Not treated|2|||
144470188|NCT00677352|520918144|FG000|Tapering Phase|Adverse Event|1|||
144470189|NCT00677352|520918145|FG001|Tapering Phase|Adverse Event|5|||
144470190|NCT00677352|520918144|FG000|Tapering Phase|Withdrawal by Subject|5|||
144470191|NCT00677352|520918145|FG001|Tapering Phase|Withdrawal by Subject|3|||
144470192|NCT00677352|520918144|FG000|Tapering Phase|Pregnancy|0|||
144470193|NCT00677352|520918145|FG001|Tapering Phase|Pregnancy|1|||
144470194|NCT00677352|520918144|FG000|Tapering Phase|Job transfer|0|||
144470195|NCT00677352|520918145|FG001|Tapering Phase|Job transfer|1|||
144470196|NCT01814748|520918149|FG000|Overall Study|Lost to Follow-up|1|||
144470197|NCT01814748|520918150|FG001|Overall Study|Lost to Follow-up|2|||
144470198|NCT01814748|520918149|FG000|Overall Study|Study site terminated by sponsor|1|||
144470199|NCT01814748|520918150|FG001|Overall Study|Study site terminated by sponsor|1|||
144470200|NCT01814748|520918149|FG000|Overall Study|Withdrawal by Subject|6|||
144470201|NCT01814748|520918150|FG001|Overall Study|Withdrawal by Subject|4|||
144470202|NCT04044456|520918151|FG000|Overall Study|Lost to Follow-up|4|||
144470203|NCT04044456|520918152|FG001|Overall Study|Lost to Follow-up|1|||
144470204|NCT04044456|520918151|FG000|Overall Study|Withdrawal by Subject|1|||
144470205|NCT04044456|520918152|FG001|Overall Study|Withdrawal by Subject|0|||
144470206|NCT00330174|520918154|FG000|Overall Study|Withdrawal by Subject|7|||
144470207|NCT00330174|520918155|FG001|Overall Study|Withdrawal by Subject|7|||
144470208|NCT00330174|520918154|FG000|Overall Study|Lost to Follow-up|4|||
144470209|NCT00330174|520918155|FG001|Overall Study|Lost to Follow-up|1|||
144470210|NCT00330174|520918154|FG000|Overall Study|Clinical deterioration|1|||
144470211|NCT00330174|520918155|FG001|Overall Study|Clinical deterioration|2|||
144470212|NCT00330174|520918154|FG000|Overall Study|Excessive missed visits|3|||
144470213|NCT00330174|520918155|FG001|Overall Study|Excessive missed visits|8|||
144470214|NCT00330174|520918154|FG000|Overall Study|Miscellaneous reasons|7|||
144470215|NCT00330174|520918155|FG001|Overall Study|Miscellaneous reasons|1|||
144470216|NCT02316769|520918158|FG000|Overall Study|Physician Decision|1|||
144470217|NCT02316769|520918159|FG001|Overall Study|Physician Decision|0|||
144470218|NCT02316769|520918158|FG000|Overall Study|Withdrawal by Subject|1|||
144470219|NCT02316769|520918159|FG001|Overall Study|Withdrawal by Subject|0|||
144470220|NCT02403180|520918160|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
144470221|NCT02403180|520918161|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
144470222|NCT02403180|520918160|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
144470223|NCT02403180|520918161|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
144470224|NCT00645164|520918165|FG000|Overall Study|Lost to Follow-up|2|||
144470225|NCT00645164|520918165|FG000|Overall Study|Withdrawal by Subject|4|||
144470226|NCT00645164|520918165|FG000|Overall Study|Protocol Violation|1|||
144726489|NCT04603937|521852768|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
144726490|NCT04603937|521852769|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
144726491|NCT05125952|521852771|FG000|Overall Study|Physician Decision|1|||
144726492|NCT05067504|521852773|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
144726493|NCT05067504|521852774|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
144726494|NCT05067504|521852773|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
144726495|NCT05067504|521852774|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
144726496|NCT05067504|521852773|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
144726497|NCT05067504|521852774|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
144726498|NCT03717064|521854277|FG000|Period 2|Adverse Event|1|||
144726499|NCT01210001|521854278|FG000|Overall Study|Not treated|1|||
144726500|NCT01210001|521854279|FG001|Overall Study|Not treated|0|||
144726501|NCT01210001|521854280|FG002|Overall Study|Not treated|0|||
144726502|NCT01210001|521854278|FG000|Overall Study|Adverse Event|4|||
144726503|NCT01210001|521854279|FG001|Overall Study|Adverse Event|2|||
144726504|NCT01210001|521854280|FG002|Overall Study|Adverse Event|5|||
144726505|NCT01210001|521854278|FG000|Overall Study|Non compliant with protocol|2|||
144726506|NCT01210001|521854279|FG001|Overall Study|Non compliant with protocol|2|||
144726507|NCT01210001|521854280|FG002|Overall Study|Non compliant with protocol|3|||
144726508|NCT01210001|521854278|FG000|Overall Study|Lost to Follow-up|4|||
144726509|NCT01210001|521854279|FG001|Overall Study|Lost to Follow-up|3|||
144726510|NCT01210001|521854280|FG002|Overall Study|Lost to Follow-up|2|||
144726511|NCT01210001|521854278|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
144726512|NCT01210001|521854279|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
144726513|NCT01210001|521854280|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
144726514|NCT01210001|521854278|FG000|Overall Study|Other reason not defined above|2|||
144726515|NCT01210001|521854279|FG001|Overall Study|Other reason not defined above|2|||
144726516|NCT01210001|521854280|FG002|Overall Study|Other reason not defined above|1|||
144726517|NCT00788125|521854281|FG000|Overall Study|Death|6|||
144726518|NCT02180711|521854286|FG000|Overall Study|Death|0|||
144726519|NCT02180711|521854287|FG001|Overall Study|Death|1|||
144726520|NCT02180711|521854288|FG002|Overall Study|Death|0|||
144726521|NCT02180711|521854289|FG003|Overall Study|Death|0|||
144726522|NCT02180711|521854290|FG004|Overall Study|Death|7|||
144726523|NCT02180711|521854291|FG005|Overall Study|Death|0|||
144726524|NCT02180711|521854292|FG006|Overall Study|Death|1|||
144726525|NCT02180711|521854293|FG007|Overall Study|Death|3|||
144726526|NCT02180711|521854286|FG000|Overall Study|Lost to Follow-up|0|||
144726527|NCT02180711|521854287|FG001|Overall Study|Lost to Follow-up|1|||
144726528|NCT02180711|521854288|FG002|Overall Study|Lost to Follow-up|0|||
144726529|NCT02180711|521854289|FG003|Overall Study|Lost to Follow-up|0|||
144726530|NCT02180711|521854290|FG004|Overall Study|Lost to Follow-up|1|||
144470227|NCT01984697|520919605|FG000|Overall Study|Adverse Event|0|||
144470228|NCT01984697|520919606|FG001|Overall Study|Adverse Event|0|||
144470229|NCT01984697|520919607|FG002|Overall Study|Adverse Event|2|||
144470230|NCT01984697|520919608|FG003|Overall Study|Adverse Event|0|||
144470231|NCT01984697|520919609|FG004|Overall Study|Adverse Event|0|||
144470232|NCT01984697|520919605|FG000|Overall Study|Lost to Follow-up|14|||
144470233|NCT01984697|520919606|FG001|Overall Study|Lost to Follow-up|5|||
144470234|NCT01984697|520919607|FG002|Overall Study|Lost to Follow-up|10|||
144470235|NCT01984697|520919608|FG003|Overall Study|Lost to Follow-up|6|||
144470236|NCT01984697|520919609|FG004|Overall Study|Lost to Follow-up|21|||
144470237|NCT01984697|520919605|FG000|Overall Study|Physician Decision|3|||
144470238|NCT01984697|520919606|FG001|Overall Study|Physician Decision|0|||
144726531|NCT02180711|521854291|FG005|Overall Study|Lost to Follow-up|1|||
144470239|NCT01984697|520919607|FG002|Overall Study|Physician Decision|0|||
144726532|NCT02180711|521854292|FG006|Overall Study|Lost to Follow-up|0|||
144726533|NCT02180711|521854293|FG007|Overall Study|Lost to Follow-up|3|||
144726534|NCT02180711|521854286|FG000|Overall Study|Withdrawal by Subject|2|||
144726535|NCT02180711|521854287|FG001|Overall Study|Withdrawal by Subject|1|||
144726536|NCT02180711|521854288|FG002|Overall Study|Withdrawal by Subject|0|||
144726537|NCT02180711|521854289|FG003|Overall Study|Withdrawal by Subject|4|||
144726538|NCT02180711|521854290|FG004|Overall Study|Withdrawal by Subject|3|||
144726539|NCT02180711|521854291|FG005|Overall Study|Withdrawal by Subject|0|||
144726540|NCT02180711|521854292|FG006|Overall Study|Withdrawal by Subject|3|||
144726541|NCT02180711|521854293|FG007|Overall Study|Withdrawal by Subject|2|||
144726542|NCT02180711|521854286|FG000|Overall Study|- Disease Progression|0|||
144726543|NCT02180711|521854287|FG001|Overall Study|- Disease Progression|1|||
144726544|NCT02180711|521854288|FG002|Overall Study|- Disease Progression|0|||
144726545|NCT02180711|521854289|FG003|Overall Study|- Disease Progression|0|||
144726546|NCT02180711|521854290|FG004|Overall Study|- Disease Progression|0|||
144726547|NCT02180711|521854291|FG005|Overall Study|- Disease Progression|0|||
144470240|NCT01984697|520919608|FG003|Overall Study|Physician Decision|1|||
144470241|NCT01984697|520919609|FG004|Overall Study|Physician Decision|0|||
144470242|NCT01984697|520919605|FG000|Overall Study|Protocol Violation|8|||
144726548|NCT02180711|521854292|FG006|Overall Study|- Disease Progression|0|||
144726549|NCT02180711|521854293|FG007|Overall Study|- Disease Progression|0|||
144470243|NCT01984697|520919606|FG001|Overall Study|Protocol Violation|5|||
144470244|NCT01984697|520919607|FG002|Overall Study|Protocol Violation|3|||
144470245|NCT01984697|520919608|FG003|Overall Study|Protocol Violation|2|||
144470246|NCT01984697|520919609|FG004|Overall Study|Protocol Violation|0|||
144470247|NCT01984697|520919605|FG000|Overall Study|Withdrawal by Subject|15|||
144470248|NCT01984697|520919606|FG001|Overall Study|Withdrawal by Subject|21|||
144470249|NCT01984697|520919607|FG002|Overall Study|Withdrawal by Subject|13|||
144470250|NCT01984697|520919608|FG003|Overall Study|Withdrawal by Subject|11|||
144470251|NCT01984697|520919609|FG004|Overall Study|Withdrawal by Subject|13|||
144470252|NCT01984697|520919605|FG000|Overall Study|Missed last follow-up visit|1|||
144470253|NCT01984697|520919606|FG001|Overall Study|Missed last follow-up visit|0|||
144470254|NCT01984697|520919607|FG002|Overall Study|Missed last follow-up visit|0|||
144470255|NCT01984697|520919608|FG003|Overall Study|Missed last follow-up visit|0|||
144470256|NCT01984697|520919609|FG004|Overall Study|Missed last follow-up visit|0|||
144470257|NCT01984697|520919605|FG000|Overall Study|Death|0|||
144470258|NCT01984697|520919606|FG001|Overall Study|Death|0|||
144470259|NCT01984697|520919607|FG002|Overall Study|Death|0|||
144537349|NCT02502526|521170937|FG001|Overall Study|Withdrawal by Subject|1|||
144537350|NCT02502526|521170938|FG002|Overall Study|Withdrawal by Subject|1|||
144537351|NCT02502526|521170936|FG000|Overall Study|Disqualified due to cataract grading|0|||
144537352|NCT02502526|521170937|FG001|Overall Study|Disqualified due to cataract grading|0|||
144537353|NCT02502526|521170938|FG002|Overall Study|Disqualified due to cataract grading|1|||
144613958|NCT01445951|521447062|FG001|Overall Study|Death|0|||
144613959|NCT01445951|521447063|FG002|Overall Study|Death|1|||
144613960|NCT01445951|521447061|FG000|Overall Study|Non-compliance with study drug|1|||
144613961|NCT01445951|521447062|FG001|Overall Study|Non-compliance with study drug|2|||
144613962|NCT01445951|521447063|FG002|Overall Study|Non-compliance with study drug|0|||
144613963|NCT01445951|521447061|FG000|Overall Study|Non-compliance with protocol|0|||
144613964|NCT01445951|521447062|FG001|Overall Study|Non-compliance with protocol|1|||
144613965|NCT01445951|521447063|FG002|Overall Study|Non-compliance with protocol|0|||
144613966|NCT01445951|521447061|FG000|Overall Study|Sponsor decision - subject travel|0|||
144613967|NCT01445951|521447062|FG001|Overall Study|Sponsor decision - subject travel|1|||
144613968|NCT01445951|521447063|FG002|Overall Study|Sponsor decision - subject travel|0|||
144613969|NCT01445951|521447061|FG000|Overall Study|Cough|0|||
144613970|NCT01445951|521447062|FG001|Overall Study|Cough|1|||
144613971|NCT01445951|521447063|FG002|Overall Study|Cough|0|||
144613972|NCT01473563|521447066|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
144613973|NCT01519765|521447067|FG000|Overall Study|Adverse Event|0|||
144613974|NCT01519765|521447068|FG001|Overall Study|Adverse Event|1|||
144613975|NCT01519765|521447067|FG000|Overall Study|Lack of Efficacy|2|||
144613976|NCT01519765|521447068|FG001|Overall Study|Lack of Efficacy|0|||
144613977|NCT01519765|521447067|FG000|Overall Study|Protocol Violation|1|||
144470260|NCT01984697|520919608|FG003|Overall Study|Death|1|||
144470261|NCT01984697|520919609|FG004|Overall Study|Death|0|||
144537354|NCT02502526|521170936|FG000|Overall Study|Enrollment suspension|4|||
144537355|NCT02502526|521170937|FG001|Overall Study|Enrollment suspension|1|||
144537356|NCT02502526|521170938|FG002|Overall Study|Enrollment suspension|1|||
144537357|NCT01342367|521170939|FG000|Overall Study|Death|1|||
144537358|NCT01342367|521170940|FG001|Overall Study|Death|0|||
144537359|NCT01342367|521170939|FG000|Overall Study|Withdrawal by Subject|1|||
144537360|NCT01342367|521170940|FG001|Overall Study|Withdrawal by Subject|2|||
144537361|NCT02964741|521170941|FG000|Overall Study|Protocol Violation|1|||
144537362|NCT02964741|521170942|FG001|Overall Study|Protocol Violation|0|||
144537363|NCT02964741|521170943|FG002|Overall Study|Protocol Violation|0|||
144537364|NCT02964741|521170941|FG000|Overall Study|Withdrawal by Subject|0|||
144537365|NCT02964741|521170942|FG001|Overall Study|Withdrawal by Subject|1|||
144537366|NCT02964741|521170943|FG002|Overall Study|Withdrawal by Subject|0|||
144537367|NCT02964741|521170941|FG000|Overall Study|claustrophobia|1|||
144537368|NCT02964741|521170942|FG001|Overall Study|claustrophobia|0|||
144537369|NCT02964741|521170943|FG002|Overall Study|claustrophobia|0|||
144537370|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
144537371|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
144613978|NCT01519765|521447068|FG001|Overall Study|Protocol Violation|0|||
144470262|NCT01984697|520919605|FG000|Overall Study|Pregnancy|2|||
144537372|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
144537373|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
144537374|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
144613979|NCT01519765|521447067|FG000|Overall Study|Withdrawal by Subject|0|||
144613980|NCT01519765|521447068|FG001|Overall Study|Withdrawal by Subject|1|||
144470263|NCT01984697|520919606|FG001|Overall Study|Pregnancy|0|||
144470264|NCT01984697|520919607|FG002|Overall Study|Pregnancy|1|||
144470265|NCT01984697|520919608|FG003|Overall Study|Pregnancy|0|||
144537375|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
144613981|NCT03610724|521447069|FG000|Overall Study|Death|17|||
144613982|NCT03610724|521447069|FG000|Overall Study|Lost to Follow-up|1|||
144613983|NCT03610724|521447069|FG000|Overall Study|Physician Decision|1|||
144470266|NCT01984697|520919609|FG004|Overall Study|Pregnancy|1|||
144470267|NCT04737109|520919611|FG000|Study Treatment|Disease Progression|5|||
144470268|NCT04737109|520919612|FG001|Study Treatment|Disease Progression|0|||
144470269|NCT04737109|520919613|FG002|Study Treatment|Disease Progression|0|||
144613984|NCT03610724|521447069|FG000|Overall Study|Died prior to infusion|1|||
144613985|NCT02739620|521447070|FG000|Overall Study|Lost to Follow-up|3|||
144470270|NCT04737109|520919614|FG003|Study Treatment|Disease Progression|0|||
144470271|NCT04737109|520919611|FG000|Study Treatment|Death on study|1|||
144470272|NCT04737109|520919612|FG001|Study Treatment|Death on study|0|||
144470273|NCT04737109|520919613|FG002|Study Treatment|Death on study|0|||
144470274|NCT04737109|520919614|FG003|Study Treatment|Death on study|0|||
144470275|NCT01582789|520919616|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
144470276|NCT01582789|520919617|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
144470277|NCT02276066|520919618|FG000|Overall Study|Lost to Follow-up|21|||
144470278|NCT02276066|520919619|FG001|Overall Study|Lost to Follow-up|11|||
144470279|NCT05050578|520919620|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
144470280|NCT05050578|520919621|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
144470281|NCT05050578|520919620|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
144470282|NCT05050578|520919621|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
144470283|NCT05050578|520919620|FG000|Period 2, 30 Days|Protocol Violation|0|||
144470284|NCT05050578|520919621|FG001|Period 2, 30 Days|Protocol Violation|1|||
144470285|NCT03386032|520919623|FG000|Overall Study|Lack of Efficacy|6|||
144470286|NCT03386032|520919624|FG001|Overall Study|Lack of Efficacy|2|||
144470287|NCT03386032|520919625|FG002|Overall Study|Lack of Efficacy|0|||
144470288|NCT03386032|520919623|FG000|Overall Study|Adverse Event|2|||
144470289|NCT03386032|520919624|FG001|Overall Study|Adverse Event|2|||
144613986|NCT02739620|521447071|FG001|Overall Study|Lost to Follow-up|1|||
144613987|NCT02739620|521447070|FG000|Overall Study|Adverse Event|0|||
144613988|NCT02739620|521447071|FG001|Overall Study|Adverse Event|1|||
144613989|NCT02354222|521447072|FG000|Overall Study|Adverse Event|0|||
144613990|NCT02354222|521447073|FG001|Overall Study|Adverse Event|3|||
144613991|NCT02354222|521447072|FG000|Overall Study|Physician Decision|1|||
144613992|NCT02354222|521447073|FG001|Overall Study|Physician Decision|1|||
144613993|NCT02354222|521447072|FG000|Overall Study|Pregnancy|1|||
144613994|NCT02354222|521447073|FG001|Overall Study|Pregnancy|0|||
144613995|NCT02354222|521447072|FG000|Overall Study|Withdrawal by Subject|2|||
144470290|NCT03386032|520919625|FG002|Overall Study|Adverse Event|0|||
144470291|NCT03386032|520919623|FG000|Overall Study|Withdrawal by Subject|1|||
144470292|NCT03386032|520919624|FG001|Overall Study|Withdrawal by Subject|0|||
144470293|NCT03386032|520919625|FG002|Overall Study|Withdrawal by Subject|0|||
144470294|NCT03386032|520919623|FG000|Overall Study|Lost to Follow-up|9|||
144470295|NCT03386032|520919624|FG001|Overall Study|Lost to Follow-up|3|||
144470296|NCT03386032|520919625|FG002|Overall Study|Lost to Follow-up|0|||
144470297|NCT02710292|520919630|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
144537376|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
144613996|NCT02354222|521447073|FG001|Overall Study|Withdrawal by Subject|3|||
144613997|NCT02354222|521447072|FG000|Overall Study|Conflict with the stopping criteria|0|||
144613998|NCT02354222|521447073|FG001|Overall Study|Conflict with the stopping criteria|4|||
144613999|NCT00786565|521447074|FG000|Enrollment Prior to Surgery|Site Closed|3|||
144614000|NCT00786565|521447074|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
144614001|NCT00786565|521447074|FG000|Post Surgery|Abnormal macular pucker|1|||
144614002|NCT00786565|521447074|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
144614003|NCT00754793|521447078|FG000|Overall Study|voluntary withdrawn from study|0|||
144537377|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
144537378|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
144537379|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
144537380|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
144537381|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
144537382|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
144537383|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
144537384|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
144537385|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
144614004|NCT00754793|521447079|FG001|Overall Study|voluntary withdrawn from study|1|||
144614005|NCT02437864|521447083|FG000|Overall Study|Protocol Violation|4|||
144614006|NCT02437864|521447084|FG001|Overall Study|Protocol Violation|0|||
144614007|NCT02577146|521447085|FG000|Overall Study|Lost to Follow-up|8|||
144614008|NCT02577146|521447085|FG000|Overall Study|Physician Decision|3|||
144470298|NCT02710292|520919631|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
144470299|NCT02710292|520919630|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
144537386|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
144537387|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
144614009|NCT02577146|521447085|FG000|Overall Study|Screen Failure|17|||
144614010|NCT03765138|521447086|FG000|Overall Study|Lost to Follow-up|1|||
144614011|NCT00361270|521447087|FG000|Overall Study|Death|0|||
144470300|NCT02710292|520919631|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
144470301|NCT03122119|520919632|FG000|Overall Study|Did not meet eligibility critria|1|||
144726550|NCT02180711|521854286|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
144726551|NCT02180711|521854287|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
144726552|NCT02180711|521854288|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
144726553|NCT02180711|521854289|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
144726554|NCT02180711|521854290|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
144470302|NCT02364180|520919638|FG000|Overall Study|Screen Fail|1|||
144470303|NCT01783418|520919639|FG000|Overall Study|Withdrawal by Subject|1|||
144470304|NCT01783418|520919640|FG001|Overall Study|Withdrawal by Subject|0|||
144470305|NCT00089141|520919641|FG000|Overall Study|Termination of trial|18|||
144470306|NCT00089141|520919642|FG001|Overall Study|Termination of trial|24|||
144470307|NCT00508261|520919643|FG000|Overall Study|Other|0|||
144470308|NCT00508261|520919644|FG001|Overall Study|Other|1|||
144470309|NCT00508261|520919645|FG002|Overall Study|Other|1|||
144726555|NCT02180711|521854291|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
144726556|NCT02180711|521854292|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
144726557|NCT02180711|521854293|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
144726558|NCT02180711|521854286|FG000|Overall Study|- Study Terminated by Sponsor|2|||
144726559|NCT02180711|521854287|FG001|Overall Study|- Study Terminated by Sponsor|3|||
144726560|NCT02180711|521854288|FG002|Overall Study|- Study Terminated by Sponsor|0|||
144726561|NCT02180711|521854289|FG003|Overall Study|- Study Terminated by Sponsor|5|||
144726562|NCT02180711|521854290|FG004|Overall Study|- Study Terminated by Sponsor|32|||
144726563|NCT02180711|521854291|FG005|Overall Study|- Study Terminated by Sponsor|0|||
144726564|NCT02180711|521854292|FG006|Overall Study|- Study Terminated by Sponsor|4|||
144726565|NCT02180711|521854293|FG007|Overall Study|- Study Terminated by Sponsor|13|||
144726566|NCT02180711|521854286|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
144726567|NCT02180711|521854287|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
144726568|NCT02180711|521854288|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
144726569|NCT02180711|521854289|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
144726570|NCT02180711|521854290|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
144726571|NCT02180711|521854291|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
144726572|NCT02180711|521854292|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
144726573|NCT02180711|521854293|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
144726574|NCT02180711|521854286|FG000|Overall Study|- Other|1|||
144470310|NCT00508261|520919646|FG003|Overall Study|Other|0|||
144470311|NCT00508261|520919643|FG000|Overall Study|Serious Adverse Event|0|||
144726575|NCT02180711|521854287|FG001|Overall Study|- Other|0|||
144726576|NCT02180711|521854288|FG002|Overall Study|- Other|0|||
144726577|NCT02180711|521854289|FG003|Overall Study|- Other|1|||
144726578|NCT02180711|521854290|FG004|Overall Study|- Other|0|||
144726579|NCT02180711|521854291|FG005|Overall Study|- Other|0|||
144726580|NCT02180711|521854292|FG006|Overall Study|- Other|0|||
144726581|NCT02180711|521854293|FG007|Overall Study|- Other|0|||
144726582|NCT01374919|521854300|FG000|Overall Study|Withdrawal by Subject|2|||
144726583|NCT03805438|521854301|FG000|Overall Study|Lack of Efficacy|1|||
144470312|NCT00508261|520919644|FG001|Overall Study|Serious Adverse Event|1|||
144470313|NCT00508261|520919645|FG002|Overall Study|Serious Adverse Event|0|||
144470314|NCT00508261|520919646|FG003|Overall Study|Serious Adverse Event|0|||
144470315|NCT00508261|520919643|FG000|Overall Study|Withdrawal by Subject|3|||
144470316|NCT00508261|520919644|FG001|Overall Study|Withdrawal by Subject|4|||
144470317|NCT00508261|520919645|FG002|Overall Study|Withdrawal by Subject|4|||
144470318|NCT00508261|520919646|FG003|Overall Study|Withdrawal by Subject|0|||
144470319|NCT00508261|520919643|FG000|Overall Study|Migrated/ moved from study area|0|||
144470320|NCT00508261|520919644|FG001|Overall Study|Migrated/ moved from study area|1|||
144470321|NCT00508261|520919645|FG002|Overall Study|Migrated/ moved from study area|0|||
144470322|NCT00508261|520919646|FG003|Overall Study|Migrated/ moved from study area|0|||
144470323|NCT00508261|520919643|FG000|Overall Study|Lost to Follow-up|0|||
144614012|NCT00361270|521447088|FG001|Overall Study|Death|0|||
144614013|NCT00361270|521447089|FG002|Overall Study|Death|0|||
144614014|NCT00361270|521447090|FG003|Overall Study|Death|2|||
144614015|NCT00361270|521447087|FG000|Overall Study|Lost to Follow-up|4|||
144614016|NCT00361270|521447088|FG001|Overall Study|Lost to Follow-up|1|||
144614017|NCT00361270|521447089|FG002|Overall Study|Lost to Follow-up|0|||
144614018|NCT00361270|521447090|FG003|Overall Study|Lost to Follow-up|0|||
144614019|NCT00361270|521447087|FG000|Overall Study|Physician Decision|0|||
144614020|NCT00361270|521447088|FG001|Overall Study|Physician Decision|0|||
144614021|NCT00361270|521447089|FG002|Overall Study|Physician Decision|1|||
144614022|NCT00361270|521447090|FG003|Overall Study|Physician Decision|0|||
144614023|NCT00361270|521447087|FG000|Overall Study|Protocol Violation|9|||
144614024|NCT00361270|521447088|FG001|Overall Study|Protocol Violation|4|||
144614025|NCT00361270|521447089|FG002|Overall Study|Protocol Violation|5|||
144470324|NCT00508261|520919644|FG001|Overall Study|Lost to Follow-up|1|||
144470325|NCT00508261|520919645|FG002|Overall Study|Lost to Follow-up|1|||
144614026|NCT00361270|521447090|FG003|Overall Study|Protocol Violation|4|||
144614027|NCT00361270|521447087|FG000|Overall Study|Withdrawal by Subject|6|||
144614028|NCT00361270|521447088|FG001|Overall Study|Withdrawal by Subject|6|||
144726584|NCT03805438|521854301|FG000|Overall Study|Protocol Violation|1|||
144726585|NCT00366899|521854302|FG000|Infant Series|Withdrawal by Subject|4|||
144726586|NCT00366899|521854303|FG001|Infant Series|Withdrawal by Subject|7|||
144726587|NCT00366899|521854302|FG000|Infant Series|Protocol Violation|2|||
144726588|NCT00366899|521854303|FG001|Infant Series|Protocol Violation|1|||
144726589|NCT00366899|521854302|FG000|Infant Series|Failed to return|1|||
144726590|NCT00366899|521854303|FG001|Infant Series|Failed to return|1|||
144726591|NCT00366899|521854302|FG000|Infant Series|Lost to Follow-up|0|||
144726592|NCT00366899|521854303|FG001|Infant Series|Lost to Follow-up|2|||
144726593|NCT00366899|521854302|FG000|Infant Series|Adverse Event|0|||
144726594|NCT00366899|521854303|FG001|Infant Series|Adverse Event|1|||
144726595|NCT00366899|521854302|FG000|Infant Series|Physician Decision|1|||
144726596|NCT00366899|521854303|FG001|Infant Series|Physician Decision|0|||
144726597|NCT00366899|521854302|FG000|Infant Series|Randomized but not consented|1|||
144614029|NCT00361270|521447089|FG002|Overall Study|Withdrawal by Subject|3|||
144614030|NCT00361270|521447090|FG003|Overall Study|Withdrawal by Subject|7|||
144614031|NCT00361270|521447087|FG000|Overall Study|Afraid of Hypnosis|1|||
144614032|NCT00361270|521447088|FG001|Overall Study|Afraid of Hypnosis|2|||
144614033|NCT00361270|521447089|FG002|Overall Study|Afraid of Hypnosis|0|||
144614034|NCT00361270|521447090|FG003|Overall Study|Afraid of Hypnosis|0|||
144614035|NCT00361270|521447087|FG000|Overall Study|Problems with Transportation|4|||
144614036|NCT00361270|521447088|FG001|Overall Study|Problems with Transportation|0|||
144614037|NCT00361270|521447089|FG002|Overall Study|Problems with Transportation|0|||
144614038|NCT00361270|521447090|FG003|Overall Study|Problems with Transportation|0|||
144614039|NCT00361270|521447087|FG000|Overall Study|Adverse Event|0|||
144614040|NCT00361270|521447088|FG001|Overall Study|Adverse Event|1|||
144614041|NCT00361270|521447089|FG002|Overall Study|Adverse Event|1|||
144614042|NCT00361270|521447090|FG003|Overall Study|Adverse Event|0|||
144614043|NCT03116698|521447094|FG000|Overall Study|Adverse Event|1|||
144614044|NCT03116698|521447095|FG001|Overall Study|Adverse Event|1|||
144614045|NCT03116698|521447096|FG002|Overall Study|Adverse Event|1|||
144614046|NCT03116698|521447097|FG003|Overall Study|Adverse Event|0|||
144614047|NCT03116698|521447094|FG000|Overall Study|Withdrawal by Subject|1|||
144614048|NCT03116698|521447095|FG001|Overall Study|Withdrawal by Subject|4|||
144614049|NCT03116698|521447096|FG002|Overall Study|Withdrawal by Subject|5|||
144614050|NCT03116698|521447097|FG003|Overall Study|Withdrawal by Subject|2|||
144614051|NCT03116698|521447094|FG000|Overall Study|Lost to Follow-up|2|||
144614052|NCT03116698|521447095|FG001|Overall Study|Lost to Follow-up|0|||
144614053|NCT03116698|521447096|FG002|Overall Study|Lost to Follow-up|0|||
144614054|NCT03116698|521447097|FG003|Overall Study|Lost to Follow-up|0|||
144614055|NCT03116698|521447094|FG000|Overall Study|Physician Decision|1|||
144614056|NCT03116698|521447095|FG001|Overall Study|Physician Decision|1|||
144614057|NCT03116698|521447096|FG002|Overall Study|Physician Decision|0|||
144614058|NCT03116698|521447097|FG003|Overall Study|Physician Decision|0|||
144614059|NCT03116698|521447094|FG000|Overall Study|Protocol Violation|1|||
144614060|NCT03116698|521447095|FG001|Overall Study|Protocol Violation|0|||
144614061|NCT03116698|521447096|FG002|Overall Study|Protocol Violation|0|||
144614062|NCT03116698|521447097|FG003|Overall Study|Protocol Violation|0|||
144614063|NCT03116698|521447094|FG000|Overall Study|Death|0|||
144614064|NCT03116698|521447095|FG001|Overall Study|Death|0|||
144614065|NCT03116698|521447096|FG002|Overall Study|Death|2|||
144614066|NCT03116698|521447097|FG003|Overall Study|Death|0|||
144614067|NCT00788372|521447098|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
144614068|NCT00788372|521447098|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
144614069|NCT00788372|521447098|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
144614070|NCT00788372|521447098|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
144614071|NCT00788372|521447098|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
144614072|NCT00788372|521447098|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
144614073|NCT00788372|521447098|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
144614074|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
144726598|NCT00366899|521854303|FG001|Infant Series|Randomized but not consented|0|||
144726599|NCT00366899|521854302|FG000|After Infant Series|Lost to Follow-up|4|||
144614075|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
144614076|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
144614077|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
144726600|NCT00366899|521854303|FG001|After Infant Series|Lost to Follow-up|3|||
144614078|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
144614079|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
144614080|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
144726601|NCT00366899|521854302|FG000|After Infant Series|Withdrawal by Subject|1|||
144726602|NCT00366899|521854303|FG001|After Infant Series|Withdrawal by Subject|4|||
144726603|NCT00366899|521854302|FG000|After Infant Series|Adverse Event|1|||
144726604|NCT00366899|521854303|FG001|After Infant Series|Adverse Event|2|||
144470326|NCT00508261|520919646|FG003|Overall Study|Lost to Follow-up|1|||
144470327|NCT01201811|520919647|FG000|Overall Study|Adverse Event|6|||
144470328|NCT01201811|520919647|FG000|Overall Study|Disease progression|3|||
144470329|NCT01201811|520919647|FG000|Overall Study|Withdrawal by Subject|3|||
144470330|NCT01201811|520919647|FG000|Overall Study|Death|4|||
144470331|NCT01201811|520919647|FG000|Overall Study|Treatment Failure|2|||
144258373|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
144470332|NCT01201811|520919647|FG000|Overall Study|Physician Decision|1|||
144470333|NCT01820559|520919648|FG000|Overall Study|Adverse Event|4|||
144470334|NCT01820559|520919649|FG001|Overall Study|Adverse Event|6|||
144470335|NCT01820559|520919650|FG002|Overall Study|Adverse Event|13|||
144470336|NCT01820559|520919648|FG000|Overall Study|Withdrawal by Subject|1|||
144470337|NCT01820559|520919649|FG001|Overall Study|Withdrawal by Subject|2|||
144537388|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
144537389|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
144537390|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
144537391|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
144537392|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
144537393|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
144537394|NCT01074294|521170947|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
144537395|NCT01074294|521170948|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
144537396|NCT01074294|521170949|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
144537397|NCT01074294|521170950|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
144537398|NCT01074294|521170947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
144537399|NCT01074294|521170948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
144537400|NCT01074294|521170949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
144537401|NCT01074294|521170950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
144537402|NCT01074294|521170947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
144537403|NCT01074294|521170948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
144537404|NCT01074294|521170949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
144537405|NCT01074294|521170950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
144537406|NCT01074294|521170947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
144537407|NCT01074294|521170948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
144537408|NCT01074294|521170949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
144537409|NCT01074294|521170950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
144537410|NCT01074294|521170947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
144537411|NCT01074294|521170948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
144537412|NCT01074294|521170949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
144537413|NCT01074294|521170950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
144537414|NCT01074294|521170947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
144537415|NCT01074294|521170948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
144537416|NCT01074294|521170949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
144537417|NCT01074294|521170950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
144537418|NCT01074294|521170947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
144537419|NCT01074294|521170948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
144537420|NCT01074294|521170949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
144537421|NCT01074294|521170950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
144537422|NCT00640159|521170951|FG000|Overall Study|Lost to Follow-up|2|||
144537423|NCT00112359|521170952|FG000|Overall Study|Unrelated adverse event|16|||
144537424|NCT00112359|521170953|FG001|Overall Study|Unrelated adverse event|8|||
144537425|NCT00112359|521170952|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
144537426|NCT00112359|521170953|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
144537427|NCT00112359|521170952|FG000|Overall Study|Related adverse event|5|||
144537428|NCT00112359|521170953|FG001|Overall Study|Related adverse event|3|||
144537429|NCT00112359|521170952|FG000|Overall Study|Lost to Follow-up|0|||
144537430|NCT00112359|521170953|FG001|Overall Study|Lost to Follow-up|1|||
144537431|NCT00112359|521170952|FG000|Overall Study|Personal/administrative|1|||
144537432|NCT00112359|521170953|FG001|Overall Study|Personal/administrative|1|||
144537433|NCT00112359|521170952|FG000|Overall Study|Other|3|||
144537434|NCT00112359|521170953|FG001|Overall Study|Other|0|||
144537435|NCT01952366|521170954|FG000|Overall Study|Death|22|||
144537436|NCT01952366|521170954|FG000|Overall Study|Withdrawal by Subject|9|||
144537437|NCT00623194|521170955|FG000|Overall Study|Lack of Efficacy|1|||
144537438|NCT00623194|521170955|FG000|Overall Study|Protocol Violation|3|||
144537439|NCT00623194|521170955|FG000|Overall Study|Unclassified|1|||
144537440|NCT04860505|521170956|FG000|Overall Study|Lost to Follow-up|2|||
144537441|NCT00857766|521170957|FG000|Overall Study|Adverse Event|13|||
144537442|NCT00857766|521170958|FG001|Overall Study|Adverse Event|12|||
144537443|NCT00857766|521170957|FG000|Overall Study|Protocol Violation|11|||
144259309|NCT00511810|520150364|FG001|Overall Study|Lack of Efficacy|2|||
144726605|NCT00366899|521854302|FG000|After Infant Series|Protocol Violation|1|||
144726606|NCT00366899|521854303|FG001|After Infant Series|Protocol Violation|0|||
144726607|NCT00366899|521854302|FG000|Toddler Dose|Withdrawal by Subject|1|||
144726608|NCT00366899|521854303|FG001|Toddler Dose|Withdrawal by Subject|1|||
144726609|NCT00366899|521854302|FG000|Toddler Dose|Protocol Violation|1|||
144726610|NCT00366899|521854303|FG001|Toddler Dose|Protocol Violation|0|||
144726611|NCT02848326|521854304|FG000|Treatment Period|Adverse Event|5|||
144726612|NCT02848326|521854305|FG001|Treatment Period|Adverse Event|4|||
144726613|NCT02848326|521854306|FG002|Treatment Period|Adverse Event|11|||
144726614|NCT02848326|521854307|FG003|Treatment Period|Adverse Event|6|||
144726615|NCT02848326|521854308|FG004|Treatment Period|Adverse Event|5|||
144726616|NCT02848326|521854309|FG005|Treatment Period|Adverse Event|7|||
144726617|NCT02848326|521854304|FG000|Treatment Period|Withdrawal of Consent|20|||
144726618|NCT02848326|521854305|FG001|Treatment Period|Withdrawal of Consent|6|||
144470338|NCT01820559|520919650|FG002|Overall Study|Withdrawal by Subject|5|||
144470339|NCT01820559|520919648|FG000|Overall Study|Protocol Violation|2|||
144470340|NCT01820559|520919649|FG001|Overall Study|Protocol Violation|1|||
144470341|NCT01820559|520919650|FG002|Overall Study|Protocol Violation|3|||
144726619|NCT02848326|521854306|FG002|Treatment Period|Withdrawal of Consent|9|||
144726620|NCT02848326|521854307|FG003|Treatment Period|Withdrawal of Consent|6|||
144726621|NCT02848326|521854308|FG004|Treatment Period|Withdrawal of Consent|9|||
144470342|NCT01820559|520919648|FG000|Overall Study|Subject's non-compliance|1|||
144470343|NCT01820559|520919649|FG001|Overall Study|Subject's non-compliance|0|||
144470344|NCT01820559|520919650|FG002|Overall Study|Subject's non-compliance|2|||
144470345|NCT01820559|520919648|FG000|Overall Study|Lost to Follow-up|3|||
144470346|NCT01820559|520919649|FG001|Overall Study|Lost to Follow-up|2|||
144470347|NCT01820559|520919650|FG002|Overall Study|Lost to Follow-up|2|||
144470348|NCT01820559|520919648|FG000|Overall Study|At sponsor request|0|||
144470349|NCT01820559|520919649|FG001|Overall Study|At sponsor request|0|||
144726622|NCT02848326|521854309|FG005|Treatment Period|Withdrawal of Consent|6|||
144726623|NCT02848326|521854304|FG000|Treatment Period|Lost to Follow-up|5|||
144726624|NCT02848326|521854305|FG001|Treatment Period|Lost to Follow-up|1|||
144470350|NCT01820559|520919650|FG002|Overall Study|At sponsor request|1|||
144470351|NCT01820559|520919648|FG000|Overall Study|Lack of Efficacy|3|||
144470352|NCT01820559|520919649|FG001|Overall Study|Lack of Efficacy|2|||
144470353|NCT01820559|520919650|FG002|Overall Study|Lack of Efficacy|3|||
144470354|NCT03641313|520919657|FG000|Overall Study|Death|1|||
144470355|NCT03641313|520919657|FG000|Overall Study|Withdrawal by Subject|2|||
144470356|NCT03641313|520919657|FG000|Overall Study|Declining health|1|||
144470357|NCT03641313|520919657|FG000|Overall Study|Adverse Event|1|||
144470358|NCT03033225|520919658|FG000|Overall Study|Withdrawal by Subject|5|||
144470359|NCT00946296|520919659|FG000|Overall Study|Physician Decision|3|||
144470360|NCT00946296|520919660|FG001|Overall Study|Physician Decision|0|||
144470361|NCT03434678|520919661|FG000|Overall Study|Withdrawal by Subject|13|||
144470362|NCT03434678|520919662|FG001|Overall Study|Withdrawal by Subject|13|||
144470363|NCT03434678|520919661|FG000|Overall Study|Found to be ineligible post randomization|2|||
144470364|NCT03434678|520919662|FG001|Overall Study|Found to be ineligible post randomization|1|||
144470365|NCT06060457|520919665|FG000|Overall Study|Adverse Event|1|||
144470366|NCT06060457|520919666|FG001|Overall Study|Adverse Event|1|||
144470367|NCT06060457|520919665|FG000|Overall Study|Death|2|||
144470368|NCT06060457|520919666|FG001|Overall Study|Death|2|||
144470369|NCT06060457|520919665|FG000|Overall Study|Lost to Follow-up|17|||
144470370|NCT06060457|520919666|FG001|Overall Study|Lost to Follow-up|19|||
144470371|NCT06060457|520919665|FG000|Overall Study|Physician Decision|0|||
144470372|NCT06060457|520919666|FG001|Overall Study|Physician Decision|1|||
144470373|NCT06060457|520919665|FG000|Overall Study|Protocol Violation|1|||
144470374|NCT06060457|520919666|FG001|Overall Study|Protocol Violation|1|||
144470375|NCT06060457|520919665|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
144470376|NCT06060457|520919666|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
144470377|NCT06060457|520919665|FG000|Overall Study|Withdrawal by Subject|12|||
144470378|NCT06060457|520919666|FG001|Overall Study|Withdrawal by Subject|15|||
144470379|NCT06060457|520919665|FG000|Overall Study|Other Than Specified|2|||
144470380|NCT06060457|520919666|FG001|Overall Study|Other Than Specified|1|||
144470381|NCT02061202|520919667|FG000|Overall Study|Lost to Follow-up|1|||
144470382|NCT02061202|520919668|FG001|Overall Study|Lost to Follow-up|1|||
144470383|NCT01533493|520919669|FG000|Overall Study|Adverse Event|2|||
144470384|NCT01533493|520919670|FG001|Overall Study|Adverse Event|1|||
144470385|NCT01533493|520919669|FG000|Overall Study|Withdrawal by Subject|1|||
144726625|NCT02848326|521854306|FG002|Treatment Period|Lost to Follow-up|11|||
144726626|NCT02848326|521854307|FG003|Treatment Period|Lost to Follow-up|7|||
144470386|NCT01533493|520919670|FG001|Overall Study|Withdrawal by Subject|2|||
144470387|NCT01533493|520919669|FG000|Overall Study|Lost to Follow-up|2|||
144470388|NCT01533493|520919670|FG001|Overall Study|Lost to Follow-up|0|||
144470389|NCT05163522|520919678|FG000|Overall Study|Withdrawal by Subject|0|||
144470390|NCT05163522|520919679|FG001|Overall Study|Withdrawal by Subject|0|||
144470391|NCT05163522|520919680|FG002|Overall Study|Withdrawal by Subject|1|||
144470392|NCT05163522|520919681|FG003|Overall Study|Withdrawal by Subject|0|||
144726627|NCT02848326|521854308|FG004|Treatment Period|Lost to Follow-up|2|||
144614081|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
144614082|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to death|4|||
144614083|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to death|3|||
144614084|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
144614085|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
144614086|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
144614087|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
144614088|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
144614089|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
144614090|NCT02258451|521447099|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
144614091|NCT02258451|521447100|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
144614092|NCT02258451|521447099|FG000|Overall Study|Other reason|1|||
144614093|NCT02258451|521447100|FG001|Overall Study|Other reason|1|||
144614094|NCT02258451|521447099|FG000|Overall Study|Never treated|2|||
144614095|NCT02258451|521447100|FG001|Overall Study|Never treated|3|||
144614096|NCT03099187|521447103|FG000|Double-blind Treatment|Adverse Event|19|||
144614097|NCT03099187|521447104|FG001|Double-blind Treatment|Adverse Event|1|||
144614098|NCT03099187|521447105|FG002|Double-blind Treatment|Adverse Event|0|||
144614099|NCT03099187|521447106|FG003|Double-blind Treatment|Adverse Event|0|||
144614100|NCT03099187|521447103|FG000|Double-blind Treatment|Death|1|||
144614101|NCT03099187|521447104|FG001|Double-blind Treatment|Death|3|||
144614102|NCT03099187|521447105|FG002|Double-blind Treatment|Death|0|||
144614103|NCT03099187|521447106|FG003|Double-blind Treatment|Death|0|||
144614104|NCT03099187|521447103|FG000|Double-blind Treatment|Lack of Efficacy|1|||
144614105|NCT03099187|521447104|FG001|Double-blind Treatment|Lack of Efficacy|0|||
144614106|NCT03099187|521447105|FG002|Double-blind Treatment|Lack of Efficacy|0|||
144614107|NCT03099187|521447106|FG003|Double-blind Treatment|Lack of Efficacy|0|||
144614108|NCT03099187|521447103|FG000|Double-blind Treatment|Physician Decision|2|||
144614109|NCT03099187|521447104|FG001|Double-blind Treatment|Physician Decision|1|||
144614110|NCT03099187|521447105|FG002|Double-blind Treatment|Physician Decision|0|||
144614111|NCT03099187|521447106|FG003|Double-blind Treatment|Physician Decision|0|||
144614112|NCT03099187|521447103|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
144614113|NCT03099187|521447104|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
144614114|NCT03099187|521447105|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
144614115|NCT03099187|521447106|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
144614116|NCT03099187|521447103|FG000|Double-blind Treatment|Lung transplantation|0|||
144614117|NCT03099187|521447104|FG001|Double-blind Treatment|Lung transplantation|1|||
144614118|NCT03099187|521447105|FG002|Double-blind Treatment|Lung transplantation|0|||
144614119|NCT03099187|521447106|FG003|Double-blind Treatment|Lung transplantation|0|||
144614120|NCT03099187|521447103|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
144614121|NCT03099187|521447104|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
144614122|NCT03099187|521447105|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
144614123|NCT03099187|521447106|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
144614124|NCT03099187|521447103|FG000|Double-blind Treatment|Disease progression|0|||
144614125|NCT03099187|521447104|FG001|Double-blind Treatment|Disease progression|1|||
144614126|NCT03099187|521447105|FG002|Double-blind Treatment|Disease progression|0|||
144614127|NCT03099187|521447106|FG003|Double-blind Treatment|Disease progression|0|||
144614128|NCT03099187|521447103|FG000|Double-blind Treatment|Randomization error|0|||
144614129|NCT03099187|521447104|FG001|Double-blind Treatment|Randomization error|2|||
144614130|NCT03099187|521447105|FG002|Double-blind Treatment|Randomization error|0|||
144614131|NCT03099187|521447106|FG003|Double-blind Treatment|Randomization error|0|||
144614132|NCT03099187|521447103|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
144614133|NCT03099187|521447104|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
144614134|NCT03099187|521447105|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
144470393|NCT05163522|520919682|FG004|Overall Study|Withdrawal by Subject|0|||
144470394|NCT05163522|520919683|FG005|Overall Study|Withdrawal by Subject|0|||
144470395|NCT05163522|520919684|FG006|Overall Study|Withdrawal by Subject|0|||
144470396|NCT05163522|520919685|FG007|Overall Study|Withdrawal by Subject|0|||
144470397|NCT05163522|520919686|FG008|Overall Study|Withdrawal by Subject|0|||
144470398|NCT05163522|520919687|FG009|Overall Study|Withdrawal by Subject|0|||
144470399|NCT05163522|520919688|FG010|Overall Study|Withdrawal by Subject|0|||
144470400|NCT00715429|520919690|FG000|Overall Study|Did not complete the study diary|0|||
144470401|NCT00715429|520919691|FG001|Overall Study|Did not complete the study diary|1|||
144470402|NCT04899245|520919699|FG000|Overall Study|Withdrawal by Subject|3|||
144470403|NCT04899245|520919700|FG001|Overall Study|Withdrawal by Subject|5|||
144470404|NCT04899245|520919701|FG002|Overall Study|Withdrawal by Subject|2|||
144614135|NCT03099187|521447106|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
144614136|NCT03099187|521447103|FG000|12-month Safety Follow-up|Adverse Event|0|||
144614137|NCT03099187|521447104|FG001|12-month Safety Follow-up|Adverse Event|0|||
144470405|NCT04899245|520919699|FG000|Overall Study|No longer eligible - Left staff position|0|||
144470406|NCT04899245|520919700|FG001|Overall Study|No longer eligible - Left staff position|0|||
144470407|NCT04899245|520919701|FG002|Overall Study|No longer eligible - Left staff position|1|||
144470408|NCT04899245|520919699|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
144470409|NCT04899245|520919700|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
144470410|NCT04899245|520919701|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
144470411|NCT04899245|520919699|FG000|Overall Study|No longer eligible - Moved away from area|2|||
144470412|NCT04899245|520919700|FG001|Overall Study|No longer eligible - Moved away from area|2|||
144470413|NCT04899245|520919701|FG002|Overall Study|No longer eligible - Moved away from area|0|||
144470414|NCT01648348|520919719|FG000|Overall Study|Cancel|1|||
144470415|NCT01648348|520919720|FG001|Overall Study|Cancel|0|||
144470416|NCT01648348|520919721|FG002|Overall Study|Cancel|0|||
144470417|NCT01648348|520919722|FG003|Overall Study|Cancel|0|||
144470418|NCT01648348|520919723|FG004|Overall Study|Cancel|3|||
144470419|NCT01648348|520919724|FG005|Overall Study|Cancel|6|||
144470420|NCT01648348|520919719|FG000|Overall Study|Replaced for MTD analysis|1|||
144470421|NCT01648348|520919720|FG001|Overall Study|Replaced for MTD analysis|0|||
144470422|NCT01648348|520919721|FG002|Overall Study|Replaced for MTD analysis|1|||
144470423|NCT01648348|520919722|FG003|Overall Study|Replaced for MTD analysis|0|||
144470424|NCT01648348|520919723|FG004|Overall Study|Replaced for MTD analysis|0|||
144470425|NCT01648348|520919724|FG005|Overall Study|Replaced for MTD analysis|0|||
144470426|NCT02495025|520919729|FG000|Overall Study|Lost to Follow-up|21|||
144470427|NCT02495025|520919730|FG001|Overall Study|Lost to Follow-up|14|||
144470428|NCT02495025|520919729|FG000|Overall Study|Withdrawal by Subject|5|||
144470429|NCT02495025|520919730|FG001|Overall Study|Withdrawal by Subject|0|||
144470430|NCT02778100|520919733|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
144470431|NCT02778100|520919734|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
144470432|NCT03419364|520919739|FG000|Overall Study|Delivery due to maternal condition|2|||
144470433|NCT03419364|520919740|FG001|Overall Study|Delivery due to maternal condition|0|||
144470434|NCT03419364|520919741|FG002|Overall Study|Delivery due to maternal condition|0|||
144470435|NCT00552084|520919742|FG000|Overall Study|Adverse Event|2|||
144470436|NCT00552084|520919743|FG001|Overall Study|Adverse Event|3|||
144470437|NCT00552084|520919742|FG000|Overall Study|Withdrawal by Subject|4|||
144470438|NCT00552084|520919743|FG001|Overall Study|Withdrawal by Subject|5|||
144470439|NCT00552084|520919742|FG000|Overall Study|Protocol Violation|1|||
144470440|NCT00552084|520919743|FG001|Overall Study|Protocol Violation|0|||
144470441|NCT00552084|520919742|FG000|Overall Study|change in anti-arrythmic drug|1|||
144470442|NCT00552084|520919743|FG001|Overall Study|change in anti-arrythmic drug|1|||
144470443|NCT01338025|520919744|FG000|Overall Study|Unexpected closure of study|10|||
144470444|NCT01338025|520919745|FG001|Overall Study|Unexpected closure of study|9|||
144614138|NCT03099187|521447105|FG002|12-month Safety Follow-up|Adverse Event|5|||
144614139|NCT03099187|521447106|FG003|12-month Safety Follow-up|Adverse Event|12|||
144614140|NCT03099187|521447103|FG000|12-month Safety Follow-up|Death|0|||
144614141|NCT03099187|521447104|FG001|12-month Safety Follow-up|Death|0|||
144614142|NCT03099187|521447105|FG002|12-month Safety Follow-up|Death|7|||
144614143|NCT03099187|521447106|FG003|12-month Safety Follow-up|Death|9|||
144614144|NCT03099187|521447103|FG000|12-month Safety Follow-up|Lung transplantation|0|||
144614145|NCT03099187|521447104|FG001|12-month Safety Follow-up|Lung transplantation|0|||
144614146|NCT03099187|521447105|FG002|12-month Safety Follow-up|Lung transplantation|2|||
144614147|NCT03099187|521447106|FG003|12-month Safety Follow-up|Lung transplantation|1|||
144614148|NCT03099187|521447103|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
144614149|NCT03099187|521447104|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
144614150|NCT03099187|521447105|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
144614151|NCT03099187|521447106|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
144614152|NCT03099187|521447103|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
144614153|NCT03099187|521447104|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
144614154|NCT03099187|521447105|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
144614155|NCT03099187|521447106|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
144614156|NCT03099187|521447103|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
144614157|NCT03099187|521447104|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
144614158|NCT03099187|521447105|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
144614159|NCT03099187|521447106|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
144614160|NCT03099187|521447103|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
144614161|NCT03099187|521447104|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
144614162|NCT03099187|521447105|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
144614163|NCT03099187|521447106|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
144614164|NCT01439555|521447111|FG000|Overall Study|Protocol Violation|1|||
144614165|NCT00129766|521448385|FG000|Overall Study|Death|3|||
144614166|NCT00129766|521448386|FG001|Overall Study|Death|8|||
144614167|NCT00129766|521448385|FG000|Overall Study|Withdrawal of consent|31|||
144614168|NCT00129766|521448386|FG001|Overall Study|Withdrawal of consent|30|||
144614169|NCT00129766|521448385|FG000|Overall Study|Lost to Follow-up|26|||
144614170|NCT00129766|521448386|FG001|Overall Study|Lost to Follow-up|21|||
144470445|NCT01338025|520919744|FG000|Overall Study|Withdrawal by Subject|0|||
144470446|NCT01338025|520919745|FG001|Overall Study|Withdrawal by Subject|2|||
144470447|NCT01338025|520919744|FG000|Overall Study|Found ineligible after starting|1|||
144470448|NCT01338025|520919745|FG001|Overall Study|Found ineligible after starting|0|||
144470449|NCT03017079|520919746|FG000|Overall Study|Physician Decision|1|||
144470450|NCT03017079|520919747|FG001|Overall Study|Physician Decision|1|||
144470451|NCT03017079|520919746|FG000|Overall Study|Death|3|||
144470452|NCT03017079|520919747|FG001|Overall Study|Death|2|||
144614171|NCT01081912|521448388|FG000|Conversion/Titration|Adverse Event|47|||
144614172|NCT01081912|521448389|FG001|Conversion/Titration|Adverse Event|0|||
144614173|NCT01081912|521448390|FG002|Conversion/Titration|Adverse Event|0|||
144614174|NCT01081912|521448388|FG000|Conversion/Titration|Lack of Efficacy|17|||
144614175|NCT01081912|521448389|FG001|Conversion/Titration|Lack of Efficacy|0|||
144614176|NCT01081912|521448390|FG002|Conversion/Titration|Lack of Efficacy|0|||
144614177|NCT01081912|521448388|FG000|Conversion/Titration|Lost to Follow-up|5|||
144614178|NCT01081912|521448389|FG001|Conversion/Titration|Lost to Follow-up|0|||
144614179|NCT01081912|521448390|FG002|Conversion/Titration|Lost to Follow-up|0|||
144614180|NCT01081912|521448388|FG000|Conversion/Titration|Physician Decision|2|||
144614181|NCT01081912|521448389|FG001|Conversion/Titration|Physician Decision|0|||
144614182|NCT01081912|521448390|FG002|Conversion/Titration|Physician Decision|0|||
144614183|NCT01081912|521448388|FG000|Conversion/Titration|Protocol Violation|67|||
144470453|NCT03017079|520919746|FG000|Overall Study|Lack of Efficacy|2|||
144470454|NCT03017079|520919747|FG001|Overall Study|Lack of Efficacy|2|||
144470455|NCT03017079|520919746|FG000|Overall Study|Protocol Violation|0|||
144470456|NCT03017079|520919747|FG001|Overall Study|Protocol Violation|1|||
144614184|NCT01081912|521448389|FG001|Conversion/Titration|Protocol Violation|0|||
144470457|NCT04349280|520919750|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
144470458|NCT04349280|520919751|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
144470459|NCT04349280|520919750|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
144470460|NCT04349280|520919751|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
144470461|NCT04349280|520919750|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
144470462|NCT04349280|520919751|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
144470463|NCT03779906|520919754|FG000|Overall Study|Lost to Follow-up|7|||
144470464|NCT03779906|520919754|FG000|Overall Study|COVID pandemic|1|||
144470465|NCT00526630|520921094|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
144470466|NCT00526630|520921095|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
144470467|NCT00526630|520921094|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
144470468|NCT00526630|520921095|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
144470469|NCT05168579|520921096|FG000|Overall Study|Lack of Consent|1|||
144470470|NCT05168579|520921097|FG001|Overall Study|Lack of Consent|0|||
144470471|NCT05168579|520921096|FG000|Overall Study|Conflicts with time|2|||
144470472|NCT05168579|520921097|FG001|Overall Study|Conflicts with time|0|||
144470473|NCT05168579|520921096|FG000|Overall Study|Time slots were full|3|||
144470474|NCT05168579|520921097|FG001|Overall Study|Time slots were full|0|||
144470475|NCT05168579|520921096|FG000|Overall Study|Lost to Follow-up|0|||
144470476|NCT05168579|520921097|FG001|Overall Study|Lost to Follow-up|15|||
144470477|NCT00840801|520921098|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
144470478|NCT00840801|520921099|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
144470479|NCT00840801|520921100|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
144470480|NCT00840801|520921098|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
144470481|NCT00840801|520921099|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
144470482|NCT00840801|520921100|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
144470483|NCT00840801|520921098|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
144470484|NCT00840801|520921099|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
144470485|NCT00840801|520921100|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
144470486|NCT00840801|520921098|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
144470487|NCT00840801|520921099|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
144470488|NCT00840801|520921100|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
144470489|NCT01242748|520921101|FG000|Overall Study|Adverse Event|10|||
144470490|NCT01242748|520921102|FG001|Overall Study|Adverse Event|5|||
144470491|NCT01242748|520921101|FG000|Overall Study|Lost to Follow-up|6|||
144470492|NCT01242748|520921102|FG001|Overall Study|Lost to Follow-up|2|||
144470493|NCT01242748|520921101|FG000|Overall Study|Physician Decision|3|||
144470494|NCT01242748|520921102|FG001|Overall Study|Physician Decision|2|||
144470495|NCT01242748|520921101|FG000|Overall Study|Protocol Violation|1|||
144470496|NCT01242748|520921102|FG001|Overall Study|Protocol Violation|0|||
144470497|NCT01242748|520921101|FG000|Overall Study|Withdrawal by Subject|10|||
144470498|NCT01242748|520921102|FG001|Overall Study|Withdrawal by Subject|2|||
144470499|NCT01242748|520921101|FG000|Overall Study|Miscellaneous reasons|8|||
144470500|NCT01242748|520921102|FG001|Overall Study|Miscellaneous reasons|3|||
144470501|NCT00335452|520921103|FG000|Overall Study|Death|156|||
144470502|NCT00335452|520921104|FG001|Overall Study|Death|144|||
144614185|NCT01081912|521448390|FG002|Conversion/Titration|Protocol Violation|0|||
144614186|NCT01081912|521448388|FG000|Conversion/Titration|Withdrawal by Subject|23|||
144470503|NCT00335452|520921105|FG002|Overall Study|Death|158|||
144726628|NCT02848326|521854309|FG005|Treatment Period|Lost to Follow-up|3|||
144726629|NCT02848326|521854304|FG000|Treatment Period|Pregnancy|0|||
144726630|NCT02848326|521854305|FG001|Treatment Period|Pregnancy|0|||
144726631|NCT02848326|521854306|FG002|Treatment Period|Pregnancy|1|||
144726632|NCT02848326|521854307|FG003|Treatment Period|Pregnancy|1|||
144726633|NCT02848326|521854308|FG004|Treatment Period|Pregnancy|0|||
144726634|NCT02848326|521854309|FG005|Treatment Period|Pregnancy|1|||
144726635|NCT02848326|521854304|FG000|Treatment Period|Protocol Violation|4|||
144726636|NCT02848326|521854305|FG001|Treatment Period|Protocol Violation|3|||
144726637|NCT02848326|521854306|FG002|Treatment Period|Protocol Violation|4|||
144726638|NCT02848326|521854307|FG003|Treatment Period|Protocol Violation|2|||
144726639|NCT02848326|521854308|FG004|Treatment Period|Protocol Violation|3|||
144726640|NCT02848326|521854309|FG005|Treatment Period|Protocol Violation|3|||
144726641|NCT02848326|521854304|FG000|Treatment Period|Non-compliance with Study Drug|4|||
144726642|NCT02848326|521854305|FG001|Treatment Period|Non-compliance with Study Drug|0|||
144726643|NCT02848326|521854306|FG002|Treatment Period|Non-compliance with Study Drug|0|||
144726644|NCT02848326|521854307|FG003|Treatment Period|Non-compliance with Study Drug|1|||
144726645|NCT02848326|521854308|FG004|Treatment Period|Non-compliance with Study Drug|0|||
144726646|NCT02848326|521854309|FG005|Treatment Period|Non-compliance with Study Drug|0|||
144726647|NCT02848326|521854304|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
144726648|NCT02848326|521854305|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
144726649|NCT02848326|521854306|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
144726650|NCT02848326|521854307|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
144726651|NCT02848326|521854308|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
144726652|NCT02848326|521854309|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
144726653|NCT02848326|521854304|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
144726654|NCT02848326|521854305|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
144726655|NCT02848326|521854306|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
144726656|NCT02848326|521854307|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
144726657|NCT02848326|521854308|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
144726658|NCT02848326|521854309|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
144726659|NCT00414466|521854310|FG000|Overall Study|Adverse Event|0|||
144726660|NCT00414466|521854311|FG001|Overall Study|Adverse Event|0|||
144726661|NCT00414466|521854312|FG002|Overall Study|Adverse Event|1|||
144726662|NCT00414466|521854313|FG003|Overall Study|Adverse Event|1|||
144726663|NCT00414466|521854310|FG000|Overall Study|Lack of Efficacy|1|||
144726664|NCT00414466|521854311|FG001|Overall Study|Lack of Efficacy|0|||
144726665|NCT00414466|521854312|FG002|Overall Study|Lack of Efficacy|0|||
144726666|NCT00414466|521854313|FG003|Overall Study|Lack of Efficacy|0|||
144726667|NCT00414466|521854310|FG000|Overall Study|Withdrawn by Sponsor|1|||
144726668|NCT00414466|521854311|FG001|Overall Study|Withdrawn by Sponsor|0|||
144726669|NCT00414466|521854312|FG002|Overall Study|Withdrawn by Sponsor|0|||
144726670|NCT00414466|521854313|FG003|Overall Study|Withdrawn by Sponsor|0|||
144726671|NCT02684344|521854316|FG000|Overall Study|Withdrawal by Subject|0|||
144470504|NCT00335452|520921106|FG003|Overall Study|Death|129|||
144470505|NCT00335452|520921103|FG000|Overall Study|Lost to Follow-up|2|||
144726672|NCT02684344|521854317|FG001|Overall Study|Withdrawal by Subject|1|||
144726673|NCT03480425|521854318|FG000|Overall Study|Force transducer technical failure|1|||
144726674|NCT01451762|521854319|FG000|Overall Study|Lost to Follow-up|3|||
144470506|NCT00335452|520921104|FG001|Overall Study|Lost to Follow-up|3|||
144470507|NCT00335452|520921105|FG002|Overall Study|Lost to Follow-up|1|||
144470508|NCT00335452|520921106|FG003|Overall Study|Lost to Follow-up|2|||
144470509|NCT02736825|520921108|FG000|Overall Study|Lost to Follow-up|10|||
144470510|NCT02736825|520921109|FG001|Overall Study|Lost to Follow-up|11|||
144470511|NCT02736825|520921108|FG000|Overall Study|Early Termination|0|||
144470512|NCT02736825|520921109|FG001|Overall Study|Early Termination|1|||
144470513|NCT00790452|520921110|FG000|Overall Study|Drug supply issue|1|||
144470514|NCT00790452|520921111|FG001|Overall Study|Drug supply issue|0|||
144470515|NCT02940574|520921112|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
144470516|NCT02940574|520921113|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
144470517|NCT02940574|520921112|FG000|1-year Follow-up|Lost to Follow-up|3|||
144470518|NCT02940574|520921113|FG001|1-year Follow-up|Lost to Follow-up|4|||
144470519|NCT01750879|520921116|FG000|Overall Study|Adverse Event|8|||
144470520|NCT01750879|520921117|FG001|Overall Study|Adverse Event|0|||
144470521|NCT01750879|520921116|FG000|Overall Study|Lack of Efficacy|1|||
144470522|NCT01750879|520921117|FG001|Overall Study|Lack of Efficacy|0|||
144470523|NCT01750879|520921116|FG000|Overall Study|Withdrawal by Subject|1|||
144470524|NCT01750879|520921117|FG001|Overall Study|Withdrawal by Subject|0|||
144470525|NCT01750879|520921116|FG000|Overall Study|Did not complete per protocol|0|||
144259310|NCT00511810|520150363|FG000|Overall Study|Refused second scn|0|||
144470526|NCT01750879|520921117|FG001|Overall Study|Did not complete per protocol|3|||
144470527|NCT04810221|520921118|FG000|Overall Study|Physician Decision|3|||
144470528|NCT03642938|520921119|FG000|Overall Study|Withdrawal by Subject|0|||
144726675|NCT01451762|521854320|FG001|Overall Study|Lost to Follow-up|6|||
144726676|NCT01451762|521854321|FG002|Overall Study|Lost to Follow-up|6|||
144726677|NCT00863746|521854324|FG000|Treatment|Not treated|4|||
144726678|NCT00863746|521854325|FG001|Treatment|Not treated|2|||
144726679|NCT00863746|521854324|FG000|Treatment|Adverse Event|41|||
144726680|NCT00863746|521854325|FG001|Treatment|Adverse Event|16|||
144726681|NCT00863746|521854324|FG000|Treatment|non-compliant with study medication|4|||
144726682|NCT00863746|521854325|FG001|Treatment|non-compliant with study medication|0|||
144726683|NCT00863746|521854324|FG000|Treatment|Consent withdrawn|15|||
144726684|NCT00863746|521854325|FG001|Treatment|Consent withdrawn|14|||
144726685|NCT00863746|521854324|FG000|Treatment|Lost to Follow-up|1|||
144726686|NCT00863746|521854325|FG001|Treatment|Lost to Follow-up|0|||
144726687|NCT00863746|521854324|FG000|Treatment|Protocol Violation|5|||
144726688|NCT00863746|521854325|FG001|Treatment|Protocol Violation|3|||
144726689|NCT00863746|521854324|FG000|Treatment|Other|1|||
144726690|NCT00863746|521854325|FG001|Treatment|Other|0|||
144726691|NCT00863746|521854324|FG000|Survival Follow up|Death|244|||
144726692|NCT00863746|521854325|FG001|Survival Follow up|Death|271|||
144726693|NCT00863746|521854324|FG000|Survival Follow up|Lost to Follow-up|2|||
144726694|NCT00863746|521854325|FG001|Survival Follow up|Lost to Follow-up|1|||
144726695|NCT00863746|521854324|FG000|Survival Follow up|Consent Withdrawn|7|||
144726696|NCT00863746|521854325|FG001|Survival Follow up|Consent Withdrawn|8|||
144726697|NCT03292653|521854328|FG000|Overall Study|Adverse Event|0|||
144726698|NCT03292653|521854329|FG001|Overall Study|Adverse Event|0|||
144726699|NCT03292653|521854330|FG002|Overall Study|Adverse Event|1|||
144726700|NCT03292653|521854328|FG000|Overall Study|Did not Receive Treatment|1|||
144726701|NCT03292653|521854329|FG001|Overall Study|Did not Receive Treatment|0|||
144726702|NCT03292653|521854330|FG002|Overall Study|Did not Receive Treatment|0|||
144726703|NCT04720664|521854331|FG000|Overall Study|Adverse Event|2|||
144726704|NCT04720664|521854331|FG000|Overall Study|Lack of Efficacy|9|||
144726705|NCT05037097|521854332|FG000|Overall Study|Withdrawal by Subject|0|||
144726706|NCT05037097|521854333|FG001|Overall Study|Withdrawal by Subject|1|||
144726707|NCT05037097|521854334|FG002|Overall Study|Withdrawal by Subject|0|||
144726708|NCT05037097|521854335|FG003|Overall Study|Withdrawal by Subject|1|||
144726709|NCT05037097|521854336|FG004|Overall Study|Withdrawal by Subject|0|||
144726710|NCT05037097|521854337|FG005|Overall Study|Withdrawal by Subject|2|||
144726711|NCT05037097|521854338|FG006|Overall Study|Withdrawal by Subject|0|||
144726712|NCT05037097|521854339|FG007|Overall Study|Withdrawal by Subject|0|||
144726713|NCT05037097|521854332|FG000|Overall Study|Lost to Follow-up|0|||
144726714|NCT05037097|521854333|FG001|Overall Study|Lost to Follow-up|1|||
144726715|NCT05037097|521854334|FG002|Overall Study|Lost to Follow-up|0|||
144726716|NCT05037097|521854335|FG003|Overall Study|Lost to Follow-up|0|||
144726717|NCT05037097|521854336|FG004|Overall Study|Lost to Follow-up|1|||
144726718|NCT05037097|521854337|FG005|Overall Study|Lost to Follow-up|1|||
144726719|NCT05037097|521854338|FG006|Overall Study|Lost to Follow-up|0|||
144726720|NCT05037097|521854339|FG007|Overall Study|Lost to Follow-up|0|||
144726721|NCT02322047|521854340|FG000|Overall Study|Physician Decision|1|||
144726722|NCT02322047|521854341|FG001|Overall Study|Physician Decision|0|||
144726723|NCT02322047|521854342|FG002|Overall Study|Physician Decision|0|||
144726724|NCT02322047|521854343|FG003|Overall Study|Physician Decision|0|||
144726725|NCT02322047|521854340|FG000|Overall Study|Withdrawal by Subject|1|||
144726726|NCT02322047|521854341|FG001|Overall Study|Withdrawal by Subject|0|||
144726727|NCT02322047|521854342|FG002|Overall Study|Withdrawal by Subject|0|||
144726728|NCT02322047|521854343|FG003|Overall Study|Withdrawal by Subject|1|||
144726729|NCT02322047|521854340|FG000|Overall Study|Adverse Event|0|||
144726730|NCT02322047|521854341|FG001|Overall Study|Adverse Event|1|||
144726731|NCT02322047|521854342|FG002|Overall Study|Adverse Event|0|||
144726732|NCT02322047|521854343|FG003|Overall Study|Adverse Event|0|||
144726733|NCT02322047|521854340|FG000|Overall Study|Lost to Follow-up|0|||
144726734|NCT02322047|521854341|FG001|Overall Study|Lost to Follow-up|0|||
144726735|NCT02322047|521854342|FG002|Overall Study|Lost to Follow-up|1|||
144726736|NCT02322047|521854343|FG003|Overall Study|Lost to Follow-up|1|||
144726737|NCT03103100|521854344|FG000|Overall Study|Adverse Event|1|||
144726738|NCT03103100|521854345|FG001|Overall Study|Adverse Event|0|||
144726739|NCT03103100|521854346|FG002|Overall Study|Adverse Event|0|||
144726740|NCT03103100|521854344|FG000|Overall Study|Physician Decision|1|||
144726741|NCT03103100|521854345|FG001|Overall Study|Physician Decision|0|||
144726742|NCT03103100|521854346|FG002|Overall Study|Physician Decision|2|||
144726743|NCT02906709|521854347|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
144726744|NCT02906709|521854348|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
144726745|NCT02906709|521854347|FG000|Phase A (Week 0 to Week 16)|Death|0|||
144726746|NCT02906709|521854348|FG001|Phase A (Week 0 to Week 16)|Death|1|||
144197462|NCT01859130|519920275|FG000|Overall Study|Withdrawal by Subject|17|||
144197463|NCT01859130|519920275|FG000|Overall Study|Adverse Event|11|||
144726747|NCT02906709|521854347|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
144726748|NCT02906709|521854348|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
144726749|NCT02906709|521854347|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
144726750|NCT02906709|521854348|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
144726751|NCT01124149|521854350|FG000|Acute Phase|Withdrawal by Subject|22|||
144726752|NCT01124149|521854350|FG000|Acute Phase|Adverse Event|21|||
144726753|NCT01124149|521854350|FG000|Acute Phase|Lack of Efficacy|17|||
144614187|NCT01081912|521448389|FG001|Conversion/Titration|Withdrawal by Subject|0|||
144614188|NCT01081912|521448390|FG002|Conversion/Titration|Withdrawal by Subject|0|||
144614189|NCT01081912|521448388|FG000|Conversion/Titration|Non-Compliance|47|||
144614190|NCT01081912|521448389|FG001|Conversion/Titration|Non-Compliance|0|||
144614191|NCT01081912|521448390|FG002|Conversion/Titration|Non-Compliance|0|||
144614192|NCT01081912|521448388|FG000|Maintenance Treatment|Adverse Event|0|||
144614193|NCT01081912|521448389|FG001|Maintenance Treatment|Adverse Event|2|||
144614194|NCT01081912|521448390|FG002|Maintenance Treatment|Adverse Event|12|||
144614195|NCT01081912|521448388|FG000|Maintenance Treatment|Lack of Efficacy|0|||
144614196|NCT01081912|521448389|FG001|Maintenance Treatment|Lack of Efficacy|14|||
144614197|NCT01081912|521448390|FG002|Maintenance Treatment|Lack of Efficacy|64|||
144614198|NCT01081912|521448388|FG000|Maintenance Treatment|Lost to Follow-up|0|||
144614199|NCT01081912|521448389|FG001|Maintenance Treatment|Lost to Follow-up|1|||
144614200|NCT01081912|521448390|FG002|Maintenance Treatment|Lost to Follow-up|0|||
144614201|NCT01081912|521448388|FG000|Maintenance Treatment|Physician Decision|0|||
144614202|NCT01081912|521448389|FG001|Maintenance Treatment|Physician Decision|0|||
144614203|NCT01081912|521448390|FG002|Maintenance Treatment|Physician Decision|1|||
144614204|NCT01081912|521448388|FG000|Maintenance Treatment|Protocol Violation|0|||
144614205|NCT01081912|521448389|FG001|Maintenance Treatment|Protocol Violation|1|||
144614206|NCT01081912|521448390|FG002|Maintenance Treatment|Protocol Violation|2|||
144614207|NCT01081912|521448388|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
144614208|NCT01081912|521448389|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
144614209|NCT01081912|521448390|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
144614210|NCT01081912|521448388|FG000|Maintenance Treatment|Non-Compliance|0|||
144614211|NCT01081912|521448389|FG001|Maintenance Treatment|Non-Compliance|4|||
144614212|NCT01081912|521448390|FG002|Maintenance Treatment|Non-Compliance|7|||
144614213|NCT01081912|521448388|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
144614214|NCT01081912|521448389|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
144614215|NCT01081912|521448390|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
144614216|NCT02699892|521448396|FG000|Overall Study|Other|36|||
144614217|NCT02770547|521448397|FG000|Overall Study|Patient non-compliant|1|||
144614218|NCT02770547|521448398|FG001|Overall Study|Patient non-compliant|0|||
144614219|NCT02770547|521448397|FG000|Overall Study|Adverse Event|0|||
144614220|NCT02770547|521448398|FG001|Overall Study|Adverse Event|1|||
144614221|NCT00847912|521448404|FG000|Overall Study|Protocol Violation|6|||
144614222|NCT00847912|521448405|FG001|Overall Study|Protocol Violation|7|||
144614223|NCT00847912|521448404|FG000|Overall Study|Withdrawal by Subject|3|||
144614224|NCT00847912|521448405|FG001|Overall Study|Withdrawal by Subject|6|||
144614225|NCT01324232|521448406|FG000|Overall Study|Protocol Violation|0|||
144614226|NCT01324232|521448407|FG001|Overall Study|Protocol Violation|0|||
144614227|NCT01324232|521448408|FG002|Overall Study|Protocol Violation|0|||
144614228|NCT01324232|521448409|FG003|Overall Study|Protocol Violation|2|||
144614229|NCT01324232|521448406|FG000|Overall Study|Missing|0|||
144614230|NCT01324232|521448407|FG001|Overall Study|Missing|0|||
144614231|NCT01324232|521448408|FG002|Overall Study|Missing|1|||
144614232|NCT01324232|521448409|FG003|Overall Study|Missing|0|||
144614233|NCT01324232|521448406|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
144614234|NCT01324232|521448407|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
144614235|NCT01324232|521448408|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
144614236|NCT01324232|521448409|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
144614237|NCT01324232|521448406|FG000|Overall Study|Lack of Efficacy|2|||
144614238|NCT01324232|521448407|FG001|Overall Study|Lack of Efficacy|1|||
144614239|NCT01324232|521448408|FG002|Overall Study|Lack of Efficacy|2|||
144614240|NCT01324232|521448409|FG003|Overall Study|Lack of Efficacy|2|||
144614241|NCT01324232|521448406|FG000|Overall Study|Participant Refused Medication|0|||
144614242|NCT01324232|521448407|FG001|Overall Study|Participant Refused Medication|1|||
144614243|NCT01324232|521448408|FG002|Overall Study|Participant Refused Medication|0|||
144614244|NCT01324232|521448409|FG003|Overall Study|Participant Refused Medication|0|||
144614245|NCT01324232|521448406|FG000|Overall Study|Intercurrent illness|0|||
144614246|NCT01324232|521448407|FG001|Overall Study|Intercurrent illness|0|||
144614247|NCT01324232|521448408|FG002|Overall Study|Intercurrent illness|0|||
144614248|NCT01324232|521448409|FG003|Overall Study|Intercurrent illness|1|||
144614249|NCT01324232|521448406|FG000|Overall Study|Adverse Event|2|||
144614250|NCT01324232|521448407|FG001|Overall Study|Adverse Event|5|||
144614251|NCT01324232|521448408|FG002|Overall Study|Adverse Event|6|||
144614252|NCT01324232|521448409|FG003|Overall Study|Adverse Event|6|||
144614253|NCT01324232|521448406|FG000|Overall Study|Withdrawal by Subject|0|||
144614254|NCT01324232|521448407|FG001|Overall Study|Withdrawal by Subject|3|||
144614255|NCT01324232|521448408|FG002|Overall Study|Withdrawal by Subject|4|||
144614256|NCT01324232|521448409|FG003|Overall Study|Withdrawal by Subject|0|||
144614257|NCT01324232|521448406|FG000|Overall Study|Lost to Follow-up|1|||
144614258|NCT01324232|521448407|FG001|Overall Study|Lost to Follow-up|0|||
144614259|NCT01324232|521448408|FG002|Overall Study|Lost to Follow-up|0|||
144614260|NCT01324232|521448409|FG003|Overall Study|Lost to Follow-up|0|||
144614261|NCT05440539|521448411|FG000|Overall Study|Lost to Follow-up|4|||
144614262|NCT05440539|521448412|FG001|Overall Study|Lost to Follow-up|4|||
144470529|NCT03642938|520921120|FG001|Overall Study|Withdrawal by Subject|0|||
144470530|NCT03642938|520921121|FG002|Overall Study|Withdrawal by Subject|0|||
144470531|NCT03642938|520921122|FG003|Overall Study|Withdrawal by Subject|1|||
144470532|NCT00105235|520921123|FG000|Overall Study|Death|4|||
144470533|NCT00105235|520921123|FG000|Overall Study|Physician Decision|1|||
144470534|NCT00105235|520921123|FG000|Overall Study|Withdrawal by Subject|2|||
144470535|NCT01964326|520921124|FG000|Overall Study|Adverse Event|48|||
144470536|NCT01964326|520921124|FG000|Overall Study|Death|2|||
144470537|NCT01964326|520921124|FG000|Overall Study|Protocol Violation|4|||
144470538|NCT01964326|520921124|FG000|Overall Study|Lost to Follow-up|88|||
144470539|NCT01964326|520921124|FG000|Overall Study|Withdrawal by Subject|87|||
144470540|NCT01964326|520921124|FG000|Overall Study|Pregnancy|1|||
144470541|NCT01964326|520921124|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
144470542|NCT01964326|520921124|FG000|Overall Study|Physician Decision|55|||
144470543|NCT01964326|520921124|FG000|Overall Study|Investigator Discretion|1|||
144470544|NCT01964326|520921124|FG000|Overall Study|Other|9|||
144470545|NCT01964326|520921124|FG000|Overall Study|Did not meet eligibility criteria|1|||
144470546|NCT02347657|520921125|FG000|Overall Study|Physician Decision|0|||
144470547|NCT02347657|520921126|FG001|Overall Study|Physician Decision|1|||
144470548|NCT02347657|520921125|FG000|Overall Study|Adverse Event|8|||
144470549|NCT02347657|520921126|FG001|Overall Study|Adverse Event|4|||
144470550|NCT02347657|520921125|FG000|Overall Study|Withdrawal by Subject|6|||
144470551|NCT02347657|520921126|FG001|Overall Study|Withdrawal by Subject|7|||
144470552|NCT02347657|520921125|FG000|Overall Study|Randomized but not treated|1|||
144470553|NCT02347657|520921126|FG001|Overall Study|Randomized but not treated|0|||
144470554|NCT02347657|520921125|FG000|Overall Study|Other|3|||
144470555|NCT02347657|520921126|FG001|Overall Study|Other|3|||
144470556|NCT02093663|520921133|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
144470557|NCT02093663|520921134|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
144470558|NCT02093663|520921135|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
144470559|NCT02093663|520921136|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
144470560|NCT02093663|520921137|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
144470561|NCT02093663|520921133|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
144470562|NCT02093663|520921134|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470563|NCT02093663|520921135|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470564|NCT02093663|520921136|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470565|NCT02093663|520921137|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470566|NCT02093663|520921133|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
144470567|NCT02093663|520921134|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
144470568|NCT02093663|520921135|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
144470569|NCT02093663|520921136|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
144470570|NCT02093663|520921137|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
144470571|NCT02093663|520921133|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
144470572|NCT02093663|520921134|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
144470573|NCT02093663|520921135|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
144470574|NCT02093663|520921136|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
144470575|NCT02093663|520921137|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
144470576|NCT02093663|520921133|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470577|NCT02093663|520921134|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470578|NCT02093663|520921135|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
144470579|NCT02093663|520921136|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470580|NCT02093663|520921137|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
144470581|NCT02093663|520921133|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
144470582|NCT02093663|520921134|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
144470583|NCT02093663|520921135|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
144470584|NCT02093663|520921136|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
144470585|NCT02093663|520921137|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
144197464|NCT04325204|519920276|FG000|Overall Study|Death|0|||
144470586|NCT02093663|520921133|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
144470587|NCT02093663|520921134|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
144470588|NCT02093663|520921135|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
144197465|NCT04325204|519920277|FG001|Overall Study|Death|1|||
144470589|NCT02093663|520921136|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
144470590|NCT02093663|520921137|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
144470591|NCT02093663|520921133|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
144470592|NCT02093663|520921134|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
144470593|NCT02093663|520921135|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
144470594|NCT02093663|520921136|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
144470595|NCT02093663|520921137|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
144470596|NCT02093663|520921133|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
144470597|NCT02093663|520921134|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
144614263|NCT05440539|521448411|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
144614264|NCT05440539|521448412|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
144614265|NCT00393887|521448413|FG000|Overall Study|Physician Decision|5|||
144614266|NCT00393887|521448414|FG001|Overall Study|Physician Decision|0|||
144614267|NCT00393887|521448413|FG000|Overall Study|Lost to Follow-up|11|||
144614268|NCT00393887|521448414|FG001|Overall Study|Lost to Follow-up|9|||
144614269|NCT01650636|521448419|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
144614270|NCT01650636|521448420|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
144614271|NCT01650636|521448419|FG000|Washout up to 5 Months|Physician Decision|2|||
144614272|NCT01650636|521448420|FG001|Washout up to 5 Months|Physician Decision|2|||
144614273|NCT01650636|521448419|FG000|Washout up to 5 Months|Death|1|||
144614274|NCT01650636|521448420|FG001|Washout up to 5 Months|Death|0|||
144614275|NCT01650636|521448419|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
144614276|NCT01650636|521448420|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
144614277|NCT01650636|521448419|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
144614278|NCT01650636|521448420|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
144614279|NCT01650636|521448419|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
144470598|NCT02093663|520921135|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
144470599|NCT02093663|520921136|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
144470600|NCT02093663|520921137|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
144470601|NCT00508404|520921138|FG000|Overall Study|Ongoing at Data Cut-off|12|||
144614280|NCT01650636|521448420|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
144470602|NCT00508404|520921138|FG000|Overall Study|Adverse Event|2|||
144470603|NCT00508404|520921138|FG000|Overall Study|Death|16|||
144470604|NCT00508404|520921138|FG000|Overall Study|Physician Decision|2|||
144470605|NCT00508404|520921138|FG000|Overall Study|Withdrawal by Subject|3|||
144470606|NCT00508404|520921138|FG000|Overall Study|Protocol-specified Criteria|2|||
144470607|NCT00508404|520921138|FG000|Overall Study|Lost to Follow-up|2|||
144470608|NCT00508404|520921138|FG000|Overall Study|Other - Not Specified|3|||
144470609|NCT01424930|520921139|FG000|Overall Study|Adverse Event|0|||
144470610|NCT01424930|520921140|FG001|Overall Study|Adverse Event|1|||
144470611|NCT01424930|520921139|FG000|Overall Study|Death|1|||
144470612|NCT01424930|520921140|FG001|Overall Study|Death|0|||
144614281|NCT00631020|521448423|FG000|Overall Study|Lost to Follow-up|7|||
144614282|NCT00631020|521448423|FG000|Overall Study|Incarcerated|1|||
144614283|NCT01576549|521448424|FG000|Overall Study|Sponsor Decision|2|||
144614284|NCT03975920|521448427|FG000|Overall Study|Lost to Follow-up|1|||
144614285|NCT03975920|521448428|FG001|Overall Study|Lost to Follow-up|2|||
144614286|NCT03975920|521448427|FG000|Overall Study|Protocol Violation|1|||
144614287|NCT03975920|521448428|FG001|Overall Study|Protocol Violation|1|||
144614288|NCT03975920|521448427|FG000|Overall Study|Did not complete survey|2|||
144614289|NCT03975920|521448428|FG001|Overall Study|Did not complete survey|1|||
144614290|NCT00586495|521448429|FG000|Treatment Period|Adverse Event|11|||
144614291|NCT00586495|521448429|FG000|Treatment Period|Death|1|||
144614292|NCT00586495|521448429|FG000|Treatment Period|Protocol Violation|1|||
144614293|NCT00586495|521448429|FG000|Treatment Period|Withdrawal by Subject|1|||
144614294|NCT00586495|521448429|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
144614295|NCT00586495|521448429|FG000|Treatment Period|Switch to commercial drug|10|||
144614296|NCT00586495|521448429|FG000|Follow-up|Death|40|||
144614297|NCT00586495|521448429|FG000|Follow-up|Lost to Follow-up|1|||
144614298|NCT00586495|521448429|FG000|Follow-up|Withdrawal by Subject|4|||
144614299|NCT00586495|521448429|FG000|Follow-up|Protocol driven decision point|37|||
144614300|NCT00586495|521448429|FG000|Follow-up|Switch to commercial drug|10|||
144614301|NCT02182687|521448433|FG000|Overall Study|Withdrawal by Subject|4|||
144614302|NCT02182687|521448434|FG001|Overall Study|Withdrawal by Subject|0|||
144614303|NCT02182687|521448433|FG000|Overall Study|Adverse Event|1|||
144614304|NCT02182687|521448434|FG001|Overall Study|Adverse Event|0|||
144614305|NCT02182687|521448433|FG000|Overall Study|Lost to Follow-up|0|||
144614306|NCT02182687|521448434|FG001|Overall Study|Lost to Follow-up|1|||
144614307|NCT03882970|521448439|FG000|Overall Study|Adverse Event|5|||
144614308|NCT03882970|521448440|FG001|Overall Study|Adverse Event|7|||
144614309|NCT03882970|521448441|FG002|Overall Study|Adverse Event|3|||
144614310|NCT03882970|521448442|FG003|Overall Study|Adverse Event|1|||
144614311|NCT03882970|521448439|FG000|Overall Study|Death|1|||
144614312|NCT03882970|521448440|FG001|Overall Study|Death|2|||
144614313|NCT03882970|521448441|FG002|Overall Study|Death|1|||
144614314|NCT03882970|521448442|FG003|Overall Study|Death|1|||
144614315|NCT03882970|521448439|FG000|Overall Study|Lost to Follow-up|8|||
144614316|NCT03882970|521448440|FG001|Overall Study|Lost to Follow-up|9|||
144614317|NCT03882970|521448441|FG002|Overall Study|Lost to Follow-up|5|||
144614318|NCT03882970|521448442|FG003|Overall Study|Lost to Follow-up|5|||
144614319|NCT03882970|521448439|FG000|Overall Study|Physician Decision|0|||
144470613|NCT01424930|520921139|FG000|Overall Study|Progressive Disease|3|||
144470614|NCT01424930|520921140|FG001|Overall Study|Progressive Disease|6|||
144470615|NCT01424930|520921139|FG000|Overall Study|Screen Failure|0|||
144614320|NCT03882970|521448440|FG001|Overall Study|Physician Decision|2|||
144470616|NCT01424930|520921140|FG001|Overall Study|Screen Failure|1|||
144614321|NCT03882970|521448441|FG002|Overall Study|Physician Decision|2|||
144614322|NCT03882970|521448442|FG003|Overall Study|Physician Decision|2|||
144470617|NCT01424930|520921139|FG000|Overall Study|Reason not specified|0|||
144470618|NCT01424930|520921140|FG001|Overall Study|Reason not specified|6|||
144470619|NCT01078155|520921145|FG000|Overall Study|Adverse Event|7|||
144470620|NCT01078155|520921145|FG000|Overall Study|Lack of Efficacy|16|||
144470621|NCT01078155|520921145|FG000|Overall Study|Participant's Decision|6|||
144470622|NCT01078155|520921145|FG000|Overall Study|Lost to Follow-up|15|||
144470623|NCT03286751|520921146|FG000|Washout Period 1|Withdrawal by Subject|0|||
144614323|NCT03882970|521448439|FG000|Overall Study|Protocol Violation|2|||
144614324|NCT03882970|521448440|FG001|Overall Study|Protocol Violation|0|||
144614325|NCT03882970|521448441|FG002|Overall Study|Protocol Violation|0|||
144614326|NCT03882970|521448442|FG003|Overall Study|Protocol Violation|0|||
144614327|NCT03882970|521448439|FG000|Overall Study|Withdrawal by Subject|8|||
144614328|NCT03882970|521448440|FG001|Overall Study|Withdrawal by Subject|17|||
144614329|NCT03882970|521448441|FG002|Overall Study|Withdrawal by Subject|7|||
144614330|NCT03882970|521448442|FG003|Overall Study|Withdrawal by Subject|22|||
144614331|NCT03882970|521448439|FG000|Overall Study|Personal Reason|2|||
144614332|NCT03882970|521448440|FG001|Overall Study|Personal Reason|3|||
144614333|NCT03882970|521448441|FG002|Overall Study|Personal Reason|1|||
144614334|NCT03882970|521448442|FG003|Overall Study|Personal Reason|3|||
144614335|NCT02716987|521448457|FG000|Overall Study|Ligand synthesis failure|0|||
144614336|NCT02716987|521448458|FG001|Overall Study|Ligand synthesis failure|0|||
144614337|NCT02716987|521448459|FG002|Overall Study|Ligand synthesis failure|1|||
144614338|NCT02716987|521448460|FG003|Overall Study|Ligand synthesis failure|0|||
144614339|NCT02716987|521448461|FG004|Overall Study|Ligand synthesis failure|0|||
144614340|NCT02716987|521448462|FG005|Overall Study|Ligand synthesis failure|0|||
144614341|NCT02716987|521448457|FG000|Overall Study|Withdrawal by Subject|0|||
144614342|NCT02716987|521448458|FG001|Overall Study|Withdrawal by Subject|0|||
144614343|NCT02716987|521448459|FG002|Overall Study|Withdrawal by Subject|0|||
144614344|NCT02716987|521448460|FG003|Overall Study|Withdrawal by Subject|0|||
144614345|NCT02716987|521448461|FG004|Overall Study|Withdrawal by Subject|1|||
144614346|NCT02716987|521448462|FG005|Overall Study|Withdrawal by Subject|1|||
144614347|NCT02829138|521448463|FG000|Overall Study|Withdrawal by Subject|1|||
144614348|NCT02829138|521448464|FG001|Overall Study|Withdrawal by Subject|0|||
144614349|NCT01765920|521448469|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
144614350|NCT01765920|521448470|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
144614351|NCT01765920|521448469|FG000|Overall Study|Patient code disclosure|0|||
144614352|NCT01765920|521448470|FG001|Overall Study|Patient code disclosure|1|||
144614353|NCT01081249|521448471|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
144614354|NCT01081249|521448472|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
144614355|NCT01439204|521448475|FG000|Overall Study|Withdrawal by Subject|0|||
144614356|NCT01439204|521448476|FG001|Overall Study|Withdrawal by Subject|1|||
144614357|NCT01439204|521448475|FG000|Overall Study|Lost to Follow-up|0|||
144614358|NCT01439204|521448476|FG001|Overall Study|Lost to Follow-up|2|||
144614359|NCT01439204|521448475|FG000|Overall Study|No longer meets study criteria|1|||
144614360|NCT01439204|521448476|FG001|Overall Study|No longer meets study criteria|0|||
144614361|NCT01439204|521448475|FG000|Overall Study|poor/non-compliance|3|||
144614362|NCT01439204|521448476|FG001|Overall Study|poor/non-compliance|0|||
144614363|NCT03775421|521448477|FG000|Overall Study|Lost to Follow-up|2|||
144614364|NCT03775421|521448477|FG000|Overall Study|Withdrawal by Subject|10|||
144614365|NCT03775421|521448477|FG000|Overall Study|Physician Decision|3|||
144614366|NCT03775421|521448477|FG000|Overall Study|Death|1|||
144614367|NCT03775421|521448477|FG000|Overall Study|Study Terminated by Sponsor|94|||
144614368|NCT02287623|521448483|FG000|Overall Study|Protocol Violation|0|||
144614369|NCT02287623|521448484|FG001|Overall Study|Protocol Violation|1|||
144614370|NCT00506883|521448487|FG000|Overall Study|Lost to Follow-up|1|||
144614371|NCT00506883|521448488|FG001|Overall Study|Lost to Follow-up|1|||
144614372|NCT00506883|521448489|FG002|Overall Study|Lost to Follow-up|1|||
144614373|NCT00506883|521448487|FG000|Overall Study|Withdrawal by Subject|1|||
144614374|NCT00506883|521448488|FG001|Overall Study|Withdrawal by Subject|0|||
144470624|NCT03286751|520921147|FG001|Washout Period 1|Withdrawal by Subject|0|||
144470625|NCT03286751|520921148|FG002|Washout Period 1|Withdrawal by Subject|0|||
144197466|NCT04325204|519920276|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
144197467|NCT04325204|519920277|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
144470626|NCT03286751|520921149|FG003|Washout Period 1|Withdrawal by Subject|0|||
144470627|NCT03286751|520921150|FG004|Washout Period 1|Withdrawal by Subject|1|||
144197468|NCT04325204|519920276|FG000|Overall Study|Lost to Follow-up|8|||
144470628|NCT03286751|520921151|FG005|Washout Period 1|Withdrawal by Subject|0|||
144614375|NCT00506883|521448489|FG002|Overall Study|Withdrawal by Subject|1|||
144614376|NCT00506883|521448487|FG000|Overall Study|Lack of Efficacy|0|||
144614377|NCT00506883|521448488|FG001|Overall Study|Lack of Efficacy|1|||
144614378|NCT00506883|521448489|FG002|Overall Study|Lack of Efficacy|1|||
144614379|NCT00506883|521448487|FG000|Overall Study|Other|5|||
144614380|NCT00506883|521448488|FG001|Overall Study|Other|1|||
144470629|NCT03286751|520921146|FG000|Washout Period 2|Personal Reasons|0|||
144726754|NCT01124149|521854350|FG000|Acute Phase|Protocol Violation|14|||
144614381|NCT00506883|521448489|FG002|Overall Study|Other|1|||
144614382|NCT02943564|521448490|FG000|Overall Study|Miscellaneous Reasons|0|||
144614383|NCT02943564|521448491|FG001|Overall Study|Miscellaneous Reasons|0|||
144614384|NCT02943564|521448492|FG002|Overall Study|Miscellaneous Reasons|3|||
144614385|NCT02943564|521448490|FG000|Overall Study|Site terminated by sponsor|0|||
144614386|NCT02943564|521448491|FG001|Overall Study|Site terminated by sponsor|1|||
144614387|NCT02943564|521448492|FG002|Overall Study|Site terminated by sponsor|0|||
144614388|NCT02943564|521448490|FG000|Overall Study|Non-compliance with study drug|0|||
144614389|NCT02943564|521448491|FG001|Overall Study|Non-compliance with study drug|1|||
144614390|NCT02943564|521448492|FG002|Overall Study|Non-compliance with study drug|0|||
144614391|NCT02943564|521448490|FG000|Overall Study|Pregnancy|0|||
144614392|NCT02943564|521448491|FG001|Overall Study|Pregnancy|1|||
144614393|NCT02943564|521448492|FG002|Overall Study|Pregnancy|1|||
144614394|NCT02943564|521448490|FG000|Overall Study|Protocol Violation|2|||
144614395|NCT02943564|521448491|FG001|Overall Study|Protocol Violation|2|||
144614396|NCT02943564|521448492|FG002|Overall Study|Protocol Violation|2|||
144614397|NCT02943564|521448490|FG000|Overall Study|Lost to Follow-up|1|||
144614398|NCT02943564|521448491|FG001|Overall Study|Lost to Follow-up|0|||
144614399|NCT02943564|521448492|FG002|Overall Study|Lost to Follow-up|0|||
144614400|NCT02943564|521448490|FG000|Overall Study|Withdrawal by Subject|6|||
144614401|NCT02943564|521448491|FG001|Overall Study|Withdrawal by Subject|5|||
144614402|NCT02943564|521448492|FG002|Overall Study|Withdrawal by Subject|2|||
144614403|NCT02943564|521448490|FG000|Overall Study|Adverse Event|1|||
144614404|NCT02943564|521448491|FG001|Overall Study|Adverse Event|2|||
144614405|NCT02943564|521448492|FG002|Overall Study|Adverse Event|1|||
144614406|NCT02943564|521448490|FG000|Overall Study|Lack of Efficacy|0|||
144614407|NCT02943564|521448491|FG001|Overall Study|Lack of Efficacy|1|||
144614408|NCT02943564|521448492|FG002|Overall Study|Lack of Efficacy|0|||
144614409|NCT00917150|521448495|FG000|Overall Study|Adverse Event|12|||
144614410|NCT00917150|521448496|FG001|Overall Study|Adverse Event|7|||
144614411|NCT00917150|521448497|FG002|Overall Study|Adverse Event|12|||
144614412|NCT00917150|521448498|FG003|Overall Study|Adverse Event|11|||
144614413|NCT00917150|521448495|FG000|Overall Study|Death|1|||
144614414|NCT00917150|521448496|FG001|Overall Study|Death|4|||
144614415|NCT00917150|521448497|FG002|Overall Study|Death|3|||
144614416|NCT00917150|521448498|FG003|Overall Study|Death|2|||
144614417|NCT00917150|521448495|FG000|Overall Study|Lost to Follow-up|1|||
144614418|NCT00917150|521448496|FG001|Overall Study|Lost to Follow-up|0|||
144726755|NCT01124149|521854350|FG000|Acute Phase|Lost to Follow-up|2|||
144726756|NCT01124149|521854350|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
144726757|NCT01124149|521854350|FG000|Acute Phase|Sponsor request|1|||
144614419|NCT00917150|521448497|FG002|Overall Study|Lost to Follow-up|4|||
144614420|NCT00917150|521448498|FG003|Overall Study|Lost to Follow-up|2|||
144726758|NCT01124149|521854350|FG000|Acute Phase|UC symptoms not ameliorated|1|||
144726759|NCT01124149|521854350|FG000|Acute Phase|Non-compliance|1|||
144726760|NCT01124149|521854350|FG000|Acute Phase|Low hemoglobin|1|||
144614421|NCT00917150|521448495|FG000|Overall Study|Physician Decision|0|||
144614422|NCT00917150|521448496|FG001|Overall Study|Physician Decision|2|||
144614423|NCT00917150|521448497|FG002|Overall Study|Physician Decision|0|||
144614424|NCT00917150|521448498|FG003|Overall Study|Physician Decision|1|||
144614425|NCT00917150|521448495|FG000|Overall Study|Protocol Violation|5|||
144614426|NCT00917150|521448496|FG001|Overall Study|Protocol Violation|5|||
144614427|NCT00917150|521448497|FG002|Overall Study|Protocol Violation|3|||
144614428|NCT00917150|521448498|FG003|Overall Study|Protocol Violation|5|||
144614429|NCT00917150|521448495|FG000|Overall Study|Withdrawal by Subject|15|||
144614430|NCT00917150|521448496|FG001|Overall Study|Withdrawal by Subject|16|||
144614431|NCT00917150|521448497|FG002|Overall Study|Withdrawal by Subject|18|||
144614432|NCT00917150|521448498|FG003|Overall Study|Withdrawal by Subject|11|||
144614433|NCT00917150|521448495|FG000|Overall Study|Other than specified|3|||
144614434|NCT00917150|521448496|FG001|Overall Study|Other than specified|3|||
144614435|NCT00917150|521448497|FG002|Overall Study|Other than specified|2|||
144614436|NCT00917150|521448498|FG003|Overall Study|Other than specified|2|||
144614437|NCT03891264|521448499|FG000|Overall Study|Adverse Event|1|||
144614438|NCT03891264|521448499|FG000|Overall Study|Withdrawal by Subject|2|||
144614439|NCT03891264|521448499|FG000|Overall Study|Physician Decision|2|||
144614440|NCT04143009|521448500|FG000|Pilot Trial|Lost to Follow-up|0|||
144614441|NCT04143009|521448501|FG001|Pilot Trial|Lost to Follow-up|1|||
144614442|NCT04143009|521448502|FG002|Pilot Trial|Lost to Follow-up|1|||
144614443|NCT01505634|521448503|FG000|Overall Study|Withdrawal by Subject|2|||
144614444|NCT01505634|521448504|FG001|Overall Study|Withdrawal by Subject|5|||
144614445|NCT01505634|521448505|FG002|Overall Study|Withdrawal by Subject|1|||
144614446|NCT01505634|521448503|FG000|Overall Study|Physician Decision|1|||
144614447|NCT01505634|521448504|FG001|Overall Study|Physician Decision|1|||
144614448|NCT01505634|521448505|FG002|Overall Study|Physician Decision|0|||
144614449|NCT01505634|521448503|FG000|Overall Study|Adverse Event|1|||
144614450|NCT01505634|521448504|FG001|Overall Study|Adverse Event|0|||
144614451|NCT01505634|521448505|FG002|Overall Study|Adverse Event|0|||
144726761|NCT01124149|521854350|FG000|Acute Phase|Travelling to another country|1|||
144614452|NCT01505634|521448503|FG000|Overall Study|Insufficient supply of drug at site|1|||
144726762|NCT01124149|521854350|FG000|Acute Phase|Sponsor decision|1|||
144197469|NCT04325204|519920277|FG001|Overall Study|Lost to Follow-up|8|||
144197470|NCT04325204|519920276|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
144197471|NCT04325204|519920277|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
144197472|NCT00912093|519920278|FG000|The Controlled Phase|Death|0|||
144197473|NCT00912093|519920279|FG001|The Controlled Phase|Death|1|||
144197474|NCT00912093|519920280|FG002|The Controlled Phase|Death|0|||
144197475|NCT00912093|519920281|FG003|The Controlled Phase|Death|0|||
144197476|NCT00912093|519920282|FG004|The Controlled Phase|Death|0|||
144197477|NCT00912093|519920278|FG000|The Controlled Phase|Medical Condition|0|||
144197478|NCT00912093|519920279|FG001|The Controlled Phase|Medical Condition|1|||
144197479|NCT00912093|519920280|FG002|The Controlled Phase|Medical Condition|0|||
144197480|NCT00912093|519920281|FG003|The Controlled Phase|Medical Condition|0|||
144197481|NCT00912093|519920282|FG004|The Controlled Phase|Medical Condition|0|||
144197482|NCT00912093|519920278|FG000|The Controlled Phase|Lost to Follow-up|0|||
144197483|NCT00912093|519920279|FG001|The Controlled Phase|Lost to Follow-up|0|||
144197484|NCT00912093|519920280|FG002|The Controlled Phase|Lost to Follow-up|0|||
144197485|NCT00912093|519920281|FG003|The Controlled Phase|Lost to Follow-up|0|||
144197486|NCT00912093|519920282|FG004|The Controlled Phase|Lost to Follow-up|1|||
144197487|NCT00891371|519920287|FG000|Pre-assignment|Inclusion/exclusion|5|||
144197488|NCT00891371|519920287|FG000|Pre-assignment|Consent withdrawal|1|||
144197489|NCT00891371|519920287|FG000|Treatment|Lack of Efficacy|5|||
144197490|NCT00891371|519920287|FG000|Treatment|Adverse Event|2|||
144197491|NCT00891371|519920287|FG000|Treatment|Death|1|||
144470630|NCT03286751|520921147|FG001|Washout Period 2|Personal Reasons|1|||
144470631|NCT03286751|520921148|FG002|Washout Period 2|Personal Reasons|0|||
144614453|NCT01505634|521448504|FG001|Overall Study|Insufficient supply of drug at site|0|||
144614454|NCT01505634|521448505|FG002|Overall Study|Insufficient supply of drug at site|0|||
144614455|NCT01505634|521448503|FG000|Overall Study|Protocol Violation|2|||
144470632|NCT03286751|520921149|FG003|Washout Period 2|Personal Reasons|0|||
144470633|NCT03286751|520921150|FG004|Washout Period 2|Personal Reasons|0|||
144470634|NCT03286751|520921151|FG005|Washout Period 2|Personal Reasons|0|||
144470635|NCT03286751|520921146|FG000|Washout Period 5|Adverse Event|0|||
144470636|NCT03286751|520921147|FG001|Washout Period 5|Adverse Event|0|||
144470637|NCT03286751|520921148|FG002|Washout Period 5|Adverse Event|0|||
144470638|NCT03286751|520921149|FG003|Washout Period 5|Adverse Event|0|||
144470639|NCT03286751|520921150|FG004|Washout Period 5|Adverse Event|1|||
144470640|NCT03286751|520921151|FG005|Washout Period 5|Adverse Event|0|||
144470641|NCT01059643|520921152|FG000|Overall Study|Adverse Event|3|||
144470642|NCT01059643|520921152|FG000|Overall Study|Withdrawal by Subject|2|||
144470643|NCT01059643|520921152|FG000|Overall Study|Physician Decision|1|||
144470644|NCT01621880|520921153|FG000|Overall Study|Adverse Event|5|||
144470645|NCT01621880|520921154|FG001|Overall Study|Adverse Event|1|||
144470646|NCT01621880|520921153|FG000|Overall Study|Withdrawal by Subject|5|||
144470647|NCT01621880|520921154|FG001|Overall Study|Withdrawal by Subject|4|||
144470648|NCT02313909|520921164|FG000|Overall Study|Consent withdrawn by participant|33|||
144470649|NCT02313909|520921165|FG001|Overall Study|Consent withdrawn by participant|33|||
144470650|NCT02313909|520921164|FG000|Overall Study|Lost to Follow-up|24|||
144470651|NCT02313909|520921165|FG001|Overall Study|Lost to Follow-up|17|||
144470652|NCT00643123|520921171|FG000|Overall Study|Lost to Follow-up|4|||
144470653|NCT00643123|520921172|FG001|Overall Study|Lost to Follow-up|0|||
144470654|NCT00643123|520921171|FG000|Overall Study|Withdrawal by Subject|1|||
144470655|NCT00643123|520921172|FG001|Overall Study|Withdrawal by Subject|1|||
144470656|NCT02309112|520921173|FG000|Overall Study|Withdrawal by Subject|1|||
144470657|NCT02309112|520921174|FG001|Overall Study|Withdrawal by Subject|0|||
144470658|NCT02309112|520921175|FG002|Overall Study|Withdrawal by Subject|1|||
144470659|NCT02309112|520921173|FG000|Overall Study|Lost to Follow-up|0|||
144470660|NCT02309112|520921174|FG001|Overall Study|Lost to Follow-up|1|||
144470661|NCT02309112|520921175|FG002|Overall Study|Lost to Follow-up|0|||
144470662|NCT01972529|520921178|FG000|Overall Study|Adverse Event|0|||
144470663|NCT01972529|520921179|FG001|Overall Study|Adverse Event|1|||
144470664|NCT01972529|520921180|FG002|Overall Study|Adverse Event|0|||
144614456|NCT01505634|521448504|FG001|Overall Study|Protocol Violation|0|||
144614457|NCT01505634|521448505|FG002|Overall Study|Protocol Violation|0|||
144614458|NCT01505634|521448503|FG000|Overall Study|Lost to Follow-up|1|||
144614459|NCT01505634|521448504|FG001|Overall Study|Lost to Follow-up|4|||
144614460|NCT01505634|521448505|FG002|Overall Study|Lost to Follow-up|4|||
144614461|NCT01505634|521448503|FG000|Overall Study|Death|1|||
144614462|NCT01505634|521448504|FG001|Overall Study|Death|0|||
144614463|NCT01505634|521448505|FG002|Overall Study|Death|0|||
144470665|NCT01972529|520921181|FG003|Overall Study|Adverse Event|0|||
144470666|NCT01972529|520921178|FG000|Overall Study|Lost to Follow-up|1|||
144470667|NCT01972529|520921179|FG001|Overall Study|Lost to Follow-up|0|||
144470668|NCT01972529|520921180|FG002|Overall Study|Lost to Follow-up|0|||
144470669|NCT01972529|520921181|FG003|Overall Study|Lost to Follow-up|0|||
144197492|NCT00891371|519920287|FG000|Treatment|Lost to Follow-up|1|||
144197493|NCT00307034|519920288|FG000|Overall Study|Adverse Event|1|||
144470670|NCT01972529|520921178|FG000|Overall Study|Participant Choice|0|||
144614464|NCT01505634|521448503|FG000|Overall Study|In a conflict zone|0|||
144470671|NCT01972529|520921179|FG001|Overall Study|Participant Choice|1|||
144470672|NCT01972529|520921180|FG002|Overall Study|Participant Choice|0|||
144470673|NCT01972529|520921181|FG003|Overall Study|Participant Choice|0|||
144258374|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
144258375|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
144258376|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
144258377|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
144258378|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
144258379|NCT01990768|520147029|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
144258380|NCT01990768|520147030|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
144258381|NCT01990768|520147031|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
144258382|NCT01990768|520147029|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
144258383|NCT01990768|520147030|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
144258384|NCT01990768|520147031|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
144258385|NCT01990768|520147029|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
144258386|NCT01990768|520147030|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
144470674|NCT01972529|520921178|FG000|Overall Study|Withdrawl of Consent|1|||
144470675|NCT01972529|520921179|FG001|Overall Study|Withdrawl of Consent|2|||
144470676|NCT01972529|520921180|FG002|Overall Study|Withdrawl of Consent|0|||
144470677|NCT01972529|520921181|FG003|Overall Study|Withdrawl of Consent|1|||
144470678|NCT01972529|520921178|FG000|Overall Study|Other|0|||
144470679|NCT01972529|520921179|FG001|Overall Study|Other|0|||
144470680|NCT01972529|520921180|FG002|Overall Study|Other|0|||
144470681|NCT01972529|520921181|FG003|Overall Study|Other|2|||
144470682|NCT01972529|520921178|FG000|Overall Study|Not treated|0|||
144470683|NCT01972529|520921179|FG001|Overall Study|Not treated|1|||
144470684|NCT01972529|520921180|FG002|Overall Study|Not treated|2|||
144470685|NCT01972529|520921181|FG003|Overall Study|Not treated|1|||
144470686|NCT02277990|520921185|FG000|Overall Study|Death|170|||
144470687|NCT02277990|520921186|FG001|Overall Study|Death|188|||
144470688|NCT02277990|520921185|FG000|Overall Study|Withdrawal by Subject|64|||
144470689|NCT02277990|520921186|FG001|Overall Study|Withdrawal by Subject|53|||
144470690|NCT02277990|520921185|FG000|Overall Study|Physician Decision|40|||
144470691|NCT02277990|520921186|FG001|Overall Study|Physician Decision|34|||
144470692|NCT02277990|520921185|FG000|Overall Study|Lost to Follow-up|66|||
144470693|NCT02277990|520921186|FG001|Overall Study|Lost to Follow-up|69|||
144470694|NCT02277990|520921185|FG000|Overall Study|Had other reason|26|||
144470695|NCT02277990|520921186|FG001|Overall Study|Had other reason|32|||
144470696|NCT03351738|520921187|FG000|Overall Study|Withdrawal by Subject|0|||
144470697|NCT03351738|520921188|FG001|Overall Study|Withdrawal by Subject|1|||
144470698|NCT03351738|520921189|FG002|Overall Study|Withdrawal by Subject|0|||
144470699|NCT03351738|520921190|FG003|Overall Study|Withdrawal by Subject|1|||
144470700|NCT03351738|520921191|FG004|Overall Study|Withdrawal by Subject|0|||
144470701|NCT03351738|520921192|FG005|Overall Study|Withdrawal by Subject|0|||
144470702|NCT01570868|520921197|FG000|Overall Study|Adverse Event|8|||
144470703|NCT01570868|520921198|FG001|Overall Study|Adverse Event|1|||
144537444|NCT00857766|521170958|FG001|Overall Study|Protocol Violation|11|||
144537445|NCT00857766|521170957|FG000|Overall Study|Lost to Follow-up|1|||
144537446|NCT00857766|521170958|FG001|Overall Study|Lost to Follow-up|0|||
144537447|NCT00857766|521170957|FG000|Overall Study|Investigator Discretion|2|||
144537448|NCT00857766|521170958|FG001|Overall Study|Investigator Discretion|3|||
144537449|NCT00857766|521170957|FG000|Overall Study|Participant Withdrew Consent|4|||
144537450|NCT00857766|521170958|FG001|Overall Study|Participant Withdrew Consent|4|||
144537451|NCT01988402|521170959|FG000|Overall Study|Adverse Event|1|||
144537452|NCT01988402|521170960|FG001|Overall Study|Adverse Event|2|||
144537453|NCT01988402|521170959|FG000|Overall Study|Withdrawal by Subject|1|||
144537454|NCT01988402|521170960|FG001|Overall Study|Withdrawal by Subject|0|||
144537455|NCT01961609|521170961|FG000|Initiation|Missing|3|||
144537456|NCT01961609|521170962|FG001|Initiation|Missing|2|||
144537457|NCT01961609|521170963|FG002|Initiation|Missing|0|||
144537458|NCT01961609|521170964|FG003|Initiation|Missing|0|||
144537459|NCT01961609|521170961|FG000|Initiation|Protocol deviation|1|||
144537460|NCT01961609|521170962|FG001|Initiation|Protocol deviation|0|||
144537461|NCT01961609|521170963|FG002|Initiation|Protocol deviation|0|||
144537462|NCT01961609|521170964|FG003|Initiation|Protocol deviation|0|||
144537463|NCT01961609|521170961|FG000|Initiation|Death|0|||
144537464|NCT01961609|521170962|FG001|Initiation|Death|1|||
144537465|NCT01961609|521170963|FG002|Initiation|Death|0|||
144537466|NCT01961609|521170964|FG003|Initiation|Death|0|||
144537467|NCT01961609|521170961|FG000|Initiation|Administrative problems|1|||
144537468|NCT01961609|521170962|FG001|Initiation|Administrative problems|0|||
144537469|NCT01961609|521170963|FG002|Initiation|Administrative problems|0|||
144470704|NCT01570868|520921197|FG000|Overall Study|FDA Recommendation|23|||
144470705|NCT01570868|520921198|FG001|Overall Study|FDA Recommendation|3|||
144470706|NCT01570868|520921197|FG000|Overall Study|Physician Decision|10|||
144537470|NCT01961609|521170964|FG003|Initiation|Administrative problems|0|||
144537471|NCT01961609|521170961|FG000|Initiation|Withdrawal by Subject|1|||
144537472|NCT01961609|521170962|FG001|Initiation|Withdrawal by Subject|2|||
144258387|NCT01990768|520147031|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
144258388|NCT01990768|520147029|FG000|6-Month Follow-up|No contact information|5|||
144258389|NCT01990768|520147030|FG001|6-Month Follow-up|No contact information|6|||
144258390|NCT01990768|520147031|FG002|6-Month Follow-up|No contact information|5|||
144258391|NCT01990768|520147029|FG000|6-Month Follow-up|Homeless|4|||
144258392|NCT01990768|520147030|FG001|6-Month Follow-up|Homeless|3|||
144258393|NCT01990768|520147031|FG002|6-Month Follow-up|Homeless|6|||
144258394|NCT01990768|520147029|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
144258395|NCT01990768|520147030|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
144614465|NCT01505634|521448504|FG001|Overall Study|In a conflict zone|0|||
144614466|NCT01505634|521448505|FG002|Overall Study|In a conflict zone|1|||
144614467|NCT04013529|521448510|FG000|Overall Study|Withdrawal by Subject|1|||
144614468|NCT04013529|521448511|FG001|Overall Study|Withdrawal by Subject|1|||
144614469|NCT04869345|521448514|FG000|Overall Study|Lost to Follow-up|8|||
144614470|NCT04869345|521448515|FG001|Overall Study|Lost to Follow-up|3|||
144614471|NCT02581202|521448525|FG000|Overall Study|Lack of Efficacy|2|||
144614472|NCT02581202|521448525|FG000|Overall Study|Withdrawal by Subject|4|||
144614473|NCT02581202|521448525|FG000|Overall Study|Lost to Follow-up|5|||
144614474|NCT02581202|521448525|FG000|Overall Study|Pregnancy|3|||
144614475|NCT05054114|521448529|FG000|Overall Study|Protocol Violation|13|||
144614476|NCT05054114|521448530|FG001|Overall Study|Protocol Violation|1|||
144614477|NCT05054114|521448529|FG000|Overall Study|Pregnancy|0|||
144614478|NCT05054114|521448530|FG001|Overall Study|Pregnancy|1|||
144614479|NCT01806779|521448531|FG000|Overall Study|Physician Decision|2|||
144614480|NCT01806779|521448532|FG001|Overall Study|Physician Decision|0|||
144614481|NCT01806779|521448533|FG002|Overall Study|Physician Decision|1|||
144614482|NCT01806779|521448531|FG000|Overall Study|Lack of Efficacy|1|||
144614483|NCT01806779|521448532|FG001|Overall Study|Lack of Efficacy|1|||
144614484|NCT01806779|521448533|FG002|Overall Study|Lack of Efficacy|0|||
144614485|NCT01806779|521448531|FG000|Overall Study|Lost to Follow-up|19|||
144197494|NCT00307034|519920289|FG001|Overall Study|Adverse Event|2|||
144197495|NCT00307034|519920288|FG000|Overall Study|Withdrawal by Subject|1|||
144197496|NCT00307034|519920289|FG001|Overall Study|Withdrawal by Subject|2|||
144197497|NCT00307034|519920288|FG000|Overall Study|Lost to Follow-up|0|||
144197498|NCT00307034|519920289|FG001|Overall Study|Lost to Follow-up|3|||
144197499|NCT02621034|519920290|FG000|Overall Study|Lost to Follow-up|3|||
144197500|NCT02621034|519920291|FG001|Overall Study|Lost to Follow-up|2|||
144197501|NCT02621034|519920292|FG002|Overall Study|Lost to Follow-up|5|||
144197502|NCT01691820|519920306|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
144614486|NCT01806779|521448532|FG001|Overall Study|Lost to Follow-up|20|||
144614487|NCT01806779|521448533|FG002|Overall Study|Lost to Follow-up|0|||
144614488|NCT01806779|521448531|FG000|Overall Study|Withdrawal by Subject|20|||
144614489|NCT01806779|521448532|FG001|Overall Study|Withdrawal by Subject|23|||
144614490|NCT01806779|521448533|FG002|Overall Study|Withdrawal by Subject|22|||
144614491|NCT02595450|521448534|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
144614492|NCT02595450|521448534|FG000|Overall Study|Enrolled, but not treated|8|||
144614493|NCT01934556|521448538|FG000|Overall Study|Withdrawal by Subject|0|||
144614494|NCT01934556|521448539|FG001|Overall Study|Withdrawal by Subject|1|||
144614495|NCT01934556|521448540|FG002|Overall Study|Withdrawal by Subject|1|||
144614496|NCT01934556|521448538|FG000|Overall Study|Lost to Follow-up|4|||
144614497|NCT01934556|521448539|FG001|Overall Study|Lost to Follow-up|10|||
144614498|NCT01934556|521448540|FG002|Overall Study|Lost to Follow-up|7|||
144614499|NCT01934556|521448538|FG000|Overall Study|Death|1|||
144614500|NCT01934556|521448539|FG001|Overall Study|Death|5|||
144614501|NCT01934556|521448540|FG002|Overall Study|Death|2|||
144614502|NCT00102960|521448543|FG000|Overall Study|Death|23|||
144197503|NCT01691820|519920307|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
144197504|NCT01691820|519920306|FG000|Overall Study|Migrated/moved from study area|7|||
144197505|NCT01691820|519920307|FG001|Overall Study|Migrated/moved from study area|4|||
144197506|NCT01691820|519920306|FG000|Overall Study|Lost to Follow-up|6|||
144197507|NCT01691820|519920307|FG001|Overall Study|Lost to Follow-up|17|||
144197508|NCT01691820|519920306|FG000|Overall Study|Other (unspecified)|4|||
144258396|NCT01990768|520147031|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
144197509|NCT01691820|519920307|FG001|Overall Study|Other (unspecified)|1|||
144197510|NCT02372071|519920320|FG000|Overall Study|Protocol Violation|18|||
144197511|NCT02836496|519920321|FG000|Overall Study|Adverse Event|2|||
144197512|NCT02836496|519920322|FG001|Overall Study|Adverse Event|1|||
144197513|NCT02836496|519920321|FG000|Overall Study|Withdrawal by Subject|0|||
144197514|NCT02836496|519920322|FG001|Overall Study|Withdrawal by Subject|1|||
144197515|NCT02618408|519920324|FG000|Overall Study|Withdrawal by Subject|1|||
144197516|NCT02618408|519920325|FG001|Overall Study|Withdrawal by Subject|0|||
144258397|NCT01990768|520147029|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
144614503|NCT00102960|521448544|FG001|Overall Study|Death|11|||
144614504|NCT00102960|521448545|FG002|Overall Study|Death|11|||
144614505|NCT00102960|521448543|FG000|Overall Study|Lost to Follow-up|6|||
144614506|NCT00102960|521448544|FG001|Overall Study|Lost to Follow-up|12|||
144614507|NCT00102960|521448545|FG002|Overall Study|Lost to Follow-up|16|||
144614508|NCT00102960|521448543|FG000|Overall Study|Withdrawal by Subject|1|||
144614509|NCT00102960|521448544|FG001|Overall Study|Withdrawal by Subject|0|||
144614510|NCT00102960|521448545|FG002|Overall Study|Withdrawal by Subject|1|||
144614511|NCT00609791|521450086|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
144614512|NCT04218201|521450087|FG000|Overall Study|Death|0|||
144614513|NCT04218201|521450088|FG001|Overall Study|Death|0|||
144614514|NCT04218201|521450089|FG002|Overall Study|Death|2|||
144614515|NCT04218201|521450090|FG003|Overall Study|Death|0|||
144614516|NCT04218201|521450087|FG000|Overall Study|Unable to contact participant|4|||
144614517|NCT04218201|521450088|FG001|Overall Study|Unable to contact participant|0|||
144614518|NCT04218201|521450089|FG002|Overall Study|Unable to contact participant|3|||
144197517|NCT02618408|519920326|FG002|Overall Study|Withdrawal by Subject|4|||
144197518|NCT02618408|519920324|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
144197519|NCT02618408|519920325|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
144197520|NCT02618408|519920326|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
144197521|NCT02618408|519920324|FG000|Overall Study|Lost to Follow-up|4|||
144614519|NCT04218201|521450090|FG003|Overall Study|Unable to contact participant|0|||
144614520|NCT04218201|521450087|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
144614521|NCT04218201|521450088|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
144614522|NCT04218201|521450089|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
144614523|NCT04218201|521450090|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
144614524|NCT04218201|521450087|FG000|Overall Study|Withdrawal by Subject|2|||
144614525|NCT04218201|521450088|FG001|Overall Study|Withdrawal by Subject|0|||
144614526|NCT04218201|521450089|FG002|Overall Study|Withdrawal by Subject|0|||
144197522|NCT02618408|519920325|FG001|Overall Study|Lost to Follow-up|2|||
144197523|NCT02618408|519920326|FG002|Overall Study|Lost to Follow-up|6|||
144197524|NCT02618408|519920324|FG000|Overall Study|Adverse Event|4|||
144197525|NCT02618408|519920325|FG001|Overall Study|Adverse Event|0|||
144197526|NCT02618408|519920326|FG002|Overall Study|Adverse Event|10|||
144197527|NCT02618408|519920324|FG000|Overall Study|Physician Decision|1|||
144197528|NCT02618408|519920325|FG001|Overall Study|Physician Decision|1|||
144197529|NCT02618408|519920326|FG002|Overall Study|Physician Decision|2|||
144197530|NCT02618408|519920324|FG000|Overall Study|Protocol Violation|1|||
144197531|NCT02618408|519920325|FG001|Overall Study|Protocol Violation|1|||
144197532|NCT02618408|519920326|FG002|Overall Study|Protocol Violation|2|||
144197533|NCT02618408|519920324|FG000|Overall Study|Other, Multiple Categories|0|||
144197534|NCT02618408|519920325|FG001|Overall Study|Other, Multiple Categories|0|||
144197535|NCT02618408|519920326|FG002|Overall Study|Other, Multiple Categories|4|||
144197536|NCT03914950|519920334|FG000|Overall Study|Physician Decision|54|||
144197537|NCT01936623|519920335|FG000|Overall Study|Lost to Follow-up|0|||
144197538|NCT01936623|519920336|FG001|Overall Study|Lost to Follow-up|5|||
144197539|NCT03201250|519920337|FG000|Overall Study|screen failures|3|||
144197540|NCT03201250|519920338|FG001|Overall Study|screen failures|0|||
144197541|NCT03201250|519920339|FG002|Overall Study|screen failures|0|||
144197542|NCT02575911|519920342|FG000|Overall Study|Lost to Follow-up|1|||
144197543|NCT00359632|519920347|FG000|Overall Study|Death|2|||
144197544|NCT00359632|519920348|FG001|Overall Study|Death|0|||
144197545|NCT00359632|519920347|FG000|Overall Study|Adverse Event|1|||
144197546|NCT00359632|519920348|FG001|Overall Study|Adverse Event|0|||
144197547|NCT00359632|519920347|FG000|Overall Study|Non-compliance with visit schedule|1|||
144197548|NCT00359632|519920348|FG001|Overall Study|Non-compliance with visit schedule|0|||
144197549|NCT02749292|519920356|FG000|Overall Study|Physician Decision|1|||
144197550|NCT02749292|519920357|FG001|Overall Study|Physician Decision|0|||
144197551|NCT02749292|519920356|FG000|Overall Study|Withdrawal by Subject|5|||
144197552|NCT02749292|519920357|FG001|Overall Study|Withdrawal by Subject|7|||
144197553|NCT02749292|519920356|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
144197554|NCT02749292|519920357|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
144197555|NCT02749292|519920356|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
144197556|NCT02749292|519920357|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
144197557|NCT02749292|519920356|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
144197558|NCT02749292|519920357|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
144197559|NCT02749292|519920356|FG000|Overall Study|Adverse Event|4|||
144197560|NCT02749292|519920357|FG001|Overall Study|Adverse Event|1|||
144197561|NCT02749292|519920356|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
144197562|NCT02749292|519920357|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
144197563|NCT02749292|519920356|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
144197564|NCT02749292|519920357|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
144197565|NCT02749292|519920356|FG000|Overall Study|Requiring glucocorticoids|0|||
144197566|NCT02749292|519920357|FG001|Overall Study|Requiring glucocorticoids|3|||
144614527|NCT04218201|521450090|FG003|Overall Study|Withdrawal by Subject|0|||
144197567|NCT02749292|519920356|FG000|Overall Study|Cancer|1|||
144197568|NCT02749292|519920357|FG001|Overall Study|Cancer|0|||
144197569|NCT02458092|519920358|FG000|Overall Study|Withdrawal by Subject|1|||
144197570|NCT02458092|519920359|FG001|Overall Study|Withdrawal by Subject|0|||
144197571|NCT00251641|519920360|FG000|Overall Study|Adverse Event|80|||
144197572|NCT00251641|519920361|FG001|Overall Study|Adverse Event|8|||
144197573|NCT00251641|519920360|FG000|Overall Study|Lack of Efficacy|2|||
144197574|NCT00251641|519920361|FG001|Overall Study|Lack of Efficacy|1|||
144197575|NCT00251641|519920360|FG000|Overall Study|Progression of Disease|0|||
144197576|NCT00251641|519920361|FG001|Overall Study|Progression of Disease|2|||
144197577|NCT00251641|519920360|FG000|Overall Study|Lost to Follow-up|3|||
144197578|NCT00251641|519920361|FG001|Overall Study|Lost to Follow-up|3|||
144197579|NCT00251641|519920360|FG000|Overall Study|Withdrawal by Subject|6|||
144197580|NCT00251641|519920361|FG001|Overall Study|Withdrawal by Subject|8|||
144197581|NCT00251641|519920360|FG000|Overall Study|Protocol Violation|10|||
144197582|NCT00251641|519920361|FG001|Overall Study|Protocol Violation|2|||
144197583|NCT00251641|519920360|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
144197584|NCT00251641|519920361|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
144197585|NCT00251641|519920360|FG000|Overall Study|Switched Treatment|9|||
144197586|NCT00251641|519920361|FG001|Overall Study|Switched Treatment|63|||
144197587|NCT00876018|519920362|FG000|Overall Study|Lost to Follow-up|0|||
144197588|NCT00876018|519920363|FG001|Overall Study|Lost to Follow-up|1|||
144197589|NCT00876018|519920364|FG002|Overall Study|Lost to Follow-up|1|||
144197590|NCT00876018|519920362|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
144197591|NCT00876018|519920363|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
144197592|NCT00876018|519920364|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
144258398|NCT01990768|520147030|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
144258399|NCT01990768|520147031|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
144258400|NCT01990768|520147029|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
144258401|NCT01990768|520147030|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
144258402|NCT01990768|520147031|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
144258403|NCT00154375|520147032|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
144258404|NCT00154375|520147033|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
144258405|NCT00154375|520147032|FG000|Overall Study|Adverse Event|18|||
144258406|NCT00154375|520147033|FG001|Overall Study|Adverse Event|20|||
144258407|NCT00154375|520147032|FG000|Overall Study|Withdrawal by Subject|14|||
144258408|NCT00154375|520147033|FG001|Overall Study|Withdrawal by Subject|10|||
144258409|NCT00154375|520147032|FG000|Overall Study|Death|5|||
144258410|NCT00154375|520147033|FG001|Overall Study|Death|13|||
144258411|NCT00154375|520147032|FG000|Overall Study|Study drug no longer required|5|||
144258412|NCT00154375|520147033|FG001|Overall Study|Study drug no longer required|3|||
144258413|NCT00154375|520147032|FG000|Overall Study|Lost to Follow-up|2|||
144258414|NCT00154375|520147033|FG001|Overall Study|Lost to Follow-up|1|||
144258415|NCT00154375|520147032|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144258416|NCT00154375|520147033|FG001|Overall Study|Abnormal laboratory value(s)|2|||
144258417|NCT00154375|520147032|FG000|Overall Study|Protocol Violation|0|||
144258418|NCT00154375|520147033|FG001|Overall Study|Protocol Violation|1|||
144258419|NCT00154375|520147032|FG000|Overall Study|Suspected progression of disease|44|||
144258420|NCT00154375|520147033|FG001|Overall Study|Suspected progression of disease|30|||
144258421|NCT01588405|520147036|FG000|Overall Study|Adverse Event|1|||
144258422|NCT01588405|520147036|FG000|Overall Study|Clinical Worsening|1|||
144258423|NCT01216332|520147037|FG000|Overall Study|Withdrawal by Subject|4|||
144258424|NCT01216332|520147038|FG001|Overall Study|Withdrawal by Subject|0|||
144258425|NCT01124292|520147039|FG000|Overall Study|Lost to Follow-up|2|||
144258426|NCT01124292|520147040|FG001|Overall Study|Lost to Follow-up|4|||
144258427|NCT01124292|520147041|FG002|Overall Study|Lost to Follow-up|3|||
144258428|NCT01124292|520147039|FG000|Overall Study|Physician Decision|0|||
144537473|NCT01961609|521170963|FG002|Initiation|Withdrawal by Subject|0|||
144537474|NCT01961609|521170964|FG003|Initiation|Withdrawal by Subject|0|||
144197593|NCT01230892|519920365|FG000|Overall Study|Withdrawal by Subject|1|||
144258429|NCT01124292|520147040|FG001|Overall Study|Physician Decision|3|||
144258430|NCT01124292|520147041|FG002|Overall Study|Physician Decision|2|||
144258431|NCT01124292|520147039|FG000|Overall Study|Withdrawal by Subject|0|||
144258432|NCT01124292|520147040|FG001|Overall Study|Withdrawal by Subject|6|||
144258433|NCT01124292|520147041|FG002|Overall Study|Withdrawal by Subject|2|||
144258434|NCT01124292|520147039|FG000|Overall Study|medical issue unrelated to the study|0|||
144258435|NCT01124292|520147040|FG001|Overall Study|medical issue unrelated to the study|0|||
144197594|NCT01230892|519920366|FG001|Overall Study|Withdrawal by Subject|1|||
144197595|NCT01230892|519920365|FG000|Overall Study|Lost to Follow-up|2|||
144258436|NCT01124292|520147041|FG002|Overall Study|medical issue unrelated to the study|2|||
144258437|NCT01124292|520147039|FG000|Overall Study|piercing track closed|0|||
144258438|NCT01124292|520147040|FG001|Overall Study|piercing track closed|2|||
144258439|NCT01124292|520147041|FG002|Overall Study|piercing track closed|1|||
144258440|NCT01237327|520147043|FG000|Overall Study|Protocol Violation: Core Study|1|||
144258441|NCT01237327|520147044|FG001|Overall Study|Protocol Violation: Core Study|0|||
144197596|NCT01230892|519920366|FG001|Overall Study|Lost to Follow-up|0|||
144197597|NCT00725621|519920369|FG000|Overall Study|Adverse Event|25|||
144197598|NCT00725621|519920369|FG000|Overall Study|Lack of Efficacy|46|||
144258442|NCT01237327|520147043|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
144197599|NCT00725621|519920369|FG000|Overall Study|Withdrawal by Subject|57|||
144197600|NCT00725621|519920369|FG000|Overall Study|Physician Decision|19|||
144258443|NCT01237327|520147044|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
144258444|NCT01237327|520147043|FG000|Overall Study|Progression of Disease: Core Study|18|||
144258445|NCT01237327|520147044|FG001|Overall Study|Progression of Disease: Core Study|22|||
144258446|NCT01237327|520147043|FG000|Overall Study|Progression of Disease: Extension Study|15|||
144258447|NCT01237327|520147044|FG001|Overall Study|Progression of Disease: Extension Study|13|||
144258448|NCT01237327|520147043|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
144258449|NCT01237327|520147044|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
144258450|NCT01237327|520147043|FG000|Overall Study|Withdrawal by Subject|1|||
144258451|NCT01237327|520147044|FG001|Overall Study|Withdrawal by Subject|3|||
144258452|NCT01237327|520147043|FG000|Overall Study|Lost to Follow-up|3|||
144258453|NCT01237327|520147044|FG001|Overall Study|Lost to Follow-up|0|||
144258454|NCT01554163|520147047|FG000|Overall Study|Adverse Event|3|||
144258455|NCT01554163|520147048|FG001|Overall Study|Adverse Event|0|||
144258456|NCT01554163|520147047|FG000|Overall Study|Lack of Efficacy|1|||
144258457|NCT01554163|520147048|FG001|Overall Study|Lack of Efficacy|0|||
144258458|NCT01554163|520147047|FG000|Overall Study|Lost to Follow-up|1|||
144258459|NCT01554163|520147048|FG001|Overall Study|Lost to Follow-up|0|||
144258460|NCT01554163|520147047|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144258461|NCT01554163|520147048|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144258462|NCT01554163|520147047|FG000|Overall Study|Protocol Violation|0|||
144258463|NCT01554163|520147048|FG001|Overall Study|Protocol Violation|4|||
144258464|NCT01554163|520147047|FG000|Overall Study|Withdrawal by Subject|1|||
144258465|NCT01554163|520147048|FG001|Overall Study|Withdrawal by Subject|5|||
144258466|NCT01554163|520147047|FG000|Overall Study|Not Treated|1|||
144258467|NCT01554163|520147048|FG001|Overall Study|Not Treated|0|||
144258468|NCT02557516|520147050|FG000|Overall Study|Adverse Event|1|||
144258469|NCT02557516|520147051|FG001|Overall Study|Adverse Event|0|||
144470707|NCT01570868|520921198|FG001|Overall Study|Physician Decision|4|||
144470708|NCT01570868|520921197|FG000|Overall Study|Lost to Follow-up|1|||
144537475|NCT01961609|521170961|FG000|Initiation|Lack of Efficacy|2|||
144258470|NCT02557516|520147052|FG002|Overall Study|Adverse Event|2|||
144258471|NCT02557516|520147053|FG003|Overall Study|Adverse Event|1|||
144258472|NCT02557516|520147050|FG000|Overall Study|Disease progression|0|||
144258473|NCT02557516|520147051|FG001|Overall Study|Disease progression|2|||
144258474|NCT02557516|520147052|FG002|Overall Study|Disease progression|0|||
144258475|NCT02557516|520147053|FG003|Overall Study|Disease progression|0|||
144258476|NCT02557516|520147050|FG000|Overall Study|Physician Decision|0|||
144258477|NCT02557516|520147051|FG001|Overall Study|Physician Decision|2|||
144470709|NCT01570868|520921198|FG001|Overall Study|Lost to Follow-up|0|||
144470710|NCT01570868|520921197|FG000|Overall Study|Withdrawal by Subject|1|||
144470711|NCT01570868|520921198|FG001|Overall Study|Withdrawal by Subject|0|||
144470712|NCT02515279|520921204|FG000|Overall Study|Adverse Event|7|||
144470713|NCT02515279|520921204|FG000|Overall Study|Lack of Efficacy|31|||
144470714|NCT02515279|520921204|FG000|Overall Study|Lost to Follow-up|9|||
144470715|NCT02515279|520921204|FG000|Overall Study|Withdrawal by Subject|18|||
144470716|NCT02515279|520921204|FG000|Overall Study|End-of-treatment visit not attended|17|||
144470717|NCT02515279|520921204|FG000|Overall Study|Other|22|||
144470718|NCT01800968|520921205|FG000|Overall Study|Death|23|||
144470719|NCT01800968|520921206|FG001|Overall Study|Death|16|||
144470720|NCT01800968|520921205|FG000|Overall Study|Lost to Follow-up|5|||
144470721|NCT01800968|520921206|FG001|Overall Study|Lost to Follow-up|7|||
144470722|NCT01800968|520921205|FG000|Overall Study|Withdrawal by Subject|7|||
144470723|NCT01800968|520921206|FG001|Overall Study|Withdrawal by Subject|9|||
144470724|NCT01800968|520921205|FG000|Overall Study|Physician Decision|1|||
144470725|NCT01800968|520921206|FG001|Overall Study|Physician Decision|0|||
144470726|NCT00701038|520921211|FG000|Overall Study|study amended pilot group of patients|4|||
144470727|NCT00701038|520921212|FG001|Overall Study|study amended pilot group of patients|4|||
144470728|NCT00386022|520921223|FG000|Plus Estrogen|Lost to Follow-up|2|||
144470729|NCT00386022|520921224|FG001|Plus Estrogen|Lost to Follow-up|0|||
144470730|NCT00386022|520921223|FG000|Plus Estrogen|Adverse Event|0|||
144470731|NCT00386022|520921224|FG001|Plus Estrogen|Adverse Event|1|||
144470732|NCT00504426|520921229|FG000|Overall Study|Adverse Event|0|||
144470733|NCT00504426|520921230|FG001|Overall Study|Adverse Event|0|||
144470734|NCT00504426|520921231|FG002|Overall Study|Adverse Event|2|||
144470735|NCT00504426|520921232|FG003|Overall Study|Adverse Event|0|||
144470736|NCT00504426|520921229|FG000|Overall Study|Protocol Violation|1|||
144470737|NCT00504426|520921230|FG001|Overall Study|Protocol Violation|1|||
144470738|NCT00504426|520921231|FG002|Overall Study|Protocol Violation|2|||
144470739|NCT00504426|520921232|FG003|Overall Study|Protocol Violation|0|||
144470740|NCT00504426|520921229|FG000|Overall Study|Withdrawal by Subject|2|||
144470741|NCT00504426|520921230|FG001|Overall Study|Withdrawal by Subject|0|||
144470742|NCT00504426|520921231|FG002|Overall Study|Withdrawal by Subject|0|||
144470743|NCT00504426|520921232|FG003|Overall Study|Withdrawal by Subject|0|||
144470744|NCT00031486|520921236|FG000|Overall Study|Adverse Event|1|||
144470745|NCT00031486|520921237|FG001|Overall Study|Adverse Event|0|||
144470746|NCT00031486|520921236|FG000|Overall Study|Lost to Follow-up|0|||
144258478|NCT02557516|520147052|FG002|Overall Study|Physician Decision|0|||
144470747|NCT00031486|520921237|FG001|Overall Study|Lost to Follow-up|1|||
144197601|NCT00725621|519920369|FG000|Overall Study|Lost to Follow-up|52|||
144197602|NCT00725621|519920369|FG000|Overall Study|Non-compliance|8|||
144197603|NCT00725621|519920369|FG000|Overall Study|Continued treatment by other physician|6|||
144197604|NCT00725621|519920369|FG000|Overall Study|Switched to other study|1|||
144197605|NCT00725621|519920369|FG000|Overall Study|Switched to other drug|1|||
144197606|NCT00725621|519920369|FG000|Overall Study|Prepared for elective surgery|1|||
144197607|NCT00725621|519920369|FG000|Overall Study|Reason not specified|55|||
144197608|NCT01189500|519920370|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
144258479|NCT02557516|520147053|FG003|Overall Study|Physician Decision|0|||
144258480|NCT02557516|520147050|FG000|Overall Study|Sponsor decision|0|||
144258481|NCT02557516|520147051|FG001|Overall Study|Sponsor decision|1|||
144258482|NCT02557516|520147052|FG002|Overall Study|Sponsor decision|2|||
144258483|NCT02557516|520147053|FG003|Overall Study|Sponsor decision|8|||
144258484|NCT02748057|520148502|FG000|Overall Study|Adverse Event|1|||
144258485|NCT02748057|520148503|FG001|Overall Study|Adverse Event|0|||
144258486|NCT02748057|520148502|FG000|Overall Study|Physician Decision|0|||
144258487|NCT02748057|520148503|FG001|Overall Study|Physician Decision|1|||
144258488|NCT02748057|520148502|FG000|Overall Study|Protocol Violation|2|||
144258489|NCT02748057|520148503|FG001|Overall Study|Protocol Violation|1|||
144258490|NCT02748057|520148502|FG000|Overall Study|Participant Moved|1|||
144258491|NCT02748057|520148503|FG001|Overall Study|Participant Moved|0|||
144258492|NCT02748057|520148502|FG000|Overall Study|Withdrawal by Subject|1|||
144258493|NCT02748057|520148503|FG001|Overall Study|Withdrawal by Subject|0|||
144258494|NCT03335813|520148506|FG000|Overall Study|Withdrawal by Subject|1|||
144258495|NCT02861664|520148507|FG000|Overall Study|Withdrawal of Consent|0|||
144258496|NCT02861664|520148508|FG001|Overall Study|Withdrawal of Consent|1|||
144258497|NCT00905632|520148509|FG000|Overall Study|Adverse Event|0|||
144258498|NCT00905632|520148510|FG001|Overall Study|Adverse Event|0|||
144470748|NCT00031486|520921236|FG000|Overall Study|Withdrawal by Subject|3|||
144470749|NCT00031486|520921237|FG001|Overall Study|Withdrawal by Subject|2|||
144470750|NCT00031486|520921236|FG000|Overall Study|Death|0|||
144470751|NCT00031486|520921237|FG001|Overall Study|Death|3|||
144470752|NCT00031486|520921236|FG000|Overall Study|Non-compliant|0|||
144470753|NCT00031486|520921237|FG001|Overall Study|Non-compliant|4|||
144470754|NCT00031486|520921236|FG000|Overall Study|Did not meet eligibility requirement|2|||
144470755|NCT00031486|520921237|FG001|Overall Study|Did not meet eligibility requirement|1|||
144470756|NCT00031486|520921236|FG000|Overall Study|Other|1|||
144470757|NCT00031486|520921237|FG001|Overall Study|Other|1|||
144470758|NCT03685591|520921240|FG000|Overall Study|Global Deterioration of Health Status|0|||
144470759|NCT03685591|520921241|FG001|Overall Study|Global Deterioration of Health Status|0|||
144470760|NCT03685591|520921242|FG002|Overall Study|Global Deterioration of Health Status|0|||
144470761|NCT03685591|520921243|FG003|Overall Study|Global Deterioration of Health Status|1|||
144470762|NCT03685591|520921244|FG004|Overall Study|Global Deterioration of Health Status|2|||
144470763|NCT03685591|520921245|FG005|Overall Study|Global Deterioration of Health Status|4|||
144470764|NCT03685591|520921246|FG006|Overall Study|Global Deterioration of Health Status|1|||
144470765|NCT03685591|520921247|FG007|Overall Study|Global Deterioration of Health Status|1|||
144470766|NCT03685591|520921248|FG008|Overall Study|Global Deterioration of Health Status|0|||
144470767|NCT03685591|520921240|FG000|Overall Study|Progressive Disease|1|||
144470768|NCT03685591|520921241|FG001|Overall Study|Progressive Disease|1|||
144470769|NCT03685591|520921242|FG002|Overall Study|Progressive Disease|0|||
144470770|NCT03685591|520921243|FG003|Overall Study|Progressive Disease|3|||
144470771|NCT03685591|520921244|FG004|Overall Study|Progressive Disease|5|||
144470772|NCT03685591|520921245|FG005|Overall Study|Progressive Disease|4|||
144470773|NCT03685591|520921246|FG006|Overall Study|Progressive Disease|3|||
144470774|NCT03685591|520921247|FG007|Overall Study|Progressive Disease|2|||
144470775|NCT03685591|520921248|FG008|Overall Study|Progressive Disease|1|||
144470776|NCT03685591|520921240|FG000|Overall Study|Other|0|||
144470777|NCT03685591|520921241|FG001|Overall Study|Other|0|||
144470778|NCT03685591|520921242|FG002|Overall Study|Other|1|||
144470779|NCT03685591|520921243|FG003|Overall Study|Other|0|||
144470780|NCT03685591|520921244|FG004|Overall Study|Other|2|||
144537476|NCT01961609|521170962|FG001|Initiation|Lack of Efficacy|1|||
144537477|NCT01961609|521170963|FG002|Initiation|Lack of Efficacy|0|||
144537478|NCT01961609|521170964|FG003|Initiation|Lack of Efficacy|0|||
144537479|NCT01961609|521170961|FG000|Initiation|Abnormal lab values|0|||
144537480|NCT01961609|521170962|FG001|Initiation|Abnormal lab values|1|||
144537481|NCT01961609|521170963|FG002|Initiation|Abnormal lab values|0|||
144537482|NCT01961609|521170964|FG003|Initiation|Abnormal lab values|0|||
144537483|NCT01961609|521170961|FG000|Initiation|Adverse Event|3|||
144537484|NCT01961609|521170962|FG001|Initiation|Adverse Event|5|||
144537485|NCT01961609|521170963|FG002|Initiation|Adverse Event|0|||
144537486|NCT01961609|521170964|FG003|Initiation|Adverse Event|0|||
144537487|NCT01961609|521170961|FG000|Initiation|Randomized but not treated|1|||
144537488|NCT01961609|521170962|FG001|Initiation|Randomized but not treated|1|||
144537489|NCT01961609|521170963|FG002|Initiation|Randomized but not treated|0|||
144537490|NCT01961609|521170964|FG003|Initiation|Randomized but not treated|0|||
144537491|NCT01961609|521170961|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
144258499|NCT00905632|520148511|FG002|Overall Study|Adverse Event|0|||
144258500|NCT00905632|520148512|FG003|Overall Study|Adverse Event|0|||
144258501|NCT00905632|520148513|FG004|Overall Study|Adverse Event|0|||
144197609|NCT01189500|519920370|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
144197610|NCT01301508|519920372|FG000|Overall Study|Withdrawal by Subject|1|||
144197611|NCT01301508|519920373|FG001|Overall Study|Withdrawal by Subject|2|||
144197612|NCT01301508|519920372|FG000|Overall Study|Lost to Follow-up|0|||
144197613|NCT01301508|519920373|FG001|Overall Study|Lost to Follow-up|1|||
144197614|NCT02192164|519920374|FG000|Overall Study|Other|8|||
144197615|NCT02192164|519920374|FG000|Overall Study|Withdrawal by Subject|1|||
144197616|NCT02192164|519920374|FG000|Overall Study|Physician Decision|4|||
144197617|NCT02192164|519920374|FG000|Overall Study|Did not meet the exclusion criteria|1|||
144197618|NCT01300923|519920375|FG000|Overall Study|Physician Decision|0|||
144197619|NCT01300923|519920376|FG001|Overall Study|Physician Decision|2|||
144197620|NCT01940497|519920379|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
144197621|NCT01940497|519920380|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
144197622|NCT01940497|519920379|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
144197623|NCT01940497|519920380|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
144197624|NCT01940497|519920379|FG000|Overall Study|Violation of Entry Criteria|1|||
144197625|NCT01940497|519920380|FG001|Overall Study|Violation of Entry Criteria|1|||
144197626|NCT01940497|519920379|FG000|Overall Study|Refused Treatment|1|||
144197627|NCT01940497|519920380|FG001|Overall Study|Refused Treatment|3|||
144197628|NCT01940497|519920379|FG000|Overall Study|Withdrew Consent|6|||
144197629|NCT01940497|519920380|FG001|Overall Study|Withdrew Consent|2|||
144197630|NCT01940497|519920379|FG000|Overall Study|Administrative/Other|1|||
144197631|NCT01940497|519920380|FG001|Overall Study|Administrative/Other|1|||
144197632|NCT02707861|519920381|FG000|Overall Study|Went onto commercial drug|30|||
144197633|NCT02707861|519920382|FG001|Overall Study|Went onto commercial drug|23|||
144197634|NCT02707861|519920381|FG000|Overall Study|Adverse Event|2|||
144197635|NCT02707861|519920382|FG001|Overall Study|Adverse Event|3|||
144197636|NCT02707861|519920381|FG000|Overall Study|Death|5|||
144197637|NCT02707861|519920382|FG001|Overall Study|Death|2|||
144197638|NCT02707861|519920381|FG000|Overall Study|Lack of Efficacy|0|||
144197639|NCT02707861|519920382|FG001|Overall Study|Lack of Efficacy|2|||
144197640|NCT02707861|519920381|FG000|Overall Study|Physician Decision|1|||
144197641|NCT02707861|519920382|FG001|Overall Study|Physician Decision|4|||
144197642|NCT02707861|519920381|FG000|Overall Study|Withdrawal by Subject|2|||
144197643|NCT02707861|519920382|FG001|Overall Study|Withdrawal by Subject|1|||
144197644|NCT02707861|519920381|FG000|Overall Study|Lost to Follow-up|1|||
144197645|NCT02707861|519920382|FG001|Overall Study|Lost to Follow-up|3|||
144197646|NCT03123861|519920383|FG000|Overall Study|Protocol Violation|1|||
144197647|NCT03123861|519920384|FG001|Overall Study|Protocol Violation|1|||
144197648|NCT03123861|519920383|FG000|Overall Study|Withdrawal by Subject|2|||
144197649|NCT03123861|519920384|FG001|Overall Study|Withdrawal by Subject|2|||
144197650|NCT00448136|519920387|FG000|Overall Study|Death|3|||
144197651|NCT00448136|519920388|FG001|Overall Study|Death|8|||
144197652|NCT00448136|519920387|FG000|Overall Study|Investigator's decision (progression)|1|||
144197653|NCT00448136|519920388|FG001|Overall Study|Investigator's decision (progression)|0|||
144197654|NCT00609466|519920389|FG000|Overall Study|Withdrawal by Subject|0|||
144197655|NCT00609466|519920390|FG001|Overall Study|Withdrawal by Subject|1|||
144197656|NCT00609466|519920391|FG002|Overall Study|Withdrawal by Subject|1|||
144197657|NCT00609466|519920389|FG000|Overall Study|Adverse Event|2|||
144197658|NCT00609466|519920390|FG001|Overall Study|Adverse Event|3|||
144197659|NCT00609466|519920391|FG002|Overall Study|Adverse Event|1|||
144197660|NCT00609466|519920389|FG000|Overall Study|Lack of Efficacy|0|||
144197661|NCT00609466|519920390|FG001|Overall Study|Lack of Efficacy|2|||
144197662|NCT00609466|519920391|FG002|Overall Study|Lack of Efficacy|2|||
144197663|NCT03512262|519920392|FG000|Overall Study|Adverse Event|8|||
144258502|NCT00905632|520148514|FG005|Overall Study|Adverse Event|1|||
144258503|NCT00905632|520148515|FG006|Overall Study|Adverse Event|4|||
144258504|NCT00577772|520148516|FG000|Overall Study|Lost to Follow-up|0|||
144258505|NCT00577772|520148517|FG001|Overall Study|Lost to Follow-up|1|||
144258506|NCT00856999|520148518|FG000|Overall Study|Withdrawal by Subject|5|||
144258507|NCT00610168|520148520|FG000|Overall Study|Withdrawal by Subject|2|||
144258508|NCT00610168|520148521|FG001|Overall Study|Withdrawal by Subject|0|||
144258509|NCT00878800|520148528|FG000|Overall Study|Adverse Event|0|||
144258510|NCT00878800|520148529|FG001|Overall Study|Adverse Event|0|||
144197664|NCT03512262|519920393|FG001|Overall Study|Adverse Event|3|||
144197665|NCT03512262|519920392|FG000|Overall Study|Death (non-treatment emergent)|1|||
144197666|NCT03512262|519920393|FG001|Overall Study|Death (non-treatment emergent)|0|||
144258511|NCT00878800|520148530|FG002|Overall Study|Adverse Event|2|||
144258512|NCT00878800|520148531|FG003|Overall Study|Adverse Event|0|||
144197667|NCT03512262|519920392|FG000|Overall Study|Withdrawal by Subject|17|||
144197668|NCT03512262|519920393|FG001|Overall Study|Withdrawal by Subject|9|||
144197669|NCT03512262|519920392|FG000|Overall Study|Lost to Follow-up|7|||
144197670|NCT03512262|519920393|FG001|Overall Study|Lost to Follow-up|1|||
144197671|NCT03512262|519920392|FG000|Overall Study|Other than Specified|2|||
144258513|NCT00878800|520148532|FG004|Overall Study|Adverse Event|1|||
144197672|NCT03512262|519920393|FG001|Overall Study|Other than Specified|2|||
144197673|NCT01299805|519920396|FG000|Overall Study|Adverse Event|2|||
144197674|NCT01299805|519920397|FG001|Overall Study|Adverse Event|0|||
144197675|NCT03407430|519920398|FG000|Washout|Protocol Violation|1|||
144197676|NCT03407430|519920399|FG001|Washout|Protocol Violation|0|||
144197677|NCT00922987|519920401|FG000|Overall Study|Insufficient clinical response|1|||
144197678|NCT00922987|519920401|FG000|Overall Study|Protocol Violation|2|||
144197679|NCT00922987|519920401|FG000|Overall Study|Adverse Event|1|||
144197680|NCT03510182|519920402|FG000|Overall Study|Withdrawal by Subject|2|||
144197681|NCT00375492|519920409|FG000|Overall Study|Adverse Event|4|||
144197682|NCT00375492|519920410|FG001|Overall Study|Adverse Event|5|||
144197683|NCT00375492|519920409|FG000|Overall Study|Entry Criteria Not Met|0|||
144197684|NCT00375492|519920410|FG001|Overall Study|Entry Criteria Not Met|1|||
144197685|NCT00375492|519920409|FG000|Overall Study|Loss of Glucose Control|0|||
144197686|NCT00375492|519920410|FG001|Overall Study|Loss of Glucose Control|1|||
144258514|NCT00878800|520148528|FG000|Overall Study|Progressive disease|1|||
144258515|NCT00878800|520148529|FG001|Overall Study|Progressive disease|5|||
144258516|NCT00878800|520148530|FG002|Overall Study|Progressive disease|6|||
144258517|NCT00878800|520148531|FG003|Overall Study|Progressive disease|5|||
144258518|NCT00878800|520148532|FG004|Overall Study|Progressive disease|13|||
144258519|NCT00878800|520148528|FG000|Overall Study|Withdrew consent|1|||
144258520|NCT00878800|520148529|FG001|Overall Study|Withdrew consent|1|||
144258521|NCT00878800|520148530|FG002|Overall Study|Withdrew consent|0|||
144258522|NCT00878800|520148531|FG003|Overall Study|Withdrew consent|1|||
144258523|NCT00878800|520148532|FG004|Overall Study|Withdrew consent|1|||
144258524|NCT00878800|520148528|FG000|Overall Study|Death|0|||
144258525|NCT00878800|520148529|FG001|Overall Study|Death|0|||
144258526|NCT00878800|520148530|FG002|Overall Study|Death|1|||
144258527|NCT00878800|520148531|FG003|Overall Study|Death|0|||
144258528|NCT00878800|520148532|FG004|Overall Study|Death|0|||
144258529|NCT00878800|520148528|FG000|Overall Study|Other|1|||
144258530|NCT00878800|520148529|FG001|Overall Study|Other|1|||
144537492|NCT01961609|521170962|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
144537493|NCT01961609|521170963|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
144197687|NCT00375492|519920409|FG000|Overall Study|Lost to Follow-up|10|||
144197688|NCT00375492|519920410|FG001|Overall Study|Lost to Follow-up|5|||
144197689|NCT00375492|519920409|FG000|Overall Study|Physician Decision|0|||
144197690|NCT00375492|519920410|FG001|Overall Study|Physician Decision|4|||
144537494|NCT01961609|521170964|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
144537495|NCT01961609|521170961|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
144537496|NCT01961609|521170962|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
144537497|NCT01961609|521170963|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
144537498|NCT01961609|521170964|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
144537499|NCT01961609|521170961|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
144537500|NCT01961609|521170962|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
144537501|NCT01961609|521170963|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
144537502|NCT01961609|521170964|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
144537503|NCT01961609|521170961|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
144537504|NCT01961609|521170962|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
144537505|NCT01961609|521170963|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
144537506|NCT01961609|521170964|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
144537507|NCT01961609|521170961|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
144537508|NCT01961609|521170962|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
144537509|NCT01961609|521170963|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
144537510|NCT01961609|521170964|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
144537511|NCT01961609|521170961|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
144537512|NCT01961609|521170962|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
144537513|NCT01961609|521170963|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
144537514|NCT01961609|521170964|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
144537515|NCT01961609|521170961|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
144537516|NCT01961609|521170962|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
144537517|NCT01961609|521170963|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
144537518|NCT01961609|521170964|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
144537519|NCT01961609|521170961|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
144537520|NCT01961609|521170962|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
144537521|NCT01961609|521170963|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
144614528|NCT04218201|521450087|FG000|Overall Study|PCP plans to leave practice|0|||
144197691|NCT00375492|519920409|FG000|Overall Study|Protocol Violation|6|||
144258531|NCT00878800|520148530|FG002|Overall Study|Other|0|||
144258532|NCT00878800|520148531|FG003|Overall Study|Other|0|||
144258533|NCT00878800|520148532|FG004|Overall Study|Other|1|||
144197692|NCT00375492|519920410|FG001|Overall Study|Protocol Violation|3|||
144197693|NCT00375492|519920409|FG000|Overall Study|Sponsor Decision|0|||
144258534|NCT00613821|520148533|FG000|Overall Study|Withdrawal by Subject|1|||
144726763|NCT01124149|521854350|FG000|Maintenance Phase|Lack of Efficacy|40|||
144726764|NCT01124149|521854350|FG000|Maintenance Phase|Adverse Event|24|||
144726765|NCT01124149|521854350|FG000|Maintenance Phase|Lost to Follow-up|15|||
144726766|NCT01124149|521854350|FG000|Maintenance Phase|Withdrawal by Subject|10|||
144726767|NCT01124149|521854350|FG000|Maintenance Phase|Protocol Violation|5|||
144726768|NCT01124149|521854350|FG000|Maintenance Phase|Coordinator error|1|||
144726769|NCT01124149|521854350|FG000|Maintenance Phase|Non-compliance|1|||
144726770|NCT04557124|521854357|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
144726771|NCT04557124|521854358|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
144726772|NCT04557124|521854357|FG000|Mid-point (1 Month)|Missed testing|5|||
144726773|NCT04557124|521854358|FG001|Mid-point (1 Month)|Missed testing|4|||
144726774|NCT04557124|521854357|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
144726775|NCT04557124|521854358|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
144726776|NCT04557124|521854357|FG000|Post-testing (2 Months)|Missed testing|1|||
144726777|NCT04557124|521854358|FG001|Post-testing (2 Months)|Missed testing|5|||
144726778|NCT04557124|521854357|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
144726779|NCT04557124|521854358|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
144726780|NCT04557124|521854357|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
144726781|NCT04557124|521854358|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
144726782|NCT00001849|521854359|FG000|Overall Study|Death|4|||
144726783|NCT00001849|521854359|FG000|Overall Study|Lost to Follow-up|2|||
144726784|NCT00001849|521854359|FG000|Overall Study|Withdrawal by Subject|2|||
144726785|NCT00001849|521854359|FG000|Overall Study|tumor remained occult|6|||
144726786|NCT03127137|521854363|FG000|Overall Study|Requested sedation after consent|1|||
144726787|NCT03127137|521854364|FG001|Overall Study|Requested sedation after consent|0|||
144726788|NCT03127137|521854363|FG000|Overall Study|Malfunction in electronic data collection|1|||
144726789|NCT03127137|521854364|FG001|Overall Study|Malfunction in electronic data collection|0|||
144726790|NCT03127137|521854363|FG000|Overall Study|Post procedure testing could not be obtained|0|||
144726791|NCT03127137|521854364|FG001|Overall Study|Post procedure testing could not be obtained|1|||
144726792|NCT02319148|521854366|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
144726793|NCT02319148|521854367|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
144726794|NCT02319148|521854368|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
144726795|NCT02319148|521854369|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
144726796|NCT02319148|521854366|FG000|Second Intervention Period|No longer willing to participate|0|||
144726797|NCT02319148|521854367|FG001|Second Intervention Period|No longer willing to participate|1|||
144726798|NCT02319148|521854368|FG002|Second Intervention Period|No longer willing to participate|0|||
144726799|NCT02319148|521854369|FG003|Second Intervention Period|No longer willing to participate|0|||
144726800|NCT02319148|521854366|FG000|Second Intervention Period|Other|0|||
144726801|NCT02319148|521854367|FG001|Second Intervention Period|Other|0|||
144726802|NCT02319148|521854368|FG002|Second Intervention Period|Other|0|||
144726803|NCT02319148|521854369|FG003|Second Intervention Period|Other|1|||
144726804|NCT00264797|521854370|FG000|Overall Study|Withdrawal by Subject|11|||
144726805|NCT00264797|521854371|FG001|Overall Study|Withdrawal by Subject|11|||
144726806|NCT00264797|521854370|FG000|Overall Study|Lost to Follow-up|9|||
144197694|NCT00375492|519920410|FG001|Overall Study|Sponsor Decision|1|||
144197695|NCT00375492|519920409|FG000|Overall Study|Withdrawal by Subject|6|||
144197696|NCT00375492|519920410|FG001|Overall Study|Withdrawal by Subject|6|||
144197697|NCT00290251|519920411|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
144197698|NCT00290251|519920412|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
144197699|NCT00290251|519920413|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
144197700|NCT00290251|519920414|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
144197701|NCT00290251|519920415|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
144197702|NCT00290251|519920416|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
144197703|NCT00290251|519920411|FG000|Treatment 1 (Months 2-4)|headache|0|||
144197704|NCT00290251|519920412|FG001|Treatment 1 (Months 2-4)|headache|0|||
144197705|NCT00290251|519920413|FG002|Treatment 1 (Months 2-4)|headache|0|||
144197706|NCT00290251|519920414|FG003|Treatment 1 (Months 2-4)|headache|0|||
144197707|NCT00290251|519920415|FG004|Treatment 1 (Months 2-4)|headache|1|||
144197708|NCT00290251|519920416|FG005|Treatment 1 (Months 2-4)|headache|0|||
144197709|NCT00290251|519920411|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
144197710|NCT00290251|519920412|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
144197711|NCT00290251|519920413|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
144197712|NCT00290251|519920414|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
144197713|NCT00290251|519920415|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
144197714|NCT00290251|519920416|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
144197715|NCT06077487|519922838|FG000|Overall Study|Withdrawal by Subject|0|||
144197716|NCT06077487|519922839|FG001|Overall Study|Withdrawal by Subject|1|||
144197717|NCT04905290|519922840|FG000|Overall Study|Adverse Event|4|||
144726807|NCT00264797|521854371|FG001|Overall Study|Lost to Follow-up|17|||
144197718|NCT04905290|519922840|FG000|Overall Study|Death|2|||
144197719|NCT04905290|519922840|FG000|Overall Study|Withdrawal by Subject|4|||
144197720|NCT04905290|519922840|FG000|Overall Study|Physician Decision|2|||
144197721|NCT04905290|519922840|FG000|Overall Study|Lost to Follow-up|2|||
144197722|NCT04905290|519922840|FG000|Overall Study|Screen Failure|2|||
144197723|NCT04905290|519922840|FG000|Overall Study|Unsuccessful Procedure|2|||
144197724|NCT05101486|519922841|FG000|Overall Study|Death|1|||
144197725|NCT05101486|519922842|FG001|Overall Study|Death|0|||
144197726|NCT05101486|519922843|FG002|Overall Study|Death|1|||
144197727|NCT05101486|519922841|FG000|Overall Study|Lost to Follow-up|12|||
144197728|NCT05101486|519922842|FG001|Overall Study|Lost to Follow-up|8|||
144197729|NCT05101486|519922843|FG002|Overall Study|Lost to Follow-up|17|||
144258535|NCT00613821|520148534|FG001|Overall Study|Withdrawal by Subject|0|||
144197730|NCT05101486|519922841|FG000|Overall Study|Physician Decision|1|||
144258536|NCT00613821|520148533|FG000|Overall Study|Physician Decision|1|||
144258537|NCT00613821|520148534|FG001|Overall Study|Physician Decision|1|||
144258538|NCT01266824|520148536|FG000|Overall Study|Study terminated prior to completion|2|||
144258539|NCT01266824|520148537|FG001|Overall Study|Study terminated prior to completion|3|||
144258540|NCT02302846|520148538|FG000|Overall Study|Withdrawal by Subject|1|||
144258541|NCT01806168|520148541|FG000|Overall Study|Adverse Event|1|||
144258542|NCT01806168|520148542|FG001|Overall Study|Adverse Event|0|||
144258543|NCT01806168|520148543|FG002|Overall Study|Adverse Event|0|||
144258544|NCT01806168|520148541|FG000|Overall Study|Withdrawal by Subject|0|||
144258545|NCT01806168|520148542|FG001|Overall Study|Withdrawal by Subject|1|||
144258546|NCT01806168|520148543|FG002|Overall Study|Withdrawal by Subject|2|||
144258547|NCT01806168|520148541|FG000|Overall Study|Protocol Violation|0|||
144470781|NCT03685591|520921245|FG005|Overall Study|Other|3|||
144470782|NCT03685591|520921246|FG006|Overall Study|Other|0|||
144470783|NCT03685591|520921247|FG007|Overall Study|Other|0|||
144470784|NCT03685591|520921248|FG008|Overall Study|Other|0|||
144470785|NCT03685591|520921240|FG000|Overall Study|Withdrawal by Subject|0|||
144470786|NCT03685591|520921241|FG001|Overall Study|Withdrawal by Subject|0|||
144470787|NCT03685591|520921242|FG002|Overall Study|Withdrawal by Subject|0|||
144470788|NCT03685591|520921243|FG003|Overall Study|Withdrawal by Subject|0|||
144470789|NCT03685591|520921244|FG004|Overall Study|Withdrawal by Subject|3|||
144470790|NCT03685591|520921245|FG005|Overall Study|Withdrawal by Subject|2|||
144470791|NCT03685591|520921246|FG006|Overall Study|Withdrawal by Subject|0|||
144470792|NCT03685591|520921247|FG007|Overall Study|Withdrawal by Subject|0|||
144470793|NCT03685591|520921248|FG008|Overall Study|Withdrawal by Subject|1|||
144470794|NCT03685591|520921240|FG000|Overall Study|Adverse Event|0|||
144470795|NCT03685591|520921241|FG001|Overall Study|Adverse Event|0|||
144470796|NCT03685591|520921242|FG002|Overall Study|Adverse Event|0|||
144470797|NCT03685591|520921243|FG003|Overall Study|Adverse Event|1|||
144470798|NCT03685591|520921244|FG004|Overall Study|Adverse Event|1|||
144470799|NCT03685591|520921245|FG005|Overall Study|Adverse Event|4|||
144470800|NCT03685591|520921246|FG006|Overall Study|Adverse Event|0|||
144470801|NCT03685591|520921247|FG007|Overall Study|Adverse Event|1|||
144470802|NCT03685591|520921248|FG008|Overall Study|Adverse Event|1|||
144470803|NCT01685138|520921249|FG000|Overall Study|Lost to Follow-up|1|||
144470804|NCT01685138|520921249|FG000|Overall Study|Protocol Violation|1|||
144470805|NCT01685138|520921249|FG000|Overall Study|No longer requires treatment|1|||
144470806|NCT01685138|520921249|FG000|Overall Study|Subject/guardian decision|2|||
144470807|NCT01685138|520921249|FG000|Overall Study|Physician Decision|6|||
144470808|NCT01685138|520921249|FG000|Overall Study|Death|10|||
144470809|NCT01685138|520921249|FG000|Overall Study|Adverse Event|18|||
144470810|NCT01685138|520921249|FG000|Overall Study|Progressive disease|53|||
144470811|NCT00689026|520921252|FG000|Overall Study|Withdrawal by Subject|13|||
144470812|NCT00689026|520921253|FG001|Overall Study|Withdrawal by Subject|6|||
144470813|NCT03988166|520921254|FG000|Overall Study|Lost to Follow-up|2|||
144470814|NCT03988166|520921254|FG000|Overall Study|Death|1|||
144470815|NCT00717860|520921255|FG000|Overall Study|Clinical adverse experience|5|||
144470816|NCT00717860|520921256|FG001|Overall Study|Clinical adverse experience|9|||
144470817|NCT00717860|520921255|FG000|Overall Study|Laboratory adverse experience|2|||
144470818|NCT00717860|520921256|FG001|Overall Study|Laboratory adverse experience|2|||
144470819|NCT00717860|520921255|FG000|Overall Study|Lack of Efficacy|7|||
144470820|NCT00717860|520921256|FG001|Overall Study|Lack of Efficacy|13|||
144470821|NCT00717860|520921255|FG000|Overall Study|Discontinued for other reason|6|||
144470822|NCT00717860|520921256|FG001|Overall Study|Discontinued for other reason|1|||
144470823|NCT00717860|520921255|FG000|Overall Study|Withdrew consent|7|||
144726808|NCT00264797|521854370|FG000|Overall Study|Moved from area|3|||
144470824|NCT00717860|520921256|FG001|Overall Study|Withdrew consent|3|||
144470825|NCT02901626|520923276|FG000|Overall Study|Lost to Follow-up|1|||
144470826|NCT02901626|520923277|FG001|Overall Study|Lost to Follow-up|1|||
144470827|NCT04082884|520923278|FG000|Overall Study|Withdrawal by Subject|1|||
144470828|NCT04857034|520923280|FG000|Placebo-Controlled Period|Request to discontinue|2|||
144470829|NCT04857034|520923281|FG001|Placebo-Controlled Period|Request to discontinue|2|||
144470830|NCT04857034|520923282|FG002|Placebo-Controlled Period|Request to discontinue|0|||
144470831|NCT04857034|520923283|FG003|Placebo-Controlled Period|Request to discontinue|0|||
144470832|NCT04857034|520923284|FG004|Placebo-Controlled Period|Request to discontinue|0|||
144470833|NCT04857034|520923280|FG000|Placebo-Controlled Period|withdrew consent|1|||
144197731|NCT05101486|519922842|FG001|Overall Study|Physician Decision|0|||
144470834|NCT04857034|520923281|FG001|Placebo-Controlled Period|withdrew consent|1|||
144726809|NCT00264797|521854371|FG001|Overall Study|Moved from area|1|||
144726810|NCT00264797|521854370|FG000|Overall Study|Practical Problems|2|||
144726811|NCT00264797|521854371|FG001|Overall Study|Practical Problems|3|||
144726812|NCT00264797|521854370|FG000|Overall Study|Incarceration|4|||
144726813|NCT00264797|521854371|FG001|Overall Study|Incarceration|5|||
144726814|NCT00264797|521854370|FG000|Overall Study|Pressure/advice from Outsiders|1|||
144726815|NCT00264797|521854371|FG001|Overall Study|Pressure/advice from Outsiders|1|||
144726816|NCT00264797|521854370|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
144726817|NCT00264797|521854371|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
144726818|NCT00264797|521854370|FG000|Overall Study|Other|3|||
144726819|NCT00264797|521854371|FG001|Overall Study|Other|4|||
144726820|NCT03992196|521854372|FG000|Enrollment|lost to follow-up prior dosing|1|||
144726821|NCT03992196|521854373|FG001|Enrollment|lost to follow-up prior dosing|0|||
144726822|NCT03992196|521854374|FG002|Enrollment|lost to follow-up prior dosing|0|||
144726823|NCT03992196|521854372|FG000|Treatment|Protocol Violation|0|||
144726824|NCT03992196|521854373|FG001|Treatment|Protocol Violation|0|||
144726825|NCT03992196|521854374|FG002|Treatment|Protocol Violation|1|||
144726826|NCT03992196|521854372|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
144726827|NCT03992196|521854373|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
144726828|NCT03992196|521854374|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
144726829|NCT03992196|521854372|FG000|Treatment|Withdrawal due to non-compliance|0|||
144726830|NCT03992196|521854373|FG001|Treatment|Withdrawal due to non-compliance|0|||
144726831|NCT03992196|521854374|FG002|Treatment|Withdrawal due to non-compliance|1|||
144726832|NCT03992196|521854372|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
144726833|NCT03992196|521854373|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
144726834|NCT03992196|521854374|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
144726835|NCT03992196|521854372|FG000|Treatment|Withdrawal by parent/guardian|0|||
144726836|NCT03992196|521854373|FG001|Treatment|Withdrawal by parent/guardian|0|||
144726837|NCT03992196|521854374|FG002|Treatment|Withdrawal by parent/guardian|2|||
144726838|NCT00048048|521854375|FG000|Core Treatment|Withdrawal by Subject|0|||
144726839|NCT00048048|521854376|FG001|Core Treatment|Withdrawal by Subject|0|||
144726840|NCT00048048|521854377|FG002|Core Treatment|Withdrawal by Subject|1|||
144726841|NCT00048048|521854378|FG003|Core Treatment|Withdrawal by Subject|0|||
144726842|NCT00048048|521854379|FG004|Core Treatment|Withdrawal by Subject|0|||
144726843|NCT00048048|521854380|FG005|Core Treatment|Withdrawal by Subject|0|||
144726844|NCT00048048|521854381|FG006|Core Treatment|Withdrawal by Subject|0|||
144726845|NCT00048048|521854382|FG007|Core Treatment|Withdrawal by Subject|0|||
144726846|NCT00048048|521854383|FG008|Core Treatment|Withdrawal by Subject|0|||
144726847|NCT00048048|521854384|FG009|Core Treatment|Withdrawal by Subject|0|||
144726848|NCT00048048|521854385|FG010|Core Treatment|Withdrawal by Subject|0|||
144726849|NCT00048048|521854386|FG011|Core Treatment|Withdrawal by Subject|0|||
144726850|NCT00048048|521854375|FG000|Core Treatment|Adverse Event|0|||
144726851|NCT00048048|521854376|FG001|Core Treatment|Adverse Event|0|||
144726852|NCT00048048|521854377|FG002|Core Treatment|Adverse Event|0|||
144726853|NCT00048048|521854378|FG003|Core Treatment|Adverse Event|0|||
144726854|NCT00048048|521854379|FG004|Core Treatment|Adverse Event|0|||
144726855|NCT00048048|521854380|FG005|Core Treatment|Adverse Event|0|||
144726856|NCT00048048|521854381|FG006|Core Treatment|Adverse Event|0|||
144726857|NCT00048048|521854382|FG007|Core Treatment|Adverse Event|1|||
144726858|NCT00048048|521854383|FG008|Core Treatment|Adverse Event|0|||
144726859|NCT00048048|521854384|FG009|Core Treatment|Adverse Event|0|||
144197732|NCT05101486|519922843|FG002|Overall Study|Physician Decision|0|||
144197733|NCT05101486|519922841|FG000|Overall Study|Protocol Violation|0|||
144197734|NCT05101486|519922842|FG001|Overall Study|Protocol Violation|0|||
144726860|NCT00048048|521854385|FG010|Core Treatment|Adverse Event|0|||
144726861|NCT00048048|521854386|FG011|Core Treatment|Adverse Event|0|||
144197735|NCT05101486|519922843|FG002|Overall Study|Protocol Violation|1|||
144197736|NCT05101486|519922841|FG000|Overall Study|Withdrawal by Subject|5|||
144197737|NCT05101486|519922842|FG001|Overall Study|Withdrawal by Subject|2|||
144197738|NCT05101486|519922843|FG002|Overall Study|Withdrawal by Subject|4|||
144197739|NCT05101486|519922841|FG000|Overall Study|Randomized but not vaccinated|1|||
144197740|NCT05101486|519922842|FG001|Overall Study|Randomized but not vaccinated|1|||
144726862|NCT00048048|521854375|FG000|Extension Year 1|Early withdrawals|0|||
144726863|NCT00048048|521854376|FG001|Extension Year 1|Early withdrawals|0|||
144197741|NCT05101486|519922843|FG002|Overall Study|Randomized but not vaccinated|1|||
144197742|NCT03295318|519922844|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
144470835|NCT04857034|520923282|FG002|Placebo-Controlled Period|withdrew consent|2|||
144470836|NCT04857034|520923283|FG003|Placebo-Controlled Period|withdrew consent|0|||
144470837|NCT04857034|520923284|FG004|Placebo-Controlled Period|withdrew consent|0|||
144470838|NCT04857034|520923280|FG000|Placebo-Controlled Period|Pregnancy|1|||
144470839|NCT04857034|520923281|FG001|Placebo-Controlled Period|Pregnancy|1|||
144470840|NCT04857034|520923282|FG002|Placebo-Controlled Period|Pregnancy|0|||
144470841|NCT04857034|520923283|FG003|Placebo-Controlled Period|Pregnancy|0|||
144470842|NCT04857034|520923284|FG004|Placebo-Controlled Period|Pregnancy|0|||
144197743|NCT03295318|519922845|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
144197744|NCT03295318|519922846|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
144197745|NCT03295318|519922844|FG000|Overall Study|Death|1|||
144197746|NCT03295318|519922845|FG001|Overall Study|Death|1|||
144197747|NCT03295318|519922846|FG002|Overall Study|Death|1|||
144197748|NCT03295318|519922844|FG000|Overall Study|Protocol Violation|4|||
144197749|NCT03295318|519922845|FG001|Overall Study|Protocol Violation|3|||
144197750|NCT03295318|519922846|FG002|Overall Study|Protocol Violation|3|||
144197751|NCT03295318|519922844|FG000|Overall Study|Withdrawal by Subject|0|||
144197752|NCT03295318|519922845|FG001|Overall Study|Withdrawal by Subject|0|||
144197753|NCT03295318|519922846|FG002|Overall Study|Withdrawal by Subject|1|||
144197754|NCT03295318|519922844|FG000|Overall Study|Subject discontinued due to travel|0|||
144197755|NCT03295318|519922845|FG001|Overall Study|Subject discontinued due to travel|1|||
144197756|NCT03295318|519922846|FG002|Overall Study|Subject discontinued due to travel|0|||
144197757|NCT03747601|519922847|FG000|Overall Study|COVID halt to visits|4|||
144197758|NCT02788045|519922848|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
144197759|NCT02788045|519922849|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
144197760|NCT02788045|519922850|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
144197761|NCT02788045|519922848|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
144197762|NCT02788045|519922849|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
144197763|NCT02788045|519922850|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
144197764|NCT02788045|519922848|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
144197765|NCT02788045|519922849|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
144197766|NCT02788045|519922850|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
144197767|NCT02788045|519922848|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
144197768|NCT02788045|519922849|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
144197769|NCT02788045|519922850|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
144197770|NCT02788045|519922848|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
144197771|NCT02788045|519922849|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
144197772|NCT02788045|519922850|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
144197773|NCT02788045|519922848|FG000|Main Study (Up to Week 72)|Other|3|||
144197774|NCT02788045|519922849|FG001|Main Study (Up to Week 72)|Other|0|||
144197775|NCT02788045|519922850|FG002|Main Study (Up to Week 72)|Other|0|||
144197776|NCT02788045|519922848|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
144197777|NCT02788045|519922849|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
144197778|NCT02788045|519922850|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
144197779|NCT02788045|519922848|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
144197780|NCT02788045|519922849|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
144197781|NCT02788045|519922850|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
144197782|NCT02788045|519922848|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
144197783|NCT02788045|519922849|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
144197784|NCT02788045|519922850|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
144197785|NCT03303625|519922851|FG000|Overall Study|Withdrawal by Subject|2|||
144197786|NCT03303625|519922852|FG001|Overall Study|Withdrawal by Subject|0|||
144197787|NCT03303625|519922853|FG002|Overall Study|Withdrawal by Subject|0|||
144197788|NCT03303625|519922854|FG003|Overall Study|Withdrawal by Subject|0|||
144197789|NCT01288053|519922855|FG000|Overall Study|Death|1|||
144197790|NCT03188666|519922856|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
144197791|NCT03188666|519922857|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
144197792|NCT03188666|519922858|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
144197793|NCT03188666|519922859|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
144197794|NCT03188666|519922856|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
144197795|NCT03188666|519922857|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
144197796|NCT03188666|519922858|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
144197797|NCT03188666|519922859|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
144197798|NCT03188666|519922856|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
144197799|NCT03188666|519922857|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
144197800|NCT03188666|519922858|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
144537522|NCT01961609|521170964|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
144537523|NCT01961609|521170961|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
144537524|NCT01961609|521170962|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
144537525|NCT01961609|521170963|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
144537526|NCT01961609|521170964|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
144197801|NCT03188666|519922859|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
144197802|NCT03188666|519922856|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
144197803|NCT03188666|519922857|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
144197804|NCT03188666|519922858|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
144197805|NCT03188666|519922859|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
144197806|NCT00144781|519922860|FG000|Overall Study|Adverse Event|0|||
144197807|NCT00144781|519922861|FG001|Overall Study|Adverse Event|1|||
144197808|NCT00144781|519922862|FG002|Overall Study|Adverse Event|0|||
144197809|NCT00144781|519922863|FG003|Overall Study|Adverse Event|0|||
144197810|NCT00144781|519922860|FG000|Overall Study|Non-compliant|0|||
144726864|NCT00048048|521854377|FG002|Extension Year 1|Early withdrawals|0|||
144726865|NCT00048048|521854378|FG003|Extension Year 1|Early withdrawals|0|||
144726866|NCT00048048|521854379|FG004|Extension Year 1|Early withdrawals|0|||
144726867|NCT00048048|521854380|FG005|Extension Year 1|Early withdrawals|0|||
144726868|NCT00048048|521854381|FG006|Extension Year 1|Early withdrawals|0|||
144726869|NCT00048048|521854382|FG007|Extension Year 1|Early withdrawals|0|||
144726870|NCT00048048|521854383|FG008|Extension Year 1|Early withdrawals|0|||
144197811|NCT00144781|519922861|FG001|Overall Study|Non-compliant|1|||
144197812|NCT00144781|519922862|FG002|Overall Study|Non-compliant|0|||
144258548|NCT01806168|520148542|FG001|Overall Study|Protocol Violation|0|||
144258549|NCT01806168|520148543|FG002|Overall Study|Protocol Violation|1|||
144258550|NCT01029262|520148546|FG000|Overall Study|Adverse Event|9|||
144258551|NCT01029262|520148547|FG001|Overall Study|Adverse Event|52|||
144258552|NCT01029262|520148546|FG000|Overall Study|Lack of therapeutic effect|57|||
144197813|NCT00144781|519922863|FG003|Overall Study|Non-compliant|0|||
144197814|NCT02068092|519922864|FG000|Overall Study|Physician Decision|2|||
144197815|NCT02068092|519922864|FG000|Overall Study|Adverse Event|2|||
144197816|NCT02068092|519922864|FG000|Overall Study|Lost to Follow-up|4|||
144197817|NCT02068092|519922864|FG000|Overall Study|Withdrawal by Subject|2|||
144197818|NCT03502707|519922865|FG000|Overall Study|Adverse Event|0|||
144197819|NCT03502707|519922866|FG001|Overall Study|Adverse Event|0|||
144197820|NCT03502707|519922867|FG002|Overall Study|Adverse Event|0|||
144197821|NCT03502707|519922868|FG003|Overall Study|Adverse Event|0|||
144197822|NCT03502707|519922869|FG004|Overall Study|Adverse Event|0|||
144197823|NCT03502707|519922870|FG005|Overall Study|Adverse Event|0|||
144197824|NCT03502707|519922871|FG006|Overall Study|Adverse Event|0|||
144197825|NCT03502707|519922872|FG007|Overall Study|Adverse Event|0|||
144197826|NCT03502707|519922873|FG008|Overall Study|Adverse Event|0|||
144197827|NCT03502707|519922874|FG009|Overall Study|Adverse Event|0|||
144197828|NCT03502707|519922875|FG010|Overall Study|Adverse Event|0|||
144197829|NCT03502707|519922876|FG011|Overall Study|Adverse Event|0|||
144197830|NCT03502707|519922877|FG012|Overall Study|Adverse Event|0|||
144197831|NCT03502707|519922878|FG013|Overall Study|Adverse Event|0|||
144197832|NCT03502707|519922879|FG014|Overall Study|Adverse Event|0|||
144197833|NCT03502707|519922880|FG015|Overall Study|Adverse Event|1|||
144197834|NCT03502707|519922881|FG016|Overall Study|Adverse Event|5|||
144197835|NCT03502707|519922882|FG017|Overall Study|Adverse Event|0|||
144197836|NCT03502707|519922865|FG000|Overall Study|Death|0|||
144197837|NCT03502707|519922866|FG001|Overall Study|Death|0|||
144197838|NCT03502707|519922867|FG002|Overall Study|Death|0|||
144197839|NCT03502707|519922868|FG003|Overall Study|Death|1|||
144197840|NCT03502707|519922869|FG004|Overall Study|Death|0|||
144197841|NCT03502707|519922870|FG005|Overall Study|Death|0|||
144258553|NCT01029262|520148547|FG001|Overall Study|Lack of therapeutic effect|76|||
144258554|NCT01029262|520148546|FG000|Overall Study|Withdrawal by Subject|10|||
144258555|NCT01029262|520148547|FG001|Overall Study|Withdrawal by Subject|17|||
144258556|NCT01029262|520148546|FG000|Overall Study|Protocol Violation|2|||
144258557|NCT01029262|520148547|FG001|Overall Study|Protocol Violation|3|||
144258558|NCT01029262|520148546|FG000|Overall Study|Miscellaneous|1|||
144258559|NCT01029262|520148547|FG001|Overall Study|Miscellaneous|9|||
144258560|NCT01029262|520148546|FG000|Overall Study|Death|0|||
144258561|NCT01029262|520148547|FG001|Overall Study|Death|3|||
144258562|NCT01462630|520148550|FG000|Overall Study|Did not initiate therapy|3|||
144258563|NCT01462630|520148550|FG000|Overall Study|Death|1|||
144258564|NCT01462630|520148550|FG000|Overall Study|Protocol Violation|2|||
144258565|NCT01462630|520148550|FG000|Overall Study|Adverse Event|1|||
144258566|NCT01096160|520148553|FG000|Overall Study|Adverse Event|0|||
144258567|NCT01096160|520148554|FG001|Overall Study|Adverse Event|0|||
144258568|NCT01096160|520148555|FG002|Overall Study|Adverse Event|1|||
144258569|NCT01096160|520148556|FG003|Overall Study|Adverse Event|0|||
144258570|NCT01096160|520148557|FG004|Overall Study|Adverse Event|0|||
144258571|NCT01096160|520148558|FG005|Overall Study|Adverse Event|0|||
144537527|NCT01961609|521170961|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
144726871|NCT00048048|521854384|FG009|Extension Year 1|Early withdrawals|2|||
144726872|NCT00048048|521854385|FG010|Extension Year 1|Early withdrawals|2|||
144726873|NCT00048048|521854386|FG011|Extension Year 1|Early withdrawals|4|||
144726874|NCT00048048|521854375|FG000|Extension Year 2|Early withdrawals|0|||
144197842|NCT03502707|519922871|FG006|Overall Study|Death|0|||
144197843|NCT03502707|519922872|FG007|Overall Study|Death|0|||
144197844|NCT03502707|519922873|FG008|Overall Study|Death|1|||
144197845|NCT03502707|519922874|FG009|Overall Study|Death|1|||
144197846|NCT03502707|519922875|FG010|Overall Study|Death|0|||
144197847|NCT03502707|519922876|FG011|Overall Study|Death|0|||
144197848|NCT03502707|519922877|FG012|Overall Study|Death|1|||
144197849|NCT03502707|519922878|FG013|Overall Study|Death|0|||
144197850|NCT03502707|519922879|FG014|Overall Study|Death|0|||
144197851|NCT03502707|519922880|FG015|Overall Study|Death|1|||
144197852|NCT03502707|519922881|FG016|Overall Study|Death|0|||
144258572|NCT01096160|520148559|FG006|Overall Study|Adverse Event|0|||
144258573|NCT01096160|520148560|FG007|Overall Study|Adverse Event|0|||
144258574|NCT01096160|520148561|FG008|Overall Study|Adverse Event|0|||
144726875|NCT00048048|521854376|FG001|Extension Year 2|Early withdrawals|0|||
144726876|NCT00048048|521854377|FG002|Extension Year 2|Early withdrawals|0|||
144726877|NCT00048048|521854378|FG003|Extension Year 2|Early withdrawals|0|||
144726878|NCT00048048|521854379|FG004|Extension Year 2|Early withdrawals|0|||
144726879|NCT00048048|521854380|FG005|Extension Year 2|Early withdrawals|0|||
144726880|NCT00048048|521854381|FG006|Extension Year 2|Early withdrawals|0|||
144197853|NCT03502707|519922882|FG017|Overall Study|Death|0|||
144197854|NCT03502707|519922865|FG000|Overall Study|Lost to Follow-up|0|||
144197855|NCT03502707|519922866|FG001|Overall Study|Lost to Follow-up|0|||
144197856|NCT03502707|519922867|FG002|Overall Study|Lost to Follow-up|0|||
144197857|NCT03502707|519922868|FG003|Overall Study|Lost to Follow-up|0|||
144197858|NCT03502707|519922869|FG004|Overall Study|Lost to Follow-up|0|||
144197859|NCT03502707|519922870|FG005|Overall Study|Lost to Follow-up|0|||
144197860|NCT03502707|519922871|FG006|Overall Study|Lost to Follow-up|0|||
144197861|NCT03502707|519922872|FG007|Overall Study|Lost to Follow-up|5|||
144197862|NCT03502707|519922873|FG008|Overall Study|Lost to Follow-up|0|||
144197863|NCT03502707|519922874|FG009|Overall Study|Lost to Follow-up|2|||
144197864|NCT03502707|519922875|FG010|Overall Study|Lost to Follow-up|1|||
144197865|NCT03502707|519922876|FG011|Overall Study|Lost to Follow-up|2|||
144197866|NCT03502707|519922877|FG012|Overall Study|Lost to Follow-up|1|||
144197867|NCT03502707|519922878|FG013|Overall Study|Lost to Follow-up|1|||
144197868|NCT03502707|519922879|FG014|Overall Study|Lost to Follow-up|0|||
144197869|NCT03502707|519922880|FG015|Overall Study|Lost to Follow-up|4|||
144197870|NCT03502707|519922881|FG016|Overall Study|Lost to Follow-up|9|||
144197871|NCT03502707|519922882|FG017|Overall Study|Lost to Follow-up|2|||
144197872|NCT03502707|519922865|FG000|Overall Study|Physician Decision|0|||
144197873|NCT03502707|519922866|FG001|Overall Study|Physician Decision|0|||
144197874|NCT03502707|519922867|FG002|Overall Study|Physician Decision|0|||
144197875|NCT03502707|519922868|FG003|Overall Study|Physician Decision|0|||
144197876|NCT03502707|519922869|FG004|Overall Study|Physician Decision|0|||
144197877|NCT03502707|519922870|FG005|Overall Study|Physician Decision|0|||
144197878|NCT03502707|519922871|FG006|Overall Study|Physician Decision|0|||
144197879|NCT03502707|519922872|FG007|Overall Study|Physician Decision|0|||
144197880|NCT03502707|519922873|FG008|Overall Study|Physician Decision|2|||
144197881|NCT03502707|519922874|FG009|Overall Study|Physician Decision|1|||
144197882|NCT03502707|519922875|FG010|Overall Study|Physician Decision|0|||
144197883|NCT03502707|519922876|FG011|Overall Study|Physician Decision|0|||
144197884|NCT03502707|519922877|FG012|Overall Study|Physician Decision|0|||
144197885|NCT03502707|519922878|FG013|Overall Study|Physician Decision|0|||
144197886|NCT03502707|519922879|FG014|Overall Study|Physician Decision|1|||
144197887|NCT03502707|519922880|FG015|Overall Study|Physician Decision|3|||
144197888|NCT03502707|519922881|FG016|Overall Study|Physician Decision|0|||
144197889|NCT03502707|519922882|FG017|Overall Study|Physician Decision|0|||
144197890|NCT03502707|519922865|FG000|Overall Study|Protocol Violation|0|||
144197891|NCT03502707|519922866|FG001|Overall Study|Protocol Violation|0|||
144197892|NCT03502707|519922867|FG002|Overall Study|Protocol Violation|0|||
144197893|NCT03502707|519922868|FG003|Overall Study|Protocol Violation|0|||
144197894|NCT03502707|519922869|FG004|Overall Study|Protocol Violation|0|||
144197895|NCT03502707|519922870|FG005|Overall Study|Protocol Violation|0|||
144614529|NCT04218201|521450088|FG001|Overall Study|PCP plans to leave practice|8|||
144614530|NCT04218201|521450089|FG002|Overall Study|PCP plans to leave practice|0|||
144614531|NCT04218201|521450090|FG003|Overall Study|PCP plans to leave practice|5|||
144614532|NCT04218201|521450087|FG000|Overall Study|Reduced panel|0|||
144614533|NCT04218201|521450088|FG001|Overall Study|Reduced panel|0|||
144614534|NCT04218201|521450089|FG002|Overall Study|Reduced panel|0|||
144614535|NCT04218201|521450090|FG003|Overall Study|Reduced panel|1|||
144614536|NCT04218201|521450087|FG000|Overall Study|No longer interested in participating|0|||
144614537|NCT04218201|521450088|FG001|Overall Study|No longer interested in participating|1|||
144614538|NCT04218201|521450089|FG002|Overall Study|No longer interested in participating|0|||
144614539|NCT04218201|521450090|FG003|Overall Study|No longer interested in participating|0|||
144614540|NCT04649255|521450093|FG000|Overall Study|Death|9|||
144614541|NCT04649255|521450093|FG000|Overall Study|Withdrawal by Subject|1|||
144614542|NCT02484911|521450094|FG000|Overall Study|Withdrawal by Subject|2|||
144614543|NCT02484911|521450095|FG001|Overall Study|Withdrawal by Subject|1|||
144614544|NCT02484911|521450094|FG000|Overall Study|Protocol Violation|2|||
144614545|NCT02484911|521450095|FG001|Overall Study|Protocol Violation|1|||
144614546|NCT04129528|521450096|FG000|Overall Study|Adverse Event|1|||
144614547|NCT04129528|521450097|FG001|Overall Study|Adverse Event|0|||
144614548|NCT04129528|521450096|FG000|Overall Study|Physician Decision|1|||
144614549|NCT04129528|521450097|FG001|Overall Study|Physician Decision|1|||
144614550|NCT04129528|521450096|FG000|Overall Study|Withdrawal by Subject|1|||
144614551|NCT04129528|521450097|FG001|Overall Study|Withdrawal by Subject|1|||
144614552|NCT01395394|521450106|FG000|Baseline Study Visit|Protocol Violation|1|||
144614553|NCT01395394|521450107|FG001|Baseline Study Visit|Protocol Violation|0|||
144614554|NCT01395394|521450108|FG002|Baseline Study Visit|Protocol Violation|0|||
144197896|NCT03502707|519922871|FG006|Overall Study|Protocol Violation|0|||
144614555|NCT05121480|521450111|FG000|Overall Study|Lack of Efficacy|2|||
144614556|NCT05121480|521450112|FG001|Overall Study|Lack of Efficacy|2|||
144614557|NCT05121480|521450113|FG002|Overall Study|Lack of Efficacy|1|||
144258575|NCT01096160|520148562|FG009|Overall Study|Adverse Event|1|||
144258576|NCT01096160|520148553|FG000|Overall Study|Met stopping criteria per protocol|0|||
144258577|NCT01096160|520148554|FG001|Overall Study|Met stopping criteria per protocol|0|||
144614558|NCT05121480|521450114|FG003|Overall Study|Lack of Efficacy|4|||
144614559|NCT05121480|521450115|FG004|Overall Study|Lack of Efficacy|0|||
144614560|NCT05121480|521450116|FG005|Overall Study|Lack of Efficacy|1|||
144614561|NCT05121480|521450117|FG006|Overall Study|Lack of Efficacy|0|||
144614562|NCT05121480|521450118|FG007|Overall Study|Lack of Efficacy|2|||
144614563|NCT05121480|521450111|FG000|Overall Study|Treatment Failure|0|||
144614564|NCT05121480|521450112|FG001|Overall Study|Treatment Failure|2|||
144614565|NCT05121480|521450113|FG002|Overall Study|Treatment Failure|0|||
144614566|NCT05121480|521450114|FG003|Overall Study|Treatment Failure|1|||
144614567|NCT05121480|521450115|FG004|Overall Study|Treatment Failure|0|||
144614568|NCT05121480|521450116|FG005|Overall Study|Treatment Failure|0|||
144614569|NCT05121480|521450117|FG006|Overall Study|Treatment Failure|0|||
144614570|NCT05121480|521450118|FG007|Overall Study|Treatment Failure|0|||
144614571|NCT05121480|521450111|FG000|Overall Study|Adverse Event|0|||
144614572|NCT05121480|521450112|FG001|Overall Study|Adverse Event|1|||
144614573|NCT05121480|521450113|FG002|Overall Study|Adverse Event|0|||
144614574|NCT05121480|521450114|FG003|Overall Study|Adverse Event|5|||
144614575|NCT05121480|521450115|FG004|Overall Study|Adverse Event|3|||
144614576|NCT05121480|521450116|FG005|Overall Study|Adverse Event|2|||
144614577|NCT05121480|521450117|FG006|Overall Study|Adverse Event|0|||
144614578|NCT05121480|521450118|FG007|Overall Study|Adverse Event|4|||
144614579|NCT05121480|521450111|FG000|Overall Study|Withdrawal by Subject|4|||
144614580|NCT05121480|521450112|FG001|Overall Study|Withdrawal by Subject|9|||
144614581|NCT05121480|521450113|FG002|Overall Study|Withdrawal by Subject|1|||
144614582|NCT05121480|521450114|FG003|Overall Study|Withdrawal by Subject|8|||
144614583|NCT05121480|521450115|FG004|Overall Study|Withdrawal by Subject|0|||
144614584|NCT05121480|521450116|FG005|Overall Study|Withdrawal by Subject|9|||
144614585|NCT05121480|521450117|FG006|Overall Study|Withdrawal by Subject|0|||
144614586|NCT05121480|521450118|FG007|Overall Study|Withdrawal by Subject|4|||
144614587|NCT05121480|521450111|FG000|Overall Study|Non-compliance with the protocol|0|||
144614588|NCT05121480|521450112|FG001|Overall Study|Non-compliance with the protocol|0|||
144614589|NCT05121480|521450113|FG002|Overall Study|Non-compliance with the protocol|0|||
144614590|NCT05121480|521450114|FG003|Overall Study|Non-compliance with the protocol|0|||
144614591|NCT05121480|521450115|FG004|Overall Study|Non-compliance with the protocol|1|||
144614592|NCT05121480|521450116|FG005|Overall Study|Non-compliance with the protocol|6|||
144614593|NCT05121480|521450117|FG006|Overall Study|Non-compliance with the protocol|0|||
144614594|NCT05121480|521450118|FG007|Overall Study|Non-compliance with the protocol|1|||
144614595|NCT05121480|521450111|FG000|Overall Study|Lost to Follow-up|0|||
144614596|NCT05121480|521450112|FG001|Overall Study|Lost to Follow-up|4|||
144614597|NCT05121480|521450113|FG002|Overall Study|Lost to Follow-up|1|||
144614598|NCT05121480|521450114|FG003|Overall Study|Lost to Follow-up|3|||
144614599|NCT05121480|521450115|FG004|Overall Study|Lost to Follow-up|1|||
144614600|NCT05121480|521450116|FG005|Overall Study|Lost to Follow-up|1|||
144614601|NCT05121480|521450117|FG006|Overall Study|Lost to Follow-up|1|||
144614602|NCT05121480|521450118|FG007|Overall Study|Lost to Follow-up|4|||
144614603|NCT05121480|521450111|FG000|Overall Study|Physician Decision|0|||
144614604|NCT05121480|521450112|FG001|Overall Study|Physician Decision|0|||
144614605|NCT05121480|521450113|FG002|Overall Study|Physician Decision|0|||
144614606|NCT05121480|521450114|FG003|Overall Study|Physician Decision|0|||
144614607|NCT05121480|521450115|FG004|Overall Study|Physician Decision|0|||
144614608|NCT05121480|521450116|FG005|Overall Study|Physician Decision|1|||
144614609|NCT05121480|521450117|FG006|Overall Study|Physician Decision|0|||
144614610|NCT05121480|521450118|FG007|Overall Study|Physician Decision|1|||
144614611|NCT05121480|521450111|FG000|Overall Study|Other Reason|0|||
144614612|NCT05121480|521450112|FG001|Overall Study|Other Reason|0|||
144614613|NCT05121480|521450113|FG002|Overall Study|Other Reason|0|||
144614614|NCT05121480|521450114|FG003|Overall Study|Other Reason|0|||
144614615|NCT05121480|521450115|FG004|Overall Study|Other Reason|0|||
144614616|NCT05121480|521450116|FG005|Overall Study|Other Reason|1|||
144614617|NCT05121480|521450117|FG006|Overall Study|Other Reason|1|||
144614618|NCT05121480|521450118|FG007|Overall Study|Other Reason|1|||
144614619|NCT01908101|521450121|FG000|Overall Study|Physician Decision|1|||
144614620|NCT01908101|521450121|FG000|Overall Study|Withdrawal by Subject|1|||
144614621|NCT01908101|521450121|FG000|Overall Study|Incorrect Diagnosis|2|||
144614622|NCT01908101|521450121|FG000|Overall Study|Incorrect Starting Dose|1|||
144614623|NCT01908101|521450121|FG000|Overall Study|Did not complete the first cycle|4|||
144614624|NCT02356562|521450125|FG000|Overall Study|Withdrawal by Subject|0|||
144258578|NCT01096160|520148555|FG002|Overall Study|Met stopping criteria per protocol|0|||
144258579|NCT01096160|520148556|FG003|Overall Study|Met stopping criteria per protocol|0|||
144614625|NCT02356562|521450126|FG001|Overall Study|Withdrawal by Subject|1|||
144614626|NCT02356562|521450125|FG000|Overall Study|Re-entered treatment in a previous study|1|||
144614627|NCT02356562|521450126|FG001|Overall Study|Re-entered treatment in a previous study|0|||
144614628|NCT02356562|521450125|FG000|Overall Study|site closure|1|||
144614629|NCT02356562|521450126|FG001|Overall Study|site closure|0|||
144614630|NCT00150592|521450127|FG000|Overall Study|Adverse Event|4|||
144197897|NCT03502707|519922872|FG007|Overall Study|Protocol Violation|0|||
144197898|NCT03502707|519922873|FG008|Overall Study|Protocol Violation|0|||
144197899|NCT03502707|519922874|FG009|Overall Study|Protocol Violation|0|||
144197900|NCT03502707|519922875|FG010|Overall Study|Protocol Violation|0|||
144197901|NCT03502707|519922876|FG011|Overall Study|Protocol Violation|0|||
144197902|NCT03502707|519922877|FG012|Overall Study|Protocol Violation|0|||
144197903|NCT03502707|519922878|FG013|Overall Study|Protocol Violation|0|||
144197904|NCT03502707|519922879|FG014|Overall Study|Protocol Violation|0|||
144197905|NCT03502707|519922880|FG015|Overall Study|Protocol Violation|1|||
144197906|NCT03502707|519922881|FG016|Overall Study|Protocol Violation|0|||
144197907|NCT03502707|519922882|FG017|Overall Study|Protocol Violation|0|||
144197908|NCT03502707|519922865|FG000|Overall Study|Withdrawal by Subject|1|||
144197909|NCT03502707|519922866|FG001|Overall Study|Withdrawal by Subject|1|||
144197910|NCT03502707|519922867|FG002|Overall Study|Withdrawal by Subject|0|||
144197911|NCT03502707|519922868|FG003|Overall Study|Withdrawal by Subject|0|||
144197912|NCT03502707|519922869|FG004|Overall Study|Withdrawal by Subject|0|||
144197913|NCT03502707|519922870|FG005|Overall Study|Withdrawal by Subject|2|||
144197914|NCT03502707|519922871|FG006|Overall Study|Withdrawal by Subject|0|||
144197915|NCT03502707|519922872|FG007|Overall Study|Withdrawal by Subject|3|||
144197916|NCT03502707|519922873|FG008|Overall Study|Withdrawal by Subject|1|||
144197917|NCT03502707|519922874|FG009|Overall Study|Withdrawal by Subject|2|||
144197918|NCT03502707|519922875|FG010|Overall Study|Withdrawal by Subject|12|||
144197919|NCT03502707|519922876|FG011|Overall Study|Withdrawal by Subject|23|||
144197920|NCT03502707|519922877|FG012|Overall Study|Withdrawal by Subject|5|||
144197921|NCT03502707|519922878|FG013|Overall Study|Withdrawal by Subject|3|||
144197922|NCT03502707|519922879|FG014|Overall Study|Withdrawal by Subject|3|||
144197923|NCT03502707|519922880|FG015|Overall Study|Withdrawal by Subject|43|||
144197924|NCT03502707|519922881|FG016|Overall Study|Withdrawal by Subject|44|||
144197925|NCT03502707|519922882|FG017|Overall Study|Withdrawal by Subject|18|||
144197926|NCT03502707|519922865|FG000|Overall Study|Sponsor's Decision|1|||
144197927|NCT03502707|519922866|FG001|Overall Study|Sponsor's Decision|0|||
144197928|NCT03502707|519922867|FG002|Overall Study|Sponsor's Decision|0|||
144197929|NCT03502707|519922868|FG003|Overall Study|Sponsor's Decision|0|||
144197930|NCT03502707|519922869|FG004|Overall Study|Sponsor's Decision|0|||
144197931|NCT03502707|519922870|FG005|Overall Study|Sponsor's Decision|0|||
144197932|NCT03502707|519922871|FG006|Overall Study|Sponsor's Decision|0|||
144197933|NCT03502707|519922872|FG007|Overall Study|Sponsor's Decision|0|||
144197934|NCT03502707|519922873|FG008|Overall Study|Sponsor's Decision|0|||
144197935|NCT03502707|519922874|FG009|Overall Study|Sponsor's Decision|1|||
144197936|NCT03502707|519922875|FG010|Overall Study|Sponsor's Decision|0|||
144197937|NCT03502707|519922876|FG011|Overall Study|Sponsor's Decision|0|||
144197938|NCT03502707|519922877|FG012|Overall Study|Sponsor's Decision|0|||
144197939|NCT03502707|519922878|FG013|Overall Study|Sponsor's Decision|0|||
144197940|NCT03502707|519922879|FG014|Overall Study|Sponsor's Decision|0|||
144197941|NCT03502707|519922880|FG015|Overall Study|Sponsor's Decision|2|||
144197942|NCT03502707|519922881|FG016|Overall Study|Sponsor's Decision|1|||
144197943|NCT03502707|519922882|FG017|Overall Study|Sponsor's Decision|0|||
144197944|NCT03502707|519922865|FG000|Overall Study|Initiated Prohibited Medication|0|||
144197945|NCT03502707|519922866|FG001|Overall Study|Initiated Prohibited Medication|0|||
144197946|NCT03502707|519922867|FG002|Overall Study|Initiated Prohibited Medication|0|||
144197947|NCT03502707|519922868|FG003|Overall Study|Initiated Prohibited Medication|0|||
144197948|NCT03502707|519922869|FG004|Overall Study|Initiated Prohibited Medication|0|||
144197949|NCT03502707|519922870|FG005|Overall Study|Initiated Prohibited Medication|0|||
144197950|NCT03502707|519922871|FG006|Overall Study|Initiated Prohibited Medication|0|||
144197951|NCT03502707|519922872|FG007|Overall Study|Initiated Prohibited Medication|0|||
144197952|NCT03502707|519922873|FG008|Overall Study|Initiated Prohibited Medication|0|||
144197953|NCT03502707|519922874|FG009|Overall Study|Initiated Prohibited Medication|0|||
144197954|NCT03502707|519922875|FG010|Overall Study|Initiated Prohibited Medication|0|||
144197955|NCT03502707|519922876|FG011|Overall Study|Initiated Prohibited Medication|0|||
144197956|NCT03502707|519922877|FG012|Overall Study|Initiated Prohibited Medication|0|||
144197957|NCT03502707|519922878|FG013|Overall Study|Initiated Prohibited Medication|0|||
144197958|NCT03502707|519922879|FG014|Overall Study|Initiated Prohibited Medication|0|||
144197959|NCT03502707|519922880|FG015|Overall Study|Initiated Prohibited Medication|0|||
144197960|NCT03502707|519922881|FG016|Overall Study|Initiated Prohibited Medication|1|||
144197961|NCT03502707|519922882|FG017|Overall Study|Initiated Prohibited Medication|0|||
144197962|NCT03502707|519922865|FG000|Overall Study|Other|0|||
144197963|NCT03502707|519922866|FG001|Overall Study|Other|0|||
144197964|NCT03502707|519922867|FG002|Overall Study|Other|0|||
144197965|NCT03502707|519922868|FG003|Overall Study|Other|0|||
144197966|NCT03502707|519922869|FG004|Overall Study|Other|0|||
144197967|NCT03502707|519922870|FG005|Overall Study|Other|0|||
144197968|NCT03502707|519922871|FG006|Overall Study|Other|0|||
144197969|NCT03502707|519922872|FG007|Overall Study|Other|0|||
144197970|NCT03502707|519922873|FG008|Overall Study|Other|1|||
144197971|NCT03502707|519922874|FG009|Overall Study|Other|1|||
144197972|NCT03502707|519922875|FG010|Overall Study|Other|2|||
144197973|NCT03502707|519922876|FG011|Overall Study|Other|0|||
144197974|NCT03502707|519922877|FG012|Overall Study|Other|0|||
144197975|NCT03502707|519922878|FG013|Overall Study|Other|0|||
144197976|NCT03502707|519922879|FG014|Overall Study|Other|0|||
144197977|NCT03502707|519922880|FG015|Overall Study|Other|4|||
144197978|NCT03502707|519922881|FG016|Overall Study|Other|1|||
144197979|NCT03502707|519922882|FG017|Overall Study|Other|0|||
144197980|NCT03502707|519922865|FG000|Overall Study|Randomized but not vaccinated|0|||
144197981|NCT03502707|519922866|FG001|Overall Study|Randomized but not vaccinated|0|||
144197982|NCT03502707|519922867|FG002|Overall Study|Randomized but not vaccinated|0|||
144197983|NCT03502707|519922868|FG003|Overall Study|Randomized but not vaccinated|0|||
144197984|NCT03502707|519922869|FG004|Overall Study|Randomized but not vaccinated|0|||
144197985|NCT03502707|519922870|FG005|Overall Study|Randomized but not vaccinated|0|||
144197986|NCT03502707|519922871|FG006|Overall Study|Randomized but not vaccinated|0|||
144197987|NCT03502707|519922872|FG007|Overall Study|Randomized but not vaccinated|0|||
144197988|NCT03502707|519922873|FG008|Overall Study|Randomized but not vaccinated|0|||
144197989|NCT03502707|519922874|FG009|Overall Study|Randomized but not vaccinated|0|||
144197990|NCT03502707|519922875|FG010|Overall Study|Randomized but not vaccinated|0|||
144197991|NCT03502707|519922876|FG011|Overall Study|Randomized but not vaccinated|1|||
144197992|NCT03502707|519922877|FG012|Overall Study|Randomized but not vaccinated|0|||
144197993|NCT03502707|519922878|FG013|Overall Study|Randomized but not vaccinated|0|||
144197994|NCT03502707|519922879|FG014|Overall Study|Randomized but not vaccinated|0|||
144197995|NCT03502707|519922880|FG015|Overall Study|Randomized but not vaccinated|0|||
144197996|NCT03502707|519922881|FG016|Overall Study|Randomized but not vaccinated|0|||
144197997|NCT03502707|519922882|FG017|Overall Study|Randomized but not vaccinated|1|||
144197998|NCT01045421|519922884|FG000|Phase 1|Progressive Disease|0|||
144197999|NCT01045421|519922885|FG001|Phase 1|Progressive Disease|0|||
144198000|NCT01045421|519922886|FG002|Phase 1|Progressive Disease|0|||
144198001|NCT01045421|519922887|FG003|Phase 1|Progressive Disease|0|||
144198002|NCT01045421|519922888|FG004|Phase 1|Progressive Disease|1|||
144198003|NCT01045421|519922889|FG005|Phase 1|Progressive Disease|0|||
144198004|NCT01045421|519922890|FG006|Phase 1|Progressive Disease|0|||
144198005|NCT01045421|519922891|FG007|Phase 1|Progressive Disease|0|||
144198006|NCT01045421|519922892|FG008|Phase 1|Progressive Disease|0|||
144198007|NCT01045421|519922893|FG009|Phase 1|Progressive Disease|0|||
144198008|NCT01045421|519922894|FG010|Phase 1|Progressive Disease|0|||
144198009|NCT01045421|519922884|FG000|Phase 1|Withdrawal by Subject|0|||
144198010|NCT01045421|519922885|FG001|Phase 1|Withdrawal by Subject|0|||
144198011|NCT01045421|519922886|FG002|Phase 1|Withdrawal by Subject|0|||
144198012|NCT01045421|519922887|FG003|Phase 1|Withdrawal by Subject|1|||
144198013|NCT01045421|519922888|FG004|Phase 1|Withdrawal by Subject|0|||
144198014|NCT01045421|519922889|FG005|Phase 1|Withdrawal by Subject|0|||
144198015|NCT01045421|519922890|FG006|Phase 1|Withdrawal by Subject|0|||
144198016|NCT01045421|519922891|FG007|Phase 1|Withdrawal by Subject|0|||
144198017|NCT01045421|519922892|FG008|Phase 1|Withdrawal by Subject|0|||
144198018|NCT01045421|519922893|FG009|Phase 1|Withdrawal by Subject|0|||
144198019|NCT01045421|519922894|FG010|Phase 1|Withdrawal by Subject|0|||
144198020|NCT01045421|519922884|FG000|Phase 2|Progressive Disease|0|||
144198021|NCT01045421|519922885|FG001|Phase 2|Progressive Disease|0|||
144198022|NCT01045421|519922886|FG002|Phase 2|Progressive Disease|0|||
144198023|NCT01045421|519922887|FG003|Phase 2|Progressive Disease|0|||
144198024|NCT01045421|519922888|FG004|Phase 2|Progressive Disease|0|||
144198025|NCT01045421|519922889|FG005|Phase 2|Progressive Disease|0|||
144198026|NCT01045421|519922890|FG006|Phase 2|Progressive Disease|0|||
144198027|NCT01045421|519922891|FG007|Phase 2|Progressive Disease|1|||
144198028|NCT01045421|519922892|FG008|Phase 2|Progressive Disease|1|||
144198029|NCT01045421|519922893|FG009|Phase 2|Progressive Disease|1|||
144198030|NCT01045421|519922894|FG010|Phase 2|Progressive Disease|1|||
144198031|NCT01045421|519922884|FG000|Phase 2|Death|0|||
144198032|NCT01045421|519922885|FG001|Phase 2|Death|0|||
144614631|NCT00150592|521450128|FG001|Overall Study|Adverse Event|1|||
144614632|NCT00150592|521450127|FG000|Overall Study|Protocol Violation|1|||
144614633|NCT00150592|521450128|FG001|Overall Study|Protocol Violation|0|||
144614634|NCT00150592|521450127|FG000|Overall Study|Withdrawal by Subject|1|||
144614635|NCT00150592|521450128|FG001|Overall Study|Withdrawal by Subject|2|||
144614636|NCT00150592|521450127|FG000|Overall Study|Non-compliance|1|||
144614637|NCT00150592|521450128|FG001|Overall Study|Non-compliance|0|||
144198033|NCT01045421|519922886|FG002|Phase 2|Death|0|||
144198034|NCT01045421|519922887|FG003|Phase 2|Death|0|||
144198035|NCT01045421|519922888|FG004|Phase 2|Death|0|||
144198036|NCT01045421|519922889|FG005|Phase 2|Death|0|||
144198037|NCT01045421|519922890|FG006|Phase 2|Death|0|||
144198038|NCT01045421|519922891|FG007|Phase 2|Death|1|||
144198039|NCT01045421|519922892|FG008|Phase 2|Death|1|||
144198040|NCT01045421|519922893|FG009|Phase 2|Death|2|||
144614638|NCT00412750|521450129|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144198041|NCT01045421|519922894|FG010|Phase 2|Death|0|||
144198042|NCT01045421|519922884|FG000|Phase 2|Other|0|||
144198043|NCT01045421|519922885|FG001|Phase 2|Other|0|||
144198044|NCT01045421|519922886|FG002|Phase 2|Other|0|||
144198045|NCT01045421|519922887|FG003|Phase 2|Other|0|||
144198046|NCT01045421|519922888|FG004|Phase 2|Other|0|||
144614639|NCT00412750|521450130|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144198047|NCT01045421|519922889|FG005|Phase 2|Other|0|||
144198048|NCT01045421|519922890|FG006|Phase 2|Other|0|||
144198049|NCT01045421|519922891|FG007|Phase 2|Other|3|||
144198050|NCT01045421|519922892|FG008|Phase 2|Other|0|||
144198051|NCT01045421|519922893|FG009|Phase 2|Other|0|||
144198052|NCT01045421|519922894|FG010|Phase 2|Other|1|||
144198053|NCT03340064|519922895|FG000|First Period|Adverse Event, non-fatal|2|||
144198054|NCT03340064|519922896|FG001|First Period|Adverse Event, non-fatal|0|||
144198055|NCT03340064|519922895|FG000|First Period|Lack of Efficacy|3|||
144198056|NCT03340064|519922896|FG001|First Period|Lack of Efficacy|0|||
144198057|NCT03340064|519922895|FG000|Second Period|Adverse Event, non-fatal|1|||
144198058|NCT03340064|519922896|FG001|Second Period|Adverse Event, non-fatal|1|||
144198059|NCT03340064|519922895|FG000|Second Period|Lack of Efficacy|11|||
144198060|NCT03340064|519922896|FG001|Second Period|Lack of Efficacy|0|||
144198061|NCT03340064|519922895|FG000|Second Period|Physician Decision|3|||
144198062|NCT03340064|519922896|FG001|Second Period|Physician Decision|0|||
144198063|NCT03340064|519922895|FG000|Second Period|Withdrawal by Subject|2|||
144198064|NCT03340064|519922896|FG001|Second Period|Withdrawal by Subject|1|||
144198065|NCT03340064|519922895|FG000|Second Period|Approved Drug Available For Indication|1|||
144198066|NCT03340064|519922896|FG001|Second Period|Approved Drug Available For Indication|0|||
144198067|NCT03340064|519922895|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
144198068|NCT03340064|519922896|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
144198069|NCT02221037|519922897|FG000|Overall Study|Physician Decision|0|||
144198070|NCT02221037|519922898|FG001|Overall Study|Physician Decision|0|||
144198071|NCT02221037|519922899|FG002|Overall Study|Physician Decision|1|||
144198072|NCT02221037|519922900|FG003|Overall Study|Physician Decision|0|||
144198073|NCT00062010|519922903|FG000|Overall Study|Ineligible|3|||
144198074|NCT02944383|519922904|FG000|Overall Study|Lost to Follow-up|0|||
144198075|NCT02944383|519922905|FG001|Overall Study|Lost to Follow-up|0|||
144198076|NCT02944383|519922906|FG002|Overall Study|Lost to Follow-up|1|||
144198077|NCT02944383|519922904|FG000|Overall Study|Withdrawal by Subject|1|||
144198078|NCT02944383|519922905|FG001|Overall Study|Withdrawal by Subject|0|||
144198079|NCT02944383|519922906|FG002|Overall Study|Withdrawal by Subject|0|||
144198080|NCT00852969|519922911|FG000|Overall Study|Adverse Event|0|||
144198081|NCT00852969|519922912|FG001|Overall Study|Adverse Event|1|||
144198082|NCT00852969|519922911|FG000|Overall Study|Lost to Follow-up|0|||
144198083|NCT00852969|519922912|FG001|Overall Study|Lost to Follow-up|1|||
144198084|NCT00678041|519922918|FG000|Overall Study|Physician Decision|5|||
144198085|NCT00678041|519922919|FG001|Overall Study|Physician Decision|5|||
144198086|NCT02358343|519922920|FG000|Screening Intervention|Death|0|||
144198087|NCT02358343|519922921|FG001|Screening Intervention|Death|2|||
144198088|NCT02358343|519922922|FG002|Screening Intervention|Death|0|||
144198089|NCT02358343|519922923|FG003|Screening Intervention|Death|0|||
144198090|NCT02358343|519922924|FG004|Screening Intervention|Death|0|||
144198091|NCT02358343|519922920|FG000|Screening Intervention|Withdrawal by Subject|1|||
144198092|NCT02358343|519922921|FG001|Screening Intervention|Withdrawal by Subject|0|||
144198093|NCT02358343|519922922|FG002|Screening Intervention|Withdrawal by Subject|0|||
144198094|NCT02358343|519922923|FG003|Screening Intervention|Withdrawal by Subject|0|||
144198095|NCT02358343|519922924|FG004|Screening Intervention|Withdrawal by Subject|0|||
144198096|NCT02358343|519922920|FG000|Screening Intervention|Determined Ineligible|5|||
144198097|NCT02358343|519922921|FG001|Screening Intervention|Determined Ineligible|6|||
144198098|NCT02358343|519922922|FG002|Screening Intervention|Determined Ineligible|0|||
144198099|NCT02358343|519922923|FG003|Screening Intervention|Determined Ineligible|0|||
144198100|NCT02358343|519922924|FG004|Screening Intervention|Determined Ineligible|0|||
144198101|NCT02358343|519922920|FG000|Comparative Efficacy Trial / Observation|Death|0|||
144198102|NCT02358343|519922921|FG001|Comparative Efficacy Trial / Observation|Death|0|||
144198103|NCT02358343|519922922|FG002|Comparative Efficacy Trial / Observation|Death|2|||
144198104|NCT02358343|519922923|FG003|Comparative Efficacy Trial / Observation|Death|0|||
144198105|NCT02358343|519922924|FG004|Comparative Efficacy Trial / Observation|Death|0|||
144198106|NCT02358343|519922920|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
144198107|NCT02358343|519922921|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
144258580|NCT01096160|520148557|FG004|Overall Study|Met stopping criteria per protocol|1|||
144198108|NCT02358343|519922922|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
144198109|NCT02358343|519922923|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
144198110|NCT02358343|519922924|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
144198111|NCT02358343|519922920|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
144198112|NCT02358343|519922921|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
144198113|NCT02358343|519922922|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
144198114|NCT02358343|519922923|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
144198115|NCT02358343|519922924|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
144198116|NCT00090610|519922927|FG000|Overall Study|Withdrawal by Subject|1|||
144198117|NCT00090610|519922928|FG001|Overall Study|Withdrawal by Subject|1|||
144258581|NCT01096160|520148558|FG005|Overall Study|Met stopping criteria per protocol|0|||
144198118|NCT00807248|519922929|FG000|Overall Study|Adverse Event|1|||
144258582|NCT01096160|520148559|FG006|Overall Study|Met stopping criteria per protocol|2|||
144258583|NCT01096160|520148560|FG007|Overall Study|Met stopping criteria per protocol|0|||
144258584|NCT01096160|520148561|FG008|Overall Study|Met stopping criteria per protocol|2|||
144258585|NCT01096160|520148562|FG009|Overall Study|Met stopping criteria per protocol|0|||
144258586|NCT01048541|520148564|FG000|Overall Study|Withdrawal by Subject|1|||
144258587|NCT01048541|520148565|FG001|Overall Study|Withdrawal by Subject|0|||
144258588|NCT00627497|520148566|FG000|Overall Study|Lost to Follow-up|1|||
144258589|NCT00627497|520148567|FG001|Overall Study|Lost to Follow-up|1|||
144258590|NCT00627497|520148568|FG002|Overall Study|Lost to Follow-up|0|||
144258591|NCT00627497|520148569|FG003|Overall Study|Lost to Follow-up|0|||
144258592|NCT00791700|520148574|FG000|Overall Study|Insufficient clinical response|1|||
144258593|NCT00791700|520148575|FG001|Overall Study|Insufficient clinical response|4|||
144258594|NCT00791700|520148576|FG002|Overall Study|Insufficient clinical response|1|||
144258595|NCT00791700|520148577|FG003|Overall Study|Insufficient clinical response|8|||
144258596|NCT00791700|520148574|FG000|Overall Study|No longer willing to participate|1|||
144258597|NCT00791700|520148575|FG001|Overall Study|No longer willing to participate|1|||
144258598|NCT00791700|520148576|FG002|Overall Study|No longer willing to participate|0|||
144258599|NCT00791700|520148577|FG003|Overall Study|No longer willing to participate|8|||
144258600|NCT00791700|520148574|FG000|Overall Study|Non-compliance with study treatment|0|||
144258601|NCT00791700|520148575|FG001|Overall Study|Non-compliance with study treatment|2|||
144258602|NCT00791700|520148576|FG002|Overall Study|Non-compliance with study treatment|0|||
144258603|NCT00791700|520148577|FG003|Overall Study|Non-compliance with study treatment|4|||
144258604|NCT00791700|520148574|FG000|Overall Study|Withdrawn due to pregnancy|0|||
144258605|NCT00791700|520148575|FG001|Overall Study|Withdrawn due to pregnancy|0|||
144258606|NCT00791700|520148576|FG002|Overall Study|Withdrawn due to pregnancy|0|||
144258607|NCT00791700|520148577|FG003|Overall Study|Withdrawn due to pregnancy|1|||
144198119|NCT00807248|519922930|FG001|Overall Study|Adverse Event|2|||
144198120|NCT00807248|519922931|FG002|Overall Study|Adverse Event|2|||
144198121|NCT00807248|519922932|FG003|Overall Study|Adverse Event|6|||
144198122|NCT00807248|519922929|FG000|Overall Study|Lack of Efficacy|14|||
144198123|NCT00807248|519922930|FG001|Overall Study|Lack of Efficacy|4|||
144198124|NCT00807248|519922931|FG002|Overall Study|Lack of Efficacy|8|||
144198125|NCT00807248|519922932|FG003|Overall Study|Lack of Efficacy|3|||
144198126|NCT00807248|519922929|FG000|Overall Study|Protocol Violation|0|||
144198127|NCT00807248|519922930|FG001|Overall Study|Protocol Violation|1|||
144198128|NCT00807248|519922931|FG002|Overall Study|Protocol Violation|1|||
144198129|NCT00807248|519922932|FG003|Overall Study|Protocol Violation|0|||
144198130|NCT00807248|519922929|FG000|Overall Study|Withdrawal of Consent|5|||
144198131|NCT00807248|519922930|FG001|Overall Study|Withdrawal of Consent|5|||
144198132|NCT00807248|519922931|FG002|Overall Study|Withdrawal of Consent|5|||
144198133|NCT00807248|519922932|FG003|Overall Study|Withdrawal of Consent|5|||
144198134|NCT00807248|519922929|FG000|Overall Study|Lost to Follow-up|1|||
144198135|NCT00807248|519922930|FG001|Overall Study|Lost to Follow-up|0|||
144198136|NCT00807248|519922931|FG002|Overall Study|Lost to Follow-up|0|||
144198137|NCT00807248|519922932|FG003|Overall Study|Lost to Follow-up|0|||
144198138|NCT00807248|519922929|FG000|Overall Study|Other Reason|0|||
144198139|NCT00807248|519922930|FG001|Overall Study|Other Reason|0|||
144198140|NCT00807248|519922931|FG002|Overall Study|Other Reason|2|||
144198141|NCT00807248|519922932|FG003|Overall Study|Other Reason|0|||
144198142|NCT02444793|519922933|FG000|Overall Study|Lost to Follow-up|2|||
144198143|NCT02444793|519922934|FG001|Overall Study|Lost to Follow-up|2|||
144198144|NCT02444793|519922935|FG002|Overall Study|Lost to Follow-up|0|||
144198145|NCT02444793|519922936|FG003|Overall Study|Lost to Follow-up|0|||
144258608|NCT00791700|520148574|FG000|Overall Study|Other|0|||
144258609|NCT00791700|520148575|FG001|Overall Study|Other|1|||
144470843|NCT04857034|520923280|FG000|Placebo-Controlled Period|Ongoing study period|0|||
144198146|NCT02444793|519922933|FG000|Overall Study|Death|0|||
144198147|NCT02444793|519922934|FG001|Overall Study|Death|3|||
144198148|NCT02444793|519922935|FG002|Overall Study|Death|0|||
144470844|NCT04857034|520923281|FG001|Placebo-Controlled Period|Ongoing study period|1|||
144470845|NCT04857034|520923282|FG002|Placebo-Controlled Period|Ongoing study period|0|||
144470846|NCT04857034|520923283|FG003|Placebo-Controlled Period|Ongoing study period|0|||
144470847|NCT04857034|520923284|FG004|Placebo-Controlled Period|Ongoing study period|0|||
144470848|NCT04857034|520923280|FG000|Active Treatment Period|Lack of Efficacy|1|||
144470849|NCT04857034|520923281|FG001|Active Treatment Period|Lack of Efficacy|0|||
144470850|NCT04857034|520923282|FG002|Active Treatment Period|Lack of Efficacy|0|||
144470851|NCT04857034|520923283|FG003|Active Treatment Period|Lack of Efficacy|0|||
144470852|NCT04857034|520923284|FG004|Active Treatment Period|Lack of Efficacy|0|||
144198149|NCT02444793|519922936|FG003|Overall Study|Death|0|||
144470853|NCT04857034|520923280|FG000|Active Treatment Period|request to discontinue|0|||
144198150|NCT02444793|519922933|FG000|Overall Study|Other|0|||
144258610|NCT00791700|520148576|FG002|Overall Study|Other|0|||
144258611|NCT00791700|520148577|FG003|Overall Study|Other|1|||
144258612|NCT00791700|520148574|FG000|Overall Study|Death|0|||
144198151|NCT02444793|519922934|FG001|Overall Study|Other|0|||
144198152|NCT02444793|519922935|FG002|Overall Study|Other|2|||
144198153|NCT02444793|519922936|FG003|Overall Study|Other|0|||
144537528|NCT01961609|521170962|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
144198154|NCT02444793|519922933|FG000|Overall Study|Objective progression or relapse|9|||
144198155|NCT02444793|519922934|FG001|Overall Study|Objective progression or relapse|1|||
144198156|NCT02444793|519922935|FG002|Overall Study|Objective progression or relapse|2|||
144198157|NCT02444793|519922936|FG003|Overall Study|Objective progression or relapse|3|||
144198158|NCT02504671|519922940|FG000|Overall Study|Withdrawal by Subject|1|||
144198159|NCT02504671|519922941|FG001|Overall Study|Withdrawal by Subject|5|||
144198160|NCT02504671|519922942|FG002|Overall Study|Withdrawal by Subject|4|||
144198161|NCT02504671|519922943|FG003|Overall Study|Withdrawal by Subject|4|||
144198162|NCT02504671|519922944|FG004|Overall Study|Withdrawal by Subject|5|||
144198163|NCT02504671|519922945|FG005|Overall Study|Withdrawal by Subject|3|||
144198164|NCT02504671|519922940|FG000|Overall Study|Lack of Efficacy|1|||
144198165|NCT02504671|519922941|FG001|Overall Study|Lack of Efficacy|3|||
144198166|NCT02504671|519922942|FG002|Overall Study|Lack of Efficacy|1|||
144198167|NCT02504671|519922943|FG003|Overall Study|Lack of Efficacy|0|||
144198168|NCT02504671|519922944|FG004|Overall Study|Lack of Efficacy|4|||
144198169|NCT02504671|519922945|FG005|Overall Study|Lack of Efficacy|4|||
144198170|NCT02504671|519922940|FG000|Overall Study|Adverse Event|1|||
144198171|NCT02504671|519922941|FG001|Overall Study|Adverse Event|1|||
144198172|NCT02504671|519922942|FG002|Overall Study|Adverse Event|0|||
144198173|NCT02504671|519922943|FG003|Overall Study|Adverse Event|1|||
144198174|NCT02504671|519922944|FG004|Overall Study|Adverse Event|0|||
144198175|NCT02504671|519922945|FG005|Overall Study|Adverse Event|2|||
144198176|NCT02504671|519922940|FG000|Overall Study|Protocol Violation|2|||
144198177|NCT02504671|519922941|FG001|Overall Study|Protocol Violation|1|||
144198178|NCT02504671|519922942|FG002|Overall Study|Protocol Violation|0|||
144258613|NCT00791700|520148575|FG001|Overall Study|Death|0|||
144537529|NCT01961609|521170963|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
144537530|NCT01961609|521170964|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
144537531|NCT01961609|521170961|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
144537532|NCT01961609|521170962|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
144537533|NCT01961609|521170963|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
144537534|NCT01961609|521170964|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
144537535|NCT01961609|521170961|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
144537536|NCT01961609|521170962|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
144537537|NCT01961609|521170963|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
144537538|NCT01961609|521170964|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
144537539|NCT00312208|521170965|FG000|Overall Study|Adverse Event|97|||
144537540|NCT00312208|521170966|FG001|Overall Study|Adverse Event|61|||
144537541|NCT00312208|521170965|FG000|Overall Study|Protocol Violation|5|||
144537542|NCT00312208|521170966|FG001|Overall Study|Protocol Violation|3|||
144537543|NCT00312208|521170965|FG000|Overall Study|Death|2|||
144537544|NCT00312208|521170966|FG001|Overall Study|Death|1|||
144537545|NCT00312208|521170965|FG000|Overall Study|Lack of Efficacy|7|||
144537546|NCT00312208|521170966|FG001|Overall Study|Lack of Efficacy|4|||
144537547|NCT00312208|521170965|FG000|Overall Study|Lost to Follow-up|3|||
144537548|NCT00312208|521170966|FG001|Overall Study|Lost to Follow-up|5|||
144537549|NCT00312208|521170965|FG000|Overall Study|Withdrawal by Subject|53|||
144537550|NCT00312208|521170966|FG001|Overall Study|Withdrawal by Subject|42|||
144537551|NCT00312208|521170965|FG000|Overall Study|Other|5|||
144537552|NCT00312208|521170966|FG001|Overall Study|Other|7|||
144537553|NCT03222609|521170991|FG000|Overall Study|Withdrew consent|2|||
144537554|NCT03222609|521170992|FG001|Overall Study|Withdrew consent|3|||
144537555|NCT03222609|521170993|FG002|Overall Study|Withdrew consent|4|||
144537556|NCT03222609|521170994|FG003|Overall Study|Withdrew consent|2|||
144537557|NCT03222609|521170991|FG000|Overall Study|Lost to Follow-up|1|||
144537558|NCT03222609|521170992|FG001|Overall Study|Lost to Follow-up|0|||
144537559|NCT03222609|521170993|FG002|Overall Study|Lost to Follow-up|0|||
144537560|NCT03222609|521170994|FG003|Overall Study|Lost to Follow-up|0|||
144537561|NCT03222609|521170991|FG000|Overall Study|Death|16|||
144537562|NCT03222609|521170992|FG001|Overall Study|Death|13|||
144537563|NCT03222609|521170993|FG002|Overall Study|Death|9|||
144537564|NCT03222609|521170994|FG003|Overall Study|Death|6|||
144537565|NCT03222609|521170991|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
144198179|NCT02504671|519922943|FG003|Overall Study|Protocol Violation|0|||
144198180|NCT02504671|519922944|FG004|Overall Study|Protocol Violation|0|||
144537566|NCT03222609|521170992|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
144258614|NCT00791700|520148576|FG002|Overall Study|Death|0|||
144537567|NCT03222609|521170993|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
144537568|NCT03222609|521170994|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
144537569|NCT03834740|521170995|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
144537570|NCT03834740|521170996|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
144614640|NCT00412750|521450131|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144537571|NCT03834740|521170997|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
144614641|NCT00412750|521450129|FG000|Overall Study|Administrative problems|21|||
144614642|NCT00412750|521450130|FG001|Overall Study|Administrative problems|17|||
144198181|NCT02504671|519922945|FG005|Overall Study|Protocol Violation|1|||
144198182|NCT02504671|519922940|FG000|Overall Study|Lost to Follow-up|0|||
144198183|NCT02504671|519922941|FG001|Overall Study|Lost to Follow-up|0|||
144198184|NCT02504671|519922942|FG002|Overall Study|Lost to Follow-up|2|||
144198185|NCT02504671|519922943|FG003|Overall Study|Lost to Follow-up|0|||
144198186|NCT02504671|519922944|FG004|Overall Study|Lost to Follow-up|0|||
144198187|NCT02504671|519922945|FG005|Overall Study|Lost to Follow-up|1|||
144198188|NCT02504671|519922940|FG000|Overall Study|Protocol defined stopping criteria|7|||
144198189|NCT02504671|519922941|FG001|Overall Study|Protocol defined stopping criteria|4|||
144198190|NCT02504671|519922942|FG002|Overall Study|Protocol defined stopping criteria|3|||
144198191|NCT02504671|519922943|FG003|Overall Study|Protocol defined stopping criteria|5|||
144198192|NCT02504671|519922944|FG004|Overall Study|Protocol defined stopping criteria|3|||
144198193|NCT02504671|519922945|FG005|Overall Study|Protocol defined stopping criteria|3|||
144198194|NCT00210249|519922946|FG000|Overall Study|Lost to Follow-up|5|||
144198195|NCT00210249|519922946|FG000|Overall Study|Protocol Violation|11|||
144198196|NCT04280705|519922949|FG000|Overall Study|Enrolled but not treated|4|||
144198197|NCT04280705|519922950|FG001|Overall Study|Enrolled but not treated|10|||
144198198|NCT04280705|519922949|FG000|Overall Study|Physician Decision|1|||
144198199|NCT04280705|519922950|FG001|Overall Study|Physician Decision|0|||
144198200|NCT04280705|519922949|FG000|Overall Study|Withdrawal by Subject|7|||
144198201|NCT04280705|519922950|FG001|Overall Study|Withdrawal by Subject|9|||
144198202|NCT04280705|519922949|FG000|Overall Study|Adverse Event|0|||
144198203|NCT04280705|519922950|FG001|Overall Study|Adverse Event|4|||
144198204|NCT04280705|519922949|FG000|Overall Study|Transferred to another hospital|1|||
144198205|NCT04280705|519922950|FG001|Overall Study|Transferred to another hospital|1|||
144198206|NCT02518919|519922953|FG000|Overall Study|Protocol Violation|1|||
144198207|NCT02518919|519922954|FG001|Overall Study|Protocol Violation|1|||
144198208|NCT02518919|519922955|FG002|Overall Study|Protocol Violation|2|||
144198209|NCT00599521|519922956|FG000|Overall Study|Lack of Efficacy|4|||
144198210|NCT00599521|519922957|FG001|Overall Study|Lack of Efficacy|8|||
144198211|NCT00599521|519922956|FG000|Overall Study|Adverse Event|4|||
144198212|NCT00599521|519922957|FG001|Overall Study|Adverse Event|1|||
144198213|NCT00599521|519922956|FG000|Overall Study|Withdrawal by Subject|28|||
144198214|NCT00599521|519922957|FG001|Overall Study|Withdrawal by Subject|34|||
144198215|NCT00599521|519922956|FG000|Overall Study|Protocol Violation|1|||
144198216|NCT00599521|519922957|FG001|Overall Study|Protocol Violation|1|||
144198217|NCT00599521|519922956|FG000|Overall Study|Lost to Follow-up|23|||
144198218|NCT00599521|519922957|FG001|Overall Study|Lost to Follow-up|23|||
144198219|NCT00599521|519922956|FG000|Overall Study|Pregnancy|0|||
144198220|NCT00599521|519922957|FG001|Overall Study|Pregnancy|2|||
144198221|NCT00103311|519922966|FG000|Overall Study|Lost to Follow-up|1|||
144198222|NCT00103311|519922967|FG001|Overall Study|Lost to Follow-up|0|||
144537572|NCT01208974|521170998|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
144537573|NCT01208974|521170999|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
144537574|NCT01208974|521171000|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
144537575|NCT01208974|521171001|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
144537576|NCT01208974|521170998|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
144537577|NCT01208974|521170999|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
144537578|NCT01208974|521171000|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
144537579|NCT01208974|521171001|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
144537580|NCT01208974|521170998|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
144537581|NCT01208974|521170999|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
144537582|NCT01208974|521171000|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
144537583|NCT01208974|521171001|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
144537584|NCT03593226|521171002|FG000|Overall Study|Disease progression|6|||
144537585|NCT03593226|521171003|FG001|Overall Study|Disease progression|13|||
144614643|NCT00412750|521450131|FG002|Overall Study|Administrative problems|14|||
144614644|NCT00412750|521450129|FG000|Overall Study|Adverse Event|8|||
144614645|NCT00412750|521450130|FG001|Overall Study|Adverse Event|3|||
144614646|NCT00412750|521450131|FG002|Overall Study|Adverse Event|3|||
144614647|NCT00412750|521450129|FG000|Overall Study|Lost to Follow-up|1|||
144614648|NCT00412750|521450130|FG001|Overall Study|Lost to Follow-up|0|||
144614649|NCT00412750|521450131|FG002|Overall Study|Lost to Follow-up|1|||
144614650|NCT00412750|521450129|FG000|Overall Study|Withdrawal by Subject|0|||
144614651|NCT00412750|521450130|FG001|Overall Study|Withdrawal by Subject|1|||
144614652|NCT00412750|521450131|FG002|Overall Study|Withdrawal by Subject|2|||
144198223|NCT00103311|519922966|FG000|Overall Study|Withdrawal by Subject|2|||
144198224|NCT00103311|519922967|FG001|Overall Study|Withdrawal by Subject|1|||
144198225|NCT00103311|519922966|FG000|Overall Study|Adverse Event|1|||
144198226|NCT00103311|519922967|FG001|Overall Study|Adverse Event|0|||
144198227|NCT03827564|519922968|FG000|Overall Study|Discontinued due to Study Termination|1|||
144198228|NCT03827564|519922969|FG001|Overall Study|Discontinued due to Study Termination|0|||
144198229|NCT00270257|519922972|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
144198230|NCT00270257|519922973|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
144198231|NCT01195103|519922974|FG000|Overall Study|Withdrawal by Subject|1|||
144198232|NCT01195103|519922975|FG001|Overall Study|Withdrawal by Subject|0|||
144614653|NCT00412750|521450129|FG000|Overall Study|Lack of Efficacy|0|||
144614654|NCT00412750|521450130|FG001|Overall Study|Lack of Efficacy|0|||
144614655|NCT00412750|521450131|FG002|Overall Study|Lack of Efficacy|3|||
144614656|NCT00874120|521450138|FG000|First Intervention|Adverse Event|0|||
144614657|NCT00874120|521450139|FG001|First Intervention|Adverse Event|1|||
144614658|NCT00874120|521450138|FG000|First Intervention|Withdrawal by Subject|2|||
144614659|NCT00874120|521450139|FG001|First Intervention|Withdrawal by Subject|0|||
144614660|NCT00874120|521450138|FG000|First Intervention|Lost to Follow-up|0|||
144614661|NCT00874120|521450139|FG001|First Intervention|Lost to Follow-up|1|||
144614662|NCT00874120|521450138|FG000|First Intervention|Protocol Violation|3|||
144614663|NCT00874120|521450139|FG001|First Intervention|Protocol Violation|0|||
144726881|NCT00048048|521854382|FG007|Extension Year 2|Early withdrawals|0|||
144726882|NCT00048048|521854383|FG008|Extension Year 2|Early withdrawals|0|||
144726883|NCT00048048|521854384|FG009|Extension Year 2|Early withdrawals|0|||
144726884|NCT00048048|521854385|FG010|Extension Year 2|Early withdrawals|4|||
144726885|NCT00048048|521854386|FG011|Extension Year 2|Early withdrawals|2|||
144726886|NCT02388763|521854389|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
144726887|NCT02388763|521854390|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
144726888|NCT02388763|521854389|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
144726889|NCT02388763|521854390|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
144726890|NCT05518487|521854391|FG000|Overall Study|Withdrawal by Subject|3|||
144726891|NCT02194998|521854394|FG000|On-HCV Treatment|Did not pick up study medication|0|||
144726892|NCT02194998|521854395|FG001|On-HCV Treatment|Did not pick up study medication|1|||
144726893|NCT02194998|521854396|FG002|On-HCV Treatment|Did not pick up study medication|0|||
144726894|NCT02194998|521854397|FG003|On-HCV Treatment|Did not pick up study medication|0|||
144726895|NCT02194998|521854394|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
144726896|NCT02194998|521854395|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
144726897|NCT02194998|521854396|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
144726898|NCT02194998|521854397|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
144258615|NCT00791700|520148577|FG003|Overall Study|Death|1|||
144258616|NCT00791700|520148574|FG000|Overall Study|Lost to Follow-up|4|||
144614664|NCT00874120|521450138|FG000|First Intervention|positive drug test|1|||
144614665|NCT00874120|521450139|FG001|First Intervention|positive drug test|0|||
144614666|NCT00874120|521450138|FG000|Second Intervention|Withdrawal by Subject|1|||
144614667|NCT00874120|521450139|FG001|Second Intervention|Withdrawal by Subject|0|||
144614668|NCT00874120|521450138|FG000|Second Intervention|Protocol Violation|1|||
144614669|NCT00874120|521450139|FG001|Second Intervention|Protocol Violation|0|||
144614670|NCT02135692|521450147|FG000|Overall Study|Adverse Event|3|||
144614671|NCT02135692|521450147|FG000|Overall Study|Lack of Efficacy|2|||
144614672|NCT02135692|521450147|FG000|Overall Study|Protocol Violation|2|||
144258617|NCT00791700|520148575|FG001|Overall Study|Lost to Follow-up|3|||
144258618|NCT00791700|520148576|FG002|Overall Study|Lost to Follow-up|4|||
144258619|NCT00791700|520148577|FG003|Overall Study|Lost to Follow-up|6|||
144258620|NCT00791700|520148574|FG000|Overall Study|Adverse Event|0|||
144258621|NCT00791700|520148575|FG001|Overall Study|Adverse Event|0|||
144258622|NCT00791700|520148576|FG002|Overall Study|Adverse Event|1|||
144258623|NCT00791700|520148577|FG003|Overall Study|Adverse Event|1|||
144258624|NCT01720524|520148580|FG000|Part A|Insufficient Clinical Response|2|||
144258625|NCT01720524|520148581|FG001|Part A|Insufficient Clinical Response|4|||
144258626|NCT01720524|520148580|FG000|Part A|Adverse Event|2|||
144258627|NCT01720524|520148581|FG001|Part A|Adverse Event|2|||
144258628|NCT01720524|520148580|FG000|Part A|Death|2|||
144258629|NCT01720524|520148581|FG001|Part A|Death|1|||
144258630|NCT01720524|520148580|FG000|Part A|Lost to Follow-up|0|||
144258631|NCT01720524|520148581|FG001|Part A|Lost to Follow-up|1|||
144258632|NCT01720524|520148580|FG000|Part A|Missed 28 day follow-up visit|1|||
144258633|NCT01720524|520148581|FG001|Part A|Missed 28 day follow-up visit|1|||
144258634|NCT01720524|520148580|FG000|Part A|Withdrawal by Subject|0|||
144258635|NCT01720524|520148581|FG001|Part A|Withdrawal by Subject|1|||
144258636|NCT01720524|520148580|FG000|Part A|Other|0|||
144258637|NCT01720524|520148581|FG001|Part A|Other|1|||
144258638|NCT01720524|520148580|FG000|Part A|Lost to Follow-up|0|||
144258639|NCT01720524|520148581|FG001|Part A|Lost to Follow-up|1|||
144258640|NCT01720524|520148580|FG000|Part B|No longer willing to participate in study|1|||
144258641|NCT01720524|520148581|FG001|Part B|No longer willing to participate in study|4|||
144258642|NCT01720524|520148580|FG000|Part B|Other|2|||
144258643|NCT01720524|520148581|FG001|Part B|Other|0|||
144258644|NCT01720524|520148580|FG000|Part B|Lost to Follow-up|2|||
144258645|NCT01720524|520148581|FG001|Part B|Lost to Follow-up|3|||
144258646|NCT01720524|520148580|FG000|Part B|Death|0|||
144258647|NCT01720524|520148581|FG001|Part B|Death|2|||
144258648|NCT00996034|520148582|FG000|Overall Study|Lost to Follow-up|2|||
144614673|NCT02135692|521450147|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
144614674|NCT02135692|521450147|FG000|Overall Study|Product commercially available|159|||
144726899|NCT04276883|521854400|FG000|Overall Study|Withdrawal by Subject|2|||
144726900|NCT04276883|521854401|FG001|Overall Study|Withdrawal by Subject|3|||
144726901|NCT04276883|521854402|FG002|Overall Study|Withdrawal by Subject|6|||
144726902|NCT04276883|521854400|FG000|Overall Study|Lost to Follow-up|1|||
144726903|NCT04276883|521854401|FG001|Overall Study|Lost to Follow-up|3|||
144258649|NCT00996034|520148582|FG000|Overall Study|withdrawn by PI|1|||
144537586|NCT03593226|521171004|FG002|Overall Study|Disease progression|5|||
144258650|NCT02105285|520148583|FG000|Overall Study|Adverse Event|1|||
144258651|NCT02105285|520148584|FG001|Overall Study|Adverse Event|1|||
144258652|NCT02105285|520148585|FG002|Overall Study|Adverse Event|0|||
144258653|NCT02105285|520148583|FG000|Overall Study|Protocol Violation|0|||
144258654|NCT02105285|520148584|FG001|Overall Study|Protocol Violation|1|||
144258655|NCT02105285|520148585|FG002|Overall Study|Protocol Violation|0|||
144258656|NCT02105285|520148583|FG000|Overall Study|Withdrawal by Subject|1|||
144258657|NCT02105285|520148584|FG001|Overall Study|Withdrawal by Subject|0|||
144258658|NCT02105285|520148585|FG002|Overall Study|Withdrawal by Subject|0|||
144258659|NCT02959918|520148586|FG000|Overall Study|Adverse Event|1|||
144258660|NCT02959918|520148587|FG001|Overall Study|Adverse Event|1|||
144258661|NCT02959918|520148588|FG002|Overall Study|Adverse Event|2|||
144258662|NCT02959918|520148589|FG003|Overall Study|Adverse Event|0|||
144258663|NCT02959918|520148590|FG004|Overall Study|Adverse Event|0|||
144258664|NCT02959918|520148591|FG005|Overall Study|Adverse Event|2|||
144258665|NCT02959918|520148592|FG006|Overall Study|Adverse Event|2|||
144258666|NCT02959918|520148593|FG007|Overall Study|Adverse Event|1|||
144258667|NCT02959918|520148594|FG008|Overall Study|Adverse Event|2|||
144258668|NCT02959918|520148595|FG009|Overall Study|Adverse Event|1|||
144258669|NCT02959918|520148596|FG010|Overall Study|Adverse Event|1|||
144258670|NCT02959918|520148597|FG011|Overall Study|Adverse Event|3|||
144258671|NCT02959918|520148598|FG012|Overall Study|Adverse Event|2|||
144258672|NCT02959918|520148599|FG013|Overall Study|Adverse Event|4|||
144258673|NCT02959918|520148586|FG000|Overall Study|Lost to Follow-up|0|||
144258674|NCT02959918|520148587|FG001|Overall Study|Lost to Follow-up|0|||
144258675|NCT02959918|520148588|FG002|Overall Study|Lost to Follow-up|0|||
144258676|NCT02959918|520148589|FG003|Overall Study|Lost to Follow-up|0|||
144258677|NCT02959918|520148590|FG004|Overall Study|Lost to Follow-up|0|||
144258678|NCT02959918|520148591|FG005|Overall Study|Lost to Follow-up|0|||
144258679|NCT02959918|520148592|FG006|Overall Study|Lost to Follow-up|0|||
144258680|NCT02959918|520148593|FG007|Overall Study|Lost to Follow-up|0|||
144258681|NCT02959918|520148594|FG008|Overall Study|Lost to Follow-up|0|||
144258682|NCT02959918|520148595|FG009|Overall Study|Lost to Follow-up|1|||
144258683|NCT02959918|520148596|FG010|Overall Study|Lost to Follow-up|0|||
144258684|NCT02959918|520148597|FG011|Overall Study|Lost to Follow-up|0|||
144258685|NCT02959918|520148598|FG012|Overall Study|Lost to Follow-up|1|||
144258686|NCT02959918|520148599|FG013|Overall Study|Lost to Follow-up|0|||
144258687|NCT02959918|520148586|FG000|Overall Study|Withdrawal by Subject|0|||
144258688|NCT02959918|520148587|FG001|Overall Study|Withdrawal by Subject|0|||
144258689|NCT02959918|520148588|FG002|Overall Study|Withdrawal by Subject|1|||
144258690|NCT02959918|520148589|FG003|Overall Study|Withdrawal by Subject|2|||
144258691|NCT02959918|520148590|FG004|Overall Study|Withdrawal by Subject|0|||
144258692|NCT02959918|520148591|FG005|Overall Study|Withdrawal by Subject|0|||
144258693|NCT02959918|520148592|FG006|Overall Study|Withdrawal by Subject|1|||
144258694|NCT02959918|520148593|FG007|Overall Study|Withdrawal by Subject|0|||
144258695|NCT02959918|520148594|FG008|Overall Study|Withdrawal by Subject|1|||
144258696|NCT02959918|520148595|FG009|Overall Study|Withdrawal by Subject|1|||
144258697|NCT02959918|520148596|FG010|Overall Study|Withdrawal by Subject|2|||
144258698|NCT02959918|520148597|FG011|Overall Study|Withdrawal by Subject|3|||
144537587|NCT03593226|521171005|FG003|Overall Study|Disease progression|6|||
144537588|NCT03593226|521171002|FG000|Overall Study|Adverse Event|0|||
144537589|NCT03593226|521171003|FG001|Overall Study|Adverse Event|1|||
144537590|NCT03593226|521171004|FG002|Overall Study|Adverse Event|0|||
144537591|NCT03593226|521171005|FG003|Overall Study|Adverse Event|0|||
144537592|NCT03593226|521171002|FG000|Overall Study|Withdrawal by Subject|0|||
144537593|NCT03593226|521171003|FG001|Overall Study|Withdrawal by Subject|4|||
144537594|NCT03593226|521171004|FG002|Overall Study|Withdrawal by Subject|1|||
144537595|NCT03593226|521171005|FG003|Overall Study|Withdrawal by Subject|0|||
144537596|NCT03593226|521171002|FG000|Overall Study|Physician Decision|0|||
144537597|NCT03593226|521171003|FG001|Overall Study|Physician Decision|1|||
144537598|NCT03593226|521171004|FG002|Overall Study|Physician Decision|0|||
144537599|NCT03593226|521171005|FG003|Overall Study|Physician Decision|0|||
144537600|NCT03593226|521171002|FG000|Overall Study|Clinical disease progression|0|||
144537601|NCT03593226|521171003|FG001|Overall Study|Clinical disease progression|0|||
144537602|NCT03593226|521171004|FG002|Overall Study|Clinical disease progression|1|||
144537603|NCT03593226|521171005|FG003|Overall Study|Clinical disease progression|0|||
144537604|NCT03777657|521171006|FG000|Overall Study|Death|397|||
144258699|NCT02959918|520148598|FG012|Overall Study|Withdrawal by Subject|1|||
144258700|NCT02959918|520148599|FG013|Overall Study|Withdrawal by Subject|1|||
144258701|NCT02959918|520148586|FG000|Overall Study|Protocol Violation|0|||
144258702|NCT02959918|520148587|FG001|Overall Study|Protocol Violation|0|||
144258703|NCT02959918|520148588|FG002|Overall Study|Protocol Violation|1|||
144258704|NCT02959918|520148589|FG003|Overall Study|Protocol Violation|0|||
144258705|NCT02959918|520148590|FG004|Overall Study|Protocol Violation|0|||
144258706|NCT02959918|520148591|FG005|Overall Study|Protocol Violation|1|||
144258707|NCT02959918|520148592|FG006|Overall Study|Protocol Violation|0|||
144537605|NCT03777657|521171007|FG001|Overall Study|Death|431|||
144198233|NCT01195103|519922976|FG002|Overall Study|Withdrawal by Subject|0|||
144537606|NCT03777657|521171006|FG000|Overall Study|Study Closed by Sponsor|77|||
144537607|NCT03777657|521171007|FG001|Overall Study|Study Closed by Sponsor|38|||
144537608|NCT03777657|521171006|FG000|Overall Study|Withdrawal by Subject|20|||
144537609|NCT03777657|521171007|FG001|Overall Study|Withdrawal by Subject|17|||
144537610|NCT03777657|521171006|FG000|Overall Study|Lost to Follow-up|6|||
144198234|NCT00974974|519922978|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
144537611|NCT03777657|521171007|FG001|Overall Study|Lost to Follow-up|10|||
144537612|NCT03789110|521171008|FG000|Overall Study|Adverse Event|2|||
144537613|NCT03789110|521171008|FG000|Overall Study|Physician Decision|1|||
144537614|NCT03789110|521171008|FG000|Overall Study|Withdrawal by Subject|2|||
144537615|NCT03789110|521171008|FG000|Overall Study|Lack of Efficacy|22|||
144537616|NCT03789110|521171008|FG000|Overall Study|still on treatment|3|||
144537617|NCT00545545|521171009|FG000|Overall Study|Progressive Neoplastic Disease|1|||
144537618|NCT00545545|521171010|FG001|Overall Study|Progressive Neoplastic Disease|5|||
144537619|NCT00545545|521171011|FG002|Overall Study|Progressive Neoplastic Disease|0|||
144537620|NCT00545545|521171012|FG003|Overall Study|Progressive Neoplastic Disease|4|||
144537621|NCT00545545|521171013|FG004|Overall Study|Progressive Neoplastic Disease|8|||
144537622|NCT00545545|521171014|FG005|Overall Study|Progressive Neoplastic Disease|7|||
144537623|NCT00545545|521171009|FG000|Overall Study|Withdrawal by Subject|0|||
144537624|NCT00545545|521171010|FG001|Overall Study|Withdrawal by Subject|1|||
144537625|NCT00545545|521171011|FG002|Overall Study|Withdrawal by Subject|0|||
144537626|NCT00545545|521171012|FG003|Overall Study|Withdrawal by Subject|0|||
144537627|NCT00545545|521171013|FG004|Overall Study|Withdrawal by Subject|0|||
144537628|NCT00545545|521171014|FG005|Overall Study|Withdrawal by Subject|0|||
144537629|NCT00545545|521171009|FG000|Overall Study|Physician Decision|1|||
144537630|NCT00545545|521171010|FG001|Overall Study|Physician Decision|0|||
144537631|NCT00545545|521171011|FG002|Overall Study|Physician Decision|0|||
144537632|NCT00545545|521171012|FG003|Overall Study|Physician Decision|0|||
144537633|NCT00545545|521171013|FG004|Overall Study|Physician Decision|0|||
144537634|NCT00545545|521171014|FG005|Overall Study|Physician Decision|1|||
144537635|NCT00545545|521171009|FG000|Overall Study|Irinotecan intolerance|1|||
144537636|NCT00545545|521171010|FG001|Overall Study|Irinotecan intolerance|1|||
144537637|NCT00545545|521171011|FG002|Overall Study|Irinotecan intolerance|0|||
144537638|NCT00545545|521171012|FG003|Overall Study|Irinotecan intolerance|0|||
144537639|NCT00545545|521171013|FG004|Overall Study|Irinotecan intolerance|0|||
144537640|NCT00545545|521171014|FG005|Overall Study|Irinotecan intolerance|0|||
144537641|NCT00545545|521171009|FG000|Overall Study|No target lesions to track post surgery|0|||
144537642|NCT00545545|521171010|FG001|Overall Study|No target lesions to track post surgery|0|||
144537643|NCT00545545|521171011|FG002|Overall Study|No target lesions to track post surgery|0|||
144537644|NCT00545545|521171012|FG003|Overall Study|No target lesions to track post surgery|0|||
144537645|NCT00545545|521171013|FG004|Overall Study|No target lesions to track post surgery|1|||
144537646|NCT00545545|521171014|FG005|Overall Study|No target lesions to track post surgery|1|||
144537647|NCT03691493|521171015|FG000|Overall Study|Withdrawal by Subject|1|||
144198235|NCT00974974|519922979|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
144198236|NCT00974974|519922978|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
144198237|NCT00974974|519922979|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
144198238|NCT00974974|519922978|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
144198239|NCT00974974|519922979|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
144198240|NCT00974974|519922978|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
144198241|NCT00974974|519922979|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
144198242|NCT00974974|519922978|FG000|IR CD-LD Dose Adjustment|Various|0|||
144198243|NCT00974974|519922979|FG001|IR CD-LD Dose Adjustment|Various|9|||
144198244|NCT00974974|519922978|FG000|IPX066 Dose Conversion|Adverse Event|23|||
144198245|NCT00974974|519922979|FG001|IPX066 Dose Conversion|Adverse Event|0|||
144198246|NCT00974974|519922978|FG000|IPX066 Dose Conversion|Death|2|||
144198247|NCT00974974|519922979|FG001|IPX066 Dose Conversion|Death|0|||
144198248|NCT00974974|519922978|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
144198249|NCT00974974|519922979|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
144198250|NCT00974974|519922978|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
144198251|NCT00974974|519922979|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
144198252|NCT00974974|519922978|FG000|IPX066 Dose Conversion|Various|3|||
144198253|NCT00974974|519922979|FG001|IPX066 Dose Conversion|Various|0|||
144258708|NCT02959918|520148593|FG007|Overall Study|Protocol Violation|0|||
144258709|NCT02959918|520148594|FG008|Overall Study|Protocol Violation|2|||
144258710|NCT02959918|520148595|FG009|Overall Study|Protocol Violation|1|||
144537648|NCT05464732|521171025|FG000|Overall Study|Lost to Follow-up|0|||
144537649|NCT05464732|521171026|FG001|Overall Study|Lost to Follow-up|1|||
144198254|NCT00974974|519922978|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
144198255|NCT00974974|519922979|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
144198256|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
144198257|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
144258711|NCT02959918|520148596|FG010|Overall Study|Protocol Violation|0|||
144537650|NCT05464732|521171025|FG000|Overall Study|Adverse Event|1|||
144537651|NCT05464732|521171026|FG001|Overall Study|Adverse Event|0|||
144198258|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
144198259|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
144198260|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
144198261|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
144198262|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
144198263|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
144198264|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
144198265|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
144198266|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
144198267|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
144198268|NCT00974974|519922978|FG000|Maintenance - Double Blind Treatment|Various|4|||
144198269|NCT00974974|519922979|FG001|Maintenance - Double Blind Treatment|Various|0|||
144198270|NCT01959035|519922980|FG000|Overall Study|Adverse Event|5|||
144198271|NCT01959035|519922980|FG000|Overall Study|Withdrawal by Subject|4|||
144198272|NCT01959035|519922980|FG000|Overall Study|Lost to Follow-up|1|||
144198273|NCT01959035|519922980|FG000|Overall Study|Other (no primary reason given)|1|||
144198274|NCT00450619|519922981|FG000|Overall Study|refused treatment after randomization|2|||
144198275|NCT00450619|519922982|FG001|Overall Study|refused treatment after randomization|0|||
144198276|NCT00450619|519922981|FG000|Overall Study|did not progress; refused further trmt|1|||
144198277|NCT00450619|519922982|FG001|Overall Study|did not progress; refused further trmt|1|||
144198278|NCT00450619|519922981|FG000|Overall Study|Adverse Event|1|||
144198279|NCT00450619|519922982|FG001|Overall Study|Adverse Event|0|||
144198280|NCT02034058|519922983|FG000|Overall Study|Death|3|||
144198281|NCT03254602|519922984|FG000|Overall Study|Lost to Follow-up|4|||
144198282|NCT01249365|519922987|FG000|Overall Study|Lost to Follow-up|1|||
144198283|NCT03551496|519922988|FG000|Overall Study|Death|11|||
144198284|NCT03551496|519922989|FG001|Overall Study|Death|7|||
144198285|NCT03551496|519922988|FG000|Overall Study|Withdrawal by Subject|4|||
144198286|NCT03551496|519922989|FG001|Overall Study|Withdrawal by Subject|3|||
144198287|NCT03551496|519922988|FG000|Overall Study|Other Reasons|1|||
144198288|NCT03551496|519922989|FG001|Overall Study|Other Reasons|0|||
144198289|NCT01524679|519922990|FG000|Overall Study|Lost to Follow-up|1|||
144198290|NCT01524679|519922991|FG001|Overall Study|Lost to Follow-up|4|||
144198291|NCT01524679|519922990|FG000|Overall Study|Withdrawal by Subject|4|||
144198292|NCT01524679|519922991|FG001|Overall Study|Withdrawal by Subject|4|||
144198293|NCT01524679|519922990|FG000|Overall Study|Adverse Event|9|||
144198294|NCT01524679|519922991|FG001|Overall Study|Adverse Event|0|||
144198295|NCT01524679|519922990|FG000|Overall Study|Protocol Violation|1|||
144198296|NCT01524679|519922991|FG001|Overall Study|Protocol Violation|0|||
144198297|NCT01524679|519922990|FG000|Overall Study|Lack of Efficacy|2|||
144198298|NCT01524679|519922991|FG001|Overall Study|Lack of Efficacy|0|||
144198299|NCT01524679|519922990|FG000|Overall Study|e.g.wish for children, relocation|6|||
144198300|NCT01524679|519922991|FG001|Overall Study|e.g.wish for children, relocation|1|||
144198301|NCT00801099|519922992|FG000|Overall Study|Lost to Follow-up|101|||
144198302|NCT03321630|519922995|FG000|Overall Study|Adverse Event|1|||
144198303|NCT03321630|519922995|FG000|Overall Study|Investigator Discretion|2|||
144198304|NCT03321630|519922995|FG000|Overall Study|Withdrawal by Subject|1|||
144198305|NCT00140426|519922996|FG000|Overall Study|Withdrawal by Subject|0|||
144198306|NCT00140426|519922997|FG001|Overall Study|Withdrawal by Subject|3|||
144198307|NCT00950963|519922998|FG000|Overall Study|Lost to Follow-up|29|||
144198308|NCT00950963|519922999|FG001|Overall Study|Lost to Follow-up|24|||
144198309|NCT01675661|519923000|FG000|Overall Study|Lost to Follow-up|22|||
144198310|NCT01675661|519923001|FG001|Overall Study|Lost to Follow-up|23|||
144198311|NCT01675661|519923000|FG000|Overall Study|Practical problems|9|||
144198312|NCT01675661|519923001|FG001|Overall Study|Practical problems|5|||
144198313|NCT01675661|519923000|FG000|Overall Study|Moved away|5|||
144198314|NCT01675661|519923001|FG001|Overall Study|Moved away|6|||
144198315|NCT01675661|519923000|FG000|Overall Study|Withdrawal by Subject|3|||
144198316|NCT01675661|519923001|FG001|Overall Study|Withdrawal by Subject|7|||
144198317|NCT01675661|519923000|FG000|Overall Study|Physician Decision|0|||
144198318|NCT01675661|519923001|FG001|Overall Study|Physician Decision|2|||
144198319|NCT01675661|519923000|FG000|Overall Study|Death|0|||
144198320|NCT01675661|519923001|FG001|Overall Study|Death|1|||
144198321|NCT01675661|519923000|FG000|Overall Study|Other reason|1|||
144198322|NCT01675661|519923001|FG001|Overall Study|Other reason|2|||
144198323|NCT04765384|519923002|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
144198324|NCT04765384|519923003|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
144198325|NCT04765384|519923004|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
144470854|NCT04857034|520923281|FG001|Active Treatment Period|request to discontinue|1|||
144470855|NCT04857034|520923282|FG002|Active Treatment Period|request to discontinue|0|||
144470856|NCT04857034|520923283|FG003|Active Treatment Period|request to discontinue|1|||
144470857|NCT04857034|520923284|FG004|Active Treatment Period|request to discontinue|0|||
144470858|NCT04857034|520923280|FG000|Active Treatment Period|administrative reason by sponsor|1|||
144470859|NCT04857034|520923281|FG001|Active Treatment Period|administrative reason by sponsor|5|||
144470860|NCT04857034|520923282|FG002|Active Treatment Period|administrative reason by sponsor|0|||
144198326|NCT04765384|519923005|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
144198327|NCT04765384|519923006|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
144198328|NCT04765384|519923007|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
144198329|NCT04765384|519923002|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
144198330|NCT04765384|519923003|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
144198331|NCT04765384|519923004|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
144198332|NCT04765384|519923005|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
144198333|NCT04765384|519923006|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
144198334|NCT04765384|519923007|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
144198335|NCT04765384|519923002|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
144198336|NCT04765384|519923003|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
144198337|NCT04765384|519923004|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
144198338|NCT04765384|519923005|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
144198339|NCT04765384|519923006|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
144198340|NCT04765384|519923007|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
144198341|NCT04765384|519923002|FG000|Post-natal: Neonates and Infants|Death|0|||
144198342|NCT04765384|519923003|FG001|Post-natal: Neonates and Infants|Death|0|||
144198343|NCT04765384|519923004|FG002|Post-natal: Neonates and Infants|Death|0|||
144198344|NCT04765384|519923005|FG003|Post-natal: Neonates and Infants|Death|1|||
144198345|NCT04765384|519923006|FG004|Post-natal: Neonates and Infants|Death|0|||
144198346|NCT04765384|519923007|FG005|Post-natal: Neonates and Infants|Death|0|||
144198347|NCT04765384|519923002|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
144198348|NCT04765384|519923003|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
144198349|NCT04765384|519923004|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
144198350|NCT04765384|519923005|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
144198351|NCT04765384|519923006|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
144198352|NCT04765384|519923007|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
144198353|NCT00987389|519923008|FG000|Overall Study|Ineligible|0|||
144198354|NCT00987389|519923009|FG001|Overall Study|Ineligible|3|||
144198355|NCT00987389|519923010|FG002|Overall Study|Ineligible|0|||
144198356|NCT00987389|519923011|FG003|Overall Study|Ineligible|0|||
144198357|NCT00987389|519923008|FG000|Overall Study|Lost to Follow-up|4|||
144198358|NCT00987389|519923009|FG001|Overall Study|Lost to Follow-up|1|||
144198359|NCT00987389|519923010|FG002|Overall Study|Lost to Follow-up|3|||
144198360|NCT00987389|519923011|FG003|Overall Study|Lost to Follow-up|1|||
144198361|NCT00987389|519923008|FG000|Overall Study|Withdrawal by Subject|4|||
144198362|NCT00987389|519923009|FG001|Overall Study|Withdrawal by Subject|3|||
144198363|NCT00987389|519923010|FG002|Overall Study|Withdrawal by Subject|2|||
144198364|NCT00987389|519923011|FG003|Overall Study|Withdrawal by Subject|1|||
144537652|NCT03959423|521171031|FG000|Overall Study|Withdrawal by Subject|2|||
144537653|NCT03959423|521171032|FG001|Overall Study|Withdrawal by Subject|3|||
144537654|NCT03959423|521171031|FG000|Overall Study|Physician Decision|0|||
144537655|NCT03959423|521171032|FG001|Overall Study|Physician Decision|1|||
144537656|NCT03959423|521171031|FG000|Overall Study|Lost to Follow-up|1|||
144537657|NCT03959423|521171032|FG001|Overall Study|Lost to Follow-up|0|||
144537658|NCT03959423|521171031|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
144537659|NCT03959423|521171032|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144537660|NCT05704725|521171033|FG000|Overall Study|Lost to Follow-up|0|||
144537661|NCT05704725|521171034|FG001|Overall Study|Lost to Follow-up|1|||
144537662|NCT05704725|521171033|FG000|Overall Study|Withdrawal by Subject|1|||
144537663|NCT05704725|521171034|FG001|Overall Study|Withdrawal by Subject|0|||
144537664|NCT00593840|521171035|FG000|Overall Study|Withdrawal by Subject|1|||
144537665|NCT00210106|521172226|FG000|Overall Study|Death|1|||
144537666|NCT00210106|521172226|FG000|Overall Study|Protocol Violation|13|||
144537667|NCT01184326|521172230|FG000|Overall Study|Adverse Event|1|||
144537668|NCT01184326|521172231|FG001|Overall Study|Adverse Event|2|||
144537669|NCT01184326|521172232|FG002|Overall Study|Adverse Event|0|||
144537670|NCT01184326|521172230|FG000|Overall Study|Death|0|||
144537671|NCT01184326|521172231|FG001|Overall Study|Death|0|||
144537672|NCT01184326|521172232|FG002|Overall Study|Death|1|||
144537673|NCT01184326|521172230|FG000|Overall Study|Withdrawal by Subject|0|||
144537674|NCT01184326|521172231|FG001|Overall Study|Withdrawal by Subject|0|||
144537675|NCT01184326|521172232|FG002|Overall Study|Withdrawal by Subject|1|||
144198365|NCT00987389|519923008|FG000|Overall Study|Withdrawn from Treatment|0|||
144198366|NCT00987389|519923009|FG001|Overall Study|Withdrawn from Treatment|1|||
144198367|NCT00987389|519923010|FG002|Overall Study|Withdrawn from Treatment|0|||
144198368|NCT00987389|519923011|FG003|Overall Study|Withdrawn from Treatment|0|||
144198369|NCT00987389|519923008|FG000|Overall Study|Multiple different reasons|1|||
144198370|NCT00987389|519923009|FG001|Overall Study|Multiple different reasons|0|||
144198371|NCT00987389|519923010|FG002|Overall Study|Multiple different reasons|3|||
144537676|NCT01184326|521172230|FG000|Overall Study|Physician Decision|1|||
144537677|NCT01184326|521172231|FG001|Overall Study|Physician Decision|1|||
144537678|NCT01184326|521172232|FG002|Overall Study|Physician Decision|0|||
144537679|NCT01184326|521172230|FG000|Overall Study|Disease Progression|1|||
144537680|NCT01184326|521172231|FG001|Overall Study|Disease Progression|3|||
144537681|NCT01184326|521172232|FG002|Overall Study|Disease Progression|12|||
144537682|NCT00945321|521172236|FG000|Period 1|Adverse Event|0|||
144537683|NCT00945321|521172237|FG001|Period 1|Adverse Event|0|||
144537684|NCT00945321|521172238|FG002|Period 1|Adverse Event|0|||
144537685|NCT00945321|521172239|FG003|Period 1|Adverse Event|0|||
144537686|NCT00945321|521172240|FG004|Period 1|Adverse Event|1|||
144537687|NCT00945321|521172241|FG005|Period 1|Adverse Event|0|||
144537688|NCT00945321|521172236|FG000|Period 4|Lost to Follow-up|0|||
144537689|NCT00945321|521172237|FG001|Period 4|Lost to Follow-up|0|||
144537690|NCT00945321|521172238|FG002|Period 4|Lost to Follow-up|0|||
144537691|NCT00945321|521172239|FG003|Period 4|Lost to Follow-up|0|||
144537692|NCT00945321|521172240|FG004|Period 4|Lost to Follow-up|0|||
144537693|NCT00945321|521172241|FG005|Period 4|Lost to Follow-up|1|||
144537694|NCT04017611|521172242|FG000|Overall Study|Withdrawn prior to completion|1|||
144537695|NCT00692913|521172243|FG000|Overall Study|Adverse Event|8|||
144537696|NCT00692913|521172244|FG001|Overall Study|Adverse Event|4|||
144537697|NCT00692913|521172243|FG000|Overall Study|Lost to Follow-up|3|||
144537698|NCT00692913|521172244|FG001|Overall Study|Lost to Follow-up|5|||
144537699|NCT00692913|521172243|FG000|Overall Study|Physician Decision|2|||
144537700|NCT00692913|521172244|FG001|Overall Study|Physician Decision|0|||
144537701|NCT00692913|521172243|FG000|Overall Study|Protocol Violation|1|||
144537702|NCT00692913|521172244|FG001|Overall Study|Protocol Violation|1|||
144537703|NCT00692913|521172243|FG000|Overall Study|Withdrawal by Subject|15|||
144537704|NCT00692913|521172244|FG001|Overall Study|Withdrawal by Subject|20|||
144537705|NCT02291913|521172253|FG000|Overall Study|Progressive Disease|32|||
144537706|NCT02291913|521172253|FG000|Overall Study|Adverse Event|11|||
144537707|NCT02291913|521172253|FG000|Overall Study|Death|2|||
144537708|NCT02291913|521172253|FG000|Overall Study|Physician Decision|1|||
144537709|NCT02291913|521172253|FG000|Overall Study|Withdrawal by Subject|1|||
144537710|NCT02291913|521172253|FG000|Overall Study|Protocol Violation|1|||
144537711|NCT01637402|521172254|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
144537712|NCT01637402|521172255|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
144537713|NCT01637402|521172254|FG000|Standard Dose Regimen|Adverse Event|1|||
144537714|NCT01637402|521172255|FG001|Standard Dose Regimen|Adverse Event|0|||
144537715|NCT01637402|521172254|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
144537716|NCT01637402|521172255|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
144537717|NCT01637402|521172254|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
144537718|NCT01637402|521172255|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
144537719|NCT01637402|521172254|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
144537720|NCT01637402|521172255|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
144537721|NCT01637402|521172254|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
144537722|NCT01637402|521172255|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
144537723|NCT04876417|521172258|FG000|Overall Study|Lost to Follow-up|5|||
144537724|NCT04876417|521172259|FG001|Overall Study|Lost to Follow-up|8|||
144537725|NCT04876417|521172260|FG002|Overall Study|Lost to Follow-up|0|||
144537726|NCT04876417|521172261|FG003|Overall Study|Lost to Follow-up|0|||
144537727|NCT01128595|521172266|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144537728|NCT01128595|521172267|FG001|Treatment Period 3|Withdrawal by Subject|1|||
144537729|NCT01128595|521172268|FG002|Treatment Period 3|Withdrawal by Subject|0|||
144537730|NCT01128595|521172269|FG003|Treatment Period 3|Withdrawal by Subject|0|||
144537731|NCT00605306|521172270|FG000|Overall Study|Adverse Event|0|||
144537732|NCT00605306|521172271|FG001|Overall Study|Adverse Event|1|||
144614675|NCT02135692|521450147|FG000|Overall Study|Study closed/terminated|153|||
144198372|NCT00987389|519923011|FG003|Overall Study|Multiple different reasons|1|||
144198373|NCT01006135|519923016|FG000|Overall Study|Adverse Event|22|||
144198374|NCT01006135|519923016|FG000|Overall Study|Protocol Violation|14|||
144198375|NCT01006135|519923016|FG000|Overall Study|Lost to Follow-up|32|||
144198376|NCT01006135|519923016|FG000|Overall Study|Other|72|||
144198377|NCT01732484|519923020|FG000|Overall Study|Death|7|||
144198378|NCT01732484|519923020|FG000|Overall Study|Lost to Follow-up|14|||
144198379|NCT01732484|519923020|FG000|Overall Study|chronical illness|5|||
144537733|NCT00724126|521172272|FG000|Overall Study|Adverse Event|2|||
144537734|NCT00724126|521172273|FG001|Overall Study|Adverse Event|0|||
144537735|NCT00724126|521172272|FG000|Overall Study|Withdrawal by Subject|8|||
144537736|NCT00724126|521172273|FG001|Overall Study|Withdrawal by Subject|6|||
144614676|NCT02135692|521450147|FG000|Overall Study|Lost to Follow-up|4|||
144537737|NCT00724126|521172272|FG000|Overall Study|Lost to Follow-up|6|||
144537738|NCT00724126|521172273|FG001|Overall Study|Lost to Follow-up|6|||
144537739|NCT00724126|521172272|FG000|Overall Study|Noncompliance|2|||
144537740|NCT00724126|521172273|FG001|Overall Study|Noncompliance|1|||
144537741|NCT00724126|521172272|FG000|Overall Study|Subject randomized although ineligible|1|||
144537742|NCT00724126|521172273|FG001|Overall Study|Subject randomized although ineligible|1|||
144537743|NCT00724126|521172272|FG000|Overall Study|Subject had to leave vicinity of site|0|||
144537744|NCT00724126|521172273|FG001|Overall Study|Subject had to leave vicinity of site|1|||
144198380|NCT01169532|519923024|FG000|Overall Study|Withdrawal by Subject|1|||
144198381|NCT02032706|519923032|FG000|Overall Study|Did not qualify|5|||
144537745|NCT00739934|521172274|FG000|Voriconazole IV|Adverse Event|6|||
144537746|NCT00739934|521172274|FG000|Voriconazole Oral|Other|3|||
144537747|NCT01212744|521172279|FG000|Overall Study|Withdrawal by Subject|1|||
144537748|NCT02167451|521172281|FG000|Overall Study|Withdrawal by Subject|1|||
144537749|NCT00571649|521172282|FG000|Treatment Period|Adverse Event|438|||
144537750|NCT00571649|521172283|FG001|Treatment Period|Adverse Event|385|||
144537751|NCT00571649|521172282|FG000|Treatment Period|Clinical endpoint reached|50|||
144537752|NCT00571649|521172283|FG001|Treatment Period|Clinical endpoint reached|56|||
144537753|NCT00571649|521172282|FG000|Treatment Period|Withdrawal by Subject|285|||
144537754|NCT00571649|521172283|FG001|Treatment Period|Withdrawal by Subject|255|||
144537755|NCT00571649|521172282|FG000|Treatment Period|Death|76|||
144537756|NCT00571649|521172283|FG001|Treatment Period|Death|59|||
144537757|NCT00571649|521172282|FG000|Treatment Period|Physician Decision|8|||
144537758|NCT00571649|521172283|FG001|Treatment Period|Physician Decision|9|||
144537759|NCT00571649|521172282|FG000|Treatment Period|Lost to Follow-up|43|||
144537760|NCT00571649|521172283|FG001|Treatment Period|Lost to Follow-up|41|||
144537761|NCT00571649|521172282|FG000|Treatment Period|Non-compliant with study medication|88|||
144537762|NCT00571649|521172283|FG001|Treatment Period|Non-compliant with study medication|89|||
144537763|NCT00571649|521172282|FG000|Treatment Period|Patient convenience|11|||
144537764|NCT00571649|521172283|FG001|Treatment Period|Patient convenience|13|||
144537765|NCT00571649|521172282|FG000|Treatment Period|Protocol Violation|90|||
144537766|NCT00571649|521172283|FG001|Treatment Period|Protocol Violation|92|||
144537767|NCT00571649|521172282|FG000|Treatment Period|Technical problems|3|||
144537768|NCT00571649|521172283|FG001|Treatment Period|Technical problems|5|||
144537769|NCT00571649|521172282|FG000|Follow-up Period|Adverse Event|46|||
144537770|NCT00571649|521172283|FG001|Follow-up Period|Adverse Event|40|||
144537771|NCT00571649|521172282|FG000|Follow-up Period|Clinical endpoint reached|5|||
144537772|NCT00571649|521172283|FG001|Follow-up Period|Clinical endpoint reached|2|||
144537773|NCT00571649|521172282|FG000|Follow-up Period|Withdrawal by Subject|119|||
144537774|NCT00571649|521172283|FG001|Follow-up Period|Withdrawal by Subject|115|||
144537775|NCT00571649|521172282|FG000|Follow-up Period|Death|132|||
144537776|NCT00571649|521172283|FG001|Follow-up Period|Death|133|||
144537777|NCT00571649|521172282|FG000|Follow-up Period|Physician Decision|7|||
144537778|NCT00571649|521172283|FG001|Follow-up Period|Physician Decision|13|||
144537779|NCT00571649|521172282|FG000|Follow-up Period|Lost to Follow-up|95|||
144537780|NCT00571649|521172283|FG001|Follow-up Period|Lost to Follow-up|92|||
144537781|NCT00571649|521172282|FG000|Follow-up Period|Patient convenience|136|||
144537782|NCT00571649|521172283|FG001|Follow-up Period|Patient convenience|121|||
144537783|NCT00571649|521172282|FG000|Follow-up Period|Protocol Violation|5|||
144537784|NCT00571649|521172283|FG001|Follow-up Period|Protocol Violation|12|||
144537785|NCT01218659|521172284|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
144537786|NCT01218659|521172285|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
144537787|NCT01218659|521172286|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
144537788|NCT01218659|521172284|FG000|18-Month Randomized Period|Did not receive study drug|0|||
144537789|NCT01218659|521172285|FG001|18-Month Randomized Period|Did not receive study drug|3|||
144537790|NCT01218659|521172286|FG002|18-Month Randomized Period|Did not receive study drug|0|||
144537791|NCT01218659|521172284|FG000|12-Month OLE|Withdrawal by Subject|0|||
144537792|NCT01218659|521172285|FG001|12-Month OLE|Withdrawal by Subject|0|||
144537793|NCT01218659|521172286|FG002|12-Month OLE|Withdrawal by Subject|2|||
144537794|NCT01218659|521172284|FG000|12-Month OLE|Physician Decision|0|||
144537795|NCT01218659|521172285|FG001|12-Month OLE|Physician Decision|0|||
144537796|NCT01218659|521172286|FG002|12-Month OLE|Physician Decision|1|||
144537797|NCT01218659|521172284|FG000|12-Month OLE|Lost to Follow-up|0|||
144537798|NCT01218659|521172285|FG001|12-Month OLE|Lost to Follow-up|0|||
144537799|NCT01218659|521172286|FG002|12-Month OLE|Lost to Follow-up|1|||
144537800|NCT01218659|521172284|FG000|12-Month OLE|Pregnancy|0|||
144537801|NCT01218659|521172285|FG001|12-Month OLE|Pregnancy|0|||
144537802|NCT01218659|521172286|FG002|12-Month OLE|Pregnancy|1|||
144537803|NCT01218659|521172284|FG000|12-Month OLE|Lack of Efficacy|0|||
144537804|NCT01218659|521172285|FG001|12-Month OLE|Lack of Efficacy|0|||
144537805|NCT01218659|521172286|FG002|12-Month OLE|Lack of Efficacy|1|||
144537806|NCT01218659|521172284|FG000|12-Month OLE|Declined to participate in the OLE|0|||
144537807|NCT01218659|521172285|FG001|12-Month OLE|Declined to participate in the OLE|0|||
144537808|NCT01218659|521172286|FG002|12-Month OLE|Declined to participate in the OLE|4|||
144258712|NCT02959918|520148597|FG011|Overall Study|Protocol Violation|1|||
144258713|NCT02959918|520148598|FG012|Overall Study|Protocol Violation|1|||
144537809|NCT03066609|521172293|FG000|INDUCTION|Pregnancy|0|||
144537810|NCT03066609|521172294|FG001|INDUCTION|Pregnancy|0|||
144537811|NCT03066609|521172295|FG002|INDUCTION|Pregnancy|1|||
144537812|NCT03066609|521172296|FG003|INDUCTION|Pregnancy|0|||
144537813|NCT03066609|521172293|FG000|INDUCTION|Lack of Efficacy|0|||
144537814|NCT03066609|521172294|FG001|INDUCTION|Lack of Efficacy|0|||
144537815|NCT03066609|521172295|FG002|INDUCTION|Lack of Efficacy|1|||
144537816|NCT03066609|521172296|FG003|INDUCTION|Lack of Efficacy|0|||
144537817|NCT03066609|521172293|FG000|INDUCTION|Adverse Event|2|||
144537818|NCT03066609|521172294|FG001|INDUCTION|Adverse Event|2|||
144537819|NCT03066609|521172295|FG002|INDUCTION|Adverse Event|0|||
144537820|NCT03066609|521172296|FG003|INDUCTION|Adverse Event|0|||
144537821|NCT03066609|521172293|FG000|MAINTENANCE|Adverse Event|0|||
144614677|NCT02135692|521450147|FG000|Overall Study|Withdrawal by Subject|15|||
144614678|NCT01611974|521450150|FG000|Overall Study|Death|10|||
144614679|NCT01611974|521450151|FG001|Overall Study|Death|12|||
144614680|NCT01611974|521450152|FG002|Overall Study|Death|10|||
144614681|NCT01611974|521450150|FG000|Overall Study|Lost to Follow-up|0|||
144614682|NCT01611974|521450151|FG001|Overall Study|Lost to Follow-up|1|||
144614683|NCT01611974|521450152|FG002|Overall Study|Lost to Follow-up|0|||
144614684|NCT01611974|521450150|FG000|Overall Study|Physician Decision|5|||
144614685|NCT01611974|521450151|FG001|Overall Study|Physician Decision|1|||
144614686|NCT01611974|521450152|FG002|Overall Study|Physician Decision|2|||
144614687|NCT01611974|521450150|FG000|Overall Study|Withdrawal by Subject|0|||
144614688|NCT01611974|521450151|FG001|Overall Study|Withdrawal by Subject|1|||
144614689|NCT01611974|521450152|FG002|Overall Study|Withdrawal by Subject|4|||
144614690|NCT01097746|521450153|FG000|Overall Study|Adverse Event|4|||
144614691|NCT01097746|521450153|FG000|Overall Study|taken off study before any treatment given|1|||
144198382|NCT02032706|519923032|FG000|Overall Study|Protocol Violation|1|||
144198383|NCT00928707|519923033|FG000|Overall Study|Protocol Violation|1|||
144198384|NCT00928707|519923034|FG001|Overall Study|Protocol Violation|0|||
144198385|NCT00132028|519923035|FG000|Overall Study|Adverse Event|7|||
144198386|NCT00132028|519923035|FG000|Overall Study|Death|2|||
144198387|NCT00132028|519923035|FG000|Overall Study|Lack of Efficacy|11|||
144470861|NCT04857034|520923283|FG003|Active Treatment Period|administrative reason by sponsor|2|||
144470862|NCT04857034|520923284|FG004|Active Treatment Period|administrative reason by sponsor|2|||
144470863|NCT04857034|520923280|FG000|Active Treatment Period|other reasons|1|||
144470864|NCT04857034|520923281|FG001|Active Treatment Period|other reasons|1|||
144470865|NCT04857034|520923282|FG002|Active Treatment Period|other reasons|0|||
144470866|NCT04857034|520923283|FG003|Active Treatment Period|other reasons|0|||
144470867|NCT04857034|520923284|FG004|Active Treatment Period|other reasons|1|||
144470868|NCT04857034|520923280|FG000|Active Treatment Period|Ongoing Study Period|2|||
144470869|NCT04857034|520923281|FG001|Active Treatment Period|Ongoing Study Period|4|||
144470870|NCT04857034|520923282|FG002|Active Treatment Period|Ongoing Study Period|0|||
144470871|NCT04857034|520923283|FG003|Active Treatment Period|Ongoing Study Period|1|||
144470872|NCT04857034|520923284|FG004|Active Treatment Period|Ongoing Study Period|0|||
144470873|NCT00387894|520923285|FG000|Overall Study|Withdrawal by Subject|1|||
144470874|NCT00659490|520923286|FG000|Overall Study|Lost to Follow-up|2|||
144470875|NCT00659490|520923287|FG001|Overall Study|Lost to Follow-up|0|||
144470876|NCT00659490|520923288|FG002|Overall Study|Lost to Follow-up|1|||
144470877|NCT00827541|520923289|FG000|Overall Study|Exitus|1|||
144470878|NCT00827541|520923290|FG001|Overall Study|Exitus|8|||
144470879|NCT00827541|520923289|FG000|Overall Study|Other|1|||
144470880|NCT00827541|520923290|FG001|Overall Study|Other|3|||
144470881|NCT00827541|520923289|FG000|Overall Study|Pathogen not susceptible|1|||
144470882|NCT00827541|520923290|FG001|Overall Study|Pathogen not susceptible|0|||
144470883|NCT00827541|520923289|FG000|Overall Study|Lack of effectiveness|1|||
144470884|NCT00827541|520923290|FG001|Overall Study|Lack of effectiveness|0|||
144470885|NCT01649232|520923291|FG000|Overall Study|Physician Decision|2|||
144470886|NCT01649232|520923292|FG001|Overall Study|Physician Decision|0|||
144470887|NCT02421666|520923293|FG000|6-month Follow-up|Lost to Follow-up|8|||
144470888|NCT02421666|520923294|FG001|6-month Follow-up|Lost to Follow-up|7|||
144470889|NCT02421666|520923293|FG000|6-month Follow-up|Withdrawal by Subject|5|||
144470890|NCT02421666|520923294|FG001|6-month Follow-up|Withdrawal by Subject|6|||
144470891|NCT02421666|520923293|FG000|12-month Follow-up|Lost to Follow-up|5|||
144470892|NCT02421666|520923294|FG001|12-month Follow-up|Lost to Follow-up|5|||
144470893|NCT02421666|520923293|FG000|12-month Follow-up|Withdrawal by Subject|6|||
144470894|NCT02421666|520923294|FG001|12-month Follow-up|Withdrawal by Subject|11|||
144470895|NCT00106184|520923296|FG000|Overall Study|Withdrawal by Subject|3|||
144470896|NCT00106184|520923297|FG001|Overall Study|Withdrawal by Subject|2|||
144470897|NCT02133872|520923298|FG000|Overall Study|Withdrawal by Subject|5|||
144470898|NCT02133872|520923299|FG001|Overall Study|Withdrawal by Subject|3|||
144470899|NCT02133872|520923300|FG002|Overall Study|Withdrawal by Subject|0|||
144470900|NCT02923739|520923301|FG000|Overall Study|Withdrawal by Subject|2|||
144470901|NCT02923739|520923302|FG001|Overall Study|Withdrawal by Subject|0|||
144198388|NCT00132028|519923035|FG000|Overall Study|Withdrawal by Subject|2|||
144198389|NCT00132028|519923035|FG000|Overall Study|not eligible|2|||
144198390|NCT00132028|519923035|FG000|Overall Study|Physician Decision|3|||
144470902|NCT02923739|520923303|FG002|Overall Study|Withdrawal by Subject|0|||
144470903|NCT02923739|520923304|FG003|Overall Study|Withdrawal by Subject|0|||
144470904|NCT02923739|520923301|FG000|Overall Study|Failed Screening|3|||
144470905|NCT02923739|520923302|FG001|Overall Study|Failed Screening|0|||
144470906|NCT02923739|520923303|FG002|Overall Study|Failed Screening|0|||
144470907|NCT02923739|520923304|FG003|Overall Study|Failed Screening|0|||
144614692|NCT00522431|521450154|FG000|Overall Study|Adverse Event|5|||
144614693|NCT00522431|521450154|FG000|Overall Study|Protocol Violation|2|||
144614694|NCT00522431|521450154|FG000|Overall Study|Withdrawal by Subject|2|||
144614695|NCT00522431|521450154|FG000|Overall Study|Subject non-compliance|1|||
144614696|NCT00522431|521450154|FG000|Overall Study|Other/unknown|1|||
144198391|NCT02140411|519923036|FG000|Overall Study|Adverse Event|1|||
144198392|NCT05070546|519923043|FG000|Overall Study|Death|0|||
144470908|NCT00118716|520923312|FG000|Overall Study|Adverse Event|2|||
144470909|NCT00118716|520923313|FG001|Overall Study|Adverse Event|7|||
144470910|NCT00118716|520923312|FG000|Overall Study|Protocol Violation|5|||
144470911|NCT00118716|520923313|FG001|Overall Study|Protocol Violation|4|||
144470912|NCT00118716|520923312|FG000|Overall Study|Withdrawal by Subject|0|||
144470913|NCT00118716|520923313|FG001|Overall Study|Withdrawal by Subject|1|||
144470914|NCT00118716|520923312|FG000|Overall Study|Exacerbation|2|||
144470915|NCT00118716|520923313|FG001|Overall Study|Exacerbation|2|||
144470916|NCT00118716|520923312|FG000|Overall Study|Discontinued by sponsor|1|||
144470917|NCT00118716|520923313|FG001|Overall Study|Discontinued by sponsor|1|||
144470918|NCT00118716|520923312|FG000|Overall Study|Non-compliance|1|||
144470919|NCT00118716|520923313|FG001|Overall Study|Non-compliance|3|||
144470920|NCT00118716|520923312|FG000|Overall Study|misrandomized|1|||
144470921|NCT00118716|520923313|FG001|Overall Study|misrandomized|1|||
144470922|NCT00118716|520923312|FG000|Overall Study|Expired drug use|1|||
144470923|NCT00118716|520923313|FG001|Overall Study|Expired drug use|2|||
144470924|NCT00118716|520923312|FG000|Overall Study|Investigator discretion|0|||
144470925|NCT00118716|520923313|FG001|Overall Study|Investigator discretion|1|||
144470926|NCT00855062|520923314|FG000|Step1|Early Study Closure|5|||
144470927|NCT00855062|520923315|FG001|Step1|Early Study Closure|7|||
144470928|NCT00855062|520923314|FG000|Step1|Adverse Event|1|||
144470929|NCT00855062|520923315|FG001|Step1|Adverse Event|1|||
144470930|NCT00855062|520923314|FG000|Step1|Protocol Violation|1|||
144470931|NCT00855062|520923315|FG001|Step1|Protocol Violation|0|||
144470932|NCT00855062|520923314|FG000|Step1|Pregnancy|1|||
144470933|NCT00855062|520923315|FG001|Step1|Pregnancy|0|||
144470934|NCT00855062|520923314|FG000|Step1|Withdrawal by Subject|2|||
144470935|NCT00855062|520923315|FG001|Step1|Withdrawal by Subject|3|||
144470936|NCT00855062|520923314|FG000|Step2|Early Study Closure|6|||
144470937|NCT00855062|520923315|FG001|Step2|Early Study Closure|2|||
144470938|NCT00855062|520923314|FG000|Step2|Adverse Event|0|||
144470939|NCT00855062|520923315|FG001|Step2|Adverse Event|3|||
144470940|NCT00855062|520923314|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
144470941|NCT00855062|520923315|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
144470942|NCT01376323|520923316|FG000|Overall Study|Adverse Event|1|||
144470943|NCT01376323|520923317|FG001|Overall Study|Adverse Event|0|||
144470944|NCT01376323|520923318|FG002|Overall Study|Adverse Event|0|||
144470945|NCT01376323|520923319|FG003|Overall Study|Adverse Event|2|||
144470946|NCT01376323|520923320|FG004|Overall Study|Adverse Event|0|||
144470947|NCT01376323|520923316|FG000|Overall Study|Lost to Follow-up|0|||
144470948|NCT01376323|520923317|FG001|Overall Study|Lost to Follow-up|0|||
144470949|NCT01376323|520923318|FG002|Overall Study|Lost to Follow-up|0|||
144470950|NCT01376323|520923319|FG003|Overall Study|Lost to Follow-up|2|||
144470951|NCT01376323|520923320|FG004|Overall Study|Lost to Follow-up|0|||
144470952|NCT01376323|520923316|FG000|Overall Study|Physician Decision|1|||
144470953|NCT01376323|520923317|FG001|Overall Study|Physician Decision|0|||
144470954|NCT01376323|520923318|FG002|Overall Study|Physician Decision|2|||
144470955|NCT01376323|520923319|FG003|Overall Study|Physician Decision|1|||
144470956|NCT01376323|520923320|FG004|Overall Study|Physician Decision|1|||
144470957|NCT01376323|520923316|FG000|Overall Study|Withdrawal by Subject|0|||
144470958|NCT01376323|520923317|FG001|Overall Study|Withdrawal by Subject|1|||
144470959|NCT01376323|520923318|FG002|Overall Study|Withdrawal by Subject|1|||
144470960|NCT01376323|520923319|FG003|Overall Study|Withdrawal by Subject|0|||
144470961|NCT01376323|520923320|FG004|Overall Study|Withdrawal by Subject|0|||
144470962|NCT02436811|520923321|FG000|Overall Study|Lost to Follow-up|2|||
144470963|NCT02436811|520923322|FG001|Overall Study|Lost to Follow-up|9|||
144470964|NCT02436811|520923323|FG002|Overall Study|Lost to Follow-up|7|||
144470965|NCT03595332|520923324|FG000|Overall Study|Lost to Follow-up|16|||
144470966|NCT03595332|520923325|FG001|Overall Study|Lost to Follow-up|22|||
144470967|NCT03595332|520923324|FG000|Overall Study|Unable to retrieve ID from school|0|||
144470968|NCT03595332|520923325|FG001|Overall Study|Unable to retrieve ID from school|2|||
144470969|NCT02227875|520923326|FG000|Overall Study|Protocol Violation|10|||
144470970|NCT02227875|520923327|FG001|Overall Study|Protocol Violation|7|||
144470971|NCT02227875|520923326|FG000|Overall Study|Other|1|||
144470972|NCT02227875|520923327|FG001|Overall Study|Other|3|||
144470973|NCT02227875|520923326|FG000|Overall Study|Physician Decision|1|||
144470974|NCT02227875|520923327|FG001|Overall Study|Physician Decision|0|||
144470975|NCT02227875|520923326|FG000|Overall Study|Adverse Event|3|||
144470976|NCT02227875|520923327|FG001|Overall Study|Adverse Event|0|||
144470977|NCT02227875|520923326|FG000|Overall Study|Withdrawal by Subject|12|||
144470978|NCT02227875|520923327|FG001|Overall Study|Withdrawal by Subject|13|||
144470979|NCT02227875|520923326|FG000|Overall Study|Lost to Follow-up|10|||
144470980|NCT02227875|520923327|FG001|Overall Study|Lost to Follow-up|10|||
144470981|NCT04209725|520923328|FG000|Overall Study|Adverse Event|1|||
144470982|NCT02657317|520923331|FG000|Overall Study|Withdrawal by Subject|2|||
144470983|NCT02657317|520923332|FG001|Overall Study|Withdrawal by Subject|0|||
144470984|NCT02657317|520923331|FG000|Overall Study|Lost to Follow-up|3|||
144470985|NCT02657317|520923332|FG001|Overall Study|Lost to Follow-up|3|||
144470986|NCT01089374|520923333|FG000|Overall Study|Lost to Follow-up|3|||
144470987|NCT01089374|520923334|FG001|Overall Study|Lost to Follow-up|0|||
144470988|NCT01089374|520923333|FG000|Overall Study|Withdrawal by Subject|1|||
144537822|NCT03066609|521172294|FG001|MAINTENANCE|Adverse Event|0|||
144537823|NCT03066609|521172295|FG002|MAINTENANCE|Adverse Event|0|||
144198393|NCT05070546|519923044|FG001|Overall Study|Death|0|||
144198394|NCT05070546|519923045|FG002|Overall Study|Death|0|||
144198395|NCT05070546|519923046|FG003|Overall Study|Death|0|||
144198396|NCT05070546|519923047|FG004|Overall Study|Death|0|||
144198397|NCT05070546|519923048|FG005|Overall Study|Death|1|||
144198398|NCT05070546|519923043|FG000|Overall Study|Lost to Follow-up|8|||
144537824|NCT03066609|521172296|FG003|MAINTENANCE|Adverse Event|1|||
144537825|NCT03066609|521172293|FG000|MAINTENANCE|Withdrawal by Subject|4|||
144537826|NCT03066609|521172294|FG001|MAINTENANCE|Withdrawal by Subject|2|||
144537827|NCT03066609|521172295|FG002|MAINTENANCE|Withdrawal by Subject|1|||
144537828|NCT03066609|521172296|FG003|MAINTENANCE|Withdrawal by Subject|1|||
144537829|NCT03066609|521172293|FG000|MAINTENANCE|Lost to Follow-up|0|||
144537830|NCT03066609|521172294|FG001|MAINTENANCE|Lost to Follow-up|1|||
144537831|NCT03066609|521172295|FG002|MAINTENANCE|Lost to Follow-up|1|||
144537832|NCT03066609|521172296|FG003|MAINTENANCE|Lost to Follow-up|0|||
144537833|NCT03066609|521172293|FG000|MAINTENANCE|Pregnancy|1|||
144537834|NCT03066609|521172294|FG001|MAINTENANCE|Pregnancy|0|||
144537835|NCT03066609|521172295|FG002|MAINTENANCE|Pregnancy|0|||
144537836|NCT03066609|521172296|FG003|MAINTENANCE|Pregnancy|0|||
144537837|NCT03066609|521172293|FG000|MAINTENANCE|Lack of Efficacy|2|||
144537838|NCT03066609|521172294|FG001|MAINTENANCE|Lack of Efficacy|1|||
144537839|NCT03066609|521172295|FG002|MAINTENANCE|Lack of Efficacy|0|||
144537840|NCT03066609|521172296|FG003|MAINTENANCE|Lack of Efficacy|1|||
144537841|NCT03066609|521172293|FG000|OVERALL STUDY|Adverse Event|2|||
144537842|NCT03066609|521172294|FG001|OVERALL STUDY|Adverse Event|2|||
144537843|NCT03066609|521172295|FG002|OVERALL STUDY|Adverse Event|0|||
144537844|NCT03066609|521172296|FG003|OVERALL STUDY|Adverse Event|1|||
144537845|NCT03066609|521172293|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
144537846|NCT03066609|521172294|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
144537847|NCT03066609|521172295|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
144537848|NCT03066609|521172296|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
144537849|NCT03066609|521172293|FG000|OVERALL STUDY|Lost to Follow-up|1|||
144537850|NCT03066609|521172294|FG001|OVERALL STUDY|Lost to Follow-up|1|||
144537851|NCT03066609|521172295|FG002|OVERALL STUDY|Lost to Follow-up|1|||
144537852|NCT03066609|521172296|FG003|OVERALL STUDY|Lost to Follow-up|1|||
144537853|NCT03066609|521172293|FG000|OVERALL STUDY|Pregnancy|1|||
144537854|NCT03066609|521172294|FG001|OVERALL STUDY|Pregnancy|0|||
144614697|NCT00772954|521450155|FG000|Overall Study|Adverse Event|0|||
144614698|NCT00772954|521450156|FG001|Overall Study|Adverse Event|0|||
144614699|NCT00772954|521450157|FG002|Overall Study|Adverse Event|1|||
144614700|NCT02495844|521450161|FG000|Overall Study|Lack of Efficacy|1|||
144614701|NCT02495844|521450162|FG001|Overall Study|Lack of Efficacy|2|||
144614702|NCT02495844|521450161|FG000|Overall Study|AE, non-fatal|0|||
144614703|NCT02495844|521450162|FG001|Overall Study|AE, non-fatal|1|||
144614704|NCT02495844|521450161|FG000|Overall Study|Hepatitis Positivity|0|||
144198399|NCT05070546|519923044|FG001|Overall Study|Lost to Follow-up|2|||
144198400|NCT05070546|519923045|FG002|Overall Study|Lost to Follow-up|7|||
144198401|NCT05070546|519923046|FG003|Overall Study|Lost to Follow-up|1|||
144198402|NCT05070546|519923047|FG004|Overall Study|Lost to Follow-up|2|||
144198403|NCT05070546|519923048|FG005|Overall Study|Lost to Follow-up|0|||
144198404|NCT05070546|519923043|FG000|Overall Study|Withdrawal by Subject|1|||
144537855|NCT03066609|521172295|FG002|OVERALL STUDY|Pregnancy|1|||
144537856|NCT03066609|521172296|FG003|OVERALL STUDY|Pregnancy|0|||
144537857|NCT03066609|521172293|FG000|OVERALL STUDY|Lack of Efficacy|2|||
144537858|NCT03066609|521172294|FG001|OVERALL STUDY|Lack of Efficacy|1|||
144537859|NCT03066609|521172295|FG002|OVERALL STUDY|Lack of Efficacy|1|||
144537860|NCT03066609|521172296|FG003|OVERALL STUDY|Lack of Efficacy|1|||
144537861|NCT03066609|521172293|FG000|OVERALL STUDY|discontinued follow up|0|||
144537862|NCT03066609|521172294|FG001|OVERALL STUDY|discontinued follow up|2|||
144537863|NCT03066609|521172295|FG002|OVERALL STUDY|discontinued follow up|0|||
144537864|NCT03066609|521172296|FG003|OVERALL STUDY|discontinued follow up|0|||
144537865|NCT03355573|521172297|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
144614705|NCT02495844|521450162|FG001|Overall Study|Hepatitis Positivity|1|||
144614706|NCT00789529|521450165|FG000|Overall Study|Withdrawal by Subject|0|||
144537866|NCT03355573|521172297|FG000|Overall Study|Sponsor's decision|1|||
144537867|NCT03355573|521172297|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
144537868|NCT03355573|521172297|FG000|Overall Study|PI's decision|2|||
144614707|NCT00789529|521450166|FG001|Overall Study|Withdrawal by Subject|1|||
144614708|NCT00789529|521450165|FG000|Overall Study|Other Reason|1|||
144198405|NCT05070546|519923044|FG001|Overall Study|Withdrawal by Subject|1|||
144198406|NCT05070546|519923045|FG002|Overall Study|Withdrawal by Subject|3|||
144198407|NCT05070546|519923046|FG003|Overall Study|Withdrawal by Subject|0|||
144198408|NCT05070546|519923047|FG004|Overall Study|Withdrawal by Subject|0|||
144258714|NCT02959918|520148599|FG013|Overall Study|Protocol Violation|0|||
144537869|NCT03355573|521172297|FG000|Overall Study|Withdrawal by Subject|23|||
144537870|NCT03355573|521172297|FG000|Overall Study|Lost to Follow-up|4|||
144537871|NCT03355573|521172297|FG000|Overall Study|Lack of Efficacy|2|||
144537872|NCT03355573|521172297|FG000|Overall Study|Adverse Event, non-fatal|17|||
144726904|NCT04276883|521854402|FG002|Overall Study|Lost to Follow-up|0|||
144726905|NCT04276883|521854400|FG000|Overall Study|Adverse Event|0|||
144726906|NCT04276883|521854401|FG001|Overall Study|Adverse Event|1|||
144726907|NCT04276883|521854402|FG002|Overall Study|Adverse Event|0|||
144726908|NCT04276883|521854400|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
144726909|NCT04276883|521854401|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
144726910|NCT04276883|521854402|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
144726911|NCT00320112|521854403|FG000|Overall Study|Lost to Follow-up|3|||
144726912|NCT00320112|521854404|FG001|Overall Study|Lost to Follow-up|4|||
144726913|NCT00320112|521854403|FG000|Overall Study|Withdrawal by Subject|3|||
144726914|NCT00320112|521854404|FG001|Overall Study|Withdrawal by Subject|0|||
144726915|NCT00320112|521854403|FG000|Overall Study|Death|2|||
144726916|NCT00320112|521854404|FG001|Overall Study|Death|1|||
144726917|NCT01199861|521854405|FG000|Overall Study|Administrative problems|1|||
144726918|NCT01199861|521854406|FG001|Overall Study|Administrative problems|0|||
144726919|NCT01199861|521854405|FG000|Overall Study|Adverse Event|1|||
144726920|NCT01199861|521854406|FG001|Overall Study|Adverse Event|0|||
144726921|NCT04981912|521854407|FG000|Overall Study|Physician Decision|2|||
144726922|NCT00661505|521854408|FG000|Overall Study|Adverse Event|3|||
144726923|NCT00661505|521854408|FG000|Overall Study|Protocol Violation|14|||
144726924|NCT00661505|521854408|FG000|Overall Study|Withdrawal by Subject|8|||
144726925|NCT00661505|521854408|FG000|Overall Study|Lost to Follow-up|3|||
144726926|NCT00661505|521854408|FG000|Overall Study|Other|2|||
144726927|NCT04534283|521854409|FG000|Overall Study|Physician Decision|2|||
144726928|NCT04534283|521854409|FG000|Overall Study|Withdrawal by Subject|1|||
144726929|NCT04534283|521854409|FG000|Overall Study|Disease Progression|12|||
144726930|NCT04534283|521854409|FG000|Overall Study|Adverse Event|1|||
144726931|NCT05630547|521854410|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
144726932|NCT05630547|521854411|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
144726933|NCT05630547|521854412|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
144726934|NCT05630547|521854413|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
144726935|NCT05630547|521854410|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
144726936|NCT05630547|521854411|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
144726937|NCT05630547|521854412|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
144726938|NCT05630547|521854413|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
144726939|NCT05630547|521854410|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
144726940|NCT05630547|521854411|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
144726941|NCT05630547|521854412|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
144726942|NCT05630547|521854413|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
144726943|NCT05630547|521854410|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
144726944|NCT05630547|521854411|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
144726945|NCT05630547|521854412|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
144726946|NCT05630547|521854413|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
144726947|NCT05630547|521854410|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
144258715|NCT02959918|520148586|FG000|Overall Study|Stopping Rule Met|1|||
144470989|NCT01089374|520923334|FG001|Overall Study|Withdrawal by Subject|0|||
144470990|NCT01089374|520923333|FG000|Overall Study|Study closed early - low accrual|6|||
144470991|NCT01089374|520923334|FG001|Overall Study|Study closed early - low accrual|0|||
144470992|NCT03494166|520923335|FG000|Overall Study|Death|0|||
144470993|NCT03494166|520923336|FG001|Overall Study|Death|0|||
144470994|NCT03494166|520923337|FG002|Overall Study|Death|0|||
144470995|NCT03494166|520923338|FG003|Overall Study|Death|1|||
144470996|NCT03494166|520923339|FG004|Overall Study|Death|3|||
144470997|NCT03494166|520923340|FG005|Overall Study|Death|0|||
144470998|NCT03494166|520923335|FG000|Overall Study|Lost to Follow-up|2|||
144470999|NCT03494166|520923336|FG001|Overall Study|Lost to Follow-up|2|||
144471000|NCT03494166|520923337|FG002|Overall Study|Lost to Follow-up|2|||
144471001|NCT03494166|520923338|FG003|Overall Study|Lost to Follow-up|2|||
144471002|NCT03494166|520923339|FG004|Overall Study|Lost to Follow-up|14|||
144471003|NCT03494166|520923340|FG005|Overall Study|Lost to Follow-up|0|||
144471004|NCT03494166|520923335|FG000|Overall Study|Withdrawal by Subject|10|||
144471005|NCT03494166|520923336|FG001|Overall Study|Withdrawal by Subject|7|||
144471006|NCT03494166|520923337|FG002|Overall Study|Withdrawal by Subject|0|||
144471007|NCT03494166|520923338|FG003|Overall Study|Withdrawal by Subject|5|||
144471008|NCT03494166|520923339|FG004|Overall Study|Withdrawal by Subject|3|||
144471009|NCT03494166|520923340|FG005|Overall Study|Withdrawal by Subject|17|||
144471010|NCT03494166|520923335|FG000|Overall Study|Screen failure|1|||
144471011|NCT03494166|520923336|FG001|Overall Study|Screen failure|0|||
144471012|NCT03494166|520923337|FG002|Overall Study|Screen failure|0|||
144471013|NCT03494166|520923338|FG003|Overall Study|Screen failure|0|||
144471014|NCT03494166|520923339|FG004|Overall Study|Screen failure|1|||
144471015|NCT03494166|520923340|FG005|Overall Study|Screen failure|0|||
144471016|NCT02857426|520923341|FG000|Overall Study|Disease progression|34|||
144726948|NCT05630547|521854411|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
144726949|NCT05630547|521854412|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
144537873|NCT03355573|521172297|FG000|Overall Study|Adverse Event, serious fatal|2|||
144537874|NCT01566890|521172298|FG000|Overall Study|Adverse Event|1|||
144537875|NCT01566890|521172299|FG001|Overall Study|Adverse Event|0|||
144537876|NCT01566890|521172300|FG002|Overall Study|Adverse Event|0|||
144537877|NCT01566890|521172301|FG003|Overall Study|Adverse Event|0|||
144537878|NCT01566890|521172302|FG004|Overall Study|Adverse Event|0|||
144537879|NCT01566890|521172298|FG000|Overall Study|Withdrawal by Subject|3|||
144537880|NCT01566890|521172299|FG001|Overall Study|Withdrawal by Subject|1|||
144537881|NCT01566890|521172300|FG002|Overall Study|Withdrawal by Subject|1|||
144537882|NCT01566890|521172301|FG003|Overall Study|Withdrawal by Subject|1|||
144537883|NCT01566890|521172302|FG004|Overall Study|Withdrawal by Subject|0|||
144537884|NCT01566890|521172298|FG000|Overall Study|Screen failure|6|||
144537885|NCT01566890|521172299|FG001|Overall Study|Screen failure|0|||
144537886|NCT01566890|521172300|FG002|Overall Study|Screen failure|1|||
144537887|NCT01566890|521172301|FG003|Overall Study|Screen failure|1|||
144537888|NCT01566890|521172302|FG004|Overall Study|Screen failure|0|||
144537889|NCT01566890|521172298|FG000|Overall Study|Incomplete CEU data|1|||
144537890|NCT01566890|521172299|FG001|Overall Study|Incomplete CEU data|3|||
144537891|NCT01566890|521172300|FG002|Overall Study|Incomplete CEU data|5|||
144537892|NCT01566890|521172301|FG003|Overall Study|Incomplete CEU data|8|||
144537893|NCT01566890|521172302|FG004|Overall Study|Incomplete CEU data|0|||
144537894|NCT01566890|521172298|FG000|Overall Study|Lost to Follow-up|0|||
144537895|NCT01566890|521172299|FG001|Overall Study|Lost to Follow-up|0|||
144537896|NCT01566890|521172300|FG002|Overall Study|Lost to Follow-up|4|||
144537897|NCT01566890|521172301|FG003|Overall Study|Lost to Follow-up|4|||
144537898|NCT01566890|521172302|FG004|Overall Study|Lost to Follow-up|0|||
144537899|NCT01566890|521172298|FG000|Overall Study|Other|0|||
144537900|NCT01566890|521172299|FG001|Overall Study|Other|0|||
144537901|NCT01566890|521172300|FG002|Overall Study|Other|0|||
144537902|NCT01566890|521172301|FG003|Overall Study|Other|0|||
144537903|NCT01566890|521172302|FG004|Overall Study|Other|7|||
144537904|NCT00523419|521172313|FG000|Overall Study|Adverse Event|1|||
144537905|NCT00523419|521172313|FG000|Overall Study|Withdrawal by Subject|1|||
144537906|NCT00523419|521172313|FG000|Overall Study|Physician Decision|2|||
144537907|NCT00523419|521172313|FG000|Overall Study|Progressive Disease|22|||
144537908|NCT00523419|521172313|FG000|Overall Study|Death due to Study Disease|4|||
144537909|NCT00523419|521172313|FG000|Overall Study|Death due to Adverse Event|2|||
144537910|NCT01211184|521172314|FG000|Overall Study|Withdrawal by Subject|0|||
144537911|NCT01211184|521172315|FG001|Overall Study|Withdrawal by Subject|2|||
144537912|NCT01211184|521172316|FG002|Overall Study|Withdrawal by Subject|1|||
144537913|NCT01421667|521172317|FG000|Overall Study|Withdrawal by Subject|0|||
144537914|NCT01421667|521172318|FG001|Overall Study|Withdrawal by Subject|1|||
144537915|NCT01421667|521172319|FG002|Overall Study|Withdrawal by Subject|2|||
144537916|NCT01421667|521172320|FG003|Overall Study|Withdrawal by Subject|1|||
144537917|NCT01421667|521172317|FG000|Overall Study|Lost to Follow-up|0|||
144537918|NCT01421667|521172318|FG001|Overall Study|Lost to Follow-up|1|||
144537919|NCT01421667|521172319|FG002|Overall Study|Lost to Follow-up|0|||
144537920|NCT01421667|521172320|FG003|Overall Study|Lost to Follow-up|0|||
144537921|NCT00822120|521172321|FG000|Initial Registration|Adverse Event|1|||
144537922|NCT00822120|521172322|FG001|Initial Registration|Adverse Event|0|||
144537923|NCT00822120|521172323|FG002|Initial Registration|Adverse Event|0|||
144537924|NCT00822120|521172324|FG003|Initial Registration|Adverse Event|0|||
144537925|NCT00822120|521172325|FG004|Initial Registration|Adverse Event|0|||
144537926|NCT00822120|521172326|FG005|Initial Registration|Adverse Event|0|||
144537927|NCT00822120|521172321|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
144537928|NCT00822120|521172322|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
144537929|NCT00822120|521172323|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
144537930|NCT00822120|521172324|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
144537931|NCT00822120|521172325|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
144537932|NCT00822120|521172326|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
144614709|NCT00789529|521450166|FG001|Overall Study|Other Reason|0|||
144614710|NCT01135498|521450167|FG000|Overall Study|Adverse Event|20|||
144614711|NCT01135498|521450167|FG000|Overall Study|Progressive disease|38|||
144614712|NCT01135498|521450167|FG000|Overall Study|Investigator judgement|25|||
144614713|NCT01135498|521450167|FG000|Overall Study|Withdrawal by Subject|4|||
144614714|NCT01135498|521450167|FG000|Overall Study|Death|1|||
144614715|NCT01135498|521450167|FG000|Overall Study|Ongoing at time of analysis|2|||
144614716|NCT01732796|521450169|FG000|Overall Study|Adverse Event|16|||
144614717|NCT01732796|521450170|FG001|Overall Study|Adverse Event|16|||
144537933|NCT00822120|521172321|FG000|Initial Registration|Reasons not Protocol Specified|2|||
144537934|NCT00822120|521172322|FG001|Initial Registration|Reasons not Protocol Specified|0|||
144537935|NCT00822120|521172323|FG002|Initial Registration|Reasons not Protocol Specified|0|||
144537936|NCT00822120|521172324|FG003|Initial Registration|Reasons not Protocol Specified|0|||
144537937|NCT00822120|521172325|FG004|Initial Registration|Reasons not Protocol Specified|0|||
144537938|NCT00822120|521172326|FG005|Initial Registration|Reasons not Protocol Specified|0|||
144537939|NCT00822120|521172321|FG000|Initial Registration|Ineligible|22|||
144614718|NCT01732796|521450171|FG002|Overall Study|Adverse Event|4|||
144198409|NCT05070546|519923048|FG005|Overall Study|Withdrawal by Subject|0|||
144198410|NCT05070546|519923043|FG000|Overall Study|Other|0|||
144198411|NCT05070546|519923044|FG001|Overall Study|Other|0|||
144198412|NCT05070546|519923045|FG002|Overall Study|Other|0|||
144198413|NCT05070546|519923046|FG003|Overall Study|Other|0|||
144198414|NCT05070546|519923047|FG004|Overall Study|Other|3|||
144198415|NCT05070546|519923048|FG005|Overall Study|Other|0|||
144198416|NCT05070546|519923043|FG000|Overall Study|Randomized but not vaccinated|1|||
144198417|NCT05070546|519923044|FG001|Overall Study|Randomized but not vaccinated|0|||
144198418|NCT05070546|519923045|FG002|Overall Study|Randomized but not vaccinated|1|||
144198419|NCT05070546|519923046|FG003|Overall Study|Randomized but not vaccinated|1|||
144198420|NCT05070546|519923047|FG004|Overall Study|Randomized but not vaccinated|3|||
144198421|NCT05070546|519923048|FG005|Overall Study|Randomized but not vaccinated|0|||
144198422|NCT03696953|519925030|FG000|Overall Study|Withdrawal by Subject|6|||
144198423|NCT03696953|519925031|FG001|Overall Study|Withdrawal by Subject|1|||
144198424|NCT03696953|519925030|FG000|Overall Study|missed GBS swabs|2|||
144198425|NCT03696953|519925031|FG001|Overall Study|missed GBS swabs|2|||
144198426|NCT03696953|519925030|FG000|Overall Study|lost study bottle containing capsules|2|||
144198427|NCT03696953|519925031|FG001|Overall Study|lost study bottle containing capsules|0|||
144198428|NCT03696953|519925030|FG000|Overall Study|Premature birth|1|||
144198429|NCT03696953|519925031|FG001|Overall Study|Premature birth|4|||
144198430|NCT03696953|519925030|FG000|Overall Study|Gestational hypertension|1|||
144198431|NCT03696953|519925031|FG001|Overall Study|Gestational hypertension|1|||
144198432|NCT03696953|519925030|FG000|Overall Study|Gestational diabetes|2|||
144198433|NCT03696953|519925031|FG001|Overall Study|Gestational diabetes|1|||
144198434|NCT03696953|519925030|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
144198435|NCT03696953|519925031|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
144198436|NCT03696953|519925030|FG000|Overall Study|Changed prenatal provider|1|||
144198437|NCT03696953|519925031|FG001|Overall Study|Changed prenatal provider|1|||
144198438|NCT00759902|519925033|FG000|Overall Study|Adverse Event|0|||
144198439|NCT00759902|519925034|FG001|Overall Study|Adverse Event|1|||
144198440|NCT02128217|519925037|FG000|Overall Study|Lost to Follow-up|0|||
144198441|NCT02128217|519925038|FG001|Overall Study|Lost to Follow-up|1|||
144198442|NCT05071313|519925039|FG000|Overall Study|Lost to Follow-up|17|||
144198443|NCT05071313|519925040|FG001|Overall Study|Lost to Follow-up|10|||
144198444|NCT05071313|519925039|FG000|Overall Study|Physician Decision|1|||
144198445|NCT05071313|519925040|FG001|Overall Study|Physician Decision|6|||
144198446|NCT05071313|519925039|FG000|Overall Study|Death|1|||
144198447|NCT05071313|519925040|FG001|Overall Study|Death|0|||
144198448|NCT05071313|519925039|FG000|Overall Study|Withdrawal by Subject|10|||
144198449|NCT05071313|519925040|FG001|Overall Study|Withdrawal by Subject|15|||
144198450|NCT05071313|519925039|FG000|Overall Study|Other|1|||
144198451|NCT05071313|519925040|FG001|Overall Study|Other|0|||
144198452|NCT05071313|519925039|FG000|Overall Study|Randomized but not vaccinated|4|||
144198453|NCT05071313|519925040|FG001|Overall Study|Randomized but not vaccinated|2|||
144198454|NCT01183221|519925041|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
144198455|NCT01183221|519925042|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
144198456|NCT03596151|519925043|FG000|Overall Study|Withdrawal by Subject|1|||
144198457|NCT03222583|519925047|FG000|Overall Study|Withdrawal by Subject|3|||
144198458|NCT03222583|519925048|FG001|Overall Study|Withdrawal by Subject|3|||
144198459|NCT03222583|519925047|FG000|Overall Study|Lost to Follow-up|1|||
144198460|NCT03222583|519925048|FG001|Overall Study|Lost to Follow-up|0|||
144198461|NCT03222583|519925047|FG000|Overall Study|Other|1|||
144198462|NCT03222583|519925048|FG001|Overall Study|Other|3|||
144198463|NCT04498403|519925049|FG000|Overall Study|Adverse Event|1|||
144198464|NCT04498403|519925050|FG001|Overall Study|Adverse Event|0|||
144198465|NCT04498403|519925049|FG000|Overall Study|Study Terminated By Sponsor|29|||
144198466|NCT04498403|519925050|FG001|Overall Study|Study Terminated By Sponsor|10|||
144471017|NCT02857426|520923342|FG001|Overall Study|Disease progression|13|||
144471018|NCT02857426|520923341|FG000|Overall Study|Study drug toxicity|4|||
144471019|NCT02857426|520923342|FG001|Overall Study|Study drug toxicity|1|||
144471020|NCT02857426|520923341|FG000|Overall Study|Death|1|||
144471021|NCT02857426|520923342|FG001|Overall Study|Death|0|||
144471022|NCT02857426|520923341|FG000|Overall Study|Adverse event unrelated to study drug|6|||
144471023|NCT02857426|520923342|FG001|Overall Study|Adverse event unrelated to study drug|2|||
144471024|NCT02857426|520923341|FG000|Overall Study|Participant withdrew consent|1|||
144471025|NCT02857426|520923342|FG001|Overall Study|Participant withdrew consent|1|||
144471026|NCT02857426|520923341|FG000|Overall Study|Maximum clinical benefit|1|||
144471027|NCT02857426|520923342|FG001|Overall Study|Maximum clinical benefit|0|||
144471028|NCT02857426|520923341|FG000|Overall Study|Completed treatment|0|||
144471029|NCT02857426|520923342|FG001|Overall Study|Completed treatment|2|||
144471030|NCT01960725|520923343|FG000|Overall Study|Lost to Follow-up|4|||
144471031|NCT01960725|520923344|FG001|Overall Study|Lost to Follow-up|3|||
144471032|NCT01960725|520923343|FG000|Overall Study|Withdrawal by Subject|1|||
144471033|NCT01960725|520923344|FG001|Overall Study|Withdrawal by Subject|0|||
144471034|NCT01960725|520923343|FG000|Overall Study|unable to obtain blood sample|1|||
144471035|NCT01960725|520923344|FG001|Overall Study|unable to obtain blood sample|2|||
144198467|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Death|89|||
144471036|NCT02634788|520923346|FG000|Overall Study|Adverse Event|0|||
144471037|NCT02634788|520923347|FG001|Overall Study|Adverse Event|8|||
144471038|NCT02634788|520923348|FG002|Overall Study|Adverse Event|3|||
144471039|NCT02634788|520923349|FG003|Overall Study|Adverse Event|1|||
144471040|NCT02634788|520923346|FG000|Overall Study|Lack of Efficacy|4|||
144471041|NCT02634788|520923347|FG001|Overall Study|Lack of Efficacy|0|||
144471042|NCT02634788|520923348|FG002|Overall Study|Lack of Efficacy|1|||
144471043|NCT02634788|520923349|FG003|Overall Study|Lack of Efficacy|4|||
144471044|NCT02634788|520923346|FG000|Overall Study|Lost to Follow-up|0|||
144471045|NCT02634788|520923347|FG001|Overall Study|Lost to Follow-up|1|||
144471046|NCT02634788|520923348|FG002|Overall Study|Lost to Follow-up|0|||
144471047|NCT02634788|520923349|FG003|Overall Study|Lost to Follow-up|0|||
144471048|NCT02634788|520923346|FG000|Overall Study|Withdrawal by Subject|0|||
144471049|NCT02634788|520923347|FG001|Overall Study|Withdrawal by Subject|1|||
144471050|NCT02634788|520923348|FG002|Overall Study|Withdrawal by Subject|1|||
144471051|NCT02634788|520923349|FG003|Overall Study|Withdrawal by Subject|0|||
144471052|NCT02831257|520923350|FG000|Overall Study|Lack of Efficacy|3|||
144471053|NCT02831257|520923350|FG000|Overall Study|Adverse Event|2|||
144471054|NCT02831257|520923350|FG000|Overall Study|Physician Decision|1|||
144471055|NCT02831257|520923350|FG000|Overall Study|Withdrawal by Subject|6|||
144471056|NCT01780935|520923351|FG000|Overall Study|Admin problems due to early termination|321|||
144471057|NCT01780935|520923352|FG001|Overall Study|Admin problems due to early termination|309|||
144471058|NCT01780935|520923351|FG000|Overall Study|Adverse Event|2|||
144471059|NCT01780935|520923352|FG001|Overall Study|Adverse Event|4|||
144471060|NCT01780935|520923351|FG000|Overall Study|Death|1|||
144471061|NCT01780935|520923352|FG001|Overall Study|Death|6|||
144471062|NCT01780935|520923351|FG000|Overall Study|Lost to Follow-up|2|||
144471063|NCT01780935|520923352|FG001|Overall Study|Lost to Follow-up|6|||
144471064|NCT01780935|520923351|FG000|Overall Study|Physician Decision|1|||
144471065|NCT01780935|520923352|FG001|Overall Study|Physician Decision|1|||
144471066|NCT01780935|520923351|FG000|Overall Study|Protocol deviation|0|||
144471067|NCT01780935|520923352|FG001|Overall Study|Protocol deviation|1|||
144471068|NCT01780935|520923351|FG000|Overall Study|Patient withdrew consent|8|||
144471069|NCT01780935|520923352|FG001|Overall Study|Patient withdrew consent|9|||
144471070|NCT00855595|520923353|FG000|Overall Study|Withdrawal by Subject|1|||
144471071|NCT00855595|520923354|FG001|Overall Study|Withdrawal by Subject|2|||
144471072|NCT00855595|520923353|FG000|Overall Study|Lost to Follow-up|3|||
144471073|NCT00855595|520923354|FG001|Overall Study|Lost to Follow-up|3|||
144471074|NCT00855595|520923353|FG000|Overall Study|Adverse Event|1|||
144471075|NCT00855595|520923354|FG001|Overall Study|Adverse Event|1|||
144471076|NCT00855595|520923353|FG000|Overall Study|patient moved out of state|1|||
144471077|NCT00855595|520923354|FG001|Overall Study|patient moved out of state|0|||
144471078|NCT00855595|520923353|FG000|Overall Study|patient left country|0|||
144471079|NCT00855595|520923354|FG001|Overall Study|patient left country|1|||
144471080|NCT01844284|520923355|FG000|Overall Study|Lost to Follow-up|12|||
144471081|NCT01844284|520923356|FG001|Overall Study|Lost to Follow-up|7|||
144471082|NCT00611858|520923357|FG000|Overall Study|Adverse Event|2|||
144471083|NCT00611858|520923357|FG000|Overall Study|Withdrawal by Subject|2|||
144471084|NCT01058304|520923359|FG000|Overall Study|Withdrawal by Subject|8|||
144471085|NCT01058304|520923360|FG001|Overall Study|Withdrawal by Subject|5|||
144471086|NCT01058304|520923359|FG000|Overall Study|Lost to Follow-up|13|||
144471087|NCT01058304|520923360|FG001|Overall Study|Lost to Follow-up|16|||
144471088|NCT01058304|520923359|FG000|Overall Study|Developed exclusion criterion|6|||
144471089|NCT01058304|520923360|FG001|Overall Study|Developed exclusion criterion|12|||
144471090|NCT02755597|520923361|FG000|Overall Study|Withdrew consent|27|||
144471091|NCT02755597|520923362|FG001|Overall Study|Withdrew consent|11|||
144471092|NCT02755597|520923361|FG000|Overall Study|Lost to Follow-up|1|||
144471093|NCT02755597|520923362|FG001|Overall Study|Lost to Follow-up|0|||
144471094|NCT02755597|520923361|FG000|Overall Study|Death|78|||
144471095|NCT02755597|520923362|FG001|Overall Study|Death|36|||
144471096|NCT02755597|520923361|FG000|Overall Study|Study terminated by Sponsor|67|||
144471097|NCT02755597|520923362|FG001|Overall Study|Study terminated by Sponsor|47|||
144471098|NCT02755597|520923361|FG000|Overall Study|Other, not specified|20|||
144471099|NCT02755597|520923362|FG001|Overall Study|Other, not specified|3|||
144471100|NCT02755597|520923361|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
144471101|NCT02755597|520923362|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
144537940|NCT00822120|521172322|FG001|Initial Registration|Ineligible|1|||
144537941|NCT00822120|521172323|FG002|Initial Registration|Ineligible|0|||
144471102|NCT02496767|520923364|FG000|Open-label Lead-in Phase|Adverse Event|176|||
144471103|NCT02496767|520923365|FG001|Open-label Lead-in Phase|Adverse Event|0|||
144471104|NCT02496767|520923366|FG002|Open-label Lead-in Phase|Adverse Event|0|||
144471105|NCT02496767|520923367|FG003|Open-label Lead-in Phase|Adverse Event|0|||
144471106|NCT02496767|520923368|FG004|Open-label Lead-in Phase|Adverse Event|0|||
144471107|NCT02496767|520923369|FG005|Open-label Lead-in Phase|Adverse Event|0|||
144471108|NCT02496767|520923370|FG006|Open-label Lead-in Phase|Adverse Event|0|||
144471109|NCT02496767|520923371|FG007|Open-label Lead-in Phase|Adverse Event|0|||
144537942|NCT00822120|521172324|FG003|Initial Registration|Ineligible|0|||
144258716|NCT02959918|520148587|FG001|Overall Study|Stopping Rule Met|0|||
144471110|NCT02496767|520923364|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
144471111|NCT02496767|520923365|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
144471112|NCT02496767|520923366|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
144471113|NCT02496767|520923367|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
144471114|NCT02496767|520923368|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
144471115|NCT02496767|520923369|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
144471116|NCT02496767|520923370|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
144471117|NCT02496767|520923371|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
144471118|NCT02496767|520923364|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
144471119|NCT02496767|520923365|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471120|NCT02496767|520923366|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471121|NCT02496767|520923367|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471122|NCT02496767|520923368|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471123|NCT02496767|520923369|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471124|NCT02496767|520923370|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471125|NCT02496767|520923371|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
144471126|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
144471127|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
144471128|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
144471129|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
144471130|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
144471131|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
144471132|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
144471133|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
144471134|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
144471135|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
144471136|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
144471137|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
144471138|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
144471139|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
144471140|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
144471141|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
144471142|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
144471143|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
144471144|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
144471145|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
144471146|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
144471147|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
144471148|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
144471149|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
144471150|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
144471151|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
144471152|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
144471153|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
144471154|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
144471155|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
144471156|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
144471157|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
144471158|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144471159|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
144471160|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
144471161|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
144471162|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
144471163|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144471164|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144471165|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144471166|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144471167|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
144471168|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
144471169|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144471170|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144471171|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144471172|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144471173|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144471174|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144471175|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
144198468|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Death|193|||
144198469|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Death|198|||
144198470|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
144198471|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
144198472|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
144198473|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
144198474|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
144198475|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
144198476|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
144198477|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
144198478|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
144198479|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
144198480|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
144198481|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
144198482|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
144198483|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
144198484|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
144198485|NCT02031458|519925051|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
144198486|NCT02031458|519925052|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
144198487|NCT02031458|519925053|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
144198488|NCT02031458|519925051|FG000|Baseline to May 8, 2015|Death|36|||
144198489|NCT02031458|519925052|FG001|Baseline to May 8, 2015|Death|87|||
144198490|NCT02031458|519925053|FG002|Baseline to May 8, 2015|Death|100|||
144198491|NCT02031458|519925051|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
144198492|NCT02031458|519925052|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
144198493|NCT02031458|519925053|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
144198494|NCT02031458|519925051|FG000|Baseline to May 8, 2015|Physician Decision|0|||
144537943|NCT00822120|521172325|FG004|Initial Registration|Ineligible|0|||
144537944|NCT00822120|521172326|FG005|Initial Registration|Ineligible|0|||
144537945|NCT00822120|521172321|FG000|PET-directed Therapy|Adverse Event|0|||
144537946|NCT00822120|521172322|FG001|PET-directed Therapy|Adverse Event|0|||
144537947|NCT00822120|521172323|FG002|PET-directed Therapy|Adverse Event|0|||
144537948|NCT00822120|521172324|FG003|PET-directed Therapy|Adverse Event|1|||
144537949|NCT00822120|521172325|FG004|PET-directed Therapy|Adverse Event|0|||
144537950|NCT00822120|521172326|FG005|PET-directed Therapy|Adverse Event|0|||
144537951|NCT00822120|521172321|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
144537952|NCT00822120|521172322|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
144537953|NCT00822120|521172323|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
144537954|NCT00822120|521172324|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
144537955|NCT00822120|521172325|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
144537956|NCT00822120|521172326|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
144537957|NCT00822120|521172321|FG000|PET-directed Therapy|Death|0|||
144537958|NCT00822120|521172322|FG001|PET-directed Therapy|Death|0|||
144537959|NCT00822120|521172323|FG002|PET-directed Therapy|Death|0|||
144537960|NCT00822120|521172324|FG003|PET-directed Therapy|Death|2|||
144537961|NCT00822120|521172325|FG004|PET-directed Therapy|Death|0|||
144537962|NCT00822120|521172326|FG005|PET-directed Therapy|Death|0|||
144537963|NCT00822120|521172321|FG000|PET-directed Therapy|Protocol Violation|0|||
144537964|NCT00822120|521172322|FG001|PET-directed Therapy|Protocol Violation|0|||
144537965|NCT00822120|521172323|FG002|PET-directed Therapy|Protocol Violation|0|||
144537966|NCT00822120|521172324|FG003|PET-directed Therapy|Protocol Violation|6|||
144537967|NCT00822120|521172325|FG004|PET-directed Therapy|Protocol Violation|0|||
144537968|NCT00822120|521172326|FG005|PET-directed Therapy|Protocol Violation|0|||
144537969|NCT04060212|521172328|FG000|Overall Study|Withdrawal by Subject|7|||
144537970|NCT00811941|521172332|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
144537971|NCT00811941|521172333|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
144198495|NCT02031458|519925052|FG001|Baseline to May 8, 2015|Physician Decision|1|||
144471176|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144471177|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
144471178|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
144471179|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144471180|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144471181|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144471182|NCT02496767|520923364|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144471183|NCT02496767|520923365|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
144471184|NCT02496767|520923366|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144537972|NCT00811941|521172332|FG000|All Treated Patients|Adverse Event|2|||
144537973|NCT00811941|521172333|FG001|All Treated Patients|Adverse Event|43|||
144614719|NCT01732796|521450169|FG000|Overall Study|Lack of Efficacy|21|||
144614720|NCT01732796|521450170|FG001|Overall Study|Lack of Efficacy|18|||
144537974|NCT00811941|521172332|FG000|All Treated Patients|Lack of Efficacy|2|||
144537975|NCT00811941|521172333|FG001|All Treated Patients|Lack of Efficacy|3|||
144537976|NCT00811941|521172332|FG000|All Treated Patients|Non-compliance|1|||
144537977|NCT00811941|521172333|FG001|All Treated Patients|Non-compliance|8|||
144537978|NCT00811941|521172332|FG000|All Treated Patients|Protocol Violation|5|||
144537979|NCT00811941|521172333|FG001|All Treated Patients|Protocol Violation|17|||
144198496|NCT02031458|519925053|FG002|Baseline to May 8, 2015|Physician Decision|0|||
144198497|NCT02031458|519925051|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
144198498|NCT02031458|519925052|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
144198499|NCT02031458|519925053|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
144198500|NCT02031458|519925051|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
144198501|NCT02031458|519925052|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
144537980|NCT00811941|521172332|FG000|All Treated Patients|Withdrawal by Subject|35|||
144537981|NCT00811941|521172333|FG001|All Treated Patients|Withdrawal by Subject|94|||
144537982|NCT00811941|521172332|FG000|All Treated Patients|Lost to Follow-up|3|||
144537983|NCT00811941|521172333|FG001|All Treated Patients|Lost to Follow-up|12|||
144537984|NCT00811941|521172332|FG000|All Treated Patients|Other Reason|4|||
144537985|NCT00811941|521172333|FG001|All Treated Patients|Other Reason|14|||
144537986|NCT03885232|521172334|FG000|Overall Study|Lost to Follow-up|74|||
144537987|NCT03885232|521172335|FG001|Overall Study|Lost to Follow-up|32|||
144537988|NCT03885232|521172334|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
144537989|NCT03885232|521172335|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
144537990|NCT02397096|521172336|FG000|Day 1 to Week 24|Adverse Event|7|||
144537991|NCT02397096|521172337|FG001|Day 1 to Week 24|Adverse Event|1|||
144537992|NCT02397096|521172336|FG000|Day 1 to Week 24|Death|1|||
144537993|NCT02397096|521172337|FG001|Day 1 to Week 24|Death|0|||
144537994|NCT02397096|521172336|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
144537995|NCT02397096|521172337|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
144537996|NCT02397096|521172336|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
144537997|NCT02397096|521172337|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
144537998|NCT02397096|521172336|FG000|Day 1 to Week 24|Physician Decision|2|||
144537999|NCT02397096|521172337|FG001|Day 1 to Week 24|Physician Decision|3|||
144538000|NCT02397096|521172336|FG000|Day 1 to Week 24|Protocol Violation|1|||
144538001|NCT02397096|521172337|FG001|Day 1 to Week 24|Protocol Violation|4|||
144538002|NCT02397096|521172336|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
144538003|NCT02397096|521172337|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
144538004|NCT02397096|521172336|FG000|Day 1 to Week 24|Randomized, not treated|3|||
144538005|NCT02397096|521172337|FG001|Day 1 to Week 24|Randomized, not treated|0|||
144538006|NCT02397096|521172336|FG000|Week 24 to Week 48|Adverse Event|6|||
144538007|NCT02397096|521172337|FG001|Week 24 to Week 48|Adverse Event|2|||
144538008|NCT02397096|521172336|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
144538009|NCT02397096|521172337|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
144538010|NCT02397096|521172336|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
144538011|NCT02397096|521172337|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
144538012|NCT02397096|521172336|FG000|Week 24 to Week 48|Physician Decision|2|||
144538013|NCT02397096|521172337|FG001|Week 24 to Week 48|Physician Decision|1|||
144538014|NCT02397096|521172336|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
144538015|NCT02397096|521172337|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
144538016|NCT02397096|521172336|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
144538017|NCT02397096|521172337|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
144538018|NCT02397096|521172336|FG000|Study Extension 1|Adverse Event|7|||
144538019|NCT02397096|521172337|FG001|Study Extension 1|Adverse Event|5|||
144538020|NCT02397096|521172336|FG000|Study Extension 1|Death|1|||
144538021|NCT02397096|521172337|FG001|Study Extension 1|Death|0|||
144538022|NCT02397096|521172336|FG000|Study Extension 1|Lack of Efficacy|2|||
144538023|NCT02397096|521172337|FG001|Study Extension 1|Lack of Efficacy|5|||
144538024|NCT02397096|521172336|FG000|Study Extension 1|Lost to Follow-up|2|||
144538025|NCT02397096|521172337|FG001|Study Extension 1|Lost to Follow-up|3|||
144614721|NCT01732796|521450171|FG002|Overall Study|Lack of Efficacy|5|||
144614722|NCT01732796|521450169|FG000|Overall Study|Lost to Follow-up|2|||
144614723|NCT01732796|521450170|FG001|Overall Study|Lost to Follow-up|0|||
144614724|NCT01732796|521450171|FG002|Overall Study|Lost to Follow-up|0|||
144614725|NCT01732796|521450169|FG000|Overall Study|Withdrawal by Subject|6|||
144614726|NCT01732796|521450170|FG001|Overall Study|Withdrawal by Subject|8|||
144614727|NCT01732796|521450171|FG002|Overall Study|Withdrawal by Subject|2|||
144614728|NCT01732796|521450169|FG000|Overall Study|Other reason not defined above|1|||
144614729|NCT01732796|521450170|FG001|Overall Study|Other reason not defined above|0|||
144614730|NCT01732796|521450171|FG002|Overall Study|Other reason not defined above|2|||
144614731|NCT01379274|521450172|FG000|Overall Study|funding withdrawn|1|||
144614732|NCT03287219|521450174|FG000|Overall Study|Protocol Violation|0|||
144614733|NCT03287219|521450175|FG001|Overall Study|Protocol Violation|2|||
144198502|NCT02031458|519925053|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
144538026|NCT02397096|521172336|FG000|Study Extension 1|Non-compliance with study drug|3|||
144538027|NCT02397096|521172337|FG001|Study Extension 1|Non-compliance with study drug|0|||
144538028|NCT02397096|521172336|FG000|Study Extension 1|Physician Decision|4|||
144614734|NCT04081363|521450182|FG000|Overall Study|Withdrawal by Subject|1|||
144538029|NCT02397096|521172337|FG001|Study Extension 1|Physician Decision|2|||
144538030|NCT02397096|521172336|FG000|Study Extension 1|Pregnancy|1|||
144538031|NCT02397096|521172337|FG001|Study Extension 1|Pregnancy|0|||
144538032|NCT02397096|521172336|FG000|Study Extension 1|Protocol Violation|0|||
144538033|NCT02397096|521172337|FG001|Study Extension 1|Protocol Violation|1|||
144538034|NCT02397096|521172336|FG000|Study Extension 1|Withdrawal by Subject|21|||
144538035|NCT02397096|521172337|FG001|Study Extension 1|Withdrawal by Subject|7|||
144538036|NCT02397096|521172336|FG000|Study Extension 2|Adverse Event|3|||
144538037|NCT02397096|521172337|FG001|Study Extension 2|Adverse Event|3|||
144538038|NCT02397096|521172336|FG000|Study Extension 2|Availability of study medication locally|152|||
144538039|NCT02397096|521172337|FG001|Study Extension 2|Availability of study medication locally|64|||
144538040|NCT02397096|521172336|FG000|Study Extension 2|Death|2|||
144538041|NCT02397096|521172337|FG001|Study Extension 2|Death|0|||
144538042|NCT02397096|521172336|FG000|Study Extension 2|Lack of Efficacy|1|||
144538043|NCT02397096|521172337|FG001|Study Extension 2|Lack of Efficacy|0|||
144538044|NCT02397096|521172336|FG000|Study Extension 2|Lost to Follow-up|2|||
144538045|NCT02397096|521172337|FG001|Study Extension 2|Lost to Follow-up|1|||
144538046|NCT02397096|521172336|FG000|Study Extension 2|Non-compliance with study drug|1|||
144538047|NCT02397096|521172337|FG001|Study Extension 2|Non-compliance with study drug|0|||
144538048|NCT02397096|521172336|FG000|Study Extension 2|Physician Decision|2|||
144538049|NCT02397096|521172337|FG001|Study Extension 2|Physician Decision|5|||
144538050|NCT02397096|521172336|FG000|Study Extension 2|Pregnancy|1|||
144538051|NCT02397096|521172337|FG001|Study Extension 2|Pregnancy|0|||
144538052|NCT02397096|521172336|FG000|Study Extension 2|Withdrawal by Subject|10|||
144538053|NCT02397096|521172337|FG001|Study Extension 2|Withdrawal by Subject|3|||
144538054|NCT02397096|521172336|FG000|Study Extension 3|Adverse Event|1|||
144538055|NCT02397096|521172337|FG001|Study Extension 3|Adverse Event|0|||
144538056|NCT02397096|521172336|FG000|Study Extension 3|Availability of study medication locally|11|||
144538057|NCT02397096|521172337|FG001|Study Extension 3|Availability of study medication locally|3|||
144538058|NCT02397096|521172336|FG000|Study Extension 3|Lost to Follow-up|1|||
144538059|NCT02397096|521172337|FG001|Study Extension 3|Lost to Follow-up|0|||
144538060|NCT02397096|521172336|FG000|Study Extension 3|Withdrawal by Subject|2|||
144538061|NCT02397096|521172337|FG001|Study Extension 3|Withdrawal by Subject|1|||
144538062|NCT03840902|521172338|FG000|Overall Study|Randomized but not treated|1|||
144538063|NCT03840902|521172339|FG001|Overall Study|Randomized but not treated|1|||
144538064|NCT06688357|521172341|FG000|Overall Study|Adverse Event|0|||
144538065|NCT06688357|521172342|FG001|Overall Study|Adverse Event|1|||
144538066|NCT05139992|521172345|FG000|Overall Study|Withdrawal by Subject|12|||
144538067|NCT05139992|521172345|FG000|Overall Study|Lost to Follow-up|6|||
144538068|NCT04517435|521172362|FG000|Overall Study|Withdrawal by Subject|0|||
144538069|NCT04517435|521172363|FG001|Overall Study|Withdrawal by Subject|0|||
144538070|NCT04517435|521172364|FG002|Overall Study|Withdrawal by Subject|1|||
144538071|NCT04517435|521172362|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
144538072|NCT04517435|521172363|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
144538073|NCT04517435|521172364|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
144538074|NCT06191679|521172365|FG000|Baseline|Lost to Follow-up|1|||
144538075|NCT06191679|521172366|FG001|Baseline|Lost to Follow-up|0|||
144538076|NCT06191679|521172367|FG002|Baseline|Lost to Follow-up|1|||
144538077|NCT06191679|521172368|FG003|Baseline|Lost to Follow-up|0|||
144538078|NCT06191679|521172365|FG000|Allocation to Group|Withdrawal by Subject|0|||
144538079|NCT06191679|521172366|FG001|Allocation to Group|Withdrawal by Subject|1|||
144538080|NCT06191679|521172367|FG002|Allocation to Group|Withdrawal by Subject|2|||
144538081|NCT06191679|521172368|FG003|Allocation to Group|Withdrawal by Subject|0|||
144538082|NCT06191679|521172365|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
144538083|NCT06191679|521172366|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
144538084|NCT06191679|521172367|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
144538085|NCT06191679|521172368|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
144538086|NCT06191679|521172365|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
144538087|NCT06191679|521172366|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
144538088|NCT06191679|521172367|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
144538089|NCT06191679|521172368|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
144538090|NCT06191679|521172365|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
144538091|NCT06191679|521172366|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
144538092|NCT06191679|521172367|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
144538093|NCT06191679|521172368|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
144538094|NCT03211247|521172369|FG000|Overall Study|Adverse Event|8|||
144538095|NCT03211247|521172370|FG001|Overall Study|Adverse Event|0|||
144538096|NCT03211247|521172371|FG002|Overall Study|Adverse Event|1|||
144538097|NCT03211247|521172372|FG003|Overall Study|Adverse Event|0|||
144538098|NCT03211247|521172373|FG004|Overall Study|Adverse Event|0|||
144538099|NCT03211247|521172369|FG000|Overall Study|Lost to Follow-up|2|||
144538100|NCT03211247|521172370|FG001|Overall Study|Lost to Follow-up|1|||
144198503|NCT02031458|519925051|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
144198504|NCT02031458|519925052|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
144198505|NCT02031458|519925053|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
144198506|NCT02031458|519925051|FG000|Baseline to May 8, 2015|On Treatment|43|||
144198507|NCT02031458|519925052|FG001|Baseline to May 8, 2015|On Treatment|81|||
144198508|NCT02031458|519925053|FG002|Baseline to May 8, 2015|On Treatment|73|||
144198509|NCT02031458|519925051|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
144471185|NCT02496767|520923367|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144471186|NCT02496767|520923368|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144471187|NCT02496767|520923369|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144471188|NCT02496767|520923370|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144471189|NCT02496767|520923371|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
144471190|NCT02496767|520923364|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
144471191|NCT02496767|520923365|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
144471192|NCT02496767|520923366|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
144471193|NCT02496767|520923367|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
144471194|NCT02496767|520923368|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
144471195|NCT02496767|520923369|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
144471196|NCT02496767|520923370|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
144471197|NCT02496767|520923371|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
144471198|NCT02496767|520923364|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
144471199|NCT02496767|520923365|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
144471200|NCT02496767|520923366|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
144471201|NCT02496767|520923367|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
144471202|NCT02496767|520923368|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
144471203|NCT02496767|520923369|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
144471204|NCT02496767|520923370|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
144471205|NCT02496767|520923371|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
144471206|NCT02496767|520923364|FG000|Double-blind, Withdrawal Phase|Death|0|||
144471207|NCT02496767|520923365|FG001|Double-blind, Withdrawal Phase|Death|0|||
144471208|NCT02496767|520923366|FG002|Double-blind, Withdrawal Phase|Death|0|||
144471209|NCT02496767|520923367|FG003|Double-blind, Withdrawal Phase|Death|0|||
144471210|NCT02496767|520923368|FG004|Double-blind, Withdrawal Phase|Death|0|||
144471211|NCT02496767|520923369|FG005|Double-blind, Withdrawal Phase|Death|0|||
144471212|NCT02496767|520923370|FG006|Double-blind, Withdrawal Phase|Death|1|||
144471213|NCT02496767|520923371|FG007|Double-blind, Withdrawal Phase|Death|2|||
144471214|NCT02496767|520923364|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
144471215|NCT02496767|520923365|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
144471216|NCT02496767|520923366|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
144471217|NCT02496767|520923367|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
144471218|NCT02496767|520923368|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
144471219|NCT02496767|520923369|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
144471220|NCT02496767|520923370|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
144471221|NCT02496767|520923371|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
144471222|NCT02889133|520923372|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
144471223|NCT02889133|520923373|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
144471224|NCT02889133|520923372|FG000|Completed Primary Outcome|Manufacturing error|3|||
144471225|NCT02889133|520923373|FG001|Completed Primary Outcome|Manufacturing error|8|||
144471226|NCT02889133|520923372|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
144471227|NCT02889133|520923373|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
144471228|NCT02889133|520923372|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
144471229|NCT02889133|520923373|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
144471230|NCT02889133|520923372|FG000|Completed Primary Outcome|Protocol Violation|1|||
144471231|NCT02889133|520923373|FG001|Completed Primary Outcome|Protocol Violation|0|||
144471232|NCT02889133|520923372|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
144471233|NCT02889133|520923373|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
144471234|NCT02889133|520923372|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
144471235|NCT02889133|520923373|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
144471236|NCT02889133|520923372|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
144471237|NCT02889133|520923373|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
144471238|NCT02889133|520923372|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
144471239|NCT02889133|520923373|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
144471240|NCT02889133|520923372|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
144471241|NCT02889133|520923373|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
144471242|NCT00166296|520923374|FG000|Overall Study|Withdrawal by Subject|1|||
144471243|NCT00166296|520923375|FG001|Overall Study|Withdrawal by Subject|3|||
144198510|NCT02031458|519925052|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
144198511|NCT02031458|519925053|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
144538101|NCT03211247|521172371|FG002|Overall Study|Lost to Follow-up|0|||
144538102|NCT03211247|521172372|FG003|Overall Study|Lost to Follow-up|0|||
144538103|NCT03211247|521172373|FG004|Overall Study|Lost to Follow-up|0|||
144538104|NCT03211247|521172369|FG000|Overall Study|Physician Decision|1|||
144538105|NCT03211247|521172370|FG001|Overall Study|Physician Decision|2|||
144538106|NCT03211247|521172371|FG002|Overall Study|Physician Decision|0|||
144538107|NCT03211247|521172372|FG003|Overall Study|Physician Decision|0|||
144538108|NCT03211247|521172373|FG004|Overall Study|Physician Decision|0|||
144538109|NCT03211247|521172369|FG000|Overall Study|Non-compliance with study drug|2|||
144198512|NCT00609518|519925056|FG000|Overall Study|Death from Study Disease|32|||
144198513|NCT00609518|519925057|FG001|Overall Study|Death from Study Disease|32|||
144198514|NCT00609518|519925056|FG000|Overall Study|Withdrawal by Subject|5|||
144198515|NCT00609518|519925057|FG001|Overall Study|Withdrawal by Subject|3|||
144198516|NCT00609518|519925056|FG000|Overall Study|Lost to Follow-up|3|||
144198517|NCT00609518|519925057|FG001|Overall Study|Lost to Follow-up|0|||
144198518|NCT00609518|519925056|FG000|Overall Study|Physician Decision|1|||
144198519|NCT00609518|519925057|FG001|Overall Study|Physician Decision|3|||
144198520|NCT00609518|519925056|FG000|Overall Study|Death from Adverse Event|2|||
144198521|NCT00609518|519925057|FG001|Overall Study|Death from Adverse Event|2|||
144198522|NCT01687478|519925058|FG000|Overall Study|Adverse Event|3|||
144198523|NCT01687478|519925059|FG001|Overall Study|Adverse Event|10|||
144198524|NCT01687478|519925058|FG000|Overall Study|Lost to Follow-up|1|||
144471244|NCT00166296|520923374|FG000|Overall Study|Adverse Event|2|||
144471245|NCT00166296|520923375|FG001|Overall Study|Adverse Event|4|||
144471246|NCT00166296|520923374|FG000|Overall Study|Lost to Follow-up|4|||
144471247|NCT00166296|520923375|FG001|Overall Study|Lost to Follow-up|2|||
144471248|NCT04035200|520923381|FG000|Overall Study|Lost to Follow-up|0|||
144471249|NCT04035200|520923382|FG001|Overall Study|Lost to Follow-up|1|||
144471250|NCT04035200|520923383|FG002|Overall Study|Lost to Follow-up|0|||
144471251|NCT04035200|520923381|FG000|Overall Study|Withdrawal by Subject|1|||
144471252|NCT04035200|520923382|FG001|Overall Study|Withdrawal by Subject|4|||
144471253|NCT04035200|520923383|FG002|Overall Study|Withdrawal by Subject|4|||
144471254|NCT04035200|520923381|FG000|Overall Study|COVID-19|1|||
144471255|NCT04035200|520923382|FG001|Overall Study|COVID-19|0|||
144471256|NCT04035200|520923383|FG002|Overall Study|COVID-19|0|||
144471257|NCT04035200|520923381|FG000|Overall Study|Early Termination|0|||
144471258|NCT04035200|520923382|FG001|Overall Study|Early Termination|1|||
144471259|NCT04035200|520923383|FG002|Overall Study|Early Termination|0|||
144471260|NCT04035200|520923381|FG000|Overall Study|Non-compliance|0|||
144471261|NCT04035200|520923382|FG001|Overall Study|Non-compliance|1|||
144471262|NCT04035200|520923383|FG002|Overall Study|Non-compliance|0|||
144471263|NCT05479604|520923384|FG000|Overall Study|Lost to Follow-up|1|||
144471264|NCT05479604|520923385|FG001|Overall Study|Lost to Follow-up|5|||
144471265|NCT03138733|520923386|FG000|Overall Study|Death|17|||
144471266|NCT03138733|520923387|FG001|Overall Study|Death|18|||
144471267|NCT03138733|520923386|FG000|Overall Study|Withdrawal by Subject|11|||
144471268|NCT03138733|520923387|FG001|Overall Study|Withdrawal by Subject|6|||
144471269|NCT03138733|520923386|FG000|Overall Study|Lost to Follow-up|3|||
144471270|NCT03138733|520923387|FG001|Overall Study|Lost to Follow-up|2|||
144471271|NCT03138733|520923386|FG000|Overall Study|Adverse Event|1|||
144471272|NCT03138733|520923387|FG001|Overall Study|Adverse Event|0|||
144471273|NCT03138733|520923386|FG000|Overall Study|Protocol Violation|1|||
144471274|NCT03138733|520923387|FG001|Overall Study|Protocol Violation|3|||
144471275|NCT03138733|520923386|FG000|Overall Study|Administrative or logistical reason|1|||
144471276|NCT03138733|520923387|FG001|Overall Study|Administrative or logistical reason|0|||
144471277|NCT03138733|520923386|FG000|Overall Study|The patient was transferred to another hospital|1|||
144471278|NCT03138733|520923387|FG001|Overall Study|The patient was transferred to another hospital|0|||
144471279|NCT02521285|520923396|FG000|Overall Study|Lost to Follow-up|1|||
144471280|NCT02521285|520923397|FG001|Overall Study|Lost to Follow-up|1|||
144471281|NCT02521285|520923396|FG000|Overall Study|Withdrawal by Subject|1|||
144471282|NCT02521285|520923397|FG001|Overall Study|Withdrawal by Subject|1|||
144471283|NCT02521285|520923396|FG000|Overall Study|Adverse Event|0|||
144471284|NCT02521285|520923397|FG001|Overall Study|Adverse Event|1|||
144471285|NCT02753595|520923399|FG000|Overall Study|Sponsor termination|2|||
144471286|NCT02753595|520923400|FG001|Overall Study|Sponsor termination|2|||
144471287|NCT03185481|520923401|FG000|Overall Study|Adverse Event|1|||
144471288|NCT03185481|520923401|FG000|Overall Study|Study Terminated by Sponsor|4|||
144471289|NCT03371940|520923402|FG000|Overall Study|Withdrawal by Subject|8|||
144471290|NCT03371940|520923403|FG001|Overall Study|Withdrawal by Subject|1|||
144471291|NCT03371940|520923404|FG002|Overall Study|Withdrawal by Subject|3|||
144471292|NCT03371940|520923405|FG003|Overall Study|Withdrawal by Subject|4|||
144471293|NCT05099926|520923406|FG000|Overall Study|Lost to Follow-up|1|||
144471294|NCT02068495|520923407|FG000|Overall Study|Case Report Forms Uncollected|60|||
144471295|NCT02068495|520923407|FG000|Overall Study|Protocol Deviation|49|||
144471296|NCT02220894|520923409|FG000|Overall Study|Adverse Event|127|||
144471297|NCT02220894|520923410|FG001|Overall Study|Adverse Event|74|||
144471298|NCT02220894|520923409|FG000|Overall Study|Death|418|||
144538110|NCT03211247|521172370|FG001|Overall Study|Non-compliance with study drug|0|||
144198525|NCT01687478|519925059|FG001|Overall Study|Lost to Follow-up|3|||
144198526|NCT01687478|519925058|FG000|Overall Study|Protocol Violation|0|||
144198527|NCT01687478|519925059|FG001|Overall Study|Protocol Violation|2|||
144198528|NCT01687478|519925058|FG000|Overall Study|Withdrawal by Subject|21|||
144198529|NCT01687478|519925059|FG001|Overall Study|Withdrawal by Subject|19|||
144198530|NCT01687478|519925058|FG000|Overall Study|Physician Decision|1|||
144614735|NCT04081363|521450183|FG001|Overall Study|Withdrawal by Subject|0|||
144198531|NCT01687478|519925059|FG001|Overall Study|Physician Decision|3|||
144198532|NCT01687478|519925058|FG000|Overall Study|Entry Criteria Not Met|6|||
144198533|NCT01687478|519925059|FG001|Overall Study|Entry Criteria Not Met|2|||
144258717|NCT02959918|520148588|FG002|Overall Study|Stopping Rule Met|3|||
144258718|NCT02959918|520148589|FG003|Overall Study|Stopping Rule Met|4|||
144258719|NCT02959918|520148590|FG004|Overall Study|Stopping Rule Met|5|||
144258720|NCT02959918|520148591|FG005|Overall Study|Stopping Rule Met|3|||
144258721|NCT02959918|520148592|FG006|Overall Study|Stopping Rule Met|2|||
144258722|NCT02959918|520148593|FG007|Overall Study|Stopping Rule Met|4|||
144258723|NCT02959918|520148594|FG008|Overall Study|Stopping Rule Met|1|||
144258724|NCT02959918|520148595|FG009|Overall Study|Stopping Rule Met|1|||
144258725|NCT02959918|520148596|FG010|Overall Study|Stopping Rule Met|3|||
144258726|NCT02959918|520148597|FG011|Overall Study|Stopping Rule Met|5|||
144258727|NCT02959918|520148598|FG012|Overall Study|Stopping Rule Met|2|||
144258728|NCT02959918|520148599|FG013|Overall Study|Stopping Rule Met|1|||
144258729|NCT02959918|520148586|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
144258730|NCT02959918|520148587|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
144258731|NCT02959918|520148588|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
144258732|NCT02959918|520148589|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
144258733|NCT02959918|520148590|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258734|NCT02959918|520148591|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258735|NCT02959918|520148592|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258736|NCT02959918|520148593|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258737|NCT02959918|520148594|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258738|NCT02959918|520148595|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144471299|NCT02220894|520923410|FG001|Overall Study|Death|508|||
144471300|NCT02220894|520923409|FG000|Overall Study|Lost to Follow-up|0|||
144471301|NCT02220894|520923410|FG001|Overall Study|Lost to Follow-up|4|||
144471302|NCT02220894|520923409|FG000|Overall Study|Site Terminated by Sponsor|2|||
144471303|NCT02220894|520923410|FG001|Overall Study|Site Terminated by Sponsor|0|||
144471304|NCT02220894|520923409|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
144471305|NCT02220894|520923410|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
144471306|NCT02220894|520923409|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144471307|NCT02220894|520923410|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144471308|NCT02220894|520923409|FG000|Overall Study|Withdrawal by Subject|10|||
144471309|NCT02220894|520923410|FG001|Overall Study|Withdrawal by Subject|9|||
144471310|NCT04992546|520923411|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
144471311|NCT04992546|520923411|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
144471312|NCT04992546|520923411|FG000|Open-Label Treatment Period|Adverse Event|3|||
144471313|NCT04992546|520923411|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
144471314|NCT02703922|520923414|FG000|Overall Study|Death|5|||
144471315|NCT02703922|520923415|FG001|Overall Study|Death|8|||
144471316|NCT02703922|520923414|FG000|Overall Study|Lost to Follow-up|10|||
144471317|NCT02703922|520923415|FG001|Overall Study|Lost to Follow-up|10|||
144471318|NCT00500903|520923417|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
144471319|NCT00500903|520923418|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
144471320|NCT00500903|520923419|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
144471321|NCT00500903|520923417|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
144471322|NCT00500903|520923418|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
144471323|NCT00500903|520923419|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
144471324|NCT00500903|520923417|FG000|Overall Study|Progressive Disease|41|||
144471325|NCT00500903|520923418|FG001|Overall Study|Progressive Disease|2|||
144471326|NCT00500903|520923419|FG002|Overall Study|Progressive Disease|15|||
144471327|NCT00500903|520923417|FG000|Overall Study|Patient Declined Further Treatment|0|||
144471328|NCT00500903|520923418|FG001|Overall Study|Patient Declined Further Treatment|0|||
144471329|NCT00500903|520923419|FG002|Overall Study|Patient Declined Further Treatment|3|||
144471330|NCT00500903|520923417|FG000|Overall Study|Symptomatic Deterioration|2|||
144471331|NCT00500903|520923418|FG001|Overall Study|Symptomatic Deterioration|0|||
144198534|NCT03188718|519925060|FG000|Overall Study|Participant noncompliance|4|||
144259311|NCT00511810|520150364|FG001|Overall Study|Refused second scn|1|||
144471332|NCT00500903|520923419|FG002|Overall Study|Symptomatic Deterioration|0|||
144471333|NCT00500903|520923417|FG000|Overall Study|Reason Not Specified|10|||
144471334|NCT00500903|520923418|FG001|Overall Study|Reason Not Specified|0|||
144471335|NCT00500903|520923419|FG002|Overall Study|Reason Not Specified|2|||
144471336|NCT04058353|520923420|FG000|Overall Study|Adverse Event|2|||
144471337|NCT04058353|520923421|FG001|Overall Study|Adverse Event|1|||
144471338|NCT04058353|520923420|FG000|Overall Study|Physician Decision|1|||
144538111|NCT03211247|521172371|FG002|Overall Study|Non-compliance with study drug|0|||
144538112|NCT03211247|521172372|FG003|Overall Study|Non-compliance with study drug|0|||
144538113|NCT03211247|521172373|FG004|Overall Study|Non-compliance with study drug|0|||
144538114|NCT03211247|521172369|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
144538115|NCT03211247|521172370|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
144198535|NCT03188718|519925060|FG000|Overall Study|Withdrawal by Subject|1|||
144198536|NCT03188718|519925060|FG000|Overall Study|Device failure|3|||
144198537|NCT05855616|519925064|FG000|Overall Study|Lost to Follow-up|1|||
144198538|NCT05855616|519925065|FG001|Overall Study|Lost to Follow-up|2|||
144198539|NCT04032158|519925066|FG000|Overall Study|Study Termination|2|||
144198540|NCT04032158|519925067|FG001|Overall Study|Study Termination|1|||
144198541|NCT00824616|519925068|FG000|Overall Study|Adverse Event|2|||
144198542|NCT00824616|519925069|FG001|Overall Study|Adverse Event|1|||
144198543|NCT00824616|519925068|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
144198544|NCT00824616|519925069|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
144198545|NCT00824616|519925068|FG000|Overall Study|Hyperglycemia|1|||
144198546|NCT00824616|519925069|FG001|Overall Study|Hyperglycemia|1|||
144198547|NCT00824616|519925068|FG000|Overall Study|Lack of Efficacy|2|||
144198548|NCT00824616|519925069|FG001|Overall Study|Lack of Efficacy|1|||
144198549|NCT00824616|519925068|FG000|Overall Study|Lost to Follow-up|0|||
144198550|NCT00824616|519925069|FG001|Overall Study|Lost to Follow-up|1|||
144198551|NCT00824616|519925068|FG000|Overall Study|Withdrawal by Subject|1|||
144198552|NCT00824616|519925069|FG001|Overall Study|Withdrawal by Subject|1|||
144198553|NCT00577395|519925070|FG000|Overall Study|Study was terminated early by Sponsor|7|||
144198554|NCT00577395|519925071|FG001|Overall Study|Study was terminated early by Sponsor|6|||
144198555|NCT02963311|519925072|FG000|Overall Study|Withdrawal by Subject|1|||
144198556|NCT02963311|519925072|FG000|Overall Study|Screen Failure|4|||
144198557|NCT04442490|519925073|FG000|Overall Study|Withdrawal by Subject|18|||
144198558|NCT04442490|519925074|FG001|Overall Study|Withdrawal by Subject|10|||
144198559|NCT04442490|519925073|FG000|Overall Study|Lost to Follow-up|7|||
144198560|NCT04442490|519925074|FG001|Overall Study|Lost to Follow-up|7|||
144198561|NCT04442490|519925073|FG000|Overall Study|Adverse Event|2|||
144198562|NCT04442490|519925074|FG001|Overall Study|Adverse Event|6|||
144198563|NCT04442490|519925073|FG000|Overall Study|Noncompliance|3|||
144198564|NCT04442490|519925074|FG001|Overall Study|Noncompliance|1|||
144198565|NCT04442490|519925073|FG000|Overall Study|Physician Decision|2|||
144198566|NCT04442490|519925074|FG001|Overall Study|Physician Decision|1|||
144198567|NCT04442490|519925073|FG000|Overall Study|Reason not Specified|2|||
144198568|NCT04442490|519925074|FG001|Overall Study|Reason not Specified|1|||
144198569|NCT04442490|519925073|FG000|Overall Study|Randomized but not Treated|3|||
144198570|NCT04442490|519925074|FG001|Overall Study|Randomized but not Treated|3|||
144198571|NCT01449279|519925075|FG000|Overall Study|Lack of Efficacy|5|||
144198572|NCT01449279|519925075|FG000|Overall Study|Toxicity|2|||
144198573|NCT00158600|519925080|FG000|Overall Study|unable to commit time to study|0|||
144198574|NCT00158600|519925081|FG001|Overall Study|unable to commit time to study|1|||
144198575|NCT00158600|519925080|FG000|Overall Study|Adverse Event|2|||
144198576|NCT00158600|519925081|FG001|Overall Study|Adverse Event|1|||
144198577|NCT00158600|519925080|FG000|Overall Study|Death|1|||
144198578|NCT00158600|519925081|FG001|Overall Study|Death|0|||
144198579|NCT00158600|519925080|FG000|Overall Study|Withdrawal by Subject|2|||
144198580|NCT00158600|519925081|FG001|Overall Study|Withdrawal by Subject|2|||
144198581|NCT02038907|519925082|FG000|Overall Study|Protocol Violation|0|||
144198582|NCT02038907|519925083|FG001|Overall Study|Protocol Violation|0|||
144198583|NCT02038907|519925084|FG002|Overall Study|Protocol Violation|0|||
144198584|NCT02038907|519925085|FG003|Overall Study|Protocol Violation|0|||
144198585|NCT02038907|519925086|FG004|Overall Study|Protocol Violation|0|||
144198586|NCT02038907|519925087|FG005|Overall Study|Protocol Violation|0|||
144198587|NCT02038907|519925088|FG006|Overall Study|Protocol Violation|0|||
144198588|NCT02038907|519925089|FG007|Overall Study|Protocol Violation|0|||
144198589|NCT02038907|519925090|FG008|Overall Study|Protocol Violation|0|||
144198590|NCT02038907|519925091|FG009|Overall Study|Protocol Violation|0|||
144198591|NCT02038907|519925092|FG010|Overall Study|Protocol Violation|1|||
144198592|NCT02038907|519925093|FG011|Overall Study|Protocol Violation|0|||
144198593|NCT02038907|519925094|FG012|Overall Study|Protocol Violation|0|||
144198594|NCT02038907|519925095|FG013|Overall Study|Protocol Violation|0|||
144198595|NCT02038907|519925082|FG000|Overall Study|Withdrawal by Subject|0|||
144198596|NCT02038907|519925083|FG001|Overall Study|Withdrawal by Subject|0|||
144198597|NCT02038907|519925084|FG002|Overall Study|Withdrawal by Subject|0|||
144198598|NCT02038907|519925085|FG003|Overall Study|Withdrawal by Subject|0|||
144198599|NCT02038907|519925086|FG004|Overall Study|Withdrawal by Subject|0|||
144198600|NCT02038907|519925087|FG005|Overall Study|Withdrawal by Subject|0|||
144198601|NCT02038907|519925088|FG006|Overall Study|Withdrawal by Subject|0|||
144198602|NCT02038907|519925089|FG007|Overall Study|Withdrawal by Subject|0|||
144198603|NCT02038907|519925090|FG008|Overall Study|Withdrawal by Subject|0|||
144198604|NCT02038907|519925091|FG009|Overall Study|Withdrawal by Subject|0|||
144198605|NCT02038907|519925092|FG010|Overall Study|Withdrawal by Subject|1|||
144198606|NCT02038907|519925093|FG011|Overall Study|Withdrawal by Subject|0|||
144538116|NCT03211247|521172371|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
144538117|NCT03211247|521172372|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
144538118|NCT03211247|521172373|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
144198607|NCT02038907|519925094|FG012|Overall Study|Withdrawal by Subject|0|||
144198608|NCT02038907|519925095|FG013|Overall Study|Withdrawal by Subject|0|||
144198609|NCT03579966|519925098|FG000|Overall Study|Adverse Event|6|||
144198610|NCT03579966|519925098|FG000|Overall Study|Lost to Follow-up|4|||
144198611|NCT03579966|519925098|FG000|Overall Study|Physician Decision|10|||
144198612|NCT03579966|519925098|FG000|Overall Study|Pregnancy|1|||
144198613|NCT03579966|519925098|FG000|Overall Study|Withdrawal by Subject|16|||
144198614|NCT03579966|519925098|FG000|Overall Study|Study terminated by Sponsor|22|||
144198615|NCT03579966|519925098|FG000|Overall Study|Protocol Violation|1|||
144198616|NCT01340768|519925099|FG000|Overall Study|Lost to Follow-up|10|||
144198617|NCT01340768|519925100|FG001|Overall Study|Lost to Follow-up|4|||
144198618|NCT01340768|519925099|FG000|Overall Study|Withdrawal by Subject|5|||
144198619|NCT01340768|519925100|FG001|Overall Study|Withdrawal by Subject|1|||
144198620|NCT01340768|519925099|FG000|Overall Study|Other|2|||
144198621|NCT01340768|519925100|FG001|Overall Study|Other|0|||
144198622|NCT03052959|519925101|FG000|Overall Study|Lost to Follow-up|4|||
144198623|NCT03052959|519925102|FG001|Overall Study|Lost to Follow-up|5|||
144198624|NCT02992418|519925103|FG000|Overall Study|Withdrawal by Subject|11|||
144198625|NCT02992418|519925104|FG001|Overall Study|Withdrawal by Subject|12|||
144198626|NCT02992418|519925103|FG000|Overall Study|Non-compliance with the protocol|308|||
144198627|NCT02992418|519925104|FG001|Overall Study|Non-compliance with the protocol|308|||
144198628|NCT02992418|519925103|FG000|Overall Study|Lost to Follow-up|27|||
144198629|NCT02992418|519925104|FG001|Overall Study|Lost to Follow-up|22|||
144198630|NCT04465630|519925105|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
144198631|NCT04465630|519925105|FG000|Overall Study|Screen failure|8|||
144198632|NCT04465630|519925105|FG000|Overall Study|Baseline failure|16|||
144198633|NCT01087489|519925106|FG000|Overall Study|enrolled in another VA study|0|||
144198634|NCT01087489|519925107|FG001|Overall Study|enrolled in another VA study|1|||
144198635|NCT01087489|519925106|FG000|Overall Study|Death|0|||
144198636|NCT01087489|519925107|FG001|Overall Study|Death|1|||
144198637|NCT01087489|519925106|FG000|Overall Study|unable to survey by telephone|0|||
144198638|NCT01087489|519925107|FG001|Overall Study|unable to survey by telephone|1|||
144198639|NCT04620135|519925111|FG000|Study Completion|Adverse Event|2|||
144198640|NCT04620135|519925112|FG001|Study Completion|Adverse Event|3|||
144198641|NCT04620135|519925111|FG000|Study Completion|Withdrawal by Subject|2|||
144198642|NCT04620135|519925112|FG001|Study Completion|Withdrawal by Subject|0|||
144198643|NCT02005887|519925113|FG000|Overall Study|Protocol Violation|0|||
144198644|NCT02005887|519925114|FG001|Overall Study|Protocol Violation|2|||
144198645|NCT04771403|519925115|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
144198646|NCT04771403|519925116|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
144198647|NCT04771403|519925115|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
144198648|NCT04771403|519925116|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
144198649|NCT04771403|519925115|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
144198650|NCT04771403|519925116|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
144198651|NCT04771403|519925115|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
144198652|NCT04771403|519925116|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
144198653|NCT04771403|519925115|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
144198654|NCT04771403|519925116|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
144198655|NCT04771403|519925115|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
144198656|NCT04771403|519925116|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
144198657|NCT04771403|519925115|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
144198658|NCT04771403|519925116|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
144198659|NCT04771403|519925115|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
144198660|NCT04771403|519925116|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
144198661|NCT01615263|519925117|FG000|Overall Study|Post-randomization exclusion|0|||
144198662|NCT01615263|519925118|FG001|Overall Study|Post-randomization exclusion|2|||
144198663|NCT00857259|519925119|FG000|Overall Study|Protocol Violation|1|||
144198664|NCT00857259|519925120|FG001|Overall Study|Protocol Violation|0|||
144198665|NCT00857259|519925121|FG002|Overall Study|Protocol Violation|1|||
144198666|NCT02701413|519925122|FG000|Overall Study|Withdrawal by Subject|7|||
144198667|NCT02701413|519925123|FG001|Overall Study|Withdrawal by Subject|11|||
144258739|NCT02959918|520148596|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258740|NCT02959918|520148597|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258741|NCT02959918|520148598|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258742|NCT02959918|520148599|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
144258743|NCT02959918|520148586|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258744|NCT02959918|520148587|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258745|NCT02959918|520148588|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258746|NCT02959918|520148589|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258747|NCT02959918|520148590|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258748|NCT02959918|520148591|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258749|NCT02959918|520148592|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258750|NCT02959918|520148593|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
144258751|NCT02959918|520148594|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258752|NCT02959918|520148595|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258753|NCT02959918|520148596|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258754|NCT02959918|520148597|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258755|NCT02959918|520148598|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258756|NCT02959918|520148599|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
144258757|NCT02959918|520148586|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258758|NCT02959918|520148587|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258759|NCT02959918|520148588|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258760|NCT02959918|520148589|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258761|NCT02959918|520148590|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258762|NCT02959918|520148591|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258763|NCT02959918|520148592|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258764|NCT02959918|520148593|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258765|NCT02959918|520148594|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
144258766|NCT02959918|520148595|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258767|NCT02959918|520148596|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258768|NCT02959918|520148597|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258769|NCT02959918|520148598|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258770|NCT02959918|520148599|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
144258771|NCT02959918|520148586|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258772|NCT02959918|520148587|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258773|NCT02959918|520148588|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258774|NCT02959918|520148589|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258775|NCT02959918|520148590|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258776|NCT02959918|520148591|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258777|NCT02959918|520148592|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258778|NCT02959918|520148593|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258779|NCT02959918|520148594|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258780|NCT02959918|520148595|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
144258781|NCT02959918|520148596|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258782|NCT02959918|520148597|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258783|NCT02959918|520148598|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258784|NCT02959918|520148599|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
144258785|NCT02364388|520148600|FG000|Overall Study|Protocol Violation|1|||
144258786|NCT02364388|520148600|FG000|Overall Study|Technical Failure|3|||
144258787|NCT02364388|520148600|FG000|Overall Study|No OA/US data|2|||
144258788|NCT02364388|520148600|FG000|Overall Study|No Biopsy|2|||
144258789|NCT03414229|520148601|FG000|Overall Study|Adverse Event|1|||
144258790|NCT03414229|520148602|FG001|Overall Study|Adverse Event|0|||
144258791|NCT03414229|520148603|FG002|Overall Study|Adverse Event|2|||
144258792|NCT03414229|520148604|FG003|Overall Study|Adverse Event|1|||
144258793|NCT03414229|520148601|FG000|Overall Study|Lack of Efficacy|7|||
144258794|NCT03414229|520148602|FG001|Overall Study|Lack of Efficacy|4|||
144258795|NCT03414229|520148603|FG002|Overall Study|Lack of Efficacy|1|||
144258796|NCT03414229|520148604|FG003|Overall Study|Lack of Efficacy|9|||
144258797|NCT03414229|520148601|FG000|Overall Study|Change in therapy|1|||
144258798|NCT03414229|520148602|FG001|Overall Study|Change in therapy|0|||
144258799|NCT03414229|520148603|FG002|Overall Study|Change in therapy|0|||
144258800|NCT03414229|520148604|FG003|Overall Study|Change in therapy|0|||
144258801|NCT03414229|520148601|FG000|Overall Study|Pregnancy|0|||
144258802|NCT03414229|520148602|FG001|Overall Study|Pregnancy|0|||
144258803|NCT03414229|520148603|FG002|Overall Study|Pregnancy|1|||
144258804|NCT03414229|520148604|FG003|Overall Study|Pregnancy|0|||
144258805|NCT03414229|520148601|FG000|Overall Study|Withdrawal by Subject|0|||
144258806|NCT03414229|520148602|FG001|Overall Study|Withdrawal by Subject|1|||
144258807|NCT03414229|520148603|FG002|Overall Study|Withdrawal by Subject|1|||
144258808|NCT03414229|520148604|FG003|Overall Study|Withdrawal by Subject|0|||
144538119|NCT03211247|521172369|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
144538120|NCT03211247|521172370|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
144538121|NCT03211247|521172371|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
144538122|NCT03211247|521172372|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
144538123|NCT03211247|521172373|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
144538124|NCT03211247|521172369|FG000|Overall Study|Protocol Violation|0|||
144538125|NCT03211247|521172370|FG001|Overall Study|Protocol Violation|1|||
144538126|NCT03211247|521172371|FG002|Overall Study|Protocol Violation|0|||
144538127|NCT03211247|521172372|FG003|Overall Study|Protocol Violation|0|||
144538128|NCT03211247|521172373|FG004|Overall Study|Protocol Violation|0|||
144538129|NCT02415127|521172374|FG000|Overall Study|Adverse Event|1|||
144538130|NCT02415127|521172375|FG001|Overall Study|Adverse Event|0|||
144538131|NCT02678689|521172376|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
144538132|NCT02678689|521172377|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
144538133|NCT02549352|521172378|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
144538134|NCT02549352|521172379|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
144726950|NCT05630547|521854413|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
144258809|NCT04533438|520148608|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
144258810|NCT04533438|520148609|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
144258811|NCT05568797|520148613|FG000|Overall Study|Adverse Event|0|||
144258812|NCT05568797|520148614|FG001|Overall Study|Adverse Event|8|||
144258813|NCT05568797|520148613|FG000|Overall Study|Lost to Follow-up|2|||
144258814|NCT05568797|520148614|FG001|Overall Study|Lost to Follow-up|3|||
144258815|NCT05568797|520148613|FG000|Overall Study|Withdrawal by Subject|1|||
144258816|NCT05568797|520148614|FG001|Overall Study|Withdrawal by Subject|10|||
144258817|NCT05568797|520148613|FG000|Overall Study|Other|2|||
144258818|NCT05568797|520148614|FG001|Overall Study|Other|2|||
144258819|NCT02998996|520148636|FG000|Overall Study|Lost to Follow-up|0|||
144258820|NCT02998996|520148637|FG001|Overall Study|Lost to Follow-up|0|||
144258821|NCT02998996|520148638|FG002|Overall Study|Lost to Follow-up|1|||
144258822|NCT02998996|520148639|FG003|Overall Study|Lost to Follow-up|0|||
144258823|NCT02998996|520148640|FG004|Overall Study|Lost to Follow-up|0|||
144258824|NCT02998996|520148641|FG005|Overall Study|Lost to Follow-up|0|||
144258825|NCT02998996|520148636|FG000|Overall Study|Pregnancy|0|||
144258826|NCT02998996|520148637|FG001|Overall Study|Pregnancy|1|||
144258827|NCT02998996|520148638|FG002|Overall Study|Pregnancy|0|||
144258828|NCT02998996|520148639|FG003|Overall Study|Pregnancy|0|||
144258829|NCT02998996|520148640|FG004|Overall Study|Pregnancy|0|||
144258830|NCT02998996|520148641|FG005|Overall Study|Pregnancy|0|||
144258831|NCT02998996|520148636|FG000|Overall Study|Family reasons|0|||
144258832|NCT02998996|520148637|FG001|Overall Study|Family reasons|0|||
144258833|NCT02998996|520148638|FG002|Overall Study|Family reasons|0|||
144258834|NCT02998996|520148639|FG003|Overall Study|Family reasons|0|||
144258835|NCT02998996|520148640|FG004|Overall Study|Family reasons|1|||
144258836|NCT02998996|520148641|FG005|Overall Study|Family reasons|0|||
144258837|NCT01670045|520148644|FG000|Overall Study|Withdrawal by Subject|3|||
144258838|NCT01670045|520148644|FG000|Overall Study|Adverse Event|1|||
144258839|NCT01670045|520148644|FG000|Overall Study|Death|1|||
144258840|NCT01670045|520148644|FG000|Overall Study|Lost to Follow-up|11|||
144258841|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
144258842|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
144258843|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
144258844|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
144258845|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
144258846|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
144258847|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
144258848|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
144258849|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
144258850|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
144258851|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
144258852|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
144258853|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
144258854|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
144258855|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
144258856|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
144258857|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
144259312|NCT01300247|520150367|FG000|Overall Study|Death|1|||
144538135|NCT02549352|521172378|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
144198668|NCT02138136|519925124|FG000|Overall Study|Protocol Violation|4|||
144198669|NCT02138136|519925124|FG000|Overall Study|Physician Decision|7|||
144198670|NCT02138136|519925124|FG000|Overall Study|Lack of Efficacy|35|||
144198671|NCT02138136|519925124|FG000|Overall Study|Pregnancy|2|||
144198672|NCT02138136|519925124|FG000|Overall Study|Adverse Event|18|||
144198673|NCT02138136|519925124|FG000|Overall Study|Withdrawal by Subject|36|||
144198674|NCT02138136|519925124|FG000|Overall Study|Lost to Follow-up|32|||
144198675|NCT02138136|519925124|FG000|Overall Study|Withdrawn by Sponsor|5|||
144198676|NCT01359644|519925129|FG000|Treatment Period|Lack of Efficacy|0|||
144198677|NCT01359644|519925130|FG001|Treatment Period|Lack of Efficacy|1|||
144198678|NCT01359644|519925131|FG002|Treatment Period|Lack of Efficacy|0|||
144198679|NCT01359644|519925132|FG003|Treatment Period|Lack of Efficacy|0|||
144198680|NCT01359644|519925133|FG004|Treatment Period|Lack of Efficacy|0|||
144198681|NCT01359644|519925134|FG005|Treatment Period|Lack of Efficacy|0|||
144198682|NCT01359644|519925135|FG006|Treatment Period|Lack of Efficacy|0|||
144198683|NCT01359644|519925136|FG007|Treatment Period|Lack of Efficacy|0|||
144198684|NCT01359644|519925137|FG008|Treatment Period|Lack of Efficacy|0|||
144471339|NCT04058353|520923421|FG001|Overall Study|Physician Decision|0|||
144471340|NCT04058353|520923420|FG000|Overall Study|Other|1|||
144471341|NCT04058353|520923421|FG001|Overall Study|Other|0|||
144471342|NCT02390531|520923422|FG000|Overall Study|Death|0|||
144471343|NCT02390531|520923423|FG001|Overall Study|Death|2|||
144471344|NCT02390531|520923424|FG002|Overall Study|Death|0|||
144471345|NCT02390531|520923425|FG003|Overall Study|Death|1|||
144471346|NCT02390531|520923426|FG004|Overall Study|Death|0|||
144471347|NCT02390531|520923427|FG005|Overall Study|Death|0|||
144471348|NCT02390531|520923428|FG006|Overall Study|Death|0|||
144471349|NCT02390531|520923429|FG007|Overall Study|Death|1|||
144471350|NCT02390531|520923422|FG000|Overall Study|Protocol Violation|0|||
144471351|NCT02390531|520923423|FG001|Overall Study|Protocol Violation|0|||
144471352|NCT02390531|520923424|FG002|Overall Study|Protocol Violation|0|||
144471353|NCT02390531|520923425|FG003|Overall Study|Protocol Violation|0|||
144471354|NCT02390531|520923426|FG004|Overall Study|Protocol Violation|1|||
144471355|NCT02390531|520923427|FG005|Overall Study|Protocol Violation|0|||
144471356|NCT02390531|520923428|FG006|Overall Study|Protocol Violation|2|||
144471357|NCT02390531|520923429|FG007|Overall Study|Protocol Violation|0|||
144471358|NCT02618616|520923430|FG000|Overall Study|Lack of Efficacy|4|||
144471359|NCT02618616|520923431|FG001|Overall Study|Lack of Efficacy|0|||
144471360|NCT02618616|520923430|FG000|Overall Study|Pregnancy|0|||
144471361|NCT02618616|520923431|FG001|Overall Study|Pregnancy|1|||
144471362|NCT02618616|520923430|FG000|Overall Study|Adverse Event|8|||
144471363|NCT02618616|520923431|FG001|Overall Study|Adverse Event|0|||
144471364|NCT02618616|520923430|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
144471365|NCT02618616|520923431|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
144471366|NCT02618616|520923430|FG000|Overall Study|Consent withdrawn by subject|8|||
144471367|NCT02618616|520923431|FG001|Overall Study|Consent withdrawn by subject|5|||
144471368|NCT02618616|520923430|FG000|Overall Study|Lost to Follow-up|0|||
144471369|NCT02618616|520923431|FG001|Overall Study|Lost to Follow-up|1|||
144471370|NCT01951638|520923432|FG000|Treatment Period|Protocol Violation|0|||
144471371|NCT01951638|520923433|FG001|Treatment Period|Protocol Violation|0|||
144471372|NCT01951638|520923434|FG002|Treatment Period|Protocol Violation|0|||
144471373|NCT01951638|520923435|FG003|Treatment Period|Protocol Violation|2|||
144471374|NCT01951638|520923436|FG004|Treatment Period|Protocol Violation|0|||
144471375|NCT01951638|520923432|FG000|Treatment Period|Protocol-driven decision point|1|||
144471376|NCT01951638|520923433|FG001|Treatment Period|Protocol-driven decision point|3|||
144471377|NCT01951638|520923434|FG002|Treatment Period|Protocol-driven decision point|0|||
144471378|NCT01951638|520923435|FG003|Treatment Period|Protocol-driven decision point|0|||
144471379|NCT01951638|520923436|FG004|Treatment Period|Protocol-driven decision point|0|||
144198685|NCT01359644|519925138|FG009|Treatment Period|Lack of Efficacy|0|||
144198686|NCT01359644|519925129|FG000|Treatment Period|Adverse Event|0|||
144198687|NCT01359644|519925130|FG001|Treatment Period|Adverse Event|0|||
144198688|NCT01359644|519925131|FG002|Treatment Period|Adverse Event|1|||
144198689|NCT01359644|519925132|FG003|Treatment Period|Adverse Event|0|||
144471380|NCT01951638|520923432|FG000|Treatment Period|Logistical difficulties|0|||
144471381|NCT01951638|520923433|FG001|Treatment Period|Logistical difficulties|1|||
144471382|NCT01951638|520923434|FG002|Treatment Period|Logistical difficulties|1|||
144471383|NCT01951638|520923435|FG003|Treatment Period|Logistical difficulties|0|||
144198690|NCT01359644|519925133|FG004|Treatment Period|Adverse Event|0|||
144198691|NCT01359644|519925134|FG005|Treatment Period|Adverse Event|1|||
144471384|NCT01951638|520923436|FG004|Treatment Period|Logistical difficulties|0|||
144471385|NCT01951638|520923432|FG000|Treatment Period|Withdrawal by Subject|9|||
144471386|NCT01951638|520923433|FG001|Treatment Period|Withdrawal by Subject|6|||
144471387|NCT01951638|520923434|FG002|Treatment Period|Withdrawal by Subject|4|||
144471388|NCT01951638|520923435|FG003|Treatment Period|Withdrawal by Subject|5|||
144471389|NCT01951638|520923436|FG004|Treatment Period|Withdrawal by Subject|4|||
144471390|NCT01951638|520923432|FG000|Treatment Period|Death|0|||
144471391|NCT01951638|520923433|FG001|Treatment Period|Death|0|||
144471392|NCT01951638|520923434|FG002|Treatment Period|Death|0|||
144471393|NCT01951638|520923435|FG003|Treatment Period|Death|3|||
144471394|NCT01951638|520923436|FG004|Treatment Period|Death|1|||
144258858|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
144258859|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
144258860|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
144258861|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
144258862|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
144258863|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
144258864|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
144258865|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
144258866|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
144258867|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
144258868|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
144258869|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
144258870|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
144258871|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
144258872|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
144258873|NCT03538691|520148646|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
144258874|NCT03538691|520148647|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
144258875|NCT03538691|520148648|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
144258876|NCT03538691|520148649|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
144258877|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
144258878|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
144258879|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
144258880|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
144258881|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
144471395|NCT01951638|520923432|FG000|Treatment Period|Adverse Event|3|||
144471396|NCT01951638|520923433|FG001|Treatment Period|Adverse Event|4|||
144471397|NCT01951638|520923434|FG002|Treatment Period|Adverse Event|8|||
144471398|NCT01951638|520923435|FG003|Treatment Period|Adverse Event|6|||
144471399|NCT01951638|520923436|FG004|Treatment Period|Adverse Event|5|||
144471400|NCT01951638|520923432|FG000|Follow-up Period|Protocol Violation|0|||
144471401|NCT01951638|520923433|FG001|Follow-up Period|Protocol Violation|0|||
144471402|NCT01951638|520923434|FG002|Follow-up Period|Protocol Violation|0|||
144538136|NCT02549352|521172379|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
144538137|NCT02549352|521172378|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
144538138|NCT02549352|521172379|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
144538139|NCT02549352|521172378|FG000|12-month Follow-up|Withdrawal by Subject|4|||
144471403|NCT01951638|520923435|FG003|Follow-up Period|Protocol Violation|1|||
144538140|NCT02549352|521172379|FG001|12-month Follow-up|Withdrawal by Subject|5|||
144538141|NCT02549352|521172378|FG000|12-month Follow-up|Lost to Follow-up|3|||
144538142|NCT02549352|521172379|FG001|12-month Follow-up|Lost to Follow-up|2|||
144538143|NCT02549352|521172378|FG000|12-month Follow-up|Death|0|||
144538144|NCT02549352|521172379|FG001|12-month Follow-up|Death|1|||
144614736|NCT00708500|521450184|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
144471404|NCT01951638|520923436|FG004|Follow-up Period|Protocol Violation|0|||
144471405|NCT01951638|520923432|FG000|Follow-up Period|Logistical difficulties|0|||
144471406|NCT01951638|520923433|FG001|Follow-up Period|Logistical difficulties|2|||
144471407|NCT01951638|520923434|FG002|Follow-up Period|Logistical difficulties|0|||
144471408|NCT01951638|520923435|FG003|Follow-up Period|Logistical difficulties|0|||
144471409|NCT01951638|520923436|FG004|Follow-up Period|Logistical difficulties|1|||
144471410|NCT01951638|520923432|FG000|Follow-up Period|Withdrawal by Subject|1|||
144471411|NCT01951638|520923433|FG001|Follow-up Period|Withdrawal by Subject|5|||
144471412|NCT01951638|520923434|FG002|Follow-up Period|Withdrawal by Subject|2|||
144471413|NCT01951638|520923435|FG003|Follow-up Period|Withdrawal by Subject|1|||
144471414|NCT01951638|520923436|FG004|Follow-up Period|Withdrawal by Subject|2|||
144471415|NCT01951638|520923432|FG000|Follow-up Period|Lost to Follow-up|0|||
144471416|NCT01951638|520923433|FG001|Follow-up Period|Lost to Follow-up|1|||
144471417|NCT01951638|520923434|FG002|Follow-up Period|Lost to Follow-up|0|||
144471418|NCT01951638|520923435|FG003|Follow-up Period|Lost to Follow-up|1|||
144471419|NCT01951638|520923436|FG004|Follow-up Period|Lost to Follow-up|0|||
144471420|NCT01951638|520923432|FG000|Follow-up Period|Death|1|||
144471421|NCT01951638|520923433|FG001|Follow-up Period|Death|0|||
144471422|NCT01951638|520923434|FG002|Follow-up Period|Death|1|||
144471423|NCT01951638|520923435|FG003|Follow-up Period|Death|4|||
144471424|NCT01951638|520923436|FG004|Follow-up Period|Death|1|||
144471425|NCT01951638|520923432|FG000|Follow-up Period|Adverse Event|0|||
144538145|NCT02549352|521172378|FG000|12-month Follow-up|Protocol Violation|0|||
144538146|NCT02549352|521172379|FG001|12-month Follow-up|Protocol Violation|1|||
144538147|NCT02549352|521172378|FG000|12-month Follow-up|Other|1|||
144614737|NCT00708500|521450185|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
144198692|NCT01359644|519925135|FG006|Treatment Period|Adverse Event|0|||
144198693|NCT01359644|519925136|FG007|Treatment Period|Adverse Event|0|||
144198694|NCT01359644|519925137|FG008|Treatment Period|Adverse Event|0|||
144198695|NCT01359644|519925138|FG009|Treatment Period|Adverse Event|0|||
144198696|NCT01359644|519925129|FG000|Treatment Period|Lost to Follow-up|0|||
144198697|NCT01359644|519925130|FG001|Treatment Period|Lost to Follow-up|0|||
144198698|NCT01359644|519925131|FG002|Treatment Period|Lost to Follow-up|0|||
144198699|NCT01359644|519925132|FG003|Treatment Period|Lost to Follow-up|0|||
144198700|NCT01359644|519925133|FG004|Treatment Period|Lost to Follow-up|0|||
144198701|NCT01359644|519925134|FG005|Treatment Period|Lost to Follow-up|1|||
144198702|NCT01359644|519925135|FG006|Treatment Period|Lost to Follow-up|0|||
144198703|NCT01359644|519925136|FG007|Treatment Period|Lost to Follow-up|0|||
144198704|NCT01359644|519925137|FG008|Treatment Period|Lost to Follow-up|0|||
144198705|NCT01359644|519925138|FG009|Treatment Period|Lost to Follow-up|0|||
144198706|NCT01359644|519925129|FG000|Follow-up Period|Withdrawal by Subject|0|||
144198707|NCT01359644|519925130|FG001|Follow-up Period|Withdrawal by Subject|0|||
144198708|NCT01359644|519925131|FG002|Follow-up Period|Withdrawal by Subject|0|||
144198709|NCT01359644|519925132|FG003|Follow-up Period|Withdrawal by Subject|0|||
144198710|NCT01359644|519925133|FG004|Follow-up Period|Withdrawal by Subject|0|||
144198711|NCT01359644|519925134|FG005|Follow-up Period|Withdrawal by Subject|1|||
144198712|NCT01359644|519925135|FG006|Follow-up Period|Withdrawal by Subject|0|||
144198713|NCT01359644|519925136|FG007|Follow-up Period|Withdrawal by Subject|0|||
144198714|NCT01359644|519925137|FG008|Follow-up Period|Withdrawal by Subject|0|||
144198715|NCT01359644|519925138|FG009|Follow-up Period|Withdrawal by Subject|0|||
144198716|NCT01359644|519925129|FG000|Follow-up Period|Lost to Follow-up|0|||
144198717|NCT01359644|519925130|FG001|Follow-up Period|Lost to Follow-up|0|||
144198718|NCT01359644|519925131|FG002|Follow-up Period|Lost to Follow-up|0|||
144198719|NCT01359644|519925132|FG003|Follow-up Period|Lost to Follow-up|0|||
144198720|NCT01359644|519925133|FG004|Follow-up Period|Lost to Follow-up|0|||
144198721|NCT01359644|519925134|FG005|Follow-up Period|Lost to Follow-up|0|||
144198722|NCT01359644|519925135|FG006|Follow-up Period|Lost to Follow-up|1|||
144198723|NCT01359644|519925136|FG007|Follow-up Period|Lost to Follow-up|2|||
144198724|NCT01359644|519925137|FG008|Follow-up Period|Lost to Follow-up|0|||
144614738|NCT00708500|521450186|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
144614739|NCT00708500|521450184|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
144198725|NCT01359644|519925138|FG009|Follow-up Period|Lost to Follow-up|0|||
144198726|NCT01660334|519925140|FG000|Overall Study|Lost to Follow-up|1|||
144198727|NCT00311311|519925141|FG000|Overall Study|Adverse Event|3|||
144471426|NCT01951638|520923433|FG001|Follow-up Period|Adverse Event|1|||
144471427|NCT01951638|520923434|FG002|Follow-up Period|Adverse Event|2|||
144471428|NCT01951638|520923435|FG003|Follow-up Period|Adverse Event|1|||
144198728|NCT00311311|519925142|FG001|Overall Study|Adverse Event|2|||
144471429|NCT01951638|520923436|FG004|Follow-up Period|Adverse Event|1|||
144471430|NCT04225988|520923437|FG000|Overall Study|Withdrawal by Subject|2|||
144471431|NCT04225988|520923438|FG001|Overall Study|Withdrawal by Subject|0|||
144471432|NCT00514683|520925208|FG000|Overall Study|Not treated|2|||
144471433|NCT00514683|520925209|FG001|Overall Study|Not treated|1|||
144471434|NCT00514683|520925210|FG002|Overall Study|Not treated|0|||
144471435|NCT00514683|520925211|FG003|Overall Study|Not treated|0|||
144471436|NCT00514683|520925212|FG004|Overall Study|Not treated|1|||
144471437|NCT00514683|520925208|FG000|Overall Study|Adverse Event|21|||
144471438|NCT00514683|520925209|FG001|Overall Study|Adverse Event|20|||
144471439|NCT00514683|520925210|FG002|Overall Study|Adverse Event|15|||
144471440|NCT00514683|520925211|FG003|Overall Study|Adverse Event|13|||
144471441|NCT00514683|520925212|FG004|Overall Study|Adverse Event|27|||
144471442|NCT00514683|520925208|FG000|Overall Study|Protocol Violation|1|||
144471443|NCT00514683|520925209|FG001|Overall Study|Protocol Violation|1|||
144471444|NCT00514683|520925210|FG002|Overall Study|Protocol Violation|0|||
144471445|NCT00514683|520925211|FG003|Overall Study|Protocol Violation|1|||
144471446|NCT00514683|520925212|FG004|Overall Study|Protocol Violation|0|||
144471447|NCT00514683|520925208|FG000|Overall Study|Withdrawal by Subject|2|||
144471448|NCT00514683|520925209|FG001|Overall Study|Withdrawal by Subject|2|||
144471449|NCT00514683|520925210|FG002|Overall Study|Withdrawal by Subject|1|||
144471450|NCT00514683|520925211|FG003|Overall Study|Withdrawal by Subject|0|||
144471451|NCT00514683|520925212|FG004|Overall Study|Withdrawal by Subject|4|||
144471452|NCT00514683|520925208|FG000|Overall Study|Reason other than listed above|0|||
144471453|NCT00514683|520925209|FG001|Overall Study|Reason other than listed above|1|||
144471454|NCT00514683|520925210|FG002|Overall Study|Reason other than listed above|2|||
144198729|NCT00311311|519925141|FG000|Overall Study|Withdrawal by Subject|1|||
144198730|NCT00311311|519925142|FG001|Overall Study|Withdrawal by Subject|1|||
144198731|NCT00311311|519925141|FG000|Overall Study|Noncompliance|0|||
144198732|NCT00311311|519925142|FG001|Overall Study|Noncompliance|1|||
144198733|NCT00311311|519925141|FG000|Overall Study|Study Termination by Sponsor|3|||
144198734|NCT00311311|519925142|FG001|Overall Study|Study Termination by Sponsor|4|||
144471455|NCT00514683|520925211|FG003|Overall Study|Reason other than listed above|0|||
144471456|NCT00514683|520925212|FG004|Overall Study|Reason other than listed above|1|||
144471457|NCT01564368|520925219|FG000|Overall Study|Ineligible|18|||
144471458|NCT01564368|520925219|FG000|Overall Study|Not Randomized in Parent study|116|||
144471459|NCT01564368|520925219|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
144471460|NCT01564368|520925219|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
144471461|NCT01802437|520925223|FG000|Overall Study|Lost to Follow-up|1|||
144471462|NCT01802437|520925224|FG001|Overall Study|Lost to Follow-up|0|||
144471463|NCT01802437|520925223|FG000|Overall Study|Withdrawal by Subject|3|||
144471464|NCT01802437|520925224|FG001|Overall Study|Withdrawal by Subject|4|||
144471465|NCT05674890|520925225|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
144471466|NCT05674890|520925226|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
144471467|NCT05674890|520925225|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
144471468|NCT05674890|520925226|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
144471469|NCT05674890|520925225|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
144471470|NCT05674890|520925226|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
144471471|NCT02228967|520925227|FG000|Overall Study|Lost to Follow-up|146|||
144471472|NCT02228967|520925228|FG001|Overall Study|Lost to Follow-up|142|||
144471473|NCT02228967|520925227|FG000|Overall Study|Withdrawal by Subject|13|||
144471474|NCT02228967|520925228|FG001|Overall Study|Withdrawal by Subject|18|||
144471475|NCT00520975|520925229|FG000|Overall Study|Disease progression|31|||
144471476|NCT00520975|520925230|FG001|Overall Study|Disease progression|23|||
144471477|NCT00520975|520925229|FG000|Overall Study|Adverse Event|7|||
144471478|NCT00520975|520925230|FG001|Overall Study|Adverse Event|10|||
144471479|NCT00520975|520925229|FG000|Overall Study|Death|0|||
144471480|NCT00520975|520925230|FG001|Overall Study|Death|2|||
144471481|NCT00520975|520925229|FG000|Overall Study|Withdrawal by Subject|3|||
144471482|NCT00520975|520925230|FG001|Overall Study|Withdrawal by Subject|5|||
144471483|NCT00520975|520925229|FG000|Overall Study|Other therapy|2|||
144471484|NCT00520975|520925230|FG001|Overall Study|Other therapy|4|||
144471485|NCT00520975|520925229|FG000|Overall Study|Other reasons|4|||
144471486|NCT00520975|520925230|FG001|Overall Study|Other reasons|2|||
144471487|NCT00520975|520925229|FG000|Overall Study|Not start protocol therapy|1|||
144471488|NCT00520975|520925230|FG001|Overall Study|Not start protocol therapy|2|||
144471489|NCT04998604|520925231|FG000|Overall Study|Adverse Event|3|||
144471490|NCT04998604|520925232|FG001|Overall Study|Adverse Event|2|||
144471491|NCT04998604|520925231|FG000|Overall Study|Withdrawal by Subject|2|||
144471492|NCT04998604|520925232|FG001|Overall Study|Withdrawal by Subject|4|||
144471493|NCT04998604|520925231|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
144471494|NCT04998604|520925232|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
144471495|NCT00642902|520925233|FG000|Overall Study|Adverse Event|0|||
144471496|NCT00642902|520925234|FG001|Overall Study|Adverse Event|1|||
144471497|NCT00642902|520925235|FG002|Overall Study|Adverse Event|3|||
144471498|NCT00642902|520925236|FG003|Overall Study|Adverse Event|1|||
144471499|NCT00642902|520925233|FG000|Overall Study|Lost to Follow-up|1|||
144471500|NCT00642902|520925234|FG001|Overall Study|Lost to Follow-up|1|||
144471501|NCT00642902|520925235|FG002|Overall Study|Lost to Follow-up|0|||
144471502|NCT00642902|520925236|FG003|Overall Study|Lost to Follow-up|0|||
144471503|NCT00642902|520925233|FG000|Overall Study|Lack of Efficacy|0|||
144471504|NCT00642902|520925234|FG001|Overall Study|Lack of Efficacy|3|||
144471505|NCT00642902|520925235|FG002|Overall Study|Lack of Efficacy|3|||
144471506|NCT00642902|520925236|FG003|Overall Study|Lack of Efficacy|0|||
144471507|NCT00642902|520925233|FG000|Overall Study|Death|1|||
144471508|NCT00642902|520925234|FG001|Overall Study|Death|0|||
144471509|NCT00642902|520925235|FG002|Overall Study|Death|0|||
144471510|NCT00642902|520925236|FG003|Overall Study|Death|0|||
144471511|NCT00642902|520925233|FG000|Overall Study|Premature termination of clinical trial|37|||
144471512|NCT00642902|520925234|FG001|Overall Study|Premature termination of clinical trial|32|||
144471513|NCT00642902|520925235|FG002|Overall Study|Premature termination of clinical trial|35|||
144471514|NCT00642902|520925236|FG003|Overall Study|Premature termination of clinical trial|35|||
144471515|NCT00642902|520925233|FG000|Overall Study|Randomized, but not treated|0|||
144471516|NCT00642902|520925234|FG001|Overall Study|Randomized, but not treated|0|||
144471517|NCT00642902|520925235|FG002|Overall Study|Randomized, but not treated|1|||
144471518|NCT00642902|520925236|FG003|Overall Study|Randomized, but not treated|0|||
144471519|NCT00642902|520925233|FG000|Overall Study|Other|1|||
144471520|NCT00642902|520925234|FG001|Overall Study|Other|5|||
144471521|NCT00642902|520925235|FG002|Overall Study|Other|1|||
144471522|NCT00642902|520925236|FG003|Overall Study|Other|4|||
144471523|NCT00429663|520925237|FG000|Overall Study|Lost to Follow-up|24|||
144471524|NCT00429663|520925238|FG001|Overall Study|Lost to Follow-up|31|||
144471525|NCT00429663|520925237|FG000|Overall Study|Physician Decision|6|||
144471526|NCT00429663|520925238|FG001|Overall Study|Physician Decision|3|||
144471527|NCT00429663|520925237|FG000|Overall Study|Withdrawal by Subject|2|||
144471528|NCT00429663|520925238|FG001|Overall Study|Withdrawal by Subject|5|||
144471529|NCT00429663|520925237|FG000|Overall Study|Death|4|||
144471530|NCT00429663|520925238|FG001|Overall Study|Death|0|||
144471531|NCT03953898|520925244|FG000|Overall Study|Lack of Efficacy|8|||
144198735|NCT00311311|519925141|FG000|Overall Study|Death|1|||
144198736|NCT00311311|519925142|FG001|Overall Study|Death|0|||
144198737|NCT00311311|519925141|FG000|Overall Study|Lack of ancillary assistance|0|||
144198738|NCT00311311|519925142|FG001|Overall Study|Lack of ancillary assistance|1|||
144198739|NCT00546572|519925143|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
144198740|NCT00546572|519925144|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
144198741|NCT00546572|519925143|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
144198742|NCT00546572|519925144|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
144198743|NCT00546572|519925143|FG000|Vax 1 / Year 0|Protocol Violation|3|||
144198744|NCT00546572|519925144|FG001|Vax 1 / Year 0|Protocol Violation|4|||
144198745|NCT00546572|519925143|FG000|Vax 1 / Year 0|Death|2|||
144198746|NCT00546572|519925144|FG001|Vax 1 / Year 0|Death|2|||
144198747|NCT00546572|519925143|FG000|Vax 1 / Year 0|Adverse Event|0|||
144198748|NCT00546572|519925144|FG001|Vax 1 / Year 0|Adverse Event|1|||
144198749|NCT00546572|519925143|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
144198750|NCT00546572|519925144|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
144198751|NCT00546572|519925143|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
144198752|NCT00546572|519925144|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
144198753|NCT00546572|519925143|FG000|Vax 2 / Year 1|Other|1|||
144198754|NCT00546572|519925144|FG001|Vax 2 / Year 1|Other|1|||
144198755|NCT00546572|519925143|FG000|Vax 2 / Year 1|Adverse Event|1|||
144198756|NCT00546572|519925144|FG001|Vax 2 / Year 1|Adverse Event|0|||
144258882|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
144258883|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
144258884|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
144258885|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
144258886|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
144258887|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
144258888|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
144258889|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
144258890|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
144258891|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
144258892|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
144258893|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
144258894|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
144258895|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
144258896|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
144258897|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
144258898|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
144258899|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
144258900|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
144258901|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
144258902|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
144258903|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
144258904|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
144258905|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
144258906|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
144258907|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
144258908|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
144258909|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
144258910|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
144258911|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
144258912|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
144258913|NCT03538691|520148646|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
144258914|NCT03538691|520148647|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
144258915|NCT03538691|520148648|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
144258916|NCT03538691|520148649|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
144258917|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
144258918|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
144258919|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
144471532|NCT03953898|520925244|FG000|Overall Study|Death|3|||
144471533|NCT03953898|520925244|FG000|Overall Study|Withdrawal by Subject|2|||
144471534|NCT03953898|520925244|FG000|Overall Study|Adverse Event|1|||
144471535|NCT03261271|520925245|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
144471536|NCT03261271|520925246|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
144198757|NCT00546572|519925143|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
144198758|NCT00546572|519925144|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
144198759|NCT02685202|519925145|FG000|Overall Study|Lost to Follow-up|9|||
144198760|NCT01229735|519925146|FG000|Overall Study|Lack of Efficacy|8|||
144198761|NCT01229735|519925147|FG001|Overall Study|Lack of Efficacy|8|||
144198762|NCT01229735|519925146|FG000|Overall Study|Protocol Violation|13|||
144198763|NCT01229735|519925147|FG001|Overall Study|Protocol Violation|8|||
144198764|NCT01229735|519925146|FG000|Overall Study|Lost to Follow-up|0|||
144198765|NCT01229735|519925147|FG001|Overall Study|Lost to Follow-up|2|||
144198766|NCT01229735|519925146|FG000|Overall Study|Withdrawal by Subject|18|||
144198767|NCT01229735|519925147|FG001|Overall Study|Withdrawal by Subject|17|||
144198768|NCT01229735|519925146|FG000|Overall Study|Other Reason|13|||
144198769|NCT01229735|519925147|FG001|Overall Study|Other Reason|10|||
144198770|NCT01229735|519925146|FG000|Overall Study|SAE, non-fatal|0|||
144198771|NCT01229735|519925147|FG001|Overall Study|SAE, non-fatal|4|||
144198772|NCT01229735|519925146|FG000|Overall Study|AE, non-serious non-fatal|13|||
144198773|NCT01229735|519925147|FG001|Overall Study|AE, non-serious non-fatal|17|||
144198774|NCT01229735|519925146|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144198775|NCT01229735|519925147|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
144198776|NCT02130882|519925148|FG000|Overall Study|Withdrawal by Subject|0|||
144198777|NCT02130882|519925149|FG001|Overall Study|Withdrawal by Subject|1|||
144198778|NCT02615171|519925154|FG000|Overall Study|Lost to Follow-up|2|||
144198779|NCT02615171|519925155|FG001|Overall Study|Lost to Follow-up|1|||
144198780|NCT00741936|519925168|FG000|Overall Study|Lost to Follow-up|1|||
144198781|NCT00741936|519925169|FG001|Overall Study|Lost to Follow-up|1|||
144198782|NCT00741936|519925168|FG000|Overall Study|Adverse Event|3|||
144198783|NCT00741936|519925169|FG001|Overall Study|Adverse Event|4|||
144198784|NCT00741936|519925168|FG000|Overall Study|Pregnancy|0|||
144198785|NCT00741936|519925169|FG001|Overall Study|Pregnancy|1|||
144198786|NCT00741936|519925168|FG000|Overall Study|Protocol Violation|2|||
144198787|NCT00741936|519925169|FG001|Overall Study|Protocol Violation|0|||
144198788|NCT00741936|519925168|FG000|Overall Study|Lack of Efficacy|0|||
144198789|NCT00741936|519925169|FG001|Overall Study|Lack of Efficacy|2|||
144198790|NCT00741936|519925168|FG000|Overall Study|Low compliance|3|||
144198791|NCT00741936|519925169|FG001|Overall Study|Low compliance|0|||
144198792|NCT00369382|519925170|FG000|Overall Study|Death|0|||
144198793|NCT00369382|519925171|FG001|Overall Study|Death|2|||
144198794|NCT00369382|519925170|FG000|Overall Study|Physician Decision|2|||
144198795|NCT00369382|519925171|FG001|Overall Study|Physician Decision|1|||
144198796|NCT00369382|519925170|FG000|Overall Study|Withdrawal by Subject|5|||
144198797|NCT00369382|519925171|FG001|Overall Study|Withdrawal by Subject|0|||
144198798|NCT00369382|519925170|FG000|Overall Study|Randomized, not treated|2|||
144198799|NCT00369382|519925171|FG001|Overall Study|Randomized, not treated|0|||
144198800|NCT00369382|519925170|FG000|Overall Study|Other|1|||
144198801|NCT00369382|519925171|FG001|Overall Study|Other|0|||
144198802|NCT03176459|519925175|FG000|Overall Study|Lost to Follow-up|5|||
144198803|NCT03176459|519925176|FG001|Overall Study|Lost to Follow-up|7|||
144198804|NCT00446199|519925179|FG000|Overall Study|Adverse Event|7|||
144198805|NCT00446199|519925180|FG001|Overall Study|Adverse Event|4|||
144198806|NCT00446199|519925181|FG002|Overall Study|Adverse Event|6|||
144198807|NCT00446199|519925182|FG003|Overall Study|Adverse Event|4|||
144198808|NCT00446199|519925179|FG000|Overall Study|Lost to Follow-up|4|||
144198809|NCT00446199|519925180|FG001|Overall Study|Lost to Follow-up|5|||
144198810|NCT00446199|519925181|FG002|Overall Study|Lost to Follow-up|2|||
144198811|NCT00446199|519925182|FG003|Overall Study|Lost to Follow-up|6|||
144198812|NCT00446199|519925179|FG000|Overall Study|Protocol Violation|1|||
144198813|NCT00446199|519925180|FG001|Overall Study|Protocol Violation|2|||
144198814|NCT00446199|519925181|FG002|Overall Study|Protocol Violation|1|||
144198815|NCT00446199|519925182|FG003|Overall Study|Protocol Violation|3|||
144198816|NCT00446199|519925179|FG000|Overall Study|Withdrawal by Subject|2|||
144198817|NCT00446199|519925180|FG001|Overall Study|Withdrawal by Subject|5|||
144198818|NCT00446199|519925181|FG002|Overall Study|Withdrawal by Subject|9|||
144198819|NCT00446199|519925182|FG003|Overall Study|Withdrawal by Subject|10|||
144198820|NCT00446199|519925179|FG000|Overall Study|Site termination|2|||
144471537|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
144471538|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
144471539|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
144471540|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
144471541|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
144471542|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
144471543|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
144471544|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
144471545|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
144471546|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
144471547|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
144471548|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
144198821|NCT00446199|519925180|FG001|Overall Study|Site termination|0|||
144198822|NCT00446199|519925181|FG002|Overall Study|Site termination|0|||
144198823|NCT00446199|519925182|FG003|Overall Study|Site termination|1|||
144198824|NCT00446199|519925179|FG000|Overall Study|Randomization in Error|2|||
144198825|NCT00446199|519925180|FG001|Overall Study|Randomization in Error|0|||
144258920|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
144258921|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
144258922|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
144258923|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
144258924|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
144258925|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
144258926|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
144258927|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
144258928|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
144258929|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
144258930|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
144258931|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
144258932|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
144258933|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
144258934|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
144258935|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
144258936|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
144258937|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
144258938|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
144258939|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
144258940|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
144258941|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
144258942|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
144258943|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
144258944|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
144258945|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
144258946|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
144258947|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
144258948|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
144258949|NCT03538691|520148646|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
144258950|NCT03538691|520148647|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
144258951|NCT03538691|520148648|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
144258952|NCT03538691|520148649|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
144258953|NCT01066871|520148653|FG000|Overall Study|Lost to Follow-up|0|||
144258954|NCT01066871|520148654|FG001|Overall Study|Lost to Follow-up|2|||
144258955|NCT01066871|520148655|FG002|Overall Study|Lost to Follow-up|2|||
144258956|NCT01066871|520148656|FG003|Overall Study|Lost to Follow-up|0|||
144258957|NCT01066871|520148653|FG000|Overall Study|Protocol Violation|1|||
144258958|NCT01066871|520148654|FG001|Overall Study|Protocol Violation|0|||
144258959|NCT01066871|520148655|FG002|Overall Study|Protocol Violation|3|||
144258960|NCT01066871|520148656|FG003|Overall Study|Protocol Violation|2|||
144258961|NCT01066871|520148653|FG000|Overall Study|Lack of Efficacy|0|||
144258962|NCT01066871|520148654|FG001|Overall Study|Lack of Efficacy|0|||
144258963|NCT01066871|520148655|FG002|Overall Study|Lack of Efficacy|0|||
144258964|NCT01066871|520148656|FG003|Overall Study|Lack of Efficacy|1|||
144258965|NCT01066871|520148653|FG000|Overall Study|Withdrawal by Subject|3|||
144258966|NCT01066871|520148654|FG001|Overall Study|Withdrawal by Subject|1|||
144258967|NCT01066871|520148655|FG002|Overall Study|Withdrawal by Subject|0|||
144258968|NCT01066871|520148656|FG003|Overall Study|Withdrawal by Subject|0|||
144258969|NCT01066871|520148653|FG000|Overall Study|Other|0|||
144258970|NCT01066871|520148654|FG001|Overall Study|Other|2|||
144258971|NCT01066871|520148655|FG002|Overall Study|Other|1|||
144258972|NCT01066871|520148656|FG003|Overall Study|Other|2|||
144258973|NCT04162795|520148659|FG000|Overall Study|Other|16|||
144258974|NCT04162795|520148659|FG000|Overall Study|Screen failures|10|||
144258975|NCT02029274|520148662|FG000|Overall Study|Adverse Event|1|||
144258976|NCT02029274|520148663|FG001|Overall Study|Adverse Event|0|||
144258977|NCT02029274|520148664|FG002|Overall Study|Adverse Event|2|||
144258978|NCT02029274|520148665|FG003|Overall Study|Adverse Event|2|||
144258979|NCT00636636|520148666|FG000|Overall Study|Other reason|4|||
144258980|NCT00636636|520148667|FG001|Overall Study|Other reason|6|||
144258981|NCT00636636|520148666|FG000|Overall Study|Adverse Event|19|||
144258982|NCT00636636|520148667|FG001|Overall Study|Adverse Event|8|||
144258983|NCT00636636|520148666|FG000|Overall Study|Lack of Efficacy|7|||
144258984|NCT00636636|520148667|FG001|Overall Study|Lack of Efficacy|12|||
144258985|NCT00636636|520148666|FG000|Overall Study|Protocol Violation|2|||
144258986|NCT00636636|520148667|FG001|Overall Study|Protocol Violation|2|||
144258987|NCT00636636|520148666|FG000|Overall Study|Lost to Follow-up|0|||
144258988|NCT00636636|520148667|FG001|Overall Study|Lost to Follow-up|1|||
144258989|NCT00636636|520148666|FG000|Overall Study|Death|0|||
144258990|NCT00636636|520148667|FG001|Overall Study|Death|1|||
144258991|NCT00636636|520148666|FG000|Overall Study|Withdrawal by Subject|4|||
144258992|NCT00636636|520148667|FG001|Overall Study|Withdrawal by Subject|9|||
144258993|NCT01366638|520148668|FG000|Overall Study|Withdrawal by Subject|0|||
144258994|NCT01366638|520148669|FG001|Overall Study|Withdrawal by Subject|0|||
144258995|NCT01366638|520148670|FG002|Overall Study|Withdrawal by Subject|6|||
144258996|NCT01366638|520148668|FG000|Overall Study|Other|1|||
144258997|NCT01366638|520148669|FG001|Overall Study|Other|0|||
144258998|NCT01366638|520148670|FG002|Overall Study|Other|0|||
144258999|NCT03300180|520148671|FG000|Baseline|Withdrawal by Subject|4|||
144259000|NCT03300180|520148672|FG001|Baseline|Withdrawal by Subject|6|||
144259001|NCT03300180|520148673|FG002|Baseline|Withdrawal by Subject|4|||
144538148|NCT02549352|521172379|FG001|12-month Follow-up|Other|3|||
144538149|NCT03459196|521174099|FG000|Overall Study|Subject didn't receive study catheter|2|||
144538150|NCT04503681|521174102|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
144538151|NCT04503681|521174103|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
144259002|NCT03300180|520148671|FG000|6 Month Outcome|Withdrawal by Subject|12|||
144259003|NCT03300180|520148672|FG001|6 Month Outcome|Withdrawal by Subject|12|||
144259004|NCT03300180|520148673|FG002|6 Month Outcome|Withdrawal by Subject|19|||
144259005|NCT03300180|520148671|FG000|6 Month Outcome|Death|2|||
144259006|NCT03300180|520148672|FG001|6 Month Outcome|Death|4|||
144259007|NCT03300180|520148673|FG002|6 Month Outcome|Death|3|||
144259008|NCT03300180|520148671|FG000|6 Month Outcome|Missed Assessment|43|||
144259009|NCT03300180|520148672|FG001|6 Month Outcome|Missed Assessment|52|||
144259010|NCT03300180|520148673|FG002|6 Month Outcome|Missed Assessment|46|||
144259011|NCT03300180|520148671|FG000|12 Month Outcome|Withdrawal by Subject|3|||
144259012|NCT03300180|520148672|FG001|12 Month Outcome|Withdrawal by Subject|6|||
144259013|NCT03300180|520148673|FG002|12 Month Outcome|Withdrawal by Subject|6|||
144259014|NCT03300180|520148671|FG000|12 Month Outcome|Death|9|||
144259015|NCT03300180|520148672|FG001|12 Month Outcome|Death|6|||
144259016|NCT03300180|520148673|FG002|12 Month Outcome|Death|6|||
144259017|NCT03300180|520148671|FG000|12 Month Outcome|Missed Assessment|62|||
144259018|NCT03300180|520148672|FG001|12 Month Outcome|Missed Assessment|59|||
144259019|NCT03300180|520148673|FG002|12 Month Outcome|Missed Assessment|58|||
144259020|NCT03300180|520148671|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
144259021|NCT03300180|520148672|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
144259022|NCT03300180|520148673|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
144259023|NCT03300180|520148671|FG000|18 Month Outcome Assessment|Death|8|||
144259024|NCT03300180|520148672|FG001|18 Month Outcome Assessment|Death|5|||
144259025|NCT03300180|520148673|FG002|18 Month Outcome Assessment|Death|5|||
144259026|NCT03300180|520148671|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
144259027|NCT03300180|520148672|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
144259028|NCT03300180|520148673|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
144259029|NCT03300180|520148671|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
144538152|NCT03752684|521174104|FG000|Overall Study|Lost to Follow-up|4|||
144538153|NCT03352713|521174107|FG000|Overall Study|Lost to Follow-up|8|||
144538154|NCT03352713|521174107|FG000|Overall Study|Withdrawn by investigator|5|||
144538155|NCT03352713|521174107|FG000|Overall Study|Completed 0 EMAs|8|||
144538156|NCT03352713|521174107|FG000|Overall Study|Device incompatible/stolen|5|||
144538157|NCT01812759|521174108|FG000|Overall Study|Physician Decision|0|||
144538158|NCT01812759|521174109|FG001|Overall Study|Physician Decision|0|||
144538159|NCT01812759|521174110|FG002|Overall Study|Physician Decision|1|||
144538160|NCT00536120|521174111|FG000|Overall Study|Lost to Follow-up|1|||
144538161|NCT00536120|521174112|FG001|Overall Study|Lost to Follow-up|0|||
144538162|NCT00536120|521174111|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
144538163|NCT00536120|521174112|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
144538164|NCT00536120|521174111|FG000|Overall Study|Non-compliance|1|||
144538165|NCT00536120|521174112|FG001|Overall Study|Non-compliance|0|||
144538166|NCT00536120|521174111|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
144538167|NCT00536120|521174112|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
144538168|NCT00536120|521174111|FG000|Overall Study|Steroid Use|0|||
144538169|NCT00536120|521174112|FG001|Overall Study|Steroid Use|2|||
144538170|NCT00536120|521174111|FG000|Overall Study|Missed Study Visit|0|||
144538171|NCT00536120|521174112|FG001|Overall Study|Missed Study Visit|1|||
144538172|NCT02722434|521174113|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
144538173|NCT02722434|521174114|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
144538174|NCT02722434|521174113|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
144259030|NCT03300180|520148672|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
144259031|NCT03300180|520148673|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
144259032|NCT03300180|520148671|FG000|24 Month Outcome Assessment|Death|13|||
144259033|NCT03300180|520148672|FG001|24 Month Outcome Assessment|Death|13|||
144259034|NCT03300180|520148673|FG002|24 Month Outcome Assessment|Death|3|||
144259035|NCT03300180|520148671|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
144259036|NCT03300180|520148672|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
144259037|NCT03300180|520148673|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
144259038|NCT01941537|520148676|FG000|Overall Study|Lack of Efficacy|1|||
144614740|NCT00708500|521450185|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
144614741|NCT00708500|521450186|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
144614742|NCT00708500|521450184|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
144471549|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
144471550|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
144471551|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
144471552|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
144471553|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
144471554|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
144471555|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
144471556|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
144471557|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Death|2|||
144471558|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Death|2|||
144471559|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Death|0|||
144471560|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Death|0|||
144471561|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Death|0|||
144471562|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
144471563|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
144471564|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
144471565|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
144471566|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
144471567|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
144471568|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
144471569|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
144471570|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
144471571|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
144471572|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
144471573|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
144471574|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
144471575|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
144471576|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
144471577|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
144471578|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
144471579|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
144471580|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
144471581|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
144471582|NCT03420781|520925247|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
144471583|NCT03420781|520925248|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
144471584|NCT03420781|520925249|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
144471585|NCT03420781|520925250|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
144471586|NCT03420781|520925251|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
144471587|NCT03420781|520925247|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
144471588|NCT03420781|520925248|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
144471589|NCT03420781|520925249|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
144471590|NCT03420781|520925250|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
144471591|NCT03420781|520925251|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
144471592|NCT03420781|520925247|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
144471593|NCT03420781|520925248|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
144471594|NCT03420781|520925249|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
144471595|NCT03420781|520925250|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
144471596|NCT03420781|520925251|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
144471597|NCT03420781|520925247|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
144471598|NCT03420781|520925248|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
144471599|NCT03420781|520925249|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
144471600|NCT03420781|520925250|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
144471601|NCT03420781|520925251|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
144471602|NCT00246337|520925252|FG000|Overall Study|Lost to Follow-up|3|||
144471603|NCT00246337|520925253|FG001|Overall Study|Lost to Follow-up|0|||
144471604|NCT00246337|520925254|FG002|Overall Study|Lost to Follow-up|0|||
144471605|NCT00246337|520925255|FG003|Overall Study|Lost to Follow-up|0|||
144471606|NCT00246337|520925256|FG004|Overall Study|Lost to Follow-up|2|||
144471607|NCT00246337|520925257|FG005|Overall Study|Lost to Follow-up|2|||
144471608|NCT00246337|520925258|FG006|Overall Study|Lost to Follow-up|1|||
144471609|NCT00246337|520925259|FG007|Overall Study|Lost to Follow-up|2|||
144471610|NCT00246337|520925260|FG008|Overall Study|Lost to Follow-up|0|||
144471611|NCT00246337|520925252|FG000|Overall Study|Protocol Violation|1|||
144471612|NCT00246337|520925253|FG001|Overall Study|Protocol Violation|0|||
144471613|NCT00246337|520925254|FG002|Overall Study|Protocol Violation|0|||
144198826|NCT00446199|519925181|FG002|Overall Study|Randomization in Error|1|||
144198827|NCT00446199|519925182|FG003|Overall Study|Randomization in Error|1|||
144198828|NCT00446199|519925179|FG000|Overall Study|Lack of Efficacy|1|||
144198829|NCT00446199|519925180|FG001|Overall Study|Lack of Efficacy|0|||
144198830|NCT00446199|519925181|FG002|Overall Study|Lack of Efficacy|0|||
144198831|NCT00446199|519925182|FG003|Overall Study|Lack of Efficacy|1|||
144198832|NCT00446199|519925179|FG000|Overall Study|Non-compliant with study drug|1|||
144198833|NCT00446199|519925180|FG001|Overall Study|Non-compliant with study drug|0|||
144198834|NCT00446199|519925181|FG002|Overall Study|Non-compliant with study drug|5|||
144198835|NCT00446199|519925182|FG003|Overall Study|Non-compliant with study drug|0|||
144198836|NCT00446199|519925179|FG000|Overall Study|Non-compliant with visit schedule|1|||
144198837|NCT00446199|519925180|FG001|Overall Study|Non-compliant with visit schedule|1|||
144198838|NCT00446199|519925181|FG002|Overall Study|Non-compliant with visit schedule|1|||
144198839|NCT00446199|519925182|FG003|Overall Study|Non-compliant with visit schedule|2|||
144198840|NCT00446199|519925179|FG000|Overall Study|Hormone fear|0|||
144198841|NCT00446199|519925180|FG001|Overall Study|Hormone fear|0|||
144198842|NCT00446199|519925181|FG002|Overall Study|Hormone fear|0|||
144198843|NCT00446199|519925182|FG003|Overall Study|Hormone fear|1|||
144198844|NCT00446199|519925179|FG000|Overall Study|Lost interest in study participation|0|||
144259039|NCT01941537|520148677|FG001|Overall Study|Lack of Efficacy|2|||
144259040|NCT01941537|520148676|FG000|Overall Study|Lost to Follow-up|1|||
144259041|NCT01941537|520148677|FG001|Overall Study|Lost to Follow-up|0|||
144259042|NCT01941537|520148676|FG000|Overall Study|Pregnancy|1|||
144259043|NCT01941537|520148677|FG001|Overall Study|Pregnancy|0|||
144259044|NCT01941537|520148676|FG000|Overall Study|Adverse Event|1|||
144259045|NCT01941537|520148677|FG001|Overall Study|Adverse Event|0|||
144259046|NCT01941537|520148676|FG000|Overall Study|Withdrawal by Subject|0|||
144259047|NCT01941537|520148677|FG001|Overall Study|Withdrawal by Subject|1|||
144198845|NCT00446199|519925180|FG001|Overall Study|Lost interest in study participation|1|||
144198846|NCT00446199|519925181|FG002|Overall Study|Lost interest in study participation|0|||
144198847|NCT00446199|519925182|FG003|Overall Study|Lost interest in study participation|0|||
144198848|NCT00446199|519925179|FG000|Overall Study|In-/Exclusion criterion violated|2|||
144198849|NCT00446199|519925180|FG001|Overall Study|In-/Exclusion criterion violated|1|||
144198850|NCT00446199|519925181|FG002|Overall Study|In-/Exclusion criterion violated|2|||
144198851|NCT00446199|519925182|FG003|Overall Study|In-/Exclusion criterion violated|1|||
144198852|NCT00446199|519925179|FG000|Overall Study|Move|0|||
144198853|NCT00446199|519925180|FG001|Overall Study|Move|1|||
144198854|NCT00446199|519925181|FG002|Overall Study|Move|0|||
144198855|NCT00446199|519925182|FG003|Overall Study|Move|0|||
144198856|NCT02049450|519926403|FG000|Overall Study|Adverse Event|2|||
144198857|NCT02049450|519926403|FG000|Overall Study|Withdrawal by Subject|1|||
144198858|NCT02049450|519926403|FG000|Overall Study|Patients/guardian decision|1|||
144198859|NCT04711902|519926404|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
144198860|NCT04711902|519926405|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
144198861|NCT04711902|519926406|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
144198862|NCT04711902|519926407|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
144198863|NCT04711902|519926408|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
144198864|NCT04711902|519926409|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
144198865|NCT04710979|519926410|FG000|Overall Study|Lost to Follow-up|2|||
144198866|NCT04710979|519926411|FG001|Overall Study|Lost to Follow-up|4|||
144198867|NCT04710979|519926410|FG000|Overall Study|Withdrawal by Subject|1|||
144198868|NCT04710979|519926411|FG001|Overall Study|Withdrawal by Subject|0|||
144198869|NCT01462318|519926414|FG000|Main Study / TP-DI Study|Other|2|||
144198870|NCT01462318|519926415|FG001|Main Study / TP-DI Study|Other|0|||
144198871|NCT01462318|519926416|FG002|Main Study / TP-DI Study|Other|0|||
144198872|NCT01462318|519926414|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
144198873|NCT01462318|519926415|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
144259048|NCT01243177|520148678|FG000|Overall Study|Lack of Efficacy|47|||
144259049|NCT01243177|520148679|FG001|Overall Study|Lack of Efficacy|31|||
144259050|NCT01243177|520148678|FG000|Overall Study|Protocol Violation|11|||
144198874|NCT01462318|519926416|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
144259051|NCT01243177|520148679|FG001|Overall Study|Protocol Violation|10|||
144198875|NCT01462318|519926414|FG000|Main Study / TP-DI Study|Adverse Event|4|||
144259052|NCT01243177|520148678|FG000|Overall Study|Lost to Follow-up|15|||
144198876|NCT01462318|519926415|FG001|Main Study / TP-DI Study|Adverse Event|0|||
144259053|NCT01243177|520148679|FG001|Overall Study|Lost to Follow-up|18|||
144259054|NCT01243177|520148678|FG000|Overall Study|Withdrawal by Subject|46|||
144614743|NCT00708500|521450185|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
144198877|NCT01462318|519926416|FG002|Main Study / TP-DI Study|Adverse Event|0|||
144198878|NCT01462318|519926414|FG000|Extension Phase|Lost to Follow-up|0|||
144198879|NCT01462318|519926415|FG001|Extension Phase|Lost to Follow-up|0|||
144198880|NCT01462318|519926416|FG002|Extension Phase|Lost to Follow-up|1|||
144198881|NCT01462318|519926414|FG000|Extension Phase|Other|0|||
144259055|NCT01243177|520148679|FG001|Overall Study|Withdrawal by Subject|38|||
144259056|NCT01243177|520148678|FG000|Overall Study|AE, serious fatal|0|||
144259057|NCT01243177|520148679|FG001|Overall Study|AE, serious fatal|1|||
144259058|NCT01243177|520148678|FG000|Overall Study|SAE, non-fatal|7|||
144259059|NCT01243177|520148679|FG001|Overall Study|SAE, non-fatal|9|||
144259060|NCT01243177|520148678|FG000|Overall Study|AE, non-serious non-fatal|40|||
144259061|NCT01243177|520148679|FG001|Overall Study|AE, non-serious non-fatal|58|||
144259062|NCT01243177|520148678|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
144259063|NCT01243177|520148679|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
144259064|NCT01243177|520148678|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
144259065|NCT01243177|520148679|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
144259066|NCT01243177|520148678|FG000|Overall Study|Other Reason|11|||
144259067|NCT01243177|520148679|FG001|Overall Study|Other Reason|12|||
144259068|NCT05259163|520150256|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
144259069|NCT05259163|520150257|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
144259070|NCT05251233|520150258|FG000|Overall Study|Disease progression - did not start treatment|0|||
144259071|NCT05251233|520150259|FG001|Overall Study|Disease progression - did not start treatment|0|||
144259072|NCT05251233|520150260|FG002|Overall Study|Disease progression - did not start treatment|5|||
144259073|NCT05251233|520150258|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
144259074|NCT05251233|520150259|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
144259075|NCT05251233|520150260|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
144259076|NCT05251233|520150258|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
144259077|NCT05251233|520150259|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
144259078|NCT05251233|520150260|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
144259079|NCT05251233|520150258|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
144259080|NCT05251233|520150259|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
144259081|NCT05251233|520150260|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
144259082|NCT05251233|520150258|FG000|Overall Study|Death - did not start treatment|3|||
144259083|NCT05251233|520150259|FG001|Overall Study|Death - did not start treatment|0|||
144259084|NCT05251233|520150260|FG002|Overall Study|Death - did not start treatment|0|||
144259085|NCT05251233|520150258|FG000|Overall Study|Withdrawal by Subject|2|||
144259086|NCT05251233|520150259|FG001|Overall Study|Withdrawal by Subject|2|||
144259087|NCT05251233|520150260|FG002|Overall Study|Withdrawal by Subject|0|||
144259088|NCT05251233|520150258|FG000|Overall Study|Other complicating disease|2|||
144259089|NCT05251233|520150259|FG001|Overall Study|Other complicating disease|1|||
144259090|NCT05251233|520150260|FG002|Overall Study|Other complicating disease|0|||
144259091|NCT05251233|520150258|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
144259092|NCT05251233|520150259|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
144259093|NCT05251233|520150260|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
144259094|NCT05251233|520150258|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
144259095|NCT05251233|520150259|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
144259096|NCT05251233|520150260|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
144259097|NCT02624947|520150266|FG000|Maternal Participants|Adverse Event|5|||
144259098|NCT02624947|520150267|FG001|Maternal Participants|Adverse Event|0|||
144259099|NCT02624947|520150266|FG000|Maternal Participants|Investigator Decision|5|||
144259100|NCT02624947|520150267|FG001|Maternal Participants|Investigator Decision|3|||
144259101|NCT02624947|520150266|FG000|Maternal Participants|Lost to Follow-up|54|||
144259102|NCT02624947|520150267|FG001|Maternal Participants|Lost to Follow-up|24|||
144259103|NCT02624947|520150266|FG000|Maternal Participants|Non Compliance|8|||
144259104|NCT02624947|520150267|FG001|Maternal Participants|Non Compliance|5|||
144259105|NCT02624947|520150266|FG000|Maternal Participants|Sponsor Request|1|||
144259106|NCT02624947|520150267|FG001|Maternal Participants|Sponsor Request|1|||
144259107|NCT02624947|520150266|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
144259108|NCT02624947|520150267|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
144259109|NCT02624947|520150266|FG000|Maternal Participants|Miscellaneous|23|||
144259110|NCT02624947|520150267|FG001|Maternal Participants|Miscellaneous|15|||
144259111|NCT02624947|520150266|FG000|Infant Participants|Adverse Event|18|||
144259112|NCT02624947|520150267|FG001|Infant Participants|Adverse Event|11|||
144259113|NCT02624947|520150266|FG000|Infant Participants|Investigator Decision|5|||
144259114|NCT02624947|520150267|FG001|Infant Participants|Investigator Decision|4|||
144259115|NCT02624947|520150266|FG000|Infant Participants|Lost to Follow-up|93|||
144259116|NCT02624947|520150267|FG001|Infant Participants|Lost to Follow-up|58|||
144259117|NCT02624947|520150266|FG000|Infant Participants|Non Compliance|17|||
144259118|NCT02624947|520150267|FG001|Infant Participants|Non Compliance|7|||
144259119|NCT02624947|520150266|FG000|Infant Participants|Sponsor Request|0|||
144259120|NCT02624947|520150267|FG001|Infant Participants|Sponsor Request|1|||
144259121|NCT02624947|520150266|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
144259122|NCT02624947|520150267|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
144259123|NCT02624947|520150266|FG000|Infant Participants|Miscellaneous|50|||
144259124|NCT02624947|520150267|FG001|Infant Participants|Miscellaneous|26|||
144259125|NCT00669318|520150276|FG000|Overall Study|Withdrawal by Subject|2|||
144259126|NCT01239394|520150280|FG000|Overall Study|Adverse Event|1|||
144259127|NCT00524771|520150284|FG000|Overall Study|Protocol Violation|220|||
144259128|NCT00524771|520150285|FG001|Overall Study|Protocol Violation|585|||
144259129|NCT01223404|520150286|FG000|First Intervention (1 Day)|Adverse Event|0|||
144259130|NCT01223404|520150287|FG001|First Intervention (1 Day)|Adverse Event|0|||
144259131|NCT01223404|520150288|FG002|First Intervention (1 Day)|Adverse Event|0|||
144259132|NCT01223404|520150289|FG003|First Intervention (1 Day)|Adverse Event|1|||
144259133|NCT01223404|520150290|FG004|First Intervention (1 Day)|Adverse Event|0|||
144259134|NCT01223404|520150291|FG005|First Intervention (1 Day)|Adverse Event|0|||
144259135|NCT01223404|520150286|FG000|Second Intervention (1 Day)|Adverse Event|1|||
144259136|NCT01223404|520150287|FG001|Second Intervention (1 Day)|Adverse Event|0|||
144259137|NCT01223404|520150288|FG002|Second Intervention (1 Day)|Adverse Event|0|||
144259138|NCT01223404|520150289|FG003|Second Intervention (1 Day)|Adverse Event|0|||
144259139|NCT01223404|520150290|FG004|Second Intervention (1 Day)|Adverse Event|0|||
144259140|NCT01223404|520150291|FG005|Second Intervention (1 Day)|Adverse Event|0|||
144259141|NCT01223404|520150286|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
144259142|NCT01223404|520150287|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
144259143|NCT01223404|520150288|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
144259144|NCT01223404|520150289|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
144259145|NCT01223404|520150290|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
144259146|NCT01223404|520150291|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
144259147|NCT02492165|520150292|FG000|Overall Study|Withdrawal by Subject|0|||
144259148|NCT02492165|520150293|FG001|Overall Study|Withdrawal by Subject|1|||
144259149|NCT02492165|520150294|FG002|Overall Study|Withdrawal by Subject|0|||
144259150|NCT02492165|520150295|FG003|Overall Study|Withdrawal by Subject|0|||
144259151|NCT00707057|520150296|FG000|Overall Study|Withdrawal by Subject|8|||
144259152|NCT00707057|520150297|FG001|Overall Study|Withdrawal by Subject|3|||
144259153|NCT00707057|520150296|FG000|Overall Study|Dosed incorrectly|0|||
144259154|NCT00707057|520150297|FG001|Overall Study|Dosed incorrectly|1|||
144259155|NCT01639144|520150298|FG000|Overall Study|Withdrawal by Subject|4|||
144259156|NCT01639144|520150299|FG001|Overall Study|Withdrawal by Subject|2|||
144259157|NCT01639144|520150298|FG000|Overall Study|Physician Decision|2|||
144259158|NCT01639144|520150299|FG001|Overall Study|Physician Decision|0|||
144259159|NCT01639144|520150298|FG000|Overall Study|Met postoperative exclusion criteria|4|||
144259160|NCT01639144|520150299|FG001|Overall Study|Met postoperative exclusion criteria|3|||
144259161|NCT00305227|520150306|FG000|Overall Study|Lost to Follow-up|7|||
144259162|NCT00305227|520150307|FG001|Overall Study|Lost to Follow-up|6|||
144259163|NCT03492437|520150309|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144259164|NCT03492437|520150310|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144259165|NCT02915159|520150311|FG000|Overall Study|Participant no longer meets criteria|2|||
144259166|NCT02915159|520150312|FG001|Overall Study|Participant no longer meets criteria|0|||
144259167|NCT02915159|520150311|FG000|Overall Study|poor/non-compliance|1|||
144259168|NCT02915159|520150312|FG001|Overall Study|poor/non-compliance|0|||
144259169|NCT02915159|520150311|FG000|Overall Study|Participant withdrew consent|5|||
144259170|NCT02915159|520150312|FG001|Overall Study|Participant withdrew consent|1|||
144259171|NCT02915159|520150311|FG000|Overall Study|Request to discontinue treatment|1|||
144259172|NCT02915159|520150312|FG001|Overall Study|Request to discontinue treatment|2|||
144259173|NCT02915159|520150311|FG000|Overall Study|Adverse Event|2|||
144259174|NCT02915159|520150312|FG001|Overall Study|Adverse Event|2|||
144259175|NCT02915159|520150311|FG000|Overall Study|Lack of Efficacy|0|||
144259176|NCT02915159|520150312|FG001|Overall Study|Lack of Efficacy|3|||
144259177|NCT04534517|520150313|FG000|Overall Study|Adverse Event|1|||
144259178|NCT04534517|520150313|FG000|Overall Study|Withdrawal by Subject|1|||
144259179|NCT04534517|520150313|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
144259180|NCT04534517|520150313|FG000|Overall Study|COVID-19 Related|1|||
144259181|NCT03872843|520150314|FG000|Overall Study|Lost to Follow-up|5|||
144259182|NCT03872843|520150315|FG001|Overall Study|Lost to Follow-up|7|||
144726951|NCT05630547|521854410|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
144198882|NCT01462318|519926415|FG001|Extension Phase|Other|0|||
144198883|NCT01462318|519926416|FG002|Extension Phase|Other|1|||
144198884|NCT01462318|519926414|FG000|Extension Phase|Disease Progression|0|||
144198885|NCT01462318|519926415|FG001|Extension Phase|Disease Progression|0|||
144198886|NCT01462318|519926416|FG002|Extension Phase|Disease Progression|1|||
144198887|NCT01462318|519926414|FG000|Extension Phase|Withdrawal by Subject|0|||
144198888|NCT01462318|519926415|FG001|Extension Phase|Withdrawal by Subject|0|||
144198889|NCT01462318|519926416|FG002|Extension Phase|Withdrawal by Subject|15|||
144198890|NCT01462318|519926414|FG000|Extension Phase|Investigator Decision|0|||
144198891|NCT01462318|519926415|FG001|Extension Phase|Investigator Decision|0|||
144198892|NCT01462318|519926416|FG002|Extension Phase|Investigator Decision|5|||
144198893|NCT01462318|519926414|FG000|Extension Phase|Adverse Event|0|||
144198894|NCT01462318|519926415|FG001|Extension Phase|Adverse Event|0|||
144198895|NCT01462318|519926416|FG002|Extension Phase|Adverse Event|22|||
144198896|NCT02227147|519926417|FG000|Controlled Treatment Period|Adverse Event|4|||
144198897|NCT02227147|519926418|FG001|Controlled Treatment Period|Adverse Event|3|||
144198898|NCT02227147|519926417|FG000|Controlled Treatment Period|Other|2|||
144198899|NCT02227147|519926418|FG001|Controlled Treatment Period|Other|0|||
144198900|NCT02227147|519926417|FG000|Follow-up Period|Other|3|||
144198901|NCT02227147|519926418|FG001|Follow-up Period|Other|5|||
144198902|NCT03347422|519926419|FG000|Part A (26 Weeks)|Adverse Event|3|||
144198903|NCT03347422|519926420|FG001|Part A (26 Weeks)|Adverse Event|0|||
144198904|NCT03347422|519926419|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
144198905|NCT03347422|519926420|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
144198906|NCT03347422|519926419|FG000|Part B (149 Weeks)|Adverse Event|0|||
144198907|NCT03347422|519926420|FG001|Part B (149 Weeks)|Adverse Event|1|||
144198908|NCT03347422|519926419|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
144198909|NCT03347422|519926420|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
144198910|NCT03347422|519926419|FG000|Part B (149 Weeks)|Other|1|||
144198911|NCT03347422|519926420|FG001|Part B (149 Weeks)|Other|0|||
144198912|NCT02397408|519926421|FG000|Overall Study|Physician Decision|4|||
144198913|NCT02397408|519926421|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
144198914|NCT04049617|519926422|FG000|Overall Study|Adverse Event|0|||
144198915|NCT04049617|519926423|FG001|Overall Study|Adverse Event|0|||
144198916|NCT04049617|519926424|FG002|Overall Study|Adverse Event|0|||
144198917|NCT04049617|519926425|FG003|Overall Study|Adverse Event|1|||
144198918|NCT04049617|519926426|FG004|Overall Study|Adverse Event|0|||
144198919|NCT04049617|519926427|FG005|Overall Study|Adverse Event|0|||
144198920|NCT04049617|519926422|FG000|Overall Study|Death|0|||
144198921|NCT04049617|519926423|FG001|Overall Study|Death|0|||
144198922|NCT04049617|519926424|FG002|Overall Study|Death|0|||
144198923|NCT04049617|519926425|FG003|Overall Study|Death|0|||
144198924|NCT04049617|519926426|FG004|Overall Study|Death|0|||
144198925|NCT04049617|519926427|FG005|Overall Study|Death|1|||
144198926|NCT04049617|519926422|FG000|Overall Study|Lost to Follow-up|0|||
144198927|NCT04049617|519926423|FG001|Overall Study|Lost to Follow-up|0|||
144198928|NCT04049617|519926424|FG002|Overall Study|Lost to Follow-up|0|||
144198929|NCT04049617|519926425|FG003|Overall Study|Lost to Follow-up|1|||
144198930|NCT04049617|519926426|FG004|Overall Study|Lost to Follow-up|0|||
144198931|NCT04049617|519926427|FG005|Overall Study|Lost to Follow-up|0|||
144198932|NCT04049617|519926422|FG000|Overall Study|Withdrew consent|0|||
144198933|NCT04049617|519926423|FG001|Overall Study|Withdrew consent|0|||
144198934|NCT04049617|519926424|FG002|Overall Study|Withdrew consent|1|||
144198935|NCT04049617|519926425|FG003|Overall Study|Withdrew consent|0|||
144198936|NCT04049617|519926426|FG004|Overall Study|Withdrew consent|0|||
144198937|NCT04049617|519926427|FG005|Overall Study|Withdrew consent|0|||
144198938|NCT03397771|519926430|FG000|Overall Study|2 erroneously randomized, never treated|3|||
144198939|NCT03397771|519926431|FG001|Overall Study|2 erroneously randomized, never treated|1|||
144198940|NCT03397771|519926430|FG000|Overall Study|Withdrawal by Subject|1|||
144198941|NCT03397771|519926431|FG001|Overall Study|Withdrawal by Subject|3|||
144198942|NCT03397771|519926430|FG000|Overall Study|Protocol Violation|2|||
144198943|NCT03397771|519926431|FG001|Overall Study|Protocol Violation|2|||
144198944|NCT03397771|519926430|FG000|Overall Study|Adverse Event|2|||
144198945|NCT03397771|519926431|FG001|Overall Study|Adverse Event|1|||
144198946|NCT04078126|519926432|FG000|Washout|Study put on hold due to COVID-19|0|||
144198947|NCT04078126|519926433|FG001|Washout|Study put on hold due to COVID-19|2|||
144198948|NCT04078126|519926432|FG000|Period 2|Study put on hold due to COVID-19|1|||
144198949|NCT04078126|519926433|FG001|Period 2|Study put on hold due to COVID-19|1|||
144198950|NCT02669758|519926436|FG000|Overall Study|Withdrawal by Subject|43|||
144198951|NCT02669758|519926436|FG000|Overall Study|Lost to Follow-up|19|||
144198952|NCT02669758|519926436|FG000|Overall Study|Adverse Event|16|||
144198953|NCT02669758|519926436|FG000|Overall Study|Non-Compliance with Study Drug|8|||
144198954|NCT02669758|519926436|FG000|Overall Study|Lack of Efficacy|5|||
144198955|NCT02669758|519926436|FG000|Overall Study|Pregnancy|1|||
144198956|NCT02669758|519926436|FG000|Overall Study|Study noncompliance|1|||
144198957|NCT02669758|519926436|FG000|Overall Study|Protocol Violation|1|||
144198958|NCT02149108|519926437|FG000|Overall Study|Not treated|1|||
144198959|NCT02149108|519926438|FG001|Overall Study|Not treated|2|||
144198960|NCT02149108|519926437|FG000|Overall Study|Progressive Disease (PD)|324|||
144198961|NCT02149108|519926438|FG001|Overall Study|Progressive Disease (PD)|318|||
144198962|NCT02149108|519926437|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
144198963|NCT02149108|519926438|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
144198964|NCT02149108|519926437|FG000|Overall Study|Other Adverse Event (AE)|8|||
144198965|NCT02149108|519926438|FG001|Overall Study|Other Adverse Event (AE)|18|||
144198966|NCT02149108|519926437|FG000|Overall Study|Other not defined above|0|||
144198967|NCT02149108|519926438|FG001|Overall Study|Other not defined above|2|||
144198968|NCT02149108|519926437|FG000|Overall Study|Refusal to continue trial medication|15|||
144198969|NCT02149108|519926438|FG001|Overall Study|Refusal to continue trial medication|11|||
144198970|NCT02149108|519926437|FG000|Overall Study|Lost to Follow-up|1|||
144198971|NCT02149108|519926438|FG001|Overall Study|Lost to Follow-up|0|||
144198972|NCT02455050|519926439|FG000|Treatment Period 1|Lost to Follow-up|1|||
144198973|NCT02455050|519926440|FG001|Treatment Period 1|Lost to Follow-up|1|||
144198974|NCT02455050|519926441|FG002|Treatment Period 1|Lost to Follow-up|1|||
144198975|NCT02455050|519926442|FG003|Treatment Period 1|Lost to Follow-up|2|||
144198976|NCT02455050|519926439|FG000|Treatment Period 2|Lost to Follow-up|1|||
144198977|NCT02455050|519926440|FG001|Treatment Period 2|Lost to Follow-up|0|||
144198978|NCT02455050|519926441|FG002|Treatment Period 2|Lost to Follow-up|2|||
144198979|NCT02455050|519926442|FG003|Treatment Period 2|Lost to Follow-up|1|||
144198980|NCT03402750|519926443|FG000|Overall Study|Lost to Follow-up|2|||
144259183|NCT05133323|520150316|FG000|Overall Study|Lack of Efficacy|0|||
144259184|NCT05133323|520150317|FG001|Overall Study|Lack of Efficacy|0|||
144259185|NCT05133323|520150318|FG002|Overall Study|Lack of Efficacy|1|||
144259186|NCT05133323|520150316|FG000|Overall Study|Withdrawal by Subject|2|||
144259187|NCT05133323|520150317|FG001|Overall Study|Withdrawal by Subject|1|||
144259188|NCT05133323|520150318|FG002|Overall Study|Withdrawal by Subject|0|||
144259189|NCT01714544|520150319|FG000|Overall Study|Lost to Follow-up|1|||
144259190|NCT01714544|520150319|FG000|Overall Study|Physician Decision|1|||
144259191|NCT01714544|520150319|FG000|Overall Study|Withdrawal by Subject|1|||
144259192|NCT00003483|520150330|FG000|Overall Study|Not evaluable|1|||
144259193|NCT01968811|520150331|FG000|Overall Study|Protocol Violation|4|||
144259194|NCT01968811|520150331|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
144259195|NCT00411450|520150333|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
144259196|NCT01716663|520150334|FG000|Overall Study|Withdrawn prior to procedure|4|||
144259197|NCT01716663|520150334|FG000|Overall Study|Treated with non-study catheter|2|||
144259198|NCT01059773|520150335|FG000|Overall Study|Adverse Event|2|||
144259199|NCT01059773|520150336|FG001|Overall Study|Adverse Event|2|||
144259200|NCT01059773|520150335|FG000|Overall Study|Withdrawal by Subject|1|||
144259201|NCT01059773|520150336|FG001|Overall Study|Withdrawal by Subject|5|||
144259202|NCT01059773|520150335|FG000|Overall Study|Lost to Follow-up|1|||
144259203|NCT01059773|520150336|FG001|Overall Study|Lost to Follow-up|1|||
144259204|NCT01059773|520150335|FG000|Overall Study|Pregnancy|1|||
144259205|NCT01059773|520150336|FG001|Overall Study|Pregnancy|1|||
144259206|NCT01059773|520150335|FG000|Overall Study|Protocol Violation|6|||
144259207|NCT01059773|520150336|FG001|Overall Study|Protocol Violation|2|||
144259208|NCT01059773|520150335|FG000|Overall Study|Physician Decision|5|||
144259209|NCT01059773|520150336|FG001|Overall Study|Physician Decision|4|||
144259210|NCT01059773|520150335|FG000|Overall Study|Lack of Efficacy|3|||
144259211|NCT01059773|520150336|FG001|Overall Study|Lack of Efficacy|3|||
144259212|NCT01059773|520150335|FG000|Overall Study|Death|0|||
144259213|NCT01059773|520150336|FG001|Overall Study|Death|1|||
144259214|NCT01059773|520150335|FG000|Overall Study|Malignancy including squamous cell skin|0|||
144259215|NCT01059773|520150336|FG001|Overall Study|Malignancy including squamous cell skin|1|||
144259216|NCT01059773|520150335|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
144259217|NCT01059773|520150336|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
144198981|NCT03402750|519926444|FG001|Overall Study|Lost to Follow-up|1|||
144198982|NCT02981303|519926445|FG000|Overall Study|Progressive Disease|17|||
144198983|NCT02981303|519926446|FG001|Overall Study|Progressive Disease|37|||
144198984|NCT02981303|519926445|FG000|Overall Study|Adverse Event|1|||
144198985|NCT02981303|519926446|FG001|Overall Study|Adverse Event|4|||
144198986|NCT02981303|519926445|FG000|Overall Study|Withdrawal by Subject|0|||
144198987|NCT02981303|519926446|FG001|Overall Study|Withdrawal by Subject|1|||
144198988|NCT00507130|519926447|FG000|Overall Study|Lost to Follow-up|0|||
144198989|NCT00507130|519926448|FG001|Overall Study|Lost to Follow-up|0|||
144198990|NCT00507130|519926449|FG002|Overall Study|Lost to Follow-up|1|||
144198991|NCT00507130|519926450|FG003|Overall Study|Lost to Follow-up|1|||
144198992|NCT00507130|519926447|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
144198993|NCT00507130|519926448|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
144198994|NCT00507130|519926449|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
144198995|NCT00507130|519926450|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
144198996|NCT01460901|519926455|FG000|Overall Study|Withdrawal by Subject|2|||
144198997|NCT00893737|519926456|FG000|Overall Study|Adverse Event|4|||
144259218|NCT01059773|520150335|FG000|Overall Study|Other|1|||
144259219|NCT01059773|520150336|FG001|Overall Study|Other|3|||
144259220|NCT00872521|520150337|FG000|Completed PAD Induction|Patient choice|0|||
144198998|NCT00893737|519926456|FG000|Overall Study|Withdrawal by Subject|2|||
144198999|NCT00893737|519926456|FG000|Overall Study|Lost to Follow-up|6|||
144199000|NCT01156142|519926457|FG000|Overall Study|Withdrawal by Subject|8|||
144199001|NCT01156142|519926458|FG001|Overall Study|Withdrawal by Subject|6|||
144259221|NCT00872521|520150338|FG001|Completed PAD Induction|Patient choice|1|||
144259222|NCT00872521|520150339|FG002|Completed PAD Induction|Patient choice|0|||
144259223|NCT00872521|520150337|FG000|Completed PAD Induction|Disease progression|0|||
144259224|NCT00872521|520150338|FG001|Completed PAD Induction|Disease progression|2|||
144259225|NCT00872521|520150339|FG002|Completed PAD Induction|Disease progression|0|||
144259226|NCT00872521|520150337|FG000|Completed PAD Induction|Adverse Event|4|||
144199002|NCT01156142|519926457|FG000|Overall Study|Ineligible|0|||
144199003|NCT01156142|519926458|FG001|Overall Study|Ineligible|1|||
144259227|NCT00872521|520150338|FG001|Completed PAD Induction|Adverse Event|0|||
144199004|NCT03981419|519926459|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
144259228|NCT00872521|520150339|FG002|Completed PAD Induction|Adverse Event|0|||
144259229|NCT00872521|520150337|FG000|Completed PAD Induction|Death|1|||
144199005|NCT03981419|519926460|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
144199006|NCT01330459|519926461|FG000|Overall Study|Physician Decision|0|||
144199007|NCT01330459|519926462|FG001|Overall Study|Physician Decision|2|||
144199008|NCT00895947|519926463|FG000|Overall Study|Adverse Event|3|||
144199009|NCT00895947|519926464|FG001|Overall Study|Adverse Event|4|||
144199010|NCT00895947|519926463|FG000|Overall Study|Lost to Follow-up|3|||
144199011|NCT00895947|519926464|FG001|Overall Study|Lost to Follow-up|4|||
144199012|NCT00895947|519926463|FG000|Overall Study|Protocol Violation|4|||
144614744|NCT00708500|521450186|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
144199013|NCT00895947|519926464|FG001|Overall Study|Protocol Violation|2|||
144199014|NCT00895947|519926463|FG000|Overall Study|Withdrawal by Subject|2|||
144199015|NCT00895947|519926464|FG001|Overall Study|Withdrawal by Subject|0|||
144199016|NCT02272634|519926468|FG000|Overall Study|Adverse Event|1|||
144199017|NCT02272634|519926469|FG001|Overall Study|Adverse Event|0|||
144199018|NCT02272634|519926470|FG002|Overall Study|Adverse Event|0|||
144199019|NCT02272634|519926468|FG000|Overall Study|Protocol Violation|0|||
144199020|NCT02272634|519926469|FG001|Overall Study|Protocol Violation|0|||
144199021|NCT02272634|519926470|FG002|Overall Study|Protocol Violation|1|||
144199022|NCT02272634|519926468|FG000|Overall Study|Withdrawal by Subject|0|||
144199023|NCT02272634|519926469|FG001|Overall Study|Withdrawal by Subject|1|||
144199024|NCT02272634|519926470|FG002|Overall Study|Withdrawal by Subject|0|||
144199025|NCT01437943|519926471|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
144199026|NCT01437943|519926472|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
144199027|NCT01437943|519926471|FG000|Overall Study|Subject expressed pregnancy plans|1|||
144199028|NCT01437943|519926472|FG001|Overall Study|Subject expressed pregnancy plans|0|||
144199029|NCT01437943|519926471|FG000|Overall Study|Adverse Event|2|||
144199030|NCT01437943|519926472|FG001|Overall Study|Adverse Event|0|||
144199031|NCT03979820|519926473|FG000|Overall Study|Protocol Violation|1|||
144199032|NCT03979820|519926474|FG001|Overall Study|Protocol Violation|0|||
144199033|NCT03979820|519926475|FG002|Overall Study|Protocol Violation|0|||
144199034|NCT03979820|519926476|FG003|Overall Study|Protocol Violation|0|||
144199035|NCT03979820|519926473|FG000|Overall Study|Withdrawal by Subject|0|||
144199036|NCT03979820|519926474|FG001|Overall Study|Withdrawal by Subject|0|||
144199037|NCT03979820|519926475|FG002|Overall Study|Withdrawal by Subject|1|||
144199038|NCT03979820|519926476|FG003|Overall Study|Withdrawal by Subject|0|||
144199039|NCT03979820|519926473|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
144199040|NCT03979820|519926474|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
144199041|NCT03979820|519926475|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
144199042|NCT03979820|519926476|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
144199043|NCT00988065|519926477|FG000|Overall Study|Adverse Event|4|||
144199044|NCT00988065|519926478|FG001|Overall Study|Adverse Event|10|||
144199045|NCT00988065|519926479|FG002|Overall Study|Adverse Event|2|||
144199046|NCT00988065|519926477|FG000|Overall Study|Lost to Follow-up|1|||
144199047|NCT00988065|519926478|FG001|Overall Study|Lost to Follow-up|2|||
144199048|NCT00988065|519926479|FG002|Overall Study|Lost to Follow-up|2|||
144199049|NCT00988065|519926477|FG000|Overall Study|Subject withdrew consent|3|||
144199050|NCT00988065|519926478|FG001|Overall Study|Subject withdrew consent|5|||
144199051|NCT00988065|519926479|FG002|Overall Study|Subject withdrew consent|2|||
144199052|NCT00988065|519926477|FG000|Overall Study|Noncompliance with protocol|5|||
144199053|NCT00988065|519926478|FG001|Overall Study|Noncompliance with protocol|6|||
144199054|NCT00988065|519926479|FG002|Overall Study|Noncompliance with protocol|9|||
144199055|NCT01355159|519926500|FG000|Overall Study|Withdrew consent|39|||
144199056|NCT01355159|519926501|FG001|Overall Study|Withdrew consent|47|||
144199057|NCT01355159|519926500|FG000|Overall Study|No primary outcome data|17|||
144199058|NCT01355159|519926501|FG001|Overall Study|No primary outcome data|11|||
144199059|NCT01355159|519926500|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
144199060|NCT01355159|519926501|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
144199061|NCT01355159|519926500|FG000|Overall Study|Early intrauterine fetal death|6|||
144199062|NCT01355159|519926501|FG001|Overall Study|Early intrauterine fetal death|6|||
144199063|NCT01941940|519926502|FG000|Overall Study|Adverse Event|11|||
144199064|NCT01941940|519926502|FG000|Overall Study|Lost to Follow-up|2|||
144199065|NCT01941940|519926502|FG000|Overall Study|Physician Decision|2|||
144199066|NCT01941940|519926502|FG000|Overall Study|Withdrawal by Subject|15|||
144199067|NCT01941940|519926502|FG000|Overall Study|Death|1|||
144199068|NCT01941940|519926502|FG000|Overall Study|Other|1|||
144199069|NCT01941940|519926502|FG000|Overall Study|Other|1|||
144199070|NCT00502801|519926503|FG000|Treatment Period|Withdrawal by Subject|3|||
144199071|NCT00502801|519926503|FG000|Treatment Period|Adverse Event|7|||
144199072|NCT00502801|519926503|FG000|Treatment Period|Death|14|||
144199073|NCT00502801|519926503|FG000|Treatment Period|OTHER|30|||
144199074|NCT00502801|519926503|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
144199075|NCT00502801|519926503|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
144199076|NCT00502801|519926503|FG000|End of Therapy to Test of Cure|Death|3|||
144199077|NCT00502801|519926503|FG000|End of Therapy to Test of Cure|OTHER|2|||
144199078|NCT03212521|519926506|FG000|Overall Study|Adverse Event|1|||
144259230|NCT00872521|520150338|FG001|Completed PAD Induction|Death|1|||
144259231|NCT00872521|520150339|FG002|Completed PAD Induction|Death|0|||
144259232|NCT00872521|520150337|FG000|Primary Endpoint Analysis|Other|1|||
144259233|NCT00872521|520150338|FG001|Primary Endpoint Analysis|Other|2|||
144259234|NCT00872521|520150339|FG002|Primary Endpoint Analysis|Other|0|||
144259235|NCT00872521|520150337|FG000|Primary Endpoint Analysis|Patient choice|0|||
144259236|NCT00872521|520150338|FG001|Primary Endpoint Analysis|Patient choice|1|||
144259237|NCT00872521|520150339|FG002|Primary Endpoint Analysis|Patient choice|0|||
144259238|NCT00872521|520150337|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
144259239|NCT00872521|520150338|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
144259240|NCT00872521|520150339|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
144259241|NCT00872521|520150337|FG000|Primary Endpoint Analysis|Patient response missing|0|||
144259242|NCT00872521|520150338|FG001|Primary Endpoint Analysis|Patient response missing|0|||
144259243|NCT00872521|520150339|FG002|Primary Endpoint Analysis|Patient response missing|1|||
144259244|NCT00872521|520150337|FG000|Completed 3-month Follow up|Other|0|||
144259245|NCT00872521|520150338|FG001|Completed 3-month Follow up|Other|2|||
144259246|NCT00872521|520150339|FG002|Completed 3-month Follow up|Other|0|||
144259247|NCT00872521|520150337|FG000|Completed 3-month Follow up|Physician Decision|0|||
144259248|NCT00872521|520150338|FG001|Completed 3-month Follow up|Physician Decision|1|||
144259249|NCT00872521|520150339|FG002|Completed 3-month Follow up|Physician Decision|0|||
144259250|NCT00872521|520150337|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
144259251|NCT00872521|520150338|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
144259252|NCT00872521|520150339|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
144259253|NCT00141518|520150341|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
144259254|NCT00141518|520150342|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
144259255|NCT00141518|520150343|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
144259256|NCT00141518|520150341|FG000|Overall Study|Adverse Event|7|||
144614745|NCT00708500|521450184|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
144614746|NCT00708500|521450185|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
144199079|NCT03212521|519926506|FG000|Overall Study|Lost to Follow-up|4|||
144199080|NCT03212521|519926506|FG000|Overall Study|Withdrawal by Subject|1|||
144199081|NCT03212521|519926506|FG000|Overall Study|Other|1|||
144199082|NCT00444457|519926508|FG000|Infant Series|Other|0|||
144199083|NCT00444457|519926509|FG001|Infant Series|Other|1|||
144199084|NCT00444457|519926510|FG002|Infant Series|Other|0|||
144199085|NCT00444457|519926511|FG003|Infant Series|Other|0|||
144199086|NCT00444457|519926508|FG000|Infant Series|Parent or legal guardian request|18|||
144199087|NCT00444457|519926509|FG001|Infant Series|Parent or legal guardian request|29|||
144199088|NCT00444457|519926510|FG002|Infant Series|Parent or legal guardian request|34|||
144199089|NCT00444457|519926511|FG003|Infant Series|Parent or legal guardian request|14|||
144199090|NCT00444457|519926508|FG000|Infant Series|Lost to Follow-up|10|||
144199091|NCT00444457|519926509|FG001|Infant Series|Lost to Follow-up|11|||
144199092|NCT00444457|519926510|FG002|Infant Series|Lost to Follow-up|7|||
144199093|NCT00444457|519926511|FG003|Infant Series|Lost to Follow-up|6|||
144199094|NCT00444457|519926508|FG000|Infant Series|Protocol Violation|16|||
144199095|NCT00444457|519926509|FG001|Infant Series|Protocol Violation|8|||
144199096|NCT00444457|519926510|FG002|Infant Series|Protocol Violation|6|||
144199097|NCT00444457|519926511|FG003|Infant Series|Protocol Violation|3|||
144199098|NCT00444457|519926508|FG000|Infant Series|Failed to return|5|||
144199099|NCT00444457|519926509|FG001|Infant Series|Failed to return|4|||
144199100|NCT00444457|519926510|FG002|Infant Series|Failed to return|4|||
144199101|NCT00444457|519926511|FG003|Infant Series|Failed to return|2|||
144199102|NCT00444457|519926508|FG000|Infant Series|Investigator request|4|||
144199103|NCT00444457|519926509|FG001|Infant Series|Investigator request|3|||
144199104|NCT00444457|519926510|FG002|Infant Series|Investigator request|3|||
144199105|NCT00444457|519926511|FG003|Infant Series|Investigator request|2|||
144199106|NCT00444457|519926508|FG000|Infant Series|Other|0|||
144199107|NCT00444457|519926509|FG001|Infant Series|Other|2|||
144199108|NCT00444457|519926510|FG002|Infant Series|Other|4|||
144199109|NCT00444457|519926511|FG003|Infant Series|Other|0|||
144199110|NCT00444457|519926508|FG000|Infant Series|Adverse Event|1|||
144199111|NCT00444457|519926509|FG001|Infant Series|Adverse Event|2|||
144199112|NCT00444457|519926510|FG002|Infant Series|Adverse Event|2|||
144199113|NCT00444457|519926511|FG003|Infant Series|Adverse Event|0|||
144199114|NCT00444457|519926508|FG000|Infant Series|Death|0|||
144199115|NCT00444457|519926509|FG001|Infant Series|Death|1|||
144199116|NCT00444457|519926510|FG002|Infant Series|Death|1|||
144199117|NCT00444457|519926511|FG003|Infant Series|Death|1|||
144199118|NCT00444457|519926508|FG000|After Infant Series|Other|0|||
144199119|NCT00444457|519926509|FG001|After Infant Series|Other|1|||
144199120|NCT00444457|519926510|FG002|After Infant Series|Other|1|||
144199121|NCT00444457|519926511|FG003|After Infant Series|Other|1|||
144199122|NCT00444457|519926508|FG000|After Infant Series|Parent or legal guardian request|4|||
144199123|NCT00444457|519926509|FG001|After Infant Series|Parent or legal guardian request|11|||
144199124|NCT00444457|519926510|FG002|After Infant Series|Parent or legal guardian request|6|||
144259257|NCT00141518|520150342|FG001|Overall Study|Adverse Event|5|||
144259258|NCT00141518|520150343|FG002|Overall Study|Adverse Event|2|||
144259259|NCT00141518|520150341|FG000|Overall Study|Withdrawal by Subject|2|||
144259260|NCT00141518|520150342|FG001|Overall Study|Withdrawal by Subject|0|||
144259261|NCT00141518|520150343|FG002|Overall Study|Withdrawal by Subject|2|||
144259262|NCT00141518|520150341|FG000|Overall Study|Protocol Violation|1|||
144259263|NCT00141518|520150342|FG001|Overall Study|Protocol Violation|1|||
144259264|NCT00141518|520150343|FG002|Overall Study|Protocol Violation|2|||
144259265|NCT00141518|520150341|FG000|Overall Study|Lack of Efficacy|5|||
144199125|NCT00444457|519926511|FG003|After Infant Series|Parent or legal guardian request|3|||
144199126|NCT00444457|519926508|FG000|After Infant Series|Failed to return|7|||
144199127|NCT00444457|519926509|FG001|After Infant Series|Failed to return|6|||
144199128|NCT00444457|519926510|FG002|After Infant Series|Failed to return|5|||
144199129|NCT00444457|519926511|FG003|After Infant Series|Failed to return|1|||
144199130|NCT00444457|519926508|FG000|After Infant Series|Lost to Follow-up|5|||
144199131|NCT00444457|519926509|FG001|After Infant Series|Lost to Follow-up|5|||
144199132|NCT00444457|519926510|FG002|After Infant Series|Lost to Follow-up|5|||
144199133|NCT00444457|519926511|FG003|After Infant Series|Lost to Follow-up|2|||
144199134|NCT00444457|519926508|FG000|After Infant Series|Protocol Violation|2|||
144199135|NCT00444457|519926509|FG001|After Infant Series|Protocol Violation|4|||
144199136|NCT00444457|519926510|FG002|After Infant Series|Protocol Violation|2|||
144199137|NCT00444457|519926511|FG003|After Infant Series|Protocol Violation|2|||
144199138|NCT00444457|519926508|FG000|After Infant Series|Adverse Event|2|||
144199139|NCT00444457|519926509|FG001|After Infant Series|Adverse Event|2|||
144199140|NCT00444457|519926510|FG002|After Infant Series|Adverse Event|0|||
144199141|NCT00444457|519926511|FG003|After Infant Series|Adverse Event|0|||
144199142|NCT00444457|519926508|FG000|After Infant Series|Investigator request|0|||
144199143|NCT00444457|519926509|FG001|After Infant Series|Investigator request|0|||
144199144|NCT00444457|519926510|FG002|After Infant Series|Investigator request|0|||
144199145|NCT00444457|519926511|FG003|After Infant Series|Investigator request|1|||
144199146|NCT00444457|519926508|FG000|After Infant Series|Other|0|||
144199147|NCT00444457|519926509|FG001|After Infant Series|Other|1|||
144199148|NCT00444457|519926510|FG002|After Infant Series|Other|0|||
144199149|NCT00444457|519926511|FG003|After Infant Series|Other|0|||
144199150|NCT00444457|519926508|FG000|Toddler Dose|Lost to Follow-up|4|||
144199151|NCT00444457|519926509|FG001|Toddler Dose|Lost to Follow-up|1|||
144199152|NCT00444457|519926510|FG002|Toddler Dose|Lost to Follow-up|1|||
144199153|NCT00444457|519926511|FG003|Toddler Dose|Lost to Follow-up|3|||
144199154|NCT00444457|519926508|FG000|Toddler Dose|Failed to return|2|||
144199155|NCT00444457|519926509|FG001|Toddler Dose|Failed to return|2|||
144199156|NCT00444457|519926510|FG002|Toddler Dose|Failed to return|1|||
144199157|NCT00444457|519926511|FG003|Toddler Dose|Failed to return|3|||
144199158|NCT00444457|519926508|FG000|Toddler Dose|Parent or legal guardian request|0|||
144199159|NCT00444457|519926509|FG001|Toddler Dose|Parent or legal guardian request|3|||
144199160|NCT00444457|519926510|FG002|Toddler Dose|Parent or legal guardian request|2|||
144199161|NCT00444457|519926511|FG003|Toddler Dose|Parent or legal guardian request|1|||
144199162|NCT00444457|519926508|FG000|Toddler Dose|Protocol Violation|1|||
144199163|NCT00444457|519926509|FG001|Toddler Dose|Protocol Violation|0|||
144199164|NCT00444457|519926510|FG002|Toddler Dose|Protocol Violation|0|||
144199165|NCT00444457|519926511|FG003|Toddler Dose|Protocol Violation|1|||
144199166|NCT00914459|519926514|FG000|Overall Study|Protocol Violation|0|||
144199167|NCT00914459|519926515|FG001|Overall Study|Protocol Violation|1|||
144199168|NCT00914459|519926514|FG000|Overall Study|Parent/Legal guardian request|1|||
144199169|NCT00914459|519926515|FG001|Overall Study|Parent/Legal guardian request|0|||
144199170|NCT01661179|519926516|FG000|Overall Study|Death|1|||
144199171|NCT01661179|519926516|FG000|Overall Study|Withdrawal by Subject|1|||
144199172|NCT01661179|519926516|FG000|Overall Study|Other Eligibility criteria|4|||
144199173|NCT00321737|519926517|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
144199174|NCT00321737|519926518|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
144199175|NCT00321737|519926519|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
144199176|NCT00321737|519926517|FG000|Overall Study|Adverse Event|11|||
144199177|NCT00321737|519926518|FG001|Overall Study|Adverse Event|3|||
144199178|NCT00321737|519926519|FG002|Overall Study|Adverse Event|6|||
144259266|NCT00141518|520150342|FG001|Overall Study|Lack of Efficacy|0|||
144199179|NCT00321737|519926517|FG000|Overall Study|Lost to Follow-up|5|||
144259267|NCT00141518|520150343|FG002|Overall Study|Lack of Efficacy|0|||
144259268|NCT03006562|520150344|FG000|Overall Study|Lost to Follow-up|0|||
144199180|NCT00321737|519926518|FG001|Overall Study|Lost to Follow-up|5|||
144199181|NCT00321737|519926519|FG002|Overall Study|Lost to Follow-up|6|||
144259269|NCT03006562|520150345|FG001|Overall Study|Lost to Follow-up|1|||
144259270|NCT00614874|520150346|FG000|Overall Study|Protocol Violation|1|||
144259271|NCT00614874|520150346|FG000|Overall Study|Withdrawal by Subject|1|||
144259272|NCT01001910|520150347|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
144199182|NCT00321737|519926517|FG000|Overall Study|Withdrawal by Subject|19|||
144199183|NCT00321737|519926518|FG001|Overall Study|Withdrawal by Subject|12|||
144199184|NCT00321737|519926519|FG002|Overall Study|Withdrawal by Subject|17|||
144199185|NCT00321737|519926517|FG000|Overall Study|Protocol Violation|0|||
144259370|NCT05464420|520150401|FG001|Overall Study|Withdrawal by Subject|8|||
144259371|NCT05464420|520150402|FG002|Overall Study|Withdrawal by Subject|3|||
144259372|NCT05464420|520150403|FG003|Overall Study|Withdrawal by Subject|1|||
144259373|NCT05464420|520150400|FG000|Overall Study|Protocol Violation|0|||
144259374|NCT05464420|520150401|FG001|Overall Study|Protocol Violation|0|||
144259375|NCT05464420|520150402|FG002|Overall Study|Protocol Violation|1|||
144259376|NCT05464420|520150403|FG003|Overall Study|Protocol Violation|1|||
144259377|NCT05464420|520150400|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
144259378|NCT05464420|520150401|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
144259379|NCT05464420|520150402|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
144259380|NCT05464420|520150403|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
144259381|NCT01383018|520150404|FG000|Overall Study|Adverse Event|14|||
144259382|NCT01383018|520150404|FG000|Overall Study|Death|10|||
144259383|NCT01383018|520150404|FG000|Overall Study|Lost to Follow-up|5|||
144259384|NCT01383018|520150404|FG000|Overall Study|Physician Decision|5|||
144259385|NCT01383018|520150404|FG000|Overall Study|Withdrawal by Subject|9|||
144259386|NCT01383018|520150404|FG000|Overall Study|Subject not implanted|76|||
144259387|NCT01383018|520150404|FG000|Overall Study|Missed Visit|247|||
144259388|NCT01383018|520150404|FG000|Overall Study|Site closed early-not compliance related|7|||
144259389|NCT01383018|520150404|FG000|Overall Study|Patient moved away from site|1|||
144259390|NCT01383018|520150404|FG000|Overall Study|Subject Incarcerated|1|||
144259391|NCT00099632|520150405|FG000|Overall Study|Lost to Follow-up|1|||
144259392|NCT00099632|520150406|FG001|Overall Study|Lost to Follow-up|0|||
144259393|NCT00099632|520150407|FG002|Overall Study|Lost to Follow-up|3|||
144259394|NCT00099632|520150408|FG003|Overall Study|Lost to Follow-up|1|||
144259395|NCT00099632|520150409|FG004|Overall Study|Lost to Follow-up|1|||
144259396|NCT00099632|520150410|FG005|Overall Study|Lost to Follow-up|0|||
144259397|NCT00099632|520150405|FG000|Overall Study|Withdrawal by Subject|0|||
144259398|NCT00099632|520150406|FG001|Overall Study|Withdrawal by Subject|1|||
144259399|NCT00099632|520150407|FG002|Overall Study|Withdrawal by Subject|0|||
144259400|NCT00099632|520150408|FG003|Overall Study|Withdrawal by Subject|0|||
144259401|NCT00099632|520150409|FG004|Overall Study|Withdrawal by Subject|0|||
144259402|NCT00099632|520150410|FG005|Overall Study|Withdrawal by Subject|1|||
144259403|NCT00099632|520150405|FG000|Overall Study|Protocol Violation|0|||
144259404|NCT00099632|520150406|FG001|Overall Study|Protocol Violation|0|||
144259405|NCT00099632|520150407|FG002|Overall Study|Protocol Violation|0|||
144259406|NCT00099632|520150408|FG003|Overall Study|Protocol Violation|0|||
144259407|NCT00099632|520150409|FG004|Overall Study|Protocol Violation|0|||
144259408|NCT00099632|520150410|FG005|Overall Study|Protocol Violation|1|||
144259409|NCT00103285|520151860|FG000|Induction|Adverse Event|14|||
144259410|NCT00103285|520151861|FG001|Induction|Adverse Event|0|||
144259411|NCT00103285|520151862|FG002|Induction|Adverse Event|0|||
144259412|NCT00103285|520151863|FG003|Induction|Adverse Event|0|||
144259413|NCT00103285|520151864|FG004|Induction|Adverse Event|0|||
144259414|NCT00103285|520151865|FG005|Induction|Adverse Event|0|||
144259415|NCT00103285|520151866|FG006|Induction|Adverse Event|0|||
144259416|NCT00103285|520151867|FG007|Induction|Adverse Event|0|||
144259417|NCT00103285|520151860|FG000|Induction|Death|24|||
144259418|NCT00103285|520151861|FG001|Induction|Death|0|||
144259419|NCT00103285|520151862|FG002|Induction|Death|0|||
144259420|NCT00103285|520151863|FG003|Induction|Death|0|||
144259421|NCT00103285|520151864|FG004|Induction|Death|0|||
144259422|NCT00103285|520151865|FG005|Induction|Death|0|||
144259423|NCT00103285|520151866|FG006|Induction|Death|0|||
144259424|NCT00103285|520151867|FG007|Induction|Death|0|||
144259425|NCT00103285|520151860|FG000|Induction|Physician Decision|103|||
144259426|NCT00103285|520151861|FG001|Induction|Physician Decision|0|||
144259427|NCT00103285|520151862|FG002|Induction|Physician Decision|0|||
144259428|NCT00103285|520151863|FG003|Induction|Physician Decision|0|||
144259429|NCT00103285|520151864|FG004|Induction|Physician Decision|0|||
144259430|NCT00103285|520151865|FG005|Induction|Physician Decision|0|||
144259431|NCT00103285|520151866|FG006|Induction|Physician Decision|0|||
144259432|NCT00103285|520151867|FG007|Induction|Physician Decision|0|||
144259433|NCT00103285|520151860|FG000|Induction|Withdrawal by Subject|1|||
144259434|NCT00103285|520151861|FG001|Induction|Withdrawal by Subject|0|||
144259435|NCT00103285|520151862|FG002|Induction|Withdrawal by Subject|0|||
144259436|NCT00103285|520151863|FG003|Induction|Withdrawal by Subject|0|||
144259437|NCT00103285|520151864|FG004|Induction|Withdrawal by Subject|0|||
144259438|NCT00103285|520151865|FG005|Induction|Withdrawal by Subject|0|||
144259439|NCT00103285|520151866|FG006|Induction|Withdrawal by Subject|0|||
144259440|NCT00103285|520151867|FG007|Induction|Withdrawal by Subject|0|||
144259441|NCT00103285|520151860|FG000|Induction|Ineligible|43|||
144259442|NCT00103285|520151861|FG001|Induction|Ineligible|0|||
144259443|NCT00103285|520151862|FG002|Induction|Ineligible|0|||
144259444|NCT00103285|520151863|FG003|Induction|Ineligible|0|||
144259445|NCT00103285|520151864|FG004|Induction|Ineligible|0|||
144259446|NCT00103285|520151865|FG005|Induction|Ineligible|0|||
144259447|NCT00103285|520151866|FG006|Induction|Ineligible|0|||
144259448|NCT00103285|520151867|FG007|Induction|Ineligible|0|||
144259449|NCT00103285|520151860|FG000|Induction|Refusal|906|||
144259450|NCT00103285|520151861|FG001|Induction|Refusal|0|||
144259451|NCT00103285|520151862|FG002|Induction|Refusal|0|||
144259452|NCT00103285|520151863|FG003|Induction|Refusal|0|||
144259453|NCT00103285|520151864|FG004|Induction|Refusal|0|||
144259454|NCT00103285|520151865|FG005|Induction|Refusal|0|||
144259455|NCT00103285|520151866|FG006|Induction|Refusal|0|||
144259456|NCT00103285|520151867|FG007|Induction|Refusal|0|||
144259457|NCT00103285|520151860|FG000|Induction|Other|258|||
144259458|NCT00103285|520151861|FG001|Induction|Other|0|||
144259459|NCT00103285|520151862|FG002|Induction|Other|0|||
144259460|NCT00103285|520151863|FG003|Induction|Other|0|||
144259461|NCT00103285|520151864|FG004|Induction|Other|0|||
144259462|NCT00103285|520151865|FG005|Induction|Other|0|||
144259463|NCT00103285|520151866|FG006|Induction|Other|0|||
144259464|NCT00103285|520151867|FG007|Induction|Other|0|||
144259465|NCT00103285|520151860|FG000|Response Assignment|Adverse Event|0|||
144259466|NCT00103285|520151861|FG001|Response Assignment|Adverse Event|8|||
144259467|NCT00103285|520151862|FG002|Response Assignment|Adverse Event|3|||
144259468|NCT00103285|520151863|FG003|Response Assignment|Adverse Event|2|||
144259469|NCT00103285|520151864|FG004|Response Assignment|Adverse Event|3|||
144259470|NCT00103285|520151865|FG005|Response Assignment|Adverse Event|1|||
144259471|NCT00103285|520151866|FG006|Response Assignment|Adverse Event|1|||
144259472|NCT00103285|520151867|FG007|Response Assignment|Adverse Event|2|||
144259473|NCT00103285|520151860|FG000|Response Assignment|Death|0|||
144259474|NCT00103285|520151861|FG001|Response Assignment|Death|5|||
144259475|NCT00103285|520151862|FG002|Response Assignment|Death|2|||
144259476|NCT00103285|520151863|FG003|Response Assignment|Death|2|||
144259477|NCT00103285|520151864|FG004|Response Assignment|Death|3|||
144259478|NCT00103285|520151865|FG005|Response Assignment|Death|1|||
144259479|NCT00103285|520151866|FG006|Response Assignment|Death|0|||
144259480|NCT00103285|520151867|FG007|Response Assignment|Death|8|||
144259481|NCT00103285|520151860|FG000|Response Assignment|Lost to Follow-up|0|||
144259482|NCT00103285|520151861|FG001|Response Assignment|Lost to Follow-up|9|||
144259483|NCT00103285|520151862|FG002|Response Assignment|Lost to Follow-up|5|||
144259484|NCT00103285|520151863|FG003|Response Assignment|Lost to Follow-up|5|||
144259485|NCT00103285|520151864|FG004|Response Assignment|Lost to Follow-up|1|||
144259486|NCT00103285|520151865|FG005|Response Assignment|Lost to Follow-up|2|||
144259487|NCT00103285|520151866|FG006|Response Assignment|Lost to Follow-up|2|||
144259488|NCT00103285|520151867|FG007|Response Assignment|Lost to Follow-up|5|||
144259489|NCT00103285|520151860|FG000|Response Assignment|Physician Decision|0|||
144259490|NCT00103285|520151861|FG001|Response Assignment|Physician Decision|13|||
144259491|NCT00103285|520151862|FG002|Response Assignment|Physician Decision|14|||
144259492|NCT00103285|520151863|FG003|Response Assignment|Physician Decision|9|||
144259493|NCT00103285|520151864|FG004|Response Assignment|Physician Decision|13|||
144259494|NCT00103285|520151865|FG005|Response Assignment|Physician Decision|7|||
144259495|NCT00103285|520151866|FG006|Response Assignment|Physician Decision|4|||
144259496|NCT00103285|520151867|FG007|Response Assignment|Physician Decision|35|||
144259497|NCT00103285|520151860|FG000|Response Assignment|Protocol Violation|0|||
144259498|NCT00103285|520151861|FG001|Response Assignment|Protocol Violation|2|||
144259499|NCT00103285|520151862|FG002|Response Assignment|Protocol Violation|0|||
144259500|NCT00103285|520151863|FG003|Response Assignment|Protocol Violation|0|||
144259501|NCT00103285|520151864|FG004|Response Assignment|Protocol Violation|0|||
144259502|NCT00103285|520151865|FG005|Response Assignment|Protocol Violation|0|||
144259503|NCT00103285|520151866|FG006|Response Assignment|Protocol Violation|0|||
144259504|NCT00103285|520151867|FG007|Response Assignment|Protocol Violation|0|||
144259505|NCT00103285|520151860|FG000|Response Assignment|Withdrawal by Subject|0|||
144259506|NCT00103285|520151861|FG001|Response Assignment|Withdrawal by Subject|4|||
144259507|NCT00103285|520151862|FG002|Response Assignment|Withdrawal by Subject|1|||
144727090|NCT05097989|521854426|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
144727091|NCT05097989|521854427|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
144727092|NCT05097989|521854428|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
144727093|NCT05097989|521854429|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
144727094|NCT05097989|521854430|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
144727095|NCT05097989|521854431|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
144727096|NCT05097989|521854423|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
144727097|NCT05097989|521854424|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
144727098|NCT05097989|521854425|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
144727099|NCT05097989|521854426|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
144727100|NCT05097989|521854427|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
144727101|NCT05097989|521854428|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
144727102|NCT05097989|521854429|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
144259508|NCT00103285|520151863|FG003|Response Assignment|Withdrawal by Subject|1|||
144259509|NCT00103285|520151864|FG004|Response Assignment|Withdrawal by Subject|2|||
144259510|NCT00103285|520151865|FG005|Response Assignment|Withdrawal by Subject|2|||
144259511|NCT00103285|520151866|FG006|Response Assignment|Withdrawal by Subject|0|||
144259512|NCT00103285|520151867|FG007|Response Assignment|Withdrawal by Subject|2|||
144727103|NCT05097989|521854430|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
144259513|NCT00103285|520151860|FG000|Response Assignment|Ineligible|0|||
144259514|NCT00103285|520151861|FG001|Response Assignment|Ineligible|8|||
144259515|NCT00103285|520151862|FG002|Response Assignment|Ineligible|6|||
144259516|NCT00103285|520151863|FG003|Response Assignment|Ineligible|2|||
144259517|NCT00103285|520151864|FG004|Response Assignment|Ineligible|0|||
144259518|NCT00103285|520151865|FG005|Response Assignment|Ineligible|3|||
144259519|NCT00103285|520151866|FG006|Response Assignment|Ineligible|1|||
144259520|NCT00103285|520151867|FG007|Response Assignment|Ineligible|5|||
144259521|NCT00103285|520151860|FG000|Response Assignment|Refusal|0|||
144259522|NCT00103285|520151861|FG001|Response Assignment|Refusal|53|||
144259523|NCT00103285|520151862|FG002|Response Assignment|Refusal|5|||
144259524|NCT00103285|520151863|FG003|Response Assignment|Refusal|3|||
144259525|NCT00103285|520151864|FG004|Response Assignment|Refusal|25|||
144259526|NCT00103285|520151865|FG005|Response Assignment|Refusal|15|||
144259527|NCT00103285|520151866|FG006|Response Assignment|Refusal|30|||
144259528|NCT00103285|520151867|FG007|Response Assignment|Refusal|10|||
144259529|NCT00103285|520151860|FG000|Response Assignment|Other|0|||
144259530|NCT00103285|520151861|FG001|Response Assignment|Other|30|||
144259531|NCT00103285|520151862|FG002|Response Assignment|Other|48|||
144259532|NCT00103285|520151863|FG003|Response Assignment|Other|38|||
144259533|NCT00103285|520151864|FG004|Response Assignment|Other|37|||
144259534|NCT00103285|520151865|FG005|Response Assignment|Other|17|||
144259535|NCT00103285|520151866|FG006|Response Assignment|Other|11|||
144259536|NCT00103285|520151867|FG007|Response Assignment|Other|53|||
144259537|NCT01381926|520151868|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
144259538|NCT01381926|520151869|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
144259539|NCT01381926|520151868|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
144259540|NCT01381926|520151869|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
144259541|NCT02100839|520151882|FG000|Multiple Ascending Dose|Adverse Event|2|||
144259542|NCT02100839|520151883|FG001|Multiple Ascending Dose|Adverse Event|0|||
144259543|NCT02100839|520151882|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
144259544|NCT02100839|520151883|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
144259545|NCT00463801|520151886|FG000|Overall Study|Protocol Violation|1|||
144259546|NCT00463801|520151886|FG000|Overall Study|Lack of Efficacy|2|||
144259547|NCT00463801|520151886|FG000|Overall Study|Adverse Event|4|||
144259548|NCT00463801|520151886|FG000|Overall Study|Lost to Follow-up|5|||
144259549|NCT00463801|520151886|FG000|Overall Study|No longer require therapy|1|||
144259550|NCT00940888|520151887|FG000|Overall Study|Unsuccessful Implant|4|||
144259551|NCT00940888|520151887|FG000|Overall Study|Death|461|||
144259552|NCT00940888|520151887|FG000|Overall Study|Withdrawn - Non-Death|364|||
144259553|NCT00940888|520151887|FG000|Overall Study|Lost to Follow-up|6|||
144259554|NCT01409915|520151888|FG000|Overall Study|Adverse Event|0|||
144259555|NCT01409915|520151889|FG001|Overall Study|Adverse Event|2|||
144259556|NCT01409915|520151888|FG000|Overall Study|Withdrawal by Subject|0|||
144259557|NCT01409915|520151889|FG001|Overall Study|Withdrawal by Subject|1|||
144259558|NCT01409915|520151888|FG000|Overall Study|Protocol Violation|1|||
144259559|NCT01409915|520151889|FG001|Overall Study|Protocol Violation|0|||
144259560|NCT00391872|520151890|FG000|Overall Study|Protocol Violation|7|||
144259561|NCT00391872|520151891|FG001|Overall Study|Protocol Violation|2|||
144259562|NCT00391872|520151890|FG000|Overall Study|Withdrawal by Subject|296|||
144259563|NCT00391872|520151891|FG001|Overall Study|Withdrawal by Subject|249|||
144259564|NCT00391872|520151890|FG000|Overall Study|Reason unknown|2|||
144259565|NCT00391872|520151891|FG001|Overall Study|Reason unknown|4|||
144259566|NCT00391872|520151890|FG000|Overall Study|Lost to Follow-up|2|||
144259567|NCT00391872|520151891|FG001|Overall Study|Lost to Follow-up|0|||
144259568|NCT02781818|520151899|FG000|Overall Study|Lost to Follow-up|4|||
144259569|NCT02781818|520151900|FG001|Overall Study|Lost to Follow-up|2|||
144259570|NCT02781818|520151901|FG002|Overall Study|Lost to Follow-up|1|||
144259571|NCT01877668|520151902|FG000|Overall Study|Death|0|||
144259572|NCT01877668|520151903|FG001|Overall Study|Death|0|||
144259573|NCT01877668|520151904|FG002|Overall Study|Death|0|||
144259574|NCT01877668|520151905|FG003|Overall Study|Death|1|||
144259575|NCT01877668|520151906|FG004|Overall Study|Death|0|||
144259576|NCT01877668|520151902|FG000|Overall Study|No longer met study criteria|1|||
144259577|NCT01877668|520151903|FG001|Overall Study|No longer met study criteria|0|||
144259578|NCT01877668|520151904|FG002|Overall Study|No longer met study criteria|1|||
144259579|NCT01877668|520151905|FG003|Overall Study|No longer met study criteria|0|||
144259580|NCT01877668|520151906|FG004|Overall Study|No longer met study criteria|0|||
144259581|NCT01877668|520151902|FG000|Overall Study|Insufficient clinical response|0|||
144259582|NCT01877668|520151903|FG001|Overall Study|Insufficient clinical response|1|||
144259583|NCT01877668|520151904|FG002|Overall Study|Insufficient clinical response|2|||
144259584|NCT01877668|520151905|FG003|Overall Study|Insufficient clinical response|2|||
144259585|NCT01877668|520151906|FG004|Overall Study|Insufficient clinical response|0|||
144259586|NCT01877668|520151902|FG000|Overall Study|Lost to Follow-up|0|||
144259587|NCT01877668|520151903|FG001|Overall Study|Lost to Follow-up|2|||
144259588|NCT01877668|520151904|FG002|Overall Study|Lost to Follow-up|1|||
144259589|NCT01877668|520151905|FG003|Overall Study|Lost to Follow-up|0|||
144259590|NCT01877668|520151906|FG004|Overall Study|Lost to Follow-up|0|||
144259591|NCT01877668|520151902|FG000|Overall Study|Withdrawal by Subject|2|||
144259592|NCT01877668|520151903|FG001|Overall Study|Withdrawal by Subject|0|||
144259593|NCT01877668|520151904|FG002|Overall Study|Withdrawal by Subject|3|||
144259594|NCT01877668|520151905|FG003|Overall Study|Withdrawal by Subject|2|||
144259595|NCT01877668|520151906|FG004|Overall Study|Withdrawal by Subject|2|||
144259596|NCT01877668|520151902|FG000|Overall Study|Other|1|||
144259597|NCT01877668|520151903|FG001|Overall Study|Other|1|||
144259598|NCT01877668|520151904|FG002|Overall Study|Other|1|||
144259599|NCT01877668|520151905|FG003|Overall Study|Other|1|||
144259600|NCT01877668|520151906|FG004|Overall Study|Other|3|||
144259601|NCT01877668|520151902|FG000|Overall Study|Protocol Violation|1|||
144259602|NCT01877668|520151903|FG001|Overall Study|Protocol Violation|1|||
144259603|NCT01877668|520151904|FG002|Overall Study|Protocol Violation|0|||
144259604|NCT01877668|520151905|FG003|Overall Study|Protocol Violation|0|||
144259605|NCT01877668|520151906|FG004|Overall Study|Protocol Violation|3|||
144259606|NCT01877668|520151902|FG000|Overall Study|Adverse event related to study drug|2|||
144259607|NCT01877668|520151903|FG001|Overall Study|Adverse event related to study drug|2|||
144259608|NCT01877668|520151904|FG002|Overall Study|Adverse event related to study drug|2|||
144259609|NCT01877668|520151905|FG003|Overall Study|Adverse event related to study drug|2|||
144259610|NCT01877668|520151906|FG004|Overall Study|Adverse event related to study drug|1|||
144259611|NCT01877668|520151902|FG000|Overall Study|Adverse event unrelated to study drug|4|||
144259612|NCT01877668|520151903|FG001|Overall Study|Adverse event unrelated to study drug|1|||
144259613|NCT01877668|520151904|FG002|Overall Study|Adverse event unrelated to study drug|2|||
144259614|NCT01877668|520151905|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144259615|NCT01877668|520151906|FG004|Overall Study|Adverse event unrelated to study drug|1|||
144259616|NCT01697800|520151907|FG000|Overall Study|Death|0|||
144259617|NCT01697800|520151908|FG001|Overall Study|Death|1|||
144259618|NCT01302418|520151909|FG000|Overall Study|Protocol Violation|9|||
144259619|NCT01302418|520151909|FG000|Overall Study|Non-evaluable|9|||
144259620|NCT02750332|520151910|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144259621|NCT02750332|520151911|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144259622|NCT00823264|520151914|FG000|Overall Study|Protocol Violation|2|||
144259623|NCT00823264|520151915|FG001|Overall Study|Protocol Violation|0|||
144259624|NCT01093586|520151924|FG000|Overall Study|Failed to engraft|3|||
144259625|NCT02907463|520151925|FG000|Overall Study|Lost to Follow-up|17|||
144259626|NCT02907463|520151925|FG000|Overall Study|Death|10|||
144259627|NCT02907463|520151925|FG000|Overall Study|Withdrawal by Subject|4|||
144259628|NCT02907463|520151925|FG000|Overall Study|MIS Approach was not used|2|||
144259629|NCT02907463|520151925|FG000|Overall Study|Not Implanted with Study Device|2|||
144259630|NCT02907463|520151925|FG000|Overall Study|Device Explanted|1|||
144259631|NCT02907463|520151925|FG000|Overall Study|Missing Exit Form|1|||
144259632|NCT04878055|520151926|FG000|Overall Study|Patient transferred in another department|0|||
144259633|NCT04878055|520151927|FG001|Overall Study|Patient transferred in another department|2|||
144259634|NCT04878055|520151926|FG000|Overall Study|Physician Decision|1|||
144259635|NCT04878055|520151927|FG001|Overall Study|Physician Decision|1|||
144259636|NCT04878055|520151926|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
144259637|NCT04878055|520151927|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
144259638|NCT04878055|520151926|FG000|Overall Study|Adverse Event|12|||
144259639|NCT04878055|520151927|FG001|Overall Study|Adverse Event|7|||
144259640|NCT04878055|520151926|FG000|Overall Study|Other|5|||
144259641|NCT04878055|520151927|FG001|Overall Study|Other|0|||
144259642|NCT04878055|520151926|FG000|Overall Study|Withdrawal by Subject|7|||
144259643|NCT04878055|520151927|FG001|Overall Study|Withdrawal by Subject|3|||
144259644|NCT04878055|520151926|FG000|Overall Study|Lost to Follow-up|10|||
144259645|NCT04878055|520151927|FG001|Overall Study|Lost to Follow-up|1|||
144259646|NCT02427841|520151933|FG000|Overall Study|Lack of Efficacy|5|||
144259647|NCT02427841|520151933|FG000|Overall Study|Physician Decision|2|||
144259648|NCT02427841|520151933|FG000|Overall Study|Withdrawal by Subject|1|||
144259649|NCT02592447|520151934|FG000|Overall Study|Lost to Follow-up|1|||
144259650|NCT02592447|520151935|FG001|Overall Study|Lost to Follow-up|0|||
144259651|NCT02592447|520151934|FG000|Overall Study|Ineligible after randomization|1|||
144259652|NCT02592447|520151935|FG001|Overall Study|Ineligible after randomization|0|||
144259653|NCT02592447|520151934|FG000|Overall Study|Withdrawal by Subject|0|||
144259654|NCT02592447|520151935|FG001|Overall Study|Withdrawal by Subject|1|||
144259655|NCT00922116|520151940|FG000|Overall Study|Adverse Event|4|||
144259656|NCT00922116|520151940|FG000|Overall Study|Death|1|||
144259657|NCT00922116|520151940|FG000|Overall Study|Lost to Follow-up|1|||
144259658|NCT00922116|520151940|FG000|Overall Study|Withdrawal by Subject|4|||
144259659|NCT00922116|520151940|FG000|Overall Study|Other|5|||
144538460|NCT01500200|521174197|FG002|Stage 1|Noncompliance with Study Drug|0|||
144538461|NCT01500200|521174198|FG003|Stage 1|Noncompliance with Study Drug|0|||
144259660|NCT02028507|520151941|FG000|Overall Study|Progressive Disease|122|||
144259661|NCT02028507|520151942|FG001|Overall Study|Progressive Disease|90|||
144259662|NCT02028507|520151943|FG002|Overall Study|Progressive Disease|102|||
144259663|NCT02028507|520151944|FG003|Overall Study|Progressive Disease|89|||
144259664|NCT02028507|520151941|FG000|Overall Study|Adverse Event|8|||
144259665|NCT02028507|520151942|FG001|Overall Study|Adverse Event|25|||
144259666|NCT02028507|520151943|FG002|Overall Study|Adverse Event|3|||
144259667|NCT02028507|520151944|FG003|Overall Study|Adverse Event|16|||
144259668|NCT02028507|520151941|FG000|Overall Study|Withdrawal by Subject|6|||
144700079|NCT02161380|521754499|FG002|Overall Study|Lost to Follow-up|0|||
144538462|NCT01500200|521174199|FG004|Stage 1|Noncompliance with Study Drug|0|||
144538463|NCT01500200|521174200|FG005|Stage 1|Noncompliance with Study Drug|0|||
144538464|NCT01500200|521174195|FG000|Stage 1|Physician Decision|1|||
144538465|NCT01500200|521174196|FG001|Stage 1|Physician Decision|0|||
144538466|NCT01500200|521174197|FG002|Stage 1|Physician Decision|0|||
144538467|NCT01500200|521174198|FG003|Stage 1|Physician Decision|0|||
144538468|NCT01500200|521174199|FG004|Stage 1|Physician Decision|0|||
144538469|NCT01500200|521174200|FG005|Stage 1|Physician Decision|0|||
144538470|NCT01500200|521174195|FG000|Stage 2|Adverse Event|0|||
144538471|NCT01500200|521174196|FG001|Stage 2|Adverse Event|0|||
144538472|NCT01500200|521174197|FG002|Stage 2|Adverse Event|0|||
144538473|NCT01500200|521174198|FG003|Stage 2|Adverse Event|0|||
144538474|NCT01500200|521174199|FG004|Stage 2|Adverse Event|5|||
144538475|NCT01500200|521174200|FG005|Stage 2|Adverse Event|4|||
144538476|NCT03802994|521174201|FG000|Overall Study|Lost to Follow-up|0|||
144614804|NCT01624662|521450216|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
144614805|NCT01624662|521450217|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
144614806|NCT01624662|521450218|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
144614807|NCT01624662|521450215|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
144614808|NCT01624662|521450216|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
144614809|NCT01624662|521450217|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
144614810|NCT01624662|521450218|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
144614811|NCT01624662|521450215|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
144614812|NCT01624662|521450216|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
144614813|NCT01624662|521450217|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
144614814|NCT01624662|521450218|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
144614815|NCT01624662|521450215|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
144614816|NCT01624662|521450216|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
144614817|NCT01624662|521450217|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
144614818|NCT01624662|521450218|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
144614819|NCT01624662|521450215|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
144614820|NCT01624662|521450216|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
144614821|NCT01624662|521450217|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
144614822|NCT01624662|521450218|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
144614823|NCT01624662|521450215|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
144614824|NCT01624662|521450216|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
144614825|NCT01624662|521450217|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
144614826|NCT01624662|521450218|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
144614827|NCT01624662|521450215|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
144199352|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
144199353|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
144199354|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
144199355|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
144199356|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
144199357|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
144199358|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
144199359|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
144199360|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
144199361|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
144199362|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
144199363|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
144199364|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
144199365|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
144199366|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
144199367|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
144199368|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
144199369|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
144199370|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
144199371|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
144199372|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
144199373|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
144199374|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
144199375|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
144614828|NCT01624662|521450216|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
144614829|NCT01624662|521450217|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
144199376|NCT03514641|519928878|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
144199377|NCT03514641|519928879|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
144538477|NCT03802994|521174202|FG001|Overall Study|Lost to Follow-up|2|||
144538478|NCT03802994|521174203|FG002|Overall Study|Lost to Follow-up|3|||
144259669|NCT02028507|520151942|FG001|Overall Study|Withdrawal by Subject|8|||
144259670|NCT02028507|520151943|FG002|Overall Study|Withdrawal by Subject|5|||
144259671|NCT02028507|520151944|FG003|Overall Study|Withdrawal by Subject|9|||
144259672|NCT02028507|520151941|FG000|Overall Study|Protocol Violation|2|||
144259673|NCT02028507|520151942|FG001|Overall Study|Protocol Violation|4|||
144259674|NCT02028507|520151943|FG002|Overall Study|Protocol Violation|1|||
144259675|NCT02028507|520151944|FG003|Overall Study|Protocol Violation|3|||
144259676|NCT02028507|520151941|FG000|Overall Study|Physician Decision|0|||
144259677|NCT02028507|520151942|FG001|Overall Study|Physician Decision|4|||
144259678|NCT02028507|520151943|FG002|Overall Study|Physician Decision|0|||
144259679|NCT02028507|520151944|FG003|Overall Study|Physician Decision|0|||
144259680|NCT02028507|520151941|FG000|Overall Study|Death|1|||
144259681|NCT02028507|520151942|FG001|Overall Study|Death|0|||
144259682|NCT02028507|520151943|FG002|Overall Study|Death|1|||
144259683|NCT02028507|520151944|FG003|Overall Study|Death|3|||
144538479|NCT03802994|521174204|FG003|Overall Study|Lost to Follow-up|2|||
144538480|NCT03802994|521174205|FG004|Overall Study|Lost to Follow-up|2|||
144538481|NCT03611556|521174206|FG000|Overall Study|Death|7|||
144538482|NCT03611556|521174207|FG001|Overall Study|Death|7|||
144538483|NCT03611556|521174208|FG002|Overall Study|Death|3|||
144538484|NCT03611556|521174209|FG003|Overall Study|Death|8|||
144538485|NCT03611556|521174210|FG004|Overall Study|Death|47|||
144538486|NCT03611556|521174211|FG005|Overall Study|Death|32|||
144538487|NCT03611556|521174212|FG006|Overall Study|Death|53|||
144538488|NCT03611556|521174206|FG000|Overall Study|Withdrawal by Subject|0|||
144259684|NCT02028507|520151941|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
144259685|NCT02028507|520151942|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
144259686|NCT02028507|520151943|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
144538489|NCT03611556|521174207|FG001|Overall Study|Withdrawal by Subject|0|||
144538490|NCT03611556|521174208|FG002|Overall Study|Withdrawal by Subject|0|||
144538491|NCT03611556|521174209|FG003|Overall Study|Withdrawal by Subject|0|||
144538492|NCT03611556|521174210|FG004|Overall Study|Withdrawal by Subject|4|||
144259687|NCT02028507|520151944|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
144538493|NCT03611556|521174211|FG005|Overall Study|Withdrawal by Subject|2|||
144538494|NCT03611556|521174212|FG006|Overall Study|Withdrawal by Subject|4|||
144538495|NCT03611556|521174206|FG000|Overall Study|Sponsor decision|0|||
144538496|NCT03611556|521174207|FG001|Overall Study|Sponsor decision|0|||
144538497|NCT03611556|521174208|FG002|Overall Study|Sponsor decision|0|||
144538498|NCT03611556|521174209|FG003|Overall Study|Sponsor decision|0|||
144538499|NCT03611556|521174210|FG004|Overall Study|Sponsor decision|9|||
144538500|NCT03611556|521174211|FG005|Overall Study|Sponsor decision|4|||
144538501|NCT03611556|521174212|FG006|Overall Study|Sponsor decision|12|||
144538502|NCT03611556|521174206|FG000|Overall Study|Reasons|0|||
144538503|NCT03611556|521174207|FG001|Overall Study|Reasons|0|||
144538504|NCT03611556|521174208|FG002|Overall Study|Reasons|0|||
144538505|NCT03611556|521174209|FG003|Overall Study|Reasons|0|||
144538506|NCT03611556|521174210|FG004|Overall Study|Reasons|2|||
144538507|NCT03611556|521174211|FG005|Overall Study|Reasons|0|||
144538508|NCT03611556|521174212|FG006|Overall Study|Reasons|1|||
144538509|NCT02646618|521174214|FG000|Overall Study|Lost to Follow-up|10|||
144538510|NCT02646618|521174215|FG001|Overall Study|Lost to Follow-up|14|||
144538511|NCT02844439|521174216|FG000|Overall Study|Withdrawal by Subject|1|||
144538512|NCT02844439|521174216|FG000|Overall Study|Lost to Follow-up|2|||
144538513|NCT02844439|521174216|FG000|Overall Study|Termination by Sponsor|4|||
144538514|NCT02844439|521174216|FG000|Overall Study|Death|28|||
144538515|NCT02844439|521174216|FG000|Overall Study|Other|5|||
144538516|NCT05580003|521174220|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538517|NCT05580003|521174221|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538518|NCT05580003|521174222|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538519|NCT05580003|521174223|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538520|NCT05580003|521174224|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538521|NCT05580003|521174225|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538522|NCT05580003|521174226|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
144538523|NCT05580003|521174227|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538524|NCT05580003|521174228|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538525|NCT05580003|521174229|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538526|NCT05580003|521174230|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538527|NCT05580003|521174231|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538528|NCT05580003|521174232|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538529|NCT05580003|521174233|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538530|NCT05580003|521174234|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538531|NCT05580003|521174235|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538532|NCT05580003|521174236|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538533|NCT05580003|521174237|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144700080|NCT02161380|521754500|FG003|Overall Study|Lost to Follow-up|0|||
144259688|NCT02028507|520151941|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
144259689|NCT02028507|520151942|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
144259690|NCT02028507|520151943|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
144259691|NCT02028507|520151944|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
144259692|NCT02028507|520151941|FG000|Overall Study|Randomized But Not Treated|3|||
144259693|NCT02028507|520151942|FG001|Overall Study|Randomized But Not Treated|6|||
144259694|NCT02028507|520151943|FG002|Overall Study|Randomized But Not Treated|0|||
144259695|NCT02028507|520151944|FG003|Overall Study|Randomized But Not Treated|4|||
144259696|NCT02028507|520151941|FG000|Overall Study|Enzyme defect|0|||
144259697|NCT02028507|520151942|FG001|Overall Study|Enzyme defect|0|||
144259698|NCT02028507|520151943|FG002|Overall Study|Enzyme defect|0|||
144259699|NCT02028507|520151944|FG003|Overall Study|Enzyme defect|1|||
144259700|NCT02028507|520151941|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
144259701|NCT02028507|520151942|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
144259702|NCT02028507|520151943|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
144259703|NCT02028507|520151944|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
144259704|NCT02028507|520151941|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
144259705|NCT02028507|520151942|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
144259706|NCT02028507|520151943|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
144259707|NCT02028507|520151944|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
144259708|NCT03743025|520151945|FG000|Overall Study|Surgery was cancelled|2|||
144259709|NCT03743025|520151946|FG001|Overall Study|Surgery was cancelled|1|||
144259710|NCT01808261|520151947|FG000|Overall Study|Physician Decision|0|||
144259711|NCT01808261|520151948|FG001|Overall Study|Physician Decision|2|||
144259712|NCT01808261|520151947|FG000|Overall Study|Study Closed/Terminated|25|||
144259713|NCT01808261|520151948|FG001|Overall Study|Study Closed/Terminated|23|||
144259714|NCT01808261|520151947|FG000|Overall Study|Adverse event, non-fatal|2|||
144259715|NCT01808261|520151948|FG001|Overall Study|Adverse event, non-fatal|0|||
144259716|NCT01808261|520151947|FG000|Overall Study|Consent withdrawn by subject|6|||
144259717|NCT01808261|520151948|FG001|Overall Study|Consent withdrawn by subject|7|||
144259718|NCT01808261|520151947|FG000|Overall Study|Lost to Follow-up|3|||
144259719|NCT01808261|520151948|FG001|Overall Study|Lost to Follow-up|1|||
144259720|NCT04501952|520151953|FG000|Overall Study|Adverse Event|0|||
144259721|NCT04501952|520151954|FG001|Overall Study|Adverse Event|3|||
144259722|NCT04501952|520151953|FG000|Overall Study|Investigator's Discretion|0|||
144259723|NCT04501952|520151954|FG001|Overall Study|Investigator's Discretion|1|||
144259724|NCT04501952|520151953|FG000|Overall Study|Protocol Violation|1|||
144259725|NCT04501952|520151954|FG001|Overall Study|Protocol Violation|1|||
144259726|NCT04501952|520151953|FG000|Overall Study|Withdrew Consent|5|||
144259727|NCT04501952|520151954|FG001|Overall Study|Withdrew Consent|4|||
144259728|NCT04501952|520151953|FG000|Overall Study|Lost to Follow-up|7|||
144259729|NCT04501952|520151954|FG001|Overall Study|Lost to Follow-up|2|||
144259730|NCT04501952|520151953|FG000|Overall Study|Randomized and Never Treated|13|||
144259731|NCT04501952|520151954|FG001|Overall Study|Randomized and Never Treated|9|||
144259732|NCT00991289|520151955|FG000|Overall Study|Adverse Event|1|||
144259733|NCT00991289|520151955|FG000|Overall Study|Physician Decision|2|||
144259734|NCT00991289|520151955|FG000|Overall Study|Withdrawal by Subject|3|||
144259735|NCT00991289|520151955|FG000|Overall Study|Lost to Follow-up|4|||
144259736|NCT00991289|520151955|FG000|Overall Study|Protocol Violation|2|||
144259737|NCT02472886|520151956|FG000|Overall Study|Lack of Efficacy|0|||
144259738|NCT02472886|520151957|FG001|Overall Study|Lack of Efficacy|2|||
144259739|NCT02472886|520151958|FG002|Overall Study|Lack of Efficacy|1|||
144259740|NCT02797678|520151960|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
144259741|NCT02797678|520151961|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
144259742|NCT02797678|520151962|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
144259743|NCT02797678|520151963|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
144259744|NCT02797678|520151960|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
144259745|NCT02797678|520151961|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
144259746|NCT02797678|520151962|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
144259747|NCT02797678|520151963|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
144727104|NCT05097989|521854431|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
144727105|NCT05097989|521854423|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
144727106|NCT05097989|521854424|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
144727107|NCT05097989|521854425|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144727108|NCT05097989|521854426|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144727109|NCT05097989|521854427|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144727110|NCT05097989|521854428|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144727111|NCT05097989|521854429|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144727112|NCT05097989|521854430|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144727113|NCT05097989|521854431|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
144259748|NCT02797678|520151960|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
144259749|NCT02797678|520151961|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
144259750|NCT02797678|520151962|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
144259751|NCT02797678|520151963|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
144259752|NCT03131687|520151964|FG000|Overall Study|Adverse Event|0|||
144259753|NCT03131687|520151965|FG001|Overall Study|Adverse Event|1|||
144259754|NCT03131687|520151966|FG002|Overall Study|Adverse Event|0|||
144259755|NCT03131687|520151967|FG003|Overall Study|Adverse Event|1|||
144259756|NCT03131687|520151968|FG004|Overall Study|Adverse Event|2|||
144259757|NCT03131687|520151969|FG005|Overall Study|Adverse Event|2|||
144259758|NCT03131687|520151964|FG000|Overall Study|Death|1|||
144259759|NCT03131687|520151965|FG001|Overall Study|Death|0|||
144259760|NCT03131687|520151966|FG002|Overall Study|Death|0|||
144259761|NCT03131687|520151967|FG003|Overall Study|Death|0|||
144259762|NCT03131687|520151968|FG004|Overall Study|Death|0|||
144259763|NCT03131687|520151969|FG005|Overall Study|Death|0|||
144259764|NCT03131687|520151964|FG000|Overall Study|Withdrawal by Subject|3|||
144259765|NCT03131687|520151965|FG001|Overall Study|Withdrawal by Subject|3|||
144259766|NCT03131687|520151966|FG002|Overall Study|Withdrawal by Subject|3|||
144259767|NCT03131687|520151967|FG003|Overall Study|Withdrawal by Subject|1|||
144259768|NCT03131687|520151968|FG004|Overall Study|Withdrawal by Subject|2|||
144259769|NCT03131687|520151969|FG005|Overall Study|Withdrawal by Subject|1|||
144259770|NCT03131687|520151964|FG000|Overall Study|Lost to Follow-up|1|||
144259771|NCT03131687|520151965|FG001|Overall Study|Lost to Follow-up|4|||
144259772|NCT03131687|520151966|FG002|Overall Study|Lost to Follow-up|0|||
144259773|NCT03131687|520151967|FG003|Overall Study|Lost to Follow-up|1|||
144259774|NCT03131687|520151968|FG004|Overall Study|Lost to Follow-up|4|||
144259775|NCT03131687|520151969|FG005|Overall Study|Lost to Follow-up|2|||
144259776|NCT03131687|520151964|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
144259777|NCT03131687|520151965|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
144259778|NCT03131687|520151966|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
144259779|NCT03131687|520151967|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
144259780|NCT03131687|520151968|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
144259781|NCT03131687|520151969|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
144259782|NCT03131687|520151964|FG000|Overall Study|Principle Investigator Decision|0|||
144259783|NCT03131687|520151965|FG001|Overall Study|Principle Investigator Decision|1|||
144259784|NCT03131687|520151966|FG002|Overall Study|Principle Investigator Decision|0|||
144259785|NCT03131687|520151967|FG003|Overall Study|Principle Investigator Decision|0|||
144259786|NCT03131687|520151968|FG004|Overall Study|Principle Investigator Decision|0|||
144259787|NCT03131687|520151969|FG005|Overall Study|Principle Investigator Decision|0|||
144259788|NCT03131687|520151964|FG000|Overall Study|Inadvertent Enrollment|0|||
144259789|NCT03131687|520151965|FG001|Overall Study|Inadvertent Enrollment|0|||
144259790|NCT03131687|520151966|FG002|Overall Study|Inadvertent Enrollment|0|||
144259791|NCT03131687|520151967|FG003|Overall Study|Inadvertent Enrollment|1|||
144259792|NCT03131687|520151968|FG004|Overall Study|Inadvertent Enrollment|0|||
144259793|NCT03131687|520151969|FG005|Overall Study|Inadvertent Enrollment|0|||
144259794|NCT00869128|520151970|FG000|Overall Study|lack of Compliance|6|||
144259795|NCT00869128|520151971|FG001|Overall Study|lack of Compliance|6|||
144259796|NCT01118663|520151977|FG000|Overall Study|Adverse Event|2|||
144259797|NCT01118663|520151978|FG001|Overall Study|Adverse Event|1|||
144259798|NCT01118663|520151977|FG000|Overall Study|Withdrawal by Subject|0|||
144259799|NCT01118663|520151978|FG001|Overall Study|Withdrawal by Subject|1|||
144259800|NCT03046953|520151979|FG000|Overall Study|Relapse/progressive disease|21|||
144259801|NCT03046953|520151979|FG000|Overall Study|Death|2|||
144259802|NCT03046953|520151979|FG000|Overall Study|Withdrawal by Subject|3|||
144259803|NCT04039204|520151980|FG000|Overall Study|Withdrawal by Subject|0|||
144259804|NCT04039204|520151981|FG001|Overall Study|Withdrawal by Subject|2|||
144259805|NCT02716584|520151982|FG000|Overall Study|Lost to Follow-up|8|||
144259806|NCT02716584|520151983|FG001|Overall Study|Lost to Follow-up|5|||
144259807|NCT00656175|520151984|FG000|Overall Study|Adverse Event|1|||
144259808|NCT00656175|520151985|FG001|Overall Study|Adverse Event|0|||
144259809|NCT00656175|520151984|FG000|Overall Study|Transportation issues|0|||
144259810|NCT00656175|520151985|FG001|Overall Study|Transportation issues|1|||
144259811|NCT01903993|520151989|FG000|Overall Study|Death|118|||
144259812|NCT01903993|520151990|FG001|Overall Study|Death|121|||
144259813|NCT01903993|520151989|FG000|Overall Study|Withdrawal by Subject|15|||
144259814|NCT01903993|520151990|FG001|Overall Study|Withdrawal by Subject|4|||
144259815|NCT01903993|520151989|FG000|Overall Study|Lost to Follow-up|2|||
144259816|NCT01903993|520151990|FG001|Overall Study|Lost to Follow-up|3|||
144259817|NCT01903993|520151989|FG000|Overall Study|Study Terminated by Sponsor|8|||
144259818|NCT01903993|520151990|FG001|Overall Study|Study Terminated by Sponsor|14|||
144259819|NCT01903993|520151989|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
144259820|NCT01903993|520151990|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
144259821|NCT02282163|520151994|FG000|Overall Study|Protocol Violation|1|||
144259822|NCT03472521|520151995|FG000|Overall Study|Lost to Follow-up|3|||
144259823|NCT03472521|520151996|FG001|Overall Study|Lost to Follow-up|2|||
144259824|NCT03472521|520151995|FG000|Overall Study|Discontinued intervention|3|||
144259825|NCT03472521|520151996|FG001|Overall Study|Discontinued intervention|1|||
144259826|NCT02385110|520151997|FG000|Overall Study|Early Death|1|||
144259827|NCT02385110|520151998|FG001|Overall Study|Early Death|0|||
144259828|NCT03654729|520154382|FG000|Overall Study|Death|9|||
144259829|NCT03654729|520154383|FG001|Overall Study|Death|9|||
144259830|NCT03654729|520154384|FG002|Overall Study|Death|16|||
144259831|NCT03654729|520154382|FG000|Overall Study|Withdrawal by Subject|8|||
144259832|NCT03654729|520154383|FG001|Overall Study|Withdrawal by Subject|6|||
144259833|NCT03654729|520154384|FG002|Overall Study|Withdrawal by Subject|4|||
144259834|NCT03654729|520154382|FG000|Overall Study|Study terminated by Sponsor|3|||
144259835|NCT03654729|520154383|FG001|Overall Study|Study terminated by Sponsor|5|||
144259836|NCT03654729|520154384|FG002|Overall Study|Study terminated by Sponsor|4|||
144259837|NCT03654729|520154382|FG000|Overall Study|Not reported|2|||
144259838|NCT03654729|520154383|FG001|Overall Study|Not reported|4|||
144259839|NCT03654729|520154384|FG002|Overall Study|Not reported|5|||
144259840|NCT03654729|520154382|FG000|Overall Study|Progressive disease|3|||
144259841|NCT03654729|520154383|FG001|Overall Study|Progressive disease|0|||
144259842|NCT03654729|520154384|FG002|Overall Study|Progressive disease|0|||
144259843|NCT03654729|520154382|FG000|Overall Study|Lost to Follow-up|2|||
144259844|NCT03654729|520154383|FG001|Overall Study|Lost to Follow-up|0|||
144259845|NCT03654729|520154384|FG002|Overall Study|Lost to Follow-up|0|||
144259846|NCT03654729|520154382|FG000|Overall Study|Physician Decision|2|||
144259847|NCT03654729|520154383|FG001|Overall Study|Physician Decision|0|||
144259848|NCT03654729|520154384|FG002|Overall Study|Physician Decision|0|||
144259849|NCT03654729|520154382|FG000|Overall Study|Protocol Violation|1|||
144259850|NCT03654729|520154383|FG001|Overall Study|Protocol Violation|1|||
144259851|NCT03654729|520154384|FG002|Overall Study|Protocol Violation|0|||
144259852|NCT03654729|520154382|FG000|Overall Study|Non-compliance with study drug|0|||
144259853|NCT03654729|520154383|FG001|Overall Study|Non-compliance with study drug|1|||
144259854|NCT03654729|520154384|FG002|Overall Study|Non-compliance with study drug|0|||
144259855|NCT03654729|520154382|FG000|Overall Study|Site terminated by Sponsor|1|||
144259856|NCT03654729|520154383|FG001|Overall Study|Site terminated by Sponsor|0|||
144259857|NCT03654729|520154384|FG002|Overall Study|Site terminated by Sponsor|0|||
144259858|NCT01919164|520154385|FG000|Overall Study|Adverse Event|6|||
144259859|NCT01919164|520154386|FG001|Overall Study|Adverse Event|4|||
144259860|NCT01919164|520154387|FG002|Overall Study|Adverse Event|9|||
144259861|NCT01919164|520154388|FG003|Overall Study|Adverse Event|3|||
144259862|NCT01919164|520154389|FG004|Overall Study|Adverse Event|2|||
144259863|NCT01919164|520154385|FG000|Overall Study|Lost to Follow-up|2|||
144259864|NCT01919164|520154386|FG001|Overall Study|Lost to Follow-up|2|||
144259865|NCT01919164|520154387|FG002|Overall Study|Lost to Follow-up|2|||
144259866|NCT01919164|520154388|FG003|Overall Study|Lost to Follow-up|0|||
144259867|NCT01919164|520154389|FG004|Overall Study|Lost to Follow-up|4|||
144259868|NCT01919164|520154385|FG000|Overall Study|Death|1|||
144259869|NCT01919164|520154386|FG001|Overall Study|Death|0|||
144259870|NCT01919164|520154387|FG002|Overall Study|Death|0|||
144259871|NCT01919164|520154388|FG003|Overall Study|Death|0|||
144259872|NCT01919164|520154389|FG004|Overall Study|Death|0|||
144259873|NCT01919164|520154385|FG000|Overall Study|Protocol Violation|6|||
144259874|NCT01919164|520154386|FG001|Overall Study|Protocol Violation|0|||
144259875|NCT01919164|520154387|FG002|Overall Study|Protocol Violation|3|||
144259876|NCT01919164|520154388|FG003|Overall Study|Protocol Violation|2|||
144259877|NCT01919164|520154389|FG004|Overall Study|Protocol Violation|2|||
144259878|NCT01919164|520154385|FG000|Overall Study|Disease progression|2|||
144259879|NCT01919164|520154386|FG001|Overall Study|Disease progression|2|||
144259880|NCT01919164|520154387|FG002|Overall Study|Disease progression|1|||
144259881|NCT01919164|520154388|FG003|Overall Study|Disease progression|2|||
144259882|NCT01919164|520154389|FG004|Overall Study|Disease progression|1|||
144259883|NCT01919164|520154385|FG000|Overall Study|Withdrew consent|13|||
144259884|NCT01919164|520154386|FG001|Overall Study|Withdrew consent|13|||
144614830|NCT01624662|521450218|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
144614831|NCT02457637|521450221|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
144614832|NCT00159861|521450222|FG000|Core Study - 16 Weeks|Death|3|||
144614833|NCT00159861|521450223|FG001|Core Study - 16 Weeks|Death|0|||
144614834|NCT00159861|521450222|FG000|Core Study - 16 Weeks|Adverse Event|12|||
144614835|NCT00159861|521450223|FG001|Core Study - 16 Weeks|Adverse Event|6|||
144259885|NCT01919164|520154387|FG002|Overall Study|Withdrew consent|14|||
144259886|NCT01919164|520154388|FG003|Overall Study|Withdrew consent|14|||
144259887|NCT01919164|520154389|FG004|Overall Study|Withdrew consent|9|||
144259888|NCT01919164|520154385|FG000|Overall Study|Other Un-specified|13|||
144259889|NCT01919164|520154386|FG001|Overall Study|Other Un-specified|9|||
144259890|NCT01919164|520154387|FG002|Overall Study|Other Un-specified|8|||
144259891|NCT01919164|520154388|FG003|Overall Study|Other Un-specified|7|||
144259892|NCT01919164|520154389|FG004|Overall Study|Other Un-specified|15|||
144259893|NCT00588146|520154390|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
144259894|NCT00588146|520154391|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
144259895|NCT03272347|520154392|FG000|Overall Study|Death|0|||
144259896|NCT03272347|520154393|FG001|Overall Study|Death|0|||
144259897|NCT03272347|520154394|FG002|Overall Study|Death|0|||
144259898|NCT03272347|520154395|FG003|Overall Study|Death|1|||
144614836|NCT00159861|521450222|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
144614837|NCT00159861|521450223|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
144614838|NCT00159861|521450222|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
144614839|NCT00159861|521450223|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
144614840|NCT00159861|521450222|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
144614841|NCT00159861|521450223|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
144614842|NCT00159861|521450222|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
144614843|NCT00159861|521450223|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
144614844|NCT00159861|521450222|FG000|Extension Study - up to 3 Years|Death|24|||
144614845|NCT00159861|521450223|FG001|Extension Study - up to 3 Years|Death|28|||
144614846|NCT00159861|521450222|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
144614847|NCT00159861|521450223|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
144614848|NCT00159861|521450222|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
144727114|NCT05097989|521854423|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
144727115|NCT05097989|521854424|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
144727116|NCT05097989|521854425|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
144727117|NCT05097989|521854426|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
144727118|NCT05097989|521854427|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
144727119|NCT05097989|521854428|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
144727120|NCT05097989|521854429|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
144727121|NCT05097989|521854430|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
144727122|NCT05097989|521854431|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
144727123|NCT00117949|521854444|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
144727124|NCT00117949|521854445|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
144727125|NCT00117949|521854446|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
144727126|NCT00117949|521854447|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
144727127|NCT00117949|521854444|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
144727128|NCT00117949|521854445|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
144727129|NCT00117949|521854446|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
144727130|NCT00117949|521854447|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
144727131|NCT00117949|521854444|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
144727132|NCT00117949|521854445|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
144727133|NCT00117949|521854446|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
144727134|NCT00117949|521854447|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
144727135|NCT00117949|521854444|FG000|Overall Study|PSA increase >=10ng/mL|0|||
144727136|NCT00117949|521854445|FG001|Overall Study|PSA increase >=10ng/mL|1|||
144727137|NCT00117949|521854446|FG002|Overall Study|PSA increase >=10ng/mL|1|||
144727138|NCT00117949|521854447|FG003|Overall Study|PSA increase >=10ng/mL|0|||
144727139|NCT00117949|521854444|FG000|Overall Study|PSA reduction <=50%|0|||
144727140|NCT00117949|521854445|FG001|Overall Study|PSA reduction <=50%|2|||
144727141|NCT00117949|521854446|FG002|Overall Study|PSA reduction <=50%|2|||
144727142|NCT00117949|521854447|FG003|Overall Study|PSA reduction <=50%|4|||
144727143|NCT00117949|521854444|FG000|Overall Study|Hepatic abnormalities|0|||
144727144|NCT00117949|521854445|FG001|Overall Study|Hepatic abnormalities|1|||
144727145|NCT00117949|521854446|FG002|Overall Study|Hepatic abnormalities|0|||
144727146|NCT00117949|521854447|FG003|Overall Study|Hepatic abnormalities|1|||
144727147|NCT00630305|521856498|FG000|Overall Study|Withdrawal by Subject|1|||
144727148|NCT00630305|521856498|FG000|Overall Study|Inability to insert contact lens|1|||
144727149|NCT00376220|521856503|FG000|Overall Study|Lost to Follow-up|7|||
144727150|NCT00376220|521856504|FG001|Overall Study|Lost to Follow-up|10|||
144727151|NCT00376220|521856503|FG000|Overall Study|Withdrawal by Subject|3|||
144727152|NCT00376220|521856504|FG001|Overall Study|Withdrawal by Subject|2|||
144727153|NCT02564263|521856507|FG000|Overall Study|Adverse Event|31|||
144727154|NCT02564263|521856508|FG001|Overall Study|Adverse Event|29|||
144727155|NCT02564263|521856507|FG000|Overall Study|Death|270|||
144727156|NCT02564263|521856508|FG001|Overall Study|Death|262|||
144727157|NCT02564263|521856507|FG000|Overall Study|Withdrawal by Subject|4|||
144727158|NCT02564263|521856508|FG001|Overall Study|Withdrawal by Subject|19|||
144199378|NCT03514641|519928880|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
144199379|NCT03514641|519928881|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
144199380|NCT03514641|519928878|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
144199381|NCT03514641|519928879|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
144199382|NCT03514641|519928880|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
144199383|NCT03514641|519928881|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
144199384|NCT03514641|519928878|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
144199385|NCT03514641|519928879|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
144259899|NCT03272347|520154392|FG000|Overall Study|Lost to Follow-up|1|||
144614849|NCT00159861|521450223|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
144727159|NCT02564263|521856507|FG000|Overall Study|Sponsor's decision|9|||
144727160|NCT02564263|521856508|FG001|Overall Study|Sponsor's decision|4|||
144727161|NCT03311646|521856509|FG000|Overall Study|Physician Decision|1|||
144727162|NCT03311646|521856509|FG000|Overall Study|Withdrawal by Subject|5|||
144259900|NCT03272347|520154393|FG001|Overall Study|Lost to Follow-up|3|||
144259901|NCT03272347|520154394|FG002|Overall Study|Lost to Follow-up|5|||
144259902|NCT03272347|520154395|FG003|Overall Study|Lost to Follow-up|1|||
144259903|NCT03272347|520154392|FG000|Overall Study|Physician Decision|4|||
144259904|NCT03272347|520154393|FG001|Overall Study|Physician Decision|2|||
144259905|NCT03272347|520154394|FG002|Overall Study|Physician Decision|5|||
144259906|NCT03272347|520154395|FG003|Overall Study|Physician Decision|4|||
144259907|NCT03272347|520154392|FG000|Overall Study|Screen Failure|1|||
144259908|NCT03272347|520154393|FG001|Overall Study|Screen Failure|0|||
144259909|NCT03272347|520154394|FG002|Overall Study|Screen Failure|0|||
144259910|NCT03272347|520154395|FG003|Overall Study|Screen Failure|0|||
144259911|NCT03272347|520154392|FG000|Overall Study|Withdrawal by Subject|5|||
144259912|NCT03272347|520154393|FG001|Overall Study|Withdrawal by Subject|1|||
144259913|NCT03272347|520154394|FG002|Overall Study|Withdrawal by Subject|2|||
144259914|NCT03272347|520154395|FG003|Overall Study|Withdrawal by Subject|1|||
144259915|NCT01971567|520154399|FG000|Overall Study|Withdrawal by Subject|3|||
144259916|NCT01971567|520154400|FG001|Overall Study|Withdrawal by Subject|2|||
144259917|NCT01971567|520154399|FG000|Overall Study|Lost to Follow-up|1|||
144259918|NCT01971567|520154400|FG001|Overall Study|Lost to Follow-up|0|||
144259919|NCT02250300|520154401|FG000|Expansion Phase|Death|6|||
144259920|NCT02250300|520154402|FG001|Expansion Phase|Death|7|||
144259921|NCT02250300|520154403|FG002|Expansion Phase|Death|0|||
144259922|NCT02250300|520154404|FG003|Expansion Phase|Death|0|||
144259923|NCT00215644|520154405|FG000|Overall Study|Disease Progression|28|||
144259924|NCT00215644|520154406|FG001|Overall Study|Disease Progression|10|||
144259925|NCT00215644|520154405|FG000|Overall Study|Adverse Event|2|||
144727163|NCT03311646|521856509|FG000|Overall Study|Lost to Follow-up|5|||
144727164|NCT03311646|521856509|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
144259926|NCT00215644|520154406|FG001|Overall Study|Adverse Event|9|||
144259927|NCT00215644|520154405|FG000|Overall Study|Death|1|||
144259928|NCT00215644|520154406|FG001|Overall Study|Death|2|||
144259929|NCT00215644|520154405|FG000|Overall Study|Withdrawal by Subject|1|||
144259930|NCT00215644|520154406|FG001|Overall Study|Withdrawal by Subject|0|||
144259931|NCT00215644|520154405|FG000|Overall Study|Other|3|||
144259932|NCT00215644|520154406|FG001|Overall Study|Other|15|||
144259933|NCT00215644|520154405|FG000|Overall Study|Randomized but Not Treated|1|||
144259934|NCT00215644|520154406|FG001|Overall Study|Randomized but Not Treated|0|||
144259935|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
144259936|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
144259937|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
144259938|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
144259939|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
144727165|NCT00531206|521856510|FG000|Overall Study|Adverse Event related|5|||
144727166|NCT00531206|521856510|FG000|Overall Study|Lack of Efficacy|2|||
144727167|NCT00531206|521856510|FG000|Overall Study|Lost to Follow-up|5|||
144727168|NCT00531206|521856510|FG000|Overall Study|including non-related adverse events|8|||
144727169|NCT00720096|521856511|FG000|Overall Study|Withdrawal by Subject|0|||
144727170|NCT00720096|521856512|FG001|Overall Study|Withdrawal by Subject|2|||
144727171|NCT01458405|521856515|FG000|Phase 1 (up to 12 Months)|Other|0|||
144727172|NCT01458405|521856516|FG001|Phase 1 (up to 12 Months)|Other|1|||
144727173|NCT01458405|521856517|FG002|Phase 1 (up to 12 Months)|Other|0|||
144727174|NCT01458405|521856518|FG003|Phase 1 (up to 12 Months)|Other|0|||
144727175|NCT01458405|521856515|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
144727176|NCT01458405|521856516|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
144727177|NCT01458405|521856517|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
144727178|NCT01458405|521856518|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
144727179|NCT01458405|521856515|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
144727180|NCT01458405|521856516|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
144727181|NCT01458405|521856517|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
144259940|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
144259941|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
144259942|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
144259943|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
144259944|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
144259945|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
144259946|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
144259947|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
144259948|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
144259949|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
144259950|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
144727182|NCT01458405|521856518|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
144727183|NCT01458405|521856515|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
144727184|NCT01458405|521856516|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
144727185|NCT01458405|521856517|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
144727186|NCT01458405|521856518|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
144614850|NCT00159861|521450222|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
144614851|NCT00159861|521450223|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
144614852|NCT00159861|521450222|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
144614853|NCT00159861|521450223|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
144614854|NCT00278993|521450226|FG000|Overall Study|Adverse Event|24|||
144614855|NCT00278993|521450226|FG000|Overall Study|Withdrawal by Subject|5|||
144614856|NCT00278993|521450226|FG000|Overall Study|Progressive Disease|65|||
144614857|NCT00278993|521450226|FG000|Overall Study|Physician Decision|9|||
144199386|NCT03514641|519928880|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
144199387|NCT03514641|519928881|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
144199388|NCT03514641|519928878|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
144199389|NCT03514641|519928879|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
144199390|NCT03514641|519928880|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
144199391|NCT03514641|519928881|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
144199392|NCT03514641|519928878|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
144199393|NCT03514641|519928879|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
144199394|NCT03514641|519928880|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
144199395|NCT03514641|519928881|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
144199396|NCT03514641|519928878|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
144199397|NCT03514641|519928879|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
144199398|NCT03514641|519928880|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
144199399|NCT03514641|519928881|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
144199400|NCT03709823|519928882|FG000|Overall Study|Adverse Event|0|||
144199401|NCT03709823|519928883|FG001|Overall Study|Adverse Event|0|||
144199402|NCT03709823|519928884|FG002|Overall Study|Adverse Event|1|||
144199403|NCT03709823|519928885|FG003|Overall Study|Adverse Event|0|||
144199404|NCT03709823|519928886|FG004|Overall Study|Adverse Event|0|||
144199405|NCT03709823|519928887|FG005|Overall Study|Adverse Event|0|||
144199406|NCT03709823|519928882|FG000|Overall Study|Lost to Follow-up|2|||
144199407|NCT03709823|519928883|FG001|Overall Study|Lost to Follow-up|2|||
144199408|NCT03709823|519928884|FG002|Overall Study|Lost to Follow-up|2|||
144199409|NCT03709823|519928885|FG003|Overall Study|Lost to Follow-up|1|||
144199410|NCT03709823|519928886|FG004|Overall Study|Lost to Follow-up|1|||
144199411|NCT03709823|519928887|FG005|Overall Study|Lost to Follow-up|0|||
144199412|NCT03709823|519928882|FG000|Overall Study|Withdrawal by Subject|1|||
144199413|NCT03709823|519928883|FG001|Overall Study|Withdrawal by Subject|3|||
144199414|NCT03709823|519928884|FG002|Overall Study|Withdrawal by Subject|0|||
144199415|NCT03709823|519928885|FG003|Overall Study|Withdrawal by Subject|0|||
144199416|NCT03709823|519928886|FG004|Overall Study|Withdrawal by Subject|0|||
144199417|NCT03709823|519928887|FG005|Overall Study|Withdrawal by Subject|0|||
144199418|NCT03709823|519928882|FG000|Overall Study|Other, Not Specified|0|||
144199419|NCT03709823|519928883|FG001|Overall Study|Other, Not Specified|0|||
144199420|NCT03709823|519928884|FG002|Overall Study|Other, Not Specified|0|||
144199421|NCT03709823|519928885|FG003|Overall Study|Other, Not Specified|1|||
144199422|NCT03709823|519928886|FG004|Overall Study|Other, Not Specified|0|||
144199423|NCT03709823|519928887|FG005|Overall Study|Other, Not Specified|0|||
144199424|NCT01246011|519928895|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
144199425|NCT01246011|519928896|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
144199426|NCT01246011|519928897|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
144199427|NCT01246011|519928895|FG000|Overall Study|Withdrawal by Subject|0|||
144199428|NCT01246011|519928896|FG001|Overall Study|Withdrawal by Subject|0|||
144199429|NCT01246011|519928897|FG002|Overall Study|Withdrawal by Subject|1|||
144199430|NCT05183217|519928901|FG000|Overall Study|Withdrawal by Subject|1|||
144199431|NCT05183217|519928902|FG001|Overall Study|Withdrawal by Subject|1|||
144199432|NCT01155024|519928904|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
144199433|NCT01155024|519928905|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
144199434|NCT01155024|519928904|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
144199435|NCT01155024|519928905|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
144199436|NCT01155024|519928904|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
144199437|NCT01155024|519928905|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
144199438|NCT01593696|519928906|FG000|Dose Escalation|Progressive Disease|2|||
144199439|NCT01593696|519928907|FG001|Dose Escalation|Progressive Disease|0|||
144199440|NCT01593696|519928908|FG002|Dose Escalation|Progressive Disease|0|||
144199441|NCT01593696|519928909|FG003|Dose Escalation|Progressive Disease|0|||
144199442|NCT01593696|519928906|FG000|Dose Expansion|Fungal infection|0|||
144199443|NCT01593696|519928907|FG001|Dose Expansion|Fungal infection|0|||
144199444|NCT01593696|519928908|FG002|Dose Expansion|Fungal infection|1|||
144199445|NCT01593696|519928909|FG003|Dose Expansion|Fungal infection|0|||
144199446|NCT03412396|519928910|FG000|Overall Study|Withdrawal by Subject|2|||
144614858|NCT00278993|521450226|FG000|Overall Study|Not Otherwise Specified|4|||
144199447|NCT03412396|519928910|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
144614859|NCT03077685|521450230|FG000|Overall Study|Lost to Follow-up|0|||
144259951|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
144259952|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
144259953|NCT03569098|520154407|FG000|Double-Blind Treatment Cycle 1|Other|1|||
144259954|NCT03569098|520154408|FG001|Double-Blind Treatment Cycle 1|Other|0|||
144259955|NCT03569098|520154409|FG002|Double-Blind Treatment Cycle 1|Other|1|||
144259956|NCT03569098|520154407|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
144259957|NCT03569098|520154408|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
144259958|NCT03569098|520154409|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
144259959|NCT03569098|520154407|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
144259960|NCT03569098|520154408|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
144259961|NCT03569098|520154409|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
144259962|NCT03569098|520154407|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
144259963|NCT03569098|520154408|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
144259964|NCT03569098|520154409|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
144259965|NCT03569098|520154407|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
144259966|NCT03569098|520154408|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
144259967|NCT03569098|520154409|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
144259968|NCT03569098|520154407|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
144259969|NCT03569098|520154408|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
144259970|NCT03569098|520154409|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
144259971|NCT03569098|520154407|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
144259972|NCT03569098|520154408|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
144259973|NCT03569098|520154409|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
144259974|NCT01516736|520154410|FG000|Overall Study|Withdrawal by Subject|10|||
144259975|NCT01516736|520154411|FG001|Overall Study|Withdrawal by Subject|4|||
144259976|NCT01516736|520154410|FG000|Overall Study|Adverse Event|4|||
144259977|NCT01516736|520154411|FG001|Overall Study|Adverse Event|5|||
144259978|NCT01516736|520154410|FG000|Overall Study|Death|3|||
144259979|NCT01516736|520154411|FG001|Overall Study|Death|1|||
144259980|NCT01516736|520154410|FG000|Overall Study|Physician Decision|2|||
144259981|NCT01516736|520154411|FG001|Overall Study|Physician Decision|1|||
144259982|NCT01516736|520154410|FG000|Overall Study|Lack of Efficacy|1|||
144259983|NCT01516736|520154411|FG001|Overall Study|Lack of Efficacy|0|||
144259984|NCT01516736|520154410|FG000|Overall Study|Protocol Violation|0|||
144259985|NCT01516736|520154411|FG001|Overall Study|Protocol Violation|1|||
144259986|NCT01516736|520154410|FG000|Overall Study|Other (not specified)|0|||
144259987|NCT01516736|520154411|FG001|Overall Study|Other (not specified)|1|||
144259988|NCT01957579|520154417|FG000|Overall Study|Withdrawal of concent|0|||
144259989|NCT01957579|520154418|FG001|Overall Study|Withdrawal of concent|1|||
144259990|NCT01957579|520154419|FG002|Overall Study|Withdrawal of concent|0|||
144259991|NCT01957579|520154420|FG003|Overall Study|Withdrawal of concent|0|||
144259992|NCT01957579|520154417|FG000|Overall Study|Death|0|||
144259993|NCT01957579|520154418|FG001|Overall Study|Death|0|||
144259994|NCT01957579|520154419|FG002|Overall Study|Death|2|||
144259995|NCT01957579|520154420|FG003|Overall Study|Death|0|||
144259996|NCT01000974|520154421|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
144259997|NCT01000974|520154422|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
144259998|NCT01000974|520154423|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
144259999|NCT01000974|520154421|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
144260000|NCT01000974|520154422|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
144260001|NCT01000974|520154423|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
144260002|NCT01000974|520154421|FG000|Primary Vaccination Phase|Protocol Violation|40|||
144260003|NCT01000974|520154422|FG001|Primary Vaccination Phase|Protocol Violation|3|||
144260004|NCT01000974|520154423|FG002|Primary Vaccination Phase|Protocol Violation|2|||
144260005|NCT01000974|520154421|FG000|Primary Vaccination Phase|Adverse Event|14|||
144260006|NCT01000974|520154422|FG001|Primary Vaccination Phase|Adverse Event|2|||
144260007|NCT01000974|520154423|FG002|Primary Vaccination Phase|Adverse Event|2|||
144260008|NCT01000974|520154421|FG000|Primary Vaccination Phase|Other|4|||
144260009|NCT01000974|520154422|FG001|Primary Vaccination Phase|Other|9|||
144260010|NCT01000974|520154423|FG002|Primary Vaccination Phase|Other|12|||
144260011|NCT01000974|520154421|FG000|Booster Vaccination Phase|Protocol Violation|0|||
144260012|NCT01000974|520154422|FG001|Booster Vaccination Phase|Protocol Violation|0|||
144260013|NCT01000974|520154423|FG002|Booster Vaccination Phase|Protocol Violation|2|||
144260014|NCT01000974|520154421|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
144260015|NCT01000974|520154422|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
144260016|NCT01000974|520154423|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
144260017|NCT01000974|520154421|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
144260018|NCT01000974|520154422|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
144260019|NCT01000974|520154423|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
144260020|NCT01000974|520154421|FG000|Booster Vaccination Phase|Other|24|||
144260021|NCT01000974|520154422|FG001|Booster Vaccination Phase|Other|6|||
144260022|NCT01000974|520154423|FG002|Booster Vaccination Phase|Other|4|||
144260023|NCT01307891|520154425|FG000|Overall Study|Progressive Disease|3|||
144260024|NCT01307891|520154426|FG001|Overall Study|Progressive Disease|1|||
144614860|NCT03077685|521450231|FG001|Overall Study|Lost to Follow-up|0|||
144614861|NCT03077685|521450232|FG002|Overall Study|Lost to Follow-up|0|||
144614862|NCT03077685|521450233|FG003|Overall Study|Lost to Follow-up|0|||
144614863|NCT03077685|521450234|FG004|Overall Study|Lost to Follow-up|1|||
144614864|NCT03077685|521450230|FG000|Overall Study|Death|0|||
144614865|NCT03077685|521450231|FG001|Overall Study|Death|0|||
144260025|NCT03365934|520154427|FG000|Overall Study|Adverse Event|1|||
144260026|NCT03365934|520154427|FG000|Overall Study|Withdrawal by Subject|1|||
144260027|NCT02937740|520154428|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
144260028|NCT02937740|520154429|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
144260029|NCT02937740|520154428|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
144260030|NCT02937740|520154429|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
144260031|NCT02937740|520154428|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
144260032|NCT02937740|520154429|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
144260033|NCT02937740|520154428|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
144260034|NCT02937740|520154429|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
144260035|NCT02937740|520154428|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
144260036|NCT02937740|520154429|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
144260037|NCT02937740|520154428|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
144260038|NCT02937740|520154429|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
144260039|NCT02485483|520154435|FG000|Overall Study|Depression at baseline|15|||
144260040|NCT02485483|520154436|FG001|Overall Study|Depression at baseline|0|||
144260041|NCT02485483|520154435|FG000|Overall Study|Discontinued after baseline|39|||
144260042|NCT02485483|520154436|FG001|Overall Study|Discontinued after baseline|0|||
144260043|NCT02465437|520154444|FG000|Overall Study|Physician Decision|0|||
144260044|NCT02465437|520154445|FG001|Overall Study|Physician Decision|0|||
144260045|NCT02465437|520154446|FG002|Overall Study|Physician Decision|1|||
144260046|NCT02465437|520154447|FG003|Overall Study|Physician Decision|0|||
144260047|NCT02465437|520154444|FG000|Overall Study|Withdrawal by Subject|1|||
144260048|NCT02465437|520154445|FG001|Overall Study|Withdrawal by Subject|0|||
144260049|NCT02465437|520154446|FG002|Overall Study|Withdrawal by Subject|0|||
144260050|NCT02465437|520154447|FG003|Overall Study|Withdrawal by Subject|1|||
144260051|NCT02465437|520154444|FG000|Overall Study|Adverse Event|0|||
144260052|NCT02465437|520154445|FG001|Overall Study|Adverse Event|1|||
144260053|NCT02465437|520154446|FG002|Overall Study|Adverse Event|0|||
144260054|NCT02465437|520154447|FG003|Overall Study|Adverse Event|0|||
144260055|NCT00103662|520154448|FG000|Overall Study|Entered Rescue Procedure|0|||
144538534|NCT05580003|521174238|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538535|NCT05580003|521174239|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538536|NCT05580003|521174240|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538537|NCT05580003|521174241|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538538|NCT05580003|521174242|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538539|NCT05580003|521174243|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538540|NCT05580003|521174244|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538541|NCT05580003|521174245|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538542|NCT05580003|521174246|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538543|NCT05580003|521174247|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144538544|NCT05580003|521174220|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538545|NCT05580003|521174221|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538546|NCT05580003|521174222|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538547|NCT05580003|521174223|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538548|NCT05580003|521174224|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538549|NCT05580003|521174225|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
144538550|NCT05580003|521174226|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538551|NCT05580003|521174227|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538552|NCT05580003|521174228|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538553|NCT05580003|521174229|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538554|NCT05580003|521174230|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538555|NCT05580003|521174231|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538556|NCT05580003|521174232|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144614866|NCT03077685|521450232|FG002|Overall Study|Death|1|||
144614867|NCT03077685|521450233|FG003|Overall Study|Death|1|||
144614868|NCT03077685|521450234|FG004|Overall Study|Death|3|||
144260056|NCT00103662|520154449|FG001|Overall Study|Entered Rescue Procedure|7|||
144260057|NCT00103662|520154448|FG000|Overall Study|Death|7|||
144260058|NCT00103662|520154449|FG001|Overall Study|Death|7|||
144260059|NCT00103662|520154448|FG000|Overall Study|Elective Withdrawal|5|||
144260060|NCT00103662|520154449|FG001|Overall Study|Elective Withdrawal|5|||
144260061|NCT00103662|520154448|FG000|Overall Study|Lost to Follow-up|0|||
144260062|NCT00103662|520154449|FG001|Overall Study|Lost to Follow-up|1|||
144260063|NCT00103662|520154448|FG000|Overall Study|Other|6|||
144260064|NCT00103662|520154449|FG001|Overall Study|Other|9|||
144199448|NCT03412396|519928910|FG000|Overall Study|Did not undergo RP|2|||
144199449|NCT01383135|519928920|FG000|Overall Study|Not Scanned / Imaged|1|||
144199450|NCT01383135|519928921|FG001|Overall Study|Not Scanned / Imaged|0|||
144538557|NCT05580003|521174233|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538558|NCT05580003|521174234|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538559|NCT05580003|521174235|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538560|NCT05580003|521174236|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538561|NCT05580003|521174237|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144727187|NCT01249664|521856521|FG000|Overall Study|Withdrawal by Subject|5|||
144260065|NCT00103662|520154448|FG000|Overall Study|Failed mobilization|0|||
144260066|NCT00103662|520154449|FG001|Overall Study|Failed mobilization|4|||
144260067|NCT00103662|520154448|FG000|Overall Study|Intercurrent illness|1|||
144260068|NCT00103662|520154449|FG001|Overall Study|Intercurrent illness|0|||
144260069|NCT03334188|520154452|FG000|Overall Study|Withdrawal by Subject|0|||
144199451|NCT01383135|519928922|FG002|Overall Study|Not Scanned / Imaged|1|||
144260070|NCT03334188|520154453|FG001|Overall Study|Withdrawal by Subject|1|||
144260071|NCT03334188|520154452|FG000|Overall Study|Death|1|||
144260072|NCT03334188|520154453|FG001|Overall Study|Death|0|||
144260073|NCT03334188|520154452|FG000|Overall Study|Never had qualifying clinic visit|7|||
144260074|NCT03334188|520154453|FG001|Overall Study|Never had qualifying clinic visit|7|||
144260075|NCT03373760|520154454|FG000|Overall Study|Adverse Event|8|||
144260076|NCT03373760|520154454|FG000|Overall Study|Disease Progression|46|||
144260077|NCT03373760|520154454|FG000|Overall Study|Death|4|||
144260078|NCT03442088|520154457|FG000|Overall Study|Adverse Event|1|||
144260079|NCT03442088|520154457|FG000|Overall Study|Lack of Efficacy|2|||
144260080|NCT03442088|520154457|FG000|Overall Study|Lost to Follow-up|2|||
144260081|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
144260082|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
144260083|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
144260084|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
144260085|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
144260086|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
144260087|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
144260088|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
144260089|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
144260090|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
144260091|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
144260092|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
144260093|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
144260094|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
144260095|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Death|1|||
144260096|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Death|0|||
144260097|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
144260098|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
144260099|NCT00105989|520154458|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
144260100|NCT00105989|520154459|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
144260101|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
144260102|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
144260103|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
144260104|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
144260105|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
144260106|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
144260107|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
144260108|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
144260109|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
144727188|NCT01249664|521856522|FG001|Overall Study|Withdrawal by Subject|0|||
144199452|NCT01383135|519928923|FG003|Overall Study|Not Scanned / Imaged|0|||
144199453|NCT03167723|519928927|FG000|Overall Study|Protocol Violation|4|||
144199454|NCT03167723|519928928|FG001|Overall Study|Protocol Violation|6|||
144199455|NCT00415194|519928930|FG000|Overall Study|Adverse Event|37|||
144199456|NCT00415194|519928931|FG001|Overall Study|Adverse Event|32|||
144260110|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
144260111|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
144260112|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
144260113|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
144260114|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
144538562|NCT05580003|521174238|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144260115|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Death|0|||
144727189|NCT01249664|521856521|FG000|Overall Study|Adverse Event|1|||
144199457|NCT00415194|519928930|FG000|Overall Study|Entry Criteria Not Met|4|||
144199458|NCT00415194|519928931|FG001|Overall Study|Entry Criteria Not Met|8|||
144727190|NCT01249664|521856522|FG001|Overall Study|Adverse Event|0|||
144727191|NCT00762086|521856523|FG000|Overall Study|Adverse Event|2|||
144727192|NCT00762086|521856524|FG001|Overall Study|Adverse Event|0|||
144727193|NCT00762086|521856523|FG000|Overall Study|Lost to Follow-up|0|||
144727194|NCT00762086|521856524|FG001|Overall Study|Lost to Follow-up|2|||
144727195|NCT00762086|521856523|FG000|Overall Study|Non compliance|1|||
144727196|NCT00762086|521856524|FG001|Overall Study|Non compliance|0|||
144727197|NCT00762086|521856523|FG000|Overall Study|Withdrawal by Subject|2|||
144727198|NCT00762086|521856524|FG001|Overall Study|Withdrawal by Subject|2|||
144727199|NCT00762086|521856523|FG000|Overall Study|Ineligible to participate in the study|1|||
144727200|NCT00762086|521856524|FG001|Overall Study|Ineligible to participate in the study|0|||
144727201|NCT00860405|521856525|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
144727202|NCT00860405|521856526|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
144727203|NCT01074554|521856528|FG000|Overall Study|Adverse Event|3|||
144727204|NCT01074554|521856529|FG001|Overall Study|Adverse Event|3|||
144727205|NCT01074554|521856528|FG000|Overall Study|Lost to Follow-up|0|||
144727206|NCT01074554|521856529|FG001|Overall Study|Lost to Follow-up|1|||
144727207|NCT00497796|521856530|FG000|Overall Study|Adverse event (not related)|9|||
144727208|NCT00497796|521856531|FG001|Overall Study|Adverse event (not related)|9|||
144727209|NCT00497796|521856530|FG000|Overall Study|Adverse event (related)|5|||
144727210|NCT00497796|521856531|FG001|Overall Study|Adverse event (related)|4|||
144727211|NCT00497796|521856530|FG000|Overall Study|CMV infection or disease treatment|30|||
144727212|NCT00497796|521856531|FG001|Overall Study|CMV infection or disease treatment|4|||
144727213|NCT00497796|521856530|FG000|Overall Study|Consent withdrawn|10|||
144727214|NCT00497796|521856531|FG001|Overall Study|Consent withdrawn|3|||
144727215|NCT00497796|521856530|FG000|Overall Study|Investigator/sponsor discretion|31|||
144727216|NCT00497796|521856531|FG001|Overall Study|Investigator/sponsor discretion|34|||
144727217|NCT00497796|521856530|FG000|Overall Study|Lost to Follow-up|0|||
144727218|NCT00497796|521856531|FG001|Overall Study|Lost to Follow-up|1|||
144727219|NCT00497796|521856530|FG000|Overall Study|Not applicable (randomized not treated)|0|||
144727220|NCT00497796|521856531|FG001|Overall Study|Not applicable (randomized not treated)|4|||
144727221|NCT02073643|521856536|FG000|Overall Study|Lost to Follow-up|24|||
144727222|NCT05956665|521856547|FG000|Overall Study|Death|1|||
144727223|NCT05956665|521856547|FG000|Overall Study|Withdrawal by Subject|1|||
144727224|NCT01939197|521856548|FG000|Overall Study|Withdrawal by Subject|1|||
144727225|NCT01939197|521856549|FG001|Overall Study|Withdrawal by Subject|0|||
144727226|NCT01939197|521856550|FG002|Overall Study|Withdrawal by Subject|0|||
144727227|NCT01939197|521856551|FG003|Overall Study|Withdrawal by Subject|0|||
144727228|NCT01939197|521856552|FG004|Overall Study|Withdrawal by Subject|1|||
144727229|NCT01939197|521856553|FG005|Overall Study|Withdrawal by Subject|0|||
144727230|NCT01939197|521856554|FG006|Overall Study|Withdrawal by Subject|0|||
144727231|NCT01939197|521856548|FG000|Overall Study|Lost to Follow-up|0|||
144727232|NCT01939197|521856549|FG001|Overall Study|Lost to Follow-up|1|||
144727233|NCT01939197|521856550|FG002|Overall Study|Lost to Follow-up|0|||
144199459|NCT00415194|519928930|FG000|Overall Study|Lost to Follow-up|1|||
144199460|NCT00415194|519928931|FG001|Overall Study|Lost to Follow-up|0|||
144199461|NCT00415194|519928930|FG000|Overall Study|Physician Decision|10|||
144199462|NCT00415194|519928931|FG001|Overall Study|Physician Decision|16|||
144199463|NCT00415194|519928930|FG000|Overall Study|Progressive Disease|180|||
144199464|NCT00415194|519928931|FG001|Overall Study|Progressive Disease|217|||
144199465|NCT00415194|519928930|FG000|Overall Study|Protocol Violation|4|||
144199466|NCT00415194|519928931|FG001|Overall Study|Protocol Violation|2|||
144199467|NCT00415194|519928930|FG000|Overall Study|Withdrawal by Subject|28|||
144199468|NCT00415194|519928931|FG001|Overall Study|Withdrawal by Subject|21|||
144199469|NCT00415194|519928930|FG000|Overall Study|Death Due to Study Disease|26|||
144727234|NCT01939197|521856551|FG003|Overall Study|Lost to Follow-up|1|||
144727235|NCT01939197|521856552|FG004|Overall Study|Lost to Follow-up|3|||
144727236|NCT01939197|521856553|FG005|Overall Study|Lost to Follow-up|1|||
144727237|NCT01939197|521856554|FG006|Overall Study|Lost to Follow-up|2|||
144727238|NCT02545998|521856555|FG000|Overall Study|Lost to Follow-up|12|||
144727239|NCT02545998|521856556|FG001|Overall Study|Lost to Follow-up|3|||
144727240|NCT02545998|521856555|FG000|Overall Study|Withdrawal by Subject|3|||
144727241|NCT02545998|521856556|FG001|Overall Study|Withdrawal by Subject|2|||
144727242|NCT00958243|521856576|FG000|Overall Study|Withdrawal by Subject|0|||
144727243|NCT00958243|521856577|FG001|Overall Study|Withdrawal by Subject|1|||
144727244|NCT00958243|521856578|FG002|Overall Study|Withdrawal by Subject|3|||
144727245|NCT00958243|521856579|FG003|Overall Study|Withdrawal by Subject|1|||
144727246|NCT00958243|521856580|FG004|Overall Study|Withdrawal by Subject|1|||
144727247|NCT00958243|521856581|FG005|Overall Study|Withdrawal by Subject|5|||
144727248|NCT00958243|521856576|FG000|Overall Study|Lost to Follow-up|2|||
144727249|NCT00958243|521856577|FG001|Overall Study|Lost to Follow-up|5|||
144727250|NCT00958243|521856578|FG002|Overall Study|Lost to Follow-up|11|||
144727251|NCT00958243|521856579|FG003|Overall Study|Lost to Follow-up|2|||
144727252|NCT00958243|521856580|FG004|Overall Study|Lost to Follow-up|8|||
144727253|NCT00958243|521856581|FG005|Overall Study|Lost to Follow-up|5|||
144727254|NCT04646109|521856582|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
144199470|NCT00415194|519928931|FG001|Overall Study|Death Due to Study Disease|29|||
144199471|NCT00415194|519928930|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
144538563|NCT05580003|521174239|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538564|NCT05580003|521174240|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538565|NCT05580003|521174241|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538566|NCT05580003|521174242|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538567|NCT05580003|521174243|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538568|NCT05580003|521174244|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538569|NCT05580003|521174245|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538570|NCT05580003|521174246|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538571|NCT05580003|521174247|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
144538572|NCT05580003|521174220|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538573|NCT05580003|521174221|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538574|NCT05580003|521174222|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144199472|NCT00415194|519928931|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
144199473|NCT00415194|519928930|FG000|Overall Study|Death Due to Procedural Related AE|0|||
144199474|NCT00415194|519928931|FG001|Overall Study|Death Due to Procedural Related AE|1|||
144199475|NCT00415194|519928930|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
144199476|NCT00415194|519928931|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
144199477|NCT01297465|519928932|FG000|Overall Study|Lack of Ovarian Response|1|||
144199478|NCT01297465|519928933|FG001|Overall Study|Lack of Ovarian Response|1|||
144199479|NCT01297465|519928932|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
144199480|NCT01297465|519928933|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
144199481|NCT01297465|519928932|FG000|Overall Study|No Oocytes Retrieved|1|||
144199482|NCT01297465|519928933|FG001|Overall Study|No Oocytes Retrieved|1|||
144199483|NCT01297465|519928932|FG000|Overall Study|Poor oocyte quality|0|||
144199484|NCT01297465|519928933|FG001|Overall Study|Poor oocyte quality|1|||
144199485|NCT01297465|519928932|FG000|Overall Study|No Fertilization|6|||
144199486|NCT01297465|519928933|FG001|Overall Study|No Fertilization|4|||
144199487|NCT01297465|519928932|FG000|Overall Study|All Embryos Discarded|0|||
144199488|NCT01297465|519928933|FG001|Overall Study|All Embryos Discarded|1|||
144199489|NCT01297465|519928932|FG000|Overall Study|Intention to Freeze all Embryos|0|||
144199490|NCT01297465|519928933|FG001|Overall Study|Intention to Freeze all Embryos|1|||
144199491|NCT00969540|519928934|FG000|Overall Study|Lost to Follow-up|1|||
144199492|NCT00969540|519928935|FG001|Overall Study|Lost to Follow-up|1|||
144199493|NCT00369655|519928936|FG000|Overall Study|Refusal of further treatment|2|||
144199494|NCT01646138|519928937|FG000|Overall Study|Lost to Follow-up|0|||
144199495|NCT01646138|519928938|FG001|Overall Study|Lost to Follow-up|0|||
144199496|NCT01646138|519928939|FG002|Overall Study|Lost to Follow-up|0|||
144199497|NCT01646138|519928940|FG003|Overall Study|Lost to Follow-up|0|||
144199498|NCT01646138|519928941|FG004|Overall Study|Lost to Follow-up|2|||
144199499|NCT01683838|519928942|FG000|Overall Study|Adverse Event|12|||
144199500|NCT01683838|519928943|FG001|Overall Study|Adverse Event|2|||
144199501|NCT01683838|519928942|FG000|Overall Study|Protocol Violation|3|||
144199502|NCT01683838|519928943|FG001|Overall Study|Protocol Violation|1|||
144199503|NCT01683838|519928942|FG000|Overall Study|Withdrawal by Subject|6|||
144199504|NCT01683838|519928943|FG001|Overall Study|Withdrawal by Subject|5|||
144199505|NCT01683838|519928942|FG000|Overall Study|Lost to Follow-up|1|||
144199506|NCT01683838|519928943|FG001|Overall Study|Lost to Follow-up|1|||
144199507|NCT01683838|519928942|FG000|Overall Study|Other|4|||
144199508|NCT01683838|519928943|FG001|Overall Study|Other|3|||
144199509|NCT02325518|519928947|FG000|Overall Study|Adverse Event|4|||
144199510|NCT02325518|519928948|FG001|Overall Study|Adverse Event|1|||
144199511|NCT02325518|519928947|FG000|Overall Study|Physician Decision|0|||
144199512|NCT02325518|519928948|FG001|Overall Study|Physician Decision|1|||
144199513|NCT02325518|519928947|FG000|Overall Study|Withdrawal by Subject|0|||
144199514|NCT02325518|519928948|FG001|Overall Study|Withdrawal by Subject|1|||
144199515|NCT03393806|519928951|FG000|Overall Study|Physician Decision|1|||
144199516|NCT03393806|519928952|FG001|Overall Study|Physician Decision|0|||
144199517|NCT01259115|519928953|FG000|Period 1|Adverse Event|1|||
144199518|NCT01259115|519928954|FG001|Period 1|Adverse Event|0|||
144199519|NCT01259115|519928953|FG000|Period 1|Protocol Violation|2|||
144199520|NCT01259115|519928954|FG001|Period 1|Protocol Violation|0|||
144199521|NCT01259115|519928953|FG000|Period 1|Lost to Follow-up|0|||
144199522|NCT01259115|519928954|FG001|Period 1|Lost to Follow-up|1|||
144199523|NCT01259115|519928953|FG000|Period 2|Adverse Event|1|||
144199524|NCT01259115|519928954|FG001|Period 2|Adverse Event|0|||
144199525|NCT01971970|519928955|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
144199526|NCT01971970|519928956|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
144199527|NCT01971970|519928955|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
144199528|NCT01971970|519928956|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
144199529|NCT01971970|519928955|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
144199530|NCT01971970|519928956|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
144199531|NCT01971970|519928955|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
144199532|NCT01971970|519928956|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
144199533|NCT01971970|519928955|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
144199534|NCT01971970|519928956|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
144199535|NCT01971970|519928955|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
144199536|NCT01971970|519928956|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
144199537|NCT01971970|519928955|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
144199538|NCT01971970|519928956|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
144199539|NCT00848107|519928957|FG000|Overall Study|Lost to Follow-up|2|||
144199540|NCT00848107|519928957|FG000|Overall Study|Withdrawal by Subject|8|||
144199541|NCT00848107|519928957|FG000|Overall Study|Adverse Event|9|||
144199542|NCT00848107|519928957|FG000|Overall Study|Death|1|||
144199543|NCT00848107|519928957|FG000|Overall Study|Pregnancy|1|||
144199544|NCT01831765|519928958|FG000|Overall Study|Lack of Efficacy|1|||
144199545|NCT01831765|519928959|FG001|Overall Study|Lack of Efficacy|0|||
144199546|NCT01831765|519928960|FG002|Overall Study|Lack of Efficacy|0|||
144199547|NCT01831765|519928958|FG000|Overall Study|Other, sponsor withdrew subject|0|||
144199548|NCT01831765|519928959|FG001|Overall Study|Other, sponsor withdrew subject|1|||
144199549|NCT01831765|519928960|FG002|Overall Study|Other, sponsor withdrew subject|0|||
144199550|NCT01831765|519928958|FG000|Overall Study|Pregnancy|1|||
144199551|NCT01831765|519928959|FG001|Overall Study|Pregnancy|1|||
144199552|NCT01831765|519928960|FG002|Overall Study|Pregnancy|2|||
144199553|NCT01831765|519928958|FG000|Overall Study|Death|0|||
144199554|NCT01831765|519928959|FG001|Overall Study|Death|1|||
144199555|NCT01831765|519928960|FG002|Overall Study|Death|1|||
144199556|NCT01831765|519928958|FG000|Overall Study|Other, site closed|1|||
144199557|NCT01831765|519928959|FG001|Overall Study|Other, site closed|1|||
144199558|NCT01831765|519928960|FG002|Overall Study|Other, site closed|0|||
144199559|NCT01831765|519928958|FG000|Overall Study|Adverse Event|5|||
144199560|NCT01831765|519928959|FG001|Overall Study|Adverse Event|3|||
144199561|NCT01831765|519928960|FG002|Overall Study|Adverse Event|3|||
144199562|NCT01831765|519928958|FG000|Overall Study|Withdrawal by Subject|22|||
144199563|NCT01831765|519928959|FG001|Overall Study|Withdrawal by Subject|7|||
144199564|NCT01831765|519928960|FG002|Overall Study|Withdrawal by Subject|17|||
144199565|NCT01831765|519928958|FG000|Overall Study|Withdrawal criteria|12|||
144199566|NCT01831765|519928959|FG001|Overall Study|Withdrawal criteria|10|||
144199567|NCT01831765|519928960|FG002|Overall Study|Withdrawal criteria|16|||
144199568|NCT01831765|519928958|FG000|Overall Study|Lost to Follow-up|2|||
144199569|NCT01831765|519928959|FG001|Overall Study|Lost to Follow-up|3|||
144199570|NCT01831765|519928960|FG002|Overall Study|Lost to Follow-up|3|||
144199571|NCT00859586|519928961|FG000|Overall Study|Donors|4|||
144199572|NCT02524730|519928962|FG000|Overall Study|Lost to Follow-up|5|||
144199573|NCT02524730|519928962|FG000|Overall Study|Withdrawal by Subject|18|||
144199574|NCT02524730|519928962|FG000|Overall Study|Death|10|||
144199575|NCT02524730|519928962|FG000|Overall Study|Adverse Event|8|||
144199576|NCT02524730|519928962|FG000|Overall Study|Protocol Violation|1|||
144199577|NCT02524730|519928962|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
144199578|NCT00080938|519928965|FG000|Overall Study|Adverse Event|3|||
144199579|NCT00080938|519928965|FG000|Overall Study|Withdrawal by Subject|6|||
144199580|NCT00080938|519928965|FG000|Overall Study|Death|2|||
144199581|NCT00080938|519928965|FG000|Overall Study|Lack of Efficacy|7|||
144199582|NCT00080938|519928965|FG000|Overall Study|other disease|1|||
144199583|NCT00080938|519928965|FG000|Overall Study|Not started protocol therapy|1|||
144199584|NCT00080938|519928965|FG000|Overall Study|Ineligible|4|||
144199585|NCT00706511|519928970|FG000|Overall Study|Withdrawal by Subject|1|||
144199586|NCT00706511|519928971|FG001|Overall Study|Withdrawal by Subject|0|||
144199587|NCT00706511|519928972|FG002|Overall Study|Withdrawal by Subject|0|||
144199588|NCT00706511|519928973|FG003|Overall Study|Withdrawal by Subject|0|||
144199589|NCT02605993|519928974|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
144199590|NCT02605993|519928975|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
144199591|NCT02605993|519928976|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
144199592|NCT02605993|519928977|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
144199593|NCT03493386|519928982|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144199594|NCT03493386|519928983|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
144199595|NCT03493386|519928984|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144199596|NCT03493386|519928985|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144199597|NCT04645966|519928986|FG000|Vaccination Phase|Adverse Event|1|||
144199598|NCT04645966|519928987|FG001|Vaccination Phase|Adverse Event|0|||
144199599|NCT04645966|519928988|FG002|Vaccination Phase|Adverse Event|0|||
144199600|NCT04645966|519928989|FG003|Vaccination Phase|Adverse Event|0|||
144199601|NCT04645966|519928990|FG004|Vaccination Phase|Adverse Event|0|||
144199602|NCT04645966|519928991|FG005|Vaccination Phase|Adverse Event|0|||
144199603|NCT04645966|519928992|FG006|Vaccination Phase|Adverse Event|1|||
144199604|NCT04645966|519928993|FG007|Vaccination Phase|Adverse Event|0|||
144199605|NCT04645966|519928994|FG008|Vaccination Phase|Adverse Event|0|||
144260116|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Death|0|||
144260117|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
144260118|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
144260119|NCT00105989|520154458|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
144260120|NCT00105989|520154459|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
144260121|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
144260122|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
144260123|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
144260124|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
144260125|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
144260126|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
144260127|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
144260128|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
144260129|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
144260130|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
144260131|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
144260132|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
144260133|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
144260134|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
144260135|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
144260136|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
144260137|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
144260138|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
144260139|NCT00105989|520154458|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
144260140|NCT00105989|520154459|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
144260141|NCT01001520|520154460|FG000|Medication Period 1|Withdrawal by Subject|2|||
144260142|NCT01001520|520154461|FG001|Medication Period 1|Withdrawal by Subject|2|||
144260143|NCT01001520|520154460|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
144260144|NCT01001520|520154461|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
144260145|NCT01001520|520154460|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
144260146|NCT01001520|520154461|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
144260147|NCT01001520|520154460|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
144260148|NCT01001520|520154461|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
144260149|NCT01001520|520154460|FG000|Washout Period|Withdrawal by Subject|2|||
144260150|NCT01001520|520154461|FG001|Washout Period|Withdrawal by Subject|1|||
144260151|NCT01001520|520154460|FG000|Medication Period 2|Withdrawal by Subject|0|||
144260152|NCT01001520|520154461|FG001|Medication Period 2|Withdrawal by Subject|3|||
144260153|NCT00357877|520154464|FG000|Overall Study|Death|2|||
144260154|NCT00357877|520154465|FG001|Overall Study|Death|1|||
144260155|NCT00357877|520154464|FG000|Overall Study|Lost to Follow-up|20|||
144260156|NCT00357877|520154465|FG001|Overall Study|Lost to Follow-up|23|||
144260157|NCT00357877|520154464|FG000|Overall Study|Withdrawal by Subject|3|||
144260158|NCT00357877|520154465|FG001|Overall Study|Withdrawal by Subject|3|||
144260159|NCT00357877|520154464|FG000|Overall Study|Administrative withdrawal|1|||
144260160|NCT00357877|520154465|FG001|Overall Study|Administrative withdrawal|1|||
144260161|NCT00357877|520154464|FG000|Overall Study|Other|0|||
144260162|NCT00357877|520154465|FG001|Overall Study|Other|2|||
144260163|NCT04668209|520154466|FG000|Overall Study|Withdrawal by Subject|2|||
144260164|NCT04668209|520154467|FG001|Overall Study|Withdrawal by Subject|2|||
144260165|NCT04668209|520154466|FG000|Overall Study|Lost to Follow-up|3|||
144538575|NCT05580003|521174223|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
144538576|NCT05580003|521174224|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538577|NCT05580003|521174225|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538578|NCT05580003|521174226|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538579|NCT05580003|521174227|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538580|NCT05580003|521174228|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144199606|NCT04645966|519928986|FG000|Vaccination Phase|Death|0|||
144199607|NCT04645966|519928987|FG001|Vaccination Phase|Death|0|||
144199608|NCT04645966|519928988|FG002|Vaccination Phase|Death|0|||
144199609|NCT04645966|519928989|FG003|Vaccination Phase|Death|0|||
144199610|NCT04645966|519928990|FG004|Vaccination Phase|Death|0|||
144199611|NCT04645966|519928991|FG005|Vaccination Phase|Death|1|||
144199612|NCT04645966|519928992|FG006|Vaccination Phase|Death|0|||
144199613|NCT04645966|519928993|FG007|Vaccination Phase|Death|0|||
144199614|NCT04645966|519928994|FG008|Vaccination Phase|Death|0|||
144199615|NCT04645966|519928986|FG000|Vaccination Phase|Protocol Violation|0|||
144260166|NCT04668209|520154467|FG001|Overall Study|Lost to Follow-up|4|||
144260167|NCT04668209|520154466|FG000|Overall Study|Subject Expired|2|||
144260168|NCT04668209|520154467|FG001|Overall Study|Subject Expired|0|||
144260169|NCT04668209|520154466|FG000|Overall Study|Withdrawn from study|0|||
144538581|NCT05580003|521174229|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538582|NCT05580003|521174230|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144199616|NCT04645966|519928987|FG001|Vaccination Phase|Protocol Violation|0|||
144199617|NCT04645966|519928988|FG002|Vaccination Phase|Protocol Violation|0|||
144199618|NCT04645966|519928989|FG003|Vaccination Phase|Protocol Violation|0|||
144199619|NCT04645966|519928990|FG004|Vaccination Phase|Protocol Violation|1|||
144199620|NCT04645966|519928991|FG005|Vaccination Phase|Protocol Violation|0|||
144199621|NCT04645966|519928992|FG006|Vaccination Phase|Protocol Violation|0|||
144199622|NCT04645966|519928993|FG007|Vaccination Phase|Protocol Violation|0|||
144199623|NCT04645966|519928994|FG008|Vaccination Phase|Protocol Violation|0|||
144199624|NCT04645966|519928986|FG000|Vaccination Phase|Study terminated by sponsor|0|||
144199625|NCT04645966|519928987|FG001|Vaccination Phase|Study terminated by sponsor|0|||
144199626|NCT04645966|519928988|FG002|Vaccination Phase|Study terminated by sponsor|14|||
144199627|NCT04645966|519928989|FG003|Vaccination Phase|Study terminated by sponsor|15|||
144199628|NCT04645966|519928990|FG004|Vaccination Phase|Study terminated by sponsor|47|||
144199629|NCT04645966|519928991|FG005|Vaccination Phase|Study terminated by sponsor|43|||
144199630|NCT04645966|519928992|FG006|Vaccination Phase|Study terminated by sponsor|29|||
144199631|NCT04645966|519928993|FG007|Vaccination Phase|Study terminated by sponsor|29|||
144199632|NCT04645966|519928994|FG008|Vaccination Phase|Study terminated by sponsor|12|||
144199633|NCT04645966|519928986|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
144199634|NCT04645966|519928987|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
144199635|NCT04645966|519928988|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
144199636|NCT04645966|519928989|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
144199637|NCT04645966|519928990|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
144199638|NCT04645966|519928991|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
144199639|NCT04645966|519928992|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
144199640|NCT04645966|519928993|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
144199641|NCT04645966|519928994|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
144199642|NCT04645966|519928986|FG000|Vaccination Phase|Other|0|||
144199643|NCT04645966|519928987|FG001|Vaccination Phase|Other|0|||
144538583|NCT05580003|521174231|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144614869|NCT03077685|521450230|FG000|Overall Study|Withdrawal by Subject|0|||
144614870|NCT03077685|521450231|FG001|Overall Study|Withdrawal by Subject|0|||
144614871|NCT03077685|521450232|FG002|Overall Study|Withdrawal by Subject|0|||
144614872|NCT03077685|521450233|FG003|Overall Study|Withdrawal by Subject|2|||
144614873|NCT03077685|521450234|FG004|Overall Study|Withdrawal by Subject|1|||
144614874|NCT03077685|521450230|FG000|Overall Study|Physician Decision|0|||
144614875|NCT03077685|521450231|FG001|Overall Study|Physician Decision|0|||
144614876|NCT03077685|521450232|FG002|Overall Study|Physician Decision|1|||
144614877|NCT03077685|521450233|FG003|Overall Study|Physician Decision|0|||
144614878|NCT03077685|521450234|FG004|Overall Study|Physician Decision|3|||
144614879|NCT03077685|521450230|FG000|Overall Study|Disease Progression|1|||
144727255|NCT04646109|521856583|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
144727256|NCT06176768|521856584|FG000|Overall Study|Adverse Event|1|||
144727257|NCT06176768|521856585|FG001|Overall Study|Adverse Event|0|||
144727258|NCT06176768|521856584|FG000|Overall Study|Assigned treatment by mistake|1|||
144727259|NCT06176768|521856585|FG001|Overall Study|Assigned treatment by mistake|0|||
144727260|NCT06176768|521856584|FG000|Overall Study|Lost to Follow-up|0|||
144727261|NCT06176768|521856585|FG001|Overall Study|Lost to Follow-up|3|||
144727262|NCT06176768|521856584|FG000|Overall Study|Physician Decision|1|||
144727263|NCT06176768|521856585|FG001|Overall Study|Physician Decision|0|||
144727264|NCT06176768|521856584|FG000|Overall Study|Protocol deviation|3|||
144199644|NCT04645966|519928988|FG002|Vaccination Phase|Other|0|||
144538584|NCT05580003|521174232|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538585|NCT05580003|521174233|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538586|NCT05580003|521174234|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538587|NCT05580003|521174235|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538588|NCT05580003|521174236|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538589|NCT05580003|521174237|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538590|NCT05580003|521174238|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538591|NCT05580003|521174239|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538592|NCT05580003|521174240|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538593|NCT05580003|521174241|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538594|NCT05580003|521174242|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538595|NCT05580003|521174243|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538596|NCT05580003|521174244|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538597|NCT05580003|521174245|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538598|NCT05580003|521174246|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538599|NCT05580003|521174247|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
144538600|NCT05580003|521174220|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538601|NCT05580003|521174221|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
144538602|NCT05580003|521174222|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538603|NCT05580003|521174223|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144614880|NCT03077685|521450231|FG001|Overall Study|Disease Progression|0|||
144614881|NCT03077685|521450232|FG002|Overall Study|Disease Progression|0|||
144614882|NCT03077685|521450233|FG003|Overall Study|Disease Progression|2|||
144538604|NCT05580003|521174224|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538605|NCT05580003|521174225|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538606|NCT05580003|521174226|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538607|NCT05580003|521174227|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538608|NCT05580003|521174228|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538609|NCT05580003|521174229|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538610|NCT05580003|521174230|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538611|NCT05580003|521174231|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538612|NCT05580003|521174232|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538613|NCT05580003|521174233|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538614|NCT05580003|521174234|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538615|NCT05580003|521174235|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538616|NCT05580003|521174236|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538617|NCT05580003|521174237|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538618|NCT05580003|521174238|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144614883|NCT03077685|521450234|FG004|Overall Study|Disease Progression|1|||
144614884|NCT03077685|521450230|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
144614885|NCT03077685|521450231|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
144614886|NCT03077685|521450232|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
144614887|NCT03077685|521450233|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
144614888|NCT03077685|521450234|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
144614889|NCT03077685|521450230|FG000|Overall Study|Subject entered hospice care|0|||
144614890|NCT03077685|521450231|FG001|Overall Study|Subject entered hospice care|0|||
144614891|NCT03077685|521450232|FG002|Overall Study|Subject entered hospice care|0|||
144614892|NCT03077685|521450233|FG003|Overall Study|Subject entered hospice care|0|||
144614893|NCT03077685|521450234|FG004|Overall Study|Subject entered hospice care|1|||
144614894|NCT01979536|521450235|FG000|Overall Study|Physician Decision|2|||
144614895|NCT01979536|521450236|FG001|Overall Study|Physician Decision|3|||
144614896|NCT01979536|521450235|FG000|Overall Study|Withdrawal by Subject|0|||
144614897|NCT01979536|521450236|FG001|Overall Study|Withdrawal by Subject|1|||
144614898|NCT01979536|521450235|FG000|Overall Study|Refusal|0|||
144614899|NCT01979536|521450236|FG001|Overall Study|Refusal|1|||
144614900|NCT01979536|521450235|FG000|Overall Study|Relapse|0|||
144614901|NCT01979536|521450236|FG001|Overall Study|Relapse|1|||
144727265|NCT06176768|521856585|FG001|Overall Study|Protocol deviation|1|||
144727266|NCT06176768|521856584|FG000|Overall Study|Other|1|||
144727267|NCT06176768|521856585|FG001|Overall Study|Other|0|||
144727268|NCT06176768|521856584|FG000|Overall Study|Withdrawal by Subject|6|||
144727269|NCT06176768|521856585|FG001|Overall Study|Withdrawal by Subject|9|||
144727270|NCT01226797|521856586|FG000|Overall Study|Adverse Event|1|||
144727271|NCT01226797|521856587|FG001|Overall Study|Adverse Event|0|||
144727272|NCT01226797|521856586|FG000|Overall Study|No longer willing to participate|1|||
144727273|NCT01226797|521856587|FG001|Overall Study|No longer willing to participate|0|||
144727274|NCT01226797|521856586|FG000|Overall Study|Protocol Violation|0|||
144727275|NCT01226797|521856587|FG001|Overall Study|Protocol Violation|1|||
144727276|NCT00577460|521856590|FG000|Overall Study|Adverse Event|11|||
144727277|NCT00577460|521856591|FG001|Overall Study|Adverse Event|7|||
144727278|NCT00577460|521856592|FG002|Overall Study|Adverse Event|14|||
144727279|NCT00577460|521856590|FG000|Overall Study|Protocol Violation|0|||
144727280|NCT00577460|521856591|FG001|Overall Study|Protocol Violation|1|||
144727281|NCT00577460|521856592|FG002|Overall Study|Protocol Violation|1|||
144727282|NCT00577460|521856590|FG000|Overall Study|Lost to Follow-up|0|||
144727283|NCT00577460|521856591|FG001|Overall Study|Lost to Follow-up|3|||
144727284|NCT00577460|521856592|FG002|Overall Study|Lost to Follow-up|4|||
144727285|NCT00577460|521856590|FG000|Overall Study|Withdrawal by Subject|5|||
144727286|NCT00577460|521856591|FG001|Overall Study|Withdrawal by Subject|5|||
144727287|NCT00577460|521856592|FG002|Overall Study|Withdrawal by Subject|6|||
144727288|NCT00577460|521856590|FG000|Overall Study|Other|0|||
144727289|NCT00577460|521856591|FG001|Overall Study|Other|3|||
144727290|NCT00577460|521856592|FG002|Overall Study|Other|2|||
144727291|NCT01318499|521856595|FG000|Overall Study|Adverse Event|16|||
144727292|NCT01318499|521856596|FG001|Overall Study|Adverse Event|11|||
144727293|NCT01318499|521856597|FG002|Overall Study|Adverse Event|6|||
144727294|NCT01318499|521856595|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
144727295|NCT01318499|521856596|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
144199645|NCT04645966|519928989|FG003|Vaccination Phase|Other|0|||
144199646|NCT04645966|519928990|FG004|Vaccination Phase|Other|0|||
144199647|NCT04645966|519928991|FG005|Vaccination Phase|Other|2|||
144199648|NCT04645966|519928992|FG006|Vaccination Phase|Other|0|||
144199649|NCT04645966|519928993|FG007|Vaccination Phase|Other|0|||
144199650|NCT04645966|519928994|FG008|Vaccination Phase|Other|0|||
144199651|NCT04645966|519928986|FG000|Vaccination Phase|Lost to Follow-up|0|||
144199652|NCT04645966|519928987|FG001|Vaccination Phase|Lost to Follow-up|0|||
144614902|NCT01979536|521450235|FG000|Overall Study|Study terminated by Sponsor|0|||
144614903|NCT01979536|521450236|FG001|Overall Study|Study terminated by Sponsor|1|||
144260170|NCT04668209|520154467|FG001|Overall Study|Withdrawn from study|1|||
144260171|NCT04668209|520154466|FG000|Overall Study|Adverse Event|0|||
144260172|NCT04668209|520154467|FG001|Overall Study|Adverse Event|1|||
144260173|NCT00613366|520154477|FG000|Overall Study|Withdrawal by Subject|3|||
144260174|NCT00613366|520154478|FG001|Overall Study|Withdrawal by Subject|2|||
144260175|NCT05225558|520154479|FG000|Overall Study|Withdrawal by Subject|4|||
144260176|NCT05225558|520154480|FG001|Overall Study|Withdrawal by Subject|3|||
144260177|NCT05225558|520154479|FG000|Overall Study|Adverse Event|1|||
144260178|NCT05225558|520154480|FG001|Overall Study|Adverse Event|0|||
144260179|NCT05225558|520154479|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
144260180|NCT05225558|520154480|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
144260181|NCT05225558|520154479|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
144260182|NCT05225558|520154480|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
144538619|NCT05580003|521174239|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538620|NCT05580003|521174240|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144260183|NCT00447772|520154481|FG000|Overall Study|Lack of Efficacy|3|||
144260184|NCT00447772|520154481|FG000|Overall Study|Insufficient compliance|6|||
144260185|NCT00447772|520154481|FG000|Overall Study|Discontinuation of drug therapy|1|||
144260186|NCT00447772|520154481|FG000|Overall Study|Lost to Follow-up|9|||
144260187|NCT00447772|520154481|FG000|Overall Study|Withdrawal by Subject|1|||
144260188|NCT00447772|520154481|FG000|Overall Study|Unable to attend all study visits|2|||
144260189|NCT00447772|520154481|FG000|Overall Study|Adverse Event|1|||
144260190|NCT00447772|520154481|FG000|Overall Study|Patient relocated|1|||
144260191|NCT00447772|520154481|FG000|Overall Study|Incomplete documentation at visit 1|1|||
144260192|NCT00447772|520154481|FG000|Overall Study|Chemotherapy for lung cancer|1|||
144260193|NCT00447772|520154481|FG000|Overall Study|Premature re-injection required|1|||
144260194|NCT00716456|520154482|FG000|Overall Study|Adverse Event|0|||
144260195|NCT00716456|520154483|FG001|Overall Study|Adverse Event|2|||
144260196|NCT00716456|520154484|FG002|Overall Study|Adverse Event|0|||
144260197|NCT00875563|520154489|FG000|Overall Study|Death|4|||
144260198|NCT00875563|520154489|FG000|Overall Study|Withdrawal by Subject|7|||
144260199|NCT00875563|520154489|FG000|Overall Study|No long-term (3-5 year) consent|6|||
144260200|NCT00875563|520154489|FG000|Overall Study|Still be eligible for follow-up|7|||
144260201|NCT02896569|520154490|FG000|Overall Study|Lost to Follow-up|2|||
144260202|NCT02896569|520154491|FG001|Overall Study|Lost to Follow-up|1|||
144260203|NCT02896569|520154490|FG000|Overall Study|Physician Decision|1|||
144260204|NCT02896569|520154491|FG001|Overall Study|Physician Decision|3|||
144260205|NCT02896569|520154490|FG000|Overall Study|Adverse Event|0|||
144260206|NCT02896569|520154491|FG001|Overall Study|Adverse Event|1|||
144260207|NCT02896569|520154490|FG000|Overall Study|Withdrawal by Subject|1|||
144260208|NCT02896569|520154491|FG001|Overall Study|Withdrawal by Subject|0|||
144538621|NCT05580003|521174241|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538622|NCT05580003|521174242|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538623|NCT05580003|521174243|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538624|NCT05580003|521174244|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538625|NCT05580003|521174245|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538626|NCT05580003|521174246|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538627|NCT05580003|521174247|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
144538628|NCT05580003|521174220|FG000|Part 2 (up to 10 Days)|Other|0|||
144538629|NCT05580003|521174221|FG001|Part 2 (up to 10 Days)|Other|0|||
144538630|NCT05580003|521174222|FG002|Part 2 (up to 10 Days)|Other|0|||
144538631|NCT05580003|521174223|FG003|Part 2 (up to 10 Days)|Other|0|||
144538632|NCT05580003|521174224|FG004|Part 2 (up to 10 Days)|Other|0|||
144538633|NCT05580003|521174225|FG005|Part 2 (up to 10 Days)|Other|0|||
144538634|NCT05580003|521174226|FG006|Part 2 (up to 10 Days)|Other|0|||
144538635|NCT05580003|521174227|FG007|Part 2 (up to 10 Days)|Other|0|||
144538636|NCT05580003|521174228|FG008|Part 2 (up to 10 Days)|Other|0|||
144260209|NCT03257436|520154492|FG000|Overall Study|Withdrawal by Subject|76|||
144260210|NCT03257436|520154492|FG000|Overall Study|Death|19|||
144260211|NCT00970489|520154493|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
144260212|NCT00970489|520154494|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
144260213|NCT02659943|520154495|FG000|Overall Study|Switched to alternative treatment|1|||
144260214|NCT02659943|520154496|FG001|Overall Study|Switched to alternative treatment|1|||
144260215|NCT02659943|520154497|FG002|Overall Study|Switched to alternative treatment|0|||
144260216|NCT02659943|520154498|FG003|Overall Study|Switched to alternative treatment|2|||
144260217|NCT02659943|520154499|FG004|Overall Study|Switched to alternative treatment|1|||
144260218|NCT02659943|520154500|FG005|Overall Study|Switched to alternative treatment|0|||
144260219|NCT02659943|520154501|FG006|Overall Study|Switched to alternative treatment|1|||
144260220|NCT02659943|520154495|FG000|Overall Study|Disease progression on study|0|||
144538637|NCT05580003|521174229|FG009|Part 2 (up to 10 Days)|Other|1|||
144260221|NCT02659943|520154496|FG001|Overall Study|Disease progression on study|1|||
144260222|NCT02659943|520154497|FG002|Overall Study|Disease progression on study|1|||
144538638|NCT05580003|521174230|FG010|Part 2 (up to 10 Days)|Other|0|||
144538639|NCT05580003|521174231|FG011|Part 2 (up to 10 Days)|Other|0|||
144538640|NCT05580003|521174232|FG012|Part 2 (up to 10 Days)|Other|0|||
144538641|NCT05580003|521174233|FG013|Part 2 (up to 10 Days)|Other|0|||
144538642|NCT05580003|521174234|FG014|Part 2 (up to 10 Days)|Other|0|||
144538643|NCT05580003|521174235|FG015|Part 2 (up to 10 Days)|Other|0|||
144538644|NCT05580003|521174236|FG016|Part 2 (up to 10 Days)|Other|0|||
144538645|NCT05580003|521174237|FG017|Part 2 (up to 10 Days)|Other|0|||
144538646|NCT05580003|521174238|FG018|Part 2 (up to 10 Days)|Other|0|||
144538647|NCT05580003|521174239|FG019|Part 2 (up to 10 Days)|Other|0|||
144538648|NCT05580003|521174240|FG020|Part 2 (up to 10 Days)|Other|0|||
144538649|NCT05580003|521174241|FG021|Part 2 (up to 10 Days)|Other|0|||
144538650|NCT05580003|521174242|FG022|Part 2 (up to 10 Days)|Other|0|||
144538651|NCT05580003|521174243|FG023|Part 2 (up to 10 Days)|Other|0|||
144260223|NCT02659943|520154498|FG003|Overall Study|Disease progression on study|1|||
144260224|NCT02659943|520154499|FG004|Overall Study|Disease progression on study|1|||
144260225|NCT02659943|520154500|FG005|Overall Study|Disease progression on study|4|||
144260226|NCT02659943|520154501|FG006|Overall Study|Disease progression on study|0|||
144260227|NCT02659943|520154495|FG000|Overall Study|Patient's condition per principal investigator|0|||
144260228|NCT02659943|520154496|FG001|Overall Study|Patient's condition per principal investigator|0|||
144260229|NCT02659943|520154497|FG002|Overall Study|Patient's condition per principal investigator|0|||
144260230|NCT02659943|520154498|FG003|Overall Study|Patient's condition per principal investigator|0|||
144260231|NCT02659943|520154499|FG004|Overall Study|Patient's condition per principal investigator|0|||
144260232|NCT02659943|520154500|FG005|Overall Study|Patient's condition per principal investigator|1|||
144260233|NCT02659943|520154501|FG006|Overall Study|Patient's condition per principal investigator|0|||
144260234|NCT02659943|520154495|FG000|Overall Study|Ineligible|0|||
144260235|NCT02659943|520154496|FG001|Overall Study|Ineligible|0|||
144260236|NCT02659943|520154497|FG002|Overall Study|Ineligible|0|||
144260237|NCT02659943|520154498|FG003|Overall Study|Ineligible|0|||
144260238|NCT02659943|520154499|FG004|Overall Study|Ineligible|0|||
144260239|NCT02659943|520154500|FG005|Overall Study|Ineligible|0|||
144260240|NCT02659943|520154501|FG006|Overall Study|Ineligible|1|||
144260241|NCT02659943|520154495|FG000|Overall Study|No longer meets eligibility|0|||
144260242|NCT02659943|520154496|FG001|Overall Study|No longer meets eligibility|0|||
144260243|NCT02659943|520154497|FG002|Overall Study|No longer meets eligibility|0|||
144260244|NCT02659943|520154498|FG003|Overall Study|No longer meets eligibility|0|||
144260245|NCT02659943|520154499|FG004|Overall Study|No longer meets eligibility|0|||
144260246|NCT02659943|520154500|FG005|Overall Study|No longer meets eligibility|0|||
144260247|NCT02659943|520154501|FG006|Overall Study|No longer meets eligibility|1|||
144260248|NCT02659943|520154495|FG000|Overall Study|No treatment, per protocol|0|||
144260249|NCT02659943|520154496|FG001|Overall Study|No treatment, per protocol|0|||
144260250|NCT02659943|520154497|FG002|Overall Study|No treatment, per protocol|0|||
144260251|NCT02659943|520154498|FG003|Overall Study|No treatment, per protocol|0|||
144260252|NCT02659943|520154499|FG004|Overall Study|No treatment, per protocol|0|||
144260253|NCT02659943|520154500|FG005|Overall Study|No treatment, per protocol|0|||
144260254|NCT02659943|520154501|FG006|Overall Study|No treatment, per protocol|3|||
144260255|NCT01723072|520154506|FG000|Overall Study|Withdrawal by Subject|7|||
144260256|NCT01723072|520154507|FG001|Overall Study|Withdrawal by Subject|13|||
144260257|NCT01723072|520154506|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
144260258|NCT01723072|520154507|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
144260259|NCT01723072|520154506|FG000|Overall Study|Other|4|||
144260260|NCT01723072|520154507|FG001|Overall Study|Other|3|||
144260261|NCT03428100|520154508|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
144260262|NCT03428100|520154509|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260263|NCT03428100|520154510|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
144260264|NCT03428100|520154511|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
144260265|NCT03428100|520154512|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260266|NCT03428100|520154513|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260267|NCT03428100|520154514|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260268|NCT03428100|520154515|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260269|NCT03428100|520154516|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260270|NCT03428100|520154517|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260271|NCT03428100|520154518|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260272|NCT03428100|520154519|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260273|NCT03428100|520154520|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260274|NCT03428100|520154521|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260275|NCT03428100|520154522|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260276|NCT03428100|520154523|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260277|NCT03428100|520154524|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260278|NCT03428100|520154525|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144538652|NCT05580003|521174244|FG024|Part 2 (up to 10 Days)|Other|0|||
144538653|NCT05580003|521174245|FG025|Part 2 (up to 10 Days)|Other|0|||
144538654|NCT05580003|521174246|FG026|Part 2 (up to 10 Days)|Other|0|||
144538655|NCT05580003|521174247|FG027|Part 2 (up to 10 Days)|Other|0|||
144260279|NCT03428100|520154526|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
144260280|NCT03428100|520154508|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
144260281|NCT03428100|520154509|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
144260282|NCT03428100|520154510|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
144260283|NCT03428100|520154511|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
144260284|NCT03428100|520154512|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260285|NCT03428100|520154513|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260286|NCT03428100|520154514|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260287|NCT03428100|520154515|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260288|NCT03428100|520154516|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260289|NCT03428100|520154517|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260290|NCT03428100|520154518|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260291|NCT03428100|520154519|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260292|NCT03428100|520154520|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260293|NCT03428100|520154521|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260294|NCT03428100|520154522|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260295|NCT03428100|520154523|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260296|NCT03428100|520154524|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260297|NCT03428100|520154525|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260298|NCT03428100|520154526|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
144260299|NCT03428100|520154508|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260300|NCT03428100|520154509|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
144260301|NCT03428100|520154510|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
144260302|NCT03428100|520154511|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260303|NCT03428100|520154512|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260304|NCT03428100|520154513|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260305|NCT03428100|520154514|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260306|NCT03428100|520154515|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260307|NCT03428100|520154516|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260308|NCT03428100|520154517|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260309|NCT03428100|520154518|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260310|NCT03428100|520154519|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260311|NCT03428100|520154520|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260312|NCT03428100|520154521|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260313|NCT03428100|520154522|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260314|NCT03428100|520154523|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260315|NCT03428100|520154524|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260316|NCT03428100|520154525|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260317|NCT03428100|520154526|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
144260318|NCT03428100|520154508|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
144260319|NCT03428100|520154509|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260320|NCT03428100|520154510|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260321|NCT03428100|520154511|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260322|NCT03428100|520154512|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260323|NCT03428100|520154513|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260324|NCT03428100|520154514|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260325|NCT03428100|520154515|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260326|NCT03428100|520154516|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260327|NCT03428100|520154517|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260328|NCT03428100|520154518|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260329|NCT03428100|520154519|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260330|NCT03428100|520154520|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260331|NCT03428100|520154521|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144614904|NCT01979536|521450235|FG000|Overall Study|Did not start treatment|0|||
144614905|NCT01979536|521450236|FG001|Overall Study|Did not start treatment|1|||
144614906|NCT04294901|521450246|FG000|Overall Study|Death|86|||
144614907|NCT04294901|521450247|FG001|Overall Study|Death|110|||
144614908|NCT04294901|521450246|FG000|Overall Study|Provider did not have historical control patients|581|||
144614909|NCT04294901|521450247|FG001|Overall Study|Provider did not have historical control patients|0|||
144614910|NCT04294901|521450246|FG000|Overall Study|Provider did not have intervention patients|0|||
144614911|NCT04294901|521450247|FG001|Overall Study|Provider did not have intervention patients|98|||
144614912|NCT05038020|521450249|FG000|Overall Study|Early Termination|3|||
144614913|NCT05038020|521450250|FG001|Overall Study|Early Termination|0|||
144614914|NCT01823679|521451935|FG000|Overall Study|Death|1|||
144614915|NCT03927105|521451936|FG000|Overall Study|Death|1|||
144199653|NCT04645966|519928988|FG002|Vaccination Phase|Lost to Follow-up|0|||
144199654|NCT04645966|519928989|FG003|Vaccination Phase|Lost to Follow-up|0|||
144199655|NCT04645966|519928990|FG004|Vaccination Phase|Lost to Follow-up|0|||
144199656|NCT04645966|519928991|FG005|Vaccination Phase|Lost to Follow-up|0|||
144199657|NCT04645966|519928992|FG006|Vaccination Phase|Lost to Follow-up|0|||
144199658|NCT04645966|519928993|FG007|Vaccination Phase|Lost to Follow-up|1|||
144199659|NCT04645966|519928994|FG008|Vaccination Phase|Lost to Follow-up|0|||
144199660|NCT04645966|519928986|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
144199661|NCT04645966|519928987|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
144199662|NCT04645966|519928988|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
144199663|NCT04645966|519928989|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
144260332|NCT03428100|520154522|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260333|NCT03428100|520154523|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260334|NCT03428100|520154524|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260335|NCT03428100|520154525|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260336|NCT03428100|520154526|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
144260337|NCT03428100|520154508|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260338|NCT03428100|520154509|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
144260339|NCT03428100|520154510|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260340|NCT03428100|520154511|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260341|NCT03428100|520154512|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260342|NCT03428100|520154513|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260343|NCT03428100|520154514|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144538656|NCT05580003|521174220|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538657|NCT05580003|521174221|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538658|NCT05580003|521174222|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538659|NCT05580003|521174223|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538660|NCT05580003|521174224|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538661|NCT05580003|521174225|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538662|NCT05580003|521174226|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538663|NCT05580003|521174227|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538664|NCT05580003|521174228|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538665|NCT05580003|521174229|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538666|NCT05580003|521174230|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538667|NCT05580003|521174231|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538668|NCT05580003|521174232|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538669|NCT05580003|521174233|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538670|NCT05580003|521174234|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538671|NCT05580003|521174235|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538672|NCT05580003|521174236|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538673|NCT05580003|521174237|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538674|NCT05580003|521174238|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538675|NCT05580003|521174239|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
144538676|NCT05580003|521174240|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538677|NCT05580003|521174241|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538678|NCT05580003|521174242|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538679|NCT05580003|521174243|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538680|NCT05580003|521174244|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538681|NCT05580003|521174245|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538682|NCT05580003|521174246|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538683|NCT05580003|521174247|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
144538684|NCT05580003|521174220|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538685|NCT05580003|521174221|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538686|NCT05580003|521174222|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538687|NCT05580003|521174223|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538688|NCT05580003|521174224|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538689|NCT05580003|521174225|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538690|NCT05580003|521174226|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538691|NCT05580003|521174227|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538692|NCT05580003|521174228|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538693|NCT05580003|521174229|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538694|NCT05580003|521174230|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538695|NCT05580003|521174231|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538696|NCT05580003|521174232|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538697|NCT05580003|521174233|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538698|NCT05580003|521174234|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538699|NCT05580003|521174235|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538700|NCT05580003|521174236|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538701|NCT05580003|521174237|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538702|NCT05580003|521174238|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538703|NCT05580003|521174239|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538704|NCT05580003|521174240|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
144538705|NCT05580003|521174241|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538706|NCT05580003|521174242|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538707|NCT05580003|521174243|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538708|NCT05580003|521174244|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538709|NCT05580003|521174245|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538710|NCT05580003|521174246|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538711|NCT05580003|521174247|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
144538712|NCT05580003|521174220|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538713|NCT05580003|521174221|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538714|NCT05580003|521174222|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538715|NCT05580003|521174223|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538716|NCT05580003|521174224|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538717|NCT05580003|521174225|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538718|NCT05580003|521174226|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538719|NCT05580003|521174227|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538720|NCT05580003|521174228|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538721|NCT05580003|521174229|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538722|NCT05580003|521174230|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538723|NCT05580003|521174231|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144199664|NCT04645966|519928990|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
144199665|NCT04645966|519928991|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
144199666|NCT04645966|519928992|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
144538724|NCT05580003|521174232|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144199667|NCT04645966|519928993|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
144199668|NCT04645966|519928994|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
144199669|NCT04645966|519928986|FG000|Follow-up Phase|Lost to Follow-up|0|||
144199670|NCT04645966|519928987|FG001|Follow-up Phase|Lost to Follow-up|0|||
144199671|NCT04645966|519928988|FG002|Follow-up Phase|Lost to Follow-up|0|||
144199672|NCT04645966|519928989|FG003|Follow-up Phase|Lost to Follow-up|0|||
144199673|NCT04645966|519928990|FG004|Follow-up Phase|Lost to Follow-up|0|||
144199674|NCT04645966|519928991|FG005|Follow-up Phase|Lost to Follow-up|0|||
144199675|NCT04645966|519928992|FG006|Follow-up Phase|Lost to Follow-up|0|||
144199676|NCT04645966|519928993|FG007|Follow-up Phase|Lost to Follow-up|1|||
144199677|NCT04645966|519928994|FG008|Follow-up Phase|Lost to Follow-up|0|||
144199678|NCT03246126|519928995|FG000|Overall Study|Withdrawal by Subject|0|||
144199679|NCT03246126|519928996|FG001|Overall Study|Withdrawal by Subject|1|||
144199680|NCT04647721|519928997|FG000|Overall Study|Withdrawal by Subject|0|||
144199681|NCT04647721|519928998|FG001|Overall Study|Withdrawal by Subject|2|||
144199682|NCT04647721|519928997|FG000|Overall Study|Lost to Follow-up|2|||
144199683|NCT04647721|519928998|FG001|Overall Study|Lost to Follow-up|0|||
144199684|NCT01974440|519929002|FG000|Overall Study|Lost to Follow-up|7|||
144199685|NCT01974440|519929003|FG001|Overall Study|Lost to Follow-up|7|||
144199686|NCT01974440|519929002|FG000|Overall Study|Withdrawal by Subject|24|||
144199687|NCT01974440|519929003|FG001|Overall Study|Withdrawal by Subject|20|||
144199688|NCT01974440|519929002|FG000|Overall Study|Sponsor decision|109|||
144199689|NCT01974440|519929003|FG001|Overall Study|Sponsor decision|110|||
144199690|NCT00762437|519929004|FG000|Overall Study|Lost to Follow-up|7|||
144199691|NCT00762437|519929004|FG000|Overall Study|Missed final study visit|11|||
144199692|NCT00762437|519929004|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
144199693|NCT00302081|519929005|FG000|Overall Study|Adverse Event|6|||
144199694|NCT00302081|519929006|FG001|Overall Study|Adverse Event|5|||
144199695|NCT00302081|519929007|FG002|Overall Study|Adverse Event|4|||
144199696|NCT00302081|519929005|FG000|Overall Study|Lost to Follow-up|21|||
144199697|NCT00302081|519929006|FG001|Overall Study|Lost to Follow-up|18|||
144199698|NCT00302081|519929007|FG002|Overall Study|Lost to Follow-up|28|||
144199699|NCT00302081|519929005|FG000|Overall Study|Withdrawal by Subject|8|||
144199700|NCT00302081|519929006|FG001|Overall Study|Withdrawal by Subject|12|||
144199701|NCT00302081|519929007|FG002|Overall Study|Withdrawal by Subject|8|||
144199702|NCT00302081|519929005|FG000|Overall Study|Protocol Violation|5|||
144199703|NCT00302081|519929006|FG001|Overall Study|Protocol Violation|1|||
144199704|NCT00302081|519929007|FG002|Overall Study|Protocol Violation|2|||
144199705|NCT00302081|519929005|FG000|Overall Study|Lack of Efficacy|1|||
144199706|NCT00302081|519929006|FG001|Overall Study|Lack of Efficacy|0|||
144199707|NCT00302081|519929007|FG002|Overall Study|Lack of Efficacy|5|||
144199708|NCT00302081|519929005|FG000|Overall Study|Death|2|||
144199709|NCT00302081|519929006|FG001|Overall Study|Death|1|||
144199710|NCT00302081|519929007|FG002|Overall Study|Death|0|||
144199711|NCT00302081|519929005|FG000|Overall Study|Other|13|||
144199712|NCT00302081|519929006|FG001|Overall Study|Other|6|||
144538725|NCT05580003|521174233|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538726|NCT05580003|521174234|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538727|NCT05580003|521174235|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538728|NCT05580003|521174236|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538729|NCT05580003|521174237|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538730|NCT05580003|521174238|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538731|NCT05580003|521174239|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538732|NCT05580003|521174240|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538733|NCT05580003|521174241|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
144538734|NCT05580003|521174242|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538735|NCT05580003|521174243|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538736|NCT05580003|521174244|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538737|NCT05580003|521174245|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538738|NCT05580003|521174246|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538739|NCT05580003|521174247|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
144538740|NCT05580003|521174220|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538741|NCT05580003|521174221|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538742|NCT05580003|521174222|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538743|NCT05580003|521174223|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538744|NCT05580003|521174224|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538745|NCT05580003|521174225|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538746|NCT05580003|521174226|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538747|NCT05580003|521174227|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538748|NCT05580003|521174228|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538749|NCT05580003|521174229|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538750|NCT05580003|521174230|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538751|NCT05580003|521174231|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538752|NCT05580003|521174232|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538753|NCT05580003|521174233|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538754|NCT05580003|521174234|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538755|NCT05580003|521174235|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538756|NCT05580003|521174236|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538757|NCT05580003|521174237|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538758|NCT05580003|521174238|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538759|NCT05580003|521174239|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538760|NCT05580003|521174240|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538761|NCT05580003|521174241|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538762|NCT05580003|521174242|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538763|NCT05580003|521174243|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538764|NCT05580003|521174244|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538765|NCT05580003|521174245|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538766|NCT05580003|521174246|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
144538767|NCT05580003|521174247|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
144538768|NCT05580003|521174220|FG000|Part 6 Period 2 (Day 1)|Other|0|||
144538769|NCT05580003|521174221|FG001|Part 6 Period 2 (Day 1)|Other|0|||
144538770|NCT05580003|521174222|FG002|Part 6 Period 2 (Day 1)|Other|0|||
144538771|NCT05580003|521174223|FG003|Part 6 Period 2 (Day 1)|Other|0|||
144538772|NCT05580003|521174224|FG004|Part 6 Period 2 (Day 1)|Other|0|||
144538773|NCT05580003|521174225|FG005|Part 6 Period 2 (Day 1)|Other|0|||
144472244|NCT04711603|520926728|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
144472245|NCT04711603|520926729|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
144472246|NCT04711603|520926726|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
144472247|NCT04711603|520926727|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
144472248|NCT04711603|520926728|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
144472249|NCT04711603|520926729|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
144472250|NCT04711603|520926726|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
144472251|NCT04711603|520926727|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
144538774|NCT05580003|521174226|FG006|Part 6 Period 2 (Day 1)|Other|0|||
144538775|NCT05580003|521174227|FG007|Part 6 Period 2 (Day 1)|Other|0|||
144538776|NCT05580003|521174228|FG008|Part 6 Period 2 (Day 1)|Other|0|||
144538777|NCT05580003|521174229|FG009|Part 6 Period 2 (Day 1)|Other|0|||
144538778|NCT05580003|521174230|FG010|Part 6 Period 2 (Day 1)|Other|0|||
144472252|NCT04711603|520926728|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
144472253|NCT04711603|520926729|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
144538779|NCT05580003|521174231|FG011|Part 6 Period 2 (Day 1)|Other|0|||
144538780|NCT05580003|521174232|FG012|Part 6 Period 2 (Day 1)|Other|0|||
144538781|NCT05580003|521174233|FG013|Part 6 Period 2 (Day 1)|Other|0|||
144538782|NCT05580003|521174234|FG014|Part 6 Period 2 (Day 1)|Other|0|||
144538783|NCT05580003|521174235|FG015|Part 6 Period 2 (Day 1)|Other|0|||
144538784|NCT05580003|521174236|FG016|Part 6 Period 2 (Day 1)|Other|0|||
144538785|NCT05580003|521174237|FG017|Part 6 Period 2 (Day 1)|Other|0|||
144538786|NCT05580003|521174238|FG018|Part 6 Period 2 (Day 1)|Other|0|||
144538787|NCT05580003|521174239|FG019|Part 6 Period 2 (Day 1)|Other|0|||
144538788|NCT05580003|521174240|FG020|Part 6 Period 2 (Day 1)|Other|0|||
144614916|NCT03927105|521451936|FG000|Overall Study|In observation for potential re-treatment|2|||
144614917|NCT03927105|521451936|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
144614918|NCT02145741|521451938|FG000|Overall Study|Progressive disease|3|||
144614919|NCT02145741|521451939|FG001|Overall Study|Progressive disease|6|||
144614920|NCT02145741|521451940|FG002|Overall Study|Progressive disease|6|||
144614921|NCT02145741|521451938|FG000|Overall Study|quality issue with the administered drug|3|||
144614922|NCT02145741|521451939|FG001|Overall Study|quality issue with the administered drug|0|||
144614923|NCT02145741|521451940|FG002|Overall Study|quality issue with the administered drug|0|||
144614924|NCT05634577|521451941|FG000|Overall Study|Lost to Follow-up|1|||
144614925|NCT05634577|521451941|FG000|Overall Study|Withdrawal by Subject|1|||
144614926|NCT02311153|521451943|FG000|Overall Study|Lost to Follow-up|5|||
144614927|NCT02311153|521451944|FG001|Overall Study|Lost to Follow-up|7|||
144614928|NCT00405067|521451945|FG000|Overall Study|Adverse Event|4|||
144614929|NCT00405067|521451946|FG001|Overall Study|Adverse Event|9|||
144614930|NCT00405067|521451947|FG002|Overall Study|Adverse Event|4|||
144614931|NCT00405067|521451945|FG000|Overall Study|Lost to Follow-up|0|||
144614932|NCT00405067|521451946|FG001|Overall Study|Lost to Follow-up|0|||
144614933|NCT00405067|521451947|FG002|Overall Study|Lost to Follow-up|1|||
144614934|NCT01560780|521451948|FG000|Overall Study|Death|2|||
144614935|NCT01560780|521451949|FG001|Overall Study|Death|1|||
144614936|NCT01560780|521451948|FG000|Overall Study|Patient Preference|11|||
144614937|NCT01560780|521451949|FG001|Overall Study|Patient Preference|11|||
144614938|NCT01577186|521451950|FG000|Overall Study|Adverse Event|23|||
144614939|NCT01577186|521451950|FG000|Overall Study|Death|1|||
144614940|NCT01577186|521451950|FG000|Overall Study|Lost to Follow-up|28|||
144614941|NCT01577186|521451950|FG000|Overall Study|Withdrawal by Subject|35|||
144614942|NCT01577186|521451950|FG000|Overall Study|Insufficient Response|18|||
144614943|NCT01577186|521451950|FG000|Overall Study|Ineligible to Continue|15|||
144614944|NCT01577186|521451950|FG000|Overall Study|Non-Compliant|8|||
144614945|NCT01577186|521451950|FG000|Overall Study|Other|2|||
144614946|NCT00957008|521451951|FG000|Overall Study|Withdrawal by Subject|13|||
144614947|NCT00957008|521451952|FG001|Overall Study|Withdrawal by Subject|10|||
144614948|NCT00957008|521451953|FG002|Overall Study|Withdrawal by Subject|12|||
144614949|NCT00957008|521451954|FG003|Overall Study|Withdrawal by Subject|16|||
144614950|NCT00957008|521451951|FG000|Overall Study|Lost to Follow-up|3|||
144614951|NCT00957008|521451952|FG001|Overall Study|Lost to Follow-up|1|||
144614952|NCT00957008|521451953|FG002|Overall Study|Lost to Follow-up|3|||
144614953|NCT00957008|521451954|FG003|Overall Study|Lost to Follow-up|4|||
144614954|NCT00957008|521451951|FG000|Overall Study|Physician Decision|1|||
144614955|NCT00957008|521451952|FG001|Overall Study|Physician Decision|0|||
144614956|NCT00957008|521451953|FG002|Overall Study|Physician Decision|1|||
144614957|NCT00957008|521451954|FG003|Overall Study|Physician Decision|1|||
144614958|NCT00957008|521451951|FG000|Overall Study|Relocated; Family conflict|4|||
144614959|NCT00957008|521451952|FG001|Overall Study|Relocated; Family conflict|1|||
144614960|NCT00957008|521451953|FG002|Overall Study|Relocated; Family conflict|1|||
144614961|NCT00957008|521451954|FG003|Overall Study|Relocated; Family conflict|3|||
144614962|NCT01118351|521451955|FG000|Overall Study|Adverse Event|3|||
144614963|NCT01118351|521451955|FG000|Overall Study|Withdrawal by Subject|1|||
144614964|NCT00811135|521451956|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
144614965|NCT00811135|521451956|FG000|Overall Study|Death|3|||
144614966|NCT00811135|521451956|FG000|Overall Study|Protocol Violation|2|||
144614967|NCT00811135|521451956|FG000|Overall Study|Violation of Selection Criteria|1|||
144614968|NCT00811135|521451956|FG000|Overall Study|Refused Treatment|1|||
144614969|NCT00811135|521451956|FG000|Overall Study|Withdrawal by Subject|3|||
144614970|NCT00811135|521451956|FG000|Overall Study|Administrative/Other Unspecified|11|||
144614971|NCT00811135|521451956|FG000|Overall Study|Ongoing|59|||
144614972|NCT02797808|521451960|FG000|Overall Study|Withdrawal by Subject|1|||
144614973|NCT02797808|521451961|FG001|Overall Study|Withdrawal by Subject|1|||
144614974|NCT02797808|521451960|FG000|Overall Study|Physician Decision|6|||
144614975|NCT02797808|521451961|FG001|Overall Study|Physician Decision|2|||
144614976|NCT02192827|521451962|FG000|Overall Study|Lost to Follow-up|25|||
144614977|NCT02192827|521451963|FG001|Overall Study|Lost to Follow-up|27|||
144614978|NCT02192827|521451962|FG000|Overall Study|Given additional steroids with admission|13|||
144614979|NCT02192827|521451963|FG001|Overall Study|Given additional steroids with admission|11|||
144614980|NCT00845728|521451964|FG000|Overall Study|Abnormal laboratory value (s)|2|||
144614981|NCT00845728|521451965|FG001|Overall Study|Abnormal laboratory value (s)|2|||
144614982|NCT00845728|521451964|FG000|Overall Study|Patient's inability to use the device|4|||
144614983|NCT00845728|521451965|FG001|Overall Study|Patient's inability to use the device|6|||
144614984|NCT00845728|521451964|FG000|Overall Study|Abnormal test procedure result (s)|7|||
144614985|NCT00845728|521451965|FG001|Overall Study|Abnormal test procedure result (s)|2|||
144614986|NCT00845728|521451964|FG000|Overall Study|Lost to Follow-up|22|||
144614987|NCT00845728|521451965|FG001|Overall Study|Lost to Follow-up|13|||
144614988|NCT00845728|521451964|FG000|Overall Study|Death|24|||
144614989|NCT00845728|521451965|FG001|Overall Study|Death|26|||
144614990|NCT00845728|521451964|FG000|Overall Study|Administrative Problems|34|||
144614991|NCT00845728|521451965|FG001|Overall Study|Administrative Problems|26|||
144614992|NCT00845728|521451964|FG000|Overall Study|Protocol Violation|36|||
144614993|NCT00845728|521451965|FG001|Overall Study|Protocol Violation|24|||
144614994|NCT00845728|521451964|FG000|Overall Study|Lack of Efficacy|51|||
144614995|NCT00845728|521451965|FG001|Overall Study|Lack of Efficacy|39|||
144614996|NCT00845728|521451964|FG000|Overall Study|Adverse Event|101|||
144614997|NCT00845728|521451965|FG001|Overall Study|Adverse Event|96|||
144614998|NCT00845728|521451964|FG000|Overall Study|Withdrawal by Subject|105|||
144614999|NCT00845728|521451965|FG001|Overall Study|Withdrawal by Subject|108|||
144615000|NCT00794677|521451970|FG000|First Intervention|Withdrawal by Subject|2|||
144615001|NCT00794677|521451971|FG001|First Intervention|Withdrawal by Subject|0|||
144615002|NCT02863809|521451972|FG000|Overall Study|Adverse Event|8|||
144199713|NCT00302081|519929007|FG002|Overall Study|Other|5|||
144199714|NCT04480710|519929008|FG000|Overall Study|Adverse Event|0|||
144199715|NCT04480710|519929009|FG001|Overall Study|Adverse Event|2|||
144199716|NCT04480710|519929010|FG002|Overall Study|Adverse Event|0|||
144199717|NCT04480710|519929011|FG003|Overall Study|Adverse Event|0|||
144199718|NCT04480710|519929008|FG000|Overall Study|Withdrawal by Subject|0|||
144199719|NCT04480710|519929009|FG001|Overall Study|Withdrawal by Subject|1|||
144199720|NCT04480710|519929010|FG002|Overall Study|Withdrawal by Subject|0|||
144199721|NCT04480710|519929011|FG003|Overall Study|Withdrawal by Subject|0|||
144199722|NCT04480710|519929008|FG000|Overall Study|Physician Decision|0|||
144199723|NCT04480710|519929009|FG001|Overall Study|Physician Decision|0|||
144199724|NCT04480710|519929010|FG002|Overall Study|Physician Decision|1|||
144199725|NCT04480710|519929011|FG003|Overall Study|Physician Decision|0|||
144199726|NCT05084963|519929013|FG000|Overall Study|Withdrawal by Subject|0|||
144199727|NCT05084963|519929014|FG001|Overall Study|Withdrawal by Subject|0|||
144199728|NCT05084963|519929015|FG002|Overall Study|Withdrawal by Subject|1|||
144199729|NCT03569228|519929016|FG000|Overall Study|Withdrawal by PI|0|||
144199730|NCT03569228|519929017|FG001|Overall Study|Withdrawal by PI|0|||
144199731|NCT03569228|519929018|FG002|Overall Study|Withdrawal by PI|2|||
144199732|NCT03569228|519929019|FG003|Overall Study|Withdrawal by PI|2|||
144199733|NCT03569228|519929020|FG004|Overall Study|Withdrawal by PI|1|||
144199734|NCT03569228|519929021|FG005|Overall Study|Withdrawal by PI|0|||
144199735|NCT03569228|519929022|FG006|Overall Study|Withdrawal by PI|0|||
144199736|NCT03569228|519929023|FG007|Overall Study|Withdrawal by PI|0|||
144199737|NCT03569228|519929024|FG008|Overall Study|Withdrawal by PI|0|||
144199738|NCT03569228|519929016|FG000|Overall Study|Lost to Follow-up|0|||
144199739|NCT03569228|519929017|FG001|Overall Study|Lost to Follow-up|0|||
144199740|NCT03569228|519929018|FG002|Overall Study|Lost to Follow-up|0|||
144199741|NCT03569228|519929019|FG003|Overall Study|Lost to Follow-up|0|||
144199742|NCT03569228|519929020|FG004|Overall Study|Lost to Follow-up|0|||
144199743|NCT03569228|519929021|FG005|Overall Study|Lost to Follow-up|0|||
144199744|NCT03569228|519929022|FG006|Overall Study|Lost to Follow-up|0|||
144199745|NCT03569228|519929023|FG007|Overall Study|Lost to Follow-up|0|||
144199746|NCT03569228|519929024|FG008|Overall Study|Lost to Follow-up|1|||
144199747|NCT03569228|519929016|FG000|Overall Study|Screen Fail|2|||
144199748|NCT03569228|519929017|FG001|Overall Study|Screen Fail|2|||
144199749|NCT03569228|519929018|FG002|Overall Study|Screen Fail|1|||
144199750|NCT03569228|519929019|FG003|Overall Study|Screen Fail|1|||
144199751|NCT03569228|519929020|FG004|Overall Study|Screen Fail|1|||
144199752|NCT03569228|519929021|FG005|Overall Study|Screen Fail|3|||
144199753|NCT03569228|519929022|FG006|Overall Study|Screen Fail|1|||
144199754|NCT03569228|519929023|FG007|Overall Study|Screen Fail|5|||
144199755|NCT03569228|519929024|FG008|Overall Study|Screen Fail|2|||
144199756|NCT05442866|519929025|FG000|Overall Study|Death|1|||
144199757|NCT05442866|519929025|FG000|Overall Study|Lost to Follow-up|9|||
144199758|NCT05442866|519929025|FG000|Overall Study|Protocol Violation|1|||
144199759|NCT03819049|519929026|FG000|Overall Study|Lost to Follow-up|1|||
144199760|NCT03819049|519929027|FG001|Overall Study|Lost to Follow-up|2|||
144199761|NCT03819049|519929028|FG002|Overall Study|Lost to Follow-up|9|||
144199762|NCT03819049|519929029|FG003|Overall Study|Lost to Follow-up|0|||
144199763|NCT03819049|519929030|FG004|Overall Study|Lost to Follow-up|3|||
144199764|NCT03819049|519929031|FG005|Overall Study|Lost to Follow-up|1|||
144199765|NCT03819049|519929032|FG006|Overall Study|Lost to Follow-up|0|||
144199766|NCT03819049|519929026|FG000|Overall Study|Withdrawal by Subject|0|||
144199767|NCT03819049|519929027|FG001|Overall Study|Withdrawal by Subject|0|||
144199768|NCT03819049|519929028|FG002|Overall Study|Withdrawal by Subject|18|||
144199769|NCT03819049|519929029|FG003|Overall Study|Withdrawal by Subject|0|||
144199770|NCT03819049|519929030|FG004|Overall Study|Withdrawal by Subject|10|||
144615003|NCT02863809|521451973|FG001|Overall Study|Adverse Event|8|||
144615004|NCT02863809|521451972|FG000|Overall Study|Withdrawal by Subject|0|||
144615005|NCT02863809|521451973|FG001|Overall Study|Withdrawal by Subject|1|||
144615006|NCT02863809|521451972|FG000|Overall Study|Lost to Follow-up|1|||
144615007|NCT02863809|521451973|FG001|Overall Study|Lost to Follow-up|1|||
144615008|NCT02863809|521451972|FG000|Overall Study|Death|1|||
144199771|NCT03819049|519929031|FG005|Overall Study|Withdrawal by Subject|9|||
144199772|NCT03819049|519929032|FG006|Overall Study|Withdrawal by Subject|1|||
144199773|NCT03819049|519929026|FG000|Overall Study|Ongoing|0|||
144199774|NCT03819049|519929027|FG001|Overall Study|Ongoing|0|||
144615009|NCT02863809|521451973|FG001|Overall Study|Death|0|||
144615010|NCT00607386|521451974|FG000|Overall Study|Physician Decision|1|||
144615011|NCT01422915|521451977|FG000|Overall Study|Adverse Event|1|||
144538789|NCT05580003|521174241|FG021|Part 6 Period 2 (Day 1)|Other|0|||
144538790|NCT05580003|521174242|FG022|Part 6 Period 2 (Day 1)|Other|0|||
144538791|NCT05580003|521174243|FG023|Part 6 Period 2 (Day 1)|Other|0|||
144538792|NCT05580003|521174244|FG024|Part 6 Period 2 (Day 1)|Other|1|||
144538793|NCT05580003|521174245|FG025|Part 6 Period 2 (Day 1)|Other|0|||
144538794|NCT05580003|521174246|FG026|Part 6 Period 2 (Day 1)|Other|0|||
144538795|NCT05580003|521174247|FG027|Part 6 Period 2 (Day 1)|Other|0|||
144538796|NCT03500549|521174248|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
144538797|NCT03500549|521174249|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
144538798|NCT03500549|521174248|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
144538799|NCT03500549|521174249|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
144538800|NCT01738438|521174251|FG000|Overall Study|Disease Progression|32|||
144538801|NCT01738438|521174251|FG000|Overall Study|Adverse Event|3|||
144538802|NCT00918203|521174252|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
144538803|NCT00918203|521174253|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
144538804|NCT00918203|521174254|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
144538805|NCT00918203|521174252|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
144538806|NCT00918203|521174253|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
144538807|NCT00918203|521174254|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
144538808|NCT00918203|521174252|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
144538809|NCT00918203|521174253|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
144538810|NCT00918203|521174254|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
144538811|NCT00918203|521174252|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
144538812|NCT00918203|521174253|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
144538813|NCT00918203|521174254|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
144538814|NCT00701701|521174257|FG000|Overall Study|Withdrawal by Subject|0|||
144538815|NCT00701701|521174258|FG001|Overall Study|Withdrawal by Subject|1|||
144538816|NCT00701701|521174257|FG000|Overall Study|Adverse Event|0|||
144538817|NCT00701701|521174258|FG001|Overall Study|Adverse Event|1|||
144538818|NCT00589875|521174259|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
144538819|NCT00589875|521174259|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
144538820|NCT03357952|521174260|FG000|Overall Study|Withdrawal by Subject|0|||
144727296|NCT01318499|521856597|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
144727297|NCT01318499|521856595|FG000|Overall Study|Noncompliance|2|||
144727298|NCT01318499|521856596|FG001|Overall Study|Noncompliance|3|||
144727299|NCT01318499|521856597|FG002|Overall Study|Noncompliance|0|||
144727300|NCT01318499|521856595|FG000|Overall Study|Treatment Failure|19|||
144727301|NCT01318499|521856596|FG001|Overall Study|Treatment Failure|19|||
144727302|NCT01318499|521856597|FG002|Overall Study|Treatment Failure|101|||
144727303|NCT01318499|521856595|FG000|Overall Study|Protocol Violation|2|||
144727304|NCT01318499|521856596|FG001|Overall Study|Protocol Violation|4|||
144727305|NCT01318499|521856597|FG002|Overall Study|Protocol Violation|2|||
144727306|NCT01318499|521856595|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
144727307|NCT01318499|521856596|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
144727308|NCT01318499|521856597|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
144727309|NCT01318499|521856595|FG000|Overall Study|Other|7|||
144727310|NCT01318499|521856596|FG001|Overall Study|Other|10|||
144727311|NCT01318499|521856597|FG002|Overall Study|Other|22|||
144727312|NCT01974141|521856603|FG000|Overall Study|Other Reasons|28|||
144727313|NCT01974141|521856604|FG001|Overall Study|Other Reasons|18|||
144727314|NCT01974141|521856603|FG000|Overall Study|Protocol Violation|2|||
144727315|NCT01974141|521856604|FG001|Overall Study|Protocol Violation|6|||
144727316|NCT01974141|521856603|FG000|Overall Study|Personal Reasons|21|||
144727317|NCT01974141|521856604|FG001|Overall Study|Personal Reasons|20|||
144727318|NCT01974141|521856603|FG000|Overall Study|Lost to Follow-up|38|||
144727319|NCT01974141|521856604|FG001|Overall Study|Lost to Follow-up|29|||
144727320|NCT01974141|521856603|FG000|Overall Study|Pregnancy|3|||
144727321|NCT01974141|521856604|FG001|Overall Study|Pregnancy|3|||
144727322|NCT01974141|521856603|FG000|Overall Study|Lack of Efficacy|0|||
144727323|NCT01974141|521856604|FG001|Overall Study|Lack of Efficacy|1|||
144727324|NCT01974141|521856603|FG000|Overall Study|Adverse Event|4|||
144199775|NCT03819049|519929028|FG002|Overall Study|Ongoing|75|||
144199776|NCT03819049|519929029|FG003|Overall Study|Ongoing|0|||
144199777|NCT03819049|519929030|FG004|Overall Study|Ongoing|41|||
144199778|NCT03819049|519929031|FG005|Overall Study|Ongoing|0|||
144199779|NCT03819049|519929032|FG006|Overall Study|Ongoing|0|||
144727325|NCT01974141|521856604|FG001|Overall Study|Adverse Event|5|||
144727326|NCT04028843|521856607|FG000|Overall Study|Lost to Follow-up|32|||
144727327|NCT04028843|521856608|FG001|Overall Study|Lost to Follow-up|39|||
144199780|NCT03819049|519929026|FG000|Overall Study|Other|0|||
144199781|NCT03819049|519929027|FG001|Overall Study|Other|0|||
144538821|NCT03357952|521174261|FG001|Overall Study|Withdrawal by Subject|1|||
144538822|NCT03357952|521174260|FG000|Overall Study|Sponsor Decision|9|||
144538823|NCT03357952|521174261|FG001|Overall Study|Sponsor Decision|0|||
144538824|NCT03280030|521174262|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
144727328|NCT04028843|521856607|FG000|Overall Study|Adverse Event|1|||
144538825|NCT03280030|521174263|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
144538826|NCT03280030|521174264|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
144538827|NCT03280030|521174262|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
144260344|NCT03428100|520154515|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260345|NCT03428100|520154516|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260346|NCT03428100|520154517|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260347|NCT03428100|520154518|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144538828|NCT03280030|521174263|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
144538829|NCT03280030|521174264|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
144538830|NCT03280030|521174262|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
144538831|NCT03280030|521174263|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
144538832|NCT03280030|521174264|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
144538833|NCT03280030|521174262|FG000|Part 2 - Efficacy|Adverse Event|0|||
144538834|NCT03280030|521174263|FG001|Part 2 - Efficacy|Adverse Event|4|||
144538835|NCT03280030|521174264|FG002|Part 2 - Efficacy|Adverse Event|6|||
144538836|NCT03280030|521174262|FG000|Part 2 - Efficacy|Death|0|||
144538837|NCT03280030|521174263|FG001|Part 2 - Efficacy|Death|3|||
144538838|NCT03280030|521174264|FG002|Part 2 - Efficacy|Death|0|||
144538839|NCT03280030|521174262|FG000|Part 2 - Efficacy|Physician Decision|0|||
144538840|NCT03280030|521174263|FG001|Part 2 - Efficacy|Physician Decision|10|||
144538841|NCT03280030|521174264|FG002|Part 2 - Efficacy|Physician Decision|16|||
144538842|NCT03280030|521174262|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
144538843|NCT03280030|521174263|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
144538844|NCT03280030|521174264|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
144538845|NCT03280030|521174262|FG000|Part 2 - Efficacy|Progressive disease|0|||
144538846|NCT03280030|521174263|FG001|Part 2 - Efficacy|Progressive disease|7|||
144260348|NCT03428100|520154519|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144538847|NCT03280030|521174264|FG002|Part 2 - Efficacy|Progressive disease|5|||
144538848|NCT06056310|521175637|FG000|Overall Study|Other Reasons|2|||
144538849|NCT06056310|521175637|FG000|Overall Study|Sponsor Request|16|||
144538850|NCT02633215|521175646|FG000|Overall Study|Lost to Follow-up|2|||
144538851|NCT02633215|521175647|FG001|Overall Study|Lost to Follow-up|3|||
144538852|NCT00754325|521175648|FG000|Initial Treatment|Continuing Active Treatment|4|||
144538853|NCT00754325|521175649|FG001|Initial Treatment|Continuing Active Treatment|5|||
144538854|NCT00754325|521175648|FG000|Initial Treatment|Adverse Event|7|||
144538855|NCT00754325|521175649|FG001|Initial Treatment|Adverse Event|6|||
144538856|NCT00754325|521175648|FG000|Initial Treatment|Withdrawal by Subject|2|||
144538857|NCT00754325|521175649|FG001|Initial Treatment|Withdrawal by Subject|2|||
144538858|NCT00754325|521175648|FG000|Initial Treatment|Physician Decision|2|||
144538859|NCT00754325|521175649|FG001|Initial Treatment|Physician Decision|0|||
144538860|NCT00754325|521175648|FG000|Initial Treatment|Sponsor Request|0|||
144538861|NCT00754325|521175649|FG001|Initial Treatment|Sponsor Request|1|||
144538862|NCT00754325|521175648|FG000|Initial Treatment|Disease Progression|35|||
144538863|NCT00754325|521175649|FG001|Initial Treatment|Disease Progression|35|||
144538864|NCT03442777|521175650|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
144538865|NCT03442777|521175651|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
144538866|NCT03442777|521175652|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
144538867|NCT00890591|521175653|FG000|Overall Study|Lack of Efficacy|20|||
144538868|NCT01436175|521175654|FG000|Overall Study|Adverse Event|111|||
144538869|NCT01436175|521175654|FG000|Overall Study|Protocol Violation|49|||
144538870|NCT01436175|521175654|FG000|Overall Study|Withdrawal by Subject|108|||
144538871|NCT01436175|521175654|FG000|Overall Study|Lost to Follow-up|89|||
144538872|NCT01436175|521175654|FG000|Overall Study|Lack of Efficacy|24|||
144538873|NCT01436175|521175654|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
144538874|NCT01436175|521175654|FG000|Overall Study|Other|826|||
144538875|NCT05405244|521175655|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
144538876|NCT05405244|521175656|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
144260349|NCT03428100|520154520|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260350|NCT03428100|520154521|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260351|NCT03428100|520154522|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144538877|NCT05405244|521175655|FG000|Washout (2 Weeks)|Adverse Event|2|||
144538878|NCT05405244|521175656|FG001|Washout (2 Weeks)|Adverse Event|0|||
144538879|NCT05405244|521175655|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
144538880|NCT05405244|521175656|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
144538881|NCT00263757|521175657|FG000|Overall Study|Withdrawal by Subject|5|||
144538882|NCT00263757|521175658|FG001|Overall Study|Withdrawal by Subject|4|||
144538883|NCT00263757|521175657|FG000|Overall Study|Screen failure|0|||
144538884|NCT00263757|521175658|FG001|Overall Study|Screen failure|1|||
144538885|NCT00263757|521175657|FG000|Overall Study|Adverse Event|3|||
144538886|NCT00263757|521175658|FG001|Overall Study|Adverse Event|3|||
144538887|NCT02101775|521175662|FG000|Overall Study|Adverse Event|4|||
144538888|NCT02101775|521175663|FG001|Overall Study|Adverse Event|0|||
144538889|NCT02101775|521175664|FG002|Overall Study|Adverse Event|0|||
144538890|NCT02101775|521175662|FG000|Overall Study|Admission to Hospital|0|||
144538891|NCT02101775|521175663|FG001|Overall Study|Admission to Hospital|1|||
144538892|NCT02101775|521175664|FG002|Overall Study|Admission to Hospital|0|||
144538893|NCT00503906|521175665|FG000|Overall Study|Withdrawal by Subject|1|||
144538894|NCT01499849|521175666|FG000|Overall Study|Adverse Event|28|||
144538895|NCT01499849|521175667|FG001|Overall Study|Adverse Event|32|||
144538896|NCT01499849|521175666|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
144538897|NCT01499849|521175667|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
144538898|NCT01499849|521175666|FG000|Overall Study|Withdrawal by Subject|43|||
144538899|NCT01499849|521175667|FG001|Overall Study|Withdrawal by Subject|43|||
144538900|NCT01499849|521175666|FG000|Overall Study|Death|5|||
144538901|NCT01499849|521175667|FG001|Overall Study|Death|7|||
144538902|NCT01499849|521175666|FG000|Overall Study|Disease Progression|11|||
144538903|NCT01499849|521175667|FG001|Overall Study|Disease Progression|10|||
144727329|NCT04028843|521856608|FG001|Overall Study|Adverse Event|0|||
144727330|NCT04028843|521856607|FG000|Overall Study|Non-viable Pregnancy|0|||
144727331|NCT04028843|521856608|FG001|Overall Study|Non-viable Pregnancy|1|||
144727332|NCT04028843|521856607|FG000|Overall Study|Withdrawal by Subject|4|||
144727333|NCT04028843|521856608|FG001|Overall Study|Withdrawal by Subject|2|||
144199782|NCT03819049|519929028|FG002|Overall Study|Other|2|||
144538904|NCT01499849|521175666|FG000|Overall Study|Protocol Violation|11|||
144538905|NCT01499849|521175667|FG001|Overall Study|Protocol Violation|11|||
144538906|NCT01499849|521175666|FG000|Overall Study|Physician Decision|20|||
144538907|NCT01499849|521175667|FG001|Overall Study|Physician Decision|19|||
144538908|NCT01499849|521175666|FG000|Overall Study|Lack of Efficacy|3|||
144538909|NCT01499849|521175667|FG001|Overall Study|Lack of Efficacy|4|||
144538910|NCT01499849|521175666|FG000|Overall Study|Lost to Follow-up|6|||
144538911|NCT01499849|521175667|FG001|Overall Study|Lost to Follow-up|3|||
144538912|NCT01499849|521175666|FG000|Overall Study|Other Reasons|27|||
144538913|NCT01499849|521175667|FG001|Overall Study|Other Reasons|30|||
144538914|NCT00174252|521175668|FG000|Overall Study|Protocol Violation|2|||
144538915|NCT00622700|521175674|FG000|Core Treatment Period|Randomized but Not Treated|0|||
144538916|NCT00622700|521175675|FG001|Core Treatment Period|Randomized but Not Treated|2|||
144538917|NCT00622700|521175676|FG002|Core Treatment Period|Randomized but Not Treated|2|||
144538918|NCT00622700|521175677|FG003|Core Treatment Period|Randomized but Not Treated|0|||
144538919|NCT00622700|521175678|FG004|Core Treatment Period|Randomized but Not Treated|0|||
144538920|NCT00622700|521175679|FG005|Core Treatment Period|Randomized but Not Treated|0|||
144538921|NCT00622700|521175680|FG006|Core Treatment Period|Randomized but Not Treated|0|||
144538922|NCT00622700|521175674|FG000|Core Treatment Period|Adverse Event|18|||
144538923|NCT00622700|521175675|FG001|Core Treatment Period|Adverse Event|25|||
144538924|NCT00622700|521175676|FG002|Core Treatment Period|Adverse Event|18|||
144538925|NCT00622700|521175677|FG003|Core Treatment Period|Adverse Event|0|||
144538926|NCT00622700|521175678|FG004|Core Treatment Period|Adverse Event|0|||
144538927|NCT00622700|521175679|FG005|Core Treatment Period|Adverse Event|0|||
144538928|NCT00622700|521175680|FG006|Core Treatment Period|Adverse Event|0|||
144538929|NCT00622700|521175674|FG000|Core Treatment Period|Lack of Efficacy|19|||
144538930|NCT00622700|521175675|FG001|Core Treatment Period|Lack of Efficacy|6|||
144538931|NCT00622700|521175676|FG002|Core Treatment Period|Lack of Efficacy|12|||
144538932|NCT00622700|521175677|FG003|Core Treatment Period|Lack of Efficacy|0|||
144538933|NCT00622700|521175678|FG004|Core Treatment Period|Lack of Efficacy|0|||
144538934|NCT00622700|521175679|FG005|Core Treatment Period|Lack of Efficacy|0|||
144538935|NCT00622700|521175680|FG006|Core Treatment Period|Lack of Efficacy|0|||
144538936|NCT00622700|521175674|FG000|Core Treatment Period|Lost to Follow-up|1|||
144538937|NCT00622700|521175675|FG001|Core Treatment Period|Lost to Follow-up|1|||
144538938|NCT00622700|521175676|FG002|Core Treatment Period|Lost to Follow-up|1|||
144538939|NCT00622700|521175677|FG003|Core Treatment Period|Lost to Follow-up|0|||
144538940|NCT00622700|521175678|FG004|Core Treatment Period|Lost to Follow-up|0|||
144538941|NCT00622700|521175679|FG005|Core Treatment Period|Lost to Follow-up|0|||
144538942|NCT00622700|521175680|FG006|Core Treatment Period|Lost to Follow-up|0|||
144538943|NCT00622700|521175674|FG000|Core Treatment Period|Death|1|||
144538944|NCT00622700|521175675|FG001|Core Treatment Period|Death|0|||
144538945|NCT00622700|521175676|FG002|Core Treatment Period|Death|0|||
144199783|NCT03819049|519929029|FG003|Overall Study|Other|0|||
144538946|NCT00622700|521175677|FG003|Core Treatment Period|Death|0|||
144538947|NCT00622700|521175678|FG004|Core Treatment Period|Death|0|||
144538948|NCT00622700|521175679|FG005|Core Treatment Period|Death|0|||
144538949|NCT00622700|521175680|FG006|Core Treatment Period|Death|0|||
144538950|NCT00622700|521175674|FG000|Core Treatment Period|Progressive Disease|3|||
144538951|NCT00622700|521175675|FG001|Core Treatment Period|Progressive Disease|1|||
144538952|NCT00622700|521175676|FG002|Core Treatment Period|Progressive Disease|0|||
144727334|NCT04977336|521856609|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
144199784|NCT03819049|519929030|FG004|Overall Study|Other|0|||
144538953|NCT00622700|521175677|FG003|Core Treatment Period|Progressive Disease|0|||
144538954|NCT00622700|521175678|FG004|Core Treatment Period|Progressive Disease|0|||
144538955|NCT00622700|521175679|FG005|Core Treatment Period|Progressive Disease|0|||
144538956|NCT00622700|521175680|FG006|Core Treatment Period|Progressive Disease|0|||
144538957|NCT00622700|521175674|FG000|Core Treatment Period|Withdrawal by Subject|12|||
144538958|NCT00622700|521175675|FG001|Core Treatment Period|Withdrawal by Subject|18|||
144538959|NCT00622700|521175676|FG002|Core Treatment Period|Withdrawal by Subject|15|||
144538960|NCT00622700|521175677|FG003|Core Treatment Period|Withdrawal by Subject|0|||
144538961|NCT00622700|521175678|FG004|Core Treatment Period|Withdrawal by Subject|0|||
144538962|NCT00622700|521175679|FG005|Core Treatment Period|Withdrawal by Subject|0|||
144538963|NCT00622700|521175680|FG006|Core Treatment Period|Withdrawal by Subject|0|||
144615012|NCT01265797|521451978|FG000|Run-in Month|Withdrawal by Subject|0|||
144615013|NCT01265797|521451979|FG001|Run-in Month|Withdrawal by Subject|4|||
144615014|NCT01265797|521451978|FG000|Run-in Month|1st seizure during run-in month|0|||
144615015|NCT01265797|521451979|FG001|Run-in Month|1st seizure during run-in month|1|||
144615016|NCT01265797|521451978|FG000|Blinded Month|Lack of Efficacy|5|||
144199785|NCT03819049|519929031|FG005|Overall Study|Other|0|||
144199786|NCT03819049|519929032|FG006|Overall Study|Other|0|||
144199787|NCT03819049|519929026|FG000|Overall Study|Randomized but not vaccinated|0|||
144199788|NCT03819049|519929027|FG001|Overall Study|Randomized but not vaccinated|0|||
144199789|NCT03819049|519929028|FG002|Overall Study|Randomized but not vaccinated|0|||
144199790|NCT03819049|519929029|FG003|Overall Study|Randomized but not vaccinated|1|||
144199791|NCT03819049|519929030|FG004|Overall Study|Randomized but not vaccinated|0|||
144199792|NCT03819049|519929031|FG005|Overall Study|Randomized but not vaccinated|2|||
144199793|NCT03819049|519929032|FG006|Overall Study|Randomized but not vaccinated|1|||
144199794|NCT03819049|519929026|FG000|Overall Study|Physician Decision|0|||
144199795|NCT03819049|519929027|FG001|Overall Study|Physician Decision|0|||
144199796|NCT03819049|519929028|FG002|Overall Study|Physician Decision|0|||
144199797|NCT03819049|519929029|FG003|Overall Study|Physician Decision|0|||
144199798|NCT03819049|519929030|FG004|Overall Study|Physician Decision|0|||
144199799|NCT03819049|519929031|FG005|Overall Study|Physician Decision|0|||
144199800|NCT03819049|519929032|FG006|Overall Study|Physician Decision|1|||
144199801|NCT01616953|519929033|FG000|Overall Study|Lost to Follow-up|1|||
144199802|NCT01616953|519929034|FG001|Overall Study|Lost to Follow-up|0|||
144199803|NCT01616953|519929033|FG000|Overall Study|lack of bone and soft tissue|1|||
144199804|NCT01616953|519929034|FG001|Overall Study|lack of bone and soft tissue|0|||
144199805|NCT01568320|519929035|FG000|Overall Study|Death|20|||
144199806|NCT01568320|519929035|FG000|Overall Study|Lost to Follow-up|9|||
144199807|NCT01568320|519929035|FG000|Overall Study|Withdrawal by Subject|10|||
144199808|NCT01568320|519929035|FG000|Overall Study|Conversion to open repair|1|||
144199809|NCT01568320|519929035|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
144199810|NCT01970865|519929040|FG000|Overall Study|Death|3|||
144199811|NCT01970865|519929041|FG001|Overall Study|Death|2|||
144199812|NCT01970865|519929042|FG002|Overall Study|Death|3|||
144199813|NCT01970865|519929043|FG003|Overall Study|Death|6|||
144199814|NCT01970865|519929044|FG004|Overall Study|Death|9|||
144199815|NCT01970865|519929045|FG005|Overall Study|Death|3|||
144199816|NCT01970865|519929046|FG006|Overall Study|Death|2|||
144199817|NCT01970865|519929047|FG007|Overall Study|Death|3|||
144199818|NCT01970865|519929048|FG008|Overall Study|Death|2|||
144199819|NCT01970865|519929049|FG009|Overall Study|Death|2|||
144199820|NCT01970865|519929050|FG010|Overall Study|Death|8|||
144199821|NCT01970865|519929051|FG011|Overall Study|Death|13|||
144199822|NCT01970865|519929052|FG012|Overall Study|Death|25|||
144199823|NCT01970865|519929053|FG013|Overall Study|Death|46|||
144199824|NCT01970865|519929054|FG014|Overall Study|Death|37|||
144199825|NCT01970865|519929055|FG015|Overall Study|Death|22|||
144199826|NCT01970865|519929056|FG016|Overall Study|Death|1|||
144199827|NCT01970865|519929057|FG017|Overall Study|Death|17|||
144199828|NCT01970865|519929040|FG000|Overall Study|Lost to Follow-up|0|||
144199829|NCT01970865|519929041|FG001|Overall Study|Lost to Follow-up|0|||
144199830|NCT01970865|519929042|FG002|Overall Study|Lost to Follow-up|0|||
144199831|NCT01970865|519929043|FG003|Overall Study|Lost to Follow-up|1|||
144538964|NCT00622700|521175674|FG000|Core Treatment Period|Other than specified above|2|||
144538965|NCT00622700|521175675|FG001|Core Treatment Period|Other than specified above|2|||
144615017|NCT01265797|521451979|FG001|Blinded Month|Lack of Efficacy|0|||
144615018|NCT01265797|521451978|FG000|Blinded Month|Lost to Follow-up|1|||
144615019|NCT01265797|521451979|FG001|Blinded Month|Lost to Follow-up|0|||
144615020|NCT01265797|521451978|FG000|Blinded Month|Protocol Violation|2|||
144199832|NCT01970865|519929044|FG004|Overall Study|Lost to Follow-up|1|||
144199833|NCT01970865|519929045|FG005|Overall Study|Lost to Follow-up|0|||
144199834|NCT01970865|519929046|FG006|Overall Study|Lost to Follow-up|0|||
144199835|NCT01970865|519929047|FG007|Overall Study|Lost to Follow-up|0|||
144199836|NCT01970865|519929048|FG008|Overall Study|Lost to Follow-up|0|||
144199837|NCT01970865|519929049|FG009|Overall Study|Lost to Follow-up|0|||
144260352|NCT03428100|520154523|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144615021|NCT01265797|521451979|FG001|Blinded Month|Protocol Violation|1|||
144199838|NCT01970865|519929050|FG010|Overall Study|Lost to Follow-up|1|||
144199839|NCT01970865|519929051|FG011|Overall Study|Lost to Follow-up|0|||
144199840|NCT01970865|519929052|FG012|Overall Study|Lost to Follow-up|2|||
144199841|NCT01970865|519929053|FG013|Overall Study|Lost to Follow-up|0|||
144199842|NCT01970865|519929054|FG014|Overall Study|Lost to Follow-up|1|||
144199843|NCT01970865|519929055|FG015|Overall Study|Lost to Follow-up|4|||
144538966|NCT00622700|521175676|FG002|Core Treatment Period|Other than specified above|5|||
144538967|NCT00622700|521175677|FG003|Core Treatment Period|Other than specified above|0|||
144538968|NCT00622700|521175678|FG004|Core Treatment Period|Other than specified above|0|||
144538969|NCT00622700|521175679|FG005|Core Treatment Period|Other than specified above|0|||
144538970|NCT00622700|521175680|FG006|Core Treatment Period|Other than specified above|0|||
144538971|NCT00622700|521175674|FG000|Extension Treatment Period|Adverse Event|0|||
144727335|NCT04977336|521856610|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
144727336|NCT04977336|521856611|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
144727337|NCT04977336|521856612|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
144727338|NCT04977336|521856613|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
144727339|NCT04977336|521856609|FG000|Overall Study|Lost to Follow-up|0|||
144727340|NCT04977336|521856610|FG001|Overall Study|Lost to Follow-up|0|||
144727341|NCT04977336|521856611|FG002|Overall Study|Lost to Follow-up|1|||
144727342|NCT04977336|521856612|FG003|Overall Study|Lost to Follow-up|0|||
144727343|NCT04977336|521856613|FG004|Overall Study|Lost to Follow-up|0|||
144727344|NCT03298451|521856614|FG000|Overall Study|Death|275|||
144727345|NCT03298451|521856615|FG001|Overall Study|Death|260|||
144538972|NCT00622700|521175675|FG001|Extension Treatment Period|Adverse Event|0|||
144538973|NCT00622700|521175676|FG002|Extension Treatment Period|Adverse Event|0|||
144538974|NCT00622700|521175677|FG003|Extension Treatment Period|Adverse Event|5|||
144538975|NCT00622700|521175678|FG004|Extension Treatment Period|Adverse Event|9|||
144538976|NCT00622700|521175679|FG005|Extension Treatment Period|Adverse Event|6|||
144538977|NCT00622700|521175680|FG006|Extension Treatment Period|Adverse Event|8|||
144538978|NCT00622700|521175674|FG000|Extension Treatment Period|Lack of Efficacy|0|||
144538979|NCT00622700|521175675|FG001|Extension Treatment Period|Lack of Efficacy|0|||
144538980|NCT00622700|521175676|FG002|Extension Treatment Period|Lack of Efficacy|0|||
144538981|NCT00622700|521175677|FG003|Extension Treatment Period|Lack of Efficacy|2|||
144538982|NCT00622700|521175678|FG004|Extension Treatment Period|Lack of Efficacy|8|||
144538983|NCT00622700|521175679|FG005|Extension Treatment Period|Lack of Efficacy|1|||
144538984|NCT00622700|521175680|FG006|Extension Treatment Period|Lack of Efficacy|9|||
144538985|NCT00622700|521175674|FG000|Extension Treatment Period|Protocol Violation|0|||
144538986|NCT00622700|521175675|FG001|Extension Treatment Period|Protocol Violation|0|||
144538987|NCT00622700|521175676|FG002|Extension Treatment Period|Protocol Violation|0|||
144538988|NCT00622700|521175677|FG003|Extension Treatment Period|Protocol Violation|0|||
144538989|NCT00622700|521175678|FG004|Extension Treatment Period|Protocol Violation|0|||
144538990|NCT00622700|521175679|FG005|Extension Treatment Period|Protocol Violation|2|||
144538991|NCT00622700|521175680|FG006|Extension Treatment Period|Protocol Violation|0|||
144538992|NCT00622700|521175674|FG000|Extension Treatment Period|Lost to Follow-up|0|||
144727346|NCT03298451|521856616|FG002|Overall Study|Death|122|||
144727347|NCT03298451|521856617|FG003|Overall Study|Death|280|||
144727348|NCT03298451|521856614|FG000|Overall Study|Lost to Follow-up|1|||
144727349|NCT03298451|521856615|FG001|Overall Study|Lost to Follow-up|1|||
144727350|NCT03298451|521856616|FG002|Overall Study|Lost to Follow-up|0|||
144727351|NCT03298451|521856617|FG003|Overall Study|Lost to Follow-up|7|||
144727352|NCT03298451|521856614|FG000|Overall Study|Withdrawal by Subject|9|||
144727353|NCT03298451|521856615|FG001|Overall Study|Withdrawal by Subject|7|||
144727354|NCT03298451|521856616|FG002|Overall Study|Withdrawal by Subject|1|||
144727355|NCT03298451|521856617|FG003|Overall Study|Withdrawal by Subject|20|||
144727356|NCT01347710|521856618|FG000|Overall Study|Withdrawal by Subject|2|||
144727357|NCT01347710|521856618|FG000|Overall Study|Adverse Event|4|||
144727358|NCT01347710|521856618|FG000|Overall Study|Angio or SPECT not completed|18|||
144727359|NCT01347710|521856618|FG000|Overall Study|issue with vitals prior to dosing|1|||
144727360|NCT01347710|521856618|FG000|Overall Study|Lost to Follow-up|1|||
144727361|NCT01347710|521856618|FG000|Overall Study|Physician Decision|2|||
144260353|NCT03428100|520154524|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144538993|NCT00622700|521175675|FG001|Extension Treatment Period|Lost to Follow-up|0|||
144538994|NCT00622700|521175676|FG002|Extension Treatment Period|Lost to Follow-up|0|||
144538995|NCT00622700|521175677|FG003|Extension Treatment Period|Lost to Follow-up|0|||
144538996|NCT00622700|521175678|FG004|Extension Treatment Period|Lost to Follow-up|1|||
144538997|NCT00622700|521175679|FG005|Extension Treatment Period|Lost to Follow-up|0|||
144538998|NCT00622700|521175680|FG006|Extension Treatment Period|Lost to Follow-up|0|||
144538999|NCT00622700|521175674|FG000|Extension Treatment Period|Progressive Disease|0|||
144539000|NCT00622700|521175675|FG001|Extension Treatment Period|Progressive Disease|0|||
144539001|NCT00622700|521175676|FG002|Extension Treatment Period|Progressive Disease|0|||
144539002|NCT00622700|521175677|FG003|Extension Treatment Period|Progressive Disease|1|||
144727362|NCT01347710|521856618|FG000|Overall Study|Other|3|||
144727363|NCT04591626|521856620|FG000|Overall Study|Adverse Event|4|||
144727364|NCT04591626|521856621|FG001|Overall Study|Adverse Event|0|||
144539003|NCT00622700|521175678|FG004|Extension Treatment Period|Progressive Disease|2|||
144539004|NCT00622700|521175679|FG005|Extension Treatment Period|Progressive Disease|0|||
144727365|NCT04591626|521856620|FG000|Overall Study|Withdrawal by Subject|5|||
144727366|NCT04591626|521856621|FG001|Overall Study|Withdrawal by Subject|3|||
144727367|NCT04591626|521856620|FG000|Overall Study|Physician Decision|0|||
144727368|NCT04591626|521856621|FG001|Overall Study|Physician Decision|1|||
144472254|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
144472255|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
144199844|NCT01970865|519929056|FG016|Overall Study|Lost to Follow-up|0|||
144199845|NCT01970865|519929057|FG017|Overall Study|Lost to Follow-up|1|||
144199846|NCT01970865|519929040|FG000|Overall Study|Other|0|||
144199847|NCT01970865|519929041|FG001|Overall Study|Other|1|||
144199848|NCT01970865|519929042|FG002|Overall Study|Other|0|||
144199849|NCT01970865|519929043|FG003|Overall Study|Other|1|||
144199850|NCT01970865|519929044|FG004|Overall Study|Other|1|||
144199851|NCT01970865|519929045|FG005|Overall Study|Other|0|||
144199852|NCT01970865|519929046|FG006|Overall Study|Other|1|||
144199853|NCT01970865|519929047|FG007|Overall Study|Other|0|||
144199854|NCT01970865|519929048|FG008|Overall Study|Other|0|||
144199855|NCT01970865|519929049|FG009|Overall Study|Other|0|||
144199856|NCT01970865|519929050|FG010|Overall Study|Other|2|||
144199857|NCT01970865|519929051|FG011|Overall Study|Other|3|||
144199858|NCT01970865|519929052|FG012|Overall Study|Other|8|||
144199859|NCT01970865|519929053|FG013|Overall Study|Other|3|||
144199860|NCT01970865|519929054|FG014|Overall Study|Other|2|||
144199861|NCT01970865|519929055|FG015|Overall Study|Other|3|||
144199862|NCT01970865|519929056|FG016|Overall Study|Other|0|||
144199863|NCT01970865|519929057|FG017|Overall Study|Other|2|||
144199864|NCT01970865|519929040|FG000|Overall Study|Participant refused further follow-up|0|||
144199865|NCT01970865|519929041|FG001|Overall Study|Participant refused further follow-up|0|||
144199866|NCT01970865|519929042|FG002|Overall Study|Participant refused further follow-up|0|||
144199867|NCT01970865|519929043|FG003|Overall Study|Participant refused further follow-up|2|||
144199868|NCT01970865|519929044|FG004|Overall Study|Participant refused further follow-up|3|||
144199869|NCT01970865|519929045|FG005|Overall Study|Participant refused further follow-up|0|||
144199870|NCT01970865|519929046|FG006|Overall Study|Participant refused further follow-up|0|||
144199871|NCT01970865|519929047|FG007|Overall Study|Participant refused further follow-up|0|||
144199872|NCT01970865|519929048|FG008|Overall Study|Participant refused further follow-up|0|||
144199873|NCT01970865|519929049|FG009|Overall Study|Participant refused further follow-up|0|||
144199874|NCT01970865|519929050|FG010|Overall Study|Participant refused further follow-up|1|||
144199875|NCT01970865|519929051|FG011|Overall Study|Participant refused further follow-up|4|||
144199876|NCT01970865|519929052|FG012|Overall Study|Participant refused further follow-up|7|||
144199877|NCT01970865|519929053|FG013|Overall Study|Participant refused further follow-up|8|||
144199878|NCT01970865|519929054|FG014|Overall Study|Participant refused further follow-up|3|||
144199879|NCT01970865|519929055|FG015|Overall Study|Participant refused further follow-up|11|||
144199880|NCT01970865|519929056|FG016|Overall Study|Participant refused further follow-up|0|||
144199881|NCT01970865|519929057|FG017|Overall Study|Participant refused further follow-up|6|||
144199882|NCT01946191|519929058|FG000|Allocation|Did not complete orientation|1|||
144199883|NCT01946191|519929059|FG001|Allocation|Did not complete orientation|1|||
144199884|NCT01946191|519929058|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
144199885|NCT01946191|519929059|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
144199886|NCT01946191|519929058|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
144199887|NCT01946191|519929059|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
144199888|NCT01946191|519929058|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
144199889|NCT01946191|519929059|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
144199890|NCT02041091|519929060|FG000|Treatment|Adverse Event|3|||
144199891|NCT02041091|519929061|FG001|Treatment|Adverse Event|3|||
144199892|NCT02041091|519929060|FG000|Treatment|Withdrawal by Subject|2|||
144199893|NCT02041091|519929061|FG001|Treatment|Withdrawal by Subject|4|||
144199894|NCT02041091|519929060|FG000|Treatment|Physician Decision|1|||
144199895|NCT02041091|519929061|FG001|Treatment|Physician Decision|0|||
144199896|NCT02041091|519929060|FG000|Treatment|Sponsor Decision|15|||
144199897|NCT02041091|519929061|FG001|Treatment|Sponsor Decision|16|||
144199898|NCT02041091|519929060|FG000|Treatment|Lost to Follow-up|1|||
144199899|NCT02041091|519929061|FG001|Treatment|Lost to Follow-up|0|||
144199900|NCT02041091|519929060|FG000|Optional Safety Extension Period|Adverse Event|4|||
144199901|NCT02041091|519929061|FG001|Optional Safety Extension Period|Adverse Event|2|||
144199902|NCT02041091|519929060|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
144472256|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
144472257|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
144199903|NCT02041091|519929061|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
144199904|NCT02041091|519929060|FG000|Optional Safety Extension Period|Protocol Violation|2|||
144199905|NCT02041091|519929061|FG001|Optional Safety Extension Period|Protocol Violation|0|||
144199906|NCT02041091|519929060|FG000|Optional Safety Extension Period|Physician Decision|2|||
144199907|NCT02041091|519929061|FG001|Optional Safety Extension Period|Physician Decision|1|||
144199908|NCT02041091|519929060|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
144199909|NCT02041091|519929061|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
144199910|NCT02041091|519929060|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
144199911|NCT02041091|519929061|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
144199912|NCT01855074|519929062|FG000|Overall Study|Adverse Event|1|||
144199913|NCT01855074|519929062|FG000|Overall Study|Lost to Follow-up|4|||
144472258|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
144472259|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
144472260|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
144472261|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
144472262|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
144472263|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
144472264|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
144472265|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
144472266|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
144472267|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
144472268|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
144472269|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
144472270|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
144472271|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
144472272|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
144472273|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
144472274|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
144472275|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
144472276|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
144472277|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
144472278|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
144472279|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
144472280|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
144472281|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
144472282|NCT04711603|520926726|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
144472283|NCT04711603|520926727|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
144472284|NCT04711603|520926728|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
144472285|NCT04711603|520926729|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
144472286|NCT04252742|520926732|FG000|Overall Study|Decision by sponsor|0|||
144472287|NCT04252742|520926733|FG001|Overall Study|Decision by sponsor|2|||
144472288|NCT04252742|520926732|FG000|Overall Study|Withdrawal by Subject|15|||
144472289|NCT04252742|520926733|FG001|Overall Study|Withdrawal by Subject|9|||
144472290|NCT04252742|520926732|FG000|Overall Study|Lost to Follow-up|0|||
144472291|NCT04252742|520926733|FG001|Overall Study|Lost to Follow-up|1|||
144472292|NCT04179032|520926734|FG000|Part B (Up to Week 52)|Adverse Event|1|||
144472293|NCT04179032|520926734|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
144472294|NCT04179032|520926734|FG000|Access Extension Phase|Ongoing|11|||
144472295|NCT00459342|520926742|FG000|Overall Study|Not eligible|1|||
144472296|NCT02686034|520926743|FG000|Run-In Period 1|Eligibility|12|||
144472297|NCT02686034|520926744|FG001|Run-In Period 1|Eligibility|10|||
144472298|NCT02686034|520926743|FG000|Run-In Period 1|Withdrawal by Subject|4|||
144472299|NCT02686034|520926744|FG001|Run-In Period 1|Withdrawal by Subject|3|||
144472300|NCT02686034|520926743|FG000|Run-In Period 1|Lost to Follow-up|4|||
144472301|NCT02686034|520926744|FG001|Run-In Period 1|Lost to Follow-up|4|||
144472302|NCT02686034|520926743|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
144472303|NCT02686034|520926744|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
144472304|NCT02686034|520926743|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
144472305|NCT02686034|520926744|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
144472306|NCT02686034|520926743|FG000|Randomized Controlled Period 2|Adverse Event|0|||
144199914|NCT01855074|519929062|FG000|Overall Study|Withdrawal by Subject|8|||
144199915|NCT01855074|519929062|FG000|Overall Study|Started but not treated|1|||
144199916|NCT01602965|519929063|FG000|Overall Study|Lost to Follow-up|4|||
144199917|NCT01602965|519929064|FG001|Overall Study|Lost to Follow-up|2|||
144199918|NCT01150890|519929065|FG000|Overall Study|Other|0|||
144199919|NCT01150890|519929066|FG001|Overall Study|Other|1|||
144199920|NCT01150890|519929067|FG002|Overall Study|Other|0|||
144199921|NCT01150890|519929068|FG003|Overall Study|Other|2|||
144199922|NCT01150890|519929065|FG000|Overall Study|Pregnancy|0|||
144199923|NCT01150890|519929066|FG001|Overall Study|Pregnancy|0|||
144199924|NCT01150890|519929067|FG002|Overall Study|Pregnancy|0|||
144199925|NCT01150890|519929068|FG003|Overall Study|Pregnancy|1|||
144199926|NCT01150890|519929065|FG000|Overall Study|Administrative Decision|4|||
144199927|NCT01150890|519929066|FG001|Overall Study|Administrative Decision|4|||
144199928|NCT01150890|519929067|FG002|Overall Study|Administrative Decision|5|||
144199929|NCT01150890|519929068|FG003|Overall Study|Administrative Decision|6|||
144199930|NCT01150890|519929065|FG000|Overall Study|Ineligibility determined|0|||
144472307|NCT02686034|520926744|FG001|Randomized Controlled Period 2|Adverse Event|2|||
144615022|NCT01265797|521451978|FG000|Blinded Month|Adverse Event|2|||
144199931|NCT01150890|519929066|FG001|Overall Study|Ineligibility determined|1|||
144539005|NCT00622700|521175680|FG006|Extension Treatment Period|Progressive Disease|2|||
144539006|NCT00622700|521175674|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
144539007|NCT00622700|521175675|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
144539008|NCT00622700|521175676|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
144539009|NCT00622700|521175677|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
144539010|NCT00622700|521175678|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
144539011|NCT00622700|521175679|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
144539012|NCT00622700|521175680|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
144260354|NCT03428100|520154525|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260355|NCT03428100|520154526|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
144260356|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260357|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260358|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260359|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260360|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260361|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
144260362|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
144260363|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
144260364|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
144260365|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260366|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
144260367|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144539013|NCT00622700|521175674|FG000|Extension Treatment Period|Missing|0|||
144539014|NCT00622700|521175675|FG001|Extension Treatment Period|Missing|0|||
144539015|NCT00622700|521175676|FG002|Extension Treatment Period|Missing|0|||
144260368|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
144260369|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
144260370|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
144260371|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
144260372|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
144260373|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260374|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
144260375|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
144260376|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
144260377|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
144260378|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
144260379|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
144260380|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
144260381|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
144260382|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
144539016|NCT00622700|521175677|FG003|Extension Treatment Period|Missing|2|||
144539017|NCT00622700|521175678|FG004|Extension Treatment Period|Missing|3|||
144539018|NCT00622700|521175679|FG005|Extension Treatment Period|Missing|1|||
144539019|NCT00622700|521175680|FG006|Extension Treatment Period|Missing|0|||
144539020|NCT00622700|521175674|FG000|Extension Treatment Period|Other than specified above|0|||
144539021|NCT00622700|521175675|FG001|Extension Treatment Period|Other than specified above|0|||
144539022|NCT00622700|521175676|FG002|Extension Treatment Period|Other than specified above|0|||
144539023|NCT00622700|521175677|FG003|Extension Treatment Period|Other than specified above|0|||
144539024|NCT00622700|521175678|FG004|Extension Treatment Period|Other than specified above|0|||
144539025|NCT00622700|521175679|FG005|Extension Treatment Period|Other than specified above|1|||
144539026|NCT00622700|521175680|FG006|Extension Treatment Period|Other than specified above|1|||
144539027|NCT00942266|521175681|FG000|Overall Study|Withdrawal by Subject|1|||
144539028|NCT00942266|521175682|FG001|Overall Study|Withdrawal by Subject|0|||
144539029|NCT00942266|521175681|FG000|Overall Study|Adverse Event|2|||
144539030|NCT00942266|521175682|FG001|Overall Study|Adverse Event|1|||
144539031|NCT00942266|521175681|FG000|Overall Study|Disease Progression|38|||
144539032|NCT00942266|521175682|FG001|Overall Study|Disease Progression|11|||
144539033|NCT00942266|521175681|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
144539034|NCT00942266|521175682|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
144539035|NCT00942266|521175681|FG000|Overall Study|Intercurrent illness|0|||
144539036|NCT00942266|521175682|FG001|Overall Study|Intercurrent illness|1|||
144539037|NCT00942266|521175681|FG000|Overall Study|Physician Decision|2|||
144539038|NCT00942266|521175682|FG001|Overall Study|Physician Decision|0|||
144539039|NCT00942266|521175681|FG000|Overall Study|medical deterioration (pneumonia)|0|||
144260383|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
144260384|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
144539040|NCT00942266|521175682|FG001|Overall Study|medical deterioration (pneumonia)|1|||
144539041|NCT04035447|521175689|FG000|Treatment Period|Lost to Follow-up|6|||
144539042|NCT04035447|521175690|FG001|Treatment Period|Lost to Follow-up|5|||
144539043|NCT04035447|521175689|FG000|Treatment Period|Physician Decision|0|||
144539044|NCT04035447|521175690|FG001|Treatment Period|Physician Decision|2|||
144539045|NCT02029235|521175691|FG000|Overall Study|Non-compliance with study meds or diary|4|||
144539046|NCT02029235|521175692|FG001|Overall Study|Non-compliance with study meds or diary|1|||
144539047|NCT04337931|521175695|FG000|Overall Study|Death|4|||
144539048|NCT04337931|521175696|FG001|Overall Study|Death|1|||
144539049|NCT04337931|521175697|FG002|Overall Study|Death|7|||
144539050|NCT04337931|521175695|FG000|Overall Study|Withdrawal by Subject|0|||
144539051|NCT04337931|521175696|FG001|Overall Study|Withdrawal by Subject|1|||
144539052|NCT04337931|521175697|FG002|Overall Study|Withdrawal by Subject|0|||
144539053|NCT04337931|521175695|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
144539054|NCT04337931|521175696|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
144615023|NCT01265797|521451979|FG001|Blinded Month|Adverse Event|0|||
144615024|NCT01265797|521451978|FG000|Blinded Month|Diary data incomplete|0|||
144199932|NCT01150890|519929067|FG002|Overall Study|Ineligibility determined|0|||
144199933|NCT01150890|519929068|FG003|Overall Study|Ineligibility determined|0|||
144199934|NCT01150890|519929065|FG000|Overall Study|Adverse Event|0|||
144199935|NCT01150890|519929066|FG001|Overall Study|Adverse Event|0|||
144199936|NCT01150890|519929067|FG002|Overall Study|Adverse Event|2|||
144199937|NCT01150890|519929068|FG003|Overall Study|Adverse Event|0|||
144199938|NCT01150890|519929065|FG000|Overall Study|Withdrawal by Subject|0|||
144199939|NCT01150890|519929066|FG001|Overall Study|Withdrawal by Subject|0|||
144199940|NCT01150890|519929067|FG002|Overall Study|Withdrawal by Subject|2|||
144199941|NCT01150890|519929068|FG003|Overall Study|Withdrawal by Subject|1|||
144199942|NCT01150890|519929065|FG000|Overall Study|Disease progression|0|||
144199943|NCT01150890|519929066|FG001|Overall Study|Disease progression|7|||
144199944|NCT01150890|519929067|FG002|Overall Study|Disease progression|3|||
144199945|NCT01150890|519929068|FG003|Overall Study|Disease progression|7|||
144199946|NCT03118570|519929069|FG000|Overall Study|Adverse Event|2|||
144199947|NCT03118570|519929070|FG001|Overall Study|Adverse Event|0|||
144199948|NCT03118570|519929071|FG002|Overall Study|Adverse Event|0|||
144199949|NCT03118570|519929072|FG003|Overall Study|Adverse Event|0|||
144199950|NCT03118570|519929073|FG004|Overall Study|Adverse Event|3|||
144199951|NCT03118570|519929069|FG000|Overall Study|Withdrawal by Subject|0|||
144199952|NCT03118570|519929070|FG001|Overall Study|Withdrawal by Subject|1|||
144199953|NCT03118570|519929071|FG002|Overall Study|Withdrawal by Subject|4|||
144199954|NCT03118570|519929072|FG003|Overall Study|Withdrawal by Subject|0|||
144199955|NCT03118570|519929073|FG004|Overall Study|Withdrawal by Subject|1|||
144199956|NCT03118570|519929069|FG000|Overall Study|Lost to Follow-up|2|||
144199957|NCT03118570|519929070|FG001|Overall Study|Lost to Follow-up|3|||
144199958|NCT03118570|519929071|FG002|Overall Study|Lost to Follow-up|1|||
144199959|NCT03118570|519929072|FG003|Overall Study|Lost to Follow-up|0|||
144199960|NCT03118570|519929073|FG004|Overall Study|Lost to Follow-up|1|||
144199961|NCT03118570|519929069|FG000|Overall Study|Other, Not Specified|1|||
144199962|NCT03118570|519929070|FG001|Overall Study|Other, Not Specified|3|||
144199963|NCT03118570|519929071|FG002|Overall Study|Other, Not Specified|0|||
144199964|NCT03118570|519929072|FG003|Overall Study|Other, Not Specified|0|||
144199965|NCT03118570|519929073|FG004|Overall Study|Other, Not Specified|0|||
144199966|NCT03071094|519929074|FG000|Overall Study|Death|1|||
144199967|NCT03071094|519929075|FG001|Overall Study|Death|1|||
144199968|NCT03071094|519929074|FG000|Overall Study|Adverse Event|1|||
144199969|NCT03071094|519929075|FG001|Overall Study|Adverse Event|0|||
144199970|NCT02312063|519929076|FG000|Overall Study|Withdrawal by Subject|0|||
144199971|NCT02312063|519929077|FG001|Overall Study|Withdrawal by Subject|1|||
144199972|NCT01195272|519929083|FG000|Overall Study|Adverse Event|1|||
144199973|NCT01195272|519929083|FG000|Overall Study|Lack of Efficacy|3|||
144199974|NCT06218823|519931537|FG000|Overall Study|Death|3|||
144199975|NCT06218823|519931538|FG001|Overall Study|Death|0|||
144199976|NCT06218823|519931537|FG000|Overall Study|Lost to Follow-up|0|||
144199977|NCT06218823|519931538|FG001|Overall Study|Lost to Follow-up|2|||
144199978|NCT04732221|519931539|FG000|Base Period|Death|2|||
144199979|NCT04732221|519931540|FG001|Base Period|Death|0|||
144199980|NCT04732221|519931541|FG002|Base Period|Death|0|||
144539055|NCT04337931|521175697|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
144539056|NCT04337931|521175695|FG000|Overall Study|Study terminated by sponsor|3|||
144615025|NCT01265797|521451979|FG001|Blinded Month|Diary data incomplete|1|||
144199981|NCT04732221|519931542|FG003|Base Period|Death|0|||
144199982|NCT04732221|519931543|FG004|Base Period|Death|0|||
144615026|NCT01265797|521451978|FG000|Open Label Month|Lost to Follow-up|0|||
144199983|NCT04732221|519931544|FG005|Base Period|Death|0|||
144199984|NCT04732221|519931545|FG006|Base Period|Death|0|||
144199985|NCT04732221|519931539|FG000|Base Period|Withdrawal by Subject|0|||
144199986|NCT04732221|519931540|FG001|Base Period|Withdrawal by Subject|1|||
144199987|NCT04732221|519931541|FG002|Base Period|Withdrawal by Subject|1|||
144199988|NCT04732221|519931542|FG003|Base Period|Withdrawal by Subject|0|||
144615027|NCT01265797|521451979|FG001|Open Label Month|Lost to Follow-up|1|||
144199989|NCT04732221|519931543|FG004|Base Period|Withdrawal by Subject|0|||
144199990|NCT04732221|519931544|FG005|Base Period|Withdrawal by Subject|0|||
144199991|NCT04732221|519931545|FG006|Base Period|Withdrawal by Subject|0|||
144539057|NCT04337931|521175696|FG001|Overall Study|Study terminated by sponsor|6|||
144539058|NCT04337931|521175697|FG002|Overall Study|Study terminated by sponsor|2|||
144539059|NCT04337931|521175695|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
144539060|NCT04337931|521175696|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
144539061|NCT04337931|521175697|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
144539062|NCT04337931|521175695|FG000|Overall Study|Colorectal cancer treatment|1|||
144199992|NCT04732221|519931539|FG000|Extension Period|Adverse Event|0|||
144199993|NCT04732221|519931540|FG001|Extension Period|Adverse Event|0|||
144199994|NCT04732221|519931541|FG002|Extension Period|Adverse Event|0|||
144199995|NCT04732221|519931542|FG003|Extension Period|Adverse Event|0|||
144199996|NCT04732221|519931543|FG004|Extension Period|Adverse Event|0|||
144199997|NCT04732221|519931544|FG005|Extension Period|Adverse Event|1|||
144199998|NCT04732221|519931545|FG006|Extension Period|Adverse Event|0|||
144199999|NCT04732221|519931539|FG000|Extension Period|Death|0|||
144200000|NCT04732221|519931540|FG001|Extension Period|Death|0|||
144200001|NCT04732221|519931541|FG002|Extension Period|Death|0|||
144200002|NCT04732221|519931542|FG003|Extension Period|Death|0|||
144200003|NCT04732221|519931543|FG004|Extension Period|Death|1|||
144200004|NCT04732221|519931544|FG005|Extension Period|Death|0|||
144200005|NCT04732221|519931545|FG006|Extension Period|Death|2|||
144200006|NCT04732221|519931539|FG000|Extension Period|Pregnancy|0|||
144200007|NCT04732221|519931540|FG001|Extension Period|Pregnancy|0|||
144200008|NCT04732221|519931541|FG002|Extension Period|Pregnancy|0|||
144200009|NCT04732221|519931542|FG003|Extension Period|Pregnancy|0|||
144200010|NCT04732221|519931543|FG004|Extension Period|Pregnancy|1|||
144539063|NCT04337931|521175696|FG001|Overall Study|Colorectal cancer treatment|0|||
144539064|NCT04337931|521175697|FG002|Overall Study|Colorectal cancer treatment|0|||
144539065|NCT04337931|521175695|FG000|Overall Study|Participant decision|0|||
144539066|NCT04337931|521175696|FG001|Overall Study|Participant decision|1|||
144539067|NCT04337931|521175697|FG002|Overall Study|Participant decision|0|||
144539068|NCT04436289|521175698|FG000|Overall Study|Death prior to hospital discharge|8|||
144539069|NCT04436289|521175699|FG001|Overall Study|Death prior to hospital discharge|5|||
144539070|NCT04436289|521175700|FG002|Overall Study|Death prior to hospital discharge|0|||
144539071|NCT04436289|521175701|FG003|Overall Study|Death prior to hospital discharge|1|||
144539072|NCT04436289|521175698|FG000|Overall Study|Withdrawal by Subject|0|||
144539073|NCT04436289|521175699|FG001|Overall Study|Withdrawal by Subject|1|||
144539074|NCT04436289|521175700|FG002|Overall Study|Withdrawal by Subject|4|||
144539075|NCT04436289|521175701|FG003|Overall Study|Withdrawal by Subject|0|||
144539076|NCT04436289|521175698|FG000|Overall Study|Extended hospital stay|0|||
144539077|NCT04436289|521175699|FG001|Overall Study|Extended hospital stay|1|||
144539078|NCT04436289|521175700|FG002|Overall Study|Extended hospital stay|0|||
144539079|NCT04436289|521175701|FG003|Overall Study|Extended hospital stay|0|||
144539080|NCT04436289|521175698|FG000|Overall Study|Lost to Follow-up|0|||
144539081|NCT04436289|521175699|FG001|Overall Study|Lost to Follow-up|4|||
144539082|NCT04436289|521175700|FG002|Overall Study|Lost to Follow-up|1|||
144539083|NCT04436289|521175701|FG003|Overall Study|Lost to Follow-up|3|||
144539084|NCT02928172|521175702|FG000|Overall Study|Device did not record data|1|||
144539085|NCT01532999|521175703|FG000|Overall Study|Lost to Follow-up|14|||
144539086|NCT01532999|521175704|FG001|Overall Study|Lost to Follow-up|8|||
144539087|NCT01532999|521175703|FG000|Overall Study|Physician Decision|1|||
144539088|NCT01532999|521175704|FG001|Overall Study|Physician Decision|2|||
144539089|NCT01532999|521175703|FG000|Overall Study|Withdrawal by Subject|5|||
144539090|NCT01532999|521175704|FG001|Overall Study|Withdrawal by Subject|0|||
144539091|NCT01532999|521175703|FG000|Overall Study|Relocated|2|||
144539092|NCT01532999|521175704|FG001|Overall Study|Relocated|0|||
144539093|NCT01532999|521175703|FG000|Overall Study|should not have been randomized|1|||
144539094|NCT01532999|521175704|FG001|Overall Study|should not have been randomized|0|||
144539095|NCT01532999|521175703|FG000|Overall Study|substantial noncompliance|2|||
144539096|NCT01532999|521175704|FG001|Overall Study|substantial noncompliance|0|||
144200011|NCT04732221|519931544|FG005|Extension Period|Pregnancy|0|||
144200012|NCT04732221|519931545|FG006|Extension Period|Pregnancy|0|||
144200013|NCT04732221|519931539|FG000|Extension Period|Sponsors Decision|0|||
144727369|NCT04591626|521856620|FG000|Overall Study|Death|0|||
144200014|NCT04732221|519931540|FG001|Extension Period|Sponsors Decision|0|||
144200015|NCT04732221|519931541|FG002|Extension Period|Sponsors Decision|0|||
144200016|NCT04732221|519931542|FG003|Extension Period|Sponsors Decision|0|||
144200017|NCT04732221|519931543|FG004|Extension Period|Sponsors Decision|41|||
144200018|NCT04732221|519931544|FG005|Extension Period|Sponsors Decision|40|||
144200019|NCT04732221|519931545|FG006|Extension Period|Sponsors Decision|40|||
144200020|NCT04732221|519931539|FG000|Extension Period|Withdrawal by Subject|0|||
144539097|NCT01532999|521175703|FG000|Overall Study|no show for week 9 assessments|6|||
144539098|NCT01532999|521175704|FG001|Overall Study|no show for week 9 assessments|4|||
144539099|NCT01532999|521175703|FG000|Overall Study|Adverse Event|0|||
144539100|NCT01532999|521175704|FG001|Overall Study|Adverse Event|1|||
144539101|NCT01532999|521175703|FG000|Overall Study|incarcerated|0|||
144539102|NCT01532999|521175704|FG001|Overall Study|incarcerated|1|||
144539103|NCT01532999|521175703|FG000|Overall Study|New job|0|||
144539104|NCT01532999|521175704|FG001|Overall Study|New job|2|||
144727370|NCT04591626|521856621|FG001|Overall Study|Death|1|||
144200021|NCT04732221|519931540|FG001|Extension Period|Withdrawal by Subject|0|||
144200022|NCT04732221|519931541|FG002|Extension Period|Withdrawal by Subject|0|||
144200023|NCT04732221|519931542|FG003|Extension Period|Withdrawal by Subject|0|||
144200024|NCT04732221|519931543|FG004|Extension Period|Withdrawal by Subject|1|||
144200025|NCT04732221|519931544|FG005|Extension Period|Withdrawal by Subject|5|||
144200026|NCT04732221|519931545|FG006|Extension Period|Withdrawal by Subject|2|||
144200027|NCT04385277|519931546|FG000|Overall Study|Physician Decision|2|||
144200028|NCT04385277|519931546|FG000|Overall Study|Ineligible|1|||
144200029|NCT04385277|519931546|FG000|Overall Study|Patient/Parent Refusal|2|||
144200030|NCT00461253|519931550|FG000|Overall Study|Death|985|||
144200031|NCT00461253|519931551|FG001|Overall Study|Death|0|||
144200032|NCT00461253|519931550|FG000|Overall Study|Protocol Violation|613|||
144200033|NCT00461253|519931551|FG001|Overall Study|Protocol Violation|236|||
144200034|NCT00461253|519931550|FG000|Overall Study|no response|2609|||
144200035|NCT00461253|519931551|FG001|Overall Study|no response|11789|||
144200036|NCT00461253|519931550|FG000|Overall Study|administrative|773|||
144200037|NCT00461253|519931551|FG001|Overall Study|administrative|7773|||
144200038|NCT02799095|519931552|FG000|Part A|Adverse Event|1|||
144200039|NCT02799095|519931553|FG001|Part A|Adverse Event|0|||
144200040|NCT02799095|519931554|FG002|Part A|Adverse Event|1|||
144200041|NCT02799095|519931555|FG003|Part A|Adverse Event|4|||
144200042|NCT02799095|519931556|FG004|Part A|Adverse Event|1|||
144200043|NCT02799095|519931557|FG005|Part A|Adverse Event|0|||
144200044|NCT02799095|519931558|FG006|Part A|Adverse Event|0|||
144200045|NCT02799095|519931559|FG007|Part A|Adverse Event|0|||
144200046|NCT02799095|519931560|FG008|Part A|Adverse Event|0|||
144200047|NCT02799095|519931561|FG009|Part A|Adverse Event|0|||
144200048|NCT02799095|519931562|FG010|Part A|Adverse Event|0|||
144200049|NCT02799095|519931563|FG011|Part A|Adverse Event|0|||
144200050|NCT02799095|519931564|FG012|Part A|Adverse Event|0|||
144200051|NCT02799095|519931565|FG013|Part A|Adverse Event|0|||
144200052|NCT02799095|519931566|FG014|Part A|Adverse Event|0|||
144200053|NCT02799095|519931567|FG015|Part A|Adverse Event|0|||
144200054|NCT02799095|519931568|FG016|Part A|Adverse Event|0|||
144200055|NCT02799095|519931552|FG000|Part A|Death|0|||
144200056|NCT02799095|519931553|FG001|Part A|Death|0|||
144200057|NCT02799095|519931554|FG002|Part A|Death|0|||
144200058|NCT02799095|519931555|FG003|Part A|Death|0|||
144200059|NCT02799095|519931556|FG004|Part A|Death|0|||
144200060|NCT02799095|519931557|FG005|Part A|Death|0|||
144200061|NCT02799095|519931558|FG006|Part A|Death|3|||
144200062|NCT02799095|519931559|FG007|Part A|Death|0|||
144200063|NCT02799095|519931560|FG008|Part A|Death|0|||
144200064|NCT02799095|519931561|FG009|Part A|Death|0|||
144200065|NCT02799095|519931562|FG010|Part A|Death|0|||
144200066|NCT02799095|519931563|FG011|Part A|Death|0|||
144200067|NCT02799095|519931564|FG012|Part A|Death|0|||
144200068|NCT02799095|519931565|FG013|Part A|Death|0|||
144200069|NCT02799095|519931566|FG014|Part A|Death|0|||
144200070|NCT02799095|519931567|FG015|Part A|Death|0|||
144200071|NCT02799095|519931568|FG016|Part A|Death|0|||
144200072|NCT02799095|519931552|FG000|Part A|Lost to Follow-up|0|||
144200073|NCT02799095|519931553|FG001|Part A|Lost to Follow-up|1|||
144200074|NCT02799095|519931554|FG002|Part A|Lost to Follow-up|0|||
144200075|NCT02799095|519931555|FG003|Part A|Lost to Follow-up|0|||
144200076|NCT02799095|519931556|FG004|Part A|Lost to Follow-up|0|||
144200077|NCT02799095|519931557|FG005|Part A|Lost to Follow-up|0|||
144200078|NCT02799095|519931558|FG006|Part A|Lost to Follow-up|1|||
144200079|NCT02799095|519931559|FG007|Part A|Lost to Follow-up|0|||
144200080|NCT02799095|519931560|FG008|Part A|Lost to Follow-up|0|||
144200081|NCT02799095|519931561|FG009|Part A|Lost to Follow-up|0|||
144200082|NCT02799095|519931562|FG010|Part A|Lost to Follow-up|0|||
144472308|NCT02686034|520926743|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
144472309|NCT02686034|520926744|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
144200083|NCT02799095|519931563|FG011|Part A|Lost to Follow-up|0|||
144200084|NCT02799095|519931564|FG012|Part A|Lost to Follow-up|0|||
144200085|NCT02799095|519931565|FG013|Part A|Lost to Follow-up|0|||
144200086|NCT02799095|519931566|FG014|Part A|Lost to Follow-up|0|||
144200087|NCT02799095|519931567|FG015|Part A|Lost to Follow-up|0|||
144472310|NCT02686034|520926743|FG000|Open Label Period 3|Lost to Follow-up|0|||
144200088|NCT02799095|519931568|FG016|Part A|Lost to Follow-up|0|||
144200089|NCT02799095|519931552|FG000|Part A|Progressive Disease|3|||
144200090|NCT02799095|519931553|FG001|Part A|Progressive Disease|3|||
144200091|NCT02799095|519931554|FG002|Part A|Progressive Disease|3|||
144200092|NCT02799095|519931555|FG003|Part A|Progressive Disease|2|||
144200093|NCT02799095|519931556|FG004|Part A|Progressive Disease|2|||
144200094|NCT02799095|519931557|FG005|Part A|Progressive Disease|0|||
144472311|NCT02686034|520926744|FG001|Open Label Period 3|Lost to Follow-up|1|||
144200095|NCT02799095|519931558|FG006|Part A|Progressive Disease|0|||
144200096|NCT02799095|519931559|FG007|Part A|Progressive Disease|0|||
144200097|NCT02799095|519931560|FG008|Part A|Progressive Disease|0|||
144200098|NCT02799095|519931561|FG009|Part A|Progressive Disease|0|||
144200099|NCT02799095|519931562|FG010|Part A|Progressive Disease|0|||
144200100|NCT02799095|519931563|FG011|Part A|Progressive Disease|0|||
144200101|NCT02799095|519931564|FG012|Part A|Progressive Disease|0|||
144200102|NCT02799095|519931565|FG013|Part A|Progressive Disease|0|||
144200103|NCT02799095|519931566|FG014|Part A|Progressive Disease|0|||
144200104|NCT02799095|519931567|FG015|Part A|Progressive Disease|0|||
144200105|NCT02799095|519931568|FG016|Part A|Progressive Disease|0|||
144200106|NCT02799095|519931552|FG000|Part A|Clinical Progression|1|||
144200107|NCT02799095|519931553|FG001|Part A|Clinical Progression|0|||
144200108|NCT02799095|519931554|FG002|Part A|Clinical Progression|2|||
144200109|NCT02799095|519931555|FG003|Part A|Clinical Progression|1|||
144200110|NCT02799095|519931556|FG004|Part A|Clinical Progression|5|||
144200111|NCT02799095|519931557|FG005|Part A|Clinical Progression|0|||
144200112|NCT02799095|519931558|FG006|Part A|Clinical Progression|0|||
144200113|NCT02799095|519931559|FG007|Part A|Clinical Progression|0|||
144200114|NCT02799095|519931560|FG008|Part A|Clinical Progression|0|||
144200115|NCT02799095|519931561|FG009|Part A|Clinical Progression|0|||
144200116|NCT02799095|519931562|FG010|Part A|Clinical Progression|0|||
144200117|NCT02799095|519931563|FG011|Part A|Clinical Progression|0|||
144200118|NCT02799095|519931564|FG012|Part A|Clinical Progression|0|||
144200119|NCT02799095|519931565|FG013|Part A|Clinical Progression|0|||
144200120|NCT02799095|519931566|FG014|Part A|Clinical Progression|0|||
144200121|NCT02799095|519931567|FG015|Part A|Clinical Progression|0|||
144200122|NCT02799095|519931568|FG016|Part A|Clinical Progression|0|||
144200123|NCT02799095|519931552|FG000|Part A|Protocol Deviation|0|||
144200124|NCT02799095|519931553|FG001|Part A|Protocol Deviation|0|||
144200125|NCT02799095|519931554|FG002|Part A|Protocol Deviation|1|||
144200126|NCT02799095|519931555|FG003|Part A|Protocol Deviation|0|||
144200127|NCT02799095|519931556|FG004|Part A|Protocol Deviation|0|||
144200128|NCT02799095|519931557|FG005|Part A|Protocol Deviation|0|||
144200129|NCT02799095|519931558|FG006|Part A|Protocol Deviation|0|||
144200130|NCT02799095|519931559|FG007|Part A|Protocol Deviation|0|||
144200131|NCT02799095|519931560|FG008|Part A|Protocol Deviation|0|||
144200132|NCT02799095|519931561|FG009|Part A|Protocol Deviation|0|||
144200133|NCT02799095|519931562|FG010|Part A|Protocol Deviation|0|||
144200134|NCT02799095|519931563|FG011|Part A|Protocol Deviation|0|||
144200135|NCT02799095|519931564|FG012|Part A|Protocol Deviation|0|||
144200136|NCT02799095|519931565|FG013|Part A|Protocol Deviation|0|||
144200137|NCT02799095|519931566|FG014|Part A|Protocol Deviation|0|||
144200138|NCT02799095|519931567|FG015|Part A|Protocol Deviation|0|||
144200139|NCT02799095|519931568|FG016|Part A|Protocol Deviation|0|||
144200140|NCT02799095|519931552|FG000|Part A|Withdrawal by Subject|0|||
144200141|NCT02799095|519931553|FG001|Part A|Withdrawal by Subject|0|||
144200142|NCT02799095|519931554|FG002|Part A|Withdrawal by Subject|0|||
144200143|NCT02799095|519931555|FG003|Part A|Withdrawal by Subject|1|||
144200144|NCT02799095|519931556|FG004|Part A|Withdrawal by Subject|3|||
144200145|NCT02799095|519931557|FG005|Part A|Withdrawal by Subject|1|||
144200146|NCT02799095|519931558|FG006|Part A|Withdrawal by Subject|1|||
144200147|NCT02799095|519931559|FG007|Part A|Withdrawal by Subject|0|||
144200148|NCT02799095|519931560|FG008|Part A|Withdrawal by Subject|0|||
144200149|NCT02799095|519931561|FG009|Part A|Withdrawal by Subject|0|||
144200150|NCT02799095|519931562|FG010|Part A|Withdrawal by Subject|0|||
144200151|NCT02799095|519931563|FG011|Part A|Withdrawal by Subject|0|||
144200152|NCT02799095|519931564|FG012|Part A|Withdrawal by Subject|0|||
144200153|NCT02799095|519931565|FG013|Part A|Withdrawal by Subject|0|||
144200154|NCT02799095|519931566|FG014|Part A|Withdrawal by Subject|0|||
144200155|NCT02799095|519931567|FG015|Part A|Withdrawal by Subject|0|||
144200156|NCT02799095|519931568|FG016|Part A|Withdrawal by Subject|0|||
144200157|NCT02799095|519931552|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
144200158|NCT02799095|519931553|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
144200159|NCT02799095|519931554|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
144200160|NCT02799095|519931555|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
144200161|NCT02799095|519931556|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
144200162|NCT02799095|519931557|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
144200163|NCT02799095|519931558|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
144200164|NCT02799095|519931559|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
144200165|NCT02799095|519931560|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
144200166|NCT02799095|519931561|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
144200167|NCT02799095|519931562|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
144200168|NCT02799095|519931563|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
144200169|NCT02799095|519931564|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
144200170|NCT02799095|519931565|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
144200171|NCT02799095|519931566|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
144200172|NCT02799095|519931567|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
144200173|NCT02799095|519931568|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
144200174|NCT02799095|519931552|FG000|Part B|Death|0|||
144200175|NCT02799095|519931553|FG001|Part B|Death|0|||
144200176|NCT02799095|519931554|FG002|Part B|Death|0|||
144200177|NCT02799095|519931555|FG003|Part B|Death|0|||
144200178|NCT02799095|519931556|FG004|Part B|Death|0|||
144200179|NCT02799095|519931557|FG005|Part B|Death|0|||
144200180|NCT02799095|519931558|FG006|Part B|Death|0|||
144200181|NCT02799095|519931559|FG007|Part B|Death|7|||
144200182|NCT02799095|519931560|FG008|Part B|Death|7|||
144200183|NCT02799095|519931561|FG009|Part B|Death|0|||
144200184|NCT02799095|519931562|FG010|Part B|Death|0|||
144200185|NCT02799095|519931563|FG011|Part B|Death|0|||
144260385|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
144260386|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
144260387|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
144260388|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
144260389|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
144260390|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
144260391|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
144260392|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
144260393|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
144260394|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
144260395|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
144260396|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
144260397|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
144260398|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
144260399|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
144260400|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
144260401|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
144260402|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
144260403|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
144260404|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
144260405|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
144260406|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
144260407|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
144260408|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
144260409|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
144260410|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
144260411|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
144260412|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
144260413|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260414|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260415|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260416|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260417|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260418|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260419|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260420|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
144260421|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260422|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260423|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260424|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
144615028|NCT00879645|521451980|FG000|Overall Study|Adverse Event|1|||
144615029|NCT00879645|521451981|FG001|Overall Study|Adverse Event|0|||
144200186|NCT02799095|519931564|FG012|Part B|Death|0|||
144200187|NCT02799095|519931565|FG013|Part B|Death|0|||
144200188|NCT02799095|519931566|FG014|Part B|Death|0|||
144200189|NCT02799095|519931567|FG015|Part B|Death|0|||
144200190|NCT02799095|519931568|FG016|Part B|Death|0|||
144200191|NCT02799095|519931552|FG000|Part B|Progressive Disease|0|||
144200192|NCT02799095|519931553|FG001|Part B|Progressive Disease|0|||
144200193|NCT02799095|519931554|FG002|Part B|Progressive Disease|0|||
144200194|NCT02799095|519931555|FG003|Part B|Progressive Disease|0|||
144200195|NCT02799095|519931556|FG004|Part B|Progressive Disease|0|||
144200196|NCT02799095|519931557|FG005|Part B|Progressive Disease|0|||
144200197|NCT02799095|519931558|FG006|Part B|Progressive Disease|0|||
144200198|NCT02799095|519931559|FG007|Part B|Progressive Disease|1|||
144200199|NCT02799095|519931560|FG008|Part B|Progressive Disease|0|||
144200200|NCT02799095|519931561|FG009|Part B|Progressive Disease|0|||
144200201|NCT02799095|519931562|FG010|Part B|Progressive Disease|0|||
144200202|NCT02799095|519931563|FG011|Part B|Progressive Disease|0|||
144200203|NCT02799095|519931564|FG012|Part B|Progressive Disease|0|||
144200204|NCT02799095|519931565|FG013|Part B|Progressive Disease|0|||
144200205|NCT02799095|519931566|FG014|Part B|Progressive Disease|0|||
144200206|NCT02799095|519931567|FG015|Part B|Progressive Disease|0|||
144200207|NCT02799095|519931568|FG016|Part B|Progressive Disease|0|||
144260425|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
144472312|NCT00542880|520926745|FG000|Period 1|Eligibility criteria not fulfilled|2|||
144472313|NCT00542880|520926746|FG001|Period 1|Eligibility criteria not fulfilled|6|||
144615030|NCT00879645|521451982|FG002|Overall Study|Adverse Event|0|||
144200208|NCT02799095|519931552|FG000|Part B|Withdrawal by Subject|0|||
144200209|NCT02799095|519931553|FG001|Part B|Withdrawal by Subject|0|||
144200210|NCT02799095|519931554|FG002|Part B|Withdrawal by Subject|0|||
144200211|NCT02799095|519931555|FG003|Part B|Withdrawal by Subject|0|||
144260426|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144260427|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
144260428|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144539105|NCT02408887|521175705|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
144539106|NCT02408887|521175706|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
144539107|NCT02408887|521175705|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
144539108|NCT02408887|521175706|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
144539109|NCT03333109|521175707|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
144539110|NCT03333109|521175708|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
144539111|NCT03333109|521175709|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
144539112|NCT03333109|521175707|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144539113|NCT03333109|521175708|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
144539114|NCT03333109|521175709|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
144539115|NCT03333109|521175707|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
144539116|NCT03333109|521175708|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
144539117|NCT03333109|521175709|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
144539118|NCT03333109|521175707|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
144539119|NCT03333109|521175708|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
144539120|NCT03333109|521175709|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
144539121|NCT03333109|521175707|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
144539122|NCT03333109|521175708|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
144539123|NCT03333109|521175709|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
144539124|NCT03333109|521175707|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
144539125|NCT03333109|521175708|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
144539126|NCT03333109|521175709|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
144539127|NCT03333109|521175707|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
144539128|NCT03333109|521175708|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
144539129|NCT03333109|521175709|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
144539130|NCT03333109|521175707|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
144539131|NCT03333109|521175708|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
144539132|NCT03333109|521175709|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
144539133|NCT02016872|521175713|FG000|Overall Study|Withdrawal by Subject|10|||
144539134|NCT02016872|521175713|FG000|Overall Study|Death Progression|2|||
144539135|NCT02016872|521175713|FG000|Overall Study|No FMISO scan|1|||
144539136|NCT02016872|521175713|FG000|Overall Study|Ineligible|2|||
144539137|NCT03160885|521175716|FG000|Initial Treatment Period|Not dosed|2|||
144539138|NCT03160885|521175717|FG001|Initial Treatment Period|Not dosed|0|||
144539139|NCT03160885|521175718|FG002|Initial Treatment Period|Not dosed|0|||
144539140|NCT03160885|521175719|FG003|Initial Treatment Period|Not dosed|0|||
144539141|NCT03160885|521175720|FG004|Initial Treatment Period|Not dosed|0|||
144539142|NCT03160885|521175721|FG005|Initial Treatment Period|Not dosed|0|||
144539143|NCT03160885|521175722|FG006|Initial Treatment Period|Not dosed|0|||
144539144|NCT03160885|521175716|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
144539145|NCT03160885|521175717|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
144539146|NCT03160885|521175718|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144539147|NCT03160885|521175719|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144539148|NCT03160885|521175720|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144539149|NCT03160885|521175721|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144539150|NCT03160885|521175722|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
144539151|NCT03160885|521175716|FG000|Open-label Treatment|Not dosed|0|||
144539152|NCT03160885|521175717|FG001|Open-label Treatment|Not dosed|0|||
144539153|NCT03160885|521175718|FG002|Open-label Treatment|Not dosed|0|||
144539154|NCT03160885|521175719|FG003|Open-label Treatment|Not dosed|0|||
144539155|NCT03160885|521175720|FG004|Open-label Treatment|Not dosed|0|||
144539156|NCT03160885|521175721|FG005|Open-label Treatment|Not dosed|0|||
144539157|NCT03160885|521175722|FG006|Open-label Treatment|Not dosed|2|||
144539158|NCT03160885|521175716|FG000|Open-label Treatment|Discontinued IMP|0|||
144539159|NCT03160885|521175717|FG001|Open-label Treatment|Discontinued IMP|0|||
144539160|NCT03160885|521175718|FG002|Open-label Treatment|Discontinued IMP|0|||
144615031|NCT00879645|521451983|FG003|Overall Study|Adverse Event|0|||
144615032|NCT04288154|521451984|FG000|Overall Study|Withdrawal by Subject|9|||
144615033|NCT04288154|521451985|FG001|Overall Study|Withdrawal by Subject|9|||
144615034|NCT00996944|521451986|FG000|Double-blind Treatment Period|Adverse Event|2|||
144615035|NCT00996944|521451987|FG001|Double-blind Treatment Period|Adverse Event|1|||
144615036|NCT00996944|521451986|FG000|Double-blind Treatment Period|Protocol Violation|1|||
144615037|NCT00996944|521451987|FG001|Double-blind Treatment Period|Protocol Violation|0|||
144260429|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144539161|NCT03160885|521175719|FG003|Open-label Treatment|Discontinued IMP|0|||
144539162|NCT03160885|521175720|FG004|Open-label Treatment|Discontinued IMP|0|||
144539163|NCT03160885|521175721|FG005|Open-label Treatment|Discontinued IMP|0|||
144200212|NCT02799095|519931556|FG004|Part B|Withdrawal by Subject|0|||
144200213|NCT02799095|519931557|FG005|Part B|Withdrawal by Subject|0|||
144200214|NCT02799095|519931558|FG006|Part B|Withdrawal by Subject|0|||
144200215|NCT02799095|519931559|FG007|Part B|Withdrawal by Subject|10|||
144200216|NCT02799095|519931560|FG008|Part B|Withdrawal by Subject|7|||
144200217|NCT02799095|519931561|FG009|Part B|Withdrawal by Subject|0|||
144200218|NCT02799095|519931562|FG010|Part B|Withdrawal by Subject|0|||
144200219|NCT02799095|519931563|FG011|Part B|Withdrawal by Subject|0|||
144200220|NCT02799095|519931564|FG012|Part B|Withdrawal by Subject|0|||
144200221|NCT02799095|519931565|FG013|Part B|Withdrawal by Subject|0|||
144200222|NCT02799095|519931566|FG014|Part B|Withdrawal by Subject|0|||
144200223|NCT02799095|519931567|FG015|Part B|Withdrawal by Subject|0|||
144200224|NCT02799095|519931568|FG016|Part B|Withdrawal by Subject|0|||
144200225|NCT02799095|519931552|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
144200226|NCT02799095|519931553|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
144200227|NCT02799095|519931554|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
144200228|NCT02799095|519931555|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
144200229|NCT02799095|519931556|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
144200230|NCT02799095|519931557|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
144200231|NCT02799095|519931558|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
144200232|NCT02799095|519931559|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
144200233|NCT02799095|519931560|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
144200234|NCT02799095|519931561|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
144200235|NCT02799095|519931562|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
144200236|NCT02799095|519931563|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
144200237|NCT02799095|519931564|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
144200238|NCT02799095|519931565|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
144200239|NCT02799095|519931566|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
144200240|NCT02799095|519931567|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
144200241|NCT02799095|519931568|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
144200242|NCT02799095|519931552|FG000|Part C|Adverse Event|0|||
144200243|NCT02799095|519931553|FG001|Part C|Adverse Event|0|||
144200244|NCT02799095|519931554|FG002|Part C|Adverse Event|0|||
144200245|NCT02799095|519931555|FG003|Part C|Adverse Event|0|||
144200246|NCT02799095|519931556|FG004|Part C|Adverse Event|0|||
144200247|NCT02799095|519931557|FG005|Part C|Adverse Event|0|||
144200248|NCT02799095|519931558|FG006|Part C|Adverse Event|0|||
144200249|NCT02799095|519931559|FG007|Part C|Adverse Event|0|||
144200250|NCT02799095|519931560|FG008|Part C|Adverse Event|0|||
144200251|NCT02799095|519931561|FG009|Part C|Adverse Event|0|||
144200252|NCT02799095|519931562|FG010|Part C|Adverse Event|3|||
144200253|NCT02799095|519931563|FG011|Part C|Adverse Event|1|||
144200254|NCT02799095|519931564|FG012|Part C|Adverse Event|0|||
144200255|NCT02799095|519931565|FG013|Part C|Adverse Event|1|||
144200256|NCT02799095|519931566|FG014|Part C|Adverse Event|0|||
144200257|NCT02799095|519931567|FG015|Part C|Adverse Event|0|||
144200258|NCT02799095|519931568|FG016|Part C|Adverse Event|0|||
144200259|NCT02799095|519931552|FG000|Part C|Death|0|||
144200260|NCT02799095|519931553|FG001|Part C|Death|0|||
144200261|NCT02799095|519931554|FG002|Part C|Death|0|||
144200262|NCT02799095|519931555|FG003|Part C|Death|0|||
144200263|NCT02799095|519931556|FG004|Part C|Death|0|||
144200264|NCT02799095|519931557|FG005|Part C|Death|0|||
144200265|NCT02799095|519931558|FG006|Part C|Death|0|||
144200266|NCT02799095|519931559|FG007|Part C|Death|0|||
144200267|NCT02799095|519931560|FG008|Part C|Death|0|||
144200268|NCT02799095|519931561|FG009|Part C|Death|0|||
144200269|NCT02799095|519931562|FG010|Part C|Death|7|||
144200270|NCT02799095|519931563|FG011|Part C|Death|5|||
144200271|NCT02799095|519931564|FG012|Part C|Death|6|||
144200272|NCT02799095|519931565|FG013|Part C|Death|8|||
144200273|NCT02799095|519931566|FG014|Part C|Death|1|||
144200274|NCT02799095|519931567|FG015|Part C|Death|8|||
144200275|NCT02799095|519931568|FG016|Part C|Death|1|||
144200276|NCT02799095|519931552|FG000|Part C|Lost to Follow-up|0|||
144200277|NCT02799095|519931553|FG001|Part C|Lost to Follow-up|0|||
144200278|NCT02799095|519931554|FG002|Part C|Lost to Follow-up|0|||
144200279|NCT02799095|519931555|FG003|Part C|Lost to Follow-up|0|||
144200280|NCT02799095|519931556|FG004|Part C|Lost to Follow-up|0|||
144200281|NCT02799095|519931557|FG005|Part C|Lost to Follow-up|0|||
144200282|NCT02799095|519931558|FG006|Part C|Lost to Follow-up|0|||
144200283|NCT02799095|519931559|FG007|Part C|Lost to Follow-up|0|||
144200284|NCT02799095|519931560|FG008|Part C|Lost to Follow-up|0|||
144200285|NCT02799095|519931561|FG009|Part C|Lost to Follow-up|0|||
144200286|NCT02799095|519931562|FG010|Part C|Lost to Follow-up|1|||
144200287|NCT02799095|519931563|FG011|Part C|Lost to Follow-up|1|||
144200288|NCT02799095|519931564|FG012|Part C|Lost to Follow-up|1|||
144200289|NCT02799095|519931565|FG013|Part C|Lost to Follow-up|3|||
144200290|NCT02799095|519931566|FG014|Part C|Lost to Follow-up|0|||
144200291|NCT02799095|519931567|FG015|Part C|Lost to Follow-up|0|||
144200292|NCT02799095|519931568|FG016|Part C|Lost to Follow-up|0|||
144200293|NCT02799095|519931552|FG000|Part C|Progressive Disease|0|||
144200294|NCT02799095|519931553|FG001|Part C|Progressive Disease|0|||
144200295|NCT02799095|519931554|FG002|Part C|Progressive Disease|0|||
144200296|NCT02799095|519931555|FG003|Part C|Progressive Disease|0|||
144615038|NCT00996944|521451986|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
144615039|NCT00996944|521451987|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
144615040|NCT00996944|521451986|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
144615041|NCT00996944|521451987|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
144615042|NCT00996944|521451986|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
144615043|NCT00996944|521451987|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
144615044|NCT00769184|521451988|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
144615045|NCT00769184|521451989|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
144615046|NCT00769184|521451988|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
144615047|NCT00769184|521451989|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
144615048|NCT00769184|521451988|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
144615049|NCT00769184|521451989|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
144615050|NCT00385255|521451990|FG000|Overall Study|Serious Adverse Event|1|||
144615051|NCT00385255|521451991|FG001|Overall Study|Serious Adverse Event|2|||
144615052|NCT00385255|521451990|FG000|Overall Study|Protocol Violation|0|||
144615053|NCT00385255|521451991|FG001|Overall Study|Protocol Violation|4|||
144615054|NCT00385255|521451990|FG000|Overall Study|Withdrawal by Subject|0|||
144615055|NCT00385255|521451991|FG001|Overall Study|Withdrawal by Subject|8|||
144615056|NCT00385255|521451990|FG000|Overall Study|Migrated/moved from study area|0|||
144615057|NCT00385255|521451991|FG001|Overall Study|Migrated/moved from study area|1|||
144615058|NCT00385255|521451990|FG000|Overall Study|Lost to Follow-up|20|||
144615059|NCT00385255|521451991|FG001|Overall Study|Lost to Follow-up|58|||
144615060|NCT00583362|521451992|FG000|Overall Study|Adverse Event|44|||
144615061|NCT00583362|521451992|FG000|Overall Study|Lack of Efficacy|22|||
144615062|NCT00583362|521451992|FG000|Overall Study|Lost to Follow-up|4|||
144615063|NCT00583362|521451992|FG000|Overall Study|Non-compliance with study drug|28|||
144472314|NCT00542880|520926745|FG000|Period 1|Adverse Event|2|||
144472315|NCT00542880|520926746|FG001|Period 1|Adverse Event|2|||
144472316|NCT00542880|520926745|FG000|Period 1|Development of study-specific criteria|1|||
144472317|NCT00542880|520926746|FG001|Period 1|Development of study-specific criteria|2|||
144472318|NCT00542880|520926745|FG000|Period 1|Withdrawal by Subject|1|||
144472319|NCT00542880|520926746|FG001|Period 1|Withdrawal by Subject|1|||
144472320|NCT00542880|520926745|FG000|Period 1|Protocol Violation|0|||
144472321|NCT00542880|520926746|FG001|Period 1|Protocol Violation|1|||
144472322|NCT00542880|520926745|FG000|Period 2|Adverse Event|5|||
144472323|NCT00542880|520926746|FG001|Period 2|Adverse Event|7|||
144472324|NCT00542880|520926745|FG000|Period 2|Eligibility not fulfilled|0|||
144472325|NCT00542880|520926746|FG001|Period 2|Eligibility not fulfilled|1|||
144472326|NCT00542880|520926745|FG000|Period 2|Discontinuation criteria|2|||
144472327|NCT00542880|520926746|FG001|Period 2|Discontinuation criteria|0|||
144472328|NCT00542880|520926745|FG000|Period 2|Severe non-compliance|0|||
144472329|NCT00542880|520926746|FG001|Period 2|Severe non-compliance|1|||
144472330|NCT00542880|520926745|FG000|Period 2|Other|0|||
144472331|NCT00542880|520926746|FG001|Period 2|Other|1|||
144472332|NCT00542880|520926745|FG000|Period 3|Adverse Event|0|||
144472333|NCT00542880|520926746|FG001|Period 3|Adverse Event|2|||
144472334|NCT00696384|520926747|FG000|Open Label Phase|Adverse Event|27|||
144472335|NCT00696384|520926748|FG001|Open Label Phase|Adverse Event|0|||
144472336|NCT00696384|520926749|FG002|Open Label Phase|Adverse Event|0|||
144472337|NCT00696384|520926747|FG000|Open Label Phase|Protocol Violation|18|||
144472338|NCT00696384|520926748|FG001|Open Label Phase|Protocol Violation|0|||
144472339|NCT00696384|520926749|FG002|Open Label Phase|Protocol Violation|0|||
144472340|NCT00696384|520926747|FG000|Open Label Phase|Lost to Follow-up|24|||
144472341|NCT00696384|520926748|FG001|Open Label Phase|Lost to Follow-up|0|||
144472342|NCT00696384|520926749|FG002|Open Label Phase|Lost to Follow-up|0|||
144472343|NCT00696384|520926747|FG000|Open Label Phase|Withdrawal by Subject|37|||
144472344|NCT00696384|520926748|FG001|Open Label Phase|Withdrawal by Subject|0|||
144472345|NCT00696384|520926749|FG002|Open Label Phase|Withdrawal by Subject|0|||
144472346|NCT00696384|520926747|FG000|Open Label Phase|Other|6|||
144472347|NCT00696384|520926748|FG001|Open Label Phase|Other|0|||
144472348|NCT00696384|520926749|FG002|Open Label Phase|Other|0|||
144472349|NCT00696384|520926747|FG000|Open Label Phase|Lack of Efficacy|3|||
144472350|NCT00696384|520926748|FG001|Open Label Phase|Lack of Efficacy|0|||
144472351|NCT00696384|520926749|FG002|Open Label Phase|Lack of Efficacy|0|||
144472352|NCT00696384|520926747|FG000|Open Label Phase|Physician Decision|4|||
144472353|NCT00696384|520926748|FG001|Open Label Phase|Physician Decision|0|||
144472354|NCT00696384|520926749|FG002|Open Label Phase|Physician Decision|0|||
144472355|NCT00696384|520926747|FG000|Double Blind Phase|Adverse Event|0|||
144472356|NCT00696384|520926748|FG001|Double Blind Phase|Adverse Event|2|||
144472357|NCT00696384|520926749|FG002|Double Blind Phase|Adverse Event|2|||
144472358|NCT00696384|520926747|FG000|Double Blind Phase|Lost to Follow-up|0|||
144472359|NCT00696384|520926748|FG001|Double Blind Phase|Lost to Follow-up|2|||
144472360|NCT00696384|520926749|FG002|Double Blind Phase|Lost to Follow-up|1|||
144615064|NCT00583362|521451992|FG000|Overall Study|Pregnancy|7|||
144727371|NCT04591626|521856620|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144472361|NCT00696384|520926747|FG000|Double Blind Phase|Withdrawal by Subject|0|||
144615065|NCT00583362|521451992|FG000|Overall Study|Miscommunication of visit window|5|||
144615066|NCT00583362|521451992|FG000|Overall Study|Current site closed|7|||
144615067|NCT00583362|521451992|FG000|Overall Study|Subject not dosed in LBSL99|1|||
144615068|NCT00583362|521451992|FG000|Overall Study|Subject moved out of the country/state|2|||
144615069|NCT00583362|521451992|FG000|Overall Study|Missed visits due to staff changes|1|||
144615070|NCT00583362|521451992|FG000|Overall Study|Misunderstanding of protocol|1|||
144200297|NCT02799095|519931556|FG004|Part C|Progressive Disease|0|||
144200298|NCT02799095|519931557|FG005|Part C|Progressive Disease|0|||
144200299|NCT02799095|519931558|FG006|Part C|Progressive Disease|0|||
144200300|NCT02799095|519931559|FG007|Part C|Progressive Disease|0|||
144200301|NCT02799095|519931560|FG008|Part C|Progressive Disease|0|||
144200302|NCT02799095|519931561|FG009|Part C|Progressive Disease|2|||
144200303|NCT02799095|519931562|FG010|Part C|Progressive Disease|13|||
144200304|NCT02799095|519931563|FG011|Part C|Progressive Disease|2|||
144200305|NCT02799095|519931564|FG012|Part C|Progressive Disease|0|||
144200306|NCT02799095|519931565|FG013|Part C|Progressive Disease|1|||
144200307|NCT02799095|519931566|FG014|Part C|Progressive Disease|0|||
144200308|NCT02799095|519931567|FG015|Part C|Progressive Disease|0|||
144200309|NCT02799095|519931568|FG016|Part C|Progressive Disease|0|||
144200310|NCT02799095|519931552|FG000|Part C|Clinical Progression|0|||
144200311|NCT02799095|519931553|FG001|Part C|Clinical Progression|0|||
144200312|NCT02799095|519931554|FG002|Part C|Clinical Progression|0|||
144200313|NCT02799095|519931555|FG003|Part C|Clinical Progression|0|||
144200314|NCT02799095|519931556|FG004|Part C|Clinical Progression|0|||
144200315|NCT02799095|519931557|FG005|Part C|Clinical Progression|0|||
144200316|NCT02799095|519931558|FG006|Part C|Clinical Progression|0|||
144200317|NCT02799095|519931559|FG007|Part C|Clinical Progression|0|||
144200318|NCT02799095|519931560|FG008|Part C|Clinical Progression|0|||
144200319|NCT02799095|519931561|FG009|Part C|Clinical Progression|1|||
144539164|NCT03160885|521175722|FG006|Open-label Treatment|Discontinued IMP|131|||
144539165|NCT03160885|521175716|FG000|Open-label Treatment|Completed Week 50|0|||
144539166|NCT03160885|521175717|FG001|Open-label Treatment|Completed Week 50|0|||
144539167|NCT03160885|521175718|FG002|Open-label Treatment|Completed Week 50|0|||
144200320|NCT02799095|519931562|FG010|Part C|Clinical Progression|3|||
144539168|NCT03160885|521175719|FG003|Open-label Treatment|Completed Week 50|0|||
144539169|NCT03160885|521175720|FG004|Open-label Treatment|Completed Week 50|0|||
144200321|NCT02799095|519931563|FG011|Part C|Clinical Progression|0|||
144200322|NCT02799095|519931564|FG012|Part C|Clinical Progression|0|||
144200323|NCT02799095|519931565|FG013|Part C|Clinical Progression|1|||
144200324|NCT02799095|519931566|FG014|Part C|Clinical Progression|0|||
144200325|NCT02799095|519931567|FG015|Part C|Clinical Progression|0|||
144200326|NCT02799095|519931568|FG016|Part C|Clinical Progression|0|||
144200327|NCT02799095|519931552|FG000|Part C|Withdrawal by Subject|0|||
144200328|NCT02799095|519931553|FG001|Part C|Withdrawal by Subject|0|||
144200329|NCT02799095|519931554|FG002|Part C|Withdrawal by Subject|0|||
144200330|NCT02799095|519931555|FG003|Part C|Withdrawal by Subject|0|||
144200331|NCT02799095|519931556|FG004|Part C|Withdrawal by Subject|0|||
144200332|NCT02799095|519931557|FG005|Part C|Withdrawal by Subject|0|||
144200333|NCT02799095|519931558|FG006|Part C|Withdrawal by Subject|0|||
144200334|NCT02799095|519931559|FG007|Part C|Withdrawal by Subject|0|||
144200335|NCT02799095|519931560|FG008|Part C|Withdrawal by Subject|0|||
144200336|NCT02799095|519931561|FG009|Part C|Withdrawal by Subject|0|||
144200337|NCT02799095|519931562|FG010|Part C|Withdrawal by Subject|13|||
144200338|NCT02799095|519931563|FG011|Part C|Withdrawal by Subject|15|||
144200339|NCT02799095|519931564|FG012|Part C|Withdrawal by Subject|13|||
144200340|NCT02799095|519931565|FG013|Part C|Withdrawal by Subject|21|||
144200341|NCT02799095|519931566|FG014|Part C|Withdrawal by Subject|0|||
144615071|NCT00583362|521451992|FG000|Overall Study|Behavioral problems and non-compliance|1|||
144615072|NCT00583362|521451992|FG000|Overall Study|Sponsor request due to missed doses|1|||
144615073|NCT00583362|521451992|FG000|Overall Study|Physician Decision|19|||
144200342|NCT02799095|519931567|FG015|Part C|Withdrawal by Subject|12|||
144200343|NCT02799095|519931568|FG016|Part C|Withdrawal by Subject|1|||
144200344|NCT02799095|519931552|FG000|Part C|Physician Decision|0|||
144539170|NCT03160885|521175721|FG005|Open-label Treatment|Completed Week 50|0|||
144200345|NCT02799095|519931553|FG001|Part C|Physician Decision|0|||
144200346|NCT02799095|519931554|FG002|Part C|Physician Decision|0|||
144200347|NCT02799095|519931555|FG003|Part C|Physician Decision|0|||
144200348|NCT02799095|519931556|FG004|Part C|Physician Decision|0|||
144200349|NCT02799095|519931557|FG005|Part C|Physician Decision|0|||
144200350|NCT02799095|519931558|FG006|Part C|Physician Decision|0|||
144200351|NCT02799095|519931559|FG007|Part C|Physician Decision|0|||
144615074|NCT00583362|521451992|FG000|Overall Study|Protocol Violation|2|||
144200352|NCT02799095|519931560|FG008|Part C|Physician Decision|0|||
144200353|NCT02799095|519931561|FG009|Part C|Physician Decision|0|||
144200354|NCT02799095|519931562|FG010|Part C|Physician Decision|1|||
144200355|NCT02799095|519931563|FG011|Part C|Physician Decision|0|||
144615075|NCT00583362|521451992|FG000|Overall Study|Withdrawal by Subject|57|||
144200356|NCT02799095|519931564|FG012|Part C|Physician Decision|0|||
144200357|NCT02799095|519931565|FG013|Part C|Physician Decision|0|||
144200358|NCT02799095|519931566|FG014|Part C|Physician Decision|0|||
144200359|NCT02799095|519931567|FG015|Part C|Physician Decision|0|||
144200360|NCT02799095|519931568|FG016|Part C|Physician Decision|0|||
144615076|NCT04247061|521451993|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
144615077|NCT04247061|521451993|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
144615078|NCT04247061|521451993|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
144615079|NCT01136655|521451998|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
144615080|NCT01136655|521451998|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
144615081|NCT01136655|521451998|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
144615082|NCT01136655|521451998|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
144615083|NCT02873936|521451999|FG000|Overall Study|Withdrew Consent|4|||
144615084|NCT02873936|521452000|FG001|Overall Study|Withdrew Consent|11|||
144615085|NCT02873936|521452001|FG002|Overall Study|Withdrew Consent|20|||
144615086|NCT02873936|521451999|FG000|Overall Study|Investigator's Discretion|3|||
144615087|NCT02873936|521452000|FG001|Overall Study|Investigator's Discretion|5|||
144615088|NCT02873936|521452001|FG002|Overall Study|Investigator's Discretion|4|||
144727372|NCT04591626|521856621|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144727373|NCT01139164|521856625|FG000|Overall Study|Withdrawn prior to study start|0|||
144727374|NCT01139164|521856626|FG001|Overall Study|Withdrawn prior to study start|2|||
144727375|NCT01139164|521856627|FG002|Overall Study|Withdrawn prior to study start|0|||
144727376|NCT00878995|521856628|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
144727377|NCT00878995|521856629|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
144727378|NCT00406848|521856630|FG000|Overall Study|Withdrawal by Subject|27|||
144727379|NCT00406848|521856631|FG001|Overall Study|Withdrawal by Subject|22|||
144727380|NCT00406848|521856630|FG000|Overall Study|Adverse Event|38|||
144727381|NCT00406848|521856631|FG001|Overall Study|Adverse Event|7|||
144727382|NCT00406848|521856630|FG000|Overall Study|Lack of Efficacy|9|||
144727383|NCT00406848|521856631|FG001|Overall Study|Lack of Efficacy|14|||
144727384|NCT00406848|521856630|FG000|Overall Study|Protocol Violation|10|||
144727385|NCT00406848|521856631|FG001|Overall Study|Protocol Violation|6|||
144727386|NCT00406848|521856630|FG000|Overall Study|Lost to Follow-up|6|||
144727387|NCT00406848|521856631|FG001|Overall Study|Lost to Follow-up|2|||
144727388|NCT00406848|521856630|FG000|Overall Study|Physician Decision|2|||
144727389|NCT00406848|521856631|FG001|Overall Study|Physician Decision|2|||
144727390|NCT00406848|521856630|FG000|Overall Study|Sponsor Decision|1|||
144727391|NCT00406848|521856631|FG001|Overall Study|Sponsor Decision|1|||
144727392|NCT01355081|521856634|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
144727393|NCT01355081|521856635|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
144727394|NCT01355081|521856636|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
144727395|NCT01355081|521856634|FG000|Overall Study|Major Protocol Deviation|0|||
144727396|NCT01355081|521856635|FG001|Overall Study|Major Protocol Deviation|1|||
144727397|NCT01355081|521856636|FG002|Overall Study|Major Protocol Deviation|0|||
144727398|NCT01355081|521856634|FG000|Overall Study|Lost to Follow-up|0|||
144727399|NCT01355081|521856635|FG001|Overall Study|Lost to Follow-up|0|||
144727400|NCT01355081|521856636|FG002|Overall Study|Lost to Follow-up|1|||
144727401|NCT01355081|521856634|FG000|Overall Study|Withdrawal of Consent|2|||
144727402|NCT01355081|521856635|FG001|Overall Study|Withdrawal of Consent|3|||
144727403|NCT01355081|521856636|FG002|Overall Study|Withdrawal of Consent|3|||
144472362|NCT00696384|520926748|FG001|Double Blind Phase|Withdrawal by Subject|4|||
144472363|NCT00696384|520926749|FG002|Double Blind Phase|Withdrawal by Subject|3|||
144472364|NCT00696384|520926747|FG000|Double Blind Phase|Lack of Efficacy|0|||
144472365|NCT00696384|520926748|FG001|Double Blind Phase|Lack of Efficacy|1|||
144472366|NCT00696384|520926749|FG002|Double Blind Phase|Lack of Efficacy|0|||
144472367|NCT00696384|520926747|FG000|Double Blind Phase|Physician Decision|0|||
144472368|NCT00696384|520926748|FG001|Double Blind Phase|Physician Decision|2|||
144472369|NCT00696384|520926749|FG002|Double Blind Phase|Physician Decision|0|||
144472370|NCT01678131|520926750|FG000|Overall Study|Adverse Event|0|||
144472371|NCT01678131|520926751|FG001|Overall Study|Adverse Event|1|||
144472372|NCT01678131|520926752|FG002|Overall Study|Adverse Event|0|||
144472373|NCT01678131|520926750|FG000|Overall Study|Withdrawal by Subject|0|||
144472374|NCT01678131|520926751|FG001|Overall Study|Withdrawal by Subject|0|||
144472375|NCT01678131|520926752|FG002|Overall Study|Withdrawal by Subject|2|||
144472376|NCT00558064|520926754|FG000|Overall Study|Adverse Event|3|||
144472377|NCT00558064|520926755|FG001|Overall Study|Adverse Event|2|||
144472378|NCT00558064|520926754|FG000|Overall Study|Lack of Efficacy|0|||
144472379|NCT00558064|520926755|FG001|Overall Study|Lack of Efficacy|1|||
144472380|NCT00558064|520926754|FG000|Overall Study|Protocol Violation|1|||
144472381|NCT00558064|520926755|FG001|Overall Study|Protocol Violation|0|||
144727404|NCT01355081|521856634|FG000|Overall Study|Lack of Efficacy|2|||
144727405|NCT01355081|521856635|FG001|Overall Study|Lack of Efficacy|1|||
144727406|NCT01355081|521856636|FG002|Overall Study|Lack of Efficacy|1|||
144727407|NCT01355081|521856634|FG000|Overall Study|Non Compliance with Study Medication|0|||
144727408|NCT01355081|521856635|FG001|Overall Study|Non Compliance with Study Medication|1|||
144472382|NCT00558064|520926754|FG000|Overall Study|Lost to Follow-up|0|||
144472383|NCT00558064|520926755|FG001|Overall Study|Lost to Follow-up|1|||
144472384|NCT00558064|520926754|FG000|Overall Study|Withdrawal by Subject|0|||
144472385|NCT00558064|520926755|FG001|Overall Study|Withdrawal by Subject|1|||
144539171|NCT03160885|521175722|FG006|Open-label Treatment|Completed Week 50|4|||
144539172|NCT03160885|521175716|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
144539173|NCT03160885|521175717|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
144200361|NCT02799095|519931552|FG000|Part C|Other|0|||
144200362|NCT02799095|519931553|FG001|Part C|Other|0|||
144200363|NCT02799095|519931554|FG002|Part C|Other|0|||
144200364|NCT02799095|519931555|FG003|Part C|Other|0|||
144200365|NCT02799095|519931556|FG004|Part C|Other|0|||
144200366|NCT02799095|519931557|FG005|Part C|Other|0|||
144200367|NCT02799095|519931558|FG006|Part C|Other|0|||
144200368|NCT02799095|519931559|FG007|Part C|Other|0|||
144200369|NCT02799095|519931560|FG008|Part C|Other|0|||
144200370|NCT02799095|519931561|FG009|Part C|Other|0|||
144200371|NCT02799095|519931562|FG010|Part C|Other|0|||
144200372|NCT02799095|519931563|FG011|Part C|Other|2|||
144200373|NCT02799095|519931564|FG012|Part C|Other|2|||
144200374|NCT02799095|519931565|FG013|Part C|Other|0|||
144200375|NCT02799095|519931566|FG014|Part C|Other|0|||
144200376|NCT02799095|519931567|FG015|Part C|Other|0|||
144200377|NCT02799095|519931568|FG016|Part C|Other|0|||
144200378|NCT01933113|519931569|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
144200379|NCT02297438|519931570|FG000|Overall Study|Death|79|||
144200380|NCT02297438|519931571|FG001|Overall Study|Death|86|||
144200381|NCT02297438|519931570|FG000|Overall Study|Lost to Follow-up|9|||
144200382|NCT02297438|519931571|FG001|Overall Study|Lost to Follow-up|7|||
144200383|NCT02297438|519931570|FG000|Overall Study|Withdrawal by Subject|7|||
144200384|NCT02297438|519931571|FG001|Overall Study|Withdrawal by Subject|0|||
144200385|NCT02297438|519931570|FG000|Overall Study|Other|9|||
144200386|NCT02297438|519931571|FG001|Overall Study|Other|5|||
144200387|NCT02297438|519931570|FG000|Overall Study|Ongoing|65|||
144200388|NCT02297438|519931571|FG001|Overall Study|Ongoing|73|||
144200389|NCT04092894|519931576|FG000|Overall Study|Withdrawal by Subject|2|||
144200390|NCT04092894|519931577|FG001|Overall Study|Withdrawal by Subject|4|||
144200391|NCT04092894|519931576|FG000|Overall Study|Discontinued EEG after randomization|10|||
144200392|NCT04092894|519931577|FG001|Overall Study|Discontinued EEG after randomization|6|||
144200393|NCT01951885|519931578|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
144200394|NCT01951885|519931579|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
144200395|NCT01951885|519931578|FG000|Overall Study|Adverse Event|1|||
144200396|NCT01951885|519931579|FG001|Overall Study|Adverse Event|0|||
144539174|NCT03160885|521175718|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
144539175|NCT03160885|521175719|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
144539176|NCT03160885|521175720|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
144539177|NCT03160885|521175721|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
144539178|NCT03160885|521175722|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
144539179|NCT03160885|521175716|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
144539180|NCT03160885|521175717|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
144539181|NCT03160885|521175718|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
144539182|NCT03160885|521175719|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
144539183|NCT03160885|521175720|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
144539184|NCT03160885|521175721|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
144539185|NCT03160885|521175722|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
144539186|NCT03160885|521175716|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144539187|NCT03160885|521175717|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144539188|NCT03160885|521175718|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
144539189|NCT03160885|521175719|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
144539190|NCT03160885|521175720|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
144539191|NCT03160885|521175721|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
144539192|NCT03160885|521175722|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
144539193|NCT03160885|521175716|FG000|Maintenance Treatment Period|Completed Week 50|0|||
144539194|NCT03160885|521175717|FG001|Maintenance Treatment Period|Completed Week 50|0|||
144539195|NCT03160885|521175718|FG002|Maintenance Treatment Period|Completed Week 50|1|||
144539196|NCT03160885|521175719|FG003|Maintenance Treatment Period|Completed Week 50|0|||
144539197|NCT03160885|521175720|FG004|Maintenance Treatment Period|Completed Week 50|0|||
144200397|NCT01951885|519931578|FG000|Overall Study|Withdrawal by Subject|0|||
144200398|NCT01951885|519931579|FG001|Overall Study|Withdrawal by Subject|1|||
144200399|NCT01951885|519931578|FG000|Overall Study|ineligible due to a change in donor|0|||
144200400|NCT01951885|519931579|FG001|Overall Study|ineligible due to a change in donor|1|||
144200401|NCT01951885|519931578|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
144200402|NCT01951885|519931579|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
144615089|NCT02873936|521451999|FG000|Overall Study|Adverse Event|3|||
144615090|NCT02873936|521452000|FG001|Overall Study|Adverse Event|5|||
144200403|NCT02238626|519931580|FG000|Overall Study|Adverse Event|3|||
144200404|NCT02238626|519931581|FG001|Overall Study|Adverse Event|5|||
144200405|NCT02238626|519931582|FG002|Overall Study|Adverse Event|0|||
144200406|NCT02238626|519931583|FG003|Overall Study|Adverse Event|3|||
144200407|NCT02238626|519931580|FG000|Overall Study|Lost to Follow-up|2|||
144200408|NCT02238626|519931581|FG001|Overall Study|Lost to Follow-up|4|||
144200409|NCT02238626|519931582|FG002|Overall Study|Lost to Follow-up|2|||
144200410|NCT02238626|519931583|FG003|Overall Study|Lost to Follow-up|2|||
144200411|NCT02238626|519931580|FG000|Overall Study|Withdrawal by Subject|0|||
144200412|NCT02238626|519931581|FG001|Overall Study|Withdrawal by Subject|3|||
144200413|NCT02238626|519931582|FG002|Overall Study|Withdrawal by Subject|0|||
144200414|NCT02238626|519931583|FG003|Overall Study|Withdrawal by Subject|1|||
144200415|NCT02238626|519931580|FG000|Overall Study|Death|0|||
144200416|NCT02238626|519931581|FG001|Overall Study|Death|0|||
144200417|NCT02238626|519931582|FG002|Overall Study|Death|1|||
144200418|NCT02238626|519931583|FG003|Overall Study|Death|1|||
144200419|NCT02238626|519931580|FG000|Overall Study|Other|0|||
144200420|NCT02238626|519931581|FG001|Overall Study|Other|2|||
144200421|NCT02238626|519931582|FG002|Overall Study|Other|0|||
144200422|NCT02238626|519931583|FG003|Overall Study|Other|0|||
144200423|NCT02622113|519931586|FG000|Overall Study|Adverse Event|4|||
144200424|NCT02622113|519931587|FG001|Overall Study|Adverse Event|4|||
144200425|NCT02622113|519931586|FG000|Overall Study|Physician Decision|0|||
144200426|NCT02622113|519931587|FG001|Overall Study|Physician Decision|1|||
144200427|NCT02622113|519931586|FG000|Overall Study|Withdrawal by Subject|0|||
144200428|NCT02622113|519931587|FG001|Overall Study|Withdrawal by Subject|2|||
144200429|NCT02622113|519931586|FG000|Overall Study|Stopping Criteria|1|||
144200430|NCT02622113|519931587|FG001|Overall Study|Stopping Criteria|3|||
144200431|NCT00667810|519931588|FG000|Overall Study|Adverse Event|13|||
144200432|NCT00667810|519931589|FG001|Overall Study|Adverse Event|14|||
144200433|NCT00667810|519931590|FG002|Overall Study|Adverse Event|19|||
144200434|NCT00667810|519931591|FG003|Overall Study|Adverse Event|1|||
144200435|NCT00667810|519931588|FG000|Overall Study|Death|1|||
144200436|NCT00667810|519931589|FG001|Overall Study|Death|1|||
144200437|NCT00667810|519931590|FG002|Overall Study|Death|3|||
144200438|NCT00667810|519931591|FG003|Overall Study|Death|0|||
144200439|NCT00667810|519931588|FG000|Overall Study|Lack of Efficacy|1|||
144200440|NCT00667810|519931589|FG001|Overall Study|Lack of Efficacy|0|||
144200441|NCT00667810|519931590|FG002|Overall Study|Lack of Efficacy|2|||
144472386|NCT00558064|520926754|FG000|Overall Study|No visit within allowance period|1|||
144472387|NCT00558064|520926755|FG001|Overall Study|No visit within allowance period|0|||
144472388|NCT02027402|520926756|FG000|Overall Study|Withdrawal by Subject|4|||
144472389|NCT02027402|520926757|FG001|Overall Study|Withdrawal by Subject|1|||
144472390|NCT00941798|520926760|FG000|Overall Study|Withdrawal by Subject|72|||
144472391|NCT00941798|520926761|FG001|Overall Study|Withdrawal by Subject|74|||
144472392|NCT00941798|520926760|FG000|Overall Study|Adverse Event|43|||
144472393|NCT00941798|520926761|FG001|Overall Study|Adverse Event|23|||
144472394|NCT00941798|520926760|FG000|Overall Study|Lost to Follow-up|29|||
144472395|NCT00941798|520926761|FG001|Overall Study|Lost to Follow-up|23|||
144472396|NCT00941798|520926760|FG000|Overall Study|Protocol Violation|17|||
144472397|NCT00941798|520926761|FG001|Overall Study|Protocol Violation|20|||
144472398|NCT00941798|520926760|FG000|Overall Study|Administrative problems|13|||
144472399|NCT00941798|520926761|FG001|Overall Study|Administrative problems|23|||
144472400|NCT00941798|520926760|FG000|Overall Study|Lack of Efficacy|10|||
144472401|NCT00941798|520926761|FG001|Overall Study|Lack of Efficacy|17|||
144472402|NCT00941798|520926760|FG000|Overall Study|Patient's inability to use device|6|||
144472403|NCT00941798|520926761|FG001|Overall Study|Patient's inability to use device|1|||
144472404|NCT00941798|520926760|FG000|Overall Study|Abnormal test procedure results|3|||
144472405|NCT00941798|520926761|FG001|Overall Study|Abnormal test procedure results|1|||
144472406|NCT00941798|520926760|FG000|Overall Study|Abnormal laboratory values|1|||
144472407|NCT00941798|520926761|FG001|Overall Study|Abnormal laboratory values|2|||
144472408|NCT00941798|520926760|FG000|Overall Study|Death|0|||
144472409|NCT00941798|520926761|FG001|Overall Study|Death|1|||
144200442|NCT00667810|519931591|FG003|Overall Study|Lack of Efficacy|0|||
144200443|NCT00667810|519931588|FG000|Overall Study|Lost to Follow-up|1|||
144200444|NCT00667810|519931589|FG001|Overall Study|Lost to Follow-up|4|||
144200445|NCT00667810|519931590|FG002|Overall Study|Lost to Follow-up|2|||
144200446|NCT00667810|519931591|FG003|Overall Study|Lost to Follow-up|0|||
144200447|NCT00667810|519931588|FG000|Overall Study|Physician Decision|1|||
144200448|NCT00667810|519931589|FG001|Overall Study|Physician Decision|1|||
144200449|NCT00667810|519931590|FG002|Overall Study|Physician Decision|2|||
144200450|NCT00667810|519931591|FG003|Overall Study|Physician Decision|0|||
144200451|NCT00667810|519931588|FG000|Overall Study|Protocol Violation|0|||
144200452|NCT00667810|519931589|FG001|Overall Study|Protocol Violation|2|||
144200453|NCT00667810|519931590|FG002|Overall Study|Protocol Violation|0|||
144200454|NCT00667810|519931591|FG003|Overall Study|Protocol Violation|0|||
144472410|NCT04179721|520926764|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
144472411|NCT04179721|520926765|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
144472412|NCT04179721|520926764|FG000|Overall Study|Lost to Follow-up|0|||
144472413|NCT04179721|520926765|FG001|Overall Study|Lost to Follow-up|1|||
144472414|NCT01489189|520926766|FG000|Overall Study|Withdrawal by Subject|20|||
144472415|NCT01489189|520926767|FG001|Overall Study|Withdrawal by Subject|23|||
144200455|NCT00667810|519931588|FG000|Overall Study|Withdrawal by Subject|14|||
144200456|NCT00667810|519931589|FG001|Overall Study|Withdrawal by Subject|20|||
144200457|NCT00667810|519931590|FG002|Overall Study|Withdrawal by Subject|29|||
144200458|NCT00667810|519931591|FG003|Overall Study|Withdrawal by Subject|1|||
144200459|NCT00667810|519931588|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
144200460|NCT00667810|519931589|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
144200461|NCT00667810|519931590|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
144200462|NCT00667810|519931591|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
144200463|NCT00667810|519931588|FG000|Overall Study|Failed to Return|0|||
144200464|NCT00667810|519931589|FG001|Overall Study|Failed to Return|0|||
144200465|NCT00667810|519931590|FG002|Overall Study|Failed to Return|2|||
144200466|NCT00667810|519931591|FG003|Overall Study|Failed to Return|0|||
144200467|NCT00667810|519931588|FG000|Overall Study|Loss of Caregiver|0|||
144200468|NCT00667810|519931589|FG001|Overall Study|Loss of Caregiver|1|||
144200469|NCT00667810|519931590|FG002|Overall Study|Loss of Caregiver|3|||
144200470|NCT00667810|519931591|FG003|Overall Study|Loss of Caregiver|0|||
144200471|NCT00667810|519931588|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
144200472|NCT00667810|519931589|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
144200473|NCT00667810|519931590|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
144200474|NCT00667810|519931591|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
144200475|NCT00667810|519931588|FG000|Overall Study|Other|6|||
144200476|NCT00667810|519931589|FG001|Overall Study|Other|6|||
144200477|NCT00667810|519931590|FG002|Overall Study|Other|5|||
144200478|NCT00667810|519931591|FG003|Overall Study|Other|0|||
144200479|NCT00505375|519931602|FG000|Overall Study|Death|1|||
144200480|NCT00505375|519931603|FG001|Overall Study|Death|0|||
144200481|NCT00505375|519931602|FG000|Overall Study|Withdrawal by Subject|2|||
144200482|NCT00505375|519931603|FG001|Overall Study|Withdrawal by Subject|2|||
144200483|NCT00505375|519931602|FG000|Overall Study|Lost to Follow-up|0|||
144200484|NCT00505375|519931603|FG001|Overall Study|Lost to Follow-up|2|||
144200485|NCT00505375|519931602|FG000|Overall Study|Pregnancy|1|||
144200486|NCT00505375|519931603|FG001|Overall Study|Pregnancy|0|||
144200487|NCT00505375|519931602|FG000|Overall Study|Travel issues|0|||
144200488|NCT00505375|519931603|FG001|Overall Study|Travel issues|1|||
144200489|NCT01561430|519931604|FG000|Overall Study|Adverse Event|0|||
144200490|NCT01561430|519931605|FG001|Overall Study|Adverse Event|0|||
144200491|NCT01561430|519931606|FG002|Overall Study|Adverse Event|3|||
144200492|NCT01561430|519931607|FG003|Overall Study|Adverse Event|1|||
144200493|NCT01561430|519931604|FG000|Overall Study|Withdrawal by Subject|0|||
144200494|NCT01561430|519931605|FG001|Overall Study|Withdrawal by Subject|0|||
144200495|NCT01561430|519931606|FG002|Overall Study|Withdrawal by Subject|1|||
144200496|NCT01561430|519931607|FG003|Overall Study|Withdrawal by Subject|0|||
144200497|NCT01561430|519931604|FG000|Overall Study|Physician Decision|0|||
144200498|NCT01561430|519931605|FG001|Overall Study|Physician Decision|1|||
144539198|NCT03160885|521175721|FG005|Maintenance Treatment Period|Completed Week 50|0|||
144539199|NCT03160885|521175722|FG006|Maintenance Treatment Period|Completed Week 50|0|||
144539200|NCT02761187|521175723|FG000|Overall Study|Too ill to Participate|13|||
144539201|NCT02761187|521175724|FG001|Overall Study|Too ill to Participate|8|||
144539202|NCT02761187|521175723|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
144539203|NCT02761187|521175724|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
144539204|NCT02761187|521175723|FG000|Overall Study|Patient withdrew consent|64|||
144539205|NCT02761187|521175724|FG001|Overall Study|Patient withdrew consent|58|||
144539206|NCT02761187|521175723|FG000|Overall Study|Physician discretion|4|||
144539207|NCT02761187|521175724|FG001|Overall Study|Physician discretion|8|||
144539208|NCT02761187|521175723|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
144539209|NCT02761187|521175724|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
144539210|NCT02761187|521175723|FG000|Overall Study|On Hospice|20|||
144539211|NCT02761187|521175724|FG001|Overall Study|On Hospice|26|||
144539212|NCT02761187|521175723|FG000|Overall Study|Deceased|474|||
144539213|NCT02761187|521175724|FG001|Overall Study|Deceased|642|||
144539214|NCT02761187|521175723|FG000|Overall Study|Lost to Follow-up|73|||
144200499|NCT01561430|519931606|FG002|Overall Study|Physician Decision|0|||
144200500|NCT01561430|519931607|FG003|Overall Study|Physician Decision|0|||
144200501|NCT01561430|519931604|FG000|Overall Study|Sponsor Decision|1|||
144200502|NCT01561430|519931605|FG001|Overall Study|Sponsor Decision|14|||
144200503|NCT01561430|519931606|FG002|Overall Study|Sponsor Decision|13|||
144200504|NCT01561430|519931607|FG003|Overall Study|Sponsor Decision|12|||
144539215|NCT02761187|521175724|FG001|Overall Study|Lost to Follow-up|63|||
144200505|NCT02564211|519931608|FG000|Overall Study|Adverse Event|4|||
144200506|NCT04492020|519931610|FG000|Overall Study|Adverse Event|1|||
144200507|NCT04492020|519931611|FG001|Overall Study|Adverse Event|3|||
144200508|NCT04492020|519931610|FG000|Overall Study|Withdrawal by Subject|4|||
144200509|NCT04492020|519931611|FG001|Overall Study|Withdrawal by Subject|3|||
144200510|NCT04492020|519931610|FG000|Overall Study|Lost to Follow-up|4|||
144539216|NCT02761187|521175723|FG000|Overall Study|Due to study discontinued at site|100|||
144539217|NCT02761187|521175724|FG001|Overall Study|Due to study discontinued at site|85|||
144200511|NCT04492020|519931611|FG001|Overall Study|Lost to Follow-up|3|||
144200512|NCT04492020|519931610|FG000|Overall Study|Protocol Violation|5|||
144200513|NCT04492020|519931611|FG001|Overall Study|Protocol Violation|2|||
144200514|NCT04492020|519931610|FG000|Overall Study|Lack of Qualifying Event|25|||
144200515|NCT04492020|519931611|FG001|Overall Study|Lack of Qualifying Event|27|||
144200516|NCT04492020|519931610|FG000|Overall Study|Non-compliance with Study Drug|2|||
144200517|NCT04492020|519931611|FG001|Overall Study|Non-compliance with Study Drug|1|||
144200518|NCT04594707|519931612|FG000|Overall Study|Adverse Event|0|||
144200519|NCT04594707|519931613|FG001|Overall Study|Adverse Event|0|||
144200520|NCT04594707|519931614|FG002|Overall Study|Adverse Event|1|||
144200521|NCT04594707|519931612|FG000|Overall Study|Death|0|||
144200522|NCT04594707|519931613|FG001|Overall Study|Death|2|||
144200523|NCT04594707|519931614|FG002|Overall Study|Death|2|||
144200524|NCT04594707|519931612|FG000|Overall Study|Lung Transplant|0|||
144200525|NCT04594707|519931613|FG001|Overall Study|Lung Transplant|0|||
144200526|NCT04594707|519931614|FG002|Overall Study|Lung Transplant|1|||
144200527|NCT04594707|519931612|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
144200528|NCT04594707|519931613|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
144200529|NCT04594707|519931614|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
144200530|NCT04594707|519931612|FG000|Overall Study|Study Terminated By Sponsor|19|||
144200531|NCT04594707|519931613|FG001|Overall Study|Study Terminated By Sponsor|47|||
144200532|NCT04594707|519931614|FG002|Overall Study|Study Terminated By Sponsor|41|||
144200533|NCT04594707|519931612|FG000|Overall Study|Withdrawal by Subject|1|||
144200534|NCT04594707|519931613|FG001|Overall Study|Withdrawal by Subject|0|||
144200535|NCT04594707|519931614|FG002|Overall Study|Withdrawal by Subject|2|||
144200536|NCT00289536|519931616|FG000|Period 3|Lost to Follow-up|0|||
144200537|NCT00289536|519931617|FG001|Period 3|Lost to Follow-up|0|||
144200538|NCT00289536|519931618|FG002|Period 3|Lost to Follow-up|1|||
144200539|NCT02116608|519931623|FG000|Overall Study|Lost to Follow-up|0|||
144200540|NCT02116608|519931624|FG001|Overall Study|Lost to Follow-up|0|||
144200541|NCT02116608|519931625|FG002|Overall Study|Lost to Follow-up|1|||
144200542|NCT02116608|519931623|FG000|Overall Study|Physician Decision|0|||
144200543|NCT02116608|519931624|FG001|Overall Study|Physician Decision|1|||
144200544|NCT02116608|519931625|FG002|Overall Study|Physician Decision|0|||
144200545|NCT02116608|519931623|FG000|Overall Study|Death|0|||
144200546|NCT02116608|519931624|FG001|Overall Study|Death|1|||
144200547|NCT02116608|519931625|FG002|Overall Study|Death|0|||
144200548|NCT00988442|519931627|FG000|Overall Study|Death|1|||
144200549|NCT00988442|519931628|FG001|Overall Study|Death|2|||
144200550|NCT00988442|519931627|FG000|Overall Study|Lost to Follow-up|0|||
144200551|NCT00988442|519931628|FG001|Overall Study|Lost to Follow-up|1|||
144200552|NCT00988442|519931627|FG000|Overall Study|Early Study Closure|29|||
144200553|NCT00988442|519931628|FG001|Overall Study|Early Study Closure|25|||
144200554|NCT05297578|519931641|FG000|Overall Study|Lost to Follow-up|1|||
144200555|NCT05297578|519931642|FG001|Overall Study|Lost to Follow-up|1|||
144200556|NCT05297578|519931643|FG002|Overall Study|Lost to Follow-up|2|||
144200557|NCT05297578|519931644|FG003|Overall Study|Lost to Follow-up|1|||
144200558|NCT05297578|519931641|FG000|Overall Study|Death|0|||
144200559|NCT05297578|519931642|FG001|Overall Study|Death|1|||
144200560|NCT05297578|519931643|FG002|Overall Study|Death|0|||
144200561|NCT05297578|519931644|FG003|Overall Study|Death|0|||
144200562|NCT05297578|519931641|FG000|Overall Study|Withdrawal by Subject|0|||
144260430|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
144539218|NCT02761187|521175723|FG000|Overall Study|Reason not Specified|1484|||
144539219|NCT02761187|521175724|FG001|Overall Study|Reason not Specified|937|||
144539220|NCT04153890|521175725|FG000|Overall Study|Lost to Follow-up|9|||
144539221|NCT04153890|521175726|FG001|Overall Study|Lost to Follow-up|0|||
144539222|NCT04153890|521175727|FG002|Overall Study|Lost to Follow-up|9|||
144539223|NCT04153890|521175728|FG003|Overall Study|Lost to Follow-up|0|||
144539224|NCT04153890|521175725|FG000|Overall Study|Death|0|||
144539225|NCT04153890|521175726|FG001|Overall Study|Death|2|||
144539226|NCT04153890|521175727|FG002|Overall Study|Death|0|||
144539227|NCT04153890|521175728|FG003|Overall Study|Death|0|||
144539228|NCT04153890|521175725|FG000|Overall Study|Withdrawal by Subject|0|||
144539229|NCT04153890|521175726|FG001|Overall Study|Withdrawal by Subject|0|||
144200563|NCT05297578|519931642|FG001|Overall Study|Withdrawal by Subject|0|||
144200564|NCT05297578|519931643|FG002|Overall Study|Withdrawal by Subject|1|||
144260431|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
144539230|NCT04153890|521175727|FG002|Overall Study|Withdrawal by Subject|0|||
144200565|NCT05297578|519931644|FG003|Overall Study|Withdrawal by Subject|0|||
144200566|NCT00117325|519931646|FG000|Overall Study|Adverse Event|3|||
144200567|NCT00117325|519931647|FG001|Overall Study|Adverse Event|3|||
144200568|NCT00117325|519931646|FG000|Overall Study|Lost to Follow-up|1|||
144200569|NCT00117325|519931647|FG001|Overall Study|Lost to Follow-up|1|||
144539231|NCT04153890|521175728|FG003|Overall Study|Withdrawal by Subject|2|||
144200570|NCT00117325|519931646|FG000|Overall Study|Protocol Violation|2|||
144200571|NCT00117325|519931647|FG001|Overall Study|Protocol Violation|3|||
144200572|NCT00117325|519931646|FG000|Overall Study|Withdrawal by Subject|3|||
144200573|NCT00117325|519931647|FG001|Overall Study|Withdrawal by Subject|2|||
144200574|NCT00117325|519931646|FG000|Overall Study|Lack of Efficacy|1|||
144200575|NCT00117325|519931647|FG001|Overall Study|Lack of Efficacy|0|||
144539232|NCT03997474|521175731|FG000|Overall Study|Death|6|||
144539233|NCT03997474|521175732|FG001|Overall Study|Death|2|||
144539234|NCT03997474|521175733|FG002|Overall Study|Death|1|||
144539235|NCT03997474|521175731|FG000|Overall Study|Physician Decision|2|||
144539236|NCT03997474|521175732|FG001|Overall Study|Physician Decision|0|||
144539237|NCT03997474|521175733|FG002|Overall Study|Physician Decision|0|||
144539238|NCT03997474|521175731|FG000|Overall Study|study terminated by sponsor|1|||
144539239|NCT03997474|521175732|FG001|Overall Study|study terminated by sponsor|0|||
144539240|NCT03997474|521175733|FG002|Overall Study|study terminated by sponsor|1|||
144539241|NCT05786612|521175735|FG000|Overall Study|Adverse Event|1|||
144539242|NCT05786612|521175736|FG001|Overall Study|Adverse Event|2|||
144539243|NCT05786612|521175735|FG000|Overall Study|one screening failure|0|||
144539244|NCT05786612|521175736|FG001|Overall Study|one screening failure|2|||
144539245|NCT05630833|521175739|FG000|Overall Study|Adverse Event|3|||
144539246|NCT05630833|521175740|FG001|Overall Study|Adverse Event|0|||
144539247|NCT05630833|521175739|FG000|Overall Study|Lack of Efficacy|0|||
144539248|NCT05630833|521175740|FG001|Overall Study|Lack of Efficacy|1|||
144539249|NCT05630833|521175739|FG000|Overall Study|Lost to Follow-up|1|||
144539250|NCT05630833|521175740|FG001|Overall Study|Lost to Follow-up|0|||
144615091|NCT02873936|521452001|FG002|Overall Study|Adverse Event|3|||
144615092|NCT02873936|521451999|FG000|Overall Study|Protocol Violation|0|||
144615093|NCT02873936|521452000|FG001|Overall Study|Protocol Violation|1|||
144615094|NCT02873936|521452001|FG002|Overall Study|Protocol Violation|3|||
144615095|NCT02873936|521451999|FG000|Overall Study|Lost to Follow-up|1|||
144615096|NCT02873936|521452000|FG001|Overall Study|Lost to Follow-up|1|||
144615097|NCT02873936|521452001|FG002|Overall Study|Lost to Follow-up|1|||
144615098|NCT02873936|521451999|FG000|Overall Study|Non-compliance With Study Drug|1|||
144615099|NCT02873936|521452000|FG001|Overall Study|Non-compliance With Study Drug|0|||
144615100|NCT02873936|521452001|FG002|Overall Study|Non-compliance With Study Drug|1|||
144615101|NCT02873936|521451999|FG000|Overall Study|Randomized but not Dosed|1|||
144615102|NCT02873936|521452000|FG001|Overall Study|Randomized but not Dosed|0|||
144615103|NCT02873936|521452001|FG002|Overall Study|Randomized but not Dosed|0|||
144615104|NCT05513625|521452002|FG000|Overall Study|Withdrawal by Subject|1|||
144615105|NCT01015768|521452003|FG000|Overall Study|Some subject data unuseable|4|||
144615106|NCT01015768|521452004|FG001|Overall Study|Some subject data unuseable|4|||
144615107|NCT01225731|521452006|FG000|Part 1|Did not meet eligibility criteria|1|||
144615108|NCT01225731|521452007|FG001|Part 1|Did not meet eligibility criteria|0|||
144615109|NCT01225731|521452008|FG002|Part 1|Did not meet eligibility criteria|0|||
144615110|NCT01225731|521452009|FG003|Part 1|Did not meet eligibility criteria|0|||
144615111|NCT01225731|521452010|FG004|Part 1|Did not meet eligibility criteria|1|||
144615112|NCT01225731|521452011|FG005|Part 1|Did not meet eligibility criteria|0|||
144615113|NCT01225731|521452012|FG006|Part 1|Did not meet eligibility criteria|0|||
144615114|NCT01225731|521452013|FG007|Part 1|Did not meet eligibility criteria|0|||
144615115|NCT01225731|521452014|FG008|Part 1|Did not meet eligibility criteria|0|||
144615116|NCT01225731|521452015|FG009|Part 1|Did not meet eligibility criteria|0|||
144615117|NCT01225731|521452016|FG010|Part 1|Did not meet eligibility criteria|0|||
144615118|NCT01225731|521452017|FG011|Part 1|Did not meet eligibility criteria|0|||
144615119|NCT01225731|521452018|FG012|Part 1|Did not meet eligibility criteria|0|||
144615120|NCT01225731|521452006|FG000|Part 1|Adverse Event|1|||
144615121|NCT01225731|521452007|FG001|Part 1|Adverse Event|2|||
144615122|NCT01225731|521452008|FG002|Part 1|Adverse Event|1|||
144615123|NCT01225731|521452009|FG003|Part 1|Adverse Event|1|||
144615124|NCT01225731|521452010|FG004|Part 1|Adverse Event|1|||
144615125|NCT01225731|521452011|FG005|Part 1|Adverse Event|0|||
144615126|NCT01225731|521452012|FG006|Part 1|Adverse Event|0|||
144615127|NCT01225731|521452013|FG007|Part 1|Adverse Event|0|||
144615128|NCT01225731|521452014|FG008|Part 1|Adverse Event|0|||
144615129|NCT01225731|521452015|FG009|Part 1|Adverse Event|0|||
144615130|NCT01225731|521452016|FG010|Part 1|Adverse Event|0|||
144615131|NCT01225731|521452017|FG011|Part 1|Adverse Event|0|||
144615132|NCT01225731|521452018|FG012|Part 1|Adverse Event|0|||
144615133|NCT01225731|521452006|FG000|Part 1|Withdrawal by Subject|0|||
144615134|NCT01225731|521452007|FG001|Part 1|Withdrawal by Subject|3|||
144615135|NCT01225731|521452008|FG002|Part 1|Withdrawal by Subject|0|||
144539251|NCT05630833|521175739|FG000|Overall Study|Withdrawal by Subject|3|||
144539252|NCT05630833|521175740|FG001|Overall Study|Withdrawal by Subject|1|||
144539253|NCT03277989|521175742|FG000|Overall Study|Lost to Follow-up|6|||
144539254|NCT03277989|521175742|FG000|Overall Study|Adverse Event|6|||
144539255|NCT03277989|521175742|FG000|Overall Study|Withdrawal by Subject|3|||
144615136|NCT01225731|521452009|FG003|Part 1|Withdrawal by Subject|0|||
144615137|NCT01225731|521452010|FG004|Part 1|Withdrawal by Subject|4|||
144615138|NCT01225731|521452011|FG005|Part 1|Withdrawal by Subject|0|||
144615139|NCT01225731|521452012|FG006|Part 1|Withdrawal by Subject|0|||
144615140|NCT01225731|521452013|FG007|Part 1|Withdrawal by Subject|0|||
144615141|NCT01225731|521452014|FG008|Part 1|Withdrawal by Subject|0|||
144615142|NCT01225731|521452015|FG009|Part 1|Withdrawal by Subject|0|||
144615143|NCT01225731|521452016|FG010|Part 1|Withdrawal by Subject|0|||
144615144|NCT01225731|521452017|FG011|Part 1|Withdrawal by Subject|0|||
144615145|NCT01225731|521452018|FG012|Part 1|Withdrawal by Subject|0|||
144615146|NCT01225731|521452006|FG000|Part 1|Protocol Violation|0|||
144539256|NCT03277989|521175742|FG000|Overall Study|Didn't Receive Study Device|7|||
144539257|NCT03277989|521175742|FG000|Overall Study|Site Closure|26|||
144539258|NCT03277989|521175742|FG000|Overall Study|Sponsor Closure|107|||
144539259|NCT05485805|521175743|FG000|Overall Study|Withdrawal by Subject|1|||
144539260|NCT05485805|521175744|FG001|Overall Study|Withdrawal by Subject|2|||
144539261|NCT05485805|521175745|FG002|Overall Study|Withdrawal by Subject|2|||
144539262|NCT05485805|521175746|FG003|Overall Study|Withdrawal by Subject|0|||
144539263|NCT05485805|521175747|FG004|Overall Study|Withdrawal by Subject|2|||
144539264|NCT05485805|521175743|FG000|Overall Study|Adverse Event|0|||
144539265|NCT05485805|521175744|FG001|Overall Study|Adverse Event|1|||
144539266|NCT05485805|521175745|FG002|Overall Study|Adverse Event|0|||
144539267|NCT05485805|521175746|FG003|Overall Study|Adverse Event|0|||
144539268|NCT05485805|521175747|FG004|Overall Study|Adverse Event|0|||
144539269|NCT05485805|521175743|FG000|Overall Study|Lost to Follow-up|1|||
144539270|NCT05485805|521175744|FG001|Overall Study|Lost to Follow-up|1|||
144539271|NCT05485805|521175745|FG002|Overall Study|Lost to Follow-up|3|||
144539272|NCT05485805|521175746|FG003|Overall Study|Lost to Follow-up|1|||
144539273|NCT05485805|521175747|FG004|Overall Study|Lost to Follow-up|0|||
144539274|NCT00490139|521175748|FG000|Overall Study|Lost to Follow-up|249|||
144539275|NCT00490139|521175749|FG001|Overall Study|Lost to Follow-up|216|||
144539276|NCT00490139|521175750|FG002|Overall Study|Lost to Follow-up|205|||
144539277|NCT00490139|521175751|FG003|Overall Study|Lost to Follow-up|229|||
144539278|NCT00490139|521175748|FG000|Overall Study|Withdrawal by Subject|333|||
144539279|NCT00490139|521175749|FG001|Overall Study|Withdrawal by Subject|322|||
144539280|NCT00490139|521175750|FG002|Overall Study|Withdrawal by Subject|396|||
144539281|NCT00490139|521175751|FG003|Overall Study|Withdrawal by Subject|295|||
144539282|NCT00490139|521175748|FG000|Overall Study|Patient did not sign ICF 12|169|||
144539283|NCT00490139|521175749|FG001|Overall Study|Patient did not sign ICF 12|176|||
144539284|NCT00490139|521175750|FG002|Overall Study|Patient did not sign ICF 12|139|||
144539285|NCT00490139|521175751|FG003|Overall Study|Patient did not sign ICF 12|167|||
144200576|NCT00117325|519931646|FG000|Overall Study|Use of prohibited medicine|1|||
144200577|NCT00117325|519931647|FG001|Overall Study|Use of prohibited medicine|2|||
144539286|NCT00490139|521175748|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
144539287|NCT00490139|521175749|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
144200578|NCT00117325|519931646|FG000|Overall Study|Early termination|1|||
144200579|NCT00117325|519931647|FG001|Overall Study|Early termination|1|||
144200580|NCT00117325|519931646|FG000|Overall Study|Admisnitrative|1|||
144200581|NCT00117325|519931647|FG001|Overall Study|Admisnitrative|0|||
144200582|NCT02731326|519931652|FG000|Overall Study|Withdrawal by Subject|4|||
144200583|NCT02731326|519931653|FG001|Overall Study|Withdrawal by Subject|1|||
144200584|NCT02731326|519931652|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
144200585|NCT02731326|519931653|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
144200586|NCT02731326|519931652|FG000|Overall Study|Discharged without AliveCor|10|||
144200587|NCT02731326|519931653|FG001|Overall Study|Discharged without AliveCor|0|||
144200588|NCT02731326|519931652|FG000|Overall Study|Duplicate Participant|1|||
144200589|NCT02731326|519931653|FG001|Overall Study|Duplicate Participant|1|||
144200590|NCT00816361|519931656|FG000|Overall Study|Withdrawal by Subject|0|||
144200591|NCT00816361|519931657|FG001|Overall Study|Withdrawal by Subject|0|||
144200592|NCT00816361|519931658|FG002|Overall Study|Withdrawal by Subject|0|||
144200593|NCT00816361|519931659|FG003|Overall Study|Withdrawal by Subject|0|||
144200594|NCT00816361|519931660|FG004|Overall Study|Withdrawal by Subject|1|||
144200595|NCT00816361|519931661|FG005|Overall Study|Withdrawal by Subject|2|||
144200596|NCT00816361|519931662|FG006|Overall Study|Withdrawal by Subject|0|||
144200597|NCT00816361|519931663|FG007|Overall Study|Withdrawal by Subject|2|||
144200598|NCT00816361|519931664|FG008|Overall Study|Withdrawal by Subject|1|||
144539288|NCT00490139|521175750|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
144539289|NCT00490139|521175751|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
144539290|NCT00490139|521175748|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
144539291|NCT00490139|521175749|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
144539292|NCT00490139|521175750|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
144539293|NCT00490139|521175751|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
144200599|NCT00816361|519931656|FG000|Overall Study|Death|4|||
144200600|NCT00816361|519931657|FG001|Overall Study|Death|3|||
144200601|NCT00816361|519931658|FG002|Overall Study|Death|3|||
144200602|NCT00816361|519931659|FG003|Overall Study|Death|3|||
144200603|NCT00816361|519931660|FG004|Overall Study|Death|1|||
144260432|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
144260433|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
144539294|NCT00490139|521175748|FG000|Overall Study|Other reasons as defined per protocol|98|||
144539295|NCT00490139|521175749|FG001|Overall Study|Other reasons as defined per protocol|84|||
144539296|NCT00490139|521175750|FG002|Overall Study|Other reasons as defined per protocol|82|||
144539297|NCT00490139|521175751|FG003|Overall Study|Other reasons as defined per protocol|105|||
144539298|NCT02798471|521175754|FG000|Overall Study|Adverse Event|7|||
144539299|NCT02798471|521175755|FG001|Overall Study|Adverse Event|2|||
144200604|NCT00816361|519931661|FG005|Overall Study|Death|1|||
144539300|NCT02798471|521175754|FG000|Overall Study|Physician Decision|3|||
144539301|NCT02798471|521175755|FG001|Overall Study|Physician Decision|7|||
144539302|NCT02798471|521175754|FG000|Overall Study|Death|2|||
144539303|NCT02798471|521175755|FG001|Overall Study|Death|3|||
144539304|NCT02798471|521175754|FG000|Overall Study|Lost to Follow-up|0|||
144539305|NCT02798471|521175755|FG001|Overall Study|Lost to Follow-up|1|||
144539306|NCT02798471|521175754|FG000|Overall Study|Other|5|||
144539307|NCT02798471|521175755|FG001|Overall Study|Other|3|||
144539308|NCT02798471|521175754|FG000|Overall Study|Subject withdrew consent|0|||
144539309|NCT02798471|521175755|FG001|Overall Study|Subject withdrew consent|6|||
144539310|NCT02798471|521175754|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
144539311|NCT02798471|521175755|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
144539312|NCT02798471|521175754|FG000|Overall Study|Randomized, but not treated|0|||
144539313|NCT02798471|521175755|FG001|Overall Study|Randomized, but not treated|2|||
144539314|NCT03083366|521177318|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
144539315|NCT03083366|521177319|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
144539316|NCT03083366|521177318|FG000|Enrollment Period|Lack of Efficacy|1|||
144539317|NCT03083366|521177319|FG001|Enrollment Period|Lack of Efficacy|0|||
144539318|NCT02702843|521177324|FG000|Overall Study|Insufficient data to analyze|15|||
144539319|NCT02702843|521177325|FG001|Overall Study|Insufficient data to analyze|23|||
144539320|NCT05250115|521177326|FG000|Overall Study|Premature study end|40|||
144539321|NCT05250115|521177326|FG000|Overall Study|Adverse Event|8|||
144539322|NCT05250115|521177326|FG000|Overall Study|Lost to Follow-up|7|||
144539323|NCT05250115|521177326|FG000|Overall Study|Withdrawal by Subject|6|||
144539324|NCT05250115|521177326|FG000|Overall Study|Withdrawal of informed consent|1|||
144539325|NCT05250115|521177326|FG000|Overall Study|Other|7|||
144539326|NCT03758638|521177327|FG000|Overall Study|Pregnancy|17|||
144539327|NCT03758638|521177328|FG001|Overall Study|Pregnancy|25|||
144539328|NCT03758638|521177327|FG000|Overall Study|Lost to Follow-up|60|||
144539329|NCT03758638|521177328|FG001|Overall Study|Lost to Follow-up|54|||
144539330|NCT03758638|521177327|FG000|Overall Study|Protocol Violation|2|||
144539331|NCT03758638|521177328|FG001|Overall Study|Protocol Violation|0|||
144539332|NCT03758638|521177327|FG000|Overall Study|Withdrawal by Subject|8|||
144539333|NCT03758638|521177328|FG001|Overall Study|Withdrawal by Subject|2|||
144539334|NCT03758638|521177327|FG000|Overall Study|Providers not included in the primary outcome.|183|||
144539335|NCT03758638|521177328|FG001|Overall Study|Providers not included in the primary outcome.|128|||
144539336|NCT01314118|521177329|FG000|Overall Study|Adverse Event|9|||
144539337|NCT01314118|521177329|FG000|Overall Study|Progressive disease|27|||
144539338|NCT01314118|521177329|FG000|Overall Study|Physician Decision|11|||
144539339|NCT01314118|521177329|FG000|Overall Study|Death|4|||
144539340|NCT01314118|521177329|FG000|Overall Study|Protocol Violation|5|||
144539341|NCT01314118|521177329|FG000|Overall Study|Withdrawal by Subject|11|||
144539342|NCT01314118|521177329|FG000|Overall Study|Other|2|||
144539343|NCT01314118|521177329|FG000|Overall Study|Ongoing|62|||
144539344|NCT00065182|521177333|FG000|Overall Study|Adverse Event|24|||
144539345|NCT00065182|521177334|FG001|Overall Study|Adverse Event|17|||
144539346|NCT00065182|521177333|FG000|Overall Study|Lost to Follow-up|0|||
144539347|NCT00065182|521177334|FG001|Overall Study|Lost to Follow-up|4|||
144539348|NCT00065182|521177333|FG000|Overall Study|Protocol Violation|3|||
144539349|NCT00065182|521177334|FG001|Overall Study|Protocol Violation|4|||
144539350|NCT00065182|521177333|FG000|Overall Study|Serious adverse events (SAE)|1|||
144539351|NCT00065182|521177334|FG001|Overall Study|Serious adverse events (SAE)|0|||
144539352|NCT00065182|521177333|FG000|Overall Study|Sponsor Decision|11|||
144539353|NCT00065182|521177334|FG001|Overall Study|Sponsor Decision|7|||
144539354|NCT00065182|521177333|FG000|Overall Study|Withdrawal by Subject|8|||
144539355|NCT00065182|521177334|FG001|Overall Study|Withdrawal by Subject|3|||
144539356|NCT00065182|521177333|FG000|Overall Study|No clinical benefit|1|||
144539357|NCT00065182|521177334|FG001|Overall Study|No clinical benefit|0|||
144539358|NCT00065182|521177333|FG000|Overall Study|Death|0|||
144539359|NCT00065182|521177334|FG001|Overall Study|Death|1|||
144539360|NCT00065182|521177333|FG000|Overall Study|Decline in Status|0|||
144539361|NCT00065182|521177334|FG001|Overall Study|Decline in Status|1|||
144539362|NCT00790569|521177335|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
144539363|NCT00790569|521177336|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
144200605|NCT00816361|519931662|FG006|Overall Study|Death|3|||
144200606|NCT00816361|519931663|FG007|Overall Study|Death|7|||
144539364|NCT00790569|521177337|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
144539365|NCT00790569|521177335|FG000|End of Treatment (6 Month Interview)|Death|0|||
144539366|NCT00790569|521177336|FG001|End of Treatment (6 Month Interview)|Death|2|||
144539367|NCT00790569|521177337|FG002|End of Treatment (6 Month Interview)|Death|1|||
144539368|NCT00790569|521177335|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
144539369|NCT00790569|521177336|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
144539370|NCT00790569|521177337|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
144539371|NCT00790569|521177335|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
144539372|NCT00790569|521177336|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
144200607|NCT00816361|519931664|FG008|Overall Study|Death|8|||
144539373|NCT00790569|521177337|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
144539374|NCT00790569|521177335|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
144539375|NCT00790569|521177336|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
144539376|NCT00790569|521177337|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
144539377|NCT00790569|521177335|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
144539378|NCT00790569|521177336|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
144539379|NCT00790569|521177337|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
144539380|NCT03244800|521177338|FG000|Overall Study|Adverse Event|0|||
144539381|NCT03244800|521177339|FG001|Overall Study|Adverse Event|1|||
144539382|NCT03244800|521177340|FG002|Overall Study|Adverse Event|0|||
144539383|NCT03244800|521177341|FG003|Overall Study|Adverse Event|1|||
144539384|NCT03244800|521177338|FG000|Overall Study|Withdrew treatment|0|||
144539385|NCT03244800|521177339|FG001|Overall Study|Withdrew treatment|0|||
144539386|NCT03244800|521177340|FG002|Overall Study|Withdrew treatment|0|||
144539387|NCT03244800|521177341|FG003|Overall Study|Withdrew treatment|1|||
144615147|NCT01225731|521452007|FG001|Part 1|Protocol Violation|0|||
144615148|NCT01225731|521452008|FG002|Part 1|Protocol Violation|0|||
144615149|NCT01225731|521452009|FG003|Part 1|Protocol Violation|1|||
144615150|NCT01225731|521452010|FG004|Part 1|Protocol Violation|0|||
144615151|NCT01225731|521452011|FG005|Part 1|Protocol Violation|0|||
144615152|NCT01225731|521452012|FG006|Part 1|Protocol Violation|0|||
144615153|NCT01225731|521452013|FG007|Part 1|Protocol Violation|0|||
144615154|NCT01225731|521452014|FG008|Part 1|Protocol Violation|0|||
144615155|NCT01225731|521452015|FG009|Part 1|Protocol Violation|0|||
144615156|NCT01225731|521452016|FG010|Part 1|Protocol Violation|0|||
144615157|NCT01225731|521452017|FG011|Part 1|Protocol Violation|0|||
144615158|NCT01225731|521452018|FG012|Part 1|Protocol Violation|0|||
144615159|NCT01225731|521452006|FG000|Part 2|Protocol Violation|0|||
144615160|NCT01225731|521452007|FG001|Part 2|Protocol Violation|0|||
144615161|NCT01225731|521452008|FG002|Part 2|Protocol Violation|0|||
144615162|NCT01225731|521452009|FG003|Part 2|Protocol Violation|0|||
144615163|NCT01225731|521452010|FG004|Part 2|Protocol Violation|0|||
144615164|NCT01225731|521452011|FG005|Part 2|Protocol Violation|1|||
144727409|NCT01355081|521856636|FG002|Overall Study|Non Compliance with Study Medication|0|||
144727410|NCT02480764|521856637|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
144727411|NCT02480764|521856638|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
144539388|NCT02941549|521177345|FG000|Overall Study|Adverse Event|1|||
144539389|NCT02941549|521177346|FG001|Overall Study|Adverse Event|0|||
144539390|NCT02941549|521177347|FG002|Overall Study|Adverse Event|0|||
144539391|NCT02941549|521177345|FG000|Overall Study|Withdrawal by Subject|2|||
144539392|NCT02941549|521177346|FG001|Overall Study|Withdrawal by Subject|1|||
144539393|NCT02941549|521177347|FG002|Overall Study|Withdrawal by Subject|2|||
144539394|NCT03451422|521177351|FG000|Overall Study|Lost to Follow-up|0|||
144539395|NCT03451422|521177352|FG001|Overall Study|Lost to Follow-up|0|||
144539396|NCT03451422|521177353|FG002|Overall Study|Lost to Follow-up|0|||
144539397|NCT03451422|521177354|FG003|Overall Study|Lost to Follow-up|0|||
144539398|NCT03451422|521177355|FG004|Overall Study|Lost to Follow-up|0|||
144539399|NCT03451422|521177356|FG005|Overall Study|Lost to Follow-up|1|||
144539400|NCT03451422|521177351|FG000|Overall Study|Decision by sponsor|1|||
144539401|NCT03451422|521177352|FG001|Overall Study|Decision by sponsor|0|||
144539402|NCT03451422|521177353|FG002|Overall Study|Decision by sponsor|1|||
144539403|NCT03451422|521177354|FG003|Overall Study|Decision by sponsor|0|||
144539404|NCT03451422|521177355|FG004|Overall Study|Decision by sponsor|0|||
144539405|NCT03451422|521177356|FG005|Overall Study|Decision by sponsor|0|||
144539406|NCT03451422|521177351|FG000|Overall Study|Withdrawal by Subject|0|||
144539407|NCT03451422|521177352|FG001|Overall Study|Withdrawal by Subject|0|||
144539408|NCT03451422|521177353|FG002|Overall Study|Withdrawal by Subject|2|||
144539409|NCT03451422|521177354|FG003|Overall Study|Withdrawal by Subject|3|||
144539410|NCT03451422|521177355|FG004|Overall Study|Withdrawal by Subject|2|||
144539411|NCT03451422|521177356|FG005|Overall Study|Withdrawal by Subject|1|||
144539412|NCT03601715|521177357|FG000|Second Intervention|Lost to Follow-up|1|||
144539413|NCT03601715|521177358|FG001|Second Intervention|Lost to Follow-up|1|||
144539414|NCT03601715|521177359|FG002|Second Intervention|Lost to Follow-up|0|||
144539415|NCT01478594|521177360|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
144539416|NCT01478594|521177361|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
144615165|NCT01225731|521452012|FG006|Part 2|Protocol Violation|0|||
144615166|NCT01225731|521452013|FG007|Part 2|Protocol Violation|0|||
144615167|NCT01225731|521452014|FG008|Part 2|Protocol Violation|1|||
144539417|NCT01478594|521177360|FG000|Overall Study|Death|45|||
144539418|NCT01478594|521177361|FG001|Overall Study|Death|18|||
144539419|NCT01478594|521177360|FG000|Overall Study|Lost to Follow-up|3|||
144539420|NCT01478594|521177361|FG001|Overall Study|Lost to Follow-up|1|||
144539421|NCT01478594|521177360|FG000|Overall Study|Withdrawal by Subject|9|||
144539422|NCT01478594|521177361|FG001|Overall Study|Withdrawal by Subject|3|||
144615168|NCT01225731|521452015|FG009|Part 2|Protocol Violation|0|||
144615169|NCT01225731|521452016|FG010|Part 2|Protocol Violation|0|||
144615170|NCT01225731|521452017|FG011|Part 2|Protocol Violation|0|||
144615171|NCT01225731|521452018|FG012|Part 2|Protocol Violation|0|||
144615172|NCT01225731|521452006|FG000|Part 2|Adverse Event|0|||
144615173|NCT01225731|521452007|FG001|Part 2|Adverse Event|0|||
144200608|NCT00816361|519931656|FG000|Overall Study|Other|0|||
144200609|NCT00816361|519931657|FG001|Overall Study|Other|0|||
144200610|NCT00816361|519931658|FG002|Overall Study|Other|0|||
144200611|NCT00816361|519931659|FG003|Overall Study|Other|0|||
144200612|NCT00816361|519931660|FG004|Overall Study|Other|0|||
144200613|NCT00816361|519931661|FG005|Overall Study|Other|0|||
144200614|NCT00816361|519931662|FG006|Overall Study|Other|0|||
144539423|NCT01478594|521177360|FG000|Overall Study|Study Closed by Sponsor|8|||
144539424|NCT01478594|521177361|FG001|Overall Study|Study Closed by Sponsor|5|||
144539425|NCT00918333|521177362|FG000|Overall Study|Drug not taken per protocol|1|||
144539426|NCT00918333|521177363|FG001|Overall Study|Drug not taken per protocol|0|||
144539427|NCT00918333|521177362|FG000|Overall Study|Inadequate amount of drugs provided|1|||
144539428|NCT00918333|521177363|FG001|Overall Study|Inadequate amount of drugs provided|4|||
144539429|NCT00918333|521177362|FG000|Overall Study|Ineligible|1|||
144539430|NCT00918333|521177363|FG001|Overall Study|Ineligible|0|||
144539431|NCT00918333|521177362|FG000|Overall Study|Withdrawal by Subject|0|||
144539432|NCT00918333|521177363|FG001|Overall Study|Withdrawal by Subject|1|||
144539433|NCT01313884|521177365|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
144539434|NCT00713596|521177366|FG000|Overall Study|Study was terminated|2|||
144539435|NCT00713596|521177367|FG001|Overall Study|Study was terminated|3|||
144539436|NCT00713596|521177368|FG002|Overall Study|Study was terminated|2|||
144539437|NCT04545619|521177369|FG000|Overall Study|due to equipment challenges|1|||
144539438|NCT02854436|521177370|FG000|Overall Study|Adverse Event|1|||
144539439|NCT02854436|521177370|FG000|Overall Study|Death|208|||
144539440|NCT02854436|521177370|FG000|Overall Study|Lost to Follow-up|5|||
144539441|NCT02854436|521177370|FG000|Overall Study|Withdrawal by Subject|24|||
144539442|NCT02854436|521177370|FG000|Overall Study|Other|45|||
144539443|NCT02854436|521177370|FG000|Overall Study|Physician Decision|6|||
144539444|NCT00754065|521177375|FG000|Overall Study|Never received treatment|12|||
144539445|NCT00754065|521177376|FG001|Overall Study|Never received treatment|2|||
144539446|NCT00754065|521177375|FG000|Overall Study|Adverse Event|19|||
144539447|NCT00754065|521177376|FG001|Overall Study|Adverse Event|25|||
144539448|NCT00754065|521177375|FG000|Overall Study|Lost to Follow-up|7|||
144539449|NCT00754065|521177376|FG001|Overall Study|Lost to Follow-up|11|||
144539450|NCT00754065|521177375|FG000|Overall Study|Protocol Violation|12|||
144539451|NCT00754065|521177376|FG001|Overall Study|Protocol Violation|10|||
144539452|NCT00754065|521177375|FG000|Overall Study|Withdrawal by Subject|4|||
144539453|NCT00754065|521177376|FG001|Overall Study|Withdrawal by Subject|5|||
144539454|NCT00754065|521177375|FG000|Overall Study|Pregnancy|6|||
144539455|NCT00754065|521177376|FG001|Overall Study|Pregnancy|0|||
144539456|NCT00754065|521177375|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
144539457|NCT00754065|521177376|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
144539458|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
144539459|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
144539460|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539461|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539462|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539463|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
144539464|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
144539465|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539466|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539467|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539468|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539469|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539470|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539471|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
144539472|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539473|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144615174|NCT01225731|521452008|FG002|Part 2|Adverse Event|0|||
144200615|NCT00816361|519931663|FG007|Overall Study|Other|0|||
144200616|NCT00816361|519931664|FG008|Overall Study|Other|1|||
144200617|NCT01394952|519931665|FG000|Overall Study|Lost to Follow-up|0|||
144200618|NCT01394952|519931666|FG001|Overall Study|Lost to Follow-up|5|||
144539474|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539475|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539476|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539477|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
144539478|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
144539479|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539480|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539481|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144200619|NCT01394952|519931665|FG000|Overall Study|Withdrawal by Subject|10|||
144200620|NCT01394952|519931666|FG001|Overall Study|Withdrawal by Subject|5|||
144200621|NCT01394952|519931665|FG000|Overall Study|Physician Decision|2|||
144200622|NCT01394952|519931666|FG001|Overall Study|Physician Decision|0|||
144539482|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539483|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539484|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539485|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
144539486|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
144539487|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144200623|NCT01394952|519931665|FG000|Overall Study|Sponsor Decision|5|||
144200624|NCT01394952|519931666|FG001|Overall Study|Sponsor Decision|7|||
144200625|NCT01986010|519931667|FG000|Overall Study|Adverse Event|0|||
144200626|NCT01986010|519931668|FG001|Overall Study|Adverse Event|1|||
144200627|NCT01986010|519931669|FG002|Overall Study|Adverse Event|0|||
144200628|NCT01986010|519931670|FG003|Overall Study|Adverse Event|0|||
144200629|NCT01986010|519931671|FG004|Overall Study|Adverse Event|0|||
144200630|NCT01986010|519931672|FG005|Overall Study|Adverse Event|0|||
144200631|NCT01986010|519931673|FG006|Overall Study|Adverse Event|0|||
144200632|NCT01986010|519931674|FG007|Overall Study|Adverse Event|0|||
144200633|NCT01986010|519931675|FG008|Overall Study|Adverse Event|0|||
144200634|NCT01986010|519931676|FG009|Overall Study|Adverse Event|0|||
144200635|NCT01986010|519931677|FG010|Overall Study|Adverse Event|0|||
144200636|NCT01986010|519931678|FG011|Overall Study|Adverse Event|0|||
144200637|NCT01986010|519931679|FG012|Overall Study|Adverse Event|0|||
144200638|NCT01986010|519931680|FG013|Overall Study|Adverse Event|0|||
144200639|NCT01986010|519931681|FG014|Overall Study|Adverse Event|0|||
144200640|NCT01986010|519931682|FG015|Overall Study|Adverse Event|1|||
144200641|NCT01986010|519931683|FG016|Overall Study|Adverse Event|0|||
144200642|NCT01986010|519931667|FG000|Overall Study|Lost to Follow-up|2|||
144200643|NCT01986010|519931668|FG001|Overall Study|Lost to Follow-up|1|||
144200644|NCT01986010|519931669|FG002|Overall Study|Lost to Follow-up|2|||
144200645|NCT01986010|519931670|FG003|Overall Study|Lost to Follow-up|2|||
144200646|NCT01986010|519931671|FG004|Overall Study|Lost to Follow-up|2|||
144200647|NCT01986010|519931672|FG005|Overall Study|Lost to Follow-up|2|||
144200648|NCT01986010|519931673|FG006|Overall Study|Lost to Follow-up|0|||
144200649|NCT01986010|519931674|FG007|Overall Study|Lost to Follow-up|0|||
144200650|NCT01986010|519931675|FG008|Overall Study|Lost to Follow-up|4|||
144200651|NCT01986010|519931676|FG009|Overall Study|Lost to Follow-up|2|||
144200652|NCT01986010|519931677|FG010|Overall Study|Lost to Follow-up|0|||
144200653|NCT01986010|519931678|FG011|Overall Study|Lost to Follow-up|1|||
144200654|NCT01986010|519931679|FG012|Overall Study|Lost to Follow-up|1|||
144200655|NCT01986010|519931680|FG013|Overall Study|Lost to Follow-up|1|||
144200656|NCT01986010|519931681|FG014|Overall Study|Lost to Follow-up|2|||
144200657|NCT01986010|519931682|FG015|Overall Study|Lost to Follow-up|0|||
144260434|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
144539488|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539489|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539490|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539491|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539492|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
144539493|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539494|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539495|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539496|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539497|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539498|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539499|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
144539500|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539501|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539502|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539503|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539504|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539505|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
144539506|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
144200658|NCT01986010|519931683|FG016|Overall Study|Lost to Follow-up|0|||
144200659|NCT01986010|519931667|FG000|Overall Study|Physician Decision|0|||
144200660|NCT01986010|519931668|FG001|Overall Study|Physician Decision|0|||
144200661|NCT01986010|519931669|FG002|Overall Study|Physician Decision|0|||
144200662|NCT01986010|519931670|FG003|Overall Study|Physician Decision|0|||
144260435|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
144539507|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539508|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539509|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144200663|NCT01986010|519931671|FG004|Overall Study|Physician Decision|0|||
144200664|NCT01986010|519931672|FG005|Overall Study|Physician Decision|0|||
144200665|NCT01986010|519931673|FG006|Overall Study|Physician Decision|0|||
144200666|NCT01986010|519931674|FG007|Overall Study|Physician Decision|0|||
144539510|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539511|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539512|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539513|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
144539514|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539515|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539516|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539517|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539518|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539519|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539520|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
144539521|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539522|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539523|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539524|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539525|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539526|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539527|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
144539528|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
144539529|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
144200667|NCT01986010|519931675|FG008|Overall Study|Physician Decision|0|||
144200668|NCT01986010|519931676|FG009|Overall Study|Physician Decision|0|||
144200669|NCT01986010|519931677|FG010|Overall Study|Physician Decision|0|||
144200670|NCT01986010|519931678|FG011|Overall Study|Physician Decision|0|||
144200671|NCT01986010|519931679|FG012|Overall Study|Physician Decision|0|||
144200672|NCT01986010|519931680|FG013|Overall Study|Physician Decision|0|||
144200673|NCT01986010|519931681|FG014|Overall Study|Physician Decision|1|||
144200674|NCT01986010|519931682|FG015|Overall Study|Physician Decision|0|||
144200675|NCT01986010|519931683|FG016|Overall Study|Physician Decision|0|||
144200676|NCT01986010|519931667|FG000|Overall Study|Withdrawal by Subject|2|||
144200677|NCT01986010|519931668|FG001|Overall Study|Withdrawal by Subject|2|||
144200678|NCT01986010|519931669|FG002|Overall Study|Withdrawal by Subject|3|||
144200679|NCT01986010|519931670|FG003|Overall Study|Withdrawal by Subject|0|||
144200680|NCT01986010|519931671|FG004|Overall Study|Withdrawal by Subject|2|||
144200681|NCT01986010|519931672|FG005|Overall Study|Withdrawal by Subject|4|||
144200682|NCT01986010|519931673|FG006|Overall Study|Withdrawal by Subject|0|||
144200683|NCT01986010|519931674|FG007|Overall Study|Withdrawal by Subject|0|||
144200684|NCT01986010|519931675|FG008|Overall Study|Withdrawal by Subject|0|||
144200685|NCT01986010|519931676|FG009|Overall Study|Withdrawal by Subject|0|||
144200686|NCT01986010|519931677|FG010|Overall Study|Withdrawal by Subject|0|||
144200687|NCT01986010|519931678|FG011|Overall Study|Withdrawal by Subject|2|||
144200688|NCT01986010|519931679|FG012|Overall Study|Withdrawal by Subject|0|||
144200689|NCT01986010|519931680|FG013|Overall Study|Withdrawal by Subject|1|||
144200690|NCT01986010|519931681|FG014|Overall Study|Withdrawal by Subject|2|||
144200691|NCT01986010|519931682|FG015|Overall Study|Withdrawal by Subject|0|||
144200692|NCT01986010|519931683|FG016|Overall Study|Withdrawal by Subject|0|||
144200693|NCT01986010|519931667|FG000|Overall Study|Status Not Recorded|2|||
144200694|NCT01986010|519931668|FG001|Overall Study|Status Not Recorded|4|||
144200695|NCT01986010|519931669|FG002|Overall Study|Status Not Recorded|2|||
144200696|NCT01986010|519931670|FG003|Overall Study|Status Not Recorded|0|||
144200697|NCT01986010|519931671|FG004|Overall Study|Status Not Recorded|1|||
144200698|NCT01986010|519931672|FG005|Overall Study|Status Not Recorded|2|||
144200699|NCT01986010|519931673|FG006|Overall Study|Status Not Recorded|0|||
144200700|NCT01986010|519931674|FG007|Overall Study|Status Not Recorded|0|||
144200701|NCT01986010|519931675|FG008|Overall Study|Status Not Recorded|2|||
144200702|NCT01986010|519931676|FG009|Overall Study|Status Not Recorded|1|||
144200703|NCT01986010|519931677|FG010|Overall Study|Status Not Recorded|7|||
144200704|NCT01986010|519931678|FG011|Overall Study|Status Not Recorded|7|||
144260436|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
144539530|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
144539531|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539532|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539533|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
144539534|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
144539535|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144200705|NCT01986010|519931679|FG012|Overall Study|Status Not Recorded|9|||
144200706|NCT01986010|519931680|FG013|Overall Study|Status Not Recorded|9|||
144200707|NCT01986010|519931681|FG014|Overall Study|Status Not Recorded|5|||
144539536|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539537|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144200708|NCT01986010|519931682|FG015|Overall Study|Status Not Recorded|10|||
144200709|NCT01986010|519931683|FG016|Overall Study|Status Not Recorded|4|||
144200710|NCT01335997|519931686|FG000|Period I and II|Adverse Event|63|||
144260437|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
144260438|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
144260439|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
144260440|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
144260441|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
144260442|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
144260443|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
144260444|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
144260445|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
144260446|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
144260447|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
144260448|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
144260449|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
144260450|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
144260451|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260452|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260453|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260454|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260455|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260456|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260457|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
144260458|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260459|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260460|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260461|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260462|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260463|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260464|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260465|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260466|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260467|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260468|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
144260469|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
144260470|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
144260471|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
144260472|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
144260473|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
144260474|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
144260475|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
144260476|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
144260477|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
144260478|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
144260479|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
144260480|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
144260481|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
144260482|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
144260483|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
144260484|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
144260485|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
144260486|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
144260487|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
144260488|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
144260489|NCT03428100|520154508|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260490|NCT03428100|520154509|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260491|NCT03428100|520154510|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260492|NCT03428100|520154511|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260493|NCT03428100|520154512|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
144472416|NCT01489189|520926766|FG000|Overall Study|Death|10|||
144472417|NCT01489189|520926767|FG001|Overall Study|Death|8|||
144472418|NCT01489189|520926766|FG000|Overall Study|Missed Visit|1|||
144615175|NCT01225731|521452009|FG003|Part 2|Adverse Event|0|||
144472419|NCT01489189|520926767|FG001|Overall Study|Missed Visit|4|||
144472420|NCT00112580|520926768|FG000|Overall Study|Adverse Event|1|||
144472421|NCT00112580|520926769|FG001|Overall Study|Adverse Event|2|||
144539538|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539539|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539540|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539541|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
144539542|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539543|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
144539544|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539545|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539546|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539547|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
144539548|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539549|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539550|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539551|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539552|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539553|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539554|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539555|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
144539556|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
144539557|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539558|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539559|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539560|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539561|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
144539562|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539563|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539564|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539565|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539566|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539567|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539568|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539569|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
144539570|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539571|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539572|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539573|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
144539574|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
144539575|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539576|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539577|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
144539578|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
144539579|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539580|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539581|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539582|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539583|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
144539584|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539585|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539586|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539587|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539588|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539589|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539590|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539591|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
144615176|NCT01225731|521452010|FG004|Part 2|Adverse Event|0|||
144615177|NCT01225731|521452011|FG005|Part 2|Adverse Event|0|||
144615178|NCT01225731|521452012|FG006|Part 2|Adverse Event|4|||
144615179|NCT01225731|521452013|FG007|Part 2|Adverse Event|4|||
144615180|NCT01225731|521452014|FG008|Part 2|Adverse Event|2|||
144615181|NCT01225731|521452015|FG009|Part 2|Adverse Event|0|||
144260494|NCT03428100|520154513|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144615182|NCT01225731|521452016|FG010|Part 2|Adverse Event|0|||
144615183|NCT01225731|521452017|FG011|Part 2|Adverse Event|0|||
144615184|NCT01225731|521452018|FG012|Part 2|Adverse Event|0|||
144615185|NCT01225731|521452006|FG000|Part 2|Lack of Efficacy|0|||
144615186|NCT01225731|521452007|FG001|Part 2|Lack of Efficacy|0|||
144615187|NCT01225731|521452008|FG002|Part 2|Lack of Efficacy|0|||
144615188|NCT01225731|521452009|FG003|Part 2|Lack of Efficacy|0|||
144200711|NCT01335997|519931687|FG001|Period I and II|Adverse Event|43|||
144539592|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
144539593|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539594|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539595|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539596|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539597|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
144539598|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539599|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539600|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539601|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539602|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539603|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539604|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539605|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539606|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
144539607|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539608|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539609|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539610|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539611|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
144539612|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539613|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539614|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539615|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
144539616|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539617|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539618|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539619|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539620|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539621|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539622|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539623|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539624|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539625|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
144539626|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539627|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539628|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539629|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539630|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539631|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539632|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539633|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
144539634|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
144539635|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539636|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539637|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539638|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539639|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
144539640|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539641|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539642|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539643|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539644|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539645|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539646|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539647|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
144200712|NCT01335997|519931686|FG000|Period I and II|Noncompliance with Study Drug|1|||
144200713|NCT01335997|519931687|FG001|Period I and II|Noncompliance with Study Drug|1|||
144539648|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539649|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539650|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539651|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539652|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144200714|NCT01335997|519931686|FG000|Period I and II|Lost to Follow-up|3|||
144200715|NCT01335997|519931687|FG001|Period I and II|Lost to Follow-up|5|||
144539653|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
144539654|NCT04033445|521177377|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144200716|NCT01335997|519931686|FG000|Period I and II|Withdrawal by Subject|9|||
144200717|NCT01335997|519931687|FG001|Period I and II|Withdrawal by Subject|4|||
144200718|NCT01335997|519931686|FG000|Period I and II|Study Terminated by Sponsor|406|||
144200719|NCT01335997|519931687|FG001|Period I and II|Study Terminated by Sponsor|415|||
144200720|NCT01335997|519931686|FG000|Period I and II|Protocol Violation|9|||
144539655|NCT04033445|521177378|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539656|NCT04033445|521177379|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539657|NCT04033445|521177380|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539658|NCT04033445|521177381|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539659|NCT04033445|521177382|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539660|NCT04033445|521177383|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539661|NCT04033445|521177384|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
144539662|NCT04033445|521177385|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539663|NCT04033445|521177386|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539664|NCT04033445|521177387|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539665|NCT04033445|521177388|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539666|NCT04033445|521177389|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539667|NCT04033445|521177390|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
144539668|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539669|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539670|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539671|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539672|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539673|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539674|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539675|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539676|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
144539677|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
144539678|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
144539679|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
144539680|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
144539681|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
144539682|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539683|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539684|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539685|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539686|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539687|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539688|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539689|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539690|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
144539691|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
144539692|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
144539693|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
144539694|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
144200721|NCT01335997|519931687|FG001|Period I and II|Protocol Violation|10|||
144200722|NCT01335997|519931686|FG000|Period I and II|Physician Decision|2|||
144200723|NCT01335997|519931687|FG001|Period I and II|Physician Decision|1|||
144200724|NCT01335997|519931686|FG000|Period III|Adverse Event|0|||
144200725|NCT01335997|519931687|FG001|Period III|Adverse Event|2|||
144200726|NCT01335997|519931686|FG000|Period III|Study Terminated by Sponsor|77|||
144539695|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
144539696|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539697|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539698|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539699|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144615189|NCT01225731|521452010|FG004|Part 2|Lack of Efficacy|0|||
144615190|NCT01225731|521452011|FG005|Part 2|Lack of Efficacy|1|||
144539700|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539701|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144200727|NCT01335997|519931687|FG001|Period III|Study Terminated by Sponsor|76|||
144200728|NCT01335997|519931686|FG000|Period III|Protocol Violation|0|||
144200729|NCT01335997|519931687|FG001|Period III|Protocol Violation|1|||
144200730|NCT01335997|519931686|FG000|Period III|Lost to Follow-up|1|||
144615191|NCT01225731|521452012|FG006|Part 2|Lack of Efficacy|0|||
144260495|NCT03428100|520154514|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
144260496|NCT03428100|520154515|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
144260497|NCT03428100|520154516|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260498|NCT03428100|520154517|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
144260499|NCT03428100|520154518|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
144260500|NCT03428100|520154519|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
144260501|NCT03428100|520154520|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
144260502|NCT03428100|520154521|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
144260503|NCT03428100|520154522|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
144260504|NCT03428100|520154523|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260505|NCT03428100|520154524|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
144260506|NCT03428100|520154525|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
144260507|NCT03428100|520154526|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
144260508|NCT00527826|520154536|FG000|Overall Study|Adverse Event|10|||
144260509|NCT00527826|520154537|FG001|Overall Study|Adverse Event|10|||
144260510|NCT00527826|520154536|FG000|Overall Study|Lost to Follow-up|3|||
144260511|NCT00527826|520154537|FG001|Overall Study|Lost to Follow-up|2|||
144260512|NCT00527826|520154536|FG000|Overall Study|Withdrawal by Subject|5|||
144260513|NCT00527826|520154537|FG001|Overall Study|Withdrawal by Subject|8|||
144260514|NCT00527826|520154536|FG000|Overall Study|Inclusion Criteria Not Met|3|||
144260515|NCT00527826|520154537|FG001|Overall Study|Inclusion Criteria Not Met|3|||
144260516|NCT00527826|520154536|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
144472422|NCT00112580|520926768|FG000|Overall Study|Disease progression|5|||
144472423|NCT00112580|520926769|FG001|Overall Study|Disease progression|16|||
144472424|NCT00112580|520926768|FG000|Overall Study|Participant withdrew consent|2|||
144472425|NCT00112580|520926769|FG001|Overall Study|Participant withdrew consent|1|||
144472426|NCT05597722|520926772|FG000|Overall Study|Study was terminated|6|||
144472427|NCT05597722|520926773|FG001|Overall Study|Study was terminated|1|||
144472428|NCT00404495|520926774|FG000|Overall Study|Death|37|||
144472429|NCT00404495|520926775|FG001|Overall Study|Death|11|||
144472430|NCT00404495|520926774|FG000|Overall Study|Lost to Follow-up|5|||
144472431|NCT00404495|520926775|FG001|Overall Study|Lost to Follow-up|0|||
144472432|NCT00404495|520926774|FG000|Overall Study|Other|1|||
144472433|NCT00404495|520926775|FG001|Overall Study|Other|0|||
144472434|NCT00404495|520926774|FG000|Overall Study|Withdrawal by Subject|1|||
144472435|NCT00404495|520926775|FG001|Overall Study|Withdrawal by Subject|0|||
144472436|NCT03904043|520926780|FG000|Overall Study|Adverse Event|1|||
144472437|NCT03904043|520926781|FG001|Overall Study|Adverse Event|1|||
144472438|NCT03904043|520926780|FG000|Overall Study|Withdrawal by Subject|1|||
144472439|NCT03904043|520926781|FG001|Overall Study|Withdrawal by Subject|0|||
144472440|NCT03904043|520926780|FG000|Overall Study|Non-compliance|1|||
144472441|NCT03904043|520926781|FG001|Overall Study|Non-compliance|0|||
144472442|NCT03904043|520926780|FG000|Overall Study|Did not start treatment|1|||
144472443|NCT03904043|520926781|FG001|Overall Study|Did not start treatment|0|||
144472444|NCT05619003|520926782|FG000|Overall Study|Adverse Event|1|||
144472445|NCT03538951|520926783|FG000|Overall Study|Withdrawal by Subject|1|||
144472446|NCT03538951|520926784|FG001|Overall Study|Withdrawal by Subject|2|||
144472447|NCT01160484|520928464|FG000|Overall Study|Lack of Efficacy|9|||
144472448|NCT01160484|520928464|FG000|Overall Study|Adverse Event|6|||
144472449|NCT01160484|520928464|FG000|Overall Study|Withdrawal by Subject|2|||
144472450|NCT01160484|520928464|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
144472451|NCT00803101|520928465|FG000|Overall Study|Death / Serious Adverse Event|4|||
144472452|NCT00803101|520928466|FG001|Overall Study|Death / Serious Adverse Event|6|||
144472453|NCT00803101|520928465|FG000|Overall Study|Withdrawal by Subject|6|||
144472454|NCT00803101|520928466|FG001|Overall Study|Withdrawal by Subject|4|||
144472455|NCT00803101|520928465|FG000|Overall Study|Lost to Follow-up|2|||
144472456|NCT00803101|520928466|FG001|Overall Study|Lost to Follow-up|2|||
144472457|NCT00803101|520928465|FG000|Overall Study|Protocol Violation|1|||
144472458|NCT00803101|520928466|FG001|Overall Study|Protocol Violation|7|||
144472459|NCT00803101|520928465|FG000|Overall Study|Surgery finished outside protocol window|1|||
144472460|NCT00803101|520928466|FG001|Overall Study|Surgery finished outside protocol window|1|||
144472461|NCT00803101|520928465|FG000|Overall Study|Patient died outside SAE report period|1|||
144472462|NCT00803101|520928466|FG001|Overall Study|Patient died outside SAE report period|0|||
144472463|NCT00803101|520928465|FG000|Overall Study|Patient did not attend scheduled visit|2|||
144472464|NCT00803101|520928466|FG001|Overall Study|Patient did not attend scheduled visit|1|||
144472465|NCT00803101|520928465|FG000|Overall Study|Patient did not have surgery|1|||
144472466|NCT00803101|520928466|FG001|Overall Study|Patient did not have surgery|1|||
144472467|NCT01529008|520928469|FG000|Bone Marrow Harvesting|Physician Decision|1|||
144472468|NCT01529008|520928470|FG001|Bone Marrow Harvesting|Physician Decision|1|||
144472469|NCT01529008|520928469|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
144472470|NCT01529008|520928470|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
144472471|NCT01529008|520928469|FG000|Treatment|Adverse Event|6|||
144615192|NCT01225731|521452013|FG007|Part 2|Lack of Efficacy|12|||
144615193|NCT01225731|521452014|FG008|Part 2|Lack of Efficacy|3|||
144615194|NCT01225731|521452015|FG009|Part 2|Lack of Efficacy|0|||
144615195|NCT01225731|521452016|FG010|Part 2|Lack of Efficacy|0|||
144615196|NCT01225731|521452017|FG011|Part 2|Lack of Efficacy|0|||
144615197|NCT01225731|521452018|FG012|Part 2|Lack of Efficacy|0|||
144615198|NCT01225731|521452006|FG000|Part 2|Pregnancy|0|||
144615199|NCT01225731|521452007|FG001|Part 2|Pregnancy|0|||
144615200|NCT01225731|521452008|FG002|Part 2|Pregnancy|0|||
144615201|NCT01225731|521452009|FG003|Part 2|Pregnancy|0|||
144615202|NCT01225731|521452010|FG004|Part 2|Pregnancy|0|||
144615203|NCT01225731|521452011|FG005|Part 2|Pregnancy|0|||
144615204|NCT01225731|521452012|FG006|Part 2|Pregnancy|1|||
144615205|NCT01225731|521452013|FG007|Part 2|Pregnancy|0|||
144615206|NCT01225731|521452014|FG008|Part 2|Pregnancy|1|||
144615207|NCT01225731|521452015|FG009|Part 2|Pregnancy|0|||
144615208|NCT01225731|521452016|FG010|Part 2|Pregnancy|0|||
144615209|NCT01225731|521452017|FG011|Part 2|Pregnancy|0|||
144539702|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539703|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539704|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539705|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539706|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
144539707|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
144539708|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
144539709|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
144539710|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539711|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539712|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539713|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539714|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539715|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539716|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539717|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539718|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539719|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
144539720|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
144539721|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
144539722|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
144539723|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
144539724|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539725|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144615210|NCT01225731|521452018|FG012|Part 2|Pregnancy|0|||
144615211|NCT01225731|521452006|FG000|Part 2|Lost to Follow-up|0|||
144615212|NCT01225731|521452007|FG001|Part 2|Lost to Follow-up|0|||
144615213|NCT01225731|521452008|FG002|Part 2|Lost to Follow-up|0|||
144615214|NCT01225731|521452009|FG003|Part 2|Lost to Follow-up|0|||
144615215|NCT01225731|521452010|FG004|Part 2|Lost to Follow-up|0|||
144615216|NCT01225731|521452011|FG005|Part 2|Lost to Follow-up|0|||
144615217|NCT01225731|521452012|FG006|Part 2|Lost to Follow-up|0|||
144615218|NCT01225731|521452013|FG007|Part 2|Lost to Follow-up|3|||
144615219|NCT01225731|521452014|FG008|Part 2|Lost to Follow-up|1|||
144615220|NCT01225731|521452015|FG009|Part 2|Lost to Follow-up|0|||
144615221|NCT01225731|521452016|FG010|Part 2|Lost to Follow-up|0|||
144615222|NCT01225731|521452017|FG011|Part 2|Lost to Follow-up|0|||
144615223|NCT01225731|521452018|FG012|Part 2|Lost to Follow-up|0|||
144615224|NCT01225731|521452006|FG000|Part 2|Physician Decision|0|||
144615225|NCT01225731|521452007|FG001|Part 2|Physician Decision|0|||
144615226|NCT01225731|521452008|FG002|Part 2|Physician Decision|0|||
144615227|NCT01225731|521452009|FG003|Part 2|Physician Decision|0|||
144615228|NCT01225731|521452010|FG004|Part 2|Physician Decision|0|||
144615229|NCT01225731|521452011|FG005|Part 2|Physician Decision|0|||
144615230|NCT01225731|521452012|FG006|Part 2|Physician Decision|0|||
144615231|NCT01225731|521452013|FG007|Part 2|Physician Decision|2|||
144615232|NCT01225731|521452014|FG008|Part 2|Physician Decision|2|||
144615233|NCT01225731|521452015|FG009|Part 2|Physician Decision|0|||
144615234|NCT01225731|521452016|FG010|Part 2|Physician Decision|0|||
144615235|NCT01225731|521452017|FG011|Part 2|Physician Decision|0|||
144615236|NCT01225731|521452018|FG012|Part 2|Physician Decision|0|||
144615237|NCT01225731|521452006|FG000|Part 2|Withdrawal by Subject|0|||
144615238|NCT01225731|521452007|FG001|Part 2|Withdrawal by Subject|0|||
144615239|NCT01225731|521452008|FG002|Part 2|Withdrawal by Subject|0|||
144615240|NCT01225731|521452009|FG003|Part 2|Withdrawal by Subject|0|||
144615241|NCT01225731|521452010|FG004|Part 2|Withdrawal by Subject|0|||
144615242|NCT01225731|521452011|FG005|Part 2|Withdrawal by Subject|1|||
144615243|NCT01225731|521452012|FG006|Part 2|Withdrawal by Subject|3|||
144615244|NCT01225731|521452013|FG007|Part 2|Withdrawal by Subject|4|||
144615245|NCT01225731|521452014|FG008|Part 2|Withdrawal by Subject|1|||
144615246|NCT01225731|521452015|FG009|Part 2|Withdrawal by Subject|0|||
144615247|NCT01225731|521452016|FG010|Part 2|Withdrawal by Subject|0|||
144539726|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539727|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539728|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539729|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539730|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539731|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539732|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
144539733|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
144539734|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
144539735|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
144539736|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
144539737|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
144539738|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539739|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539740|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539741|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539742|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539743|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539744|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539745|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539746|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539747|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539748|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539749|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539750|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
144539751|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
144539752|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539753|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539754|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539755|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539756|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539757|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539758|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539759|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539760|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
144539761|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
144539762|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
144539763|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
144539764|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
144539765|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
144539766|NCT04033445|521177377|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539767|NCT04033445|521177378|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539768|NCT04033445|521177379|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539769|NCT04033445|521177380|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539770|NCT04033445|521177381|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539771|NCT04033445|521177382|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539772|NCT04033445|521177383|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539773|NCT04033445|521177384|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539774|NCT04033445|521177385|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539775|NCT04033445|521177386|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
144539776|NCT04033445|521177387|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539777|NCT04033445|521177388|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
144539778|NCT04033445|521177389|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
144539779|NCT04033445|521177390|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
144539780|NCT04353492|521177393|FG000|Overall Study|Subject decision|24|||
144539781|NCT04353492|521177393|FG000|Overall Study|Physician Decision|5|||
144539782|NCT04353492|521177393|FG000|Overall Study|Adverse Event|3|||
144539783|NCT04353492|521177393|FG000|Overall Study|Pregnancy|3|||
144539784|NCT04353492|521177393|FG000|Overall Study|Lost to Follow-up|2|||
144539785|NCT04353492|521177393|FG000|Overall Study|Protocol deviation|1|||
144539786|NCT04353492|521177393|FG000|Overall Study|Technical problems|1|||
144539787|NCT04250194|521177394|FG000|Overall Study|Declined to schedule biopsy|6|||
144539788|NCT04250194|521177395|FG001|Overall Study|Declined to schedule biopsy|10|||
144539789|NCT04250194|521177394|FG000|Overall Study|Medically Unfit for Biopsy|2|||
144539790|NCT04250194|521177395|FG001|Overall Study|Medically Unfit for Biopsy|1|||
144539791|NCT04250194|521177394|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
144539792|NCT04250194|521177395|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
144539793|NCT04250194|521177394|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
144539794|NCT04250194|521177395|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
144539795|NCT04250194|521177394|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
144539796|NCT04250194|521177395|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
144539797|NCT00776009|521177398|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
144539798|NCT00776009|521177399|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
144539799|NCT00776009|521177400|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
144539800|NCT00776009|521177401|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
144539801|NCT00776009|521177402|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
144539802|NCT00776009|521177403|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
144539803|NCT00776009|521177398|FG000|Period 1: First Intervention|Protocol Violation|0|||
144539804|NCT00776009|521177399|FG001|Period 1: First Intervention|Protocol Violation|1|||
144539805|NCT00776009|521177400|FG002|Period 1: First Intervention|Protocol Violation|0|||
144539806|NCT00776009|521177401|FG003|Period 1: First Intervention|Protocol Violation|0|||
144539807|NCT00776009|521177402|FG004|Period 1: First Intervention|Protocol Violation|1|||
144539808|NCT00776009|521177403|FG005|Period 1: First Intervention|Protocol Violation|0|||
144539809|NCT00776009|521177398|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
144539810|NCT00776009|521177399|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
144539811|NCT00776009|521177400|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
144539812|NCT00776009|521177401|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
144539813|NCT00776009|521177402|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
144539814|NCT00776009|521177403|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
144539815|NCT00776009|521177398|FG000|Period 2: Second Intervention|Protocol Violation|1|||
144539816|NCT00776009|521177399|FG001|Period 2: Second Intervention|Protocol Violation|0|||
144539817|NCT00776009|521177400|FG002|Period 2: Second Intervention|Protocol Violation|1|||
144539818|NCT00776009|521177401|FG003|Period 2: Second Intervention|Protocol Violation|0|||
144539819|NCT00776009|521177402|FG004|Period 2: Second Intervention|Protocol Violation|0|||
144539820|NCT00776009|521177403|FG005|Period 2: Second Intervention|Protocol Violation|0|||
144539821|NCT00776009|521177398|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
144539822|NCT00776009|521177399|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
144539823|NCT00776009|521177400|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
144539824|NCT00776009|521177401|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
144539825|NCT00776009|521177402|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
144539826|NCT00776009|521177403|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
144539827|NCT00582972|521177404|FG000|Overall Study|Protocol Violation|2|||
144539828|NCT03304587|521177407|FG000|Overall Study|Headache after intervention|0|||
144539829|NCT03304587|521177408|FG001|Overall Study|Headache after intervention|1|||
144539830|NCT03304587|521177407|FG000|Overall Study|Withdrawal by Subject|1|||
144539831|NCT03304587|521177408|FG001|Overall Study|Withdrawal by Subject|0|||
144539832|NCT01458366|521177411|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
144539833|NCT01458366|521177412|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
144539834|NCT01458366|521177413|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
144539835|NCT01458366|521177414|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
144539836|NCT01458366|521177415|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
144539837|NCT01458366|521177411|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
144539838|NCT01458366|521177412|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
144539839|NCT01458366|521177413|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
144539840|NCT01458366|521177414|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
144539841|NCT01458366|521177415|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
144539842|NCT02787005|521177416|FG000|Overall Study|Adverse Event|24|||
144539843|NCT02787005|521177417|FG001|Overall Study|Adverse Event|9|||
144539844|NCT02787005|521177418|FG002|Overall Study|Adverse Event|9|||
144539845|NCT02787005|521177419|FG003|Overall Study|Adverse Event|7|||
144539846|NCT02787005|521177420|FG004|Overall Study|Adverse Event|2|||
144539847|NCT02787005|521177416|FG000|Overall Study|Death|100|||
144539848|NCT02787005|521177417|FG001|Overall Study|Death|53|||
144539849|NCT02787005|521177418|FG002|Overall Study|Death|48|||
144539850|NCT02787005|521177419|FG003|Overall Study|Death|69|||
144539851|NCT02787005|521177420|FG004|Overall Study|Death|38|||
144539852|NCT02787005|521177416|FG000|Overall Study|Sponsor Decision|7|||
144539853|NCT02787005|521177417|FG001|Overall Study|Sponsor Decision|4|||
144539854|NCT02787005|521177418|FG002|Overall Study|Sponsor Decision|0|||
144539855|NCT02787005|521177419|FG003|Overall Study|Sponsor Decision|4|||
144539856|NCT02787005|521177420|FG004|Overall Study|Sponsor Decision|5|||
144539857|NCT02787005|521177416|FG000|Overall Study|Withdrawal by Subject|2|||
144539858|NCT02787005|521177417|FG001|Overall Study|Withdrawal by Subject|1|||
144260517|NCT00527826|520154537|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
144260518|NCT00527826|520154536|FG000|Overall Study|Additional Intake of Viani forte|0|||
144260519|NCT00527826|520154537|FG001|Overall Study|Additional Intake of Viani forte|1|||
144260520|NCT00527826|520154536|FG000|Overall Study|Participant moved away|0|||
144260521|NCT00527826|520154537|FG001|Overall Study|Participant moved away|1|||
144260522|NCT00327717|520154538|FG000|Overall Study|Adverse Event|6|||
144260523|NCT00327717|520154539|FG001|Overall Study|Adverse Event|6|||
144260524|NCT00327717|520154538|FG000|Overall Study|Lack of Efficacy|0|||
144260525|NCT00327717|520154539|FG001|Overall Study|Lack of Efficacy|1|||
144260526|NCT00327717|520154538|FG000|Overall Study|Withdrawal by Subject|3|||
144260527|NCT00327717|520154539|FG001|Overall Study|Withdrawal by Subject|7|||
144260528|NCT01502033|520154540|FG000|Overall Study|1 participant had scalp discomfort|1|||
144260529|NCT01502033|520154540|FG000|Overall Study|1 participant had worsening depression|1|||
144260530|NCT01502033|520154540|FG000|Overall Study|1 participant went back to school|1|||
144260531|NCT02080364|520154541|FG000|Baseline Period|Protocol Violation|2|||
144260532|NCT02080364|520154542|FG001|Baseline Period|Protocol Violation|1|||
144260533|NCT02080364|520154543|FG002|Baseline Period|Protocol Violation|0|||
144260534|NCT02080364|520154544|FG003|Baseline Period|Protocol Violation|0|||
144260535|NCT02080364|520154541|FG000|Baseline Period|Other|0|||
144260536|NCT02080364|520154542|FG001|Baseline Period|Other|1|||
144260537|NCT02080364|520154543|FG002|Baseline Period|Other|1|||
144260538|NCT02080364|520154544|FG003|Baseline Period|Other|0|||
144260539|NCT02080364|520154541|FG000|Treatment Period|Adverse Event|10|||
144260540|NCT02080364|520154542|FG001|Treatment Period|Adverse Event|15|||
144260541|NCT02080364|520154543|FG002|Treatment Period|Adverse Event|11|||
144260542|NCT02080364|520154544|FG003|Treatment Period|Adverse Event|14|||
144260543|NCT02080364|520154541|FG000|Treatment Period|Lost to Follow-up|2|||
144260544|NCT02080364|520154542|FG001|Treatment Period|Lost to Follow-up|3|||
144260545|NCT02080364|520154543|FG002|Treatment Period|Lost to Follow-up|5|||
144260546|NCT02080364|520154544|FG003|Treatment Period|Lost to Follow-up|0|||
144260547|NCT02080364|520154541|FG000|Treatment Period|Protocol Violation|5|||
144260548|NCT02080364|520154542|FG001|Treatment Period|Protocol Violation|3|||
144260549|NCT02080364|520154543|FG002|Treatment Period|Protocol Violation|5|||
144260550|NCT02080364|520154544|FG003|Treatment Period|Protocol Violation|1|||
144260551|NCT02080364|520154541|FG000|Treatment Period|Withdrawal by Subject|16|||
144260552|NCT02080364|520154542|FG001|Treatment Period|Withdrawal by Subject|16|||
144260553|NCT02080364|520154543|FG002|Treatment Period|Withdrawal by Subject|15|||
144260554|NCT02080364|520154544|FG003|Treatment Period|Withdrawal by Subject|10|||
144260555|NCT02080364|520154541|FG000|Treatment Period|Study Terminated by Sponsor|0|||
144260556|NCT02080364|520154542|FG001|Treatment Period|Study Terminated by Sponsor|0|||
144260557|NCT02080364|520154543|FG002|Treatment Period|Study Terminated by Sponsor|180|||
144260558|NCT02080364|520154544|FG003|Treatment Period|Study Terminated by Sponsor|183|||
144260559|NCT02080364|520154541|FG000|Treatment Period|Other|14|||
144260560|NCT02080364|520154542|FG001|Treatment Period|Other|12|||
144260561|NCT02080364|520154543|FG002|Treatment Period|Other|21|||
144260562|NCT02080364|520154544|FG003|Treatment Period|Other|16|||
144539859|NCT02787005|521177418|FG002|Overall Study|Withdrawal by Subject|1|||
144539860|NCT02787005|521177419|FG003|Overall Study|Withdrawal by Subject|0|||
144539861|NCT02787005|521177420|FG004|Overall Study|Withdrawal by Subject|1|||
144539862|NCT02787005|521177416|FG000|Overall Study|Screen Failure|0|||
144539863|NCT02787005|521177417|FG001|Overall Study|Screen Failure|2|||
144539864|NCT02787005|521177418|FG002|Overall Study|Screen Failure|0|||
144260563|NCT03804268|520154545|FG000|Overall Study|Adverse Event|2|||
144260564|NCT03804268|520154546|FG001|Overall Study|Adverse Event|2|||
144539865|NCT02787005|521177419|FG003|Overall Study|Screen Failure|0|||
144539866|NCT02787005|521177420|FG004|Overall Study|Screen Failure|1|||
144539867|NCT02787005|521177416|FG000|Overall Study|Lost to Follow-up|0|||
144539868|NCT02787005|521177417|FG001|Overall Study|Lost to Follow-up|0|||
144615248|NCT01225731|521452017|FG011|Part 2|Withdrawal by Subject|0|||
144615249|NCT01225731|521452018|FG012|Part 2|Withdrawal by Subject|0|||
144615250|NCT01225731|521452006|FG000|Part 3|Adverse Event|0|||
144615251|NCT01225731|521452007|FG001|Part 3|Adverse Event|0|||
144615252|NCT01225731|521452008|FG002|Part 3|Adverse Event|0|||
144615253|NCT01225731|521452009|FG003|Part 3|Adverse Event|0|||
144615254|NCT01225731|521452010|FG004|Part 3|Adverse Event|0|||
144615255|NCT01225731|521452011|FG005|Part 3|Adverse Event|0|||
144727412|NCT02480764|521856639|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
144260565|NCT03804268|520154545|FG000|Overall Study|Withdrawal by Subject|2|||
144260566|NCT03804268|520154546|FG001|Overall Study|Withdrawal by Subject|0|||
144260567|NCT03804268|520154545|FG000|Overall Study|Lost to Follow-up|1|||
144615256|NCT01225731|521452012|FG006|Part 3|Adverse Event|0|||
144260568|NCT03804268|520154546|FG001|Overall Study|Lost to Follow-up|0|||
144727413|NCT02480764|521856637|FG000|Overall Study|Major Protocol Deviation|1|||
144260569|NCT03804268|520154545|FG000|Overall Study|Physician Decision|2|||
144539869|NCT02787005|521177418|FG002|Overall Study|Lost to Follow-up|0|||
144539870|NCT02787005|521177419|FG003|Overall Study|Lost to Follow-up|1|||
144615257|NCT01225731|521452013|FG007|Part 3|Adverse Event|0|||
144615258|NCT01225731|521452014|FG008|Part 3|Adverse Event|0|||
144615259|NCT01225731|521452015|FG009|Part 3|Adverse Event|0|||
144539871|NCT02787005|521177420|FG004|Overall Study|Lost to Follow-up|0|||
144539872|NCT01753999|521177421|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
144539873|NCT01753999|521177422|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
144539874|NCT01753999|521177421|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
144539875|NCT01753999|521177422|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
144539876|NCT01753999|521177421|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
144539877|NCT01753999|521177422|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
144539878|NCT01753999|521177421|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
144539879|NCT01753999|521177422|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
144539880|NCT01753999|521177421|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
144539881|NCT01753999|521177422|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
144539882|NCT01753999|521177421|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
144539883|NCT01753999|521177422|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
144539884|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
144539885|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
144539886|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
144539887|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
144539888|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
144539889|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
144539890|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
144539891|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
144539892|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
144539893|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
144539894|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
144539895|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
144539896|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144539897|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144539898|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144539899|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144539900|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144539901|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
144539902|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
144539903|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
144539904|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
144539905|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
144539906|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
144539907|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
144200731|NCT01335997|519931687|FG001|Period III|Lost to Follow-up|0|||
144200732|NCT02440568|519931688|FG000|Overall Study|Death|1|||
144200733|NCT02440568|519931689|FG001|Overall Study|Death|3|||
144200734|NCT02440568|519931690|FG002|Overall Study|Death|4|||
144200735|NCT02440568|519931691|FG003|Overall Study|Death|2|||
144200736|NCT02440568|519931688|FG000|Overall Study|Lack of Efficacy|2|||
144200737|NCT02440568|519931689|FG001|Overall Study|Lack of Efficacy|0|||
144200738|NCT02440568|519931690|FG002|Overall Study|Lack of Efficacy|1|||
144200739|NCT02440568|519931691|FG003|Overall Study|Lack of Efficacy|0|||
144200740|NCT02440568|519931688|FG000|Overall Study|Lost to Follow-up|1|||
144200741|NCT02440568|519931689|FG001|Overall Study|Lost to Follow-up|0|||
144200742|NCT02440568|519931690|FG002|Overall Study|Lost to Follow-up|0|||
144260570|NCT03804268|520154546|FG001|Overall Study|Physician Decision|0|||
144615260|NCT01225731|521452016|FG010|Part 3|Adverse Event|1|||
144615261|NCT01225731|521452017|FG011|Part 3|Adverse Event|1|||
144615262|NCT01225731|521452018|FG012|Part 3|Adverse Event|0|||
144615263|NCT01225731|521452006|FG000|Part 3|Lost to Follow-up|0|||
144615264|NCT01225731|521452007|FG001|Part 3|Lost to Follow-up|0|||
144615265|NCT01225731|521452008|FG002|Part 3|Lost to Follow-up|0|||
144615266|NCT01225731|521452009|FG003|Part 3|Lost to Follow-up|0|||
144615267|NCT01225731|521452010|FG004|Part 3|Lost to Follow-up|0|||
144615268|NCT01225731|521452011|FG005|Part 3|Lost to Follow-up|0|||
144727414|NCT02480764|521856638|FG001|Overall Study|Major Protocol Deviation|4|||
144615269|NCT01225731|521452012|FG006|Part 3|Lost to Follow-up|0|||
144615270|NCT01225731|521452013|FG007|Part 3|Lost to Follow-up|0|||
144615271|NCT01225731|521452014|FG008|Part 3|Lost to Follow-up|0|||
144615272|NCT01225731|521452015|FG009|Part 3|Lost to Follow-up|0|||
144615273|NCT01225731|521452016|FG010|Part 3|Lost to Follow-up|1|||
144727415|NCT02480764|521856639|FG002|Overall Study|Major Protocol Deviation|3|||
144200743|NCT02440568|519931691|FG003|Overall Study|Lost to Follow-up|0|||
144200744|NCT00536263|519931692|FG000|Overall Study|Adverse Event|5|||
144200745|NCT00536263|519931693|FG001|Overall Study|Adverse Event|5|||
144615274|NCT01225731|521452017|FG011|Part 3|Lost to Follow-up|2|||
144615275|NCT01225731|521452018|FG012|Part 3|Lost to Follow-up|1|||
144539908|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
144615276|NCT01225731|521452006|FG000|Part 3|Physician Decision|0|||
144615277|NCT01225731|521452007|FG001|Part 3|Physician Decision|0|||
144615278|NCT01225731|521452008|FG002|Part 3|Physician Decision|0|||
144615279|NCT01225731|521452009|FG003|Part 3|Physician Decision|0|||
144200746|NCT00536263|519931694|FG002|Overall Study|Adverse Event|7|||
144200747|NCT00536263|519931692|FG000|Overall Study|Lost to Follow-up|3|||
144200748|NCT00536263|519931693|FG001|Overall Study|Lost to Follow-up|4|||
144200749|NCT00536263|519931694|FG002|Overall Study|Lost to Follow-up|4|||
144200750|NCT00536263|519931692|FG000|Overall Study|Subject withdrew - not treatment related|2|||
144200751|NCT00536263|519931693|FG001|Overall Study|Subject withdrew - not treatment related|0|||
144200752|NCT00536263|519931694|FG002|Overall Study|Subject withdrew - not treatment related|5|||
144200753|NCT00536263|519931692|FG000|Overall Study|Subject withdrew - treatment related|0|||
144200754|NCT00536263|519931693|FG001|Overall Study|Subject withdrew - treatment related|3|||
144200755|NCT00536263|519931694|FG002|Overall Study|Subject withdrew - treatment related|2|||
144200756|NCT00536263|519931692|FG000|Overall Study|Noncompliance with protocol|0|||
144200757|NCT00536263|519931693|FG001|Overall Study|Noncompliance with protocol|0|||
144200758|NCT00536263|519931694|FG002|Overall Study|Noncompliance with protocol|1|||
144200759|NCT00536263|519931692|FG000|Overall Study|Did not meet protocol eligibility|1|||
144200760|NCT00536263|519931693|FG001|Overall Study|Did not meet protocol eligibility|2|||
144200761|NCT00536263|519931694|FG002|Overall Study|Did not meet protocol eligibility|2|||
144200762|NCT00826449|519931695|FG000|Overall Study|Disease Progression|4|||
144200763|NCT00826449|519931695|FG000|Overall Study|Withdrawal by Subject|1|||
144200764|NCT01103466|519931696|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
144200765|NCT01103466|519931697|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
144200766|NCT01103466|519931698|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
144200767|NCT01103466|519931696|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
144200768|NCT01103466|519931697|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
144200769|NCT01103466|519931698|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
144200770|NCT01103466|519931696|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
144200771|NCT01103466|519931697|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
144200772|NCT01103466|519931698|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
144200773|NCT01103466|519931696|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
144200774|NCT01103466|519931697|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
144200775|NCT01103466|519931698|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
144200776|NCT01103466|519931696|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
144200777|NCT01103466|519931697|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
144200778|NCT01103466|519931698|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
144200779|NCT01103466|519931696|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
144200780|NCT01103466|519931697|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
144200781|NCT01103466|519931698|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
144200782|NCT02994940|519931699|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
144200783|NCT02994940|519931700|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
144200784|NCT02994940|519931699|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
144200785|NCT02994940|519931700|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
144200786|NCT02994940|519931699|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
144200787|NCT02994940|519931700|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
144200788|NCT04305496|519931703|FG000|Global Cohort|Withdrawal by Subject|13|||
144200789|NCT04305496|519931704|FG001|Global Cohort|Withdrawal by Subject|6|||
144200790|NCT04305496|519931703|FG000|Global Cohort|Physician Decision|1|||
144200791|NCT04305496|519931704|FG001|Global Cohort|Physician Decision|1|||
144200792|NCT04305496|519931703|FG000|Global Cohort|Subjective disease progression|16|||
144200793|NCT04305496|519931704|FG001|Global Cohort|Subjective disease progression|17|||
144200794|NCT04305496|519931703|FG000|Global Cohort|Condition under investigation worsened|209|||
144200795|NCT04305496|519931704|FG001|Global Cohort|Condition under investigation worsened|273|||
144200796|NCT04305496|519931703|FG000|Global Cohort|Protocol Violation|2|||
144200797|NCT04305496|519931704|FG001|Global Cohort|Protocol Violation|0|||
144200798|NCT04305496|519931703|FG000|Global Cohort|Adverse Event|44|||
144200799|NCT04305496|519931704|FG001|Global Cohort|Adverse Event|6|||
144200800|NCT04305496|519931703|FG000|Global Cohort|Death|3|||
144260571|NCT02256839|520154547|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
144260572|NCT02256839|520154548|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
144260573|NCT01843803|520154549|FG000|Overall Study|not a Veteran, did not see provider|1|||
144539909|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
144539910|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
144539911|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
144539912|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
144539913|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
144539914|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
144539915|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
144539916|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
144539917|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
144539918|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
144200801|NCT04305496|519931704|FG001|Global Cohort|Death|2|||
144200802|NCT04305496|519931703|FG000|Global Cohort|Any reason not specifically recorded|4|||
144539919|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
144539920|NCT02392234|521177423|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
144539921|NCT02392234|521177424|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
144539922|NCT02392234|521177425|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
144539923|NCT02392234|521177426|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
144539924|NCT02392234|521177427|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
144539925|NCT02392234|521177428|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
144539926|NCT02392234|521177423|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
144539927|NCT02392234|521177424|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
144539928|NCT02392234|521177425|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
144539929|NCT02392234|521177426|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
144539930|NCT02392234|521177427|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
144539931|NCT02392234|521177428|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
144539932|NCT01387516|521177429|FG000|Overall Study|Lost to Follow-up|4|||
144539933|NCT01387516|521177430|FG001|Overall Study|Lost to Follow-up|4|||
144539934|NCT01387516|521177431|FG002|Overall Study|Lost to Follow-up|2|||
144539935|NCT01387516|521177432|FG003|Overall Study|Lost to Follow-up|3|||
144539936|NCT01387516|521177429|FG000|Overall Study|Withdrawal by Subject|1|||
144539937|NCT01387516|521177430|FG001|Overall Study|Withdrawal by Subject|1|||
144539938|NCT01387516|521177431|FG002|Overall Study|Withdrawal by Subject|2|||
144539939|NCT01387516|521177432|FG003|Overall Study|Withdrawal by Subject|0|||
144539940|NCT01387516|521177429|FG000|Overall Study|Death|0|||
144539941|NCT01387516|521177430|FG001|Overall Study|Death|0|||
144539942|NCT01387516|521177431|FG002|Overall Study|Death|0|||
144539943|NCT01387516|521177432|FG003|Overall Study|Death|1|||
144539944|NCT03170648|521177435|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
144539945|NCT03170648|521177435|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
144539946|NCT02052440|521177436|FG000|Overall Study|Withdrawal by Subject|0|||
144539947|NCT02052440|521177437|FG001|Overall Study|Withdrawal by Subject|1|||
144539948|NCT03509909|521177438|FG000|Overall Study|Withdrawal by Subject|16|||
144539949|NCT03509909|521177439|FG001|Overall Study|Withdrawal by Subject|9|||
144539950|NCT03509909|521177438|FG000|Overall Study|Lost to Follow-up|3|||
144539951|NCT03509909|521177439|FG001|Overall Study|Lost to Follow-up|4|||
144539952|NCT03509909|521177438|FG000|Overall Study|Adverse Event|2|||
144539953|NCT03509909|521177439|FG001|Overall Study|Adverse Event|0|||
144539954|NCT02107261|521177440|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
144539955|NCT02107261|521177441|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
144539956|NCT02107261|521177440|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
144539957|NCT02107261|521177441|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
144539958|NCT02130557|521177444|FG000|Overall Study|Withdrawal by Subject|12|||
144539959|NCT02130557|521177445|FG001|Overall Study|Withdrawal by Subject|12|||
144539960|NCT02130557|521177444|FG000|Overall Study|Investigator Request|0|||
144539961|NCT02130557|521177445|FG001|Overall Study|Investigator Request|2|||
144539962|NCT02130557|521177444|FG000|Overall Study|Deceased|14|||
144539963|NCT02130557|521177445|FG001|Overall Study|Deceased|14|||
144539964|NCT02130557|521177444|FG000|Overall Study|Lost to Follow-up|6|||
144539965|NCT02130557|521177445|FG001|Overall Study|Lost to Follow-up|7|||
144539966|NCT02130557|521177444|FG000|Overall Study|Other|2|||
144539967|NCT02130557|521177445|FG001|Overall Study|Other|1|||
144539968|NCT02130557|521177444|FG000|Overall Study|Missing|2|||
144539969|NCT02130557|521177445|FG001|Overall Study|Missing|1|||
144539970|NCT04066075|521177446|FG000|Overall Study|Lost to Follow-up|3|||
144539971|NCT04066075|521177447|FG001|Overall Study|Lost to Follow-up|3|||
144539972|NCT04066075|521177446|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
144539973|NCT04066075|521177447|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
144539974|NCT04066075|521177446|FG000|Overall Study|Withdrawal by Subject|2|||
144539975|NCT04066075|521177447|FG001|Overall Study|Withdrawal by Subject|2|||
144539976|NCT00309166|521177448|FG000|Overall Study|Adverse event, non-fatal|1|||
144539977|NCT00309166|521177449|FG001|Overall Study|Adverse event, non-fatal|0|||
144539978|NCT00309166|521177448|FG000|Overall Study|Withdrawal by Subject|4|||
144539979|NCT00309166|521177449|FG001|Overall Study|Withdrawal by Subject|3|||
144539980|NCT04088227|521177454|FG000|Overall Study|Withdrawal by Subject|1|||
144539981|NCT04088227|521177455|FG001|Overall Study|Withdrawal by Subject|0|||
144539982|NCT04088227|521177454|FG000|Overall Study|Surgery postponed >5weeks|1|||
144539983|NCT04088227|521177455|FG001|Overall Study|Surgery postponed >5weeks|0|||
144539984|NCT05349838|521177456|FG000|Overall Study|Virological Failure|1|||
144539985|NCT05349838|521177457|FG001|Overall Study|Virological Failure|2|||
144539986|NCT05349838|521177456|FG000|Overall Study|Withdrawal by Subject|2|||
144539987|NCT05349838|521177457|FG001|Overall Study|Withdrawal by Subject|3|||
144539988|NCT05349838|521177456|FG000|Overall Study|Adverse Event|3|||
144539989|NCT05349838|521177457|FG001|Overall Study|Adverse Event|1|||
144539990|NCT05349838|521177456|FG000|Overall Study|Lost to Follow-up|1|||
144539991|NCT05349838|521177457|FG001|Overall Study|Lost to Follow-up|2|||
144539992|NCT05349838|521177456|FG000|Overall Study|Other reasons|5|||
144539993|NCT05349838|521177457|FG001|Overall Study|Other reasons|1|||
144539994|NCT04484623|521177459|FG000|Overall Study|Lost to Follow-up|0|||
144539995|NCT04484623|521177460|FG001|Overall Study|Lost to Follow-up|1|||
144539996|NCT04484623|521177459|FG000|Overall Study|Protocol Deviation|1|||
144539997|NCT04484623|521177460|FG001|Overall Study|Protocol Deviation|0|||
144539998|NCT04484623|521177459|FG000|Overall Study|Physician Decision|1|||
144539999|NCT04484623|521177460|FG001|Overall Study|Physician Decision|0|||
144540000|NCT04484623|521177459|FG000|Overall Study|Withdrawal by Subject|11|||
144540001|NCT04484623|521177460|FG001|Overall Study|Withdrawal by Subject|8|||
144540002|NCT04484623|521177459|FG000|Overall Study|Ongoing|94|||
144540003|NCT04484623|521177460|FG001|Overall Study|Ongoing|84|||
144540004|NCT03664804|521177462|FG000|Overall Study|Withdrawal by Subject|7|||
144540005|NCT05529992|521177463|FG000|Overall Study|Withdrawal by Subject|1|||
144540006|NCT06140290|521177464|FG000|Period 1|Adverse Event|1|||
144540007|NCT06140290|521177465|FG001|Period 1|Adverse Event|0|||
144540008|NCT06140290|521177464|FG000|Period 2|Assigned but not treated|0|||
144540009|NCT06140290|521177465|FG001|Period 2|Assigned but not treated|1|||
144540010|NCT06140290|521177464|FG000|Period 2|Withdrawal by Subject|0|||
144540011|NCT06140290|521177465|FG001|Period 2|Withdrawal by Subject|1|||
144540012|NCT03595124|521178427|FG000|Overall Study|Physician Decision|1|||
144540013|NCT03595124|521178428|FG001|Overall Study|Physician Decision|1|||
144540014|NCT03595124|521178429|FG002|Overall Study|Physician Decision|1|||
144540015|NCT03595124|521178427|FG000|Overall Study|Ineligible|1|||
144540016|NCT03595124|521178428|FG001|Overall Study|Ineligible|1|||
144540017|NCT03595124|521178429|FG002|Overall Study|Ineligible|0|||
144540018|NCT03595124|521178427|FG000|Overall Study|Disease Progression|4|||
144540019|NCT03595124|521178428|FG001|Overall Study|Disease Progression|1|||
144540020|NCT03595124|521178429|FG002|Overall Study|Disease Progression|4|||
144540021|NCT02866942|521178433|FG000|Overall Study|Invalid consent|1|||
144540022|NCT04162210|521178434|FG000|Overall Study|Lost to Follow-up|4|||
144540023|NCT04162210|521178435|FG001|Overall Study|Lost to Follow-up|1|||
144540024|NCT04162210|521178434|FG000|Overall Study|Withdrawal by Subject|17|||
144540025|NCT04162210|521178435|FG001|Overall Study|Withdrawal by Subject|9|||
144540026|NCT04162210|521178434|FG000|Overall Study|Ongoing|113|||
144540027|NCT04162210|521178435|FG001|Overall Study|Ongoing|59|||
144540028|NCT02568215|521178436|FG000|Overall Study|Death|1|||
144540029|NCT02568215|521178437|FG001|Overall Study|Death|2|||
144540030|NCT02568215|521178438|FG002|Overall Study|Death|0|||
144540031|NCT02568215|521178436|FG000|Overall Study|Physician Decision|2|||
144540032|NCT02568215|521178437|FG001|Overall Study|Physician Decision|2|||
144540033|NCT02568215|521178438|FG002|Overall Study|Physician Decision|2|||
144540034|NCT02568215|521178436|FG000|Overall Study|Lost to Follow-up|29|||
144540035|NCT02568215|521178437|FG001|Overall Study|Lost to Follow-up|32|||
144540036|NCT02568215|521178438|FG002|Overall Study|Lost to Follow-up|41|||
144540037|NCT02568215|521178436|FG000|Overall Study|Withdrawal by Subject|21|||
144540038|NCT02568215|521178437|FG001|Overall Study|Withdrawal by Subject|19|||
144540039|NCT02568215|521178438|FG002|Overall Study|Withdrawal by Subject|22|||
144540040|NCT02568215|521178436|FG000|Overall Study|Protocol Violation|1|||
144540041|NCT02568215|521178437|FG001|Overall Study|Protocol Violation|1|||
144540042|NCT02568215|521178438|FG002|Overall Study|Protocol Violation|0|||
144540043|NCT02568215|521178436|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
144540044|NCT02568215|521178437|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
144540045|NCT02568215|521178438|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
144540046|NCT02568215|521178436|FG000|Overall Study|Other|0|||
144540047|NCT02568215|521178437|FG001|Overall Study|Other|1|||
144540048|NCT02568215|521178438|FG002|Overall Study|Other|4|||
144540049|NCT01641900|521178439|FG000|Overall Study|Withdrawal by Subject|2|||
144540050|NCT01641900|521178440|FG001|Overall Study|Withdrawal by Subject|2|||
144540051|NCT00371345|521178441|FG000|Overall Study|Disease Progression|21|||
144615280|NCT01225731|521452010|FG004|Part 3|Physician Decision|0|||
144615281|NCT01225731|521452011|FG005|Part 3|Physician Decision|0|||
144615282|NCT01225731|521452012|FG006|Part 3|Physician Decision|0|||
144615283|NCT01225731|521452013|FG007|Part 3|Physician Decision|0|||
144615284|NCT01225731|521452014|FG008|Part 3|Physician Decision|0|||
144615285|NCT01225731|521452015|FG009|Part 3|Physician Decision|0|||
144540052|NCT00371345|521178442|FG001|Overall Study|Disease Progression|35|||
144540053|NCT00371345|521178441|FG000|Overall Study|Study Drug Toxicity|1|||
144540054|NCT00371345|521178442|FG001|Overall Study|Study Drug Toxicity|7|||
144540055|NCT00371345|521178441|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
144540056|NCT00371345|521178442|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
144540057|NCT00371345|521178441|FG000|Overall Study|Participant Request|1|||
144540058|NCT00371345|521178442|FG001|Overall Study|Participant Request|1|||
144540059|NCT00371345|521178441|FG000|Overall Study|Participant Withdrew Consent|0|||
144540060|NCT00371345|521178442|FG001|Overall Study|Participant Withdrew Consent|1|||
144540061|NCT04384172|521178448|FG000|Overall Study|Lost to Follow-up|0|||
144540062|NCT04384172|521178449|FG001|Overall Study|Lost to Follow-up|2|||
144540063|NCT04384172|521178448|FG000|Overall Study|Pregnancy|1|||
144615286|NCT01225731|521452016|FG010|Part 3|Physician Decision|0|||
144615287|NCT01225731|521452017|FG011|Part 3|Physician Decision|1|||
144615288|NCT01225731|521452018|FG012|Part 3|Physician Decision|2|||
144540064|NCT04384172|521178449|FG001|Overall Study|Pregnancy|0|||
144615289|NCT01225731|521452006|FG000|Part 3|Withdrawal by Subject|0|||
144615290|NCT01225731|521452007|FG001|Part 3|Withdrawal by Subject|0|||
144540065|NCT04384172|521178448|FG000|Overall Study|Withdrawal by Subject|0|||
144540066|NCT04384172|521178449|FG001|Overall Study|Withdrawal by Subject|1|||
144540067|NCT02463448|521178450|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
144540068|NCT02463448|521178450|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
144540069|NCT02463448|521178450|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
144540070|NCT02463448|521178450|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
144540071|NCT01640951|521178451|FG000|Overall Study|Adverse Event|8|||
144540072|NCT01640951|521178452|FG001|Overall Study|Adverse Event|3|||
144540073|NCT01640951|521178453|FG002|Overall Study|Adverse Event|10|||
144540074|NCT01640951|521178454|FG003|Overall Study|Adverse Event|6|||
144540075|NCT01640951|521178455|FG004|Overall Study|Adverse Event|1|||
144540076|NCT01640951|521178456|FG005|Overall Study|Adverse Event|11|||
144540077|NCT01640951|521178457|FG006|Overall Study|Adverse Event|1|||
144540078|NCT01640951|521178458|FG007|Overall Study|Adverse Event|3|||
144540079|NCT01640951|521178451|FG000|Overall Study|Lack of Efficacy|20|||
144540080|NCT01640951|521178452|FG001|Overall Study|Lack of Efficacy|1|||
144540081|NCT01640951|521178453|FG002|Overall Study|Lack of Efficacy|7|||
144540082|NCT01640951|521178454|FG003|Overall Study|Lack of Efficacy|14|||
144540083|NCT01640951|521178455|FG004|Overall Study|Lack of Efficacy|0|||
144540084|NCT01640951|521178456|FG005|Overall Study|Lack of Efficacy|6|||
144540085|NCT01640951|521178457|FG006|Overall Study|Lack of Efficacy|5|||
144540086|NCT01640951|521178458|FG007|Overall Study|Lack of Efficacy|6|||
144540087|NCT01640951|521178451|FG000|Overall Study|Lost to Follow-up|1|||
144540088|NCT01640951|521178452|FG001|Overall Study|Lost to Follow-up|0|||
144540089|NCT01640951|521178453|FG002|Overall Study|Lost to Follow-up|6|||
144540090|NCT01640951|521178454|FG003|Overall Study|Lost to Follow-up|2|||
144540091|NCT01640951|521178455|FG004|Overall Study|Lost to Follow-up|2|||
144540092|NCT01640951|521178456|FG005|Overall Study|Lost to Follow-up|3|||
144540093|NCT01640951|521178457|FG006|Overall Study|Lost to Follow-up|1|||
144540094|NCT01640951|521178458|FG007|Overall Study|Lost to Follow-up|1|||
144540095|NCT01640951|521178451|FG000|Overall Study|Non-compliance with study treatment|0|||
144540096|NCT01640951|521178452|FG001|Overall Study|Non-compliance with study treatment|0|||
144540097|NCT01640951|521178453|FG002|Overall Study|Non-compliance with study treatment|1|||
144540098|NCT01640951|521178454|FG003|Overall Study|Non-compliance with study treatment|1|||
144540099|NCT01640951|521178455|FG004|Overall Study|Non-compliance with study treatment|1|||
144540100|NCT01640951|521178456|FG005|Overall Study|Non-compliance with study treatment|4|||
144540101|NCT01640951|521178457|FG006|Overall Study|Non-compliance with study treatment|1|||
144540102|NCT01640951|521178458|FG007|Overall Study|Non-compliance with study treatment|0|||
144540103|NCT01640951|521178451|FG000|Overall Study|Physician Decision|2|||
144540104|NCT01640951|521178452|FG001|Overall Study|Physician Decision|5|||
144540105|NCT01640951|521178453|FG002|Overall Study|Physician Decision|2|||
144540106|NCT01640951|521178454|FG003|Overall Study|Physician Decision|2|||
144540107|NCT01640951|521178455|FG004|Overall Study|Physician Decision|2|||
144540108|NCT01640951|521178456|FG005|Overall Study|Physician Decision|3|||
144540109|NCT01640951|521178457|FG006|Overall Study|Physician Decision|3|||
144540110|NCT01640951|521178458|FG007|Overall Study|Physician Decision|0|||
144540111|NCT01640951|521178451|FG000|Overall Study|Pregnancy|3|||
144540112|NCT01640951|521178452|FG001|Overall Study|Pregnancy|0|||
144540113|NCT01640951|521178453|FG002|Overall Study|Pregnancy|0|||
144540114|NCT01640951|521178454|FG003|Overall Study|Pregnancy|4|||
144540115|NCT01640951|521178455|FG004|Overall Study|Pregnancy|0|||
144540116|NCT01640951|521178456|FG005|Overall Study|Pregnancy|0|||
144540117|NCT01640951|521178457|FG006|Overall Study|Pregnancy|2|||
144540118|NCT01640951|521178458|FG007|Overall Study|Pregnancy|0|||
144540119|NCT01640951|521178451|FG000|Overall Study|Protocol Deviation|0|||
144540120|NCT01640951|521178452|FG001|Overall Study|Protocol Deviation|1|||
144540121|NCT01640951|521178453|FG002|Overall Study|Protocol Deviation|2|||
144540122|NCT01640951|521178454|FG003|Overall Study|Protocol Deviation|1|||
144540123|NCT01640951|521178455|FG004|Overall Study|Protocol Deviation|0|||
144540124|NCT01640951|521178456|FG005|Overall Study|Protocol Deviation|1|||
144540125|NCT01640951|521178457|FG006|Overall Study|Protocol Deviation|0|||
144540126|NCT01640951|521178458|FG007|Overall Study|Protocol Deviation|0|||
144540127|NCT01640951|521178451|FG000|Overall Study|Subject/Guardian decision|12|||
144540128|NCT01640951|521178452|FG001|Overall Study|Subject/Guardian decision|4|||
144540129|NCT01640951|521178453|FG002|Overall Study|Subject/Guardian decision|13|||
144540130|NCT01640951|521178454|FG003|Overall Study|Subject/Guardian decision|15|||
144540131|NCT01640951|521178455|FG004|Overall Study|Subject/Guardian decision|7|||
144540132|NCT01640951|521178456|FG005|Overall Study|Subject/Guardian decision|19|||
144540133|NCT01640951|521178457|FG006|Overall Study|Subject/Guardian decision|5|||
144540134|NCT01640951|521178458|FG007|Overall Study|Subject/Guardian decision|4|||
144727416|NCT02480764|521856637|FG000|Overall Study|Lost to Follow-up|0|||
144540135|NCT01640951|521178451|FG000|Overall Study|Death|0|||
144540136|NCT01640951|521178452|FG001|Overall Study|Death|1|||
144540137|NCT01640951|521178453|FG002|Overall Study|Death|1|||
144540138|NCT01640951|521178454|FG003|Overall Study|Death|0|||
144540139|NCT01640951|521178455|FG004|Overall Study|Death|0|||
144540140|NCT01640951|521178456|FG005|Overall Study|Death|0|||
144540141|NCT01640951|521178457|FG006|Overall Study|Death|0|||
144540142|NCT01640951|521178458|FG007|Overall Study|Death|2|||
144540143|NCT04949542|521178459|FG000|Overall Study|Lost to Follow-up|4|||
144540144|NCT04949542|521178460|FG001|Overall Study|Lost to Follow-up|1|||
144540145|NCT01536093|521178461|FG000|Overall Study|Death|1|||
144540146|NCT01536093|521178462|FG001|Overall Study|Death|2|||
144540147|NCT01536093|521178461|FG000|Overall Study|absence of maternal colostrum|2|||
144540148|NCT01536093|521178462|FG001|Overall Study|absence of maternal colostrum|0|||
144540149|NCT01536093|521178461|FG000|Overall Study|Withdrawal by Subject|0|||
144540150|NCT01536093|521178462|FG001|Overall Study|Withdrawal by Subject|1|||
144540151|NCT02275611|521178463|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
144540152|NCT02275611|521178464|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
144540153|NCT02275611|521178465|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
144540154|NCT02275611|521178466|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
144540155|NCT00293397|521178469|FG000|Overall Study|Death|2|||
144540156|NCT01437319|521178472|FG000|Phase I|Lost to Follow-up|2|||
144540157|NCT01437319|521178473|FG001|Phase I|Lost to Follow-up|0|||
144540158|NCT01437319|521178474|FG002|Phase I|Lost to Follow-up|0|||
144540159|NCT01437319|521178472|FG000|Phase I|Protocol Violation|1|||
144540160|NCT01437319|521178473|FG001|Phase I|Protocol Violation|0|||
144540161|NCT01437319|521178474|FG002|Phase I|Protocol Violation|0|||
144540162|NCT01437319|521178472|FG000|Phase I|Study related symptoms/complaints|27|||
144540163|NCT01437319|521178473|FG001|Phase I|Study related symptoms/complaints|0|||
144540164|NCT01437319|521178474|FG002|Phase I|Study related symptoms/complaints|0|||
144540165|NCT01437319|521178472|FG000|Phase I|Withdrawal by Subject|25|||
144540166|NCT01437319|521178473|FG001|Phase I|Withdrawal by Subject|0|||
144540167|NCT01437319|521178474|FG002|Phase I|Withdrawal by Subject|0|||
144540168|NCT01437319|521178472|FG000|Phase II|Withdrawal by Subject|0|||
144540169|NCT01437319|521178473|FG001|Phase II|Withdrawal by Subject|8|||
144540170|NCT01437319|521178474|FG002|Phase II|Withdrawal by Subject|16|||
144540171|NCT01437319|521178472|FG000|Phase II|Lost to Follow-up|0|||
144540172|NCT01437319|521178473|FG001|Phase II|Lost to Follow-up|7|||
144540173|NCT01437319|521178474|FG002|Phase II|Lost to Follow-up|2|||
144540174|NCT01437319|521178472|FG000|Phase II|Study related symptoms/complaints|0|||
144540175|NCT01437319|521178473|FG001|Phase II|Study related symptoms/complaints|28|||
144540176|NCT01437319|521178474|FG002|Phase II|Study related symptoms/complaints|19|||
144540177|NCT01437319|521178472|FG000|Phase II|Protocol Violation|0|||
144540178|NCT01437319|521178473|FG001|Phase II|Protocol Violation|1|||
144540179|NCT01437319|521178474|FG002|Phase II|Protocol Violation|0|||
144540180|NCT03473743|521178475|FG000|Overall Study|Withdrawal by Subject|0|||
144540181|NCT03473743|521178476|FG001|Overall Study|Withdrawal by Subject|0|||
144540182|NCT03473743|521178477|FG002|Overall Study|Withdrawal by Subject|0|||
144540183|NCT03473743|521178478|FG003|Overall Study|Withdrawal by Subject|0|||
144540184|NCT03473743|521178479|FG004|Overall Study|Withdrawal by Subject|0|||
144540185|NCT03473743|521178480|FG005|Overall Study|Withdrawal by Subject|0|||
144540186|NCT03473743|521178481|FG006|Overall Study|Withdrawal by Subject|0|||
144540187|NCT03473743|521178482|FG007|Overall Study|Withdrawal by Subject|3|||
144540188|NCT03473743|521178475|FG000|Overall Study|Other|0|||
144540189|NCT03473743|521178476|FG001|Overall Study|Other|0|||
144540190|NCT03473743|521178477|FG002|Overall Study|Other|0|||
144540191|NCT03473743|521178478|FG003|Overall Study|Other|1|||
144540192|NCT03473743|521178479|FG004|Overall Study|Other|0|||
144540193|NCT03473743|521178480|FG005|Overall Study|Other|0|||
144540194|NCT03473743|521178481|FG006|Overall Study|Other|0|||
144540195|NCT03473743|521178482|FG007|Overall Study|Other|0|||
144540196|NCT03473743|521178475|FG000|Overall Study|Ongoing|0|||
144540197|NCT03473743|521178476|FG001|Overall Study|Ongoing|0|||
144540198|NCT03473743|521178477|FG002|Overall Study|Ongoing|6|||
144540199|NCT03473743|521178478|FG003|Overall Study|Ongoing|8|||
144540200|NCT03473743|521178479|FG004|Overall Study|Ongoing|1|||
144540201|NCT03473743|521178480|FG005|Overall Study|Ongoing|1|||
144540202|NCT03473743|521178481|FG006|Overall Study|Ongoing|22|||
144540203|NCT03473743|521178482|FG007|Overall Study|Ongoing|24|||
144200803|NCT04305496|519931704|FG001|Global Cohort|Any reason not specifically recorded|5|||
144200804|NCT04305496|519931703|FG000|China Cohort|Any reason not specifically recorded|1|||
144200805|NCT04305496|519931704|FG001|China Cohort|Any reason not specifically recorded|1|||
144540204|NCT03473743|521178475|FG000|Overall Study|Randomized but not treated|0|||
144540205|NCT03473743|521178476|FG001|Overall Study|Randomized but not treated|0|||
144200806|NCT04305496|519931703|FG000|China Cohort|Adverse Event|8|||
144540206|NCT03473743|521178477|FG002|Overall Study|Randomized but not treated|0|||
144540207|NCT03473743|521178478|FG003|Overall Study|Randomized but not treated|0|||
144540208|NCT03473743|521178479|FG004|Overall Study|Randomized but not treated|0|||
144540209|NCT03473743|521178480|FG005|Overall Study|Randomized but not treated|0|||
144540210|NCT03473743|521178481|FG006|Overall Study|Randomized but not treated|1|||
144540211|NCT03473743|521178482|FG007|Overall Study|Randomized but not treated|1|||
144540212|NCT03375320|521178486|FG000|Overall Study|Adverse Event|34|||
144540213|NCT03375320|521178487|FG001|Overall Study|Adverse Event|9|||
144540214|NCT03375320|521178488|FG002|Overall Study|Adverse Event|10|||
144540215|NCT03375320|521178489|FG003|Overall Study|Adverse Event|0|||
144540216|NCT03375320|521178486|FG000|Overall Study|Death|6|||
144540217|NCT03375320|521178487|FG001|Overall Study|Death|3|||
144540218|NCT03375320|521178488|FG002|Overall Study|Death|0|||
144540219|NCT03375320|521178489|FG003|Overall Study|Death|0|||
144540220|NCT03375320|521178486|FG000|Overall Study|Withdrawal by Subject|7|||
144540221|NCT03375320|521178487|FG001|Overall Study|Withdrawal by Subject|4|||
144540222|NCT03375320|521178488|FG002|Overall Study|Withdrawal by Subject|5|||
144540223|NCT03375320|521178489|FG003|Overall Study|Withdrawal by Subject|4|||
144540224|NCT03375320|521178486|FG000|Overall Study|Progressive disease|55|||
144540225|NCT03375320|521178487|FG001|Overall Study|Progressive disease|41|||
144540226|NCT03375320|521178488|FG002|Overall Study|Progressive disease|29|||
144540227|NCT03375320|521178489|FG003|Overall Study|Progressive disease|24|||
144540228|NCT03375320|521178486|FG000|Overall Study|Alternative treatment|6|||
144540229|NCT03375320|521178487|FG001|Overall Study|Alternative treatment|1|||
144540230|NCT03375320|521178488|FG002|Overall Study|Alternative treatment|1|||
144540231|NCT03375320|521178489|FG003|Overall Study|Alternative treatment|0|||
144540232|NCT03375320|521178486|FG000|Overall Study|Other disease|1|||
144540233|NCT03375320|521178487|FG001|Overall Study|Other disease|1|||
144540234|NCT03375320|521178488|FG002|Overall Study|Other disease|3|||
144540235|NCT03375320|521178489|FG003|Overall Study|Other disease|0|||
144540236|NCT03375320|521178486|FG000|Overall Study|Withdrawal prior to initiation|2|||
144540237|NCT03375320|521178487|FG001|Overall Study|Withdrawal prior to initiation|2|||
144540238|NCT03375320|521178488|FG002|Overall Study|Withdrawal prior to initiation|1|||
144540239|NCT03375320|521178489|FG003|Overall Study|Withdrawal prior to initiation|0|||
144540240|NCT03375320|521178486|FG000|Overall Study|Physician Decision|1|||
144540241|NCT03375320|521178487|FG001|Overall Study|Physician Decision|1|||
144540242|NCT03375320|521178488|FG002|Overall Study|Physician Decision|1|||
144540243|NCT03375320|521178489|FG003|Overall Study|Physician Decision|1|||
144540244|NCT03375320|521178486|FG000|Overall Study|Non-compliance|1|||
144540245|NCT03375320|521178487|FG001|Overall Study|Non-compliance|0|||
144540246|NCT03375320|521178488|FG002|Overall Study|Non-compliance|0|||
144540247|NCT03375320|521178489|FG003|Overall Study|Non-compliance|0|||
144540248|NCT00274261|521178490|FG000|Overall Study|Adverse Event|19|||
144540249|NCT00274261|521178491|FG001|Overall Study|Adverse Event|11|||
144540250|NCT00274261|521178490|FG000|Overall Study|Pregnancy|114|||
144540251|NCT00274261|521178491|FG001|Overall Study|Pregnancy|83|||
144540252|NCT00274261|521178490|FG000|Overall Study|Withdrawal by Subject|179|||
144540253|NCT00274261|521178491|FG001|Overall Study|Withdrawal by Subject|126|||
144540254|NCT00274261|521178490|FG000|Overall Study|Protocol Violation|71|||
144540255|NCT00274261|521178491|FG001|Overall Study|Protocol Violation|42|||
144540256|NCT00274261|521178490|FG000|Overall Study|Lost to Follow-up|106|||
144540257|NCT00274261|521178491|FG001|Overall Study|Lost to Follow-up|75|||
144540258|NCT03431350|521178492|FG000|Overall Study|ONGOING|0|||
144540259|NCT03431350|521178493|FG001|Overall Study|ONGOING|0|||
144540260|NCT03431350|521178494|FG002|Overall Study|ONGOING|2|||
144540261|NCT03431350|521178495|FG003|Overall Study|ONGOING|0|||
144540262|NCT03431350|521178496|FG004|Overall Study|ONGOING|1|||
144540263|NCT03431350|521178497|FG005|Overall Study|ONGOING|3|||
144540264|NCT03431350|521178498|FG006|Overall Study|ONGOING|0|||
144540265|NCT03431350|521178499|FG007|Overall Study|ONGOING|1|||
144540266|NCT03431350|521178500|FG008|Overall Study|ONGOING|3|||
144540267|NCT03431350|521178501|FG009|Overall Study|ONGOING|4|||
144540268|NCT03431350|521178502|FG010|Overall Study|ONGOING|2|||
144540269|NCT03431350|521178503|FG011|Overall Study|ONGOING|1|||
144540270|NCT03431350|521178492|FG000|Overall Study|Death|6|||
144540271|NCT03431350|521178493|FG001|Overall Study|Death|5|||
144540272|NCT03431350|521178494|FG002|Overall Study|Death|18|||
144540273|NCT03431350|521178495|FG003|Overall Study|Death|7|||
144540274|NCT03431350|521178496|FG004|Overall Study|Death|4|||
144540275|NCT03431350|521178497|FG005|Overall Study|Death|3|||
144540276|NCT03431350|521178498|FG006|Overall Study|Death|2|||
144540277|NCT03431350|521178499|FG007|Overall Study|Death|0|||
144540278|NCT03431350|521178500|FG008|Overall Study|Death|0|||
144540279|NCT03431350|521178501|FG009|Overall Study|Death|0|||
144540280|NCT03431350|521178502|FG010|Overall Study|Death|4|||
144540281|NCT03431350|521178503|FG011|Overall Study|Death|0|||
144540282|NCT03431350|521178492|FG000|Overall Study|Lost to Follow-up|0|||
144200807|NCT04305496|519931704|FG001|China Cohort|Adverse Event|2|||
144540283|NCT03431350|521178493|FG001|Overall Study|Lost to Follow-up|1|||
144540284|NCT03431350|521178494|FG002|Overall Study|Lost to Follow-up|0|||
144540285|NCT03431350|521178495|FG003|Overall Study|Lost to Follow-up|0|||
144540286|NCT03431350|521178496|FG004|Overall Study|Lost to Follow-up|0|||
144200808|NCT04305496|519931703|FG000|China Cohort|Condition under investigation worsened|40|||
144540287|NCT03431350|521178497|FG005|Overall Study|Lost to Follow-up|0|||
144540288|NCT03431350|521178498|FG006|Overall Study|Lost to Follow-up|0|||
144540289|NCT03431350|521178499|FG007|Overall Study|Lost to Follow-up|0|||
144540290|NCT03431350|521178500|FG008|Overall Study|Lost to Follow-up|0|||
144540291|NCT03431350|521178501|FG009|Overall Study|Lost to Follow-up|0|||
144540292|NCT03431350|521178502|FG010|Overall Study|Lost to Follow-up|0|||
144540293|NCT03431350|521178503|FG011|Overall Study|Lost to Follow-up|0|||
144540294|NCT03431350|521178492|FG000|Overall Study|Withdrawal by Subject|0|||
144540295|NCT03431350|521178493|FG001|Overall Study|Withdrawal by Subject|0|||
144540296|NCT03431350|521178494|FG002|Overall Study|Withdrawal by Subject|0|||
144540297|NCT03431350|521178495|FG003|Overall Study|Withdrawal by Subject|1|||
144540298|NCT03431350|521178496|FG004|Overall Study|Withdrawal by Subject|1|||
144540299|NCT03431350|521178497|FG005|Overall Study|Withdrawal by Subject|1|||
144540300|NCT03431350|521178498|FG006|Overall Study|Withdrawal by Subject|0|||
144540301|NCT03431350|521178499|FG007|Overall Study|Withdrawal by Subject|0|||
144540302|NCT03431350|521178500|FG008|Overall Study|Withdrawal by Subject|0|||
144540303|NCT03431350|521178501|FG009|Overall Study|Withdrawal by Subject|2|||
144540304|NCT03431350|521178502|FG010|Overall Study|Withdrawal by Subject|0|||
144540305|NCT03431350|521178503|FG011|Overall Study|Withdrawal by Subject|1|||
144540306|NCT03431350|521178492|FG000|Overall Study|Other|0|||
144540307|NCT03431350|521178493|FG001|Overall Study|Other|0|||
144540308|NCT03431350|521178494|FG002|Overall Study|Other|1|||
144540309|NCT03431350|521178495|FG003|Overall Study|Other|3|||
144540310|NCT03431350|521178496|FG004|Overall Study|Other|2|||
144540311|NCT03431350|521178497|FG005|Overall Study|Other|2|||
144540312|NCT03431350|521178498|FG006|Overall Study|Other|4|||
144540313|NCT03431350|521178499|FG007|Overall Study|Other|0|||
144540314|NCT03431350|521178500|FG008|Overall Study|Other|14|||
144540315|NCT03431350|521178501|FG009|Overall Study|Other|11|||
144540316|NCT03431350|521178502|FG010|Overall Study|Other|11|||
144540317|NCT03431350|521178503|FG011|Overall Study|Other|15|||
144540318|NCT04325828|521178504|FG000|Overall Study|Ongoing|26|||
144540319|NCT05509816|521178505|FG000|Overall Study|Lost to Follow-up|1|||
144540320|NCT04801420|521178506|FG000|Overall Study|Other|1|||
144540321|NCT04801420|521178507|FG001|Overall Study|Other|2|||
144540322|NCT04801420|521178508|FG002|Overall Study|Other|1|||
144540323|NCT04801420|521178506|FG000|Overall Study|Lost to Follow-up|7|||
144540324|NCT04801420|521178507|FG001|Overall Study|Lost to Follow-up|9|||
144540325|NCT04801420|521178508|FG002|Overall Study|Lost to Follow-up|10|||
144540326|NCT04801420|521178506|FG000|Overall Study|Moved from study area|0|||
144540327|NCT04801420|521178507|FG001|Overall Study|Moved from study area|1|||
144540328|NCT04801420|521178508|FG002|Overall Study|Moved from study area|1|||
144540329|NCT04801420|521178506|FG000|Overall Study|Withdrawal by Subject|5|||
144540330|NCT04801420|521178507|FG001|Overall Study|Withdrawal by Subject|1|||
144540331|NCT04801420|521178508|FG002|Overall Study|Withdrawal by Subject|4|||
144540332|NCT04801420|521178506|FG000|Overall Study|Individual stopping criteria reached|0|||
144540333|NCT04801420|521178507|FG001|Overall Study|Individual stopping criteria reached|1|||
144540334|NCT04801420|521178508|FG002|Overall Study|Individual stopping criteria reached|0|||
144540335|NCT04801420|521178506|FG000|Overall Study|Ongoing in the study|195|||
144540336|NCT04801420|521178507|FG001|Overall Study|Ongoing in the study|195|||
144540337|NCT04801420|521178508|FG002|Overall Study|Ongoing in the study|192|||
144540338|NCT02078648|521178509|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
144540339|NCT02078648|521178510|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
144540340|NCT02078648|521178509|FG000|Overall Study|Adverse Event|0|||
144540341|NCT02078648|521178510|FG001|Overall Study|Adverse Event|1|||
144540342|NCT02078648|521178509|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
144540343|NCT02078648|521178510|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
144540344|NCT02078648|521178509|FG000|Overall Study|Withdrawal by Subject|3|||
144540345|NCT02078648|521178510|FG001|Overall Study|Withdrawal by Subject|1|||
144540346|NCT02078648|521178509|FG000|Overall Study|Investigator Decision|5|||
144540347|NCT02078648|521178510|FG001|Overall Study|Investigator Decision|7|||
144540348|NCT02078648|521178509|FG000|Overall Study|Death|1|||
144540349|NCT02078648|521178510|FG001|Overall Study|Death|1|||
144540350|NCT02078648|521178509|FG000|Overall Study|Undefined|0|||
144540351|NCT02078648|521178510|FG001|Overall Study|Undefined|1|||
144540352|NCT01675492|521178511|FG000|Overall Study|study completed early - product approval|42|||
144540353|NCT04306367|521178518|FG000|Overall Study|Progression of Disease|9|||
144615291|NCT01225731|521452008|FG002|Part 3|Withdrawal by Subject|0|||
144615292|NCT01225731|521452009|FG003|Part 3|Withdrawal by Subject|0|||
144615293|NCT01225731|521452010|FG004|Part 3|Withdrawal by Subject|0|||
144615294|NCT01225731|521452011|FG005|Part 3|Withdrawal by Subject|0|||
144615295|NCT01225731|521452012|FG006|Part 3|Withdrawal by Subject|0|||
144615296|NCT01225731|521452013|FG007|Part 3|Withdrawal by Subject|0|||
144615297|NCT01225731|521452014|FG008|Part 3|Withdrawal by Subject|0|||
144540354|NCT04306367|521178518|FG000|Overall Study|Adverse Event|3|||
144540355|NCT04306367|521178518|FG000|Overall Study|Withdrawal by Subject|1|||
144540356|NCT02401815|521178519|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540357|NCT02401815|521178520|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540358|NCT02401815|521178521|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540359|NCT02401815|521178522|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
144540360|NCT02401815|521178523|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144727417|NCT02480764|521856638|FG001|Overall Study|Lost to Follow-up|1|||
144727418|NCT02480764|521856639|FG002|Overall Study|Lost to Follow-up|2|||
144727419|NCT02480764|521856637|FG000|Overall Study|Voluntary Withdrawal|6|||
144727420|NCT02480764|521856638|FG001|Overall Study|Voluntary Withdrawal|5|||
144727421|NCT02480764|521856639|FG002|Overall Study|Voluntary Withdrawal|10|||
144727422|NCT02480764|521856637|FG000|Overall Study|Lack of Efficacy|0|||
144615298|NCT01225731|521452015|FG009|Part 3|Withdrawal by Subject|0|||
144615299|NCT01225731|521452016|FG010|Part 3|Withdrawal by Subject|4|||
144540361|NCT02401815|521178524|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540362|NCT02401815|521178525|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540363|NCT02401815|521178526|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540364|NCT02401815|521178527|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540365|NCT02401815|521178528|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
144540366|NCT02401815|521178519|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
144540367|NCT02401815|521178520|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540368|NCT02401815|521178521|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540369|NCT02401815|521178522|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
144540370|NCT02401815|521178523|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540371|NCT02401815|521178524|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540372|NCT02401815|521178525|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540373|NCT02401815|521178526|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540374|NCT02401815|521178527|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540375|NCT02401815|521178528|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
144540376|NCT02401815|521178519|FG000|Dose Escalation (up to 670 Days)|Death|1|||
144540377|NCT02401815|521178520|FG001|Dose Escalation (up to 670 Days)|Death|2|||
144540378|NCT02401815|521178521|FG002|Dose Escalation (up to 670 Days)|Death|3|||
144540379|NCT02401815|521178522|FG003|Dose Escalation (up to 670 Days)|Death|5|||
144540380|NCT02401815|521178523|FG004|Dose Escalation (up to 670 Days)|Death|4|||
144540381|NCT02401815|521178524|FG005|Dose Escalation (up to 670 Days)|Death|0|||
144540382|NCT02401815|521178525|FG006|Dose Escalation (up to 670 Days)|Death|0|||
144540383|NCT02401815|521178526|FG007|Dose Escalation (up to 670 Days)|Death|0|||
144540384|NCT02401815|521178527|FG008|Dose Escalation (up to 670 Days)|Death|0|||
144540385|NCT02401815|521178528|FG009|Dose Escalation (up to 670 Days)|Death|0|||
144540386|NCT02401815|521178519|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540387|NCT02401815|521178520|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
144540388|NCT02401815|521178521|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540389|NCT02401815|521178522|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540390|NCT02401815|521178523|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
144540391|NCT02401815|521178524|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144615300|NCT01225731|521452017|FG011|Part 3|Withdrawal by Subject|6|||
144615301|NCT01225731|521452018|FG012|Part 3|Withdrawal by Subject|4|||
144472472|NCT01529008|520928470|FG001|Treatment|Adverse Event|0|||
144472473|NCT01529008|520928469|FG000|Treatment|Other|3|||
144472474|NCT01529008|520928470|FG001|Treatment|Other|1|||
144472475|NCT01529008|520928469|FG000|Efficacy Analysis|Protocol Violation|2|||
144472476|NCT01529008|520928470|FG001|Efficacy Analysis|Protocol Violation|0|||
144472477|NCT01529008|520928469|FG000|Efficacy Analysis|Physician Decision|0|||
144472478|NCT01529008|520928470|FG001|Efficacy Analysis|Physician Decision|1|||
144472479|NCT01529008|520928469|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
144472480|NCT01529008|520928470|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
144472481|NCT00332332|520928471|FG000|Overall Study|Adverse Event|13|||
144472482|NCT00332332|520928471|FG000|Overall Study|Death|1|||
144472483|NCT00332332|520928471|FG000|Overall Study|Withdrawal by Subject|8|||
144472484|NCT00332332|520928471|FG000|Overall Study|Physician Decision|1|||
144472485|NCT00332332|520928471|FG000|Overall Study|Lost to Follow-up|3|||
144472486|NCT00332332|520928471|FG000|Overall Study|Protocol deviation|4|||
144472487|NCT00332332|520928471|FG000|Overall Study|Noncompliance|2|||
144472488|NCT00332332|520928471|FG000|Overall Study|Disease progression|2|||
144472489|NCT00332332|520928471|FG000|Overall Study|Other|18|||
144472490|NCT00332332|520928471|FG000|Overall Study|Did not receive study treatment|16|||
144472491|NCT01382602|520928472|FG000|Overall Study|Protocol Violation|0|||
144472492|NCT01382602|520928473|FG001|Overall Study|Protocol Violation|3|||
144472493|NCT01382602|520928472|FG000|Overall Study|Withdrawal by Subject|0|||
144472494|NCT01382602|520928473|FG001|Overall Study|Withdrawal by Subject|1|||
144472495|NCT02790073|520928476|FG000|Overall Study|Death|1|||
144472496|NCT02790073|520928476|FG000|Overall Study|Withdrawal from HD|1|||
144472497|NCT02790073|520928476|FG000|Overall Study|Withdrawal by Subject|1|||
144472498|NCT04170686|520928477|FG000|Screening|Physician Decision|12|||
144472499|NCT04170686|520928478|FG001|Screening|Physician Decision|13|||
144472500|NCT04170686|520928477|FG000|Randomization and Treatment|Lost to Follow-up|26|||
144472501|NCT04170686|520928478|FG001|Randomization and Treatment|Lost to Follow-up|15|||
144472502|NCT03328143|520928479|FG000|Overall Study|Declined|3|||
144472503|NCT03328143|520928479|FG000|Overall Study|Required increased sedation|4|||
144472504|NCT03328143|520928479|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
144472505|NCT03328143|520928479|FG000|Overall Study|Surgery cancelled|1|||
144472506|NCT02259517|520928480|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
144472507|NCT02259517|520928481|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
144472508|NCT02259517|520928482|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
144472509|NCT02259517|520928480|FG000|Overall Study|Withdrawal by Subject|0|||
144472510|NCT02259517|520928481|FG001|Overall Study|Withdrawal by Subject|0|||
144260574|NCT01843803|520154550|FG001|Overall Study|not a Veteran, did not see provider|3|||
144540392|NCT02401815|521178525|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540393|NCT02401815|521178526|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540394|NCT02401815|521178527|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540395|NCT02401815|521178528|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
144540396|NCT02401815|521178519|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
144540397|NCT02401815|521178520|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540398|NCT02401815|521178521|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540399|NCT02401815|521178522|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540400|NCT02401815|521178523|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
144540401|NCT02401815|521178524|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540402|NCT02401815|521178525|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540403|NCT02401815|521178526|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540404|NCT02401815|521178527|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540405|NCT02401815|521178528|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
144540406|NCT02401815|521178519|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540407|NCT02401815|521178520|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540408|NCT02401815|521178521|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540409|NCT02401815|521178522|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540410|NCT02401815|521178523|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540411|NCT02401815|521178524|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
144540412|NCT02401815|521178525|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540413|NCT02401815|521178526|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540414|NCT02401815|521178527|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540415|NCT02401815|521178528|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
144540416|NCT02401815|521178519|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540417|NCT02401815|521178520|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540418|NCT02401815|521178521|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540419|NCT02401815|521178522|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540420|NCT02401815|521178523|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540421|NCT02401815|521178524|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540422|NCT02401815|521178525|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
144540423|NCT02401815|521178526|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540424|NCT02401815|521178527|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540425|NCT02401815|521178528|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540426|NCT02401815|521178519|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540427|NCT02401815|521178520|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540428|NCT02401815|521178521|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540429|NCT02401815|521178522|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540430|NCT02401815|521178523|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540431|NCT02401815|521178524|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
144540432|NCT02401815|521178525|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
144540433|NCT02401815|521178526|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540434|NCT02401815|521178527|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540435|NCT02401815|521178528|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
144540436|NCT02401815|521178519|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540437|NCT02401815|521178520|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540438|NCT02401815|521178521|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540439|NCT02401815|521178522|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540440|NCT02401815|521178523|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540441|NCT02401815|521178524|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
144540442|NCT02401815|521178525|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540443|NCT02401815|521178526|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540444|NCT02401815|521178527|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540445|NCT02401815|521178528|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
144540446|NCT02401815|521178519|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144540447|NCT02401815|521178520|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144540448|NCT02401815|521178521|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144540449|NCT02401815|521178522|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144540450|NCT02401815|521178523|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144540451|NCT02401815|521178524|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144615302|NCT00577642|521452019|FG000|Overall Study|Clinical Disease Progression|1|||
144615303|NCT02039375|521452024|FG000|Overall Study|Lost to Follow-up|2|||
144260575|NCT03311841|520154551|FG000|14-day Wash-out|Adverse Event|0|||
144540452|NCT02401815|521178525|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
144540453|NCT02401815|521178526|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
144540454|NCT02401815|521178527|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
144540455|NCT02401815|521178528|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
144540456|NCT02401815|521178519|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540457|NCT02401815|521178520|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540458|NCT02401815|521178521|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540459|NCT02401815|521178522|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540460|NCT02401815|521178523|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540461|NCT02401815|521178524|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540462|NCT02401815|521178525|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144540463|NCT02401815|521178526|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
144200809|NCT04305496|519931704|FG001|China Cohort|Condition under investigation worsened|47|||
144200810|NCT04305496|519931703|FG000|China Cohort|Subjective disease progression|2|||
144540464|NCT02401815|521178527|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
144540465|NCT02401815|521178528|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
144540466|NCT02401815|521178519|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540467|NCT02401815|521178520|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540468|NCT02401815|521178521|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540469|NCT02401815|521178522|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540470|NCT02401815|521178523|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540471|NCT02401815|521178524|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540472|NCT02401815|521178525|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540473|NCT02401815|521178526|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540474|NCT02401815|521178527|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
144540475|NCT02401815|521178528|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
144540476|NCT02401815|521178519|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540477|NCT02401815|521178520|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540478|NCT02401815|521178521|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540479|NCT02401815|521178522|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540480|NCT02401815|521178523|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540481|NCT02401815|521178524|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540482|NCT02401815|521178525|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540483|NCT02401815|521178526|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540484|NCT02401815|521178527|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
144540485|NCT02401815|521178528|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
144540486|NCT02401815|521178519|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540487|NCT02401815|521178520|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540488|NCT02401815|521178521|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540489|NCT02401815|521178522|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540490|NCT02401815|521178523|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540491|NCT02401815|521178524|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540492|NCT02401815|521178525|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540493|NCT02401815|521178526|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
144540494|NCT02401815|521178527|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
144540495|NCT02401815|521178528|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
144540496|NCT04218357|521178529|FG000|1st Allocation|Withdrawal by Subject|1|||
144540497|NCT04218357|521178530|FG001|1st Allocation|Withdrawal by Subject|0|||
144540498|NCT05199571|521179942|FG000|Treatment Period|Participant decision|3|||
144540499|NCT05199571|521179942|FG000|Treatment Period|Physician Decision|1|||
144540500|NCT05199571|521179942|FG000|Post-treatment Follow up Period|Participant decision|3|||
144540501|NCT03367156|521179943|FG000|Overall Study|Lack of interest|3|||
144540502|NCT03367156|521179944|FG001|Overall Study|Lack of interest|1|||
144540503|NCT03367156|521179943|FG000|Overall Study|Death|2|||
144540504|NCT03367156|521179944|FG001|Overall Study|Death|0|||
144540505|NCT03367156|521179943|FG000|Overall Study|Lost to Follow-up|2|||
144540506|NCT03367156|521179944|FG001|Overall Study|Lost to Follow-up|1|||
144540507|NCT03367156|521179943|FG000|Overall Study|Became ineligible|1|||
144540508|NCT03367156|521179944|FG001|Overall Study|Became ineligible|2|||
144540509|NCT03367156|521179943|FG000|Overall Study|Hospitalization|1|||
144540510|NCT03367156|521179944|FG001|Overall Study|Hospitalization|0|||
144540511|NCT03367156|521179943|FG000|Overall Study|Concerned about Treatment|11|||
144615304|NCT00542269|521452035|FG000|Overall Study|Adverse Event|10|||
144615305|NCT00542269|521452036|FG001|Overall Study|Adverse Event|4|||
144615306|NCT00542269|521452037|FG002|Overall Study|Adverse Event|5|||
144615307|NCT00542269|521452035|FG000|Overall Study|Protocol Violation|1|||
144540512|NCT03367156|521179944|FG001|Overall Study|Concerned about Treatment|3|||
144540513|NCT03367156|521179943|FG000|Overall Study|Started new treatment|4|||
144540514|NCT03367156|521179944|FG001|Overall Study|Started new treatment|1|||
144200811|NCT04305496|519931704|FG001|China Cohort|Subjective disease progression|2|||
144540515|NCT00092534|521179945|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
144540516|NCT00092534|521179946|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
144540517|NCT00092534|521179947|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144540518|NCT00092534|521179948|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144540519|NCT00092534|521179949|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144540520|NCT00092534|521179945|FG000|Base Study Vaccination Period|Adverse Event|3|||
144540521|NCT00092534|521179946|FG001|Base Study Vaccination Period|Adverse Event|1|||
144540522|NCT00092534|521179947|FG002|Base Study Vaccination Period|Adverse Event|0|||
144540523|NCT00092534|521179948|FG003|Base Study Vaccination Period|Adverse Event|0|||
144540524|NCT00092534|521179949|FG004|Base Study Vaccination Period|Adverse Event|0|||
144540525|NCT00092534|521179945|FG000|Base Study Vaccination Period|Death|5|||
144540526|NCT00092534|521179946|FG001|Base Study Vaccination Period|Death|4|||
144540527|NCT00092534|521179947|FG002|Base Study Vaccination Period|Death|0|||
144540528|NCT00092534|521179948|FG003|Base Study Vaccination Period|Death|0|||
144540529|NCT00092534|521179949|FG004|Base Study Vaccination Period|Death|0|||
144540530|NCT00092534|521179945|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
144540531|NCT00092534|521179946|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
144540532|NCT00092534|521179947|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
144540533|NCT00092534|521179948|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
144540534|NCT00092534|521179949|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
144540535|NCT00092534|521179945|FG000|Base Study Vaccination Period|Physician Decision|1|||
144540536|NCT00092534|521179946|FG001|Base Study Vaccination Period|Physician Decision|0|||
144540537|NCT00092534|521179947|FG002|Base Study Vaccination Period|Physician Decision|0|||
144540538|NCT00092534|521179948|FG003|Base Study Vaccination Period|Physician Decision|0|||
144540539|NCT00092534|521179949|FG004|Base Study Vaccination Period|Physician Decision|0|||
144540540|NCT00092534|521179945|FG000|Base Study Vaccination Period|Pregnancy|9|||
144540541|NCT00092534|521179946|FG001|Base Study Vaccination Period|Pregnancy|7|||
144540542|NCT00092534|521179947|FG002|Base Study Vaccination Period|Pregnancy|0|||
144540543|NCT00092534|521179948|FG003|Base Study Vaccination Period|Pregnancy|0|||
144540544|NCT00092534|521179949|FG004|Base Study Vaccination Period|Pregnancy|0|||
144540545|NCT00092534|521179945|FG000|Base Study Vaccination Period|Protocol Violation|2|||
144540546|NCT00092534|521179946|FG001|Base Study Vaccination Period|Protocol Violation|1|||
144540547|NCT00092534|521179947|FG002|Base Study Vaccination Period|Protocol Violation|0|||
144540548|NCT00092534|521179948|FG003|Base Study Vaccination Period|Protocol Violation|0|||
144540549|NCT00092534|521179949|FG004|Base Study Vaccination Period|Protocol Violation|0|||
144540550|NCT00092534|521179945|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
144540551|NCT00092534|521179946|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
144540552|NCT00092534|521179947|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
144540553|NCT00092534|521179948|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
144540554|NCT00092534|521179949|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
144540555|NCT00092534|521179945|FG000|Base Study Vaccination Period|Moved|14|||
144540556|NCT00092534|521179946|FG001|Base Study Vaccination Period|Moved|12|||
144540557|NCT00092534|521179947|FG002|Base Study Vaccination Period|Moved|0|||
144540558|NCT00092534|521179948|FG003|Base Study Vaccination Period|Moved|0|||
144540559|NCT00092534|521179949|FG004|Base Study Vaccination Period|Moved|0|||
144540560|NCT00092534|521179945|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
144540561|NCT00092534|521179946|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
144540562|NCT00092534|521179947|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
144200812|NCT04305496|519931703|FG000|China Cohort|Withdrawal by Subject|2|||
144200813|NCT04305496|519931704|FG001|China Cohort|Withdrawal by Subject|1|||
144200814|NCT01157897|519931705|FG000|Overall Study|Lost to Follow-up|2|||
144200815|NCT01157897|519931706|FG001|Overall Study|Lost to Follow-up|0|||
144200816|NCT01157897|519931707|FG002|Overall Study|Lost to Follow-up|0|||
144200817|NCT01157897|519931708|FG003|Overall Study|Lost to Follow-up|1|||
144540563|NCT00092534|521179948|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
144540564|NCT00092534|521179949|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
144540565|NCT00092534|521179945|FG000|Base Study Vaccination Period|Travel|1|||
144540566|NCT00092534|521179946|FG001|Base Study Vaccination Period|Travel|0|||
144200818|NCT01157897|519931705|FG000|Overall Study|Relocated|0|||
144200819|NCT01157897|519931706|FG001|Overall Study|Relocated|2|||
144200820|NCT01157897|519931707|FG002|Overall Study|Relocated|0|||
144200821|NCT01157897|519931708|FG003|Overall Study|Relocated|0|||
144200822|NCT00681590|519931709|FG000|Overall Study|Withdrawal by Subject|2|||
144540567|NCT00092534|521179947|FG002|Base Study Vaccination Period|Travel|0|||
144200823|NCT00681590|519931710|FG001|Overall Study|Withdrawal by Subject|12|||
144200824|NCT02912650|519931711|FG000|Overall Study|Withdrawal by Subject|1|||
144200825|NCT02912650|519931712|FG001|Overall Study|Withdrawal by Subject|0|||
144200826|NCT02912650|519931713|FG002|Overall Study|Withdrawal by Subject|1|||
144200827|NCT02912650|519931714|FG003|Overall Study|Withdrawal by Subject|5|||
144200828|NCT02912650|519931711|FG000|Overall Study|Adverse Event|0|||
144540568|NCT00092534|521179948|FG003|Base Study Vaccination Period|Travel|0|||
144540569|NCT00092534|521179949|FG004|Base Study Vaccination Period|Travel|0|||
144540570|NCT00092534|521179945|FG000|Base Study Vaccination Period|Site Closed|0|||
144540571|NCT00092534|521179946|FG001|Base Study Vaccination Period|Site Closed|1|||
144540572|NCT00092534|521179947|FG002|Base Study Vaccination Period|Site Closed|0|||
144540573|NCT00092534|521179948|FG003|Base Study Vaccination Period|Site Closed|0|||
144540574|NCT00092534|521179949|FG004|Base Study Vaccination Period|Site Closed|0|||
144540575|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Adverse Event|2|||
144540576|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Adverse Event|4|||
144540577|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Adverse Event|0|||
144540578|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Adverse Event|0|||
144540579|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Adverse Event|0|||
144540580|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Death|2|||
144540581|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Death|1|||
144540582|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Death|0|||
144540583|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Death|0|||
144540584|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Death|0|||
144540585|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
144540586|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
144540587|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
144540588|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
144540589|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
144540590|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Pregnancy|6|||
144540591|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Pregnancy|10|||
144540592|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Pregnancy|0|||
144540593|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Pregnancy|0|||
144540594|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Pregnancy|0|||
144540595|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
144540596|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
144540597|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
144540598|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
144540599|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
144540600|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
144540601|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
144540602|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
144540603|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
144540604|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
144540605|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Moved|62|||
144540606|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Moved|58|||
144540607|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Moved|0|||
144540608|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Moved|0|||
144540609|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Moved|0|||
144540610|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Travel|10|||
144540611|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Travel|7|||
144540612|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Travel|0|||
144540613|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Travel|0|||
144540614|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Travel|0|||
144540615|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Site Closed|0|||
144540616|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Site Closed|2|||
144540617|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Site Closed|0|||
144540618|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Site Closed|0|||
144540619|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Site Closed|0|||
144540620|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
144540621|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
144540622|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
144540623|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
144540624|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
144540625|NCT00092534|521179945|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
144540626|NCT00092534|521179946|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
144540627|NCT00092534|521179947|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
144540628|NCT00092534|521179948|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
144540629|NCT00092534|521179949|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
144540630|NCT00092534|521179945|FG000|Base Study EXT|Lost to Follow-up|0|||
144727423|NCT02480764|521856638|FG001|Overall Study|Lack of Efficacy|3|||
144200829|NCT02912650|519931712|FG001|Overall Study|Adverse Event|0|||
144200830|NCT02912650|519931713|FG002|Overall Study|Adverse Event|1|||
144200831|NCT02912650|519931714|FG003|Overall Study|Adverse Event|0|||
144200832|NCT01791153|519931716|FG000|Part 1: Blinded Period|Adverse Event|7|||
144200833|NCT01791153|519931717|FG001|Part 1: Blinded Period|Adverse Event|3|||
144200834|NCT01791153|519931718|FG002|Part 1: Blinded Period|Adverse Event|2|||
144200835|NCT01791153|519931719|FG003|Part 1: Blinded Period|Adverse Event|0|||
144540631|NCT00092534|521179946|FG001|Base Study EXT|Lost to Follow-up|0|||
144727424|NCT02480764|521856639|FG002|Overall Study|Lack of Efficacy|3|||
144615308|NCT00542269|521452036|FG001|Overall Study|Protocol Violation|1|||
144615309|NCT00542269|521452037|FG002|Overall Study|Protocol Violation|0|||
144615310|NCT00542269|521452035|FG000|Overall Study|Withdrawal by Subject|1|||
144615311|NCT00542269|521452036|FG001|Overall Study|Withdrawal by Subject|0|||
144615312|NCT00542269|521452037|FG002|Overall Study|Withdrawal by Subject|0|||
144260576|NCT03311841|520154552|FG001|14-day Wash-out|Adverse Event|1|||
144540632|NCT00092534|521179947|FG002|Base Study EXT|Lost to Follow-up|41|||
144540633|NCT00092534|521179948|FG003|Base Study EXT|Lost to Follow-up|0|||
144540634|NCT00092534|521179949|FG004|Base Study EXT|Lost to Follow-up|0|||
144540635|NCT00092534|521179945|FG000|Base Study EXT|Physician Decision|0|||
144540636|NCT00092534|521179946|FG001|Base Study EXT|Physician Decision|0|||
144540637|NCT00092534|521179947|FG002|Base Study EXT|Physician Decision|1|||
144540638|NCT00092534|521179948|FG003|Base Study EXT|Physician Decision|0|||
144540639|NCT00092534|521179949|FG004|Base Study EXT|Physician Decision|0|||
144540640|NCT00092534|521179945|FG000|Base Study EXT|Pregnancy|0|||
144540641|NCT00092534|521179946|FG001|Base Study EXT|Pregnancy|0|||
144540642|NCT00092534|521179947|FG002|Base Study EXT|Pregnancy|12|||
144540643|NCT00092534|521179948|FG003|Base Study EXT|Pregnancy|0|||
144540644|NCT00092534|521179949|FG004|Base Study EXT|Pregnancy|0|||
144540645|NCT00092534|521179945|FG000|Base Study EXT|Withdrawal by Subject|0|||
144540646|NCT00092534|521179946|FG001|Base Study EXT|Withdrawal by Subject|0|||
144540647|NCT00092534|521179947|FG002|Base Study EXT|Withdrawal by Subject|18|||
144540648|NCT00092534|521179948|FG003|Base Study EXT|Withdrawal by Subject|0|||
144540649|NCT00092534|521179949|FG004|Base Study EXT|Withdrawal by Subject|0|||
144540650|NCT00092534|521179945|FG000|Base Study EXT|Participant moved|0|||
144540651|NCT00092534|521179946|FG001|Base Study EXT|Participant moved|0|||
144540652|NCT00092534|521179947|FG002|Base Study EXT|Participant moved|6|||
144540653|NCT00092534|521179948|FG003|Base Study EXT|Participant moved|0|||
144540654|NCT00092534|521179949|FG004|Base Study EXT|Participant moved|0|||
144540655|NCT00092534|521179945|FG000|Base Study EXT|Travel|0|||
144540656|NCT00092534|521179946|FG001|Base Study EXT|Travel|0|||
144540657|NCT00092534|521179947|FG002|Base Study EXT|Travel|2|||
144540658|NCT00092534|521179948|FG003|Base Study EXT|Travel|0|||
144540659|NCT00092534|521179949|FG004|Base Study EXT|Travel|0|||
144540660|NCT00092534|521179945|FG000|Base Study EXT|Site closed|0|||
144540661|NCT00092534|521179946|FG001|Base Study EXT|Site closed|0|||
144540662|NCT00092534|521179947|FG002|Base Study EXT|Site closed|21|||
144540663|NCT00092534|521179948|FG003|Base Study EXT|Site closed|0|||
144540664|NCT00092534|521179949|FG004|Base Study EXT|Site closed|0|||
144540665|NCT00092534|521179945|FG000|Base Study EXT|Study ended|0|||
144540666|NCT00092534|521179946|FG001|Base Study EXT|Study ended|0|||
144540667|NCT00092534|521179947|FG002|Base Study EXT|Study ended|29|||
144540668|NCT00092534|521179948|FG003|Base Study EXT|Study ended|0|||
144540669|NCT00092534|521179949|FG004|Base Study EXT|Study ended|0|||
144540670|NCT00092534|521179945|FG000|Base Study EXT|Protocol Violation|0|||
144540671|NCT00092534|521179946|FG001|Base Study EXT|Protocol Violation|0|||
144540672|NCT00092534|521179947|FG002|Base Study EXT|Protocol Violation|15|||
144540673|NCT00092534|521179948|FG003|Base Study EXT|Protocol Violation|0|||
144540674|NCT00092534|521179949|FG004|Base Study EXT|Protocol Violation|0|||
144540675|NCT00092534|521179945|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
144540676|NCT00092534|521179946|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
144540677|NCT00092534|521179947|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
144540678|NCT00092534|521179948|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
144540679|NCT00092534|521179949|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
144540680|NCT01171898|521179953|FG000|Overall Study|Death|0|||
144540681|NCT01171898|521179954|FG001|Overall Study|Death|0|||
144540682|NCT01171898|521179955|FG002|Overall Study|Death|2|||
144540683|NCT01171898|521179956|FG003|Overall Study|Death|0|||
144540684|NCT01171898|521179953|FG000|Overall Study|Lost to Follow-up|0|||
144540685|NCT01171898|521179954|FG001|Overall Study|Lost to Follow-up|1|||
144540686|NCT01171898|521179955|FG002|Overall Study|Lost to Follow-up|1|||
144540687|NCT01171898|521179956|FG003|Overall Study|Lost to Follow-up|1|||
144540688|NCT01171898|521179953|FG000|Overall Study|Withdrawal by Subject|1|||
144540689|NCT01171898|521179954|FG001|Overall Study|Withdrawal by Subject|4|||
144540690|NCT01171898|521179955|FG002|Overall Study|Withdrawal by Subject|6|||
144540691|NCT01171898|521179956|FG003|Overall Study|Withdrawal by Subject|3|||
144540692|NCT01171898|521179953|FG000|Overall Study|Terminated by Sponsor|1|||
144540693|NCT01171898|521179954|FG001|Overall Study|Terminated by Sponsor|0|||
144540694|NCT01171898|521179955|FG002|Overall Study|Terminated by Sponsor|0|||
144540695|NCT01171898|521179956|FG003|Overall Study|Terminated by Sponsor|0|||
144540696|NCT01171898|521179953|FG000|Overall Study|Ongoing|1|||
144540697|NCT01171898|521179954|FG001|Overall Study|Ongoing|9|||
144540698|NCT01171898|521179955|FG002|Overall Study|Ongoing|3|||
144540699|NCT01171898|521179956|FG003|Overall Study|Ongoing|0|||
144260577|NCT03311841|520154553|FG002|14-day Wash-out|Adverse Event|0|||
144540700|NCT01171898|521179953|FG000|Overall Study|Other|1|||
144540701|NCT01171898|521179954|FG001|Overall Study|Other|5|||
144540702|NCT01171898|521179955|FG002|Overall Study|Other|0|||
144540703|NCT01171898|521179956|FG003|Overall Study|Other|2|||
144540704|NCT05802173|521179957|FG000|Overall Study|Withdrawal by Subject|2|||
144727425|NCT02480764|521856637|FG000|Overall Study|Reason not Specified|0|||
144727426|NCT02480764|521856638|FG001|Overall Study|Reason not Specified|1|||
144727427|NCT02480764|521856639|FG002|Overall Study|Reason not Specified|0|||
144727428|NCT02719522|521856640|FG000|Overall Study|Implant Failure|4|||
144472511|NCT02259517|520928482|FG002|Overall Study|Withdrawal by Subject|3|||
144472512|NCT04770753|520928483|FG000|Overall Study|Randomized, never treated|1|||
144472513|NCT04770753|520928484|FG001|Overall Study|Randomized, never treated|1|||
144472514|NCT04770753|520928483|FG000|Overall Study|Withdrawal by Subject|3|||
144472515|NCT04770753|520928484|FG001|Overall Study|Withdrawal by Subject|1|||
144472516|NCT04770753|520928483|FG000|Overall Study|Adverse Event|2|||
144472517|NCT04770753|520928484|FG001|Overall Study|Adverse Event|0|||
144472518|NCT04770753|520928483|FG000|Overall Study|Pregnancy|1|||
144472519|NCT04770753|520928484|FG001|Overall Study|Pregnancy|0|||
144472520|NCT04770753|520928483|FG000|Overall Study|Other un-specified|1|||
144472521|NCT04770753|520928484|FG001|Overall Study|Other un-specified|0|||
144472522|NCT02305381|520928485|FG000|Overall Study|Unclassified|5|||
144472523|NCT02305381|520928486|FG001|Overall Study|Unclassified|5|||
144472524|NCT02305381|520928487|FG002|Overall Study|Unclassified|7|||
144472525|NCT02882282|520928488|FG000|Overall Study|Adverse Event|1|||
144472526|NCT02882282|520928489|FG001|Overall Study|Adverse Event|0|||
144472527|NCT04425902|520928494|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
144472528|NCT01191840|520928500|FG000|Overall Study|withdrew consent|2|||
144472529|NCT01191840|520928501|FG001|Overall Study|withdrew consent|1|||
144472530|NCT01191840|520928500|FG000|Overall Study|Subject discontinued treatment|1|||
144472531|NCT01191840|520928501|FG001|Overall Study|Subject discontinued treatment|2|||
144472532|NCT01191840|520928500|FG000|Overall Study|Lost to Follow-up|4|||
144472533|NCT01191840|520928501|FG001|Overall Study|Lost to Follow-up|6|||
144472534|NCT01191840|520928500|FG000|Overall Study|Non Staph Infection|4|||
144472535|NCT01191840|520928501|FG001|Overall Study|Non Staph Infection|3|||
144472536|NCT01191840|520928500|FG000|Overall Study|ineligible at enrollment|1|||
144472537|NCT01191840|520928501|FG001|Overall Study|ineligible at enrollment|0|||
144472538|NCT01191840|520928500|FG000|Overall Study|IRB approval lapse|0|||
144472539|NCT01191840|520928501|FG001|Overall Study|IRB approval lapse|2|||
144472540|NCT01191840|520928500|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
144472541|NCT01191840|520928501|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
144472542|NCT01191840|520928500|FG000|Overall Study|Withdrawal by Subject|2|||
144472543|NCT01191840|520928501|FG001|Overall Study|Withdrawal by Subject|0|||
144472544|NCT01392300|520928502|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
144472545|NCT01392300|520928503|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
144472546|NCT01392300|520928504|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
144472547|NCT01392300|520928502|FG000|Main Period (MP)|Withdrawal by Subject|5|||
144472548|NCT01392300|520928503|FG001|Main Period (MP)|Withdrawal by Subject|1|||
144472549|NCT01392300|520928504|FG002|Main Period (MP)|Withdrawal by Subject|0|||
144472550|NCT01392300|520928502|FG000|Main Period (MP)|Lost to Follow-up|3|||
144472551|NCT01392300|520928503|FG001|Main Period (MP)|Lost to Follow-up|3|||
144472552|NCT01392300|520928504|FG002|Main Period (MP)|Lost to Follow-up|0|||
144472553|NCT01392300|520928502|FG000|Main Period (MP)|Non-compliance|1|||
144472554|NCT01392300|520928503|FG001|Main Period (MP)|Non-compliance|0|||
144472555|NCT01392300|520928504|FG002|Main Period (MP)|Non-compliance|0|||
144472556|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
144472557|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
144472558|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
144472559|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
144472560|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
144472561|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
144472562|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
144472563|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
144472564|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
144472565|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Death|0|||
144472566|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Death|0|||
144472567|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Death|4|||
144472568|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
144472569|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
144472570|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
144472571|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
144472572|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
144472573|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
144472574|NCT01392300|520928502|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
144472575|NCT01392300|520928503|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
144472576|NCT01392300|520928504|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
144472577|NCT04669600|520928509|FG000|Overall Study|Withdrawal by Subject|1|||
144472578|NCT04669600|520928509|FG000|Overall Study|Other|6|||
144200836|NCT01791153|519931720|FG004|Part 1: Blinded Period|Adverse Event|0|||
144260578|NCT03311841|520154554|FG003|14-day Wash-out|Adverse Event|0|||
144200837|NCT01791153|519931721|FG005|Part 1: Blinded Period|Adverse Event|0|||
144200838|NCT01791153|519931722|FG006|Part 1: Blinded Period|Adverse Event|0|||
144200839|NCT01791153|519931723|FG007|Part 1: Blinded Period|Adverse Event|0|||
144200840|NCT01791153|519931716|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
144200841|NCT01791153|519931717|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
144200842|NCT01791153|519931718|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
144200843|NCT01791153|519931719|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
144200844|NCT01791153|519931720|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
144200845|NCT01791153|519931721|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
144200846|NCT01791153|519931722|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
144200847|NCT01791153|519931723|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
144200848|NCT01791153|519931716|FG000|Part 1: Blinded Period|Non-Compliance|1|||
144200849|NCT01791153|519931717|FG001|Part 1: Blinded Period|Non-Compliance|0|||
144200850|NCT01791153|519931718|FG002|Part 1: Blinded Period|Non-Compliance|0|||
144200851|NCT01791153|519931719|FG003|Part 1: Blinded Period|Non-Compliance|0|||
144540705|NCT05802173|521179958|FG001|Overall Study|Withdrawal by Subject|0|||
144540706|NCT05802173|521179959|FG002|Overall Study|Withdrawal by Subject|0|||
144540707|NCT05802173|521179957|FG000|Overall Study|Protocol Violation|1|||
144540708|NCT05802173|521179958|FG001|Overall Study|Protocol Violation|0|||
144540709|NCT05802173|521179959|FG002|Overall Study|Protocol Violation|0|||
144540710|NCT05802173|521179957|FG000|Overall Study|Lost to Follow-up|0|||
144540711|NCT05802173|521179958|FG001|Overall Study|Lost to Follow-up|6|||
144540712|NCT05802173|521179959|FG002|Overall Study|Lost to Follow-up|4|||
144540713|NCT05802173|521179957|FG000|Overall Study|non-compliance|0|||
144540714|NCT05802173|521179958|FG001|Overall Study|non-compliance|1|||
144540715|NCT05802173|521179959|FG002|Overall Study|non-compliance|0|||
144540716|NCT02932410|521179960|FG000|Overall Study|Death|7|||
144540717|NCT02932410|521179961|FG001|Overall Study|Death|6|||
144540718|NCT02932410|521179962|FG002|Overall Study|Death|0|||
144540719|NCT02932410|521179963|FG003|Overall Study|Death|0|||
144540720|NCT02932410|521179960|FG000|Overall Study|Lost to Follow-up|1|||
144540721|NCT02932410|521179961|FG001|Overall Study|Lost to Follow-up|2|||
144540722|NCT02932410|521179962|FG002|Overall Study|Lost to Follow-up|0|||
144540723|NCT02932410|521179963|FG003|Overall Study|Lost to Follow-up|0|||
144200852|NCT01791153|519931720|FG004|Part 1: Blinded Period|Non-Compliance|0|||
144200853|NCT01791153|519931721|FG005|Part 1: Blinded Period|Non-Compliance|0|||
144200854|NCT01791153|519931722|FG006|Part 1: Blinded Period|Non-Compliance|0|||
144200855|NCT01791153|519931723|FG007|Part 1: Blinded Period|Non-Compliance|0|||
144200856|NCT01791153|519931716|FG000|Part 1: Blinded Period|Physician Decision|0|||
144200857|NCT01791153|519931717|FG001|Part 1: Blinded Period|Physician Decision|0|||
144260579|NCT03311841|520154555|FG004|14-day Wash-out|Adverse Event|0|||
144260580|NCT03311841|520154551|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
144540724|NCT02932410|521179960|FG000|Overall Study|Parent/Subjects decision|6|||
144540725|NCT02932410|521179961|FG001|Overall Study|Parent/Subjects decision|6|||
144540726|NCT02932410|521179962|FG002|Overall Study|Parent/Subjects decision|1|||
144540727|NCT02932410|521179963|FG003|Overall Study|Parent/Subjects decision|0|||
144540728|NCT02932410|521179960|FG000|Overall Study|Physician Decision|0|||
144540729|NCT02932410|521179961|FG001|Overall Study|Physician Decision|1|||
144540730|NCT02932410|521179962|FG002|Overall Study|Physician Decision|0|||
144540731|NCT02932410|521179963|FG003|Overall Study|Physician Decision|0|||
144540732|NCT00360269|521179964|FG000|Overall Study|Lost to Follow-up|7|||
144540733|NCT00360269|521179965|FG001|Overall Study|Lost to Follow-up|9|||
144540734|NCT00360269|521179964|FG000|Overall Study|Physician Decision|1|||
144540735|NCT00360269|521179965|FG001|Overall Study|Physician Decision|2|||
144540736|NCT00360269|521179964|FG000|Overall Study|Adverse Event|1|||
144540737|NCT00360269|521179965|FG001|Overall Study|Adverse Event|0|||
144540738|NCT00360269|521179964|FG000|Overall Study|Withdrawal by Subject|1|||
144540739|NCT00360269|521179965|FG001|Overall Study|Withdrawal by Subject|1|||
144540740|NCT03002194|521179966|FG000|Overall Study|Lost to Follow-up|6|||
144540741|NCT03002194|521179966|FG000|Overall Study|Adverse Event|1|||
144540742|NCT03002194|521179966|FG000|Overall Study|Lack of Efficacy|1|||
144540743|NCT03002194|521179966|FG000|Overall Study|Withdrawal by Subject|2|||
144540744|NCT00048932|521179969|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
144540745|NCT00048932|521179970|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
144540746|NCT00048932|521179971|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
144540747|NCT00048932|521179969|FG000|Double Blind Period (DB)|Adverse Event|51|||
144540748|NCT00048932|521179970|FG001|Double Blind Period (DB)|Adverse Event|19|||
144540749|NCT00048932|521179971|FG002|Double Blind Period (DB)|Adverse Event|0|||
144540750|NCT00048932|521179969|FG000|Double Blind Period (DB)|Death|5|||
144540751|NCT00048932|521179970|FG001|Double Blind Period (DB)|Death|3|||
144540752|NCT00048932|521179971|FG002|Double Blind Period (DB)|Death|0|||
144540753|NCT00048932|521179969|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
144540754|NCT00048932|521179970|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
144200858|NCT01791153|519931718|FG002|Part 1: Blinded Period|Physician Decision|0|||
144200859|NCT01791153|519931719|FG003|Part 1: Blinded Period|Physician Decision|1|||
144200860|NCT01791153|519931720|FG004|Part 1: Blinded Period|Physician Decision|0|||
144260581|NCT03311841|520154552|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
144200861|NCT01791153|519931721|FG005|Part 1: Blinded Period|Physician Decision|0|||
144540755|NCT00048932|521179971|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
144540756|NCT00048932|521179969|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
144540757|NCT00048932|521179970|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
144540758|NCT00048932|521179971|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
144540759|NCT00048932|521179969|FG000|Double Blind Period (DB)|Relocation|1|||
144540760|NCT00048932|521179970|FG001|Double Blind Period (DB)|Relocation|0|||
144540761|NCT00048932|521179971|FG002|Double Blind Period (DB)|Relocation|0|||
144540762|NCT00048932|521179969|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
144200862|NCT01791153|519931722|FG006|Part 1: Blinded Period|Physician Decision|0|||
144200863|NCT01791153|519931723|FG007|Part 1: Blinded Period|Physician Decision|0|||
144540763|NCT00048932|521179970|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
144540764|NCT00048932|521179971|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
144540765|NCT00048932|521179969|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
144540766|NCT00048932|521179970|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
144540767|NCT00048932|521179971|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
144540768|NCT00048932|521179969|FG000|Double Blind Period (DB)|Pregnancy|1|||
144540769|NCT00048932|521179970|FG001|Double Blind Period (DB)|Pregnancy|0|||
144540770|NCT00048932|521179971|FG002|Double Blind Period (DB)|Pregnancy|0|||
144540771|NCT00048932|521179969|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
144540772|NCT00048932|521179970|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
144540773|NCT00048932|521179971|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
144540774|NCT00048932|521179969|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
144540775|NCT00048932|521179970|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
144540776|NCT00048932|521179971|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
144540777|NCT00048932|521179969|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
144540778|NCT00048932|521179970|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
144540779|NCT00048932|521179971|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
144540780|NCT00048932|521179969|FG000|Open Label Period (OL)|Death|0|||
144540781|NCT00048932|521179970|FG001|Open Label Period (OL)|Death|0|||
144540782|NCT00048932|521179971|FG002|Open Label Period (OL)|Death|25|||
144540783|NCT00048932|521179969|FG000|Open Label Period (OL)|Adverse Event|0|||
144540784|NCT00048932|521179970|FG001|Open Label Period (OL)|Adverse Event|0|||
144540785|NCT00048932|521179971|FG002|Open Label Period (OL)|Adverse Event|103|||
144540786|NCT00048932|521179969|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
144540787|NCT00048932|521179970|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
144540788|NCT00048932|521179971|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
144540789|NCT00048932|521179969|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
144540790|NCT00048932|521179970|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
144540791|NCT00048932|521179971|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
144540792|NCT00048932|521179969|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
144540793|NCT00048932|521179970|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
144540794|NCT00048932|521179971|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
144540795|NCT00048932|521179969|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
144540796|NCT00048932|521179970|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
144540797|NCT00048932|521179971|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
144540798|NCT00048932|521179969|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
144540799|NCT00048932|521179970|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
144540800|NCT00048932|521179971|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
144540801|NCT00048932|521179969|FG000|Open Label Period (OL)|Pregnancy|0|||
144540802|NCT00048932|521179970|FG001|Open Label Period (OL)|Pregnancy|0|||
144540803|NCT00048932|521179971|FG002|Open Label Period (OL)|Pregnancy|6|||
144540804|NCT00048932|521179969|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
144540805|NCT00048932|521179970|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
144540806|NCT00048932|521179971|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
144540807|NCT00048932|521179969|FG000|Open Label Period (OL)|Investigator Retiring|0|||
144540808|NCT00048932|521179970|FG001|Open Label Period (OL)|Investigator Retiring|0|||
144540809|NCT00048932|521179971|FG002|Open Label Period (OL)|Investigator Retiring|2|||
144540810|NCT00048932|521179969|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
144540811|NCT00048932|521179970|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
144540812|NCT00048932|521179971|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
144540813|NCT00048932|521179969|FG000|Open Label Period (OL)|Participant Relocated|0|||
144540814|NCT00048932|521179970|FG001|Open Label Period (OL)|Participant Relocated|0|||
144540815|NCT00048932|521179971|FG002|Open Label Period (OL)|Participant Relocated|6|||
144540816|NCT00048932|521179969|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
144540817|NCT00048932|521179970|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
144540818|NCT00048932|521179971|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
144540819|NCT00048932|521179969|FG000|Open Label Period (OL)|Site Closure|0|||
144540820|NCT00048932|521179970|FG001|Open Label Period (OL)|Site Closure|0|||
144200864|NCT01791153|519931716|FG000|Part 1: Blinded Period|Protocol Violation|0|||
144200865|NCT01791153|519931717|FG001|Part 1: Blinded Period|Protocol Violation|0|||
144540821|NCT00048932|521179971|FG002|Open Label Period (OL)|Site Closure|3|||
144540822|NCT00048932|521179969|FG000|Open Label Period (OL)|Trial Terminated|0|||
144540823|NCT00048932|521179970|FG001|Open Label Period (OL)|Trial Terminated|0|||
144540824|NCT00048932|521179971|FG002|Open Label Period (OL)|Trial Terminated|1|||
144540825|NCT00048932|521179969|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
144540826|NCT00048932|521179970|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
144540827|NCT00048932|521179971|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
144540828|NCT00048932|521179969|FG000|Open Label Period (OL)|Patient Decision|0|||
144540829|NCT00048932|521179970|FG001|Open Label Period (OL)|Patient Decision|0|||
144540830|NCT00048932|521179971|FG002|Open Label Period (OL)|Patient Decision|4|||
144540831|NCT00048932|521179969|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
144540832|NCT00048932|521179970|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
144540833|NCT00048932|521179971|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
144540834|NCT00048932|521179969|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
144540835|NCT00048932|521179970|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
144540836|NCT00048932|521179971|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
144540837|NCT00048932|521179969|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
144540838|NCT00048932|521179970|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
144540839|NCT00048932|521179971|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
144540840|NCT00048932|521179969|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
144540841|NCT00048932|521179970|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
144540842|NCT00048932|521179971|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
144540843|NCT00048932|521179969|FG000|Open Label Period (OL)|Investigator Decision|0|||
144540844|NCT00048932|521179970|FG001|Open Label Period (OL)|Investigator Decision|0|||
144540845|NCT00048932|521179971|FG002|Open Label Period (OL)|Investigator Decision|4|||
144540846|NCT00048932|521179969|FG000|Open Label Period (OL)|Site Staff Issues|0|||
144540847|NCT00048932|521179970|FG001|Open Label Period (OL)|Site Staff Issues|0|||
144540848|NCT00048932|521179971|FG002|Open Label Period (OL)|Site Staff Issues|2|||
144540849|NCT00048932|521179969|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
144540850|NCT00048932|521179970|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
144540851|NCT00048932|521179971|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
144540852|NCT00048932|521179969|FG000|Open Label Period (OL)|Participant Surgery|0|||
144540853|NCT00048932|521179970|FG001|Open Label Period (OL)|Participant Surgery|0|||
144540854|NCT00048932|521179971|FG002|Open Label Period (OL)|Participant Surgery|1|||
144540855|NCT02200705|521179972|FG000|Overall Study|Excluded|12|||
144540856|NCT02200705|521179972|FG000|Overall Study|Death|21|||
144540857|NCT02200705|521179972|FG000|Overall Study|Withdrawal by Subject|22|||
144540858|NCT02200705|521179972|FG000|Overall Study|Lost to Follow-up|13|||
144540859|NCT02200705|521179972|FG000|Overall Study|Physician Decision|5|||
144540860|NCT02200705|521179972|FG000|Overall Study|Adverse Event|2|||
144540861|NCT03738228|521179973|FG000|Overall Study|Never received study treatment|2|||
144540862|NCT03738228|521179974|FG001|Overall Study|Never received study treatment|2|||
144540863|NCT06212752|521179975|FG000|Overall Study|Death|5|||
144540864|NCT06212752|521179976|FG001|Overall Study|Death|3|||
144540865|NCT06212752|521179975|FG000|Overall Study|Participants ongoing|23|||
144540866|NCT06212752|521179976|FG001|Overall Study|Participants ongoing|8|||
144540867|NCT03021993|521179977|FG000|Overall Study|Withdrawal by Subject|4|||
144540868|NCT03021993|521179977|FG000|Overall Study|Physician Decision|1|||
144540869|NCT03021993|521179977|FG000|Overall Study|enrolled but were not treated|1|||
144540870|NCT03021993|521179977|FG000|Overall Study|Death|3|||
144540871|NCT02365597|521179978|FG000|Overall Study|Lost to Follow-up|0|||
144540872|NCT02365597|521179979|FG001|Overall Study|Lost to Follow-up|1|||
144540873|NCT02365597|521179980|FG002|Overall Study|Lost to Follow-up|0|||
144540874|NCT02365597|521179981|FG003|Overall Study|Lost to Follow-up|1|||
144540875|NCT02365597|521179978|FG000|Overall Study|Withdrawal by Subject|1|||
144540876|NCT02365597|521179979|FG001|Overall Study|Withdrawal by Subject|8|||
144540877|NCT02365597|521179980|FG002|Overall Study|Withdrawal by Subject|5|||
144540878|NCT02365597|521179981|FG003|Overall Study|Withdrawal by Subject|1|||
144540879|NCT02365597|521179978|FG000|Overall Study|Sponsor's decision|1|||
144540880|NCT02365597|521179979|FG001|Overall Study|Sponsor's decision|3|||
144540881|NCT02365597|521179980|FG002|Overall Study|Sponsor's decision|13|||
144615313|NCT00542269|521452035|FG000|Overall Study|Administrative problems|1|||
144615314|NCT00542269|521452036|FG001|Overall Study|Administrative problems|1|||
144615315|NCT00542269|521452037|FG002|Overall Study|Administrative problems|1|||
144615316|NCT03873714|521452038|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
144615317|NCT01970501|521452039|FG000|Overall Study|Discontinuation of study by sponsor|16|||
144200866|NCT01791153|519931718|FG002|Part 1: Blinded Period|Protocol Violation|0|||
144200867|NCT01791153|519931719|FG003|Part 1: Blinded Period|Protocol Violation|1|||
144200868|NCT01791153|519931720|FG004|Part 1: Blinded Period|Protocol Violation|0|||
144200869|NCT01791153|519931721|FG005|Part 1: Blinded Period|Protocol Violation|0|||
144540882|NCT02365597|521179981|FG003|Overall Study|Sponsor's decision|0|||
144540883|NCT02365597|521179978|FG000|Overall Study|Other|0|||
144540884|NCT02365597|521179979|FG001|Overall Study|Other|4|||
144200870|NCT01791153|519931722|FG006|Part 1: Blinded Period|Protocol Violation|0|||
144200871|NCT01791153|519931723|FG007|Part 1: Blinded Period|Protocol Violation|0|||
144200872|NCT01791153|519931716|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
144200873|NCT01791153|519931717|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
144200874|NCT01791153|519931718|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
144200875|NCT01791153|519931719|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
144200876|NCT01791153|519931720|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
144200877|NCT01791153|519931721|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
144200878|NCT01791153|519931722|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
144200879|NCT01791153|519931723|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
144200880|NCT01791153|519931716|FG000|Part 2: Open-label Period|Adverse Event|0|||
144200881|NCT01791153|519931717|FG001|Part 2: Open-label Period|Adverse Event|0|||
144200882|NCT01791153|519931718|FG002|Part 2: Open-label Period|Adverse Event|0|||
144200883|NCT01791153|519931719|FG003|Part 2: Open-label Period|Adverse Event|0|||
144200884|NCT01791153|519931720|FG004|Part 2: Open-label Period|Adverse Event|0|||
144200885|NCT01791153|519931721|FG005|Part 2: Open-label Period|Adverse Event|1|||
144200886|NCT01791153|519931722|FG006|Part 2: Open-label Period|Adverse Event|1|||
144200887|NCT01791153|519931723|FG007|Part 2: Open-label Period|Adverse Event|2|||
144200888|NCT01791153|519931716|FG000|Part 2: Open-label Period|Death|0|||
144200889|NCT01791153|519931717|FG001|Part 2: Open-label Period|Death|0|||
144200890|NCT01791153|519931718|FG002|Part 2: Open-label Period|Death|0|||
144200891|NCT01791153|519931719|FG003|Part 2: Open-label Period|Death|0|||
144200892|NCT01791153|519931720|FG004|Part 2: Open-label Period|Death|0|||
144200893|NCT01791153|519931721|FG005|Part 2: Open-label Period|Death|1|||
144200894|NCT01791153|519931722|FG006|Part 2: Open-label Period|Death|1|||
144200895|NCT01791153|519931723|FG007|Part 2: Open-label Period|Death|1|||
144200896|NCT01791153|519931716|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
144200897|NCT01791153|519931717|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
144200898|NCT01791153|519931718|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
144200899|NCT01791153|519931719|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
144200900|NCT01791153|519931720|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
144200901|NCT01791153|519931721|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
144200902|NCT01791153|519931722|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
144200903|NCT01791153|519931723|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
144200904|NCT01791153|519931716|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
144200905|NCT01791153|519931717|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
144200906|NCT01791153|519931718|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
144200907|NCT01791153|519931719|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
144200908|NCT01791153|519931720|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
144200909|NCT01791153|519931721|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
144200910|NCT01791153|519931722|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
144200911|NCT01791153|519931723|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
144200912|NCT01791153|519931716|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
144200913|NCT01791153|519931717|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
144200914|NCT01791153|519931718|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
144200915|NCT01791153|519931719|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
144200916|NCT01791153|519931720|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
144200917|NCT01791153|519931721|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
144200918|NCT01791153|519931722|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
144200919|NCT01791153|519931723|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
144200920|NCT01791153|519931716|FG000|Part 2: Open-label Period|Physician Decision|0|||
144200921|NCT01791153|519931717|FG001|Part 2: Open-label Period|Physician Decision|0|||
144200922|NCT01791153|519931718|FG002|Part 2: Open-label Period|Physician Decision|0|||
144200923|NCT01791153|519931719|FG003|Part 2: Open-label Period|Physician Decision|0|||
144200924|NCT01791153|519931720|FG004|Part 2: Open-label Period|Physician Decision|1|||
144200925|NCT01791153|519931721|FG005|Part 2: Open-label Period|Physician Decision|1|||
144200926|NCT01791153|519931722|FG006|Part 2: Open-label Period|Physician Decision|0|||
144200927|NCT01791153|519931723|FG007|Part 2: Open-label Period|Physician Decision|0|||
144200928|NCT02562482|519931727|FG000|Overall Study|Enrolled, but did not receive product|4|||
144200929|NCT02562482|519931728|FG001|Overall Study|Enrolled, but did not receive product|0|||
144200930|NCT02562482|519931727|FG000|Overall Study|Lost to Follow-up|9|||
144200931|NCT02562482|519931728|FG001|Overall Study|Lost to Follow-up|6|||
144200932|NCT02562482|519931727|FG000|Overall Study|Moved from area|2|||
144200933|NCT02562482|519931728|FG001|Overall Study|Moved from area|3|||
144200934|NCT02562482|519931727|FG000|Overall Study|Withdrawal by Subject|5|||
144200935|NCT02562482|519931728|FG001|Overall Study|Withdrawal by Subject|3|||
144200936|NCT02562482|519931727|FG000|Overall Study|Physician Decision|1|||
144200937|NCT02562482|519931728|FG001|Overall Study|Physician Decision|3|||
144200938|NCT02562482|519931727|FG000|Overall Study|Illness/Injury unrelated to product|0|||
144200939|NCT02562482|519931728|FG001|Overall Study|Illness/Injury unrelated to product|1|||
144200940|NCT00975286|519931736|FG000|Overall Study|Adverse Event|9|||
144200941|NCT00975286|519931737|FG001|Overall Study|Adverse Event|19|||
144200942|NCT00975286|519931736|FG000|Overall Study|Protocol Violation|1|||
144200943|NCT00975286|519931737|FG001|Overall Study|Protocol Violation|2|||
144200944|NCT00975286|519931736|FG000|Overall Study|Withdrawal by Subject|0|||
144200945|NCT00975286|519931737|FG001|Overall Study|Withdrawal by Subject|2|||
144200946|NCT00975286|519931736|FG000|Overall Study|Familial and Personal Reasons|2|||
144200947|NCT00975286|519931737|FG001|Overall Study|Familial and Personal Reasons|2|||
144200948|NCT00975286|519931736|FG000|Overall Study|Poor Compliance to Protocol|0|||
144200949|NCT00975286|519931737|FG001|Overall Study|Poor Compliance to Protocol|2|||
144200950|NCT00975286|519931736|FG000|Overall Study|Sponsor Decision|0|||
144200951|NCT00975286|519931737|FG001|Overall Study|Sponsor Decision|2|||
144200952|NCT02357342|519931738|FG000|First 6 Months|Death|2|||
144200953|NCT02357342|519931739|FG001|First 6 Months|Death|0|||
144200954|NCT01674647|519931740|FG000|Treatment Period|Death|4|||
144200955|NCT01674647|519931741|FG001|Treatment Period|Death|1|||
144200956|NCT01674647|519931740|FG000|Treatment Period|Efficacy outcome reached|0|||
144200957|NCT01674647|519931741|FG001|Treatment Period|Efficacy outcome reached|1|||
144200958|NCT01674647|519931740|FG000|Treatment Period|Physician Decision|3|||
144200959|NCT01674647|519931741|FG001|Treatment Period|Physician Decision|1|||
144200960|NCT01674647|519931740|FG000|Treatment Period|Adverse Event|60|||
144200961|NCT01674647|519931741|FG001|Treatment Period|Adverse Event|22|||
144200962|NCT01674647|519931740|FG000|Treatment Period|Non-compliance with study drug|3|||
144200963|NCT01674647|519931741|FG001|Treatment Period|Non-compliance with study drug|0|||
144200964|NCT01674647|519931740|FG000|Treatment Period|Lost to Follow-up|1|||
144200965|NCT01674647|519931741|FG001|Treatment Period|Lost to Follow-up|1|||
144200966|NCT01674647|519931740|FG000|Treatment Period|Withdrawal by Subject|19|||
144200967|NCT01674647|519931741|FG001|Treatment Period|Withdrawal by Subject|16|||
144200968|NCT01674647|519931740|FG000|Treatment Period|Switching to other therapy|5|||
144200969|NCT01674647|519931741|FG001|Treatment Period|Switching to other therapy|2|||
144200970|NCT01674647|519931740|FG000|Treatment Period|Logistical difficulties|5|||
144200971|NCT01674647|519931741|FG001|Treatment Period|Logistical difficulties|8|||
144200972|NCT01674647|519931740|FG000|Treatment Period|Treatment failure|0|||
144200973|NCT01674647|519931741|FG001|Treatment Period|Treatment failure|14|||
144200974|NCT01674647|519931740|FG000|Treatment Period|Protocol Violation|56|||
144200975|NCT01674647|519931741|FG001|Treatment Period|Protocol Violation|36|||
144200976|NCT01674647|519931740|FG000|30-day Safety Follow-up Period|Death|3|||
144200977|NCT01674647|519931741|FG001|30-day Safety Follow-up Period|Death|2|||
144200978|NCT01674647|519931740|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
144200979|NCT01674647|519931741|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
144200980|NCT01674647|519931740|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
144200981|NCT01674647|519931741|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
144200982|NCT01674647|519931740|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
144200983|NCT01674647|519931741|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
144200984|NCT01674647|519931740|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
144200985|NCT01674647|519931741|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
144200986|NCT01674647|519931740|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
144200987|NCT01674647|519931741|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
144200988|NCT01490866|519931743|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
144200989|NCT01490866|519931743|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
144200990|NCT01490866|519931743|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
144200991|NCT01490866|519931743|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
144200992|NCT01490866|519931743|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
144200993|NCT01490866|519931743|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
144200994|NCT01490866|519931743|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
144200995|NCT01490866|519931743|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
144200996|NCT01490866|519931743|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
144200997|NCT01490866|519931743|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
144200998|NCT01490866|519931743|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
144200999|NCT03201211|519931746|FG000|Overall Study|Adverse Event|1|||
144201000|NCT03201211|519931747|FG001|Overall Study|Adverse Event|0|||
144201001|NCT03201211|519931748|FG002|Overall Study|Adverse Event|0|||
144201002|NCT03201211|519931746|FG000|Overall Study|Protocol Violation|1|||
144201003|NCT03201211|519931747|FG001|Overall Study|Protocol Violation|0|||
144201004|NCT03201211|519931748|FG002|Overall Study|Protocol Violation|0|||
144201005|NCT03201211|519931746|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144615318|NCT01970501|521452040|FG001|Overall Study|Discontinuation of study by sponsor|14|||
144615319|NCT01970501|521452039|FG000|Overall Study|Withdrawal by Subject|6|||
144615320|NCT01970501|521452040|FG001|Overall Study|Withdrawal by Subject|7|||
144201006|NCT03201211|519931747|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144201007|NCT03201211|519931748|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
144201008|NCT03201211|519931746|FG000|Overall Study|OTHER unknown reasons|0|||
144201009|NCT03201211|519931747|FG001|Overall Study|OTHER unknown reasons|1|||
144201010|NCT03201211|519931748|FG002|Overall Study|OTHER unknown reasons|0|||
144201011|NCT00594646|519931752|FG000|Overall Study|Withdrawal by Subject|1|||
144201012|NCT00594646|519931752|FG000|Overall Study|Lost to Follow-up|15|||
144615321|NCT01970501|521452039|FG000|Overall Study|Adverse Event|2|||
144615322|NCT01970501|521452040|FG001|Overall Study|Adverse Event|4|||
144615323|NCT01970501|521452039|FG000|Overall Study|Death|1|||
144615324|NCT01970501|521452040|FG001|Overall Study|Death|3|||
144615325|NCT01970501|521452039|FG000|Overall Study|Physician Decision|2|||
144472579|NCT00710606|520928512|FG000|Overall Study|Adverse Event|0|||
144472580|NCT00710606|520928513|FG001|Overall Study|Adverse Event|2|||
144472581|NCT00676130|520928516|FG000|Overall Study|Lost to Follow-up|0|||
144472582|NCT00676130|520928517|FG001|Overall Study|Lost to Follow-up|1|||
144472583|NCT00676130|520928516|FG000|Overall Study|Found ineligible|3|||
144472584|NCT00676130|520928517|FG001|Overall Study|Found ineligible|2|||
144472585|NCT00676130|520928516|FG000|Overall Study|Withdrawal by Subject|0|||
144472586|NCT00676130|520928517|FG001|Overall Study|Withdrawal by Subject|1|||
144472587|NCT00331344|520928522|FG000|Phase I|Adverse Event|0|||
144472588|NCT00331344|520928523|FG001|Phase I|Adverse Event|0|||
144472589|NCT00331344|520928524|FG002|Phase I|Adverse Event|0|||
144472590|NCT00331344|520928525|FG003|Phase I|Adverse Event|1|||
144472591|NCT00331344|520928526|FG004|Phase I|Adverse Event|2|||
144472592|NCT00331344|520928527|FG005|Phase I|Adverse Event|2|||
144472593|NCT00331344|520928528|FG006|Phase I|Adverse Event|0|||
144472594|NCT00331344|520928529|FG007|Phase I|Adverse Event|1|||
144472595|NCT00331344|520928530|FG008|Phase I|Adverse Event|0|||
144472596|NCT00331344|520928522|FG000|Phase II|Death|0|||
144472597|NCT00331344|520928523|FG001|Phase II|Death|0|||
144472598|NCT00331344|520928524|FG002|Phase II|Death|0|||
144472599|NCT00331344|520928525|FG003|Phase II|Death|0|||
144472600|NCT00331344|520928526|FG004|Phase II|Death|0|||
144472601|NCT00331344|520928527|FG005|Phase II|Death|0|||
144472602|NCT00331344|520928528|FG006|Phase II|Death|0|||
144472603|NCT00331344|520928529|FG007|Phase II|Death|0|||
144472604|NCT00331344|520928530|FG008|Phase II|Death|4|||
144472605|NCT01373931|520928536|FG000|Lead-in Period|Adverse Event|2|||
144472606|NCT01373931|520928537|FG001|Lead-in Period|Adverse Event|0|||
144472607|NCT01373931|520928536|FG000|Period 1|Adverse Event|2|||
144472608|NCT01373931|520928537|FG001|Period 1|Adverse Event|0|||
144472609|NCT01373931|520928536|FG000|Period 1|Withdrawal by Subject|0|||
144472610|NCT01373931|520928537|FG001|Period 1|Withdrawal by Subject|2|||
144472611|NCT04538144|520928538|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
144472612|NCT04538144|520928539|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
144472613|NCT04538144|520928540|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
144472614|NCT04538144|520928541|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
144472615|NCT01682213|520928549|FG000|Overall Study|Withdrawal by Subject|2|||
144472616|NCT01995539|520928550|FG000|Overall Study|Screening Failure|1|||
144472617|NCT01995539|520928550|FG000|Overall Study|Withdrawal by Investigator|15|||
144472618|NCT01995539|520928550|FG000|Overall Study|Withdrawal by Subject|11|||
144472619|NCT01995539|520928550|FG000|Overall Study|Lost to Follow-up|5|||
144472620|NCT01995539|520928550|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
144472621|NCT01264380|520928551|FG000|Period C|Disease Progression|0|||
144472622|NCT01264380|520928552|FG001|Period C|Disease Progression|0|||
144472623|NCT01264380|520928553|FG002|Period C|Disease Progression|4|||
144472624|NCT01264380|520928551|FG000|Period C|Death|0|||
144472625|NCT01264380|520928552|FG001|Period C|Death|0|||
144472626|NCT01264380|520928553|FG002|Period C|Death|2|||
144472627|NCT01264380|520928551|FG000|Period C|Follow-up for survival status|0|||
144472628|NCT01264380|520928552|FG001|Period C|Follow-up for survival status|0|||
144472629|NCT01264380|520928553|FG002|Period C|Follow-up for survival status|6|||
144472630|NCT01264380|520928551|FG000|Period C|Withdrawal by Subject|0|||
144472631|NCT01264380|520928552|FG001|Period C|Withdrawal by Subject|0|||
144472632|NCT01264380|520928553|FG002|Period C|Withdrawal by Subject|1|||
144472633|NCT01264380|520928551|FG000|Period C|Adverse Event|0|||
144472634|NCT01264380|520928552|FG001|Period C|Adverse Event|0|||
144472635|NCT01264380|520928553|FG002|Period C|Adverse Event|1|||
144472636|NCT01147822|520928554|FG000|Overall Study|Lost to Follow-up|14|||
144472637|NCT01147822|520928555|FG001|Overall Study|Lost to Follow-up|6|||
144472638|NCT01147822|520928554|FG000|Overall Study|Withdrawal by Subject|10|||
144472639|NCT01147822|520928555|FG001|Overall Study|Withdrawal by Subject|16|||
144472640|NCT01147822|520928554|FG000|Overall Study|Physician Decision|9|||
144472641|NCT01147822|520928555|FG001|Overall Study|Physician Decision|8|||
144472642|NCT01147822|520928554|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
144472643|NCT01147822|520928555|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
144472644|NCT01147822|520928554|FG000|Overall Study|Protocol Violation|1|||
144472645|NCT01147822|520928555|FG001|Overall Study|Protocol Violation|1|||
144615326|NCT01970501|521452040|FG001|Overall Study|Physician Decision|0|||
144615327|NCT00794157|521452041|FG000|Overall Study|Adverse Event|4|||
144615328|NCT00794157|521452042|FG001|Overall Study|Adverse Event|1|||
144615329|NCT00794157|521452043|FG002|Overall Study|Adverse Event|8|||
144472646|NCT00261495|520928559|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
144472647|NCT00261495|520928560|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
144472648|NCT00261495|520928559|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
144472649|NCT00261495|520928560|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
144615330|NCT00794157|521452041|FG000|Overall Study|Subject withdrew consent|2|||
144615331|NCT00794157|521452042|FG001|Overall Study|Subject withdrew consent|0|||
144615332|NCT00794157|521452043|FG002|Overall Study|Subject withdrew consent|3|||
144201013|NCT05011123|519934262|FG000|Overall Study|Withdrawal by Subject|4|||
144201014|NCT05011123|519934263|FG001|Overall Study|Withdrawal by Subject|2|||
144201015|NCT05011123|519934262|FG000|Overall Study|Lost to Follow-up|7|||
144201016|NCT05011123|519934263|FG001|Overall Study|Lost to Follow-up|6|||
144201017|NCT05011123|519934262|FG000|Overall Study|Ongoing at the time of DBL date|36|||
144201018|NCT05011123|519934263|FG001|Overall Study|Ongoing at the time of DBL date|10|||
144201019|NCT05011123|519934262|FG000|Overall Study|Randomized but did not receive vaccination|1|||
144201020|NCT05011123|519934263|FG001|Overall Study|Randomized but did not receive vaccination|0|||
144201021|NCT03845296|519934275|FG000|Overall Study|On Treatment|2|||
144201022|NCT03845296|519934276|FG001|Overall Study|On Treatment|1|||
144201023|NCT03845296|519934275|FG000|Overall Study|Adverse Event|4|||
144201024|NCT03845296|519934276|FG001|Overall Study|Adverse Event|11|||
144201025|NCT03845296|519934275|FG000|Overall Study|Refusal unrelated to adverse event|0|||
144201026|NCT03845296|519934276|FG001|Overall Study|Refusal unrelated to adverse event|1|||
144201027|NCT03845296|519934275|FG000|Overall Study|Progression/relapse|14|||
144201028|NCT03845296|519934276|FG001|Overall Study|Progression/relapse|18|||
144201029|NCT03845296|519934275|FG000|Overall Study|Death|4|||
144201030|NCT03845296|519934276|FG001|Overall Study|Death|0|||
144201031|NCT03845296|519934275|FG000|Overall Study|Other - not protocol specified|1|||
144201032|NCT03845296|519934276|FG001|Overall Study|Other - not protocol specified|3|||
144201033|NCT05327816|519934279|FG000|Overall Study|Lost to Follow-up|1|||
144201034|NCT05327816|519934280|FG001|Overall Study|Lost to Follow-up|0|||
144201035|NCT05327816|519934281|FG002|Overall Study|Lost to Follow-up|0|||
144201036|NCT05327816|519934282|FG003|Overall Study|Lost to Follow-up|0|||
144201037|NCT05327816|519934283|FG004|Overall Study|Lost to Follow-up|0|||
144201038|NCT05327816|519934284|FG005|Overall Study|Lost to Follow-up|0|||
144201039|NCT05327816|519934285|FG006|Overall Study|Lost to Follow-up|0|||
144201040|NCT05327816|519934286|FG007|Overall Study|Lost to Follow-up|0|||
144201041|NCT05327816|519934287|FG008|Overall Study|Lost to Follow-up|0|||
144201042|NCT05327816|519934288|FG009|Overall Study|Lost to Follow-up|1|||
144201043|NCT05327816|519934289|FG010|Overall Study|Lost to Follow-up|0|||
144201044|NCT05327816|519934279|FG000|Overall Study|Withdrawal by Subject|0|||
144201045|NCT05327816|519934280|FG001|Overall Study|Withdrawal by Subject|0|||
144201046|NCT05327816|519934281|FG002|Overall Study|Withdrawal by Subject|0|||
144201047|NCT05327816|519934282|FG003|Overall Study|Withdrawal by Subject|0|||
144201048|NCT05327816|519934283|FG004|Overall Study|Withdrawal by Subject|1|||
144201049|NCT05327816|519934284|FG005|Overall Study|Withdrawal by Subject|1|||
144201050|NCT05327816|519934285|FG006|Overall Study|Withdrawal by Subject|0|||
144201051|NCT05327816|519934286|FG007|Overall Study|Withdrawal by Subject|0|||
144201052|NCT05327816|519934287|FG008|Overall Study|Withdrawal by Subject|0|||
144201053|NCT05327816|519934288|FG009|Overall Study|Withdrawal by Subject|0|||
144201054|NCT05327816|519934289|FG010|Overall Study|Withdrawal by Subject|0|||
144201055|NCT05327816|519934279|FG000|Overall Study|Study Terminated by Sponsor|11|||
144201056|NCT05327816|519934280|FG001|Overall Study|Study Terminated by Sponsor|12|||
144201057|NCT05327816|519934281|FG002|Overall Study|Study Terminated by Sponsor|12|||
144201058|NCT05327816|519934282|FG003|Overall Study|Study Terminated by Sponsor|12|||
144201059|NCT05327816|519934283|FG004|Overall Study|Study Terminated by Sponsor|11|||
144201060|NCT05327816|519934284|FG005|Overall Study|Study Terminated by Sponsor|11|||
144201061|NCT05327816|519934285|FG006|Overall Study|Study Terminated by Sponsor|11|||
144201062|NCT05327816|519934286|FG007|Overall Study|Study Terminated by Sponsor|11|||
144201063|NCT05327816|519934287|FG008|Overall Study|Study Terminated by Sponsor|11|||
144201064|NCT05327816|519934288|FG009|Overall Study|Study Terminated by Sponsor|11|||
144201065|NCT05327816|519934289|FG010|Overall Study|Study Terminated by Sponsor|12|||
144201066|NCT05327816|519934279|FG000|Overall Study|Randomized but not treated|0|||
144201067|NCT05327816|519934280|FG001|Overall Study|Randomized but not treated|0|||
144201068|NCT05327816|519934281|FG002|Overall Study|Randomized but not treated|0|||
144201069|NCT05327816|519934282|FG003|Overall Study|Randomized but not treated|0|||
144201070|NCT05327816|519934283|FG004|Overall Study|Randomized but not treated|0|||
144201071|NCT05327816|519934284|FG005|Overall Study|Randomized but not treated|0|||
144201072|NCT05327816|519934285|FG006|Overall Study|Randomized but not treated|1|||
144615333|NCT00794157|521452041|FG000|Overall Study|Lost to Follow-up|2|||
144615334|NCT00794157|521452042|FG001|Overall Study|Lost to Follow-up|0|||
144201073|NCT05327816|519934286|FG007|Overall Study|Randomized but not treated|1|||
144201074|NCT05327816|519934287|FG008|Overall Study|Randomized but not treated|1|||
144201075|NCT05327816|519934288|FG009|Overall Study|Randomized but not treated|0|||
144201076|NCT05327816|519934289|FG010|Overall Study|Randomized but not treated|0|||
144201077|NCT00658658|519934296|FG000|Overall Study|Withdrawal by Subject|0|||
144201078|NCT00658658|519934297|FG001|Overall Study|Withdrawal by Subject|1|||
144201079|NCT00658658|519934298|FG002|Overall Study|Withdrawal by Subject|0|||
144201080|NCT00658658|519934299|FG003|Overall Study|Withdrawal by Subject|0|||
144201081|NCT00658658|519934300|FG004|Overall Study|Withdrawal by Subject|0|||
144201082|NCT00658658|519934296|FG000|Overall Study|Death|4|||
144260582|NCT03311841|520154553|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
144201083|NCT00658658|519934297|FG001|Overall Study|Death|0|||
144615335|NCT00794157|521452043|FG002|Overall Study|Lost to Follow-up|1|||
144260583|NCT03311841|520154554|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
144260584|NCT03311841|520154555|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
144260585|NCT05285787|520154560|FG000|Overall Study|Withdrawal by Subject|1|||
144260586|NCT01051817|520154568|FG000|Overall Study|Adverse Event|0|||
144260587|NCT01051817|520154569|FG001|Overall Study|Adverse Event|2|||
144260588|NCT01051817|520154568|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
144260589|NCT01051817|520154569|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
144260590|NCT01051817|520154568|FG000|Overall Study|Withdrawal by Subject|3|||
144260591|NCT01051817|520154569|FG001|Overall Study|Withdrawal by Subject|5|||
144260592|NCT01051817|520154568|FG000|Overall Study|Protocol Violation|0|||
144260593|NCT01051817|520154569|FG001|Overall Study|Protocol Violation|1|||
144260594|NCT04346199|520154570|FG000|Overall Study|Death|8|||
144260595|NCT04346199|520154571|FG001|Overall Study|Death|9|||
144260596|NCT04346199|520154570|FG000|Overall Study|Lost to Follow-up|0|||
144260597|NCT04346199|520154571|FG001|Overall Study|Lost to Follow-up|1|||
144260598|NCT04346199|520154570|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
144260599|NCT04346199|520154571|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
144260600|NCT04346199|520154570|FG000|Overall Study|Withdrawal by Subject|5|||
144260601|NCT04346199|520154571|FG001|Overall Study|Withdrawal by Subject|1|||
144260602|NCT01026948|520154572|FG000|Overall Study|Physician Decision|8|||
144260603|NCT00627926|520154573|FG000|Overall Study|Adverse Event|26|||
144260604|NCT00627926|520154574|FG001|Overall Study|Adverse Event|37|||
144260605|NCT00627926|520154575|FG002|Overall Study|Adverse Event|36|||
144260606|NCT00627926|520154573|FG000|Overall Study|Death|1|||
144260607|NCT00627926|520154574|FG001|Overall Study|Death|0|||
144260608|NCT00627926|520154575|FG002|Overall Study|Death|0|||
144260609|NCT00627926|520154573|FG000|Overall Study|Lost to Follow-up|4|||
144260610|NCT00627926|520154574|FG001|Overall Study|Lost to Follow-up|3|||
144260611|NCT00627926|520154575|FG002|Overall Study|Lost to Follow-up|4|||
144260612|NCT00627926|520154573|FG000|Overall Study|Withdrawal by Subject|2|||
144260613|NCT00627926|520154574|FG001|Overall Study|Withdrawal by Subject|1|||
144260614|NCT00627926|520154575|FG002|Overall Study|Withdrawal by Subject|0|||
144260615|NCT00627926|520154573|FG000|Overall Study|Lack of Efficacy|118|||
144260616|NCT00627926|520154574|FG001|Overall Study|Lack of Efficacy|40|||
144260617|NCT00627926|520154575|FG002|Overall Study|Lack of Efficacy|38|||
144260618|NCT00627926|520154573|FG000|Overall Study|Noncompliance/unspecified|8|||
144260619|NCT00627926|520154574|FG001|Overall Study|Noncompliance/unspecified|23|||
144260620|NCT00627926|520154575|FG002|Overall Study|Noncompliance/unspecified|17|||
144260621|NCT02401035|520154577|FG000|Overall Study|Withdrawal by Subject|1|||
144260622|NCT02401035|520154578|FG001|Overall Study|Withdrawal by Subject|0|||
144260623|NCT01189461|520154580|FG000|Overall Study|Lack of Efficacy|13|||
144260624|NCT01189461|520154580|FG000|Overall Study|Lost to Follow-up|1|||
144260625|NCT01189461|520154580|FG000|Overall Study|Withdrawal by Subject|6|||
144260626|NCT01189461|520154580|FG000|Overall Study|Protocol Violation|1|||
144260627|NCT01189461|520154580|FG000|Overall Study|Adverse Event|2|||
144260628|NCT01189461|520154580|FG000|Overall Study|Did not meet entrance criteria|3|||
144260629|NCT01189461|520154580|FG000|Overall Study|Other|8|||
144260630|NCT00452439|520156476|FG000|Overall Study|Lost to Follow-up|1|||
144260631|NCT00452439|520156477|FG001|Overall Study|Lost to Follow-up|1|||
144260632|NCT00452439|520156476|FG000|Overall Study|Refused Treatment|4|||
144201084|NCT00658658|519934298|FG002|Overall Study|Death|0|||
144201085|NCT00658658|519934299|FG003|Overall Study|Death|1|||
144201086|NCT00658658|519934300|FG004|Overall Study|Death|1|||
144201087|NCT00658658|519934296|FG000|Overall Study|Disease Progression|0|||
144201088|NCT00658658|519934297|FG001|Overall Study|Disease Progression|1|||
144201089|NCT00658658|519934298|FG002|Overall Study|Disease Progression|0|||
144201090|NCT00658658|519934299|FG003|Overall Study|Disease Progression|1|||
144201091|NCT00658658|519934300|FG004|Overall Study|Disease Progression|3|||
144260633|NCT00452439|520156477|FG001|Overall Study|Refused Treatment|3|||
144260634|NCT00452439|520156476|FG000|Overall Study|Death|3|||
144201092|NCT00658658|519934296|FG000|Overall Study|Protocol-specified Criteria|1|||
144260635|NCT00452439|520156477|FG001|Overall Study|Death|1|||
144260636|NCT00452439|520156476|FG000|Overall Study|Bone Marrow Transplant|0|||
144260637|NCT00452439|520156477|FG001|Overall Study|Bone Marrow Transplant|1|||
144260638|NCT00452439|520156476|FG000|Overall Study|Too Ill to Continue|0|||
144260639|NCT00452439|520156477|FG001|Overall Study|Too Ill to Continue|1|||
144201093|NCT00658658|519934297|FG001|Overall Study|Protocol-specified Criteria|0|||
144201094|NCT00658658|519934298|FG002|Overall Study|Protocol-specified Criteria|0|||
144201095|NCT00658658|519934299|FG003|Overall Study|Protocol-specified Criteria|0|||
144201096|NCT00658658|519934300|FG004|Overall Study|Protocol-specified Criteria|0|||
144201097|NCT00658658|519934296|FG000|Overall Study|Other|0|||
144472650|NCT00261495|520928559|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
144201098|NCT00658658|519934297|FG001|Overall Study|Other|0|||
144201099|NCT00658658|519934298|FG002|Overall Study|Other|0|||
144201100|NCT00658658|519934299|FG003|Overall Study|Other|0|||
144201101|NCT00658658|519934300|FG004|Overall Study|Other|1|||
144260640|NCT00452439|520156476|FG000|Overall Study|Failed to achieve complete response|2|||
144260641|NCT00452439|520156477|FG001|Overall Study|Failed to achieve complete response|0|||
144201102|NCT03986138|519934301|FG000|First MRI Examination|Physician Decision|0|||
144201103|NCT03986138|519934302|FG001|First MRI Examination|Physician Decision|1|||
144201104|NCT03986138|519934301|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
144201105|NCT03986138|519934302|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
144201106|NCT03986138|519934301|FG000|Washout|Withdrawal by Subject|4|||
144201107|NCT03986138|519934302|FG001|Washout|Withdrawal by Subject|5|||
144201108|NCT03986138|519934301|FG000|Washout|Lost to Follow-up|0|||
144201109|NCT03986138|519934302|FG001|Washout|Lost to Follow-up|2|||
144201110|NCT03986138|519934301|FG000|Washout|Adverse Event|1|||
144201111|NCT03986138|519934302|FG001|Washout|Adverse Event|1|||
144201112|NCT03986138|519934301|FG000|Washout|Other reason|5|||
144201113|NCT03986138|519934302|FG001|Washout|Other reason|5|||
144201114|NCT03986138|519934301|FG000|Second MRI Examination|Withdrawal by Subject|0|||
144201115|NCT03986138|519934302|FG001|Second MRI Examination|Withdrawal by Subject|2|||
144201116|NCT04305587|519934303|FG000|Overall Study|Withdrawal by Subject|0|||
144201117|NCT04305587|519934304|FG001|Overall Study|Withdrawal by Subject|0|||
144201118|NCT04305587|519934305|FG002|Overall Study|Withdrawal by Subject|0|||
144201119|NCT04305587|519934306|FG003|Overall Study|Withdrawal by Subject|1|||
144201120|NCT04305587|519934307|FG004|Overall Study|Withdrawal by Subject|0|||
144201121|NCT04305587|519934308|FG005|Overall Study|Withdrawal by Subject|0|||
144201122|NCT04305587|519934309|FG006|Overall Study|Withdrawal by Subject|0|||
144201123|NCT04305587|519934310|FG007|Overall Study|Withdrawal by Subject|0|||
144201124|NCT04305587|519934311|FG008|Overall Study|Withdrawal by Subject|0|||
144201125|NCT01523457|519934312|FG000|Overall Study|Withdrawal by Subject|7|||
144201126|NCT01523457|519934313|FG001|Overall Study|Withdrawal by Subject|2|||
144201127|NCT01367665|519934314|FG000|Overall Study|Death|102|||
144201128|NCT01367665|519934315|FG001|Overall Study|Death|19|||
144201129|NCT01367665|519934314|FG000|Overall Study|Lost to Follow-up|222|||
144201130|NCT01367665|519934315|FG001|Overall Study|Lost to Follow-up|22|||
144201131|NCT01367665|519934314|FG000|Overall Study|Not Done|118|||
144201132|NCT01367665|519934315|FG001|Overall Study|Not Done|14|||
144201133|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
144201134|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
144201135|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
144201136|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
144201137|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
144201138|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
144201139|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
144201140|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
144201141|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
144201142|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
144201143|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
144201144|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
144201145|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
144201146|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
144201147|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
144201148|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
144201149|NCT03182244|519934316|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
144201150|NCT03182244|519934317|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
144201151|NCT03182244|519934316|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
144201152|NCT03182244|519934317|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
144201153|NCT03182244|519934316|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
144201154|NCT03182244|519934317|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
144201155|NCT03182244|519934316|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
144201156|NCT03182244|519934317|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
144201157|NCT03182244|519934316|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
144201158|NCT03182244|519934317|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
144201159|NCT01200992|519934318|FG000|Overall Study|Study terminated early|35|||
144201160|NCT01200992|519934319|FG001|Overall Study|Study terminated early|41|||
144201161|NCT01200992|519934318|FG000|Overall Study|Randomized but not treated|2|||
144201162|NCT01200992|519934319|FG001|Overall Study|Randomized but not treated|0|||
144201163|NCT00368979|519934323|FG000|Overall Study|Adverse Event|9|||
144201164|NCT00368979|519934324|FG001|Overall Study|Adverse Event|16|||
144201165|NCT00368979|519934323|FG000|Overall Study|Lack of Efficacy|5|||
144201166|NCT00368979|519934324|FG001|Overall Study|Lack of Efficacy|3|||
144201167|NCT00368979|519934323|FG000|Overall Study|Other|3|||
144201168|NCT00368979|519934324|FG001|Overall Study|Other|1|||
144201169|NCT00368979|519934323|FG000|Overall Study|Lost to Follow-up|1|||
144201170|NCT00368979|519934324|FG001|Overall Study|Lost to Follow-up|0|||
144201171|NCT00368979|519934323|FG000|Overall Study|Protocol Violation|2|||
144201172|NCT00368979|519934324|FG001|Overall Study|Protocol Violation|1|||
144201173|NCT00368979|519934323|FG000|Overall Study|Withdrawal by Subject|5|||
144201174|NCT00368979|519934324|FG001|Overall Study|Withdrawal by Subject|9|||
144201175|NCT01345175|519934326|FG000|Overall Study|Physician Decision|0|||
144201176|NCT01345175|519934327|FG001|Overall Study|Physician Decision|1|||
144201177|NCT01345175|519934326|FG000|Overall Study|Withdrawal by Subject|1|||
144201178|NCT01345175|519934327|FG001|Overall Study|Withdrawal by Subject|1|||
144201179|NCT01345175|519934326|FG000|Overall Study|Failed to complete BFI|3|||
144201180|NCT01345175|519934327|FG001|Overall Study|Failed to complete BFI|2|||
144201181|NCT01345175|519934326|FG000|Overall Study|Stopped taking medication|2|||
144201182|NCT01345175|519934327|FG001|Overall Study|Stopped taking medication|2|||
144201183|NCT04112173|519934328|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
144201184|NCT04234984|519934336|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
144201185|NCT04234984|519934336|FG000|Follow-up at the Second Time Point|Death|1|||
144201186|NCT04234984|519934336|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
144201187|NCT01055132|519934337|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
144201188|NCT01055132|519934338|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
144201189|NCT01055132|519934337|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
144201190|NCT01055132|519934338|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
144201191|NCT02570113|519934339|FG000|Overall Study|Withdrawal by Subject|3|||
144201192|NCT02746471|519934340|FG000|Overall Study|Death|43|||
144201193|NCT02746471|519934340|FG000|Overall Study|Exited before 36 months|1119|||
144201194|NCT04585789|519934341|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
144201195|NCT04585789|519934342|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
144201196|NCT04585789|519934343|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
144201197|NCT04585789|519934341|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
144201198|NCT04585789|519934342|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
144201199|NCT04585789|519934343|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
144201200|NCT01175811|519934344|FG000|Overall Study|Adverse Event|1|||
144201201|NCT01175811|519934345|FG001|Overall Study|Adverse Event|1|||
144201202|NCT01175811|519934344|FG000|Overall Study|Entry criteria not met|3|||
144201203|NCT01175811|519934345|FG001|Overall Study|Entry criteria not met|1|||
144201204|NCT01175811|519934344|FG000|Overall Study|Lack of Efficacy|1|||
144201205|NCT01175811|519934345|FG001|Overall Study|Lack of Efficacy|0|||
144201206|NCT01175811|519934344|FG000|Overall Study|Lost to Follow-up|3|||
144201207|NCT01175811|519934345|FG001|Overall Study|Lost to Follow-up|2|||
144201208|NCT01175811|519934344|FG000|Overall Study|Physician Decision|1|||
144201209|NCT01175811|519934345|FG001|Overall Study|Physician Decision|1|||
144201210|NCT01175811|519934344|FG000|Overall Study|Protocol Violation|1|||
144201211|NCT01175811|519934345|FG001|Overall Study|Protocol Violation|2|||
144201212|NCT01175811|519934344|FG000|Overall Study|Withdrawal by Subject|6|||
144201213|NCT01175811|519934345|FG001|Overall Study|Withdrawal by Subject|7|||
144201214|NCT02628743|519934347|FG000|Overall Study|Other|3|||
144201215|NCT02628743|519934347|FG000|Overall Study|Withdrawal by Subject|50|||
144201216|NCT02628743|519934347|FG000|Overall Study|Study Terminated by Sponsor|76|||
144201217|NCT02628743|519934347|FG000|Overall Study|Physician Decision|2|||
144201218|NCT02534844|519934348|FG000|Part B|Withdrawal by Subject|0|||
144201219|NCT02534844|519934349|FG001|Part B|Withdrawal by Subject|0|||
144201220|NCT02534844|519934350|FG002|Part B|Withdrawal by Subject|0|||
144201221|NCT02534844|519934351|FG003|Part B|Withdrawal by Subject|0|||
144201222|NCT02534844|519934352|FG004|Part B|Withdrawal by Subject|2|||
144201223|NCT02534844|519934353|FG005|Part B|Withdrawal by Subject|1|||
144201224|NCT00655876|519934354|FG000|Overall Study|Protocol Violation|9|||
144201225|NCT00655876|519934355|FG001|Overall Study|Protocol Violation|7|||
144201226|NCT00326963|519934356|FG000|Overall Study|Adverse Event|2|||
144201227|NCT00326963|519934356|FG000|Overall Study|Injection site reaction|1|||
144201228|NCT00326963|519934356|FG000|Overall Study|Death|1|||
144201229|NCT00326963|519934356|FG000|Overall Study|Failure to return|10|||
144201230|NCT00326963|519934356|FG000|Overall Study|Withdrawal by Subject|10|||
144201231|NCT00326963|519934356|FG000|Overall Study|Refused treatment / did not cooperate|5|||
144201232|NCT00326963|519934356|FG000|Overall Study|Violation of selection criteria at entry|2|||
144201233|NCT00326963|519934356|FG000|Overall Study|Other protocol violation|1|||
144260642|NCT00452439|520156476|FG000|Overall Study|Relapse|3|||
144540885|NCT02365597|521179980|FG002|Overall Study|Other|0|||
144540886|NCT02365597|521179981|FG003|Overall Study|Other|0|||
144540887|NCT02365597|521179978|FG000|Overall Study|Enrolled but not treated|0|||
144540888|NCT02365597|521179979|FG001|Overall Study|Enrolled but not treated|1|||
144540889|NCT02365597|521179980|FG002|Overall Study|Enrolled but not treated|1|||
144540890|NCT02365597|521179981|FG003|Overall Study|Enrolled but not treated|0|||
144540891|NCT02365597|521179978|FG000|Overall Study|Ongoing|0|||
144540892|NCT02365597|521179979|FG001|Overall Study|Ongoing|0|||
144540893|NCT02365597|521179980|FG002|Overall Study|Ongoing|0|||
144540894|NCT02365597|521179981|FG003|Overall Study|Ongoing|17|||
144540895|NCT01759862|521179985|FG000|Overall Study|Physician Decision|3|||
144201234|NCT00326963|519934356|FG000|Overall Study|Administrative / other|1|||
144201235|NCT02331368|519934360|FG000|Overall Study|Withdrawal by Subject|3|||
144260643|NCT00452439|520156477|FG001|Overall Study|Relapse|0|||
144260644|NCT00452439|520156476|FG000|Overall Study|Fracture|1|||
144540896|NCT01759862|521179986|FG001|Overall Study|Physician Decision|1|||
144540897|NCT01759862|521179985|FG000|Overall Study|Adverse Event|0|||
144615336|NCT00794157|521452041|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144615337|NCT00794157|521452042|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144615338|NCT00794157|521452043|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144615339|NCT00794157|521452041|FG000|Overall Study|Administrative problems|1|||
144615340|NCT00794157|521452042|FG001|Overall Study|Administrative problems|7|||
144615341|NCT00794157|521452043|FG002|Overall Study|Administrative problems|4|||
144615342|NCT00794157|521452041|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144615343|NCT00794157|521452042|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144615344|NCT00794157|521452043|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144615345|NCT00794157|521452041|FG000|Overall Study|Protocol deviation|0|||
144615346|NCT00794157|521452042|FG001|Overall Study|Protocol deviation|1|||
144615347|NCT00794157|521452043|FG002|Overall Study|Protocol deviation|1|||
144615348|NCT01692275|521452044|FG000|Overall Study|Lost to Follow-up|57|||
144615349|NCT01692275|521452045|FG001|Overall Study|Lost to Follow-up|48|||
144615350|NCT01692275|521452044|FG000|Overall Study|Withdrawal by Subject|9|||
144615351|NCT01692275|521452045|FG001|Overall Study|Withdrawal by Subject|11|||
144615352|NCT00814892|521452048|FG000|Overall Study|Disease Progression|1|||
144615353|NCT00814892|521452048|FG000|Overall Study|Study Termination|1|||
144615354|NCT00401375|521452051|FG000|Overall Study|Protocol Violation|2|||
144615355|NCT00401375|521452052|FG001|Overall Study|Protocol Violation|2|||
144615356|NCT00401375|521452053|FG002|Overall Study|Protocol Violation|1|||
144615357|NCT00401375|521452051|FG000|Overall Study|Adverse Event|6|||
144615358|NCT00401375|521452052|FG001|Overall Study|Adverse Event|11|||
144615359|NCT00401375|521452053|FG002|Overall Study|Adverse Event|10|||
144615360|NCT00401375|521452051|FG000|Overall Study|Withdrawal by Subject|9|||
144615361|NCT00401375|521452052|FG001|Overall Study|Withdrawal by Subject|7|||
144615362|NCT00401375|521452053|FG002|Overall Study|Withdrawal by Subject|7|||
144615363|NCT00401375|521452051|FG000|Overall Study|Lost to Follow-up|0|||
144615364|NCT00401375|521452052|FG001|Overall Study|Lost to Follow-up|1|||
144615365|NCT00401375|521452053|FG002|Overall Study|Lost to Follow-up|1|||
144615366|NCT00401375|521452051|FG000|Overall Study|Other than specified|2|||
144615367|NCT00401375|521452052|FG001|Overall Study|Other than specified|1|||
144615368|NCT00401375|521452053|FG002|Overall Study|Other than specified|3|||
144615369|NCT00401375|521452051|FG000|Overall Study|Randomized but not treated|3|||
144615370|NCT00401375|521452052|FG001|Overall Study|Randomized but not treated|3|||
144615371|NCT00401375|521452053|FG002|Overall Study|Randomized but not treated|3|||
144615372|NCT00950664|521452054|FG000|First Intervention|Lost to Follow-up|1|||
144615373|NCT00950664|521452055|FG001|First Intervention|Lost to Follow-up|3|||
144615374|NCT00950664|521452054|FG000|First Intervention|Withdrawal by Subject|2|||
144615375|NCT00950664|521452055|FG001|First Intervention|Withdrawal by Subject|2|||
144615376|NCT00677014|521452056|FG000|Overall Study|Lost to Follow-up|20|||
144615377|NCT00677014|521452057|FG001|Overall Study|Lost to Follow-up|12|||
144615378|NCT00677014|521452058|FG002|Overall Study|Lost to Follow-up|24|||
144615379|NCT00677014|521452056|FG000|Overall Study|Death|6|||
144615380|NCT00677014|521452057|FG001|Overall Study|Death|15|||
144615381|NCT00677014|521452058|FG002|Overall Study|Death|7|||
144615382|NCT00677014|521452056|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
144615383|NCT00677014|521452057|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
144615384|NCT00677014|521452058|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
144615385|NCT00640328|521452059|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
144615386|NCT00640328|521452060|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
144615387|NCT00640328|521452061|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
144615388|NCT00640328|521452062|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
144615389|NCT00640328|521452063|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
144615390|NCT00640328|521452064|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
144615391|NCT00640328|521452059|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
144615392|NCT00640328|521452060|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
144615393|NCT00640328|521452061|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
144615394|NCT00640328|521452062|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
144615395|NCT00640328|521452063|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
144615396|NCT00640328|521452064|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
144615397|NCT00640328|521452059|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
144615398|NCT00640328|521452060|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
144615399|NCT00640328|521452061|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
144615400|NCT00640328|521452062|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
144615401|NCT00640328|521452063|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
144615402|NCT00640328|521452064|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
144615403|NCT00640328|521452059|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
144615404|NCT00640328|521452060|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
144615405|NCT00640328|521452061|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
144615406|NCT00640328|521452062|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
144615407|NCT00640328|521452063|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
144260645|NCT00452439|520156477|FG001|Overall Study|Fracture|0|||
144260646|NCT04826484|520156486|FG000|Overall Study|Lost to Follow-up|2|||
144260647|NCT04826484|520156487|FG001|Overall Study|Lost to Follow-up|0|||
144260648|NCT03512353|520156490|FG000|Overall Study|Sponsor Decision|3|||
144260649|NCT03512353|520156490|FG000|Overall Study|Death|1|||
144260650|NCT00758498|520156491|FG000|Overall Study|Adverse Event|2|||
144260651|NCT00758498|520156492|FG001|Overall Study|Adverse Event|2|||
144260652|NCT00758498|520156493|FG002|Overall Study|Adverse Event|3|||
144260653|NCT00758498|520156491|FG000|Overall Study|Subject legally detained out of state|1|||
144260654|NCT00758498|520156492|FG001|Overall Study|Subject legally detained out of state|0|||
144260655|NCT00758498|520156493|FG002|Overall Study|Subject legally detained out of state|0|||
144260656|NCT00758498|520156491|FG000|Overall Study|Withdrawal by Subject|0|||
144260657|NCT00758498|520156492|FG001|Overall Study|Withdrawal by Subject|0|||
144260658|NCT00758498|520156493|FG002|Overall Study|Withdrawal by Subject|1|||
144260659|NCT00758498|520156491|FG000|Overall Study|Noncompliance to study procedures|0|||
144260660|NCT00758498|520156492|FG001|Overall Study|Noncompliance to study procedures|0|||
144260661|NCT00758498|520156493|FG002|Overall Study|Noncompliance to study procedures|1|||
144260662|NCT02581488|520156497|FG000|Overall Study|Adverse Event|6|||
144260663|NCT02581488|520156498|FG001|Overall Study|Adverse Event|7|||
144260664|NCT02581488|520156497|FG000|Overall Study|Lost to Follow-up|1|||
144260665|NCT02581488|520156498|FG001|Overall Study|Lost to Follow-up|0|||
144260666|NCT02581488|520156497|FG000|Overall Study|Withdrawal by Subject|1|||
144260667|NCT02581488|520156498|FG001|Overall Study|Withdrawal by Subject|0|||
144260668|NCT02581488|520156497|FG000|Overall Study|Non-Compliance|1|||
144260669|NCT02581488|520156498|FG001|Overall Study|Non-Compliance|0|||
144260670|NCT02581488|520156497|FG000|Overall Study|Protocol Violation|0|||
144260671|NCT02581488|520156498|FG001|Overall Study|Protocol Violation|4|||
144260672|NCT00954122|520156499|FG000|Overall Study|Withdrawal by Subject|5|||
144260673|NCT00954122|520156499|FG000|Overall Study|Adverse Event|1|||
144260674|NCT00954122|520156499|FG000|Overall Study|Safety Reason|1|||
144260675|NCT02291029|520156502|FG000|Overall Study|Withdrawal by Subject|0|||
144260676|NCT02291029|520156503|FG001|Overall Study|Withdrawal by Subject|0|||
144260677|NCT02291029|520156504|FG002|Overall Study|Withdrawal by Subject|1|||
144260678|NCT02291029|520156505|FG003|Overall Study|Withdrawal by Subject|0|||
144260679|NCT02291029|520156506|FG004|Overall Study|Withdrawal by Subject|0|||
144260680|NCT02291029|520156507|FG005|Overall Study|Withdrawal by Subject|0|||
144260681|NCT02291029|520156502|FG000|Overall Study|Adverse Event|0|||
144260682|NCT02291029|520156503|FG001|Overall Study|Adverse Event|1|||
144260683|NCT02291029|520156504|FG002|Overall Study|Adverse Event|0|||
144260684|NCT02291029|520156505|FG003|Overall Study|Adverse Event|0|||
144260685|NCT02291029|520156506|FG004|Overall Study|Adverse Event|0|||
144260686|NCT02291029|520156507|FG005|Overall Study|Adverse Event|0|||
144260687|NCT00522548|520156508|FG000|Overall Study|Adverse Event|2|||
144260688|NCT00522548|520156509|FG001|Overall Study|Adverse Event|2|||
144260689|NCT00522548|520156508|FG000|Overall Study|Withdrawal by Subject|0|||
144260690|NCT00522548|520156509|FG001|Overall Study|Withdrawal by Subject|2|||
144260691|NCT00493012|520156510|FG000|Overall Study|Lost to Follow-up|18|||
144260692|NCT00493012|520156511|FG001|Overall Study|Lost to Follow-up|17|||
144260693|NCT04147247|520156512|FG000|Overall Study|Progressive disease|3|||
144260694|NCT04147247|520156513|FG001|Overall Study|Progressive disease|3|||
144260695|NCT04147247|520156514|FG002|Overall Study|Progressive disease|4|||
144260696|NCT04147247|520156515|FG003|Overall Study|Progressive disease|4|||
144260697|NCT04147247|520156516|FG004|Overall Study|Progressive disease|3|||
144260698|NCT04147247|520156512|FG000|Overall Study|Physician Decision|0|||
144260699|NCT04147247|520156513|FG001|Overall Study|Physician Decision|1|||
144260700|NCT04147247|520156514|FG002|Overall Study|Physician Decision|0|||
144260701|NCT04147247|520156515|FG003|Overall Study|Physician Decision|0|||
144260702|NCT04147247|520156516|FG004|Overall Study|Physician Decision|0|||
144260703|NCT04147247|520156512|FG000|Overall Study|Clinical Disease Progression|0|||
144260704|NCT04147247|520156513|FG001|Overall Study|Clinical Disease Progression|0|||
144260705|NCT04147247|520156514|FG002|Overall Study|Clinical Disease Progression|0|||
144540898|NCT01759862|521179986|FG001|Overall Study|Adverse Event|1|||
144727429|NCT02719522|521856640|FG000|Overall Study|Death|2|||
144260706|NCT04147247|520156515|FG003|Overall Study|Clinical Disease Progression|0|||
144260707|NCT04147247|520156516|FG004|Overall Study|Clinical Disease Progression|1|||
144260708|NCT04147247|520156512|FG000|Overall Study|Adverse Event|0|||
144260709|NCT04147247|520156513|FG001|Overall Study|Adverse Event|0|||
144260710|NCT04147247|520156514|FG002|Overall Study|Adverse Event|1|||
144260711|NCT04147247|520156515|FG003|Overall Study|Adverse Event|0|||
144260712|NCT04147247|520156516|FG004|Overall Study|Adverse Event|1|||
144260713|NCT04085601|520156517|FG000|Overall Study|Lost to Follow-up|1|||
144260714|NCT04085601|520156518|FG001|Overall Study|Lost to Follow-up|0|||
144260715|NCT04085601|520156517|FG000|Overall Study|Death|1|||
144260716|NCT04085601|520156518|FG001|Overall Study|Death|1|||
144260717|NCT00113295|520156519|FG000|Overall Study|Adverse Event|4|||
144260718|NCT00113295|520156520|FG001|Overall Study|Adverse Event|1|||
144260719|NCT00113295|520156519|FG000|Overall Study|Unrelated Medical Illness|1|||
144260720|NCT00113295|520156520|FG001|Overall Study|Unrelated Medical Illness|0|||
144472651|NCT00261495|520928560|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
144615408|NCT00640328|521452064|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
144615409|NCT02374099|521452067|FG000|Overall Study|Adverse Event|1|||
144615410|NCT02374099|521452068|FG001|Overall Study|Adverse Event|0|||
144615411|NCT02374099|521452067|FG000|Overall Study|Progressive Disease|35|||
144615412|NCT02374099|521452068|FG001|Overall Study|Progressive Disease|40|||
144615413|NCT02374099|521452067|FG000|Overall Study|Withdrawal by Subject|5|||
144615414|NCT02374099|521452068|FG001|Overall Study|Withdrawal by Subject|1|||
144615415|NCT02374099|521452067|FG000|Overall Study|Miscellaneous|2|||
144615416|NCT02374099|521452068|FG001|Overall Study|Miscellaneous|3|||
144615417|NCT02374099|521452067|FG000|Overall Study|Randomized, but not treated|2|||
144615418|NCT02374099|521452068|FG001|Overall Study|Randomized, but not treated|1|||
144615419|NCT02374099|521452067|FG000|Overall Study|Study Terminated by Sponsor|3|||
144615420|NCT02374099|521452068|FG001|Overall Study|Study Terminated by Sponsor|4|||
144615421|NCT04294719|521452069|FG000|Overall Study|Withdrawal by Subject|1|||
144615422|NCT01714687|521452070|FG000|Overall Study|Withdrawal by Subject|1|||
144615423|NCT01714687|521452071|FG001|Overall Study|Withdrawal by Subject|0|||
144615424|NCT01714687|521452070|FG000|Overall Study|Lost to Follow-up|2|||
144615425|NCT01714687|521452071|FG001|Overall Study|Lost to Follow-up|4|||
144615426|NCT03693625|521452072|FG000|Overall Study|Adverse Event|2|||
144615427|NCT03693625|521452073|FG001|Overall Study|Adverse Event|0|||
144615428|NCT03693625|521452072|FG000|Overall Study|Study Terminated By Sponsor|20|||
144615429|NCT03693625|521452073|FG001|Overall Study|Study Terminated By Sponsor|7|||
144615430|NCT03693625|521452072|FG000|Overall Study|Withdrawal by Subject|1|||
144615431|NCT03693625|521452073|FG001|Overall Study|Withdrawal by Subject|1|||
144615432|NCT01883635|521452074|FG000|Overall Study|Withdrawal by Subject|4|||
144615433|NCT01883635|521452075|FG001|Overall Study|Withdrawal by Subject|0|||
144615434|NCT01187953|521452076|FG000|Overall Study|Death|11|||
144615435|NCT01187953|521452077|FG001|Overall Study|Death|13|||
144615436|NCT01187953|521452076|FG000|Overall Study|Adverse Event|1|||
144615437|NCT01187953|521452077|FG001|Overall Study|Adverse Event|2|||
144615438|NCT01187953|521452076|FG000|Overall Study|Lost to Follow-up|0|||
144615439|NCT01187953|521452077|FG001|Overall Study|Lost to Follow-up|3|||
144615440|NCT01187953|521452076|FG000|Overall Study|Withdrawal by Subject|3|||
144615441|NCT01187953|521452077|FG001|Overall Study|Withdrawal by Subject|3|||
144615442|NCT01464307|521452081|FG000|Main Period|Death|0|||
144615443|NCT01464307|521452082|FG001|Main Period|Death|1|||
144615444|NCT01464307|521452081|FG000|Main Period|Adverse Event|6|||
144615445|NCT01464307|521452082|FG001|Main Period|Adverse Event|1|||
144615446|NCT01464307|521452081|FG000|Main Period|Lack of Efficacy|2|||
144615447|NCT01464307|521452082|FG001|Main Period|Lack of Efficacy|0|||
144615448|NCT01464307|521452081|FG000|Main Period|Withdrawal by Subject|5|||
144615449|NCT01464307|521452082|FG001|Main Period|Withdrawal by Subject|2|||
144615450|NCT01464307|521452081|FG000|Main Period|Predefined discontinuation criteria|2|||
144615451|NCT01464307|521452082|FG001|Main Period|Predefined discontinuation criteria|1|||
144615452|NCT01464307|521452081|FG000|Open-Label Extension Period|Adverse Event|15|||
144615453|NCT01464307|521452082|FG001|Open-Label Extension Period|Adverse Event|0|||
144615454|NCT01464307|521452081|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
144615455|NCT01464307|521452082|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
144615456|NCT01464307|521452081|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
144615457|NCT01464307|521452082|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
144615458|NCT01464307|521452081|FG000|Open-Label Extension Period|Death|1|||
144615459|NCT01464307|521452082|FG001|Open-Label Extension Period|Death|0|||
144615460|NCT01464307|521452081|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
144615461|NCT01464307|521452082|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
144615462|NCT01464307|521452081|FG000|Open-Label Extension Period|Non-compliance|9|||
144615463|NCT01464307|521452082|FG001|Open-Label Extension Period|Non-compliance|0|||
144615464|NCT01464307|521452081|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
144615465|NCT01464307|521452082|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
144615466|NCT01553136|521452087|FG000|Overall Study|Adverse Event|3|||
144201236|NCT01763684|519934362|FG000|Overall Study|Study terminated early due to low enrollment|126|||
144201237|NCT01763684|519934363|FG001|Overall Study|Study terminated early due to low enrollment|127|||
144201238|NCT01763684|519934362|FG000|Overall Study|Study surgery not performed|7|||
144201239|NCT01763684|519934363|FG001|Overall Study|Study surgery not performed|6|||
144201240|NCT02987959|519934364|FG000|Overall Study|Grantor stopped supply of drugs|6|||
144201241|NCT02302859|519934365|FG000|Overall Study|Lost Phone|1|||
144201242|NCT02302859|519934366|FG001|Overall Study|Lost Phone|1|||
144201243|NCT02302859|519934365|FG000|Overall Study|Withdrawal by Subject|0|||
144615467|NCT01553136|521452088|FG001|Overall Study|Adverse Event|2|||
144615468|NCT01553136|521452087|FG000|Overall Study|Withdrawal by Subject|2|||
144615469|NCT01553136|521452088|FG001|Overall Study|Withdrawal by Subject|3|||
144615470|NCT01553136|521452087|FG000|Overall Study|Lost to Follow-up|4|||
144615471|NCT01553136|521452088|FG001|Overall Study|Lost to Follow-up|10|||
144615472|NCT01553136|521452087|FG000|Overall Study|Physician Decision|2|||
144615473|NCT01553136|521452088|FG001|Overall Study|Physician Decision|3|||
144201244|NCT02302859|519934366|FG001|Overall Study|Withdrawal by Subject|1|||
144260721|NCT00994110|520156521|FG000|Overall Study|Withdrawal by Subject|9|||
144260722|NCT00994110|520156522|FG001|Overall Study|Withdrawal by Subject|9|||
144260723|NCT00994110|520156521|FG000|Overall Study|Not Treated|4|||
144260724|NCT00994110|520156522|FG001|Overall Study|Not Treated|8|||
144260725|NCT00994110|520156521|FG000|Overall Study|Adverse Event|1|||
144260726|NCT00994110|520156522|FG001|Overall Study|Adverse Event|0|||
144260727|NCT00994110|520156521|FG000|Overall Study|Patient not resected|41|||
144260728|NCT00994110|520156522|FG001|Overall Study|Patient not resected|52|||
144260729|NCT00994110|520156521|FG000|Overall Study|Pt not eligible|10|||
144260730|NCT00994110|520156522|FG001|Overall Study|Pt not eligible|5|||
144260731|NCT01914393|520156523|FG000|Overall Study|Protocol Violation|11|||
144260732|NCT01914393|520156524|FG001|Overall Study|Protocol Violation|3|||
144260733|NCT01914393|520156525|FG002|Overall Study|Protocol Violation|19|||
144260734|NCT01914393|520156523|FG000|Overall Study|Lack of Efficacy|11|||
144260735|NCT01914393|520156524|FG001|Overall Study|Lack of Efficacy|16|||
144260736|NCT01914393|520156525|FG002|Overall Study|Lack of Efficacy|5|||
144260737|NCT01914393|520156523|FG000|Overall Study|no reason given|14|||
144260738|NCT01914393|520156524|FG001|Overall Study|no reason given|8|||
144260739|NCT01914393|520156525|FG002|Overall Study|no reason given|16|||
144260740|NCT01914393|520156523|FG000|Overall Study|Adverse Event|29|||
144260741|NCT01914393|520156524|FG001|Overall Study|Adverse Event|18|||
144260742|NCT01914393|520156525|FG002|Overall Study|Adverse Event|31|||
144260743|NCT01914393|520156523|FG000|Overall Study|Withdrawal by Subject|38|||
144260744|NCT01914393|520156524|FG001|Overall Study|Withdrawal by Subject|20|||
144260745|NCT01914393|520156525|FG002|Overall Study|Withdrawal by Subject|47|||
144260746|NCT01914393|520156523|FG000|Overall Study|Lost to Follow-up|12|||
144260747|NCT01914393|520156524|FG001|Overall Study|Lost to Follow-up|6|||
144260748|NCT01914393|520156525|FG002|Overall Study|Lost to Follow-up|19|||
144260749|NCT01914393|520156523|FG000|Overall Study|subject never dosed|0|||
144260750|NCT01914393|520156524|FG001|Overall Study|subject never dosed|0|||
144260751|NCT01914393|520156525|FG002|Overall Study|subject never dosed|1|||
144260752|NCT00666211|520156526|FG000|Overall Study|Withdrawal by Subject|10|||
144260753|NCT00666211|520156527|FG001|Overall Study|Withdrawal by Subject|13|||
144260754|NCT00666211|520156526|FG000|Overall Study|went off medication, no more pain|1|||
144260755|NCT00666211|520156527|FG001|Overall Study|went off medication, no more pain|0|||
144260756|NCT00666211|520156526|FG000|Overall Study|patient non-compliant|6|||
144260757|NCT00666211|520156527|FG001|Overall Study|patient non-compliant|6|||
144260758|NCT00666211|520156526|FG000|Overall Study|disease progression|1|||
144260759|NCT00666211|520156527|FG001|Overall Study|disease progression|8|||
144260760|NCT00666211|520156526|FG000|Overall Study|Lost to Follow-up|2|||
144260761|NCT00666211|520156527|FG001|Overall Study|Lost to Follow-up|0|||
144260762|NCT00666211|520156526|FG000|Overall Study|toxicity|0|||
144260763|NCT00666211|520156527|FG001|Overall Study|toxicity|2|||
144260764|NCT00666211|520156526|FG000|Overall Study|hospital admission|0|||
144260765|NCT00666211|520156527|FG001|Overall Study|hospital admission|5|||
144260766|NCT00666211|520156526|FG000|Overall Study|Death|0|||
144260767|NCT00666211|520156527|FG001|Overall Study|Death|2|||
144260768|NCT00666211|520156526|FG000|Overall Study|off tx for other complicating disease|0|||
144260769|NCT00666211|520156527|FG001|Overall Study|off tx for other complicating disease|1|||
144260770|NCT00666211|520156526|FG000|Overall Study|Physician Decision|0|||
144260771|NCT00666211|520156527|FG001|Overall Study|Physician Decision|1|||
144260772|NCT02999789|520156528|FG000|Overall Study|Withdrawal by Subject|0|||
144260773|NCT02999789|520156529|FG001|Overall Study|Withdrawal by Subject|1|||
144260774|NCT02999789|520156528|FG000|Overall Study|Became ineligible|1|||
144260775|NCT02999789|520156529|FG001|Overall Study|Became ineligible|2|||
144260776|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
144260777|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
144260778|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
144260779|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
144260780|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
144260781|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
144727430|NCT02719522|521856640|FG000|Overall Study|Lost to Follow-up|5|||
144727431|NCT02457832|521856641|FG000|Training|Lost to Follow-up|10|||
144260782|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
144260783|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
144260784|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
144260785|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
144260786|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
144260787|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
144727432|NCT02457832|521856642|FG001|Training|Lost to Follow-up|6|||
144260788|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
144260789|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
144260790|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
144260791|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
144260792|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
144260793|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
144260794|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
144260795|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
144260796|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
144260797|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
144260798|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
144260799|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
144260800|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
144260801|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
144260802|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
144260803|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
144260804|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
144260805|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
144260806|NCT01111565|520156530|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
144260807|NCT01111565|520156531|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
144260808|NCT01111565|520156532|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
144260809|NCT01111565|520156533|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
144260810|NCT01111565|520156534|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
144260811|NCT01111565|520156530|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144260812|NCT01111565|520156531|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144260813|NCT01111565|520156532|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144260814|NCT01111565|520156533|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
144260815|NCT01111565|520156534|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144260816|NCT01111565|520156530|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144260817|NCT01111565|520156531|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144260818|NCT01111565|520156532|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
144260819|NCT01111565|520156533|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144260820|NCT01111565|520156534|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144260821|NCT01111565|520156530|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
144260822|NCT01111565|520156531|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
144260823|NCT01111565|520156532|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
144260824|NCT01111565|520156533|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
144260825|NCT01111565|520156534|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
144260826|NCT01111565|520156530|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
144260827|NCT01111565|520156531|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
144260828|NCT01111565|520156532|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
144260829|NCT01111565|520156533|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
144260830|NCT01111565|520156534|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
144260831|NCT01111565|520156530|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
144260832|NCT01111565|520156531|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
144260833|NCT01111565|520156532|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
144260834|NCT01111565|520156533|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
144260835|NCT01111565|520156534|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
144260836|NCT02824224|520156535|FG000|Overall Study|Discontinued, IUS expulsion|0|||
144260837|NCT02824224|520156536|FG001|Overall Study|Discontinued, IUS expulsion|1|||
144260838|NCT02824224|520156535|FG000|Overall Study|Did not show up for allocation visit|2|||
144260839|NCT02824224|520156536|FG001|Overall Study|Did not show up for allocation visit|0|||
144260840|NCT02683239|520156537|FG000|Overall Study|Protocol Violation|35|||
144260841|NCT02683239|520156538|FG001|Overall Study|Protocol Violation|23|||
144260842|NCT02683239|520156539|FG002|Overall Study|Protocol Violation|26|||
144260843|NCT02683239|520156540|FG003|Overall Study|Protocol Violation|4|||
144260844|NCT02683239|520156541|FG004|Overall Study|Protocol Violation|35|||
144260845|NCT02683239|520156542|FG005|Overall Study|Protocol Violation|4|||
144260846|NCT02683239|520156543|FG006|Overall Study|Protocol Violation|5|||
144260847|NCT02683239|520156537|FG000|Overall Study|Adverse Event|64|||
144260848|NCT02683239|520156538|FG001|Overall Study|Adverse Event|39|||
144260849|NCT02683239|520156539|FG002|Overall Study|Adverse Event|42|||
144260850|NCT02683239|520156540|FG003|Overall Study|Adverse Event|16|||
144260851|NCT02683239|520156541|FG004|Overall Study|Adverse Event|189|||
144260852|NCT02683239|520156542|FG005|Overall Study|Adverse Event|9|||
144260853|NCT02683239|520156543|FG006|Overall Study|Adverse Event|9|||
144260854|NCT02683239|520156537|FG000|Overall Study|Physician Decision|38|||
144260855|NCT02683239|520156538|FG001|Overall Study|Physician Decision|19|||
144260856|NCT02683239|520156539|FG002|Overall Study|Physician Decision|14|||
144260857|NCT02683239|520156540|FG003|Overall Study|Physician Decision|73|||
144260858|NCT02683239|520156541|FG004|Overall Study|Physician Decision|143|||
144260859|NCT02683239|520156542|FG005|Overall Study|Physician Decision|14|||
144260860|NCT02683239|520156543|FG006|Overall Study|Physician Decision|15|||
144260861|NCT02683239|520156537|FG000|Overall Study|Withdrawal by Subject|187|||
144260862|NCT02683239|520156538|FG001|Overall Study|Withdrawal by Subject|99|||
144260863|NCT02683239|520156539|FG002|Overall Study|Withdrawal by Subject|91|||
144260864|NCT02683239|520156540|FG003|Overall Study|Withdrawal by Subject|18|||
144615474|NCT01553136|521452087|FG000|Overall Study|Scheduling Difficulties|5|||
144615475|NCT01553136|521452088|FG001|Overall Study|Scheduling Difficulties|4|||
144201245|NCT00643565|519934369|FG000|Overall Study|Death|12|||
144201246|NCT00643565|519934370|FG001|Overall Study|Death|11|||
144201247|NCT00643565|519934369|FG000|Overall Study|Withdrawal by Subject|4|||
144201248|NCT00643565|519934370|FG001|Overall Study|Withdrawal by Subject|1|||
144201249|NCT00643565|519934369|FG000|Overall Study|Lost to Follow-up|0|||
144201250|NCT00643565|519934370|FG001|Overall Study|Lost to Follow-up|6|||
144201251|NCT00643565|519934369|FG000|Overall Study|Other|7|||
144201252|NCT00643565|519934370|FG001|Overall Study|Other|8|||
144201253|NCT00643565|519934369|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
144201254|NCT00643565|519934370|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
144201255|NCT00643565|519934369|FG000|Overall Study|Recurrence of Disease|2|||
144201256|NCT00643565|519934370|FG001|Overall Study|Recurrence of Disease|1|||
144201257|NCT00643565|519934369|FG000|Overall Study|Progression of Disease|18|||
144201258|NCT00643565|519934370|FG001|Overall Study|Progression of Disease|14|||
144201259|NCT00643565|519934369|FG000|Overall Study|Protocol Violation|3|||
144201260|NCT00643565|519934370|FG001|Overall Study|Protocol Violation|0|||
144201261|NCT00643565|519934369|FG000|Overall Study|Did Not Cooperate|0|||
144201262|NCT00643565|519934370|FG001|Overall Study|Did Not Cooperate|1|||
144201263|NCT00643565|519934369|FG000|Overall Study|Administrative|22|||
144201264|NCT00643565|519934370|FG001|Overall Study|Administrative|16|||
144201265|NCT00643565|519934369|FG000|Overall Study|Adverse Event|5|||
144201266|NCT00643565|519934370|FG001|Overall Study|Adverse Event|8|||
144201267|NCT03285308|519934379|FG000|Overall Study|Adverse Event|3|||
144201268|NCT03285308|519934380|FG001|Overall Study|Adverse Event|7|||
144201269|NCT03285308|519934379|FG000|Overall Study|Withdrawal by Subject|8|||
144201270|NCT03285308|519934380|FG001|Overall Study|Withdrawal by Subject|9|||
144201271|NCT03285308|519934379|FG000|Overall Study|Lost to Follow-up|3|||
144201272|NCT03285308|519934380|FG001|Overall Study|Lost to Follow-up|1|||
144201273|NCT03285308|519934379|FG000|Overall Study|Protocol Deviation|6|||
144201274|NCT03285308|519934380|FG001|Overall Study|Protocol Deviation|5|||
144201275|NCT03285308|519934379|FG000|Overall Study|Reason not Specified|0|||
144201276|NCT03285308|519934380|FG001|Overall Study|Reason not Specified|1|||
144201277|NCT02283983|519934381|FG000|Overall Study|Inclusion criteria not met|0|||
144201278|NCT02283983|519934382|FG001|Overall Study|Inclusion criteria not met|1|||
144201279|NCT02283983|519934381|FG000|Overall Study|Withdrawal by Subject|4|||
144201280|NCT02283983|519934382|FG001|Overall Study|Withdrawal by Subject|2|||
144201281|NCT02283983|519934381|FG000|Overall Study|Protocol Violation|0|||
144201282|NCT02283983|519934382|FG001|Overall Study|Protocol Violation|4|||
144201283|NCT02283983|519934381|FG000|Overall Study|Physician Decision|2|||
144201284|NCT02283983|519934382|FG001|Overall Study|Physician Decision|4|||
144201285|NCT02283983|519934381|FG000|Overall Study|Death|1|||
144201286|NCT02283983|519934382|FG001|Overall Study|Death|0|||
144201287|NCT02283983|519934381|FG000|Overall Study|Adverse Event|1|||
144201288|NCT02283983|519934382|FG001|Overall Study|Adverse Event|0|||
144201289|NCT02283983|519934381|FG000|Overall Study|Lost to Follow-up|9|||
144201290|NCT02283983|519934382|FG001|Overall Study|Lost to Follow-up|8|||
144201291|NCT02283983|519934381|FG000|Overall Study|Relapse|1|||
144201292|NCT02283983|519934382|FG001|Overall Study|Relapse|0|||
144201293|NCT03283761|519934383|FG000|Study Treatment|Patient Non-Compliance|1|||
144201294|NCT03283761|519934383|FG000|Study Treatment|Alternative Cancer Therapy|7|||
144201295|NCT03283761|519934383|FG000|Study Treatment|Disease progression|21|||
144201296|NCT03283761|519934383|FG000|Study Treatment|Adverse Event|3|||
144201297|NCT03283761|519934383|FG000|Study Treatment|Withdrawal by Subject|4|||
144201298|NCT03283761|519934383|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
144201299|NCT03283761|519934383|FG000|Study Treatment|Symptomatic Deterioration|1|||
144201300|NCT03283761|519934383|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
144260865|NCT02683239|520156541|FG004|Overall Study|Withdrawal by Subject|248|||
144540899|NCT03631407|521179987|FG000|Overall Study|Withdrawal by Subject|3|||
144540900|NCT03631407|521179988|FG001|Overall Study|Withdrawal by Subject|2|||
144540901|NCT03631407|521179987|FG000|Overall Study|Sponsor Decision|0|||
144540902|NCT03631407|521179988|FG001|Overall Study|Sponsor Decision|2|||
144540903|NCT03631407|521179987|FG000|Overall Study|Death|16|||
144540904|NCT03631407|521179988|FG001|Overall Study|Death|16|||
144540905|NCT03631407|521179987|FG000|Overall Study|Randomized by mistake without study treatment|1|||
144540906|NCT03631407|521179988|FG001|Overall Study|Randomized by mistake without study treatment|0|||
144540907|NCT00983294|521179989|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
144540908|NCT00983294|521179989|FG000|Colchicine With Azithromycin|Adverse Event|1|||
144540909|NCT00390884|521179992|FG000|Overall Study|Withdrawal by Subject|2|||
144540910|NCT00390884|521179993|FG001|Overall Study|Withdrawal by Subject|2|||
144540911|NCT00756574|521179994|FG000|Overall Study|Withdrawal by Subject|9|||
144540912|NCT00756574|521179995|FG001|Overall Study|Withdrawal by Subject|7|||
144540913|NCT00756574|521179994|FG000|Overall Study|Lost to Follow-up|4|||
144540914|NCT00756574|521179995|FG001|Overall Study|Lost to Follow-up|4|||
144540915|NCT04622332|521179996|FG000|Overall Study|Withdrawal by Subject|4|||
144260866|NCT02683239|520156542|FG005|Overall Study|Withdrawal by Subject|22|||
144260867|NCT02683239|520156543|FG006|Overall Study|Withdrawal by Subject|28|||
144260868|NCT02683239|520156537|FG000|Overall Study|Lost to Follow-up|77|||
144260869|NCT02683239|520156538|FG001|Overall Study|Lost to Follow-up|24|||
144260870|NCT02683239|520156539|FG002|Overall Study|Lost to Follow-up|25|||
144260871|NCT02683239|520156540|FG003|Overall Study|Lost to Follow-up|7|||
144260872|NCT02683239|520156541|FG004|Overall Study|Lost to Follow-up|88|||
144260873|NCT02683239|520156542|FG005|Overall Study|Lost to Follow-up|8|||
144260874|NCT02683239|520156543|FG006|Overall Study|Lost to Follow-up|11|||
144260875|NCT02683239|520156537|FG000|Overall Study|Death|9|||
144260876|NCT02683239|520156538|FG001|Overall Study|Death|5|||
144260877|NCT02683239|520156539|FG002|Overall Study|Death|8|||
144260878|NCT02683239|520156540|FG003|Overall Study|Death|0|||
144260879|NCT02683239|520156541|FG004|Overall Study|Death|12|||
144260880|NCT02683239|520156542|FG005|Overall Study|Death|1|||
144260881|NCT02683239|520156543|FG006|Overall Study|Death|0|||
144260882|NCT02683239|520156537|FG000|Overall Study|Lack of Efficacy|50|||
144260883|NCT02683239|520156538|FG001|Overall Study|Lack of Efficacy|23|||
144260884|NCT02683239|520156539|FG002|Overall Study|Lack of Efficacy|12|||
144260885|NCT02683239|520156540|FG003|Overall Study|Lack of Efficacy|2|||
144260886|NCT02683239|520156541|FG004|Overall Study|Lack of Efficacy|29|||
144260887|NCT02683239|520156542|FG005|Overall Study|Lack of Efficacy|2|||
144260888|NCT02683239|520156543|FG006|Overall Study|Lack of Efficacy|3|||
144260889|NCT02683239|520156537|FG000|Overall Study|Missing data|0|||
144260890|NCT02683239|520156538|FG001|Overall Study|Missing data|1|||
144260891|NCT02683239|520156539|FG002|Overall Study|Missing data|1|||
144260892|NCT02683239|520156540|FG003|Overall Study|Missing data|0|||
144260893|NCT02683239|520156541|FG004|Overall Study|Missing data|1|||
144260894|NCT02683239|520156542|FG005|Overall Study|Missing data|0|||
144260895|NCT02683239|520156543|FG006|Overall Study|Missing data|0|||
144260896|NCT04131712|520156544|FG000|Overall Study|COVID related|0|||
144260897|NCT04131712|520156545|FG001|Overall Study|COVID related|0|||
144260898|NCT04131712|520156546|FG002|Overall Study|COVID related|2|||
144260899|NCT04131712|520156547|FG003|Overall Study|COVID related|0|||
144260900|NCT04131712|520156544|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
144260901|NCT04131712|520156545|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
144260902|NCT04131712|520156546|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
144260903|NCT04131712|520156547|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
144260904|NCT01348139|520156552|FG000|Period 1|Adverse Event|1|||
144260905|NCT01348139|520156553|FG001|Period 1|Adverse Event|0|||
144260906|NCT01348139|520156554|FG002|Period 1|Adverse Event|0|||
144260907|NCT01348139|520156555|FG003|Period 1|Adverse Event|0|||
144260908|NCT01348139|520156556|FG004|Period 1|Adverse Event|0|||
144260909|NCT01348139|520156557|FG005|Period 1|Adverse Event|0|||
144615476|NCT03885089|521452089|FG000|Overall Study|No informed consent for publication of study results|2|||
144615477|NCT03349099|521452090|FG000|Overall Study|Physician Decision|3|||
144615478|NCT03349099|521452091|FG001|Overall Study|Physician Decision|4|||
144615479|NCT03349099|521452090|FG000|Overall Study|Stone migrated from the kidney|1|||
144615480|NCT03349099|521452091|FG001|Overall Study|Stone migrated from the kidney|0|||
144615481|NCT04194528|521452092|FG000|Overall Study|Adverse Event|1|||
144615482|NCT03921424|521452095|FG000|Overall Study|Lost to Follow-up|0|||
144615483|NCT03921424|521452096|FG001|Overall Study|Lost to Follow-up|1|||
144201301|NCT03283761|519934383|FG000|Follow up|Lost to Follow-up|1|||
144201302|NCT03283761|519934383|FG000|Follow up|Symptomatic Deterioration|1|||
144201303|NCT03283761|519934383|FG000|Follow up|Death|29|||
144201304|NCT03283761|519934383|FG000|Follow up|study terminated|4|||
144201305|NCT03283761|519934383|FG000|Follow up|Primary Investigator Withdrawal|1|||
144201306|NCT03283761|519934383|FG000|Follow up|Switched to alternative therapy|1|||
144201307|NCT03283761|519934383|FG000|Follow up|Subject is now in Hospice|1|||
144201308|NCT04453202|519934389|FG000|Overall Study|Adverse Event|0|||
144201309|NCT04453202|519934390|FG001|Overall Study|Adverse Event|0|||
144615484|NCT03921424|521452095|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
144615485|NCT03921424|521452096|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
144700081|NCT00931515|521754504|FG000|Overall Study|Lost to Follow-up|2|||
144700082|NCT00931515|521754505|FG001|Overall Study|Lost to Follow-up|5|||
144700083|NCT03759340|521754506|FG000|Overall Study|Adverse Event|2|||
144201310|NCT04453202|519934391|FG002|Overall Study|Adverse Event|0|||
144260910|NCT02254772|520156560|FG000|Overall Study|Ineligible|1|||
144260911|NCT02254772|520156560|FG000|Overall Study|Withdrawal by Subject|1|||
144260912|NCT01841970|520156561|FG000|Overall Study|Withdrawal by Subject|1|||
144260913|NCT01841970|520156561|FG000|Overall Study|Physician Decision|2|||
144260914|NCT01841970|520156561|FG000|Overall Study|Lost to Follow-up|8|||
144260915|NCT04556760|520156562|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
144260916|NCT04556760|520156563|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
144260917|NCT04556760|520156564|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
144260918|NCT04556760|520156565|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
144260919|NCT04556760|520156566|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
144700084|NCT03759340|521754506|FG000|Overall Study|Lost to Follow-up|1|||
144260920|NCT04556760|520156567|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
144260921|NCT04556760|520156562|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
144260922|NCT04556760|520156563|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
144260923|NCT04556760|520156564|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
144260924|NCT04556760|520156565|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
144260925|NCT04556760|520156566|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
144260926|NCT04556760|520156567|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
144260927|NCT01462110|520156574|FG000|Overall Study|Adverse Event|1|||
144260928|NCT01462110|520156575|FG001|Overall Study|Adverse Event|0|||
144260929|NCT00753675|520156576|FG000|Overall Study|other reason|11|||
144260930|NCT00753675|520156577|FG001|Overall Study|other reason|12|||
144260931|NCT00753675|520156578|FG002|Overall Study|other reason|13|||
144260932|NCT00753675|520156576|FG000|Overall Study|Death|1|||
144260933|NCT00753675|520156577|FG001|Overall Study|Death|2|||
144260934|NCT00753675|520156578|FG002|Overall Study|Death|4|||
144260935|NCT00753675|520156576|FG000|Overall Study|Adverse Event|11|||
144260936|NCT00753675|520156577|FG001|Overall Study|Adverse Event|9|||
144260937|NCT00753675|520156578|FG002|Overall Study|Adverse Event|4|||
144260938|NCT00753675|520156576|FG000|Overall Study|Objective progression of disease|35|||
144260939|NCT00753675|520156577|FG001|Overall Study|Objective progression of disease|35|||
144260940|NCT00753675|520156578|FG002|Overall Study|Objective progression of disease|35|||
144260941|NCT00753675|520156576|FG000|Overall Study|Withdrawal by Subject|0|||
144260942|NCT00753675|520156577|FG001|Overall Study|Withdrawal by Subject|1|||
144260943|NCT00753675|520156578|FG002|Overall Study|Withdrawal by Subject|0|||
144260944|NCT00753675|520156576|FG000|Overall Study|Lost to Follow-up|1|||
144260945|NCT00753675|520156577|FG001|Overall Study|Lost to Follow-up|0|||
144260946|NCT00753675|520156578|FG002|Overall Study|Lost to Follow-up|0|||
144615486|NCT01964352|521454475|FG000|Overall Study|Adverse Event|13|||
144615487|NCT01964352|521454476|FG001|Overall Study|Adverse Event|3|||
144615488|NCT01964352|521454477|FG002|Overall Study|Adverse Event|4|||
144615489|NCT01964352|521454478|FG003|Overall Study|Adverse Event|3|||
144615490|NCT01964352|521454475|FG000|Overall Study|Lack of Efficacy|6|||
144615491|NCT01964352|521454476|FG001|Overall Study|Lack of Efficacy|0|||
144615492|NCT01964352|521454477|FG002|Overall Study|Lack of Efficacy|0|||
144615493|NCT01964352|521454478|FG003|Overall Study|Lack of Efficacy|0|||
144615494|NCT01964352|521454475|FG000|Overall Study|Protocol Violation|2|||
144615495|NCT01964352|521454476|FG001|Overall Study|Protocol Violation|4|||
144615496|NCT01964352|521454477|FG002|Overall Study|Protocol Violation|0|||
144615497|NCT01964352|521454478|FG003|Overall Study|Protocol Violation|2|||
144615498|NCT01964352|521454475|FG000|Overall Study|Lost to Follow-up|1|||
144615499|NCT01964352|521454476|FG001|Overall Study|Lost to Follow-up|0|||
144615500|NCT01964352|521454477|FG002|Overall Study|Lost to Follow-up|0|||
144615501|NCT01964352|521454478|FG003|Overall Study|Lost to Follow-up|1|||
144615502|NCT01964352|521454475|FG000|Overall Study|Withdrawal by Subject|4|||
144615503|NCT01964352|521454476|FG001|Overall Study|Withdrawal by Subject|2|||
144615504|NCT01964352|521454477|FG002|Overall Study|Withdrawal by Subject|1|||
144615505|NCT01964352|521454478|FG003|Overall Study|Withdrawal by Subject|0|||
144615506|NCT01964352|521454475|FG000|Overall Study|Other than stated above|0|||
144615507|NCT01964352|521454476|FG001|Overall Study|Other than stated above|2|||
144615508|NCT01964352|521454477|FG002|Overall Study|Other than stated above|1|||
144615509|NCT01964352|521454478|FG003|Overall Study|Other than stated above|2|||
144615510|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
144615511|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
144615512|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
144615513|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
144615514|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
144615515|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
144615516|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
144615517|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
144615518|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
144615519|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
144615520|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
144615521|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
144615522|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
144615523|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
144615524|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
144615525|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
144260947|NCT05279131|520156580|FG000|Overall Study|Lost to Follow-up|1|||
144260948|NCT05279131|520156580|FG000|Overall Study|Death|1|||
144260949|NCT05279131|520156580|FG000|Overall Study|Physician Decision|1|||
144260950|NCT02149264|520156586|FG000|Overall Study|Withdrawal by Subject|9|||
144260951|NCT02149264|520156586|FG000|Overall Study|Adverse Event|7|||
144260952|NCT02149264|520156586|FG000|Overall Study|Physician Decision|3|||
144615526|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
144615527|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
144615528|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
144615529|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
144615530|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
144615531|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
144615532|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
144615533|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
144615534|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
144615535|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
144615536|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
144615537|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
144615538|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
144615539|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
144615540|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
144615541|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
144615542|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
144615543|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
144615544|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
144615545|NCT02831673|521454479|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
144615546|NCT02831673|521454480|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
144615547|NCT02831673|521454481|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
144615548|NCT02831673|521454482|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
144615549|NCT02831673|521454483|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
144615550|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
144615551|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
144615552|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
144615553|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
144615554|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
144615555|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144615556|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144615557|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
144615558|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
144615559|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144615560|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144615561|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144615562|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144615563|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
144615564|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144615565|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
144615566|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
144615567|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
144615568|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
144615569|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
144615570|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
144615571|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
144615572|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
144615573|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
144615574|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
144201311|NCT04453202|519934392|FG003|Overall Study|Adverse Event|0|||
144201312|NCT04453202|519934393|FG004|Overall Study|Adverse Event|0|||
144201313|NCT04453202|519934394|FG005|Overall Study|Adverse Event|0|||
144201314|NCT04453202|519934395|FG006|Overall Study|Adverse Event|1|||
144201315|NCT04453202|519934396|FG007|Overall Study|Adverse Event|0|||
144201316|NCT04453202|519934397|FG008|Overall Study|Adverse Event|0|||
144201317|NCT04453202|519934398|FG009|Overall Study|Adverse Event|0|||
144201318|NCT04453202|519934399|FG010|Overall Study|Adverse Event|0|||
144201319|NCT04453202|519934389|FG000|Overall Study|Death|0|||
144201320|NCT04453202|519934390|FG001|Overall Study|Death|0|||
144201321|NCT04453202|519934391|FG002|Overall Study|Death|0|||
144201322|NCT04453202|519934392|FG003|Overall Study|Death|0|||
144201323|NCT04453202|519934393|FG004|Overall Study|Death|0|||
144201324|NCT04453202|519934394|FG005|Overall Study|Death|0|||
144201325|NCT04453202|519934395|FG006|Overall Study|Death|0|||
144201326|NCT04453202|519934396|FG007|Overall Study|Death|0|||
144201327|NCT04453202|519934397|FG008|Overall Study|Death|0|||
144201328|NCT04453202|519934398|FG009|Overall Study|Death|1|||
144201329|NCT04453202|519934399|FG010|Overall Study|Death|0|||
144201330|NCT04453202|519934389|FG000|Overall Study|Lost to Follow-up|0|||
144201331|NCT04453202|519934390|FG001|Overall Study|Lost to Follow-up|1|||
144201332|NCT04453202|519934391|FG002|Overall Study|Lost to Follow-up|0|||
144201333|NCT04453202|519934392|FG003|Overall Study|Lost to Follow-up|1|||
144201334|NCT04453202|519934393|FG004|Overall Study|Lost to Follow-up|0|||
144201335|NCT04453202|519934394|FG005|Overall Study|Lost to Follow-up|0|||
144201336|NCT04453202|519934395|FG006|Overall Study|Lost to Follow-up|0|||
144201337|NCT04453202|519934396|FG007|Overall Study|Lost to Follow-up|0|||
144201338|NCT04453202|519934397|FG008|Overall Study|Lost to Follow-up|0|||
144201339|NCT04453202|519934398|FG009|Overall Study|Lost to Follow-up|1|||
144201340|NCT04453202|519934399|FG010|Overall Study|Lost to Follow-up|1|||
144201341|NCT04453202|519934389|FG000|Overall Study|Withdrawal by Subject|1|||
144201342|NCT04453202|519934390|FG001|Overall Study|Withdrawal by Subject|2|||
144201343|NCT04453202|519934391|FG002|Overall Study|Withdrawal by Subject|1|||
144201344|NCT04453202|519934392|FG003|Overall Study|Withdrawal by Subject|2|||
144201345|NCT04453202|519934393|FG004|Overall Study|Withdrawal by Subject|1|||
144201346|NCT04453202|519934394|FG005|Overall Study|Withdrawal by Subject|1|||
144201347|NCT04453202|519934395|FG006|Overall Study|Withdrawal by Subject|0|||
144201348|NCT04453202|519934396|FG007|Overall Study|Withdrawal by Subject|0|||
144201349|NCT04453202|519934397|FG008|Overall Study|Withdrawal by Subject|0|||
144201350|NCT04453202|519934398|FG009|Overall Study|Withdrawal by Subject|1|||
144201351|NCT04453202|519934399|FG010|Overall Study|Withdrawal by Subject|0|||
144201352|NCT04453202|519934389|FG000|Overall Study|Adverse Event|0|||
144201353|NCT04453202|519934390|FG001|Overall Study|Adverse Event|0|||
144201354|NCT04453202|519934391|FG002|Overall Study|Adverse Event|0|||
144201355|NCT04453202|519934392|FG003|Overall Study|Adverse Event|0|||
144201356|NCT04453202|519934393|FG004|Overall Study|Adverse Event|0|||
144201357|NCT04453202|519934394|FG005|Overall Study|Adverse Event|1|||
144201358|NCT04453202|519934395|FG006|Overall Study|Adverse Event|0|||
144201359|NCT04453202|519934396|FG007|Overall Study|Adverse Event|0|||
144201360|NCT04453202|519934397|FG008|Overall Study|Adverse Event|0|||
144201361|NCT04453202|519934398|FG009|Overall Study|Adverse Event|0|||
144201362|NCT04453202|519934399|FG010|Overall Study|Adverse Event|0|||
144201363|NCT00669071|519934403|FG000|Overall Study|Lost to Follow-up|3|||
144201364|NCT00669071|519934403|FG000|Overall Study|Final visit 40 days out of window|1|||
144201365|NCT03276221|519934404|FG000|Overall Study|Lost to Follow-up|6|||
144201366|NCT03276221|519934405|FG001|Overall Study|Lost to Follow-up|2|||
144201367|NCT03276221|519934406|FG002|Overall Study|Lost to Follow-up|0|||
144201368|NCT03276221|519934404|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
144201369|NCT03276221|519934405|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
144201370|NCT03276221|519934406|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
144201371|NCT00424775|519934407|FG000|Overall Study|Adverse Event|2|||
144201372|NCT00424775|519934408|FG001|Overall Study|Adverse Event|0|||
144201373|NCT00424775|519934407|FG000|Overall Study|Lack of Efficacy|1|||
144201374|NCT00424775|519934408|FG001|Overall Study|Lack of Efficacy|0|||
144201375|NCT02900976|519934410|FG000|Overall Study|Adverse Event|0|||
144201376|NCT02900976|519934411|FG001|Overall Study|Adverse Event|1|||
144201377|NCT02900976|519934410|FG000|Overall Study|Physician Decision|0|||
144201378|NCT02900976|519934411|FG001|Overall Study|Physician Decision|2|||
144201379|NCT02900976|519934410|FG000|Overall Study|Progressive disease|0|||
144201380|NCT02900976|519934411|FG001|Overall Study|Progressive disease|6|||
144201381|NCT01408628|519934412|FG000|Consented|Withdrawal by Subject|12|||
144201382|NCT01408628|519934412|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
144201383|NCT01408628|519934412|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
144201384|NCT01408628|519934412|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
144201385|NCT01181271|519934413|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
144201386|NCT01181271|519934413|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
144201387|NCT01181271|519934413|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
144201388|NCT01181271|519934413|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
144201389|NCT00750308|519934414|FG000|First Treatment|Adverse Event|0|||
144201390|NCT00750308|519934415|FG001|First Treatment|Adverse Event|1|||
144201391|NCT00750308|519934416|FG002|First Treatment|Adverse Event|0|||
144201392|NCT00750308|519934417|FG003|First Treatment|Adverse Event|0|||
144201393|NCT00750308|519934418|FG004|First Treatment|Adverse Event|0|||
144201394|NCT00750308|519934419|FG005|First Treatment|Adverse Event|0|||
144201395|NCT00750308|519934420|FG006|First Treatment|Adverse Event|0|||
144201396|NCT00750308|519934421|FG007|First Treatment|Adverse Event|0|||
144201397|NCT00750308|519934422|FG008|First Treatment|Adverse Event|0|||
144201398|NCT00750308|519934423|FG009|First Treatment|Adverse Event|0|||
144201399|NCT00750308|519934424|FG010|First Treatment|Adverse Event|1|||
144201400|NCT00750308|519934425|FG011|First Treatment|Adverse Event|1|||
144615575|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
144201401|NCT00750308|519934414|FG000|First Treatment|Withdrawal by Subject|0|||
144201402|NCT00750308|519934415|FG001|First Treatment|Withdrawal by Subject|0|||
144201403|NCT00750308|519934416|FG002|First Treatment|Withdrawal by Subject|0|||
144201404|NCT00750308|519934417|FG003|First Treatment|Withdrawal by Subject|1|||
144201405|NCT00750308|519934418|FG004|First Treatment|Withdrawal by Subject|0|||
144260953|NCT02149264|520156586|FG000|Overall Study|Protocol Violation|1|||
144260954|NCT03283930|520156587|FG000|Overall Study|Scheduling conflict|8|||
144260955|NCT03283930|520156588|FG001|Overall Study|Scheduling conflict|10|||
144260956|NCT03283930|520156587|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
144260957|NCT03283930|520156588|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
144260958|NCT03283930|520156587|FG000|Overall Study|Technical software issue|2|||
144260959|NCT03283930|520156588|FG001|Overall Study|Technical software issue|2|||
144260960|NCT00672633|520156594|FG000|Overall Study|Withdrawal by Subject|0|||
144260961|NCT00672633|520156595|FG001|Overall Study|Withdrawal by Subject|1|||
144260962|NCT01938846|520156596|FG000|Overall Study|Progressive disease|26|||
144260963|NCT01938846|520156597|FG001|Overall Study|Progressive disease|18|||
144260964|NCT01938846|520156598|FG002|Overall Study|Progressive disease|16|||
144260965|NCT01938846|520156596|FG000|Overall Study|Adverse Event|8|||
144260966|NCT01938846|520156597|FG001|Overall Study|Adverse Event|4|||
144260967|NCT01938846|520156598|FG002|Overall Study|Adverse Event|3|||
144260968|NCT01938846|520156596|FG000|Overall Study|Withdrawal by Subject|2|||
144260969|NCT01938846|520156597|FG001|Overall Study|Withdrawal by Subject|2|||
144260970|NCT01938846|520156598|FG002|Overall Study|Withdrawal by Subject|1|||
144260971|NCT01938846|520156596|FG000|Overall Study|Other than listed|5|||
144260972|NCT01938846|520156597|FG001|Overall Study|Other than listed|1|||
144260973|NCT01938846|520156598|FG002|Overall Study|Other than listed|4|||
144260974|NCT02499120|520156599|FG000|Overall Study|Death|52|||
144260975|NCT02499120|520156600|FG001|Overall Study|Death|43|||
144260976|NCT02499120|520156599|FG000|Overall Study|Lost to Follow-up|1|||
144260977|NCT02499120|520156600|FG001|Overall Study|Lost to Follow-up|2|||
144260978|NCT02499120|520156599|FG000|Overall Study|Participant refused further follow-up|1|||
144260979|NCT02499120|520156600|FG001|Overall Study|Participant refused further follow-up|0|||
144260980|NCT02499120|520156599|FG000|Overall Study|Withdrawal by Subject|2|||
144260981|NCT02499120|520156600|FG001|Overall Study|Withdrawal by Subject|5|||
144260982|NCT02499120|520156599|FG000|Overall Study|Other|9|||
144260983|NCT02499120|520156600|FG001|Overall Study|Other|10|||
144260984|NCT00964028|520156607|FG000|Overall Study|Withdrawal by Subject|0|||
144260985|NCT00964028|520156608|FG001|Overall Study|Withdrawal by Subject|1|||
144260986|NCT01603407|520156609|FG000|Overall Study|Adverse Event|1|||
144260987|NCT01603407|520156610|FG001|Overall Study|Adverse Event|1|||
144260988|NCT01603407|520156611|FG002|Overall Study|Adverse Event|1|||
144260989|NCT01603407|520156609|FG000|Overall Study|Protocol Violation|2|||
144260990|NCT01603407|520156610|FG001|Overall Study|Protocol Violation|2|||
144260991|NCT01603407|520156611|FG002|Overall Study|Protocol Violation|0|||
144260992|NCT01603407|520156609|FG000|Overall Study|Withdrawal by Subject|8|||
144260993|NCT01603407|520156610|FG001|Overall Study|Withdrawal by Subject|5|||
144260994|NCT01603407|520156611|FG002|Overall Study|Withdrawal by Subject|7|||
144260995|NCT01603407|520156609|FG000|Overall Study|Lost to Follow-up|0|||
144260996|NCT01603407|520156610|FG001|Overall Study|Lost to Follow-up|3|||
144260997|NCT01603407|520156611|FG002|Overall Study|Lost to Follow-up|2|||
144260998|NCT02106351|520156616|FG000|Treatment Cycle 1|Adverse Event|2|||
144260999|NCT02106351|520156617|FG001|Treatment Cycle 1|Adverse Event|0|||
144261000|NCT02106351|520156618|FG002|Treatment Cycle 1|Adverse Event|0|||
144261001|NCT02106351|520156616|FG000|Treatment Cycle 1|Consent withdrawn|1|||
144261002|NCT02106351|520156617|FG001|Treatment Cycle 1|Consent withdrawn|0|||
144261003|NCT02106351|520156618|FG002|Treatment Cycle 1|Consent withdrawn|2|||
144261004|NCT02106351|520156616|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
144261005|NCT02106351|520156617|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
144261006|NCT02106351|520156618|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
144261007|NCT02106351|520156616|FG000|Treatment Cycle 1|Other|0|||
144261008|NCT02106351|520156617|FG001|Treatment Cycle 1|Other|3|||
144261009|NCT02106351|520156618|FG002|Treatment Cycle 1|Other|1|||
144261010|NCT02106351|520156616|FG000|Treatment Cycle 1|Randomised but not treated|1|||
144261011|NCT02106351|520156617|FG001|Treatment Cycle 1|Randomised but not treated|0|||
144261012|NCT02106351|520156618|FG002|Treatment Cycle 1|Randomised but not treated|1|||
144261013|NCT02106351|520156616|FG000|Treatment Cycle 2|Adverse Event|0|||
144261014|NCT02106351|520156617|FG001|Treatment Cycle 2|Adverse Event|2|||
144261015|NCT02106351|520156618|FG002|Treatment Cycle 2|Adverse Event|0|||
144261016|NCT02106351|520156616|FG000|Treatment Cycle 2|Consent withdrawn|0|||
144261017|NCT02106351|520156617|FG001|Treatment Cycle 2|Consent withdrawn|1|||
144261018|NCT02106351|520156618|FG002|Treatment Cycle 2|Consent withdrawn|1|||
144261019|NCT02106351|520156616|FG000|Treatment Cycle 2|Other|0|||
144261020|NCT02106351|520156617|FG001|Treatment Cycle 2|Other|2|||
144261021|NCT02106351|520156618|FG002|Treatment Cycle 2|Other|2|||
144261022|NCT02106351|520156616|FG000|Treatment Cycle 3|Adverse Event|0|||
144261023|NCT02106351|520156617|FG001|Treatment Cycle 3|Adverse Event|1|||
144261024|NCT02106351|520156618|FG002|Treatment Cycle 3|Adverse Event|0|||
144261025|NCT02106351|520156616|FG000|Treatment Cycle 3|Consent withdrawn|0|||
144261026|NCT02106351|520156617|FG001|Treatment Cycle 3|Consent withdrawn|0|||
144261027|NCT02106351|520156618|FG002|Treatment Cycle 3|Consent withdrawn|2|||
144261028|NCT02106351|520156616|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
144261029|NCT02106351|520156617|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
144261030|NCT02106351|520156618|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
144615576|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
144615577|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
144615578|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
144615579|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
144615580|NCT02831673|521454479|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
144615581|NCT02831673|521454480|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
144615582|NCT02831673|521454481|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
144615583|NCT02831673|521454482|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
144615584|NCT02831673|521454483|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
144615585|NCT02831673|521454479|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
144615586|NCT02831673|521454480|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
144615587|NCT02831673|521454481|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
144615588|NCT02831673|521454482|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
144615589|NCT02831673|521454483|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
144615590|NCT02831673|521454479|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144615591|NCT02831673|521454480|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144615592|NCT02831673|521454481|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144727433|NCT02457832|521856643|FG002|Training|Lost to Follow-up|3|||
144727434|NCT02457832|521856641|FG000|One Month Washout|Lost to Follow-up|0|||
144727435|NCT02457832|521856642|FG001|One Month Washout|Lost to Follow-up|1|||
144727436|NCT02457832|521856643|FG002|One Month Washout|Lost to Follow-up|1|||
144727437|NCT03184441|521856644|FG000|Overall Study|Withdrawal by Subject|1|||
144727438|NCT01868009|521856647|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
144727439|NCT01868009|521856648|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
144727440|NCT01868009|521856647|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
144201406|NCT00750308|519934419|FG005|First Treatment|Withdrawal by Subject|0|||
144201407|NCT00750308|519934420|FG006|First Treatment|Withdrawal by Subject|0|||
144201408|NCT00750308|519934421|FG007|First Treatment|Withdrawal by Subject|1|||
144201409|NCT00750308|519934422|FG008|First Treatment|Withdrawal by Subject|0|||
144201410|NCT00750308|519934423|FG009|First Treatment|Withdrawal by Subject|0|||
144201411|NCT00750308|519934424|FG010|First Treatment|Withdrawal by Subject|0|||
144201412|NCT00750308|519934425|FG011|First Treatment|Withdrawal by Subject|0|||
144201413|NCT00750308|519934414|FG000|Second Treatment|Adverse Event|0|||
144201414|NCT00750308|519934415|FG001|Second Treatment|Adverse Event|0|||
144201415|NCT00750308|519934416|FG002|Second Treatment|Adverse Event|0|||
144201416|NCT00750308|519934417|FG003|Second Treatment|Adverse Event|0|||
144201417|NCT00750308|519934418|FG004|Second Treatment|Adverse Event|0|||
144201418|NCT00750308|519934419|FG005|Second Treatment|Adverse Event|1|||
144201419|NCT00750308|519934420|FG006|Second Treatment|Adverse Event|0|||
144201420|NCT00750308|519934421|FG007|Second Treatment|Adverse Event|0|||
144201421|NCT00750308|519934422|FG008|Second Treatment|Adverse Event|1|||
144201422|NCT00750308|519934423|FG009|Second Treatment|Adverse Event|0|||
144201423|NCT00750308|519934424|FG010|Second Treatment|Adverse Event|0|||
144201424|NCT00750308|519934425|FG011|Second Treatment|Adverse Event|0|||
144201425|NCT00750308|519934414|FG000|Second Treatment|Withdrawal by Subject|0|||
144201426|NCT00750308|519934415|FG001|Second Treatment|Withdrawal by Subject|0|||
144201427|NCT00750308|519934416|FG002|Second Treatment|Withdrawal by Subject|0|||
144201428|NCT00750308|519934417|FG003|Second Treatment|Withdrawal by Subject|0|||
144201429|NCT00750308|519934418|FG004|Second Treatment|Withdrawal by Subject|1|||
144201430|NCT00750308|519934419|FG005|Second Treatment|Withdrawal by Subject|0|||
144201431|NCT00750308|519934420|FG006|Second Treatment|Withdrawal by Subject|0|||
144201432|NCT00750308|519934421|FG007|Second Treatment|Withdrawal by Subject|0|||
144201433|NCT00750308|519934422|FG008|Second Treatment|Withdrawal by Subject|0|||
144201434|NCT00750308|519934423|FG009|Second Treatment|Withdrawal by Subject|0|||
144201435|NCT00750308|519934424|FG010|Second Treatment|Withdrawal by Subject|0|||
144201436|NCT00750308|519934425|FG011|Second Treatment|Withdrawal by Subject|0|||
144201437|NCT00750308|519934414|FG000|Third Treatment|Withdrawal by Subject|0|||
144201438|NCT00750308|519934415|FG001|Third Treatment|Withdrawal by Subject|1|||
144201439|NCT00750308|519934416|FG002|Third Treatment|Withdrawal by Subject|0|||
144201440|NCT00750308|519934417|FG003|Third Treatment|Withdrawal by Subject|0|||
144201441|NCT00750308|519934418|FG004|Third Treatment|Withdrawal by Subject|0|||
144201442|NCT00750308|519934419|FG005|Third Treatment|Withdrawal by Subject|0|||
144201443|NCT00750308|519934420|FG006|Third Treatment|Withdrawal by Subject|0|||
144472652|NCT00261495|520928559|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
144201444|NCT00750308|519934421|FG007|Third Treatment|Withdrawal by Subject|0|||
144201445|NCT00750308|519934422|FG008|Third Treatment|Withdrawal by Subject|0|||
144201446|NCT00750308|519934423|FG009|Third Treatment|Withdrawal by Subject|0|||
144201447|NCT00750308|519934424|FG010|Third Treatment|Withdrawal by Subject|0|||
144201448|NCT00750308|519934425|FG011|Third Treatment|Withdrawal by Subject|0|||
144201449|NCT02980874|519934426|FG000|Overall Study|Adverse Event|2|||
144201450|NCT02980874|519934427|FG001|Overall Study|Adverse Event|7|||
144201451|NCT02980874|519934426|FG000|Overall Study|Withdrawal by Subject|7|||
144201452|NCT02980874|519934427|FG001|Overall Study|Withdrawal by Subject|2|||
144615593|NCT02831673|521454482|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144615594|NCT02831673|521454483|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
144615595|NCT02831673|521454479|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144615596|NCT02831673|521454480|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144615597|NCT02831673|521454481|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144615598|NCT02831673|521454482|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144615599|NCT02831673|521454483|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
144615600|NCT02831673|521454479|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144615601|NCT02831673|521454480|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144615602|NCT02831673|521454481|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144615603|NCT02831673|521454482|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144615604|NCT02831673|521454483|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
144615605|NCT02831673|521454479|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144615606|NCT02831673|521454480|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144615607|NCT02831673|521454481|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144615608|NCT02831673|521454482|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144615609|NCT02831673|521454483|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
144615610|NCT00513409|521454488|FG000|Overall Study|Adverse Event|0|||
144615611|NCT00513409|521454489|FG001|Overall Study|Adverse Event|1|||
144615612|NCT00513409|521454488|FG000|Overall Study|Withdrawal by Subject|0|||
144615613|NCT00513409|521454489|FG001|Overall Study|Withdrawal by Subject|2|||
144615614|NCT00513409|521454488|FG000|Overall Study|Lost to Follow-up|0|||
144615615|NCT00513409|521454489|FG001|Overall Study|Lost to Follow-up|1|||
144615616|NCT00513409|521454488|FG000|Overall Study|Physician Decision|1|||
144615617|NCT00513409|521454489|FG001|Overall Study|Physician Decision|0|||
144615618|NCT00513409|521454488|FG000|Overall Study|Visit 3 not done|1|||
144615619|NCT00513409|521454489|FG001|Overall Study|Visit 3 not done|2|||
144615620|NCT01049035|521454490|FG000|Overall Study|Serious adverse event|0|||
144615621|NCT01049035|521454491|FG001|Overall Study|Serious adverse event|1|||
144615622|NCT01049035|521454492|FG002|Overall Study|Serious adverse event|1|||
144615623|NCT01049035|521454493|FG003|Overall Study|Serious adverse event|2|||
144615624|NCT01049035|521454494|FG004|Overall Study|Serious adverse event|0|||
144615625|NCT01049035|521454495|FG005|Overall Study|Serious adverse event|0|||
144615626|NCT01049035|521454496|FG006|Overall Study|Serious adverse event|0|||
144615627|NCT01049035|521454490|FG000|Overall Study|Other adverse event (AE)|0|||
144615628|NCT01049035|521454491|FG001|Overall Study|Other adverse event (AE)|0|||
144615629|NCT01049035|521454492|FG002|Overall Study|Other adverse event (AE)|0|||
144615630|NCT01049035|521454493|FG003|Overall Study|Other adverse event (AE)|1|||
144615631|NCT01049035|521454494|FG004|Overall Study|Other adverse event (AE)|0|||
144615632|NCT01049035|521454495|FG005|Overall Study|Other adverse event (AE)|0|||
144615633|NCT01049035|521454496|FG006|Overall Study|Other adverse event (AE)|0|||
144615634|NCT01049035|521454490|FG000|Overall Study|Non-compliance with the protocol|12|||
144615635|NCT01049035|521454491|FG001|Overall Study|Non-compliance with the protocol|6|||
144615636|NCT01049035|521454492|FG002|Overall Study|Non-compliance with the protocol|14|||
144615637|NCT01049035|521454493|FG003|Overall Study|Non-compliance with the protocol|5|||
144615638|NCT01049035|521454494|FG004|Overall Study|Non-compliance with the protocol|3|||
144615639|NCT01049035|521454495|FG005|Overall Study|Non-compliance with the protocol|4|||
144615640|NCT01049035|521454496|FG006|Overall Study|Non-compliance with the protocol|10|||
144615641|NCT01049035|521454490|FG000|Overall Study|Lost to Follow-up|5|||
144615642|NCT01049035|521454491|FG001|Overall Study|Lost to Follow-up|4|||
144615643|NCT01049035|521454492|FG002|Overall Study|Lost to Follow-up|4|||
144615644|NCT01049035|521454493|FG003|Overall Study|Lost to Follow-up|1|||
144615645|NCT01049035|521454494|FG004|Overall Study|Lost to Follow-up|0|||
144615646|NCT01049035|521454495|FG005|Overall Study|Lost to Follow-up|3|||
144615647|NCT01049035|521454496|FG006|Overall Study|Lost to Follow-up|3|||
144615648|NCT01049035|521454490|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
144615649|NCT01049035|521454491|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
144201453|NCT02980874|519934426|FG000|Overall Study|Lost to Follow-up|5|||
144201454|NCT02980874|519934427|FG001|Overall Study|Lost to Follow-up|5|||
144201455|NCT02980874|519934426|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
144201456|NCT02980874|519934427|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
144201457|NCT02980874|519934426|FG000|Overall Study|Unknown study completion status|1|||
144201458|NCT02980874|519934427|FG001|Overall Study|Unknown study completion status|0|||
144201459|NCT00513682|519934428|FG000|Washout Phase|Adverse Event|2|||
144615650|NCT01049035|521454492|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
144615651|NCT01049035|521454493|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
144615652|NCT01049035|521454494|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
144727441|NCT01868009|521856648|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
144201460|NCT04156620|519934429|FG000|Overall Study|Adverse event - TP 1|5|||
144615653|NCT01049035|521454495|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
144261031|NCT02106351|520156616|FG000|Treatment Cycle 3|Other|0|||
144261032|NCT02106351|520156617|FG001|Treatment Cycle 3|Other|2|||
144261033|NCT02106351|520156618|FG002|Treatment Cycle 3|Other|3|||
144261034|NCT02106351|520156616|FG000|Treatment Cycle 4|Consent withdrawn|0|||
144261035|NCT02106351|520156617|FG001|Treatment Cycle 4|Consent withdrawn|0|||
144261036|NCT02106351|520156618|FG002|Treatment Cycle 4|Consent withdrawn|2|||
144261037|NCT02106351|520156616|FG000|Treatment Cycle 4|Other|0|||
144261038|NCT02106351|520156617|FG001|Treatment Cycle 4|Other|1|||
144261039|NCT02106351|520156618|FG002|Treatment Cycle 4|Other|0|||
144261040|NCT00069823|520156623|FG000|Overall Study|Did not have follow-up diary cards|6|||
144261041|NCT00069823|520156624|FG001|Overall Study|Did not have follow-up diary cards|3|||
144261042|NCT03560869|520156625|FG000|Overall Study|Withdrawal by Subject|3|||
144261043|NCT03560869|520156626|FG001|Overall Study|Withdrawal by Subject|4|||
144261044|NCT03560869|520156625|FG000|Overall Study|Screening failure|4|||
144261045|NCT03560869|520156626|FG001|Overall Study|Screening failure|4|||
144261046|NCT03560869|520156625|FG000|Overall Study|Withdrawal by PI|0|||
144261047|NCT03560869|520156626|FG001|Overall Study|Withdrawal by PI|1|||
144261048|NCT01801111|520156627|FG000|Overall Study|Adverse Event|12|||
144261049|NCT01801111|520156627|FG000|Overall Study|Death|8|||
144615654|NCT01049035|521454496|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
144615655|NCT05594173|521454503|FG000|Overall Study|Adverse Event|1|||
144615656|NCT05594173|521454503|FG000|Overall Study|COVID-19 Pandemic|2|||
144201461|NCT04156620|519934430|FG001|Overall Study|Adverse event - TP 1|2|||
144201462|NCT04156620|519934429|FG000|Overall Study|Lost to follow-up TP 1|1|||
144201463|NCT04156620|519934430|FG001|Overall Study|Lost to follow-up TP 1|1|||
144201464|NCT04156620|519934429|FG000|Overall Study|Progressive disease - TP 1|0|||
144201465|NCT04156620|519934430|FG001|Overall Study|Progressive disease - TP 1|1|||
144201466|NCT04156620|519934429|FG000|Overall Study|Subject decision - TP 1|3|||
144201467|NCT04156620|519934430|FG001|Overall Study|Subject decision - TP 1|5|||
144201468|NCT04156620|519934429|FG000|Overall Study|Adverse event - TP 2|5|||
144201469|NCT04156620|519934430|FG001|Overall Study|Adverse event - TP 2|6|||
144201470|NCT04156620|519934429|FG000|Overall Study|Death - TP 2|1|||
144201471|NCT04156620|519934430|FG001|Overall Study|Death - TP 2|0|||
144201472|NCT04156620|519934429|FG000|Overall Study|Lost to follow-up - TP 2|5|||
144201473|NCT04156620|519934430|FG001|Overall Study|Lost to follow-up - TP 2|2|||
144201474|NCT04156620|519934429|FG000|Overall Study|Physician decision - TP 2|4|||
144201475|NCT04156620|519934430|FG001|Overall Study|Physician decision - TP 2|2|||
144201476|NCT04156620|519934429|FG000|Overall Study|Pregnancy - TP 2|1|||
144201477|NCT04156620|519934430|FG001|Overall Study|Pregnancy - TP 2|1|||
144201478|NCT04156620|519934429|FG000|Overall Study|Subject decision - TP 2|11|||
144201479|NCT04156620|519934430|FG001|Overall Study|Subject decision - TP 2|9|||
144201480|NCT04156620|519934429|FG000|Overall Study|New therapy for study indication - TP 2|1|||
144201481|NCT04156620|519934430|FG001|Overall Study|New therapy for study indication - TP 2|0|||
144201482|NCT02450526|519934431|FG000|DB Period (Cycle 1)|Adverse Event|0|||
144201483|NCT02450526|519934432|FG001|DB Period (Cycle 1)|Adverse Event|0|||
144201484|NCT02450526|519934433|FG002|DB Period (Cycle 1)|Adverse Event|2|||
144201485|NCT02450526|519934434|FG003|DB Period (Cycle 1)|Adverse Event|0|||
144201486|NCT02450526|519934435|FG004|DB Period (Cycle 1)|Adverse Event|0|||
144201487|NCT02450526|519934431|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
144201488|NCT02450526|519934432|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
144201489|NCT02450526|519934433|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
144201490|NCT02450526|519934434|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
144201491|NCT02450526|519934435|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
144201492|NCT02450526|519934431|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
144201493|NCT02450526|519934432|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
144201494|NCT02450526|519934433|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
144201495|NCT02450526|519934434|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
144201496|NCT02450526|519934435|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
144201497|NCT02450526|519934431|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
144201498|NCT02450526|519934432|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
144201499|NCT02450526|519934433|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
144201500|NCT02450526|519934434|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
144201501|NCT02450526|519934435|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
144201502|NCT02450526|519934431|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
144201503|NCT02450526|519934432|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
144201504|NCT02450526|519934433|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
144201505|NCT02450526|519934434|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
144201506|NCT02450526|519934435|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
144201507|NCT02450526|519934431|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
144201508|NCT02450526|519934432|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
144615657|NCT01192022|521454504|FG000|Overall Study|Withdrawal of Consent|3|||
144201509|NCT02450526|519934433|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
144201510|NCT02450526|519934434|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
144201511|NCT02450526|519934435|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
144261050|NCT01801111|520156627|FG000|Overall Study|Physician Decision|5|||
144261051|NCT01801111|520156627|FG000|Overall Study|Other|1|||
144261052|NCT01801111|520156627|FG000|Overall Study|Withdrawal by Subject|4|||
144261053|NCT01801111|520156627|FG000|Overall Study|Study Terminated by Sponsor|27|||
144261054|NCT01801111|520156627|FG000|Overall Study|Progressive Disease|81|||
144261055|NCT01210482|520156628|FG000|Overall Study|Protocol Violation|1|||
144261056|NCT01210482|520156628|FG000|Overall Study|Case Report Forms were not collected|18|||
144261057|NCT01210482|520156628|FG000|Overall Study|Duplicated|2|||
144261058|NCT01210482|520156628|FG000|Overall Study|No Drug Administration|28|||
144261059|NCT01223937|520156629|FG000|Overall Study|Withdrawal by Subject|3|||
144261060|NCT01223937|520156630|FG001|Overall Study|Withdrawal by Subject|2|||
144261061|NCT01223937|520156629|FG000|Overall Study|Lost to Follow-up|1|||
144261062|NCT01223937|520156630|FG001|Overall Study|Lost to Follow-up|4|||
144261063|NCT01223937|520156629|FG000|Overall Study|Adverse Event|1|||
144261064|NCT01223937|520156630|FG001|Overall Study|Adverse Event|4|||
144261065|NCT01223937|520156629|FG000|Overall Study|Protocol Violation|8|||
144261066|NCT01223937|520156630|FG001|Overall Study|Protocol Violation|7|||
144261067|NCT01223937|520156629|FG000|Overall Study|Other|4|||
144261068|NCT01223937|520156630|FG001|Overall Study|Other|1|||
144261069|NCT00765817|520156631|FG000|Overall Study|Adverse Event|13|||
144261070|NCT00765817|520156632|FG001|Overall Study|Adverse Event|1|||
144261071|NCT00765817|520156631|FG000|Overall Study|Death|0|||
144261072|NCT00765817|520156632|FG001|Overall Study|Death|1|||
144261073|NCT00765817|520156631|FG000|Overall Study|Entry criteria not met|2|||
144261074|NCT00765817|520156632|FG001|Overall Study|Entry criteria not met|2|||
144261075|NCT00765817|520156631|FG000|Overall Study|Loss of glucose control|0|||
144261076|NCT00765817|520156632|FG001|Overall Study|Loss of glucose control|2|||
144261077|NCT00765817|520156631|FG000|Overall Study|Lost to Follow-up|1|||
144261078|NCT00765817|520156632|FG001|Overall Study|Lost to Follow-up|3|||
144261079|NCT00765817|520156631|FG000|Overall Study|Physician Decision|2|||
144261080|NCT00765817|520156632|FG001|Overall Study|Physician Decision|1|||
144261081|NCT00765817|520156631|FG000|Overall Study|Protocol Violation|1|||
144261082|NCT00765817|520156632|FG001|Overall Study|Protocol Violation|1|||
144261083|NCT00765817|520156631|FG000|Overall Study|Subject decision|7|||
144261084|NCT00765817|520156632|FG001|Overall Study|Subject decision|11|||
144261085|NCT06597084|520156633|FG000|Overall Study|Withdrawal by Subject|4|||
144261086|NCT06597084|520156634|FG001|Overall Study|Withdrawal by Subject|9|||
144261087|NCT06597084|520156633|FG000|Overall Study|Consent was not given by the patient until V2|0|||
144261088|NCT06597084|520156634|FG001|Overall Study|Consent was not given by the patient until V2|3|||
144261089|NCT06597084|520156633|FG000|Overall Study|Physician Decision|1|||
144261090|NCT06597084|520156634|FG001|Overall Study|Physician Decision|0|||
144261091|NCT06597084|520156633|FG000|Overall Study|Adverse Event|3|||
144261092|NCT06597084|520156634|FG001|Overall Study|Adverse Event|2|||
144261093|NCT06597084|520156633|FG000|Overall Study|Death|4|||
144261094|NCT06597084|520156634|FG001|Overall Study|Death|0|||
144261095|NCT06597084|520156633|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
144261096|NCT06597084|520156634|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
144261097|NCT06597084|520156633|FG000|Overall Study|Lost to Follow-up|4|||
144261098|NCT06597084|520156634|FG001|Overall Study|Lost to Follow-up|2|||
144261099|NCT06597084|520156633|FG000|Overall Study|Other. Not specified|1|||
144261100|NCT06597084|520156634|FG001|Overall Study|Other. Not specified|0|||
144261101|NCT00255164|520156639|FG000|Overall Study|Adverse Event|10|||
144261102|NCT00255164|520156640|FG001|Overall Study|Adverse Event|6|||
144261103|NCT00255164|520156641|FG002|Overall Study|Adverse Event|9|||
144261104|NCT00255164|520156639|FG000|Overall Study|Lost to Follow-up|4|||
144261105|NCT00255164|520156640|FG001|Overall Study|Lost to Follow-up|3|||
144261106|NCT00255164|520156641|FG002|Overall Study|Lost to Follow-up|4|||
144261107|NCT00255164|520156639|FG000|Overall Study|Withdrawal by Subject|18|||
144261108|NCT00255164|520156640|FG001|Overall Study|Withdrawal by Subject|17|||
144261109|NCT00255164|520156641|FG002|Overall Study|Withdrawal by Subject|8|||
144261110|NCT00255164|520156639|FG000|Overall Study|Noncompliance|0|||
144261111|NCT00255164|520156640|FG001|Overall Study|Noncompliance|1|||
144261112|NCT00255164|520156641|FG002|Overall Study|Noncompliance|2|||
144261113|NCT00255164|520156639|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
144261114|NCT00255164|520156640|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
144261115|NCT00255164|520156641|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
144261116|NCT00255164|520156639|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
144261117|NCT00255164|520156640|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
144261118|NCT00255164|520156641|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
144261119|NCT00255164|520156639|FG000|Overall Study|Possible Barrett's Esophagus|1|||
144261120|NCT00255164|520156640|FG001|Overall Study|Possible Barrett's Esophagus|3|||
144261121|NCT00255164|520156641|FG002|Overall Study|Possible Barrett's Esophagus|8|||
144261122|NCT00255164|520156639|FG000|Overall Study|Esophageal Stricture|0|||
144261123|NCT00255164|520156640|FG001|Overall Study|Esophageal Stricture|0|||
144261124|NCT00255164|520156641|FG002|Overall Study|Esophageal Stricture|1|||
144261125|NCT00255164|520156639|FG000|Overall Study|Therapeutic Failure|11|||
144261126|NCT00255164|520156640|FG001|Overall Study|Therapeutic Failure|2|||
144261127|NCT00255164|520156641|FG002|Overall Study|Therapeutic Failure|3|||
144261128|NCT03677869|520156642|FG000|Overall Study|Withdrawal by Subject|1|||
144261129|NCT01845597|520158051|FG000|Overall Study|Death|8|||
144201512|NCT02450526|519934431|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
144201513|NCT02450526|519934432|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
144201514|NCT02450526|519934433|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
144201515|NCT02450526|519934434|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
144201516|NCT02450526|519934435|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
144201517|NCT02450526|519934431|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
144201518|NCT02450526|519934432|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
144201519|NCT02450526|519934433|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
144201520|NCT02450526|519934434|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
144201521|NCT02450526|519934435|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
144201522|NCT04135196|519934436|FG000|Overall Study|Lost to Follow-up|8|||
144201523|NCT04135196|519934437|FG001|Overall Study|Lost to Follow-up|7|||
144201524|NCT04135196|519934438|FG002|Overall Study|Lost to Follow-up|8|||
144201525|NCT04135196|519934439|FG003|Overall Study|Lost to Follow-up|9|||
144201526|NCT04135196|519934440|FG004|Overall Study|Lost to Follow-up|1|||
144201527|NCT04135196|519934436|FG000|Overall Study|Pregnancy|0|||
144201528|NCT04135196|519934437|FG001|Overall Study|Pregnancy|0|||
144201529|NCT04135196|519934438|FG002|Overall Study|Pregnancy|1|||
144201530|NCT04135196|519934439|FG003|Overall Study|Pregnancy|0|||
144201531|NCT04135196|519934440|FG004|Overall Study|Pregnancy|0|||
144201532|NCT04135196|519934436|FG000|Overall Study|Withdrawal by Subject|0|||
144201533|NCT04135196|519934437|FG001|Overall Study|Withdrawal by Subject|0|||
144201534|NCT04135196|519934438|FG002|Overall Study|Withdrawal by Subject|0|||
144201535|NCT04135196|519934439|FG003|Overall Study|Withdrawal by Subject|0|||
144201536|NCT04135196|519934440|FG004|Overall Study|Withdrawal by Subject|1|||
144201537|NCT01121666|519934441|FG000|Overall Study|Protocol Violation|29|||
144201538|NCT01121666|519934442|FG001|Overall Study|Protocol Violation|10|||
144201539|NCT01083810|519934445|FG000|Overall Study|Lost to Follow-up|23|||
144201540|NCT01083810|519934446|FG001|Overall Study|Lost to Follow-up|11|||
144201541|NCT01083810|519934447|FG002|Overall Study|Lost to Follow-up|4|||
144201542|NCT01083810|519934445|FG000|Overall Study|Adverse Event|15|||
144201543|NCT01083810|519934446|FG001|Overall Study|Adverse Event|11|||
144201544|NCT01083810|519934447|FG002|Overall Study|Adverse Event|4|||
144201545|NCT01083810|519934445|FG000|Overall Study|Withdrawal by Subject|7|||
144201546|NCT01083810|519934446|FG001|Overall Study|Withdrawal by Subject|2|||
144201547|NCT01083810|519934447|FG002|Overall Study|Withdrawal by Subject|4|||
144201548|NCT01083810|519934445|FG000|Overall Study|Reason not reported|6|||
144201549|NCT01083810|519934446|FG001|Overall Study|Reason not reported|1|||
144201550|NCT01083810|519934447|FG002|Overall Study|Reason not reported|1|||
144201551|NCT01083810|519934445|FG000|Overall Study|Non-compliance|4|||
144201552|NCT01083810|519934446|FG001|Overall Study|Non-compliance|7|||
144201553|NCT01083810|519934447|FG002|Overall Study|Non-compliance|2|||
144201554|NCT01083810|519934445|FG000|Overall Study|Simplification|4|||
144201555|NCT01083810|519934446|FG001|Overall Study|Simplification|1|||
144201556|NCT01083810|519934447|FG002|Overall Study|Simplification|0|||
144201557|NCT01083810|519934445|FG000|Overall Study|Death|2|||
144201558|NCT01083810|519934446|FG001|Overall Study|Death|2|||
144201559|NCT01083810|519934447|FG002|Overall Study|Death|3|||
144201560|NCT01083810|519934445|FG000|Overall Study|Co-morbidities|1|||
144201561|NCT01083810|519934446|FG001|Overall Study|Co-morbidities|0|||
144201562|NCT01083810|519934447|FG002|Overall Study|Co-morbidities|0|||
144201563|NCT01083810|519934445|FG000|Overall Study|Participation in study|1|||
144201564|NCT01083810|519934446|FG001|Overall Study|Participation in study|0|||
144201565|NCT01083810|519934447|FG002|Overall Study|Participation in study|0|||
144201566|NCT01083810|519934445|FG000|Overall Study|Therapy break|1|||
144201567|NCT01083810|519934446|FG001|Overall Study|Therapy break|2|||
144201568|NCT01083810|519934447|FG002|Overall Study|Therapy break|2|||
144201569|NCT01083810|519934445|FG000|Overall Study|Virologic failure|1|||
144201570|NCT01083810|519934446|FG001|Overall Study|Virologic failure|8|||
144201571|NCT01083810|519934447|FG002|Overall Study|Virologic failure|0|||
144201572|NCT02132754|519934448|FG000|Overall Study|Adverse Event|0|||
144201573|NCT02132754|519934449|FG001|Overall Study|Adverse Event|0|||
144201574|NCT02132754|519934450|FG002|Overall Study|Adverse Event|0|||
144201575|NCT02132754|519934451|FG003|Overall Study|Adverse Event|0|||
144201576|NCT02132754|519934452|FG004|Overall Study|Adverse Event|0|||
144201577|NCT02132754|519934453|FG005|Overall Study|Adverse Event|0|||
144201578|NCT02132754|519934454|FG006|Overall Study|Adverse Event|0|||
144201579|NCT02132754|519934455|FG007|Overall Study|Adverse Event|0|||
144201580|NCT02132754|519934456|FG008|Overall Study|Adverse Event|0|||
144201581|NCT02132754|519934457|FG009|Overall Study|Adverse Event|0|||
144201582|NCT02132754|519934458|FG010|Overall Study|Adverse Event|0|||
144201583|NCT02132754|519934459|FG011|Overall Study|Adverse Event|0|||
144201584|NCT02132754|519934460|FG012|Overall Study|Adverse Event|0|||
144201585|NCT02132754|519934461|FG013|Overall Study|Adverse Event|0|||
144201586|NCT02132754|519934462|FG014|Overall Study|Adverse Event|0|||
144201587|NCT02132754|519934463|FG015|Overall Study|Adverse Event|0|||
144201588|NCT02132754|519934464|FG016|Overall Study|Adverse Event|0|||
144201589|NCT02132754|519934465|FG017|Overall Study|Adverse Event|1|||
144201590|NCT02132754|519934466|FG018|Overall Study|Adverse Event|0|||
144201591|NCT02132754|519934467|FG019|Overall Study|Adverse Event|0|||
144615658|NCT01192022|521454505|FG001|Overall Study|Withdrawal of Consent|1|||
144615659|NCT01192022|521454506|FG002|Overall Study|Withdrawal of Consent|0|||
144615660|NCT01192022|521454507|FG003|Overall Study|Withdrawal of Consent|0|||
144615661|NCT01192022|521454508|FG004|Overall Study|Withdrawal of Consent|0|||
144615662|NCT01192022|521454504|FG000|Overall Study|Lost to Follow-up|4|||
144615663|NCT01192022|521454505|FG001|Overall Study|Lost to Follow-up|2|||
144615664|NCT01192022|521454506|FG002|Overall Study|Lost to Follow-up|1|||
144615665|NCT01192022|521454507|FG003|Overall Study|Lost to Follow-up|1|||
144615666|NCT01192022|521454508|FG004|Overall Study|Lost to Follow-up|0|||
144615667|NCT01192022|521454504|FG000|Overall Study|Adverse Event|1|||
144615668|NCT01192022|521454505|FG001|Overall Study|Adverse Event|0|||
144615669|NCT01192022|521454506|FG002|Overall Study|Adverse Event|0|||
144615670|NCT01192022|521454507|FG003|Overall Study|Adverse Event|0|||
144615671|NCT01192022|521454508|FG004|Overall Study|Adverse Event|0|||
144261130|NCT01845597|520158051|FG000|Overall Study|Lost to Follow-up|22|||
144261131|NCT04194489|520158053|FG000|Overall Study|Withdrawal by Subject|5|||
144261132|NCT04194489|520158053|FG000|Overall Study|Lost to Follow-up|48|||
144261133|NCT00377637|520158059|FG000|Induction Phase|Adverse Event|12|||
144261134|NCT00377637|520158060|FG001|Induction Phase|Adverse Event|21|||
144261135|NCT00377637|520158061|FG002|Induction Phase|Adverse Event|0|||
144615672|NCT01192022|521454504|FG000|Overall Study|Fatal Adverse Event|4|||
144615673|NCT01192022|521454505|FG001|Overall Study|Fatal Adverse Event|6|||
144615674|NCT01192022|521454506|FG002|Overall Study|Fatal Adverse Event|0|||
144615675|NCT01192022|521454507|FG003|Overall Study|Fatal Adverse Event|0|||
144615676|NCT01192022|521454508|FG004|Overall Study|Fatal Adverse Event|1|||
144615677|NCT01192022|521454504|FG000|Overall Study|Physician withdrew-patient hardship|1|||
144615678|NCT01192022|521454505|FG001|Overall Study|Physician withdrew-patient hardship|0|||
144615679|NCT01192022|521454506|FG002|Overall Study|Physician withdrew-patient hardship|0|||
144615680|NCT01192022|521454507|FG003|Overall Study|Physician withdrew-patient hardship|0|||
144615681|NCT01192022|521454508|FG004|Overall Study|Physician withdrew-patient hardship|0|||
144615682|NCT01192022|521454504|FG000|Overall Study|Patient too sick from chemotherapy|0|||
144261136|NCT00377637|520158062|FG003|Induction Phase|Adverse Event|0|||
144261137|NCT00377637|520158059|FG000|Induction Phase|Deterioration/serum creatinine|2|||
144261138|NCT00377637|520158060|FG001|Induction Phase|Deterioration/serum creatinine|0|||
144261139|NCT00377637|520158061|FG002|Induction Phase|Deterioration/serum creatinine|0|||
144261140|NCT00377637|520158062|FG003|Induction Phase|Deterioration/serum creatinine|0|||
144261141|NCT00377637|520158059|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
144261142|NCT00377637|520158060|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
144261143|NCT00377637|520158061|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
144261144|NCT00377637|520158062|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
144261145|NCT00377637|520158059|FG000|Induction Phase|Lost to Follow-up|2|||
144261146|NCT00377637|520158060|FG001|Induction Phase|Lost to Follow-up|1|||
144261147|NCT00377637|520158061|FG002|Induction Phase|Lost to Follow-up|0|||
144261148|NCT00377637|520158062|FG003|Induction Phase|Lost to Follow-up|0|||
144261149|NCT00377637|520158059|FG000|Induction Phase|Death|1|||
144261150|NCT00377637|520158060|FG001|Induction Phase|Death|3|||
144261151|NCT00377637|520158061|FG002|Induction Phase|Death|0|||
144261152|NCT00377637|520158062|FG003|Induction Phase|Death|0|||
144261153|NCT00377637|520158059|FG000|Induction Phase|Withdrawal by Subject|5|||
144261154|NCT00377637|520158060|FG001|Induction Phase|Withdrawal by Subject|6|||
144261155|NCT00377637|520158061|FG002|Induction Phase|Withdrawal by Subject|0|||
144261156|NCT00377637|520158062|FG003|Induction Phase|Withdrawal by Subject|0|||
144261157|NCT00377637|520158059|FG000|Induction Phase|Physician Decision|3|||
144261158|NCT00377637|520158060|FG001|Induction Phase|Physician Decision|1|||
144261159|NCT00377637|520158061|FG002|Induction Phase|Physician Decision|0|||
144261160|NCT00377637|520158062|FG003|Induction Phase|Physician Decision|0|||
144261161|NCT00377637|520158059|FG000|Induction Phase|Sponsor decision|1|||
144261162|NCT00377637|520158060|FG001|Induction Phase|Sponsor decision|2|||
144261163|NCT00377637|520158061|FG002|Induction Phase|Sponsor decision|0|||
144261164|NCT00377637|520158062|FG003|Induction Phase|Sponsor decision|0|||
144615683|NCT01192022|521454505|FG001|Overall Study|Patient too sick from chemotherapy|1|||
144615684|NCT01192022|521454506|FG002|Overall Study|Patient too sick from chemotherapy|0|||
144615685|NCT01192022|521454507|FG003|Overall Study|Patient too sick from chemotherapy|0|||
144615686|NCT01192022|521454508|FG004|Overall Study|Patient too sick from chemotherapy|0|||
144615687|NCT01192022|521454504|FG000|Overall Study|Patient needed surgery|0|||
144615688|NCT01192022|521454505|FG001|Overall Study|Patient needed surgery|1|||
144615689|NCT01192022|521454506|FG002|Overall Study|Patient needed surgery|0|||
144615690|NCT01192022|521454507|FG003|Overall Study|Patient needed surgery|0|||
144261165|NCT00377637|520158059|FG000|Induction Phase|Non-Compliance|1|||
144261166|NCT00377637|520158060|FG001|Induction Phase|Non-Compliance|0|||
144261167|NCT00377637|520158061|FG002|Induction Phase|Non-Compliance|0|||
144261168|NCT00377637|520158062|FG003|Induction Phase|Non-Compliance|0|||
144615691|NCT01192022|521454508|FG004|Overall Study|Patient needed surgery|0|||
144615692|NCT01192022|521454504|FG000|Overall Study|Parents did not allow all follow up|0|||
144615693|NCT01192022|521454505|FG001|Overall Study|Parents did not allow all follow up|0|||
144615694|NCT01192022|521454506|FG002|Overall Study|Parents did not allow all follow up|0|||
144615695|NCT01192022|521454507|FG003|Overall Study|Parents did not allow all follow up|1|||
144615696|NCT01192022|521454508|FG004|Overall Study|Parents did not allow all follow up|0|||
144615697|NCT01351389|521454509|FG000|Overall Study|Withdrawal by Subject|7|||
144615698|NCT01351389|521454510|FG001|Overall Study|Withdrawal by Subject|0|||
144615699|NCT01351389|521454509|FG000|Overall Study|did not complete intervention|23|||
144615700|NCT01351389|521454510|FG001|Overall Study|did not complete intervention|15|||
144615701|NCT04839978|521454511|FG000|Overall Study|Lost to Follow-up|135|||
144615702|NCT04839978|521454512|FG001|Overall Study|Lost to Follow-up|147|||
144615703|NCT02646982|521454513|FG000|Overall Study|Adverse Event|1|||
144615704|NCT02646982|521454514|FG001|Overall Study|Adverse Event|1|||
144615705|NCT02646982|521454513|FG000|Overall Study|Withdrawal by Subject|2|||
144615706|NCT02646982|521454514|FG001|Overall Study|Withdrawal by Subject|1|||
144615707|NCT00713700|521454515|FG000|Overall Study|Lost to Follow-up|3|||
144615708|NCT00713700|521454515|FG000|Overall Study|Withdrawal by Subject|1|||
144615709|NCT00623480|521454516|FG000|Overall Study|Lost to Follow-up|0|||
144615710|NCT00623480|521454517|FG001|Overall Study|Lost to Follow-up|1|||
144615711|NCT00623480|521454516|FG000|Overall Study|Withdrawal by Subject|2|||
144615712|NCT00623480|521454517|FG001|Overall Study|Withdrawal by Subject|4|||
144615713|NCT00623480|521454516|FG000|Overall Study|Lack of Efficacy|1|||
144615714|NCT00623480|521454517|FG001|Overall Study|Lack of Efficacy|0|||
144615715|NCT00623480|521454516|FG000|Overall Study|Non-compliant with study medication|4|||
144615716|NCT00623480|521454517|FG001|Overall Study|Non-compliant with study medication|0|||
144615717|NCT00623480|521454516|FG000|Overall Study|Protocol Violation|0|||
144615718|NCT00623480|521454517|FG001|Overall Study|Protocol Violation|1|||
144615719|NCT00623480|521454516|FG000|Overall Study|Site closed by sponsor|0|||
144615720|NCT00623480|521454517|FG001|Overall Study|Site closed by sponsor|1|||
144615721|NCT00781456|521454518|FG000|Overall Study|Adverse Event|3|||
144615722|NCT00781456|521454519|FG001|Overall Study|Adverse Event|3|||
144615723|NCT00781456|521454518|FG000|Overall Study|Withdrawal by Subject|3|||
144615724|NCT00781456|521454519|FG001|Overall Study|Withdrawal by Subject|5|||
144615725|NCT00781456|521454518|FG000|Overall Study|Protocol Violation|4|||
144615726|NCT00781456|521454519|FG001|Overall Study|Protocol Violation|1|||
144201592|NCT02132754|519934468|FG020|Overall Study|Adverse Event|0|||
144201593|NCT02132754|519934469|FG021|Overall Study|Adverse Event|0|||
144201594|NCT02132754|519934470|FG022|Overall Study|Adverse Event|0|||
144201595|NCT02132754|519934471|FG023|Overall Study|Adverse Event|0|||
144201596|NCT02132754|519934472|FG024|Overall Study|Adverse Event|0|||
144201597|NCT02132754|519934473|FG025|Overall Study|Adverse Event|1|||
144201598|NCT02132754|519934474|FG026|Overall Study|Adverse Event|1|||
144201599|NCT02132754|519934475|FG027|Overall Study|Adverse Event|0|||
144201600|NCT02132754|519934476|FG028|Overall Study|Adverse Event|0|||
144201601|NCT02132754|519934477|FG029|Overall Study|Adverse Event|0|||
144201602|NCT02132754|519934478|FG030|Overall Study|Adverse Event|1|||
144201603|NCT02132754|519934479|FG031|Overall Study|Adverse Event|0|||
144201604|NCT02132754|519934480|FG032|Overall Study|Adverse Event|1|||
144201605|NCT02132754|519934481|FG033|Overall Study|Adverse Event|1|||
144201606|NCT02132754|519934448|FG000|Overall Study|Clinical Progression|0|||
144201607|NCT02132754|519934449|FG001|Overall Study|Clinical Progression|0|||
144201608|NCT02132754|519934450|FG002|Overall Study|Clinical Progression|0|||
144201609|NCT02132754|519934451|FG003|Overall Study|Clinical Progression|0|||
144201610|NCT02132754|519934452|FG004|Overall Study|Clinical Progression|0|||
144201611|NCT02132754|519934453|FG005|Overall Study|Clinical Progression|0|||
144201612|NCT02132754|519934454|FG006|Overall Study|Clinical Progression|0|||
144201613|NCT02132754|519934455|FG007|Overall Study|Clinical Progression|0|||
144201614|NCT02132754|519934456|FG008|Overall Study|Clinical Progression|0|||
144201615|NCT02132754|519934457|FG009|Overall Study|Clinical Progression|1|||
144201616|NCT02132754|519934458|FG010|Overall Study|Clinical Progression|0|||
144201617|NCT02132754|519934459|FG011|Overall Study|Clinical Progression|0|||
144201618|NCT02132754|519934460|FG012|Overall Study|Clinical Progression|0|||
144201619|NCT02132754|519934461|FG013|Overall Study|Clinical Progression|0|||
144201620|NCT02132754|519934462|FG014|Overall Study|Clinical Progression|0|||
144201621|NCT02132754|519934463|FG015|Overall Study|Clinical Progression|0|||
144201622|NCT02132754|519934464|FG016|Overall Study|Clinical Progression|1|||
144201623|NCT02132754|519934465|FG017|Overall Study|Clinical Progression|1|||
144201624|NCT02132754|519934466|FG018|Overall Study|Clinical Progression|0|||
144201625|NCT02132754|519934467|FG019|Overall Study|Clinical Progression|1|||
144615727|NCT00781456|521454518|FG000|Overall Study|Noncompliance With Protocol|1|||
144615728|NCT00781456|521454519|FG001|Overall Study|Noncompliance With Protocol|1|||
144615729|NCT00781456|521454518|FG000|Overall Study|Lost to Follow-up|10|||
144615730|NCT00781456|521454519|FG001|Overall Study|Lost to Follow-up|5|||
144727442|NCT01868009|521856647|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
144201626|NCT02132754|519934468|FG020|Overall Study|Clinical Progression|0|||
144201627|NCT02132754|519934469|FG021|Overall Study|Clinical Progression|0|||
144201628|NCT02132754|519934470|FG022|Overall Study|Clinical Progression|1|||
144201629|NCT02132754|519934471|FG023|Overall Study|Clinical Progression|0|||
144201630|NCT02132754|519934472|FG024|Overall Study|Clinical Progression|1|||
144727443|NCT01868009|521856648|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
144615731|NCT00781456|521454518|FG000|Overall Study|Other Reason, Unknown|0|||
144615732|NCT00781456|521454519|FG001|Overall Study|Other Reason, Unknown|1|||
144615733|NCT03551509|521454520|FG000|Overall Study|Lost to Follow-up|0|||
144615734|NCT03551509|521454521|FG001|Overall Study|Lost to Follow-up|1|||
144615735|NCT03551509|521454522|FG002|Overall Study|Lost to Follow-up|0|||
144615736|NCT01594853|521454523|FG000|Overall Study|Withdrawal by Subject|1|||
144615737|NCT01594853|521454524|FG001|Overall Study|Withdrawal by Subject|1|||
144615738|NCT01594853|521454523|FG000|Overall Study|Lost to Follow-up|1|||
144615739|NCT01594853|521454524|FG001|Overall Study|Lost to Follow-up|1|||
144615740|NCT01594853|521454523|FG000|Overall Study|noncompliance with exercise|0|||
144615741|NCT01594853|521454524|FG001|Overall Study|noncompliance with exercise|1|||
144615742|NCT02631200|521454527|FG000|First Period|Death|1|||
144615743|NCT02631200|521454528|FG001|First Period|Death|2|||
144615744|NCT02631200|521454527|FG000|First Period|Patient ill-health|2|||
144615745|NCT02631200|521454528|FG001|First Period|Patient ill-health|4|||
144615746|NCT02631200|521454527|FG000|First Period|Withdrawal by Subject|4|||
144615747|NCT02631200|521454528|FG001|First Period|Withdrawal by Subject|1|||
144615748|NCT02631200|521454527|FG000|Deferred Period|Death|0|||
144201631|NCT02132754|519934473|FG025|Overall Study|Clinical Progression|1|||
144201632|NCT02132754|519934474|FG026|Overall Study|Clinical Progression|0|||
144201633|NCT02132754|519934475|FG027|Overall Study|Clinical Progression|1|||
144201634|NCT02132754|519934476|FG028|Overall Study|Clinical Progression|1|||
144201635|NCT02132754|519934477|FG029|Overall Study|Clinical Progression|0|||
144201636|NCT02132754|519934478|FG030|Overall Study|Clinical Progression|1|||
144201637|NCT02132754|519934479|FG031|Overall Study|Clinical Progression|0|||
144201638|NCT02132754|519934480|FG032|Overall Study|Clinical Progression|0|||
144201639|NCT02132754|519934481|FG033|Overall Study|Clinical Progression|2|||
144201640|NCT02132754|519934448|FG000|Overall Study|Death|0|||
144201641|NCT02132754|519934449|FG001|Overall Study|Death|0|||
144201642|NCT02132754|519934450|FG002|Overall Study|Death|0|||
144201643|NCT02132754|519934451|FG003|Overall Study|Death|0|||
144201644|NCT02132754|519934452|FG004|Overall Study|Death|0|||
144201645|NCT02132754|519934453|FG005|Overall Study|Death|0|||
144201646|NCT02132754|519934454|FG006|Overall Study|Death|0|||
144201647|NCT02132754|519934455|FG007|Overall Study|Death|0|||
144201648|NCT02132754|519934456|FG008|Overall Study|Death|0|||
144201649|NCT02132754|519934457|FG009|Overall Study|Death|0|||
144201650|NCT02132754|519934458|FG010|Overall Study|Death|0|||
144201651|NCT02132754|519934459|FG011|Overall Study|Death|0|||
144201652|NCT02132754|519934460|FG012|Overall Study|Death|0|||
144201653|NCT02132754|519934461|FG013|Overall Study|Death|0|||
144201654|NCT02132754|519934462|FG014|Overall Study|Death|0|||
144201655|NCT02132754|519934463|FG015|Overall Study|Death|1|||
144201656|NCT02132754|519934464|FG016|Overall Study|Death|0|||
144201657|NCT02132754|519934465|FG017|Overall Study|Death|0|||
144201658|NCT02132754|519934466|FG018|Overall Study|Death|0|||
144201659|NCT02132754|519934467|FG019|Overall Study|Death|1|||
144201660|NCT02132754|519934468|FG020|Overall Study|Death|0|||
144201661|NCT02132754|519934469|FG021|Overall Study|Death|1|||
144201662|NCT02132754|519934470|FG022|Overall Study|Death|0|||
144201663|NCT02132754|519934471|FG023|Overall Study|Death|0|||
144201664|NCT02132754|519934472|FG024|Overall Study|Death|0|||
144201665|NCT02132754|519934473|FG025|Overall Study|Death|0|||
144201666|NCT02132754|519934474|FG026|Overall Study|Death|1|||
144201667|NCT02132754|519934475|FG027|Overall Study|Death|0|||
144201668|NCT02132754|519934476|FG028|Overall Study|Death|0|||
144201669|NCT02132754|519934477|FG029|Overall Study|Death|0|||
144201670|NCT02132754|519934478|FG030|Overall Study|Death|0|||
144201671|NCT02132754|519934479|FG031|Overall Study|Death|0|||
144201672|NCT02132754|519934480|FG032|Overall Study|Death|0|||
144201673|NCT02132754|519934481|FG033|Overall Study|Death|2|||
144201674|NCT02132754|519934448|FG000|Overall Study|Excluded Medication|0|||
144201675|NCT02132754|519934449|FG001|Overall Study|Excluded Medication|0|||
144201676|NCT02132754|519934450|FG002|Overall Study|Excluded Medication|0|||
144201677|NCT02132754|519934451|FG003|Overall Study|Excluded Medication|0|||
144201678|NCT02132754|519934452|FG004|Overall Study|Excluded Medication|0|||
144201679|NCT02132754|519934453|FG005|Overall Study|Excluded Medication|0|||
144201680|NCT02132754|519934454|FG006|Overall Study|Excluded Medication|0|||
144615749|NCT02631200|521454528|FG001|Deferred Period|Death|1|||
144201681|NCT02132754|519934455|FG007|Overall Study|Excluded Medication|0|||
144201682|NCT02132754|519934456|FG008|Overall Study|Excluded Medication|0|||
144201683|NCT02132754|519934457|FG009|Overall Study|Excluded Medication|0|||
144201684|NCT02132754|519934458|FG010|Overall Study|Excluded Medication|0|||
144201685|NCT02132754|519934459|FG011|Overall Study|Excluded Medication|0|||
144201686|NCT02132754|519934460|FG012|Overall Study|Excluded Medication|0|||
144201687|NCT02132754|519934461|FG013|Overall Study|Excluded Medication|0|||
144201688|NCT02132754|519934462|FG014|Overall Study|Excluded Medication|0|||
144615750|NCT02631200|521454527|FG000|Deferred Period|Received kidney transplant|0|||
144615751|NCT02631200|521454528|FG001|Deferred Period|Received kidney transplant|1|||
144201689|NCT02132754|519934463|FG015|Overall Study|Excluded Medication|0|||
144201690|NCT02132754|519934464|FG016|Overall Study|Excluded Medication|0|||
144201691|NCT02132754|519934465|FG017|Overall Study|Excluded Medication|0|||
144201692|NCT02132754|519934466|FG018|Overall Study|Excluded Medication|0|||
144261169|NCT00377637|520158059|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
144201693|NCT02132754|519934467|FG019|Overall Study|Excluded Medication|0|||
144201694|NCT02132754|519934468|FG020|Overall Study|Excluded Medication|1|||
144201695|NCT02132754|519934469|FG021|Overall Study|Excluded Medication|0|||
144201696|NCT02132754|519934470|FG022|Overall Study|Excluded Medication|0|||
144201697|NCT02132754|519934471|FG023|Overall Study|Excluded Medication|0|||
144201698|NCT02132754|519934472|FG024|Overall Study|Excluded Medication|0|||
144201699|NCT02132754|519934473|FG025|Overall Study|Excluded Medication|0|||
144201700|NCT02132754|519934474|FG026|Overall Study|Excluded Medication|0|||
144201701|NCT02132754|519934475|FG027|Overall Study|Excluded Medication|0|||
144201702|NCT02132754|519934476|FG028|Overall Study|Excluded Medication|0|||
144201703|NCT02132754|519934477|FG029|Overall Study|Excluded Medication|0|||
144201704|NCT02132754|519934478|FG030|Overall Study|Excluded Medication|0|||
144201705|NCT02132754|519934479|FG031|Overall Study|Excluded Medication|0|||
144201706|NCT02132754|519934480|FG032|Overall Study|Excluded Medication|0|||
144201707|NCT02132754|519934481|FG033|Overall Study|Excluded Medication|1|||
144201708|NCT02132754|519934448|FG000|Overall Study|Physician Decision|0|||
144201709|NCT02132754|519934449|FG001|Overall Study|Physician Decision|0|||
144201710|NCT02132754|519934450|FG002|Overall Study|Physician Decision|0|||
144201711|NCT02132754|519934451|FG003|Overall Study|Physician Decision|0|||
144201712|NCT02132754|519934452|FG004|Overall Study|Physician Decision|0|||
144201713|NCT02132754|519934453|FG005|Overall Study|Physician Decision|0|||
144201714|NCT02132754|519934454|FG006|Overall Study|Physician Decision|0|||
144201715|NCT02132754|519934455|FG007|Overall Study|Physician Decision|0|||
144201716|NCT02132754|519934456|FG008|Overall Study|Physician Decision|0|||
144201717|NCT02132754|519934457|FG009|Overall Study|Physician Decision|1|||
144201718|NCT02132754|519934458|FG010|Overall Study|Physician Decision|0|||
144201719|NCT02132754|519934459|FG011|Overall Study|Physician Decision|1|||
144201720|NCT02132754|519934460|FG012|Overall Study|Physician Decision|1|||
144201721|NCT02132754|519934461|FG013|Overall Study|Physician Decision|0|||
144201722|NCT02132754|519934462|FG014|Overall Study|Physician Decision|0|||
144201723|NCT02132754|519934463|FG015|Overall Study|Physician Decision|1|||
144201724|NCT02132754|519934464|FG016|Overall Study|Physician Decision|0|||
144201725|NCT02132754|519934465|FG017|Overall Study|Physician Decision|0|||
144201726|NCT02132754|519934466|FG018|Overall Study|Physician Decision|0|||
144201727|NCT02132754|519934467|FG019|Overall Study|Physician Decision|0|||
144201728|NCT02132754|519934468|FG020|Overall Study|Physician Decision|0|||
144201729|NCT02132754|519934469|FG021|Overall Study|Physician Decision|0|||
144201730|NCT02132754|519934470|FG022|Overall Study|Physician Decision|0|||
144201731|NCT02132754|519934471|FG023|Overall Study|Physician Decision|0|||
144201732|NCT02132754|519934472|FG024|Overall Study|Physician Decision|1|||
144201733|NCT02132754|519934473|FG025|Overall Study|Physician Decision|0|||
144201734|NCT02132754|519934474|FG026|Overall Study|Physician Decision|0|||
144201735|NCT02132754|519934475|FG027|Overall Study|Physician Decision|0|||
144201736|NCT02132754|519934476|FG028|Overall Study|Physician Decision|0|||
144201737|NCT02132754|519934477|FG029|Overall Study|Physician Decision|0|||
144201738|NCT02132754|519934478|FG030|Overall Study|Physician Decision|0|||
144201739|NCT02132754|519934479|FG031|Overall Study|Physician Decision|1|||
144201740|NCT02132754|519934480|FG032|Overall Study|Physician Decision|0|||
144201741|NCT02132754|519934481|FG033|Overall Study|Physician Decision|3|||
144201742|NCT02132754|519934448|FG000|Overall Study|Progressive Disease|1|||
144201743|NCT02132754|519934449|FG001|Overall Study|Progressive Disease|1|||
144201744|NCT02132754|519934450|FG002|Overall Study|Progressive Disease|1|||
144201745|NCT02132754|519934451|FG003|Overall Study|Progressive Disease|1|||
144201746|NCT02132754|519934452|FG004|Overall Study|Progressive Disease|1|||
144201747|NCT02132754|519934453|FG005|Overall Study|Progressive Disease|1|||
144201748|NCT02132754|519934454|FG006|Overall Study|Progressive Disease|1|||
144201749|NCT02132754|519934455|FG007|Overall Study|Progressive Disease|1|||
144201750|NCT02132754|519934456|FG008|Overall Study|Progressive Disease|1|||
144201751|NCT02132754|519934457|FG009|Overall Study|Progressive Disease|3|||
144201752|NCT02132754|519934458|FG010|Overall Study|Progressive Disease|3|||
144201753|NCT02132754|519934459|FG011|Overall Study|Progressive Disease|2|||
144201754|NCT02132754|519934460|FG012|Overall Study|Progressive Disease|2|||
144201755|NCT02132754|519934461|FG013|Overall Study|Progressive Disease|3|||
144201756|NCT02132754|519934462|FG014|Overall Study|Progressive Disease|2|||
144201757|NCT02132754|519934463|FG015|Overall Study|Progressive Disease|1|||
144201758|NCT02132754|519934464|FG016|Overall Study|Progressive Disease|2|||
144201759|NCT02132754|519934465|FG017|Overall Study|Progressive Disease|1|||
144201760|NCT02132754|519934466|FG018|Overall Study|Progressive Disease|3|||
144201761|NCT02132754|519934467|FG019|Overall Study|Progressive Disease|1|||
144261170|NCT00377637|520158060|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
144201762|NCT02132754|519934468|FG020|Overall Study|Progressive Disease|1|||
144201763|NCT02132754|519934469|FG021|Overall Study|Progressive Disease|3|||
144201764|NCT02132754|519934470|FG022|Overall Study|Progressive Disease|2|||
144201765|NCT02132754|519934471|FG023|Overall Study|Progressive Disease|3|||
144201766|NCT02132754|519934472|FG024|Overall Study|Progressive Disease|0|||
144201767|NCT02132754|519934473|FG025|Overall Study|Progressive Disease|1|||
144201768|NCT02132754|519934474|FG026|Overall Study|Progressive Disease|2|||
144201769|NCT02132754|519934475|FG027|Overall Study|Progressive Disease|1|||
144201770|NCT02132754|519934476|FG028|Overall Study|Progressive Disease|2|||
144201771|NCT02132754|519934477|FG029|Overall Study|Progressive Disease|3|||
144261171|NCT00377637|520158061|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
144261172|NCT00377637|520158062|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
144261173|NCT00377637|520158059|FG000|Maintenance Phase|Adverse Event|0|||
144261174|NCT00377637|520158060|FG001|Maintenance Phase|Adverse Event|0|||
144261175|NCT00377637|520158061|FG002|Maintenance Phase|Adverse Event|29|||
144261176|NCT00377637|520158062|FG003|Maintenance Phase|Adverse Event|43|||
144261177|NCT00377637|520158059|FG000|Maintenance Phase|Physician Decision|0|||
144261178|NCT00377637|520158060|FG001|Maintenance Phase|Physician Decision|0|||
144261179|NCT00377637|520158061|FG002|Maintenance Phase|Physician Decision|5|||
144261180|NCT00377637|520158062|FG003|Maintenance Phase|Physician Decision|4|||
144261181|NCT00377637|520158059|FG000|Maintenance Phase|Lost to Follow-up|0|||
144261182|NCT00377637|520158060|FG001|Maintenance Phase|Lost to Follow-up|0|||
144261183|NCT00377637|520158061|FG002|Maintenance Phase|Lost to Follow-up|3|||
144261184|NCT00377637|520158062|FG003|Maintenance Phase|Lost to Follow-up|1|||
144261185|NCT00377637|520158059|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144261186|NCT00377637|520158060|FG001|Maintenance Phase|Withdrawal by Subject|0|||
144261187|NCT00377637|520158061|FG002|Maintenance Phase|Withdrawal by Subject|3|||
144261188|NCT00377637|520158062|FG003|Maintenance Phase|Withdrawal by Subject|3|||
144261189|NCT00377637|520158059|FG000|Maintenance Phase|Sponsor decision|0|||
144261190|NCT00377637|520158060|FG001|Maintenance Phase|Sponsor decision|0|||
144615752|NCT02631200|521454527|FG000|Deferred Period|Withdrawal by Subject|0|||
144615753|NCT02631200|521454528|FG001|Deferred Period|Withdrawal by Subject|2|||
144615754|NCT02631200|521454527|FG000|Deferred Period|Lost to Follow-up|0|||
144615755|NCT02631200|521454528|FG001|Deferred Period|Lost to Follow-up|1|||
144615756|NCT01877187|521454529|FG000|Overall Study|Death|2|||
144615757|NCT01877187|521454529|FG000|Overall Study|Withdrawal by Subject|4|||
144615758|NCT01877187|521454529|FG000|Overall Study|Lost to Follow-up|3|||
144615759|NCT01877187|521454529|FG000|Overall Study|Declining clinical status|11|||
144615760|NCT01877187|521454529|FG000|Overall Study|Liver transplant|2|||
144615761|NCT00769002|521454531|FG000|Overall Study|Study was not completed, no data|9|||
144261191|NCT00377637|520158061|FG002|Maintenance Phase|Sponsor decision|2|||
144261192|NCT00377637|520158062|FG003|Maintenance Phase|Sponsor decision|3|||
144261193|NCT00377637|520158059|FG000|Maintenance Phase|Non-compliance|0|||
144261194|NCT00377637|520158060|FG001|Maintenance Phase|Non-compliance|0|||
144261195|NCT00377637|520158061|FG002|Maintenance Phase|Non-compliance|1|||
144261196|NCT00377637|520158062|FG003|Maintenance Phase|Non-compliance|1|||
144261197|NCT00377637|520158059|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
144261198|NCT00377637|520158060|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
144261199|NCT00377637|520158061|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
144261200|NCT00377637|520158062|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
144261201|NCT00377637|520158059|FG000|Maintenance Phase|Death|0|||
144261202|NCT00377637|520158060|FG001|Maintenance Phase|Death|0|||
144261203|NCT00377637|520158061|FG002|Maintenance Phase|Death|0|||
144261204|NCT00377637|520158062|FG003|Maintenance Phase|Death|1|||
144615762|NCT00769002|521454532|FG001|Overall Study|Study was not completed, no data|9|||
144615763|NCT03776175|521454534|FG000|Treatment Period (42 Days)|Adverse Event|0|||
144615764|NCT03776175|521454535|FG001|Treatment Period (42 Days)|Adverse Event|1|||
144615765|NCT03776175|521454536|FG002|Treatment Period (42 Days)|Adverse Event|1|||
144615766|NCT03776175|521454537|FG003|Treatment Period (42 Days)|Adverse Event|0|||
144615767|NCT03776175|521454534|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
144615768|NCT03776175|521454535|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
144615769|NCT03776175|521454536|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
144615770|NCT03776175|521454537|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
144615771|NCT03776175|521454534|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
144615772|NCT03776175|521454535|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
144615773|NCT03776175|521454536|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
144615774|NCT03776175|521454537|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
144615775|NCT03776175|521454534|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
144615776|NCT03776175|521454535|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
144615777|NCT03776175|521454536|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
144615778|NCT03776175|521454537|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
144615779|NCT03776175|521454534|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
144615780|NCT03776175|521454535|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
144615781|NCT03776175|521454536|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
144615782|NCT03776175|521454537|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
144261205|NCT00327340|520158063|FG000|Overall Study|Withdrawal by Subject|1|||
144261206|NCT00327340|520158064|FG001|Overall Study|Withdrawal by Subject|5|||
144261207|NCT00327340|520158063|FG000|Overall Study|Physician Decision|1|||
144261208|NCT00327340|520158064|FG001|Overall Study|Physician Decision|1|||
144615783|NCT03776175|521454534|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
144261209|NCT00327340|520158063|FG000|Overall Study|Disease Progression|10|||
144261210|NCT00327340|520158064|FG001|Overall Study|Disease Progression|19|||
144261211|NCT00327340|520158063|FG000|Overall Study|Symptomatic Disease|0|||
144261212|NCT00327340|520158064|FG001|Overall Study|Symptomatic Disease|2|||
144615784|NCT03776175|521454535|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
144615785|NCT03776175|521454536|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
144615786|NCT03776175|521454537|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
144615787|NCT00960661|521454538|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
144615788|NCT00960661|521454539|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
144615789|NCT00960661|521454540|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
144615790|NCT00960661|521454538|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
144615791|NCT00960661|521454539|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
144615792|NCT00960661|521454540|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
144615793|NCT00960661|521454538|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
144615794|NCT00960661|521454539|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
144615795|NCT00960661|521454540|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
144615796|NCT00960661|521454538|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
144615797|NCT00960661|521454539|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
144615798|NCT00960661|521454540|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
144615799|NCT00960661|521454538|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
144615800|NCT00960661|521454539|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
144615801|NCT00960661|521454540|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
144615802|NCT00960661|521454538|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
144615803|NCT00960661|521454539|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
144615804|NCT00960661|521454540|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
144615805|NCT00960661|521454538|FG000|Interventional Phase|Adverse Event|0|||
144615806|NCT00960661|521454539|FG001|Interventional Phase|Adverse Event|17|||
144615807|NCT00960661|521454540|FG002|Interventional Phase|Adverse Event|8|||
144615808|NCT00960661|521454538|FG000|Interventional Phase|Death|0|||
144615809|NCT00960661|521454539|FG001|Interventional Phase|Death|1|||
144615810|NCT00960661|521454540|FG002|Interventional Phase|Death|0|||
144615811|NCT00960661|521454538|FG000|Interventional Phase|Lost to Follow-up|0|||
144615812|NCT00960661|521454539|FG001|Interventional Phase|Lost to Follow-up|0|||
144615813|NCT00960661|521454540|FG002|Interventional Phase|Lost to Follow-up|2|||
144615814|NCT00960661|521454538|FG000|Interventional Phase|entry criteria not met|0|||
144727444|NCT02101853|521856651|FG000|Block 1 Induction|Adverse Event|11|||
144201772|NCT02132754|519934478|FG030|Overall Study|Progressive Disease|1|||
144201773|NCT02132754|519934479|FG031|Overall Study|Progressive Disease|1|||
144201774|NCT02132754|519934480|FG032|Overall Study|Progressive Disease|3|||
144201775|NCT02132754|519934481|FG033|Overall Study|Progressive Disease|6|||
144201776|NCT02132754|519934448|FG000|Overall Study|Screen Failure|0|||
144201777|NCT02132754|519934449|FG001|Overall Study|Screen Failure|0|||
144201778|NCT02132754|519934450|FG002|Overall Study|Screen Failure|0|||
144201779|NCT02132754|519934451|FG003|Overall Study|Screen Failure|0|||
144201780|NCT02132754|519934452|FG004|Overall Study|Screen Failure|0|||
144201781|NCT02132754|519934453|FG005|Overall Study|Screen Failure|0|||
144201782|NCT02132754|519934454|FG006|Overall Study|Screen Failure|0|||
144201783|NCT02132754|519934455|FG007|Overall Study|Screen Failure|0|||
144201784|NCT02132754|519934456|FG008|Overall Study|Screen Failure|0|||
144201785|NCT02132754|519934457|FG009|Overall Study|Screen Failure|0|||
144201786|NCT02132754|519934458|FG010|Overall Study|Screen Failure|0|||
144201787|NCT02132754|519934459|FG011|Overall Study|Screen Failure|0|||
144201788|NCT02132754|519934460|FG012|Overall Study|Screen Failure|0|||
144201789|NCT02132754|519934461|FG013|Overall Study|Screen Failure|0|||
144201790|NCT02132754|519934462|FG014|Overall Study|Screen Failure|0|||
144201791|NCT02132754|519934463|FG015|Overall Study|Screen Failure|0|||
144201792|NCT02132754|519934464|FG016|Overall Study|Screen Failure|0|||
144201793|NCT02132754|519934465|FG017|Overall Study|Screen Failure|0|||
144201794|NCT02132754|519934466|FG018|Overall Study|Screen Failure|0|||
144201795|NCT02132754|519934467|FG019|Overall Study|Screen Failure|1|||
144201796|NCT02132754|519934468|FG020|Overall Study|Screen Failure|0|||
144201797|NCT02132754|519934469|FG021|Overall Study|Screen Failure|1|||
144201798|NCT02132754|519934470|FG022|Overall Study|Screen Failure|0|||
144201799|NCT02132754|519934471|FG023|Overall Study|Screen Failure|0|||
144201800|NCT02132754|519934472|FG024|Overall Study|Screen Failure|0|||
144201801|NCT02132754|519934473|FG025|Overall Study|Screen Failure|0|||
144201802|NCT02132754|519934474|FG026|Overall Study|Screen Failure|0|||
144201803|NCT02132754|519934475|FG027|Overall Study|Screen Failure|0|||
144201804|NCT02132754|519934476|FG028|Overall Study|Screen Failure|0|||
144201805|NCT02132754|519934477|FG029|Overall Study|Screen Failure|0|||
144201806|NCT02132754|519934478|FG030|Overall Study|Screen Failure|0|||
144201807|NCT02132754|519934479|FG031|Overall Study|Screen Failure|0|||
144201808|NCT02132754|519934480|FG032|Overall Study|Screen Failure|0|||
144727445|NCT02101853|521856652|FG001|Block 1 Induction|Adverse Event|0|||
144201809|NCT02132754|519934481|FG033|Overall Study|Screen Failure|0|||
144201810|NCT02132754|519934448|FG000|Overall Study|Transferred to Extension Study|0|||
144201811|NCT02132754|519934449|FG001|Overall Study|Transferred to Extension Study|0|||
144201812|NCT02132754|519934450|FG002|Overall Study|Transferred to Extension Study|0|||
144261213|NCT00327340|520158063|FG000|Overall Study|Adverse Event|3|||
144261214|NCT00327340|520158064|FG001|Overall Study|Adverse Event|3|||
144261215|NCT00956839|520158065|FG000|Overall Study|Lost to Follow-up|3|||
144261216|NCT00956839|520158066|FG001|Overall Study|Lost to Follow-up|0|||
144261217|NCT00956839|520158067|FG002|Overall Study|Lost to Follow-up|3|||
144261218|NCT02121795|520158068|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
144261219|NCT02121795|520158069|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
144261220|NCT02121795|520158068|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
144261221|NCT02121795|520158069|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
144261222|NCT02121795|520158068|FG000|Double-Blind Phase|Lost to Follow-up|7|||
144261223|NCT02121795|520158069|FG001|Double-Blind Phase|Lost to Follow-up|4|||
144261224|NCT02121795|520158068|FG000|Double-Blind Phase|Physician Decision|2|||
144261225|NCT02121795|520158069|FG001|Double-Blind Phase|Physician Decision|5|||
144261226|NCT02121795|520158068|FG000|Double-Blind Phase|Adverse Event|5|||
144261227|NCT02121795|520158069|FG001|Double-Blind Phase|Adverse Event|0|||
144261228|NCT02121795|520158068|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
144261229|NCT02121795|520158069|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
144261230|NCT02121795|520158068|FG000|Double-Blind Phase|Protocol Violation|0|||
144261231|NCT02121795|520158069|FG001|Double-Blind Phase|Protocol Violation|3|||
144261232|NCT02121795|520158068|FG000|Double-Blind Phase|Death|1|||
144261233|NCT02121795|520158069|FG001|Double-Blind Phase|Death|1|||
144261234|NCT02121795|520158068|FG000|Open-Label Phase|Physician Decision|8|||
144261235|NCT02121795|520158069|FG001|Open-Label Phase|Physician Decision|8|||
144261236|NCT02121795|520158068|FG000|Open-Label Phase|Withdrawal by Subject|3|||
144261237|NCT02121795|520158069|FG001|Open-Label Phase|Withdrawal by Subject|2|||
144261238|NCT02121795|520158068|FG000|Open-Label Phase|Lost to Follow-up|1|||
144261239|NCT02121795|520158069|FG001|Open-Label Phase|Lost to Follow-up|0|||
144261240|NCT04155463|520158070|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
144261241|NCT04155463|520158071|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
144261242|NCT00368108|520158076|FG000|Overall Study|Adverse Event|38|||
144261243|NCT00368108|520158077|FG001|Overall Study|Adverse Event|26|||
144261244|NCT00368108|520158078|FG002|Overall Study|Adverse Event|44|||
144261245|NCT00368108|520158076|FG000|Overall Study|Abnormal Laboratory Value|0|||
144261246|NCT00368108|520158077|FG001|Overall Study|Abnormal Laboratory Value|0|||
144261247|NCT00368108|520158078|FG002|Overall Study|Abnormal Laboratory Value|3|||
144261248|NCT00368108|520158076|FG000|Overall Study|Protocol Violation|5|||
144261249|NCT00368108|520158077|FG001|Overall Study|Protocol Violation|9|||
144261250|NCT00368108|520158078|FG002|Overall Study|Protocol Violation|9|||
144261251|NCT00368108|520158076|FG000|Overall Study|Withdrawal by Subject|9|||
144261252|NCT00368108|520158077|FG001|Overall Study|Withdrawal by Subject|3|||
144261253|NCT00368108|520158078|FG002|Overall Study|Withdrawal by Subject|5|||
144261254|NCT00368108|520158076|FG000|Overall Study|Lack of Efficacy|7|||
144261255|NCT00368108|520158077|FG001|Overall Study|Lack of Efficacy|8|||
144261256|NCT00368108|520158078|FG002|Overall Study|Lack of Efficacy|5|||
144261257|NCT00368108|520158076|FG000|Overall Study|Physician Decision|2|||
144261258|NCT00368108|520158077|FG001|Overall Study|Physician Decision|0|||
144261259|NCT00368108|520158078|FG002|Overall Study|Physician Decision|1|||
144261260|NCT00368108|520158076|FG000|Overall Study|Other|3|||
144261261|NCT00368108|520158077|FG001|Overall Study|Other|7|||
144261262|NCT00368108|520158078|FG002|Overall Study|Other|1|||
144261263|NCT02299388|520158079|FG000|Overall Study|Withdrawal by Subject|0|||
144261264|NCT02299388|520158080|FG001|Overall Study|Withdrawal by Subject|1|||
144261265|NCT00130689|520158082|FG000|Overall Study|Progressive Disease|29|||
144540916|NCT04622332|521179997|FG001|Overall Study|Withdrawal by Subject|2|||
144540917|NCT04622332|521179996|FG000|Overall Study|Physician Decision|1|||
144540918|NCT04622332|521179997|FG001|Overall Study|Physician Decision|1|||
144540919|NCT04622332|521179996|FG000|Overall Study|Adverse Event|0|||
144540920|NCT04622332|521179997|FG001|Overall Study|Adverse Event|2|||
144540921|NCT04622332|521179996|FG000|Overall Study|Protocol Violation|0|||
144540922|NCT04622332|521179997|FG001|Overall Study|Protocol Violation|1|||
144540923|NCT05966155|521179998|FG000|Overall Study|Death|1|||
144540924|NCT05966155|521179999|FG001|Overall Study|Death|2|||
144540925|NCT05966155|521179998|FG000|Overall Study|Lost to Follow-up|63|||
144540926|NCT05966155|521179999|FG001|Overall Study|Lost to Follow-up|67|||
144540927|NCT05966155|521179998|FG000|Overall Study|Protocol Violation|1|||
144540928|NCT05966155|521179999|FG001|Overall Study|Protocol Violation|0|||
144540929|NCT05966155|521179998|FG000|Overall Study|Withdrawal by Subject|8|||
144540930|NCT05966155|521179999|FG001|Overall Study|Withdrawal by Subject|9|||
144540931|NCT05966155|521179998|FG000|Overall Study|Enrolled Erroneously|0|||
144261266|NCT00130689|520158082|FG000|Overall Study|Death|1|||
144261267|NCT00130689|520158082|FG000|Overall Study|Clinical Deterioration|4|||
144261268|NCT00130689|520158082|FG000|Overall Study|Withdrawal by Subject|3|||
144261269|NCT00130689|520158082|FG000|Overall Study|Ineligible|6|||
144261270|NCT00766597|520158083|FG000|Overall Study|Unexpected closure of study|4|||
144261271|NCT00766597|520158083|FG000|Overall Study|Without CCR5-tropic virus|5|||
144261272|NCT00943397|520158084|FG000|Overall Study|Adverse Event|0|||
144261273|NCT00943397|520158085|FG001|Overall Study|Adverse Event|6|||
144540932|NCT05966155|521179999|FG001|Overall Study|Enrolled Erroneously|1|||
144261274|NCT00943397|520158084|FG000|Overall Study|Lost to Follow-up|0|||
144261275|NCT00943397|520158085|FG001|Overall Study|Lost to Follow-up|4|||
144261276|NCT00943397|520158084|FG000|Overall Study|Protocol Violation|2|||
144261277|NCT00943397|520158085|FG001|Overall Study|Protocol Violation|5|||
144261278|NCT00943397|520158084|FG000|Overall Study|Withdrawal by Subject|1|||
144261279|NCT00943397|520158085|FG001|Overall Study|Withdrawal by Subject|1|||
144261280|NCT00943397|520158084|FG000|Overall Study|Site terminated and other|12|||
144261281|NCT00943397|520158085|FG001|Overall Study|Site terminated and other|56|||
144261282|NCT01254656|520158086|FG000|Overall Study|Discontinued due to termination of study|40|||
144261283|NCT01254656|520158087|FG001|Overall Study|Discontinued due to termination of study|39|||
144261284|NCT01254656|520158088|FG002|Overall Study|Discontinued due to termination of study|13|||
144261285|NCT01254656|520158086|FG000|Overall Study|Lack of Efficacy|3|||
144261286|NCT01254656|520158087|FG001|Overall Study|Lack of Efficacy|0|||
144261287|NCT01254656|520158088|FG002|Overall Study|Lack of Efficacy|0|||
144261288|NCT01254656|520158086|FG000|Overall Study|Lost to Follow-up|1|||
144261289|NCT01254656|520158087|FG001|Overall Study|Lost to Follow-up|0|||
144261290|NCT01254656|520158088|FG002|Overall Study|Lost to Follow-up|2|||
144261291|NCT01254656|520158086|FG000|Overall Study|Withdrawal by Subject|2|||
144261292|NCT01254656|520158087|FG001|Overall Study|Withdrawal by Subject|2|||
144261293|NCT01254656|520158088|FG002|Overall Study|Withdrawal by Subject|1|||
144261294|NCT01254656|520158086|FG000|Overall Study|Pregnancy|0|||
144261295|NCT01254656|520158087|FG001|Overall Study|Pregnancy|0|||
144261296|NCT01254656|520158088|FG002|Overall Study|Pregnancy|2|||
144261297|NCT01254656|520158086|FG000|Overall Study|Adverse Event|1|||
144261298|NCT01254656|520158087|FG001|Overall Study|Adverse Event|1|||
144261299|NCT01254656|520158088|FG002|Overall Study|Adverse Event|0|||
144261300|NCT01254656|520158086|FG000|Overall Study|Death|0|||
144261301|NCT01254656|520158087|FG001|Overall Study|Death|1|||
144261302|NCT01254656|520158088|FG002|Overall Study|Death|0|||
144261303|NCT02948829|520158089|FG000|Overall Study|Lost to Follow-up|2|||
144261304|NCT02948829|520158089|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
144261305|NCT02948829|520158089|FG000|Overall Study|Pregnancy|1|||
144261306|NCT02948829|520158089|FG000|Overall Study|Other: Reason not Specified|8|||
144261307|NCT00369915|520158090|FG000|Overall Study|expected side effects|2|||
144261308|NCT00369915|520158091|FG001|Overall Study|expected side effects|1|||
144261309|NCT00369915|520158090|FG000|Overall Study|Withdrawal by Subject|4|||
144261310|NCT00369915|520158091|FG001|Overall Study|Withdrawal by Subject|1|||
144261311|NCT00369915|520158090|FG000|Overall Study|W/drawl by investigators|0|||
144261312|NCT00369915|520158091|FG001|Overall Study|W/drawl by investigators|1|||
144261313|NCT01265394|520158105|FG000|Overall Study|Subjects withdrawn|37|||
144261314|NCT00268983|520158106|FG000|Overall Study|Death|3|||
144261315|NCT00268983|520158107|FG001|Overall Study|Death|0|||
144261316|NCT01719380|520158108|FG000|Overall Study|Adverse Event|0|||
144261317|NCT01719380|520158109|FG001|Overall Study|Adverse Event|0|||
144261318|NCT01719380|520158110|FG002|Overall Study|Adverse Event|1|||
144261319|NCT01719380|520158111|FG003|Overall Study|Adverse Event|2|||
144261320|NCT01719380|520158112|FG004|Overall Study|Adverse Event|0|||
144261321|NCT01719380|520158113|FG005|Overall Study|Adverse Event|1|||
144261322|NCT01719380|520158114|FG006|Overall Study|Adverse Event|0|||
144261323|NCT01719380|520158115|FG007|Overall Study|Adverse Event|1|||
144201813|NCT02132754|519934451|FG003|Overall Study|Transferred to Extension Study|0|||
144201814|NCT02132754|519934452|FG004|Overall Study|Transferred to Extension Study|0|||
144201815|NCT02132754|519934453|FG005|Overall Study|Transferred to Extension Study|0|||
144201816|NCT02132754|519934454|FG006|Overall Study|Transferred to Extension Study|0|||
144201817|NCT02132754|519934455|FG007|Overall Study|Transferred to Extension Study|0|||
144201818|NCT02132754|519934456|FG008|Overall Study|Transferred to Extension Study|0|||
144201819|NCT02132754|519934457|FG009|Overall Study|Transferred to Extension Study|0|||
144201820|NCT02132754|519934458|FG010|Overall Study|Transferred to Extension Study|0|||
144201821|NCT02132754|519934459|FG011|Overall Study|Transferred to Extension Study|0|||
144201822|NCT02132754|519934460|FG012|Overall Study|Transferred to Extension Study|0|||
144201823|NCT02132754|519934461|FG013|Overall Study|Transferred to Extension Study|0|||
144201824|NCT02132754|519934462|FG014|Overall Study|Transferred to Extension Study|0|||
144201825|NCT02132754|519934463|FG015|Overall Study|Transferred to Extension Study|0|||
144261324|NCT01719380|520158116|FG008|Overall Study|Adverse Event|4|||
144261325|NCT01719380|520158117|FG009|Overall Study|Adverse Event|3|||
144261326|NCT01719380|520158108|FG000|Overall Study|Death|0|||
144261327|NCT01719380|520158109|FG001|Overall Study|Death|1|||
144261328|NCT01719380|520158110|FG002|Overall Study|Death|0|||
144261329|NCT01719380|520158111|FG003|Overall Study|Death|0|||
144261330|NCT01719380|520158112|FG004|Overall Study|Death|0|||
144261331|NCT01719380|520158113|FG005|Overall Study|Death|0|||
144261332|NCT01719380|520158114|FG006|Overall Study|Death|0|||
144261333|NCT01719380|520158115|FG007|Overall Study|Death|0|||
144201826|NCT02132754|519934464|FG016|Overall Study|Transferred to Extension Study|0|||
144261334|NCT01719380|520158116|FG008|Overall Study|Death|3|||
144727446|NCT02101853|521856653|FG002|Block 1 Induction|Adverse Event|0|||
144261335|NCT01719380|520158117|FG009|Overall Study|Death|3|||
144261336|NCT01719380|520158108|FG000|Overall Study|Participant/Guardian Decision|0|||
144261337|NCT01719380|520158109|FG001|Overall Study|Participant/Guardian Decision|0|||
144201827|NCT02132754|519934465|FG017|Overall Study|Transferred to Extension Study|0|||
144201828|NCT02132754|519934466|FG018|Overall Study|Transferred to Extension Study|0|||
144201829|NCT02132754|519934467|FG019|Overall Study|Transferred to Extension Study|0|||
144201830|NCT02132754|519934468|FG020|Overall Study|Transferred to Extension Study|0|||
144201831|NCT02132754|519934469|FG021|Overall Study|Transferred to Extension Study|0|||
144201832|NCT02132754|519934470|FG022|Overall Study|Transferred to Extension Study|0|||
144201833|NCT02132754|519934471|FG023|Overall Study|Transferred to Extension Study|0|||
144615815|NCT00960661|521454539|FG001|Interventional Phase|entry criteria not met|3|||
144615816|NCT00960661|521454540|FG002|Interventional Phase|entry criteria not met|0|||
144615817|NCT00960661|521454538|FG000|Interventional Phase|Protocol Violation|0|||
144615818|NCT00960661|521454539|FG001|Interventional Phase|Protocol Violation|7|||
144615819|NCT00960661|521454540|FG002|Interventional Phase|Protocol Violation|2|||
144615820|NCT00960661|521454538|FG000|Interventional Phase|Withdrawal by Subject|0|||
144615821|NCT00960661|521454539|FG001|Interventional Phase|Withdrawal by Subject|18|||
144615822|NCT00960661|521454540|FG002|Interventional Phase|Withdrawal by Subject|29|||
144615823|NCT00960661|521454538|FG000|Interventional Phase|Physician Decision|0|||
144615824|NCT00960661|521454539|FG001|Interventional Phase|Physician Decision|3|||
144201834|NCT02132754|519934472|FG024|Overall Study|Transferred to Extension Study|0|||
144615825|NCT00960661|521454540|FG002|Interventional Phase|Physician Decision|5|||
144615826|NCT00960661|521454538|FG000|Interventional Phase|sponsor decision|0|||
144615827|NCT00960661|521454539|FG001|Interventional Phase|sponsor decision|1|||
144615828|NCT00960661|521454540|FG002|Interventional Phase|sponsor decision|0|||
144615829|NCT00960661|521454538|FG000|Interventional Phase|Lack of Efficacy|0|||
144615830|NCT00960661|521454539|FG001|Interventional Phase|Lack of Efficacy|2|||
144615831|NCT00960661|521454540|FG002|Interventional Phase|Lack of Efficacy|0|||
144615832|NCT04091087|521454542|FG000|Overall Study|Not treated|1|||
144615833|NCT04091087|521454543|FG001|Overall Study|Not treated|0|||
144615834|NCT04091087|521454542|FG000|Overall Study|Adverse Event|4|||
144615835|NCT04091087|521454543|FG001|Overall Study|Adverse Event|4|||
144615836|NCT04091087|521454542|FG000|Overall Study|Protocol Violation|0|||
144615837|NCT04091087|521454543|FG001|Overall Study|Protocol Violation|1|||
144615838|NCT04091087|521454542|FG000|Overall Study|Withdrawal by Subject|5|||
144615839|NCT04091087|521454543|FG001|Overall Study|Withdrawal by Subject|2|||
144615840|NCT04677712|521454544|FG000|Overall Study|Lost to Follow-up|0|||
144615841|NCT04677712|521454545|FG001|Overall Study|Lost to Follow-up|1|||
144615842|NCT04677712|521454546|FG002|Overall Study|Lost to Follow-up|0|||
144615843|NCT04677712|521454547|FG003|Overall Study|Lost to Follow-up|0|||
144615844|NCT04677712|521454548|FG004|Overall Study|Lost to Follow-up|0|||
144615845|NCT04677712|521454549|FG005|Overall Study|Lost to Follow-up|0|||
144615846|NCT00711100|521454550|FG000|Overall Study|Lack of Efficacy|5|||
144615847|NCT00711100|521454550|FG000|Overall Study|Withdrawal by Subject|8|||
144615848|NCT00783094|521454551|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
144615849|NCT00783094|521454552|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
144615850|NCT00783094|521454553|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
144615851|NCT00783094|521454551|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
144615852|NCT00783094|521454552|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
144201835|NCT02132754|519934473|FG025|Overall Study|Transferred to Extension Study|0|||
144201836|NCT02132754|519934474|FG026|Overall Study|Transferred to Extension Study|0|||
144201837|NCT02132754|519934475|FG027|Overall Study|Transferred to Extension Study|0|||
144201838|NCT02132754|519934476|FG028|Overall Study|Transferred to Extension Study|0|||
144201839|NCT02132754|519934477|FG029|Overall Study|Transferred to Extension Study|0|||
144201840|NCT02132754|519934478|FG030|Overall Study|Transferred to Extension Study|0|||
144201841|NCT02132754|519934479|FG031|Overall Study|Transferred to Extension Study|0|||
144201842|NCT02132754|519934480|FG032|Overall Study|Transferred to Extension Study|0|||
144201843|NCT02132754|519934481|FG033|Overall Study|Transferred to Extension Study|6|||
144201844|NCT02132754|519934448|FG000|Overall Study|Withdrawal by Subject|0|||
144201845|NCT02132754|519934449|FG001|Overall Study|Withdrawal by Subject|0|||
144201846|NCT02132754|519934450|FG002|Overall Study|Withdrawal by Subject|0|||
144201847|NCT02132754|519934451|FG003|Overall Study|Withdrawal by Subject|0|||
144201848|NCT02132754|519934452|FG004|Overall Study|Withdrawal by Subject|0|||
144201849|NCT02132754|519934453|FG005|Overall Study|Withdrawal by Subject|0|||
144201850|NCT02132754|519934454|FG006|Overall Study|Withdrawal by Subject|0|||
144201851|NCT02132754|519934455|FG007|Overall Study|Withdrawal by Subject|0|||
144201852|NCT02132754|519934456|FG008|Overall Study|Withdrawal by Subject|0|||
144201853|NCT02132754|519934457|FG009|Overall Study|Withdrawal by Subject|1|||
144201854|NCT02132754|519934458|FG010|Overall Study|Withdrawal by Subject|0|||
144201855|NCT02132754|519934459|FG011|Overall Study|Withdrawal by Subject|0|||
144201856|NCT02132754|519934460|FG012|Overall Study|Withdrawal by Subject|1|||
144201857|NCT02132754|519934461|FG013|Overall Study|Withdrawal by Subject|0|||
144201858|NCT02132754|519934462|FG014|Overall Study|Withdrawal by Subject|1|||
144615853|NCT00783094|521454553|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
144615854|NCT00783094|521454551|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
144615855|NCT00783094|521454552|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
144540933|NCT05966155|521179998|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
144540934|NCT05966155|521179999|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
144540935|NCT00980954|521180000|FG000|Overall Study|Protocol Violation|9|||
144540936|NCT00980954|521180001|FG001|Overall Study|Protocol Violation|15|||
144540937|NCT05036278|521180004|FG000|Overall Study|Withdrawal by Subject|1|||
144540938|NCT05036278|521180004|FG000|Overall Study|Adverse Event|1|||
144540939|NCT04647487|521180007|FG000|Overall Study|Protocol Deviation|0|||
144540940|NCT04647487|521180008|FG001|Overall Study|Protocol Deviation|0|||
144540941|NCT04647487|521180009|FG002|Overall Study|Protocol Deviation|1|||
144540942|NCT04647487|521180007|FG000|Overall Study|Withdrawal by Subject|1|||
144540943|NCT04647487|521180008|FG001|Overall Study|Withdrawal by Subject|0|||
144540944|NCT04647487|521180009|FG002|Overall Study|Withdrawal by Subject|2|||
144540945|NCT03348631|521180012|FG000|Overall Study|Not Eligible, No treatment|0|||
144540946|NCT03348631|521180013|FG001|Overall Study|Not Eligible, No treatment|1|||
144540947|NCT03348631|521180012|FG000|Overall Study|Not Eligible, Treated|2|||
144540948|NCT03348631|521180013|FG001|Overall Study|Not Eligible, Treated|0|||
144540949|NCT03348631|521180012|FG000|Overall Study|Eligible, No Treatment|1|||
144540950|NCT03348631|521180013|FG001|Overall Study|Eligible, No Treatment|0|||
144540951|NCT01946204|521180014|FG000|Overall Study|Death|38|||
144540952|NCT01946204|521180015|FG001|Overall Study|Death|59|||
144540953|NCT01946204|521180014|FG000|Overall Study|Withdrawal by Subject|37|||
144540954|NCT01946204|521180015|FG001|Overall Study|Withdrawal by Subject|50|||
144540955|NCT01946204|521180014|FG000|Overall Study|Lost to Follow-up|3|||
144540956|NCT01946204|521180015|FG001|Overall Study|Lost to Follow-up|7|||
144540957|NCT01946204|521180014|FG000|Overall Study|Ongoing|316|||
144540958|NCT01946204|521180015|FG001|Overall Study|Ongoing|687|||
144540959|NCT01946204|521180014|FG000|Overall Study|Other|7|||
144540960|NCT01946204|521180015|FG001|Overall Study|Other|3|||
144540961|NCT03466411|521180016|FG000|Overall Study|Lost to Follow-up|0|||
144540962|NCT03466411|521180017|FG001|Overall Study|Lost to Follow-up|1|||
144540963|NCT03466411|521180018|FG002|Overall Study|Lost to Follow-up|1|||
144540964|NCT03466411|521180019|FG003|Overall Study|Lost to Follow-up|0|||
144540965|NCT03466411|521180020|FG004|Overall Study|Lost to Follow-up|0|||
144540966|NCT03466411|521180021|FG005|Overall Study|Lost to Follow-up|0|||
144540967|NCT03466411|521180022|FG006|Overall Study|Lost to Follow-up|1|||
144540968|NCT03466411|521180023|FG007|Overall Study|Lost to Follow-up|1|||
144540969|NCT03466411|521180024|FG008|Overall Study|Lost to Follow-up|0|||
144540970|NCT03466411|521180025|FG009|Overall Study|Lost to Follow-up|1|||
144540971|NCT03466411|521180026|FG010|Overall Study|Lost to Follow-up|1|||
144540972|NCT03466411|521180027|FG011|Overall Study|Lost to Follow-up|1|||
144540973|NCT03466411|521180028|FG012|Overall Study|Lost to Follow-up|0|||
144540974|NCT03466411|521180016|FG000|Overall Study|Withdrawal by Subject|14|||
144540975|NCT03466411|521180017|FG001|Overall Study|Withdrawal by Subject|7|||
144540976|NCT03466411|521180018|FG002|Overall Study|Withdrawal by Subject|8|||
144540977|NCT03466411|521180019|FG003|Overall Study|Withdrawal by Subject|4|||
144540978|NCT03466411|521180020|FG004|Overall Study|Withdrawal by Subject|6|||
144540979|NCT03466411|521180021|FG005|Overall Study|Withdrawal by Subject|3|||
144540980|NCT03466411|521180022|FG006|Overall Study|Withdrawal by Subject|6|||
144201859|NCT02132754|519934463|FG015|Overall Study|Withdrawal by Subject|2|||
144201860|NCT02132754|519934464|FG016|Overall Study|Withdrawal by Subject|1|||
144201861|NCT02132754|519934465|FG017|Overall Study|Withdrawal by Subject|0|||
144201862|NCT02132754|519934466|FG018|Overall Study|Withdrawal by Subject|0|||
144201863|NCT02132754|519934467|FG019|Overall Study|Withdrawal by Subject|0|||
144201864|NCT02132754|519934468|FG020|Overall Study|Withdrawal by Subject|1|||
144201865|NCT02132754|519934469|FG021|Overall Study|Withdrawal by Subject|0|||
144201866|NCT02132754|519934470|FG022|Overall Study|Withdrawal by Subject|0|||
144201867|NCT02132754|519934471|FG023|Overall Study|Withdrawal by Subject|0|||
144201868|NCT02132754|519934472|FG024|Overall Study|Withdrawal by Subject|1|||
144540981|NCT03466411|521180023|FG007|Overall Study|Withdrawal by Subject|9|||
144540982|NCT03466411|521180024|FG008|Overall Study|Withdrawal by Subject|6|||
144540983|NCT03466411|521180025|FG009|Overall Study|Withdrawal by Subject|11|||
144540984|NCT03466411|521180026|FG010|Overall Study|Withdrawal by Subject|14|||
144540985|NCT03466411|521180027|FG011|Overall Study|Withdrawal by Subject|12|||
144540986|NCT03466411|521180028|FG012|Overall Study|Withdrawal by Subject|7|||
144540987|NCT03466411|521180016|FG000|Overall Study|Other|1|||
144540988|NCT03466411|521180017|FG001|Overall Study|Other|1|||
144615856|NCT00783094|521454553|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
144540989|NCT03466411|521180018|FG002|Overall Study|Other|0|||
144540990|NCT03466411|521180019|FG003|Overall Study|Other|1|||
144727447|NCT02101853|521856654|FG003|Block 1 Induction|Adverse Event|0|||
144201869|NCT02132754|519934473|FG025|Overall Study|Withdrawal by Subject|0|||
144201870|NCT02132754|519934474|FG026|Overall Study|Withdrawal by Subject|0|||
144540991|NCT03466411|521180020|FG004|Overall Study|Other|2|||
144540992|NCT03466411|521180021|FG005|Overall Study|Other|0|||
144540993|NCT03466411|521180022|FG006|Overall Study|Other|0|||
144540994|NCT03466411|521180023|FG007|Overall Study|Other|0|||
144201871|NCT02132754|519934475|FG027|Overall Study|Withdrawal by Subject|1|||
144540995|NCT03466411|521180024|FG008|Overall Study|Other|0|||
144540996|NCT03466411|521180025|FG009|Overall Study|Other|1|||
144540997|NCT03466411|521180026|FG010|Overall Study|Other|2|||
144540998|NCT03466411|521180027|FG011|Overall Study|Other|0|||
144540999|NCT03466411|521180028|FG012|Overall Study|Other|0|||
144541000|NCT03466411|521180016|FG000|Overall Study|Randomized but not Treated|0|||
144541001|NCT03466411|521180017|FG001|Overall Study|Randomized but not Treated|0|||
144541002|NCT03466411|521180018|FG002|Overall Study|Randomized but not Treated|0|||
144541003|NCT03466411|521180019|FG003|Overall Study|Randomized but not Treated|0|||
144541004|NCT03466411|521180020|FG004|Overall Study|Randomized but not Treated|0|||
144541005|NCT03466411|521180021|FG005|Overall Study|Randomized but not Treated|0|||
144541006|NCT03466411|521180022|FG006|Overall Study|Randomized but not Treated|1|||
144615857|NCT00783094|521454551|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
144615858|NCT00783094|521454552|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
144615859|NCT00783094|521454553|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
144615860|NCT00783094|521454551|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
144615861|NCT00783094|521454552|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
144615862|NCT00783094|521454553|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
144615863|NCT00783094|521454551|FG000|Open-Label Extension Period|Adverse Event|12|||
144615864|NCT00783094|521454552|FG001|Open-Label Extension Period|Adverse Event|7|||
144615865|NCT00783094|521454553|FG002|Open-Label Extension Period|Adverse Event|16|||
144615866|NCT00783094|521454551|FG000|Open-Label Extension Period|Death|0|||
144615867|NCT00783094|521454552|FG001|Open-Label Extension Period|Death|0|||
144615868|NCT00783094|521454553|FG002|Open-Label Extension Period|Death|1|||
144615869|NCT00783094|521454551|FG000|Open-Label Extension Period|Protocol Violation|4|||
144615870|NCT00783094|521454552|FG001|Open-Label Extension Period|Protocol Violation|5|||
144615871|NCT00783094|521454553|FG002|Open-Label Extension Period|Protocol Violation|7|||
144615872|NCT00783094|521454551|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
144615873|NCT00783094|521454552|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
144615874|NCT00783094|521454553|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
144615875|NCT00783094|521454551|FG000|Open-Label Extension Period|Physician Decision|4|||
144615876|NCT00783094|521454552|FG001|Open-Label Extension Period|Physician Decision|2|||
144615877|NCT00783094|521454553|FG002|Open-Label Extension Period|Physician Decision|3|||
144615878|NCT00783094|521454551|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
144615879|NCT00783094|521454552|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
144615880|NCT00783094|521454553|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
144615881|NCT02513329|521454554|FG000|Overall Study|Lost to Follow-up|5|||
144615882|NCT02513329|521454555|FG001|Overall Study|Lost to Follow-up|2|||
144615883|NCT01294670|521454556|FG000|Overall Study|Not treated|1|||
144615884|NCT01294670|521454557|FG001|Overall Study|Not treated|0|||
144615885|NCT01294670|521454558|FG002|Overall Study|Not treated|0|||
144615886|NCT01294670|521454559|FG003|Overall Study|Not treated|0|||
144615887|NCT01294670|521454560|FG004|Overall Study|Not treated|0|||
144615888|NCT03808077|521454562|FG000|Overall Study|Physician Decision|2|||
144615889|NCT03808077|521454563|FG001|Overall Study|Physician Decision|3|||
144615890|NCT03808077|521454562|FG000|Overall Study|Withdrawal by Subject|1|||
144615891|NCT03808077|521454563|FG001|Overall Study|Withdrawal by Subject|0|||
144615892|NCT03808077|521454562|FG000|Overall Study|Equipment Issues|2|||
144615893|NCT03808077|521454563|FG001|Overall Study|Equipment Issues|1|||
144615894|NCT04152161|521454564|FG000|Overall Study|Death|0|||
144615895|NCT04152161|521454565|FG001|Overall Study|Death|1|||
144615896|NCT04152161|521454564|FG000|Overall Study|Physician Decision|0|||
144615897|NCT04152161|521454565|FG001|Overall Study|Physician Decision|1|||
144615898|NCT04152161|521454564|FG000|Overall Study|Lost to Follow-up|9|||
144615899|NCT04152161|521454565|FG001|Overall Study|Lost to Follow-up|3|||
144615900|NCT04152161|521454564|FG000|Overall Study|Protocol Violation|1|||
144615901|NCT04152161|521454565|FG001|Overall Study|Protocol Violation|0|||
144615902|NCT04152161|521454564|FG000|Overall Study|Withdrawal by Subject|29|||
144615903|NCT04152161|521454565|FG001|Overall Study|Withdrawal by Subject|28|||
144615904|NCT04152161|521454564|FG000|Overall Study|Sponsor termination of study|750|||
144541007|NCT03466411|521180023|FG007|Overall Study|Randomized but not Treated|0|||
144615905|NCT04152161|521454565|FG001|Overall Study|Sponsor termination of study|755|||
144615906|NCT04152161|521454564|FG000|Overall Study|Other|20|||
144201872|NCT02132754|519934476|FG028|Overall Study|Withdrawal by Subject|0|||
144615907|NCT04152161|521454565|FG001|Overall Study|Other|18|||
144615908|NCT00001379|521454566|FG000|Initial Treatment|Disease progression|21|||
144615909|NCT00001379|521454567|FG001|Initial Treatment|Disease progression|3|||
144727448|NCT02101853|521856655|FG004|Block 1 Induction|Adverse Event|0|||
144201873|NCT02132754|519934477|FG029|Overall Study|Withdrawal by Subject|0|||
144541008|NCT03466411|521180024|FG008|Overall Study|Randomized but not Treated|0|||
144541009|NCT03466411|521180025|FG009|Overall Study|Randomized but not Treated|0|||
144541010|NCT03466411|521180026|FG010|Overall Study|Randomized but not Treated|0|||
144615910|NCT00001379|521454568|FG002|Initial Treatment|Disease progression|0|||
144615911|NCT00001379|521454569|FG003|Initial Treatment|Disease progression|0|||
144615912|NCT00001379|521454566|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
144615913|NCT00001379|521454567|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
144615914|NCT00001379|521454568|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
144541011|NCT03466411|521180027|FG011|Overall Study|Randomized but not Treated|0|||
144541012|NCT03466411|521180028|FG012|Overall Study|Randomized but not Treated|0|||
144541013|NCT03516812|521180039|FG000|Overall Study|Adverse Event|4|||
144541014|NCT03516812|521180039|FG000|Overall Study|Lack of Efficacy|2|||
144541015|NCT04795167|521180040|FG000|Overall Study|Death|1|||
144541016|NCT04795167|521180041|FG001|Overall Study|Death|18|||
144541017|NCT04795167|521180042|FG002|Overall Study|Death|1|||
144541018|NCT04795167|521180040|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
144541019|NCT04795167|521180041|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
144541020|NCT04795167|521180042|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
144541021|NCT03582475|521180047|FG000|Treatment Period|Withdrawal by Subject|0|||
144541022|NCT03582475|521180048|FG001|Treatment Period|Withdrawal by Subject|1|||
144541023|NCT03582475|521180047|FG000|Follow-up Period|Withdrawal by Subject|0|||
144541024|NCT03582475|521180048|FG001|Follow-up Period|Withdrawal by Subject|1|||
144541025|NCT02257736|521180049|FG000|Overall Study|Progressive disease|365|||
144541026|NCT02257736|521180050|FG001|Overall Study|Progressive disease|327|||
144541027|NCT02257736|521180049|FG000|Overall Study|Adverse Event|45|||
144541028|NCT02257736|521180050|FG001|Overall Study|Adverse Event|56|||
144541029|NCT02257736|521180049|FG000|Overall Study|Withdrawal by Subject|21|||
144541030|NCT02257736|521180050|FG001|Overall Study|Withdrawal by Subject|38|||
144541031|NCT02257736|521180049|FG000|Overall Study|Death|11|||
144541032|NCT02257736|521180050|FG001|Overall Study|Death|6|||
144541033|NCT02257736|521180049|FG000|Overall Study|Physician Decision|5|||
144541034|NCT02257736|521180050|FG001|Overall Study|Physician Decision|9|||
144541035|NCT02257736|521180049|FG000|Overall Study|Non-Compliance with study drug|1|||
144541036|NCT02257736|521180050|FG001|Overall Study|Non-Compliance with study drug|2|||
144541037|NCT02257736|521180049|FG000|Overall Study|Protocol Violation|1|||
144541038|NCT02257736|521180050|FG001|Overall Study|Protocol Violation|0|||
144541039|NCT02257736|521180049|FG000|Overall Study|Other|1|||
144541040|NCT02257736|521180050|FG001|Overall Study|Other|7|||
144541041|NCT02257736|521180049|FG000|Overall Study|Randomized, not treated|1|||
144541042|NCT02257736|521180050|FG001|Overall Study|Randomized, not treated|2|||
144541043|NCT05628103|521180052|FG000|Overall Study|Adverse Event|7|||
144541044|NCT05628103|521180052|FG000|Overall Study|Withdrawal by Subject|3|||
144541045|NCT05628103|521180052|FG000|Overall Study|Lost to Follow-up|3|||
144541046|NCT05628103|521180052|FG000|Overall Study|Lack of Efficacy|1|||
144541047|NCT05628103|521180052|FG000|Overall Study|Non-Compliance With Study Drug|4|||
144541048|NCT03492177|521180054|FG000|Overall Study|Adverse Event|1|||
144541049|NCT03492177|521180055|FG001|Overall Study|Adverse Event|0|||
144541050|NCT03492177|521180056|FG002|Overall Study|Adverse Event|0|||
144541051|NCT03492177|521180054|FG000|Overall Study|Death|3|||
144541052|NCT03492177|521180055|FG001|Overall Study|Death|0|||
144541053|NCT03492177|521180056|FG002|Overall Study|Death|3|||
144541054|NCT03492177|521180054|FG000|Overall Study|Lack of Efficacy|1|||
144541055|NCT03492177|521180055|FG001|Overall Study|Lack of Efficacy|2|||
144541056|NCT03492177|521180056|FG002|Overall Study|Lack of Efficacy|0|||
144541057|NCT03492177|521180054|FG000|Overall Study|Other|1|||
144541058|NCT03492177|521180055|FG001|Overall Study|Other|0|||
144541059|NCT03492177|521180056|FG002|Overall Study|Other|0|||
144541060|NCT03492177|521180054|FG000|Overall Study|Ongoing|16|||
144541061|NCT03492177|521180055|FG001|Overall Study|Ongoing|19|||
144541062|NCT03492177|521180056|FG002|Overall Study|Ongoing|17|||
144541063|NCT02499328|521180057|FG000|Overall Study|Withdrawal by Subject|1|||
144541064|NCT02499328|521180058|FG001|Overall Study|Withdrawal by Subject|1|||
144541065|NCT02499328|521180059|FG002|Overall Study|Withdrawal by Subject|5|||
144541066|NCT02499328|521180060|FG003|Overall Study|Withdrawal by Subject|3|||
144541067|NCT02499328|521180061|FG004|Overall Study|Withdrawal by Subject|5|||
144541068|NCT02499328|521180062|FG005|Overall Study|Withdrawal by Subject|0|||
144541069|NCT02499328|521180063|FG006|Overall Study|Withdrawal by Subject|0|||
144541070|NCT02499328|521180064|FG007|Overall Study|Withdrawal by Subject|0|||
144541071|NCT02499328|521180065|FG008|Overall Study|Withdrawal by Subject|2|||
144541072|NCT02499328|521180066|FG009|Overall Study|Withdrawal by Subject|2|||
144541073|NCT02499328|521180067|FG010|Overall Study|Withdrawal by Subject|0|||
144541074|NCT02499328|521180068|FG011|Overall Study|Withdrawal by Subject|3|||
144541075|NCT02499328|521180069|FG012|Overall Study|Withdrawal by Subject|7|||
144541076|NCT02499328|521180070|FG013|Overall Study|Withdrawal by Subject|3|||
144541077|NCT02499328|521180071|FG014|Overall Study|Withdrawal by Subject|1|||
144541078|NCT02499328|521180072|FG015|Overall Study|Withdrawal by Subject|0|||
144541079|NCT02499328|521180073|FG016|Overall Study|Withdrawal by Subject|0|||
144541080|NCT02499328|521180074|FG017|Overall Study|Withdrawal by Subject|3|||
144541081|NCT02499328|521180075|FG018|Overall Study|Withdrawal by Subject|0|||
144541082|NCT02499328|521180057|FG000|Overall Study|Lost to Follow-up|0|||
144541083|NCT02499328|521180058|FG001|Overall Study|Lost to Follow-up|1|||
144541084|NCT02499328|521180059|FG002|Overall Study|Lost to Follow-up|1|||
144541085|NCT02499328|521180060|FG003|Overall Study|Lost to Follow-up|2|||
144541086|NCT02499328|521180061|FG004|Overall Study|Lost to Follow-up|0|||
144541087|NCT02499328|521180062|FG005|Overall Study|Lost to Follow-up|0|||
144541088|NCT02499328|521180063|FG006|Overall Study|Lost to Follow-up|0|||
144541089|NCT02499328|521180064|FG007|Overall Study|Lost to Follow-up|2|||
144472653|NCT00261495|520928560|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
144472654|NCT00261495|520928559|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
144472655|NCT00261495|520928560|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
144472656|NCT00261495|520928559|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
144472657|NCT00261495|520928560|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
144472658|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
144472659|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
144472660|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
144472661|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
144472662|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
144472663|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
144472664|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
144472665|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
144472666|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
144472667|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
144472668|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
144472669|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
144472670|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
144472671|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
144472672|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
144472673|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
144472674|NCT00261495|520928559|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
144472675|NCT00261495|520928560|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
144472676|NCT00261495|520928559|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
144472677|NCT00261495|520928560|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
144472678|NCT00261495|520928559|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
144472679|NCT00261495|520928560|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
144472680|NCT00261495|520928559|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
144472681|NCT00261495|520928560|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
144472682|NCT00261495|520928559|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144472683|NCT00261495|520928560|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
144472684|NCT00261495|520928559|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
144472685|NCT00261495|520928560|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
144472686|NCT00261495|520928559|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
144472687|NCT00261495|520928560|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144472688|NCT03474107|520928561|FG000|Overall Study|Adverse Event|42|||
144472689|NCT03474107|520928562|FG001|Overall Study|Adverse Event|46|||
144472690|NCT03474107|520928561|FG000|Overall Study|Death|2|||
144472691|NCT03474107|520928562|FG001|Overall Study|Death|2|||
144472692|NCT03474107|520928561|FG000|Overall Study|Lost to Follow-up|0|||
144472693|NCT03474107|520928562|FG001|Overall Study|Lost to Follow-up|1|||
144472694|NCT03474107|520928561|FG000|Overall Study|Progressive Disease|177|||
144472695|NCT03474107|520928562|FG001|Overall Study|Progressive Disease|180|||
144472696|NCT03474107|520928561|FG000|Overall Study|Protocol Violation|1|||
144472697|NCT03474107|520928562|FG001|Overall Study|Protocol Violation|1|||
144472698|NCT03474107|520928561|FG000|Overall Study|Withdrawal by Subject|15|||
144472699|NCT03474107|520928562|FG001|Overall Study|Withdrawal by Subject|27|||
144472700|NCT03474107|520928561|FG000|Overall Study|Physician Decision|7|||
144472701|NCT03474107|520928562|FG001|Overall Study|Physician Decision|22|||
144472702|NCT03474107|520928561|FG000|Overall Study|Miscellaneous|1|||
144472703|NCT03474107|520928562|FG001|Overall Study|Miscellaneous|6|||
144472704|NCT01932697|520928563|FG000|Overall Study|Received a different amount of tx|1|||
144472705|NCT01932697|520928564|FG001|Overall Study|Received a different amount of tx|0|||
144472706|NCT01932697|520928563|FG000|Overall Study|Ineligible|1|||
144472707|NCT01932697|520928564|FG001|Overall Study|Ineligible|0|||
144472708|NCT01330316|520928565|FG000|Overall Study|Adverse Event|2|||
144472709|NCT01330316|520928566|FG001|Overall Study|Adverse Event|2|||
144472710|NCT01330316|520928565|FG000|Overall Study|Lack of Efficacy|0|||
144472711|NCT01330316|520928566|FG001|Overall Study|Lack of Efficacy|10|||
144472712|NCT01330316|520928565|FG000|Overall Study|Lost to Follow-up|0|||
144472713|NCT01330316|520928566|FG001|Overall Study|Lost to Follow-up|1|||
144472714|NCT01330316|520928565|FG000|Overall Study|Withdrawal by Subject|0|||
144472715|NCT01330316|520928566|FG001|Overall Study|Withdrawal by Subject|1|||
144472716|NCT01330316|520928565|FG000|Overall Study|other than above|0|||
144472717|NCT01330316|520928566|FG001|Overall Study|other than above|1|||
144472718|NCT02696564|520928568|FG000|Overall Study|Death|1|||
144472719|NCT02696564|520928569|FG001|Overall Study|Death|2|||
144472720|NCT02696564|520928568|FG000|Overall Study|Withdrawal by Subject|3|||
144472721|NCT02696564|520928569|FG001|Overall Study|Withdrawal by Subject|2|||
144472722|NCT02696564|520928568|FG000|Overall Study|Lost to Follow-up|3|||
144472723|NCT02696564|520928569|FG001|Overall Study|Lost to Follow-up|3|||
144472724|NCT02696564|520928568|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
144615915|NCT00001379|521454569|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
144541090|NCT02499328|521180065|FG008|Overall Study|Lost to Follow-up|3|||
144541091|NCT02499328|521180066|FG009|Overall Study|Lost to Follow-up|0|||
144541092|NCT02499328|521180067|FG010|Overall Study|Lost to Follow-up|0|||
144541093|NCT02499328|521180068|FG011|Overall Study|Lost to Follow-up|0|||
144541094|NCT02499328|521180069|FG012|Overall Study|Lost to Follow-up|0|||
144541095|NCT02499328|521180070|FG013|Overall Study|Lost to Follow-up|0|||
144541096|NCT02499328|521180071|FG014|Overall Study|Lost to Follow-up|0|||
144541097|NCT02499328|521180072|FG015|Overall Study|Lost to Follow-up|0|||
144541098|NCT02499328|521180073|FG016|Overall Study|Lost to Follow-up|0|||
144541099|NCT02499328|521180074|FG017|Overall Study|Lost to Follow-up|0|||
144541100|NCT02499328|521180075|FG018|Overall Study|Lost to Follow-up|1|||
144541101|NCT02499328|521180057|FG000|Overall Study|Death|0|||
144541102|NCT02499328|521180058|FG001|Overall Study|Death|3|||
144541103|NCT02499328|521180059|FG002|Overall Study|Death|3|||
144541104|NCT02499328|521180060|FG003|Overall Study|Death|2|||
144541105|NCT02499328|521180061|FG004|Overall Study|Death|4|||
144541106|NCT02499328|521180062|FG005|Overall Study|Death|7|||
144541107|NCT02499328|521180063|FG006|Overall Study|Death|3|||
144541108|NCT02499328|521180064|FG007|Overall Study|Death|0|||
144541109|NCT02499328|521180065|FG008|Overall Study|Death|2|||
144541110|NCT02499328|521180066|FG009|Overall Study|Death|6|||
144541111|NCT02499328|521180067|FG010|Overall Study|Death|6|||
144541112|NCT02499328|521180068|FG011|Overall Study|Death|20|||
144541113|NCT02499328|521180069|FG012|Overall Study|Death|9|||
144541114|NCT02499328|521180070|FG013|Overall Study|Death|7|||
144541115|NCT02499328|521180071|FG014|Overall Study|Death|3|||
144541116|NCT02499328|521180072|FG015|Overall Study|Death|1|||
144541117|NCT02499328|521180073|FG016|Overall Study|Death|1|||
144541118|NCT02499328|521180074|FG017|Overall Study|Death|16|||
144541119|NCT02499328|521180075|FG018|Overall Study|Death|5|||
144541120|NCT02499328|521180057|FG000|Overall Study|"Other"|2|||
144541121|NCT02499328|521180058|FG001|Overall Study|"Other"|2|||
144541122|NCT02499328|521180059|FG002|Overall Study|"Other"|1|||
144541123|NCT02499328|521180060|FG003|Overall Study|"Other"|3|||
144541124|NCT02499328|521180061|FG004|Overall Study|"Other"|6|||
144541125|NCT02499328|521180062|FG005|Overall Study|"Other"|2|||
144541126|NCT02499328|521180063|FG006|Overall Study|"Other"|3|||
144541127|NCT02499328|521180064|FG007|Overall Study|"Other"|4|||
144541128|NCT02499328|521180065|FG008|Overall Study|"Other"|6|||
144541129|NCT02499328|521180066|FG009|Overall Study|"Other"|16|||
144541130|NCT02499328|521180067|FG010|Overall Study|"Other"|13|||
144541131|NCT02499328|521180068|FG011|Overall Study|"Other"|31|||
144541132|NCT02499328|521180069|FG012|Overall Study|"Other"|8|||
144541133|NCT02499328|521180070|FG013|Overall Study|"Other"|7|||
144541134|NCT02499328|521180071|FG014|Overall Study|"Other"|6|||
144541135|NCT02499328|521180072|FG015|Overall Study|"Other"|0|||
144541136|NCT02499328|521180073|FG016|Overall Study|"Other"|0|||
144541137|NCT02499328|521180074|FG017|Overall Study|"Other"|34|||
144541138|NCT02499328|521180075|FG018|Overall Study|"Other"|43|||
144541139|NCT02499328|521180057|FG000|Overall Study|Disease Progression|0|||
144541140|NCT02499328|521180058|FG001|Overall Study|Disease Progression|0|||
144541141|NCT02499328|521180059|FG002|Overall Study|Disease Progression|0|||
144615916|NCT00001379|521454566|FG000|Initial Treatment|Received alternative treatment|2|||
144615917|NCT00001379|521454567|FG001|Initial Treatment|Received alternative treatment|1|||
144615918|NCT00001379|521454568|FG002|Initial Treatment|Received alternative treatment|0|||
144615919|NCT00001379|521454569|FG003|Initial Treatment|Received alternative treatment|0|||
144615920|NCT00001379|521454566|FG000|Initial Treatment|Refused further treatment|2|||
144541142|NCT02499328|521180060|FG003|Overall Study|Disease Progression|0|||
144541143|NCT02499328|521180061|FG004|Overall Study|Disease Progression|0|||
144541144|NCT02499328|521180062|FG005|Overall Study|Disease Progression|0|||
144541145|NCT02499328|521180063|FG006|Overall Study|Disease Progression|1|||
144541146|NCT02499328|521180064|FG007|Overall Study|Disease Progression|0|||
144615921|NCT00001379|521454567|FG001|Initial Treatment|Refused further treatment|0|||
144541147|NCT02499328|521180065|FG008|Overall Study|Disease Progression|1|||
144541148|NCT02499328|521180066|FG009|Overall Study|Disease Progression|0|||
144615922|NCT00001379|521454568|FG002|Initial Treatment|Refused further treatment|0|||
144541149|NCT02499328|521180067|FG010|Overall Study|Disease Progression|1|||
144541150|NCT02499328|521180068|FG011|Overall Study|Disease Progression|0|||
144541151|NCT02499328|521180069|FG012|Overall Study|Disease Progression|0|||
144541152|NCT02499328|521180070|FG013|Overall Study|Disease Progression|0|||
144541153|NCT02499328|521180071|FG014|Overall Study|Disease Progression|0|||
144541154|NCT02499328|521180072|FG015|Overall Study|Disease Progression|0|||
144541155|NCT02499328|521180073|FG016|Overall Study|Disease Progression|0|||
144541156|NCT02499328|521180074|FG017|Overall Study|Disease Progression|2|||
144541157|NCT02499328|521180075|FG018|Overall Study|Disease Progression|0|||
144541158|NCT02499328|521180057|FG000|Overall Study|Adverse Event|1|||
144541159|NCT02499328|521180058|FG001|Overall Study|Adverse Event|0|||
144541160|NCT02499328|521180059|FG002|Overall Study|Adverse Event|0|||
144541161|NCT02499328|521180060|FG003|Overall Study|Adverse Event|1|||
144541162|NCT02499328|521180061|FG004|Overall Study|Adverse Event|0|||
144541163|NCT02499328|521180062|FG005|Overall Study|Adverse Event|0|||
144541164|NCT02499328|521180063|FG006|Overall Study|Adverse Event|0|||
144541165|NCT02499328|521180064|FG007|Overall Study|Adverse Event|0|||
144615923|NCT00001379|521454569|FG003|Initial Treatment|Refused further treatment|0|||
144615924|NCT00001379|521454566|FG000|Initial Treatment|Did not receive protocol treatment|0|||
144615925|NCT00001379|521454567|FG001|Initial Treatment|Did not receive protocol treatment|0|||
144615926|NCT00001379|521454568|FG002|Initial Treatment|Did not receive protocol treatment|5|||
144615927|NCT00001379|521454569|FG003|Initial Treatment|Did not receive protocol treatment|0|||
144615928|NCT00001379|521454566|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
144615929|NCT00001379|521454567|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
144615930|NCT00001379|521454568|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
144615931|NCT00001379|521454569|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
144615932|NCT00001379|521454566|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
144615933|NCT00001379|521454567|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
144615934|NCT00001379|521454568|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
144615935|NCT00001379|521454569|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
144615936|NCT00001379|521454566|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
144615937|NCT00001379|521454567|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
144615938|NCT00001379|521454568|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
144615939|NCT00001379|521454569|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
144615940|NCT00001379|521454566|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
144615941|NCT00001379|521454567|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
144615942|NCT00001379|521454568|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
144541166|NCT02499328|521180065|FG008|Overall Study|Adverse Event|0|||
144541167|NCT02499328|521180066|FG009|Overall Study|Adverse Event|0|||
144201874|NCT02132754|519934478|FG030|Overall Study|Withdrawal by Subject|0|||
144541168|NCT02499328|521180067|FG010|Overall Study|Adverse Event|0|||
144541169|NCT02499328|521180068|FG011|Overall Study|Adverse Event|0|||
144541170|NCT02499328|521180069|FG012|Overall Study|Adverse Event|1|||
144541171|NCT02499328|521180070|FG013|Overall Study|Adverse Event|0|||
144541172|NCT02499328|521180071|FG014|Overall Study|Adverse Event|0|||
144541173|NCT02499328|521180072|FG015|Overall Study|Adverse Event|0|||
144541174|NCT02499328|521180073|FG016|Overall Study|Adverse Event|0|||
144541175|NCT02499328|521180074|FG017|Overall Study|Adverse Event|0|||
144541176|NCT02499328|521180075|FG018|Overall Study|Adverse Event|0|||
144541177|NCT05663866|521180080|FG000|Overall Study|Adverse Event|0|||
144541178|NCT05663866|521180081|FG001|Overall Study|Adverse Event|0|||
144541179|NCT05663866|521180082|FG002|Overall Study|Adverse Event|1|||
144541180|NCT05663866|521180083|FG003|Overall Study|Adverse Event|0|||
144541181|NCT05663866|521180080|FG000|Overall Study|Physician Decision|0|||
144541182|NCT05663866|521180081|FG001|Overall Study|Physician Decision|0|||
144541183|NCT05663866|521180082|FG002|Overall Study|Physician Decision|0|||
144541184|NCT05663866|521180083|FG003|Overall Study|Physician Decision|1|||
144541185|NCT05663866|521180080|FG000|Overall Study|Withdrawal by Subject|0|||
144541186|NCT05663866|521180081|FG001|Overall Study|Withdrawal by Subject|2|||
144541187|NCT05663866|521180082|FG002|Overall Study|Withdrawal by Subject|1|||
144541188|NCT05663866|521180083|FG003|Overall Study|Withdrawal by Subject|2|||
144541189|NCT05663866|521180080|FG000|Overall Study|Progressive disease|4|||
144541190|NCT05663866|521180081|FG001|Overall Study|Progressive disease|8|||
144541191|NCT05663866|521180082|FG002|Overall Study|Progressive disease|5|||
144541192|NCT05663866|521180083|FG003|Overall Study|Progressive disease|2|||
144541193|NCT05663866|521180080|FG000|Overall Study|Other|1|||
144541194|NCT05663866|521180081|FG001|Overall Study|Other|0|||
144541195|NCT05663866|521180082|FG002|Overall Study|Other|0|||
144541196|NCT05663866|521180083|FG003|Overall Study|Other|0|||
144615943|NCT00001379|521454569|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
144615944|NCT00001379|521454566|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
144615945|NCT00001379|521454567|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
144615946|NCT00001379|521454568|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
144615947|NCT00001379|521454569|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
144201875|NCT02132754|519934479|FG031|Overall Study|Withdrawal by Subject|1|||
144541197|NCT05663866|521180080|FG000|Overall Study|Ongoing|1|||
144541198|NCT05663866|521180081|FG001|Overall Study|Ongoing|27|||
144541199|NCT05663866|521180082|FG002|Overall Study|Ongoing|6|||
144541200|NCT05663866|521180083|FG003|Overall Study|Ongoing|1|||
144541201|NCT03598907|521180088|FG000|Overall Study|Physician Decision|14|||
144541202|NCT03598907|521180089|FG001|Overall Study|Physician Decision|19|||
144541203|NCT05741528|521180090|FG000|Overall Study|Withdrawal by Subject|11|||
144541204|NCT05741528|521180090|FG000|Overall Study|Lost to Follow-up|3|||
144541205|NCT05741528|521180090|FG000|Overall Study|Adverse Event|2|||
144541206|NCT05741528|521180090|FG000|Overall Study|Non-Compliance With Study Drug|2|||
144541207|NCT05741528|521180090|FG000|Overall Study|Reason Not Specified|1|||
144541208|NCT03907488|521180091|FG000|Overall Study|Adverse Event|20|||
144541209|NCT03907488|521180092|FG001|Overall Study|Adverse Event|20|||
144541210|NCT03907488|521180091|FG000|Overall Study|Withdrawal by Subject|9|||
144201876|NCT02132754|519934480|FG032|Overall Study|Withdrawal by Subject|0|||
144201877|NCT02132754|519934481|FG033|Overall Study|Withdrawal by Subject|2|||
144201878|NCT03548064|519936909|FG000|Overall Study|Withdrawal by Subject|0|||
144201879|NCT03548064|519936910|FG001|Overall Study|Withdrawal by Subject|0|||
144201880|NCT03548064|519936911|FG002|Overall Study|Withdrawal by Subject|0|||
144541211|NCT03907488|521180092|FG001|Overall Study|Withdrawal by Subject|13|||
144541212|NCT03907488|521180091|FG000|Overall Study|Lack of Efficacy|0|||
144541213|NCT03907488|521180092|FG001|Overall Study|Lack of Efficacy|9|||
144541214|NCT03907488|521180091|FG000|Overall Study|Death|3|||
144541215|NCT03907488|521180092|FG001|Overall Study|Death|8|||
144541216|NCT03907488|521180091|FG000|Overall Study|not protocol specified|5|||
144541217|NCT03907488|521180092|FG001|Overall Study|not protocol specified|8|||
144541218|NCT03907488|521180091|FG000|Overall Study|Ineligible|9|||
144541219|NCT03907488|521180092|FG001|Overall Study|Ineligible|15|||
144541220|NCT03414684|521180093|FG000|First-course Treatment|Complete response|0|||
144541221|NCT03414684|521180094|FG001|First-course Treatment|Complete response|1|||
144541222|NCT03414684|521180093|FG000|First-course Treatment|Intercurrent illness|1|||
144541223|NCT03414684|521180094|FG001|First-course Treatment|Intercurrent illness|0|||
144541224|NCT03414684|521180093|FG000|First-course Treatment|Progressive Disease|31|||
144541225|NCT03414684|521180094|FG001|First-course Treatment|Progressive Disease|32|||
144541226|NCT03414684|521180093|FG000|First-course Treatment|Adverse Event|1|||
144541227|NCT03414684|521180094|FG001|First-course Treatment|Adverse Event|2|||
144541228|NCT03414684|521180093|FG000|First-course Treatment|Physician Decision|0|||
144541229|NCT03414684|521180094|FG001|First-course Treatment|Physician Decision|1|||
144541230|NCT03414684|521180093|FG000|First-course Treatment|Withdrawal by Subject|0|||
144541231|NCT03414684|521180094|FG001|First-course Treatment|Withdrawal by Subject|1|||
144541232|NCT03414684|521180093|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
144541233|NCT03414684|521180094|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
144541234|NCT03414684|521180093|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
144541235|NCT03414684|521180094|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
144541236|NCT03414684|521180093|FG000|First-course Treatment|Still on treatment|3|||
144541237|NCT03414684|521180094|FG001|First-course Treatment|Still on treatment|0|||
144541238|NCT03414684|521180093|FG000|First-course Treatment|Never started protocol therapy|2|||
144541239|NCT03414684|521180094|FG001|First-course Treatment|Never started protocol therapy|1|||
144541240|NCT03414684|521180093|FG000|Crossover Treatment|Progressive disease|0|||
144541241|NCT03414684|521180094|FG001|Crossover Treatment|Progressive disease|12|||
144541242|NCT03414684|521180093|FG000|Crossover Treatment|Adverse Event|0|||
144541243|NCT03414684|521180094|FG001|Crossover Treatment|Adverse Event|3|||
144541244|NCT03414684|521180093|FG000|Crossover Treatment|Physician Decision|0|||
144541245|NCT03414684|521180094|FG001|Crossover Treatment|Physician Decision|1|||
144541246|NCT03414684|521180093|FG000|Crossover Treatment|Still on treatment|0|||
144541247|NCT03414684|521180094|FG001|Crossover Treatment|Still on treatment|2|||
144541248|NCT03656718|521180097|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
144541249|NCT03656718|521180098|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
144541250|NCT03656718|521180099|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
144541251|NCT03656718|521180100|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
144541252|NCT03656718|521180101|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
144541253|NCT03656718|521180102|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
144541254|NCT03656718|521180103|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
144541255|NCT03656718|521180097|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
144541256|NCT03656718|521180098|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
144541257|NCT03656718|521180099|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
144541258|NCT03656718|521180100|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
144541259|NCT03656718|521180101|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
144541260|NCT03656718|521180102|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
144541261|NCT03656718|521180103|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
144541262|NCT03656718|521180097|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
144541263|NCT03656718|521180098|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
144541264|NCT03656718|521180099|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
144541265|NCT03656718|521180100|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
144541266|NCT03656718|521180101|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
144541267|NCT03656718|521180102|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
144541268|NCT03656718|521180103|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
144541269|NCT03656718|521180097|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
144541270|NCT03656718|521180098|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
144541271|NCT03656718|521180099|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
144541272|NCT03656718|521180100|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
144615948|NCT03703102|521454575|FG000|Overall Study|Adverse Event|4|||
144615949|NCT03703102|521454576|FG001|Overall Study|Adverse Event|3|||
144201881|NCT03548064|519936912|FG003|Overall Study|Withdrawal by Subject|1|||
144541273|NCT03656718|521180101|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
144541274|NCT03656718|521180102|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
144541275|NCT03656718|521180103|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
144541276|NCT03656718|521180097|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
144541277|NCT03656718|521180098|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
144541278|NCT03656718|521180099|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
144541279|NCT03656718|521180100|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
144541280|NCT03656718|521180101|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
144541281|NCT03656718|521180102|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
144541282|NCT03656718|521180103|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
144541283|NCT03656718|521180097|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
144541284|NCT03656718|521180098|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
144541285|NCT03656718|521180099|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
144541286|NCT03656718|521180100|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
144541287|NCT03656718|521180101|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
144541288|NCT03656718|521180102|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
144541289|NCT03656718|521180103|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
144541290|NCT03656718|521180097|FG000|Treatment Period Part C|Disease progression|0|||
144541291|NCT03656718|521180098|FG001|Treatment Period Part C|Disease progression|0|||
144541292|NCT03656718|521180099|FG002|Treatment Period Part C|Disease progression|0|||
144541293|NCT03656718|521180100|FG003|Treatment Period Part C|Disease progression|0|||
144541294|NCT03656718|521180101|FG004|Treatment Period Part C|Disease progression|12|||
144541295|NCT03656718|521180102|FG005|Treatment Period Part C|Disease progression|0|||
144541296|NCT03656718|521180103|FG006|Treatment Period Part C|Disease progression|0|||
144541297|NCT03656718|521180097|FG000|Treatment Period Part C|Death|0|||
144541298|NCT03656718|521180098|FG001|Treatment Period Part C|Death|0|||
144541299|NCT03656718|521180099|FG002|Treatment Period Part C|Death|0|||
144541300|NCT03656718|521180100|FG003|Treatment Period Part C|Death|0|||
144541301|NCT03656718|521180101|FG004|Treatment Period Part C|Death|1|||
144541302|NCT03656718|521180102|FG005|Treatment Period Part C|Death|0|||
144541303|NCT03656718|521180103|FG006|Treatment Period Part C|Death|0|||
144541304|NCT03656718|521180097|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
144541305|NCT03656718|521180098|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
144541306|NCT03656718|521180099|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
144541307|NCT03656718|521180100|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
144541308|NCT03656718|521180101|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
144541309|NCT03656718|521180102|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
144541310|NCT03656718|521180103|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
144541311|NCT03656718|521180097|FG000|Treatment Period Part C|Other reasons|0|||
144541312|NCT03656718|521180098|FG001|Treatment Period Part C|Other reasons|0|||
144541313|NCT03656718|521180099|FG002|Treatment Period Part C|Other reasons|0|||
144541314|NCT03656718|521180100|FG003|Treatment Period Part C|Other reasons|0|||
144541315|NCT03656718|521180101|FG004|Treatment Period Part C|Other reasons|1|||
144541316|NCT03656718|521180102|FG005|Treatment Period Part C|Other reasons|0|||
144541317|NCT03656718|521180103|FG006|Treatment Period Part C|Other reasons|0|||
144541318|NCT03656718|521180097|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
144541319|NCT03656718|521180098|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
144541320|NCT03656718|521180099|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
144541321|NCT03656718|521180100|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
144541322|NCT03656718|521180101|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
144541323|NCT03656718|521180102|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
144541324|NCT03656718|521180103|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
144541325|NCT02751528|521180107|FG000|Overall Study|Withdrawal by Subject|1|||
144541326|NCT02751528|521180107|FG000|Overall Study|Adverse Event|1|||
144541327|NCT01958021|521180109|FG000|Treatment|Progressive disease|206|||
144541328|NCT01958021|521180110|FG001|Treatment|Progressive disease|265|||
144541329|NCT01958021|521180109|FG000|Treatment|Adverse Event|38|||
144541330|NCT01958021|521180110|FG001|Treatment|Adverse Event|10|||
144541331|NCT01958021|521180109|FG000|Treatment|Subject/guardian decision|29|||
144541332|NCT01958021|521180110|FG001|Treatment|Subject/guardian decision|25|||
144541333|NCT01958021|521180109|FG000|Treatment|Physician Decision|28|||
144541334|NCT01958021|521180110|FG001|Treatment|Physician Decision|21|||
144541335|NCT01958021|521180109|FG000|Treatment|Death|6|||
144541336|NCT01958021|521180110|FG001|Treatment|Death|1|||
144541337|NCT01958021|521180109|FG000|Treatment|Protocol deviation|3|||
144541338|NCT01958021|521180110|FG001|Treatment|Protocol deviation|1|||
144615950|NCT03703102|521454577|FG002|Overall Study|Adverse Event|7|||
144615951|NCT03703102|521454578|FG003|Overall Study|Adverse Event|3|||
144615952|NCT03703102|521454579|FG004|Overall Study|Adverse Event|13|||
144615953|NCT03703102|521454575|FG000|Overall Study|Lack of Efficacy|4|||
144615954|NCT03703102|521454576|FG001|Overall Study|Lack of Efficacy|0|||
144615955|NCT03703102|521454577|FG002|Overall Study|Lack of Efficacy|1|||
144615956|NCT03703102|521454578|FG003|Overall Study|Lack of Efficacy|4|||
144615957|NCT03703102|521454579|FG004|Overall Study|Lack of Efficacy|1|||
144615958|NCT03703102|521454575|FG000|Overall Study|Lost to Follow-up|0|||
144615959|NCT03703102|521454576|FG001|Overall Study|Lost to Follow-up|0|||
144615960|NCT03703102|521454577|FG002|Overall Study|Lost to Follow-up|1|||
144615961|NCT03703102|521454578|FG003|Overall Study|Lost to Follow-up|2|||
144615962|NCT03703102|521454579|FG004|Overall Study|Lost to Follow-up|2|||
144615963|NCT03703102|521454575|FG000|Overall Study|Physician Decision|2|||
144615964|NCT03703102|521454576|FG001|Overall Study|Physician Decision|2|||
144615965|NCT03703102|521454577|FG002|Overall Study|Physician Decision|2|||
144615966|NCT03703102|521454578|FG003|Overall Study|Physician Decision|2|||
144615967|NCT03703102|521454579|FG004|Overall Study|Physician Decision|4|||
144615968|NCT03703102|521454575|FG000|Overall Study|Withdrawal by Subject|7|||
144615969|NCT03703102|521454576|FG001|Overall Study|Withdrawal by Subject|5|||
144615970|NCT03703102|521454577|FG002|Overall Study|Withdrawal by Subject|5|||
144615971|NCT03703102|521454578|FG003|Overall Study|Withdrawal by Subject|5|||
144615972|NCT03703102|521454579|FG004|Overall Study|Withdrawal by Subject|9|||
144615973|NCT03703102|521454575|FG000|Overall Study|Ineligibility|0|||
144615974|NCT03703102|521454576|FG001|Overall Study|Ineligibility|0|||
144615975|NCT03703102|521454577|FG002|Overall Study|Ineligibility|1|||
144615976|NCT03703102|521454578|FG003|Overall Study|Ineligibility|0|||
144615977|NCT03703102|521454579|FG004|Overall Study|Ineligibility|0|||
144615978|NCT03703102|521454575|FG000|Overall Study|Protocol Deviation|4|||
144615979|NCT03703102|521454576|FG001|Overall Study|Protocol Deviation|4|||
144615980|NCT03703102|521454577|FG002|Overall Study|Protocol Deviation|3|||
144615981|NCT03703102|521454578|FG003|Overall Study|Protocol Deviation|0|||
144541339|NCT01958021|521180109|FG000|Treatment|Sponsor decision|24|||
144541340|NCT01958021|521180110|FG001|Treatment|Sponsor decision|11|||
144541341|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
144541342|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144541343|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Death|1|||
144541344|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Death|0|||
144541345|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
144541346|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144541347|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144541348|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
144541349|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
144541350|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
144541351|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
144541352|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
144541353|NCT01958021|521180109|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
144541354|NCT01958021|521180110|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
144541355|NCT03762850|521181398|FG000|Overall Study|Death|0|||
144541356|NCT03762850|521181399|FG001|Overall Study|Death|1|||
144541357|NCT03762850|521181398|FG000|Overall Study|Lost to Follow-up|0|||
144541358|NCT03762850|521181399|FG001|Overall Study|Lost to Follow-up|1|||
144541359|NCT03762850|521181398|FG000|Overall Study|Physician Decision|0|||
144541360|NCT03762850|521181399|FG001|Overall Study|Physician Decision|1|||
144541361|NCT03762850|521181398|FG000|Overall Study|Withdrawal by Subject|4|||
144541362|NCT03762850|521181399|FG001|Overall Study|Withdrawal by Subject|9|||
144541363|NCT02036970|521181402|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
144615982|NCT03703102|521454579|FG004|Overall Study|Protocol Deviation|0|||
144615983|NCT03703102|521454575|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144615984|NCT03703102|521454576|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144615985|NCT03703102|521454577|FG002|Overall Study|Non-Compliance with Study Drug|2|||
144615986|NCT03703102|521454578|FG003|Overall Study|Non-Compliance with Study Drug|1|||
144615987|NCT03703102|521454579|FG004|Overall Study|Non-Compliance with Study Drug|4|||
144541364|NCT02036970|521181403|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
144541365|NCT02036970|521181404|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
144541366|NCT02036970|521181405|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
144615988|NCT00876187|521454580|FG000|Overall Study|Adverse Event|14|||
144615989|NCT00876187|521454581|FG001|Overall Study|Adverse Event|12|||
144615990|NCT00876187|521454582|FG002|Overall Study|Adverse Event|19|||
144615991|NCT00876187|521454583|FG003|Overall Study|Adverse Event|29|||
144615992|NCT00876187|521454584|FG004|Overall Study|Adverse Event|10|||
144615993|NCT00876187|521454580|FG000|Overall Study|Lack of Efficacy|59|||
144615994|NCT00876187|521454581|FG001|Overall Study|Lack of Efficacy|34|||
144615995|NCT00876187|521454582|FG002|Overall Study|Lack of Efficacy|45|||
144615996|NCT00876187|521454583|FG003|Overall Study|Lack of Efficacy|34|||
144615997|NCT00876187|521454584|FG004|Overall Study|Lack of Efficacy|59|||
144615998|NCT00876187|521454580|FG000|Overall Study|Lost to Follow-up|9|||
144727449|NCT02101853|521856656|FG005|Block 1 Induction|Adverse Event|0|||
144615999|NCT00876187|521454581|FG001|Overall Study|Lost to Follow-up|10|||
144616000|NCT00876187|521454582|FG002|Overall Study|Lost to Follow-up|8|||
144616001|NCT00876187|521454583|FG003|Overall Study|Lost to Follow-up|8|||
144616002|NCT00876187|521454584|FG004|Overall Study|Lost to Follow-up|11|||
144616003|NCT00876187|521454580|FG000|Overall Study|Protocol Violation|6|||
144616004|NCT00876187|521454581|FG001|Overall Study|Protocol Violation|7|||
144616005|NCT00876187|521454582|FG002|Overall Study|Protocol Violation|7|||
144616006|NCT00876187|521454583|FG003|Overall Study|Protocol Violation|6|||
144616007|NCT00876187|521454584|FG004|Overall Study|Protocol Violation|3|||
144616008|NCT00876187|521454580|FG000|Overall Study|Withdrawal by Subject|16|||
144616009|NCT00876187|521454581|FG001|Overall Study|Withdrawal by Subject|26|||
144616010|NCT00876187|521454582|FG002|Overall Study|Withdrawal by Subject|32|||
144616011|NCT00876187|521454583|FG003|Overall Study|Withdrawal by Subject|38|||
144616012|NCT00876187|521454584|FG004|Overall Study|Withdrawal by Subject|37|||
144616013|NCT00876187|521454580|FG000|Overall Study|Entered extension study|101|||
144616014|NCT00876187|521454581|FG001|Overall Study|Entered extension study|120|||
144616015|NCT00876187|521454582|FG002|Overall Study|Entered extension study|156|||
144616016|NCT00876187|521454583|FG003|Overall Study|Entered extension study|151|||
144616017|NCT00876187|521454584|FG004|Overall Study|Entered extension study|144|||
144616018|NCT00876187|521454580|FG000|Overall Study|Randomized but not treated|3|||
144616019|NCT00876187|521454581|FG001|Overall Study|Randomized but not treated|1|||
144616020|NCT00876187|521454582|FG002|Overall Study|Randomized but not treated|3|||
144616021|NCT00876187|521454583|FG003|Overall Study|Randomized but not treated|2|||
144541367|NCT02036970|521181406|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
144616022|NCT00876187|521454584|FG004|Overall Study|Randomized but not treated|3|||
144616023|NCT00876187|521454580|FG000|Overall Study|Other|2|||
144616024|NCT00876187|521454581|FG001|Overall Study|Other|5|||
144616025|NCT00876187|521454582|FG002|Overall Study|Other|9|||
144616026|NCT00876187|521454583|FG003|Overall Study|Other|7|||
144616027|NCT00876187|521454584|FG004|Overall Study|Other|4|||
144616028|NCT01032915|521454589|FG000|Overall Study|Adverse Event|2|||
144616029|NCT01032915|521454590|FG001|Overall Study|Adverse Event|2|||
144616030|NCT01032915|521454591|FG002|Overall Study|Adverse Event|1|||
144616031|NCT01032915|521454592|FG003|Overall Study|Adverse Event|1|||
144616032|NCT01032915|521454589|FG000|Overall Study|Abnormal test procedure result|0|||
144616033|NCT01032915|521454590|FG001|Overall Study|Abnormal test procedure result|0|||
144616034|NCT01032915|521454591|FG002|Overall Study|Abnormal test procedure result|1|||
144616035|NCT01032915|521454592|FG003|Overall Study|Abnormal test procedure result|0|||
144616036|NCT01032915|521454589|FG000|Overall Study|Withdrawal by Subject|0|||
144541368|NCT02036970|521181407|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
144541369|NCT02036970|521181408|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
144541370|NCT02036970|521181409|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
144541371|NCT02036970|521181410|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
144541372|NCT02036970|521181411|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
144541373|NCT02036970|521181402|FG000|Part 1: Day 1 Through Week 16|Death|0|||
144541374|NCT02036970|521181403|FG001|Part 1: Day 1 Through Week 16|Death|0|||
144541375|NCT02036970|521181404|FG002|Part 1: Day 1 Through Week 16|Death|0|||
144541376|NCT02036970|521181405|FG003|Part 1: Day 1 Through Week 16|Death|0|||
144541377|NCT02036970|521181406|FG004|Part 1: Day 1 Through Week 16|Death|0|||
144541378|NCT02036970|521181407|FG005|Part 1: Day 1 Through Week 16|Death|0|||
144541379|NCT02036970|521181408|FG006|Part 1: Day 1 Through Week 16|Death|0|||
144541380|NCT02036970|521181409|FG007|Part 1: Day 1 Through Week 16|Death|0|||
144541381|NCT02036970|521181410|FG008|Part 1: Day 1 Through Week 16|Death|1|||
144541382|NCT02036970|521181411|FG009|Part 1: Day 1 Through Week 16|Death|0|||
144541383|NCT02036970|521181402|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
144541384|NCT02036970|521181403|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144541385|NCT02036970|521181404|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
144541386|NCT02036970|521181405|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144616037|NCT01032915|521454590|FG001|Overall Study|Withdrawal by Subject|3|||
144616038|NCT01032915|521454591|FG002|Overall Study|Withdrawal by Subject|1|||
144201882|NCT03548064|519936913|FG004|Overall Study|Withdrawal by Subject|0|||
144201883|NCT03548064|519936914|FG005|Overall Study|Withdrawal by Subject|0|||
144201884|NCT03548064|519936915|FG006|Overall Study|Withdrawal by Subject|0|||
144541387|NCT02036970|521181406|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144541388|NCT02036970|521181407|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144616039|NCT01032915|521454592|FG003|Overall Study|Withdrawal by Subject|1|||
144616040|NCT01032915|521454589|FG000|Overall Study|Administrative reasons|5|||
144616041|NCT01032915|521454590|FG001|Overall Study|Administrative reasons|6|||
144616042|NCT01032915|521454591|FG002|Overall Study|Administrative reasons|4|||
144616043|NCT01032915|521454592|FG003|Overall Study|Administrative reasons|4|||
144616044|NCT01032915|521454589|FG000|Overall Study|Protocol Violation|1|||
144616045|NCT01032915|521454590|FG001|Overall Study|Protocol Violation|0|||
144616046|NCT01032915|521454591|FG002|Overall Study|Protocol Violation|0|||
144201885|NCT03548064|519936916|FG007|Overall Study|Withdrawal by Subject|0|||
144616047|NCT01032915|521454592|FG003|Overall Study|Protocol Violation|1|||
144616048|NCT00763815|521454596|FG000|Overall Study|Adverse Event|14|||
144541389|NCT02036970|521181408|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144541390|NCT02036970|521181409|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144541391|NCT02036970|521181410|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
144541392|NCT02036970|521181411|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
144541393|NCT02036970|521181402|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144541394|NCT02036970|521181403|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144541395|NCT02036970|521181404|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144261338|NCT01719380|520158110|FG002|Overall Study|Participant/Guardian Decision|1|||
144261339|NCT01719380|520158111|FG003|Overall Study|Participant/Guardian Decision|0|||
144541396|NCT02036970|521181405|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144541397|NCT02036970|521181406|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
144541398|NCT02036970|521181407|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144541399|NCT02036970|521181408|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144541400|NCT02036970|521181409|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
144541401|NCT02036970|521181410|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
144541402|NCT02036970|521181411|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
144541403|NCT02036970|521181402|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541404|NCT02036970|521181403|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541405|NCT02036970|521181404|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541406|NCT02036970|521181405|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
144541407|NCT02036970|521181406|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541408|NCT02036970|521181407|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541409|NCT02036970|521181408|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541410|NCT02036970|521181409|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541411|NCT02036970|521181410|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541412|NCT02036970|521181411|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
144541413|NCT02036970|521181402|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
144541414|NCT02036970|521181403|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
144541415|NCT02036970|521181404|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
144541416|NCT02036970|521181405|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
144541417|NCT02036970|521181406|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
144541418|NCT02036970|521181407|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
144541419|NCT02036970|521181408|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
144541420|NCT02036970|521181409|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
144541421|NCT02036970|521181410|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
144541422|NCT02036970|521181411|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
144541423|NCT02036970|521181402|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541424|NCT02036970|521181403|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541425|NCT02036970|521181404|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541426|NCT02036970|521181405|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541427|NCT02036970|521181406|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541428|NCT02036970|521181407|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541429|NCT02036970|521181408|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541430|NCT02036970|521181409|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
144541431|NCT02036970|521181410|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541432|NCT02036970|521181411|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
144541433|NCT02036970|521181402|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541434|NCT02036970|521181403|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
144541435|NCT02036970|521181404|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
144541436|NCT02036970|521181405|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541437|NCT02036970|521181406|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541438|NCT02036970|521181407|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541439|NCT02036970|521181408|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541440|NCT02036970|521181409|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541441|NCT02036970|521181410|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
144541442|NCT02036970|521181411|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
144541443|NCT02036970|521181402|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
144541444|NCT02036970|521181403|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
144541445|NCT02036970|521181404|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
144541446|NCT02036970|521181405|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
144541447|NCT02036970|521181406|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
144541448|NCT02036970|521181407|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
144541449|NCT02036970|521181408|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
144541450|NCT02036970|521181409|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
144541451|NCT02036970|521181410|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
144541452|NCT02036970|521181411|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
144616049|NCT00763815|521454597|FG001|Overall Study|Adverse Event|29|||
144616050|NCT00763815|521454596|FG000|Overall Study|Lack of Efficacy|10|||
144616051|NCT00763815|521454597|FG001|Overall Study|Lack of Efficacy|11|||
144616052|NCT00763815|521454596|FG000|Overall Study|Poor Compliance to Protocol|6|||
144727450|NCT02101853|521856651|FG000|Block 1 Induction|Death|20|||
144261340|NCT01719380|520158112|FG004|Overall Study|Participant/Guardian Decision|0|||
144261341|NCT01719380|520158113|FG005|Overall Study|Participant/Guardian Decision|0|||
144261342|NCT01719380|520158114|FG006|Overall Study|Participant/Guardian Decision|0|||
144261343|NCT01719380|520158115|FG007|Overall Study|Participant/Guardian Decision|0|||
144261344|NCT01719380|520158116|FG008|Overall Study|Participant/Guardian Decision|2|||
144261345|NCT01719380|520158117|FG009|Overall Study|Participant/Guardian Decision|2|||
144261346|NCT01719380|520158108|FG000|Overall Study|Physician Decision|0|||
144541453|NCT02232737|521181416|FG000|Overall Study|Lost to Follow-up|18|||
144541454|NCT02232737|521181417|FG001|Overall Study|Lost to Follow-up|28|||
144541455|NCT02232737|521181418|FG002|Overall Study|Lost to Follow-up|33|||
144541456|NCT02232737|521181416|FG000|Overall Study|Personal reasons|7|||
144541457|NCT02232737|521181417|FG001|Overall Study|Personal reasons|8|||
144541458|NCT02232737|521181418|FG002|Overall Study|Personal reasons|14|||
144541459|NCT02232737|521181416|FG000|Overall Study|Adverse Event|6|||
144541460|NCT02232737|521181417|FG001|Overall Study|Adverse Event|3|||
144541461|NCT02232737|521181418|FG002|Overall Study|Adverse Event|8|||
144541462|NCT02232737|521181416|FG000|Overall Study|Incarcerated|2|||
144541463|NCT02232737|521181417|FG001|Overall Study|Incarcerated|1|||
144541464|NCT02232737|521181418|FG002|Overall Study|Incarcerated|2|||
144541465|NCT02232737|521181416|FG000|Overall Study|Withdrawal by Subject|0|||
144541466|NCT02232737|521181417|FG001|Overall Study|Withdrawal by Subject|1|||
144541467|NCT02232737|521181418|FG002|Overall Study|Withdrawal by Subject|2|||
144541468|NCT02232737|521181416|FG000|Overall Study|Death|0|||
144541469|NCT02232737|521181417|FG001|Overall Study|Death|1|||
144541470|NCT02232737|521181418|FG002|Overall Study|Death|1|||
144541471|NCT02232737|521181416|FG000|Overall Study|Physician Decision|1|||
144541472|NCT02232737|521181417|FG001|Overall Study|Physician Decision|3|||
144541473|NCT02232737|521181418|FG002|Overall Study|Physician Decision|1|||
144541474|NCT02232737|521181416|FG000|Overall Study|Protocol Violation|1|||
144541475|NCT02232737|521181417|FG001|Overall Study|Protocol Violation|0|||
144541476|NCT02232737|521181418|FG002|Overall Study|Protocol Violation|1|||
144541477|NCT02232737|521181416|FG000|Overall Study|Reason unknown|1|||
144541478|NCT02232737|521181417|FG001|Overall Study|Reason unknown|0|||
144541479|NCT02232737|521181418|FG002|Overall Study|Reason unknown|0|||
144541480|NCT04083976|521181419|FG000|Overall Study|Lost to Follow-up|3|||
144541481|NCT04083976|521181420|FG001|Overall Study|Lost to Follow-up|0|||
144541482|NCT04083976|521181421|FG002|Overall Study|Lost to Follow-up|0|||
144541483|NCT04083976|521181422|FG003|Overall Study|Lost to Follow-up|1|||
144541484|NCT04083976|521181419|FG000|Overall Study|Withdrawal by Subject|16|||
144541485|NCT04083976|521181420|FG001|Overall Study|Withdrawal by Subject|1|||
144541486|NCT04083976|521181421|FG002|Overall Study|Withdrawal by Subject|9|||
144541487|NCT04083976|521181422|FG003|Overall Study|Withdrawal by Subject|0|||
144541488|NCT04083976|521181419|FG000|Overall Study|Sponsor Decision|14|||
144541489|NCT04083976|521181420|FG001|Overall Study|Sponsor Decision|0|||
144541490|NCT04083976|521181421|FG002|Overall Study|Sponsor Decision|0|||
144541491|NCT04083976|521181422|FG003|Overall Study|Sponsor Decision|7|||
144541492|NCT04083976|521181419|FG000|Overall Study|Other|1|||
144541493|NCT04083976|521181420|FG001|Overall Study|Other|0|||
144541494|NCT04083976|521181421|FG002|Overall Study|Other|1|||
144541495|NCT04083976|521181422|FG003|Overall Study|Other|0|||
144541496|NCT03683576|521181431|FG000|Overall Study|Withdrawal by Subject|2|||
144541497|NCT03683576|521181432|FG001|Overall Study|Withdrawal by Subject|0|||
144541498|NCT03683576|521181433|FG002|Overall Study|Withdrawal by Subject|8|||
144541499|NCT03683576|521181434|FG003|Overall Study|Withdrawal by Subject|3|||
144541500|NCT03683576|521181431|FG000|Overall Study|Adverse Event|3|||
144541501|NCT03683576|521181432|FG001|Overall Study|Adverse Event|0|||
144541502|NCT03683576|521181433|FG002|Overall Study|Adverse Event|0|||
144541503|NCT03683576|521181434|FG003|Overall Study|Adverse Event|4|||
144541504|NCT03683576|521181431|FG000|Overall Study|Lack of Efficacy|1|||
144541505|NCT03683576|521181432|FG001|Overall Study|Lack of Efficacy|0|||
144541506|NCT03683576|521181433|FG002|Overall Study|Lack of Efficacy|1|||
144541507|NCT03683576|521181434|FG003|Overall Study|Lack of Efficacy|1|||
144541508|NCT03683576|521181431|FG000|Overall Study|Lost to Follow-up|0|||
144541509|NCT03683576|521181432|FG001|Overall Study|Lost to Follow-up|1|||
144541510|NCT03683576|521181433|FG002|Overall Study|Lost to Follow-up|2|||
144541511|NCT03683576|521181434|FG003|Overall Study|Lost to Follow-up|0|||
144541512|NCT03683576|521181431|FG000|Overall Study|Other, Not Specified|0|||
144541513|NCT03683576|521181432|FG001|Overall Study|Other, Not Specified|2|||
144541514|NCT03683576|521181433|FG002|Overall Study|Other, Not Specified|0|||
144541515|NCT03683576|521181434|FG003|Overall Study|Other, Not Specified|0|||
144541516|NCT03683576|521181431|FG000|Overall Study|Protocol Violation|0|||
144541517|NCT03683576|521181432|FG001|Overall Study|Protocol Violation|1|||
144541518|NCT03683576|521181433|FG002|Overall Study|Protocol Violation|1|||
144541519|NCT03683576|521181434|FG003|Overall Study|Protocol Violation|0|||
144541520|NCT02628626|521181435|FG000|Overall Study|Withdrawal by Subject|2|||
144541521|NCT02628626|521181436|FG001|Overall Study|Withdrawal by Subject|2|||
144727451|NCT02101853|521856652|FG001|Block 1 Induction|Death|0|||
144541522|NCT02744066|521181437|FG000|Overall Study|Withdrawal by parent|0|||
144541523|NCT02744066|521181438|FG001|Overall Study|Withdrawal by parent|1|||
144201886|NCT03548064|519936909|FG000|Overall Study|Lost to Follow-up|0|||
144201887|NCT03548064|519936910|FG001|Overall Study|Lost to Follow-up|0|||
144201888|NCT03548064|519936911|FG002|Overall Study|Lost to Follow-up|0|||
144201889|NCT03548064|519936912|FG003|Overall Study|Lost to Follow-up|0|||
144201890|NCT03548064|519936913|FG004|Overall Study|Lost to Follow-up|2|||
144201891|NCT03548064|519936914|FG005|Overall Study|Lost to Follow-up|0|||
144201892|NCT03548064|519936915|FG006|Overall Study|Lost to Follow-up|0|||
144541524|NCT02744066|521181437|FG000|Overall Study|Discharged from NICU prior to completion|0|||
144541525|NCT02744066|521181438|FG001|Overall Study|Discharged from NICU prior to completion|4|||
144541526|NCT01400958|521181441|FG000|Overall Study|Physician Decision|0|||
144541527|NCT01400958|521181442|FG001|Overall Study|Physician Decision|1|||
144541528|NCT01400958|521181441|FG000|Overall Study|Withdrawal by Subject|0|||
144541529|NCT01400958|521181442|FG001|Overall Study|Withdrawal by Subject|1|||
144541530|NCT01400958|521181441|FG000|Overall Study|Adverse Event|1|||
144541531|NCT01400958|521181442|FG001|Overall Study|Adverse Event|0|||
144541532|NCT03102034|521181445|FG000|Overall Study|Withdrawal by Subject|1|||
144541533|NCT03102034|521181446|FG001|Overall Study|Withdrawal by Subject|0|||
144541534|NCT02972359|521181447|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
144541535|NCT02972359|521181447|FG000|Overall Study|Lack of Efficacy|1|||
144541536|NCT02972359|521181447|FG000|Overall Study|Adverse Event|4|||
144541537|NCT02972359|521181447|FG000|Overall Study|Death|1|||
144541538|NCT02972359|521181447|FG000|Overall Study|Withdrawal by Subject|30|||
144541539|NCT02972359|521181447|FG000|Overall Study|Protocol Violation|1|||
144541540|NCT02972359|521181447|FG000|Overall Study|Lost to Follow-up|26|||
144541541|NCT02972359|521181447|FG000|Overall Study|Other reasons|5|||
144541542|NCT02972359|521181447|FG000|Overall Study|Missing|1|||
144541543|NCT03371017|521181448|FG000|Overall Study|Physician Decision|0|||
144541544|NCT03371017|521181449|FG001|Overall Study|Physician Decision|1|||
144541545|NCT03371017|521181448|FG000|Overall Study|Reason not Specified|0|||
144541546|NCT03371017|521181449|FG001|Overall Study|Reason not Specified|1|||
144541547|NCT03371017|521181448|FG000|Overall Study|Lost to Follow-up|13|||
144541548|NCT03371017|521181449|FG001|Overall Study|Lost to Follow-up|16|||
144541549|NCT03371017|521181448|FG000|Overall Study|Death|228|||
144541550|NCT03371017|521181449|FG001|Overall Study|Death|215|||
144541551|NCT03371017|521181448|FG000|Overall Study|Withdrawal by Subject|20|||
144541552|NCT03371017|521181449|FG001|Overall Study|Withdrawal by Subject|25|||
144541553|NCT03371017|521181448|FG000|Overall Study|Study Ended by Sponsor|37|||
144541554|NCT03371017|521181449|FG001|Overall Study|Study Ended by Sponsor|38|||
144541555|NCT03371017|521181448|FG000|Overall Study|Protocol Deviation|0|||
144541556|NCT03371017|521181449|FG001|Overall Study|Protocol Deviation|1|||
144541557|NCT05379270|521181450|FG000|Overall Study|Withdrawal by Subject|1|||
144541558|NCT05379270|521181451|FG001|Overall Study|Withdrawal by Subject|1|||
144541559|NCT00489307|521181460|FG000|Overall Study|Death|1|||
144541560|NCT00489307|521181461|FG001|Overall Study|Death|1|||
144541561|NCT00489307|521181460|FG000|Overall Study|Lost to Follow-up|2|||
144541562|NCT00489307|521181461|FG001|Overall Study|Lost to Follow-up|2|||
144541563|NCT00489307|521181460|FG000|Overall Study|Physician Decision|1|||
144541564|NCT00489307|521181461|FG001|Overall Study|Physician Decision|0|||
144541565|NCT00489307|521181460|FG000|Overall Study|Withdrawal by Subject|2|||
144541566|NCT00489307|521181461|FG001|Overall Study|Withdrawal by Subject|4|||
144541567|NCT00489307|521181460|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
144541568|NCT00489307|521181461|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
144541569|NCT00489307|521181460|FG000|Overall Study|Surgery after assignment|1|||
144541570|NCT00489307|521181461|FG001|Overall Study|Surgery after assignment|0|||
144541571|NCT00489307|521181460|FG000|Overall Study|Did not fill up the forms|2|||
144541572|NCT00489307|521181461|FG001|Overall Study|Did not fill up the forms|1|||
144541573|NCT00489307|521181460|FG000|Overall Study|Patient or family refusal|5|||
144541574|NCT00489307|521181461|FG001|Overall Study|Patient or family refusal|9|||
144541575|NCT02307682|521181462|FG000|Overall Study|Adverse Event|9|||
144541576|NCT02307682|521181463|FG001|Overall Study|Adverse Event|8|||
144541577|NCT02307682|521181464|FG002|Overall Study|Adverse Event|12|||
144541578|NCT02307682|521181462|FG000|Overall Study|Lack of Efficacy|1|||
144541579|NCT02307682|521181463|FG001|Overall Study|Lack of Efficacy|0|||
144541580|NCT02307682|521181464|FG002|Overall Study|Lack of Efficacy|1|||
144541581|NCT02307682|521181462|FG000|Overall Study|Physician Decision|2|||
144541582|NCT02307682|521181463|FG001|Overall Study|Physician Decision|2|||
144201893|NCT03548064|519936916|FG007|Overall Study|Lost to Follow-up|0|||
144201894|NCT03548064|519936909|FG000|Overall Study|Covid-19 Pandemic|0|||
144541583|NCT02307682|521181464|FG002|Overall Study|Physician Decision|8|||
144541584|NCT02307682|521181462|FG000|Overall Study|Progressive Disease|1|||
144727452|NCT02101853|521856653|FG002|Block 1 Induction|Death|0|||
144201895|NCT03548064|519936910|FG001|Overall Study|Covid-19 Pandemic|0|||
144541585|NCT02307682|521181463|FG001|Overall Study|Progressive Disease|0|||
144541586|NCT02307682|521181464|FG002|Overall Study|Progressive Disease|0|||
144541587|NCT02307682|521181462|FG000|Overall Study|Withdrawal by Subject|26|||
144541588|NCT02307682|521181463|FG001|Overall Study|Withdrawal by Subject|34|||
144541589|NCT02307682|521181464|FG002|Overall Study|Withdrawal by Subject|23|||
144541590|NCT02307682|521181462|FG000|Overall Study|Death|9|||
144541591|NCT02307682|521181463|FG001|Overall Study|Death|7|||
144201896|NCT03548064|519936911|FG002|Overall Study|Covid-19 Pandemic|0|||
144201897|NCT03548064|519936912|FG003|Overall Study|Covid-19 Pandemic|0|||
144201898|NCT03548064|519936913|FG004|Overall Study|Covid-19 Pandemic|10|||
144201899|NCT03548064|519936914|FG005|Overall Study|Covid-19 Pandemic|3|||
144201900|NCT03548064|519936915|FG006|Overall Study|Covid-19 Pandemic|0|||
144201901|NCT03548064|519936916|FG007|Overall Study|Covid-19 Pandemic|0|||
144472725|NCT02696564|520928569|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
144472726|NCT02696564|520928568|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
144472727|NCT02696564|520928569|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
144472728|NCT02696564|520928568|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
144472729|NCT02696564|520928569|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
144472730|NCT02696564|520928568|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
144472731|NCT02696564|520928569|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
144472732|NCT02696564|520928568|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
144472733|NCT02696564|520928569|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
144472734|NCT01337986|520928570|FG000|Overall Study|Adverse Event|2|||
144472735|NCT01337986|520928571|FG001|Overall Study|Adverse Event|2|||
144472736|NCT01337986|520928570|FG000|Overall Study|Lost to Follow-up|1|||
144472737|NCT01337986|520928571|FG001|Overall Study|Lost to Follow-up|0|||
144472738|NCT01337986|520928570|FG000|Overall Study|Protocol Violation|0|||
144472739|NCT01337986|520928571|FG001|Overall Study|Protocol Violation|3|||
144472740|NCT03633929|520928572|FG000|Overall Study|Lost to Follow-up|1|||
144472741|NCT03633929|520928572|FG000|Overall Study|Did not login to software. Did not participate|3|||
144472742|NCT01520402|520928574|FG000|Overall Study|Withdrawal by Subject|2|||
144472743|NCT01520402|520928574|FG000|Overall Study|Physician Decision|3|||
144472744|NCT01722162|520928575|FG000|Overall Study|Withdrawal by Subject|1|||
144472745|NCT01722162|520928576|FG001|Overall Study|Withdrawal by Subject|1|||
144472746|NCT01722162|520928575|FG000|Overall Study|Found ineligible|1|||
144472747|NCT01722162|520928576|FG001|Overall Study|Found ineligible|0|||
144472748|NCT01722162|520928575|FG000|Overall Study|Unrelated to study adverse event|2|||
144472749|NCT01722162|520928576|FG001|Overall Study|Unrelated to study adverse event|2|||
144472750|NCT01722162|520928575|FG000|Overall Study|Adverse Event|1|||
144472751|NCT01722162|520928576|FG001|Overall Study|Adverse Event|1|||
144472752|NCT01722162|520928575|FG000|Overall Study|Insurance denial post enrollment|0|||
144472753|NCT01722162|520928576|FG001|Overall Study|Insurance denial post enrollment|1|||
144472754|NCT01722162|520928575|FG000|Overall Study|Noncompliance|0|||
144472755|NCT01722162|520928576|FG001|Overall Study|Noncompliance|1|||
144472756|NCT03086018|520928578|FG000|Final Testing for End of Trial|Adverse Event|1|||
144472757|NCT03086018|520928578|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
144472758|NCT04026165|520928580|FG000|Run-in Placebo Period|Enrollment Error|13|||
144472759|NCT04026165|520928581|FG001|Run-in Placebo Period|Enrollment Error|0|||
144472760|NCT04026165|520928582|FG002|Run-in Placebo Period|Enrollment Error|0|||
144472761|NCT04026165|520928583|FG003|Run-in Placebo Period|Enrollment Error|0|||
144472762|NCT04026165|520928580|FG000|Run-in Placebo Period|Run-in Failure|4|||
144472763|NCT04026165|520928581|FG001|Run-in Placebo Period|Run-in Failure|0|||
144472764|NCT04026165|520928582|FG002|Run-in Placebo Period|Run-in Failure|0|||
144472765|NCT04026165|520928583|FG003|Run-in Placebo Period|Run-in Failure|0|||
144472766|NCT04026165|520928580|FG000|Run-in Placebo Period|Protocol Violation|2|||
144472767|NCT04026165|520928581|FG001|Run-in Placebo Period|Protocol Violation|0|||
144472768|NCT04026165|520928582|FG002|Run-in Placebo Period|Protocol Violation|0|||
144472769|NCT04026165|520928583|FG003|Run-in Placebo Period|Protocol Violation|0|||
144472770|NCT04026165|520928580|FG000|Run-in Placebo Period|Withdrew Consent|2|||
144472771|NCT04026165|520928581|FG001|Run-in Placebo Period|Withdrew Consent|0|||
144472772|NCT04026165|520928582|FG002|Run-in Placebo Period|Withdrew Consent|0|||
144541592|NCT02307682|521181464|FG002|Overall Study|Death|12|||
144541593|NCT02307682|521181462|FG000|Overall Study|Lost to Follow-up|1|||
144541594|NCT02307682|521181463|FG001|Overall Study|Lost to Follow-up|5|||
144541595|NCT02307682|521181464|FG002|Overall Study|Lost to Follow-up|6|||
144541596|NCT02307682|521181462|FG000|Overall Study|Protocol Deviation|0|||
144201902|NCT04941729|519936917|FG000|Overall Study|Death|0|||
144541597|NCT02307682|521181463|FG001|Overall Study|Protocol Deviation|0|||
144541598|NCT02307682|521181464|FG002|Overall Study|Protocol Deviation|2|||
144541599|NCT02307682|521181462|FG000|Overall Study|Other|1|||
144201903|NCT04941729|519936918|FG001|Overall Study|Death|1|||
144541600|NCT02307682|521181463|FG001|Overall Study|Other|1|||
144541601|NCT02307682|521181464|FG002|Overall Study|Other|0|||
144541602|NCT02517268|521181467|FG000|Overall Study|Withdrawal by Subject|1|||
144541603|NCT02517268|521181468|FG001|Overall Study|Withdrawal by Subject|0|||
144541604|NCT04686266|521181469|FG000|Overall Study|Withdrawal by Subject|0|||
144541605|NCT04686266|521181470|FG001|Overall Study|Withdrawal by Subject|1|||
144541606|NCT03227861|521181471|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
144541607|NCT03227861|521181471|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
144541608|NCT03227861|521181471|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
144541609|NCT03227861|521181471|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
144541610|NCT03227861|521181471|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
144541611|NCT03227861|521181471|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
144541612|NCT03227861|521181471|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
144541613|NCT03227861|521181471|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
144541614|NCT03227861|521181471|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
144541615|NCT03227861|521181471|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
144541616|NCT00748709|521181472|FG000|Overall Study|Progressive disease|15|||
144541617|NCT00748709|521181472|FG000|Overall Study|Drug reducing Toxity|2|||
144541618|NCT00748709|521181472|FG000|Overall Study|Other Adverse Event|1|||
144541619|NCT00748709|521181472|FG000|Overall Study|Withdrawal by Subject|1|||
144541620|NCT00748709|521181472|FG000|Overall Study|Other Reasons|1|||
144541621|NCT05071430|521181477|FG000|Overall Study|Adverse Event|1|||
144541622|NCT05071430|521181478|FG001|Overall Study|Adverse Event|2|||
144541623|NCT05071430|521181477|FG000|Overall Study|Lost to Follow-up|4|||
144541624|NCT05071430|521181478|FG001|Overall Study|Lost to Follow-up|4|||
144541625|NCT05071430|521181477|FG000|Overall Study|Protocol Violation|1|||
144541626|NCT05071430|521181478|FG001|Overall Study|Protocol Violation|0|||
144541627|NCT05071430|521181477|FG000|Overall Study|Withdrawal by Subject|3|||
144541628|NCT05071430|521181478|FG001|Overall Study|Withdrawal by Subject|2|||
144541629|NCT05071430|521181477|FG000|Overall Study|Other|1|||
144541630|NCT05071430|521181478|FG001|Overall Study|Other|1|||
144541631|NCT05810285|521181482|FG000|Overall Study|Death|4|||
144541632|NCT05810285|521181483|FG001|Overall Study|Death|21|||
144541633|NCT05810285|521181482|FG000|Overall Study|Adverse Event|18|||
144541634|NCT05810285|521181483|FG001|Overall Study|Adverse Event|16|||
144541635|NCT05470114|521181484|FG000|Overall Study|Withdrawal by Subject|1|||
144541636|NCT05470114|521181485|FG001|Overall Study|Withdrawal by Subject|0|||
144541637|NCT05470114|521181484|FG000|Overall Study|Lost to Follow-up|1|||
144541638|NCT05470114|521181485|FG001|Overall Study|Lost to Follow-up|0|||
144541639|NCT02488408|521181486|FG000|Part A|Adverse Event|2|||
144541640|NCT02488408|521181487|FG001|Part A|Adverse Event|0|||
144541641|NCT02488408|521181488|FG002|Part A|Adverse Event|0|||
144541642|NCT02488408|521181489|FG003|Part A|Adverse Event|0|||
144541643|NCT02488408|521181490|FG004|Part A|Adverse Event|0|||
144541644|NCT02488408|521181491|FG005|Part A|Adverse Event|0|||
144541645|NCT02488408|521181492|FG006|Part A|Adverse Event|0|||
144541646|NCT02488408|521181493|FG007|Part A|Adverse Event|0|||
144541647|NCT02488408|521181494|FG008|Part A|Adverse Event|0|||
144541648|NCT02488408|521181495|FG009|Part A|Adverse Event|0|||
144541649|NCT02488408|521181486|FG000|Part A|Death|1|||
144541650|NCT02488408|521181487|FG001|Part A|Death|5|||
144541651|NCT02488408|521181488|FG002|Part A|Death|0|||
144541652|NCT02488408|521181489|FG003|Part A|Death|0|||
144541653|NCT02488408|521181490|FG004|Part A|Death|3|||
144541654|NCT02488408|521181491|FG005|Part A|Death|0|||
144541655|NCT02488408|521181492|FG006|Part A|Death|0|||
144541656|NCT02488408|521181493|FG007|Part A|Death|0|||
144541657|NCT02488408|521181494|FG008|Part A|Death|0|||
144541658|NCT02488408|521181495|FG009|Part A|Death|0|||
144541659|NCT02488408|521181486|FG000|Part A|Disease Progression|2|||
144541660|NCT02488408|521181487|FG001|Part A|Disease Progression|8|||
144541661|NCT02488408|521181488|FG002|Part A|Disease Progression|2|||
144541662|NCT02488408|521181489|FG003|Part A|Disease Progression|3|||
144541663|NCT02488408|521181490|FG004|Part A|Disease Progression|4|||
144541664|NCT02488408|521181491|FG005|Part A|Disease Progression|0|||
144541665|NCT02488408|521181492|FG006|Part A|Disease Progression|0|||
144541666|NCT02488408|521181493|FG007|Part A|Disease Progression|0|||
144541667|NCT02488408|521181494|FG008|Part A|Disease Progression|0|||
144541668|NCT02488408|521181495|FG009|Part A|Disease Progression|0|||
144541669|NCT02488408|521181486|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
144541670|NCT02488408|521181487|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
144541671|NCT02488408|521181488|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
144201904|NCT04941729|519936917|FG000|Overall Study|Study terminated by sponsor|11|||
144201905|NCT04941729|519936918|FG001|Overall Study|Study terminated by sponsor|10|||
144201906|NCT00006721|519936919|FG000|Overall Study|Adverse Event|0|||
144201907|NCT00006721|519936920|FG001|Overall Study|Adverse Event|4|||
144201908|NCT00006721|519936921|FG002|Overall Study|Adverse Event|4|||
144541672|NCT02488408|521181489|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
144541673|NCT02488408|521181490|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
144541674|NCT02488408|521181491|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
144541675|NCT02488408|521181492|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
144541676|NCT02488408|521181493|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
144541677|NCT02488408|521181494|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
144541678|NCT02488408|521181495|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
144541679|NCT02488408|521181486|FG000|Part A|Investigator Decision|0|||
144541680|NCT02488408|521181487|FG001|Part A|Investigator Decision|1|||
144541681|NCT02488408|521181488|FG002|Part A|Investigator Decision|1|||
144541682|NCT02488408|521181489|FG003|Part A|Investigator Decision|0|||
144541683|NCT02488408|521181490|FG004|Part A|Investigator Decision|0|||
144541684|NCT02488408|521181491|FG005|Part A|Investigator Decision|0|||
144541685|NCT02488408|521181492|FG006|Part A|Investigator Decision|0|||
144541686|NCT02488408|521181493|FG007|Part A|Investigator Decision|0|||
144541687|NCT02488408|521181494|FG008|Part A|Investigator Decision|0|||
144541688|NCT02488408|521181495|FG009|Part A|Investigator Decision|0|||
144541689|NCT02488408|521181486|FG000|Part A|Withdrawal by Subject|0|||
144541690|NCT02488408|521181487|FG001|Part A|Withdrawal by Subject|0|||
144541691|NCT02488408|521181488|FG002|Part A|Withdrawal by Subject|2|||
144541692|NCT02488408|521181489|FG003|Part A|Withdrawal by Subject|0|||
144541693|NCT02488408|521181490|FG004|Part A|Withdrawal by Subject|0|||
144541694|NCT02488408|521181491|FG005|Part A|Withdrawal by Subject|0|||
144541695|NCT02488408|521181492|FG006|Part A|Withdrawal by Subject|0|||
144541696|NCT02488408|521181493|FG007|Part A|Withdrawal by Subject|0|||
144541697|NCT02488408|521181494|FG008|Part A|Withdrawal by Subject|0|||
144541698|NCT02488408|521181495|FG009|Part A|Withdrawal by Subject|0|||
144541699|NCT02488408|521181486|FG000|Part A|Other|1|||
144541700|NCT02488408|521181487|FG001|Part A|Other|0|||
144541701|NCT02488408|521181488|FG002|Part A|Other|0|||
144541702|NCT02488408|521181489|FG003|Part A|Other|0|||
144541703|NCT02488408|521181490|FG004|Part A|Other|0|||
144541704|NCT02488408|521181491|FG005|Part A|Other|0|||
144541705|NCT02488408|521181492|FG006|Part A|Other|0|||
144541706|NCT02488408|521181493|FG007|Part A|Other|0|||
144541707|NCT02488408|521181494|FG008|Part A|Other|0|||
144541708|NCT02488408|521181495|FG009|Part A|Other|0|||
144541709|NCT02488408|521181486|FG000|Part B|Adverse Event|0|||
144541710|NCT02488408|521181487|FG001|Part B|Adverse Event|0|||
144541711|NCT02488408|521181488|FG002|Part B|Adverse Event|0|||
144541712|NCT02488408|521181489|FG003|Part B|Adverse Event|0|||
144541713|NCT02488408|521181490|FG004|Part B|Adverse Event|0|||
144541714|NCT02488408|521181491|FG005|Part B|Adverse Event|2|||
144201909|NCT00006721|519936919|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
144201910|NCT00006721|519936920|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
144201911|NCT00006721|519936921|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
144541715|NCT02488408|521181492|FG006|Part B|Adverse Event|2|||
144201912|NCT00006721|519936919|FG000|Overall Study|Progression/Relapse|0|||
144541716|NCT02488408|521181493|FG007|Part B|Adverse Event|7|||
144541717|NCT02488408|521181494|FG008|Part B|Adverse Event|2|||
144541718|NCT02488408|521181495|FG009|Part B|Adverse Event|2|||
144541719|NCT02488408|521181486|FG000|Part B|Death|0|||
144541720|NCT02488408|521181487|FG001|Part B|Death|0|||
144541721|NCT02488408|521181488|FG002|Part B|Death|0|||
144541722|NCT02488408|521181489|FG003|Part B|Death|0|||
144541723|NCT02488408|521181490|FG004|Part B|Death|0|||
144541724|NCT02488408|521181491|FG005|Part B|Death|3|||
144541725|NCT02488408|521181492|FG006|Part B|Death|1|||
144541726|NCT02488408|521181493|FG007|Part B|Death|2|||
144541727|NCT02488408|521181494|FG008|Part B|Death|2|||
144541728|NCT02488408|521181495|FG009|Part B|Death|2|||
144541729|NCT02488408|521181486|FG000|Part B|Death due to Disease Progression|0|||
144541730|NCT02488408|521181487|FG001|Part B|Death due to Disease Progression|0|||
144541731|NCT02488408|521181488|FG002|Part B|Death due to Disease Progression|0|||
144541732|NCT02488408|521181489|FG003|Part B|Death due to Disease Progression|0|||
144541733|NCT02488408|521181490|FG004|Part B|Death due to Disease Progression|0|||
144541734|NCT02488408|521181491|FG005|Part B|Death due to Disease Progression|2|||
144541735|NCT02488408|521181492|FG006|Part B|Death due to Disease Progression|2|||
144541736|NCT02488408|521181493|FG007|Part B|Death due to Disease Progression|1|||
144541737|NCT02488408|521181494|FG008|Part B|Death due to Disease Progression|1|||
144541738|NCT02488408|521181495|FG009|Part B|Death due to Disease Progression|1|||
144541739|NCT02488408|521181486|FG000|Part B|Disease Progression|0|||
144541740|NCT02488408|521181487|FG001|Part B|Disease Progression|0|||
144541741|NCT02488408|521181488|FG002|Part B|Disease Progression|0|||
144541742|NCT02488408|521181489|FG003|Part B|Disease Progression|0|||
144201913|NCT00006721|519936920|FG001|Overall Study|Progression/Relapse|1|||
144541743|NCT02488408|521181490|FG004|Part B|Disease Progression|0|||
144201914|NCT00006721|519936921|FG002|Overall Study|Progression/Relapse|2|||
144541744|NCT02488408|521181491|FG005|Part B|Disease Progression|6|||
144541745|NCT02488408|521181492|FG006|Part B|Disease Progression|9|||
144541746|NCT02488408|521181493|FG007|Part B|Disease Progression|7|||
144541747|NCT02488408|521181494|FG008|Part B|Disease Progression|9|||
144616053|NCT00763815|521454597|FG001|Overall Study|Poor Compliance to Protocol|6|||
144541748|NCT02488408|521181495|FG009|Part B|Disease Progression|11|||
144541749|NCT02488408|521181486|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
144541750|NCT02488408|521181487|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
144541751|NCT02488408|521181488|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
144541752|NCT02488408|521181489|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
144541753|NCT02488408|521181490|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
144541754|NCT02488408|521181491|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
144541755|NCT02488408|521181492|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
144541756|NCT02488408|521181493|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
144541757|NCT02488408|521181494|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
144541758|NCT02488408|521181495|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
144541759|NCT02488408|521181486|FG000|Part B|Investigator Decision|0|||
144541760|NCT02488408|521181487|FG001|Part B|Investigator Decision|0|||
144541761|NCT02488408|521181488|FG002|Part B|Investigator Decision|0|||
144541762|NCT02488408|521181489|FG003|Part B|Investigator Decision|0|||
144541763|NCT02488408|521181490|FG004|Part B|Investigator Decision|0|||
144541764|NCT02488408|521181491|FG005|Part B|Investigator Decision|0|||
144541765|NCT02488408|521181492|FG006|Part B|Investigator Decision|1|||
144541766|NCT02488408|521181493|FG007|Part B|Investigator Decision|0|||
144541767|NCT02488408|521181494|FG008|Part B|Investigator Decision|2|||
144541768|NCT02488408|521181495|FG009|Part B|Investigator Decision|1|||
144541769|NCT05037513|521181496|FG000|Intervention Period|Lost to Follow-up|1|||
144541770|NCT05037513|521181497|FG001|Intervention Period|Lost to Follow-up|2|||
144541771|NCT05037513|521181496|FG000|Follow Up Period|Lost to Follow-up|16|||
144541772|NCT05037513|521181497|FG001|Follow Up Period|Lost to Follow-up|21|||
144541773|NCT05037513|521181496|FG000|Follow Up Period|Death|0|||
144541774|NCT05037513|521181497|FG001|Follow Up Period|Death|1|||
144541775|NCT05037513|521181496|FG000|Follow Up Period|Incarcerated|4|||
144541776|NCT05037513|521181497|FG001|Follow Up Period|Incarcerated|2|||
144541777|NCT05886777|521181498|FG000|Overall Study|Lost to Follow-up|1|||
144541778|NCT05886777|521181499|FG001|Overall Study|Lost to Follow-up|0|||
144541779|NCT05886777|521181500|FG002|Overall Study|Lost to Follow-up|2|||
144541780|NCT05886777|521181501|FG003|Overall Study|Lost to Follow-up|1|||
144541781|NCT05886777|521181502|FG004|Overall Study|Lost to Follow-up|0|||
144541782|NCT05886777|521181503|FG005|Overall Study|Lost to Follow-up|2|||
144541783|NCT05886777|521181504|FG006|Overall Study|Lost to Follow-up|0|||
144541784|NCT05886777|521181498|FG000|Overall Study|Other|0|||
144541785|NCT05886777|521181499|FG001|Overall Study|Other|2|||
144541786|NCT05886777|521181500|FG002|Overall Study|Other|1|||
144541787|NCT05886777|521181501|FG003|Overall Study|Other|0|||
144541788|NCT05886777|521181502|FG004|Overall Study|Other|0|||
144541789|NCT05886777|521181503|FG005|Overall Study|Other|0|||
144541790|NCT05886777|521181504|FG006|Overall Study|Other|0|||
144541791|NCT05886777|521181498|FG000|Overall Study|Withdrawal by Subject|1|||
144541792|NCT05886777|521181499|FG001|Overall Study|Withdrawal by Subject|0|||
144541793|NCT05886777|521181500|FG002|Overall Study|Withdrawal by Subject|1|||
144541794|NCT05886777|521181501|FG003|Overall Study|Withdrawal by Subject|4|||
144541795|NCT05886777|521181502|FG004|Overall Study|Withdrawal by Subject|3|||
144541796|NCT05886777|521181503|FG005|Overall Study|Withdrawal by Subject|1|||
144541797|NCT05886777|521181504|FG006|Overall Study|Withdrawal by Subject|1|||
144541798|NCT05886777|521181498|FG000|Overall Study|Protocol Violation|0|||
144541799|NCT05886777|521181499|FG001|Overall Study|Protocol Violation|0|||
144541800|NCT05886777|521181500|FG002|Overall Study|Protocol Violation|1|||
144541801|NCT05886777|521181501|FG003|Overall Study|Protocol Violation|0|||
144541802|NCT05886777|521181502|FG004|Overall Study|Protocol Violation|0|||
144541803|NCT05886777|521181503|FG005|Overall Study|Protocol Violation|0|||
144541804|NCT05886777|521181504|FG006|Overall Study|Protocol Violation|0|||
144541805|NCT05886777|521181498|FG000|Overall Study|No longer met eligibility criteria|0|||
144541806|NCT05886777|521181499|FG001|Overall Study|No longer met eligibility criteria|1|||
144541807|NCT05886777|521181500|FG002|Overall Study|No longer met eligibility criteria|0|||
144541808|NCT05886777|521181501|FG003|Overall Study|No longer met eligibility criteria|0|||
144541809|NCT05886777|521181502|FG004|Overall Study|No longer met eligibility criteria|0|||
144541810|NCT05886777|521181503|FG005|Overall Study|No longer met eligibility criteria|0|||
144541811|NCT05886777|521181504|FG006|Overall Study|No longer met eligibility criteria|0|||
144541812|NCT03773107|521181505|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
144541813|NCT03773107|521181506|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
144541814|NCT03773107|521181507|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
144541815|NCT03773107|521181508|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
144541816|NCT07204444|521181511|FG000|Overall Study|Medical/Hospitalization|6|||
144541817|NCT07204444|521181512|FG001|Overall Study|Medical/Hospitalization|9|||
144541818|NCT07204444|521181513|FG002|Overall Study|Medical/Hospitalization|6|||
144541819|NCT07204444|521181511|FG000|Overall Study|Treatment Provider Issue|1|||
144541820|NCT07204444|521181512|FG001|Overall Study|Treatment Provider Issue|3|||
144541821|NCT07204444|521181513|FG002|Overall Study|Treatment Provider Issue|0|||
144541822|NCT07204444|521181511|FG000|Overall Study|Withdrawal by Subject|11|||
144541823|NCT07204444|521181512|FG001|Overall Study|Withdrawal by Subject|5|||
144541824|NCT07204444|521181513|FG002|Overall Study|Withdrawal by Subject|5|||
144541825|NCT07204444|521181511|FG000|Overall Study|Death|3|||
144541826|NCT07204444|521181512|FG001|Overall Study|Death|6|||
144541827|NCT07204444|521181513|FG002|Overall Study|Death|1|||
144541828|NCT07204444|521181511|FG000|Overall Study|Unable To Reach|29|||
144541829|NCT07204444|521181512|FG001|Overall Study|Unable To Reach|26|||
144541830|NCT07204444|521181513|FG002|Overall Study|Unable To Reach|17|||
144541831|NCT07204444|521181511|FG000|Overall Study|Protocol Deviation|3|||
144541832|NCT07204444|521181512|FG001|Overall Study|Protocol Deviation|2|||
144541833|NCT07204444|521181513|FG002|Overall Study|Protocol Deviation|0|||
144541834|NCT00512252|521182519|FG000|Overall Study|Lost to Follow-up|0|||
144541835|NCT00512252|521182520|FG001|Overall Study|Lost to Follow-up|0|||
144541836|NCT00512252|521182521|FG002|Overall Study|Lost to Follow-up|1|||
144541837|NCT00512252|521182519|FG000|Overall Study|Protocol Violation|0|||
144541838|NCT00512252|521182520|FG001|Overall Study|Protocol Violation|0|||
144541839|NCT00512252|521182521|FG002|Overall Study|Protocol Violation|1|||
144541840|NCT00512252|521182519|FG000|Overall Study|Death|0|||
144541841|NCT00512252|521182520|FG001|Overall Study|Death|0|||
144541842|NCT00512252|521182521|FG002|Overall Study|Death|1|||
144541843|NCT00705406|521182522|FG000|Overall Study|Lost to Follow-up|3|||
144541844|NCT00705406|521182523|FG001|Overall Study|Lost to Follow-up|3|||
144541845|NCT00705406|521182522|FG000|Overall Study|Did not receive study drug|1|||
144541846|NCT00705406|521182523|FG001|Overall Study|Did not receive study drug|2|||
144541847|NCT02357966|521182524|FG000|Overall Study|Death|0|||
144541848|NCT02357966|521182525|FG001|Overall Study|Death|0|||
144541849|NCT02357966|521182526|FG002|Overall Study|Death|1|||
144541850|NCT02357966|521182527|FG003|Overall Study|Death|0|||
144541851|NCT02357966|521182528|FG004|Overall Study|Death|2|||
144541852|NCT02357966|521182529|FG005|Overall Study|Death|0|||
144541853|NCT02357966|521182524|FG000|Overall Study|Physician Decision|1|||
144541854|NCT02357966|521182525|FG001|Overall Study|Physician Decision|0|||
144541855|NCT02357966|521182526|FG002|Overall Study|Physician Decision|0|||
144541856|NCT02357966|521182527|FG003|Overall Study|Physician Decision|0|||
144541857|NCT02357966|521182528|FG004|Overall Study|Physician Decision|1|||
144541858|NCT02357966|521182529|FG005|Overall Study|Physician Decision|0|||
144541859|NCT01779700|521182530|FG000|Overall Study|Adverse Event|4|||
144541860|NCT01779700|521182531|FG001|Overall Study|Adverse Event|3|||
144541861|NCT01779700|521182530|FG000|Overall Study|Withdrawal by Subject|0|||
144541862|NCT01779700|521182531|FG001|Overall Study|Withdrawal by Subject|2|||
144541863|NCT00442104|521182535|FG000|Overall Study|Adverse Event|5|||
144541864|NCT00442104|521182535|FG000|Overall Study|Death|2|||
144541865|NCT00442104|521182535|FG000|Overall Study|Lost to Follow-up|3|||
144541866|NCT00442104|521182535|FG000|Overall Study|Withdrawal by Subject|5|||
144201915|NCT00006721|519936919|FG000|Overall Study|Death|0|||
144201916|NCT00006721|519936920|FG001|Overall Study|Death|1|||
144201917|NCT00006721|519936921|FG002|Overall Study|Death|2|||
144201918|NCT00006721|519936919|FG000|Overall Study|Other - Not Protocol Specified|0|||
144201919|NCT00006721|519936920|FG001|Overall Study|Other - Not Protocol Specified|7|||
144541867|NCT00442104|521182535|FG000|Overall Study|Insufficient Clinical Response|10|||
144541868|NCT00442104|521182535|FG000|Overall Study|Other|21|||
144541869|NCT00442104|521182535|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
144541870|NCT04608409|521182536|FG000|Overall Study|Physician Decision|1|||
144541871|NCT04608409|521182537|FG001|Overall Study|Physician Decision|1|||
144541872|NCT04608409|521182538|FG002|Overall Study|Physician Decision|2|||
144541873|NCT04497415|521182539|FG000|Overall Study|Lost to Follow-up|43|||
144541874|NCT04497415|521182540|FG001|Overall Study|Lost to Follow-up|27|||
144616054|NCT00763815|521454596|FG000|Overall Study|Lost to Follow-up|2|||
144616055|NCT00763815|521454597|FG001|Overall Study|Lost to Follow-up|4|||
144616056|NCT00763815|521454596|FG000|Overall Study|Early Termination|1|||
144616057|NCT00763815|521454597|FG001|Overall Study|Early Termination|0|||
144616058|NCT00763815|521454596|FG000|Overall Study|Familial and Personal Reasons|9|||
144616059|NCT00763815|521454597|FG001|Overall Study|Familial and Personal Reasons|16|||
144616060|NCT00763815|521454596|FG000|Overall Study|Physician Decision|1|||
144616061|NCT00763815|521454597|FG001|Overall Study|Physician Decision|0|||
144616062|NCT00763815|521454596|FG000|Overall Study|Withdrawal by Subject|7|||
144616063|NCT00763815|521454597|FG001|Overall Study|Withdrawal by Subject|12|||
144616064|NCT00763815|521454596|FG000|Overall Study|Protocol Violation|2|||
144616065|NCT00763815|521454597|FG001|Overall Study|Protocol Violation|5|||
144616066|NCT00763815|521454596|FG000|Overall Study|Sponsor's Decision|0|||
144616067|NCT00763815|521454597|FG001|Overall Study|Sponsor's Decision|1|||
144616068|NCT00414453|521454598|FG000|Overall Study|Abnormal lab work|16|||
144616069|NCT01780831|521454599|FG000|Overall Study|Withdrawal by Subject|0|||
144201920|NCT00006721|519936921|FG002|Overall Study|Other - Not Protocol Specified|7|||
144616070|NCT01780831|521454600|FG001|Overall Study|Withdrawal by Subject|0|||
144616071|NCT01780831|521454601|FG002|Overall Study|Withdrawal by Subject|4|||
144616072|NCT01780831|521454602|FG003|Overall Study|Withdrawal by Subject|0|||
144201921|NCT00006721|519936919|FG000|Overall Study|Ineligible|2|||
144541875|NCT02362035|521182543|FG000|Overall Study|Death|67|||
144616073|NCT01780831|521454599|FG000|Overall Study|Lost to Follow-up|0|||
144616074|NCT01780831|521454600|FG001|Overall Study|Lost to Follow-up|0|||
144201922|NCT00006721|519936920|FG001|Overall Study|Ineligible|12|||
144541876|NCT02362035|521182543|FG000|Overall Study|Lost to Follow-up|3|||
144541877|NCT02362035|521182543|FG000|Overall Study|Adverse Event|1|||
144541878|NCT02362035|521182543|FG000|Overall Study|Physician Decision|1|||
144616075|NCT01780831|521454601|FG002|Overall Study|Lost to Follow-up|0|||
144616076|NCT01780831|521454602|FG003|Overall Study|Lost to Follow-up|1|||
144616077|NCT00183274|521454603|FG000|Phase 1: Open-Label|Adverse Event|31|||
144201923|NCT00006721|519936921|FG002|Overall Study|Ineligible|10|||
144541879|NCT02362035|521182543|FG000|Overall Study|Subject started another cancer therapy|10|||
144541880|NCT02362035|521182543|FG000|Overall Study|Study terminated by sponsor|45|||
144541881|NCT02362035|521182543|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
144616078|NCT00183274|521454604|FG001|Phase 1: Open-Label|Adverse Event|0|||
144616079|NCT00183274|521454605|FG002|Phase 1: Open-Label|Adverse Event|0|||
144616080|NCT00183274|521454606|FG003|Phase 1: Open-Label|Adverse Event|0|||
144616081|NCT00183274|521454607|FG004|Phase 1: Open-Label|Adverse Event|0|||
144616082|NCT00183274|521454608|FG005|Phase 1: Open-Label|Adverse Event|0|||
144616083|NCT00183274|521454603|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
144616084|NCT00183274|521454604|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
144616085|NCT00183274|521454605|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
144616086|NCT00183274|521454606|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
144616087|NCT00183274|521454607|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
144616088|NCT00183274|521454608|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
144616089|NCT00183274|521454603|FG000|Phase 1: Open-Label|Protocol Violation|11|||
144616090|NCT00183274|521454604|FG001|Phase 1: Open-Label|Protocol Violation|0|||
144616091|NCT00183274|521454605|FG002|Phase 1: Open-Label|Protocol Violation|0|||
144616092|NCT00183274|521454606|FG003|Phase 1: Open-Label|Protocol Violation|0|||
144616093|NCT00183274|521454607|FG004|Phase 1: Open-Label|Protocol Violation|0|||
144616094|NCT00183274|521454608|FG005|Phase 1: Open-Label|Protocol Violation|0|||
144472773|NCT04026165|520928583|FG003|Run-in Placebo Period|Withdrew Consent|0|||
144616095|NCT00183274|521454603|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
144616096|NCT00183274|521454604|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
144616097|NCT00183274|521454605|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
144616098|NCT00183274|521454606|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
144616099|NCT00183274|521454607|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
144616100|NCT00183274|521454608|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
144616101|NCT00183274|521454603|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
144616102|NCT00183274|521454604|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
144616103|NCT00183274|521454605|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
144616104|NCT00183274|521454606|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
144616105|NCT00183274|521454607|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
144616106|NCT00183274|521454608|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
144616107|NCT00183274|521454603|FG000|Phase 1: Open-Label|Other|9|||
144616108|NCT00183274|521454604|FG001|Phase 1: Open-Label|Other|0|||
144616109|NCT00183274|521454605|FG002|Phase 1: Open-Label|Other|0|||
144616110|NCT00183274|521454606|FG003|Phase 1: Open-Label|Other|0|||
144616111|NCT00183274|521454607|FG004|Phase 1: Open-Label|Other|0|||
144616112|NCT00183274|521454608|FG005|Phase 1: Open-Label|Other|0|||
144616113|NCT00183274|521454603|FG000|Phase 2: Double-Blind|Relapsed|0|||
144616114|NCT00183274|521454604|FG001|Phase 2: Double-Blind|Relapsed|8|||
144616115|NCT00183274|521454605|FG002|Phase 2: Double-Blind|Relapsed|29|||
144616116|NCT00183274|521454606|FG003|Phase 2: Double-Blind|Relapsed|0|||
144616117|NCT00183274|521454607|FG004|Phase 2: Double-Blind|Relapsed|0|||
144616118|NCT00183274|521454608|FG005|Phase 2: Double-Blind|Relapsed|0|||
144616119|NCT00183274|521454603|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
144616120|NCT00183274|521454604|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
144616121|NCT00183274|521454605|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
144727453|NCT02101853|521856654|FG003|Block 1 Induction|Death|0|||
144472774|NCT04026165|520928580|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
144472775|NCT04026165|520928581|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
144472776|NCT04026165|520928582|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
144472777|NCT04026165|520928583|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
144472778|NCT04026165|520928580|FG000|Run-in SEL Period|Run-in Failure|0|||
144472779|NCT04026165|520928581|FG001|Run-in SEL Period|Run-in Failure|26|||
144472780|NCT04026165|520928582|FG002|Run-in SEL Period|Run-in Failure|0|||
144472781|NCT04026165|520928583|FG003|Run-in SEL Period|Run-in Failure|0|||
144472782|NCT04026165|520928580|FG000|Run-in SEL Period|Withdrew Consent|0|||
144472783|NCT04026165|520928581|FG001|Run-in SEL Period|Withdrew Consent|10|||
144472784|NCT04026165|520928582|FG002|Run-in SEL Period|Withdrew Consent|0|||
144472785|NCT04026165|520928583|FG003|Run-in SEL Period|Withdrew Consent|0|||
144472786|NCT04026165|520928580|FG000|Run-in SEL Period|Enrollment Error|0|||
144472787|NCT04026165|520928581|FG001|Run-in SEL Period|Enrollment Error|4|||
144472788|NCT04026165|520928582|FG002|Run-in SEL Period|Enrollment Error|0|||
144472789|NCT04026165|520928583|FG003|Run-in SEL Period|Enrollment Error|0|||
144472790|NCT04026165|520928580|FG000|Run-in SEL Period|Protocol Violation|0|||
144472791|NCT04026165|520928581|FG001|Run-in SEL Period|Protocol Violation|3|||
144472792|NCT04026165|520928582|FG002|Run-in SEL Period|Protocol Violation|0|||
144472793|NCT04026165|520928583|FG003|Run-in SEL Period|Protocol Violation|0|||
144472794|NCT04026165|520928580|FG000|Run-in SEL Period|Investigator's Discretion|0|||
144472795|NCT04026165|520928581|FG001|Run-in SEL Period|Investigator's Discretion|2|||
144472796|NCT04026165|520928582|FG002|Run-in SEL Period|Investigator's Discretion|0|||
144472797|NCT04026165|520928583|FG003|Run-in SEL Period|Investigator's Discretion|0|||
144472798|NCT04026165|520928580|FG000|Run-in SEL Period|Death|0|||
144472799|NCT04026165|520928581|FG001|Run-in SEL Period|Death|1|||
144472800|NCT04026165|520928582|FG002|Run-in SEL Period|Death|0|||
144472801|NCT04026165|520928583|FG003|Run-in SEL Period|Death|0|||
144472802|NCT04026165|520928580|FG000|Randomized Period|Withdrew Consent|0|||
144472803|NCT04026165|520928581|FG001|Randomized Period|Withdrew Consent|0|||
144472804|NCT04026165|520928582|FG002|Randomized Period|Withdrew Consent|5|||
144727454|NCT02101853|521856655|FG004|Block 1 Induction|Death|0|||
144541882|NCT02362035|521182543|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
144541883|NCT02362035|521182543|FG000|Overall Study|Disease progression|11|||
144541884|NCT02362035|521182543|FG000|Overall Study|Withdrawal by Subject|20|||
144541885|NCT00463229|521182549|FG000|Overall Study|Lost to Follow-up|5|||
144541886|NCT00463229|521182550|FG001|Overall Study|Lost to Follow-up|7|||
144541887|NCT00463229|521182549|FG000|Overall Study|Death|4|||
144541888|NCT00463229|521182550|FG001|Overall Study|Death|3|||
144541889|NCT01767467|521182557|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
144541890|NCT01767467|521182558|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
144541891|NCT01767467|521182557|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
144541892|NCT01767467|521182558|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
144541893|NCT01767467|521182557|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
144541894|NCT01767467|521182558|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
144541895|NCT01767467|521182557|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
144541896|NCT01767467|521182558|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
144541897|NCT01767467|521182557|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
144541898|NCT01767467|521182558|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
144541899|NCT01767467|521182557|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
144541900|NCT01767467|521182558|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
144541901|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
144541902|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
144201924|NCT00006721|519936919|FG000|Overall Study|Eligible but no Treatment Received|1|||
144201925|NCT00006721|519936920|FG001|Overall Study|Eligible but no Treatment Received|0|||
144201926|NCT00006721|519936921|FG002|Overall Study|Eligible but no Treatment Received|0|||
144201927|NCT05424042|519936922|FG000|Overall Study|Withdrawal by Subject|2|||
144201928|NCT05424042|519936923|FG001|Overall Study|Withdrawal by Subject|0|||
144201929|NCT05424042|519936924|FG002|Overall Study|Withdrawal by Subject|4|||
144541903|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
144541904|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
144541905|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
144541906|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
144541907|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
144541908|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
144541909|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
144541910|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
144541911|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
144541912|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
144541913|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
144541914|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
144541915|NCT01767467|521182557|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
144541916|NCT01767467|521182558|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
144541917|NCT01359150|521182559|FG000|Overall Study|Lack of Efficacy|1|||
144541918|NCT01359150|521182560|FG001|Overall Study|Lack of Efficacy|1|||
144541919|NCT01359150|521182559|FG000|Overall Study|Withdrawal by Subject|1|||
144541920|NCT01359150|521182560|FG001|Overall Study|Withdrawal by Subject|1|||
144541921|NCT01359150|521182559|FG000|Overall Study|Adverse Event|4|||
144541922|NCT01359150|521182560|FG001|Overall Study|Adverse Event|3|||
144541923|NCT01359150|521182559|FG000|Overall Study|Other|1|||
144541924|NCT01359150|521182560|FG001|Overall Study|Other|0|||
144541925|NCT03041233|521182563|FG000|Overall Study|Death|5|||
144541926|NCT03041233|521182563|FG000|Overall Study|Physician Decision|1|||
144541927|NCT03041233|521182563|FG000|Overall Study|Lost to Follow-up|16|||
144541928|NCT03041233|521182563|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
144541929|NCT03041233|521182563|FG000|Overall Study|Sponsor Request|1|||
144541930|NCT03041233|521182563|FG000|Overall Study|Duplicate subject|1|||
144541931|NCT03041233|521182563|FG000|Overall Study|Re-ablation|1|||
144541932|NCT00853593|521182567|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
144541933|NCT00853593|521182567|FG000|Overall Study|Model 4396 lead not attempted|29|||
144541934|NCT00853593|521182567|FG000|Overall Study|Implant not attempted|4|||
144541935|NCT00687219|521182577|FG000|Overall Study|Adverse Event|8|||
144541936|NCT00687219|521182577|FG000|Overall Study|Discontinuance criteria met|7|||
144541937|NCT00687219|521182577|FG000|Overall Study|HCV-RNA positive conversion|34|||
144541938|NCT00687219|521182577|FG000|Overall Study|Withdrawal by Subject|1|||
144541939|NCT00687219|521182577|FG000|Overall Study|Lack of Efficacy|1|||
144541940|NCT02235298|521182585|FG000|Overall Study|Lost to Follow-up|6|||
144541941|NCT02235298|521182586|FG001|Overall Study|Lost to Follow-up|5|||
144541942|NCT02235298|521182585|FG000|Overall Study|Adverse Event|2|||
144201930|NCT05424042|519936922|FG000|Overall Study|Lost to Follow-up|0|||
144201931|NCT05424042|519936923|FG001|Overall Study|Lost to Follow-up|0|||
144201932|NCT05424042|519936924|FG002|Overall Study|Lost to Follow-up|1|||
144201933|NCT05091307|519936925|FG000|Overall Study|Death|0|||
144541943|NCT02235298|521182586|FG001|Overall Study|Adverse Event|2|||
144201934|NCT05091307|519936926|FG001|Overall Study|Death|0|||
144201935|NCT05091307|519936927|FG002|Overall Study|Death|1|||
144201936|NCT05091307|519936928|FG003|Overall Study|Death|0|||
144541944|NCT02235298|521182585|FG000|Overall Study|Withdrawal by Subject|0|||
144541945|NCT02235298|521182586|FG001|Overall Study|Withdrawal by Subject|1|||
144541946|NCT01588951|521182590|FG000|Overall Study|Ineligible in retrospect|0|||
144541947|NCT01588951|521182591|FG001|Overall Study|Ineligible in retrospect|0|||
144541948|NCT01588951|521182592|FG002|Overall Study|Ineligible in retrospect|1|||
144541949|NCT02350634|521182593|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
144541950|NCT00914966|521182607|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
144541951|NCT00914966|521182607|FG000|Step 1: 1500 Units|Physician Decision|1|||
144541952|NCT00914966|521182607|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
144541953|NCT03488719|521182608|FG000|Overall Study|Adverse Event|0|||
144541954|NCT03488719|521182609|FG001|Overall Study|Adverse Event|4|||
144541955|NCT03488719|521182610|FG002|Overall Study|Adverse Event|2|||
144541956|NCT03488719|521182608|FG000|Overall Study|Other|0|||
144541957|NCT03488719|521182609|FG001|Overall Study|Other|0|||
144541958|NCT03488719|521182610|FG002|Overall Study|Other|5|||
144541959|NCT03477175|521182611|FG000|Overall Study|Unable to travel due to COVID-19|0|||
144541960|NCT03477175|521182612|FG001|Overall Study|Unable to travel due to COVID-19|1|||
144541961|NCT03477175|521182611|FG000|Overall Study|Physician Decision|1|||
144541962|NCT03477175|521182612|FG001|Overall Study|Physician Decision|0|||
144541963|NCT03477175|521182611|FG000|Overall Study|Transitioned to commercial drug|6|||
144541964|NCT03477175|521182612|FG001|Overall Study|Transitioned to commercial drug|6|||
144541965|NCT03477175|521182611|FG000|Overall Study|Lost to Follow-up|1|||
144541966|NCT03477175|521182612|FG001|Overall Study|Lost to Follow-up|1|||
144541967|NCT03477175|521182611|FG000|Overall Study|Withdrawal by Subject|3|||
144541968|NCT03477175|521182612|FG001|Overall Study|Withdrawal by Subject|1|||
144541969|NCT03477175|521182611|FG000|Overall Study|Adverse Event|1|||
144541970|NCT03477175|521182612|FG001|Overall Study|Adverse Event|5|||
144541971|NCT03477175|521182611|FG000|Overall Study|Disease Progression|7|||
144541972|NCT03477175|521182612|FG001|Overall Study|Disease Progression|7|||
144541973|NCT01855750|521182613|FG000|Overall Study|Death|78|||
144541974|NCT01855750|521182614|FG001|Overall Study|Death|78|||
144541975|NCT01855750|521182613|FG000|Overall Study|Lost to Follow-up|9|||
144541976|NCT01855750|521182614|FG001|Overall Study|Lost to Follow-up|23|||
144541977|NCT01855750|521182613|FG000|Overall Study|Withdrawal by Subject|35|||
144541978|NCT01855750|521182614|FG001|Overall Study|Withdrawal by Subject|28|||
144541979|NCT01855750|521182613|FG000|Overall Study|Sponsor ends the study|297|||
144541980|NCT01855750|521182614|FG001|Overall Study|Sponsor ends the study|290|||
144541981|NCT04300023|521182615|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
144541982|NCT04300023|521182616|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
144541983|NCT05525572|521182617|FG000|Overall Study|Lost to Follow-up|2|||
144541984|NCT05025384|521182618|FG000|Overall Study|Physician Decision|5|||
144541985|NCT05025384|521182619|FG001|Overall Study|Physician Decision|6|||
144541986|NCT05251363|521182620|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
144541987|NCT05251363|521182620|FG000|Overall Study After Implant Period|Death|9|||
144541988|NCT05251363|521182620|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
144541989|NCT05251363|521182620|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
144541990|NCT05251363|521182620|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
144616122|NCT00183274|521454606|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
144616123|NCT00183274|521454607|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
144616124|NCT00183274|521454608|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
144616125|NCT00183274|521454603|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
144541991|NCT05251363|521182620|FG000|Overall Study After Implant Period|Physician Decision|1|||
144541992|NCT05251363|521182620|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
144541993|NCT03425682|521182621|FG000|Overall Study|Lost to Follow-up|2|||
144541994|NCT03425682|521182622|FG001|Overall Study|Lost to Follow-up|4|||
144541995|NCT03425682|521182621|FG000|Overall Study|Withdrawal by Subject|0|||
144541996|NCT03425682|521182622|FG001|Overall Study|Withdrawal by Subject|3|||
144541997|NCT03425682|521182621|FG000|Overall Study|Subject did not meet I/E|4|||
144541998|NCT03425682|521182622|FG001|Overall Study|Subject did not meet I/E|10|||
144541999|NCT03610581|521182623|FG000|Overall Study|Study terminated by sponsor|2|||
144542000|NCT03610581|521182624|FG001|Overall Study|Study terminated by sponsor|0|||
144542001|NCT03610581|521182623|FG000|Overall Study|Other|0|||
144616126|NCT00183274|521454604|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
144616127|NCT00183274|521454605|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
144201937|NCT05091307|519936925|FG000|Overall Study|Lost to Follow-up|33|||
144542002|NCT03610581|521182624|FG001|Overall Study|Other|1|||
144542003|NCT03610581|521182623|FG000|Overall Study|Withdrawal by Subject|1|||
144542004|NCT03610581|521182624|FG001|Overall Study|Withdrawal by Subject|0|||
144542005|NCT04649047|521182627|FG000|Overall Study|Withdrawal by Subject|3|||
144616128|NCT00183274|521454606|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
144542006|NCT00719888|521182628|FG000|Overall Study|Death|24|||
144201938|NCT05091307|519936926|FG001|Overall Study|Lost to Follow-up|33|||
144542007|NCT00719888|521182629|FG001|Overall Study|Death|9|||
144542008|NCT00719888|521182628|FG000|Overall Study|Relapse|8|||
144542009|NCT00719888|521182629|FG001|Overall Study|Relapse|3|||
144542010|NCT00719888|521182628|FG000|Overall Study|Physician Decision|1|||
144542011|NCT00719888|521182629|FG001|Overall Study|Physician Decision|0|||
144542012|NCT00719888|521182628|FG000|Overall Study|Withdrawal by Subject|1|||
144542013|NCT00719888|521182629|FG001|Overall Study|Withdrawal by Subject|0|||
144542014|NCT04577651|521182630|FG000|Overall Study|Screen Failure|7|||
144542015|NCT04577651|521182630|FG000|Overall Study|Adverse Event|1|||
144542016|NCT04577651|521182630|FG000|Overall Study|Death|1|||
144542017|NCT04577651|521182630|FG000|Overall Study|Physician Decision|1|||
144542018|NCT04577651|521182630|FG000|Overall Study|Withdrawal by Subject|3|||
144542019|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
144542020|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
144542021|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
144542022|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
144542023|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
144542024|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
144542025|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
144542026|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
144542027|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
144542028|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
144542029|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
144542030|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
144542031|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
144542032|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
144542033|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
144542034|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
144542035|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
144542036|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
144542037|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
144542038|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
144542039|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
144542040|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
144542041|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
144542042|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
144542043|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
144542044|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Other|1|||
144542045|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Other|0|||
144542046|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Other|0|||
144542047|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Other|0|||
144542048|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Other|0|||
144542049|NCT02386098|521184042|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
144542050|NCT02386098|521184043|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
144542051|NCT02386098|521184044|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
144542052|NCT02386098|521184045|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
144542053|NCT02386098|521184046|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
144542054|NCT03861052|521184047|FG000|Overall Study|Adverse Event|1|||
144542055|NCT03861052|521184048|FG001|Overall Study|Adverse Event|1|||
144542056|NCT03861052|521184049|FG002|Overall Study|Adverse Event|2|||
144542057|NCT03861052|521184050|FG003|Overall Study|Adverse Event|4|||
144542058|NCT03861052|521184047|FG000|Overall Study|Lost to Follow-up|0|||
144542059|NCT03861052|521184048|FG001|Overall Study|Lost to Follow-up|0|||
144542060|NCT03861052|521184049|FG002|Overall Study|Lost to Follow-up|0|||
144542061|NCT03861052|521184050|FG003|Overall Study|Lost to Follow-up|1|||
144542062|NCT03861052|521184047|FG000|Overall Study|Physician Decision|0|||
144542063|NCT03861052|521184048|FG001|Overall Study|Physician Decision|1|||
144542064|NCT03861052|521184049|FG002|Overall Study|Physician Decision|0|||
144542065|NCT03861052|521184050|FG003|Overall Study|Physician Decision|0|||
144542066|NCT03861052|521184047|FG000|Overall Study|Withdrawal by Subject|2|||
144727455|NCT02101853|521856656|FG005|Block 1 Induction|Death|0|||
144201939|NCT05091307|519936927|FG002|Overall Study|Lost to Follow-up|2|||
144201940|NCT05091307|519936928|FG003|Overall Study|Lost to Follow-up|0|||
144201941|NCT05091307|519936925|FG000|Overall Study|Physician Decision|1|||
144201942|NCT05091307|519936926|FG001|Overall Study|Physician Decision|0|||
144201943|NCT05091307|519936927|FG002|Overall Study|Physician Decision|0|||
144201944|NCT05091307|519936928|FG003|Overall Study|Physician Decision|0|||
144542067|NCT03861052|521184048|FG001|Overall Study|Withdrawal by Subject|5|||
144542068|NCT03861052|521184049|FG002|Overall Study|Withdrawal by Subject|3|||
144542069|NCT03861052|521184050|FG003|Overall Study|Withdrawal by Subject|0|||
144542070|NCT03861052|521184047|FG000|Overall Study|Relocation to other city|1|||
144542071|NCT03861052|521184048|FG001|Overall Study|Relocation to other city|0|||
144542072|NCT03861052|521184049|FG002|Overall Study|Relocation to other city|0|||
144542073|NCT03861052|521184050|FG003|Overall Study|Relocation to other city|0|||
144542074|NCT03712371|521184057|FG000|Overall Study|Lack of Efficacy|0|||
144542075|NCT03712371|521184058|FG001|Overall Study|Lack of Efficacy|0|||
144542076|NCT03712371|521184059|FG002|Overall Study|Lack of Efficacy|0|||
144542077|NCT03712371|521184060|FG003|Overall Study|Lack of Efficacy|1|||
144542078|NCT00229658|521184069|FG000|Overall Study|Administrative|2|||
144542079|NCT00229658|521184070|FG001|Overall Study|Administrative|1|||
144542080|NCT00229658|521184069|FG000|Overall Study|Investigator decision|13|||
144542081|NCT00229658|521184070|FG001|Overall Study|Investigator decision|10|||
144542082|NCT00229658|521184069|FG000|Overall Study|Other|80|||
144542083|NCT00229658|521184070|FG001|Overall Study|Other|60|||
144542084|NCT00229658|521184069|FG000|Overall Study|Lost to Follow-up|82|||
144542085|NCT00229658|521184070|FG001|Overall Study|Lost to Follow-up|55|||
144542086|NCT00229658|521184069|FG000|Overall Study|Serious Adverse Event|2|||
144201945|NCT05091307|519936925|FG000|Overall Study|Protocol Violation|1|||
144201946|NCT05091307|519936926|FG001|Overall Study|Protocol Violation|0|||
144201947|NCT05091307|519936927|FG002|Overall Study|Protocol Violation|0|||
144201948|NCT05091307|519936928|FG003|Overall Study|Protocol Violation|0|||
144542087|NCT00229658|521184070|FG001|Overall Study|Serious Adverse Event|2|||
144542088|NCT00229658|521184069|FG000|Overall Study|Withdrawal of consent|46|||
144542089|NCT00229658|521184070|FG001|Overall Study|Withdrawal of consent|39|||
144542090|NCT02157116|521184071|FG000|Overall Study|Withdrawal by Subject|4|||
144542091|NCT02157116|521184071|FG000|Overall Study|Physician Decision|3|||
144542092|NCT02157116|521184071|FG000|Overall Study|Failed Screening|2|||
144542093|NCT00093496|521184072|FG000|Overall Study|Protocol Violation|1|||
144542094|NCT00093496|521184073|FG001|Overall Study|Protocol Violation|3|||
144542095|NCT00975585|521184074|FG000|Overall Study|Adverse Event|0|||
144542096|NCT00975585|521184075|FG001|Overall Study|Adverse Event|4|||
144542097|NCT00975585|521184074|FG000|Overall Study|Lost to Follow-up|3|||
144542098|NCT00975585|521184075|FG001|Overall Study|Lost to Follow-up|5|||
144542099|NCT00975585|521184074|FG000|Overall Study|Withdrawal by Subject|2|||
144616129|NCT00183274|521454607|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
144616130|NCT00183274|521454608|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
144616131|NCT00183274|521454603|FG000|Phase 3: Double-Blind|Relapsed|0|||
144616132|NCT00183274|521454604|FG001|Phase 3: Double-Blind|Relapsed|0|||
144616133|NCT00183274|521454605|FG002|Phase 3: Double-Blind|Relapsed|0|||
144616134|NCT00183274|521454606|FG003|Phase 3: Double-Blind|Relapsed|1|||
144616135|NCT00183274|521454607|FG004|Phase 3: Double-Blind|Relapsed|11|||
144616136|NCT00183274|521454608|FG005|Phase 3: Double-Blind|Relapsed|2|||
144201949|NCT05091307|519936925|FG000|Overall Study|Withdrawal by Subject|16|||
144472805|NCT04026165|520928583|FG003|Randomized Period|Withdrew Consent|8|||
144472806|NCT04026165|520928580|FG000|Randomized Period|Death|0|||
144472807|NCT04026165|520928581|FG001|Randomized Period|Death|0|||
144472808|NCT04026165|520928582|FG002|Randomized Period|Death|5|||
144472809|NCT04026165|520928583|FG003|Randomized Period|Death|7|||
144472810|NCT04026165|520928580|FG000|Randomized Period|Investigator's Discretion|0|||
144472811|NCT04026165|520928581|FG001|Randomized Period|Investigator's Discretion|0|||
144472812|NCT04026165|520928582|FG002|Randomized Period|Investigator's Discretion|2|||
144472813|NCT04026165|520928583|FG003|Randomized Period|Investigator's Discretion|2|||
144472814|NCT04026165|520928580|FG000|Randomized Period|Lost to Follow-up|0|||
144472815|NCT04026165|520928581|FG001|Randomized Period|Lost to Follow-up|0|||
144472816|NCT04026165|520928582|FG002|Randomized Period|Lost to Follow-up|2|||
144472817|NCT04026165|520928583|FG003|Randomized Period|Lost to Follow-up|2|||
144472818|NCT00077064|520928584|FG000|Overall Study|Adverse Event|0|||
144472819|NCT00077064|520928585|FG001|Overall Study|Adverse Event|4|||
144472820|NCT00077064|520928584|FG000|Overall Study|Patient refusal|0|||
144472821|NCT00077064|520928585|FG001|Overall Study|Patient refusal|2|||
144472822|NCT03815019|520928586|FG000|Overall Study|Withdrawal by Subject|6|||
144472823|NCT03815019|520928587|FG001|Overall Study|Withdrawal by Subject|8|||
144472824|NCT05398796|520928588|FG000|Overall Study|Participant moved from the area|0|||
144472825|NCT05398796|520928589|FG001|Overall Study|Participant moved from the area|1|||
144472826|NCT05398796|520928590|FG002|Overall Study|Participant moved from the area|0|||
144472827|NCT05398796|520928591|FG003|Overall Study|Participant moved from the area|0|||
144472828|NCT04270747|520928593|FG000|Through Week 16|Adverse Event|1|||
144472829|NCT04270747|520928594|FG001|Through Week 16|Adverse Event|2|||
144472830|NCT04270747|520928595|FG002|Through Week 16|Adverse Event|0|||
144472831|NCT04270747|520928593|FG000|Through Week 16|Death|0|||
144472832|NCT04270747|520928594|FG001|Through Week 16|Death|2|||
144472833|NCT04270747|520928595|FG002|Through Week 16|Death|0|||
144472834|NCT04270747|520928593|FG000|Through Week 16|Consent Withdrawn|3|||
144472835|NCT04270747|520928594|FG001|Through Week 16|Consent Withdrawn|3|||
144472836|NCT04270747|520928595|FG002|Through Week 16|Consent Withdrawn|0|||
144472837|NCT04270747|520928593|FG000|Through Week 16|Physician Decision|1|||
144472838|NCT04270747|520928594|FG001|Through Week 16|Physician Decision|1|||
144472839|NCT04270747|520928595|FG002|Through Week 16|Physician Decision|0|||
144542100|NCT00975585|521184075|FG001|Overall Study|Withdrawal by Subject|1|||
144616137|NCT00618410|521454619|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
144472840|NCT04270747|520928593|FG000|Through Week 16|Lost to Follow-up|2|||
144472841|NCT04270747|520928594|FG001|Through Week 16|Lost to Follow-up|0|||
144472842|NCT04270747|520928595|FG002|Through Week 16|Lost to Follow-up|0|||
144616138|NCT00618410|521454620|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
144616139|NCT02980224|521454630|FG000|Overall Study|Adverse Event|4|||
144201950|NCT05091307|519936926|FG001|Overall Study|Withdrawal by Subject|16|||
144201951|NCT05091307|519936927|FG002|Overall Study|Withdrawal by Subject|0|||
144616140|NCT02980224|521454631|FG001|Overall Study|Adverse Event|1|||
144616141|NCT02980224|521454630|FG000|Overall Study|Withdrawal by Subject|0|||
144616142|NCT02980224|521454631|FG001|Overall Study|Withdrawal by Subject|2|||
144616143|NCT04770389|521454634|FG000|Overall Study|Adverse Event|1|||
144616144|NCT04770389|521454635|FG001|Overall Study|Adverse Event|2|||
144201952|NCT05091307|519936928|FG003|Overall Study|Withdrawal by Subject|1|||
144201953|NCT05091307|519936925|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
144201954|NCT05091307|519936926|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
144201955|NCT05091307|519936927|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
144201956|NCT05091307|519936928|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
144542101|NCT00975585|521184074|FG000|Overall Study|Lens issue|2|||
144542102|NCT00975585|521184075|FG001|Overall Study|Lens issue|2|||
144542103|NCT01953224|521184076|FG000|Overall Study|Lost to Follow-up|1|||
144542104|NCT01953224|521184077|FG001|Overall Study|Lost to Follow-up|1|||
144542105|NCT01953224|521184076|FG000|Overall Study|Withdrawal by Subject|1|||
144542106|NCT01953224|521184077|FG001|Overall Study|Withdrawal by Subject|2|||
144542107|NCT00683800|521184079|FG000|Overall Study|Adverse Event|195|||
144542108|NCT00683800|521184080|FG001|Overall Study|Adverse Event|102|||
144542109|NCT00683800|521184079|FG000|Overall Study|Death|0|||
144542110|NCT00683800|521184080|FG001|Overall Study|Death|1|||
144542111|NCT00683800|521184079|FG000|Overall Study|Lost to Follow-up|57|||
144542112|NCT00683800|521184080|FG001|Overall Study|Lost to Follow-up|44|||
144542113|NCT00683800|521184079|FG000|Overall Study|Other|5|||
144542114|NCT00683800|521184080|FG001|Overall Study|Other|2|||
144542115|NCT00683800|521184079|FG000|Overall Study|Protocol Violation|13|||
144542116|NCT00683800|521184080|FG001|Overall Study|Protocol Violation|16|||
144542117|NCT00683800|521184079|FG000|Overall Study|Withdrawal by Subject|66|||
144542118|NCT00683800|521184080|FG001|Overall Study|Withdrawal by Subject|64|||
144542119|NCT00683800|521184079|FG000|Overall Study|Lack of Efficacy|61|||
144542120|NCT00683800|521184080|FG001|Overall Study|Lack of Efficacy|104|||
144542121|NCT00683800|521184079|FG000|Overall Study|Randomized, not treated|35|||
144542122|NCT00683800|521184080|FG001|Overall Study|Randomized, not treated|33|||
144542123|NCT00205179|521184083|FG000|Overall Study|Death|0|||
144542124|NCT00205179|521184084|FG001|Overall Study|Death|2|||
144542125|NCT00205179|521184083|FG000|Overall Study|Physician Decision|1|||
144542126|NCT00205179|521184084|FG001|Overall Study|Physician Decision|1|||
144542127|NCT00205179|521184083|FG000|Overall Study|Adverse Event|1|||
144542128|NCT00205179|521184084|FG001|Overall Study|Adverse Event|1|||
144542129|NCT01932970|521184085|FG000|Overall Study|Withdrawal by Subject|5|||
144542130|NCT01932970|521184085|FG000|Overall Study|Death|1|||
144542131|NCT01932970|521184085|FG000|Overall Study|Lost to Follow-up|2|||
144542132|NCT01932970|521184085|FG000|Overall Study|Protocol Specified Criteria|10|||
144542133|NCT00853580|521184086|FG000|Overall Study|Lost to Follow-up|3|||
144542134|NCT00853580|521184087|FG001|Overall Study|Lost to Follow-up|5|||
144542135|NCT00853580|521184086|FG000|Overall Study|Protocol Violation|2|||
144542136|NCT00853580|521184087|FG001|Overall Study|Protocol Violation|1|||
144542137|NCT00853580|521184086|FG000|Overall Study|Withdrawal by Subject|2|||
144542138|NCT00853580|521184087|FG001|Overall Study|Withdrawal by Subject|8|||
144542139|NCT00853580|521184086|FG000|Overall Study|Commenced contraindicated therapy|0|||
144542140|NCT00853580|521184087|FG001|Overall Study|Commenced contraindicated therapy|2|||
144542141|NCT01700205|521184088|FG000|Overall Study|Withdrawal by Subject|13|||
144542142|NCT01700205|521184089|FG001|Overall Study|Withdrawal by Subject|13|||
144542143|NCT01700205|521184088|FG000|Overall Study|Protocol Violation|2|||
144542144|NCT01700205|521184089|FG001|Overall Study|Protocol Violation|2|||
144542145|NCT03113409|521184090|FG000|Overall Study|Withdrawal by Subject|5|||
144616145|NCT04770389|521454636|FG002|Overall Study|Adverse Event|0|||
144261347|NCT01719380|520158109|FG001|Overall Study|Physician Decision|0|||
144261348|NCT01719380|520158110|FG002|Overall Study|Physician Decision|2|||
144261349|NCT01719380|520158111|FG003|Overall Study|Physician Decision|0|||
144542146|NCT03113409|521184091|FG001|Overall Study|Withdrawal by Subject|0|||
144542147|NCT03113409|521184092|FG002|Overall Study|Withdrawal by Subject|0|||
144616146|NCT04770389|521454637|FG003|Overall Study|Adverse Event|1|||
144542148|NCT01787032|521184095|FG000|Overall Study|Protocol Violation|0|||
144542149|NCT01787032|521184096|FG001|Overall Study|Protocol Violation|0|||
144542150|NCT01787032|521184097|FG002|Overall Study|Protocol Violation|0|||
144542151|NCT01787032|521184098|FG003|Overall Study|Protocol Violation|0|||
144542152|NCT01787032|521184099|FG004|Overall Study|Protocol Violation|1|||
144542153|NCT01787032|521184100|FG005|Overall Study|Protocol Violation|1|||
144542154|NCT02040870|521184101|FG000|Overall Study|Completed treatment phase|6|||
144201957|NCT05091307|519936925|FG000|Overall Study|Initiated Prohibited Medication|1|||
144201958|NCT05091307|519936926|FG001|Overall Study|Initiated Prohibited Medication|0|||
144542155|NCT02040870|521184101|FG000|Overall Study|Adverse Event|7|||
144542156|NCT02040870|521184101|FG000|Overall Study|Progressive disease|58|||
144616147|NCT04770389|521454634|FG000|Overall Study|Withdrawal by Subject|0|||
144616148|NCT04770389|521454635|FG001|Overall Study|Withdrawal by Subject|2|||
144616149|NCT04770389|521454636|FG002|Overall Study|Withdrawal by Subject|1|||
144616150|NCT04770389|521454637|FG003|Overall Study|Withdrawal by Subject|0|||
144616151|NCT04770389|521454634|FG000|Overall Study|Failed attempt to draw blood|1|||
144616152|NCT04770389|521454635|FG001|Overall Study|Failed attempt to draw blood|0|||
144616153|NCT04770389|521454636|FG002|Overall Study|Failed attempt to draw blood|0|||
144616154|NCT04770389|521454637|FG003|Overall Study|Failed attempt to draw blood|0|||
144616155|NCT04770389|521454634|FG000|Overall Study|Left the country|0|||
144616156|NCT04770389|521454635|FG001|Overall Study|Left the country|0|||
144616157|NCT04770389|521454636|FG002|Overall Study|Left the country|1|||
144616158|NCT04770389|521454637|FG003|Overall Study|Left the country|2|||
144616159|NCT04770389|521454634|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
144616160|NCT04770389|521454635|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
144616161|NCT04770389|521454636|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
144616162|NCT04770389|521454637|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
144616163|NCT04770389|521454634|FG000|Overall Study|Lost to Follow-up|0|||
144542157|NCT02040870|521184101|FG000|Overall Study|Physician Decision|6|||
144542158|NCT02040870|521184101|FG000|Overall Study|Subject/guardian decision|10|||
144542159|NCT02040870|521184101|FG000|Overall Study|Lost to Follow-up|3|||
144542160|NCT02040870|521184101|FG000|Overall Study|Death|13|||
144542161|NCT03335488|521184104|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
144542162|NCT03335488|521184105|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
144542163|NCT03335488|521184104|FG000|Safety Extension Period|Adverse Event|1|||
144542164|NCT03335488|521184105|FG001|Safety Extension Period|Adverse Event|0|||
144542165|NCT03335488|521184104|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
144542166|NCT03335488|521184105|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
144542167|NCT00388726|521184106|FG000|Overall Study|Adverse Event|50|||
144542168|NCT00388726|521184107|FG001|Overall Study|Adverse Event|24|||
144542169|NCT00388726|521184106|FG000|Overall Study|Progressive Disease|336|||
144542170|NCT00388726|521184107|FG001|Overall Study|Progressive Disease|153|||
144542171|NCT00388726|521184106|FG000|Overall Study|Clinical Progression|61|||
144542172|NCT00388726|521184107|FG001|Overall Study|Clinical Progression|36|||
144542173|NCT00388726|521184106|FG000|Overall Study|Withdrawal by Subject|10|||
144542174|NCT00388726|521184107|FG001|Overall Study|Withdrawal by Subject|7|||
144542175|NCT00388726|521184106|FG000|Overall Study|Administrative|6|||
144542176|NCT00388726|521184107|FG001|Overall Study|Administrative|9|||
144542177|NCT00388726|521184106|FG000|Overall Study|Physician Decision|18|||
144542178|NCT00388726|521184107|FG001|Overall Study|Physician Decision|13|||
144542179|NCT00388726|521184106|FG000|Overall Study|Death|3|||
144542180|NCT00388726|521184107|FG001|Overall Study|Death|2|||
144542181|NCT04971733|521184108|FG000|Overall Study|Adverse Event|1|||
144542182|NCT04971733|521184109|FG001|Overall Study|Adverse Event|1|||
144542183|NCT04971733|521184108|FG000|Overall Study|Subject choice|2|||
144542184|NCT04971733|521184109|FG001|Overall Study|Subject choice|0|||
144542185|NCT04971733|521184108|FG000|Overall Study|Withdrawal by Subject|1|||
144542186|NCT04971733|521184109|FG001|Overall Study|Withdrawal by Subject|0|||
144542187|NCT04971733|521184108|FG000|Overall Study|Other|1|||
144542188|NCT04971733|521184109|FG001|Overall Study|Other|0|||
144542189|NCT03229408|521184111|FG000|Overall Study|Withdrawal by Subject|4|||
144542190|NCT03229408|521184112|FG001|Overall Study|Withdrawal by Subject|1|||
144542191|NCT03229408|521184111|FG000|Overall Study|Adverse Event|2|||
144542192|NCT03229408|521184112|FG001|Overall Study|Adverse Event|0|||
144542193|NCT03229408|521184111|FG000|Overall Study|Pregnancy|0|||
144542194|NCT03229408|521184112|FG001|Overall Study|Pregnancy|1|||
144542195|NCT03229408|521184111|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
144542196|NCT03229408|521184112|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
144542197|NCT04200664|521184113|FG000|Overall Study|Withdrawal by Subject|1|||
144542198|NCT04200664|521184114|FG001|Overall Study|Withdrawal by Subject|0|||
144542199|NCT04200664|521184115|FG002|Overall Study|Withdrawal by Subject|0|||
144542200|NCT03890289|521184120|FG000|Overall Study|Adverse Event|1|||
144542201|NCT03890289|521184120|FG000|Overall Study|Physician Decision|1|||
144542202|NCT03890289|521184120|FG000|Overall Study|Lack of Efficacy|2|||
144542203|NCT02816398|521184121|FG000|Overall Study|Death|5|||
144542204|NCT02816398|521184121|FG000|Overall Study|Lack of Efficacy|8|||
144542205|NCT02816398|521184121|FG000|Overall Study|Lost to Follow-up|1|||
144542206|NCT03362190|521184122|FG000|Overall Study|Adverse Event|0|||
144542207|NCT03362190|521184123|FG001|Overall Study|Adverse Event|0|||
144616164|NCT04770389|521454635|FG001|Overall Study|Lost to Follow-up|0|||
144201959|NCT05091307|519936927|FG002|Overall Study|Initiated Prohibited Medication|0|||
144201960|NCT05091307|519936928|FG003|Overall Study|Initiated Prohibited Medication|0|||
144542208|NCT03362190|521184124|FG002|Overall Study|Adverse Event|0|||
144542209|NCT03362190|521184125|FG003|Overall Study|Adverse Event|1|||
144542210|NCT03362190|521184122|FG000|Overall Study|Withdrawal by Subject|0|||
144616165|NCT04770389|521454636|FG002|Overall Study|Lost to Follow-up|0|||
144616166|NCT04770389|521454637|FG003|Overall Study|Lost to Follow-up|1|||
144616167|NCT04770389|521454634|FG000|Overall Study|Moved away from study site|0|||
144542211|NCT03362190|521184123|FG001|Overall Study|Withdrawal by Subject|0|||
144542212|NCT03362190|521184124|FG002|Overall Study|Withdrawal by Subject|0|||
144542213|NCT03362190|521184125|FG003|Overall Study|Withdrawal by Subject|1|||
144542214|NCT01367236|521184126|FG000|Overall Study|Withdrawal by Subject|3|||
144542215|NCT01367236|521184127|FG001|Overall Study|Withdrawal by Subject|1|||
144542216|NCT01593020|521184132|FG000|Overall Study|Adverse Event|1|||
144542217|NCT01593020|521184133|FG001|Overall Study|Adverse Event|1|||
144542218|NCT01593020|521184132|FG000|Overall Study|Death|0|||
144542219|NCT01593020|521184133|FG001|Overall Study|Death|1|||
144542220|NCT01593020|521184132|FG000|Overall Study|Ineligible|1|||
144542221|NCT01593020|521184133|FG001|Overall Study|Ineligible|0|||
144542222|NCT02063659|521184134|FG000|Double-Blind Treatment Period|Adverse Event|1|||
144542223|NCT02063659|521184135|FG001|Double-Blind Treatment Period|Adverse Event|2|||
144542224|NCT02063659|521184136|FG002|Double-Blind Treatment Period|Adverse Event|0|||
144542225|NCT02063659|521184137|FG003|Double-Blind Treatment Period|Adverse Event|0|||
144542226|NCT02063659|521184134|FG000|Double-Blind Treatment Period|Physician Decision|1|||
144542227|NCT02063659|521184135|FG001|Double-Blind Treatment Period|Physician Decision|0|||
144542228|NCT02063659|521184136|FG002|Double-Blind Treatment Period|Physician Decision|0|||
144542229|NCT02063659|521184137|FG003|Double-Blind Treatment Period|Physician Decision|0|||
144542230|NCT02063659|521184134|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
144542231|NCT02063659|521184135|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
144542232|NCT02063659|521184136|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
144542233|NCT02063659|521184137|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
144542234|NCT02063659|521184134|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
144542235|NCT02063659|521184135|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
144542236|NCT02063659|521184136|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
144542237|NCT02063659|521184137|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
144542238|NCT02063659|521184134|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
144542239|NCT02063659|521184135|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
144542240|NCT02063659|521184136|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
144542241|NCT02063659|521184137|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
144542242|NCT02063659|521184134|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
144542243|NCT02063659|521184135|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
144542244|NCT02063659|521184136|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
144542245|NCT02063659|521184137|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
144542246|NCT02063659|521184134|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
144542247|NCT02063659|521184135|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
144542248|NCT02063659|521184136|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
144542249|NCT02063659|521184137|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
144542250|NCT02063659|521184134|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
144542251|NCT02063659|521184135|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
144542252|NCT02063659|521184136|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
144201961|NCT05091307|519936925|FG000|Overall Study|Other|4|||
144201962|NCT05091307|519936926|FG001|Overall Study|Other|4|||
144201963|NCT05091307|519936927|FG002|Overall Study|Other|0|||
144542253|NCT02063659|521184137|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
144542254|NCT04057131|521184140|FG000|Overall Study|Protocol Violation|24|||
144542255|NCT04445831|521184141|FG000|Overall Study|Withdrawal by Subject|2|||
144542256|NCT04445831|521184142|FG001|Overall Study|Withdrawal by Subject|1|||
144542257|NCT04445831|521184143|FG002|Overall Study|Withdrawal by Subject|1|||
144542258|NCT04445831|521184144|FG003|Overall Study|Withdrawal by Subject|0|||
144542259|NCT04445831|521184145|FG004|Overall Study|Withdrawal by Subject|0|||
144542260|NCT04445831|521184146|FG005|Overall Study|Withdrawal by Subject|0|||
144542261|NCT04445831|521184147|FG006|Overall Study|Withdrawal by Subject|0|||
144542262|NCT04445831|521184141|FG000|Overall Study|Subject withdrawal by caregiver|0|||
144542263|NCT04445831|521184142|FG001|Overall Study|Subject withdrawal by caregiver|1|||
144542264|NCT04445831|521184143|FG002|Overall Study|Subject withdrawal by caregiver|0|||
144542265|NCT04445831|521184144|FG003|Overall Study|Subject withdrawal by caregiver|0|||
144542266|NCT04445831|521184145|FG004|Overall Study|Subject withdrawal by caregiver|0|||
144542267|NCT04445831|521184146|FG005|Overall Study|Subject withdrawal by caregiver|0|||
144542268|NCT04445831|521184147|FG006|Overall Study|Subject withdrawal by caregiver|0|||
144542269|NCT05613907|521184148|FG000|Overall Study|Lost to Follow-up|5|||
144542270|NCT05613907|521184148|FG000|Overall Study|Death|3|||
144616168|NCT04770389|521454635|FG001|Overall Study|Moved away from study site|1|||
144616169|NCT04770389|521454636|FG002|Overall Study|Moved away from study site|0|||
144616170|NCT04770389|521454637|FG003|Overall Study|Moved away from study site|0|||
144201964|NCT05091307|519936928|FG003|Overall Study|Other|0|||
144616171|NCT00708123|521454639|FG000|Period 1|Protocol Violation|0|||
144201965|NCT05091307|519936925|FG000|Overall Study|Randomized but not vaccinated|0|||
144542271|NCT05613907|521184148|FG000|Overall Study|Withdrawal by Subject|2|||
144542272|NCT04701203|521184165|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
144616172|NCT00708123|521454640|FG001|Period 1|Protocol Violation|1|||
144616173|NCT00708123|521454641|FG002|Period 1|Protocol Violation|0|||
144542273|NCT04701203|521184166|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
144542274|NCT04701203|521184167|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
144542275|NCT04701203|521184165|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
144542276|NCT04701203|521184166|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
144542277|NCT04701203|521184167|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
144542278|NCT04701203|521184165|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
144542279|NCT04701203|521184166|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
144542280|NCT04701203|521184167|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
144542281|NCT04701203|521184165|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
144542282|NCT04701203|521184166|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
144542283|NCT04701203|521184167|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
144542284|NCT05422339|521185216|FG000|Overall Study|Withdrawal by Subject|17|||
144542285|NCT05422339|521185217|FG001|Overall Study|Withdrawal by Subject|15|||
144542286|NCT04172675|521185218|FG000|Overall Study|Withdrawal by Subject|7|||
144542287|NCT04172675|521185219|FG001|Overall Study|Withdrawal by Subject|5|||
144542288|NCT04172675|521185220|FG002|Overall Study|Withdrawal by Subject|1|||
144542289|NCT04172675|521185221|FG003|Overall Study|Withdrawal by Subject|4|||
144542290|NCT03070392|521185222|FG000|Overall Study|Not Treated|7|||
144542291|NCT03070392|521185223|FG001|Overall Study|Not Treated|0|||
144542292|NCT03070392|521185224|FG002|Overall Study|Not Treated|3|||
144542293|NCT03070392|521185225|FG003|Overall Study|Not Treated|12|||
144542294|NCT03070392|521185222|FG000|Overall Study|Death|3|||
144542295|NCT03070392|521185223|FG001|Overall Study|Death|0|||
144542296|NCT03070392|521185224|FG002|Overall Study|Death|0|||
144542297|NCT03070392|521185225|FG003|Overall Study|Death|1|||
144542298|NCT03070392|521185222|FG000|Overall Study|Withdrawal by Subject|7|||
144542299|NCT03070392|521185223|FG001|Overall Study|Withdrawal by Subject|0|||
144542300|NCT03070392|521185224|FG002|Overall Study|Withdrawal by Subject|0|||
144542301|NCT03070392|521185225|FG003|Overall Study|Withdrawal by Subject|3|||
144542302|NCT03070392|521185222|FG000|Overall Study|Physician Decision|1|||
144542303|NCT03070392|521185223|FG001|Overall Study|Physician Decision|0|||
144542304|NCT03070392|521185224|FG002|Overall Study|Physician Decision|0|||
144542305|NCT03070392|521185225|FG003|Overall Study|Physician Decision|2|||
144542306|NCT03070392|521185222|FG000|Overall Study|Progressive Disease|154|||
144542307|NCT03070392|521185223|FG001|Overall Study|Progressive Disease|6|||
144542308|NCT03070392|521185224|FG002|Overall Study|Progressive Disease|2|||
144542309|NCT03070392|521185225|FG003|Overall Study|Progressive Disease|70|||
144542310|NCT03070392|521185222|FG000|Overall Study|Adverse Event|6|||
144542311|NCT03070392|521185223|FG001|Overall Study|Adverse Event|1|||
144542312|NCT03070392|521185224|FG002|Overall Study|Adverse Event|1|||
144542313|NCT03070392|521185225|FG003|Overall Study|Adverse Event|3|||
144542314|NCT03070392|521185222|FG000|Overall Study|Alternate anticancer treatment|1|||
144542315|NCT03070392|521185223|FG001|Overall Study|Alternate anticancer treatment|0|||
144542316|NCT03070392|521185224|FG002|Overall Study|Alternate anticancer treatment|0|||
144542317|NCT03070392|521185225|FG003|Overall Study|Alternate anticancer treatment|1|||
144542318|NCT03070392|521185222|FG000|Overall Study|Ongoing|73|||
144542319|NCT03070392|521185223|FG001|Overall Study|Ongoing|0|||
144542320|NCT03070392|521185224|FG002|Overall Study|Ongoing|0|||
144542321|NCT03070392|521185225|FG003|Overall Study|Ongoing|11|||
144542322|NCT01278030|521185226|FG000|Overall Study|Withdrawal by Subject|8|||
144542323|NCT01278030|521185227|FG001|Overall Study|Withdrawal by Subject|4|||
144542324|NCT00458783|521185229|FG000|Overall Study|Protocol Violation|1228|||
144542325|NCT00458783|521185230|FG001|Overall Study|Protocol Violation|1220|||
144542326|NCT01737398|521185231|FG000|Overall Study|Adverse event or SAE|16|||
144542327|NCT01737398|521185232|FG001|Overall Study|Adverse event or SAE|1|||
144542328|NCT01737398|521185231|FG000|Overall Study|Stopping rule met|2|||
144542329|NCT01737398|521185232|FG001|Overall Study|Stopping rule met|1|||
144542330|NCT01737398|521185231|FG000|Overall Study|Voluntary withdrawal|2|||
144542331|NCT01737398|521185232|FG001|Overall Study|Voluntary withdrawal|3|||
144542332|NCT01737398|521185231|FG000|Overall Study|Ineligibility|1|||
144542333|NCT01737398|521185232|FG001|Overall Study|Ineligibility|0|||
144542334|NCT01737398|521185231|FG000|Overall Study|Liver transplant|1|||
144542335|NCT01737398|521185232|FG001|Overall Study|Liver transplant|0|||
144542336|NCT01737398|521185231|FG000|Overall Study|Disease progression|2|||
144542337|NCT01737398|521185232|FG001|Overall Study|Disease progression|3|||
144542338|NCT01737398|521185231|FG000|Overall Study|Sponsor's decision|2|||
144542339|NCT01737398|521185232|FG001|Overall Study|Sponsor's decision|0|||
144727456|NCT02101853|521856651|FG000|Block 1 Induction|Lack of Efficacy|6|||
144542340|NCT03220724|521185236|FG000|Overall Study|Lost to Follow-up|2|||
144542341|NCT03220724|521185237|FG001|Overall Study|Lost to Follow-up|2|||
144542342|NCT03220724|521185238|FG002|Overall Study|Lost to Follow-up|0|||
144727457|NCT02101853|521856652|FG001|Block 1 Induction|Lack of Efficacy|0|||
144542343|NCT03220724|521185239|FG003|Overall Study|Lost to Follow-up|3|||
144542344|NCT03220724|521185240|FG004|Overall Study|Lost to Follow-up|1|||
144542345|NCT03220724|521185241|FG005|Overall Study|Lost to Follow-up|0|||
144542346|NCT03220724|521185242|FG006|Overall Study|Lost to Follow-up|2|||
144542347|NCT03220724|521185243|FG007|Overall Study|Lost to Follow-up|1|||
144542348|NCT03220724|521185244|FG008|Overall Study|Lost to Follow-up|0|||
144201966|NCT05091307|519936926|FG001|Overall Study|Randomized but not vaccinated|2|||
144201967|NCT05091307|519936927|FG002|Overall Study|Randomized but not vaccinated|0|||
144201968|NCT05091307|519936928|FG003|Overall Study|Randomized but not vaccinated|0|||
144542349|NCT03220724|521185236|FG000|Overall Study|Withdrawal by Subject|1|||
144542350|NCT03220724|521185237|FG001|Overall Study|Withdrawal by Subject|0|||
144542351|NCT03220724|521185238|FG002|Overall Study|Withdrawal by Subject|1|||
144542352|NCT03220724|521185239|FG003|Overall Study|Withdrawal by Subject|0|||
144542353|NCT03220724|521185240|FG004|Overall Study|Withdrawal by Subject|0|||
144542354|NCT03220724|521185241|FG005|Overall Study|Withdrawal by Subject|0|||
144542355|NCT03220724|521185242|FG006|Overall Study|Withdrawal by Subject|0|||
144542356|NCT03220724|521185243|FG007|Overall Study|Withdrawal by Subject|0|||
144542357|NCT03220724|521185244|FG008|Overall Study|Withdrawal by Subject|0|||
144542358|NCT01728324|521185248|FG000|Termination of DBV|Adverse Event|14|||
144542359|NCT01728324|521185249|FG001|Termination of DBV|Adverse Event|13|||
144542360|NCT01728324|521185250|FG002|Termination of DBV|Adverse Event|4|||
144542361|NCT01728324|521185248|FG000|Termination of DBV|Lack of Efficacy|14|||
144542362|NCT01728324|521185249|FG001|Termination of DBV|Lack of Efficacy|12|||
144542363|NCT01728324|521185250|FG002|Termination of DBV|Lack of Efficacy|8|||
144542364|NCT01728324|521185248|FG000|Termination of DBV|Withdrawal by Subject|9|||
144542365|NCT01728324|521185249|FG001|Termination of DBV|Withdrawal by Subject|6|||
144542366|NCT01728324|521185250|FG002|Termination of DBV|Withdrawal by Subject|2|||
144542367|NCT01728324|521185248|FG000|Termination of DBV|Other than stated|1|||
144542368|NCT01728324|521185249|FG001|Termination of DBV|Other than stated|3|||
144542369|NCT01728324|521185250|FG002|Termination of DBV|Other than stated|0|||
144542370|NCT01728324|521185248|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
144542371|NCT01728324|521185249|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
144542372|NCT01728324|521185250|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
144542373|NCT01728324|521185248|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
144542374|NCT01728324|521185249|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
144542375|NCT01728324|521185250|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
144201969|NCT03611543|519936929|FG000|Overall Study|Withdrawal by Subject|4|||
144201970|NCT03611543|519936930|FG001|Overall Study|Withdrawal by Subject|4|||
144201971|NCT03611543|519936929|FG000|Overall Study|Physician Decision|1|||
144201972|NCT03611543|519936930|FG001|Overall Study|Physician Decision|1|||
144201973|NCT03611543|519936929|FG000|Overall Study|Protocol Violation|2|||
144201974|NCT03611543|519936930|FG001|Overall Study|Protocol Violation|2|||
144201975|NCT03611543|519936929|FG000|Overall Study|Device failure|2|||
144201976|NCT03611543|519936930|FG001|Overall Study|Device failure|2|||
144261350|NCT01719380|520158112|FG004|Overall Study|Physician Decision|0|||
144261351|NCT01719380|520158113|FG005|Overall Study|Physician Decision|0|||
144261352|NCT01719380|520158114|FG006|Overall Study|Physician Decision|0|||
144261353|NCT01719380|520158115|FG007|Overall Study|Physician Decision|0|||
144261354|NCT01719380|520158116|FG008|Overall Study|Physician Decision|1|||
144261355|NCT01719380|520158117|FG009|Overall Study|Physician Decision|1|||
144261356|NCT01719380|520158108|FG000|Overall Study|Lack of Efficacy|2|||
144261357|NCT01719380|520158109|FG001|Overall Study|Lack of Efficacy|6|||
144261358|NCT01719380|520158110|FG002|Overall Study|Lack of Efficacy|5|||
144542376|NCT01728324|521185248|FG000|Termination of FDV|Adverse Event|14|||
144542377|NCT01728324|521185249|FG001|Termination of FDV|Adverse Event|13|||
144201977|NCT03611543|519936929|FG000|Overall Study|Missing information|5|||
144201978|NCT03611543|519936930|FG001|Overall Study|Missing information|5|||
144201979|NCT04394351|519936931|FG000|Part A (16 Weeks)|Adverse Event|1|||
144201980|NCT04394351|519936932|FG001|Part A (16 Weeks)|Adverse Event|0|||
144201981|NCT04394351|519936933|FG002|Part A (16 Weeks)|Adverse Event|0|||
144201982|NCT04394351|519936934|FG003|Part A (16 Weeks)|Adverse Event|0|||
144201983|NCT04394351|519936935|FG004|Part A (16 Weeks)|Adverse Event|0|||
144201984|NCT04394351|519936936|FG005|Part A (16 Weeks)|Adverse Event|0|||
144542378|NCT01728324|521185250|FG002|Termination of FDV|Adverse Event|4|||
144542379|NCT01728324|521185248|FG000|Termination of FDV|Lack of Efficacy|14|||
144542380|NCT01728324|521185249|FG001|Termination of FDV|Lack of Efficacy|12|||
144542381|NCT01728324|521185250|FG002|Termination of FDV|Lack of Efficacy|8|||
144542382|NCT01728324|521185248|FG000|Termination of FDV|Withdrawal by Subject|9|||
144542383|NCT01728324|521185249|FG001|Termination of FDV|Withdrawal by Subject|6|||
144542384|NCT01728324|521185250|FG002|Termination of FDV|Withdrawal by Subject|2|||
144201985|NCT04394351|519936937|FG006|Part A (16 Weeks)|Adverse Event|0|||
144201986|NCT04394351|519936938|FG007|Part A (16 Weeks)|Adverse Event|0|||
144201987|NCT04394351|519936931|FG000|Part A (16 Weeks)|Physician Decision|0|||
144201988|NCT04394351|519936932|FG001|Part A (16 Weeks)|Physician Decision|1|||
144261359|NCT01719380|520158111|FG003|Overall Study|Lack of Efficacy|6|||
144261360|NCT01719380|520158112|FG004|Overall Study|Lack of Efficacy|3|||
144261361|NCT01719380|520158113|FG005|Overall Study|Lack of Efficacy|7|||
144261362|NCT01719380|520158114|FG006|Overall Study|Lack of Efficacy|10|||
144261363|NCT01719380|520158115|FG007|Overall Study|Lack of Efficacy|6|||
144201989|NCT04394351|519936933|FG002|Part A (16 Weeks)|Physician Decision|0|||
144261364|NCT01719380|520158116|FG008|Overall Study|Lack of Efficacy|39|||
144261365|NCT01719380|520158117|FG009|Overall Study|Lack of Efficacy|42|||
144261366|NCT01719380|520158108|FG000|Overall Study|Progressive Disease|0|||
144542385|NCT01728324|521185248|FG000|Termination of FDV|Other than stated|1|||
144542386|NCT01728324|521185249|FG001|Termination of FDV|Other than stated|3|||
144542387|NCT01728324|521185250|FG002|Termination of FDV|Other than stated|0|||
144542388|NCT01728324|521185248|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
144542389|NCT01728324|521185249|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
144542390|NCT01728324|521185250|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
144542391|NCT01728324|521185248|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
144542392|NCT01728324|521185249|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
144542393|NCT01728324|521185250|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
144542394|NCT01728324|521185248|FG000|Termination of RBV|Adverse Event|15|||
144542395|NCT01728324|521185249|FG001|Termination of RBV|Adverse Event|16|||
144542396|NCT01728324|521185250|FG002|Termination of RBV|Adverse Event|5|||
144542397|NCT01728324|521185248|FG000|Termination of RBV|Lack of Efficacy|14|||
144542398|NCT01728324|521185249|FG001|Termination of RBV|Lack of Efficacy|11|||
144542399|NCT01728324|521185250|FG002|Termination of RBV|Lack of Efficacy|7|||
144542400|NCT01728324|521185248|FG000|Termination of RBV|Withdrawal by Subject|9|||
144542401|NCT01728324|521185249|FG001|Termination of RBV|Withdrawal by Subject|5|||
144542402|NCT01728324|521185250|FG002|Termination of RBV|Withdrawal by Subject|2|||
144542403|NCT01728324|521185248|FG000|Termination of RBV|Other than stated|1|||
144542404|NCT01728324|521185249|FG001|Termination of RBV|Other than stated|3|||
144542405|NCT01728324|521185250|FG002|Termination of RBV|Other than stated|1|||
144542406|NCT01728324|521185248|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
144542407|NCT01728324|521185249|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
144542408|NCT01728324|521185250|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
144542409|NCT01728324|521185248|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
144542410|NCT01728324|521185249|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
144542411|NCT01728324|521185250|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
144542412|NCT02406092|521185262|FG000|Overall Study|Screen failure|10|||
144542413|NCT02406092|521185263|FG001|Overall Study|Screen failure|7|||
144542414|NCT02406092|521185262|FG000|Overall Study|Death|22|||
144542415|NCT02406092|521185263|FG001|Overall Study|Death|5|||
144542416|NCT02406092|521185262|FG000|Overall Study|Lost to Follow-up|4|||
144542417|NCT02406092|521185263|FG001|Overall Study|Lost to Follow-up|1|||
144542418|NCT02406092|521185262|FG000|Overall Study|Adverse Event|1|||
144542419|NCT02406092|521185263|FG001|Overall Study|Adverse Event|0|||
144542420|NCT02406092|521185262|FG000|Overall Study|Withdrawal by Subject|1|||
144542421|NCT02406092|521185263|FG001|Overall Study|Withdrawal by Subject|0|||
144542422|NCT00600353|521185267|FG000|Overall Study|history of malignancy within 5 years|1|||
144542423|NCT00600353|521185268|FG001|Overall Study|history of malignancy within 5 years|0|||
144542424|NCT00600353|521185267|FG000|Overall Study|History of prepartive regimen|0|||
144261367|NCT01719380|520158109|FG001|Overall Study|Progressive Disease|0|||
144542425|NCT00600353|521185268|FG001|Overall Study|History of prepartive regimen|1|||
144542426|NCT04941482|521185269|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
144542427|NCT04941482|521185270|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
144542428|NCT03745313|521185271|FG000|At 30 Days Follow-up|Death|2|||
144542429|NCT03745313|521185271|FG000|At 6 Months Follow-up|Death|1|||
144542430|NCT03745313|521185271|FG000|At 6 Months Follow-up|Missed Visit|1|||
144542431|NCT03745313|521185271|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
144542432|NCT03745313|521185271|FG000|At 1 Year Follow-up|Death|2|||
144542433|NCT03745313|521185271|FG000|At 1 Year Follow-up|Missed Visit|2|||
144542434|NCT03745313|521185271|FG000|At 2 Year Follow-up|Missed Visit|1|||
144542435|NCT03611075|521185273|FG000|Overall Study|Physician Decision|0|||
144542436|NCT03611075|521185274|FG001|Overall Study|Physician Decision|1|||
144542437|NCT03611075|521185275|FG002|Overall Study|Physician Decision|1|||
144542438|NCT03611075|521185276|FG003|Overall Study|Physician Decision|0|||
144542439|NCT03611075|521185277|FG004|Overall Study|Physician Decision|0|||
144542440|NCT03611075|521185278|FG005|Overall Study|Physician Decision|0|||
144542441|NCT03611075|521185279|FG006|Overall Study|Physician Decision|0|||
144542442|NCT03611075|521185280|FG007|Overall Study|Physician Decision|0|||
144542443|NCT03611075|521185281|FG008|Overall Study|Physician Decision|0|||
144542444|NCT03611075|521185273|FG000|Overall Study|Lost to Follow-up|1|||
144542445|NCT03611075|521185274|FG001|Overall Study|Lost to Follow-up|0|||
144542446|NCT03611075|521185275|FG002|Overall Study|Lost to Follow-up|0|||
144542447|NCT03611075|521185276|FG003|Overall Study|Lost to Follow-up|2|||
144542448|NCT03611075|521185277|FG004|Overall Study|Lost to Follow-up|0|||
144542449|NCT03611075|521185278|FG005|Overall Study|Lost to Follow-up|0|||
144542450|NCT03611075|521185279|FG006|Overall Study|Lost to Follow-up|0|||
144542451|NCT03611075|521185280|FG007|Overall Study|Lost to Follow-up|0|||
144542452|NCT03611075|521185281|FG008|Overall Study|Lost to Follow-up|0|||
144542453|NCT03611075|521185273|FG000|Overall Study|Withdrawal by Subject|0|||
144542454|NCT03611075|521185274|FG001|Overall Study|Withdrawal by Subject|1|||
144616174|NCT00708123|521454642|FG003|Period 1|Protocol Violation|1|||
144616175|NCT00708123|521454643|FG004|Period 1|Protocol Violation|0|||
144261368|NCT01719380|520158110|FG002|Overall Study|Progressive Disease|0|||
144261369|NCT01719380|520158111|FG003|Overall Study|Progressive Disease|0|||
144542455|NCT03611075|521185275|FG002|Overall Study|Withdrawal by Subject|1|||
144542456|NCT03611075|521185276|FG003|Overall Study|Withdrawal by Subject|1|||
144542457|NCT03611075|521185277|FG004|Overall Study|Withdrawal by Subject|0|||
144542458|NCT03611075|521185278|FG005|Overall Study|Withdrawal by Subject|0|||
144542459|NCT03611075|521185279|FG006|Overall Study|Withdrawal by Subject|1|||
144542460|NCT03611075|521185280|FG007|Overall Study|Withdrawal by Subject|0|||
144542461|NCT03611075|521185281|FG008|Overall Study|Withdrawal by Subject|0|||
144542462|NCT03611075|521185273|FG000|Overall Study|Reason unknown|0|||
144542463|NCT03611075|521185274|FG001|Overall Study|Reason unknown|0|||
144542464|NCT03611075|521185275|FG002|Overall Study|Reason unknown|0|||
144542465|NCT03611075|521185276|FG003|Overall Study|Reason unknown|1|||
144542466|NCT03611075|521185277|FG004|Overall Study|Reason unknown|0|||
144542467|NCT03611075|521185278|FG005|Overall Study|Reason unknown|0|||
144542468|NCT03611075|521185279|FG006|Overall Study|Reason unknown|1|||
144542469|NCT03611075|521185280|FG007|Overall Study|Reason unknown|0|||
144542470|NCT03611075|521185281|FG008|Overall Study|Reason unknown|0|||
144542471|NCT01701401|521185282|FG000|Overall Study|Randomized But Not Treated|3|||
144542472|NCT01701401|521185283|FG001|Overall Study|Randomized But Not Treated|1|||
144542473|NCT01701401|521185284|FG002|Overall Study|Randomized But Not Treated|0|||
144542474|NCT01701401|521185285|FG003|Overall Study|Randomized But Not Treated|1|||
144542475|NCT01701401|521185282|FG000|Overall Study|Lost to Follow-up|5|||
144542476|NCT01701401|521185283|FG001|Overall Study|Lost to Follow-up|5|||
144542477|NCT01701401|521185284|FG002|Overall Study|Lost to Follow-up|1|||
144542478|NCT01701401|521185285|FG003|Overall Study|Lost to Follow-up|3|||
144542479|NCT01701401|521185282|FG000|Overall Study|Withdrew Consent|0|||
144542480|NCT01701401|521185283|FG001|Overall Study|Withdrew Consent|3|||
144542481|NCT01701401|521185284|FG002|Overall Study|Withdrew Consent|1|||
144542482|NCT01701401|521185285|FG003|Overall Study|Withdrew Consent|2|||
144542483|NCT01701401|521185282|FG000|Overall Study|Lack of Efficacy|1|||
144542484|NCT01701401|521185283|FG001|Overall Study|Lack of Efficacy|0|||
144542485|NCT01701401|521185284|FG002|Overall Study|Lack of Efficacy|2|||
144201990|NCT04394351|519936934|FG003|Part A (16 Weeks)|Physician Decision|0|||
144201991|NCT04394351|519936935|FG004|Part A (16 Weeks)|Physician Decision|0|||
144201992|NCT04394351|519936936|FG005|Part A (16 Weeks)|Physician Decision|0|||
144542486|NCT01701401|521185285|FG003|Overall Study|Lack of Efficacy|0|||
144542487|NCT01701401|521185282|FG000|Overall Study|Adverse Event|1|||
144542488|NCT01701401|521185283|FG001|Overall Study|Adverse Event|0|||
144616176|NCT00708123|521454639|FG000|Period 1|Adverse Event|0|||
144616177|NCT00708123|521454640|FG001|Period 1|Adverse Event|0|||
144616178|NCT00708123|521454641|FG002|Period 1|Adverse Event|1|||
144616179|NCT00708123|521454642|FG003|Period 1|Adverse Event|0|||
144616180|NCT00708123|521454643|FG004|Period 1|Adverse Event|0|||
144616181|NCT00708123|521454639|FG000|Period 2|Protocol Violation|0|||
144616182|NCT00708123|521454640|FG001|Period 2|Protocol Violation|0|||
144616183|NCT00708123|521454641|FG002|Period 2|Protocol Violation|0|||
144616184|NCT00708123|521454642|FG003|Period 2|Protocol Violation|1|||
144616185|NCT00708123|521454643|FG004|Period 2|Protocol Violation|0|||
144616186|NCT00708123|521454639|FG000|Period 2|Other Reason|1|||
144616187|NCT00708123|521454640|FG001|Period 2|Other Reason|0|||
144616188|NCT00708123|521454641|FG002|Period 2|Other Reason|0|||
144616189|NCT00708123|521454642|FG003|Period 2|Other Reason|0|||
144616190|NCT00708123|521454643|FG004|Period 2|Other Reason|0|||
144616191|NCT00708123|521454639|FG000|Period 3|Lost to Follow-up|0|||
144616192|NCT00708123|521454640|FG001|Period 3|Lost to Follow-up|0|||
144616193|NCT00708123|521454641|FG002|Period 3|Lost to Follow-up|1|||
144616194|NCT00708123|521454642|FG003|Period 3|Lost to Follow-up|1|||
144727458|NCT02101853|521856653|FG002|Block 1 Induction|Lack of Efficacy|0|||
144727459|NCT02101853|521856654|FG003|Block 1 Induction|Lack of Efficacy|0|||
144727460|NCT02101853|521856655|FG004|Block 1 Induction|Lack of Efficacy|0|||
144201993|NCT04394351|519936937|FG006|Part A (16 Weeks)|Physician Decision|0|||
144727461|NCT02101853|521856656|FG005|Block 1 Induction|Lack of Efficacy|0|||
144727462|NCT02101853|521856651|FG000|Block 1 Induction|Physician Decision|61|||
144727463|NCT02101853|521856652|FG001|Block 1 Induction|Physician Decision|0|||
144727464|NCT02101853|521856653|FG002|Block 1 Induction|Physician Decision|0|||
144542489|NCT01701401|521185284|FG002|Overall Study|Adverse Event|0|||
144542490|NCT01701401|521185285|FG003|Overall Study|Adverse Event|0|||
144542491|NCT01701401|521185282|FG000|Overall Study|Protocol Violation|0|||
144727465|NCT02101853|521856654|FG003|Block 1 Induction|Physician Decision|0|||
144201994|NCT04394351|519936938|FG007|Part A (16 Weeks)|Physician Decision|0|||
144201995|NCT04394351|519936931|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
144201996|NCT04394351|519936932|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
144542492|NCT01701401|521185283|FG001|Overall Study|Protocol Violation|0|||
144542493|NCT01701401|521185284|FG002|Overall Study|Protocol Violation|1|||
144542494|NCT01701401|521185285|FG003|Overall Study|Protocol Violation|0|||
144616195|NCT00708123|521454643|FG004|Period 3|Lost to Follow-up|0|||
144542495|NCT04827732|521185294|FG000|Overall Study|Did not start treatment|0|||
144616196|NCT00708123|521454639|FG000|Period 4|Protocol Violation|0|||
144616197|NCT00708123|521454640|FG001|Period 4|Protocol Violation|1|||
144616198|NCT00708123|521454641|FG002|Period 4|Protocol Violation|0|||
144616199|NCT00708123|521454642|FG003|Period 4|Protocol Violation|0|||
144201997|NCT04394351|519936933|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
144201998|NCT04394351|519936934|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
144201999|NCT04394351|519936935|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
144202000|NCT04394351|519936936|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
144202001|NCT04394351|519936937|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
144202002|NCT04394351|519936938|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
144202003|NCT04394351|519936931|FG000|Part B (36 Weeks)|Adverse Event|0|||
144202004|NCT04394351|519936932|FG001|Part B (36 Weeks)|Adverse Event|0|||
144202005|NCT04394351|519936933|FG002|Part B (36 Weeks)|Adverse Event|0|||
144202006|NCT04394351|519936934|FG003|Part B (36 Weeks)|Adverse Event|0|||
144202007|NCT04394351|519936935|FG004|Part B (36 Weeks)|Adverse Event|0|||
144202008|NCT04394351|519936936|FG005|Part B (36 Weeks)|Adverse Event|0|||
144202009|NCT04394351|519936937|FG006|Part B (36 Weeks)|Adverse Event|1|||
144202010|NCT04394351|519936938|FG007|Part B (36 Weeks)|Adverse Event|0|||
144202011|NCT04394351|519936931|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202012|NCT04394351|519936932|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202013|NCT04394351|519936933|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202014|NCT04394351|519936934|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202015|NCT04394351|519936935|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202016|NCT04394351|519936936|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202017|NCT04394351|519936937|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
144202018|NCT04394351|519936938|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
144202019|NCT04394351|519936931|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202020|NCT04394351|519936932|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202021|NCT04394351|519936933|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202022|NCT04394351|519936934|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202023|NCT04394351|519936935|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202024|NCT04394351|519936936|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202025|NCT04394351|519936937|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
144202026|NCT04394351|519936938|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
144202027|NCT04394351|519936931|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202028|NCT04394351|519936932|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202029|NCT04394351|519936933|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202030|NCT04394351|519936934|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202031|NCT04394351|519936935|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202032|NCT04394351|519936936|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202033|NCT04394351|519936937|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
144202034|NCT04394351|519936938|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
144202035|NCT04394351|519936931|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144202036|NCT04394351|519936932|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144202037|NCT04394351|519936933|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144202038|NCT04394351|519936934|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144202039|NCT04394351|519936935|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144202040|NCT04394351|519936936|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144542496|NCT04827732|521185295|FG001|Overall Study|Did not start treatment|1|||
144542497|NCT04827732|521185296|FG002|Overall Study|Did not start treatment|0|||
144542498|NCT04827732|521185297|FG003|Overall Study|Did not start treatment|1|||
144542499|NCT04038580|521185299|FG000|Washout 1|Death|0|||
144542500|NCT04038580|521185300|FG001|Washout 1|Death|0|||
144542501|NCT04038580|521185301|FG002|Washout 1|Death|0|||
144542502|NCT04038580|521185302|FG003|Washout 1|Death|1|||
144542503|NCT04038580|521185303|FG004|Washout 1|Death|0|||
144542504|NCT04038580|521185304|FG005|Washout 1|Death|0|||
144542505|NCT04038580|521185299|FG000|Washout 1|Withdrawal by Subject|0|||
144542506|NCT04038580|521185300|FG001|Washout 1|Withdrawal by Subject|0|||
144542507|NCT04038580|521185301|FG002|Washout 1|Withdrawal by Subject|0|||
144542508|NCT04038580|521185302|FG003|Washout 1|Withdrawal by Subject|0|||
144542509|NCT04038580|521185303|FG004|Washout 1|Withdrawal by Subject|1|||
144542510|NCT04038580|521185304|FG005|Washout 1|Withdrawal by Subject|0|||
144542511|NCT04038580|521185299|FG000|Wash-out 2|Withdrawal by Subject|1|||
144542512|NCT04038580|521185300|FG001|Wash-out 2|Withdrawal by Subject|0|||
144542513|NCT04038580|521185301|FG002|Wash-out 2|Withdrawal by Subject|0|||
144542514|NCT04038580|521185302|FG003|Wash-out 2|Withdrawal by Subject|2|||
144542515|NCT04038580|521185303|FG004|Wash-out 2|Withdrawal by Subject|0|||
144202041|NCT04394351|519936937|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
144202042|NCT04394351|519936938|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
144542516|NCT04038580|521185304|FG005|Wash-out 2|Withdrawal by Subject|1|||
144542517|NCT04038580|521185299|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
144542518|NCT04038580|521185300|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
144202043|NCT03653507|519936939|FG000|Overall Study|Miscellaneous|28|||
144202044|NCT03653507|519936940|FG001|Overall Study|Miscellaneous|19|||
144202045|NCT03653507|519936939|FG000|Overall Study|Withdrawal by Subject|37|||
144542519|NCT04038580|521185301|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
144616200|NCT00708123|521454643|FG004|Period 4|Protocol Violation|0|||
144616201|NCT00845650|521454644|FG000|Overall Study|Withdrawal by Subject|0|||
144616202|NCT00845650|521454645|FG001|Overall Study|Withdrawal by Subject|0|||
144616203|NCT00845650|521454646|FG002|Overall Study|Withdrawal by Subject|0|||
144616204|NCT00845650|521454647|FG003|Overall Study|Withdrawal by Subject|0|||
144616205|NCT00845650|521454648|FG004|Overall Study|Withdrawal by Subject|2|||
144616206|NCT00845650|521454649|FG005|Overall Study|Withdrawal by Subject|0|||
144616207|NCT00845650|521454644|FG000|Overall Study|Lost to Follow-up|0|||
144616208|NCT00845650|521454645|FG001|Overall Study|Lost to Follow-up|0|||
144616209|NCT00845650|521454646|FG002|Overall Study|Lost to Follow-up|3|||
144616210|NCT00845650|521454647|FG003|Overall Study|Lost to Follow-up|1|||
144616211|NCT00845650|521454648|FG004|Overall Study|Lost to Follow-up|0|||
144616212|NCT00845650|521454649|FG005|Overall Study|Lost to Follow-up|1|||
144616213|NCT00845650|521454644|FG000|Overall Study|Sponsor hold on dosing|0|||
144616214|NCT00845650|521454645|FG001|Overall Study|Sponsor hold on dosing|0|||
144616215|NCT00845650|521454646|FG002|Overall Study|Sponsor hold on dosing|0|||
144616216|NCT00845650|521454647|FG003|Overall Study|Sponsor hold on dosing|0|||
144616217|NCT00845650|521454648|FG004|Overall Study|Sponsor hold on dosing|1|||
144616218|NCT00845650|521454649|FG005|Overall Study|Sponsor hold on dosing|1|||
144616219|NCT00845650|521454644|FG000|Overall Study|Unable to access IV line|1|||
144616220|NCT00845650|521454645|FG001|Overall Study|Unable to access IV line|0|||
144616221|NCT00845650|521454646|FG002|Overall Study|Unable to access IV line|0|||
144616222|NCT00845650|521454647|FG003|Overall Study|Unable to access IV line|0|||
144616223|NCT00845650|521454648|FG004|Overall Study|Unable to access IV line|0|||
144616224|NCT00845650|521454649|FG005|Overall Study|Unable to access IV line|0|||
144616225|NCT04486950|521454650|FG000|Overall Study|Lost to Follow-up|0|||
144616226|NCT04486950|521454651|FG001|Overall Study|Lost to Follow-up|0|||
144616227|NCT04486950|521454652|FG002|Overall Study|Lost to Follow-up|0|||
144616228|NCT04486950|521454653|FG003|Overall Study|Lost to Follow-up|0|||
144616229|NCT04486950|521454654|FG004|Overall Study|Lost to Follow-up|0|||
144616230|NCT04486950|521454655|FG005|Overall Study|Lost to Follow-up|1|||
144616231|NCT04486950|521454656|FG006|Overall Study|Lost to Follow-up|0|||
144616232|NCT02821715|521454657|FG000|Overall Study|Protocol Violation|1|||
144542520|NCT04038580|521185302|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
144542521|NCT04038580|521185303|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
144542522|NCT04038580|521185304|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
144542523|NCT04038580|521185299|FG000|Wash-out 3|Withdrawal by Subject|1|||
144542524|NCT04038580|521185300|FG001|Wash-out 3|Withdrawal by Subject|0|||
144542525|NCT04038580|521185301|FG002|Wash-out 3|Withdrawal by Subject|2|||
144542526|NCT04038580|521185302|FG003|Wash-out 3|Withdrawal by Subject|0|||
144542527|NCT04038580|521185303|FG004|Wash-out 3|Withdrawal by Subject|0|||
144542528|NCT04038580|521185304|FG005|Wash-out 3|Withdrawal by Subject|0|||
144542529|NCT04021862|521185305|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
144542530|NCT04021862|521185306|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
144542531|NCT04021862|521185307|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
144542532|NCT04021862|521185308|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
144542533|NCT04021862|521185309|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
144542534|NCT04021862|521185310|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
144542535|NCT04021862|521185305|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
144542536|NCT04021862|521185306|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
144542537|NCT04021862|521185307|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
144542538|NCT04021862|521185308|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
144542539|NCT04021862|521185309|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
144542540|NCT04021862|521185310|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
144542541|NCT04021862|521185305|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
144542542|NCT04021862|521185306|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
144542543|NCT04021862|521185307|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
144542544|NCT04021862|521185308|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
144542545|NCT04021862|521185309|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
144542546|NCT04021862|521185310|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
144542547|NCT04021862|521185305|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
144542548|NCT04021862|521185306|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
144542549|NCT04021862|521185307|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
144542550|NCT04021862|521185308|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
144616233|NCT02821715|521454658|FG001|Overall Study|Protocol Violation|0|||
144616234|NCT02821715|521454659|FG002|Overall Study|Protocol Violation|0|||
144616235|NCT02821715|521454660|FG003|Overall Study|Protocol Violation|0|||
144616236|NCT02821715|521454661|FG004|Overall Study|Protocol Violation|0|||
144616237|NCT02821715|521454662|FG005|Overall Study|Protocol Violation|0|||
144616238|NCT01033825|521454663|FG000|Overall Study|Withdrawal by Subject|2|||
144616239|NCT01033825|521454664|FG001|Overall Study|Withdrawal by Subject|3|||
144616240|NCT01033825|521454665|FG002|Overall Study|Withdrawal by Subject|2|||
144616241|NCT01033825|521454666|FG003|Overall Study|Withdrawal by Subject|1|||
144616242|NCT01033825|521454667|FG004|Overall Study|Withdrawal by Subject|1|||
144616243|NCT01033825|521454668|FG005|Overall Study|Withdrawal by Subject|0|||
144616244|NCT01033825|521454669|FG006|Overall Study|Withdrawal by Subject|0|||
144616245|NCT01033825|521454663|FG000|Overall Study|Adverse Event|0|||
144616246|NCT01033825|521454664|FG001|Overall Study|Adverse Event|0|||
144616247|NCT01033825|521454665|FG002|Overall Study|Adverse Event|0|||
144616248|NCT01033825|521454666|FG003|Overall Study|Adverse Event|1|||
144616249|NCT01033825|521454667|FG004|Overall Study|Adverse Event|0|||
144616250|NCT01033825|521454668|FG005|Overall Study|Adverse Event|0|||
144616251|NCT01033825|521454669|FG006|Overall Study|Adverse Event|0|||
144616252|NCT01033825|521454663|FG000|Overall Study|Protocol Violation|1|||
144616253|NCT01033825|521454664|FG001|Overall Study|Protocol Violation|0|||
144616254|NCT01033825|521454665|FG002|Overall Study|Protocol Violation|0|||
144616255|NCT01033825|521454666|FG003|Overall Study|Protocol Violation|0|||
144616256|NCT01033825|521454667|FG004|Overall Study|Protocol Violation|0|||
144616257|NCT01033825|521454668|FG005|Overall Study|Protocol Violation|0|||
144616258|NCT01033825|521454669|FG006|Overall Study|Protocol Violation|0|||
144616259|NCT01033825|521454663|FG000|Overall Study|Other|0|||
144616260|NCT01033825|521454664|FG001|Overall Study|Other|0|||
144616261|NCT01033825|521454665|FG002|Overall Study|Other|0|||
144616262|NCT01033825|521454666|FG003|Overall Study|Other|0|||
144616263|NCT01033825|521454667|FG004|Overall Study|Other|1|||
144616264|NCT01033825|521454668|FG005|Overall Study|Other|0|||
144616265|NCT01033825|521454669|FG006|Overall Study|Other|0|||
144616266|NCT00081159|521454671|FG000|Overall Study|Withdrawal by Subject|0|||
144616267|NCT00081159|521454672|FG001|Overall Study|Withdrawal by Subject|3|||
144616268|NCT00081159|521454671|FG000|Overall Study|Myelosuppression prior to treatment|0|||
144616269|NCT00081159|521454672|FG001|Overall Study|Myelosuppression prior to treatment|1|||
144616270|NCT00081159|521454671|FG000|Overall Study|Lost to Follow-up|2|||
144616271|NCT00081159|521454672|FG001|Overall Study|Lost to Follow-up|1|||
144616272|NCT00761514|521454674|FG000|Overall Study|Adverse Event|1|||
144616273|NCT00761514|521454674|FG000|Overall Study|Withdrawal by Subject|2|||
144616274|NCT00761514|521454674|FG000|Overall Study|Lost to Follow-up|1|||
144616275|NCT00761514|521454674|FG000|Overall Study|Health insurance didn't cover study drug|1|||
144616276|NCT00761514|521454674|FG000|Overall Study|Problem complying with study visit|1|||
144616277|NCT00761514|521454674|FG000|Overall Study|Unable to pay for medications|1|||
144616278|NCT03770260|521456275|FG000|Overall Study|Disease progression|0|||
144616279|NCT03770260|521456276|FG001|Overall Study|Disease progression|1|||
144616280|NCT03770260|521456277|FG002|Overall Study|Disease progression|0|||
144616281|NCT03770260|521456278|FG003|Overall Study|Disease progression|0|||
144616282|NCT03451773|521456280|FG000|Overall Study|Death on study|1|||
144616283|NCT03451773|521456281|FG001|Overall Study|Death on study|5|||
144616284|NCT03451773|521456280|FG000|Overall Study|Death during follow-up period|0|||
144616285|NCT03451773|521456281|FG001|Overall Study|Death during follow-up period|1|||
144616286|NCT03468855|521456282|FG000|Overall Study|Adverse Event|2|||
144616287|NCT03468855|521456282|FG000|Overall Study|Lost to Follow-up|5|||
144616288|NCT03468855|521456282|FG000|Overall Study|Withdrawal by Subject|3|||
144616289|NCT03468855|521456282|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
144616290|NCT01394939|521456283|FG000|Overall Study|Adverse Event|1|||
144616291|NCT01394939|521456284|FG001|Overall Study|Adverse Event|3|||
144616292|NCT01394939|521456285|FG002|Overall Study|Adverse Event|0|||
144616293|NCT01394939|521456286|FG003|Overall Study|Adverse Event|2|||
144727466|NCT02101853|521856655|FG004|Block 1 Induction|Physician Decision|0|||
144727467|NCT02101853|521856656|FG005|Block 1 Induction|Physician Decision|0|||
144542551|NCT04021862|521185309|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
144542552|NCT04021862|521185310|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
144542553|NCT04021862|521185305|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
144542554|NCT04021862|521185306|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
144542555|NCT04021862|521185307|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
144542556|NCT04021862|521185308|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
144542557|NCT04021862|521185309|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
144542558|NCT04021862|521185310|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
144542559|NCT03835754|521185311|FG000|Overall Study|Death|4|||
144542560|NCT02830204|521185312|FG000|Overall Study|Death|9|||
144616294|NCT01394939|521456283|FG000|Overall Study|Death|0|||
144616295|NCT01394939|521456284|FG001|Overall Study|Death|2|||
144616296|NCT01394939|521456285|FG002|Overall Study|Death|0|||
144616297|NCT01394939|521456286|FG003|Overall Study|Death|0|||
144616298|NCT01394939|521456283|FG000|Overall Study|Physician Decision|0|||
144616299|NCT01394939|521456284|FG001|Overall Study|Physician Decision|1|||
144616300|NCT01394939|521456285|FG002|Overall Study|Physician Decision|0|||
144542561|NCT02830204|521185312|FG000|Overall Study|Withdrawal by Subject|1|||
144616301|NCT01394939|521456286|FG003|Overall Study|Physician Decision|0|||
144616302|NCT01394939|521456283|FG000|Overall Study|Withdrawal by Subject|0|||
144616303|NCT01394939|521456284|FG001|Overall Study|Withdrawal by Subject|2|||
144616304|NCT01394939|521456285|FG002|Overall Study|Withdrawal by Subject|0|||
144616305|NCT01394939|521456286|FG003|Overall Study|Withdrawal by Subject|2|||
144616306|NCT01394939|521456283|FG000|Overall Study|Others|0|||
144616307|NCT01394939|521456284|FG001|Overall Study|Others|2|||
144202046|NCT03653507|519936940|FG001|Overall Study|Withdrawal by Subject|22|||
144202047|NCT03653507|519936939|FG000|Overall Study|Protocol Deviation|2|||
144542562|NCT05293717|521185321|FG000|Overall Study|Physician Decision|1|||
144542563|NCT02328014|521186611|FG000|Overall Study|Adverse Event|1|||
144542564|NCT02328014|521186612|FG001|Overall Study|Adverse Event|0|||
144542565|NCT02328014|521186613|FG002|Overall Study|Adverse Event|0|||
144542566|NCT02328014|521186614|FG003|Overall Study|Adverse Event|1|||
144542567|NCT02328014|521186611|FG000|Overall Study|Death|0|||
144542568|NCT02328014|521186612|FG001|Overall Study|Death|0|||
144542569|NCT02328014|521186613|FG002|Overall Study|Death|0|||
144542570|NCT02328014|521186614|FG003|Overall Study|Death|4|||
144542571|NCT02328014|521186611|FG000|Overall Study|Physician Decision|0|||
144542572|NCT02328014|521186612|FG001|Overall Study|Physician Decision|0|||
144542573|NCT02328014|521186613|FG002|Overall Study|Physician Decision|0|||
144542574|NCT02328014|521186614|FG003|Overall Study|Physician Decision|1|||
144542575|NCT02328014|521186611|FG000|Overall Study|Disease Progression|1|||
144542576|NCT02328014|521186612|FG001|Overall Study|Disease Progression|0|||
144542577|NCT02328014|521186613|FG002|Overall Study|Disease Progression|1|||
144542578|NCT02328014|521186614|FG003|Overall Study|Disease Progression|3|||
144542579|NCT02328014|521186611|FG000|Overall Study|Study Terminated by Sponsor|4|||
144542580|NCT02328014|521186612|FG001|Overall Study|Study Terminated by Sponsor|1|||
144542581|NCT02328014|521186613|FG002|Overall Study|Study Terminated by Sponsor|1|||
144542582|NCT02328014|521186614|FG003|Overall Study|Study Terminated by Sponsor|0|||
144542583|NCT02328014|521186611|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
144542584|NCT02328014|521186612|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
144542585|NCT02328014|521186613|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
144542586|NCT02328014|521186614|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
144542587|NCT02328014|521186611|FG000|Overall Study|Withdrawal by Subject|0|||
144616308|NCT01394939|521456285|FG002|Overall Study|Others|0|||
144616309|NCT01394939|521456286|FG003|Overall Study|Others|3|||
144616310|NCT00477165|521456287|FG000|Overall Study|Adverse Event|7|||
144616311|NCT00477165|521456288|FG001|Overall Study|Adverse Event|2|||
144616312|NCT01623271|521456294|FG000|Overall Study|Withdrawal by Subject|2|||
144616313|NCT00879229|521456301|FG000|Overall Study|Study terminated by Sponsor|13|||
144616314|NCT00879229|521456302|FG001|Overall Study|Study terminated by Sponsor|12|||
144616315|NCT00879229|521456301|FG000|Overall Study|Death|4|||
144616316|NCT00879229|521456302|FG001|Overall Study|Death|2|||
144616317|NCT00879229|521456301|FG000|Overall Study|Adverse Event|2|||
144616318|NCT00879229|521456302|FG001|Overall Study|Adverse Event|0|||
144616319|NCT00879229|521456301|FG000|Overall Study|Withdrawal by Subject|1|||
144616320|NCT00879229|521456302|FG001|Overall Study|Withdrawal by Subject|0|||
144616321|NCT00879229|521456301|FG000|Overall Study|Clinical status did not improve|1|||
144616322|NCT00879229|521456302|FG001|Overall Study|Clinical status did not improve|0|||
144616323|NCT00879229|521456301|FG000|Overall Study|Other|1|||
144616324|NCT00879229|521456302|FG001|Overall Study|Other|0|||
144616325|NCT00631371|521456303|FG000|Overall Study|Lost to Follow-up|24|||
144616326|NCT00631371|521456304|FG001|Overall Study|Lost to Follow-up|19|||
144616327|NCT00631371|521456303|FG000|Overall Study|Other reason|5|||
144616328|NCT00631371|521456304|FG001|Overall Study|Other reason|12|||
144616329|NCT00631371|521456303|FG000|Overall Study|subject request|38|||
144616330|NCT00631371|521456304|FG001|Overall Study|subject request|45|||
144616331|NCT00631371|521456303|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
144616332|NCT00631371|521456304|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
144616333|NCT00631371|521456303|FG000|Overall Study|Death|263|||
144616334|NCT00631371|521456304|FG001|Overall Study|Death|239|||
144616335|NCT00812214|521456307|FG000|Overall Study|Lost to Follow-up|3|||
144616336|NCT00812214|521456308|FG001|Overall Study|Lost to Follow-up|1|||
144616337|NCT01659320|521456309|FG000|Overall Study|Withdrawal by Subject|2|||
144616338|NCT01659320|521456309|FG000|Overall Study|Physician Decision|1|||
144616339|NCT00590590|521456310|FG000|Overall Study|Lack of Efficacy|1|||
144616340|NCT00590590|521456311|FG001|Overall Study|Lack of Efficacy|2|||
144616341|NCT00590590|521456312|FG002|Overall Study|Lack of Efficacy|0|||
144616342|NCT00590590|521456310|FG000|Overall Study|Adverse Event|1|||
144616343|NCT00590590|521456311|FG001|Overall Study|Adverse Event|0|||
144616344|NCT00590590|521456312|FG002|Overall Study|Adverse Event|0|||
144616345|NCT00590590|521456310|FG000|Overall Study|Protocol Violation|0|||
144616346|NCT00590590|521456311|FG001|Overall Study|Protocol Violation|0|||
144616347|NCT00590590|521456312|FG002|Overall Study|Protocol Violation|2|||
144202048|NCT03653507|519936940|FG001|Overall Study|Protocol Deviation|1|||
144202049|NCT03653507|519936939|FG000|Overall Study|Progressive disease|117|||
144542588|NCT02328014|521186612|FG001|Overall Study|Withdrawal by Subject|0|||
144542589|NCT02328014|521186613|FG002|Overall Study|Withdrawal by Subject|0|||
144616348|NCT00590590|521456310|FG000|Overall Study|Lost to Follow-up|4|||
144616349|NCT00590590|521456311|FG001|Overall Study|Lost to Follow-up|1|||
144616350|NCT00590590|521456312|FG002|Overall Study|Lost to Follow-up|2|||
144616351|NCT00590590|521456310|FG000|Overall Study|Withdrawal by Subject|0|||
144202050|NCT03653507|519936940|FG001|Overall Study|Progressive disease|168|||
144616352|NCT00590590|521456311|FG001|Overall Study|Withdrawal by Subject|1|||
144616353|NCT00590590|521456312|FG002|Overall Study|Withdrawal by Subject|1|||
144542590|NCT02328014|521186614|FG003|Overall Study|Withdrawal by Subject|1|||
144542591|NCT05029284|521186621|FG000|Overall Study|Lost to Follow-up|1|||
144542592|NCT02972034|521186622|FG000|Overall Study|Death|11|||
144542593|NCT02972034|521186623|FG001|Overall Study|Death|1|||
144542594|NCT02972034|521186624|FG002|Overall Study|Death|3|||
144542595|NCT02972034|521186625|FG003|Overall Study|Death|3|||
144542596|NCT02972034|521186626|FG004|Overall Study|Death|2|||
144542597|NCT02972034|521186627|FG005|Overall Study|Death|2|||
144542598|NCT02972034|521186628|FG006|Overall Study|Death|3|||
144542599|NCT02972034|521186629|FG007|Overall Study|Death|4|||
144542600|NCT02972034|521186630|FG008|Overall Study|Death|8|||
144542601|NCT02972034|521186631|FG009|Overall Study|Death|11|||
144542602|NCT02972034|521186632|FG010|Overall Study|Death|3|||
144542603|NCT02972034|521186633|FG011|Overall Study|Death|2|||
144542604|NCT02972034|521186634|FG012|Overall Study|Death|11|||
144542605|NCT02972034|521186635|FG013|Overall Study|Death|10|||
144542606|NCT02972034|521186636|FG014|Overall Study|Death|9|||
144542607|NCT02972034|521186622|FG000|Overall Study|Lost to Follow-up|0|||
144542608|NCT02972034|521186623|FG001|Overall Study|Lost to Follow-up|0|||
144542609|NCT02972034|521186624|FG002|Overall Study|Lost to Follow-up|0|||
144542610|NCT02972034|521186625|FG003|Overall Study|Lost to Follow-up|0|||
144542611|NCT02972034|521186626|FG004|Overall Study|Lost to Follow-up|1|||
144542612|NCT02972034|521186627|FG005|Overall Study|Lost to Follow-up|0|||
144542613|NCT02972034|521186628|FG006|Overall Study|Lost to Follow-up|0|||
144542614|NCT02972034|521186629|FG007|Overall Study|Lost to Follow-up|1|||
144542615|NCT02972034|521186630|FG008|Overall Study|Lost to Follow-up|0|||
144542616|NCT02972034|521186631|FG009|Overall Study|Lost to Follow-up|0|||
144542617|NCT02972034|521186632|FG010|Overall Study|Lost to Follow-up|0|||
144542618|NCT02972034|521186633|FG011|Overall Study|Lost to Follow-up|0|||
144542619|NCT02972034|521186634|FG012|Overall Study|Lost to Follow-up|0|||
144542620|NCT02972034|521186635|FG013|Overall Study|Lost to Follow-up|0|||
144542621|NCT02972034|521186636|FG014|Overall Study|Lost to Follow-up|1|||
144542622|NCT02972034|521186622|FG000|Overall Study|Physician Decision|0|||
144542623|NCT02972034|521186623|FG001|Overall Study|Physician Decision|0|||
144542624|NCT02972034|521186624|FG002|Overall Study|Physician Decision|0|||
144542625|NCT02972034|521186625|FG003|Overall Study|Physician Decision|0|||
144542626|NCT02972034|521186626|FG004|Overall Study|Physician Decision|0|||
144542627|NCT02972034|521186627|FG005|Overall Study|Physician Decision|0|||
144542628|NCT02972034|521186628|FG006|Overall Study|Physician Decision|0|||
144542629|NCT02972034|521186629|FG007|Overall Study|Physician Decision|1|||
144542630|NCT02972034|521186630|FG008|Overall Study|Physician Decision|0|||
144542631|NCT02972034|521186631|FG009|Overall Study|Physician Decision|0|||
144542632|NCT02972034|521186632|FG010|Overall Study|Physician Decision|1|||
144542633|NCT02972034|521186633|FG011|Overall Study|Physician Decision|0|||
144542634|NCT02972034|521186634|FG012|Overall Study|Physician Decision|0|||
144542635|NCT02972034|521186635|FG013|Overall Study|Physician Decision|0|||
144542636|NCT02972034|521186636|FG014|Overall Study|Physician Decision|0|||
144542637|NCT02972034|521186622|FG000|Overall Study|Sponsor Decision|0|||
144542638|NCT02972034|521186623|FG001|Overall Study|Sponsor Decision|0|||
144542639|NCT02972034|521186624|FG002|Overall Study|Sponsor Decision|0|||
144542640|NCT02972034|521186625|FG003|Overall Study|Sponsor Decision|1|||
144542641|NCT02972034|521186626|FG004|Overall Study|Sponsor Decision|0|||
144542642|NCT02972034|521186627|FG005|Overall Study|Sponsor Decision|0|||
144542643|NCT02972034|521186628|FG006|Overall Study|Sponsor Decision|1|||
144542644|NCT02972034|521186629|FG007|Overall Study|Sponsor Decision|1|||
144542645|NCT02972034|521186630|FG008|Overall Study|Sponsor Decision|1|||
144542646|NCT02972034|521186631|FG009|Overall Study|Sponsor Decision|2|||
144542647|NCT02972034|521186632|FG010|Overall Study|Sponsor Decision|2|||
144542648|NCT02972034|521186633|FG011|Overall Study|Sponsor Decision|0|||
144542649|NCT02972034|521186634|FG012|Overall Study|Sponsor Decision|1|||
144542650|NCT02972034|521186635|FG013|Overall Study|Sponsor Decision|0|||
144542651|NCT02972034|521186636|FG014|Overall Study|Sponsor Decision|1|||
144542652|NCT02972034|521186622|FG000|Overall Study|Withdrawal by Subject|3|||
144542653|NCT02972034|521186623|FG001|Overall Study|Withdrawal by Subject|0|||
144542654|NCT02972034|521186624|FG002|Overall Study|Withdrawal by Subject|0|||
144542655|NCT02972034|521186625|FG003|Overall Study|Withdrawal by Subject|0|||
144616354|NCT00590590|521456310|FG000|Overall Study|Did not complete due to study closure|1|||
144616355|NCT00590590|521456311|FG001|Overall Study|Did not complete due to study closure|1|||
144616356|NCT00590590|521456312|FG002|Overall Study|Did not complete due to study closure|1|||
144202051|NCT03653507|519936939|FG000|Overall Study|Lost to Follow-up|1|||
144542656|NCT02972034|521186626|FG004|Overall Study|Withdrawal by Subject|1|||
144542657|NCT02972034|521186627|FG005|Overall Study|Withdrawal by Subject|1|||
144542658|NCT02972034|521186628|FG006|Overall Study|Withdrawal by Subject|0|||
144542659|NCT02972034|521186629|FG007|Overall Study|Withdrawal by Subject|0|||
144542660|NCT02972034|521186630|FG008|Overall Study|Withdrawal by Subject|1|||
144542661|NCT02972034|521186631|FG009|Overall Study|Withdrawal by Subject|1|||
144542662|NCT02972034|521186632|FG010|Overall Study|Withdrawal by Subject|2|||
144542663|NCT02972034|521186633|FG011|Overall Study|Withdrawal by Subject|1|||
144542664|NCT02972034|521186634|FG012|Overall Study|Withdrawal by Subject|1|||
144542665|NCT02972034|521186635|FG013|Overall Study|Withdrawal by Subject|1|||
144542666|NCT02972034|521186636|FG014|Overall Study|Withdrawal by Subject|0|||
144542667|NCT02972034|521186622|FG000|Overall Study|Screen Failure|0|||
144542668|NCT02972034|521186623|FG001|Overall Study|Screen Failure|0|||
144542669|NCT02972034|521186624|FG002|Overall Study|Screen Failure|0|||
144542670|NCT02972034|521186625|FG003|Overall Study|Screen Failure|0|||
144542671|NCT02972034|521186626|FG004|Overall Study|Screen Failure|0|||
144542672|NCT02972034|521186627|FG005|Overall Study|Screen Failure|0|||
144542673|NCT02972034|521186628|FG006|Overall Study|Screen Failure|0|||
144727468|NCT02101853|521856651|FG000|Block 1 Induction|Protocol Violation|2|||
144727469|NCT02101853|521856652|FG001|Block 1 Induction|Protocol Violation|0|||
144727470|NCT02101853|521856653|FG002|Block 1 Induction|Protocol Violation|0|||
144727471|NCT02101853|521856654|FG003|Block 1 Induction|Protocol Violation|0|||
144727472|NCT02101853|521856655|FG004|Block 1 Induction|Protocol Violation|0|||
144727473|NCT02101853|521856656|FG005|Block 1 Induction|Protocol Violation|0|||
144727474|NCT02101853|521856651|FG000|Block 1 Induction|Withdrawal by Subject|65|||
144727475|NCT02101853|521856652|FG001|Block 1 Induction|Withdrawal by Subject|0|||
144542674|NCT02972034|521186629|FG007|Overall Study|Screen Failure|0|||
144542675|NCT02972034|521186630|FG008|Overall Study|Screen Failure|0|||
144542676|NCT02972034|521186631|FG009|Overall Study|Screen Failure|0|||
144542677|NCT02972034|521186632|FG010|Overall Study|Screen Failure|0|||
144542678|NCT02972034|521186633|FG011|Overall Study|Screen Failure|0|||
144542679|NCT02972034|521186634|FG012|Overall Study|Screen Failure|1|||
144542680|NCT02972034|521186635|FG013|Overall Study|Screen Failure|0|||
144542681|NCT02972034|521186636|FG014|Overall Study|Screen Failure|0|||
144542682|NCT03009344|521186637|FG000|Overall Study|Lack of Efficacy|5|||
144542683|NCT03009344|521186637|FG000|Overall Study|Withdrawal by Subject|1|||
144542684|NCT03009344|521186637|FG000|Overall Study|Adverse Event|1|||
144542685|NCT00378898|521186638|FG000|Overall Study|Withdrawal by Subject|10|||
144542686|NCT00378898|521186639|FG001|Overall Study|Withdrawal by Subject|5|||
144542687|NCT00378898|521186638|FG000|Overall Study|Protocol Violation|1|||
144542688|NCT00378898|521186639|FG001|Overall Study|Protocol Violation|1|||
144542689|NCT02534233|521186645|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
144542690|NCT02278796|521186649|FG000|Overall Study|Death|2|||
144542691|NCT02278796|521186650|FG001|Overall Study|Death|3|||
144542692|NCT03214081|521186651|FG000|Overall Study|Case Report Forms Uncollected|9|||
144542693|NCT03214081|521186651|FG000|Overall Study|Protocol Deviation|54|||
144542694|NCT02962284|521186652|FG000|Overall Study|Death|2|||
144542695|NCT02962284|521186653|FG001|Overall Study|Death|0|||
144542696|NCT02962284|521186652|FG000|Overall Study|Progressive disease|2|||
144542697|NCT02962284|521186653|FG001|Overall Study|Progressive disease|3|||
144542698|NCT02962284|521186652|FG000|Overall Study|Withdrawal by Subject|1|||
144542699|NCT02962284|521186653|FG001|Overall Study|Withdrawal by Subject|0|||
144542700|NCT02372799|521186656|FG000|Treatment Period|Adverse Event|3|||
144542701|NCT02372799|521186657|FG001|Treatment Period|Adverse Event|10|||
144542702|NCT02372799|521186658|FG002|Treatment Period|Adverse Event|6|||
144542703|NCT02372799|521186656|FG000|Treatment Period|Insufficient therapeutic response|2|||
144542704|NCT02372799|521186657|FG001|Treatment Period|Insufficient therapeutic response|2|||
144542705|NCT02372799|521186658|FG002|Treatment Period|Insufficient therapeutic response|0|||
144542706|NCT02372799|521186656|FG000|Treatment Period|Withdrawal by Subject|10|||
144542707|NCT02372799|521186657|FG001|Treatment Period|Withdrawal by Subject|10|||
144542708|NCT02372799|521186658|FG002|Treatment Period|Withdrawal by Subject|2|||
144542709|NCT02372799|521186656|FG000|Treatment Period|Lost to Follow-up|11|||
144542710|NCT02372799|521186657|FG001|Treatment Period|Lost to Follow-up|5|||
144542711|NCT02372799|521186658|FG002|Treatment Period|Lost to Follow-up|3|||
144542712|NCT02372799|521186656|FG000|Treatment Period|Protocol Violation|3|||
144542713|NCT02372799|521186657|FG001|Treatment Period|Protocol Violation|0|||
144542714|NCT02372799|521186658|FG002|Treatment Period|Protocol Violation|0|||
144542715|NCT02372799|521186656|FG000|Treatment Period|Non-compliance with study drug|4|||
144727476|NCT02101853|521856653|FG002|Block 1 Induction|Withdrawal by Subject|0|||
144727477|NCT02101853|521856654|FG003|Block 1 Induction|Withdrawal by Subject|0|||
144727478|NCT02101853|521856655|FG004|Block 1 Induction|Withdrawal by Subject|0|||
144202052|NCT03653507|519936940|FG001|Overall Study|Lost to Follow-up|1|||
144727479|NCT02101853|521856656|FG005|Block 1 Induction|Withdrawal by Subject|0|||
144727480|NCT02101853|521856651|FG000|Block 1 Induction|Ineligible|8|||
144202053|NCT03653507|519936939|FG000|Overall Study|Death|25|||
144542716|NCT02372799|521186657|FG001|Treatment Period|Non-compliance with study drug|4|||
144542717|NCT02372799|521186658|FG002|Treatment Period|Non-compliance with study drug|4|||
144542718|NCT02372799|521186656|FG000|Treatment Period|Miscellaneous Reasons|1|||
144542719|NCT02372799|521186657|FG001|Treatment Period|Miscellaneous Reasons|1|||
144542720|NCT02372799|521186658|FG002|Treatment Period|Miscellaneous Reasons|0|||
144542721|NCT02372799|521186656|FG000|Down-taper Period|Lost to Follow-up|1|||
144542722|NCT02372799|521186657|FG001|Down-taper Period|Lost to Follow-up|2|||
144542723|NCT02372799|521186658|FG002|Down-taper Period|Lost to Follow-up|2|||
144542724|NCT00089609|521186659|FG000|Overall Study|Withdrawal by Subject|3|||
144542725|NCT00089609|521186660|FG001|Overall Study|Withdrawal by Subject|1|||
144542726|NCT05815342|521186662|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
144202054|NCT03653507|519936940|FG001|Overall Study|Death|22|||
144472843|NCT04270747|520928593|FG000|Through Week 16|Protocol Violation|1|||
144472844|NCT04270747|520928594|FG001|Through Week 16|Protocol Violation|2|||
144472845|NCT04270747|520928595|FG002|Through Week 16|Protocol Violation|0|||
144472846|NCT04270747|520928593|FG000|Through Week 16|Protocol Specified Criteria|6|||
144472847|NCT04270747|520928594|FG001|Through Week 16|Protocol Specified Criteria|7|||
144472848|NCT04270747|520928595|FG002|Through Week 16|Protocol Specified Criteria|0|||
144472849|NCT04270747|520928593|FG000|Through Week 16|Miscellaneous|1|||
144472850|NCT04270747|520928594|FG001|Through Week 16|Miscellaneous|1|||
144472851|NCT04270747|520928595|FG002|Through Week 16|Miscellaneous|0|||
144472852|NCT04270747|520928593|FG000|Post Week 16|Adverse Event|7|||
144472853|NCT04270747|520928594|FG001|Post Week 16|Adverse Event|5|||
144472854|NCT04270747|520928595|FG002|Post Week 16|Adverse Event|1|||
144472855|NCT04270747|520928593|FG000|Post Week 16|Death|2|||
144472856|NCT04270747|520928594|FG001|Post Week 16|Death|0|||
144472857|NCT04270747|520928595|FG002|Post Week 16|Death|2|||
144472858|NCT04270747|520928593|FG000|Post Week 16|Consent Withdrawn|4|||
144472859|NCT04270747|520928594|FG001|Post Week 16|Consent Withdrawn|3|||
144472860|NCT04270747|520928595|FG002|Post Week 16|Consent Withdrawn|6|||
144472861|NCT04270747|520928593|FG000|Post Week 16|Physician Decision|3|||
144472862|NCT04270747|520928594|FG001|Post Week 16|Physician Decision|1|||
144472863|NCT04270747|520928595|FG002|Post Week 16|Physician Decision|1|||
144472864|NCT04270747|520928593|FG000|Post Week 16|Lost to Follow-up|2|||
144472865|NCT04270747|520928594|FG001|Post Week 16|Lost to Follow-up|1|||
144472866|NCT04270747|520928595|FG002|Post Week 16|Lost to Follow-up|0|||
144472867|NCT04270747|520928593|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
144472868|NCT04270747|520928594|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
144472869|NCT04270747|520928595|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
144472870|NCT04270747|520928593|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
144472871|NCT04270747|520928594|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
144472872|NCT04270747|520928595|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
144472873|NCT04270747|520928593|FG000|Post Week 16|Miscellaneous|1|||
144472874|NCT04270747|520928594|FG001|Post Week 16|Miscellaneous|0|||
144472875|NCT04270747|520928595|FG002|Post Week 16|Miscellaneous|1|||
144472876|NCT05960097|520928596|FG000|Overall Study|Lost to Follow-up|3|||
144472877|NCT05960097|520928597|FG001|Overall Study|Lost to Follow-up|1|||
144472878|NCT05960097|520928598|FG002|Overall Study|Lost to Follow-up|1|||
144472879|NCT05960097|520928599|FG003|Overall Study|Lost to Follow-up|2|||
144472880|NCT05960097|520928600|FG004|Overall Study|Lost to Follow-up|1|||
144472881|NCT05960097|520928601|FG005|Overall Study|Lost to Follow-up|1|||
144472882|NCT05960097|520928602|FG006|Overall Study|Lost to Follow-up|2|||
144616357|NCT00590590|521456310|FG000|Overall Study|Did not complete study|0|||
144616358|NCT00590590|521456311|FG001|Overall Study|Did not complete study|1|||
144616359|NCT00590590|521456312|FG002|Overall Study|Did not complete study|0|||
144616360|NCT01514682|521456313|FG000|Overall Study|Withdrawal by Subject|2|||
144616361|NCT01514682|521456314|FG001|Overall Study|Withdrawal by Subject|3|||
144616362|NCT01514682|521456313|FG000|Overall Study|Physician Decision|4|||
144616363|NCT01514682|521456314|FG001|Overall Study|Physician Decision|3|||
144616364|NCT00132132|521456315|FG000|Overall Study|Lost to Follow-up|7|||
144616365|NCT00132132|521456316|FG001|Overall Study|Lost to Follow-up|2|||
144616366|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
144261370|NCT01719380|520158112|FG004|Overall Study|Progressive Disease|0|||
144472883|NCT05960097|520928603|FG007|Overall Study|Lost to Follow-up|3|||
144472884|NCT05960097|520928596|FG000|Overall Study|Physician Decision|0|||
144472885|NCT05960097|520928597|FG001|Overall Study|Physician Decision|0|||
144472886|NCT05960097|520928598|FG002|Overall Study|Physician Decision|0|||
144472887|NCT05960097|520928599|FG003|Overall Study|Physician Decision|0|||
144472888|NCT05960097|520928600|FG004|Overall Study|Physician Decision|0|||
144472889|NCT05960097|520928601|FG005|Overall Study|Physician Decision|0|||
144472890|NCT05960097|520928602|FG006|Overall Study|Physician Decision|1|||
144472891|NCT05960097|520928603|FG007|Overall Study|Physician Decision|0|||
144472892|NCT05960097|520928596|FG000|Overall Study|Withdrawal by Subject|1|||
144472893|NCT05960097|520928597|FG001|Overall Study|Withdrawal by Subject|0|||
144472894|NCT05960097|520928598|FG002|Overall Study|Withdrawal by Subject|0|||
144472895|NCT05960097|520928599|FG003|Overall Study|Withdrawal by Subject|1|||
144472896|NCT05960097|520928600|FG004|Overall Study|Withdrawal by Subject|1|||
144472897|NCT05960097|520928601|FG005|Overall Study|Withdrawal by Subject|0|||
144472898|NCT05960097|520928602|FG006|Overall Study|Withdrawal by Subject|0|||
144472899|NCT05960097|520928603|FG007|Overall Study|Withdrawal by Subject|0|||
144472900|NCT05960097|520928596|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144472901|NCT05960097|520928597|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144616367|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
144616368|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
144616369|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
144616370|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
144616371|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
144261371|NCT01719380|520158113|FG005|Overall Study|Progressive Disease|0|||
144202055|NCT03653507|519936939|FG000|Overall Study|Adverse Event|35|||
144202056|NCT03653507|519936940|FG001|Overall Study|Adverse Event|14|||
144202057|NCT03047473|519936951|FG000|Overall Study|Lost to Follow-up|2|||
144202058|NCT01106014|519936952|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
144472902|NCT05960097|520928598|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
144542727|NCT05815342|521186662|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
144542728|NCT05815342|521186662|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
144542729|NCT05815342|521186662|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
144542730|NCT05815342|521186662|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
144542731|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
144542732|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
144542733|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
144542734|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
144542735|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
144542736|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
144542737|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
144542738|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
144542739|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
144542740|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
144542741|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
144472903|NCT05960097|520928599|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144472904|NCT05960097|520928600|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144472905|NCT05960097|520928601|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144472906|NCT05960097|520928602|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144472907|NCT05960097|520928603|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
144472908|NCT05805657|520928604|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
144472909|NCT05805657|520928605|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
144472910|NCT05056870|520929996|FG000|Period 1|Site COVID-19 Related|3|||
144472911|NCT05056870|520929997|FG001|Period 1|Site COVID-19 Related|3|||
144472912|NCT05056870|520929996|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
144472913|NCT05056870|520929997|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
144472914|NCT05056870|520929996|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
144472915|NCT05056870|520929997|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144472916|NCT05056870|520929996|FG000|Period 2|COVID-19 Related|1|||
144472917|NCT05056870|520929997|FG001|Period 2|COVID-19 Related|0|||
144472918|NCT05056870|520929996|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
144472919|NCT05056870|520929997|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
144472920|NCT02487498|520929998|FG000|Period: Period 1|Adverse Event|2|||
144472921|NCT02487498|520929999|FG001|Period: Period 1|Adverse Event|4|||
144472922|NCT02487498|520929998|FG000|Period: Period 1|Subject/guardian decision|2|||
144472923|NCT02487498|520929999|FG001|Period: Period 1|Subject/guardian decision|4|||
144472924|NCT02487498|520929998|FG000|Period: Period 1|Lost to Follow-up|0|||
144472925|NCT02487498|520929999|FG001|Period: Period 1|Lost to Follow-up|2|||
144472926|NCT02487498|520929998|FG000|Period: Period 1|Lack of Efficacy|1|||
144472927|NCT02487498|520929999|FG001|Period: Period 1|Lack of Efficacy|0|||
144472928|NCT02487498|520929998|FG000|Period: Period 1|Physician Decision|0|||
144472929|NCT02487498|520929999|FG001|Period: Period 1|Physician Decision|1|||
144472930|NCT02487498|520929998|FG000|Period: Period 1|Protocol deviation|1|||
144472931|NCT02487498|520929999|FG001|Period: Period 1|Protocol deviation|0|||
144472932|NCT02487498|520929998|FG000|Period: Washout|Subject/guardian decision|0|||
144472933|NCT02487498|520929999|FG001|Period: Washout|Subject/guardian decision|5|||
144472934|NCT02487498|520929998|FG000|Period: Washout|Lack of Efficacy|1|||
144472935|NCT02487498|520929999|FG001|Period: Washout|Lack of Efficacy|1|||
144472936|NCT02487498|520929998|FG000|Period: Washout|Physician Decision|1|||
144472937|NCT02487498|520929999|FG001|Period: Washout|Physician Decision|0|||
144472938|NCT02487498|520929998|FG000|Period: Washout|Non-compliance with study treatment|0|||
144472939|NCT02487498|520929999|FG001|Period: Washout|Non-compliance with study treatment|1|||
144472940|NCT02487498|520929998|FG000|Period: Period 2|Adverse Event|2|||
144472941|NCT02487498|520929999|FG001|Period: Period 2|Adverse Event|2|||
144472942|NCT02487498|520929998|FG000|Period: Period 2|Subject/guardian decision|2|||
144472943|NCT02487498|520929999|FG001|Period: Period 2|Subject/guardian decision|1|||
144472944|NCT02487498|520929998|FG000|Period: Period 2|Lost to Follow-up|1|||
144472945|NCT02487498|520929999|FG001|Period: Period 2|Lost to Follow-up|1|||
144472946|NCT02487498|520929998|FG000|Period: Period 2|Death|0|||
144472947|NCT02487498|520929999|FG001|Period: Period 2|Death|1|||
144472948|NCT02487498|520929998|FG000|Period: Period 2|Physician Decision|1|||
144616372|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
144202059|NCT01106014|519936953|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
144472949|NCT02487498|520929999|FG001|Period: Period 2|Physician Decision|0|||
144472950|NCT02798211|520930002|FG000|Period 1|Adverse Event|1|||
144542742|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
144542743|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
144542744|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
144202060|NCT01106014|519936952|FG000|Overall Study|Adverse Event|78|||
144202061|NCT01106014|519936953|FG001|Overall Study|Adverse Event|42|||
144202062|NCT01106014|519936952|FG000|Overall Study|Withdrawal by Subject|43|||
144202063|NCT01106014|519936953|FG001|Overall Study|Withdrawal by Subject|37|||
144542745|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
144542746|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
144542747|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
144542748|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
144542749|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
144542750|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
144542751|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
144542752|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
144542753|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
144542754|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
144542755|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
144542756|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
144542757|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
144542758|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
144542759|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
144542760|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
144542761|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
144542762|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
144542763|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
144542764|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
144542765|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
144542766|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
144542767|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
144542768|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
144542769|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
144542770|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
144542771|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
144542772|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
144542773|NCT03732807|521186666|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144542774|NCT03732807|521186667|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144542775|NCT03732807|521186668|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144542776|NCT03732807|521186669|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144542777|NCT03732807|521186670|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144542778|NCT03732807|521186671|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
144542779|NCT03732807|521186672|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
144542780|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
144542781|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
144542782|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
144542783|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
144542784|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
144542785|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
144542786|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
144542787|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
144542788|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
144542789|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
144542790|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
144542791|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
144542792|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
144542793|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
144542794|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
144542795|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
144542796|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
144542797|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
144542798|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
144542799|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
144542800|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
144542801|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
144542802|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
144202064|NCT01106014|519936952|FG000|Overall Study|Administrative reason|7|||
144202065|NCT01106014|519936953|FG001|Overall Study|Administrative reason|6|||
144542803|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
144542804|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
144542805|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
144542806|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
144542807|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
144542808|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
144542809|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
144542810|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
144542811|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
144542812|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
144542813|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
144542814|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
144542815|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
144542816|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
144542817|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
144542818|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
144542819|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
144542820|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
144542821|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
144542822|NCT03732807|521186666|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
144542823|NCT03732807|521186667|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
144542824|NCT03732807|521186668|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
144542825|NCT03732807|521186669|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
144542826|NCT03732807|521186670|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
144542827|NCT03732807|521186671|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
144542828|NCT03732807|521186672|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
144542829|NCT00019604|521186673|FG000|Overall Study|Death|1|||
144542830|NCT00019604|521186673|FG000|Overall Study|Progressive disease|23|||
144542831|NCT00019604|521186673|FG000|Overall Study|Refused treatment|1|||
144542832|NCT00019604|521186673|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
144542833|NCT00019604|521186673|FG000|Overall Study|Going to have liver transplant|1|||
144542834|NCT00019604|521186673|FG000|Overall Study|Move to a different study|1|||
144542835|NCT00019604|521186673|FG000|Overall Study|Non compliant on systemic CH|1|||
144542836|NCT00019604|521186673|FG000|Overall Study|Non compliant|1|||
144542837|NCT00019604|521186673|FG000|Overall Study|Resectable disease|1|||
144542838|NCT00019604|521186673|FG000|Overall Study|Started new chemo regimen|1|||
144542839|NCT00019604|521186673|FG000|Overall Study|Pt going to immunotherapy study|1|||
144542840|NCT00019604|521186673|FG000|Overall Study|Too much disease|1|||
144542841|NCT00019604|521186673|FG000|Overall Study|Unable to evaluate|1|||
144542842|NCT00019604|521186673|FG000|Overall Study|Details for other not available|4|||
144542843|NCT00599196|521186674|FG000|Overall Study|Lack of Efficacy|22|||
144542844|NCT00599196|521186674|FG000|Overall Study|Adverse Event|93|||
144542845|NCT00599196|521186674|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
144542846|NCT00599196|521186674|FG000|Overall Study|Subject withdrew consent|43|||
144542847|NCT00599196|521186674|FG000|Overall Study|Study ended per sponsor|197|||
144542848|NCT00599196|521186674|FG000|Overall Study|Lost to Follow-up|17|||
144542849|NCT00599196|521186674|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
144542850|NCT00599196|521186674|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
144542851|NCT00599196|521186674|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
144542852|NCT00599196|521186674|FG000|Overall Study|Other: Pt Moved To Australia|1|||
144542853|NCT00599196|521186674|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
144542854|NCT00599196|521186674|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
144542855|NCT00454194|521186690|FG000|Overall Study|Adverse Event|7|||
144542856|NCT00454194|521186691|FG001|Overall Study|Adverse Event|2|||
144542857|NCT00454194|521186690|FG000|Overall Study|Withdrawal by Subject|12|||
144542858|NCT00454194|521186691|FG001|Overall Study|Withdrawal by Subject|8|||
144542859|NCT00454194|521186690|FG000|Overall Study|Other Medical Problems|1|||
144542860|NCT00454194|521186691|FG001|Overall Study|Other Medical Problems|2|||
144542861|NCT00454194|521186690|FG000|Overall Study|Other Unspecified Reason|2|||
144542862|NCT00454194|521186691|FG001|Overall Study|Other Unspecified Reason|2|||
144542863|NCT01170208|521186701|FG000|Overall Study|Withdrawal by Subject|5|||
144542864|NCT01170208|521186702|FG001|Overall Study|Withdrawal by Subject|0|||
144542865|NCT01170208|521186703|FG002|Overall Study|Withdrawal by Subject|1|||
144542866|NCT01170208|521186701|FG000|Overall Study|Protocol Violation|1|||
144542867|NCT01170208|521186702|FG001|Overall Study|Protocol Violation|0|||
144542868|NCT01170208|521186703|FG002|Overall Study|Protocol Violation|1|||
144542869|NCT01160354|521186708|FG000|Overall Study|Death|0|||
144542870|NCT01160354|521186709|FG001|Overall Study|Death|1|||
144542871|NCT01160354|521186710|FG002|Overall Study|Death|1|||
144542872|NCT02743819|521186712|FG000|Overall Study|Lack of Efficacy|5|||
144542873|NCT02743819|521186712|FG000|Overall Study|Death|2|||
144472951|NCT02798211|520930003|FG001|Period 1|Adverse Event|1|||
144472952|NCT02798211|520930004|FG002|Period 1|Adverse Event|0|||
144616373|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
144616374|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
144616375|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
144616376|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
144616377|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
144616378|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
144616379|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
144616380|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
144616381|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
144616382|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
144616383|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
144472953|NCT02798211|520930005|FG003|Period 1|Adverse Event|0|||
144472954|NCT02798211|520930006|FG004|Period 1|Adverse Event|0|||
144472955|NCT02798211|520930007|FG005|Period 1|Adverse Event|0|||
144472956|NCT02798211|520930002|FG000|Period 1|Lost to Follow-up|2|||
144472957|NCT02798211|520930003|FG001|Period 1|Lost to Follow-up|1|||
144542874|NCT02743819|521186712|FG000|Overall Study|Adverse Event|1|||
144542875|NCT03389802|521186713|FG000|Overall Study|Lack of Efficacy|3|||
144542876|NCT03389802|521186714|FG001|Overall Study|Lack of Efficacy|3|||
144542877|NCT03389802|521186715|FG002|Overall Study|Lack of Efficacy|13|||
144542878|NCT03389802|521186716|FG003|Overall Study|Lack of Efficacy|6|||
144542879|NCT03389802|521186717|FG004|Overall Study|Lack of Efficacy|1|||
144542880|NCT03389802|521186713|FG000|Overall Study|Adverse Event|0|||
144542881|NCT03389802|521186714|FG001|Overall Study|Adverse Event|0|||
144542882|NCT03389802|521186715|FG002|Overall Study|Adverse Event|1|||
144542883|NCT03389802|521186716|FG003|Overall Study|Adverse Event|0|||
144542884|NCT03389802|521186717|FG004|Overall Study|Adverse Event|4|||
144542885|NCT03389802|521186713|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
144542886|NCT03389802|521186714|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
144542887|NCT03389802|521186715|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
144542888|NCT03389802|521186716|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
144542889|NCT03389802|521186717|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
144542890|NCT01706159|521186718|FG000|Overall Study|Withdrawal Criteria|2|||
144542891|NCT01706159|521186719|FG001|Overall Study|Withdrawal Criteria|1|||
144542892|NCT01706159|521186718|FG000|Overall Study|Unclassified|6|||
144542893|NCT01706159|521186719|FG001|Overall Study|Unclassified|1|||
144542894|NCT02454959|521186721|FG000|Overall Study|Protocol-Specified Criteria|3|||
144542895|NCT02454959|521186721|FG000|Overall Study|Physician Decision|1|||
144542896|NCT02454959|521186721|FG000|Overall Study|Withdrawal by Subject|3|||
144542897|NCT02454959|521186721|FG000|Overall Study|Adverse Event|2|||
144542898|NCT05366751|521186722|FG000|Overall Study|Adverse Event|25|||
144542899|NCT05366751|521186722|FG000|Overall Study|Physician Decision|3|||
144542900|NCT05366751|521186722|FG000|Overall Study|Lost to Follow-up|2|||
144542901|NCT05366751|521186722|FG000|Overall Study|Withdrawal by Subject|14|||
144542902|NCT05366751|521186722|FG000|Overall Study|Study Terminated by Sponsor|50|||
144542903|NCT05366751|521186722|FG000|Overall Study|Site Terminated by Sponsor|3|||
144542904|NCT01690624|521186723|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
144542905|NCT01690624|521186724|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
144542906|NCT01690624|521186725|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
144542907|NCT01690624|521186726|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
144542908|NCT01690624|521186723|FG000|Overall Study|Adverse event (other than DLT)|3|||
144542909|NCT01690624|521186724|FG001|Overall Study|Adverse event (other than DLT)|1|||
144542910|NCT01690624|521186725|FG002|Overall Study|Adverse event (other than DLT)|1|||
144542911|NCT01690624|521186726|FG003|Overall Study|Adverse event (other than DLT)|1|||
144542912|NCT01690624|521186723|FG000|Overall Study|Withdrawal by Subject|0|||
144542913|NCT01690624|521186724|FG001|Overall Study|Withdrawal by Subject|0|||
144542914|NCT01690624|521186725|FG002|Overall Study|Withdrawal by Subject|1|||
144542915|NCT01690624|521186726|FG003|Overall Study|Withdrawal by Subject|0|||
144472958|NCT02798211|520930004|FG002|Period 1|Lost to Follow-up|0|||
144472959|NCT02798211|520930005|FG003|Period 1|Lost to Follow-up|0|||
144542916|NCT01690624|521186723|FG000|Overall Study|Sponsor is ending trial|0|||
144542917|NCT01690624|521186724|FG001|Overall Study|Sponsor is ending trial|0|||
144542918|NCT01690624|521186725|FG002|Overall Study|Sponsor is ending trial|0|||
144542919|NCT01690624|521186726|FG003|Overall Study|Sponsor is ending trial|1|||
144542920|NCT01690624|521186723|FG000|Overall Study|Physician Decision|0|||
144542921|NCT01690624|521186724|FG001|Overall Study|Physician Decision|0|||
144542922|NCT01690624|521186725|FG002|Overall Study|Physician Decision|0|||
144542923|NCT01690624|521186726|FG003|Overall Study|Physician Decision|1|||
144542924|NCT01690624|521186723|FG000|Overall Study|Withdrawal by Subject|0|||
144616384|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
144616385|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
144616386|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
144616387|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
144616388|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
144616389|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
144616390|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
144616391|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
144616392|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
144616393|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
144616394|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
144616395|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
144616396|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
144616397|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
144616398|NCT03605680|521456318|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
144616399|NCT03605680|521456319|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
144616400|NCT03605680|521456320|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
144616401|NCT03605680|521456321|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
144616402|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
144616403|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
144616404|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
144616405|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
144616406|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
144616407|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
144202066|NCT01106014|519936952|FG000|Overall Study|Lost to Follow-up|2|||
144202067|NCT01106014|519936953|FG001|Overall Study|Lost to Follow-up|3|||
144202068|NCT02752906|519936955|FG000|Overall Study|Protocol Violation|2|||
144472960|NCT02798211|520930006|FG004|Period 1|Lost to Follow-up|0|||
144472961|NCT02798211|520930007|FG005|Period 1|Lost to Follow-up|0|||
144472962|NCT02798211|520930002|FG000|Period 1|Protocol Violation|0|||
144472963|NCT02798211|520930003|FG001|Period 1|Protocol Violation|0|||
144472964|NCT02798211|520930004|FG002|Period 1|Protocol Violation|2|||
144472965|NCT02798211|520930005|FG003|Period 1|Protocol Violation|0|||
144472966|NCT02798211|520930006|FG004|Period 1|Protocol Violation|0|||
144472967|NCT02798211|520930007|FG005|Period 1|Protocol Violation|0|||
144472968|NCT02798211|520930002|FG000|Period 1|Withdrawal by Subject|1|||
144472969|NCT02798211|520930003|FG001|Period 1|Withdrawal by Subject|1|||
144472970|NCT02798211|520930004|FG002|Period 1|Withdrawal by Subject|0|||
144472971|NCT02798211|520930005|FG003|Period 1|Withdrawal by Subject|0|||
144472972|NCT02798211|520930006|FG004|Period 1|Withdrawal by Subject|0|||
144472973|NCT02798211|520930007|FG005|Period 1|Withdrawal by Subject|0|||
144472974|NCT02798211|520930002|FG000|Period 1|Death|0|||
144472975|NCT02798211|520930003|FG001|Period 1|Death|0|||
144472976|NCT02798211|520930004|FG002|Period 1|Death|1|||
144472977|NCT02798211|520930005|FG003|Period 1|Death|0|||
144472978|NCT02798211|520930006|FG004|Period 1|Death|0|||
144472979|NCT02798211|520930007|FG005|Period 1|Death|0|||
144472980|NCT02798211|520930002|FG000|Period 1|Withdrawal of Informed Consent|2|||
144472981|NCT02798211|520930003|FG001|Period 1|Withdrawal of Informed Consent|7|||
144472982|NCT02798211|520930004|FG002|Period 1|Withdrawal of Informed Consent|3|||
144472983|NCT02798211|520930005|FG003|Period 1|Withdrawal of Informed Consent|0|||
144472984|NCT02798211|520930006|FG004|Period 1|Withdrawal of Informed Consent|0|||
144472985|NCT02798211|520930007|FG005|Period 1|Withdrawal of Informed Consent|0|||
144472986|NCT02798211|520930002|FG000|Period 2|Withdrawal by Subject|2|||
144472987|NCT02798211|520930003|FG001|Period 2|Withdrawal by Subject|0|||
144472988|NCT02798211|520930004|FG002|Period 2|Withdrawal by Subject|0|||
144472989|NCT02798211|520930005|FG003|Period 2|Withdrawal by Subject|0|||
144472990|NCT02798211|520930006|FG004|Period 2|Withdrawal by Subject|2|||
144472991|NCT02798211|520930007|FG005|Period 2|Withdrawal by Subject|2|||
144472992|NCT02798211|520930002|FG000|Period 2|Adverse Event|5|||
144472993|NCT02798211|520930003|FG001|Period 2|Adverse Event|0|||
144472994|NCT02798211|520930004|FG002|Period 2|Adverse Event|0|||
144472995|NCT02798211|520930005|FG003|Period 2|Adverse Event|0|||
144472996|NCT02798211|520930006|FG004|Period 2|Adverse Event|1|||
144616408|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
144616409|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
144616410|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144616411|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144616412|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144616413|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
144472997|NCT02798211|520930007|FG005|Period 2|Adverse Event|0|||
144472998|NCT02798211|520930002|FG000|Period 2|Lack of Efficacy|1|||
144472999|NCT02798211|520930003|FG001|Period 2|Lack of Efficacy|0|||
144473000|NCT02798211|520930004|FG002|Period 2|Lack of Efficacy|0|||
144473001|NCT02798211|520930005|FG003|Period 2|Lack of Efficacy|1|||
144473002|NCT02798211|520930006|FG004|Period 2|Lack of Efficacy|0|||
144473003|NCT02798211|520930007|FG005|Period 2|Lack of Efficacy|1|||
144542925|NCT01690624|521186724|FG001|Overall Study|Withdrawal by Subject|1|||
144542926|NCT01690624|521186725|FG002|Overall Study|Withdrawal by Subject|0|||
144202069|NCT02752906|519936956|FG001|Overall Study|Protocol Violation|1|||
144202070|NCT02752906|519936955|FG000|Overall Study|Withdrawal by Subject|2|||
144202071|NCT02752906|519936956|FG001|Overall Study|Withdrawal by Subject|2|||
144202072|NCT02752906|519936955|FG000|Overall Study|Lost to Follow-up|3|||
144202073|NCT02752906|519936956|FG001|Overall Study|Lost to Follow-up|2|||
144202074|NCT02492880|519936957|FG000|Overall Study|Lost to Follow-up|1|||
144202075|NCT02492880|519936957|FG000|Overall Study|Protocol Violation|1|||
144542927|NCT01690624|521186726|FG003|Overall Study|Withdrawal by Subject|0|||
144542928|NCT01690624|521186723|FG000|Overall Study|Lack of Efficacy|1|||
144542929|NCT01690624|521186724|FG001|Overall Study|Lack of Efficacy|1|||
144542930|NCT01690624|521186725|FG002|Overall Study|Lack of Efficacy|3|||
144542931|NCT01690624|521186726|FG003|Overall Study|Lack of Efficacy|0|||
144542932|NCT00491894|521186730|FG000|Overall Study|Adverse Event|14|||
144542933|NCT00491894|521186730|FG000|Overall Study|Withdrawal by Subject|5|||
144542934|NCT00491894|521186730|FG000|Overall Study|Death|3|||
144542935|NCT00491894|521186730|FG000|Overall Study|Lost to Follow-up|3|||
144542936|NCT00491894|521186730|FG000|Overall Study|Lack of Efficacy|2|||
144542937|NCT00491894|521186730|FG000|Overall Study|Other-Failed to meet any criteria|2|||
144542938|NCT00491894|521186730|FG000|Overall Study|Physician Decision|2|||
144542939|NCT00491894|521186730|FG000|Overall Study|Protocol Violation|2|||
144542940|NCT00491894|521186730|FG000|Overall Study|Other-Intake of prohibited medication|1|||
144542941|NCT01563185|521186731|FG000|Overall Study|Withdrawal by Subject|1|||
144542942|NCT01563185|521186731|FG000|Overall Study|Non-Compliance with study drug|1|||
144542943|NCT03147287|521186732|FG000|Overall Study|Randomized Not Treated|2|||
144542944|NCT03147287|521186733|FG001|Overall Study|Randomized Not Treated|1|||
144542945|NCT03147287|521186734|FG002|Overall Study|Randomized Not Treated|1|||
144542946|NCT03147287|521186732|FG000|Overall Study|Progressive Disease RECIST|31|||
144542947|NCT03147287|521186733|FG001|Overall Study|Progressive Disease RECIST|72|||
144542948|NCT03147287|521186734|FG002|Overall Study|Progressive Disease RECIST|32|||
144542949|NCT03147287|521186732|FG000|Overall Study|Progressive Disease not RECIST|13|||
144542950|NCT03147287|521186733|FG001|Overall Study|Progressive Disease not RECIST|21|||
144542951|NCT03147287|521186734|FG002|Overall Study|Progressive Disease not RECIST|13|||
144542952|NCT03147287|521186732|FG000|Overall Study|Physician Decision|1|||
144542953|NCT03147287|521186733|FG001|Overall Study|Physician Decision|2|||
144542954|NCT03147287|521186734|FG002|Overall Study|Physician Decision|1|||
144542955|NCT03147287|521186732|FG000|Overall Study|Intercurrent illness|0|||
144542956|NCT03147287|521186733|FG001|Overall Study|Intercurrent illness|1|||
144542957|NCT03147287|521186734|FG002|Overall Study|Intercurrent illness|0|||
144542958|NCT03147287|521186732|FG000|Overall Study|Withdrawal by Subject|2|||
144542959|NCT03147287|521186733|FG001|Overall Study|Withdrawal by Subject|3|||
144542960|NCT03147287|521186734|FG002|Overall Study|Withdrawal by Subject|2|||
144542961|NCT03147287|521186732|FG000|Overall Study|Patient Non-Compliance|0|||
144542962|NCT03147287|521186733|FG001|Overall Study|Patient Non-Compliance|2|||
144542963|NCT03147287|521186734|FG002|Overall Study|Patient Non-Compliance|0|||
144542964|NCT03147287|521186732|FG000|Overall Study|Patient moved|0|||
144542965|NCT03147287|521186733|FG001|Overall Study|Patient moved|1|||
144542966|NCT03147287|521186734|FG002|Overall Study|Patient moved|0|||
144542967|NCT03147287|521186732|FG000|Overall Study|Arm A crossover without PD|1|||
144542968|NCT03147287|521186733|FG001|Overall Study|Arm A crossover without PD|0|||
144542969|NCT03147287|521186734|FG002|Overall Study|Arm A crossover without PD|0|||
144542970|NCT03147287|521186732|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
144542971|NCT03147287|521186733|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
144542972|NCT03147287|521186734|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
144542973|NCT00925548|521188161|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
144542974|NCT00925548|521188162|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
144542975|NCT03116464|521188163|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
144542976|NCT00747006|521188164|FG000|Overall Study|Adverse Event|1|||
144542977|NCT00747006|521188165|FG001|Overall Study|Adverse Event|0|||
144542978|NCT00747006|521188166|FG002|Overall Study|Adverse Event|0|||
144542979|NCT00747006|521188164|FG000|Overall Study|Lost to Follow-up|0|||
144542980|NCT00747006|521188165|FG001|Overall Study|Lost to Follow-up|1|||
144542981|NCT00747006|521188166|FG002|Overall Study|Lost to Follow-up|0|||
144202076|NCT00792935|519936958|FG000|Overall Study|Adverse Event|2|||
144202077|NCT00792935|519936959|FG001|Overall Study|Adverse Event|1|||
144202078|NCT00792935|519936958|FG000|Overall Study|Lost to Follow-up|0|||
144542982|NCT00747006|521188164|FG000|Overall Study|Physician Decision|2|||
144542983|NCT00747006|521188165|FG001|Overall Study|Physician Decision|0|||
144542984|NCT00747006|521188166|FG002|Overall Study|Physician Decision|1|||
144542985|NCT00357994|521188167|FG000|Overall Study|Adverse Event|1|||
144542986|NCT00357994|521188168|FG001|Overall Study|Adverse Event|2|||
144542987|NCT00357994|521188167|FG000|Overall Study|Lack of Efficacy|0|||
144542988|NCT00357994|521188168|FG001|Overall Study|Lack of Efficacy|1|||
144542989|NCT00357994|521188167|FG000|Overall Study|Protocol Violation|1|||
144542990|NCT00357994|521188168|FG001|Overall Study|Protocol Violation|0|||
144542991|NCT00345046|521188171|FG000|Overall Study|Protocol Violation|1|||
144616414|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
144616415|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
144542992|NCT00345046|521188172|FG001|Overall Study|Protocol Violation|1|||
144542993|NCT00345046|521188173|FG002|Overall Study|Protocol Violation|2|||
144542994|NCT04652869|521188178|FG000|Overall Study|Withdrawal by Subject|0|||
144542995|NCT04652869|521188179|FG001|Overall Study|Withdrawal by Subject|2|||
144542996|NCT04652869|521188180|FG002|Overall Study|Withdrawal by Subject|0|||
144542997|NCT01372085|521188181|FG000|Washout Period 2|Physician Decision|0|||
144616416|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
144616417|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
144473004|NCT02798211|520930002|FG000|Period 2|Lost to Follow-up|3|||
144473005|NCT02798211|520930003|FG001|Period 2|Lost to Follow-up|0|||
144473006|NCT02798211|520930004|FG002|Period 2|Lost to Follow-up|0|||
144473007|NCT02798211|520930005|FG003|Period 2|Lost to Follow-up|0|||
144473008|NCT02798211|520930006|FG004|Period 2|Lost to Follow-up|2|||
144473009|NCT02798211|520930007|FG005|Period 2|Lost to Follow-up|0|||
144473010|NCT02798211|520930002|FG000|Period 2|Physician Decision|1|||
144473011|NCT02798211|520930003|FG001|Period 2|Physician Decision|0|||
144473012|NCT02798211|520930004|FG002|Period 2|Physician Decision|0|||
144473013|NCT02798211|520930005|FG003|Period 2|Physician Decision|1|||
144473014|NCT02798211|520930006|FG004|Period 2|Physician Decision|1|||
144473015|NCT02798211|520930007|FG005|Period 2|Physician Decision|0|||
144473016|NCT02798211|520930002|FG000|Period 2|Pregnancy|0|||
144473017|NCT02798211|520930003|FG001|Period 2|Pregnancy|0|||
144473018|NCT02798211|520930004|FG002|Period 2|Pregnancy|0|||
144473019|NCT02798211|520930005|FG003|Period 2|Pregnancy|2|||
144473020|NCT02798211|520930006|FG004|Period 2|Pregnancy|0|||
144473021|NCT02798211|520930007|FG005|Period 2|Pregnancy|0|||
144473022|NCT02798211|520930002|FG000|Period 2|Technical problems|1|||
144473023|NCT02798211|520930003|FG001|Period 2|Technical problems|0|||
144473024|NCT02798211|520930004|FG002|Period 2|Technical problems|0|||
144473025|NCT02798211|520930005|FG003|Period 2|Technical problems|1|||
144473026|NCT02798211|520930006|FG004|Period 2|Technical problems|0|||
144473027|NCT02798211|520930007|FG005|Period 2|Technical problems|0|||
144473028|NCT02798211|520930002|FG000|Period 2|Withdrawal of Informed Consent|1|||
144473029|NCT02798211|520930003|FG001|Period 2|Withdrawal of Informed Consent|0|||
144542998|NCT01372085|521188182|FG001|Washout Period 2|Physician Decision|0|||
144542999|NCT01372085|521188183|FG002|Washout Period 2|Physician Decision|0|||
144543000|NCT01372085|521188184|FG003|Washout Period 2|Physician Decision|0|||
144543001|NCT01372085|521188185|FG004|Washout Period 2|Physician Decision|1|||
144543002|NCT01372085|521188186|FG005|Washout Period 2|Physician Decision|0|||
144543003|NCT01372085|521188187|FG006|Washout Period 2|Physician Decision|0|||
144543004|NCT01372085|521188188|FG007|Washout Period 2|Physician Decision|0|||
144543005|NCT01372085|521188189|FG008|Washout Period 2|Physician Decision|0|||
144543006|NCT01372085|521188190|FG009|Washout Period 2|Physician Decision|0|||
144543007|NCT01372085|521188181|FG000|Washout Period 3|Withdrawal by Subject|0|||
144543008|NCT01372085|521188182|FG001|Washout Period 3|Withdrawal by Subject|0|||
144543009|NCT01372085|521188183|FG002|Washout Period 3|Withdrawal by Subject|0|||
144543010|NCT01372085|521188184|FG003|Washout Period 3|Withdrawal by Subject|0|||
144543011|NCT01372085|521188185|FG004|Washout Period 3|Withdrawal by Subject|0|||
144543012|NCT01372085|521188186|FG005|Washout Period 3|Withdrawal by Subject|2|||
144543013|NCT01372085|521188187|FG006|Washout Period 3|Withdrawal by Subject|0|||
144543014|NCT01372085|521188188|FG007|Washout Period 3|Withdrawal by Subject|0|||
144543015|NCT01372085|521188189|FG008|Washout Period 3|Withdrawal by Subject|0|||
144543016|NCT01372085|521188190|FG009|Washout Period 3|Withdrawal by Subject|0|||
144543017|NCT00562094|521188191|FG000|Overall Study|Lost to Follow-up|62|||
144473030|NCT02798211|520930004|FG002|Period 2|Withdrawal of Informed Consent|0|||
144473031|NCT02798211|520930005|FG003|Period 2|Withdrawal of Informed Consent|2|||
144473032|NCT02798211|520930006|FG004|Period 2|Withdrawal of Informed Consent|2|||
144473033|NCT02798211|520930007|FG005|Period 2|Withdrawal of Informed Consent|3|||
144543018|NCT03689946|521188192|FG000|Overall Study|Withdrawal by Subject|3|||
144543019|NCT03689946|521188192|FG000|Overall Study|Lost to Follow-up|3|||
144543020|NCT03689946|521188192|FG000|Overall Study|Data corruption|2|||
144543021|NCT01555138|521188193|FG000|Overall Study|Death|0|||
144543022|NCT01555138|521188194|FG001|Overall Study|Death|1|||
144543023|NCT01555138|521188193|FG000|Overall Study|Lost to Follow-up|1|||
144543024|NCT01555138|521188194|FG001|Overall Study|Lost to Follow-up|0|||
144616418|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
144727481|NCT02101853|521856652|FG001|Block 1 Induction|Ineligible|0|||
144473034|NCT01782872|520930008|FG000|Overall Study|Protocol Violation|0|||
144473035|NCT01782872|520930009|FG001|Overall Study|Protocol Violation|0|||
144473036|NCT01782872|520930010|FG002|Overall Study|Protocol Violation|0|||
144473037|NCT01782872|520930011|FG003|Overall Study|Protocol Violation|1|||
144473038|NCT01782872|520930008|FG000|Overall Study|Withdrawal by Subject|0|||
144473039|NCT01782872|520930009|FG001|Overall Study|Withdrawal by Subject|1|||
144473040|NCT01782872|520930010|FG002|Overall Study|Withdrawal by Subject|0|||
144473041|NCT01782872|520930011|FG003|Overall Study|Withdrawal by Subject|0|||
144543025|NCT01555138|521188193|FG000|Overall Study|Abnormal Lab reults|1|||
144543026|NCT01555138|521188194|FG001|Overall Study|Abnormal Lab reults|3|||
144543027|NCT01555138|521188193|FG000|Overall Study|Lack of Efficacy|2|||
144543028|NCT01555138|521188194|FG001|Overall Study|Lack of Efficacy|2|||
144543029|NCT01555138|521188193|FG000|Overall Study|Protocol Violation|5|||
144543030|NCT01555138|521188194|FG001|Overall Study|Protocol Violation|3|||
144543031|NCT01555138|521188193|FG000|Overall Study|Administrative problems|8|||
144543032|NCT01555138|521188194|FG001|Overall Study|Administrative problems|0|||
144543033|NCT01555138|521188193|FG000|Overall Study|Withdrawal by Subject|16|||
144543034|NCT01555138|521188194|FG001|Overall Study|Withdrawal by Subject|15|||
144543035|NCT01555138|521188193|FG000|Overall Study|Adverse Event|14|||
144543036|NCT01555138|521188194|FG001|Overall Study|Adverse Event|14|||
144543037|NCT01613417|521188195|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
144543038|NCT01613417|521188196|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
144543039|NCT01079806|521188199|FG000|Day 1 to Week 96|Adverse Event|0|||
144543040|NCT01079806|521188200|FG001|Day 1 to Week 96|Adverse Event|3|||
144543041|NCT01079806|521188199|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
144543042|NCT01079806|521188200|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
144543043|NCT01079806|521188199|FG000|Day 1 to Week 96|Pregnancy|0|||
144543044|NCT01079806|521188200|FG001|Day 1 to Week 96|Pregnancy|1|||
144543045|NCT01079806|521188199|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
144543046|NCT01079806|521188200|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
144543047|NCT01079806|521188199|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
144543048|NCT01079806|521188200|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
144543049|NCT01079806|521188199|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
144543050|NCT01079806|521188200|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
144543051|NCT01079806|521188199|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
144543052|NCT01079806|521188200|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
144543053|NCT01079806|521188199|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
144543054|NCT01079806|521188200|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
144543055|NCT01079806|521188199|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
144543056|NCT01079806|521188200|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
144543057|NCT01079806|521188199|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
144543058|NCT01079806|521188200|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
144543059|NCT01009645|521188203|FG000|Overall Study|Lost to Follow-up|2|||
144543060|NCT01009645|521188204|FG001|Overall Study|Lost to Follow-up|8|||
144543061|NCT01009645|521188205|FG002|Overall Study|Lost to Follow-up|4|||
144543062|NCT01009645|521188206|FG003|Overall Study|Lost to Follow-up|5|||
144543063|NCT03345979|521188207|FG000|Overall Study|Withdrawal by Subject|20|||
144543064|NCT03345979|521188208|FG001|Overall Study|Withdrawal by Subject|31|||
144543065|NCT03345979|521188207|FG000|Overall Study|Adverse Event|10|||
144543066|NCT03345979|521188208|FG001|Overall Study|Adverse Event|11|||
144543067|NCT03345979|521188207|FG000|Overall Study|Lost to Follow-up|8|||
144543068|NCT03345979|521188208|FG001|Overall Study|Lost to Follow-up|9|||
144543069|NCT03345979|521188207|FG000|Overall Study|Lack of Efficacy|4|||
144543070|NCT03345979|521188208|FG001|Overall Study|Lack of Efficacy|2|||
144543071|NCT03345979|521188207|FG000|Overall Study|Protocol Violation|1|||
144543072|NCT03345979|521188208|FG001|Overall Study|Protocol Violation|3|||
144543073|NCT03345979|521188207|FG000|Overall Study|Physician Decision|0|||
144543074|NCT03345979|521188208|FG001|Overall Study|Physician Decision|2|||
144543075|NCT00999596|521188209|FG000|Overall Study|Statistical population not required|101|||
144543076|NCT02085941|521188211|FG000|Overall Study|Lack of Efficacy|1|||
144543077|NCT02085941|521188212|FG001|Overall Study|Lack of Efficacy|0|||
144543078|NCT02085941|521188211|FG000|Overall Study|Death|6|||
144543079|NCT02085941|521188212|FG001|Overall Study|Death|1|||
144543080|NCT02085941|521188211|FG000|Overall Study|Lost to Follow-up|1|||
144543081|NCT02085941|521188212|FG001|Overall Study|Lost to Follow-up|0|||
144543082|NCT02085941|521188211|FG000|Overall Study|Physician Decision|0|||
144543083|NCT02085941|521188212|FG001|Overall Study|Physician Decision|2|||
144543084|NCT02788981|521188218|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
144543085|NCT02788981|521188219|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
144543086|NCT00249769|521188220|FG000|Overall Study|Withdrawal by Subject|1|||
144543087|NCT00249769|521188221|FG001|Overall Study|Withdrawal by Subject|10|||
144543088|NCT00249769|521188222|FG002|Overall Study|Withdrawal by Subject|6|||
144543089|NCT00249769|521188220|FG000|Overall Study|Migration from Study Area|1|||
144543090|NCT00249769|521188221|FG001|Overall Study|Migration from Study Area|3|||
144543091|NCT00249769|521188222|FG002|Overall Study|Migration from Study Area|14|||
144543092|NCT00249769|521188220|FG000|Overall Study|Miscellaneous|0|||
144543093|NCT00249769|521188221|FG001|Overall Study|Miscellaneous|2|||
144543094|NCT00249769|521188222|FG002|Overall Study|Miscellaneous|2|||
144543095|NCT00249769|521188220|FG000|Overall Study|Adverse Event|0|||
144543096|NCT00249769|521188221|FG001|Overall Study|Adverse Event|0|||
144543097|NCT00249769|521188222|FG002|Overall Study|Adverse Event|1|||
144543098|NCT00249769|521188220|FG000|Overall Study|Physician Decision|0|||
144543099|NCT00249769|521188221|FG001|Overall Study|Physician Decision|0|||
144543100|NCT00249769|521188222|FG002|Overall Study|Physician Decision|2|||
144543101|NCT00249769|521188220|FG000|Overall Study|Lost to Follow-up|0|||
144543102|NCT00249769|521188221|FG001|Overall Study|Lost to Follow-up|0|||
144543103|NCT00249769|521188222|FG002|Overall Study|Lost to Follow-up|3|||
144543104|NCT02022657|521188223|FG000|Overall Study|Withdrawal by Subject|2|||
144543105|NCT02022657|521188224|FG001|Overall Study|Withdrawal by Subject|0|||
144543106|NCT02022657|521188225|FG002|Overall Study|Withdrawal by Subject|1|||
144543107|NCT02022657|521188226|FG003|Overall Study|Withdrawal by Subject|0|||
144543108|NCT02022657|521188227|FG004|Overall Study|Withdrawal by Subject|0|||
144543109|NCT02022657|521188228|FG005|Overall Study|Withdrawal by Subject|0|||
144543110|NCT02022657|521188223|FG000|Overall Study|Physician Decision|0|||
144543111|NCT02022657|521188224|FG001|Overall Study|Physician Decision|0|||
144543112|NCT02022657|521188225|FG002|Overall Study|Physician Decision|0|||
144543113|NCT02022657|521188226|FG003|Overall Study|Physician Decision|0|||
144543114|NCT02022657|521188227|FG004|Overall Study|Physician Decision|0|||
144543115|NCT02022657|521188228|FG005|Overall Study|Physician Decision|1|||
144543116|NCT03274076|521188229|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
144543117|NCT03274076|521188230|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
144543118|NCT03274076|521188231|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
144543119|NCT03274076|521188232|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
144543120|NCT03274076|521188229|FG000|24 Weeks Open Label|Adverse Event|0|||
144543121|NCT03274076|521188230|FG001|24 Weeks Open Label|Adverse Event|0|||
144543122|NCT03274076|521188231|FG002|24 Weeks Open Label|Adverse Event|2|||
144543123|NCT03274076|521188232|FG003|24 Weeks Open Label|Adverse Event|0|||
144543124|NCT03274076|521188229|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
144543125|NCT03274076|521188230|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
144543126|NCT03274076|521188231|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
144543127|NCT03274076|521188232|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
144543128|NCT00586313|521188233|FG000|Overall Study|Lack of Efficacy|2|||
144543129|NCT03205566|521188236|FG000|Phase 1|Protocol Violation|1|||
144473042|NCT01892345|520930012|FG000|Overall Study|Adverse Event|0|||
144473043|NCT01892345|520930013|FG001|Overall Study|Adverse Event|2|||
144473044|NCT01892345|520930012|FG000|Overall Study|Death|1|||
144473045|NCT01892345|520930013|FG001|Overall Study|Death|0|||
144473046|NCT01892345|520930012|FG000|Overall Study|Lost to Follow-up|3|||
144543130|NCT03205566|521188237|FG001|Phase 1|Protocol Violation|1|||
144543131|NCT03739866|521188238|FG000|Overall Study|Lost to Follow-up|0|||
144543132|NCT03739866|521188239|FG001|Overall Study|Lost to Follow-up|0|||
144543133|NCT03739866|521188240|FG002|Overall Study|Lost to Follow-up|0|||
144543134|NCT03739866|521188241|FG003|Overall Study|Lost to Follow-up|1|||
144543135|NCT03739866|521188242|FG004|Overall Study|Lost to Follow-up|0|||
144543136|NCT03739866|521188243|FG005|Overall Study|Lost to Follow-up|0|||
144543137|NCT03739866|521188244|FG006|Overall Study|Lost to Follow-up|0|||
144543138|NCT03739866|521188245|FG007|Overall Study|Lost to Follow-up|0|||
144543139|NCT03739866|521188238|FG000|Overall Study|Enrolled but not treated|0|||
144543140|NCT03739866|521188239|FG001|Overall Study|Enrolled but not treated|0|||
144543141|NCT03739866|521188240|FG002|Overall Study|Enrolled but not treated|1|||
144543142|NCT03739866|521188241|FG003|Overall Study|Enrolled but not treated|0|||
144543143|NCT03739866|521188242|FG004|Overall Study|Enrolled but not treated|1|||
144543144|NCT03739866|521188243|FG005|Overall Study|Enrolled but not treated|0|||
144543145|NCT03739866|521188244|FG006|Overall Study|Enrolled but not treated|0|||
144543146|NCT03739866|521188245|FG007|Overall Study|Enrolled but not treated|0|||
144543147|NCT03184987|521188246|FG000|Overall Study|Withdrawal by Subject|0|||
144543148|NCT03184987|521188247|FG001|Overall Study|Withdrawal by Subject|1|||
144543149|NCT03184987|521188248|FG002|Overall Study|Withdrawal by Subject|2|||
144727482|NCT02101853|521856653|FG002|Block 1 Induction|Ineligible|0|||
144473047|NCT01892345|520930013|FG001|Overall Study|Lost to Follow-up|0|||
144473048|NCT01892345|520930012|FG000|Overall Study|Withdrawal by Subject|12|||
144473049|NCT01892345|520930013|FG001|Overall Study|Withdrawal by Subject|1|||
144473050|NCT03505476|520930014|FG000|Overall Study|Physician Decision|18|||
144543150|NCT03184987|521188246|FG000|Overall Study|Physician Decision|0|||
144543151|NCT03184987|521188247|FG001|Overall Study|Physician Decision|0|||
144543152|NCT03184987|521188248|FG002|Overall Study|Physician Decision|1|||
144543153|NCT03184987|521188246|FG000|Overall Study|Adverse Event|1|||
144543154|NCT03184987|521188247|FG001|Overall Study|Adverse Event|0|||
144543155|NCT03184987|521188248|FG002|Overall Study|Adverse Event|1|||
144543156|NCT01619059|521188249|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
144543157|NCT01619059|521188250|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
144543158|NCT01619059|521188249|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
144543159|NCT01619059|521188250|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
144543160|NCT01619059|521188249|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
144473051|NCT03505476|520930014|FG000|Overall Study|Device Malfunctioned|101|||
144473052|NCT03505476|520930014|FG000|Overall Study|Data Corrupt|6|||
144473053|NCT03505476|520930014|FG000|Overall Study|Device application insufficiant|3|||
144543161|NCT01619059|521188250|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
144543162|NCT01619059|521188249|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
144543163|NCT01619059|521188250|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
144543164|NCT01619059|521188249|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
144202079|NCT00792935|519936959|FG001|Overall Study|Lost to Follow-up|1|||
144543165|NCT01619059|521188250|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
144543166|NCT01619059|521188249|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
144543167|NCT01619059|521188250|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
144543168|NCT01619059|521188249|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
144543169|NCT01619059|521188250|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
144543170|NCT01619059|521188249|FG000|Long-Term (LT) Treatment Period|Death|1|||
144543171|NCT01619059|521188250|FG001|Long-Term (LT) Treatment Period|Death|0|||
144543172|NCT01619059|521188249|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
144543173|NCT01619059|521188250|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
144202080|NCT00792935|519936958|FG000|Overall Study|Protocol Violation|2|||
144202081|NCT00792935|519936959|FG001|Overall Study|Protocol Violation|0|||
144202082|NCT00792935|519936958|FG000|Overall Study|Withdrawal by Subject|0|||
144202083|NCT00792935|519936959|FG001|Overall Study|Withdrawal by Subject|1|||
144202084|NCT03186781|519936960|FG000|Overall Study|Lost to Follow-up|0|||
144202085|NCT03186781|519936961|FG001|Overall Study|Lost to Follow-up|0|||
144202086|NCT03186781|519936962|FG002|Overall Study|Lost to Follow-up|1|||
144202087|NCT03186781|519936963|FG003|Overall Study|Lost to Follow-up|0|||
144202088|NCT03186781|519936964|FG004|Overall Study|Lost to Follow-up|1|||
144202089|NCT03186781|519936965|FG005|Overall Study|Lost to Follow-up|0|||
144202090|NCT03186781|519936960|FG000|Overall Study|Moved from Area|0|||
144202091|NCT03186781|519936961|FG001|Overall Study|Moved from Area|0|||
144543174|NCT01619059|521188249|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
144543175|NCT01619059|521188250|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
144543176|NCT01953692|521188253|FG000|Overall Study|Adverse Event|5|||
144543177|NCT01953692|521188254|FG001|Overall Study|Adverse Event|2|||
144543178|NCT01953692|521188255|FG002|Overall Study|Adverse Event|4|||
144543179|NCT01953692|521188256|FG003|Overall Study|Adverse Event|2|||
144543180|NCT01953692|521188257|FG004|Overall Study|Adverse Event|1|||
144543181|NCT01953692|521188258|FG005|Overall Study|Adverse Event|2|||
144543182|NCT01953692|521188259|FG006|Overall Study|Adverse Event|0|||
144543183|NCT01953692|521188260|FG007|Overall Study|Adverse Event|0|||
144543184|NCT01953692|521188261|FG008|Overall Study|Adverse Event|0|||
144543185|NCT01953692|521188253|FG000|Overall Study|Clinical Progression|0|||
144543186|NCT01953692|521188254|FG001|Overall Study|Clinical Progression|15|||
144543187|NCT01953692|521188255|FG002|Overall Study|Clinical Progression|7|||
144543188|NCT01953692|521188256|FG003|Overall Study|Clinical Progression|5|||
144543189|NCT01953692|521188257|FG004|Overall Study|Clinical Progression|0|||
144543190|NCT01953692|521188258|FG005|Overall Study|Clinical Progression|7|||
144543191|NCT01953692|521188259|FG006|Overall Study|Clinical Progression|20|||
144543192|NCT01953692|521188260|FG007|Overall Study|Clinical Progression|3|||
144543193|NCT01953692|521188261|FG008|Overall Study|Clinical Progression|3|||
144543194|NCT01953692|521188253|FG000|Overall Study|Death|5|||
144543195|NCT01953692|521188254|FG001|Overall Study|Death|0|||
144543196|NCT01953692|521188255|FG002|Overall Study|Death|2|||
144543197|NCT01953692|521188256|FG003|Overall Study|Death|2|||
144543198|NCT01953692|521188257|FG004|Overall Study|Death|1|||
144543199|NCT01953692|521188258|FG005|Overall Study|Death|3|||
144543200|NCT01953692|521188259|FG006|Overall Study|Death|6|||
144543201|NCT01953692|521188260|FG007|Overall Study|Death|2|||
144543202|NCT01953692|521188261|FG008|Overall Study|Death|1|||
144543203|NCT01953692|521188253|FG000|Overall Study|Excluded Medication|1|||
144543204|NCT01953692|521188254|FG001|Overall Study|Excluded Medication|0|||
144543205|NCT01953692|521188255|FG002|Overall Study|Excluded Medication|0|||
144543206|NCT01953692|521188256|FG003|Overall Study|Excluded Medication|0|||
144543207|NCT01953692|521188257|FG004|Overall Study|Excluded Medication|0|||
144543208|NCT01953692|521188258|FG005|Overall Study|Excluded Medication|0|||
144543209|NCT01953692|521188259|FG006|Overall Study|Excluded Medication|0|||
144202092|NCT03186781|519936962|FG002|Overall Study|Moved from Area|0|||
144202093|NCT03186781|519936963|FG003|Overall Study|Moved from Area|0|||
144543210|NCT01953692|521188260|FG007|Overall Study|Excluded Medication|0|||
144543211|NCT01953692|521188261|FG008|Overall Study|Excluded Medication|0|||
144543212|NCT01953692|521188253|FG000|Overall Study|Lost to Follow-up|1|||
144543213|NCT01953692|521188254|FG001|Overall Study|Lost to Follow-up|0|||
144543214|NCT01953692|521188255|FG002|Overall Study|Lost to Follow-up|3|||
144543215|NCT01953692|521188256|FG003|Overall Study|Lost to Follow-up|1|||
144543216|NCT01953692|521188257|FG004|Overall Study|Lost to Follow-up|0|||
144202094|NCT03186781|519936964|FG004|Overall Study|Moved from Area|1|||
144202095|NCT03186781|519936965|FG005|Overall Study|Moved from Area|0|||
144202096|NCT03186781|519936960|FG000|Overall Study|Withdrawal by Subject|0|||
144543217|NCT01953692|521188258|FG005|Overall Study|Lost to Follow-up|1|||
144543218|NCT01953692|521188259|FG006|Overall Study|Lost to Follow-up|0|||
144543219|NCT01953692|521188260|FG007|Overall Study|Lost to Follow-up|0|||
144543220|NCT01953692|521188261|FG008|Overall Study|Lost to Follow-up|0|||
144543221|NCT01953692|521188253|FG000|Overall Study|Physician Decision|11|||
144543222|NCT01953692|521188254|FG001|Overall Study|Physician Decision|4|||
144543223|NCT01953692|521188255|FG002|Overall Study|Physician Decision|2|||
144543224|NCT01953692|521188256|FG003|Overall Study|Physician Decision|2|||
144543225|NCT01953692|521188257|FG004|Overall Study|Physician Decision|1|||
144543226|NCT01953692|521188258|FG005|Overall Study|Physician Decision|2|||
144543227|NCT01953692|521188259|FG006|Overall Study|Physician Decision|4|||
144543228|NCT01953692|521188260|FG007|Overall Study|Physician Decision|1|||
144543229|NCT01953692|521188261|FG008|Overall Study|Physician Decision|0|||
144543230|NCT01953692|521188253|FG000|Overall Study|Protocol Violation|0|||
144543231|NCT01953692|521188254|FG001|Overall Study|Protocol Violation|2|||
144543232|NCT01953692|521188255|FG002|Overall Study|Protocol Violation|1|||
144543233|NCT01953692|521188256|FG003|Overall Study|Protocol Violation|0|||
144543234|NCT01953692|521188257|FG004|Overall Study|Protocol Violation|0|||
144543235|NCT01953692|521188258|FG005|Overall Study|Protocol Violation|0|||
144543236|NCT01953692|521188259|FG006|Overall Study|Protocol Violation|0|||
144543237|NCT01953692|521188260|FG007|Overall Study|Protocol Violation|1|||
144543238|NCT01953692|521188261|FG008|Overall Study|Protocol Violation|0|||
144543239|NCT01953692|521188253|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543240|NCT01953692|521188254|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543241|NCT01953692|521188255|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543242|NCT01953692|521188256|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543243|NCT01953692|521188257|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543244|NCT01953692|521188258|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543245|NCT01953692|521188259|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543246|NCT01953692|521188260|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
144543247|NCT01953692|521188261|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
144543248|NCT01953692|521188253|FG000|Overall Study|Withdrawal by Subject|4|||
144543249|NCT01953692|521188254|FG001|Overall Study|Withdrawal by Subject|2|||
144543250|NCT01953692|521188255|FG002|Overall Study|Withdrawal by Subject|1|||
144543251|NCT01953692|521188256|FG003|Overall Study|Withdrawal by Subject|2|||
144202097|NCT03186781|519936961|FG001|Overall Study|Withdrawal by Subject|0|||
144202098|NCT03186781|519936962|FG002|Overall Study|Withdrawal by Subject|0|||
144202099|NCT03186781|519936963|FG003|Overall Study|Withdrawal by Subject|0|||
144543252|NCT01953692|521188257|FG004|Overall Study|Withdrawal by Subject|0|||
144543253|NCT01953692|521188258|FG005|Overall Study|Withdrawal by Subject|3|||
144543254|NCT01953692|521188259|FG006|Overall Study|Withdrawal by Subject|2|||
144543255|NCT01953692|521188260|FG007|Overall Study|Withdrawal by Subject|1|||
144543256|NCT01953692|521188261|FG008|Overall Study|Withdrawal by Subject|1|||
144543257|NCT00641537|521188266|FG000|96-week Period|Adverse Event|0|||
144543258|NCT00641537|521188267|FG001|96-week Period|Adverse Event|1|||
144543259|NCT00641537|521188268|FG002|96-week Period|Adverse Event|3|||
144543260|NCT00641537|521188269|FG003|96-week Period|Adverse Event|0|||
144543261|NCT00641537|521188270|FG004|96-week Period|Adverse Event|2|||
144543262|NCT00641537|521188271|FG005|96-week Period|Adverse Event|0|||
144543263|NCT00641537|521188272|FG006|96-week Period|Adverse Event|0|||
144543264|NCT00641537|521188273|FG007|96-week Period|Adverse Event|0|||
144543265|NCT00641537|521188266|FG000|96-week Period|Lost to Follow-up|3|||
144543266|NCT00641537|521188267|FG001|96-week Period|Lost to Follow-up|1|||
144543267|NCT00641537|521188268|FG002|96-week Period|Lost to Follow-up|2|||
144543268|NCT00641537|521188269|FG003|96-week Period|Lost to Follow-up|2|||
144543269|NCT00641537|521188270|FG004|96-week Period|Lost to Follow-up|4|||
144543270|NCT00641537|521188271|FG005|96-week Period|Lost to Follow-up|0|||
144543271|NCT00641537|521188272|FG006|96-week Period|Lost to Follow-up|1|||
144543272|NCT00641537|521188273|FG007|96-week Period|Lost to Follow-up|0|||
144543273|NCT00641537|521188266|FG000|96-week Period|Protocol Violation|0|||
144543274|NCT00641537|521188267|FG001|96-week Period|Protocol Violation|1|||
144543275|NCT00641537|521188268|FG002|96-week Period|Protocol Violation|0|||
144543276|NCT00641537|521188269|FG003|96-week Period|Protocol Violation|1|||
144543277|NCT00641537|521188270|FG004|96-week Period|Protocol Violation|0|||
144543278|NCT00641537|521188271|FG005|96-week Period|Protocol Violation|1|||
144543279|NCT00641537|521188272|FG006|96-week Period|Protocol Violation|0|||
144543280|NCT00641537|521188273|FG007|96-week Period|Protocol Violation|0|||
144543281|NCT00641537|521188266|FG000|96-week Period|Death|2|||
144543282|NCT00641537|521188267|FG001|96-week Period|Death|0|||
144202100|NCT03186781|519936964|FG004|Overall Study|Withdrawal by Subject|1|||
144202101|NCT03186781|519936965|FG005|Overall Study|Withdrawal by Subject|0|||
144202102|NCT01783548|519936968|FG000|Overall Study|Adverse Event|8|||
144543283|NCT00641537|521188268|FG002|96-week Period|Death|1|||
144543284|NCT00641537|521188269|FG003|96-week Period|Death|0|||
144543285|NCT00641537|521188270|FG004|96-week Period|Death|0|||
144543286|NCT00641537|521188271|FG005|96-week Period|Death|0|||
144616419|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
144202103|NCT01783548|519936969|FG001|Overall Study|Adverse Event|4|||
144543287|NCT00641537|521188272|FG006|96-week Period|Death|0|||
144543288|NCT00641537|521188273|FG007|96-week Period|Death|0|||
144543289|NCT00641537|521188266|FG000|96-week Period|Other|4|||
144543290|NCT00641537|521188267|FG001|96-week Period|Other|7|||
144543291|NCT00641537|521188268|FG002|96-week Period|Other|14|||
144543292|NCT00641537|521188269|FG003|96-week Period|Other|9|||
144543293|NCT00641537|521188270|FG004|96-week Period|Other|11|||
144543294|NCT00641537|521188271|FG005|96-week Period|Other|6|||
144543295|NCT00641537|521188272|FG006|96-week Period|Other|4|||
144543296|NCT00641537|521188273|FG007|96-week Period|Other|6|||
144543297|NCT00641537|521188266|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
144543298|NCT00641537|521188267|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
144543299|NCT00641537|521188268|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
144543300|NCT00641537|521188269|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
144543301|NCT00641537|521188270|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
144543302|NCT00641537|521188271|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
144543303|NCT00641537|521188272|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
144543304|NCT00641537|521188273|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
144543305|NCT00641537|521188266|FG000|24-Week Supplemental Follow-up Period|Other|0|||
144543306|NCT00641537|521188267|FG001|24-Week Supplemental Follow-up Period|Other|2|||
144543307|NCT00641537|521188268|FG002|24-Week Supplemental Follow-up Period|Other|2|||
144543308|NCT00641537|521188269|FG003|24-Week Supplemental Follow-up Period|Other|1|||
144543309|NCT00641537|521188270|FG004|24-Week Supplemental Follow-up Period|Other|3|||
144543310|NCT00641537|521188271|FG005|24-Week Supplemental Follow-up Period|Other|0|||
144543311|NCT00641537|521188272|FG006|24-Week Supplemental Follow-up Period|Other|1|||
144543312|NCT00641537|521188273|FG007|24-Week Supplemental Follow-up Period|Other|1|||
144543313|NCT01801007|521188274|FG000|Overall Study|Adverse Event|2|||
144543314|NCT01801007|521188274|FG000|Overall Study|Lost to Follow-up|4|||
144543315|NCT01801007|521188274|FG000|Overall Study|Withdrawal by Subject|5|||
144543316|NCT00665392|521188275|FG000|Overall Study|not treated|1|||
144543317|NCT00553332|521188281|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
144543318|NCT00989196|521188286|FG000|Treatment Period|Lost to Follow-up|1|||
144543319|NCT00989196|521188287|FG001|Treatment Period|Lost to Follow-up|0|||
144543320|NCT02409680|521188288|FG000|Overall Study|Lost to Follow-up|15|||
144543321|NCT02409680|521188289|FG001|Overall Study|Lost to Follow-up|30|||
144543322|NCT04912856|521188293|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
144543323|NCT04912856|521188294|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
144543324|NCT04912856|521188293|FG000|Overall Study|Not reported in synoptic CSR.|0|||
144543325|NCT04912856|521188294|FG001|Overall Study|Not reported in synoptic CSR.|1|||
144543326|NCT03789656|521188295|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
144543327|NCT03789656|521188296|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
144543328|NCT03789656|521188297|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
144543329|NCT03789656|521188298|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
144543330|NCT03789656|521188299|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
144543331|NCT03789656|521188295|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
144543332|NCT03789656|521188296|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
144543333|NCT03789656|521188297|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
144543334|NCT03789656|521188298|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
144543335|NCT03789656|521188299|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
144543336|NCT03789656|521188295|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
144543337|NCT03789656|521188296|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
144543338|NCT03789656|521188297|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
144543339|NCT03789656|521188298|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
144543340|NCT03789656|521188299|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
144543341|NCT03789656|521188295|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
144543342|NCT03789656|521188296|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
144543343|NCT03789656|521188297|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
144543344|NCT03789656|521188298|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
144543345|NCT03789656|521188299|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
144543346|NCT05325294|521188304|FG000|Overall Study|Adverse Event|3|||
144543347|NCT05325294|521188305|FG001|Overall Study|Adverse Event|3|||
144543348|NCT05325294|521188304|FG000|Overall Study|Physician Decision|0|||
144543349|NCT05325294|521188305|FG001|Overall Study|Physician Decision|1|||
144543350|NCT05325294|521188304|FG000|Overall Study|Withdrawal by Subject|0|||
144543351|NCT05325294|521188305|FG001|Overall Study|Withdrawal by Subject|3|||
144543352|NCT05325294|521188304|FG000|Overall Study|Lost to Follow-up|1|||
144543353|NCT05325294|521188305|FG001|Overall Study|Lost to Follow-up|0|||
144543354|NCT05325294|521188304|FG000|Overall Study|Sponsor Request|0|||
144543355|NCT05325294|521188305|FG001|Overall Study|Sponsor Request|2|||
144543356|NCT02434328|521188307|FG000|Overall Study|Adverse Event|9|||
144543357|NCT02434328|521188308|FG001|Overall Study|Adverse Event|4|||
144543358|NCT02434328|521188307|FG000|Overall Study|Lack of Efficacy|0|||
144543359|NCT02434328|521188308|FG001|Overall Study|Lack of Efficacy|2|||
144543360|NCT02434328|521188307|FG000|Overall Study|Physician Decision|0|||
144543361|NCT02434328|521188308|FG001|Overall Study|Physician Decision|1|||
144543362|NCT02434328|521188307|FG000|Overall Study|Withdrawal by Subject|12|||
144543363|NCT02434328|521188308|FG001|Overall Study|Withdrawal by Subject|21|||
144543364|NCT02434328|521188307|FG000|Overall Study|Death|4|||
144543365|NCT02434328|521188308|FG001|Overall Study|Death|7|||
144543366|NCT02434328|521188307|FG000|Overall Study|Lost to Follow-up|1|||
144543367|NCT02434328|521188308|FG001|Overall Study|Lost to Follow-up|6|||
144543368|NCT02434328|521188307|FG000|Overall Study|Other|4|||
144202104|NCT01783548|519936968|FG000|Overall Study|Withdrawal by Subject|11|||
144202105|NCT01783548|519936969|FG001|Overall Study|Withdrawal by Subject|8|||
144202106|NCT01783548|519936968|FG000|Overall Study|Non-compliance|4|||
144202107|NCT01783548|519936969|FG001|Overall Study|Non-compliance|0|||
144202108|NCT01783548|519936968|FG000|Overall Study|Protocol Violation|2|||
144202109|NCT01783548|519936969|FG001|Overall Study|Protocol Violation|2|||
144202110|NCT01783548|519936968|FG000|Overall Study|Lost to Follow-up|8|||
144202111|NCT01783548|519936969|FG001|Overall Study|Lost to Follow-up|3|||
144202112|NCT01783548|519936968|FG000|Overall Study|Lack of Efficacy|1|||
144202113|NCT01783548|519936969|FG001|Overall Study|Lack of Efficacy|1|||
144202114|NCT03825341|519936970|FG000|Overall Study|Withdrawal by Subject|0|||
144261372|NCT01719380|520158114|FG006|Overall Study|Progressive Disease|0|||
144261373|NCT01719380|520158115|FG007|Overall Study|Progressive Disease|0|||
144261374|NCT01719380|520158116|FG008|Overall Study|Progressive Disease|1|||
144261375|NCT01719380|520158117|FG009|Overall Study|Progressive Disease|0|||
144261376|NCT02762084|520158120|FG000|Overall Study|Withdrawal by Subject|1|||
144261377|NCT02762084|520158121|FG001|Overall Study|Withdrawal by Subject|0|||
144261378|NCT02762084|520158122|FG002|Overall Study|Withdrawal by Subject|0|||
144261379|NCT02762084|520158120|FG000|Overall Study|Adverse Event|0|||
144261380|NCT02762084|520158121|FG001|Overall Study|Adverse Event|0|||
144261381|NCT02762084|520158122|FG002|Overall Study|Adverse Event|1|||
144261382|NCT01781962|520158123|FG000|Overall Study|Other Miscellaneous Reasons|5|||
144261383|NCT03200548|520158124|FG000|Overall Study|Withdrawal by Subject|5|||
144261384|NCT03200548|520158125|FG001|Overall Study|Withdrawal by Subject|11|||
144261385|NCT03200548|520158126|FG002|Overall Study|Withdrawal by Subject|7|||
144261386|NCT03200548|520158127|FG003|Overall Study|Withdrawal by Subject|6|||
144473054|NCT01059630|520930015|FG000|Overall Study|Death|100|||
144473055|NCT01059630|520930016|FG001|Overall Study|Death|84|||
144473056|NCT01059630|520930015|FG000|Overall Study|Lost to Follow-up|4|||
144473057|NCT01059630|520930016|FG001|Overall Study|Lost to Follow-up|1|||
144473058|NCT01059630|520930015|FG000|Overall Study|Physician Decision|2|||
144473059|NCT01059630|520930016|FG001|Overall Study|Physician Decision|4|||
144473060|NCT01059630|520930015|FG000|Overall Study|Withdrawal by Subject|21|||
144473061|NCT01059630|520930016|FG001|Overall Study|Withdrawal by Subject|14|||
144473062|NCT03170375|520930017|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
144473063|NCT03170375|520930018|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
144473064|NCT03170375|520930019|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
144473065|NCT03170375|520930017|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
144473066|NCT03170375|520930018|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
144473067|NCT03170375|520930019|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
144473068|NCT00441701|520930020|FG000|Overall Study|Adverse Event|3|||
144473069|NCT00441701|520930021|FG001|Overall Study|Adverse Event|2|||
144473070|NCT00441701|520930022|FG002|Overall Study|Adverse Event|1|||
144473071|NCT00441701|520930023|FG003|Overall Study|Adverse Event|0|||
144473072|NCT00441701|520930024|FG004|Overall Study|Adverse Event|2|||
144473073|NCT00441701|520930025|FG005|Overall Study|Adverse Event|2|||
144473074|NCT00441701|520930026|FG006|Overall Study|Adverse Event|0|||
144473075|NCT00441701|520930027|FG007|Overall Study|Adverse Event|0|||
144473076|NCT00441701|520930028|FG008|Overall Study|Adverse Event|0|||
144473077|NCT00441701|520930029|FG009|Overall Study|Adverse Event|0|||
144473078|NCT00441701|520930020|FG000|Overall Study|Lack of Efficacy|2|||
144473079|NCT00441701|520930021|FG001|Overall Study|Lack of Efficacy|0|||
144473080|NCT00441701|520930022|FG002|Overall Study|Lack of Efficacy|2|||
144473081|NCT00441701|520930023|FG003|Overall Study|Lack of Efficacy|2|||
144473082|NCT00441701|520930024|FG004|Overall Study|Lack of Efficacy|0|||
144473083|NCT00441701|520930025|FG005|Overall Study|Lack of Efficacy|1|||
144473084|NCT00441701|520930026|FG006|Overall Study|Lack of Efficacy|0|||
144473085|NCT00441701|520930027|FG007|Overall Study|Lack of Efficacy|0|||
144473086|NCT00441701|520930028|FG008|Overall Study|Lack of Efficacy|0|||
144473087|NCT00441701|520930029|FG009|Overall Study|Lack of Efficacy|0|||
144473088|NCT00441701|520930020|FG000|Overall Study|Withdrawal by Subject|0|||
144473089|NCT00441701|520930021|FG001|Overall Study|Withdrawal by Subject|2|||
144473090|NCT00441701|520930022|FG002|Overall Study|Withdrawal by Subject|1|||
144473091|NCT00441701|520930023|FG003|Overall Study|Withdrawal by Subject|1|||
144473092|NCT00441701|520930024|FG004|Overall Study|Withdrawal by Subject|0|||
144473093|NCT00441701|520930025|FG005|Overall Study|Withdrawal by Subject|0|||
144473094|NCT00441701|520930026|FG006|Overall Study|Withdrawal by Subject|0|||
144473095|NCT00441701|520930027|FG007|Overall Study|Withdrawal by Subject|0|||
144473096|NCT00441701|520930028|FG008|Overall Study|Withdrawal by Subject|0|||
144473097|NCT00441701|520930029|FG009|Overall Study|Withdrawal by Subject|0|||
144473098|NCT00621543|520930033|FG000|Overall Study|Lost to Follow-up|23|||
144473099|NCT02007434|520930038|FG000|Overall Study|Lost to Follow-up|0|||
144473100|NCT02007434|520930039|FG001|Overall Study|Lost to Follow-up|1|||
144473101|NCT02007434|520930040|FG002|Overall Study|Lost to Follow-up|0|||
144261387|NCT00313846|520158128|FG000|Overall Study|Withdrawal by Subject|2|||
144473102|NCT02007434|520930041|FG003|Overall Study|Lost to Follow-up|0|||
144473103|NCT02007434|520930042|FG004|Overall Study|Lost to Follow-up|0|||
144473104|NCT02007434|520930043|FG005|Overall Study|Lost to Follow-up|0|||
144473105|NCT02007434|520930044|FG006|Overall Study|Lost to Follow-up|0|||
144473106|NCT02007434|520930045|FG007|Overall Study|Lost to Follow-up|0|||
144473107|NCT02007434|520930038|FG000|Overall Study|Non-compliance|1|||
144473108|NCT02007434|520930039|FG001|Overall Study|Non-compliance|0|||
144473109|NCT02007434|520930040|FG002|Overall Study|Non-compliance|1|||
144473110|NCT02007434|520930041|FG003|Overall Study|Non-compliance|0|||
144473111|NCT02007434|520930042|FG004|Overall Study|Non-compliance|0|||
144473112|NCT02007434|520930043|FG005|Overall Study|Non-compliance|0|||
144473113|NCT02007434|520930044|FG006|Overall Study|Non-compliance|0|||
144473114|NCT02007434|520930045|FG007|Overall Study|Non-compliance|0|||
144473115|NCT01287611|520930046|FG000|Overall Study|Lost to Follow-up|29|||
144473116|NCT01287611|520930047|FG001|Overall Study|Lost to Follow-up|16|||
144473117|NCT01287611|520930046|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
144473118|NCT01287611|520930047|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
144473119|NCT00763958|520930050|FG000|Overall Study|did not meet final criteria|4|||
144473120|NCT00763958|520930051|FG001|Overall Study|did not meet final criteria|4|||
144473121|NCT00763958|520930050|FG000|Overall Study|Lost to Follow-up|10|||
144473122|NCT00763958|520930051|FG001|Overall Study|Lost to Follow-up|2|||
144473123|NCT00763958|520930050|FG000|Overall Study|Believed they were receiving placebo|0|||
144473124|NCT00763958|520930051|FG001|Overall Study|Believed they were receiving placebo|5|||
144202115|NCT03825341|519936971|FG001|Overall Study|Withdrawal by Subject|1|||
144202116|NCT04053465|519936975|FG000|Overall Study|Withdrawal by Subject|4|||
144202117|NCT04053465|519936976|FG001|Overall Study|Withdrawal by Subject|4|||
144202118|NCT01468818|519936980|FG000|Overall Study|Death during treatment|2|||
144202119|NCT00338455|519936983|FG000|Overall Study|Death|2|||
144202120|NCT00338455|519936984|FG001|Overall Study|Death|1|||
144261388|NCT00313846|520158129|FG001|Overall Study|Withdrawal by Subject|0|||
144261389|NCT00313846|520158128|FG000|Overall Study|Adverse Event|1|||
144261390|NCT00313846|520158129|FG001|Overall Study|Adverse Event|8|||
144261391|NCT00313846|520158128|FG000|Overall Study|Administrative|2|||
144261392|NCT00313846|520158129|FG001|Overall Study|Administrative|3|||
144261393|NCT01765296|520158130|FG000|Overall Study|Protocol Violation|0|||
144261394|NCT01765296|520158131|FG001|Overall Study|Protocol Violation|5|||
144261395|NCT01765296|520158132|FG002|Overall Study|Protocol Violation|4|||
144261396|NCT01765296|520158130|FG000|Overall Study|Withdrawal by Subject|4|||
144261397|NCT01765296|520158131|FG001|Overall Study|Withdrawal by Subject|2|||
144261398|NCT01765296|520158132|FG002|Overall Study|Withdrawal by Subject|2|||
144261399|NCT01765296|520158130|FG000|Overall Study|Adverse Event|1|||
144261400|NCT01765296|520158131|FG001|Overall Study|Adverse Event|13|||
144261401|NCT01765296|520158132|FG002|Overall Study|Adverse Event|5|||
144261402|NCT01765296|520158130|FG000|Overall Study|Lack of Efficacy|0|||
144261403|NCT01765296|520158131|FG001|Overall Study|Lack of Efficacy|0|||
144261404|NCT01765296|520158132|FG002|Overall Study|Lack of Efficacy|2|||
144261405|NCT01619852|520158133|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
144261406|NCT01619852|520158134|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
144261407|NCT01619852|520158133|FG000|3 Month Follow up|Lost to Follow-up|31|||
144261408|NCT01619852|520158134|FG001|3 Month Follow up|Lost to Follow-up|34|||
144261409|NCT03478371|520158135|FG000|Overall Study|non-compliance|1|||
144261410|NCT03478371|520158135|FG000|Overall Study|Lost to Follow-up|4|||
144261411|NCT02849743|520158136|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
144261412|NCT02849743|520158137|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
144261413|NCT02849743|520158136|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
144261414|NCT02849743|520158137|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
144261415|NCT02168491|520158141|FG000|Overall Study|Withdrawal by Subject|1|||
144261416|NCT03874013|520158142|FG000|Overall Study|Adverse Event|0|||
144261417|NCT03874013|520158143|FG001|Overall Study|Adverse Event|1|||
144261418|NCT00838097|520158151|FG000|Overall Study|Ineligibility determined|6|||
144261419|NCT00838097|520158151|FG000|Overall Study|Adverse Event|2|||
144261420|NCT00838097|520158151|FG000|Overall Study|Withdrawal by Subject|3|||
144261421|NCT00838097|520158151|FG000|Overall Study|Requirement for alternative therapy|2|||
144261422|NCT00838097|520158151|FG000|Overall Study|Physician Decision|4|||
144261423|NCT00838097|520158151|FG000|Overall Study|Lost to Follow-up|11|||
144261424|NCT00838097|520158151|FG000|Overall Study|Death|6|||
144473125|NCT02192970|520930052|FG000|Overall Study|Lost to Follow-up|6|||
144727483|NCT02101853|521856654|FG003|Block 1 Induction|Ineligible|0|||
144202121|NCT00338455|519936983|FG000|Overall Study|Physician Decision|1|||
144202122|NCT00338455|519936984|FG001|Overall Study|Physician Decision|0|||
144473126|NCT02192970|520930053|FG001|Overall Study|Lost to Follow-up|0|||
144473127|NCT04074590|520930054|FG000|Overall Study|Adverse Event|1|||
144473128|NCT04074590|520930055|FG001|Overall Study|Adverse Event|0|||
144473129|NCT04074590|520930054|FG000|Overall Study|Physician Decision|1|||
144202123|NCT02266134|519936987|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
144261425|NCT00838097|520158151|FG000|Overall Study|Protocol-specified criteria|142|||
144261426|NCT01951417|520158168|FG000|Overall Study|Withdrawal by Subject|1|||
144261427|NCT01951417|520158168|FG000|Overall Study|Protocol Violation|2|||
144261428|NCT01951417|520158168|FG000|Overall Study|Lost to Follow-up|6|||
144261429|NCT00977613|520158169|FG000|Overall Study|Lost to Follow-up|16|||
144261430|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
144727484|NCT02101853|521856655|FG004|Block 1 Induction|Ineligible|0|||
144261431|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
144261432|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Adverse Event|57|||
144261433|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Adverse Event|49|||
144261434|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
144261435|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
144261436|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Site closure|3|||
144261437|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Site closure|2|||
144261438|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
144261439|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
144261440|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Physician Decision|48|||
144261441|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Physician Decision|38|||
144261442|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
144261443|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
144261444|NCT01705977|520158174|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
144261445|NCT01705977|520158175|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
144261446|NCT01705977|520158174|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
144261447|NCT01705977|520158175|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
144261448|NCT01705977|520158174|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
144261449|NCT01705977|520158175|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
144261450|NCT01705977|520158174|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
144261451|NCT01705977|520158175|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
144261452|NCT01705977|520158174|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
144261453|NCT01705977|520158175|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
144261454|NCT02989402|520158178|FG000|Overall Study|Adverse event, or serious adverse event|4|||
144261455|NCT02989402|520158178|FG000|Overall Study|Death|2|||
144261456|NCT02989402|520158178|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
144261457|NCT02989402|520158178|FG000|Overall Study|Lost to Follow-up|8|||
144261458|NCT02989402|520158178|FG000|Overall Study|Patient no longer on monotherapy|1|||
144261459|NCT02989402|520158178|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
144261460|NCT02989402|520158178|FG000|Overall Study|Withdrawal by Subject|7|||
144261461|NCT02989402|520158178|FG000|Overall Study|Other|2|||
144261462|NCT02039778|520158179|FG000|Overall Study|Death|2|||
144261463|NCT02039778|520158179|FG000|Overall Study|Withdrawal by Subject|1|||
144261464|NCT02039778|520158179|FG000|Overall Study|Never started the protocol treatment|1|||
144261465|NCT02824627|520158192|FG000|Overall Study|Adverse Event|1|||
144261466|NCT02824627|520158193|FG001|Overall Study|Adverse Event|2|||
144261467|NCT02824627|520158192|FG000|Overall Study|Lost to Follow-up|2|||
144261468|NCT02824627|520158193|FG001|Overall Study|Lost to Follow-up|1|||
144261469|NCT01128296|520159687|FG000|Overall Study|Physician Decision|0|||
144261470|NCT01128296|520159688|FG001|Overall Study|Physician Decision|0|||
144261471|NCT01128296|520159689|FG002|Overall Study|Physician Decision|0|||
144261472|NCT01128296|520159690|FG003|Overall Study|Physician Decision|0|||
144261473|NCT01128296|520159691|FG004|Overall Study|Physician Decision|0|||
144261474|NCT01128296|520159692|FG005|Overall Study|Physician Decision|3|||
144261475|NCT01128296|520159687|FG000|Overall Study|Withdrawal by Subject|0|||
144261476|NCT01128296|520159688|FG001|Overall Study|Withdrawal by Subject|0|||
144261477|NCT01128296|520159689|FG002|Overall Study|Withdrawal by Subject|0|||
144261478|NCT01128296|520159690|FG003|Overall Study|Withdrawal by Subject|0|||
144261479|NCT01128296|520159691|FG004|Overall Study|Withdrawal by Subject|0|||
144261480|NCT01128296|520159692|FG005|Overall Study|Withdrawal by Subject|2|||
144261481|NCT03316586|520159697|FG000|Overall Study|Adverse Event|2|||
144261482|NCT03316586|520159697|FG000|Overall Study|Physician Decision|3|||
144261483|NCT03316586|520159697|FG000|Overall Study|Lack of Efficacy|10|||
144261484|NCT03316586|520159697|FG000|Overall Study|still on treatment|1|||
144261485|NCT03316586|520159697|FG000|Overall Study|Patient needed radiation therapy|1|||
144261486|NCT03316586|520159697|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
144261487|NCT00873730|520159699|FG000|Overall Study|Protocol Deviation|5|||
144261488|NCT00873730|520159700|FG001|Overall Study|Protocol Deviation|2|||
144261489|NCT00873730|520159699|FG000|Overall Study|Adverse Event|0|||
144261490|NCT00873730|520159700|FG001|Overall Study|Adverse Event|2|||
144261491|NCT00873730|520159699|FG000|Overall Study|Withdrawal by Subject|0|||
144261492|NCT00873730|520159700|FG001|Overall Study|Withdrawal by Subject|1|||
144261493|NCT00873730|520159699|FG000|Overall Study|Sponsor decision|1|||
144261494|NCT00873730|520159700|FG001|Overall Study|Sponsor decision|0|||
144261495|NCT04613739|520159701|FG000|Overall Study|Lost to Follow-up|6|||
144261496|NCT04613739|520159702|FG001|Overall Study|Lost to Follow-up|9|||
144261497|NCT04613739|520159701|FG000|Overall Study|potentially duplicative/fraudulent|1|||
144261498|NCT04613739|520159702|FG001|Overall Study|potentially duplicative/fraudulent|3|||
144261499|NCT00003537|520159703|FG000|Overall Study|Not evalauable|1|||
144261500|NCT01051557|520159704|FG000|Overall Study|Physician Decision|1|||
144261501|NCT01051557|520159705|FG001|Overall Study|Physician Decision|0|||
144261502|NCT01051557|520159706|FG002|Overall Study|Physician Decision|0|||
144261503|NCT01051557|520159707|FG003|Overall Study|Physician Decision|0|||
144261504|NCT01051557|520159708|FG004|Overall Study|Physician Decision|0|||
144543369|NCT02434328|521188308|FG001|Overall Study|Other|1|||
144543370|NCT00647387|521188311|FG000|Overall Study|Lost to Follow-up|6|||
144543371|NCT00647387|521188311|FG000|Overall Study|Unsuccessful implant|5|||
144543372|NCT00647387|521188311|FG000|Overall Study|Device explanted|3|||
144543373|NCT00647387|521188311|FG000|Overall Study|Other Reason|3|||
144543374|NCT00647387|521188311|FG000|Overall Study|Death|2|||
144202124|NCT02266134|519936988|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
144202125|NCT02266134|519936989|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
144202126|NCT02266134|519936990|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
144202127|NCT02266134|519936987|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
144202128|NCT02266134|519936988|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
144202129|NCT02266134|519936989|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
144202130|NCT02266134|519936990|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
144202131|NCT02266134|519936987|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
144202132|NCT02266134|519936988|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
144202133|NCT02266134|519936989|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
144202134|NCT02266134|519936990|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
144202135|NCT02266134|519936987|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
144202136|NCT02266134|519936988|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
144202137|NCT02266134|519936989|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
144202138|NCT02266134|519936990|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
144202139|NCT02266134|519936987|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
144202140|NCT02266134|519936988|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
144202141|NCT02266134|519936989|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
144202142|NCT02266134|519936990|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
144202143|NCT02266134|519936987|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
144202144|NCT02266134|519936988|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
144202145|NCT02266134|519936989|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
144202146|NCT02266134|519936990|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
144202147|NCT01085201|519936992|FG000|Overall Study|Scheduling conflict|1|||
144202148|NCT01085201|519936993|FG001|Overall Study|Scheduling conflict|0|||
144202149|NCT01085201|519936994|FG002|Overall Study|Scheduling conflict|1|||
144202150|NCT01085201|519936995|FG003|Overall Study|Scheduling conflict|0|||
144202151|NCT01085201|519936996|FG004|Overall Study|Scheduling conflict|0|||
144202152|NCT01085201|519936992|FG000|Overall Study|Unknown- no study drug|2|||
144202153|NCT01085201|519936993|FG001|Overall Study|Unknown- no study drug|0|||
144202154|NCT01085201|519936994|FG002|Overall Study|Unknown- no study drug|0|||
144202155|NCT01085201|519936995|FG003|Overall Study|Unknown- no study drug|0|||
144202156|NCT01085201|519936996|FG004|Overall Study|Unknown- no study drug|0|||
144202157|NCT01085201|519936992|FG000|Overall Study|Fond ineligible after consent|0|||
144202158|NCT01085201|519936993|FG001|Overall Study|Fond ineligible after consent|1|||
144202159|NCT01085201|519936994|FG002|Overall Study|Fond ineligible after consent|1|||
144202160|NCT01085201|519936995|FG003|Overall Study|Fond ineligible after consent|0|||
144202161|NCT01085201|519936996|FG004|Overall Study|Fond ineligible after consent|0|||
144202162|NCT02643355|519936997|FG000|Overall Study|Withdrawal by Subject|1|||
144202163|NCT02643355|519936998|FG001|Overall Study|Withdrawal by Subject|3|||
144202164|NCT02643355|519936997|FG000|Overall Study|Protocol Violation|0|||
144202165|NCT02643355|519936998|FG001|Overall Study|Protocol Violation|2|||
144202166|NCT01715571|519937001|FG000|Overall Study|Lost to Follow-up|8|||
144202167|NCT04658095|519937006|FG000|Overall Study|Study terminated|5|||
144202168|NCT04658095|519937007|FG001|Overall Study|Study terminated|1|||
144202169|NCT04658095|519937008|FG002|Overall Study|Study terminated|4|||
144202170|NCT05788289|519937009|FG000|Overall Study|Death|3|||
144202171|NCT05961215|519937010|FG000|Overall Study|Withdrawal by Subject|1|||
144202172|NCT05187013|519937011|FG000|Overall Study|Withdrawal by Subject|1|||
144202173|NCT05187013|519937012|FG001|Overall Study|Withdrawal by Subject|1|||
144202174|NCT05187013|519937013|FG002|Overall Study|Withdrawal by Subject|0|||
144202175|NCT05187013|519937011|FG000|Overall Study|Death|0|||
144202176|NCT05187013|519937012|FG001|Overall Study|Death|1|||
144202177|NCT05187013|519937013|FG002|Overall Study|Death|0|||
144202178|NCT05187013|519937011|FG000|Overall Study|Lost to Follow-up|20|||
144202179|NCT05187013|519937012|FG001|Overall Study|Lost to Follow-up|17|||
144202180|NCT05187013|519937013|FG002|Overall Study|Lost to Follow-up|0|||
144202181|NCT05187013|519937011|FG000|Overall Study|Ongoing Participants|3|||
144202182|NCT05187013|519937012|FG001|Overall Study|Ongoing Participants|5|||
144202183|NCT05187013|519937013|FG002|Overall Study|Ongoing Participants|0|||
144202184|NCT02387983|519937014|FG000|Overall Study|Adverse Event|4|||
144202185|NCT02387983|519937014|FG000|Overall Study|Protocol Violation|1|||
144202186|NCT02387983|519937014|FG000|Overall Study|Withdrawal by Subject|2|||
144202187|NCT00077857|519937017|FG000|Overall Study|Adverse Event|30|||
144202188|NCT00077857|519937018|FG001|Overall Study|Adverse Event|32|||
144202189|NCT00077857|519937017|FG000|Overall Study|Death|7|||
144543375|NCT03678688|521190313|FG000|Overall Study|Reason not Specified|0|||
144543376|NCT03678688|521190314|FG001|Overall Study|Reason not Specified|0|||
144202190|NCT00077857|519937018|FG001|Overall Study|Death|3|||
144202191|NCT00077857|519937017|FG000|Overall Study|Insufficient therapeutic response|112|||
144202192|NCT00077857|519937018|FG001|Overall Study|Insufficient therapeutic response|128|||
144202193|NCT00077857|519937017|FG000|Overall Study|Violation of selection criteria at entry|3|||
144473130|NCT04074590|520930055|FG001|Overall Study|Physician Decision|0|||
144473131|NCT04074590|520930054|FG000|Overall Study|Withdrawal by Subject|2|||
144473132|NCT04074590|520930055|FG001|Overall Study|Withdrawal by Subject|0|||
144473133|NCT03745222|520930069|FG000|Overall Study|Withdrawal by Subject|0|||
144473134|NCT03745222|520930070|FG001|Overall Study|Withdrawal by Subject|1|||
144473135|NCT03745222|520930071|FG002|Overall Study|Withdrawal by Subject|0|||
144473136|NCT00792103|520930072|FG000|Overall Study|Enrolled, not treated|15|||
144473137|NCT00792103|520930072|FG000|Overall Study|Lost to Follow-up|17|||
144473138|NCT00792103|520930072|FG000|Overall Study|Adverse Event|25|||
144473139|NCT00792103|520930072|FG000|Overall Study|Withdrawal by Subject|52|||
144473140|NCT00792103|520930072|FG000|Overall Study|Protocol Violation|10|||
144473141|NCT00792103|520930072|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
144473142|NCT03299686|520930073|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
144473143|NCT03299686|520930074|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
144473144|NCT03299686|520930073|FG000|Treatment Epoch|Physician Decision|1|||
144473145|NCT03299686|520930074|FG001|Treatment Epoch|Physician Decision|0|||
144473146|NCT03299686|520930073|FG000|Treatment Epoch|Adverse Event|8|||
144473147|NCT03299686|520930074|FG001|Treatment Epoch|Adverse Event|4|||
144473148|NCT03299686|520930073|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
144473149|NCT03299686|520930074|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
144473150|NCT02709005|520930075|FG000|Overall Study|Lost to Follow-up|1|||
144473151|NCT02709005|520930076|FG001|Overall Study|Lost to Follow-up|1|||
144473152|NCT02709005|520930075|FG000|Overall Study|Withdrawal by Subject|3|||
144473153|NCT02709005|520930076|FG001|Overall Study|Withdrawal by Subject|0|||
144473154|NCT00499863|520930082|FG000|Overall Study|Lack of Efficacy|21|||
144473155|NCT00499863|520930083|FG001|Overall Study|Lack of Efficacy|27|||
144473156|NCT00499863|520930082|FG000|Overall Study|Protocol Violation|12|||
144473157|NCT00499863|520930083|FG001|Overall Study|Protocol Violation|7|||
144473158|NCT00499863|520930082|FG000|Overall Study|Withdrawal by Subject|6|||
144473159|NCT00499863|520930083|FG001|Overall Study|Withdrawal by Subject|4|||
144473160|NCT00499863|520930082|FG000|Overall Study|Adverse Event|8|||
144473161|NCT00499863|520930083|FG001|Overall Study|Adverse Event|2|||
144473162|NCT00499863|520930082|FG000|Overall Study|Sponsor decision|2|||
144473163|NCT00499863|520930083|FG001|Overall Study|Sponsor decision|2|||
144473164|NCT00499863|520930082|FG000|Overall Study|Lost to Follow-up|1|||
144473165|NCT00499863|520930083|FG001|Overall Study|Lost to Follow-up|1|||
144473166|NCT01060553|520930084|FG000|Overall Study|Lost to Follow-up|3|||
144473167|NCT01060553|520930085|FG001|Overall Study|Lost to Follow-up|5|||
144473168|NCT01060553|520930084|FG000|Overall Study|Withdrawal by Subject|5|||
144473169|NCT01060553|520930085|FG001|Overall Study|Withdrawal by Subject|5|||
144473170|NCT01060553|520930084|FG000|Overall Study|Lack of Efficacy|1|||
144473171|NCT01060553|520930085|FG001|Overall Study|Lack of Efficacy|0|||
144473172|NCT03056534|520930088|FG000|Overall Study|Participant withdrew consent|8|||
144473173|NCT03056534|520930088|FG000|Overall Study|Participant not able to return|6|||
144473174|NCT03056534|520930088|FG000|Overall Study|Lost to Follow-up|37|||
144473175|NCT03056534|520930088|FG000|Overall Study|Investigator judgment|1|||
144473176|NCT03056534|520930088|FG000|Overall Study|Death|4|||
144473177|NCT03056534|520930088|FG000|Overall Study|Adverse Event|1|||
144473178|NCT03056534|520930088|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
144473179|NCT02675465|520930089|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
144473180|NCT02675465|520930090|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
144473181|NCT02675465|520930091|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
144473182|NCT02675465|520930092|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
144473183|NCT02675465|520930093|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
144473184|NCT02675465|520930094|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
144473185|NCT02675465|520930089|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
144473186|NCT02675465|520930090|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
144473187|NCT02675465|520930091|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
144473188|NCT02675465|520930092|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
144473189|NCT02675465|520930093|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
144202194|NCT00077857|519937018|FG001|Overall Study|Violation of selection criteria at entry|1|||
144202195|NCT00077857|519937017|FG000|Overall Study|Other protocol violation|0|||
144473190|NCT02675465|520930094|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
144473191|NCT02675465|520930089|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
144473192|NCT02675465|520930090|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
144473193|NCT02675465|520930091|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
144473194|NCT02675465|520930092|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
144473195|NCT02675465|520930093|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
144473196|NCT02675465|520930094|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
144473197|NCT02675465|520930089|FG000|Stage 4: Long Term Extension|Death|0|||
144473198|NCT02675465|520930090|FG001|Stage 4: Long Term Extension|Death|0|||
144543377|NCT03678688|521190315|FG002|Overall Study|Reason not Specified|3|||
144543378|NCT03678688|521190316|FG003|Overall Study|Reason not Specified|0|||
144543379|NCT03678688|521190317|FG004|Overall Study|Reason not Specified|1|||
144543380|NCT03678688|521190318|FG005|Overall Study|Reason not Specified|0|||
144543381|NCT03678688|521190319|FG006|Overall Study|Reason not Specified|0|||
144543382|NCT03678688|521190320|FG007|Overall Study|Reason not Specified|0|||
144543383|NCT03678688|521190321|FG008|Overall Study|Reason not Specified|0|||
144543384|NCT03678688|521190313|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
144543385|NCT03678688|521190314|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
144543386|NCT03678688|521190315|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
144543387|NCT03678688|521190316|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
144543388|NCT03678688|521190317|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
144543389|NCT03678688|521190318|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
144202196|NCT00077857|519937018|FG001|Overall Study|Other protocol violation|1|||
144543390|NCT03678688|521190319|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
144543391|NCT03678688|521190320|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
144543392|NCT03678688|521190321|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
144543393|NCT03678688|521190313|FG000|Overall Study|Covid Related Adverse Event|0|||
144543394|NCT03678688|521190314|FG001|Overall Study|Covid Related Adverse Event|0|||
144543395|NCT03678688|521190315|FG002|Overall Study|Covid Related Adverse Event|0|||
144543396|NCT03678688|521190316|FG003|Overall Study|Covid Related Adverse Event|0|||
144543397|NCT03678688|521190317|FG004|Overall Study|Covid Related Adverse Event|0|||
144543398|NCT03678688|521190318|FG005|Overall Study|Covid Related Adverse Event|3|||
144543399|NCT03678688|521190319|FG006|Overall Study|Covid Related Adverse Event|1|||
144543400|NCT03678688|521190320|FG007|Overall Study|Covid Related Adverse Event|1|||
144543401|NCT03678688|521190321|FG008|Overall Study|Covid Related Adverse Event|0|||
144543402|NCT03678688|521190313|FG000|Overall Study|Physician Decision|0|||
144543403|NCT03678688|521190314|FG001|Overall Study|Physician Decision|0|||
144543404|NCT03678688|521190315|FG002|Overall Study|Physician Decision|0|||
144543405|NCT03678688|521190316|FG003|Overall Study|Physician Decision|0|||
144543406|NCT03678688|521190317|FG004|Overall Study|Physician Decision|0|||
144543407|NCT03678688|521190318|FG005|Overall Study|Physician Decision|1|||
144543408|NCT03678688|521190319|FG006|Overall Study|Physician Decision|0|||
144543409|NCT03678688|521190320|FG007|Overall Study|Physician Decision|0|||
144543410|NCT03678688|521190321|FG008|Overall Study|Physician Decision|0|||
144543411|NCT03678688|521190313|FG000|Overall Study|Withdrawal by Subject|0|||
144543412|NCT03678688|521190314|FG001|Overall Study|Withdrawal by Subject|0|||
144543413|NCT03678688|521190315|FG002|Overall Study|Withdrawal by Subject|0|||
144543414|NCT03678688|521190316|FG003|Overall Study|Withdrawal by Subject|0|||
144543415|NCT03678688|521190317|FG004|Overall Study|Withdrawal by Subject|0|||
144202197|NCT00077857|519937017|FG000|Overall Study|Refused treatment|29|||
144202198|NCT00077857|519937018|FG001|Overall Study|Refused treatment|21|||
144202199|NCT00077857|519937017|FG000|Overall Study|Failure to return|5|||
144202200|NCT00077857|519937018|FG001|Overall Study|Failure to return|5|||
144202201|NCT00077857|519937017|FG000|Overall Study|Other|15|||
144202202|NCT00077857|519937018|FG001|Overall Study|Other|13|||
144202203|NCT04480021|519937019|FG000|Overall Study|Lost to Follow-up|3|||
144202204|NCT04480021|519937020|FG001|Overall Study|Lost to Follow-up|4|||
144202205|NCT02970318|519937021|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
144202206|NCT02970318|519937022|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
144202207|NCT02970318|519937023|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
144202208|NCT02970318|519937024|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
144202209|NCT02970318|519937021|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
144202210|NCT02970318|519937022|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
144202211|NCT02970318|519937023|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
144202212|NCT02970318|519937024|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
144202213|NCT02970318|519937021|FG000|Overall for Arm A & Main for Arm B|Death|41|||
144202214|NCT02970318|519937022|FG001|Overall for Arm A & Main for Arm B|Death|33|||
144202215|NCT02970318|519937023|FG002|Overall for Arm A & Main for Arm B|Death|0|||
144202216|NCT02970318|519937024|FG003|Overall for Arm A & Main for Arm B|Death|0|||
144202217|NCT02970318|519937021|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
144202218|NCT02970318|519937022|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
144202219|NCT02970318|519937023|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
144202220|NCT02970318|519937024|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
144202221|NCT02970318|519937021|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
144202222|NCT02970318|519937022|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
144543416|NCT03678688|521190318|FG005|Overall Study|Withdrawal by Subject|0|||
144543417|NCT03678688|521190319|FG006|Overall Study|Withdrawal by Subject|2|||
144543418|NCT03678688|521190320|FG007|Overall Study|Withdrawal by Subject|1|||
144543419|NCT03678688|521190321|FG008|Overall Study|Withdrawal by Subject|0|||
144543420|NCT03137459|521190322|FG000|2-month Assessment|Withdrawal by Subject|13|||
144543421|NCT03137459|521190323|FG001|2-month Assessment|Withdrawal by Subject|3|||
144261505|NCT01051557|520159709|FG005|Overall Study|Physician Decision|0|||
144543422|NCT03137459|521190322|FG000|2-month Assessment|Unable to reach|42|||
144543423|NCT03137459|521190323|FG001|2-month Assessment|Unable to reach|32|||
144202223|NCT02970318|519937023|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
144202224|NCT02970318|519937024|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
144202225|NCT02970318|519937021|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
144202226|NCT02970318|519937022|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
144202227|NCT02970318|519937023|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
144202228|NCT02970318|519937024|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
144473199|NCT02675465|520930091|FG002|Stage 4: Long Term Extension|Death|0|||
144473200|NCT02675465|520930092|FG003|Stage 4: Long Term Extension|Death|1|||
144473201|NCT02675465|520930093|FG004|Stage 4: Long Term Extension|Death|0|||
144473202|NCT02675465|520930094|FG005|Stage 4: Long Term Extension|Death|0|||
144473203|NCT05031078|520930095|FG000|Overall Study|Withdrawal by Subject|0|||
144473204|NCT05031078|520930096|FG001|Overall Study|Withdrawal by Subject|1|||
144473205|NCT05031078|520930097|FG002|Overall Study|Withdrawal by Subject|0|||
144473206|NCT01784068|520930098|FG000|NTCS Phase|Adverse Event|5|||
144473207|NCT01784068|520930099|FG001|NTCS Phase|Adverse Event|0|||
144473208|NCT01784068|520930098|FG000|NTCS Phase|Physician Decision|2|||
144473209|NCT01784068|520930099|FG001|NTCS Phase|Physician Decision|0|||
144473210|NCT01784068|520930098|FG000|NTCS Phase|Patient/guardian decision|3|||
144473211|NCT01784068|520930099|FG001|NTCS Phase|Patient/guardian decision|0|||
144473212|NCT01784068|520930098|FG000|NTCS Phase|Death|2|||
144473213|NCT01784068|520930099|FG001|NTCS Phase|Death|0|||
144473214|NCT01784068|520930098|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
144473215|NCT01784068|520930099|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
144473216|NCT01784068|520930098|FG000|TFR Phase|Physician Decision|0|||
144473217|NCT01784068|520930099|FG001|TFR Phase|Physician Decision|1|||
144473218|NCT01784068|520930098|FG000|TFR Phase|Patient/guardian decision|0|||
144473219|NCT01784068|520930099|FG001|TFR Phase|Patient/guardian decision|3|||
144473220|NCT01784068|520930098|FG000|TFR Phase|Death|0|||
144473221|NCT01784068|520930099|FG001|TFR Phase|Death|1|||
144473222|NCT01784068|520930098|FG000|TFR Phase|Lack of Efficacy|0|||
144473223|NCT01784068|520930099|FG001|TFR Phase|Lack of Efficacy|88|||
144473224|NCT03759834|520930100|FG000|Overall Study|Withdrawal by Subject|1|||
144473225|NCT02063828|520930101|FG000|Overall Study|Withdrawal by Subject|4|||
144473226|NCT02063828|520930102|FG001|Overall Study|Withdrawal by Subject|6|||
144473227|NCT02063828|520930103|FG002|Overall Study|Withdrawal by Subject|3|||
144473228|NCT02063828|520930101|FG000|Overall Study|Death|0|||
144473229|NCT02063828|520930102|FG001|Overall Study|Death|0|||
144473230|NCT02063828|520930103|FG002|Overall Study|Death|1|||
144473231|NCT02036645|520930108|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473232|NCT02036645|520930109|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473233|NCT02036645|520930110|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473234|NCT02036645|520930111|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473235|NCT02036645|520930112|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473236|NCT02036645|520930113|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473237|NCT02036645|520930114|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
144473238|NCT02036645|520930115|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473239|NCT02036645|520930116|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473240|NCT02036645|520930117|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473241|NCT02036645|520930118|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473242|NCT02036645|520930119|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
144473243|NCT02036645|520930108|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473244|NCT02036645|520930109|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473245|NCT02036645|520930110|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473246|NCT02036645|520930111|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
144473247|NCT02036645|520930112|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473248|NCT02036645|520930113|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473249|NCT02036645|520930114|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473250|NCT02036645|520930115|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473251|NCT02036645|520930116|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473252|NCT02036645|520930117|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473253|NCT02036645|520930118|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473254|NCT02036645|520930119|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
144473255|NCT00633464|520930120|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
144473256|NCT00633464|520930121|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
144473257|NCT00633464|520930120|FG000|Overall Study|Never Treated (Randomized in error)|0|||
144473258|NCT00633464|520930121|FG001|Overall Study|Never Treated (Randomized in error)|1|||
144473259|NCT02612064|520930122|FG000|Overall Study|Withdrawal by Subject|1|||
144473260|NCT02612064|520930123|FG001|Overall Study|Withdrawal by Subject|1|||
144473261|NCT02612064|520930122|FG000|Overall Study|Other|0|||
144473262|NCT02612064|520930123|FG001|Overall Study|Other|2|||
144543424|NCT03137459|521190322|FG000|2-month Assessment|Refused assessment|7|||
144543425|NCT03137459|521190323|FG001|2-month Assessment|Refused assessment|5|||
144543426|NCT03137459|521190322|FG000|2-month Assessment|Acutely ill|6|||
144543427|NCT03137459|521190323|FG001|2-month Assessment|Acutely ill|2|||
144543428|NCT03137459|521190322|FG000|4-month Assessment|Death|4|||
144543429|NCT03137459|521190323|FG001|4-month Assessment|Death|2|||
144543430|NCT03137459|521190322|FG000|4-month Assessment|Withdrawal by Subject|4|||
144543431|NCT03137459|521190323|FG001|4-month Assessment|Withdrawal by Subject|2|||
144616420|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
144616421|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
144473263|NCT00316173|520930128|FG000|Run-in Phase|Adverse Event|1|||
144473264|NCT00316173|520930129|FG001|Run-in Phase|Adverse Event|0|||
144473265|NCT00316173|520930128|FG000|Run-in Phase|Protocol Violation|1|||
144473266|NCT00316173|520930129|FG001|Run-in Phase|Protocol Violation|0|||
144473267|NCT00316173|520930128|FG000|Run-in Phase|Study Follow-up Stopped|5|||
144473268|NCT00316173|520930129|FG001|Run-in Phase|Study Follow-up Stopped|0|||
144473269|NCT00316173|520930128|FG000|Treatment Phase|Adverse Event|0|||
144473270|NCT00316173|520930129|FG001|Treatment Phase|Adverse Event|1|||
144473271|NCT00316173|520930128|FG000|Treatment Phase|Lack of Efficacy|0|||
144473272|NCT00316173|520930129|FG001|Treatment Phase|Lack of Efficacy|3|||
144473273|NCT00316173|520930128|FG000|Treatment Phase|Lost to Follow-up|0|||
144473274|NCT00316173|520930129|FG001|Treatment Phase|Lost to Follow-up|3|||
144473275|NCT00316173|520930128|FG000|Treatment Phase|Withdrawal by Subject|0|||
144473276|NCT00316173|520930129|FG001|Treatment Phase|Withdrawal by Subject|1|||
144473277|NCT00316173|520930128|FG000|Treatment Phase|Study Follow-up Stopped|0|||
144473278|NCT00316173|520930129|FG001|Treatment Phase|Study Follow-up Stopped|34|||
144473279|NCT03764072|520930130|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
144473280|NCT03764072|520930131|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
144473281|NCT03764072|520930132|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
144473282|NCT03764072|520930133|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
144473283|NCT03764072|520930134|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
144473284|NCT03764072|520930135|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
144473285|NCT03764072|520930130|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
144473286|NCT03764072|520930131|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
144473287|NCT03764072|520930132|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
144473288|NCT03764072|520930133|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
144473289|NCT03764072|520930134|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
144473290|NCT03764072|520930135|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
144473291|NCT03764072|520930130|FG000|Overall Study|Lost to Follow-up|0|||
144473292|NCT03764072|520930131|FG001|Overall Study|Lost to Follow-up|0|||
144473293|NCT03764072|520930132|FG002|Overall Study|Lost to Follow-up|0|||
144473294|NCT03764072|520930133|FG003|Overall Study|Lost to Follow-up|0|||
144473295|NCT03764072|520930134|FG004|Overall Study|Lost to Follow-up|1|||
144473296|NCT03764072|520930135|FG005|Overall Study|Lost to Follow-up|0|||
144473297|NCT00982930|520930136|FG000|Overall Study|Adverse Event|1|||
144473298|NCT00982930|520930136|FG000|Overall Study|Withdrawal by Subject|1|||
144473299|NCT00982930|520930136|FG000|Overall Study|Administrative Problems|2|||
144473300|NCT05559866|520930137|FG000|Overall Study|Withdrawal by Subject|1|||
144473301|NCT05559866|520930138|FG001|Overall Study|Withdrawal by Subject|0|||
144473302|NCT07018999|520930142|FG000|Overall Study|Protocol Violation|0|||
144473303|NCT07018999|520930143|FG001|Overall Study|Protocol Violation|1|||
144473304|NCT07018999|520930142|FG000|Overall Study|Incomplete data entry|4|||
144473305|NCT07018999|520930143|FG001|Overall Study|Incomplete data entry|7|||
144473306|NCT03444376|520930144|FG000|Part A|Disease relapse or Progression|1|||
144473307|NCT03444376|520930144|FG000|Part A|Withdrawal by Subject|2|||
144727485|NCT02101853|521856656|FG005|Block 1 Induction|Ineligible|0|||
144202229|NCT02970318|519937021|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
144202230|NCT02970318|519937022|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
144202231|NCT02970318|519937023|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
144202232|NCT02970318|519937024|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
144473308|NCT03444376|520930144|FG000|Part A|Adverse Event|1|||
144473309|NCT03444376|520930144|FG000|Part B|Disease relapse or Progression|18|||
144473310|NCT03444376|520930144|FG000|Part B|Withdrawal by Subject|2|||
144473311|NCT03444376|520930144|FG000|Part B|Adverse Event|2|||
144202233|NCT01096368|519937027|FG000|Overall Study|Death|0|||
144473312|NCT03444376|520930144|FG000|Part B|Physician Decision|1|||
144202234|NCT01096368|519937028|FG001|Overall Study|Death|1|||
144473313|NCT03444376|520930144|FG000|Part C|Disease relapse or Progression|43|||
144473314|NCT03444376|520930144|FG000|Part C|Withdrawal by Subject|5|||
144473315|NCT03444376|520930144|FG000|Part C|Adverse Event|2|||
144473316|NCT03444376|520930144|FG000|Part C|Physician Decision|2|||
144473317|NCT03444376|520930144|FG000|Part C|Death|1|||
144473318|NCT00856167|520930148|FG000|Period 1|Withdrawal by Subject|1|||
144473319|NCT00856167|520930149|FG001|Period 1|Withdrawal by Subject|4|||
144473320|NCT00856167|520930150|FG002|Period 1|Withdrawal by Subject|0|||
144543432|NCT03137459|521190322|FG000|4-month Assessment|Unable to reach|44|||
144473321|NCT00856167|520930151|FG003|Period 1|Withdrawal by Subject|0|||
144543433|NCT03137459|521190323|FG001|4-month Assessment|Unable to reach|29|||
144543434|NCT03137459|521190322|FG000|4-month Assessment|Refused assessment|24|||
144543435|NCT03137459|521190323|FG001|4-month Assessment|Refused assessment|10|||
144543436|NCT03137459|521190322|FG000|4-month Assessment|Acutely ill|2|||
144543437|NCT03137459|521190323|FG001|4-month Assessment|Acutely ill|3|||
144543438|NCT03137459|521190322|FG000|6-months|Lost to Follow-up|14|||
144543439|NCT03137459|521190323|FG001|6-months|Lost to Follow-up|11|||
144543440|NCT03137459|521190322|FG000|6-months|Death|0|||
144543441|NCT03137459|521190323|FG001|6-months|Death|2|||
144543442|NCT03137459|521190322|FG000|6-months|Refused assessment|6|||
144473322|NCT00856167|520930148|FG000|Period 1|Lost to Follow-up|2|||
144543443|NCT03137459|521190323|FG001|6-months|Refused assessment|3|||
144543444|NCT03137459|521190322|FG000|6-months|Acutely ill|1|||
144543445|NCT03137459|521190323|FG001|6-months|Acutely ill|1|||
144543446|NCT01732757|521190324|FG000|Overall Study|Lost to Follow-up|1|||
144543447|NCT01732757|521190325|FG001|Overall Study|Lost to Follow-up|0|||
144543448|NCT01732757|521190326|FG002|Overall Study|Lost to Follow-up|0|||
144543449|NCT00491400|521190327|FG000|Overall Study|Withdrawal by Subject|5|||
144543450|NCT00491400|521190328|FG001|Overall Study|Withdrawal by Subject|4|||
144543451|NCT01583166|521190333|FG000|Overall Study|Withdrawal by Subject|4|||
144543452|NCT01583166|521190334|FG001|Overall Study|Withdrawal by Subject|6|||
144473323|NCT00856167|520930149|FG001|Period 1|Lost to Follow-up|1|||
144473324|NCT00856167|520930150|FG002|Period 1|Lost to Follow-up|0|||
144473325|NCT00856167|520930151|FG003|Period 1|Lost to Follow-up|0|||
144473326|NCT00856167|520930148|FG000|Period 2|Lost to Follow-up|0|||
144473327|NCT00856167|520930149|FG001|Period 2|Lost to Follow-up|0|||
144473328|NCT00856167|520930150|FG002|Period 2|Lost to Follow-up|3|||
144473329|NCT00856167|520930151|FG003|Period 2|Lost to Follow-up|1|||
144473330|NCT00856167|520930148|FG000|Period 2|Withdrawal by Subject|0|||
144543453|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
144543454|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
144202235|NCT01096368|519937029|FG002|Overall Study|Death|0|||
144202236|NCT01096368|519937030|FG003|Overall Study|Death|0|||
144202237|NCT01096368|519937031|FG004|Overall Study|Death|0|||
144202238|NCT01096368|519937027|FG000|Overall Study|Physician Decision|0|||
144202239|NCT01096368|519937028|FG001|Overall Study|Physician Decision|13|||
144202240|NCT01096368|519937029|FG002|Overall Study|Physician Decision|2|||
144202241|NCT01096368|519937030|FG003|Overall Study|Physician Decision|4|||
144202242|NCT01096368|519937031|FG004|Overall Study|Physician Decision|6|||
144202243|NCT01096368|519937027|FG000|Overall Study|Withdrawal by Subject|0|||
144202244|NCT01096368|519937028|FG001|Overall Study|Withdrawal by Subject|52|||
144202245|NCT01096368|519937029|FG002|Overall Study|Withdrawal by Subject|0|||
144202246|NCT01096368|519937030|FG003|Overall Study|Withdrawal by Subject|10|||
144202247|NCT01096368|519937031|FG004|Overall Study|Withdrawal by Subject|14|||
144202248|NCT01096368|519937027|FG000|Overall Study|Ineligible|0|||
144202249|NCT01096368|519937028|FG001|Overall Study|Ineligible|3|||
144202250|NCT01096368|519937029|FG002|Overall Study|Ineligible|2|||
144202251|NCT01096368|519937030|FG003|Overall Study|Ineligible|0|||
144202252|NCT01096368|519937031|FG004|Overall Study|Ineligible|25|||
144202253|NCT01096368|519937027|FG000|Overall Study|Did not start treatment|0|||
144202254|NCT01096368|519937028|FG001|Overall Study|Did not start treatment|4|||
144202255|NCT01096368|519937029|FG002|Overall Study|Did not start treatment|4|||
144202256|NCT01096368|519937030|FG003|Overall Study|Did not start treatment|0|||
144202257|NCT01096368|519937031|FG004|Overall Study|Did not start treatment|0|||
144202258|NCT01096368|519937027|FG000|Overall Study|Progressive disease|0|||
144202259|NCT01096368|519937028|FG001|Overall Study|Progressive disease|6|||
144202260|NCT01096368|519937029|FG002|Overall Study|Progressive disease|0|||
144202261|NCT01096368|519937030|FG003|Overall Study|Progressive disease|10|||
144202262|NCT01096368|519937031|FG004|Overall Study|Progressive disease|3|||
144202263|NCT01096368|519937027|FG000|Overall Study|Other|0|||
144202264|NCT01096368|519937028|FG001|Overall Study|Other|0|||
144202265|NCT01096368|519937029|FG002|Overall Study|Other|1|||
144202266|NCT01096368|519937030|FG003|Overall Study|Other|0|||
144202267|NCT01096368|519937031|FG004|Overall Study|Other|0|||
144202268|NCT01096368|519937027|FG000|Overall Study|Treated with institutional review|0|||
144202269|NCT01096368|519937028|FG001|Overall Study|Treated with institutional review|0|||
144202270|NCT01096368|519937029|FG002|Overall Study|Treated with institutional review|0|||
144202271|NCT01096368|519937030|FG003|Overall Study|Treated with institutional review|0|||
144202272|NCT01096368|519937031|FG004|Overall Study|Treated with institutional review|1|||
144202273|NCT06187909|519937032|FG000|Overall Study|Withdrawal by Subject|2|||
144202274|NCT06187909|519937033|FG001|Overall Study|Withdrawal by Subject|2|||
144202275|NCT06354998|519937034|FG000|Overall Study|Withdrawal by Subject|3|||
144202276|NCT06354998|519937035|FG001|Overall Study|Withdrawal by Subject|0|||
144543455|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
144543456|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
144543457|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
144543458|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
144202277|NCT04740814|519937037|FG000|Overall Study|Adverse Event|3|||
144202278|NCT04740814|519937037|FG000|Overall Study|Protocol Violation|2|||
144473331|NCT00856167|520930149|FG001|Period 2|Withdrawal by Subject|0|||
144473332|NCT00856167|520930150|FG002|Period 2|Withdrawal by Subject|2|||
144473333|NCT00856167|520930151|FG003|Period 2|Withdrawal by Subject|4|||
144473334|NCT06027619|520930154|FG000|Overall Study|Adverse Event|0|||
144473335|NCT06027619|520930155|FG001|Overall Study|Adverse Event|0|||
144473336|NCT06027619|520930156|FG002|Overall Study|Adverse Event|1|||
144473337|NCT00742079|520931881|FG000|Overall Study|Lost to Follow-up|0|||
144473338|NCT00742079|520931882|FG001|Overall Study|Lost to Follow-up|1|||
144473339|NCT04382924|520931885|FG000|Overall Study|Death|2|||
144473340|NCT04382924|520931886|FG001|Overall Study|Death|5|||
144473341|NCT04382924|520931887|FG002|Overall Study|Death|4|||
144473342|NCT04382924|520931885|FG000|Overall Study|Protocol Violation|0|||
144473343|NCT04382924|520931886|FG001|Overall Study|Protocol Violation|1|||
144473344|NCT04382924|520931887|FG002|Overall Study|Protocol Violation|1|||
144473345|NCT04382924|520931885|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
144473346|NCT04382924|520931886|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
144473347|NCT04382924|520931887|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
144473348|NCT04382924|520931885|FG000|Overall Study|Withdrawal by Subject|6|||
144473349|NCT04382924|520931886|FG001|Overall Study|Withdrawal by Subject|3|||
144473350|NCT04382924|520931887|FG002|Overall Study|Withdrawal by Subject|6|||
144473351|NCT04207840|520931891|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
144473352|NCT04207840|520931892|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
144473353|NCT04207840|520931893|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
144473354|NCT04207840|520931891|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
144543459|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
144543460|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
144543461|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
144543462|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
144543463|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
144543464|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
144543465|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Other|1|||
144543466|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Other|0|||
144543467|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Other|0|||
144543468|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
144543469|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
144543470|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
144543471|NCT00887224|521190335|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
144543472|NCT00887224|521190336|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
144543473|NCT00887224|521190337|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
144543474|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
144543475|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
144543476|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
144543477|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
144543478|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
144202279|NCT04740814|519937037|FG000|Overall Study|Lost to Follow-up|2|||
144202280|NCT04740814|519937037|FG000|Overall Study|Withdrawal by Subject|3|||
144202281|NCT00085423|519937038|FG000|Overall Study|Withdrawal by Subject|1|||
144202282|NCT00085423|519937038|FG000|Overall Study|screen failure|1|||
144202283|NCT02500641|519937041|FG000|Overall Study|Adverse Event|0|||
144202284|NCT02500641|519937042|FG001|Overall Study|Adverse Event|2|||
144202285|NCT02500641|519937041|FG000|Overall Study|Withdrawal by Subject|4|||
144202286|NCT02500641|519937042|FG001|Overall Study|Withdrawal by Subject|5|||
144202287|NCT02500641|519937041|FG000|Overall Study|Unable to follow study procedures|3|||
144202288|NCT02500641|519937042|FG001|Overall Study|Unable to follow study procedures|2|||
144202289|NCT02500641|519937041|FG000|Overall Study|Protocol Violation|1|||
144202290|NCT02500641|519937042|FG001|Overall Study|Protocol Violation|2|||
144202291|NCT02500641|519937041|FG000|Overall Study|Lost to Follow-up|1|||
144202292|NCT02500641|519937042|FG001|Overall Study|Lost to Follow-up|0|||
144202293|NCT02500641|519937041|FG000|Overall Study|Sponsor decision|1|||
144202294|NCT02500641|519937042|FG001|Overall Study|Sponsor decision|0|||
144202295|NCT02500641|519937041|FG000|Overall Study|Non compliance to study drug|0|||
144202296|NCT02500641|519937042|FG001|Overall Study|Non compliance to study drug|1|||
144202297|NCT02317614|519937050|FG000|Overall Study|Lost to Follow-up|1|||
144202298|NCT02317614|519937051|FG001|Overall Study|Lost to Follow-up|1|||
144202299|NCT02317614|519937050|FG000|Overall Study|Withdrawal by Subject|1|||
144202300|NCT02317614|519937051|FG001|Overall Study|Withdrawal by Subject|0|||
144202301|NCT02317614|519937050|FG000|Overall Study|Death|1|||
144202302|NCT02317614|519937051|FG001|Overall Study|Death|1|||
144202303|NCT01753336|519937052|FG000|Overall Study|Patient decision|12|||
144202304|NCT01753336|519937052|FG000|Overall Study|Lost to Follow-up|3|||
144202305|NCT01753336|519937052|FG000|Overall Study|Physician Decision|2|||
144202306|NCT01753336|519937052|FG000|Overall Study|Sponsor's decision|2|||
144202307|NCT01753336|519937052|FG000|Overall Study|Withdrawal by Subject|1|||
144473355|NCT04207840|520931892|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
144473356|NCT04207840|520931893|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
144473357|NCT02173054|520931894|FG000|Overall Study|lack of compliance|1|||
144473358|NCT02173054|520931895|FG001|Overall Study|lack of compliance|0|||
144473359|NCT02173054|520931896|FG002|Overall Study|lack of compliance|0|||
144473360|NCT02173054|520931894|FG000|Overall Study|Withdrawal by Subject|0|||
144473361|NCT02173054|520931895|FG001|Overall Study|Withdrawal by Subject|0|||
144473362|NCT02173054|520931896|FG002|Overall Study|Withdrawal by Subject|1|||
144473363|NCT01114204|520931897|FG000|Overall Study|Adverse Event|3|||
144473364|NCT01114204|520931898|FG001|Overall Study|Adverse Event|2|||
144473365|NCT01114204|520931897|FG000|Overall Study|Lost to Follow-up|1|||
144473366|NCT01114204|520931898|FG001|Overall Study|Lost to Follow-up|0|||
144473367|NCT01114204|520931897|FG000|Overall Study|Withdrawal by Subject|10|||
144473368|NCT01114204|520931898|FG001|Overall Study|Withdrawal by Subject|6|||
144473369|NCT01114204|520931897|FG000|Overall Study|Death|1|||
144473370|NCT01114204|520931898|FG001|Overall Study|Death|0|||
144473371|NCT01114204|520931897|FG000|Overall Study|Other-Personal reasons|2|||
144473372|NCT01114204|520931898|FG001|Overall Study|Other-Personal reasons|0|||
144543479|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
144543480|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
144543481|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
144543482|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
144727486|NCT02101853|521856651|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
144727487|NCT02101853|521856652|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
144473373|NCT01114204|520931897|FG000|Overall Study|Other-Medical monitor request|1|||
144473374|NCT01114204|520931898|FG001|Overall Study|Other-Medical monitor request|0|||
144473375|NCT01114204|520931897|FG000|Overall Study|Other-Participant request|2|||
144473376|NCT01114204|520931898|FG001|Overall Study|Other-Participant request|0|||
144473377|NCT01114204|520931897|FG000|Overall Study|Other-Protocol Violation|1|||
144473378|NCT01114204|520931898|FG001|Overall Study|Other-Protocol Violation|0|||
144473379|NCT00991341|520931903|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
144473380|NCT00991341|520931904|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
144473381|NCT00991341|520931903|FG000|Overall Study|Death|3|||
144473382|NCT00991341|520931904|FG001|Overall Study|Death|0|||
144473383|NCT00991341|520931903|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
144473384|NCT00991341|520931904|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
144473385|NCT00991341|520931903|FG000|Overall Study|Physician Decision|1|||
144473386|NCT00991341|520931904|FG001|Overall Study|Physician Decision|2|||
144473387|NCT00991341|520931903|FG000|Overall Study|Withdrawal by Subject|3|||
144473388|NCT00991341|520931904|FG001|Overall Study|Withdrawal by Subject|4|||
144727488|NCT02101853|521856653|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
144202308|NCT02435836|519937053|FG000|Overall Study|Lost to Follow-up|21|||
144202309|NCT02435836|519937053|FG000|Overall Study|Lack of Efficacy|1|||
144202310|NCT02435836|519937053|FG000|Overall Study|Withdrawal by Subject|236|||
144202311|NCT02435836|519937053|FG000|Overall Study|Insufficient Clinical Response|26|||
144202312|NCT02435836|519937053|FG000|Overall Study|Adverse Event|44|||
144202313|NCT02435836|519937053|FG000|Overall Study|Sponsor discontinued trial|167|||
144202314|NCT02435836|519937053|FG000|Overall Study|Noncompliance|27|||
144202315|NCT02435836|519937053|FG000|Overall Study|Protocol Violation|6|||
144202316|NCT02435836|519937053|FG000|Overall Study|Met Withdrawal Criteria|7|||
144202317|NCT02435836|519937053|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
144202318|NCT01629966|519937054|FG000|Overall Study|Pregnancy|0|||
144202319|NCT01629966|519937055|FG001|Overall Study|Pregnancy|1|||
144202320|NCT01629966|519937056|FG002|Overall Study|Pregnancy|0|||
144202321|NCT01629966|519937054|FG000|Overall Study|Lost to Follow-up|10|||
144202322|NCT01629966|519937055|FG001|Overall Study|Lost to Follow-up|13|||
144202323|NCT01629966|519937056|FG002|Overall Study|Lost to Follow-up|9|||
144202324|NCT01629966|519937054|FG000|Overall Study|Withdrawal by Subject|8|||
144202325|NCT01629966|519937055|FG001|Overall Study|Withdrawal by Subject|9|||
144202326|NCT01629966|519937056|FG002|Overall Study|Withdrawal by Subject|16|||
144202327|NCT01629966|519937054|FG000|Overall Study|Protocol Violation|7|||
144202328|NCT01629966|519937055|FG001|Overall Study|Protocol Violation|9|||
144202329|NCT01629966|519937056|FG002|Overall Study|Protocol Violation|7|||
144202330|NCT01629966|519937054|FG000|Overall Study|Lack of Efficacy|5|||
144202331|NCT01629966|519937055|FG001|Overall Study|Lack of Efficacy|2|||
144202332|NCT01629966|519937056|FG002|Overall Study|Lack of Efficacy|4|||
144202333|NCT01629966|519937054|FG000|Overall Study|Adverse Event|11|||
144202334|NCT01629966|519937055|FG001|Overall Study|Adverse Event|18|||
144202335|NCT01629966|519937056|FG002|Overall Study|Adverse Event|30|||
144202336|NCT02991430|519937059|FG000|Treatment Period 1|Adverse Event|1|||
144202337|NCT02991430|519937060|FG001|Treatment Period 1|Adverse Event|0|||
144202338|NCT02991430|519937061|FG002|Treatment Period 1|Adverse Event|2|||
144202339|NCT02991430|519937059|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144202340|NCT02991430|519937060|FG001|Treatment Period 1|Withdrawal by Subject|4|||
144202341|NCT02991430|519937061|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144261506|NCT01051557|520159710|FG006|Overall Study|Physician Decision|0|||
144261507|NCT01051557|520159704|FG000|Overall Study|disease progression|3|||
144261508|NCT01051557|520159705|FG001|Overall Study|disease progression|3|||
144261509|NCT01051557|520159706|FG002|Overall Study|disease progression|5|||
144261510|NCT01051557|520159707|FG003|Overall Study|disease progression|2|||
144261511|NCT01051557|520159708|FG004|Overall Study|disease progression|4|||
144261512|NCT01051557|520159709|FG005|Overall Study|disease progression|3|||
144261513|NCT01051557|520159710|FG006|Overall Study|disease progression|1|||
144261514|NCT01051557|520159704|FG000|Overall Study|Withdrawal by Subject|0|||
144261515|NCT01051557|520159705|FG001|Overall Study|Withdrawal by Subject|0|||
144261516|NCT01051557|520159706|FG002|Overall Study|Withdrawal by Subject|1|||
144261517|NCT01051557|520159707|FG003|Overall Study|Withdrawal by Subject|0|||
144261518|NCT01051557|520159708|FG004|Overall Study|Withdrawal by Subject|2|||
144261519|NCT01051557|520159709|FG005|Overall Study|Withdrawal by Subject|0|||
144261520|NCT01051557|520159710|FG006|Overall Study|Withdrawal by Subject|1|||
144261521|NCT01051557|520159704|FG000|Overall Study|Adverse Event|0|||
144261522|NCT01051557|520159705|FG001|Overall Study|Adverse Event|0|||
144261523|NCT01051557|520159706|FG002|Overall Study|Adverse Event|0|||
144261524|NCT01051557|520159707|FG003|Overall Study|Adverse Event|1|||
144261525|NCT01051557|520159708|FG004|Overall Study|Adverse Event|1|||
144261526|NCT01051557|520159709|FG005|Overall Study|Adverse Event|3|||
144261527|NCT01051557|520159710|FG006|Overall Study|Adverse Event|4|||
144261528|NCT01178125|520159711|FG000|Overall Study|Lost to Follow-up|397|||
144543483|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
144261529|NCT01178125|520159711|FG000|Overall Study|Adverse Event|244|||
144261530|NCT01178125|520159711|FG000|Overall Study|Withdrawal by Subject|209|||
144261531|NCT01178125|520159711|FG000|Overall Study|Noncompliance|184|||
144261532|NCT01178125|520159711|FG000|Overall Study|Pregnancy|55|||
144261533|NCT01178125|520159711|FG000|Overall Study|Other Reason|39|||
144261534|NCT01178125|520159711|FG000|Overall Study|Sponsor Decision|28|||
144261535|NCT01178125|520159711|FG000|Overall Study|Protocol Violation|17|||
144261536|NCT01178125|520159711|FG000|Overall Study|Investigator Decision|5|||
144261537|NCT01004978|520159712|FG000|Overall Study|Disease progression|31|||
144261538|NCT01004978|520159713|FG001|Overall Study|Disease progression|48|||
144261539|NCT01004978|520159712|FG000|Overall Study|Adverse Event|42|||
144261540|NCT01004978|520159713|FG001|Overall Study|Adverse Event|22|||
144261541|NCT01004978|520159712|FG000|Overall Study|Death|3|||
144261542|NCT01004978|520159713|FG001|Overall Study|Death|2|||
144261543|NCT01004978|520159712|FG000|Overall Study|Withdrawal by Subject|16|||
144261544|NCT01004978|520159713|FG001|Overall Study|Withdrawal by Subject|16|||
144261545|NCT01004978|520159712|FG000|Overall Study|Alternative therapy|4|||
144261546|NCT01004978|520159713|FG001|Overall Study|Alternative therapy|8|||
144261547|NCT01004978|520159712|FG000|Overall Study|Physician Decision|6|||
144261548|NCT01004978|520159713|FG001|Overall Study|Physician Decision|3|||
144261549|NCT01004978|520159712|FG000|Overall Study|Other complicating disease|2|||
144261550|NCT01004978|520159713|FG001|Overall Study|Other complicating disease|2|||
144261551|NCT01004978|520159712|FG000|Overall Study|Protocol Violation|2|||
144261552|NCT01004978|520159713|FG001|Overall Study|Protocol Violation|3|||
144473389|NCT03010462|520931922|FG000|Overall Study|Withdrawal by Subject|3|||
144473390|NCT03010462|520931923|FG001|Overall Study|Withdrawal by Subject|1|||
144473391|NCT02799472|520931926|FG000|Overall Study|Withdrawal by Subject|2|||
144473392|NCT02799472|520931927|FG001|Overall Study|Withdrawal by Subject|4|||
144473393|NCT02799472|520931926|FG000|Overall Study|Lack of Efficacy|2|||
144473394|NCT02799472|520931927|FG001|Overall Study|Lack of Efficacy|0|||
144473395|NCT02799472|520931926|FG000|Overall Study|Lost to Follow-up|0|||
144473396|NCT02799472|520931927|FG001|Overall Study|Lost to Follow-up|1|||
144473397|NCT02287584|520931928|FG000|the Double-blind Phase|Adverse Event|17|||
144473398|NCT02287584|520931929|FG001|the Double-blind Phase|Adverse Event|17|||
144473399|NCT02287584|520931930|FG002|the Double-blind Phase|Adverse Event|12|||
144473400|NCT02287584|520931931|FG003|the Double-blind Phase|Adverse Event|0|||
144473401|NCT02287584|520931932|FG004|the Double-blind Phase|Adverse Event|0|||
144473402|NCT02287584|520931933|FG005|the Double-blind Phase|Adverse Event|0|||
144473403|NCT02287584|520931928|FG000|the Double-blind Phase|Lack of Efficacy|18|||
144473404|NCT02287584|520931929|FG001|the Double-blind Phase|Lack of Efficacy|8|||
144473405|NCT02287584|520931930|FG002|the Double-blind Phase|Lack of Efficacy|8|||
144473406|NCT02287584|520931931|FG003|the Double-blind Phase|Lack of Efficacy|0|||
144473407|NCT02287584|520931932|FG004|the Double-blind Phase|Lack of Efficacy|0|||
144473408|NCT02287584|520931933|FG005|the Double-blind Phase|Lack of Efficacy|0|||
144473409|NCT02287584|520931928|FG000|the Double-blind Phase|Lost to Follow-up|0|||
144473410|NCT02287584|520931929|FG001|the Double-blind Phase|Lost to Follow-up|1|||
144473411|NCT02287584|520931930|FG002|the Double-blind Phase|Lost to Follow-up|1|||
144473412|NCT02287584|520931931|FG003|the Double-blind Phase|Lost to Follow-up|0|||
144473413|NCT02287584|520931932|FG004|the Double-blind Phase|Lost to Follow-up|0|||
144473414|NCT02287584|520931933|FG005|the Double-blind Phase|Lost to Follow-up|0|||
144473415|NCT02287584|520931928|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
144261553|NCT01004978|520159712|FG000|Overall Study|Non-compliance|3|||
144261554|NCT01004978|520159713|FG001|Overall Study|Non-compliance|2|||
144473416|NCT02287584|520931929|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
144261555|NCT01004978|520159712|FG000|Overall Study|Ineligible|1|||
144261556|NCT01004978|520159713|FG001|Overall Study|Ineligible|0|||
144261557|NCT01004978|520159712|FG000|Overall Study|Unblinded|0|||
144261558|NCT01004978|520159713|FG001|Overall Study|Unblinded|1|||
144261559|NCT01004978|520159712|FG000|Overall Study|Performance status worsening|0|||
144261560|NCT01004978|520159713|FG001|Overall Study|Performance status worsening|1|||
144261561|NCT01004978|520159712|FG000|Overall Study|Never started treatment|8|||
144261562|NCT01004978|520159713|FG001|Overall Study|Never started treatment|9|||
144261563|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261564|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
144261565|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
144261566|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261567|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261568|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261569|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261570|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261571|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261572|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261573|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261574|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261575|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261576|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261577|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144261578|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
144261579|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
144261580|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261581|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261582|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261583|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261584|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261585|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144473417|NCT02287584|520931930|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
144473418|NCT02287584|520931931|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
144543484|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
144543485|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
144543486|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Other|1|||
144543487|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Other|0|||
144543488|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Other|0|||
144261586|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144473419|NCT02287584|520931932|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
144473420|NCT02287584|520931933|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
144473421|NCT02287584|520931928|FG000|the Double-blind Phase|Pregnancy|0|||
144473422|NCT02287584|520931929|FG001|the Double-blind Phase|Pregnancy|1|||
144473423|NCT02287584|520931930|FG002|the Double-blind Phase|Pregnancy|0|||
144473424|NCT02287584|520931931|FG003|the Double-blind Phase|Pregnancy|0|||
144473425|NCT02287584|520931932|FG004|the Double-blind Phase|Pregnancy|0|||
144473426|NCT02287584|520931933|FG005|the Double-blind Phase|Pregnancy|0|||
144473427|NCT02287584|520931928|FG000|the Double-blind Phase|Protocol Violation|0|||
144473428|NCT02287584|520931929|FG001|the Double-blind Phase|Protocol Violation|3|||
144473429|NCT02287584|520931930|FG002|the Double-blind Phase|Protocol Violation|0|||
144473430|NCT02287584|520931931|FG003|the Double-blind Phase|Protocol Violation|0|||
144473431|NCT02287584|520931932|FG004|the Double-blind Phase|Protocol Violation|0|||
144473432|NCT02287584|520931933|FG005|the Double-blind Phase|Protocol Violation|0|||
144473433|NCT02287584|520931928|FG000|the Double-blind Phase|other reasons|0|||
144473434|NCT02287584|520931929|FG001|the Double-blind Phase|other reasons|0|||
144473435|NCT02287584|520931930|FG002|the Double-blind Phase|other reasons|1|||
144473436|NCT02287584|520931931|FG003|the Double-blind Phase|other reasons|0|||
144473437|NCT02287584|520931932|FG004|the Double-blind Phase|other reasons|0|||
144473438|NCT02287584|520931933|FG005|the Double-blind Phase|other reasons|0|||
144473439|NCT02287584|520931928|FG000|the Open-label Phase|Did not receive drug|0|||
144473440|NCT02287584|520931929|FG001|the Open-label Phase|Did not receive drug|0|||
144473441|NCT02287584|520931930|FG002|the Open-label Phase|Did not receive drug|0|||
144473442|NCT02287584|520931931|FG003|the Open-label Phase|Did not receive drug|7|||
144473443|NCT02287584|520931932|FG004|the Open-label Phase|Did not receive drug|6|||
144473444|NCT02287584|520931933|FG005|the Open-label Phase|Did not receive drug|4|||
144473445|NCT02287584|520931928|FG000|the Open-label Phase|Adverse Event|0|||
144473446|NCT02287584|520931929|FG001|the Open-label Phase|Adverse Event|0|||
144473447|NCT02287584|520931930|FG002|the Open-label Phase|Adverse Event|0|||
144473448|NCT02287584|520931931|FG003|the Open-label Phase|Adverse Event|15|||
144473449|NCT02287584|520931932|FG004|the Open-label Phase|Adverse Event|12|||
144473450|NCT02287584|520931933|FG005|the Open-label Phase|Adverse Event|16|||
144473451|NCT02287584|520931928|FG000|the Open-label Phase|Lack of Efficacy|0|||
144261587|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261588|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261589|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261590|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261591|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261592|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144261593|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
144261594|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
144261595|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
144261596|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261597|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261598|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261599|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261600|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261601|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261602|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261603|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261604|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261605|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261606|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144202342|NCT02991430|519937059|FG000|Treatment Period 2|Study Termination|6|||
144202343|NCT02991430|519937060|FG001|Treatment Period 2|Study Termination|3|||
144202344|NCT02991430|519937061|FG002|Treatment Period 2|Study Termination|3|||
144202345|NCT02991430|519937059|FG000|Treatment Period 2|Lost to Follow-up|0|||
144202346|NCT02991430|519937060|FG001|Treatment Period 2|Lost to Follow-up|0|||
144261607|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144261608|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261609|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261610|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
144261611|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261612|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261613|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261614|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261615|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261616|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261617|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261618|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261619|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144202347|NCT02991430|519937061|FG002|Treatment Period 2|Lost to Follow-up|1|||
144261620|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261621|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261622|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
144261623|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144202348|NCT02991430|519937059|FG000|Post-treatment Observation Period|Study Termination|3|||
144202349|NCT02991430|519937060|FG001|Post-treatment Observation Period|Study Termination|6|||
144202350|NCT02991430|519937061|FG002|Post-treatment Observation Period|Study Termination|5|||
144261624|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144473452|NCT02287584|520931929|FG001|the Open-label Phase|Lack of Efficacy|0|||
144473453|NCT02287584|520931930|FG002|the Open-label Phase|Lack of Efficacy|0|||
144473454|NCT02287584|520931931|FG003|the Open-label Phase|Lack of Efficacy|8|||
144473455|NCT02287584|520931932|FG004|the Open-label Phase|Lack of Efficacy|3|||
144473456|NCT02287584|520931933|FG005|the Open-label Phase|Lack of Efficacy|7|||
144473457|NCT02287584|520931928|FG000|the Open-label Phase|Lost to Follow-up|0|||
144473458|NCT02287584|520931929|FG001|the Open-label Phase|Lost to Follow-up|0|||
144473459|NCT02287584|520931930|FG002|the Open-label Phase|Lost to Follow-up|0|||
144473460|NCT02287584|520931931|FG003|the Open-label Phase|Lost to Follow-up|4|||
144473461|NCT02287584|520931932|FG004|the Open-label Phase|Lost to Follow-up|1|||
144473462|NCT02287584|520931933|FG005|the Open-label Phase|Lost to Follow-up|2|||
144473463|NCT02287584|520931928|FG000|the Open-label Phase|Withdrawal by Subject|0|||
144473464|NCT02287584|520931929|FG001|the Open-label Phase|Withdrawal by Subject|0|||
144473465|NCT02287584|520931930|FG002|the Open-label Phase|Withdrawal by Subject|0|||
144473466|NCT02287584|520931931|FG003|the Open-label Phase|Withdrawal by Subject|18|||
144473467|NCT02287584|520931932|FG004|the Open-label Phase|Withdrawal by Subject|29|||
144473468|NCT02287584|520931933|FG005|the Open-label Phase|Withdrawal by Subject|21|||
144202351|NCT03970837|519937062|FG000|Overall Study|Adverse Event|23|||
144202352|NCT03970837|519937063|FG001|Overall Study|Adverse Event|20|||
144202353|NCT03970837|519937064|FG002|Overall Study|Adverse Event|16|||
144261625|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
144473469|NCT02287584|520931928|FG000|the Open-label Phase|non-compliance|0|||
144261626|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261627|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144543489|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
144543490|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
144543491|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
144543492|NCT00887224|521190335|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
144543493|NCT00887224|521190336|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
144543494|NCT00887224|521190337|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
144261628|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261629|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261630|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261631|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261632|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261633|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261634|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261635|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261636|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261637|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
144261638|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261639|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144543495|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
144543496|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
144543497|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
144543498|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
144543499|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
144543500|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
144543501|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
144543502|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
144543503|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
144543504|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
144543505|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
144543506|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
144543507|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Other|30|||
144543508|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Other|0|||
144543509|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Other|0|||
144543510|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
144543511|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
144543512|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
144543513|NCT00887224|521190335|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
144543514|NCT00887224|521190336|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
144543515|NCT00887224|521190337|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
144543516|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Adverse Event|0|||
144543517|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Adverse Event|7|||
144543518|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Adverse Event|2|||
144543519|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Failed to return|0|||
144543520|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Failed to return|2|||
144543521|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Failed to return|2|||
144543522|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
144543523|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
144543524|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
144543525|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
144543526|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
144543527|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
144543528|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Other|0|||
144543529|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Other|2|||
144543530|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Other|0|||
144543531|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
144543532|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
144543533|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
144543534|NCT00887224|521190335|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
144543535|NCT00887224|521190336|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
144543536|NCT00887224|521190337|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
144543537|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
144543538|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
144543539|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
144727489|NCT02101853|521856654|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
144543540|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
144543541|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
144543542|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
144543543|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
144543544|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
144543545|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
144543546|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
144543547|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
144543548|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
144543549|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
144543550|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
144543551|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
144543552|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
144543553|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
144543554|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
144543555|NCT00887224|521190335|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
144543556|NCT00887224|521190336|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
144543557|NCT00887224|521190337|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
144543558|NCT02000752|521190342|FG000|Overall Study|Dystocic delivery|19|||
144543559|NCT02000752|521190343|FG001|Overall Study|Dystocic delivery|8|||
144543560|NCT02000752|521190342|FG000|Overall Study|Shift Changes|12|||
144543561|NCT02000752|521190343|FG001|Overall Study|Shift Changes|5|||
144543562|NCT00047385|521190345|FG000|Overall Study|Death before any screening|2|||
144543563|NCT00047385|521190346|FG001|Overall Study|Death before any screening|5|||
144543564|NCT00047385|521190345|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
144543565|NCT00047385|521190346|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
144543566|NCT00047385|521190345|FG000|Overall Study|Eligible for screening but had no screen|260|||
144543567|NCT00047385|521190346|FG001|Overall Study|Eligible for screening but had no screen|492|||
144543568|NCT03392194|521190347|FG000|Overall Study|Withdrawal by Subject|1|||
144543569|NCT03392194|521190348|FG001|Overall Study|Withdrawal by Subject|2|||
144543570|NCT03392194|521190347|FG000|Overall Study|Conflicts with personal schedule|1|||
144543571|NCT03392194|521190348|FG001|Overall Study|Conflicts with personal schedule|0|||
144543572|NCT03865732|521190349|FG000|Overall Study|Adverse Event|0|||
144543573|NCT03865732|521190350|FG001|Overall Study|Adverse Event|1|||
144543574|NCT00620854|521190352|FG000|Washout 1|Withdrawal by Subject|0|||
144543575|NCT00620854|521190353|FG001|Washout 1|Withdrawal by Subject|0|||
144543576|NCT00620854|521190354|FG002|Washout 1|Withdrawal by Subject|1|||
144543577|NCT00620854|521190355|FG003|Washout 1|Withdrawal by Subject|1|||
144543578|NCT00620854|521190356|FG004|Washout 1|Withdrawal by Subject|0|||
144543579|NCT00620854|521190357|FG005|Washout 1|Withdrawal by Subject|0|||
144543580|NCT00734578|521190358|FG000|Overall Study|Adverse Event|4|||
144543581|NCT00734578|521190359|FG001|Overall Study|Adverse Event|6|||
144543582|NCT00734578|521190360|FG002|Overall Study|Adverse Event|1|||
144543583|NCT00734578|521190358|FG000|Overall Study|Protocol Violation|8|||
144543584|NCT00734578|521190359|FG001|Overall Study|Protocol Violation|6|||
144543585|NCT00734578|521190360|FG002|Overall Study|Protocol Violation|3|||
144543586|NCT00734578|521190358|FG000|Overall Study|Withdrawal by Subject|7|||
144543587|NCT00734578|521190359|FG001|Overall Study|Withdrawal by Subject|8|||
144543588|NCT00734578|521190360|FG002|Overall Study|Withdrawal by Subject|11|||
144202354|NCT03970837|519937065|FG003|Overall Study|Adverse Event|6|||
144202355|NCT03970837|519937066|FG004|Overall Study|Adverse Event|4|||
144202356|NCT03970837|519937067|FG005|Overall Study|Adverse Event|5|||
144202357|NCT03970837|519937068|FG006|Overall Study|Adverse Event|1|||
144473470|NCT02287584|520931929|FG001|the Open-label Phase|non-compliance|0|||
144473471|NCT02287584|520931930|FG002|the Open-label Phase|non-compliance|0|||
144473472|NCT02287584|520931931|FG003|the Open-label Phase|non-compliance|2|||
144473473|NCT02287584|520931932|FG004|the Open-label Phase|non-compliance|5|||
144473474|NCT02287584|520931933|FG005|the Open-label Phase|non-compliance|1|||
144473475|NCT02287584|520931928|FG000|the Open-label Phase|other reasons|0|||
144473476|NCT02287584|520931929|FG001|the Open-label Phase|other reasons|0|||
144473477|NCT02287584|520931930|FG002|the Open-label Phase|other reasons|0|||
144473478|NCT02287584|520931931|FG003|the Open-label Phase|other reasons|3|||
144473479|NCT02287584|520931932|FG004|the Open-label Phase|other reasons|6|||
144473480|NCT02287584|520931933|FG005|the Open-label Phase|other reasons|6|||
144473481|NCT01492686|520931936|FG000|Double-blind Phase|Adverse Event|0|||
144473482|NCT01492686|520931937|FG001|Double-blind Phase|Adverse Event|2|||
144473483|NCT01492686|520931936|FG000|Double-blind Phase|Physician Decision|0|||
144473484|NCT01492686|520931937|FG001|Double-blind Phase|Physician Decision|1|||
144473485|NCT01492686|520931936|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144473486|NCT01492686|520931937|FG001|Double-blind Phase|Withdrawal by Subject|2|||
144543589|NCT00734578|521190358|FG000|Overall Study|Lost to Follow-up|9|||
144543590|NCT00734578|521190359|FG001|Overall Study|Lost to Follow-up|3|||
144543591|NCT00734578|521190360|FG002|Overall Study|Lost to Follow-up|5|||
144543592|NCT00734578|521190358|FG000|Overall Study|Lack of Efficacy|3|||
144543593|NCT00734578|521190359|FG001|Overall Study|Lack of Efficacy|2|||
144543594|NCT00734578|521190360|FG002|Overall Study|Lack of Efficacy|5|||
144543595|NCT00734578|521190358|FG000|Overall Study|Randomized in error|1|||
144543596|NCT00734578|521190359|FG001|Overall Study|Randomized in error|0|||
144543597|NCT00734578|521190360|FG002|Overall Study|Randomized in error|0|||
144543598|NCT00734578|521190358|FG000|Overall Study|Exclusion criteria|1|||
144543599|NCT00734578|521190359|FG001|Overall Study|Exclusion criteria|0|||
144543600|NCT00734578|521190360|FG002|Overall Study|Exclusion criteria|0|||
144543601|NCT02095145|521190361|FG000|Overall Study|Withdrawal by Subject|1|||
144543602|NCT02095145|521190362|FG001|Overall Study|Withdrawal by Subject|0|||
144543603|NCT01698918|521190363|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
144543604|NCT01698918|521190363|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
144543605|NCT01698918|521190363|FG000|First Line Treatment (Core+Extension)|Death|2|||
144543606|NCT01698918|521190363|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
144543607|NCT01698918|521190363|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
144543608|NCT01698918|521190363|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
144543609|NCT01698918|521190363|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
144543610|NCT01698918|521190363|FG000|Second Line Treatment (Core+Extension)|Death|1|||
144543611|NCT01698918|521190363|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
144543612|NCT01698918|521190363|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
144543613|NCT05553366|521190366|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
144543614|NCT05553366|521190367|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
144543615|NCT05553366|521190368|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
144543616|NCT05553366|521190366|FG000|Overall Study|Lost to Follow-up|3|||
144543617|NCT05553366|521190367|FG001|Overall Study|Lost to Follow-up|3|||
144543618|NCT05553366|521190368|FG002|Overall Study|Lost to Follow-up|3|||
144543619|NCT05553366|521190366|FG000|Overall Study|Other non-compliance|1|||
144543620|NCT05553366|521190367|FG001|Overall Study|Other non-compliance|1|||
144543621|NCT05553366|521190368|FG002|Overall Study|Other non-compliance|0|||
144543622|NCT05553366|521190366|FG000|Overall Study|Randomized but not dosed|0|||
144543623|NCT05553366|521190367|FG001|Overall Study|Randomized but not dosed|0|||
144543624|NCT05553366|521190368|FG002|Overall Study|Randomized but not dosed|2|||
144543625|NCT00795184|521190374|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
144543626|NCT00795184|521190375|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
144543627|NCT02079649|521190376|FG000|Overall Study|Lost to Follow-up|0|||
144543628|NCT02079649|521190377|FG001|Overall Study|Lost to Follow-up|0|||
144543629|NCT02079649|521190378|FG002|Overall Study|Lost to Follow-up|0|||
144543630|NCT02079649|521190379|FG003|Overall Study|Lost to Follow-up|1|||
144543631|NCT02079649|521190376|FG000|Overall Study|Withdrawal by Subject|0|||
144543632|NCT02079649|521190377|FG001|Overall Study|Withdrawal by Subject|0|||
144543633|NCT02079649|521190378|FG002|Overall Study|Withdrawal by Subject|0|||
144543634|NCT02079649|521190379|FG003|Overall Study|Withdrawal by Subject|1|||
144543635|NCT02079649|521190376|FG000|Overall Study|Randomization error (prior to treatment)|1|||
144543636|NCT02079649|521190377|FG001|Overall Study|Randomization error (prior to treatment)|0|||
144543637|NCT02079649|521190378|FG002|Overall Study|Randomization error (prior to treatment)|1|||
144543638|NCT02079649|521190379|FG003|Overall Study|Randomization error (prior to treatment)|0|||
144543639|NCT03057600|521190404|FG000|Overall Study|Adverse Event|0|||
144543640|NCT03057600|521190405|FG001|Overall Study|Adverse Event|0|||
144543641|NCT03057600|521190406|FG002|Overall Study|Adverse Event|4|||
144543642|NCT03057600|521190407|FG003|Overall Study|Adverse Event|0|||
144543643|NCT03057600|521190404|FG000|Overall Study|Radiologic Disease Progression|8|||
144543644|NCT03057600|521190405|FG001|Overall Study|Radiologic Disease Progression|7|||
144543645|NCT03057600|521190406|FG002|Overall Study|Radiologic Disease Progression|13|||
144543646|NCT03057600|521190407|FG003|Overall Study|Radiologic Disease Progression|10|||
144543647|NCT03057600|521190404|FG000|Overall Study|Symptomatic Deterioration|0|||
144543648|NCT03057600|521190405|FG001|Overall Study|Symptomatic Deterioration|1|||
144543649|NCT03057600|521190406|FG002|Overall Study|Symptomatic Deterioration|1|||
144543650|NCT03057600|521190407|FG003|Overall Study|Symptomatic Deterioration|0|||
144543651|NCT03057600|521190404|FG000|Overall Study|Investigator Decision|0|||
144543652|NCT03057600|521190405|FG001|Overall Study|Investigator Decision|0|||
144543653|NCT03057600|521190406|FG002|Overall Study|Investigator Decision|1|||
144543654|NCT03057600|521190407|FG003|Overall Study|Investigator Decision|0|||
144543655|NCT03057600|521190404|FG000|Overall Study|Study Termination by Sponsor|0|||
144616422|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
144543656|NCT03057600|521190405|FG001|Overall Study|Study Termination by Sponsor|0|||
144543657|NCT03057600|521190406|FG002|Overall Study|Study Termination by Sponsor|0|||
144543658|NCT03057600|521190407|FG003|Overall Study|Study Termination by Sponsor|2|||
144543659|NCT03057600|521190404|FG000|Overall Study|Withdrawal by Subject|0|||
144543660|NCT03057600|521190405|FG001|Overall Study|Withdrawal by Subject|1|||
144543661|NCT03057600|521190406|FG002|Overall Study|Withdrawal by Subject|0|||
144543662|NCT03057600|521190407|FG003|Overall Study|Withdrawal by Subject|0|||
144543663|NCT03057600|521190404|FG000|Overall Study|Other, Not Specified|1|||
144543664|NCT03057600|521190405|FG001|Overall Study|Other, Not Specified|1|||
144543665|NCT03057600|521190406|FG002|Overall Study|Other, Not Specified|1|||
144473487|NCT01492686|520931936|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
144473488|NCT01492686|520931937|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
144543666|NCT03057600|521190407|FG003|Overall Study|Other, Not Specified|1|||
144543667|NCT01968967|521190408|FG000|Treatment Period|Other|22|||
144543668|NCT01968967|521190409|FG001|Treatment Period|Other|22|||
144543669|NCT01968967|521190410|FG002|Treatment Period|Other|0|||
144543670|NCT01968967|521190411|FG003|Treatment Period|Other|0|||
144543671|NCT01968967|521190412|FG004|Treatment Period|Other|0|||
144543672|NCT01968967|521190408|FG000|Treatment Period|Withdrawal by Subject|71|||
144543673|NCT01968967|521190409|FG001|Treatment Period|Withdrawal by Subject|61|||
144543674|NCT01968967|521190410|FG002|Treatment Period|Withdrawal by Subject|0|||
144543675|NCT01968967|521190411|FG003|Treatment Period|Withdrawal by Subject|0|||
144543676|NCT01968967|521190412|FG004|Treatment Period|Withdrawal by Subject|0|||
144543677|NCT01968967|521190408|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
144543678|NCT01968967|521190409|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
144543679|NCT01968967|521190410|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
144543680|NCT01968967|521190411|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
144543681|NCT01968967|521190412|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
144543682|NCT01968967|521190408|FG000|Treatment Period|Lost to Follow-up|26|||
144543683|NCT01968967|521190409|FG001|Treatment Period|Lost to Follow-up|31|||
144543684|NCT01968967|521190410|FG002|Treatment Period|Lost to Follow-up|0|||
144543685|NCT01968967|521190411|FG003|Treatment Period|Lost to Follow-up|0|||
144543686|NCT01968967|521190412|FG004|Treatment Period|Lost to Follow-up|0|||
144543687|NCT01968967|521190408|FG000|Treatment Period|Protocol Violation|1|||
144543688|NCT01968967|521190409|FG001|Treatment Period|Protocol Violation|2|||
144543689|NCT01968967|521190410|FG002|Treatment Period|Protocol Violation|0|||
144543690|NCT01968967|521190411|FG003|Treatment Period|Protocol Violation|0|||
144543691|NCT01968967|521190412|FG004|Treatment Period|Protocol Violation|0|||
144543692|NCT01968967|521190408|FG000|Treatment Period|Adverse Event|9|||
144543693|NCT01968967|521190409|FG001|Treatment Period|Adverse Event|8|||
144543694|NCT01968967|521190410|FG002|Treatment Period|Adverse Event|0|||
144543695|NCT01968967|521190411|FG003|Treatment Period|Adverse Event|0|||
144543696|NCT01968967|521190412|FG004|Treatment Period|Adverse Event|0|||
144543697|NCT01968967|521190408|FG000|Treatment Period|Death|9|||
144543698|NCT01968967|521190409|FG001|Treatment Period|Death|2|||
144543699|NCT01968967|521190410|FG002|Treatment Period|Death|0|||
144543700|NCT01968967|521190411|FG003|Treatment Period|Death|0|||
144543701|NCT01968967|521190412|FG004|Treatment Period|Death|0|||
144543702|NCT01968967|521190408|FG000|Treatment Period|Randomized Not Treated|6|||
144543703|NCT01968967|521190409|FG001|Treatment Period|Randomized Not Treated|5|||
144543704|NCT01968967|521190410|FG002|Treatment Period|Randomized Not Treated|0|||
144543705|NCT01968967|521190411|FG003|Treatment Period|Randomized Not Treated|0|||
144543706|NCT01968967|521190412|FG004|Treatment Period|Randomized Not Treated|0|||
144543707|NCT01968967|521190408|FG000|Extension Period|Withdrew Consent|0|||
144543708|NCT01968967|521190409|FG001|Extension Period|Withdrew Consent|0|||
144543709|NCT01968967|521190410|FG002|Extension Period|Withdrew Consent|2|||
144543710|NCT01968967|521190411|FG003|Extension Period|Withdrew Consent|0|||
144543711|NCT01968967|521190412|FG004|Extension Period|Withdrew Consent|5|||
144543712|NCT03489369|521190413|FG000|Overall Study|Documented Progressive Disease|3|||
144543713|NCT03489369|521190414|FG001|Overall Study|Documented Progressive Disease|2|||
144473489|NCT01492686|520931936|FG000|Open-label Phase|Adverse Event|1|||
144473490|NCT01492686|520931937|FG001|Open-label Phase|Adverse Event|2|||
144543714|NCT03489369|521190415|FG002|Overall Study|Documented Progressive Disease|3|||
144543715|NCT03489369|521190416|FG003|Overall Study|Documented Progressive Disease|6|||
144543716|NCT03489369|521190413|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
144543717|NCT03489369|521190414|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
144473491|NCT01492686|520931936|FG000|Open-label Phase|Physician Decision|1|||
144473492|NCT01492686|520931937|FG001|Open-label Phase|Physician Decision|0|||
144473493|NCT01492686|520931936|FG000|Open-label Phase|Withdrawal by Subject|6|||
144473494|NCT01492686|520931937|FG001|Open-label Phase|Withdrawal by Subject|7|||
144473495|NCT01492686|520931936|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
144473496|NCT01492686|520931937|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
144473497|NCT03124199|520931939|FG000|Overall Study|Lost to Follow-up|4|||
144473498|NCT02748694|520931940|FG000|Overall Study|Voluntary Withdrawal|0|||
144473499|NCT02748694|520931941|FG001|Overall Study|Voluntary Withdrawal|0|||
144543718|NCT03489369|521190415|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
144543719|NCT03489369|521190416|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
144543720|NCT02022670|521190423|FG000|Overall Study|Adverse Event|1|||
144543721|NCT02022670|521190424|FG001|Overall Study|Adverse Event|0|||
144543722|NCT02022670|521190425|FG002|Overall Study|Adverse Event|1|||
144543723|NCT02426138|521190439|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
144543724|NCT02426138|521190440|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
144543725|NCT04677738|521190441|FG000|Overall Study|Withdrawal by Subject|4|||
144543726|NCT04677738|521190442|FG001|Overall Study|Withdrawal by Subject|2|||
144543727|NCT03697603|521190449|FG000|Overall Study|Adverse Event|3|||
144543728|NCT03697603|521190450|FG001|Overall Study|Adverse Event|18|||
144473500|NCT02748694|520931942|FG002|Overall Study|Voluntary Withdrawal|0|||
144473501|NCT02748694|520931943|FG003|Overall Study|Voluntary Withdrawal|0|||
144473502|NCT02748694|520931944|FG004|Overall Study|Voluntary Withdrawal|0|||
144473503|NCT02748694|520931945|FG005|Overall Study|Voluntary Withdrawal|0|||
144473504|NCT02748694|520931946|FG006|Overall Study|Voluntary Withdrawal|0|||
144473505|NCT02748694|520931947|FG007|Overall Study|Voluntary Withdrawal|0|||
144473506|NCT02748694|520931948|FG008|Overall Study|Voluntary Withdrawal|0|||
144473507|NCT02748694|520931949|FG009|Overall Study|Voluntary Withdrawal|0|||
144473508|NCT02748694|520931950|FG010|Overall Study|Voluntary Withdrawal|0|||
144473509|NCT02748694|520931951|FG011|Overall Study|Voluntary Withdrawal|0|||
144473510|NCT02748694|520931952|FG012|Overall Study|Voluntary Withdrawal|0|||
144473511|NCT02748694|520931953|FG013|Overall Study|Voluntary Withdrawal|0|||
144473512|NCT02748694|520931954|FG014|Overall Study|Voluntary Withdrawal|2|||
144473513|NCT00659984|520931957|FG000|Overall Study|Adverse Event|1|||
144473514|NCT02535364|520931960|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
144473515|NCT02535364|520931960|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
144473516|NCT02535364|520931960|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
144473517|NCT02535364|520931960|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
144473518|NCT02535364|520931960|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
144473519|NCT02535364|520931960|FG000|Part B Screening|Death|2|||
144473520|NCT02535364|520931960|FG000|Part B Screening|Physician Decision|1|||
144473521|NCT02535364|520931960|FG000|Part B Screening|Withdrawal by Subject|1|||
144473522|NCT02535364|520931960|FG000|Part B Screening|Adverse Event|1|||
144473523|NCT02535364|520931960|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
144473524|NCT02535364|520931960|FG000|Study Treatment|Death|1|||
144473525|NCT02535364|520931960|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
144473526|NCT02535364|520931960|FG000|12-Month Follow-up Period|Disease progression|22|||
144473527|NCT02535364|520931960|FG000|12-Month Follow-up Period|Death|5|||
144473528|NCT02535364|520931960|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
144473529|NCT02535364|520931960|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
144473530|NCT02535364|520931960|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
144473531|NCT00571701|520931961|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
144473532|NCT00571701|520931962|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
144473533|NCT00571701|520931961|FG000|First Intervention 12 Months|Death|1|||
144473534|NCT00571701|520931962|FG001|First Intervention 12 Months|Death|0|||
144473535|NCT00571701|520931961|FG000|Second Intervention 12 Months|Adverse Event|0|||
144473536|NCT00571701|520931962|FG001|Second Intervention 12 Months|Adverse Event|1|||
144473537|NCT00571701|520931961|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
144473538|NCT00571701|520931962|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
144473539|NCT00691132|520931965|FG000|Overall Study|Adverse Event|2|||
144473540|NCT00691132|520931966|FG001|Overall Study|Adverse Event|3|||
144473541|NCT00691132|520931965|FG000|Overall Study|Withdrawal by Subject|10|||
144473542|NCT00691132|520931966|FG001|Overall Study|Withdrawal by Subject|10|||
144473543|NCT04766086|520931967|FG000|Overall Study|Lost to Follow-up|3|||
144473544|NCT04766086|520931968|FG001|Overall Study|Lost to Follow-up|5|||
144473545|NCT04766086|520931969|FG002|Overall Study|Lost to Follow-up|3|||
144473546|NCT04766086|520931967|FG000|Overall Study|Withdrawal by Subject|1|||
144473547|NCT04766086|520931968|FG001|Overall Study|Withdrawal by Subject|1|||
144473548|NCT04766086|520931969|FG002|Overall Study|Withdrawal by Subject|2|||
144473549|NCT04766086|520931967|FG000|Overall Study|Other|0|||
144473550|NCT04766086|520931968|FG001|Overall Study|Other|0|||
144473551|NCT04766086|520931969|FG002|Overall Study|Other|1|||
144473552|NCT01959347|520931972|FG000|Overall Study|Protocol Violation|9|||
144473553|NCT01959347|520931973|FG001|Overall Study|Protocol Violation|7|||
144473554|NCT03541044|520931974|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
144473555|NCT03541044|520931975|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
144473556|NCT03541044|520931974|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
144473557|NCT03541044|520931975|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
144473558|NCT00860067|520931978|FG000|Overall Study|Lost to Follow-up|46|||
144473559|NCT00860067|520931979|FG001|Overall Study|Lost to Follow-up|9|||
144473560|NCT00860067|520931980|FG002|Overall Study|Lost to Follow-up|9|||
144473561|NCT00860067|520931978|FG000|Overall Study|Withdrawal by Subject|4|||
144473562|NCT00860067|520931979|FG001|Overall Study|Withdrawal by Subject|0|||
144473563|NCT00860067|520931980|FG002|Overall Study|Withdrawal by Subject|0|||
144473564|NCT00860067|520931978|FG000|Overall Study|Pregnancy|1|||
144473565|NCT00860067|520931979|FG001|Overall Study|Pregnancy|0|||
144473566|NCT00860067|520931980|FG002|Overall Study|Pregnancy|0|||
144473567|NCT01282801|520931981|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
144473568|NCT01282801|520931982|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
144473569|NCT01498822|520931984|FG000|Overall Study|Protocol Violation|8|||
144473570|NCT01498822|520931985|FG001|Overall Study|Protocol Violation|4|||
144473571|NCT01498822|520931984|FG000|Overall Study|Other Reason|5|||
144473572|NCT01498822|520931985|FG001|Overall Study|Other Reason|2|||
144473573|NCT01498822|520931984|FG000|Overall Study|Lack of Efficacy|7|||
144473574|NCT01498822|520931985|FG001|Overall Study|Lack of Efficacy|2|||
144473575|NCT01498822|520931984|FG000|Overall Study|AE, non-serious non-fatal|8|||
144473576|NCT01498822|520931985|FG001|Overall Study|AE, non-serious non-fatal|17|||
144473577|NCT01498822|520931984|FG000|Overall Study|SAE, non-fatal|2|||
144473578|NCT01498822|520931985|FG001|Overall Study|SAE, non-fatal|2|||
144473579|NCT01498822|520931984|FG000|Overall Study|Adverse Event, serious fatal|1|||
144473580|NCT01498822|520931985|FG001|Overall Study|Adverse Event, serious fatal|1|||
144473581|NCT01498822|520931984|FG000|Overall Study|Withdrawal by Subject|15|||
144473582|NCT01498822|520931985|FG001|Overall Study|Withdrawal by Subject|25|||
144473583|NCT01498822|520931984|FG000|Overall Study|Lost to Follow-up|8|||
144473584|NCT01498822|520931985|FG001|Overall Study|Lost to Follow-up|3|||
144473585|NCT04707196|520931986|FG000|Overall Study|Withdrawal by Subject|9|||
144473586|NCT04707196|520931987|FG001|Overall Study|Withdrawal by Subject|6|||
144473587|NCT04707196|520931986|FG000|Overall Study|Lost to Follow-up|1|||
144473588|NCT04707196|520931987|FG001|Overall Study|Lost to Follow-up|0|||
144473589|NCT04707196|520931986|FG000|Overall Study|Protocol Violation|4|||
144473590|NCT04707196|520931987|FG001|Overall Study|Protocol Violation|1|||
144473591|NCT04707196|520931986|FG000|Overall Study|Adverse Event|2|||
144473592|NCT04707196|520931987|FG001|Overall Study|Adverse Event|2|||
144473593|NCT04707196|520931986|FG000|Overall Study|Death|3|||
144473594|NCT04707196|520931987|FG001|Overall Study|Death|1|||
144473595|NCT04707196|520931986|FG000|Overall Study|Non-compliance with study drug|1|||
144473596|NCT04707196|520931987|FG001|Overall Study|Non-compliance with study drug|0|||
144473597|NCT04707196|520931986|FG000|Overall Study|Progressive disease|9|||
144473598|NCT04707196|520931987|FG001|Overall Study|Progressive disease|10|||
144473599|NCT01862796|520931988|FG000|Overall Study|Prohibited medications|0|||
144473600|NCT01862796|520931989|FG001|Overall Study|Prohibited medications|0|||
144473601|NCT01862796|520931990|FG002|Overall Study|Prohibited medications|1|||
144473602|NCT01462162|520931991|FG000|Overall Study|Adverse Event|5|||
144473603|NCT01462162|520931991|FG000|Overall Study|Lack of Efficacy|4|||
144473604|NCT01462162|520931991|FG000|Overall Study|Abnormal laboratory parameters|1|||
144473605|NCT01462162|520931991|FG000|Overall Study|Other|2|||
144473606|NCT04404478|520931992|FG000|Overall Study|Withdrawal by Subject|1|||
144473607|NCT04404478|520931993|FG001|Overall Study|Withdrawal by Subject|3|||
144473608|NCT03333928|520931994|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
144473609|NCT03333928|520931995|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
144473610|NCT03333928|520931996|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
144473611|NCT03333928|520931994|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
144473612|NCT03333928|520931995|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
144473613|NCT03333928|520931996|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
144543729|NCT03697603|521190451|FG002|Overall Study|Adverse Event|3|||
144543730|NCT03697603|521190449|FG000|Overall Study|Physician Decision|1|||
144543731|NCT03697603|521190450|FG001|Overall Study|Physician Decision|0|||
144202358|NCT03970837|519937069|FG007|Overall Study|Adverse Event|5|||
144202359|NCT03970837|519937070|FG008|Overall Study|Adverse Event|0|||
144543732|NCT03697603|521190451|FG002|Overall Study|Physician Decision|2|||
144543733|NCT03697603|521190449|FG000|Overall Study|Protocol Violation|3|||
144543734|NCT03697603|521190450|FG001|Overall Study|Protocol Violation|8|||
144543735|NCT03697603|521190451|FG002|Overall Study|Protocol Violation|5|||
144543736|NCT03697603|521190449|FG000|Overall Study|Withdrawal by Subject|5|||
144543737|NCT03697603|521190450|FG001|Overall Study|Withdrawal by Subject|1|||
144543738|NCT03697603|521190451|FG002|Overall Study|Withdrawal by Subject|1|||
144543739|NCT03697603|521190449|FG000|Overall Study|Protocol Violation|0|||
144543740|NCT03697603|521190450|FG001|Overall Study|Protocol Violation|0|||
144543741|NCT03697603|521190451|FG002|Overall Study|Protocol Violation|1|||
144543742|NCT00467272|521190459|FG000|Overall Study|Pneumonia|2|||
144543743|NCT00467272|521190459|FG000|Overall Study|Thrombophlebitis|1|||
144543744|NCT05212285|521190462|FG000|Overall Study|Lack of Efficacy|12|||
144543745|NCT05212285|521190463|FG001|Overall Study|Lack of Efficacy|8|||
144202360|NCT03970837|519937071|FG009|Overall Study|Adverse Event|0|||
144202361|NCT03970837|519937072|FG010|Overall Study|Adverse Event|1|||
144202362|NCT03970837|519937073|FG011|Overall Study|Adverse Event|1|||
144202363|NCT03970837|519937062|FG000|Overall Study|Lack of Efficacy|14|||
144473614|NCT03333928|520931994|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
144473615|NCT03333928|520931995|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
144473616|NCT03333928|520931996|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
144473617|NCT03333928|520931994|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
144473618|NCT03333928|520931995|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
144473619|NCT03333928|520931996|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
144473620|NCT03333928|520931994|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
144473621|NCT03333928|520931995|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
144543746|NCT05212285|521190462|FG000|Overall Study|Withdrawal by Subject|8|||
144543747|NCT05212285|521190463|FG001|Overall Study|Withdrawal by Subject|1|||
144543748|NCT05212285|521190462|FG000|Overall Study|Lost to Follow-up|13|||
144543749|NCT05212285|521190463|FG001|Overall Study|Lost to Follow-up|1|||
144543750|NCT05212285|521190462|FG000|Overall Study|miss data|21|||
144543751|NCT05212285|521190463|FG001|Overall Study|miss data|2|||
144543752|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
144543753|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
144543754|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
144543755|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
144543756|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
144543757|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
144543758|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
144543759|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
144261640|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
144261641|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261642|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261643|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261644|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144543760|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
144543761|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
144543762|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
144543763|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
144543764|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
144543765|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
144543766|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
144261645|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261646|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261647|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261648|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261649|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261650|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144261651|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144473622|NCT03333928|520931996|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
144473623|NCT03333928|520931994|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
144473624|NCT03333928|520931995|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
144473625|NCT03333928|520931996|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
144473626|NCT03333928|520931994|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
144473627|NCT03333928|520931995|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
144473628|NCT03333928|520931996|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
144473629|NCT03333928|520931994|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
144473630|NCT03333928|520931995|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
144473631|NCT03333928|520931996|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
144473632|NCT01375205|520932007|FG000|Overall Study|Lost to Follow-up|15|||
144473633|NCT01375205|520932008|FG001|Overall Study|Lost to Follow-up|12|||
144473634|NCT01375205|520932007|FG000|Overall Study|Withdrawal by Subject|6|||
144473635|NCT01375205|520932008|FG001|Overall Study|Withdrawal by Subject|1|||
144473636|NCT05687032|520932009|FG000|Treatment Phase|Adverse Event|13|||
144473637|NCT05687032|520932009|FG000|Treatment Phase|Death|1|||
144473638|NCT05687032|520932009|FG000|Treatment Phase|Physician Decision|3|||
144473639|NCT05687032|520932009|FG000|Treatment Phase|Progressive disease|9|||
144473640|NCT05687032|520932009|FG000|Treatment Phase|Withdrawal by Subject|5|||
144473641|NCT05687032|520932009|FG000|Follow-Up Phase|Death|16|||
144473642|NCT05687032|520932009|FG000|Follow-Up Phase|Ongoing|26|||
144473643|NCT01674621|520932010|FG000|Overall Study|Adverse Event|3|||
144473644|NCT01674621|520932011|FG001|Overall Study|Adverse Event|2|||
144473645|NCT01674621|520932012|FG002|Overall Study|Adverse Event|5|||
144473646|NCT01674621|520932013|FG003|Overall Study|Adverse Event|5|||
144473647|NCT01674621|520932014|FG004|Overall Study|Adverse Event|1|||
144473648|NCT01674621|520932010|FG000|Overall Study|Inability to Complete Study Procedures|0|||
144473649|NCT01674621|520932011|FG001|Overall Study|Inability to Complete Study Procedures|0|||
144473650|NCT01674621|520932012|FG002|Overall Study|Inability to Complete Study Procedures|0|||
144473651|NCT01674621|520932013|FG003|Overall Study|Inability to Complete Study Procedures|0|||
144473652|NCT01674621|520932014|FG004|Overall Study|Inability to Complete Study Procedures|2|||
144473653|NCT01674621|520932010|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
144473654|NCT01674621|520932011|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
144473655|NCT01674621|520932012|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
144473656|NCT01674621|520932013|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
144473657|NCT01674621|520932014|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
144543767|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
144543768|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
144543769|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
144543770|NCT02222493|521190466|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
144543771|NCT02222493|521190467|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
144543772|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
144473658|NCT01674621|520932010|FG000|Overall Study|Withdrawal by Subject|2|||
144473659|NCT01674621|520932011|FG001|Overall Study|Withdrawal by Subject|5|||
144473660|NCT01674621|520932012|FG002|Overall Study|Withdrawal by Subject|2|||
144473661|NCT01674621|520932013|FG003|Overall Study|Withdrawal by Subject|0|||
144473662|NCT01674621|520932014|FG004|Overall Study|Withdrawal by Subject|1|||
144473663|NCT01674621|520932010|FG000|Overall Study|Other than specified|0|||
144473664|NCT01674621|520932011|FG001|Overall Study|Other than specified|1|||
144543773|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
144543774|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
144543775|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
144543776|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
144473665|NCT01674621|520932012|FG002|Overall Study|Other than specified|0|||
144473666|NCT01674621|520932013|FG003|Overall Study|Other than specified|0|||
144473667|NCT01674621|520932014|FG004|Overall Study|Other than specified|2|||
144202364|NCT03970837|519937063|FG001|Overall Study|Lack of Efficacy|12|||
144202365|NCT03970837|519937064|FG002|Overall Study|Lack of Efficacy|1|||
144473668|NCT01148862|520932015|FG000|Second Intervention|Withdrawal by Subject|0|||
144473669|NCT01148862|520932016|FG001|Second Intervention|Withdrawal by Subject|2|||
144473670|NCT04954586|520932017|FG000|Overall Study|Withdrawal by Subject|5|||
144473671|NCT04987762|520932018|FG000|Overall Study|Study was Terminated by Sponsor|103|||
144473672|NCT02034708|520932021|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
144473673|NCT02034708|520932022|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
144473674|NCT02034708|520932021|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
144473675|NCT02034708|520932022|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
144473676|NCT02034708|520932021|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
144473677|NCT02034708|520932022|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
144473678|NCT02034708|520932021|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
144473679|NCT02034708|520932022|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
144202366|NCT03970837|519937065|FG003|Overall Study|Lack of Efficacy|2|||
144202367|NCT03970837|519937066|FG004|Overall Study|Lack of Efficacy|3|||
144202368|NCT03970837|519937067|FG005|Overall Study|Lack of Efficacy|4|||
144202369|NCT03970837|519937068|FG006|Overall Study|Lack of Efficacy|6|||
144543777|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
144543778|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
144543779|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
144543780|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
144543781|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
144543782|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
144543783|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
144543784|NCT02222493|521190466|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
144543785|NCT02222493|521190467|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
144543786|NCT02222493|521190466|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
144543787|NCT02222493|521190467|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
144543788|NCT02222493|521190466|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
144543789|NCT02222493|521190467|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
144543790|NCT02222493|521190466|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
144543791|NCT02222493|521190467|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
144543792|NCT02222493|521190466|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
144543793|NCT02222493|521190467|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
144543794|NCT02222493|521190466|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
144473680|NCT04108000|520932039|FG000|Overall Study|Death of patient|1|||
144473681|NCT04108000|520932040|FG001|Overall Study|Death of patient|0|||
144473682|NCT04108000|520932041|FG002|Overall Study|Death of patient|1|||
144473683|NCT04108000|520932042|FG003|Overall Study|Death of patient|0|||
144473684|NCT04108000|520932039|FG000|Overall Study|Withdrawal by Subject|2|||
144202370|NCT03970837|519937069|FG007|Overall Study|Lack of Efficacy|1|||
144261652|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
144473685|NCT04108000|520932040|FG001|Overall Study|Withdrawal by Subject|2|||
144473686|NCT04108000|520932041|FG002|Overall Study|Withdrawal by Subject|0|||
144473687|NCT04108000|520932042|FG003|Overall Study|Withdrawal by Subject|0|||
144473688|NCT04108000|520932039|FG000|Overall Study|Death of surrogate partner|0|||
144473689|NCT04108000|520932040|FG001|Overall Study|Death of surrogate partner|1|||
144202371|NCT03970837|519937070|FG008|Overall Study|Lack of Efficacy|1|||
144202372|NCT03970837|519937071|FG009|Overall Study|Lack of Efficacy|0|||
144202373|NCT03970837|519937072|FG010|Overall Study|Lack of Efficacy|0|||
144202374|NCT03970837|519937073|FG011|Overall Study|Lack of Efficacy|0|||
144202375|NCT03970837|519937062|FG000|Overall Study|Lost to Follow-up|6|||
144473690|NCT04108000|520932041|FG002|Overall Study|Death of surrogate partner|0|||
144473691|NCT04108000|520932042|FG003|Overall Study|Death of surrogate partner|1|||
144473692|NCT03750006|520932043|FG000|Overall Study|Withdrawal by Subject|8|||
144473693|NCT03750006|520932043|FG000|Overall Study|COVID PANDEMIC|11|||
144473694|NCT03881696|520932047|FG000|Overall Study|Adverse Event|2|||
144473695|NCT03881696|520932048|FG001|Overall Study|Adverse Event|0|||
144473696|NCT03881696|520932047|FG000|Overall Study|Withdrawal by Subject|2|||
144473697|NCT03881696|520932048|FG001|Overall Study|Withdrawal by Subject|0|||
144473698|NCT03881696|520932047|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
144473699|NCT03881696|520932048|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
144473700|NCT03881696|520932047|FG000|Overall Study|Failure to meet continuation criteria|1|||
144473701|NCT03881696|520932048|FG001|Overall Study|Failure to meet continuation criteria|0|||
144473702|NCT01061333|520932049|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
144473703|NCT01061333|520932050|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
144543795|NCT02222493|521190467|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
144543796|NCT00145470|521190468|FG000|Overall Study|Adverse Event|19|||
144543797|NCT00145470|521190469|FG001|Overall Study|Adverse Event|25|||
144543798|NCT00145470|521190468|FG000|Overall Study|Lack of Efficacy|27|||
144543799|NCT00145470|521190469|FG001|Overall Study|Lack of Efficacy|13|||
144543800|NCT00145470|521190468|FG000|Overall Study|Withdrawal by Subject|36|||
144543801|NCT00145470|521190469|FG001|Overall Study|Withdrawal by Subject|34|||
144543802|NCT00145470|521190468|FG000|Overall Study|Lost to Follow-up|21|||
144543803|NCT00145470|521190469|FG001|Overall Study|Lost to Follow-up|17|||
144543804|NCT00145470|521190468|FG000|Overall Study|Reason Not Reported|9|||
144543805|NCT00145470|521190469|FG001|Overall Study|Reason Not Reported|9|||
144543806|NCT00676091|521190472|FG000|Infant Series|Parent or legal guardian request|10|||
144543807|NCT00676091|521190473|FG001|Infant Series|Parent or legal guardian request|8|||
144543808|NCT00676091|521190472|FG000|Infant Series|Protocol Violation|6|||
144543809|NCT00676091|521190473|FG001|Infant Series|Protocol Violation|3|||
144543810|NCT00676091|521190472|FG000|Infant Series|Adverse Event|2|||
144543811|NCT00676091|521190473|FG001|Infant Series|Adverse Event|3|||
144543812|NCT00676091|521190472|FG000|Infant Series|Failed to return|1|||
144543813|NCT00676091|521190473|FG001|Infant Series|Failed to return|3|||
144543814|NCT00676091|521190472|FG000|Infant Series|Lost to Follow-up|1|||
144543815|NCT00676091|521190473|FG001|Infant Series|Lost to Follow-up|0|||
144543816|NCT00676091|521190472|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
144543817|NCT00676091|521190473|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
144543818|NCT00676091|521190472|FG000|After Infant Series|Adverse Event|0|||
144543819|NCT00676091|521190473|FG001|After Infant Series|Adverse Event|1|||
144543820|NCT00676091|521190472|FG000|After Infant Series|Protocol Violation|0|||
144543821|NCT00676091|521190473|FG001|After Infant Series|Protocol Violation|1|||
144543822|NCT00676091|521190472|FG000|After Infant Series|Failed to return|1|||
144543823|NCT00676091|521190473|FG001|After Infant Series|Failed to return|1|||
144543824|NCT00676091|521190472|FG000|Toddler Dose|Failed to return|2|||
144543825|NCT00676091|521190473|FG001|Toddler Dose|Failed to return|0|||
144543826|NCT00676091|521190472|FG000|Toddler Dose|Parent or legal guardian request|1|||
144543827|NCT00676091|521190473|FG001|Toddler Dose|Parent or legal guardian request|0|||
144543828|NCT00933270|521190477|FG000|Overall Study|Withdrawal by Subject|26|||
144543829|NCT00933270|521190477|FG000|Overall Study|Insufficient Follow-up|10|||
144543830|NCT00933270|521190477|FG000|Overall Study|Lost to Follow-up|14|||
144543831|NCT00933270|521190477|FG000|Overall Study|Adverse Event|1|||
144543832|NCT00933270|521190477|FG000|Overall Study|Missed Visit|2|||
144543833|NCT00933270|521190477|FG000|Overall Study|Death|24|||
144543834|NCT00933270|521190477|FG000|Overall Study|Moved or would not return|10|||
144543835|NCT01000805|521190478|FG000|Overall Study|Adverse Event|21|||
144543836|NCT01000805|521190479|FG001|Overall Study|Adverse Event|9|||
144543837|NCT01000805|521190478|FG000|Overall Study|Lack of Efficacy|5|||
144543838|NCT01000805|521190479|FG001|Overall Study|Lack of Efficacy|16|||
144543839|NCT01000805|521190478|FG000|Overall Study|Lost to Follow-up|16|||
144543840|NCT01000805|521190479|FG001|Overall Study|Lost to Follow-up|21|||
144543841|NCT01000805|521190478|FG000|Overall Study|Physician Decision|0|||
144543842|NCT01000805|521190479|FG001|Overall Study|Physician Decision|1|||
144543843|NCT01000805|521190478|FG000|Overall Study|Protocol Violation|12|||
144543844|NCT01000805|521190479|FG001|Overall Study|Protocol Violation|8|||
144543845|NCT01000805|521190478|FG000|Overall Study|Withdrawal by Subject|16|||
144543846|NCT01000805|521190479|FG001|Overall Study|Withdrawal by Subject|6|||
144543847|NCT01000805|521190478|FG000|Overall Study|Sponsor Decision|0|||
144543848|NCT01000805|521190479|FG001|Overall Study|Sponsor Decision|1|||
144543849|NCT03924869|521190483|FG000|Overall Study|Death|66|||
144543850|NCT03924869|521190484|FG001|Overall Study|Death|53|||
144543851|NCT03924869|521190483|FG000|Overall Study|Lost to Follow-up|2|||
144543852|NCT03924869|521190484|FG001|Overall Study|Lost to Follow-up|0|||
144543853|NCT03924869|521190483|FG000|Overall Study|Physician Decision|0|||
144543854|NCT03924869|521190484|FG001|Overall Study|Physician Decision|3|||
144543855|NCT03924869|521190483|FG000|Overall Study|Withdrawal by Subject|5|||
144543856|NCT03924869|521190484|FG001|Overall Study|Withdrawal by Subject|1|||
144543857|NCT03924869|521190483|FG000|Overall Study|Participants Ongoing|154|||
144543858|NCT03924869|521190484|FG001|Overall Study|Participants Ongoing|164|||
144543859|NCT04762277|521190487|FG000|Overall Study|Withdrawal by Subject|0|||
144543860|NCT04762277|521190488|FG001|Overall Study|Withdrawal by Subject|2|||
144543861|NCT04762277|521190487|FG000|Overall Study|Protocol Violation|0|||
144543862|NCT04762277|521190488|FG001|Overall Study|Protocol Violation|1|||
144543863|NCT04762277|521190487|FG000|Overall Study|Adverse Event|1|||
144543864|NCT04762277|521190488|FG001|Overall Study|Adverse Event|0|||
144543865|NCT05824559|521190489|FG000|Overall Study|Adverse Event|2|||
144543866|NCT05824559|521190489|FG000|Overall Study|Physician Decision|2|||
144543867|NCT05824559|521190489|FG000|Overall Study|Progressive Disease|16|||
144261653|NCT02326272|520159714|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261654|NCT02326272|520159715|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261655|NCT02326272|520159716|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
144261656|NCT02326272|520159717|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261657|NCT02326272|520159718|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261658|NCT02326272|520159719|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261659|NCT02326272|520159720|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261660|NCT02326272|520159721|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261661|NCT02326272|520159722|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261662|NCT02326272|520159723|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261663|NCT02326272|520159724|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261664|NCT02326272|520159725|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261665|NCT02326272|520159726|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261666|NCT02326272|520159727|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261667|NCT02326272|520159728|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
144261668|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261669|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261670|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261671|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261672|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
144261673|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
144261674|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
144261675|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
144261676|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
144261677|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261678|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261679|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261680|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261681|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261682|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144261683|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261684|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261685|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144543868|NCT05824559|521190489|FG000|Overall Study|Study Terminated by Sponsor|1|||
144543869|NCT05824559|521190489|FG000|Overall Study|Withdrawal by Subject|2|||
144543870|NCT03343704|521190490|FG000|Overall Study|Refused to complete follow up|0|||
144543871|NCT03343704|521190491|FG001|Overall Study|Refused to complete follow up|1|||
144543872|NCT03343704|521190490|FG000|Overall Study|Death|0|||
144543873|NCT03343704|521190491|FG001|Overall Study|Death|1|||
144543874|NCT03343704|521190490|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
144543875|NCT03343704|521190491|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
144543876|NCT05349721|521192230|FG000|Part A (24 Weeks)|Adverse Event|9|||
144543877|NCT05349721|521192231|FG001|Part A (24 Weeks)|Adverse Event|2|||
144543878|NCT05349721|521192230|FG000|Part A (24 Weeks)|Death|8|||
144543879|NCT05349721|521192231|FG001|Part A (24 Weeks)|Death|3|||
144543880|NCT05349721|521192230|FG000|Part A (24 Weeks)|Disease Progression|1|||
144543881|NCT05349721|521192231|FG001|Part A (24 Weeks)|Disease Progression|1|||
144543882|NCT05349721|521192230|FG000|Part A (24 Weeks)|Screen Failure|2|||
144543883|NCT05349721|521192231|FG001|Part A (24 Weeks)|Screen Failure|0|||
144543884|NCT05349721|521192230|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
144543885|NCT05349721|521192231|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
144543886|NCT05349721|521192230|FG000|Part A (24 Weeks)|Other Than Specified|5|||
144543887|NCT05349721|521192231|FG001|Part A (24 Weeks)|Other Than Specified|1|||
144543888|NCT05349721|521192230|FG000|Part B (28 Weeks)|Adverse Event|3|||
144261686|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261687|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261688|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
144261689|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
144261690|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261691|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
144543889|NCT05349721|521192231|FG001|Part B (28 Weeks)|Adverse Event|0|||
144543890|NCT05349721|521192230|FG000|Part B (28 Weeks)|Death|21|||
144543891|NCT05349721|521192231|FG001|Part B (28 Weeks)|Death|11|||
144543892|NCT05349721|521192230|FG000|Part B (28 Weeks)|Disease Progression|2|||
144543893|NCT05349721|521192231|FG001|Part B (28 Weeks)|Disease Progression|1|||
144543894|NCT05349721|521192230|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
144543895|NCT05349721|521192231|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
144543896|NCT05349721|521192230|FG000|Part B (28 Weeks)|Physician Decision|1|||
144543897|NCT05349721|521192231|FG001|Part B (28 Weeks)|Physician Decision|0|||
144543898|NCT05349721|521192230|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
144543899|NCT05349721|521192231|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
144543900|NCT05349721|521192230|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
144543901|NCT05349721|521192231|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
144543902|NCT05349721|521192230|FG000|Part B (28 Weeks)|Other Than Specified|4|||
144543903|NCT05349721|521192231|FG001|Part B (28 Weeks)|Other Than Specified|2|||
144543904|NCT05349721|521192230|FG000|Part C (108 Weeks)|Death|0|||
144543905|NCT05349721|521192231|FG001|Part C (108 Weeks)|Death|1|||
144543906|NCT05349721|521192230|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
144543907|NCT05349721|521192231|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
144543908|NCT05349721|521192230|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
144543909|NCT05349721|521192231|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
144543910|NCT05349721|521192230|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
144543911|NCT05349721|521192231|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
144543912|NCT03136159|521192233|FG000|Overall Study|chorioamnionitis|2|||
144543913|NCT03136159|521192234|FG001|Overall Study|chorioamnionitis|0|||
144543914|NCT03136159|521192233|FG000|Overall Study|vertical skin incision|1|||
144543915|NCT03136159|521192234|FG001|Overall Study|vertical skin incision|0|||
144543916|NCT03136159|521192233|FG000|Overall Study|additional dressing|1|||
144543917|NCT03136159|521192234|FG001|Overall Study|additional dressing|0|||
144543918|NCT03136159|521192233|FG000|Overall Study|never got dressing placed|1|||
144543919|NCT03136159|521192234|FG001|Overall Study|never got dressing placed|0|||
144543920|NCT03823703|521192235|FG000|Overall Study|Sponsor request|0|||
144543921|NCT03823703|521192236|FG001|Overall Study|Sponsor request|3|||
144543922|NCT03823703|521192237|FG002|Overall Study|Sponsor request|4|||
144543923|NCT03823703|521192235|FG000|Overall Study|Adverse Event|3|||
144543924|NCT03823703|521192236|FG001|Overall Study|Adverse Event|1|||
144543925|NCT03823703|521192237|FG002|Overall Study|Adverse Event|0|||
144543926|NCT03823703|521192235|FG000|Overall Study|Withdrawal by Subject|0|||
144543927|NCT03823703|521192236|FG001|Overall Study|Withdrawal by Subject|1|||
144543928|NCT03823703|521192237|FG002|Overall Study|Withdrawal by Subject|0|||
144543929|NCT00985088|521192238|FG000|Overall Study|Serious Adverse Event|1|||
144543930|NCT00985088|521192239|FG001|Overall Study|Serious Adverse Event|1|||
144543931|NCT00985088|521192240|FG002|Overall Study|Serious Adverse Event|0|||
144543932|NCT00985088|521192241|FG003|Overall Study|Serious Adverse Event|0|||
144543933|NCT00985088|521192242|FG004|Overall Study|Serious Adverse Event|0|||
144543934|NCT00985088|521192243|FG005|Overall Study|Serious Adverse Event|0|||
144543935|NCT00985088|521192244|FG006|Overall Study|Serious Adverse Event|0|||
144543936|NCT00985088|521192245|FG007|Overall Study|Serious Adverse Event|1|||
144543937|NCT00985088|521192238|FG000|Overall Study|Adverse Event|0|||
144543938|NCT00985088|521192239|FG001|Overall Study|Adverse Event|0|||
144543939|NCT00985088|521192240|FG002|Overall Study|Adverse Event|1|||
144543940|NCT00985088|521192241|FG003|Overall Study|Adverse Event|0|||
144543941|NCT00985088|521192242|FG004|Overall Study|Adverse Event|0|||
144543942|NCT00985088|521192243|FG005|Overall Study|Adverse Event|0|||
144543943|NCT00985088|521192244|FG006|Overall Study|Adverse Event|0|||
144543944|NCT00985088|521192245|FG007|Overall Study|Adverse Event|0|||
144543945|NCT00985088|521192238|FG000|Overall Study|Withdrawal by Subject|4|||
144543946|NCT00985088|521192239|FG001|Overall Study|Withdrawal by Subject|0|||
144543947|NCT00985088|521192240|FG002|Overall Study|Withdrawal by Subject|0|||
144543948|NCT00985088|521192241|FG003|Overall Study|Withdrawal by Subject|1|||
144543949|NCT00985088|521192242|FG004|Overall Study|Withdrawal by Subject|3|||
144543950|NCT00985088|521192243|FG005|Overall Study|Withdrawal by Subject|2|||
144543951|NCT00985088|521192244|FG006|Overall Study|Withdrawal by Subject|1|||
144543952|NCT00985088|521192245|FG007|Overall Study|Withdrawal by Subject|2|||
144543953|NCT00985088|521192238|FG000|Overall Study|Migrated/moved from study area|0|||
144543954|NCT00985088|521192239|FG001|Overall Study|Migrated/moved from study area|0|||
144543955|NCT00985088|521192240|FG002|Overall Study|Migrated/moved from study area|1|||
144543956|NCT00985088|521192241|FG003|Overall Study|Migrated/moved from study area|0|||
144543957|NCT00985088|521192242|FG004|Overall Study|Migrated/moved from study area|0|||
144543958|NCT00985088|521192243|FG005|Overall Study|Migrated/moved from study area|0|||
144543959|NCT00985088|521192244|FG006|Overall Study|Migrated/moved from study area|0|||
144543960|NCT00985088|521192245|FG007|Overall Study|Migrated/moved from study area|1|||
144543961|NCT00985088|521192238|FG000|Overall Study|Lost to Follow-up|6|||
144543962|NCT00985088|521192239|FG001|Overall Study|Lost to Follow-up|1|||
144543963|NCT00985088|521192240|FG002|Overall Study|Lost to Follow-up|2|||
144543964|NCT00985088|521192241|FG003|Overall Study|Lost to Follow-up|6|||
144543965|NCT00985088|521192242|FG004|Overall Study|Lost to Follow-up|6|||
144543966|NCT00985088|521192243|FG005|Overall Study|Lost to Follow-up|5|||
144543967|NCT00985088|521192244|FG006|Overall Study|Lost to Follow-up|3|||
144543968|NCT00985088|521192245|FG007|Overall Study|Lost to Follow-up|2|||
144543969|NCT01970878|521192247|FG000|Overall Study|Withdrawal by Subject|11|||
144543970|NCT01970878|521192248|FG001|Overall Study|Withdrawal by Subject|10|||
144543971|NCT01970878|521192249|FG002|Overall Study|Withdrawal by Subject|14|||
144543972|NCT01970878|521192250|FG003|Overall Study|Withdrawal by Subject|7|||
144543973|NCT01970878|521192247|FG000|Overall Study|Lost to Follow-up|1|||
144543974|NCT01970878|521192248|FG001|Overall Study|Lost to Follow-up|3|||
144543975|NCT01970878|521192249|FG002|Overall Study|Lost to Follow-up|2|||
144543976|NCT01970878|521192250|FG003|Overall Study|Lost to Follow-up|4|||
144543977|NCT01970878|521192247|FG000|Overall Study|Administrative Reasons|1|||
144543978|NCT01970878|521192248|FG001|Overall Study|Administrative Reasons|0|||
144543979|NCT01970878|521192249|FG002|Overall Study|Administrative Reasons|0|||
144543980|NCT01970878|521192250|FG003|Overall Study|Administrative Reasons|4|||
144543981|NCT01970878|521192247|FG000|Overall Study|Lack of Efficacy|2|||
144543982|NCT01970878|521192248|FG001|Overall Study|Lack of Efficacy|1|||
144543983|NCT01970878|521192249|FG002|Overall Study|Lack of Efficacy|2|||
144543984|NCT01970878|521192250|FG003|Overall Study|Lack of Efficacy|0|||
144543985|NCT01970878|521192247|FG000|Overall Study|Adverse Event|12|||
144543986|NCT01970878|521192248|FG001|Overall Study|Adverse Event|7|||
144543987|NCT01970878|521192249|FG002|Overall Study|Adverse Event|4|||
144543988|NCT01970878|521192250|FG003|Overall Study|Adverse Event|3|||
144543989|NCT01970878|521192247|FG000|Overall Study|Protocol Specified Criteria|10|||
144543990|NCT01970878|521192248|FG001|Overall Study|Protocol Specified Criteria|4|||
144543991|NCT01970878|521192249|FG002|Overall Study|Protocol Specified Criteria|3|||
144543992|NCT01970878|521192250|FG003|Overall Study|Protocol Specified Criteria|6|||
144543993|NCT01970878|521192247|FG000|Overall Study|Physician Decision|0|||
144543994|NCT01970878|521192248|FG001|Overall Study|Physician Decision|1|||
144543995|NCT01970878|521192249|FG002|Overall Study|Physician Decision|1|||
144616423|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
144202376|NCT03970837|519937063|FG001|Overall Study|Lost to Follow-up|5|||
144202377|NCT03970837|519937064|FG002|Overall Study|Lost to Follow-up|5|||
144202378|NCT03970837|519937065|FG003|Overall Study|Lost to Follow-up|1|||
144202379|NCT03970837|519937066|FG004|Overall Study|Lost to Follow-up|0|||
144202380|NCT03970837|519937067|FG005|Overall Study|Lost to Follow-up|2|||
144202381|NCT03970837|519937068|FG006|Overall Study|Lost to Follow-up|0|||
144202382|NCT03970837|519937069|FG007|Overall Study|Lost to Follow-up|0|||
144202383|NCT03970837|519937070|FG008|Overall Study|Lost to Follow-up|0|||
144202384|NCT03970837|519937071|FG009|Overall Study|Lost to Follow-up|0|||
144202385|NCT03970837|519937072|FG010|Overall Study|Lost to Follow-up|0|||
144202386|NCT03970837|519937073|FG011|Overall Study|Lost to Follow-up|0|||
144202387|NCT03970837|519937062|FG000|Overall Study|Protocol Violation|1|||
144202388|NCT03970837|519937063|FG001|Overall Study|Protocol Violation|0|||
144202389|NCT03970837|519937064|FG002|Overall Study|Protocol Violation|0|||
144202390|NCT03970837|519937065|FG003|Overall Study|Protocol Violation|0|||
144202391|NCT03970837|519937066|FG004|Overall Study|Protocol Violation|0|||
144202392|NCT03970837|519937067|FG005|Overall Study|Protocol Violation|0|||
144202393|NCT03970837|519937068|FG006|Overall Study|Protocol Violation|0|||
144202394|NCT03970837|519937069|FG007|Overall Study|Protocol Violation|0|||
144202395|NCT03970837|519937070|FG008|Overall Study|Protocol Violation|0|||
144202396|NCT03970837|519937071|FG009|Overall Study|Protocol Violation|0|||
144202397|NCT03970837|519937072|FG010|Overall Study|Protocol Violation|0|||
144202398|NCT03970837|519937073|FG011|Overall Study|Protocol Violation|0|||
144202399|NCT03970837|519937062|FG000|Overall Study|Physician Decision|5|||
144202400|NCT03970837|519937063|FG001|Overall Study|Physician Decision|8|||
144202401|NCT03970837|519937064|FG002|Overall Study|Physician Decision|4|||
144202402|NCT03970837|519937065|FG003|Overall Study|Physician Decision|1|||
144202403|NCT03970837|519937066|FG004|Overall Study|Physician Decision|5|||
144202404|NCT03970837|519937067|FG005|Overall Study|Physician Decision|2|||
144202405|NCT03970837|519937068|FG006|Overall Study|Physician Decision|4|||
144202406|NCT03970837|519937069|FG007|Overall Study|Physician Decision|5|||
144202407|NCT03970837|519937070|FG008|Overall Study|Physician Decision|0|||
144543996|NCT01970878|521192250|FG003|Overall Study|Physician Decision|0|||
144543997|NCT01970878|521192247|FG000|Overall Study|No Completion Status|0|||
144543998|NCT01970878|521192248|FG001|Overall Study|No Completion Status|1|||
144543999|NCT01970878|521192249|FG002|Overall Study|No Completion Status|0|||
144544000|NCT01970878|521192250|FG003|Overall Study|No Completion Status|0|||
144544001|NCT06571695|521192251|FG000|Overall Study|Lost to Follow-up|1|||
144544002|NCT06571695|521192252|FG001|Overall Study|Lost to Follow-up|6|||
144202408|NCT03970837|519937071|FG009|Overall Study|Physician Decision|1|||
144202409|NCT03970837|519937072|FG010|Overall Study|Physician Decision|0|||
144544003|NCT04921358|521192253|FG000|Overall Study|Withdrawal by Subject|6|||
144544004|NCT04921358|521192254|FG001|Overall Study|Withdrawal by Subject|13|||
144544005|NCT04921358|521192253|FG000|Overall Study|Lost to Follow-up|3|||
144544006|NCT04921358|521192254|FG001|Overall Study|Lost to Follow-up|6|||
144544007|NCT04921358|521192253|FG000|Overall Study|Study Terminated by Sponsor|86|||
144544008|NCT04921358|521192254|FG001|Overall Study|Study Terminated by Sponsor|89|||
144544009|NCT04921358|521192253|FG000|Overall Study|Death|92|||
144544010|NCT04921358|521192254|FG001|Overall Study|Death|82|||
144544011|NCT04926857|521192255|FG000|Overall Study|Withdrawal by Subject|40|||
144544012|NCT04926857|521192255|FG000|Overall Study|Death|9|||
144544013|NCT04926857|521192255|FG000|Overall Study|Study product no longer in use|44|||
144544014|NCT04926857|521192255|FG000|Overall Study|Inadequate data to address primary objective|16|||
144544015|NCT02637063|521192256|FG000|Overall Study|Lost to Follow-up|3|||
144544016|NCT02637063|521192257|FG001|Overall Study|Lost to Follow-up|2|||
144544017|NCT02637063|521192258|FG002|Overall Study|Lost to Follow-up|3|||
144544018|NCT02637063|521192256|FG000|Overall Study|Withdrawal by Subject|2|||
144544019|NCT02637063|521192257|FG001|Overall Study|Withdrawal by Subject|2|||
144544020|NCT02637063|521192258|FG002|Overall Study|Withdrawal by Subject|3|||
144544021|NCT02132949|521192263|FG000|Overall Study|Death|7|||
144544022|NCT02132949|521192264|FG001|Overall Study|Death|13|||
144544023|NCT02132949|521192263|FG000|Overall Study|Lost to Follow-up|14|||
144544024|NCT02132949|521192264|FG001|Overall Study|Lost to Follow-up|4|||
144544025|NCT02132949|521192263|FG000|Overall Study|Withdrawal by Subject|6|||
144544026|NCT02132949|521192264|FG001|Overall Study|Withdrawal by Subject|5|||
144544027|NCT02132949|521192263|FG000|Overall Study|Noncompliance|5|||
144544028|NCT02132949|521192264|FG001|Overall Study|Noncompliance|1|||
144544029|NCT02132949|521192263|FG000|Overall Study|Physician Decision|3|||
144261692|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
144544030|NCT02132949|521192264|FG001|Overall Study|Physician Decision|1|||
144544031|NCT02132949|521192263|FG000|Overall Study|Disease Progression|3|||
144544032|NCT02132949|521192264|FG001|Overall Study|Disease Progression|0|||
144544033|NCT02132949|521192263|FG000|Overall Study|Adverse Event|2|||
144261693|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261694|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261695|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261696|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261697|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
144261698|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261699|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261700|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261701|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261702|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261703|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
144261704|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261705|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
144261706|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261707|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261708|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261709|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261710|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261711|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144544034|NCT02132949|521192264|FG001|Overall Study|Adverse Event|1|||
144544035|NCT02132949|521192263|FG000|Overall Study|Withdrew Prior to Treatment|1|||
144544036|NCT02132949|521192264|FG001|Overall Study|Withdrew Prior to Treatment|2|||
144544037|NCT02132949|521192263|FG000|Overall Study|Reason Unspecified|0|||
144544038|NCT02132949|521192264|FG001|Overall Study|Reason Unspecified|1|||
144544039|NCT00745875|521192268|FG000|Overall Study|Continuing study treatment|4|||
144544040|NCT00745875|521192269|FG001|Overall Study|Continuing study treatment|4|||
144544041|NCT02310581|521192270|FG000|Overall Study|Adverse Event|1|||
144544042|NCT02310581|521192271|FG001|Overall Study|Adverse Event|1|||
144544043|NCT02310581|521192272|FG002|Overall Study|Adverse Event|1|||
144544044|NCT02310581|521192273|FG003|Overall Study|Adverse Event|0|||
144544045|NCT02310581|521192270|FG000|Overall Study|Withdrawal by Subject|2|||
144544046|NCT02310581|521192271|FG001|Overall Study|Withdrawal by Subject|1|||
144544047|NCT02310581|521192272|FG002|Overall Study|Withdrawal by Subject|0|||
144544048|NCT02310581|521192273|FG003|Overall Study|Withdrawal by Subject|1|||
144544049|NCT02824198|521192274|FG000|Overall Study|Non-compliance with the protocol|5|||
144544050|NCT02824198|521192275|FG001|Overall Study|Non-compliance with the protocol|1|||
144544051|NCT02824198|521192274|FG000|Overall Study|Lost to Follow-up|5|||
144544052|NCT02824198|521192275|FG001|Overall Study|Lost to Follow-up|2|||
144544053|NCT02824198|521192274|FG000|Overall Study|Withdrawal by Subject|5|||
144544054|NCT02824198|521192275|FG001|Overall Study|Withdrawal by Subject|0|||
144544055|NCT03883828|521192276|FG000|Overall Study|Did not start radiotherapy|1|||
144544056|NCT03883828|521192277|FG001|Overall Study|Did not start radiotherapy|2|||
144261712|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144261713|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144544057|NCT01256359|521192278|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
144544058|NCT01256359|521192279|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
144544059|NCT01256359|521192278|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
144544060|NCT01256359|521192279|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
144544061|NCT04693637|521192287|FG000|Overall Study|Death|4|||
144544062|NCT04693637|521192287|FG000|Overall Study|Withdrawal by Subject|3|||
144544063|NCT04693637|521192287|FG000|Overall Study|Physician Decision|2|||
144544064|NCT04693637|521192287|FG000|Overall Study|Lost to Follow-up|1|||
144544065|NCT04885998|521192288|FG000|Overall Study|Withdrawal by Subject|0|||
144544066|NCT04885998|521192289|FG001|Overall Study|Withdrawal by Subject|2|||
144544067|NCT04885998|521192290|FG002|Overall Study|Withdrawal by Subject|0|||
144544068|NCT04885998|521192291|FG003|Overall Study|Withdrawal by Subject|3|||
144544069|NCT04885998|521192288|FG000|Overall Study|Lost to Follow-up|1|||
144544070|NCT04885998|521192289|FG001|Overall Study|Lost to Follow-up|1|||
144544071|NCT04885998|521192290|FG002|Overall Study|Lost to Follow-up|0|||
144544072|NCT04885998|521192291|FG003|Overall Study|Lost to Follow-up|0|||
144544073|NCT04885998|521192288|FG000|Overall Study|Death|2|||
144544074|NCT04885998|521192289|FG001|Overall Study|Death|1|||
144544075|NCT04885998|521192290|FG002|Overall Study|Death|2|||
144544076|NCT04885998|521192291|FG003|Overall Study|Death|2|||
144544077|NCT04885998|521192288|FG000|Overall Study|Decision by sponsor|1|||
144544078|NCT04885998|521192289|FG001|Overall Study|Decision by sponsor|1|||
144544079|NCT04885998|521192290|FG002|Overall Study|Decision by sponsor|0|||
144544080|NCT04885998|521192291|FG003|Overall Study|Decision by sponsor|0|||
144544081|NCT03781375|521192296|FG000|Double-blind Phase|Adverse Event|0|||
144544082|NCT03781375|521192297|FG001|Double-blind Phase|Adverse Event|1|||
144544083|NCT03781375|521192296|FG000|Double-blind Phase|Lack of Response|6|||
144544084|NCT03781375|521192297|FG001|Double-blind Phase|Lack of Response|2|||
144544085|NCT03781375|521192296|FG000|Double-blind Phase|Other|1|||
144544086|NCT03781375|521192297|FG001|Double-blind Phase|Other|3|||
144544087|NCT03781375|521192296|FG000|Open-label Phase|Protocol Issues|0|||
144544088|NCT03781375|521192297|FG001|Open-label Phase|Protocol Issues|1|||
144544089|NCT03781375|521192296|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
144544090|NCT03781375|521192297|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
144261714|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261715|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261716|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144544091|NCT03781375|521192296|FG000|Open-label Phase|Other|2|||
144544092|NCT03781375|521192297|FG001|Open-label Phase|Other|2|||
144544093|NCT01034306|521192299|FG000|Overall Study|Adverse Event|1|||
144544094|NCT01034306|521192300|FG001|Overall Study|Adverse Event|0|||
144544095|NCT01034306|521192299|FG000|Overall Study|Lost to Follow-up|0|||
144544096|NCT01034306|521192300|FG001|Overall Study|Lost to Follow-up|1|||
144544097|NCT01034306|521192299|FG000|Overall Study|Withdrawal by Subject|2|||
144544098|NCT01034306|521192300|FG001|Overall Study|Withdrawal by Subject|2|||
144544099|NCT01034306|521192299|FG000|Overall Study|hospitalized and decided to stop|1|||
144544100|NCT01034306|521192300|FG001|Overall Study|hospitalized and decided to stop|0|||
144544101|NCT01034306|521192299|FG000|Overall Study|Noncomplience|1|||
144544102|NCT01034306|521192300|FG001|Overall Study|Noncomplience|0|||
144544103|NCT02203799|521192301|FG000|Overall Study|Withdrawal by Subject|3|||
144544104|NCT02384382|521192302|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
144544105|NCT02384382|521192302|FG000|Overall Study|Death|1|||
144544106|NCT02384382|521192302|FG000|Overall Study|Adverse Event|1|||
144544107|NCT02384382|521192302|FG000|Overall Study|Disease progression|16|||
144544108|NCT02113449|521192303|FG000|Overall Study|Adverse Event|4|||
144544109|NCT01328496|521192304|FG000|Overall Study|Significant Change in Health Status|1|||
144544110|NCT01328496|521192305|FG001|Overall Study|Significant Change in Health Status|0|||
144544111|NCT02091752|521192308|FG000|Overall Study|Study terminated by Sponsor|2|||
144544112|NCT02091752|521192308|FG000|Overall Study|Adverse Event|1|||
144544113|NCT04029090|521192309|FG000|Overall Study|Protocol Violation|1|||
144544114|NCT04029090|521192310|FG001|Overall Study|Protocol Violation|0|||
144261717|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261718|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
144544115|NCT04029090|521192311|FG002|Overall Study|Protocol Violation|0|||
144544116|NCT04029090|521192309|FG000|Overall Study|Withdrawal by Subject|0|||
144544117|NCT04029090|521192310|FG001|Overall Study|Withdrawal by Subject|1|||
144544118|NCT04029090|521192311|FG002|Overall Study|Withdrawal by Subject|0|||
144544119|NCT01065779|521192312|FG000|Overall Study|Duplicate Investigation|1|||
144544120|NCT01065779|521192312|FG000|Overall Study|Investigation Before Contract Date|37|||
144544121|NCT01065779|521192312|FG000|Overall Study|Non-enrollment Period Administration|10|||
144544122|NCT01065779|521192312|FG000|Overall Study|Not Administered With Study Drug|17|||
144544123|NCT01065779|521192312|FG000|Overall Study|Failed to Follow-up|10|||
144544124|NCT01065779|521192312|FG000|Overall Study|Inclusion Criteria Violation|7|||
144544125|NCT02157948|521192313|FG000|Overall Study|Withdrawal by Subject|4|||
144544126|NCT02157948|521192314|FG001|Overall Study|Withdrawal by Subject|5|||
144544127|NCT02157948|521192313|FG000|Overall Study|Lost to Follow-up|3|||
144544128|NCT02157948|521192314|FG001|Overall Study|Lost to Follow-up|2|||
144544129|NCT02157948|521192313|FG000|Overall Study|Protocol Specified Criteria|2|||
144544130|NCT02157948|521192314|FG001|Overall Study|Protocol Specified Criteria|1|||
144544131|NCT02157948|521192313|FG000|Overall Study|Decision by Sponsor|0|||
144544132|NCT02157948|521192314|FG001|Overall Study|Decision by Sponsor|1|||
144544133|NCT01604824|521192315|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
144544134|NCT01604824|521192316|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
144544135|NCT01604824|521192317|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
144544136|NCT01604824|521192318|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
144544137|NCT01604824|521192319|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
144544138|NCT01604824|521192320|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
144544139|NCT01604824|521192315|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
144544140|NCT01604824|521192316|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
144544141|NCT01604824|521192317|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
144544142|NCT01604824|521192318|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
144544143|NCT01604824|521192319|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
144544144|NCT01604824|521192320|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
144544145|NCT02630966|521192321|FG000|Overall Study|Adverse Event|1|||
144544146|NCT02630966|521192322|FG001|Overall Study|Adverse Event|3|||
144544147|NCT02630966|521192321|FG000|Overall Study|Significant Protocol Deviation|0|||
144544148|NCT02630966|521192322|FG001|Overall Study|Significant Protocol Deviation|2|||
144544149|NCT02630966|521192321|FG000|Overall Study|Voluntary Withdrawal|1|||
144544150|NCT02630966|521192322|FG001|Overall Study|Voluntary Withdrawal|1|||
144544151|NCT02630966|521192321|FG000|Overall Study|Lack of Efficacy|0|||
144544152|NCT02630966|521192322|FG001|Overall Study|Lack of Efficacy|2|||
144544153|NCT03822832|521192327|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
144544154|NCT03822832|521192328|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
144544155|NCT03822832|521192327|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
144544156|NCT03822832|521192328|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
144544157|NCT03822832|521192327|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
144544158|NCT03822832|521192328|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
144544159|NCT03822832|521192327|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
144544160|NCT03822832|521192328|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
144544161|NCT03822832|521192327|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
144544162|NCT03822832|521192328|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
144544163|NCT03822832|521192327|FG000|Re-allocation|Not re-allocated to open label period|2|||
144544164|NCT03822832|521192328|FG001|Re-allocation|Not re-allocated to open label period|6|||
144544165|NCT03822832|521192327|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
144544166|NCT03822832|521192328|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
144544167|NCT03822832|521192327|FG000|Period 2 - Open Label Period|Adverse Event|0|||
144544168|NCT03822832|521192328|FG001|Period 2 - Open Label Period|Adverse Event|3|||
144544169|NCT04248803|521192330|FG000|Overall Study|Lost to Follow-up|7|||
144544170|NCT04248803|521192331|FG001|Overall Study|Lost to Follow-up|7|||
144544171|NCT04248803|521192332|FG002|Overall Study|Lost to Follow-up|7|||
144544172|NCT04248803|521192333|FG003|Overall Study|Lost to Follow-up|7|||
144544173|NCT04248803|521192334|FG004|Overall Study|Lost to Follow-up|7|||
144544174|NCT04248803|521192335|FG005|Overall Study|Lost to Follow-up|7|||
144544175|NCT05352230|521192336|FG000|First Intervention (3 Months)|study terminated|2|||
144544176|NCT05352230|521192337|FG001|First Intervention (3 Months)|study terminated|2|||
144544177|NCT04399837|521192338|FG000|Overall Study|Other than listed|0|||
144544178|NCT04399837|521192339|FG001|Overall Study|Other than listed|2|||
144544179|NCT04399837|521192340|FG002|Overall Study|Other than listed|2|||
144544180|NCT04399837|521192341|FG003|Overall Study|Other than listed|3|||
144544181|NCT04399837|521192338|FG000|Overall Study|Withdrawal by Subject|1|||
144544182|NCT04399837|521192339|FG001|Overall Study|Withdrawal by Subject|2|||
144544183|NCT04399837|521192340|FG002|Overall Study|Withdrawal by Subject|1|||
144544184|NCT04399837|521192341|FG003|Overall Study|Withdrawal by Subject|1|||
144544185|NCT01683409|521192342|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
144544186|NCT01683409|521192343|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
144544187|NCT01683409|521192344|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
144544188|NCT01683409|521192345|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
144544189|NCT01683409|521192346|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
144544190|NCT01683409|521192342|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
144544191|NCT01683409|521192343|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
144544192|NCT01683409|521192344|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
144544193|NCT01683409|521192345|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
144544194|NCT01683409|521192346|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
144544195|NCT01683409|521192342|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
144544196|NCT01683409|521192343|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
144544197|NCT01683409|521192344|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
144544198|NCT01683409|521192345|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
144544199|NCT01683409|521192346|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
144544200|NCT01683409|521192342|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
144544201|NCT01683409|521192343|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
144544202|NCT01683409|521192344|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
144544203|NCT01683409|521192345|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
144544204|NCT01683409|521192346|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
144544205|NCT01683409|521192342|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
144544206|NCT01683409|521192343|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
144544207|NCT01683409|521192344|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
144544208|NCT01683409|521192345|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
144544209|NCT01683409|521192346|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
144261719|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144544210|NCT01683409|521192342|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
144544211|NCT01683409|521192343|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
144544212|NCT01683409|521192344|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
144544213|NCT01683409|521192345|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
144544214|NCT01683409|521192346|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
144616424|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
144616425|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
144616426|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
144616427|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
144616428|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
144616429|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
144616430|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
144616431|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
144616432|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
144261720|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144544215|NCT01683409|521192342|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
144544216|NCT01683409|521192343|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
144544217|NCT01683409|521192344|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
144544218|NCT01683409|521192345|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
144544219|NCT01683409|521192346|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
144544220|NCT01683409|521192342|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
144544221|NCT01683409|521192343|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
144544222|NCT01683409|521192344|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
144544223|NCT01683409|521192345|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
144544224|NCT01683409|521192346|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
144616433|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
144261721|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261722|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144261723|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261724|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261725|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261726|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261727|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144261728|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261729|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261730|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261731|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261732|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261733|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261734|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261735|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
144261736|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261737|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261738|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261739|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261740|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261741|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144544225|NCT01683409|521192342|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
144544226|NCT01683409|521192343|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
144544227|NCT01683409|521192344|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
144544228|NCT01683409|521192345|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
144544229|NCT01683409|521192346|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
144544230|NCT01683409|521192342|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
144544231|NCT01683409|521192343|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
144544232|NCT01683409|521192344|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
144544233|NCT01683409|521192345|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
144544234|NCT01683409|521192346|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
144544235|NCT01683409|521192342|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
144202410|NCT03970837|519937073|FG011|Overall Study|Physician Decision|0|||
144202411|NCT03970837|519937062|FG000|Overall Study|Withdrawal by Subject|32|||
144202412|NCT03970837|519937063|FG001|Overall Study|Withdrawal by Subject|35|||
144202413|NCT03970837|519937064|FG002|Overall Study|Withdrawal by Subject|12|||
144202414|NCT03970837|519937065|FG003|Overall Study|Withdrawal by Subject|8|||
144544236|NCT01683409|521192343|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
144544237|NCT01683409|521192344|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
144544238|NCT01683409|521192345|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
144544239|NCT01683409|521192346|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
144202415|NCT03970837|519937066|FG004|Overall Study|Withdrawal by Subject|6|||
144202416|NCT03970837|519937067|FG005|Overall Study|Withdrawal by Subject|8|||
144202417|NCT03970837|519937068|FG006|Overall Study|Withdrawal by Subject|2|||
144202418|NCT03970837|519937069|FG007|Overall Study|Withdrawal by Subject|3|||
144202419|NCT03970837|519937070|FG008|Overall Study|Withdrawal by Subject|0|||
144202420|NCT03970837|519937071|FG009|Overall Study|Withdrawal by Subject|0|||
144202421|NCT03970837|519937072|FG010|Overall Study|Withdrawal by Subject|0|||
144202422|NCT03970837|519937073|FG011|Overall Study|Withdrawal by Subject|1|||
144202423|NCT03970837|519937062|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
144202424|NCT03970837|519937063|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
144202425|NCT03970837|519937064|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
144202426|NCT03970837|519937065|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
144202427|NCT03970837|519937066|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
144202428|NCT03970837|519937067|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144202429|NCT03970837|519937068|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144202430|NCT03970837|519937069|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144202431|NCT03970837|519937070|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144202432|NCT03970837|519937071|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
144202433|NCT03970837|519937072|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
144202434|NCT03970837|519937073|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
144202435|NCT03970837|519937062|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144202436|NCT03970837|519937063|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144202437|NCT03970837|519937064|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144202438|NCT03970837|519937065|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144202439|NCT03970837|519937066|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144202440|NCT03970837|519937067|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144202441|NCT03970837|519937068|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
144202442|NCT03970837|519937069|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
144202443|NCT03970837|519937070|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
144202444|NCT03970837|519937071|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
144202445|NCT03970837|519937072|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
144202446|NCT03970837|519937073|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
144202447|NCT00228423|519937078|FG000|Overall Study|Adverse Event|2|||
144202448|NCT00228423|519937079|FG001|Overall Study|Adverse Event|5|||
144202449|NCT00228423|519937078|FG000|Overall Study|Withdrawal by Subject|7|||
144202450|NCT00228423|519937079|FG001|Overall Study|Withdrawal by Subject|3|||
144202451|NCT00228423|519937078|FG000|Overall Study|Protocol Violation|1|||
144202452|NCT00228423|519937079|FG001|Overall Study|Protocol Violation|3|||
144202453|NCT00228423|519937078|FG000|Overall Study|Physician Decision|0|||
144202454|NCT00228423|519937079|FG001|Overall Study|Physician Decision|1|||
144202455|NCT03870477|519937088|FG000|Overall Study|Early Study Termination|1|||
144202456|NCT04555720|519937089|FG000|Overall Study|Lost to Follow-up|2|||
144202457|NCT04555720|519937090|FG001|Overall Study|Lost to Follow-up|0|||
144202458|NCT04555720|519937091|FG002|Overall Study|Lost to Follow-up|0|||
144202459|NCT04555720|519937092|FG003|Overall Study|Lost to Follow-up|0|||
144202460|NCT04555720|519937089|FG000|Overall Study|Withdrawal by Subject|4|||
144202461|NCT04555720|519937090|FG001|Overall Study|Withdrawal by Subject|6|||
144202462|NCT04555720|519937091|FG002|Overall Study|Withdrawal by Subject|0|||
144202463|NCT04555720|519937092|FG003|Overall Study|Withdrawal by Subject|0|||
144202464|NCT00719849|519937093|FG000|Overall Study|Death|0|||
144202465|NCT00719849|519937094|FG001|Overall Study|Death|1|||
144202466|NCT02201290|519937096|FG000|Overall Study|Withdrawal by Subject|2|||
144202467|NCT02201290|519937096|FG000|Overall Study|Lack of Efficacy|2|||
144202468|NCT02201290|519937096|FG000|Overall Study|Adverse Event|1|||
144202469|NCT03907462|519937097|FG000|Overall Study|Physician Decision|1|||
144202470|NCT03907462|519937098|FG001|Overall Study|Physician Decision|3|||
144544240|NCT04218864|521192347|FG000|Overall Study|Lost to Follow-up|8|||
144261742|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
144261743|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261744|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261745|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144544241|NCT04218864|521192348|FG001|Overall Study|Lost to Follow-up|4|||
144544242|NCT04218864|521192347|FG000|Overall Study|Withdrawal by Subject|1|||
144544243|NCT04218864|521192348|FG001|Overall Study|Withdrawal by Subject|3|||
144544244|NCT03520036|521192349|FG000|Overall Study|Adverse Event|1|||
144544245|NCT03520036|521192350|FG001|Overall Study|Adverse Event|2|||
144544246|NCT03520036|521192351|FG002|Overall Study|Adverse Event|0|||
144544247|NCT03520036|521192349|FG000|Overall Study|Protocol Violation|1|||
144544248|NCT03520036|521192350|FG001|Overall Study|Protocol Violation|0|||
144544249|NCT03520036|521192351|FG002|Overall Study|Protocol Violation|0|||
144544250|NCT03520036|521192349|FG000|Overall Study|Withdrawal by Subject|0|||
144544251|NCT03520036|521192350|FG001|Overall Study|Withdrawal by Subject|1|||
144544252|NCT03520036|521192351|FG002|Overall Study|Withdrawal by Subject|4|||
144544253|NCT03520036|521192349|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
144544254|NCT03520036|521192350|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
144544255|NCT03520036|521192351|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
144544256|NCT01227421|521192352|FG000|Overall Study|Lost to Follow-up|6|||
144544257|NCT01227421|521192353|FG001|Overall Study|Lost to Follow-up|7|||
144544258|NCT01227421|521192354|FG002|Overall Study|Lost to Follow-up|5|||
144544259|NCT01227421|521192352|FG000|Overall Study|Adverse Event|2|||
144544260|NCT01227421|521192353|FG001|Overall Study|Adverse Event|7|||
144544261|NCT01227421|521192354|FG002|Overall Study|Adverse Event|2|||
144544262|NCT01227421|521192352|FG000|Overall Study|Withdrawal by Subject|1|||
144544263|NCT01227421|521192353|FG001|Overall Study|Withdrawal by Subject|2|||
144544264|NCT01227421|521192354|FG002|Overall Study|Withdrawal by Subject|1|||
144544265|NCT01227421|521192352|FG000|Overall Study|Protocol Violation|1|||
144544266|NCT01227421|521192353|FG001|Overall Study|Protocol Violation|1|||
144544267|NCT01227421|521192354|FG002|Overall Study|Protocol Violation|2|||
144544268|NCT01227421|521192352|FG000|Overall Study|Randomized in error|1|||
144544269|NCT01227421|521192353|FG001|Overall Study|Randomized in error|1|||
144544270|NCT01227421|521192354|FG002|Overall Study|Randomized in error|0|||
144544271|NCT01827839|521192357|FG000|Overall Study|Adverse Event|1|||
144544272|NCT01827839|521192357|FG000|Overall Study|Consent Withdrawal|2|||
144544273|NCT00614614|521192360|FG000|Primary Vaccination Phase|Adverse Event|6|||
144544274|NCT00614614|521192361|FG001|Primary Vaccination Phase|Adverse Event|0|||
144261746|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261747|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261748|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261749|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
144261750|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261751|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261752|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261753|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261754|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261755|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261756|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261757|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144261758|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261759|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261760|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144544275|NCT00614614|521192362|FG002|Primary Vaccination Phase|Adverse Event|0|||
144544276|NCT00614614|521192363|FG003|Primary Vaccination Phase|Adverse Event|0|||
144544277|NCT00614614|521192364|FG004|Primary Vaccination Phase|Adverse Event|0|||
144544278|NCT00614614|521192360|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
144544279|NCT00614614|521192361|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
144544280|NCT00614614|521192362|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
144544281|NCT00614614|521192363|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
144544282|NCT00614614|521192364|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
144544283|NCT00614614|521192360|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
144616434|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
144261761|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261762|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261763|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144544284|NCT00614614|521192361|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
144544285|NCT00614614|521192362|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
144544286|NCT00614614|521192363|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
144544287|NCT00614614|521192364|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
144544288|NCT00614614|521192360|FG000|Primary Vaccination Phase|Protocol Violation|9|||
144261764|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261765|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261766|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
144261767|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261768|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261769|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261770|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261771|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261772|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
144261773|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261774|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261775|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261776|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261777|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261778|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
144261779|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
144261780|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
144261781|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
144261782|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261783|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261784|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261785|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261786|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261787|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
144261788|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261789|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261790|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261791|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261792|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261793|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
144261794|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261795|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261796|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261797|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261798|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261799|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261800|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261801|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261802|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
144261803|NCT02326272|520159714|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261804|NCT02326272|520159715|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261805|NCT02326272|520159716|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261806|NCT02326272|520159717|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261807|NCT02326272|520159718|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261808|NCT02326272|520159719|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261809|NCT02326272|520159720|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
144261810|NCT02326272|520159721|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261811|NCT02326272|520159722|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261812|NCT02326272|520159723|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261813|NCT02326272|520159724|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261814|NCT02326272|520159725|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261815|NCT02326272|520159726|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261816|NCT02326272|520159727|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261817|NCT02326272|520159728|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
144261818|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
144261819|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
144261820|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
144616435|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
144616436|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
144616437|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
144544289|NCT00614614|521192361|FG001|Primary Vaccination Phase|Protocol Violation|3|||
144544290|NCT00614614|521192362|FG002|Primary Vaccination Phase|Protocol Violation|0|||
144544291|NCT00614614|521192363|FG003|Primary Vaccination Phase|Protocol Violation|0|||
144544292|NCT00614614|521192364|FG004|Primary Vaccination Phase|Protocol Violation|0|||
144544293|NCT00614614|521192360|FG000|Primary Vaccination Phase|Other|4|||
144544294|NCT00614614|521192361|FG001|Primary Vaccination Phase|Other|0|||
144544295|NCT00614614|521192362|FG002|Primary Vaccination Phase|Other|0|||
144544296|NCT00614614|521192363|FG003|Primary Vaccination Phase|Other|0|||
144544297|NCT00614614|521192364|FG004|Primary Vaccination Phase|Other|0|||
144544298|NCT00614614|521192360|FG000|Booster Vaccination Phase|Adverse Event|0|||
144544299|NCT00614614|521192361|FG001|Booster Vaccination Phase|Adverse Event|0|||
144544300|NCT00614614|521192362|FG002|Booster Vaccination Phase|Adverse Event|1|||
144544301|NCT00614614|521192363|FG003|Booster Vaccination Phase|Adverse Event|1|||
144544302|NCT00614614|521192364|FG004|Booster Vaccination Phase|Adverse Event|0|||
144544303|NCT00614614|521192360|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
144544304|NCT00614614|521192361|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
144544305|NCT00614614|521192362|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
144544306|NCT00614614|521192363|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
144544307|NCT00614614|521192364|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
144544308|NCT00614614|521192360|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
144544309|NCT00614614|521192361|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
144544310|NCT00614614|521192362|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
144544311|NCT00614614|521192363|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
144544312|NCT00614614|521192364|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
144544313|NCT00614614|521192360|FG000|Booster Vaccination Phase|Protocol Violation|0|||
144544314|NCT00614614|521192361|FG001|Booster Vaccination Phase|Protocol Violation|0|||
144544315|NCT00614614|521192362|FG002|Booster Vaccination Phase|Protocol Violation|2|||
144544316|NCT00614614|521192363|FG003|Booster Vaccination Phase|Protocol Violation|3|||
144544317|NCT00614614|521192364|FG004|Booster Vaccination Phase|Protocol Violation|0|||
144544318|NCT00614614|521192360|FG000|Booster Vaccination Phase|Other|0|||
144544319|NCT00614614|521192361|FG001|Booster Vaccination Phase|Other|1|||
144544320|NCT00614614|521192362|FG002|Booster Vaccination Phase|Other|3|||
144544321|NCT00614614|521192363|FG003|Booster Vaccination Phase|Other|2|||
144544322|NCT00614614|521192364|FG004|Booster Vaccination Phase|Other|1|||
144616438|NCT03605680|521456318|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
144616439|NCT03605680|521456319|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
144616440|NCT03605680|521456320|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
144616441|NCT03605680|521456321|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
144616442|NCT03189446|521456322|FG000|Overall Study|Adverse Event|2|||
144616443|NCT03189446|521456322|FG000|Overall Study|Withdrawal by Subject|2|||
144616444|NCT03189446|521456322|FG000|Overall Study|Physician Decision|1|||
144616445|NCT00647556|521456323|FG000|Overall Study|Adverse Event|0|||
144616446|NCT00647556|521456324|FG001|Overall Study|Adverse Event|1|||
144616447|NCT00647556|521456323|FG000|Overall Study|Lost to Follow-up|1|||
144616448|NCT00647556|521456324|FG001|Overall Study|Lost to Follow-up|0|||
144202471|NCT03907462|519937099|FG002|Overall Study|Physician Decision|1|||
144202472|NCT03907462|519937097|FG000|Overall Study|Withdrawal by Subject|6|||
144202473|NCT03907462|519937098|FG001|Overall Study|Withdrawal by Subject|3|||
144202474|NCT03907462|519937099|FG002|Overall Study|Withdrawal by Subject|3|||
144202475|NCT03907462|519937097|FG000|Overall Study|Pregnancy|4|||
144202476|NCT03907462|519937098|FG001|Overall Study|Pregnancy|2|||
144202477|NCT03907462|519937099|FG002|Overall Study|Pregnancy|6|||
144202478|NCT03907462|519937097|FG000|Overall Study|Lost to Follow-up|16|||
144202479|NCT03907462|519937098|FG001|Overall Study|Lost to Follow-up|18|||
144202480|NCT03907462|519937099|FG002|Overall Study|Lost to Follow-up|22|||
144202481|NCT02370329|519940185|FG000|Overall Study|Alternate treatment|1|||
144202482|NCT02370329|519940185|FG000|Overall Study|Adverse Event|1|||
144202483|NCT02370329|519940185|FG000|Overall Study|Disease progression|3|||
144202484|NCT02370329|519940185|FG000|Overall Study|Physician Decision|2|||
144202485|NCT02370329|519940185|FG000|Overall Study|Study closure|4|||
144202486|NCT03283319|519940190|FG000|Overall Study|Lost to Follow-up|5|||
144202487|NCT03283319|519940191|FG001|Overall Study|Lost to Follow-up|4|||
144202488|NCT03283319|519940192|FG002|Overall Study|Lost to Follow-up|5|||
144202489|NCT03283319|519940193|FG003|Overall Study|Lost to Follow-up|5|||
144202490|NCT03283319|519940194|FG004|Overall Study|Lost to Follow-up|4|||
144202491|NCT03283319|519940195|FG005|Overall Study|Lost to Follow-up|3|||
144202492|NCT03283319|519940190|FG000|Overall Study|Withdrawal by Subject|2|||
144202493|NCT03283319|519940191|FG001|Overall Study|Withdrawal by Subject|2|||
144202494|NCT03283319|519940192|FG002|Overall Study|Withdrawal by Subject|2|||
144544323|NCT04745676|521192365|FG000|Overall Study|Death|1|||
144544324|NCT04745676|521192366|FG001|Overall Study|Death|0|||
144202495|NCT03283319|519940193|FG003|Overall Study|Withdrawal by Subject|1|||
144544325|NCT04745676|521192367|FG002|Overall Study|Death|0|||
144202496|NCT03283319|519940194|FG004|Overall Study|Withdrawal by Subject|0|||
144202497|NCT03283319|519940195|FG005|Overall Study|Withdrawal by Subject|1|||
144202498|NCT03283319|519940190|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
144202499|NCT03283319|519940191|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
144202500|NCT03283319|519940192|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
144544326|NCT05426109|521192368|FG000|Overall Study|Withdrawal by Subject|0|||
144544327|NCT05426109|521192369|FG001|Overall Study|Withdrawal by Subject|1|||
144544328|NCT03683030|521192370|FG000|Overall Study|Enrolled but screen failures|12|||
144544329|NCT03683030|521192371|FG001|Overall Study|Enrolled but screen failures|7|||
144544330|NCT03683030|521192370|FG000|Overall Study|Enrolled but no catheter inserted|11|||
144202501|NCT03283319|519940193|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
144202502|NCT03283319|519940194|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
144202503|NCT03283319|519940195|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
144202504|NCT03954834|519940196|FG000|Overall Study|Adverse Event|1|||
144202505|NCT03954834|519940197|FG001|Overall Study|Adverse Event|3|||
144202506|NCT03954834|519940198|FG002|Overall Study|Adverse Event|1|||
144202507|NCT03954834|519940199|FG003|Overall Study|Adverse Event|1|||
144202508|NCT03954834|519940196|FG000|Overall Study|Death|0|||
144202509|NCT03954834|519940197|FG001|Overall Study|Death|0|||
144202510|NCT03954834|519940198|FG002|Overall Study|Death|0|||
144202511|NCT03954834|519940199|FG003|Overall Study|Death|1|||
144202512|NCT03954834|519940196|FG000|Overall Study|Physician Decision|0|||
144202513|NCT03954834|519940197|FG001|Overall Study|Physician Decision|1|||
144202514|NCT03954834|519940198|FG002|Overall Study|Physician Decision|0|||
144202515|NCT03954834|519940199|FG003|Overall Study|Physician Decision|2|||
144202516|NCT03954834|519940196|FG000|Overall Study|Protocol Violation|1|||
144202517|NCT03954834|519940197|FG001|Overall Study|Protocol Violation|0|||
144202518|NCT03954834|519940198|FG002|Overall Study|Protocol Violation|0|||
144202519|NCT03954834|519940199|FG003|Overall Study|Protocol Violation|1|||
144202520|NCT03954834|519940196|FG000|Overall Study|Withdrawal by Subject|2|||
144202521|NCT03954834|519940197|FG001|Overall Study|Withdrawal by Subject|3|||
144202522|NCT03954834|519940198|FG002|Overall Study|Withdrawal by Subject|13|||
144202523|NCT03954834|519940199|FG003|Overall Study|Withdrawal by Subject|6|||
144202524|NCT03954834|519940196|FG000|Overall Study|Participant left the country|0|||
144202525|NCT03954834|519940197|FG001|Overall Study|Participant left the country|0|||
144202526|NCT03954834|519940198|FG002|Overall Study|Participant left the country|1|||
144202527|NCT03954834|519940199|FG003|Overall Study|Participant left the country|0|||
144202528|NCT03954834|519940196|FG000|Overall Study|Lost to Follow-up|3|||
144202529|NCT03954834|519940197|FG001|Overall Study|Lost to Follow-up|2|||
144202530|NCT03954834|519940198|FG002|Overall Study|Lost to Follow-up|3|||
144202531|NCT03954834|519940199|FG003|Overall Study|Lost to Follow-up|5|||
144202532|NCT03786718|519940204|FG000|Overall Study|Lost to Follow-up|3|||
144202533|NCT03786718|519940204|FG000|Overall Study|Withdrawal by Subject|1|||
144202534|NCT03786718|519940204|FG000|Overall Study|Did not use the intervention|2|||
144202535|NCT03786718|519940204|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
144202536|NCT00372411|519940213|FG000|Overall Study|Withdrawal by Subject|3|||
144202537|NCT00372411|519940214|FG001|Overall Study|Withdrawal by Subject|4|||
144202538|NCT00372411|519940215|FG002|Overall Study|Withdrawal by Subject|1|||
144202539|NCT00372411|519940213|FG000|Overall Study|Death|0|||
144202540|NCT00372411|519940214|FG001|Overall Study|Death|2|||
144202541|NCT00372411|519940215|FG002|Overall Study|Death|1|||
144202542|NCT00372411|519940213|FG000|Overall Study|Lost to Follow-up|1|||
144202543|NCT00372411|519940214|FG001|Overall Study|Lost to Follow-up|1|||
144202544|NCT00372411|519940215|FG002|Overall Study|Lost to Follow-up|1|||
144202545|NCT00372411|519940213|FG000|Overall Study|Adverse Event|1|||
144202546|NCT00372411|519940214|FG001|Overall Study|Adverse Event|1|||
144202547|NCT00372411|519940215|FG002|Overall Study|Adverse Event|0|||
144202548|NCT01398514|519940216|FG000|Overall Study|Adverse Event|1|||
144202549|NCT01398514|519940217|FG001|Overall Study|Adverse Event|0|||
144202550|NCT01398514|519940216|FG000|Overall Study|Non-compliance with study procedures|2|||
144202551|NCT01398514|519940217|FG001|Overall Study|Non-compliance with study procedures|0|||
144202552|NCT01398514|519940216|FG000|Overall Study|Physiologic non-responsiveness|1|||
144202553|NCT01398514|519940217|FG001|Overall Study|Physiologic non-responsiveness|3|||
144202554|NCT01398514|519940216|FG000|Overall Study|Failure to show a conditioned response|4|||
144202555|NCT01398514|519940217|FG001|Overall Study|Failure to show a conditioned response|3|||
144616449|NCT00647556|521456323|FG000|Overall Study|Protocol Violation|0|||
144202556|NCT00805675|519940218|FG000|Overall Study|Adverse Event|0|||
144202557|NCT00805675|519940219|FG001|Overall Study|Adverse Event|0|||
144202558|NCT00805675|519940220|FG002|Overall Study|Adverse Event|1|||
144202559|NCT02906930|519940221|FG000|Overall Study|Withdrawal by Subject|0|||
144202560|NCT02906930|519940222|FG001|Overall Study|Withdrawal by Subject|5|||
144616450|NCT00647556|521456324|FG001|Overall Study|Protocol Violation|1|||
144616451|NCT00647556|521456323|FG000|Overall Study|Withdrawal by Subject|1|||
144616452|NCT00647556|521456324|FG001|Overall Study|Withdrawal by Subject|0|||
144616453|NCT00647556|521456323|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
144616454|NCT00647556|521456324|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
144616455|NCT03865706|521456326|FG000|Overall Study|Death|0|||
144616456|NCT03865706|521456327|FG001|Overall Study|Death|3|||
144616457|NCT03865706|521456328|FG002|Overall Study|Death|1|||
144544331|NCT03683030|521192371|FG001|Overall Study|Enrolled but no catheter inserted|13|||
144544332|NCT03683030|521192370|FG000|Overall Study|Withdrawal by Subject|0|||
144544333|NCT03683030|521192371|FG001|Overall Study|Withdrawal by Subject|2|||
144544334|NCT03683030|521192370|FG000|Overall Study|Early termination by subject|1|||
144544335|NCT03683030|521192371|FG001|Overall Study|Early termination by subject|0|||
144544336|NCT03683030|521192370|FG000|Overall Study|Lost to Follow-up|0|||
144544337|NCT03683030|521192371|FG001|Overall Study|Lost to Follow-up|6|||
144544338|NCT03683030|521192370|FG000|Overall Study|Death|0|||
144544339|NCT03683030|521192371|FG001|Overall Study|Death|2|||
144544340|NCT03683030|521192370|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
144544341|NCT03683030|521192371|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
144544342|NCT00302211|521192375|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
144544343|NCT00302211|521192376|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
144544344|NCT00302211|521192377|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
144544345|NCT00302211|521192378|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
144544346|NCT00302211|521192379|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
144544347|NCT00302211|521192375|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
144544348|NCT00302211|521192376|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
144544349|NCT00302211|521192377|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
144544350|NCT00302211|521192378|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
144544351|NCT00302211|521192379|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
144544352|NCT00302211|521192375|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
144544353|NCT00302211|521192376|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
144544354|NCT00302211|521192377|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
144544355|NCT00302211|521192378|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
144544356|NCT00302211|521192379|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
144544357|NCT00302211|521192375|FG000|Double Blind Period (New Patients)|Disease progression|0|||
144544358|NCT00302211|521192376|FG001|Double Blind Period (New Patients)|Disease progression|1|||
144544359|NCT00302211|521192377|FG002|Double Blind Period (New Patients)|Disease progression|1|||
144544360|NCT00302211|521192378|FG003|Double Blind Period (New Patients)|Disease progression|0|||
144544361|NCT00302211|521192379|FG004|Double Blind Period (New Patients)|Disease progression|0|||
144544362|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
144544363|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
144544364|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
144544365|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
144544366|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
144544367|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
144544368|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
144544369|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
144544370|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
144544371|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
144544372|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
144544373|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
144544374|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
144544375|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
144544376|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
144544377|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
144544378|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
144544379|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
144544380|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
144544381|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
144544382|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Death|0|||
144544383|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Death|0|||
144544384|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Death|0|||
144544385|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Death|1|||
144544386|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Death|1|||
144544387|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
144544388|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
144544389|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
144544390|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
144544391|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
144544392|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
144544393|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
144544394|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
144544395|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
144544396|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
144202561|NCT02906930|519940223|FG002|Overall Study|Withdrawal by Subject|5|||
144202562|NCT02906930|519940224|FG003|Overall Study|Withdrawal by Subject|4|||
144202563|NCT02906930|519940221|FG000|Overall Study|Lost to Follow-up|5|||
144202564|NCT02906930|519940222|FG001|Overall Study|Lost to Follow-up|7|||
144202565|NCT02906930|519940223|FG002|Overall Study|Lost to Follow-up|5|||
144544397|NCT00302211|521192375|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
144544398|NCT00302211|521192376|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
144544399|NCT00302211|521192377|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
144544400|NCT00302211|521192378|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
144544401|NCT00302211|521192379|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
144544402|NCT05432986|521192382|FG000|Overall Study|Withdrawal by Subject|2|||
144544403|NCT05432986|521192382|FG000|Overall Study|incomplete measurement|7|||
144544404|NCT00597376|521193633|FG000|Overall Study|Withdrawal by Subject|4|||
144544405|NCT00597376|521193634|FG001|Overall Study|Withdrawal by Subject|3|||
144544406|NCT00597376|521193633|FG000|Overall Study|Adverse Event|4|||
144544407|NCT00597376|521193634|FG001|Overall Study|Adverse Event|1|||
144544408|NCT02634307|521193635|FG000|Overall Study|Adverse Event|50|||
144544409|NCT02634307|521193636|FG001|Overall Study|Adverse Event|24|||
144544410|NCT02634307|521193637|FG002|Overall Study|Adverse Event|14|||
144544411|NCT02634307|521193635|FG000|Overall Study|Lost to Follow-up|21|||
144544412|NCT02634307|521193636|FG001|Overall Study|Lost to Follow-up|5|||
144544413|NCT02634307|521193637|FG002|Overall Study|Lost to Follow-up|6|||
144261821|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
144261822|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
144202566|NCT02906930|519940224|FG003|Overall Study|Lost to Follow-up|2|||
144202567|NCT02906930|519940221|FG000|Overall Study|Death|0|||
144202568|NCT02906930|519940222|FG001|Overall Study|Death|0|||
144202569|NCT02906930|519940223|FG002|Overall Study|Death|1|||
144202570|NCT02906930|519940224|FG003|Overall Study|Death|0|||
144202571|NCT02906930|519940221|FG000|Overall Study|Other|1|||
144202572|NCT02906930|519940222|FG001|Overall Study|Other|2|||
144202573|NCT02906930|519940223|FG002|Overall Study|Other|1|||
144261823|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
144261824|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
144261825|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
144261826|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
144261827|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
144261828|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
144261829|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
144261830|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
144261831|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
144261832|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
144261833|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261834|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261835|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261836|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261837|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261838|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261839|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261840|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261841|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261842|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261843|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
144261844|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
144261845|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
144261846|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144261847|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
144261848|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144544414|NCT02634307|521193635|FG000|Overall Study|Pregnancy|5|||
144544415|NCT02634307|521193636|FG001|Overall Study|Pregnancy|1|||
144544416|NCT02634307|521193637|FG002|Overall Study|Pregnancy|3|||
144544417|NCT02634307|521193635|FG000|Overall Study|Withdrawal by Subject|38|||
144544418|NCT02634307|521193636|FG001|Overall Study|Withdrawal by Subject|24|||
144544419|NCT02634307|521193637|FG002|Overall Study|Withdrawal by Subject|18|||
144544420|NCT02634307|521193635|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144544421|NCT02634307|521193636|FG001|Overall Study|Non-Compliance with Study Drug|2|||
144544422|NCT02634307|521193637|FG002|Overall Study|Non-Compliance with Study Drug|2|||
144544423|NCT02634307|521193635|FG000|Overall Study|Lack of Efficacy|1|||
144544424|NCT02634307|521193636|FG001|Overall Study|Lack of Efficacy|5|||
144616458|NCT02095535|521456329|FG000|Recruitment|Protocol Violation|2|||
144202574|NCT02906930|519940224|FG003|Overall Study|Other|2|||
144261849|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144202575|NCT00910091|519940225|FG000|Pre-assignment|Withdrawal by Subject|0|||
144202576|NCT00910091|519940226|FG001|Pre-assignment|Withdrawal by Subject|2|||
144202577|NCT00910091|519940225|FG000|Treatment and Survival|Withdrawal by Subject|3|||
144202578|NCT00910091|519940226|FG001|Treatment and Survival|Withdrawal by Subject|4|||
144202579|NCT00910091|519940225|FG000|Treatment and Survival|Adverse Event|1|||
144544425|NCT02634307|521193637|FG002|Overall Study|Lack of Efficacy|3|||
144544426|NCT02634307|521193635|FG000|Overall Study|Physician Decision|7|||
144544427|NCT02634307|521193636|FG001|Overall Study|Physician Decision|5|||
144544428|NCT02634307|521193637|FG002|Overall Study|Physician Decision|5|||
144544429|NCT02634307|521193635|FG000|Overall Study|Reason not Specified|3|||
144544430|NCT02634307|521193636|FG001|Overall Study|Reason not Specified|5|||
144544431|NCT02634307|521193637|FG002|Overall Study|Reason not Specified|10|||
144544432|NCT00667017|521193642|FG000|Overall Study|Withdrawal by Subject|1|||
144544433|NCT01823224|521193643|FG000|Overall Study|Lost to Follow-up|5|||
144544434|NCT01823224|521193644|FG001|Overall Study|Lost to Follow-up|6|||
144544435|NCT01823224|521193643|FG000|Overall Study|didn't qualify|1|||
144544436|NCT01823224|521193644|FG001|Overall Study|didn't qualify|2|||
144544437|NCT01823224|521193643|FG000|Overall Study|pharmacy error|0|||
144544438|NCT01823224|521193644|FG001|Overall Study|pharmacy error|1|||
144544439|NCT01823224|521193643|FG000|Overall Study|missed med dose|0|||
144544440|NCT01823224|521193644|FG001|Overall Study|missed med dose|1|||
144544441|NCT01823224|521193643|FG000|Overall Study|Withdrawal by Subject|0|||
144544442|NCT01823224|521193644|FG001|Overall Study|Withdrawal by Subject|1|||
144544443|NCT01532648|521193645|FG000|Overall Study|Lost to Follow-up|3|||
144544444|NCT01532648|521193646|FG001|Overall Study|Lost to Follow-up|4|||
144544445|NCT01532648|521193645|FG000|Overall Study|Lack of Efficacy|4|||
144544446|NCT01532648|521193646|FG001|Overall Study|Lack of Efficacy|1|||
144544447|NCT01532648|521193645|FG000|Overall Study|Protocol Violation|1|||
144544448|NCT01532648|521193646|FG001|Overall Study|Protocol Violation|1|||
144544449|NCT01532648|521193645|FG000|Overall Study|Adverse Event|12|||
144544450|NCT01532648|521193646|FG001|Overall Study|Adverse Event|9|||
144544451|NCT01532648|521193645|FG000|Overall Study|Withdrawal by Subject|16|||
144544452|NCT01532648|521193646|FG001|Overall Study|Withdrawal by Subject|2|||
144544453|NCT01833455|521193647|FG000|Overall Study|Withdrawal by Subject|1|||
144544454|NCT01833455|521193648|FG001|Overall Study|Withdrawal by Subject|0|||
144544455|NCT00022672|521193650|FG000|Main Phase: 24 Months|Adverse Event|6|||
144544456|NCT00022672|521193651|FG001|Main Phase: 24 Months|Adverse Event|0|||
144544457|NCT00022672|521193650|FG000|Main Phase: 24 Months|Death|0|||
144544458|NCT00022672|521193651|FG001|Main Phase: 24 Months|Death|3|||
144544459|NCT00022672|521193650|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
144544460|NCT00022672|521193651|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
144544461|NCT00022672|521193650|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
144544462|NCT00022672|521193651|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
144544463|NCT00022672|521193650|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
144544464|NCT00022672|521193651|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
144544465|NCT00022672|521193650|FG000|Main Phase: 24 Months|Refused Treatment|3|||
144544466|NCT00022672|521193651|FG001|Main Phase: 24 Months|Refused Treatment|4|||
144544467|NCT00022672|521193650|FG000|Main Phase: 24 Months|Failure to Return|1|||
144544468|NCT00022672|521193651|FG001|Main Phase: 24 Months|Failure to Return|1|||
144202580|NCT00910091|519940226|FG001|Treatment and Survival|Adverse Event|0|||
144202581|NCT01908816|519940227|FG000|Overall Study|Subject's no longer requires study drug|0|||
144202582|NCT01908816|519940228|FG001|Overall Study|Subject's no longer requires study drug|0|||
144202583|NCT01908816|519940229|FG002|Overall Study|Subject's no longer requires study drug|0|||
144202584|NCT01908816|519940230|FG003|Overall Study|Subject's no longer requires study drug|1|||
144544469|NCT00022672|521193650|FG000|Main Phase: 24 Months|Other|1|||
144544470|NCT00022672|521193651|FG001|Main Phase: 24 Months|Other|0|||
144544471|NCT00022672|521193650|FG000|Extension Phase|Adverse Event|1|||
144202585|NCT01908816|519940227|FG000|Overall Study|Protocol deviation|1|||
144202586|NCT01908816|519940228|FG001|Overall Study|Protocol deviation|2|||
144202587|NCT01908816|519940229|FG002|Overall Study|Protocol deviation|1|||
144202588|NCT01908816|519940230|FG003|Overall Study|Protocol deviation|1|||
144202589|NCT01908816|519940227|FG000|Overall Study|Withdrawal by Subject|0|||
144202590|NCT01908816|519940228|FG001|Overall Study|Withdrawal by Subject|4|||
144202591|NCT01908816|519940229|FG002|Overall Study|Withdrawal by Subject|2|||
144202592|NCT01908816|519940230|FG003|Overall Study|Withdrawal by Subject|2|||
144202593|NCT01908816|519940227|FG000|Overall Study|Lost to Follow-up|3|||
144202594|NCT01908816|519940228|FG001|Overall Study|Lost to Follow-up|5|||
144202595|NCT01908816|519940229|FG002|Overall Study|Lost to Follow-up|4|||
144544472|NCT00022672|521193651|FG001|Extension Phase|Adverse Event|3|||
144544473|NCT00022672|521193650|FG000|Extension Phase|Death|0|||
144544474|NCT00022672|521193651|FG001|Extension Phase|Death|1|||
144544475|NCT00022672|521193650|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
144544476|NCT00022672|521193651|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
144544477|NCT00022672|521193650|FG000|Extension Phase|Refused Treatment|0|||
144544478|NCT00022672|521193651|FG001|Extension Phase|Refused Treatment|2|||
144544479|NCT00022672|521193650|FG000|Extension Phase|Other|1|||
144544480|NCT00022672|521193651|FG001|Extension Phase|Other|1|||
144544481|NCT00403494|521193652|FG000|Overall Study|Adverse Event|10|||
144544482|NCT00403494|521193653|FG001|Overall Study|Adverse Event|8|||
144544483|NCT00403494|521193652|FG000|Overall Study|Withdrew Consent|3|||
144544484|NCT00403494|521193653|FG001|Overall Study|Withdrew Consent|2|||
144544485|NCT00403494|521193652|FG000|Overall Study|Inappropriately enrolled|0|||
144544486|NCT00403494|521193653|FG001|Overall Study|Inappropriately enrolled|1|||
144544487|NCT00403494|521193652|FG000|Overall Study|Lost to Follow-up|0|||
144544488|NCT00403494|521193653|FG001|Overall Study|Lost to Follow-up|2|||
144544489|NCT00403494|521193652|FG000|Overall Study|Protocol noncompliance|0|||
144544490|NCT00403494|521193653|FG001|Overall Study|Protocol noncompliance|1|||
144544491|NCT00403494|521193652|FG000|Overall Study|Death|1|||
144544492|NCT00403494|521193653|FG001|Overall Study|Death|0|||
144544493|NCT00403494|521193652|FG000|Overall Study|Sponsor Request|1|||
144544494|NCT00403494|521193653|FG001|Overall Study|Sponsor Request|0|||
144544495|NCT02575365|521193656|FG000|Overall Study|Lost to Follow-up|4|||
144544496|NCT00487240|521193660|FG000|Overall Study|Withdrawal by Subject|12|||
144544497|NCT00487240|521193661|FG001|Overall Study|Withdrawal by Subject|6|||
144544498|NCT00487240|521193660|FG000|Overall Study|Lost to Follow-up|7|||
144544499|NCT00487240|521193661|FG001|Overall Study|Lost to Follow-up|6|||
144544500|NCT00487240|521193660|FG000|Overall Study|Adverse Event|0|||
144544501|NCT00487240|521193661|FG001|Overall Study|Adverse Event|4|||
144544502|NCT00487240|521193660|FG000|Overall Study|Protocol Violation|5|||
144544503|NCT00487240|521193661|FG001|Overall Study|Protocol Violation|5|||
144544504|NCT00487240|521193660|FG000|Overall Study|Entry Criteria Not Met|3|||
144544505|NCT00487240|521193661|FG001|Overall Study|Entry Criteria Not Met|4|||
144616459|NCT03273166|521456332|FG000|Overall Study|Withdrawn prior to Completion|31|||
144202596|NCT01908816|519940230|FG003|Overall Study|Lost to Follow-up|2|||
144202597|NCT01908816|519940227|FG000|Overall Study|Death|1|||
144202598|NCT01908816|519940228|FG001|Overall Study|Death|0|||
144202599|NCT01908816|519940229|FG002|Overall Study|Death|7|||
144202600|NCT01908816|519940230|FG003|Overall Study|Death|1|||
144202601|NCT01908816|519940227|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144202602|NCT01908816|519940228|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
144202603|NCT01908816|519940229|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
144202604|NCT01908816|519940230|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
144202605|NCT01908816|519940227|FG000|Overall Study|Early termination|87|||
144202606|NCT01908816|519940228|FG001|Overall Study|Early termination|60|||
144202607|NCT01908816|519940229|FG002|Overall Study|Early termination|43|||
144202608|NCT01908816|519940230|FG003|Overall Study|Early termination|28|||
144202609|NCT00114166|519940231|FG000|Overall Study|Wrong primary|0|||
144202610|NCT00114166|519940232|FG001|Overall Study|Wrong primary|1|||
144202611|NCT01154816|519940233|FG000|Overall Study|Withdrawal by Subject|1|||
144202612|NCT01154816|519940234|FG001|Overall Study|Withdrawal by Subject|0|||
144202613|NCT01154816|519940235|FG002|Overall Study|Withdrawal by Subject|0|||
144202614|NCT01154816|519940236|FG003|Overall Study|Withdrawal by Subject|1|||
144202615|NCT01154816|519940237|FG004|Overall Study|Withdrawal by Subject|0|||
144202616|NCT01154816|519940238|FG005|Overall Study|Withdrawal by Subject|0|||
144202617|NCT01154816|519940239|FG006|Overall Study|Withdrawal by Subject|0|||
144202618|NCT01154816|519940240|FG007|Overall Study|Withdrawal by Subject|0|||
144202619|NCT01154816|519940241|FG008|Overall Study|Withdrawal by Subject|1|||
144202620|NCT01154816|519940242|FG009|Overall Study|Withdrawal by Subject|3|||
144202621|NCT01154816|519940243|FG010|Overall Study|Withdrawal by Subject|0|||
144202622|NCT01154816|519940244|FG011|Overall Study|Withdrawal by Subject|0|||
144202623|NCT01154816|519940233|FG000|Overall Study|Progressive Disease|13|||
144202624|NCT01154816|519940234|FG001|Overall Study|Progressive Disease|8|||
144202625|NCT01154816|519940235|FG002|Overall Study|Progressive Disease|9|||
144202626|NCT01154816|519940236|FG003|Overall Study|Progressive Disease|9|||
144202627|NCT01154816|519940237|FG004|Overall Study|Progressive Disease|8|||
144202628|NCT01154816|519940238|FG005|Overall Study|Progressive Disease|8|||
144202629|NCT01154816|519940239|FG006|Overall Study|Progressive Disease|5|||
144202630|NCT01154816|519940240|FG007|Overall Study|Progressive Disease|6|||
144202631|NCT01154816|519940241|FG008|Overall Study|Progressive Disease|8|||
144202632|NCT01154816|519940242|FG009|Overall Study|Progressive Disease|6|||
144202633|NCT01154816|519940243|FG010|Overall Study|Progressive Disease|10|||
144202634|NCT01154816|519940244|FG011|Overall Study|Progressive Disease|3|||
144202635|NCT01154816|519940233|FG000|Overall Study|Physician Decision|1|||
144202636|NCT01154816|519940234|FG001|Overall Study|Physician Decision|0|||
144202637|NCT01154816|519940235|FG002|Overall Study|Physician Decision|1|||
144202638|NCT01154816|519940236|FG003|Overall Study|Physician Decision|0|||
144202639|NCT01154816|519940237|FG004|Overall Study|Physician Decision|2|||
144202640|NCT01154816|519940238|FG005|Overall Study|Physician Decision|0|||
144202641|NCT01154816|519940239|FG006|Overall Study|Physician Decision|0|||
144202642|NCT01154816|519940240|FG007|Overall Study|Physician Decision|0|||
144202643|NCT01154816|519940241|FG008|Overall Study|Physician Decision|0|||
144202644|NCT01154816|519940242|FG009|Overall Study|Physician Decision|1|||
144202645|NCT01154816|519940243|FG010|Overall Study|Physician Decision|1|||
144544506|NCT00487240|521193660|FG000|Overall Study|Sponsor Decision|2|||
144544507|NCT00487240|521193661|FG001|Overall Study|Sponsor Decision|1|||
144544508|NCT00487240|521193660|FG000|Overall Study|Physician Decision|2|||
144202646|NCT01154816|519940244|FG011|Overall Study|Physician Decision|1|||
144202647|NCT01154816|519940233|FG000|Overall Study|Adverse Event|5|||
144544509|NCT00487240|521193661|FG001|Overall Study|Physician Decision|0|||
144544510|NCT01019135|521193662|FG000|Overall Study|Did not receive allocated intervention|12|||
144544511|NCT01019135|521193663|FG001|Overall Study|Did not receive allocated intervention|6|||
144544512|NCT01019135|521193664|FG002|Overall Study|Did not receive allocated intervention|25|||
144544513|NCT01019135|521193662|FG000|Overall Study|Did not attend CR|8|||
144544514|NCT01019135|521193663|FG001|Overall Study|Did not attend CR|13|||
144544515|NCT01019135|521193664|FG002|Overall Study|Did not attend CR|6|||
144544516|NCT04237792|521193665|FG000|Treatment (Day 1)|Adverse Event|1|||
144544517|NCT04237792|521193666|FG001|Treatment (Day 1)|Adverse Event|0|||
144544518|NCT04237792|521193667|FG002|Treatment (Day 1)|Adverse Event|0|||
144544519|NCT04237792|521193668|FG003|Treatment (Day 1)|Adverse Event|0|||
144544520|NCT04237792|521193669|FG004|Treatment (Day 1)|Adverse Event|1|||
144544521|NCT04237792|521193670|FG005|Treatment (Day 1)|Adverse Event|1|||
144544522|NCT04237792|521193665|FG000|Treatment (Day 1)|Other|0|||
144544523|NCT04237792|521193666|FG001|Treatment (Day 1)|Other|0|||
144544524|NCT04237792|521193667|FG002|Treatment (Day 1)|Other|1|||
144544525|NCT04237792|521193668|FG003|Treatment (Day 1)|Other|0|||
144544526|NCT04237792|521193669|FG004|Treatment (Day 1)|Other|0|||
144544527|NCT04237792|521193670|FG005|Treatment (Day 1)|Other|1|||
144544528|NCT04237792|521193665|FG000|Treatment (Day 1)|Not treated|1|||
144544529|NCT04237792|521193666|FG001|Treatment (Day 1)|Not treated|1|||
144544530|NCT04237792|521193667|FG002|Treatment (Day 1)|Not treated|2|||
144544531|NCT04237792|521193668|FG003|Treatment (Day 1)|Not treated|1|||
144544532|NCT04237792|521193669|FG004|Treatment (Day 1)|Not treated|0|||
144544533|NCT04237792|521193670|FG005|Treatment (Day 1)|Not treated|1|||
144544534|NCT00910962|521193671|FG000|Overall Study|Adverse Event|5|||
144202648|NCT01154816|519940234|FG001|Overall Study|Adverse Event|2|||
144544535|NCT00910962|521193672|FG001|Overall Study|Adverse Event|20|||
144544536|NCT00910962|521193673|FG002|Overall Study|Adverse Event|17|||
144544537|NCT00910962|521193671|FG000|Overall Study|Protocol Violation|1|||
144544538|NCT00910962|521193672|FG001|Overall Study|Protocol Violation|3|||
144544539|NCT00910962|521193673|FG002|Overall Study|Protocol Violation|3|||
144544540|NCT00910962|521193671|FG000|Overall Study|Lost to Follow-up|0|||
144544541|NCT00910962|521193672|FG001|Overall Study|Lost to Follow-up|3|||
144544542|NCT00910962|521193673|FG002|Overall Study|Lost to Follow-up|1|||
144544543|NCT00910962|521193671|FG000|Overall Study|Physician Decision|0|||
144544544|NCT00910962|521193672|FG001|Overall Study|Physician Decision|6|||
144544545|NCT00910962|521193673|FG002|Overall Study|Physician Decision|6|||
144544546|NCT00910962|521193671|FG000|Overall Study|Withdrawal by Subject|25|||
144544547|NCT00910962|521193672|FG001|Overall Study|Withdrawal by Subject|32|||
144544548|NCT00910962|521193673|FG002|Overall Study|Withdrawal by Subject|32|||
144544549|NCT00910962|521193671|FG000|Overall Study|Reached defined stopping criteria|12|||
144544550|NCT00910962|521193672|FG001|Overall Study|Reached defined stopping criteria|14|||
144544551|NCT00910962|521193673|FG002|Overall Study|Reached defined stopping criteria|17|||
144544552|NCT01485887|521193674|FG000|Overall Study|Withdrawal by Subject|2|||
144202649|NCT01154816|519940235|FG002|Overall Study|Adverse Event|0|||
144202650|NCT01154816|519940236|FG003|Overall Study|Adverse Event|0|||
144202651|NCT01154816|519940237|FG004|Overall Study|Adverse Event|0|||
144202652|NCT01154816|519940238|FG005|Overall Study|Adverse Event|0|||
144202653|NCT01154816|519940239|FG006|Overall Study|Adverse Event|1|||
144202654|NCT01154816|519940240|FG007|Overall Study|Adverse Event|1|||
144202655|NCT01154816|519940241|FG008|Overall Study|Adverse Event|0|||
144202656|NCT01154816|519940242|FG009|Overall Study|Adverse Event|0|||
144202657|NCT01154816|519940243|FG010|Overall Study|Adverse Event|0|||
144202658|NCT01154816|519940244|FG011|Overall Study|Adverse Event|0|||
144202659|NCT02393248|519940245|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202660|NCT02393248|519940246|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
144202661|NCT02393248|519940247|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202662|NCT02393248|519940248|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202663|NCT02393248|519940249|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202664|NCT02393248|519940250|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
144202665|NCT02393248|519940251|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
144202666|NCT02393248|519940252|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202667|NCT02393248|519940253|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202668|NCT02393248|519940254|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202669|NCT02393248|519940255|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202670|NCT02393248|519940256|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202671|NCT02393248|519940257|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202672|NCT02393248|519940258|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144544553|NCT01485887|521193674|FG000|Overall Study|Adverse Event|8|||
144544554|NCT01485887|521193674|FG000|Overall Study|Deterioration of primary disease|1|||
144544555|NCT01485887|521193674|FG000|Overall Study|Primary disease markedly improved|1|||
144544556|NCT00836498|521193679|FG000|Overall Study|Adverse Event|1|||
144544557|NCT00836498|521193680|FG001|Overall Study|Adverse Event|0|||
144261850|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261851|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261852|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261853|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261854|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261855|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261856|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261857|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261858|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
144261859|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261860|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
144261861|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261862|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144261863|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261864|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261865|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261866|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261867|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261868|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261869|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261870|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261871|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261872|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261873|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261874|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
144261875|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261876|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261877|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144261878|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261879|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261880|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261881|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261882|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261883|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261884|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261885|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261886|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261887|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261888|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
144261889|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261890|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
144261891|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144261892|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
144261893|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261894|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261895|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261896|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261897|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261898|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261899|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144202673|NCT02393248|519940259|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202674|NCT02393248|519940260|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202675|NCT02393248|519940261|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202676|NCT02393248|519940262|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202677|NCT02393248|519940263|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202678|NCT02393248|519940264|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202679|NCT02393248|519940265|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202680|NCT02393248|519940266|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202681|NCT02393248|519940267|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202682|NCT02393248|519940268|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202683|NCT02393248|519940269|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
144202684|NCT02393248|519940245|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202685|NCT02393248|519940246|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
144202686|NCT02393248|519940247|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144261900|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261901|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261902|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261903|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261904|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
144261905|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261906|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144261907|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
144261908|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261909|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261910|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261911|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261912|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261913|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261914|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261915|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261916|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261917|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261918|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261919|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
144261920|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
144261921|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144261922|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
144261923|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261924|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261925|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261926|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261927|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261928|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261929|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261930|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261931|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261932|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261933|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261934|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
144261935|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261936|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261937|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
144261938|NCT02326272|520159714|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261939|NCT02326272|520159715|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261940|NCT02326272|520159716|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261941|NCT02326272|520159717|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261942|NCT02326272|520159718|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261943|NCT02326272|520159719|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261944|NCT02326272|520159720|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261945|NCT02326272|520159721|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261946|NCT02326272|520159722|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261947|NCT02326272|520159723|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261948|NCT02326272|520159724|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261949|NCT02326272|520159725|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261950|NCT02326272|520159726|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
144261951|NCT02326272|520159727|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261952|NCT02326272|520159728|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
144261953|NCT01447407|520159745|FG000|Overall Study|Withdrawal by Subject|2|||
144261954|NCT01447407|520159746|FG001|Overall Study|Withdrawal by Subject|0|||
144261955|NCT01447407|520159747|FG002|Overall Study|Withdrawal by Subject|0|||
144261956|NCT01447407|520159748|FG003|Overall Study|Withdrawal by Subject|1|||
144261957|NCT01447407|520159745|FG000|Overall Study|Physician Decision|0|||
144261958|NCT01447407|520159746|FG001|Overall Study|Physician Decision|0|||
144261959|NCT01447407|520159747|FG002|Overall Study|Physician Decision|1|||
144261960|NCT01447407|520159748|FG003|Overall Study|Physician Decision|1|||
144261961|NCT00735943|520159749|FG000|Overall Study|Lost to Follow-up|1|||
144261962|NCT00735943|520159749|FG000|Overall Study|Adverse Event|1|||
144261963|NCT01064414|520159750|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
144261964|NCT01064414|520159751|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
144261965|NCT01064414|520159752|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
144261966|NCT01064414|520159750|FG000|Core Period: Baseline to Week 26|Death|0|||
144202687|NCT02393248|519940248|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144261967|NCT01064414|520159751|FG001|Core Period: Baseline to Week 26|Death|1|||
144261968|NCT01064414|520159752|FG002|Core Period: Baseline to Week 26|Death|0|||
144261969|NCT01064414|520159750|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
144261970|NCT01064414|520159751|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
144261971|NCT01064414|520159752|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
144261972|NCT01064414|520159750|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
144261973|NCT01064414|520159751|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
144261974|NCT01064414|520159752|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
144261975|NCT01064414|520159750|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144261976|NCT01064414|520159751|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
144544558|NCT00836498|521193679|FG000|Overall Study|Lost to Follow-up|1|||
144202688|NCT02393248|519940249|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202689|NCT02393248|519940250|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202690|NCT02393248|519940251|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202691|NCT02393248|519940252|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202692|NCT02393248|519940253|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202693|NCT02393248|519940254|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202694|NCT02393248|519940255|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202695|NCT02393248|519940256|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202696|NCT02393248|519940257|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202697|NCT02393248|519940258|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202698|NCT02393248|519940259|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202699|NCT02393248|519940260|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202700|NCT02393248|519940261|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202701|NCT02393248|519940262|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202702|NCT02393248|519940263|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202703|NCT02393248|519940264|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202704|NCT02393248|519940265|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202705|NCT02393248|519940266|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202706|NCT02393248|519940267|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202707|NCT02393248|519940268|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202708|NCT02393248|519940269|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
144202709|NCT02393248|519940245|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
144202710|NCT02393248|519940246|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
144202711|NCT02393248|519940247|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
144202712|NCT02393248|519940248|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
144202713|NCT02393248|519940249|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
144202714|NCT02393248|519940250|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
144202715|NCT02393248|519940251|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
144202716|NCT02393248|519940252|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
144202717|NCT02393248|519940253|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
144202718|NCT02393248|519940254|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
144202719|NCT02393248|519940255|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
144202720|NCT02393248|519940256|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
144544559|NCT00836498|521193680|FG001|Overall Study|Lost to Follow-up|0|||
144544560|NCT00836498|521193679|FG000|Overall Study|Withdrawal by Subject|2|||
144544561|NCT00836498|521193680|FG001|Overall Study|Withdrawal by Subject|1|||
144544562|NCT03418545|521193681|FG000|Overall Study|Withdrawal by Participant|2|||
144544563|NCT03418545|521193682|FG001|Overall Study|Withdrawal by Participant|4|||
144544564|NCT03418545|521193681|FG000|Overall Study|Lost to Follow-up|3|||
144544565|NCT03418545|521193682|FG001|Overall Study|Lost to Follow-up|5|||
144544566|NCT03418545|521193681|FG000|Overall Study|Reason Not Specified|0|||
144544567|NCT03418545|521193682|FG001|Overall Study|Reason Not Specified|1|||
144544568|NCT03418545|521193681|FG000|Overall Study|Missing Completion Status|0|||
144544569|NCT03418545|521193682|FG001|Overall Study|Missing Completion Status|1|||
144544570|NCT02106884|521193683|FG000|Overall Study|Change of diagnosis/exclusion|0|||
144544571|NCT02106884|521193684|FG001|Overall Study|Change of diagnosis/exclusion|1|||
144544572|NCT04638816|521193690|FG000|Overall Study|Withdrawal by Subject|0|||
144544573|NCT04638816|521193691|FG001|Overall Study|Withdrawal by Subject|1|||
144544574|NCT04638816|521193690|FG000|Overall Study|Lost to Follow-up|0|||
144544575|NCT04638816|521193691|FG001|Overall Study|Lost to Follow-up|1|||
144202721|NCT02393248|519940257|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
144202722|NCT02393248|519940258|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
144202723|NCT02393248|519940259|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
144202724|NCT02393248|519940260|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
144544576|NCT02251652|521193692|FG000|Overall Study|Withdrawal by Subject|1|||
144544577|NCT01074242|521193695|FG000|Overall Study|Case report before date of contract|40|||
144544578|NCT01074242|521193695|FG000|Overall Study|Lost to Follow-up|1|||
144544579|NCT01074242|521193695|FG000|Overall Study|Case report unclear|6|||
144544580|NCT01074242|521193695|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
144202725|NCT02393248|519940261|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
144202726|NCT02393248|519940262|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
144202727|NCT02393248|519940263|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
144202728|NCT02393248|519940264|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
144202729|NCT02393248|519940265|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
144202730|NCT02393248|519940266|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
144202731|NCT02393248|519940267|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
144202732|NCT02393248|519940268|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
144202733|NCT02393248|519940269|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
144202734|NCT02393248|519940245|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
144202735|NCT02393248|519940246|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202736|NCT02393248|519940247|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202737|NCT02393248|519940248|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202738|NCT02393248|519940249|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202739|NCT02393248|519940250|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144261977|NCT01064414|520159752|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144261978|NCT01064414|520159750|FG000|Core Period: Baseline to Week 26|Other|4|||
144261979|NCT01064414|520159751|FG001|Core Period: Baseline to Week 26|Other|7|||
144261980|NCT01064414|520159752|FG002|Core Period: Baseline to Week 26|Other|2|||
144261981|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
144261982|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
144261983|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
144261984|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Death|0|||
144261985|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Death|1|||
144261986|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Death|0|||
144261987|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
144261988|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144261989|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144261990|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
144261991|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144261992|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144261993|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144261994|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
144261995|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144261996|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
144261997|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
144261998|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
144261999|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
144262000|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
144262001|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
144262002|NCT01064414|520159750|FG000|Extension Period: Week 26 to Week 52|Other|5|||
144262003|NCT01064414|520159751|FG001|Extension Period: Week 26 to Week 52|Other|2|||
144262004|NCT01064414|520159752|FG002|Extension Period: Week 26 to Week 52|Other|1|||
144262005|NCT02185417|520159753|FG000|Overall Study|Death|448|||
144262006|NCT02185417|520159754|FG001|Overall Study|Death|446|||
144262007|NCT02185417|520159755|FG002|Overall Study|Death|0|||
144262008|NCT02185417|520159753|FG000|Overall Study|Withdrawal by Subject|7|||
144262009|NCT02185417|520159754|FG001|Overall Study|Withdrawal by Subject|12|||
144262010|NCT02185417|520159755|FG002|Overall Study|Withdrawal by Subject|0|||
144262011|NCT02532374|520159763|FG000|Overall Study|Withdrawal by Subject|1|||
144262012|NCT02532374|520159763|FG000|Overall Study|Physician Decision|1|||
144262013|NCT03131167|520159764|FG000|Overall Study|Other (Unspecified)|0|||
144262014|NCT03131167|520159765|FG001|Overall Study|Other (Unspecified)|0|||
144262015|NCT03131167|520159766|FG002|Overall Study|Other (Unspecified)|0|||
144262016|NCT03131167|520159767|FG003|Overall Study|Other (Unspecified)|0|||
144262017|NCT03131167|520159768|FG004|Overall Study|Other (Unspecified)|0|||
144262018|NCT03131167|520159769|FG005|Overall Study|Other (Unspecified)|1|||
144262019|NCT03131167|520159770|FG006|Overall Study|Other (Unspecified)|0|||
144262020|NCT03131167|520159771|FG007|Overall Study|Other (Unspecified)|0|||
144262021|NCT03131167|520159772|FG008|Overall Study|Other (Unspecified)|0|||
144262022|NCT03131167|520159773|FG009|Overall Study|Other (Unspecified)|0|||
144262023|NCT03131167|520159774|FG010|Overall Study|Other (Unspecified)|0|||
144262024|NCT03131167|520159775|FG011|Overall Study|Other (Unspecified)|0|||
144262025|NCT03131167|520159776|FG012|Overall Study|Other (Unspecified)|0|||
144262026|NCT03933449|520159777|FG000|Overall Study|Adverse Event|6|||
144262027|NCT03933449|520159778|FG001|Overall Study|Adverse Event|4|||
144262028|NCT03933449|520159777|FG000|Overall Study|Death|55|||
144262029|NCT03933449|520159778|FG001|Overall Study|Death|57|||
144262030|NCT03933449|520159777|FG000|Overall Study|Sponsor Decision|1|||
144262031|NCT03933449|520159778|FG001|Overall Study|Sponsor Decision|0|||
144202740|NCT02393248|519940251|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144262032|NCT03075267|520159783|FG000|Overall Study|Protocol Violation|1|||
144262033|NCT03075267|520159784|FG001|Overall Study|Protocol Violation|0|||
144262034|NCT03075267|520159785|FG002|Overall Study|Protocol Violation|0|||
144262035|NCT00809445|520159786|FG000|1 Month Follow-up|Lost contact|1|||
144262036|NCT00809445|520159787|FG001|1 Month Follow-up|Lost contact|2|||
144262037|NCT00809445|520159788|FG002|1 Month Follow-up|Lost contact|1|||
144262038|NCT00809445|520159786|FG000|1 Month Follow-up|Withdrew consent|1|||
144262039|NCT00809445|520159787|FG001|1 Month Follow-up|Withdrew consent|1|||
144262040|NCT00809445|520159788|FG002|1 Month Follow-up|Withdrew consent|1|||
144262041|NCT00809445|520159786|FG000|1 Month Follow-up|Death|0|||
144262042|NCT00809445|520159787|FG001|1 Month Follow-up|Death|1|||
144262043|NCT00809445|520159788|FG002|1 Month Follow-up|Death|1|||
144262044|NCT00809445|520159786|FG000|1 Month Follow-up|Incarcerated|0|||
144262045|NCT00809445|520159787|FG001|1 Month Follow-up|Incarcerated|0|||
144262046|NCT00809445|520159788|FG002|1 Month Follow-up|Incarcerated|1|||
144262047|NCT00809445|520159786|FG000|6 Month Follow-up|Lost contact|16|||
144262048|NCT00809445|520159787|FG001|6 Month Follow-up|Lost contact|14|||
144262049|NCT00809445|520159788|FG002|6 Month Follow-up|Lost contact|14|||
144262050|NCT00809445|520159786|FG000|6 Month Follow-up|Death|2|||
144262051|NCT00809445|520159787|FG001|6 Month Follow-up|Death|1|||
144262052|NCT00809445|520159788|FG002|6 Month Follow-up|Death|1|||
144262053|NCT00809445|520159786|FG000|6 Month Follow-up|Incarcerated|6|||
144262054|NCT00809445|520159787|FG001|6 Month Follow-up|Incarcerated|8|||
144262055|NCT00809445|520159788|FG002|6 Month Follow-up|Incarcerated|8|||
144262056|NCT00809445|520159786|FG000|6 Month Follow-up|Withdrew consent|0|||
144262057|NCT00809445|520159787|FG001|6 Month Follow-up|Withdrew consent|0|||
144262058|NCT00809445|520159788|FG002|6 Month Follow-up|Withdrew consent|1|||
144262059|NCT01610037|520159790|FG000|All Patients|Adverse Event|27|||
144262060|NCT01610037|520159791|FG001|All Patients|Adverse Event|22|||
144262061|NCT01610037|520159792|FG002|All Patients|Adverse Event|26|||
144262062|NCT01610037|520159790|FG000|All Patients|Withdrawal by Subject|12|||
144262063|NCT01610037|520159791|FG001|All Patients|Withdrawal by Subject|10|||
144262064|NCT01610037|520159792|FG002|All Patients|Withdrawal by Subject|20|||
144262065|NCT01610037|520159790|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
144262066|NCT01610037|520159791|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
144262067|NCT01610037|520159792|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
144262068|NCT01610037|520159790|FG000|All Patients|Death|4|||
144262069|NCT01610037|520159791|FG001|All Patients|Death|2|||
144262070|NCT01610037|520159792|FG002|All Patients|Death|1|||
144262071|NCT01610037|520159790|FG000|All Patients|Protocol deviation|4|||
144262072|NCT01610037|520159791|FG001|All Patients|Protocol deviation|3|||
144262073|NCT01610037|520159792|FG002|All Patients|Protocol deviation|3|||
144262074|NCT01610037|520159790|FG000|All Patients|Abnormal laboratory value|1|||
144262075|NCT01610037|520159791|FG001|All Patients|Abnormal laboratory value|1|||
144262076|NCT01610037|520159792|FG002|All Patients|Abnormal laboratory value|0|||
144262077|NCT01610037|520159790|FG000|All Patients|Administrative problems|1|||
144262078|NCT01610037|520159791|FG001|All Patients|Administrative problems|4|||
144262079|NCT01610037|520159792|FG002|All Patients|Administrative problems|4|||
144262080|NCT01610037|520159790|FG000|All Patients|Lost to Follow-up|1|||
144262081|NCT01610037|520159791|FG001|All Patients|Lost to Follow-up|0|||
144262082|NCT01610037|520159792|FG002|All Patients|Lost to Follow-up|0|||
144262083|NCT01610037|520159790|FG000|All Patients|Abnormal test procedure result(s)|0|||
144262084|NCT01610037|520159791|FG001|All Patients|Abnormal test procedure result(s)|1|||
144262085|NCT01610037|520159792|FG002|All Patients|Abnormal test procedure result(s)|3|||
144262086|NCT01610037|520159790|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
144262087|NCT01610037|520159791|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
144262088|NCT01610037|520159792|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
144262089|NCT01610037|520159790|FG000|Treatment and Follow up Period|Death|10|||
144262090|NCT01610037|520159791|FG001|Treatment and Follow up Period|Death|5|||
144262091|NCT01610037|520159792|FG002|Treatment and Follow up Period|Death|4|||
144262092|NCT01610037|520159790|FG000|Treatment and Follow up Period|Administrative problems|1|||
144262093|NCT01610037|520159791|FG001|Treatment and Follow up Period|Administrative problems|3|||
144262094|NCT01610037|520159792|FG002|Treatment and Follow up Period|Administrative problems|2|||
144262095|NCT01610037|520159790|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
144262096|NCT01610037|520159791|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
144262097|NCT01610037|520159792|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
144262098|NCT00705757|520159794|FG000|Overall Study|Lack of Efficacy|5|||
144262099|NCT00705757|520159795|FG001|Overall Study|Lack of Efficacy|1|||
144262100|NCT00705757|520159796|FG002|Overall Study|Lack of Efficacy|3|||
144262101|NCT00705757|520159794|FG000|Overall Study|Lost to Follow-up|7|||
144262102|NCT00705757|520159795|FG001|Overall Study|Lost to Follow-up|6|||
144262103|NCT00705757|520159796|FG002|Overall Study|Lost to Follow-up|6|||
144544581|NCT01074242|521193695|FG000|Overall Study|Duplicate Case Report Form|5|||
144262104|NCT00705757|520159794|FG000|Overall Study|Withdrawal by Subject|1|||
144262105|NCT00705757|520159795|FG001|Overall Study|Withdrawal by Subject|1|||
144262106|NCT00705757|520159796|FG002|Overall Study|Withdrawal by Subject|2|||
144262107|NCT01411852|520159797|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
144544582|NCT00109031|521193696|FG000|Overall Study|Adverse Event|0|||
144202741|NCT02393248|519940252|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202742|NCT02393248|519940253|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202743|NCT02393248|519940254|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202744|NCT02393248|519940255|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202745|NCT02393248|519940256|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202746|NCT02393248|519940257|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202747|NCT02393248|519940258|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202748|NCT02393248|519940259|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202749|NCT02393248|519940260|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202750|NCT02393248|519940261|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202751|NCT02393248|519940262|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202752|NCT02393248|519940263|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202753|NCT02393248|519940264|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202754|NCT02393248|519940265|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202755|NCT02393248|519940266|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202756|NCT02393248|519940267|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202757|NCT02393248|519940268|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202758|NCT02393248|519940269|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
144202759|NCT02393248|519940245|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202760|NCT02393248|519940246|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202761|NCT02393248|519940247|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202762|NCT02393248|519940248|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202763|NCT02393248|519940249|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202764|NCT02393248|519940250|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
144202765|NCT02393248|519940251|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
144202766|NCT02393248|519940252|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202767|NCT02393248|519940253|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202768|NCT02393248|519940254|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
144202769|NCT02393248|519940255|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202770|NCT02393248|519940256|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202771|NCT02393248|519940257|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202772|NCT02393248|519940258|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202773|NCT02393248|519940259|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202774|NCT02393248|519940260|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202775|NCT02393248|519940261|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202776|NCT02393248|519940262|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202777|NCT02393248|519940263|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202778|NCT02393248|519940264|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202779|NCT02393248|519940265|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202780|NCT02393248|519940266|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202781|NCT02393248|519940267|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202782|NCT02393248|519940268|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202783|NCT02393248|519940269|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
144202784|NCT02393248|519940245|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202785|NCT02393248|519940246|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202786|NCT02393248|519940247|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202787|NCT02393248|519940248|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202788|NCT02393248|519940249|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202789|NCT02393248|519940250|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202790|NCT02393248|519940251|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
144202791|NCT02393248|519940252|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202792|NCT02393248|519940253|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202793|NCT02393248|519940254|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202794|NCT02393248|519940255|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202795|NCT02393248|519940256|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202796|NCT02393248|519940257|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202797|NCT02393248|519940258|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202798|NCT02393248|519940259|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202799|NCT02393248|519940260|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202800|NCT02393248|519940261|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144544583|NCT00109031|521193697|FG001|Overall Study|Adverse Event|0|||
144544584|NCT00109031|521193698|FG002|Overall Study|Adverse Event|1|||
144544585|NCT00109031|521193699|FG003|Overall Study|Adverse Event|0|||
144544586|NCT00109031|521193696|FG000|Overall Study|Withdrawal by Subject|0|||
144544587|NCT00109031|521193697|FG001|Overall Study|Withdrawal by Subject|1|||
144544588|NCT00109031|521193698|FG002|Overall Study|Withdrawal by Subject|0|||
144544589|NCT00109031|521193699|FG003|Overall Study|Withdrawal by Subject|0|||
144544590|NCT00109031|521193696|FG000|Overall Study|Physician Decision|0|||
144544591|NCT00109031|521193697|FG001|Overall Study|Physician Decision|1|||
144544592|NCT00109031|521193698|FG002|Overall Study|Physician Decision|0|||
144544593|NCT00109031|521193699|FG003|Overall Study|Physician Decision|0|||
144544594|NCT00109031|521193696|FG000|Overall Study|Protocol Violation|0|||
144544595|NCT00109031|521193697|FG001|Overall Study|Protocol Violation|0|||
144544596|NCT00109031|521193698|FG002|Overall Study|Protocol Violation|1|||
144544597|NCT00109031|521193699|FG003|Overall Study|Protocol Violation|0|||
144544598|NCT01822756|521193700|FG000|Overall Study|Adverse Event|0|||
144544599|NCT01822756|521193701|FG001|Overall Study|Adverse Event|0|||
144544600|NCT01822756|521193702|FG002|Overall Study|Adverse Event|0|||
144544601|NCT01822756|521193703|FG003|Overall Study|Adverse Event|2|||
144544602|NCT01822756|521193704|FG004|Overall Study|Adverse Event|0|||
144544603|NCT01822756|521193700|FG000|Overall Study|Disease progression|11|||
144544604|NCT01822756|521193701|FG001|Overall Study|Disease progression|1|||
144544605|NCT01822756|521193702|FG002|Overall Study|Disease progression|7|||
144544606|NCT01822756|521193703|FG003|Overall Study|Disease progression|2|||
144544607|NCT01822756|521193704|FG004|Overall Study|Disease progression|6|||
144544608|NCT01822756|521193700|FG000|Overall Study|Death|2|||
144544609|NCT01822756|521193701|FG001|Overall Study|Death|2|||
144544610|NCT01822756|521193702|FG002|Overall Study|Death|1|||
144544611|NCT01822756|521193703|FG003|Overall Study|Death|0|||
144544612|NCT01822756|521193704|FG004|Overall Study|Death|0|||
144544613|NCT01822756|521193700|FG000|Overall Study|Lost to Follow-up|1|||
144544614|NCT01822756|521193701|FG001|Overall Study|Lost to Follow-up|0|||
144544615|NCT01822756|521193702|FG002|Overall Study|Lost to Follow-up|1|||
144544616|NCT01822756|521193703|FG003|Overall Study|Lost to Follow-up|0|||
144544617|NCT01822756|521193704|FG004|Overall Study|Lost to Follow-up|1|||
144544618|NCT01822756|521193700|FG000|Overall Study|Physician Decision|0|||
144544619|NCT01822756|521193701|FG001|Overall Study|Physician Decision|1|||
144544620|NCT01822756|521193702|FG002|Overall Study|Physician Decision|0|||
144544621|NCT01822756|521193703|FG003|Overall Study|Physician Decision|0|||
144544622|NCT01822756|521193704|FG004|Overall Study|Physician Decision|0|||
144544623|NCT01822756|521193700|FG000|Overall Study|disease progression & patient preference|2|||
144544624|NCT01822756|521193701|FG001|Overall Study|disease progression & patient preference|0|||
144544625|NCT01822756|521193702|FG002|Overall Study|disease progression & patient preference|1|||
144544626|NCT01822756|521193703|FG003|Overall Study|disease progression & patient preference|0|||
144544627|NCT01822756|521193704|FG004|Overall Study|disease progression & patient preference|0|||
144544628|NCT02060487|521193713|FG000|Overall Study|Other|1|||
144544629|NCT02060487|521193714|FG001|Overall Study|Other|2|||
144544630|NCT02060487|521193715|FG002|Overall Study|Other|1|||
144544631|NCT02060487|521193713|FG000|Overall Study|Lack of Efficacy|0|||
144544632|NCT02060487|521193714|FG001|Overall Study|Lack of Efficacy|1|||
144544633|NCT02060487|521193715|FG002|Overall Study|Lack of Efficacy|0|||
144544634|NCT02060487|521193713|FG000|Overall Study|Withdrawal by Subject|3|||
144544635|NCT02060487|521193714|FG001|Overall Study|Withdrawal by Subject|10|||
144544636|NCT02060487|521193715|FG002|Overall Study|Withdrawal by Subject|4|||
144544637|NCT02060487|521193713|FG000|Overall Study|Study Terminated By Sponsor|87|||
144544638|NCT02060487|521193714|FG001|Overall Study|Study Terminated By Sponsor|89|||
144544639|NCT02060487|521193715|FG002|Overall Study|Study Terminated By Sponsor|100|||
144544640|NCT02060487|521193713|FG000|Overall Study|Randomized in error|1|||
144544641|NCT02060487|521193714|FG001|Overall Study|Randomized in error|0|||
144544642|NCT02060487|521193715|FG002|Overall Study|Randomized in error|0|||
144544643|NCT02060487|521193713|FG000|Overall Study|Protocol Violation|0|||
144544644|NCT02060487|521193714|FG001|Overall Study|Protocol Violation|1|||
144544645|NCT02060487|521193715|FG002|Overall Study|Protocol Violation|1|||
144544646|NCT02060487|521193713|FG000|Overall Study|Lost to Follow-up|3|||
144544647|NCT02060487|521193714|FG001|Overall Study|Lost to Follow-up|0|||
144544648|NCT02060487|521193715|FG002|Overall Study|Lost to Follow-up|2|||
144544649|NCT02060487|521193713|FG000|Overall Study|Death|34|||
144544650|NCT02060487|521193714|FG001|Overall Study|Death|25|||
144544651|NCT02060487|521193715|FG002|Overall Study|Death|19|||
144544652|NCT02060487|521193713|FG000|Overall Study|Adverse Event|0|||
144544653|NCT02060487|521193714|FG001|Overall Study|Adverse Event|0|||
144544654|NCT02060487|521193715|FG002|Overall Study|Adverse Event|1|||
144544655|NCT05182606|521193721|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
144544656|NCT02686658|521193722|FG000|Overall Study|Adverse Event|0|||
144544657|NCT02686658|521193723|FG001|Overall Study|Adverse Event|0|||
144544658|NCT02686658|521193724|FG002|Overall Study|Adverse Event|1|||
144544659|NCT02686658|521193725|FG003|Overall Study|Adverse Event|1|||
144544660|NCT02686658|521193726|FG004|Overall Study|Adverse Event|2|||
144544661|NCT02686658|521193727|FG005|Overall Study|Adverse Event|1|||
144544662|NCT02686658|521193722|FG000|Overall Study|Investigator decision|0|||
144544663|NCT02686658|521193723|FG001|Overall Study|Investigator decision|0|||
144544664|NCT02686658|521193724|FG002|Overall Study|Investigator decision|0|||
144544665|NCT02686658|521193725|FG003|Overall Study|Investigator decision|1|||
144544666|NCT02686658|521193726|FG004|Overall Study|Investigator decision|2|||
144544667|NCT02686658|521193727|FG005|Overall Study|Investigator decision|1|||
144544668|NCT02686658|521193722|FG000|Overall Study|Sponsor decision|1|||
144544669|NCT02686658|521193723|FG001|Overall Study|Sponsor decision|2|||
144544670|NCT02686658|521193724|FG002|Overall Study|Sponsor decision|1|||
144544671|NCT02686658|521193725|FG003|Overall Study|Sponsor decision|5|||
144544672|NCT02686658|521193726|FG004|Overall Study|Sponsor decision|13|||
144544673|NCT02686658|521193727|FG005|Overall Study|Sponsor decision|2|||
144544674|NCT02686658|521193722|FG000|Overall Study|Lost to Follow-up|0|||
144544675|NCT02686658|521193723|FG001|Overall Study|Lost to Follow-up|0|||
144544676|NCT02686658|521193724|FG002|Overall Study|Lost to Follow-up|2|||
144544677|NCT02686658|521193725|FG003|Overall Study|Lost to Follow-up|0|||
144544678|NCT02686658|521193726|FG004|Overall Study|Lost to Follow-up|0|||
144544679|NCT02686658|521193727|FG005|Overall Study|Lost to Follow-up|1|||
144544680|NCT02686658|521193722|FG000|Overall Study|Death|1|||
144544681|NCT02686658|521193723|FG001|Overall Study|Death|0|||
144544682|NCT02686658|521193724|FG002|Overall Study|Death|0|||
144544683|NCT02686658|521193725|FG003|Overall Study|Death|1|||
144544684|NCT02686658|521193726|FG004|Overall Study|Death|1|||
144544685|NCT02686658|521193727|FG005|Overall Study|Death|1|||
144544686|NCT02686658|521193722|FG000|Overall Study|Withdrawal by Subject|2|||
144544687|NCT02686658|521193723|FG001|Overall Study|Withdrawal by Subject|5|||
144544688|NCT02686658|521193724|FG002|Overall Study|Withdrawal by Subject|4|||
144202801|NCT02393248|519940262|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202802|NCT02393248|519940263|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202803|NCT02393248|519940264|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202804|NCT02393248|519940265|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202805|NCT02393248|519940266|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202806|NCT02393248|519940267|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202807|NCT02393248|519940268|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202808|NCT02393248|519940269|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
144202809|NCT02393248|519940245|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202810|NCT02393248|519940246|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202811|NCT02393248|519940247|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202812|NCT02393248|519940248|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202813|NCT02393248|519940249|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202814|NCT02393248|519940250|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202815|NCT02393248|519940251|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144544689|NCT02686658|521193725|FG003|Overall Study|Withdrawal by Subject|4|||
144544690|NCT02686658|521193726|FG004|Overall Study|Withdrawal by Subject|17|||
144544691|NCT02686658|521193727|FG005|Overall Study|Withdrawal by Subject|8|||
144202816|NCT02393248|519940252|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202817|NCT02393248|519940253|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202818|NCT02393248|519940254|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202819|NCT02393248|519940255|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202820|NCT02393248|519940256|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
144544692|NCT02686658|521193722|FG000|Overall Study|Placed in hospice care|0|||
144544693|NCT02686658|521193723|FG001|Overall Study|Placed in hospice care|0|||
144544694|NCT02686658|521193724|FG002|Overall Study|Placed in hospice care|1|||
144544695|NCT02686658|521193725|FG003|Overall Study|Placed in hospice care|0|||
144544696|NCT02686658|521193726|FG004|Overall Study|Placed in hospice care|0|||
144544697|NCT02686658|521193727|FG005|Overall Study|Placed in hospice care|0|||
144544698|NCT02686658|521193722|FG000|Overall Study|Participant non-compliance|0|||
144544699|NCT02686658|521193723|FG001|Overall Study|Participant non-compliance|0|||
144544700|NCT02686658|521193724|FG002|Overall Study|Participant non-compliance|0|||
144544701|NCT02686658|521193725|FG003|Overall Study|Participant non-compliance|0|||
144544702|NCT02686658|521193726|FG004|Overall Study|Participant non-compliance|0|||
144544703|NCT02686658|521193727|FG005|Overall Study|Participant non-compliance|1|||
144544704|NCT02686658|521193722|FG000|Overall Study|Concern over coronavirus disease care|0|||
144544705|NCT02686658|521193723|FG001|Overall Study|Concern over coronavirus disease care|0|||
144544706|NCT02686658|521193724|FG002|Overall Study|Concern over coronavirus disease care|0|||
144544707|NCT02686658|521193725|FG003|Overall Study|Concern over coronavirus disease care|0|||
144544708|NCT02686658|521193726|FG004|Overall Study|Concern over coronavirus disease care|2|||
144544709|NCT02686658|521193727|FG005|Overall Study|Concern over coronavirus disease care|1|||
144544710|NCT02542943|521193730|FG000|Overall Study|Lost to Follow-up|1|||
144544711|NCT02542943|521193731|FG001|Overall Study|Lost to Follow-up|0|||
144544712|NCT02542943|521193732|FG002|Overall Study|Lost to Follow-up|0|||
144544713|NCT02542943|521193730|FG000|Overall Study|Withdrawal by Subject|0|||
144544714|NCT02542943|521193731|FG001|Overall Study|Withdrawal by Subject|1|||
144544715|NCT02542943|521193732|FG002|Overall Study|Withdrawal by Subject|0|||
144544716|NCT03476798|521193733|FG000|Overall Study|Death|1|||
144544717|NCT03476798|521193733|FG000|Overall Study|Withdrawal by Subject|2|||
144544718|NCT03476798|521193733|FG000|Overall Study|Protocol Violation|2|||
144544719|NCT06269003|521193734|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
144544720|NCT06269003|521193735|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
144544721|NCT06269003|521193736|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
144544722|NCT06269003|521193737|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
144544723|NCT05865392|521193741|FG000|Overall Study|Withdrawal by Subject|4|||
144544724|NCT05865392|521193742|FG001|Overall Study|Withdrawal by Subject|0|||
144544725|NCT05865392|521193741|FG000|Overall Study|Didn't meet inclusion criteria|4|||
144544726|NCT05865392|521193742|FG001|Overall Study|Didn't meet inclusion criteria|0|||
144544727|NCT04447027|521193745|FG000|Dose Escalation|Withdrawal by Subject|1|||
144544728|NCT04447027|521193746|FG001|Dose Escalation|Withdrawal by Subject|4|||
144544729|NCT04447027|521193747|FG002|Dose Escalation|Withdrawal by Subject|3|||
144544730|NCT04447027|521193748|FG003|Dose Escalation|Withdrawal by Subject|3|||
144544731|NCT04447027|521193749|FG004|Dose Escalation|Withdrawal by Subject|1|||
144544732|NCT04447027|521193750|FG005|Dose Escalation|Withdrawal by Subject|0|||
144544733|NCT04447027|521193751|FG006|Dose Escalation|Withdrawal by Subject|0|||
144544734|NCT04447027|521193752|FG007|Dose Escalation|Withdrawal by Subject|0|||
144544735|NCT04447027|521193753|FG008|Dose Escalation|Withdrawal by Subject|0|||
144544736|NCT04447027|521193745|FG000|Dose Escalation|Refused further treatment|0|||
144544737|NCT04447027|521193746|FG001|Dose Escalation|Refused further treatment|1|||
144202821|NCT02393248|519940257|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
144202822|NCT02393248|519940258|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
144202823|NCT02393248|519940259|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
144202824|NCT02393248|519940260|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202825|NCT02393248|519940261|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144544738|NCT04447027|521193747|FG002|Dose Escalation|Refused further treatment|1|||
144544739|NCT04447027|521193748|FG003|Dose Escalation|Refused further treatment|0|||
144544740|NCT04447027|521193749|FG004|Dose Escalation|Refused further treatment|0|||
144544741|NCT04447027|521193750|FG005|Dose Escalation|Refused further treatment|0|||
144544742|NCT04447027|521193751|FG006|Dose Escalation|Refused further treatment|0|||
144544743|NCT04447027|521193752|FG007|Dose Escalation|Refused further treatment|0|||
144544744|NCT04447027|521193753|FG008|Dose Escalation|Refused further treatment|0|||
144544745|NCT04447027|521193745|FG000|Dose Expansion|Withdrawal by Subject|0|||
144544746|NCT04447027|521193746|FG001|Dose Expansion|Withdrawal by Subject|0|||
144544747|NCT04447027|521193747|FG002|Dose Expansion|Withdrawal by Subject|0|||
144202826|NCT02393248|519940262|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144262108|NCT01411852|520159798|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
144262109|NCT01411852|520159797|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
144544748|NCT04447027|521193748|FG003|Dose Expansion|Withdrawal by Subject|0|||
144544749|NCT04447027|521193749|FG004|Dose Expansion|Withdrawal by Subject|0|||
144544750|NCT04447027|521193750|FG005|Dose Expansion|Withdrawal by Subject|2|||
144202827|NCT02393248|519940263|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144262110|NCT01411852|520159798|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
144202828|NCT02393248|519940264|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202829|NCT02393248|519940265|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144262111|NCT01411852|520159797|FG000|Prehospital Intervention Phase|Found to be under age|0|||
144544751|NCT04447027|521193751|FG006|Dose Expansion|Withdrawal by Subject|0|||
144544752|NCT04447027|521193752|FG007|Dose Expansion|Withdrawal by Subject|2|||
144202830|NCT02393248|519940266|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202831|NCT02393248|519940267|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202832|NCT02393248|519940268|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202833|NCT02393248|519940269|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
144202834|NCT02393248|519940245|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202835|NCT02393248|519940246|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202836|NCT02393248|519940247|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202837|NCT02393248|519940248|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202838|NCT02393248|519940249|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144262112|NCT01411852|520159798|FG001|Prehospital Intervention Phase|Found to be under age|1|||
144262113|NCT01411852|520159797|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
144262114|NCT01411852|520159798|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
144544753|NCT04447027|521193753|FG008|Dose Expansion|Withdrawal by Subject|0|||
144544754|NCT02556918|521195088|FG000|Overall Study|Protocol Violation|5|||
144544755|NCT02556918|521195089|FG001|Overall Study|Protocol Violation|6|||
144544756|NCT02556918|521195088|FG000|Overall Study|Withdrawal by Subject|4|||
144544757|NCT02556918|521195089|FG001|Overall Study|Withdrawal by Subject|4|||
144544758|NCT00551421|521195092|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
144544759|NCT00799409|521195094|FG000|Overall Study|Withdrawal by Subject|1|||
144262115|NCT01411852|520159797|FG000|Hospital Intervention Phase|Severe head injury|5|||
144262116|NCT01411852|520159798|FG001|Hospital Intervention Phase|Severe head injury|4|||
144262117|NCT01411852|520159797|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
144262118|NCT01411852|520159798|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
144262119|NCT01411852|520159797|FG000|Hospital Intervention Phase|Miscommunication error|1|||
144262120|NCT01411852|520159798|FG001|Hospital Intervention Phase|Miscommunication error|2|||
144262121|NCT01411852|520159797|FG000|Hospital Intervention Phase|CPR administered|3|||
144262122|NCT01411852|520159798|FG001|Hospital Intervention Phase|CPR administered|1|||
144262123|NCT01411852|520159797|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
144262124|NCT01411852|520159798|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
144262125|NCT01411852|520159797|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
144262126|NCT01411852|520159798|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
144544760|NCT00799409|521195095|FG001|Overall Study|Withdrawal by Subject|0|||
144544761|NCT00799409|521195096|FG002|Overall Study|Withdrawal by Subject|0|||
144544762|NCT00799409|521195094|FG000|Overall Study|Lost to Follow-up|1|||
144544763|NCT00799409|521195095|FG001|Overall Study|Lost to Follow-up|0|||
144544764|NCT00799409|521195096|FG002|Overall Study|Lost to Follow-up|0|||
144544765|NCT00799409|521195094|FG000|Overall Study|Optimal Dose Not Achieved|2|||
144262127|NCT01411852|520159797|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
144262128|NCT01411852|520159798|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
144262129|NCT01411852|520159797|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
144262130|NCT01411852|520159798|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
144262131|NCT01411852|520159797|FG000|Hospital Intervention Phase|Other ineligible|2|||
144262132|NCT01411852|520159798|FG001|Hospital Intervention Phase|Other ineligible|2|||
144262133|NCT01411852|520159797|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
144262134|NCT01411852|520159798|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
144262135|NCT01411852|520159797|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
144262136|NCT01411852|520159798|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
144262137|NCT01411852|520159797|FG000|Hospital Intervention Phase|Vascular access failed|1|||
144262138|NCT01411852|520159798|FG001|Hospital Intervention Phase|Vascular access failed|0|||
144544766|NCT00799409|521195095|FG001|Overall Study|Optimal Dose Not Achieved|0|||
144544767|NCT00799409|521195096|FG002|Overall Study|Optimal Dose Not Achieved|0|||
144544768|NCT00799409|521195094|FG000|Overall Study|Failure to follow study protocol)|1|||
144544769|NCT00799409|521195095|FG001|Overall Study|Failure to follow study protocol)|0|||
144544770|NCT00799409|521195096|FG002|Overall Study|Failure to follow study protocol)|0|||
144544771|NCT00799409|521195094|FG000|Overall Study|Did not attend lab school day 1|1|||
144544772|NCT00799409|521195095|FG001|Overall Study|Did not attend lab school day 1|0|||
144544773|NCT00799409|521195096|FG002|Overall Study|Did not attend lab school day 1|0|||
144544774|NCT00799409|521195094|FG000|Overall Study|medication compliance|1|||
144544775|NCT00799409|521195095|FG001|Overall Study|medication compliance|0|||
144544776|NCT00799409|521195096|FG002|Overall Study|medication compliance|0|||
144544777|NCT04323800|521195098|FG000|Overall Study|Withdrawal by Subject|4|||
144544778|NCT04323800|521195099|FG001|Overall Study|Withdrawal by Subject|4|||
144544779|NCT04323800|521195098|FG000|Overall Study|Incomplete transfusion|1|||
144544780|NCT04323800|521195099|FG001|Overall Study|Incomplete transfusion|0|||
144262139|NCT00321906|520159799|FG000|Overall Study|Adverse Event|36|||
144262140|NCT00321906|520159800|FG001|Overall Study|Adverse Event|44|||
144262141|NCT00321906|520159799|FG000|Overall Study|Death|9|||
144262142|NCT00321906|520159800|FG001|Overall Study|Death|6|||
144544781|NCT04323800|521195098|FG000|Overall Study|Other|0|||
144544782|NCT04323800|521195099|FG001|Overall Study|Other|1|||
144544783|NCT04323800|521195098|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
144544784|NCT04323800|521195099|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
144544785|NCT00489554|521195100|FG000|Overall Study|Adverse Event|2|||
144544786|NCT00489554|521195100|FG000|Overall Study|Withdrawal by Subject|1|||
144544787|NCT00489554|521195100|FG000|Overall Study|Lost to Follow-up|1|||
144544788|NCT00731692|521195101|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
144544789|NCT00731692|521195102|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
144544790|NCT00731692|521195103|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
144544791|NCT00731692|521195101|FG000|Core Study (36 Months)|Physician Decision|1|||
144544792|NCT00731692|521195102|FG001|Core Study (36 Months)|Physician Decision|0|||
144544793|NCT00731692|521195103|FG002|Core Study (36 Months)|Physician Decision|2|||
144544794|NCT00731692|521195101|FG000|Core Study (36 Months)|Death|2|||
144544795|NCT00731692|521195102|FG001|Core Study (36 Months)|Death|1|||
144544796|NCT00731692|521195103|FG002|Core Study (36 Months)|Death|2|||
144544797|NCT00731692|521195101|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
144544798|NCT00731692|521195102|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
144544799|NCT00731692|521195103|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
144544800|NCT00731692|521195101|FG000|Core Study (36 Months)|Administrative|2|||
144262143|NCT00321906|520159799|FG000|Overall Study|Lost to Follow-up|1|||
144262144|NCT00321906|520159800|FG001|Overall Study|Lost to Follow-up|2|||
144544801|NCT00731692|521195102|FG001|Core Study (36 Months)|Administrative|2|||
144544802|NCT00731692|521195103|FG002|Core Study (36 Months)|Administrative|6|||
144544803|NCT00731692|521195101|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
144544804|NCT00731692|521195102|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
144544805|NCT00731692|521195103|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
144544806|NCT00731692|521195101|FG000|Core Study (36 Months)|Protocol Violation|4|||
144544807|NCT00731692|521195102|FG001|Core Study (36 Months)|Protocol Violation|5|||
144544808|NCT00731692|521195103|FG002|Core Study (36 Months)|Protocol Violation|8|||
144544809|NCT00731692|521195101|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
144544810|NCT00731692|521195102|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
144544811|NCT00731692|521195103|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
144544812|NCT00731692|521195101|FG000|Core Study (36 Months)|Adverse Event|25|||
144544813|NCT00731692|521195102|FG001|Core Study (36 Months)|Adverse Event|28|||
144544814|NCT00731692|521195103|FG002|Core Study (36 Months)|Adverse Event|29|||
144544815|NCT00731692|521195101|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
144544816|NCT00731692|521195102|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
144544817|NCT00731692|521195103|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
144544818|NCT00731692|521195101|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
144544819|NCT00731692|521195102|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
144544820|NCT00731692|521195103|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
144544821|NCT00731692|521195101|FG000|Extension Phase|Abnormal test procedure|0|||
144544822|NCT00731692|521195102|FG001|Extension Phase|Abnormal test procedure|0|||
144544823|NCT00731692|521195103|FG002|Extension Phase|Abnormal test procedure|1|||
144544824|NCT00731692|521195101|FG000|Extension Phase|Abnormal lab values|0|||
144544825|NCT00731692|521195102|FG001|Extension Phase|Abnormal lab values|0|||
144544826|NCT00731692|521195103|FG002|Extension Phase|Abnormal lab values|1|||
144544827|NCT00731692|521195101|FG000|Extension Phase|Lost to Follow-up|0|||
144544828|NCT00731692|521195102|FG001|Extension Phase|Lost to Follow-up|1|||
144544829|NCT00731692|521195103|FG002|Extension Phase|Lost to Follow-up|4|||
144544830|NCT00731692|521195101|FG000|Extension Phase|Withdrawal by Subject|4|||
144544831|NCT00731692|521195102|FG001|Extension Phase|Withdrawal by Subject|5|||
144544832|NCT00731692|521195103|FG002|Extension Phase|Withdrawal by Subject|3|||
144544833|NCT00731692|521195101|FG000|Extension Phase|Adverse Event|1|||
144544834|NCT00731692|521195102|FG001|Extension Phase|Adverse Event|1|||
144544835|NCT00731692|521195103|FG002|Extension Phase|Adverse Event|15|||
144544836|NCT01214200|521195104|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
144544837|NCT01214200|521195104|FG000|Overall Study|Withdrawal by Subject|2|||
144544838|NCT00670488|521195106|FG000|Overall Study|Adverse Event|0|||
144544839|NCT00670488|521195107|FG001|Overall Study|Adverse Event|7|||
144544840|NCT00670488|521195108|FG002|Overall Study|Adverse Event|0|||
144544841|NCT00670488|521195109|FG003|Overall Study|Adverse Event|3|||
144544842|NCT00670488|521195110|FG004|Overall Study|Adverse Event|1|||
144544843|NCT00670488|521195111|FG005|Overall Study|Adverse Event|1|||
144544844|NCT00670488|521195112|FG006|Overall Study|Adverse Event|5|||
144544845|NCT00670488|521195113|FG007|Overall Study|Adverse Event|1|||
144544846|NCT00670488|521195114|FG008|Overall Study|Adverse Event|0|||
144544847|NCT00670488|521195115|FG009|Overall Study|Adverse Event|1|||
144544848|NCT00670488|521195106|FG000|Overall Study|Physician Decision|1|||
144544849|NCT00670488|521195107|FG001|Overall Study|Physician Decision|9|||
144544850|NCT00670488|521195108|FG002|Overall Study|Physician Decision|0|||
144544851|NCT00670488|521195109|FG003|Overall Study|Physician Decision|1|||
144544852|NCT00670488|521195110|FG004|Overall Study|Physician Decision|0|||
144544853|NCT00670488|521195111|FG005|Overall Study|Physician Decision|0|||
144544854|NCT00670488|521195112|FG006|Overall Study|Physician Decision|0|||
144544855|NCT00670488|521195113|FG007|Overall Study|Physician Decision|0|||
144544856|NCT00670488|521195114|FG008|Overall Study|Physician Decision|0|||
144544857|NCT00670488|521195115|FG009|Overall Study|Physician Decision|0|||
144544858|NCT00670488|521195106|FG000|Overall Study|Progressive Disease|2|||
144544859|NCT00670488|521195107|FG001|Overall Study|Progressive Disease|41|||
144544860|NCT00670488|521195108|FG002|Overall Study|Progressive Disease|3|||
144544861|NCT00670488|521195109|FG003|Overall Study|Progressive Disease|2|||
144544862|NCT00670488|521195110|FG004|Overall Study|Progressive Disease|2|||
144544863|NCT00670488|521195111|FG005|Overall Study|Progressive Disease|4|||
144544864|NCT00670488|521195112|FG006|Overall Study|Progressive Disease|11|||
144544865|NCT00670488|521195113|FG007|Overall Study|Progressive Disease|2|||
144544866|NCT00670488|521195114|FG008|Overall Study|Progressive Disease|2|||
144544867|NCT00670488|521195115|FG009|Overall Study|Progressive Disease|1|||
144544868|NCT00670488|521195106|FG000|Overall Study|Withdrawal by Subject|0|||
144544869|NCT00670488|521195107|FG001|Overall Study|Withdrawal by Subject|1|||
144544870|NCT00670488|521195108|FG002|Overall Study|Withdrawal by Subject|0|||
144544871|NCT00670488|521195109|FG003|Overall Study|Withdrawal by Subject|1|||
144544872|NCT00670488|521195110|FG004|Overall Study|Withdrawal by Subject|0|||
144544873|NCT00670488|521195111|FG005|Overall Study|Withdrawal by Subject|0|||
144544874|NCT00670488|521195112|FG006|Overall Study|Withdrawal by Subject|1|||
144544875|NCT00670488|521195113|FG007|Overall Study|Withdrawal by Subject|0|||
144544876|NCT00670488|521195114|FG008|Overall Study|Withdrawal by Subject|1|||
144544877|NCT00670488|521195115|FG009|Overall Study|Withdrawal by Subject|0|||
144544878|NCT02708498|521195116|FG000|Overall Study|Death|20|||
144727490|NCT02101853|521856655|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
144727491|NCT02101853|521856656|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
144727492|NCT02101853|521856651|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
144727493|NCT02101853|521856652|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727494|NCT02101853|521856653|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727495|NCT02101853|521856654|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727496|NCT02101853|521856655|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727497|NCT02101853|521856656|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727498|NCT02101853|521856651|FG000|Post Induction Randomization|Adverse Event|0|||
144727499|NCT02101853|521856652|FG001|Post Induction Randomization|Adverse Event|3|||
144727500|NCT02101853|521856653|FG002|Post Induction Randomization|Adverse Event|8|||
144727501|NCT02101853|521856654|FG003|Post Induction Randomization|Adverse Event|4|||
144727502|NCT02101853|521856655|FG004|Post Induction Randomization|Adverse Event|4|||
144544879|NCT02708498|521195117|FG001|Overall Study|Death|19|||
144202839|NCT02393248|519940250|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144544880|NCT02708498|521195118|FG002|Overall Study|Death|0|||
144544881|NCT02708498|521195119|FG003|Overall Study|Death|0|||
144544882|NCT02708498|521195120|FG004|Overall Study|Death|1|||
144544883|NCT02708498|521195121|FG005|Overall Study|Death|0|||
144544884|NCT02708498|521195122|FG006|Overall Study|Death|0|||
144544885|NCT02708498|521195123|FG007|Overall Study|Death|0|||
144544886|NCT02708498|521195116|FG000|Overall Study|Unknown reason, missing data|0|||
144544887|NCT02708498|521195117|FG001|Overall Study|Unknown reason, missing data|0|||
144544888|NCT02708498|521195118|FG002|Overall Study|Unknown reason, missing data|62|||
144544889|NCT02708498|521195119|FG003|Overall Study|Unknown reason, missing data|51|||
144544890|NCT02708498|521195120|FG004|Overall Study|Unknown reason, missing data|195|||
144544891|NCT02708498|521195121|FG005|Overall Study|Unknown reason, missing data|132|||
144544892|NCT02708498|521195122|FG006|Overall Study|Unknown reason, missing data|0|||
144544893|NCT02708498|521195123|FG007|Overall Study|Unknown reason, missing data|0|||
144544894|NCT03052517|521195124|FG000|Overall Study|Study Terminated By Sponsor|928|||
144544895|NCT03052517|521195125|FG001|Overall Study|Study Terminated By Sponsor|938|||
144544896|NCT03052517|521195126|FG002|Overall Study|Study Terminated By Sponsor|296|||
144544897|NCT03052517|521195124|FG000|Overall Study|Subject/Guardian Decision|50|||
144544898|NCT03052517|521195125|FG001|Overall Study|Subject/Guardian Decision|45|||
144544899|NCT03052517|521195126|FG002|Overall Study|Subject/Guardian Decision|22|||
144544900|NCT03052517|521195124|FG000|Overall Study|Lack of Efficacy|23|||
144544901|NCT03052517|521195125|FG001|Overall Study|Lack of Efficacy|14|||
144544902|NCT03052517|521195126|FG002|Overall Study|Lack of Efficacy|7|||
144544903|NCT03052517|521195124|FG000|Overall Study|Adverse Event|6|||
144544904|NCT03052517|521195125|FG001|Overall Study|Adverse Event|5|||
144544905|NCT03052517|521195126|FG002|Overall Study|Adverse Event|0|||
144544906|NCT03052517|521195124|FG000|Overall Study|Physician Decision|4|||
144544907|NCT03052517|521195125|FG001|Overall Study|Physician Decision|5|||
144544908|NCT03052517|521195126|FG002|Overall Study|Physician Decision|1|||
144544909|NCT03052517|521195124|FG000|Overall Study|Death|3|||
144544910|NCT03052517|521195125|FG001|Overall Study|Death|0|||
144544911|NCT03052517|521195126|FG002|Overall Study|Death|1|||
144544912|NCT03052517|521195124|FG000|Overall Study|Lost to Follow-up|2|||
144544913|NCT03052517|521195125|FG001|Overall Study|Lost to Follow-up|4|||
144544914|NCT03052517|521195126|FG002|Overall Study|Lost to Follow-up|0|||
144544915|NCT03052517|521195124|FG000|Overall Study|Pregnancy|1|||
144544916|NCT03052517|521195125|FG001|Overall Study|Pregnancy|0|||
144544917|NCT03052517|521195126|FG002|Overall Study|Pregnancy|1|||
144544918|NCT03052517|521195124|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
144544919|NCT03052517|521195125|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
144544920|NCT03052517|521195126|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
144544921|NCT03052517|521195124|FG000|Overall Study|Technical Problems|0|||
144544922|NCT03052517|521195125|FG001|Overall Study|Technical Problems|1|||
144544923|NCT03052517|521195126|FG002|Overall Study|Technical Problems|0|||
144544924|NCT00195819|521195127|FG000|Double-Blind|Withdrawal by Subject|1|||
144544925|NCT00195819|521195128|FG001|Double-Blind|Withdrawal by Subject|0|||
144544926|NCT00195819|521195127|FG000|Double-Blind|Moved|1|||
144202840|NCT02393248|519940251|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202841|NCT02393248|519940252|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202842|NCT02393248|519940253|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202843|NCT02393248|519940254|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202844|NCT02393248|519940255|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
144544927|NCT00195819|521195128|FG001|Double-Blind|Moved|0|||
144544928|NCT00195819|521195127|FG000|Open-label|Adverse Event|0|||
144544929|NCT00195819|521195128|FG001|Open-label|Adverse Event|9|||
144544930|NCT00195819|521195127|FG000|Open-label|Lack of Efficacy|0|||
144544931|NCT00195819|521195128|FG001|Open-label|Lack of Efficacy|2|||
144544932|NCT00195819|521195127|FG000|Open-label|Pregnancy|0|||
144202845|NCT02393248|519940256|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
144202846|NCT02393248|519940257|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202847|NCT02393248|519940258|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202848|NCT02393248|519940259|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144544933|NCT00195819|521195128|FG001|Open-label|Pregnancy|1|||
144544934|NCT00195819|521195127|FG000|Open-label|Protocol Violation|0|||
144544935|NCT00195819|521195128|FG001|Open-label|Protocol Violation|2|||
144544936|NCT00195819|521195127|FG000|Open-label|Moved|0|||
144544937|NCT00195819|521195128|FG001|Open-label|Moved|1|||
144544938|NCT00195819|521195127|FG000|Open-label|Withdrawal by Subject|0|||
144544939|NCT00195819|521195128|FG001|Open-label|Withdrawal by Subject|5|||
144544940|NCT01124045|521195129|FG000|Overall Study|Lost to Follow-up|0|||
144544941|NCT01124045|521195130|FG001|Overall Study|Lost to Follow-up|1|||
144544942|NCT01124045|521195129|FG000|Overall Study|Physician Decision|0|||
144544943|NCT01124045|521195130|FG001|Overall Study|Physician Decision|2|||
144544944|NCT03298087|521195131|FG000|Overall Study|Withdrawal by Subject|4|||
144544945|NCT01629589|521195132|FG000|Overall Study|Protocol Violation|4|||
144544946|NCT01629589|521195133|FG001|Overall Study|Protocol Violation|2|||
144544947|NCT01629589|521195132|FG000|Overall Study|Lost to Follow-up|2|||
144544948|NCT01629589|521195133|FG001|Overall Study|Lost to Follow-up|1|||
144544949|NCT01629589|521195132|FG000|Overall Study|Withdrawal by Subject|2|||
144544950|NCT01629589|521195133|FG001|Overall Study|Withdrawal by Subject|3|||
144544951|NCT01629589|521195132|FG000|Overall Study|Did not receive study vaccine|0|||
144544952|NCT01629589|521195133|FG001|Overall Study|Did not receive study vaccine|1|||
144544953|NCT01530334|521195134|FG000|Overall Study|Adverse Event|3|||
144544954|NCT01530334|521195134|FG000|Overall Study|unknown reason|1|||
144544955|NCT01530334|521195134|FG000|Overall Study|Progressive disease|47|||
144544956|NCT01303510|521195135|FG000|Overall Study|Lost to Follow-up|1|||
144544957|NCT01303510|521195136|FG001|Overall Study|Lost to Follow-up|0|||
144544958|NCT00822900|521195137|FG000|Overall Study|Withdrawal by Subject|14|||
144544959|NCT00822900|521195138|FG001|Overall Study|Withdrawal by Subject|14|||
144544960|NCT00822900|521195137|FG000|Overall Study|Lost to Follow-up|9|||
144544961|NCT00822900|521195138|FG001|Overall Study|Lost to Follow-up|9|||
144544962|NCT00822900|521195137|FG000|Overall Study|Death|83|||
144544963|NCT00822900|521195138|FG001|Overall Study|Death|69|||
144544964|NCT00822900|521195137|FG000|Overall Study|Became a ward of the state|2|||
144544965|NCT00822900|521195138|FG001|Overall Study|Became a ward of the state|1|||
144544966|NCT02234141|521195139|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
144544967|NCT02234141|521195140|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
144544968|NCT02234141|521195141|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
144544969|NCT02234141|521195142|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
144544970|NCT02234141|521195143|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
144544971|NCT02234141|521195144|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
144544972|NCT02234141|521195145|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
144544973|NCT02234141|521195139|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
144544974|NCT02234141|521195140|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
144544975|NCT02234141|521195141|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
144544976|NCT02234141|521195142|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
144544977|NCT02234141|521195143|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
144544978|NCT02234141|521195144|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
144544979|NCT02234141|521195145|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
144544980|NCT02234141|521195139|FG000|Treatment Period (24 Weeks)|Death|1|||
144544981|NCT02234141|521195140|FG001|Treatment Period (24 Weeks)|Death|2|||
144544982|NCT02234141|521195141|FG002|Treatment Period (24 Weeks)|Death|0|||
144544983|NCT02234141|521195142|FG003|Treatment Period (24 Weeks)|Death|1|||
144544984|NCT02234141|521195143|FG004|Treatment Period (24 Weeks)|Death|0|||
144544985|NCT02234141|521195144|FG005|Treatment Period (24 Weeks)|Death|0|||
144544986|NCT02234141|521195145|FG006|Treatment Period (24 Weeks)|Death|0|||
144544987|NCT02234141|521195139|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
144544988|NCT02234141|521195140|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
144544989|NCT02234141|521195141|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
144544990|NCT02234141|521195142|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
144544991|NCT02234141|521195143|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
144544992|NCT02234141|521195144|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
144544993|NCT02234141|521195145|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
144544994|NCT02234141|521195139|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
144544995|NCT02234141|521195140|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
144544996|NCT02234141|521195141|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
144544997|NCT02234141|521195142|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
144544998|NCT02234141|521195143|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
144544999|NCT02234141|521195144|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
144545000|NCT02234141|521195145|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
144545001|NCT02234141|521195139|FG000|Long-Term Treatment Period|Death|0|||
144545002|NCT02234141|521195140|FG001|Long-Term Treatment Period|Death|0|||
144545003|NCT02234141|521195141|FG002|Long-Term Treatment Period|Death|0|||
144262145|NCT00321906|520159799|FG000|Overall Study|Withdrawal by Subject|0|||
144262146|NCT00321906|520159800|FG001|Overall Study|Withdrawal by Subject|4|||
144262147|NCT00807885|520159805|FG000|Overall Study|Lost to Follow-up|0|||
144262148|NCT00807885|520159806|FG001|Overall Study|Lost to Follow-up|0|||
144545004|NCT02234141|521195142|FG003|Long-Term Treatment Period|Death|0|||
144545005|NCT02234141|521195143|FG004|Long-Term Treatment Period|Death|0|||
144545006|NCT02234141|521195144|FG005|Long-Term Treatment Period|Death|1|||
144545007|NCT02234141|521195145|FG006|Long-Term Treatment Period|Death|0|||
144545008|NCT02234141|521195139|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
144545009|NCT02234141|521195140|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
144545010|NCT02234141|521195141|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
144545011|NCT02234141|521195142|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
144545012|NCT02234141|521195143|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
144545013|NCT02234141|521195144|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
144545014|NCT02234141|521195145|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
144545015|NCT02234141|521195139|FG000|Long-Term Treatment Period|Adverse Event|4|||
144545016|NCT02234141|521195140|FG001|Long-Term Treatment Period|Adverse Event|0|||
144727503|NCT02101853|521856656|FG005|Post Induction Randomization|Adverse Event|0|||
144545017|NCT02234141|521195141|FG002|Long-Term Treatment Period|Adverse Event|5|||
144545018|NCT02234141|521195142|FG003|Long-Term Treatment Period|Adverse Event|0|||
144545019|NCT02234141|521195143|FG004|Long-Term Treatment Period|Adverse Event|1|||
144545020|NCT02234141|521195144|FG005|Long-Term Treatment Period|Adverse Event|1|||
144545021|NCT02234141|521195145|FG006|Long-Term Treatment Period|Adverse Event|1|||
144545022|NCT02234141|521195139|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
144545023|NCT02234141|521195140|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
144545024|NCT02234141|521195141|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
144545025|NCT02234141|521195142|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
144545026|NCT02234141|521195143|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
144545027|NCT02234141|521195144|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
144545028|NCT02234141|521195145|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
144545029|NCT02234141|521195139|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
144545030|NCT02234141|521195140|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
144545031|NCT02234141|521195141|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
144262149|NCT00807885|520159807|FG002|Overall Study|Lost to Follow-up|0|||
144262150|NCT00807885|520159808|FG003|Overall Study|Lost to Follow-up|0|||
144262151|NCT00807885|520159809|FG004|Overall Study|Lost to Follow-up|0|||
144545032|NCT02234141|521195142|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
144545033|NCT02234141|521195143|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
144545034|NCT02234141|521195144|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
144545035|NCT02234141|521195145|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
144545036|NCT03162614|521195146|FG000|Overall Study|Lost to Follow-up|2|||
144545037|NCT03162614|521195147|FG001|Overall Study|Lost to Follow-up|1|||
144727504|NCT02101853|521856651|FG000|Post Induction Randomization|Death|0|||
144545038|NCT03162614|521195148|FG002|Overall Study|Lost to Follow-up|1|||
144545039|NCT03162614|521195149|FG003|Overall Study|Lost to Follow-up|1|||
144545040|NCT03162614|521195150|FG004|Overall Study|Lost to Follow-up|2|||
144545041|NCT03162614|521195151|FG005|Overall Study|Lost to Follow-up|0|||
144545042|NCT03162614|521195146|FG000|Overall Study|Protocol Violation|0|||
144545043|NCT03162614|521195147|FG001|Overall Study|Protocol Violation|1|||
144545044|NCT03162614|521195148|FG002|Overall Study|Protocol Violation|0|||
144545045|NCT03162614|521195149|FG003|Overall Study|Protocol Violation|1|||
144545046|NCT03162614|521195150|FG004|Overall Study|Protocol Violation|0|||
144545047|NCT03162614|521195151|FG005|Overall Study|Protocol Violation|0|||
144545048|NCT03162614|521195146|FG000|Overall Study|Withdrawal by Subject|2|||
144545049|NCT03162614|521195147|FG001|Overall Study|Withdrawal by Subject|1|||
144545050|NCT03162614|521195148|FG002|Overall Study|Withdrawal by Subject|1|||
144545051|NCT03162614|521195149|FG003|Overall Study|Withdrawal by Subject|1|||
144545052|NCT03162614|521195150|FG004|Overall Study|Withdrawal by Subject|0|||
144545053|NCT03162614|521195151|FG005|Overall Study|Withdrawal by Subject|0|||
144545054|NCT03162614|521195146|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
144545055|NCT03162614|521195147|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
144545056|NCT03162614|521195148|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
144727505|NCT02101853|521856652|FG001|Post Induction Randomization|Death|9|||
144727506|NCT02101853|521856653|FG002|Post Induction Randomization|Death|2|||
144727507|NCT02101853|521856654|FG003|Post Induction Randomization|Death|2|||
144727508|NCT02101853|521856655|FG004|Post Induction Randomization|Death|0|||
144727509|NCT02101853|521856656|FG005|Post Induction Randomization|Death|0|||
144262152|NCT00807885|520159810|FG005|Overall Study|Lost to Follow-up|1|||
144545057|NCT03162614|521195149|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
144545058|NCT03162614|521195150|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
144545059|NCT03162614|521195151|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
144545060|NCT01957163|521195152|FG000|Overall Study|Adverse Event|5|||
144262153|NCT00807885|520159811|FG006|Overall Study|Lost to Follow-up|0|||
144545061|NCT01957163|521195153|FG001|Overall Study|Adverse Event|2|||
144545062|NCT01957163|521195154|FG002|Overall Study|Adverse Event|4|||
144545063|NCT01957163|521195152|FG000|Overall Study|Lack of Efficacy|5|||
144545064|NCT01957163|521195153|FG001|Overall Study|Lack of Efficacy|4|||
144545065|NCT01957163|521195154|FG002|Overall Study|Lack of Efficacy|9|||
144545066|NCT01957163|521195152|FG000|Overall Study|Protocol Violation|1|||
144545067|NCT01957163|521195153|FG001|Overall Study|Protocol Violation|2|||
144545068|NCT01957163|521195154|FG002|Overall Study|Protocol Violation|0|||
144545069|NCT01957163|521195152|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
144545070|NCT01957163|521195153|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
144545071|NCT01957163|521195154|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
144545072|NCT01957163|521195152|FG000|Overall Study|Lost to Follow-up|0|||
144545073|NCT01957163|521195153|FG001|Overall Study|Lost to Follow-up|1|||
144545074|NCT01957163|521195154|FG002|Overall Study|Lost to Follow-up|0|||
144545075|NCT01957163|521195152|FG000|Overall Study|Withdrawal by Subject|4|||
144545076|NCT01957163|521195153|FG001|Overall Study|Withdrawal by Subject|2|||
144545077|NCT01957163|521195154|FG002|Overall Study|Withdrawal by Subject|4|||
144545078|NCT00243867|521195159|FG000|Overall Study|Adverse Event|24|||
144545079|NCT00243867|521195160|FG001|Overall Study|Adverse Event|34|||
144545080|NCT00243867|521195159|FG000|Overall Study|Lack of Efficacy|115|||
144545081|NCT00243867|521195160|FG001|Overall Study|Lack of Efficacy|78|||
144545082|NCT00243867|521195159|FG000|Overall Study|Withdrawal by Subject|11|||
144545083|NCT00243867|521195160|FG001|Overall Study|Withdrawal by Subject|23|||
144545084|NCT00243867|521195159|FG000|Overall Study|Lost to Follow-up|2|||
144545085|NCT00243867|521195160|FG001|Overall Study|Lost to Follow-up|1|||
144545086|NCT00243867|521195159|FG000|Overall Study|Physician Decision|2|||
144545087|NCT00243867|521195160|FG001|Overall Study|Physician Decision|7|||
144545088|NCT00243867|521195159|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
144545089|NCT00243867|521195160|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
144545090|NCT01321073|521195166|FG000|Overall Study|Did not attempt implant|4|||
144545091|NCT01321073|521195166|FG000|Overall Study|Death|3|||
144545092|NCT02309294|521195174|FG000|Overall Study|Withdrawal by Subject|2|||
144545093|NCT02609048|521195184|FG000|Overall Study|Adverse Event|3|||
144545094|NCT02609048|521195185|FG001|Overall Study|Adverse Event|0|||
144545095|NCT02609048|521195186|FG002|Overall Study|Adverse Event|0|||
144545096|NCT02609048|521195184|FG000|Overall Study|Randomized but never treated|1|||
144545097|NCT02609048|521195185|FG001|Overall Study|Randomized but never treated|1|||
144202849|NCT02393248|519940260|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202850|NCT02393248|519940261|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202851|NCT02393248|519940262|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144262154|NCT00807885|520159812|FG007|Overall Study|Lost to Follow-up|0|||
144545098|NCT02609048|521195186|FG002|Overall Study|Randomized but never treated|1|||
144545099|NCT02609048|521195184|FG000|Overall Study|Withdrawal of informed consent|1|||
144545100|NCT02609048|521195185|FG001|Overall Study|Withdrawal of informed consent|0|||
144545101|NCT02609048|521195186|FG002|Overall Study|Withdrawal of informed consent|0|||
144545102|NCT02609048|521195184|FG000|Overall Study|Reason not specified|6|||
144545103|NCT02609048|521195185|FG001|Overall Study|Reason not specified|9|||
144545104|NCT02609048|521195186|FG002|Overall Study|Reason not specified|9|||
144545105|NCT04186247|521195191|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
144545106|NCT04186247|521195192|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
144545107|NCT04186247|521195193|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
144545108|NCT04186247|521195194|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
144545109|NCT04186247|521195195|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
144545110|NCT04118894|521195196|FG000|Overall Study|Lost to Follow-up|21|||
144545111|NCT04118894|521195196|FG000|Overall Study|Withdrawal by Subject|10|||
144545112|NCT04118894|521195196|FG000|Overall Study|Adverse Event|4|||
144545113|NCT02969356|521195203|FG000|Overall Study|Adverse Event|7|||
144545114|NCT02969356|521195203|FG000|Overall Study|Consent withdrawn|2|||
144545115|NCT02969356|521195203|FG000|Overall Study|Lost to Follow-up|3|||
144545116|NCT02969356|521195203|FG000|Overall Study|Did not need to be reinjected|6|||
144727510|NCT02101853|521856651|FG000|Post Induction Randomization|Lack of Efficacy|0|||
144727511|NCT02101853|521856652|FG001|Post Induction Randomization|Lack of Efficacy|14|||
144727512|NCT02101853|521856653|FG002|Post Induction Randomization|Lack of Efficacy|23|||
144727513|NCT02101853|521856654|FG003|Post Induction Randomization|Lack of Efficacy|18|||
144545117|NCT02969356|521195203|FG000|Overall Study|Personal reasons|5|||
144545118|NCT04511702|521196067|FG000|Overall Study|Lost to Follow-up|3|||
144545119|NCT04511702|521196068|FG001|Overall Study|Lost to Follow-up|0|||
144545120|NCT04511702|521196069|FG002|Overall Study|Lost to Follow-up|4|||
144545121|NCT04511702|521196067|FG000|Overall Study|Withdrawal by Subject|17|||
144545122|NCT04511702|521196068|FG001|Overall Study|Withdrawal by Subject|1|||
144545123|NCT04511702|521196069|FG002|Overall Study|Withdrawal by Subject|8|||
144545124|NCT04493424|521196070|FG000|Overall Study|Termination of the trial by the sponsor|89|||
144545125|NCT04493424|521196070|FG000|Overall Study|Withdrawal by Subject|9|||
144545126|NCT04493424|521196070|FG000|Overall Study|Lost to Follow-up|2|||
144545127|NCT04493424|521196070|FG000|Overall Study|Lack of Efficacy|3|||
144545128|NCT04493424|521196070|FG000|Overall Study|Adverse Event|5|||
144545129|NCT04992273|521196074|FG000|Overall Study|Lost to Follow-up|0|||
144545130|NCT04992273|521196075|FG001|Overall Study|Lost to Follow-up|1|||
144545131|NCT01364597|521196076|FG000|Overall Study|Adverse Event|4|||
144545132|NCT01364597|521196077|FG001|Overall Study|Adverse Event|5|||
144262155|NCT00807885|520159813|FG008|Overall Study|Lost to Follow-up|0|||
144262156|NCT00810069|520159817|FG000|Lead-in Period I|Adverse Event|43|||
144262157|NCT00810069|520159818|FG001|Lead-in Period I|Adverse Event|0|||
144262158|NCT00810069|520159819|FG002|Lead-in Period I|Adverse Event|0|||
144545133|NCT01364597|521196078|FG002|Overall Study|Adverse Event|16|||
144545134|NCT01364597|521196079|FG003|Overall Study|Adverse Event|7|||
144262159|NCT00810069|520159817|FG000|Lead-in Period I|Lack of Efficacy|1|||
144262160|NCT00810069|520159818|FG001|Lead-in Period I|Lack of Efficacy|0|||
144262161|NCT00810069|520159819|FG002|Lead-in Period I|Lack of Efficacy|0|||
144262162|NCT00810069|520159817|FG000|Lead-in Period I|Lost to Follow-up|19|||
144262163|NCT00810069|520159818|FG001|Lead-in Period I|Lost to Follow-up|0|||
144262164|NCT00810069|520159819|FG002|Lead-in Period I|Lost to Follow-up|0|||
144262165|NCT00810069|520159817|FG000|Lead-in Period I|Physician Decision|1|||
144262166|NCT00810069|520159818|FG001|Lead-in Period I|Physician Decision|0|||
144262167|NCT00810069|520159819|FG002|Lead-in Period I|Physician Decision|0|||
144262168|NCT00810069|520159817|FG000|Lead-in Period I|Protocol Violation|1|||
144262169|NCT00810069|520159818|FG001|Lead-in Period I|Protocol Violation|0|||
144262170|NCT00810069|520159819|FG002|Lead-in Period I|Protocol Violation|0|||
144262171|NCT00810069|520159817|FG000|Lead-in Period I|Withdrawal by Subject|46|||
144262172|NCT00810069|520159818|FG001|Lead-in Period I|Withdrawal by Subject|0|||
144262173|NCT00810069|520159819|FG002|Lead-in Period I|Withdrawal by Subject|0|||
144262174|NCT00810069|520159817|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
144262175|NCT00810069|520159818|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
144262176|NCT00810069|520159819|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
144262177|NCT00810069|520159817|FG000|Lead-in Period I|Randomization criteria not met|158|||
144262178|NCT00810069|520159818|FG001|Lead-in Period I|Randomization criteria not met|0|||
144545135|NCT01364597|521196076|FG000|Overall Study|Lack of Efficacy|4|||
144545136|NCT01364597|521196077|FG001|Overall Study|Lack of Efficacy|4|||
144545137|NCT01364597|521196078|FG002|Overall Study|Lack of Efficacy|23|||
144545138|NCT01364597|521196079|FG003|Overall Study|Lack of Efficacy|8|||
144545139|NCT01364597|521196076|FG000|Overall Study|Protocol Violation|0|||
144545140|NCT01364597|521196077|FG001|Overall Study|Protocol Violation|0|||
144545141|NCT01364597|521196078|FG002|Overall Study|Protocol Violation|2|||
144545142|NCT01364597|521196079|FG003|Overall Study|Protocol Violation|0|||
144545143|NCT01364597|521196076|FG000|Overall Study|Lost to Follow-up|0|||
144545144|NCT01364597|521196077|FG001|Overall Study|Lost to Follow-up|0|||
144545145|NCT01364597|521196078|FG002|Overall Study|Lost to Follow-up|5|||
144545146|NCT01364597|521196079|FG003|Overall Study|Lost to Follow-up|3|||
144545147|NCT01364597|521196076|FG000|Overall Study|Withdrawal by Subject|4|||
144545148|NCT01364597|521196077|FG001|Overall Study|Withdrawal by Subject|1|||
144545149|NCT01364597|521196078|FG002|Overall Study|Withdrawal by Subject|18|||
144545150|NCT01364597|521196079|FG003|Overall Study|Withdrawal by Subject|6|||
144545151|NCT01364597|521196076|FG000|Overall Study|Non compliance|1|||
144545152|NCT01364597|521196077|FG001|Overall Study|Non compliance|0|||
144545153|NCT01364597|521196078|FG002|Overall Study|Non compliance|1|||
144545154|NCT01364597|521196079|FG003|Overall Study|Non compliance|0|||
144545155|NCT01364597|521196076|FG000|Overall Study|Lack of compliance|1|||
144545156|NCT01364597|521196077|FG001|Overall Study|Lack of compliance|0|||
144545157|NCT01364597|521196078|FG002|Overall Study|Lack of compliance|0|||
144545158|NCT01364597|521196079|FG003|Overall Study|Lack of compliance|0|||
144545159|NCT01364597|521196076|FG000|Overall Study|End of treatment epilepsy|1|||
144545160|NCT01364597|521196077|FG001|Overall Study|End of treatment epilepsy|0|||
144545161|NCT01364597|521196078|FG002|Overall Study|End of treatment epilepsy|0|||
144545162|NCT01364597|521196079|FG003|Overall Study|End of treatment epilepsy|0|||
144545163|NCT01364597|521196076|FG000|Overall Study|No Seizures|1|||
144545164|NCT01364597|521196077|FG001|Overall Study|No Seizures|0|||
144545165|NCT01364597|521196078|FG002|Overall Study|No Seizures|0|||
144545166|NCT01364597|521196079|FG003|Overall Study|No Seizures|0|||
144545167|NCT01364597|521196076|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
144545168|NCT01364597|521196077|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
144545169|NCT01364597|521196078|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
144545170|NCT01364597|521196079|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
144545171|NCT01364597|521196076|FG000|Overall Study|Cure|1|||
144545172|NCT01364597|521196077|FG001|Overall Study|Cure|0|||
144545173|NCT01364597|521196078|FG002|Overall Study|Cure|0|||
144545174|NCT01364597|521196079|FG003|Overall Study|Cure|0|||
144262179|NCT00810069|520159819|FG002|Lead-in Period I|Randomization criteria not met|0|||
144262180|NCT00810069|520159817|FG000|Double-Blind Period II|Adverse Event|0|||
144262181|NCT00810069|520159818|FG001|Double-Blind Period II|Adverse Event|9|||
144262182|NCT00810069|520159819|FG002|Double-Blind Period II|Adverse Event|8|||
144545175|NCT01364597|521196076|FG000|Overall Study|Patient was moving|0|||
144545176|NCT01364597|521196077|FG001|Overall Study|Patient was moving|1|||
144202852|NCT02393248|519940263|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202853|NCT02393248|519940264|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202854|NCT02393248|519940265|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202855|NCT02393248|519940266|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202856|NCT02393248|519940267|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202857|NCT02393248|519940268|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202858|NCT02393248|519940269|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
144202859|NCT02393248|519940245|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
144202860|NCT02393248|519940246|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
144202861|NCT02393248|519940247|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
144202862|NCT02393248|519940248|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
144202863|NCT02393248|519940249|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
144545177|NCT01364597|521196078|FG002|Overall Study|Patient was moving|0|||
144545178|NCT01364597|521196079|FG003|Overall Study|Patient was moving|0|||
144545179|NCT01364597|521196076|FG000|Overall Study|Seizures resolved|0|||
144545180|NCT01364597|521196077|FG001|Overall Study|Seizures resolved|0|||
144262183|NCT00810069|520159817|FG000|Double-Blind Period II|Lack of Efficacy|0|||
144262184|NCT00810069|520159818|FG001|Double-Blind Period II|Lack of Efficacy|7|||
144262185|NCT00810069|520159819|FG002|Double-Blind Period II|Lack of Efficacy|12|||
144262186|NCT00810069|520159817|FG000|Double-Blind Period II|Lost to Follow-up|0|||
144262187|NCT00810069|520159818|FG001|Double-Blind Period II|Lost to Follow-up|9|||
144262188|NCT00810069|520159819|FG002|Double-Blind Period II|Lost to Follow-up|9|||
144262189|NCT00810069|520159817|FG000|Double-Blind Period II|Physician Decision|0|||
144262190|NCT00810069|520159818|FG001|Double-Blind Period II|Physician Decision|0|||
144262191|NCT00810069|520159819|FG002|Double-Blind Period II|Physician Decision|1|||
144262192|NCT00810069|520159817|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
144262193|NCT00810069|520159818|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
144262194|NCT00810069|520159819|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
144262195|NCT00810069|520159817|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
144262196|NCT00810069|520159818|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
144262197|NCT00810069|520159819|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
144262198|NCT00810069|520159817|FG000|Double-Blind Period II|Clinical relapse|0|||
144262199|NCT00810069|520159818|FG001|Double-Blind Period II|Clinical relapse|3|||
144262200|NCT00810069|520159819|FG002|Double-Blind Period II|Clinical relapse|0|||
144262201|NCT00810069|520159817|FG000|Double-Blind Period II|Protocol Violation|0|||
144262202|NCT00810069|520159818|FG001|Double-Blind Period II|Protocol Violation|7|||
144262203|NCT00810069|520159819|FG002|Double-Blind Period II|Protocol Violation|6|||
144262204|NCT03489343|520159820|FG000|Overall Study|Documented progressive disease|1|||
144262205|NCT03489343|520159821|FG001|Overall Study|Documented progressive disease|0|||
144262206|NCT03489343|520159822|FG002|Overall Study|Documented progressive disease|3|||
144262207|NCT03489343|520159823|FG003|Overall Study|Documented progressive disease|1|||
144262208|NCT03489343|520159824|FG004|Overall Study|Documented progressive disease|3|||
144262209|NCT03489343|520159825|FG005|Overall Study|Documented progressive disease|5|||
144262210|NCT03489343|520159826|FG006|Overall Study|Documented progressive disease|4|||
144545181|NCT01364597|521196078|FG002|Overall Study|Seizures resolved|1|||
144545182|NCT01364597|521196079|FG003|Overall Study|Seizures resolved|0|||
144545183|NCT01364597|521196076|FG000|Overall Study|Patient became seizure-free after surgery|0|||
144545184|NCT01364597|521196077|FG001|Overall Study|Patient became seizure-free after surgery|0|||
144545185|NCT01364597|521196078|FG002|Overall Study|Patient became seizure-free after surgery|1|||
144545186|NCT01364597|521196079|FG003|Overall Study|Patient became seizure-free after surgery|0|||
144545187|NCT01364597|521196076|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
144545188|NCT01364597|521196077|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
144545189|NCT01364597|521196078|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
144545190|NCT01364597|521196079|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
144545191|NCT01364597|521196076|FG000|Overall Study|Patient cured from Epilepsy|0|||
144545192|NCT01364597|521196077|FG001|Overall Study|Patient cured from Epilepsy|0|||
144262211|NCT03489343|520159820|FG000|Overall Study|Adverse Event|0|||
144262212|NCT03489343|520159821|FG001|Overall Study|Adverse Event|1|||
144262213|NCT03489343|520159822|FG002|Overall Study|Adverse Event|0|||
144262214|NCT03489343|520159823|FG003|Overall Study|Adverse Event|0|||
144262215|NCT03489343|520159824|FG004|Overall Study|Adverse Event|0|||
144262216|NCT03489343|520159825|FG005|Overall Study|Adverse Event|1|||
144262217|NCT03489343|520159826|FG006|Overall Study|Adverse Event|0|||
144262218|NCT03489343|520159820|FG000|Overall Study|Withdrawal by Subject|0|||
144262219|NCT03489343|520159821|FG001|Overall Study|Withdrawal by Subject|0|||
144262220|NCT03489343|520159822|FG002|Overall Study|Withdrawal by Subject|0|||
144262221|NCT03489343|520159823|FG003|Overall Study|Withdrawal by Subject|1|||
144262222|NCT03489343|520159824|FG004|Overall Study|Withdrawal by Subject|0|||
144262223|NCT03489343|520159825|FG005|Overall Study|Withdrawal by Subject|1|||
144262224|NCT03489343|520159826|FG006|Overall Study|Withdrawal by Subject|1|||
144202864|NCT02393248|519940250|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
144202865|NCT02393248|519940251|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
144262225|NCT03489343|520159820|FG000|Overall Study|Clinical progression|0|||
144262226|NCT03489343|520159821|FG001|Overall Study|Clinical progression|0|||
144262227|NCT03489343|520159822|FG002|Overall Study|Clinical progression|0|||
144262228|NCT03489343|520159823|FG003|Overall Study|Clinical progression|1|||
144262229|NCT03489343|520159824|FG004|Overall Study|Clinical progression|0|||
144262230|NCT03489343|520159825|FG005|Overall Study|Clinical progression|0|||
144262231|NCT03489343|520159826|FG006|Overall Study|Clinical progression|1|||
144262232|NCT01630135|520159829|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
144262233|NCT01630135|520159830|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
144262234|NCT04767373|520159831|FG000|Overall Study|Death|6|||
144262235|NCT04767373|520159832|FG001|Overall Study|Death|3|||
144262236|NCT04767373|520159831|FG000|Overall Study|Lost to Follow-up|67|||
144262237|NCT04767373|520159832|FG001|Overall Study|Lost to Follow-up|35|||
144262238|NCT04767373|520159831|FG000|Overall Study|Physician Decision|15|||
144262239|NCT04767373|520159832|FG001|Overall Study|Physician Decision|4|||
144262240|NCT04767373|520159831|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144262241|NCT04767373|520159832|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144262242|NCT04767373|520159831|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
144262243|NCT04767373|520159832|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
144262244|NCT04767373|520159831|FG000|Overall Study|Other|1|||
144262245|NCT04767373|520159832|FG001|Overall Study|Other|2|||
144262246|NCT02658669|520159833|FG000|Overall Study|Lost to Follow-up|7|||
144262247|NCT02658669|520159834|FG001|Overall Study|Lost to Follow-up|5|||
144262248|NCT00186485|520159835|FG000|Overall Study|Lost to Follow-up|3|||
144262249|NCT05225389|520159836|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
144262250|NCT01585246|520159837|FG000|Overall Study|Lost to Follow-up|0|||
144262251|NCT01585246|520159838|FG001|Overall Study|Lost to Follow-up|0|||
144262252|NCT01585246|520159839|FG002|Overall Study|Lost to Follow-up|2|||
144262253|NCT01585246|520159840|FG003|Overall Study|Lost to Follow-up|1|||
144262254|NCT01585246|520159841|FG004|Overall Study|Lost to Follow-up|0|||
144262255|NCT01585246|520159837|FG000|Overall Study|Protocol Violation|0|||
144262256|NCT01585246|520159838|FG001|Overall Study|Protocol Violation|0|||
144262257|NCT01585246|520159839|FG002|Overall Study|Protocol Violation|0|||
144262258|NCT01585246|520159840|FG003|Overall Study|Protocol Violation|0|||
144262259|NCT01585246|520159841|FG004|Overall Study|Protocol Violation|1|||
144262260|NCT01585246|520159837|FG000|Overall Study|Withdrawal by Subject|0|||
144262261|NCT01585246|520159838|FG001|Overall Study|Withdrawal by Subject|0|||
144545193|NCT01364597|521196078|FG002|Overall Study|Patient cured from Epilepsy|1|||
144545194|NCT01364597|521196079|FG003|Overall Study|Patient cured from Epilepsy|0|||
144545195|NCT01364597|521196076|FG000|Overall Study|Investigator decision|0|||
144545196|NCT01364597|521196077|FG001|Overall Study|Investigator decision|0|||
144545197|NCT01364597|521196078|FG002|Overall Study|Investigator decision|1|||
144545198|NCT01364597|521196079|FG003|Overall Study|Investigator decision|0|||
144545199|NCT01364597|521196076|FG000|Overall Study|Sponsor recommended discontinuation|0|||
144545200|NCT01364597|521196077|FG001|Overall Study|Sponsor recommended discontinuation|0|||
144545201|NCT01364597|521196078|FG002|Overall Study|Sponsor recommended discontinuation|0|||
144545202|NCT01364597|521196079|FG003|Overall Study|Sponsor recommended discontinuation|1|||
144545203|NCT01364597|521196076|FG000|Overall Study|Parents went abroad with the patient|0|||
144545204|NCT01364597|521196077|FG001|Overall Study|Parents went abroad with the patient|0|||
144545205|NCT01364597|521196078|FG002|Overall Study|Parents went abroad with the patient|1|||
144545206|NCT01364597|521196079|FG003|Overall Study|Parents went abroad with the patient|0|||
144545207|NCT01364597|521196076|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
144545208|NCT01364597|521196077|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
144262262|NCT01585246|520159839|FG002|Overall Study|Withdrawal by Subject|1|||
144262263|NCT01585246|520159840|FG003|Overall Study|Withdrawal by Subject|2|||
144262264|NCT01585246|520159841|FG004|Overall Study|Withdrawal by Subject|1|||
144262265|NCT01585246|520159837|FG000|Overall Study|Other|0|||
144262266|NCT01585246|520159838|FG001|Overall Study|Other|1|||
144262267|NCT01585246|520159839|FG002|Overall Study|Other|1|||
144262268|NCT01585246|520159840|FG003|Overall Study|Other|1|||
144262269|NCT01585246|520159841|FG004|Overall Study|Other|0|||
144262270|NCT01598610|520159848|FG000|Overall Study|Adverse Event|1|||
144262271|NCT00520039|520159851|FG000|Overall Study|Exclusion criteria met at first visit|7|||
144262272|NCT00520039|520159852|FG001|Overall Study|Exclusion criteria met at first visit|5|||
144262273|NCT02329327|520159853|FG000|Overall Study|Death|78|||
144262274|NCT02329327|520159854|FG001|Overall Study|Death|0|||
144262275|NCT02329327|520159853|FG000|Overall Study|Withdrawal by Subject|3|||
144262276|NCT02329327|520159854|FG001|Overall Study|Withdrawal by Subject|0|||
144262277|NCT02329327|520159853|FG000|Overall Study|Lost to Follow-up|4|||
144262278|NCT02329327|520159854|FG001|Overall Study|Lost to Follow-up|0|||
144262279|NCT00325819|520159855|FG000|Overall Study|Study product lost in mail|2|||
144262280|NCT00325819|520159856|FG001|Overall Study|Study product lost in mail|1|||
144262281|NCT00325819|520159855|FG000|Overall Study|Did not take a dose of study product|4|||
144262282|NCT00325819|520159856|FG001|Overall Study|Did not take a dose of study product|9|||
144262283|NCT00325819|520159855|FG000|Overall Study|Lost to Follow-up|3|||
144262284|NCT00325819|520159856|FG001|Overall Study|Lost to Follow-up|3|||
144262285|NCT05176717|520159858|FG000|Overall Study|Sponsor Decision|1|||
144262286|NCT05176717|520159859|FG001|Overall Study|Sponsor Decision|2|||
144262287|NCT05176717|520159860|FG002|Overall Study|Sponsor Decision|2|||
144262288|NCT03284853|520159861|FG000|Overall Study|Adverse Event|40|||
144262289|NCT03284853|520159862|FG001|Overall Study|Adverse Event|4|||
144262290|NCT03284853|520159861|FG000|Overall Study|Withdrawal by Subject|5|||
144262291|NCT03284853|520159862|FG001|Overall Study|Withdrawal by Subject|1|||
144262292|NCT03284853|520159861|FG000|Overall Study|Lost to Follow-up|1|||
144262293|NCT03284853|520159862|FG001|Overall Study|Lost to Follow-up|0|||
144262294|NCT03284853|520159861|FG000|Overall Study|Lack of Efficacy|1|||
144262295|NCT03284853|520159862|FG001|Overall Study|Lack of Efficacy|0|||
144262296|NCT03284853|520159861|FG000|Overall Study|Disallowed Concurrent Medication|1|||
144262297|NCT03284853|520159862|FG001|Overall Study|Disallowed Concurrent Medication|1|||
144262298|NCT03284853|520159861|FG000|Overall Study|Protocol Violation|3|||
144262299|NCT03284853|520159862|FG001|Overall Study|Protocol Violation|3|||
144262300|NCT03284853|520159861|FG000|Overall Study|Death|0|||
144262301|NCT03284853|520159862|FG001|Overall Study|Death|1|||
144262302|NCT03284853|520159861|FG000|Overall Study|Other - Reason not reported in CSR|4|||
144616460|NCT02083380|521456335|FG000|Overall Study|Lack of Efficacy|68|||
144616461|NCT02083380|521456336|FG001|Overall Study|Lack of Efficacy|79|||
144616462|NCT02083380|521456337|FG002|Overall Study|Lack of Efficacy|64|||
144616463|NCT02083380|521456335|FG000|Overall Study|Withdrawal by Subject|9|||
144616464|NCT02083380|521456336|FG001|Overall Study|Withdrawal by Subject|3|||
144616465|NCT02083380|521456337|FG002|Overall Study|Withdrawal by Subject|7|||
144616466|NCT02083380|521456335|FG000|Overall Study|Physician Decision|1|||
144616467|NCT02083380|521456336|FG001|Overall Study|Physician Decision|6|||
144616468|NCT02083380|521456337|FG002|Overall Study|Physician Decision|3|||
144616469|NCT02083380|521456335|FG000|Overall Study|Adverse Event|0|||
144616470|NCT02083380|521456336|FG001|Overall Study|Adverse Event|0|||
144616471|NCT02083380|521456337|FG002|Overall Study|Adverse Event|1|||
144616472|NCT02083380|521456335|FG000|Overall Study|Lost to Follow-up|5|||
144616473|NCT02083380|521456336|FG001|Overall Study|Lost to Follow-up|3|||
144616474|NCT02083380|521456337|FG002|Overall Study|Lost to Follow-up|3|||
144616475|NCT02083380|521456335|FG000|Overall Study|Other|8|||
144616476|NCT02083380|521456336|FG001|Overall Study|Other|4|||
144616477|NCT02083380|521456337|FG002|Overall Study|Other|6|||
144616478|NCT02412787|521456338|FG000|Overall Study|Withdrawal by Subject|9|||
144616479|NCT02412787|521456338|FG000|Overall Study|Participation Terminated by Investigator|1|||
144616480|NCT02412787|521456338|FG000|Overall Study|Site Terminated by Sponsor|21|||
144616481|NCT02412787|521456338|FG000|Overall Study|Technical Problems|1|||
144616482|NCT02412787|521456338|FG000|Overall Study|Reason Not Specified|1|||
144616483|NCT03246958|521456339|FG000|Overall Study|Withdrawal by Subject|0|||
144616484|NCT03246958|521456340|FG001|Overall Study|Withdrawal by Subject|1|||
144616485|NCT03246958|521456341|FG002|Overall Study|Withdrawal by Subject|0|||
144616486|NCT03246958|521456342|FG003|Overall Study|Withdrawal by Subject|0|||
144616487|NCT03246958|521456343|FG004|Overall Study|Withdrawal by Subject|0|||
144616488|NCT03246958|521456344|FG005|Overall Study|Withdrawal by Subject|1|||
144616489|NCT03246958|521456345|FG006|Overall Study|Withdrawal by Subject|0|||
144616490|NCT03246958|521456339|FG000|Overall Study|Progression|13|||
144616491|NCT03246958|521456340|FG001|Overall Study|Progression|9|||
144616492|NCT03246958|521456341|FG002|Overall Study|Progression|3|||
144616493|NCT03246958|521456342|FG003|Overall Study|Progression|2|||
144616494|NCT03246958|521456343|FG004|Overall Study|Progression|1|||
144616495|NCT03246958|521456344|FG005|Overall Study|Progression|2|||
144616496|NCT03246958|521456345|FG006|Overall Study|Progression|1|||
144616497|NCT03246958|521456339|FG000|Overall Study|Adverse Event|2|||
144616498|NCT03246958|521456340|FG001|Overall Study|Adverse Event|2|||
144616499|NCT03246958|521456341|FG002|Overall Study|Adverse Event|0|||
144616500|NCT03246958|521456342|FG003|Overall Study|Adverse Event|1|||
144616501|NCT03246958|521456343|FG004|Overall Study|Adverse Event|1|||
144616502|NCT03246958|521456344|FG005|Overall Study|Adverse Event|0|||
144616503|NCT03246958|521456345|FG006|Overall Study|Adverse Event|2|||
144262303|NCT03284853|520159862|FG001|Overall Study|Other - Reason not reported in CSR|3|||
144262304|NCT02143024|520159865|FG000|Overall Study|Lost to Follow-up|1|||
144616504|NCT03246958|521456339|FG000|Overall Study|Death|0|||
144616505|NCT03246958|521456340|FG001|Overall Study|Death|1|||
144616506|NCT03246958|521456341|FG002|Overall Study|Death|0|||
144616507|NCT03246958|521456342|FG003|Overall Study|Death|0|||
144616508|NCT03246958|521456343|FG004|Overall Study|Death|0|||
144262305|NCT02143024|520159866|FG001|Overall Study|Lost to Follow-up|1|||
144616509|NCT03246958|521456344|FG005|Overall Study|Death|0|||
144616510|NCT03246958|521456345|FG006|Overall Study|Death|0|||
144616511|NCT03246958|521456339|FG000|Overall Study|Physician Decision|0|||
144616512|NCT03246958|521456340|FG001|Overall Study|Physician Decision|0|||
144262306|NCT02143024|520159865|FG000|Overall Study|Withdrawal by Subject|1|||
144262307|NCT02143024|520159866|FG001|Overall Study|Withdrawal by Subject|0|||
144616513|NCT03246958|521456341|FG002|Overall Study|Physician Decision|0|||
144616514|NCT03246958|521456342|FG003|Overall Study|Physician Decision|1|||
144616515|NCT03246958|521456343|FG004|Overall Study|Physician Decision|0|||
144545209|NCT01364597|521196078|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
144545210|NCT01364597|521196079|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
144545211|NCT01364597|521196076|FG000|Overall Study|BRV administration dropout|0|||
144545212|NCT01364597|521196077|FG001|Overall Study|BRV administration dropout|0|||
144545213|NCT01364597|521196078|FG002|Overall Study|BRV administration dropout|1|||
144545214|NCT01364597|521196079|FG003|Overall Study|BRV administration dropout|0|||
144545215|NCT01364597|521196076|FG000|Overall Study|Dropout|0|||
144545216|NCT01364597|521196077|FG001|Overall Study|Dropout|0|||
144545217|NCT01364597|521196078|FG002|Overall Study|Dropout|3|||
144545218|NCT01364597|521196079|FG003|Overall Study|Dropout|1|||
144545219|NCT01364597|521196076|FG000|Overall Study|Unreliable subject|0|||
144545220|NCT01364597|521196077|FG001|Overall Study|Unreliable subject|0|||
144545221|NCT01364597|521196078|FG002|Overall Study|Unreliable subject|0|||
144545222|NCT01364597|521196079|FG003|Overall Study|Unreliable subject|1|||
144545223|NCT01364597|521196076|FG000|Overall Study|Other|0|||
144545224|NCT01364597|521196077|FG001|Overall Study|Other|0|||
144545225|NCT01364597|521196078|FG002|Overall Study|Other|0|||
144545226|NCT01364597|521196079|FG003|Overall Study|Other|1|||
144545227|NCT02698475|521196083|FG000|Main Study Period|Lack of Efficacy|1|||
144545228|NCT02698475|521196083|FG000|Main Study Period|Protocol Violation|2|||
144545229|NCT02698475|521196083|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
144545230|NCT02698475|521196083|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
144545231|NCT02698475|521196083|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
144545232|NCT02698475|521196083|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
144545233|NCT02698475|521196083|FG000|Long-Term Extension Period|Other|1|||
144545234|NCT02148705|521196087|FG000|Overall Study|Death|2|||
144545235|NCT02148705|521196088|FG001|Overall Study|Death|0|||
144545236|NCT02148705|521196089|FG002|Overall Study|Death|0|||
144545237|NCT02148705|521196087|FG000|Overall Study|Lost to Follow-up|13|||
144545238|NCT02148705|521196088|FG001|Overall Study|Lost to Follow-up|4|||
144545239|NCT02148705|521196089|FG002|Overall Study|Lost to Follow-up|10|||
144545240|NCT02148705|521196087|FG000|Overall Study|Withdrawal by Subject|3|||
144545241|NCT02148705|521196088|FG001|Overall Study|Withdrawal by Subject|0|||
144545242|NCT02148705|521196089|FG002|Overall Study|Withdrawal by Subject|2|||
144545243|NCT02148705|521196087|FG000|Overall Study|Not Treated|0|||
144545244|NCT02148705|521196088|FG001|Overall Study|Not Treated|1|||
144545245|NCT02148705|521196089|FG002|Overall Study|Not Treated|5|||
144545246|NCT01737021|521196090|FG000|Overall Study|Lost to Follow-up|5|||
144545247|NCT01737021|521196091|FG001|Overall Study|Lost to Follow-up|3|||
144545248|NCT03960645|521196092|FG000|Overall Study|Protocol Violation|1|||
144545249|NCT03960645|521196093|FG001|Overall Study|Protocol Violation|0|||
144545250|NCT04938453|521196094|FG000|Washout Period 1|Adverse Event|1|||
144545251|NCT04938453|521196095|FG001|Washout Period 1|Adverse Event|0|||
144545252|NCT04938453|521196094|FG000|Washout Period 1|Physician Decision|0|||
144545253|NCT04938453|521196095|FG001|Washout Period 1|Physician Decision|1|||
144545254|NCT03292406|521196098|FG000|Overall Study|Progressive Disease|6|||
144545255|NCT03292406|521196099|FG001|Overall Study|Progressive Disease|3|||
144545256|NCT03292406|521196100|FG002|Overall Study|Progressive Disease|4|||
144545257|NCT03292406|521196098|FG000|Overall Study|Adverse Event|7|||
144545258|NCT03292406|521196099|FG001|Overall Study|Adverse Event|1|||
144545259|NCT03292406|521196100|FG002|Overall Study|Adverse Event|4|||
144545260|NCT03292406|521196098|FG000|Overall Study|Withdrawal by Subject|0|||
144545261|NCT03292406|521196099|FG001|Overall Study|Withdrawal by Subject|7|||
144545262|NCT03292406|521196100|FG002|Overall Study|Withdrawal by Subject|2|||
144545263|NCT03292406|521196098|FG000|Overall Study|Protocol Violation|0|||
144545264|NCT03292406|521196099|FG001|Overall Study|Protocol Violation|1|||
144545265|NCT03292406|521196100|FG002|Overall Study|Protocol Violation|1|||
144545266|NCT03292406|521196098|FG000|Overall Study|Other|0|||
144545267|NCT03292406|521196099|FG001|Overall Study|Other|1|||
144202866|NCT02393248|519940252|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
144545268|NCT03292406|521196100|FG002|Overall Study|Other|2|||
144545269|NCT04658784|521196105|FG000|6-month Follow-up|Lost to Follow-up|2|||
144545270|NCT04658784|521196106|FG001|6-month Follow-up|Lost to Follow-up|5|||
144545271|NCT05260437|521196109|FG000|Overall Study|Lost to Follow-up|5|||
144545272|NCT05260437|521196110|FG001|Overall Study|Lost to Follow-up|2|||
144545273|NCT05260437|521196111|FG002|Overall Study|Lost to Follow-up|1|||
144545274|NCT05260437|521196112|FG003|Overall Study|Lost to Follow-up|2|||
144545275|NCT05260437|521196113|FG004|Overall Study|Lost to Follow-up|2|||
144545276|NCT05260437|521196109|FG000|Overall Study|Withdrawal by Subject|3|||
144202867|NCT02393248|519940253|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
144545277|NCT05260437|521196110|FG001|Overall Study|Withdrawal by Subject|0|||
144545278|NCT05260437|521196111|FG002|Overall Study|Withdrawal by Subject|4|||
144545279|NCT05260437|521196112|FG003|Overall Study|Withdrawal by Subject|5|||
144545280|NCT05260437|521196113|FG004|Overall Study|Withdrawal by Subject|0|||
144545281|NCT05260437|521196109|FG000|Overall Study|Vaccine Not Administered|0|||
144262308|NCT02308228|520159867|FG000|Overall Study|Adverse Event|3|||
144545282|NCT05260437|521196110|FG001|Overall Study|Vaccine Not Administered|1|||
144545283|NCT05260437|521196111|FG002|Overall Study|Vaccine Not Administered|0|||
144545284|NCT05260437|521196112|FG003|Overall Study|Vaccine Not Administered|0|||
144545285|NCT05260437|521196113|FG004|Overall Study|Vaccine Not Administered|0|||
144545286|NCT01858688|521196114|FG000|Overall Study|Withdrawal by Subject|8|||
144545287|NCT01858688|521196114|FG000|Overall Study|Participant began another therapy|3|||
144545288|NCT01858688|521196114|FG000|Overall Study|Physician Decision|2|||
144545289|NCT01858688|521196114|FG000|Overall Study|Progressive Disease|2|||
144545290|NCT01858688|521196114|FG000|Overall Study|Reason not reproted|5|||
144545291|NCT00895245|521196117|FG000|Overall Study|Lack of Efficacy|6|||
144545292|NCT02095678|521196118|FG000|Overall Study|Withdrawal by Subject|0|||
144545293|NCT02095678|521196119|FG001|Overall Study|Withdrawal by Subject|1|||
144545294|NCT02095678|521196118|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
144545295|NCT02095678|521196119|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
144545296|NCT02095678|521196118|FG000|Overall Study|lesion impacted by previous treatment|1|||
144545297|NCT02095678|521196119|FG001|Overall Study|lesion impacted by previous treatment|1|||
144545298|NCT02095678|521196118|FG000|Overall Study|No Confirmed Diagnosis|0|||
144545299|NCT02095678|521196119|FG001|Overall Study|No Confirmed Diagnosis|3|||
144545300|NCT02095678|521196118|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
144545301|NCT02095678|521196119|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
144545302|NCT02095678|521196118|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
144545303|NCT02095678|521196119|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
144545304|NCT00681109|521196120|FG000|Overall Study|Lost to Follow-up|2|||
144545305|NCT00681109|521196121|FG001|Overall Study|Lost to Follow-up|6|||
144545306|NCT00681109|521196122|FG002|Overall Study|Lost to Follow-up|0|||
144545307|NCT00701415|521196123|FG000|Overall Study|Adverse Event|0|||
144545308|NCT00701415|521196124|FG001|Overall Study|Adverse Event|1|||
144545309|NCT00701415|521196123|FG000|Overall Study|Social/family issues and needle phobia|1|||
144545310|NCT00701415|521196124|FG001|Overall Study|Social/family issues and needle phobia|0|||
144545311|NCT03131713|521196125|FG000|Overall Study|Lost to Follow-up|5|||
144545312|NCT03131713|521196126|FG001|Overall Study|Lost to Follow-up|0|||
144545313|NCT02208843|521196131|FG000|Overall Study|Clinical symptoms of progression|2|||
144545314|NCT02208843|521196131|FG000|Overall Study|Progression disease according to RECIST|24|||
144545315|NCT02208843|521196131|FG000|Overall Study|Adverse Event|12|||
144545316|NCT02208843|521196131|FG000|Overall Study|Protocol Violation|1|||
144545317|NCT02208843|521196131|FG000|Overall Study|Withdrawal by Subject|1|||
144545318|NCT02208843|521196131|FG000|Overall Study|Switched to commercial afatinib|20|||
144545319|NCT01972776|521196140|FG000|Part 1|Withdrawal by Subject|0|||
144545320|NCT01972776|521196141|FG001|Part 1|Withdrawal by Subject|0|||
144545321|NCT01972776|521196142|FG002|Part 1|Withdrawal by Subject|1|||
144545322|NCT01972776|521196143|FG003|Part 1|Withdrawal by Subject|0|||
144545323|NCT01972776|521196144|FG004|Part 1|Withdrawal by Subject|0|||
144545324|NCT01972776|521196145|FG005|Part 1|Withdrawal by Subject|0|||
144545325|NCT01972776|521196140|FG000|Part 1|Adverse Event|0|||
144545326|NCT01972776|521196141|FG001|Part 1|Adverse Event|0|||
144727514|NCT02101853|521856655|FG004|Post Induction Randomization|Lack of Efficacy|21|||
144727515|NCT02101853|521856656|FG005|Post Induction Randomization|Lack of Efficacy|0|||
144727516|NCT02101853|521856651|FG000|Post Induction Randomization|Physician Decision|0|||
144727517|NCT02101853|521856652|FG001|Post Induction Randomization|Physician Decision|43|||
144727518|NCT02101853|521856653|FG002|Post Induction Randomization|Physician Decision|23|||
144727519|NCT02101853|521856654|FG003|Post Induction Randomization|Physician Decision|14|||
144727520|NCT02101853|521856655|FG004|Post Induction Randomization|Physician Decision|14|||
144727521|NCT02101853|521856656|FG005|Post Induction Randomization|Physician Decision|0|||
144545327|NCT01972776|521196142|FG002|Part 1|Adverse Event|1|||
144545328|NCT01972776|521196143|FG003|Part 1|Adverse Event|1|||
144545329|NCT01972776|521196144|FG004|Part 1|Adverse Event|0|||
144545330|NCT01972776|521196145|FG005|Part 1|Adverse Event|0|||
144545331|NCT01972776|521196140|FG000|Part 2|Adverse Event|0|||
144545332|NCT01972776|521196141|FG001|Part 2|Adverse Event|0|||
144545333|NCT01972776|521196142|FG002|Part 2|Adverse Event|0|||
144545334|NCT01972776|521196143|FG003|Part 2|Adverse Event|0|||
144545335|NCT01972776|521196144|FG004|Part 2|Adverse Event|3|||
144545336|NCT01972776|521196145|FG005|Part 2|Adverse Event|0|||
144545337|NCT01972776|521196140|FG000|Part 2|Administrative problems|0|||
144545338|NCT01972776|521196141|FG001|Part 2|Administrative problems|0|||
144545339|NCT01972776|521196142|FG002|Part 2|Administrative problems|0|||
144727522|NCT02101853|521856651|FG000|Post Induction Randomization|Protocol Violation|0|||
144545340|NCT01972776|521196143|FG003|Part 2|Administrative problems|0|||
144545341|NCT01972776|521196144|FG004|Part 2|Administrative problems|10|||
144545342|NCT01972776|521196145|FG005|Part 2|Administrative problems|7|||
144545343|NCT02382640|521196159|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
144545344|NCT02382640|521196160|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
144545345|NCT02382640|521196161|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
144727523|NCT02101853|521856652|FG001|Post Induction Randomization|Protocol Violation|3|||
144545346|NCT02382640|521196162|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
144545347|NCT01560429|521196163|FG000|Overall Study|Protocol Violation|3|||
144545348|NCT01560429|521196164|FG001|Overall Study|Protocol Violation|6|||
144545349|NCT00570505|521196167|FG000|Overall Study|Adverse Event|7|||
144616516|NCT03246958|521456344|FG005|Overall Study|Physician Decision|0|||
144616517|NCT03246958|521456345|FG006|Overall Study|Physician Decision|0|||
144616518|NCT03246958|521456339|FG000|Overall Study|Never start treatment|1|||
144616519|NCT03246958|521456340|FG001|Overall Study|Never start treatment|0|||
144545350|NCT00570505|521196167|FG000|Overall Study|Withdrawal by Subject|7|||
144545351|NCT00570505|521196167|FG000|Overall Study|Lost to Follow-up|23|||
144545352|NCT00570505|521196167|FG000|Overall Study|Other loss to follow-up|4|||
144545353|NCT04224272|521196168|FG000|Part 1 - Dose Finding|Death|4|||
144545354|NCT04224272|521196168|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
144545355|NCT04224272|521196168|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
144545356|NCT04224272|521196168|FG000|Part 2 - Dose Expansion|Death|10|||
144545357|NCT04224272|521196168|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
144545358|NCT02485925|521196169|FG000|Overall Study|Withdrawal by Subject|3|||
144545359|NCT02485925|521196169|FG000|Overall Study|Death|1|||
144545360|NCT02485925|521196169|FG000|Overall Study|Lost to Follow-up|11|||
144545361|NCT00108355|521198233|FG000|Overall Study|Peritonitis at index paracentesis|1|||
144545362|NCT00108355|521198234|FG001|Overall Study|Peritonitis at index paracentesis|1|||
144545363|NCT00108355|521198233|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
144545364|NCT00108355|521198234|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
144545365|NCT03493282|521198235|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
144545366|NCT03493282|521198236|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
144545367|NCT03493282|521198237|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
144545368|NCT03493282|521198235|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
144545369|NCT03493282|521198236|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
144545370|NCT03493282|521198237|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
144545371|NCT01380145|521198238|FG000|Overall Study|Progressive disease|4|||
144545372|NCT02038049|521198239|FG000|Overall Study|Lost to Follow-up|1|||
144545373|NCT02038049|521198240|FG001|Overall Study|Lost to Follow-up|0|||
144545374|NCT02771366|521198241|FG000|Period 1|Withdrawal by Subject|0|||
144545375|NCT02771366|521198242|FG001|Period 1|Withdrawal by Subject|2|||
144545376|NCT02771366|521198241|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
144545377|NCT02771366|521198242|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
144545378|NCT00587171|521198245|FG000|Overall Study|Lost to Follow-up|1|||
144545379|NCT00587171|521198246|FG001|Overall Study|Lost to Follow-up|1|||
144545380|NCT01673594|521198249|FG000|Overall Study|Adverse Event|3|||
144545381|NCT01673594|521198250|FG001|Overall Study|Adverse Event|1|||
144545382|NCT01673594|521198249|FG000|Overall Study|Lost to Follow-up|1|||
144545383|NCT01673594|521198250|FG001|Overall Study|Lost to Follow-up|0|||
144545384|NCT01673594|521198249|FG000|Overall Study|Physician Decision|2|||
144545385|NCT01673594|521198250|FG001|Overall Study|Physician Decision|4|||
144545386|NCT01673594|521198249|FG000|Overall Study|Withdrawal by Subject|0|||
144545387|NCT01673594|521198250|FG001|Overall Study|Withdrawal by Subject|1|||
144545388|NCT02605174|521198254|FG000|Overall Study|Adverse Event|0|||
144545389|NCT02605174|521198255|FG001|Overall Study|Adverse Event|0|||
144545390|NCT02605174|521198256|FG002|Overall Study|Adverse Event|1|||
144545391|NCT02605174|521198257|FG003|Overall Study|Adverse Event|0|||
144545392|NCT02605174|521198258|FG004|Overall Study|Adverse Event|4|||
144545393|NCT02605174|521198259|FG005|Overall Study|Adverse Event|0|||
144545394|NCT02605174|521198260|FG006|Overall Study|Adverse Event|0|||
144545395|NCT02605174|521198254|FG000|Overall Study|Lost to Follow-up|20|||
144545396|NCT02605174|521198255|FG001|Overall Study|Lost to Follow-up|7|||
144545397|NCT02605174|521198256|FG002|Overall Study|Lost to Follow-up|27|||
144545398|NCT02605174|521198257|FG003|Overall Study|Lost to Follow-up|10|||
144616520|NCT03246958|521456341|FG002|Overall Study|Never start treatment|0|||
144616521|NCT03246958|521456342|FG003|Overall Study|Never start treatment|0|||
144616522|NCT03246958|521456343|FG004|Overall Study|Never start treatment|0|||
144616523|NCT03246958|521456344|FG005|Overall Study|Never start treatment|0|||
144616524|NCT03246958|521456345|FG006|Overall Study|Never start treatment|0|||
144616525|NCT03246958|521456339|FG000|Overall Study|Over enrollment|0|||
144727524|NCT02101853|521856653|FG002|Post Induction Randomization|Protocol Violation|0|||
144727525|NCT02101853|521856654|FG003|Post Induction Randomization|Protocol Violation|0|||
144202868|NCT02393248|519940254|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
144202869|NCT02393248|519940255|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
144202870|NCT02393248|519940256|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
144202871|NCT02393248|519940257|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
144545399|NCT02605174|521198258|FG004|Overall Study|Lost to Follow-up|20|||
144545400|NCT02605174|521198259|FG005|Overall Study|Lost to Follow-up|10|||
144545401|NCT02605174|521198260|FG006|Overall Study|Lost to Follow-up|29|||
144545402|NCT02605174|521198254|FG000|Overall Study|Protocol Violation|10|||
144545403|NCT02605174|521198255|FG001|Overall Study|Protocol Violation|4|||
144545404|NCT02605174|521198256|FG002|Overall Study|Protocol Violation|14|||
144545405|NCT02605174|521198257|FG003|Overall Study|Protocol Violation|6|||
144545406|NCT02605174|521198258|FG004|Overall Study|Protocol Violation|7|||
144545407|NCT02605174|521198259|FG005|Overall Study|Protocol Violation|7|||
144545408|NCT02605174|521198260|FG006|Overall Study|Protocol Violation|12|||
144545409|NCT02605174|521198254|FG000|Overall Study|Pregnancy|1|||
144545410|NCT02605174|521198255|FG001|Overall Study|Pregnancy|0|||
144545411|NCT02605174|521198256|FG002|Overall Study|Pregnancy|0|||
144545412|NCT02605174|521198257|FG003|Overall Study|Pregnancy|2|||
144545413|NCT02605174|521198258|FG004|Overall Study|Pregnancy|0|||
144545414|NCT02605174|521198259|FG005|Overall Study|Pregnancy|0|||
144545415|NCT02605174|521198260|FG006|Overall Study|Pregnancy|0|||
144545416|NCT02605174|521198254|FG000|Overall Study|Withdrawal by Subject|9|||
144545417|NCT02605174|521198255|FG001|Overall Study|Withdrawal by Subject|6|||
144545418|NCT02605174|521198256|FG002|Overall Study|Withdrawal by Subject|14|||
144545419|NCT02605174|521198257|FG003|Overall Study|Withdrawal by Subject|11|||
144545420|NCT02605174|521198258|FG004|Overall Study|Withdrawal by Subject|6|||
144545421|NCT02605174|521198259|FG005|Overall Study|Withdrawal by Subject|4|||
144545422|NCT02605174|521198260|FG006|Overall Study|Withdrawal by Subject|15|||
144545423|NCT02605174|521198254|FG000|Overall Study|Physician Decision|2|||
144545424|NCT02605174|521198255|FG001|Overall Study|Physician Decision|0|||
144545425|NCT02605174|521198256|FG002|Overall Study|Physician Decision|0|||
144545426|NCT02605174|521198257|FG003|Overall Study|Physician Decision|0|||
144545427|NCT02605174|521198258|FG004|Overall Study|Physician Decision|0|||
144545428|NCT02605174|521198259|FG005|Overall Study|Physician Decision|0|||
144545429|NCT02605174|521198260|FG006|Overall Study|Physician Decision|3|||
144545430|NCT02605174|521198254|FG000|Overall Study|Randomization Failure|22|||
144545431|NCT02605174|521198255|FG001|Overall Study|Randomization Failure|6|||
144545432|NCT02605174|521198256|FG002|Overall Study|Randomization Failure|20|||
144545433|NCT02605174|521198257|FG003|Overall Study|Randomization Failure|7|||
144545434|NCT02605174|521198258|FG004|Overall Study|Randomization Failure|16|||
144545435|NCT02605174|521198259|FG005|Overall Study|Randomization Failure|11|||
144545436|NCT02605174|521198260|FG006|Overall Study|Randomization Failure|30|||
144545437|NCT04250636|521198261|FG000|Overall Study|Lost to Follow-up|2|||
144545438|NCT01779050|521198263|FG000|Overall Study|Withdrawal by Subject|1|||
144545439|NCT01779050|521198264|FG001|Overall Study|Withdrawal by Subject|0|||
144545440|NCT01353274|521198265|FG000|Overall Study|No case report form (CRF) collected|28|||
144545441|NCT03737110|521198268|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
144545442|NCT03737110|521198269|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
144545443|NCT03737110|521198270|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
144545444|NCT03737110|521198271|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
144545445|NCT03737110|521198272|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
144545446|NCT03737110|521198273|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
144545447|NCT03737110|521198268|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
144545448|NCT03737110|521198269|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
144545449|NCT03737110|521198270|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
144545450|NCT03737110|521198271|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
144545451|NCT03737110|521198272|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
144545452|NCT03737110|521198273|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
144545453|NCT03737110|521198268|FG000|Run-in (RI) Period|Adverse Event|4|||
144545454|NCT03737110|521198269|FG001|Run-in (RI) Period|Adverse Event|0|||
144545455|NCT03737110|521198270|FG002|Run-in (RI) Period|Adverse Event|0|||
144545456|NCT03737110|521198271|FG003|Run-in (RI) Period|Adverse Event|0|||
144545457|NCT03737110|521198272|FG004|Run-in (RI) Period|Adverse Event|0|||
144545458|NCT03737110|521198273|FG005|Run-in (RI) Period|Adverse Event|0|||
144545459|NCT03737110|521198268|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
144545460|NCT03737110|521198269|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
144545461|NCT03737110|521198270|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
144545462|NCT03737110|521198271|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
144545463|NCT03737110|521198272|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
144545464|NCT03737110|521198273|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
144545465|NCT03737110|521198268|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
144545466|NCT03737110|521198269|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
144545467|NCT03737110|521198270|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
144545468|NCT03737110|521198271|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
144545469|NCT03737110|521198272|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
144545470|NCT03737110|521198273|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
144545471|NCT03737110|521198268|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
144545472|NCT03737110|521198269|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
144545473|NCT03737110|521198270|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
144545474|NCT03737110|521198271|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
144545475|NCT03737110|521198272|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
144545476|NCT03737110|521198273|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
144545477|NCT03737110|521198268|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
144545478|NCT03737110|521198269|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
144545479|NCT03737110|521198270|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
144545480|NCT03737110|521198271|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
144616526|NCT03246958|521456340|FG001|Overall Study|Over enrollment|2|||
144545481|NCT03737110|521198272|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
144545482|NCT03737110|521198273|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
144545483|NCT03737110|521198268|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
144545484|NCT03737110|521198269|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
144545485|NCT03737110|521198270|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
144545486|NCT03737110|521198271|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
144545487|NCT03737110|521198272|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
144545488|NCT03737110|521198273|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
144545489|NCT03648541|521198274|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
144545490|NCT03648541|521198275|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
144545491|NCT03648541|521198274|FG000|Re-induction Period Only|Lack of Efficacy|7|||
144545492|NCT03648541|521198275|FG001|Re-induction Period Only|Lack of Efficacy|0|||
144545493|NCT03648541|521198274|FG000|Maintenance Period Only|Missing|0|||
144545494|NCT03648541|521198275|FG001|Maintenance Period Only|Missing|1|||
144545495|NCT03648541|521198274|FG000|Maintenance Period Only|Other not listed below|0|||
144545496|NCT03648541|521198275|FG001|Maintenance Period Only|Other not listed below|4|||
144545497|NCT03648541|521198274|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
144545498|NCT03648541|521198275|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
144545499|NCT03648541|521198274|FG000|Maintenance Period Only|Protocol Violation|0|||
144545500|NCT03648541|521198275|FG001|Maintenance Period Only|Protocol Violation|1|||
144545501|NCT03648541|521198274|FG000|Maintenance Period Only|Lack of Efficacy|0|||
144545502|NCT03648541|521198275|FG001|Maintenance Period Only|Lack of Efficacy|18|||
144545503|NCT03648541|521198274|FG000|Maintenance Period Only|Adverse Event|0|||
144545504|NCT03648541|521198275|FG001|Maintenance Period Only|Adverse Event|4|||
144545505|NCT03648541|521198274|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
144545506|NCT03648541|521198275|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
144545507|NCT00273052|521198289|FG000|Overall Study|Withdrawal by Subject|16|||
144545508|NCT00273052|521198290|FG001|Overall Study|Withdrawal by Subject|19|||
144545509|NCT00273052|521198289|FG000|Overall Study|Adverse Event|21|||
144545510|NCT00273052|521198290|FG001|Overall Study|Adverse Event|19|||
144545511|NCT00273052|521198289|FG000|Overall Study|Protocol Violation|14|||
144545512|NCT00273052|521198290|FG001|Overall Study|Protocol Violation|18|||
144545513|NCT00273052|521198289|FG000|Overall Study|Lost to Follow-up|7|||
144545514|NCT00273052|521198290|FG001|Overall Study|Lost to Follow-up|25|||
144545515|NCT00273052|521198289|FG000|Overall Study|Lack of Efficacy|6|||
144545516|NCT00273052|521198290|FG001|Overall Study|Lack of Efficacy|4|||
144545517|NCT00273052|521198289|FG000|Overall Study|Non-Compliance|3|||
144545518|NCT00273052|521198290|FG001|Overall Study|Non-Compliance|1|||
144545519|NCT00273052|521198289|FG000|Overall Study|Other|2|||
144545520|NCT00273052|521198290|FG001|Overall Study|Other|0|||
144545521|NCT00273052|521198289|FG000|Overall Study|Worsening serum lipid levels|0|||
144545522|NCT00273052|521198290|FG001|Overall Study|Worsening serum lipid levels|2|||
144545523|NCT02224755|521198291|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
144545524|NCT02224755|521198292|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
144545525|NCT02224755|521198291|FG000|Two Year Follow up Post-implant|Death|103|||
144545526|NCT02224755|521198292|FG001|Two Year Follow up Post-implant|Death|98|||
144545527|NCT02224755|521198291|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
144545528|NCT02224755|521198292|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
144545529|NCT02224755|521198291|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
144545530|NCT02224755|521198292|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
144545531|NCT02224755|521198291|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
144545532|NCT02224755|521198292|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
144545533|NCT01951703|521198293|FG000|First Intervention|Withdrawal by Subject|1|||
144545534|NCT01951703|521198294|FG001|First Intervention|Withdrawal by Subject|0|||
144545535|NCT01951703|521198293|FG000|First Intervention|Subject was not compliant|1|||
144545536|NCT01951703|521198294|FG001|First Intervention|Subject was not compliant|1|||
144545537|NCT01951703|521198293|FG000|First Intervention|Physician Decision|1|||
144545538|NCT01951703|521198294|FG001|First Intervention|Physician Decision|0|||
144545539|NCT01951703|521198293|FG000|Second Intervention|Protocol Violation|0|||
144545540|NCT01951703|521198294|FG001|Second Intervention|Protocol Violation|1|||
144545541|NCT01951703|521198293|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
144545542|NCT01951703|521198294|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
144545543|NCT02827201|521198295|FG000|Overall Study|Death|1|||
144545544|NCT02827201|521198296|FG001|Overall Study|Death|2|||
144202872|NCT02393248|519940258|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
144202873|NCT02393248|519940259|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
144202874|NCT02393248|519940260|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
144202875|NCT02393248|519940261|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
144202876|NCT02393248|519940262|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
144202877|NCT02393248|519940263|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
144545545|NCT02827201|521198295|FG000|Overall Study|Patients not treated|1|||
144545546|NCT02827201|521198296|FG001|Overall Study|Patients not treated|1|||
144545547|NCT02736188|521198299|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
144545548|NCT02736188|521198299|FG000|Overall Study|Adverse Event|1|||
144545549|NCT02736188|521198299|FG000|Overall Study|Withdrawal by Subject|1|||
144545550|NCT02736188|521198299|FG000|Overall Study|Other|6|||
144545551|NCT00240994|521198300|FG000|Overall Study|Lost to Follow-up|1|||
144545552|NCT00240994|521198300|FG000|Overall Study|Protocol Violation|1|||
144545553|NCT00240994|521198300|FG000|Overall Study|Graft failure|1|||
144545554|NCT02630186|521198301|FG000|Overall Study|Withdrawal by Subject|1|||
144545555|NCT00439218|521198302|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
144545556|NCT03176407|521198303|FG000|Overall Study|Protocol Violation|1|||
144545557|NCT03176407|521198303|FG000|Overall Study|human failure|1|||
144545558|NCT03176407|521198303|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
144545559|NCT05124210|521198304|FG000|Overall Study|Lost to Follow-up|1|||
144545560|NCT05124210|521198305|FG001|Overall Study|Lost to Follow-up|0|||
144545561|NCT05124210|521198304|FG000|Overall Study|Withdrawal by Subject|1|||
144545562|NCT05124210|521198305|FG001|Overall Study|Withdrawal by Subject|0|||
144545563|NCT01428583|521198306|FG000|Overall Study|Adverse Event|75|||
144545564|NCT01428583|521198306|FG000|Overall Study|Withdrawal by Subject|51|||
144545565|NCT01428583|521198306|FG000|Overall Study|Lack of Efficacy|37|||
144545566|NCT01428583|521198306|FG000|Overall Study|Lost to Follow-up|17|||
144545567|NCT01428583|521198306|FG000|Overall Study|Death|1|||
144545568|NCT01428583|521198306|FG000|Overall Study|Pregnancy|1|||
144545569|NCT01428583|521198306|FG000|Overall Study|Protocol Violation|1|||
144545570|NCT01428583|521198306|FG000|Overall Study|Physician Decision|12|||
144545571|NCT01428583|521198306|FG000|Overall Study|Non-compliant|25|||
144545572|NCT01428583|521198306|FG000|Overall Study|Confirmed positive urine drug test|8|||
144545573|NCT01428583|521198306|FG000|Overall Study|Sponsor's request|3|||
144545574|NCT01428583|521198306|FG000|Overall Study|Other|6|||
144545575|NCT00768755|521198309|FG000|Phase 1|Death|6|||
144545576|NCT00768755|521198310|FG001|Phase 1|Death|0|||
144545577|NCT00768755|521198311|FG002|Phase 1|Death|0|||
144545578|NCT00768755|521198312|FG003|Phase 1|Death|0|||
144545579|NCT00768755|521198309|FG000|Phase 1|Other|4|||
144545580|NCT00768755|521198310|FG001|Phase 1|Other|0|||
144545581|NCT00768755|521198311|FG002|Phase 1|Other|0|||
144545582|NCT00768755|521198312|FG003|Phase 1|Other|0|||
144545583|NCT00768755|521198309|FG000|Phase 2|Death|0|||
144545584|NCT00768755|521198310|FG001|Phase 2|Death|37|||
144545585|NCT00768755|521198311|FG002|Phase 2|Death|48|||
144545586|NCT00768755|521198312|FG003|Phase 2|Death|31|||
144545587|NCT00768755|521198309|FG000|Phase 2|Protocol Violation|0|||
144545588|NCT00768755|521198310|FG001|Phase 2|Protocol Violation|2|||
144545589|NCT00768755|521198311|FG002|Phase 2|Protocol Violation|0|||
144545590|NCT00768755|521198312|FG003|Phase 2|Protocol Violation|1|||
144545591|NCT00768755|521198309|FG000|Phase 2|Lost to Follow-up|0|||
144545592|NCT00768755|521198310|FG001|Phase 2|Lost to Follow-up|1|||
144545593|NCT00768755|521198311|FG002|Phase 2|Lost to Follow-up|1|||
144545594|NCT00768755|521198312|FG003|Phase 2|Lost to Follow-up|4|||
144545595|NCT00768755|521198309|FG000|Phase 2|Withdrawal by Subject|0|||
144545596|NCT00768755|521198310|FG001|Phase 2|Withdrawal by Subject|1|||
144545597|NCT00768755|521198311|FG002|Phase 2|Withdrawal by Subject|0|||
144545598|NCT00768755|521198312|FG003|Phase 2|Withdrawal by Subject|1|||
144545599|NCT00768755|521198309|FG000|Phase 2|Other|0|||
144545600|NCT00768755|521198310|FG001|Phase 2|Other|1|||
144545601|NCT00768755|521198311|FG002|Phase 2|Other|2|||
144545602|NCT00768755|521198312|FG003|Phase 2|Other|4|||
144545603|NCT00768755|521198309|FG000|Phase 2|Study Terminated by Sponsor|0|||
144545604|NCT00768755|521198310|FG001|Phase 2|Study Terminated by Sponsor|13|||
144545605|NCT00768755|521198311|FG002|Phase 2|Study Terminated by Sponsor|7|||
144545606|NCT00768755|521198312|FG003|Phase 2|Study Terminated by Sponsor|14|||
144545607|NCT00768755|521198309|FG000|Phase 2|Randomized but not treated|0|||
144545608|NCT00768755|521198310|FG001|Phase 2|Randomized but not treated|0|||
144545609|NCT00768755|521198311|FG002|Phase 2|Randomized but not treated|0|||
144545610|NCT00768755|521198312|FG003|Phase 2|Randomized but not treated|2|||
144545611|NCT03142932|521198316|FG000|Overall Study|Lost to Follow-up|2|||
144545612|NCT03142932|521198317|FG001|Overall Study|Lost to Follow-up|11|||
144545613|NCT02128269|521198318|FG000|Treatment Period|Adverse Event|1|||
144545614|NCT02128269|521198318|FG000|Treatment Period|Physician Decision|1|||
144545615|NCT00878189|521198319|FG000|Overall Study|Death|0|||
144545616|NCT00878189|521198320|FG001|Overall Study|Death|1|||
144545617|NCT00878189|521198321|FG002|Overall Study|Death|0|||
144545618|NCT00878189|521198322|FG003|Overall Study|Death|1|||
144545619|NCT00878189|521198323|FG004|Overall Study|Death|0|||
144545620|NCT00878189|521198324|FG005|Overall Study|Death|0|||
144545621|NCT00878189|521198325|FG006|Overall Study|Death|0|||
144545622|NCT00878189|521198326|FG007|Overall Study|Death|0|||
144545623|NCT00878189|521198327|FG008|Overall Study|Death|1|||
144545624|NCT00878189|521198319|FG000|Overall Study|Participant Refused to Follow-up|0|||
144545625|NCT00878189|521198320|FG001|Overall Study|Participant Refused to Follow-up|0|||
144545626|NCT00878189|521198321|FG002|Overall Study|Participant Refused to Follow-up|0|||
144727526|NCT02101853|521856655|FG004|Post Induction Randomization|Protocol Violation|0|||
144727527|NCT02101853|521856656|FG005|Post Induction Randomization|Protocol Violation|0|||
144727528|NCT02101853|521856651|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
144727529|NCT02101853|521856652|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
144545627|NCT00878189|521198322|FG003|Overall Study|Participant Refused to Follow-up|0|||
144545628|NCT00878189|521198323|FG004|Overall Study|Participant Refused to Follow-up|0|||
144545629|NCT00878189|521198324|FG005|Overall Study|Participant Refused to Follow-up|4|||
144545630|NCT00878189|521198325|FG006|Overall Study|Participant Refused to Follow-up|0|||
144545631|NCT00878189|521198326|FG007|Overall Study|Participant Refused to Follow-up|0|||
144545632|NCT00878189|521198327|FG008|Overall Study|Participant Refused to Follow-up|0|||
144545633|NCT00878189|521198319|FG000|Overall Study|Other|3|||
144545634|NCT00878189|521198320|FG001|Overall Study|Other|2|||
144545635|NCT00878189|521198321|FG002|Overall Study|Other|4|||
144545636|NCT00878189|521198322|FG003|Overall Study|Other|7|||
144545637|NCT00878189|521198323|FG004|Overall Study|Other|4|||
144545638|NCT00878189|521198324|FG005|Overall Study|Other|18|||
144545639|NCT00878189|521198325|FG006|Overall Study|Other|15|||
144545640|NCT00878189|521198326|FG007|Overall Study|Other|3|||
144545641|NCT00878189|521198327|FG008|Overall Study|Other|4|||
144545642|NCT00878189|521198319|FG000|Overall Study|Lost to Follow-up|0|||
144545643|NCT00878189|521198320|FG001|Overall Study|Lost to Follow-up|0|||
144545644|NCT00878189|521198321|FG002|Overall Study|Lost to Follow-up|0|||
144545645|NCT00878189|521198322|FG003|Overall Study|Lost to Follow-up|0|||
144545646|NCT00878189|521198323|FG004|Overall Study|Lost to Follow-up|0|||
144545647|NCT00878189|521198324|FG005|Overall Study|Lost to Follow-up|1|||
144545648|NCT00878189|521198325|FG006|Overall Study|Lost to Follow-up|1|||
144545649|NCT00878189|521198326|FG007|Overall Study|Lost to Follow-up|0|||
144545650|NCT00878189|521198327|FG008|Overall Study|Lost to Follow-up|0|||
144545651|NCT00878189|521198319|FG000|Overall Study|Objection Progression or Relapse|0|||
144545652|NCT00878189|521198320|FG001|Overall Study|Objection Progression or Relapse|0|||
144545653|NCT00878189|521198321|FG002|Overall Study|Objection Progression or Relapse|0|||
144545654|NCT00878189|521198322|FG003|Overall Study|Objection Progression or Relapse|0|||
144545655|NCT00878189|521198323|FG004|Overall Study|Objection Progression or Relapse|0|||
144545656|NCT00878189|521198324|FG005|Overall Study|Objection Progression or Relapse|0|||
144545657|NCT00878189|521198325|FG006|Overall Study|Objection Progression or Relapse|0|||
144545658|NCT00878189|521198326|FG007|Overall Study|Objection Progression or Relapse|0|||
144545659|NCT00878189|521198327|FG008|Overall Study|Objection Progression or Relapse|3|||
144545660|NCT02007070|521198328|FG000|Overall Study|Adverse Event|4|||
144545661|NCT02007070|521198328|FG000|Overall Study|Clinical Progression|4|||
144545662|NCT02007070|521198328|FG000|Overall Study|Death|1|||
144545663|NCT02007070|521198328|FG000|Overall Study|Protocol Violation|2|||
144545664|NCT02007070|521198328|FG000|Overall Study|Physician Decision|1|||
144545665|NCT02007070|521198328|FG000|Overall Study|Progressive Disease|21|||
144545666|NCT01480258|521198329|FG000|Infant Series|Protocol Violation|2|||
144545667|NCT01480258|521198330|FG001|Infant Series|Protocol Violation|0|||
144545668|NCT01480258|521198329|FG000|Infant Series|Physician Decision|0|||
144545669|NCT01480258|521198330|FG001|Infant Series|Physician Decision|1|||
144545670|NCT01480258|521198329|FG000|Infant Series|Not Vaccinated|3|||
144545671|NCT01480258|521198330|FG001|Infant Series|Not Vaccinated|0|||
144545672|NCT01480258|521198329|FG000|Infant Series|Adverse Event|1|||
144545673|NCT01480258|521198330|FG001|Infant Series|Adverse Event|1|||
144545674|NCT01480258|521198329|FG000|Infant Series|Withdrawal by Subject|1|||
144545675|NCT01480258|521198330|FG001|Infant Series|Withdrawal by Subject|6|||
144545676|NCT01480258|521198329|FG000|Interim Period|Lost to Follow-up|0|||
144545677|NCT01480258|521198330|FG001|Interim Period|Lost to Follow-up|2|||
144545678|NCT01480258|521198329|FG000|Interim Period|Physician Decision|1|||
144545679|NCT01480258|521198330|FG001|Interim Period|Physician Decision|0|||
144545680|NCT01480258|521198329|FG000|Interim Period|Protocol Violation|0|||
144545681|NCT01480258|521198330|FG001|Interim Period|Protocol Violation|1|||
144545682|NCT01480258|521198329|FG000|Interim Period|Withdrawal by Subject|9|||
144545683|NCT01480258|521198330|FG001|Interim Period|Withdrawal by Subject|6|||
144545684|NCT01640288|521198333|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
144727530|NCT02101853|521856653|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
144202878|NCT02393248|519940264|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
144202879|NCT02393248|519940265|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
144545685|NCT01640288|521198334|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
144545686|NCT01640288|521198333|FG000|Overall Study|Screen Failure|20|||
144545687|NCT01640288|521198334|FG001|Overall Study|Screen Failure|18|||
144202880|NCT02393248|519940266|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
144545688|NCT01640288|521198333|FG000|Overall Study|Withdrawn by PI|5|||
144545689|NCT01640288|521198334|FG001|Overall Study|Withdrawn by PI|0|||
144545690|NCT01640288|521198333|FG000|Overall Study|Withdrawal by Subject|1|||
144545691|NCT01640288|521198334|FG001|Overall Study|Withdrawal by Subject|0|||
144545692|NCT00787176|521198336|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
144545693|NCT00787176|521198337|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
144545694|NCT00787176|521198338|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
144202881|NCT02393248|519940267|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
144202882|NCT02393248|519940268|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
144202883|NCT02393248|519940269|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
144202884|NCT02393248|519940245|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144545695|NCT00787176|521198339|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
144545696|NCT04660799|521198344|FG000|Overall Study|Progressive Disease|1|||
144545697|NCT04660799|521198345|FG001|Overall Study|Progressive Disease|1|||
144545698|NCT04660799|521198344|FG000|Overall Study|Death|2|||
144545699|NCT04660799|521198345|FG001|Overall Study|Death|1|||
144545700|NCT04660799|521198344|FG000|Overall Study|Adverse Event|2|||
144545701|NCT04660799|521198345|FG001|Overall Study|Adverse Event|1|||
144545702|NCT04660799|521198344|FG000|Overall Study|Withdrawal by Subject|2|||
144545703|NCT04660799|521198345|FG001|Overall Study|Withdrawal by Subject|5|||
144545704|NCT02706483|521198346|FG000|Overall Study|Adverse Event|97|||
144545705|NCT02706483|521198346|FG000|Overall Study|Death|1|||
144202885|NCT02393248|519940246|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144545706|NCT02706483|521198346|FG000|Overall Study|Lack of Efficacy|39|||
144545707|NCT02706483|521198346|FG000|Overall Study|Lost to Follow-up|101|||
144545708|NCT02706483|521198346|FG000|Overall Study|Non-compliance with study drug|15|||
144545709|NCT02706483|521198346|FG000|Overall Study|Physician Decision|6|||
144545710|NCT02706483|521198346|FG000|Overall Study|Pregnancy|6|||
144545711|NCT02706483|521198346|FG000|Overall Study|Protocol Violation|18|||
144545712|NCT02706483|521198346|FG000|Overall Study|Withdrawal by Subject|136|||
144545713|NCT02706483|521198346|FG000|Overall Study|Non-compliance with visits|6|||
144545714|NCT02706483|521198346|FG000|Overall Study|Site closure|4|||
144545715|NCT02706483|521198346|FG000|Overall Study|Subject moved|1|||
144545716|NCT00659373|521198348|FG000|Overall Study|Withdrawal by Subject|3|||
144545717|NCT00659373|521198349|FG001|Overall Study|Withdrawal by Subject|5|||
144545718|NCT00659373|521198348|FG000|Overall Study|Assessment Missed|2|||
144545719|NCT00659373|521198349|FG001|Overall Study|Assessment Missed|2|||
144545720|NCT03042767|521198350|FG000|Overall Study|Lost to Follow-up|1|||
144545721|NCT03042767|521198351|FG001|Overall Study|Lost to Follow-up|2|||
144545722|NCT01543204|521198352|FG000|Overall Study|Non-compliance|1|||
144545723|NCT01543204|521198352|FG000|Overall Study|Adverse Event|1|||
144545724|NCT01543204|521198352|FG000|Overall Study|Withdrawal by Subject|4|||
144545725|NCT01543204|521198352|FG000|Overall Study|Requirement for Alternative Therapy|1|||
144545726|NCT01543204|521198352|FG000|Overall Study|Lost to Follow-up|1|||
144545727|NCT01220999|521198353|FG000|Overall Study|Progressive disease|0|||
144545728|NCT01220999|521198354|FG001|Overall Study|Progressive disease|0|||
144545729|NCT01220999|521198355|FG002|Overall Study|Progressive disease|1|||
144545730|NCT01220999|521198356|FG003|Overall Study|Progressive disease|0|||
144545731|NCT01220999|521198357|FG004|Overall Study|Progressive disease|0|||
144545732|NCT03326856|521198359|FG000|Overall Study|Lost to Follow-up|1|||
144545733|NCT03326856|521198360|FG001|Overall Study|Lost to Follow-up|1|||
144545734|NCT03326856|521198361|FG002|Overall Study|Lost to Follow-up|0|||
144545735|NCT03326856|521198362|FG003|Overall Study|Lost to Follow-up|0|||
144545736|NCT03326856|521198363|FG004|Overall Study|Lost to Follow-up|0|||
144545737|NCT02037568|521198364|FG000|Overall Study|Withdrawal by Subject|17|||
144545738|NCT02037568|521198365|FG001|Overall Study|Withdrawal by Subject|24|||
144545739|NCT02037568|521198364|FG000|Overall Study|Lost to Follow-up|16|||
144545740|NCT02037568|521198365|FG001|Overall Study|Lost to Follow-up|13|||
144545741|NCT02037568|521198364|FG000|Overall Study|Screen Failure|3|||
144545742|NCT02037568|521198365|FG001|Overall Study|Screen Failure|1|||
144545743|NCT02037568|521198364|FG000|Overall Study|Patient did not receive transplant|0|||
144545744|NCT02037568|521198365|FG001|Overall Study|Patient did not receive transplant|1|||
144545745|NCT00721734|521198368|FG000|Overall Study|Progressive Disease|3|||
144202886|NCT02393248|519940247|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144545746|NCT00721734|521198369|FG001|Overall Study|Progressive Disease|10|||
144545747|NCT00721734|521198370|FG002|Overall Study|Progressive Disease|4|||
144727531|NCT02101853|521856654|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
144202887|NCT02393248|519940248|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144262309|NCT02308228|520159868|FG001|Overall Study|Adverse Event|4|||
144727532|NCT02101853|521856655|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
144202888|NCT02393248|519940249|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144545748|NCT00721734|521198371|FG003|Overall Study|Progressive Disease|5|||
144545749|NCT00721734|521198372|FG004|Overall Study|Progressive Disease|2|||
144545750|NCT00721734|521198368|FG000|Overall Study|Adverse Event|3|||
144545751|NCT00721734|521198369|FG001|Overall Study|Adverse Event|1|||
144545752|NCT00721734|521198370|FG002|Overall Study|Adverse Event|4|||
144545753|NCT00721734|521198371|FG003|Overall Study|Adverse Event|0|||
144545754|NCT00721734|521198372|FG004|Overall Study|Adverse Event|3|||
144545755|NCT00721734|521198368|FG000|Overall Study|Withdrawal by Subject|2|||
144545756|NCT00721734|521198369|FG001|Overall Study|Withdrawal by Subject|1|||
144545757|NCT00721734|521198370|FG002|Overall Study|Withdrawal by Subject|0|||
144545758|NCT00721734|521198371|FG003|Overall Study|Withdrawal by Subject|0|||
144545759|NCT00721734|521198372|FG004|Overall Study|Withdrawal by Subject|1|||
144545760|NCT00721734|521198368|FG000|Overall Study|Other|0|||
144545761|NCT00721734|521198369|FG001|Overall Study|Other|0|||
144545762|NCT00721734|521198370|FG002|Overall Study|Other|0|||
144545763|NCT00721734|521198371|FG003|Overall Study|Other|1|||
144545764|NCT00721734|521198372|FG004|Overall Study|Other|0|||
144545765|NCT02833948|521198375|FG000|Overall Study|Death|2|||
144545766|NCT02833948|521198376|FG001|Overall Study|Death|3|||
144545767|NCT02833948|521198375|FG000|Overall Study|were not scanned|8|||
144545768|NCT02833948|521198376|FG001|Overall Study|were not scanned|13|||
144545769|NCT02833948|521198375|FG000|Overall Study|scans could not be evaluated|5|||
144545770|NCT02833948|521198376|FG001|Overall Study|scans could not be evaluated|2|||
144545771|NCT05169684|521198380|FG000|Overall Study|Adverse Event|1|||
144545772|NCT05169684|521198381|FG001|Overall Study|Adverse Event|3|||
144545773|NCT05169684|521198380|FG000|Overall Study|Physician Decision|0|||
144545774|NCT05169684|521198381|FG001|Overall Study|Physician Decision|1|||
144545775|NCT05169684|521198380|FG000|Overall Study|Progressive Disease|1|||
144545776|NCT05169684|521198381|FG001|Overall Study|Progressive Disease|1|||
144545777|NCT05169684|521198380|FG000|Overall Study|Participant request to discontinue treatment|0|||
144545778|NCT05169684|521198381|FG001|Overall Study|Participant request to discontinue treatment|1|||
144545779|NCT05169684|521198380|FG000|Overall Study|Other Reason|0|||
144545780|NCT05169684|521198381|FG001|Overall Study|Other Reason|1|||
144545781|NCT03539055|521198382|FG000|Overall Study|Death|4|||
144545782|NCT03539055|521198382|FG000|Overall Study|Lost to Follow-up|1|||
144545783|NCT03539055|521198382|FG000|Overall Study|Withdrawal by Subject|2|||
144545784|NCT03539055|521198382|FG000|Overall Study|Screen Fail|7|||
144545785|NCT03539055|521198382|FG000|Overall Study|Drug Intolerance|2|||
144545786|NCT01638000|521198389|FG000|Overall Study|Randomized but Never Received Drug|7|||
144545787|NCT01638000|521198390|FG001|Overall Study|Randomized but Never Received Drug|10|||
144545788|NCT01638000|521198389|FG000|Overall Study|Adverse Event|14|||
144545789|NCT01638000|521198390|FG001|Overall Study|Adverse Event|16|||
144545790|NCT01638000|521198389|FG000|Overall Study|Lack of Efficacy|5|||
144545791|NCT01638000|521198390|FG001|Overall Study|Lack of Efficacy|6|||
144545792|NCT01638000|521198389|FG000|Overall Study|Protocol Violation|11|||
144545793|NCT01638000|521198390|FG001|Overall Study|Protocol Violation|13|||
144545794|NCT01638000|521198389|FG000|Overall Study|Withdrawal by Subject|21|||
144545795|NCT01638000|521198390|FG001|Overall Study|Withdrawal by Subject|24|||
144545796|NCT01638000|521198389|FG000|Overall Study|Miscellaneous|2|||
144545797|NCT01638000|521198390|FG001|Overall Study|Miscellaneous|2|||
144545798|NCT05484661|521198391|FG000|Overall Study|Withdrawal by Subject|1|||
144545799|NCT05484661|521198392|FG001|Overall Study|Withdrawal by Subject|0|||
144545800|NCT03775213|521198393|FG000|Overall Study|Withdrawal by Subject|51|||
144545801|NCT03775213|521198394|FG001|Overall Study|Withdrawal by Subject|53|||
144545802|NCT03775213|521198393|FG000|Overall Study|Incomplete Survey|7|||
144545803|NCT03775213|521198394|FG001|Overall Study|Incomplete Survey|7|||
144545804|NCT05163353|521198395|FG000|Overall Study|Adverse Event|1|||
144545805|NCT05163353|521198396|FG001|Overall Study|Adverse Event|0|||
144545806|NCT05163353|521198395|FG000|Overall Study|Withdrawal by Subject|21|||
144545807|NCT05163353|521198396|FG001|Overall Study|Withdrawal by Subject|6|||
144545808|NCT05163353|521198395|FG000|Overall Study|Protocol Violation|0|||
144545809|NCT05163353|521198396|FG001|Overall Study|Protocol Violation|1|||
144545810|NCT05163353|521198395|FG000|Overall Study|Lost to Follow-up|13|||
144545811|NCT05163353|521198396|FG001|Overall Study|Lost to Follow-up|2|||
144545812|NCT06086028|521198397|FG000|Overall Study|Withdrawal by Subject|1|||
144545813|NCT06086028|521198398|FG001|Overall Study|Withdrawal by Subject|1|||
144545814|NCT06086028|521198397|FG000|Overall Study|Lost to Follow-up|2|||
144545815|NCT06086028|521198398|FG001|Overall Study|Lost to Follow-up|3|||
144545816|NCT02521493|521198400|FG000|Overall Study|Death|3|||
144545817|NCT02521493|521198401|FG001|Overall Study|Death|4|||
144545818|NCT02521493|521198402|FG002|Overall Study|Death|1|||
144545819|NCT02521493|521198400|FG000|Overall Study|Physician Decision|19|||
144545820|NCT02521493|521198401|FG001|Overall Study|Physician Decision|1|||
144545821|NCT02521493|521198402|FG002|Overall Study|Physician Decision|2|||
144545822|NCT02521493|521198400|FG000|Overall Study|Withdrawal by Subject|3|||
144545823|NCT02521493|521198401|FG001|Overall Study|Withdrawal by Subject|0|||
144262310|NCT02308228|520159867|FG000|Overall Study|Withdrawal by Subject|5|||
144262311|NCT02308228|520159868|FG001|Overall Study|Withdrawal by Subject|3|||
144262312|NCT03999749|520159873|FG000|Overall Study|Toxicity|16|||
144545824|NCT02521493|521198402|FG002|Overall Study|Withdrawal by Subject|0|||
144545825|NCT02521493|521198400|FG000|Overall Study|Ineligible|0|||
144545826|NCT02521493|521198401|FG001|Overall Study|Ineligible|1|||
144545827|NCT02521493|521198402|FG002|Overall Study|Ineligible|0|||
144545828|NCT02521493|521198400|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
144545829|NCT02521493|521198401|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
144545830|NCT02521493|521198402|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
144545831|NCT02521493|521198400|FG000|Overall Study|No MRD result|0|||
144545832|NCT02521493|521198401|FG001|Overall Study|No MRD result|0|||
144545833|NCT02521493|521198402|FG002|Overall Study|No MRD result|4|||
144545834|NCT05615363|521198403|FG000|Overall Study|Adverse Event|0|||
144545835|NCT05615363|521198404|FG001|Overall Study|Adverse Event|4|||
144545836|NCT05615363|521198405|FG002|Overall Study|Adverse Event|4|||
144545837|NCT05615363|521198406|FG003|Overall Study|Adverse Event|3|||
144545838|NCT05615363|521198407|FG004|Overall Study|Adverse Event|1|||
144545839|NCT05615363|521198403|FG000|Overall Study|Physician Decision|2|||
144545840|NCT05615363|521198404|FG001|Overall Study|Physician Decision|0|||
144545841|NCT05615363|521198405|FG002|Overall Study|Physician Decision|4|||
144545842|NCT05615363|521198406|FG003|Overall Study|Physician Decision|1|||
144545843|NCT05615363|521198407|FG004|Overall Study|Physician Decision|3|||
144545844|NCT05615363|521198403|FG000|Overall Study|Protocol Violation|2|||
144545845|NCT05615363|521198404|FG001|Overall Study|Protocol Violation|0|||
144545846|NCT05615363|521198405|FG002|Overall Study|Protocol Violation|0|||
144545847|NCT05615363|521198406|FG003|Overall Study|Protocol Violation|0|||
144545848|NCT05615363|521198407|FG004|Overall Study|Protocol Violation|1|||
144545849|NCT05615363|521198403|FG000|Overall Study|Withdrawal by Subject|0|||
144545850|NCT05615363|521198404|FG001|Overall Study|Withdrawal by Subject|0|||
144545851|NCT05615363|521198405|FG002|Overall Study|Withdrawal by Subject|1|||
144545852|NCT05615363|521198406|FG003|Overall Study|Withdrawal by Subject|0|||
144545853|NCT05615363|521198407|FG004|Overall Study|Withdrawal by Subject|0|||
144545854|NCT04924608|521200498|FG000|Overall Study|Adverse Event|10|||
144545855|NCT04924608|521200499|FG001|Overall Study|Adverse Event|6|||
144545856|NCT04924608|521200498|FG000|Overall Study|Lost to Follow-up|1|||
144545857|NCT04924608|521200499|FG001|Overall Study|Lost to Follow-up|1|||
144545858|NCT04924608|521200498|FG000|Overall Study|Ongoing at the data cut-off date|54|||
144545859|NCT04924608|521200499|FG001|Overall Study|Ongoing at the data cut-off date|60|||
144545860|NCT04924608|521200498|FG000|Overall Study|Progressive Disease|2|||
144545861|NCT04924608|521200499|FG001|Overall Study|Progressive Disease|0|||
144545862|NCT04924608|521200498|FG000|Overall Study|Withdrawal by Subject|3|||
144545863|NCT04924608|521200499|FG001|Overall Study|Withdrawal by Subject|6|||
144545864|NCT04924608|521200498|FG000|Overall Study|Other reason|1|||
144545865|NCT04924608|521200499|FG001|Overall Study|Other reason|1|||
144545866|NCT00949117|521200500|FG000|Overall Study|Lack of Efficacy|2|||
144545867|NCT00949117|521200501|FG001|Overall Study|Lack of Efficacy|3|||
144545868|NCT00949117|521200500|FG000|Overall Study|Protocol Violation|1|||
144545869|NCT00949117|521200501|FG001|Overall Study|Protocol Violation|1|||
144545870|NCT00949117|521200500|FG000|Overall Study|Adverse Event|0|||
144545871|NCT00949117|521200501|FG001|Overall Study|Adverse Event|1|||
144545872|NCT03769090|521200502|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
144545873|NCT03769090|521200503|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
144545874|NCT03769090|521200504|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
144545875|NCT03769090|521200502|FG000|Overall Study|Withdrawal by Subject|52|||
144545876|NCT03769090|521200503|FG001|Overall Study|Withdrawal by Subject|62|||
144545877|NCT03769090|521200504|FG002|Overall Study|Withdrawal by Subject|74|||
144545878|NCT03769090|521200502|FG000|Overall Study|Death|4|||
144545879|NCT03769090|521200503|FG001|Overall Study|Death|2|||
144545880|NCT03769090|521200504|FG002|Overall Study|Death|2|||
144545881|NCT03769090|521200502|FG000|Overall Study|Adverse Event|7|||
144545882|NCT03769090|521200503|FG001|Overall Study|Adverse Event|7|||
144545883|NCT03769090|521200504|FG002|Overall Study|Adverse Event|8|||
144545884|NCT03769090|521200502|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
144545885|NCT03769090|521200503|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
144545886|NCT03769090|521200504|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
144545887|NCT03769090|521200502|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
144545888|NCT03769090|521200503|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
144545889|NCT03769090|521200504|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
144545890|NCT03769090|521200502|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
144545891|NCT03769090|521200503|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
144545892|NCT03769090|521200504|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
144545893|NCT03769090|521200502|FG000|Overall Study|Protocol Violation|5|||
144545894|NCT03769090|521200503|FG001|Overall Study|Protocol Violation|6|||
144545895|NCT03769090|521200504|FG002|Overall Study|Protocol Violation|8|||
144545896|NCT03769090|521200502|FG000|Overall Study|Pregnancy|1|||
144545897|NCT03769090|521200503|FG001|Overall Study|Pregnancy|0|||
144545898|NCT03769090|521200504|FG002|Overall Study|Pregnancy|3|||
144545899|NCT03769090|521200502|FG000|Overall Study|Lost to Follow-up|19|||
144545900|NCT03769090|521200503|FG001|Overall Study|Lost to Follow-up|25|||
144545901|NCT03769090|521200504|FG002|Overall Study|Lost to Follow-up|21|||
144545902|NCT03769090|521200502|FG000|Overall Study|Condition under investigation worsened|2|||
144545903|NCT03769090|521200503|FG001|Overall Study|Condition under investigation worsened|0|||
144545904|NCT03769090|521200504|FG002|Overall Study|Condition under investigation worsened|1|||
144262313|NCT03999749|520159873|FG000|Overall Study|Withdrawal by Subject|3|||
144545905|NCT03769090|521200502|FG000|Overall Study|Lack of Efficacy|1|||
144545906|NCT03769090|521200503|FG001|Overall Study|Lack of Efficacy|2|||
144545907|NCT03769090|521200504|FG002|Overall Study|Lack of Efficacy|2|||
144545908|NCT03769090|521200502|FG000|Overall Study|Other reasons|8|||
144545909|NCT03769090|521200503|FG001|Overall Study|Other reasons|12|||
144545910|NCT03769090|521200504|FG002|Overall Study|Other reasons|15|||
144545911|NCT03964974|521200505|FG000|Overall Study|Lost to Follow-up|3|||
144545912|NCT03964974|521200506|FG001|Overall Study|Lost to Follow-up|2|||
144545913|NCT03964974|521200505|FG000|Overall Study|Withdrawal by Subject|0|||
144545914|NCT03964974|521200506|FG001|Overall Study|Withdrawal by Subject|3|||
144545915|NCT02014402|521200507|FG000|Overall Study|Adverse Event|1|||
144545916|NCT02014402|521200508|FG001|Overall Study|Adverse Event|0|||
144545917|NCT02014402|521200509|FG002|Overall Study|Adverse Event|0|||
144545918|NCT02014402|521200510|FG003|Overall Study|Adverse Event|0|||
144545919|NCT02014402|521200507|FG000|Overall Study|Withdrawal by Subject|1|||
144545920|NCT02014402|521200508|FG001|Overall Study|Withdrawal by Subject|2|||
144545921|NCT02014402|521200509|FG002|Overall Study|Withdrawal by Subject|2|||
144545922|NCT02014402|521200510|FG003|Overall Study|Withdrawal by Subject|1|||
144545923|NCT02014402|521200507|FG000|Overall Study|Subject did not have transportation|0|||
144545924|NCT02014402|521200508|FG001|Overall Study|Subject did not have transportation|1|||
144545925|NCT02014402|521200509|FG002|Overall Study|Subject did not have transportation|0|||
144545926|NCT02014402|521200510|FG003|Overall Study|Subject did not have transportation|0|||
144545927|NCT02014402|521200507|FG000|Overall Study|Lost to Follow-up|0|||
144545928|NCT02014402|521200508|FG001|Overall Study|Lost to Follow-up|0|||
144545929|NCT02014402|521200509|FG002|Overall Study|Lost to Follow-up|1|||
144545930|NCT02014402|521200510|FG003|Overall Study|Lost to Follow-up|2|||
144545931|NCT02713594|521200514|FG000|Overall Study|Withdrawal by Subject|32|||
144545932|NCT02713594|521200515|FG001|Overall Study|Withdrawal by Subject|22|||
144545933|NCT02713594|521200514|FG000|Overall Study|Lost to Follow-up|358|||
144545934|NCT02713594|521200515|FG001|Overall Study|Lost to Follow-up|374|||
144545935|NCT02660086|521200516|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
144545936|NCT02660086|521200517|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
144545937|NCT02660086|521200516|FG000|Overall Study- 12-month|Left full-time employment|12|||
144545938|NCT02660086|521200517|FG001|Overall Study- 12-month|Left full-time employment|20|||
144545939|NCT02660086|521200516|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
144545940|NCT02660086|521200517|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
144545941|NCT02660086|521200516|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
144545942|NCT02660086|521200517|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
144545943|NCT02660086|521200516|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
144545944|NCT02660086|521200517|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
144545945|NCT02660086|521200516|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
144545946|NCT02660086|521200517|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
144545947|NCT03928743|521200523|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
144545948|NCT03928743|521200524|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
144545949|NCT03928743|521200525|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
144545950|NCT03928743|521200523|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
144545951|NCT03928743|521200524|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
144545952|NCT03928743|521200525|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
144545953|NCT03928743|521200523|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
144727533|NCT02101853|521856656|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
144727534|NCT02101853|521856651|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727535|NCT02101853|521856652|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144545954|NCT03928743|521200524|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
144545955|NCT03928743|521200525|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
144545956|NCT03928743|521200523|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
144545957|NCT03928743|521200524|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
144545958|NCT03928743|521200525|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
144545959|NCT03928743|521200523|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
144545960|NCT03928743|521200524|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
144545961|NCT03928743|521200525|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
144545962|NCT03928743|521200523|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
144545963|NCT03928743|521200524|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
144545964|NCT03928743|521200525|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
144545965|NCT03928743|521200523|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
144727536|NCT02101853|521856653|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727537|NCT02101853|521856654|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
144545966|NCT03928743|521200524|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
144545967|NCT03928743|521200525|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
144545968|NCT03928743|521200523|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
144545969|NCT03928743|521200524|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
144545970|NCT03928743|521200525|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
144545971|NCT03928743|521200523|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
144545972|NCT03928743|521200524|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
144545973|NCT03928743|521200525|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
144545974|NCT03928743|521200523|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
144545975|NCT03928743|521200524|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
144545976|NCT03928743|521200525|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
144545977|NCT03928743|521200523|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
144545978|NCT03928743|521200524|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
144545979|NCT03928743|521200525|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
144545980|NCT05005247|521200526|FG000|Overall Study|Withdrawal by Subject|0|||
144545981|NCT05005247|521200527|FG001|Overall Study|Withdrawal by Subject|1|||
144545982|NCT05005247|521200528|FG002|Overall Study|Withdrawal by Subject|0|||
144545983|NCT01450007|521200529|FG000|Overall Study|Late exclusion before treatment|2|||
144545984|NCT01450007|521200530|FG001|Overall Study|Late exclusion before treatment|3|||
144545985|NCT01450007|521200531|FG002|Overall Study|Late exclusion before treatment|2|||
144545986|NCT01450007|521200529|FG000|Overall Study|Protocol Violation|0|||
144545987|NCT01450007|521200530|FG001|Overall Study|Protocol Violation|1|||
144545988|NCT01450007|521200531|FG002|Overall Study|Protocol Violation|1|||
144545989|NCT01450007|521200529|FG000|Overall Study|Adverse Event|0|||
144545990|NCT01450007|521200530|FG001|Overall Study|Adverse Event|1|||
144545991|NCT01450007|521200531|FG002|Overall Study|Adverse Event|0|||
144545992|NCT02958553|521200532|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
144545993|NCT02958553|521200532|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
144545994|NCT01852045|521200533|FG000|Overall Study|Adverse Event|1|||
144545995|NCT01852045|521200534|FG001|Overall Study|Adverse Event|0|||
144545996|NCT01852045|521200535|FG002|Overall Study|Adverse Event|0|||
144545997|NCT01852045|521200533|FG000|Overall Study|Lack of Efficacy|3|||
144545998|NCT01852045|521200534|FG001|Overall Study|Lack of Efficacy|0|||
144545999|NCT01852045|521200535|FG002|Overall Study|Lack of Efficacy|0|||
144546000|NCT01852045|521200533|FG000|Overall Study|Lost to Follow-up|0|||
144546001|NCT01852045|521200534|FG001|Overall Study|Lost to Follow-up|1|||
144546002|NCT01852045|521200535|FG002|Overall Study|Lost to Follow-up|1|||
144546003|NCT01852045|521200533|FG000|Overall Study|Withdrawal by Subject|1|||
144546004|NCT01852045|521200534|FG001|Overall Study|Withdrawal by Subject|0|||
144546005|NCT01852045|521200535|FG002|Overall Study|Withdrawal by Subject|1|||
144546006|NCT01852045|521200533|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144546007|NCT01852045|521200534|FG001|Overall Study|Other Miscellaneous Reasons|3|||
144546008|NCT01852045|521200535|FG002|Overall Study|Other Miscellaneous Reasons|2|||
144546009|NCT00638456|521200538|FG000|Overall Study|Withdrawal by Subject|6|||
144546010|NCT00638456|521200539|FG001|Overall Study|Withdrawal by Subject|2|||
144546011|NCT00703092|521200540|FG000|Overall Study|Withdrawal by Subject|2|||
144546012|NCT01021748|521200541|FG000|Overall Study|Adverse Event|2|||
144546013|NCT01021748|521200542|FG001|Overall Study|Adverse Event|1|||
144546014|NCT01021748|521200543|FG002|Overall Study|Adverse Event|2|||
144546015|NCT01021748|521200544|FG003|Overall Study|Adverse Event|0|||
144546016|NCT01021748|521200545|FG004|Overall Study|Adverse Event|2|||
144546017|NCT01021748|521200546|FG005|Overall Study|Adverse Event|0|||
144546018|NCT01021748|521200547|FG006|Overall Study|Adverse Event|1|||
144546019|NCT01021748|521200548|FG007|Overall Study|Adverse Event|0|||
144546020|NCT01021748|521200549|FG008|Overall Study|Adverse Event|7|||
144546021|NCT01021748|521200541|FG000|Overall Study|Physician Decision|1|||
144546022|NCT01021748|521200542|FG001|Overall Study|Physician Decision|0|||
144546023|NCT01021748|521200543|FG002|Overall Study|Physician Decision|1|||
144546024|NCT01021748|521200544|FG003|Overall Study|Physician Decision|1|||
144546025|NCT01021748|521200545|FG004|Overall Study|Physician Decision|0|||
144546026|NCT01021748|521200546|FG005|Overall Study|Physician Decision|0|||
144546027|NCT01021748|521200547|FG006|Overall Study|Physician Decision|1|||
144546028|NCT01021748|521200548|FG007|Overall Study|Physician Decision|1|||
144546029|NCT01021748|521200549|FG008|Overall Study|Physician Decision|2|||
144546030|NCT01021748|521200541|FG000|Overall Study|Progressive Disease|3|||
144546031|NCT01021748|521200542|FG001|Overall Study|Progressive Disease|3|||
144546032|NCT01021748|521200543|FG002|Overall Study|Progressive Disease|4|||
144546033|NCT01021748|521200544|FG003|Overall Study|Progressive Disease|6|||
144546034|NCT01021748|521200545|FG004|Overall Study|Progressive Disease|7|||
144546035|NCT01021748|521200546|FG005|Overall Study|Progressive Disease|3|||
144546036|NCT01021748|521200547|FG006|Overall Study|Progressive Disease|0|||
144546037|NCT01021748|521200548|FG007|Overall Study|Progressive Disease|5|||
144546038|NCT01021748|521200549|FG008|Overall Study|Progressive Disease|6|||
144546039|NCT01021748|521200541|FG000|Overall Study|Withdrawal by Subject|0|||
144546040|NCT01021748|521200542|FG001|Overall Study|Withdrawal by Subject|0|||
144546041|NCT01021748|521200543|FG002|Overall Study|Withdrawal by Subject|0|||
144546042|NCT01021748|521200544|FG003|Overall Study|Withdrawal by Subject|0|||
144546043|NCT01021748|521200545|FG004|Overall Study|Withdrawal by Subject|0|||
144546044|NCT01021748|521200546|FG005|Overall Study|Withdrawal by Subject|0|||
144546045|NCT01021748|521200547|FG006|Overall Study|Withdrawal by Subject|1|||
144546046|NCT01021748|521200548|FG007|Overall Study|Withdrawal by Subject|0|||
144546047|NCT01021748|521200549|FG008|Overall Study|Withdrawal by Subject|1|||
144546048|NCT01021748|521200541|FG000|Overall Study|Not Treated|0|||
144546049|NCT01021748|521200542|FG001|Overall Study|Not Treated|1|||
144262314|NCT03999749|520159873|FG000|Overall Study|Disease progression|26|||
144262315|NCT03999749|520159873|FG000|Overall Study|Physician Decision|4|||
144546050|NCT01021748|521200543|FG002|Overall Study|Not Treated|0|||
144546051|NCT01021748|521200544|FG003|Overall Study|Not Treated|0|||
144546052|NCT01021748|521200545|FG004|Overall Study|Not Treated|0|||
144546053|NCT01021748|521200546|FG005|Overall Study|Not Treated|0|||
144546054|NCT01021748|521200547|FG006|Overall Study|Not Treated|0|||
144546055|NCT01021748|521200548|FG007|Overall Study|Not Treated|0|||
144546056|NCT01021748|521200549|FG008|Overall Study|Not Treated|0|||
144546057|NCT01829711|521200550|FG000|Overall Study|Lost to Follow-up|2|||
144546058|NCT01829711|521200550|FG000|Overall Study|Withdrawal by Subject|3|||
144546059|NCT01829711|521200550|FG000|Overall Study|Death|4|||
144546060|NCT01829711|521200550|FG000|Overall Study|Started new therapies|17|||
144546061|NCT01829711|521200550|FG000|Overall Study|Adverse Event|3|||
144546062|NCT01829711|521200550|FG000|Overall Study|Due to progression of disease|13|||
144546063|NCT01829711|521200550|FG000|Overall Study|Due to lack of response|1|||
144546064|NCT02935673|521200551|FG000|Overall Study|Adverse Event|0|||
144546065|NCT02935673|521200552|FG001|Overall Study|Adverse Event|1|||
144546066|NCT02935673|521200553|FG002|Overall Study|Adverse Event|0|||
144546067|NCT02935673|521200551|FG000|Overall Study|Withdrawal by Subject|1|||
144546068|NCT02935673|521200552|FG001|Overall Study|Withdrawal by Subject|2|||
144546069|NCT02935673|521200553|FG002|Overall Study|Withdrawal by Subject|0|||
144546070|NCT01228734|521200554|FG000|Overall Study|Randomized, but not treated|0|||
144546071|NCT01228734|521200555|FG001|Overall Study|Randomized, but not treated|4|||
144546072|NCT00089791|521200556|FG000|Overall Study|Physician Decision|6|||
144546073|NCT00089791|521200557|FG001|Overall Study|Physician Decision|3|||
144546074|NCT00089791|521200556|FG000|Overall Study|Adverse Event|81|||
144546075|NCT00089791|521200557|FG001|Overall Study|Adverse Event|93|||
144546076|NCT00089791|521200556|FG000|Overall Study|Withdrawal by Subject|403|||
144546077|NCT00089791|521200557|FG001|Overall Study|Withdrawal by Subject|344|||
144546078|NCT00089791|521200556|FG000|Overall Study|Death|78|||
144546079|NCT00089791|521200557|FG001|Overall Study|Death|62|||
144546080|NCT00089791|521200556|FG000|Overall Study|Disease progression|7|||
144546081|NCT00089791|521200557|FG001|Overall Study|Disease progression|3|||
144546082|NCT00089791|521200556|FG000|Overall Study|Ineligibility determined|12|||
144546083|NCT00089791|521200557|FG001|Overall Study|Ineligibility determined|9|||
144546084|NCT00089791|521200556|FG000|Overall Study|Lost to Follow-up|57|||
144546085|NCT00089791|521200557|FG001|Overall Study|Lost to Follow-up|57|||
144546086|NCT00089791|521200556|FG000|Overall Study|Noncompliance|17|||
144546087|NCT00089791|521200557|FG001|Overall Study|Noncompliance|13|||
144546088|NCT00089791|521200556|FG000|Overall Study|Other|20|||
144546089|NCT00089791|521200557|FG001|Overall Study|Other|32|||
144546090|NCT00089791|521200556|FG000|Overall Study|Protocol deviation|12|||
144546091|NCT00089791|521200557|FG001|Overall Study|Protocol deviation|10|||
144546092|NCT00089791|521200556|FG000|Overall Study|Requirement for alternative therapy|7|||
144546093|NCT00089791|521200557|FG001|Overall Study|Requirement for alternative therapy|4|||
144546094|NCT00621842|521200558|FG000|Overall Study|Adverse Event|6|||
144546095|NCT00621842|521200558|FG000|Overall Study|Withdrawal by Subject|7|||
144546096|NCT00621842|521200558|FG000|Overall Study|Protocol Violation|4|||
144546097|NCT00621842|521200558|FG000|Overall Study|Lack of Efficacy|2|||
144546098|NCT05074433|521200561|FG000|Overall Study|Adverse Event|0|||
144546099|NCT05074433|521200562|FG001|Overall Study|Adverse Event|2|||
144546100|NCT05074433|521200563|FG002|Overall Study|Adverse Event|0|||
144546101|NCT05074433|521200564|FG003|Overall Study|Adverse Event|1|||
144546102|NCT05074433|521200561|FG000|Overall Study|Sponsor Request|0|||
144546103|NCT05074433|521200562|FG001|Overall Study|Sponsor Request|1|||
144546104|NCT05074433|521200563|FG002|Overall Study|Sponsor Request|1|||
144546105|NCT05074433|521200564|FG003|Overall Study|Sponsor Request|0|||
144546106|NCT05074433|521200561|FG000|Overall Study|Death|1|||
144546107|NCT05074433|521200562|FG001|Overall Study|Death|0|||
144546108|NCT05074433|521200563|FG002|Overall Study|Death|0|||
144262316|NCT03999749|520159873|FG000|Overall Study|Death|5|||
144262317|NCT03999749|520159873|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
144262318|NCT04888494|520159874|FG000|Overall Study|Lost to Follow-up|2|||
144546109|NCT05074433|521200564|FG003|Overall Study|Death|0|||
144546110|NCT05074433|521200561|FG000|Overall Study|Lost to Follow-up|0|||
144546111|NCT05074433|521200562|FG001|Overall Study|Lost to Follow-up|0|||
144546112|NCT05074433|521200563|FG002|Overall Study|Lost to Follow-up|2|||
144546113|NCT05074433|521200564|FG003|Overall Study|Lost to Follow-up|0|||
144546114|NCT05074433|521200561|FG000|Overall Study|Subject Decision|8|||
144546115|NCT05074433|521200562|FG001|Overall Study|Subject Decision|6|||
144546116|NCT05074433|521200563|FG002|Overall Study|Subject Decision|4|||
144546117|NCT05074433|521200564|FG003|Overall Study|Subject Decision|5|||
144546118|NCT04397263|521200565|FG000|Overall Study|Withdrawal by Subject|2|||
144546119|NCT01989689|521200566|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
144546120|NCT01989689|521200567|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
144262319|NCT04888494|520159875|FG001|Overall Study|Lost to Follow-up|3|||
144546121|NCT01989689|521200566|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
144546122|NCT01989689|521200567|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
144546123|NCT00391170|521200574|FG000|Overall Study|Withdrawal by Subject|1|||
144546124|NCT00391170|521200575|FG001|Overall Study|Withdrawal by Subject|0|||
144546125|NCT00391170|521200574|FG000|Overall Study|Adverse Event|3|||
144546126|NCT00391170|521200575|FG001|Overall Study|Adverse Event|2|||
144546127|NCT00391170|521200574|FG000|Overall Study|Physician Decision|2|||
144546128|NCT00391170|521200575|FG001|Overall Study|Physician Decision|2|||
144546129|NCT03026166|521200582|FG000|Overall Study|Death|22|||
144546130|NCT03026166|521200583|FG001|Overall Study|Death|7|||
144546131|NCT03026166|521200582|FG000|Overall Study|Physician Decision|2|||
144546132|NCT03026166|521200583|FG001|Overall Study|Physician Decision|0|||
144546133|NCT03026166|521200582|FG000|Overall Study|Withdrawal by Subject|1|||
144546134|NCT03026166|521200583|FG001|Overall Study|Withdrawal by Subject|2|||
144546135|NCT03026166|521200582|FG000|Overall Study|Lost to Follow-up|1|||
144546136|NCT03026166|521200583|FG001|Overall Study|Lost to Follow-up|0|||
144546137|NCT03026166|521200582|FG000|Overall Study|Study Terminated by Sponsor|3|||
144546138|NCT03026166|521200583|FG001|Overall Study|Study Terminated by Sponsor|3|||
144546139|NCT03026166|521200582|FG000|Overall Study|Other|1|||
144546140|NCT03026166|521200583|FG001|Overall Study|Other|0|||
144546141|NCT05270460|521200584|FG000|Overall Study|Adverse Event|0|||
144546142|NCT05270460|521200585|FG001|Overall Study|Adverse Event|1|||
144546143|NCT05270460|521200586|FG002|Overall Study|Adverse Event|0|||
144546144|NCT05270460|521200584|FG000|Overall Study|Early Termination|0|||
144546145|NCT05270460|521200585|FG001|Overall Study|Early Termination|1|||
144546146|NCT05270460|521200586|FG002|Overall Study|Early Termination|0|||
144546147|NCT00380250|521200587|FG000|Overall Study|Withdrawal by Subject|39|||
144546148|NCT00380250|521200588|FG001|Overall Study|Withdrawal by Subject|28|||
144546149|NCT00380250|521200587|FG000|Overall Study|Adverse Event|20|||
144546150|NCT00380250|521200588|FG001|Overall Study|Adverse Event|9|||
144546151|NCT00380250|521200587|FG000|Overall Study|Lack of Efficacy|10|||
144546152|NCT00380250|521200588|FG001|Overall Study|Lack of Efficacy|8|||
144546153|NCT00380250|521200587|FG000|Overall Study|Protocol Violation|15|||
144546154|NCT00380250|521200588|FG001|Overall Study|Protocol Violation|5|||
144546155|NCT00380250|521200587|FG000|Overall Study|Lost to Follow-up|14|||
144546156|NCT00380250|521200588|FG001|Overall Study|Lost to Follow-up|5|||
144546157|NCT00380250|521200587|FG000|Overall Study|Physician Decision|1|||
144546158|NCT00380250|521200588|FG001|Overall Study|Physician Decision|0|||
144546159|NCT05613088|521200589|FG000|Treatment|Ongoing Study Treatment|9|||
144546160|NCT05613088|521200590|FG001|Treatment|Ongoing Study Treatment|2|||
144546161|NCT05613088|521200589|FG000|Treatment|Adverse Event|3|||
144546162|NCT05613088|521200590|FG001|Treatment|Adverse Event|1|||
144546163|NCT05613088|521200589|FG000|Treatment|Other Reasons|0|||
144546164|NCT05613088|521200590|FG001|Treatment|Other Reasons|1|||
144546165|NCT05613088|521200589|FG000|Treatment|Progressive Disease|58|||
144546166|NCT05613088|521200590|FG001|Treatment|Progressive Disease|26|||
144546167|NCT05613088|521200589|FG000|Treatment|Withdrawal by Subject|0|||
144546168|NCT05613088|521200590|FG001|Treatment|Withdrawal by Subject|4|||
144546169|NCT01668719|521200591|FG000|Phase I|On treatment|1|||
144546170|NCT01668719|521200592|FG001|Phase I|On treatment|0|||
144546171|NCT01668719|521200593|FG002|Phase I|On treatment|0|||
144546172|NCT01668719|521200591|FG000|Phase I|Adverse Event|2|||
144546173|NCT01668719|521200592|FG001|Phase I|Adverse Event|0|||
144546174|NCT01668719|521200593|FG002|Phase I|Adverse Event|0|||
144546175|NCT01668719|521200591|FG000|Phase I|Progression/relapse|1|||
144546176|NCT01668719|521200592|FG001|Phase I|Progression/relapse|0|||
144546177|NCT01668719|521200593|FG002|Phase I|Progression/relapse|0|||
144546178|NCT01668719|521200591|FG000|Phase I|not protocol specified|2|||
144546179|NCT01668719|521200592|FG001|Phase I|not protocol specified|0|||
144546180|NCT01668719|521200593|FG002|Phase I|not protocol specified|0|||
144546181|NCT01668719|521200591|FG000|Phase II|On treatment|0|||
144546182|NCT01668719|521200592|FG001|Phase II|On treatment|4|||
144546183|NCT01668719|521200593|FG002|Phase II|On treatment|3|||
144546184|NCT01668719|521200591|FG000|Phase II|Adverse Event|0|||
144546185|NCT01668719|521200592|FG001|Phase II|Adverse Event|18|||
144546186|NCT01668719|521200593|FG002|Phase II|Adverse Event|18|||
144546187|NCT01668719|521200591|FG000|Phase II|Refusal unrelated to adverse event|0|||
144546188|NCT01668719|521200592|FG001|Phase II|Refusal unrelated to adverse event|4|||
144546189|NCT01668719|521200593|FG002|Phase II|Refusal unrelated to adverse event|1|||
144546190|NCT01668719|521200591|FG000|Phase II|Progression/relapse|0|||
144546191|NCT01668719|521200592|FG001|Phase II|Progression/relapse|13|||
144546192|NCT01668719|521200593|FG002|Phase II|Progression/relapse|17|||
144546193|NCT01668719|521200591|FG000|Phase II|Death|0|||
144546194|NCT01668719|521200592|FG001|Phase II|Death|0|||
144546195|NCT01668719|521200593|FG002|Phase II|Death|2|||
144546196|NCT01668719|521200591|FG000|Phase II|not protocol specified|0|||
144546197|NCT01668719|521200592|FG001|Phase II|not protocol specified|13|||
144546198|NCT01668719|521200593|FG002|Phase II|not protocol specified|7|||
144546199|NCT00875706|521200596|FG000|Overall Study|Withdrawal by Subject|1|||
144546200|NCT00875706|521200597|FG001|Overall Study|Withdrawal by Subject|0|||
144546201|NCT00875706|521200598|FG002|Overall Study|Withdrawal by Subject|0|||
144546202|NCT03205488|521200599|FG000|Overall Study|Adverse Event|1|||
144546203|NCT03205488|521200600|FG001|Overall Study|Adverse Event|2|||
144546204|NCT03205488|521200601|FG002|Overall Study|Adverse Event|4|||
144546205|NCT03205488|521200599|FG000|Overall Study|Protocol Violation|0|||
144546206|NCT03205488|521200600|FG001|Overall Study|Protocol Violation|0|||
144546207|NCT03205488|521200601|FG002|Overall Study|Protocol Violation|1|||
144546208|NCT00786188|521200602|FG000|Overall Study|Adverse Event|3|||
144546209|NCT00786188|521200603|FG001|Overall Study|Adverse Event|1|||
144546210|NCT00786188|521200602|FG000|Overall Study|Withdrawal by Subject|2|||
144546211|NCT00786188|521200603|FG001|Overall Study|Withdrawal by Subject|0|||
144546212|NCT04821271|521200605|FG000|Period 1|Withdrawal by Subject|2|||
144546213|NCT04821271|521200606|FG001|Period 1|Withdrawal by Subject|0|||
144546214|NCT01218594|521200607|FG000|Overall Study|Death|1|||
144546215|NCT01218594|521200607|FG000|Overall Study|Withdrawal by Subject|3|||
144546216|NCT01218594|521200607|FG000|Overall Study|Adverse Event|2|||
144546217|NCT01218594|521200607|FG000|Overall Study|Physician Decision|6|||
144546218|NCT04748341|521200608|FG000|Overall Study|Lost to Follow-up|1|||
144546219|NCT04748341|521200609|FG001|Overall Study|Lost to Follow-up|1|||
144546220|NCT04197713|521200612|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
144546221|NCT04197713|521200613|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
144546222|NCT02334215|521200618|FG000|Overall Study|Death|1|||
144546223|NCT02334215|521200619|FG001|Overall Study|Death|1|||
144546224|NCT02334215|521200620|FG002|Overall Study|Death|0|||
144546225|NCT02334215|521200618|FG000|Overall Study|Lost to Follow-up|1|||
144546226|NCT02334215|521200619|FG001|Overall Study|Lost to Follow-up|0|||
144546227|NCT02334215|521200620|FG002|Overall Study|Lost to Follow-up|4|||
144546228|NCT02334215|521200618|FG000|Overall Study|Withdrawal by Subject|2|||
144546229|NCT02334215|521200619|FG001|Overall Study|Withdrawal by Subject|2|||
144546230|NCT02334215|521200620|FG002|Overall Study|Withdrawal by Subject|1|||
144546231|NCT02334215|521200618|FG000|Overall Study|Not released from incarceration on time|3|||
144546232|NCT02334215|521200619|FG001|Overall Study|Not released from incarceration on time|3|||
144546233|NCT02334215|521200620|FG002|Overall Study|Not released from incarceration on time|3|||
144546234|NCT02334215|521200618|FG000|Overall Study|Incarcerated|0|||
144546235|NCT02334215|521200619|FG001|Overall Study|Incarcerated|0|||
144546236|NCT02334215|521200620|FG002|Overall Study|Incarcerated|7|||
144546237|NCT04602728|521200625|FG000|Overall Study|Lost to Follow-up|4|||
144546238|NCT04602728|521200626|FG001|Overall Study|Lost to Follow-up|4|||
144546239|NCT03905642|521200630|FG000|Overall Study|Withdrawal by Subject|3|||
144546240|NCT03905642|521200630|FG000|Overall Study|Pregnancy|1|||
144546241|NCT03905642|521200630|FG000|Overall Study|Adverse Event|1|||
144546242|NCT03905642|521200630|FG000|Overall Study|Lack of Efficacy|1|||
144546243|NCT03905642|521200630|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
144546244|NCT02159989|521200636|FG000|Overall Study|Adverse Event|1|||
144546245|NCT02159989|521200637|FG001|Overall Study|Adverse Event|0|||
144546246|NCT02159989|521200638|FG002|Overall Study|Adverse Event|0|||
144546247|NCT02159989|521200639|FG003|Overall Study|Adverse Event|0|||
144546248|NCT02159989|521200640|FG004|Overall Study|Adverse Event|1|||
144546249|NCT02159989|521200641|FG005|Overall Study|Adverse Event|0|||
144546250|NCT02159989|521200642|FG006|Overall Study|Adverse Event|1|||
144546251|NCT02159989|521200643|FG007|Overall Study|Adverse Event|2|||
144546252|NCT02159989|521200644|FG008|Overall Study|Adverse Event|0|||
144546253|NCT02159989|521200645|FG009|Overall Study|Adverse Event|2|||
144546254|NCT02159989|521200646|FG010|Overall Study|Adverse Event|1|||
144546255|NCT02159989|521200636|FG000|Overall Study|Death|0|||
144546256|NCT02159989|521200637|FG001|Overall Study|Death|0|||
144546257|NCT02159989|521200638|FG002|Overall Study|Death|0|||
144546258|NCT02159989|521200639|FG003|Overall Study|Death|0|||
144546259|NCT02159989|521200640|FG004|Overall Study|Death|0|||
144546260|NCT02159989|521200641|FG005|Overall Study|Death|0|||
144546261|NCT02159989|521200642|FG006|Overall Study|Death|0|||
144546262|NCT02159989|521200643|FG007|Overall Study|Death|0|||
144546263|NCT02159989|521200644|FG008|Overall Study|Death|0|||
144546264|NCT02159989|521200645|FG009|Overall Study|Death|0|||
144546265|NCT02159989|521200646|FG010|Overall Study|Death|1|||
144727538|NCT02101853|521856655|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144727539|NCT02101853|521856656|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
144546266|NCT02159989|521200636|FG000|Overall Study|Lack of Efficacy|2|||
144546267|NCT02159989|521200637|FG001|Overall Study|Lack of Efficacy|3|||
144727540|NCT02101853|521856651|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
144546268|NCT02159989|521200638|FG002|Overall Study|Lack of Efficacy|3|||
144546269|NCT02159989|521200639|FG003|Overall Study|Lack of Efficacy|0|||
144546270|NCT02159989|521200640|FG004|Overall Study|Lack of Efficacy|2|||
144546271|NCT02159989|521200641|FG005|Overall Study|Lack of Efficacy|3|||
144546272|NCT02159989|521200642|FG006|Overall Study|Lack of Efficacy|3|||
144546273|NCT02159989|521200643|FG007|Overall Study|Lack of Efficacy|1|||
144546274|NCT02159989|521200644|FG008|Overall Study|Lack of Efficacy|3|||
144546275|NCT02159989|521200645|FG009|Overall Study|Lack of Efficacy|6|||
144546276|NCT02159989|521200646|FG010|Overall Study|Lack of Efficacy|7|||
144546277|NCT02159989|521200636|FG000|Overall Study|Lost to Follow-up|0|||
144546278|NCT02159989|521200637|FG001|Overall Study|Lost to Follow-up|0|||
144546279|NCT02159989|521200638|FG002|Overall Study|Lost to Follow-up|0|||
144202889|NCT02393248|519940250|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546280|NCT02159989|521200639|FG003|Overall Study|Lost to Follow-up|1|||
144546281|NCT02159989|521200640|FG004|Overall Study|Lost to Follow-up|0|||
144546282|NCT02159989|521200641|FG005|Overall Study|Lost to Follow-up|0|||
144546283|NCT02159989|521200642|FG006|Overall Study|Lost to Follow-up|0|||
144546284|NCT02159989|521200643|FG007|Overall Study|Lost to Follow-up|0|||
144546285|NCT02159989|521200644|FG008|Overall Study|Lost to Follow-up|0|||
144546286|NCT02159989|521200645|FG009|Overall Study|Lost to Follow-up|0|||
144546287|NCT02159989|521200646|FG010|Overall Study|Lost to Follow-up|1|||
144546288|NCT02159989|521200636|FG000|Overall Study|Withdrawal by Subject|2|||
144546289|NCT02159989|521200637|FG001|Overall Study|Withdrawal by Subject|0|||
144546290|NCT02159989|521200638|FG002|Overall Study|Withdrawal by Subject|0|||
144546291|NCT02159989|521200639|FG003|Overall Study|Withdrawal by Subject|2|||
144546292|NCT02159989|521200640|FG004|Overall Study|Withdrawal by Subject|1|||
144546293|NCT02159989|521200641|FG005|Overall Study|Withdrawal by Subject|0|||
144546294|NCT02159989|521200642|FG006|Overall Study|Withdrawal by Subject|3|||
144546295|NCT02159989|521200643|FG007|Overall Study|Withdrawal by Subject|1|||
144546296|NCT02159989|521200644|FG008|Overall Study|Withdrawal by Subject|0|||
144546297|NCT02159989|521200645|FG009|Overall Study|Withdrawal by Subject|0|||
144546298|NCT02159989|521200646|FG010|Overall Study|Withdrawal by Subject|0|||
144546299|NCT02159989|521200636|FG000|Overall Study|New treatment|0|||
144546300|NCT02159989|521200637|FG001|Overall Study|New treatment|1|||
144546301|NCT02159989|521200638|FG002|Overall Study|New treatment|0|||
144546302|NCT02159989|521200639|FG003|Overall Study|New treatment|0|||
144546303|NCT02159989|521200640|FG004|Overall Study|New treatment|0|||
144546304|NCT02159989|521200641|FG005|Overall Study|New treatment|0|||
144546305|NCT02159989|521200642|FG006|Overall Study|New treatment|0|||
144546306|NCT02159989|521200643|FG007|Overall Study|New treatment|0|||
144202890|NCT02393248|519940251|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546307|NCT02159989|521200644|FG008|Overall Study|New treatment|0|||
144546308|NCT02159989|521200645|FG009|Overall Study|New treatment|0|||
144546309|NCT02159989|521200646|FG010|Overall Study|New treatment|0|||
144727541|NCT02101853|521856652|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
144546310|NCT02159989|521200636|FG000|Overall Study|Insurance Issues|0|||
144546311|NCT02159989|521200637|FG001|Overall Study|Insurance Issues|0|||
144546312|NCT02159989|521200638|FG002|Overall Study|Insurance Issues|0|||
144546313|NCT02159989|521200639|FG003|Overall Study|Insurance Issues|0|||
144546314|NCT02159989|521200640|FG004|Overall Study|Insurance Issues|0|||
144546315|NCT02159989|521200641|FG005|Overall Study|Insurance Issues|0|||
144546316|NCT02159989|521200642|FG006|Overall Study|Insurance Issues|0|||
144546317|NCT02159989|521200643|FG007|Overall Study|Insurance Issues|0|||
144546318|NCT02159989|521200644|FG008|Overall Study|Insurance Issues|0|||
144546319|NCT02159989|521200645|FG009|Overall Study|Insurance Issues|1|||
144546320|NCT02159989|521200646|FG010|Overall Study|Insurance Issues|0|||
144546321|NCT05289037|521200650|FG000|Overall Study|Withdrawal by Subject|7|||
144546322|NCT05289037|521200651|FG001|Overall Study|Withdrawal by Subject|0|||
144546323|NCT05289037|521200652|FG002|Overall Study|Withdrawal by Subject|3|||
144546324|NCT05289037|521200653|FG003|Overall Study|Withdrawal by Subject|3|||
144546325|NCT05289037|521200654|FG004|Overall Study|Withdrawal by Subject|1|||
144546326|NCT05289037|521200655|FG005|Overall Study|Withdrawal by Subject|5|||
144546327|NCT05289037|521200656|FG006|Overall Study|Withdrawal by Subject|2|||
144546328|NCT05289037|521200657|FG007|Overall Study|Withdrawal by Subject|1|||
144546329|NCT05289037|521200658|FG008|Overall Study|Withdrawal by Subject|2|||
144546330|NCT05289037|521200659|FG009|Overall Study|Withdrawal by Subject|2|||
144546331|NCT05289037|521200660|FG010|Overall Study|Withdrawal by Subject|1|||
144546332|NCT05289037|521200661|FG011|Overall Study|Withdrawal by Subject|0|||
144546333|NCT05289037|521200662|FG012|Overall Study|Withdrawal by Subject|1|||
144546334|NCT05289037|521200663|FG013|Overall Study|Withdrawal by Subject|2|||
144546335|NCT05289037|521200664|FG014|Overall Study|Withdrawal by Subject|0|||
144202891|NCT02393248|519940252|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202892|NCT02393248|519940253|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202893|NCT02393248|519940254|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546336|NCT05289037|521200665|FG015|Overall Study|Withdrawal by Subject|3|||
144546337|NCT05289037|521200666|FG016|Overall Study|Withdrawal by Subject|3|||
144546338|NCT05289037|521200650|FG000|Overall Study|Lost to Follow-up|1|||
144546339|NCT05289037|521200651|FG001|Overall Study|Lost to Follow-up|4|||
144546340|NCT05289037|521200652|FG002|Overall Study|Lost to Follow-up|3|||
144546341|NCT05289037|521200653|FG003|Overall Study|Lost to Follow-up|3|||
144546342|NCT05289037|521200654|FG004|Overall Study|Lost to Follow-up|3|||
144546343|NCT05289037|521200655|FG005|Overall Study|Lost to Follow-up|2|||
144546344|NCT05289037|521200656|FG006|Overall Study|Lost to Follow-up|3|||
144546345|NCT05289037|521200657|FG007|Overall Study|Lost to Follow-up|2|||
144546346|NCT05289037|521200658|FG008|Overall Study|Lost to Follow-up|2|||
144546347|NCT05289037|521200659|FG009|Overall Study|Lost to Follow-up|1|||
144546348|NCT05289037|521200660|FG010|Overall Study|Lost to Follow-up|3|||
144546349|NCT05289037|521200661|FG011|Overall Study|Lost to Follow-up|4|||
144546350|NCT05289037|521200662|FG012|Overall Study|Lost to Follow-up|2|||
144202894|NCT02393248|519940255|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546351|NCT05289037|521200663|FG013|Overall Study|Lost to Follow-up|7|||
144546352|NCT05289037|521200664|FG014|Overall Study|Lost to Follow-up|4|||
144546353|NCT05289037|521200665|FG015|Overall Study|Lost to Follow-up|6|||
144202895|NCT02393248|519940256|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
144202896|NCT02393248|519940257|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546354|NCT05289037|521200666|FG016|Overall Study|Lost to Follow-up|4|||
144546355|NCT05289037|521200650|FG000|Overall Study|Death|0|||
144546356|NCT05289037|521200651|FG001|Overall Study|Death|0|||
144546357|NCT05289037|521200652|FG002|Overall Study|Death|0|||
144546358|NCT05289037|521200653|FG003|Overall Study|Death|0|||
144546359|NCT05289037|521200654|FG004|Overall Study|Death|0|||
144546360|NCT05289037|521200655|FG005|Overall Study|Death|1|||
144546361|NCT05289037|521200656|FG006|Overall Study|Death|0|||
144546362|NCT05289037|521200657|FG007|Overall Study|Death|0|||
144546363|NCT05289037|521200658|FG008|Overall Study|Death|0|||
144546364|NCT05289037|521200659|FG009|Overall Study|Death|0|||
144546365|NCT05289037|521200660|FG010|Overall Study|Death|0|||
144546366|NCT05289037|521200661|FG011|Overall Study|Death|0|||
144546367|NCT05289037|521200662|FG012|Overall Study|Death|0|||
144546368|NCT05289037|521200663|FG013|Overall Study|Death|0|||
144546369|NCT05289037|521200664|FG014|Overall Study|Death|1|||
144546370|NCT05289037|521200665|FG015|Overall Study|Death|0|||
144546371|NCT05289037|521200666|FG016|Overall Study|Death|0|||
144546372|NCT05289037|521200650|FG000|Overall Study|Did not receive vaccine|0|||
144546373|NCT05289037|521200651|FG001|Overall Study|Did not receive vaccine|3|||
144546374|NCT05289037|521200652|FG002|Overall Study|Did not receive vaccine|0|||
144546375|NCT05289037|521200653|FG003|Overall Study|Did not receive vaccine|0|||
144546376|NCT05289037|521200654|FG004|Overall Study|Did not receive vaccine|1|||
144546377|NCT05289037|521200655|FG005|Overall Study|Did not receive vaccine|1|||
144546378|NCT05289037|521200656|FG006|Overall Study|Did not receive vaccine|1|||
144546379|NCT05289037|521200657|FG007|Overall Study|Did not receive vaccine|0|||
144546380|NCT05289037|521200658|FG008|Overall Study|Did not receive vaccine|0|||
144546381|NCT05289037|521200659|FG009|Overall Study|Did not receive vaccine|0|||
144546382|NCT05289037|521200660|FG010|Overall Study|Did not receive vaccine|0|||
144546383|NCT05289037|521200661|FG011|Overall Study|Did not receive vaccine|0|||
144546384|NCT05289037|521200662|FG012|Overall Study|Did not receive vaccine|0|||
144546385|NCT05289037|521200663|FG013|Overall Study|Did not receive vaccine|0|||
144546386|NCT05289037|521200664|FG014|Overall Study|Did not receive vaccine|1|||
144546387|NCT05289037|521200665|FG015|Overall Study|Did not receive vaccine|0|||
144546388|NCT05289037|521200666|FG016|Overall Study|Did not receive vaccine|0|||
144546389|NCT05289037|521200650|FG000|Overall Study|Unable to make last visit|0|||
144546390|NCT05289037|521200651|FG001|Overall Study|Unable to make last visit|0|||
144546391|NCT05289037|521200652|FG002|Overall Study|Unable to make last visit|1|||
144546392|NCT05289037|521200653|FG003|Overall Study|Unable to make last visit|0|||
144546393|NCT05289037|521200654|FG004|Overall Study|Unable to make last visit|0|||
144546394|NCT05289037|521200655|FG005|Overall Study|Unable to make last visit|0|||
144546395|NCT05289037|521200656|FG006|Overall Study|Unable to make last visit|0|||
144546396|NCT05289037|521200657|FG007|Overall Study|Unable to make last visit|0|||
144546397|NCT05289037|521200658|FG008|Overall Study|Unable to make last visit|0|||
144546398|NCT05289037|521200659|FG009|Overall Study|Unable to make last visit|0|||
144546399|NCT05289037|521200660|FG010|Overall Study|Unable to make last visit|0|||
144546400|NCT05289037|521200661|FG011|Overall Study|Unable to make last visit|0|||
144546401|NCT05289037|521200662|FG012|Overall Study|Unable to make last visit|0|||
144546402|NCT05289037|521200663|FG013|Overall Study|Unable to make last visit|0|||
144546403|NCT05289037|521200664|FG014|Overall Study|Unable to make last visit|0|||
144546404|NCT05289037|521200665|FG015|Overall Study|Unable to make last visit|0|||
144546405|NCT05289037|521200666|FG016|Overall Study|Unable to make last visit|0|||
144546406|NCT05289037|521200650|FG000|Overall Study|Protocol deviation|0|||
144546407|NCT05289037|521200651|FG001|Overall Study|Protocol deviation|0|||
144546408|NCT05289037|521200652|FG002|Overall Study|Protocol deviation|0|||
144546409|NCT05289037|521200653|FG003|Overall Study|Protocol deviation|0|||
144546410|NCT05289037|521200654|FG004|Overall Study|Protocol deviation|0|||
144546411|NCT05289037|521200655|FG005|Overall Study|Protocol deviation|0|||
144546412|NCT05289037|521200656|FG006|Overall Study|Protocol deviation|0|||
144546413|NCT05289037|521200657|FG007|Overall Study|Protocol deviation|0|||
144546414|NCT05289037|521200658|FG008|Overall Study|Protocol deviation|0|||
144546415|NCT05289037|521200659|FG009|Overall Study|Protocol deviation|0|||
144546416|NCT05289037|521200660|FG010|Overall Study|Protocol deviation|0|||
144546417|NCT05289037|521200661|FG011|Overall Study|Protocol deviation|0|||
144546418|NCT05289037|521200662|FG012|Overall Study|Protocol deviation|0|||
144546419|NCT05289037|521200663|FG013|Overall Study|Protocol deviation|0|||
144546420|NCT05289037|521200664|FG014|Overall Study|Protocol deviation|0|||
144546421|NCT05289037|521200665|FG015|Overall Study|Protocol deviation|1|||
144546422|NCT05289037|521200666|FG016|Overall Study|Protocol deviation|0|||
144546423|NCT02831049|521200667|FG000|Overall Study|Lost to Follow-up|0|||
144546424|NCT02831049|521200668|FG001|Overall Study|Lost to Follow-up|0|||
144546425|NCT02831049|521200669|FG002|Overall Study|Lost to Follow-up|1|||
144546426|NCT02831049|521200667|FG000|Overall Study|Withdrawal by Subject|0|||
144546427|NCT02831049|521200668|FG001|Overall Study|Withdrawal by Subject|1|||
144616527|NCT03246958|521456341|FG002|Overall Study|Over enrollment|0|||
144616528|NCT03246958|521456342|FG003|Overall Study|Over enrollment|0|||
144616529|NCT03246958|521456343|FG004|Overall Study|Over enrollment|0|||
144616530|NCT03246958|521456344|FG005|Overall Study|Over enrollment|0|||
144616531|NCT03246958|521456345|FG006|Overall Study|Over enrollment|0|||
144616532|NCT03363321|521456346|FG000|Overall Study|Withdrawal by Subject|0|||
144616533|NCT03363321|521456347|FG001|Overall Study|Withdrawal by Subject|1|||
144616534|NCT03363321|521456348|FG002|Overall Study|Withdrawal by Subject|0|||
144546428|NCT02831049|521200669|FG002|Overall Study|Withdrawal by Subject|1|||
144546429|NCT02831049|521200667|FG000|Overall Study|Pandemic shutdown|1|||
144546430|NCT02831049|521200668|FG001|Overall Study|Pandemic shutdown|0|||
144546431|NCT02831049|521200669|FG002|Overall Study|Pandemic shutdown|0|||
144546432|NCT04937504|521200670|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
144546433|NCT04937504|521200671|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
144546434|NCT04937504|521200670|FG000|9 Months Assessment|Lost to Follow-up|3|||
144546435|NCT04937504|521200671|FG001|9 Months Assessment|Lost to Follow-up|2|||
144546436|NCT03662659|521200672|FG000|Pre-treatment|Participant no longer met study criteria|1|||
144546437|NCT03662659|521200673|FG001|Pre-treatment|Participant no longer met study criteria|1|||
144546438|NCT03662659|521200672|FG000|Pre-treatment|Other reasons|1|||
144546439|NCT03662659|521200673|FG001|Pre-treatment|Other reasons|0|||
144546440|NCT03662659|521200672|FG000|Treatment|Completed Treatment|0|||
144546441|NCT03662659|521200673|FG001|Treatment|Completed Treatment|2|||
144546442|NCT03662659|521200672|FG000|Treatment|Disease Progression|85|||
144546443|NCT03662659|521200673|FG001|Treatment|Disease Progression|97|||
144616535|NCT03363321|521456349|FG003|Overall Study|Withdrawal by Subject|1|||
144727542|NCT02101853|521856653|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
144546444|NCT03662659|521200672|FG000|Treatment|Study Drug Toxicity|19|||
144546445|NCT03662659|521200673|FG001|Treatment|Study Drug Toxicity|9|||
144546446|NCT03662659|521200672|FG000|Treatment|Death|11|||
144546447|NCT03662659|521200673|FG001|Treatment|Death|9|||
144546448|NCT03662659|521200672|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
144546449|NCT03662659|521200673|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
144546450|NCT03662659|521200672|FG000|Treatment|Withdrawal by Subject|1|||
144546451|NCT03662659|521200673|FG001|Treatment|Withdrawal by Subject|1|||
144546452|NCT03662659|521200672|FG000|Treatment|Poor/Non-compliance|1|||
144546453|NCT03662659|521200673|FG001|Treatment|Poor/Non-compliance|0|||
144546454|NCT03662659|521200672|FG000|Treatment|Participant no longer meets study criteria|1|||
144727543|NCT02101853|521856654|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
144546455|NCT03662659|521200673|FG001|Treatment|Participant no longer meets study criteria|0|||
144546456|NCT03662659|521200672|FG000|Treatment|Other reasons|10|||
144546457|NCT03662659|521200673|FG001|Treatment|Other reasons|8|||
144546458|NCT03662659|521200672|FG000|Treatment|Administrative reasons by sponsor|1|||
144546459|NCT03662659|521200673|FG001|Treatment|Administrative reasons by sponsor|0|||
144546460|NCT03662659|521200672|FG000|Treatment|maximum clinical benefit|0|||
144546461|NCT03662659|521200673|FG001|Treatment|maximum clinical benefit|2|||
144546462|NCT01668355|521202342|FG000|Overall Study|Death|3|||
144546463|NCT01668355|521202343|FG001|Overall Study|Death|1|||
144546464|NCT01668355|521202342|FG000|Overall Study|Withdrawal by Subject|6|||
144546465|NCT01668355|521202343|FG001|Overall Study|Withdrawal by Subject|1|||
144546466|NCT01277302|521202347|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
144546467|NCT01277302|521202348|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
144546468|NCT01277302|521202349|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
144546469|NCT01277302|521202347|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
144546470|NCT01277302|521202348|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
144546471|NCT01277302|521202349|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
144546472|NCT01277302|521202347|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
144546473|NCT01277302|521202348|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
144546474|NCT01277302|521202349|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
144546475|NCT01277302|521202347|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
144546476|NCT01277302|521202348|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
144546477|NCT01277302|521202349|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
144546478|NCT01277302|521202347|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
144546479|NCT01277302|521202348|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
144546480|NCT01277302|521202349|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
144546481|NCT01277302|521202347|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
144546482|NCT01277302|521202348|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
144616536|NCT03363321|521456350|FG004|Overall Study|Withdrawal by Subject|0|||
144616537|NCT02915523|521456352|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
144546483|NCT01277302|521202349|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
144546484|NCT01277302|521202347|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
144616538|NCT02915523|521456353|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
144202897|NCT02393248|519940258|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
144202898|NCT02393248|519940259|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546485|NCT01277302|521202348|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
144546486|NCT01277302|521202349|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
144546487|NCT01277302|521202347|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
144546488|NCT01277302|521202348|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
144546489|NCT01277302|521202349|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
144546490|NCT01277302|521202347|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
144546491|NCT01277302|521202348|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
144546492|NCT01277302|521202349|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
144546493|NCT02710669|521202352|FG000|Overall Study|Physician Decision|2|||
144546494|NCT02710669|521202353|FG001|Overall Study|Physician Decision|1|||
144546495|NCT02710669|521202354|FG002|Overall Study|Physician Decision|0|||
144546496|NCT02710669|521202352|FG000|Overall Study|Institutional delays (including COVID)|2|||
144546497|NCT02710669|521202353|FG001|Overall Study|Institutional delays (including COVID)|2|||
144546498|NCT02710669|521202354|FG002|Overall Study|Institutional delays (including COVID)|0|||
144546499|NCT02710669|521202352|FG000|Overall Study|arrived in afib/aflutter|10|||
144546500|NCT02710669|521202353|FG001|Overall Study|arrived in afib/aflutter|8|||
144546501|NCT02710669|521202354|FG002|Overall Study|arrived in afib/aflutter|2|||
144546502|NCT01190124|521202356|FG000|Overall Study|Death|3|||
144546503|NCT01190124|521202357|FG001|Overall Study|Death|0|||
144546504|NCT01190124|521202358|FG002|Overall Study|Death|0|||
144546505|NCT01190124|521202356|FG000|Overall Study|Therapeutic Failure|12|||
144546506|NCT01190124|521202357|FG001|Overall Study|Therapeutic Failure|0|||
144546507|NCT01190124|521202358|FG002|Overall Study|Therapeutic Failure|1|||
144546508|NCT01190124|521202356|FG000|Overall Study|Lost to Follow-up|2|||
144546509|NCT01190124|521202357|FG001|Overall Study|Lost to Follow-up|0|||
144546510|NCT01190124|521202358|FG002|Overall Study|Lost to Follow-up|0|||
144546511|NCT00070707|521202359|FG000|Overall Study|Adverse Event|1|||
144546512|NCT00070707|521202360|FG001|Overall Study|Adverse Event|2|||
144546513|NCT00070707|521202359|FG000|Overall Study|Lack of Efficacy|4|||
144546514|NCT00070707|521202360|FG001|Overall Study|Lack of Efficacy|1|||
144546515|NCT00070707|521202359|FG000|Overall Study|Protocol Violation|8|||
144546516|NCT00070707|521202360|FG001|Overall Study|Protocol Violation|4|||
144546517|NCT00070707|521202359|FG000|Overall Study|Unrelated to Study Medication|1|||
144546518|NCT00070707|521202360|FG001|Overall Study|Unrelated to Study Medication|0|||
144546519|NCT00670449|521202361|FG000|Overall Study|Adverse Event|6|||
144546520|NCT00670449|521202362|FG001|Overall Study|Adverse Event|2|||
144546521|NCT00670449|521202363|FG002|Overall Study|Adverse Event|8|||
144546522|NCT00670449|521202364|FG003|Overall Study|Adverse Event|5|||
144546523|NCT00670449|521202361|FG000|Overall Study|Protocol Deviation|1|||
144546524|NCT00670449|521202362|FG001|Overall Study|Protocol Deviation|2|||
144546525|NCT00670449|521202363|FG002|Overall Study|Protocol Deviation|0|||
144546526|NCT00670449|521202364|FG003|Overall Study|Protocol Deviation|1|||
144546527|NCT00670449|521202361|FG000|Overall Study|Administrative Problems|0|||
144546528|NCT00670449|521202362|FG001|Overall Study|Administrative Problems|2|||
144546529|NCT00670449|521202363|FG002|Overall Study|Administrative Problems|0|||
144546530|NCT00670449|521202364|FG003|Overall Study|Administrative Problems|1|||
144546531|NCT00670449|521202361|FG000|Overall Study|Subject Withdrew Consent|0|||
144546532|NCT00670449|521202362|FG001|Overall Study|Subject Withdrew Consent|2|||
144546533|NCT00670449|521202363|FG002|Overall Study|Subject Withdrew Consent|0|||
144546534|NCT00670449|521202364|FG003|Overall Study|Subject Withdrew Consent|1|||
144546535|NCT00670449|521202361|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
144546536|NCT00670449|521202362|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144546537|NCT00670449|521202363|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
144546538|NCT00670449|521202364|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144546539|NCT00670449|521202361|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
144546540|NCT00670449|521202362|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
144546541|NCT00670449|521202363|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
144546542|NCT00670449|521202364|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
144546543|NCT03690219|521202365|FG000|Overall Study|no injuries|9|||
144546544|NCT03690219|521202366|FG001|Overall Study|no injuries|20|||
144546545|NCT03690219|521202365|FG000|Overall Study|missing information|7|||
144546546|NCT03690219|521202366|FG001|Overall Study|missing information|7|||
144546547|NCT01523392|521202367|FG000|Treatment Period 1|Withdrawal by Subject|2|||
144546548|NCT01523392|521202368|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144546549|NCT01523392|521202367|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
144546550|NCT01523392|521202368|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
144546551|NCT01523392|521202367|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
144546552|NCT01523392|521202368|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
144546553|NCT04809623|521202369|FG000|Overall Study|Study Terminated by Sponsor|1|||
144546554|NCT04809623|521202370|FG001|Overall Study|Study Terminated by Sponsor|0|||
144546555|NCT00413283|521202371|FG000|Overall Study|Withdrawal by Subject|1|||
144546556|NCT00413283|521202372|FG001|Overall Study|Withdrawal by Subject|0|||
144546557|NCT00413283|521202373|FG002|Overall Study|Withdrawal by Subject|0|||
144202899|NCT02393248|519940260|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202900|NCT02393248|519940261|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546558|NCT00413283|521202374|FG003|Overall Study|Withdrawal by Subject|1|||
144546559|NCT00413283|521202371|FG000|Overall Study|Death|0|||
144546560|NCT00413283|521202372|FG001|Overall Study|Death|0|||
144546561|NCT00413283|521202373|FG002|Overall Study|Death|1|||
144546562|NCT00413283|521202374|FG003|Overall Study|Death|1|||
144546563|NCT00413283|521202371|FG000|Overall Study|Adverse Event|0|||
144546564|NCT00413283|521202372|FG001|Overall Study|Adverse Event|0|||
144546565|NCT00413283|521202373|FG002|Overall Study|Adverse Event|0|||
144546566|NCT00413283|521202374|FG003|Overall Study|Adverse Event|1|||
144546567|NCT00413283|521202371|FG000|Overall Study|Ineligibility determined|0|||
144546568|NCT00413283|521202372|FG001|Overall Study|Ineligibility determined|0|||
144546569|NCT00413283|521202373|FG002|Overall Study|Ineligibility determined|0|||
144546570|NCT00413283|521202374|FG003|Overall Study|Ineligibility determined|1|||
144546571|NCT00413283|521202371|FG000|Overall Study|Protocol deviation|0|||
144546572|NCT00413283|521202372|FG001|Overall Study|Protocol deviation|1|||
144546573|NCT00413283|521202373|FG002|Overall Study|Protocol deviation|0|||
144546574|NCT00413283|521202374|FG003|Overall Study|Protocol deviation|0|||
144546575|NCT00413283|521202371|FG000|Overall Study|Requirement for alternative therapy|0|||
144546576|NCT00413283|521202372|FG001|Overall Study|Requirement for alternative therapy|2|||
144546577|NCT00413283|521202373|FG002|Overall Study|Requirement for alternative therapy|0|||
144546578|NCT00413283|521202374|FG003|Overall Study|Requirement for alternative therapy|0|||
144546579|NCT00413283|521202371|FG000|Overall Study|Other|0|||
144546580|NCT00413283|521202372|FG001|Overall Study|Other|0|||
144546581|NCT00413283|521202373|FG002|Overall Study|Other|1|||
144546582|NCT00413283|521202374|FG003|Overall Study|Other|0|||
144546583|NCT00671853|521202375|FG000|Overall Study|Lack of Efficacy|3|||
144546584|NCT00671853|521202376|FG001|Overall Study|Lack of Efficacy|7|||
144546585|NCT00671853|521202375|FG000|Overall Study|Adverse Event|7|||
144546586|NCT00671853|521202376|FG001|Overall Study|Adverse Event|1|||
144546587|NCT00671853|521202375|FG000|Overall Study|Withdrawal by Subject|1|||
144546588|NCT00671853|521202376|FG001|Overall Study|Withdrawal by Subject|5|||
144546589|NCT00671853|521202375|FG000|Overall Study|Lost to Follow-up|8|||
144546590|NCT00671853|521202376|FG001|Overall Study|Lost to Follow-up|8|||
144546591|NCT00671853|521202375|FG000|Overall Study|Physician Decision|0|||
144546592|NCT00671853|521202376|FG001|Overall Study|Physician Decision|2|||
144546593|NCT00671853|521202375|FG000|Overall Study|Non-adherence with study procedures|1|||
144546594|NCT00671853|521202376|FG001|Overall Study|Non-adherence with study procedures|4|||
144546595|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
144546596|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144546597|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144546598|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144546599|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
144546600|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144546601|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144546602|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144546603|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
144546604|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144546605|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144546606|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144546607|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
144546608|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144546609|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144546610|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144546611|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
144546612|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144546613|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144546614|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144546615|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
144546616|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144546617|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144546618|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144546619|NCT01185340|521202379|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
144546620|NCT01185340|521202380|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144546621|NCT01185340|521202381|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144546622|NCT01185340|521202382|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144546623|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
144546624|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
144546625|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
144546626|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
144546627|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
144546628|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
144546629|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
144546630|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
144546631|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
144546632|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
144546633|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
144546634|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
144546635|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144546636|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
144546637|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144546638|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
144546639|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
144546640|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
144546641|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
144546642|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
144546643|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
144546644|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
144546645|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
144546646|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
144202901|NCT02393248|519940262|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202902|NCT02393248|519940263|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202903|NCT02393248|519940264|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202904|NCT02393248|519940265|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202905|NCT02393248|519940266|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202906|NCT02393248|519940267|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144546647|NCT01185340|521202379|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
144546648|NCT01185340|521202380|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
144546649|NCT01185340|521202381|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
144546650|NCT01185340|521202382|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
144546651|NCT01719172|521202383|FG000|Overall Study|Lost to Follow-up|1|||
144546652|NCT01719172|521202383|FG000|Overall Study|Death|1|||
144546653|NCT02236611|521202388|FG000|Overall Study|Adverse Event|10|||
144546654|NCT02236611|521202389|FG001|Overall Study|Adverse Event|16|||
144546655|NCT02236611|521202388|FG000|Overall Study|Lack of Efficacy|4|||
144546656|NCT02236611|521202389|FG001|Overall Study|Lack of Efficacy|7|||
144546657|NCT02236611|521202388|FG000|Overall Study|Lost to Follow-up|0|||
144546658|NCT02236611|521202389|FG001|Overall Study|Lost to Follow-up|2|||
144546659|NCT02236611|521202388|FG000|Overall Study|Protocol deviation|3|||
144546660|NCT02236611|521202389|FG001|Overall Study|Protocol deviation|5|||
144546661|NCT02236611|521202388|FG000|Overall Study|Withdrew consent|9|||
144546662|NCT02236611|521202389|FG001|Overall Study|Withdrew consent|4|||
144546663|NCT03041090|521202390|FG000|Overall Study|technical error|0|||
144546664|NCT03041090|521202391|FG001|Overall Study|technical error|3|||
144546665|NCT01128959|521202392|FG000|Lead in Period|Adverse Event|3|||
144546666|NCT01128959|521202392|FG000|Treatment Period|Adverse Event|3|||
144546667|NCT01128959|521202392|FG000|Treatment Period|Withdrawal by Subject|1|||
144546668|NCT02701296|521202393|FG000|Overall Study|Incomplete Data|0|||
144546669|NCT02701296|521202394|FG001|Overall Study|Incomplete Data|2|||
144546670|NCT01409837|521202395|FG000|Overall Study|Withdrawal by Subject|2|||
144546671|NCT01409837|521202396|FG001|Overall Study|Withdrawal by Subject|1|||
144546672|NCT01409837|521202395|FG000|Overall Study|Lost to Follow-up|1|||
144546673|NCT01409837|521202396|FG001|Overall Study|Lost to Follow-up|0|||
144546674|NCT01409837|521202395|FG000|Overall Study|Physician Decision|0|||
144546675|NCT01409837|521202396|FG001|Overall Study|Physician Decision|1|||
144546676|NCT03490032|521202398|FG000|Overall Study|family issue (child custody)|1|||
144546677|NCT03490032|521202399|FG001|Overall Study|family issue (child custody)|0|||
144546678|NCT03490032|521202400|FG002|Overall Study|family issue (child custody)|0|||
144546679|NCT00308308|521202401|FG000|Overall Study|Adverse Event|17|||
144546680|NCT00308308|521202402|FG001|Overall Study|Adverse Event|2|||
144546681|NCT00308308|521202401|FG000|Overall Study|Lost to Follow-up|5|||
144546682|NCT00308308|521202402|FG001|Overall Study|Lost to Follow-up|5|||
144546683|NCT00308308|521202401|FG000|Overall Study|Physician Decision|15|||
144546684|NCT00308308|521202402|FG001|Overall Study|Physician Decision|7|||
144546685|NCT00308308|521202401|FG000|Overall Study|Protocol Violation|3|||
144546686|NCT00308308|521202402|FG001|Overall Study|Protocol Violation|14|||
144546687|NCT00308308|521202401|FG000|Overall Study|Withdrawal by Subject|47|||
144546688|NCT00308308|521202402|FG001|Overall Study|Withdrawal by Subject|19|||
144546689|NCT00308308|521202401|FG000|Overall Study|Various|7|||
144546690|NCT00308308|521202402|FG001|Overall Study|Various|5|||
144546691|NCT00308308|521202401|FG000|Overall Study|Randomized but not dosed|8|||
144546692|NCT00308308|521202402|FG001|Overall Study|Randomized but not dosed|16|||
144546693|NCT00308308|521202401|FG000|Overall Study|Other|1|||
144546694|NCT00308308|521202402|FG001|Overall Study|Other|0|||
144546695|NCT04679675|521202407|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
144546696|NCT04679675|521202408|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
144546697|NCT04679675|521202409|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
144546698|NCT04679675|521202410|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
144546699|NCT04679675|521202407|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
144546700|NCT04679675|521202408|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
144546701|NCT04679675|521202409|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
144546702|NCT04679675|521202410|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
144546703|NCT02362789|521202416|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
144546704|NCT02362789|521202417|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
144546705|NCT02362789|521202418|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
144546706|NCT02362789|521202416|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
144546707|NCT02362789|521202417|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
144546708|NCT02362789|521202418|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
144546709|NCT02362789|521202416|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
144546710|NCT02362789|521202417|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
144546711|NCT02362789|521202418|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
144546712|NCT02362789|521202416|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
144546713|NCT02362789|521202417|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
144546714|NCT02362789|521202418|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
144546715|NCT02362789|521202416|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
144546716|NCT02362789|521202417|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
144546717|NCT02362789|521202418|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
144546718|NCT02066636|521202420|FG000|Overall Study|Disease progression|51|||
144546719|NCT02066636|521202421|FG001|Overall Study|Disease progression|60|||
144546720|NCT02066636|521202422|FG002|Overall Study|Disease progression|700|||
144546721|NCT02066636|521202420|FG000|Overall Study|Study drug toxicity|13|||
144546722|NCT02066636|521202421|FG001|Overall Study|Study drug toxicity|2|||
144546723|NCT02066636|521202422|FG002|Overall Study|Study drug toxicity|58|||
144546724|NCT02066636|521202420|FG000|Overall Study|Death|4|||
144546725|NCT02066636|521202421|FG001|Overall Study|Death|2|||
144546726|NCT02066636|521202422|FG002|Overall Study|Death|158|||
144546727|NCT02066636|521202420|FG000|Overall Study|Adverse event unrelated to study drug|6|||
144546728|NCT02066636|521202421|FG001|Overall Study|Adverse event unrelated to study drug|4|||
144546729|NCT02066636|521202422|FG002|Overall Study|Adverse event unrelated to study drug|45|||
144546730|NCT02066636|521202420|FG000|Overall Study|Participant request to discontinue treatment|12|||
144546731|NCT02066636|521202421|FG001|Overall Study|Participant request to discontinue treatment|12|||
144546732|NCT02066636|521202422|FG002|Overall Study|Participant request to discontinue treatment|70|||
144546733|NCT02066636|521202420|FG000|Overall Study|Participant withdrew consent|10|||
144546734|NCT02066636|521202421|FG001|Overall Study|Participant withdrew consent|18|||
144546735|NCT02066636|521202422|FG002|Overall Study|Participant withdrew consent|61|||
144546736|NCT02066636|521202420|FG000|Overall Study|Lost to Follow-up|0|||
144546737|NCT02066636|521202421|FG001|Overall Study|Lost to Follow-up|2|||
144546738|NCT02066636|521202422|FG002|Overall Study|Lost to Follow-up|2|||
144546739|NCT02066636|521202420|FG000|Overall Study|Maximum clinical benefit|2|||
144546740|NCT02066636|521202421|FG001|Overall Study|Maximum clinical benefit|2|||
144546741|NCT02066636|521202422|FG002|Overall Study|Maximum clinical benefit|3|||
144546742|NCT02066636|521202420|FG000|Overall Study|Poor/non-compliance|2|||
144546743|NCT02066636|521202421|FG001|Overall Study|Poor/non-compliance|1|||
144546744|NCT02066636|521202422|FG002|Overall Study|Poor/non-compliance|1|||
144546745|NCT02066636|521202420|FG000|Overall Study|Participant no loner meets study criteria|3|||
144546746|NCT02066636|521202421|FG001|Overall Study|Participant no loner meets study criteria|2|||
144546747|NCT02066636|521202422|FG002|Overall Study|Participant no loner meets study criteria|28|||
144546748|NCT02066636|521202420|FG000|Overall Study|Administrative reasons by sponsor|8|||
144546749|NCT02066636|521202421|FG001|Overall Study|Administrative reasons by sponsor|5|||
144546750|NCT02066636|521202422|FG002|Overall Study|Administrative reasons by sponsor|0|||
144546751|NCT02066636|521202420|FG000|Overall Study|Other reasons|16|||
144546752|NCT02066636|521202421|FG001|Overall Study|Other reasons|15|||
144546753|NCT02066636|521202422|FG002|Overall Study|Other reasons|50|||
144546754|NCT03567616|521202425|FG000|Overall Study|Disease progression|4|||
144546755|NCT03567616|521202425|FG000|Overall Study|Withdrawal by Subject|1|||
144546756|NCT03567616|521202425|FG000|Overall Study|Physician Decision|1|||
144546757|NCT03567616|521202425|FG000|Overall Study|Death|1|||
144546758|NCT03567616|521202425|FG000|Overall Study|Adverse Event|1|||
144546759|NCT00705159|521202433|FG000|Overall Study|Withdrawal by Subject|0|||
144546760|NCT00705159|521202434|FG001|Overall Study|Withdrawal by Subject|1|||
144546761|NCT00705159|521202435|FG002|Overall Study|Withdrawal by Subject|1|||
144546762|NCT00705159|521202436|FG003|Overall Study|Withdrawal by Subject|1|||
144546763|NCT00705159|521202433|FG000|Overall Study|Protocol Violation|0|||
144546764|NCT00705159|521202434|FG001|Overall Study|Protocol Violation|1|||
144546765|NCT00705159|521202435|FG002|Overall Study|Protocol Violation|0|||
144202907|NCT02393248|519940268|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202908|NCT02393248|519940269|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
144202909|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202910|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144546766|NCT00705159|521202436|FG003|Overall Study|Protocol Violation|0|||
144546767|NCT00705159|521202433|FG000|Overall Study|Adverse Event|0|||
144546768|NCT00705159|521202434|FG001|Overall Study|Adverse Event|0|||
144546769|NCT00705159|521202435|FG002|Overall Study|Adverse Event|1|||
144546770|NCT00705159|521202436|FG003|Overall Study|Adverse Event|0|||
144546771|NCT00705159|521202433|FG000|Overall Study|Lost to Follow-up|0|||
144546772|NCT00705159|521202434|FG001|Overall Study|Lost to Follow-up|0|||
144546773|NCT00705159|521202435|FG002|Overall Study|Lost to Follow-up|3|||
144546774|NCT00705159|521202436|FG003|Overall Study|Lost to Follow-up|2|||
144546775|NCT00705159|521202433|FG000|Overall Study|Screen Failure|0|||
144546776|NCT00705159|521202434|FG001|Overall Study|Screen Failure|0|||
144546777|NCT00705159|521202435|FG002|Overall Study|Screen Failure|0|||
144546778|NCT00705159|521202436|FG003|Overall Study|Screen Failure|1|||
144546779|NCT00526994|521202437|FG000|Overall Study|Lost to Follow-up|98|||
144546780|NCT00526994|521202438|FG001|Overall Study|Lost to Follow-up|108|||
144546781|NCT00526994|521202439|FG002|Overall Study|Lost to Follow-up|96|||
144546782|NCT00526994|521202437|FG000|Overall Study|Death|4|||
144546783|NCT00526994|521202438|FG001|Overall Study|Death|3|||
144546784|NCT00526994|521202439|FG002|Overall Study|Death|3|||
144546785|NCT00526994|521202437|FG000|Overall Study|Withdrawal by Subject|2|||
144546786|NCT00526994|521202438|FG001|Overall Study|Withdrawal by Subject|7|||
144546787|NCT00526994|521202439|FG002|Overall Study|Withdrawal by Subject|5|||
144546788|NCT00526994|521202437|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
144546789|NCT00526994|521202438|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
144546790|NCT00526994|521202439|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
144546791|NCT03035942|521202440|FG000|Overall Study|Adverse Event|8|||
144546792|NCT03035942|521202441|FG001|Overall Study|Adverse Event|4|||
144546793|NCT03035942|521202442|FG002|Overall Study|Adverse Event|5|||
144546794|NCT02538094|521202443|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
144546795|NCT02538094|521202444|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
144546796|NCT02538094|521202443|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
144546797|NCT02538094|521202444|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
144546798|NCT01989104|521202445|FG000|Overall Study|Withdrawal by Subject|3|||
144546799|NCT01989104|521202446|FG001|Overall Study|Withdrawal by Subject|0|||
144546800|NCT01989104|521202447|FG002|Overall Study|Withdrawal by Subject|0|||
144546801|NCT01989104|521202448|FG003|Overall Study|Withdrawal by Subject|0|||
144546802|NCT01989104|521202449|FG004|Overall Study|Withdrawal by Subject|0|||
144546803|NCT02691702|521202450|FG000|Overall Study|Adverse Event|1|||
144546804|NCT02691702|521202451|FG001|Overall Study|Adverse Event|0|||
144546805|NCT02691702|521202452|FG002|Overall Study|Adverse Event|0|||
144546806|NCT02691702|521202453|FG003|Overall Study|Adverse Event|0|||
144546807|NCT02691702|521202454|FG004|Overall Study|Adverse Event|0|||
144546808|NCT02691702|521202455|FG005|Overall Study|Adverse Event|0|||
144546809|NCT02691702|521202456|FG006|Overall Study|Adverse Event|0|||
144546810|NCT02691702|521202457|FG007|Overall Study|Adverse Event|0|||
144546811|NCT02691702|521202458|FG008|Overall Study|Adverse Event|1|||
144546812|NCT02691702|521202459|FG009|Overall Study|Adverse Event|0|||
144546813|NCT02691702|521202460|FG010|Overall Study|Adverse Event|1|||
144546814|NCT02691702|521202450|FG000|Overall Study|Lost to Follow-up|0|||
144546815|NCT02691702|521202451|FG001|Overall Study|Lost to Follow-up|0|||
144546816|NCT02691702|521202452|FG002|Overall Study|Lost to Follow-up|1|||
144546817|NCT02691702|521202453|FG003|Overall Study|Lost to Follow-up|0|||
144546818|NCT02691702|521202454|FG004|Overall Study|Lost to Follow-up|0|||
144546819|NCT02691702|521202455|FG005|Overall Study|Lost to Follow-up|2|||
144546820|NCT02691702|521202456|FG006|Overall Study|Lost to Follow-up|0|||
144546821|NCT02691702|521202457|FG007|Overall Study|Lost to Follow-up|0|||
144546822|NCT02691702|521202458|FG008|Overall Study|Lost to Follow-up|0|||
144546823|NCT02691702|521202459|FG009|Overall Study|Lost to Follow-up|0|||
144546824|NCT02691702|521202460|FG010|Overall Study|Lost to Follow-up|1|||
144546825|NCT02691702|521202450|FG000|Overall Study|Withdrawal by Subject|1|||
144546826|NCT02691702|521202451|FG001|Overall Study|Withdrawal by Subject|1|||
144546827|NCT02691702|521202452|FG002|Overall Study|Withdrawal by Subject|0|||
144546828|NCT02691702|521202453|FG003|Overall Study|Withdrawal by Subject|0|||
144546829|NCT02691702|521202454|FG004|Overall Study|Withdrawal by Subject|0|||
144546830|NCT02691702|521202455|FG005|Overall Study|Withdrawal by Subject|1|||
144546831|NCT02691702|521202456|FG006|Overall Study|Withdrawal by Subject|2|||
144546832|NCT02691702|521202457|FG007|Overall Study|Withdrawal by Subject|0|||
144546833|NCT02691702|521202458|FG008|Overall Study|Withdrawal by Subject|0|||
144546834|NCT02691702|521202459|FG009|Overall Study|Withdrawal by Subject|0|||
144546835|NCT02691702|521202460|FG010|Overall Study|Withdrawal by Subject|0|||
144546836|NCT02691702|521202450|FG000|Overall Study|Other|0|||
144546837|NCT02691702|521202451|FG001|Overall Study|Other|0|||
144546838|NCT02691702|521202452|FG002|Overall Study|Other|0|||
144546839|NCT02691702|521202453|FG003|Overall Study|Other|0|||
144546840|NCT02691702|521202454|FG004|Overall Study|Other|0|||
144546841|NCT02691702|521202455|FG005|Overall Study|Other|0|||
144546842|NCT02691702|521202456|FG006|Overall Study|Other|1|||
144546843|NCT02691702|521202457|FG007|Overall Study|Other|0|||
144546844|NCT02691702|521202458|FG008|Overall Study|Other|1|||
144546845|NCT02691702|521202459|FG009|Overall Study|Other|0|||
144546846|NCT02691702|521202460|FG010|Overall Study|Other|0|||
144546847|NCT02691702|521202450|FG000|Overall Study|Protocol Violation|0|||
144546848|NCT02691702|521202451|FG001|Overall Study|Protocol Violation|0|||
144546849|NCT02691702|521202452|FG002|Overall Study|Protocol Violation|0|||
144546850|NCT02691702|521202453|FG003|Overall Study|Protocol Violation|0|||
144546851|NCT02691702|521202454|FG004|Overall Study|Protocol Violation|0|||
144546852|NCT02691702|521202455|FG005|Overall Study|Protocol Violation|0|||
144546853|NCT02691702|521202456|FG006|Overall Study|Protocol Violation|0|||
144546854|NCT02691702|521202457|FG007|Overall Study|Protocol Violation|0|||
144546855|NCT02691702|521202458|FG008|Overall Study|Protocol Violation|0|||
144546856|NCT02691702|521202459|FG009|Overall Study|Protocol Violation|2|||
144546857|NCT02691702|521202460|FG010|Overall Study|Protocol Violation|0|||
144546858|NCT00326183|521202461|FG000|Overall Study|Lost to Follow-up|104|||
144546859|NCT00326183|521202462|FG001|Overall Study|Lost to Follow-up|56|||
144546860|NCT00326183|521202461|FG000|Overall Study|Protocol Violation|6|||
144546861|NCT00326183|521202462|FG001|Overall Study|Protocol Violation|3|||
144546862|NCT00326183|521202461|FG000|Overall Study|Withdrawal by Subject|35|||
144546863|NCT00326183|521202462|FG001|Overall Study|Withdrawal by Subject|7|||
144546864|NCT00326183|521202461|FG000|Overall Study|Subject Moved|7|||
144546865|NCT00326183|521202462|FG001|Overall Study|Subject Moved|4|||
144546866|NCT00326183|521202461|FG000|Overall Study|Other|47|||
144546867|NCT00326183|521202462|FG001|Overall Study|Other|13|||
144546868|NCT00326183|521202461|FG000|Overall Study|Adverse Event|1|||
144546869|NCT00326183|521202462|FG001|Overall Study|Adverse Event|0|||
144546870|NCT00824408|521202466|FG000|Run-in Phase|Progressive disease|4|||
144546871|NCT00824408|521202467|FG001|Run-in Phase|Progressive disease|4|||
144546872|NCT00824408|521202468|FG002|Run-in Phase|Progressive disease|0|||
144546873|NCT00824408|521202469|FG003|Run-in Phase|Progressive disease|0|||
144546874|NCT00824408|521202470|FG004|Run-in Phase|Progressive disease|0|||
144546875|NCT00824408|521202466|FG000|Run-in Phase|Adverse Event|1|||
144546876|NCT00824408|521202467|FG001|Run-in Phase|Adverse Event|1|||
144546877|NCT00824408|521202468|FG002|Run-in Phase|Adverse Event|0|||
144546878|NCT00824408|521202469|FG003|Run-in Phase|Adverse Event|0|||
144546879|NCT00824408|521202470|FG004|Run-in Phase|Adverse Event|0|||
144546880|NCT00824408|521202466|FG000|Run-in Phase|Refused to continue medication|1|||
144546881|NCT00824408|521202467|FG001|Run-in Phase|Refused to continue medication|0|||
144546882|NCT00824408|521202468|FG002|Run-in Phase|Refused to continue medication|0|||
144546883|NCT00824408|521202469|FG003|Run-in Phase|Refused to continue medication|0|||
144546884|NCT00824408|521202470|FG004|Run-in Phase|Refused to continue medication|0|||
144546885|NCT00824408|521202466|FG000|Run-in Phase|Other reason not defined above|0|||
144546886|NCT00824408|521202467|FG001|Run-in Phase|Other reason not defined above|1|||
144546887|NCT00824408|521202468|FG002|Run-in Phase|Other reason not defined above|0|||
144546888|NCT00824408|521202469|FG003|Run-in Phase|Other reason not defined above|0|||
144546889|NCT00824408|521202470|FG004|Run-in Phase|Other reason not defined above|0|||
144546890|NCT00824408|521202466|FG000|Randomized Phase|Not treated|0|||
144546891|NCT00824408|521202467|FG001|Randomized Phase|Not treated|0|||
144546892|NCT00824408|521202468|FG002|Randomized Phase|Not treated|1|||
144546893|NCT00824408|521202469|FG003|Randomized Phase|Not treated|1|||
144546894|NCT00824408|521202470|FG004|Randomized Phase|Not treated|1|||
144546895|NCT00824408|521202466|FG000|Randomized Phase|Progressive disease|0|||
144546896|NCT00824408|521202467|FG001|Randomized Phase|Progressive disease|0|||
144546897|NCT00824408|521202468|FG002|Randomized Phase|Progressive disease|25|||
144546898|NCT00824408|521202469|FG003|Randomized Phase|Progressive disease|36|||
144546899|NCT00824408|521202470|FG004|Randomized Phase|Progressive disease|34|||
144546900|NCT00824408|521202466|FG000|Randomized Phase|Adverse Event|0|||
144546901|NCT00824408|521202467|FG001|Randomized Phase|Adverse Event|0|||
144202911|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144546902|NCT00824408|521202468|FG002|Randomized Phase|Adverse Event|4|||
144546903|NCT00824408|521202469|FG003|Randomized Phase|Adverse Event|5|||
144546904|NCT00824408|521202470|FG004|Randomized Phase|Adverse Event|5|||
144546905|NCT00824408|521202466|FG000|Randomized Phase|Refused to continue medication|0|||
144546906|NCT00824408|521202467|FG001|Randomized Phase|Refused to continue medication|0|||
144546907|NCT00824408|521202468|FG002|Randomized Phase|Refused to continue medication|2|||
144546908|NCT00824408|521202469|FG003|Randomized Phase|Refused to continue medication|2|||
144546909|NCT00824408|521202470|FG004|Randomized Phase|Refused to continue medication|2|||
144546910|NCT00824408|521202466|FG000|Randomized Phase|Other reason not defined above|0|||
144546911|NCT00824408|521202467|FG001|Randomized Phase|Other reason not defined above|0|||
144546912|NCT00824408|521202468|FG002|Randomized Phase|Other reason not defined above|4|||
144546913|NCT00824408|521202469|FG003|Randomized Phase|Other reason not defined above|2|||
144202912|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144546914|NCT00824408|521202470|FG004|Randomized Phase|Other reason not defined above|4|||
144546915|NCT04083781|521202471|FG000|Main Part|Physician Decision|0|||
144546916|NCT04083781|521202472|FG001|Main Part|Physician Decision|1|||
144546917|NCT04083781|521202473|FG002|Main Part|Physician Decision|2|||
144546918|NCT04083781|521202474|FG003|Main Part|Physician Decision|0|||
144546919|NCT04083781|521202471|FG000|Main Part|Death|1|||
144546920|NCT04083781|521202472|FG001|Main Part|Death|3|||
144546921|NCT04083781|521202473|FG002|Main Part|Death|1|||
144546922|NCT04083781|521202474|FG003|Main Part|Death|0|||
144546923|NCT04083781|521202471|FG000|Main Part|Withdrawal by Subject|5|||
144546924|NCT04083781|521202472|FG001|Main Part|Withdrawal by Subject|2|||
144546925|NCT04083781|521202473|FG002|Main Part|Withdrawal by Subject|3|||
144546926|NCT04083781|521202474|FG003|Main Part|Withdrawal by Subject|7|||
144546927|NCT04083781|521202471|FG000|Extension Part|Physician Decision|0|||
144546928|NCT04083781|521202472|FG001|Extension Part|Physician Decision|0|||
144546929|NCT04083781|521202473|FG002|Extension Part|Physician Decision|0|||
144546930|NCT04083781|521202474|FG003|Extension Part|Physician Decision|1|||
144546931|NCT04083781|521202471|FG000|Extension Part|Death|0|||
144546932|NCT04083781|521202472|FG001|Extension Part|Death|1|||
144546933|NCT04083781|521202473|FG002|Extension Part|Death|0|||
144546934|NCT04083781|521202474|FG003|Extension Part|Death|1|||
144546935|NCT04083781|521202471|FG000|Extension Part|Withdrawal by Subject|0|||
144546936|NCT04083781|521202472|FG001|Extension Part|Withdrawal by Subject|1|||
144546937|NCT04083781|521202473|FG002|Extension Part|Withdrawal by Subject|0|||
144546938|NCT04083781|521202474|FG003|Extension Part|Withdrawal by Subject|0|||
144546939|NCT04083781|521202471|FG000|Extension Part|Ongoing|13|||
144546940|NCT04083781|521202472|FG001|Extension Part|Ongoing|25|||
144546941|NCT04083781|521202473|FG002|Extension Part|Ongoing|15|||
144546942|NCT04083781|521202474|FG003|Extension Part|Ongoing|51|||
144546943|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
144546944|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
144546945|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
144546946|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
144546947|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
144546948|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
144546949|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
144546950|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
144546951|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
144546952|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
144546953|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
144546954|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
144546955|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
144546956|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
144546957|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
144546958|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
144546959|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
144546960|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
144546961|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
144546962|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
144546963|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
144546964|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
144546965|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
144546966|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
144546967|NCT02203032|521202476|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
144546968|NCT02203032|521202477|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
144546969|NCT02203032|521202478|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
144546970|NCT02203032|521202479|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
144546971|NCT02203032|521202476|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
144546972|NCT02203032|521202477|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
144546973|NCT02203032|521202478|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
144546974|NCT02203032|521202479|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
144546975|NCT02203032|521202476|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
144546976|NCT02203032|521202477|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
144546977|NCT02203032|521202478|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
144546978|NCT02203032|521202479|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
144546979|NCT02203032|521202476|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
144546980|NCT02203032|521202477|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
144202913|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144546981|NCT02203032|521202478|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
144616539|NCT02915523|521456354|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
144202914|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144546982|NCT02203032|521202479|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
144546983|NCT02203032|521202476|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
144546984|NCT02203032|521202477|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
144546985|NCT02203032|521202478|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
144546986|NCT02203032|521202479|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
144546987|NCT02203032|521202476|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
144546988|NCT02203032|521202477|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
144546989|NCT02203032|521202478|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
144546990|NCT02203032|521202479|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
144546991|NCT02241785|521202482|FG000|Overall Study|Sponsor Termination|43|||
144546992|NCT02241785|521202482|FG000|Overall Study|Withdrawal by Subject|1|||
144546993|NCT02241785|521202482|FG000|Overall Study|Lost to Follow-up|2|||
144546994|NCT02241785|521202482|FG000|Overall Study|Adverse Event|1|||
144546995|NCT00452114|521202483|FG000|Overall Study|Physician Decision|3|||
144546996|NCT00452114|521202484|FG001|Overall Study|Physician Decision|3|||
144546997|NCT05338476|521202485|FG000|Period 2|Adverse Event|0|||
144546998|NCT05338476|521202486|FG001|Period 2|Adverse Event|1|||
144546999|NCT05995977|521202489|FG000|Overall Study|Withdrawal by Subject|1|||
144547000|NCT05995977|521202490|FG001|Overall Study|Withdrawal by Subject|4|||
144547001|NCT05995977|521202489|FG000|Overall Study|Lost to Follow-up|2|||
144547002|NCT05995977|521202490|FG001|Overall Study|Lost to Follow-up|0|||
144547003|NCT04181788|521202491|FG000|TREATMENT|Adverse Event|0|||
144547004|NCT04181788|521202492|FG001|TREATMENT|Adverse Event|2|||
144547005|NCT04181788|521202493|FG002|TREATMENT|Adverse Event|1|||
144547006|NCT04181788|521202494|FG003|TREATMENT|Adverse Event|0|||
144547007|NCT04181788|521202495|FG004|TREATMENT|Adverse Event|1|||
144547008|NCT04181788|521202496|FG005|TREATMENT|Adverse Event|3|||
144547009|NCT04181788|521202491|FG000|TREATMENT|Death|0|||
144547010|NCT04181788|521202492|FG001|TREATMENT|Death|0|||
144547011|NCT04181788|521202493|FG002|TREATMENT|Death|0|||
144547012|NCT04181788|521202494|FG003|TREATMENT|Death|0|||
144547013|NCT04181788|521202495|FG004|TREATMENT|Death|8|||
144547014|NCT04181788|521202496|FG005|TREATMENT|Death|8|||
144547015|NCT04181788|521202491|FG000|TREATMENT|Physician Decision|0|||
144547016|NCT04181788|521202492|FG001|TREATMENT|Physician Decision|0|||
144547017|NCT04181788|521202493|FG002|TREATMENT|Physician Decision|0|||
144547018|NCT04181788|521202494|FG003|TREATMENT|Physician Decision|0|||
144547019|NCT04181788|521202495|FG004|TREATMENT|Physician Decision|0|||
144547020|NCT04181788|521202496|FG005|TREATMENT|Physician Decision|1|||
144547021|NCT04181788|521202491|FG000|TREATMENT|Progressive disease|3|||
144547022|NCT04181788|521202492|FG001|TREATMENT|Progressive disease|3|||
144547023|NCT04181788|521202493|FG002|TREATMENT|Progressive disease|5|||
144547024|NCT04181788|521202494|FG003|TREATMENT|Progressive disease|7|||
144547025|NCT04181788|521202495|FG004|TREATMENT|Progressive disease|20|||
144547026|NCT04181788|521202496|FG005|TREATMENT|Progressive disease|38|||
144547027|NCT04181788|521202491|FG000|TREATMENT|Global deterioration of health status|0|||
144547028|NCT04181788|521202492|FG001|TREATMENT|Global deterioration of health status|2|||
144547029|NCT04181788|521202493|FG002|TREATMENT|Global deterioration of health status|0|||
144547030|NCT04181788|521202494|FG003|TREATMENT|Global deterioration of health status|0|||
144547031|NCT04181788|521202495|FG004|TREATMENT|Global deterioration of health status|2|||
144547032|NCT04181788|521202496|FG005|TREATMENT|Global deterioration of health status|8|||
144547033|NCT04181788|521202491|FG000|TREATMENT|Withdrawal by Subject|1|||
144547034|NCT04181788|521202492|FG001|TREATMENT|Withdrawal by Subject|2|||
144547035|NCT04181788|521202493|FG002|TREATMENT|Withdrawal by Subject|0|||
144547036|NCT04181788|521202494|FG003|TREATMENT|Withdrawal by Subject|0|||
144202915|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144547037|NCT04181788|521202495|FG004|TREATMENT|Withdrawal by Subject|3|||
144547038|NCT04181788|521202496|FG005|TREATMENT|Withdrawal by Subject|5|||
144547039|NCT04181788|521202491|FG000|TREATMENT|Other unspecified|0|||
144547040|NCT04181788|521202492|FG001|TREATMENT|Other unspecified|0|||
144547041|NCT04181788|521202493|FG002|TREATMENT|Other unspecified|0|||
144547042|NCT04181788|521202494|FG003|TREATMENT|Other unspecified|0|||
144547043|NCT04181788|521202495|FG004|TREATMENT|Other unspecified|0|||
144547044|NCT04181788|521202496|FG005|TREATMENT|Other unspecified|2|||
144547045|NCT04181788|521202491|FG000|TREATMENT|Ongoing|0|||
144547046|NCT04181788|521202492|FG001|TREATMENT|Ongoing|3|||
144547047|NCT04181788|521202493|FG002|TREATMENT|Ongoing|0|||
144547048|NCT04181788|521202494|FG003|TREATMENT|Ongoing|5|||
144547049|NCT04181788|521202495|FG004|TREATMENT|Ongoing|7|||
144547050|NCT04181788|521202496|FG005|TREATMENT|Ongoing|15|||
144547051|NCT04181788|521202491|FG000|FOLLOW-UP|Death|0|||
144547052|NCT04181788|521202492|FG001|FOLLOW-UP|Death|0|||
144547053|NCT04181788|521202493|FG002|FOLLOW-UP|Death|1|||
144547054|NCT04181788|521202494|FG003|FOLLOW-UP|Death|2|||
144547055|NCT04181788|521202495|FG004|FOLLOW-UP|Death|8|||
144547056|NCT04181788|521202496|FG005|FOLLOW-UP|Death|20|||
144547057|NCT04181788|521202491|FG000|FOLLOW-UP|Lost to Follow-up|0|||
144547058|NCT04181788|521202492|FG001|FOLLOW-UP|Lost to Follow-up|0|||
144547059|NCT04181788|521202493|FG002|FOLLOW-UP|Lost to Follow-up|0|||
144547060|NCT04181788|521202494|FG003|FOLLOW-UP|Lost to Follow-up|0|||
144547061|NCT04181788|521202495|FG004|FOLLOW-UP|Lost to Follow-up|0|||
144547062|NCT04181788|521202496|FG005|FOLLOW-UP|Lost to Follow-up|2|||
144547063|NCT04181788|521202491|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
144547064|NCT04181788|521202492|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
144547065|NCT04181788|521202493|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
144547066|NCT04181788|521202494|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
144547067|NCT04181788|521202495|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
144547068|NCT04181788|521202496|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
144547069|NCT04181788|521202491|FG000|FOLLOW-UP|Other unspecified|0|||
144547070|NCT04181788|521202492|FG001|FOLLOW-UP|Other unspecified|1|||
144547071|NCT04181788|521202493|FG002|FOLLOW-UP|Other unspecified|0|||
144547072|NCT04181788|521202494|FG003|FOLLOW-UP|Other unspecified|0|||
144547073|NCT04181788|521202495|FG004|FOLLOW-UP|Other unspecified|0|||
144547074|NCT04181788|521202496|FG005|FOLLOW-UP|Other unspecified|3|||
144547075|NCT04181788|521202491|FG000|FOLLOW-UP|Ongoing|0|||
144547076|NCT04181788|521202492|FG001|FOLLOW-UP|Ongoing|0|||
144547077|NCT04181788|521202493|FG002|FOLLOW-UP|Ongoing|1|||
144547078|NCT04181788|521202494|FG003|FOLLOW-UP|Ongoing|3|||
144547079|NCT04181788|521202495|FG004|FOLLOW-UP|Ongoing|2|||
144547080|NCT04181788|521202496|FG005|FOLLOW-UP|Ongoing|2|||
144547081|NCT04535414|521202498|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
144547082|NCT04535414|521202499|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
144547083|NCT04535414|521202498|FG000|Overall Study|Cancelled appointment|1|||
144547084|NCT04535414|521202499|FG001|Overall Study|Cancelled appointment|0|||
144547085|NCT04535414|521202498|FG000|Overall Study|cancelled - food in stomach|2|||
144547086|NCT04535414|521202499|FG001|Overall Study|cancelled - food in stomach|0|||
144547087|NCT04535414|521202498|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
144547088|NCT04535414|521202499|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
144547089|NCT04535414|521202498|FG000|Overall Study|Withdrawal by Subject|0|||
144547090|NCT04535414|521202499|FG001|Overall Study|Withdrawal by Subject|1|||
144547091|NCT01276509|521204578|FG000|Overall Study|Adverse Event|9|||
144547092|NCT01276509|521204579|FG001|Overall Study|Adverse Event|8|||
144547093|NCT01276509|521204580|FG002|Overall Study|Adverse Event|4|||
144547094|NCT01276509|521204581|FG003|Overall Study|Adverse Event|3|||
144547095|NCT01276509|521204578|FG000|Overall Study|Lack of Efficacy|2|||
144547096|NCT01276509|521204579|FG001|Overall Study|Lack of Efficacy|1|||
144727544|NCT02101853|521856655|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
144727545|NCT02101853|521856656|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
144727546|NCT02101853|521856651|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
144727547|NCT02101853|521856652|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
144547097|NCT01276509|521204580|FG002|Overall Study|Lack of Efficacy|1|||
144547098|NCT01276509|521204581|FG003|Overall Study|Lack of Efficacy|2|||
144727548|NCT02101853|521856653|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
144727549|NCT02101853|521856654|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
144727550|NCT02101853|521856655|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
144727551|NCT02101853|521856656|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
144727552|NCT02101853|521856651|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
144727553|NCT02101853|521856652|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
144727554|NCT02101853|521856653|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
144727555|NCT02101853|521856654|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
144727556|NCT02101853|521856655|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
144727557|NCT02101853|521856656|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
144727558|NCT02101853|521856651|FG000|Blinatumomab Salvage Therapy|Death|0|||
144727559|NCT02101853|521856652|FG001|Blinatumomab Salvage Therapy|Death|0|||
144727560|NCT02101853|521856653|FG002|Blinatumomab Salvage Therapy|Death|0|||
144727561|NCT02101853|521856654|FG003|Blinatumomab Salvage Therapy|Death|0|||
144547099|NCT01276509|521204578|FG000|Overall Study|Pregnancy|1|||
144547100|NCT01276509|521204579|FG001|Overall Study|Pregnancy|0|||
144547101|NCT01276509|521204580|FG002|Overall Study|Pregnancy|0|||
144547102|NCT01276509|521204581|FG003|Overall Study|Pregnancy|0|||
144547103|NCT01276509|521204578|FG000|Overall Study|Withdrawal by Subject|1|||
144547104|NCT01276509|521204579|FG001|Overall Study|Withdrawal by Subject|2|||
144547105|NCT01276509|521204580|FG002|Overall Study|Withdrawal by Subject|0|||
144547106|NCT01276509|521204581|FG003|Overall Study|Withdrawal by Subject|0|||
144547107|NCT01276509|521204578|FG000|Overall Study|Other|0|||
144547108|NCT01276509|521204579|FG001|Overall Study|Other|1|||
144727562|NCT02101853|521856655|FG004|Blinatumomab Salvage Therapy|Death|0|||
144547109|NCT01276509|521204580|FG002|Overall Study|Other|0|||
144727563|NCT02101853|521856656|FG005|Blinatumomab Salvage Therapy|Death|2|||
144547110|NCT01276509|521204581|FG003|Overall Study|Other|0|||
144547111|NCT00535626|521204584|FG000|Overall Study|Death|15|||
144727564|NCT02101853|521856651|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
144547112|NCT00535626|521204584|FG000|Overall Study|Lost to Follow-up|29|||
144547113|NCT00535626|521204584|FG000|Overall Study|Withdrawal by Subject|20|||
144547114|NCT00535626|521204584|FG000|Overall Study|Removal/revision of study component|8|||
144547115|NCT00535626|521204584|FG000|Overall Study|Subject terminated|31|||
144547116|NCT00535626|521204584|FG000|Overall Study|Unable to return|2|||
144616540|NCT02915523|521456355|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
144616541|NCT02915523|521456352|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
144202916|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144547117|NCT02830893|521204585|FG000|Overall Study|Relocation to out of the country|1|||
144547118|NCT02830893|521204586|FG001|Overall Study|Relocation to out of the country|0|||
144547119|NCT02830893|521204585|FG000|Overall Study|Lost to Follow-up|0|||
144547120|NCT02830893|521204586|FG001|Overall Study|Lost to Follow-up|2|||
144547121|NCT02830893|521204585|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
144547122|NCT02830893|521204586|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
144547123|NCT01567852|521204587|FG000|Overall Study|Withdrawal by Subject|3|||
144547124|NCT01567852|521204588|FG001|Overall Study|Withdrawal by Subject|6|||
144202917|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202918|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202919|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202920|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202921|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202922|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144262320|NCT04888494|520159874|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
144547125|NCT01567852|521204587|FG000|Overall Study|ECT discontinued|1|||
144547126|NCT01567852|521204588|FG001|Overall Study|ECT discontinued|1|||
144547127|NCT01808534|521204598|FG000|Overall Study|Disease progression|3|||
144547128|NCT01808534|521204598|FG000|Overall Study|Physician Decision|1|||
144547129|NCT02002689|521204599|FG000|Overall Study|Disease Progression|7|||
144547130|NCT02002689|521204599|FG000|Overall Study|Adverse Event|3|||
144547131|NCT02354417|521204600|FG000|Overall Study|Physician Decision|1|||
144547132|NCT01148017|521204601|FG000|Overall Study|Withdrawal by Subject|31|||
144547133|NCT01148017|521204602|FG001|Overall Study|Withdrawal by Subject|14|||
144547134|NCT01148017|521204603|FG002|Overall Study|Withdrawal by Subject|0|||
144547135|NCT01148017|521204604|FG003|Overall Study|Withdrawal by Subject|0|||
144547136|NCT01148017|521204601|FG000|Overall Study|Lost to Follow-up|23|||
144547137|NCT01148017|521204602|FG001|Overall Study|Lost to Follow-up|10|||
144547138|NCT01148017|521204603|FG002|Overall Study|Lost to Follow-up|0|||
144547139|NCT01148017|521204604|FG003|Overall Study|Lost to Follow-up|0|||
144547140|NCT01148017|521204601|FG000|Overall Study|Inappropriate enrollment|1|||
144547141|NCT01148017|521204602|FG001|Overall Study|Inappropriate enrollment|0|||
144547142|NCT01148017|521204603|FG002|Overall Study|Inappropriate enrollment|0|||
144547143|NCT01148017|521204604|FG003|Overall Study|Inappropriate enrollment|0|||
144547144|NCT01148017|521204601|FG000|Overall Study|Administrative reason|22|||
144547145|NCT01148017|521204602|FG001|Overall Study|Administrative reason|9|||
144547146|NCT01148017|521204603|FG002|Overall Study|Administrative reason|0|||
144547147|NCT01148017|521204604|FG003|Overall Study|Administrative reason|0|||
144547148|NCT01148017|521204601|FG000|Overall Study|Unable to classify|3|||
144547149|NCT01148017|521204602|FG001|Overall Study|Unable to classify|1|||
144547150|NCT01148017|521204603|FG002|Overall Study|Unable to classify|0|||
144547151|NCT01148017|521204604|FG003|Overall Study|Unable to classify|0|||
144547152|NCT01848483|521204605|FG000|Overall Study|Death|2|||
144547153|NCT01848483|521204606|FG001|Overall Study|Death|1|||
144547154|NCT01848483|521204605|FG000|Overall Study|Lost to Follow-up|6|||
144547155|NCT01848483|521204606|FG001|Overall Study|Lost to Follow-up|8|||
144547156|NCT01848483|521204605|FG000|Overall Study|Withdrawal by Subject|1|||
144547157|NCT01848483|521204606|FG001|Overall Study|Withdrawal by Subject|0|||
144547158|NCT01848483|521204605|FG000|Overall Study|Incarceration|2|||
144547159|NCT01848483|521204606|FG001|Overall Study|Incarceration|2|||
144547160|NCT00246129|521204611|FG000|Overall Study|Lost to Follow-up|1|||
144547161|NCT00246129|521204612|FG001|Overall Study|Lost to Follow-up|0|||
144547162|NCT00246129|521204611|FG000|Overall Study|Death|2|||
144547163|NCT00246129|521204612|FG001|Overall Study|Death|1|||
144547164|NCT00246129|521204611|FG000|Overall Study|suffered primary non-function|1|||
144547165|NCT00246129|521204612|FG001|Overall Study|suffered primary non-function|0|||
144547166|NCT00246129|521204611|FG000|Overall Study|grafts failed|3|||
144547167|NCT00246129|521204612|FG001|Overall Study|grafts failed|1|||
144547168|NCT03740737|521204613|FG000|Overall Study|Protocol deviation|13|||
144547169|NCT03740737|521204614|FG001|Overall Study|Protocol deviation|0|||
144547170|NCT03740737|521204613|FG000|Overall Study|Adverse Event|2|||
144547171|NCT03740737|521204614|FG001|Overall Study|Adverse Event|0|||
144547172|NCT03740737|521204613|FG000|Overall Study|Lost to Follow-up|1|||
144547173|NCT03740737|521204614|FG001|Overall Study|Lost to Follow-up|0|||
144547174|NCT03740737|521204613|FG000|Overall Study|Randomization failure|1|||
144547175|NCT03740737|521204614|FG001|Overall Study|Randomization failure|0|||
144547176|NCT03740737|521204613|FG000|Overall Study|Participant withdrew consent|1|||
144616542|NCT02915523|521456353|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
144547177|NCT03740737|521204614|FG001|Overall Study|Participant withdrew consent|0|||
144547178|NCT03740737|521204613|FG000|Overall Study|Participant withdrew from trial|2|||
144547179|NCT03740737|521204614|FG001|Overall Study|Participant withdrew from trial|1|||
144547180|NCT03469258|521204615|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
144547181|NCT02202317|521204619|FG000|Overall Study|Lost to Follow-up|1|||
144202923|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144547182|NCT03403036|521204620|FG000|Overall Study|Lack of Efficacy|5|||
144547183|NCT02338999|521204621|FG000|First Intervention|Withdrawal by Subject|3|||
144547184|NCT02338999|521204622|FG001|First Intervention|Withdrawal by Subject|1|||
144547185|NCT02338999|521204621|FG000|Washout Period|Withdrawal by Subject|0|||
144547186|NCT02338999|521204622|FG001|Washout Period|Withdrawal by Subject|2|||
144547187|NCT02338999|521204621|FG000|Second Intervention|Withdrawal by Subject|0|||
144547188|NCT02338999|521204622|FG001|Second Intervention|Withdrawal by Subject|2|||
144547189|NCT00569166|521204626|FG000|Overall Study|Withdrawal by Subject|7|||
144547190|NCT00569166|521204627|FG001|Overall Study|Withdrawal by Subject|5|||
144547191|NCT00569166|521204628|FG002|Overall Study|Withdrawal by Subject|3|||
144547192|NCT00569166|521204626|FG000|Overall Study|Lost to Follow-up|2|||
144547193|NCT00569166|521204627|FG001|Overall Study|Lost to Follow-up|1|||
144547194|NCT00569166|521204628|FG002|Overall Study|Lost to Follow-up|1|||
144547195|NCT01536704|521204630|FG000|Washout Period 1|Withdrawal by Subject|1|||
144547196|NCT01536704|521204631|FG001|Washout Period 1|Withdrawal by Subject|2|||
144547197|NCT01536704|521204632|FG002|Washout Period 1|Withdrawal by Subject|0|||
144547198|NCT01536704|521204633|FG003|Washout Period 1|Withdrawal by Subject|0|||
144547199|NCT01536704|521204630|FG000|Washout Period 2|Adverse Event|1|||
144547200|NCT01536704|521204631|FG001|Washout Period 2|Adverse Event|0|||
144547201|NCT01536704|521204632|FG002|Washout Period 2|Adverse Event|0|||
144547202|NCT01536704|521204633|FG003|Washout Period 2|Adverse Event|0|||
144547203|NCT01536704|521204630|FG000|Washout Period 2|Withdrawal by Subject|0|||
144547204|NCT01536704|521204631|FG001|Washout Period 2|Withdrawal by Subject|0|||
144547205|NCT01536704|521204632|FG002|Washout Period 2|Withdrawal by Subject|0|||
144547206|NCT01536704|521204633|FG003|Washout Period 2|Withdrawal by Subject|1|||
144547207|NCT01536704|521204630|FG000|Period 3|Adverse Event|0|||
144547208|NCT01536704|521204631|FG001|Period 3|Adverse Event|0|||
144547209|NCT01536704|521204632|FG002|Period 3|Adverse Event|0|||
144547210|NCT01536704|521204633|FG003|Period 3|Adverse Event|1|||
144547211|NCT01536704|521204630|FG000|Washout Period 3|Adverse Event|0|||
144547212|NCT01536704|521204631|FG001|Washout Period 3|Adverse Event|0|||
144547213|NCT01536704|521204632|FG002|Washout Period 3|Adverse Event|1|||
144547214|NCT01536704|521204633|FG003|Washout Period 3|Adverse Event|0|||
144547215|NCT03236779|521204634|FG000|Overall Study|Lost to Follow-up|13|||
144547216|NCT03236779|521204635|FG001|Overall Study|Lost to Follow-up|21|||
144547217|NCT03316170|521204636|FG000|Overall Study|Death|1|||
144547218|NCT03316170|521204637|FG001|Overall Study|Death|0|||
144547219|NCT03316170|521204636|FG000|Overall Study|Lost to Follow-up|6|||
144547220|NCT03316170|521204637|FG001|Overall Study|Lost to Follow-up|7|||
144547221|NCT00578344|521204638|FG000|Overall Study|Insurance problems|1|||
144547222|NCT00578344|521204638|FG000|Overall Study|Graft failure|1|||
144547223|NCT01836523|521204639|FG000|Overall Study|Adverse Event|15|||
144547224|NCT01836523|521204640|FG001|Overall Study|Adverse Event|41|||
144547225|NCT01836523|521204641|FG002|Overall Study|Adverse Event|49|||
144547226|NCT01836523|521204642|FG003|Overall Study|Adverse Event|14|||
144547227|NCT01836523|521204639|FG000|Overall Study|Protocol Violation|6|||
144547228|NCT01836523|521204640|FG001|Overall Study|Protocol Violation|3|||
144547229|NCT01836523|521204641|FG002|Overall Study|Protocol Violation|2|||
144547230|NCT01836523|521204642|FG003|Overall Study|Protocol Violation|4|||
144547231|NCT01836523|521204639|FG000|Overall Study|Met Withdrawal Criteria|13|||
144547232|NCT01836523|521204640|FG001|Overall Study|Met Withdrawal Criteria|13|||
144547233|NCT01836523|521204641|FG002|Overall Study|Met Withdrawal Criteria|21|||
144547234|NCT01836523|521204642|FG003|Overall Study|Met Withdrawal Criteria|27|||
144547235|NCT01836523|521204639|FG000|Overall Study|Unclassified|17|||
144547236|NCT01836523|521204640|FG001|Overall Study|Unclassified|28|||
144547237|NCT01836523|521204641|FG002|Overall Study|Unclassified|19|||
144547238|NCT01836523|521204642|FG003|Overall Study|Unclassified|29|||
144547239|NCT04803734|521204643|FG000|Overall Study|Withdrawal by Subject|0|||
144547240|NCT04803734|521204644|FG001|Overall Study|Withdrawal by Subject|1|||
144547241|NCT04803734|521204643|FG000|Overall Study|Protocol Violation|0|||
144547242|NCT04803734|521204644|FG001|Overall Study|Protocol Violation|1|||
144547243|NCT00749944|521204648|FG000|Overall Study|Lost to Follow-up|2|||
144547244|NCT00749944|521204649|FG001|Overall Study|Lost to Follow-up|1|||
144547245|NCT00749944|521204648|FG000|Overall Study|Other|1|||
144547246|NCT00749944|521204649|FG001|Overall Study|Other|0|||
144547247|NCT00749944|521204648|FG000|Overall Study|Withdrawal by Subject|2|||
144547248|NCT00749944|521204649|FG001|Overall Study|Withdrawal by Subject|0|||
144547249|NCT02547974|521204650|FG000|Overall Study|Withdrawal by Subject|1|||
144547250|NCT02547974|521204651|FG001|Overall Study|Withdrawal by Subject|0|||
144547251|NCT02547974|521204652|FG002|Overall Study|Withdrawal by Subject|0|||
144547252|NCT02547974|521204653|FG003|Overall Study|Withdrawal by Subject|0|||
144547253|NCT02245620|521204659|FG000|Overall Study|Physician Decision|1|||
144547254|NCT02245620|521204660|FG001|Overall Study|Physician Decision|1|||
144547255|NCT01999335|521204661|FG000|Overall Study|Discontinued before receiving treatment|0|||
144547256|NCT01999335|521204662|FG001|Overall Study|Discontinued before receiving treatment|0|||
144547257|NCT01999335|521204663|FG002|Overall Study|Discontinued before receiving treatment|0|||
144547258|NCT01999335|521204664|FG003|Overall Study|Discontinued before receiving treatment|0|||
144547259|NCT01999335|521204665|FG004|Overall Study|Discontinued before receiving treatment|2|||
144547260|NCT03909100|521204666|FG000|Overall Study|Protocol Deviation|2|||
144547261|NCT03909100|521204666|FG000|Overall Study|Technical Problems|4|||
144547262|NCT03909100|521204666|FG000|Overall Study|Withdrawal by Subject|4|||
144547263|NCT03909100|521204666|FG000|Overall Study|Lost to Follow-up|1|||
144547264|NCT03909100|521204666|FG000|Overall Study|Reason not Specified|4|||
144547265|NCT03259568|521204667|FG000|Overall Study|Participant performance was low|3|||
144547266|NCT04248868|521204668|FG000|Overall Study|Death|1|||
144547267|NCT04248868|521204668|FG000|Overall Study|Lost to Follow-up|3|||
144547268|NCT04248868|521204668|FG000|Overall Study|Protocol Violation|2|||
144547269|NCT03128099|521204671|FG000|Overall Study|High dose task was too long|0|||
144547270|NCT03128099|521204672|FG001|Overall Study|High dose task was too long|4|||
144547271|NCT03128099|521204673|FG002|Overall Study|High dose task was too long|0|||
144547272|NCT03128099|521204671|FG000|Overall Study|Participant got a full time job.|1|||
144547273|NCT03128099|521204672|FG001|Overall Study|Participant got a full time job.|0|||
144547274|NCT03128099|521204673|FG002|Overall Study|Participant got a full time job.|0|||
144547275|NCT03128099|521204671|FG000|Overall Study|Became homeless and lost contact|1|||
144547276|NCT03128099|521204672|FG001|Overall Study|Became homeless and lost contact|0|||
144547277|NCT03128099|521204673|FG002|Overall Study|Became homeless and lost contact|0|||
144547278|NCT03128099|521204671|FG000|Overall Study|Did not complete all the assessments|0|||
144547279|NCT03128099|521204672|FG001|Overall Study|Did not complete all the assessments|0|||
144547280|NCT03128099|521204673|FG002|Overall Study|Did not complete all the assessments|1|||
144547281|NCT00148122|521204674|FG000|Overall Study|Withdrawal by Subject|2|||
144547282|NCT02449902|521204677|FG000|Overall Study|Adverse Event|0|||
144547283|NCT02449902|521204678|FG001|Overall Study|Adverse Event|1|||
144547284|NCT02449902|521204677|FG000|Overall Study|Withdrawal by Subject|0|||
144547285|NCT02449902|521204678|FG001|Overall Study|Withdrawal by Subject|1|||
144547286|NCT01365546|521204682|FG000|Overall Study|Withdrawal by Subject|1|||
144547287|NCT01365546|521204682|FG000|Overall Study|Screen failure|9|||
144547288|NCT01365546|521204682|FG000|Overall Study|Study termination|1|||
144547289|NCT03861234|521204684|FG000|Overall Study|Not treated|0|||
144547290|NCT03861234|521204685|FG001|Overall Study|Not treated|0|||
144547291|NCT03861234|521204686|FG002|Overall Study|Not treated|0|||
144547292|NCT03861234|521204687|FG003|Overall Study|Not treated|0|||
144547293|NCT03861234|521204688|FG004|Overall Study|Not treated|0|||
144547294|NCT03861234|521204689|FG005|Overall Study|Not treated|1|||
144547295|NCT03861234|521204690|FG006|Overall Study|Not treated|0|||
144547296|NCT03861234|521204691|FG007|Overall Study|Not treated|0|||
144547297|NCT03861234|521204684|FG000|Overall Study|Adverse Event|0|||
144547298|NCT03861234|521204685|FG001|Overall Study|Adverse Event|0|||
144547299|NCT03861234|521204686|FG002|Overall Study|Adverse Event|0|||
144547300|NCT03861234|521204687|FG003|Overall Study|Adverse Event|0|||
144547301|NCT03861234|521204688|FG004|Overall Study|Adverse Event|0|||
144547302|NCT03861234|521204689|FG005|Overall Study|Adverse Event|1|||
144547303|NCT03861234|521204690|FG006|Overall Study|Adverse Event|0|||
144547304|NCT03861234|521204691|FG007|Overall Study|Adverse Event|0|||
144547305|NCT03861234|521204684|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
144547306|NCT03861234|521204685|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
144547307|NCT03861234|521204686|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
144547308|NCT03861234|521204687|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
144547309|NCT03861234|521204688|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
144547310|NCT03861234|521204689|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
144547311|NCT03861234|521204690|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
144547312|NCT03861234|521204691|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
144547313|NCT03861234|521204684|FG000|Overall Study|As per sponsor decision|0|||
144547314|NCT03861234|521204685|FG001|Overall Study|As per sponsor decision|0|||
144547315|NCT03861234|521204686|FG002|Overall Study|As per sponsor decision|0|||
144547316|NCT03861234|521204687|FG003|Overall Study|As per sponsor decision|0|||
144547317|NCT03861234|521204688|FG004|Overall Study|As per sponsor decision|0|||
144547318|NCT03861234|521204689|FG005|Overall Study|As per sponsor decision|0|||
144547319|NCT03861234|521204690|FG006|Overall Study|As per sponsor decision|1|||
144547320|NCT03861234|521204691|FG007|Overall Study|As per sponsor decision|0|||
144547321|NCT03861234|521204684|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
144547322|NCT03861234|521204685|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
144547323|NCT03861234|521204686|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
144547324|NCT03861234|521204687|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
144547325|NCT03861234|521204688|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
144547326|NCT03861234|521204689|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
144547327|NCT03861234|521204690|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
144547328|NCT03861234|521204691|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
144547329|NCT00274287|521204692|FG000|Overall Study|Withdrawal by Subject|1|||
144547330|NCT00274287|521204692|FG000|Overall Study|subject non-compliance|1|||
144547331|NCT03200574|521204694|FG000|Overall Study|Death|4|||
144547332|NCT03200574|521204694|FG000|Overall Study|Withdrawal by Subject|8|||
144547333|NCT03200574|521204694|FG000|Overall Study|Long-Term need for anticoagulation|1|||
144547334|NCT03200574|521204694|FG000|Overall Study|Relocation|2|||
144547335|NCT03200574|521204694|FG000|Overall Study|Lost to Follow-up|2|||
144547336|NCT00680771|521204695|FG000|Overall Study|Withdrawal by Subject|1|||
144547337|NCT00680771|521204696|FG001|Overall Study|Withdrawal by Subject|0|||
144547338|NCT00680771|521204695|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
144547339|NCT00680771|521204696|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
144547340|NCT00680771|521204695|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
144547341|NCT00680771|521204696|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
144547342|NCT03652610|521204697|FG000|Overall Study|Lost to Follow-up|1|||
144547343|NCT03652610|521204698|FG001|Overall Study|Lost to Follow-up|0|||
144547344|NCT03652610|521204697|FG000|Overall Study|Withdrawal by Subject|3|||
144547345|NCT03652610|521204698|FG001|Overall Study|Withdrawal by Subject|5|||
144547346|NCT01860079|521204699|FG000|Overall Study|Physician Decision|14|||
144547347|NCT01860079|521204700|FG001|Overall Study|Physician Decision|22|||
144547348|NCT03803475|521204707|FG000|Overall Study|Physician Decision|1|||
144547349|NCT01880736|521204708|FG000|Overall Study|Adverse Event|0|||
144547350|NCT01880736|521204709|FG001|Overall Study|Adverse Event|0|||
144547351|NCT01880736|521204710|FG002|Overall Study|Adverse Event|0|||
144547352|NCT01880736|521204711|FG003|Overall Study|Adverse Event|1|||
144547353|NCT01880736|521204708|FG000|Overall Study|Withdrawal Criteria|1|||
144547354|NCT01880736|521204709|FG001|Overall Study|Withdrawal Criteria|2|||
144547355|NCT01880736|521204710|FG002|Overall Study|Withdrawal Criteria|1|||
144547356|NCT01880736|521204711|FG003|Overall Study|Withdrawal Criteria|5|||
144547357|NCT01263496|521204715|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
144547358|NCT01263496|521204716|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547359|NCT01263496|521204717|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547360|NCT01263496|521204718|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547361|NCT01263496|521204719|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547362|NCT01263496|521204720|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547363|NCT01263496|521204721|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547364|NCT01263496|521204722|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547365|NCT01263496|521204723|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
144547366|NCT01263496|521204715|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547367|NCT01263496|521204716|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547368|NCT01263496|521204717|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547369|NCT01263496|521204718|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
144547370|NCT01263496|521204719|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
144547371|NCT01263496|521204720|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547372|NCT01263496|521204721|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547373|NCT01263496|521204722|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547374|NCT01263496|521204723|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144547375|NCT01263496|521204715|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
144547376|NCT01263496|521204716|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
144547377|NCT01263496|521204717|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
144547378|NCT01263496|521204718|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
144547379|NCT01263496|521204719|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
144547380|NCT01263496|521204720|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
144547381|NCT01263496|521204721|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
144547382|NCT01263496|521204722|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
144547383|NCT01263496|521204723|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
144547384|NCT01263496|521204715|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547385|NCT01263496|521204716|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
144547386|NCT01263496|521204717|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547387|NCT01263496|521204718|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547388|NCT01263496|521204719|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547389|NCT01263496|521204720|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547390|NCT01263496|521204721|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547391|NCT01263496|521204722|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547392|NCT01263496|521204723|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144547393|NCT01263496|521204715|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144547394|NCT01263496|521204716|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144547395|NCT01263496|521204717|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144547396|NCT01263496|521204718|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144547397|NCT01263496|521204719|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
144547398|NCT01263496|521204720|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144547399|NCT01263496|521204721|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144547400|NCT01263496|521204722|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144547401|NCT01263496|521204723|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144202924|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202925|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202926|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202927|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
144547402|NCT01263496|521204715|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
144547403|NCT01263496|521204716|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
144547404|NCT01263496|521204717|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
144547405|NCT01263496|521204718|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
144547406|NCT01263496|521204719|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
144547407|NCT01263496|521204720|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
144547408|NCT01263496|521204721|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
144547409|NCT01263496|521204722|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
144547410|NCT01263496|521204723|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
144547411|NCT01263496|521204715|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547412|NCT01263496|521204716|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547413|NCT01263496|521204717|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547414|NCT01263496|521204718|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547415|NCT01263496|521204719|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547416|NCT01263496|521204720|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547417|NCT01263496|521204721|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547418|NCT01263496|521204722|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
144547419|NCT01263496|521204723|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144547420|NCT00266656|521204727|FG000|Overall Study|Death|1|||
144547421|NCT00266656|521204728|FG001|Overall Study|Death|0|||
144547422|NCT00266656|521204727|FG000|Overall Study|Lost to Follow-up|4|||
144547423|NCT00266656|521204728|FG001|Overall Study|Lost to Follow-up|1|||
144547424|NCT00266656|521204727|FG000|Overall Study|Withdrawal by Subject|4|||
144547425|NCT00266656|521204728|FG001|Overall Study|Withdrawal by Subject|2|||
144547426|NCT00266656|521204727|FG000|Overall Study|Did Not Reach Final Height|4|||
144547427|NCT00266656|521204728|FG001|Overall Study|Did Not Reach Final Height|8|||
144547428|NCT00266656|521204727|FG000|Overall Study|Parent/Caregiver Decision|1|||
144262321|NCT04888494|520159875|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
144262322|NCT03430856|520159876|FG000|Overall Study|Adverse Event|0|||
144262323|NCT03430856|520159877|FG001|Overall Study|Adverse Event|1|||
144262324|NCT03430856|520159878|FG002|Overall Study|Adverse Event|0|||
144262325|NCT03430856|520159876|FG000|Overall Study|Rescue criteria|1|||
144262326|NCT03430856|520159877|FG001|Overall Study|Rescue criteria|1|||
144262327|NCT03430856|520159878|FG002|Overall Study|Rescue criteria|0|||
144547429|NCT00266656|521204728|FG001|Overall Study|Parent/Caregiver Decision|2|||
144547430|NCT04852978|521204729|FG000|Overall Study|Physician Decision|0|||
144547431|NCT04852978|521204730|FG001|Overall Study|Physician Decision|1|||
144547432|NCT04852978|521204731|FG002|Overall Study|Physician Decision|0|||
144547433|NCT04852978|521204732|FG003|Overall Study|Physician Decision|0|||
144547434|NCT04852978|521204733|FG004|Overall Study|Physician Decision|0|||
144547435|NCT04852978|521204734|FG005|Overall Study|Physician Decision|0|||
144547436|NCT04852978|521204735|FG006|Overall Study|Physician Decision|0|||
144547437|NCT04852978|521204736|FG007|Overall Study|Physician Decision|2|||
144547438|NCT04852978|521204737|FG008|Overall Study|Physician Decision|0|||
144547439|NCT04852978|521204729|FG000|Overall Study|Sponsor request|0|||
144547440|NCT04852978|521204730|FG001|Overall Study|Sponsor request|0|||
144547441|NCT04852978|521204731|FG002|Overall Study|Sponsor request|1|||
144547442|NCT04852978|521204732|FG003|Overall Study|Sponsor request|0|||
144547443|NCT04852978|521204733|FG004|Overall Study|Sponsor request|0|||
144547444|NCT04852978|521204734|FG005|Overall Study|Sponsor request|0|||
144547445|NCT04852978|521204735|FG006|Overall Study|Sponsor request|0|||
144547446|NCT04852978|521204736|FG007|Overall Study|Sponsor request|0|||
144547447|NCT04852978|521204737|FG008|Overall Study|Sponsor request|0|||
144547448|NCT04852978|521204729|FG000|Overall Study|Death|0|||
144547449|NCT04852978|521204730|FG001|Overall Study|Death|0|||
144202928|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202929|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
144547450|NCT04852978|521204731|FG002|Overall Study|Death|0|||
144202930|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
144202931|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202932|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
144262328|NCT03430856|520159876|FG000|Overall Study|Voluntary withdrawal of consent|1|||
144262329|NCT03430856|520159877|FG001|Overall Study|Voluntary withdrawal of consent|1|||
144547451|NCT04852978|521204732|FG003|Overall Study|Death|0|||
144547452|NCT04852978|521204733|FG004|Overall Study|Death|0|||
144547453|NCT04852978|521204734|FG005|Overall Study|Death|0|||
144547454|NCT04852978|521204735|FG006|Overall Study|Death|1|||
144547455|NCT04852978|521204736|FG007|Overall Study|Death|0|||
144547456|NCT04852978|521204737|FG008|Overall Study|Death|0|||
144547457|NCT04852978|521204729|FG000|Overall Study|Lost to Follow-up|3|||
144547458|NCT04852978|521204730|FG001|Overall Study|Lost to Follow-up|2|||
144547459|NCT04852978|521204731|FG002|Overall Study|Lost to Follow-up|2|||
144547460|NCT04852978|521204732|FG003|Overall Study|Lost to Follow-up|0|||
144547461|NCT04852978|521204733|FG004|Overall Study|Lost to Follow-up|2|||
144547462|NCT04852978|521204734|FG005|Overall Study|Lost to Follow-up|4|||
144547463|NCT04852978|521204735|FG006|Overall Study|Lost to Follow-up|1|||
144547464|NCT04852978|521204736|FG007|Overall Study|Lost to Follow-up|2|||
144547465|NCT04852978|521204737|FG008|Overall Study|Lost to Follow-up|2|||
144547466|NCT04852978|521204729|FG000|Overall Study|Withdrawal by Subject|4|||
144547467|NCT04852978|521204730|FG001|Overall Study|Withdrawal by Subject|2|||
144547468|NCT04852978|521204731|FG002|Overall Study|Withdrawal by Subject|2|||
144547469|NCT04852978|521204732|FG003|Overall Study|Withdrawal by Subject|1|||
144547470|NCT04852978|521204733|FG004|Overall Study|Withdrawal by Subject|5|||
144547471|NCT04852978|521204734|FG005|Overall Study|Withdrawal by Subject|3|||
144547472|NCT04852978|521204735|FG006|Overall Study|Withdrawal by Subject|2|||
144547473|NCT04852978|521204736|FG007|Overall Study|Withdrawal by Subject|2|||
144547474|NCT04852978|521204737|FG008|Overall Study|Withdrawal by Subject|1|||
144547475|NCT03332589|521206304|FG000|Overall Study|Lack of Efficacy|2|||
144547476|NCT03332589|521206305|FG001|Overall Study|Lack of Efficacy|0|||
144547477|NCT03332589|521206306|FG002|Overall Study|Lack of Efficacy|0|||
144547478|NCT03332589|521206304|FG000|Overall Study|Adverse Event|1|||
144547479|NCT03332589|521206305|FG001|Overall Study|Adverse Event|0|||
144547480|NCT03332589|521206306|FG002|Overall Study|Adverse Event|0|||
144547481|NCT03332589|521206304|FG000|Overall Study|Death|1|||
144547482|NCT03332589|521206305|FG001|Overall Study|Death|0|||
144547483|NCT03332589|521206306|FG002|Overall Study|Death|0|||
144547484|NCT00443820|521206307|FG000|Overall Study|Adverse Event|1|||
144547485|NCT00443820|521206308|FG001|Overall Study|Adverse Event|1|||
144547486|NCT00443820|521206309|FG002|Overall Study|Adverse Event|0|||
144547487|NCT00443820|521206310|FG003|Overall Study|Adverse Event|0|||
144547488|NCT00443820|521206307|FG000|Overall Study|Lack of Efficacy|3|||
144547489|NCT00443820|521206308|FG001|Overall Study|Lack of Efficacy|2|||
144547490|NCT00443820|521206309|FG002|Overall Study|Lack of Efficacy|1|||
144547491|NCT00443820|521206310|FG003|Overall Study|Lack of Efficacy|1|||
144547492|NCT00443820|521206307|FG000|Overall Study|Protocol Violation|2|||
144547493|NCT00443820|521206308|FG001|Overall Study|Protocol Violation|1|||
144547494|NCT00443820|521206309|FG002|Overall Study|Protocol Violation|2|||
144547495|NCT00443820|521206310|FG003|Overall Study|Protocol Violation|1|||
144547496|NCT00443820|521206307|FG000|Overall Study|Withdrawal by Subject|6|||
144547497|NCT00443820|521206308|FG001|Overall Study|Withdrawal by Subject|7|||
144547498|NCT00443820|521206309|FG002|Overall Study|Withdrawal by Subject|8|||
144547499|NCT00443820|521206310|FG003|Overall Study|Withdrawal by Subject|9|||
144547500|NCT00443820|521206307|FG000|Overall Study|Lost to Follow-up|9|||
144616543|NCT02915523|521456354|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
144616544|NCT02915523|521456355|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
144616545|NCT02915523|521456352|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
144616546|NCT02915523|521456353|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
144616547|NCT02915523|521456354|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
144547501|NCT00443820|521206308|FG001|Overall Study|Lost to Follow-up|8|||
144547502|NCT00443820|521206309|FG002|Overall Study|Lost to Follow-up|6|||
144547503|NCT00443820|521206310|FG003|Overall Study|Lost to Follow-up|5|||
144547504|NCT00443820|521206307|FG000|Overall Study|Administrative problems|0|||
144547505|NCT00443820|521206308|FG001|Overall Study|Administrative problems|0|||
144547506|NCT00443820|521206309|FG002|Overall Study|Administrative problems|0|||
144547507|NCT00443820|521206310|FG003|Overall Study|Administrative problems|1|||
144547508|NCT00443820|521206307|FG000|Overall Study|Death|0|||
144547509|NCT00443820|521206308|FG001|Overall Study|Death|0|||
144547510|NCT00443820|521206309|FG002|Overall Study|Death|1|||
144616548|NCT02915523|521456355|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
144547511|NCT00443820|521206310|FG003|Overall Study|Death|0|||
144547512|NCT04633200|521206311|FG000|Overall Study|Lost to Follow-up|3|||
144547513|NCT04633200|521206312|FG001|Overall Study|Lost to Follow-up|5|||
144547514|NCT01377844|521206313|FG000|Overall Study|Withdrawal by Subject|25|||
144547515|NCT01377844|521206314|FG001|Overall Study|Withdrawal by Subject|28|||
144547516|NCT01377844|521206313|FG000|Overall Study|Protocol Violation|2|||
144547517|NCT01377844|521206314|FG001|Overall Study|Protocol Violation|3|||
144547518|NCT01377844|521206313|FG000|Overall Study|Adverse Event|3|||
144547519|NCT01377844|521206314|FG001|Overall Study|Adverse Event|0|||
144547520|NCT01377844|521206313|FG000|Overall Study|Physician Decision|6|||
144547521|NCT01377844|521206314|FG001|Overall Study|Physician Decision|3|||
144547522|NCT01377844|521206313|FG000|Overall Study|Study terminated by Sponsor|0|||
144547523|NCT01377844|521206314|FG001|Overall Study|Study terminated by Sponsor|1|||
144547524|NCT02092285|521206315|FG000|Induction Phase|Adverse Event|7|||
144547525|NCT02092285|521206315|FG000|Induction Phase|Physician Decision|4|||
144547526|NCT02092285|521206315|FG000|Induction Phase|Pregnancy|1|||
144547527|NCT02092285|521206315|FG000|Induction Phase|Relapse/Recurrence|7|||
144547528|NCT02092285|521206315|FG000|Induction Phase|Withdrawal by Subject|2|||
144547529|NCT02092285|521206315|FG000|Induction Phase|Lack of Efficacy|14|||
144616549|NCT02915523|521456352|FG000|Expansion Phase (Phase 2)|Death|0|||
144616550|NCT02915523|521456353|FG001|Expansion Phase (Phase 2)|Death|0|||
144616551|NCT02915523|521456354|FG002|Expansion Phase (Phase 2)|Death|26|||
144616552|NCT02915523|521456355|FG003|Expansion Phase (Phase 2)|Death|53|||
144616553|NCT02915523|521456352|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
144616554|NCT02915523|521456353|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
144616555|NCT02915523|521456354|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
144616556|NCT02915523|521456355|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
144616557|NCT02915523|521456352|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
144616558|NCT02915523|521456353|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
144616559|NCT02915523|521456354|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
144616560|NCT02915523|521456355|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
144202933|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
144202934|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Death|0|||
144202935|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Death|0|||
144202936|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Death|0|||
144202937|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Death|0|||
144202938|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Death|0|||
144202939|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Death|0|||
144202940|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Death|0|||
144202941|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Death|0|||
144202942|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Death|0|||
144202943|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Death|0|||
144202944|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Death|0|||
144547530|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
144547531|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
144547532|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
144547533|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
144547534|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
144547535|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
144547536|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
144547537|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
144547538|NCT02092285|521206315|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
144547539|NCT00087516|521206316|FG000|Overall Study|Adverse Event|10|||
144547540|NCT00087516|521206317|FG001|Overall Study|Adverse Event|10|||
144547541|NCT00087516|521206318|FG002|Overall Study|Adverse Event|3|||
144547542|NCT00087516|521206319|FG003|Overall Study|Adverse Event|6|||
144547543|NCT00087516|521206316|FG000|Overall Study|Lack of Efficacy|82|||
144547544|NCT00087516|521206317|FG001|Overall Study|Lack of Efficacy|80|||
144547545|NCT00087516|521206318|FG002|Overall Study|Lack of Efficacy|39|||
144547546|NCT00087516|521206319|FG003|Overall Study|Lack of Efficacy|29|||
144547547|NCT00087516|521206316|FG000|Overall Study|Lost to Follow-up|8|||
144547548|NCT00087516|521206317|FG001|Overall Study|Lost to Follow-up|6|||
144547549|NCT00087516|521206318|FG002|Overall Study|Lost to Follow-up|5|||
144547550|NCT00087516|521206319|FG003|Overall Study|Lost to Follow-up|5|||
144547551|NCT00087516|521206316|FG000|Overall Study|Protocol Violation|4|||
144547552|NCT00087516|521206317|FG001|Overall Study|Protocol Violation|8|||
144547553|NCT00087516|521206318|FG002|Overall Study|Protocol Violation|3|||
144547554|NCT00087516|521206319|FG003|Overall Study|Protocol Violation|6|||
144547555|NCT00087516|521206316|FG000|Overall Study|Withdrawal by Subject|16|||
144547556|NCT00087516|521206317|FG001|Overall Study|Withdrawal by Subject|27|||
144547557|NCT00087516|521206318|FG002|Overall Study|Withdrawal by Subject|11|||
144547558|NCT00087516|521206319|FG003|Overall Study|Withdrawal by Subject|12|||
144547559|NCT00087516|521206316|FG000|Overall Study|Site terminated|0|||
144547560|NCT00087516|521206317|FG001|Overall Study|Site terminated|2|||
144547561|NCT00087516|521206318|FG002|Overall Study|Site terminated|1|||
144547562|NCT00087516|521206319|FG003|Overall Study|Site terminated|0|||
144547563|NCT00087516|521206316|FG000|Overall Study|Protocol specified discontinuation|35|||
144547564|NCT00087516|521206317|FG001|Overall Study|Protocol specified discontinuation|33|||
144547565|NCT00087516|521206318|FG002|Overall Study|Protocol specified discontinuation|33|||
144616561|NCT02915523|521456352|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
144202945|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Death|0|||
144202946|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Death|0|||
144202947|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Death|0|||
144202948|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Death|0|||
144202949|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Death|1|||
144202950|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Death|7|||
144547566|NCT00087516|521206319|FG003|Overall Study|Protocol specified discontinuation|26|||
144547567|NCT00087516|521206316|FG000|Overall Study|Patient moved|3|||
144547568|NCT00087516|521206317|FG001|Overall Study|Patient moved|2|||
144547569|NCT00087516|521206318|FG002|Overall Study|Patient moved|1|||
144547570|NCT00087516|521206319|FG003|Overall Study|Patient moved|0|||
144547571|NCT00087516|521206316|FG000|Overall Study|Patient was non-compliant|3|||
144547572|NCT00087516|521206317|FG001|Overall Study|Patient was non-compliant|1|||
144547573|NCT00087516|521206318|FG002|Overall Study|Patient was non-compliant|0|||
144202951|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Death|5|||
144202952|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Death|5|||
144547574|NCT00087516|521206319|FG003|Overall Study|Patient was non-compliant|0|||
144547575|NCT00087516|521206316|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
144547576|NCT00087516|521206317|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
144547577|NCT00087516|521206318|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
144547578|NCT00087516|521206319|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
144547579|NCT00087516|521206316|FG000|Overall Study|Other|0|||
144547580|NCT00087516|521206317|FG001|Overall Study|Other|0|||
144547581|NCT00087516|521206318|FG002|Overall Study|Other|1|||
144547582|NCT00087516|521206319|FG003|Overall Study|Other|0|||
144547583|NCT00278395|521206320|FG000|Overall Study|Adverse Event|2|||
144547584|NCT00278395|521206320|FG000|Overall Study|Nonevaluable|1|||
144616562|NCT02915523|521456353|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
144202953|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Death|3|||
144202954|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Death|7|||
144547585|NCT03851094|521206323|FG000|Overall Study|Withdrawal by Subject|0|||
144547586|NCT03851094|521206324|FG001|Overall Study|Withdrawal by Subject|1|||
144547587|NCT03851094|521206323|FG000|Overall Study|Participant lost device|0|||
144547588|NCT03851094|521206324|FG001|Overall Study|Participant lost device|1|||
144547589|NCT03851094|521206323|FG000|Overall Study|Participant returned device|0|||
144547590|NCT03851094|521206324|FG001|Overall Study|Participant returned device|2|||
144547591|NCT01332266|521206325|FG000|Phase 1b|Death|3|||
144547592|NCT01332266|521206326|FG001|Phase 1b|Death|3|||
144547593|NCT01332266|521206327|FG002|Phase 1b|Death|2|||
144547594|NCT01332266|521206328|FG003|Phase 1b|Death|0|||
144547595|NCT01332266|521206329|FG004|Phase 1b|Death|0|||
144547596|NCT01332266|521206325|FG000|Phase 1b|Lost to Follow-up|0|||
144547597|NCT01332266|521206326|FG001|Phase 1b|Lost to Follow-up|1|||
144547598|NCT01332266|521206327|FG002|Phase 1b|Lost to Follow-up|0|||
144547599|NCT01332266|521206328|FG003|Phase 1b|Lost to Follow-up|0|||
144547600|NCT01332266|521206329|FG004|Phase 1b|Lost to Follow-up|0|||
144547601|NCT01332266|521206325|FG000|Phase 1b|Withdrawal by Subject|1|||
144547602|NCT01332266|521206326|FG001|Phase 1b|Withdrawal by Subject|1|||
144547603|NCT01332266|521206327|FG002|Phase 1b|Withdrawal by Subject|1|||
144547604|NCT01332266|521206328|FG003|Phase 1b|Withdrawal by Subject|0|||
144547605|NCT01332266|521206329|FG004|Phase 1b|Withdrawal by Subject|0|||
144547606|NCT01332266|521206325|FG000|Phase 2|Death|0|||
144547607|NCT01332266|521206326|FG001|Phase 2|Death|0|||
144547608|NCT01332266|521206327|FG002|Phase 2|Death|0|||
144547609|NCT01332266|521206328|FG003|Phase 2|Death|33|||
144547610|NCT01332266|521206329|FG004|Phase 2|Death|36|||
144547611|NCT01332266|521206325|FG000|Phase 2|Lost to Follow-up|0|||
144547612|NCT01332266|521206326|FG001|Phase 2|Lost to Follow-up|0|||
144547613|NCT01332266|521206327|FG002|Phase 2|Lost to Follow-up|0|||
144547614|NCT01332266|521206328|FG003|Phase 2|Lost to Follow-up|2|||
144547615|NCT01332266|521206329|FG004|Phase 2|Lost to Follow-up|0|||
144547616|NCT01332266|521206325|FG000|Phase 2|Physician Decision|0|||
144547617|NCT01332266|521206326|FG001|Phase 2|Physician Decision|0|||
144547618|NCT01332266|521206327|FG002|Phase 2|Physician Decision|0|||
144547619|NCT01332266|521206328|FG003|Phase 2|Physician Decision|3|||
144547620|NCT01332266|521206329|FG004|Phase 2|Physician Decision|1|||
144547621|NCT01332266|521206325|FG000|Phase 2|Symptomatic deterioration|0|||
144547622|NCT01332266|521206326|FG001|Phase 2|Symptomatic deterioration|0|||
144547623|NCT01332266|521206327|FG002|Phase 2|Symptomatic deterioration|0|||
144547624|NCT01332266|521206328|FG003|Phase 2|Symptomatic deterioration|0|||
144547625|NCT01332266|521206329|FG004|Phase 2|Symptomatic deterioration|1|||
144547626|NCT01332266|521206325|FG000|Phase 2|Progression Disease|0|||
144547627|NCT01332266|521206326|FG001|Phase 2|Progression Disease|0|||
144547628|NCT01332266|521206327|FG002|Phase 2|Progression Disease|0|||
144547629|NCT01332266|521206328|FG003|Phase 2|Progression Disease|2|||
144547630|NCT01332266|521206329|FG004|Phase 2|Progression Disease|1|||
144547631|NCT01332266|521206325|FG000|Phase 2|Withdrawal by Subject|0|||
144616563|NCT02915523|521456354|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
144616564|NCT02915523|521456355|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
144616565|NCT00915681|521456356|FG000|Overall Study|Screening failures|46|||
144616566|NCT03221751|521456358|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
144547632|NCT01332266|521206326|FG001|Phase 2|Withdrawal by Subject|0|||
144547633|NCT01332266|521206327|FG002|Phase 2|Withdrawal by Subject|0|||
144547634|NCT01332266|521206328|FG003|Phase 2|Withdrawal by Subject|2|||
144547635|NCT01332266|521206329|FG004|Phase 2|Withdrawal by Subject|2|||
144547636|NCT02392507|521206332|FG000|Induction Regimen|Death|3|||
144547637|NCT02392507|521206332|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
144547638|NCT02392507|521206332|FG000|Induction Regimen|Physician Decision|1|||
144547639|NCT02392507|521206332|FG000|Induction Regimen|Withdrawal by Subject|2|||
144547640|NCT02392507|521206332|FG000|Maintenance Regimen|Death|1|||
144547641|NCT02392507|521206332|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
144547642|NCT01802333|521206333|FG000|Overall Study|Ineligible|2|||
144547643|NCT01802333|521206334|FG001|Overall Study|Ineligible|6|||
144547644|NCT01802333|521206335|FG002|Overall Study|Ineligible|8|||
144547645|NCT01802333|521206333|FG000|Overall Study|Adverse Event|1|||
144547646|NCT01802333|521206334|FG001|Overall Study|Adverse Event|8|||
144616567|NCT03221751|521456359|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
144616568|NCT00267748|521456362|FG000|Non-randomized Period|Progressive disease|10|||
144616569|NCT00267748|521456363|FG001|Non-randomized Period|Progressive disease|0|||
144616570|NCT00267748|521456364|FG002|Non-randomized Period|Progressive disease|0|||
144616571|NCT00267748|521456362|FG000|Non-randomized Period|Adverse Event|8|||
144616572|NCT00267748|521456363|FG001|Non-randomized Period|Adverse Event|0|||
144616573|NCT00267748|521456364|FG002|Non-randomized Period|Adverse Event|0|||
144616574|NCT00267748|521456362|FG000|Non-randomized Period|Death|1|||
144616575|NCT00267748|521456363|FG001|Non-randomized Period|Death|0|||
144616576|NCT00267748|521456364|FG002|Non-randomized Period|Death|0|||
144616577|NCT00267748|521456362|FG000|Non-randomized Period|Participant not willing to participate|1|||
144202955|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Death|5|||
144202956|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Death|6|||
144202957|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Death|3|||
144202958|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Death|0|||
144202959|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202960|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202961|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202962|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202963|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202964|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202965|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202966|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202967|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202968|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202969|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202970|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202971|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202972|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202973|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144547647|NCT01802333|521206335|FG002|Overall Study|Adverse Event|8|||
144547648|NCT01802333|521206333|FG000|Overall Study|Withdrawal by Subject|6|||
144547649|NCT01802333|521206334|FG001|Overall Study|Withdrawal by Subject|6|||
144547650|NCT01802333|521206335|FG002|Overall Study|Withdrawal by Subject|5|||
144547651|NCT01802333|521206333|FG000|Overall Study|Progression/relapse|1|||
144547652|NCT01802333|521206334|FG001|Overall Study|Progression/relapse|3|||
144547653|NCT01802333|521206335|FG002|Overall Study|Progression/relapse|0|||
144547654|NCT01802333|521206333|FG000|Overall Study|Death|7|||
144547655|NCT01802333|521206334|FG001|Overall Study|Death|14|||
144547656|NCT01802333|521206335|FG002|Overall Study|Death|13|||
144547657|NCT01802333|521206333|FG000|Overall Study|Other - not protocol specified|32|||
144547658|NCT01802333|521206334|FG001|Overall Study|Other - not protocol specified|22|||
144547659|NCT01802333|521206335|FG002|Overall Study|Other - not protocol specified|24|||
144547660|NCT01802333|521206333|FG000|Overall Study|Did not start treatment|0|||
144547661|NCT01802333|521206334|FG001|Overall Study|Did not start treatment|2|||
144547662|NCT01802333|521206335|FG002|Overall Study|Did not start treatment|5|||
144547663|NCT01947491|521206336|FG000|Overall Study|Lost to Follow-up|5|||
144547664|NCT01947491|521206337|FG001|Overall Study|Lost to Follow-up|3|||
144547665|NCT01947491|521206338|FG002|Overall Study|Lost to Follow-up|1|||
144547666|NCT01947491|521206339|FG003|Overall Study|Lost to Follow-up|2|||
144547667|NCT01947491|521206336|FG000|Overall Study|Lack of Efficacy|1|||
144547668|NCT01947491|521206337|FG001|Overall Study|Lack of Efficacy|0|||
144547669|NCT01947491|521206338|FG002|Overall Study|Lack of Efficacy|0|||
144547670|NCT01947491|521206339|FG003|Overall Study|Lack of Efficacy|1|||
144547671|NCT01947491|521206336|FG000|Overall Study|Protocol Violation|1|||
144547672|NCT01947491|521206337|FG001|Overall Study|Protocol Violation|0|||
144547673|NCT01947491|521206338|FG002|Overall Study|Protocol Violation|0|||
144547674|NCT01947491|521206339|FG003|Overall Study|Protocol Violation|0|||
144547675|NCT01947491|521206336|FG000|Overall Study|Withdrawal by Subject|1|||
144547676|NCT01947491|521206337|FG001|Overall Study|Withdrawal by Subject|1|||
144547677|NCT01947491|521206338|FG002|Overall Study|Withdrawal by Subject|1|||
144616578|NCT00267748|521456363|FG001|Non-randomized Period|Participant not willing to participate|0|||
144616579|NCT00267748|521456364|FG002|Non-randomized Period|Participant not willing to participate|0|||
144616580|NCT00267748|521456362|FG000|Non-randomized Period|Other|3|||
144616581|NCT00267748|521456363|FG001|Non-randomized Period|Other|0|||
144202974|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144547678|NCT01947491|521206339|FG003|Overall Study|Withdrawal by Subject|0|||
144547679|NCT01947491|521206336|FG000|Overall Study|Worsening of condition|0|||
144547680|NCT01947491|521206337|FG001|Overall Study|Worsening of condition|1|||
144547681|NCT01947491|521206338|FG002|Overall Study|Worsening of condition|0|||
144547682|NCT01947491|521206339|FG003|Overall Study|Worsening of condition|0|||
144547683|NCT01947491|521206336|FG000|Overall Study|Adverse Event|0|||
144547684|NCT01947491|521206337|FG001|Overall Study|Adverse Event|1|||
144547685|NCT01947491|521206338|FG002|Overall Study|Adverse Event|0|||
144547686|NCT01947491|521206339|FG003|Overall Study|Adverse Event|2|||
144547687|NCT02067663|521206341|FG000|Overall Study|Lost to Follow-up|13|||
144547688|NCT02067663|521206342|FG001|Overall Study|Lost to Follow-up|14|||
144547689|NCT00704340|521206343|FG000|Overall Study|Lost to Follow-up|2|||
144547690|NCT00704340|521206344|FG001|Overall Study|Lost to Follow-up|1|||
144547691|NCT00704340|521206343|FG000|Overall Study|Death|0|||
144547692|NCT00704340|521206344|FG001|Overall Study|Death|1|||
144547693|NCT00486954|521206349|FG000|Pilot Part|Adverse Event|4|||
144547694|NCT00486954|521206350|FG001|Pilot Part|Adverse Event|0|||
144547695|NCT00486954|521206351|FG002|Pilot Part|Adverse Event|5|||
144547696|NCT00486954|521206352|FG003|Pilot Part|Adverse Event|0|||
144547697|NCT00486954|521206353|FG004|Pilot Part|Adverse Event|0|||
144547698|NCT00486954|521206349|FG000|Pilot Part|Disease Progression|2|||
144547699|NCT00486954|521206350|FG001|Pilot Part|Disease Progression|0|||
144547700|NCT00486954|521206351|FG002|Pilot Part|Disease Progression|1|||
144547701|NCT00486954|521206352|FG003|Pilot Part|Disease Progression|0|||
144547702|NCT00486954|521206353|FG004|Pilot Part|Disease Progression|0|||
144547703|NCT00486954|521206349|FG000|Randomized Part|Lost to Follow-up|0|||
144547704|NCT00486954|521206350|FG001|Randomized Part|Lost to Follow-up|0|||
144547705|NCT00486954|521206351|FG002|Randomized Part|Lost to Follow-up|0|||
144547706|NCT00486954|521206352|FG003|Randomized Part|Lost to Follow-up|0|||
144547707|NCT00486954|521206353|FG004|Randomized Part|Lost to Follow-up|1|||
144547708|NCT00486954|521206349|FG000|Randomized Part|Withdrawal by Subject|0|||
144547709|NCT00486954|521206350|FG001|Randomized Part|Withdrawal by Subject|0|||
144547710|NCT00486954|521206351|FG002|Randomized Part|Withdrawal by Subject|0|||
144547711|NCT00486954|521206352|FG003|Randomized Part|Withdrawal by Subject|1|||
144547712|NCT00486954|521206353|FG004|Randomized Part|Withdrawal by Subject|0|||
144547713|NCT00486954|521206349|FG000|Randomized Part|Sponsor Terminated Study|0|||
144547714|NCT00486954|521206350|FG001|Randomized Part|Sponsor Terminated Study|0|||
144547715|NCT00486954|521206351|FG002|Randomized Part|Sponsor Terminated Study|0|||
144547716|NCT00486954|521206352|FG003|Randomized Part|Sponsor Terminated Study|19|||
144547717|NCT00486954|521206353|FG004|Randomized Part|Sponsor Terminated Study|13|||
144547718|NCT00929526|521206358|FG000|Overall Study|Withdrawal by Subject|1|||
144547719|NCT00929526|521206359|FG001|Overall Study|Withdrawal by Subject|11|||
144547720|NCT00929526|521206358|FG000|Overall Study|Lost to Follow-up|8|||
144547721|NCT00929526|521206359|FG001|Overall Study|Lost to Follow-up|12|||
144547722|NCT00929526|521206358|FG000|Overall Study|Other|8|||
144547723|NCT00929526|521206359|FG001|Overall Study|Other|6|||
144547724|NCT02169414|521206360|FG000|Overall Study|Withdrawal by Subject|1|||
144547725|NCT02169414|521206361|FG001|Overall Study|Withdrawal by Subject|0|||
144547726|NCT02169414|521206362|FG002|Overall Study|Withdrawal by Subject|0|||
144547727|NCT02169414|521206363|FG003|Overall Study|Withdrawal by Subject|0|||
144547728|NCT02169414|521206360|FG000|Overall Study|Adverse Event|0|||
144547729|NCT02169414|521206361|FG001|Overall Study|Adverse Event|1|||
144547730|NCT02169414|521206362|FG002|Overall Study|Adverse Event|0|||
144202975|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202976|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
144202977|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
144202978|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
144202979|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
144202980|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
144202981|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
144202982|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
144202983|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
144202984|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Disease Progression|0|||
144202985|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Disease Progression|0|||
144202986|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Disease Progression|0|||
144547731|NCT02169414|521206363|FG003|Overall Study|Adverse Event|0|||
144547732|NCT03374254|521206364|FG000|Overall Study|Death|5|||
144547733|NCT03374254|521206365|FG001|Overall Study|Death|16|||
144547734|NCT03374254|521206366|FG002|Overall Study|Death|13|||
144547735|NCT03374254|521206367|FG003|Overall Study|Death|11|||
144727565|NCT02101853|521856652|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
144202987|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Disease Progression|0|||
144202988|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Disease Progression|0|||
144547736|NCT03374254|521206368|FG004|Overall Study|Death|9|||
144547737|NCT03374254|521206369|FG005|Overall Study|Death|12|||
144547738|NCT03374254|521206370|FG006|Overall Study|Death|11|||
144547739|NCT03374254|521206371|FG007|Overall Study|Death|6|||
144547740|NCT03374254|521206372|FG008|Overall Study|Death|7|||
144547741|NCT03374254|521206364|FG000|Overall Study|Lost to Follow-up|0|||
144547742|NCT03374254|521206365|FG001|Overall Study|Lost to Follow-up|0|||
144547743|NCT03374254|521206366|FG002|Overall Study|Lost to Follow-up|0|||
144547744|NCT03374254|521206367|FG003|Overall Study|Lost to Follow-up|0|||
144547745|NCT03374254|521206368|FG004|Overall Study|Lost to Follow-up|0|||
144547746|NCT03374254|521206369|FG005|Overall Study|Lost to Follow-up|0|||
144547747|NCT03374254|521206370|FG006|Overall Study|Lost to Follow-up|2|||
144547748|NCT03374254|521206371|FG007|Overall Study|Lost to Follow-up|0|||
144547749|NCT03374254|521206372|FG008|Overall Study|Lost to Follow-up|0|||
144547750|NCT03374254|521206364|FG000|Overall Study|Sponsor Decision|1|||
144547751|NCT03374254|521206365|FG001|Overall Study|Sponsor Decision|0|||
144547752|NCT03374254|521206366|FG002|Overall Study|Sponsor Decision|2|||
144547753|NCT03374254|521206367|FG003|Overall Study|Sponsor Decision|3|||
144547754|NCT03374254|521206368|FG004|Overall Study|Sponsor Decision|2|||
144547755|NCT03374254|521206369|FG005|Overall Study|Sponsor Decision|3|||
144547756|NCT03374254|521206370|FG006|Overall Study|Sponsor Decision|3|||
144547757|NCT03374254|521206371|FG007|Overall Study|Sponsor Decision|3|||
144547758|NCT03374254|521206372|FG008|Overall Study|Sponsor Decision|4|||
144547759|NCT03374254|521206364|FG000|Overall Study|Withdrawal by Subject|0|||
144547760|NCT03374254|521206365|FG001|Overall Study|Withdrawal by Subject|0|||
144547761|NCT03374254|521206366|FG002|Overall Study|Withdrawal by Subject|0|||
144547762|NCT03374254|521206367|FG003|Overall Study|Withdrawal by Subject|2|||
144547763|NCT03374254|521206368|FG004|Overall Study|Withdrawal by Subject|0|||
144547764|NCT03374254|521206369|FG005|Overall Study|Withdrawal by Subject|1|||
144547765|NCT03374254|521206370|FG006|Overall Study|Withdrawal by Subject|0|||
144547766|NCT03374254|521206371|FG007|Overall Study|Withdrawal by Subject|0|||
144547767|NCT03374254|521206372|FG008|Overall Study|Withdrawal by Subject|0|||
144547768|NCT02309515|521206374|FG000|Overall Study|Withdrawal by Subject|0|||
144547769|NCT02309515|521206375|FG001|Overall Study|Withdrawal by Subject|1|||
144547770|NCT04070105|521206376|FG000|Overall Study|Lost to Follow-up|0|||
144547771|NCT04070105|521206377|FG001|Overall Study|Lost to Follow-up|0|||
144547772|NCT04070105|521206378|FG002|Overall Study|Lost to Follow-up|0|||
144547773|NCT04070105|521206379|FG003|Overall Study|Lost to Follow-up|0|||
144547774|NCT04070105|521206380|FG004|Overall Study|Lost to Follow-up|0|||
144547775|NCT04070105|521206381|FG005|Overall Study|Lost to Follow-up|1|||
144547776|NCT01102426|521206391|FG000|Overall Study|Randomized but not treated|4|||
144547777|NCT01102426|521206392|FG001|Overall Study|Randomized but not treated|1|||
144262330|NCT03430856|520159878|FG002|Overall Study|Voluntary withdrawal of consent|1|||
144547778|NCT01102426|521206391|FG000|Overall Study|Adverse Events (treatment-related)|15|||
144547779|NCT01102426|521206392|FG001|Overall Study|Adverse Events (treatment-related)|8|||
144547780|NCT01102426|521206391|FG000|Overall Study|Physician Decision|9|||
144547781|NCT01102426|521206392|FG001|Overall Study|Physician Decision|6|||
144547782|NCT01102426|521206391|FG000|Overall Study|Progressive Disease|85|||
144547783|NCT01102426|521206392|FG001|Overall Study|Progressive Disease|44|||
144547784|NCT01102426|521206391|FG000|Overall Study|Adverse Events (unrelated to|9|||
144547785|NCT01102426|521206392|FG001|Overall Study|Adverse Events (unrelated to|1|||
144547786|NCT01102426|521206391|FG000|Overall Study|Patient Refusal|24|||
144547787|NCT01102426|521206392|FG001|Overall Study|Patient Refusal|12|||
144547788|NCT01102426|521206391|FG000|Overall Study|Death (due to adverse events|0|||
144547789|NCT01102426|521206392|FG001|Overall Study|Death (due to adverse events|1|||
144547790|NCT01102426|521206391|FG000|Overall Study|Death (non-related to the study|19|||
144547791|NCT01102426|521206392|FG001|Overall Study|Death (non-related to the study|8|||
144547792|NCT01393964|521206403|FG000|Overall Study|Disease Progression|4|||
144547793|NCT01393964|521206404|FG001|Overall Study|Disease Progression|3|||
144547794|NCT01393964|521206405|FG002|Overall Study|Disease Progression|5|||
144547795|NCT01393964|521206403|FG000|Overall Study|Study drug toxicity|1|||
144547796|NCT01393964|521206404|FG001|Overall Study|Study drug toxicity|0|||
144547797|NCT01393964|521206405|FG002|Overall Study|Study drug toxicity|0|||
144547798|NCT01393964|521206403|FG000|Overall Study|Withdrawal by Subject|0|||
144547799|NCT01393964|521206404|FG001|Overall Study|Withdrawal by Subject|0|||
144547800|NCT01393964|521206405|FG002|Overall Study|Withdrawal by Subject|1|||
144547801|NCT01393964|521206403|FG000|Overall Study|Adverse event unrelated to study drug|0|||
144547802|NCT01393964|521206404|FG001|Overall Study|Adverse event unrelated to study drug|3|||
144547803|NCT01393964|521206405|FG002|Overall Study|Adverse event unrelated to study drug|0|||
144262331|NCT05219968|520159880|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
144262332|NCT05219968|520159881|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
144547804|NCT01393964|521206403|FG000|Overall Study|Subject request stop study treatment|0|||
144547805|NCT01393964|521206404|FG001|Overall Study|Subject request stop study treatment|1|||
144547806|NCT01393964|521206405|FG002|Overall Study|Subject request stop study treatment|0|||
144547807|NCT01393964|521206403|FG000|Overall Study|Subject decided to move to transplant|1|||
144547808|NCT01393964|521206404|FG001|Overall Study|Subject decided to move to transplant|0|||
144547809|NCT01393964|521206405|FG002|Overall Study|Subject decided to move to transplant|0|||
144547810|NCT01393964|521206403|FG000|Overall Study|Subject switched to commercial supply|1|||
144547811|NCT01393964|521206404|FG001|Overall Study|Subject switched to commercial supply|0|||
144547812|NCT01393964|521206405|FG002|Overall Study|Subject switched to commercial supply|2|||
144547813|NCT01393964|521206403|FG000|Overall Study|Subject plateaued in terms of effect|1|||
144547814|NCT01393964|521206404|FG001|Overall Study|Subject plateaued in terms of effect|0|||
144547815|NCT01393964|521206405|FG002|Overall Study|Subject plateaued in terms of effect|0|||
144547816|NCT01393964|521206403|FG000|Overall Study|Investigator removed subject from study|0|||
144547817|NCT01393964|521206404|FG001|Overall Study|Investigator removed subject from study|1|||
144547818|NCT01393964|521206405|FG002|Overall Study|Investigator removed subject from study|0|||
144547819|NCT01393964|521206403|FG000|Overall Study|Subject converted to roll-over study|0|||
144547820|NCT01393964|521206404|FG001|Overall Study|Subject converted to roll-over study|1|||
144547821|NCT01393964|521206405|FG002|Overall Study|Subject converted to roll-over study|0|||
144547822|NCT01393964|521206403|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
144547823|NCT01393964|521206404|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
144547824|NCT01393964|521206405|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
144262333|NCT05219968|520159882|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
144262334|NCT05219968|520159883|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
144262335|NCT05219968|520159884|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
144262336|NCT05219968|520159880|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
144262337|NCT05219968|520159881|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
144262338|NCT05219968|520159882|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
144262339|NCT05219968|520159883|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
144262340|NCT05219968|520159884|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
144262341|NCT05219968|520159880|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
144262342|NCT05219968|520159881|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
144262343|NCT05219968|520159882|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
144547825|NCT02988713|521206409|FG000|Overall Study|Withdrawal by Subject|1|||
144547826|NCT02988713|521206409|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
144547827|NCT01918033|521206410|FG000|Overall Study|Adverse Event|1|||
144547828|NCT01918033|521206411|FG001|Overall Study|Adverse Event|0|||
144547829|NCT01918033|521206412|FG002|Overall Study|Adverse Event|2|||
144547830|NCT01918033|521206410|FG000|Overall Study|Lost to Follow-up|0|||
144547831|NCT01918033|521206411|FG001|Overall Study|Lost to Follow-up|1|||
144547832|NCT01918033|521206412|FG002|Overall Study|Lost to Follow-up|0|||
144547833|NCT01918033|521206410|FG000|Overall Study|Protocol Violation|2|||
144547834|NCT01918033|521206411|FG001|Overall Study|Protocol Violation|0|||
144547835|NCT01918033|521206412|FG002|Overall Study|Protocol Violation|1|||
144547836|NCT01918033|521206410|FG000|Overall Study|Withdrawal by Subject|2|||
144547837|NCT01918033|521206411|FG001|Overall Study|Withdrawal by Subject|1|||
144547838|NCT01918033|521206412|FG002|Overall Study|Withdrawal by Subject|0|||
144547839|NCT04492475|521206413|FG000|Overall Study|Enrolled but not treated|8|||
144547840|NCT04492475|521206414|FG001|Overall Study|Enrolled but not treated|8|||
144547841|NCT04492475|521206413|FG000|Overall Study|Withdrawal by Subject|4|||
144547842|NCT04492475|521206414|FG001|Overall Study|Withdrawal by Subject|0|||
144547843|NCT04492475|521206413|FG000|Overall Study|Became ineligible after enrollment|2|||
144547844|NCT04492475|521206414|FG001|Overall Study|Became ineligible after enrollment|0|||
144547845|NCT03938272|521206424|FG000|Overall Study|Withdrawal by Subject|1|||
144547846|NCT03938272|521206425|FG001|Overall Study|Withdrawal by Subject|0|||
144547847|NCT03938272|521206424|FG000|Overall Study|Physician Decision|0|||
144547848|NCT03938272|521206425|FG001|Overall Study|Physician Decision|2|||
144547849|NCT03938272|521206424|FG000|Overall Study|Study termination by sponsor|10|||
144547850|NCT03938272|521206425|FG001|Overall Study|Study termination by sponsor|8|||
144547851|NCT03692871|521206428|FG000|Overall Study|Death|1|||
144547852|NCT03692871|521206429|FG001|Overall Study|Death|1|||
144547853|NCT03692871|521206428|FG000|Overall Study|Lost to Follow-up|24|||
144547854|NCT03692871|521206429|FG001|Overall Study|Lost to Follow-up|9|||
144202989|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Disease Progression|0|||
144202990|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Disease Progression|0|||
144202991|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Disease Progression|0|||
144202992|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Disease Progression|0|||
144202993|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Disease Progression|0|||
144202994|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Disease Progression|0|||
144202995|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Disease Progression|0|||
144202996|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Disease Progression|0|||
144202997|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Disease Progression|0|||
144202998|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Disease Progression|0|||
144547855|NCT03692871|521206428|FG000|Overall Study|Physician Decision|22|||
144547856|NCT03692871|521206429|FG001|Overall Study|Physician Decision|7|||
144547857|NCT03692871|521206428|FG000|Overall Study|Protocol Deviation|1|||
144202999|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Disease Progression|0|||
144262344|NCT05219968|520159883|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
144262345|NCT05219968|520159884|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
144547858|NCT03692871|521206429|FG001|Overall Study|Protocol Deviation|0|||
144262346|NCT05219968|520159880|FG000|Week 24 Treatment Period|Adverse Event|3|||
144547859|NCT03692871|521206428|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
144547860|NCT03692871|521206429|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
144547861|NCT02852824|521206433|FG000|Overall Study|Withdrawal by Subject|1|||
144547862|NCT02852824|521206434|FG001|Overall Study|Withdrawal by Subject|0|||
144547863|NCT02852824|521206435|FG002|Overall Study|Withdrawal by Subject|0|||
144547864|NCT02852824|521206436|FG003|Overall Study|Withdrawal by Subject|0|||
144547865|NCT02852824|521206437|FG004|Overall Study|Withdrawal by Subject|0|||
144727566|NCT02101853|521856653|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
144203000|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Disease Progression|0|||
144203001|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Disease Progression|0|||
144203002|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Disease Progression|0|||
144203003|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Disease Progression|0|||
144203004|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Disease Progression|2|||
144547866|NCT02852824|521206438|FG005|Overall Study|Withdrawal by Subject|0|||
144547867|NCT02852824|521206439|FG006|Overall Study|Withdrawal by Subject|0|||
144547868|NCT02852824|521206433|FG000|Overall Study|Adverse Event|0|||
144547869|NCT02852824|521206434|FG001|Overall Study|Adverse Event|0|||
144547870|NCT02852824|521206435|FG002|Overall Study|Adverse Event|0|||
144547871|NCT02852824|521206436|FG003|Overall Study|Adverse Event|0|||
144547872|NCT02852824|521206437|FG004|Overall Study|Adverse Event|2|||
144547873|NCT02852824|521206438|FG005|Overall Study|Adverse Event|0|||
144547874|NCT02852824|521206439|FG006|Overall Study|Adverse Event|0|||
144547875|NCT01915914|521206448|FG000|Acute Phase|Withdrawal by Subject|4|||
144547876|NCT01915914|521206449|FG001|Acute Phase|Withdrawal by Subject|0|||
144547877|NCT01915914|521206450|FG002|Acute Phase|Withdrawal by Subject|0|||
144547878|NCT01915914|521206451|FG003|Acute Phase|Withdrawal by Subject|0|||
144547879|NCT01915914|521206448|FG000|Acute Phase|Lost to Follow-up|4|||
144547880|NCT01915914|521206449|FG001|Acute Phase|Lost to Follow-up|0|||
144547881|NCT01915914|521206450|FG002|Acute Phase|Lost to Follow-up|0|||
144547882|NCT01915914|521206451|FG003|Acute Phase|Lost to Follow-up|0|||
144547883|NCT01915914|521206448|FG000|Acute Phase|Physician Decision|1|||
144547884|NCT01915914|521206449|FG001|Acute Phase|Physician Decision|0|||
144547885|NCT01915914|521206450|FG002|Acute Phase|Physician Decision|0|||
144547886|NCT01915914|521206451|FG003|Acute Phase|Physician Decision|0|||
144547887|NCT01915914|521206448|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
144547888|NCT01915914|521206449|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
144547889|NCT01915914|521206450|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
144547890|NCT01915914|521206451|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
144547891|NCT01915914|521206448|FG000|Acute Phase|"Not Achieved treatment success"|1|||
144547892|NCT01915914|521206449|FG001|Acute Phase|"Not Achieved treatment success"|0|||
144547893|NCT01915914|521206450|FG002|Acute Phase|"Not Achieved treatment success"|0|||
144547894|NCT01915914|521206451|FG003|Acute Phase|"Not Achieved treatment success"|0|||
144547895|NCT01915914|521206448|FG000|Acute Phase|Missing|1|||
144547896|NCT01915914|521206449|FG001|Acute Phase|Missing|0|||
144547897|NCT01915914|521206450|FG002|Acute Phase|Missing|0|||
144547898|NCT01915914|521206451|FG003|Acute Phase|Missing|0|||
144547899|NCT01915914|521206448|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144547900|NCT01915914|521206449|FG001|Maintenance Phase|Withdrawal by Subject|1|||
144547901|NCT01915914|521206450|FG002|Maintenance Phase|Withdrawal by Subject|1|||
144547902|NCT01915914|521206451|FG003|Maintenance Phase|Withdrawal by Subject|0|||
144547903|NCT01915914|521206448|FG000|Maintenance Phase|Lost to Follow-up|0|||
144547904|NCT01915914|521206449|FG001|Maintenance Phase|Lost to Follow-up|4|||
144547905|NCT01915914|521206450|FG002|Maintenance Phase|Lost to Follow-up|1|||
144547906|NCT01915914|521206451|FG003|Maintenance Phase|Lost to Follow-up|0|||
144547907|NCT01915914|521206448|FG000|Maintenance Phase|Missing|0|||
144547908|NCT01915914|521206449|FG001|Maintenance Phase|Missing|1|||
144547909|NCT01915914|521206450|FG002|Maintenance Phase|Missing|0|||
144547910|NCT01915914|521206451|FG003|Maintenance Phase|Missing|0|||
144547911|NCT01915914|521206448|FG000|Follow-up Phase|Withdrawal by Subject|0|||
144547912|NCT01915914|521206449|FG001|Follow-up Phase|Withdrawal by Subject|0|||
144547913|NCT01915914|521206450|FG002|Follow-up Phase|Withdrawal by Subject|0|||
144547914|NCT01915914|521206451|FG003|Follow-up Phase|Withdrawal by Subject|1|||
144547915|NCT01915914|521206448|FG000|Follow-up Phase|Physician Decision|0|||
144547916|NCT01915914|521206449|FG001|Follow-up Phase|Physician Decision|0|||
144547917|NCT01915914|521206450|FG002|Follow-up Phase|Physician Decision|0|||
144547918|NCT01915914|521206451|FG003|Follow-up Phase|Physician Decision|1|||
144547919|NCT01736475|521206452|FG000|Overall Study|Adverse Event|4|||
144547920|NCT01736475|521206453|FG001|Overall Study|Adverse Event|0|||
144547921|NCT01736475|521206452|FG000|Overall Study|Withdrawal by Subject|2|||
144547922|NCT01736475|521206453|FG001|Overall Study|Withdrawal by Subject|0|||
144547923|NCT01736475|521206452|FG000|Overall Study|Protocol Violation|4|||
144547924|NCT01736475|521206453|FG001|Overall Study|Protocol Violation|0|||
144727567|NCT02101853|521856654|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
144547925|NCT01736475|521206452|FG000|Overall Study|Other - Screen failure|1|||
144547926|NCT01736475|521206453|FG001|Overall Study|Other - Screen failure|0|||
144727568|NCT02101853|521856655|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
144203005|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Disease Progression|1|||
144547927|NCT01736475|521206452|FG000|Overall Study|Other - Surgical procedure|1|||
144547928|NCT01736475|521206453|FG001|Overall Study|Other - Surgical procedure|0|||
144547929|NCT00513071|521206454|FG000|Overall Study|Adverse Event|1|||
144547930|NCT00513071|521206454|FG000|Overall Study|Withdrawal by Subject|1|||
144547931|NCT00513071|521206454|FG000|Overall Study|Physician Decision|3|||
144547932|NCT00667732|521206457|FG000|Run -In (8 Weeks)|Adverse Event|4|||
144547933|NCT00667732|521206458|FG001|Run -In (8 Weeks)|Adverse Event|0|||
144727569|NCT02101853|521856656|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
144727570|NCT02101853|521856651|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
144727571|NCT02101853|521856652|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
144203006|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Disease Progression|0|||
144203007|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Disease Progression|0|||
144203008|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Disease Progression|0|||
144203009|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203010|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
144547934|NCT00667732|521206459|FG002|Run -In (8 Weeks)|Adverse Event|0|||
144547935|NCT00667732|521206457|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
144547936|NCT00667732|521206458|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
144547937|NCT00667732|521206459|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
144547938|NCT00667732|521206457|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
144547939|NCT00667732|521206458|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
144547940|NCT00667732|521206459|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
144547941|NCT02106325|521206464|FG000|Phase 1|Lost to Follow-up|2|||
144547942|NCT02106325|521206465|FG001|Phase 1|Lost to Follow-up|2|||
144547943|NCT02106325|521206464|FG000|Phase 2|Lost to Follow-up|2|||
144547944|NCT02106325|521206465|FG001|Phase 2|Lost to Follow-up|3|||
144547945|NCT02106325|521206464|FG000|Phase 3|Lost to Follow-up|2|||
144547946|NCT02106325|521206465|FG001|Phase 3|Lost to Follow-up|1|||
144547947|NCT00824850|521206467|FG000|Overall Study|Withdrawal by Subject|0|||
144547948|NCT00824850|521206468|FG001|Overall Study|Withdrawal by Subject|1|||
144547949|NCT03242863|521206469|FG000|Study Week 1|Withdrawal by Subject|0|||
144547950|NCT03242863|521206470|FG001|Study Week 1|Withdrawal by Subject|1|||
144547951|NCT03242863|521206471|FG002|Study Week 1|Withdrawal by Subject|0|||
144547952|NCT03242863|521206472|FG003|Study Week 1|Withdrawal by Subject|0|||
144547953|NCT03242863|521206473|FG004|Study Week 1|Withdrawal by Subject|3|||
144547954|NCT03242863|521206474|FG005|Study Week 1|Withdrawal by Subject|0|||
144547955|NCT04820491|521206475|FG000|Overall Study|Withdrawal by Subject|1|||
144547956|NCT04820491|521206476|FG001|Overall Study|Withdrawal by Subject|0|||
144547957|NCT04369664|521208213|FG000|Overall Study|Physician Decision|1|||
144547958|NCT04369664|521208214|FG001|Overall Study|Physician Decision|0|||
144547959|NCT00215943|521208215|FG000|Overall Study|Disease Progression|3|||
144547960|NCT00215943|521208216|FG001|Overall Study|Disease Progression|5|||
144547961|NCT00215943|521208215|FG000|Overall Study|Alternate therapy|0|||
144547962|NCT00215943|521208216|FG001|Overall Study|Alternate therapy|1|||
144547963|NCT00215943|521208215|FG000|Overall Study|Adverse Event|3|||
144547964|NCT00215943|521208216|FG001|Overall Study|Adverse Event|6|||
144547965|NCT00215943|521208215|FG000|Overall Study|Other disease|0|||
144547966|NCT00215943|521208216|FG001|Overall Study|Other disease|1|||
144547967|NCT00215943|521208215|FG000|Overall Study|Other complications|3|||
144547968|NCT00215943|521208216|FG001|Overall Study|Other complications|1|||
144547969|NCT02507297|521208217|FG000|Overall Study|Withdrawal by Subject|1|||
144547970|NCT02507297|521208218|FG001|Overall Study|Withdrawal by Subject|0|||
144547971|NCT02507297|521208217|FG000|Overall Study|Lost to Follow-up|0|||
144727572|NCT02101853|521856653|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
144727573|NCT02101853|521856654|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
144727574|NCT02101853|521856655|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
144547972|NCT02507297|521208218|FG001|Overall Study|Lost to Follow-up|1|||
144547973|NCT04909593|521208219|FG000|Overall Study|Withdrawal by Subject|1|||
144547974|NCT01018992|521208220|FG000|Overall Study|Adverse Event|8|||
144547975|NCT01018992|521208221|FG001|Overall Study|Adverse Event|3|||
144547976|NCT01018992|521208220|FG000|Overall Study|Withdrawal by Subject|3|||
144547977|NCT01018992|521208221|FG001|Overall Study|Withdrawal by Subject|8|||
144547978|NCT01018992|521208220|FG000|Overall Study|Protocol Violation|0|||
144547979|NCT01018992|521208221|FG001|Overall Study|Protocol Violation|4|||
144547980|NCT01018992|521208220|FG000|Overall Study|Lost to Follow-up|5|||
144547981|NCT01018992|521208221|FG001|Overall Study|Lost to Follow-up|1|||
144547982|NCT01825785|521208222|FG000|Overall Study|Adverse Event|0|||
144547983|NCT01825785|521208223|FG001|Overall Study|Adverse Event|0|||
144547984|NCT01825785|521208224|FG002|Overall Study|Adverse Event|0|||
144547985|NCT01825785|521208225|FG003|Overall Study|Adverse Event|0|||
144547986|NCT01825785|521208226|FG004|Overall Study|Adverse Event|1|||
144203011|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
144547987|NCT01825785|521208227|FG005|Overall Study|Adverse Event|0|||
144547988|NCT01825785|521208228|FG006|Overall Study|Adverse Event|0|||
144547989|NCT01825785|521208222|FG000|Overall Study|Withdrawal by Subject|0|||
144547990|NCT01825785|521208223|FG001|Overall Study|Withdrawal by Subject|0|||
144547991|NCT01825785|521208224|FG002|Overall Study|Withdrawal by Subject|0|||
144547992|NCT01825785|521208225|FG003|Overall Study|Withdrawal by Subject|0|||
144547993|NCT01825785|521208226|FG004|Overall Study|Withdrawal by Subject|1|||
144547994|NCT01825785|521208227|FG005|Overall Study|Withdrawal by Subject|1|||
144547995|NCT01825785|521208228|FG006|Overall Study|Withdrawal by Subject|0|||
144727575|NCT02101853|521856656|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
144547996|NCT01304940|521208230|FG000|Overall Study|not meet symptom severity requirement|3|||
144547997|NCT01304940|521208231|FG001|Overall Study|not meet symptom severity requirement|0|||
144547998|NCT02065895|521208232|FG000|Overall Study|Protocol Violation|1|||
144547999|NCT02065895|521208233|FG001|Overall Study|Protocol Violation|0|||
144548000|NCT02065895|521208234|FG002|Overall Study|Protocol Violation|0|||
144548001|NCT02065895|521208235|FG003|Overall Study|Protocol Violation|1|||
144548002|NCT02065895|521208236|FG004|Overall Study|Protocol Violation|0|||
144548003|NCT02065895|521208237|FG005|Overall Study|Protocol Violation|0|||
144548004|NCT02065895|521208232|FG000|Overall Study|Scheduling conflicts|0|||
144548005|NCT02065895|521208233|FG001|Overall Study|Scheduling conflicts|1|||
144548006|NCT02065895|521208234|FG002|Overall Study|Scheduling conflicts|0|||
144548007|NCT02065895|521208235|FG003|Overall Study|Scheduling conflicts|0|||
144548008|NCT02065895|521208236|FG004|Overall Study|Scheduling conflicts|0|||
144548009|NCT02065895|521208237|FG005|Overall Study|Scheduling conflicts|0|||
144548010|NCT00484198|521208240|FG000|Overall Study|Participant Withdrew Consent|12|||
144548011|NCT00484198|521208241|FG001|Overall Study|Participant Withdrew Consent|21|||
144548012|NCT00484198|521208242|FG002|Overall Study|Participant Withdrew Consent|47|||
144548013|NCT00484198|521208243|FG003|Overall Study|Participant Withdrew Consent|59|||
144548014|NCT00484198|521208240|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
144548015|NCT00484198|521208241|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
144548016|NCT00484198|521208242|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
144548017|NCT00484198|521208243|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
144548018|NCT00484198|521208240|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
144548019|NCT00484198|521208241|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
144548020|NCT00484198|521208242|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
144548021|NCT00484198|521208243|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
144548022|NCT00484198|521208240|FG000|Overall Study|Adverse Event|3|||
144548023|NCT00484198|521208241|FG001|Overall Study|Adverse Event|11|||
144616582|NCT00267748|521456364|FG002|Non-randomized Period|Other|0|||
144548024|NCT00484198|521208242|FG002|Overall Study|Adverse Event|32|||
144548025|NCT00484198|521208243|FG003|Overall Study|Adverse Event|31|||
144548026|NCT00484198|521208240|FG000|Overall Study|Protocol Violation|0|||
144548027|NCT00484198|521208241|FG001|Overall Study|Protocol Violation|5|||
144548028|NCT00484198|521208242|FG002|Overall Study|Protocol Violation|6|||
144548029|NCT00484198|521208243|FG003|Overall Study|Protocol Violation|8|||
144548030|NCT00484198|521208240|FG000|Overall Study|Other|7|||
144548031|NCT00484198|521208241|FG001|Overall Study|Other|10|||
144548032|NCT00484198|521208242|FG002|Overall Study|Other|31|||
144548033|NCT00484198|521208243|FG003|Overall Study|Other|28|||
144548034|NCT01686152|521208244|FG000|Overall Study|Withdrawal by Subject|11|||
144548035|NCT01686152|521208245|FG001|Overall Study|Withdrawal by Subject|11|||
144548036|NCT01686152|521208246|FG002|Overall Study|Withdrawal by Subject|3|||
144548037|NCT01686152|521208244|FG000|Overall Study|Drug Code Unblinded|0|||
144548038|NCT01686152|521208245|FG001|Overall Study|Drug Code Unblinded|1|||
144548039|NCT01686152|521208246|FG002|Overall Study|Drug Code Unblinded|0|||
144548040|NCT01686152|521208244|FG000|Overall Study|Protocol Violation|6|||
144548041|NCT01686152|521208245|FG001|Overall Study|Protocol Violation|1|||
144548042|NCT01686152|521208246|FG002|Overall Study|Protocol Violation|0|||
144548043|NCT01686152|521208244|FG000|Overall Study|Adverse Event|12|||
144548044|NCT01686152|521208245|FG001|Overall Study|Adverse Event|11|||
144548045|NCT01686152|521208246|FG002|Overall Study|Adverse Event|0|||
144548046|NCT01686152|521208244|FG000|Overall Study|Lack of Efficacy|0|||
144548047|NCT01686152|521208245|FG001|Overall Study|Lack of Efficacy|0|||
144548048|NCT01686152|521208246|FG002|Overall Study|Lack of Efficacy|1|||
144548049|NCT01686152|521208244|FG000|Overall Study|IP Non-compliance|5|||
144548050|NCT01686152|521208245|FG001|Overall Study|IP Non-compliance|5|||
144548051|NCT01686152|521208246|FG002|Overall Study|IP Non-compliance|0|||
144548052|NCT01686152|521208244|FG000|Overall Study|Lost to Follow-up|7|||
144548053|NCT01686152|521208245|FG001|Overall Study|Lost to Follow-up|6|||
144548054|NCT01686152|521208246|FG002|Overall Study|Lost to Follow-up|5|||
144548055|NCT01853384|521208247|FG000|Randomized|Adverse Event|5|||
144548056|NCT01853384|521208248|FG001|Randomized|Adverse Event|3|||
144548057|NCT01853384|521208247|FG000|Randomized|Death|1|||
144548058|NCT01853384|521208248|FG001|Randomized|Death|2|||
144548059|NCT01853384|521208247|FG000|Randomized|Lost to Follow-up|1|||
144616583|NCT00267748|521456362|FG000|Randomized Period|Death|0|||
144548060|NCT01853384|521208248|FG001|Randomized|Lost to Follow-up|1|||
144548061|NCT01853384|521208247|FG000|Randomized|Withdrawal by Subject|5|||
144548062|NCT01853384|521208248|FG001|Randomized|Withdrawal by Subject|3|||
144548063|NCT01853384|521208247|FG000|Randomized|Sponsor Decision|47|||
144548064|NCT01853384|521208248|FG001|Randomized|Sponsor Decision|34|||
144548065|NCT01853384|521208247|FG000|Randomized|Other|3|||
144548066|NCT01853384|521208248|FG001|Randomized|Other|3|||
144548067|NCT01853384|521208247|FG000|Completed Follow up Visit 1|Early Termination|13|||
144548068|NCT01853384|521208248|FG001|Completed Follow up Visit 1|Early Termination|9|||
144548069|NCT01853384|521208247|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
144548070|NCT01853384|521208248|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
144548071|NCT01853384|521208247|FG000|Completed Follow up Visit 2|Adverse Event|1|||
144616584|NCT00267748|521456363|FG001|Randomized Period|Death|2|||
144548072|NCT01853384|521208248|FG001|Completed Follow up Visit 2|Adverse Event|0|||
144548073|NCT01853384|521208247|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
144548074|NCT01853384|521208248|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
144548075|NCT01853384|521208247|FG000|Completed Follow up Visit 2|Death|1|||
144548076|NCT01853384|521208248|FG001|Completed Follow up Visit 2|Death|0|||
144548077|NCT01853384|521208247|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
144548078|NCT01853384|521208248|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
144548079|NCT03137784|521208249|FG000|Overall Study|Adverse Event|1|||
144548080|NCT03137784|521208250|FG001|Overall Study|Adverse Event|1|||
144548081|NCT03137784|521208251|FG002|Overall Study|Adverse Event|0|||
144548082|NCT03137784|521208252|FG003|Overall Study|Adverse Event|0|||
144548083|NCT03137784|521208253|FG004|Overall Study|Adverse Event|0|||
144548084|NCT03137784|521208254|FG005|Overall Study|Adverse Event|0|||
144548085|NCT03137784|521208249|FG000|Overall Study|Subject/guardian decision|1|||
144548086|NCT03137784|521208250|FG001|Overall Study|Subject/guardian decision|0|||
144548087|NCT03137784|521208251|FG002|Overall Study|Subject/guardian decision|0|||
144548088|NCT03137784|521208252|FG003|Overall Study|Subject/guardian decision|0|||
144548089|NCT03137784|521208253|FG004|Overall Study|Subject/guardian decision|0|||
144548090|NCT03137784|521208254|FG005|Overall Study|Subject/guardian decision|0|||
144548091|NCT03137784|521208249|FG000|Overall Study|Non-compliance with study treatment|0|||
144548092|NCT03137784|521208250|FG001|Overall Study|Non-compliance with study treatment|0|||
144548093|NCT03137784|521208251|FG002|Overall Study|Non-compliance with study treatment|0|||
144548094|NCT03137784|521208252|FG003|Overall Study|Non-compliance with study treatment|0|||
144548095|NCT03137784|521208253|FG004|Overall Study|Non-compliance with study treatment|1|||
144548096|NCT03137784|521208254|FG005|Overall Study|Non-compliance with study treatment|0|||
144548097|NCT01205126|521208255|FG000|Titration Phase|Adverse Event|5|||
144548098|NCT01205126|521208256|FG001|Titration Phase|Adverse Event|3|||
144548099|NCT01205126|521208255|FG000|Titration Phase|Withdrawal by Subject|5|||
144548100|NCT01205126|521208256|FG001|Titration Phase|Withdrawal by Subject|5|||
144548101|NCT01205126|521208255|FG000|Titration Phase|Lost to Follow-up|2|||
144548102|NCT01205126|521208256|FG001|Titration Phase|Lost to Follow-up|2|||
144548103|NCT01205126|521208255|FG000|Titration Phase|No stable titration dose|1|||
144548104|NCT01205126|521208256|FG001|Titration Phase|No stable titration dose|0|||
144548105|NCT01205126|521208255|FG000|Titration Phase|More than maximum dosage required|2|||
144548106|NCT01205126|521208256|FG001|Titration Phase|More than maximum dosage required|3|||
144548107|NCT01205126|521208255|FG000|Titration Phase|Other|8|||
144548108|NCT01205126|521208256|FG001|Titration Phase|Other|6|||
144548109|NCT01205126|521208255|FG000|Between Titration & Maintenance Phase|Other|0|||
144548110|NCT01205126|521208256|FG001|Between Titration & Maintenance Phase|Other|4|||
144548111|NCT01205126|521208255|FG000|Maintenance Phase|Adverse Event|3|||
144548112|NCT01205126|521208256|FG001|Maintenance Phase|Adverse Event|7|||
144548113|NCT01205126|521208255|FG000|Maintenance Phase|Death|4|||
144548114|NCT01205126|521208256|FG001|Maintenance Phase|Death|4|||
144548115|NCT01205126|521208255|FG000|Maintenance Phase|More than the maximum dosage required|5|||
144548116|NCT01205126|521208256|FG001|Maintenance Phase|More than the maximum dosage required|5|||
144548117|NCT01205126|521208255|FG000|Maintenance Phase|Prohibited drugs used|1|||
144548118|NCT01205126|521208256|FG001|Maintenance Phase|Prohibited drugs used|0|||
144548119|NCT01205126|521208255|FG000|Maintenance Phase|Other|11|||
144548120|NCT01205126|521208256|FG001|Maintenance Phase|Other|8|||
144548121|NCT01205126|521208255|FG000|Maintenance Phase|Lost to Follow-up|5|||
144548122|NCT01205126|521208256|FG001|Maintenance Phase|Lost to Follow-up|5|||
144548123|NCT01205126|521208255|FG000|Maintenance Phase|Withdrawal by Subject|8|||
144548124|NCT01205126|521208256|FG001|Maintenance Phase|Withdrawal by Subject|11|||
144548125|NCT00403845|521208257|FG000|Treatment Period 1|Subject withdrew consent|1|||
144548126|NCT00403845|521208258|FG001|Treatment Period 1|Subject withdrew consent|0|||
144548127|NCT00403845|521208259|FG002|Treatment Period 1|Subject withdrew consent|0|||
144548128|NCT00403845|521208260|FG003|Treatment Period 1|Subject withdrew consent|0|||
144548129|NCT00403845|521208257|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
144548130|NCT00403845|521208258|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
144548131|NCT00403845|521208259|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
144548132|NCT00403845|521208260|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
144548133|NCT00403845|521208257|FG000|Treatment Period 2|Subject withdrew consent|1|||
144548134|NCT00403845|521208258|FG001|Treatment Period 2|Subject withdrew consent|0|||
144548135|NCT00403845|521208259|FG002|Treatment Period 2|Subject withdrew consent|0|||
144548136|NCT00403845|521208260|FG003|Treatment Period 2|Subject withdrew consent|0|||
144548137|NCT00403845|521208257|FG000|Treatment Period 3|Subject withdrew consent|0|||
144548138|NCT00403845|521208258|FG001|Treatment Period 3|Subject withdrew consent|0|||
144548139|NCT00403845|521208259|FG002|Treatment Period 3|Subject withdrew consent|0|||
144548140|NCT00403845|521208260|FG003|Treatment Period 3|Subject withdrew consent|1|||
144548141|NCT00403845|521208257|FG000|Treatment Period 3|Adverse Event|0|||
144548142|NCT00403845|521208258|FG001|Treatment Period 3|Adverse Event|0|||
144548143|NCT00403845|521208259|FG002|Treatment Period 3|Adverse Event|0|||
144548144|NCT00403845|521208260|FG003|Treatment Period 3|Adverse Event|1|||
144548145|NCT00805792|521208261|FG000|Overall Study|Death|3|||
144548146|NCT00805792|521208261|FG000|Overall Study|Lost to Follow-up|2|||
144548147|NCT04328467|521208269|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
144548148|NCT04328467|521208270|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
144548149|NCT04328467|521208271|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
144548150|NCT00624377|521208272|FG000|Overall Study|Lost to Follow-up|355|||
144548151|NCT00624377|521208272|FG000|Overall Study|Withdrawal by Subject|100|||
144548152|NCT00624377|521208272|FG000|Overall Study|Adverse Event|14|||
144548153|NCT00624377|521208272|FG000|Overall Study|Other|91|||
144548154|NCT00624377|521208272|FG000|Overall Study|Non-evaluable population|84|||
144548155|NCT00923078|521208273|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
144548156|NCT00923078|521208274|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
144548157|NCT00923078|521208275|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
144548158|NCT00923078|521208273|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
144548159|NCT00923078|521208274|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
144548160|NCT00923078|521208275|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
144548161|NCT01393600|521208279|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
144548162|NCT01393600|521208280|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
144548163|NCT01393600|521208281|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
144548164|NCT01393600|521208282|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
144548165|NCT01393600|521208279|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
144548166|NCT01393600|521208280|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
144548167|NCT01393600|521208281|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
144548168|NCT01393600|521208282|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
144548169|NCT01393600|521208279|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
144548170|NCT01393600|521208280|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
144548171|NCT01393600|521208281|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
144548172|NCT01393600|521208282|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
144548173|NCT01393600|521208279|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
144548174|NCT01393600|521208280|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
144548175|NCT01393600|521208281|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
144548176|NCT01393600|521208282|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
144548177|NCT01393600|521208279|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
144548178|NCT01393600|521208280|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
144548179|NCT01393600|521208281|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
144548180|NCT01393600|521208282|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
144548181|NCT01393600|521208279|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
144548182|NCT01393600|521208280|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
144548183|NCT01393600|521208281|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
144548184|NCT01393600|521208282|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
144548185|NCT01393600|521208279|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
144548186|NCT01393600|521208280|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
144548187|NCT01393600|521208281|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
144548188|NCT01393600|521208282|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
144548189|NCT02784834|521208283|FG000|Overall Study|Lack of Efficacy|1|||
144548190|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
144548191|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
144548192|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
144548193|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
144548194|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Adverse Event|7|||
144548195|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Adverse Event|8|||
144548196|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Adverse Event|8|||
144548197|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Adverse Event|9|||
144548198|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
144548199|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
144548200|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
144548201|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
144548202|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
144548203|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
144548204|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
144548205|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
144548206|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Pregnancy|0|||
144548207|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Pregnancy|2|||
144548208|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Pregnancy|2|||
144203012|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203013|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
144548209|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Pregnancy|0|||
144548210|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Non-compliance|1|||
144548211|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Non-compliance|0|||
144548212|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Non-compliance|0|||
144203014|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203015|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
144548213|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Non-compliance|3|||
144548214|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Other|3|||
144548215|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Other|0|||
144548216|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Other|3|||
144548217|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Other|2|||
144548218|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
144548219|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
144548220|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
144548221|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
144548222|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
144548223|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
144548224|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
144548225|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
144548226|NCT02143713|521208284|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
144548227|NCT02143713|521208285|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
144548228|NCT02143713|521208286|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
144548229|NCT02143713|521208287|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
144548230|NCT02143713|521208284|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
144548231|NCT02143713|521208285|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
144548232|NCT02143713|521208286|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
144548233|NCT02143713|521208287|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
144548234|NCT02143713|521208284|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
144548235|NCT02143713|521208285|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
144548236|NCT02143713|521208286|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
144548237|NCT02143713|521208287|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
144548238|NCT02143713|521208284|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
144548239|NCT02143713|521208285|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
144548240|NCT02143713|521208286|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
144548241|NCT02143713|521208287|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
144548242|NCT02143713|521208284|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
144548243|NCT02143713|521208285|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
144548244|NCT02143713|521208286|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
144548245|NCT02143713|521208287|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
144548246|NCT02143713|521208284|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
144548247|NCT02143713|521208285|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
144548248|NCT02143713|521208286|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
144548249|NCT02143713|521208287|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
144548250|NCT02143713|521208284|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
144548251|NCT02143713|521208285|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
144548252|NCT02143713|521208286|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
144548253|NCT02143713|521208287|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
144548254|NCT01768572|521208288|FG000|Overall Study|Adverse Event|7|||
144548255|NCT01768572|521208289|FG001|Overall Study|Adverse Event|8|||
144548256|NCT01768572|521208290|FG002|Overall Study|Adverse Event|4|||
144548257|NCT01768572|521208288|FG000|Overall Study|Lack of Efficacy|1|||
144548258|NCT01768572|521208289|FG001|Overall Study|Lack of Efficacy|3|||
144548259|NCT01768572|521208290|FG002|Overall Study|Lack of Efficacy|1|||
144548260|NCT01768572|521208288|FG000|Overall Study|Other, Not due to an adverse event|1|||
144548261|NCT01768572|521208289|FG001|Overall Study|Other, Not due to an adverse event|1|||
144548262|NCT01768572|521208290|FG002|Overall Study|Other, Not due to an adverse event|1|||
144548263|NCT04766996|521208293|FG000|Overall Study|Withdrawal by Subject|1|||
144548264|NCT04766996|521208294|FG001|Overall Study|Withdrawal by Subject|0|||
144548265|NCT04766996|521208295|FG002|Overall Study|Withdrawal by Subject|13|||
144548266|NCT02404441|521208299|FG000|Phase 1 Part|Adverse Event|1|||
144548267|NCT02404441|521208300|FG001|Phase 1 Part|Adverse Event|0|||
144548268|NCT02404441|521208301|FG002|Phase 1 Part|Adverse Event|0|||
144548269|NCT02404441|521208302|FG003|Phase 1 Part|Adverse Event|0|||
144548270|NCT02404441|521208303|FG004|Phase 1 Part|Adverse Event|0|||
144548271|NCT02404441|521208304|FG005|Phase 1 Part|Adverse Event|0|||
144548272|NCT02404441|521208305|FG006|Phase 1 Part|Adverse Event|0|||
144548273|NCT02404441|521208306|FG007|Phase 1 Part|Adverse Event|0|||
144548274|NCT02404441|521208307|FG008|Phase 1 Part|Adverse Event|0|||
144548275|NCT02404441|521208308|FG009|Phase 1 Part|Adverse Event|0|||
144548276|NCT02404441|521208299|FG000|Phase 1 Part|Physician Decision|0|||
144548277|NCT02404441|521208300|FG001|Phase 1 Part|Physician Decision|1|||
144548278|NCT02404441|521208301|FG002|Phase 1 Part|Physician Decision|0|||
144548279|NCT02404441|521208302|FG003|Phase 1 Part|Physician Decision|0|||
144203016|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203017|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
144727576|NCT02101853|521856651|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
144727577|NCT02101853|521856652|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
144727578|NCT02101853|521856653|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
144727579|NCT02101853|521856654|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
144727580|NCT02101853|521856655|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
144727581|NCT02101853|521856656|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
144727582|NCT00860028|521856657|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
144727583|NCT00860028|521856658|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
144727584|NCT00936390|521856659|FG000|Overall Study|Protocol Violation|21|||
144727585|NCT00936390|521856660|FG001|Overall Study|Protocol Violation|25|||
144727586|NCT02514174|521856664|FG000|Overall Study|Patient refused to continue medication|1|||
144727587|NCT02514174|521856664|FG000|Overall Study|Adverse Event|2|||
144727588|NCT02514174|521856664|FG000|Overall Study|Study closed by sponsor|9|||
144727589|NCT02514174|521856664|FG000|Overall Study|Progressive disease|11|||
144727590|NCT02514174|521856664|FG000|Overall Study|Treatment change|1|||
144727591|NCT02514174|521856664|FG000|Overall Study|Treated off study with Afatinib.|1|||
144727592|NCT02130466|521856665|FG000|Overall Study|Death|4|||
144727593|NCT02130466|521856666|FG001|Overall Study|Death|1|||
144727594|NCT02130466|521856667|FG002|Overall Study|Death|1|||
144727595|NCT02130466|521856668|FG003|Overall Study|Death|3|||
144727596|NCT02130466|521856669|FG004|Overall Study|Death|2|||
144727597|NCT02130466|521856670|FG005|Overall Study|Death|30|||
144727598|NCT02130466|521856671|FG006|Overall Study|Death|45|||
144727599|NCT02130466|521856672|FG007|Overall Study|Death|2|||
144727600|NCT02130466|521856673|FG008|Overall Study|Death|3|||
144727601|NCT02130466|521856674|FG009|Overall Study|Death|4|||
144548280|NCT02404441|521208303|FG004|Phase 1 Part|Physician Decision|0|||
144548281|NCT02404441|521208304|FG005|Phase 1 Part|Physician Decision|0|||
144548282|NCT02404441|521208305|FG006|Phase 1 Part|Physician Decision|0|||
144548283|NCT02404441|521208306|FG007|Phase 1 Part|Physician Decision|0|||
144548284|NCT02404441|521208307|FG008|Phase 1 Part|Physician Decision|0|||
144548285|NCT02404441|521208308|FG009|Phase 1 Part|Physician Decision|0|||
144548286|NCT02404441|521208299|FG000|Phase 1 Part|Progressive Disease|14|||
144548287|NCT02404441|521208300|FG001|Phase 1 Part|Progressive Disease|11|||
144548288|NCT02404441|521208301|FG002|Phase 1 Part|Progressive Disease|7|||
144548289|NCT02404441|521208302|FG003|Phase 1 Part|Progressive Disease|6|||
144548290|NCT02404441|521208303|FG004|Phase 1 Part|Progressive Disease|9|||
144548291|NCT02404441|521208304|FG005|Phase 1 Part|Progressive Disease|0|||
144548292|NCT02404441|521208305|FG006|Phase 1 Part|Progressive Disease|0|||
144548293|NCT02404441|521208306|FG007|Phase 1 Part|Progressive Disease|0|||
144548294|NCT02404441|521208307|FG008|Phase 1 Part|Progressive Disease|0|||
144548295|NCT02404441|521208308|FG009|Phase 1 Part|Progressive Disease|0|||
144548296|NCT02404441|521208299|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
144548297|NCT02404441|521208300|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
144548298|NCT02404441|521208301|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
144548299|NCT02404441|521208302|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
144548300|NCT02404441|521208303|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
144548301|NCT02404441|521208304|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
144548302|NCT02404441|521208305|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
144548303|NCT02404441|521208306|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
144548304|NCT02404441|521208307|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
144727602|NCT02130466|521856675|FG010|Overall Study|Death|5|||
144727603|NCT02130466|521856676|FG011|Overall Study|Death|3|||
144727604|NCT02130466|521856677|FG012|Overall Study|Death|11|||
144727605|NCT02130466|521856678|FG013|Overall Study|Death|7|||
144727606|NCT02130466|521856665|FG000|Overall Study|Lost to Follow-up|1|||
144727607|NCT02130466|521856666|FG001|Overall Study|Lost to Follow-up|0|||
144727608|NCT02130466|521856667|FG002|Overall Study|Lost to Follow-up|0|||
144727609|NCT02130466|521856668|FG003|Overall Study|Lost to Follow-up|0|||
144727610|NCT02130466|521856669|FG004|Overall Study|Lost to Follow-up|0|||
144727611|NCT02130466|521856670|FG005|Overall Study|Lost to Follow-up|1|||
144727612|NCT02130466|521856671|FG006|Overall Study|Lost to Follow-up|0|||
144727613|NCT02130466|521856672|FG007|Overall Study|Lost to Follow-up|0|||
144727614|NCT02130466|521856673|FG008|Overall Study|Lost to Follow-up|0|||
144727615|NCT02130466|521856674|FG009|Overall Study|Lost to Follow-up|0|||
144727616|NCT02130466|521856675|FG010|Overall Study|Lost to Follow-up|0|||
144727617|NCT02130466|521856676|FG011|Overall Study|Lost to Follow-up|0|||
144727618|NCT02130466|521856677|FG012|Overall Study|Lost to Follow-up|1|||
144727619|NCT02130466|521856678|FG013|Overall Study|Lost to Follow-up|0|||
144727620|NCT02130466|521856665|FG000|Overall Study|Physician Decision|0|||
144727621|NCT02130466|521856666|FG001|Overall Study|Physician Decision|0|||
144548305|NCT02404441|521208308|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
144548306|NCT02404441|521208299|FG000|Phase 1 Part|Death|1|||
144548307|NCT02404441|521208300|FG001|Phase 1 Part|Death|1|||
144548308|NCT02404441|521208301|FG002|Phase 1 Part|Death|1|||
144548309|NCT02404441|521208302|FG003|Phase 1 Part|Death|0|||
144548310|NCT02404441|521208303|FG004|Phase 1 Part|Death|1|||
144727622|NCT02130466|521856667|FG002|Overall Study|Physician Decision|0|||
144727623|NCT02130466|521856668|FG003|Overall Study|Physician Decision|0|||
144203018|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203019|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203020|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203021|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203022|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203023|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
144548311|NCT02404441|521208304|FG005|Phase 1 Part|Death|0|||
144548312|NCT02404441|521208305|FG006|Phase 1 Part|Death|0|||
144548313|NCT02404441|521208306|FG007|Phase 1 Part|Death|0|||
144548314|NCT02404441|521208307|FG008|Phase 1 Part|Death|0|||
144548315|NCT02404441|521208308|FG009|Phase 1 Part|Death|0|||
144548316|NCT02404441|521208299|FG000|Phase 2 Part|Adverse Event|0|||
144548317|NCT02404441|521208300|FG001|Phase 2 Part|Adverse Event|0|||
144548318|NCT02404441|521208301|FG002|Phase 2 Part|Adverse Event|0|||
144548319|NCT02404441|521208302|FG003|Phase 2 Part|Adverse Event|0|||
144548320|NCT02404441|521208303|FG004|Phase 2 Part|Adverse Event|0|||
144548321|NCT02404441|521208304|FG005|Phase 2 Part|Adverse Event|2|||
144548322|NCT02404441|521208305|FG006|Phase 2 Part|Adverse Event|3|||
144548323|NCT02404441|521208306|FG007|Phase 2 Part|Adverse Event|3|||
144548324|NCT02404441|521208307|FG008|Phase 2 Part|Adverse Event|6|||
144548325|NCT02404441|521208308|FG009|Phase 2 Part|Adverse Event|1|||
144548326|NCT02404441|521208299|FG000|Phase 2 Part|Physician Decision|0|||
144548327|NCT02404441|521208300|FG001|Phase 2 Part|Physician Decision|0|||
144548328|NCT02404441|521208301|FG002|Phase 2 Part|Physician Decision|0|||
144548329|NCT02404441|521208302|FG003|Phase 2 Part|Physician Decision|0|||
144548330|NCT02404441|521208303|FG004|Phase 2 Part|Physician Decision|0|||
144548331|NCT02404441|521208304|FG005|Phase 2 Part|Physician Decision|7|||
144548332|NCT02404441|521208305|FG006|Phase 2 Part|Physician Decision|9|||
144548333|NCT02404441|521208306|FG007|Phase 2 Part|Physician Decision|2|||
144548334|NCT02404441|521208307|FG008|Phase 2 Part|Physician Decision|1|||
144548335|NCT02404441|521208308|FG009|Phase 2 Part|Physician Decision|3|||
144548336|NCT02404441|521208299|FG000|Phase 2 Part|Progressive disease|0|||
144548337|NCT02404441|521208300|FG001|Phase 2 Part|Progressive disease|0|||
144548338|NCT02404441|521208301|FG002|Phase 2 Part|Progressive disease|0|||
144548339|NCT02404441|521208302|FG003|Phase 2 Part|Progressive disease|0|||
144548340|NCT02404441|521208303|FG004|Phase 2 Part|Progressive disease|0|||
144548341|NCT02404441|521208304|FG005|Phase 2 Part|Progressive disease|43|||
144548342|NCT02404441|521208305|FG006|Phase 2 Part|Progressive disease|32|||
144548343|NCT02404441|521208306|FG007|Phase 2 Part|Progressive disease|31|||
144548344|NCT02404441|521208307|FG008|Phase 2 Part|Progressive disease|39|||
144548345|NCT02404441|521208308|FG009|Phase 2 Part|Progressive disease|27|||
144548346|NCT02404441|521208299|FG000|Phase 2 Part|Subject/guardian decision|0|||
144548347|NCT02404441|521208300|FG001|Phase 2 Part|Subject/guardian decision|0|||
144548348|NCT02404441|521208301|FG002|Phase 2 Part|Subject/guardian decision|0|||
144548349|NCT02404441|521208302|FG003|Phase 2 Part|Subject/guardian decision|0|||
144548350|NCT02404441|521208303|FG004|Phase 2 Part|Subject/guardian decision|0|||
144548351|NCT02404441|521208304|FG005|Phase 2 Part|Subject/guardian decision|3|||
144548352|NCT02404441|521208305|FG006|Phase 2 Part|Subject/guardian decision|9|||
144548353|NCT02404441|521208306|FG007|Phase 2 Part|Subject/guardian decision|0|||
144548354|NCT02404441|521208307|FG008|Phase 2 Part|Subject/guardian decision|3|||
144548355|NCT02404441|521208308|FG009|Phase 2 Part|Subject/guardian decision|2|||
144548356|NCT02404441|521208299|FG000|Phase 2 Part|Death|0|||
144548357|NCT02404441|521208300|FG001|Phase 2 Part|Death|0|||
144548358|NCT02404441|521208301|FG002|Phase 2 Part|Death|0|||
144548359|NCT02404441|521208302|FG003|Phase 2 Part|Death|0|||
144548360|NCT02404441|521208303|FG004|Phase 2 Part|Death|0|||
144548361|NCT02404441|521208304|FG005|Phase 2 Part|Death|4|||
144548362|NCT02404441|521208305|FG006|Phase 2 Part|Death|8|||
144616585|NCT00267748|521456364|FG002|Randomized Period|Death|3|||
144203024|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203025|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
144548363|NCT02404441|521208306|FG007|Phase 2 Part|Death|4|||
144548364|NCT02404441|521208307|FG008|Phase 2 Part|Death|10|||
144548365|NCT02404441|521208308|FG009|Phase 2 Part|Death|9|||
144548366|NCT03265132|521208309|FG000|Overall Study|Adverse Event|0|||
144203026|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203027|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
144548367|NCT03265132|521208310|FG001|Overall Study|Adverse Event|1|||
144548368|NCT03265132|521208309|FG000|Overall Study|Lack of Efficacy|0|||
144548369|NCT03265132|521208310|FG001|Overall Study|Lack of Efficacy|2|||
144548370|NCT03265132|521208309|FG000|Overall Study|Progressive disease|0|||
144548371|NCT03265132|521208310|FG001|Overall Study|Progressive disease|2|||
144548372|NCT03265132|521208309|FG000|Overall Study|Withdrawal by Subject|0|||
144548373|NCT03265132|521208310|FG001|Overall Study|Withdrawal by Subject|1|||
144548374|NCT01976507|521208314|FG000|Overall Study|Adverse Event|6|||
144548375|NCT01976507|521208314|FG000|Overall Study|ablation not done, drug not given|1|||
144548376|NCT01794299|521208316|FG000|Overall Study|ATIR manufacturing not possible|1|||
144548377|NCT01794299|521208316|FG000|Overall Study|Death|14|||
144548378|NCT01794299|521208316|FG000|Overall Study|Graft failure|1|||
144548379|NCT01794299|521208316|FG000|Overall Study|ATIR batch rejected|2|||
144548380|NCT01794299|521208316|FG000|Overall Study|Relapse|2|||
144548381|NCT01794299|521208316|FG000|Overall Study|Discontinued from active follow-up|1|||
144203028|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203029|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
144203030|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
144203031|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203032|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203033|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
144203034|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144548382|NCT01794299|521208316|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
144548383|NCT03006393|521208317|FG000|Overall Study|Withdrawal by Subject|1|||
144548384|NCT03006393|521208318|FG001|Overall Study|Withdrawal by Subject|1|||
144548385|NCT03006393|521208317|FG000|Overall Study|Pregnancy|0|||
144548386|NCT03006393|521208318|FG001|Overall Study|Pregnancy|1|||
144548387|NCT03006393|521208317|FG000|Overall Study|Lost to Follow-up|0|||
144548388|NCT03006393|521208318|FG001|Overall Study|Lost to Follow-up|1|||
144548389|NCT02161458|521208319|FG000|Overall Study|Withdrawal by Subject|0|||
144548390|NCT02161458|521208320|FG001|Overall Study|Withdrawal by Subject|4|||
144548391|NCT02161458|521208321|FG002|Overall Study|Withdrawal by Subject|4|||
144548392|NCT02161458|521208322|FG003|Overall Study|Withdrawal by Subject|0|||
144548393|NCT02161458|521208319|FG000|Overall Study|Lost to Follow-up|0|||
144548394|NCT02161458|521208320|FG001|Overall Study|Lost to Follow-up|2|||
144548395|NCT02161458|521208321|FG002|Overall Study|Lost to Follow-up|1|||
144548396|NCT02161458|521208322|FG003|Overall Study|Lost to Follow-up|0|||
144548397|NCT03136861|521208326|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
144548398|NCT03136861|521208327|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
144548399|NCT03136861|521208328|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
144548400|NCT03136861|521208329|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
144548401|NCT03136861|521208330|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
144548402|NCT03136861|521208331|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
144548403|NCT03136861|521208332|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
144548404|NCT03136861|521208326|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
144548405|NCT03136861|521208327|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
144548406|NCT03136861|521208328|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
144548407|NCT03136861|521208329|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
144548408|NCT03136861|521208330|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
144548409|NCT03136861|521208331|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
144727624|NCT02130466|521856669|FG004|Overall Study|Physician Decision|0|||
144262347|NCT05219968|520159881|FG001|Week 24 Treatment Period|Adverse Event|0|||
144548410|NCT03136861|521208332|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
144548411|NCT03136861|521208326|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
144548412|NCT03136861|521208327|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
144548413|NCT03136861|521208328|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
144548414|NCT03136861|521208329|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
144548415|NCT03136861|521208330|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
144548416|NCT03136861|521208331|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
144548417|NCT03136861|521208332|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
144548418|NCT03136861|521208326|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
144548419|NCT03136861|521208327|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
144548420|NCT03136861|521208328|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
144548421|NCT03136861|521208329|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
144548422|NCT03136861|521208330|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
144548423|NCT03136861|521208331|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
144548424|NCT03136861|521208332|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
144548425|NCT03136861|521208326|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
144548426|NCT03136861|521208327|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
144548427|NCT03136861|521208328|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
144548428|NCT03136861|521208329|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
144548429|NCT03136861|521208330|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
144548430|NCT03136861|521208331|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
144548431|NCT03136861|521208332|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
144548432|NCT03136861|521208326|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
144548433|NCT03136861|521208327|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
144548434|NCT03136861|521208328|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
144548435|NCT03136861|521208329|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
144548436|NCT03136861|521208330|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
144727625|NCT02130466|521856670|FG005|Overall Study|Physician Decision|1|||
144548437|NCT03136861|521208331|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
144548438|NCT03136861|521208332|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
144548439|NCT03136861|521208326|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
144548440|NCT03136861|521208327|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
144548441|NCT03136861|521208328|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
144548442|NCT03136861|521208329|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
144548443|NCT03136861|521208330|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
144548444|NCT03136861|521208331|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
144548445|NCT03136861|521208332|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
144548446|NCT03136861|521208326|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
144548447|NCT03136861|521208327|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
144548448|NCT03136861|521208328|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
144548449|NCT03136861|521208329|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
144548450|NCT03136861|521208330|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
144548451|NCT03136861|521208331|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
144548452|NCT03136861|521208332|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
144548453|NCT03390166|521208333|FG000|Overall Study|Death|0|||
144548454|NCT03390166|521208334|FG001|Overall Study|Death|1|||
144548455|NCT03390166|521208333|FG000|Overall Study|Lost to Follow-up|6|||
144548456|NCT03390166|521208334|FG001|Overall Study|Lost to Follow-up|4|||
144548457|NCT03390166|521208333|FG000|Overall Study|Physician Decision|2|||
144548458|NCT03390166|521208334|FG001|Overall Study|Physician Decision|1|||
144548459|NCT03390166|521208333|FG000|Overall Study|Move from study area|3|||
144548460|NCT03390166|521208334|FG001|Overall Study|Move from study area|2|||
144548461|NCT03390166|521208333|FG000|Overall Study|To militarycamp for conscript|1|||
144548462|NCT03390166|521208334|FG001|Overall Study|To militarycamp for conscript|0|||
144548463|NCT03390166|521208333|FG000|Overall Study|To drug therapy course|0|||
144548464|NCT03390166|521208334|FG001|Overall Study|To drug therapy course|1|||
144548465|NCT03390166|521208333|FG000|Overall Study|Move to work oversea|0|||
144548466|NCT03390166|521208334|FG001|Overall Study|Move to work oversea|1|||
144548467|NCT01328756|521208338|FG000|Overall Study|Protocol Violation|4|||
144548468|NCT01328756|521208338|FG000|Overall Study|Adverse Event|39|||
144548469|NCT01328756|521208338|FG000|Overall Study|Lack of Efficacy|5|||
144548470|NCT01328756|521208338|FG000|Overall Study|Withdrawal by Subject|41|||
144548471|NCT01328756|521208338|FG000|Overall Study|Lost to Follow-up|5|||
144548472|NCT01328756|521208338|FG000|Overall Study|Other|29|||
144548473|NCT01262456|521208341|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
144548474|NCT01262456|521208342|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
144548475|NCT01262456|521208343|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
144548476|NCT01262456|521208341|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
144548477|NCT01262456|521208342|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
144548478|NCT01262456|521208343|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
144548479|NCT01262456|521208341|FG000|3-Month Double-Blind Period|Adverse Event|6|||
144548480|NCT01262456|521208342|FG001|3-Month Double-Blind Period|Adverse Event|4|||
144548481|NCT01262456|521208343|FG002|3-Month Double-Blind Period|Adverse Event|8|||
144548482|NCT01262456|521208341|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
144548483|NCT01262456|521208342|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
144548484|NCT01262456|521208343|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
144548485|NCT01262456|521208341|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
144548486|NCT01262456|521208342|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
144548487|NCT01262456|521208343|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
144548488|NCT01262456|521208341|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
144548489|NCT01262456|521208342|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
144548490|NCT01262456|521208343|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
144548491|NCT01262456|521208341|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
144548492|NCT01262456|521208342|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
144548493|NCT01262456|521208343|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
144548494|NCT01262456|521208341|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
144548495|NCT01262456|521208342|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
144548496|NCT01262456|521208343|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
144548497|NCT01262456|521208341|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
144548498|NCT01262456|521208342|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
144548499|NCT01262456|521208343|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
144548500|NCT01316913|521208346|FG000|Overall Study|Adverse Event|17|||
144548501|NCT01316913|521208347|FG001|Overall Study|Adverse Event|20|||
144548502|NCT01316913|521208348|FG002|Overall Study|Adverse Event|15|||
144548503|NCT01316913|521208349|FG003|Overall Study|Adverse Event|11|||
144203035|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203036|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144548504|NCT01316913|521208346|FG000|Overall Study|Lack of Efficacy|22|||
144548505|NCT01316913|521208347|FG001|Overall Study|Lack of Efficacy|12|||
144548506|NCT01316913|521208348|FG002|Overall Study|Lack of Efficacy|9|||
144548507|NCT01316913|521208349|FG003|Overall Study|Lack of Efficacy|13|||
144548508|NCT01316913|521208346|FG000|Overall Study|Protocol Violation|1|||
144548509|NCT01316913|521208347|FG001|Overall Study|Protocol Violation|4|||
144548510|NCT01316913|521208348|FG002|Overall Study|Protocol Violation|4|||
144548511|NCT01316913|521208349|FG003|Overall Study|Protocol Violation|1|||
144548512|NCT01316913|521208346|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
144548513|NCT01316913|521208347|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
144548514|NCT01316913|521208348|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
144548515|NCT01316913|521208349|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
144548516|NCT01316913|521208346|FG000|Overall Study|Lost to Follow-up|0|||
144548517|NCT01316913|521208347|FG001|Overall Study|Lost to Follow-up|1|||
144548518|NCT01316913|521208348|FG002|Overall Study|Lost to Follow-up|0|||
144548519|NCT01316913|521208349|FG003|Overall Study|Lost to Follow-up|2|||
144548520|NCT01316913|521208346|FG000|Overall Study|Withdrawal by Subject|10|||
144548521|NCT01316913|521208347|FG001|Overall Study|Withdrawal by Subject|9|||
144548522|NCT01316913|521208348|FG002|Overall Study|Withdrawal by Subject|10|||
144548523|NCT01316913|521208349|FG003|Overall Study|Withdrawal by Subject|6|||
144548524|NCT05445557|521208350|FG000|Double Blind Part|Lost to Follow-up|1|||
144548525|NCT01323790|521208351|FG000|Overall Study|Other|3|||
144548526|NCT01323790|521208352|FG001|Overall Study|Other|2|||
144548527|NCT01323790|521208353|FG002|Overall Study|Other|1|||
144548528|NCT01323790|521208351|FG000|Overall Study|Lost to Follow-up|11|||
144548529|NCT01323790|521208352|FG001|Overall Study|Lost to Follow-up|9|||
144548530|NCT01323790|521208353|FG002|Overall Study|Lost to Follow-up|9|||
144548531|NCT01323790|521208351|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
144548532|NCT01323790|521208352|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
144548533|NCT01323790|521208353|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
144548534|NCT01323790|521208351|FG000|Overall Study|Lack of Efficacy|3|||
144548535|NCT01323790|521208352|FG001|Overall Study|Lack of Efficacy|0|||
144548536|NCT01323790|521208353|FG002|Overall Study|Lack of Efficacy|3|||
144548537|NCT01323790|521208351|FG000|Overall Study|Adverse Event|11|||
144548538|NCT01323790|521208352|FG001|Overall Study|Adverse Event|24|||
144548539|NCT01323790|521208353|FG002|Overall Study|Adverse Event|12|||
144548540|NCT01323790|521208351|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144548541|NCT01323790|521208352|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144548542|NCT01323790|521208353|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
144548543|NCT01323790|521208351|FG000|Overall Study|Withdrawal by Subject|23|||
144548544|NCT01323790|521208352|FG001|Overall Study|Withdrawal by Subject|20|||
144548545|NCT01323790|521208353|FG002|Overall Study|Withdrawal by Subject|13|||
144548546|NCT01323790|521208351|FG000|Overall Study|Did Not Receive Treatment|2|||
144548547|NCT01323790|521208352|FG001|Overall Study|Did Not Receive Treatment|0|||
144548548|NCT01323790|521208353|FG002|Overall Study|Did Not Receive Treatment|1|||
144548549|NCT01323790|521208351|FG000|Overall Study|Severe non-compliance with protocol|2|||
144548550|NCT01323790|521208352|FG001|Overall Study|Severe non-compliance with protocol|2|||
144548551|NCT01323790|521208353|FG002|Overall Study|Severe non-compliance with protocol|2|||
144548552|NCT02915783|521208354|FG000|Overall Study|Death|21|||
144548553|NCT02915783|521208354|FG000|Overall Study|Lost to Follow-up|1|||
144548554|NCT02915783|521208354|FG000|Overall Study|Withdrawal by Subject|2|||
144548555|NCT02950961|521208355|FG000|Overall Study|Study had to stop due to COVID.|7|||
144548556|NCT03055988|521208356|FG000|Period 1|Adverse Event|0|||
144548557|NCT03055988|521208357|FG001|Period 1|Adverse Event|1|||
144548558|NCT03055988|521208356|FG000|Period 1|Lost to Follow-up|1|||
144548559|NCT03055988|521208357|FG001|Period 1|Lost to Follow-up|0|||
144548560|NCT03055988|521208356|FG000|Period 1|Withdrawal by Subject|0|||
144548561|NCT03055988|521208357|FG001|Period 1|Withdrawal by Subject|4|||
144548562|NCT03055988|521208356|FG000|Period 2|Adverse Event|0|||
144548563|NCT03055988|521208357|FG001|Period 2|Adverse Event|1|||
144548564|NCT03055988|521208356|FG000|Period 2|Other than listed|1|||
144548565|NCT03055988|521208357|FG001|Period 2|Other than listed|1|||
144548566|NCT00428714|521208359|FG000|Overall Study|Progressive Disease|28|||
144548567|NCT00428714|521208360|FG001|Overall Study|Progressive Disease|36|||
144548568|NCT00428714|521208359|FG000|Overall Study|Withdrawal by Subject|0|||
144548569|NCT00428714|521208360|FG001|Overall Study|Withdrawal by Subject|3|||
144548570|NCT00428714|521208359|FG000|Overall Study|Adverse Event|0|||
144548571|NCT00428714|521208360|FG001|Overall Study|Adverse Event|2|||
144548572|NCT00428714|521208359|FG000|Overall Study|Physician Decision|1|||
144548573|NCT00428714|521208360|FG001|Overall Study|Physician Decision|1|||
144548574|NCT00428714|521208359|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
144548575|NCT00428714|521208360|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
144548576|NCT00428714|521208359|FG000|Overall Study|Death due to other then PD|1|||
144548577|NCT00428714|521208360|FG001|Overall Study|Death due to other then PD|0|||
144548578|NCT02326220|521208365|FG000|Double-blind Treatment Period|Adverse Event|1|||
144548579|NCT02326220|521208366|FG001|Double-blind Treatment Period|Adverse Event|2|||
144548580|NCT02326220|521208367|FG002|Double-blind Treatment Period|Adverse Event|0|||
144548581|NCT02326220|521208365|FG000|Double-blind Treatment Period|Protocol Violation|0|||
144548582|NCT02326220|521208366|FG001|Double-blind Treatment Period|Protocol Violation|1|||
144548583|NCT02326220|521208367|FG002|Double-blind Treatment Period|Protocol Violation|0|||
144548584|NCT02326220|521208365|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
144548585|NCT02326220|521208366|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
144548586|NCT02326220|521208367|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144548587|NCT02326220|521208365|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
144548588|NCT02326220|521208366|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
144548589|NCT02326220|521208367|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
144548590|NCT02326220|521208365|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
144548591|NCT02326220|521208366|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
144548592|NCT02326220|521208367|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
144548593|NCT02114515|521208369|FG000|Overall Study|Lost to Follow-up|52|||
144548594|NCT02114515|521208370|FG001|Overall Study|Lost to Follow-up|55|||
144548595|NCT02114515|521208369|FG000|Overall Study|Death|12|||
144548596|NCT02114515|521208370|FG001|Overall Study|Death|12|||
144548597|NCT02114515|521208369|FG000|Overall Study|Withdrawal by Subject|4|||
144548598|NCT02114515|521208370|FG001|Overall Study|Withdrawal by Subject|22|||
144548599|NCT02114515|521208369|FG000|Overall Study|Other|65|||
144548600|NCT02114515|521208370|FG001|Overall Study|Other|61|||
144548601|NCT02699099|521208371|FG000|Overall Study|Adverse Event|1|||
144548602|NCT02699099|521208372|FG001|Overall Study|Adverse Event|0|||
144548603|NCT02699099|521208373|FG002|Overall Study|Adverse Event|2|||
144548604|NCT02699099|521208371|FG000|Overall Study|Lost to Follow-up|0|||
144548605|NCT02699099|521208372|FG001|Overall Study|Lost to Follow-up|1|||
144548606|NCT02699099|521208373|FG002|Overall Study|Lost to Follow-up|0|||
144548607|NCT02699099|521208371|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
144548608|NCT02699099|521208372|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
144548609|NCT02699099|521208373|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
144548610|NCT02659540|521208374|FG000|Overall Study|Adverse Event|3|||
144548611|NCT02659540|521208375|FG001|Overall Study|Adverse Event|2|||
144548612|NCT02659540|521208374|FG000|Overall Study|Death|1|||
144548613|NCT02659540|521208375|FG001|Overall Study|Death|0|||
144548614|NCT02659540|521208374|FG000|Overall Study|Progressive disease|2|||
144548615|NCT02659540|521208375|FG001|Overall Study|Progressive disease|6|||
144548616|NCT02489799|521209395|FG000|Overall Study|Lost to Follow-up|4|||
144548617|NCT02489799|521209396|FG001|Overall Study|Lost to Follow-up|1|||
144548618|NCT02489799|521209395|FG000|Overall Study|Failure to Maintain Eligibility|4|||
144548619|NCT02489799|521209396|FG001|Overall Study|Failure to Maintain Eligibility|6|||
144548620|NCT02489799|521209395|FG000|Overall Study|Withdrawal by Subject|1|||
144548621|NCT02489799|521209396|FG001|Overall Study|Withdrawal by Subject|1|||
144548622|NCT02489799|521209395|FG000|Overall Study|Death|0|||
144548623|NCT02489799|521209396|FG001|Overall Study|Death|1|||
144548624|NCT01655498|521209399|FG000|Overall Study|Unrelated health issue|2|||
144548625|NCT01655498|521209399|FG000|Overall Study|Protocol Violation|2|||
144548626|NCT01655498|521209399|FG000|Overall Study|Withdrawal by Subject|1|||
144548627|NCT01072149|521209402|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548628|NCT01072149|521209403|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548629|NCT01072149|521209404|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
144727626|NCT02130466|521856671|FG006|Overall Study|Physician Decision|1|||
144727627|NCT02130466|521856672|FG007|Overall Study|Physician Decision|0|||
144727628|NCT02130466|521856673|FG008|Overall Study|Physician Decision|0|||
144727629|NCT02130466|521856674|FG009|Overall Study|Physician Decision|0|||
144548630|NCT01072149|521209405|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548631|NCT01072149|521209406|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548632|NCT01072149|521209407|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548633|NCT01072149|521209408|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548634|NCT01072149|521209409|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144727630|NCT02130466|521856675|FG010|Overall Study|Physician Decision|0|||
144548635|NCT01072149|521209410|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548636|NCT01072149|521209411|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548637|NCT01072149|521209412|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144727631|NCT02130466|521856676|FG011|Overall Study|Physician Decision|0|||
144727632|NCT02130466|521856677|FG012|Overall Study|Physician Decision|0|||
144727633|NCT02130466|521856678|FG013|Overall Study|Physician Decision|0|||
144548638|NCT01072149|521209413|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144727634|NCT02130466|521856665|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
144548639|NCT01072149|521209414|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548640|NCT01072149|521209415|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548641|NCT01072149|521209416|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548642|NCT01072149|521209417|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548643|NCT01072149|521209418|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144548644|NCT01072149|521209419|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144203037|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203038|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203039|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203040|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203041|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203042|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203043|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203044|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144548645|NCT01072149|521209402|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548646|NCT01072149|521209403|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548647|NCT01072149|521209404|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548648|NCT01072149|521209405|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548649|NCT01072149|521209406|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548650|NCT01072149|521209407|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548651|NCT01072149|521209408|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548652|NCT01072149|521209409|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548653|NCT01072149|521209410|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548654|NCT01072149|521209411|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548655|NCT01072149|521209412|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548656|NCT01072149|521209413|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548657|NCT01072149|521209414|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548658|NCT01072149|521209415|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548659|NCT01072149|521209416|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548660|NCT01072149|521209417|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548661|NCT01072149|521209418|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
144548662|NCT01072149|521209419|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
144548663|NCT01072149|521209402|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548664|NCT01072149|521209403|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548665|NCT01072149|521209404|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548666|NCT01072149|521209405|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548667|NCT01072149|521209406|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548668|NCT01072149|521209407|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548669|NCT01072149|521209408|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548670|NCT01072149|521209409|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548671|NCT01072149|521209410|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548672|NCT01072149|521209411|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548673|NCT01072149|521209412|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
144548674|NCT01072149|521209413|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548675|NCT01072149|521209414|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548676|NCT01072149|521209415|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548677|NCT01072149|521209416|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548678|NCT01072149|521209417|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548679|NCT01072149|521209418|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548680|NCT01072149|521209419|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
144548681|NCT01072149|521209402|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548682|NCT01072149|521209403|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
144548683|NCT01072149|521209404|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548684|NCT01072149|521209405|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548685|NCT01072149|521209406|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548686|NCT01072149|521209407|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548687|NCT01072149|521209408|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548688|NCT01072149|521209409|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548689|NCT01072149|521209410|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548690|NCT01072149|521209411|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548691|NCT01072149|521209412|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548692|NCT01072149|521209413|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548693|NCT01072149|521209414|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548694|NCT01072149|521209415|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548695|NCT01072149|521209416|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548696|NCT01072149|521209417|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548697|NCT01072149|521209418|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548698|NCT01072149|521209419|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
144548699|NCT01072149|521209402|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548700|NCT01072149|521209403|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548701|NCT01072149|521209404|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
144548702|NCT01072149|521209405|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548703|NCT01072149|521209406|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144203045|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203046|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203047|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203048|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203049|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203050|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203051|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203052|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203053|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203054|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
144203055|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203056|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203057|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144203058|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
144548704|NCT01072149|521209407|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548705|NCT01072149|521209408|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548706|NCT01072149|521209409|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548707|NCT01072149|521209410|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548708|NCT01072149|521209411|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548709|NCT01072149|521209412|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548710|NCT01072149|521209413|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548711|NCT01072149|521209414|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548712|NCT01072149|521209415|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548713|NCT01072149|521209416|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548714|NCT01072149|521209417|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548715|NCT01072149|521209418|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548716|NCT01072149|521209419|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
144548717|NCT01072149|521209402|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548718|NCT01072149|521209403|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548719|NCT01072149|521209404|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548720|NCT01072149|521209405|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548721|NCT01072149|521209406|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548722|NCT01072149|521209407|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548723|NCT01072149|521209408|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548724|NCT01072149|521209409|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
144548725|NCT01072149|521209410|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548726|NCT01072149|521209411|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548727|NCT01072149|521209412|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548728|NCT01072149|521209413|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548729|NCT01072149|521209414|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548730|NCT01072149|521209415|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548731|NCT01072149|521209416|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548732|NCT01072149|521209417|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548733|NCT01072149|521209418|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548734|NCT01072149|521209419|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
144548735|NCT01072149|521209402|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
144548736|NCT01072149|521209403|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
144548737|NCT01072149|521209404|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
144548738|NCT01072149|521209405|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
144548739|NCT01072149|521209406|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
144548740|NCT01072149|521209407|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
144548741|NCT01072149|521209408|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
144548742|NCT01072149|521209409|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
144548743|NCT01072149|521209410|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
144548744|NCT01072149|521209411|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
144548745|NCT01072149|521209412|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
144548746|NCT01072149|521209413|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
144548747|NCT01072149|521209414|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
144548748|NCT01072149|521209415|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
144548749|NCT01072149|521209416|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
144548750|NCT01072149|521209417|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
144548751|NCT01072149|521209418|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
144548752|NCT01072149|521209419|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
144548753|NCT01072149|521209402|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548754|NCT01072149|521209403|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548755|NCT01072149|521209404|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548756|NCT01072149|521209405|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548757|NCT01072149|521209406|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548758|NCT01072149|521209407|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548759|NCT01072149|521209408|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548760|NCT01072149|521209409|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548761|NCT01072149|521209410|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548762|NCT01072149|521209411|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548763|NCT01072149|521209412|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548764|NCT01072149|521209413|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548765|NCT01072149|521209414|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548766|NCT01072149|521209415|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548767|NCT01072149|521209416|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548768|NCT01072149|521209417|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
144548769|NCT01072149|521209418|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548770|NCT01072149|521209419|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
144548771|NCT01072149|521209402|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
144548772|NCT01072149|521209403|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
144548773|NCT01072149|521209404|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
144548774|NCT01072149|521209405|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
144548775|NCT01072149|521209406|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
144548776|NCT01072149|521209407|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
144548777|NCT01072149|521209408|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
144548778|NCT01072149|521209409|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
144548779|NCT01072149|521209410|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
144548780|NCT01072149|521209411|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
144548781|NCT01072149|521209412|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
144548782|NCT01072149|521209413|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
144548783|NCT01072149|521209414|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
144548784|NCT01072149|521209415|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
144548785|NCT01072149|521209416|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
144548786|NCT01072149|521209417|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
144548787|NCT01072149|521209418|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
144548788|NCT01072149|521209419|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
144548789|NCT01072149|521209402|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548790|NCT01072149|521209403|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548791|NCT01072149|521209404|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548792|NCT01072149|521209405|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548793|NCT01072149|521209406|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144203059|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Adverse Event|0|||
144548794|NCT01072149|521209407|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548795|NCT01072149|521209408|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548796|NCT01072149|521209409|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548797|NCT01072149|521209410|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548798|NCT01072149|521209411|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548799|NCT01072149|521209412|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548800|NCT01072149|521209413|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548801|NCT01072149|521209414|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
144548802|NCT01072149|521209415|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548803|NCT01072149|521209416|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144203060|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Adverse Event|0|||
144203061|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Adverse Event|0|||
144203062|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Adverse Event|0|||
144203063|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Adverse Event|0|||
144203064|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Adverse Event|0|||
144203065|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Adverse Event|0|||
144203066|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Adverse Event|0|||
144203067|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Adverse Event|0|||
144203068|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Adverse Event|0|||
144203069|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Adverse Event|0|||
144203070|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Adverse Event|0|||
144548804|NCT01072149|521209417|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144616586|NCT00267748|521456362|FG000|Randomized Period|Adverse Event|0|||
144203071|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Adverse Event|0|||
144203072|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Adverse Event|0|||
144203073|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Adverse Event|0|||
144548805|NCT01072149|521209418|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548806|NCT01072149|521209419|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
144548807|NCT01072149|521209402|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144203074|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Adverse Event|0|||
144203075|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Adverse Event|0|||
144203076|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Adverse Event|0|||
144548808|NCT01072149|521209403|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548809|NCT01072149|521209404|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
144548810|NCT01072149|521209405|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548811|NCT01072149|521209406|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548812|NCT01072149|521209407|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548813|NCT01072149|521209408|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548814|NCT01072149|521209409|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548815|NCT01072149|521209410|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548816|NCT01072149|521209411|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548817|NCT01072149|521209412|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548818|NCT01072149|521209413|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548819|NCT01072149|521209414|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548820|NCT01072149|521209415|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
144548821|NCT01072149|521209416|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548822|NCT01072149|521209417|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548823|NCT01072149|521209418|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548824|NCT01072149|521209419|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
144548825|NCT00080119|521209420|FG000|Overall Study|Discontinued because of study closure|0|||
144548826|NCT00080119|521209421|FG001|Overall Study|Discontinued because of study closure|0|||
144548827|NCT00080119|521209422|FG002|Overall Study|Discontinued because of study closure|130|||
144548828|NCT00080119|521209423|FG003|Overall Study|Discontinued because of study closure|141|||
144548829|NCT00080119|521209420|FG000|Overall Study|Unable to get to clinic|24|||
144548830|NCT00080119|521209421|FG001|Overall Study|Unable to get to clinic|24|||
144548831|NCT00080119|521209422|FG002|Overall Study|Unable to get to clinic|7|||
144548832|NCT00080119|521209423|FG003|Overall Study|Unable to get to clinic|1|||
144548833|NCT00080119|521209420|FG000|Overall Study|Consent withdrawn|13|||
144548834|NCT00080119|521209421|FG001|Overall Study|Consent withdrawn|17|||
144548835|NCT00080119|521209422|FG002|Overall Study|Consent withdrawn|4|||
144548836|NCT00080119|521209423|FG003|Overall Study|Consent withdrawn|6|||
144548837|NCT00080119|521209420|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
144548838|NCT00080119|521209421|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
144548839|NCT00080119|521209422|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
144548840|NCT00080119|521209423|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
144548841|NCT00080119|521209420|FG000|Overall Study|Lost to Follow-up|16|||
144548842|NCT00080119|521209421|FG001|Overall Study|Lost to Follow-up|19|||
144548843|NCT00080119|521209422|FG002|Overall Study|Lost to Follow-up|19|||
144548844|NCT00080119|521209423|FG003|Overall Study|Lost to Follow-up|14|||
144548845|NCT01322386|521209424|FG000|Overall Study|Protocol Violation|0|||
144548846|NCT01322386|521209425|FG001|Overall Study|Protocol Violation|1|||
144548847|NCT01322386|521209424|FG000|Overall Study|Physician Decision|0|||
144548848|NCT01322386|521209425|FG001|Overall Study|Physician Decision|1|||
144548849|NCT00889863|521209430|FG000|Part I: Open Label|Death|1|||
144548850|NCT00889863|521209431|FG001|Part I: Open Label|Death|0|||
144548851|NCT00889863|521209430|FG000|Part I: Open Label|Adverse Event|4|||
144548852|NCT00889863|521209431|FG001|Part I: Open Label|Adverse Event|0|||
144548853|NCT00889863|521209430|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
144548854|NCT00889863|521209431|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
144548855|NCT00889863|521209430|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
144548856|NCT00889863|521209431|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
144548857|NCT00889863|521209430|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
144548858|NCT00889863|521209431|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
144548859|NCT00889863|521209430|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
144548860|NCT00889863|521209431|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
144548861|NCT00889863|521209430|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
144548862|NCT00889863|521209431|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
144548863|NCT02291861|521209433|FG000|Overall Study|Adverse Event|2|||
144548864|NCT02291861|521209434|FG001|Overall Study|Adverse Event|4|||
144548865|NCT02291861|521209435|FG002|Overall Study|Adverse Event|1|||
144548866|NCT02291861|521209436|FG003|Overall Study|Adverse Event|2|||
144548867|NCT02291861|521209433|FG000|Overall Study|Death|0|||
144548868|NCT02291861|521209434|FG001|Overall Study|Death|0|||
144548869|NCT02291861|521209435|FG002|Overall Study|Death|1|||
144548870|NCT02291861|521209436|FG003|Overall Study|Death|1|||
144548871|NCT02291861|521209433|FG000|Overall Study|Protocol Violation|1|||
144548872|NCT02291861|521209434|FG001|Overall Study|Protocol Violation|0|||
144203077|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Adverse Event|0|||
144548873|NCT02291861|521209435|FG002|Overall Study|Protocol Violation|0|||
144548874|NCT02291861|521209436|FG003|Overall Study|Protocol Violation|1|||
144548875|NCT02291861|521209433|FG000|Overall Study|Withdrawal by Subject|1|||
144203078|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Adverse Event|0|||
144203079|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Adverse Event|0|||
144203080|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Adverse Event|0|||
144203081|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Adverse Event|0|||
144203082|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Adverse Event|1|||
144203083|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Adverse Event|0|||
144203084|NCT02393248|519940245|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203085|NCT02393248|519940246|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203086|NCT02393248|519940247|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203087|NCT02393248|519940248|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203088|NCT02393248|519940249|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203089|NCT02393248|519940250|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203090|NCT02393248|519940251|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203091|NCT02393248|519940252|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203092|NCT02393248|519940253|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203093|NCT02393248|519940254|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203094|NCT02393248|519940255|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203095|NCT02393248|519940256|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203096|NCT02393248|519940257|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203097|NCT02393248|519940258|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203098|NCT02393248|519940259|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203099|NCT02393248|519940260|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203100|NCT02393248|519940261|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203101|NCT02393248|519940262|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203102|NCT02393248|519940263|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203103|NCT02393248|519940264|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144548876|NCT02291861|521209434|FG001|Overall Study|Withdrawal by Subject|2|||
144548877|NCT02291861|521209435|FG002|Overall Study|Withdrawal by Subject|1|||
144548878|NCT02291861|521209436|FG003|Overall Study|Withdrawal by Subject|4|||
144548879|NCT02291861|521209433|FG000|Overall Study|Noncompliance|1|||
144548880|NCT02291861|521209434|FG001|Overall Study|Noncompliance|1|||
144548881|NCT02291861|521209435|FG002|Overall Study|Noncompliance|2|||
144548882|NCT02291861|521209436|FG003|Overall Study|Noncompliance|1|||
144548883|NCT02291861|521209433|FG000|Overall Study|Lost to Follow-up|2|||
144548884|NCT02291861|521209434|FG001|Overall Study|Lost to Follow-up|1|||
144548885|NCT02291861|521209435|FG002|Overall Study|Lost to Follow-up|4|||
144548886|NCT02291861|521209436|FG003|Overall Study|Lost to Follow-up|0|||
144548887|NCT02291861|521209433|FG000|Overall Study|Other|0|||
144548888|NCT02291861|521209434|FG001|Overall Study|Other|0|||
144548889|NCT02291861|521209435|FG002|Overall Study|Other|0|||
144548890|NCT02291861|521209436|FG003|Overall Study|Other|1|||
144548891|NCT03547154|521209441|FG000|Overall Study|Disease Progression/Recurrence|6|||
144548892|NCT03547154|521209442|FG001|Overall Study|Disease Progression/Recurrence|14|||
144548893|NCT03547154|521209441|FG000|Overall Study|Adverse Event|26|||
144548894|NCT03547154|521209442|FG001|Overall Study|Adverse Event|31|||
144548895|NCT03547154|521209441|FG000|Overall Study|Protocol Violation|6|||
144548896|NCT03547154|521209442|FG001|Overall Study|Protocol Violation|1|||
144548897|NCT03547154|521209441|FG000|Overall Study|Physician Decision|4|||
144548898|NCT03547154|521209442|FG001|Overall Study|Physician Decision|3|||
144548899|NCT03547154|521209441|FG000|Overall Study|Insufficient Therapeutic Response|13|||
144548900|NCT03547154|521209442|FG001|Overall Study|Insufficient Therapeutic Response|10|||
144548901|NCT03547154|521209441|FG000|Overall Study|Withdrawal by Subject|10|||
144548902|NCT03547154|521209442|FG001|Overall Study|Withdrawal by Subject|6|||
144548903|NCT03547154|521209441|FG000|Overall Study|Not Selected|0|||
144548904|NCT03547154|521209442|FG001|Overall Study|Not Selected|1|||
144548905|NCT03547154|521209441|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
144548906|NCT03547154|521209442|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
144548907|NCT00088166|521209447|FG000|Overall Study|Adverse Event|11|||
144548908|NCT00088166|521209448|FG001|Overall Study|Adverse Event|9|||
144548909|NCT00088166|521209447|FG000|Overall Study|Death|3|||
144548910|NCT00088166|521209448|FG001|Overall Study|Death|1|||
144548911|NCT00088166|521209447|FG000|Overall Study|Lost to Follow-up|0|||
144548912|NCT00088166|521209448|FG001|Overall Study|Lost to Follow-up|1|||
144548913|NCT00088166|521209447|FG000|Overall Study|Physician Decision|4|||
144548914|NCT00088166|521209448|FG001|Overall Study|Physician Decision|1|||
144548915|NCT00088166|521209447|FG000|Overall Study|Protocol Violation|1|||
144548916|NCT00088166|521209448|FG001|Overall Study|Protocol Violation|5|||
144548917|NCT00088166|521209447|FG000|Overall Study|Patient deterioration|29|||
144548918|NCT00088166|521209448|FG001|Overall Study|Patient deterioration|39|||
144548919|NCT00088166|521209447|FG000|Overall Study|Withdrawal by Subject|5|||
144548920|NCT00088166|521209448|FG001|Overall Study|Withdrawal by Subject|5|||
144616587|NCT00267748|521456363|FG001|Randomized Period|Adverse Event|23|||
144548921|NCT00666705|521209449|FG000|Overall Study|Withdrawal by Subject|1|||
144548922|NCT01029704|521209452|FG000|Overall Study|Adverse Event|0|||
144548923|NCT01029704|521209453|FG001|Overall Study|Adverse Event|0|||
144548924|NCT01029704|521209454|FG002|Overall Study|Adverse Event|0|||
144548925|NCT01029704|521209455|FG003|Overall Study|Adverse Event|0|||
144548926|NCT01029704|521209456|FG004|Overall Study|Adverse Event|0|||
144548927|NCT01029704|521209457|FG005|Overall Study|Adverse Event|0|||
144548928|NCT01029704|521209458|FG006|Overall Study|Adverse Event|1|||
144548929|NCT01029704|521209459|FG007|Overall Study|Adverse Event|1|||
144548930|NCT01029704|521209460|FG008|Overall Study|Adverse Event|0|||
144548931|NCT01029704|521209452|FG000|Overall Study|Withdrawal by Subject|0|||
144548932|NCT01029704|521209453|FG001|Overall Study|Withdrawal by Subject|0|||
144548933|NCT01029704|521209454|FG002|Overall Study|Withdrawal by Subject|0|||
144548934|NCT01029704|521209455|FG003|Overall Study|Withdrawal by Subject|0|||
144548935|NCT01029704|521209456|FG004|Overall Study|Withdrawal by Subject|2|||
144548936|NCT01029704|521209457|FG005|Overall Study|Withdrawal by Subject|1|||
144548937|NCT01029704|521209458|FG006|Overall Study|Withdrawal by Subject|1|||
144548938|NCT01029704|521209459|FG007|Overall Study|Withdrawal by Subject|1|||
144548939|NCT01029704|521209460|FG008|Overall Study|Withdrawal by Subject|0|||
144548940|NCT01029704|521209452|FG000|Overall Study|Lost to Follow-up|0|||
144548941|NCT01029704|521209453|FG001|Overall Study|Lost to Follow-up|0|||
144548942|NCT01029704|521209454|FG002|Overall Study|Lost to Follow-up|0|||
144548943|NCT01029704|521209455|FG003|Overall Study|Lost to Follow-up|0|||
144548944|NCT01029704|521209456|FG004|Overall Study|Lost to Follow-up|0|||
144548945|NCT01029704|521209457|FG005|Overall Study|Lost to Follow-up|0|||
144548946|NCT01029704|521209458|FG006|Overall Study|Lost to Follow-up|1|||
144548947|NCT01029704|521209459|FG007|Overall Study|Lost to Follow-up|1|||
144203104|NCT02393248|519940265|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203105|NCT02393248|519940266|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203106|NCT02393248|519940267|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203107|NCT02393248|519940268|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
144203108|NCT02393248|519940269|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
144203109|NCT03560986|519940270|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
144203110|NCT03560986|519940271|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
144203111|NCT03560986|519940270|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
144203112|NCT03560986|519940271|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
144203113|NCT03560986|519940270|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
144203114|NCT03560986|519940271|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
144203115|NCT03560986|519940270|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
144203116|NCT03560986|519940271|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
144203117|NCT03560986|519940270|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
144203118|NCT03560986|519940271|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
144203119|NCT03560986|519940270|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
144203120|NCT03560986|519940271|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
144203121|NCT03560986|519940270|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
144203122|NCT03560986|519940271|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
144203123|NCT00977379|519940283|FG000|Overall Study|Withdrawal by Subject|1|||
144203124|NCT00977379|519940284|FG001|Overall Study|Withdrawal by Subject|1|||
144203125|NCT00977379|519940283|FG000|Overall Study|Death|7|||
144203126|NCT00977379|519940284|FG001|Overall Study|Death|9|||
144203127|NCT00977379|519940283|FG000|Overall Study|Premature Study Termination|4|||
144203128|NCT00977379|519940284|FG001|Overall Study|Premature Study Termination|0|||
144548948|NCT01029704|521209460|FG008|Overall Study|Lost to Follow-up|1|||
144548949|NCT01029704|521209452|FG000|Overall Study|Lack of Efficacy|0|||
144548950|NCT01029704|521209453|FG001|Overall Study|Lack of Efficacy|0|||
144548951|NCT01029704|521209454|FG002|Overall Study|Lack of Efficacy|0|||
144548952|NCT01029704|521209455|FG003|Overall Study|Lack of Efficacy|0|||
144548953|NCT01029704|521209456|FG004|Overall Study|Lack of Efficacy|2|||
144548954|NCT01029704|521209457|FG005|Overall Study|Lack of Efficacy|3|||
144548955|NCT01029704|521209458|FG006|Overall Study|Lack of Efficacy|1|||
144548956|NCT01029704|521209459|FG007|Overall Study|Lack of Efficacy|2|||
144548957|NCT01029704|521209460|FG008|Overall Study|Lack of Efficacy|0|||
144548958|NCT01029704|521209452|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
144548959|NCT01029704|521209453|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
144548960|NCT01029704|521209454|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
144548961|NCT01029704|521209455|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
144548962|NCT01029704|521209456|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
144548963|NCT01029704|521209457|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
144548964|NCT01029704|521209458|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
144548965|NCT01029704|521209459|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
144548966|NCT01029704|521209460|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
144548967|NCT00687297|521209461|FG000|Randomization|Withdrawal by Subject|2|||
144548968|NCT00687297|521209462|FG001|Randomization|Withdrawal by Subject|0|||
144548969|NCT00687297|521209461|FG000|Randomization|Withdrew before treatment, ineligible|1|||
144548970|NCT00687297|521209462|FG001|Randomization|Withdrew before treatment, ineligible|1|||
144548971|NCT00687297|521209461|FG000|Induction|Withdrawal by Subject|4|||
144548972|NCT00687297|521209462|FG001|Induction|Withdrawal by Subject|4|||
144548973|NCT00687297|521209461|FG000|Induction|Adverse Event|16|||
144548974|NCT00687297|521209462|FG001|Induction|Adverse Event|15|||
144548975|NCT00687297|521209461|FG000|Induction|Death|7|||
144548976|NCT00687297|521209462|FG001|Induction|Death|11|||
144548977|NCT00687297|521209461|FG000|Induction|Lack of Efficacy|17|||
144548978|NCT00687297|521209462|FG001|Induction|Lack of Efficacy|21|||
144548979|NCT00687297|521209461|FG000|Induction|Ineligible|0|||
144548980|NCT00687297|521209462|FG001|Induction|Ineligible|1|||
144548981|NCT00687297|521209461|FG000|Induction|Patient Noncompliance|1|||
144548982|NCT00687297|521209462|FG001|Induction|Patient Noncompliance|0|||
144548983|NCT00687297|521209461|FG000|Induction|Physician Decision|0|||
144548984|NCT00687297|521209462|FG001|Induction|Physician Decision|2|||
144548985|NCT00687297|521209461|FG000|Induction|Other|0|||
144548986|NCT00687297|521209462|FG001|Induction|Other|1|||
144548987|NCT05376397|521209465|FG000|Overall Study|Lost to Follow-up|1|||
144548988|NCT01535261|521209466|FG000|Overall Study|Physician Decision|8|||
144548989|NCT01535261|521209466|FG000|Overall Study|Protocol Violation|3|||
144548990|NCT01535261|521209466|FG000|Overall Study|Death|5|||
144548991|NCT01535261|521209466|FG000|Overall Study|Lost to Follow-up|8|||
144548992|NCT01535261|521209466|FG000|Overall Study|Withdrawal by Subject|14|||
144548993|NCT01535261|521209466|FG000|Overall Study|Adverse Event|12|||
144548994|NCT02525744|521209467|FG000|Period 1|Physician Decision|0|||
144548995|NCT02525744|521209468|FG001|Period 1|Physician Decision|0|||
144548996|NCT02525744|521209469|FG002|Period 1|Physician Decision|1|||
144548997|NCT02525744|521209470|FG003|Period 1|Physician Decision|0|||
144548998|NCT02525744|521209467|FG000|Period 3|Adverse Event|0|||
144548999|NCT02525744|521209468|FG001|Period 3|Adverse Event|1|||
144549000|NCT02525744|521209469|FG002|Period 3|Adverse Event|0|||
144549001|NCT02525744|521209470|FG003|Period 3|Adverse Event|0|||
144549002|NCT02525744|521209467|FG000|Period 4|Withdrawal by Subject|1|||
144549003|NCT02525744|521209468|FG001|Period 4|Withdrawal by Subject|0|||
144549004|NCT02525744|521209469|FG002|Period 4|Withdrawal by Subject|0|||
144549005|NCT02525744|521209470|FG003|Period 4|Withdrawal by Subject|0|||
144549006|NCT02525744|521209467|FG000|Period 5|Physician Decision|1|||
144549007|NCT02525744|521209468|FG001|Period 5|Physician Decision|0|||
144549008|NCT02525744|521209469|FG002|Period 5|Physician Decision|0|||
144549009|NCT02525744|521209470|FG003|Period 5|Physician Decision|0|||
144549010|NCT00472082|521209471|FG000|Overall Study|Study prematurely terminated|5|||
144549011|NCT02069379|521209472|FG000|Baseline Measurements|Lost to Follow-up|1|||
144549012|NCT02069379|521209473|FG001|Baseline Measurements|Lost to Follow-up|0|||
144549013|NCT02069379|521209474|FG002|Baseline Measurements|Lost to Follow-up|0|||
144549014|NCT02069379|521209475|FG003|Baseline Measurements|Lost to Follow-up|0|||
144549015|NCT02069379|521209472|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
144549016|NCT02069379|521209473|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
144549017|NCT02069379|521209474|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
144549018|NCT02069379|521209475|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
144549019|NCT02069379|521209472|FG000|First Treatment Arm|Lost to Follow-up|0|||
144549020|NCT02069379|521209473|FG001|First Treatment Arm|Lost to Follow-up|1|||
144549021|NCT02069379|521209474|FG002|First Treatment Arm|Lost to Follow-up|1|||
144549022|NCT02069379|521209475|FG003|First Treatment Arm|Lost to Follow-up|0|||
144549023|NCT02069379|521209472|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
144616588|NCT00267748|521456364|FG002|Randomized Period|Adverse Event|25|||
144616589|NCT00267748|521456362|FG000|Randomized Period|Global deterioration of health status|0|||
144616590|NCT00267748|521456363|FG001|Randomized Period|Global deterioration of health status|6|||
144616591|NCT00267748|521456364|FG002|Randomized Period|Global deterioration of health status|7|||
144549024|NCT02069379|521209473|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
144549025|NCT02069379|521209474|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
144549026|NCT02069379|521209475|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
144549027|NCT02069379|521209472|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
144549028|NCT02069379|521209473|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
144549029|NCT02069379|521209474|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
144549030|NCT02069379|521209475|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
144549031|NCT02069379|521209472|FG000|Second Treatment Arm|Lost to Follow-up|0|||
144549032|NCT02069379|521209473|FG001|Second Treatment Arm|Lost to Follow-up|0|||
144549033|NCT02069379|521209474|FG002|Second Treatment Arm|Lost to Follow-up|1|||
144549034|NCT02069379|521209475|FG003|Second Treatment Arm|Lost to Follow-up|0|||
144549035|NCT04421456|521209476|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
144549036|NCT04421456|521209477|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
144549037|NCT04421456|521209478|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
144616592|NCT00267748|521456362|FG000|Randomized Period|Lost to Follow-up|0|||
144616593|NCT00267748|521456363|FG001|Randomized Period|Lost to Follow-up|1|||
144549038|NCT04421456|521209476|FG000|Randomized Treatment Period|Adverse Event|0|||
144549039|NCT04421456|521209477|FG001|Randomized Treatment Period|Adverse Event|1|||
144549040|NCT04421456|521209478|FG002|Randomized Treatment Period|Adverse Event|0|||
144549041|NCT04421456|521209476|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
144549042|NCT04421456|521209477|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
144549043|NCT04421456|521209478|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
144549044|NCT04421456|521209476|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
144549045|NCT04421456|521209477|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
144549046|NCT04421456|521209478|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
144549047|NCT04421456|521209476|FG000|Randomized Treatment Period|Participant non-compliance|1|||
144549048|NCT04421456|521209477|FG001|Randomized Treatment Period|Participant non-compliance|1|||
144549049|NCT04421456|521209478|FG002|Randomized Treatment Period|Participant non-compliance|2|||
144549050|NCT04421456|521209476|FG000|Randomized Treatment Period|Other|0|||
144549051|NCT04421456|521209477|FG001|Randomized Treatment Period|Other|1|||
144549052|NCT04421456|521209478|FG002|Randomized Treatment Period|Other|3|||
144549053|NCT04617847|521209479|FG000|Overall Study|Withdrawal by Subject|1|||
144549054|NCT04617847|521209480|FG001|Overall Study|Withdrawal by Subject|0|||
144549055|NCT04617847|521209479|FG000|Overall Study|Adverse Event|0|||
144549056|NCT04617847|521209480|FG001|Overall Study|Adverse Event|2|||
144549057|NCT04617847|521209479|FG000|Overall Study|Death|0|||
144549058|NCT04617847|521209480|FG001|Overall Study|Death|1|||
144549059|NCT04617847|521209479|FG000|Overall Study|Termination of Study by Sponsor|2|||
144549060|NCT04617847|521209480|FG001|Overall Study|Termination of Study by Sponsor|21|||
144549061|NCT03989232|521209481|FG000|Overall Study|Lost to Follow-up|3|||
144549062|NCT03989232|521209482|FG001|Overall Study|Lost to Follow-up|10|||
144549063|NCT03989232|521209481|FG000|Overall Study|Withdrawal by Subject|6|||
144549064|NCT03989232|521209482|FG001|Overall Study|Withdrawal by Subject|6|||
144549065|NCT03989232|521209481|FG000|Overall Study|Death|1|||
144549066|NCT03989232|521209482|FG001|Overall Study|Death|2|||
144549067|NCT01930188|521209483|FG000|Overall Study|unclassified|4|||
144549068|NCT01930188|521209484|FG001|Overall Study|unclassified|5|||
144549069|NCT01930188|521209485|FG002|Overall Study|unclassified|3|||
144549070|NCT01930188|521209483|FG000|Overall Study|Missing follow-up information|2|||
144549071|NCT01930188|521209484|FG001|Overall Study|Missing follow-up information|2|||
144549072|NCT01930188|521209485|FG002|Overall Study|Missing follow-up information|3|||
144549073|NCT01930188|521209483|FG000|Overall Study|Lost to Follow-up|5|||
144549074|NCT01930188|521209484|FG001|Overall Study|Lost to Follow-up|2|||
144549075|NCT01930188|521209485|FG002|Overall Study|Lost to Follow-up|2|||
144549076|NCT01930188|521209483|FG000|Overall Study|Death|2|||
144549077|NCT01930188|521209484|FG001|Overall Study|Death|1|||
144549078|NCT01930188|521209485|FG002|Overall Study|Death|3|||
144549079|NCT01930188|521209483|FG000|Overall Study|Withdrawal by Subject|9|||
144549080|NCT01930188|521209484|FG001|Overall Study|Withdrawal by Subject|11|||
144549081|NCT01930188|521209485|FG002|Overall Study|Withdrawal by Subject|8|||
144549082|NCT00337610|521209488|FG000|Overall Study|Adverse Event|2|||
144549083|NCT00337610|521209489|FG001|Overall Study|Adverse Event|2|||
144549084|NCT00337610|521209488|FG000|Overall Study|Death|0|||
144549085|NCT00337610|521209489|FG001|Overall Study|Death|1|||
144549086|NCT00337610|521209488|FG000|Overall Study|Lack of Efficacy|6|||
144549087|NCT00337610|521209489|FG001|Overall Study|Lack of Efficacy|3|||
144549088|NCT00337610|521209488|FG000|Overall Study|Lost to Follow-up|3|||
144549089|NCT00337610|521209489|FG001|Overall Study|Lost to Follow-up|3|||
144549090|NCT00337610|521209488|FG000|Overall Study|Withdrawal by Subject|6|||
144549091|NCT00337610|521209489|FG001|Overall Study|Withdrawal by Subject|5|||
144549092|NCT01681511|521209492|FG000|Overall Study|No Treatment Received|1|||
144549093|NCT01681511|521209493|FG001|Overall Study|No Treatment Received|3|||
144549094|NCT01681511|521209492|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
144549095|NCT01681511|521209493|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
144549096|NCT01681511|521209492|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
144549097|NCT01681511|521209493|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
144616594|NCT00267748|521456364|FG002|Randomized Period|Lost to Follow-up|0|||
144616595|NCT00267748|521456362|FG000|Randomized Period|Objective progression or relapse|0|||
144616596|NCT00267748|521456363|FG001|Randomized Period|Objective progression or relapse|77|||
144616597|NCT00267748|521456364|FG002|Randomized Period|Objective progression or relapse|86|||
144616598|NCT00267748|521456362|FG000|Randomized Period|Withdrawal by Subject|0|||
144616599|NCT00267748|521456363|FG001|Randomized Period|Withdrawal by Subject|9|||
144616600|NCT00267748|521456364|FG002|Randomized Period|Withdrawal by Subject|2|||
144616601|NCT00267748|521456362|FG000|Randomized Period|Other|0|||
144616602|NCT00267748|521456363|FG001|Randomized Period|Other|9|||
144203129|NCT00977379|519940283|FG000|Overall Study|Participant Moving House|0|||
144549098|NCT01681511|521209492|FG000|Overall Study|No Daily Urine Sample Collected|0|||
144549099|NCT01681511|521209493|FG001|Overall Study|No Daily Urine Sample Collected|1|||
144549100|NCT01681511|521209492|FG000|Overall Study|No post-catheter sample collected|11|||
144549101|NCT01681511|521209493|FG001|Overall Study|No post-catheter sample collected|4|||
144616603|NCT00267748|521456364|FG002|Randomized Period|Other|6|||
144616604|NCT00267748|521456362|FG000|Randomized Period|randomized but not treated|0|||
144616605|NCT00267748|521456363|FG001|Randomized Period|randomized but not treated|0|||
144616606|NCT00267748|521456364|FG002|Randomized Period|randomized but not treated|3|||
144616607|NCT02706873|521456365|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
144616608|NCT02706873|521456366|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
144616609|NCT02706873|521456367|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
144616610|NCT02706873|521456368|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
144549102|NCT01156675|521209494|FG000|Overall Study|Death|5|||
144549103|NCT01156675|521209495|FG001|Overall Study|Death|3|||
144549104|NCT01156675|521209496|FG002|Overall Study|Death|0|||
144549105|NCT01156675|521209494|FG000|Overall Study|No data|29|||
144549106|NCT01156675|521209495|FG001|Overall Study|No data|22|||
144549107|NCT01156675|521209496|FG002|Overall Study|No data|2|||
144549108|NCT02807857|521209497|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
144549109|NCT02807857|521209497|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
144549110|NCT02807857|521209497|FG000|Follow-Up Set|Withdrawal by Subject|8|||
144549111|NCT02807857|521209497|FG000|Follow-Up Set|Lost to Follow-up|7|||
144549112|NCT02807857|521209497|FG000|Follow-Up Set|Physician Decision|6|||
144549113|NCT02807857|521209497|FG000|Follow-Up Set|Adverse Event|3|||
144549114|NCT02807857|521209497|FG000|Follow-Up Set|Death|27|||
144549115|NCT02807857|521209497|FG000|Follow-Up Set|Relocation|2|||
144549116|NCT01240590|521209498|FG000|Phase I|Refused further treatment|0|||
144549117|NCT01240590|521209499|FG001|Phase I|Refused further treatment|0|||
144203130|NCT00977379|519940284|FG001|Overall Study|Participant Moving House|1|||
144203131|NCT00977379|519940283|FG000|Overall Study|Randomization Error|0|||
144203132|NCT00977379|519940284|FG001|Overall Study|Randomization Error|1|||
144203133|NCT02603393|519940285|FG000|Overall Study|Patient/guardian decision|32|||
144203134|NCT02603393|519940286|FG001|Overall Study|Patient/guardian decision|18|||
144203135|NCT02603393|519940285|FG000|Overall Study|Adverse Event|17|||
144203136|NCT02603393|519940286|FG001|Overall Study|Adverse Event|15|||
144203137|NCT02603393|519940285|FG000|Overall Study|Technical problems|4|||
144203138|NCT02603393|519940286|FG001|Overall Study|Technical problems|7|||
144203139|NCT02603393|519940285|FG000|Overall Study|Lack of Efficacy|7|||
144203140|NCT02603393|519940286|FG001|Overall Study|Lack of Efficacy|2|||
144203141|NCT02603393|519940285|FG000|Overall Study|Death|3|||
144203142|NCT02603393|519940286|FG001|Overall Study|Death|4|||
144203143|NCT02603393|519940285|FG000|Overall Study|Physician Decision|3|||
144203144|NCT02603393|519940286|FG001|Overall Study|Physician Decision|3|||
144203145|NCT02603393|519940285|FG000|Overall Study|Protocol deviation|2|||
144203146|NCT02603393|519940286|FG001|Overall Study|Protocol deviation|3|||
144262348|NCT05219968|520159882|FG002|Week 24 Treatment Period|Adverse Event|0|||
144549118|NCT01240590|521209500|FG002|Phase I|Refused further treatment|3|||
144549119|NCT01240590|521209501|FG003|Phase I|Refused further treatment|0|||
144549120|NCT01240590|521209502|FG004|Phase I|Refused further treatment|0|||
144549121|NCT01240590|521209498|FG000|Phase II|Refused further treatment|0|||
144549122|NCT01240590|521209499|FG001|Phase II|Refused further treatment|0|||
144549123|NCT01240590|521209500|FG002|Phase II|Refused further treatment|0|||
144549124|NCT01240590|521209501|FG003|Phase II|Refused further treatment|2|||
144549125|NCT01240590|521209502|FG004|Phase II|Refused further treatment|1|||
144549126|NCT01075152|521209504|FG000|Overall Study|Withdrawal by Subject|1|||
144549127|NCT01075152|521209505|FG001|Overall Study|Withdrawal by Subject|0|||
144549128|NCT01079949|521209506|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
144549129|NCT01079949|521209507|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
144549130|NCT01079949|521209506|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
144549131|NCT01079949|521209507|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
144549132|NCT01079949|521209506|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
144549133|NCT01079949|521209507|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
144549134|NCT01079949|521209506|FG000|Overall Study|Randomized but not treated|1|||
144549135|NCT01079949|521209507|FG001|Overall Study|Randomized but not treated|0|||
144549136|NCT02144285|521209508|FG000|Overall Study|Withdrawal by Subject|0|||
144616611|NCT02706873|521456365|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
144616612|NCT02706873|521456366|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
144616613|NCT02706873|521456367|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
144262349|NCT05219968|520159883|FG003|Week 24 Treatment Period|Adverse Event|0|||
144549137|NCT02144285|521209509|FG001|Overall Study|Withdrawal by Subject|0|||
144616614|NCT02706873|521456368|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
144203147|NCT02603393|519940285|FG000|Overall Study|Lost to Follow-up|1|||
144549138|NCT02144285|521209510|FG002|Overall Study|Withdrawal by Subject|0|||
144549139|NCT02144285|521209511|FG003|Overall Study|Withdrawal by Subject|0|||
144549140|NCT02144285|521209512|FG004|Overall Study|Withdrawal by Subject|1|||
144616615|NCT02706873|521456365|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
144203148|NCT02603393|519940286|FG001|Overall Study|Lost to Follow-up|2|||
144203149|NCT02603393|519940285|FG000|Overall Study|Non-compliance with study treatment|1|||
144549141|NCT02144285|521209513|FG005|Overall Study|Withdrawal by Subject|0|||
144549142|NCT02144285|521209514|FG006|Overall Study|Withdrawal by Subject|0|||
144203150|NCT02603393|519940286|FG001|Overall Study|Non-compliance with study treatment|0|||
144549143|NCT02144285|521209515|FG007|Overall Study|Withdrawal by Subject|0|||
144549144|NCT02144285|521209516|FG008|Overall Study|Withdrawal by Subject|0|||
144549145|NCT02144285|521209517|FG009|Overall Study|Withdrawal by Subject|0|||
144549146|NCT01529632|521209518|FG000|Overall Study|Administrative problem|2|||
144549147|NCT01529632|521209519|FG001|Overall Study|Administrative problem|1|||
144549148|NCT01529632|521209518|FG000|Overall Study|Protocol Violation|0|||
144549149|NCT01529632|521209519|FG001|Overall Study|Protocol Violation|1|||
144549150|NCT01529632|521209518|FG000|Overall Study|Adverse Event|1|||
144549151|NCT01529632|521209519|FG001|Overall Study|Adverse Event|1|||
144549152|NCT00452452|521209520|FG000|Overall Study|Protocol Violation|0|||
144549153|NCT00452452|521209521|FG001|Overall Study|Protocol Violation|0|||
144549154|NCT00452452|521209522|FG002|Overall Study|Protocol Violation|1|||
144549155|NCT00452452|521209520|FG000|Overall Study|Withdrawal by Subject|1|||
144549156|NCT00452452|521209521|FG001|Overall Study|Withdrawal by Subject|0|||
144549157|NCT00452452|521209522|FG002|Overall Study|Withdrawal by Subject|0|||
144549158|NCT00452452|521209520|FG000|Overall Study|Lost to Follow-up|1|||
144549159|NCT00452452|521209521|FG001|Overall Study|Lost to Follow-up|0|||
144549160|NCT00452452|521209522|FG002|Overall Study|Lost to Follow-up|0|||
144549161|NCT05184062|521209523|FG000|Overall Study|Lost to Follow-up|5|||
144549162|NCT05184062|521209524|FG001|Overall Study|Lost to Follow-up|1|||
144549163|NCT05184062|521209523|FG000|Overall Study|Withdrawal by Subject|1|||
144549164|NCT05184062|521209524|FG001|Overall Study|Withdrawal by Subject|0|||
144549165|NCT02196259|521211236|FG000|Overall Study|Researcher choice|0|||
144549166|NCT02196259|521211237|FG001|Overall Study|Researcher choice|0|||
144549167|NCT02196259|521211238|FG002|Overall Study|Researcher choice|1|||
144549168|NCT02196259|521211236|FG000|Overall Study|Partial data analysis|0|||
144549169|NCT02196259|521211237|FG001|Overall Study|Partial data analysis|3|||
144549170|NCT02196259|521211238|FG002|Overall Study|Partial data analysis|0|||
144549171|NCT02164578|521211239|FG000|Treatment Period|Withdrawal by Subject|3|||
144549172|NCT02164578|521211240|FG001|Treatment Period|Withdrawal by Subject|3|||
144549173|NCT02164578|521211239|FG000|Treatment Period|Adverse Event|13|||
144549174|NCT02164578|521211240|FG001|Treatment Period|Adverse Event|6|||
144549175|NCT02164578|521211239|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
144549176|NCT02164578|521211240|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
144549177|NCT02164578|521211239|FG000|Treatment Period|Protocol Violation|0|||
144549178|NCT02164578|521211240|FG001|Treatment Period|Protocol Violation|2|||
144549179|NCT02164578|521211239|FG000|Extension Period|Withdrawal by Subject|2|||
144549180|NCT02164578|521211240|FG001|Extension Period|Withdrawal by Subject|0|||
144549181|NCT02164578|521211239|FG000|Extension Period|Adverse Event|4|||
144549182|NCT02164578|521211240|FG001|Extension Period|Adverse Event|0|||
144549183|NCT02164578|521211239|FG000|Extension Period|Expiry of study medication|1|||
144549184|NCT02164578|521211240|FG001|Extension Period|Expiry of study medication|0|||
144549185|NCT02164578|521211239|FG000|Extension Period|Protocol Violation|0|||
144549186|NCT02164578|521211240|FG001|Extension Period|Protocol Violation|1|||
144549187|NCT01241448|521211241|FG000|Overall Study|Adverse Event|1|||
144549188|NCT01241448|521211242|FG001|Overall Study|Adverse Event|0|||
144549189|NCT01241448|521211243|FG002|Overall Study|Adverse Event|2|||
144549190|NCT01241448|521211244|FG003|Overall Study|Adverse Event|2|||
144549191|NCT01241448|521211241|FG000|Overall Study|Lost to Follow-up|2|||
144549192|NCT01241448|521211242|FG001|Overall Study|Lost to Follow-up|1|||
144549193|NCT01241448|521211243|FG002|Overall Study|Lost to Follow-up|1|||
144549194|NCT01241448|521211244|FG003|Overall Study|Lost to Follow-up|1|||
144549195|NCT01241448|521211241|FG000|Overall Study|Physician Decision|0|||
144549196|NCT01241448|521211242|FG001|Overall Study|Physician Decision|2|||
144549197|NCT01241448|521211243|FG002|Overall Study|Physician Decision|0|||
144549198|NCT01241448|521211244|FG003|Overall Study|Physician Decision|0|||
144549199|NCT01241448|521211241|FG000|Overall Study|Protocol Violation|10|||
144549200|NCT01241448|521211242|FG001|Overall Study|Protocol Violation|5|||
144549201|NCT01241448|521211243|FG002|Overall Study|Protocol Violation|3|||
144549202|NCT01241448|521211244|FG003|Overall Study|Protocol Violation|6|||
144549203|NCT01241448|521211241|FG000|Overall Study|Sponsor Decision|17|||
144549204|NCT01241448|521211242|FG001|Overall Study|Sponsor Decision|14|||
144549205|NCT01241448|521211243|FG002|Overall Study|Sponsor Decision|12|||
144549206|NCT01241448|521211244|FG003|Overall Study|Sponsor Decision|6|||
144549207|NCT01241448|521211241|FG000|Overall Study|Withdrawal by Subject|4|||
144549208|NCT01241448|521211242|FG001|Overall Study|Withdrawal by Subject|5|||
144616616|NCT02706873|521456366|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
144549209|NCT01241448|521211243|FG002|Overall Study|Withdrawal by Subject|3|||
144549210|NCT01241448|521211244|FG003|Overall Study|Withdrawal by Subject|6|||
144616617|NCT02706873|521456367|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
144549211|NCT01241448|521211241|FG000|Overall Study|Excluded due to data integrity issues|3|||
144549212|NCT01241448|521211242|FG001|Overall Study|Excluded due to data integrity issues|2|||
144549213|NCT01241448|521211243|FG002|Overall Study|Excluded due to data integrity issues|2|||
144549214|NCT01241448|521211244|FG003|Overall Study|Excluded due to data integrity issues|2|||
144549215|NCT03340961|521211245|FG000|Overall Study|Adverse Event|1|||
144549216|NCT03340961|521211246|FG001|Overall Study|Adverse Event|3|||
144549217|NCT03340961|521211247|FG002|Overall Study|Adverse Event|2|||
144549218|NCT03340961|521211248|FG003|Overall Study|Adverse Event|4|||
144549219|NCT03340961|521211245|FG000|Overall Study|Lost to Follow-up|0|||
144549220|NCT03340961|521211246|FG001|Overall Study|Lost to Follow-up|1|||
144549221|NCT03340961|521211247|FG002|Overall Study|Lost to Follow-up|0|||
144549222|NCT03340961|521211248|FG003|Overall Study|Lost to Follow-up|1|||
144549223|NCT03340961|521211245|FG000|Overall Study|Withdrawal by Subject|3|||
144549224|NCT03340961|521211246|FG001|Overall Study|Withdrawal by Subject|2|||
144549225|NCT03340961|521211247|FG002|Overall Study|Withdrawal by Subject|4|||
144549226|NCT03340961|521211248|FG003|Overall Study|Withdrawal by Subject|7|||
144549227|NCT03340961|521211245|FG000|Overall Study|Use of prohibited treatment|0|||
144549228|NCT03340961|521211246|FG001|Overall Study|Use of prohibited treatment|3|||
144549229|NCT03340961|521211247|FG002|Overall Study|Use of prohibited treatment|2|||
144549230|NCT03340961|521211248|FG003|Overall Study|Use of prohibited treatment|4|||
144549231|NCT03340961|521211245|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
144549232|NCT03340961|521211246|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
144549233|NCT03340961|521211247|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
144549234|NCT03340961|521211248|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
144549235|NCT03340961|521211245|FG000|Overall Study|Subject developed an exclusion criterion|0|||
144549236|NCT03340961|521211246|FG001|Overall Study|Subject developed an exclusion criterion|1|||
144549237|NCT03340961|521211247|FG002|Overall Study|Subject developed an exclusion criterion|0|||
144549238|NCT03340961|521211248|FG003|Overall Study|Subject developed an exclusion criterion|0|||
144549239|NCT03340961|521211245|FG000|Overall Study|Protocol Violation|1|||
144549240|NCT03340961|521211246|FG001|Overall Study|Protocol Violation|0|||
144549241|NCT03340961|521211247|FG002|Overall Study|Protocol Violation|1|||
144549242|NCT03340961|521211248|FG003|Overall Study|Protocol Violation|0|||
144549243|NCT03340961|521211245|FG000|Overall Study|Adverse Event|1|||
144549244|NCT03340961|521211246|FG001|Overall Study|Adverse Event|1|||
144549245|NCT03340961|521211247|FG002|Overall Study|Adverse Event|0|||
144549246|NCT03340961|521211248|FG003|Overall Study|Adverse Event|0|||
144549247|NCT03340961|521211245|FG000|Overall Study|Lack of Efficacy|0|||
144549248|NCT03340961|521211246|FG001|Overall Study|Lack of Efficacy|0|||
144549249|NCT03340961|521211247|FG002|Overall Study|Lack of Efficacy|0|||
144549250|NCT03340961|521211248|FG003|Overall Study|Lack of Efficacy|1|||
144549251|NCT04311983|521211249|FG000|Overall Study|Lost to Follow-up|421|||
144549252|NCT04311983|521211250|FG001|Overall Study|Lost to Follow-up|456|||
144549253|NCT04311983|521211249|FG000|Overall Study|Incomplete survey|7|||
144549254|NCT04311983|521211250|FG001|Overall Study|Incomplete survey|9|||
144549255|NCT04311983|521211249|FG000|Overall Study|Death|1|||
144549256|NCT04311983|521211250|FG001|Overall Study|Death|0|||
144549257|NCT02165202|521211256|FG000|Oral Phase|Refused further participation|5|||
144549258|NCT02165202|521211257|FG001|Oral Phase|Refused further participation|1|||
144549259|NCT02165202|521211256|FG000|Oral Phase|Study product Related Toxicity|1|||
144549260|NCT02165202|521211257|FG001|Oral Phase|Study product Related Toxicity|0|||
144549261|NCT02165202|521211256|FG000|Oral Phase|Unable to contact Participant|1|||
144549262|NCT02165202|521211257|FG001|Oral Phase|Unable to contact Participant|1|||
144549263|NCT02165202|521211256|FG000|Oral Phase|Clinical reasons|1|||
144549264|NCT02165202|521211257|FG001|Oral Phase|Clinical reasons|0|||
144549265|NCT02165202|521211256|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
144549266|NCT02165202|521211257|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
144549267|NCT02165202|521211256|FG000|Oral Phase|CMC advised termination|1|||
144549268|NCT02165202|521211257|FG001|Oral Phase|CMC advised termination|0|||
144549269|NCT02165202|521211256|FG000|Oral Phase|Relocated, no follow-up planned|1|||
144549270|NCT02165202|521211257|FG001|Oral Phase|Relocated, no follow-up planned|0|||
144549271|NCT02165202|521211256|FG000|Oral Phase|Abnormal EKG|0|||
144549272|NCT02165202|521211257|FG001|Oral Phase|Abnormal EKG|1|||
144549273|NCT02165202|521211256|FG000|Injection Phase|Abnormal Lab Value|5|||
144549274|NCT02165202|521211257|FG001|Injection Phase|Abnormal Lab Value|1|||
144549275|NCT02165202|521211256|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
144549276|NCT02165202|521211257|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
144549277|NCT02165202|521211256|FG000|Injection Phase|Unable to attend within Visit Window|1|||
144549278|NCT02165202|521211257|FG001|Injection Phase|Unable to attend within Visit Window|0|||
144549279|NCT02165202|521211256|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
144549280|NCT02165202|521211257|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
144549281|NCT02165202|521211256|FG000|Injection Phase|End of Study|2|||
144549282|NCT02165202|521211257|FG001|Injection Phase|End of Study|1|||
144549283|NCT02165202|521211256|FG000|Injection Phase|Study Product related Toxicity|1|||
144549284|NCT02165202|521211257|FG001|Injection Phase|Study Product related Toxicity|0|||
144549285|NCT02165202|521211256|FG000|Injection Phase|No longer interested|0|||
144549286|NCT02165202|521211257|FG001|Injection Phase|No longer interested|1|||
144549287|NCT02165202|521211256|FG000|Injection Phase|Participant unwilling to comply|1|||
144549288|NCT02165202|521211257|FG001|Injection Phase|Participant unwilling to comply|0|||
144549289|NCT01975701|521211265|FG000|Overall Study|Lost to Follow-up|1|||
144549290|NCT01975701|521211265|FG000|Overall Study|Death|23|||
144549291|NCT01975701|521211265|FG000|Overall Study|Physician Decision|1|||
144549292|NCT02753075|521211266|FG000|Overall Study|Adverse Event|2|||
144549293|NCT02753075|521211267|FG001|Overall Study|Adverse Event|1|||
144549294|NCT02753075|521211268|FG002|Overall Study|Adverse Event|0|||
144549295|NCT02753075|521211266|FG000|Overall Study|Lost to Follow-up|2|||
144549296|NCT02753075|521211267|FG001|Overall Study|Lost to Follow-up|0|||
144549297|NCT02753075|521211268|FG002|Overall Study|Lost to Follow-up|0|||
144549298|NCT02753075|521211266|FG000|Overall Study|Withdrawal of Consent|1|||
144549299|NCT02753075|521211267|FG001|Overall Study|Withdrawal of Consent|1|||
144549300|NCT02753075|521211268|FG002|Overall Study|Withdrawal of Consent|3|||
144549301|NCT02753075|521211266|FG000|Overall Study|Physician Decision|3|||
144549302|NCT02753075|521211267|FG001|Overall Study|Physician Decision|1|||
144549303|NCT02753075|521211268|FG002|Overall Study|Physician Decision|0|||
144549304|NCT02152384|521211271|FG000|Period 1|Withdrawal by Subject|0|||
144549305|NCT02152384|521211272|FG001|Period 1|Withdrawal by Subject|1|||
144549306|NCT02152384|521211271|FG000|Period 1|Adverse Event|1|||
144549307|NCT02152384|521211272|FG001|Period 1|Adverse Event|1|||
144549308|NCT02446015|521211273|FG000|Overall Study|Adverse Event|0|||
144549309|NCT02446015|521211274|FG001|Overall Study|Adverse Event|1|||
144549310|NCT02446015|521211273|FG000|Overall Study|Withdrawal by Subject|1|||
144549311|NCT02446015|521211274|FG001|Overall Study|Withdrawal by Subject|0|||
144549312|NCT00603798|521211275|FG000|Overall Study|Adverse Event|4|||
144549313|NCT00603798|521211276|FG001|Overall Study|Adverse Event|2|||
144549314|NCT00603798|521211277|FG002|Overall Study|Adverse Event|1|||
144549315|NCT00603798|521211275|FG000|Overall Study|Withdrawal by Subject|4|||
144549316|NCT00603798|521211276|FG001|Overall Study|Withdrawal by Subject|3|||
144549317|NCT00603798|521211277|FG002|Overall Study|Withdrawal by Subject|4|||
144549318|NCT00603798|521211275|FG000|Overall Study|Lost to Follow-up|1|||
144549319|NCT00603798|521211276|FG001|Overall Study|Lost to Follow-up|0|||
144549320|NCT00603798|521211277|FG002|Overall Study|Lost to Follow-up|1|||
144549321|NCT00603798|521211275|FG000|Overall Study|Non-compliance with study procedures|0|||
144549322|NCT00603798|521211276|FG001|Overall Study|Non-compliance with study procedures|1|||
144549323|NCT00603798|521211277|FG002|Overall Study|Non-compliance with study procedures|0|||
144549324|NCT00603798|521211275|FG000|Overall Study|Not due to AE|1|||
144549325|NCT00603798|521211276|FG001|Overall Study|Not due to AE|1|||
144549326|NCT00603798|521211277|FG002|Overall Study|Not due to AE|4|||
144549327|NCT00871494|521211281|FG000|Overall Study|Protocol Violation|5|||
144549328|NCT00871494|521211281|FG000|Overall Study|Lack of Efficacy|4|||
144549329|NCT00871494|521211281|FG000|Overall Study|Adverse Event|4|||
144549330|NCT00871494|521211281|FG000|Overall Study|Lost to Follow-up|1|||
144549331|NCT01090739|521211285|FG000|Enrollment|Withdrawal by Subject|24|||
144549332|NCT01090739|521211285|FG000|Enrollment|Protocol Violation|14|||
144549333|NCT01090739|521211285|FG000|Enrollment|Lost to Follow-up|5|||
144549334|NCT01090739|521211285|FG000|Enrollment|Physician Decision|5|||
144549335|NCT01090739|521211285|FG000|Enrollment|Sponsor termination of site|4|||
144549336|NCT01090739|521211285|FG000|Enrollment|Study implant limit reached|2|||
144549337|NCT01090739|521211285|FG000|Enrollment|Adverse Event|1|||
144549338|NCT01090739|521211285|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
144549339|NCT01090739|521211285|FG000|12 Month Follow-up|Lost to Follow-up|1|||
144549340|NCT01090739|521211285|FG000|12 Month Follow-up|Physician Decision|1|||
144549341|NCT01090739|521211285|FG000|12 Month Follow-up|Death|1|||
144549342|NCT01090739|521211285|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
144549343|NCT01090739|521211285|FG000|24 Month Follow-up|Lost to Follow-up|1|||
144549344|NCT01090739|521211285|FG000|24 Month Follow-up|Death|1|||
144549345|NCT01090739|521211285|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
144549346|NCT01090739|521211285|FG000|36 Month Follow-up|Visit still pending|17|||
144549347|NCT00988429|521211286|FG000|Overall Study|Adverse Event|9|||
144549348|NCT00988429|521211287|FG001|Overall Study|Adverse Event|21|||
144549349|NCT00988429|521211288|FG002|Overall Study|Adverse Event|45|||
144549350|NCT00988429|521211286|FG000|Overall Study|Lack of Efficacy|0|||
144549351|NCT00988429|521211287|FG001|Overall Study|Lack of Efficacy|0|||
144549352|NCT00988429|521211288|FG002|Overall Study|Lack of Efficacy|1|||
144549353|NCT00988429|521211286|FG000|Overall Study|Non-Compliance with Study Drug|5|||
144549354|NCT00988429|521211287|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144549355|NCT00988429|521211288|FG002|Overall Study|Non-Compliance with Study Drug|3|||
144549356|NCT00988429|521211286|FG000|Overall Study|Physician Decision|1|||
144549357|NCT00988429|521211287|FG001|Overall Study|Physician Decision|0|||
144549358|NCT00988429|521211288|FG002|Overall Study|Physician Decision|3|||
144549359|NCT00988429|521211286|FG000|Overall Study|Pregnancy|2|||
144549360|NCT00988429|521211287|FG001|Overall Study|Pregnancy|1|||
144549361|NCT00988429|521211288|FG002|Overall Study|Pregnancy|0|||
144549362|NCT00988429|521211286|FG000|Overall Study|Protocol Violation|4|||
144549363|NCT00988429|521211287|FG001|Overall Study|Protocol Violation|3|||
144549364|NCT00988429|521211288|FG002|Overall Study|Protocol Violation|3|||
144727635|NCT02130466|521856666|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
144203151|NCT02603393|519940285|FG000|Overall Study|Sponsor decision|1|||
144549365|NCT00988429|521211286|FG000|Overall Study|Withdrawal by Subject|7|||
144549366|NCT00988429|521211287|FG001|Overall Study|Withdrawal by Subject|7|||
144549367|NCT00988429|521211288|FG002|Overall Study|Withdrawal by Subject|12|||
144549368|NCT00988429|521211286|FG000|Overall Study|Administrative Reasons|1|||
144549369|NCT00988429|521211287|FG001|Overall Study|Administrative Reasons|2|||
144549370|NCT00988429|521211288|FG002|Overall Study|Administrative Reasons|1|||
144549371|NCT00988429|521211286|FG000|Overall Study|other reasons|8|||
144549372|NCT00988429|521211287|FG001|Overall Study|other reasons|8|||
144549373|NCT00988429|521211288|FG002|Overall Study|other reasons|1|||
144549374|NCT00441168|521211289|FG000|Treatment Period|Death|3|||
144549375|NCT00441168|521211290|FG001|Treatment Period|Death|0|||
144549376|NCT00441168|521211289|FG000|Treatment Period|Adverse Event|1|||
144549377|NCT00441168|521211290|FG001|Treatment Period|Adverse Event|2|||
144549378|NCT00441168|521211289|FG000|Treatment Period|Progressive Disease|0|||
144549379|NCT00441168|521211290|FG001|Treatment Period|Progressive Disease|2|||
144549380|NCT00441168|521211289|FG000|Treatment Period|Protocol Violation|0|||
144549381|NCT00441168|521211290|FG001|Treatment Period|Protocol Violation|1|||
144549382|NCT00441168|521211289|FG000|Treatment Period|Lost to Follow-up|0|||
144549383|NCT00441168|521211290|FG001|Treatment Period|Lost to Follow-up|1|||
144549384|NCT00441168|521211289|FG000|Treatment Period|Withdrawal by Subject|3|||
144549385|NCT00441168|521211290|FG001|Treatment Period|Withdrawal by Subject|0|||
144549386|NCT00441168|521211289|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
144549387|NCT00441168|521211290|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
144549388|NCT00441168|521211289|FG000|Treatment Period|refractory disease|1|||
144549389|NCT00441168|521211290|FG001|Treatment Period|refractory disease|0|||
144549390|NCT00441168|521211289|FG000|Follow-up Period|Death|3|||
144549391|NCT00441168|521211290|FG001|Follow-up Period|Death|0|||
144549392|NCT00441168|521211289|FG000|Follow-up Period|Lost to Follow-up|5|||
144549393|NCT00441168|521211290|FG001|Follow-up Period|Lost to Follow-up|6|||
144549394|NCT00441168|521211289|FG000|Follow-up Period|Withdrawal by Subject|3|||
144549395|NCT00441168|521211290|FG001|Follow-up Period|Withdrawal by Subject|0|||
144549396|NCT00441168|521211289|FG000|Follow-up Period|Other|1|||
144549397|NCT00441168|521211290|FG001|Follow-up Period|Other|3|||
144549398|NCT02964234|521211291|FG000|Overall Study|Lost to Follow-up|22|||
144549399|NCT02964234|521211292|FG001|Overall Study|Lost to Follow-up|13|||
144549400|NCT01799993|521211293|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
144549401|NCT01799993|521211294|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
144549402|NCT01799993|521211293|FG000|Overall Study|Death|61|||
144549403|NCT01799993|521211294|FG001|Overall Study|Death|45|||
144549404|NCT01799993|521211293|FG000|Overall Study|Withdrawal by Subject|23|||
144549405|NCT01799993|521211294|FG001|Overall Study|Withdrawal by Subject|24|||
144549406|NCT01799993|521211293|FG000|Overall Study|Lost to Follow-up|5|||
144549407|NCT01799993|521211294|FG001|Overall Study|Lost to Follow-up|8|||
144549408|NCT01799993|521211293|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
144549409|NCT01799993|521211294|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
144549410|NCT01799993|521211293|FG000|Overall Study|Protocol driven decision point|0|||
144549411|NCT01799993|521211294|FG001|Overall Study|Protocol driven decision point|3|||
144549412|NCT01799993|521211293|FG000|Overall Study|Protocol Violation|1|||
144549413|NCT01799993|521211294|FG001|Overall Study|Protocol Violation|1|||
144549414|NCT01799993|521211293|FG000|Overall Study|Deterioration of general conditions|2|||
144549415|NCT01799993|521211294|FG001|Overall Study|Deterioration of general conditions|0|||
144549416|NCT01799993|521211293|FG000|Overall Study|Screen failure|0|||
144549417|NCT01799993|521211294|FG001|Overall Study|Screen failure|1|||
144549418|NCT01799993|521211293|FG000|Overall Study|Adverse Event|1|||
144549419|NCT01799993|521211294|FG001|Overall Study|Adverse Event|0|||
144549420|NCT01799993|521211293|FG000|Overall Study|Lack of Efficacy|1|||
144549421|NCT01799993|521211294|FG001|Overall Study|Lack of Efficacy|0|||
144549422|NCT01799993|521211293|FG000|Overall Study|Recovery|0|||
144549423|NCT01799993|521211294|FG001|Overall Study|Recovery|1|||
144549424|NCT01799993|521211293|FG000|Overall Study|Logistical difficulties|1|||
144549425|NCT01799993|521211294|FG001|Overall Study|Logistical difficulties|0|||
144549426|NCT01799993|521211293|FG000|Overall Study|Protocol deviation|1|||
144549427|NCT01799993|521211294|FG001|Overall Study|Protocol deviation|0|||
144549428|NCT01799993|521211293|FG000|Overall Study|Non-compliance with medical device|1|||
144549429|NCT01799993|521211294|FG001|Overall Study|Non-compliance with medical device|0|||
144549430|NCT01799993|521211293|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144549431|NCT01799993|521211294|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144549432|NCT01799993|521211293|FG000|Overall Study|Other|1|||
144549433|NCT01799993|521211294|FG001|Overall Study|Other|0|||
144549434|NCT01799993|521211293|FG000|Overall Study|Subject didn't return for follow-up|0|||
144549435|NCT01799993|521211294|FG001|Overall Study|Subject didn't return for follow-up|1|||
144549436|NCT04410445|521211295|FG000|Overall Study|Lost to Follow-up|3|||
144549437|NCT04410445|521211296|FG001|Overall Study|Lost to Follow-up|9|||
144549438|NCT04410445|521211295|FG000|Overall Study|Withdrawal by Subject|27|||
144549439|NCT04410445|521211296|FG001|Overall Study|Withdrawal by Subject|15|||
144727636|NCT02130466|521856667|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
144549440|NCT01320683|521211297|FG000|Overall Study|Positive antibody response|1|||
144727637|NCT02130466|521856668|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
144549441|NCT02671266|521211300|FG000|Overall Study|Withdrawal by Subject|1|||
144549442|NCT02671266|521211301|FG001|Overall Study|Withdrawal by Subject|1|||
144549443|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
144549444|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
144549445|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
144549446|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
144549447|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Death|0|||
144549448|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Death|0|||
144549449|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Death|1|||
144549450|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Death|0|||
144549451|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
144549452|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
144549453|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
144549454|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
144549455|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
144549456|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
144549457|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
144549458|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
144549459|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
144549460|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
144549461|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
144549462|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
144549463|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
144549464|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
144549465|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
144549466|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
144549467|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
144549468|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
144549469|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
144549470|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
144549471|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Other|2|||
144549472|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Other|0|||
144549473|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Other|0|||
144549474|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Other|0|||
144549475|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
144549476|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
144549477|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
144549478|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
144549479|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
144549480|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
144549481|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
144549482|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
144549483|NCT03845517|521211305|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
144549484|NCT03845517|521211306|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
144549485|NCT03845517|521211307|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
144549486|NCT03845517|521211308|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
144549487|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
144549488|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
144549489|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
144549490|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
144549491|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Death|0|||
144549492|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Death|0|||
144549493|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Death|1|||
144549494|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Death|1|||
144549495|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
144549496|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
144549497|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
144549498|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
144549499|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
144203152|NCT02603393|519940286|FG001|Overall Study|Sponsor decision|0|||
144549500|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
144203153|NCT00593736|519940287|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
144549501|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
144549502|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
144549503|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
144549504|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
144549505|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
144616618|NCT02706873|521456368|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
144616619|NCT02706873|521456365|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
144549506|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
144549507|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Other|1|||
144549508|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Other|0|||
144549509|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Other|1|||
144549510|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Other|0|||
144549511|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
144549512|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
144727638|NCT02130466|521856669|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
144549513|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
144549514|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
144549515|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
144549516|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
144549517|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
144549518|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
144549519|NCT03845517|521211305|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
144549520|NCT03845517|521211306|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
144549521|NCT03845517|521211307|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
144549522|NCT03845517|521211308|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
144549523|NCT01109979|521211309|FG000|Overall Study|Physician Decision|2|||
144549524|NCT01109979|521211310|FG001|Overall Study|Physician Decision|0|||
144549525|NCT01109979|521211309|FG000|Overall Study|Withdrawal by Subject|0|||
144549526|NCT01109979|521211310|FG001|Overall Study|Withdrawal by Subject|1|||
144549527|NCT00807599|521211314|FG000|Overall Study|Not treated on protocol study|0|||
144549528|NCT00807599|521211315|FG001|Overall Study|Not treated on protocol study|0|||
144549529|NCT00807599|521211316|FG002|Overall Study|Not treated on protocol study|2|||
144549530|NCT00807599|521211314|FG000|Overall Study|Adverse Event|0|||
144549531|NCT00807599|521211315|FG001|Overall Study|Adverse Event|0|||
144549532|NCT00807599|521211316|FG002|Overall Study|Adverse Event|5|||
144549533|NCT00807599|521211314|FG000|Overall Study|Inadequate response to induction|0|||
144549534|NCT00807599|521211315|FG001|Overall Study|Inadequate response to induction|0|||
144549535|NCT00807599|521211316|FG002|Overall Study|Inadequate response to induction|9|||
144549536|NCT00807599|521211314|FG000|Overall Study|Withdrawal by Subject|0|||
144549537|NCT00807599|521211315|FG001|Overall Study|Withdrawal by Subject|0|||
144549538|NCT00807599|521211316|FG002|Overall Study|Withdrawal by Subject|1|||
144549539|NCT01137682|521211321|FG000|Overall Study|Adverse Event-CORE|2|||
144549540|NCT01137682|521211322|FG001|Overall Study|Adverse Event-CORE|4|||
144549541|NCT01137682|521211323|FG002|Overall Study|Adverse Event-CORE|0|||
144549542|NCT01137682|521211321|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
144549543|NCT01137682|521211322|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
144549544|NCT01137682|521211323|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
144549545|NCT01137682|521211321|FG000|Overall Study|Administrative problems-CORE|2|||
144549546|NCT01137682|521211322|FG001|Overall Study|Administrative problems-CORE|1|||
144549547|NCT01137682|521211323|FG002|Overall Study|Administrative problems-CORE|0|||
144549548|NCT01137682|521211321|FG000|Overall Study|Protocol Violation-CORE|0|||
144549549|NCT01137682|521211322|FG001|Overall Study|Protocol Violation-CORE|1|||
144549550|NCT01137682|521211323|FG002|Overall Study|Protocol Violation-CORE|1|||
144549551|NCT01137682|521211321|FG000|Overall Study|Adverse Event-Extension|4|||
144549552|NCT01137682|521211322|FG001|Overall Study|Adverse Event-Extension|8|||
144549553|NCT01137682|521211323|FG002|Overall Study|Adverse Event-Extension|7|||
144549554|NCT01137682|521211321|FG000|Overall Study|Lack of Efficacy-Extension|15|||
144549555|NCT01137682|521211322|FG001|Overall Study|Lack of Efficacy-Extension|9|||
144549556|NCT01137682|521211323|FG002|Overall Study|Lack of Efficacy-Extension|13|||
144549557|NCT01137682|521211321|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
144549558|NCT01137682|521211322|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
144549559|NCT01137682|521211323|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
144549560|NCT01137682|521211321|FG000|Overall Study|Lost to Follow Up-Extension|0|||
144549561|NCT01137682|521211322|FG001|Overall Study|Lost to Follow Up-Extension|1|||
144549562|NCT01137682|521211323|FG002|Overall Study|Lost to Follow Up-Extension|0|||
144549563|NCT01137682|521211321|FG000|Overall Study|Administrative problems-Extension|0|||
144549564|NCT01137682|521211322|FG001|Overall Study|Administrative problems-Extension|2|||
144549565|NCT01137682|521211323|FG002|Overall Study|Administrative problems-Extension|0|||
144549566|NCT01137682|521211321|FG000|Overall Study|Death-Extension|2|||
144549567|NCT01137682|521211322|FG001|Overall Study|Death-Extension|0|||
144549568|NCT01137682|521211323|FG002|Overall Study|Death-Extension|0|||
144549569|NCT01137682|521211321|FG000|Overall Study|Protocol Violation-Extension|2|||
144549570|NCT01137682|521211322|FG001|Overall Study|Protocol Violation-Extension|1|||
144549571|NCT01137682|521211323|FG002|Overall Study|Protocol Violation-Extension|0|||
144549572|NCT01137682|521211321|FG000|Overall Study|Did not enter extension|2|||
144549573|NCT01137682|521211322|FG001|Overall Study|Did not enter extension|3|||
144549574|NCT01137682|521211323|FG002|Overall Study|Did not enter extension|2|||
144549575|NCT01137682|521211321|FG000|Overall Study|Did not receive treatment in extension|0|||
144549576|NCT01137682|521211322|FG001|Overall Study|Did not receive treatment in extension|0|||
144549577|NCT01137682|521211323|FG002|Overall Study|Did not receive treatment in extension|1|||
144549578|NCT02009332|521211324|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
144549579|NCT02009332|521211325|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
144549580|NCT02009332|521211326|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
144549581|NCT02009332|521211327|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
144549582|NCT02009332|521211328|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
144549583|NCT02009332|521211329|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
144549584|NCT02009332|521211324|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
144549585|NCT02009332|521211325|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
144549586|NCT02009332|521211326|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
144549587|NCT02009332|521211327|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
144549588|NCT02009332|521211328|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
144549589|NCT02009332|521211329|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
144549590|NCT02009332|521211324|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
144549591|NCT02009332|521211325|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
144549592|NCT02009332|521211326|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
144549593|NCT02009332|521211327|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
144549594|NCT02009332|521211328|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
144549595|NCT02009332|521211329|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
144549596|NCT01912599|521211330|FG000|Overall Study|Withdrawal by Subject|0|||
144549597|NCT01912599|521211331|FG001|Overall Study|Withdrawal by Subject|1|||
144549598|NCT03449979|521211339|FG000|Overall Study|Technical difficulty|0|||
144549599|NCT03449979|521211340|FG001|Overall Study|Technical difficulty|0|||
144549600|NCT03449979|521211341|FG002|Overall Study|Technical difficulty|0|||
144549601|NCT03449979|521211342|FG003|Overall Study|Technical difficulty|1|||
144549602|NCT04183491|521211343|FG000|Overall Study|Withdrawal by Subject|0|||
144549603|NCT04183491|521211344|FG001|Overall Study|Withdrawal by Subject|0|||
144549604|NCT04183491|521211345|FG002|Overall Study|Withdrawal by Subject|1|||
144549605|NCT04183491|521211346|FG003|Overall Study|Withdrawal by Subject|0|||
144549606|NCT04183491|521211347|FG004|Overall Study|Withdrawal by Subject|0|||
144549607|NCT04183491|521211348|FG005|Overall Study|Withdrawal by Subject|1|||
144549608|NCT04183491|521211349|FG006|Overall Study|Withdrawal by Subject|0|||
144549609|NCT00068107|521211353|FG000|Overall Study|end-stage renal disease|6|||
144549610|NCT00068107|521211353|FG000|Overall Study|Death|2|||
144549611|NCT00068107|521211353|FG000|Overall Study|Withdrawal by Subject|1|||
144549612|NCT03288506|521211354|FG000|Overall Study|Withdrawal by Subject|52|||
144549613|NCT02644122|521211358|FG000|Overall Study|Withdrawal by Subject|1|||
144549614|NCT04867382|521211359|FG000|Overall Study|Did not complete the survey|2|||
144549615|NCT04867382|521211360|FG001|Overall Study|Did not complete the survey|1|||
144549616|NCT02102724|521211365|FG000|Overall Study|Lost to Follow-up|1|||
144549617|NCT02102724|521211366|FG001|Overall Study|Lost to Follow-up|0|||
144549618|NCT02102724|521211365|FG000|Overall Study|surgery for brain aneurysm|1|||
144549619|NCT02102724|521211366|FG001|Overall Study|surgery for brain aneurysm|1|||
144549620|NCT02203513|521211370|FG000|Overall Study|Refused further treatment|2|||
144549621|NCT02203513|521211371|FG001|Overall Study|Refused further treatment|0|||
144549622|NCT02203513|521211372|FG002|Overall Study|Refused further treatment|1|||
144549623|NCT02203513|521211373|FG003|Overall Study|Refused further treatment|0|||
144549624|NCT02203513|521211374|FG004|Overall Study|Refused further treatment|0|||
144549625|NCT02203513|521211370|FG000|Overall Study|Switched to alternative treatment|3|||
144549626|NCT02203513|521211371|FG001|Overall Study|Switched to alternative treatment|4|||
144549627|NCT02203513|521211372|FG002|Overall Study|Switched to alternative treatment|0|||
144549628|NCT02203513|521211373|FG003|Overall Study|Switched to alternative treatment|0|||
144549629|NCT02203513|521211374|FG004|Overall Study|Switched to alternative treatment|4|||
144549630|NCT02203513|521211370|FG000|Overall Study|Did not receive investigational product (IP)|0|||
144549631|NCT02203513|521211371|FG001|Overall Study|Did not receive investigational product (IP)|1|||
144549632|NCT02203513|521211372|FG002|Overall Study|Did not receive investigational product (IP)|0|||
144549633|NCT02203513|521211373|FG003|Overall Study|Did not receive investigational product (IP)|0|||
144549634|NCT02203513|521211374|FG004|Overall Study|Did not receive investigational product (IP)|0|||
144549635|NCT02203513|521211370|FG000|Overall Study|Death (unrelated to study therapy)|1|||
144549636|NCT02203513|521211371|FG001|Overall Study|Death (unrelated to study therapy)|3|||
144549637|NCT02203513|521211372|FG002|Overall Study|Death (unrelated to study therapy)|1|||
144549638|NCT02203513|521211373|FG003|Overall Study|Death (unrelated to study therapy)|0|||
144549639|NCT02203513|521211374|FG004|Overall Study|Death (unrelated to study therapy)|2|||
144549640|NCT02203513|521211370|FG000|Overall Study|Lost to Follow-up|0|||
144549641|NCT02203513|521211371|FG001|Overall Study|Lost to Follow-up|0|||
144549642|NCT02203513|521211372|FG002|Overall Study|Lost to Follow-up|1|||
144549643|NCT02203513|521211373|FG003|Overall Study|Lost to Follow-up|1|||
144549644|NCT02203513|521211374|FG004|Overall Study|Lost to Follow-up|0|||
144549645|NCT02008916|521211375|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
144549646|NCT02008916|521211376|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
144549647|NCT02008916|521211377|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
144549648|NCT02008916|521211375|FG000|Week 16 - 156|Adverse Event|4|||
144549649|NCT02008916|521211376|FG001|Week 16 - 156|Adverse Event|2|||
144549650|NCT02008916|521211377|FG002|Week 16 - 156|Adverse Event|3|||
144549651|NCT02008916|521211375|FG000|Week 16 - 156|Withdrawal by Subject|7|||
144549652|NCT02008916|521211376|FG001|Week 16 - 156|Withdrawal by Subject|3|||
144616620|NCT02706873|521456366|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
144616621|NCT02706873|521456367|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
144616622|NCT02706873|521456368|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
144549653|NCT02008916|521211377|FG002|Week 16 - 156|Withdrawal by Subject|5|||
144549654|NCT02008916|521211375|FG000|Week 16 - 156|No longer requires treatment|0|||
144549655|NCT02008916|521211376|FG001|Week 16 - 156|No longer requires treatment|1|||
144549656|NCT02008916|521211377|FG002|Week 16 - 156|No longer requires treatment|0|||
144549657|NCT02008916|521211375|FG000|Week 16 - 156|Lost to Follow-up|5|||
144549658|NCT02008916|521211376|FG001|Week 16 - 156|Lost to Follow-up|0|||
144549659|NCT02008916|521211377|FG002|Week 16 - 156|Lost to Follow-up|0|||
144549660|NCT02008916|521211375|FG000|Week 16 - 156|Lack of Efficacy|3|||
144549661|NCT02008916|521211376|FG001|Week 16 - 156|Lack of Efficacy|5|||
144549662|NCT02008916|521211377|FG002|Week 16 - 156|Lack of Efficacy|2|||
144549663|NCT02008916|521211375|FG000|Week 16 - 156|Pregnancy|0|||
144549664|NCT02008916|521211376|FG001|Week 16 - 156|Pregnancy|1|||
144549665|NCT02008916|521211377|FG002|Week 16 - 156|Pregnancy|0|||
144549666|NCT02008916|521211375|FG000|Week 16 - 156|Physician Decision|0|||
144549667|NCT02008916|521211376|FG001|Week 16 - 156|Physician Decision|1|||
144549668|NCT02008916|521211377|FG002|Week 16 - 156|Physician Decision|0|||
144549669|NCT01528605|521211378|FG000|Overall Study|Lost to Follow-up|1|||
144549670|NCT01528605|521211379|FG001|Overall Study|Lost to Follow-up|0|||
144549671|NCT01528605|521211380|FG002|Overall Study|Lost to Follow-up|1|||
144549672|NCT01528605|521211381|FG003|Overall Study|Lost to Follow-up|1|||
144549673|NCT01528605|521211382|FG004|Overall Study|Lost to Follow-up|0|||
144549674|NCT01528605|521211383|FG005|Overall Study|Lost to Follow-up|0|||
144549675|NCT01528605|521211378|FG000|Overall Study|Death|1|||
144549676|NCT01528605|521211379|FG001|Overall Study|Death|0|||
144549677|NCT01528605|521211380|FG002|Overall Study|Death|0|||
144549678|NCT01528605|521211381|FG003|Overall Study|Death|0|||
144549679|NCT01528605|521211382|FG004|Overall Study|Death|0|||
144549680|NCT01528605|521211383|FG005|Overall Study|Death|0|||
144549681|NCT02432274|521211397|FG000|Overall Study|Death|2|||
144549682|NCT02432274|521211398|FG001|Overall Study|Death|6|||
144549683|NCT02432274|521211399|FG002|Overall Study|Death|7|||
144549684|NCT02432274|521211400|FG003|Overall Study|Death|0|||
144549685|NCT02432274|521211401|FG004|Overall Study|Death|27|||
144549686|NCT02432274|521211402|FG005|Overall Study|Death|7|||
144549687|NCT02432274|521211403|FG006|Overall Study|Death|9|||
144549688|NCT02432274|521211404|FG007|Overall Study|Death|14|||
144549689|NCT02432274|521211397|FG000|Overall Study|Withdrawal of Consent|0|||
144549690|NCT02432274|521211398|FG001|Overall Study|Withdrawal of Consent|0|||
144549691|NCT02432274|521211399|FG002|Overall Study|Withdrawal of Consent|0|||
144549692|NCT02432274|521211400|FG003|Overall Study|Withdrawal of Consent|0|||
144549693|NCT02432274|521211401|FG004|Overall Study|Withdrawal of Consent|2|||
144549694|NCT02432274|521211402|FG005|Overall Study|Withdrawal of Consent|0|||
144549695|NCT02432274|521211403|FG006|Overall Study|Withdrawal of Consent|1|||
144549696|NCT02432274|521211404|FG007|Overall Study|Withdrawal of Consent|2|||
144549697|NCT00090519|521211405|FG000|Overall Study|Adverse Event|5|||
144549698|NCT00090519|521211406|FG001|Overall Study|Adverse Event|4|||
144549699|NCT00090519|521211405|FG000|Overall Study|Death|9|||
144549700|NCT00090519|521211406|FG001|Overall Study|Death|9|||
144549701|NCT00090519|521211405|FG000|Overall Study|Lost to Follow-up|26|||
144549702|NCT00090519|521211406|FG001|Overall Study|Lost to Follow-up|29|||
144549703|NCT00090519|521211405|FG000|Overall Study|Withdrawal by Subject|28|||
144549704|NCT00090519|521211406|FG001|Overall Study|Withdrawal by Subject|29|||
144549705|NCT00090519|521211405|FG000|Overall Study|Physician Decision|2|||
144549706|NCT00090519|521211406|FG001|Overall Study|Physician Decision|3|||
144549707|NCT00090519|521211405|FG000|Overall Study|Sponsor Decision|3|||
144549708|NCT00090519|521211406|FG001|Overall Study|Sponsor Decision|1|||
144549709|NCT00116649|521211407|FG000|Overall Study|Adverse Event|20|||
144549710|NCT00116649|521211407|FG000|Overall Study|Lack of Efficacy|1|||
144549711|NCT00116649|521211407|FG000|Overall Study|Lost to Follow-up|32|||
144549712|NCT00116649|521211407|FG000|Overall Study|Withdrawal by Subject|68|||
144549713|NCT00116649|521211407|FG000|Overall Study|Local Skin Reaction|9|||
144549714|NCT00116649|521211407|FG000|Overall Study|Various Reasons|18|||
144549715|NCT00116649|521211407|FG000|Overall Study|Protocol Specified|7|||
144549716|NCT02161146|521211408|FG000|Overall Study|Adverse Event|1|||
144549717|NCT02161146|521211409|FG001|Overall Study|Adverse Event|1|||
144549718|NCT02161146|521211410|FG002|Overall Study|Adverse Event|0|||
144549719|NCT02161146|521211411|FG003|Overall Study|Adverse Event|1|||
144549720|NCT02161146|521211412|FG004|Overall Study|Adverse Event|0|||
144549721|NCT02161146|521211408|FG000|Overall Study|Lost to Follow-up|0|||
144549722|NCT02161146|521211409|FG001|Overall Study|Lost to Follow-up|1|||
144549723|NCT02161146|521211410|FG002|Overall Study|Lost to Follow-up|0|||
144549724|NCT02161146|521211411|FG003|Overall Study|Lost to Follow-up|0|||
144549725|NCT02161146|521211412|FG004|Overall Study|Lost to Follow-up|0|||
144549726|NCT02161146|521211408|FG000|Overall Study|Personal Reasons|0|||
144549727|NCT02161146|521211409|FG001|Overall Study|Personal Reasons|1|||
144616623|NCT02706873|521456365|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
144549728|NCT02161146|521211410|FG002|Overall Study|Personal Reasons|0|||
144549729|NCT02161146|521211411|FG003|Overall Study|Personal Reasons|2|||
144549730|NCT02161146|521211412|FG004|Overall Study|Personal Reasons|1|||
144549731|NCT02161146|521211408|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144549732|NCT02161146|521211409|FG001|Overall Study|Other Miscellaneous Reasons|1|||
144549733|NCT02161146|521211410|FG002|Overall Study|Other Miscellaneous Reasons|0|||
144549734|NCT02161146|521211411|FG003|Overall Study|Other Miscellaneous Reasons|0|||
144549735|NCT02161146|521211412|FG004|Overall Study|Other Miscellaneous Reasons|0|||
144549736|NCT00845520|521211413|FG000|Overall Study|Death|1|||
144549737|NCT00845520|521211414|FG001|Overall Study|Death|2|||
144549738|NCT00845520|521211415|FG002|Overall Study|Death|0|||
144549739|NCT00845520|521211413|FG000|Overall Study|Lost to Follow-up|1|||
144549740|NCT00845520|521211414|FG001|Overall Study|Lost to Follow-up|0|||
144549741|NCT00845520|521211415|FG002|Overall Study|Lost to Follow-up|0|||
144549742|NCT00845520|521211413|FG000|Overall Study|Adverse Event|0|||
144549743|NCT00845520|521211414|FG001|Overall Study|Adverse Event|0|||
144549744|NCT00845520|521211415|FG002|Overall Study|Adverse Event|1|||
144549745|NCT02613403|521211416|FG000|Overall Study|Lost to Follow-up|0|||
144549746|NCT02613403|521211417|FG001|Overall Study|Lost to Follow-up|1|||
144549747|NCT02613403|521211418|FG002|Overall Study|Lost to Follow-up|0|||
144549748|NCT02613403|521211419|FG003|Overall Study|Lost to Follow-up|0|||
144549749|NCT02613403|521211420|FG004|Overall Study|Lost to Follow-up|0|||
144549750|NCT02613403|521211416|FG000|Overall Study|Withdrawal by Subject|2|||
144549751|NCT02613403|521211417|FG001|Overall Study|Withdrawal by Subject|0|||
144549752|NCT02613403|521211418|FG002|Overall Study|Withdrawal by Subject|0|||
144549753|NCT02613403|521211419|FG003|Overall Study|Withdrawal by Subject|0|||
144549754|NCT02613403|521211420|FG004|Overall Study|Withdrawal by Subject|0|||
144549755|NCT00800176|521211421|FG000|Overall Study|Adverse Event|2|||
144549756|NCT00800176|521211422|FG001|Overall Study|Adverse Event|1|||
144549757|NCT00800176|521211423|FG002|Overall Study|Adverse Event|0|||
144549758|NCT00800176|521211424|FG003|Overall Study|Adverse Event|2|||
144549759|NCT00800176|521211425|FG004|Overall Study|Adverse Event|1|||
144549760|NCT00800176|521211426|FG005|Overall Study|Adverse Event|1|||
144549761|NCT00800176|521211421|FG000|Overall Study|Refused treatment|3|||
144549762|NCT00800176|521211422|FG001|Overall Study|Refused treatment|2|||
144549763|NCT00800176|521211423|FG002|Overall Study|Refused treatment|0|||
144549764|NCT00800176|521211424|FG003|Overall Study|Refused treatment|0|||
144549765|NCT00800176|521211425|FG004|Overall Study|Refused treatment|1|||
144549766|NCT00800176|521211426|FG005|Overall Study|Refused treatment|4|||
144549767|NCT00800176|521211421|FG000|Overall Study|Failure to return|3|||
144549768|NCT00800176|521211422|FG001|Overall Study|Failure to return|3|||
144549769|NCT00800176|521211423|FG002|Overall Study|Failure to return|0|||
144549770|NCT00800176|521211424|FG003|Overall Study|Failure to return|2|||
144549771|NCT00800176|521211425|FG004|Overall Study|Failure to return|0|||
144549772|NCT00800176|521211426|FG005|Overall Study|Failure to return|0|||
144549773|NCT00800176|521211421|FG000|Overall Study|Other|1|||
144549774|NCT00800176|521211422|FG001|Overall Study|Other|0|||
144549775|NCT00800176|521211423|FG002|Overall Study|Other|0|||
144549776|NCT00800176|521211424|FG003|Overall Study|Other|0|||
144549777|NCT00800176|521211425|FG004|Overall Study|Other|2|||
144549778|NCT00800176|521211426|FG005|Overall Study|Other|0|||
144549779|NCT00805441|521211429|FG000|Overall Study|Adverse Event|5|||
144549780|NCT00805441|521211430|FG001|Overall Study|Adverse Event|2|||
144549781|NCT00805441|521211429|FG000|Overall Study|Lack of Efficacy|0|||
144549782|NCT00805441|521211430|FG001|Overall Study|Lack of Efficacy|2|||
144549783|NCT00805441|521211429|FG000|Overall Study|Protocol Violation|4|||
144549784|NCT00805441|521211430|FG001|Overall Study|Protocol Violation|8|||
144549785|NCT00805441|521211429|FG000|Overall Study|Lost to Follow-up|10|||
144549786|NCT00805441|521211430|FG001|Overall Study|Lost to Follow-up|13|||
144549787|NCT00805441|521211429|FG000|Overall Study|Withdrawal by Subject|15|||
144549788|NCT00805441|521211430|FG001|Overall Study|Withdrawal by Subject|9|||
144549789|NCT00805441|521211429|FG000|Overall Study|Physician Decision|0|||
144549790|NCT00805441|521211430|FG001|Overall Study|Physician Decision|1|||
144549791|NCT00805441|521211429|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
144549792|NCT00805441|521211430|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
144549793|NCT02935894|521211432|FG000|Overall Study|Subject dismissed|1|||
144549794|NCT03786471|521211437|FG000|Overall Study|Death|254|||
144549795|NCT03786471|521211438|FG001|Overall Study|Death|223|||
144549796|NCT03786471|521211439|FG002|Overall Study|Death|37|||
144616624|NCT02706873|521456366|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
144616625|NCT02706873|521456367|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
144616626|NCT02706873|521456368|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
144549797|NCT03786471|521211437|FG000|Overall Study|Lost to Follow-up|63|||
144549798|NCT03786471|521211438|FG001|Overall Study|Lost to Follow-up|50|||
144549799|NCT03786471|521211439|FG002|Overall Study|Lost to Follow-up|15|||
144549800|NCT03786471|521211437|FG000|Overall Study|Withdrawal by Subject|99|||
144549801|NCT03786471|521211438|FG001|Overall Study|Withdrawal by Subject|81|||
144549802|NCT03786471|521211439|FG002|Overall Study|Withdrawal by Subject|11|||
144549803|NCT00747149|521213008|FG000|Overall Study|Adverse Event|0|||
144549804|NCT00747149|521213009|FG001|Overall Study|Adverse Event|15|||
144549805|NCT00747149|521213008|FG000|Overall Study|Lost to Follow-up|0|||
144549806|NCT00747149|521213009|FG001|Overall Study|Lost to Follow-up|10|||
144549807|NCT00747149|521213008|FG000|Overall Study|Withdrawal by Subject|0|||
144549808|NCT00747149|521213009|FG001|Overall Study|Withdrawal by Subject|6|||
144549809|NCT00747149|521213008|FG000|Overall Study|Did not receive treatment|0|||
144549810|NCT00747149|521213009|FG001|Overall Study|Did not receive treatment|1|||
144549811|NCT00747149|521213008|FG000|Overall Study|Incorrect enrollment|0|||
144549812|NCT00747149|521213009|FG001|Overall Study|Incorrect enrollment|6|||
144549813|NCT00747149|521213008|FG000|Overall Study|Severe non-compliance to protocol|0|||
144549814|NCT00747149|521213009|FG001|Overall Study|Severe non-compliance to protocol|1|||
144549815|NCT00747149|521213008|FG000|Overall Study|Not reported|1|||
144549816|NCT00747149|521213009|FG001|Overall Study|Not reported|4|||
144549817|NCT03840200|521213014|FG000|Overall Study|Death|6|||
144549818|NCT03840200|521213015|FG001|Overall Study|Death|3|||
144549819|NCT03840200|521213016|FG002|Overall Study|Death|6|||
144549820|NCT03840200|521213017|FG003|Overall Study|Death|10|||
144549821|NCT03840200|521213014|FG000|Overall Study|Reason Not Specified|2|||
144549822|NCT03840200|521213015|FG001|Overall Study|Reason Not Specified|2|||
144549823|NCT03840200|521213016|FG002|Overall Study|Reason Not Specified|1|||
144549824|NCT03840200|521213017|FG003|Overall Study|Reason Not Specified|15|||
144549825|NCT03840200|521213014|FG000|Overall Study|Physician Decision|0|||
144549826|NCT03840200|521213015|FG001|Overall Study|Physician Decision|0|||
144549827|NCT03840200|521213016|FG002|Overall Study|Physician Decision|0|||
144549828|NCT03840200|521213017|FG003|Overall Study|Physician Decision|2|||
144549829|NCT03840200|521213014|FG000|Overall Study|Progressive Disease|0|||
144549830|NCT03840200|521213015|FG001|Overall Study|Progressive Disease|0|||
144549831|NCT03840200|521213016|FG002|Overall Study|Progressive Disease|0|||
144549832|NCT03840200|521213017|FG003|Overall Study|Progressive Disease|1|||
144549833|NCT03840200|521213014|FG000|Overall Study|Withdrawal by Subject|0|||
144549834|NCT03840200|521213015|FG001|Overall Study|Withdrawal by Subject|1|||
144549835|NCT03840200|521213016|FG002|Overall Study|Withdrawal by Subject|0|||
144549836|NCT03840200|521213017|FG003|Overall Study|Withdrawal by Subject|2|||
144549837|NCT05522777|521213018|FG000|Overall Study|Lack of Efficacy|1|||
144549838|NCT05522777|521213018|FG000|Overall Study|Withdrawal by Subject|1|||
144549839|NCT05006703|521213021|FG000|Overall Study|Withdrawal by Subject|1|||
144549840|NCT05006703|521213022|FG001|Overall Study|Withdrawal by Subject|0|||
144549841|NCT05006703|521213021|FG000|Overall Study|Lost to Follow-up|13|||
144549842|NCT05006703|521213022|FG001|Overall Study|Lost to Follow-up|5|||
144549843|NCT04620733|521213023|FG000|Overall Study|Adverse Event|4|||
144549844|NCT04620733|521213024|FG001|Overall Study|Adverse Event|3|||
144549845|NCT04620733|521213023|FG000|Overall Study|Withdrawal by Subject|2|||
144549846|NCT04620733|521213024|FG001|Overall Study|Withdrawal by Subject|5|||
144549847|NCT04620733|521213023|FG000|Overall Study|Lost to Follow-up|1|||
144549848|NCT04620733|521213024|FG001|Overall Study|Lost to Follow-up|1|||
144549849|NCT04620733|521213023|FG000|Overall Study|Protocol Deviation|1|||
144549850|NCT04620733|521213024|FG001|Overall Study|Protocol Deviation|1|||
144549851|NCT04620733|521213023|FG000|Overall Study|Reason Not Specified|0|||
144549852|NCT04620733|521213024|FG001|Overall Study|Reason Not Specified|1|||
144549853|NCT00264576|521213029|FG000|Overall Study|Lost to Follow-up|1|||
144549854|NCT00264576|521213030|FG001|Overall Study|Lost to Follow-up|1|||
144549855|NCT02659059|521213033|FG000|Overall Study|Other reasons|6|||
144549856|NCT02659059|521213034|FG001|Overall Study|Other reasons|1|||
144549857|NCT02659059|521213033|FG000|Overall Study|Disease Progression|143|||
144549858|NCT02659059|521213034|FG001|Overall Study|Disease Progression|16|||
144549859|NCT02659059|521213033|FG000|Overall Study|Study Drug toxicity|56|||
144549860|NCT02659059|521213034|FG001|Overall Study|Study Drug toxicity|9|||
144549861|NCT02659059|521213033|FG000|Overall Study|Death|3|||
144549862|NCT02659059|521213034|FG001|Overall Study|Death|1|||
144549863|NCT02659059|521213033|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
144549864|NCT02659059|521213034|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
144549865|NCT02659059|521213033|FG000|Overall Study|Participant request to discontinue study treatment|5|||
144549866|NCT02659059|521213034|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144549867|NCT02659059|521213033|FG000|Overall Study|Participant withdrew consent|6|||
144549868|NCT02659059|521213034|FG001|Overall Study|Participant withdrew consent|1|||
144549869|NCT00092456|521213040|FG000|Overall Study|Adverse Event|0|||
144549870|NCT00092456|521213041|FG001|Overall Study|Adverse Event|0|||
144549871|NCT00092456|521213042|FG002|Overall Study|Adverse Event|1|||
144549872|NCT00092456|521213043|FG003|Overall Study|Adverse Event|1|||
144549873|NCT00092456|521213040|FG000|Overall Study|Lost to Follow-up|2|||
144549874|NCT00092456|521213041|FG001|Overall Study|Lost to Follow-up|2|||
144549875|NCT00092456|521213042|FG002|Overall Study|Lost to Follow-up|1|||
144549876|NCT00092456|521213043|FG003|Overall Study|Lost to Follow-up|2|||
144549877|NCT00092456|521213040|FG000|Overall Study|Protocol Violation|5|||
144549878|NCT00092456|521213041|FG001|Overall Study|Protocol Violation|7|||
144549879|NCT00092456|521213042|FG002|Overall Study|Protocol Violation|8|||
144549880|NCT00092456|521213043|FG003|Overall Study|Protocol Violation|6|||
144549881|NCT00092456|521213040|FG000|Overall Study|Withdrawal by Subject|13|||
144549882|NCT00092456|521213041|FG001|Overall Study|Withdrawal by Subject|5|||
144549883|NCT00092456|521213042|FG002|Overall Study|Withdrawal by Subject|16|||
144549884|NCT00092456|521213043|FG003|Overall Study|Withdrawal by Subject|6|||
144549885|NCT00092456|521213040|FG000|Overall Study|Moved|1|||
144549886|NCT00092456|521213041|FG001|Overall Study|Moved|1|||
144549887|NCT00092456|521213042|FG002|Overall Study|Moved|0|||
144549888|NCT00092456|521213043|FG003|Overall Study|Moved|1|||
144549889|NCT00092456|521213040|FG000|Overall Study|Other|4|||
144549890|NCT00092456|521213041|FG001|Overall Study|Other|2|||
144549891|NCT00092456|521213042|FG002|Overall Study|Other|3|||
144549892|NCT00092456|521213043|FG003|Overall Study|Other|0|||
144549893|NCT04783389|521213044|FG000|Overall Study|Withdrawal by Subject|2|||
144549894|NCT04783389|521213045|FG001|Overall Study|Withdrawal by Subject|0|||
144549895|NCT04783389|521213046|FG002|Overall Study|Withdrawal by Subject|0|||
144549896|NCT04783389|521213044|FG000|Overall Study|Termination of Study by Sponsor|10|||
144549897|NCT04783389|521213045|FG001|Overall Study|Termination of Study by Sponsor|12|||
144549898|NCT04783389|521213046|FG002|Overall Study|Termination of Study by Sponsor|14|||
144549899|NCT00451906|521213047|FG000|Overall Study|Adverse Event|515|||
144549900|NCT00451906|521213047|FG000|Overall Study|Lost to Follow-up|31|||
144549901|NCT00451906|521213047|FG000|Overall Study|Withdrawal by Subject|111|||
144549902|NCT00451906|521213047|FG000|Overall Study|Protocol Violation|21|||
144549903|NCT00451906|521213047|FG000|Overall Study|Progressive disease|1328|||
144549904|NCT00451906|521213047|FG000|Overall Study|Termination of the study|108|||
144549905|NCT00451906|521213047|FG000|Overall Study|Other Reasons|121|||
144549906|NCT00451906|521213047|FG000|Overall Study|Did not complete final visit|4|||
144549907|NCT03924193|521213053|FG000|Overall Study|Adverse Event|10|||
144549908|NCT03924193|521213054|FG001|Overall Study|Adverse Event|0|||
144549909|NCT03924193|521213055|FG002|Overall Study|Adverse Event|10|||
144549910|NCT03924193|521213053|FG000|Overall Study|Withdrawal by Subject|5|||
144549911|NCT03924193|521213054|FG001|Overall Study|Withdrawal by Subject|10|||
144549912|NCT03924193|521213055|FG002|Overall Study|Withdrawal by Subject|2|||
144549913|NCT00647699|521213056|FG000|Overall Study|Lost to Follow-up|5|||
144549914|NCT00647699|521213057|FG001|Overall Study|Lost to Follow-up|4|||
144549915|NCT00647699|521213056|FG000|Overall Study|Withdrawal by Subject|3|||
144549916|NCT00647699|521213057|FG001|Overall Study|Withdrawal by Subject|8|||
144549917|NCT03029585|521213058|FG000|Overall Study|Death|1|||
144549918|NCT03029585|521213059|FG001|Overall Study|Death|1|||
144549919|NCT03029585|521213058|FG000|Overall Study|Withdrawal by Subject|1|||
144549920|NCT03029585|521213059|FG001|Overall Study|Withdrawal by Subject|0|||
144549921|NCT00990184|521213060|FG000|Overall Study|Physician Decision|1|||
144549922|NCT04361617|521213061|FG000|Overall Study|Withdrawal by Subject|0|||
144549923|NCT04361617|521213062|FG001|Overall Study|Withdrawal by Subject|1|||
144549924|NCT02005484|521213064|FG000|Overall Study|Death|1|||
144549925|NCT02005484|521213064|FG000|Overall Study|Disease progression|1|||
144549926|NCT02005484|521213064|FG000|Overall Study|Changed to a Different Study|1|||
144549927|NCT02005484|521213064|FG000|Overall Study|Sponsor decision|1|||
144549928|NCT03695185|521213071|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
144549929|NCT03695185|521213071|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
144549930|NCT03695185|521213071|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
144549931|NCT03695185|521213071|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
144549932|NCT03695185|521213071|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
144549933|NCT03695185|521213071|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
144549934|NCT02137785|521213072|FG000|Overall Study|Lost to Follow-up|1|||
144549935|NCT02137785|521213073|FG001|Overall Study|Lost to Follow-up|0|||
144549936|NCT02137785|521213072|FG000|Overall Study|Withdrawal by Subject|1|||
144549937|NCT02137785|521213073|FG001|Overall Study|Withdrawal by Subject|4|||
144549938|NCT02137785|521213072|FG000|Overall Study|subject moved out of state|1|||
144549939|NCT02137785|521213073|FG001|Overall Study|subject moved out of state|0|||
144549940|NCT02584257|521213074|FG000|Period 1|Withdrawal by Subject|0|||
144549941|NCT02584257|521213075|FG001|Period 1|Withdrawal by Subject|0|||
144549942|NCT02584257|521213076|FG002|Period 1|Withdrawal by Subject|0|||
144549943|NCT02584257|521213077|FG003|Period 1|Withdrawal by Subject|0|||
144549944|NCT02584257|521213078|FG004|Period 1|Withdrawal by Subject|0|||
144549945|NCT02584257|521213079|FG005|Period 1|Withdrawal by Subject|0|||
144549946|NCT02584257|521213080|FG006|Period 1|Withdrawal by Subject|1|||
144549947|NCT02584257|521213081|FG007|Period 1|Withdrawal by Subject|0|||
144549948|NCT02584257|521213082|FG008|Period 1|Withdrawal by Subject|0|||
144549949|NCT02584257|521213074|FG000|Period 2|Physician Decision|1|||
144549950|NCT02584257|521213075|FG001|Period 2|Physician Decision|0|||
144549951|NCT02584257|521213076|FG002|Period 2|Physician Decision|0|||
144549952|NCT02584257|521213077|FG003|Period 2|Physician Decision|0|||
144549953|NCT02584257|521213078|FG004|Period 2|Physician Decision|0|||
144549954|NCT02584257|521213079|FG005|Period 2|Physician Decision|0|||
144549955|NCT02584257|521213080|FG006|Period 2|Physician Decision|0|||
144727639|NCT02130466|521856670|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
144549956|NCT02584257|521213081|FG007|Period 2|Physician Decision|0|||
144549957|NCT02584257|521213082|FG008|Period 2|Physician Decision|0|||
144549958|NCT02584257|521213074|FG000|Period 2|Adverse Event|0|||
144549959|NCT02584257|521213075|FG001|Period 2|Adverse Event|1|||
144549960|NCT02584257|521213076|FG002|Period 2|Adverse Event|0|||
144549961|NCT02584257|521213077|FG003|Period 2|Adverse Event|0|||
144549962|NCT02584257|521213078|FG004|Period 2|Adverse Event|0|||
144549963|NCT02584257|521213079|FG005|Period 2|Adverse Event|0|||
144549964|NCT02584257|521213080|FG006|Period 2|Adverse Event|0|||
144549965|NCT02584257|521213081|FG007|Period 2|Adverse Event|0|||
144549966|NCT02584257|521213082|FG008|Period 2|Adverse Event|0|||
144549967|NCT01670877|521213083|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
144549968|NCT01670877|521213084|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
144549969|NCT01670877|521213085|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
144549970|NCT01670877|521213086|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
144549971|NCT01670877|521213087|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
144549972|NCT01670877|521213088|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
144549973|NCT01670877|521213083|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
144549974|NCT01670877|521213084|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
144549975|NCT01670877|521213085|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
144549976|NCT01670877|521213086|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
144549977|NCT01670877|521213087|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
144549978|NCT01670877|521213088|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
144549979|NCT01670877|521213083|FG000|Part I and Part 2|Grade 2 vomiting|0|||
144549980|NCT01670877|521213084|FG001|Part I and Part 2|Grade 2 vomiting|0|||
144549981|NCT01670877|521213085|FG002|Part I and Part 2|Grade 2 vomiting|0|||
144549982|NCT01670877|521213086|FG003|Part I and Part 2|Grade 2 vomiting|1|||
144549983|NCT01670877|521213087|FG004|Part I and Part 2|Grade 2 vomiting|0|||
144549984|NCT01670877|521213088|FG005|Part I and Part 2|Grade 2 vomiting|0|||
144549985|NCT01670877|521213083|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
144549986|NCT01670877|521213084|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
144549987|NCT01670877|521213085|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
144549988|NCT01670877|521213086|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
144549989|NCT01670877|521213087|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
144549990|NCT01670877|521213088|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
144549991|NCT01670877|521213083|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
144549992|NCT01670877|521213084|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
144549993|NCT01670877|521213085|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
144549994|NCT01670877|521213086|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
144549995|NCT01670877|521213087|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
144549996|NCT01670877|521213088|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
144549997|NCT00417885|521213089|FG000|Overall Study|Adverse Event|1|||
144549998|NCT00417885|521213089|FG000|Overall Study|Objective Progression or Relapse|3|||
144549999|NCT00417885|521213089|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
144550000|NCT02309892|521213090|FG000|Overall Study|Physician Decision|1|||
144550001|NCT02309892|521213091|FG001|Overall Study|Physician Decision|0|||
144550002|NCT02309892|521213092|FG002|Overall Study|Physician Decision|0|||
144550003|NCT02309892|521213093|FG003|Overall Study|Physician Decision|0|||
144550004|NCT02309892|521213094|FG004|Overall Study|Physician Decision|0|||
144550005|NCT02309892|521213095|FG005|Overall Study|Physician Decision|0|||
144550006|NCT02309892|521213096|FG006|Overall Study|Physician Decision|0|||
144550007|NCT02309892|521213090|FG000|Overall Study|Adverse Event|1|||
144550008|NCT02309892|521213091|FG001|Overall Study|Adverse Event|0|||
144550009|NCT02309892|521213092|FG002|Overall Study|Adverse Event|1|||
144550010|NCT02309892|521213093|FG003|Overall Study|Adverse Event|0|||
144550011|NCT02309892|521213094|FG004|Overall Study|Adverse Event|0|||
144550012|NCT02309892|521213095|FG005|Overall Study|Adverse Event|0|||
144550013|NCT02309892|521213096|FG006|Overall Study|Adverse Event|0|||
144550014|NCT02309892|521213090|FG000|Overall Study|Progressive Disease|0|||
144550015|NCT02309892|521213091|FG001|Overall Study|Progressive Disease|1|||
144550016|NCT02309892|521213092|FG002|Overall Study|Progressive Disease|0|||
144550017|NCT02309892|521213093|FG003|Overall Study|Progressive Disease|0|||
144550018|NCT02309892|521213094|FG004|Overall Study|Progressive Disease|1|||
144550019|NCT02309892|521213095|FG005|Overall Study|Progressive Disease|0|||
144550020|NCT02309892|521213096|FG006|Overall Study|Progressive Disease|0|||
144550021|NCT02309892|521213090|FG000|Overall Study|Death|0|||
144550022|NCT02309892|521213091|FG001|Overall Study|Death|0|||
144550023|NCT02309892|521213092|FG002|Overall Study|Death|0|||
144550024|NCT02309892|521213093|FG003|Overall Study|Death|0|||
144550025|NCT02309892|521213094|FG004|Overall Study|Death|0|||
144550026|NCT02309892|521213095|FG005|Overall Study|Death|1|||
144550027|NCT02309892|521213096|FG006|Overall Study|Death|0|||
144550028|NCT01584648|521213097|FG000|Overall Study|Death|136|||
144550029|NCT01584648|521213098|FG001|Overall Study|Death|146|||
144550030|NCT01584648|521213097|FG000|Overall Study|Lost to Follow-up|9|||
144550031|NCT01584648|521213098|FG001|Overall Study|Lost to Follow-up|9|||
144550032|NCT01584648|521213097|FG000|Overall Study|Investigator discretion|3|||
144550033|NCT01584648|521213098|FG001|Overall Study|Investigator discretion|2|||
144550034|NCT01584648|521213097|FG000|Overall Study|Withdrew consent|13|||
144550035|NCT01584648|521213098|FG001|Overall Study|Withdrew consent|4|||
144550036|NCT01584648|521213097|FG000|Overall Study|Study closed/terminated|50|||
144550037|NCT01584648|521213098|FG001|Overall Study|Study closed/terminated|23|||
144550038|NCT01584648|521213097|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
144550039|NCT01584648|521213098|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
144550040|NCT01722097|521213099|FG000|Overall Study|Patient sheets not returned|6|||
144550041|NCT01722097|521213100|FG001|Overall Study|Patient sheets not returned|5|||
144550042|NCT01757288|521213103|FG000|Overall Study|Consent withdrawal|0|||
144550043|NCT01757288|521213104|FG001|Overall Study|Consent withdrawal|4|||
144550044|NCT01757288|521213105|FG002|Overall Study|Consent withdrawal|4|||
144550045|NCT01757288|521213103|FG000|Overall Study|Patient off study, IRB hold.|0|||
144550046|NCT01757288|521213104|FG001|Overall Study|Patient off study, IRB hold.|0|||
144550047|NCT01757288|521213105|FG002|Overall Study|Patient off study, IRB hold.|1|||
144550048|NCT01757288|521213103|FG000|Overall Study|Patient death prior to starting treatment|0|||
144550049|NCT01757288|521213104|FG001|Overall Study|Patient death prior to starting treatment|0|||
144550050|NCT01757288|521213105|FG002|Overall Study|Patient death prior to starting treatment|1|||
144550051|NCT01757288|521213103|FG000|Overall Study|Wrong medication administered|0|||
144550052|NCT01757288|521213104|FG001|Overall Study|Wrong medication administered|1|||
144550053|NCT01757288|521213105|FG002|Overall Study|Wrong medication administered|0|||
144550054|NCT01757288|521213103|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
144550055|NCT01757288|521213104|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
144550056|NCT01757288|521213105|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
144550057|NCT01757288|521213103|FG000|Overall Study|Not meeting protocol constraints|0|||
144550058|NCT01757288|521213104|FG001|Overall Study|Not meeting protocol constraints|1|||
144550059|NCT01757288|521213105|FG002|Overall Study|Not meeting protocol constraints|1|||
144550060|NCT01757288|521213103|FG000|Overall Study|Multiple missed appointments|0|||
144550061|NCT01757288|521213104|FG001|Overall Study|Multiple missed appointments|1|||
144550062|NCT01757288|521213105|FG002|Overall Study|Multiple missed appointments|0|||
144550063|NCT01757288|521213103|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
144550064|NCT01757288|521213104|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
144550065|NCT01757288|521213105|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
144550066|NCT01757288|521213103|FG000|Overall Study|>2 weeks treatment break|0|||
144550067|NCT01757288|521213104|FG001|Overall Study|>2 weeks treatment break|0|||
144550068|NCT01757288|521213105|FG002|Overall Study|>2 weeks treatment break|1|||
144550069|NCT02825550|521213106|FG000|Overall Study|Physician Decision|1|||
144550070|NCT00042939|521213110|FG000|Overall Study|Adverse Event|6|||
144550071|NCT00042939|521213111|FG001|Overall Study|Adverse Event|7|||
144550072|NCT00042939|521213110|FG000|Overall Study|Death|3|||
144550073|NCT00042939|521213111|FG001|Overall Study|Death|2|||
144550074|NCT00042939|521213110|FG000|Overall Study|Withdrawal by Subject|3|||
144550075|NCT00042939|521213111|FG001|Overall Study|Withdrawal by Subject|4|||
144550076|NCT00042939|521213110|FG000|Overall Study|Other disease|1|||
144550077|NCT00042939|521213111|FG001|Overall Study|Other disease|0|||
144550078|NCT00042939|521213110|FG000|Overall Study|Ineligible|2|||
144550079|NCT00042939|521213111|FG001|Overall Study|Ineligible|2|||
144550080|NCT00042939|521213110|FG000|Overall Study|Deterioration of health|3|||
144550081|NCT00042939|521213111|FG001|Overall Study|Deterioration of health|4|||
144550082|NCT00042939|521213110|FG000|Overall Study|QOL diminished|1|||
144550083|NCT00042939|521213111|FG001|Overall Study|QOL diminished|0|||
144550084|NCT00042939|521213110|FG000|Overall Study|Rising ca 19-9|1|||
144550085|NCT00042939|521213111|FG001|Overall Study|Rising ca 19-9|0|||
144550086|NCT00042939|521213110|FG000|Overall Study|Patient non-compliance|1|||
144550087|NCT00042939|521213111|FG001|Overall Study|Patient non-compliance|0|||
144550088|NCT00042939|521213110|FG000|Overall Study|Still on treatment|1|||
144550089|NCT00042939|521213111|FG001|Overall Study|Still on treatment|0|||
144550090|NCT00042939|521213110|FG000|Overall Study|Treatment break > 4 weeks|0|||
144550091|NCT00042939|521213111|FG001|Overall Study|Treatment break > 4 weeks|1|||
144550092|NCT00042939|521213110|FG000|Overall Study|Did not start treatment|2|||
144550093|NCT00042939|521213111|FG001|Overall Study|Did not start treatment|1|||
144550094|NCT00795639|521213112|FG000|Overall Study|Death|1|||
144550095|NCT00795639|521213113|FG001|Overall Study|Death|6|||
144550096|NCT00795639|521213112|FG000|Overall Study|Withdrawal by Subject|1|||
144550097|NCT00795639|521213113|FG001|Overall Study|Withdrawal by Subject|3|||
144550098|NCT00795639|521213112|FG000|Overall Study|Pregnancy|1|||
144550099|NCT00795639|521213113|FG001|Overall Study|Pregnancy|0|||
144550100|NCT00795639|521213112|FG000|Overall Study|Adverse Event|5|||
144550101|NCT00795639|521213113|FG001|Overall Study|Adverse Event|2|||
144550102|NCT00795639|521213112|FG000|Overall Study|Other|0|||
144550103|NCT00795639|521213113|FG001|Overall Study|Other|2|||
144550104|NCT00795639|521213112|FG000|Overall Study|Terminated by sponsor|13|||
144550105|NCT00795639|521213113|FG001|Overall Study|Terminated by sponsor|12|||
144550106|NCT00795639|521213112|FG000|Overall Study|Randomized and not treated|0|||
144550107|NCT00795639|521213113|FG001|Overall Study|Randomized and not treated|1|||
144550108|NCT03349476|521213114|FG000|Overall Study|Physician Decision|3|||
144550109|NCT00248794|521213115|FG000|Overall Study|Lost to Follow-up|6|||
144550110|NCT00248794|521213116|FG001|Overall Study|Lost to Follow-up|8|||
144550111|NCT00248794|521213117|FG002|Overall Study|Lost to Follow-up|3|||
144550112|NCT01762345|521213120|FG000|Overall Study|Adverse Event|5|||
144550113|NCT01762345|521213120|FG000|Overall Study|Protocol Violation|2|||
144550114|NCT00244751|521213121|FG000|Overall Study|Adverse Event|7|||
144550115|NCT00244751|521213122|FG001|Overall Study|Adverse Event|7|||
144550116|NCT00244751|521213123|FG002|Overall Study|Adverse Event|5|||
144550117|NCT00244751|521213121|FG000|Overall Study|Lost to Follow-up|0|||
144550118|NCT00244751|521213122|FG001|Overall Study|Lost to Follow-up|1|||
144550119|NCT00244751|521213123|FG002|Overall Study|Lost to Follow-up|0|||
144550120|NCT00244751|521213121|FG000|Overall Study|Protocol Violation|1|||
144550121|NCT00244751|521213122|FG001|Overall Study|Protocol Violation|0|||
144550122|NCT00244751|521213123|FG002|Overall Study|Protocol Violation|1|||
144550123|NCT00244751|521213121|FG000|Overall Study|Withdrawal by Subject|7|||
144550124|NCT00244751|521213122|FG001|Overall Study|Withdrawal by Subject|5|||
144550125|NCT00244751|521213123|FG002|Overall Study|Withdrawal by Subject|3|||
144550126|NCT00244751|521213121|FG000|Overall Study|Elevated liver enzymes|1|||
144550127|NCT00244751|521213122|FG001|Overall Study|Elevated liver enzymes|0|||
144550128|NCT00244751|521213123|FG002|Overall Study|Elevated liver enzymes|0|||
144550129|NCT00244751|521213121|FG000|Overall Study|Lack of compliance with protocol|0|||
144550130|NCT00244751|521213122|FG001|Overall Study|Lack of compliance with protocol|1|||
144550131|NCT00244751|521213123|FG002|Overall Study|Lack of compliance with protocol|0|||
144550132|NCT00244751|521213121|FG000|Overall Study|Safety reasons|0|||
144550133|NCT00244751|521213122|FG001|Overall Study|Safety reasons|1|||
144550134|NCT00244751|521213123|FG002|Overall Study|Safety reasons|0|||
144550135|NCT00244751|521213121|FG000|Overall Study|Participant randomized by mistake|0|||
144550136|NCT00244751|521213122|FG001|Overall Study|Participant randomized by mistake|0|||
144550137|NCT00244751|521213123|FG002|Overall Study|Participant randomized by mistake|1|||
144550138|NCT02206607|521213126|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
144550139|NCT02206607|521213127|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
144550140|NCT02206607|521213128|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
144550141|NCT02206607|521213129|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
144550142|NCT02206607|521213130|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
144550143|NCT02206607|521213126|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
144550144|NCT02206607|521213127|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
144550145|NCT02206607|521213128|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
144550146|NCT02206607|521213129|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
144550147|NCT02206607|521213130|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
144550148|NCT00761267|521213131|FG000|Overall Study|Death|1|||
144550149|NCT00761267|521213132|FG001|Overall Study|Death|2|||
144550150|NCT00761267|521213133|FG002|Overall Study|Death|5|||
144550151|NCT00761267|521213131|FG000|Overall Study|Lost to Follow-up|0|||
144550152|NCT00761267|521213132|FG001|Overall Study|Lost to Follow-up|0|||
144550153|NCT00761267|521213133|FG002|Overall Study|Lost to Follow-up|1|||
144550154|NCT00761267|521213131|FG000|Overall Study|Randomized but not treated|1|||
144550155|NCT00761267|521213132|FG001|Overall Study|Randomized but not treated|1|||
144550156|NCT00761267|521213133|FG002|Overall Study|Randomized but not treated|0|||
144550157|NCT00761267|521213131|FG000|Overall Study|Withdrawal by Subject|0|||
144550158|NCT00761267|521213132|FG001|Overall Study|Withdrawal by Subject|1|||
144550159|NCT00761267|521213133|FG002|Overall Study|Withdrawal by Subject|0|||
144550160|NCT01419184|521213141|FG000|Overall Study|Site data not available|3|||
144550161|NCT01419184|521213142|FG001|Overall Study|Site data not available|2|||
144550162|NCT01419184|521213141|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
144550163|NCT01419184|521213142|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
144550164|NCT01419184|521213141|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
144550165|NCT01419184|521213142|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
144550166|NCT01419184|521213141|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
144550167|NCT01419184|521213142|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
144550168|NCT01419184|521213141|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
144550169|NCT01419184|521213142|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
144550170|NCT01419184|521213141|FG000|Overall Study|Participant randomized, not treated|1|||
144550171|NCT01419184|521213142|FG001|Overall Study|Participant randomized, not treated|0|||
144550172|NCT03541369|521213147|FG000|Overall Study|Death|0|||
144550173|NCT03541369|521213148|FG001|Overall Study|Death|0|||
144550174|NCT03541369|521213149|FG002|Overall Study|Death|0|||
144550175|NCT03541369|521213150|FG003|Overall Study|Death|0|||
144550176|NCT03541369|521213151|FG004|Overall Study|Death|1|||
144550177|NCT03541369|521213152|FG005|Overall Study|Death|1|||
144550178|NCT03541369|521213153|FG006|Overall Study|Death|0|||
144550179|NCT03541369|521213154|FG007|Overall Study|Death|2|||
144550180|NCT03541369|521213155|FG008|Overall Study|Death|1|||
144550181|NCT03541369|521213156|FG009|Overall Study|Death|2|||
144550182|NCT03541369|521213157|FG010|Overall Study|Death|1|||
144550183|NCT03541369|521213158|FG011|Overall Study|Death|0|||
144550184|NCT03541369|521213159|FG012|Overall Study|Death|2|||
144550185|NCT03541369|521213160|FG013|Overall Study|Death|1|||
144550186|NCT03541369|521213161|FG014|Overall Study|Death|1|||
144550187|NCT03541369|521213162|FG015|Overall Study|Death|1|||
144550188|NCT03541369|521213163|FG016|Overall Study|Death|0|||
144550189|NCT03541369|521213164|FG017|Overall Study|Death|1|||
144550190|NCT03541369|521213147|FG000|Overall Study|Decision by sponsor|0|||
144550191|NCT03541369|521213148|FG001|Overall Study|Decision by sponsor|0|||
144550192|NCT03541369|521213149|FG002|Overall Study|Decision by sponsor|0|||
144550193|NCT03541369|521213150|FG003|Overall Study|Decision by sponsor|1|||
144550194|NCT03541369|521213151|FG004|Overall Study|Decision by sponsor|0|||
144550195|NCT03541369|521213152|FG005|Overall Study|Decision by sponsor|2|||
144550196|NCT03541369|521213153|FG006|Overall Study|Decision by sponsor|0|||
144550197|NCT03541369|521213154|FG007|Overall Study|Decision by sponsor|1|||
144550198|NCT03541369|521213155|FG008|Overall Study|Decision by sponsor|2|||
144550199|NCT03541369|521213156|FG009|Overall Study|Decision by sponsor|0|||
144550200|NCT03541369|521213157|FG010|Overall Study|Decision by sponsor|0|||
144550201|NCT03541369|521213158|FG011|Overall Study|Decision by sponsor|0|||
144550202|NCT03541369|521213159|FG012|Overall Study|Decision by sponsor|2|||
144550203|NCT03541369|521213160|FG013|Overall Study|Decision by sponsor|2|||
144550204|NCT03541369|521213161|FG014|Overall Study|Decision by sponsor|0|||
144550205|NCT03541369|521213162|FG015|Overall Study|Decision by sponsor|1|||
144550206|NCT03541369|521213163|FG016|Overall Study|Decision by sponsor|1|||
144550207|NCT03541369|521213164|FG017|Overall Study|Decision by sponsor|1|||
144550208|NCT03541369|521213147|FG000|Overall Study|Withdrawal by Subject|0|||
144550209|NCT03541369|521213148|FG001|Overall Study|Withdrawal by Subject|0|||
144550210|NCT03541369|521213149|FG002|Overall Study|Withdrawal by Subject|0|||
144550211|NCT03541369|521213150|FG003|Overall Study|Withdrawal by Subject|0|||
144550212|NCT03541369|521213151|FG004|Overall Study|Withdrawal by Subject|0|||
144550213|NCT03541369|521213152|FG005|Overall Study|Withdrawal by Subject|0|||
144550214|NCT03541369|521213153|FG006|Overall Study|Withdrawal by Subject|1|||
144550215|NCT03541369|521213154|FG007|Overall Study|Withdrawal by Subject|0|||
144550216|NCT03541369|521213155|FG008|Overall Study|Withdrawal by Subject|0|||
144550217|NCT03541369|521213156|FG009|Overall Study|Withdrawal by Subject|0|||
144550218|NCT03541369|521213157|FG010|Overall Study|Withdrawal by Subject|0|||
144550219|NCT03541369|521213158|FG011|Overall Study|Withdrawal by Subject|1|||
144550220|NCT03541369|521213159|FG012|Overall Study|Withdrawal by Subject|0|||
144550221|NCT03541369|521213160|FG013|Overall Study|Withdrawal by Subject|0|||
144550222|NCT03541369|521213161|FG014|Overall Study|Withdrawal by Subject|3|||
144550223|NCT03541369|521213162|FG015|Overall Study|Withdrawal by Subject|0|||
144550224|NCT03541369|521213163|FG016|Overall Study|Withdrawal by Subject|4|||
144550225|NCT03541369|521213164|FG017|Overall Study|Withdrawal by Subject|2|||
144550226|NCT03541369|521213147|FG000|Overall Study|Lost to Follow-up|0|||
144550227|NCT03541369|521213148|FG001|Overall Study|Lost to Follow-up|0|||
144550228|NCT03541369|521213149|FG002|Overall Study|Lost to Follow-up|0|||
144550229|NCT03541369|521213150|FG003|Overall Study|Lost to Follow-up|0|||
144550230|NCT03541369|521213151|FG004|Overall Study|Lost to Follow-up|1|||
144550231|NCT03541369|521213152|FG005|Overall Study|Lost to Follow-up|0|||
144550232|NCT03541369|521213153|FG006|Overall Study|Lost to Follow-up|0|||
144550233|NCT03541369|521213154|FG007|Overall Study|Lost to Follow-up|0|||
144550234|NCT03541369|521213155|FG008|Overall Study|Lost to Follow-up|1|||
144550235|NCT03541369|521213156|FG009|Overall Study|Lost to Follow-up|0|||
144550236|NCT03541369|521213157|FG010|Overall Study|Lost to Follow-up|0|||
144550237|NCT03541369|521213158|FG011|Overall Study|Lost to Follow-up|0|||
144550238|NCT03541369|521213159|FG012|Overall Study|Lost to Follow-up|1|||
144550239|NCT03541369|521213160|FG013|Overall Study|Lost to Follow-up|0|||
144550240|NCT03541369|521213161|FG014|Overall Study|Lost to Follow-up|0|||
144550241|NCT03541369|521213162|FG015|Overall Study|Lost to Follow-up|0|||
144550242|NCT03541369|521213163|FG016|Overall Study|Lost to Follow-up|0|||
144550243|NCT03541369|521213164|FG017|Overall Study|Lost to Follow-up|0|||
144550244|NCT02279732|521213167|FG000|Overall Study|Death|23|||
144550245|NCT02279732|521213168|FG001|Overall Study|Death|20|||
144550246|NCT02279732|521213167|FG000|Overall Study|Disease Progression|13|||
144550247|NCT02279732|521213168|FG001|Overall Study|Disease Progression|3|||
144550248|NCT02279732|521213167|FG000|Overall Study|Withdrawal by Subject|2|||
144550249|NCT02279732|521213168|FG001|Overall Study|Withdrawal by Subject|7|||
144550250|NCT02279732|521213167|FG000|Overall Study|Adverse Event|1|||
144550251|NCT02279732|521213168|FG001|Overall Study|Adverse Event|2|||
144550252|NCT02279732|521213167|FG000|Overall Study|Administrative Reason By Sponsor|0|||
144550253|NCT02279732|521213168|FG001|Overall Study|Administrative Reason By Sponsor|2|||
144550254|NCT02279732|521213167|FG000|Overall Study|Study Drug Toxicity|2|||
144550255|NCT02279732|521213168|FG001|Overall Study|Study Drug Toxicity|0|||
144550256|NCT02279732|521213167|FG000|Overall Study|Lost to Follow-up|0|||
144550257|NCT02279732|521213168|FG001|Overall Study|Lost to Follow-up|1|||
144550258|NCT02279732|521213167|FG000|Overall Study|Maximum Clinical Benefit|1|||
144550259|NCT02279732|521213168|FG001|Overall Study|Maximum Clinical Benefit|0|||
144550260|NCT02279732|521213167|FG000|Overall Study|Subject Requested to Discontinue|0|||
144550261|NCT02279732|521213168|FG001|Overall Study|Subject Requested to Discontinue|1|||
144550262|NCT02279732|521213167|FG000|Overall Study|Other|53|||
144550263|NCT02279732|521213168|FG001|Overall Study|Other|67|||
144550264|NCT02279732|521213167|FG000|Overall Study|Other|3|||
144550265|NCT02279732|521213168|FG001|Overall Study|Other|3|||
144550266|NCT03659136|521213169|FG000|Overall Study|Not treated|2|||
144550267|NCT03659136|521213170|FG001|Overall Study|Not treated|0|||
144550268|NCT03659136|521213169|FG000|Overall Study|Covid-19 related|1|||
144550269|NCT03659136|521213170|FG001|Overall Study|Covid-19 related|1|||
144550270|NCT03659136|521213169|FG000|Overall Study|Withdrawal by Subject|1|||
144550271|NCT03659136|521213170|FG001|Overall Study|Withdrawal by Subject|6|||
144550272|NCT03659136|521213169|FG000|Overall Study|Adverse Event|4|||
144550273|NCT03659136|521213170|FG001|Overall Study|Adverse Event|6|||
144550274|NCT03659136|521213169|FG000|Overall Study|Progressive disease|37|||
144550275|NCT03659136|521213170|FG001|Overall Study|Progressive disease|31|||
144550276|NCT03659136|521213169|FG000|Overall Study|Study closure|2|||
144550277|NCT03659136|521213170|FG001|Overall Study|Study closure|2|||
144550278|NCT03659136|521213169|FG000|Overall Study|Sponsor decision/recommendation|3|||
144550279|NCT03659136|521213170|FG001|Overall Study|Sponsor decision/recommendation|2|||
144550280|NCT03659136|521213169|FG000|Overall Study|Switched to other drug/therapy|2|||
144550281|NCT03659136|521213170|FG001|Overall Study|Switched to other drug/therapy|2|||
144550282|NCT03659136|521213169|FG000|Overall Study|Lack of clinical benefit|0|||
144550283|NCT03659136|521213170|FG001|Overall Study|Lack of clinical benefit|1|||
144550284|NCT05487300|521214650|FG000|Overall Study|Withdrawal by Subject|1|||
144550285|NCT05487300|521214651|FG001|Overall Study|Withdrawal by Subject|0|||
144550286|NCT03976102|521214657|FG000|Overall Study|Withdrawal by Subject|4|||
144550287|NCT03976102|521214658|FG001|Overall Study|Withdrawal by Subject|4|||
144550288|NCT03976102|521214657|FG000|Overall Study|Adverse Event|2|||
144550289|NCT03976102|521214658|FG001|Overall Study|Adverse Event|4|||
144550290|NCT03976102|521214657|FG000|Overall Study|Not related to Covid-19|9|||
144550291|NCT03976102|521214658|FG001|Overall Study|Not related to Covid-19|13|||
144550292|NCT03976102|521214657|FG000|Overall Study|Lost to Follow-up|0|||
144550293|NCT03976102|521214658|FG001|Overall Study|Lost to Follow-up|2|||
144550294|NCT03976102|521214657|FG000|Overall Study|Death|3|||
144550295|NCT03976102|521214658|FG001|Overall Study|Death|2|||
144550296|NCT03976102|521214657|FG000|Overall Study|Physician Decision|1|||
144550297|NCT03976102|521214658|FG001|Overall Study|Physician Decision|1|||
144550298|NCT02121808|521214661|FG000|Overall Study|Technical problem|3|||
144550299|NCT05066230|521214662|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
144550300|NCT05066230|521214663|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
144550301|NCT05066230|521214662|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
144550302|NCT05066230|521214663|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
144550303|NCT05066230|521214662|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
144550304|NCT05066230|521214663|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
144550305|NCT05066230|521214662|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
144550306|NCT05066230|521214663|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
144550307|NCT05066230|521214662|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
144550308|NCT05066230|521214663|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
144550309|NCT05066230|521214662|FG000|After Week 48|Adverse Event|1|||
144550310|NCT05066230|521214663|FG001|After Week 48|Adverse Event|0|||
144550311|NCT05066230|521214662|FG000|After Week 48|Non-compliance with study schedule|1|||
144550312|NCT05066230|521214663|FG001|After Week 48|Non-compliance with study schedule|0|||
144550313|NCT05066230|521214662|FG000|After Week 48|Withdrawal by Subject|0|||
144550314|NCT05066230|521214663|FG001|After Week 48|Withdrawal by Subject|1|||
144550315|NCT05066230|521214662|FG000|After Week 48|Lost to Follow-up|3|||
144550316|NCT05066230|521214663|FG001|After Week 48|Lost to Follow-up|3|||
144550317|NCT05066230|521214662|FG000|After Week 48|Sponsor Request|115|||
144550318|NCT05066230|521214663|FG001|After Week 48|Sponsor Request|111|||
144550319|NCT03072238|521214664|FG000|Overall Study|Withdrawal by Subject|44|||
144550320|NCT03072238|521214665|FG001|Overall Study|Withdrawal by Subject|64|||
144550321|NCT03072238|521214664|FG000|Overall Study|Lost to Follow-up|14|||
144550322|NCT03072238|521214665|FG001|Overall Study|Lost to Follow-up|5|||
144550323|NCT03072238|521214664|FG000|Overall Study|Physician Decision|4|||
144550324|NCT03072238|521214665|FG001|Overall Study|Physician Decision|6|||
144550325|NCT03072238|521214664|FG000|Overall Study|Death|351|||
144550326|NCT03072238|521214665|FG001|Overall Study|Death|318|||
144550327|NCT03072238|521214664|FG000|Overall Study|Progressive Disease|3|||
144550328|NCT03072238|521214665|FG001|Overall Study|Progressive Disease|4|||
144550329|NCT03072238|521214664|FG000|Overall Study|Reason Not Specified|138|||
144550330|NCT03072238|521214665|FG001|Overall Study|Reason Not Specified|150|||
144550331|NCT00307489|521214666|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
144550332|NCT00307489|521214667|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
144550333|NCT00307489|521214666|FG000|Baseline Through Week 48|Physician Decision|1|||
144550334|NCT00307489|521214667|FG001|Baseline Through Week 48|Physician Decision|0|||
144550335|NCT00307489|521214666|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
144550336|NCT00307489|521214667|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
144550337|NCT00307489|521214666|FG000|Week 48 Through Week 168|Adverse Event|1|||
144550338|NCT00307489|521214667|FG001|Week 48 Through Week 168|Adverse Event|0|||
144550339|NCT00307489|521214666|FG000|Week 48 Through Week 168|Physician Decision|1|||
144550340|NCT00307489|521214667|FG001|Week 48 Through Week 168|Physician Decision|0|||
144550341|NCT00307489|521214666|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
144550342|NCT00307489|521214667|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
144550343|NCT00307489|521214666|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
144550344|NCT00307489|521214667|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
144550345|NCT00307489|521214666|FG000|Week 48 Through Week 168|Death|0|||
144550346|NCT00307489|521214667|FG001|Week 48 Through Week 168|Death|1|||
144550347|NCT00307489|521214666|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
144203154|NCT00593736|519940288|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
144550348|NCT00307489|521214667|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
144550349|NCT00307489|521214666|FG000|Week 48 Through Week 168|Seroconversion|1|||
144550350|NCT00307489|521214667|FG001|Week 48 Through Week 168|Seroconversion|0|||
144550351|NCT04025762|521214671|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
144550352|NCT04025762|521214672|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
144550353|NCT01286311|521214674|FG000|Overall Study|Physician did not want outreach sent|14|||
144550354|NCT01286311|521214675|FG001|Overall Study|Physician did not want outreach sent|0|||
144550355|NCT01381549|521214678|FG000|Overall Study|Ineligible: No organisms isolated|0|||
144550356|NCT01381549|521214679|FG001|Overall Study|Ineligible: No organisms isolated|0|||
144550357|NCT01381549|521214680|FG002|Overall Study|Ineligible: No organisms isolated|1|||
144550358|NCT02981953|521214681|FG000|Overall Study|Death|9|||
144550359|NCT02981953|521214681|FG000|Overall Study|Withdrawal by Subject|1|||
144550360|NCT02981953|521214681|FG000|Overall Study|Withdrawal to non-compliance|1|||
144550361|NCT02889900|521214682|FG000|Overall Study|Adverse Event|11|||
144550362|NCT02889900|521214682|FG000|Overall Study|Condition under investigation worsened|32|||
144550363|NCT02889900|521214682|FG000|Overall Study|Other|5|||
144550364|NCT02889900|521214682|FG000|Overall Study|Withdrawal by Subject|7|||
144550365|NCT02889900|521214682|FG000|Overall Study|Not treated|2|||
144550366|NCT00813709|521214693|FG000|Double Blind Period|Adverse Event|4|||
144550367|NCT00813709|521214694|FG001|Double Blind Period|Adverse Event|1|||
144550368|NCT00813709|521214695|FG002|Double Blind Period|Adverse Event|4|||
144550369|NCT00813709|521214696|FG003|Double Blind Period|Adverse Event|0|||
144550370|NCT00813709|521214697|FG004|Double Blind Period|Adverse Event|0|||
144550371|NCT00813709|521214698|FG005|Double Blind Period|Adverse Event|0|||
144550372|NCT00813709|521214693|FG000|Double Blind Period|Lost to Follow-up|3|||
144550373|NCT00813709|521214694|FG001|Double Blind Period|Lost to Follow-up|2|||
144550374|NCT00813709|521214695|FG002|Double Blind Period|Lost to Follow-up|2|||
144550375|NCT00813709|521214696|FG003|Double Blind Period|Lost to Follow-up|0|||
144550376|NCT00813709|521214697|FG004|Double Blind Period|Lost to Follow-up|0|||
144550377|NCT00813709|521214698|FG005|Double Blind Period|Lost to Follow-up|0|||
144550378|NCT00813709|521214693|FG000|Double Blind Period|Switched to open label phase|9|||
144550379|NCT00813709|521214694|FG001|Double Blind Period|Switched to open label phase|26|||
144550380|NCT00813709|521214695|FG002|Double Blind Period|Switched to open label phase|18|||
144550381|NCT00813709|521214696|FG003|Double Blind Period|Switched to open label phase|0|||
144550382|NCT00813709|521214697|FG004|Double Blind Period|Switched to open label phase|0|||
144550383|NCT00813709|521214698|FG005|Double Blind Period|Switched to open label phase|0|||
144550384|NCT00813709|521214693|FG000|Double Blind Period|Randomized but not treated|1|||
144550385|NCT00813709|521214694|FG001|Double Blind Period|Randomized but not treated|3|||
144550386|NCT00813709|521214695|FG002|Double Blind Period|Randomized but not treated|1|||
144550387|NCT00813709|521214696|FG003|Double Blind Period|Randomized but not treated|0|||
144550388|NCT00813709|521214697|FG004|Double Blind Period|Randomized but not treated|0|||
144550389|NCT00813709|521214698|FG005|Double Blind Period|Randomized but not treated|0|||
144550390|NCT00813709|521214693|FG000|Double Blind Period|Other|14|||
144550391|NCT00813709|521214694|FG001|Double Blind Period|Other|9|||
144550392|NCT00813709|521214695|FG002|Double Blind Period|Other|6|||
144550393|NCT00813709|521214696|FG003|Double Blind Period|Other|0|||
144550394|NCT00813709|521214697|FG004|Double Blind Period|Other|0|||
144550395|NCT00813709|521214698|FG005|Double Blind Period|Other|0|||
144550396|NCT00813709|521214693|FG000|Open Label Period|Adverse Event|0|||
144550397|NCT00813709|521214694|FG001|Open Label Period|Adverse Event|0|||
144550398|NCT00813709|521214695|FG002|Open Label Period|Adverse Event|0|||
144550399|NCT00813709|521214696|FG003|Open Label Period|Adverse Event|5|||
144550400|NCT00813709|521214697|FG004|Open Label Period|Adverse Event|4|||
144550401|NCT00813709|521214698|FG005|Open Label Period|Adverse Event|3|||
144550402|NCT00813709|521214693|FG000|Open Label Period|Lack of Efficacy|0|||
144550403|NCT00813709|521214694|FG001|Open Label Period|Lack of Efficacy|0|||
144550404|NCT00813709|521214695|FG002|Open Label Period|Lack of Efficacy|0|||
144550405|NCT00813709|521214696|FG003|Open Label Period|Lack of Efficacy|3|||
144550406|NCT00813709|521214697|FG004|Open Label Period|Lack of Efficacy|1|||
144550407|NCT00813709|521214698|FG005|Open Label Period|Lack of Efficacy|1|||
144550408|NCT00813709|521214693|FG000|Open Label Period|Randomized but not treated|0|||
144550409|NCT00813709|521214694|FG001|Open Label Period|Randomized but not treated|0|||
144550410|NCT00813709|521214695|FG002|Open Label Period|Randomized but not treated|0|||
144550411|NCT00813709|521214696|FG003|Open Label Period|Randomized but not treated|1|||
144550412|NCT00813709|521214697|FG004|Open Label Period|Randomized but not treated|0|||
144550413|NCT00813709|521214698|FG005|Open Label Period|Randomized but not treated|1|||
144550414|NCT00813709|521214693|FG000|Open Label Period|Other|0|||
144550415|NCT00813709|521214694|FG001|Open Label Period|Other|0|||
144550416|NCT00813709|521214695|FG002|Open Label Period|Other|0|||
144550417|NCT00813709|521214696|FG003|Open Label Period|Other|11|||
144550418|NCT00813709|521214697|FG004|Open Label Period|Other|5|||
144550419|NCT00813709|521214698|FG005|Open Label Period|Other|6|||
144550420|NCT00759681|521214701|FG000|Overall Study|Death|2|||
144550421|NCT00759681|521214702|FG001|Overall Study|Death|5|||
144550422|NCT00759681|521214701|FG000|Overall Study|Lost to Follow-up|8|||
144550423|NCT00759681|521214702|FG001|Overall Study|Lost to Follow-up|5|||
144550424|NCT03209492|521214705|FG000|Overall Study|Case Report Forms Uncollected|5|||
144550425|NCT01133678|521214708|FG000|Overall Study|Death|1|||
144550426|NCT01133678|521214709|FG001|Overall Study|Death|1|||
144550427|NCT00879710|521214710|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
144550428|NCT00879710|521214711|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
144550429|NCT00879710|521214712|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
144550430|NCT00879710|521214713|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
144550431|NCT00879710|521214710|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
144550432|NCT00879710|521214711|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
144550433|NCT00879710|521214712|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
144550434|NCT00879710|521214713|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
144550435|NCT01864200|521214714|FG000|Overall Study|Lost to Follow-up|1|||
144550436|NCT01864200|521214715|FG001|Overall Study|Lost to Follow-up|3|||
144550437|NCT01864200|521214714|FG000|Overall Study|Protocol Violation|1|||
144550438|NCT01864200|521214715|FG001|Overall Study|Protocol Violation|0|||
144550439|NCT01777932|521214719|FG000|Overall Study|Disease progression|136|||
144550440|NCT01777932|521214719|FG000|Overall Study|Death|3|||
144550441|NCT01777932|521214719|FG000|Overall Study|Adverse Event|34|||
144550442|NCT01777932|521214719|FG000|Overall Study|Lost to Follow-up|3|||
144550443|NCT01777932|521214719|FG000|Overall Study|Investigator decision|10|||
144550444|NCT01777932|521214719|FG000|Overall Study|Reimbursement limit|9|||
144550445|NCT01777932|521214719|FG000|Overall Study|Patient refused further treatment|10|||
144550446|NCT03031782|521214726|FG000|Treatment Period 1|Lack of Efficacy|3|||
144550447|NCT03031782|521214727|FG001|Treatment Period 1|Lack of Efficacy|0|||
144550448|NCT03031782|521214728|FG002|Treatment Period 1|Lack of Efficacy|0|||
144550449|NCT03031782|521214729|FG003|Treatment Period 1|Lack of Efficacy|0|||
144550450|NCT03031782|521214730|FG004|Treatment Period 1|Lack of Efficacy|0|||
144550451|NCT03031782|521214726|FG000|Treatment Period 2|Physician Decision|0|||
144550452|NCT03031782|521214727|FG001|Treatment Period 2|Physician Decision|1|||
144550453|NCT03031782|521214728|FG002|Treatment Period 2|Physician Decision|0|||
144550454|NCT03031782|521214729|FG003|Treatment Period 2|Physician Decision|0|||
144550455|NCT03031782|521214730|FG004|Treatment Period 2|Physician Decision|3|||
144550456|NCT03031782|521214726|FG000|Treatment Period 2|Lack of Efficacy|0|||
144550457|NCT03031782|521214727|FG001|Treatment Period 2|Lack of Efficacy|1|||
144550458|NCT03031782|521214728|FG002|Treatment Period 2|Lack of Efficacy|0|||
144550459|NCT03031782|521214729|FG003|Treatment Period 2|Lack of Efficacy|0|||
144550460|NCT03031782|521214730|FG004|Treatment Period 2|Lack of Efficacy|1|||
144550461|NCT03031782|521214726|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144550462|NCT03031782|521214727|FG001|Treatment Period 2|Withdrawal by Subject|3|||
144550463|NCT03031782|521214728|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144550464|NCT03031782|521214729|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144550465|NCT03031782|521214730|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144550466|NCT03031782|521214726|FG000|Treatment Period 2|Adverse Event|0|||
144550467|NCT03031782|521214727|FG001|Treatment Period 2|Adverse Event|1|||
144550468|NCT03031782|521214728|FG002|Treatment Period 2|Adverse Event|2|||
144550469|NCT03031782|521214729|FG003|Treatment Period 2|Adverse Event|0|||
144550470|NCT03031782|521214730|FG004|Treatment Period 2|Adverse Event|0|||
144550471|NCT03031782|521214726|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144550472|NCT03031782|521214727|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144550473|NCT03031782|521214728|FG002|Treatment Period 3|Withdrawal by Subject|0|||
144550474|NCT03031782|521214729|FG003|Treatment Period 3|Withdrawal by Subject|1|||
144550475|NCT03031782|521214730|FG004|Treatment Period 3|Withdrawal by Subject|0|||
144550476|NCT00424476|521214731|FG000|Overall Study|Withdrawal by Subject|7|||
144550477|NCT00424476|521214732|FG001|Overall Study|Withdrawal by Subject|6|||
144550478|NCT00424476|521214733|FG002|Overall Study|Withdrawal by Subject|3|||
144550479|NCT00424476|521214731|FG000|Overall Study|Adverse Event|19|||
144550480|NCT00424476|521214732|FG001|Overall Study|Adverse Event|16|||
144550481|NCT00424476|521214733|FG002|Overall Study|Adverse Event|15|||
144550482|NCT00424476|521214731|FG000|Overall Study|Lack of Efficacy|16|||
144550483|NCT00424476|521214732|FG001|Overall Study|Lack of Efficacy|12|||
144550484|NCT00424476|521214733|FG002|Overall Study|Lack of Efficacy|12|||
144550485|NCT00424476|521214731|FG000|Overall Study|Lack of Compliance|1|||
144550486|NCT00424476|521214732|FG001|Overall Study|Lack of Compliance|1|||
144550487|NCT00424476|521214733|FG002|Overall Study|Lack of Compliance|1|||
144550488|NCT00424476|521214731|FG000|Overall Study|Lost to Follow-up|4|||
144550489|NCT00424476|521214732|FG001|Overall Study|Lost to Follow-up|6|||
144550490|NCT00424476|521214733|FG002|Overall Study|Lost to Follow-up|3|||
144550491|NCT00424476|521214731|FG000|Overall Study|Protocol Violation|7|||
144550492|NCT00424476|521214732|FG001|Overall Study|Protocol Violation|2|||
144550493|NCT00424476|521214733|FG002|Overall Study|Protocol Violation|3|||
144550494|NCT00424476|521214731|FG000|Overall Study|Physician Decision|3|||
144550495|NCT00424476|521214732|FG001|Overall Study|Physician Decision|2|||
144550496|NCT00424476|521214733|FG002|Overall Study|Physician Decision|3|||
144550497|NCT00424476|521214731|FG000|Overall Study|Other|4|||
144550498|NCT00424476|521214732|FG001|Overall Study|Other|3|||
144550499|NCT00424476|521214733|FG002|Overall Study|Other|9|||
144550500|NCT02514824|521214734|FG000|Overall Study|Withdrawal by Subject|1|||
144550501|NCT02514824|521214735|FG001|Overall Study|Withdrawal by Subject|0|||
144550502|NCT02514824|521214736|FG002|Overall Study|Withdrawal by Subject|0|||
144550503|NCT02514824|521214737|FG003|Overall Study|Withdrawal by Subject|0|||
144550504|NCT02514824|521214734|FG000|Overall Study|Dose-Limiting Toxicity|0|||
144550505|NCT02514824|521214735|FG001|Overall Study|Dose-Limiting Toxicity|1|||
144550506|NCT02514824|521214736|FG002|Overall Study|Dose-Limiting Toxicity|0|||
144550507|NCT02514824|521214737|FG003|Overall Study|Dose-Limiting Toxicity|0|||
144550508|NCT02170207|521214740|FG000|Overall Study|Case report forms unavailable|5|||
144550509|NCT03122860|521214741|FG000|Overall Study|Discontinued Before Treatment|1|||
144550510|NCT03122860|521214742|FG001|Overall Study|Discontinued Before Treatment|1|||
144550511|NCT03122860|521214743|FG002|Overall Study|Discontinued Before Treatment|2|||
144550512|NCT03122860|521214744|FG003|Overall Study|Discontinued Before Treatment|0|||
144550513|NCT03122860|521214745|FG004|Overall Study|Discontinued Before Treatment|1|||
144550514|NCT03122860|521214746|FG005|Overall Study|Discontinued Before Treatment|0|||
144550515|NCT03122860|521214741|FG000|Overall Study|Adverse Event|1|||
144550516|NCT03122860|521214742|FG001|Overall Study|Adverse Event|0|||
144550517|NCT03122860|521214743|FG002|Overall Study|Adverse Event|1|||
144550518|NCT03122860|521214744|FG003|Overall Study|Adverse Event|1|||
144550519|NCT03122860|521214745|FG004|Overall Study|Adverse Event|0|||
144550520|NCT03122860|521214746|FG005|Overall Study|Adverse Event|0|||
144550521|NCT03122860|521214741|FG000|Overall Study|Lost to Follow-up|5|||
144550522|NCT03122860|521214742|FG001|Overall Study|Lost to Follow-up|2|||
144550523|NCT03122860|521214743|FG002|Overall Study|Lost to Follow-up|3|||
144550524|NCT03122860|521214744|FG003|Overall Study|Lost to Follow-up|3|||
144550525|NCT03122860|521214745|FG004|Overall Study|Lost to Follow-up|5|||
144550526|NCT03122860|521214746|FG005|Overall Study|Lost to Follow-up|4|||
144550527|NCT03122860|521214741|FG000|Overall Study|Subject Non-Compliance|0|||
144550528|NCT03122860|521214742|FG001|Overall Study|Subject Non-Compliance|0|||
144550529|NCT03122860|521214743|FG002|Overall Study|Subject Non-Compliance|1|||
144550530|NCT03122860|521214744|FG003|Overall Study|Subject Non-Compliance|0|||
144550531|NCT03122860|521214745|FG004|Overall Study|Subject Non-Compliance|0|||
144550532|NCT03122860|521214746|FG005|Overall Study|Subject Non-Compliance|0|||
144550533|NCT03122860|521214741|FG000|Overall Study|Withdrawal by Subject|3|||
144550534|NCT03122860|521214742|FG001|Overall Study|Withdrawal by Subject|2|||
144550535|NCT03122860|521214743|FG002|Overall Study|Withdrawal by Subject|5|||
144550536|NCT03122860|521214744|FG003|Overall Study|Withdrawal by Subject|7|||
144550537|NCT03122860|521214745|FG004|Overall Study|Withdrawal by Subject|9|||
144550538|NCT03122860|521214746|FG005|Overall Study|Withdrawal by Subject|8|||
144550539|NCT01138657|521214747|FG000|Overall Study|Adverse Event|3|||
144550540|NCT01138657|521214748|FG001|Overall Study|Adverse Event|10|||
144550541|NCT01138657|521214747|FG000|Overall Study|Lack of Efficacy|2|||
144550542|NCT01138657|521214748|FG001|Overall Study|Lack of Efficacy|1|||
144550543|NCT01138657|521214747|FG000|Overall Study|Lost to Follow-up|0|||
144550544|NCT01138657|521214748|FG001|Overall Study|Lost to Follow-up|3|||
144550545|NCT01138657|521214747|FG000|Overall Study|Miscellaneous Reasons|3|||
144550546|NCT01138657|521214748|FG001|Overall Study|Miscellaneous Reasons|4|||
144550547|NCT03979040|521214749|FG000|Overall Study|Withdrawal by Subject|24|||
144550548|NCT03979040|521214750|FG001|Overall Study|Withdrawal by Subject|32|||
144550549|NCT03979040|521214749|FG000|Overall Study|randomized but never started treatment|32|||
144550550|NCT03979040|521214750|FG001|Overall Study|randomized but never started treatment|39|||
144550551|NCT03979040|521214749|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
144550552|NCT03979040|521214750|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
144550553|NCT01916109|521214751|FG000|Overall Study|Withdrawal by Subject|1|||
144550554|NCT00103857|521214754|FG000|54-Week Base Study|Adverse Event|12|||
144550555|NCT00103857|521214755|FG001|54-Week Base Study|Adverse Event|9|||
144550556|NCT00103857|521214756|FG002|54-Week Base Study|Adverse Event|11|||
144550557|NCT00103857|521214757|FG003|54-Week Base Study|Adverse Event|6|||
144550558|NCT00103857|521214758|FG004|54-Week Base Study|Adverse Event|5|||
144550559|NCT00103857|521214759|FG005|54-Week Base Study|Adverse Event|11|||
144550560|NCT00103857|521214760|FG006|54-Week Base Study|Adverse Event|3|||
144550561|NCT00103857|521214754|FG000|54-Week Base Study|Death|0|||
144550562|NCT00103857|521214755|FG001|54-Week Base Study|Death|0|||
144550563|NCT00103857|521214756|FG002|54-Week Base Study|Death|0|||
144550564|NCT00103857|521214757|FG003|54-Week Base Study|Death|0|||
144550565|NCT00103857|521214758|FG004|54-Week Base Study|Death|1|||
144550566|NCT00103857|521214759|FG005|54-Week Base Study|Death|1|||
144550567|NCT00103857|521214760|FG006|54-Week Base Study|Death|0|||
144550568|NCT00103857|521214754|FG000|54-Week Base Study|Lack of Efficacy|11|||
144550569|NCT00103857|521214755|FG001|54-Week Base Study|Lack of Efficacy|14|||
144550570|NCT00103857|521214756|FG002|54-Week Base Study|Lack of Efficacy|8|||
144550571|NCT00103857|521214757|FG003|54-Week Base Study|Lack of Efficacy|4|||
144550572|NCT00103857|521214758|FG004|54-Week Base Study|Lack of Efficacy|3|||
144550573|NCT00103857|521214759|FG005|54-Week Base Study|Lack of Efficacy|14|||
144550574|NCT00103857|521214760|FG006|54-Week Base Study|Lack of Efficacy|19|||
144550575|NCT00103857|521214754|FG000|54-Week Base Study|Lost to Follow-up|5|||
144550576|NCT00103857|521214755|FG001|54-Week Base Study|Lost to Follow-up|4|||
144550577|NCT00103857|521214756|FG002|54-Week Base Study|Lost to Follow-up|7|||
144550578|NCT00103857|521214757|FG003|54-Week Base Study|Lost to Follow-up|5|||
144550579|NCT00103857|521214758|FG004|54-Week Base Study|Lost to Follow-up|10|||
144550580|NCT00103857|521214759|FG005|54-Week Base Study|Lost to Follow-up|9|||
144550581|NCT00103857|521214760|FG006|54-Week Base Study|Lost to Follow-up|3|||
144550582|NCT00103857|521214754|FG000|54-Week Base Study|Physician Decision|1|||
144550583|NCT00103857|521214755|FG001|54-Week Base Study|Physician Decision|1|||
144550584|NCT00103857|521214756|FG002|54-Week Base Study|Physician Decision|0|||
144550585|NCT00103857|521214757|FG003|54-Week Base Study|Physician Decision|0|||
144550586|NCT00103857|521214758|FG004|54-Week Base Study|Physician Decision|1|||
144550587|NCT00103857|521214759|FG005|54-Week Base Study|Physician Decision|0|||
144550588|NCT00103857|521214760|FG006|54-Week Base Study|Physician Decision|0|||
144550589|NCT00103857|521214754|FG000|54-Week Base Study|Pregnancy|1|||
144550590|NCT00103857|521214755|FG001|54-Week Base Study|Pregnancy|0|||
144550591|NCT00103857|521214756|FG002|54-Week Base Study|Pregnancy|0|||
144550592|NCT00103857|521214757|FG003|54-Week Base Study|Pregnancy|0|||
144550593|NCT00103857|521214758|FG004|54-Week Base Study|Pregnancy|1|||
144550594|NCT00103857|521214759|FG005|54-Week Base Study|Pregnancy|0|||
144550595|NCT00103857|521214760|FG006|54-Week Base Study|Pregnancy|1|||
144550596|NCT00103857|521214754|FG000|54-Week Base Study|Protocol Violation|6|||
144550597|NCT00103857|521214755|FG001|54-Week Base Study|Protocol Violation|4|||
144550598|NCT00103857|521214756|FG002|54-Week Base Study|Protocol Violation|2|||
144550599|NCT00103857|521214757|FG003|54-Week Base Study|Protocol Violation|4|||
144550600|NCT00103857|521214758|FG004|54-Week Base Study|Protocol Violation|0|||
144550601|NCT00103857|521214759|FG005|54-Week Base Study|Protocol Violation|3|||
144550602|NCT00103857|521214760|FG006|54-Week Base Study|Protocol Violation|3|||
144550603|NCT00103857|521214754|FG000|54-Week Base Study|Withdrawal by Subject|17|||
144550604|NCT00103857|521214755|FG001|54-Week Base Study|Withdrawal by Subject|16|||
144550605|NCT00103857|521214756|FG002|54-Week Base Study|Withdrawal by Subject|16|||
144550606|NCT00103857|521214757|FG003|54-Week Base Study|Withdrawal by Subject|15|||
144550607|NCT00103857|521214758|FG004|54-Week Base Study|Withdrawal by Subject|10|||
144550608|NCT00103857|521214759|FG005|54-Week Base Study|Withdrawal by Subject|15|||
144550609|NCT00103857|521214760|FG006|54-Week Base Study|Withdrawal by Subject|4|||
144550610|NCT00103857|521214754|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
144550611|NCT00103857|521214755|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
144550612|NCT00103857|521214756|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
144550613|NCT00103857|521214757|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
144550614|NCT00103857|521214758|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
144550615|NCT00103857|521214759|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
144550616|NCT00103857|521214760|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
144550617|NCT00103857|521214754|FG000|54-Week Base Study|patient moved|0|||
144550618|NCT00103857|521214755|FG001|54-Week Base Study|patient moved|1|||
144550619|NCT00103857|521214756|FG002|54-Week Base Study|patient moved|1|||
144550620|NCT00103857|521214757|FG003|54-Week Base Study|patient moved|2|||
144550621|NCT00103857|521214758|FG004|54-Week Base Study|patient moved|3|||
144550622|NCT00103857|521214759|FG005|54-Week Base Study|patient moved|1|||
144550623|NCT00103857|521214760|FG006|54-Week Base Study|patient moved|0|||
144550624|NCT00103857|521214754|FG000|54-Week Base Study|non-compliance with study procedures|1|||
144550625|NCT00103857|521214755|FG001|54-Week Base Study|non-compliance with study procedures|2|||
144550626|NCT00103857|521214756|FG002|54-Week Base Study|non-compliance with study procedures|0|||
144550627|NCT00103857|521214757|FG003|54-Week Base Study|non-compliance with study procedures|0|||
144550628|NCT00103857|521214758|FG004|54-Week Base Study|non-compliance with study procedures|0|||
144550629|NCT00103857|521214759|FG005|54-Week Base Study|non-compliance with study procedures|2|||
144550630|NCT00103857|521214760|FG006|54-Week Base Study|non-compliance with study procedures|0|||
144550631|NCT00103857|521214754|FG000|54-Week Base Study|patient incarcerated|0|||
144550632|NCT00103857|521214755|FG001|54-Week Base Study|patient incarcerated|0|||
144550633|NCT00103857|521214756|FG002|54-Week Base Study|patient incarcerated|0|||
144550634|NCT00103857|521214757|FG003|54-Week Base Study|patient incarcerated|0|||
144550635|NCT00103857|521214758|FG004|54-Week Base Study|patient incarcerated|1|||
144550636|NCT00103857|521214759|FG005|54-Week Base Study|patient incarcerated|1|||
144550637|NCT00103857|521214760|FG006|54-Week Base Study|patient incarcerated|0|||
144550638|NCT00103857|521214754|FG000|54-Week Base Study|laboratory reporting error|0|||
144550639|NCT00103857|521214755|FG001|54-Week Base Study|laboratory reporting error|0|||
144550640|NCT00103857|521214756|FG002|54-Week Base Study|laboratory reporting error|0|||
144550641|NCT00103857|521214757|FG003|54-Week Base Study|laboratory reporting error|0|||
144550642|NCT00103857|521214758|FG004|54-Week Base Study|laboratory reporting error|1|||
144550643|NCT00103857|521214759|FG005|54-Week Base Study|laboratory reporting error|0|||
144550644|NCT00103857|521214760|FG006|54-Week Base Study|laboratory reporting error|0|||
144550645|NCT00103857|521214754|FG000|54-Week Base Study|site error|0|||
144550646|NCT00103857|521214755|FG001|54-Week Base Study|site error|0|||
144550647|NCT00103857|521214756|FG002|54-Week Base Study|site error|0|||
144616627|NCT02706873|521456365|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
144550648|NCT00103857|521214757|FG003|54-Week Base Study|site error|0|||
144550649|NCT00103857|521214758|FG004|54-Week Base Study|site error|0|||
144550650|NCT00103857|521214759|FG005|54-Week Base Study|site error|1|||
144616628|NCT02706873|521456366|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
144550651|NCT00103857|521214760|FG006|54-Week Base Study|site error|0|||
144550652|NCT00103857|521214754|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
144550653|NCT00103857|521214755|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
144550654|NCT00103857|521214756|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
144550655|NCT00103857|521214757|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
144550656|NCT00103857|521214758|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
144550657|NCT00103857|521214759|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
144550658|NCT00103857|521214760|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
144550659|NCT00103857|521214754|FG000|50-Week Extension Study|Adverse Event|2|||
144550660|NCT00103857|521214755|FG001|50-Week Extension Study|Adverse Event|3|||
144550661|NCT00103857|521214756|FG002|50-Week Extension Study|Adverse Event|2|||
144550662|NCT00103857|521214757|FG003|50-Week Extension Study|Adverse Event|0|||
144550663|NCT00103857|521214758|FG004|50-Week Extension Study|Adverse Event|1|||
144550664|NCT00103857|521214759|FG005|50-Week Extension Study|Adverse Event|1|||
144550665|NCT00103857|521214760|FG006|50-Week Extension Study|Adverse Event|0|||
144550666|NCT00103857|521214754|FG000|50-Week Extension Study|Death|0|||
144550667|NCT00103857|521214755|FG001|50-Week Extension Study|Death|0|||
144550668|NCT00103857|521214756|FG002|50-Week Extension Study|Death|0|||
144550669|NCT00103857|521214757|FG003|50-Week Extension Study|Death|1|||
144550670|NCT00103857|521214758|FG004|50-Week Extension Study|Death|0|||
144550671|NCT00103857|521214759|FG005|50-Week Extension Study|Death|1|||
144550672|NCT00103857|521214760|FG006|50-Week Extension Study|Death|0|||
144727640|NCT02130466|521856671|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
144727641|NCT02130466|521856672|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
144727642|NCT02130466|521856673|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
144727643|NCT02130466|521856674|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
144727644|NCT02130466|521856675|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
144727645|NCT02130466|521856676|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
144727646|NCT02130466|521856677|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
144727647|NCT02130466|521856678|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
144727648|NCT02130466|521856665|FG000|Overall Study|Withdrawal by Subject|1|||
144727649|NCT02130466|521856666|FG001|Overall Study|Withdrawal by Subject|0|||
144727650|NCT02130466|521856667|FG002|Overall Study|Withdrawal by Subject|0|||
144727651|NCT02130466|521856668|FG003|Overall Study|Withdrawal by Subject|0|||
144727652|NCT02130466|521856669|FG004|Overall Study|Withdrawal by Subject|0|||
144727653|NCT02130466|521856670|FG005|Overall Study|Withdrawal by Subject|1|||
144727654|NCT02130466|521856671|FG006|Overall Study|Withdrawal by Subject|0|||
144727655|NCT02130466|521856672|FG007|Overall Study|Withdrawal by Subject|0|||
144727656|NCT02130466|521856673|FG008|Overall Study|Withdrawal by Subject|1|||
144727657|NCT02130466|521856674|FG009|Overall Study|Withdrawal by Subject|0|||
144727658|NCT02130466|521856675|FG010|Overall Study|Withdrawal by Subject|0|||
144727659|NCT02130466|521856676|FG011|Overall Study|Withdrawal by Subject|0|||
144727660|NCT02130466|521856677|FG012|Overall Study|Withdrawal by Subject|0|||
144727661|NCT02130466|521856678|FG013|Overall Study|Withdrawal by Subject|0|||
144727662|NCT04529109|521856679|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
144727663|NCT04529109|521856680|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
144727664|NCT01922349|521856681|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
144727665|NCT01922349|521856682|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
144727666|NCT01922349|521856683|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
144550673|NCT00103857|521214754|FG000|50-Week Extension Study|Lack of Efficacy|26|||
144550674|NCT00103857|521214755|FG001|50-Week Extension Study|Lack of Efficacy|15|||
144550675|NCT00103857|521214756|FG002|50-Week Extension Study|Lack of Efficacy|13|||
144550676|NCT00103857|521214757|FG003|50-Week Extension Study|Lack of Efficacy|16|||
144550677|NCT00103857|521214758|FG004|50-Week Extension Study|Lack of Efficacy|8|||
144550678|NCT00103857|521214759|FG005|50-Week Extension Study|Lack of Efficacy|8|||
144550679|NCT00103857|521214760|FG006|50-Week Extension Study|Lack of Efficacy|0|||
144550680|NCT00103857|521214754|FG000|50-Week Extension Study|Lost to Follow-up|4|||
144550681|NCT00103857|521214755|FG001|50-Week Extension Study|Lost to Follow-up|0|||
144550682|NCT00103857|521214756|FG002|50-Week Extension Study|Lost to Follow-up|1|||
144550683|NCT00103857|521214757|FG003|50-Week Extension Study|Lost to Follow-up|4|||
144727667|NCT01922349|521856684|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
144727668|NCT00922779|521856685|FG000|Overall Study|Adverse Event|67|||
144727669|NCT00922779|521856685|FG000|Overall Study|Pregnancy|7|||
144727670|NCT00922779|521856685|FG000|Overall Study|Withdrawal by Subject|308|||
144727671|NCT00922779|521856685|FG000|Overall Study|Lost to Follow-up|44|||
144727672|NCT00922779|521856685|FG000|Overall Study|Other|27|||
144550684|NCT00103857|521214758|FG004|50-Week Extension Study|Lost to Follow-up|3|||
144550685|NCT00103857|521214759|FG005|50-Week Extension Study|Lost to Follow-up|3|||
144727673|NCT00922779|521856685|FG000|Overall Study|Missing|1874|||
144727674|NCT00993616|521856686|FG000|Overall Study|No tumor at entry|1|||
144727675|NCT00993616|521856686|FG000|Overall Study|Never treated|1|||
144727676|NCT00444145|521858009|FG000|Overall Study|Withdrawal by Subject|2|||
144727677|NCT00444145|521858009|FG000|Overall Study|Lost to Follow-up|1|||
144550686|NCT00103857|521214760|FG006|50-Week Extension Study|Lost to Follow-up|0|||
144550687|NCT00103857|521214754|FG000|50-Week Extension Study|Physician Decision|0|||
144550688|NCT00103857|521214755|FG001|50-Week Extension Study|Physician Decision|1|||
144550689|NCT00103857|521214756|FG002|50-Week Extension Study|Physician Decision|1|||
144550690|NCT00103857|521214757|FG003|50-Week Extension Study|Physician Decision|0|||
144550691|NCT00103857|521214758|FG004|50-Week Extension Study|Physician Decision|0|||
144550692|NCT00103857|521214759|FG005|50-Week Extension Study|Physician Decision|0|||
144550693|NCT00103857|521214760|FG006|50-Week Extension Study|Physician Decision|0|||
144550694|NCT00103857|521214754|FG000|50-Week Extension Study|Pregnancy|0|||
144550695|NCT00103857|521214755|FG001|50-Week Extension Study|Pregnancy|0|||
144550696|NCT00103857|521214756|FG002|50-Week Extension Study|Pregnancy|1|||
144550697|NCT00103857|521214757|FG003|50-Week Extension Study|Pregnancy|0|||
144550698|NCT00103857|521214758|FG004|50-Week Extension Study|Pregnancy|1|||
144550699|NCT00103857|521214759|FG005|50-Week Extension Study|Pregnancy|0|||
144550700|NCT00103857|521214760|FG006|50-Week Extension Study|Pregnancy|0|||
144550701|NCT00103857|521214754|FG000|50-Week Extension Study|Protocol Violation|1|||
144550702|NCT00103857|521214755|FG001|50-Week Extension Study|Protocol Violation|1|||
144550703|NCT00103857|521214756|FG002|50-Week Extension Study|Protocol Violation|1|||
144550704|NCT00103857|521214757|FG003|50-Week Extension Study|Protocol Violation|2|||
144550705|NCT00103857|521214758|FG004|50-Week Extension Study|Protocol Violation|0|||
144550706|NCT00103857|521214759|FG005|50-Week Extension Study|Protocol Violation|1|||
144550707|NCT00103857|521214760|FG006|50-Week Extension Study|Protocol Violation|0|||
144550708|NCT00103857|521214754|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
144550709|NCT00103857|521214755|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
144550710|NCT00103857|521214756|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
144550711|NCT00103857|521214757|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
144550712|NCT00103857|521214758|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
144550713|NCT00103857|521214759|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
144550714|NCT00103857|521214760|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
144550715|NCT00103857|521214754|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
144550716|NCT00103857|521214755|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
144550717|NCT00103857|521214756|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
144550718|NCT00103857|521214757|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
144550719|NCT00103857|521214758|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
144550720|NCT00103857|521214759|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
144550721|NCT00103857|521214760|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
144550722|NCT00103857|521214754|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
144550723|NCT00103857|521214755|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
144550724|NCT00103857|521214756|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
144550725|NCT00103857|521214757|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
144550726|NCT00103857|521214758|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
144550727|NCT00103857|521214759|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
144550728|NCT00103857|521214760|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
144550729|NCT00103857|521214754|FG000|50-Week Extension Study|patient moved|0|||
144550730|NCT00103857|521214755|FG001|50-Week Extension Study|patient moved|0|||
144550731|NCT00103857|521214756|FG002|50-Week Extension Study|patient moved|1|||
144550732|NCT00103857|521214757|FG003|50-Week Extension Study|patient moved|2|||
144550733|NCT00103857|521214758|FG004|50-Week Extension Study|patient moved|0|||
144550734|NCT00103857|521214759|FG005|50-Week Extension Study|patient moved|0|||
144550735|NCT00103857|521214760|FG006|50-Week Extension Study|patient moved|0|||
144550736|NCT00103857|521214754|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
144550737|NCT00103857|521214755|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
144550738|NCT00103857|521214756|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
144550739|NCT00103857|521214757|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
144550740|NCT00103857|521214758|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
144550741|NCT00103857|521214759|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
144550742|NCT00103857|521214760|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
144550743|NCT00103857|521214754|FG000|50-Week Extension Study|reason unspecified|0|||
144550744|NCT00103857|521214755|FG001|50-Week Extension Study|reason unspecified|0|||
144550745|NCT00103857|521214756|FG002|50-Week Extension Study|reason unspecified|0|||
144550746|NCT00103857|521214757|FG003|50-Week Extension Study|reason unspecified|0|||
144550747|NCT00103857|521214758|FG004|50-Week Extension Study|reason unspecified|1|||
144550748|NCT00103857|521214759|FG005|50-Week Extension Study|reason unspecified|0|||
144550749|NCT00103857|521214760|FG006|50-Week Extension Study|reason unspecified|0|||
144550750|NCT01856569|521214761|FG000|Overall Study|Other|1|||
144550751|NCT01856569|521214761|FG000|Overall Study|Changed Site/Structure|1|||
144550752|NCT01856569|521214761|FG000|Overall Study|Lost to Follow-up|3|||
144550753|NCT01856569|521214761|FG000|Overall Study|Did not met inclusion criteria|8|||
144616629|NCT02706873|521456367|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
144616630|NCT02706873|521456368|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
144550754|NCT00696241|521214764|FG000|Overall Study|Adverse Event|11|||
144550755|NCT00696241|521214765|FG001|Overall Study|Adverse Event|3|||
144550756|NCT00696241|521214766|FG002|Overall Study|Adverse Event|6|||
144550757|NCT00696241|521214767|FG003|Overall Study|Adverse Event|4|||
144550758|NCT00696241|521214768|FG004|Overall Study|Adverse Event|5|||
144550759|NCT00696241|521214764|FG000|Overall Study|Protocol Violation|1|||
144550760|NCT00696241|521214765|FG001|Overall Study|Protocol Violation|1|||
144550761|NCT00696241|521214766|FG002|Overall Study|Protocol Violation|2|||
144550762|NCT00696241|521214767|FG003|Overall Study|Protocol Violation|0|||
144550763|NCT00696241|521214768|FG004|Overall Study|Protocol Violation|3|||
144550764|NCT00696241|521214764|FG000|Overall Study|Lost to Follow-up|1|||
144550765|NCT00696241|521214765|FG001|Overall Study|Lost to Follow-up|4|||
144550766|NCT00696241|521214766|FG002|Overall Study|Lost to Follow-up|1|||
144203155|NCT00593736|519940289|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
144203156|NCT00593736|519940290|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
144203157|NCT00593736|519940287|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
144203158|NCT00593736|519940288|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
144203159|NCT00593736|519940289|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
144550767|NCT00696241|521214767|FG003|Overall Study|Lost to Follow-up|2|||
144550768|NCT00696241|521214768|FG004|Overall Study|Lost to Follow-up|0|||
144550769|NCT00696241|521214764|FG000|Overall Study|Withdrawal by Subject|4|||
144550770|NCT00696241|521214765|FG001|Overall Study|Withdrawal by Subject|8|||
144550771|NCT00696241|521214766|FG002|Overall Study|Withdrawal by Subject|6|||
144550772|NCT00696241|521214767|FG003|Overall Study|Withdrawal by Subject|1|||
144550773|NCT00696241|521214768|FG004|Overall Study|Withdrawal by Subject|0|||
144550774|NCT00696241|521214764|FG000|Overall Study|Lack of Efficacy|1|||
144550775|NCT00696241|521214765|FG001|Overall Study|Lack of Efficacy|5|||
144550776|NCT00696241|521214766|FG002|Overall Study|Lack of Efficacy|4|||
144550777|NCT00696241|521214767|FG003|Overall Study|Lack of Efficacy|5|||
144550778|NCT00696241|521214768|FG004|Overall Study|Lack of Efficacy|3|||
144550779|NCT00696241|521214764|FG000|Overall Study|Other|6|||
144550780|NCT00696241|521214765|FG001|Overall Study|Other|1|||
144550781|NCT00696241|521214766|FG002|Overall Study|Other|5|||
144550782|NCT00696241|521214767|FG003|Overall Study|Other|2|||
144550783|NCT00696241|521214768|FG004|Overall Study|Other|1|||
144550784|NCT03065400|521214771|FG000|Overall Study|Adverse Event|1|||
144550785|NCT03065400|521214771|FG000|Overall Study|Physician Decision|3|||
144550786|NCT03065400|521214771|FG000|Overall Study|Withdrawal by Subject|1|||
144550787|NCT03065400|521214771|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
144550788|NCT03072862|521214773|FG000|Overall Study|Withdrawal by Subject|4|||
144550789|NCT03072862|521214773|FG000|Overall Study|Lost to Follow-up|6|||
144550790|NCT03072862|521214773|FG000|Overall Study|Protocol Violation|4|||
144550791|NCT03072862|521214773|FG000|Overall Study|Physician Decision|2|||
144550792|NCT03072862|521214773|FG000|Overall Study|Death|1|||
144550793|NCT03072862|521214773|FG000|Overall Study|Adverse Event|1|||
144550794|NCT01441596|521214774|FG000|Overall Study|Other reason not defined below|0|||
144550795|NCT01441596|521214775|FG001|Overall Study|Other reason not defined below|2|||
144550796|NCT01441596|521214776|FG002|Overall Study|Other reason not defined below|1|||
144550797|NCT01441596|521214774|FG000|Overall Study|Withdrawal by Subject|4|||
144550798|NCT01441596|521214775|FG001|Overall Study|Withdrawal by Subject|0|||
144550799|NCT01441596|521214776|FG002|Overall Study|Withdrawal by Subject|2|||
144550800|NCT01441596|521214774|FG000|Overall Study|Not treated|0|||
144550801|NCT01441596|521214775|FG001|Overall Study|Not treated|1|||
144550802|NCT01441596|521214776|FG002|Overall Study|Not treated|1|||
144550803|NCT02513667|521214777|FG000|Overall Study|Withdrawal by Subject|0|||
144550804|NCT02513667|521214778|FG001|Overall Study|Withdrawal by Subject|1|||
144550805|NCT03347396|521214779|FG000|Part A (26 Weeks)|Adverse Event|1|||
144550806|NCT03347396|521214780|FG001|Part A (26 Weeks)|Adverse Event|0|||
144550807|NCT03347396|521214779|FG000|Part A (26 Weeks)|Death|0|||
144550808|NCT03347396|521214780|FG001|Part A (26 Weeks)|Death|1|||
144550809|NCT03347396|521214779|FG000|Part B (149 Weeks)|Adverse Event|1|||
144550810|NCT03347396|521214780|FG001|Part B (149 Weeks)|Adverse Event|1|||
144203160|NCT00593736|519940290|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
144203161|NCT00593736|519940287|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
144550811|NCT03347396|521214779|FG000|Part B (149 Weeks)|Death|1|||
144550812|NCT03347396|521214780|FG001|Part B (149 Weeks)|Death|0|||
144550813|NCT01670526|521214787|FG000|Overall Study|Withdrawal by Subject|3|||
144550814|NCT01670526|521214788|FG001|Overall Study|Withdrawal by Subject|1|||
144550815|NCT01670526|521214787|FG000|Overall Study|Lost to Follow-up|9|||
144550816|NCT01670526|521214788|FG001|Overall Study|Lost to Follow-up|5|||
144550817|NCT03060525|521214789|FG000|Overall Study|moved out of state|1|||
144550818|NCT03060525|521214790|FG001|Overall Study|moved out of state|1|||
144550819|NCT03060525|521214791|FG002|Overall Study|moved out of state|1|||
144550820|NCT03060525|521214792|FG003|Overall Study|moved out of state|1|||
144550821|NCT03060525|521214789|FG000|Overall Study|unable to meet time commitment required of study|2|||
144550822|NCT03060525|521214790|FG001|Overall Study|unable to meet time commitment required of study|3|||
144550823|NCT03060525|521214791|FG002|Overall Study|unable to meet time commitment required of study|3|||
144727678|NCT00444145|521858009|FG000|Overall Study|non-compliant|11|||
144550824|NCT03060525|521214792|FG003|Overall Study|unable to meet time commitment required of study|1|||
144550825|NCT03060525|521214789|FG000|Overall Study|no longer interested in doing intervention|0|||
144550826|NCT03060525|521214790|FG001|Overall Study|no longer interested in doing intervention|0|||
144550827|NCT03060525|521214791|FG002|Overall Study|no longer interested in doing intervention|0|||
144550828|NCT03060525|521214792|FG003|Overall Study|no longer interested in doing intervention|1|||
144550829|NCT03890484|521214804|FG000|Overall Study|Lost to Follow-up|1|||
144550830|NCT03890484|521214805|FG001|Overall Study|Lost to Follow-up|1|||
144550831|NCT00518206|521214806|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
144550832|NCT00518206|521214807|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
144550833|NCT00518206|521214806|FG000|Overall Study|Withdrawal by Subject|2|||
144550834|NCT00518206|521214807|FG001|Overall Study|Withdrawal by Subject|0|||
144550835|NCT00518206|521214806|FG000|Overall Study|Drug Supply Issue|1|||
144550836|NCT00518206|521214807|FG001|Overall Study|Drug Supply Issue|0|||
144550837|NCT00518206|521214806|FG000|Overall Study|Reason Unknown|1|||
144550838|NCT00518206|521214807|FG001|Overall Study|Reason Unknown|0|||
144550839|NCT00518206|521214806|FG000|Overall Study|Completion Status Unknown|1|||
144550840|NCT00518206|521214807|FG001|Overall Study|Completion Status Unknown|0|||
144550841|NCT01294644|521214808|FG000|Overall Study|Adverse Event|2|||
144550842|NCT01294644|521214809|FG001|Overall Study|Adverse Event|0|||
144550843|NCT01294644|521214810|FG002|Overall Study|Adverse Event|1|||
144550844|NCT01294644|521214808|FG000|Overall Study|Withdrawal by Subject|3|||
144550845|NCT01294644|521214809|FG001|Overall Study|Withdrawal by Subject|7|||
144550846|NCT01294644|521214810|FG002|Overall Study|Withdrawal by Subject|4|||
144550847|NCT01294644|521214808|FG000|Overall Study|Lost to Follow-up|3|||
144550848|NCT01294644|521214809|FG001|Overall Study|Lost to Follow-up|2|||
144203162|NCT00593736|519940288|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
144203163|NCT00593736|519940289|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
144203164|NCT00593736|519940290|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
144550849|NCT01294644|521214810|FG002|Overall Study|Lost to Follow-up|5|||
144550850|NCT01294644|521214808|FG000|Overall Study|Miscellaneous Reason|2|||
144550851|NCT01294644|521214809|FG001|Overall Study|Miscellaneous Reason|1|||
144550852|NCT01294644|521214810|FG002|Overall Study|Miscellaneous Reason|4|||
144550853|NCT02188459|521214811|FG000|Overall Study|Lost to Follow-up|3|||
144550854|NCT02188459|521214812|FG001|Overall Study|Lost to Follow-up|4|||
144550855|NCT02188459|521214811|FG000|Overall Study|Early Termination|0|||
144550856|NCT02188459|521214812|FG001|Overall Study|Early Termination|3|||
144550857|NCT04914897|521216868|FG000|Overall Study|Withdrawal by Subject|3|||
144550858|NCT04914897|521216869|FG001|Overall Study|Withdrawal by Subject|1|||
144550859|NCT04914897|521216870|FG002|Overall Study|Withdrawal by Subject|1|||
144550860|NCT04914897|521216871|FG003|Overall Study|Withdrawal by Subject|1|||
144550861|NCT04914897|521216868|FG000|Overall Study|Poor compliance to protocol|0|||
144550862|NCT04914897|521216869|FG001|Overall Study|Poor compliance to protocol|0|||
144550863|NCT04914897|521216870|FG002|Overall Study|Poor compliance to protocol|1|||
144550864|NCT04914897|521216871|FG003|Overall Study|Poor compliance to protocol|0|||
144550865|NCT04914897|521216868|FG000|Overall Study|Progressive disease|5|||
144550866|NCT04914897|521216869|FG001|Overall Study|Progressive disease|14|||
144550867|NCT04914897|521216870|FG002|Overall Study|Progressive disease|30|||
144550868|NCT04914897|521216871|FG003|Overall Study|Progressive disease|21|||
144550869|NCT04914897|521216868|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
144550870|NCT04914897|521216869|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
144550871|NCT04914897|521216870|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
144550872|NCT04914897|521216871|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
144550873|NCT04914897|521216868|FG000|Overall Study|Other|1|||
144550874|NCT04914897|521216869|FG001|Overall Study|Other|0|||
144550875|NCT04914897|521216870|FG002|Overall Study|Other|0|||
144550876|NCT04914897|521216871|FG003|Overall Study|Other|1|||
144550877|NCT03141177|521216872|FG000|Overall Study|Death|62|||
144550878|NCT03141177|521216873|FG001|Overall Study|Death|13|||
144550879|NCT03141177|521216874|FG002|Overall Study|Death|84|||
144550880|NCT03141177|521216872|FG000|Overall Study|Participant withdrew consent|9|||
144550881|NCT03141177|521216873|FG001|Overall Study|Participant withdrew consent|2|||
144550882|NCT03141177|521216874|FG002|Overall Study|Participant withdrew consent|13|||
144550883|NCT03141177|521216872|FG000|Overall Study|Not reported|1|||
144550884|NCT03141177|521216873|FG001|Overall Study|Not reported|0|||
144550885|NCT03141177|521216874|FG002|Overall Study|Not reported|1|||
144550886|NCT03141177|521216872|FG000|Overall Study|Lost to Follow-up|2|||
144550887|NCT03141177|521216873|FG001|Overall Study|Lost to Follow-up|1|||
144550888|NCT03141177|521216874|FG002|Overall Study|Lost to Follow-up|1|||
144550889|NCT03141177|521216872|FG000|Overall Study|Other reasons|4|||
144550890|NCT03141177|521216873|FG001|Overall Study|Other reasons|0|||
144550891|NCT03141177|521216874|FG002|Overall Study|Other reasons|11|||
144727679|NCT00444145|521858009|FG000|Overall Study|Screen Failures|5|||
144550892|NCT03141177|521216872|FG000|Overall Study|Participants did not start treatment period|3|||
144550893|NCT03141177|521216873|FG001|Overall Study|Participants did not start treatment period|0|||
144550894|NCT03141177|521216874|FG002|Overall Study|Participants did not start treatment period|8|||
144550895|NCT03020914|521216875|FG000|Overall Study|Surgery Cancelled|1|||
144550896|NCT03020914|521216876|FG001|Overall Study|Surgery Cancelled|0|||
144550897|NCT01562275|521216883|FG000|Stage 1|Adverse Event|0|||
144550898|NCT01562275|521216884|FG001|Stage 1|Adverse Event|0|||
144550899|NCT01562275|521216885|FG002|Stage 1|Adverse Event|0|||
144550900|NCT01562275|521216886|FG003|Stage 1|Adverse Event|1|||
144550901|NCT01562275|521216887|FG004|Stage 1|Adverse Event|1|||
144550902|NCT01562275|521216888|FG005|Stage 1|Adverse Event|0|||
144550903|NCT01562275|521216889|FG006|Stage 1|Adverse Event|0|||
144550904|NCT01562275|521216890|FG007|Stage 1|Adverse Event|0|||
144550905|NCT01562275|521216891|FG008|Stage 1|Adverse Event|0|||
144550906|NCT01562275|521216892|FG009|Stage 1|Adverse Event|1|||
144550907|NCT01562275|521216893|FG010|Stage 1|Adverse Event|0|||
144550908|NCT01562275|521216894|FG011|Stage 1|Adverse Event|0|||
144550909|NCT01562275|521216895|FG012|Stage 1|Adverse Event|0|||
144550910|NCT01562275|521216883|FG000|Stage 1|Death|1|||
144550911|NCT01562275|521216884|FG001|Stage 1|Death|0|||
144550912|NCT01562275|521216885|FG002|Stage 1|Death|0|||
144550913|NCT01562275|521216886|FG003|Stage 1|Death|0|||
144550914|NCT01562275|521216887|FG004|Stage 1|Death|0|||
144550915|NCT01562275|521216888|FG005|Stage 1|Death|0|||
144550916|NCT01562275|521216889|FG006|Stage 1|Death|0|||
144550917|NCT01562275|521216890|FG007|Stage 1|Death|0|||
144550918|NCT01562275|521216891|FG008|Stage 1|Death|0|||
144550919|NCT01562275|521216892|FG009|Stage 1|Death|0|||
144550920|NCT01562275|521216893|FG010|Stage 1|Death|0|||
144550921|NCT01562275|521216894|FG011|Stage 1|Death|0|||
144550922|NCT01562275|521216895|FG012|Stage 1|Death|0|||
144550923|NCT01562275|521216883|FG000|Stage 1|Non Compliance|0|||
144550924|NCT01562275|521216884|FG001|Stage 1|Non Compliance|0|||
144550925|NCT01562275|521216885|FG002|Stage 1|Non Compliance|1|||
144550926|NCT01562275|521216886|FG003|Stage 1|Non Compliance|0|||
144550927|NCT01562275|521216887|FG004|Stage 1|Non Compliance|0|||
144550928|NCT01562275|521216888|FG005|Stage 1|Non Compliance|0|||
144550929|NCT01562275|521216889|FG006|Stage 1|Non Compliance|0|||
144550930|NCT01562275|521216890|FG007|Stage 1|Non Compliance|0|||
144550931|NCT01562275|521216891|FG008|Stage 1|Non Compliance|0|||
144550932|NCT01562275|521216892|FG009|Stage 1|Non Compliance|0|||
144550933|NCT01562275|521216893|FG010|Stage 1|Non Compliance|0|||
144550934|NCT01562275|521216894|FG011|Stage 1|Non Compliance|0|||
144550935|NCT01562275|521216895|FG012|Stage 1|Non Compliance|0|||
144550936|NCT01562275|521216883|FG000|Stage 1|Physician Decision|0|||
144550937|NCT01562275|521216884|FG001|Stage 1|Physician Decision|0|||
144550938|NCT01562275|521216885|FG002|Stage 1|Physician Decision|0|||
144550939|NCT01562275|521216886|FG003|Stage 1|Physician Decision|0|||
144550940|NCT01562275|521216887|FG004|Stage 1|Physician Decision|1|||
144550941|NCT01562275|521216888|FG005|Stage 1|Physician Decision|0|||
144550942|NCT01562275|521216889|FG006|Stage 1|Physician Decision|1|||
144550943|NCT01562275|521216890|FG007|Stage 1|Physician Decision|0|||
144550944|NCT01562275|521216891|FG008|Stage 1|Physician Decision|1|||
144550945|NCT01562275|521216892|FG009|Stage 1|Physician Decision|0|||
144550946|NCT01562275|521216893|FG010|Stage 1|Physician Decision|0|||
144550947|NCT01562275|521216894|FG011|Stage 1|Physician Decision|0|||
144550948|NCT01562275|521216895|FG012|Stage 1|Physician Decision|0|||
144550949|NCT01562275|521216883|FG000|Stage 1|Progression of Disease|2|||
144550950|NCT01562275|521216884|FG001|Stage 1|Progression of Disease|6|||
144550951|NCT01562275|521216885|FG002|Stage 1|Progression of Disease|2|||
144550952|NCT01562275|521216886|FG003|Stage 1|Progression of Disease|1|||
144550953|NCT01562275|521216887|FG004|Stage 1|Progression of Disease|2|||
144550954|NCT01562275|521216888|FG005|Stage 1|Progression of Disease|4|||
144550955|NCT01562275|521216889|FG006|Stage 1|Progression of Disease|1|||
144550956|NCT01562275|521216890|FG007|Stage 1|Progression of Disease|7|||
144550957|NCT01562275|521216891|FG008|Stage 1|Progression of Disease|2|||
144550958|NCT01562275|521216892|FG009|Stage 1|Progression of Disease|5|||
144550959|NCT01562275|521216893|FG010|Stage 1|Progression of Disease|3|||
144550960|NCT01562275|521216894|FG011|Stage 1|Progression of Disease|0|||
144550961|NCT01562275|521216895|FG012|Stage 1|Progression of Disease|0|||
144550962|NCT01562275|521216883|FG000|Stage 1|Withdrawal by Subject|0|||
144550963|NCT01562275|521216884|FG001|Stage 1|Withdrawal by Subject|1|||
144550964|NCT01562275|521216885|FG002|Stage 1|Withdrawal by Subject|0|||
144550965|NCT01562275|521216886|FG003|Stage 1|Withdrawal by Subject|2|||
144550966|NCT01562275|521216887|FG004|Stage 1|Withdrawal by Subject|0|||
144550967|NCT01562275|521216888|FG005|Stage 1|Withdrawal by Subject|0|||
144550968|NCT01562275|521216889|FG006|Stage 1|Withdrawal by Subject|1|||
144550969|NCT01562275|521216890|FG007|Stage 1|Withdrawal by Subject|0|||
144550970|NCT01562275|521216891|FG008|Stage 1|Withdrawal by Subject|0|||
144550971|NCT01562275|521216892|FG009|Stage 1|Withdrawal by Subject|1|||
144550972|NCT01562275|521216893|FG010|Stage 1|Withdrawal by Subject|0|||
144550973|NCT01562275|521216894|FG011|Stage 1|Withdrawal by Subject|0|||
144550974|NCT01562275|521216895|FG012|Stage 1|Withdrawal by Subject|0|||
144550975|NCT01562275|521216883|FG000|Stage 2|Death|0|||
144550976|NCT01562275|521216884|FG001|Stage 2|Death|0|||
144550977|NCT01562275|521216885|FG002|Stage 2|Death|0|||
144550978|NCT01562275|521216886|FG003|Stage 2|Death|0|||
144550979|NCT01562275|521216887|FG004|Stage 2|Death|0|||
144550980|NCT01562275|521216888|FG005|Stage 2|Death|0|||
144550981|NCT01562275|521216889|FG006|Stage 2|Death|0|||
144550982|NCT01562275|521216890|FG007|Stage 2|Death|0|||
144550983|NCT01562275|521216891|FG008|Stage 2|Death|0|||
144550984|NCT01562275|521216892|FG009|Stage 2|Death|0|||
144550985|NCT01562275|521216893|FG010|Stage 2|Death|0|||
144550986|NCT01562275|521216894|FG011|Stage 2|Death|2|||
144550987|NCT01562275|521216895|FG012|Stage 2|Death|1|||
144550988|NCT01562275|521216883|FG000|Stage 2|Progression of Disease|0|||
144550989|NCT01562275|521216884|FG001|Stage 2|Progression of Disease|0|||
144550990|NCT01562275|521216885|FG002|Stage 2|Progression of Disease|0|||
144550991|NCT01562275|521216886|FG003|Stage 2|Progression of Disease|0|||
144550992|NCT01562275|521216887|FG004|Stage 2|Progression of Disease|0|||
144550993|NCT01562275|521216888|FG005|Stage 2|Progression of Disease|0|||
144550994|NCT01562275|521216889|FG006|Stage 2|Progression of Disease|0|||
144550995|NCT01562275|521216890|FG007|Stage 2|Progression of Disease|0|||
144550996|NCT01562275|521216891|FG008|Stage 2|Progression of Disease|0|||
144550997|NCT01562275|521216892|FG009|Stage 2|Progression of Disease|0|||
144550998|NCT01562275|521216893|FG010|Stage 2|Progression of Disease|0|||
144550999|NCT01562275|521216894|FG011|Stage 2|Progression of Disease|12|||
144551000|NCT01562275|521216895|FG012|Stage 2|Progression of Disease|4|||
144551001|NCT01863368|521216896|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
144551002|NCT01863368|521216897|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
144551003|NCT01863368|521216896|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
144551004|NCT01863368|521216897|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
144551005|NCT01863368|521216896|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
144551006|NCT01863368|521216897|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
144551007|NCT01863368|521216896|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
144551008|NCT01863368|521216897|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
144551009|NCT01863368|521216896|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
144551010|NCT01863368|521216897|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
144551011|NCT01863368|521216896|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
144551012|NCT01863368|521216897|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
144551013|NCT00515112|521216899|FG000|Overall Study|Death|0|||
144551014|NCT00515112|521216900|FG001|Overall Study|Death|1|||
144551015|NCT00515112|521216899|FG000|Overall Study|The study was terminated|3|||
144551016|NCT00515112|521216900|FG001|Overall Study|The study was terminated|2|||
144551017|NCT04425252|521216903|FG000|Overall Study|Withdrawal by Subject|2|||
144551018|NCT04425252|521216904|FG001|Overall Study|Withdrawal by Subject|1|||
144551019|NCT04425252|521216903|FG000|Overall Study|Lost to Follow-up|1|||
144551020|NCT04425252|521216904|FG001|Overall Study|Lost to Follow-up|0|||
144551021|NCT04425252|521216903|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
144551022|NCT04425252|521216904|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
144551023|NCT00304278|521216905|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
144551024|NCT00304278|521216905|FG000|Overall Study|PT had medical condition preventing TX|1|||
144551025|NCT03840993|521216908|FG000|Overall Study|Adverse Event|1|||
144551026|NCT03840993|521216909|FG001|Overall Study|Adverse Event|0|||
144551027|NCT03840993|521216908|FG000|Overall Study|Lost to Follow-up|4|||
144551028|NCT03840993|521216909|FG001|Overall Study|Lost to Follow-up|0|||
144551029|NCT03840993|521216908|FG000|Overall Study|Physician Decision|0|||
144551030|NCT03840993|521216909|FG001|Overall Study|Physician Decision|1|||
144551031|NCT03840993|521216908|FG000|Overall Study|Pregnancy|0|||
144551032|NCT03840993|521216909|FG001|Overall Study|Pregnancy|1|||
144551033|NCT03840993|521216908|FG000|Overall Study|Withdrawal by Subject|1|||
144551034|NCT03840993|521216909|FG001|Overall Study|Withdrawal by Subject|3|||
144551035|NCT03840993|521216908|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
144551036|NCT03840993|521216909|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
144551037|NCT04271254|521216910|FG000|Overall Study|Withdrawal by Subject|3|||
144551038|NCT01123356|521216911|FG000|Overall Study|Adverse Event|2|||
144551039|NCT01123356|521216911|FG000|Overall Study|Lack of Efficacy|4|||
144551040|NCT01123356|521216911|FG000|Overall Study|Withdrawal by Subject|1|||
144551041|NCT00930644|521216912|FG000|Overall Study|Withdrawal by Subject|4|||
144551042|NCT00930644|521216912|FG000|Overall Study|Physician Decision|2|||
144551043|NCT00930644|521216912|FG000|Overall Study|Death|1|||
144551044|NCT00930644|521216912|FG000|Overall Study|Adverse Event|16|||
144551045|NCT01113541|521216919|FG000|Overall Study|Withdrawal by Subject|1|||
144551046|NCT01113541|521216919|FG000|Overall Study|Protocol Violation|1|||
144551047|NCT01113541|521216919|FG000|Overall Study|Study Terminated by Sponsor|7|||
144551048|NCT01113541|521216919|FG000|Overall Study|Adverse Event|4|||
144551049|NCT03745651|521216920|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
144551050|NCT03745651|521216921|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
144551051|NCT03745651|521216922|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144551052|NCT03745651|521216923|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144551053|NCT03745651|521216924|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144551054|NCT03745651|521216925|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144551055|NCT03745651|521216926|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144551056|NCT03745651|521216920|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
144551057|NCT03745651|521216921|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
144551058|NCT03745651|521216922|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
144551059|NCT03745651|521216923|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144551060|NCT03745651|521216924|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144551061|NCT03745651|521216925|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144551062|NCT03745651|521216926|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144551063|NCT03745651|521216920|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
144551064|NCT03745651|521216921|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144551065|NCT03745651|521216922|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
144551066|NCT03745651|521216923|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144551067|NCT03745651|521216924|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144551068|NCT03745651|521216925|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144551069|NCT03745651|521216926|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144551070|NCT03745651|521216920|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144551071|NCT03745651|521216921|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
144551072|NCT03745651|521216922|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144551073|NCT03745651|521216923|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144551074|NCT03745651|521216924|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144551075|NCT03745651|521216925|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144551076|NCT03745651|521216926|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144551077|NCT03745651|521216920|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
144551078|NCT03745651|521216921|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
144551079|NCT03745651|521216922|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
144551080|NCT03745651|521216923|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144551081|NCT03745651|521216924|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144551082|NCT03745651|521216925|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144551083|NCT03745651|521216926|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144551084|NCT03745651|521216920|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
144551085|NCT03745651|521216921|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
144551086|NCT03745651|521216922|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
144551087|NCT03745651|521216923|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
144551088|NCT03745651|521216924|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
144551089|NCT03745651|521216925|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
144551090|NCT03745651|521216926|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
144551091|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144551092|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144551093|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144551094|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144551095|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144551096|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
144551097|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144551098|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144551099|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144551100|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144551101|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
144551102|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144551103|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
144551104|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
144551105|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144551106|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144551107|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144551108|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
144551109|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
144551110|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
144551111|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
144551112|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144551113|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144551114|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144551115|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
144551116|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144551117|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
144262350|NCT05219968|520159884|FG004|Week 24 Treatment Period|Adverse Event|0|||
144262351|NCT05219968|520159880|FG000|Week 24 Treatment Period|Physician Decision|0|||
144551118|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
144551119|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
144551120|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
144551121|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
144551122|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
144551123|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
144551124|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
144551125|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
144551126|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144551127|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144551128|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144551129|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144551130|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144551131|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
144551132|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144551133|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144551134|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144551135|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144551136|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
144551137|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
144551138|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
144551139|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
144551140|NCT03745651|521216920|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
144551141|NCT03745651|521216921|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
144551142|NCT03745651|521216922|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
144551143|NCT03745651|521216923|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
144551144|NCT03745651|521216924|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
144551145|NCT03745651|521216925|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
144551146|NCT03745651|521216926|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
144551147|NCT04175834|521216927|FG000|Overall Study|Withdrawal by Subject|1|||
144551148|NCT04175834|521216928|FG001|Overall Study|Withdrawal by Subject|0|||
144551149|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
144551150|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
144551151|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
144551152|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
144551153|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
144551154|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
144551155|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
144551156|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
144551157|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
144551158|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
144551159|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
144551160|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
144551161|NCT01494467|521216937|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
144551162|NCT01494467|521216938|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
144551163|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
144551164|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
144551165|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
144551166|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
144551167|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
144551168|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
144551169|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
144551170|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
144551171|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
144551172|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
144551173|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
144551174|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
144551175|NCT01494467|521216937|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
144551176|NCT01494467|521216938|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
144551177|NCT03693989|521216941|FG000|Overall Study|Protocol Violation|3|||
144551178|NCT03693989|521216942|FG001|Overall Study|Protocol Violation|4|||
144551179|NCT01190436|521216943|FG000|Overall Study|Lost to Follow-up|35|||
144551180|NCT01190436|521216943|FG000|Overall Study|Other|4|||
144551181|NCT03146845|521216944|FG000|Overall Study|Reference ulcer healed|1|||
144551182|NCT03146845|521216945|FG001|Overall Study|Reference ulcer healed|0|||
144551183|NCT03146845|521216944|FG000|Overall Study|Physician Decision|1|||
144551184|NCT03146845|521216945|FG001|Overall Study|Physician Decision|0|||
144551185|NCT03146845|521216944|FG000|Overall Study|Adverse Event|1|||
144551186|NCT03146845|521216945|FG001|Overall Study|Adverse Event|0|||
144551187|NCT03146845|521216944|FG000|Overall Study|Withdrawal by Subject|2|||
144551188|NCT03146845|521216945|FG001|Overall Study|Withdrawal by Subject|0|||
144551189|NCT03146845|521216944|FG000|Overall Study|Noncompliance|0|||
144551190|NCT03146845|521216945|FG001|Overall Study|Noncompliance|1|||
144551191|NCT03146845|521216944|FG000|Overall Study|Protocol Violation|0|||
144551192|NCT03146845|521216945|FG001|Overall Study|Protocol Violation|2|||
144551193|NCT03146845|521216944|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
144551194|NCT03146845|521216945|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
144551195|NCT02721147|521216946|FG000|Overall Study|Lost to Follow-up|2|||
144551196|NCT02721147|521216947|FG001|Overall Study|Lost to Follow-up|0|||
144551197|NCT02721147|521216948|FG002|Overall Study|Lost to Follow-up|0|||
144551198|NCT00113529|521216952|FG000|Overall Study|Adverse Event|4|||
144551199|NCT00113529|521216952|FG000|Overall Study|Lack of Efficacy|20|||
144551200|NCT00113529|521216952|FG000|Overall Study|Decision of sponsor|6|||
144551201|NCT00113529|521216952|FG000|Overall Study|Withdrawal by Subject|4|||
144551202|NCT00648895|521216955|FG000|Overall Study|Lack of Efficacy|0|||
144551203|NCT00648895|521216956|FG001|Overall Study|Lack of Efficacy|1|||
144551204|NCT03386344|521216957|FG000|Overall Study|Adverse Event|6|||
144551205|NCT03386344|521216958|FG001|Overall Study|Adverse Event|3|||
144551206|NCT03386344|521216959|FG002|Overall Study|Adverse Event|1|||
144551207|NCT03386344|521216957|FG000|Overall Study|Poor Compliance to Protocol|0|||
144551208|NCT03386344|521216958|FG001|Overall Study|Poor Compliance to Protocol|1|||
144551209|NCT03386344|521216959|FG002|Overall Study|Poor Compliance to Protocol|0|||
144551210|NCT03386344|521216957|FG000|Overall Study|Study Terminated by Sponsor|101|||
144551211|NCT03386344|521216958|FG001|Overall Study|Study Terminated by Sponsor|102|||
144551212|NCT03386344|521216959|FG002|Overall Study|Study Terminated by Sponsor|106|||
144551213|NCT03386344|521216957|FG000|Overall Study|Lost to Follow-up|3|||
144551214|NCT03386344|521216958|FG001|Overall Study|Lost to Follow-up|2|||
144551215|NCT03386344|521216959|FG002|Overall Study|Lost to Follow-up|1|||
144551216|NCT03386344|521216957|FG000|Overall Study|At the Participant's own Request|7|||
144551217|NCT03386344|521216958|FG001|Overall Study|At the Participant's own Request|7|||
144551218|NCT03386344|521216959|FG002|Overall Study|At the Participant's own Request|8|||
144551219|NCT03386344|521216957|FG000|Overall Study|Reason not Specified|0|||
144551220|NCT03386344|521216958|FG001|Overall Study|Reason not Specified|1|||
144551221|NCT03386344|521216959|FG002|Overall Study|Reason not Specified|0|||
144551222|NCT01077284|521216962|FG000|Overall Study|Adverse Event|2|||
144551223|NCT01077284|521216963|FG001|Overall Study|Adverse Event|0|||
144551224|NCT01077284|521216964|FG002|Overall Study|Adverse Event|1|||
144551225|NCT01077284|521216962|FG000|Overall Study|Lost to Follow-up|1|||
144551226|NCT01077284|521216963|FG001|Overall Study|Lost to Follow-up|2|||
144551227|NCT01077284|521216964|FG002|Overall Study|Lost to Follow-up|0|||
144551228|NCT01077284|521216962|FG000|Overall Study|Withdrawal by Subject|2|||
144551229|NCT01077284|521216963|FG001|Overall Study|Withdrawal by Subject|3|||
144551230|NCT01077284|521216964|FG002|Overall Study|Withdrawal by Subject|1|||
144551231|NCT01077284|521216962|FG000|Overall Study|Other|0|||
144551232|NCT01077284|521216963|FG001|Overall Study|Other|0|||
144551233|NCT01077284|521216964|FG002|Overall Study|Other|1|||
144551234|NCT01280721|521216965|FG000|Overall Study|Adverse Event|4|||
144551235|NCT01280721|521216965|FG000|Overall Study|Physician Decision|3|||
144551236|NCT01280721|521216965|FG000|Overall Study|Withdrawal by Subject|6|||
144551237|NCT01280721|521216965|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
144551238|NCT01280721|521216965|FG000|Overall Study|No tolerability for the lowest dose|2|||
144551239|NCT01180400|521216966|FG000|Overall Study|Withdrawal by Subject|5|||
144551240|NCT01180400|521216967|FG001|Overall Study|Withdrawal by Subject|6|||
144551241|NCT01180400|521216966|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144551242|NCT01180400|521216967|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
144551243|NCT01180400|521216966|FG000|Overall Study|Adverse Event|12|||
144551244|NCT01180400|521216967|FG001|Overall Study|Adverse Event|10|||
144551245|NCT01180400|521216966|FG000|Overall Study|Severe non-compliance to protocol|1|||
144551246|NCT01180400|521216967|FG001|Overall Study|Severe non-compliance to protocol|2|||
144551247|NCT01180400|521216966|FG000|Overall Study|Condition under investigation worsened|2|||
144551248|NCT01180400|521216967|FG001|Overall Study|Condition under investigation worsened|1|||
144551249|NCT01180400|521216966|FG000|Overall Study|Lack of Efficacy|2|||
144551250|NCT01180400|521216967|FG001|Overall Study|Lack of Efficacy|0|||
144551251|NCT01180400|521216966|FG000|Overall Study|Study-specific withdrawal criteria|1|||
144727680|NCT01619800|521858010|FG000|Overall Study|study terminated|2|||
144551252|NCT01180400|521216967|FG001|Overall Study|Study-specific withdrawal criteria|2|||
144551253|NCT01180400|521216966|FG000|Overall Study|Lost to Follow-up|2|||
144551254|NCT01180400|521216967|FG001|Overall Study|Lost to Follow-up|3|||
144551255|NCT01180400|521216966|FG000|Overall Study|Other|0|||
144551256|NCT01180400|521216967|FG001|Overall Study|Other|1|||
144727681|NCT01619800|521858011|FG001|Overall Study|study terminated|0|||
144551257|NCT01182285|521216968|FG000|First Intervention Week 1-10|Disease progression|1|||
144551258|NCT01182285|521216969|FG001|First Intervention Week 1-10|Disease progression|0|||
144551259|NCT01182285|521216970|FG002|First Intervention Week 1-10|Disease progression|0|||
144551260|NCT01182285|521216968|FG000|First Intervention Week 1-10|Adverse Event|1|||
144551261|NCT01182285|521216969|FG001|First Intervention Week 1-10|Adverse Event|0|||
144551262|NCT01182285|521216970|FG002|First Intervention Week 1-10|Adverse Event|0|||
144551263|NCT01182285|521216968|FG000|First Intervention Week 1-10|Non-compliance|1|||
144551264|NCT01182285|521216969|FG001|First Intervention Week 1-10|Non-compliance|0|||
144551265|NCT01182285|521216970|FG002|First Intervention Week 1-10|Non-compliance|0|||
144551266|NCT01182285|521216968|FG000|Third Intervention Week 11-52|Disease Progression|0|||
144551267|NCT01182285|521216969|FG001|Third Intervention Week 11-52|Disease Progression|0|||
144551268|NCT01182285|521216970|FG002|Third Intervention Week 11-52|Disease Progression|6|||
144551269|NCT01182285|521216968|FG000|Third Intervention Week 11-52|Other|0|||
144551270|NCT01182285|521216969|FG001|Third Intervention Week 11-52|Other|0|||
144551271|NCT01182285|521216970|FG002|Third Intervention Week 11-52|Other|2|||
144551272|NCT02632747|521216971|FG000|Wash-out Period|Adverse Event|1|||
144551273|NCT02632747|521216972|FG001|Wash-out Period|Adverse Event|0|||
144551274|NCT01525875|521216973|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
144551275|NCT01525875|521216974|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
144551276|NCT01525875|521216973|FG000|Open-label Period|Lost to Follow-up|0|||
144551277|NCT01525875|521216974|FG001|Open-label Period|Lost to Follow-up|2|||
144551278|NCT00700999|521216975|FG000|Overall Study|Lost to Follow-up|7|||
144551279|NCT00700999|521216976|FG001|Overall Study|Lost to Follow-up|7|||
144551280|NCT00700999|521216975|FG000|Overall Study|Excluded - did not meet study criteria|0|||
144551281|NCT00700999|521216976|FG001|Overall Study|Excluded - did not meet study criteria|1|||
144551282|NCT00700999|521216975|FG000|Overall Study|Withdrawal by Subject|8|||
144551283|NCT00700999|521216976|FG001|Overall Study|Withdrawal by Subject|1|||
144551284|NCT02379078|521216977|FG000|Overall Study|Lost to Follow-up|33|||
144551285|NCT02379078|521216978|FG001|Overall Study|Lost to Follow-up|30|||
144551286|NCT02379078|521216977|FG000|Overall Study|Withdrawal by Subject|6|||
144551287|NCT02379078|521216978|FG001|Overall Study|Withdrawal by Subject|5|||
144551288|NCT03481725|521216979|FG000|Overall Study|Withdrawal by Subject|1|||
144551289|NCT03481725|521216980|FG001|Overall Study|Withdrawal by Subject|0|||
144551290|NCT01894620|521216981|FG000|Overall Study|Withdrawal by Subject|0|||
144551291|NCT01894620|521216982|FG001|Overall Study|Withdrawal by Subject|1|||
144551292|NCT03875729|521216989|FG000|Overall Study|Adverse Event|0|||
144551293|NCT03875729|521216990|FG001|Overall Study|Adverse Event|5|||
144551294|NCT03875729|521216989|FG000|Overall Study|Withdrawal by Subject|8|||
144551295|NCT03875729|521216990|FG001|Overall Study|Withdrawal by Subject|11|||
144551296|NCT03875729|521216989|FG000|Overall Study|Pregnancy|0|||
144551297|NCT03875729|521216990|FG001|Overall Study|Pregnancy|1|||
144551298|NCT03875729|521216989|FG000|Overall Study|Lost to Follow-up|0|||
144551299|NCT03875729|521216990|FG001|Overall Study|Lost to Follow-up|5|||
144551300|NCT03875729|521216989|FG000|Overall Study|Personal reasons|2|||
144551301|NCT03875729|521216990|FG001|Overall Study|Personal reasons|0|||
144551302|NCT02399449|521216993|FG000|Overall Study|Withdrawal by Subject|3|||
144551303|NCT02399449|521216994|FG001|Overall Study|Withdrawal by Subject|9|||
144551304|NCT02399449|521216993|FG000|Overall Study|Physician Decision|0|||
144551305|NCT02399449|521216994|FG001|Overall Study|Physician Decision|1|||
144262352|NCT05219968|520159881|FG001|Week 24 Treatment Period|Physician Decision|1|||
144262353|NCT05219968|520159882|FG002|Week 24 Treatment Period|Physician Decision|0|||
144262354|NCT05219968|520159883|FG003|Week 24 Treatment Period|Physician Decision|0|||
144262355|NCT05219968|520159884|FG004|Week 24 Treatment Period|Physician Decision|0|||
144262356|NCT05219968|520159880|FG000|Week 24 Treatment Period|Other, not specified|3|||
144262357|NCT05219968|520159881|FG001|Week 24 Treatment Period|Other, not specified|0|||
144262358|NCT05219968|520159882|FG002|Week 24 Treatment Period|Other, not specified|0|||
144262359|NCT05219968|520159883|FG003|Week 24 Treatment Period|Other, not specified|0|||
144262360|NCT05219968|520159884|FG004|Week 24 Treatment Period|Other, not specified|0|||
144262361|NCT05219968|520159880|FG000|Safety Extension Period|Treatment administration failure|0|||
144262362|NCT05219968|520159881|FG001|Safety Extension Period|Treatment administration failure|0|||
144262363|NCT05219968|520159882|FG002|Safety Extension Period|Treatment administration failure|0|||
144262364|NCT05219968|520159883|FG003|Safety Extension Period|Treatment administration failure|1|||
144262365|NCT05219968|520159884|FG004|Safety Extension Period|Treatment administration failure|4|||
144262366|NCT05219968|520159880|FG000|Safety Extension Period|Bilateral dislodgement|0|||
144262367|NCT05219968|520159881|FG001|Safety Extension Period|Bilateral dislodgement|0|||
144262368|NCT05219968|520159882|FG002|Safety Extension Period|Bilateral dislodgement|4|||
144262369|NCT05219968|520159883|FG003|Safety Extension Period|Bilateral dislodgement|0|||
144262370|NCT05219968|520159884|FG004|Safety Extension Period|Bilateral dislodgement|1|||
144551306|NCT02516202|521216995|FG000|Overall Study|Withdrawal by Subject|1|||
144551307|NCT02516202|521216996|FG001|Overall Study|Withdrawal by Subject|0|||
144551308|NCT02516202|521216997|FG002|Overall Study|Withdrawal by Subject|1|||
144551309|NCT02516202|521216995|FG000|Overall Study|Lost to Follow-up|1|||
144551310|NCT02516202|521216996|FG001|Overall Study|Lost to Follow-up|1|||
144551311|NCT02516202|521216997|FG002|Overall Study|Lost to Follow-up|1|||
144551312|NCT02516202|521216995|FG000|Overall Study|Stopped Follow-up|0|||
144551313|NCT02516202|521216996|FG001|Overall Study|Stopped Follow-up|0|||
144551314|NCT02516202|521216997|FG002|Overall Study|Stopped Follow-up|1|||
144551315|NCT02159352|521217000|FG000|Overall Study|Adverse Event|3|||
144551316|NCT02159352|521217001|FG001|Overall Study|Adverse Event|1|||
144551317|NCT02159352|521217000|FG000|Overall Study|Withdrawal by Subject|0|||
144551318|NCT02159352|521217001|FG001|Overall Study|Withdrawal by Subject|1|||
144551319|NCT00529529|521217002|FG000|Overall Study|Adverse Event|12|||
144551320|NCT00529529|521217003|FG001|Overall Study|Adverse Event|17|||
144551321|NCT00529529|521217004|FG002|Overall Study|Adverse Event|8|||
144551322|NCT00529529|521217002|FG000|Overall Study|Subject withdrew consent|12|||
144551323|NCT00529529|521217003|FG001|Overall Study|Subject withdrew consent|9|||
144551324|NCT00529529|521217004|FG002|Overall Study|Subject withdrew consent|12|||
144551325|NCT00529529|521217002|FG000|Overall Study|Protocol deviation|8|||
144551326|NCT00529529|521217003|FG001|Overall Study|Protocol deviation|12|||
144551327|NCT00529529|521217004|FG002|Overall Study|Protocol deviation|5|||
144551328|NCT00529529|521217002|FG000|Overall Study|Lost to Follow-up|5|||
144551329|NCT00529529|521217003|FG001|Overall Study|Lost to Follow-up|3|||
144551330|NCT00529529|521217004|FG002|Overall Study|Lost to Follow-up|1|||
144551331|NCT00529529|521217002|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144551332|NCT00529529|521217003|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144551333|NCT00529529|521217004|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144551334|NCT00529529|521217002|FG000|Overall Study|Death|2|||
144551335|NCT00529529|521217003|FG001|Overall Study|Death|0|||
144551336|NCT00529529|521217004|FG002|Overall Study|Death|0|||
144551337|NCT00529529|521217002|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144551338|NCT00529529|521217003|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144551339|NCT00529529|521217004|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144551340|NCT00529529|521217002|FG000|Overall Study|Administrative problems|1|||
144551341|NCT00529529|521217003|FG001|Overall Study|Administrative problems|0|||
144551342|NCT00529529|521217004|FG002|Overall Study|Administrative problems|3|||
144551343|NCT01020435|521217009|FG000|Overall Study|Lost to Follow-up|0|||
144551344|NCT01020435|521217010|FG001|Overall Study|Lost to Follow-up|1|||
144551345|NCT01000649|521217011|FG000|Overall Study|Adverse Event|5|||
144551346|NCT01000649|521217012|FG001|Overall Study|Adverse Event|1|||
144551347|NCT01000649|521217013|FG002|Overall Study|Adverse Event|2|||
144551348|NCT01000649|521217014|FG003|Overall Study|Adverse Event|4|||
144551349|NCT01000649|521217011|FG000|Overall Study|Lost to Follow-up|0|||
144551350|NCT01000649|521217012|FG001|Overall Study|Lost to Follow-up|2|||
144551351|NCT01000649|521217013|FG002|Overall Study|Lost to Follow-up|0|||
144551352|NCT01000649|521217014|FG003|Overall Study|Lost to Follow-up|2|||
144551353|NCT02707952|521217017|FG000|Overall Study|Adverse Event|1|||
144551354|NCT02707952|521217018|FG001|Overall Study|Adverse Event|0|||
144551355|NCT02707952|521217019|FG002|Overall Study|Adverse Event|0|||
144551356|NCT02707952|521217020|FG003|Overall Study|Adverse Event|0|||
144551357|NCT02707952|521217017|FG000|Overall Study|Lost to Follow-up|1|||
144551358|NCT02707952|521217018|FG001|Overall Study|Lost to Follow-up|0|||
144551359|NCT02707952|521217019|FG002|Overall Study|Lost to Follow-up|0|||
144551360|NCT02707952|521217020|FG003|Overall Study|Lost to Follow-up|0|||
144551361|NCT02707952|521217017|FG000|Overall Study|Withdrawal by Subject|0|||
144551362|NCT02707952|521217018|FG001|Overall Study|Withdrawal by Subject|1|||
144551363|NCT02707952|521217019|FG002|Overall Study|Withdrawal by Subject|2|||
144551364|NCT02707952|521217020|FG003|Overall Study|Withdrawal by Subject|0|||
144551365|NCT00871715|521217021|FG000|Overall Study|Withdrawal by Subject|6|||
144551366|NCT00871715|521217022|FG001|Overall Study|Withdrawal by Subject|10|||
144551367|NCT00871715|521217023|FG002|Overall Study|Withdrawal by Subject|15|||
144551368|NCT00871715|521217021|FG000|Overall Study|Physician Decision|6|||
144551369|NCT00871715|521217022|FG001|Overall Study|Physician Decision|0|||
144551370|NCT00871715|521217023|FG002|Overall Study|Physician Decision|2|||
144551371|NCT00871715|521217021|FG000|Overall Study|Lost to Follow-up|3|||
144551372|NCT00871715|521217022|FG001|Overall Study|Lost to Follow-up|6|||
144551373|NCT00871715|521217023|FG002|Overall Study|Lost to Follow-up|9|||
144551374|NCT00392197|521217024|FG000|Overall Study|Adverse Event|4|||
144551375|NCT00392197|521217025|FG001|Overall Study|Adverse Event|12|||
144551376|NCT00392197|521217024|FG000|Overall Study|Lack of Efficacy|3|||
144551377|NCT00392197|521217025|FG001|Overall Study|Lack of Efficacy|4|||
144551378|NCT00392197|521217024|FG000|Overall Study|Lost to Follow-up|0|||
144551379|NCT00392197|521217025|FG001|Overall Study|Lost to Follow-up|1|||
144551380|NCT00392197|521217024|FG000|Overall Study|Physician Decision|3|||
144551381|NCT00392197|521217025|FG001|Overall Study|Physician Decision|2|||
144727682|NCT00419770|521858015|FG000|Overall Study|Withdrawal by Subject|5|||
144727683|NCT00419770|521858016|FG001|Overall Study|Withdrawal by Subject|1|||
144727684|NCT04526210|521858023|FG000|Overall Study|Sponsor decision|7|||
144727685|NCT04526210|521858024|FG001|Overall Study|Sponsor decision|5|||
144727686|NCT04526210|521858023|FG000|Overall Study|Withdrawal by Subject|3|||
144551382|NCT00392197|521217024|FG000|Overall Study|Protocol Violation|7|||
144551383|NCT00392197|521217025|FG001|Overall Study|Protocol Violation|5|||
144551384|NCT00392197|521217024|FG000|Overall Study|Withdrawal by Subject|4|||
144551385|NCT00392197|521217025|FG001|Overall Study|Withdrawal by Subject|6|||
144551386|NCT01794689|521217026|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
144551387|NCT01794689|521217027|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
144551388|NCT01794689|521217028|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
144551389|NCT01794689|521217029|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
144551390|NCT01794689|521217026|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
144551391|NCT01794689|521217027|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
144551392|NCT01794689|521217028|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
144551393|NCT01794689|521217029|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
144551394|NCT01794689|521217026|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
144551395|NCT01794689|521217027|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
144551396|NCT01794689|521217028|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
144551397|NCT01794689|521217029|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
144551398|NCT01794689|521217026|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
144551399|NCT01794689|521217027|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
144551400|NCT01794689|521217028|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
144551401|NCT01794689|521217029|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
144551402|NCT01970527|521217031|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
144551403|NCT01970527|521217032|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
144551404|NCT01970527|521217031|FG000|Treatment|Disease progression|0|||
144551405|NCT01970527|521217032|FG001|Treatment|Disease progression|1|||
144551406|NCT01970527|521217031|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
144551407|NCT01970527|521217032|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
144551408|NCT01970527|521217031|FG000|Treatment|Death|0|||
144551409|NCT01970527|521217032|FG001|Treatment|Death|1|||
144551410|NCT01970527|521217031|FG000|Follow-up Clinic Visit|Disease progression|1|||
144551411|NCT01970527|521217032|FG001|Follow-up Clinic Visit|Disease progression|1|||
144551412|NCT01970527|521217031|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
144551413|NCT01970527|521217032|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
144551414|NCT01970527|521217031|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
144551415|NCT01970527|521217032|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
144551416|NCT02147093|521217033|FG000|Period 1|Lost to Follow-up|0|||
144551417|NCT02147093|521217034|FG001|Period 1|Lost to Follow-up|1|||
144551418|NCT02147093|521217033|FG000|Period 2|Protocol Violation|2|||
144551419|NCT02147093|521217034|FG001|Period 2|Protocol Violation|0|||
144551420|NCT01147471|521217035|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
144551421|NCT01147471|521217036|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
144551422|NCT01147471|521217035|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
144551423|NCT01147471|521217036|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
144551424|NCT01147471|521217035|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
144551425|NCT01147471|521217036|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
144551426|NCT01147471|521217035|FG000|3 Month Follow Up|Lost to Follow-up|1|||
144551427|NCT01147471|521217036|FG001|3 Month Follow Up|Lost to Follow-up|1|||
144551428|NCT01147471|521217035|FG000|3 Month Follow Up|Physician Decision|0|||
144551429|NCT01147471|521217036|FG001|3 Month Follow Up|Physician Decision|1|||
144551430|NCT01147471|521217035|FG000|6 Month Follow Up|Lost to Follow-up|4|||
144551431|NCT01147471|521217036|FG001|6 Month Follow Up|Lost to Follow-up|2|||
144551432|NCT02612285|521217037|FG000|Overall Study|Withdrawal by Subject|1|||
144551433|NCT01986348|521217038|FG000|Overall Study|Death|8|||
144551434|NCT01986348|521217039|FG001|Overall Study|Death|22|||
144551435|NCT01986348|521217040|FG002|Overall Study|Death|10|||
144551436|NCT01986348|521217041|FG003|Overall Study|Death|21|||
144551437|NCT01986348|521217038|FG000|Overall Study|Lost to Follow-up|0|||
144551438|NCT01986348|521217039|FG001|Overall Study|Lost to Follow-up|0|||
144551439|NCT01986348|521217040|FG002|Overall Study|Lost to Follow-up|0|||
144551440|NCT01986348|521217041|FG003|Overall Study|Lost to Follow-up|2|||
144551441|NCT01986348|521217038|FG000|Overall Study|Physician Decision|0|||
144551442|NCT01986348|521217039|FG001|Overall Study|Physician Decision|0|||
144551443|NCT01986348|521217040|FG002|Overall Study|Physician Decision|0|||
144551444|NCT01986348|521217041|FG003|Overall Study|Physician Decision|1|||
144551445|NCT01986348|521217038|FG000|Overall Study|Progressive Disease|0|||
144551446|NCT01986348|521217039|FG001|Overall Study|Progressive Disease|0|||
144551447|NCT01986348|521217040|FG002|Overall Study|Progressive Disease|2|||
144551448|NCT01986348|521217041|FG003|Overall Study|Progressive Disease|0|||
144551449|NCT01986348|521217038|FG000|Overall Study|Withdrawal by Participant|0|||
144551450|NCT01986348|521217039|FG001|Overall Study|Withdrawal by Participant|1|||
144551451|NCT01986348|521217040|FG002|Overall Study|Withdrawal by Participant|2|||
144551452|NCT01986348|521217041|FG003|Overall Study|Withdrawal by Participant|1|||
144551453|NCT01986348|521217038|FG000|Overall Study|Study Terminated by Sponsor|0|||
144616631|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
144551454|NCT01986348|521217039|FG001|Overall Study|Study Terminated by Sponsor|0|||
144551455|NCT01986348|521217040|FG002|Overall Study|Study Terminated by Sponsor|0|||
144551456|NCT01986348|521217041|FG003|Overall Study|Study Terminated by Sponsor|3|||
144551457|NCT01986348|521217038|FG000|Overall Study|Other-unspecified|0|||
144551458|NCT01986348|521217039|FG001|Overall Study|Other-unspecified|1|||
144551459|NCT01986348|521217040|FG002|Overall Study|Other-unspecified|0|||
144551460|NCT01986348|521217041|FG003|Overall Study|Other-unspecified|2|||
144551461|NCT02548585|521217042|FG000|Overall Study|Withdrawal by Subject|0|||
144551462|NCT02548585|521217043|FG001|Overall Study|Withdrawal by Subject|0|||
144551463|NCT02548585|521217044|FG002|Overall Study|Withdrawal by Subject|0|||
144551464|NCT02548585|521217045|FG003|Overall Study|Withdrawal by Subject|0|||
144551465|NCT02548585|521217046|FG004|Overall Study|Withdrawal by Subject|0|||
144551466|NCT02548585|521217047|FG005|Overall Study|Withdrawal by Subject|1|||
144551467|NCT02548585|521217048|FG006|Overall Study|Withdrawal by Subject|0|||
144551468|NCT02548585|521217042|FG000|Overall Study|Lost to Follow-up|1|||
144551469|NCT02548585|521217043|FG001|Overall Study|Lost to Follow-up|0|||
144551470|NCT02548585|521217044|FG002|Overall Study|Lost to Follow-up|0|||
144551471|NCT02548585|521217045|FG003|Overall Study|Lost to Follow-up|0|||
144551472|NCT02548585|521217046|FG004|Overall Study|Lost to Follow-up|0|||
144551473|NCT02548585|521217047|FG005|Overall Study|Lost to Follow-up|0|||
144551474|NCT02548585|521217048|FG006|Overall Study|Lost to Follow-up|0|||
144551475|NCT02548585|521217042|FG000|Overall Study|Other|1|||
144551476|NCT02548585|521217043|FG001|Overall Study|Other|0|||
144551477|NCT02548585|521217044|FG002|Overall Study|Other|0|||
144551478|NCT02548585|521217045|FG003|Overall Study|Other|2|||
144551479|NCT02548585|521217046|FG004|Overall Study|Other|3|||
144551480|NCT02548585|521217047|FG005|Overall Study|Other|0|||
144551481|NCT02548585|521217048|FG006|Overall Study|Other|1|||
144551482|NCT02548585|521217042|FG000|Overall Study|Randomized but not treated|0|||
144551483|NCT02548585|521217043|FG001|Overall Study|Randomized but not treated|0|||
144551484|NCT02548585|521217044|FG002|Overall Study|Randomized but not treated|0|||
144551485|NCT02548585|521217045|FG003|Overall Study|Randomized but not treated|0|||
144551486|NCT02548585|521217046|FG004|Overall Study|Randomized but not treated|0|||
144551487|NCT02548585|521217047|FG005|Overall Study|Randomized but not treated|1|||
144551488|NCT02548585|521217048|FG006|Overall Study|Randomized but not treated|0|||
144551489|NCT00853957|521217053|FG000|Overall Study|Adverse Event|9|||
144551490|NCT00853957|521217054|FG001|Overall Study|Adverse Event|3|||
144551491|NCT00853957|521217053|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144551492|NCT00853957|521217054|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144551493|NCT00853957|521217053|FG000|Overall Study|Subject withdrew consent|4|||
144551494|NCT00853957|521217054|FG001|Overall Study|Subject withdrew consent|5|||
144551495|NCT00853957|521217053|FG000|Overall Study|Lost to Follow-up|1|||
144551496|NCT00853957|521217054|FG001|Overall Study|Lost to Follow-up|6|||
144551497|NCT00853957|521217053|FG000|Overall Study|Protocol deviation|0|||
144551498|NCT00853957|521217054|FG001|Overall Study|Protocol deviation|3|||
144551499|NCT02942771|521217055|FG000|Overall Study|Adverse Event|1|||
144551500|NCT02942771|521217056|FG001|Overall Study|Adverse Event|0|||
144551501|NCT02942771|521217057|FG002|Overall Study|Adverse Event|0|||
144551502|NCT02942771|521217058|FG003|Overall Study|Adverse Event|0|||
144551503|NCT02942771|521217059|FG004|Overall Study|Adverse Event|2|||
144551504|NCT02942771|521217055|FG000|Overall Study|Lost to Follow-up|1|||
144551505|NCT02942771|521217056|FG001|Overall Study|Lost to Follow-up|0|||
144551506|NCT02942771|521217057|FG002|Overall Study|Lost to Follow-up|0|||
144551507|NCT02942771|521217058|FG003|Overall Study|Lost to Follow-up|0|||
144551508|NCT02942771|521217059|FG004|Overall Study|Lost to Follow-up|0|||
144551509|NCT02942771|521217055|FG000|Overall Study|Withdrawal by Subject|1|||
144551510|NCT02942771|521217056|FG001|Overall Study|Withdrawal by Subject|0|||
144551511|NCT02942771|521217057|FG002|Overall Study|Withdrawal by Subject|0|||
144551512|NCT02942771|521217058|FG003|Overall Study|Withdrawal by Subject|0|||
144551513|NCT02942771|521217059|FG004|Overall Study|Withdrawal by Subject|2|||
144262371|NCT05219968|520159880|FG000|Safety Extension Period|Withdrawal by Subject|0|||
144262372|NCT05219968|520159881|FG001|Safety Extension Period|Withdrawal by Subject|0|||
144262373|NCT05219968|520159882|FG002|Safety Extension Period|Withdrawal by Subject|2|||
144262374|NCT05219968|520159883|FG003|Safety Extension Period|Withdrawal by Subject|0|||
144551514|NCT04919499|521217060|FG000|Overall Study|Adverse Event|0|||
144551515|NCT04919499|521217061|FG001|Overall Study|Adverse Event|0|||
144551516|NCT04919499|521217062|FG002|Overall Study|Adverse Event|0|||
144551517|NCT04919499|521217063|FG003|Overall Study|Adverse Event|0|||
144551518|NCT04919499|521217064|FG004|Overall Study|Adverse Event|2|||
144551519|NCT04919499|521217060|FG000|Overall Study|Not treated|0|||
144551520|NCT04919499|521217061|FG001|Overall Study|Not treated|0|||
144551521|NCT04919499|521217062|FG002|Overall Study|Not treated|0|||
144551522|NCT04919499|521217063|FG003|Overall Study|Not treated|1|||
144551523|NCT04919499|521217064|FG004|Overall Study|Not treated|0|||
144551524|NCT04820023|521218822|FG000|Overall Study|Death|0|||
144551525|NCT04820023|521218823|FG001|Overall Study|Death|0|||
144551526|NCT04820023|521218824|FG002|Overall Study|Death|0|||
144551527|NCT04820023|521218825|FG003|Overall Study|Death|0|||
144551528|NCT04820023|521218826|FG004|Overall Study|Death|0|||
144551529|NCT04820023|521218827|FG005|Overall Study|Death|0|||
144551530|NCT04820023|521218828|FG006|Overall Study|Death|1|||
144551531|NCT04820023|521218829|FG007|Overall Study|Death|0|||
144551532|NCT04820023|521218830|FG008|Overall Study|Death|1|||
144551533|NCT04820023|521218822|FG000|Overall Study|Withdrawal by Subject|1|||
144551534|NCT04820023|521218823|FG001|Overall Study|Withdrawal by Subject|2|||
144551535|NCT04820023|521218824|FG002|Overall Study|Withdrawal by Subject|2|||
144551536|NCT04820023|521218825|FG003|Overall Study|Withdrawal by Subject|1|||
144262375|NCT05219968|520159884|FG004|Safety Extension Period|Withdrawal by Subject|4|||
144551537|NCT04820023|521218826|FG004|Overall Study|Withdrawal by Subject|4|||
144551538|NCT04820023|521218827|FG005|Overall Study|Withdrawal by Subject|3|||
144551539|NCT04820023|521218828|FG006|Overall Study|Withdrawal by Subject|3|||
144551540|NCT04820023|521218829|FG007|Overall Study|Withdrawal by Subject|6|||
144551541|NCT04820023|521218830|FG008|Overall Study|Withdrawal by Subject|5|||
144551542|NCT04820023|521218822|FG000|Overall Study|Progressive Disease|3|||
144551543|NCT04820023|521218823|FG001|Overall Study|Progressive Disease|0|||
144551544|NCT04820023|521218824|FG002|Overall Study|Progressive Disease|2|||
144551545|NCT04820023|521218825|FG003|Overall Study|Progressive Disease|2|||
144551546|NCT04820023|521218826|FG004|Overall Study|Progressive Disease|2|||
144551547|NCT04820023|521218827|FG005|Overall Study|Progressive Disease|0|||
144551548|NCT04820023|521218828|FG006|Overall Study|Progressive Disease|1|||
144551549|NCT04820023|521218829|FG007|Overall Study|Progressive Disease|1|||
144551550|NCT04820023|521218830|FG008|Overall Study|Progressive Disease|0|||
144551551|NCT04820023|521218822|FG000|Overall Study|New anti-cancer therapy|0|||
144551552|NCT04820023|521218823|FG001|Overall Study|New anti-cancer therapy|0|||
144551553|NCT04820023|521218824|FG002|Overall Study|New anti-cancer therapy|0|||
144551554|NCT04820023|521218825|FG003|Overall Study|New anti-cancer therapy|0|||
144551555|NCT04820023|521218826|FG004|Overall Study|New anti-cancer therapy|2|||
144551556|NCT04820023|521218827|FG005|Overall Study|New anti-cancer therapy|0|||
144551557|NCT04820023|521218828|FG006|Overall Study|New anti-cancer therapy|0|||
144551558|NCT04820023|521218829|FG007|Overall Study|New anti-cancer therapy|0|||
144551559|NCT04820023|521218830|FG008|Overall Study|New anti-cancer therapy|0|||
144551560|NCT04820023|521218822|FG000|Overall Study|Other|0|||
144551561|NCT04820023|521218823|FG001|Overall Study|Other|1|||
144551562|NCT04820023|521218824|FG002|Overall Study|Other|0|||
144551563|NCT04820023|521218825|FG003|Overall Study|Other|0|||
144551564|NCT04820023|521218826|FG004|Overall Study|Other|0|||
144551565|NCT04820023|521218827|FG005|Overall Study|Other|0|||
144551566|NCT04820023|521218828|FG006|Overall Study|Other|0|||
144551567|NCT04820023|521218829|FG007|Overall Study|Other|2|||
144551568|NCT04820023|521218830|FG008|Overall Study|Other|0|||
144551569|NCT01020487|521218831|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
144551570|NCT01020487|521218832|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
144551571|NCT01020487|521218833|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
144551572|NCT01020487|521218831|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
144551573|NCT01020487|521218832|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
144551574|NCT01020487|521218833|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
144551575|NCT01020487|521218831|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
144551576|NCT01020487|521218832|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
144551577|NCT01020487|521218833|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
144551578|NCT01020487|521218831|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
144551579|NCT01020487|521218832|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
144551580|NCT01020487|521218833|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
144551581|NCT01020487|521218831|FG000|Part 2 Open-label Period|Adverse Event|0|||
144551582|NCT01020487|521218832|FG001|Part 2 Open-label Period|Adverse Event|4|||
144551583|NCT01020487|521218833|FG002|Part 2 Open-label Period|Adverse Event|1|||
144551584|NCT01945593|521218834|FG000|Overall Study|Adverse Event|0|||
144551585|NCT01945593|521218835|FG001|Overall Study|Adverse Event|0|||
144551586|NCT01945593|521218836|FG002|Overall Study|Adverse Event|0|||
144551587|NCT01945593|521218837|FG003|Overall Study|Adverse Event|5|||
144551588|NCT01945593|521218834|FG000|Overall Study|Physician Decision|0|||
144551589|NCT01945593|521218835|FG001|Overall Study|Physician Decision|0|||
144551590|NCT01945593|521218836|FG002|Overall Study|Physician Decision|1|||
144551591|NCT01945593|521218837|FG003|Overall Study|Physician Decision|1|||
144551592|NCT01945593|521218834|FG000|Overall Study|Withdrawal by Subject|0|||
144551593|NCT01945593|521218835|FG001|Overall Study|Withdrawal by Subject|2|||
144551594|NCT01945593|521218836|FG002|Overall Study|Withdrawal by Subject|0|||
144551595|NCT01945593|521218837|FG003|Overall Study|Withdrawal by Subject|4|||
144551596|NCT01945593|521218834|FG000|Overall Study|Protocol Violation|0|||
144551597|NCT01945593|521218835|FG001|Overall Study|Protocol Violation|2|||
144551598|NCT01945593|521218836|FG002|Overall Study|Protocol Violation|1|||
144551599|NCT01945593|521218837|FG003|Overall Study|Protocol Violation|3|||
144551600|NCT01945593|521218834|FG000|Overall Study|Death|0|||
144262376|NCT05219968|520159880|FG000|Safety Extension Period|Adverse Event|0|||
144262377|NCT05219968|520159881|FG001|Safety Extension Period|Adverse Event|0|||
144551601|NCT01945593|521218835|FG001|Overall Study|Death|0|||
144551602|NCT01945593|521218836|FG002|Overall Study|Death|1|||
144551603|NCT01945593|521218837|FG003|Overall Study|Death|0|||
144551604|NCT01945593|521218834|FG000|Overall Study|Other: Terminated|0|||
144551605|NCT01945593|521218835|FG001|Overall Study|Other: Terminated|0|||
144551606|NCT01945593|521218836|FG002|Overall Study|Other: Terminated|0|||
144551607|NCT01945593|521218837|FG003|Overall Study|Other: Terminated|1|||
144551608|NCT01945593|521218834|FG000|Overall Study|Other: Surgical Procedure|0|||
144551609|NCT01945593|521218835|FG001|Overall Study|Other: Surgical Procedure|2|||
144203165|NCT00593736|519940287|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
144203166|NCT00593736|519940288|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
144203167|NCT00593736|519940289|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
144203168|NCT00593736|519940290|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
144203169|NCT00593736|519940287|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
144203170|NCT00593736|519940288|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
144203171|NCT00593736|519940289|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
144203172|NCT00593736|519940290|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
144203173|NCT00593736|519940287|FG000|Screening Period and Placebo Run-in|Various|0|||
144262378|NCT05219968|520159882|FG002|Safety Extension Period|Adverse Event|2|||
144262379|NCT05219968|520159883|FG003|Safety Extension Period|Adverse Event|1|||
144262380|NCT05219968|520159884|FG004|Safety Extension Period|Adverse Event|1|||
144551610|NCT01945593|521218836|FG002|Overall Study|Other: Surgical Procedure|0|||
144551611|NCT01945593|521218837|FG003|Overall Study|Other: Surgical Procedure|6|||
144551612|NCT01945593|521218834|FG000|Overall Study|Other: Screen Failure|0|||
144551613|NCT01945593|521218835|FG001|Overall Study|Other: Screen Failure|2|||
144551614|NCT01945593|521218836|FG002|Overall Study|Other: Screen Failure|0|||
144551615|NCT01945593|521218837|FG003|Overall Study|Other: Screen Failure|0|||
144551616|NCT00228813|521218838|FG000|Overall Study|Death|4|||
144551617|NCT00507429|521218839|FG000|Treatment Phase|Disease Progression|12|||
144551618|NCT00507429|521218840|FG001|Treatment Phase|Disease Progression|5|||
144551619|NCT00507429|521218839|FG000|Treatment Phase|Adverse Event|12|||
144551620|NCT00507429|521218840|FG001|Treatment Phase|Adverse Event|5|||
144551621|NCT00507429|521218839|FG000|Treatment Phase|Withdrawal by Subject|3|||
144551622|NCT00507429|521218840|FG001|Treatment Phase|Withdrawal by Subject|3|||
144551623|NCT00507429|521218839|FG000|Treatment Phase|Physician Decision|4|||
144551624|NCT00507429|521218840|FG001|Treatment Phase|Physician Decision|2|||
144551625|NCT00507429|521218839|FG000|Treatment Phase|Other|6|||
144551626|NCT00507429|521218840|FG001|Treatment Phase|Other|3|||
144551627|NCT00507429|521218839|FG000|Maintenance Phase|Progressive Disease|14|||
144551628|NCT00507429|521218840|FG001|Maintenance Phase|Progressive Disease|0|||
144551629|NCT01437540|521218842|FG000|Overall Study|Not listed below|7|||
144551630|NCT01437540|521218843|FG001|Overall Study|Not listed below|6|||
144551631|NCT01437540|521218842|FG000|Overall Study|COPD exacerbation|13|||
144551632|NCT01437540|521218843|FG001|Overall Study|COPD exacerbation|3|||
144551633|NCT01437540|521218842|FG000|Overall Study|Lost to Follow-up|3|||
144551634|NCT01437540|521218843|FG001|Overall Study|Lost to Follow-up|5|||
144551635|NCT01437540|521218842|FG000|Overall Study|Lack of Efficacy|23|||
144551636|NCT01437540|521218843|FG001|Overall Study|Lack of Efficacy|11|||
144551637|NCT01437540|521218842|FG000|Overall Study|Protocol Violation|24|||
144551638|NCT01437540|521218843|FG001|Overall Study|Protocol Violation|12|||
144551639|NCT01437540|521218842|FG000|Overall Study|Adverse Event|26|||
144551640|NCT01437540|521218843|FG001|Overall Study|Adverse Event|13|||
144551641|NCT01437540|521218842|FG000|Overall Study|Withdrawal by Subject|31|||
144551642|NCT01437540|521218843|FG001|Overall Study|Withdrawal by Subject|15|||
144551643|NCT00608959|521218847|FG000|Part 1|Did not meet eligibility criteria|1|||
144551644|NCT01416285|521218848|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
144551645|NCT01416285|521218849|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
144551646|NCT01248715|521218851|FG000|Overall Study|Not influenza positive|501|||
144551647|NCT01248715|521218852|FG001|Overall Study|Not influenza positive|510|||
144551648|NCT01215253|521218856|FG000|Overall Study|Withdrawal by Subject|57|||
144551649|NCT01215253|521218857|FG001|Overall Study|Withdrawal by Subject|35|||
144551650|NCT01215253|521218856|FG000|Overall Study|Physician Decision|9|||
144551651|NCT01215253|521218857|FG001|Overall Study|Physician Decision|12|||
144551652|NCT01215253|521218856|FG000|Overall Study|Lost to Follow-up|6|||
144551653|NCT01215253|521218857|FG001|Overall Study|Lost to Follow-up|4|||
144551654|NCT01215253|521218856|FG000|Overall Study|Other|14|||
144551655|NCT01215253|521218857|FG001|Overall Study|Other|12|||
144551656|NCT01919489|521218858|FG000|Overall Study|Rejected the need of injections|4|||
144551657|NCT01919489|521218859|FG001|Overall Study|Rejected the need of injections|7|||
144551658|NCT01919489|521218858|FG000|Overall Study|Adverse Event|10|||
144551659|NCT01919489|521218859|FG001|Overall Study|Adverse Event|0|||
144551660|NCT01919489|521218858|FG000|Overall Study|Hospital readmission|2|||
144551661|NCT01919489|521218859|FG001|Overall Study|Hospital readmission|9|||
144551662|NCT01919489|521218858|FG000|Overall Study|Death|2|||
144203174|NCT00593736|519940288|FG001|Screening Period and Placebo Run-in|Various|0|||
144551663|NCT01919489|521218859|FG001|Overall Study|Death|1|||
144551664|NCT01919489|521218858|FG000|Overall Study|Lost to Follow-up|38|||
144551665|NCT01919489|521218859|FG001|Overall Study|Lost to Follow-up|27|||
144551666|NCT03761849|521218860|FG000|Overall Study|transferred to OpenLabelExtension|35|||
144551667|NCT03761849|521218861|FG001|Overall Study|transferred to OpenLabelExtension|34|||
144727687|NCT04526210|521858024|FG001|Overall Study|Withdrawal by Subject|2|||
144262381|NCT05219968|520159880|FG000|Safety Extension Period|Lost to Follow-up|0|||
144551668|NCT03761849|521218862|FG002|Overall Study|transferred to OpenLabelExtension|36|||
144551669|NCT03761849|521218863|FG003|Overall Study|transferred to OpenLabelExtension|0|||
144551670|NCT03761849|521218864|FG004|Overall Study|transferred to OpenLabelExtension|0|||
144551671|NCT03761849|521218865|FG005|Overall Study|transferred to OpenLabelExtension|0|||
144551672|NCT03761849|521218860|FG000|Overall Study|Adverse Event|1|||
144551673|NCT03761849|521218861|FG001|Overall Study|Adverse Event|0|||
144551674|NCT03761849|521218862|FG002|Overall Study|Adverse Event|0|||
144551675|NCT03761849|521218863|FG003|Overall Study|Adverse Event|0|||
144551676|NCT03761849|521218864|FG004|Overall Study|Adverse Event|2|||
144551677|NCT03761849|521218865|FG005|Overall Study|Adverse Event|3|||
144551678|NCT03761849|521218860|FG000|Overall Study|Withdrawal by Subject|0|||
144551679|NCT03761849|521218861|FG001|Overall Study|Withdrawal by Subject|0|||
144551680|NCT03761849|521218862|FG002|Overall Study|Withdrawal by Subject|0|||
144551681|NCT03761849|521218863|FG003|Overall Study|Withdrawal by Subject|41|||
144551682|NCT03761849|521218864|FG004|Overall Study|Withdrawal by Subject|43|||
144551683|NCT03761849|521218865|FG005|Overall Study|Withdrawal by Subject|35|||
144551684|NCT03761849|521218860|FG000|Overall Study|Lost to Follow-up|0|||
144551685|NCT03761849|521218861|FG001|Overall Study|Lost to Follow-up|1|||
144551686|NCT03761849|521218862|FG002|Overall Study|Lost to Follow-up|0|||
144551687|NCT03761849|521218863|FG003|Overall Study|Lost to Follow-up|2|||
144551688|NCT03761849|521218864|FG004|Overall Study|Lost to Follow-up|4|||
144551689|NCT03761849|521218865|FG005|Overall Study|Lost to Follow-up|5|||
144551690|NCT03761849|521218860|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
144551691|NCT03761849|521218861|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
144551692|NCT03761849|521218862|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
144551693|NCT03761849|521218863|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
144551694|NCT03761849|521218864|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
144551695|NCT03761849|521218865|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
144551696|NCT03761849|521218860|FG000|Overall Study|Physician Decision|0|||
144551697|NCT03761849|521218861|FG001|Overall Study|Physician Decision|0|||
144551698|NCT03761849|521218862|FG002|Overall Study|Physician Decision|0|||
144551699|NCT03761849|521218863|FG003|Overall Study|Physician Decision|1|||
144551700|NCT03761849|521218864|FG004|Overall Study|Physician Decision|4|||
144551701|NCT03761849|521218865|FG005|Overall Study|Physician Decision|4|||
144551702|NCT03761849|521218860|FG000|Overall Study|Death|0|||
144551703|NCT03761849|521218861|FG001|Overall Study|Death|0|||
144551704|NCT03761849|521218862|FG002|Overall Study|Death|0|||
144551705|NCT03761849|521218863|FG003|Overall Study|Death|1|||
144551706|NCT03761849|521218864|FG004|Overall Study|Death|1|||
144551707|NCT03761849|521218865|FG005|Overall Study|Death|3|||
144551708|NCT03761849|521218860|FG000|Overall Study|Protocol Violation|0|||
144551709|NCT03761849|521218861|FG001|Overall Study|Protocol Violation|0|||
144551710|NCT03761849|521218862|FG002|Overall Study|Protocol Violation|0|||
144551711|NCT03761849|521218863|FG003|Overall Study|Protocol Violation|2|||
144551712|NCT03761849|521218864|FG004|Overall Study|Protocol Violation|2|||
144551713|NCT03761849|521218865|FG005|Overall Study|Protocol Violation|1|||
144551714|NCT03761849|521218860|FG000|Overall Study|Participant could not come to site|0|||
144551715|NCT03761849|521218861|FG001|Overall Study|Participant could not come to site|0|||
144203175|NCT00593736|519940289|FG002|Screening Period and Placebo Run-in|Various|0|||
144203176|NCT00593736|519940290|FG003|Screening Period and Placebo Run-in|Various|25|||
144203177|NCT00593736|519940287|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
144551716|NCT03761849|521218862|FG002|Overall Study|Participant could not come to site|0|||
144551717|NCT03761849|521218863|FG003|Overall Study|Participant could not come to site|0|||
144551718|NCT03761849|521218864|FG004|Overall Study|Participant could not come to site|1|||
144551719|NCT03761849|521218865|FG005|Overall Study|Participant could not come to site|0|||
144551720|NCT03761849|521218860|FG000|Overall Study|SF- safety Finding|0|||
144551721|NCT03761849|521218861|FG001|Overall Study|SF- safety Finding|0|||
144551722|NCT03761849|521218862|FG002|Overall Study|SF- safety Finding|0|||
144551723|NCT03761849|521218863|FG003|Overall Study|SF- safety Finding|0|||
144551724|NCT03761849|521218864|FG004|Overall Study|SF- safety Finding|0|||
144551725|NCT03761849|521218865|FG005|Overall Study|SF- safety Finding|1|||
144203178|NCT00593736|519940288|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
144551726|NCT03761849|521218860|FG000|Overall Study|Patient did not attend visit|0|||
144551727|NCT03761849|521218861|FG001|Overall Study|Patient did not attend visit|0|||
144616632|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
144616633|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
144616634|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
144616635|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
144203179|NCT00593736|519940289|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
144551728|NCT03761849|521218862|FG002|Overall Study|Patient did not attend visit|0|||
144551729|NCT03761849|521218863|FG003|Overall Study|Patient did not attend visit|0|||
144551730|NCT03761849|521218864|FG004|Overall Study|Patient did not attend visit|0|||
144551731|NCT03761849|521218865|FG005|Overall Study|Patient did not attend visit|1|||
144551732|NCT01131325|521218866|FG000|Overall Study|Adverse Event|1|||
144551733|NCT01131325|521218866|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
144551734|NCT00828139|521218867|FG000|Overall Study|Adverse Event|8|||
144616636|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
144616637|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
144551735|NCT00828139|521218868|FG001|Overall Study|Adverse Event|1|||
144551736|NCT00828139|521218869|FG002|Overall Study|Adverse Event|10|||
144551737|NCT00828139|521218870|FG003|Overall Study|Adverse Event|5|||
144551738|NCT00828139|521218867|FG000|Overall Study|Death|2|||
144551739|NCT00828139|521218868|FG001|Overall Study|Death|1|||
144551740|NCT00828139|521218869|FG002|Overall Study|Death|0|||
144551741|NCT00828139|521218870|FG003|Overall Study|Death|2|||
144551742|NCT00828139|521218867|FG000|Overall Study|Refusal unrelated to toxicity|3|||
144551743|NCT00828139|521218868|FG001|Overall Study|Refusal unrelated to toxicity|4|||
144551744|NCT00828139|521218869|FG002|Overall Study|Refusal unrelated to toxicity|5|||
144551745|NCT00828139|521218870|FG003|Overall Study|Refusal unrelated to toxicity|3|||
144551746|NCT00828139|521218867|FG000|Overall Study|Disease Progression|24|||
144551747|NCT00828139|521218868|FG001|Overall Study|Disease Progression|33|||
144551748|NCT00828139|521218869|FG002|Overall Study|Disease Progression|35|||
144551749|NCT00828139|521218870|FG003|Overall Study|Disease Progression|39|||
144551750|NCT00828139|521218867|FG000|Overall Study|Other|4|||
144551751|NCT00828139|521218868|FG001|Overall Study|Other|2|||
144551752|NCT00828139|521218869|FG002|Overall Study|Other|5|||
144551753|NCT00828139|521218870|FG003|Overall Study|Other|2|||
144551754|NCT01714947|521218871|FG000|Part B|Progressive Disease|3|||
144551755|NCT04751929|521218872|FG000|Overall Study|Withdrawal by Subject|2|||
144551756|NCT04751929|521218873|FG001|Overall Study|Withdrawal by Subject|0|||
144551757|NCT04751929|521218874|FG002|Overall Study|Withdrawal by Subject|0|||
144551758|NCT04751929|521218875|FG003|Overall Study|Withdrawal by Subject|0|||
144551759|NCT04751929|521218872|FG000|Overall Study|Rising PSA|0|||
144551760|NCT04751929|521218873|FG001|Overall Study|Rising PSA|1|||
144551761|NCT04751929|521218874|FG002|Overall Study|Rising PSA|0|||
144551762|NCT04751929|521218875|FG003|Overall Study|Rising PSA|0|||
144551763|NCT04751929|521218872|FG000|Overall Study|Adverse Event|1|||
144551764|NCT04751929|521218873|FG001|Overall Study|Adverse Event|2|||
144551765|NCT04751929|521218874|FG002|Overall Study|Adverse Event|0|||
144551766|NCT04751929|521218875|FG003|Overall Study|Adverse Event|0|||
144551767|NCT04751929|521218872|FG000|Overall Study|Progressive Disease|3|||
144551768|NCT04751929|521218873|FG001|Overall Study|Progressive Disease|4|||
144551769|NCT04751929|521218874|FG002|Overall Study|Progressive Disease|4|||
144551770|NCT04751929|521218875|FG003|Overall Study|Progressive Disease|0|||
144551771|NCT04751929|521218872|FG000|Overall Study|Death|1|||
144551772|NCT04751929|521218873|FG001|Overall Study|Death|1|||
144551773|NCT04751929|521218874|FG002|Overall Study|Death|0|||
144551774|NCT04751929|521218875|FG003|Overall Study|Death|0|||
144551775|NCT00376259|521218878|FG000|Overall Study|Sponsor request - study termination|21|||
144551776|NCT00376259|521218879|FG001|Overall Study|Sponsor request - study termination|21|||
144551777|NCT00376259|521218878|FG000|Overall Study|Patient request|1|||
144551778|NCT00376259|521218879|FG001|Overall Study|Patient request|0|||
144551779|NCT01877720|521218880|FG000|Overall Study|Adverse Event|1|||
144551780|NCT01877720|521218881|FG001|Overall Study|Adverse Event|0|||
144551781|NCT02068352|521218882|FG000|Overall Study|Lost to Follow-up|0|||
144551782|NCT02068352|521218883|FG001|Overall Study|Lost to Follow-up|2|||
144727688|NCT01781637|521858025|FG000|Overall Study|Adverse Event|1|||
144203180|NCT00593736|519940290|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
144203181|NCT00593736|519940287|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
144203182|NCT00593736|519940288|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
144551783|NCT02068352|521218884|FG002|Overall Study|Lost to Follow-up|0|||
144551784|NCT02068352|521218882|FG000|Overall Study|Adverse Event|4|||
144551785|NCT02068352|521218883|FG001|Overall Study|Adverse Event|2|||
144551786|NCT02068352|521218884|FG002|Overall Study|Adverse Event|7|||
144551787|NCT02068352|521218882|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
144551788|NCT02068352|521218883|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
144551789|NCT02068352|521218884|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
144551790|NCT02068352|521218882|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
144551791|NCT02068352|521218883|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
144551792|NCT02068352|521218884|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
144551793|NCT02068352|521218882|FG000|Overall Study|Protocol Deviation|0|||
144203183|NCT00593736|519940289|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
144203184|NCT00593736|519940290|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
144203185|NCT00593736|519940287|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
144551794|NCT02068352|521218883|FG001|Overall Study|Protocol Deviation|0|||
144551795|NCT02068352|521218884|FG002|Overall Study|Protocol Deviation|1|||
144551796|NCT00473512|521218890|FG000|Period 1 (Phase 1)|Adverse Event|0|||
144551797|NCT00473512|521218891|FG001|Period 1 (Phase 1)|Adverse Event|0|||
144551798|NCT00473512|521218892|FG002|Period 1 (Phase 1)|Adverse Event|0|||
144551799|NCT00473512|521218893|FG003|Period 1 (Phase 1)|Adverse Event|5|||
144551800|NCT00473512|521218894|FG004|Period 1 (Phase 1)|Adverse Event|0|||
144551801|NCT00473512|521218890|FG000|Period 1 (Phase 1)|Death|0|||
144551802|NCT00473512|521218891|FG001|Period 1 (Phase 1)|Death|0|||
144551803|NCT00473512|521218892|FG002|Period 1 (Phase 1)|Death|0|||
144551804|NCT00473512|521218893|FG003|Period 1 (Phase 1)|Death|1|||
144551805|NCT00473512|521218894|FG004|Period 1 (Phase 1)|Death|0|||
144551806|NCT00473512|521218890|FG000|Period 1 (Phase 1)|Disease Progression|1|||
144551807|NCT00473512|521218891|FG001|Period 1 (Phase 1)|Disease Progression|1|||
144551808|NCT00473512|521218892|FG002|Period 1 (Phase 1)|Disease Progression|0|||
144551809|NCT00473512|521218893|FG003|Period 1 (Phase 1)|Disease Progression|10|||
144551810|NCT00473512|521218894|FG004|Period 1 (Phase 1)|Disease Progression|1|||
144551811|NCT00473512|521218890|FG000|Period 1 (Phase 1)|Other|0|||
144551812|NCT00473512|521218891|FG001|Period 1 (Phase 1)|Other|0|||
144551813|NCT00473512|521218892|FG002|Period 1 (Phase 1)|Other|0|||
144551814|NCT00473512|521218893|FG003|Period 1 (Phase 1)|Other|1|||
144551815|NCT00473512|521218894|FG004|Period 1 (Phase 1)|Other|0|||
144551816|NCT00473512|521218890|FG000|Period 2 (Phase 2)|Adverse Event|0|||
144551817|NCT00473512|521218891|FG001|Period 2 (Phase 2)|Adverse Event|0|||
144551818|NCT00473512|521218892|FG002|Period 2 (Phase 2)|Adverse Event|0|||
144551819|NCT00473512|521218893|FG003|Period 2 (Phase 2)|Adverse Event|1|||
144551820|NCT00473512|521218894|FG004|Period 2 (Phase 2)|Adverse Event|0|||
144551821|NCT00473512|521218890|FG000|Period 2 (Phase 2)|Death|0|||
144551822|NCT00473512|521218891|FG001|Period 2 (Phase 2)|Death|0|||
144551823|NCT00473512|521218892|FG002|Period 2 (Phase 2)|Death|0|||
144551824|NCT00473512|521218893|FG003|Period 2 (Phase 2)|Death|1|||
144551825|NCT00473512|521218894|FG004|Period 2 (Phase 2)|Death|1|||
144551826|NCT00473512|521218890|FG000|Period 2 (Phase 2)|Disease Progression|0|||
144551827|NCT00473512|521218891|FG001|Period 2 (Phase 2)|Disease Progression|2|||
144551828|NCT00473512|521218892|FG002|Period 2 (Phase 2)|Disease Progression|2|||
144551829|NCT00473512|521218893|FG003|Period 2 (Phase 2)|Disease Progression|17|||
144551830|NCT00473512|521218894|FG004|Period 2 (Phase 2)|Disease Progression|1|||
144551831|NCT00473512|521218890|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
144551832|NCT00473512|521218891|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
144551833|NCT00473512|521218892|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
144551834|NCT00473512|521218893|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
144551835|NCT00473512|521218894|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
144551836|NCT00473512|521218890|FG000|Period 2 (Phase 2)|Other|1|||
144551837|NCT00473512|521218891|FG001|Period 2 (Phase 2)|Other|0|||
144551838|NCT00473512|521218892|FG002|Period 2 (Phase 2)|Other|0|||
144551839|NCT00473512|521218893|FG003|Period 2 (Phase 2)|Other|3|||
144551840|NCT00473512|521218894|FG004|Period 2 (Phase 2)|Other|0|||
144551841|NCT00267956|521218895|FG000|Controlled Period|Adverse Event|4|||
144551842|NCT00267956|521218896|FG001|Controlled Period|Adverse Event|1|||
144551843|NCT00267956|521218897|FG002|Controlled Period|Adverse Event|0|||
144551844|NCT00267956|521218898|FG003|Controlled Period|Adverse Event|0|||
144551845|NCT00267956|521218895|FG000|Controlled Period|Lack of Efficacy|4|||
144551846|NCT00267956|521218896|FG001|Controlled Period|Lack of Efficacy|2|||
144551847|NCT00267956|521218897|FG002|Controlled Period|Lack of Efficacy|0|||
144551848|NCT00267956|521218898|FG003|Controlled Period|Lack of Efficacy|0|||
144551849|NCT00267956|521218895|FG000|Controlled Period|Lost to Follow-up|2|||
144551850|NCT00267956|521218896|FG001|Controlled Period|Lost to Follow-up|0|||
144551851|NCT00267956|521218897|FG002|Controlled Period|Lost to Follow-up|0|||
144551852|NCT00267956|521218898|FG003|Controlled Period|Lost to Follow-up|0|||
144551853|NCT00267956|521218895|FG000|Controlled Period|Withdrew consent|3|||
144551854|NCT00267956|521218896|FG001|Controlled Period|Withdrew consent|1|||
144551855|NCT00267956|521218897|FG002|Controlled Period|Withdrew consent|0|||
144551856|NCT00267956|521218898|FG003|Controlled Period|Withdrew consent|0|||
144551857|NCT00267956|521218895|FG000|After Controlled Period|Adverse Event|0|||
144551858|NCT00267956|521218896|FG001|After Controlled Period|Adverse Event|0|||
144551859|NCT00267956|521218897|FG002|After Controlled Period|Adverse Event|2|||
144616638|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
144616639|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
144616640|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
144616641|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
144616642|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
144616643|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
144616644|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
144616645|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
144616646|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
144616647|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
144616648|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
144551860|NCT00267956|521218898|FG003|After Controlled Period|Adverse Event|1|||
144551861|NCT00267956|521218895|FG000|After Controlled Period|Lack of Efficacy|0|||
144616649|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
144551862|NCT00267956|521218896|FG001|After Controlled Period|Lack of Efficacy|0|||
144551863|NCT00267956|521218897|FG002|After Controlled Period|Lack of Efficacy|1|||
144551864|NCT00267956|521218898|FG003|After Controlled Period|Lack of Efficacy|1|||
144551865|NCT00267956|521218895|FG000|After Controlled Period|Lost to Follow-up|0|||
144551866|NCT00267956|521218896|FG001|After Controlled Period|Lost to Follow-up|0|||
144551867|NCT00267956|521218897|FG002|After Controlled Period|Lost to Follow-up|1|||
144551868|NCT00267956|521218898|FG003|After Controlled Period|Lost to Follow-up|0|||
144551869|NCT00267956|521218895|FG000|After Controlled Period|Withdrew consent|0|||
144551870|NCT00267956|521218896|FG001|After Controlled Period|Withdrew consent|0|||
144551871|NCT00267956|521218897|FG002|After Controlled Period|Withdrew consent|1|||
144551872|NCT00267956|521218898|FG003|After Controlled Period|Withdrew consent|0|||
144551873|NCT01263223|521218899|FG000|Period 2|Withdrawal by Subject|0|||
144551874|NCT01263223|521218900|FG001|Period 2|Withdrawal by Subject|1|||
144551875|NCT01263223|521218899|FG000|7-day Follow-up|Withdrawal by Subject|0|||
144551876|NCT01263223|521218900|FG001|7-day Follow-up|Withdrawal by Subject|1|||
144551877|NCT01263223|521218899|FG000|7-day Follow-up|Lost to Follow-up|1|||
144551878|NCT01263223|521218900|FG001|7-day Follow-up|Lost to Follow-up|0|||
144551879|NCT01129011|521218901|FG000|Overall Study|Adverse Event|20|||
144551880|NCT01129011|521218902|FG001|Overall Study|Adverse Event|30|||
144551881|NCT01129011|521218901|FG000|Overall Study|Withdrawal by Subject|24|||
144551882|NCT01129011|521218902|FG001|Overall Study|Withdrawal by Subject|8|||
144551883|NCT01129011|521218901|FG000|Overall Study|Lost to Follow-up|6|||
144551884|NCT01129011|521218902|FG001|Overall Study|Lost to Follow-up|7|||
144551885|NCT01129011|521218901|FG000|Overall Study|Duodenal Ulcer|2|||
144551886|NCT01129011|521218902|FG001|Overall Study|Duodenal Ulcer|8|||
144551887|NCT01129011|521218901|FG000|Overall Study|misc|7|||
144551888|NCT01129011|521218902|FG001|Overall Study|misc|4|||
144551889|NCT02246647|521218903|FG000|Overall Study|Withdrawal by Subject|1|||
144551890|NCT02246647|521218904|FG001|Overall Study|Withdrawal by Subject|1|||
144551891|NCT02823574|521218908|FG000|Randomization|Disease Progression|0|||
144551892|NCT02823574|521218909|FG001|Randomization|Disease Progression|0|||
144551893|NCT02823574|521218910|FG002|Randomization|Disease Progression|1|||
144551894|NCT02823574|521218911|FG003|Randomization|Disease Progression|0|||
144551895|NCT02823574|521218908|FG000|Randomization|AE unrelated to Study Drug|1|||
144551896|NCT02823574|521218909|FG001|Randomization|AE unrelated to Study Drug|0|||
144551897|NCT02823574|521218910|FG002|Randomization|AE unrelated to Study Drug|0|||
144551898|NCT02823574|521218911|FG003|Randomization|AE unrelated to Study Drug|0|||
144551899|NCT02823574|521218908|FG000|Treatment Period|Poor/Non Compliance|1|||
144551900|NCT02823574|521218909|FG001|Treatment Period|Poor/Non Compliance|0|||
144551901|NCT02823574|521218910|FG002|Treatment Period|Poor/Non Compliance|0|||
144551902|NCT02823574|521218911|FG003|Treatment Period|Poor/Non Compliance|1|||
144551903|NCT02823574|521218908|FG000|Treatment Period|Maximum Clinical Benefit|8|||
144551904|NCT02823574|521218909|FG001|Treatment Period|Maximum Clinical Benefit|4|||
144551905|NCT02823574|521218910|FG002|Treatment Period|Maximum Clinical Benefit|7|||
144551906|NCT02823574|521218911|FG003|Treatment Period|Maximum Clinical Benefit|1|||
144551907|NCT02823574|521218908|FG000|Treatment Period|Lost to Follow-up|1|||
144551908|NCT02823574|521218909|FG001|Treatment Period|Lost to Follow-up|1|||
144551909|NCT02823574|521218910|FG002|Treatment Period|Lost to Follow-up|0|||
144551910|NCT02823574|521218911|FG003|Treatment Period|Lost to Follow-up|0|||
144551911|NCT02823574|521218908|FG000|Treatment Period|Participant withdrew consent|4|||
144551912|NCT02823574|521218909|FG001|Treatment Period|Participant withdrew consent|0|||
144551913|NCT02823574|521218910|FG002|Treatment Period|Participant withdrew consent|0|||
144551914|NCT02823574|521218911|FG003|Treatment Period|Participant withdrew consent|1|||
144551915|NCT02823574|521218908|FG000|Treatment Period|Participant request to discontinue|5|||
144551916|NCT02823574|521218909|FG001|Treatment Period|Participant request to discontinue|0|||
144551917|NCT02823574|521218910|FG002|Treatment Period|Participant request to discontinue|3|||
144551918|NCT02823574|521218911|FG003|Treatment Period|Participant request to discontinue|2|||
144551919|NCT02823574|521218908|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
144551920|NCT02823574|521218909|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
144616650|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
144616651|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
144616652|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
144616653|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
144616654|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
144203186|NCT00593736|519940288|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
144551921|NCT02823574|521218910|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
144551922|NCT02823574|521218911|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
144203187|NCT00593736|519940289|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
144551923|NCT02823574|521218908|FG000|Treatment Period|Study Drug Toxicity|11|||
144551924|NCT02823574|521218909|FG001|Treatment Period|Study Drug Toxicity|2|||
144551925|NCT02823574|521218910|FG002|Treatment Period|Study Drug Toxicity|14|||
144551926|NCT02823574|521218911|FG003|Treatment Period|Study Drug Toxicity|4|||
144616655|NCT02706873|521456365|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
144616656|NCT02706873|521456366|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
144551927|NCT02823574|521218908|FG000|Treatment Period|Disease Progression|113|||
144551928|NCT02823574|521218909|FG001|Treatment Period|Disease Progression|64|||
144551929|NCT02823574|521218910|FG002|Treatment Period|Disease Progression|82|||
144551930|NCT02823574|521218911|FG003|Treatment Period|Disease Progression|43|||
144551931|NCT02823574|521218908|FG000|Treatment Period|Other reasons|5|||
144551932|NCT02823574|521218909|FG001|Treatment Period|Other reasons|9|||
144551933|NCT02823574|521218910|FG002|Treatment Period|Other reasons|3|||
144551934|NCT02823574|521218911|FG003|Treatment Period|Other reasons|6|||
144551935|NCT02823574|521218908|FG000|Treatment Period|Participant no longer meets study criteria|0|||
144551936|NCT02823574|521218909|FG001|Treatment Period|Participant no longer meets study criteria|0|||
144551937|NCT02823574|521218910|FG002|Treatment Period|Participant no longer meets study criteria|1|||
144551938|NCT02823574|521218911|FG003|Treatment Period|Participant no longer meets study criteria|0|||
144551939|NCT02823574|521218908|FG000|Treatment Period|Death|0|||
144551940|NCT02823574|521218909|FG001|Treatment Period|Death|0|||
144551941|NCT02823574|521218910|FG002|Treatment Period|Death|3|||
144551942|NCT02823574|521218911|FG003|Treatment Period|Death|1|||
144551943|NCT00590759|521218912|FG000|Overall Study|Death|52|||
144551944|NCT00590759|521218912|FG000|Overall Study|Lost to Follow-up|28|||
144551945|NCT02542696|521218913|FG000|Overall Study|Adverse Event|167|||
144551946|NCT02542696|521218913|FG000|Overall Study|Lack of Efficacy|26|||
144551947|NCT02542696|521218913|FG000|Overall Study|Lost to Follow-up|6|||
144551948|NCT02542696|521218913|FG000|Overall Study|Withdrawal by Subject|104|||
144551949|NCT02542696|521218913|FG000|Overall Study|Protocol Violation|5|||
144551950|NCT02542696|521218913|FG000|Overall Study|Death|8|||
144551951|NCT02542696|521218913|FG000|Overall Study|DECREASED OFF TIME|1|||
144551952|NCT02542696|521218913|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
144551953|NCT02542696|521218913|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
144551954|NCT02542696|521218913|FG000|Overall Study|MEDICAL HISTORY|1|||
144551955|NCT02542696|521218913|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
144551956|NCT02542696|521218913|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
144551957|NCT02542696|521218913|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
144551958|NCT02542696|521218913|FG000|Overall Study|SPONSOR DECISION|3|||
144551959|NCT02542696|521218913|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
144551960|NCT02542696|521218913|FG000|Overall Study|SUBJECT DECISION|2|||
144551961|NCT02410278|521218914|FG000|Run-in Period|Adverse Event|5|||
144551962|NCT02410278|521218915|FG001|Run-in Period|Adverse Event|0|||
144551963|NCT02410278|521218916|FG002|Run-in Period|Adverse Event|0|||
144551964|NCT02410278|521218914|FG000|Run-in Period|GSRS Threshold Not Met|30|||
144551965|NCT02410278|521218915|FG001|Run-in Period|GSRS Threshold Not Met|0|||
144551966|NCT02410278|521218916|FG002|Run-in Period|GSRS Threshold Not Met|0|||
144551967|NCT02410278|521218914|FG000|Run-in Period|Lost to Follow-up|1|||
144551968|NCT02410278|521218915|FG001|Run-in Period|Lost to Follow-up|0|||
144551969|NCT02410278|521218916|FG002|Run-in Period|Lost to Follow-up|0|||
144551970|NCT02410278|521218914|FG000|Run-in Period|Withdrawal by Subject|1|||
144551971|NCT02410278|521218915|FG001|Run-in Period|Withdrawal by Subject|0|||
144551972|NCT02410278|521218916|FG002|Run-in Period|Withdrawal by Subject|0|||
144551973|NCT02410278|521218914|FG000|Run-in Period|Pregnancy|1|||
144551974|NCT02410278|521218915|FG001|Run-in Period|Pregnancy|0|||
144551975|NCT02410278|521218916|FG002|Run-in Period|Pregnancy|0|||
144551976|NCT02410278|521218914|FG000|Study Treatment Period|Adverse Event|0|||
144551977|NCT02410278|521218915|FG001|Study Treatment Period|Adverse Event|6|||
144551978|NCT02410278|521218916|FG002|Study Treatment Period|Adverse Event|3|||
144551979|NCT02410278|521218914|FG000|Study Treatment Period|Physician Decision|0|||
144551980|NCT02410278|521218915|FG001|Study Treatment Period|Physician Decision|0|||
144551981|NCT02410278|521218916|FG002|Study Treatment Period|Physician Decision|1|||
144551982|NCT02410278|521218914|FG000|Study Treatment Period|Withdrawal by Subject|0|||
144551983|NCT02410278|521218915|FG001|Study Treatment Period|Withdrawal by Subject|1|||
144551984|NCT02410278|521218916|FG002|Study Treatment Period|Withdrawal by Subject|0|||
144551985|NCT02410278|521218914|FG000|Study Treatment Period|Other|0|||
144551986|NCT02410278|521218915|FG001|Study Treatment Period|Other|3|||
144551987|NCT02410278|521218916|FG002|Study Treatment Period|Other|0|||
144551988|NCT02410278|521218914|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
144551989|NCT02410278|521218915|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
144551990|NCT02410278|521218916|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
144551991|NCT03444155|521218917|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
144551992|NCT03444155|521218918|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
144551993|NCT02877680|521218919|FG000|Overall Study|Lost to Follow-up|1|||
144551994|NCT02877680|521218920|FG001|Overall Study|Lost to Follow-up|1|||
144551995|NCT02077374|521218921|FG000|Overall Study|Withdrawal by Subject|0|||
144551996|NCT02077374|521218922|FG001|Overall Study|Withdrawal by Subject|1|||
144551997|NCT02077374|521218921|FG000|Overall Study|Protocol Violation|0|||
144551998|NCT02077374|521218922|FG001|Overall Study|Protocol Violation|1|||
144616657|NCT02706873|521456367|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
144616658|NCT02706873|521456368|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
144551999|NCT00963924|521218923|FG000|Overall Study|Adverse Event|1|||
144616659|NCT05098041|521456372|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
144552000|NCT00963924|521218924|FG001|Overall Study|Adverse Event|0|||
144552001|NCT00963924|521218923|FG000|Overall Study|Withdrawal by Subject|0|||
144552002|NCT00963924|521218924|FG001|Overall Study|Withdrawal by Subject|1|||
144552003|NCT00963924|521218923|FG000|Overall Study|Changed antipsychotic|0|||
144552004|NCT00963924|521218924|FG001|Overall Study|Changed antipsychotic|1|||
144552005|NCT00963924|521218923|FG000|Overall Study|Lost to Follow-up|0|||
144552006|NCT00963924|521218924|FG001|Overall Study|Lost to Follow-up|1|||
144552007|NCT00446095|521218925|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
144552008|NCT00446095|521218926|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
144552009|NCT00446095|521218927|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
144552010|NCT00446095|521218928|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
144552011|NCT00446095|521218929|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
144552012|NCT00446095|521218925|FG000|Phase II (8 Weeks)|Adverse Event|0|||
144552013|NCT00446095|521218926|FG001|Phase II (8 Weeks)|Adverse Event|1|||
144552014|NCT00446095|521218927|FG002|Phase II (8 Weeks)|Adverse Event|1|||
144552015|NCT00446095|521218928|FG003|Phase II (8 Weeks)|Adverse Event|0|||
144552016|NCT00446095|521218929|FG004|Phase II (8 Weeks)|Adverse Event|0|||
144552017|NCT00446095|521218925|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
144552018|NCT00446095|521218926|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
144552019|NCT00446095|521218927|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
144552020|NCT00446095|521218928|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
144552021|NCT00446095|521218929|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
144552022|NCT00446095|521218925|FG000|Phase II (8 Weeks)|Physician Decision|1|||
144552023|NCT00446095|521218926|FG001|Phase II (8 Weeks)|Physician Decision|0|||
144552024|NCT00446095|521218927|FG002|Phase II (8 Weeks)|Physician Decision|0|||
144552025|NCT00446095|521218928|FG003|Phase II (8 Weeks)|Physician Decision|0|||
144552026|NCT00446095|521218929|FG004|Phase II (8 Weeks)|Physician Decision|0|||
144552027|NCT00446095|521218925|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
144552028|NCT00446095|521218926|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
144552029|NCT00446095|521218927|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
144552030|NCT00446095|521218928|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
144552031|NCT00446095|521218929|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
144552032|NCT00446095|521218925|FG000|Phase II (8 Weeks)|Ongoing|0|||
144552033|NCT00446095|521218926|FG001|Phase II (8 Weeks)|Ongoing|0|||
144552034|NCT00446095|521218927|FG002|Phase II (8 Weeks)|Ongoing|1|||
144552035|NCT00446095|521218928|FG003|Phase II (8 Weeks)|Ongoing|0|||
144552036|NCT00446095|521218929|FG004|Phase II (8 Weeks)|Ongoing|0|||
144552037|NCT00446095|521218925|FG000|Phase I (28 Days)|Adverse Event|0|||
144552038|NCT00446095|521218926|FG001|Phase I (28 Days)|Adverse Event|0|||
144552039|NCT00446095|521218927|FG002|Phase I (28 Days)|Adverse Event|0|||
144552040|NCT00446095|521218928|FG003|Phase I (28 Days)|Adverse Event|1|||
144552041|NCT00446095|521218929|FG004|Phase I (28 Days)|Adverse Event|0|||
144552042|NCT00446095|521218925|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
144552043|NCT00446095|521218926|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
144552044|NCT00446095|521218927|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
144552045|NCT00446095|521218928|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
144552046|NCT00446095|521218929|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
144552047|NCT00886834|521218930|FG000|Overall Study|Protocol Violation|0|||
144552048|NCT00886834|521218931|FG001|Overall Study|Protocol Violation|3|||
144552049|NCT02574286|521218932|FG000|Overall Study|Adverse Event|3|||
144552050|NCT02574286|521218932|FG000|Overall Study|Withdrawal by Subject|2|||
144552051|NCT02959866|521218933|FG000|Overall Study|Withdrawal by Subject|1|||
144552052|NCT00952523|521218934|FG000|Overall Study|Withdrawal by Subject|7|||
144552053|NCT04085614|521218935|FG000|Overall Study|Protocol Violation|9|||
144552054|NCT04085614|521218936|FG001|Overall Study|Protocol Violation|6|||
144552055|NCT03150589|521218937|FG000|Overall Study|Withdrawal by Subject|16|||
144552056|NCT03150589|521218938|FG001|Overall Study|Withdrawal by Subject|9|||
144552057|NCT03150589|521218937|FG000|Overall Study|Adverse Event|7|||
144552058|NCT03150589|521218938|FG001|Overall Study|Adverse Event|6|||
144552059|NCT03150589|521218937|FG000|Overall Study|Protocol Violation|4|||
144552060|NCT03150589|521218938|FG001|Overall Study|Protocol Violation|3|||
144552061|NCT03150589|521218937|FG000|Overall Study|Lost to Follow-up|3|||
144552062|NCT03150589|521218938|FG001|Overall Study|Lost to Follow-up|3|||
144552063|NCT03150589|521218937|FG000|Overall Study|Death|2|||
144552064|NCT03150589|521218938|FG001|Overall Study|Death|3|||
144552065|NCT03150589|521218937|FG000|Overall Study|IP non-compliance and other reasons|12|||
144552066|NCT03150589|521218938|FG001|Overall Study|IP non-compliance and other reasons|3|||
144552067|NCT05265247|521218939|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
144552068|NCT05265247|521218940|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
144552069|NCT05265247|521218939|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
144552070|NCT05265247|521218940|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
144552071|NCT05265247|521218939|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
144552072|NCT05265247|521218940|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
144552073|NCT01029925|521218941|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
144552074|NCT01029925|521218941|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
144552075|NCT01029925|521218941|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
144552076|NCT01405508|521218942|FG000|Overall Study|AE, non-serious non-fatal|1|||
144552077|NCT01405508|521218943|FG001|Overall Study|AE, non-serious non-fatal|1|||
144552078|NCT01405508|521218944|FG002|Overall Study|AE, non-serious non-fatal|0|||
144552079|NCT01405508|521218945|FG003|Overall Study|AE, non-serious non-fatal|0|||
144552080|NCT00476957|521218946|FG000|Overall Study|Lost to Follow-up|176|||
144552081|NCT00476957|521218947|FG001|Overall Study|Lost to Follow-up|193|||
144552082|NCT00346398|521218952|FG000|Overall Study|Lost to Follow-up|3|||
144552083|NCT00346398|521218953|FG001|Overall Study|Lost to Follow-up|0|||
144552084|NCT00346398|521218952|FG000|Overall Study|Withdrawal by Subject|0|||
144552085|NCT00346398|521218953|FG001|Overall Study|Withdrawal by Subject|2|||
144552086|NCT01697956|521218954|FG000|Overall Study|Protocol Violation|1|||
144552087|NCT01697956|521218955|FG001|Overall Study|Protocol Violation|1|||
144552088|NCT01964547|521218956|FG000|Overall Study|Adverse Event|8|||
144552089|NCT01964547|521218957|FG001|Overall Study|Adverse Event|2|||
144552090|NCT01964547|521218956|FG000|Overall Study|Withdrawal by Subject|4|||
144552091|NCT01964547|521218957|FG001|Overall Study|Withdrawal by Subject|7|||
144552092|NCT01964547|521218956|FG000|Overall Study|Lost to Follow-up|0|||
144552093|NCT01964547|521218957|FG001|Overall Study|Lost to Follow-up|1|||
144552094|NCT01964547|521218956|FG000|Overall Study|Withdrawal by Investigator|0|||
144552095|NCT01964547|521218957|FG001|Overall Study|Withdrawal by Investigator|1|||
144552096|NCT01115309|521218958|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
144552097|NCT01115309|521218958|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
144552098|NCT01115309|521218958|FG000|Long-term Follow-up|Lost to Follow-up|6|||
144552099|NCT05700851|521218959|FG000|Overall Study|Received a kidney transplant|1|||
144552100|NCT05700851|521218959|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
144552101|NCT05700851|521218959|FG000|Overall Study|Withdrawal by Subject|1|||
144552102|NCT03246724|521218960|FG000|Overall Study|Withdrawal by Subject|5|||
144552103|NCT03246724|521218961|FG001|Overall Study|Withdrawal by Subject|2|||
144552104|NCT03246724|521218962|FG002|Overall Study|Withdrawal by Subject|4|||
144552105|NCT03246724|521218963|FG003|Overall Study|Withdrawal by Subject|2|||
144552106|NCT03246724|521218960|FG000|Overall Study|Ineligible on day of surgery|7|||
144552107|NCT03246724|521218961|FG001|Overall Study|Ineligible on day of surgery|2|||
144552108|NCT03246724|521218962|FG002|Overall Study|Ineligible on day of surgery|0|||
144552109|NCT03246724|521218963|FG003|Overall Study|Ineligible on day of surgery|3|||
144552110|NCT03246724|521218960|FG000|Overall Study|Study completed before surgical date|2|||
144552111|NCT03246724|521218961|FG001|Overall Study|Study completed before surgical date|1|||
144552112|NCT03246724|521218962|FG002|Overall Study|Study completed before surgical date|8|||
144552113|NCT03246724|521218963|FG003|Overall Study|Study completed before surgical date|1|||
144552114|NCT03246724|521218960|FG000|Overall Study|Transferred to other arm|0|||
144552115|NCT03246724|521218961|FG001|Overall Study|Transferred to other arm|0|||
144552116|NCT03246724|521218962|FG002|Overall Study|Transferred to other arm|1|||
144552117|NCT03246724|521218963|FG003|Overall Study|Transferred to other arm|0|||
144552118|NCT03246724|521218960|FG000|Overall Study|Unable to obtain medication timely|0|||
144552119|NCT03246724|521218961|FG001|Overall Study|Unable to obtain medication timely|2|||
144552120|NCT03246724|521218962|FG002|Overall Study|Unable to obtain medication timely|2|||
144552121|NCT03246724|521218963|FG003|Overall Study|Unable to obtain medication timely|1|||
144552122|NCT03246724|521218960|FG000|Overall Study|Re-consented to participate|0|||
144552123|NCT03246724|521218961|FG001|Overall Study|Re-consented to participate|0|||
144552124|NCT03246724|521218962|FG002|Overall Study|Re-consented to participate|0|||
144552125|NCT03246724|521218963|FG003|Overall Study|Re-consented to participate|1|||
144552126|NCT02978716|521218964|FG000|Overall Study|Death|25|||
144552127|NCT02978716|521218965|FG001|Overall Study|Death|13|||
144552128|NCT02978716|521218966|FG002|Overall Study|Death|20|||
144552129|NCT02978716|521218964|FG000|Overall Study|Lost to Follow-up|0|||
144552130|NCT02978716|521218965|FG001|Overall Study|Lost to Follow-up|0|||
144552131|NCT02978716|521218966|FG002|Overall Study|Lost to Follow-up|1|||
144552132|NCT02978716|521218964|FG000|Overall Study|Withdrawal by Subject|6|||
144552133|NCT02978716|521218965|FG001|Overall Study|Withdrawal by Subject|4|||
144552134|NCT02978716|521218966|FG002|Overall Study|Withdrawal by Subject|5|||
144552135|NCT02978716|521218964|FG000|Overall Study|Sponsor terminated|2|||
144552136|NCT02978716|521218965|FG001|Overall Study|Sponsor terminated|13|||
144552137|NCT02978716|521218966|FG002|Overall Study|Sponsor terminated|9|||
144552138|NCT02978716|521218964|FG000|Overall Study|Other|1|||
144552139|NCT02978716|521218965|FG001|Overall Study|Other|3|||
144552140|NCT02978716|521218966|FG002|Overall Study|Other|0|||
144552141|NCT00589628|521218967|FG000|Overall Study|Lost to Follow-up|0|||
144552142|NCT00589628|521218968|FG001|Overall Study|Lost to Follow-up|1|||
144552143|NCT02189759|521218975|FG000|Overall Study|Lost to Follow-up|0|||
144552144|NCT02189759|521218976|FG001|Overall Study|Lost to Follow-up|0|||
144552145|NCT02189759|521218977|FG002|Overall Study|Lost to Follow-up|2|||
144552146|NCT02189759|521218978|FG003|Overall Study|Lost to Follow-up|5|||
144262382|NCT05219968|520159881|FG001|Safety Extension Period|Lost to Follow-up|0|||
144552147|NCT00689351|521218981|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
144552148|NCT00689351|521218982|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
144552149|NCT00689351|521218981|FG000|Infant Series of Dosing|Adverse Event|1|||
144552150|NCT00689351|521218982|FG001|Infant Series of Dosing|Adverse Event|0|||
144552151|NCT00689351|521218981|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
144552152|NCT00689351|521218982|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
144552153|NCT00689351|521218981|FG000|After Infant Series|Parent/legal guardian request|1|||
144552154|NCT00689351|521218982|FG001|After Infant Series|Parent/legal guardian request|0|||
144552155|NCT01766206|521218983|FG000|Overall Study|Withdrawal by Subject|22|||
144552156|NCT01766206|521218983|FG000|Overall Study|Lost to Follow-up|10|||
144552157|NCT01766206|521218983|FG000|Overall Study|Inappropriate enrollment|18|||
144552158|NCT01766206|521218983|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
144552159|NCT01313663|521218984|FG000|Overall Study|Study Closed/Terminated|2|||
144552160|NCT01313663|521218985|FG001|Overall Study|Study Closed/Terminated|4|||
144552161|NCT01313663|521218984|FG000|Overall Study|Lost to Follow-up|0|||
144552162|NCT01313663|521218985|FG001|Overall Study|Lost to Follow-up|1|||
144552163|NCT01313663|521218984|FG000|Overall Study|Physician Decision|0|||
144552164|NCT01313663|521218985|FG001|Overall Study|Physician Decision|2|||
144552165|NCT01313663|521218984|FG000|Overall Study|Withdrawal by Subject|2|||
144552166|NCT01313663|521218985|FG001|Overall Study|Withdrawal by Subject|1|||
144552167|NCT03075878|521218986|FG000|Overall Study|Physician Decision|1|||
144552168|NCT02158806|521218988|FG000|Overall Study|Death|2|||
144552169|NCT02158806|521218989|FG001|Overall Study|Death|0|||
144552170|NCT02158806|521218988|FG000|Overall Study|Withdrawal by Subject|2|||
144552171|NCT02158806|521218989|FG001|Overall Study|Withdrawal by Subject|0|||
144552172|NCT02158806|521218988|FG000|Overall Study|Lost to Follow-up|0|||
144552173|NCT02158806|521218989|FG001|Overall Study|Lost to Follow-up|3|||
144552174|NCT02158806|521218988|FG000|Overall Study|Moved out of area|0|||
144552175|NCT02158806|521218989|FG001|Overall Study|Moved out of area|1|||
144552176|NCT02158806|521218988|FG000|Overall Study|Transferred to palliative care|0|||
144552177|NCT02158806|521218989|FG001|Overall Study|Transferred to palliative care|1|||
144552178|NCT01898299|521218993|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
144203188|NCT00593736|519940290|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
144203189|NCT00593736|519940287|FG000|Treatment Period and Placebo Run-out|Various|1|||
144203190|NCT00593736|519940288|FG001|Treatment Period and Placebo Run-out|Various|1|||
144203191|NCT00593736|519940289|FG002|Treatment Period and Placebo Run-out|Various|1|||
144552179|NCT01898299|521218994|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
144552180|NCT00760877|521220539|FG000|Overall Study|Protocol Violation|1|||
144552181|NCT00760877|521220540|FG001|Overall Study|Protocol Violation|0|||
144552182|NCT00760877|521220539|FG000|Overall Study|Non-compliance with protocol treatment|2|||
144552183|NCT00760877|521220540|FG001|Overall Study|Non-compliance with protocol treatment|1|||
144552184|NCT00760877|521220539|FG000|Overall Study|Pregnancy|1|||
144552185|NCT00760877|521220540|FG001|Overall Study|Pregnancy|4|||
144552186|NCT00760877|521220539|FG000|Overall Study|Death|2|||
144552187|NCT00760877|521220540|FG001|Overall Study|Death|1|||
144552188|NCT00760877|521220539|FG000|Overall Study|Withdrawal by Subject|7|||
144552189|NCT00760877|521220540|FG001|Overall Study|Withdrawal by Subject|3|||
144552190|NCT00760877|521220539|FG000|Overall Study|Adverse Event|19|||
144552191|NCT00760877|521220540|FG001|Overall Study|Adverse Event|12|||
144552192|NCT00760877|521220539|FG000|Overall Study|Participant diagnosed with AML|0|||
144552193|NCT00760877|521220540|FG001|Overall Study|Participant diagnosed with AML|1|||
144552194|NCT00760877|521220539|FG000|Overall Study|Participant not eligible to cross-over|0|||
144552195|NCT00760877|521220540|FG001|Overall Study|Participant not eligible to cross-over|1|||
144552196|NCT00760877|521220539|FG000|Overall Study|Physician Decision|1|||
144552197|NCT00760877|521220540|FG001|Overall Study|Physician Decision|2|||
144552198|NCT00760877|521220539|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
144552199|NCT00760877|521220540|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
144552200|NCT00760877|521220539|FG000|Overall Study|Treatment failure|1|||
144552201|NCT00760877|521220540|FG001|Overall Study|Treatment failure|0|||
144552202|NCT00711555|521220543|FG000|Overall Study|Adverse Event|3|||
144552203|NCT04049578|521220544|FG000|Overall Study|Physician Decision|1|||
144552204|NCT02400749|521220545|FG000|Week 0 -16|Withdrawal by Subject|5|||
144552205|NCT02400749|521220546|FG001|Week 0 -16|Withdrawal by Subject|5|||
144552206|NCT02400749|521220545|FG000|Week 0 -16|Adverse Event|3|||
144552207|NCT02400749|521220546|FG001|Week 0 -16|Adverse Event|1|||
144552208|NCT02400749|521220545|FG000|Week 0 -16|Lost to Follow-up|2|||
144552209|NCT02400749|521220546|FG001|Week 0 -16|Lost to Follow-up|0|||
144552210|NCT02400749|521220545|FG000|Week 0 -16|Protocol Violation|1|||
144552211|NCT02400749|521220546|FG001|Week 0 -16|Protocol Violation|0|||
144552212|NCT02400749|521220545|FG000|Week 17 - 32|Withdrawal by Subject|3|||
144552213|NCT02400749|521220546|FG001|Week 17 - 32|Withdrawal by Subject|2|||
144552214|NCT02400749|521220545|FG000|Week 17 - 32|Adverse Event|2|||
144552215|NCT02400749|521220546|FG001|Week 17 - 32|Adverse Event|1|||
144552216|NCT01005602|521220551|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
144552217|NCT01005602|521220552|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
144552218|NCT03884478|521220553|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
144552219|NCT03884478|521220554|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
144203192|NCT00593736|519940290|FG003|Treatment Period and Placebo Run-out|Various|0|||
144552220|NCT03884478|521220555|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
144552221|NCT03884478|521220553|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
144552222|NCT03884478|521220554|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
144552223|NCT03884478|521220555|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
144552224|NCT03884478|521220553|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
144552225|NCT03884478|521220554|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
144552226|NCT03884478|521220555|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
144616660|NCT00464334|521456374|FG000|Overall Study|Adverse Event|0|||
144552227|NCT03884478|521220553|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
144552228|NCT03884478|521220554|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
144552229|NCT03884478|521220555|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
144552230|NCT02213094|521220556|FG000|Overall Study|Adverse Event|1|||
144552231|NCT02213094|521220557|FG001|Overall Study|Adverse Event|0|||
144552232|NCT01807234|521220558|FG000|Overall Study|Lost to Follow-up|2|||
144552233|NCT01807234|521220559|FG001|Overall Study|Lost to Follow-up|5|||
144552234|NCT01807234|521220560|FG002|Overall Study|Lost to Follow-up|1|||
144552235|NCT01807234|521220561|FG003|Overall Study|Lost to Follow-up|1|||
144552236|NCT01807234|521220562|FG004|Overall Study|Lost to Follow-up|1|||
144552237|NCT01807234|521220563|FG005|Overall Study|Lost to Follow-up|2|||
144552238|NCT01807234|521220558|FG000|Overall Study|Withdrawal by Subject|3|||
144552239|NCT01807234|521220559|FG001|Overall Study|Withdrawal by Subject|1|||
144552240|NCT01807234|521220560|FG002|Overall Study|Withdrawal by Subject|1|||
144552241|NCT01807234|521220561|FG003|Overall Study|Withdrawal by Subject|1|||
144552242|NCT01807234|521220562|FG004|Overall Study|Withdrawal by Subject|2|||
144552243|NCT01807234|521220563|FG005|Overall Study|Withdrawal by Subject|1|||
144552244|NCT01807234|521220558|FG000|Overall Study|Lack of Efficacy|0|||
144552245|NCT01807234|521220559|FG001|Overall Study|Lack of Efficacy|0|||
144552246|NCT01807234|521220560|FG002|Overall Study|Lack of Efficacy|0|||
144552247|NCT01807234|521220561|FG003|Overall Study|Lack of Efficacy|0|||
144552248|NCT01807234|521220562|FG004|Overall Study|Lack of Efficacy|1|||
144552249|NCT01807234|521220563|FG005|Overall Study|Lack of Efficacy|1|||
144552250|NCT01074229|521220564|FG000|Overall Study|Lost to Follow-up|1|||
144552251|NCT01074229|521220565|FG001|Overall Study|Lost to Follow-up|0|||
144552252|NCT01074229|521220566|FG002|Overall Study|Lost to Follow-up|0|||
144552253|NCT01074229|521220564|FG000|Overall Study|Change to open surgical procedure|1|||
144552254|NCT01074229|521220565|FG001|Overall Study|Change to open surgical procedure|3|||
144552255|NCT01074229|521220566|FG002|Overall Study|Change to open surgical procedure|4|||
144552256|NCT02163499|521220567|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
144552257|NCT02163499|521220567|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
144552258|NCT02163499|521220567|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
144552259|NCT02163499|521220567|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
144552260|NCT02163499|521220567|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
144552261|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
144552262|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
144552263|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
144552264|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
144552265|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
144552266|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
144552267|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
144552268|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
144552269|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
144552270|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Death|8|||
144552271|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
144552272|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
144552273|NCT02163499|521220567|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
144552274|NCT01540474|521220568|FG000|Vaccination Period|Lost to Follow-up|0|||
144552275|NCT01540474|521220569|FG001|Vaccination Period|Lost to Follow-up|1|||
144552276|NCT01540474|521220570|FG002|Vaccination Period|Lost to Follow-up|0|||
144552277|NCT01540474|521220571|FG003|Vaccination Period|Lost to Follow-up|0|||
144552278|NCT00857311|521220572|FG000|Overall Study|Lost to Follow-up|1|||
144552279|NCT00857311|521220573|FG001|Overall Study|Lost to Follow-up|0|||
144552280|NCT00857311|521220574|FG002|Overall Study|Lost to Follow-up|0|||
144552281|NCT00857311|521220575|FG003|Overall Study|Lost to Follow-up|0|||
144552282|NCT01587703|521220576|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
144552283|NCT01587703|521220577|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552284|NCT01587703|521220578|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552285|NCT01587703|521220579|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552286|NCT01587703|521220580|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552287|NCT01587703|521220581|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552288|NCT01587703|521220582|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552289|NCT01587703|521220583|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552290|NCT01587703|521220584|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552291|NCT01587703|521220585|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552292|NCT01587703|521220586|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552293|NCT01587703|521220587|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552294|NCT01587703|521220588|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552295|NCT01587703|521220589|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144616661|NCT00464334|521456375|FG001|Overall Study|Adverse Event|0|||
144552296|NCT01587703|521220590|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144616662|NCT00464334|521456376|FG002|Overall Study|Adverse Event|0|||
144552297|NCT01587703|521220591|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552298|NCT01587703|521220592|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552299|NCT01587703|521220593|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552300|NCT01587703|521220594|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
144552301|NCT01587703|521220576|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552302|NCT01587703|521220577|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552303|NCT01587703|521220578|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552304|NCT01587703|521220579|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552305|NCT01587703|521220580|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552306|NCT01587703|521220581|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
144552307|NCT01587703|521220582|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144616663|NCT00464334|521456377|FG003|Overall Study|Adverse Event|1|||
144616664|NCT00464334|521456378|FG004|Overall Study|Adverse Event|1|||
144616665|NCT00464334|521456379|FG005|Overall Study|Adverse Event|1|||
144616666|NCT00464334|521456380|FG006|Overall Study|Adverse Event|0|||
144616667|NCT00464334|521456381|FG007|Overall Study|Adverse Event|0|||
144616668|NCT00464334|521456382|FG008|Overall Study|Adverse Event|2|||
144616669|NCT00464334|521456383|FG009|Overall Study|Adverse Event|1|||
144616670|NCT00464334|521456384|FG010|Overall Study|Adverse Event|2|||
144616671|NCT00464334|521456374|FG000|Overall Study|Lack of Efficacy|0|||
144616672|NCT00464334|521456375|FG001|Overall Study|Lack of Efficacy|1|||
144616673|NCT00464334|521456376|FG002|Overall Study|Lack of Efficacy|0|||
144616674|NCT00464334|521456377|FG003|Overall Study|Lack of Efficacy|0|||
144616675|NCT00464334|521456378|FG004|Overall Study|Lack of Efficacy|0|||
144616676|NCT00464334|521456379|FG005|Overall Study|Lack of Efficacy|0|||
144616677|NCT00464334|521456380|FG006|Overall Study|Lack of Efficacy|0|||
144616678|NCT00464334|521456381|FG007|Overall Study|Lack of Efficacy|0|||
144616679|NCT00464334|521456382|FG008|Overall Study|Lack of Efficacy|0|||
144616680|NCT00464334|521456383|FG009|Overall Study|Lack of Efficacy|0|||
144616681|NCT00464334|521456384|FG010|Overall Study|Lack of Efficacy|0|||
144616682|NCT00464334|521456374|FG000|Overall Study|Lost to Follow-up|0|||
144616683|NCT00464334|521456375|FG001|Overall Study|Lost to Follow-up|0|||
144616684|NCT00464334|521456376|FG002|Overall Study|Lost to Follow-up|1|||
144616685|NCT00464334|521456377|FG003|Overall Study|Lost to Follow-up|0|||
144616686|NCT00464334|521456378|FG004|Overall Study|Lost to Follow-up|1|||
144616687|NCT00464334|521456379|FG005|Overall Study|Lost to Follow-up|0|||
144616688|NCT00464334|521456380|FG006|Overall Study|Lost to Follow-up|1|||
144616689|NCT00464334|521456381|FG007|Overall Study|Lost to Follow-up|0|||
144616690|NCT00464334|521456382|FG008|Overall Study|Lost to Follow-up|0|||
144616691|NCT00464334|521456383|FG009|Overall Study|Lost to Follow-up|0|||
144616692|NCT00464334|521456384|FG010|Overall Study|Lost to Follow-up|2|||
144616693|NCT00464334|521456374|FG000|Overall Study|Progressive Disease|0|||
144616694|NCT00464334|521456375|FG001|Overall Study|Progressive Disease|0|||
144616695|NCT00464334|521456376|FG002|Overall Study|Progressive Disease|0|||
144616696|NCT00464334|521456377|FG003|Overall Study|Progressive Disease|0|||
144616697|NCT00464334|521456378|FG004|Overall Study|Progressive Disease|0|||
144616698|NCT00464334|521456379|FG005|Overall Study|Progressive Disease|1|||
144616699|NCT00464334|521456380|FG006|Overall Study|Progressive Disease|0|||
144616700|NCT00464334|521456381|FG007|Overall Study|Progressive Disease|0|||
144616701|NCT00464334|521456382|FG008|Overall Study|Progressive Disease|1|||
144616702|NCT00464334|521456383|FG009|Overall Study|Progressive Disease|0|||
144616703|NCT00464334|521456384|FG010|Overall Study|Progressive Disease|0|||
144616704|NCT00464334|521456374|FG000|Overall Study|Study Terminated by Sponsor|0|||
144616705|NCT00464334|521456375|FG001|Overall Study|Study Terminated by Sponsor|0|||
144616706|NCT00464334|521456376|FG002|Overall Study|Study Terminated by Sponsor|0|||
144616707|NCT00464334|521456377|FG003|Overall Study|Study Terminated by Sponsor|1|||
144616708|NCT00464334|521456378|FG004|Overall Study|Study Terminated by Sponsor|0|||
144616709|NCT00464334|521456379|FG005|Overall Study|Study Terminated by Sponsor|0|||
144616710|NCT00464334|521456380|FG006|Overall Study|Study Terminated by Sponsor|0|||
144616711|NCT00464334|521456381|FG007|Overall Study|Study Terminated by Sponsor|0|||
144616712|NCT00464334|521456382|FG008|Overall Study|Study Terminated by Sponsor|0|||
144203193|NCT01868893|519940291|FG000|Overall Study|Adverse Event|2|||
144203194|NCT01868893|519940291|FG000|Overall Study|Commercial availability of study drug|17|||
144616713|NCT00464334|521456383|FG009|Overall Study|Study Terminated by Sponsor|0|||
144616714|NCT00464334|521456384|FG010|Overall Study|Study Terminated by Sponsor|0|||
144616715|NCT00464334|521456374|FG000|Overall Study|Withdrawal by Subject|1|||
144616716|NCT00464334|521456375|FG001|Overall Study|Withdrawal by Subject|7|||
144616717|NCT00464334|521456376|FG002|Overall Study|Withdrawal by Subject|4|||
144616718|NCT00464334|521456377|FG003|Overall Study|Withdrawal by Subject|2|||
144616719|NCT00464334|521456378|FG004|Overall Study|Withdrawal by Subject|2|||
144616720|NCT00464334|521456379|FG005|Overall Study|Withdrawal by Subject|2|||
144616721|NCT00464334|521456380|FG006|Overall Study|Withdrawal by Subject|2|||
144616722|NCT00464334|521456381|FG007|Overall Study|Withdrawal by Subject|1|||
144616723|NCT00464334|521456382|FG008|Overall Study|Withdrawal by Subject|3|||
144616724|NCT00464334|521456383|FG009|Overall Study|Withdrawal by Subject|0|||
144616725|NCT00464334|521456384|FG010|Overall Study|Withdrawal by Subject|0|||
144616726|NCT03948178|521456387|FG000|Overall Study|Protocol Violation|1|||
144616727|NCT03948178|521456387|FG000|Overall Study|Lost to Follow-up|2|||
144616728|NCT03948178|521456387|FG000|Overall Study|Withdrawal by Subject|2|||
144616729|NCT03948178|521456387|FG000|Overall Study|Reason not known|2|||
144616730|NCT03948178|521456387|FG000|Overall Study|Personal reason|14|||
144616731|NCT03948178|521456387|FG000|Overall Study|Disease progression|30|||
144616732|NCT03948178|521456387|FG000|Overall Study|Adverse Event|12|||
144616733|NCT03948178|521456387|FG000|Overall Study|Sponsor terminated study|164|||
144616734|NCT01297270|521456388|FG000|Overall Study|Adverse Event|19|||
144616735|NCT01297270|521456389|FG001|Overall Study|Adverse Event|32|||
144616736|NCT01297270|521456390|FG002|Overall Study|Adverse Event|5|||
144616737|NCT01297270|521456388|FG000|Overall Study|Lack of Efficacy|15|||
144552308|NCT01587703|521220583|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
144552309|NCT01587703|521220584|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552310|NCT01587703|521220585|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552311|NCT01587703|521220586|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552312|NCT01587703|521220587|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552313|NCT01587703|521220588|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552314|NCT01587703|521220589|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552315|NCT01587703|521220590|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552316|NCT01587703|521220591|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552317|NCT01587703|521220592|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552318|NCT01587703|521220593|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552319|NCT01587703|521220594|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
144552320|NCT01587703|521220576|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552321|NCT01587703|521220577|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552322|NCT01587703|521220578|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552323|NCT01587703|521220579|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552324|NCT01587703|521220580|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552325|NCT01587703|521220581|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552326|NCT01587703|521220582|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
144552327|NCT01587703|521220583|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552328|NCT01587703|521220584|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552329|NCT01587703|521220585|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552330|NCT01587703|521220586|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552331|NCT01587703|521220587|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552332|NCT01587703|521220588|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552333|NCT01587703|521220589|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552334|NCT01587703|521220590|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552335|NCT01587703|521220591|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552336|NCT01587703|521220592|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552337|NCT01587703|521220593|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552338|NCT01587703|521220594|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
144552339|NCT01587703|521220576|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
144552340|NCT01587703|521220577|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
144552341|NCT01587703|521220578|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
144552342|NCT01587703|521220579|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
144552343|NCT01587703|521220580|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
144552344|NCT01587703|521220581|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
144552345|NCT01587703|521220582|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
144552346|NCT01587703|521220583|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
144552347|NCT01587703|521220584|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552348|NCT01587703|521220585|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552349|NCT01587703|521220586|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552350|NCT01587703|521220587|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552351|NCT01587703|521220588|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552352|NCT01587703|521220589|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552353|NCT01587703|521220590|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552354|NCT01587703|521220591|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552355|NCT01587703|521220592|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144616738|NCT01297270|521456389|FG001|Overall Study|Lack of Efficacy|17|||
144616739|NCT01297270|521456390|FG002|Overall Study|Lack of Efficacy|15|||
144616740|NCT01297270|521456388|FG000|Overall Study|Lost to Follow-up|1|||
144616741|NCT01297270|521456389|FG001|Overall Study|Lost to Follow-up|2|||
144616742|NCT01297270|521456390|FG002|Overall Study|Lost to Follow-up|1|||
144616743|NCT01297270|521456388|FG000|Overall Study|Protocol Violation|0|||
144616744|NCT01297270|521456389|FG001|Overall Study|Protocol Violation|2|||
144262383|NCT05219968|520159882|FG002|Safety Extension Period|Lost to Follow-up|0|||
144616745|NCT01297270|521456390|FG002|Overall Study|Protocol Violation|0|||
144262384|NCT05219968|520159883|FG003|Safety Extension Period|Lost to Follow-up|1|||
144552356|NCT01587703|521220593|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552357|NCT01587703|521220594|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
144552358|NCT01587703|521220576|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552359|NCT01587703|521220577|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552360|NCT01587703|521220578|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552361|NCT01587703|521220579|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552362|NCT01587703|521220580|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552363|NCT01587703|521220581|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552364|NCT01587703|521220582|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552365|NCT01587703|521220583|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552366|NCT01587703|521220584|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
144552367|NCT01587703|521220585|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
144552368|NCT01587703|521220586|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
144552369|NCT01587703|521220587|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552370|NCT01587703|521220588|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552371|NCT01587703|521220589|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552372|NCT01587703|521220590|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552373|NCT01587703|521220591|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552374|NCT01587703|521220592|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552375|NCT01587703|521220593|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552376|NCT01587703|521220594|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
144552377|NCT01587703|521220576|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552378|NCT01587703|521220577|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144203195|NCT01868893|519940291|FG000|Overall Study|Neutropenia|1|||
144552379|NCT01587703|521220578|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552380|NCT01587703|521220579|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552381|NCT01587703|521220580|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552382|NCT01587703|521220581|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552383|NCT01587703|521220582|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552384|NCT01587703|521220583|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552385|NCT01587703|521220584|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
144552386|NCT01587703|521220585|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552387|NCT01587703|521220586|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
144552388|NCT01587703|521220587|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552389|NCT01587703|521220588|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552390|NCT01587703|521220589|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552391|NCT01587703|521220590|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552392|NCT01587703|521220591|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552393|NCT01587703|521220592|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552394|NCT01587703|521220593|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552395|NCT01587703|521220594|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
144552396|NCT01587703|521220576|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552397|NCT01587703|521220577|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552398|NCT01587703|521220578|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552399|NCT01587703|521220579|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552400|NCT01587703|521220580|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552401|NCT01587703|521220581|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552402|NCT01587703|521220582|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552403|NCT01587703|521220583|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552404|NCT01587703|521220584|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552405|NCT01587703|521220585|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
144552406|NCT01587703|521220586|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
144552407|NCT01587703|521220587|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552408|NCT01587703|521220588|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552409|NCT01587703|521220589|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552410|NCT01587703|521220590|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552411|NCT01587703|521220591|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552412|NCT01587703|521220592|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552413|NCT01587703|521220593|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144203196|NCT01857271|519940292|FG000|Overall Study|Lost to Follow-up|1|||
144203197|NCT04283500|519940293|FG000|Overall Study|Lost to Follow-up|8|||
144616746|NCT01297270|521456388|FG000|Overall Study|Withdrawal by Subject|7|||
144203198|NCT04283500|519940293|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
144203199|NCT03317834|519940298|FG000|Overall Study|Death|2|||
144616747|NCT01297270|521456389|FG001|Overall Study|Withdrawal by Subject|15|||
144727689|NCT01781637|521858026|FG001|Overall Study|Adverse Event|0|||
144203200|NCT03317834|519940298|FG000|Overall Study|Device Revision|5|||
144203201|NCT03317834|519940298|FG000|Overall Study|Withdrawal by Subject|13|||
144552414|NCT01587703|521220594|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
144552415|NCT01587703|521220576|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552416|NCT01587703|521220577|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552417|NCT01587703|521220578|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552418|NCT01587703|521220579|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552419|NCT01587703|521220580|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144203202|NCT03317834|519940298|FG000|Overall Study|Lost to Follow-up|13|||
144203203|NCT04091659|519940302|FG000|Overall Study|Protocol Violation|3|||
144203204|NCT04091659|519940303|FG001|Overall Study|Protocol Violation|0|||
144203205|NCT04091659|519940302|FG000|Overall Study|Lost to Follow-up|0|||
144203206|NCT04091659|519940303|FG001|Overall Study|Lost to Follow-up|1|||
144203207|NCT01517373|519940307|FG000|Run-in Period|Death|1|||
144203208|NCT01517373|519940308|FG001|Run-in Period|Death|0|||
144203209|NCT01517373|519940309|FG002|Run-in Period|Death|0|||
144203210|NCT01517373|519940310|FG003|Run-in Period|Death|0|||
144203211|NCT01517373|519940311|FG004|Run-in Period|Death|0|||
144203212|NCT01517373|519940312|FG005|Run-in Period|Death|0|||
144203213|NCT01517373|519940307|FG000|Run-in Period|Adverse Event|5|||
144203214|NCT01517373|519940308|FG001|Run-in Period|Adverse Event|0|||
144203215|NCT01517373|519940309|FG002|Run-in Period|Adverse Event|0|||
144203216|NCT01517373|519940310|FG003|Run-in Period|Adverse Event|0|||
144203217|NCT01517373|519940311|FG004|Run-in Period|Adverse Event|0|||
144203218|NCT01517373|519940312|FG005|Run-in Period|Adverse Event|0|||
144203219|NCT01517373|519940307|FG000|Run-in Period|Did not meet eligibility criteria|34|||
144203220|NCT01517373|519940308|FG001|Run-in Period|Did not meet eligibility criteria|0|||
144203221|NCT01517373|519940309|FG002|Run-in Period|Did not meet eligibility criteria|0|||
144203222|NCT01517373|519940310|FG003|Run-in Period|Did not meet eligibility criteria|0|||
144203223|NCT01517373|519940311|FG004|Run-in Period|Did not meet eligibility criteria|0|||
144203224|NCT01517373|519940312|FG005|Run-in Period|Did not meet eligibility criteria|0|||
144203225|NCT01517373|519940307|FG000|Run-in Period|Lost to Follow-up|1|||
144203226|NCT01517373|519940308|FG001|Run-in Period|Lost to Follow-up|0|||
144203227|NCT01517373|519940309|FG002|Run-in Period|Lost to Follow-up|0|||
144203228|NCT01517373|519940310|FG003|Run-in Period|Lost to Follow-up|0|||
144203229|NCT01517373|519940311|FG004|Run-in Period|Lost to Follow-up|0|||
144203230|NCT01517373|519940312|FG005|Run-in Period|Lost to Follow-up|0|||
144203231|NCT01517373|519940307|FG000|Run-in Period|Withdrawal by Subject|12|||
144203232|NCT01517373|519940308|FG001|Run-in Period|Withdrawal by Subject|0|||
144203233|NCT01517373|519940309|FG002|Run-in Period|Withdrawal by Subject|0|||
144203234|NCT01517373|519940310|FG003|Run-in Period|Withdrawal by Subject|0|||
144203235|NCT01517373|519940311|FG004|Run-in Period|Withdrawal by Subject|0|||
144203236|NCT01517373|519940312|FG005|Run-in Period|Withdrawal by Subject|0|||
144203237|NCT01517373|519940307|FG000|Run-in Period|Sponsor Decision|3|||
144203238|NCT01517373|519940308|FG001|Run-in Period|Sponsor Decision|0|||
144203239|NCT01517373|519940309|FG002|Run-in Period|Sponsor Decision|0|||
144203240|NCT01517373|519940310|FG003|Run-in Period|Sponsor Decision|0|||
144203241|NCT01517373|519940311|FG004|Run-in Period|Sponsor Decision|0|||
144203242|NCT01517373|519940312|FG005|Run-in Period|Sponsor Decision|0|||
144203243|NCT01517373|519940307|FG000|Run-in Period|Other|1|||
144203244|NCT01517373|519940308|FG001|Run-in Period|Other|0|||
144552420|NCT01587703|521220581|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552421|NCT01587703|521220582|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552422|NCT01587703|521220583|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552423|NCT01587703|521220584|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
144616748|NCT01297270|521456390|FG002|Overall Study|Withdrawal by Subject|7|||
144616749|NCT01297270|521456388|FG000|Overall Study|Other reason not defined above|3|||
144616750|NCT01297270|521456389|FG001|Overall Study|Other reason not defined above|3|||
144616751|NCT01297270|521456390|FG002|Overall Study|Other reason not defined above|1|||
144616752|NCT01297270|521456388|FG000|Overall Study|Not treated|0|||
144616753|NCT01297270|521456389|FG001|Overall Study|Not treated|1|||
144616754|NCT01297270|521456390|FG002|Overall Study|Not treated|0|||
144616755|NCT00382993|521456391|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
144616756|NCT00382993|521456392|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
144616757|NCT00382993|521456391|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
144616758|NCT00382993|521456392|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
144616759|NCT00382993|521456391|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
144616760|NCT00382993|521456392|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
144616761|NCT00382993|521456391|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
144727690|NCT01781637|521858025|FG000|Overall Study|Lack of Efficacy|2|||
144203245|NCT01517373|519940309|FG002|Run-in Period|Other|0|||
144203246|NCT01517373|519940310|FG003|Run-in Period|Other|0|||
144203247|NCT01517373|519940311|FG004|Run-in Period|Other|0|||
144203248|NCT01517373|519940312|FG005|Run-in Period|Other|0|||
144203249|NCT01517373|519940307|FG000|Treatment Period|Adverse Event|0|||
144203250|NCT01517373|519940308|FG001|Treatment Period|Adverse Event|0|||
144616762|NCT00382993|521456392|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
144616763|NCT00382993|521456391|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
144616764|NCT00382993|521456392|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
144616765|NCT00382993|521456391|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
144616766|NCT00382993|521456392|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
144616767|NCT00382993|521456391|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
144616768|NCT00382993|521456392|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
144616769|NCT00382993|521456391|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
144616770|NCT00382993|521456392|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
144616771|NCT00382993|521456391|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
144616772|NCT00382993|521456392|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
144616773|NCT00382993|521456391|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
144616774|NCT00382993|521456392|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
144203251|NCT01517373|519940309|FG002|Treatment Period|Adverse Event|0|||
144203252|NCT01517373|519940310|FG003|Treatment Period|Adverse Event|0|||
144203253|NCT01517373|519940311|FG004|Treatment Period|Adverse Event|0|||
144203254|NCT01517373|519940312|FG005|Treatment Period|Adverse Event|2|||
144203255|NCT01517373|519940307|FG000|Treatment Period|Lost to Follow-up|0|||
144203256|NCT01517373|519940308|FG001|Treatment Period|Lost to Follow-up|0|||
144203257|NCT01517373|519940309|FG002|Treatment Period|Lost to Follow-up|1|||
144203258|NCT01517373|519940310|FG003|Treatment Period|Lost to Follow-up|1|||
144203259|NCT01517373|519940311|FG004|Treatment Period|Lost to Follow-up|0|||
144552424|NCT01587703|521220585|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552425|NCT01587703|521220586|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552426|NCT01587703|521220587|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552427|NCT01587703|521220588|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552428|NCT01587703|521220589|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552429|NCT01587703|521220590|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552430|NCT01587703|521220591|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552431|NCT01587703|521220592|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552432|NCT01587703|521220593|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552433|NCT01587703|521220594|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
144552434|NCT01587703|521220576|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552435|NCT01587703|521220577|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552436|NCT01587703|521220578|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552437|NCT01587703|521220579|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552438|NCT01587703|521220580|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552439|NCT01587703|521220581|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552440|NCT01587703|521220582|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552441|NCT01587703|521220583|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552442|NCT01587703|521220584|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552443|NCT01587703|521220585|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552444|NCT01587703|521220586|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552445|NCT01587703|521220587|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552446|NCT01587703|521220588|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552447|NCT01587703|521220589|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552448|NCT01587703|521220590|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552449|NCT01587703|521220591|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552450|NCT01587703|521220592|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552451|NCT01587703|521220593|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
144552452|NCT01587703|521220594|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
144552453|NCT01587703|521220576|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552454|NCT01587703|521220577|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552455|NCT01587703|521220578|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144616775|NCT01965262|521456399|FG000|Second Intervention (7 Days)|Discontinued|0|||
144616776|NCT01965262|521456400|FG001|Second Intervention (7 Days)|Discontinued|1|||
144616777|NCT01965262|521456399|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
144616778|NCT01965262|521456400|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
144616779|NCT01965262|521456399|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
144616780|NCT01965262|521456400|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
144203260|NCT01517373|519940312|FG005|Treatment Period|Lost to Follow-up|0|||
144203261|NCT01517373|519940307|FG000|Treatment Period|Withdrawal by Subject|0|||
144262385|NCT05219968|520159884|FG004|Safety Extension Period|Lost to Follow-up|0|||
144262386|NCT04587336|520159887|FG000|Overall Study|Lost to Follow-up|1|||
144203262|NCT01517373|519940308|FG001|Treatment Period|Withdrawal by Subject|3|||
144203263|NCT01517373|519940309|FG002|Treatment Period|Withdrawal by Subject|2|||
144552456|NCT01587703|521220579|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552457|NCT01587703|521220580|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552458|NCT01587703|521220581|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552459|NCT01587703|521220582|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552460|NCT01587703|521220583|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552461|NCT01587703|521220584|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552462|NCT01587703|521220585|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552463|NCT01587703|521220586|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552464|NCT01587703|521220587|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552465|NCT01587703|521220588|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552466|NCT01587703|521220589|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552467|NCT01587703|521220590|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552468|NCT01587703|521220591|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552469|NCT01587703|521220592|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
144552470|NCT01587703|521220593|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
144552471|NCT01587703|521220594|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
144552472|NCT01587703|521220576|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552473|NCT01587703|521220577|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552474|NCT01587703|521220578|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552475|NCT01587703|521220579|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552476|NCT01587703|521220580|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552477|NCT01587703|521220581|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552478|NCT01587703|521220582|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552479|NCT01587703|521220583|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552480|NCT01587703|521220584|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552481|NCT01587703|521220585|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552482|NCT01587703|521220586|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552483|NCT01587703|521220587|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552484|NCT01587703|521220588|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552485|NCT01587703|521220589|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552486|NCT01587703|521220590|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552487|NCT01587703|521220591|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
144552488|NCT01587703|521220592|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552489|NCT01587703|521220593|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552490|NCT01587703|521220594|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
144552491|NCT01587703|521220576|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552492|NCT01587703|521220577|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552493|NCT01587703|521220578|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552494|NCT01587703|521220579|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552495|NCT01587703|521220580|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144616781|NCT00906087|521456406|FG000|Initial Washout|Withdrawal by Subject|1|||
144616782|NCT00906087|521456406|FG000|Initial Washout|Physician Decision|1|||
144616783|NCT00513500|521456415|FG000|Overall Study|Lost to Follow-up|35|||
144203264|NCT01517373|519940310|FG003|Treatment Period|Withdrawal by Subject|2|||
144203265|NCT01517373|519940311|FG004|Treatment Period|Withdrawal by Subject|2|||
144203266|NCT01517373|519940312|FG005|Treatment Period|Withdrawal by Subject|3|||
144203267|NCT01517373|519940307|FG000|Treatment Period|Other|0|||
144203268|NCT01517373|519940308|FG001|Treatment Period|Other|0|||
144203269|NCT01517373|519940309|FG002|Treatment Period|Other|0|||
144203270|NCT01517373|519940310|FG003|Treatment Period|Other|0|||
144203271|NCT01517373|519940311|FG004|Treatment Period|Other|1|||
144203272|NCT01517373|519940312|FG005|Treatment Period|Other|0|||
144203273|NCT01517373|519940307|FG000|Treatment Period|Protocol Violation|0|||
144203274|NCT01517373|519940308|FG001|Treatment Period|Protocol Violation|0|||
144203275|NCT01517373|519940309|FG002|Treatment Period|Protocol Violation|0|||
144203276|NCT01517373|519940310|FG003|Treatment Period|Protocol Violation|0|||
144203277|NCT01517373|519940311|FG004|Treatment Period|Protocol Violation|1|||
144203278|NCT01517373|519940312|FG005|Treatment Period|Protocol Violation|0|||
144203279|NCT01517373|519940307|FG000|Treatment Period|Lack of Efficacy|0|||
144203280|NCT01517373|519940308|FG001|Treatment Period|Lack of Efficacy|1|||
144203281|NCT01517373|519940309|FG002|Treatment Period|Lack of Efficacy|1|||
144203282|NCT01517373|519940310|FG003|Treatment Period|Lack of Efficacy|3|||
144552496|NCT01587703|521220581|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552497|NCT01587703|521220582|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144616784|NCT00513500|521456416|FG001|Overall Study|Lost to Follow-up|39|||
144203283|NCT01517373|519940311|FG004|Treatment Period|Lack of Efficacy|2|||
144203284|NCT01517373|519940312|FG005|Treatment Period|Lack of Efficacy|0|||
144203285|NCT01517373|519940307|FG000|Treatment Period|Medication error without AEs|0|||
144203286|NCT01517373|519940308|FG001|Treatment Period|Medication error without AEs|0|||
144262387|NCT04587336|520159888|FG001|Overall Study|Lost to Follow-up|0|||
144552498|NCT01587703|521220583|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552499|NCT01587703|521220584|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552500|NCT01587703|521220585|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552501|NCT01587703|521220586|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552502|NCT01587703|521220587|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
144552503|NCT01587703|521220588|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552504|NCT01587703|521220589|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552505|NCT01587703|521220590|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
144552506|NCT01587703|521220591|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552507|NCT01587703|521220592|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552508|NCT01587703|521220593|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552509|NCT01587703|521220594|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
144552510|NCT01587703|521220576|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552511|NCT01587703|521220577|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552512|NCT01587703|521220578|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552513|NCT01587703|521220579|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552514|NCT01587703|521220580|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552515|NCT01587703|521220581|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552516|NCT01587703|521220582|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552517|NCT01587703|521220583|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552518|NCT01587703|521220584|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552519|NCT01587703|521220585|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552520|NCT01587703|521220586|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552521|NCT01587703|521220587|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
144552522|NCT01587703|521220588|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
144552523|NCT01587703|521220589|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
144552524|NCT01587703|521220590|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
144552525|NCT01587703|521220591|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
144552526|NCT01587703|521220592|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
144552527|NCT01587703|521220593|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552528|NCT01587703|521220594|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
144552529|NCT01587703|521220576|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552530|NCT01587703|521220577|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552531|NCT01587703|521220578|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552532|NCT01587703|521220579|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552533|NCT01587703|521220580|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552534|NCT01587703|521220581|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552535|NCT01587703|521220582|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552536|NCT01587703|521220583|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552537|NCT01587703|521220584|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552538|NCT01587703|521220585|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552539|NCT01587703|521220586|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552540|NCT01587703|521220587|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
144552541|NCT01587703|521220588|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
144552542|NCT01587703|521220589|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
144552543|NCT01587703|521220590|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
144552544|NCT01587703|521220591|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
144552545|NCT01587703|521220592|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
144552546|NCT01587703|521220593|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552547|NCT01587703|521220594|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
144552548|NCT01587703|521220576|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552549|NCT01587703|521220577|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552550|NCT01587703|521220578|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552551|NCT01587703|521220579|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552552|NCT01587703|521220580|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552553|NCT01587703|521220581|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552554|NCT01587703|521220582|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552555|NCT01587703|521220583|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552556|NCT01587703|521220584|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552557|NCT01587703|521220585|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552558|NCT01587703|521220586|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552559|NCT01587703|521220587|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
144552560|NCT01587703|521220588|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552561|NCT01587703|521220589|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552562|NCT01587703|521220590|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552563|NCT01587703|521220591|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144262388|NCT02358031|520161423|FG000|Overall Study|Death|253|||
144552564|NCT01587703|521220592|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552565|NCT01587703|521220593|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552566|NCT01587703|521220594|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
144552567|NCT01922102|521220595|FG000|Overall Study|Withdrawal by Subject|7|||
144552568|NCT01922102|521220596|FG001|Overall Study|Withdrawal by Subject|3|||
144552569|NCT01922102|521220597|FG002|Overall Study|Withdrawal by Subject|7|||
144552570|NCT01922102|521220595|FG000|Overall Study|Physician Decision|0|||
144552571|NCT01922102|521220596|FG001|Overall Study|Physician Decision|2|||
144552572|NCT01922102|521220597|FG002|Overall Study|Physician Decision|1|||
144552573|NCT01922102|521220595|FG000|Overall Study|Adverse Event|1|||
144552574|NCT01922102|521220596|FG001|Overall Study|Adverse Event|2|||
144552575|NCT01922102|521220597|FG002|Overall Study|Adverse Event|0|||
144552576|NCT01922102|521220595|FG000|Overall Study|Lost to Follow-up|1|||
144552577|NCT01922102|521220596|FG001|Overall Study|Lost to Follow-up|0|||
144552578|NCT01922102|521220597|FG002|Overall Study|Lost to Follow-up|0|||
144552579|NCT01922102|521220595|FG000|Overall Study|Administrative problems|0|||
144552580|NCT01922102|521220596|FG001|Overall Study|Administrative problems|2|||
144552581|NCT01922102|521220597|FG002|Overall Study|Administrative problems|0|||
144552582|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
144552583|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
144552584|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
144552585|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
144552586|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
144552587|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
144552588|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
144552589|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
144552590|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
144552591|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
144552592|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
144552593|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
144552594|NCT01345253|521220602|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
144552595|NCT01345253|521220603|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
144552596|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
144552597|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
144552598|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
144552599|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
144552600|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
144552601|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
144552602|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
144552603|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
144552604|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
144552605|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
144552606|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
144552607|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
144552608|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
144616785|NCT00513500|521456415|FG000|Overall Study|Death|2|||
144616786|NCT00513500|521456416|FG001|Overall Study|Death|1|||
144616787|NCT00513500|521456415|FG000|Overall Study|Hospitalized|4|||
144616788|NCT00513500|521456416|FG001|Overall Study|Hospitalized|14|||
144616789|NCT00004259|521456419|FG000|Overall Study|Protocol Violation|1|||
144616790|NCT00004259|521456420|FG001|Overall Study|Protocol Violation|2|||
144616791|NCT00004259|521456421|FG002|Overall Study|Protocol Violation|0|||
144616792|NCT00004259|521456422|FG003|Overall Study|Protocol Violation|0|||
144616793|NCT00004259|521456419|FG000|Overall Study|Withdrawal by Subject|0|||
144616794|NCT00004259|521456420|FG001|Overall Study|Withdrawal by Subject|2|||
144616795|NCT00004259|521456421|FG002|Overall Study|Withdrawal by Subject|0|||
144616796|NCT00004259|521456422|FG003|Overall Study|Withdrawal by Subject|0|||
144616797|NCT00749996|521456423|FG000|Overall Study|Lost to Follow-up|7|||
144616798|NCT00749996|521456424|FG001|Overall Study|Lost to Follow-up|4|||
144616799|NCT00749996|521456423|FG000|Overall Study|Withdrawal by Subject|5|||
144616800|NCT00749996|521456424|FG001|Overall Study|Withdrawal by Subject|4|||
144616801|NCT00749996|521456423|FG000|Overall Study|Protocol Violation|2|||
144616802|NCT00749996|521456424|FG001|Overall Study|Protocol Violation|3|||
144203287|NCT01517373|519940309|FG002|Treatment Period|Medication error without AEs|2|||
144616803|NCT00749996|521456423|FG000|Overall Study|Physician Decision|2|||
144552609|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
144552610|NCT01345253|521220602|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
144552611|NCT01345253|521220603|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
144552612|NCT05361304|521220606|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
144616804|NCT00749996|521456424|FG001|Overall Study|Physician Decision|0|||
144616805|NCT00749996|521456423|FG000|Overall Study|Pregnancy|0|||
144616806|NCT00749996|521456424|FG001|Overall Study|Pregnancy|2|||
144203288|NCT01517373|519940310|FG003|Treatment Period|Medication error without AEs|1|||
144203289|NCT01517373|519940311|FG004|Treatment Period|Medication error without AEs|0|||
144203290|NCT01517373|519940312|FG005|Treatment Period|Medication error without AEs|2|||
144203291|NCT01085734|519940321|FG000|Overall Study|Adverse Event|0|||
144203292|NCT01085734|519940322|FG001|Overall Study|Adverse Event|2|||
144203293|NCT01085734|519940321|FG000|Overall Study|Death|1|||
144203294|NCT01085734|519940322|FG001|Overall Study|Death|0|||
144203295|NCT01085734|519940321|FG000|Overall Study|Lost to Follow-up|0|||
144203296|NCT01085734|519940322|FG001|Overall Study|Lost to Follow-up|1|||
144203297|NCT01085734|519940321|FG000|Overall Study|Withdrawal by Subject|0|||
144552613|NCT05361304|521220607|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
144552614|NCT05361304|521220606|FG000|Overall Study|COVID-19 Related|1|||
144552615|NCT05361304|521220607|FG001|Overall Study|COVID-19 Related|2|||
144552616|NCT05361304|521220606|FG000|Overall Study|Withdrawal by Subject|1|||
144552617|NCT05361304|521220607|FG001|Overall Study|Withdrawal by Subject|0|||
144552618|NCT00476151|521220609|FG000|Overall Study|Adverse Event|0|||
144552619|NCT00476151|521220610|FG001|Overall Study|Adverse Event|2|||
144552620|NCT00476151|521220609|FG000|Overall Study|Protocol Violation|1|||
144552621|NCT00476151|521220610|FG001|Overall Study|Protocol Violation|3|||
144552622|NCT00476151|521220609|FG000|Overall Study|Withdrawal by Subject|2|||
144552623|NCT00476151|521220610|FG001|Overall Study|Withdrawal by Subject|0|||
144552624|NCT00476151|521220609|FG000|Overall Study|Physician Decision|0|||
144552625|NCT00476151|521220610|FG001|Overall Study|Physician Decision|2|||
144552626|NCT01012999|521220614|FG000|Overall Study|Protocol Violation|1|||
144552627|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
144552628|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
144552629|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
144552630|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
144552631|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
144552632|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
144552633|NCT03557307|521220615|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
144552634|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
144552635|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|Death|3|||
144552636|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
144552637|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
144552638|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
144552639|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
144552640|NCT03557307|521220615|FG000|Period 2: Maintenance Phase|other|3|||
144552641|NCT01322347|521220616|FG000|Overall Study|Adverse Event|7|||
144552642|NCT01322347|521220617|FG001|Overall Study|Adverse Event|2|||
144552643|NCT01322347|521220616|FG000|Overall Study|Death|5|||
144552644|NCT01322347|521220617|FG001|Overall Study|Death|3|||
144552645|NCT01322347|521220616|FG000|Overall Study|Physician Decision|2|||
144552646|NCT01322347|521220617|FG001|Overall Study|Physician Decision|1|||
144552647|NCT01322347|521220616|FG000|Overall Study|Protocol Violation|5|||
144552648|NCT01322347|521220617|FG001|Overall Study|Protocol Violation|2|||
144552649|NCT01322347|521220616|FG000|Overall Study|Withdrawal by Subject|1|||
144552650|NCT01322347|521220617|FG001|Overall Study|Withdrawal by Subject|4|||
144552651|NCT01322347|521220616|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
144552652|NCT01322347|521220617|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
144552653|NCT01322347|521220616|FG000|Overall Study|blood transfusion|5|||
144552654|NCT01322347|521220617|FG001|Overall Study|blood transfusion|5|||
144552655|NCT01322347|521220616|FG000|Overall Study|sponsor decision|1|||
144552656|NCT01322347|521220617|FG001|Overall Study|sponsor decision|3|||
144552657|NCT01322347|521220616|FG000|Overall Study|ineligible|6|||
144552658|NCT01322347|521220617|FG001|Overall Study|ineligible|3|||
144552659|NCT01322347|521220616|FG000|Overall Study|kidney transplant|3|||
144552660|NCT01322347|521220617|FG001|Overall Study|kidney transplant|1|||
144552661|NCT01322347|521220616|FG000|Overall Study|study drug withheld > 12 wks|0|||
144616807|NCT00749996|521456423|FG000|Overall Study|Adverse Event|1|||
144552662|NCT01322347|521220617|FG001|Overall Study|study drug withheld > 12 wks|1|||
144552663|NCT01322347|521220616|FG000|Overall Study|moved/changed dialysis|2|||
144552664|NCT01322347|521220617|FG001|Overall Study|moved/changed dialysis|4|||
144552665|NCT04883541|521220618|FG000|Overall Study|Not attending regular yoga class|16|||
144552666|NCT04883541|521220619|FG001|Overall Study|Not attending regular yoga class|0|||
144262389|NCT02358031|520161424|FG001|Overall Study|Death|237|||
144552667|NCT04883541|521220618|FG000|Overall Study|Not attending the pregnancy school|0|||
144552668|NCT04883541|521220619|FG001|Overall Study|Not attending the pregnancy school|9|||
144616808|NCT00749996|521456424|FG001|Overall Study|Adverse Event|0|||
144552669|NCT01369147|521220622|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
144203298|NCT01085734|519940322|FG001|Overall Study|Withdrawal by Subject|1|||
144552670|NCT01369147|521220623|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
144203299|NCT03678285|519940327|FG000|Overall Study|Adverse Event|2|||
144616809|NCT00749996|521456423|FG000|Overall Study|Death|1|||
144262390|NCT02358031|520161425|FG002|Overall Study|Death|266|||
144552671|NCT01369147|521220624|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
144552672|NCT04239911|521220625|FG000|Overall Study|Lost to Follow-up|2|||
144552673|NCT04239911|521220626|FG001|Overall Study|Lost to Follow-up|1|||
144552674|NCT03456856|521220627|FG000|Overall Study|Lost to Follow-up|2|||
144552675|NCT03456856|521220627|FG000|Overall Study|Withdrawal by Subject|1|||
144552676|NCT03262389|521220630|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
144552677|NCT03262389|521220630|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
144552678|NCT03262389|521220630|FG000|Overall Study|opted out of PET/MR|1|||
144552679|NCT01052272|521220631|FG000|Overall Study|Death|0|||
144552680|NCT01052272|521220632|FG001|Overall Study|Death|0|||
144552681|NCT01052272|521220633|FG002|Overall Study|Death|1|||
144552682|NCT01052272|521220634|FG003|Overall Study|Death|1|||
144552683|NCT01052272|521220631|FG000|Overall Study|Physician Decision|0|||
144552684|NCT01052272|521220632|FG001|Overall Study|Physician Decision|1|||
144552685|NCT01052272|521220633|FG002|Overall Study|Physician Decision|0|||
144552686|NCT01052272|521220634|FG003|Overall Study|Physician Decision|0|||
144552687|NCT01052272|521220631|FG000|Overall Study|patient refuses follow-up|5|||
144552688|NCT01052272|521220632|FG001|Overall Study|patient refuses follow-up|4|||
144552689|NCT01052272|521220633|FG002|Overall Study|patient refuses follow-up|2|||
144552690|NCT01052272|521220634|FG003|Overall Study|patient refuses follow-up|4|||
144552691|NCT01052272|521220631|FG000|Overall Study|Withdrawal by Subject|0|||
144552692|NCT01052272|521220632|FG001|Overall Study|Withdrawal by Subject|2|||
144552693|NCT01052272|521220633|FG002|Overall Study|Withdrawal by Subject|3|||
144552694|NCT01052272|521220634|FG003|Overall Study|Withdrawal by Subject|2|||
144552695|NCT01052272|521220631|FG000|Overall Study|placed in long-term care|0|||
144552696|NCT01052272|521220632|FG001|Overall Study|placed in long-term care|0|||
144552697|NCT01052272|521220633|FG002|Overall Study|placed in long-term care|1|||
144552698|NCT01052272|521220634|FG003|Overall Study|placed in long-term care|0|||
144552699|NCT01052272|521220631|FG000|Overall Study|decline in health|0|||
144552700|NCT01052272|521220632|FG001|Overall Study|decline in health|0|||
144552701|NCT01052272|521220633|FG002|Overall Study|decline in health|1|||
144552702|NCT01052272|521220634|FG003|Overall Study|decline in health|0|||
144552703|NCT00096278|521220635|FG000|Overall Study|No follow-up data|15|||
144552704|NCT00096278|521220636|FG001|Overall Study|No follow-up data|18|||
144552705|NCT00096278|521220635|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
144552706|NCT00096278|521220636|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
144552707|NCT04626128|521220637|FG000|Overall Study|Withdrawal by Subject|0|||
144552708|NCT04626128|521220638|FG001|Overall Study|Withdrawal by Subject|1|||
144552709|NCT04626128|521220639|FG002|Overall Study|Withdrawal by Subject|0|||
144552710|NCT04626128|521220640|FG003|Overall Study|Withdrawal by Subject|0|||
144552711|NCT00841321|521220641|FG000|Overall Study|Lost to Follow-up|1|||
144552712|NCT00841321|521220642|FG001|Overall Study|Lost to Follow-up|1|||
144552713|NCT00841321|521220641|FG000|Overall Study|Adverse Event|0|||
144552714|NCT00841321|521220642|FG001|Overall Study|Adverse Event|2|||
144552715|NCT00379210|521220645|FG000|Overall Study|Withdrawal by Subject|10|||
144552716|NCT00379210|521220646|FG001|Overall Study|Withdrawal by Subject|7|||
144552717|NCT04908488|521220649|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
144552718|NCT04908488|521220650|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
144552719|NCT04908488|521220649|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
144552720|NCT04908488|521220650|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
144552721|NCT01107912|521220651|FG000|Period 1|Adverse Event|0|||
144552722|NCT01107912|521220652|FG001|Period 1|Adverse Event|0|||
144552723|NCT01107912|521220653|FG002|Period 1|Adverse Event|0|||
144203300|NCT03678285|519940327|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
144203301|NCT03678285|519940327|FG000|Overall Study|Dehydrated prior to start of workout|1|||
144203302|NCT00123474|519940328|FG000|Randomized to Treatment|Randomized, never treated|1|||
144203303|NCT00123474|519940329|FG001|Randomized to Treatment|Randomized, never treated|4|||
144203304|NCT00123474|519940330|FG002|Randomized to Treatment|Randomized, never treated|2|||
144203305|NCT00123474|519940331|FG003|Randomized to Treatment|Randomized, never treated|1|||
144203306|NCT00123474|519940328|FG000|As Treated at Study Closure|not reported when site closed|1|||
144203307|NCT00123474|519940329|FG001|As Treated at Study Closure|not reported when site closed|0|||
144203308|NCT00123474|519940330|FG002|As Treated at Study Closure|not reported when site closed|1|||
144262391|NCT02358031|520161423|FG000|Overall Study|Lost to Follow-up|1|||
144262392|NCT02358031|520161424|FG001|Overall Study|Lost to Follow-up|1|||
144552724|NCT01107912|521220654|FG003|Period 1|Adverse Event|0|||
144552725|NCT01107912|521220655|FG004|Period 1|Adverse Event|2|||
144552726|NCT01107912|521220656|FG005|Period 1|Adverse Event|0|||
144552727|NCT01107912|521220651|FG000|Period 1|Physician Decision|0|||
144552728|NCT01107912|521220652|FG001|Period 1|Physician Decision|0|||
144552729|NCT01107912|521220653|FG002|Period 1|Physician Decision|0|||
144552730|NCT01107912|521220654|FG003|Period 1|Physician Decision|0|||
144552731|NCT01107912|521220655|FG004|Period 1|Physician Decision|1|||
144262393|NCT02358031|520161425|FG002|Overall Study|Lost to Follow-up|0|||
144552732|NCT01107912|521220656|FG005|Period 1|Physician Decision|0|||
144552733|NCT01107912|521220651|FG000|Period 1|Withdrawal by Subject|1|||
144727691|NCT01781637|521858026|FG001|Overall Study|Lack of Efficacy|6|||
144552734|NCT01107912|521220652|FG001|Period 1|Withdrawal by Subject|0|||
144552735|NCT01107912|521220653|FG002|Period 1|Withdrawal by Subject|0|||
144552736|NCT01107912|521220654|FG003|Period 1|Withdrawal by Subject|0|||
144552737|NCT01107912|521220655|FG004|Period 1|Withdrawal by Subject|0|||
144552738|NCT01107912|521220656|FG005|Period 1|Withdrawal by Subject|0|||
144552739|NCT01107912|521220651|FG000|Period 2|Physician Decision|0|||
144552740|NCT01107912|521220652|FG001|Period 2|Physician Decision|0|||
144552741|NCT01107912|521220653|FG002|Period 2|Physician Decision|1|||
144552742|NCT01107912|521220654|FG003|Period 2|Physician Decision|0|||
144552743|NCT01107912|521220655|FG004|Period 2|Physician Decision|0|||
144552744|NCT01107912|521220656|FG005|Period 2|Physician Decision|0|||
144552745|NCT01107912|521220651|FG000|Period 3|Adverse Event|0|||
144552746|NCT01107912|521220652|FG001|Period 3|Adverse Event|1|||
144552747|NCT01107912|521220653|FG002|Period 3|Adverse Event|1|||
144552748|NCT01107912|521220654|FG003|Period 3|Adverse Event|0|||
144552749|NCT01107912|521220655|FG004|Period 3|Adverse Event|0|||
144552750|NCT01107912|521220656|FG005|Period 3|Adverse Event|0|||
144552751|NCT01107912|521220651|FG000|Period 3|Withdrawal by Subject|0|||
144552752|NCT01107912|521220652|FG001|Period 3|Withdrawal by Subject|0|||
144552753|NCT01107912|521220653|FG002|Period 3|Withdrawal by Subject|0|||
144552754|NCT01107912|521220654|FG003|Period 3|Withdrawal by Subject|1|||
144552755|NCT01107912|521220655|FG004|Period 3|Withdrawal by Subject|0|||
144552756|NCT01107912|521220656|FG005|Period 3|Withdrawal by Subject|0|||
144552757|NCT02991118|521220661|FG000|Overall Study|Death|3|||
144552758|NCT02991118|521220662|FG001|Overall Study|Death|8|||
144552759|NCT02991118|521220661|FG000|Overall Study|Protocol Violation|0|||
144552760|NCT02991118|521220662|FG001|Overall Study|Protocol Violation|3|||
144552761|NCT02991118|521220661|FG000|Overall Study|Physician Decision|0|||
144552762|NCT02991118|521220662|FG001|Overall Study|Physician Decision|1|||
144552763|NCT02991118|521220661|FG000|Overall Study|Moved out of the country|0|||
144552764|NCT02991118|521220662|FG001|Overall Study|Moved out of the country|1|||
144552765|NCT02991118|521220661|FG000|Overall Study|Adverse Event|2|||
144552766|NCT02991118|521220662|FG001|Overall Study|Adverse Event|2|||
144552767|NCT02991118|521220661|FG000|Overall Study|Withdrawal by Subject|1|||
144552768|NCT02991118|521220662|FG001|Overall Study|Withdrawal by Subject|7|||
144552769|NCT02991118|521220661|FG000|Overall Study|Could not attend study visits|0|||
144552770|NCT02991118|521220662|FG001|Overall Study|Could not attend study visits|1|||
144552771|NCT02991118|521220661|FG000|Overall Study|Lost to Follow-up|1|||
144552772|NCT02991118|521220662|FG001|Overall Study|Lost to Follow-up|9|||
144552773|NCT00657709|521220667|FG000|Overall Study|AE or Death|7|||
144552774|NCT00657709|521220668|FG001|Overall Study|AE or Death|7|||
144552775|NCT00657709|521220669|FG002|Overall Study|AE or Death|6|||
144552776|NCT00657709|521220670|FG003|Overall Study|AE or Death|7|||
144552777|NCT00657709|521220671|FG004|Overall Study|AE or Death|1|||
144552778|NCT00657709|521220667|FG000|Overall Study|Withdrawal by Subject|7|||
144552779|NCT00657709|521220668|FG001|Overall Study|Withdrawal by Subject|15|||
144552780|NCT00657709|521220669|FG002|Overall Study|Withdrawal by Subject|15|||
144552781|NCT00657709|521220670|FG003|Overall Study|Withdrawal by Subject|5|||
144552782|NCT00657709|521220671|FG004|Overall Study|Withdrawal by Subject|9|||
144552783|NCT00657709|521220667|FG000|Overall Study|Lost to Follow-up|9|||
144552784|NCT00657709|521220668|FG001|Overall Study|Lost to Follow-up|9|||
144552785|NCT00657709|521220669|FG002|Overall Study|Lost to Follow-up|7|||
144552786|NCT00657709|521220670|FG003|Overall Study|Lost to Follow-up|1|||
144552787|NCT00657709|521220671|FG004|Overall Study|Lost to Follow-up|21|||
144552788|NCT00657709|521220667|FG000|Overall Study|Protocol Violation|0|||
144552789|NCT00657709|521220668|FG001|Overall Study|Protocol Violation|2|||
144552790|NCT00657709|521220669|FG002|Overall Study|Protocol Violation|0|||
144552791|NCT00657709|521220670|FG003|Overall Study|Protocol Violation|1|||
144552792|NCT00657709|521220671|FG004|Overall Study|Protocol Violation|2|||
144552793|NCT02607956|521220672|FG000|Double-Blinded Phase|Withdrew Consent|17|||
144552794|NCT02607956|521220673|FG001|Double-Blinded Phase|Withdrew Consent|19|||
144552795|NCT02607956|521220674|FG002|Double-Blinded Phase|Withdrew Consent|0|||
144552796|NCT02607956|521220675|FG003|Double-Blinded Phase|Withdrew Consent|0|||
144552797|NCT02607956|521220672|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
144552798|NCT02607956|521220673|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
144552799|NCT02607956|521220674|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
144552800|NCT02607956|521220675|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
144616810|NCT00749996|521456424|FG001|Overall Study|Death|0|||
144616811|NCT01627860|521456431|FG000|Overall Study|Adverse Event|9|||
144552801|NCT02607956|521220672|FG000|Double-Blinded Phase|Randomized but never treated|7|||
144552802|NCT02607956|521220673|FG001|Double-Blinded Phase|Randomized but never treated|5|||
144552803|NCT02607956|521220674|FG002|Double-Blinded Phase|Randomized but never treated|0|||
144552804|NCT02607956|521220675|FG003|Double-Blinded Phase|Randomized but never treated|0|||
144552805|NCT02607956|521220672|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
144552806|NCT02607956|521220673|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
144552807|NCT02607956|521220674|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
144552808|NCT02607956|521220675|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
144552809|NCT02607956|521220672|FG000|Double-Blinded Phase|Death|4|||
144552810|NCT02607956|521220673|FG001|Double-Blinded Phase|Death|4|||
144552811|NCT02607956|521220674|FG002|Double-Blinded Phase|Death|0|||
144552812|NCT02607956|521220675|FG003|Double-Blinded Phase|Death|0|||
144552813|NCT02607956|521220672|FG000|Double-Blinded Phase|Adverse Event|4|||
144552814|NCT02607956|521220673|FG001|Double-Blinded Phase|Adverse Event|3|||
144552815|NCT02607956|521220674|FG002|Double-Blinded Phase|Adverse Event|0|||
144552816|NCT02607956|521220675|FG003|Double-Blinded Phase|Adverse Event|0|||
144552817|NCT02607956|521220672|FG000|Double-Blinded Phase|Protocol Violation|3|||
144552818|NCT02607956|521220673|FG001|Double-Blinded Phase|Protocol Violation|1|||
144552819|NCT02607956|521220674|FG002|Double-Blinded Phase|Protocol Violation|0|||
144552820|NCT02607956|521220675|FG003|Double-Blinded Phase|Protocol Violation|0|||
144552821|NCT02607956|521220672|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
144552822|NCT02607956|521220673|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
144552823|NCT02607956|521220674|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
144552824|NCT02607956|521220675|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
144552825|NCT02607956|521220672|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
144552826|NCT02607956|521220673|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
144552827|NCT02607956|521220674|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
144552828|NCT02607956|521220675|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
144552829|NCT02607956|521220672|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
144552830|NCT02607956|521220673|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
144552831|NCT02607956|521220674|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
144552832|NCT02607956|521220675|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
144552833|NCT02607956|521220672|FG000|Open-Label Extension Phase|Death|0|||
144552834|NCT02607956|521220673|FG001|Open-Label Extension Phase|Death|0|||
144552835|NCT02607956|521220674|FG002|Open-Label Extension Phase|Death|1|||
144552836|NCT02607956|521220675|FG003|Open-Label Extension Phase|Death|3|||
144552837|NCT02607956|521220672|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
144552838|NCT02607956|521220673|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
144552839|NCT02607956|521220674|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
144552840|NCT02607956|521220675|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
144552841|NCT02607956|521220672|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
144552842|NCT02607956|521220673|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
144552843|NCT02607956|521220674|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
144552844|NCT02607956|521220675|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
144552845|NCT02607956|521220672|FG000|Open-Label Extension Phase|Protocol Violation|0|||
144552846|NCT02607956|521220673|FG001|Open-Label Extension Phase|Protocol Violation|0|||
144552847|NCT02607956|521220674|FG002|Open-Label Extension Phase|Protocol Violation|0|||
144552848|NCT02607956|521220675|FG003|Open-Label Extension Phase|Protocol Violation|2|||
144552849|NCT02607956|521220672|FG000|Open-Label Extension Phase|Pregnancy|0|||
144552850|NCT02607956|521220673|FG001|Open-Label Extension Phase|Pregnancy|0|||
144552851|NCT02607956|521220674|FG002|Open-Label Extension Phase|Pregnancy|0|||
144552852|NCT02607956|521220675|FG003|Open-Label Extension Phase|Pregnancy|1|||
144552853|NCT02006641|521220677|FG000|Overall Study|Withdrawal before treatment|2|||
144552854|NCT02006641|521220678|FG001|Overall Study|Withdrawal before treatment|5|||
144552855|NCT02006641|521220679|FG002|Overall Study|Withdrawal before treatment|3|||
144552856|NCT02006641|521220677|FG000|Overall Study|Adverse Event|15|||
144552857|NCT02006641|521220678|FG001|Overall Study|Adverse Event|11|||
144552858|NCT02006641|521220679|FG002|Overall Study|Adverse Event|15|||
144552859|NCT02006641|521220677|FG000|Overall Study|Protocol Violation|0|||
144552860|NCT02006641|521220678|FG001|Overall Study|Protocol Violation|2|||
144552861|NCT02006641|521220679|FG002|Overall Study|Protocol Violation|2|||
144552862|NCT02006641|521220677|FG000|Overall Study|Lost to Follow-up|0|||
144552863|NCT02006641|521220678|FG001|Overall Study|Lost to Follow-up|1|||
144552864|NCT02006641|521220679|FG002|Overall Study|Lost to Follow-up|0|||
144552865|NCT02006641|521220677|FG000|Overall Study|Withdrawal by Subject|7|||
144552866|NCT02006641|521220678|FG001|Overall Study|Withdrawal by Subject|12|||
144552867|NCT02006641|521220679|FG002|Overall Study|Withdrawal by Subject|11|||
144552868|NCT02006641|521220677|FG000|Overall Study|Other reason: patient didn't show up|1|||
144552869|NCT02006641|521220678|FG001|Overall Study|Other reason: patient didn't show up|0|||
144552870|NCT02006641|521220679|FG002|Overall Study|Other reason: patient didn't show up|0|||
144552871|NCT02006641|521220677|FG000|Overall Study|Other reason:patient didn't want to come|0|||
144552872|NCT02006641|521220678|FG001|Overall Study|Other reason:patient didn't want to come|0|||
144552873|NCT02006641|521220679|FG002|Overall Study|Other reason:patient didn't want to come|1|||
144552874|NCT02006641|521220677|FG000|Overall Study|Other reason: patient has moved|1|||
144552875|NCT02006641|521220678|FG001|Overall Study|Other reason: patient has moved|0|||
144552876|NCT02006641|521220679|FG002|Overall Study|Other reason: patient has moved|1|||
144552877|NCT02006641|521220677|FG000|Overall Study|Other reason: caregiver in hospital|0|||
144552878|NCT02006641|521220678|FG001|Overall Study|Other reason: caregiver in hospital|1|||
144552879|NCT02006641|521220679|FG002|Overall Study|Other reason: caregiver in hospital|0|||
144552880|NCT02006641|521220677|FG000|Overall Study|Other reason: patient's wife has died|0|||
144552881|NCT02006641|521220678|FG001|Overall Study|Other reason: patient's wife has died|0|||
144552882|NCT02006641|521220679|FG002|Overall Study|Other reason: patient's wife has died|1|||
144552883|NCT02006641|521220677|FG000|Overall Study|Other reason: hospitalisation|0|||
144552884|NCT02006641|521220678|FG001|Overall Study|Other reason: hospitalisation|1|||
144552885|NCT02006641|521220679|FG002|Overall Study|Other reason: hospitalisation|0|||
144552886|NCT02006641|521220677|FG000|Overall Study|Other reason: caregiver impossibility|0|||
144552887|NCT02006641|521220678|FG001|Overall Study|Other reason: caregiver impossibility|0|||
144552888|NCT02006641|521220679|FG002|Overall Study|Other reason: caregiver impossibility|1|||
144552889|NCT02006641|521220677|FG000|Overall Study|Other reason: protocol non-compliance|0|||
144552890|NCT02006641|521220678|FG001|Overall Study|Other reason: protocol non-compliance|0|||
144552891|NCT02006641|521220679|FG002|Overall Study|Other reason: protocol non-compliance|1|||
144552892|NCT02132195|521220680|FG000|Initial Assignment|Relapsed|14|||
144552893|NCT02132195|521220681|FG001|Initial Assignment|Relapsed|0|||
144552894|NCT02132195|521220682|FG002|Initial Assignment|Relapsed|0|||
144552895|NCT02132195|521220680|FG000|Rescue Therapy|Relapsed|0|||
144552896|NCT02132195|521220681|FG001|Rescue Therapy|Relapsed|0|||
144552897|NCT02132195|521220682|FG002|Rescue Therapy|Relapsed|7|||
144552898|NCT02132195|521220680|FG000|Rescue Therapy|Physician Decision|0|||
144552899|NCT02132195|521220681|FG001|Rescue Therapy|Physician Decision|0|||
144552900|NCT02132195|521220682|FG002|Rescue Therapy|Physician Decision|1|||
144552901|NCT02132195|521220680|FG000|Rescue Therapy|Withdrawal by Subject|0|||
144552902|NCT02132195|521220681|FG001|Rescue Therapy|Withdrawal by Subject|0|||
144552903|NCT02132195|521220682|FG002|Rescue Therapy|Withdrawal by Subject|1|||
144552904|NCT02132195|521220680|FG000|Rescue Therapy|Adverse Event|0|||
144552905|NCT02132195|521220681|FG001|Rescue Therapy|Adverse Event|0|||
144552906|NCT02132195|521220682|FG002|Rescue Therapy|Adverse Event|2|||
144552907|NCT04749797|521220683|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
144552908|NCT04749797|521220684|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
144552909|NCT04749797|521220685|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
144552910|NCT05379400|521222084|FG000|Overall Study|Lost to Follow-up|1|||
144552911|NCT05379400|521222085|FG001|Overall Study|Lost to Follow-up|1|||
144552912|NCT01279447|521222091|FG000|Overall Study|Lost to Follow-up|3|||
144552913|NCT01279447|521222092|FG001|Overall Study|Lost to Follow-up|1|||
144552914|NCT00538629|521222098|FG000|Overall Study|At subject's request|1|||
144552915|NCT00538629|521222098|FG000|Overall Study|Adverse Event|2|||
144552916|NCT00538629|521222098|FG000|Overall Study|Lack of Efficacy|12|||
144552917|NCT00538629|521222098|FG000|Overall Study|Lost to Follow-up|6|||
144552918|NCT00538629|521222098|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
144552919|NCT00555620|521222099|FG000|Overall Study|Death|0|||
144552920|NCT00555620|521222100|FG001|Overall Study|Death|1|||
144552921|NCT00555620|521222101|FG002|Overall Study|Death|0|||
144552922|NCT00555620|521222102|FG003|Overall Study|Death|0|||
144552923|NCT00555620|521222103|FG004|Overall Study|Death|0|||
144552924|NCT00555620|521222104|FG005|Overall Study|Death|1|||
144552925|NCT00555620|521222099|FG000|Overall Study|Study terminated by sponsor|0|||
144552926|NCT00555620|521222100|FG001|Overall Study|Study terminated by sponsor|0|||
144552927|NCT00555620|521222101|FG002|Overall Study|Study terminated by sponsor|1|||
144552928|NCT00555620|521222102|FG003|Overall Study|Study terminated by sponsor|0|||
144552929|NCT00555620|521222103|FG004|Overall Study|Study terminated by sponsor|0|||
144552930|NCT00555620|521222104|FG005|Overall Study|Study terminated by sponsor|0|||
144552931|NCT00555620|521222099|FG000|Overall Study|Adverse Event|0|||
144552932|NCT00555620|521222100|FG001|Overall Study|Adverse Event|0|||
144552933|NCT00555620|521222101|FG002|Overall Study|Adverse Event|1|||
144552934|NCT00555620|521222102|FG003|Overall Study|Adverse Event|5|||
144552935|NCT00555620|521222103|FG004|Overall Study|Adverse Event|0|||
144552936|NCT00555620|521222104|FG005|Overall Study|Adverse Event|1|||
144552937|NCT00555620|521222099|FG000|Overall Study|Objective progression or relapse|6|||
144552938|NCT00555620|521222100|FG001|Overall Study|Objective progression or relapse|5|||
144552939|NCT00555620|521222101|FG002|Overall Study|Objective progression or relapse|12|||
144552940|NCT00555620|521222102|FG003|Overall Study|Objective progression or relapse|17|||
144552941|NCT00555620|521222103|FG004|Overall Study|Objective progression or relapse|3|||
144552942|NCT00555620|521222104|FG005|Overall Study|Objective progression or relapse|16|||
144552943|NCT00555620|521222099|FG000|Overall Study|Participant refused treatment|0|||
144616812|NCT01627860|521456432|FG001|Overall Study|Adverse Event|4|||
144552944|NCT00555620|521222100|FG001|Overall Study|Participant refused treatment|1|||
144616813|NCT01627860|521456431|FG000|Overall Study|Withdrawal by Subject|2|||
144616814|NCT01627860|521456432|FG001|Overall Study|Withdrawal by Subject|1|||
144552945|NCT00555620|521222101|FG002|Overall Study|Participant refused treatment|1|||
144552946|NCT00555620|521222102|FG003|Overall Study|Participant refused treatment|0|||
144552947|NCT00555620|521222103|FG004|Overall Study|Participant refused treatment|0|||
144552948|NCT00555620|521222104|FG005|Overall Study|Participant refused treatment|1|||
144552949|NCT00555620|521222099|FG000|Overall Study|Other|0|||
144552950|NCT00555620|521222100|FG001|Overall Study|Other|0|||
144552951|NCT00555620|521222101|FG002|Overall Study|Other|0|||
144552952|NCT00555620|521222102|FG003|Overall Study|Other|1|||
144616815|NCT01627860|521456431|FG000|Overall Study|Seizure frequency doubled|0|||
144552953|NCT00555620|521222103|FG004|Overall Study|Other|0|||
144552954|NCT00555620|521222104|FG005|Overall Study|Other|3|||
144552955|NCT00447499|521222108|FG000|Overall Study|Adverse Event|1|||
144552956|NCT00447499|521222108|FG000|Overall Study|Patient Decision|4|||
144552957|NCT00447499|521222108|FG000|Overall Study|Sponsor Decision|1|||
144552958|NCT00447499|521222108|FG000|Overall Study|Physician Decision|1|||
144552959|NCT01767376|521222109|FG000|Overall Study|Lost to Follow-up|3|||
144552960|NCT01767376|521222110|FG001|Overall Study|Lost to Follow-up|2|||
144552961|NCT01767376|521222111|FG002|Overall Study|Lost to Follow-up|0|||
144552962|NCT01767376|521222109|FG000|Overall Study|Withdrawal by Subject|1|||
144552963|NCT01767376|521222110|FG001|Overall Study|Withdrawal by Subject|1|||
144552964|NCT01767376|521222111|FG002|Overall Study|Withdrawal by Subject|0|||
144552965|NCT03184519|521222112|FG000|Overall Study|Lost to Follow-up|6|||
144552966|NCT03184519|521222112|FG000|Overall Study|Physician Decision|21|||
144552967|NCT00595959|521222113|FG000|Overall Study|Withdrawal by Subject|1|||
144552968|NCT00595959|521222113|FG000|Overall Study|Lost to Follow-up|1|||
144552969|NCT00753896|521222116|FG000|Overall Study|Adverse Event|4|||
144552970|NCT00753896|521222116|FG000|Overall Study|Death|1|||
144552971|NCT00753896|521222116|FG000|Overall Study|Lost to Follow-up|2|||
144552972|NCT00753896|521222116|FG000|Overall Study|Protocol Violation|1|||
144552973|NCT00753896|521222116|FG000|Overall Study|Withdrawal by Subject|4|||
144552974|NCT00753896|521222116|FG000|Overall Study|Entry Criteria Not Met|4|||
144552975|NCT01280656|521222117|FG000|Overall Study|Adverse Event|1|||
144552976|NCT01280656|521222118|FG001|Overall Study|Adverse Event|14|||
144552977|NCT01280656|521222119|FG002|Overall Study|Adverse Event|13|||
144552978|NCT01280656|521222117|FG000|Overall Study|Lack of Efficacy|1|||
144552979|NCT01280656|521222118|FG001|Overall Study|Lack of Efficacy|22|||
144552980|NCT01280656|521222119|FG002|Overall Study|Lack of Efficacy|38|||
144552981|NCT01280656|521222117|FG000|Overall Study|Treatment shortening (RGT)|0|||
144552982|NCT01280656|521222118|FG001|Overall Study|Treatment shortening (RGT)|4|||
144552983|NCT01280656|521222119|FG002|Overall Study|Treatment shortening (RGT)|5|||
144552984|NCT01280656|521222117|FG000|Overall Study|Other|1|||
144552985|NCT01280656|521222118|FG001|Overall Study|Other|7|||
144552986|NCT01280656|521222119|FG002|Overall Study|Other|7|||
144552987|NCT03529942|521222120|FG000|Overall Study|Withdrawal by Subject|13|||
144552988|NCT03529942|521222120|FG000|Overall Study|Physician Decision|1|||
144552989|NCT03529942|521222120|FG000|Overall Study|Lost to Follow-up|7|||
144203309|NCT00123474|519940331|FG003|As Treated at Study Closure|not reported when site closed|0|||
144203310|NCT00123474|519940328|FG000|As Treated at Study Closure|Adverse Event|10|||
144203311|NCT00123474|519940329|FG001|As Treated at Study Closure|Adverse Event|4|||
144203312|NCT00123474|519940330|FG002|As Treated at Study Closure|Adverse Event|10|||
144203313|NCT00123474|519940331|FG003|As Treated at Study Closure|Adverse Event|8|||
144203314|NCT00123474|519940328|FG000|As Treated at Study Closure|Disease Progression|35|||
144203315|NCT00123474|519940329|FG001|As Treated at Study Closure|Disease Progression|42|||
144203316|NCT00123474|519940330|FG002|As Treated at Study Closure|Disease Progression|29|||
144203317|NCT00123474|519940331|FG003|As Treated at Study Closure|Disease Progression|27|||
144203318|NCT00123474|519940328|FG000|As Treated at Study Closure|Investigator Request|12|||
144203319|NCT00123474|519940329|FG001|As Treated at Study Closure|Investigator Request|6|||
144203320|NCT00123474|519940330|FG002|As Treated at Study Closure|Investigator Request|7|||
144203321|NCT00123474|519940331|FG003|As Treated at Study Closure|Investigator Request|5|||
144203322|NCT00123474|519940328|FG000|As Treated at Study Closure|non-specified|54|||
144203323|NCT00123474|519940329|FG001|As Treated at Study Closure|non-specified|47|||
144203324|NCT00123474|519940330|FG002|As Treated at Study Closure|non-specified|57|||
144203325|NCT00123474|519940331|FG003|As Treated at Study Closure|non-specified|60|||
144203326|NCT00123474|519940328|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
144203327|NCT00123474|519940329|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
144203328|NCT00123474|519940330|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
144203329|NCT00123474|519940331|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
144203330|NCT00123474|519940328|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
144552990|NCT03529942|521222120|FG000|Overall Study|Needle inserted but no drug administered|1|||
144552991|NCT03529942|521222120|FG000|Overall Study|Personal reasons|1|||
144552992|NCT00409747|521222123|FG000|Overall Study|Withdrawal by Subject|1|||
144552993|NCT00636168|521222124|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
144552994|NCT00636168|521222125|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
144552995|NCT00636168|521222124|FG000|Randomized to Study Drug|Adverse Event|1|||
144616816|NCT01627860|521456432|FG001|Overall Study|Seizure frequency doubled|1|||
144616817|NCT01627860|521456431|FG000|Overall Study|Protocol Violation|1|||
144616818|NCT01627860|521456432|FG001|Overall Study|Protocol Violation|0|||
144203331|NCT00123474|519940329|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
144203332|NCT00123474|519940330|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
144203333|NCT00123474|519940331|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
144616819|NCT01326546|521456433|FG000|Overall Study|Lost to Follow-up|8|||
144203334|NCT01059344|519940332|FG000|Overall Study|Adverse Event|12|||
144552996|NCT00636168|521222125|FG001|Randomized to Study Drug|Adverse Event|0|||
144552997|NCT00636168|521222124|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
144552998|NCT00636168|521222125|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
144552999|NCT00636168|521222124|FG000|Treated With Study Drug|Recurrence of disease|135|||
144553000|NCT00636168|521222125|FG001|Treated With Study Drug|Recurrence of disease|282|||
144553001|NCT00636168|521222124|FG000|Treated With Study Drug|Adverse Event|250|||
144553002|NCT00636168|521222125|FG001|Treated With Study Drug|Adverse Event|22|||
144553003|NCT00636168|521222124|FG000|Treated With Study Drug|Participant withdrew consent|16|||
144553004|NCT00636168|521222125|FG001|Treated With Study Drug|Participant withdrew consent|21|||
144553005|NCT00636168|521222124|FG000|Treated With Study Drug|Poor/non-compliance|1|||
144553006|NCT00636168|521222125|FG001|Treated With Study Drug|Poor/non-compliance|3|||
144553007|NCT00636168|521222124|FG000|Treated With Study Drug|Death|3|||
144553008|NCT00636168|521222125|FG001|Treated With Study Drug|Death|0|||
144553009|NCT00636168|521222124|FG000|Treated With Study Drug|Pregnancy|1|||
144553010|NCT00636168|521222125|FG001|Treated With Study Drug|Pregnancy|0|||
144553011|NCT00636168|521222124|FG000|Treated With Study Drug|No longer meets study criteria|1|||
144553012|NCT00636168|521222125|FG001|Treated With Study Drug|No longer meets study criteria|0|||
144553013|NCT00636168|521222124|FG000|Treated With Study Drug|Other reason|1|||
144553014|NCT00636168|521222125|FG001|Treated With Study Drug|Other reason|3|||
144553015|NCT00636168|521222124|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
144553016|NCT00636168|521222125|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
144553017|NCT00636168|521222124|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
144553018|NCT00636168|521222125|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
144553019|NCT00636168|521222124|FG000|Long Term Follow-Up|Death|8|||
144553020|NCT00636168|521222125|FG001|Long Term Follow-Up|Death|9|||
144553021|NCT01287832|521222127|FG000|Overall Study|Adverse Event|1|||
144553022|NCT01287832|521222128|FG001|Overall Study|Adverse Event|0|||
144553023|NCT01287832|521222127|FG000|Overall Study|Death|0|||
144553024|NCT01287832|521222128|FG001|Overall Study|Death|1|||
144553025|NCT00632736|521222129|FG000|Overall Study|Adverse Event|104|||
144553026|NCT00632736|521222129|FG000|Overall Study|Lost to Follow-up|15|||
144553027|NCT00632736|521222129|FG000|Overall Study|Protocol Violation|14|||
144553028|NCT00632736|521222129|FG000|Overall Study|Withdrawal by Subject|99|||
144553029|NCT00632736|521222129|FG000|Overall Study|Lack of Efficacy|5|||
144553030|NCT00632736|521222129|FG000|Overall Study|Sponsor terminated study|5|||
144553031|NCT00632736|521222129|FG000|Overall Study|Non-compliance|10|||
144553032|NCT00632736|521222129|FG000|Overall Study|Other|16|||
144553033|NCT03015220|521222130|FG000|Overall Study|Withdrawal by Subject|3|||
144553034|NCT03015220|521222131|FG001|Overall Study|Withdrawal by Subject|2|||
144553035|NCT03015220|521222132|FG002|Overall Study|Withdrawal by Subject|2|||
144553036|NCT03015220|521222133|FG003|Overall Study|Withdrawal by Subject|2|||
144553037|NCT03015220|521222130|FG000|Overall Study|Lost to Follow-up|0|||
144553038|NCT03015220|521222131|FG001|Overall Study|Lost to Follow-up|0|||
144553039|NCT03015220|521222132|FG002|Overall Study|Lost to Follow-up|1|||
144553040|NCT03015220|521222133|FG003|Overall Study|Lost to Follow-up|0|||
144553041|NCT02291549|521222134|FG000|Overall Study|Lost to Follow-up|1|||
144553042|NCT02291549|521222135|FG001|Overall Study|Lost to Follow-up|0|||
144553043|NCT02291549|521222134|FG000|Overall Study|Withdrawal by Subject|0|||
144553044|NCT02291549|521222135|FG001|Overall Study|Withdrawal by Subject|1|||
144553045|NCT00537914|521222136|FG000|Overall Study|Death|1|||
144553046|NCT00537914|521222136|FG000|Overall Study|Adverse Event|7|||
144553047|NCT00537914|521222136|FG000|Overall Study|Treatment failure|10|||
144553048|NCT00537914|521222136|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
144553049|NCT00537914|521222136|FG000|Overall Study|Lost to Follow-up|19|||
144553050|NCT00537914|521222136|FG000|Overall Study|Withdrawal of informed consent|59|||
144553051|NCT02312258|521222137|FG000|Overall Study|Lost to Follow-up|8|||
144203335|NCT01059344|519940333|FG001|Overall Study|Adverse Event|30|||
144203336|NCT01059344|519940332|FG000|Overall Study|Withdrawal by Subject|6|||
144203337|NCT01059344|519940333|FG001|Overall Study|Withdrawal by Subject|9|||
144553052|NCT02312258|521222138|FG001|Overall Study|Lost to Follow-up|8|||
144553053|NCT02312258|521222137|FG000|Overall Study|Withdrawal by Patient|49|||
144203338|NCT01059344|519940332|FG000|Overall Study|Lost to Follow-up|1|||
144203339|NCT01059344|519940333|FG001|Overall Study|Lost to Follow-up|1|||
144203340|NCT01059344|519940332|FG000|Overall Study|Other|3|||
144203341|NCT01059344|519940333|FG001|Overall Study|Other|6|||
144203342|NCT00616629|519940334|FG000|Overall Study|Protocol Violation|1|||
144203343|NCT00616629|519940335|FG001|Overall Study|Protocol Violation|2|||
144203344|NCT00616629|519940336|FG002|Overall Study|Protocol Violation|1|||
144203345|NCT00616629|519940337|FG003|Overall Study|Protocol Violation|0|||
144203346|NCT00616629|519940338|FG004|Overall Study|Protocol Violation|0|||
144203347|NCT00616629|519940334|FG000|Overall Study|AV-block|1|||
144203348|NCT00616629|519940335|FG001|Overall Study|AV-block|0|||
144203349|NCT00616629|519940336|FG002|Overall Study|AV-block|0|||
144553054|NCT02312258|521222138|FG001|Overall Study|Withdrawal by Patient|76|||
144553055|NCT02312258|521222137|FG000|Overall Study|Reason not Specified|107|||
144553056|NCT02312258|521222138|FG001|Overall Study|Reason not Specified|159|||
144553057|NCT02312258|521222137|FG000|Overall Study|Missing|2|||
144553058|NCT02312258|521222138|FG001|Overall Study|Missing|1|||
144553059|NCT02312258|521222137|FG000|Overall Study|Death|115|||
144553060|NCT02312258|521222138|FG001|Overall Study|Death|181|||
144553061|NCT01468597|521222140|FG000|Overall Study|Found ineligible|17|||
144553062|NCT01468597|521222140|FG000|Overall Study|concomitant valves|12|||
144553063|NCT01468597|521222140|FG000|Overall Study|off-pump CABG|1|||
144616820|NCT01326546|521456434|FG001|Overall Study|Lost to Follow-up|7|||
144553064|NCT01468597|521222140|FG000|Overall Study|no platelet function data|5|||
144553065|NCT04447287|521222141|FG000|Period 1: Run-in Period|Adverse Event|3|||
144553066|NCT04447287|521222142|FG001|Period 1: Run-in Period|Adverse Event|0|||
144553067|NCT04447287|521222143|FG002|Period 1: Run-in Period|Adverse Event|0|||
144553068|NCT04447287|521222141|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
144553069|NCT04447287|521222142|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
144553070|NCT04447287|521222143|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
144553071|NCT04447287|521222141|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
144553072|NCT04447287|521222142|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
144553073|NCT04447287|521222143|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
144553074|NCT00912964|521222144|FG000|Overall Study|Eligibility criterion not met|1|||
144553075|NCT00912964|521222145|FG001|Overall Study|Eligibility criterion not met|1|||
144553076|NCT00912964|521222146|FG002|Overall Study|Eligibility criterion not met|0|||
144553077|NCT00912964|521222144|FG000|Overall Study|Adverse Event|15|||
144553078|NCT00912964|521222145|FG001|Overall Study|Adverse Event|18|||
144553079|NCT00912964|521222146|FG002|Overall Study|Adverse Event|12|||
144553080|NCT00912964|521222144|FG000|Overall Study|Lack of Efficacy|11|||
144553081|NCT00912964|521222145|FG001|Overall Study|Lack of Efficacy|4|||
144553082|NCT00912964|521222146|FG002|Overall Study|Lack of Efficacy|3|||
144553083|NCT00912964|521222144|FG000|Overall Study|Withdrawal by Subject|20|||
144553084|NCT00912964|521222145|FG001|Overall Study|Withdrawal by Subject|12|||
144553085|NCT00912964|521222146|FG002|Overall Study|Withdrawal by Subject|18|||
144553086|NCT00912964|521222144|FG000|Overall Study|Lost to Follow-up|4|||
144553087|NCT00912964|521222145|FG001|Overall Study|Lost to Follow-up|3|||
144553088|NCT00912964|521222146|FG002|Overall Study|Lost to Follow-up|3|||
144553089|NCT00912964|521222144|FG000|Overall Study|Protocol Violation|5|||
144553090|NCT00912964|521222145|FG001|Overall Study|Protocol Violation|3|||
144553091|NCT00912964|521222146|FG002|Overall Study|Protocol Violation|8|||
144553092|NCT00912964|521222144|FG000|Overall Study|Taking exclusionary medications|7|||
144553093|NCT00912964|521222145|FG001|Overall Study|Taking exclusionary medications|4|||
144553094|NCT00912964|521222146|FG002|Overall Study|Taking exclusionary medications|8|||
144553095|NCT00912964|521222144|FG000|Overall Study|Medical History|1|||
144553096|NCT00912964|521222145|FG001|Overall Study|Medical History|0|||
144553097|NCT00912964|521222146|FG002|Overall Study|Medical History|0|||
144553098|NCT00912964|521222144|FG000|Overall Study|Non-compliance with study procedures|2|||
144553099|NCT00912964|521222145|FG001|Overall Study|Non-compliance with study procedures|0|||
144553100|NCT00912964|521222146|FG002|Overall Study|Non-compliance with study procedures|0|||
144553101|NCT00912964|521222144|FG000|Overall Study|Violation of exclusion criterion|0|||
144203350|NCT00616629|519940337|FG003|Overall Study|AV-block|0|||
144203351|NCT00616629|519940338|FG004|Overall Study|AV-block|0|||
144203352|NCT01739348|519940339|FG000|Part I (Base Study)|Adverse Event|41|||
144203353|NCT01739348|519940340|FG001|Part I (Base Study)|Adverse Event|52|||
144203354|NCT01739348|519940341|FG002|Part I (Base Study)|Adverse Event|8|||
144203355|NCT01739348|519940342|FG003|Part I (Base Study)|Adverse Event|33|||
144203356|NCT01739348|519940339|FG000|Part I (Base Study)|Death|10|||
144203357|NCT01739348|519940340|FG001|Part I (Base Study)|Death|7|||
144203358|NCT01739348|519940341|FG002|Part I (Base Study)|Death|2|||
144203359|NCT01739348|519940342|FG003|Part I (Base Study)|Death|8|||
144203360|NCT01739348|519940339|FG000|Part I (Base Study)|Lack of Efficacy|3|||
144203361|NCT01739348|519940340|FG001|Part I (Base Study)|Lack of Efficacy|8|||
144203362|NCT01739348|519940341|FG002|Part I (Base Study)|Lack of Efficacy|0|||
144203363|NCT01739348|519940342|FG003|Part I (Base Study)|Lack of Efficacy|7|||
144203364|NCT01739348|519940339|FG000|Part I (Base Study)|Lost to Follow-up|4|||
144203365|NCT01739348|519940340|FG001|Part I (Base Study)|Lost to Follow-up|2|||
144203366|NCT01739348|519940341|FG002|Part I (Base Study)|Lost to Follow-up|4|||
144203367|NCT01739348|519940342|FG003|Part I (Base Study)|Lost to Follow-up|4|||
144203368|NCT01739348|519940339|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
144203369|NCT01739348|519940340|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
144203370|NCT01739348|519940341|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
144553102|NCT00912964|521222145|FG001|Overall Study|Violation of exclusion criterion|0|||
144553103|NCT00912964|521222146|FG002|Overall Study|Violation of exclusion criterion|2|||
144553104|NCT00912964|521222144|FG000|Overall Study|Randomized but never received study drug|0|||
144553105|NCT00912964|521222145|FG001|Overall Study|Randomized but never received study drug|1|||
144553106|NCT00912964|521222146|FG002|Overall Study|Randomized but never received study drug|0|||
144616821|NCT01326546|521456433|FG000|Overall Study|Protocol Violation|3|||
144203371|NCT01739348|519940342|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
144203372|NCT01739348|519940339|FG000|Part I (Base Study)|Physician Decision|10|||
144203373|NCT01739348|519940340|FG001|Part I (Base Study)|Physician Decision|7|||
144262394|NCT02358031|520161423|FG000|Overall Study|Withdrawal by Subject|19|||
144203374|NCT01739348|519940341|FG002|Part I (Base Study)|Physician Decision|1|||
144203375|NCT01739348|519940342|FG003|Part I (Base Study)|Physician Decision|4|||
144203376|NCT01739348|519940339|FG000|Part I (Base Study)|Protocol Violation|2|||
144553107|NCT00655824|521222147|FG000|Overall Study|Adverse Event|3|||
144553108|NCT00655824|521222147|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
144553109|NCT00655824|521222147|FG000|Overall Study|Protocol Violation|1|||
144553110|NCT00655824|521222147|FG000|Overall Study|Withdrawal by Subject|4|||
144553111|NCT00655824|521222147|FG000|Overall Study|Deterioration of Trial Disease|2|||
144553112|NCT00960206|521222148|FG000|Overall Study|Death|7|||
144553113|NCT00960206|521222149|FG001|Overall Study|Death|4|||
144553114|NCT00960206|521222150|FG002|Overall Study|Death|1|||
144553115|NCT00960206|521222148|FG000|Overall Study|Unwilling/Unable to return|1|||
144553116|NCT00960206|521222149|FG001|Overall Study|Unwilling/Unable to return|2|||
144553117|NCT00960206|521222150|FG002|Overall Study|Unwilling/Unable to return|0|||
144553118|NCT00960206|521222148|FG000|Overall Study|Lost to Follow-up|8|||
144553119|NCT00960206|521222149|FG001|Overall Study|Lost to Follow-up|14|||
144553120|NCT00960206|521222150|FG002|Overall Study|Lost to Follow-up|8|||
144553121|NCT00960206|521222148|FG000|Overall Study|Withdrawal by Subject|2|||
144553122|NCT00960206|521222149|FG001|Overall Study|Withdrawal by Subject|4|||
144553123|NCT00960206|521222150|FG002|Overall Study|Withdrawal by Subject|0|||
144553124|NCT00960206|521222148|FG000|Overall Study|Revision of study component|2|||
144553125|NCT00960206|521222149|FG001|Overall Study|Revision of study component|2|||
144553126|NCT00960206|521222150|FG002|Overall Study|Revision of study component|2|||
144553127|NCT00960206|521222148|FG000|Overall Study|Missing 10 year data|20|||
144553128|NCT00960206|521222149|FG001|Overall Study|Missing 10 year data|1|||
144553129|NCT00960206|521222150|FG002|Overall Study|Missing 10 year data|1|||
144553130|NCT03032198|521222157|FG000|Overall Study|Screen Fail|1|||
144553131|NCT02470806|521222158|FG000|Overall Study|Lost to Follow-up|1|||
144553132|NCT02470806|521222159|FG001|Overall Study|Lost to Follow-up|1|||
144553133|NCT02470806|521222158|FG000|Overall Study|Adverse Event|5|||
144553134|NCT02470806|521222159|FG001|Overall Study|Adverse Event|2|||
144553135|NCT02470806|521222158|FG000|Overall Study|Protocol Violation|4|||
144553136|NCT02470806|521222159|FG001|Overall Study|Protocol Violation|11|||
144553137|NCT02470806|521222158|FG000|Overall Study|Physician Decision|0|||
144553138|NCT02470806|521222159|FG001|Overall Study|Physician Decision|3|||
144553139|NCT02470806|521222158|FG000|Overall Study|Withdrawal by Subject|3|||
144553140|NCT02470806|521222159|FG001|Overall Study|Withdrawal by Subject|10|||
144553141|NCT02470806|521222158|FG000|Overall Study|Lack of Efficacy|5|||
144553142|NCT02470806|521222159|FG001|Overall Study|Lack of Efficacy|15|||
144553143|NCT02892019|521222161|FG000|Overall Study|randomized but not treated|0|||
144553144|NCT02892019|521222162|FG001|Overall Study|randomized but not treated|1|||
144553145|NCT02892019|521222161|FG000|Overall Study|Withdrawal by Subject|0|||
144553146|NCT02892019|521222162|FG001|Overall Study|Withdrawal by Subject|1|||
144553147|NCT02892019|521222161|FG000|Overall Study|Adverse Event|1|||
144553148|NCT02892019|521222162|FG001|Overall Study|Adverse Event|1|||
144553149|NCT01662505|521222163|FG000|Overall Study|Progressive disease|6|||
144553150|NCT01662505|521222164|FG001|Overall Study|Progressive disease|1|||
144553151|NCT01662505|521222165|FG002|Overall Study|Progressive disease|5|||
144553152|NCT01662505|521222163|FG000|Overall Study|Refused cont. medication|0|||
144553153|NCT01662505|521222164|FG001|Overall Study|Refused cont. medication|0|||
144553154|NCT01662505|521222165|FG002|Overall Study|Refused cont. medication|1|||
144553155|NCT01662505|521222163|FG000|Overall Study|Not specified above|1|||
144553156|NCT01662505|521222164|FG001|Overall Study|Not specified above|3|||
144553157|NCT01662505|521222165|FG002|Overall Study|Not specified above|2|||
144553158|NCT01661972|521222166|FG000|Overall Study|Adverse Event|1|||
144553159|NCT01661972|521222167|FG001|Overall Study|Adverse Event|2|||
144553160|NCT01661972|521222166|FG000|Overall Study|Death during Treatment period|1|||
144553161|NCT01661972|521222167|FG001|Overall Study|Death during Treatment period|1|||
144553162|NCT01661972|521222166|FG000|Overall Study|Withdrawal by Subject|0|||
144553163|NCT01661972|521222167|FG001|Overall Study|Withdrawal by Subject|1|||
144203377|NCT01739348|519940340|FG001|Part I (Base Study)|Protocol Violation|0|||
144203378|NCT01739348|519940341|FG002|Part I (Base Study)|Protocol Violation|1|||
144203379|NCT01739348|519940342|FG003|Part I (Base Study)|Protocol Violation|2|||
144203380|NCT01739348|519940339|FG000|Part I (Base Study)|Screen Failure|2|||
144203381|NCT01739348|519940340|FG001|Part I (Base Study)|Screen Failure|0|||
144203382|NCT01739348|519940341|FG002|Part I (Base Study)|Screen Failure|0|||
144203383|NCT01739348|519940342|FG003|Part I (Base Study)|Screen Failure|0|||
144553164|NCT01229176|521222168|FG000|Overall Study|Withdrawal by Subject|0|||
144553165|NCT01229176|521222169|FG001|Overall Study|Withdrawal by Subject|0|||
144616822|NCT01326546|521456434|FG001|Overall Study|Protocol Violation|4|||
144616823|NCT01326546|521456433|FG000|Overall Study|Pregnancy|0|||
144203384|NCT01739348|519940339|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
144553166|NCT01229176|521222170|FG002|Overall Study|Withdrawal by Subject|0|||
144553167|NCT01229176|521222171|FG003|Overall Study|Withdrawal by Subject|1|||
144553168|NCT01229176|521222172|FG004|Overall Study|Withdrawal by Subject|1|||
144203385|NCT01739348|519940340|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
144262395|NCT02358031|520161424|FG001|Overall Study|Withdrawal by Subject|14|||
144553169|NCT01229176|521222173|FG005|Overall Study|Withdrawal by Subject|1|||
144553170|NCT01229176|521222174|FG006|Overall Study|Withdrawal by Subject|0|||
144553171|NCT01229176|521222175|FG007|Overall Study|Withdrawal by Subject|1|||
144553172|NCT01229176|521222168|FG000|Overall Study|Lost to Follow-up|0|||
144553173|NCT01229176|521222169|FG001|Overall Study|Lost to Follow-up|3|||
144553174|NCT01229176|521222170|FG002|Overall Study|Lost to Follow-up|0|||
144553175|NCT01229176|521222171|FG003|Overall Study|Lost to Follow-up|0|||
144553176|NCT01229176|521222172|FG004|Overall Study|Lost to Follow-up|1|||
144553177|NCT01229176|521222173|FG005|Overall Study|Lost to Follow-up|1|||
144553178|NCT01229176|521222174|FG006|Overall Study|Lost to Follow-up|0|||
144553179|NCT01229176|521222175|FG007|Overall Study|Lost to Follow-up|2|||
144553180|NCT02138838|521222178|FG000|Overall Study|Study Closure|7|||
144553181|NCT02138838|521222179|FG001|Overall Study|Study Closure|6|||
144553182|NCT02138838|521222178|FG000|Overall Study|Withdrawal by Subject|1|||
144553183|NCT02138838|521222179|FG001|Overall Study|Withdrawal by Subject|5|||
144553184|NCT00882050|521222182|FG000|Overall Study|Physician Decision|1|||
144553185|NCT00882050|521222183|FG001|Overall Study|Physician Decision|0|||
144553186|NCT00882050|521222184|FG002|Overall Study|Physician Decision|0|||
144553187|NCT02010684|521222185|FG000|Overall Study|Lost to Follow-up|8|||
144553188|NCT02010684|521222186|FG001|Overall Study|Lost to Follow-up|18|||
144553189|NCT02010684|521222185|FG000|Overall Study|Withdrawal by Subject|4|||
144553190|NCT02010684|521222186|FG001|Overall Study|Withdrawal by Subject|5|||
144553191|NCT01884571|521222191|FG000|Overall Study|Adverse Event|1|||
144553192|NCT01884571|521222191|FG000|Overall Study|Death|2|||
144553193|NCT01884571|521222191|FG000|Overall Study|Withdrawal by Subject|2|||
144553194|NCT01884571|521222191|FG000|Overall Study|Disease progression|3|||
144553195|NCT02340806|521222192|FG000|Overall Study|Protocol Violation|2|||
144553196|NCT02340806|521222193|FG001|Overall Study|Protocol Violation|0|||
144553197|NCT02340806|521222192|FG000|Overall Study|epidural catheter replaced|2|||
144553198|NCT02340806|521222193|FG001|Overall Study|epidural catheter replaced|1|||
144553199|NCT02340806|521222192|FG000|Overall Study|history of chronic pain medication|1|||
144553200|NCT02340806|521222193|FG001|Overall Study|history of chronic pain medication|0|||
144553201|NCT02340806|521222192|FG000|Overall Study|re-dose < 90 min of CSE|1|||
144553202|NCT02340806|521222193|FG001|Overall Study|re-dose < 90 min of CSE|3|||
144553203|NCT01186809|521222194|FG000|Overall Study|Death|30|||
144727692|NCT01781637|521858025|FG000|Overall Study|Withdrawal by Subject|1|||
144727693|NCT01781637|521858026|FG001|Overall Study|Withdrawal by Subject|0|||
144727694|NCT00090857|521858027|FG000|Overall Study|Lost to Follow-up|0|||
144727695|NCT00090857|521858028|FG001|Overall Study|Lost to Follow-up|1|||
144262396|NCT02358031|520161425|FG002|Overall Study|Withdrawal by Subject|18|||
144262397|NCT02358031|520161423|FG000|Overall Study|Sponsor Decision|26|||
144553204|NCT04895085|521222195|FG000|Overall Study|Death|1|||
144553205|NCT04895085|521222195|FG000|Overall Study|Withdrawal by Subject|1|||
144553206|NCT04895085|521222195|FG000|Overall Study|No longer eligible: Moved from area|1|||
144553207|NCT04433091|521222197|FG000|Overall Study|Lost to Follow-up|1|||
144553208|NCT04433091|521222198|FG001|Overall Study|Lost to Follow-up|0|||
144553209|NCT04433091|521222197|FG000|Overall Study|Withdrawn .|2|||
144553210|NCT04433091|521222198|FG001|Overall Study|Withdrawn .|4|||
144553211|NCT00946998|521223936|FG000|Overall Study|Exited prior to first outcome assessment|5|||
144553212|NCT00946998|521223937|FG001|Overall Study|Exited prior to first outcome assessment|3|||
144553213|NCT05356130|521223941|FG000|Overall Study|Withdrawal by Subject|0|||
144553214|NCT05356130|521223942|FG001|Overall Study|Withdrawal by Subject|0|||
144553215|NCT05356130|521223943|FG002|Overall Study|Withdrawal by Subject|3|||
144553216|NCT02880293|521223944|FG000|Overall Study|Inevaluable|5|||
144553217|NCT02109172|521223945|FG000|Overall Study|Withdrawal by Subject|1|||
144553218|NCT02109172|521223946|FG001|Overall Study|Withdrawal by Subject|0|||
144553219|NCT02109172|521223947|FG002|Overall Study|Withdrawal by Subject|0|||
144553220|NCT02109172|521223948|FG003|Overall Study|Withdrawal by Subject|1|||
144553221|NCT02109172|521223949|FG004|Overall Study|Withdrawal by Subject|0|||
144553222|NCT02109172|521223950|FG005|Overall Study|Withdrawal by Subject|0|||
144553223|NCT02109172|521223945|FG000|Overall Study|Adverse Event|0|||
144553224|NCT02109172|521223946|FG001|Overall Study|Adverse Event|0|||
144262398|NCT02358031|520161424|FG001|Overall Study|Sponsor Decision|28|||
144553225|NCT02109172|521223947|FG002|Overall Study|Adverse Event|1|||
144553226|NCT02109172|521223948|FG003|Overall Study|Adverse Event|0|||
144553227|NCT02109172|521223949|FG004|Overall Study|Adverse Event|0|||
144553228|NCT02109172|521223950|FG005|Overall Study|Adverse Event|1|||
144553229|NCT02109172|521223945|FG000|Overall Study|Death|0|||
144553230|NCT02109172|521223946|FG001|Overall Study|Death|0|||
144553231|NCT02109172|521223947|FG002|Overall Study|Death|0|||
144553232|NCT02109172|521223948|FG003|Overall Study|Death|0|||
144553233|NCT02109172|521223949|FG004|Overall Study|Death|1|||
144553234|NCT02109172|521223950|FG005|Overall Study|Death|0|||
144553235|NCT03409276|521223951|FG000|Overall Study|Withdrawal by Subject|0|||
144553236|NCT03409276|521223952|FG001|Overall Study|Withdrawal by Subject|0|||
144553237|NCT03409276|521223953|FG002|Overall Study|Withdrawal by Subject|0|||
144553238|NCT03409276|521223954|FG003|Overall Study|Withdrawal by Subject|0|||
144262399|NCT02358031|520161425|FG002|Overall Study|Sponsor Decision|16|||
144553239|NCT03409276|521223955|FG004|Overall Study|Withdrawal by Subject|1|||
144553240|NCT03409276|521223951|FG000|Overall Study|Lost to Follow-up|0|||
144553241|NCT03409276|521223952|FG001|Overall Study|Lost to Follow-up|0|||
144553242|NCT03409276|521223953|FG002|Overall Study|Lost to Follow-up|0|||
144553243|NCT03409276|521223954|FG003|Overall Study|Lost to Follow-up|2|||
144553244|NCT03409276|521223955|FG004|Overall Study|Lost to Follow-up|2|||
144553245|NCT05203822|521223961|FG000|Overall Study|Adverse Event|1|||
144553246|NCT05203822|521223961|FG000|Overall Study|Withdrawal by Subject|1|||
144553247|NCT03320941|521223962|FG000|Overall Study|subject/guardian decision|0|||
144553248|NCT03320941|521223963|FG001|Overall Study|subject/guardian decision|0|||
144553249|NCT03320941|521223964|FG002|Overall Study|subject/guardian decision|0|||
144553250|NCT03320941|521223965|FG003|Overall Study|subject/guardian decision|1|||
144553251|NCT03320941|521223966|FG004|Overall Study|subject/guardian decision|0|||
144553252|NCT00946088|521223968|FG000|Overall Study|Withdrawal by Subject|0|||
144553253|NCT00946088|521223969|FG001|Overall Study|Withdrawal by Subject|1|||
144553254|NCT00584909|521223971|FG000|Overall Study|Adverse Event|4|||
144553255|NCT03345407|521223972|FG000|Overall Study|Withdrawal by Subject|11|||
144553256|NCT03345407|521223973|FG001|Overall Study|Withdrawal by Subject|1|||
144553257|NCT03345407|521223974|FG002|Overall Study|Withdrawal by Subject|5|||
144553258|NCT03345407|521223975|FG003|Overall Study|Withdrawal by Subject|6|||
144553259|NCT03345407|521223976|FG004|Overall Study|Withdrawal by Subject|3|||
144553260|NCT03345407|521223977|FG005|Overall Study|Withdrawal by Subject|6|||
144553261|NCT03345407|521223978|FG006|Overall Study|Withdrawal by Subject|16|||
144553262|NCT03345407|521223972|FG000|Overall Study|Physician Decision|3|||
144553263|NCT03345407|521223973|FG001|Overall Study|Physician Decision|1|||
144553264|NCT03345407|521223974|FG002|Overall Study|Physician Decision|0|||
144553265|NCT03345407|521223975|FG003|Overall Study|Physician Decision|0|||
144553266|NCT03345407|521223976|FG004|Overall Study|Physician Decision|1|||
144553267|NCT03345407|521223977|FG005|Overall Study|Physician Decision|2|||
144553268|NCT03345407|521223978|FG006|Overall Study|Physician Decision|3|||
144553269|NCT03345407|521223972|FG000|Overall Study|Lost to Follow-up|2|||
144553270|NCT03345407|521223973|FG001|Overall Study|Lost to Follow-up|0|||
144553271|NCT03345407|521223974|FG002|Overall Study|Lost to Follow-up|1|||
144553272|NCT03345407|521223975|FG003|Overall Study|Lost to Follow-up|0|||
144553273|NCT03345407|521223976|FG004|Overall Study|Lost to Follow-up|1|||
144553274|NCT03345407|521223977|FG005|Overall Study|Lost to Follow-up|2|||
144553275|NCT03345407|521223978|FG006|Overall Study|Lost to Follow-up|3|||
144553276|NCT03345407|521223972|FG000|Overall Study|Protocol-defined stopping criteria|9|||
144553277|NCT03345407|521223973|FG001|Overall Study|Protocol-defined stopping criteria|0|||
144553278|NCT03345407|521223974|FG002|Overall Study|Protocol-defined stopping criteria|0|||
144553279|NCT03345407|521223975|FG003|Overall Study|Protocol-defined stopping criteria|0|||
144553280|NCT03345407|521223976|FG004|Overall Study|Protocol-defined stopping criteria|2|||
144553281|NCT03345407|521223977|FG005|Overall Study|Protocol-defined stopping criteria|1|||
144553282|NCT03345407|521223978|FG006|Overall Study|Protocol-defined stopping criteria|1|||
144553283|NCT03345407|521223972|FG000|Overall Study|Protocol Violation|2|||
144553284|NCT03345407|521223973|FG001|Overall Study|Protocol Violation|0|||
144553285|NCT03345407|521223974|FG002|Overall Study|Protocol Violation|0|||
144553286|NCT03345407|521223975|FG003|Overall Study|Protocol Violation|0|||
144553287|NCT03345407|521223976|FG004|Overall Study|Protocol Violation|1|||
144553288|NCT03345407|521223977|FG005|Overall Study|Protocol Violation|0|||
144553289|NCT03345407|521223978|FG006|Overall Study|Protocol Violation|3|||
144553290|NCT03345407|521223972|FG000|Overall Study|Lack of Efficacy|1|||
144203386|NCT01739348|519940341|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
144203387|NCT01739348|519940342|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
144203388|NCT01739348|519940339|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
144203389|NCT01739348|519940340|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
144203390|NCT01739348|519940341|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
144203391|NCT01739348|519940342|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
144203392|NCT01739348|519940339|FG000|Part I (Base Study)|Participant Moved|4|||
144203393|NCT01739348|519940340|FG001|Part I (Base Study)|Participant Moved|3|||
144203394|NCT01739348|519940341|FG002|Part I (Base Study)|Participant Moved|1|||
144203395|NCT01739348|519940342|FG003|Part I (Base Study)|Participant Moved|7|||
144203396|NCT01739348|519940339|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
144203397|NCT01739348|519940340|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
144203398|NCT01739348|519940341|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
144203399|NCT01739348|519940342|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
144203400|NCT01739348|519940339|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
144203401|NCT01739348|519940340|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
144203402|NCT01739348|519940341|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
144553291|NCT03345407|521223973|FG001|Overall Study|Lack of Efficacy|1|||
144553292|NCT03345407|521223974|FG002|Overall Study|Lack of Efficacy|1|||
144553293|NCT03345407|521223975|FG003|Overall Study|Lack of Efficacy|1|||
144553294|NCT03345407|521223976|FG004|Overall Study|Lack of Efficacy|1|||
144553295|NCT03345407|521223977|FG005|Overall Study|Lack of Efficacy|0|||
144553296|NCT03345407|521223978|FG006|Overall Study|Lack of Efficacy|3|||
144553297|NCT03345407|521223972|FG000|Overall Study|Adverse Event|4|||
144553298|NCT03345407|521223973|FG001|Overall Study|Adverse Event|0|||
144553299|NCT03345407|521223974|FG002|Overall Study|Adverse Event|5|||
144553300|NCT03345407|521223975|FG003|Overall Study|Adverse Event|4|||
144553301|NCT03345407|521223976|FG004|Overall Study|Adverse Event|6|||
144553302|NCT03345407|521223977|FG005|Overall Study|Adverse Event|5|||
144553303|NCT03345407|521223978|FG006|Overall Study|Adverse Event|16|||
144553304|NCT02092909|521223981|FG000|Overall Study|Adverse Event|0|||
144553305|NCT02092909|521223982|FG001|Overall Study|Adverse Event|0|||
144553306|NCT02092909|521223983|FG002|Overall Study|Adverse Event|4|||
144553307|NCT02092909|521223984|FG003|Overall Study|Adverse Event|2|||
144553308|NCT02092909|521223981|FG000|Overall Study|Lack of Efficacy|0|||
144553309|NCT02092909|521223982|FG001|Overall Study|Lack of Efficacy|2|||
144553310|NCT02092909|521223983|FG002|Overall Study|Lack of Efficacy|1|||
144553311|NCT02092909|521223984|FG003|Overall Study|Lack of Efficacy|0|||
144553312|NCT02092909|521223981|FG000|Overall Study|Withdrawal by Subject|0|||
144553313|NCT02092909|521223982|FG001|Overall Study|Withdrawal by Subject|0|||
144553314|NCT02092909|521223983|FG002|Overall Study|Withdrawal by Subject|2|||
144553315|NCT02092909|521223984|FG003|Overall Study|Withdrawal by Subject|1|||
144553316|NCT02092909|521223981|FG000|Overall Study|Study terminated by Sponsor|0|||
144553317|NCT02092909|521223982|FG001|Overall Study|Study terminated by Sponsor|0|||
144553318|NCT02092909|521223983|FG002|Overall Study|Study terminated by Sponsor|0|||
144553319|NCT02092909|521223984|FG003|Overall Study|Study terminated by Sponsor|2|||
144553320|NCT02092909|521223981|FG000|Overall Study|Miscellaneous|1|||
144553321|NCT02092909|521223982|FG001|Overall Study|Miscellaneous|1|||
144553322|NCT02092909|521223983|FG002|Overall Study|Miscellaneous|2|||
144553323|NCT02092909|521223984|FG003|Overall Study|Miscellaneous|1|||
144553324|NCT02865083|521223989|FG000|Overall Study|Early Termination|3|||
144553325|NCT02865083|521223990|FG001|Overall Study|Early Termination|1|||
144553326|NCT02727998|521223991|FG000|Overall Study|Lost to Follow-up|3|||
144553327|NCT02727998|521223992|FG001|Overall Study|Lost to Follow-up|3|||
144553328|NCT02727998|521223991|FG000|Overall Study|Withdrawal by Subject|0|||
144553329|NCT02727998|521223992|FG001|Overall Study|Withdrawal by Subject|1|||
144553330|NCT02105688|521223993|FG000|Part A: Double-Blind|Adverse Event|1|||
144553331|NCT02105688|521223994|FG001|Part A: Double-Blind|Adverse Event|0|||
144553332|NCT02105688|521223993|FG000|Part A: Double-Blind|Death|0|||
144616824|NCT01326546|521456434|FG001|Overall Study|Pregnancy|1|||
144616825|NCT01326546|521456433|FG000|Overall Study|Adverse Event|1|||
144616826|NCT01326546|521456434|FG001|Overall Study|Adverse Event|0|||
144616827|NCT01326546|521456433|FG000|Overall Study|Withdrawal by Subject|5|||
144616828|NCT01326546|521456434|FG001|Overall Study|Withdrawal by Subject|1|||
144616829|NCT03152019|521456435|FG000|Overall Study|Adverse Event|0|||
144616830|NCT03152019|521456436|FG001|Overall Study|Adverse Event|1|||
144616831|NCT00923130|521456441|FG000|Overall Study|Stopped treatment due to progression|17|||
144616832|NCT00923130|521456441|FG000|Overall Study|Death|1|||
144616833|NCT00923130|521456441|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
144616834|NCT00923130|521456441|FG000|Overall Study|Switched to alternative treatment|2|||
144616835|NCT00923130|521456441|FG000|Overall Study|Refused further treatment|2|||
144616836|NCT00894556|521456442|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
144616837|NCT00894556|521456443|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
144616838|NCT00894556|521456444|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
144616839|NCT00894556|521456445|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
144616840|NCT00894556|521456442|FG000|Treatment Phase|Lost to Follow-up|2|||
144616841|NCT00894556|521456443|FG001|Treatment Phase|Lost to Follow-up|3|||
144616842|NCT00894556|521456444|FG002|Treatment Phase|Lost to Follow-up|1|||
144616843|NCT00894556|521456445|FG003|Treatment Phase|Lost to Follow-up|0|||
144616844|NCT00894556|521456442|FG000|Treatment Phase|Lack of Qualifying Event|2|||
144616845|NCT00894556|521456443|FG001|Treatment Phase|Lack of Qualifying Event|1|||
144616846|NCT00894556|521456444|FG002|Treatment Phase|Lack of Qualifying Event|0|||
144616847|NCT00894556|521456445|FG003|Treatment Phase|Lack of Qualifying Event|0|||
144616848|NCT01014689|521456448|FG000|Overall Study|Lack of Efficacy|0|||
144616849|NCT01014689|521456449|FG001|Overall Study|Lack of Efficacy|1|||
144616850|NCT01014689|521456448|FG000|Overall Study|Adverse Event|3|||
144203403|NCT01739348|519940342|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
144203404|NCT01739348|519940339|FG000|Part II (Extension Study)|Adverse Event|10|||
144616851|NCT01014689|521456449|FG001|Overall Study|Adverse Event|0|||
144616852|NCT01014689|521456448|FG000|Overall Study|Withdrawal by Subject|5|||
144616853|NCT01014689|521456449|FG001|Overall Study|Withdrawal by Subject|4|||
144616854|NCT01014689|521456448|FG000|Overall Study|Protocol Violation|1|||
144616855|NCT01014689|521456449|FG001|Overall Study|Protocol Violation|1|||
144616856|NCT01014689|521456448|FG000|Overall Study|Lost to Follow-up|3|||
144203405|NCT01739348|519940340|FG001|Part II (Extension Study)|Adverse Event|11|||
144616857|NCT01014689|521456449|FG001|Overall Study|Lost to Follow-up|7|||
144616858|NCT01014689|521456448|FG000|Overall Study|Pregnancy|1|||
144616859|NCT01014689|521456449|FG001|Overall Study|Pregnancy|0|||
144553333|NCT02105688|521223994|FG001|Part A: Double-Blind|Death|1|||
144553334|NCT02105688|521223993|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
144553335|NCT02105688|521223994|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
144553336|NCT02105688|521223993|FG000|Part A: Double-Blind|Physician Decision|0|||
144553337|NCT02105688|521223994|FG001|Part A: Double-Blind|Physician Decision|1|||
144553338|NCT02105688|521223993|FG000|Part A: Double-Blind|Status Unknown|0|||
144553339|NCT02105688|521223994|FG001|Part A: Double-Blind|Status Unknown|2|||
144203406|NCT01739348|519940341|FG002|Part II (Extension Study)|Adverse Event|7|||
144203407|NCT01739348|519940342|FG003|Part II (Extension Study)|Adverse Event|26|||
144553340|NCT02105688|521223993|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
144553341|NCT02105688|521223994|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
144553342|NCT02105688|521223993|FG000|Part B: Observational Follow-up|Death|2|||
144553343|NCT02105688|521223994|FG001|Part B: Observational Follow-up|Death|1|||
144553344|NCT02105688|521223993|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
144553345|NCT02105688|521223994|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
144553346|NCT02105688|521223993|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
144553347|NCT02105688|521223994|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
144553348|NCT02105688|521223993|FG000|Part B: Observational Follow-up|Physician Decision|3|||
144553349|NCT02105688|521223994|FG001|Part B: Observational Follow-up|Physician Decision|1|||
144553350|NCT01358175|521223995|FG000|Overall Study|Death|1|||
144553351|NCT01358175|521223996|FG001|Overall Study|Death|0|||
144553352|NCT01358175|521223997|FG002|Overall Study|Death|1|||
144553353|NCT01358175|521223995|FG000|Overall Study|Withdrawal by Subject|9|||
144553354|NCT01358175|521223996|FG001|Overall Study|Withdrawal by Subject|5|||
144553355|NCT01358175|521223997|FG002|Overall Study|Withdrawal by Subject|10|||
144553356|NCT01358175|521223995|FG000|Overall Study|Technical issues|0|||
144553357|NCT01358175|521223996|FG001|Overall Study|Technical issues|1|||
144553358|NCT01358175|521223997|FG002|Overall Study|Technical issues|0|||
144553359|NCT01358175|521223995|FG000|Overall Study|Pregnancy|0|||
144553360|NCT01358175|521223996|FG001|Overall Study|Pregnancy|1|||
144553361|NCT01358175|521223997|FG002|Overall Study|Pregnancy|0|||
144553362|NCT01358175|521223995|FG000|Overall Study|Physician Decision|1|||
144553363|NCT01358175|521223996|FG001|Overall Study|Physician Decision|0|||
144553364|NCT01358175|521223997|FG002|Overall Study|Physician Decision|0|||
144553365|NCT01358175|521223995|FG000|Overall Study|Non Compliance with Study Treatment|0|||
144553366|NCT01358175|521223996|FG001|Overall Study|Non Compliance with Study Treatment|1|||
144553367|NCT01358175|521223997|FG002|Overall Study|Non Compliance with Study Treatment|1|||
144553368|NCT01358175|521223995|FG000|Overall Study|Lost to Follow-up|1|||
144553369|NCT01358175|521223996|FG001|Overall Study|Lost to Follow-up|1|||
144553370|NCT01358175|521223997|FG002|Overall Study|Lost to Follow-up|3|||
144553371|NCT01358175|521223995|FG000|Overall Study|Lack of Efficacy|3|||
144553372|NCT01358175|521223996|FG001|Overall Study|Lack of Efficacy|8|||
144553373|NCT01358175|521223997|FG002|Overall Study|Lack of Efficacy|6|||
144553374|NCT01358175|521223995|FG000|Overall Study|Adverse Event|6|||
144553375|NCT01358175|521223996|FG001|Overall Study|Adverse Event|11|||
144553376|NCT01358175|521223997|FG002|Overall Study|Adverse Event|11|||
144553377|NCT03651271|521223998|FG000|Overall Study|Death|4|||
144553378|NCT03651271|521223999|FG001|Overall Study|Death|37|||
144553379|NCT03651271|521224000|FG002|Overall Study|Death|0|||
144553380|NCT03651271|521224001|FG003|Overall Study|Death|2|||
144553381|NCT03651271|521224002|FG004|Overall Study|Death|6|||
144553382|NCT03651271|521223998|FG000|Overall Study|Lost to Follow-up|1|||
144553383|NCT03651271|521223999|FG001|Overall Study|Lost to Follow-up|5|||
144553384|NCT03651271|521224000|FG002|Overall Study|Lost to Follow-up|0|||
144553385|NCT03651271|521224001|FG003|Overall Study|Lost to Follow-up|1|||
144553386|NCT03651271|521224002|FG004|Overall Study|Lost to Follow-up|0|||
144553387|NCT03651271|521223998|FG000|Overall Study|Physician Decision|0|||
144553388|NCT03651271|521223999|FG001|Overall Study|Physician Decision|2|||
144553389|NCT03651271|521224000|FG002|Overall Study|Physician Decision|0|||
144553390|NCT03651271|521224001|FG003|Overall Study|Physician Decision|0|||
144553391|NCT03651271|521224002|FG004|Overall Study|Physician Decision|0|||
144553392|NCT03651271|521223998|FG000|Overall Study|Withdrawal by Subject|1|||
144553393|NCT03651271|521223999|FG001|Overall Study|Withdrawal by Subject|15|||
144553394|NCT03651271|521224000|FG002|Overall Study|Withdrawal by Subject|0|||
144553395|NCT03651271|521224001|FG003|Overall Study|Withdrawal by Subject|0|||
144553396|NCT03651271|521224002|FG004|Overall Study|Withdrawal by Subject|1|||
144553397|NCT03651271|521223998|FG000|Overall Study|Patient medically unable to continue|0|||
144553398|NCT03651271|521223999|FG001|Overall Study|Patient medically unable to continue|0|||
144553399|NCT03651271|521224000|FG002|Overall Study|Patient medically unable to continue|0|||
144553400|NCT03651271|521224001|FG003|Overall Study|Patient medically unable to continue|1|||
144553401|NCT03651271|521224002|FG004|Overall Study|Patient medically unable to continue|0|||
144553402|NCT05072795|521224003|FG000|Overall Study|Lost to Follow-up|5|||
144553403|NCT00821093|521224007|FG000|Overall Study|Adverse Event|20|||
144553404|NCT00821093|521224008|FG001|Overall Study|Adverse Event|12|||
144553405|NCT00821093|521224007|FG000|Overall Study|Withdrawal by Subject|9|||
144553406|NCT00821093|521224008|FG001|Overall Study|Withdrawal by Subject|13|||
144553407|NCT00821093|521224007|FG000|Overall Study|Lost to Follow-up|9|||
144553408|NCT00821093|521224008|FG001|Overall Study|Lost to Follow-up|3|||
144553409|NCT00821093|521224007|FG000|Overall Study|Protocol deviation|3|||
144553410|NCT00821093|521224008|FG001|Overall Study|Protocol deviation|6|||
144203408|NCT01739348|519940339|FG000|Part II (Extension Study)|Death|3|||
144553411|NCT00821093|521224007|FG000|Overall Study|Abnormal laboratory value(s)|2|||
144553412|NCT00821093|521224008|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144553413|NCT00821093|521224007|FG000|Overall Study|Lack of Efficacy|2|||
144553414|NCT00821093|521224008|FG001|Overall Study|Lack of Efficacy|2|||
144553415|NCT00821093|521224007|FG000|Overall Study|Death|2|||
144553416|NCT00821093|521224008|FG001|Overall Study|Death|1|||
144553417|NCT00821093|521224007|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144553418|NCT00821093|521224008|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144553419|NCT00821093|521224007|FG000|Overall Study|Administrative problems|1|||
144553420|NCT00821093|521224008|FG001|Overall Study|Administrative problems|2|||
144553421|NCT01601821|521224009|FG000|Overall Study|Death|2|||
144553422|NCT01601821|521224010|FG001|Overall Study|Death|5|||
144553423|NCT01601821|521224009|FG000|Overall Study|Protocol Violation|2|||
144553424|NCT01601821|521224010|FG001|Overall Study|Protocol Violation|2|||
144553425|NCT01601821|521224009|FG000|Overall Study|Lost to Follow-up|6|||
144553426|NCT01601821|521224010|FG001|Overall Study|Lost to Follow-up|14|||
144553427|NCT01601821|521224009|FG000|Overall Study|Withdrawal by Subject|1|||
144553428|NCT01601821|521224010|FG001|Overall Study|Withdrawal by Subject|0|||
144553429|NCT01601821|521224009|FG000|Overall Study|Graft Loss|6|||
144553430|NCT01601821|521224010|FG001|Overall Study|Graft Loss|6|||
144553431|NCT01601821|521224009|FG000|Overall Study|Study Events|7|||
144553432|NCT01601821|521224010|FG001|Overall Study|Study Events|1|||
144553433|NCT01601821|521224009|FG000|Overall Study|Other|5|||
144553434|NCT01601821|521224010|FG001|Overall Study|Other|1|||
144553435|NCT01901302|521224014|FG000|Overall Study|Adverse Event|2|||
144553436|NCT01901302|521224015|FG001|Overall Study|Adverse Event|1|||
144553437|NCT01901302|521224014|FG000|Overall Study|Lack of Efficacy|0|||
144553438|NCT01901302|521224015|FG001|Overall Study|Lack of Efficacy|2|||
144553439|NCT01901302|521224014|FG000|Overall Study|Study Terminated by Sponsor|23|||
144553440|NCT01901302|521224015|FG001|Overall Study|Study Terminated by Sponsor|20|||
144553441|NCT01901302|521224014|FG000|Overall Study|Withdrawal by Subject|2|||
144553442|NCT01901302|521224015|FG001|Overall Study|Withdrawal by Subject|0|||
144553443|NCT01124916|521224016|FG000|Overall Study|Lost to Follow-up|3|||
144553444|NCT01124916|521224017|FG001|Overall Study|Lost to Follow-up|2|||
144553445|NCT05104242|521224024|FG000|Overall Study|Withdrawal by Subject|1|||
144553446|NCT05104242|521224025|FG001|Overall Study|Withdrawal by Subject|5|||
144553447|NCT05104242|521224024|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
144616860|NCT00333359|521456452|FG000|Overall Study|Adverse Event|29|||
144616861|NCT00333359|521456453|FG001|Overall Study|Adverse Event|35|||
144616862|NCT00333359|521456452|FG000|Overall Study|Withdrawal by Subject|19|||
144616863|NCT00333359|521456453|FG001|Overall Study|Withdrawal by Subject|37|||
144616864|NCT00333359|521456452|FG000|Overall Study|Physician Decision|2|||
144616865|NCT00333359|521456453|FG001|Overall Study|Physician Decision|2|||
144616866|NCT00333359|521456452|FG000|Overall Study|Protocol Non-compliance|2|||
144616867|NCT00333359|521456453|FG001|Overall Study|Protocol Non-compliance|8|||
144616868|NCT00333359|521456452|FG000|Overall Study|Lost to Follow-up|15|||
144616869|NCT00333359|521456453|FG001|Overall Study|Lost to Follow-up|25|||
144203409|NCT01739348|519940340|FG001|Part II (Extension Study)|Death|3|||
144203410|NCT01739348|519940341|FG002|Part II (Extension Study)|Death|2|||
144203411|NCT01739348|519940342|FG003|Part II (Extension Study)|Death|6|||
144553448|NCT05104242|521224025|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
144553449|NCT02469155|521224030|FG000|Overall Study|Adverse Event|6|||
144553450|NCT02469155|521224031|FG001|Overall Study|Adverse Event|0|||
144553451|NCT02469155|521224032|FG002|Overall Study|Adverse Event|1|||
144553452|NCT02469155|521224033|FG003|Overall Study|Adverse Event|10|||
144553453|NCT02469155|521224030|FG000|Overall Study|Lack of Efficacy|13|||
144553454|NCT02469155|521224031|FG001|Overall Study|Lack of Efficacy|10|||
144553455|NCT02469155|521224032|FG002|Overall Study|Lack of Efficacy|10|||
144553456|NCT02469155|521224033|FG003|Overall Study|Lack of Efficacy|8|||
144553457|NCT02469155|521224030|FG000|Overall Study|Death|0|||
144616870|NCT00333359|521456452|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
144616871|NCT00333359|521456453|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
144616872|NCT00333359|521456452|FG000|Overall Study|Treatment Failure|3|||
144616873|NCT00333359|521456453|FG001|Overall Study|Treatment Failure|8|||
144203412|NCT01739348|519940339|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
144553458|NCT02469155|521224031|FG001|Overall Study|Death|0|||
144553459|NCT02469155|521224032|FG002|Overall Study|Death|0|||
144553460|NCT02469155|521224033|FG003|Overall Study|Death|1|||
144553461|NCT02469155|521224030|FG000|Overall Study|Lost to Follow-up|5|||
144616874|NCT00333359|521456452|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
144616875|NCT00333359|521456453|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
144203413|NCT01739348|519940340|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
144553462|NCT02469155|521224031|FG001|Overall Study|Lost to Follow-up|2|||
144553463|NCT02469155|521224032|FG002|Overall Study|Lost to Follow-up|7|||
144553464|NCT02469155|521224033|FG003|Overall Study|Lost to Follow-up|2|||
144616876|NCT01534533|521456454|FG000|Overall Study|Lost to Follow-up|3|||
144616877|NCT01534533|521456455|FG001|Overall Study|Lost to Follow-up|0|||
144203414|NCT01739348|519940341|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
144553465|NCT02469155|521224030|FG000|Overall Study|Physician Decision|0|||
144553466|NCT02469155|521224031|FG001|Overall Study|Physician Decision|0|||
144616878|NCT01534533|521456456|FG002|Overall Study|Lost to Follow-up|4|||
144553467|NCT02469155|521224032|FG002|Overall Study|Physician Decision|1|||
144553468|NCT02469155|521224033|FG003|Overall Study|Physician Decision|0|||
144553469|NCT02469155|521224030|FG000|Overall Study|Withdrawal by Subject|34|||
144553470|NCT02469155|521224031|FG001|Overall Study|Withdrawal by Subject|30|||
144553471|NCT02469155|521224032|FG002|Overall Study|Withdrawal by Subject|20|||
144553472|NCT02469155|521224033|FG003|Overall Study|Withdrawal by Subject|37|||
144553473|NCT02469155|521224030|FG000|Overall Study|Other|3|||
144553474|NCT02469155|521224031|FG001|Overall Study|Other|3|||
144553475|NCT02469155|521224032|FG002|Overall Study|Other|2|||
144553476|NCT02469155|521224033|FG003|Overall Study|Other|10|||
144553477|NCT02469155|521224030|FG000|Overall Study|Protocol Violation|0|||
144553478|NCT02469155|521224031|FG001|Overall Study|Protocol Violation|1|||
144553479|NCT02469155|521224032|FG002|Overall Study|Protocol Violation|0|||
144553480|NCT02469155|521224033|FG003|Overall Study|Protocol Violation|1|||
144553481|NCT00901459|521224035|FG000|Overall Study|Withdrawal by Subject|6|||
144553482|NCT02764320|521224036|FG000|Overall Study|Withdrawal by Subject|35|||
144553483|NCT02764320|521224037|FG001|Overall Study|Withdrawal by Subject|38|||
144553484|NCT02764320|521224036|FG000|Overall Study|Protocol Violation|11|||
144553485|NCT02764320|521224037|FG001|Overall Study|Protocol Violation|6|||
144553486|NCT02764320|521224036|FG000|Overall Study|Adverse Event|2|||
144553487|NCT02764320|521224037|FG001|Overall Study|Adverse Event|0|||
144553488|NCT02764320|521224036|FG000|Overall Study|Health Issues unable to continue|2|||
144553489|NCT02764320|521224037|FG001|Overall Study|Health Issues unable to continue|0|||
144553490|NCT02764320|521224036|FG000|Overall Study|Did not meet inclusion criteria|1|||
144553491|NCT02764320|521224037|FG001|Overall Study|Did not meet inclusion criteria|0|||
144553492|NCT02764320|521224036|FG000|Overall Study|Subject moved|0|||
144553493|NCT02764320|521224037|FG001|Overall Study|Subject moved|2|||
144553494|NCT02764320|521224036|FG000|Overall Study|Overused medication unavailable|0|||
144553495|NCT02764320|521224037|FG001|Overall Study|Overused medication unavailable|1|||
144553496|NCT02764320|521224036|FG000|Overall Study|Seeking care outside site|0|||
144553497|NCT02764320|521224037|FG001|Overall Study|Seeking care outside site|1|||
144553498|NCT02764320|521224036|FG000|Overall Study|Technology barriers|0|||
144553499|NCT02764320|521224037|FG001|Overall Study|Technology barriers|1|||
144553500|NCT04765046|521224038|FG000|Overall Study|Screen Failure|2|||
144553501|NCT04765046|521224038|FG000|Overall Study|Withdrawal by Subject|4|||
144553502|NCT04765046|521224038|FG000|Overall Study|Physician Decision|4|||
144553503|NCT04765046|521224038|FG000|Overall Study|Surgery Cancelled|8|||
144553504|NCT04930263|521224046|FG000|Overall Study|Withdrawal by Subject|3|||
144553505|NCT04930263|521224047|FG001|Overall Study|Withdrawal by Subject|5|||
144553506|NCT02555397|521224048|FG000|Overall Study|Withdrawal by Subject|1|||
144553507|NCT02555397|521224049|FG001|Overall Study|Withdrawal by Subject|0|||
144553508|NCT02555397|521224050|FG002|Overall Study|Withdrawal by Subject|0|||
144553509|NCT02555397|521224051|FG003|Overall Study|Withdrawal by Subject|0|||
144553510|NCT02555397|521224052|FG004|Overall Study|Withdrawal by Subject|0|||
144553511|NCT01005914|521224053|FG000|Overall Study|Adverse Event|4|||
144553512|NCT01005914|521224053|FG000|Overall Study|Death|4|||
144553513|NCT01005914|521224053|FG000|Overall Study|Lack of Efficacy|1|||
144553514|NCT01005914|521224053|FG000|Overall Study|Withdrawal by Subject|1|||
144553515|NCT00237809|521224054|FG000|Overall Study|Lost to Follow-up|11|||
144553516|NCT00237809|521224055|FG001|Overall Study|Lost to Follow-up|10|||
144553517|NCT00237809|521224056|FG002|Overall Study|Lost to Follow-up|9|||
144553518|NCT00237809|521224057|FG003|Overall Study|Lost to Follow-up|9|||
144553519|NCT00736502|521224069|FG000|Overall Study|Adverse Event|22|||
144553520|NCT00736502|521224069|FG000|Overall Study|Lack of Efficacy|16|||
144553521|NCT00736502|521224069|FG000|Overall Study|Lost to Follow-up|27|||
144553522|NCT00866619|521224070|FG000|Overall Study|Adverse Event|112|||
144262400|NCT01212094|520161426|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
144262401|NCT01212094|520161427|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
144553523|NCT00866619|521224071|FG001|Overall Study|Adverse Event|106|||
144553524|NCT00866619|521224072|FG002|Overall Study|Adverse Event|47|||
144553525|NCT00866619|521224073|FG003|Overall Study|Adverse Event|44|||
144553526|NCT00866619|521224070|FG000|Overall Study|Protocol Violation|2|||
144553527|NCT00866619|521224071|FG001|Overall Study|Protocol Violation|39|||
144262402|NCT01212094|520161428|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
144553528|NCT00866619|521224072|FG002|Overall Study|Protocol Violation|2|||
144553529|NCT00866619|521224073|FG003|Overall Study|Protocol Violation|17|||
144262403|NCT01212094|520161426|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
144262404|NCT01212094|520161427|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
144553530|NCT00866619|521224070|FG000|Overall Study|Withdrawal by Subject|587|||
144262405|NCT01212094|520161428|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
144553531|NCT00866619|521224071|FG001|Overall Study|Withdrawal by Subject|295|||
144553532|NCT00866619|521224072|FG002|Overall Study|Withdrawal by Subject|272|||
144553533|NCT00866619|521224073|FG003|Overall Study|Withdrawal by Subject|144|||
144553534|NCT00866619|521224070|FG000|Overall Study|Lost to Follow-up|1145|||
144553535|NCT00866619|521224071|FG001|Overall Study|Lost to Follow-up|830|||
144553536|NCT00866619|521224072|FG002|Overall Study|Lost to Follow-up|568|||
144553537|NCT00866619|521224073|FG003|Overall Study|Lost to Follow-up|425|||
144553538|NCT01307800|521224074|FG000|Overall Study|Adverse Event|9|||
144262406|NCT01212094|520161426|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
144553539|NCT01307800|521224075|FG001|Overall Study|Adverse Event|8|||
144553540|NCT01307800|521224076|FG002|Overall Study|Adverse Event|10|||
144553541|NCT01307800|521224077|FG003|Overall Study|Adverse Event|14|||
144553542|NCT01307800|521224074|FG000|Overall Study|Entry Criteria Not Met|0|||
144553543|NCT01307800|521224075|FG001|Overall Study|Entry Criteria Not Met|0|||
144553544|NCT01307800|521224076|FG002|Overall Study|Entry Criteria Not Met|0|||
144553545|NCT01307800|521224077|FG003|Overall Study|Entry Criteria Not Met|2|||
144553546|NCT01307800|521224074|FG000|Overall Study|Lost to Follow-up|5|||
144553547|NCT01307800|521224075|FG001|Overall Study|Lost to Follow-up|6|||
144553548|NCT01307800|521224076|FG002|Overall Study|Lost to Follow-up|2|||
144553549|NCT01307800|521224077|FG003|Overall Study|Lost to Follow-up|8|||
144553550|NCT01307800|521224074|FG000|Overall Study|Perceived Lack of Efficacy|24|||
144553551|NCT01307800|521224075|FG001|Overall Study|Perceived Lack of Efficacy|23|||
144553552|NCT01307800|521224076|FG002|Overall Study|Perceived Lack of Efficacy|20|||
144553553|NCT01307800|521224077|FG003|Overall Study|Perceived Lack of Efficacy|33|||
144553554|NCT01307800|521224074|FG000|Overall Study|Protocol Violation|0|||
144553555|NCT01307800|521224075|FG001|Overall Study|Protocol Violation|3|||
144553556|NCT01307800|521224076|FG002|Overall Study|Protocol Violation|4|||
144553557|NCT01307800|521224077|FG003|Overall Study|Protocol Violation|5|||
144553558|NCT01307800|521224074|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
144553559|NCT01307800|521224075|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
144553560|NCT01307800|521224076|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
144553561|NCT01307800|521224077|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
144553562|NCT01307800|521224074|FG000|Overall Study|Sponsor Decision|6|||
144553563|NCT01307800|521224075|FG001|Overall Study|Sponsor Decision|9|||
144553564|NCT01307800|521224076|FG002|Overall Study|Sponsor Decision|12|||
144553565|NCT01307800|521224077|FG003|Overall Study|Sponsor Decision|28|||
144553566|NCT01307800|521224074|FG000|Overall Study|Withdrawal by Subject|10|||
144553567|NCT01307800|521224075|FG001|Overall Study|Withdrawal by Subject|11|||
144553568|NCT01307800|521224076|FG002|Overall Study|Withdrawal by Subject|8|||
144553569|NCT01307800|521224077|FG003|Overall Study|Withdrawal by Subject|15|||
144553570|NCT01307800|521224074|FG000|Overall Study|Participant Moved|0|||
144553571|NCT01307800|521224075|FG001|Overall Study|Participant Moved|2|||
144553572|NCT01307800|521224076|FG002|Overall Study|Participant Moved|1|||
144553573|NCT01307800|521224077|FG003|Overall Study|Participant Moved|3|||
144553574|NCT02255474|521224078|FG000|Overall Study|Lost to Follow-up|1|||
144553575|NCT02255474|521224079|FG001|Overall Study|Lost to Follow-up|1|||
144553576|NCT02255474|521224080|FG002|Overall Study|Lost to Follow-up|3|||
144553577|NCT02255474|521224078|FG000|Overall Study|Withdrawal by Subject|1|||
144553578|NCT02255474|521224079|FG001|Overall Study|Withdrawal by Subject|1|||
144553579|NCT02255474|521224080|FG002|Overall Study|Withdrawal by Subject|0|||
144553580|NCT02367794|521224086|FG000|Overall Study|Death|252|||
144553581|NCT02367794|521224087|FG001|Overall Study|Death|245|||
144553582|NCT02367794|521224088|FG002|Overall Study|Death|243|||
144553583|NCT02367794|521224086|FG000|Overall Study|Lost to Follow-up|1|||
144553584|NCT02367794|521224087|FG001|Overall Study|Lost to Follow-up|2|||
144553585|NCT02367794|521224088|FG002|Overall Study|Lost to Follow-up|2|||
144553586|NCT02367794|521224086|FG000|Overall Study|Physician Decision|0|||
144553587|NCT02367794|521224087|FG001|Overall Study|Physician Decision|5|||
144553588|NCT02367794|521224088|FG002|Overall Study|Physician Decision|3|||
144553589|NCT02367794|521224086|FG000|Overall Study|Protocol Violation|1|||
144553590|NCT02367794|521224087|FG001|Overall Study|Protocol Violation|0|||
144553591|NCT02367794|521224088|FG002|Overall Study|Protocol Violation|1|||
144553592|NCT02367794|521224086|FG000|Overall Study|Withdrawal by Subject|25|||
144553593|NCT02367794|521224087|FG001|Overall Study|Withdrawal by Subject|12|||
144553594|NCT02367794|521224088|FG002|Overall Study|Withdrawal by Subject|20|||
144553595|NCT02367794|521224086|FG000|Overall Study|Brain metastasis|1|||
144553596|NCT02367794|521224087|FG001|Overall Study|Brain metastasis|0|||
144553597|NCT02367794|521224088|FG002|Overall Study|Brain metastasis|0|||
144553598|NCT02367794|521224086|FG000|Overall Study|Randomized in error|0|||
144553599|NCT02367794|521224087|FG001|Overall Study|Randomized in error|0|||
144553600|NCT02367794|521224088|FG002|Overall Study|Randomized in error|1|||
144553601|NCT02367794|521224086|FG000|Overall Study|Patient unable to receive carboplatin|0|||
144553602|NCT02367794|521224087|FG001|Overall Study|Patient unable to receive carboplatin|0|||
144553603|NCT02367794|521224088|FG002|Overall Study|Patient unable to receive carboplatin|1|||
144553604|NCT02367794|521224086|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
144553605|NCT02367794|521224087|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
144553606|NCT02367794|521224088|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
144553607|NCT02367794|521224086|FG000|Overall Study|Adverse Event|0|||
144553608|NCT02367794|521224087|FG001|Overall Study|Adverse Event|0|||
144553609|NCT02367794|521224088|FG002|Overall Study|Adverse Event|2|||
144553610|NCT02367794|521224086|FG000|Overall Study|Study Terminated By Sponsor|0|||
144553611|NCT02367794|521224087|FG001|Overall Study|Study Terminated By Sponsor|1|||
144553612|NCT02367794|521224088|FG002|Overall Study|Study Terminated By Sponsor|1|||
144553613|NCT02367794|521224086|FG000|Overall Study|Moved to Roll-Over Study|0|||
144553614|NCT02367794|521224087|FG001|Overall Study|Moved to Roll-Over Study|15|||
144616879|NCT01534533|521456457|FG003|Overall Study|Lost to Follow-up|3|||
144553615|NCT02367794|521224088|FG002|Overall Study|Moved to Roll-Over Study|13|||
144553616|NCT02367794|521224086|FG000|Overall Study|Sponsor Request|60|||
144553617|NCT02367794|521224087|FG001|Overall Study|Sponsor Request|57|||
144553618|NCT02367794|521224088|FG002|Overall Study|Sponsor Request|45|||
144553619|NCT02367794|521224086|FG000|Overall Study|Moved into PTAP Study|0|||
144553620|NCT02367794|521224087|FG001|Overall Study|Moved into PTAP Study|2|||
144553621|NCT02367794|521224088|FG002|Overall Study|Moved into PTAP Study|3|||
144553622|NCT02367794|521224086|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
144553623|NCT02367794|521224087|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
144553624|NCT02367794|521224088|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
144553625|NCT02367794|521224086|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
144553626|NCT02367794|521224087|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
144553627|NCT02367794|521224088|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
144553628|NCT02367794|521224086|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
144553629|NCT02367794|521224087|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
144553630|NCT02367794|521224088|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
144553631|NCT02367794|521224086|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
144553632|NCT02367794|521224087|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
144553633|NCT02367794|521224088|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
144553634|NCT00091572|521224089|FG000|Overall Study|Lost to Follow-up|1|||
144553635|NCT00091572|521224090|FG001|Overall Study|Lost to Follow-up|1|||
144553636|NCT00091572|521224089|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
144553637|NCT00091572|521224090|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
144553638|NCT00091572|521224089|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
144553639|NCT00091572|521224090|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
144553640|NCT00091572|521224089|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
144553641|NCT00091572|521224090|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
144553642|NCT00091572|521224089|FG000|Overall Study|Other Reason|6|||
144553643|NCT00091572|521224090|FG001|Overall Study|Other Reason|13|||
144553644|NCT00091572|521224089|FG000|Overall Study|Ongoing (still on treatment)|8|||
144553645|NCT00091572|521224090|FG001|Overall Study|Ongoing (still on treatment)|12|||
144553646|NCT00091572|521224089|FG000|Overall Study|Major Protocol Violation|2|||
144553647|NCT00091572|521224090|FG001|Overall Study|Major Protocol Violation|0|||
144553648|NCT00091572|521224089|FG000|Overall Study|Toxicity (Related AE)|53|||
144553649|NCT00091572|521224090|FG001|Overall Study|Toxicity (Related AE)|9|||
144553650|NCT01199302|521224092|FG000|Overall Study|Adverse Event|1|||
144553651|NCT01199302|521224093|FG001|Overall Study|Adverse Event|1|||
144553652|NCT01199302|521224094|FG002|Overall Study|Adverse Event|2|||
144553653|NCT01199302|521224095|FG003|Overall Study|Adverse Event|0|||
144553654|NCT01199302|521224092|FG000|Overall Study|Withdrawal by Subject|2|||
144553655|NCT01199302|521224093|FG001|Overall Study|Withdrawal by Subject|2|||
144553656|NCT01199302|521224094|FG002|Overall Study|Withdrawal by Subject|3|||
144553657|NCT01199302|521224095|FG003|Overall Study|Withdrawal by Subject|0|||
144553658|NCT01199302|521224092|FG000|Overall Study|Disease Progression|3|||
144553659|NCT01199302|521224093|FG001|Overall Study|Disease Progression|4|||
144553660|NCT01199302|521224094|FG002|Overall Study|Disease Progression|4|||
144553661|NCT01199302|521224095|FG003|Overall Study|Disease Progression|2|||
144553662|NCT01199302|521224092|FG000|Overall Study|Study Termination|13|||
144553663|NCT01199302|521224093|FG001|Overall Study|Study Termination|8|||
144553664|NCT01199302|521224094|FG002|Overall Study|Study Termination|11|||
144553665|NCT01199302|521224095|FG003|Overall Study|Study Termination|9|||
144553666|NCT01199302|521224092|FG000|Overall Study|Lost to Follow-up|0|||
144553667|NCT01199302|521224093|FG001|Overall Study|Lost to Follow-up|1|||
144553668|NCT01199302|521224094|FG002|Overall Study|Lost to Follow-up|0|||
144553669|NCT01199302|521224095|FG003|Overall Study|Lost to Follow-up|0|||
144553670|NCT01199302|521224092|FG000|Overall Study|Other|1|||
144553671|NCT01199302|521224093|FG001|Overall Study|Other|0|||
144553672|NCT01199302|521224094|FG002|Overall Study|Other|0|||
144553673|NCT01199302|521224095|FG003|Overall Study|Other|0|||
144553674|NCT01159600|521224096|FG000|Overall Study|Not treated|0|||
144553675|NCT01159600|521224097|FG001|Overall Study|Not treated|0|||
144553676|NCT01159600|521224098|FG002|Overall Study|Not treated|1|||
144203415|NCT01739348|519940342|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
144203416|NCT01739348|519940339|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
144203417|NCT01739348|519940340|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
144203418|NCT01739348|519940341|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
144203419|NCT01739348|519940342|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
144553677|NCT01159600|521224099|FG003|Overall Study|Not treated|0|||
144553678|NCT01159600|521224100|FG004|Overall Study|Not treated|0|||
144203420|NCT01739348|519940339|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
144553679|NCT01159600|521224101|FG005|Overall Study|Not treated|1|||
144553680|NCT01159600|521224102|FG006|Overall Study|Not treated|2|||
144553681|NCT01159600|521224103|FG007|Overall Study|Not treated|2|||
144553682|NCT01159600|521224096|FG000|Overall Study|Adverse Event|7|||
144553683|NCT01159600|521224097|FG001|Overall Study|Adverse Event|2|||
144727696|NCT00090857|521858027|FG000|Overall Study|Withdrawal by Subject|2|||
144727697|NCT00090857|521858028|FG001|Overall Study|Withdrawal by Subject|0|||
144727698|NCT00090857|521858027|FG000|Overall Study|Adverse Event|2|||
144727699|NCT00090857|521858028|FG001|Overall Study|Adverse Event|2|||
144727700|NCT05097326|521858029|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
144727701|NCT05097326|521858030|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
144727702|NCT01244126|521858031|FG000|Overall Study|Protocol Violation|3|||
144727703|NCT01244126|521858032|FG001|Overall Study|Protocol Violation|3|||
144727704|NCT01244126|521858033|FG002|Overall Study|Protocol Violation|9|||
144727705|NCT01085045|521858041|FG000|Part A|Withdrawal by Subject|4|||
144727706|NCT01085045|521858041|FG000|Part A|Adverse Event|6|||
144727707|NCT01085045|521858041|FG000|Part A|Protocol Violation|1|||
144727708|NCT01085045|521858041|FG000|Part A|Protocol Specified Criteria|7|||
144727709|NCT01085045|521858041|FG000|Part B|Withdrawal by Subject|2|||
144727710|NCT01085045|521858041|FG000|Part B|Protocol Specified Criteria|6|||
144727711|NCT01085045|521858041|FG000|Part B|Lost to Follow-up|1|||
144727712|NCT01085045|521858041|FG000|Part B|Adverse Event|6|||
144727713|NCT01494506|521858046|FG000|Overall Study|Lack of Efficacy|77|||
144727714|NCT01494506|521858047|FG001|Overall Study|Lack of Efficacy|83|||
144727715|NCT01494506|521858048|FG002|Overall Study|Lack of Efficacy|57|||
144203421|NCT01739348|519940340|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
144203422|NCT01739348|519940341|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
144203423|NCT01739348|519940342|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
144727716|NCT01494506|521858046|FG000|Overall Study|Adverse Event|17|||
144727717|NCT01494506|521858047|FG001|Overall Study|Adverse Event|10|||
144727718|NCT01494506|521858048|FG002|Overall Study|Adverse Event|11|||
144727719|NCT01494506|521858046|FG000|Overall Study|Death|9|||
144727720|NCT01494506|521858047|FG001|Overall Study|Death|5|||
144727721|NCT01494506|521858048|FG002|Overall Study|Death|2|||
144727722|NCT01494506|521858046|FG000|Overall Study|Physician Decision|7|||
144727723|NCT01494506|521858047|FG001|Overall Study|Physician Decision|5|||
144203424|NCT01739348|519940339|FG000|Part II (Extension Study)|Physician Decision|7|||
144553684|NCT01159600|521224098|FG002|Overall Study|Adverse Event|5|||
144553685|NCT01159600|521224099|FG003|Overall Study|Adverse Event|1|||
144553686|NCT01159600|521224100|FG004|Overall Study|Adverse Event|8|||
144553687|NCT01159600|521224101|FG005|Overall Study|Adverse Event|6|||
144553688|NCT01159600|521224102|FG006|Overall Study|Adverse Event|7|||
144553689|NCT01159600|521224103|FG007|Overall Study|Adverse Event|5|||
144553690|NCT01159600|521224096|FG000|Overall Study|Lack of Efficacy|0|||
144553691|NCT01159600|521224097|FG001|Overall Study|Lack of Efficacy|0|||
144553692|NCT01159600|521224098|FG002|Overall Study|Lack of Efficacy|0|||
144553693|NCT01159600|521224099|FG003|Overall Study|Lack of Efficacy|0|||
144553694|NCT01159600|521224100|FG004|Overall Study|Lack of Efficacy|2|||
144553695|NCT01159600|521224101|FG005|Overall Study|Lack of Efficacy|0|||
144553696|NCT01159600|521224102|FG006|Overall Study|Lack of Efficacy|0|||
144553697|NCT01159600|521224103|FG007|Overall Study|Lack of Efficacy|1|||
144553698|NCT01159600|521224096|FG000|Overall Study|Non compliant with protocol|2|||
144553699|NCT01159600|521224097|FG001|Overall Study|Non compliant with protocol|1|||
144553700|NCT01159600|521224098|FG002|Overall Study|Non compliant with protocol|0|||
144553701|NCT01159600|521224099|FG003|Overall Study|Non compliant with protocol|0|||
144553702|NCT01159600|521224100|FG004|Overall Study|Non compliant with protocol|2|||
144553703|NCT01159600|521224101|FG005|Overall Study|Non compliant with protocol|0|||
144553704|NCT01159600|521224102|FG006|Overall Study|Non compliant with protocol|2|||
144553705|NCT01159600|521224103|FG007|Overall Study|Non compliant with protocol|0|||
144553706|NCT01159600|521224096|FG000|Overall Study|Lost to Follow-up|2|||
144203425|NCT01739348|519940340|FG001|Part II (Extension Study)|Physician Decision|11|||
144553707|NCT01159600|521224097|FG001|Overall Study|Lost to Follow-up|3|||
144553708|NCT01159600|521224098|FG002|Overall Study|Lost to Follow-up|4|||
144727724|NCT01494506|521858048|FG002|Overall Study|Physician Decision|4|||
144727725|NCT01494506|521858046|FG000|Overall Study|Withdrawal by Subject|17|||
144727726|NCT01494506|521858047|FG001|Overall Study|Withdrawal by Subject|20|||
144727727|NCT01494506|521858048|FG002|Overall Study|Withdrawal by Subject|14|||
144203426|NCT01739348|519940341|FG002|Part II (Extension Study)|Physician Decision|6|||
144727728|NCT01494506|521858046|FG000|Overall Study|Clinical Deterioration|21|||
144727729|NCT01494506|521858047|FG001|Overall Study|Clinical Deterioration|17|||
144203427|NCT01739348|519940342|FG003|Part II (Extension Study)|Physician Decision|12|||
144553709|NCT01159600|521224099|FG003|Overall Study|Lost to Follow-up|3|||
144727730|NCT01494506|521858048|FG002|Overall Study|Clinical Deterioration|13|||
144727731|NCT01494506|521858046|FG000|Overall Study|Sponsor Decision|0|||
144727732|NCT01494506|521858047|FG001|Overall Study|Sponsor Decision|0|||
144727733|NCT01494506|521858048|FG002|Overall Study|Sponsor Decision|1|||
144727734|NCT01494506|521858046|FG000|Overall Study|Other|0|||
144553710|NCT01159600|521224100|FG004|Overall Study|Lost to Follow-up|3|||
144553711|NCT01159600|521224101|FG005|Overall Study|Lost to Follow-up|0|||
144553712|NCT01159600|521224102|FG006|Overall Study|Lost to Follow-up|3|||
144553713|NCT01159600|521224103|FG007|Overall Study|Lost to Follow-up|2|||
144553714|NCT01159600|521224096|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
144727735|NCT01494506|521858047|FG001|Overall Study|Other|3|||
144203428|NCT01739348|519940339|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
144203429|NCT01739348|519940340|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
144203430|NCT01739348|519940341|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
144553715|NCT01159600|521224097|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
144553716|NCT01159600|521224098|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
144553717|NCT01159600|521224099|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
144553718|NCT01159600|521224100|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
144553719|NCT01159600|521224101|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
144553720|NCT01159600|521224102|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
144553721|NCT01159600|521224103|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
144553722|NCT01159600|521224096|FG000|Overall Study|Other reason not defined above|3|||
144553723|NCT01159600|521224097|FG001|Overall Study|Other reason not defined above|0|||
144553724|NCT01159600|521224098|FG002|Overall Study|Other reason not defined above|4|||
144553725|NCT01159600|521224099|FG003|Overall Study|Other reason not defined above|2|||
144553726|NCT01159600|521224100|FG004|Overall Study|Other reason not defined above|5|||
144553727|NCT01159600|521224101|FG005|Overall Study|Other reason not defined above|7|||
144553728|NCT01159600|521224102|FG006|Overall Study|Other reason not defined above|3|||
144553729|NCT01159600|521224103|FG007|Overall Study|Other reason not defined above|3|||
144553730|NCT01730118|521225124|FG000|Dose Escalation|Death on study|5|||
144553731|NCT01730118|521225125|FG001|Dose Escalation|Death on study|7|||
144553732|NCT01730118|521225126|FG002|Dose Escalation|Death on study|2|||
144553733|NCT01730118|521225127|FG003|Dose Escalation|Death on study|6|||
144553734|NCT01730118|521225128|FG004|Dose Escalation|Death on study|0|||
144553735|NCT01730118|521225129|FG005|Dose Escalation|Death on study|0|||
144553736|NCT01730118|521225130|FG006|Dose Escalation|Death on study|0|||
144553737|NCT01730118|521225124|FG000|Dose Escalation|Died before treatment|0|||
144553738|NCT01730118|521225125|FG001|Dose Escalation|Died before treatment|0|||
144553739|NCT01730118|521225126|FG002|Dose Escalation|Died before treatment|0|||
144553740|NCT01730118|521225127|FG003|Dose Escalation|Died before treatment|0|||
144553741|NCT01730118|521225128|FG004|Dose Escalation|Died before treatment|0|||
144553742|NCT01730118|521225129|FG005|Dose Escalation|Died before treatment|0|||
144553743|NCT01730118|521225130|FG006|Dose Escalation|Died before treatment|1|||
144553744|NCT01730118|521225124|FG000|Dose Escalation|Chose to start a different treatment|1|||
144553745|NCT01730118|521225125|FG001|Dose Escalation|Chose to start a different treatment|0|||
144553746|NCT01730118|521225126|FG002|Dose Escalation|Chose to start a different treatment|0|||
144553747|NCT01730118|521225127|FG003|Dose Escalation|Chose to start a different treatment|0|||
144553748|NCT01730118|521225128|FG004|Dose Escalation|Chose to start a different treatment|0|||
144553749|NCT01730118|521225129|FG005|Dose Escalation|Chose to start a different treatment|0|||
144553750|NCT01730118|521225130|FG006|Dose Escalation|Chose to start a different treatment|0|||
144553751|NCT01730118|521225124|FG000|Dose Escalation|Withdrawal by Subject|0|||
144553752|NCT01730118|521225125|FG001|Dose Escalation|Withdrawal by Subject|0|||
144553753|NCT01730118|521225126|FG002|Dose Escalation|Withdrawal by Subject|1|||
144553754|NCT01730118|521225127|FG003|Dose Escalation|Withdrawal by Subject|0|||
144553755|NCT01730118|521225128|FG004|Dose Escalation|Withdrawal by Subject|0|||
144553756|NCT01730118|521225129|FG005|Dose Escalation|Withdrawal by Subject|0|||
144553757|NCT01730118|521225130|FG006|Dose Escalation|Withdrawal by Subject|0|||
144553758|NCT01730118|521225124|FG000|Dose Escalation|Disease progression prior to treatment|0|||
144553759|NCT01730118|521225125|FG001|Dose Escalation|Disease progression prior to treatment|0|||
144553760|NCT01730118|521225126|FG002|Dose Escalation|Disease progression prior to treatment|0|||
144553761|NCT01730118|521225127|FG003|Dose Escalation|Disease progression prior to treatment|0|||
144553762|NCT01730118|521225128|FG004|Dose Escalation|Disease progression prior to treatment|0|||
144553763|NCT01730118|521225129|FG005|Dose Escalation|Disease progression prior to treatment|0|||
144553764|NCT01730118|521225130|FG006|Dose Escalation|Disease progression prior to treatment|1|||
144553765|NCT01730118|521225124|FG000|Dose Expansion|Death|0|||
144553766|NCT01730118|521225125|FG001|Dose Expansion|Death|0|||
144553767|NCT01730118|521225126|FG002|Dose Expansion|Death|0|||
144553768|NCT01730118|521225127|FG003|Dose Expansion|Death|0|||
144553769|NCT01730118|521225128|FG004|Dose Expansion|Death|1|||
144553770|NCT01730118|521225129|FG005|Dose Expansion|Death|0|||
144553771|NCT01730118|521225130|FG006|Dose Expansion|Death|0|||
144553772|NCT01730118|521225124|FG000|Dose Expansion|Other medical condition|0|||
144553773|NCT01730118|521225125|FG001|Dose Expansion|Other medical condition|0|||
144616880|NCT01534533|521456454|FG000|Overall Study|Withdrawal by Subject|5|||
144616881|NCT01534533|521456455|FG001|Overall Study|Withdrawal by Subject|3|||
144203431|NCT01739348|519940342|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
144553774|NCT01730118|521225126|FG002|Dose Expansion|Other medical condition|0|||
144553775|NCT01730118|521225127|FG003|Dose Expansion|Other medical condition|0|||
144553776|NCT01730118|521225128|FG004|Dose Expansion|Other medical condition|1|||
144553777|NCT01730118|521225129|FG005|Dose Expansion|Other medical condition|0|||
144553778|NCT01730118|521225130|FG006|Dose Expansion|Other medical condition|0|||
144553779|NCT01730118|521225124|FG000|Dose Expansion|Withdrawal by Subject|0|||
144553780|NCT01730118|521225125|FG001|Dose Expansion|Withdrawal by Subject|0|||
144553781|NCT01730118|521225126|FG002|Dose Expansion|Withdrawal by Subject|0|||
144553782|NCT01730118|521225127|FG003|Dose Expansion|Withdrawal by Subject|0|||
144553783|NCT01730118|521225128|FG004|Dose Expansion|Withdrawal by Subject|1|||
144553784|NCT01730118|521225129|FG005|Dose Expansion|Withdrawal by Subject|0|||
144553785|NCT01730118|521225130|FG006|Dose Expansion|Withdrawal by Subject|0|||
144553786|NCT01730118|521225124|FG000|Dose Expansion|Disease progression|0|||
144553787|NCT01730118|521225125|FG001|Dose Expansion|Disease progression|0|||
144553788|NCT01730118|521225126|FG002|Dose Expansion|Disease progression|0|||
144553789|NCT01730118|521225127|FG003|Dose Expansion|Disease progression|0|||
144553790|NCT01730118|521225128|FG004|Dose Expansion|Disease progression|0|||
144262407|NCT01212094|520161427|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
144262408|NCT01212094|520161428|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
144262409|NCT01212094|520161426|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
144262410|NCT01212094|520161427|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
144262411|NCT01212094|520161428|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
144262412|NCT01212094|520161426|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
144262413|NCT01212094|520161427|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
144262414|NCT01212094|520161428|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
144262415|NCT01212094|520161426|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
144262416|NCT01212094|520161427|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
144262417|NCT01212094|520161428|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
144553791|NCT01730118|521225129|FG005|Dose Expansion|Disease progression|1|||
144553792|NCT01730118|521225130|FG006|Dose Expansion|Disease progression|0|||
144553793|NCT01730118|521225124|FG000|Dose Expansion|Inability to return|0|||
144553794|NCT01730118|521225125|FG001|Dose Expansion|Inability to return|0|||
144553795|NCT01730118|521225126|FG002|Dose Expansion|Inability to return|0|||
144553796|NCT01730118|521225127|FG003|Dose Expansion|Inability to return|0|||
144553797|NCT01730118|521225128|FG004|Dose Expansion|Inability to return|0|||
144553798|NCT01730118|521225129|FG005|Dose Expansion|Inability to return|1|||
144553799|NCT01730118|521225130|FG006|Dose Expansion|Inability to return|0|||
144553800|NCT01730118|521225124|FG000|Dose Expansion|Physician Decision|0|||
144553801|NCT01730118|521225125|FG001|Dose Expansion|Physician Decision|0|||
144553802|NCT01730118|521225126|FG002|Dose Expansion|Physician Decision|0|||
144553803|NCT01730118|521225127|FG003|Dose Expansion|Physician Decision|0|||
144553804|NCT01730118|521225128|FG004|Dose Expansion|Physician Decision|0|||
144553805|NCT01730118|521225129|FG005|Dose Expansion|Physician Decision|1|||
144553806|NCT01730118|521225130|FG006|Dose Expansion|Physician Decision|0|||
144553807|NCT03360071|521225141|FG000|Overall Study|Lost to Follow-up|1|||
144553808|NCT03360071|521225142|FG001|Overall Study|Lost to Follow-up|0|||
144553809|NCT01193283|521225143|FG000|Overall Study|Death|1|||
144553810|NCT01183013|521225145|FG000|Overall Study|Adverse Event|6|||
144553811|NCT01183013|521225146|FG001|Overall Study|Adverse Event|8|||
144553812|NCT01183013|521225147|FG002|Overall Study|Adverse Event|5|||
144553813|NCT01183013|521225148|FG003|Overall Study|Adverse Event|5|||
144553814|NCT01183013|521225149|FG004|Overall Study|Adverse Event|10|||
144553815|NCT01183013|521225150|FG005|Overall Study|Adverse Event|10|||
144553816|NCT01183013|521225151|FG006|Overall Study|Adverse Event|6|||
144553817|NCT01183013|521225145|FG000|Overall Study|Lack of Efficacy|3|||
144553818|NCT01183013|521225146|FG001|Overall Study|Lack of Efficacy|2|||
144553819|NCT01183013|521225147|FG002|Overall Study|Lack of Efficacy|1|||
144553820|NCT01183013|521225148|FG003|Overall Study|Lack of Efficacy|2|||
144553821|NCT01183013|521225149|FG004|Overall Study|Lack of Efficacy|1|||
144553822|NCT01183013|521225150|FG005|Overall Study|Lack of Efficacy|2|||
144553823|NCT01183013|521225151|FG006|Overall Study|Lack of Efficacy|0|||
144553824|NCT01183013|521225145|FG000|Overall Study|Protocol Violation|5|||
144553825|NCT01183013|521225146|FG001|Overall Study|Protocol Violation|2|||
144553826|NCT01183013|521225147|FG002|Overall Study|Protocol Violation|4|||
144553827|NCT01183013|521225148|FG003|Overall Study|Protocol Violation|0|||
144553828|NCT01183013|521225149|FG004|Overall Study|Protocol Violation|4|||
144553829|NCT01183013|521225150|FG005|Overall Study|Protocol Violation|3|||
144262418|NCT05664581|520161430|FG000|Overall Study|Withdrawal by Subject|2|||
144262419|NCT03101150|520161431|FG000|Overall Study|Lost to Follow-up|2|||
144262420|NCT03101150|520161432|FG001|Overall Study|Lost to Follow-up|4|||
144262421|NCT03101150|520161431|FG000|Overall Study|Miscarriage|3|||
144553830|NCT01183013|521225151|FG006|Overall Study|Protocol Violation|3|||
144553831|NCT01183013|521225145|FG000|Overall Study|Lost to Follow-up|7|||
144553832|NCT01183013|521225146|FG001|Overall Study|Lost to Follow-up|3|||
144553833|NCT01183013|521225147|FG002|Overall Study|Lost to Follow-up|4|||
144553834|NCT01183013|521225148|FG003|Overall Study|Lost to Follow-up|3|||
144553835|NCT01183013|521225149|FG004|Overall Study|Lost to Follow-up|2|||
144553836|NCT01183013|521225150|FG005|Overall Study|Lost to Follow-up|6|||
144553837|NCT01183013|521225151|FG006|Overall Study|Lost to Follow-up|5|||
144553838|NCT01183013|521225145|FG000|Overall Study|Withdrawal by Subject|9|||
144553839|NCT01183013|521225146|FG001|Overall Study|Withdrawal by Subject|13|||
144553840|NCT01183013|521225147|FG002|Overall Study|Withdrawal by Subject|10|||
144553841|NCT01183013|521225148|FG003|Overall Study|Withdrawal by Subject|8|||
144553842|NCT01183013|521225149|FG004|Overall Study|Withdrawal by Subject|7|||
144553843|NCT01183013|521225150|FG005|Overall Study|Withdrawal by Subject|9|||
144553844|NCT01183013|521225151|FG006|Overall Study|Withdrawal by Subject|10|||
144553845|NCT01183013|521225145|FG000|Overall Study|Reasons other than stated above|15|||
144553846|NCT01183013|521225146|FG001|Overall Study|Reasons other than stated above|11|||
144553847|NCT01183013|521225147|FG002|Overall Study|Reasons other than stated above|17|||
144553848|NCT01183013|521225148|FG003|Overall Study|Reasons other than stated above|12|||
144553849|NCT01183013|521225149|FG004|Overall Study|Reasons other than stated above|12|||
144553850|NCT01183013|521225150|FG005|Overall Study|Reasons other than stated above|15|||
144553851|NCT01183013|521225151|FG006|Overall Study|Reasons other than stated above|13|||
144553852|NCT03436797|521225152|FG000|Main Study|Withdrawal by Subject|2|||
144553853|NCT03436797|521225152|FG000|Main Study|Adverse Event|4|||
144553854|NCT03436797|521225152|FG000|Main Study|Lost to Follow-up|1|||
144553855|NCT03436797|521225152|FG000|Main Study|Death|1|||
144553856|NCT03436797|521225152|FG000|Main Study|Non-Specific|2|||
144553857|NCT03436797|521225152|FG000|Extended Dosing|Patient decision|1|||
144553858|NCT01951105|521225153|FG000|Overall Study|Adverse Event|0|||
144553859|NCT01951105|521225154|FG001|Overall Study|Adverse Event|5|||
144553860|NCT01951105|521225155|FG002|Overall Study|Adverse Event|0|||
144553861|NCT01951105|521225153|FG000|Overall Study|Lost to Follow-up|0|||
144553862|NCT01951105|521225154|FG001|Overall Study|Lost to Follow-up|1|||
144553863|NCT01951105|521225155|FG002|Overall Study|Lost to Follow-up|0|||
144553864|NCT01951105|521225153|FG000|Overall Study|Protocol Violation|1|||
144553865|NCT01951105|521225154|FG001|Overall Study|Protocol Violation|1|||
144553866|NCT01951105|521225155|FG002|Overall Study|Protocol Violation|1|||
144553867|NCT01951105|521225153|FG000|Overall Study|Withdrawal by Subject|0|||
144553868|NCT01951105|521225154|FG001|Overall Study|Withdrawal by Subject|3|||
144553869|NCT01951105|521225155|FG002|Overall Study|Withdrawal by Subject|1|||
144553870|NCT02812706|521225156|FG000|Phase 1|Adverse Event|0|||
144553871|NCT02812706|521225157|FG001|Phase 1|Adverse Event|2|||
144553872|NCT02812706|521225158|FG002|Phase 1|Adverse Event|0|||
144553873|NCT02812706|521225156|FG000|Phase 1|Progressive disease|3|||
144553874|NCT02812706|521225157|FG001|Phase 1|Progressive disease|3|||
144553875|NCT02812706|521225158|FG002|Phase 1|Progressive disease|0|||
144553876|NCT02812706|521225156|FG000|Phase 2|Adverse Event|0|||
144553877|NCT02812706|521225157|FG001|Phase 2|Adverse Event|0|||
144553878|NCT02812706|521225158|FG002|Phase 2|Adverse Event|2|||
144553879|NCT02812706|521225156|FG000|Phase 2|Progressive disease|0|||
144553880|NCT02812706|521225157|FG001|Phase 2|Progressive disease|0|||
144553881|NCT02812706|521225158|FG002|Phase 2|Progressive disease|22|||
144553882|NCT02812706|521225156|FG000|Phase 2|Other-Unspecified|0|||
144553883|NCT02812706|521225157|FG001|Phase 2|Other-Unspecified|0|||
144553884|NCT02812706|521225158|FG002|Phase 2|Other-Unspecified|4|||
144553885|NCT00910871|521225164|FG000|Overall Study|Adverse Event|5|||
144553886|NCT00910871|521225164|FG000|Overall Study|Death|12|||
144553887|NCT00910871|521225164|FG000|Overall Study|Lost to Follow-up|8|||
144553888|NCT00910871|521225164|FG000|Overall Study|Protocol Violation|11|||
144553889|NCT00910871|521225164|FG000|Overall Study|Withdrawal by Subject|12|||
144553890|NCT00910871|521225164|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
144553891|NCT00910871|521225164|FG000|Overall Study|Undefined|1|||
144553892|NCT01989156|521225165|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
144553893|NCT01989156|521225166|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
144553894|NCT01989156|521225167|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
144553895|NCT01989156|521225165|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
144553896|NCT01989156|521225166|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
144553897|NCT01989156|521225167|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
144553898|NCT01989156|521225165|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
144553899|NCT01989156|521225166|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
144553900|NCT01989156|521225167|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
144553901|NCT01989156|521225165|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
144553902|NCT01989156|521225166|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
144553903|NCT01989156|521225167|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
144553904|NCT01989156|521225165|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
144553905|NCT01989156|521225166|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
144553906|NCT01989156|521225167|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
144553907|NCT01989156|521225165|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
144553908|NCT01989156|521225166|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
144553909|NCT01989156|521225167|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
144553910|NCT01989156|521225165|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
144553911|NCT01989156|521225166|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
144553912|NCT01989156|521225167|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
144553913|NCT01989156|521225165|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
144553914|NCT01989156|521225166|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
144553915|NCT01989156|521225167|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
144616882|NCT01534533|521456456|FG002|Overall Study|Withdrawal by Subject|4|||
144553916|NCT00850993|521225168|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
144553917|NCT00850993|521225169|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
144553918|NCT00850993|521225170|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
144553919|NCT00850993|521225171|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
144553920|NCT03839355|521225172|FG000|Overall Study|Withdrawal by Subject|1|||
144553921|NCT03839355|521225173|FG001|Overall Study|Withdrawal by Subject|0|||
144553922|NCT04501614|521225179|FG000|Overall Study|Study Terminated by Sponsor|6|||
144553923|NCT04501614|521225180|FG001|Overall Study|Study Terminated by Sponsor|3|||
144553924|NCT04501614|521225179|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
144553925|NCT04501614|521225180|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
144553926|NCT04529941|521225181|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
144553927|NCT04529941|521225182|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
144553928|NCT01240785|521225183|FG000|Overall Study|Lost to Follow-up|1|||
144553929|NCT01240785|521225184|FG001|Overall Study|Lost to Follow-up|0|||
144553930|NCT01240785|521225183|FG000|Overall Study|Protocol Violation|0|||
144553931|NCT01240785|521225184|FG001|Overall Study|Protocol Violation|3|||
144553932|NCT01755598|521225186|FG000|Overall Study|Other|109|||
144553933|NCT01755598|521225187|FG001|Overall Study|Other|109|||
144553934|NCT01755598|521225186|FG000|Overall Study|Lost to Follow-up|32|||
144553935|NCT01755598|521225187|FG001|Overall Study|Lost to Follow-up|43|||
144553936|NCT01755598|521225186|FG000|Overall Study|Migrated/moved from study area|76|||
144553937|NCT01755598|521225187|FG001|Overall Study|Migrated/moved from study area|65|||
144553938|NCT01755598|521225186|FG000|Overall Study|Withdrawal by Subject|22|||
144553939|NCT01755598|521225187|FG001|Overall Study|Withdrawal by Subject|31|||
144553940|NCT01755598|521225186|FG000|Overall Study|Protocol Violation|7|||
144553941|NCT01755598|521225187|FG001|Overall Study|Protocol Violation|7|||
144553942|NCT01755598|521225186|FG000|Overall Study|Adverse Event|19|||
144553943|NCT01755598|521225187|FG001|Overall Study|Adverse Event|28|||
144553944|NCT02260154|521225188|FG000|Overall Study|Screening failure|2|||
144553945|NCT03905512|521225189|FG000|Overall Study|Withdrawal by Subject|9|||
144553946|NCT03905512|521225190|FG001|Overall Study|Withdrawal by Subject|8|||
144553947|NCT03905512|521225189|FG000|Overall Study|Adverse Event|1|||
144553948|NCT03905512|521225190|FG001|Overall Study|Adverse Event|2|||
144553949|NCT03905512|521225189|FG000|Overall Study|Lost to Follow-up|4|||
144553950|NCT03905512|521225190|FG001|Overall Study|Lost to Follow-up|3|||
144553951|NCT03905512|521225189|FG000|Overall Study|Other than Specified|7|||
144553952|NCT03905512|521225190|FG001|Overall Study|Other than Specified|4|||
144553953|NCT03547167|521225191|FG000|Overall Study|Withdrawal by Subject|34|||
144553954|NCT03547167|521225192|FG001|Overall Study|Withdrawal by Subject|12|||
144553955|NCT03547167|521225191|FG000|Overall Study|Screen Failure|0|||
144553956|NCT03547167|521225192|FG001|Overall Study|Screen Failure|1|||
144553957|NCT03547167|521225191|FG000|Overall Study|Lost to Follow-up|59|||
144553958|NCT03547167|521225192|FG001|Overall Study|Lost to Follow-up|15|||
144553959|NCT03547167|521225191|FG000|Overall Study|Death|4|||
144553960|NCT03547167|521225192|FG001|Overall Study|Death|2|||
144553961|NCT00070317|521225193|FG000|Overall Study|Inevaluable (Never Treated)|1|||
144553962|NCT00070317|521225193|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
144553963|NCT00070317|521225193|FG000|Overall Study|Ineligible required test not done|1|||
144553964|NCT00070317|521225193|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
144553965|NCT00070317|521225193|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
144553966|NCT00645411|521225194|FG000|Overall Study|Adverse Event|0|||
144553967|NCT00645411|521225195|FG001|Overall Study|Adverse Event|0|||
144553968|NCT00645411|521225196|FG002|Overall Study|Adverse Event|0|||
144553969|NCT00645411|521225197|FG003|Overall Study|Adverse Event|2|||
144553970|NCT00645411|521225194|FG000|Overall Study|Withdrawal by Subject|2|||
144553971|NCT00645411|521225195|FG001|Overall Study|Withdrawal by Subject|1|||
144553972|NCT00645411|521225196|FG002|Overall Study|Withdrawal by Subject|19|||
144553973|NCT00645411|521225197|FG003|Overall Study|Withdrawal by Subject|21|||
144553974|NCT00645411|521225194|FG000|Overall Study|Lost to Follow-up|10|||
144553975|NCT00645411|521225195|FG001|Overall Study|Lost to Follow-up|5|||
144553976|NCT00645411|521225196|FG002|Overall Study|Lost to Follow-up|124|||
144553977|NCT00645411|521225197|FG003|Overall Study|Lost to Follow-up|75|||
144553978|NCT00645411|521225194|FG000|Overall Study|Protocol Violation|1|||
144553979|NCT00645411|521225195|FG001|Overall Study|Protocol Violation|0|||
144553980|NCT00645411|521225196|FG002|Overall Study|Protocol Violation|1|||
144553981|NCT00645411|521225197|FG003|Overall Study|Protocol Violation|0|||
144553982|NCT00645411|521225194|FG000|Overall Study|Inappropriate enrollment|0|||
144553983|NCT00645411|521225195|FG001|Overall Study|Inappropriate enrollment|0|||
144616883|NCT01534533|521456457|FG003|Overall Study|Withdrawal by Subject|1|||
144553984|NCT00645411|521225196|FG002|Overall Study|Inappropriate enrollment|4|||
144553985|NCT00645411|521225197|FG003|Overall Study|Inappropriate enrollment|1|||
144553986|NCT00645411|521225194|FG000|Overall Study|Unable to classify|0|||
144553987|NCT00645411|521225195|FG001|Overall Study|Unable to classify|0|||
144553988|NCT00645411|521225196|FG002|Overall Study|Unable to classify|3|||
144553989|NCT00645411|521225197|FG003|Overall Study|Unable to classify|4|||
144553990|NCT02674399|521225198|FG000|Overall Study|Lost to Follow-up|2|||
144616884|NCT04311502|521457991|FG000|Overall Study|Death|1|||
144553991|NCT02674399|521225199|FG001|Overall Study|Lost to Follow-up|0|||
144553992|NCT00508144|521225200|FG000|Overall Study|Not eligible|6|||
144553993|NCT00508144|521225200|FG000|Overall Study|Death|5|||
144262422|NCT03101150|520161432|FG001|Overall Study|Miscarriage|6|||
144262423|NCT01317641|520161434|FG000|Overall Study|Not treated|0|||
144553994|NCT01084772|521225202|FG000|Baseline|Withdrawal by Subject|7|||
144553995|NCT01084772|521225203|FG001|Baseline|Withdrawal by Subject|6|||
144553996|NCT01084772|521225202|FG000|3 Months|Death|1|||
144553997|NCT01084772|521225203|FG001|3 Months|Death|0|||
144553998|NCT01084772|521225202|FG000|3 Months|Study Termination|2|||
144553999|NCT01084772|521225203|FG001|3 Months|Study Termination|2|||
144554000|NCT01084772|521225202|FG000|1 Year|Withdrawal by Subject|0|||
144554001|NCT01084772|521225203|FG001|1 Year|Withdrawal by Subject|1|||
144554002|NCT01084772|521225202|FG000|1 Year|Lost to Follow-up|3|||
144554003|NCT01084772|521225203|FG001|1 Year|Lost to Follow-up|0|||
144554004|NCT01084772|521225202|FG000|1 Year|Study Termination|0|||
144554005|NCT01084772|521225203|FG001|1 Year|Study Termination|7|||
144554006|NCT01084772|521225202|FG000|2 Years|Withdrawal by Subject|1|||
144554007|NCT01084772|521225203|FG001|2 Years|Withdrawal by Subject|0|||
144554008|NCT01084772|521225202|FG000|2 Years|Lost to Follow-up|5|||
144554009|NCT01084772|521225203|FG001|2 Years|Lost to Follow-up|2|||
144554010|NCT01084772|521225202|FG000|2 Years|Study Termination|3|||
144554011|NCT01084772|521225203|FG001|2 Years|Study Termination|2|||
144554012|NCT00525915|521225205|FG000|Overall Study|Non-Compliance|0|||
144554013|NCT00525915|521225206|FG001|Overall Study|Non-Compliance|1|||
144554014|NCT00525915|521225205|FG000|Overall Study|Disease Progression|5|||
144554015|NCT00525915|521225206|FG001|Overall Study|Disease Progression|6|||
144554016|NCT00525915|521225205|FG000|Overall Study|Withdrawal by Subject|1|||
144554017|NCT00525915|521225206|FG001|Overall Study|Withdrawal by Subject|0|||
144554018|NCT00525915|521225205|FG000|Overall Study|Refused Surgery|1|||
144554019|NCT00525915|521225206|FG001|Overall Study|Refused Surgery|2|||
144554020|NCT00525915|521225205|FG000|Overall Study|Unrelated illness|1|||
144554021|NCT00525915|521225206|FG001|Overall Study|Unrelated illness|0|||
144554022|NCT02332889|521225217|FG000|Overall Study|Physician Decision|1|||
144554023|NCT04097535|521225221|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
144554024|NCT04520256|521225223|FG000|Overall Study|Lost to Follow-up|6|||
144554025|NCT04520256|521225224|FG001|Overall Study|Lost to Follow-up|4|||
144554026|NCT04520256|521225225|FG002|Overall Study|Lost to Follow-up|2|||
144554027|NCT04520256|521225226|FG003|Overall Study|Lost to Follow-up|3|||
144554028|NCT04520256|521225227|FG004|Overall Study|Lost to Follow-up|6|||
144554029|NCT04520256|521225228|FG005|Overall Study|Lost to Follow-up|6|||
144554030|NCT04520256|521225229|FG006|Overall Study|Lost to Follow-up|4|||
144554031|NCT04520256|521225230|FG007|Overall Study|Lost to Follow-up|6|||
144554032|NCT04520256|521225231|FG008|Overall Study|Lost to Follow-up|1|||
144554033|NCT04520256|521225232|FG009|Overall Study|Lost to Follow-up|3|||
144554034|NCT04520256|521225233|FG010|Overall Study|Lost to Follow-up|3|||
144554035|NCT04520256|521225234|FG011|Overall Study|Lost to Follow-up|2|||
144554036|NCT04520256|521225235|FG012|Overall Study|Lost to Follow-up|5|||
144554037|NCT04520256|521225236|FG013|Overall Study|Lost to Follow-up|3|||
144554038|NCT04520256|521225237|FG014|Overall Study|Lost to Follow-up|3|||
144554039|NCT04520256|521225238|FG015|Overall Study|Lost to Follow-up|6|||
144554040|NCT04520256|521225239|FG016|Overall Study|Lost to Follow-up|6|||
144554041|NCT04520256|521225240|FG017|Overall Study|Lost to Follow-up|4|||
144554042|NCT04520256|521225241|FG018|Overall Study|Lost to Follow-up|3|||
144554043|NCT04520256|521225242|FG019|Overall Study|Lost to Follow-up|3|||
144554044|NCT04520256|521225243|FG020|Overall Study|Lost to Follow-up|7|||
144554045|NCT04520256|521225244|FG021|Overall Study|Lost to Follow-up|3|||
144554046|NCT04520256|521225245|FG022|Overall Study|Lost to Follow-up|3|||
144554047|NCT04520256|521225246|FG023|Overall Study|Lost to Follow-up|8|||
144554048|NCT04520256|521225247|FG024|Overall Study|Lost to Follow-up|5|||
144554049|NCT04520256|521225248|FG025|Overall Study|Lost to Follow-up|4|||
144554050|NCT04520256|521225249|FG026|Overall Study|Lost to Follow-up|3|||
144554051|NCT04520256|521225250|FG027|Overall Study|Lost to Follow-up|4|||
144554052|NCT04520256|521225251|FG028|Overall Study|Lost to Follow-up|3|||
144554053|NCT04520256|521225252|FG029|Overall Study|Lost to Follow-up|4|||
144554054|NCT04520256|521225253|FG030|Overall Study|Lost to Follow-up|4|||
144554055|NCT04520256|521225254|FG031|Overall Study|Lost to Follow-up|4|||
144554056|NCT03556891|521225255|FG000|Initial Pivotal Study|Adverse Event|4|||
144554057|NCT03556891|521225255|FG000|Initial Pivotal Study|MRI Need|3|||
144554058|NCT03556891|521225255|FG000|Initial Pivotal Study|Device Failure|1|||
144554059|NCT03556891|521225255|FG000|Initial Pivotal Study|Death|1|||
144554060|NCT03556891|521225255|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
144554061|NCT03556891|521225255|FG000|Initial Pivotal Study|Missing at random|1|||
144554062|NCT03556891|521225255|FG000|Initial Pivotal Study|Missing due to COVID|1|||
144554063|NCT03556891|521225255|FG000|Initial Pivotal Study|Protocol Violation|1|||
144554064|NCT00489489|521226106|FG000|Overall Study|Not treated due to protocol violation|0|||
144554065|NCT00489489|521226107|FG001|Overall Study|Not treated due to protocol violation|1|||
144554066|NCT00489489|521226108|FG002|Overall Study|Not treated due to protocol violation|1|||
144554067|NCT00489489|521226106|FG000|Overall Study|Adverse Event|1|||
144554068|NCT00489489|521226107|FG001|Overall Study|Adverse Event|1|||
144203432|NCT01739348|519940339|FG000|Part II (Extension Study)|Participant Moved|3|||
144203433|NCT01739348|519940340|FG001|Part II (Extension Study)|Participant Moved|3|||
144554069|NCT00489489|521226108|FG002|Overall Study|Adverse Event|1|||
144554070|NCT00489489|521226106|FG000|Overall Study|Protocol Violation|1|||
144554071|NCT00489489|521226107|FG001|Overall Study|Protocol Violation|0|||
144554072|NCT00489489|521226108|FG002|Overall Study|Protocol Violation|1|||
144554073|NCT00489489|521226106|FG000|Overall Study|Progressive disease|0|||
144554074|NCT00489489|521226107|FG001|Overall Study|Progressive disease|1|||
144554075|NCT00489489|521226108|FG002|Overall Study|Progressive disease|0|||
144554076|NCT00489489|521226106|FG000|Overall Study|Participant did not wish to continue|1|||
144554077|NCT00489489|521226107|FG001|Overall Study|Participant did not wish to continue|1|||
144554078|NCT00489489|521226108|FG002|Overall Study|Participant did not wish to continue|0|||
144554079|NCT00489489|521226106|FG000|Overall Study|Other than above|0|||
144554080|NCT00489489|521226107|FG001|Overall Study|Other than above|1|||
144554081|NCT00489489|521226108|FG002|Overall Study|Other than above|0|||
144554082|NCT04851587|521226114|FG000|Overall Study|Lost to Follow-up|18|||
144554083|NCT00668746|521226119|FG000|Overall Study|Lost to Follow-up|2|||
144554084|NCT00668746|521226120|FG001|Overall Study|Lost to Follow-up|1|||
144554085|NCT03605745|521226121|FG000|Overall Study|Study was terminated for business reasons|47|||
144554086|NCT04454125|521226122|FG000|Overall Study|Lost to Follow-up|0|||
144554087|NCT04454125|521226123|FG001|Overall Study|Lost to Follow-up|1|||
144554088|NCT03614923|521226126|FG000|Overall Study|Withdrawal by Subject|2|||
144554089|NCT03614923|521226127|FG001|Overall Study|Withdrawal by Subject|1|||
144554090|NCT03614923|521226128|FG002|Overall Study|Withdrawal by Subject|1|||
144554091|NCT03614923|521226126|FG000|Overall Study|Adverse Event|0|||
144554092|NCT03614923|521226127|FG001|Overall Study|Adverse Event|2|||
144554093|NCT03614923|521226128|FG002|Overall Study|Adverse Event|1|||
144554094|NCT03614923|521226126|FG000|Overall Study|Lost to Follow-up|1|||
144554095|NCT03614923|521226127|FG001|Overall Study|Lost to Follow-up|0|||
144554096|NCT03614923|521226128|FG002|Overall Study|Lost to Follow-up|1|||
144554097|NCT03614923|521226126|FG000|Overall Study|Lack of Efficacy|2|||
144554098|NCT03614923|521226127|FG001|Overall Study|Lack of Efficacy|0|||
144554099|NCT03614923|521226128|FG002|Overall Study|Lack of Efficacy|1|||
144554100|NCT03614923|521226126|FG000|Overall Study|Non-compliance|0|||
144554101|NCT03614923|521226127|FG001|Overall Study|Non-compliance|1|||
144554102|NCT03614923|521226128|FG002|Overall Study|Non-compliance|0|||
144554103|NCT03614923|521226126|FG000|Overall Study|Other|0|||
144554104|NCT03614923|521226127|FG001|Overall Study|Other|1|||
144554105|NCT03614923|521226128|FG002|Overall Study|Other|1|||
144554106|NCT01882088|521226129|FG000|Overall Study|Intolerance of esophageal manometry|1|||
144554107|NCT01882088|521226129|FG000|Overall Study|no possibility to place the catheter|1|||
144554108|NCT01882088|521226129|FG000|Overall Study|Protocol Violation|1|||
144554109|NCT01882088|521226129|FG000|Overall Study|inadequate pH-impedance tracings|2|||
144554110|NCT02256553|521226142|FG000|Period I|Adverse Event|5|||
144554111|NCT02256553|521226142|FG000|Period I|Protocol Violation|1|||
144554112|NCT02256553|521226142|FG000|Period II|Adverse Event|1|||
144554113|NCT02256553|521226142|FG000|Period II|Subject Moved|1|||
144554114|NCT02256553|521226142|FG000|Period III|Adverse Event|3|||
144554115|NCT04739306|521226143|FG000|Main Study Period|Adverse Event|6|||
144554116|NCT04739306|521226144|FG001|Main Study Period|Adverse Event|7|||
144554117|NCT04739306|521226143|FG000|Main Study Period|Lost to Follow-up|4|||
144554118|NCT04739306|521226144|FG001|Main Study Period|Lost to Follow-up|6|||
144554119|NCT04739306|521226143|FG000|Main Study Period|Physician Decision|1|||
144554120|NCT04739306|521226144|FG001|Main Study Period|Physician Decision|1|||
144554121|NCT04739306|521226143|FG000|Main Study Period|Withdrawal by Subject|8|||
144554122|NCT04739306|521226144|FG001|Main Study Period|Withdrawal by Subject|6|||
144554123|NCT04739306|521226143|FG000|Main Study Period|Protocol Violation|0|||
144554124|NCT04739306|521226144|FG001|Main Study Period|Protocol Violation|1|||
144554125|NCT04739306|521226143|FG000|Main Study Period|War in Ukraine|1|||
144554126|NCT04739306|521226144|FG001|Main Study Period|War in Ukraine|1|||
144554127|NCT04175392|521226145|FG000|Overall Study|Withdrawal by Subject|3|||
144554128|NCT04175392|521226146|FG001|Overall Study|Withdrawal by Subject|2|||
144554129|NCT01721109|521226151|FG000|Overall Study|Lack of Efficacy|1|||
144554130|NCT01721109|521226151|FG000|Overall Study|Non- Compliance with Study Drug|3|||
144554131|NCT01721109|521226151|FG000|Overall Study|Withdrew Consent|1|||
144554132|NCT01721109|521226151|FG000|Overall Study|Lost to Follow-up|2|||
144554133|NCT01699178|521226152|FG000|Overall Study|Adverse Event|1|||
144554134|NCT01699178|521226153|FG001|Overall Study|Adverse Event|5|||
144554135|NCT01699178|521226152|FG000|Overall Study|Lost to Follow-up|1|||
144554136|NCT01699178|521226153|FG001|Overall Study|Lost to Follow-up|6|||
144554137|NCT01699178|521226152|FG000|Overall Study|Non-compliance with Study Drug|3|||
144554138|NCT01699178|521226153|FG001|Overall Study|Non-compliance with Study Drug|1|||
144554139|NCT01699178|521226152|FG000|Overall Study|Physician Decision|1|||
144554140|NCT01699178|521226153|FG001|Overall Study|Physician Decision|0|||
144554141|NCT01699178|521226152|FG000|Overall Study|Withdrawal by Subject|4|||
144554142|NCT01699178|521226153|FG001|Overall Study|Withdrawal by Subject|12|||
144554143|NCT01699178|521226152|FG000|Overall Study|Hematocrit >54%|1|||
144554144|NCT01699178|521226153|FG001|Overall Study|Hematocrit >54%|1|||
144554145|NCT01699178|521226152|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
144554146|NCT01699178|521226153|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
144554147|NCT01699178|521226152|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
144554148|NCT01699178|521226153|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
144554149|NCT00321555|521226154|FG000|Overall Study|Developed antibodies|1|||
144554150|NCT00321555|521226154|FG000|Overall Study|Switched to alternative treatment|3|||
144554151|NCT00321555|521226154|FG000|Overall Study|Physician Decision|1|||
144554152|NCT00321555|521226154|FG000|Overall Study|Disease progression on study|1|||
144554153|NCT01885559|521226164|FG000|Overall Study|Lost to Follow-up|15|||
144554154|NCT01885559|521226165|FG001|Overall Study|Lost to Follow-up|16|||
144554155|NCT01885559|521226164|FG000|Overall Study|Less than full participation|9|||
144554156|NCT01885559|521226165|FG001|Overall Study|Less than full participation|19|||
144554157|NCT01885559|521226164|FG000|Overall Study|Protocol Violation|0|||
144554158|NCT01885559|521226165|FG001|Overall Study|Protocol Violation|1|||
144554159|NCT03560206|521226167|FG000|Overall Study|Lost to Follow-up|19|||
144554160|NCT03560206|521226168|FG001|Overall Study|Lost to Follow-up|11|||
144554161|NCT03560206|521226167|FG000|Overall Study|Withdrawal by Subject|2|||
144554162|NCT03560206|521226168|FG001|Overall Study|Withdrawal by Subject|4|||
144554163|NCT03560206|521226167|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
144554164|NCT03560206|521226168|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
144554165|NCT03560206|521226167|FG000|Overall Study|Busy schedule|14|||
144554166|NCT03560206|521226168|FG001|Overall Study|Busy schedule|2|||
144554167|NCT03560206|521226167|FG000|Overall Study|patients' new health condition such as cancer|10|||
144554168|NCT03560206|521226168|FG001|Overall Study|patients' new health condition such as cancer|1|||
144554169|NCT03987074|521226169|FG000|Overall Study|Withdrew Consent|1|||
144554170|NCT03987074|521226170|FG001|Overall Study|Withdrew Consent|1|||
144554171|NCT03987074|521226171|FG002|Overall Study|Withdrew Consent|0|||
144554172|NCT03987074|521226172|FG003|Overall Study|Withdrew Consent|2|||
144554173|NCT03987074|521226173|FG004|Overall Study|Withdrew Consent|1|||
144554174|NCT03987074|521226169|FG000|Overall Study|Adverse Event|2|||
144554175|NCT03987074|521226170|FG001|Overall Study|Adverse Event|1|||
144554176|NCT03987074|521226171|FG002|Overall Study|Adverse Event|0|||
144554177|NCT03987074|521226172|FG003|Overall Study|Adverse Event|0|||
144554178|NCT03987074|521226173|FG004|Overall Study|Adverse Event|1|||
144554179|NCT03987074|521226169|FG000|Overall Study|Lost to Follow-up|0|||
144554180|NCT03987074|521226170|FG001|Overall Study|Lost to Follow-up|0|||
144554181|NCT03987074|521226171|FG002|Overall Study|Lost to Follow-up|1|||
144554182|NCT03987074|521226172|FG003|Overall Study|Lost to Follow-up|1|||
144554183|NCT03987074|521226173|FG004|Overall Study|Lost to Follow-up|0|||
144554184|NCT03987074|521226169|FG000|Overall Study|Investigator's Discretion|0|||
144554185|NCT03987074|521226170|FG001|Overall Study|Investigator's Discretion|0|||
144554186|NCT03987074|521226171|FG002|Overall Study|Investigator's Discretion|0|||
144554187|NCT03987074|521226172|FG003|Overall Study|Investigator's Discretion|1|||
144554188|NCT03987074|521226173|FG004|Overall Study|Investigator's Discretion|0|||
144554189|NCT03100370|521226174|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144554190|NCT03100370|521226175|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144554191|NCT03100370|521226176|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144554192|NCT03100370|521226177|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144554193|NCT03100370|521226178|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144554194|NCT03100370|521226179|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
144554195|NCT01867307|521226185|FG000|Overall Study|Protocol Violation|2|||
144554196|NCT01867307|521226186|FG001|Overall Study|Protocol Violation|0|||
144554197|NCT01867307|521226185|FG000|Overall Study|Other Adverse Event|1|||
144554198|NCT01867307|521226186|FG001|Overall Study|Other Adverse Event|3|||
144554199|NCT02009865|521226191|FG000|Overall Study|Adverse Event|0|||
144554200|NCT02009865|521226192|FG001|Overall Study|Adverse Event|2|||
144554201|NCT02009865|521226191|FG000|Overall Study|Protocol Violation|0|||
144554202|NCT02009865|521226192|FG001|Overall Study|Protocol Violation|2|||
144554203|NCT02009865|521226191|FG000|Overall Study|Withdrawal by Subject|1|||
144554204|NCT02009865|521226192|FG001|Overall Study|Withdrawal by Subject|1|||
144554205|NCT01517282|521226193|FG000|Overall Study|Consent withdrawn|0|||
144554206|NCT01517282|521226194|FG001|Overall Study|Consent withdrawn|1|||
144554207|NCT01517282|521226195|FG002|Overall Study|Consent withdrawn|1|||
144554208|NCT01517282|521226196|FG003|Overall Study|Consent withdrawn|1|||
144554209|NCT01517282|521226193|FG000|Overall Study|Physician Decision|1|||
144554210|NCT01517282|521226194|FG001|Overall Study|Physician Decision|0|||
144554211|NCT01517282|521226195|FG002|Overall Study|Physician Decision|0|||
144554212|NCT01517282|521226196|FG003|Overall Study|Physician Decision|0|||
144554213|NCT01634165|521226199|FG000|Period 2|Adverse Event|0|||
144554214|NCT01634165|521226200|FG001|Period 2|Adverse Event|1|||
144262424|NCT01317641|520161435|FG001|Overall Study|Not treated|0|||
144554215|NCT01634165|521226201|FG002|Period 2|Adverse Event|0|||
144554216|NCT01634165|521226202|FG003|Period 2|Adverse Event|0|||
144554217|NCT02135445|521226203|FG000|Overall Study|Lost to Follow-up|1|||
144554218|NCT02135445|521226204|FG001|Overall Study|Lost to Follow-up|0|||
144554219|NCT02135445|521226203|FG000|Overall Study|Withdrawal by Subject|1|||
144262425|NCT01317641|520161436|FG002|Overall Study|Not treated|0|||
144554220|NCT02135445|521226204|FG001|Overall Study|Withdrawal by Subject|0|||
144554221|NCT03070301|521226205|FG000|Overall Study|Progression of disease|16|||
144554222|NCT03070301|521226205|FG000|Overall Study|Physician Decision|3|||
144554223|NCT03070301|521226205|FG000|Overall Study|Withdrawal by Subject|1|||
144554224|NCT03978130|521227369|FG000|Overall Study|Lost to Follow-up|13|||
144554225|NCT03978130|521227370|FG001|Overall Study|Lost to Follow-up|14|||
144554226|NCT03978130|521227369|FG000|Overall Study|Withdrawal by Subject|12|||
144554227|NCT03978130|521227370|FG001|Overall Study|Withdrawal by Subject|2|||
144554228|NCT03978130|521227369|FG000|Overall Study|Adverse Event|2|||
144554229|NCT03978130|521227370|FG001|Overall Study|Adverse Event|1|||
144554230|NCT05927753|521227373|FG000|Overall Study|Withdrawal by Subject|0|||
144554231|NCT05927753|521227374|FG001|Overall Study|Withdrawal by Subject|2|||
144554232|NCT05927753|521227373|FG000|Overall Study|Physician Decision|0|||
144554233|NCT05927753|521227374|FG001|Overall Study|Physician Decision|1|||
144554234|NCT02136797|521227378|FG000|Overall Study|Not Treated|8|||
144554235|NCT04523571|521227379|FG000|Received 2 Doses|Withdrawal by Subject|0|||
144554236|NCT04523571|521227380|FG001|Received 2 Doses|Withdrawal by Subject|0|||
144554237|NCT04523571|521227381|FG002|Received 2 Doses|Withdrawal by Subject|0|||
144554238|NCT04523571|521227382|FG003|Received 2 Doses|Withdrawal by Subject|1|||
144554239|NCT04523571|521227383|FG004|Received 2 Doses|Withdrawal by Subject|1|||
144554240|NCT04523571|521227384|FG005|Received 2 Doses|Withdrawal by Subject|0|||
144554241|NCT04523571|521227379|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
144554242|NCT04523571|521227380|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
144554243|NCT04523571|521227381|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
144554244|NCT04523571|521227382|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
144554245|NCT04523571|521227383|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
144554246|NCT04523571|521227384|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
144554247|NCT04523571|521227379|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
144554248|NCT04523571|521227380|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
144554249|NCT04523571|521227381|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
144554250|NCT04523571|521227382|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
144554251|NCT04523571|521227383|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
144554252|NCT04523571|521227384|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
144554253|NCT04523571|521227379|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
144554254|NCT04523571|521227380|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
144554255|NCT04523571|521227381|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
144554256|NCT04523571|521227382|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
144554257|NCT04523571|521227383|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
144554258|NCT04523571|521227384|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
144554259|NCT04198428|521227385|FG000|Overall Study|Withdrawal by Subject|150|||
144554260|NCT04198428|521227386|FG001|Overall Study|Withdrawal by Subject|156|||
144554261|NCT03344458|521227389|FG000|Overall Study|Physician Decision|1|||
144554262|NCT03344458|521227389|FG000|Overall Study|Withdrawal by Subject|16|||
144554263|NCT03344458|521227389|FG000|Overall Study|Other reasons|10|||
144554264|NCT03344458|521227389|FG000|Overall Study|Lost to Follow-up|9|||
144554265|NCT03344458|521227389|FG000|Overall Study|Protocol Violation|3|||
144554266|NCT03696342|521227392|FG000|Overall Study|Lost to Follow-up|1|||
144554267|NCT03696342|521227393|FG001|Overall Study|Lost to Follow-up|0|||
144554268|NCT01816165|521227396|FG000|Overall Study|Adverse Event|1|||
144554269|NCT01816165|521227397|FG001|Overall Study|Adverse Event|0|||
144554270|NCT01816165|521227398|FG002|Overall Study|Adverse Event|0|||
144554271|NCT01816165|521227399|FG003|Overall Study|Adverse Event|0|||
144554272|NCT02409732|521227400|FG000|Overall Study|Withdrawal by Subject|4|||
144554273|NCT02409732|521227400|FG000|Overall Study|Lost to Follow-up|2|||
144554274|NCT03960437|521227402|FG000|Overall Study|Removed by PI|4|||
144554275|NCT03960437|521227402|FG000|Overall Study|Lost to Follow-up|2|||
144554276|NCT03960437|521227402|FG000|Overall Study|Withdrawal by Subject|1|||
144554277|NCT03960437|521227402|FG000|Overall Study|Death|2|||
144554278|NCT01838499|521227403|FG000|Overall Study|Protocol Violation|0|||
144203434|NCT01739348|519940341|FG002|Part II (Extension Study)|Participant Moved|0|||
144554279|NCT01838499|521227404|FG001|Overall Study|Protocol Violation|1|||
144554280|NCT01838499|521227403|FG000|Overall Study|Lost to Follow-up|2|||
144554281|NCT01838499|521227404|FG001|Overall Study|Lost to Follow-up|4|||
144616885|NCT04311502|521457992|FG001|Overall Study|Death|1|||
144616886|NCT04311502|521457993|FG002|Overall Study|Death|1|||
144554282|NCT01838499|521227403|FG000|Overall Study|Lack of Efficacy|1|||
144554283|NCT01838499|521227404|FG001|Overall Study|Lack of Efficacy|2|||
144554284|NCT01838499|521227403|FG000|Overall Study|Adverse Event|2|||
144554285|NCT01838499|521227404|FG001|Overall Study|Adverse Event|1|||
144554286|NCT01838499|521227403|FG000|Overall Study|Withdrawal by Subject|19|||
144554287|NCT01838499|521227404|FG001|Overall Study|Withdrawal by Subject|9|||
144554288|NCT00168805|521227405|FG000|Overall Study|Adverse Event|7|||
144262426|NCT01317641|520161437|FG003|Overall Study|Not treated|0|||
144616887|NCT04311502|521457991|FG000|Overall Study|Lost to Follow-up|2|||
144616888|NCT04311502|521457992|FG001|Overall Study|Lost to Follow-up|3|||
144616889|NCT04311502|521457993|FG002|Overall Study|Lost to Follow-up|0|||
144616890|NCT04311502|521457991|FG000|Overall Study|Participant is in prison|1|||
144616891|NCT04311502|521457992|FG001|Overall Study|Participant is in prison|0|||
144616892|NCT04311502|521457993|FG002|Overall Study|Participant is in prison|0|||
144616893|NCT04311502|521457991|FG000|Overall Study|Participant moved out of country|1|||
144616894|NCT04311502|521457992|FG001|Overall Study|Participant moved out of country|0|||
144616895|NCT04311502|521457993|FG002|Overall Study|Participant moved out of country|0|||
144616896|NCT04311502|521457991|FG000|Overall Study|Withdrawal by Subject|2|||
144616897|NCT04311502|521457992|FG001|Overall Study|Withdrawal by Subject|0|||
144616898|NCT04311502|521457993|FG002|Overall Study|Withdrawal by Subject|0|||
144616899|NCT04311502|521457991|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
144616900|NCT04311502|521457992|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
144616901|NCT04311502|521457993|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
144616902|NCT01979523|521457994|FG000|Overall Study|Withdrawal by Subject|1|||
144616903|NCT01979523|521457995|FG001|Overall Study|Withdrawal by Subject|0|||
144616904|NCT03548051|521457996|FG000|Overall Study|Death|1|||
144616905|NCT03548051|521457997|FG001|Overall Study|Death|1|||
144727736|NCT01494506|521858048|FG002|Overall Study|Other|1|||
144554289|NCT00168805|521227406|FG001|Overall Study|Adverse Event|11|||
144554290|NCT00168805|521227407|FG002|Overall Study|Adverse Event|16|||
144554291|NCT00168805|521227405|FG000|Overall Study|Protocol Violation|12|||
144554292|NCT00168805|521227406|FG001|Overall Study|Protocol Violation|11|||
144554293|NCT00168805|521227407|FG002|Overall Study|Protocol Violation|8|||
144554294|NCT00168805|521227405|FG000|Overall Study|Lost to Follow-up|12|||
144554295|NCT00168805|521227406|FG001|Overall Study|Lost to Follow-up|17|||
144554296|NCT00168805|521227407|FG002|Overall Study|Lost to Follow-up|11|||
144554297|NCT00168805|521227405|FG000|Overall Study|Withdrawal by Subject|16|||
144554298|NCT00168805|521227406|FG001|Overall Study|Withdrawal by Subject|18|||
144554299|NCT00168805|521227407|FG002|Overall Study|Withdrawal by Subject|21|||
144554300|NCT00168805|521227405|FG000|Overall Study|Other|24|||
144554301|NCT00168805|521227406|FG001|Overall Study|Other|21|||
144554302|NCT00168805|521227407|FG002|Overall Study|Other|22|||
144554303|NCT00168805|521227405|FG000|Treatment|Adverse Event|25|||
144554304|NCT00168805|521227406|FG001|Treatment|Adverse Event|26|||
144554305|NCT00168805|521227407|FG002|Treatment|Adverse Event|32|||
144554306|NCT00168805|521227405|FG000|Treatment|Protocol Violation|3|||
144554307|NCT00168805|521227406|FG001|Treatment|Protocol Violation|5|||
144554308|NCT00168805|521227407|FG002|Treatment|Protocol Violation|5|||
144554309|NCT00168805|521227405|FG000|Treatment|Withdrawal by Subject|3|||
144554310|NCT00168805|521227406|FG001|Treatment|Withdrawal by Subject|7|||
144554311|NCT00168805|521227407|FG002|Treatment|Withdrawal by Subject|8|||
144554312|NCT00168805|521227405|FG000|Treatment|Other|18|||
144554313|NCT00168805|521227406|FG001|Treatment|Other|18|||
144554314|NCT00168805|521227407|FG002|Treatment|Other|17|||
144554315|NCT01114217|521227408|FG000|Overall Study|Adverse Event|5|||
144554316|NCT01114217|521227409|FG001|Overall Study|Adverse Event|3|||
144554317|NCT01114217|521227408|FG000|Overall Study|Lost to Follow-up|17|||
144554318|NCT01114217|521227409|FG001|Overall Study|Lost to Follow-up|33|||
144554319|NCT01114217|521227408|FG000|Overall Study|Withdrawal by Subject|21|||
144554320|NCT01114217|521227409|FG001|Overall Study|Withdrawal by Subject|28|||
144554321|NCT01114217|521227408|FG000|Overall Study|Other-Clerical Error|3|||
144554322|NCT01114217|521227409|FG001|Overall Study|Other-Clerical Error|0|||
144554323|NCT01114217|521227408|FG000|Overall Study|Other-Early termination|6|||
144554324|NCT01114217|521227409|FG001|Overall Study|Other-Early termination|10|||
144554325|NCT01114217|521227408|FG000|Overall Study|Other-Procedure|1|||
144554326|NCT01114217|521227409|FG001|Overall Study|Other-Procedure|1|||
144554327|NCT01114217|521227408|FG000|Overall Study|Other-Pregnancy|2|||
144554328|NCT01114217|521227409|FG001|Overall Study|Other-Pregnancy|4|||
144554329|NCT01114217|521227408|FG000|Overall Study|Other-Protocol Violation|1|||
144554330|NCT01114217|521227409|FG001|Overall Study|Other-Protocol Violation|3|||
144554331|NCT01114217|521227408|FG000|Overall Study|Other-Lack of Efficacy|1|||
144554332|NCT01114217|521227409|FG001|Overall Study|Other-Lack of Efficacy|0|||
144554333|NCT01114217|521227408|FG000|Overall Study|Other-Non Compliance|2|||
144616906|NCT03548051|521457996|FG000|Overall Study|Withdrawal by Subject|1|||
144616907|NCT03548051|521457997|FG001|Overall Study|Withdrawal by Subject|0|||
144616908|NCT01870401|521457998|FG000|Overall Study|Death|48|||
144616909|NCT01870401|521457999|FG001|Overall Study|Death|24|||
144554334|NCT01114217|521227409|FG001|Overall Study|Other-Non Compliance|0|||
144554335|NCT01114217|521227408|FG000|Overall Study|Other-Physician Decision|1|||
144554336|NCT01114217|521227409|FG001|Overall Study|Other-Physician Decision|1|||
144554337|NCT01114217|521227408|FG000|Overall Study|Other-Sponsor Decision|10|||
144554338|NCT01114217|521227409|FG001|Overall Study|Other-Sponsor Decision|12|||
144554339|NCT01114217|521227408|FG000|Overall Study|Other-Study Termination|0|||
144554340|NCT01114217|521227409|FG001|Overall Study|Other-Study Termination|1|||
144554341|NCT01114217|521227408|FG000|Overall Study|Other-Study Withdrawn|1|||
144554342|NCT01114217|521227409|FG001|Overall Study|Other-Study Withdrawn|1|||
144554343|NCT01114217|521227408|FG000|Overall Study|Other-Site Stopped Communicating|2|||
144554344|NCT01114217|521227409|FG001|Overall Study|Other-Site Stopped Communicating|0|||
144554345|NCT01114217|521227408|FG000|Overall Study|Other-Lost to Follow-up|1|||
144554346|NCT01114217|521227409|FG001|Overall Study|Other-Lost to Follow-up|0|||
144554347|NCT01114217|521227408|FG000|Overall Study|Other-Withdrawal by Subject|1|||
144554348|NCT01114217|521227409|FG001|Overall Study|Other-Withdrawal by Subject|1|||
144554349|NCT03785210|521227410|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
144554350|NCT03785210|521227411|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
144554351|NCT02062827|521227414|FG000|Overall Study|Death|1|||
144554352|NCT02062827|521227415|FG001|Overall Study|Death|0|||
144554353|NCT02062827|521227416|FG002|Overall Study|Death|0|||
144554354|NCT02062827|521227417|FG003|Overall Study|Death|0|||
144554355|NCT02062827|521227418|FG004|Overall Study|Death|0|||
144554356|NCT02062827|521227419|FG005|Overall Study|Death|0|||
144554357|NCT02062827|521227420|FG006|Overall Study|Death|0|||
144554358|NCT02062827|521227421|FG007|Overall Study|Death|0|||
144554359|NCT02062827|521227414|FG000|Overall Study|Withdrawal by Subject|3|||
144554360|NCT02062827|521227415|FG001|Overall Study|Withdrawal by Subject|1|||
144554361|NCT02062827|521227416|FG002|Overall Study|Withdrawal by Subject|1|||
144554362|NCT02062827|521227417|FG003|Overall Study|Withdrawal by Subject|2|||
144554363|NCT02062827|521227418|FG004|Overall Study|Withdrawal by Subject|6|||
144554364|NCT02062827|521227419|FG005|Overall Study|Withdrawal by Subject|0|||
144554365|NCT02062827|521227420|FG006|Overall Study|Withdrawal by Subject|5|||
144554366|NCT02062827|521227421|FG007|Overall Study|Withdrawal by Subject|0|||
144554367|NCT02062827|521227414|FG000|Overall Study|Screen Fail|0|||
144554368|NCT02062827|521227415|FG001|Overall Study|Screen Fail|0|||
144554369|NCT02062827|521227416|FG002|Overall Study|Screen Fail|0|||
144554370|NCT02062827|521227417|FG003|Overall Study|Screen Fail|0|||
144554371|NCT02062827|521227418|FG004|Overall Study|Screen Fail|0|||
144554372|NCT02062827|521227419|FG005|Overall Study|Screen Fail|0|||
144554373|NCT02062827|521227420|FG006|Overall Study|Screen Fail|0|||
144554374|NCT02062827|521227421|FG007|Overall Study|Screen Fail|8|||
144554375|NCT03708744|521227422|FG000|Overall Study|Withdrawal by Subject|0|||
144554376|NCT03708744|521227423|FG001|Overall Study|Withdrawal by Subject|0|||
144554377|NCT03708744|521227424|FG002|Overall Study|Withdrawal by Subject|1|||
144554378|NCT03708744|521227425|FG003|Overall Study|Withdrawal by Subject|0|||
144554379|NCT02213458|521227428|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
144554380|NCT02213458|521227429|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
144554381|NCT02213458|521227428|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
144554382|NCT02213458|521227429|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
144554383|NCT02213458|521227428|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
144554384|NCT02213458|521227429|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
144554385|NCT02213458|521227428|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
144554386|NCT02213458|521227429|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
144554387|NCT02213458|521227428|FG000|Overall Study|Refused re-consent|6|||
144554388|NCT02213458|521227429|FG001|Overall Study|Refused re-consent|0|||
144554389|NCT02213458|521227428|FG000|Overall Study|Lost to Follow-up|2|||
144554390|NCT02213458|521227429|FG001|Overall Study|Lost to Follow-up|2|||
144554391|NCT02213458|521227428|FG000|Overall Study|Withdrawal by Subject|26|||
144554392|NCT02213458|521227429|FG001|Overall Study|Withdrawal by Subject|8|||
144554393|NCT05740371|521227430|FG000|Overall Study|Death|1|||
144554394|NCT01613599|521227432|FG000|Overall Study|Death|9|||
144554395|NCT01613599|521227432|FG000|Overall Study|Lost to Follow-up|5|||
144554396|NCT01613599|521227432|FG000|Overall Study|Withdrawal by Subject|8|||
144554397|NCT01613599|521227432|FG000|Overall Study|Reason not specified|3|||
144554398|NCT02991456|521227433|FG000|Overall Study|Adverse Event|2|||
144554399|NCT02991456|521227434|FG001|Overall Study|Adverse Event|0|||
144203435|NCT01739348|519940342|FG003|Part II (Extension Study)|Participant Moved|3|||
144203436|NCT01739348|519940339|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
144203437|NCT01739348|519940340|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
144203438|NCT01739348|519940341|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
144203439|NCT01739348|519940342|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
144203440|NCT01739348|519940339|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
144262427|NCT01317641|520161438|FG004|Overall Study|Not treated|0|||
144262428|NCT01317641|520161439|FG005|Overall Study|Not treated|0|||
144554400|NCT02991456|521227433|FG000|Overall Study|Lost to Follow-up|0|||
144554401|NCT02991456|521227434|FG001|Overall Study|Lost to Follow-up|2|||
144554402|NCT02991456|521227433|FG000|Overall Study|Withdrawal by Subject|1|||
144554403|NCT02991456|521227434|FG001|Overall Study|Withdrawal by Subject|0|||
144554404|NCT03503188|521227435|FG000|Overall Study|Non eligible in the sub study|0|||
144554405|NCT03503188|521227436|FG001|Overall Study|Non eligible in the sub study|1|||
144554406|NCT02066389|521227440|FG000|Overall Study|Adverse Event|1|||
144554407|NCT02066389|521227441|FG001|Overall Study|Adverse Event|1|||
144554408|NCT02066389|521227442|FG002|Overall Study|Adverse Event|1|||
144554409|NCT02066389|521227443|FG003|Overall Study|Adverse Event|1|||
144554410|NCT02066389|521227444|FG004|Overall Study|Adverse Event|5|||
144554411|NCT02066389|521227445|FG005|Overall Study|Adverse Event|1|||
144554412|NCT02066389|521227440|FG000|Overall Study|Withdrawal by Subject|4|||
144554413|NCT02066389|521227441|FG001|Overall Study|Withdrawal by Subject|0|||
144554414|NCT02066389|521227442|FG002|Overall Study|Withdrawal by Subject|5|||
144554415|NCT02066389|521227443|FG003|Overall Study|Withdrawal by Subject|1|||
144554416|NCT02066389|521227444|FG004|Overall Study|Withdrawal by Subject|1|||
144554417|NCT02066389|521227445|FG005|Overall Study|Withdrawal by Subject|2|||
144554418|NCT02066389|521227440|FG000|Overall Study|Lost to Follow-up|0|||
144554419|NCT02066389|521227441|FG001|Overall Study|Lost to Follow-up|0|||
144554420|NCT02066389|521227442|FG002|Overall Study|Lost to Follow-up|0|||
144554421|NCT02066389|521227443|FG003|Overall Study|Lost to Follow-up|1|||
144554422|NCT02066389|521227444|FG004|Overall Study|Lost to Follow-up|1|||
144554423|NCT02066389|521227445|FG005|Overall Study|Lost to Follow-up|1|||
144554424|NCT02066389|521227440|FG000|Overall Study|Randomized in Error|0|||
144554425|NCT02066389|521227441|FG001|Overall Study|Randomized in Error|0|||
144554426|NCT02066389|521227442|FG002|Overall Study|Randomized in Error|0|||
144554427|NCT02066389|521227443|FG003|Overall Study|Randomized in Error|0|||
144554428|NCT02066389|521227444|FG004|Overall Study|Randomized in Error|0|||
144554429|NCT02066389|521227445|FG005|Overall Study|Randomized in Error|1|||
144554430|NCT04016415|521227446|FG000|Overall Study|Adverse Event|2|||
144554431|NCT04016415|521227447|FG001|Overall Study|Adverse Event|1|||
144554432|NCT04016415|521227446|FG000|Overall Study|Lost to Follow-up|6|||
144554433|NCT04016415|521227447|FG001|Overall Study|Lost to Follow-up|2|||
144554434|NCT04016415|521227446|FG000|Overall Study|Physician Decision|5|||
144554435|NCT04016415|521227447|FG001|Overall Study|Physician Decision|1|||
144554436|NCT04016415|521227446|FG000|Overall Study|Pregnancy|0|||
144554437|NCT04016415|521227447|FG001|Overall Study|Pregnancy|1|||
144554438|NCT04016415|521227446|FG000|Overall Study|Withdrawal by Subject|24|||
144554439|NCT04016415|521227447|FG001|Overall Study|Withdrawal by Subject|27|||
144554440|NCT04016415|521227446|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
144554441|NCT04016415|521227447|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
144554442|NCT02561195|521227450|FG000|Vaccination 1 to 3|Adverse Event|4|||
144554443|NCT02561195|521227451|FG001|Vaccination 1 to 3|Adverse Event|5|||
144554444|NCT02561195|521227452|FG002|Vaccination 1 to 3|Adverse Event|0|||
144554445|NCT02561195|521227453|FG003|Vaccination 1 to 3|Adverse Event|3|||
144554446|NCT02561195|521227454|FG004|Vaccination 1 to 3|Adverse Event|4|||
144554447|NCT02561195|521227455|FG005|Vaccination 1 to 3|Adverse Event|0|||
144554448|NCT02561195|521227456|FG006|Vaccination 1 to 3|Adverse Event|0|||
144554449|NCT02561195|521227457|FG007|Vaccination 1 to 3|Adverse Event|0|||
144554450|NCT02561195|521227458|FG008|Vaccination 1 to 3|Adverse Event|0|||
144554451|NCT02561195|521227459|FG009|Vaccination 1 to 3|Adverse Event|0|||
144554452|NCT02561195|521227460|FG010|Vaccination 1 to 3|Adverse Event|0|||
144554453|NCT02561195|521227461|FG011|Vaccination 1 to 3|Adverse Event|0|||
144554454|NCT02561195|521227462|FG012|Vaccination 1 to 3|Adverse Event|0|||
144554455|NCT02561195|521227463|FG013|Vaccination 1 to 3|Adverse Event|0|||
144554456|NCT02561195|521227450|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
144554457|NCT02561195|521227451|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
144554458|NCT02561195|521227452|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
144554459|NCT02561195|521227453|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
144554460|NCT02561195|521227454|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
144554461|NCT02561195|521227455|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
144554462|NCT02561195|521227456|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
144554463|NCT02561195|521227457|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
144554464|NCT02561195|521227458|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
144554465|NCT02561195|521227459|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
144554466|NCT02561195|521227460|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
144554467|NCT02561195|521227461|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
144554468|NCT02561195|521227462|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
144554469|NCT02561195|521227463|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
144554470|NCT02561195|521227450|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554471|NCT02561195|521227451|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
144554472|NCT02561195|521227452|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144616910|NCT01870401|521457998|FG000|Overall Study|Withdrawal by Subject|39|||
144616911|NCT01870401|521457999|FG001|Overall Study|Withdrawal by Subject|26|||
144554473|NCT02561195|521227453|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
144554474|NCT02561195|521227454|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
144554475|NCT02561195|521227455|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
144554476|NCT02561195|521227456|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554477|NCT02561195|521227457|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554478|NCT02561195|521227458|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554479|NCT02561195|521227459|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554480|NCT02561195|521227460|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554481|NCT02561195|521227461|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554482|NCT02561195|521227462|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554483|NCT02561195|521227463|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
144554484|NCT02561195|521227450|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
144554485|NCT02561195|521227451|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
144554486|NCT02561195|521227452|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
144554487|NCT02561195|521227453|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
144554488|NCT02561195|521227454|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
144554489|NCT02561195|521227455|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
144554490|NCT02561195|521227456|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
144554491|NCT02561195|521227457|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
144554492|NCT02561195|521227458|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
144554493|NCT02561195|521227459|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
144554494|NCT02561195|521227460|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
144554495|NCT02561195|521227461|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
144554496|NCT02561195|521227462|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
144554497|NCT02561195|521227463|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
144554498|NCT02561195|521227450|FG000|Vaccination 1 to 3|Other|7|||
144554499|NCT02561195|521227451|FG001|Vaccination 1 to 3|Other|3|||
144554500|NCT02561195|521227452|FG002|Vaccination 1 to 3|Other|1|||
144554501|NCT02561195|521227453|FG003|Vaccination 1 to 3|Other|7|||
144554502|NCT02561195|521227454|FG004|Vaccination 1 to 3|Other|5|||
144554503|NCT02561195|521227455|FG005|Vaccination 1 to 3|Other|1|||
144554504|NCT02561195|521227456|FG006|Vaccination 1 to 3|Other|0|||
144554505|NCT02561195|521227457|FG007|Vaccination 1 to 3|Other|0|||
144554506|NCT02561195|521227458|FG008|Vaccination 1 to 3|Other|0|||
144554507|NCT02561195|521227459|FG009|Vaccination 1 to 3|Other|0|||
144554508|NCT02561195|521227460|FG010|Vaccination 1 to 3|Other|0|||
144554509|NCT02561195|521227461|FG011|Vaccination 1 to 3|Other|0|||
144554510|NCT02561195|521227462|FG012|Vaccination 1 to 3|Other|0|||
144554511|NCT02561195|521227463|FG013|Vaccination 1 to 3|Other|0|||
144554512|NCT02561195|521227450|FG000|Vaccination 1 to 3|Protocol Violation|1|||
144554513|NCT02561195|521227451|FG001|Vaccination 1 to 3|Protocol Violation|0|||
144554514|NCT02561195|521227452|FG002|Vaccination 1 to 3|Protocol Violation|1|||
144554515|NCT02561195|521227453|FG003|Vaccination 1 to 3|Protocol Violation|2|||
144554516|NCT02561195|521227454|FG004|Vaccination 1 to 3|Protocol Violation|5|||
144554517|NCT02561195|521227455|FG005|Vaccination 1 to 3|Protocol Violation|2|||
144554518|NCT02561195|521227456|FG006|Vaccination 1 to 3|Protocol Violation|0|||
144554519|NCT02561195|521227457|FG007|Vaccination 1 to 3|Protocol Violation|0|||
144554520|NCT02561195|521227458|FG008|Vaccination 1 to 3|Protocol Violation|0|||
144554521|NCT02561195|521227459|FG009|Vaccination 1 to 3|Protocol Violation|0|||
144554522|NCT02561195|521227460|FG010|Vaccination 1 to 3|Protocol Violation|0|||
144554523|NCT02561195|521227461|FG011|Vaccination 1 to 3|Protocol Violation|0|||
144554524|NCT02561195|521227462|FG012|Vaccination 1 to 3|Protocol Violation|0|||
144554525|NCT02561195|521227463|FG013|Vaccination 1 to 3|Protocol Violation|0|||
144554526|NCT02561195|521227450|FG000|Vaccination 1 to 3|Death|2|||
144554527|NCT02561195|521227451|FG001|Vaccination 1 to 3|Death|1|||
144554528|NCT02561195|521227452|FG002|Vaccination 1 to 3|Death|0|||
144554529|NCT02561195|521227453|FG003|Vaccination 1 to 3|Death|2|||
144554530|NCT02561195|521227454|FG004|Vaccination 1 to 3|Death|0|||
144554531|NCT02561195|521227455|FG005|Vaccination 1 to 3|Death|0|||
144554532|NCT02561195|521227456|FG006|Vaccination 1 to 3|Death|0|||
144203441|NCT01739348|519940340|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
144203442|NCT01739348|519940341|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
144203443|NCT01739348|519940342|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
144203444|NCT00660400|519940348|FG000|Overall Study|Lack of insurance approval|1|||
144203445|NCT00660400|519940348|FG000|Overall Study|Suboptimal organ function|1|||
144203446|NCT00660400|519940348|FG000|Overall Study|Intracranial hemorrhage|1|||
144203447|NCT00660400|519940348|FG000|Overall Study|Withdrawal by Subject|1|||
144554533|NCT02561195|521227457|FG007|Vaccination 1 to 3|Death|0|||
144554534|NCT02561195|521227458|FG008|Vaccination 1 to 3|Death|0|||
144554535|NCT02561195|521227459|FG009|Vaccination 1 to 3|Death|0|||
144554536|NCT02561195|521227460|FG010|Vaccination 1 to 3|Death|0|||
144554537|NCT02561195|521227461|FG011|Vaccination 1 to 3|Death|0|||
144554538|NCT02561195|521227462|FG012|Vaccination 1 to 3|Death|0|||
144554539|NCT02561195|521227463|FG013|Vaccination 1 to 3|Death|0|||
144554540|NCT02561195|521227450|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
144616912|NCT01870401|521457998|FG000|Overall Study|Lost to Follow-up|19|||
144203448|NCT01447420|519940349|FG000|Overall Study|Adverse Event|2|||
144554541|NCT02561195|521227451|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
144554542|NCT02561195|521227452|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
144554543|NCT02561195|521227453|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
144554544|NCT02561195|521227454|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
144554545|NCT02561195|521227455|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554546|NCT02561195|521227456|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554547|NCT02561195|521227457|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554548|NCT02561195|521227458|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554549|NCT02561195|521227459|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554550|NCT02561195|521227460|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554551|NCT02561195|521227461|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554552|NCT02561195|521227462|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554553|NCT02561195|521227463|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
144554554|NCT02561195|521227450|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
144554555|NCT02561195|521227451|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
144554556|NCT02561195|521227452|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
144554557|NCT02561195|521227453|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
144554558|NCT02561195|521227454|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
144554559|NCT02561195|521227455|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
144554560|NCT02561195|521227456|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
144554561|NCT02561195|521227457|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
144554562|NCT02561195|521227458|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
144554563|NCT02561195|521227459|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
144554564|NCT02561195|521227460|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
144554565|NCT02561195|521227461|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
144554566|NCT02561195|521227462|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
144554567|NCT02561195|521227463|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
144554568|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554569|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554570|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554571|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554572|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554573|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554574|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554575|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554576|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
144554577|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
144554578|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
144554579|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
144554580|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
144554581|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
144554582|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554583|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554584|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554585|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
144616913|NCT01870401|521457999|FG001|Overall Study|Lost to Follow-up|14|||
144616914|NCT01870401|521457998|FG000|Overall Study|Other|9|||
144616915|NCT01870401|521457999|FG001|Overall Study|Other|7|||
144616916|NCT01870401|521457998|FG000|Overall Study|On-going in the Study|35|||
144616917|NCT01870401|521457999|FG001|Overall Study|On-going in the Study|25|||
144616918|NCT00535132|521458000|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
144616919|NCT00535132|521458001|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
144554586|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554587|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554588|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554589|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554590|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554591|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554592|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554593|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554594|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
144554595|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
144554596|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|Death|0|||
144554597|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|Death|0|||
144554598|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|Death|0|||
144554599|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|Death|0|||
144554600|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|Death|0|||
144554601|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|Death|0|||
144554602|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|Death|0|||
144554603|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|Death|0|||
144554604|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|Death|0|||
144554605|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|Death|1|||
144616920|NCT00535132|521458000|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
144554606|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|Death|0|||
144554607|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|Death|0|||
144554608|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|Death|0|||
144554609|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|Death|0|||
144554610|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554611|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554612|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554613|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554614|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554615|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554616|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
144554617|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
144554618|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554619|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
144554620|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
144554621|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
144554622|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
144554623|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
144554624|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554625|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554626|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554627|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554628|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554629|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554630|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554631|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554632|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554633|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554634|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
144554635|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
144554636|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
144554637|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
144554638|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|Other|0|||
144554639|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|Other|0|||
144554640|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|Other|0|||
144554641|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|Other|0|||
144554642|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|Other|0|||
144554643|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|Other|0|||
144554644|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|Other|0|||
144554645|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|Other|0|||
144554646|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|Other|0|||
144554647|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|Other|0|||
144554648|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|Other|2|||
144554649|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|Other|2|||
144554650|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|Other|1|||
144554651|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|Other|0|||
144554652|NCT02561195|521227450|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554653|NCT02561195|521227451|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554654|NCT02561195|521227452|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554655|NCT02561195|521227453|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554656|NCT02561195|521227454|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554657|NCT02561195|521227455|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554658|NCT02561195|521227456|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
144554659|NCT02561195|521227457|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554660|NCT02561195|521227458|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554661|NCT02561195|521227459|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554662|NCT02561195|521227460|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
144554663|NCT02561195|521227461|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
144554664|NCT02561195|521227462|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
144554665|NCT02561195|521227463|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
144554666|NCT02993926|521227471|FG000|Enantone Treatment Phase|Adverse Event|1|||
144554667|NCT02993926|521227472|FG001|Enantone Treatment Phase|Adverse Event|0|||
144727737|NCT02924038|521858056|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
144727738|NCT02924038|521858057|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
144554668|NCT02993926|521227473|FG002|Enantone Treatment Phase|Adverse Event|0|||
144554669|NCT02993926|521227471|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
144554670|NCT02993926|521227472|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
144554671|NCT02993926|521227473|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
144554672|NCT02993926|521227471|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
144554673|NCT02993926|521227472|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
144554674|NCT02993926|521227473|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
144554675|NCT02993926|521227471|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
144554676|NCT02993926|521227472|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
144554677|NCT02993926|521227473|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
144554678|NCT03394508|521227474|FG000|Overall Study|Protocol Violation|0|||
144554679|NCT03394508|521227475|FG001|Overall Study|Protocol Violation|3|||
144554680|NCT03394508|521227474|FG000|Overall Study|Lost to Follow-up|1|||
144554681|NCT03394508|521227475|FG001|Overall Study|Lost to Follow-up|0|||
144554682|NCT02819141|521227476|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
144554683|NCT02819141|521227477|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
144554684|NCT03820024|521227478|FG000|Overall Study|Physician Decision|1|||
144554685|NCT03820024|521227479|FG001|Overall Study|Physician Decision|2|||
144554686|NCT02101554|521228957|FG000|Overall Study|Protocol Violation|0|||
144554687|NCT02101554|521228958|FG001|Overall Study|Protocol Violation|1|||
144554688|NCT02101554|521228959|FG002|Overall Study|Protocol Violation|0|||
144554689|NCT02101554|521228957|FG000|Overall Study|Insufficient Clinical Response|0|||
144554690|NCT02101554|521228958|FG001|Overall Study|Insufficient Clinical Response|2|||
144554691|NCT02101554|521228959|FG002|Overall Study|Insufficient Clinical Response|0|||
144554692|NCT02101554|521228957|FG000|Overall Study|Adverse Event|2|||
144554693|NCT02101554|521228958|FG001|Overall Study|Adverse Event|1|||
144554694|NCT02101554|521228959|FG002|Overall Study|Adverse Event|1|||
144554695|NCT02101554|521228957|FG000|Overall Study|Lost to Follow-up|0|||
144554696|NCT02101554|521228958|FG001|Overall Study|Lost to Follow-up|1|||
144554697|NCT02101554|521228959|FG002|Overall Study|Lost to Follow-up|0|||
144554698|NCT02101554|521228957|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
144554699|NCT02101554|521228958|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
144554700|NCT02101554|521228959|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
144554701|NCT00409006|521228960|FG000|Overall Study|Death|15|||
144554702|NCT00409006|521228961|FG001|Overall Study|Death|6|||
144554703|NCT00409006|521228960|FG000|Overall Study|Lost to Follow-up|1|||
144554704|NCT00409006|521228961|FG001|Overall Study|Lost to Follow-up|2|||
144554705|NCT00409006|521228960|FG000|Overall Study|Withdrawal by Subject|3|||
144554706|NCT00409006|521228961|FG001|Overall Study|Withdrawal by Subject|2|||
144554707|NCT00409006|521228960|FG000|Overall Study|Physician Decision|1|||
144554708|NCT00409006|521228961|FG001|Overall Study|Physician Decision|2|||
144554709|NCT02011568|521228964|FG000|Overall Study|Withdrawal by Subject|8|||
144554710|NCT02011568|521228965|FG001|Overall Study|Withdrawal by Subject|10|||
144554711|NCT02011568|521228964|FG000|Overall Study|Physician Decision|1|||
144554712|NCT02011568|521228965|FG001|Overall Study|Physician Decision|3|||
144554713|NCT01107353|521228966|FG000|Overall Study|Positive Drug Screen|1|||
144554714|NCT01107353|521228967|FG001|Overall Study|Positive Drug Screen|0|||
144554715|NCT03034772|521228968|FG000|Overall Study|Adverse Event|0|||
144554716|NCT03034772|521228969|FG001|Overall Study|Adverse Event|1|||
144554717|NCT03034772|521228968|FG000|Overall Study|Withdrawal by Subject|0|||
144554718|NCT03034772|521228969|FG001|Overall Study|Withdrawal by Subject|1|||
144554719|NCT01136733|521228970|FG000|Phase 1b|Adverse Event|0|||
144554720|NCT01136733|521228971|FG001|Phase 1b|Adverse Event|3|||
144554721|NCT01136733|521228972|FG002|Phase 1b|Adverse Event|1|||
144554722|NCT01136733|521228973|FG003|Phase 1b|Adverse Event|0|||
144554723|NCT01136733|521228974|FG004|Phase 1b|Adverse Event|0|||
144554724|NCT01136733|521228975|FG005|Phase 1b|Adverse Event|0|||
144554725|NCT01136733|521228976|FG006|Phase 1b|Adverse Event|0|||
144554726|NCT01136733|521228970|FG000|Phase 1b|Participant Choice|0|||
144554727|NCT01136733|521228971|FG001|Phase 1b|Participant Choice|0|||
144554728|NCT01136733|521228972|FG002|Phase 1b|Participant Choice|1|||
144554729|NCT01136733|521228973|FG003|Phase 1b|Participant Choice|0|||
144554730|NCT01136733|521228974|FG004|Phase 1b|Participant Choice|0|||
144554731|NCT01136733|521228975|FG005|Phase 1b|Participant Choice|0|||
144554732|NCT01136733|521228976|FG006|Phase 1b|Participant Choice|0|||
144554733|NCT01136733|521228970|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
144554734|NCT01136733|521228971|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
144554735|NCT01136733|521228972|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
144554736|NCT01136733|521228973|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
144554737|NCT01136733|521228974|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
144554738|NCT01136733|521228975|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
144554739|NCT01136733|521228976|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
144554740|NCT01136733|521228970|FG000|Phase 1b|Clinical Progression|1|||
144554741|NCT01136733|521228971|FG001|Phase 1b|Clinical Progression|1|||
144554742|NCT01136733|521228972|FG002|Phase 1b|Clinical Progression|0|||
144554743|NCT01136733|521228973|FG003|Phase 1b|Clinical Progression|0|||
144554744|NCT01136733|521228974|FG004|Phase 1b|Clinical Progression|0|||
144554745|NCT01136733|521228975|FG005|Phase 1b|Clinical Progression|0|||
144554746|NCT01136733|521228976|FG006|Phase 1b|Clinical Progression|0|||
144554747|NCT01136733|521228970|FG000|Phase 2|Disease Progression|0|||
144554748|NCT01136733|521228971|FG001|Phase 2|Disease Progression|0|||
144554749|NCT01136733|521228972|FG002|Phase 2|Disease Progression|0|||
144554750|NCT01136733|521228973|FG003|Phase 2|Disease Progression|0|||
144554751|NCT01136733|521228974|FG004|Phase 2|Disease Progression|30|||
144554752|NCT01136733|521228975|FG005|Phase 2|Disease Progression|32|||
144554753|NCT01136733|521228976|FG006|Phase 2|Disease Progression|38|||
144554754|NCT01136733|521228970|FG000|Phase 2|Adverse Event|0|||
144554755|NCT01136733|521228971|FG001|Phase 2|Adverse Event|0|||
144554756|NCT01136733|521228972|FG002|Phase 2|Adverse Event|0|||
144554757|NCT01136733|521228973|FG003|Phase 2|Adverse Event|0|||
144616921|NCT00535132|521458001|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
144616922|NCT02590588|521458002|FG000|Overall Study|Adverse Event|1|||
144616923|NCT05630937|521458012|FG000|Overall Study|Study terminated by sponsor|1|||
144616924|NCT05630937|521458013|FG001|Overall Study|Study terminated by sponsor|1|||
144616925|NCT05630937|521458014|FG002|Overall Study|Study terminated by sponsor|8|||
144616926|NCT05630937|521458015|FG003|Overall Study|Study terminated by sponsor|0|||
144616927|NCT05630937|521458012|FG000|Overall Study|Lost to Follow-up|0|||
144616928|NCT05630937|521458013|FG001|Overall Study|Lost to Follow-up|0|||
144554758|NCT01136733|521228974|FG004|Phase 2|Adverse Event|11|||
144554759|NCT01136733|521228975|FG005|Phase 2|Adverse Event|13|||
144554760|NCT01136733|521228976|FG006|Phase 2|Adverse Event|5|||
144554761|NCT01136733|521228970|FG000|Phase 2|Participant Choice|0|||
144554762|NCT01136733|521228971|FG001|Phase 2|Participant Choice|0|||
144554763|NCT01136733|521228972|FG002|Phase 2|Participant Choice|0|||
144554764|NCT01136733|521228973|FG003|Phase 2|Participant Choice|0|||
144554765|NCT01136733|521228974|FG004|Phase 2|Participant Choice|3|||
144554766|NCT01136733|521228975|FG005|Phase 2|Participant Choice|0|||
144554767|NCT01136733|521228976|FG006|Phase 2|Participant Choice|1|||
144554768|NCT01136733|521228970|FG000|Phase 2|Administrative-Withdrew Consent|0|||
144554769|NCT01136733|521228971|FG001|Phase 2|Administrative-Withdrew Consent|0|||
144554770|NCT01136733|521228972|FG002|Phase 2|Administrative-Withdrew Consent|0|||
144554771|NCT01136733|521228973|FG003|Phase 2|Administrative-Withdrew Consent|0|||
144554772|NCT01136733|521228974|FG004|Phase 2|Administrative-Withdrew Consent|1|||
144554773|NCT01136733|521228975|FG005|Phase 2|Administrative-Withdrew Consent|0|||
144554774|NCT01136733|521228976|FG006|Phase 2|Administrative-Withdrew Consent|0|||
144554775|NCT01136733|521228970|FG000|Phase 2|Other|0|||
144554776|NCT01136733|521228971|FG001|Phase 2|Other|0|||
144554777|NCT01136733|521228972|FG002|Phase 2|Other|0|||
144554778|NCT01136733|521228973|FG003|Phase 2|Other|0|||
144554779|NCT01136733|521228974|FG004|Phase 2|Other|6|||
144554780|NCT01136733|521228975|FG005|Phase 2|Other|7|||
144554781|NCT01136733|521228976|FG006|Phase 2|Other|6|||
144554782|NCT01745380|521228977|FG000|Overall Study|Lost to Follow-up|1|||
144554783|NCT01745380|521228978|FG001|Overall Study|Lost to Follow-up|0|||
144554784|NCT01745380|521228977|FG000|Overall Study|Lack of Efficacy|0|||
144554785|NCT01745380|521228978|FG001|Overall Study|Lack of Efficacy|1|||
144554786|NCT02368691|521228979|FG000|Overall Study|Death|13|||
144554787|NCT02368691|521228979|FG000|Overall Study|Lack of Efficacy|15|||
144554788|NCT02368691|521228979|FG000|Overall Study|Physician Decision|4|||
144554789|NCT02660034|521228980|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
144554790|NCT02660034|521228981|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
144554791|NCT02660034|521228982|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
144554792|NCT02660034|521228983|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
144554793|NCT02660034|521228984|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
144554794|NCT02660034|521228985|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
144554795|NCT02660034|521228986|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
144554796|NCT02660034|521228987|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
144554797|NCT02660034|521228988|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
144554798|NCT02660034|521228989|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
144554799|NCT02660034|521228990|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
144554800|NCT02660034|521228991|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
144554801|NCT02660034|521228992|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
144554802|NCT02660034|521228993|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
144554803|NCT02660034|521228980|FG000|Overall Study|Progressive Disease (Clinical)|7|||
144554804|NCT02660034|521228981|FG001|Overall Study|Progressive Disease (Clinical)|8|||
144554805|NCT02660034|521228982|FG002|Overall Study|Progressive Disease (Clinical)|3|||
144554806|NCT02660034|521228983|FG003|Overall Study|Progressive Disease (Clinical)|9|||
144554807|NCT02660034|521228984|FG004|Overall Study|Progressive Disease (Clinical)|3|||
144554808|NCT02660034|521228985|FG005|Overall Study|Progressive Disease (Clinical)|0|||
144554809|NCT02660034|521228986|FG006|Overall Study|Progressive Disease (Clinical)|0|||
144554810|NCT02660034|521228987|FG007|Overall Study|Progressive Disease (Clinical)|0|||
144554811|NCT02660034|521228988|FG008|Overall Study|Progressive Disease (Clinical)|0|||
144554812|NCT02660034|521228989|FG009|Overall Study|Progressive Disease (Clinical)|0|||
144554813|NCT02660034|521228990|FG010|Overall Study|Progressive Disease (Clinical)|0|||
144554814|NCT02660034|521228991|FG011|Overall Study|Progressive Disease (Clinical)|0|||
144554815|NCT02660034|521228992|FG012|Overall Study|Progressive Disease (Clinical)|0|||
144554816|NCT02660034|521228993|FG013|Overall Study|Progressive Disease (Clinical)|0|||
144554817|NCT02660034|521228980|FG000|Overall Study|Lost to Follow-up|0|||
144554818|NCT02660034|521228981|FG001|Overall Study|Lost to Follow-up|0|||
144554819|NCT02660034|521228982|FG002|Overall Study|Lost to Follow-up|1|||
144554820|NCT02660034|521228983|FG003|Overall Study|Lost to Follow-up|1|||
144554821|NCT02660034|521228984|FG004|Overall Study|Lost to Follow-up|0|||
144554822|NCT02660034|521228985|FG005|Overall Study|Lost to Follow-up|0|||
144554823|NCT02660034|521228986|FG006|Overall Study|Lost to Follow-up|0|||
144554824|NCT02660034|521228987|FG007|Overall Study|Lost to Follow-up|0|||
144554825|NCT02660034|521228988|FG008|Overall Study|Lost to Follow-up|0|||
144554826|NCT02660034|521228989|FG009|Overall Study|Lost to Follow-up|1|||
144554827|NCT02660034|521228990|FG010|Overall Study|Lost to Follow-up|1|||
144554828|NCT02660034|521228991|FG011|Overall Study|Lost to Follow-up|1|||
144554829|NCT02660034|521228992|FG012|Overall Study|Lost to Follow-up|0|||
144554830|NCT02660034|521228993|FG013|Overall Study|Lost to Follow-up|0|||
144554831|NCT02660034|521228980|FG000|Overall Study|Participant moved into special access scheme|1|||
144554832|NCT02660034|521228981|FG001|Overall Study|Participant moved into special access scheme|2|||
144554833|NCT02660034|521228982|FG002|Overall Study|Participant moved into special access scheme|0|||
144554834|NCT02660034|521228983|FG003|Overall Study|Participant moved into special access scheme|0|||
144554835|NCT02660034|521228984|FG004|Overall Study|Participant moved into special access scheme|0|||
144554836|NCT02660034|521228985|FG005|Overall Study|Participant moved into special access scheme|0|||
144554837|NCT02660034|521228986|FG006|Overall Study|Participant moved into special access scheme|0|||
144554838|NCT02660034|521228987|FG007|Overall Study|Participant moved into special access scheme|0|||
144554839|NCT02660034|521228988|FG008|Overall Study|Participant moved into special access scheme|0|||
144554840|NCT02660034|521228989|FG009|Overall Study|Participant moved into special access scheme|0|||
144554841|NCT02660034|521228990|FG010|Overall Study|Participant moved into special access scheme|0|||
144554842|NCT02660034|521228991|FG011|Overall Study|Participant moved into special access scheme|0|||
144554843|NCT02660034|521228992|FG012|Overall Study|Participant moved into special access scheme|0|||
144554844|NCT02660034|521228993|FG013|Overall Study|Participant moved into special access scheme|0|||
144554845|NCT02660034|521228980|FG000|Overall Study|Adverse Event|1|||
144554846|NCT02660034|521228981|FG001|Overall Study|Adverse Event|0|||
144554847|NCT02660034|521228982|FG002|Overall Study|Adverse Event|0|||
144554848|NCT02660034|521228983|FG003|Overall Study|Adverse Event|0|||
144554849|NCT02660034|521228984|FG004|Overall Study|Adverse Event|0|||
144554850|NCT02660034|521228985|FG005|Overall Study|Adverse Event|0|||
144554851|NCT02660034|521228986|FG006|Overall Study|Adverse Event|0|||
144554852|NCT02660034|521228987|FG007|Overall Study|Adverse Event|0|||
144554853|NCT02660034|521228988|FG008|Overall Study|Adverse Event|0|||
144554854|NCT02660034|521228989|FG009|Overall Study|Adverse Event|0|||
144554855|NCT02660034|521228990|FG010|Overall Study|Adverse Event|0|||
144554856|NCT02660034|521228991|FG011|Overall Study|Adverse Event|0|||
144554857|NCT02660034|521228992|FG012|Overall Study|Adverse Event|0|||
144554858|NCT02660034|521228993|FG013|Overall Study|Adverse Event|0|||
144554859|NCT02660034|521228980|FG000|Overall Study|Sponsor Decision|0|||
144554860|NCT02660034|521228981|FG001|Overall Study|Sponsor Decision|1|||
144554861|NCT02660034|521228982|FG002|Overall Study|Sponsor Decision|2|||
144554862|NCT02660034|521228983|FG003|Overall Study|Sponsor Decision|2|||
144554863|NCT02660034|521228984|FG004|Overall Study|Sponsor Decision|3|||
144554864|NCT02660034|521228985|FG005|Overall Study|Sponsor Decision|0|||
144554865|NCT02660034|521228986|FG006|Overall Study|Sponsor Decision|0|||
144554866|NCT02660034|521228987|FG007|Overall Study|Sponsor Decision|0|||
144554867|NCT02660034|521228988|FG008|Overall Study|Sponsor Decision|0|||
144554868|NCT02660034|521228989|FG009|Overall Study|Sponsor Decision|0|||
144554869|NCT02660034|521228990|FG010|Overall Study|Sponsor Decision|0|||
144554870|NCT02660034|521228991|FG011|Overall Study|Sponsor Decision|0|||
144554871|NCT02660034|521228992|FG012|Overall Study|Sponsor Decision|0|||
144554872|NCT02660034|521228993|FG013|Overall Study|Sponsor Decision|1|||
144554873|NCT02660034|521228980|FG000|Overall Study|Withdrawal by Subject|0|||
144203449|NCT01447420|519940350|FG001|Overall Study|Adverse Event|4|||
144203450|NCT01447420|519940351|FG002|Overall Study|Adverse Event|2|||
144203451|NCT01447420|519940349|FG000|Overall Study|Protocol Violation|3|||
144203452|NCT01447420|519940350|FG001|Overall Study|Protocol Violation|3|||
144203453|NCT01447420|519940351|FG002|Overall Study|Protocol Violation|0|||
144203454|NCT01447420|519940349|FG000|Overall Study|Withdrawal by Subject|4|||
144554874|NCT02660034|521228981|FG001|Overall Study|Withdrawal by Subject|0|||
144554875|NCT02660034|521228982|FG002|Overall Study|Withdrawal by Subject|0|||
144554876|NCT02660034|521228983|FG003|Overall Study|Withdrawal by Subject|0|||
144554877|NCT02660034|521228984|FG004|Overall Study|Withdrawal by Subject|0|||
144554878|NCT02660034|521228985|FG005|Overall Study|Withdrawal by Subject|0|||
144554879|NCT02660034|521228986|FG006|Overall Study|Withdrawal by Subject|1|||
144554880|NCT02660034|521228987|FG007|Overall Study|Withdrawal by Subject|1|||
144554881|NCT02660034|521228988|FG008|Overall Study|Withdrawal by Subject|1|||
144616929|NCT05630937|521458014|FG002|Overall Study|Lost to Follow-up|1|||
144554882|NCT02660034|521228989|FG009|Overall Study|Withdrawal by Subject|0|||
144554883|NCT02660034|521228990|FG010|Overall Study|Withdrawal by Subject|0|||
144554884|NCT02660034|521228991|FG011|Overall Study|Withdrawal by Subject|1|||
144554885|NCT02660034|521228992|FG012|Overall Study|Withdrawal by Subject|2|||
144554886|NCT02660034|521228993|FG013|Overall Study|Withdrawal by Subject|0|||
144203455|NCT01447420|519940350|FG001|Overall Study|Withdrawal by Subject|1|||
144554887|NCT02660034|521228980|FG000|Overall Study|Death|0|||
144554888|NCT02660034|521228981|FG001|Overall Study|Death|0|||
144554889|NCT02660034|521228982|FG002|Overall Study|Death|0|||
144554890|NCT02660034|521228983|FG003|Overall Study|Death|0|||
144554891|NCT02660034|521228984|FG004|Overall Study|Death|0|||
144554892|NCT02660034|521228985|FG005|Overall Study|Death|13|||
144554893|NCT02660034|521228986|FG006|Overall Study|Death|14|||
144554894|NCT02660034|521228987|FG007|Overall Study|Death|10|||
144554895|NCT02660034|521228988|FG008|Overall Study|Death|9|||
144554896|NCT02660034|521228989|FG009|Overall Study|Death|21|||
144554897|NCT02660034|521228990|FG010|Overall Study|Death|17|||
144554898|NCT02660034|521228991|FG011|Overall Study|Death|15|||
144554899|NCT02660034|521228992|FG012|Overall Study|Death|18|||
144554900|NCT02660034|521228993|FG013|Overall Study|Death|7|||
144554901|NCT02660034|521228980|FG000|Overall Study|Physician Decision|0|||
144554902|NCT02660034|521228981|FG001|Overall Study|Physician Decision|0|||
144554903|NCT02660034|521228982|FG002|Overall Study|Physician Decision|0|||
144554904|NCT02660034|521228983|FG003|Overall Study|Physician Decision|0|||
144554905|NCT02660034|521228984|FG004|Overall Study|Physician Decision|0|||
144554906|NCT02660034|521228985|FG005|Overall Study|Physician Decision|0|||
144554907|NCT02660034|521228986|FG006|Overall Study|Physician Decision|0|||
144554908|NCT02660034|521228987|FG007|Overall Study|Physician Decision|0|||
144554909|NCT02660034|521228988|FG008|Overall Study|Physician Decision|0|||
144554910|NCT02660034|521228989|FG009|Overall Study|Physician Decision|0|||
144554911|NCT02660034|521228990|FG010|Overall Study|Physician Decision|0|||
144554912|NCT02660034|521228991|FG011|Overall Study|Physician Decision|0|||
144554913|NCT02660034|521228992|FG012|Overall Study|Physician Decision|0|||
144554914|NCT02660034|521228993|FG013|Overall Study|Physician Decision|1|||
144554915|NCT02660034|521228980|FG000|Overall Study|Participants transferred to LTE|0|||
144554916|NCT02660034|521228981|FG001|Overall Study|Participants transferred to LTE|0|||
144554917|NCT02660034|521228982|FG002|Overall Study|Participants transferred to LTE|0|||
144554918|NCT02660034|521228983|FG003|Overall Study|Participants transferred to LTE|0|||
144554919|NCT02660034|521228984|FG004|Overall Study|Participants transferred to LTE|0|||
144554920|NCT02660034|521228985|FG005|Overall Study|Participants transferred to LTE|10|||
144554921|NCT02660034|521228986|FG006|Overall Study|Participants transferred to LTE|8|||
144554922|NCT02660034|521228987|FG007|Overall Study|Participants transferred to LTE|8|||
144554923|NCT02660034|521228988|FG008|Overall Study|Participants transferred to LTE|10|||
144554924|NCT02660034|521228989|FG009|Overall Study|Participants transferred to LTE|1|||
144554925|NCT02660034|521228990|FG010|Overall Study|Participants transferred to LTE|2|||
144554926|NCT02660034|521228991|FG011|Overall Study|Participants transferred to LTE|4|||
144554927|NCT02660034|521228992|FG012|Overall Study|Participants transferred to LTE|1|||
144554928|NCT02660034|521228993|FG013|Overall Study|Participants transferred to LTE|1|||
144554929|NCT02069366|521228996|FG000|Overall Study|Lost to Follow-up|0|||
144554930|NCT02069366|521228997|FG001|Overall Study|Lost to Follow-up|0|||
144554931|NCT02069366|521228998|FG002|Overall Study|Lost to Follow-up|1|||
144554932|NCT02069366|521228999|FG003|Overall Study|Lost to Follow-up|0|||
144554933|NCT02069366|521229000|FG004|Overall Study|Lost to Follow-up|0|||
144554934|NCT02069366|521229001|FG005|Overall Study|Lost to Follow-up|2|||
144554935|NCT02069366|521228996|FG000|Overall Study|Protocol Violation|0|||
144554936|NCT02069366|521228997|FG001|Overall Study|Protocol Violation|0|||
144554937|NCT02069366|521228998|FG002|Overall Study|Protocol Violation|1|||
144554938|NCT02069366|521228999|FG003|Overall Study|Protocol Violation|0|||
144554939|NCT02069366|521229000|FG004|Overall Study|Protocol Violation|0|||
144554940|NCT02069366|521229001|FG005|Overall Study|Protocol Violation|0|||
144554941|NCT02069366|521228996|FG000|Overall Study|Withdrawal by Subject|1|||
144554942|NCT02069366|521228997|FG001|Overall Study|Withdrawal by Subject|0|||
144554943|NCT02069366|521228998|FG002|Overall Study|Withdrawal by Subject|1|||
144554944|NCT02069366|521228999|FG003|Overall Study|Withdrawal by Subject|2|||
144554945|NCT02069366|521229000|FG004|Overall Study|Withdrawal by Subject|0|||
144554946|NCT02069366|521229001|FG005|Overall Study|Withdrawal by Subject|0|||
144554947|NCT03314233|521229003|FG000|Overall Study|No longer eligible at time of delivery|1|||
144554948|NCT01797705|521229004|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
144554949|NCT01797705|521229004|FG000|Overall Study|Withdrawal by Subject|1|||
144554950|NCT01838447|521229005|FG000|Overall Study|Change in surgical plan|1|||
144554951|NCT01838447|521229006|FG001|Overall Study|Change in surgical plan|2|||
144554952|NCT01838447|521229005|FG000|Overall Study|Withdrawal by Subject|1|||
144554953|NCT01838447|521229006|FG001|Overall Study|Withdrawal by Subject|1|||
144554954|NCT02030847|521229010|FG000|Overall Study|Death|10|||
144554955|NCT02030847|521229010|FG000|Overall Study|Disease Progression|15|||
144554956|NCT02030847|521229010|FG000|Overall Study|New Cancer Therapy|8|||
144616930|NCT05630937|521458015|FG003|Overall Study|Lost to Follow-up|0|||
144554957|NCT02030847|521229010|FG000|Overall Study|Physician Decision|3|||
144554958|NCT02030847|521229010|FG000|Overall Study|Withdrawal by Subject|1|||
144554959|NCT06247488|521229013|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
144554960|NCT06247488|521229014|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
144554961|NCT06247488|521229015|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
144554962|NCT06247488|521229016|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
144554963|NCT06247488|521229017|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
144554964|NCT06247488|521229018|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
144554965|NCT06247488|521229013|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
144554966|NCT06247488|521229014|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
144554967|NCT06247488|521229015|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
144554968|NCT06247488|521229016|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
144554969|NCT06247488|521229017|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
144554970|NCT06247488|521229018|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
144554971|NCT06247488|521229013|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
144554972|NCT06247488|521229014|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
144554973|NCT06247488|521229015|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
144554974|NCT06247488|521229016|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
144554975|NCT06247488|521229017|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
144554976|NCT06247488|521229018|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
144554977|NCT06247488|521229013|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
144554978|NCT06247488|521229014|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
144554979|NCT06247488|521229015|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
144554980|NCT06247488|521229016|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
144554981|NCT06247488|521229017|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
144554982|NCT06247488|521229018|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
144554983|NCT06247488|521229013|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
144554984|NCT06247488|521229014|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
144554985|NCT06247488|521229015|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
144554986|NCT06247488|521229016|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
144554987|NCT06247488|521229017|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
144554988|NCT06247488|521229018|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
144554989|NCT06247488|521229013|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
144554990|NCT06247488|521229014|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
144554991|NCT06247488|521229015|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
144554992|NCT06247488|521229016|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
144554993|NCT06247488|521229017|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
144554994|NCT06247488|521229018|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
144554995|NCT06247488|521229013|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
144554996|NCT06247488|521229014|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
144554997|NCT06247488|521229015|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
144554998|NCT06247488|521229016|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
144554999|NCT06247488|521229017|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
144555000|NCT06247488|521229018|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
144555001|NCT00460434|521229021|FG000|Overall Study|Lost to Follow-up|3|||
144555002|NCT00460434|521229022|FG001|Overall Study|Lost to Follow-up|7|||
144555003|NCT02722278|521229025|FG000|Overall Study|Withdrawal by Subject|5|||
144555004|NCT02722278|521229026|FG001|Overall Study|Withdrawal by Subject|3|||
144555005|NCT02722278|521229025|FG000|Overall Study|Adverse Event|4|||
144555006|NCT02722278|521229026|FG001|Overall Study|Adverse Event|1|||
144555007|NCT02722278|521229025|FG000|Overall Study|Lost to Follow-up|2|||
144555008|NCT02722278|521229026|FG001|Overall Study|Lost to Follow-up|0|||
144555009|NCT02722278|521229025|FG000|Overall Study|Protocol Violation|1|||
144555010|NCT02722278|521229026|FG001|Overall Study|Protocol Violation|0|||
144555011|NCT02722278|521229025|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
144555012|NCT02722278|521229026|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
144555013|NCT02722278|521229025|FG000|Overall Study|Subject declined after tx assignment|0|||
144555014|NCT02722278|521229026|FG001|Overall Study|Subject declined after tx assignment|1|||
144555015|NCT02722278|521229025|FG000|Overall Study|Site closure not study related|0|||
144555016|NCT02722278|521229026|FG001|Overall Study|Site closure not study related|1|||
144555017|NCT00561678|521229027|FG000|Overall Study|Withdrawal by Subject|4|||
144555018|NCT00561678|521229028|FG001|Overall Study|Withdrawal by Subject|3|||
144555019|NCT00561678|521229027|FG000|Overall Study|surgery cancelled|1|||
144555020|NCT00561678|521229028|FG001|Overall Study|surgery cancelled|1|||
144555021|NCT00561678|521229027|FG000|Overall Study|surgery rescheduled to different site|2|||
144555022|NCT00561678|521229028|FG001|Overall Study|surgery rescheduled to different site|2|||
144555023|NCT00561678|521229027|FG000|Overall Study|anesthesia provider refusal|1|||
144555024|NCT00561678|521229028|FG001|Overall Study|anesthesia provider refusal|0|||
144555025|NCT00422162|521229029|FG000|Overall Study|Adverse Event|11|||
144555026|NCT00422162|521229030|FG001|Overall Study|Adverse Event|9|||
144555027|NCT00422162|521229029|FG000|Overall Study|Lack of Efficacy|4|||
144203456|NCT01447420|519940351|FG002|Overall Study|Withdrawal by Subject|0|||
144203457|NCT01447420|519940349|FG000|Overall Study|Lack of Efficacy|1|||
144203458|NCT01447420|519940350|FG001|Overall Study|Lack of Efficacy|19|||
144555028|NCT00422162|521229030|FG001|Overall Study|Lack of Efficacy|10|||
144555029|NCT00422162|521229029|FG000|Overall Study|Withdrawal by Subject|7|||
144555030|NCT00422162|521229030|FG001|Overall Study|Withdrawal by Subject|6|||
144555031|NCT00422162|521229029|FG000|Overall Study|Lost to Follow-up|1|||
144555032|NCT00422162|521229030|FG001|Overall Study|Lost to Follow-up|2|||
144555033|NCT00422162|521229029|FG000|Overall Study|Non-Compliant with Protocol|1|||
144555034|NCT00422162|521229030|FG001|Overall Study|Non-Compliant with Protocol|1|||
144555035|NCT00422162|521229029|FG000|Overall Study|Other|0|||
144555036|NCT00422162|521229030|FG001|Overall Study|Other|1|||
144555037|NCT00422162|521229029|FG000|Overall Study|Didn't Receive Treatment|0|||
144555038|NCT00422162|521229030|FG001|Overall Study|Didn't Receive Treatment|1|||
144555039|NCT05274906|521229032|FG000|Overall Study|Withdrawal by Subject|2|||
144555040|NCT05274906|521229033|FG001|Overall Study|Withdrawal by Subject|1|||
144555041|NCT00848198|521229034|FG000|Overall Study|Incomplete Case Report Forms|15|||
144555042|NCT02604199|521229037|FG000|Overall Study|Pregnancy|0|||
144555043|NCT02604199|521229038|FG001|Overall Study|Pregnancy|0|||
144555044|NCT02604199|521229039|FG002|Overall Study|Pregnancy|0|||
144555045|NCT02604199|521229040|FG003|Overall Study|Pregnancy|1|||
144555046|NCT02604199|521229037|FG000|Overall Study|Study terminated by sponsor|0|||
144555047|NCT02604199|521229038|FG001|Overall Study|Study terminated by sponsor|2|||
144555048|NCT02604199|521229039|FG002|Overall Study|Study terminated by sponsor|0|||
144555049|NCT02604199|521229040|FG003|Overall Study|Study terminated by sponsor|2|||
144555050|NCT02604199|521229037|FG000|Overall Study|Withdrawal by Subject|0|||
144555051|NCT02604199|521229038|FG001|Overall Study|Withdrawal by Subject|1|||
144203459|NCT01447420|519940351|FG002|Overall Study|Lack of Efficacy|8|||
144203460|NCT00528411|519940355|FG000|Overall Study|Adverse Event|4|||
144555052|NCT02604199|521229039|FG002|Overall Study|Withdrawal by Subject|0|||
144555053|NCT02604199|521229040|FG003|Overall Study|Withdrawal by Subject|0|||
144555054|NCT01622088|521229047|FG000|Overall Study|Adverse Event|20|||
144555055|NCT01622088|521229047|FG000|Overall Study|Lost to Follow-up|1|||
144555056|NCT01622088|521229047|FG000|Overall Study|Withdrawal by Subject|20|||
144555057|NCT01622088|521229047|FG000|Overall Study|Investigator Decision|1|||
144555058|NCT01622088|521229047|FG000|Overall Study|Death|53|||
144555059|NCT01622088|521229047|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
144555060|NCT00134056|521229052|FG000|Randomization|Not eligible for assigned treatment|22|||
144555061|NCT00134056|521229053|FG001|Randomization|Not eligible for assigned treatment|20|||
144555062|NCT00134056|521229052|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
144555063|NCT00134056|521229053|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
144555064|NCT00134056|521229052|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
144555065|NCT00134056|521229053|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
144555066|NCT00134056|521229052|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
144555067|NCT00134056|521229053|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
144555068|NCT00134056|521229052|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
144555069|NCT00134056|521229053|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
144555070|NCT03166215|521229054|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
144555071|NCT03166215|521229055|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
144555072|NCT03166215|521229056|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
144555073|NCT03166215|521229054|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
144555074|NCT03166215|521229055|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
144555075|NCT03166215|521229056|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
144555076|NCT00742560|521229057|FG000|Overall Study|Adverse Event|0|||
144555077|NCT00742560|521229058|FG001|Overall Study|Adverse Event|0|||
144555078|NCT00742560|521229059|FG002|Overall Study|Adverse Event|1|||
144555079|NCT00742560|521229060|FG003|Overall Study|Adverse Event|1|||
144555080|NCT00742560|521229061|FG004|Overall Study|Adverse Event|1|||
144555081|NCT00742560|521229057|FG000|Overall Study|Death|0|||
144555082|NCT00742560|521229058|FG001|Overall Study|Death|2|||
144555083|NCT00742560|521229059|FG002|Overall Study|Death|0|||
144555084|NCT00742560|521229060|FG003|Overall Study|Death|2|||
144555085|NCT00742560|521229061|FG004|Overall Study|Death|3|||
144555086|NCT00742560|521229057|FG000|Overall Study|Subject's Decision|1|||
144555087|NCT00742560|521229058|FG001|Overall Study|Subject's Decision|0|||
144555088|NCT00742560|521229059|FG002|Overall Study|Subject's Decision|2|||
144555089|NCT00742560|521229060|FG003|Overall Study|Subject's Decision|3|||
144555090|NCT00742560|521229061|FG004|Overall Study|Subject's Decision|3|||
144555091|NCT00742560|521229057|FG000|Overall Study|Investigator's Decision|0|||
144555092|NCT00742560|521229058|FG001|Overall Study|Investigator's Decision|0|||
144555093|NCT00742560|521229059|FG002|Overall Study|Investigator's Decision|4|||
144555094|NCT00742560|521229060|FG003|Overall Study|Investigator's Decision|1|||
144555095|NCT00742560|521229061|FG004|Overall Study|Investigator's Decision|0|||
144555096|NCT00742560|521229057|FG000|Overall Study|Disease Progression|1|||
144616931|NCT05630937|521458012|FG000|Overall Study|Enrolled but not treated|0|||
144203461|NCT00528411|519940356|FG001|Overall Study|Adverse Event|0|||
144203462|NCT00528411|519940357|FG002|Overall Study|Adverse Event|1|||
144203463|NCT00528411|519940355|FG000|Overall Study|Incorrect Enrolment|1|||
144203464|NCT00528411|519940356|FG001|Overall Study|Incorrect Enrolment|1|||
144555097|NCT00742560|521229058|FG001|Overall Study|Disease Progression|0|||
144555098|NCT00742560|521229059|FG002|Overall Study|Disease Progression|5|||
144555099|NCT00742560|521229060|FG003|Overall Study|Disease Progression|17|||
144555100|NCT00742560|521229061|FG004|Overall Study|Disease Progression|16|||
144555101|NCT00742560|521229057|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
144555102|NCT00742560|521229058|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
144555103|NCT00742560|521229059|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
144555104|NCT00742560|521229060|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
144555105|NCT00742560|521229061|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
144555106|NCT00742560|521229057|FG000|Overall Study|Other|0|||
144555107|NCT00742560|521229058|FG001|Overall Study|Other|1|||
144555108|NCT00742560|521229059|FG002|Overall Study|Other|8|||
144555109|NCT00742560|521229060|FG003|Overall Study|Other|9|||
144555110|NCT00742560|521229061|FG004|Overall Study|Other|9|||
144555111|NCT00742560|521229057|FG000|Overall Study|MIssing|0|||
144555112|NCT00742560|521229058|FG001|Overall Study|MIssing|0|||
144555113|NCT00742560|521229059|FG002|Overall Study|MIssing|0|||
144555114|NCT00742560|521229060|FG003|Overall Study|MIssing|0|||
144555115|NCT00742560|521229061|FG004|Overall Study|MIssing|1|||
144555116|NCT01536795|521229063|FG000|Overall Study|Lost to Follow-up|0|||
144555117|NCT01536795|521229064|FG001|Overall Study|Lost to Follow-up|2|||
144555118|NCT01536795|521229063|FG000|Overall Study|Lack of Efficacy|1|||
144555119|NCT01536795|521229064|FG001|Overall Study|Lack of Efficacy|0|||
144555120|NCT05615870|521229066|FG000|Overall Study|Lost to Follow-up|10|||
144555121|NCT05615870|521229067|FG001|Overall Study|Lost to Follow-up|13|||
144555122|NCT05615870|521229066|FG000|Overall Study|Physician Decision|2|||
144555123|NCT05615870|521229067|FG001|Overall Study|Physician Decision|0|||
144555124|NCT05615870|521229066|FG000|Overall Study|Withdrawal by Subject|0|||
144555125|NCT05615870|521229067|FG001|Overall Study|Withdrawal by Subject|2|||
144555126|NCT05615870|521229066|FG000|Overall Study|Protocol Violation|0|||
144555127|NCT05615870|521229067|FG001|Overall Study|Protocol Violation|3|||
144555128|NCT05615870|521229066|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
144555129|NCT05615870|521229067|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
144555130|NCT05615870|521229066|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
144727739|NCT02395822|521858061|FG000|Overall Study|Withdrawal by Subject|1|||
144727740|NCT02395822|521858061|FG000|Overall Study|Death|1|||
144727741|NCT02777528|521858064|FG000|Overall Study|Still in study|24|||
144727742|NCT02777528|521858065|FG001|Overall Study|Still in study|10|||
144727743|NCT02777528|521858066|FG002|Overall Study|Still in study|1|||
144727744|NCT02777528|521858064|FG000|Overall Study|Study Device Explanted|1|||
144727745|NCT02777528|521858065|FG001|Overall Study|Study Device Explanted|0|||
144727746|NCT02777528|521858066|FG002|Overall Study|Study Device Explanted|0|||
144727747|NCT02777528|521858064|FG000|Overall Study|Death|14|||
144727748|NCT02777528|521858065|FG001|Overall Study|Death|7|||
144727749|NCT02777528|521858066|FG002|Overall Study|Death|1|||
144727750|NCT02777528|521858064|FG000|Overall Study|Withdrawal by Subject|2|||
144727751|NCT02777528|521858065|FG001|Overall Study|Withdrawal by Subject|2|||
144727752|NCT02777528|521858066|FG002|Overall Study|Withdrawal by Subject|1|||
144727753|NCT02777528|521858064|FG000|Overall Study|Physician Decision|2|||
144727754|NCT02777528|521858065|FG001|Overall Study|Physician Decision|1|||
144727755|NCT02777528|521858066|FG002|Overall Study|Physician Decision|0|||
144727756|NCT02777528|521858064|FG000|Overall Study|Lost to Follow-up|2|||
144727757|NCT02777528|521858065|FG001|Overall Study|Lost to Follow-up|0|||
144727758|NCT02777528|521858066|FG002|Overall Study|Lost to Follow-up|0|||
144727759|NCT02777528|521858064|FG000|Overall Study|Discontinued due to Other|1|||
144727760|NCT02777528|521858065|FG001|Overall Study|Discontinued due to Other|0|||
144727761|NCT02777528|521858066|FG002|Overall Study|Discontinued due to Other|0|||
144727762|NCT02127281|521858069|FG000|Overall Study|Lost to Follow-up|1|||
144727763|NCT02127281|521858070|FG001|Overall Study|Lost to Follow-up|0|||
144727764|NCT04885296|521858071|FG000|Period 1|Covid-19 Related|1|||
144727765|NCT04885296|521858072|FG001|Period 1|Covid-19 Related|0|||
144727766|NCT04885296|521858071|FG000|Period 1|Adverse Event|0|||
144727767|NCT04885296|521858072|FG001|Period 1|Adverse Event|1|||
144727768|NCT04885296|521858071|FG000|Period 1|Withdrawal by Subject|1|||
144727769|NCT04885296|521858072|FG001|Period 1|Withdrawal by Subject|1|||
144727770|NCT04885296|521858071|FG000|Period 1|Test Article No Longer Available|1|||
144727771|NCT04885296|521858072|FG001|Period 1|Test Article No Longer Available|0|||
144727772|NCT04885296|521858071|FG000|Period 1|Dispensed Study lens in Error|1|||
144727773|NCT04885296|521858072|FG001|Period 1|Dispensed Study lens in Error|0|||
144727774|NCT04885296|521858071|FG000|Period 1|Lost to Follow-up|1|||
144727775|NCT04885296|521858072|FG001|Period 1|Lost to Follow-up|0|||
144727776|NCT04885296|521858071|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
144727777|NCT04885296|521858072|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
144727778|NCT04510857|521858073|FG000|Overall Study|Withdrawal by Subject|1|||
144727779|NCT04510857|521858074|FG001|Overall Study|Withdrawal by Subject|2|||
144727780|NCT05346055|521858075|FG000|Overall Study|Withdrawal by Subject|1|||
144727781|NCT05346055|521858075|FG000|Overall Study|Protocol Violation|1|||
144727782|NCT05346055|521858075|FG000|Overall Study|Therapist decision|1|||
144727783|NCT00920140|521858076|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
144727784|NCT00920140|521858077|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
144727785|NCT00920140|521858078|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
144727786|NCT00920140|521858079|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
144727787|NCT00920140|521858080|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
144555131|NCT05615870|521229067|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
144555132|NCT05615870|521229066|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
144555133|NCT05615870|521229067|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
144555134|NCT01760876|521229068|FG000|Overall Study|Non-cardiac death (head injury)|1|||
144555135|NCT01760876|521229068|FG000|Overall Study|Carcinoma of prostate|1|||
144262429|NCT01317641|520161440|FG006|Overall Study|Not treated|0|||
144555136|NCT01760876|521229068|FG000|Overall Study|Impaired renal function|1|||
144555137|NCT01760876|521229068|FG000|Overall Study|Major depression|1|||
144555138|NCT01760876|521229068|FG000|Overall Study|Very poor baseline OCT quality|2|||
144555139|NCT00732498|521229072|FG000|Overall Study|Ineligible|1|||
144555140|NCT00732498|521229072|FG000|Overall Study|Adverse Event|2|||
144555141|NCT00732498|521229072|FG000|Overall Study|Physician Decision|3|||
144555142|NCT03686176|521229075|FG000|Overall Study|Procedure cancelled|1|||
144555143|NCT03686176|521229076|FG001|Overall Study|Procedure cancelled|0|||
144555144|NCT03686176|521229077|FG002|Overall Study|Procedure cancelled|0|||
144555145|NCT03686176|521229075|FG000|Overall Study|VR Malfunction|1|||
144555146|NCT03686176|521229076|FG001|Overall Study|VR Malfunction|0|||
144555147|NCT03686176|521229077|FG002|Overall Study|VR Malfunction|0|||
144555148|NCT04295499|521229085|FG000|Overall Study|moving out of state|1|||
144555149|NCT04295499|521229086|FG001|Overall Study|moving out of state|0|||
144555150|NCT04295499|521229085|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
144555151|NCT04295499|521229086|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
144555152|NCT03122548|521229089|FG000|Overall Study|Death|2|||
144555153|NCT03122548|521229089|FG000|Overall Study|Progression - subject went into hospice|1|||
144555154|NCT03122548|521229089|FG000|Overall Study|Study Terminated by Sponsor|2|||
144555155|NCT00308113|521229090|FG000|Overall Study|Protocol closure|0|||
144555156|NCT00308113|521229091|FG001|Overall Study|Protocol closure|0|||
144555157|NCT00308113|521229092|FG002|Overall Study|Protocol closure|0|||
144555158|NCT00308113|521229093|FG003|Overall Study|Protocol closure|1|||
144555159|NCT04448561|521229094|FG000|Overall Study|Noncompliance|1|||
144555160|NCT04448561|521229095|FG001|Overall Study|Noncompliance|0|||
144555161|NCT00676195|521230616|FG000|Overall Study|Lost to Follow-up|1|||
144555162|NCT00676195|521230616|FG000|Overall Study|Adverse Event|1|||
144555163|NCT00676195|521230616|FG000|Overall Study|Physician Decision|1|||
144555164|NCT02878590|521230617|FG000|Overall Study|Withdrawal by Subject|2|||
144555165|NCT03050372|521230621|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
144555166|NCT03050372|521230622|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
144555167|NCT03050372|521230621|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
144555168|NCT03050372|521230622|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
144555169|NCT02123797|521230625|FG000|Baseline Intervention|Death|9|||
144555170|NCT02123797|521230626|FG001|Baseline Intervention|Death|16|||
144555171|NCT02123797|521230627|FG002|Baseline Intervention|Death|0|||
144555172|NCT02123797|521230628|FG003|Baseline Intervention|Death|0|||
144555173|NCT02123797|521230629|FG004|Baseline Intervention|Death|0|||
144555174|NCT02123797|521230625|FG000|Baseline Intervention|Withdrawal by Subject|2|||
144555175|NCT02123797|521230626|FG001|Baseline Intervention|Withdrawal by Subject|8|||
144555176|NCT02123797|521230627|FG002|Baseline Intervention|Withdrawal by Subject|0|||
144555177|NCT02123797|521230628|FG003|Baseline Intervention|Withdrawal by Subject|0|||
144555178|NCT02123797|521230629|FG004|Baseline Intervention|Withdrawal by Subject|0|||
144555179|NCT02123797|521230625|FG000|Baseline Intervention|Relocation|2|||
144555180|NCT02123797|521230626|FG001|Baseline Intervention|Relocation|0|||
144555181|NCT02123797|521230627|FG002|Baseline Intervention|Relocation|0|||
144555182|NCT02123797|521230628|FG003|Baseline Intervention|Relocation|0|||
144555183|NCT02123797|521230629|FG004|Baseline Intervention|Relocation|0|||
144555184|NCT02123797|521230625|FG000|Baseline Intervention|Out of window for initial survey|6|||
144555185|NCT02123797|521230626|FG001|Baseline Intervention|Out of window for initial survey|13|||
144555186|NCT02123797|521230627|FG002|Baseline Intervention|Out of window for initial survey|0|||
144555187|NCT02123797|521230628|FG003|Baseline Intervention|Out of window for initial survey|0|||
144555188|NCT02123797|521230629|FG004|Baseline Intervention|Out of window for initial survey|0|||
144555189|NCT02123797|521230625|FG000|Baseline Intervention|Lost to Follow-up|0|||
144555190|NCT02123797|521230626|FG001|Baseline Intervention|Lost to Follow-up|5|||
144555191|NCT02123797|521230627|FG002|Baseline Intervention|Lost to Follow-up|0|||
144555192|NCT02123797|521230628|FG003|Baseline Intervention|Lost to Follow-up|0|||
144555193|NCT02123797|521230629|FG004|Baseline Intervention|Lost to Follow-up|0|||
144555194|NCT02123797|521230625|FG000|Baseline Intervention|Other Disease|3|||
144555195|NCT02123797|521230626|FG001|Baseline Intervention|Other Disease|0|||
144262430|NCT01317641|520161441|FG007|Overall Study|Not treated|1|||
144555196|NCT02123797|521230627|FG002|Baseline Intervention|Other Disease|0|||
144555197|NCT02123797|521230628|FG003|Baseline Intervention|Other Disease|0|||
144555198|NCT02123797|521230629|FG004|Baseline Intervention|Other Disease|0|||
144555199|NCT02123797|521230625|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
144555200|NCT02123797|521230626|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
144555201|NCT02123797|521230627|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
144555202|NCT02123797|521230628|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
144555203|NCT02123797|521230629|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
144555204|NCT02123797|521230625|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
144555205|NCT02123797|521230626|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
144555206|NCT02123797|521230627|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
144555207|NCT02123797|521230628|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
144555208|NCT02123797|521230629|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
144555209|NCT02123797|521230625|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
144555210|NCT02123797|521230626|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
144555211|NCT02123797|521230627|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
144555212|NCT02123797|521230628|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
144555213|NCT02123797|521230629|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
144555214|NCT02123797|521230625|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
144555215|NCT02123797|521230626|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
144555216|NCT02123797|521230627|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
144555217|NCT02123797|521230628|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
144555218|NCT02123797|521230629|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
144555219|NCT02123797|521230625|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
144555220|NCT02123797|521230626|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
144555221|NCT02123797|521230627|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
144555222|NCT02123797|521230628|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
144555223|NCT02123797|521230629|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
144555224|NCT02123797|521230625|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
144555225|NCT02123797|521230626|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
144555226|NCT02123797|521230627|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
144555227|NCT02123797|521230628|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
144555228|NCT02123797|521230629|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
144555229|NCT02123797|521230625|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
144555230|NCT02123797|521230626|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
144555231|NCT02123797|521230627|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
144555232|NCT02123797|521230628|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
144555233|NCT02123797|521230629|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
144555234|NCT02123797|521230625|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
144555235|NCT02123797|521230626|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
144555236|NCT02123797|521230627|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
144555237|NCT02123797|521230628|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
144555238|NCT02123797|521230629|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
144555239|NCT02123797|521230625|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
144555240|NCT02123797|521230626|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
144555241|NCT02123797|521230627|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
144555242|NCT02123797|521230628|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
144555243|NCT02123797|521230629|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
144555244|NCT05878990|521230630|FG000|Overall Study|Lost to Follow-up|7|||
144555245|NCT05878990|521230630|FG000|Overall Study|Withdrawal by Subject|1|||
144555246|NCT00396409|521230638|FG000|Period 1 - 2007|Adverse Event|0|||
144555247|NCT00396409|521230639|FG001|Period 1 - 2007|Adverse Event|1|||
144555248|NCT00396409|521230638|FG000|Period 1 - 2007|Lack of Efficacy|0|||
144555249|NCT00396409|521230639|FG001|Period 1 - 2007|Lack of Efficacy|1|||
144555250|NCT00396409|521230638|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
144555251|NCT00396409|521230639|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
144555252|NCT00396409|521230638|FG000|Period 1 - 2007|Lost to Follow-up|2|||
144555253|NCT00396409|521230639|FG001|Period 1 - 2007|Lost to Follow-up|3|||
144555254|NCT00396409|521230638|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
144555255|NCT00396409|521230639|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
144555256|NCT00396409|521230638|FG000|Period 2 - 2008|Protocol Violation|1|||
144555257|NCT00396409|521230639|FG001|Period 2 - 2008|Protocol Violation|0|||
144555258|NCT00396409|521230638|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
144555259|NCT00396409|521230639|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
144555260|NCT00396409|521230638|FG000|Period 2 - 2008|Lost to Follow-up|3|||
144555261|NCT00396409|521230639|FG001|Period 2 - 2008|Lost to Follow-up|1|||
144555262|NCT00331799|521230640|FG000|Overall Study|Withdrawal by Subject|2|||
144555263|NCT00331799|521230640|FG000|Overall Study|Sedation|1|||
144203465|NCT00528411|519940357|FG002|Overall Study|Incorrect Enrolment|0|||
144203466|NCT00528411|519940355|FG000|Overall Study|Severe non-compliance to protocol|0|||
144203467|NCT00528411|519940356|FG001|Overall Study|Severe non-compliance to protocol|1|||
144203468|NCT00528411|519940357|FG002|Overall Study|Severe non-compliance to protocol|0|||
144203469|NCT00528411|519940355|FG000|Overall Study|Prior commitment medication|0|||
144203470|NCT00528411|519940356|FG001|Overall Study|Prior commitment medication|1|||
144203471|NCT00528411|519940357|FG002|Overall Study|Prior commitment medication|0|||
144203472|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
144203473|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
144203474|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
144555264|NCT02889809|521230641|FG000|Overall Study|Withdrawal by Subject|30|||
144555265|NCT02889809|521230642|FG001|Overall Study|Withdrawal by Subject|21|||
144555266|NCT02889809|521230641|FG000|Overall Study|Lost to Follow-up|1|||
144555267|NCT02889809|521230642|FG001|Overall Study|Lost to Follow-up|1|||
144555268|NCT02889809|521230641|FG000|Overall Study|Site Closed|12|||
144555269|NCT02889809|521230642|FG001|Overall Study|Site Closed|11|||
144555270|NCT04203199|521230645|FG000|First Intervention Period|Lost to Follow-up|0|||
144555271|NCT04203199|521230646|FG001|First Intervention Period|Lost to Follow-up|1|||
144555272|NCT04203199|521230645|FG000|Second Intervention Period|Medication change|1|||
144555273|NCT04203199|521230646|FG001|Second Intervention Period|Medication change|0|||
144555274|NCT01837719|521230655|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
144555275|NCT01837719|521230655|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
144555276|NCT01703988|521230656|FG000|Overall Study|Investigator Judgment|0|||
144555277|NCT01703988|521230657|FG001|Overall Study|Investigator Judgment|0|||
144555278|NCT01703988|521230658|FG002|Overall Study|Investigator Judgment|0|||
144555279|NCT01703988|521230659|FG003|Overall Study|Investigator Judgment|1|||
144555280|NCT02995733|521230660|FG000|Overall Study|Study site closed|9|||
144555281|NCT02995733|521230661|FG001|Overall Study|Study site closed|10|||
144555282|NCT02995733|521230660|FG000|Overall Study|Death|3|||
144555283|NCT02995733|521230661|FG001|Overall Study|Death|4|||
144555284|NCT02995733|521230660|FG000|Overall Study|Withdrawal by Subject|6|||
144555285|NCT02995733|521230661|FG001|Overall Study|Withdrawal by Subject|2|||
144555286|NCT02995733|521230660|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
144555287|NCT02995733|521230661|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
144555288|NCT02995733|521230660|FG000|Overall Study|Lost to Follow-up|48|||
144555289|NCT02995733|521230661|FG001|Overall Study|Lost to Follow-up|37|||
144555290|NCT02995733|521230660|FG000|Overall Study|Other|0|||
144555291|NCT02995733|521230661|FG001|Overall Study|Other|1|||
144555292|NCT02720198|521230662|FG000|Overall Study|Withdrawal by Subject|0|||
144555293|NCT02720198|521230663|FG001|Overall Study|Withdrawal by Subject|1|||
144555294|NCT01403805|521230666|FG000|Overall Study|Withdrawal by Subject|0|||
144555295|NCT01403805|521230667|FG001|Overall Study|Withdrawal by Subject|4|||
144555296|NCT01403805|521230666|FG000|Overall Study|Lost to Follow-up|0|||
144555297|NCT01403805|521230667|FG001|Overall Study|Lost to Follow-up|2|||
144555298|NCT01403805|521230666|FG000|Overall Study|Death|0|||
144555299|NCT01403805|521230667|FG001|Overall Study|Death|1|||
144555300|NCT01103141|521230668|FG000|Overall Study|Death|0|||
144555301|NCT01103141|521230669|FG001|Overall Study|Death|1|||
144555302|NCT01103141|521230668|FG000|Overall Study|Lost to Follow-up|2|||
144555303|NCT01103141|521230669|FG001|Overall Study|Lost to Follow-up|1|||
144555304|NCT00147745|521230670|FG000|Overall Study|Withdrawal by Subject|1|||
144555305|NCT00147745|521230671|FG001|Overall Study|Withdrawal by Subject|0|||
144555306|NCT00147745|521230672|FG002|Overall Study|Withdrawal by Subject|0|||
144555307|NCT00460577|521230681|FG000|Overall Study|Protocol Violation|2|||
144555308|NCT00460577|521230682|FG001|Overall Study|Protocol Violation|6|||
144555309|NCT04043806|521230683|FG000|Overall Study|Commercial drug is available for participants|13|||
144555310|NCT04043806|521230683|FG000|Overall Study|Physician Decision|2|||
144555311|NCT04043806|521230683|FG000|Overall Study|Other|12|||
144555312|NCT04043806|521230683|FG000|Overall Study|Adverse Event|2|||
144555313|NCT04043806|521230683|FG000|Overall Study|Lost to Follow-up|6|||
144555314|NCT04043806|521230683|FG000|Overall Study|Other non-compliance|2|||
144555315|NCT04043806|521230683|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
144555316|NCT04043806|521230683|FG000|Overall Study|Never Dosed|1|||
144555317|NCT03045302|521230684|FG000|Overall Study|Pre-treatment adverse event|1|||
144555318|NCT04362176|521230688|FG000|Overall Study|Lost to Follow-up|5|||
144555319|NCT04362176|521230689|FG001|Overall Study|Lost to Follow-up|8|||
144555320|NCT04362176|521230688|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
144555321|NCT04362176|521230689|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
144555322|NCT01812837|521230690|FG000|Overall Study|Lost to Follow-up|1|||
144555323|NCT01812837|521230691|FG001|Overall Study|Lost to Follow-up|1|||
144555324|NCT01812837|521230692|FG002|Overall Study|Lost to Follow-up|0|||
144555325|NCT01812837|521230690|FG000|Overall Study|Protocol Violation|1|||
144555326|NCT01812837|521230691|FG001|Overall Study|Protocol Violation|0|||
144555327|NCT01812837|521230692|FG002|Overall Study|Protocol Violation|0|||
144555328|NCT05234632|521230693|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
144203475|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
144203476|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
144203477|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
144203478|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
144203479|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
144203480|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
144555329|NCT05234632|521230694|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
144555330|NCT05234632|521230693|FG000|Overall Study|Withdrawal by Subject|2|||
144555331|NCT05234632|521230694|FG001|Overall Study|Withdrawal by Subject|0|||
144555332|NCT05234632|521230693|FG000|Overall Study|Adverse Event|0|||
144555333|NCT05234632|521230694|FG001|Overall Study|Adverse Event|4|||
144555334|NCT05234632|521230693|FG000|Overall Study|Physician Decision|1|||
144555335|NCT05234632|521230694|FG001|Overall Study|Physician Decision|1|||
144555336|NCT05234632|521230693|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
144262431|NCT01317641|520161442|FG008|Overall Study|Not treated|1|||
144555337|NCT05234632|521230694|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
144555338|NCT05234632|521230693|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
144555339|NCT05234632|521230694|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
144555340|NCT04799587|521230695|FG000|Overall Study|Withdrawal by Subject|0|||
144555341|NCT04799587|521230696|FG001|Overall Study|Withdrawal by Subject|1|||
144555342|NCT04985604|521230697|FG000|Overall Study|Death|4|||
144555343|NCT04985604|521230698|FG001|Overall Study|Death|6|||
144555344|NCT04985604|521230697|FG000|Overall Study|Withdrawal by Subject|0|||
144555345|NCT04985604|521230698|FG001|Overall Study|Withdrawal by Subject|1|||
144555346|NCT04598776|521230699|FG000|Overall Study|Protocol Violation|5|||
144555347|NCT04598776|521230699|FG000|Overall Study|Physician Decision|4|||
144555348|NCT00348283|521230700|FG000|Induction|Adverse Event|0|||
144555349|NCT00348283|521230701|FG001|Induction|Adverse Event|2|||
144555350|NCT00348283|521230700|FG000|Induction|Protocol Violation|0|||
144555351|NCT00348283|521230701|FG001|Induction|Protocol Violation|4|||
144555352|NCT00348283|521230700|FG000|Double Blind|Adverse Event|2|||
144555353|NCT00348283|521230701|FG001|Double Blind|Adverse Event|5|||
144555354|NCT00348283|521230700|FG000|Double Blind|Withdrawal by Subject|1|||
144555355|NCT00348283|521230701|FG001|Double Blind|Withdrawal by Subject|1|||
144555356|NCT00348283|521230700|FG000|Double Blind|Protocol Violation|0|||
144555357|NCT00348283|521230701|FG001|Double Blind|Protocol Violation|1|||
144555358|NCT00348283|521230700|FG000|Double Blind|Lack of Efficacy|2|||
144555359|NCT00348283|521230701|FG001|Double Blind|Lack of Efficacy|2|||
144555360|NCT00348283|521230700|FG000|Double Blind|Pregnancy|0|||
144555361|NCT00348283|521230701|FG001|Double Blind|Pregnancy|1|||
144555362|NCT00348283|521230700|FG000|Open Label|Adverse Event|0|||
144555363|NCT00348283|521230701|FG001|Open Label|Adverse Event|8|||
144555364|NCT00348283|521230700|FG000|Open Label|Withdrawal by Subject|0|||
144555365|NCT00348283|521230701|FG001|Open Label|Withdrawal by Subject|4|||
144555366|NCT00348283|521230700|FG000|Open Label|Lost to Follow-up|0|||
144555367|NCT00348283|521230701|FG001|Open Label|Lost to Follow-up|1|||
144555368|NCT00348283|521230700|FG000|Open Label|Lack of Efficacy|0|||
144555369|NCT00348283|521230701|FG001|Open Label|Lack of Efficacy|13|||
144555370|NCT00348283|521230700|FG000|Open Label|Administrative reasons|0|||
144555371|NCT00348283|521230701|FG001|Open Label|Administrative reasons|5|||
144555372|NCT00348283|521230700|FG000|Open Label|Subject moved to the United States|0|||
144555373|NCT00348283|521230701|FG001|Open Label|Subject moved to the United States|1|||
144555374|NCT00348283|521230700|FG000|Open Label|Pregnancy|0|||
144555375|NCT00348283|521230701|FG001|Open Label|Pregnancy|1|||
144555376|NCT00348283|521230700|FG000|Open Label|Sponsor decision|0|||
144555377|NCT00348283|521230701|FG001|Open Label|Sponsor decision|1|||
144555378|NCT02282761|521230704|FG000|Overall Study|Death|0|||
144555379|NCT02282761|521230705|FG001|Overall Study|Death|0|||
144555380|NCT02282761|521230706|FG002|Overall Study|Death|1|||
144555381|NCT02282761|521230704|FG000|Overall Study|Adverse Event|6|||
144555382|NCT02282761|521230705|FG001|Overall Study|Adverse Event|2|||
144555383|NCT02282761|521230706|FG002|Overall Study|Adverse Event|0|||
144555384|NCT02282761|521230704|FG000|Overall Study|Lack of Efficacy|11|||
144555385|NCT02282761|521230705|FG001|Overall Study|Lack of Efficacy|6|||
144555386|NCT02282761|521230706|FG002|Overall Study|Lack of Efficacy|17|||
144555387|NCT02282761|521230704|FG000|Overall Study|Lost to Follow-up|2|||
144555388|NCT02282761|521230705|FG001|Overall Study|Lost to Follow-up|2|||
144555389|NCT02282761|521230706|FG002|Overall Study|Lost to Follow-up|1|||
144555390|NCT02282761|521230704|FG000|Overall Study|Physician Decision|0|||
144555391|NCT02282761|521230705|FG001|Overall Study|Physician Decision|0|||
144555392|NCT02282761|521230706|FG002|Overall Study|Physician Decision|2|||
144555393|NCT02282761|521230704|FG000|Overall Study|Withdrawal by Subject|8|||
144555394|NCT02282761|521230705|FG001|Overall Study|Withdrawal by Subject|10|||
144555395|NCT02282761|521230706|FG002|Overall Study|Withdrawal by Subject|16|||
144555396|NCT02282761|521230704|FG000|Overall Study|Other|3|||
144555397|NCT02282761|521230705|FG001|Overall Study|Other|2|||
144555398|NCT02282761|521230706|FG002|Overall Study|Other|1|||
144555399|NCT00658632|521230709|FG000|Overall Study|Adverse Event|13|||
144555400|NCT00658632|521230710|FG001|Overall Study|Adverse Event|11|||
144555401|NCT00658632|521230709|FG000|Overall Study|Lost to Follow-up|25|||
144555402|NCT00658632|521230710|FG001|Overall Study|Lost to Follow-up|23|||
144555403|NCT00658632|521230709|FG000|Overall Study|Withdrawal by Subject|10|||
144555404|NCT00658632|521230710|FG001|Overall Study|Withdrawal by Subject|7|||
144262432|NCT01317641|520161434|FG000|Overall Study|Adverse Event|0|||
144555405|NCT00658632|521230709|FG000|Overall Study|Lack of Efficacy|0|||
144555406|NCT00658632|521230710|FG001|Overall Study|Lack of Efficacy|1|||
144555407|NCT00658632|521230709|FG000|Overall Study|Withdrawal of consent|8|||
144555408|NCT00658632|521230710|FG001|Overall Study|Withdrawal of consent|14|||
144555409|NCT00658632|521230709|FG000|Overall Study|Pregnancy|1|||
144555410|NCT00658632|521230710|FG001|Overall Study|Pregnancy|1|||
144555411|NCT00658632|521230709|FG000|Overall Study|Other|7|||
144555412|NCT00658632|521230710|FG001|Overall Study|Other|8|||
144555413|NCT06312566|521230715|FG000|Overall Study|Protocol Violation|0|||
144555414|NCT06312566|521230716|FG001|Overall Study|Protocol Violation|1|||
144555415|NCT02632045|521230717|FG000|Overall Study|Withdrawal by Subject|1|||
144203481|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144203482|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
144203483|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144203484|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144555416|NCT02632045|521230718|FG001|Overall Study|Withdrawal by Subject|2|||
144616932|NCT05630937|521458013|FG001|Overall Study|Enrolled but not treated|0|||
144616933|NCT05630937|521458014|FG002|Overall Study|Enrolled but not treated|0|||
144616934|NCT05630937|521458015|FG003|Overall Study|Enrolled but not treated|1|||
144616935|NCT01784861|521458019|FG000|Overall Study|Adverse Event|0|||
144616936|NCT01784861|521458020|FG001|Overall Study|Adverse Event|0|||
144616937|NCT01784861|521458021|FG002|Overall Study|Adverse Event|1|||
144616938|NCT01784861|521458022|FG003|Overall Study|Adverse Event|2|||
144616939|NCT01784861|521458023|FG004|Overall Study|Adverse Event|1|||
144616940|NCT01784861|521458024|FG005|Overall Study|Adverse Event|0|||
144616941|NCT01784861|521458019|FG000|Overall Study|Withdrawal by Subject|0|||
144616942|NCT01784861|521458020|FG001|Overall Study|Withdrawal by Subject|0|||
144616943|NCT01784861|521458021|FG002|Overall Study|Withdrawal by Subject|0|||
144616944|NCT01784861|521458022|FG003|Overall Study|Withdrawal by Subject|1|||
144616945|NCT01784861|521458023|FG004|Overall Study|Withdrawal by Subject|0|||
144616946|NCT01784861|521458024|FG005|Overall Study|Withdrawal by Subject|0|||
144616947|NCT01784861|521458019|FG000|Overall Study|Physician Decision|0|||
144616948|NCT01784861|521458020|FG001|Overall Study|Physician Decision|0|||
144616949|NCT01784861|521458021|FG002|Overall Study|Physician Decision|0|||
144616950|NCT01784861|521458022|FG003|Overall Study|Physician Decision|2|||
144616951|NCT01784861|521458023|FG004|Overall Study|Physician Decision|0|||
144616952|NCT01784861|521458024|FG005|Overall Study|Physician Decision|1|||
144616953|NCT00401752|521458025|FG000|Overall Study|Adverse Event|2|||
144616954|NCT00401752|521458026|FG001|Overall Study|Adverse Event|5|||
144616955|NCT00401752|521458025|FG000|Overall Study|Withdrawal by Subject|2|||
144616956|NCT00401752|521458026|FG001|Overall Study|Withdrawal by Subject|6|||
144616957|NCT00401752|521458025|FG000|Overall Study|Lost to Follow-up|1|||
144616958|NCT00401752|521458026|FG001|Overall Study|Lost to Follow-up|4|||
144616959|NCT00401752|521458025|FG000|Overall Study|Development of any exclusion criteria|4|||
144616960|NCT00401752|521458026|FG001|Overall Study|Development of any exclusion criteria|2|||
144616961|NCT00401752|521458025|FG000|Overall Study|Physician Decision|1|||
144555417|NCT05878522|521230719|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555418|NCT05878522|521230720|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555419|NCT05878522|521230721|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555420|NCT05878522|521230722|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555421|NCT05878522|521230723|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555422|NCT05878522|521230724|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555423|NCT05878522|521230725|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555424|NCT05878522|521230726|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555425|NCT05878522|521230727|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
144555426|NCT05878522|521230728|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555427|NCT05878522|521230729|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555428|NCT05878522|521230730|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
144555429|NCT05878522|521230719|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
144555430|NCT05878522|521230720|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555431|NCT05878522|521230721|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555432|NCT05878522|521230722|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555433|NCT05878522|521230723|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555434|NCT05878522|521230724|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555435|NCT05878522|521230725|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555436|NCT05878522|521230726|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555437|NCT05878522|521230727|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555438|NCT05878522|521230728|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
144555439|NCT05878522|521230729|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555440|NCT05878522|521230730|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
144555441|NCT05878522|521230719|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555442|NCT05878522|521230720|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
144555443|NCT05878522|521230721|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555444|NCT05878522|521230722|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
144616962|NCT00401752|521458026|FG001|Overall Study|Physician Decision|1|||
144616963|NCT02432235|521458027|FG000|Overall Study|Death|1|||
144616964|NCT02432235|521458028|FG001|Overall Study|Death|1|||
144616965|NCT02432235|521458029|FG002|Overall Study|Death|2|||
144616966|NCT02432235|521458030|FG003|Overall Study|Death|2|||
144616967|NCT02432235|521458031|FG004|Overall Study|Death|1|||
144616968|NCT02432235|521458032|FG005|Overall Study|Death|3|||
144616969|NCT02432235|521458033|FG006|Overall Study|Death|11|||
144616970|NCT02432235|521458034|FG007|Overall Study|Death|15|||
144616971|NCT02432235|521458035|FG008|Overall Study|Death|15|||
144555445|NCT05878522|521230723|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555446|NCT05878522|521230724|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555447|NCT05878522|521230725|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555448|NCT05878522|521230726|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555449|NCT05878522|521230727|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555450|NCT05878522|521230728|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555451|NCT05878522|521230729|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555452|NCT05878522|521230730|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
144555453|NCT05878522|521230719|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555454|NCT05878522|521230720|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555455|NCT05878522|521230721|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555456|NCT05878522|521230722|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555457|NCT05878522|521230723|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
144555458|NCT05878522|521230724|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555459|NCT05878522|521230725|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555460|NCT05878522|521230726|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555461|NCT05878522|521230727|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555462|NCT05878522|521230728|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555463|NCT05878522|521230729|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144616972|NCT02432235|521458036|FG009|Overall Study|Death|3|||
144616973|NCT02432235|521458037|FG010|Overall Study|Death|1|||
144555464|NCT05878522|521230730|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
144555465|NCT00617708|521230735|FG000|Overall Study|Adverse Event|0|||
144555466|NCT00617708|521230736|FG001|Overall Study|Adverse Event|6|||
144555467|NCT00617708|521230737|FG002|Overall Study|Adverse Event|9|||
144555468|NCT00617708|521230735|FG000|Overall Study|Withdrawal by Subject|1|||
144555469|NCT00617708|521230736|FG001|Overall Study|Withdrawal by Subject|1|||
144555470|NCT00617708|521230737|FG002|Overall Study|Withdrawal by Subject|7|||
144555471|NCT00617708|521230735|FG000|Overall Study|Death|0|||
144555472|NCT00617708|521230736|FG001|Overall Study|Death|6|||
144555473|NCT00617708|521230737|FG002|Overall Study|Death|5|||
144555474|NCT00617708|521230735|FG000|Overall Study|Progression/Relapse|7|||
144555475|NCT00617708|521230736|FG001|Overall Study|Progression/Relapse|40|||
144555476|NCT00617708|521230737|FG002|Overall Study|Progression/Relapse|36|||
144555477|NCT00617708|521230735|FG000|Overall Study|Not protocol specified|1|||
144555478|NCT00617708|521230736|FG001|Overall Study|Not protocol specified|4|||
144555479|NCT00617708|521230737|FG002|Overall Study|Not protocol specified|2|||
144555480|NCT00617708|521230735|FG000|Overall Study|Not eligible|1|||
144555481|NCT00617708|521230736|FG001|Overall Study|Not eligible|3|||
144555482|NCT00617708|521230737|FG002|Overall Study|Not eligible|5|||
144555483|NCT03747575|521230738|FG000|Overall Study|Withdrawal by Subject|6|||
144555484|NCT03747575|521230739|FG001|Overall Study|Withdrawal by Subject|3|||
144555485|NCT03747575|521230738|FG000|Overall Study|Lost to Follow-up|3|||
144555486|NCT03747575|521230739|FG001|Overall Study|Lost to Follow-up|3|||
144555487|NCT03747575|521230738|FG000|Overall Study|Adverse Event|0|||
144555488|NCT03747575|521230739|FG001|Overall Study|Adverse Event|1|||
144555489|NCT03005106|521230740|FG000|Overall Study|Lost to Follow-up|16|||
144555490|NCT03005106|521230740|FG000|Overall Study|Adverse Event|1|||
144555491|NCT03005106|521230740|FG000|Overall Study|Physician Decision|1|||
144555492|NCT03005106|521230740|FG000|Overall Study|Death|2|||
144555493|NCT00936065|521230741|FG000|Overall Study|Adverse Event|1|||
144555494|NCT00936065|521230742|FG001|Overall Study|Adverse Event|0|||
144555495|NCT00936065|521230743|FG002|Overall Study|Adverse Event|1|||
144555496|NCT00936065|521230741|FG000|Overall Study|Lack of Efficacy|1|||
144555497|NCT00936065|521230742|FG001|Overall Study|Lack of Efficacy|0|||
144555498|NCT00936065|521230743|FG002|Overall Study|Lack of Efficacy|1|||
144555499|NCT00936065|521230741|FG000|Overall Study|Lost to Follow-up|1|||
144555500|NCT00936065|521230742|FG001|Overall Study|Lost to Follow-up|0|||
144616974|NCT02432235|521458038|FG011|Overall Study|Death|0|||
144616975|NCT02432235|521458027|FG000|Overall Study|Withdrawal by Subject|0|||
144616976|NCT02432235|521458028|FG001|Overall Study|Withdrawal by Subject|1|||
144616977|NCT02432235|521458029|FG002|Overall Study|Withdrawal by Subject|0|||
144616978|NCT02432235|521458030|FG003|Overall Study|Withdrawal by Subject|0|||
144555501|NCT00936065|521230743|FG002|Overall Study|Lost to Follow-up|0|||
144555502|NCT00936065|521230741|FG000|Overall Study|Protocol Violation|1|||
144555503|NCT00936065|521230742|FG001|Overall Study|Protocol Violation|2|||
144616979|NCT02432235|521458031|FG004|Overall Study|Withdrawal by Subject|0|||
144555504|NCT00936065|521230743|FG002|Overall Study|Protocol Violation|1|||
144555505|NCT00936065|521230741|FG000|Overall Study|Withdrawal by Subject|0|||
144555506|NCT00936065|521230742|FG001|Overall Study|Withdrawal by Subject|2|||
144555507|NCT00936065|521230743|FG002|Overall Study|Withdrawal by Subject|4|||
144555508|NCT01429285|521230744|FG000|Overall Study|Protocol Violation|9|||
144616980|NCT02432235|521458032|FG005|Overall Study|Withdrawal by Subject|2|||
144616981|NCT02432235|521458033|FG006|Overall Study|Withdrawal by Subject|5|||
144555509|NCT01429285|521230745|FG001|Overall Study|Protocol Violation|4|||
144616982|NCT02432235|521458034|FG007|Overall Study|Withdrawal by Subject|3|||
144616983|NCT02432235|521458035|FG008|Overall Study|Withdrawal by Subject|1|||
144616984|NCT02432235|521458036|FG009|Overall Study|Withdrawal by Subject|0|||
144616985|NCT02432235|521458037|FG010|Overall Study|Withdrawal by Subject|0|||
144616986|NCT02432235|521458038|FG011|Overall Study|Withdrawal by Subject|0|||
144616987|NCT02432235|521458027|FG000|Overall Study|Lost to Follow-up|0|||
144555510|NCT01429285|521230744|FG000|Overall Study|Missing Data|5|||
144555511|NCT01429285|521230745|FG001|Overall Study|Missing Data|3|||
144555512|NCT01429285|521230744|FG000|Overall Study|Erroneously Enrolled Twice|8|||
144555513|NCT01429285|521230745|FG001|Overall Study|Erroneously Enrolled Twice|2|||
144555514|NCT00738400|521230746|FG000|Overall Study|Adverse Event|3|||
144555515|NCT00738400|521230747|FG001|Overall Study|Adverse Event|1|||
144555516|NCT00738400|521230746|FG000|Overall Study|Withdrawal by Subject|0|||
144555517|NCT00738400|521230747|FG001|Overall Study|Withdrawal by Subject|1|||
144555518|NCT00738400|521230746|FG000|Overall Study|Lack of Efficacy|0|||
144555519|NCT00738400|521230747|FG001|Overall Study|Lack of Efficacy|1|||
144555520|NCT00738400|521230746|FG000|Overall Study|Lost to Follow-up|0|||
144555521|NCT00738400|521230747|FG001|Overall Study|Lost to Follow-up|3|||
144555522|NCT00738400|521230746|FG000|Overall Study|Protocol Violation|1|||
144555523|NCT00738400|521230747|FG001|Overall Study|Protocol Violation|0|||
144555524|NCT00738400|521230746|FG000|Overall Study|Non-compliant with study medication|0|||
144555525|NCT00738400|521230747|FG001|Overall Study|Non-compliant with study medication|1|||
144555526|NCT01052714|521230754|FG000|Overall Study|Adverse Event|6|||
144555527|NCT01052714|521230755|FG001|Overall Study|Adverse Event|3|||
144555528|NCT01052714|521230756|FG002|Overall Study|Adverse Event|0|||
144555529|NCT01052714|521230754|FG000|Overall Study|Death|1|||
144555530|NCT01052714|521230755|FG001|Overall Study|Death|2|||
144555531|NCT01052714|521230756|FG002|Overall Study|Death|0|||
144555532|NCT01052714|521230754|FG000|Overall Study|Lost to Follow-up|2|||
144555533|NCT01052714|521230755|FG001|Overall Study|Lost to Follow-up|3|||
144555534|NCT01052714|521230756|FG002|Overall Study|Lost to Follow-up|0|||
144555535|NCT01052714|521230754|FG000|Overall Study|Physician Decision|9|||
144555536|NCT01052714|521230755|FG001|Overall Study|Physician Decision|9|||
144555537|NCT01052714|521230756|FG002|Overall Study|Physician Decision|1|||
144555538|NCT01052714|521230754|FG000|Overall Study|Withdrawal by Subject|7|||
144555539|NCT01052714|521230755|FG001|Overall Study|Withdrawal by Subject|12|||
144555540|NCT01052714|521230756|FG002|Overall Study|Withdrawal by Subject|1|||
144555541|NCT03689452|521230763|FG000|Overall Study|Lost to Follow-up|1|||
144555542|NCT03689452|521230764|FG001|Overall Study|Lost to Follow-up|1|||
144555543|NCT02676778|521230765|FG000|Overall Study|Disease Progression|7|||
144555544|NCT02676778|521230766|FG001|Overall Study|Disease Progression|3|||
144555545|NCT02676778|521230767|FG002|Overall Study|Disease Progression|1|||
144555546|NCT02676778|521230765|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
144555547|NCT02676778|521230766|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
144555548|NCT02676778|521230767|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
144555549|NCT02676778|521230765|FG000|Overall Study|Withdrawal by Subject|3|||
144555550|NCT02676778|521230766|FG001|Overall Study|Withdrawal by Subject|2|||
144555551|NCT02676778|521230767|FG002|Overall Study|Withdrawal by Subject|0|||
144555552|NCT02676778|521230765|FG000|Overall Study|Other|4|||
144555553|NCT02676778|521230766|FG001|Overall Study|Other|3|||
144555554|NCT02676778|521230767|FG002|Overall Study|Other|0|||
144555555|NCT02676778|521230765|FG000|Overall Study|Adverse Event|2|||
144555556|NCT02676778|521230766|FG001|Overall Study|Adverse Event|3|||
144555557|NCT02676778|521230767|FG002|Overall Study|Adverse Event|0|||
144555558|NCT03214198|521230775|FG000|Overall Study|Case Report Forms Uncollected|18|||
144555559|NCT03214198|521230775|FG000|Overall Study|Protocol Deviation|18|||
144555560|NCT00267865|521230776|FG000|Induction Treatment|Died before completing.|2|||
144555561|NCT00267865|521230776|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
144555562|NCT04413149|521232228|FG000|Overall Study|Death|10|||
144555563|NCT04413149|521232229|FG001|Overall Study|Death|5|||
144555564|NCT04413149|521232228|FG000|Overall Study|Lung transplantation|1|||
144555565|NCT04413149|521232229|FG001|Overall Study|Lung transplantation|0|||
144555566|NCT02661490|521232232|FG000|Overall Study|Lost to Follow-up|0|||
144555567|NCT02661490|521232233|FG001|Overall Study|Lost to Follow-up|1|||
144555568|NCT02661490|521232234|FG002|Overall Study|Lost to Follow-up|0|||
144555569|NCT02661490|521232235|FG003|Overall Study|Lost to Follow-up|0|||
144262433|NCT01317641|520161435|FG001|Overall Study|Adverse Event|1|||
144555570|NCT02661490|521232236|FG004|Overall Study|Lost to Follow-up|2|||
144555571|NCT02661490|521232232|FG000|Overall Study|Withdrawal by Subject|2|||
144555572|NCT02661490|521232233|FG001|Overall Study|Withdrawal by Subject|0|||
144555573|NCT02661490|521232234|FG002|Overall Study|Withdrawal by Subject|2|||
144555574|NCT02661490|521232235|FG003|Overall Study|Withdrawal by Subject|0|||
144555575|NCT02661490|521232236|FG004|Overall Study|Withdrawal by Subject|0|||
144555576|NCT02661490|521232232|FG000|Overall Study|Death|1|||
144616988|NCT02432235|521458028|FG001|Overall Study|Lost to Follow-up|0|||
144616989|NCT02432235|521458029|FG002|Overall Study|Lost to Follow-up|0|||
144555577|NCT02661490|521232233|FG001|Overall Study|Death|1|||
144555578|NCT02661490|521232234|FG002|Overall Study|Death|0|||
144555579|NCT02661490|521232235|FG003|Overall Study|Death|1|||
144555580|NCT02661490|521232236|FG004|Overall Study|Death|0|||
144555581|NCT02661490|521232232|FG000|Overall Study|Reason not Specified|0|||
144555582|NCT02661490|521232233|FG001|Overall Study|Reason not Specified|0|||
144555583|NCT02661490|521232234|FG002|Overall Study|Reason not Specified|0|||
144555584|NCT02661490|521232235|FG003|Overall Study|Reason not Specified|0|||
144555585|NCT02661490|521232236|FG004|Overall Study|Reason not Specified|1|||
144555586|NCT03322514|521232237|FG000|Overall Study|Withdrawal by Subject|1|||
144555587|NCT03322514|521232238|FG001|Overall Study|Withdrawal by Subject|1|||
144555588|NCT01184859|521232239|FG000|Period 1: Single Dose|Insufficient urine production|0|||
144555589|NCT01184859|521232240|FG001|Period 1: Single Dose|Insufficient urine production|1|||
144555590|NCT01184859|521232241|FG002|Period 1: Single Dose|Insufficient urine production|0|||
144555591|NCT01184859|521232242|FG003|Period 1: Single Dose|Insufficient urine production|0|||
144555592|NCT01184859|521232243|FG004|Period 1: Single Dose|Insufficient urine production|0|||
144555593|NCT01184859|521232239|FG000|Period 1: Single Dose|Protocol Violation|0|||
144555594|NCT01184859|521232240|FG001|Period 1: Single Dose|Protocol Violation|1|||
144555595|NCT01184859|521232241|FG002|Period 1: Single Dose|Protocol Violation|0|||
144555596|NCT01184859|521232242|FG003|Period 1: Single Dose|Protocol Violation|0|||
144555597|NCT01184859|521232243|FG004|Period 1: Single Dose|Protocol Violation|0|||
144555598|NCT01184859|521232239|FG000|Period 1: Single Dose|Adverse Event|0|||
144555599|NCT01184859|521232240|FG001|Period 1: Single Dose|Adverse Event|0|||
144555600|NCT01184859|521232241|FG002|Period 1: Single Dose|Adverse Event|0|||
144555601|NCT01184859|521232242|FG003|Period 1: Single Dose|Adverse Event|0|||
144555602|NCT01184859|521232243|FG004|Period 1: Single Dose|Adverse Event|1|||
144555603|NCT01184859|521232239|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
144555604|NCT01184859|521232240|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
144555605|NCT01184859|521232241|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
144555606|NCT01184859|521232242|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
144555607|NCT01184859|521232243|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
144555608|NCT01184859|521232239|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
144555609|NCT01184859|521232240|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
144555610|NCT01184859|521232241|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
144555611|NCT01184859|521232242|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
144555612|NCT01184859|521232243|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
144555613|NCT00961298|521232244|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
144555614|NCT00961298|521232244|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
144555615|NCT00961298|521232244|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
144555616|NCT00814632|521232245|FG000|Overall Study|Lack of Efficacy|2|||
144555617|NCT02514577|521232249|FG000|Overall Study|Lost to Follow-up|6|||
144555618|NCT02514577|521232250|FG001|Overall Study|Lost to Follow-up|6|||
144555619|NCT02514577|521232249|FG000|Overall Study|Protocol Violation|1|||
144555620|NCT02514577|521232250|FG001|Overall Study|Protocol Violation|0|||
144555621|NCT02514577|521232249|FG000|Overall Study|Withdrawal by Subject|6|||
144555622|NCT02514577|521232250|FG001|Overall Study|Withdrawal by Subject|6|||
144555623|NCT02514577|521232249|FG000|Overall Study|Adverse Event|1|||
144555624|NCT02514577|521232250|FG001|Overall Study|Adverse Event|1|||
144555625|NCT02388932|521232251|FG000|Overall Study|Death|1|||
144555626|NCT01234675|521232258|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
144555627|NCT01234675|521232259|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
144555628|NCT01234675|521232258|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
144555629|NCT01234675|521232259|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
144555630|NCT02186015|521232272|FG000|Overall Study|Physician Decision|1|||
144555631|NCT02186015|521232273|FG001|Overall Study|Physician Decision|0|||
144555632|NCT01533181|521232274|FG000|Overall Study|Disease progression pre-active treatment|0|||
144555633|NCT01533181|521232275|FG001|Overall Study|Disease progression pre-active treatment|1|||
144555634|NCT01533181|521232274|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
144555635|NCT01533181|521232275|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
144555636|NCT01498445|521232278|FG000|Overall Study|Lack of Efficacy|0|||
144555637|NCT01498445|521232279|FG001|Overall Study|Lack of Efficacy|0|||
144555638|NCT01498445|521232280|FG002|Overall Study|Lack of Efficacy|1|||
144555639|NCT01498445|521232281|FG003|Overall Study|Lack of Efficacy|2|||
144555640|NCT01498445|521232282|FG004|Overall Study|Lack of Efficacy|0|||
144555641|NCT01498445|521232283|FG005|Overall Study|Lack of Efficacy|0|||
144555642|NCT01498445|521232278|FG000|Overall Study|Screen Failure|0|||
144555643|NCT01498445|521232279|FG001|Overall Study|Screen Failure|0|||
144555644|NCT01498445|521232280|FG002|Overall Study|Screen Failure|0|||
144555645|NCT01498445|521232281|FG003|Overall Study|Screen Failure|0|||
144555646|NCT01498445|521232282|FG004|Overall Study|Screen Failure|1|||
144555647|NCT01498445|521232283|FG005|Overall Study|Screen Failure|1|||
144555648|NCT02023099|521232284|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
144555649|NCT02023099|521232285|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
144555650|NCT02023099|521232286|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
144555651|NCT02023099|521232284|FG000|Overall Study|Withdrawn Consent|3|||
144555652|NCT02023099|521232285|FG001|Overall Study|Withdrawn Consent|0|||
144555653|NCT02023099|521232286|FG002|Overall Study|Withdrawn Consent|1|||
144555654|NCT02023099|521232284|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
144555655|NCT02023099|521232285|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
144555656|NCT02023099|521232286|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
144555657|NCT00203502|521232287|FG000|Overall Study|Death|1|||
144555658|NCT00105521|521232310|FG000|Overall Study|Other|1|||
144555659|NCT00105521|521232311|FG001|Overall Study|Other|1|||
144555660|NCT00105521|521232312|FG002|Overall Study|Other|2|||
144555661|NCT00105521|521232313|FG003|Overall Study|Other|0|||
144555662|NCT00105521|521232310|FG000|Overall Study|Adverse Event|10|||
144555663|NCT00105521|521232311|FG001|Overall Study|Adverse Event|4|||
144555664|NCT00105521|521232312|FG002|Overall Study|Adverse Event|10|||
144555665|NCT00105521|521232313|FG003|Overall Study|Adverse Event|8|||
144555666|NCT00105521|521232310|FG000|Overall Study|Withdrawal by Subject|1|||
144555667|NCT00105521|521232311|FG001|Overall Study|Withdrawal by Subject|0|||
144555668|NCT00105521|521232312|FG002|Overall Study|Withdrawal by Subject|1|||
144555669|NCT00105521|521232313|FG003|Overall Study|Withdrawal by Subject|4|||
144555670|NCT00105521|521232310|FG000|Overall Study|Lack of Efficacy|0|||
144555671|NCT00105521|521232311|FG001|Overall Study|Lack of Efficacy|0|||
144555672|NCT00105521|521232312|FG002|Overall Study|Lack of Efficacy|0|||
144555673|NCT00105521|521232313|FG003|Overall Study|Lack of Efficacy|1|||
144555674|NCT00105521|521232310|FG000|Overall Study|Protocol Violation|3|||
144555675|NCT00105521|521232311|FG001|Overall Study|Protocol Violation|5|||
144555676|NCT00105521|521232312|FG002|Overall Study|Protocol Violation|4|||
144555677|NCT00105521|521232313|FG003|Overall Study|Protocol Violation|4|||
144555678|NCT00105521|521232310|FG000|Overall Study|Lost to Follow-up|0|||
144555679|NCT00105521|521232311|FG001|Overall Study|Lost to Follow-up|1|||
144555680|NCT00105521|521232312|FG002|Overall Study|Lost to Follow-up|0|||
144555681|NCT00105521|521232313|FG003|Overall Study|Lost to Follow-up|0|||
144555682|NCT00385697|521232315|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
144555683|NCT00385697|521232316|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
144555684|NCT00385697|521232317|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
144555685|NCT00385697|521232318|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
144555686|NCT00385697|521232319|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
144555687|NCT00385697|521232315|FG000|Open-label Segment 1|Lost to Follow-up|1|||
144555688|NCT00385697|521232316|FG001|Open-label Segment 1|Lost to Follow-up|0|||
144555689|NCT00385697|521232317|FG002|Open-label Segment 1|Lost to Follow-up|0|||
144555690|NCT00385697|521232318|FG003|Open-label Segment 1|Lost to Follow-up|0|||
144555691|NCT00385697|521232319|FG004|Open-label Segment 1|Lost to Follow-up|0|||
144555692|NCT00385697|521232315|FG000|Double-blind Segment 2|Adverse Event|0|||
144555693|NCT00385697|521232316|FG001|Double-blind Segment 2|Adverse Event|3|||
144555694|NCT00385697|521232317|FG002|Double-blind Segment 2|Adverse Event|1|||
144555695|NCT00385697|521232318|FG003|Double-blind Segment 2|Adverse Event|0|||
144555696|NCT00385697|521232319|FG004|Double-blind Segment 2|Adverse Event|0|||
144555697|NCT00385697|521232315|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
144555698|NCT00385697|521232316|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
144555699|NCT00385697|521232317|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
144555700|NCT00385697|521232318|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
144555701|NCT00385697|521232319|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
144555702|NCT00385697|521232315|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
144555703|NCT00385697|521232316|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
144555704|NCT00385697|521232317|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
144555705|NCT00385697|521232318|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
144555706|NCT00385697|521232319|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
144555707|NCT00385697|521232315|FG000|Double-blind Segment 2|Other|0|||
144555708|NCT00385697|521232316|FG001|Double-blind Segment 2|Other|2|||
144555709|NCT00385697|521232317|FG002|Double-blind Segment 2|Other|0|||
144555710|NCT00385697|521232318|FG003|Double-blind Segment 2|Other|0|||
144555711|NCT00385697|521232319|FG004|Double-blind Segment 2|Other|0|||
144555712|NCT00510783|521232323|FG000|Overall Study|Lost to Follow-up|29|||
144555713|NCT00510783|521232324|FG001|Overall Study|Lost to Follow-up|25|||
144555714|NCT00510783|521232323|FG000|Overall Study|Withdrawal by Subject|2|||
144555715|NCT00510783|521232324|FG001|Overall Study|Withdrawal by Subject|3|||
144555716|NCT00510783|521232323|FG000|Overall Study|Protocol Violation|0|||
144555717|NCT00510783|521232324|FG001|Overall Study|Protocol Violation|1|||
144555718|NCT00316121|521232325|FG000|Overall Study|Death|1|||
144555719|NCT00316121|521232326|FG001|Overall Study|Death|0|||
144555720|NCT00316121|521232325|FG000|Overall Study|Lost to Follow-up|14|||
144555721|NCT00316121|521232326|FG001|Overall Study|Lost to Follow-up|8|||
144555722|NCT00316121|521232325|FG000|Overall Study|Withdrawal by Subject|2|||
144555723|NCT00316121|521232326|FG001|Overall Study|Withdrawal by Subject|0|||
144555724|NCT00316121|521232325|FG000|Overall Study|Reason is missing|1|||
144555725|NCT00316121|521232326|FG001|Overall Study|Reason is missing|0|||
144555726|NCT00316121|521232325|FG000|Overall Study|Subject relocated|1|||
144555727|NCT00316121|521232326|FG001|Overall Study|Subject relocated|1|||
144555728|NCT00316121|521232325|FG000|Overall Study|Subject refused to return|1|||
144555729|NCT00316121|521232326|FG001|Overall Study|Subject refused to return|0|||
144555730|NCT00316121|521232325|FG000|Overall Study|Subject no show for visit x 3|1|||
144555731|NCT00316121|521232326|FG001|Overall Study|Subject no show for visit x 3|0|||
144616990|NCT02432235|521458030|FG003|Overall Study|Lost to Follow-up|0|||
144616991|NCT02432235|521458031|FG004|Overall Study|Lost to Follow-up|0|||
144616992|NCT02432235|521458032|FG005|Overall Study|Lost to Follow-up|1|||
144616993|NCT02432235|521458033|FG006|Overall Study|Lost to Follow-up|0|||
144616994|NCT02432235|521458034|FG007|Overall Study|Lost to Follow-up|0|||
144616995|NCT02432235|521458035|FG008|Overall Study|Lost to Follow-up|1|||
144616996|NCT02432235|521458036|FG009|Overall Study|Lost to Follow-up|0|||
144616997|NCT02432235|521458037|FG010|Overall Study|Lost to Follow-up|0|||
144616998|NCT02432235|521458038|FG011|Overall Study|Lost to Follow-up|0|||
144616999|NCT02432235|521458027|FG000|Overall Study|Miscellaneous|0|||
144617000|NCT02432235|521458028|FG001|Overall Study|Miscellaneous|0|||
144555732|NCT00316121|521232325|FG000|Overall Study|Subject did not have 24 month visit|1|||
144555733|NCT00316121|521232326|FG001|Overall Study|Subject did not have 24 month visit|0|||
144555734|NCT00442559|521232327|FG000|Overall Study|Lost to Follow-up|32|||
144555735|NCT00442559|521232328|FG001|Overall Study|Lost to Follow-up|34|||
144555736|NCT00442559|521232327|FG000|Overall Study|Protocol Violation|1|||
144555737|NCT00442559|521232328|FG001|Overall Study|Protocol Violation|1|||
144555738|NCT00442559|521232327|FG000|Overall Study|Withdrawal by Subject|1|||
144555739|NCT00442559|521232328|FG001|Overall Study|Withdrawal by Subject|0|||
144555740|NCT05287178|521232329|FG000|Overall Study|Lost to Follow-up|2|||
144555741|NCT01426217|521232330|FG000|Overall Study|lost sample|8|||
144555742|NCT01426217|521232331|FG001|Overall Study|lost sample|14|||
144555743|NCT01648699|521232332|FG000|Overall Study|Death|1|||
144555744|NCT01648699|521232332|FG000|Overall Study|Lost to Follow-up|2|||
144555745|NCT01648699|521232332|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
144555746|NCT02267746|521232333|FG000|Overall Study|Adverse Event|0|||
144555747|NCT02267746|521232334|FG001|Overall Study|Adverse Event|2|||
144555748|NCT02267746|521232335|FG002|Overall Study|Adverse Event|1|||
144555749|NCT02267746|521232333|FG000|Overall Study|Protocol Violation|8|||
144555750|NCT02267746|521232334|FG001|Overall Study|Protocol Violation|7|||
144555751|NCT02267746|521232335|FG002|Overall Study|Protocol Violation|3|||
144555752|NCT02267746|521232333|FG000|Overall Study|Lack of Efficacy|11|||
144555753|NCT02267746|521232334|FG001|Overall Study|Lack of Efficacy|11|||
144555754|NCT02267746|521232335|FG002|Overall Study|Lack of Efficacy|15|||
144555755|NCT02267746|521232333|FG000|Overall Study|Protocol Violation|1|||
144555756|NCT02267746|521232334|FG001|Overall Study|Protocol Violation|2|||
144555757|NCT02267746|521232335|FG002|Overall Study|Protocol Violation|1|||
144555758|NCT02267746|521232333|FG000|Overall Study|Miscellaneous|1|||
144555759|NCT02267746|521232334|FG001|Overall Study|Miscellaneous|0|||
144555760|NCT02267746|521232335|FG002|Overall Study|Miscellaneous|1|||
144555761|NCT00288353|521232340|FG000|Overall Study|Lack of Efficacy|2|||
144555762|NCT00288353|521232341|FG001|Overall Study|Lack of Efficacy|2|||
144555763|NCT00288353|521232340|FG000|Overall Study|Withdrawal by Subject|5|||
144555764|NCT00288353|521232341|FG001|Overall Study|Withdrawal by Subject|5|||
144555765|NCT05008224|521232342|FG000|Overall Study|Death|3|||
144555766|NCT05008224|521232342|FG000|Overall Study|Lost to Follow-up|2|||
144555767|NCT05008224|521232342|FG000|Overall Study|Did Not Continue on Extension Study|39|||
144555768|NCT05008224|521232342|FG000|Overall Study|Transferred to Extension Study|100|||
144555769|NCT05008224|521232342|FG000|Overall Study|Withdrawal by Subject|2|||
144555770|NCT00728884|521232343|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
144555771|NCT00728884|521232343|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
144555772|NCT05263492|521232344|FG000|Overall Study|Adverse Event|1|||
144555773|NCT05263492|521232344|FG000|Overall Study|Disease progression during active treatment|3|||
144555774|NCT03345420|521232347|FG000|Overall Study|Withdrawal by Subject|1|||
144555775|NCT04551053|521232348|FG000|Overall Study|Death|10|||
144555776|NCT04551053|521232349|FG001|Overall Study|Death|9|||
144555777|NCT04551053|521232348|FG000|Overall Study|Lost to Follow-up|0|||
144555778|NCT04551053|521232349|FG001|Overall Study|Lost to Follow-up|2|||
144555779|NCT04551053|521232348|FG000|Overall Study|Study Terminated by Sponsor|57|||
144555780|NCT04551053|521232349|FG001|Overall Study|Study Terminated by Sponsor|65|||
144555781|NCT04551053|521232348|FG000|Overall Study|Withdrawal by Subject|12|||
144555782|NCT04551053|521232349|FG001|Overall Study|Withdrawal by Subject|5|||
144555783|NCT04551053|521232348|FG000|Overall Study|Adverse Event|2|||
144555784|NCT04551053|521232349|FG001|Overall Study|Adverse Event|0|||
144555785|NCT04551053|521232348|FG000|Overall Study|Lack of Efficacy|2|||
144555786|NCT04551053|521232349|FG001|Overall Study|Lack of Efficacy|1|||
144555787|NCT04551053|521232348|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
144555788|NCT04551053|521232349|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
144555789|NCT04551053|521232348|FG000|Overall Study|Splenapendectomi|1|||
144555790|NCT04551053|521232349|FG001|Overall Study|Splenapendectomi|0|||
144617001|NCT02432235|521458029|FG002|Overall Study|Miscellaneous|0|||
144617002|NCT02432235|521458030|FG003|Overall Study|Miscellaneous|0|||
144617003|NCT02432235|521458031|FG004|Overall Study|Miscellaneous|1|||
144727788|NCT00920140|521858076|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
144555791|NCT04551053|521232348|FG000|Overall Study|Medical Decision|1|||
144555792|NCT04551053|521232349|FG001|Overall Study|Medical Decision|1|||
144555793|NCT03861078|521232350|FG000|Overall Study|COVID-19 shut down|4|||
144555794|NCT03861078|521232350|FG000|Overall Study|Lost to Follow-up|1|||
144555795|NCT03861078|521232350|FG000|Overall Study|Protocol Violation|2|||
144555796|NCT03861078|521232350|FG000|Overall Study|lack of venous access|1|||
144555797|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
144555798|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
144555799|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
144555800|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
144555801|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
144555802|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
144555803|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
144555804|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
144555805|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
144555806|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
144555807|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
144555808|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
144555809|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
144555810|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
144555811|NCT02971683|521232351|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
144555812|NCT02971683|521232352|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
144555813|NCT02971683|521232351|FG000|Open-Label|Lost to Follow-up|1|||
144555814|NCT02971683|521232352|FG001|Open-Label|Lost to Follow-up|0|||
144555815|NCT02971683|521232351|FG000|Open-Label|Participants withdrew consent|0|||
144555816|NCT02971683|521232352|FG001|Open-Label|Participants withdrew consent|2|||
144555817|NCT02971683|521232351|FG000|Open-Label|Participant request to discontinue study treatment|1|||
144555818|NCT02971683|521232352|FG001|Open-Label|Participant request to discontinue study treatment|0|||
144555819|NCT02971683|521232351|FG000|Open-Label|Lack of Efficacy|2|||
144555820|NCT02971683|521232352|FG001|Open-Label|Lack of Efficacy|0|||
144555821|NCT02971683|521232351|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
144555822|NCT02971683|521232352|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
144555823|NCT02971683|521232351|FG000|Long-Term Open Label|Participant withdrew consent|1|||
144555824|NCT02971683|521232352|FG001|Long-Term Open Label|Participant withdrew consent|0|||
144555825|NCT02971683|521232351|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
144555826|NCT02971683|521232352|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
144555827|NCT02971683|521232351|FG000|Long-Term Open Label|Adverse Event|1|||
144555828|NCT02971683|521232352|FG001|Long-Term Open Label|Adverse Event|2|||
144555829|NCT02971683|521232351|FG000|Long-Term Open Label|Lack of Efficacy|1|||
144555830|NCT02971683|521232352|FG001|Long-Term Open Label|Lack of Efficacy|1|||
144555831|NCT02924051|521232359|FG000|Overall Study|Withdrawal by Subject|1|||
144555832|NCT02924051|521232360|FG001|Overall Study|Withdrawal by Subject|9|||
144555833|NCT00512902|521232364|FG000|Overall Study|Adverse Event|7|||
144555834|NCT00512902|521232364|FG000|Overall Study|Lost to Follow-up|1|||
144555835|NCT03019289|521232365|FG000|Overall Study|Adverse Event|1|||
144555836|NCT03019289|521232366|FG001|Overall Study|Adverse Event|0|||
144555837|NCT03019289|521232367|FG002|Overall Study|Adverse Event|0|||
144555838|NCT03019289|521232368|FG003|Overall Study|Adverse Event|0|||
144555839|NCT03019289|521232369|FG004|Overall Study|Adverse Event|0|||
144555840|NCT03019289|521232370|FG005|Overall Study|Adverse Event|0|||
144555841|NCT03019289|521232371|FG006|Overall Study|Adverse Event|0|||
144555842|NCT03019289|521232372|FG007|Overall Study|Adverse Event|0|||
144555843|NCT03019289|521232373|FG008|Overall Study|Adverse Event|1|||
144555844|NCT03019289|521232365|FG000|Overall Study|Other|1|||
144617004|NCT02432235|521458032|FG005|Overall Study|Miscellaneous|6|||
144555845|NCT03019289|521232366|FG001|Overall Study|Other|0|||
144555846|NCT03019289|521232367|FG002|Overall Study|Other|0|||
144617005|NCT02432235|521458033|FG006|Overall Study|Miscellaneous|2|||
144617006|NCT02432235|521458034|FG007|Overall Study|Miscellaneous|2|||
144617007|NCT02432235|521458035|FG008|Overall Study|Miscellaneous|4|||
144617008|NCT02432235|521458036|FG009|Overall Study|Miscellaneous|0|||
144617009|NCT02432235|521458037|FG010|Overall Study|Miscellaneous|0|||
144617010|NCT02432235|521458038|FG011|Overall Study|Miscellaneous|1|||
144617011|NCT01895322|521458039|FG000|Overall Study|Adverse Event|1|||
144555847|NCT03019289|521232368|FG003|Overall Study|Other|0|||
144555848|NCT03019289|521232369|FG004|Overall Study|Other|0|||
144555849|NCT03019289|521232370|FG005|Overall Study|Other|0|||
144555850|NCT03019289|521232371|FG006|Overall Study|Other|0|||
144555851|NCT03019289|521232372|FG007|Overall Study|Other|0|||
144555852|NCT03019289|521232373|FG008|Overall Study|Other|0|||
144555853|NCT02389894|521232374|FG000|Overall Study|Death|4|||
144555854|NCT02389894|521232375|FG001|Overall Study|Death|5|||
144555855|NCT02389894|521232376|FG002|Overall Study|Death|3|||
144555856|NCT02389894|521232374|FG000|Overall Study|Withdrawal by Subject|2|||
144555857|NCT02389894|521232375|FG001|Overall Study|Withdrawal by Subject|4|||
144555858|NCT02389894|521232376|FG002|Overall Study|Withdrawal by Subject|5|||
144555859|NCT02389894|521232374|FG000|Overall Study|Lost to Follow-up|2|||
144617012|NCT01895322|521458039|FG000|Overall Study|Withdrawal by Subject|2|||
144617013|NCT01895322|521458039|FG000|Overall Study|Protocol Violation|10|||
144617014|NCT01046877|521458041|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
144555860|NCT02389894|521232375|FG001|Overall Study|Lost to Follow-up|1|||
144555861|NCT02389894|521232376|FG002|Overall Study|Lost to Follow-up|1|||
144555862|NCT01549951|521232380|FG000|Overall Study|Adverse Event|15|||
144555863|NCT01549951|521232380|FG000|Overall Study|Withdrawal by Subject|2|||
144555864|NCT01549951|521232380|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
144555865|NCT01549951|521232380|FG000|Overall Study|Progressive disease|29|||
144617015|NCT01046877|521458041|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
144617016|NCT01834274|521458042|FG000|Overall Study|Study Termination|41|||
144617017|NCT01834274|521458043|FG001|Overall Study|Study Termination|38|||
144617018|NCT01834274|521458042|FG000|Overall Study|Withdrawal by Subject|1|||
144555866|NCT01549951|521232380|FG000|Overall Study|Symptomatic deterioration|1|||
144555867|NCT01549951|521232380|FG000|Overall Study|Other|2|||
144555868|NCT03138499|521232381|FG000|Overall Study|Lost to Follow-up|1|||
144555869|NCT03138499|521232382|FG001|Overall Study|Lost to Follow-up|0|||
144555870|NCT03138499|521232381|FG000|Overall Study|Participants withdrew consent|1|||
144555871|NCT03138499|521232382|FG001|Overall Study|Participants withdrew consent|0|||
144555872|NCT03138499|521232381|FG000|Overall Study|Participant discontinued study before treatment|0|||
144555873|NCT03138499|521232382|FG001|Overall Study|Participant discontinued study before treatment|1|||
144555874|NCT03138499|521232381|FG000|Overall Study|Disease Progression|2|||
144617019|NCT01834274|521458043|FG001|Overall Study|Withdrawal by Subject|1|||
144617020|NCT01834274|521458042|FG000|Overall Study|Lost to Follow-up|3|||
144617021|NCT01834274|521458043|FG001|Overall Study|Lost to Follow-up|1|||
144617022|NCT01834274|521458042|FG000|Overall Study|Other|2|||
144617023|NCT01834274|521458043|FG001|Overall Study|Other|1|||
144617024|NCT03681119|521458046|FG000|Overall Study|No specific reason|4|||
144617025|NCT03681119|521458047|FG001|Overall Study|No specific reason|0|||
144617026|NCT03681119|521458046|FG000|Overall Study|Sickness|2|||
144617027|NCT03681119|521458047|FG001|Overall Study|Sickness|0|||
144617028|NCT02813694|521458050|FG000|Overall Study|Physician Decision|0|||
144617029|NCT02813694|521458051|FG001|Overall Study|Physician Decision|1|||
144617030|NCT02813694|521458050|FG000|Overall Study|Withdrawal by Subject|10|||
144617031|NCT02813694|521458051|FG001|Overall Study|Withdrawal by Subject|9|||
144617032|NCT02813694|521458050|FG000|Overall Study|Lost to Follow-up|1|||
144617033|NCT02813694|521458051|FG001|Overall Study|Lost to Follow-up|1|||
144617034|NCT02813694|521458050|FG000|Overall Study|Death|3|||
144617035|NCT02813694|521458051|FG001|Overall Study|Death|3|||
144617036|NCT02813694|521458050|FG000|Overall Study|Randomized- did not receive study drug|2|||
144617037|NCT02813694|521458051|FG001|Overall Study|Randomized- did not receive study drug|0|||
144617038|NCT02813694|521458050|FG000|Overall Study|Patient hospitalized|1|||
144617039|NCT02813694|521458051|FG001|Overall Study|Patient hospitalized|0|||
144617040|NCT00606320|521458058|FG000|Overall Study|Adverse Event|3|||
144617041|NCT00606320|521458058|FG000|Overall Study|Lack of Efficacy|5|||
144617042|NCT00606320|521458058|FG000|Overall Study|Physician Decision|7|||
144617043|NCT00606320|521458058|FG000|Overall Study|Protocol Violation|8|||
144617044|NCT00606320|521458058|FG000|Overall Study|Withdrawal by Subject|10|||
144617045|NCT00606320|521458058|FG000|Overall Study|Progression to depressive phase|4|||
144555875|NCT03138499|521232382|FG001|Overall Study|Disease Progression|6|||
144555876|NCT03138499|521232381|FG000|Overall Study|Study drug toxicity|2|||
144555877|NCT03138499|521232382|FG001|Overall Study|Study drug toxicity|2|||
144555878|NCT03138499|521232381|FG000|Overall Study|Participant request to discontinue study treatment|1|||
144555879|NCT03138499|521232382|FG001|Overall Study|Participant request to discontinue study treatment|1|||
144555880|NCT03138499|521232381|FG000|Overall Study|Other reasons|2|||
144555881|NCT03138499|521232382|FG001|Overall Study|Other reasons|0|||
144555882|NCT01334606|521232383|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
144555883|NCT02312245|521232384|FG000|Overall Study|Death|0|||
144555884|NCT02312245|521232385|FG001|Overall Study|Death|0|||
144617046|NCT00563186|521458059|FG000|Overall Study|LOS<48 hours|97|||
144555885|NCT02312245|521232386|FG002|Overall Study|Death|0|||
144555886|NCT02312245|521232387|FG003|Overall Study|Death|1|||
144555887|NCT02312245|521232384|FG000|Overall Study|Withdrawal by Subject|1|||
144555888|NCT02312245|521232385|FG001|Overall Study|Withdrawal by Subject|1|||
144617047|NCT00563186|521458060|FG001|Overall Study|LOS<48 hours|74|||
144617048|NCT00563186|521458059|FG000|Overall Study|Incomplete data|1|||
144617049|NCT00563186|521458060|FG001|Overall Study|Incomplete data|1|||
144617050|NCT01152021|521458061|FG000|Overall Study|Adverse Event|4|||
144555889|NCT02312245|521232386|FG002|Overall Study|Withdrawal by Subject|0|||
144555890|NCT02312245|521232387|FG003|Overall Study|Withdrawal by Subject|2|||
144555891|NCT02312245|521232384|FG000|Overall Study|Alternative Therapy|1|||
144555892|NCT02312245|521232385|FG001|Overall Study|Alternative Therapy|0|||
144555893|NCT02312245|521232386|FG002|Overall Study|Alternative Therapy|0|||
144617051|NCT01152021|521458062|FG001|Overall Study|Adverse Event|4|||
144617052|NCT01152021|521458061|FG000|Overall Study|Study drug had expired|1|||
144617053|NCT01152021|521458062|FG001|Overall Study|Study drug had expired|0|||
144617054|NCT01152021|521458061|FG000|Overall Study|Physician Decision|1|||
144617055|NCT01152021|521458062|FG001|Overall Study|Physician Decision|1|||
144617056|NCT01152021|521458061|FG000|Overall Study|No access to study drug in Pharmacy|0|||
144617057|NCT01152021|521458062|FG001|Overall Study|No access to study drug in Pharmacy|1|||
144617058|NCT02595723|521458063|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
144555894|NCT02312245|521232387|FG003|Overall Study|Alternative Therapy|0|||
144555895|NCT02312245|521232384|FG000|Overall Study|Progression|0|||
144555896|NCT02312245|521232385|FG001|Overall Study|Progression|0|||
144555897|NCT02312245|521232386|FG002|Overall Study|Progression|0|||
144555898|NCT02312245|521232387|FG003|Overall Study|Progression|5|||
144555899|NCT02312245|521232384|FG000|Overall Study|Patient went to hospice|0|||
144555900|NCT02312245|521232385|FG001|Overall Study|Patient went to hospice|0|||
144555901|NCT02312245|521232386|FG002|Overall Study|Patient went to hospice|0|||
144555902|NCT02312245|521232387|FG003|Overall Study|Patient went to hospice|1|||
144555903|NCT02312245|521232384|FG000|Overall Study|Ineligible|1|||
144555904|NCT02312245|521232385|FG001|Overall Study|Ineligible|0|||
144555905|NCT02312245|521232386|FG002|Overall Study|Ineligible|0|||
144555906|NCT02312245|521232387|FG003|Overall Study|Ineligible|0|||
144555907|NCT00448344|521232388|FG000|Overall Study|Lost to Follow-up|20|||
144555908|NCT00448344|521232389|FG001|Overall Study|Lost to Follow-up|22|||
144555909|NCT00448344|521232388|FG000|Overall Study|Withdrawal by Subject|6|||
144555910|NCT00448344|521232389|FG001|Overall Study|Withdrawal by Subject|8|||
144555911|NCT00448344|521232388|FG000|Overall Study|Death|3|||
144555912|NCT00448344|521232389|FG001|Overall Study|Death|4|||
144555913|NCT00448344|521232388|FG000|Overall Study|Physician Decision|1|||
144555914|NCT00448344|521232389|FG001|Overall Study|Physician Decision|2|||
144555915|NCT01123200|521232393|FG000|Overall Study|Withdrawal by Subject|1|||
144555916|NCT00990314|521232394|FG000|Overall Study|Death|2|||
144555917|NCT00990314|521232394|FG000|Overall Study|Adverse Event|2|||
144555918|NCT00990314|521232394|FG000|Overall Study|Withdrawal by Subject|3|||
144555919|NCT00990314|521232394|FG000|Overall Study|Non-Compliance|1|||
144555920|NCT00990314|521232394|FG000|Overall Study|Physician Decision|3|||
144555921|NCT00990314|521232394|FG000|Overall Study|Lack of Efficacy|1|||
144555922|NCT01537120|521234184|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
144555923|NCT01537120|521234184|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
144555924|NCT00627523|521234187|FG000|Overall Study|Lack of Efficacy|1|||
144555925|NCT00627523|521234188|FG001|Overall Study|Lack of Efficacy|0|||
144555926|NCT00627523|521234187|FG000|Overall Study|Withdrawal by Subject|0|||
144555927|NCT00627523|521234188|FG001|Overall Study|Withdrawal by Subject|2|||
144555928|NCT00627523|521234187|FG000|Overall Study|Other|1|||
144555929|NCT00627523|521234188|FG001|Overall Study|Other|0|||
144555930|NCT03451292|521234189|FG000|Overall Study|Death|44|||
144555931|NCT03451292|521234190|FG001|Overall Study|Death|59|||
144555932|NCT03451292|521234189|FG000|Overall Study|Withdrawal by Subject|18|||
144555933|NCT03451292|521234190|FG001|Overall Study|Withdrawal by Subject|13|||
144555934|NCT03451292|521234189|FG000|Overall Study|Transplantation|18|||
144555935|NCT03451292|521234190|FG001|Overall Study|Transplantation|12|||
144555936|NCT03451292|521234189|FG000|Overall Study|Lost to Follow-up|4|||
144555937|NCT03451292|521234190|FG001|Overall Study|Lost to Follow-up|12|||
144555938|NCT03451292|521234189|FG000|Overall Study|Physician Decision|4|||
144555939|NCT03451292|521234190|FG001|Overall Study|Physician Decision|3|||
144555940|NCT03451292|521234189|FG000|Overall Study|Adverse Event|3|||
144555941|NCT03451292|521234190|FG001|Overall Study|Adverse Event|3|||
144555942|NCT03451292|521234189|FG000|Overall Study|Non-compliance with Study Drug|2|||
144555943|NCT03451292|521234190|FG001|Overall Study|Non-compliance with Study Drug|0|||
144555944|NCT03602053|521234197|FG000|Overall Study|Withdrawal by Subject|7|||
144555945|NCT03602053|521234198|FG001|Overall Study|Withdrawal by Subject|9|||
144555946|NCT03602053|521234199|FG002|Overall Study|Withdrawal by Subject|7|||
144555947|NCT03602053|521234197|FG000|Overall Study|Lost to Follow-up|5|||
144555948|NCT03602053|521234198|FG001|Overall Study|Lost to Follow-up|6|||
144555949|NCT03602053|521234199|FG002|Overall Study|Lost to Follow-up|0|||
144555950|NCT03602053|521234197|FG000|Overall Study|Protocol Violation|3|||
144555951|NCT03602053|521234198|FG001|Overall Study|Protocol Violation|0|||
144555952|NCT03602053|521234199|FG002|Overall Study|Protocol Violation|4|||
144555953|NCT03602053|521234197|FG000|Overall Study|Physician Decision|1|||
144555954|NCT03602053|521234198|FG001|Overall Study|Physician Decision|0|||
144555955|NCT03602053|521234199|FG002|Overall Study|Physician Decision|0|||
144555956|NCT03602053|521234197|FG000|Overall Study|migration|2|||
144555957|NCT03602053|521234198|FG001|Overall Study|migration|3|||
144555958|NCT03602053|521234199|FG002|Overall Study|migration|0|||
144555959|NCT03602053|521234197|FG000|Overall Study|Other|1|||
144555960|NCT03602053|521234198|FG001|Overall Study|Other|0|||
144555961|NCT03602053|521234199|FG002|Overall Study|Other|0|||
144555962|NCT01038128|521234200|FG000|Overall Study|Lack of Efficacy|1|||
144555963|NCT01038128|521234200|FG000|Overall Study|Lost to Follow-up|1|||
144555964|NCT01038128|521234200|FG000|Overall Study|Withdrawal by Subject|2|||
144617059|NCT02595723|521458064|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
144555965|NCT01753323|521234205|FG000|Overall Study|Lack of Efficacy|0|||
144555966|NCT01753323|521234206|FG001|Overall Study|Lack of Efficacy|0|||
144555967|NCT01753323|521234207|FG002|Overall Study|Lack of Efficacy|8|||
144555968|NCT01753323|521234205|FG000|Overall Study|Protocol deviation|1|||
144617060|NCT02595723|521458065|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
144555969|NCT01753323|521234206|FG001|Overall Study|Protocol deviation|0|||
144555970|NCT01753323|521234207|FG002|Overall Study|Protocol deviation|0|||
144555971|NCT01753323|521234205|FG000|Overall Study|Adverse Event|0|||
144555972|NCT01753323|521234206|FG001|Overall Study|Adverse Event|0|||
144617061|NCT02595723|521458063|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
144555973|NCT01753323|521234207|FG002|Overall Study|Adverse Event|1|||
144555974|NCT01870999|521234209|FG000|Overall Study|Adverse Event|0|||
144555975|NCT01870999|521234210|FG001|Overall Study|Adverse Event|4|||
144555976|NCT01870999|521234211|FG002|Overall Study|Adverse Event|1|||
144555977|NCT01870999|521234209|FG000|Overall Study|Subject met withdrawal criteria|3|||
144555978|NCT01870999|521234210|FG001|Overall Study|Subject met withdrawal criteria|2|||
144555979|NCT01870999|521234211|FG002|Overall Study|Subject met withdrawal criteria|0|||
144555980|NCT01870999|521234209|FG000|Overall Study|Subject withdrawn by Investigator|1|||
144555981|NCT01870999|521234210|FG001|Overall Study|Subject withdrawn by Investigator|0|||
144555982|NCT01870999|521234211|FG002|Overall Study|Subject withdrawn by Investigator|0|||
144555983|NCT01870999|521234209|FG000|Overall Study|Withdrawal by Subject|0|||
144555984|NCT01870999|521234210|FG001|Overall Study|Withdrawal by Subject|2|||
144555985|NCT01870999|521234211|FG002|Overall Study|Withdrawal by Subject|5|||
144555986|NCT01870999|521234209|FG000|Overall Study|Protocol Violation|0|||
144555987|NCT01870999|521234210|FG001|Overall Study|Protocol Violation|0|||
144555988|NCT01870999|521234211|FG002|Overall Study|Protocol Violation|1|||
144555989|NCT01636258|521234212|FG000|Overall Study|Lost to Follow-up|1|||
144555990|NCT01636258|521234213|FG001|Overall Study|Lost to Follow-up|0|||
144555991|NCT00116584|521234214|FG000|Overall Study|Withdrawal by Subject|1|||
144555992|NCT00116584|521234215|FG001|Overall Study|Withdrawal by Subject|0|||
144555993|NCT00116584|521234214|FG000|Overall Study|Protocol Violation|1|||
144555994|NCT00116584|521234215|FG001|Overall Study|Protocol Violation|1|||
144555995|NCT02798861|521234218|FG000|Overall Study|Lost to Follow-up|22|||
144555996|NCT02798861|521234218|FG000|Overall Study|Withdrawal by Subject|1|||
144555997|NCT01695993|521234219|FG000|Overall Study|Lost to Follow-up|2|||
144555998|NCT01695993|521234220|FG001|Overall Study|Lost to Follow-up|1|||
144555999|NCT01695993|521234221|FG002|Overall Study|Lost to Follow-up|3|||
144556000|NCT01695993|521234219|FG000|Overall Study|Withdrawal by Subject|2|||
144556001|NCT01695993|521234220|FG001|Overall Study|Withdrawal by Subject|2|||
144556002|NCT01695993|521234221|FG002|Overall Study|Withdrawal by Subject|2|||
144556003|NCT01695993|521234219|FG000|Overall Study|To ill to continue|1|||
144556004|NCT01695993|521234220|FG001|Overall Study|To ill to continue|2|||
144556005|NCT01695993|521234221|FG002|Overall Study|To ill to continue|0|||
144556006|NCT01695993|521234219|FG000|Overall Study|Changed Medical Facility|0|||
144556007|NCT01695993|521234220|FG001|Overall Study|Changed Medical Facility|0|||
144556008|NCT01695993|521234221|FG002|Overall Study|Changed Medical Facility|1|||
144556009|NCT04057937|521234222|FG000|Placebo-controlled Phase|Adverse Event|3|||
144556010|NCT04057937|521234223|FG001|Placebo-controlled Phase|Adverse Event|0|||
144556011|NCT04057937|521234222|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
144556012|NCT04057937|521234223|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
144556013|NCT04057937|521234222|FG000|Active-treatment Phase|Pregnancy|0|||
144556014|NCT04057937|521234223|FG001|Active-treatment Phase|Pregnancy|1|||
144556015|NCT04057937|521234222|FG000|Active-treatment Phase|Physician Decision|0|||
144556016|NCT04057937|521234223|FG001|Active-treatment Phase|Physician Decision|1|||
144556017|NCT01072396|521234224|FG000|Period One|Adverse Event|1|||
144556018|NCT01072396|521234225|FG001|Period One|Adverse Event|1|||
144556019|NCT01072396|521234224|FG000|Period One|Protocol Violation|2|||
144556020|NCT01072396|521234225|FG001|Period One|Protocol Violation|1|||
144556021|NCT01072396|521234224|FG000|Period One|Withdrawal by Subject|2|||
144556022|NCT01072396|521234225|FG001|Period One|Withdrawal by Subject|0|||
144556023|NCT01072396|521234224|FG000|Washout Period|Missing termination information|0|||
144556024|NCT01072396|521234225|FG001|Washout Period|Missing termination information|1|||
144556025|NCT01072396|521234224|FG000|Period Two|Adverse Event|0|||
144556026|NCT01072396|521234225|FG001|Period Two|Adverse Event|3|||
144556027|NCT01072396|521234224|FG000|Period Two|Lost to Follow-up|1|||
144556028|NCT01072396|521234225|FG001|Period Two|Lost to Follow-up|0|||
144556029|NCT00472199|521234226|FG000|Overall Study|Adverse Event|19|||
144556030|NCT00472199|521234227|FG001|Overall Study|Adverse Event|23|||
144556031|NCT00472199|521234226|FG000|Overall Study|Lack of Efficacy|4|||
144556032|NCT00472199|521234227|FG001|Overall Study|Lack of Efficacy|25|||
144556033|NCT00472199|521234226|FG000|Overall Study|Lost to Follow-up|2|||
144556034|NCT00472199|521234227|FG001|Overall Study|Lost to Follow-up|4|||
144556035|NCT00472199|521234226|FG000|Overall Study|Protocol Violation|3|||
144556036|NCT00472199|521234227|FG001|Overall Study|Protocol Violation|2|||
144556037|NCT00472199|521234226|FG000|Overall Study|Withdrawal by Subject|6|||
144556038|NCT00472199|521234227|FG001|Overall Study|Withdrawal by Subject|5|||
144556039|NCT00472199|521234226|FG000|Overall Study|personal reason|0|||
144556040|NCT00472199|521234227|FG001|Overall Study|personal reason|1|||
144556041|NCT00472199|521234226|FG000|Overall Study|patient was asymptomatic|1|||
144556042|NCT00472199|521234227|FG001|Overall Study|patient was asymptomatic|0|||
144617062|NCT02595723|521458064|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
144556043|NCT01268488|521234229|FG000|Overall Study|Adverse Event|3|||
144556044|NCT01268488|521234229|FG000|Overall Study|Physician Decision|2|||
144556045|NCT02475733|521234232|FG000|Overall Study|Withdrawal by Subject|1|||
144556046|NCT02475733|521234233|FG001|Overall Study|Withdrawal by Subject|0|||
144556047|NCT02475733|521234232|FG000|Overall Study|Physician Decision|1|||
144617063|NCT02595723|521458065|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
144556048|NCT02475733|521234233|FG001|Overall Study|Physician Decision|0|||
144556049|NCT00475735|521234237|FG000|Treatment Period 1|Adverse Event|2|||
144556050|NCT00475735|521234238|FG001|Treatment Period 1|Adverse Event|0|||
144556051|NCT00475735|521234239|FG002|Treatment Period 1|Adverse Event|0|||
144556052|NCT00475735|521234240|FG003|Treatment Period 1|Adverse Event|0|||
144556053|NCT00475735|521234241|FG004|Treatment Period 1|Adverse Event|0|||
144556054|NCT00475735|521234242|FG005|Treatment Period 1|Adverse Event|0|||
144556055|NCT00475735|521234237|FG000|Treatment Period 1|Lack of Efficacy|1|||
144556056|NCT00475735|521234238|FG001|Treatment Period 1|Lack of Efficacy|0|||
144556057|NCT00475735|521234239|FG002|Treatment Period 1|Lack of Efficacy|0|||
144556058|NCT00475735|521234240|FG003|Treatment Period 1|Lack of Efficacy|0|||
144556059|NCT00475735|521234241|FG004|Treatment Period 1|Lack of Efficacy|0|||
144556060|NCT00475735|521234242|FG005|Treatment Period 1|Lack of Efficacy|0|||
144556061|NCT00475735|521234237|FG000|Treatment Period 1|Lost to Follow-up|0|||
144556062|NCT00475735|521234238|FG001|Treatment Period 1|Lost to Follow-up|0|||
144556063|NCT00475735|521234239|FG002|Treatment Period 1|Lost to Follow-up|0|||
144556064|NCT00475735|521234240|FG003|Treatment Period 1|Lost to Follow-up|0|||
144556065|NCT00475735|521234241|FG004|Treatment Period 1|Lost to Follow-up|0|||
144556066|NCT00475735|521234242|FG005|Treatment Period 1|Lost to Follow-up|1|||
144556067|NCT00475735|521234237|FG000|Treatment Period 1|Protocol Violation|0|||
144556068|NCT00475735|521234238|FG001|Treatment Period 1|Protocol Violation|0|||
144556069|NCT00475735|521234239|FG002|Treatment Period 1|Protocol Violation|0|||
144556070|NCT00475735|521234240|FG003|Treatment Period 1|Protocol Violation|1|||
144556071|NCT00475735|521234241|FG004|Treatment Period 1|Protocol Violation|0|||
144556072|NCT00475735|521234242|FG005|Treatment Period 1|Protocol Violation|0|||
144556073|NCT00475735|521234237|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144556074|NCT00475735|521234238|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144556075|NCT00475735|521234239|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144556076|NCT00475735|521234240|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144556077|NCT00475735|521234241|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144556078|NCT00475735|521234242|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144556079|NCT00475735|521234237|FG000|Treatment Period 1|DC due to AE but continuing|0|||
144556080|NCT00475735|521234238|FG001|Treatment Period 1|DC due to AE but continuing|0|||
144556081|NCT00475735|521234239|FG002|Treatment Period 1|DC due to AE but continuing|0|||
144556082|NCT00475735|521234240|FG003|Treatment Period 1|DC due to AE but continuing|1|||
144556083|NCT00475735|521234241|FG004|Treatment Period 1|DC due to AE but continuing|2|||
144556084|NCT00475735|521234242|FG005|Treatment Period 1|DC due to AE but continuing|2|||
144556085|NCT00475735|521234237|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
144556086|NCT00475735|521234238|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
144556087|NCT00475735|521234239|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
144556088|NCT00475735|521234240|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
144556089|NCT00475735|521234241|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
144556090|NCT00475735|521234242|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
144556091|NCT00475735|521234237|FG000|Treatment Washout|Lost to Follow-up|0|||
144556092|NCT00475735|521234238|FG001|Treatment Washout|Lost to Follow-up|1|||
144556093|NCT00475735|521234239|FG002|Treatment Washout|Lost to Follow-up|0|||
144556094|NCT00475735|521234240|FG003|Treatment Washout|Lost to Follow-up|0|||
144556095|NCT00475735|521234241|FG004|Treatment Washout|Lost to Follow-up|0|||
144556096|NCT00475735|521234242|FG005|Treatment Washout|Lost to Follow-up|0|||
144556097|NCT00475735|521234237|FG000|Treatment Washout|Protocol Violation|0|||
144556098|NCT00475735|521234238|FG001|Treatment Washout|Protocol Violation|1|||
144556099|NCT00475735|521234239|FG002|Treatment Washout|Protocol Violation|0|||
144556100|NCT00475735|521234240|FG003|Treatment Washout|Protocol Violation|0|||
144556101|NCT00475735|521234241|FG004|Treatment Washout|Protocol Violation|0|||
144556102|NCT00475735|521234242|FG005|Treatment Washout|Protocol Violation|0|||
144556103|NCT00475735|521234237|FG000|Treatment Period 2|Adverse Event|0|||
144556104|NCT00475735|521234238|FG001|Treatment Period 2|Adverse Event|1|||
144556105|NCT00475735|521234239|FG002|Treatment Period 2|Adverse Event|0|||
144556106|NCT00475735|521234240|FG003|Treatment Period 2|Adverse Event|2|||
144556107|NCT00475735|521234241|FG004|Treatment Period 2|Adverse Event|0|||
144556108|NCT00475735|521234242|FG005|Treatment Period 2|Adverse Event|0|||
144556109|NCT00475735|521234237|FG000|Treatment Period 2|Lack of Efficacy|0|||
144556110|NCT00475735|521234238|FG001|Treatment Period 2|Lack of Efficacy|0|||
144556111|NCT00475735|521234239|FG002|Treatment Period 2|Lack of Efficacy|0|||
144556112|NCT00475735|521234240|FG003|Treatment Period 2|Lack of Efficacy|0|||
144556113|NCT00475735|521234241|FG004|Treatment Period 2|Lack of Efficacy|0|||
144556114|NCT00475735|521234242|FG005|Treatment Period 2|Lack of Efficacy|1|||
144556115|NCT00475735|521234237|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144556116|NCT00475735|521234238|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144556117|NCT00475735|521234239|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144556118|NCT00475735|521234240|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144556119|NCT00475735|521234241|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144556120|NCT00475735|521234242|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144556121|NCT01014013|521234243|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
144556122|NCT01014013|521234244|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
144262434|NCT01317641|520161436|FG002|Overall Study|Adverse Event|0|||
144262435|NCT01317641|520161437|FG003|Overall Study|Adverse Event|1|||
144262436|NCT01317641|520161438|FG004|Overall Study|Adverse Event|0|||
144262437|NCT01317641|520161439|FG005|Overall Study|Adverse Event|0|||
144262438|NCT01317641|520161440|FG006|Overall Study|Adverse Event|2|||
144556123|NCT01014013|521234243|FG000|Overall Study|Clinical adverse experience|4|||
144556124|NCT01014013|521234244|FG001|Overall Study|Clinical adverse experience|2|||
144556125|NCT01014013|521234243|FG000|Overall Study|Laboratory adverse experience|1|||
144556126|NCT01014013|521234244|FG001|Overall Study|Laboratory adverse experience|1|||
144556127|NCT01014013|521234243|FG000|Overall Study|Protocol Violation|1|||
144556128|NCT01014013|521234244|FG001|Overall Study|Protocol Violation|3|||
144556129|NCT01014013|521234243|FG000|Overall Study|Withdrawal by Subject|7|||
144556130|NCT01014013|521234244|FG001|Overall Study|Withdrawal by Subject|4|||
144556131|NCT01014013|521234243|FG000|Overall Study|Clinical/microbiologic failure|1|||
144556132|NCT01014013|521234244|FG001|Overall Study|Clinical/microbiologic failure|2|||
144556133|NCT01014013|521234243|FG000|Overall Study|Pathogen culture = no growth|26|||
144556134|NCT01014013|521234244|FG001|Overall Study|Pathogen culture = no growth|34|||
144556135|NCT01014013|521234243|FG000|Overall Study|Negative urine culture|2|||
144556136|NCT01014013|521234244|FG001|Overall Study|Negative urine culture|0|||
144556137|NCT01014013|521234243|FG000|Overall Study|Pathogen resistant|7|||
144556138|NCT01014013|521234244|FG001|Overall Study|Pathogen resistant|4|||
144556139|NCT01014013|521234243|FG000|Overall Study|Physician Decision|0|||
144556140|NCT01014013|521234244|FG001|Overall Study|Physician Decision|1|||
144556141|NCT01014013|521234243|FG000|Overall Study|Another antibiotic therapy required|0|||
144556142|NCT01014013|521234244|FG001|Overall Study|Another antibiotic therapy required|1|||
144556143|NCT01014013|521234243|FG000|Overall Study|Appendectomy|1|||
144556144|NCT01014013|521234244|FG001|Overall Study|Appendectomy|0|||
144556145|NCT01014013|521234243|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
144556146|NCT01014013|521234244|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
144556147|NCT02305797|521234251|FG000|Overall Study|Adverse Event|11|||
144556148|NCT02305797|521234252|FG001|Overall Study|Adverse Event|2|||
144556149|NCT02305797|521234251|FG000|Overall Study|Withdrawal by Subject|9|||
144556150|NCT02305797|521234252|FG001|Overall Study|Withdrawal by Subject|10|||
144556151|NCT02305797|521234251|FG000|Overall Study|Lack of Efficacy|6|||
144556152|NCT02305797|521234252|FG001|Overall Study|Lack of Efficacy|0|||
144556153|NCT02305797|521234251|FG000|Overall Study|Lost to Follow-up|5|||
144556154|NCT02305797|521234252|FG001|Overall Study|Lost to Follow-up|11|||
144556155|NCT02305797|521234251|FG000|Overall Study|Pregnancy|0|||
144556156|NCT02305797|521234252|FG001|Overall Study|Pregnancy|2|||
144556157|NCT02305797|521234251|FG000|Overall Study|Noncompliance|14|||
144556158|NCT02305797|521234252|FG001|Overall Study|Noncompliance|12|||
144556159|NCT02305797|521234251|FG000|Overall Study|Reason not collected|0|||
144556160|NCT02305797|521234252|FG001|Overall Study|Reason not collected|1|||
144556161|NCT03508830|521234253|FG000|Overall Study|Withdrawal by Subject|3|||
144556162|NCT03508830|521234254|FG001|Overall Study|Withdrawal by Subject|4|||
144556163|NCT03508830|521234253|FG000|Overall Study|Physician Decision|2|||
144556164|NCT03508830|521234254|FG001|Overall Study|Physician Decision|2|||
144556165|NCT02097056|521234257|FG000|Overall Study|Protocol Violation|2|||
144556166|NCT02097056|521234257|FG000|Overall Study|Withdrawal by Subject|15|||
144556167|NCT02097056|521234257|FG000|Overall Study|Lost to Follow-up|2|||
144556168|NCT02097056|521234257|FG000|Overall Study|Adverse Event|37|||
144556169|NCT02097056|521234257|FG000|Overall Study|Other|2|||
144556170|NCT03906240|521234258|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
144556171|NCT03906240|521234259|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
144556172|NCT03906240|521234258|FG000|Overall Study|Lost to Follow-up|1|||
144556173|NCT03906240|521234259|FG001|Overall Study|Lost to Follow-up|0|||
144556174|NCT03906240|521234258|FG000|Overall Study|Withdrawal by Subject|0|||
144556175|NCT03906240|521234259|FG001|Overall Study|Withdrawal by Subject|1|||
144556176|NCT01446042|521234260|FG000|Overall Study|Withdrawal by Subject|12|||
144556177|NCT01446042|521234261|FG001|Overall Study|Withdrawal by Subject|2|||
144556178|NCT01446042|521234262|FG002|Overall Study|Withdrawal by Subject|4|||
144262439|NCT01317641|520161441|FG007|Overall Study|Adverse Event|1|||
144556179|NCT01446042|521234260|FG000|Overall Study|Adverse Event|1|||
144556180|NCT01446042|521234261|FG001|Overall Study|Adverse Event|0|||
144556181|NCT01446042|521234262|FG002|Overall Study|Adverse Event|4|||
144556182|NCT01446042|521234260|FG000|Overall Study|Lost to Follow-up|5|||
144556183|NCT01446042|521234261|FG001|Overall Study|Lost to Follow-up|0|||
144556184|NCT01446042|521234262|FG002|Overall Study|Lost to Follow-up|0|||
144262440|NCT01317641|520161442|FG008|Overall Study|Adverse Event|0|||
144556185|NCT01446042|521234260|FG000|Overall Study|Other reasons|2|||
144556186|NCT01446042|521234261|FG001|Overall Study|Other reasons|1|||
144556187|NCT01446042|521234262|FG002|Overall Study|Other reasons|1|||
144556188|NCT01078571|521234273|FG000|Overall Study|Adverse Event|36|||
144556189|NCT01078571|521234273|FG000|Overall Study|Lack of effectiveness|36|||
144556190|NCT01078571|521234273|FG000|Overall Study|Reason not reported|21|||
144556191|NCT01078571|521234273|FG000|Overall Study|Withdrawal by Subject|12|||
144556192|NCT01078571|521234273|FG000|Overall Study|Lost to Follow-up|8|||
144556193|NCT01078571|521234273|FG000|Overall Study|Protocol Violation|2|||
144556194|NCT01047306|521234277|FG000|Overall Study|Withdrawal by Subject|2|||
144556195|NCT01047306|521234278|FG001|Overall Study|Withdrawal by Subject|0|||
144556196|NCT01047306|521234277|FG000|Overall Study|Lost to Follow-up|1|||
144556197|NCT01047306|521234278|FG001|Overall Study|Lost to Follow-up|0|||
144556198|NCT01878253|521234280|FG000|Overall Study|Death|1|||
144556199|NCT01878253|521234280|FG000|Overall Study|SIdus System Removal|3|||
144556200|NCT01878253|521234280|FG000|Overall Study|Withdrawal by Subject|1|||
144556201|NCT01878253|521234280|FG000|Overall Study|Lost to Follow-up|2|||
144556202|NCT01878253|521234280|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
144556203|NCT05216835|521234284|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
144556204|NCT05216835|521234285|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
144556205|NCT05216835|521234286|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
144556206|NCT05216835|521234287|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
144556207|NCT05216835|521234288|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
144556208|NCT05216835|521234289|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
144556209|NCT05216835|521234290|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
144556210|NCT05216835|521234291|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
144556211|NCT05216835|521234284|FG000|Overall Study|Death|0|||
144556212|NCT05216835|521234285|FG001|Overall Study|Death|0|||
144556213|NCT05216835|521234286|FG002|Overall Study|Death|0|||
144556214|NCT05216835|521234287|FG003|Overall Study|Death|1|||
144556215|NCT05216835|521234288|FG004|Overall Study|Death|1|||
144556216|NCT05216835|521234289|FG005|Overall Study|Death|1|||
144556217|NCT05216835|521234290|FG006|Overall Study|Death|1|||
144556218|NCT05216835|521234291|FG007|Overall Study|Death|1|||
144556219|NCT05216835|521234284|FG000|Overall Study|Physician Decision|0|||
144556220|NCT05216835|521234285|FG001|Overall Study|Physician Decision|0|||
144556221|NCT05216835|521234286|FG002|Overall Study|Physician Decision|0|||
144556222|NCT05216835|521234287|FG003|Overall Study|Physician Decision|0|||
144556223|NCT05216835|521234288|FG004|Overall Study|Physician Decision|0|||
144556224|NCT05216835|521234289|FG005|Overall Study|Physician Decision|1|||
144556225|NCT05216835|521234290|FG006|Overall Study|Physician Decision|1|||
144556226|NCT05216835|521234291|FG007|Overall Study|Physician Decision|0|||
144556227|NCT05216835|521234284|FG000|Overall Study|Study terminated by Sponsor|0|||
144556228|NCT05216835|521234285|FG001|Overall Study|Study terminated by Sponsor|0|||
144556229|NCT05216835|521234286|FG002|Overall Study|Study terminated by Sponsor|0|||
144556230|NCT05216835|521234287|FG003|Overall Study|Study terminated by Sponsor|0|||
144556231|NCT05216835|521234288|FG004|Overall Study|Study terminated by Sponsor|0|||
144556232|NCT05216835|521234289|FG005|Overall Study|Study terminated by Sponsor|0|||
144556233|NCT05216835|521234290|FG006|Overall Study|Study terminated by Sponsor|0|||
144556234|NCT05216835|521234291|FG007|Overall Study|Study terminated by Sponsor|1|||
144556235|NCT05216835|521234284|FG000|Overall Study|Withdrawal by Subject|1|||
144556236|NCT05216835|521234285|FG001|Overall Study|Withdrawal by Subject|0|||
144556237|NCT05216835|521234286|FG002|Overall Study|Withdrawal by Subject|1|||
144556238|NCT05216835|521234287|FG003|Overall Study|Withdrawal by Subject|0|||
144556239|NCT05216835|521234288|FG004|Overall Study|Withdrawal by Subject|1|||
144556240|NCT05216835|521234289|FG005|Overall Study|Withdrawal by Subject|0|||
144556241|NCT05216835|521234290|FG006|Overall Study|Withdrawal by Subject|0|||
144556242|NCT05216835|521234291|FG007|Overall Study|Withdrawal by Subject|1|||
144556243|NCT05216835|521234284|FG000|Overall Study|Other|0|||
144556244|NCT05216835|521234285|FG001|Overall Study|Other|1|||
144556245|NCT05216835|521234286|FG002|Overall Study|Other|0|||
144556246|NCT05216835|521234287|FG003|Overall Study|Other|0|||
144556247|NCT05216835|521234288|FG004|Overall Study|Other|0|||
144556248|NCT05216835|521234289|FG005|Overall Study|Other|0|||
144556249|NCT05216835|521234290|FG006|Overall Study|Other|0|||
144556250|NCT05216835|521234291|FG007|Overall Study|Other|0|||
144556251|NCT05179603|521234292|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
144556252|NCT05179603|521234292|FG000|Overall Study|Withdrawal by Subject|1|||
144556253|NCT05179603|521234292|FG000|Overall Study|Progressive disease|4|||
144556254|NCT05179603|521234292|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
144556255|NCT01075815|521234294|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
144556256|NCT01075815|521234295|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
144556257|NCT01075815|521234294|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
144556258|NCT01075815|521234295|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
144262441|NCT01317641|520161434|FG000|Overall Study|Protocol Violation|1|||
144262442|NCT01317641|520161435|FG001|Overall Study|Protocol Violation|0|||
144556259|NCT01075815|521234294|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
144556260|NCT01075815|521234295|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
144556261|NCT00596960|521234298|FG000|Overall Study|Death|1|||
144556262|NCT00596960|521234299|FG001|Overall Study|Death|2|||
144556263|NCT00596960|521234298|FG000|Overall Study|Lost to Follow-up|6|||
144556264|NCT00596960|521234299|FG001|Overall Study|Lost to Follow-up|5|||
144556265|NCT00596960|521234298|FG000|Overall Study|Withdrawal by Subject|1|||
144556266|NCT00596960|521234299|FG001|Overall Study|Withdrawal by Subject|0|||
144556267|NCT00596960|521234298|FG000|Overall Study|Incarcerated|2|||
144556268|NCT00596960|521234299|FG001|Overall Study|Incarcerated|0|||
144617064|NCT04839380|521458066|FG000|Overall Study|Withdrawal by Subject|2|||
144617065|NCT04839380|521458066|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
144617066|NCT01347554|521458067|FG000|Overall Study|Lack of Efficacy|7|||
144617067|NCT01347554|521458068|FG001|Overall Study|Lack of Efficacy|11|||
144617068|NCT01902290|521458069|FG000|Overall Study|Withdrawal by Subject|19|||
144556269|NCT00596960|521234298|FG000|Overall Study|Physician Decision|1|||
144556270|NCT00596960|521234299|FG001|Overall Study|Physician Decision|0|||
144556271|NCT00596960|521234298|FG000|Overall Study|Protocol Violation|0|||
144556272|NCT00596960|521234299|FG001|Overall Study|Protocol Violation|1|||
144556273|NCT00596960|521234298|FG000|Overall Study|No alcohol use data|0|||
144556274|NCT00596960|521234299|FG001|Overall Study|No alcohol use data|1|||
144556275|NCT02058992|521234300|FG000|Overall Study|Lost to Follow-up|4|||
144556276|NCT02058992|521234300|FG000|Overall Study|Protocol Violation|92|||
144556277|NCT02058992|521234300|FG000|Overall Study|CRF Uncollected|20|||
144556278|NCT02374476|521234309|FG000|VT Induced Ablation|Screening Failures|36|||
144556279|NCT02374476|521234310|FG001|VT Induced Ablation|Screening Failures|0|||
144556280|NCT02374476|521234311|FG002|VT Induced Ablation|Screening Failures|0|||
144556281|NCT02374476|521234309|FG000|Arm Assignment|Withdrawal by Subject|0|||
144556282|NCT02374476|521234310|FG001|Arm Assignment|Withdrawal by Subject|0|||
144556283|NCT02374476|521234311|FG002|Arm Assignment|Withdrawal by Subject|1|||
144556284|NCT05431543|521234312|FG000|Overall Study|Medical History|1|||
144556285|NCT05431543|521234313|FG001|Overall Study|Medical History|0|||
144556286|NCT05431543|521234314|FG002|Overall Study|Medical History|0|||
144556287|NCT00914732|521234316|FG000|Overall Study|Lost to Follow-up|6|||
144556288|NCT00914732|521234317|FG001|Overall Study|Lost to Follow-up|7|||
144556289|NCT00914732|521234318|FG002|Overall Study|Lost to Follow-up|9|||
144556290|NCT00914732|521234316|FG000|Overall Study|Withdrawal by Subject|3|||
144556291|NCT00914732|521234317|FG001|Overall Study|Withdrawal by Subject|0|||
144556292|NCT00914732|521234318|FG002|Overall Study|Withdrawal by Subject|2|||
144556293|NCT00914732|521234316|FG000|Overall Study|Adverse Event|1|||
144556294|NCT00914732|521234317|FG001|Overall Study|Adverse Event|0|||
144556295|NCT00914732|521234318|FG002|Overall Study|Adverse Event|0|||
144556296|NCT02130401|521234319|FG000|Overall Study|Poor enrollment|6|||
144556297|NCT01855399|521234320|FG000|6 Month|Lost to Follow-up|12|||
144556298|NCT01855399|521234321|FG001|6 Month|Lost to Follow-up|9|||
144556299|NCT01855399|521234320|FG000|6 Month|Withdrawal by Subject|8|||
144556300|NCT01855399|521234321|FG001|6 Month|Withdrawal by Subject|6|||
144556301|NCT01855399|521234320|FG000|12 Month|Lost to Follow-up|7|||
144556302|NCT01855399|521234321|FG001|12 Month|Lost to Follow-up|11|||
144556303|NCT00321672|521234322|FG000|Overall Study|Withdrawal by Subject|5|||
144556304|NCT00321672|521234323|FG001|Overall Study|Withdrawal by Subject|1|||
144556305|NCT00321672|521234324|FG002|Overall Study|Withdrawal by Subject|2|||
144556306|NCT00321672|521234325|FG003|Overall Study|Withdrawal by Subject|0|||
144556307|NCT00321672|521234322|FG000|Overall Study|Noncompliance|1|||
144556308|NCT00321672|521234323|FG001|Overall Study|Noncompliance|2|||
144556309|NCT00321672|521234324|FG002|Overall Study|Noncompliance|1|||
144556310|NCT00321672|521234325|FG003|Overall Study|Noncompliance|0|||
144556311|NCT00321672|521234322|FG000|Overall Study|Adverse Event|1|||
144556312|NCT00321672|521234323|FG001|Overall Study|Adverse Event|1|||
144556313|NCT00321672|521234324|FG002|Overall Study|Adverse Event|0|||
144556314|NCT00321672|521234325|FG003|Overall Study|Adverse Event|0|||
144556315|NCT00321672|521234322|FG000|Overall Study|Lack of Efficacy|1|||
144556316|NCT00321672|521234323|FG001|Overall Study|Lack of Efficacy|1|||
144556317|NCT00321672|521234324|FG002|Overall Study|Lack of Efficacy|0|||
144556318|NCT00321672|521234325|FG003|Overall Study|Lack of Efficacy|0|||
144556319|NCT00321672|521234322|FG000|Overall Study|Lost to Follow-up|2|||
144556320|NCT00321672|521234323|FG001|Overall Study|Lost to Follow-up|0|||
144556321|NCT00321672|521234324|FG002|Overall Study|Lost to Follow-up|4|||
144556322|NCT00321672|521234325|FG003|Overall Study|Lost to Follow-up|2|||
144556323|NCT00321672|521234322|FG000|Overall Study|Death|1|||
144556324|NCT00321672|521234323|FG001|Overall Study|Death|0|||
144556325|NCT00321672|521234324|FG002|Overall Study|Death|0|||
144556326|NCT00321672|521234325|FG003|Overall Study|Death|0|||
144556327|NCT00321672|521234322|FG000|Overall Study|Too far to travel for visits|1|||
144556328|NCT00321672|521234323|FG001|Overall Study|Too far to travel for visits|0|||
144617069|NCT01902290|521458070|FG001|Overall Study|Withdrawal by Subject|27|||
144556329|NCT00321672|521234324|FG002|Overall Study|Too far to travel for visits|0|||
144556330|NCT00321672|521234325|FG003|Overall Study|Too far to travel for visits|0|||
144556331|NCT00321672|521234322|FG000|Overall Study|Incarcerated|0|||
144556332|NCT00321672|521234323|FG001|Overall Study|Incarcerated|0|||
144556333|NCT00321672|521234324|FG002|Overall Study|Incarcerated|2|||
144556334|NCT00321672|521234325|FG003|Overall Study|Incarcerated|0|||
144556335|NCT00321672|521234322|FG000|Overall Study|Moved out of state|0|||
144556336|NCT00321672|521234323|FG001|Overall Study|Moved out of state|1|||
144556337|NCT00321672|521234324|FG002|Overall Study|Moved out of state|1|||
144556338|NCT00321672|521234325|FG003|Overall Study|Moved out of state|0|||
144556339|NCT00321672|521234322|FG000|Overall Study|Protocol Violation|0|||
144556340|NCT00321672|521234323|FG001|Overall Study|Protocol Violation|0|||
144556341|NCT00321672|521234324|FG002|Overall Study|Protocol Violation|1|||
144556342|NCT00321672|521234325|FG003|Overall Study|Protocol Violation|0|||
144556343|NCT00321672|521234322|FG000|Overall Study|Diagnosis of testicular cancer|0|||
144556344|NCT00321672|521234323|FG001|Overall Study|Diagnosis of testicular cancer|1|||
144556345|NCT00321672|521234324|FG002|Overall Study|Diagnosis of testicular cancer|0|||
144556346|NCT00321672|521234325|FG003|Overall Study|Diagnosis of testicular cancer|0|||
144556347|NCT00321672|521234322|FG000|Overall Study|Extensive travel required for new job|0|||
144556348|NCT00321672|521234323|FG001|Overall Study|Extensive travel required for new job|1|||
144556349|NCT00321672|521234324|FG002|Overall Study|Extensive travel required for new job|0|||
144556350|NCT00321672|521234325|FG003|Overall Study|Extensive travel required for new job|0|||
144556351|NCT00145496|521234330|FG000|Overall Study|Adverse Event|42|||
144556352|NCT00145496|521234331|FG001|Overall Study|Adverse Event|30|||
144556353|NCT00145496|521234330|FG000|Overall Study|Lack of Efficacy|12|||
144556354|NCT00145496|521234331|FG001|Overall Study|Lack of Efficacy|7|||
144556355|NCT00145496|521234330|FG000|Overall Study|Withdrawal by Subject|32|||
144556356|NCT00145496|521234331|FG001|Overall Study|Withdrawal by Subject|26|||
144556357|NCT00145496|521234330|FG000|Overall Study|Lost to Follow-up|12|||
144556358|NCT00145496|521234331|FG001|Overall Study|Lost to Follow-up|5|||
144556359|NCT00145496|521234330|FG000|Overall Study|Other|25|||
144556360|NCT00145496|521234331|FG001|Overall Study|Other|13|||
144556361|NCT01945086|521234334|FG000|Overall Study|Withdrawal by Subject|1|||
144556362|NCT01945086|521234335|FG001|Overall Study|Withdrawal by Subject|0|||
144556363|NCT01945086|521234336|FG002|Overall Study|Withdrawal by Subject|1|||
144556364|NCT01945086|521234334|FG000|Overall Study|Adverse Event|0|||
144556365|NCT01945086|521234335|FG001|Overall Study|Adverse Event|0|||
144556366|NCT01945086|521234336|FG002|Overall Study|Adverse Event|1|||
144556367|NCT04853394|521234340|FG000|Follow-up Interviews|Lost to Follow-up|22|||
144556368|NCT04853394|521234341|FG001|Follow-up Interviews|Lost to Follow-up|15|||
144556369|NCT00748098|521234342|FG000|First Treatment Intervention Period|Adverse Event|1|||
144556370|NCT00748098|521234343|FG001|First Treatment Intervention Period|Adverse Event|1|||
144556371|NCT00748098|521234342|FG000|First Treatment Intervention Period|Protocol Violation|1|||
144556372|NCT00748098|521234343|FG001|First Treatment Intervention Period|Protocol Violation|0|||
144556373|NCT00748098|521234342|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
144556374|NCT00748098|521234343|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
144556375|NCT00748098|521234342|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
144556376|NCT00748098|521234343|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
144556377|NCT00748098|521234342|FG000|First Taper Period|Protocol Violation|1|||
144556378|NCT00748098|521234343|FG001|First Taper Period|Protocol Violation|0|||
144556379|NCT00748098|521234342|FG000|First Taper Period|Withdrawal by Subject|2|||
144556380|NCT00748098|521234343|FG001|First Taper Period|Withdrawal by Subject|0|||
144556381|NCT00748098|521234342|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
144556382|NCT00748098|521234343|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
144556383|NCT00748098|521234342|FG000|1-Week Washout Period|Adverse Event|0|||
144556384|NCT00748098|521234343|FG001|1-Week Washout Period|Adverse Event|1|||
144556385|NCT00748098|521234342|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
144556386|NCT00748098|521234343|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
144556387|NCT00748098|521234342|FG000|Second Treatment Intervention Period|Adverse Event|4|||
144556388|NCT00748098|521234343|FG001|Second Treatment Intervention Period|Adverse Event|1|||
144556389|NCT00748098|521234342|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
144556390|NCT00748098|521234343|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
144556391|NCT00748098|521234342|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
144556392|NCT00748098|521234343|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
144556393|NCT04212299|521234344|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
144556394|NCT01232569|521236058|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
144556395|NCT01232569|521236059|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
144556396|NCT01232569|521236060|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144556397|NCT01232569|521236061|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
144556398|NCT01232569|521236058|FG000|Double-blind Treatment Period|Escape|2|||
144556399|NCT01232569|521236059|FG001|Double-blind Treatment Period|Escape|2|||
144556400|NCT01232569|521236060|FG002|Double-blind Treatment Period|Escape|0|||
144556401|NCT01232569|521236061|FG003|Double-blind Treatment Period|Escape|0|||
144556402|NCT01232569|521236058|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
144556403|NCT01232569|521236059|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
144556404|NCT01232569|521236060|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
144556405|NCT01232569|521236061|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
144556406|NCT01232569|521236058|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
144556407|NCT01232569|521236059|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
144556408|NCT01232569|521236060|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
144556409|NCT01232569|521236061|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
144556410|NCT01232569|521236058|FG000|Double-blind Treatment Period|Physician Decision|1|||
144556411|NCT01232569|521236059|FG001|Double-blind Treatment Period|Physician Decision|0|||
144556412|NCT01232569|521236060|FG002|Double-blind Treatment Period|Physician Decision|0|||
144556413|NCT01232569|521236061|FG003|Double-blind Treatment Period|Physician Decision|0|||
144556414|NCT01232569|521236058|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
144556415|NCT01232569|521236059|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
144556416|NCT01232569|521236060|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
144556417|NCT01232569|521236061|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
144203485|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144203486|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144556418|NCT01232569|521236058|FG000|Double-blind Treatment Period|Death|2|||
144556419|NCT01232569|521236059|FG001|Double-blind Treatment Period|Death|0|||
144556420|NCT01232569|521236060|FG002|Double-blind Treatment Period|Death|0|||
144556421|NCT01232569|521236061|FG003|Double-blind Treatment Period|Death|0|||
144556422|NCT05335005|521236065|FG000|Overall Study|Lost to Follow-up|1|||
144556423|NCT00644332|521236067|FG000|Overall Study|Adverse Event|11|||
144556424|NCT00644332|521236067|FG000|Overall Study|Withdrawal by Subject|6|||
144556425|NCT00644332|521236067|FG000|Overall Study|Completion Status Unknown|2|||
144556426|NCT00644332|521236067|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
144556427|NCT00644332|521236067|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
144556428|NCT03694210|521236068|FG000|Overall Study|Death|1|||
144556429|NCT03694210|521236068|FG000|Overall Study|Screen Failure|7|||
144556430|NCT00443755|521236069|FG000|Overall Study|Withdrawal by Subject|2|||
144556431|NCT00443755|521236070|FG001|Overall Study|Withdrawal by Subject|1|||
144556432|NCT02706834|521236073|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144556433|NCT02706834|521236074|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
144556434|NCT02706834|521236075|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144556435|NCT02706834|521236076|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
144556436|NCT02706834|521236077|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
144556437|NCT02706834|521236078|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
144556438|NCT02706834|521236079|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
144556439|NCT02706834|521236080|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
144556440|NCT02706834|521236081|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
144556441|NCT02706834|521236082|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
144556442|NCT02706834|521236083|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
144556443|NCT02706834|521236073|FG000|Overall Study|Lost to Follow-up|0|||
144556444|NCT02706834|521236074|FG001|Overall Study|Lost to Follow-up|0|||
144556445|NCT02706834|521236075|FG002|Overall Study|Lost to Follow-up|1|||
144556446|NCT02706834|521236076|FG003|Overall Study|Lost to Follow-up|0|||
144556447|NCT02706834|521236077|FG004|Overall Study|Lost to Follow-up|0|||
144556448|NCT02706834|521236078|FG005|Overall Study|Lost to Follow-up|0|||
144556449|NCT02706834|521236079|FG006|Overall Study|Lost to Follow-up|0|||
144556450|NCT02706834|521236080|FG007|Overall Study|Lost to Follow-up|0|||
144556451|NCT02706834|521236081|FG008|Overall Study|Lost to Follow-up|0|||
144556452|NCT02706834|521236082|FG009|Overall Study|Lost to Follow-up|0|||
144556453|NCT02706834|521236083|FG010|Overall Study|Lost to Follow-up|0|||
144556454|NCT02706834|521236073|FG000|Overall Study|Voluntary Withdrawal|1|||
144556455|NCT02706834|521236074|FG001|Overall Study|Voluntary Withdrawal|0|||
144556456|NCT02706834|521236075|FG002|Overall Study|Voluntary Withdrawal|0|||
144556457|NCT02706834|521236076|FG003|Overall Study|Voluntary Withdrawal|0|||
144556458|NCT02706834|521236077|FG004|Overall Study|Voluntary Withdrawal|0|||
144556459|NCT02706834|521236078|FG005|Overall Study|Voluntary Withdrawal|0|||
144556460|NCT02706834|521236079|FG006|Overall Study|Voluntary Withdrawal|0|||
144556461|NCT02706834|521236080|FG007|Overall Study|Voluntary Withdrawal|0|||
144556462|NCT02706834|521236081|FG008|Overall Study|Voluntary Withdrawal|0|||
144556463|NCT02706834|521236082|FG009|Overall Study|Voluntary Withdrawal|1|||
144556464|NCT02706834|521236083|FG010|Overall Study|Voluntary Withdrawal|0|||
144556465|NCT02706834|521236073|FG000|Overall Study|Other Reason Not Specified|1|||
144556466|NCT02706834|521236074|FG001|Overall Study|Other Reason Not Specified|0|||
144556467|NCT02706834|521236075|FG002|Overall Study|Other Reason Not Specified|0|||
144556468|NCT02706834|521236076|FG003|Overall Study|Other Reason Not Specified|0|||
144556469|NCT02706834|521236077|FG004|Overall Study|Other Reason Not Specified|1|||
144556470|NCT02706834|521236078|FG005|Overall Study|Other Reason Not Specified|0|||
144556471|NCT02706834|521236079|FG006|Overall Study|Other Reason Not Specified|0|||
144556472|NCT02706834|521236080|FG007|Overall Study|Other Reason Not Specified|0|||
144556473|NCT02706834|521236081|FG008|Overall Study|Other Reason Not Specified|0|||
144556474|NCT02706834|521236082|FG009|Overall Study|Other Reason Not Specified|0|||
144556475|NCT02706834|521236083|FG010|Overall Study|Other Reason Not Specified|0|||
144556476|NCT00678899|521236089|FG000|Overall Study|Adverse Event|1|||
144556477|NCT04385849|521236090|FG000|Overall Study|Lost to Follow-up|1|||
144556478|NCT04385849|521236091|FG001|Overall Study|Lost to Follow-up|0|||
144556479|NCT01375777|521236092|FG000|Overall Study|Withdrawal by Subject|0|||
144556480|NCT01375777|521236093|FG001|Overall Study|Withdrawal by Subject|2|||
144556481|NCT01375777|521236094|FG002|Overall Study|Withdrawal by Subject|1|||
144556482|NCT01375777|521236095|FG003|Overall Study|Withdrawal by Subject|0|||
144556483|NCT01375777|521236096|FG004|Overall Study|Withdrawal by Subject|1|||
144556484|NCT01375777|521236097|FG005|Overall Study|Withdrawal by Subject|1|||
144556485|NCT01375777|521236098|FG006|Overall Study|Withdrawal by Subject|1|||
144556486|NCT01375777|521236099|FG007|Overall Study|Withdrawal by Subject|2|||
144556487|NCT01375777|521236100|FG008|Overall Study|Withdrawal by Subject|1|||
144556488|NCT01375777|521236092|FG000|Overall Study|Lost to Follow-up|1|||
144556489|NCT01375777|521236093|FG001|Overall Study|Lost to Follow-up|0|||
144617070|NCT01902290|521458069|FG000|Overall Study|Lost to Follow-up|2|||
144617071|NCT01902290|521458070|FG001|Overall Study|Lost to Follow-up|2|||
144617072|NCT01902290|521458069|FG000|Overall Study|Death|1|||
144617073|NCT01902290|521458070|FG001|Overall Study|Death|0|||
144617074|NCT01902290|521458069|FG000|Overall Study|Sponsor Decision|26|||
144617075|NCT01902290|521458070|FG001|Overall Study|Sponsor Decision|24|||
144617076|NCT00517829|521458071|FG000|Overall Study|Adverse Event|22|||
144617077|NCT00517829|521458072|FG001|Overall Study|Adverse Event|34|||
144617078|NCT00517829|521458071|FG000|Overall Study|Disease Progression|39|||
144617079|NCT00517829|521458072|FG001|Overall Study|Disease Progression|32|||
144617080|NCT00517829|521458071|FG000|Overall Study|Patient Request|6|||
144617081|NCT00517829|521458072|FG001|Overall Study|Patient Request|5|||
144617082|NCT00517829|521458071|FG000|Overall Study|Investigator Request|5|||
144617083|NCT00517829|521458072|FG001|Overall Study|Investigator Request|3|||
144617084|NCT00517829|521458071|FG000|Overall Study|Other|3|||
144617085|NCT00517829|521458072|FG001|Overall Study|Other|1|||
144617086|NCT00109707|521458078|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
144617087|NCT00109707|521458079|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
144617088|NCT00109707|521458080|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
144617089|NCT00109707|521458078|FG000|Overall Study|Abnormal laboratory values|1|||
144617090|NCT00109707|521458079|FG001|Overall Study|Abnormal laboratory values|0|||
144617091|NCT00109707|521458080|FG002|Overall Study|Abnormal laboratory values|0|||
144617092|NCT00109707|521458078|FG000|Overall Study|Administrative problems|2|||
144617093|NCT00109707|521458079|FG001|Overall Study|Administrative problems|0|||
144617094|NCT00109707|521458080|FG002|Overall Study|Administrative problems|1|||
144617095|NCT00109707|521458078|FG000|Overall Study|Adverse Event|10|||
144617096|NCT00109707|521458079|FG001|Overall Study|Adverse Event|2|||
144617097|NCT00109707|521458080|FG002|Overall Study|Adverse Event|3|||
144617098|NCT00109707|521458078|FG000|Overall Study|Death|4|||
144617099|NCT00109707|521458079|FG001|Overall Study|Death|0|||
144617100|NCT00109707|521458080|FG002|Overall Study|Death|0|||
144617101|NCT00109707|521458078|FG000|Overall Study|Disease progression|12|||
144617102|NCT00109707|521458079|FG001|Overall Study|Disease progression|4|||
144617103|NCT00109707|521458080|FG002|Overall Study|Disease progression|3|||
144617104|NCT00109707|521458078|FG000|Overall Study|Lost to Follow-up|3|||
144617105|NCT00109707|521458079|FG001|Overall Study|Lost to Follow-up|0|||
144617106|NCT00109707|521458080|FG002|Overall Study|Lost to Follow-up|0|||
144617107|NCT00109707|521458078|FG000|Overall Study|Protocol Violation|1|||
144617108|NCT00109707|521458079|FG001|Overall Study|Protocol Violation|0|||
144617109|NCT00109707|521458080|FG002|Overall Study|Protocol Violation|0|||
144617110|NCT00109707|521458078|FG000|Overall Study|Patient withdrew consent|6|||
144617111|NCT00109707|521458079|FG001|Overall Study|Patient withdrew consent|1|||
144617112|NCT00109707|521458080|FG002|Overall Study|Patient withdrew consent|0|||
144617113|NCT02443883|521458084|FG000|Overall Study|Adverse Event|0|||
144617114|NCT02443883|521458085|FG001|Overall Study|Adverse Event|1|||
144617115|NCT02443883|521458086|FG002|Overall Study|Adverse Event|0|||
144617116|NCT02443883|521458087|FG003|Overall Study|Adverse Event|0|||
144617117|NCT02443883|521458084|FG000|Overall Study|Lost to Follow-up|3|||
144617118|NCT02443883|521458085|FG001|Overall Study|Lost to Follow-up|2|||
144617119|NCT02443883|521458086|FG002|Overall Study|Lost to Follow-up|1|||
144617120|NCT02443883|521458087|FG003|Overall Study|Lost to Follow-up|0|||
144617121|NCT02443883|521458084|FG000|Overall Study|Physician Decision|1|||
144617122|NCT02443883|521458085|FG001|Overall Study|Physician Decision|1|||
144617123|NCT02443883|521458086|FG002|Overall Study|Physician Decision|0|||
144617124|NCT02443883|521458087|FG003|Overall Study|Physician Decision|3|||
144617125|NCT02443883|521458084|FG000|Overall Study|Withdrawal by Subject|1|||
144617126|NCT02443883|521458085|FG001|Overall Study|Withdrawal by Subject|0|||
144617127|NCT02443883|521458086|FG002|Overall Study|Withdrawal by Subject|0|||
144617128|NCT02443883|521458087|FG003|Overall Study|Withdrawal by Subject|2|||
144617129|NCT02443883|521458084|FG000|Overall Study|Randomized, but never treated|1|||
144617130|NCT02443883|521458085|FG001|Overall Study|Randomized, but never treated|0|||
144617131|NCT02443883|521458086|FG002|Overall Study|Randomized, but never treated|0|||
144617132|NCT02443883|521458087|FG003|Overall Study|Randomized, but never treated|0|||
144617133|NCT02199080|521458088|FG000|Overall Study|Protocol Violation|12|||
144617134|NCT02250274|521458089|FG000|Overall Study|Insufficient blood draw amount|7|||
144617135|NCT02250274|521458090|FG001|Overall Study|Insufficient blood draw amount|6|||
144556490|NCT01375777|521236094|FG002|Overall Study|Lost to Follow-up|0|||
144617136|NCT00446511|521458093|FG000|Overall Study|Adverse Event|7|||
144617137|NCT00446511|521458094|FG001|Overall Study|Adverse Event|2|||
144617138|NCT00446511|521458095|FG002|Overall Study|Adverse Event|3|||
144617139|NCT00446511|521458096|FG003|Overall Study|Adverse Event|1|||
144617140|NCT00446511|521458093|FG000|Overall Study|Protocol Violation|0|||
144617141|NCT00446511|521458094|FG001|Overall Study|Protocol Violation|0|||
144617142|NCT00446511|521458095|FG002|Overall Study|Protocol Violation|0|||
144617143|NCT00446511|521458096|FG003|Overall Study|Protocol Violation|1|||
144617144|NCT00446511|521458093|FG000|Overall Study|Withdrawal by Subject|0|||
144617145|NCT00446511|521458094|FG001|Overall Study|Withdrawal by Subject|0|||
144556491|NCT01375777|521236095|FG003|Overall Study|Lost to Follow-up|0|||
144556492|NCT01375777|521236096|FG004|Overall Study|Lost to Follow-up|0|||
144556493|NCT01375777|521236097|FG005|Overall Study|Lost to Follow-up|0|||
144556494|NCT01375777|521236098|FG006|Overall Study|Lost to Follow-up|1|||
144556495|NCT01375777|521236099|FG007|Overall Study|Lost to Follow-up|0|||
144556496|NCT01375777|521236100|FG008|Overall Study|Lost to Follow-up|0|||
144556497|NCT01375777|521236092|FG000|Overall Study|Other|1|||
144556498|NCT01375777|521236093|FG001|Overall Study|Other|1|||
144556499|NCT01375777|521236094|FG002|Overall Study|Other|0|||
144556500|NCT01375777|521236095|FG003|Overall Study|Other|0|||
144556501|NCT01375777|521236096|FG004|Overall Study|Other|0|||
144556502|NCT01375777|521236097|FG005|Overall Study|Other|0|||
144556503|NCT01375777|521236098|FG006|Overall Study|Other|0|||
144556504|NCT01375777|521236099|FG007|Overall Study|Other|0|||
144556505|NCT01375777|521236100|FG008|Overall Study|Other|1|||
144556506|NCT00355784|521236101|FG000|Overall Study|Withdrawal by Subject|0|||
144556507|NCT00355784|521236102|FG001|Overall Study|Withdrawal by Subject|0|||
144556508|NCT00355784|521236103|FG002|Overall Study|Withdrawal by Subject|2|||
144556509|NCT02543294|521236104|FG000|Overall Study|Lost to Follow-up|3|||
144556510|NCT02543294|521236104|FG000|Overall Study|Physician Decision|2|||
144556511|NCT02543294|521236104|FG000|Overall Study|Withdrawal by Subject|7|||
144556512|NCT02339506|521236105|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
144556513|NCT02339506|521236106|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
144556514|NCT02339506|521236105|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
144556515|NCT02339506|521236106|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
144556516|NCT03997409|521236107|FG000|Overall Study|Protocol Violation|1|||
144556517|NCT03997409|521236108|FG001|Overall Study|Protocol Violation|1|||
144556518|NCT03997409|521236109|FG002|Overall Study|Protocol Violation|0|||
144556519|NCT03997409|521236107|FG000|Overall Study|Withdrawal by Subject|3|||
144556520|NCT03997409|521236108|FG001|Overall Study|Withdrawal by Subject|0|||
144556521|NCT03997409|521236109|FG002|Overall Study|Withdrawal by Subject|0|||
144556522|NCT03997409|521236107|FG000|Overall Study|Lost to Follow-up|0|||
144556523|NCT03997409|521236108|FG001|Overall Study|Lost to Follow-up|0|||
144556524|NCT03997409|521236109|FG002|Overall Study|Lost to Follow-up|1|||
144556525|NCT00907517|521236110|FG000|Overall Study|Progressive Disease|3|||
144556526|NCT00907517|521236111|FG001|Overall Study|Progressive Disease|3|||
144556527|NCT00907517|521236112|FG002|Overall Study|Progressive Disease|4|||
144556528|NCT00907517|521236113|FG003|Overall Study|Progressive Disease|4|||
144556529|NCT00907517|521236114|FG004|Overall Study|Progressive Disease|4|||
144556530|NCT00907517|521236110|FG000|Overall Study|Symptomatic Deterioration|0|||
144556531|NCT00907517|521236111|FG001|Overall Study|Symptomatic Deterioration|0|||
144556532|NCT00907517|521236112|FG002|Overall Study|Symptomatic Deterioration|0|||
144556533|NCT00907517|521236113|FG003|Overall Study|Symptomatic Deterioration|0|||
144556534|NCT00907517|521236114|FG004|Overall Study|Symptomatic Deterioration|1|||
144556535|NCT04879823|521236122|FG000|Overall Study|Physician Decision|3|||
144556536|NCT04879823|521236123|FG001|Overall Study|Physician Decision|1|||
144556537|NCT04879823|521236122|FG000|Overall Study|Protocol Violation|2|||
144556538|NCT04879823|521236123|FG001|Overall Study|Protocol Violation|3|||
144556539|NCT04879823|521236122|FG000|Overall Study|Lost to Follow-up|43|||
144556540|NCT04879823|521236123|FG001|Overall Study|Lost to Follow-up|35|||
144556541|NCT04468633|521236124|FG000|Overall Study|Withdrawal by Subject|4|||
144556542|NCT04468633|521236125|FG001|Overall Study|Withdrawal by Subject|0|||
144556543|NCT02465866|521236126|FG000|Period 3|Withdrawal by Subject|0|||
144556544|NCT02465866|521236127|FG001|Period 3|Withdrawal by Subject|1|||
144203487|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144556545|NCT02465866|521236128|FG002|Period 3|Withdrawal by Subject|0|||
144556546|NCT02465866|521236129|FG003|Period 3|Withdrawal by Subject|0|||
144556547|NCT02592434|521236130|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
144556548|NCT02592434|521236131|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
144556549|NCT02592434|521236132|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
144556550|NCT02592434|521236130|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
144556551|NCT02592434|521236131|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
144617146|NCT00446511|521458095|FG002|Overall Study|Withdrawal by Subject|0|||
144617147|NCT00446511|521458096|FG003|Overall Study|Withdrawal by Subject|3|||
144556552|NCT02592434|521236132|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
144556553|NCT02592434|521236130|FG000|Open-Label Phase (18 Weeks)|Other|3|||
144556554|NCT02592434|521236131|FG001|Open-Label Phase (18 Weeks)|Other|0|||
144556555|NCT02592434|521236132|FG002|Open-Label Phase (18 Weeks)|Other|0|||
144556556|NCT02592434|521236130|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
144556557|NCT02592434|521236131|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
144556558|NCT02592434|521236132|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
144556559|NCT02592434|521236130|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
144617148|NCT00446511|521458093|FG000|Overall Study|Administrative Problems|3|||
144617149|NCT00446511|521458094|FG001|Overall Study|Administrative Problems|0|||
144617150|NCT00446511|521458095|FG002|Overall Study|Administrative Problems|4|||
144556560|NCT02592434|521236131|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
144556561|NCT02592434|521236132|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
144556562|NCT02592434|521236130|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
144556563|NCT02592434|521236131|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
144556564|NCT02592434|521236132|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
144556565|NCT02592434|521236130|FG000|Double Blind Phase (26 Weeks)|Other|0|||
144556566|NCT02592434|521236131|FG001|Double Blind Phase (26 Weeks)|Other|1|||
144556567|NCT02592434|521236132|FG002|Double Blind Phase (26 Weeks)|Other|0|||
144556568|NCT02592434|521236130|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
144556569|NCT02592434|521236131|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
144556570|NCT02592434|521236132|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
144556571|NCT02592434|521236130|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
144556572|NCT02592434|521236131|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
144556573|NCT02592434|521236132|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
144617151|NCT00446511|521458096|FG003|Overall Study|Administrative Problems|1|||
144556574|NCT02592434|521236130|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
144556575|NCT02592434|521236131|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
144556576|NCT02592434|521236132|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
144556577|NCT01469819|521236133|FG000|Overall Study|Withdrawal by Subject|1|||
144556578|NCT01469819|521236133|FG000|Overall Study|Did not meet inclusionary criteria|2|||
144556579|NCT01469819|521236133|FG000|Overall Study|Could not swallow SmartPill|2|||
144556580|NCT01469819|521236133|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
144556581|NCT02029521|521236136|FG000|Overall Study|Protocol Violation|1|||
144556582|NCT02029521|521236137|FG001|Overall Study|Protocol Violation|0|||
144556583|NCT02029521|521236136|FG000|Overall Study|Withdrawal by Subject|1|||
144556584|NCT02029521|521236137|FG001|Overall Study|Withdrawal by Subject|1|||
144556585|NCT01106586|521236139|FG000|Overall Study|Adverse Event|9|||
144556586|NCT01106586|521236140|FG001|Overall Study|Adverse Event|15|||
144556587|NCT01106586|521236139|FG000|Overall Study|Death|1|||
144556588|NCT01106586|521236140|FG001|Overall Study|Death|3|||
144556589|NCT01106586|521236139|FG000|Overall Study|Pregnancy|2|||
144556590|NCT01106586|521236140|FG001|Overall Study|Pregnancy|2|||
144556591|NCT01106586|521236139|FG000|Overall Study|Lack of Efficacy|1|||
144556592|NCT01106586|521236140|FG001|Overall Study|Lack of Efficacy|0|||
144556593|NCT01106586|521236139|FG000|Overall Study|Investigator's Discretion|5|||
144556594|NCT01106586|521236140|FG001|Overall Study|Investigator's Discretion|8|||
144556595|NCT01106586|521236139|FG000|Overall Study|Withdrew Consent|18|||
144556596|NCT01106586|521236140|FG001|Overall Study|Withdrew Consent|30|||
144556597|NCT01106586|521236139|FG000|Overall Study|Lost to Follow-up|24|||
144556598|NCT01106586|521236140|FG001|Overall Study|Lost to Follow-up|20|||
144556599|NCT01106586|521236139|FG000|Overall Study|Participant Noncompliance|12|||
144556600|NCT01106586|521236140|FG001|Overall Study|Participant Noncompliance|10|||
144556601|NCT01106586|521236139|FG000|Overall Study|Protocol Violation|1|||
144556602|NCT01106586|521236140|FG001|Overall Study|Protocol Violation|0|||
144556603|NCT01106586|521236139|FG000|Overall Study|Participant Transferred to Another Study|212|||
144556604|NCT01106586|521236140|FG001|Overall Study|Participant Transferred to Another Study|197|||
144556605|NCT02131155|521236141|FG000|Overall Study|Adverse Event|1|||
144556606|NCT02131155|521236142|FG001|Overall Study|Adverse Event|0|||
144556607|NCT02131155|521236141|FG000|Overall Study|Treatment completed|1|||
144556608|NCT02131155|521236142|FG001|Overall Study|Treatment completed|0|||
144556609|NCT02131155|521236141|FG000|Overall Study|Primary tumour recurrence|2|||
144556610|NCT02131155|521236142|FG001|Overall Study|Primary tumour recurrence|1|||
144556611|NCT02131155|521236141|FG000|Overall Study|Refused to continue study medication|1|||
144556612|NCT02131155|521236142|FG001|Overall Study|Refused to continue study medication|0|||
144556613|NCT02131155|521236141|FG000|Overall Study|Study early termination|20|||
144556614|NCT02131155|521236142|FG001|Overall Study|Study early termination|10|||
144556615|NCT01887418|521236145|FG000|Overall Study|Travelling difficulties|0|||
144556616|NCT01887418|521236146|FG001|Overall Study|Travelling difficulties|0|||
144556617|NCT01887418|521236147|FG002|Overall Study|Travelling difficulties|1|||
144556618|NCT03132753|521236148|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
144556619|NCT03132753|521236149|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
144556620|NCT03132753|521236148|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
144556621|NCT03132753|521236149|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
144556622|NCT00084747|521236150|FG000|Overall Study|Relapsed|8|||
144556623|NCT00084747|521236150|FG000|Overall Study|Death|3|||
144556624|NCT00084747|521236150|FG000|Overall Study|Withdrawal by Subject|2|||
144617152|NCT00835237|521458099|FG000|Overall Study|Lost to Follow-up|4|||
144556625|NCT02744898|521236152|FG000|Overall Study|Progressive Disease|2|||
144556626|NCT02744898|521236152|FG000|Overall Study|Physician Decision|1|||
144556627|NCT02744898|521236152|FG000|Overall Study|Toxicity|1|||
144617153|NCT00835237|521458100|FG001|Overall Study|Lost to Follow-up|0|||
144556628|NCT03751280|521236154|FG000|Overall Study|Adverse Event|0|||
144556629|NCT03751280|521236155|FG001|Overall Study|Adverse Event|1|||
144556630|NCT03751280|521236154|FG000|Overall Study|Lost to Follow-up|3|||
144556631|NCT03751280|521236155|FG001|Overall Study|Lost to Follow-up|5|||
144556632|NCT03751280|521236154|FG000|Overall Study|Physician Decision|0|||
144556633|NCT03751280|521236155|FG001|Overall Study|Physician Decision|2|||
144556634|NCT03751280|521236154|FG000|Overall Study|Protocol Violation|0|||
144556635|NCT03751280|521236155|FG001|Overall Study|Protocol Violation|2|||
144556636|NCT03751280|521236154|FG000|Overall Study|Withdrawal by Subject|5|||
144556637|NCT03751280|521236155|FG001|Overall Study|Withdrawal by Subject|2|||
144556638|NCT00296504|521236156|FG000|Interim Analysis|Withdrawal by Subject|8|||
144556639|NCT00296504|521236157|FG001|Interim Analysis|Withdrawal by Subject|0|||
144556640|NCT00296504|521236158|FG002|Interim Analysis|Withdrawal by Subject|12|||
144556641|NCT00296504|521236159|FG003|Interim Analysis|Withdrawal by Subject|0|||
144556642|NCT00296504|521236160|FG004|Interim Analysis|Withdrawal by Subject|5|||
144556643|NCT00296504|521236161|FG005|Interim Analysis|Withdrawal by Subject|5|||
144556644|NCT00296504|521236162|FG006|Interim Analysis|Withdrawal by Subject|9|||
144556645|NCT00296504|521236163|FG007|Interim Analysis|Withdrawal by Subject|3|||
144556646|NCT00296504|521236164|FG008|Interim Analysis|Withdrawal by Subject|0|||
144556647|NCT00296504|521236156|FG000|Interim Analysis|Lost to Follow-up|13|||
144556648|NCT00296504|521236157|FG001|Interim Analysis|Lost to Follow-up|3|||
144556649|NCT00296504|521236158|FG002|Interim Analysis|Lost to Follow-up|26|||
144556650|NCT00296504|521236159|FG003|Interim Analysis|Lost to Follow-up|8|||
144556651|NCT00296504|521236160|FG004|Interim Analysis|Lost to Follow-up|14|||
144556652|NCT00296504|521236161|FG005|Interim Analysis|Lost to Follow-up|4|||
144556653|NCT00296504|521236162|FG006|Interim Analysis|Lost to Follow-up|11|||
144556654|NCT00296504|521236163|FG007|Interim Analysis|Lost to Follow-up|4|||
144556655|NCT00296504|521236164|FG008|Interim Analysis|Lost to Follow-up|0|||
144617154|NCT00835237|521458099|FG000|Overall Study|Withdrawal by Subject|2|||
144262443|NCT01317641|520161436|FG002|Overall Study|Protocol Violation|0|||
144556656|NCT00296504|521236156|FG000|Interim Analysis|Clinical Progression|1|||
144556657|NCT00296504|521236157|FG001|Interim Analysis|Clinical Progression|0|||
144556658|NCT00296504|521236158|FG002|Interim Analysis|Clinical Progression|1|||
144556659|NCT00296504|521236159|FG003|Interim Analysis|Clinical Progression|1|||
144556660|NCT00296504|521236160|FG004|Interim Analysis|Clinical Progression|0|||
144556661|NCT00296504|521236161|FG005|Interim Analysis|Clinical Progression|2|||
144556662|NCT00296504|521236162|FG006|Interim Analysis|Clinical Progression|1|||
144556663|NCT00296504|521236163|FG007|Interim Analysis|Clinical Progression|2|||
144556664|NCT00296504|521236164|FG008|Interim Analysis|Clinical Progression|0|||
144556665|NCT00296504|521236156|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
144556666|NCT00296504|521236157|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
144556667|NCT00296504|521236158|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
144556668|NCT00296504|521236159|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
144556669|NCT00296504|521236160|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
144556670|NCT00296504|521236161|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
144556671|NCT00296504|521236162|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
144556672|NCT00296504|521236163|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
144556673|NCT00296504|521236164|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
144556674|NCT00296504|521236156|FG000|Interim Analysis|Adverse Event|0|||
144556675|NCT00296504|521236157|FG001|Interim Analysis|Adverse Event|0|||
144556676|NCT00296504|521236158|FG002|Interim Analysis|Adverse Event|13|||
144556677|NCT00296504|521236159|FG003|Interim Analysis|Adverse Event|4|||
144556678|NCT00296504|521236160|FG004|Interim Analysis|Adverse Event|6|||
144556679|NCT00296504|521236161|FG005|Interim Analysis|Adverse Event|3|||
144556680|NCT00296504|521236162|FG006|Interim Analysis|Adverse Event|4|||
144556681|NCT00296504|521236163|FG007|Interim Analysis|Adverse Event|5|||
144556682|NCT00296504|521236164|FG008|Interim Analysis|Adverse Event|0|||
144556683|NCT00296504|521236156|FG000|Interim Analysis|Protocol Violation|0|||
144556684|NCT00296504|521236157|FG001|Interim Analysis|Protocol Violation|0|||
144556685|NCT00296504|521236158|FG002|Interim Analysis|Protocol Violation|2|||
144556686|NCT00296504|521236159|FG003|Interim Analysis|Protocol Violation|0|||
144556687|NCT00296504|521236160|FG004|Interim Analysis|Protocol Violation|1|||
144556688|NCT00296504|521236161|FG005|Interim Analysis|Protocol Violation|0|||
144556689|NCT00296504|521236162|FG006|Interim Analysis|Protocol Violation|0|||
144556690|NCT00296504|521236163|FG007|Interim Analysis|Protocol Violation|1|||
144556691|NCT00296504|521236164|FG008|Interim Analysis|Protocol Violation|0|||
144556692|NCT00296504|521236156|FG000|Interim Analysis|Insufficient CD4 Response|0|||
144556693|NCT00296504|521236157|FG001|Interim Analysis|Insufficient CD4 Response|0|||
144556694|NCT00296504|521236158|FG002|Interim Analysis|Insufficient CD4 Response|0|||
144556695|NCT00296504|521236159|FG003|Interim Analysis|Insufficient CD4 Response|0|||
144556696|NCT00296504|521236160|FG004|Interim Analysis|Insufficient CD4 Response|1|||
144556697|NCT00296504|521236161|FG005|Interim Analysis|Insufficient CD4 Response|1|||
144556698|NCT00296504|521236162|FG006|Interim Analysis|Insufficient CD4 Response|0|||
144556699|NCT00296504|521236163|FG007|Interim Analysis|Insufficient CD4 Response|0|||
144617155|NCT00835237|521458100|FG001|Overall Study|Withdrawal by Subject|0|||
144556700|NCT00296504|521236164|FG008|Interim Analysis|Insufficient CD4 Response|0|||
144556701|NCT00296504|521236156|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
144556702|NCT00296504|521236157|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
144556703|NCT00296504|521236158|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
144556704|NCT00296504|521236159|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
144556705|NCT00296504|521236160|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
144556706|NCT00296504|521236161|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
144556707|NCT00296504|521236162|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
144556708|NCT00296504|521236163|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
144556709|NCT00296504|521236164|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
144556710|NCT00296504|521236156|FG000|Interim Analysis|Pregnancy|4|||
144556711|NCT00296504|521236157|FG001|Interim Analysis|Pregnancy|1|||
144556712|NCT00296504|521236158|FG002|Interim Analysis|Pregnancy|4|||
144556713|NCT00296504|521236159|FG003|Interim Analysis|Pregnancy|2|||
144556714|NCT00296504|521236160|FG004|Interim Analysis|Pregnancy|0|||
144617156|NCT01265550|521458103|FG000|Pre Randomization|Withdrawal by Subject|0|||
144617157|NCT01265550|521458104|FG001|Pre Randomization|Withdrawal by Subject|0|||
144617158|NCT01265550|521458105|FG002|Pre Randomization|Withdrawal by Subject|0|||
144556715|NCT00296504|521236161|FG005|Interim Analysis|Pregnancy|1|||
144556716|NCT00296504|521236162|FG006|Interim Analysis|Pregnancy|1|||
144556717|NCT00296504|521236163|FG007|Interim Analysis|Pregnancy|1|||
144556718|NCT00296504|521236164|FG008|Interim Analysis|Pregnancy|0|||
144556719|NCT00296504|521236156|FG000|Interim Analysis|Death|1|||
144556720|NCT00296504|521236157|FG001|Interim Analysis|Death|0|||
144556721|NCT00296504|521236158|FG002|Interim Analysis|Death|3|||
144556722|NCT00296504|521236159|FG003|Interim Analysis|Death|0|||
144556723|NCT00296504|521236160|FG004|Interim Analysis|Death|0|||
144556724|NCT00296504|521236161|FG005|Interim Analysis|Death|0|||
144556725|NCT00296504|521236162|FG006|Interim Analysis|Death|0|||
144556726|NCT00296504|521236163|FG007|Interim Analysis|Death|0|||
144556727|NCT00296504|521236164|FG008|Interim Analysis|Death|0|||
144556728|NCT00296504|521236156|FG000|Interim Analysis|Participant Non-compliant|0|||
144556729|NCT00296504|521236157|FG001|Interim Analysis|Participant Non-compliant|1|||
144556730|NCT00296504|521236158|FG002|Interim Analysis|Participant Non-compliant|2|||
144556731|NCT00296504|521236159|FG003|Interim Analysis|Participant Non-compliant|1|||
144556732|NCT00296504|521236160|FG004|Interim Analysis|Participant Non-compliant|1|||
144556733|NCT00296504|521236161|FG005|Interim Analysis|Participant Non-compliant|3|||
144556734|NCT00296504|521236162|FG006|Interim Analysis|Participant Non-compliant|6|||
144556735|NCT00296504|521236163|FG007|Interim Analysis|Participant Non-compliant|2|||
144556736|NCT00296504|521236164|FG008|Interim Analysis|Participant Non-compliant|0|||
144556737|NCT00296504|521236156|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556738|NCT00296504|521236157|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556739|NCT00296504|521236158|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
144556740|NCT00296504|521236159|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556741|NCT00296504|521236160|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556742|NCT00296504|521236161|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
144556743|NCT00296504|521236162|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556744|NCT00296504|521236163|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556745|NCT00296504|521236164|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
144556746|NCT00296504|521236156|FG000|Interim Analysis|To Simplify Treatment|0|||
144556747|NCT00296504|521236157|FG001|Interim Analysis|To Simplify Treatment|0|||
144556748|NCT00296504|521236158|FG002|Interim Analysis|To Simplify Treatment|1|||
144556749|NCT00296504|521236159|FG003|Interim Analysis|To Simplify Treatment|0|||
144556750|NCT00296504|521236160|FG004|Interim Analysis|To Simplify Treatment|0|||
144556751|NCT00296504|521236161|FG005|Interim Analysis|To Simplify Treatment|0|||
144556752|NCT00296504|521236162|FG006|Interim Analysis|To Simplify Treatment|2|||
144556753|NCT00296504|521236163|FG007|Interim Analysis|To Simplify Treatment|0|||
144556754|NCT00296504|521236164|FG008|Interim Analysis|To Simplify Treatment|0|||
144556755|NCT00296504|521236156|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556756|NCT00296504|521236157|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556757|NCT00296504|521236158|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
144556758|NCT00296504|521236159|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556759|NCT00296504|521236160|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556760|NCT00296504|521236161|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556761|NCT00296504|521236162|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556762|NCT00296504|521236163|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556763|NCT00296504|521236164|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
144556764|NCT00296504|521236156|FG000|Interim Analysis|Participant Moved|1|||
144556765|NCT00296504|521236157|FG001|Interim Analysis|Participant Moved|0|||
144556766|NCT00296504|521236158|FG002|Interim Analysis|Participant Moved|1|||
144556767|NCT00296504|521236159|FG003|Interim Analysis|Participant Moved|0|||
144556768|NCT00296504|521236160|FG004|Interim Analysis|Participant Moved|0|||
144556769|NCT00296504|521236161|FG005|Interim Analysis|Participant Moved|1|||
144556770|NCT00296504|521236162|FG006|Interim Analysis|Participant Moved|1|||
144556771|NCT00296504|521236163|FG007|Interim Analysis|Participant Moved|0|||
144556772|NCT00296504|521236164|FG008|Interim Analysis|Participant Moved|0|||
144556773|NCT00296504|521236156|FG000|Interim Analysis|Participant Was Incarcerated|2|||
144556774|NCT00296504|521236157|FG001|Interim Analysis|Participant Was Incarcerated|0|||
144556775|NCT00296504|521236158|FG002|Interim Analysis|Participant Was Incarcerated|1|||
144556776|NCT00296504|521236159|FG003|Interim Analysis|Participant Was Incarcerated|0|||
144556777|NCT00296504|521236160|FG004|Interim Analysis|Participant Was Incarcerated|0|||
144556778|NCT00296504|521236161|FG005|Interim Analysis|Participant Was Incarcerated|0|||
144556779|NCT00296504|521236162|FG006|Interim Analysis|Participant Was Incarcerated|0|||
144556780|NCT00296504|521236163|FG007|Interim Analysis|Participant Was Incarcerated|0|||
144556781|NCT00296504|521236164|FG008|Interim Analysis|Participant Was Incarcerated|0|||
144556782|NCT00296504|521236156|FG000|Interim Analysis|Resistance to FPV|0|||
144556783|NCT00296504|521236157|FG001|Interim Analysis|Resistance to FPV|0|||
144556784|NCT00296504|521236158|FG002|Interim Analysis|Resistance to FPV|1|||
144556785|NCT00296504|521236159|FG003|Interim Analysis|Resistance to FPV|0|||
144556786|NCT00296504|521236160|FG004|Interim Analysis|Resistance to FPV|0|||
144556787|NCT00296504|521236161|FG005|Interim Analysis|Resistance to FPV|0|||
144556788|NCT00296504|521236162|FG006|Interim Analysis|Resistance to FPV|0|||
144556789|NCT00296504|521236163|FG007|Interim Analysis|Resistance to FPV|0|||
144556790|NCT00296504|521236164|FG008|Interim Analysis|Resistance to FPV|0|||
144556791|NCT00296504|521236156|FG000|Interim Analysis|Physician Decision|0|||
144556792|NCT00296504|521236157|FG001|Interim Analysis|Physician Decision|0|||
144556793|NCT00296504|521236158|FG002|Interim Analysis|Physician Decision|1|||
144617159|NCT01265550|521458106|FG003|Pre Randomization|Withdrawal by Subject|70|||
144617160|NCT01265550|521458103|FG000|Pre Randomization|Technical Exclusions|0|||
144617161|NCT01265550|521458104|FG001|Pre Randomization|Technical Exclusions|0|||
144617162|NCT01265550|521458105|FG002|Pre Randomization|Technical Exclusions|0|||
144617163|NCT01265550|521458106|FG003|Pre Randomization|Technical Exclusions|54|||
144617164|NCT01265550|521458103|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
144617165|NCT01265550|521458104|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
144617166|NCT01265550|521458105|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
144617167|NCT01265550|521458106|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
144617168|NCT01265550|521458103|FG000|Pre Randomization|Non-GERD organic disorders|0|||
144617169|NCT01265550|521458104|FG001|Pre Randomization|Non-GERD organic disorders|0|||
144617170|NCT01265550|521458105|FG002|Pre Randomization|Non-GERD organic disorders|0|||
144617171|NCT01265550|521458106|FG003|Pre Randomization|Non-GERD organic disorders|23|||
144617172|NCT01265550|521458103|FG000|Pre Randomization|Functional heartburn|0|||
144617173|NCT01265550|521458104|FG001|Pre Randomization|Functional heartburn|0|||
144617174|NCT01265550|521458105|FG002|Pre Randomization|Functional heartburn|0|||
144617175|NCT01265550|521458106|FG003|Pre Randomization|Functional heartburn|99|||
144617176|NCT03436862|521458108|FG000|Overall Study|Adverse Event|4|||
144617177|NCT03436862|521458108|FG000|Overall Study|Progressive Disease|2|||
144617178|NCT02937818|521458109|FG000|Overall Study|Participants decision|2|||
144617179|NCT02937818|521458110|FG001|Overall Study|Participants decision|1|||
144617180|NCT02937818|521458111|FG002|Overall Study|Participants decision|1|||
144617181|NCT02937818|521458112|FG003|Overall Study|Participants decision|1|||
144617182|NCT02937818|521458109|FG000|Overall Study|Adverse Event|2|||
144617183|NCT02937818|521458110|FG001|Overall Study|Adverse Event|4|||
144617184|NCT02937818|521458111|FG002|Overall Study|Adverse Event|1|||
144617185|NCT02937818|521458112|FG003|Overall Study|Adverse Event|1|||
144617186|NCT02937818|521458109|FG000|Overall Study|Disease progression|17|||
144617187|NCT02937818|521458110|FG001|Overall Study|Disease progression|15|||
144617188|NCT02937818|521458111|FG002|Overall Study|Disease progression|7|||
144617189|NCT02937818|521458112|FG003|Overall Study|Disease progression|19|||
144617190|NCT02937818|521458109|FG000|Overall Study|Condition under investigation worsened|0|||
144617191|NCT02937818|521458110|FG001|Overall Study|Condition under investigation worsened|0|||
144617192|NCT02937818|521458111|FG002|Overall Study|Condition under investigation worsened|1|||
144617193|NCT02937818|521458112|FG003|Overall Study|Condition under investigation worsened|0|||
144617194|NCT00689871|521458115|FG000|Overall Study|Lost to Follow-up|123|||
144617195|NCT00689871|521458116|FG001|Overall Study|Lost to Follow-up|13|||
144617196|NCT00689871|521458117|FG002|Overall Study|Lost to Follow-up|37|||
144617197|NCT00689871|521458118|FG003|Overall Study|Lost to Follow-up|1|||
144617198|NCT00689871|521458115|FG000|Overall Study|Explanted of All Study Devices|36|||
144617199|NCT00689871|521458116|FG001|Overall Study|Explanted of All Study Devices|25|||
144617200|NCT00689871|521458117|FG002|Overall Study|Explanted of All Study Devices|29|||
144617201|NCT00689871|521458118|FG003|Overall Study|Explanted of All Study Devices|3|||
144617202|NCT00689871|521458115|FG000|Overall Study|Withdrawal by Subject|13|||
144617203|NCT00689871|521458116|FG001|Overall Study|Withdrawal by Subject|3|||
144617204|NCT00689871|521458117|FG002|Overall Study|Withdrawal by Subject|4|||
144617205|NCT00689871|521458118|FG003|Overall Study|Withdrawal by Subject|1|||
144617206|NCT00689871|521458115|FG000|Overall Study|Death|1|||
144617207|NCT00689871|521458116|FG001|Overall Study|Death|10|||
144617208|NCT00689871|521458117|FG002|Overall Study|Death|2|||
144556794|NCT00296504|521236159|FG003|Interim Analysis|Physician Decision|0|||
144556795|NCT00296504|521236160|FG004|Interim Analysis|Physician Decision|0|||
144556796|NCT00296504|521236161|FG005|Interim Analysis|Physician Decision|0|||
144556797|NCT00296504|521236162|FG006|Interim Analysis|Physician Decision|0|||
144556798|NCT00296504|521236163|FG007|Interim Analysis|Physician Decision|0|||
144556799|NCT00296504|521236164|FG008|Interim Analysis|Physician Decision|0|||
144556800|NCT00296504|521236156|FG000|Interim Analysis|Principle Investigator Discretion|2|||
144556801|NCT00296504|521236157|FG001|Interim Analysis|Principle Investigator Discretion|0|||
144556802|NCT00296504|521236158|FG002|Interim Analysis|Principle Investigator Discretion|1|||
144556803|NCT00296504|521236159|FG003|Interim Analysis|Principle Investigator Discretion|1|||
144556804|NCT00296504|521236160|FG004|Interim Analysis|Principle Investigator Discretion|0|||
144556805|NCT00296504|521236161|FG005|Interim Analysis|Principle Investigator Discretion|0|||
144556806|NCT00296504|521236162|FG006|Interim Analysis|Principle Investigator Discretion|0|||
144556807|NCT00296504|521236163|FG007|Interim Analysis|Principle Investigator Discretion|0|||
144556808|NCT00296504|521236164|FG008|Interim Analysis|Principle Investigator Discretion|0|||
144556809|NCT00296504|521236156|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
144556810|NCT00296504|521236157|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
144556811|NCT00296504|521236158|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
144556812|NCT00296504|521236159|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
144556813|NCT00296504|521236160|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
144556814|NCT00296504|521236161|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
144556815|NCT00296504|521236162|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
144556816|NCT00296504|521236163|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
144556817|NCT00296504|521236164|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
144556818|NCT00296504|521236156|FG000|Interim Analysis|Non-adherence|2|||
144556819|NCT00296504|521236157|FG001|Interim Analysis|Non-adherence|0|||
144556820|NCT00296504|521236158|FG002|Interim Analysis|Non-adherence|0|||
144556821|NCT00296504|521236159|FG003|Interim Analysis|Non-adherence|0|||
144556822|NCT00296504|521236160|FG004|Interim Analysis|Non-adherence|1|||
144556823|NCT00296504|521236161|FG005|Interim Analysis|Non-adherence|0|||
144556824|NCT00296504|521236162|FG006|Interim Analysis|Non-adherence|0|||
144556825|NCT00296504|521236163|FG007|Interim Analysis|Non-adherence|1|||
144556826|NCT00296504|521236164|FG008|Interim Analysis|Non-adherence|0|||
144556827|NCT00296504|521236156|FG000|Interim Analysis|Site Closing|1|||
144556828|NCT00296504|521236157|FG001|Interim Analysis|Site Closing|0|||
144556829|NCT00296504|521236158|FG002|Interim Analysis|Site Closing|0|||
144556830|NCT00296504|521236159|FG003|Interim Analysis|Site Closing|0|||
144556831|NCT00296504|521236160|FG004|Interim Analysis|Site Closing|0|||
144556832|NCT00296504|521236161|FG005|Interim Analysis|Site Closing|1|||
144556833|NCT00296504|521236162|FG006|Interim Analysis|Site Closing|2|||
144556834|NCT00296504|521236163|FG007|Interim Analysis|Site Closing|0|||
144556835|NCT00296504|521236164|FG008|Interim Analysis|Site Closing|0|||
144556836|NCT00296504|521236156|FG000|Interim Analysis|Lack of Personnel at Site|1|||
144556837|NCT00296504|521236157|FG001|Interim Analysis|Lack of Personnel at Site|0|||
144556838|NCT00296504|521236158|FG002|Interim Analysis|Lack of Personnel at Site|0|||
144556839|NCT00296504|521236159|FG003|Interim Analysis|Lack of Personnel at Site|0|||
144556840|NCT00296504|521236160|FG004|Interim Analysis|Lack of Personnel at Site|0|||
144556841|NCT00296504|521236161|FG005|Interim Analysis|Lack of Personnel at Site|0|||
144556842|NCT00296504|521236162|FG006|Interim Analysis|Lack of Personnel at Site|0|||
144556843|NCT00296504|521236163|FG007|Interim Analysis|Lack of Personnel at Site|0|||
144556844|NCT00296504|521236164|FG008|Interim Analysis|Lack of Personnel at Site|0|||
144556845|NCT00296504|521236156|FG000|Interim Analysis|Missed Schedule Date|1|||
144556846|NCT00296504|521236157|FG001|Interim Analysis|Missed Schedule Date|0|||
144617209|NCT00689871|521458118|FG003|Overall Study|Death|2|||
144203488|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144556847|NCT00296504|521236158|FG002|Interim Analysis|Missed Schedule Date|0|||
144556848|NCT00296504|521236159|FG003|Interim Analysis|Missed Schedule Date|0|||
144556849|NCT00296504|521236160|FG004|Interim Analysis|Missed Schedule Date|0|||
144556850|NCT00296504|521236161|FG005|Interim Analysis|Missed Schedule Date|0|||
144556851|NCT00296504|521236162|FG006|Interim Analysis|Missed Schedule Date|0|||
144556852|NCT00296504|521236163|FG007|Interim Analysis|Missed Schedule Date|0|||
144556853|NCT00296504|521236164|FG008|Interim Analysis|Missed Schedule Date|0|||
144556854|NCT00296504|521236156|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
144556855|NCT00296504|521236157|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
144556856|NCT00296504|521236158|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
144556857|NCT00296504|521236159|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
144556858|NCT00296504|521236160|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
144556859|NCT00296504|521236161|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
144556860|NCT00296504|521236162|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
144556861|NCT00296504|521236163|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
144556862|NCT00296504|521236164|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
144556863|NCT00296504|521236156|FG000|Interim Analysis|Participant Stopped|0|||
144556864|NCT00296504|521236157|FG001|Interim Analysis|Participant Stopped|0|||
144556865|NCT00296504|521236158|FG002|Interim Analysis|Participant Stopped|0|||
144556866|NCT00296504|521236159|FG003|Interim Analysis|Participant Stopped|0|||
144556867|NCT00296504|521236160|FG004|Interim Analysis|Participant Stopped|1|||
144556868|NCT00296504|521236161|FG005|Interim Analysis|Participant Stopped|0|||
144556869|NCT00296504|521236162|FG006|Interim Analysis|Participant Stopped|0|||
144556870|NCT00296504|521236163|FG007|Interim Analysis|Participant Stopped|0|||
144556871|NCT00296504|521236164|FG008|Interim Analysis|Participant Stopped|0|||
144617210|NCT00689871|521458115|FG000|Overall Study|Physician Decision|2|||
144617211|NCT00689871|521458116|FG001|Overall Study|Physician Decision|1|||
144617212|NCT00689871|521458117|FG002|Overall Study|Physician Decision|1|||
144617213|NCT00689871|521458118|FG003|Overall Study|Physician Decision|0|||
144617214|NCT02054897|521458119|FG000|Overall Study|Withdrawal by Subject|2|||
144617215|NCT02054897|521458120|FG001|Overall Study|Withdrawal by Subject|0|||
144556872|NCT00296504|521236156|FG000|Interim Analysis|Physician and Participant Decision|0|||
144556873|NCT00296504|521236157|FG001|Interim Analysis|Physician and Participant Decision|0|||
144556874|NCT00296504|521236158|FG002|Interim Analysis|Physician and Participant Decision|0|||
144556875|NCT00296504|521236159|FG003|Interim Analysis|Physician and Participant Decision|0|||
144556876|NCT00296504|521236160|FG004|Interim Analysis|Physician and Participant Decision|0|||
144556877|NCT00296504|521236161|FG005|Interim Analysis|Physician and Participant Decision|1|||
144556878|NCT00296504|521236162|FG006|Interim Analysis|Physician and Participant Decision|0|||
144556879|NCT00296504|521236163|FG007|Interim Analysis|Physician and Participant Decision|0|||
144556880|NCT00296504|521236164|FG008|Interim Analysis|Physician and Participant Decision|0|||
144556881|NCT00296504|521236156|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
144556882|NCT00296504|521236157|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
144556883|NCT00296504|521236158|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
144556884|NCT00296504|521236159|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
144556885|NCT00296504|521236160|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
144556886|NCT00296504|521236161|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
144556887|NCT00296504|521236162|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
144556888|NCT00296504|521236163|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
144556889|NCT00296504|521236164|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
144556890|NCT00296504|521236156|FG000|Interim Analysis|Study Ended|0|||
144556891|NCT00296504|521236157|FG001|Interim Analysis|Study Ended|0|||
144556892|NCT00296504|521236158|FG002|Interim Analysis|Study Ended|0|||
144556893|NCT00296504|521236159|FG003|Interim Analysis|Study Ended|0|||
144556894|NCT00296504|521236160|FG004|Interim Analysis|Study Ended|0|||
144556895|NCT00296504|521236161|FG005|Interim Analysis|Study Ended|0|||
144556896|NCT00296504|521236162|FG006|Interim Analysis|Study Ended|1|||
144556897|NCT00296504|521236163|FG007|Interim Analysis|Study Ended|0|||
144556898|NCT00296504|521236164|FG008|Interim Analysis|Study Ended|0|||
144556899|NCT00296504|521236156|FG000|Interim Analysis|Participant Needed Interferon|0|||
144556900|NCT00296504|521236157|FG001|Interim Analysis|Participant Needed Interferon|0|||
144556901|NCT00296504|521236158|FG002|Interim Analysis|Participant Needed Interferon|0|||
144556902|NCT00296504|521236159|FG003|Interim Analysis|Participant Needed Interferon|0|||
144556903|NCT00296504|521236160|FG004|Interim Analysis|Participant Needed Interferon|0|||
144556904|NCT00296504|521236161|FG005|Interim Analysis|Participant Needed Interferon|0|||
144556905|NCT00296504|521236162|FG006|Interim Analysis|Participant Needed Interferon|0|||
144556906|NCT00296504|521236163|FG007|Interim Analysis|Participant Needed Interferon|1|||
144556907|NCT00296504|521236164|FG008|Interim Analysis|Participant Needed Interferon|0|||
144556908|NCT00296504|521236156|FG000|Interim Analysis|Ongoing|32|||
144556909|NCT00296504|521236157|FG001|Interim Analysis|Ongoing|12|||
144556910|NCT00296504|521236158|FG002|Interim Analysis|Ongoing|16|||
144556911|NCT00296504|521236159|FG003|Interim Analysis|Ongoing|22|||
144556912|NCT00296504|521236160|FG004|Interim Analysis|Ongoing|0|||
144556913|NCT00296504|521236161|FG005|Interim Analysis|Ongoing|0|||
144556914|NCT00296504|521236162|FG006|Interim Analysis|Ongoing|30|||
144556915|NCT00296504|521236163|FG007|Interim Analysis|Ongoing|1|||
144556916|NCT00296504|521236164|FG008|Interim Analysis|Ongoing|0|||
144556917|NCT00296504|521236156|FG000|Final Analysis|Withdrawal by Subject|0|||
144556918|NCT00296504|521236157|FG001|Final Analysis|Withdrawal by Subject|0|||
144556919|NCT00296504|521236158|FG002|Final Analysis|Withdrawal by Subject|0|||
144556920|NCT00296504|521236159|FG003|Final Analysis|Withdrawal by Subject|0|||
144556921|NCT00296504|521236160|FG004|Final Analysis|Withdrawal by Subject|0|||
144556922|NCT00296504|521236161|FG005|Final Analysis|Withdrawal by Subject|0|||
144617216|NCT02054897|521458121|FG002|Overall Study|Withdrawal by Subject|2|||
144617217|NCT02054897|521458119|FG000|Overall Study|Missing follow-up information|3|||
144617218|NCT02054897|521458120|FG001|Overall Study|Missing follow-up information|5|||
144617219|NCT02054897|521458121|FG002|Overall Study|Missing follow-up information|3|||
144617220|NCT02054897|521458119|FG000|Overall Study|Lost to Follow-up|4|||
144617221|NCT02054897|521458120|FG001|Overall Study|Lost to Follow-up|2|||
144617222|NCT02054897|521458121|FG002|Overall Study|Lost to Follow-up|7|||
144556923|NCT00296504|521236162|FG006|Final Analysis|Withdrawal by Subject|0|||
144617223|NCT02054897|521458119|FG000|Overall Study|Randomized but not exposed|1|||
144556924|NCT00296504|521236163|FG007|Final Analysis|Withdrawal by Subject|0|||
144556925|NCT00296504|521236164|FG008|Final Analysis|Withdrawal by Subject|1|||
144556926|NCT00296504|521236156|FG000|Final Analysis|Lost to Follow-up|0|||
144556927|NCT00296504|521236157|FG001|Final Analysis|Lost to Follow-up|0|||
144556928|NCT00296504|521236158|FG002|Final Analysis|Lost to Follow-up|0|||
144556929|NCT00296504|521236159|FG003|Final Analysis|Lost to Follow-up|0|||
144556930|NCT00296504|521236160|FG004|Final Analysis|Lost to Follow-up|0|||
144556931|NCT00296504|521236161|FG005|Final Analysis|Lost to Follow-up|0|||
144556932|NCT00296504|521236162|FG006|Final Analysis|Lost to Follow-up|0|||
144727789|NCT00920140|521858077|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
144727790|NCT00920140|521858078|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
144727791|NCT00920140|521858079|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
144727792|NCT00920140|521858080|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
144727793|NCT00920140|521858076|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144727794|NCT00920140|521858077|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
144727795|NCT00920140|521858078|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144727796|NCT00920140|521858079|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144727797|NCT00920140|521858080|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
144727798|NCT00920140|521858076|FG000|Phase 2|Adverse Event|0|||
144727799|NCT00920140|521858077|FG001|Phase 2|Adverse Event|0|||
144727800|NCT00920140|521858078|FG002|Phase 2|Adverse Event|14|||
144727801|NCT00920140|521858079|FG003|Phase 2|Adverse Event|2|||
144262444|NCT01317641|520161437|FG003|Overall Study|Protocol Violation|0|||
144617224|NCT02054897|521458120|FG001|Overall Study|Randomized but not exposed|0|||
144617225|NCT02054897|521458121|FG002|Overall Study|Randomized but not exposed|0|||
144556933|NCT00296504|521236163|FG007|Final Analysis|Lost to Follow-up|0|||
144556934|NCT00296504|521236164|FG008|Final Analysis|Lost to Follow-up|5|||
144556935|NCT00296504|521236156|FG000|Final Analysis|Insufficient Viral Load Response|0|||
144556936|NCT00296504|521236157|FG001|Final Analysis|Insufficient Viral Load Response|0|||
144556937|NCT00296504|521236158|FG002|Final Analysis|Insufficient Viral Load Response|0|||
144556938|NCT00296504|521236159|FG003|Final Analysis|Insufficient Viral Load Response|0|||
144556939|NCT00296504|521236160|FG004|Final Analysis|Insufficient Viral Load Response|0|||
144556940|NCT00296504|521236161|FG005|Final Analysis|Insufficient Viral Load Response|0|||
144556941|NCT00296504|521236162|FG006|Final Analysis|Insufficient Viral Load Response|0|||
144556942|NCT00296504|521236163|FG007|Final Analysis|Insufficient Viral Load Response|0|||
144556943|NCT00296504|521236164|FG008|Final Analysis|Insufficient Viral Load Response|6|||
144556944|NCT00296504|521236156|FG000|Final Analysis|Adverse Event|0|||
144556945|NCT00296504|521236157|FG001|Final Analysis|Adverse Event|0|||
144556946|NCT00296504|521236158|FG002|Final Analysis|Adverse Event|0|||
144556947|NCT00296504|521236159|FG003|Final Analysis|Adverse Event|0|||
144556948|NCT00296504|521236160|FG004|Final Analysis|Adverse Event|0|||
144556949|NCT00296504|521236161|FG005|Final Analysis|Adverse Event|0|||
144556950|NCT00296504|521236162|FG006|Final Analysis|Adverse Event|0|||
144556951|NCT00296504|521236163|FG007|Final Analysis|Adverse Event|0|||
144556952|NCT00296504|521236164|FG008|Final Analysis|Adverse Event|2|||
144556953|NCT00296504|521236156|FG000|Final Analysis|Pregnancy|0|||
144556954|NCT00296504|521236157|FG001|Final Analysis|Pregnancy|0|||
144556955|NCT00296504|521236158|FG002|Final Analysis|Pregnancy|0|||
144556956|NCT00296504|521236159|FG003|Final Analysis|Pregnancy|0|||
144556957|NCT00296504|521236160|FG004|Final Analysis|Pregnancy|0|||
144556958|NCT00296504|521236161|FG005|Final Analysis|Pregnancy|0|||
144556959|NCT00296504|521236162|FG006|Final Analysis|Pregnancy|0|||
144556960|NCT00296504|521236163|FG007|Final Analysis|Pregnancy|0|||
144556961|NCT00296504|521236164|FG008|Final Analysis|Pregnancy|4|||
144617226|NCT00550680|521458122|FG000|Overall Study|Administrative Reasons|1|||
144617227|NCT00550680|521458122|FG000|Overall Study|Adverse Event|5|||
144556962|NCT00296504|521236156|FG000|Final Analysis|Tuberculosis|0|||
144556963|NCT00296504|521236157|FG001|Final Analysis|Tuberculosis|0|||
144556964|NCT00296504|521236158|FG002|Final Analysis|Tuberculosis|0|||
144617228|NCT00550680|521458122|FG000|Overall Study|Death|3|||
144617229|NCT00550680|521458122|FG000|Overall Study|Early Improvement|1|||
144617230|NCT00550680|521458122|FG000|Overall Study|Lost to Follow-up|3|||
144617231|NCT00550680|521458122|FG000|Overall Study|Lack of Efficacy|1|||
144262445|NCT01317641|520161438|FG004|Overall Study|Protocol Violation|0|||
144556965|NCT00296504|521236159|FG003|Final Analysis|Tuberculosis|0|||
144556966|NCT00296504|521236160|FG004|Final Analysis|Tuberculosis|0|||
144556967|NCT00296504|521236161|FG005|Final Analysis|Tuberculosis|0|||
144556968|NCT00296504|521236162|FG006|Final Analysis|Tuberculosis|0|||
144556969|NCT00296504|521236163|FG007|Final Analysis|Tuberculosis|0|||
144556970|NCT00296504|521236164|FG008|Final Analysis|Tuberculosis|1|||
144556971|NCT00296504|521236156|FG000|Final Analysis|Participant Moved to Another Country|0|||
144556972|NCT00296504|521236157|FG001|Final Analysis|Participant Moved to Another Country|0|||
144556973|NCT00296504|521236158|FG002|Final Analysis|Participant Moved to Another Country|0|||
144556974|NCT00296504|521236159|FG003|Final Analysis|Participant Moved to Another Country|0|||
144556975|NCT00296504|521236160|FG004|Final Analysis|Participant Moved to Another Country|0|||
144617232|NCT00550680|521458122|FG000|Overall Study|Other|10|||
144727802|NCT00920140|521858080|FG004|Phase 2|Adverse Event|3|||
144727803|NCT00920140|521858076|FG000|Phase 2|Lack of Efficacy|0|||
144617233|NCT00550680|521458122|FG000|Overall Study|Protocol Violation|7|||
144556976|NCT00296504|521236161|FG005|Final Analysis|Participant Moved to Another Country|0|||
144556977|NCT00296504|521236162|FG006|Final Analysis|Participant Moved to Another Country|0|||
144556978|NCT00296504|521236163|FG007|Final Analysis|Participant Moved to Another Country|0|||
144556979|NCT00296504|521236164|FG008|Final Analysis|Participant Moved to Another Country|1|||
144556980|NCT00296504|521236156|FG000|Final Analysis|Poor Adherence|0|||
144556981|NCT00296504|521236157|FG001|Final Analysis|Poor Adherence|0|||
144556982|NCT00296504|521236158|FG002|Final Analysis|Poor Adherence|0|||
144556983|NCT00296504|521236159|FG003|Final Analysis|Poor Adherence|0|||
144556984|NCT00296504|521236160|FG004|Final Analysis|Poor Adherence|0|||
144556985|NCT00296504|521236161|FG005|Final Analysis|Poor Adherence|0|||
144556986|NCT00296504|521236162|FG006|Final Analysis|Poor Adherence|0|||
144556987|NCT00296504|521236163|FG007|Final Analysis|Poor Adherence|0|||
144556988|NCT00296504|521236164|FG008|Final Analysis|Poor Adherence|1|||
144556989|NCT02162771|521236165|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
144556990|NCT02162771|521236166|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
144556991|NCT02162771|521236165|FG000|Core Study Period (Part 2)|Adverse Event|4|||
144556992|NCT02162771|521236166|FG001|Core Study Period (Part 2)|Adverse Event|1|||
144556993|NCT02162771|521236165|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
144556994|NCT02162771|521236166|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
144556995|NCT02162771|521236165|FG000|Core Study Period (Part 2)|Physician Decision|0|||
144556996|NCT02162771|521236166|FG001|Core Study Period (Part 2)|Physician Decision|2|||
144556997|NCT02162771|521236165|FG000|Core Study Period (Part 2)|Death|1|||
144556998|NCT02162771|521236166|FG001|Core Study Period (Part 2)|Death|0|||
144556999|NCT02162771|521236165|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
144557000|NCT02162771|521236166|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
144557001|NCT02162771|521236165|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
144557002|NCT02162771|521236166|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
144557003|NCT02162771|521236165|FG000|Maintenance Study Period (Part 2)|Death|2|||
144557004|NCT02162771|521236166|FG001|Maintenance Study Period (Part 2)|Death|1|||
144557005|NCT02162771|521236165|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
144557006|NCT02162771|521236166|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
144557007|NCT02162771|521236165|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
144557008|NCT02162771|521236166|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
144557009|NCT02162771|521236165|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
144557010|NCT02162771|521236166|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
144557011|NCT00274846|521236169|FG000|Overall Study|Did not receive adequate NK cells|1|||
144557012|NCT01920178|521236172|FG000|Overall Study|Lost to Follow-up|2|||
144557013|NCT01920178|521236173|FG001|Overall Study|Lost to Follow-up|1|||
144557014|NCT02849509|521236174|FG000|Overall Study|Worsening of disease under study|1|||
144557015|NCT02849509|521236175|FG001|Overall Study|Worsening of disease under study|1|||
144557016|NCT02849509|521236176|FG002|Overall Study|Worsening of disease under study|1|||
144557017|NCT02849509|521236174|FG000|Overall Study|Worsening of other pre-existing disease|0|||
144557018|NCT02849509|521236175|FG001|Overall Study|Worsening of other pre-existing disease|1|||
144557019|NCT02849509|521236176|FG002|Overall Study|Worsening of other pre-existing disease|2|||
144557020|NCT02849509|521236174|FG000|Overall Study|Other adverse event|36|||
144557021|NCT02849509|521236175|FG001|Overall Study|Other adverse event|41|||
144557022|NCT02849509|521236176|FG002|Overall Study|Other adverse event|8|||
144557023|NCT02849509|521236174|FG000|Overall Study|Withdrawal by Subject|6|||
144617234|NCT00550680|521458122|FG000|Overall Study|Refused Treatment|19|||
144617235|NCT00550680|521458122|FG000|Overall Study|Screen Failure|6|||
144617236|NCT00250835|521458125|FG000|Overall Study|Withdrawal by Subject|1|||
144617237|NCT01100437|521458126|FG000|Titration/Stabilization|Adverse Event|0|||
144617238|NCT01100437|521458127|FG001|Titration/Stabilization|Adverse Event|0|||
144557024|NCT02849509|521236175|FG001|Overall Study|Withdrawal by Subject|17|||
144557025|NCT02849509|521236176|FG002|Overall Study|Withdrawal by Subject|12|||
144557026|NCT02849509|521236174|FG000|Overall Study|Lost to Follow-up|27|||
144557027|NCT02849509|521236175|FG001|Overall Study|Lost to Follow-up|67|||
144557028|NCT02849509|521236176|FG002|Overall Study|Lost to Follow-up|36|||
144557029|NCT02849509|521236174|FG000|Overall Study|Other, reason not specified|14|||
144557030|NCT02849509|521236175|FG001|Overall Study|Other, reason not specified|29|||
144557031|NCT02849509|521236176|FG002|Overall Study|Other, reason not specified|25|||
144557032|NCT02849509|521236174|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
144557033|NCT02849509|521236175|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
144557034|NCT02849509|521236176|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
144557035|NCT00440037|521236177|FG000|Overall Study|Withdrawal by Subject|6|||
144557036|NCT00440037|521236177|FG000|Overall Study|Administrative decision|3|||
144557037|NCT03928821|521236178|FG000|Overall Study|Death|0|||
144557038|NCT03928821|521236179|FG001|Overall Study|Death|1|||
144557039|NCT03928821|521236180|FG002|Overall Study|Death|0|||
144557040|NCT03928821|521236181|FG003|Overall Study|Death|0|||
144557041|NCT03928821|521236178|FG000|Overall Study|Lost to Follow-up|0|||
144557042|NCT03928821|521236179|FG001|Overall Study|Lost to Follow-up|2|||
144617239|NCT01100437|521458128|FG002|Titration/Stabilization|Adverse Event|4|||
144557043|NCT03928821|521236180|FG002|Overall Study|Lost to Follow-up|3|||
144557044|NCT03928821|521236181|FG003|Overall Study|Lost to Follow-up|0|||
144557045|NCT03928821|521236178|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
144557046|NCT03928821|521236179|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
144557047|NCT03928821|521236180|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
144557048|NCT03928821|521236181|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
144557049|NCT01288729|521236185|FG000|Overall Study|Withdrawal by Subject|1|||
144557050|NCT01288729|521236186|FG001|Overall Study|Withdrawal by Subject|0|||
144557051|NCT00417989|521236187|FG000|Overall Study|Withdrawal by Subject|13|||
144557052|NCT00417989|521236188|FG001|Overall Study|Withdrawal by Subject|13|||
144557053|NCT00417989|521236187|FG000|Overall Study|Lost to Follow-up|1|||
144557054|NCT00417989|521236188|FG001|Overall Study|Lost to Follow-up|6|||
144557055|NCT00417989|521236187|FG000|Overall Study|Protocol Violation|1|||
144557056|NCT00417989|521236188|FG001|Overall Study|Protocol Violation|0|||
144557057|NCT00417989|521236187|FG000|Overall Study|Death|0|||
144557058|NCT00417989|521236188|FG001|Overall Study|Death|1|||
144557059|NCT00417989|521236187|FG000|Overall Study|Physician Decision|5|||
144557060|NCT00417989|521236188|FG001|Overall Study|Physician Decision|2|||
144557061|NCT01636778|521236191|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
144557062|NCT01636778|521236192|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
144557063|NCT01636778|521236193|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
144557064|NCT01636778|521236191|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
144557065|NCT01636778|521236192|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
144557066|NCT01636778|521236193|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
144557067|NCT01636778|521236191|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
144557068|NCT01636778|521236192|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
144557069|NCT01636778|521236193|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
144557070|NCT01636778|521236191|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
144557071|NCT01636778|521236192|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
144557072|NCT01636778|521236193|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
144557073|NCT01636778|521236191|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
144557074|NCT01636778|521236192|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
144557075|NCT01636778|521236193|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
144557076|NCT01636778|521236191|FG000|Follow-up Period After Part 2|Other|0|||
144557077|NCT01636778|521236192|FG001|Follow-up Period After Part 2|Other|0|||
144557078|NCT01636778|521236193|FG002|Follow-up Period After Part 2|Other|1|||
144557079|NCT01636778|521236191|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
144557080|NCT01636778|521236192|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
144557081|NCT01636778|521236193|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
144557082|NCT01636778|521236191|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
144557083|NCT01636778|521236192|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
144557084|NCT01636778|521236193|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
144557085|NCT03530345|521236194|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
144557086|NCT03530345|521236195|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
144727804|NCT00920140|521858077|FG001|Phase 2|Lack of Efficacy|0|||
144727805|NCT00920140|521858078|FG002|Phase 2|Lack of Efficacy|29|||
144262446|NCT01317641|520161439|FG005|Overall Study|Protocol Violation|0|||
144262447|NCT01317641|520161440|FG006|Overall Study|Protocol Violation|0|||
144262448|NCT01317641|520161441|FG007|Overall Study|Protocol Violation|0|||
144557087|NCT03530345|521236194|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
144557088|NCT03530345|521236195|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
144557089|NCT03530345|521236194|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
144557090|NCT03530345|521236195|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
144557091|NCT03530345|521236194|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
144557092|NCT03530345|521236195|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
144557093|NCT04150250|521236196|FG000|Overall Study|Lost to Follow-up|0|||
144557094|NCT04150250|521236197|FG001|Overall Study|Lost to Follow-up|2|||
144557095|NCT02176356|521237917|FG000|Overall Study|Screen Failure|14|||
144557096|NCT02176356|521237917|FG000|Overall Study|Lost to Follow-up|4|||
144557097|NCT02176356|521237917|FG000|Overall Study|Personal Reasons|3|||
144557098|NCT02176356|521237917|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144557099|NCT04816708|521237920|FG000|Overall Study|Lost to Follow-up|10|||
144557100|NCT04816708|521237921|FG001|Overall Study|Lost to Follow-up|4|||
144557101|NCT01503515|521237923|FG000|Overall Study|Adverse Event|4|||
144557102|NCT01503515|521237924|FG001|Overall Study|Adverse Event|5|||
144557103|NCT01503515|521237923|FG000|Overall Study|Death|0|||
144557104|NCT01503515|521237924|FG001|Overall Study|Death|1|||
144557105|NCT01503515|521237923|FG000|Overall Study|Physician Decision|14|||
144557106|NCT01503515|521237924|FG001|Overall Study|Physician Decision|23|||
144557107|NCT01503515|521237923|FG000|Overall Study|Withdrawal by Subject|0|||
144557108|NCT01503515|521237924|FG001|Overall Study|Withdrawal by Subject|1|||
144557109|NCT01503515|521237923|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
144557110|NCT01503515|521237924|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
144557111|NCT01503515|521237923|FG000|Overall Study|Ineligible|1|||
144557112|NCT01503515|521237924|FG001|Overall Study|Ineligible|1|||
144557113|NCT04050722|521237925|FG000|Overall Study|Withdrawal by Subject|1|||
144557114|NCT04050722|521237926|FG001|Overall Study|Withdrawal by Subject|0|||
144557115|NCT01350102|521237927|FG000|Overall Study|Adverse Event|0|||
144557116|NCT01350102|521237928|FG001|Overall Study|Adverse Event|0|||
144557117|NCT01350102|521237929|FG002|Overall Study|Adverse Event|1|||
144557118|NCT01350102|521237930|FG003|Overall Study|Adverse Event|0|||
144557119|NCT03087851|521237934|FG000|Overall Study|Withdraw on medical grounds|0|||
144557120|NCT03087851|521237935|FG001|Overall Study|Withdraw on medical grounds|1|||
144557121|NCT03087851|521237936|FG002|Overall Study|Withdraw on medical grounds|2|||
144557122|NCT00377312|521237939|FG000|Overall Study|Adverse Event|1|||
144557123|NCT00377312|521237940|FG001|Overall Study|Adverse Event|1|||
144557124|NCT01572493|521237945|FG000|Overall Study|Physician Decision|1|||
144557125|NCT01572493|521237946|FG001|Overall Study|Physician Decision|0|||
144557126|NCT01572493|521237947|FG002|Overall Study|Physician Decision|0|||
144557127|NCT01572493|521237948|FG003|Overall Study|Physician Decision|0|||
144557128|NCT01572493|521237949|FG004|Overall Study|Physician Decision|0|||
144557129|NCT01572493|521237950|FG005|Overall Study|Physician Decision|0|||
144557130|NCT01572493|521237951|FG006|Overall Study|Physician Decision|0|||
144557131|NCT01572493|521237952|FG007|Overall Study|Physician Decision|0|||
144557132|NCT01572493|521237953|FG008|Overall Study|Physician Decision|0|||
144557133|NCT01572493|521237945|FG000|Overall Study|Switched to alternative treatment|0|||
144557134|NCT01572493|521237946|FG001|Overall Study|Switched to alternative treatment|1|||
144557135|NCT01572493|521237947|FG002|Overall Study|Switched to alternative treatment|2|||
144557136|NCT01572493|521237948|FG003|Overall Study|Switched to alternative treatment|1|||
144557137|NCT01572493|521237949|FG004|Overall Study|Switched to alternative treatment|2|||
144557138|NCT01572493|521237950|FG005|Overall Study|Switched to alternative treatment|0|||
144557139|NCT01572493|521237951|FG006|Overall Study|Switched to alternative treatment|2|||
144557140|NCT01572493|521237952|FG007|Overall Study|Switched to alternative treatment|0|||
144557141|NCT01572493|521237953|FG008|Overall Study|Switched to alternative treatment|2|||
144557142|NCT01572493|521237945|FG000|Overall Study|Death|0|||
144557143|NCT01572493|521237946|FG001|Overall Study|Death|0|||
144557144|NCT01572493|521237947|FG002|Overall Study|Death|0|||
144557145|NCT01572493|521237948|FG003|Overall Study|Death|1|||
144557146|NCT01572493|521237949|FG004|Overall Study|Death|0|||
144617240|NCT01100437|521458126|FG000|Titration/Stabilization|Non-compliance|0|||
144617241|NCT01100437|521458127|FG001|Titration/Stabilization|Non-compliance|0|||
144617242|NCT01100437|521458128|FG002|Titration/Stabilization|Non-compliance|1|||
144617243|NCT01100437|521458126|FG000|Titration/Stabilization|Sponsor canceled study|0|||
144617244|NCT01100437|521458127|FG001|Titration/Stabilization|Sponsor canceled study|0|||
144557147|NCT01572493|521237950|FG005|Overall Study|Death|1|||
144557148|NCT01572493|521237951|FG006|Overall Study|Death|0|||
144557149|NCT01572493|521237952|FG007|Overall Study|Death|0|||
144557150|NCT01572493|521237953|FG008|Overall Study|Death|0|||
144557151|NCT01572493|521237945|FG000|Overall Study|Adverse Event|0|||
144557152|NCT01572493|521237946|FG001|Overall Study|Adverse Event|0|||
144557153|NCT01572493|521237947|FG002|Overall Study|Adverse Event|0|||
144557154|NCT01572493|521237948|FG003|Overall Study|Adverse Event|0|||
144557155|NCT01572493|521237949|FG004|Overall Study|Adverse Event|0|||
144557156|NCT01572493|521237950|FG005|Overall Study|Adverse Event|0|||
144557157|NCT01572493|521237951|FG006|Overall Study|Adverse Event|1|||
144557158|NCT01572493|521237952|FG007|Overall Study|Adverse Event|0|||
144557159|NCT01572493|521237953|FG008|Overall Study|Adverse Event|0|||
144617245|NCT01100437|521458128|FG002|Titration/Stabilization|Sponsor canceled study|1|||
144617246|NCT01100437|521458126|FG000|Maintenance|Withdrawal by Subject|0|||
144557160|NCT03672188|521237954|FG000|Overall Study|Withdrawal by Subject|0|||
144557161|NCT03672188|521237955|FG001|Overall Study|Withdrawal by Subject|0|||
144557162|NCT03672188|521237956|FG002|Overall Study|Withdrawal by Subject|0|||
144617247|NCT01100437|521458127|FG001|Maintenance|Withdrawal by Subject|0|||
144617248|NCT01100437|521458128|FG002|Maintenance|Withdrawal by Subject|1|||
144557163|NCT03672188|521237957|FG003|Overall Study|Withdrawal by Subject|3|||
144557164|NCT03672188|521237958|FG004|Overall Study|Withdrawal by Subject|0|||
144557165|NCT03672188|521237959|FG005|Overall Study|Withdrawal by Subject|0|||
144557166|NCT03672188|521237960|FG006|Overall Study|Withdrawal by Subject|0|||
144557167|NCT03672188|521237961|FG007|Overall Study|Withdrawal by Subject|0|||
144557168|NCT03672188|521237962|FG008|Overall Study|Withdrawal by Subject|0|||
144557169|NCT03672188|521237963|FG009|Overall Study|Withdrawal by Subject|0|||
144617249|NCT01100437|521458126|FG000|Maintenance|Sponsor termination of study|0|||
144557170|NCT03672188|521237964|FG010|Overall Study|Withdrawal by Subject|0|||
144557171|NCT03672188|521237965|FG011|Overall Study|Withdrawal by Subject|0|||
144557172|NCT03672188|521237966|FG012|Overall Study|Withdrawal by Subject|0|||
144557173|NCT03672188|521237967|FG013|Overall Study|Withdrawal by Subject|0|||
144557174|NCT03672188|521237968|FG014|Overall Study|Withdrawal by Subject|0|||
144557175|NCT03672188|521237954|FG000|Overall Study|Death|0|||
144557176|NCT03672188|521237955|FG001|Overall Study|Death|0|||
144557177|NCT03672188|521237956|FG002|Overall Study|Death|0|||
144557178|NCT03672188|521237957|FG003|Overall Study|Death|0|||
144557179|NCT03672188|521237958|FG004|Overall Study|Death|0|||
144557180|NCT03672188|521237959|FG005|Overall Study|Death|0|||
144557181|NCT03672188|521237960|FG006|Overall Study|Death|0|||
144557182|NCT03672188|521237961|FG007|Overall Study|Death|0|||
144557183|NCT03672188|521237962|FG008|Overall Study|Death|0|||
144557184|NCT03672188|521237963|FG009|Overall Study|Death|0|||
144557185|NCT03672188|521237964|FG010|Overall Study|Death|0|||
144557186|NCT03672188|521237965|FG011|Overall Study|Death|0|||
144557187|NCT03672188|521237966|FG012|Overall Study|Death|1|||
144557188|NCT03672188|521237967|FG013|Overall Study|Death|0|||
144557189|NCT03672188|521237968|FG014|Overall Study|Death|0|||
144557190|NCT03672188|521237954|FG000|Overall Study|Lost to Follow-up|0|||
144557191|NCT03672188|521237955|FG001|Overall Study|Lost to Follow-up|0|||
144557192|NCT03672188|521237956|FG002|Overall Study|Lost to Follow-up|1|||
144557193|NCT03672188|521237957|FG003|Overall Study|Lost to Follow-up|0|||
144557194|NCT03672188|521237958|FG004|Overall Study|Lost to Follow-up|0|||
144557195|NCT03672188|521237959|FG005|Overall Study|Lost to Follow-up|0|||
144557196|NCT03672188|521237960|FG006|Overall Study|Lost to Follow-up|0|||
144557197|NCT03672188|521237961|FG007|Overall Study|Lost to Follow-up|0|||
144557198|NCT03672188|521237962|FG008|Overall Study|Lost to Follow-up|0|||
144557199|NCT03672188|521237963|FG009|Overall Study|Lost to Follow-up|0|||
144557200|NCT03672188|521237964|FG010|Overall Study|Lost to Follow-up|0|||
144557201|NCT03672188|521237965|FG011|Overall Study|Lost to Follow-up|0|||
144557202|NCT03672188|521237966|FG012|Overall Study|Lost to Follow-up|0|||
144557203|NCT03672188|521237967|FG013|Overall Study|Lost to Follow-up|0|||
144557204|NCT03672188|521237968|FG014|Overall Study|Lost to Follow-up|0|||
144557205|NCT00609245|521237969|FG000|Overall Study|Adverse Event|1|||
144557206|NCT01090076|521237970|FG000|Overall Study|Death|1|||
144557207|NCT01090076|521237971|FG001|Overall Study|Death|1|||
144557208|NCT01090076|521237970|FG000|Overall Study|Withdrawal by Subject|0|||
144557209|NCT01090076|521237971|FG001|Overall Study|Withdrawal by Subject|1|||
144557210|NCT01116440|521237972|FG000|Treatment|Withdrawal by Subject|2|||
144557211|NCT01116440|521237973|FG001|Treatment|Withdrawal by Subject|2|||
144557212|NCT01116440|521237972|FG000|Treatment|Lost to Follow-up|1|||
144617250|NCT01100437|521458127|FG001|Maintenance|Sponsor termination of study|0|||
144617251|NCT01100437|521458128|FG002|Maintenance|Sponsor termination of study|1|||
144557213|NCT01116440|521237973|FG001|Treatment|Lost to Follow-up|1|||
144557214|NCT01116440|521237972|FG000|Treatment|Protocol Violation|0|||
144557215|NCT01116440|521237973|FG001|Treatment|Protocol Violation|2|||
144557216|NCT01116440|521237972|FG000|Treatment|Lack of Efficacy|0|||
144557217|NCT01116440|521237973|FG001|Treatment|Lack of Efficacy|1|||
144557218|NCT01116440|521237972|FG000|Treatment|Adverse Event|0|||
144557219|NCT01116440|521237973|FG001|Treatment|Adverse Event|1|||
144617252|NCT00805480|521458137|FG000|Overall Study|Withdrawal by Subject|13|||
144617253|NCT00805480|521458138|FG001|Overall Study|Withdrawal by Subject|5|||
144617254|NCT00805480|521458139|FG002|Overall Study|Withdrawal by Subject|11|||
144617255|NCT00805480|521458140|FG003|Overall Study|Withdrawal by Subject|5|||
144617256|NCT00805480|521458137|FG000|Overall Study|Lost to Follow-up|1|||
144557220|NCT01116440|521237972|FG000|Withdrawal|Withdrawal by Subject|0|||
144557221|NCT01116440|521237973|FG001|Withdrawal|Withdrawal by Subject|1|||
144557222|NCT01116440|521237972|FG000|Withdrawal|Lost to Follow-up|0|||
144617257|NCT00805480|521458138|FG001|Overall Study|Lost to Follow-up|2|||
144617258|NCT00805480|521458139|FG002|Overall Study|Lost to Follow-up|0|||
144617259|NCT00805480|521458140|FG003|Overall Study|Lost to Follow-up|0|||
144617260|NCT00805480|521458137|FG000|Overall Study|Adverse Event|0|||
144557223|NCT01116440|521237973|FG001|Withdrawal|Lost to Follow-up|1|||
144557224|NCT01116440|521237972|FG000|Follow-up|Lost to Follow-up|0|||
144557225|NCT01116440|521237973|FG001|Follow-up|Lost to Follow-up|1|||
144557226|NCT01116440|521237972|FG000|Follow-up|Withdrawal by Subject|0|||
144557227|NCT01116440|521237973|FG001|Follow-up|Withdrawal by Subject|1|||
144557228|NCT02446912|521237980|FG000|Overall Study|Adverse Event|3|||
144557229|NCT02446912|521237981|FG001|Overall Study|Adverse Event|13|||
144557230|NCT02446912|521237982|FG002|Overall Study|Adverse Event|5|||
144557231|NCT02446912|521237980|FG000|Overall Study|Condition under investigation worsened|0|||
144557232|NCT02446912|521237981|FG001|Overall Study|Condition under investigation worsened|1|||
144557233|NCT02446912|521237982|FG002|Overall Study|Condition under investigation worsened|1|||
144557234|NCT02446912|521237980|FG000|Overall Study|Study-specific withdrawal criteria|1|||
144557235|NCT02446912|521237981|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144557236|NCT02446912|521237982|FG002|Overall Study|Study-specific withdrawal criteria|0|||
144557237|NCT02446912|521237980|FG000|Overall Study|Lack of Efficacy|1|||
144557238|NCT02446912|521237981|FG001|Overall Study|Lack of Efficacy|4|||
144557239|NCT02446912|521237982|FG002|Overall Study|Lack of Efficacy|7|||
144557240|NCT02446912|521237980|FG000|Overall Study|Lost to Follow-up|0|||
144557241|NCT02446912|521237981|FG001|Overall Study|Lost to Follow-up|0|||
144557242|NCT02446912|521237982|FG002|Overall Study|Lost to Follow-up|2|||
144557243|NCT02446912|521237980|FG000|Overall Study|Severe non-compliance to protocol|1|||
144557244|NCT02446912|521237981|FG001|Overall Study|Severe non-compliance to protocol|0|||
144557245|NCT02446912|521237982|FG002|Overall Study|Severe non-compliance to protocol|1|||
144557246|NCT02446912|521237980|FG000|Overall Study|Withdrawal by Subject|10|||
144557247|NCT02446912|521237981|FG001|Overall Study|Withdrawal by Subject|15|||
144557248|NCT02446912|521237982|FG002|Overall Study|Withdrawal by Subject|15|||
144557249|NCT02446912|521237980|FG000|Overall Study|Miscellaneous|2|||
144557250|NCT02446912|521237981|FG001|Overall Study|Miscellaneous|2|||
144557251|NCT02446912|521237982|FG002|Overall Study|Miscellaneous|4|||
144557252|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Adverse Event|3|||
144557253|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Adverse Event|0|||
144557254|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
144557255|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
144557256|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Disease Progression|23|||
144557257|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Disease Progression|22|||
144557258|NCT01379521|521237985|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
144557259|NCT01379521|521237986|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
144557260|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
144557261|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
144557262|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
144557263|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
144557264|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
144557265|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
144557266|NCT01379521|521237985|FG000|Overall Study -Treatment Period|Death|2|||
144557267|NCT01379521|521237986|FG001|Overall Study -Treatment Period|Death|1|||
144557268|NCT01379521|521237985|FG000|Post-Treatment Evaluations|Disease Progression|22|||
144557269|NCT01379521|521237986|FG001|Post-Treatment Evaluations|Disease Progression|20|||
144557270|NCT01379521|521237985|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
144557271|NCT01379521|521237986|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
144557272|NCT01379521|521237985|FG000|Post-Treatment Evaluations|Death|1|||
144557273|NCT01379521|521237986|FG001|Post-Treatment Evaluations|Death|0|||
144557274|NCT01757171|521237987|FG000|Overall Study|Adverse Event|5|||
144557275|NCT01757171|521237988|FG001|Overall Study|Adverse Event|1|||
144557276|NCT01757171|521237987|FG000|Overall Study|Disease Progression|1|||
144557277|NCT01757171|521237988|FG001|Overall Study|Disease Progression|0|||
144557278|NCT01757171|521237987|FG000|Overall Study|Hospitalization|1|||
144557279|NCT01757171|521237988|FG001|Overall Study|Hospitalization|0|||
144557280|NCT01757171|521237987|FG000|Overall Study|ECOG decline|1|||
144557281|NCT01757171|521237988|FG001|Overall Study|ECOG decline|0|||
144557282|NCT02504502|521237989|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
144557283|NCT02504502|521237990|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
144557284|NCT02504502|521237989|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
144557285|NCT02504502|521237990|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
144557286|NCT01536535|521237993|FG000|Overall Study|Withdrawal by Subject|10|||
144557287|NCT01536535|521237994|FG001|Overall Study|Withdrawal by Subject|5|||
144557288|NCT01536535|521237993|FG000|Overall Study|Lost to Follow-up|4|||
144557289|NCT01536535|521237994|FG001|Overall Study|Lost to Follow-up|6|||
144557290|NCT01536535|521237993|FG000|Overall Study|Physician Decision|1|||
144557291|NCT01536535|521237994|FG001|Overall Study|Physician Decision|1|||
144557292|NCT01536535|521237993|FG000|Overall Study|Participant moved|0|||
144557293|NCT01536535|521237994|FG001|Overall Study|Participant moved|1|||
144617261|NCT00805480|521458138|FG001|Overall Study|Adverse Event|0|||
144617262|NCT00805480|521458139|FG002|Overall Study|Adverse Event|1|||
144617263|NCT00805480|521458140|FG003|Overall Study|Adverse Event|0|||
144617264|NCT03040999|521459668|FG000|Overall Study|Lost to Follow-up|2|||
144617265|NCT03040999|521459669|FG001|Overall Study|Lost to Follow-up|2|||
144617266|NCT03040999|521459668|FG000|Overall Study|Withdrawal by Subject|12|||
144557294|NCT00428441|521237998|FG000|Overall Study|Lost to Follow-up|1|||
144557295|NCT01485991|521237999|FG000|Overall Study|Adverse Event|0|||
144557296|NCT01485991|521238000|FG001|Overall Study|Adverse Event|4|||
144557297|NCT01485991|521237999|FG000|Overall Study|Lost to Follow-up|13|||
144557298|NCT01485991|521238000|FG001|Overall Study|Lost to Follow-up|10|||
144557299|NCT01485991|521237999|FG000|Overall Study|Withdrawal by Subject|13|||
144557300|NCT01485991|521238000|FG001|Overall Study|Withdrawal by Subject|20|||
144557301|NCT01485991|521237999|FG000|Overall Study|randomized but not treated|6|||
144557302|NCT01485991|521238000|FG001|Overall Study|randomized but not treated|2|||
144557303|NCT02538471|521238001|FG000|Overall Study|Progression of disease|2|||
144557304|NCT01475370|521238002|FG000|Overall Study|Exacerbation of primary disease|2|||
144557305|NCT01475370|521238003|FG001|Overall Study|Exacerbation of primary disease|2|||
144557306|NCT01475370|521238004|FG002|Overall Study|Exacerbation of primary disease|2|||
144557307|NCT01475370|521238002|FG000|Overall Study|Study drug administration difficult|0|||
144557308|NCT01475370|521238003|FG001|Overall Study|Study drug administration difficult|1|||
144557309|NCT01475370|521238004|FG002|Overall Study|Study drug administration difficult|1|||
144557310|NCT01475370|521238002|FG000|Overall Study|Other than specified|1|||
144557311|NCT01475370|521238003|FG001|Overall Study|Other than specified|0|||
144557312|NCT01475370|521238004|FG002|Overall Study|Other than specified|0|||
144557313|NCT00125853|521238005|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
144557314|NCT00125853|521238006|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
144557315|NCT02522299|521238007|FG000|Overall Study|Adverse Event|2|||
144557316|NCT02522299|521238008|FG001|Overall Study|Adverse Event|0|||
144557317|NCT02522299|521238007|FG000|Overall Study|Physician Decision|0|||
144557318|NCT02522299|521238008|FG001|Overall Study|Physician Decision|1|||
144557319|NCT02522299|521238007|FG000|Overall Study|Withdrawal by Subject|2|||
144557320|NCT02522299|521238008|FG001|Overall Study|Withdrawal by Subject|0|||
144557321|NCT04908800|521238009|FG000|Overall Study|Adverse Event|0|||
144557322|NCT04908800|521238010|FG001|Overall Study|Adverse Event|0|||
144557323|NCT04908800|521238011|FG002|Overall Study|Adverse Event|0|||
144557324|NCT04908800|521238012|FG003|Overall Study|Adverse Event|0|||
144557325|NCT04908800|521238013|FG004|Overall Study|Adverse Event|0|||
144557326|NCT04908800|521238014|FG005|Overall Study|Adverse Event|0|||
144557327|NCT04908800|521238015|FG006|Overall Study|Adverse Event|0|||
144557328|NCT04908800|521238016|FG007|Overall Study|Adverse Event|0|||
144557329|NCT04908800|521238017|FG008|Overall Study|Adverse Event|0|||
144557330|NCT04908800|521238018|FG009|Overall Study|Adverse Event|0|||
144557331|NCT04908800|521238019|FG010|Overall Study|Adverse Event|1|||
144557332|NCT04908800|521238020|FG011|Overall Study|Adverse Event|0|||
144557333|NCT04908800|521238021|FG012|Overall Study|Adverse Event|0|||
144557334|NCT00157209|521238022|FG000|Overall Study|Ongoing at data cut-off|10|||
144557335|NCT00157209|521238023|FG001|Overall Study|Ongoing at data cut-off|0|||
144557336|NCT04474691|521238024|FG000|Overall Study|Withdrawal by Subject|9|||
144557337|NCT01323309|521238025|FG000|Overall Study|Death|9|||
144557338|NCT01323309|521238026|FG001|Overall Study|Death|15|||
144557339|NCT01323309|521238027|FG002|Overall Study|Death|5|||
144557340|NCT01323309|521238025|FG000|Overall Study|Lost to Follow-up|11|||
144557341|NCT01323309|521238026|FG001|Overall Study|Lost to Follow-up|14|||
144557342|NCT01323309|521238027|FG002|Overall Study|Lost to Follow-up|24|||
144557343|NCT01323309|521238025|FG000|Overall Study|Withdrawal by Subject|14|||
144557344|NCT01323309|521238026|FG001|Overall Study|Withdrawal by Subject|14|||
144557345|NCT01323309|521238027|FG002|Overall Study|Withdrawal by Subject|18|||
144557346|NCT01323309|521238025|FG000|Overall Study|Disease progression|5|||
144557347|NCT01323309|521238026|FG001|Overall Study|Disease progression|11|||
144557348|NCT01323309|521238027|FG002|Overall Study|Disease progression|4|||
144557349|NCT01348763|521238029|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
144557350|NCT01348763|521238029|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
144557351|NCT00449033|521238045|FG000|Treatment Period|Adverse Event|117|||
144557352|NCT00449033|521238046|FG001|Treatment Period|Adverse Event|83|||
144557353|NCT00449033|521238045|FG000|Treatment Period|Death|21|||
144557354|NCT00449033|521238046|FG001|Treatment Period|Death|12|||
144557355|NCT00449033|521238045|FG000|Treatment Period|Lost to Follow-up|0|||
144557356|NCT00449033|521238046|FG001|Treatment Period|Lost to Follow-up|2|||
144557357|NCT00449033|521238045|FG000|Treatment Period|Physician Decision|4|||
144557358|NCT00449033|521238046|FG001|Treatment Period|Physician Decision|5|||
144557359|NCT00449033|521238045|FG000|Treatment Period|Protocol Violation|8|||
144557360|NCT00449033|521238046|FG001|Treatment Period|Protocol Violation|7|||
144557361|NCT00449033|521238045|FG000|Treatment Period|Disease Progression|231|||
144557362|NCT00449033|521238046|FG001|Treatment Period|Disease Progression|288|||
144557363|NCT00449033|521238045|FG000|Treatment Period|Consent Withdrawn|36|||
144557364|NCT00449033|521238046|FG001|Treatment Period|Consent Withdrawn|20|||
144557365|NCT00449033|521238045|FG000|Treatment Period|Amended Protocol Criteria|22|||
144557366|NCT00449033|521238046|FG001|Treatment Period|Amended Protocol Criteria|18|||
144557367|NCT00449033|521238045|FG000|Treatment Period|Non-compliance|7|||
144557368|NCT00449033|521238046|FG001|Treatment Period|Non-compliance|8|||
144557369|NCT00449033|521238045|FG000|Treatment Period|Second Malignancy|0|||
144617267|NCT03040999|521459669|FG001|Overall Study|Withdrawal by Subject|13|||
144617268|NCT03040999|521459668|FG000|Overall Study|Death|155|||
144617269|NCT03040999|521459669|FG001|Overall Study|Death|171|||
144557370|NCT00449033|521238046|FG001|Treatment Period|Second Malignancy|1|||
144557371|NCT00449033|521238045|FG000|Treatment Period|Reason Missing|0|||
144557372|NCT00449033|521238046|FG001|Treatment Period|Reason Missing|4|||
144557373|NCT00449033|521238045|FG000|Treatment Period|Treatment Ongoing|6|||
144557374|NCT00449033|521238046|FG001|Treatment Period|Treatment Ongoing|4|||
144557375|NCT00449033|521238045|FG000|Follow-up Period|Death|299|||
144557376|NCT00449033|521238046|FG001|Follow-up Period|Death|311|||
144557377|NCT00449033|521238045|FG000|Follow-up Period|Lost to Follow-up|6|||
144617270|NCT03040999|521459668|FG000|Overall Study|Physician Decision|0|||
144557378|NCT00449033|521238046|FG001|Follow-up Period|Lost to Follow-up|10|||
144557379|NCT00449033|521238045|FG000|Follow-up Period|Reason Missing|120|||
144557380|NCT00449033|521238046|FG001|Follow-up Period|Reason Missing|113|||
144557381|NCT01190228|521238050|FG000|Overall Study|Protocol Violation|4|||
144557382|NCT01190228|521238051|FG001|Overall Study|Protocol Violation|0|||
144557383|NCT01190228|521238052|FG002|Overall Study|Protocol Violation|0|||
144557384|NCT01190228|521238050|FG000|Overall Study|Withdrawal by Subject|1|||
144557385|NCT01190228|521238051|FG001|Overall Study|Withdrawal by Subject|0|||
144557386|NCT01190228|521238052|FG002|Overall Study|Withdrawal by Subject|0|||
144617271|NCT03040999|521459669|FG001|Overall Study|Physician Decision|3|||
144557387|NCT03023878|521238053|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
144557388|NCT03023878|521238053|FG000|Pre-Study Run-In Period|Death|1|||
144557389|NCT03023878|521238053|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
144557390|NCT03023878|521238053|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
144557391|NCT03023878|521238053|FG000|Treatment Period|Disease Progression|1|||
144557392|NCT03023878|521238053|FG000|Treatment Period|Withdrawal by Subject|1|||
144557393|NCT03023878|521238053|FG000|Treatment Period|Adverse Event|1|||
144557394|NCT03023878|521238053|FG000|Long Term Follow-Up Period|Death|2|||
144557395|NCT00498797|521238054|FG000|Overall Study|Withdrawal by Subject|4|||
144557396|NCT00498797|521238055|FG001|Overall Study|Withdrawal by Subject|2|||
144557397|NCT00498797|521238054|FG000|Overall Study|Adverse Event|12|||
144557398|NCT00498797|521238055|FG001|Overall Study|Adverse Event|5|||
144557399|NCT00498797|521238054|FG000|Overall Study|Condition under investigation worsened|19|||
144557400|NCT00498797|521238055|FG001|Overall Study|Condition under investigation worsened|21|||
144557401|NCT00498797|521238054|FG000|Overall Study|Other|3|||
144557402|NCT00498797|521238055|FG001|Overall Study|Other|1|||
144557403|NCT00985621|521238058|FG000|Overall Study|Adverse Event|2|||
144557404|NCT00985621|521238059|FG001|Overall Study|Adverse Event|3|||
144557405|NCT00985621|521238060|FG002|Overall Study|Adverse Event|4|||
144557406|NCT00985621|521238061|FG003|Overall Study|Adverse Event|16|||
144557407|NCT00985621|521238058|FG000|Overall Study|Lack of Efficacy|10|||
144557408|NCT00985621|521238059|FG001|Overall Study|Lack of Efficacy|6|||
144557409|NCT00985621|521238060|FG002|Overall Study|Lack of Efficacy|5|||
144557410|NCT00985621|521238061|FG003|Overall Study|Lack of Efficacy|12|||
144557411|NCT00985621|521238058|FG000|Overall Study|Lost to Follow-up|2|||
144557412|NCT00985621|521238059|FG001|Overall Study|Lost to Follow-up|3|||
144557413|NCT00985621|521238060|FG002|Overall Study|Lost to Follow-up|4|||
144557414|NCT00985621|521238061|FG003|Overall Study|Lost to Follow-up|4|||
144557415|NCT00985621|521238058|FG000|Overall Study|Study Terminated by Sponsor|89|||
144557416|NCT00985621|521238059|FG001|Overall Study|Study Terminated by Sponsor|108|||
144557417|NCT00985621|521238060|FG002|Overall Study|Study Terminated by Sponsor|99|||
144557418|NCT00985621|521238061|FG003|Overall Study|Study Terminated by Sponsor|92|||
144557419|NCT00985621|521238058|FG000|Overall Study|Protocol Violation|1|||
144557420|NCT00985621|521238059|FG001|Overall Study|Protocol Violation|1|||
144557421|NCT00985621|521238060|FG002|Overall Study|Protocol Violation|1|||
144557422|NCT00985621|521238061|FG003|Overall Study|Protocol Violation|0|||
144557423|NCT00985621|521238058|FG000|Overall Study|Withdrawal by Subject|8|||
144557424|NCT00985621|521238059|FG001|Overall Study|Withdrawal by Subject|10|||
144557425|NCT00985621|521238060|FG002|Overall Study|Withdrawal by Subject|8|||
144557426|NCT00985621|521238061|FG003|Overall Study|Withdrawal by Subject|12|||
144557427|NCT00985621|521238058|FG000|Overall Study|Other|1|||
144557428|NCT00985621|521238059|FG001|Overall Study|Other|0|||
144557429|NCT00985621|521238060|FG002|Overall Study|Other|0|||
144557430|NCT00985621|521238061|FG003|Overall Study|Other|0|||
144557431|NCT00985621|521238058|FG000|Overall Study|Randomized but not Treated|1|||
144557432|NCT00985621|521238059|FG001|Overall Study|Randomized but not Treated|0|||
144557433|NCT00985621|521238060|FG002|Overall Study|Randomized but not Treated|2|||
144557434|NCT00985621|521238061|FG003|Overall Study|Randomized but not Treated|1|||
144557435|NCT03953079|521238062|FG000|Core Study|Withdrawal by Subject|1|||
144557436|NCT03953079|521238063|FG001|Core Study|Withdrawal by Subject|2|||
144557437|NCT03953079|521238064|FG002|Core Study|Withdrawal by Subject|1|||
144617272|NCT05032157|521459670|FG000|Overall Study|Adverse Event|12|||
144557438|NCT03953079|521238062|FG000|Core Study|COVID-19|0|||
144557439|NCT03953079|521238063|FG001|Core Study|COVID-19|1|||
144557440|NCT03953079|521238064|FG002|Core Study|COVID-19|0|||
144557441|NCT03953079|521238062|FG000|Core Study|Difficulties leaving the house|0|||
144557442|NCT03953079|521238063|FG001|Core Study|Difficulties leaving the house|1|||
144557443|NCT03953079|521238064|FG002|Core Study|Difficulties leaving the house|0|||
144557444|NCT03953079|521238062|FG000|Extension Study|Withdrawal by Subject|1|||
144557445|NCT03953079|521238063|FG001|Extension Study|Withdrawal by Subject|0|||
144557446|NCT03953079|521238064|FG002|Extension Study|Withdrawal by Subject|0|||
144617273|NCT05032157|521459671|FG001|Overall Study|Adverse Event|7|||
144557447|NCT03953079|521238062|FG000|Extension Study|Received Rescue Treatment|5|||
144557448|NCT03953079|521238063|FG001|Extension Study|Received Rescue Treatment|6|||
144557449|NCT03953079|521238064|FG002|Extension Study|Received Rescue Treatment|5|||
144557450|NCT04743999|521238068|FG000|3-month Questionnaire|Death|1|||
144557451|NCT04743999|521238068|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
144557452|NCT04743999|521238068|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
144557453|NCT04743999|521238068|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
144617274|NCT05032157|521459670|FG000|Overall Study|Pregnancy|0|||
144557454|NCT01721759|521238069|FG000|Treatment Period|Disease Progression|85|||
144557455|NCT01721759|521238069|FG000|Treatment Period|Study drug toxicity|14|||
144557456|NCT01721759|521238069|FG000|Treatment Period|Death|1|||
144557457|NCT01721759|521238069|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
144557458|NCT01721759|521238069|FG000|Treatment Period|Participant request to withdraw|3|||
144557459|NCT01721759|521238069|FG000|Treatment Period|Other Reasons|3|||
144557460|NCT01721759|521238069|FG000|End of Study Period|Participant Withdrew Consent|5|||
144557461|NCT01721759|521238069|FG000|End of Study Period|Death|101|||
144557462|NCT01721759|521238069|FG000|End of Study Period|Lost to Follow-up|1|||
144557463|NCT01721759|521238069|FG000|End of Study Period|Other Reasons|10|||
144557464|NCT02577315|521238073|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144557465|NCT02577315|521238074|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
144557466|NCT02442622|521238083|FG000|Overall Study|Withdrawal by Subject|3|||
144557467|NCT02442622|521238084|FG001|Overall Study|Withdrawal by Subject|1|||
144557468|NCT00383500|521238085|FG000|Overall Study|Withdrawal by Subject|8|||
144557469|NCT00383500|521238086|FG001|Overall Study|Withdrawal by Subject|3|||
144557470|NCT00383500|521238087|FG002|Overall Study|Withdrawal by Subject|0|||
144557471|NCT00383500|521238085|FG000|Overall Study|Lost to Follow-up|0|||
144557472|NCT00383500|521238086|FG001|Overall Study|Lost to Follow-up|0|||
144557473|NCT00383500|521238087|FG002|Overall Study|Lost to Follow-up|2|||
144557474|NCT00088452|521239682|FG000|Overall Study|Did not receive intervention|1|||
144557475|NCT00088452|521239683|FG001|Overall Study|Did not receive intervention|0|||
144557476|NCT00088452|521239684|FG002|Overall Study|Did not receive intervention|1|||
144557477|NCT04044352|521239690|FG000|Overall Study|Lost to Follow-up|9|||
144557478|NCT04044352|521239690|FG000|Overall Study|Withdrawal by Subject|2|||
144557479|NCT01904019|521239692|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
144557480|NCT01904019|521239692|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
144557481|NCT01904019|521239692|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
144557482|NCT01904019|521239692|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
144557483|NCT01904019|521239692|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
144557484|NCT01904019|521239692|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
144557485|NCT02775214|521239693|FG000|Overall Study|Withdrawal by Subject|2|||
144557486|NCT02775214|521239694|FG001|Overall Study|Withdrawal by Subject|0|||
144557487|NCT00762723|521239695|FG000|Overall Study|Study Terminated slow enrollement|5|||
144557488|NCT00762723|521239696|FG001|Overall Study|Study Terminated slow enrollement|5|||
144557489|NCT00762723|521239697|FG002|Overall Study|Study Terminated slow enrollement|3|||
144557490|NCT02402465|521239703|FG000|Overall Study|Withdrawal by Subject|0|||
144557491|NCT02402465|521239704|FG001|Overall Study|Withdrawal by Subject|0|||
144557492|NCT02402465|521239705|FG002|Overall Study|Withdrawal by Subject|0|||
144557493|NCT02402465|521239706|FG003|Overall Study|Withdrawal by Subject|0|||
144557494|NCT02402465|521239707|FG004|Overall Study|Withdrawal by Subject|0|||
144557495|NCT02402465|521239708|FG005|Overall Study|Withdrawal by Subject|1|||
144557496|NCT02402465|521239703|FG000|Overall Study|Lost to Follow-up|0|||
144557497|NCT02402465|521239704|FG001|Overall Study|Lost to Follow-up|1|||
144557498|NCT02402465|521239705|FG002|Overall Study|Lost to Follow-up|0|||
144557499|NCT02402465|521239706|FG003|Overall Study|Lost to Follow-up|0|||
144557500|NCT02402465|521239707|FG004|Overall Study|Lost to Follow-up|1|||
144557501|NCT02402465|521239708|FG005|Overall Study|Lost to Follow-up|0|||
144617275|NCT05032157|521459671|FG001|Overall Study|Pregnancy|2|||
144617276|NCT05032157|521459670|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144617277|NCT05032157|521459671|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
144617278|NCT05032157|521459670|FG000|Overall Study|Protocol Deviation|8|||
144617279|NCT05032157|521459671|FG001|Overall Study|Protocol Deviation|4|||
144617280|NCT05032157|521459670|FG000|Overall Study|Lost to Follow-up|1|||
144617281|NCT05032157|521459671|FG001|Overall Study|Lost to Follow-up|3|||
144617282|NCT05032157|521459670|FG000|Overall Study|Physician Decision|7|||
144617283|NCT05032157|521459671|FG001|Overall Study|Physician Decision|2|||
144617284|NCT05032157|521459670|FG000|Overall Study|Patient Decision|38|||
144617285|NCT05032157|521459671|FG001|Overall Study|Patient Decision|19|||
144617286|NCT03657043|521459672|FG000|Overall Study|Withdrawal by Subject|1|||
144617287|NCT03657043|521459673|FG001|Overall Study|Withdrawal by Subject|1|||
144617288|NCT03657043|521459674|FG002|Overall Study|Withdrawal by Subject|0|||
144617289|NCT03657043|521459675|FG003|Overall Study|Withdrawal by Subject|0|||
144617290|NCT03657043|521459676|FG004|Overall Study|Withdrawal by Subject|4|||
144617291|NCT03657043|521459672|FG000|Overall Study|Study closure by Sponsor|0|||
144617292|NCT03657043|521459673|FG001|Overall Study|Study closure by Sponsor|2|||
144617293|NCT03657043|521459674|FG002|Overall Study|Study closure by Sponsor|0|||
144617294|NCT03657043|521459675|FG003|Overall Study|Study closure by Sponsor|0|||
144617295|NCT03657043|521459676|FG004|Overall Study|Study closure by Sponsor|17|||
144617296|NCT03657043|521459672|FG000|Overall Study|Lost to Follow-up|0|||
144617297|NCT03657043|521459673|FG001|Overall Study|Lost to Follow-up|0|||
144617298|NCT03657043|521459674|FG002|Overall Study|Lost to Follow-up|0|||
144617299|NCT03657043|521459675|FG003|Overall Study|Lost to Follow-up|0|||
144617300|NCT03657043|521459676|FG004|Overall Study|Lost to Follow-up|4|||
144617301|NCT03657043|521459672|FG000|Overall Study|Death|6|||
144617302|NCT03657043|521459673|FG001|Overall Study|Death|5|||
144617303|NCT03657043|521459674|FG002|Overall Study|Death|0|||
144617304|NCT03657043|521459675|FG003|Overall Study|Death|0|||
144557502|NCT01284634|521239709|FG000|Overall Study|Adverse Event|1|||
144617305|NCT03657043|521459676|FG004|Overall Study|Death|53|||
144557503|NCT01284634|521239710|FG001|Overall Study|Adverse Event|0|||
144557504|NCT01284634|521239711|FG002|Overall Study|Adverse Event|2|||
144557505|NCT01284634|521239712|FG003|Overall Study|Adverse Event|1|||
144617306|NCT03657043|521459672|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
144557506|NCT02236598|521239713|FG000|Overall Study|Adverse Event|0|||
144557507|NCT02236598|521239714|FG001|Overall Study|Adverse Event|1|||
144557508|NCT02236598|521239713|FG000|Overall Study|Withdrawal by Subject|0|||
144557509|NCT02236598|521239714|FG001|Overall Study|Withdrawal by Subject|1|||
144557510|NCT00730925|521239720|FG000|Overall Study|Progressive Disease|21|||
144557511|NCT00730925|521239720|FG000|Overall Study|Dose reducing Event|2|||
144557512|NCT00730925|521239720|FG000|Overall Study|Other Averse Event|7|||
144557513|NCT00730925|521239720|FG000|Overall Study|Protocol Violation|1|||
144557514|NCT00730925|521239720|FG000|Overall Study|Withdrawal by Subject|1|||
144557515|NCT00730925|521239720|FG000|Overall Study|Switch to combination therapy|8|||
144557516|NCT00730925|521239720|FG000|Overall Study|Other|1|||
144557517|NCT03334747|521239727|FG000|Treatment Phase|Technical problems|0|||
144557518|NCT03334747|521239728|FG001|Treatment Phase|Technical problems|0|||
144557519|NCT03334747|521239729|FG002|Treatment Phase|Technical problems|0|||
144557520|NCT03334747|521239730|FG003|Treatment Phase|Technical problems|0|||
144557521|NCT03334747|521239731|FG004|Treatment Phase|Technical problems|1|||
144557522|NCT03334747|521239732|FG005|Treatment Phase|Technical problems|0|||
144557523|NCT03334747|521239733|FG006|Treatment Phase|Technical problems|0|||
144557524|NCT03334747|521239734|FG007|Treatment Phase|Technical problems|0|||
144557525|NCT03334747|521239735|FG008|Treatment Phase|Technical problems|0|||
144557526|NCT03334747|521239727|FG000|Treatment Phase|Subject/guardian decision|1|||
144557527|NCT03334747|521239728|FG001|Treatment Phase|Subject/guardian decision|0|||
144557528|NCT03334747|521239729|FG002|Treatment Phase|Subject/guardian decision|0|||
144557529|NCT03334747|521239730|FG003|Treatment Phase|Subject/guardian decision|0|||
144557530|NCT03334747|521239731|FG004|Treatment Phase|Subject/guardian decision|0|||
144557531|NCT03334747|521239732|FG005|Treatment Phase|Subject/guardian decision|1|||
144557532|NCT03334747|521239733|FG006|Treatment Phase|Subject/guardian decision|0|||
144557533|NCT03334747|521239734|FG007|Treatment Phase|Subject/guardian decision|0|||
144557534|NCT03334747|521239735|FG008|Treatment Phase|Subject/guardian decision|0|||
144557535|NCT03334747|521239727|FG000|Follow-Up Phase|Subject/guardian decision|0|||
144557536|NCT03334747|521239728|FG001|Follow-Up Phase|Subject/guardian decision|0|||
144557537|NCT03334747|521239729|FG002|Follow-Up Phase|Subject/guardian decision|0|||
144557538|NCT03334747|521239730|FG003|Follow-Up Phase|Subject/guardian decision|0|||
144557539|NCT03334747|521239731|FG004|Follow-Up Phase|Subject/guardian decision|0|||
144557540|NCT03334747|521239732|FG005|Follow-Up Phase|Subject/guardian decision|0|||
144557541|NCT03334747|521239733|FG006|Follow-Up Phase|Subject/guardian decision|1|||
144557542|NCT03334747|521239734|FG007|Follow-Up Phase|Subject/guardian decision|0|||
144557543|NCT03334747|521239735|FG008|Follow-Up Phase|Subject/guardian decision|1|||
144557544|NCT03303521|521239736|FG000|Overall Study|Withdrawal by Subject|2|||
144557545|NCT03303521|521239737|FG001|Overall Study|Withdrawal by Subject|0|||
144557546|NCT03303521|521239736|FG000|Overall Study|Death|1|||
144557547|NCT03303521|521239737|FG001|Overall Study|Death|0|||
144557548|NCT03303521|521239736|FG000|Overall Study|Kidney transplantation|0|||
144557549|NCT03303521|521239737|FG001|Overall Study|Kidney transplantation|1|||
144557550|NCT03303521|521239736|FG000|Overall Study|Investigational product discontinuation|0|||
144557551|NCT03303521|521239737|FG001|Overall Study|Investigational product discontinuation|1|||
144557552|NCT03303521|521239736|FG000|Overall Study|Transferred to non-study dialysis center|1|||
144557553|NCT03303521|521239737|FG001|Overall Study|Transferred to non-study dialysis center|0|||
144557554|NCT03303521|521239736|FG000|Overall Study|Non-comliance to study protocol|0|||
144557555|NCT03303521|521239737|FG001|Overall Study|Non-comliance to study protocol|1|||
144557556|NCT03303521|521239736|FG000|Overall Study|Adverse Event|1|||
144557557|NCT03303521|521239737|FG001|Overall Study|Adverse Event|0|||
144557558|NCT00191984|521239738|FG000|Overall Study|Disease Progression|21|||
144557559|NCT00191984|521239738|FG000|Overall Study|Adverse Event|4|||
144557560|NCT00191984|521239738|FG000|Overall Study|Death|2|||
144557561|NCT00191984|521239738|FG000|Overall Study|Entry Criteria Exclusion|1|||
144557562|NCT00191984|521239738|FG000|Overall Study|Withdrawal by Subject|7|||
144557563|NCT00191984|521239738|FG000|Overall Study|Physician Decision|4|||
144557564|NCT01654289|521239739|FG000|Overall Study|Withdrawal by Subject|10|||
144557565|NCT01654289|521239740|FG001|Overall Study|Withdrawal by Subject|8|||
144557566|NCT01654289|521239741|FG002|Overall Study|Withdrawal by Subject|5|||
144557567|NCT01654289|521239739|FG000|Overall Study|Withdrew from intervention only|17|||
144557568|NCT01654289|521239740|FG001|Overall Study|Withdrew from intervention only|20|||
144557569|NCT01654289|521239741|FG002|Overall Study|Withdrew from intervention only|0|||
144557570|NCT01732627|521239742|FG000|Overall Study|Withdrawal by Subject|1|||
144557571|NCT01732627|521239743|FG001|Overall Study|Withdrawal by Subject|0|||
144557572|NCT02137239|521239744|FG000|Overall Study|Discontinued Study Treatment|0|||
144557573|NCT02137239|521239745|FG001|Overall Study|Discontinued Study Treatment|3|||
144557574|NCT02137239|521239744|FG000|Overall Study|Withdrew Consent|1|||
144557575|NCT02137239|521239745|FG001|Overall Study|Withdrew Consent|1|||
144727806|NCT00920140|521858079|FG003|Phase 2|Lack of Efficacy|14|||
144557576|NCT02137239|521239744|FG000|Overall Study|Adverse Event|2|||
144557577|NCT02137239|521239745|FG001|Overall Study|Adverse Event|2|||
144557578|NCT00005908|521239748|FG000|Overall Study|Withdrawal by Subject|1|||
144557579|NCT00005908|521239749|FG001|Overall Study|Withdrawal by Subject|0|||
144557580|NCT00938041|521239754|FG000|Overall Study|Lost to Follow-up|6|||
144557581|NCT00938041|521239754|FG000|Overall Study|Received Alternative Therapy|1|||
144557582|NCT00938041|521239754|FG000|Overall Study|Progressive Disease|5|||
144557583|NCT00938041|521239754|FG000|Overall Study|Death|12|||
144557584|NCT00938041|521239754|FG000|Overall Study|Adrenal Insufficiency|3|||
144557585|NCT03042559|521239758|FG000|Overall Study|drop out|1|||
144557586|NCT03042559|521239759|FG001|Overall Study|drop out|1|||
144557587|NCT00404547|521239761|FG000|Overall Study|Adverse Event|39|||
144557588|NCT00404547|521239762|FG001|Overall Study|Adverse Event|6|||
144557589|NCT00404547|521239761|FG000|Overall Study|Withdrawal by Subject|19|||
144557590|NCT00404547|521239762|FG001|Overall Study|Withdrawal by Subject|2|||
144557591|NCT00404547|521239761|FG000|Overall Study|Protocol Violation|0|||
144557592|NCT00404547|521239762|FG001|Overall Study|Protocol Violation|1|||
144557593|NCT00404547|521239761|FG000|Overall Study|Lost to Follow-up|20|||
144557594|NCT00404547|521239762|FG001|Overall Study|Lost to Follow-up|9|||
144557595|NCT00404547|521239761|FG000|Overall Study|Lack of compliance|5|||
144557596|NCT00404547|521239762|FG001|Overall Study|Lack of compliance|1|||
144557597|NCT00404547|521239761|FG000|Overall Study|Other|4|||
144557598|NCT00404547|521239762|FG001|Overall Study|Other|0|||
144557599|NCT00404547|521239761|FG000|Overall Study|Reason not stated|3|||
144557600|NCT00404547|521239762|FG001|Overall Study|Reason not stated|6|||
144557601|NCT02350127|521239768|FG000|4-Month Assessment|Withdrawal by Subject|10|||
144557602|NCT02350127|521239769|FG001|4-Month Assessment|Withdrawal by Subject|9|||
144557603|NCT02350127|521239768|FG000|4-Month Assessment|Death|1|||
144557604|NCT02350127|521239769|FG001|4-Month Assessment|Death|0|||
144557605|NCT02350127|521239768|FG000|8-Month Assessment|Death|1|||
144557606|NCT02350127|521239769|FG001|8-Month Assessment|Death|1|||
144557607|NCT02350127|521239768|FG000|8-Month Assessment|Withdrawal by Subject|5|||
144557608|NCT02350127|521239769|FG001|8-Month Assessment|Withdrawal by Subject|8|||
144557609|NCT03575572|521239772|FG000|Overall Study|Withdrawal by Subject|2|||
144557610|NCT03575572|521239772|FG000|Overall Study|Physician Decision|2|||
144557611|NCT03647709|521239779|FG000|Overall Study|Lost to Follow-up|5|||
144557612|NCT03647709|521239779|FG000|Overall Study|Physician Decision|6|||
144557613|NCT03647709|521239779|FG000|Overall Study|Withdrawal by Subject|3|||
144557614|NCT04393779|521239780|FG000|Overall Study|Death|1|||
144557615|NCT04393779|521239780|FG000|Overall Study|Device reintervention or explant|4|||
144557616|NCT03802513|521239781|FG000|Overall Study|Lost to Follow-up|1|||
144557617|NCT01395914|521239787|FG000|Overall Study|Unrelated to study drug AE|6|||
144557618|NCT01395914|521239788|FG001|Overall Study|Unrelated to study drug AE|1|||
144557619|NCT01395914|521239787|FG000|Overall Study|Death|23|||
144557620|NCT01395914|521239788|FG001|Overall Study|Death|17|||
144557621|NCT01395914|521239787|FG000|Overall Study|Other|9|||
144557622|NCT01395914|521239788|FG001|Overall Study|Other|3|||
144557623|NCT01395914|521239787|FG000|Overall Study|Withdrawal by patient|27|||
144557624|NCT01395914|521239788|FG001|Overall Study|Withdrawal by patient|14|||
144557625|NCT01395914|521239787|FG000|Overall Study|Study drug-related AE|1|||
144557626|NCT01395914|521239788|FG001|Overall Study|Study drug-related AE|0|||
144557627|NCT01395914|521239787|FG000|Overall Study|Lost to Follow-up|6|||
144557628|NCT01395914|521239788|FG001|Overall Study|Lost to Follow-up|2|||
144557629|NCT02268526|521239790|FG000|Overall Study|Adverse Event|0|||
144557630|NCT02268526|521239791|FG001|Overall Study|Adverse Event|2|||
144557631|NCT02268526|521239792|FG002|Overall Study|Adverse Event|1|||
144557632|NCT02268526|521239790|FG000|Overall Study|Death|1|||
144557633|NCT02268526|521239791|FG001|Overall Study|Death|11|||
144557634|NCT02268526|521239792|FG002|Overall Study|Death|0|||
144557635|NCT02268526|521239790|FG000|Overall Study|protocol deviation|0|||
144557636|NCT02268526|521239791|FG001|Overall Study|protocol deviation|1|||
144557637|NCT02268526|521239792|FG002|Overall Study|protocol deviation|0|||
144557638|NCT02268526|521239790|FG000|Overall Study|Physician Decision|0|||
144557639|NCT02268526|521239791|FG001|Overall Study|Physician Decision|0|||
144557640|NCT02268526|521239792|FG002|Overall Study|Physician Decision|1|||
144557641|NCT02268526|521239790|FG000|Overall Study|Subject/guardian decision|0|||
144557642|NCT02268526|521239791|FG001|Overall Study|Subject/guardian decision|7|||
144557643|NCT02268526|521239792|FG002|Overall Study|Subject/guardian decision|3|||
144557644|NCT00832650|521239795|FG000|Overall Study|Randomized but not treated|0|||
144557645|NCT00832650|521239796|FG001|Overall Study|Randomized but not treated|0|||
144557646|NCT00832650|521239797|FG002|Overall Study|Randomized but not treated|1|||
144557647|NCT03219216|521239798|FG000|Overall Study|Lost to Follow-up|0|||
144557648|NCT03219216|521239799|FG001|Overall Study|Lost to Follow-up|1|||
144557649|NCT02332824|521239800|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
144557650|NCT02332824|521239801|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
144557651|NCT02332824|521239802|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
144557652|NCT02332824|521239803|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
144557653|NCT02332824|521239804|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
144557654|NCT02332824|521239805|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
144557655|NCT02332824|521239800|FG000|Overall Study|Voluntary Withdrawal|1|||
144557656|NCT02332824|521239801|FG001|Overall Study|Voluntary Withdrawal|0|||
144557657|NCT02332824|521239802|FG002|Overall Study|Voluntary Withdrawal|0|||
144557658|NCT02332824|521239803|FG003|Overall Study|Voluntary Withdrawal|0|||
144557659|NCT02332824|521239804|FG004|Overall Study|Voluntary Withdrawal|0|||
144557660|NCT02332824|521239805|FG005|Overall Study|Voluntary Withdrawal|0|||
144557661|NCT02332824|521239800|FG000|Overall Study|Inconvenient schedule|1|||
144557662|NCT02332824|521239801|FG001|Overall Study|Inconvenient schedule|1|||
144557663|NCT02332824|521239802|FG002|Overall Study|Inconvenient schedule|0|||
144557664|NCT02332824|521239803|FG003|Overall Study|Inconvenient schedule|0|||
144557665|NCT02332824|521239804|FG004|Overall Study|Inconvenient schedule|0|||
144557666|NCT02332824|521239805|FG005|Overall Study|Inconvenient schedule|0|||
144557667|NCT02332824|521239800|FG000|Overall Study|Transfer|0|||
144557668|NCT02332824|521239801|FG001|Overall Study|Transfer|0|||
144557669|NCT02332824|521239802|FG002|Overall Study|Transfer|1|||
144557670|NCT02332824|521239803|FG003|Overall Study|Transfer|1|||
144557671|NCT02332824|521239804|FG004|Overall Study|Transfer|0|||
144557672|NCT02332824|521239805|FG005|Overall Study|Transfer|0|||
144557673|NCT02784535|521239806|FG000|Overall Study|Adverse Event|1|||
144557674|NCT02784535|521239807|FG001|Overall Study|Adverse Event|0|||
144557675|NCT02784535|521239806|FG000|Overall Study|Withdrawal by Subject|0|||
144557676|NCT02784535|521239807|FG001|Overall Study|Withdrawal by Subject|1|||
144557677|NCT02784535|521239806|FG000|Overall Study|Physician Decision|0|||
144557678|NCT02784535|521239807|FG001|Overall Study|Physician Decision|1|||
144557679|NCT03740919|521239808|FG000|Lead-in Period|Lost to Follow-up|1|||
144557680|NCT03740919|521239809|FG001|Lead-in Period|Lost to Follow-up|0|||
144557681|NCT03740919|521239810|FG002|Lead-in Period|Lost to Follow-up|0|||
144557682|NCT03740919|521239811|FG003|Lead-in Period|Lost to Follow-up|0|||
144557683|NCT03740919|521239808|FG000|Lead-in Period|Physician Decision|2|||
144557684|NCT03740919|521239809|FG001|Lead-in Period|Physician Decision|0|||
144557685|NCT03740919|521239810|FG002|Lead-in Period|Physician Decision|0|||
144557686|NCT03740919|521239811|FG003|Lead-in Period|Physician Decision|0|||
144557687|NCT03740919|521239808|FG000|Lead-in Period|Protocol Violation|1|||
144557688|NCT03740919|521239809|FG001|Lead-in Period|Protocol Violation|0|||
144557689|NCT03740919|521239810|FG002|Lead-in Period|Protocol Violation|0|||
144557690|NCT03740919|521239811|FG003|Lead-in Period|Protocol Violation|0|||
144557691|NCT03740919|521239808|FG000|Lead-in Period|Withdrawal by Subject|10|||
144557692|NCT03740919|521239809|FG001|Lead-in Period|Withdrawal by Subject|0|||
144557693|NCT03740919|521239810|FG002|Lead-in Period|Withdrawal by Subject|0|||
144557694|NCT03740919|521239811|FG003|Lead-in Period|Withdrawal by Subject|0|||
144557695|NCT03740919|521239808|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
144557696|NCT03740919|521239809|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
144557697|NCT03740919|521239810|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
144557698|NCT03740919|521239811|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
144557699|NCT03740919|521239808|FG000|Lead-in Period|Study Task Too Burdensome|1|||
144557700|NCT03740919|521239809|FG001|Lead-in Period|Study Task Too Burdensome|0|||
144557701|NCT03740919|521239810|FG002|Lead-in Period|Study Task Too Burdensome|0|||
144557702|NCT03740919|521239811|FG003|Lead-in Period|Study Task Too Burdensome|0|||
144557703|NCT03740919|521239808|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
144557704|NCT03740919|521239809|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
144557705|NCT03740919|521239810|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
144557706|NCT03740919|521239811|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
144557707|NCT03740919|521239808|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
144557708|NCT03740919|521239809|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
144617307|NCT03657043|521459673|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
144617308|NCT03657043|521459674|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
144617309|NCT03657043|521459675|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
144557709|NCT03740919|521239810|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
144557710|NCT03740919|521239811|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
144557711|NCT03740919|521239808|FG000|Treatment Period|Adverse Event|0|||
144557712|NCT03740919|521239809|FG001|Treatment Period|Adverse Event|0|||
144557713|NCT03740919|521239810|FG002|Treatment Period|Adverse Event|2|||
144557714|NCT03740919|521239811|FG003|Treatment Period|Adverse Event|0|||
144557715|NCT03740919|521239808|FG000|Treatment Period|Protocol Violation|0|||
144557716|NCT03740919|521239809|FG001|Treatment Period|Protocol Violation|1|||
144557717|NCT03740919|521239810|FG002|Treatment Period|Protocol Violation|0|||
144557718|NCT03740919|521239811|FG003|Treatment Period|Protocol Violation|0|||
144557719|NCT03740919|521239808|FG000|Treatment Period|Withdrawal by Subject|0|||
144557720|NCT03740919|521239809|FG001|Treatment Period|Withdrawal by Subject|7|||
144557721|NCT03740919|521239810|FG002|Treatment Period|Withdrawal by Subject|6|||
144557722|NCT03740919|521239811|FG003|Treatment Period|Withdrawal by Subject|2|||
144557723|NCT03740919|521239808|FG000|Treatment Period|Terminated by Sponsor|0|||
144617310|NCT03657043|521459676|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
144617311|NCT03657043|521459672|FG000|Overall Study|Adverse Event|0|||
144617312|NCT03657043|521459673|FG001|Overall Study|Adverse Event|0|||
144617313|NCT03657043|521459674|FG002|Overall Study|Adverse Event|0|||
144557724|NCT03740919|521239809|FG001|Treatment Period|Terminated by Sponsor|1|||
144557725|NCT03740919|521239810|FG002|Treatment Period|Terminated by Sponsor|0|||
144557726|NCT03740919|521239811|FG003|Treatment Period|Terminated by Sponsor|0|||
144617314|NCT03657043|521459675|FG003|Overall Study|Adverse Event|0|||
144557727|NCT03740919|521239808|FG000|Treatment Period|Issue with Insulin Pump|0|||
144557728|NCT03740919|521239809|FG001|Treatment Period|Issue with Insulin Pump|1|||
144557729|NCT03740919|521239810|FG002|Treatment Period|Issue with Insulin Pump|0|||
144557730|NCT03740919|521239811|FG003|Treatment Period|Issue with Insulin Pump|0|||
144557731|NCT03740919|521239808|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
144557732|NCT03740919|521239809|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
144557733|NCT03740919|521239810|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
144557734|NCT03740919|521239811|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
144557735|NCT03740919|521239808|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
144557736|NCT03740919|521239809|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
144557737|NCT03740919|521239810|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
144557738|NCT03740919|521239811|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
144557739|NCT03740919|521239808|FG000|Treatment Period|Not Completing Diary|0|||
144557740|NCT03740919|521239809|FG001|Treatment Period|Not Completing Diary|0|||
144557741|NCT03740919|521239810|FG002|Treatment Period|Not Completing Diary|1|||
144557742|NCT03740919|521239811|FG003|Treatment Period|Not Completing Diary|0|||
144557743|NCT03740919|521239808|FG000|Treatment Period|Insulin Painful to Participant|0|||
144557744|NCT03740919|521239809|FG001|Treatment Period|Insulin Painful to Participant|0|||
144557745|NCT03740919|521239810|FG002|Treatment Period|Insulin Painful to Participant|1|||
144557746|NCT03740919|521239811|FG003|Treatment Period|Insulin Painful to Participant|0|||
144557747|NCT04394624|521239812|FG000|Overall Study|Adverse Event|6|||
144557748|NCT04394624|521239813|FG001|Overall Study|Adverse Event|0|||
144557749|NCT04394624|521239812|FG000|Overall Study|Progressive disease|24|||
144557750|NCT04394624|521239813|FG001|Overall Study|Progressive disease|0|||
144557751|NCT04394624|521239812|FG000|Overall Study|Not related to COVID-19|1|||
144557752|NCT04394624|521239813|FG001|Overall Study|Not related to COVID-19|0|||
144557753|NCT02418819|521239815|FG000|Overall Study|Adverse Event|0|||
144557754|NCT02418819|521239816|FG001|Overall Study|Adverse Event|0|||
144557755|NCT02418819|521239817|FG002|Overall Study|Adverse Event|1|||
144557756|NCT02418819|521239818|FG003|Overall Study|Adverse Event|0|||
144557757|NCT02418819|521239815|FG000|Overall Study|Lost to Follow-up|1|||
144557758|NCT02418819|521239816|FG001|Overall Study|Lost to Follow-up|0|||
144557759|NCT02418819|521239817|FG002|Overall Study|Lost to Follow-up|0|||
144557760|NCT02418819|521239818|FG003|Overall Study|Lost to Follow-up|0|||
144557761|NCT02418819|521239815|FG000|Overall Study|No longer meets eligibility criteria|0|||
144557762|NCT02418819|521239816|FG001|Overall Study|No longer meets eligibility criteria|0|||
144557763|NCT02418819|521239817|FG002|Overall Study|No longer meets eligibility criteria|1|||
144557764|NCT02418819|521239818|FG003|Overall Study|No longer meets eligibility criteria|0|||
144557765|NCT02418819|521239815|FG000|Overall Study|No longer willing to participate|0|||
144557766|NCT02418819|521239816|FG001|Overall Study|No longer willing to participate|0|||
144557767|NCT02418819|521239817|FG002|Overall Study|No longer willing to participate|2|||
144557768|NCT02418819|521239818|FG003|Overall Study|No longer willing to participate|1|||
144557769|NCT04374253|521239819|FG000|Overall Study|Adverse Event|0|||
144557770|NCT04374253|521239820|FG001|Overall Study|Adverse Event|26|||
144557771|NCT04374253|521239821|FG002|Overall Study|Adverse Event|2|||
144557772|NCT04374253|521239822|FG003|Overall Study|Adverse Event|12|||
144557773|NCT04374253|521239819|FG000|Overall Study|Study terminated by sponsor|13|||
144557774|NCT04374253|521239820|FG001|Overall Study|Study terminated by sponsor|593|||
144557775|NCT04374253|521239821|FG002|Overall Study|Study terminated by sponsor|21|||
144557776|NCT04374253|521239822|FG003|Overall Study|Study terminated by sponsor|567|||
144557777|NCT04374253|521239819|FG000|Overall Study|Withdrawal by Subject|0|||
144557778|NCT04374253|521239820|FG001|Overall Study|Withdrawal by Subject|55|||
144557779|NCT04374253|521239821|FG002|Overall Study|Withdrawal by Subject|3|||
144557780|NCT04374253|521239822|FG003|Overall Study|Withdrawal by Subject|40|||
144262449|NCT01317641|520161442|FG008|Overall Study|Protocol Violation|0|||
144262450|NCT01317641|520161434|FG000|Overall Study|Disease progression|0|||
144262451|NCT01317641|520161435|FG001|Overall Study|Disease progression|0|||
144262452|NCT01317641|520161436|FG002|Overall Study|Disease progression|0|||
144262453|NCT01317641|520161437|FG003|Overall Study|Disease progression|0|||
144557781|NCT04374253|521239819|FG000|Overall Study|Physician Decision|1|||
144557782|NCT04374253|521239820|FG001|Overall Study|Physician Decision|10|||
144557783|NCT04374253|521239821|FG002|Overall Study|Physician Decision|1|||
144557784|NCT04374253|521239822|FG003|Overall Study|Physician Decision|10|||
144557785|NCT04374253|521239819|FG000|Overall Study|Protocol Violation|0|||
144557786|NCT04374253|521239820|FG001|Overall Study|Protocol Violation|0|||
144557787|NCT04374253|521239821|FG002|Overall Study|Protocol Violation|0|||
144557788|NCT04374253|521239822|FG003|Overall Study|Protocol Violation|2|||
144557789|NCT04374253|521239819|FG000|Overall Study|Death|0|||
144557790|NCT04374253|521239820|FG001|Overall Study|Death|3|||
144557791|NCT04374253|521239821|FG002|Overall Study|Death|1|||
144557792|NCT04374253|521239822|FG003|Overall Study|Death|1|||
144557793|NCT04374253|521239819|FG000|Overall Study|Lack of Efficacy|0|||
144557794|NCT04374253|521239820|FG001|Overall Study|Lack of Efficacy|0|||
144557795|NCT04374253|521239821|FG002|Overall Study|Lack of Efficacy|0|||
144557796|NCT04374253|521239822|FG003|Overall Study|Lack of Efficacy|1|||
144557797|NCT04374253|521239819|FG000|Overall Study|Lost to Follow-up|1|||
144262454|NCT01317641|520161438|FG004|Overall Study|Disease progression|0|||
144557798|NCT04374253|521239820|FG001|Overall Study|Lost to Follow-up|1|||
144557799|NCT04374253|521239821|FG002|Overall Study|Lost to Follow-up|0|||
144557800|NCT04374253|521239822|FG003|Overall Study|Lost to Follow-up|2|||
144557801|NCT04374253|521239819|FG000|Overall Study|Reason Not Specified|0|||
144557802|NCT04374253|521239820|FG001|Overall Study|Reason Not Specified|8|||
144557803|NCT04374253|521239821|FG002|Overall Study|Reason Not Specified|0|||
144557804|NCT04374253|521239822|FG003|Overall Study|Reason Not Specified|8|||
144557805|NCT04382053|521239828|FG000|Overall Study|Death|6|||
144557806|NCT04382053|521239829|FG001|Overall Study|Death|8|||
144557807|NCT04382053|521239828|FG000|Overall Study|Lost to Follow-up|0|||
144557808|NCT04382053|521239829|FG001|Overall Study|Lost to Follow-up|2|||
144557809|NCT04382053|521239828|FG000|Overall Study|Protocol Deviation|1|||
144557810|NCT04382053|521239829|FG001|Overall Study|Protocol Deviation|2|||
144557811|NCT04382053|521239828|FG000|Overall Study|Withdrawal by Subject|2|||
144557812|NCT04382053|521239829|FG001|Overall Study|Withdrawal by Subject|1|||
144557813|NCT00990821|521239834|FG000|Overall Study|Withdrawal by Subject|0|||
144557814|NCT00990821|521239835|FG001|Overall Study|Withdrawal by Subject|2|||
144557815|NCT00990821|521239836|FG002|Overall Study|Withdrawal by Subject|0|||
144557816|NCT00990821|521239837|FG003|Overall Study|Withdrawal by Subject|0|||
144557817|NCT00990821|521239838|FG004|Overall Study|Withdrawal by Subject|3|||
144557818|NCT00990821|521239839|FG005|Overall Study|Withdrawal by Subject|3|||
144557819|NCT00990821|521239840|FG006|Overall Study|Withdrawal by Subject|1|||
144557820|NCT00990821|521239841|FG007|Overall Study|Withdrawal by Subject|0|||
144557821|NCT00990821|521239842|FG008|Overall Study|Withdrawal by Subject|0|||
144557822|NCT00990821|521239843|FG009|Overall Study|Withdrawal by Subject|1|||
144557823|NCT00990821|521239844|FG010|Overall Study|Withdrawal by Subject|3|||
144557824|NCT00990821|521239845|FG011|Overall Study|Withdrawal by Subject|5|||
144557825|NCT00990821|521239846|FG012|Overall Study|Withdrawal by Subject|2|||
144557826|NCT00990821|521239847|FG013|Overall Study|Withdrawal by Subject|1|||
144557827|NCT01786551|521239848|FG000|Overall Study|Participant withdrew consent|2|||
144557828|NCT01002547|521241530|FG000|Overall Study|Withdrawal by Subject|4|||
144557829|NCT01002547|521241531|FG001|Overall Study|Withdrawal by Subject|0|||
144557830|NCT01002547|521241532|FG002|Overall Study|Withdrawal by Subject|5|||
144557831|NCT01002547|521241530|FG000|Overall Study|Lost to Follow-up|2|||
144557832|NCT01002547|521241531|FG001|Overall Study|Lost to Follow-up|1|||
144557833|NCT01002547|521241532|FG002|Overall Study|Lost to Follow-up|1|||
144557834|NCT01002547|521241530|FG000|Overall Study|Physician Decision|1|||
144557835|NCT01002547|521241531|FG001|Overall Study|Physician Decision|0|||
144557836|NCT01002547|521241532|FG002|Overall Study|Physician Decision|0|||
144557837|NCT01002547|521241530|FG000|Overall Study|Death|0|||
144557838|NCT01002547|521241531|FG001|Overall Study|Death|2|||
144557839|NCT01002547|521241532|FG002|Overall Study|Death|2|||
144557840|NCT01002547|521241530|FG000|Overall Study|Adverse Event|1|||
144557841|NCT01002547|521241531|FG001|Overall Study|Adverse Event|0|||
144557842|NCT01002547|521241532|FG002|Overall Study|Adverse Event|0|||
144557843|NCT00705614|521241537|FG000|Initial Intervention|Adverse Event|40|||
144557844|NCT00705614|521241538|FG001|Initial Intervention|Adverse Event|21|||
144557845|NCT00705614|521241537|FG000|Initial Intervention|Lost to Follow-up|310|||
144557846|NCT00705614|521241538|FG001|Initial Intervention|Lost to Follow-up|191|||
144557847|NCT00705614|521241537|FG000|Initial Intervention|Withdrawal by Subject|114|||
144557848|NCT00705614|521241538|FG001|Initial Intervention|Withdrawal by Subject|71|||
144557849|NCT00705614|521241537|FG000|Initial Intervention|Administrative Reason|51|||
144557850|NCT00705614|521241538|FG001|Initial Intervention|Administrative Reason|38|||
144557851|NCT00705614|521241537|FG000|Initial Intervention|Status completion unknown|3|||
144557852|NCT00705614|521241538|FG001|Initial Intervention|Status completion unknown|0|||
144557853|NCT00705614|521241537|FG000|Switch to Remicade|Adverse Event|0|||
144557854|NCT00705614|521241538|FG001|Switch to Remicade|Adverse Event|5|||
144557855|NCT00705614|521241537|FG000|Switch to Remicade|Lost to Follow-up|0|||
144557856|NCT00705614|521241538|FG001|Switch to Remicade|Lost to Follow-up|23|||
144557857|NCT00705614|521241537|FG000|Switch to Remicade|Withdrawal by Subject|0|||
144557858|NCT00705614|521241538|FG001|Switch to Remicade|Withdrawal by Subject|12|||
144557859|NCT00705614|521241537|FG000|Switch to Remicade|Administrative Reason|0|||
144557860|NCT00705614|521241538|FG001|Switch to Remicade|Administrative Reason|9|||
144557861|NCT00925288|521241539|FG000|Overall Study|Lost to Follow-up|9|||
144557862|NCT00925288|521241540|FG001|Overall Study|Lost to Follow-up|7|||
144557863|NCT02081196|521241541|FG000|Overall Study|Lost to Follow-up|1|||
144557864|NCT00434577|521241542|FG000|Months 0-3|Serious Adverse Event|0|||
144557865|NCT00434577|521241543|FG001|Months 0-3|Serious Adverse Event|0|||
144557866|NCT00434577|521241544|FG002|Months 0-3|Serious Adverse Event|1|||
144557867|NCT00434577|521241545|FG003|Months 0-3|Serious Adverse Event|0|||
144557868|NCT00434577|521241546|FG004|Months 0-3|Serious Adverse Event|0|||
144557869|NCT00434577|521241542|FG000|Months 0-3|Adverse Event|0|||
144617315|NCT03657043|521459676|FG004|Overall Study|Adverse Event|2|||
144617316|NCT03657043|521459672|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
144617317|NCT03657043|521459673|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
144557870|NCT00434577|521241543|FG001|Months 0-3|Adverse Event|1|||
144557871|NCT00434577|521241544|FG002|Months 0-3|Adverse Event|1|||
144557872|NCT00434577|521241545|FG003|Months 0-3|Adverse Event|0|||
144557873|NCT00434577|521241546|FG004|Months 0-3|Adverse Event|0|||
144557874|NCT00434577|521241542|FG000|Months 0-3|Lost to Follow-up|0|||
144557875|NCT00434577|521241543|FG001|Months 0-3|Lost to Follow-up|0|||
144557876|NCT00434577|521241544|FG002|Months 0-3|Lost to Follow-up|0|||
144557877|NCT00434577|521241545|FG003|Months 0-3|Lost to Follow-up|0|||
144557878|NCT00434577|521241546|FG004|Months 0-3|Lost to Follow-up|2|||
144557879|NCT00434577|521241542|FG000|Months 0-3|Protocol Violation|1|||
144557880|NCT00434577|521241543|FG001|Months 0-3|Protocol Violation|0|||
144557881|NCT00434577|521241544|FG002|Months 0-3|Protocol Violation|1|||
144557882|NCT00434577|521241545|FG003|Months 0-3|Protocol Violation|0|||
144557883|NCT00434577|521241546|FG004|Months 0-3|Protocol Violation|0|||
144557884|NCT00434577|521241542|FG000|Months 0-3|Withdrawal by Subject|2|||
144557885|NCT00434577|521241543|FG001|Months 0-3|Withdrawal by Subject|1|||
144557886|NCT00434577|521241544|FG002|Months 0-3|Withdrawal by Subject|1|||
144557887|NCT00434577|521241545|FG003|Months 0-3|Withdrawal by Subject|1|||
144557888|NCT00434577|521241546|FG004|Months 0-3|Withdrawal by Subject|1|||
144557889|NCT00635570|521241547|FG000|Overall Study|Lost to Follow-up|8|||
144557890|NCT00635570|521241548|FG001|Overall Study|Lost to Follow-up|8|||
144557891|NCT00635570|521241547|FG000|Overall Study|Withdrawal by Subject|1|||
144557892|NCT00635570|521241548|FG001|Overall Study|Withdrawal by Subject|1|||
144557893|NCT00635570|521241547|FG000|Overall Study|Adverse Event|2|||
144557894|NCT00635570|521241548|FG001|Overall Study|Adverse Event|0|||
144557895|NCT00635570|521241547|FG000|Overall Study|Physician Decision|1|||
144557896|NCT00635570|521241548|FG001|Overall Study|Physician Decision|0|||
144557897|NCT00635570|521241547|FG000|Overall Study|Did not complete survey|2|||
144557898|NCT00635570|521241548|FG001|Overall Study|Did not complete survey|1|||
144557899|NCT00635570|521241547|FG000|Overall Study|Early termination(No sexual activity)|1|||
144557900|NCT00635570|521241548|FG001|Overall Study|Early termination(No sexual activity)|1|||
144557901|NCT00332488|521241552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
144557902|NCT00332488|521241553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
144557903|NCT00332488|521241554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
144557904|NCT00332488|521241552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
144557905|NCT00332488|521241553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
144557906|NCT00332488|521241554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
144557907|NCT00332488|521241552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
144557908|NCT00332488|521241553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
144557909|NCT00332488|521241554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
144557910|NCT00332488|521241552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
144557911|NCT00332488|521241553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
144557912|NCT00332488|521241554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
144557913|NCT00332488|521241552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
144557914|NCT00332488|521241553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
144557915|NCT00332488|521241554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
144557916|NCT00332488|521241552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
144557917|NCT00332488|521241553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
144557918|NCT00332488|521241554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
144557919|NCT00332488|521241552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
144557920|NCT00332488|521241553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
144557921|NCT00332488|521241554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
144557922|NCT00332488|521241552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
144557923|NCT00332488|521241553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
144557924|NCT00332488|521241554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
144557925|NCT00332488|521241552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
144557926|NCT00332488|521241553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
144557927|NCT00332488|521241554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
144557928|NCT00332488|521241552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
144557929|NCT00332488|521241553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
144557930|NCT00332488|521241554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
144557931|NCT00332488|521241552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
144557932|NCT00332488|521241553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
144557933|NCT00332488|521241554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
144557934|NCT00332488|521241552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
144557935|NCT00332488|521241553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
144557936|NCT00332488|521241554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
144557937|NCT00755716|521241557|FG000|Overall Study|Adverse Event|1|||
144557938|NCT00755716|521241558|FG001|Overall Study|Adverse Event|4|||
144557939|NCT00755716|521241559|FG002|Overall Study|Adverse Event|1|||
144617318|NCT03657043|521459674|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
144617319|NCT03657043|521459675|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
144557940|NCT00755716|521241557|FG000|Overall Study|Lack of Efficacy|2|||
144557941|NCT00755716|521241558|FG001|Overall Study|Lack of Efficacy|0|||
144557942|NCT00755716|521241559|FG002|Overall Study|Lack of Efficacy|0|||
144557943|NCT00755716|521241557|FG000|Overall Study|Lost to Follow-up|5|||
144557944|NCT00755716|521241558|FG001|Overall Study|Lost to Follow-up|3|||
144557945|NCT00755716|521241559|FG002|Overall Study|Lost to Follow-up|1|||
144557946|NCT00755716|521241557|FG000|Overall Study|work schedule issues|0|||
144557947|NCT00755716|521241558|FG001|Overall Study|work schedule issues|1|||
144557948|NCT00755716|521241559|FG002|Overall Study|work schedule issues|1|||
144557949|NCT00726388|521241565|FG000|Overall Study|Withdrawal by Subject|5|||
144557950|NCT00726388|521241565|FG000|Overall Study|Adverse Event|3|||
144557951|NCT00726388|521241565|FG000|Overall Study|Lost to Follow-up|10|||
144557952|NCT00726388|521241565|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
144557953|NCT00726388|521241565|FG000|Overall Study|Other|5|||
144557954|NCT00726388|521241565|FG000|Overall Study|Enrolled, Not Treated|79|||
144557955|NCT01732588|521241571|FG000|First Intervention (7 Days)|Adverse Event|0|||
144557956|NCT01732588|521241572|FG001|First Intervention (7 Days)|Adverse Event|1|||
144557957|NCT01732588|521241573|FG002|First Intervention (7 Days)|Adverse Event|0|||
144557958|NCT05012397|521241574|FG000|Overall Study|Death|10|||
144557959|NCT05012397|521241574|FG000|Overall Study|Physician Decision|9|||
144557960|NCT05012397|521241574|FG000|Overall Study|Withdrawal by Subject|5|||
144557961|NCT05012397|521241574|FG000|Overall Study|Lost to Follow-up|2|||
144557962|NCT04748445|521241575|FG000|Overall Study|No longer met eligibility criteria|12|||
144557963|NCT04748445|521241575|FG000|Overall Study|Other|36|||
144557964|NCT04748445|521241575|FG000|Overall Study|Withdrawal by Subject|553|||
144557965|NCT04748445|521241575|FG000|Overall Study|Lost to Follow-up|30|||
144557966|NCT04736602|521241576|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
144557967|NCT04736602|521241576|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
144557968|NCT00679549|521241579|FG000|Overall Study|dropout|2|||
144557969|NCT00679549|521241580|FG001|Overall Study|dropout|4|||
144557970|NCT00679549|521241579|FG000|Overall Study|missing outcome echocardiograms|4|||
144557971|NCT00679549|521241580|FG001|Overall Study|missing outcome echocardiograms|5|||
144557972|NCT03048058|521241587|FG000|Overall Study|Lost to Follow-up|4|||
144557973|NCT03048058|521241588|FG001|Overall Study|Lost to Follow-up|0|||
144557974|NCT03048058|521241587|FG000|Overall Study|Withdrawal by Subject|0|||
144557975|NCT03048058|521241588|FG001|Overall Study|Withdrawal by Subject|4|||
144557976|NCT01257698|521241589|FG000|Overall Study|Protocol Violation|4|||
144557977|NCT01257698|521241590|FG001|Overall Study|Protocol Violation|0|||
144557978|NCT00050167|521241612|FG000|Overall Study|not eligible not invasive|1|||
144557979|NCT00050167|521241613|FG001|Overall Study|not eligible not invasive|1|||
144557980|NCT02038803|521241617|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
144557981|NCT02038803|521241617|FG000|Overall Study|Lost to Follow-up|1|||
144557982|NCT04754594|521241618|FG000|Blinded Period|Withdrawal by Subject|4|||
144557983|NCT04754594|521241619|FG001|Blinded Period|Withdrawal by Subject|9|||
144557984|NCT04754594|521241620|FG002|Blinded Period|Withdrawal by Subject|0|||
144557985|NCT04754594|521241621|FG003|Blinded Period|Withdrawal by Subject|0|||
144557986|NCT04754594|521241618|FG000|Blinded Period|Protocol Violation|2|||
144557987|NCT04754594|521241619|FG001|Blinded Period|Protocol Violation|2|||
144557988|NCT04754594|521241620|FG002|Blinded Period|Protocol Violation|0|||
144557989|NCT04754594|521241621|FG003|Blinded Period|Protocol Violation|0|||
144557990|NCT04754594|521241618|FG000|Blinded Period|Lost to Follow-up|1|||
144557991|NCT04754594|521241619|FG001|Blinded Period|Lost to Follow-up|1|||
144557992|NCT04754594|521241620|FG002|Blinded Period|Lost to Follow-up|0|||
144557993|NCT04754594|521241621|FG003|Blinded Period|Lost to Follow-up|0|||
144557994|NCT04754594|521241618|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
144557995|NCT04754594|521241619|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
144557996|NCT04754594|521241620|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
144557997|NCT04754594|521241621|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
144617320|NCT03657043|521459676|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
144617321|NCT03657043|521459672|FG000|Overall Study|Withdrawal - declined follow-up|0|||
144617322|NCT03657043|521459673|FG001|Overall Study|Withdrawal - declined follow-up|0|||
144617323|NCT03657043|521459674|FG002|Overall Study|Withdrawal - declined follow-up|0|||
144617324|NCT03657043|521459675|FG003|Overall Study|Withdrawal - declined follow-up|0|||
144617325|NCT03657043|521459676|FG004|Overall Study|Withdrawal - declined follow-up|1|||
144557998|NCT04754594|521241618|FG000|Unblinded Period|Withdrawal by Subject|6|||
144557999|NCT04754594|521241619|FG001|Unblinded Period|Withdrawal by Subject|8|||
144558000|NCT04754594|521241620|FG002|Unblinded Period|Withdrawal by Subject|0|||
144558001|NCT04754594|521241621|FG003|Unblinded Period|Withdrawal by Subject|0|||
144558002|NCT04754594|521241618|FG000|Unblinded Period|Lost to Follow-up|5|||
144558003|NCT04754594|521241619|FG001|Unblinded Period|Lost to Follow-up|3|||
144558004|NCT04754594|521241620|FG002|Unblinded Period|Lost to Follow-up|0|||
144558005|NCT04754594|521241621|FG003|Unblinded Period|Lost to Follow-up|0|||
144617326|NCT03047980|521459677|FG000|Overall Study|Adverse Event|1|||
144558006|NCT04754594|521241618|FG000|Unblinded Period|Protocol Violation|2|||
144617327|NCT00880893|521459680|FG000|Overall Study|Protocol Violation|13|||
144558007|NCT04754594|521241619|FG001|Unblinded Period|Protocol Violation|4|||
144558008|NCT04754594|521241620|FG002|Unblinded Period|Protocol Violation|0|||
144617328|NCT00880893|521459681|FG001|Overall Study|Protocol Violation|1|||
144617329|NCT00880893|521459680|FG000|Overall Study|Withdrawal by Subject|15|||
144617330|NCT00880893|521459681|FG001|Overall Study|Withdrawal by Subject|11|||
144617331|NCT00880893|521459680|FG000|Overall Study|Lost to Follow-up|76|||
144617332|NCT00880893|521459681|FG001|Overall Study|Lost to Follow-up|33|||
144617333|NCT00880893|521459680|FG000|Overall Study|Serious adverse event|3|||
144617334|NCT00880893|521459681|FG001|Overall Study|Serious adverse event|0|||
144617335|NCT01783678|521459682|FG000|Overall Study|Randomized but Not Treated|0|||
144617336|NCT01783678|521459683|FG001|Overall Study|Randomized but Not Treated|0|||
144558009|NCT04754594|521241621|FG003|Unblinded Period|Protocol Violation|0|||
144727807|NCT00920140|521858080|FG004|Phase 2|Lack of Efficacy|5|||
144558010|NCT04754594|521241618|FG000|Unblinded Period|Other|3|||
144558011|NCT04754594|521241619|FG001|Unblinded Period|Other|0|||
144558012|NCT04754594|521241620|FG002|Unblinded Period|Other|0|||
144558013|NCT04754594|521241621|FG003|Unblinded Period|Other|0|||
144558014|NCT04754594|521241618|FG000|Infant Participants|Withdrawal by Subject|0|||
144558015|NCT04754594|521241619|FG001|Infant Participants|Withdrawal by Subject|0|||
144558016|NCT04754594|521241620|FG002|Infant Participants|Withdrawal by Subject|9|||
144558017|NCT04754594|521241621|FG003|Infant Participants|Withdrawal by Subject|17|||
144558018|NCT04754594|521241618|FG000|Infant Participants|Lost to Follow-up|0|||
144558019|NCT04754594|521241619|FG001|Infant Participants|Lost to Follow-up|0|||
144558020|NCT04754594|521241620|FG002|Infant Participants|Lost to Follow-up|4|||
144558021|NCT04754594|521241621|FG003|Infant Participants|Lost to Follow-up|10|||
144558022|NCT04754594|521241618|FG000|Infant Participants|Death|0|||
144558023|NCT04754594|521241619|FG001|Infant Participants|Death|0|||
144558024|NCT04754594|521241620|FG002|Infant Participants|Death|1|||
144558025|NCT04754594|521241621|FG003|Infant Participants|Death|1|||
144558026|NCT04754594|521241618|FG000|Infant Participants|Other|0|||
144558027|NCT04754594|521241619|FG001|Infant Participants|Other|0|||
144558028|NCT04754594|521241620|FG002|Infant Participants|Other|1|||
144558029|NCT04754594|521241621|FG003|Infant Participants|Other|1|||
144558030|NCT01247922|521241622|FG000|Overall Study|Disease progression|4|||
144558031|NCT02588027|521241623|FG000|Overall Study|Withdrawal by Subject|1|||
144558032|NCT02588027|521241624|FG001|Overall Study|Withdrawal by Subject|3|||
144558033|NCT02588027|521241623|FG000|Overall Study|Protocol Violation|4|||
144558034|NCT02588027|521241624|FG001|Overall Study|Protocol Violation|1|||
144558035|NCT04372186|521241625|FG000|Overall Study|Death|24|||
144558036|NCT04372186|521241626|FG001|Overall Study|Death|11|||
144558037|NCT04372186|521241625|FG000|Overall Study|Transferred to a different facility for care|0|||
144558038|NCT04372186|521241626|FG001|Overall Study|Transferred to a different facility for care|2|||
144558039|NCT04736472|521241627|FG000|Overall Study|Lost to Follow-up|1|||
144558040|NCT04736472|521241628|FG001|Overall Study|Lost to Follow-up|0|||
144558041|NCT04736472|521241629|FG002|Overall Study|Lost to Follow-up|0|||
144558042|NCT04736472|521241627|FG000|Overall Study|Withdrawal by Subject|2|||
144558043|NCT04736472|521241628|FG001|Overall Study|Withdrawal by Subject|0|||
144558044|NCT04736472|521241629|FG002|Overall Study|Withdrawal by Subject|0|||
144558045|NCT04736472|521241627|FG000|Overall Study|Protocol Violation|48|||
144558046|NCT04736472|521241628|FG001|Overall Study|Protocol Violation|0|||
144558047|NCT04736472|521241629|FG002|Overall Study|Protocol Violation|6|||
144558048|NCT02116582|521241630|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
144558049|NCT02116582|521241630|FG000|Overall Study|Adverse Event|22|||
144558050|NCT02116582|521241630|FG000|Overall Study|Death|9|||
144558051|NCT02116582|521241630|FG000|Overall Study|Progressive Disease|148|||
144558052|NCT02116582|521241630|FG000|Overall Study|Protocol Violation|3|||
144558053|NCT02116582|521241630|FG000|Overall Study|Withdrawal by Subject|8|||
144558054|NCT02116582|521241630|FG000|Overall Study|Other: Miscellaneous|11|||
144558055|NCT02116582|521241630|FG000|Overall Study|Lost to Follow-up|1|||
144558056|NCT02116582|521241630|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
144558057|NCT01876823|521241631|FG000|Overall Study|Withdrawal by Subject|5|||
144558058|NCT01876823|521241631|FG000|Overall Study|Physician Decision|2|||
144558059|NCT01876823|521241631|FG000|Overall Study|Patients moved|2|||
144558060|NCT00577096|521241634|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
144558061|NCT00577096|521241635|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
144617337|NCT01783678|521459684|FG002|Overall Study|Randomized but Not Treated|0|||
144617338|NCT01783678|521459685|FG003|Overall Study|Randomized but Not Treated|1|||
144617339|NCT01783678|521459686|FG004|Overall Study|Randomized but Not Treated|0|||
144617340|NCT01783678|521459687|FG005|Overall Study|Randomized but Not Treated|0|||
144617341|NCT01783678|521459682|FG000|Overall Study|Lack of Efficacy|1|||
144203489|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
144203490|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203491|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
144203492|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203493|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
144203494|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203495|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144262455|NCT01317641|520161439|FG005|Overall Study|Disease progression|0|||
144558062|NCT00577096|521241634|FG000|Short Term Participation|Withdrawal by Subject|3|||
144558063|NCT00577096|521241635|FG001|Short Term Participation|Withdrawal by Subject|5|||
144558064|NCT00577096|521241634|FG000|Short Term Participation|Death|1|||
144558065|NCT00577096|521241635|FG001|Short Term Participation|Death|1|||
144558066|NCT03305458|521241636|FG000|Overall Study|Withdrawal by Subject|50|||
144558067|NCT03305458|521241637|FG001|Overall Study|Withdrawal by Subject|46|||
144558068|NCT03305458|521241638|FG002|Overall Study|Withdrawal by Subject|93|||
144558069|NCT03305458|521241636|FG000|Overall Study|Lost to Follow-up|85|||
144558070|NCT03305458|521241637|FG001|Overall Study|Lost to Follow-up|85|||
144558071|NCT03305458|521241638|FG002|Overall Study|Lost to Follow-up|35|||
144558072|NCT03562117|521241640|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
144558073|NCT03562117|521241641|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
144558074|NCT03562117|521241642|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
144558075|NCT01911819|521241649|FG000|Overall Study|Adverse Event|0|||
144558076|NCT01911819|521241650|FG001|Overall Study|Adverse Event|1|||
144558077|NCT01911819|521241651|FG002|Overall Study|Adverse Event|0|||
144558078|NCT01911819|521241649|FG000|Overall Study|Withdrawal by Subject|1|||
144558079|NCT01911819|521241650|FG001|Overall Study|Withdrawal by Subject|1|||
144558080|NCT01911819|521241651|FG002|Overall Study|Withdrawal by Subject|0|||
144558081|NCT00603278|521241652|FG000|Overall Study|Lack of Efficacy|35|||
144558082|NCT00603278|521241653|FG001|Overall Study|Lack of Efficacy|10|||
144558083|NCT00603278|521241654|FG002|Overall Study|Lack of Efficacy|11|||
144558084|NCT00603278|521241655|FG003|Overall Study|Lack of Efficacy|8|||
144558085|NCT00603278|521241656|FG004|Overall Study|Lack of Efficacy|7|||
144558086|NCT00603278|521241657|FG005|Overall Study|Lack of Efficacy|14|||
144558087|NCT00603278|521241652|FG000|Overall Study|Adverse Event|0|||
144558088|NCT00603278|521241653|FG001|Overall Study|Adverse Event|3|||
144558089|NCT00603278|521241654|FG002|Overall Study|Adverse Event|1|||
144558090|NCT00603278|521241655|FG003|Overall Study|Adverse Event|0|||
144558091|NCT00603278|521241656|FG004|Overall Study|Adverse Event|2|||
144558092|NCT00603278|521241657|FG005|Overall Study|Adverse Event|1|||
144558093|NCT00603278|521241652|FG000|Overall Study|Withdrawal by Subject|2|||
144558094|NCT00603278|521241653|FG001|Overall Study|Withdrawal by Subject|3|||
144558095|NCT00603278|521241654|FG002|Overall Study|Withdrawal by Subject|1|||
144558096|NCT00603278|521241655|FG003|Overall Study|Withdrawal by Subject|2|||
144558097|NCT00603278|521241656|FG004|Overall Study|Withdrawal by Subject|1|||
144558098|NCT00603278|521241657|FG005|Overall Study|Withdrawal by Subject|2|||
144558099|NCT00603278|521241652|FG000|Overall Study|Protocol Violation|3|||
144558100|NCT00603278|521241653|FG001|Overall Study|Protocol Violation|0|||
144558101|NCT00603278|521241654|FG002|Overall Study|Protocol Violation|1|||
144558102|NCT00603278|521241655|FG003|Overall Study|Protocol Violation|1|||
144558103|NCT00603278|521241656|FG004|Overall Study|Protocol Violation|0|||
144558104|NCT00603278|521241657|FG005|Overall Study|Protocol Violation|1|||
144558105|NCT00603278|521241652|FG000|Overall Study|Physician Decision|0|||
144558106|NCT00603278|521241653|FG001|Overall Study|Physician Decision|1|||
144558107|NCT00603278|521241654|FG002|Overall Study|Physician Decision|0|||
144558108|NCT00603278|521241655|FG003|Overall Study|Physician Decision|0|||
144558109|NCT00603278|521241656|FG004|Overall Study|Physician Decision|2|||
144558110|NCT00603278|521241657|FG005|Overall Study|Physician Decision|1|||
144558111|NCT00603278|521241652|FG000|Overall Study|Lost to Follow-up|1|||
144558112|NCT00603278|521241653|FG001|Overall Study|Lost to Follow-up|0|||
144558113|NCT00603278|521241654|FG002|Overall Study|Lost to Follow-up|0|||
144558114|NCT00603278|521241655|FG003|Overall Study|Lost to Follow-up|0|||
144558115|NCT00603278|521241656|FG004|Overall Study|Lost to Follow-up|1|||
144558116|NCT00603278|521241657|FG005|Overall Study|Lost to Follow-up|0|||
144558117|NCT01207453|521241664|FG000|First Intervention|Adverse Event|2|||
144558118|NCT01207453|521241665|FG001|First Intervention|Adverse Event|1|||
144558119|NCT01207453|521241664|FG000|Washout|Adverse Event|1|||
144558120|NCT01207453|521241665|FG001|Washout|Adverse Event|0|||
144558121|NCT01207453|521241664|FG000|Washout|Lost to Follow-up|1|||
144558122|NCT01207453|521241665|FG001|Washout|Lost to Follow-up|0|||
144558123|NCT01207453|521241664|FG000|2nd Intervention|Adverse Event|1|||
144558124|NCT01207453|521241665|FG001|2nd Intervention|Adverse Event|2|||
144558125|NCT01207453|521241664|FG000|2nd Intervention|Lost to Follow-up|1|||
144558126|NCT01207453|521241665|FG001|2nd Intervention|Lost to Follow-up|0|||
144558127|NCT00676663|521241666|FG000|Overall Study|Death|43|||
144558128|NCT00676663|521241667|FG001|Overall Study|Death|27|||
144558129|NCT00676663|521241666|FG000|Overall Study|Withdrew Consent|1|||
144558130|NCT00676663|521241667|FG001|Overall Study|Withdrew Consent|8|||
144558131|NCT00676663|521241666|FG000|Overall Study|Lost to Follow-up|1|||
144558132|NCT00676663|521241667|FG001|Overall Study|Lost to Follow-up|3|||
144558133|NCT01399905|521241668|FG000|Overall Study|Withdrawal by Subject|1|||
144558134|NCT01399905|521241669|FG001|Overall Study|Withdrawal by Subject|1|||
144558135|NCT00714688|521241675|FG000|Overall Study|Lack of Efficacy|14|||
144558136|NCT00714688|521241676|FG001|Overall Study|Lack of Efficacy|1|||
144558137|NCT00714688|521241677|FG002|Overall Study|Lack of Efficacy|4|||
144558138|NCT00714688|521241675|FG000|Overall Study|Withdrawal by Subject|4|||
144558139|NCT00714688|521241676|FG001|Overall Study|Withdrawal by Subject|3|||
144558140|NCT00714688|521241677|FG002|Overall Study|Withdrawal by Subject|3|||
144558141|NCT00714688|521241675|FG000|Overall Study|Lost to Follow-up|5|||
144558142|NCT00714688|521241676|FG001|Overall Study|Lost to Follow-up|2|||
144558143|NCT00714688|521241677|FG002|Overall Study|Lost to Follow-up|0|||
144558144|NCT00714688|521241675|FG000|Overall Study|Adverse Event|2|||
144558145|NCT00714688|521241676|FG001|Overall Study|Adverse Event|15|||
144558146|NCT00714688|521241677|FG002|Overall Study|Adverse Event|19|||
144558147|NCT00714688|521241675|FG000|Overall Study|Subject Non-compliant|3|||
144558148|NCT00714688|521241676|FG001|Overall Study|Subject Non-compliant|5|||
144558149|NCT00714688|521241677|FG002|Overall Study|Subject Non-compliant|5|||
144558150|NCT00714688|521241675|FG000|Overall Study|Ineligible to Continue the Study|0|||
144558151|NCT00714688|521241676|FG001|Overall Study|Ineligible to Continue the Study|1|||
144558152|NCT00714688|521241677|FG002|Overall Study|Ineligible to Continue the Study|1|||
144558153|NCT00714688|521241675|FG000|Overall Study|Sponsor's Decision|0|||
144558154|NCT00714688|521241676|FG001|Overall Study|Sponsor's Decision|2|||
144558155|NCT00714688|521241677|FG002|Overall Study|Sponsor's Decision|0|||
144558156|NCT00714688|521241675|FG000|Overall Study|Other|1|||
144558157|NCT00714688|521241676|FG001|Overall Study|Other|6|||
144558158|NCT00714688|521241677|FG002|Overall Study|Other|5|||
144558159|NCT00170950|521241678|FG000|Overall Study|Death|236|||
144558160|NCT00170950|521241679|FG001|Overall Study|Death|274|||
144558161|NCT00170950|521241678|FG000|Overall Study|Withdrawal by Subject|496|||
144558162|NCT00170950|521241679|FG001|Overall Study|Withdrawal by Subject|498|||
144558163|NCT00170950|521241678|FG000|Overall Study|Lost to Follow-up|134|||
144558164|NCT00170950|521241679|FG001|Overall Study|Lost to Follow-up|115|||
144558165|NCT00170950|521241678|FG000|Overall Study|Missing|2|||
144558166|NCT00170950|521241679|FG001|Overall Study|Missing|1|||
144558167|NCT00170950|521241678|FG000|Overall Study|Termination Data Not Recorded|17|||
144558168|NCT00170950|521241679|FG001|Overall Study|Termination Data Not Recorded|22|||
144558169|NCT01123642|521241681|FG000|Overall Study|Lost to Follow-up|23|||
144558170|NCT01123642|521241681|FG000|Overall Study|Withdrawal by Subject|9|||
144558171|NCT01123642|521241681|FG000|Overall Study|ineligible at baseline assessment|36|||
144558172|NCT00651937|521243620|FG000|Overall Study|Withdrawal by Subject|4|||
144558173|NCT00651937|521243621|FG001|Overall Study|Withdrawal by Subject|1|||
144558174|NCT00792259|521243627|FG000|Overall Study|Poor Quality Scans|1|||
144558175|NCT00792259|521243628|FG001|Overall Study|Poor Quality Scans|0|||
144558176|NCT00792259|521243629|FG002|Overall Study|Poor Quality Scans|0|||
144558177|NCT03721978|521243630|FG000|Overall Study|Withdrawal by Subject|6|||
144558178|NCT03721978|521243631|FG001|Overall Study|Withdrawal by Subject|1|||
144558179|NCT03721978|521243630|FG000|Overall Study|Adverse Event|1|||
144558180|NCT03721978|521243631|FG001|Overall Study|Adverse Event|1|||
144558181|NCT03721978|521243630|FG000|Overall Study|Progressive Disease|1|||
144558182|NCT03721978|521243631|FG001|Overall Study|Progressive Disease|0|||
144558183|NCT03721978|521243630|FG000|Overall Study|Lost to Follow-up|5|||
144558184|NCT03721978|521243631|FG001|Overall Study|Lost to Follow-up|1|||
144558185|NCT03721978|521243630|FG000|Overall Study|Reason not Specified|0|||
144617342|NCT01783678|521459683|FG001|Overall Study|Lack of Efficacy|13|||
144617343|NCT01783678|521459684|FG002|Overall Study|Lack of Efficacy|1|||
144617344|NCT01783678|521459685|FG003|Overall Study|Lack of Efficacy|3|||
144617345|NCT01783678|521459686|FG004|Overall Study|Lack of Efficacy|6|||
144617346|NCT01783678|521459687|FG005|Overall Study|Lack of Efficacy|5|||
144617347|NCT01783678|521459682|FG000|Overall Study|Lost to Follow-up|0|||
144727808|NCT00920140|521858076|FG000|Phase 2|Lost to Follow-up|0|||
144727809|NCT00920140|521858077|FG001|Phase 2|Lost to Follow-up|0|||
144558186|NCT03721978|521243631|FG001|Overall Study|Reason not Specified|2|||
144558187|NCT02507687|521243634|FG000|Overall Study|Adverse Event|3|||
144558188|NCT02507687|521243635|FG001|Overall Study|Adverse Event|2|||
144558189|NCT02507687|521243636|FG002|Overall Study|Adverse Event|2|||
144727810|NCT00920140|521858078|FG002|Phase 2|Lost to Follow-up|0|||
144727811|NCT00920140|521858079|FG003|Phase 2|Lost to Follow-up|1|||
144727812|NCT00920140|521858080|FG004|Phase 2|Lost to Follow-up|0|||
144727813|NCT00920140|521858076|FG000|Phase 2|Physician Decision|0|||
144727814|NCT00920140|521858077|FG001|Phase 2|Physician Decision|0|||
144727815|NCT00920140|521858078|FG002|Phase 2|Physician Decision|3|||
144727816|NCT00920140|521858079|FG003|Phase 2|Physician Decision|3|||
144558190|NCT02507687|521243637|FG003|Overall Study|Adverse Event|2|||
144558191|NCT02507687|521243634|FG000|Overall Study|Withdrawal by Subject|1|||
144558192|NCT02507687|521243635|FG001|Overall Study|Withdrawal by Subject|4|||
144558193|NCT02507687|521243636|FG002|Overall Study|Withdrawal by Subject|6|||
144558194|NCT02507687|521243637|FG003|Overall Study|Withdrawal by Subject|6|||
144617348|NCT01783678|521459683|FG001|Overall Study|Lost to Follow-up|4|||
144617349|NCT01783678|521459684|FG002|Overall Study|Lost to Follow-up|0|||
144617350|NCT01783678|521459685|FG003|Overall Study|Lost to Follow-up|2|||
144558195|NCT02507687|521243634|FG000|Overall Study|Protocol Violation|1|||
144558196|NCT02507687|521243635|FG001|Overall Study|Protocol Violation|0|||
144558197|NCT02507687|521243636|FG002|Overall Study|Protocol Violation|2|||
144558198|NCT02507687|521243637|FG003|Overall Study|Protocol Violation|0|||
144558199|NCT02507687|521243634|FG000|Overall Study|Lost to Follow-up|0|||
144617351|NCT01783678|521459686|FG004|Overall Study|Lost to Follow-up|1|||
144727817|NCT00920140|521858080|FG004|Phase 2|Physician Decision|2|||
144727818|NCT00920140|521858076|FG000|Phase 2|Withdrawal by Subject|0|||
144727819|NCT00920140|521858077|FG001|Phase 2|Withdrawal by Subject|0|||
144727820|NCT00920140|521858078|FG002|Phase 2|Withdrawal by Subject|4|||
144727821|NCT00920140|521858079|FG003|Phase 2|Withdrawal by Subject|2|||
144727822|NCT00920140|521858080|FG004|Phase 2|Withdrawal by Subject|1|||
144727823|NCT00728949|521858084|FG000|Overall Study|Adverse Event|8|||
144727824|NCT00728949|521858085|FG001|Overall Study|Adverse Event|0|||
144727825|NCT00728949|521858084|FG000|Overall Study|Withdrawal by Subject|2|||
144727826|NCT00728949|521858085|FG001|Overall Study|Withdrawal by Subject|2|||
144727827|NCT00728949|521858084|FG000|Overall Study|Abnormal Lab Results|0|||
144617352|NCT01783678|521459687|FG005|Overall Study|Lost to Follow-up|0|||
144617353|NCT01783678|521459682|FG000|Overall Study|Withdrew Consent|1|||
144617354|NCT01783678|521459683|FG001|Overall Study|Withdrew Consent|1|||
144617355|NCT01783678|521459684|FG002|Overall Study|Withdrew Consent|0|||
144617356|NCT01783678|521459685|FG003|Overall Study|Withdrew Consent|2|||
144617357|NCT01783678|521459686|FG004|Overall Study|Withdrew Consent|0|||
144617358|NCT01783678|521459687|FG005|Overall Study|Withdrew Consent|0|||
144617359|NCT00112905|521459688|FG000|Overall Study|Adverse Event|4|||
144617360|NCT00112905|521459688|FG000|Overall Study|Death|1|||
144617361|NCT00112905|521459688|FG000|Overall Study|Ineligibility|5|||
144558200|NCT02507687|521243635|FG001|Overall Study|Lost to Follow-up|0|||
144558201|NCT02507687|521243636|FG002|Overall Study|Lost to Follow-up|2|||
144558202|NCT02507687|521243637|FG003|Overall Study|Lost to Follow-up|1|||
144558203|NCT02507687|521243634|FG000|Overall Study|Screen Failure|0|||
144558204|NCT02507687|521243635|FG001|Overall Study|Screen Failure|0|||
144558205|NCT02507687|521243636|FG002|Overall Study|Screen Failure|1|||
144558206|NCT02507687|521243637|FG003|Overall Study|Screen Failure|0|||
144558207|NCT02507687|521243634|FG000|Overall Study|Other, Not Specified|0|||
144558208|NCT02507687|521243635|FG001|Overall Study|Other, Not Specified|0|||
144558209|NCT02507687|521243636|FG002|Overall Study|Other, Not Specified|2|||
144558210|NCT02507687|521243637|FG003|Overall Study|Other, Not Specified|4|||
144558211|NCT04357964|521243638|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
144558212|NCT04357964|521243639|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
144558213|NCT04357964|521243638|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
144558214|NCT04357964|521243639|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
144558215|NCT04357964|521243638|FG000|Overall Study|Adipose sample was insufficient quality|0|||
144558216|NCT04357964|521243639|FG001|Overall Study|Adipose sample was insufficient quality|1|||
144558217|NCT00733226|521243640|FG000|Overall Study|Withdrawal by Subject|1|||
144558218|NCT00733226|521243641|FG001|Overall Study|Withdrawal by Subject|0|||
144558219|NCT00733226|521243640|FG000|Overall Study|Lost to Follow-up|2|||
144558220|NCT00733226|521243641|FG001|Overall Study|Lost to Follow-up|0|||
144558221|NCT00733226|521243640|FG000|Overall Study|moved to another place|2|||
144558222|NCT00733226|521243641|FG001|Overall Study|moved to another place|0|||
144558223|NCT00848393|521243646|FG000|Overall Study|Protocol Violation|0|||
144558224|NCT00848393|521243647|FG001|Overall Study|Protocol Violation|0|||
144558225|NCT00848393|521243648|FG002|Overall Study|Protocol Violation|1|||
144558226|NCT00848393|521243646|FG000|Overall Study|surgical complications unrelated to stud|0|||
144558227|NCT00848393|521243647|FG001|Overall Study|surgical complications unrelated to stud|0|||
144558228|NCT00848393|521243648|FG002|Overall Study|surgical complications unrelated to stud|2|||
144558229|NCT02561078|521243649|FG000|Overall Study|Adverse Event|5|||
144558230|NCT02561078|521243650|FG001|Overall Study|Adverse Event|2|||
144558231|NCT02561078|521243649|FG000|Overall Study|Death|2|||
144558232|NCT02561078|521243650|FG001|Overall Study|Death|1|||
144558233|NCT02561078|521243649|FG000|Overall Study|Lost to Follow-up|2|||
144558234|NCT02561078|521243650|FG001|Overall Study|Lost to Follow-up|6|||
144558235|NCT02561078|521243649|FG000|Overall Study|Non-Compliance with Study Drug|6|||
144558236|NCT02561078|521243650|FG001|Overall Study|Non-Compliance with Study Drug|3|||
144558237|NCT02561078|521243649|FG000|Overall Study|Physician Decision|2|||
144558238|NCT02561078|521243650|FG001|Overall Study|Physician Decision|3|||
144617362|NCT00112905|521459688|FG000|Overall Study|Alternative treatment|1|||
144727828|NCT00728949|521858085|FG001|Overall Study|Abnormal Lab Results|2|||
144727829|NCT00728949|521858084|FG000|Overall Study|On treatment at cutoff date|1|||
144727830|NCT00728949|521858085|FG001|Overall Study|On treatment at cutoff date|0|||
144727831|NCT00755196|521858088|FG000|Overall Study|Lost to Follow-up|1|||
144727832|NCT00755196|521858088|FG000|Overall Study|Lack of Efficiency|1|||
144727833|NCT01604850|521858089|FG000|Overall Study|Enrolled but never treated|0|||
144558239|NCT02561078|521243649|FG000|Overall Study|Withdrawal by Subject|13|||
144558240|NCT02561078|521243650|FG001|Overall Study|Withdrawal by Subject|10|||
144558241|NCT00598871|521243653|FG000|Overall Study|Adverse Event|0|||
144558242|NCT00598871|521243654|FG001|Overall Study|Adverse Event|1|||
144558243|NCT01194271|521243655|FG000|Overall Study|Withdrawal by Subject|1|||
144558244|NCT01194271|521243655|FG000|Overall Study|Ineligible, Screen Failure|1|||
144617363|NCT00112905|521459688|FG000|Overall Study|performance status was deteiorating|1|||
144617364|NCT02600507|521459689|FG000|Overall Study|Adverse Event|3|||
144617365|NCT02600507|521459690|FG001|Overall Study|Adverse Event|15|||
144617366|NCT02600507|521459691|FG002|Overall Study|Adverse Event|5|||
144727834|NCT01604850|521858090|FG001|Overall Study|Enrolled but never treated|1|||
144617367|NCT02600507|521459689|FG000|Overall Study|Lack of Efficacy|3|||
144617368|NCT02600507|521459690|FG001|Overall Study|Lack of Efficacy|8|||
144617369|NCT02600507|521459691|FG002|Overall Study|Lack of Efficacy|5|||
144617370|NCT02600507|521459689|FG000|Overall Study|Lost to Follow-up|3|||
144617371|NCT02600507|521459690|FG001|Overall Study|Lost to Follow-up|5|||
144558245|NCT01194271|521243655|FG000|Overall Study|Death|1|||
144558246|NCT01983462|521243658|FG000|Overall Study|Adverse Event|1|||
144558247|NCT01983462|521243659|FG001|Overall Study|Adverse Event|0|||
144558248|NCT01983462|521243660|FG002|Overall Study|Adverse Event|0|||
144558249|NCT00043186|521243663|FG000|Overall Study|Physician Decision|0|||
144558250|NCT00043186|521243664|FG001|Overall Study|Physician Decision|0|||
144558251|NCT00043186|521243665|FG002|Overall Study|Physician Decision|3|||
144558252|NCT00043186|521243666|FG003|Overall Study|Physician Decision|0|||
144617372|NCT02600507|521459691|FG002|Overall Study|Lost to Follow-up|2|||
144558253|NCT00043186|521243667|FG004|Overall Study|Physician Decision|1|||
144558254|NCT00043186|521243668|FG005|Overall Study|Physician Decision|0|||
144558255|NCT00043186|521243669|FG006|Overall Study|Physician Decision|0|||
144558256|NCT00043186|521243670|FG007|Overall Study|Physician Decision|1|||
144558257|NCT00043186|521243671|FG008|Overall Study|Physician Decision|1|||
144558258|NCT00043186|521243663|FG000|Overall Study|Adverse Event|2|||
144558259|NCT00043186|521243664|FG001|Overall Study|Adverse Event|2|||
144558260|NCT00043186|521243665|FG002|Overall Study|Adverse Event|2|||
144558261|NCT00043186|521243666|FG003|Overall Study|Adverse Event|3|||
144558262|NCT00043186|521243667|FG004|Overall Study|Adverse Event|2|||
144558263|NCT00043186|521243668|FG005|Overall Study|Adverse Event|1|||
144558264|NCT00043186|521243669|FG006|Overall Study|Adverse Event|2|||
144558265|NCT00043186|521243670|FG007|Overall Study|Adverse Event|1|||
144558266|NCT00043186|521243671|FG008|Overall Study|Adverse Event|3|||
144558267|NCT00043186|521243663|FG000|Overall Study|Withdrawal by Subject|11|||
144558268|NCT00043186|521243664|FG001|Overall Study|Withdrawal by Subject|8|||
144558269|NCT00043186|521243665|FG002|Overall Study|Withdrawal by Subject|11|||
144558270|NCT00043186|521243666|FG003|Overall Study|Withdrawal by Subject|13|||
144558271|NCT00043186|521243667|FG004|Overall Study|Withdrawal by Subject|14|||
144558272|NCT00043186|521243668|FG005|Overall Study|Withdrawal by Subject|6|||
144558273|NCT00043186|521243669|FG006|Overall Study|Withdrawal by Subject|12|||
144558274|NCT00043186|521243670|FG007|Overall Study|Withdrawal by Subject|9|||
144558275|NCT00043186|521243671|FG008|Overall Study|Withdrawal by Subject|10|||
144558276|NCT00043186|521243663|FG000|Overall Study|Death|0|||
144558277|NCT00043186|521243664|FG001|Overall Study|Death|0|||
144558278|NCT00043186|521243665|FG002|Overall Study|Death|1|||
144558279|NCT00043186|521243666|FG003|Overall Study|Death|0|||
144558280|NCT00043186|521243667|FG004|Overall Study|Death|0|||
144558281|NCT00043186|521243668|FG005|Overall Study|Death|0|||
144558282|NCT00043186|521243669|FG006|Overall Study|Death|2|||
144558283|NCT00043186|521243670|FG007|Overall Study|Death|0|||
144558284|NCT00043186|521243671|FG008|Overall Study|Death|0|||
144558285|NCT00043186|521243663|FG000|Overall Study|Disease progression|1|||
144558286|NCT00043186|521243664|FG001|Overall Study|Disease progression|0|||
144558287|NCT00043186|521243665|FG002|Overall Study|Disease progression|0|||
144558288|NCT00043186|521243666|FG003|Overall Study|Disease progression|3|||
144558289|NCT00043186|521243667|FG004|Overall Study|Disease progression|0|||
144558290|NCT00043186|521243668|FG005|Overall Study|Disease progression|0|||
144558291|NCT00043186|521243669|FG006|Overall Study|Disease progression|0|||
144558292|NCT00043186|521243670|FG007|Overall Study|Disease progression|4|||
144558293|NCT00043186|521243671|FG008|Overall Study|Disease progression|0|||
144558294|NCT00043186|521243663|FG000|Overall Study|Ineligibility determined|0|||
144558295|NCT00043186|521243664|FG001|Overall Study|Ineligibility determined|0|||
144558296|NCT00043186|521243665|FG002|Overall Study|Ineligibility determined|0|||
144558297|NCT00043186|521243666|FG003|Overall Study|Ineligibility determined|0|||
144617373|NCT02600507|521459689|FG000|Overall Study|Protocol Violation|12|||
144617374|NCT02600507|521459690|FG001|Overall Study|Protocol Violation|4|||
144617375|NCT02600507|521459691|FG002|Overall Study|Protocol Violation|4|||
144617376|NCT02600507|521459689|FG000|Overall Study|Physician Decision|1|||
144558298|NCT00043186|521243667|FG004|Overall Study|Ineligibility determined|0|||
144617377|NCT02600507|521459690|FG001|Overall Study|Physician Decision|0|||
144617378|NCT02600507|521459691|FG002|Overall Study|Physician Decision|1|||
144558299|NCT00043186|521243668|FG005|Overall Study|Ineligibility determined|0|||
144558300|NCT00043186|521243669|FG006|Overall Study|Ineligibility determined|0|||
144617379|NCT02600507|521459689|FG000|Overall Study|Withdrawal by Subject|7|||
144558301|NCT00043186|521243670|FG007|Overall Study|Ineligibility determined|0|||
144558302|NCT00043186|521243671|FG008|Overall Study|Ineligibility determined|1|||
144558303|NCT00043186|521243663|FG000|Overall Study|Lost to Follow-up|3|||
144558304|NCT00043186|521243664|FG001|Overall Study|Lost to Follow-up|5|||
144558305|NCT00043186|521243665|FG002|Overall Study|Lost to Follow-up|1|||
144558306|NCT00043186|521243666|FG003|Overall Study|Lost to Follow-up|1|||
144558307|NCT00043186|521243667|FG004|Overall Study|Lost to Follow-up|1|||
144558308|NCT00043186|521243668|FG005|Overall Study|Lost to Follow-up|1|||
144558309|NCT00043186|521243669|FG006|Overall Study|Lost to Follow-up|1|||
144558310|NCT00043186|521243670|FG007|Overall Study|Lost to Follow-up|1|||
144558311|NCT00043186|521243671|FG008|Overall Study|Lost to Follow-up|2|||
144558312|NCT00043186|521243663|FG000|Overall Study|Noncompliance|0|||
144558313|NCT00043186|521243664|FG001|Overall Study|Noncompliance|0|||
144558314|NCT00043186|521243665|FG002|Overall Study|Noncompliance|1|||
144558315|NCT00043186|521243666|FG003|Overall Study|Noncompliance|1|||
144558316|NCT00043186|521243667|FG004|Overall Study|Noncompliance|0|||
144558317|NCT00043186|521243668|FG005|Overall Study|Noncompliance|0|||
144558318|NCT00043186|521243669|FG006|Overall Study|Noncompliance|0|||
144558319|NCT00043186|521243670|FG007|Overall Study|Noncompliance|0|||
144558320|NCT00043186|521243671|FG008|Overall Study|Noncompliance|0|||
144558321|NCT00043186|521243663|FG000|Overall Study|Other|0|||
144558322|NCT00043186|521243664|FG001|Overall Study|Other|0|||
144558323|NCT00043186|521243665|FG002|Overall Study|Other|1|||
144558324|NCT00043186|521243666|FG003|Overall Study|Other|1|||
144558325|NCT00043186|521243667|FG004|Overall Study|Other|0|||
144558326|NCT00043186|521243668|FG005|Overall Study|Other|0|||
144558327|NCT00043186|521243669|FG006|Overall Study|Other|0|||
144558328|NCT00043186|521243670|FG007|Overall Study|Other|0|||
144558329|NCT00043186|521243671|FG008|Overall Study|Other|0|||
144558330|NCT00958711|521243672|FG000|Overall Study|Withdrawal by Subject|0|||
144558331|NCT00958711|521243673|FG001|Overall Study|Withdrawal by Subject|4|||
144558332|NCT00958711|521243672|FG000|Overall Study|Physician Decision|5|||
144558333|NCT00958711|521243673|FG001|Overall Study|Physician Decision|7|||
144558334|NCT00958711|521243672|FG000|Overall Study|Lost to Follow-up|4|||
144558335|NCT00958711|521243673|FG001|Overall Study|Lost to Follow-up|1|||
144558336|NCT00958711|521243672|FG000|Overall Study|Other|2|||
144558337|NCT00958711|521243673|FG001|Overall Study|Other|5|||
144558338|NCT00958711|521243672|FG000|Overall Study|Death|1|||
144558339|NCT00958711|521243673|FG001|Overall Study|Death|2|||
144558340|NCT00958711|521243672|FG000|Overall Study|Adverse Event|1|||
144558341|NCT00958711|521243673|FG001|Overall Study|Adverse Event|2|||
144558342|NCT02151643|521243674|FG000|Overall Study|Adverse Event|2|||
144617380|NCT02600507|521459690|FG001|Overall Study|Withdrawal by Subject|11|||
144617381|NCT02600507|521459691|FG002|Overall Study|Withdrawal by Subject|7|||
144617382|NCT02600507|521459689|FG000|Overall Study|Other|0|||
144617383|NCT02600507|521459690|FG001|Overall Study|Other|1|||
144558343|NCT02151643|521243675|FG001|Overall Study|Adverse Event|0|||
144558344|NCT02151643|521243676|FG002|Overall Study|Adverse Event|1|||
144558345|NCT02151643|521243677|FG003|Overall Study|Adverse Event|4|||
144558346|NCT02151643|521243678|FG004|Overall Study|Adverse Event|0|||
144558347|NCT02151643|521243674|FG000|Overall Study|Withdrawal by Subject|0|||
144558348|NCT02151643|521243675|FG001|Overall Study|Withdrawal by Subject|1|||
144558349|NCT02151643|521243676|FG002|Overall Study|Withdrawal by Subject|1|||
144558350|NCT02151643|521243677|FG003|Overall Study|Withdrawal by Subject|1|||
144558351|NCT02151643|521243678|FG004|Overall Study|Withdrawal by Subject|1|||
144558352|NCT02151643|521243674|FG000|Overall Study|Hyperphosphataemia|1|||
144558353|NCT02151643|521243675|FG001|Overall Study|Hyperphosphataemia|0|||
144558354|NCT02151643|521243676|FG002|Overall Study|Hyperphosphataemia|0|||
144558355|NCT02151643|521243677|FG003|Overall Study|Hyperphosphataemia|0|||
144558356|NCT02151643|521243678|FG004|Overall Study|Hyperphosphataemia|1|||
144558357|NCT02151643|521243674|FG000|Overall Study|High Ferritin levels|3|||
144558358|NCT02151643|521243675|FG001|Overall Study|High Ferritin levels|3|||
144558359|NCT02151643|521243676|FG002|Overall Study|High Ferritin levels|2|||
144558360|NCT02151643|521243677|FG003|Overall Study|High Ferritin levels|2|||
144558361|NCT02151643|521243678|FG004|Overall Study|High Ferritin levels|1|||
144558362|NCT00550771|521243682|FG000|Overall Study|Adverse Event|11|||
144558363|NCT00550771|521243683|FG001|Overall Study|Adverse Event|3|||
144558364|NCT00550771|521243682|FG000|Overall Study|Discontinued for study-related reasons|0|||
144558365|NCT00550771|521243683|FG001|Overall Study|Discontinued for study-related reasons|1|||
144558366|NCT00550771|521243682|FG000|Overall Study|Physician Decision|2|||
144558367|NCT00550771|521243683|FG001|Overall Study|Physician Decision|0|||
144558368|NCT00550771|521243682|FG000|Overall Study|Withdrawal by Subject|0|||
144558369|NCT00550771|521243683|FG001|Overall Study|Withdrawal by Subject|1|||
144617384|NCT02600507|521459691|FG002|Overall Study|Other|1|||
144617385|NCT04541004|521459696|FG000|Overall Study|Adverse Event|2|||
144617386|NCT00605085|521459697|FG000|Overall Study|Withdrawal by Subject|8|||
144558370|NCT00550771|521243682|FG000|Overall Study|Protocol Violation|4|||
144558371|NCT00550771|521243683|FG001|Overall Study|Protocol Violation|5|||
144558372|NCT03022578|521243684|FG000|Overall Study|Adverse Event|1|||
144558373|NCT03022578|521243684|FG000|Overall Study|Lack of Efficacy|2|||
144558374|NCT03022578|521243684|FG000|Overall Study|Withdrawal by Subject|1|||
144558375|NCT03681353|521243685|FG000|Overall Study|Lost to Follow-up|2|||
144558376|NCT03681353|521243685|FG000|Overall Study|Withdrawal by Subject|3|||
144617387|NCT00605085|521459698|FG001|Overall Study|Withdrawal by Subject|5|||
144558377|NCT03681353|521243685|FG000|Overall Study|withdrawn by PI|2|||
144558378|NCT01145417|521243686|FG000|Overall Study|Death|1|||
144558379|NCT01145417|521243687|FG001|Overall Study|Death|0|||
144558380|NCT01145417|521243686|FG000|Overall Study|Lost to Follow-up|2|||
144558381|NCT01145417|521243687|FG001|Overall Study|Lost to Follow-up|1|||
144558382|NCT01145417|521243686|FG000|Overall Study|Withdrawal by Subject|1|||
144558383|NCT01145417|521243687|FG001|Overall Study|Withdrawal by Subject|2|||
144558384|NCT01145417|521243686|FG000|Overall Study|Pregnancy|1|||
144558385|NCT01145417|521243687|FG001|Overall Study|Pregnancy|0|||
144558386|NCT01145417|521243686|FG000|Overall Study|Adverse Event|0|||
144558387|NCT01145417|521243687|FG001|Overall Study|Adverse Event|1|||
144558388|NCT01145417|521243686|FG000|Overall Study|Study terminated by sponsor|35|||
144558389|NCT01145417|521243687|FG001|Overall Study|Study terminated by sponsor|43|||
144558390|NCT01145417|521243686|FG000|Overall Study|Other|1|||
144558391|NCT01145417|521243687|FG001|Overall Study|Other|0|||
144558392|NCT01797562|521243688|FG000|Overall Study|Protocol Violation|5|||
144558393|NCT03568708|521243690|FG000|Overall Study|Withdrawal by Subject|1|||
144558394|NCT03568708|521243691|FG001|Overall Study|Withdrawal by Subject|1|||
144558395|NCT03568708|521243690|FG000|Overall Study|Lost to Follow-up|0|||
144558396|NCT03568708|521243691|FG001|Overall Study|Lost to Follow-up|1|||
144558397|NCT00511147|521243692|FG000|Overall Study|Withdrawal by Subject|1|||
144558398|NCT00511147|521243692|FG000|Overall Study|Disease progression|5|||
144558399|NCT00511147|521243692|FG000|Overall Study|Required platelet transfusion|1|||
144558400|NCT05372913|521243699|FG000|Overall Study|Withdrawal by Subject|0|||
144558401|NCT05372913|521243700|FG001|Overall Study|Withdrawal by Subject|2|||
144558402|NCT05372913|521243699|FG000|Overall Study|Protocol Violation|2|||
144558403|NCT05372913|521243700|FG001|Overall Study|Protocol Violation|2|||
144558404|NCT05372913|521243699|FG000|Overall Study|Adverse Event|0|||
144558405|NCT05372913|521243700|FG001|Overall Study|Adverse Event|1|||
144558406|NCT03275402|521243701|FG000|Overall Study|Death|17|||
144558407|NCT03275402|521243701|FG000|Overall Study|Study terminated by sponsor|21|||
144558408|NCT03275402|521243701|FG000|Overall Study|Withdrawal by Subject|1|||
144558409|NCT03193216|521243702|FG000|Overall Study|Lost to Follow-up|1|||
144558410|NCT03193216|521243703|FG001|Overall Study|Lost to Follow-up|0|||
144558411|NCT03193216|521243702|FG000|Overall Study|Withdrawal by Subject|5|||
144558412|NCT03193216|521243703|FG001|Overall Study|Withdrawal by Subject|0|||
144558413|NCT03193216|521243702|FG000|Overall Study|Physician Decision|4|||
144558414|NCT03193216|521243703|FG001|Overall Study|Physician Decision|0|||
144558415|NCT01514864|521243704|FG000|Overall Study|Disease progression|7|||
144558416|NCT01514864|521243705|FG001|Overall Study|Disease progression|5|||
144558417|NCT01514864|521243704|FG000|Overall Study|Study drug toxicity|2|||
144558418|NCT01514864|521243705|FG001|Overall Study|Study drug toxicity|0|||
144558419|NCT02986659|521243706|FG000|First Intervention Period|Adverse Event|3|||
144558420|NCT02986659|521243707|FG001|First Intervention Period|Adverse Event|1|||
144558421|NCT02986659|521243706|FG000|First Intervention Period|Lost to Follow-up|1|||
144558422|NCT02986659|521243707|FG001|First Intervention Period|Lost to Follow-up|0|||
144558423|NCT02986659|521243706|FG000|First Intervention Period|Withdrawal by Subject|0|||
144558424|NCT02986659|521243707|FG001|First Intervention Period|Withdrawal by Subject|1|||
144558425|NCT02986659|521243706|FG000|Second Intervention Period|Adverse Event|0|||
144558426|NCT02986659|521243707|FG001|Second Intervention Period|Adverse Event|6|||
144558427|NCT02254681|521243713|FG000|Overall Study|Lack of Efficacy|6|||
144558428|NCT02469077|521243714|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
144558429|NCT02469077|521243715|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
144558430|NCT02469077|521243714|FG000|Post Randomization/Intervention Period|Relocated|1|||
144558431|NCT02469077|521243715|FG001|Post Randomization/Intervention Period|Relocated|1|||
144558432|NCT02469077|521243714|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
144558433|NCT02469077|521243715|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
144558434|NCT02469077|521243714|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
144558435|NCT02469077|521243715|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
144558436|NCT01059526|521243716|FG000|Overall Study|Patient enrolled but not treated|20|||
144558437|NCT01059526|521243717|FG001|Overall Study|Patient enrolled but not treated|17|||
144558438|NCT01059526|521243716|FG000|Overall Study|Adverse Event|2|||
144558439|NCT01059526|521243717|FG001|Overall Study|Adverse Event|2|||
144558440|NCT01059526|521243716|FG000|Overall Study|Protocol Violation|0|||
144558441|NCT01059526|521243717|FG001|Overall Study|Protocol Violation|1|||
144558442|NCT01059526|521243716|FG000|Overall Study|Withdrawal by Subject|3|||
144558443|NCT01059526|521243717|FG001|Overall Study|Withdrawal by Subject|1|||
144558444|NCT01059526|521243716|FG000|Overall Study|Lost to Follow-up|4|||
144262456|NCT01317641|520161440|FG006|Overall Study|Disease progression|0|||
144558445|NCT01059526|521243717|FG001|Overall Study|Lost to Follow-up|1|||
144558446|NCT01059526|521243716|FG000|Overall Study|Patient found to be dermatographic|1|||
144558447|NCT01059526|521243717|FG001|Overall Study|Patient found to be dermatographic|0|||
144558448|NCT02005029|521243718|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
144558449|NCT02005029|521243719|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
144558450|NCT02621047|521243720|FG000|Overall Study|Adverse Event|0|||
144558451|NCT02621047|521243721|FG001|Overall Study|Adverse Event|0|||
144262457|NCT01317641|520161441|FG007|Overall Study|Disease progression|3|||
144558452|NCT02621047|521243722|FG002|Overall Study|Adverse Event|1|||
144558453|NCT01370018|521243723|FG000|Overall Study|Did not meet criteria for analysis|1|||
144558454|NCT03772041|521243726|FG000|Overall Study|Adverse Event|8|||
144558455|NCT03772041|521243727|FG001|Overall Study|Adverse Event|3|||
144558456|NCT03772041|521243726|FG000|Overall Study|Withdrawal by Subject|0|||
144558457|NCT03772041|521243727|FG001|Overall Study|Withdrawal by Subject|2|||
144558458|NCT03772041|521243726|FG000|Overall Study|Protocol Violation|4|||
144558459|NCT03772041|521243727|FG001|Overall Study|Protocol Violation|2|||
144558460|NCT03772041|521243726|FG000|Overall Study|Physician Decision|2|||
144558461|NCT03772041|521243727|FG001|Overall Study|Physician Decision|3|||
144558462|NCT01525641|521243728|FG000|Overall Study|Case report form not collected|25|||
144558463|NCT01525641|521243728|FG000|Overall Study|No visit since the first visit|16|||
144558464|NCT01525641|521243728|FG000|Overall Study|Adverse Event|73|||
144558465|NCT01525641|521243728|FG000|Overall Study|Lack of Efficacy|24|||
144558466|NCT01525641|521243728|FG000|Overall Study|Improvement|5|||
144558467|NCT01525641|521243728|FG000|Overall Study|Lost to follow-up (relocation)|1|||
144558468|NCT01525641|521243728|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
144558469|NCT01525641|521243728|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
144558470|NCT01525641|521243728|FG000|Overall Study|Other than stated above|7|||
144558471|NCT02204319|521243733|FG000|Overall Study|Pregnancy|1|||
144558472|NCT02204319|521243733|FG000|Overall Study|Withdrawal by Subject|2|||
144558473|NCT03544229|521243734|FG000|Overall Study|Adverse Event|1|||
144558474|NCT03544229|521243735|FG001|Overall Study|Adverse Event|0|||
144558475|NCT03544229|521243736|FG002|Overall Study|Adverse Event|1|||
144558476|NCT03544229|521243737|FG003|Overall Study|Adverse Event|0|||
144558477|NCT03544229|521243734|FG000|Overall Study|Protocol Deviation|0|||
144558478|NCT03544229|521243735|FG001|Overall Study|Protocol Deviation|0|||
144558479|NCT03544229|521243736|FG002|Overall Study|Protocol Deviation|1|||
144558480|NCT03544229|521243737|FG003|Overall Study|Protocol Deviation|0|||
144558481|NCT03544229|521243734|FG000|Overall Study|Lost to Follow-up|3|||
144558482|NCT03544229|521243735|FG001|Overall Study|Lost to Follow-up|0|||
144558483|NCT03544229|521243736|FG002|Overall Study|Lost to Follow-up|0|||
144558484|NCT03544229|521243737|FG003|Overall Study|Lost to Follow-up|2|||
144558485|NCT03544229|521243734|FG000|Overall Study|Voluntary Withdrawal|2|||
144558486|NCT03544229|521243735|FG001|Overall Study|Voluntary Withdrawal|1|||
144558487|NCT03544229|521243736|FG002|Overall Study|Voluntary Withdrawal|3|||
144558488|NCT03544229|521243737|FG003|Overall Study|Voluntary Withdrawal|0|||
144558489|NCT03544229|521243734|FG000|Overall Study|Lack of Efficacy|0|||
144558490|NCT03544229|521243735|FG001|Overall Study|Lack of Efficacy|1|||
144558491|NCT03544229|521243736|FG002|Overall Study|Lack of Efficacy|0|||
144558492|NCT03544229|521243737|FG003|Overall Study|Lack of Efficacy|0|||
144558493|NCT03794609|521243742|FG000|Overall Study|Other|10|||
144558494|NCT03794609|521243742|FG000|Overall Study|Withdrawal by Subject|66|||
144558495|NCT03794609|521243742|FG000|Overall Study|The child is enrolled in an interventional study|70|||
144558496|NCT03794609|521243742|FG000|Overall Study|Inclusion/exclusion criteria|8|||
144558497|NCT03794609|521243742|FG000|Overall Study|At sponsor's request|151|||
144558498|NCT03794609|521243742|FG000|Overall Study|Physician Decision|1|||
144558499|NCT03794609|521243742|FG000|Overall Study|Lost to Follow-up|5|||
144558500|NCT02205476|521243743|FG000|Overall Study|Study termination by Sponsor|7|||
144558501|NCT02205476|521243744|FG001|Overall Study|Study termination by Sponsor|3|||
144558502|NCT00139659|521243749|FG000|Overall Study|Adverse Event|12|||
144558503|NCT00139659|521243750|FG001|Overall Study|Adverse Event|1|||
144558504|NCT00139659|521243749|FG000|Overall Study|Lack of Efficacy|1|||
144558505|NCT00139659|521243750|FG001|Overall Study|Lack of Efficacy|1|||
144558506|NCT00139659|521243749|FG000|Overall Study|Lost to Follow-up|7|||
144558507|NCT00139659|521243750|FG001|Overall Study|Lost to Follow-up|3|||
144558508|NCT00139659|521243749|FG000|Overall Study|Reason not Specified|6|||
144558509|NCT00139659|521243750|FG001|Overall Study|Reason not Specified|3|||
144558510|NCT00139659|521243749|FG000|Overall Study|Withdrawal by Subject|14|||
144617388|NCT00605085|521459697|FG000|Overall Study|Adverse Event|9|||
144617389|NCT00605085|521459698|FG001|Overall Study|Adverse Event|5|||
144617390|NCT00605085|521459697|FG000|Overall Study|Pregnancy|2|||
144558511|NCT00139659|521243750|FG001|Overall Study|Withdrawal by Subject|10|||
144558512|NCT04089332|521243756|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
144558513|NCT04089332|521243756|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
144558514|NCT04089332|521243756|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
144558515|NCT06016127|521243761|FG000|Overall Study|Withdrawal by Subject|4|||
144558516|NCT06016127|521243762|FG001|Overall Study|Withdrawal by Subject|3|||
144558517|NCT02256488|521243765|FG000|Overall Study|Lost to Follow-up|6|||
144558518|NCT02256488|521243766|FG001|Overall Study|Lost to Follow-up|6|||
144558519|NCT02256488|521243767|FG002|Overall Study|Lost to Follow-up|9|||
144558520|NCT02256488|521243768|FG003|Overall Study|Lost to Follow-up|3|||
144558521|NCT02256488|521243765|FG000|Overall Study|OTHER|1|||
144558522|NCT02256488|521243766|FG001|Overall Study|OTHER|0|||
144558523|NCT02256488|521243767|FG002|Overall Study|OTHER|1|||
144558524|NCT02256488|521243768|FG003|Overall Study|OTHER|1|||
144558525|NCT02256488|521243765|FG000|Overall Study|Withdrawal by Subject|1|||
144558526|NCT02256488|521243766|FG001|Overall Study|Withdrawal by Subject|0|||
144558527|NCT02256488|521243767|FG002|Overall Study|Withdrawal by Subject|0|||
144617391|NCT00605085|521459698|FG001|Overall Study|Pregnancy|0|||
144558528|NCT02256488|521243768|FG003|Overall Study|Withdrawal by Subject|2|||
144558529|NCT00975130|521243769|FG000|Study Part 1|Adverse Event|150|||
144558530|NCT00975130|521243770|FG001|Study Part 1|Adverse Event|0|||
144558531|NCT00975130|521243771|FG002|Study Part 1|Adverse Event|0|||
144727835|NCT01604850|521858089|FG000|Overall Study|Efficacy Failure|50|||
144727836|NCT01604850|521858090|FG001|Overall Study|Efficacy Failure|29|||
144727837|NCT01604850|521858089|FG000|Overall Study|Lost to Follow-up|1|||
144727838|NCT01604850|521858090|FG001|Overall Study|Lost to Follow-up|0|||
144727839|NCT01604850|521858089|FG000|Overall Study|Subject withdrew consent|1|||
144727840|NCT01604850|521858090|FG001|Overall Study|Subject withdrew consent|0|||
144727841|NCT01703832|521858091|FG000|Overall Study|Withdrawal by Subject|1|||
144727842|NCT01703832|521858092|FG001|Overall Study|Withdrawal by Subject|0|||
144727843|NCT00243932|521858093|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
144727844|NCT00243932|521858094|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
144727845|NCT00243932|521858095|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
144727846|NCT00543309|521858096|FG000|Overall Study|Physician Decision|0|||
144727847|NCT00543309|521858097|FG001|Overall Study|Physician Decision|1|||
144558532|NCT00975130|521243769|FG000|Study Part 1|Lost to Follow-up|19|||
144558533|NCT00975130|521243770|FG001|Study Part 1|Lost to Follow-up|0|||
144558534|NCT00975130|521243771|FG002|Study Part 1|Lost to Follow-up|0|||
144558535|NCT00975130|521243769|FG000|Study Part 1|Withdrawal by Subject|61|||
144558536|NCT00975130|521243770|FG001|Study Part 1|Withdrawal by Subject|0|||
144558537|NCT00975130|521243771|FG002|Study Part 1|Withdrawal by Subject|0|||
144558538|NCT00975130|521243769|FG000|Study Part 1|Protocol Violation|13|||
144558539|NCT00975130|521243770|FG001|Study Part 1|Protocol Violation|0|||
144558540|NCT00975130|521243771|FG002|Study Part 1|Protocol Violation|0|||
144558541|NCT00975130|521243769|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
144558542|NCT00975130|521243770|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
144558543|NCT00975130|521243771|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
144558544|NCT00975130|521243769|FG000|Study Part 1|Administrative|4|||
144558545|NCT00975130|521243770|FG001|Study Part 1|Administrative|0|||
144558546|NCT00975130|521243771|FG002|Study Part 1|Administrative|0|||
144558547|NCT00975130|521243769|FG000|Study Part 1|Withdrew Consent|24|||
144558548|NCT00975130|521243770|FG001|Study Part 1|Withdrew Consent|0|||
144727848|NCT00543309|521858098|FG002|Overall Study|Physician Decision|0|||
144558549|NCT00975130|521243771|FG002|Study Part 1|Withdrew Consent|0|||
144558550|NCT00975130|521243769|FG000|Study Part 2|Adverse Event|0|||
144558551|NCT00975130|521243770|FG001|Study Part 2|Adverse Event|14|||
144558552|NCT00975130|521243771|FG002|Study Part 2|Adverse Event|7|||
144558553|NCT00975130|521243769|FG000|Study Part 2|Lost to Follow-up|0|||
144558554|NCT00975130|521243770|FG001|Study Part 2|Lost to Follow-up|0|||
144558555|NCT00975130|521243771|FG002|Study Part 2|Lost to Follow-up|1|||
144558556|NCT00975130|521243769|FG000|Study Part 2|Withdrawal by Subject|0|||
144558557|NCT00975130|521243770|FG001|Study Part 2|Withdrawal by Subject|13|||
144558558|NCT00975130|521243771|FG002|Study Part 2|Withdrawal by Subject|5|||
144558559|NCT00975130|521243769|FG000|Study Part 2|Withdrew Consent|0|||
144558560|NCT00975130|521243770|FG001|Study Part 2|Withdrew Consent|6|||
144558561|NCT00975130|521243771|FG002|Study Part 2|Withdrew Consent|2|||
144558562|NCT00975130|521243769|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
144558563|NCT00975130|521243770|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
144558564|NCT00975130|521243771|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
144558565|NCT00975130|521243769|FG000|Study Part 2|Administrative|0|||
144558566|NCT00975130|521243770|FG001|Study Part 2|Administrative|1|||
144558567|NCT00975130|521243771|FG002|Study Part 2|Administrative|0|||
144558568|NCT00975130|521243769|FG000|Study Part 2|Protocol Violation|0|||
144262458|NCT01317641|520161442|FG008|Overall Study|Disease progression|4|||
144558569|NCT00975130|521243770|FG001|Study Part 2|Protocol Violation|0|||
144558570|NCT00975130|521243771|FG002|Study Part 2|Protocol Violation|1|||
144558571|NCT01261793|521243772|FG000|Overall Study|Lack of Efficacy|44|||
144558572|NCT01261793|521243773|FG001|Overall Study|Lack of Efficacy|37|||
144558573|NCT01261793|521243774|FG002|Overall Study|Lack of Efficacy|32|||
144558574|NCT01261793|521243772|FG000|Overall Study|Protocol Violation|3|||
144558575|NCT01261793|521243773|FG001|Overall Study|Protocol Violation|5|||
144558576|NCT01261793|521243774|FG002|Overall Study|Protocol Violation|6|||
144558577|NCT01261793|521243772|FG000|Overall Study|Lost to Follow-up|10|||
144558578|NCT01261793|521243773|FG001|Overall Study|Lost to Follow-up|3|||
144558579|NCT01261793|521243774|FG002|Overall Study|Lost to Follow-up|7|||
144558580|NCT01261793|521243772|FG000|Overall Study|Withdrawal by Subject|12|||
144558581|NCT01261793|521243773|FG001|Overall Study|Withdrawal by Subject|14|||
144558582|NCT01261793|521243774|FG002|Overall Study|Withdrawal by Subject|14|||
144558583|NCT01261793|521243772|FG000|Overall Study|Death|3|||
144558584|NCT01261793|521243773|FG001|Overall Study|Death|1|||
144558585|NCT01261793|521243774|FG002|Overall Study|Death|0|||
144558586|NCT01261793|521243772|FG000|Overall Study|Adverse Event|9|||
144558587|NCT01261793|521243773|FG001|Overall Study|Adverse Event|24|||
144558588|NCT01261793|521243774|FG002|Overall Study|Adverse Event|19|||
144558589|NCT01261793|521243772|FG000|Overall Study|Patient non-availability|1|||
144558590|NCT01261793|521243773|FG001|Overall Study|Patient non-availability|1|||
144558591|NCT01261793|521243774|FG002|Overall Study|Patient non-availability|1|||
144558592|NCT01261793|521243772|FG000|Overall Study|Suspected pregnancy|1|||
144558593|NCT01261793|521243773|FG001|Overall Study|Suspected pregnancy|1|||
144727849|NCT04538170|521858110|FG000|Overall Study|Withdrawal by Subject|104|||
144727850|NCT04538170|521858111|FG001|Overall Study|Withdrawal by Subject|210|||
144727851|NCT01682083|521858116|FG000|Overall Study|Lost to Follow-up|11|||
144727852|NCT01682083|521858117|FG001|Overall Study|Lost to Follow-up|18|||
144727853|NCT01682083|521858116|FG000|Overall Study|Withdrawal by Subject|31|||
144727854|NCT01682083|521858117|FG001|Overall Study|Withdrawal by Subject|40|||
144727855|NCT01682083|521858116|FG000|Overall Study|Death|60|||
144727856|NCT01682083|521858117|FG001|Overall Study|Death|93|||
144727857|NCT01682083|521858116|FG000|Overall Study|Physician Decision|5|||
144727858|NCT01682083|521858117|FG001|Overall Study|Physician Decision|4|||
144727859|NCT00864097|521858118|FG000|Overall Study|Death|0|||
144727860|NCT00864097|521858119|FG001|Overall Study|Death|1|||
144727861|NCT00864097|521858120|FG002|Overall Study|Death|0|||
144727862|NCT00864097|521858121|FG003|Overall Study|Death|0|||
144727863|NCT00864097|521858118|FG000|Overall Study|Adverse Event|6|||
144727864|NCT00864097|521858119|FG001|Overall Study|Adverse Event|8|||
144727865|NCT00864097|521858120|FG002|Overall Study|Adverse Event|11|||
144727866|NCT00864097|521858121|FG003|Overall Study|Adverse Event|9|||
144727867|NCT00864097|521858118|FG000|Overall Study|Lack of Efficacy|9|||
144727868|NCT00864097|521858119|FG001|Overall Study|Lack of Efficacy|3|||
144727869|NCT00864097|521858120|FG002|Overall Study|Lack of Efficacy|7|||
144727870|NCT00864097|521858121|FG003|Overall Study|Lack of Efficacy|2|||
144727871|NCT00864097|521858118|FG000|Overall Study|Lost to Follow-up|0|||
144727872|NCT00864097|521858119|FG001|Overall Study|Lost to Follow-up|1|||
144727873|NCT00864097|521858120|FG002|Overall Study|Lost to Follow-up|0|||
144727874|NCT00864097|521858121|FG003|Overall Study|Lost to Follow-up|1|||
144727875|NCT00864097|521858118|FG000|Overall Study|Withdrawal by Subject|15|||
144727876|NCT00864097|521858119|FG001|Overall Study|Withdrawal by Subject|11|||
144727877|NCT00864097|521858120|FG002|Overall Study|Withdrawal by Subject|11|||
144727878|NCT00864097|521858121|FG003|Overall Study|Withdrawal by Subject|12|||
144727879|NCT00864097|521858118|FG000|Overall Study|Protocol Violation|2|||
144727880|NCT00864097|521858119|FG001|Overall Study|Protocol Violation|1|||
144727881|NCT00864097|521858120|FG002|Overall Study|Protocol Violation|0|||
144727882|NCT00864097|521858121|FG003|Overall Study|Protocol Violation|1|||
144727883|NCT00864097|521858118|FG000|Overall Study|Terminated by sponsor|105|||
144727884|NCT00864097|521858119|FG001|Overall Study|Terminated by sponsor|112|||
144727885|NCT00864097|521858120|FG002|Overall Study|Terminated by sponsor|102|||
144727886|NCT00864097|521858121|FG003|Overall Study|Terminated by sponsor|99|||
144727887|NCT00864097|521858118|FG000|Overall Study|Randomized but not treated|2|||
144727888|NCT00864097|521858119|FG001|Overall Study|Randomized but not treated|0|||
144727889|NCT00864097|521858120|FG002|Overall Study|Randomized but not treated|1|||
144727890|NCT00864097|521858121|FG003|Overall Study|Randomized but not treated|0|||
144727891|NCT00864097|521858118|FG000|Overall Study|Other|0|||
144727892|NCT00864097|521858119|FG001|Overall Study|Other|0|||
144727893|NCT00864097|521858120|FG002|Overall Study|Other|0|||
144727894|NCT00864097|521858121|FG003|Overall Study|Other|1|||
144727895|NCT03883906|521858128|FG000|Overall Study|Withdrawal by Subject|2|||
144727896|NCT03883906|521858128|FG000|Overall Study|Physician Decision|5|||
144727897|NCT02603952|521858131|FG000|Overall Study|Withdrawal by Subject|1|||
144727898|NCT02603952|521858132|FG001|Overall Study|Withdrawal by Subject|0|||
144727899|NCT02603952|521858133|FG002|Overall Study|Withdrawal by Subject|0|||
144727900|NCT02603952|521858134|FG003|Overall Study|Withdrawal by Subject|0|||
144727901|NCT02603952|521858131|FG000|Overall Study|Received oseltamivir by error|0|||
144727902|NCT02603952|521858132|FG001|Overall Study|Received oseltamivir by error|0|||
144727903|NCT02603952|521858133|FG002|Overall Study|Received oseltamivir by error|0|||
144727904|NCT02603952|521858134|FG003|Overall Study|Received oseltamivir by error|1|||
144727905|NCT01004172|521858136|FG000|Overall Study|Progressive Disease in CNS Only|16|||
144727906|NCT01004172|521858136|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
144727907|NCT01004172|521858136|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
144727908|NCT01004172|521858136|FG000|Overall Study|Adverse Event|1|||
144727909|NCT01004172|521858136|FG000|Overall Study|Physician Decision|1|||
144727910|NCT01004172|521858136|FG000|Overall Study|Symptomatic Deterioration|2|||
144727911|NCT01691248|521858142|FG000|Overall Study|Protocol Violation|43|||
144727912|NCT01691248|521858143|FG001|Overall Study|Protocol Violation|27|||
144727913|NCT01691248|521858142|FG000|Overall Study|Adverse Event|24|||
144727914|NCT01691248|521858143|FG001|Overall Study|Adverse Event|22|||
144727915|NCT01691248|521858142|FG000|Overall Study|Withdrawal by Subject|20|||
144262459|NCT01317641|520161434|FG000|Overall Study|Withdrawal by Subject|0|||
144262460|NCT01317641|520161435|FG001|Overall Study|Withdrawal by Subject|0|||
144558594|NCT01261793|521243774|FG002|Overall Study|Suspected pregnancy|0|||
144558595|NCT01261793|521243772|FG000|Overall Study|Patient non-compliance|1|||
144727916|NCT01691248|521858143|FG001|Overall Study|Withdrawal by Subject|18|||
144727917|NCT01691248|521858142|FG000|Overall Study|Confirmed CDAD|14|||
144727918|NCT01691248|521858143|FG001|Overall Study|Confirmed CDAD|31|||
144727919|NCT01691248|521858142|FG000|Overall Study|Lost to Follow-up|2|||
144727920|NCT01691248|521858143|FG001|Overall Study|Lost to Follow-up|5|||
144727921|NCT01691248|521858142|FG000|Overall Study|Reason not provided|4|||
144727922|NCT01691248|521858143|FG001|Overall Study|Reason not provided|4|||
144727923|NCT01691248|521858142|FG000|Overall Study|Not Treated|4|||
144262461|NCT01317641|520161436|FG002|Overall Study|Withdrawal by Subject|0|||
144727924|NCT01691248|521858143|FG001|Overall Study|Not Treated|7|||
144558596|NCT01261793|521243773|FG001|Overall Study|Patient non-compliance|0|||
144558597|NCT01261793|521243774|FG002|Overall Study|Patient non-compliance|1|||
144558598|NCT01261793|521243772|FG000|Overall Study|Patient pregnant|1|||
144558599|NCT01261793|521243773|FG001|Overall Study|Patient pregnant|0|||
144558600|NCT01261793|521243774|FG002|Overall Study|Patient pregnant|0|||
144558601|NCT01261793|521243772|FG000|Overall Study|Outside the study area|0|||
144558602|NCT01261793|521243773|FG001|Overall Study|Outside the study area|2|||
144558603|NCT01261793|521243774|FG002|Overall Study|Outside the study area|1|||
144558604|NCT01261793|521243772|FG000|Overall Study|Lack of efficacy & patient not available|0|||
144558605|NCT01261793|521243773|FG001|Overall Study|Lack of efficacy & patient not available|1|||
144558606|NCT01261793|521243774|FG002|Overall Study|Lack of efficacy & patient not available|0|||
144558607|NCT01261793|521243772|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
144558608|NCT01261793|521243773|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
144558609|NCT01261793|521243774|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
144558610|NCT01261793|521243772|FG000|Overall Study|Randomization error|0|||
144558611|NCT01261793|521243773|FG001|Overall Study|Randomization error|1|||
144558612|NCT01261793|521243774|FG002|Overall Study|Randomization error|0|||
144558613|NCT01261793|521243772|FG000|Overall Study|Patient unable to start IV line|0|||
144558614|NCT01261793|521243773|FG001|Overall Study|Patient unable to start IV line|0|||
144558615|NCT01261793|521243774|FG002|Overall Study|Patient unable to start IV line|1|||
144558616|NCT00734851|521243775|FG000|Overall Study|Withdrawal by Subject|2|||
144558617|NCT00734851|521243775|FG000|Overall Study|Lost to Follow-up|1|||
144558618|NCT00734851|521243775|FG000|Overall Study|Physician Decision|18|||
144558619|NCT01770509|521243776|FG000|Overall Study|Injury|0|||
144558620|NCT01770509|521243777|FG001|Overall Study|Injury|1|||
144558621|NCT01770509|521243776|FG000|Overall Study|Lost to Follow-up|1|||
144558622|NCT01770509|521243777|FG001|Overall Study|Lost to Follow-up|2|||
144558623|NCT00381888|521245361|FG000|Overall Study|Death|1|||
144558624|NCT00381888|521245361|FG000|Overall Study|Withdrawal by Subject|1|||
144558625|NCT00381888|521245361|FG000|Overall Study|Physician Decision|1|||
144558626|NCT00381888|521245361|FG000|Overall Study|Protocol Violation|9|||
144558627|NCT00381888|521245361|FG000|Overall Study|Had laparoscopic surgery|2|||
144558628|NCT00381888|521245361|FG000|Overall Study|Surgery was cancelled|2|||
144558629|NCT00381888|521245361|FG000|Overall Study|Adverse Event|1|||
144558630|NCT01589523|521245364|FG000|Overall Study|Withdrawal by Subject|1|||
144558631|NCT00961896|521245365|FG000|Overall Study|Abnormal laboratory value|0|||
144558632|NCT00961896|521245366|FG001|Overall Study|Abnormal laboratory value|0|||
144558633|NCT00961896|521245367|FG002|Overall Study|Abnormal laboratory value|1|||
144558634|NCT00506922|521245368|FG000|Overall Study|Physician Decision|0|||
144558635|NCT00506922|521245369|FG001|Overall Study|Physician Decision|0|||
144558636|NCT00506922|521245370|FG002|Overall Study|Physician Decision|0|||
144558637|NCT00506922|521245371|FG003|Overall Study|Physician Decision|2|||
144558638|NCT00506922|521245372|FG004|Overall Study|Physician Decision|0|||
144558639|NCT00506922|521245368|FG000|Overall Study|Withdrawal by Subject|0|||
144558640|NCT00506922|521245369|FG001|Overall Study|Withdrawal by Subject|0|||
144558641|NCT00506922|521245370|FG002|Overall Study|Withdrawal by Subject|0|||
144558642|NCT00506922|521245371|FG003|Overall Study|Withdrawal by Subject|0|||
144558643|NCT00506922|521245372|FG004|Overall Study|Withdrawal by Subject|1|||
144558644|NCT05244226|521245373|FG000|Overall Study|Adverse Event|1|||
144558645|NCT05244226|521245374|FG001|Overall Study|Adverse Event|0|||
144558646|NCT05244226|521245375|FG002|Overall Study|Adverse Event|0|||
144558647|NCT05244226|521245373|FG000|Overall Study|Lost to Follow-up|0|||
144558648|NCT05244226|521245374|FG001|Overall Study|Lost to Follow-up|0|||
144558649|NCT05244226|521245375|FG002|Overall Study|Lost to Follow-up|1|||
144558650|NCT05244226|521245373|FG000|Overall Study|Protocol Violation|0|||
144558651|NCT05244226|521245374|FG001|Overall Study|Protocol Violation|2|||
144727925|NCT02863575|521858144|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
144727926|NCT02863575|521858145|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
144558652|NCT05244226|521245375|FG002|Overall Study|Protocol Violation|2|||
144558653|NCT02675998|521245380|FG000|8-Week Treatment Period|Adverse Event|6|||
144558654|NCT02675998|521245381|FG001|8-Week Treatment Period|Adverse Event|5|||
144558655|NCT02675998|521245382|FG002|8-Week Treatment Period|Adverse Event|6|||
144558656|NCT02675998|521245383|FG003|8-Week Treatment Period|Adverse Event|0|||
144558657|NCT02675998|521245380|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
144558658|NCT02675998|521245381|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
144558659|NCT02675998|521245382|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
144558660|NCT02675998|521245383|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
144558661|NCT02675998|521245380|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
144558662|NCT02675998|521245381|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
144558663|NCT02675998|521245382|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
144558664|NCT02675998|521245383|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
144558665|NCT02675998|521245380|FG000|8-Week Treatment Period|Physician Decision|1|||
144262462|NCT01317641|520161437|FG003|Overall Study|Withdrawal by Subject|0|||
144558666|NCT02675998|521245381|FG001|8-Week Treatment Period|Physician Decision|0|||
144558667|NCT02675998|521245382|FG002|8-Week Treatment Period|Physician Decision|2|||
144558668|NCT02675998|521245383|FG003|8-Week Treatment Period|Physician Decision|0|||
144617392|NCT00605085|521459697|FG000|Overall Study|Protocol Violation|3|||
144617393|NCT00605085|521459698|FG001|Overall Study|Protocol Violation|2|||
144617394|NCT00605085|521459697|FG000|Overall Study|Lost to Follow-up|10|||
144558669|NCT02675998|521245380|FG000|8-Week Treatment Period|GI side Effects|1|||
144558670|NCT02675998|521245381|FG001|8-Week Treatment Period|GI side Effects|4|||
144558671|NCT02675998|521245382|FG002|8-Week Treatment Period|GI side Effects|2|||
144558672|NCT02675998|521245383|FG003|8-Week Treatment Period|GI side Effects|0|||
144558673|NCT02675998|521245380|FG000|8-Week Treatment Period|Protocol Violation|1|||
144558674|NCT02675998|521245381|FG001|8-Week Treatment Period|Protocol Violation|1|||
144558675|NCT02675998|521245382|FG002|8-Week Treatment Period|Protocol Violation|1|||
144558676|NCT02675998|521245383|FG003|8-Week Treatment Period|Protocol Violation|0|||
144558677|NCT02675998|521245380|FG000|8-Week Treatment Period|Other|3|||
144558678|NCT02675998|521245381|FG001|8-Week Treatment Period|Other|1|||
144558679|NCT02675998|521245382|FG002|8-Week Treatment Period|Other|2|||
144558680|NCT02675998|521245383|FG003|8-Week Treatment Period|Other|0|||
144558681|NCT02675998|521245380|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
144558682|NCT02675998|521245381|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
144558683|NCT02675998|521245382|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
144558684|NCT02675998|521245383|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
144558685|NCT02675998|521245380|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
144558686|NCT02675998|521245381|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
144558687|NCT02675998|521245382|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
144558688|NCT02675998|521245383|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
144558689|NCT02675998|521245380|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
144558690|NCT02675998|521245381|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
144558691|NCT02675998|521245382|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
144558692|NCT02675998|521245383|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
144558693|NCT02675998|521245380|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
144558694|NCT02675998|521245381|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
144558695|NCT02675998|521245382|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
144558696|NCT02675998|521245383|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
144558697|NCT02675998|521245380|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
144558698|NCT02675998|521245381|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
144558699|NCT02675998|521245382|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
144558700|NCT02675998|521245383|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
144558701|NCT00275301|521245384|FG000|Overall Study|Adverse Event|5|||
144558702|NCT00443898|521245385|FG000|Overall Study|Adverse Event|0|||
144558703|NCT00443898|521245386|FG001|Overall Study|Adverse Event|0|||
144558704|NCT00443898|521245387|FG002|Overall Study|Adverse Event|1|||
144558705|NCT00443898|521245388|FG003|Overall Study|Adverse Event|1|||
144558706|NCT00443898|521245385|FG000|Overall Study|Lack of Efficacy|2|||
144617395|NCT00605085|521459698|FG001|Overall Study|Lost to Follow-up|5|||
144262463|NCT01317641|520161438|FG004|Overall Study|Withdrawal by Subject|0|||
144262464|NCT01317641|520161439|FG005|Overall Study|Withdrawal by Subject|0|||
144262465|NCT01317641|520161440|FG006|Overall Study|Withdrawal by Subject|1|||
144262466|NCT01317641|520161441|FG007|Overall Study|Withdrawal by Subject|0|||
144262467|NCT01317641|520161442|FG008|Overall Study|Withdrawal by Subject|0|||
144262468|NCT00823134|520161443|FG000|Overall Study|Invalid measurement|1|||
144262469|NCT02922153|520161444|FG000|Overall Study|Death|8|||
144262470|NCT02922153|520161445|FG001|Overall Study|Death|1|||
144262471|NCT02922153|520161444|FG000|Overall Study|Lost to Follow-up|1|||
144262472|NCT02922153|520161445|FG001|Overall Study|Lost to Follow-up|0|||
144262473|NCT02922153|520161444|FG000|Overall Study|Physician Decision|1|||
144262474|NCT02922153|520161445|FG001|Overall Study|Physician Decision|1|||
144262475|NCT04547140|520161448|FG000|Overall Study|Adverse Event|0|||
144262476|NCT04547140|520161449|FG001|Overall Study|Adverse Event|1|||
144262477|NCT04547140|520161448|FG000|Overall Study|Withdrawal by Subject|0|||
144262478|NCT04547140|520161449|FG001|Overall Study|Withdrawal by Subject|1|||
144262479|NCT04547140|520161448|FG000|Overall Study|Lost to Follow-up|3|||
144262480|NCT04547140|520161449|FG001|Overall Study|Lost to Follow-up|1|||
144558707|NCT00443898|521245386|FG001|Overall Study|Lack of Efficacy|3|||
144617396|NCT00605085|521459697|FG000|Overall Study|administrative reasons|18|||
144617397|NCT00605085|521459698|FG001|Overall Study|administrative reasons|8|||
144617398|NCT00621504|521459699|FG000|Overall Study|Adverse Event|1|||
144617399|NCT00621504|521459700|FG001|Overall Study|Adverse Event|3|||
144617400|NCT00621504|521459699|FG000|Overall Study|At the request of sponsor/investigator|1|||
144262481|NCT04547140|520161448|FG000|Overall Study|Death|2|||
144262482|NCT04547140|520161449|FG001|Overall Study|Death|1|||
144558708|NCT00443898|521245387|FG002|Overall Study|Lack of Efficacy|3|||
144617401|NCT00621504|521459700|FG001|Overall Study|At the request of sponsor/investigator|0|||
144262483|NCT04547140|520161448|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
144262484|NCT04547140|520161449|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
144262485|NCT04547140|520161448|FG000|Overall Study|Pregnancy|1|||
144262486|NCT04547140|520161449|FG001|Overall Study|Pregnancy|0|||
144558709|NCT00443898|521245388|FG003|Overall Study|Lack of Efficacy|1|||
144558710|NCT00443898|521245385|FG000|Overall Study|Protocol Violation|1|||
144558711|NCT00443898|521245386|FG001|Overall Study|Protocol Violation|1|||
144558712|NCT00443898|521245387|FG002|Overall Study|Protocol Violation|1|||
144558713|NCT00443898|521245388|FG003|Overall Study|Protocol Violation|0|||
144558714|NCT00443898|521245385|FG000|Overall Study|Withdrawal by Subject|11|||
144558715|NCT00443898|521245386|FG001|Overall Study|Withdrawal by Subject|10|||
144558716|NCT00443898|521245387|FG002|Overall Study|Withdrawal by Subject|10|||
144558717|NCT00443898|521245388|FG003|Overall Study|Withdrawal by Subject|6|||
144558718|NCT00443898|521245385|FG000|Overall Study|Lost to Follow-up|10|||
144558719|NCT00443898|521245386|FG001|Overall Study|Lost to Follow-up|10|||
144558720|NCT00443898|521245387|FG002|Overall Study|Lost to Follow-up|14|||
144558721|NCT00443898|521245388|FG003|Overall Study|Lost to Follow-up|10|||
144558722|NCT00443898|521245385|FG000|Overall Study|Death|0|||
144558723|NCT00443898|521245386|FG001|Overall Study|Death|1|||
144558724|NCT00443898|521245387|FG002|Overall Study|Death|0|||
144262487|NCT04547140|520161448|FG000|Overall Study|Reason Not Specified|4|||
144558725|NCT00443898|521245388|FG003|Overall Study|Death|0|||
144558726|NCT03722485|521245389|FG000|Overall Study|Withdrawal by Subject|1|||
144558727|NCT03722485|521245390|FG001|Overall Study|Withdrawal by Subject|0|||
144558728|NCT03722485|521245389|FG000|Overall Study|Adverse Event|0|||
144558729|NCT03722485|521245390|FG001|Overall Study|Adverse Event|2|||
144558730|NCT03722485|521245389|FG000|Overall Study|subject discharged prior to study completion|1|||
144558731|NCT03722485|521245390|FG001|Overall Study|subject discharged prior to study completion|5|||
144558732|NCT03722485|521245389|FG000|Overall Study|eligibility criteria not met|2|||
144558733|NCT03722485|521245390|FG001|Overall Study|eligibility criteria not met|0|||
144558734|NCT00197106|521245391|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
144558735|NCT00197106|521245392|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
144558736|NCT00197106|521245393|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
144558737|NCT00197106|521245391|FG000|Overall Treatment Period|Lack of Efficacy|0|||
144558738|NCT00197106|521245392|FG001|Overall Treatment Period|Lack of Efficacy|1|||
144558739|NCT00197106|521245393|FG002|Overall Treatment Period|Lack of Efficacy|0|||
144558740|NCT00197106|521245391|FG000|Overall Treatment Period|Lost to Follow-up|0|||
144558741|NCT00197106|521245392|FG001|Overall Treatment Period|Lost to Follow-up|0|||
144558742|NCT00197106|521245393|FG002|Overall Treatment Period|Lost to Follow-up|2|||
144558743|NCT00197106|521245391|FG000|Overall Treatment Period|Protocol Violation|0|||
144558744|NCT00197106|521245392|FG001|Overall Treatment Period|Protocol Violation|0|||
144558745|NCT00197106|521245393|FG002|Overall Treatment Period|Protocol Violation|2|||
144558746|NCT00197106|521245391|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
144558747|NCT00197106|521245392|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
144558748|NCT00197106|521245393|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
144558749|NCT00382408|521245397|FG000|Overall Study|Did not meet protocol requirement|3|||
144558750|NCT00382408|521245398|FG001|Overall Study|Did not meet protocol requirement|3|||
144617402|NCT00621504|521459699|FG000|Overall Study|Withdrew consent|9|||
144617403|NCT00621504|521459700|FG001|Overall Study|Withdrew consent|6|||
144617404|NCT00621504|521459699|FG000|Overall Study|Lost to Follow-up|8|||
144617405|NCT00621504|521459700|FG001|Overall Study|Lost to Follow-up|10|||
144617406|NCT00621504|521459699|FG000|Overall Study|Other|1|||
144617407|NCT00621504|521459700|FG001|Overall Study|Other|0|||
144617408|NCT00621504|521459699|FG000|Overall Study|Death|6|||
144617409|NCT00621504|521459700|FG001|Overall Study|Death|6|||
144617410|NCT03311711|521459705|FG000|Overall Study|Death|1|||
144617411|NCT03311711|521459706|FG001|Overall Study|Death|0|||
144617412|NCT03311711|521459707|FG002|Overall Study|Death|0|||
144617413|NCT03311711|521459708|FG003|Overall Study|Death|0|||
144617414|NCT03311711|521459709|FG004|Overall Study|Death|0|||
144617415|NCT03311711|521459710|FG005|Overall Study|Death|0|||
144617416|NCT03311711|521459711|FG006|Overall Study|Death|1|||
144617417|NCT03311711|521459712|FG007|Overall Study|Death|0|||
144617418|NCT03311711|521459713|FG008|Overall Study|Death|1|||
144617419|NCT03311711|521459714|FG009|Overall Study|Death|0|||
144617420|NCT03311711|521459705|FG000|Overall Study|Death of dyad partner|0|||
144617421|NCT03311711|521459706|FG001|Overall Study|Death of dyad partner|1|||
144617422|NCT03311711|521459707|FG002|Overall Study|Death of dyad partner|0|||
144617423|NCT03311711|521459708|FG003|Overall Study|Death of dyad partner|0|||
144617424|NCT03311711|521459709|FG004|Overall Study|Death of dyad partner|0|||
144558751|NCT00382408|521245397|FG000|Overall Study|Protocol Violation|2|||
144558752|NCT00382408|521245398|FG001|Overall Study|Protocol Violation|2|||
144558753|NCT00382408|521245397|FG000|Overall Study|Physician Decision|1|||
144558754|NCT00382408|521245398|FG001|Overall Study|Physician Decision|0|||
144558755|NCT00382408|521245397|FG000|Overall Study|Withdrawal by Subject|17|||
144558756|NCT00382408|521245398|FG001|Overall Study|Withdrawal by Subject|6|||
144558757|NCT00382408|521245397|FG000|Overall Study|Pregnancy|2|||
144617425|NCT03311711|521459710|FG005|Overall Study|Death of dyad partner|0|||
144617426|NCT03311711|521459711|FG006|Overall Study|Death of dyad partner|0|||
144617427|NCT03311711|521459712|FG007|Overall Study|Death of dyad partner|1|||
144617428|NCT03311711|521459713|FG008|Overall Study|Death of dyad partner|0|||
144617429|NCT03311711|521459714|FG009|Overall Study|Death of dyad partner|1|||
144558758|NCT00382408|521245398|FG001|Overall Study|Pregnancy|0|||
144558759|NCT00382408|521245397|FG000|Overall Study|Lost to Follow-up|19|||
144558760|NCT00382408|521245398|FG001|Overall Study|Lost to Follow-up|8|||
144558761|NCT00382408|521245397|FG000|Overall Study|Other|100|||
144558762|NCT00382408|521245398|FG001|Overall Study|Other|35|||
144558763|NCT00520403|521245399|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
144558764|NCT00520403|521245399|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
144558765|NCT00520403|521245399|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
144558766|NCT00520403|521245399|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
144558767|NCT00520403|521245399|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
144558768|NCT00520403|521245399|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
144558769|NCT00520403|521245399|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
144558770|NCT00520403|521245399|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
144558771|NCT00917462|521245400|FG000|Overall Study|Clinical Deterioration|1|||
144558772|NCT03341312|521245404|FG000|Period 1|Withdrawal by Subject|0|||
144558773|NCT03341312|521245405|FG001|Period 1|Withdrawal by Subject|1|||
144558774|NCT03341312|521245406|FG002|Period 1|Withdrawal by Subject|0|||
144558775|NCT03341312|521245407|FG003|Period 1|Withdrawal by Subject|0|||
144558776|NCT01631825|521245408|FG000|Overall Study|Adverse Event|42|||
144558777|NCT01631825|521245408|FG000|Overall Study|Lack of Efficacy|7|||
144558778|NCT01631825|521245408|FG000|Overall Study|Withdrawal by Subject|9|||
144558779|NCT01631825|521245408|FG000|Overall Study|Protocol Violation|4|||
144558780|NCT01631825|521245408|FG000|Overall Study|Discontinuation criteria|1|||
144558781|NCT01631825|521245408|FG000|Overall Study|Physician Decision|2|||
144558782|NCT02110225|521245409|FG000|Overall Study|Lost to Follow-up|0|||
144558783|NCT02110225|521245410|FG001|Overall Study|Lost to Follow-up|1|||
144558784|NCT02110225|521245411|FG002|Overall Study|Lost to Follow-up|0|||
144558785|NCT02176018|521245412|FG000|Overall Study|Adverse Event|0|||
144558786|NCT02176018|521245413|FG001|Overall Study|Adverse Event|2|||
144558787|NCT02176018|521245412|FG000|Overall Study|Lost to Follow-up|3|||
144558788|NCT02176018|521245413|FG001|Overall Study|Lost to Follow-up|1|||
144558789|NCT02176018|521245412|FG000|Overall Study|Protocol Violation|1|||
144558790|NCT02176018|521245413|FG001|Overall Study|Protocol Violation|1|||
144558791|NCT02176018|521245412|FG000|Overall Study|Withdrawal by Subject|1|||
144558792|NCT02176018|521245413|FG001|Overall Study|Withdrawal by Subject|2|||
144558793|NCT00265096|521245414|FG000|Overall Study|Adverse Event|14|||
144558794|NCT00265096|521245415|FG001|Overall Study|Adverse Event|18|||
144558795|NCT00265096|521245416|FG002|Overall Study|Adverse Event|18|||
144558796|NCT00265096|521245414|FG000|Overall Study|Lost to Follow-up|2|||
144558797|NCT00265096|521245415|FG001|Overall Study|Lost to Follow-up|5|||
144558798|NCT00265096|521245416|FG002|Overall Study|Lost to Follow-up|3|||
144203496|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144558799|NCT00265096|521245414|FG000|Overall Study|Death|0|||
144558800|NCT00265096|521245415|FG001|Overall Study|Death|1|||
144558801|NCT00265096|521245416|FG002|Overall Study|Death|2|||
144558802|NCT00265096|521245414|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
144558803|NCT00265096|521245415|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
144558804|NCT00265096|521245416|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
144203497|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203498|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203499|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144558805|NCT00265096|521245414|FG000|Overall Study|Other|11|||
144558806|NCT00265096|521245415|FG001|Overall Study|Other|19|||
144558807|NCT00265096|521245416|FG002|Overall Study|Other|10|||
144558808|NCT00774306|521245417|FG000|Overall Study|Adverse Event|3|||
144558809|NCT00774306|521245418|FG001|Overall Study|Adverse Event|0|||
144558810|NCT00774306|521245419|FG002|Overall Study|Adverse Event|0|||
144558811|NCT00774306|521245420|FG003|Overall Study|Adverse Event|0|||
144558812|NCT00774306|521245417|FG000|Overall Study|Protocol Violation|2|||
144558813|NCT00774306|521245418|FG001|Overall Study|Protocol Violation|0|||
144558814|NCT00774306|521245419|FG002|Overall Study|Protocol Violation|3|||
144617430|NCT03311711|521459705|FG000|Overall Study|Lost to Follow-up|2|||
144617431|NCT03311711|521459706|FG001|Overall Study|Lost to Follow-up|2|||
144617432|NCT03311711|521459707|FG002|Overall Study|Lost to Follow-up|0|||
144617433|NCT03311711|521459708|FG003|Overall Study|Lost to Follow-up|0|||
144617434|NCT03311711|521459709|FG004|Overall Study|Lost to Follow-up|0|||
144617435|NCT03311711|521459710|FG005|Overall Study|Lost to Follow-up|0|||
144617436|NCT03311711|521459711|FG006|Overall Study|Lost to Follow-up|1|||
144617437|NCT03311711|521459712|FG007|Overall Study|Lost to Follow-up|1|||
144617438|NCT03311711|521459713|FG008|Overall Study|Lost to Follow-up|0|||
144617439|NCT03311711|521459714|FG009|Overall Study|Lost to Follow-up|0|||
144617440|NCT03311711|521459705|FG000|Overall Study|Withdrawal by Subject|1|||
144617441|NCT03311711|521459706|FG001|Overall Study|Withdrawal by Subject|1|||
144617442|NCT03311711|521459707|FG002|Overall Study|Withdrawal by Subject|0|||
144617443|NCT03311711|521459708|FG003|Overall Study|Withdrawal by Subject|0|||
144617444|NCT03311711|521459709|FG004|Overall Study|Withdrawal by Subject|0|||
144617445|NCT03311711|521459710|FG005|Overall Study|Withdrawal by Subject|0|||
144558815|NCT00774306|521245420|FG003|Overall Study|Protocol Violation|0|||
144558816|NCT00774306|521245417|FG000|Overall Study|Withdrawal by Subject|6|||
144558817|NCT00774306|521245418|FG001|Overall Study|Withdrawal by Subject|1|||
144558818|NCT00774306|521245419|FG002|Overall Study|Withdrawal by Subject|1|||
144558819|NCT00774306|521245420|FG003|Overall Study|Withdrawal by Subject|0|||
144558820|NCT00774306|521245417|FG000|Overall Study|Lost to Follow-up|6|||
144558821|NCT00774306|521245418|FG001|Overall Study|Lost to Follow-up|0|||
144558822|NCT00774306|521245419|FG002|Overall Study|Lost to Follow-up|4|||
144558823|NCT00774306|521245420|FG003|Overall Study|Lost to Follow-up|5|||
144558824|NCT00774306|521245417|FG000|Overall Study|Death|1|||
144558825|NCT00774306|521245418|FG001|Overall Study|Death|1|||
144558826|NCT00774306|521245419|FG002|Overall Study|Death|0|||
144558827|NCT00774306|521245420|FG003|Overall Study|Death|0|||
144558828|NCT00809783|521245426|FG000|Overall Study|Death|1|||
144558829|NCT00809783|521245427|FG001|Overall Study|Death|0|||
144558830|NCT00809783|521245428|FG002|Overall Study|Death|0|||
144558831|NCT00809783|521245426|FG000|Overall Study|Adverse Event|34|||
144617446|NCT03311711|521459711|FG006|Overall Study|Withdrawal by Subject|3|||
144617447|NCT03311711|521459712|FG007|Overall Study|Withdrawal by Subject|3|||
144617448|NCT03311711|521459713|FG008|Overall Study|Withdrawal by Subject|0|||
144617449|NCT03311711|521459714|FG009|Overall Study|Withdrawal by Subject|0|||
144617450|NCT01339559|521459721|FG000|Overall Study|Adverse Event|92|||
144617451|NCT01339559|521459721|FG000|Overall Study|Death|5|||
144617452|NCT01339559|521459721|FG000|Overall Study|Lack of Efficacy|164|||
144617453|NCT01339559|521459721|FG000|Overall Study|Lost to Follow-up|22|||
144617454|NCT01339559|521459721|FG000|Overall Study|Subject choice|89|||
144617455|NCT01339559|521459721|FG000|Overall Study|Protocol Violation|15|||
144617456|NCT01339559|521459721|FG000|Overall Study|Study closure at site|1|||
144617457|NCT01339559|521459721|FG000|Overall Study|Incarcerated|2|||
144617458|NCT01339559|521459721|FG000|Overall Study|Epilepsy surgery|1|||
144617459|NCT01339559|521459721|FG000|Overall Study|Pregnancy planned|2|||
144617460|NCT01339559|521459721|FG000|Overall Study|Left the country|1|||
144617461|NCT01339559|521459721|FG000|Overall Study|Investigator decision|2|||
144617462|NCT01339559|521459721|FG000|Overall Study|Patient didn't wish to continue|1|||
144617463|NCT01339559|521459721|FG000|Overall Study|PI decision|1|||
144617464|NCT01661140|521459722|FG000|Open-Label Period|Adverse Event|44|||
144617465|NCT01661140|521459723|FG001|Open-Label Period|Adverse Event|0|||
144617466|NCT01661140|521459724|FG002|Open-Label Period|Adverse Event|0|||
144617467|NCT01661140|521459722|FG000|Open-Label Period|Protocol Violation|3|||
144617468|NCT01661140|521459723|FG001|Open-Label Period|Protocol Violation|0|||
144617469|NCT01661140|521459724|FG002|Open-Label Period|Protocol Violation|0|||
144617470|NCT01661140|521459722|FG000|Open-Label Period|Withdrawal by Subject|5|||
144617471|NCT01661140|521459723|FG001|Open-Label Period|Withdrawal by Subject|0|||
144617472|NCT01661140|521459724|FG002|Open-Label Period|Withdrawal by Subject|0|||
144617473|NCT01661140|521459722|FG000|Open-Label Period|Investigator Decision|3|||
144617474|NCT01661140|521459723|FG001|Open-Label Period|Investigator Decision|0|||
144617475|NCT01661140|521459724|FG002|Open-Label Period|Investigator Decision|0|||
144617476|NCT01661140|521459722|FG000|Open-Label Period|Death|1|||
144617477|NCT01661140|521459723|FG001|Open-Label Period|Death|0|||
144617478|NCT01661140|521459724|FG002|Open-Label Period|Death|0|||
144617479|NCT01661140|521459722|FG000|Open-Label Period|Administrative/Other|1|||
144617480|NCT01661140|521459723|FG001|Open-Label Period|Administrative/Other|0|||
144617481|NCT01661140|521459724|FG002|Open-Label Period|Administrative/Other|0|||
144617482|NCT01661140|521459722|FG000|Open-Label Period|Sponsor termination|16|||
144617483|NCT01661140|521459723|FG001|Open-Label Period|Sponsor termination|0|||
144617484|NCT01661140|521459724|FG002|Open-Label Period|Sponsor termination|0|||
144617485|NCT01661140|521459722|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
144617486|NCT01661140|521459723|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
144617487|NCT01661140|521459724|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
144617488|NCT01661140|521459722|FG000|Open-Label Period|Lost to Follow-up|2|||
144617489|NCT01661140|521459723|FG001|Open-Label Period|Lost to Follow-up|0|||
144617490|NCT01661140|521459724|FG002|Open-Label Period|Lost to Follow-up|0|||
144617491|NCT01661140|521459722|FG000|Double-Blind Period|Refused Treatment|0|||
144617492|NCT01661140|521459723|FG001|Double-Blind Period|Refused Treatment|0|||
144617493|NCT01661140|521459724|FG002|Double-Blind Period|Refused Treatment|1|||
144617494|NCT01661140|521459722|FG000|Double-Blind Period|Adverse Event|0|||
144617495|NCT01661140|521459723|FG001|Double-Blind Period|Adverse Event|16|||
144617496|NCT01661140|521459724|FG002|Double-Blind Period|Adverse Event|18|||
144617497|NCT01661140|521459722|FG000|Double-Blind Period|Protocol Violation|0|||
144558832|NCT00809783|521245427|FG001|Overall Study|Adverse Event|52|||
144558833|NCT00809783|521245428|FG002|Overall Study|Adverse Event|71|||
144617498|NCT01661140|521459723|FG001|Double-Blind Period|Protocol Violation|2|||
144617499|NCT01661140|521459724|FG002|Double-Blind Period|Protocol Violation|3|||
144617500|NCT01661140|521459722|FG000|Double-Blind Period|Withdrawal by Subject|0|||
144617501|NCT01661140|521459723|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144617502|NCT01661140|521459724|FG002|Double-Blind Period|Withdrawal by Subject|3|||
144558834|NCT00809783|521245426|FG000|Overall Study|Lack of Efficacy|39|||
144558835|NCT00809783|521245427|FG001|Overall Study|Lack of Efficacy|52|||
144727927|NCT02863575|521858146|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
144727928|NCT02863575|521858144|FG000|Overall Study|Withdrawal by Subject|0|||
144727929|NCT02863575|521858145|FG001|Overall Study|Withdrawal by Subject|1|||
144727930|NCT02863575|521858146|FG002|Overall Study|Withdrawal by Subject|1|||
144727931|NCT02863575|521858144|FG000|Overall Study|Adverse Event|0|||
144727932|NCT02863575|521858145|FG001|Overall Study|Adverse Event|1|||
144727933|NCT02863575|521858146|FG002|Overall Study|Adverse Event|0|||
144727934|NCT02637232|521859269|FG000|Overall Study|Lost to Follow-up|42|||
144727935|NCT02637232|521859269|FG000|Overall Study|Adverse Event|11|||
144727936|NCT02637232|521859269|FG000|Overall Study|patient 's decision|2|||
144727937|NCT02999178|521859270|FG000|Overall Study|Adverse Event|85|||
144727938|NCT02999178|521859271|FG001|Overall Study|Adverse Event|62|||
144727939|NCT02999178|521859270|FG000|Overall Study|Protocol Violation|1|||
144727940|NCT02999178|521859271|FG001|Overall Study|Protocol Violation|2|||
144727941|NCT02999178|521859270|FG000|Overall Study|Lost to Follow-up|0|||
144727942|NCT02999178|521859271|FG001|Overall Study|Lost to Follow-up|2|||
144727943|NCT02999178|521859270|FG000|Overall Study|Withdrawal by Subject|21|||
144727944|NCT02999178|521859271|FG001|Overall Study|Withdrawal by Subject|21|||
144727945|NCT02999178|521859270|FG000|Overall Study|Other reason not defined above|7|||
144727946|NCT02999178|521859271|FG001|Overall Study|Other reason not defined above|13|||
144727947|NCT02424188|521859272|FG000|Overall Study|Death|2|||
144727948|NCT02424188|521859273|FG001|Overall Study|Death|2|||
144727949|NCT02424188|521859272|FG000|Overall Study|Lost to Follow-up|1|||
144727950|NCT02424188|521859273|FG001|Overall Study|Lost to Follow-up|3|||
144727951|NCT02424188|521859272|FG000|Overall Study|Incarceration|1|||
144727952|NCT02424188|521859273|FG001|Overall Study|Incarceration|0|||
144727953|NCT02473640|521859274|FG000|Treatment Period 1|Adverse Event|1|||
144727954|NCT00453362|521859275|FG000|Overall Study|Adverse Event|5|||
144727955|NCT00453362|521859275|FG000|Overall Study|Death|7|||
144727956|NCT00453362|521859275|FG000|Overall Study|Physician Decision|2|||
144727957|NCT00453362|521859275|FG000|Overall Study|Withdrawal by Subject|3|||
144727958|NCT00453362|521859275|FG000|Overall Study|Progression of disease|56|||
144727959|NCT00453362|521859275|FG000|Overall Study|Screening Failure|14|||
144727960|NCT00433147|521859277|FG000|Overall Study|Adverse Event|0|||
144727961|NCT00433147|521859278|FG001|Overall Study|Adverse Event|1|||
144727962|NCT00433147|521859279|FG002|Overall Study|Adverse Event|0|||
144727963|NCT00433147|521859280|FG003|Overall Study|Adverse Event|0|||
144727964|NCT01882647|521859281|FG000|Overall Study|Lost to Follow-up|2|||
144727965|NCT01882647|521859282|FG001|Overall Study|Lost to Follow-up|2|||
144727966|NCT01882647|521859281|FG000|Overall Study|Withdrawal by Subject|0|||
144727967|NCT01882647|521859282|FG001|Overall Study|Withdrawal by Subject|4|||
144727968|NCT02937701|521859283|FG000|Day 1 to Week 22|Adverse Event|11|||
144727969|NCT02937701|521859284|FG001|Day 1 to Week 22|Adverse Event|14|||
144727970|NCT02937701|521859285|FG002|Day 1 to Week 22|Adverse Event|0|||
144727971|NCT02937701|521859286|FG003|Day 1 to Week 22|Adverse Event|0|||
144727972|NCT02937701|521859287|FG004|Day 1 to Week 22|Adverse Event|0|||
144727973|NCT02937701|521859283|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
144727974|NCT02937701|521859284|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
144727975|NCT02937701|521859285|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
144727976|NCT02937701|521859286|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
144727977|NCT02937701|521859287|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
144727978|NCT02937701|521859283|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
144727979|NCT02937701|521859284|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
144727980|NCT02937701|521859285|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
144727981|NCT02937701|521859286|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
144727982|NCT02937701|521859287|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
144727983|NCT02937701|521859283|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
144727984|NCT02937701|521859284|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
144727985|NCT02937701|521859285|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
144727986|NCT02937701|521859286|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
144727987|NCT02937701|521859287|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
144727988|NCT02937701|521859283|FG000|Day 1 to Week 22|Death|1|||
144727989|NCT02937701|521859284|FG001|Day 1 to Week 22|Death|1|||
144727990|NCT02937701|521859285|FG002|Day 1 to Week 22|Death|0|||
144727991|NCT02937701|521859286|FG003|Day 1 to Week 22|Death|0|||
144727992|NCT02937701|521859287|FG004|Day 1 to Week 22|Death|0|||
144727993|NCT02937701|521859283|FG000|Day 1 to Week 22|Protocol Violation|1|||
144727994|NCT02937701|521859284|FG001|Day 1 to Week 22|Protocol Violation|1|||
144727995|NCT02937701|521859285|FG002|Day 1 to Week 22|Protocol Violation|0|||
144727996|NCT02937701|521859286|FG003|Day 1 to Week 22|Protocol Violation|0|||
144727997|NCT02937701|521859287|FG004|Day 1 to Week 22|Protocol Violation|0|||
144727998|NCT02937701|521859283|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
144558836|NCT00809783|521245428|FG002|Overall Study|Lack of Efficacy|63|||
144558837|NCT00809783|521245426|FG000|Overall Study|Lost to Follow-up|0|||
144727999|NCT02937701|521859284|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
144728000|NCT02937701|521859285|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
144728001|NCT02937701|521859286|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
144558838|NCT00809783|521245427|FG001|Overall Study|Lost to Follow-up|3|||
144558839|NCT00809783|521245428|FG002|Overall Study|Lost to Follow-up|4|||
144558840|NCT00809783|521245426|FG000|Overall Study|Withdrawal by Subject|47|||
144558841|NCT00809783|521245427|FG001|Overall Study|Withdrawal by Subject|72|||
144558842|NCT00809783|521245428|FG002|Overall Study|Withdrawal by Subject|64|||
144558843|NCT00809783|521245426|FG000|Overall Study|Protocol Violation|2|||
144558844|NCT00809783|521245427|FG001|Overall Study|Protocol Violation|6|||
144558845|NCT00809783|521245428|FG002|Overall Study|Protocol Violation|5|||
144558846|NCT00809783|521245426|FG000|Overall Study|Randomized, but not treated|3|||
144558847|NCT00809783|521245427|FG001|Overall Study|Randomized, but not treated|0|||
144558848|NCT00809783|521245428|FG002|Overall Study|Randomized, but not treated|2|||
144558849|NCT00809783|521245426|FG000|Overall Study|Study Terminated by Sponsor|378|||
144558850|NCT00809783|521245427|FG001|Overall Study|Study Terminated by Sponsor|626|||
144558851|NCT00809783|521245428|FG002|Overall Study|Study Terminated by Sponsor|565|||
144558852|NCT00809783|521245426|FG000|Overall Study|Other|21|||
144558853|NCT00809783|521245427|FG001|Overall Study|Other|21|||
144558854|NCT00809783|521245428|FG002|Overall Study|Other|16|||
144558855|NCT00126555|521245429|FG000|Overall Study|Withdrawal by Subject|1|||
144558856|NCT00126555|521245429|FG000|Overall Study|Adverse Event|2|||
144558857|NCT00126555|521245429|FG000|Overall Study|Progressive Disease|3|||
144558858|NCT01780545|521245433|FG000|Overall Study|Withdrawal by Subject|3|||
144558859|NCT01780545|521245434|FG001|Overall Study|Withdrawal by Subject|1|||
144558860|NCT01780545|521245433|FG000|Overall Study|Lost to Follow-up|1|||
144558861|NCT01780545|521245434|FG001|Overall Study|Lost to Follow-up|1|||
144558862|NCT05135156|521245441|FG000|Overall Study|Lost to Follow-up|0|||
144558863|NCT05135156|521245442|FG001|Overall Study|Lost to Follow-up|0|||
144558864|NCT05135156|521245443|FG002|Overall Study|Lost to Follow-up|2|||
144558865|NCT00396097|521245446|FG000|Overall Study|Withdrawal by Subject|17|||
144558866|NCT00396097|521245447|FG001|Overall Study|Withdrawal by Subject|17|||
144558867|NCT00396097|521245446|FG000|Overall Study|Lost to Follow-up|4|||
144558868|NCT00396097|521245447|FG001|Overall Study|Lost to Follow-up|9|||
144558869|NCT00396097|521245446|FG000|Overall Study|Other|3|||
144558870|NCT00396097|521245447|FG001|Overall Study|Other|5|||
144558871|NCT00396097|521245446|FG000|Overall Study|Protocol Violation|0|||
144558872|NCT00396097|521245447|FG001|Overall Study|Protocol Violation|6|||
144558873|NCT00396097|521245446|FG000|Overall Study|Adverse Event|1|||
144558874|NCT00396097|521245447|FG001|Overall Study|Adverse Event|5|||
144558875|NCT00396097|521245446|FG000|Overall Study|Insufficient Clinical Response|1|||
144558876|NCT00396097|521245447|FG001|Overall Study|Insufficient Clinical Response|4|||
144558877|NCT03461211|521245448|FG000|Overall Study|Adverse Event|1|||
144558878|NCT03461211|521245449|FG001|Overall Study|Adverse Event|1|||
144558879|NCT03461211|521245448|FG000|Overall Study|Lack of Efficacy|0|||
144558880|NCT03461211|521245449|FG001|Overall Study|Lack of Efficacy|1|||
144558881|NCT03807700|521245450|FG000|Overall Study|Withdrawal by Subject|2|||
144558882|NCT03807700|521245451|FG001|Overall Study|Withdrawal by Subject|1|||
144558883|NCT02720081|521245452|FG000|Overall Study|Adverse Event|0|||
144558884|NCT02720081|521245453|FG001|Overall Study|Adverse Event|3|||
144558885|NCT02720081|521245452|FG000|Overall Study|Protocol Violation|4|||
144558886|NCT02720081|521245453|FG001|Overall Study|Protocol Violation|1|||
144558887|NCT04772313|521245457|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
144558888|NCT04772313|521245457|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
144558889|NCT01836198|521245458|FG000|Part A, Period 2|Protocol Violation|0|||
144558890|NCT01836198|521245459|FG001|Part A, Period 2|Protocol Violation|1|||
144558891|NCT01836198|521245460|FG002|Part A, Period 2|Protocol Violation|0|||
144558892|NCT03187353|521245461|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
144558893|NCT03187353|521245462|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
144558894|NCT03187353|521245461|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
144558895|NCT03187353|521245462|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
144558896|NCT03187353|521245461|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
144558897|NCT03187353|521245462|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
144558898|NCT03187353|521245461|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
144558899|NCT03187353|521245462|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
144558900|NCT03187353|521245461|FG000|Washout (2 Weeks)|Adverse Event|2|||
144558901|NCT03187353|521245462|FG001|Washout (2 Weeks)|Adverse Event|0|||
144558902|NCT03187353|521245461|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
144558903|NCT03187353|521245462|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
144558904|NCT01061775|521245465|FG000|Overall Study|Physician Decision|2|||
144558905|NCT01061775|521245465|FG000|Overall Study|Lost to Follow-up|1|||
144558906|NCT02567227|521245466|FG000|9 Weeks|Adverse Event|5|||
144558907|NCT02567227|521245467|FG001|9 Weeks|Adverse Event|5|||
144558908|NCT02567227|521245466|FG000|9 Weeks|Withdrawal by Subject|18|||
144558909|NCT02567227|521245467|FG001|9 Weeks|Withdrawal by Subject|8|||
144558910|NCT02567227|521245466|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
144558911|NCT02567227|521245467|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
144558912|NCT02567227|521245466|FG000|6 Month|Death|2|||
144558913|NCT02567227|521245467|FG001|6 Month|Death|0|||
144558914|NCT02567227|521245466|FG000|6 Month|Lost to Follow-up|43|||
144558915|NCT02567227|521245467|FG001|6 Month|Lost to Follow-up|40|||
144558916|NCT02567227|521245466|FG000|12 Months|Lost to Follow-up|31|||
144558917|NCT02567227|521245467|FG001|12 Months|Lost to Follow-up|32|||
144558918|NCT02567227|521245466|FG000|12 Months|Death|0|||
144558919|NCT02567227|521245467|FG001|12 Months|Death|2|||
144558920|NCT02498418|521245468|FG000|Overall Study|Lack of Efficacy|0|||
144558921|NCT02498418|521245469|FG001|Overall Study|Lack of Efficacy|0|||
144558922|NCT02498418|521245470|FG002|Overall Study|Lack of Efficacy|1|||
144558923|NCT02498418|521245468|FG000|Overall Study|Withdrawal by Subject|2|||
144558924|NCT02498418|521245469|FG001|Overall Study|Withdrawal by Subject|0|||
144558925|NCT02498418|521245470|FG002|Overall Study|Withdrawal by Subject|3|||
144558926|NCT02498418|521245468|FG000|Overall Study|Lost to Follow-up|0|||
144558927|NCT02498418|521245469|FG001|Overall Study|Lost to Follow-up|1|||
144558928|NCT02498418|521245470|FG002|Overall Study|Lost to Follow-up|1|||
144558929|NCT02498418|521245468|FG000|Overall Study|Participant taken prohibited medication|0|||
144558930|NCT02498418|521245469|FG001|Overall Study|Participant taken prohibited medication|1|||
144558931|NCT02498418|521245470|FG002|Overall Study|Participant taken prohibited medication|1|||
144558932|NCT01026103|521245471|FG000|Overall Study|Physician Decision|1|||
144558933|NCT01026103|521245471|FG000|Overall Study|did not receive study device bc of error|1|||
144558934|NCT00762502|521245473|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
144558935|NCT00762502|521245474|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
144558936|NCT00762502|521245475|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
144558937|NCT00762502|521245473|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
144558938|NCT00762502|521245474|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
144558939|NCT00762502|521245475|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
144558940|NCT00762502|521245473|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
144558941|NCT00762502|521245474|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
144558942|NCT00762502|521245475|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
144558943|NCT02625922|521245477|FG000|Overall Study|Non-availability of IMP|1|||
144558944|NCT02625922|521245478|FG001|Overall Study|Non-availability of IMP|1|||
144558945|NCT02625922|521245477|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
144558946|NCT02625922|521245478|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
144558947|NCT02359552|521245479|FG000|Overall Study|Lost to Follow-up|3|||
144558948|NCT02359552|521245480|FG001|Overall Study|Lost to Follow-up|4|||
144558949|NCT02282917|521245481|FG000|Overall Study|Withdrawal by Subject|1|||
144558950|NCT02282917|521245481|FG000|Overall Study|Screen Failure/Not Eligible|1|||
144558951|NCT00794573|521245482|FG000|Overall Study|Death|3|||
144558952|NCT00794573|521245483|FG001|Overall Study|Death|0|||
144558953|NCT00794573|521245482|FG000|Overall Study|Withdrawal by Subject|9|||
144558954|NCT00794573|521245483|FG001|Overall Study|Withdrawal by Subject|12|||
144558955|NCT00794573|521245482|FG000|Overall Study|Lost to Follow-up|26|||
144558956|NCT00794573|521245483|FG001|Overall Study|Lost to Follow-up|33|||
144558957|NCT01294358|521245484|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
144558958|NCT01294358|521245485|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
144558959|NCT01294358|521245486|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
144558960|NCT01294358|521245487|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
144558961|NCT01294358|521245488|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
144558962|NCT01294358|521245484|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
144558963|NCT01294358|521245485|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
144558964|NCT01294358|521245486|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
144558965|NCT01294358|521245487|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
144617503|NCT01661140|521459722|FG000|Double-Blind Period|Investigator's Decision|0|||
144617504|NCT01661140|521459723|FG001|Double-Blind Period|Investigator's Decision|1|||
144617505|NCT01661140|521459724|FG002|Double-Blind Period|Investigator's Decision|2|||
144617506|NCT01661140|521459722|FG000|Double-Blind Period|Sponsor Termination|0|||
144617507|NCT01661140|521459723|FG001|Double-Blind Period|Sponsor Termination|14|||
144617508|NCT01661140|521459724|FG002|Double-Blind Period|Sponsor Termination|17|||
144617509|NCT01661140|521459722|FG000|Double-Blind Period|Administrative/Other|0|||
144617510|NCT01661140|521459723|FG001|Double-Blind Period|Administrative/Other|7|||
144617511|NCT01661140|521459724|FG002|Double-Blind Period|Administrative/Other|6|||
144617512|NCT01137773|521459725|FG000|Overall Study|Death|3|||
144617513|NCT01137773|521459726|FG001|Overall Study|Death|3|||
144617514|NCT01137773|521459725|FG000|Overall Study|Lost to Follow-up|6|||
144617515|NCT01137773|521459726|FG001|Overall Study|Lost to Follow-up|0|||
144617516|NCT00817531|521459728|FG000|Overall Study|Adverse Event|1|||
144617517|NCT00817531|521459728|FG000|Overall Study|Lack of Efficacy|1|||
144617518|NCT02239939|521459729|FG000|Overall Study|Adverse Event|1|||
144617519|NCT02239939|521459730|FG001|Overall Study|Adverse Event|0|||
144617520|NCT02239939|521459729|FG000|Overall Study|Withdrawal by Subject|1|||
144617521|NCT02239939|521459730|FG001|Overall Study|Withdrawal by Subject|1|||
144617522|NCT02239939|521459729|FG000|Overall Study|Lost to Follow-up|0|||
144617523|NCT02239939|521459730|FG001|Overall Study|Lost to Follow-up|1|||
144617524|NCT03325673|521459732|FG000|Overall Study|Adverse Event|4|||
144617525|NCT03325673|521459733|FG001|Overall Study|Adverse Event|0|||
144617526|NCT03509350|521459736|FG000|Overall Study|Withdrawal by Subject|0|||
144617527|NCT03509350|521459737|FG001|Overall Study|Withdrawal by Subject|2|||
144617528|NCT02559687|521459738|FG000|Overall Study|Death|112|||
144558966|NCT01294358|521245488|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
144558967|NCT01294358|521245484|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
144558968|NCT01294358|521245485|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
144558969|NCT01294358|521245486|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
144558970|NCT01294358|521245487|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
144558971|NCT01294358|521245488|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
144558972|NCT01294358|521245484|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
144558973|NCT01294358|521245485|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
144558974|NCT01294358|521245486|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
144558975|NCT01294358|521245487|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
144558976|NCT01294358|521245488|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
144558977|NCT03840148|521245490|FG000|Study Drug Disposition|Adverse Event|13|||
144558978|NCT03840148|521245491|FG001|Study Drug Disposition|Adverse Event|2|||
144558979|NCT03840148|521245490|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
144558980|NCT03840148|521245491|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
144558981|NCT03840148|521245490|FG000|Study Drug Disposition|Lack of Efficacy|3|||
144558982|NCT03840148|521245491|FG001|Study Drug Disposition|Lack of Efficacy|0|||
144558983|NCT03840148|521245490|FG000|Study Drug Disposition|Physician Decision|2|||
144558984|NCT03840148|521245491|FG001|Study Drug Disposition|Physician Decision|0|||
144558985|NCT03840148|521245490|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
144558986|NCT03840148|521245491|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
144558987|NCT03840148|521245490|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
144558988|NCT03840148|521245491|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
144558989|NCT03840148|521245490|FG000|Study Completion Disposition|Physician Decision|2|||
144558990|NCT03840148|521245491|FG001|Study Completion Disposition|Physician Decision|0|||
144558991|NCT03840148|521245490|FG000|Study Completion Disposition|Covid-19 related|2|||
144558992|NCT03840148|521245491|FG001|Study Completion Disposition|Covid-19 related|0|||
144558993|NCT03840148|521245490|FG000|Study Completion Disposition|Lost to Follow-up|1|||
144558994|NCT03840148|521245491|FG001|Study Completion Disposition|Lost to Follow-up|1|||
144558995|NCT03840148|521245490|FG000|Study Completion Disposition|Death|1|||
144558996|NCT03840148|521245491|FG001|Study Completion Disposition|Death|0|||
144558997|NCT03840148|521245490|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
144558998|NCT03840148|521245491|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
144558999|NCT03615404|521245492|FG000|Overall Study|Death|1|||
144559000|NCT03615404|521245492|FG000|Overall Study|vaccine did not pass quality assurance|1|||
144559001|NCT00905255|521245494|FG000|Overall Study|Adverse Event|7|||
144559002|NCT00905255|521245495|FG001|Overall Study|Adverse Event|5|||
144559003|NCT00905255|521245494|FG000|Overall Study|Withdrawal by Subject|5|||
144559004|NCT00905255|521245495|FG001|Overall Study|Withdrawal by Subject|4|||
144559005|NCT00905255|521245494|FG000|Overall Study|Familial and Personal Reasons|1|||
144559006|NCT00905255|521245495|FG001|Overall Study|Familial and Personal Reasons|0|||
144559007|NCT03849300|521245496|FG000|Overall Study|move out to different area|1|||
144559008|NCT03849300|521245497|FG001|Overall Study|move out to different area|3|||
144559009|NCT03849300|521245498|FG002|Overall Study|move out to different area|1|||
144559010|NCT03849300|521245499|FG003|Overall Study|move out to different area|4|||
144559011|NCT03849300|521245496|FG000|Overall Study|scheduling/transportation conflict|4|||
144559012|NCT03849300|521245497|FG001|Overall Study|scheduling/transportation conflict|4|||
144559013|NCT03849300|521245498|FG002|Overall Study|scheduling/transportation conflict|3|||
144559014|NCT03849300|521245499|FG003|Overall Study|scheduling/transportation conflict|2|||
144559015|NCT01774929|521245500|FG000|Overall Study|Adverse Event|3|||
144559016|NCT04839289|521245501|FG000|Overall Study|Withdrawal by Subject|1|||
144559017|NCT04839289|521245502|FG001|Overall Study|Withdrawal by Subject|0|||
144559018|NCT00500539|521245504|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
144559019|NCT00500539|521245504|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
144559020|NCT00500539|521245504|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
144559021|NCT00500539|521245504|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
144559022|NCT00500539|521245504|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
144559023|NCT00500539|521245504|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
144559024|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
144559025|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
144559026|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
144559027|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
144559028|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Death|1|||
144559029|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
144559030|NCT00500539|521245504|FG000|Follow-up Period (16 Weeks)|Missing|3|||
144559031|NCT01524887|521245505|FG000|Overall Study|Withdrawal by Subject|6|||
144559032|NCT01524887|521245506|FG001|Overall Study|Withdrawal by Subject|2|||
144617529|NCT02559687|521459738|FG000|Overall Study|Sponsor Decision|5|||
144617530|NCT02559687|521459738|FG000|Overall Study|Withdrawal by Subject|4|||
144617531|NCT04951037|521459739|FG000|Overall Study|Lost to Follow-up|16|||
144617532|NCT04951037|521459739|FG000|Overall Study|Withdrawal by Subject|5|||
144617533|NCT04951037|521459739|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
144617534|NCT03245450|521459741|FG000|Overall Study|Radiological disease progression|3|||
144617535|NCT03245450|521459742|FG001|Overall Study|Radiological disease progression|3|||
144559033|NCT01524887|521245507|FG002|Overall Study|Withdrawal by Subject|3|||
144559034|NCT01524887|521245505|FG000|Overall Study|Adverse Event|5|||
144559035|NCT01524887|521245506|FG001|Overall Study|Adverse Event|1|||
144559036|NCT01524887|521245507|FG002|Overall Study|Adverse Event|1|||
144559037|NCT01524887|521245505|FG000|Overall Study|Protocol Violation|0|||
144559038|NCT01524887|521245506|FG001|Overall Study|Protocol Violation|0|||
144559039|NCT01524887|521245507|FG002|Overall Study|Protocol Violation|1|||
144559040|NCT01524887|521245505|FG000|Overall Study|Study termination|73|||
144559041|NCT01524887|521245506|FG001|Overall Study|Study termination|87|||
144559042|NCT01524887|521245507|FG002|Overall Study|Study termination|79|||
144559043|NCT01524887|521245505|FG000|Overall Study|Withdrawal by Caregiver|0|||
144559044|NCT01524887|521245506|FG001|Overall Study|Withdrawal by Caregiver|0|||
144559045|NCT01524887|521245507|FG002|Overall Study|Withdrawal by Caregiver|2|||
144559046|NCT01524887|521245505|FG000|Overall Study|Use of prohibited medication|1|||
144559047|NCT01524887|521245506|FG001|Overall Study|Use of prohibited medication|0|||
144559048|NCT01524887|521245507|FG002|Overall Study|Use of prohibited medication|0|||
144559049|NCT01808144|521245508|FG000|Overall Study|Death|1|||
144559050|NCT01808144|521245509|FG001|Overall Study|Death|0|||
144559051|NCT01808144|521245508|FG000|Overall Study|Withdrawal by Subject|16|||
144559052|NCT01808144|521245509|FG001|Overall Study|Withdrawal by Subject|23|||
144559053|NCT01808144|521245508|FG000|Overall Study|Lost to Follow-up|6|||
144559054|NCT01808144|521245509|FG001|Overall Study|Lost to Follow-up|3|||
144559055|NCT01808144|521245508|FG000|Overall Study|Protocol Violation|6|||
144559056|NCT01808144|521245509|FG001|Overall Study|Protocol Violation|6|||
144559057|NCT01808144|521245508|FG000|Overall Study|Gout flare|0|||
144559058|NCT01808144|521245509|FG001|Overall Study|Gout flare|1|||
144559059|NCT01808144|521245508|FG000|Overall Study|Adverse Event|11|||
144559060|NCT01808144|521245509|FG001|Overall Study|Adverse Event|15|||
144559061|NCT03993054|521245510|FG000|Overall Study|PI Decision|1|||
144559062|NCT04341584|521245511|FG000|Overall Study|Withdrew consent|0|||
144559063|NCT04341584|521245512|FG001|Overall Study|Withdrew consent|2|||
144559064|NCT04341584|521245513|FG002|Overall Study|Withdrew consent|2|||
144559065|NCT04341584|521245514|FG003|Overall Study|Withdrew consent|1|||
144559066|NCT00497198|521245516|FG000|Overall Study|Adverse Event|4|||
144559067|NCT00497198|521245517|FG001|Overall Study|Adverse Event|2|||
144559068|NCT00497198|521245516|FG000|Overall Study|Physician Decision|1|||
144559069|NCT00497198|521245517|FG001|Overall Study|Physician Decision|2|||
144559070|NCT00497198|521245516|FG000|Overall Study|Withdrawal by Subject|0|||
144559071|NCT00497198|521245517|FG001|Overall Study|Withdrawal by Subject|1|||
144559072|NCT04853238|521245518|FG000|Overall Study|Death|4|||
144559073|NCT04853238|521245519|FG001|Overall Study|Death|0|||
144559074|NCT04853238|521245520|FG002|Overall Study|Death|2|||
144559075|NCT04853238|521245518|FG000|Overall Study|Lost to Follow-up|16|||
144559076|NCT04853238|521245519|FG001|Overall Study|Lost to Follow-up|2|||
144559077|NCT04853238|521245520|FG002|Overall Study|Lost to Follow-up|37|||
144559078|NCT04853238|521245518|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
144559079|NCT04853238|521245519|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
144559080|NCT04853238|521245520|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
144559081|NCT04853238|521245518|FG000|Overall Study|Withdrawal by Subject|6|||
144559082|NCT04853238|521245519|FG001|Overall Study|Withdrawal by Subject|0|||
144559083|NCT04853238|521245520|FG002|Overall Study|Withdrawal by Subject|21|||
144559084|NCT04853238|521245518|FG000|Overall Study|Physician Decision|0|||
144559085|NCT04853238|521245519|FG001|Overall Study|Physician Decision|0|||
144617536|NCT03245450|521459743|FG002|Overall Study|Radiological disease progression|2|||
144617537|NCT03245450|521459744|FG003|Overall Study|Radiological disease progression|2|||
144617538|NCT03245450|521459745|FG004|Overall Study|Radiological disease progression|7|||
144617539|NCT03245450|521459746|FG005|Overall Study|Radiological disease progression|6|||
144617540|NCT03245450|521459747|FG006|Overall Study|Radiological disease progression|6|||
144559086|NCT04853238|521245520|FG002|Overall Study|Physician Decision|2|||
144559087|NCT04853238|521245518|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
144559088|NCT04853238|521245519|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
144559089|NCT04853238|521245520|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
144617541|NCT03245450|521459741|FG000|Overall Study|Clinical disease progression|0|||
144617542|NCT03245450|521459742|FG001|Overall Study|Clinical disease progression|0|||
144617543|NCT03245450|521459743|FG002|Overall Study|Clinical disease progression|1|||
144617544|NCT03245450|521459744|FG003|Overall Study|Clinical disease progression|0|||
144617545|NCT03245450|521459745|FG004|Overall Study|Clinical disease progression|0|||
144617546|NCT03245450|521459746|FG005|Overall Study|Clinical disease progression|2|||
144617547|NCT03245450|521459747|FG006|Overall Study|Clinical disease progression|0|||
144559090|NCT00371462|521247658|FG000|Overall Study|Withdrawal by Subject|1|||
144559091|NCT00371462|521247659|FG001|Overall Study|Withdrawal by Subject|0|||
144559092|NCT00371462|521247658|FG000|Overall Study|Other|7|||
144559093|NCT00371462|521247659|FG001|Overall Study|Other|8|||
144559094|NCT00349622|521247665|FG000|Overall Study|Death|168|||
144559095|NCT00349622|521247666|FG001|Overall Study|Death|86|||
144559096|NCT00349622|521247665|FG000|Overall Study|Lost to Follow-up|5|||
144559097|NCT00349622|521247666|FG001|Overall Study|Lost to Follow-up|1|||
144559098|NCT00349622|521247665|FG000|Overall Study|Withdrawal by Subject|5|||
144559099|NCT00349622|521247666|FG001|Overall Study|Withdrawal by Subject|9|||
144559100|NCT00508274|521247667|FG000|Overall Study|Adverse Event|5|||
144559101|NCT00508274|521247667|FG000|Overall Study|Death|7|||
144559102|NCT00508274|521247667|FG000|Overall Study|Disease progression|32|||
144559103|NCT00508274|521247667|FG000|Overall Study|Withdrawal by Subject|1|||
144559104|NCT00508274|521247667|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
144559105|NCT00508274|521247667|FG000|Overall Study|Missing|3|||
144559106|NCT03296566|521247668|FG000|Overall Study|Lost to Follow-up|19|||
144559107|NCT03296566|521247669|FG001|Overall Study|Lost to Follow-up|46|||
144559108|NCT03296566|521247668|FG000|Overall Study|Withdrawal by Subject|0|||
144559109|NCT03296566|521247669|FG001|Overall Study|Withdrawal by Subject|3|||
144559110|NCT02229396|521247676|FG000|Overall Study|Adverse Event|6|||
144559111|NCT02229396|521247677|FG001|Overall Study|Adverse Event|12|||
144559112|NCT02229396|521247678|FG002|Overall Study|Adverse Event|12|||
144559113|NCT02229396|521247676|FG000|Overall Study|Death|2|||
144559114|NCT02229396|521247677|FG001|Overall Study|Death|3|||
144559115|NCT02229396|521247678|FG002|Overall Study|Death|1|||
144559116|NCT02229396|521247676|FG000|Overall Study|Lost to Follow-up|14|||
144559117|NCT02229396|521247677|FG001|Overall Study|Lost to Follow-up|14|||
144559118|NCT02229396|521247678|FG002|Overall Study|Lost to Follow-up|21|||
144559119|NCT02229396|521247676|FG000|Overall Study|Protocol Violation|2|||
144559120|NCT02229396|521247677|FG001|Overall Study|Protocol Violation|1|||
144559121|NCT02229396|521247678|FG002|Overall Study|Protocol Violation|0|||
144559122|NCT02229396|521247676|FG000|Overall Study|Patient Incorrectly Randomized|0|||
144559123|NCT02229396|521247677|FG001|Overall Study|Patient Incorrectly Randomized|0|||
144559124|NCT02229396|521247678|FG002|Overall Study|Patient Incorrectly Randomized|1|||
144559125|NCT02229396|521247676|FG000|Overall Study|Other|10|||
144559126|NCT02229396|521247677|FG001|Overall Study|Other|18|||
144559127|NCT02229396|521247678|FG002|Overall Study|Other|15|||
144559128|NCT02229396|521247676|FG000|Overall Study|Withdrawal by Subject|42|||
144559129|NCT02229396|521247677|FG001|Overall Study|Withdrawal by Subject|28|||
144559130|NCT02229396|521247678|FG002|Overall Study|Withdrawal by Subject|41|||
144559131|NCT02229396|521247676|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
144559132|NCT02229396|521247677|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
144559133|NCT02229396|521247678|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
144559134|NCT02229396|521247676|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
144559135|NCT02229396|521247677|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
144559136|NCT02229396|521247678|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
144559137|NCT01243411|521247679|FG000|Overall Study|Withdrawal by Subject|18|||
144559138|NCT01243411|521247679|FG000|Overall Study|Lost to Follow-up|10|||
144559139|NCT01243411|521247679|FG000|Overall Study|Adverse Event|5|||
144559140|NCT01243411|521247679|FG000|Overall Study|Other|8|||
144559141|NCT00805285|521247682|FG000|Overall Study|Lack of Efficacy|1|||
144559142|NCT00839306|521247683|FG000|Overall Study|Adverse Event|3|||
144559143|NCT00839306|521247684|FG001|Overall Study|Adverse Event|5|||
144559144|NCT00839306|521247683|FG000|Overall Study|Lost to Follow-up|6|||
144559145|NCT00839306|521247684|FG001|Overall Study|Lost to Follow-up|9|||
144559146|NCT00839306|521247683|FG000|Overall Study|Withdrawal by Subject|5|||
144559147|NCT00839306|521247684|FG001|Overall Study|Withdrawal by Subject|7|||
144559148|NCT00839306|521247683|FG000|Overall Study|Lack of Efficacy|5|||
144559149|NCT00839306|521247684|FG001|Overall Study|Lack of Efficacy|4|||
144559150|NCT00839306|521247683|FG000|Overall Study|Other|6|||
144559151|NCT00839306|521247684|FG001|Overall Study|Other|18|||
144559152|NCT01812707|521247685|FG000|Overall Study|Adverse Event|0|||
144559153|NCT01812707|521247686|FG001|Overall Study|Adverse Event|0|||
144559154|NCT01812707|521247687|FG002|Overall Study|Adverse Event|0|||
144559155|NCT01812707|521247688|FG003|Overall Study|Adverse Event|2|||
144617548|NCT03245450|521459741|FG000|Overall Study|Other|0|||
144617549|NCT03245450|521459742|FG001|Overall Study|Other|0|||
144559156|NCT01812707|521247685|FG000|Overall Study|Poor compliance to protocol|1|||
144559157|NCT01812707|521247686|FG001|Overall Study|Poor compliance to protocol|0|||
144559158|NCT01812707|521247687|FG002|Overall Study|Poor compliance to protocol|0|||
144559159|NCT01812707|521247688|FG003|Overall Study|Poor compliance to protocol|0|||
144559160|NCT01812707|521247685|FG000|Overall Study|Consent withdrawn by participant|1|||
144559161|NCT01812707|521247686|FG001|Overall Study|Consent withdrawn by participant|0|||
144559162|NCT01812707|521247687|FG002|Overall Study|Consent withdrawn by participant|0|||
144559163|NCT01812707|521247688|FG003|Overall Study|Consent withdrawn by participant|0|||
144559164|NCT01066897|521247689|FG000|Overall Study|Withdrawal by Subject|1|||
144559165|NCT01066897|521247690|FG001|Overall Study|Withdrawal by Subject|0|||
144559166|NCT01066897|521247689|FG000|Overall Study|stopped study after developing the flu.|1|||
144559167|NCT01066897|521247690|FG001|Overall Study|stopped study after developing the flu.|0|||
144559168|NCT02396758|521247693|FG000|Overall Study|Withdrawal by Subject|2|||
144559169|NCT02396758|521247694|FG001|Overall Study|Withdrawal by Subject|0|||
144559170|NCT02396758|521247695|FG002|Overall Study|Withdrawal by Subject|0|||
144559171|NCT02396758|521247696|FG003|Overall Study|Withdrawal by Subject|1|||
144559172|NCT02396758|521247693|FG000|Overall Study|Lost to Follow-up|8|||
144559173|NCT02396758|521247694|FG001|Overall Study|Lost to Follow-up|5|||
144559174|NCT02396758|521247695|FG002|Overall Study|Lost to Follow-up|3|||
144559175|NCT02396758|521247696|FG003|Overall Study|Lost to Follow-up|3|||
144559176|NCT02396758|521247693|FG000|Overall Study|Death|1|||
144559177|NCT02396758|521247694|FG001|Overall Study|Death|1|||
144559178|NCT02396758|521247695|FG002|Overall Study|Death|0|||
144559179|NCT02396758|521247696|FG003|Overall Study|Death|1|||
144559180|NCT02396758|521247693|FG000|Overall Study|Randomized but not treated|1|||
144559181|NCT02396758|521247694|FG001|Overall Study|Randomized but not treated|0|||
144559182|NCT02396758|521247695|FG002|Overall Study|Randomized but not treated|1|||
144559183|NCT02396758|521247696|FG003|Overall Study|Randomized but not treated|0|||
144559184|NCT03022045|521247697|FG000|Overall Study|Adverse Event|0|||
144559185|NCT03022045|521247698|FG001|Overall Study|Adverse Event|1|||
144559186|NCT03022045|521247697|FG000|Overall Study|Withdrawal by Subject|1|||
144559187|NCT03022045|521247698|FG001|Overall Study|Withdrawal by Subject|1|||
144559188|NCT00666835|521247699|FG000|Overall Study|Withdrawal by Subject|5|||
144559189|NCT00666835|521247700|FG001|Overall Study|Withdrawal by Subject|2|||
144559190|NCT00666835|521247699|FG000|Overall Study|Lack of Efficacy|0|||
144559191|NCT00666835|521247700|FG001|Overall Study|Lack of Efficacy|1|||
144559192|NCT00666835|521247699|FG000|Overall Study|Incl./excl. not fulfilled|7|||
144559193|NCT00666835|521247700|FG001|Overall Study|Incl./excl. not fulfilled|2|||
144559194|NCT00666835|521247699|FG000|Overall Study|Adverse Event|7|||
144559195|NCT00666835|521247700|FG001|Overall Study|Adverse Event|6|||
144559196|NCT00666835|521247699|FG000|Overall Study|Protocol Violation|2|||
144559197|NCT00666835|521247700|FG001|Overall Study|Protocol Violation|0|||
144559198|NCT00666835|521247699|FG000|Overall Study|Death|15|||
144559199|NCT00666835|521247700|FG001|Overall Study|Death|4|||
144559200|NCT00666835|521247699|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
144559201|NCT00666835|521247700|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
144559202|NCT00666835|521247699|FG000|Overall Study|Hemoglobulin concentration|4|||
144559203|NCT00666835|521247700|FG001|Overall Study|Hemoglobulin concentration|3|||
144559204|NCT00666835|521247699|FG000|Overall Study|Planned operation|2|||
144559205|NCT00666835|521247700|FG001|Overall Study|Planned operation|0|||
144559206|NCT00666835|521247699|FG000|Overall Study|Physician Decision|1|||
144559207|NCT00666835|521247700|FG001|Overall Study|Physician Decision|2|||
144559208|NCT01126879|521247701|FG000|Overall Study|Progressive Disease|3|||
144559209|NCT01126879|521247702|FG001|Overall Study|Progressive Disease|1|||
144559210|NCT01126879|521247701|FG000|Overall Study|Withdrawal by Subject|1|||
144559211|NCT01126879|521247702|FG001|Overall Study|Withdrawal by Subject|0|||
144559212|NCT01126879|521247701|FG000|Overall Study|Adverse Event|0|||
144559213|NCT01126879|521247702|FG001|Overall Study|Adverse Event|1|||
144559214|NCT01126879|521247701|FG000|Overall Study|Physician Decision|1|||
144559215|NCT01126879|521247702|FG001|Overall Study|Physician Decision|0|||
144559216|NCT00899379|521247703|FG000|Overall Study|Adverse Event|2|||
144559217|NCT00899379|521247704|FG001|Overall Study|Adverse Event|2|||
144559218|NCT00899379|521247705|FG002|Overall Study|Adverse Event|1|||
144559219|NCT00899379|521247706|FG003|Overall Study|Adverse Event|1|||
144559220|NCT00899379|521247707|FG004|Overall Study|Adverse Event|2|||
144559221|NCT00899379|521247703|FG000|Overall Study|Lack of Efficacy|0|||
144559222|NCT00899379|521247704|FG001|Overall Study|Lack of Efficacy|4|||
144559223|NCT00899379|521247705|FG002|Overall Study|Lack of Efficacy|3|||
144559224|NCT00899379|521247706|FG003|Overall Study|Lack of Efficacy|0|||
144559225|NCT00899379|521247707|FG004|Overall Study|Lack of Efficacy|1|||
144559226|NCT00899379|521247703|FG000|Overall Study|Lost to Follow-up|9|||
144559227|NCT00899379|521247704|FG001|Overall Study|Lost to Follow-up|3|||
144559228|NCT00899379|521247705|FG002|Overall Study|Lost to Follow-up|0|||
144559229|NCT00899379|521247706|FG003|Overall Study|Lost to Follow-up|6|||
144559230|NCT00899379|521247707|FG004|Overall Study|Lost to Follow-up|2|||
144559231|NCT00899379|521247703|FG000|Overall Study|Protocol Violation|0|||
144559232|NCT00899379|521247704|FG001|Overall Study|Protocol Violation|0|||
144559233|NCT00899379|521247705|FG002|Overall Study|Protocol Violation|1|||
144559234|NCT00899379|521247706|FG003|Overall Study|Protocol Violation|1|||
144559235|NCT00899379|521247707|FG004|Overall Study|Protocol Violation|0|||
144559236|NCT00899379|521247703|FG000|Overall Study|Withdrawal by Subject|2|||
144559237|NCT00899379|521247704|FG001|Overall Study|Withdrawal by Subject|4|||
144559238|NCT00899379|521247705|FG002|Overall Study|Withdrawal by Subject|2|||
144559239|NCT00899379|521247706|FG003|Overall Study|Withdrawal by Subject|3|||
144559240|NCT00899379|521247707|FG004|Overall Study|Withdrawal by Subject|6|||
144559241|NCT00899379|521247703|FG000|Overall Study|Pregnancy|0|||
144559242|NCT00899379|521247704|FG001|Overall Study|Pregnancy|0|||
144559243|NCT00899379|521247705|FG002|Overall Study|Pregnancy|1|||
144559244|NCT00899379|521247706|FG003|Overall Study|Pregnancy|0|||
144559245|NCT00899379|521247707|FG004|Overall Study|Pregnancy|1|||
144559246|NCT00899379|521247703|FG000|Overall Study|Patient Uncooperative|0|||
144559247|NCT00899379|521247704|FG001|Overall Study|Patient Uncooperative|1|||
144559248|NCT00899379|521247705|FG002|Overall Study|Patient Uncooperative|0|||
144559249|NCT00899379|521247706|FG003|Overall Study|Patient Uncooperative|1|||
144559250|NCT00899379|521247707|FG004|Overall Study|Patient Uncooperative|2|||
144559251|NCT00899379|521247703|FG000|Overall Study|Abnormal Baseline ECG|0|||
144559252|NCT00899379|521247704|FG001|Overall Study|Abnormal Baseline ECG|0|||
144559253|NCT00899379|521247705|FG002|Overall Study|Abnormal Baseline ECG|0|||
144559254|NCT00899379|521247706|FG003|Overall Study|Abnormal Baseline ECG|1|||
144559255|NCT00899379|521247707|FG004|Overall Study|Abnormal Baseline ECG|0|||
144559256|NCT00899379|521247703|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
144559257|NCT00899379|521247704|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
144559258|NCT00899379|521247705|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
144559259|NCT00899379|521247706|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144559260|NCT00899379|521247707|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144559261|NCT00899379|521247703|FG000|Overall Study|Not Completed/Entered Extn|5|||
144559262|NCT00899379|521247704|FG001|Overall Study|Not Completed/Entered Extn|1|||
144559263|NCT00899379|521247705|FG002|Overall Study|Not Completed/Entered Extn|6|||
144559264|NCT00899379|521247706|FG003|Overall Study|Not Completed/Entered Extn|4|||
144559265|NCT00899379|521247707|FG004|Overall Study|Not Completed/Entered Extn|3|||
144559266|NCT00899379|521247703|FG000|Overall Study|Study Terminated|3|||
144559267|NCT00899379|521247704|FG001|Overall Study|Study Terminated|0|||
144559268|NCT00899379|521247705|FG002|Overall Study|Study Terminated|3|||
144559269|NCT00899379|521247706|FG003|Overall Study|Study Terminated|3|||
144559270|NCT00899379|521247707|FG004|Overall Study|Study Terminated|1|||
144559271|NCT00899379|521247703|FG000|Overall Study|Lost to Follow-up|3|||
144559272|NCT00899379|521247704|FG001|Overall Study|Lost to Follow-up|1|||
144559273|NCT00899379|521247705|FG002|Overall Study|Lost to Follow-up|0|||
144559274|NCT00899379|521247706|FG003|Overall Study|Lost to Follow-up|2|||
144559275|NCT00899379|521247707|FG004|Overall Study|Lost to Follow-up|5|||
144559276|NCT00899379|521247703|FG000|Overall Study|Withdrawal by Subject|4|||
144559277|NCT00899379|521247704|FG001|Overall Study|Withdrawal by Subject|7|||
144559278|NCT00899379|521247705|FG002|Overall Study|Withdrawal by Subject|4|||
144559279|NCT00899379|521247706|FG003|Overall Study|Withdrawal by Subject|7|||
144559280|NCT00899379|521247707|FG004|Overall Study|Withdrawal by Subject|2|||
144559281|NCT00899379|521247703|FG000|Overall Study|Pregnancy|1|||
144559282|NCT00899379|521247704|FG001|Overall Study|Pregnancy|0|||
144559283|NCT00899379|521247705|FG002|Overall Study|Pregnancy|0|||
144559284|NCT00899379|521247706|FG003|Overall Study|Pregnancy|0|||
144559285|NCT00899379|521247707|FG004|Overall Study|Pregnancy|0|||
144559286|NCT00899379|521247703|FG000|Overall Study|Patient Uncooperative|0|||
144559287|NCT00899379|521247704|FG001|Overall Study|Patient Uncooperative|0|||
144559288|NCT00899379|521247705|FG002|Overall Study|Patient Uncooperative|0|||
144559289|NCT00899379|521247706|FG003|Overall Study|Patient Uncooperative|1|||
144559290|NCT00899379|521247707|FG004|Overall Study|Patient Uncooperative|0|||
144559291|NCT00899379|521247703|FG000|Overall Study|Abnormal Prestudy Labs|0|||
144559292|NCT00899379|521247704|FG001|Overall Study|Abnormal Prestudy Labs|0|||
144617550|NCT03245450|521459743|FG002|Overall Study|Other|0|||
144617551|NCT03245450|521459744|FG003|Overall Study|Other|1|||
144617552|NCT03245450|521459745|FG004|Overall Study|Other|1|||
144617553|NCT03245450|521459746|FG005|Overall Study|Other|1|||
144617554|NCT03245450|521459747|FG006|Overall Study|Other|1|||
144617555|NCT03245450|521459741|FG000|Overall Study|Withdrawal by Subject|0|||
144559293|NCT00899379|521247705|FG002|Overall Study|Abnormal Prestudy Labs|0|||
144559294|NCT00899379|521247706|FG003|Overall Study|Abnormal Prestudy Labs|0|||
144559295|NCT00899379|521247707|FG004|Overall Study|Abnormal Prestudy Labs|2|||
144559296|NCT00899379|521247703|FG000|Overall Study|Abnormal Baseline ECG|0|||
144559297|NCT00899379|521247704|FG001|Overall Study|Abnormal Baseline ECG|0|||
144617556|NCT03245450|521459742|FG001|Overall Study|Withdrawal by Subject|1|||
144617557|NCT03245450|521459743|FG002|Overall Study|Withdrawal by Subject|0|||
144617558|NCT03245450|521459744|FG003|Overall Study|Withdrawal by Subject|0|||
144728002|NCT02937701|521859287|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
144559298|NCT00899379|521247705|FG002|Overall Study|Abnormal Baseline ECG|1|||
144559299|NCT00899379|521247706|FG003|Overall Study|Abnormal Baseline ECG|1|||
144559300|NCT00899379|521247707|FG004|Overall Study|Abnormal Baseline ECG|0|||
144559301|NCT00899379|521247703|FG000|Overall Study|No Attack Pretreatment|3|||
144559302|NCT00899379|521247704|FG001|Overall Study|No Attack Pretreatment|5|||
144559303|NCT00899379|521247705|FG002|Overall Study|No Attack Pretreatment|5|||
144559304|NCT00899379|521247706|FG003|Overall Study|No Attack Pretreatment|6|||
144559305|NCT00899379|521247707|FG004|Overall Study|No Attack Pretreatment|4|||
144617559|NCT03245450|521459745|FG004|Overall Study|Withdrawal by Subject|0|||
144617560|NCT03245450|521459746|FG005|Overall Study|Withdrawal by Subject|0|||
144728003|NCT02937701|521859283|FG000|Day 1 to Week 22|Physician Decision|2|||
144728004|NCT02937701|521859284|FG001|Day 1 to Week 22|Physician Decision|0|||
144559306|NCT00899379|521247703|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
144617561|NCT03245450|521459747|FG006|Overall Study|Withdrawal by Subject|0|||
144559307|NCT00899379|521247704|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144559308|NCT00899379|521247705|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144559309|NCT00899379|521247706|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144559310|NCT00899379|521247707|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
144559311|NCT00899379|521247703|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
144559312|NCT00899379|521247704|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
144559313|NCT00899379|521247705|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
144559314|NCT00899379|521247706|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
144559315|NCT00899379|521247707|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
144559316|NCT00498433|521247712|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
144559317|NCT00498433|521247713|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
144559318|NCT00498433|521247714|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
144559319|NCT00498433|521247712|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
144559320|NCT00498433|521247713|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
144559321|NCT00498433|521247714|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
144559322|NCT00498433|521247712|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
144559323|NCT00498433|521247713|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
144559324|NCT00498433|521247714|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
144559325|NCT00498433|521247712|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
144559326|NCT00498433|521247713|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
144559327|NCT00498433|521247714|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
144559328|NCT02581189|521247715|FG000|Overall Study|Failure to return|36|||
144559329|NCT02581189|521247715|FG000|Overall Study|Withdrew consent|5|||
144559330|NCT02581189|521247715|FG000|Overall Study|Death|3|||
144559331|NCT02581189|521247715|FG000|Overall Study|Insufficient virological response|2|||
144559332|NCT02581189|521247715|FG000|Overall Study|Other, not specified|7|||
144559333|NCT02253147|521247716|FG000|Overall Study|Protocol Violation|30|||
144559334|NCT02253147|521247716|FG000|Overall Study|Did not consent to study extension|9|||
144559335|NCT02253147|521247716|FG000|Overall Study|Conditional re-treatment at W52|5|||
144559336|NCT02253147|521247716|FG000|Overall Study|Lost to Follow-up|2|||
144559337|NCT02253147|521247716|FG000|Overall Study|Withdrawal by Subject|1|||
144559338|NCT02973477|521247717|FG000|First Intervention|Lost to Follow-up|0|||
144559339|NCT02973477|521247718|FG001|First Intervention|Lost to Follow-up|2|||
144559340|NCT02973477|521247717|FG000|Washout|Withdrawal by Subject|1|||
144559341|NCT02973477|521247718|FG001|Washout|Withdrawal by Subject|0|||
144559342|NCT02973477|521247717|FG000|Second Intervention|Lost to Follow-up|1|||
144559343|NCT02973477|521247718|FG001|Second Intervention|Lost to Follow-up|0|||
144559344|NCT02316847|521247719|FG000|Overall Study|Adverse Event|0|||
144559345|NCT02316847|521247720|FG001|Overall Study|Adverse Event|3|||
144559346|NCT02316847|521247719|FG000|Overall Study|Lost to Follow-up|0|||
144559347|NCT02316847|521247720|FG001|Overall Study|Lost to Follow-up|2|||
144559348|NCT02316847|521247719|FG000|Overall Study|Physician Decision|0|||
144559349|NCT02316847|521247720|FG001|Overall Study|Physician Decision|1|||
144559350|NCT02316847|521247719|FG000|Overall Study|Pregnancy|0|||
144559351|NCT02316847|521247720|FG001|Overall Study|Pregnancy|1|||
144559352|NCT02316847|521247719|FG000|Overall Study|Withdrawal by Subject|2|||
144559353|NCT02316847|521247720|FG001|Overall Study|Withdrawal by Subject|9|||
144559354|NCT02316847|521247719|FG000|Overall Study|Noncompliance with study drug|0|||
144559355|NCT02316847|521247720|FG001|Overall Study|Noncompliance with study drug|3|||
144559356|NCT02316847|521247719|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
144559357|NCT02316847|521247720|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
144559358|NCT03371485|521247723|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
144559359|NCT03371485|521247723|FG000|2-year Follow-up|Death|5|||
144559360|NCT01264887|521247727|FG000|Overall Study|Adverse Event|5|||
144559361|NCT01264887|521247727|FG000|Overall Study|Death|7|||
144559362|NCT01264887|521247727|FG000|Overall Study|Lack of Efficacy|5|||
144559363|NCT01264887|521247727|FG000|Overall Study|Physician Decision|4|||
144559364|NCT01264887|521247727|FG000|Overall Study|Withdrawal by Subject|6|||
144559365|NCT01264887|521247727|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
144559366|NCT01264887|521247727|FG000|Overall Study|Other|2|||
144559367|NCT04531813|521247730|FG000|Overall Study|Protocol Violation|1|||
144559368|NCT04531813|521247730|FG000|Overall Study|Withdrawal by Subject|1|||
144559369|NCT00591409|521247731|FG000|Overall Study|Not Treated|0|||
144559370|NCT00591409|521247732|FG001|Overall Study|Not Treated|0|||
144559371|NCT00591409|521247733|FG002|Overall Study|Not Treated|0|||
144559372|NCT00591409|521247734|FG003|Overall Study|Not Treated|0|||
144559373|NCT00591409|521247735|FG004|Overall Study|Not Treated|1|||
144559374|NCT00591409|521247736|FG005|Overall Study|Not Treated|0|||
144559375|NCT00591409|521247737|FG006|Overall Study|Not Treated|0|||
144559376|NCT00591409|521247738|FG007|Overall Study|Not Treated|0|||
144559377|NCT00591409|521247739|FG008|Overall Study|Not Treated|0|||
144559378|NCT00591409|521247740|FG009|Overall Study|Not Treated|1|||
144559379|NCT02171130|521247741|FG000|Overall Study|Death|1|||
144559380|NCT02171130|521247741|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
144559381|NCT02171130|521247741|FG000|Overall Study|Discontinued; Site Termination|5|||
144559382|NCT02171130|521247741|FG000|Overall Study|Withdrawal by Subject|3|||
144559383|NCT02171130|521247741|FG000|Overall Study|Physician Decision|1|||
144559384|NCT02171130|521247741|FG000|Overall Study|Lost to Follow-up|1|||
144559385|NCT02171130|521247741|FG000|Overall Study|Met Exclusion Criteria|1|||
144559386|NCT02853305|521247744|FG000|Overall Study|Death|287|||
144559387|NCT02853305|521247745|FG001|Overall Study|Death|249|||
144559388|NCT02853305|521247746|FG002|Overall Study|Death|300|||
144559389|NCT02853305|521247744|FG000|Overall Study|Withdrawal by Subject|2|||
144559390|NCT02853305|521247745|FG001|Overall Study|Withdrawal by Subject|8|||
144559391|NCT02853305|521247746|FG002|Overall Study|Withdrawal by Subject|3|||
144559392|NCT02853305|521247744|FG000|Overall Study|Transferred to Extension Study|46|||
144559393|NCT02853305|521247745|FG001|Overall Study|Transferred to Extension Study|30|||
144559394|NCT02853305|521247746|FG002|Overall Study|Transferred to Extension Study|25|||
144559395|NCT02853305|521247744|FG000|Overall Study|Did Not Continue on Extension Study|16|||
144559396|NCT02853305|521247745|FG001|Overall Study|Did Not Continue on Extension Study|20|||
144559397|NCT02853305|521247746|FG002|Overall Study|Did Not Continue on Extension Study|24|||
144559398|NCT02381652|521247751|FG000|Overall Study|Withdrawal by Subject|0|||
144559399|NCT02381652|521247752|FG001|Overall Study|Withdrawal by Subject|0|||
144559400|NCT02381652|521247753|FG002|Overall Study|Withdrawal by Subject|1|||
144559401|NCT03746483|521247754|FG000|Overall Study|Adverse Event|0|||
144559402|NCT03746483|521247755|FG001|Overall Study|Adverse Event|1|||
144559403|NCT03746483|521247754|FG000|Overall Study|Lack of Efficacy|3|||
144559404|NCT03746483|521247755|FG001|Overall Study|Lack of Efficacy|2|||
144559405|NCT03746483|521247754|FG000|Overall Study|Lost to Follow-up|1|||
144559406|NCT03746483|521247755|FG001|Overall Study|Lost to Follow-up|0|||
144559407|NCT03746483|521247754|FG000|Overall Study|Protocol Violation|2|||
144559408|NCT03746483|521247755|FG001|Overall Study|Protocol Violation|0|||
144559409|NCT01954771|521247756|FG000|Overall Study|Missing HbA1c of end-point|1|||
144559410|NCT01954771|521247757|FG001|Overall Study|Missing HbA1c of end-point|1|||
144559411|NCT01954771|521247758|FG002|Overall Study|Missing HbA1c of end-point|0|||
144559412|NCT01954771|521247756|FG000|Overall Study|Missing CGMS of end-point|1|||
144559413|NCT01954771|521247757|FG001|Overall Study|Missing CGMS of end-point|1|||
144559414|NCT01954771|521247758|FG002|Overall Study|Missing CGMS of end-point|0|||
144559415|NCT01954771|521247756|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
144559416|NCT01954771|521247757|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
144559417|NCT01954771|521247758|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
144559418|NCT01675050|521247762|FG000|Period One Treatment|Withdrawal by Subject|1|||
144559419|NCT01675050|521247763|FG001|Period One Treatment|Withdrawal by Subject|0|||
144559420|NCT02382406|521247764|FG000|Study Treatment|Disease Progression|8|||
144559421|NCT02382406|521247765|FG001|Study Treatment|Disease Progression|0|||
144559422|NCT02382406|521247766|FG002|Study Treatment|Disease Progression|20|||
144559423|NCT02382406|521247764|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
144559424|NCT02382406|521247765|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
144559425|NCT02382406|521247766|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
144559426|NCT02382406|521247764|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
144559427|NCT02382406|521247765|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
144559428|NCT02382406|521247766|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
144559429|NCT02382406|521247764|FG000|Study Treatment|symptomatic deterioration|1|||
144559430|NCT02382406|521247765|FG001|Study Treatment|symptomatic deterioration|0|||
144559431|NCT02382406|521247766|FG002|Study Treatment|symptomatic deterioration|1|||
144559432|NCT02382406|521247764|FG000|Study Treatment|Death|0|||
144559433|NCT02382406|521247765|FG001|Study Treatment|Death|0|||
144559434|NCT02382406|521247766|FG002|Study Treatment|Death|2|||
144559435|NCT02382406|521247764|FG000|Follow up|Death|11|||
144559436|NCT02382406|521247765|FG001|Follow up|Death|0|||
144559437|NCT02382406|521247766|FG002|Follow up|Death|19|||
144559438|NCT02382406|521247764|FG000|Follow up|Symptomatic deterioration|1|||
144617562|NCT03245450|521459741|FG000|Overall Study|Adverse Event|0|||
144617563|NCT03245450|521459742|FG001|Overall Study|Adverse Event|0|||
144617564|NCT03245450|521459743|FG002|Overall Study|Adverse Event|0|||
144617565|NCT03245450|521459744|FG003|Overall Study|Adverse Event|0|||
144617566|NCT03245450|521459745|FG004|Overall Study|Adverse Event|1|||
144617567|NCT03245450|521459746|FG005|Overall Study|Adverse Event|0|||
144262488|NCT04547140|520161449|FG001|Overall Study|Reason Not Specified|1|||
144262489|NCT01566604|520161450|FG000|Overall Study|Patient's inability to use the device|1|||
144559439|NCT02382406|521247765|FG001|Follow up|Symptomatic deterioration|0|||
144559440|NCT02382406|521247766|FG002|Follow up|Symptomatic deterioration|1|||
144617568|NCT03245450|521459747|FG006|Overall Study|Adverse Event|2|||
144617569|NCT02429414|521459748|FG000|Overall Study|Physician Decision|0|||
144617570|NCT02429414|521459749|FG001|Overall Study|Physician Decision|1|||
144262490|NCT01566604|520161451|FG001|Overall Study|Patient's inability to use the device|0|||
144559441|NCT02382406|521247764|FG000|Follow up|Patient Refused Follow-up|1|||
144559442|NCT02382406|521247765|FG001|Follow up|Patient Refused Follow-up|0|||
144559443|NCT02382406|521247766|FG002|Follow up|Patient Refused Follow-up|0|||
144559444|NCT02382406|521247764|FG000|Follow up|Study Terminated|1|||
144617571|NCT01604265|521459755|FG000|Overall Study|Adverse Event|1|||
144617572|NCT01604265|521459756|FG001|Overall Study|Adverse Event|0|||
144728005|NCT02937701|521859285|FG002|Day 1 to Week 22|Physician Decision|0|||
144728006|NCT02937701|521859286|FG003|Day 1 to Week 22|Physician Decision|0|||
144559445|NCT02382406|521247765|FG001|Follow up|Study Terminated|0|||
144559446|NCT02382406|521247766|FG002|Follow up|Study Terminated|8|||
144559447|NCT02382406|521247764|FG000|Follow up|Withdrawal by Subject|0|||
144559448|NCT02382406|521247765|FG001|Follow up|Withdrawal by Subject|0|||
144559449|NCT02382406|521247766|FG002|Follow up|Withdrawal by Subject|2|||
144559450|NCT04543942|521247767|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
144559451|NCT04543942|521247768|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
144559452|NCT04543942|521247767|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
144559453|NCT04543942|521247768|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
144559454|NCT02391116|521247773|FG000|Treatment|Withdrawal by Subject|1|||
144559455|NCT02391116|521247773|FG000|Treatment|Protocol Violation|1|||
144559456|NCT02391116|521247773|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
144559457|NCT02391116|521247773|FG000|Treatment|AE with Clinical PD|3|||
144559458|NCT02391116|521247773|FG000|Safety Follow-up|Adverse Event|1|||
144559459|NCT02391116|521247773|FG000|Safety Follow-up|Withdrawal by Subject|4|||
144559460|NCT02391116|521247773|FG000|Safety Follow-up|Switching to Other Therapy|4|||
144559461|NCT02391116|521247773|FG000|Safety Follow-up|No Follow Up|1|||
144559462|NCT02391116|521247773|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
144559463|NCT02391116|521247773|FG000|Active Follow-up|Withdrawal by Subject|1|||
144559464|NCT02391116|521247773|FG000|Active Follow-up|Switching to Other Therapy|2|||
144559465|NCT02391116|521247773|FG000|Survival Follow-up|Withdrawal by Subject|3|||
144559466|NCT02391116|521247773|FG000|Survival Follow-up|Switching to Other Therapy|1|||
144559467|NCT01747629|521247775|FG000|Overall Study|Adverse Event|1|||
144559468|NCT01747629|521247776|FG001|Overall Study|Adverse Event|2|||
144559469|NCT01747629|521247775|FG000|Overall Study|Withdrawal by Subject|2|||
144559470|NCT01747629|521247776|FG001|Overall Study|Withdrawal by Subject|2|||
144559471|NCT01747629|521247775|FG000|Overall Study|Noncompliance|1|||
144559472|NCT01747629|521247776|FG001|Overall Study|Noncompliance|1|||
144559473|NCT01747629|521247775|FG000|Overall Study|Inclusion criteria not met|1|||
144559474|NCT01747629|521247776|FG001|Overall Study|Inclusion criteria not met|0|||
144559475|NCT01747629|521247775|FG000|Overall Study|Not treated|1|||
144559476|NCT01747629|521247776|FG001|Overall Study|Not treated|0|||
144559477|NCT01747629|521247775|FG000|Overall Study|Other|2|||
144559478|NCT01747629|521247776|FG001|Overall Study|Other|1|||
144559479|NCT02506881|521247777|FG000|First Intervention (Day 1)|Protocol Violation|0|||
144559480|NCT02506881|521247778|FG001|First Intervention (Day 1)|Protocol Violation|0|||
144559481|NCT02506881|521247779|FG002|First Intervention (Day 1)|Protocol Violation|1|||
144559482|NCT02506881|521247780|FG003|First Intervention (Day 1)|Protocol Violation|0|||
144559483|NCT02506881|521247777|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
144559484|NCT02506881|521247778|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
144559485|NCT02506881|521247779|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
144559486|NCT02506881|521247780|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
144559487|NCT02506881|521247777|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
144559488|NCT02506881|521247778|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
144559489|NCT02506881|521247779|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
144559490|NCT02506881|521247780|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
144559491|NCT02391545|521247781|FG000|Overall Study|Death|0|||
144559492|NCT02391545|521247782|FG001|Overall Study|Death|2|||
144559493|NCT02391545|521247781|FG000|Overall Study|Lost to Follow-up|0|||
144559494|NCT02391545|521247782|FG001|Overall Study|Lost to Follow-up|1|||
144559495|NCT02391545|521247781|FG000|Overall Study|Termination of study by sponsor|20|||
144559496|NCT02391545|521247782|FG001|Overall Study|Termination of study by sponsor|20|||
144559497|NCT02391545|521247781|FG000|Overall Study|Withdrawal by Subject|0|||
144559498|NCT02391545|521247782|FG001|Overall Study|Withdrawal by Subject|1|||
144559499|NCT02391545|521247781|FG000|Overall Study|Other Reasons|6|||
144559500|NCT02391545|521247782|FG001|Overall Study|Other Reasons|4|||
144559501|NCT02016690|521247783|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
144728007|NCT02937701|521859287|FG004|Day 1 to Week 22|Physician Decision|0|||
144728008|NCT02937701|521859283|FG000|Day 1 to Week 22|Other|1|||
144728009|NCT02937701|521859284|FG001|Day 1 to Week 22|Other|0|||
144728010|NCT02937701|521859285|FG002|Day 1 to Week 22|Other|0|||
144728011|NCT02937701|521859286|FG003|Day 1 to Week 22|Other|0|||
144728012|NCT02937701|521859287|FG004|Day 1 to Week 22|Other|0|||
144728013|NCT02937701|521859283|FG000|Week 22 to Week 50|Adverse Event|0|||
144559502|NCT02016690|521247783|FG000|Overall Study|Excluded from SAS: Duplication|2|||
144559503|NCT02016690|521247783|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
144559504|NCT02016690|521247783|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
144559505|NCT02016690|521247783|FG000|Overall Study|Did not meet inclusion criteria|13|||
144559506|NCT02016690|521247783|FG000|Overall Study|Hospitalized for RSV at study start|3|||
144559507|NCT01363297|521247784|FG000|Overall Study|Other|0|||
144559508|NCT01363297|521247785|FG001|Overall Study|Other|0|||
144559509|NCT01363297|521247786|FG002|Overall Study|Other|0|||
144728014|NCT02937701|521859284|FG001|Week 22 to Week 50|Adverse Event|0|||
144728015|NCT02937701|521859285|FG002|Week 22 to Week 50|Adverse Event|10|||
144559510|NCT01363297|521247787|FG003|Overall Study|Other|0|||
144559511|NCT01363297|521247788|FG004|Overall Study|Other|1|||
144559512|NCT01363297|521247784|FG000|Overall Study|Death|3|||
144617573|NCT01604265|521459755|FG000|Overall Study|Withdrawal by Subject|1|||
144617574|NCT01604265|521459756|FG001|Overall Study|Withdrawal by Subject|0|||
144617575|NCT00143312|521459759|FG000|Overall Study|Death|11|||
144617576|NCT00143312|521459759|FG000|Overall Study|Adverse Event|2|||
144617577|NCT00143312|521459759|FG000|Overall Study|Lost to Follow-up|1|||
144617578|NCT00143312|521459759|FG000|Overall Study|Other|1|||
144617579|NCT00143312|521459759|FG000|Overall Study|Withdrawal by Subject|1|||
144617580|NCT01029366|521459760|FG000|Overall Study|Withdrawal by Subject|1|||
144617581|NCT01029366|521459761|FG001|Overall Study|Withdrawal by Subject|0|||
144617582|NCT01029366|521459760|FG000|Overall Study|Death|1|||
144617583|NCT01029366|521459761|FG001|Overall Study|Death|1|||
144617584|NCT01029366|521459760|FG000|Overall Study|disease progression|2|||
144617585|NCT01029366|521459761|FG001|Overall Study|disease progression|0|||
144617586|NCT01029366|521459760|FG000|Overall Study|manufacturing failure|0|||
144617587|NCT01029366|521459761|FG001|Overall Study|manufacturing failure|1|||
144617588|NCT00440947|521459762|FG000|36-Week Induction Phase|Adverse Event|16|||
144617589|NCT00440947|521459763|FG001|36-Week Induction Phase|Adverse Event|0|||
144617590|NCT00440947|521459764|FG002|36-Week Induction Phase|Adverse Event|0|||
144617591|NCT00440947|521459765|FG003|36-Week Induction Phase|Adverse Event|0|||
144617592|NCT00440947|521459766|FG004|36-Week Induction Phase|Adverse Event|0|||
144617593|NCT00440947|521459762|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
144617594|NCT00440947|521459763|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
144617595|NCT00440947|521459764|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
144617596|NCT00440947|521459765|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
144617597|NCT00440947|521459766|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
144617598|NCT00440947|521459762|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
144617599|NCT00440947|521459763|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
144559513|NCT01363297|521247785|FG001|Overall Study|Death|6|||
144559514|NCT01363297|521247786|FG002|Overall Study|Death|6|||
144559515|NCT01363297|521247787|FG003|Overall Study|Death|10|||
144559516|NCT01363297|521247788|FG004|Overall Study|Death|30|||
144559517|NCT00495612|521247789|FG000|Overall Study|Lost to Follow-up|1|||
144559518|NCT00495612|521247790|FG001|Overall Study|Lost to Follow-up|0|||
144559519|NCT00495612|521247789|FG000|Overall Study|Subject's Decision to Withdraw|3|||
144559520|NCT00495612|521247790|FG001|Overall Study|Subject's Decision to Withdraw|0|||
144559521|NCT00818519|521247798|FG000|Overall Study|Adverse Event|2|||
144559522|NCT00818519|521247799|FG001|Overall Study|Adverse Event|2|||
144559523|NCT00818519|521247798|FG000|Overall Study|Lost to Follow-up|4|||
144559524|NCT00818519|521247799|FG001|Overall Study|Lost to Follow-up|6|||
144559525|NCT00818519|521247798|FG000|Overall Study|Protocol Violation|2|||
144559526|NCT00818519|521247799|FG001|Overall Study|Protocol Violation|1|||
144559527|NCT00818519|521247798|FG000|Overall Study|Pregnancy|0|||
144559528|NCT00818519|521247799|FG001|Overall Study|Pregnancy|1|||
144559529|NCT00818519|521247798|FG000|Overall Study|Withdrawal by Subject|4|||
144559530|NCT00818519|521247799|FG001|Overall Study|Withdrawal by Subject|9|||
144559531|NCT00818519|521247798|FG000|Overall Study|participant recovered completely|1|||
144559532|NCT00818519|521247799|FG001|Overall Study|participant recovered completely|0|||
144559533|NCT00818519|521247798|FG000|Overall Study|participant will leave for long tme|1|||
144559534|NCT00818519|521247799|FG001|Overall Study|participant will leave for long tme|0|||
144559535|NCT03356145|521247809|FG000|Overall Study|Withdrawal by Subject|2|||
144559536|NCT03356145|521247810|FG001|Overall Study|Withdrawal by Subject|1|||
144559537|NCT03356145|521247809|FG000|Overall Study|Did not meet inclusion criteria|1|||
144559538|NCT03356145|521247810|FG001|Overall Study|Did not meet inclusion criteria|0|||
144559539|NCT02963922|521247811|FG000|Overall Study|Adverse Event|15|||
144559540|NCT02963922|521247812|FG001|Overall Study|Adverse Event|6|||
144559541|NCT02963922|521247811|FG000|Overall Study|Protocol deviation|6|||
144559542|NCT02963922|521247812|FG001|Overall Study|Protocol deviation|6|||
144559543|NCT02963922|521247811|FG000|Overall Study|Lack of Efficacy|1|||
144617600|NCT00440947|521459764|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
144617601|NCT00440947|521459765|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
144617602|NCT00440947|521459766|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
144617603|NCT00440947|521459762|FG000|36-Week Induction Phase|Non-compliance|10|||
144559544|NCT02963922|521247812|FG001|Overall Study|Lack of Efficacy|1|||
144559545|NCT02963922|521247811|FG000|Overall Study|Lost to Follow-up|2|||
144559546|NCT02963922|521247812|FG001|Overall Study|Lost to Follow-up|3|||
144559547|NCT02963922|521247811|FG000|Overall Study|Other|8|||
144559548|NCT02963922|521247812|FG001|Overall Study|Other|14|||
144559549|NCT00655668|521247823|FG000|Overall Study|Adverse Event|6|||
144559550|NCT00655668|521247823|FG000|Overall Study|Death|5|||
144617604|NCT00440947|521459763|FG001|36-Week Induction Phase|Non-compliance|0|||
144559551|NCT00655668|521247823|FG000|Overall Study|Disease Progression|27|||
144559552|NCT00655668|521247823|FG000|Overall Study|Study Terminated|9|||
144559553|NCT00655668|521247823|FG000|Overall Study|Other|1|||
144559554|NCT00655668|521247823|FG000|Overall Study|New Lymphoma Treatment Started|4|||
144559555|NCT00655668|521247823|FG000|Overall Study|Withdrawal by Subject|2|||
144559556|NCT00257556|521247826|FG000|Overall Study|Adverse Event|1|||
144559557|NCT00257556|521247827|FG001|Overall Study|Adverse Event|4|||
144559558|NCT00257556|521247826|FG000|Overall Study|Physician Decision|6|||
144559559|NCT00257556|521247827|FG001|Overall Study|Physician Decision|0|||
144559560|NCT00257556|521247826|FG000|Overall Study|Did not meet hCG criterion|3|||
144559561|NCT00257556|521247827|FG001|Overall Study|Did not meet hCG criterion|0|||
144559562|NCT00257556|521247826|FG000|Overall Study|other reason|4|||
144559563|NCT00257556|521247827|FG001|Overall Study|other reason|6|||
144559564|NCT03873038|521247828|FG000|Part 2|Withdrawal by Subject|0|||
144559565|NCT03873038|521247829|FG001|Part 2|Withdrawal by Subject|0|||
144559566|NCT03873038|521247830|FG002|Part 2|Withdrawal by Subject|0|||
144559567|NCT03873038|521247831|FG003|Part 2|Withdrawal by Subject|0|||
144559568|NCT03873038|521247832|FG004|Part 2|Withdrawal by Subject|0|||
144559569|NCT03873038|521247833|FG005|Part 2|Withdrawal by Subject|1|||
144559570|NCT03873038|521247828|FG000|Part 2|Unknon|0|||
144559571|NCT03873038|521247829|FG001|Part 2|Unknon|0|||
144559572|NCT03873038|521247830|FG002|Part 2|Unknon|0|||
144559573|NCT03873038|521247831|FG003|Part 2|Unknon|0|||
144559574|NCT03873038|521247832|FG004|Part 2|Unknon|1|||
144559575|NCT03873038|521247833|FG005|Part 2|Unknon|0|||
144559576|NCT01332318|521247834|FG000|Overall Study|Adverse Event|0|||
144559577|NCT01332318|521247835|FG001|Overall Study|Adverse Event|3|||
144559578|NCT01332318|521247836|FG002|Overall Study|Adverse Event|0|||
144559579|NCT01332318|521247837|FG003|Overall Study|Adverse Event|0|||
144559580|NCT01332318|521247834|FG000|Overall Study|Withdrawal by Subject|1|||
144559581|NCT01332318|521247835|FG001|Overall Study|Withdrawal by Subject|1|||
144559582|NCT01332318|521247836|FG002|Overall Study|Withdrawal by Subject|0|||
144559583|NCT01332318|521247837|FG003|Overall Study|Withdrawal by Subject|1|||
144559584|NCT01332318|521247834|FG000|Overall Study|Protocol Violation|1|||
144559585|NCT01332318|521247835|FG001|Overall Study|Protocol Violation|0|||
144559586|NCT01332318|521247836|FG002|Overall Study|Protocol Violation|1|||
144559587|NCT01332318|521247837|FG003|Overall Study|Protocol Violation|1|||
144559588|NCT02040532|521247838|FG000|Overall Study|Lost to Follow-up|1|||
144559589|NCT02040532|521247838|FG000|Overall Study|Physician Decision|4|||
144559590|NCT02040532|521247838|FG000|Overall Study|Adverse Event|4|||
144559591|NCT02040532|521247838|FG000|Overall Study|Withdrawal by Subject|3|||
144559592|NCT00464737|521247839|FG000|Overall Study|Adverse Event|12|||
144559593|NCT00464737|521247840|FG001|Overall Study|Adverse Event|17|||
144559594|NCT00464737|521247841|FG002|Overall Study|Adverse Event|33|||
144559595|NCT00464737|521247839|FG000|Overall Study|Lack of Efficacy|7|||
144559596|NCT00464737|521247840|FG001|Overall Study|Lack of Efficacy|7|||
144559597|NCT00464737|521247841|FG002|Overall Study|Lack of Efficacy|4|||
144559598|NCT00464737|521247839|FG000|Overall Study|Withdrawal by Subject|5|||
144559599|NCT00464737|521247840|FG001|Overall Study|Withdrawal by Subject|3|||
144559600|NCT00464737|521247841|FG002|Overall Study|Withdrawal by Subject|5|||
144559601|NCT00464737|521247839|FG000|Overall Study|Protocol Violation|1|||
144559602|NCT00464737|521247840|FG001|Overall Study|Protocol Violation|1|||
144559603|NCT00464737|521247841|FG002|Overall Study|Protocol Violation|5|||
144559604|NCT00464737|521247839|FG000|Overall Study|Non-compliance|0|||
144559605|NCT00464737|521247840|FG001|Overall Study|Non-compliance|1|||
144559606|NCT00464737|521247841|FG002|Overall Study|Non-compliance|1|||
144559607|NCT00464737|521247839|FG000|Overall Study|Lost to Follow-up|5|||
144559608|NCT00464737|521247840|FG001|Overall Study|Lost to Follow-up|2|||
144559609|NCT00464737|521247841|FG002|Overall Study|Lost to Follow-up|5|||
144559610|NCT00464737|521247839|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
144559611|NCT00464737|521247840|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
144559612|NCT00464737|521247841|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
144559613|NCT00464737|521247839|FG000|Overall Study|Other: Subject left town; family illness|1|||
144559614|NCT00464737|521247840|FG001|Overall Study|Other: Subject left town; family illness|0|||
144559615|NCT00464737|521247841|FG002|Overall Study|Other: Subject left town; family illness|0|||
144559616|NCT00464737|521247839|FG000|Overall Study|Other: Study demands too great|0|||
144559617|NCT00464737|521247840|FG001|Overall Study|Other: Study demands too great|1|||
144559618|NCT00464737|521247841|FG002|Overall Study|Other: Study demands too great|0|||
144559619|NCT00464737|521247839|FG000|Overall Study|Other: Personal family reasons|0|||
144559620|NCT00464737|521247840|FG001|Overall Study|Other: Personal family reasons|0|||
144559621|NCT00464737|521247841|FG002|Overall Study|Other: Personal family reasons|1|||
144559622|NCT00464737|521247839|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
144559623|NCT00464737|521247840|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
144559624|NCT00464737|521247841|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
144559625|NCT00141271|521247842|FG000|Overall Study|Adverse Event|31|||
144559626|NCT00141271|521247843|FG001|Overall Study|Adverse Event|19|||
144559627|NCT00141271|521247844|FG002|Overall Study|Adverse Event|17|||
144559628|NCT00141271|521247842|FG000|Overall Study|Laboratory Abnormality|2|||
144559629|NCT00141271|521247843|FG001|Overall Study|Laboratory Abnormality|1|||
144559630|NCT00141271|521247844|FG002|Overall Study|Laboratory Abnormality|1|||
144559631|NCT00141271|521247842|FG000|Overall Study|Lack of Efficacy|7|||
144559632|NCT00141271|521247843|FG001|Overall Study|Lack of Efficacy|7|||
144262491|NCT01566604|520161450|FG000|Overall Study|Administrative problems|1|||
144559633|NCT00141271|521247844|FG002|Overall Study|Lack of Efficacy|3|||
144559634|NCT00141271|521247842|FG000|Overall Study|Lost to Follow-up|15|||
144559635|NCT00141271|521247843|FG001|Overall Study|Lost to Follow-up|15|||
144559636|NCT00141271|521247844|FG002|Overall Study|Lost to Follow-up|21|||
144559637|NCT00141271|521247842|FG000|Overall Study|Withdrawal by Subject|14|||
144559638|NCT00141271|521247843|FG001|Overall Study|Withdrawal by Subject|9|||
144559639|NCT00141271|521247844|FG002|Overall Study|Withdrawal by Subject|10|||
144559640|NCT00141271|521247842|FG000|Overall Study|Other|11|||
144559641|NCT00141271|521247843|FG001|Overall Study|Other|12|||
144559642|NCT00141271|521247844|FG002|Overall Study|Other|5|||
144559643|NCT01544153|521247845|FG000|Overall Study|Under 18|0|||
144559644|NCT01544153|521247846|FG001|Overall Study|Under 18|1|||
144559645|NCT01544153|521247847|FG002|Overall Study|Under 18|0|||
144559646|NCT01544153|521247848|FG003|Overall Study|Under 18|0|||
144559647|NCT01544153|521247845|FG000|Overall Study|Non-smoker|0|||
144559648|NCT01544153|521247846|FG001|Overall Study|Non-smoker|0|||
144559649|NCT01544153|521247847|FG002|Overall Study|Non-smoker|1|||
144559650|NCT01544153|521247848|FG003|Overall Study|Non-smoker|0|||
144559651|NCT00390806|521247849|FG000|Overall Study|Lost to Follow-up|7|||
144559652|NCT00390806|521247850|FG001|Overall Study|Lost to Follow-up|6|||
144559653|NCT00390806|521247849|FG000|Overall Study|Protocol Violation|2|||
144559654|NCT00390806|521247850|FG001|Overall Study|Protocol Violation|2|||
144559655|NCT00390806|521247849|FG000|Overall Study|Withdrawal by Subject|12|||
144559656|NCT00390806|521247850|FG001|Overall Study|Withdrawal by Subject|15|||
144559657|NCT00390806|521247849|FG000|Overall Study|Investigator Decision|4|||
144559658|NCT00390806|521247850|FG001|Overall Study|Investigator Decision|6|||
144559659|NCT00390806|521247849|FG000|Overall Study|Death|1|||
144559660|NCT00390806|521247850|FG001|Overall Study|Death|0|||
144559661|NCT00390806|521247849|FG000|Overall Study|Physician Decision|0|||
144559662|NCT00390806|521247850|FG001|Overall Study|Physician Decision|1|||
144559663|NCT00390806|521247849|FG000|Overall Study|Ongoing|4|||
144559664|NCT00390806|521247850|FG001|Overall Study|Ongoing|2|||
144559665|NCT00663923|521247851|FG000|Overall Study|Lost to Follow-up|2|||
144559666|NCT02093897|521249486|FG000|Overall Study|Physician Decision|1|||
144559667|NCT02093897|521249486|FG000|Overall Study|Planned age group closure - no's reached|17|||
144559668|NCT02093897|521249486|FG000|Overall Study|Adverse event, non-fatal|1|||
144559669|NCT02972242|521249487|FG000|Overall Study|Withdrawal by Subject|1|||
144559670|NCT02972242|521249488|FG001|Overall Study|Withdrawal by Subject|0|||
144559671|NCT03098797|521249489|FG000|Part 2 Open Label Extension|Adverse Event|2|||
144559672|NCT03098797|521249490|FG001|Part 2 Open Label Extension|Adverse Event|0|||
144559673|NCT00796614|521249491|FG000|Overall Study|Adverse Event|1|||
144559674|NCT00796614|521249492|FG001|Overall Study|Adverse Event|2|||
144559675|NCT00796614|521249493|FG002|Overall Study|Adverse Event|0|||
144559676|NCT00796614|521249494|FG003|Overall Study|Adverse Event|0|||
144559677|NCT00796614|521249491|FG000|Overall Study|Protocol Violation|0|||
144559678|NCT00796614|521249492|FG001|Overall Study|Protocol Violation|0|||
144559679|NCT00796614|521249493|FG002|Overall Study|Protocol Violation|2|||
144559680|NCT00796614|521249494|FG003|Overall Study|Protocol Violation|0|||
144559681|NCT00796614|521249491|FG000|Overall Study|Lost to Follow-up|2|||
144559682|NCT00796614|521249492|FG001|Overall Study|Lost to Follow-up|2|||
144559683|NCT00796614|521249493|FG002|Overall Study|Lost to Follow-up|1|||
144559684|NCT00796614|521249494|FG003|Overall Study|Lost to Follow-up|0|||
144559685|NCT00796614|521249491|FG000|Overall Study|Withdrawal by Subject|1|||
144559686|NCT00796614|521249492|FG001|Overall Study|Withdrawal by Subject|0|||
144262492|NCT01566604|520161451|FG001|Overall Study|Administrative problems|0|||
144559687|NCT00796614|521249493|FG002|Overall Study|Withdrawal by Subject|0|||
144559688|NCT00796614|521249494|FG003|Overall Study|Withdrawal by Subject|1|||
144559689|NCT00796614|521249491|FG000|Overall Study|Other than stated|1|||
144559690|NCT00796614|521249492|FG001|Overall Study|Other than stated|0|||
144559691|NCT00796614|521249493|FG002|Overall Study|Other than stated|0|||
144559692|NCT00796614|521249494|FG003|Overall Study|Other than stated|0|||
144559693|NCT00509821|521249495|FG000|Study Period 1 (Induction)|Death|0|||
144617605|NCT00440947|521459764|FG002|36-Week Induction Phase|Non-compliance|0|||
144617606|NCT00440947|521459765|FG003|36-Week Induction Phase|Non-compliance|0|||
144617607|NCT00440947|521459766|FG004|36-Week Induction Phase|Non-compliance|0|||
144559694|NCT00509821|521249496|FG001|Study Period 1 (Induction)|Death|1|||
144559695|NCT00509821|521249495|FG000|Study Period 1 (Induction)|Adverse Event|0|||
144559696|NCT00509821|521249496|FG001|Study Period 1 (Induction)|Adverse Event|2|||
144559697|NCT00509821|521249495|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
144559698|NCT00509821|521249496|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
144559699|NCT00552513|521249501|FG000|Overall Study|Lost to Follow-up|5|||
144559700|NCT00552513|521249502|FG001|Overall Study|Lost to Follow-up|1|||
144559701|NCT01816685|521249503|FG000|Overall Study|Lost to Follow-up|7|||
144559702|NCT01816685|521249504|FG001|Overall Study|Lost to Follow-up|9|||
144559703|NCT01816685|521249503|FG000|Overall Study|Surgery Cancelled|3|||
144559704|NCT01816685|521249504|FG001|Overall Study|Surgery Cancelled|2|||
144559705|NCT02720185|521249505|FG000|Overall Study|Lost to Follow-up|1|||
144559706|NCT00746785|521249506|FG000|Overall Study|Lost to Follow-up|29|||
144559707|NCT00746785|521249507|FG001|Overall Study|Lost to Follow-up|25|||
144559708|NCT00746785|521249508|FG002|Overall Study|Lost to Follow-up|27|||
144559709|NCT01580995|521249510|FG000|Overall Study|Lost to Follow-up|2|||
144559710|NCT01580995|521249511|FG001|Overall Study|Lost to Follow-up|2|||
144559711|NCT02916706|521249512|FG000|Overall Study|Adverse Event|0|||
144559712|NCT02916706|521249513|FG001|Overall Study|Adverse Event|1|||
144728016|NCT02937701|521859286|FG003|Week 22 to Week 50|Adverse Event|3|||
144728017|NCT02937701|521859287|FG004|Week 22 to Week 50|Adverse Event|3|||
144728018|NCT02937701|521859283|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
144728019|NCT02937701|521859284|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
144728020|NCT02937701|521859285|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
144728021|NCT02937701|521859286|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
144728022|NCT02937701|521859287|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
144728023|NCT02937701|521859283|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
144728024|NCT02937701|521859284|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
144728025|NCT02937701|521859285|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
144728026|NCT02937701|521859286|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
144728027|NCT02937701|521859287|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
144728028|NCT02937701|521859283|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
144728029|NCT02937701|521859284|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
144728030|NCT02937701|521859285|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
144728031|NCT02937701|521859286|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
144728032|NCT02937701|521859287|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
144728033|NCT02937701|521859283|FG000|Week 22 to Week 50|Physician Decision|0|||
144728034|NCT02937701|521859284|FG001|Week 22 to Week 50|Physician Decision|0|||
144728035|NCT02937701|521859285|FG002|Week 22 to Week 50|Physician Decision|2|||
144728036|NCT02937701|521859286|FG003|Week 22 to Week 50|Physician Decision|0|||
144728037|NCT02937701|521859287|FG004|Week 22 to Week 50|Physician Decision|1|||
144728038|NCT02937701|521859283|FG000|Week 22 to Week 50|Other|0|||
144728039|NCT02937701|521859284|FG001|Week 22 to Week 50|Other|0|||
144728040|NCT02937701|521859285|FG002|Week 22 to Week 50|Other|0|||
144728041|NCT02937701|521859286|FG003|Week 22 to Week 50|Other|0|||
144728042|NCT02937701|521859287|FG004|Week 22 to Week 50|Other|1|||
144728043|NCT00416520|521859289|FG000|Open-label Period|Adverse Event|28|||
144728044|NCT00416520|521859290|FG001|Open-label Period|Adverse Event|10|||
144728045|NCT00416520|521859291|FG002|Open-label Period|Adverse Event|0|||
144728046|NCT00416520|521859292|FG003|Open-label Period|Adverse Event|0|||
144728047|NCT00416520|521859289|FG000|Open-label Period|Death|2|||
144728048|NCT00416520|521859290|FG001|Open-label Period|Death|1|||
144728049|NCT00416520|521859291|FG002|Open-label Period|Death|0|||
144728050|NCT00416520|521859292|FG003|Open-label Period|Death|0|||
144728051|NCT00416520|521859289|FG000|Open-label Period|Lack of Efficacy|8|||
144728052|NCT00416520|521859290|FG001|Open-label Period|Lack of Efficacy|1|||
144728053|NCT00416520|521859291|FG002|Open-label Period|Lack of Efficacy|0|||
144728054|NCT00416520|521859292|FG003|Open-label Period|Lack of Efficacy|0|||
144728055|NCT00416520|521859289|FG000|Open-label Period|Protocol Violation|3|||
144728056|NCT00416520|521859290|FG001|Open-label Period|Protocol Violation|3|||
144728057|NCT00416520|521859291|FG002|Open-label Period|Protocol Violation|0|||
144728058|NCT00416520|521859292|FG003|Open-label Period|Protocol Violation|0|||
144728059|NCT00416520|521859289|FG000|Open-label Period|Withdrawal by Subject|16|||
144728060|NCT00416520|521859290|FG001|Open-label Period|Withdrawal by Subject|5|||
144728061|NCT00416520|521859291|FG002|Open-label Period|Withdrawal by Subject|0|||
144728062|NCT00416520|521859292|FG003|Open-label Period|Withdrawal by Subject|0|||
144728063|NCT00416520|521859289|FG000|Open-label Period|Other Reasons|3|||
144728064|NCT00416520|521859290|FG001|Open-label Period|Other Reasons|12|||
144728065|NCT00416520|521859291|FG002|Open-label Period|Other Reasons|0|||
144728066|NCT00416520|521859292|FG003|Open-label Period|Other Reasons|0|||
144728067|NCT00416520|521859289|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
144728068|NCT00416520|521859290|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
144728069|NCT00416520|521859291|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
144728070|NCT00416520|521859292|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
144728071|NCT00416520|521859289|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
144728072|NCT00416520|521859290|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
144728073|NCT00416520|521859291|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
144203500|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
144728074|NCT00416520|521859292|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
144728075|NCT00416520|521859289|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
144728076|NCT00416520|521859290|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
144728077|NCT00416520|521859291|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
144728078|NCT00416520|521859292|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
144728079|NCT03601637|521859294|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
144728080|NCT03601637|521859295|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
144728081|NCT03601637|521859294|FG000|Overall Study|Adverse Event|1|||
144728082|NCT03601637|521859295|FG001|Overall Study|Adverse Event|1|||
144728083|NCT03601637|521859294|FG000|Overall Study|Other|0|||
144559713|NCT02916706|521249512|FG000|Overall Study|Lost to Follow-up|0|||
144728084|NCT03601637|521859295|FG001|Overall Study|Other|1|||
144728085|NCT01108094|521859299|FG000|Overall Study|Adverse Event|2|||
144728086|NCT01108094|521859300|FG001|Overall Study|Adverse Event|0|||
144728087|NCT01108094|521859301|FG002|Overall Study|Adverse Event|0|||
144728088|NCT01108094|521859302|FG003|Overall Study|Adverse Event|0|||
144728089|NCT01108094|521859299|FG000|Overall Study|Withdrawal by Subject|1|||
144728090|NCT01108094|521859300|FG001|Overall Study|Withdrawal by Subject|0|||
144728091|NCT01108094|521859301|FG002|Overall Study|Withdrawal by Subject|0|||
144728092|NCT01108094|521859302|FG003|Overall Study|Withdrawal by Subject|0|||
144728093|NCT01996033|521859312|FG000|Overall Study|Death|1|||
144728094|NCT01996033|521859312|FG000|Overall Study|Physician Decision|1|||
144728095|NCT01996033|521859312|FG000|Overall Study|Withdrawal by Subject|4|||
144728096|NCT01996033|521859312|FG000|Overall Study|Lost to Follow-up|3|||
144728097|NCT01087970|521859317|FG000|Overall Study|Protocol Violation|2|||
144728098|NCT02143102|521859320|FG000|Overall Study|Lost to Follow-up|11|||
144728099|NCT02143102|521859321|FG001|Overall Study|Lost to Follow-up|0|||
144728100|NCT02636907|521859324|FG000|Autoinjector Assessment Period|Adverse Event|2|||
144728101|NCT02636907|521859324|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
144728102|NCT02636907|521859324|FG000|Extension Phase|Adverse Event|2|||
144728103|NCT02636907|521859324|FG000|Extension Phase|Withdrawal by Subject|4|||
144728104|NCT02636907|521859324|FG000|Extension Phase|Physician Decision|1|||
144728105|NCT02636907|521859324|FG000|Extension Phase|Lost to Follow-up|2|||
144728106|NCT02636907|521859324|FG000|Extension Phase|Lack of Efficacy|1|||
144728107|NCT04099888|521859325|FG000|Overall Study|Study terminated by sponsor|9|||
144728108|NCT04099888|521859326|FG001|Overall Study|Study terminated by sponsor|11|||
144728109|NCT04099888|521859325|FG000|Overall Study|Lost to Follow-up|1|||
144559714|NCT02916706|521249513|FG001|Overall Study|Lost to Follow-up|1|||
144559715|NCT02916706|521249512|FG000|Overall Study|Physician Decision|1|||
144559716|NCT02916706|521249513|FG001|Overall Study|Physician Decision|0|||
144559717|NCT02916706|521249512|FG000|Overall Study|Protocol Violation|3|||
144559718|NCT02916706|521249513|FG001|Overall Study|Protocol Violation|1|||
144559719|NCT02916706|521249512|FG000|Overall Study|Withdrawal by Subject|6|||
144559720|NCT02916706|521249513|FG001|Overall Study|Withdrawal by Subject|9|||
144559721|NCT02916706|521249512|FG000|Overall Study|Other|5|||
144559722|NCT02916706|521249513|FG001|Overall Study|Other|19|||
144559723|NCT01902381|521249514|FG000|Overall Study|Withdrawal by Subject|1|||
144559724|NCT02762500|521249515|FG000|Overall Study|Lack of Efficacy|1|||
144559725|NCT02762500|521249516|FG001|Overall Study|Lack of Efficacy|0|||
144559726|NCT02762500|521249515|FG000|Overall Study|Withdrawal by Subject|1|||
144559727|NCT02762500|521249516|FG001|Overall Study|Withdrawal by Subject|1|||
144559728|NCT02762500|521249515|FG000|Overall Study|Adverse Event|0|||
144559729|NCT02762500|521249516|FG001|Overall Study|Adverse Event|2|||
144559730|NCT00730847|521249517|FG000|Overall Study|Adverse Event|1|||
144559731|NCT00730847|521249517|FG000|Overall Study|Protocol Violation|2|||
144559732|NCT00730847|521249517|FG000|Overall Study|Withdrawal by Subject|16|||
144559733|NCT00730847|521249517|FG000|Overall Study|Lost to Follow-up|67|||
144559734|NCT00730847|521249517|FG000|Overall Study|Unknown completion status|21|||
144559735|NCT00730847|521249517|FG000|Overall Study|Other|24|||
144559736|NCT00280683|521249518|FG000|Overall Study|Withdrawal by Subject|1|||
144559737|NCT00280683|521249519|FG001|Overall Study|Withdrawal by Subject|2|||
144559738|NCT00280683|521249518|FG000|Overall Study|Adverse Event|1|||
144559739|NCT00280683|521249519|FG001|Overall Study|Adverse Event|1|||
144559740|NCT02679079|521249529|FG000|Overall Study|Adverse Event|2|||
144559741|NCT02679079|521249530|FG001|Overall Study|Adverse Event|0|||
144559742|NCT02679079|521249531|FG002|Overall Study|Adverse Event|2|||
144559743|NCT02679079|521249529|FG000|Overall Study|Protocol Violation|0|||
144559744|NCT02679079|521249530|FG001|Overall Study|Protocol Violation|1|||
144559745|NCT02679079|521249531|FG002|Overall Study|Protocol Violation|0|||
144559746|NCT02679079|521249529|FG000|Overall Study|Withdrawal by Subject|2|||
144559747|NCT02679079|521249530|FG001|Overall Study|Withdrawal by Subject|1|||
144559748|NCT02679079|521249531|FG002|Overall Study|Withdrawal by Subject|0|||
144559749|NCT01441583|521249537|FG000|Overall Study|Withdrawal by Subject|1|||
144559750|NCT01441583|521249538|FG001|Overall Study|Withdrawal by Subject|1|||
144559751|NCT01441583|521249539|FG002|Overall Study|Withdrawal by Subject|1|||
144559752|NCT01441583|521249537|FG000|Overall Study|Death|1|||
144559753|NCT01441583|521249538|FG001|Overall Study|Death|0|||
144559754|NCT01441583|521249539|FG002|Overall Study|Death|4|||
144559755|NCT01441583|521249537|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
144728110|NCT04099888|521859326|FG001|Overall Study|Lost to Follow-up|1|||
144728111|NCT04099888|521859325|FG000|Overall Study|Withdrawal by Subject|5|||
144728112|NCT04099888|521859326|FG001|Overall Study|Withdrawal by Subject|6|||
144728113|NCT04099888|521859325|FG000|Overall Study|Death|5|||
144728114|NCT04099888|521859326|FG001|Overall Study|Death|2|||
144728115|NCT04099888|521859325|FG000|Overall Study|Other|1|||
144728116|NCT04099888|521859326|FG001|Overall Study|Other|0|||
144728117|NCT01225146|521859331|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
144559756|NCT01441583|521249538|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
144559757|NCT01441583|521249539|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
144617608|NCT00440947|521459762|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
144559758|NCT05060237|521249541|FG000|Overall Study|Withdrawal by Subject|4|||
144559759|NCT05060237|521249541|FG000|Overall Study|Screening failure|8|||
144559760|NCT01697592|521249545|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
144559761|NCT01697592|521249546|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559762|NCT01697592|521249547|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559763|NCT01697592|521249548|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559764|NCT01697592|521249549|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559765|NCT01697592|521249550|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559766|NCT01697592|521249551|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559767|NCT01697592|521249552|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559768|NCT01697592|521249553|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559769|NCT01697592|521249554|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
144559770|NCT01697592|521249545|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559771|NCT01697592|521249546|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559772|NCT01697592|521249547|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559773|NCT01697592|521249548|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559774|NCT01697592|521249549|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559775|NCT01697592|521249550|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
144559776|NCT01697592|521249551|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559777|NCT01697592|521249552|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559778|NCT01697592|521249553|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559779|NCT01697592|521249554|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144559780|NCT01697592|521249545|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
144559781|NCT01697592|521249546|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559782|NCT01697592|521249547|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559783|NCT01697592|521249548|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559784|NCT01697592|521249549|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559785|NCT01697592|521249550|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559786|NCT01697592|521249551|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559787|NCT01697592|521249552|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559788|NCT01697592|521249553|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559789|NCT01697592|521249554|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144559790|NCT01697592|521249545|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
144559791|NCT01697592|521249546|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
144559792|NCT01697592|521249547|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144559793|NCT01697592|521249548|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144559794|NCT01697592|521249549|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144559795|NCT01697592|521249550|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144559796|NCT01697592|521249551|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
144559797|NCT01697592|521249552|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144559798|NCT01697592|521249553|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144559799|NCT01697592|521249554|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
144559800|NCT01697592|521249545|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
144559801|NCT01697592|521249546|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
144559802|NCT01697592|521249547|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
144559803|NCT01697592|521249548|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
144559804|NCT01697592|521249549|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
144559805|NCT01697592|521249550|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
144559806|NCT01697592|521249551|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
144559807|NCT01697592|521249552|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
144559808|NCT01697592|521249553|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
144559809|NCT01697592|521249554|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
144559810|NCT01697592|521249545|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
144559811|NCT01697592|521249546|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559812|NCT01697592|521249547|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559813|NCT01697592|521249548|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
144559814|NCT01697592|521249549|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144617609|NCT00440947|521459763|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
144617610|NCT00440947|521459764|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
144617611|NCT00440947|521459765|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
144617612|NCT00440947|521459766|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
144559815|NCT01697592|521249550|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559816|NCT01697592|521249551|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559817|NCT01697592|521249552|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559818|NCT01697592|521249553|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559819|NCT01697592|521249554|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
144559820|NCT01697592|521249545|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
144559821|NCT01697592|521249546|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144559822|NCT01697592|521249547|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144559823|NCT01697592|521249548|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144617613|NCT00440947|521459762|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
144617614|NCT00440947|521459763|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
144617615|NCT00440947|521459764|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
144617616|NCT00440947|521459765|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
144617617|NCT00440947|521459766|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
144203501|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144203502|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
144203503|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144203504|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144203505|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144203506|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144203507|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
144203508|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
144203509|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
144203510|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
144203511|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203512|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
144203513|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203514|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203515|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203516|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203517|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203518|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
144203519|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203520|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203521|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203522|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203523|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144559824|NCT01697592|521249549|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144559825|NCT01697592|521249550|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
144559826|NCT01697592|521249551|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144559827|NCT01697592|521249552|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
144559828|NCT01697592|521249553|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144559829|NCT01697592|521249554|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
144559830|NCT01697592|521249545|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
144559831|NCT01697592|521249546|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
144559832|NCT01697592|521249547|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
144559833|NCT01697592|521249548|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
144559834|NCT01697592|521249549|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
144559835|NCT01697592|521249550|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
144559836|NCT01697592|521249551|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
144559837|NCT01697592|521249552|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
144559838|NCT01697592|521249553|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
144559839|NCT01697592|521249554|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
144559840|NCT05109117|521249555|FG000|Overall Study|Lost to Follow-up|1|||
144559841|NCT05109117|521249555|FG000|Overall Study|Discontinued for non-compliance|1|||
144559842|NCT02499835|521249556|FG000|Overall Study|Withdrawal by Subject|1|||
144559843|NCT02499835|521249557|FG001|Overall Study|Withdrawal by Subject|0|||
144559844|NCT02499835|521249558|FG002|Overall Study|Withdrawal by Subject|0|||
144203524|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203525|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
144203526|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203527|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203528|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203529|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
144203530|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203531|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203532|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144559845|NCT02499835|521249559|FG003|Overall Study|Withdrawal by Subject|1|||
144559846|NCT02499835|521249556|FG000|Overall Study|Physician Decision|0|||
144559847|NCT02499835|521249557|FG001|Overall Study|Physician Decision|3|||
144559848|NCT02499835|521249558|FG002|Overall Study|Physician Decision|18|||
144559849|NCT02499835|521249559|FG003|Overall Study|Physician Decision|7|||
144617618|NCT00440947|521459762|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
144559850|NCT02499835|521249556|FG000|Overall Study|Adverse Event|0|||
144559851|NCT02499835|521249557|FG001|Overall Study|Adverse Event|0|||
144559852|NCT02499835|521249558|FG002|Overall Study|Adverse Event|0|||
144559853|NCT02499835|521249559|FG003|Overall Study|Adverse Event|1|||
144559854|NCT02499835|521249556|FG000|Overall Study|Disease progression|2|||
144559855|NCT02499835|521249557|FG001|Overall Study|Disease progression|1|||
144559856|NCT02499835|521249558|FG002|Overall Study|Disease progression|0|||
144559857|NCT02499835|521249559|FG003|Overall Study|Disease progression|7|||
144559858|NCT03972137|521249560|FG000|Overall Study|Lost to Follow-up|2|||
144559859|NCT03972137|521249560|FG000|Overall Study|Withdrawal by Subject|4|||
144559860|NCT03319719|521249565|FG000|Overall Study|Lost to Follow-up|1|||
144559861|NCT00744796|521249566|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
144559862|NCT01340300|521249568|FG000|Overall Study|Lost to Follow-up|3|||
144559863|NCT01340300|521249569|FG001|Overall Study|Lost to Follow-up|0|||
144559864|NCT01340300|521249570|FG002|Overall Study|Lost to Follow-up|5|||
144559865|NCT01340300|521249571|FG003|Overall Study|Lost to Follow-up|10|||
144559866|NCT01340300|521249568|FG000|Overall Study|Withdrawal by Subject|5|||
144559867|NCT01340300|521249569|FG001|Overall Study|Withdrawal by Subject|6|||
144559868|NCT01340300|521249570|FG002|Overall Study|Withdrawal by Subject|6|||
144559869|NCT01340300|521249571|FG003|Overall Study|Withdrawal by Subject|3|||
144559870|NCT01340300|521249568|FG000|Overall Study|Adverse Event|1|||
144559871|NCT01340300|521249569|FG001|Overall Study|Adverse Event|0|||
144559872|NCT01340300|521249570|FG002|Overall Study|Adverse Event|4|||
144559873|NCT01340300|521249571|FG003|Overall Study|Adverse Event|0|||
144559874|NCT01340300|521249568|FG000|Overall Study|Physician Decision|0|||
144559875|NCT01340300|521249569|FG001|Overall Study|Physician Decision|1|||
144559876|NCT01340300|521249570|FG002|Overall Study|Physician Decision|0|||
144559877|NCT01340300|521249571|FG003|Overall Study|Physician Decision|0|||
144559878|NCT01340300|521249568|FG000|Overall Study|Unrelated sickness|0|||
144559879|NCT01340300|521249569|FG001|Overall Study|Unrelated sickness|2|||
144559880|NCT01340300|521249570|FG002|Overall Study|Unrelated sickness|0|||
144559881|NCT01340300|521249571|FG003|Overall Study|Unrelated sickness|1|||
144559882|NCT04194541|521249572|FG000|Day 1 Through 13|Lost to Follow-up|3|||
144559883|NCT04194541|521249572|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
144559884|NCT04194541|521249572|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
144559885|NCT02642159|521249573|FG000|Overall Study|Randomized but not treated|1|||
144559886|NCT02642159|521249574|FG001|Overall Study|Randomized but not treated|0|||
144559887|NCT02642159|521249573|FG000|Overall Study|Adverse Event|10|||
144559888|NCT02642159|521249574|FG001|Overall Study|Adverse Event|4|||
144559889|NCT02642159|521249573|FG000|Overall Study|Withdrawal by Subject|9|||
144559890|NCT02642159|521249574|FG001|Overall Study|Withdrawal by Subject|1|||
144559891|NCT02642159|521249573|FG000|Overall Study|Poor compliance to study protocol|1|||
144559892|NCT02642159|521249574|FG001|Overall Study|Poor compliance to study protocol|0|||
144559893|NCT02642159|521249573|FG000|Overall Study|Other than specified above|10|||
144559894|NCT02642159|521249574|FG001|Overall Study|Other than specified above|3|||
144559895|NCT01820637|521249575|FG000|Overall Study|Death|2|||
144559896|NCT01820637|521249575|FG000|Overall Study|Withdrawal by Subject|1|||
144559897|NCT00583115|521249576|FG000|Overall Study|Death|1|||
144559898|NCT00264498|521249577|FG000|Randomized Treatment|Death|0|||
144559899|NCT00264498|521249578|FG001|Randomized Treatment|Death|3|||
144559900|NCT00264498|521249577|FG000|Randomized Treatment|Withdrawal by Subject|0|||
144559901|NCT00264498|521249578|FG001|Randomized Treatment|Withdrawal by Subject|1|||
144559902|NCT00264498|521249577|FG000|Randomized Treatment|Objective disease Progression|13|||
144559903|NCT00264498|521249578|FG001|Randomized Treatment|Objective disease Progression|14|||
144559904|NCT00264498|521249577|FG000|Randomized Treatment|Physician Decision|1|||
144559905|NCT00264498|521249578|FG001|Randomized Treatment|Physician Decision|0|||
144203533|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203534|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203535|NCT03893565|519940358|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
144559906|NCT00264498|521249577|FG000|Randomized Treatment|Incorrectly randomized|1|||
144559907|NCT00264498|521249578|FG001|Randomized Treatment|Incorrectly randomized|0|||
144559908|NCT00264498|521249577|FG000|Randomized Treatment|Study Closure|1|||
144559909|NCT00264498|521249578|FG001|Randomized Treatment|Study Closure|0|||
144559910|NCT00264498|521249577|FG000|Randomized Treatment|Protocol Violation|1|||
144559911|NCT00264498|521249578|FG001|Randomized Treatment|Protocol Violation|0|||
144559912|NCT00264498|521249577|FG000|Crossover Treatment|Death|1|||
144559913|NCT00264498|521249578|FG001|Crossover Treatment|Death|3|||
144559914|NCT00264498|521249577|FG000|Crossover Treatment|Objective disease progression|4|||
144617619|NCT00440947|521459763|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
144617620|NCT00440947|521459764|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
144203536|NCT03893565|519940359|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
144559915|NCT00264498|521249578|FG001|Crossover Treatment|Objective disease progression|5|||
144559916|NCT00264498|521249577|FG000|Crossover Treatment|Study closure|0|||
144559917|NCT00264498|521249578|FG001|Crossover Treatment|Study closure|1|||
144559918|NCT00264498|521249577|FG000|Crossover Treatment|Withdrawal by Subject|1|||
144617621|NCT00440947|521459765|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
144559919|NCT00264498|521249578|FG001|Crossover Treatment|Withdrawal by Subject|0|||
144559920|NCT03340766|521249582|FG000|Overall Study|Withdrawal by Subject|2|||
144559921|NCT03340766|521249583|FG001|Overall Study|Withdrawal by Subject|1|||
144559922|NCT03340766|521249584|FG002|Overall Study|Withdrawal by Subject|3|||
144559923|NCT03340766|521249582|FG000|Overall Study|Lost to Follow-up|0|||
144559924|NCT03340766|521249583|FG001|Overall Study|Lost to Follow-up|0|||
144559925|NCT03340766|521249584|FG002|Overall Study|Lost to Follow-up|1|||
144559926|NCT03340766|521249582|FG000|Overall Study|Death|6|||
144559927|NCT03340766|521249583|FG001|Overall Study|Death|7|||
144559928|NCT03340766|521249584|FG002|Overall Study|Death|4|||
144559929|NCT02864147|521249588|FG000|Overall Study|Withdrawal by Subject|3|||
144559930|NCT02864147|521249589|FG001|Overall Study|Withdrawal by Subject|2|||
144559931|NCT02864147|521249590|FG002|Overall Study|Withdrawal by Subject|1|||
144559932|NCT02864147|521249588|FG000|Overall Study|Lost to Follow-up|0|||
144559933|NCT02864147|521249589|FG001|Overall Study|Lost to Follow-up|4|||
144559934|NCT02864147|521249590|FG002|Overall Study|Lost to Follow-up|0|||
144559935|NCT02864147|521249588|FG000|Overall Study|Adverse Event|0|||
144559936|NCT02864147|521249589|FG001|Overall Study|Adverse Event|1|||
144559937|NCT02864147|521249590|FG002|Overall Study|Adverse Event|0|||
144559938|NCT02864147|521249588|FG000|Overall Study|Pregnancy|4|||
144559939|NCT02864147|521249589|FG001|Overall Study|Pregnancy|0|||
144559940|NCT02864147|521249590|FG002|Overall Study|Pregnancy|0|||
144559941|NCT02864147|521249588|FG000|Overall Study|Physician Decision|0|||
144559942|NCT02864147|521249589|FG001|Overall Study|Physician Decision|0|||
144559943|NCT02864147|521249590|FG002|Overall Study|Physician Decision|1|||
144559944|NCT02864147|521249588|FG000|Overall Study|Opted for excisional procedures|0|||
144559945|NCT02864147|521249589|FG001|Overall Study|Opted for excisional procedures|0|||
144559946|NCT02864147|521249590|FG002|Overall Study|Opted for excisional procedures|3|||
144559947|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
144559948|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
144559949|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
144559950|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
144559951|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
144559952|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
144559953|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
144559954|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
144559955|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
144559956|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
144559957|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
144559958|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
144559959|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
144559960|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
144559961|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
144559962|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
144559963|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
144559964|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
144559965|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
144559966|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
144559967|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
144559968|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
144559969|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
144559970|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
144559971|NCT02269917|521249591|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
144559972|NCT02269917|521249592|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
144203537|NCT03893565|519940360|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
144203538|NCT03893565|519940361|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
144203539|NCT03893565|519940362|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
144203540|NCT03893565|519940363|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
144203541|NCT03893565|519940364|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
144203542|NCT03893565|519940365|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
144559973|NCT02269917|521249593|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
144559974|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
144559975|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
144559976|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
144203543|NCT03893565|519940366|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
144559977|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
144559978|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
144559979|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
144203544|NCT03893565|519940358|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
144203545|NCT03893565|519940359|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
144559980|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
144559981|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
144559982|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
144559983|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
144559984|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
144559985|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
144559986|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
144559987|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
144559988|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
144559989|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
144559990|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
144559991|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
144559992|NCT02269917|521249591|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
144559993|NCT02269917|521249592|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
144559994|NCT02269917|521249593|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
144559995|NCT00240097|521249594|FG000|Part I|Adverse Event|1|||
144559996|NCT00240097|521249594|FG000|Part I|Death|1|||
144559997|NCT00240097|521249594|FG000|Part I|histology|1|||
144559998|NCT00240097|521249594|FG000|Part I|unevaluable|1|||
144559999|NCT00240097|521249594|FG000|Part II|did not continue from Part I|23|||
144560000|NCT02335242|521249595|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
144560001|NCT02335242|521249596|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
144560002|NCT02335242|521249595|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
144560003|NCT02335242|521249596|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
144560004|NCT02335242|521249595|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
144560005|NCT02335242|521249596|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
144560006|NCT04222088|521249597|FG000|Overall Study|Lost to Follow-up|5|||
144560007|NCT04222088|521249598|FG001|Overall Study|Lost to Follow-up|1|||
144560008|NCT04222088|521249597|FG000|Overall Study|Withdrawal by Subject|4|||
144560009|NCT04222088|521249598|FG001|Overall Study|Withdrawal by Subject|0|||
144560010|NCT00595764|521249599|FG000|Overall Study|Protocol Violation|24|||
144560011|NCT00595764|521249600|FG001|Overall Study|Protocol Violation|19|||
144560012|NCT00595764|521249599|FG000|Overall Study|Missed Medication >1 week|10|||
144560013|NCT00595764|521249600|FG001|Overall Study|Missed Medication >1 week|17|||
144560014|NCT00595764|521249599|FG000|Overall Study|Missed 3 PM visits|1|||
144560015|NCT00595764|521249600|FG001|Overall Study|Missed 3 PM visits|7|||
144617622|NCT00440947|521459766|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
144617623|NCT00440947|521459762|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
144617624|NCT00440947|521459763|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
144617625|NCT00440947|521459764|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
144617626|NCT00440947|521459765|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
144617627|NCT00440947|521459766|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
144617628|NCT00440947|521459762|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
144617629|NCT00440947|521459763|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
144617630|NCT00440947|521459764|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
144617631|NCT00440947|521459765|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
144617632|NCT00440947|521459766|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
144617633|NCT00440947|521459762|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
144617634|NCT00440947|521459763|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
144617635|NCT00440947|521459764|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
144617636|NCT00440947|521459765|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
144617637|NCT00440947|521459766|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
144560016|NCT00595764|521249599|FG000|Overall Study|Withdrawal by Subject|4|||
144560017|NCT00595764|521249600|FG001|Overall Study|Withdrawal by Subject|0|||
144560018|NCT00580047|521249607|FG000|Overall Study|Lost to Follow-up|1|||
144560019|NCT00580047|521249608|FG001|Overall Study|Lost to Follow-up|1|||
144560020|NCT00580047|521249609|FG002|Overall Study|Lost to Follow-up|0|||
144560021|NCT00580047|521249607|FG000|Overall Study|Withdrawal by Subject|1|||
144560022|NCT00580047|521249608|FG001|Overall Study|Withdrawal by Subject|1|||
144560023|NCT00580047|521249609|FG002|Overall Study|Withdrawal by Subject|2|||
144560024|NCT00580047|521249607|FG000|Overall Study|Withdrawal by Subject|1|||
144560025|NCT00580047|521249608|FG001|Overall Study|Withdrawal by Subject|0|||
144560026|NCT00580047|521249609|FG002|Overall Study|Withdrawal by Subject|0|||
144560027|NCT02820298|521249610|FG000|Overall Study|Withdrawal by Subject|0|||
144560028|NCT02820298|521249611|FG001|Overall Study|Withdrawal by Subject|1|||
144560029|NCT02820298|521249610|FG000|Overall Study|Physician Decision|1|||
144617638|NCT00440947|521459762|FG000|36-Week Induction Phase|Incarceration|3|||
144617639|NCT00440947|521459763|FG001|36-Week Induction Phase|Incarceration|0|||
144203546|NCT03893565|519940360|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
144560030|NCT02820298|521249611|FG001|Overall Study|Physician Decision|0|||
144560031|NCT02820298|521249610|FG000|Overall Study|Protocol Violation|0|||
144560032|NCT02820298|521249611|FG001|Overall Study|Protocol Violation|1|||
144560033|NCT01894256|521249612|FG000|Part A|Adverse Event|0|||
144560034|NCT01894256|521249613|FG001|Part A|Adverse Event|1|||
144560035|NCT01894256|521249614|FG002|Part A|Adverse Event|0|||
144560036|NCT01894256|521249612|FG000|Part B|Death|0|||
144560037|NCT01894256|521249613|FG001|Part B|Death|1|||
144560038|NCT01894256|521249614|FG002|Part B|Death|1|||
144560039|NCT01894256|521249612|FG000|Part B|Withdrawal by Subject|0|||
144560040|NCT01894256|521249613|FG001|Part B|Withdrawal by Subject|1|||
144560041|NCT01894256|521249614|FG002|Part B|Withdrawal by Subject|0|||
144560042|NCT01894256|521249612|FG000|Part B|Lack of Efficacy|15|||
144560043|NCT01894256|521249613|FG001|Part B|Lack of Efficacy|12|||
144560044|NCT01894256|521249614|FG002|Part B|Lack of Efficacy|13|||
144560045|NCT01780584|521249615|FG000|Overall Study|Death|1|||
144560046|NCT01780584|521249616|FG001|Overall Study|Death|0|||
144560047|NCT01780584|521249617|FG002|Overall Study|Death|1|||
144560048|NCT01780584|521249615|FG000|Overall Study|Adverse Event|0|||
144560049|NCT01780584|521249616|FG001|Overall Study|Adverse Event|1|||
144560050|NCT01780584|521249617|FG002|Overall Study|Adverse Event|0|||
144560051|NCT01780584|521249615|FG000|Overall Study|Protocol Violation|0|||
144560052|NCT01780584|521249616|FG001|Overall Study|Protocol Violation|0|||
144560053|NCT01780584|521249617|FG002|Overall Study|Protocol Violation|1|||
144560054|NCT02133131|521249620|FG000|Overall Study|Adverse Event|0|||
144560055|NCT02133131|521249621|FG001|Overall Study|Adverse Event|0|||
144560056|NCT02133131|521249622|FG002|Overall Study|Adverse Event|0|||
144560057|NCT02133131|521249623|FG003|Overall Study|Adverse Event|1|||
144560058|NCT02133131|521249624|FG004|Overall Study|Adverse Event|0|||
144560059|NCT02133131|521249625|FG005|Overall Study|Adverse Event|0|||
144560060|NCT02133131|521249626|FG006|Overall Study|Adverse Event|0|||
144560061|NCT02133131|521249620|FG000|Overall Study|Lost to Follow-up|1|||
144560062|NCT02133131|521249621|FG001|Overall Study|Lost to Follow-up|0|||
144560063|NCT02133131|521249622|FG002|Overall Study|Lost to Follow-up|0|||
144560064|NCT02133131|521249623|FG003|Overall Study|Lost to Follow-up|1|||
144560065|NCT02133131|521249624|FG004|Overall Study|Lost to Follow-up|0|||
144560066|NCT02133131|521249625|FG005|Overall Study|Lost to Follow-up|0|||
144560067|NCT02133131|521249626|FG006|Overall Study|Lost to Follow-up|0|||
144560068|NCT02133131|521249620|FG000|Overall Study|Status not recorded|4|||
144560069|NCT02133131|521249621|FG001|Overall Study|Status not recorded|5|||
144560070|NCT02133131|521249622|FG002|Overall Study|Status not recorded|1|||
144560071|NCT02133131|521249623|FG003|Overall Study|Status not recorded|4|||
144560072|NCT02133131|521249624|FG004|Overall Study|Status not recorded|0|||
144560073|NCT02133131|521249625|FG005|Overall Study|Status not recorded|0|||
144560074|NCT02133131|521249626|FG006|Overall Study|Status not recorded|0|||
144560075|NCT02133131|521249620|FG000|Overall Study|Ongoing in study|0|||
144560076|NCT02133131|521249621|FG001|Overall Study|Ongoing in study|0|||
144560077|NCT02133131|521249622|FG002|Overall Study|Ongoing in study|0|||
144560078|NCT02133131|521249623|FG003|Overall Study|Ongoing in study|0|||
144560079|NCT02133131|521249624|FG004|Overall Study|Ongoing in study|15|||
144560080|NCT02133131|521249625|FG005|Overall Study|Ongoing in study|14|||
144560081|NCT02133131|521249626|FG006|Overall Study|Ongoing in study|11|||
144560082|NCT02133131|521249620|FG000|Overall Study|Protocol Violation|0|||
144560083|NCT02133131|521249621|FG001|Overall Study|Protocol Violation|0|||
144560084|NCT02133131|521249622|FG002|Overall Study|Protocol Violation|0|||
144560085|NCT02133131|521249623|FG003|Overall Study|Protocol Violation|0|||
144560086|NCT02133131|521249624|FG004|Overall Study|Protocol Violation|0|||
144560087|NCT02133131|521249625|FG005|Overall Study|Protocol Violation|0|||
144560088|NCT02133131|521249626|FG006|Overall Study|Protocol Violation|1|||
144560089|NCT03169530|521249633|FG000|Overall Study|Study ended by NIH|15|||
144560090|NCT03169530|521249634|FG001|Overall Study|Study ended by NIH|17|||
144560091|NCT00884793|521249635|FG000|Overall Study|Withdrawal by Subject|1|||
144560092|NCT01032200|521249636|FG000|Overall Study|Death|1|||
144560093|NCT01032200|521249637|FG001|Overall Study|Death|1|||
144560094|NCT01032200|521249636|FG000|Overall Study|Withdrawal by Subject|1|||
144560095|NCT01032200|521249637|FG001|Overall Study|Withdrawal by Subject|3|||
144560096|NCT01032200|521249636|FG000|Overall Study|Toxicity|0|||
144560097|NCT01032200|521249637|FG001|Overall Study|Toxicity|2|||
144560098|NCT01032200|521249636|FG000|Overall Study|Progression|1|||
144560099|NCT01032200|521249637|FG001|Overall Study|Progression|0|||
144560100|NCT01032200|521249636|FG000|Overall Study|Multiple|1|||
144560101|NCT01032200|521249637|FG001|Overall Study|Multiple|1|||
144560102|NCT00727259|521249641|FG000|Overall Study|Not all questionnaires completed|1055|||
144560103|NCT01021683|521249642|FG000|Overall Study|Lack of Efficacy|12|||
144560104|NCT01021683|521249642|FG000|Overall Study|Recovery of neutrophil count|51|||
144560105|NCT01021683|521249642|FG000|Overall Study|Other|8|||
144560106|NCT01804140|521249644|FG000|Overall Study|No sampling or biopsy procedures done|114|||
144560107|NCT02785900|521249647|FG000|Overall Study|Study Termination by Sponsor|64|||
144560108|NCT02785900|521249648|FG001|Overall Study|Study Termination by Sponsor|81|||
144560109|NCT02785900|521249647|FG000|Overall Study|Death|46|||
144560110|NCT02785900|521249648|FG001|Overall Study|Death|32|||
144560111|NCT02785900|521249647|FG000|Overall Study|Withdrawal by Subject|4|||
144560112|NCT02785900|521249648|FG001|Overall Study|Withdrawal by Subject|8|||
144560113|NCT02785900|521249647|FG000|Overall Study|Physician Decision|3|||
144560114|NCT02785900|521249648|FG001|Overall Study|Physician Decision|2|||
144560115|NCT00547300|521249649|FG000|Overall Study|Study was Administratively Terminated|25|||
144560116|NCT00547300|521249650|FG001|Overall Study|Study was Administratively Terminated|24|||
144560117|NCT00547300|521249649|FG000|Overall Study|Did not Meet Entry Criteria|0|||
144560118|NCT00547300|521249650|FG001|Overall Study|Did not Meet Entry Criteria|2|||
144560119|NCT04130061|521249651|FG000|Overall Study|OR team forgot to request membrane|1|||
144560120|NCT04130061|521249652|FG001|Overall Study|OR team forgot to request membrane|0|||
144560121|NCT01772147|521251998|FG000|Overall Study|Adverse Event|13|||
144560122|NCT01772147|521251999|FG001|Overall Study|Adverse Event|10|||
144560123|NCT01772147|521252000|FG002|Overall Study|Adverse Event|6|||
144560124|NCT01772147|521251998|FG000|Overall Study|Withdrew Consent|7|||
144560125|NCT01772147|521251999|FG001|Overall Study|Withdrew Consent|8|||
144560126|NCT01772147|521252000|FG002|Overall Study|Withdrew Consent|4|||
144560127|NCT01772147|521251998|FG000|Overall Study|Lost to Follow-up|1|||
144560128|NCT01772147|521251999|FG001|Overall Study|Lost to Follow-up|0|||
144560129|NCT01772147|521252000|FG002|Overall Study|Lost to Follow-up|1|||
144560130|NCT01772147|521251998|FG000|Overall Study|Protocol Deviation|2|||
144560131|NCT01772147|521251999|FG001|Overall Study|Protocol Deviation|1|||
144560132|NCT01772147|521252000|FG002|Overall Study|Protocol Deviation|1|||
144560133|NCT01772147|521251998|FG000|Overall Study|Lack of Efficacy|8|||
144560134|NCT01772147|521251999|FG001|Overall Study|Lack of Efficacy|6|||
144560135|NCT01772147|521252000|FG002|Overall Study|Lack of Efficacy|6|||
144560136|NCT04572997|521252005|FG000|Overall Study|Adverse Event|1|||
144560137|NCT02956278|521252006|FG000|Overall Study|Withdrawal by Subject|6|||
144560138|NCT02956278|521252007|FG001|Overall Study|Withdrawal by Subject|2|||
144560139|NCT02956278|521252008|FG002|Overall Study|Withdrawal by Subject|0|||
144560140|NCT01967719|521252009|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
144560141|NCT01967719|521252010|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
144560142|NCT01967719|521252011|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
144560143|NCT01967719|521252012|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
144560144|NCT01967719|521252009|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
144560145|NCT01967719|521252010|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
144560146|NCT01967719|521252011|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
144560147|NCT01967719|521252012|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
144560148|NCT00740597|521252014|FG000|Overall Study|insurance would not cover treatment|1|||
144560149|NCT01157351|521252016|FG000|Overall Study|Adverse Event|5|||
144560150|NCT01157351|521252017|FG001|Overall Study|Adverse Event|4|||
144560151|NCT01157351|521252016|FG000|Overall Study|Death|1|||
144560152|NCT01157351|521252017|FG001|Overall Study|Death|0|||
144560153|NCT01157351|521252016|FG000|Overall Study|Lost to Follow-up|53|||
144560154|NCT01157351|521252017|FG001|Overall Study|Lost to Follow-up|55|||
144560155|NCT01157351|521252016|FG000|Overall Study|Withdrawal by Subject|37|||
144560156|NCT01157351|521252017|FG001|Overall Study|Withdrawal by Subject|27|||
144560157|NCT01157351|521252016|FG000|Overall Study|Physician Decision|5|||
144560158|NCT01157351|521252017|FG001|Overall Study|Physician Decision|4|||
144560159|NCT01157351|521252016|FG000|Overall Study|Protocol Violation|0|||
144560160|NCT01157351|521252017|FG001|Overall Study|Protocol Violation|1|||
144560161|NCT01157351|521252016|FG000|Overall Study|Other|32|||
144560162|NCT01157351|521252017|FG001|Overall Study|Other|36|||
144560163|NCT01157351|521252016|FG000|Overall Study|Noncompliance with Study Drug|0|||
144560164|NCT01157351|521252017|FG001|Overall Study|Noncompliance with Study Drug|3|||
144560165|NCT01157351|521252016|FG000|Overall Study|Randomized but not Treated|4|||
144560166|NCT01157351|521252017|FG001|Overall Study|Randomized but not Treated|2|||
144560167|NCT01231464|521252018|FG000|Overall Study|Adverse Event|0|||
144560168|NCT01231464|521252019|FG001|Overall Study|Adverse Event|1|||
144560169|NCT01231464|521252018|FG000|Overall Study|Protocol Violation|1|||
144560170|NCT01231464|521252019|FG001|Overall Study|Protocol Violation|2|||
144560171|NCT01231464|521252018|FG000|Overall Study|Lost to Follow-up|1|||
144560172|NCT01231464|521252019|FG001|Overall Study|Lost to Follow-up|2|||
144560173|NCT01231464|521252018|FG000|Overall Study|Withdrawal by Subject|3|||
144560174|NCT01231464|521252019|FG001|Overall Study|Withdrawal by Subject|2|||
144203547|NCT03893565|519940361|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
144560175|NCT03449134|521252020|FG000|52-Week Treatment Period|Death|2|||
144560176|NCT03449134|521252021|FG001|52-Week Treatment Period|Death|1|||
144560177|NCT03449134|521252022|FG002|52-Week Treatment Period|Death|0|||
144560178|NCT03449134|521252020|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
144560179|NCT03449134|521252021|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
144617640|NCT00440947|521459764|FG002|36-Week Induction Phase|Incarceration|0|||
144617641|NCT00440947|521459765|FG003|36-Week Induction Phase|Incarceration|0|||
144617642|NCT00440947|521459766|FG004|36-Week Induction Phase|Incarceration|0|||
144560180|NCT03449134|521252022|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
144560181|NCT03449134|521252020|FG000|52-Week Treatment Period|Physician Decision|2|||
144560182|NCT03449134|521252021|FG001|52-Week Treatment Period|Physician Decision|3|||
144560183|NCT03449134|521252022|FG002|52-Week Treatment Period|Physician Decision|3|||
144560184|NCT03449134|521252020|FG000|52-Week Treatment Period|Screen Failure|1|||
144560185|NCT03449134|521252021|FG001|52-Week Treatment Period|Screen Failure|0|||
144560186|NCT03449134|521252022|FG002|52-Week Treatment Period|Screen Failure|1|||
144203548|NCT03893565|519940362|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
144560187|NCT03449134|521252020|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
144560188|NCT03449134|521252021|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
144560189|NCT03449134|521252022|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
144560190|NCT03449134|521252020|FG000|52-Week Treatment Period|Site Closure|1|||
144560191|NCT03449134|521252021|FG001|52-Week Treatment Period|Site Closure|0|||
144560192|NCT03449134|521252022|FG002|52-Week Treatment Period|Site Closure|0|||
144560193|NCT00957996|521252028|FG000|Overall Study|Death|4|||
144560194|NCT00957996|521252029|FG001|Overall Study|Death|10|||
144560195|NCT00957996|521252028|FG000|Overall Study|Lost to Follow-up|4|||
144560196|NCT00957996|521252029|FG001|Overall Study|Lost to Follow-up|7|||
144560197|NCT00957996|521252028|FG000|Overall Study|Withdrawal by Subject|9|||
144560198|NCT00957996|521252029|FG001|Overall Study|Withdrawal by Subject|2|||
144560199|NCT00957996|521252028|FG000|Overall Study|Adverse Event|2|||
144560200|NCT00957996|521252029|FG001|Overall Study|Adverse Event|1|||
144560201|NCT00957996|521252028|FG000|Overall Study|Physician Decision|1|||
144560202|NCT00957996|521252029|FG001|Overall Study|Physician Decision|1|||
144560203|NCT00957996|521252028|FG000|Overall Study|Influenza-related complication|0|||
144560204|NCT00957996|521252029|FG001|Overall Study|Influenza-related complication|1|||
144560205|NCT00957996|521252028|FG000|Overall Study|Missing|1|||
144560206|NCT00957996|521252029|FG001|Overall Study|Missing|0|||
144560207|NCT00957996|521252028|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
144560208|NCT00957996|521252029|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
144560209|NCT01960348|521252034|FG000|Overall Study|Adverse event, not serious|2|||
144560210|NCT01960348|521252035|FG001|Overall Study|Adverse event, not serious|2|||
144560211|NCT01960348|521252034|FG000|Overall Study|Adverse event, serious fatal|6|||
144560212|NCT01960348|521252035|FG001|Overall Study|Adverse event, serious fatal|5|||
144617643|NCT00440947|521459762|FG000|36-Week Induction Phase|Pregnancy|1|||
144617644|NCT00440947|521459763|FG001|36-Week Induction Phase|Pregnancy|0|||
144617645|NCT00440947|521459764|FG002|36-Week Induction Phase|Pregnancy|0|||
144617646|NCT00440947|521459765|FG003|36-Week Induction Phase|Pregnancy|0|||
144617647|NCT00440947|521459766|FG004|36-Week Induction Phase|Pregnancy|0|||
144617648|NCT00440947|521459762|FG000|48-Week Randomization Phase|Adverse Event|0|||
144617649|NCT00440947|521459763|FG001|48-Week Randomization Phase|Adverse Event|2|||
144617650|NCT00440947|521459764|FG002|48-Week Randomization Phase|Adverse Event|5|||
144617651|NCT00440947|521459765|FG003|48-Week Randomization Phase|Adverse Event|0|||
144617652|NCT00440947|521459766|FG004|48-Week Randomization Phase|Adverse Event|0|||
144617653|NCT00440947|521459762|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
144617654|NCT00440947|521459763|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
144617655|NCT00440947|521459764|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
144617656|NCT00440947|521459765|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
144617657|NCT00440947|521459766|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
144617658|NCT00440947|521459762|FG000|48-Week Randomization Phase|Non-compliance|0|||
144617659|NCT00440947|521459763|FG001|48-Week Randomization Phase|Non-compliance|3|||
144617660|NCT00440947|521459764|FG002|48-Week Randomization Phase|Non-compliance|4|||
144617661|NCT00440947|521459765|FG003|48-Week Randomization Phase|Non-compliance|0|||
144617662|NCT00440947|521459766|FG004|48-Week Randomization Phase|Non-compliance|0|||
144617663|NCT00440947|521459762|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
144617664|NCT00440947|521459763|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
144617665|NCT00440947|521459764|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
144617666|NCT00440947|521459765|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
144617667|NCT00440947|521459766|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
144617668|NCT00440947|521459762|FG000|48-Week Randomization Phase|Protocol Violation|0|||
144617669|NCT00440947|521459763|FG001|48-Week Randomization Phase|Protocol Violation|0|||
144617670|NCT00440947|521459764|FG002|48-Week Randomization Phase|Protocol Violation|1|||
144617671|NCT00440947|521459765|FG003|48-Week Randomization Phase|Protocol Violation|0|||
144617672|NCT00440947|521459766|FG004|48-Week Randomization Phase|Protocol Violation|0|||
144617673|NCT00440947|521459762|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
144617674|NCT00440947|521459763|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
144617675|NCT00440947|521459764|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
144617676|NCT00440947|521459765|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
144617677|NCT00440947|521459766|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
144203549|NCT03893565|519940363|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
144203550|NCT03893565|519940364|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
144203551|NCT03893565|519940365|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
144560213|NCT01960348|521252034|FG000|Overall Study|Adverse event, serious non-fatal|0|||
144560214|NCT01960348|521252035|FG001|Overall Study|Adverse event, serious non-fatal|3|||
144560215|NCT01960348|521252034|FG000|Overall Study|Withdrawal by Subject|1|||
144560216|NCT01960348|521252035|FG001|Overall Study|Withdrawal by Subject|11|||
144560217|NCT01960348|521252034|FG000|Overall Study|Physician Decision|0|||
144560218|NCT01960348|521252035|FG001|Overall Study|Physician Decision|1|||
144617678|NCT00440947|521459762|FG000|48-Week Randomization Phase|Pregnancy|0|||
144617679|NCT00440947|521459763|FG001|48-Week Randomization Phase|Pregnancy|0|||
144560219|NCT01960348|521252034|FG000|Overall Study|Protocol Violation|1|||
144560220|NCT01960348|521252035|FG001|Overall Study|Protocol Violation|0|||
144560221|NCT01821729|521252036|FG000|Overall Study|Withdrawal by Subject|1|||
144560222|NCT00381797|521252042|FG000|Overall Study|Withdrawal by Subject|1|||
144560223|NCT00381797|521252043|FG001|Overall Study|Withdrawal by Subject|1|||
144560224|NCT00381797|521252044|FG002|Overall Study|Withdrawal by Subject|0|||
144560225|NCT00381797|521252045|FG003|Overall Study|Withdrawal by Subject|0|||
144560226|NCT00381797|521252046|FG004|Overall Study|Withdrawal by Subject|2|||
144560227|NCT00381797|521252042|FG000|Overall Study|Ineligible|0|||
144560228|NCT00381797|521252043|FG001|Overall Study|Ineligible|0|||
144560229|NCT00381797|521252044|FG002|Overall Study|Ineligible|0|||
144560230|NCT00381797|521252045|FG003|Overall Study|Ineligible|1|||
144560231|NCT00381797|521252046|FG004|Overall Study|Ineligible|0|||
144560232|NCT00684203|521252047|FG000|Overall Study|Adverse Event|6|||
144560233|NCT00684203|521252048|FG001|Overall Study|Adverse Event|4|||
144560234|NCT00684203|521252049|FG002|Overall Study|Adverse Event|8|||
144560235|NCT00684203|521252050|FG003|Overall Study|Adverse Event|0|||
144560236|NCT00684203|521252051|FG004|Overall Study|Adverse Event|0|||
144560237|NCT00684203|521252052|FG005|Overall Study|Adverse Event|0|||
144560238|NCT00684203|521252047|FG000|Overall Study|Protocol-defined clinical event|3|||
144560239|NCT00684203|521252048|FG001|Overall Study|Protocol-defined clinical event|1|||
144560240|NCT00684203|521252049|FG002|Overall Study|Protocol-defined clinical event|0|||
144560241|NCT00684203|521252050|FG003|Overall Study|Protocol-defined clinical event|0|||
144560242|NCT00684203|521252051|FG004|Overall Study|Protocol-defined clinical event|0|||
144560243|NCT00684203|521252052|FG005|Overall Study|Protocol-defined clinical event|0|||
144560244|NCT00684203|521252047|FG000|Overall Study|Withdrawal by Subject|0|||
144560245|NCT00684203|521252048|FG001|Overall Study|Withdrawal by Subject|2|||
144560246|NCT00684203|521252049|FG002|Overall Study|Withdrawal by Subject|1|||
144560247|NCT00684203|521252050|FG003|Overall Study|Withdrawal by Subject|0|||
144560248|NCT00684203|521252051|FG004|Overall Study|Withdrawal by Subject|0|||
144560249|NCT00684203|521252052|FG005|Overall Study|Withdrawal by Subject|0|||
144560250|NCT00684203|521252047|FG000|Overall Study|Did not meet protocol eligibility|0|||
144560251|NCT00684203|521252048|FG001|Overall Study|Did not meet protocol eligibility|1|||
144560252|NCT00684203|521252049|FG002|Overall Study|Did not meet protocol eligibility|0|||
144560253|NCT00684203|521252050|FG003|Overall Study|Did not meet protocol eligibility|0|||
144560254|NCT00684203|521252051|FG004|Overall Study|Did not meet protocol eligibility|0|||
144560255|NCT00684203|521252052|FG005|Overall Study|Did not meet protocol eligibility|0|||
144560256|NCT00719212|521252055|FG000|Overall Study|Death|41|||
144560257|NCT00719212|521252055|FG000|Overall Study|Lost to Follow-up|2|||
144560258|NCT00719212|521252055|FG000|Overall Study|Withdrawal by Subject|1|||
144560259|NCT04140266|521252058|FG000|Overall Study|Physician Decision|2|||
144560260|NCT04140266|521252059|FG001|Overall Study|Physician Decision|0|||
144560261|NCT04140266|521252058|FG000|Overall Study|Withdrawal by Subject|4|||
144560262|NCT04140266|521252059|FG001|Overall Study|Withdrawal by Subject|2|||
144560263|NCT03511378|521252062|FG000|Overall Study|Withdrawal by Subject|2|||
144560264|NCT03511378|521252063|FG001|Overall Study|Withdrawal by Subject|2|||
144560265|NCT03511378|521252062|FG000|Overall Study|Patient not coming or schedule visit|1|||
144560266|NCT03511378|521252063|FG001|Overall Study|Patient not coming or schedule visit|0|||
144560267|NCT00837096|521252064|FG000|Overall Study|Physician Decision|1|||
144560268|NCT00837096|521252065|FG001|Overall Study|Physician Decision|1|||
144560269|NCT00837096|521252064|FG000|Overall Study|Not reported|9|||
144560270|NCT00837096|521252065|FG001|Overall Study|Not reported|8|||
144560271|NCT00329550|521252068|FG000|Overall Study|Adverse Event|3|||
144560272|NCT00329550|521252069|FG001|Overall Study|Adverse Event|4|||
144560273|NCT00329550|521252070|FG002|Overall Study|Adverse Event|2|||
144560274|NCT00329550|521252068|FG000|Overall Study|Withdrawal of Consent|1|||
144560275|NCT00329550|521252069|FG001|Overall Study|Withdrawal of Consent|0|||
144560276|NCT00329550|521252070|FG002|Overall Study|Withdrawal of Consent|1|||
144560277|NCT00329550|521252068|FG000|Overall Study|Due to Relocation|0|||
144560278|NCT00329550|521252069|FG001|Overall Study|Due to Relocation|0|||
144560279|NCT00329550|521252070|FG002|Overall Study|Due to Relocation|1|||
144560280|NCT00111839|521252071|FG000|Overall Study|Disease Progression|30|||
144560281|NCT00111839|521252072|FG001|Overall Study|Disease Progression|33|||
144560282|NCT00111839|521252073|FG002|Overall Study|Disease Progression|33|||
144560283|NCT00111839|521252071|FG000|Overall Study|Adverse Event|5|||
144560284|NCT00111839|521252072|FG001|Overall Study|Adverse Event|3|||
144560285|NCT00111839|521252073|FG002|Overall Study|Adverse Event|1|||
144560286|NCT00111839|521252071|FG000|Overall Study|Protocol Violation|2|||
144560287|NCT00111839|521252072|FG001|Overall Study|Protocol Violation|4|||
144560288|NCT00111839|521252073|FG002|Overall Study|Protocol Violation|2|||
144560289|NCT00111839|521252071|FG000|Overall Study|Death|1|||
144560290|NCT00111839|521252072|FG001|Overall Study|Death|1|||
144560291|NCT00111839|521252073|FG002|Overall Study|Death|6|||
144560292|NCT00111839|521252071|FG000|Overall Study|Withdrawal by Subject|2|||
144560293|NCT00111839|521252072|FG001|Overall Study|Withdrawal by Subject|2|||
144560294|NCT00111839|521252073|FG002|Overall Study|Withdrawal by Subject|2|||
144560295|NCT00111839|521252071|FG000|Overall Study|Lost to Follow-up|1|||
144560296|NCT00111839|521252072|FG001|Overall Study|Lost to Follow-up|0|||
144728118|NCT01225146|521859332|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
144728119|NCT01876706|521859335|FG000|Overall Study|BPH Intervention|9|||
144728120|NCT01876706|521859335|FG000|Overall Study|Lost to Follow-up|7|||
144728121|NCT01876706|521859335|FG000|Overall Study|Withdrawals|6|||
144728122|NCT01876706|521859335|FG000|Overall Study|Death|3|||
144728123|NCT00604500|521859336|FG000|Overall Study|Adverse Event|2|||
144728124|NCT00604500|521859336|FG000|Overall Study|Protocol Violation|2|||
144728125|NCT00604500|521859336|FG000|Overall Study|Treatment Failure|1|||
144728126|NCT00604500|521859336|FG000|Overall Study|Withdrawal by Subject|4|||
144728127|NCT00604500|521859336|FG000|Overall Study|Administrative|1|||
144728128|NCT00604500|521859336|FG000|Overall Study|Did not meet protocol eligibility|1|||
144560297|NCT00111839|521252073|FG002|Overall Study|Lost to Follow-up|0|||
144560298|NCT00111839|521252071|FG000|Overall Study|Logistical Constraint|1|||
144560299|NCT00111839|521252072|FG001|Overall Study|Logistical Constraint|0|||
144560300|NCT00111839|521252073|FG002|Overall Study|Logistical Constraint|0|||
144560301|NCT00111839|521252071|FG000|Overall Study|Other|6|||
144560302|NCT00111839|521252072|FG001|Overall Study|Other|3|||
144560303|NCT00111839|521252073|FG002|Overall Study|Other|3|||
144560304|NCT00111839|521252071|FG000|Overall Study|Randomized but Not Treated|0|||
144560305|NCT00111839|521252072|FG001|Overall Study|Randomized but Not Treated|0|||
144560306|NCT00111839|521252073|FG002|Overall Study|Randomized but Not Treated|2|||
144560307|NCT01011049|521252074|FG000|Overall Study|Protocol Violation|0|||
144560308|NCT01011049|521252075|FG001|Overall Study|Protocol Violation|0|||
144560309|NCT01011049|521252076|FG002|Overall Study|Protocol Violation|2|||
144560310|NCT01011049|521252077|FG003|Overall Study|Protocol Violation|0|||
144560311|NCT01011049|521252074|FG000|Overall Study|Lost to Follow-up|1|||
144560312|NCT01011049|521252075|FG001|Overall Study|Lost to Follow-up|2|||
144560313|NCT01011049|521252076|FG002|Overall Study|Lost to Follow-up|1|||
144560314|NCT01011049|521252077|FG003|Overall Study|Lost to Follow-up|0|||
144560315|NCT01011049|521252074|FG000|Overall Study|Withdrawal by Subject|0|||
144560316|NCT01011049|521252075|FG001|Overall Study|Withdrawal by Subject|0|||
144560317|NCT01011049|521252076|FG002|Overall Study|Withdrawal by Subject|1|||
144560318|NCT01011049|521252077|FG003|Overall Study|Withdrawal by Subject|0|||
144560319|NCT00352053|521252080|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
144560320|NCT00352053|521252081|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
144560321|NCT00352053|521252080|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
144560322|NCT00352053|521252081|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
144560323|NCT00352053|521252080|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
144560324|NCT00352053|521252081|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
144560325|NCT00352053|521252080|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
144560326|NCT00352053|521252081|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
144560327|NCT00352053|521252080|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
144560328|NCT00352053|521252081|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
144560329|NCT00352053|521252080|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
144560330|NCT00352053|521252081|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
144560331|NCT00352053|521252080|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
144560332|NCT00352053|521252081|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
144560333|NCT00352053|521252080|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
144560334|NCT00352053|521252081|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
144560335|NCT00352053|521252080|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
144560336|NCT00352053|521252081|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
144560337|NCT00352053|521252080|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
144560338|NCT00352053|521252081|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
144560339|NCT00352053|521252080|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
144560340|NCT00352053|521252081|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
144560341|NCT00352053|521252080|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
144560342|NCT00352053|521252081|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
144560343|NCT00352053|521252080|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
144560344|NCT00352053|521252081|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
144560345|NCT02435381|521252082|FG000|Overall Study|Lost to Follow-up|2|||
144560346|NCT02435381|521252083|FG001|Overall Study|Lost to Follow-up|1|||
144560347|NCT03924947|521252084|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
144560348|NCT03924947|521252085|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
144560349|NCT03924947|521252086|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
144560350|NCT03924947|521252087|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
144560351|NCT03924947|521252088|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
144560352|NCT03924947|521252089|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
144560353|NCT00833898|521252095|FG000|Overall Study|Withdrawal by Subject|33|||
144560354|NCT00833898|521252096|FG001|Overall Study|Withdrawal by Subject|27|||
144560355|NCT00833898|521252095|FG000|Overall Study|Lost to Follow-up|7|||
144728129|NCT02191891|521859338|FG000|Overall Study|Withdrawal by Subject|0|||
144728130|NCT02191891|521859339|FG001|Overall Study|Withdrawal by Subject|1|||
144560356|NCT00833898|521252096|FG001|Overall Study|Lost to Follow-up|7|||
144560357|NCT00833898|521252095|FG000|Overall Study|Patient did not receive transplant|0|||
144560358|NCT00833898|521252096|FG001|Overall Study|Patient did not receive transplant|2|||
144560359|NCT00666198|521252097|FG000|Overall Study|Protocol Violation|10|||
144560360|NCT00666198|521252097|FG000|Overall Study|No Visit After First Day of Treatment|13|||
144560361|NCT00666198|521252097|FG000|Overall Study|Safety Not Assessable|6|||
144560362|NCT00666198|521252097|FG000|Overall Study|No Drug Administration|4|||
144560363|NCT03220776|521252103|FG000|Overall Study|Claustrophobia|0|||
144560364|NCT03220776|521252104|FG001|Overall Study|Claustrophobia|1|||
144560365|NCT03220776|521252105|FG002|Overall Study|Claustrophobia|1|||
144560366|NCT03220776|521252106|FG003|Overall Study|Claustrophobia|0|||
144560367|NCT03220776|521252107|FG004|Overall Study|Claustrophobia|1|||
144560368|NCT03220776|521252108|FG005|Overall Study|Claustrophobia|0|||
144560369|NCT03220776|521252103|FG000|Overall Study|MRI Equipment Failure|1|||
144560370|NCT03220776|521252104|FG001|Overall Study|MRI Equipment Failure|0|||
144560371|NCT03220776|521252105|FG002|Overall Study|MRI Equipment Failure|0|||
144560372|NCT03220776|521252106|FG003|Overall Study|MRI Equipment Failure|0|||
144560373|NCT03220776|521252107|FG004|Overall Study|MRI Equipment Failure|0|||
144560374|NCT03220776|521252108|FG005|Overall Study|MRI Equipment Failure|0|||
144560375|NCT03220776|521252103|FG000|Overall Study|Inclimate Weather|0|||
144560376|NCT03220776|521252104|FG001|Overall Study|Inclimate Weather|0|||
144560377|NCT03220776|521252105|FG002|Overall Study|Inclimate Weather|0|||
144560378|NCT03220776|521252106|FG003|Overall Study|Inclimate Weather|0|||
144560379|NCT03220776|521252107|FG004|Overall Study|Inclimate Weather|0|||
144560380|NCT03220776|521252108|FG005|Overall Study|Inclimate Weather|1|||
144560381|NCT03220776|521252103|FG000|Overall Study|Physician Decision|0|||
144560382|NCT03220776|521252104|FG001|Overall Study|Physician Decision|0|||
144560383|NCT03220776|521252105|FG002|Overall Study|Physician Decision|0|||
144560384|NCT03220776|521252106|FG003|Overall Study|Physician Decision|1|||
144560385|NCT03220776|521252107|FG004|Overall Study|Physician Decision|0|||
144560386|NCT03220776|521252108|FG005|Overall Study|Physician Decision|0|||
144560387|NCT03220776|521252103|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
144560388|NCT03220776|521252104|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
144560389|NCT03220776|521252105|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
144560390|NCT03220776|521252106|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
144560391|NCT03220776|521252107|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
144560392|NCT03220776|521252108|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
144560393|NCT03220776|521252103|FG000|Overall Study|Protocol Violation|0|||
144560394|NCT03220776|521252104|FG001|Overall Study|Protocol Violation|0|||
144560395|NCT03220776|521252105|FG002|Overall Study|Protocol Violation|0|||
144560396|NCT03220776|521252106|FG003|Overall Study|Protocol Violation|2|||
144560397|NCT03220776|521252107|FG004|Overall Study|Protocol Violation|0|||
144560398|NCT03220776|521252108|FG005|Overall Study|Protocol Violation|1|||
144560399|NCT03220776|521252103|FG000|Overall Study|Withdrawal by Subject|1|||
144560400|NCT03220776|521252104|FG001|Overall Study|Withdrawal by Subject|0|||
144560401|NCT03220776|521252105|FG002|Overall Study|Withdrawal by Subject|0|||
144560402|NCT03220776|521252106|FG003|Overall Study|Withdrawal by Subject|0|||
144560403|NCT03220776|521252107|FG004|Overall Study|Withdrawal by Subject|0|||
144560404|NCT03220776|521252108|FG005|Overall Study|Withdrawal by Subject|0|||
144560405|NCT03226353|521252109|FG000|Overall Study|Withdrawal by Subject|1|||
144560406|NCT03226353|521252109|FG000|Overall Study|Screen Failure|5|||
144560407|NCT03441789|521252110|FG000|Overall Study|Withdrawal by Subject|1|||
144560408|NCT03441789|521252111|FG001|Overall Study|Withdrawal by Subject|1|||
144560409|NCT03441789|521252110|FG000|Overall Study|Adverse Event|0|||
144560410|NCT03441789|521252111|FG001|Overall Study|Adverse Event|1|||
144560411|NCT03441789|521252110|FG000|Overall Study|Protocol Violation|0|||
144560412|NCT03441789|521252111|FG001|Overall Study|Protocol Violation|1|||
144560413|NCT03441789|521252110|FG000|Overall Study|Lost to Follow-up|0|||
144560414|NCT03441789|521252111|FG001|Overall Study|Lost to Follow-up|1|||
144560415|NCT02166047|521252114|FG000|Overall Study|Withdrawal by Participant|0|||
144560416|NCT02166047|521252115|FG001|Overall Study|Withdrawal by Participant|1|||
144560417|NCT02166047|521252116|FG002|Overall Study|Withdrawal by Participant|2|||
144560418|NCT02166047|521252117|FG003|Overall Study|Withdrawal by Participant|0|||
144728131|NCT02191891|521859340|FG002|Overall Study|Withdrawal by Subject|0|||
144728132|NCT02191891|521859341|FG003|Overall Study|Withdrawal by Subject|0|||
144728133|NCT02191891|521859342|FG004|Overall Study|Withdrawal by Subject|1|||
144560419|NCT02166047|521252118|FG004|Overall Study|Withdrawal by Participant|0|||
144728134|NCT02191891|521859338|FG000|Overall Study|Adverse Event|0|||
144560420|NCT02166047|521252119|FG005|Overall Study|Withdrawal by Participant|0|||
144560421|NCT02166047|521252120|FG006|Overall Study|Withdrawal by Participant|1|||
144560422|NCT02166047|521252121|FG007|Overall Study|Withdrawal by Participant|0|||
144560423|NCT02166047|521252122|FG008|Overall Study|Withdrawal by Participant|0|||
144560424|NCT02166047|521252123|FG009|Overall Study|Withdrawal by Participant|0|||
144560425|NCT02166047|521252124|FG010|Overall Study|Withdrawal by Participant|0|||
144560426|NCT02166047|521252125|FG011|Overall Study|Withdrawal by Participant|0|||
144728135|NCT02191891|521859339|FG001|Overall Study|Adverse Event|1|||
144560427|NCT02166047|521252114|FG000|Overall Study|Adverse Event|0|||
144560428|NCT02166047|521252115|FG001|Overall Study|Adverse Event|0|||
144560429|NCT02166047|521252116|FG002|Overall Study|Adverse Event|0|||
144560430|NCT02166047|521252117|FG003|Overall Study|Adverse Event|0|||
144560431|NCT02166047|521252118|FG004|Overall Study|Adverse Event|1|||
144560432|NCT02166047|521252119|FG005|Overall Study|Adverse Event|0|||
144560433|NCT02166047|521252120|FG006|Overall Study|Adverse Event|1|||
144560434|NCT02166047|521252121|FG007|Overall Study|Adverse Event|0|||
144560435|NCT02166047|521252122|FG008|Overall Study|Adverse Event|0|||
144560436|NCT02166047|521252123|FG009|Overall Study|Adverse Event|0|||
144560437|NCT02166047|521252124|FG010|Overall Study|Adverse Event|2|||
144728136|NCT02191891|521859340|FG002|Overall Study|Adverse Event|0|||
144728137|NCT02191891|521859341|FG003|Overall Study|Adverse Event|0|||
144728138|NCT02191891|521859342|FG004|Overall Study|Adverse Event|2|||
144728139|NCT02191891|521859338|FG000|Overall Study|Disease Progression|4|||
144728140|NCT02191891|521859339|FG001|Overall Study|Disease Progression|10|||
144728141|NCT02191891|521859340|FG002|Overall Study|Disease Progression|4|||
144728142|NCT02191891|521859341|FG003|Overall Study|Disease Progression|2|||
144560438|NCT02166047|521252125|FG011|Overall Study|Adverse Event|0|||
144560439|NCT02845375|521252127|FG000|Overall Study|upper airway obstruction|1|||
144560440|NCT02845375|521252128|FG001|Overall Study|upper airway obstruction|2|||
144560441|NCT02845375|521252129|FG002|Overall Study|upper airway obstruction|1|||
144560442|NCT01177137|521252130|FG000|Overall Study|Withdrawal by Subject|10|||
144560443|NCT01177137|521252131|FG001|Overall Study|Withdrawal by Subject|10|||
144560444|NCT01177137|521252132|FG002|Overall Study|Withdrawal by Subject|2|||
144560445|NCT02215954|521252134|FG000|Overall Study|Adverse Event|0|||
144560446|NCT02215954|521252135|FG001|Overall Study|Adverse Event|0|||
144560447|NCT02215954|521252136|FG002|Overall Study|Adverse Event|1|||
144728143|NCT02191891|521859342|FG004|Overall Study|Disease Progression|7|||
144728144|NCT00874237|521859346|FG000|Overall Study|Physician Decision|0|||
144728145|NCT00874237|521859347|FG001|Overall Study|Physician Decision|1|||
144728146|NCT00874237|521859348|FG002|Overall Study|Physician Decision|0|||
144728147|NCT00874237|521859349|FG003|Overall Study|Physician Decision|0|||
144728148|NCT00874237|521859350|FG004|Overall Study|Physician Decision|0|||
144728149|NCT00874237|521859351|FG005|Overall Study|Physician Decision|0|||
144728150|NCT00874237|521859346|FG000|Overall Study|Withdrawal by Subject|0|||
144728151|NCT00874237|521859347|FG001|Overall Study|Withdrawal by Subject|0|||
144728152|NCT00874237|521859348|FG002|Overall Study|Withdrawal by Subject|1|||
144728153|NCT00874237|521859349|FG003|Overall Study|Withdrawal by Subject|0|||
144728154|NCT00874237|521859350|FG004|Overall Study|Withdrawal by Subject|0|||
144728155|NCT00874237|521859351|FG005|Overall Study|Withdrawal by Subject|0|||
144728156|NCT03912337|521859359|FG000|Overall Study|Withdrawal of Consent From Study|1|||
144728157|NCT03912337|521859360|FG001|Overall Study|Withdrawal of Consent From Study|0|||
144728158|NCT03912337|521859359|FG000|Overall Study|Lost to Follow-up|1|||
144728159|NCT03912337|521859360|FG001|Overall Study|Lost to Follow-up|1|||
144728160|NCT02458469|521859361|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144728161|NCT02458469|521859362|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144728162|NCT02458469|521859363|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
144728163|NCT02458469|521859364|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144728164|NCT02458469|521859365|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144728165|NCT02458469|521859366|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144728166|NCT02458469|521859361|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
144728167|NCT02458469|521859362|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
144728168|NCT02458469|521859363|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
144728169|NCT02458469|521859364|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
144728170|NCT02458469|521859365|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
144728171|NCT02458469|521859366|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
144728172|NCT02458469|521859361|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
144728173|NCT02458469|521859362|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
144728174|NCT02458469|521859363|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
144728175|NCT02458469|521859364|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
144728176|NCT02458469|521859365|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
144728177|NCT02458469|521859366|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
144728178|NCT03561883|521859369|FG000|Overall Study|Adverse Event|10|||
144203552|NCT03893565|519940366|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
144560448|NCT02215954|521252134|FG000|Overall Study|Withdrawal by Subject|0|||
144560449|NCT02215954|521252135|FG001|Overall Study|Withdrawal by Subject|0|||
144560450|NCT02215954|521252136|FG002|Overall Study|Withdrawal by Subject|2|||
144560451|NCT02215954|521252134|FG000|Overall Study|Not exposed|1|||
144560452|NCT02215954|521252135|FG001|Overall Study|Not exposed|1|||
144560453|NCT02215954|521252136|FG002|Overall Study|Not exposed|3|||
144560454|NCT02460562|521252138|FG000|Overall Study|Lost to Follow-up|15|||
144560455|NCT02460562|521252139|FG001|Overall Study|Lost to Follow-up|16|||
144560456|NCT00588341|521252140|FG000|Overall Study|Withdrawal by Subject|3|||
144560457|NCT00588341|521252140|FG000|Overall Study|Not treated due to metastatic disease|1|||
144728179|NCT03561883|521859370|FG001|Overall Study|Adverse Event|13|||
144560458|NCT00588341|521252140|FG000|Overall Study|Patient ineligible|1|||
144560459|NCT01924806|521252143|FG000|Overall Study|Physician Decision|2|||
144560460|NCT01924806|521252144|FG001|Overall Study|Physician Decision|1|||
144560461|NCT03635775|521252145|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
144560462|NCT03635775|521252146|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
144560463|NCT03635775|521252147|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
144560464|NCT03635775|521252148|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
144560465|NCT00297778|521252156|FG000|Overall Study|Adverse Event|16|||
144560466|NCT00297778|521252157|FG001|Overall Study|Adverse Event|10|||
144560467|NCT00297778|521252156|FG000|Overall Study|Withdrawal by Subject|1|||
144560468|NCT00297778|521252157|FG001|Overall Study|Withdrawal by Subject|5|||
144560469|NCT00297778|521252156|FG000|Overall Study|Lack of Efficacy|2|||
144560470|NCT00297778|521252157|FG001|Overall Study|Lack of Efficacy|1|||
144560471|NCT00297778|521252156|FG000|Overall Study|Non-compliant with trial protocol|0|||
144560472|NCT00297778|521252157|FG001|Overall Study|Non-compliant with trial protocol|3|||
144560473|NCT00297778|521252156|FG000|Overall Study|Other|0|||
144560474|NCT00297778|521252157|FG001|Overall Study|Other|1|||
144560475|NCT03280108|521252159|FG000|Overall Study|Lost to Follow-up|2|||
144560476|NCT03280108|521252160|FG001|Overall Study|Lost to Follow-up|0|||
144560477|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
144560478|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144560479|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144560480|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144560481|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144560482|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
144560483|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144560484|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144560485|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144560486|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144560487|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
144560488|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144560489|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144560490|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144560491|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144560492|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
144560493|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144560494|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144560495|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144560496|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144560497|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
144560498|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144560499|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144560500|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144560501|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144560502|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
144560503|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144560504|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144560505|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144560506|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144560507|NCT01187407|521252161|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
144560508|NCT01187407|521252162|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144560509|NCT01187407|521252163|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144560510|NCT01187407|521252164|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144560511|NCT01187407|521252165|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144560512|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
144560513|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
144560514|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
144560515|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
144560516|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
144560517|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
144560518|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
144560519|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
144560520|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
144560521|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
144560522|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
144560523|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
144560524|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
144728180|NCT03561883|521859369|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144728181|NCT03561883|521859370|FG001|Overall Study|Non-Compliance With Study Drug|2|||
144728182|NCT03561883|521859369|FG000|Overall Study|Protocol Violation|2|||
144728183|NCT03561883|521859370|FG001|Overall Study|Protocol Violation|3|||
144728184|NCT03561883|521859369|FG000|Overall Study|Withdrawal by Subject|14|||
144728185|NCT03561883|521859370|FG001|Overall Study|Withdrawal by Subject|6|||
144728186|NCT03561883|521859369|FG000|Overall Study|Lost to Follow-up|2|||
144728187|NCT03561883|521859370|FG001|Overall Study|Lost to Follow-up|6|||
144728188|NCT03561883|521859369|FG000|Overall Study|Study Terminated by Sponsor|12|||
144728189|NCT03561883|521859370|FG001|Overall Study|Study Terminated by Sponsor|11|||
144728190|NCT03561883|521859369|FG000|Overall Study|Physician Decision|1|||
144728191|NCT03561883|521859370|FG001|Overall Study|Physician Decision|0|||
144728192|NCT03561883|521859369|FG000|Overall Study|Randomized by Mistake|1|||
144728193|NCT03561883|521859370|FG001|Overall Study|Randomized by Mistake|0|||
144728194|NCT03561883|521859369|FG000|Overall Study|Other, Not Specified|3|||
144728195|NCT03561883|521859370|FG001|Overall Study|Other, Not Specified|2|||
144728196|NCT00408902|521859384|FG000|Overall Study|Lack of Efficacy|7|||
144728197|NCT00408902|521859384|FG000|Overall Study|Adverse Event|3|||
144728198|NCT01759290|521859387|FG000|Overall Study|Subjects withdrawn consent|5|||
144728199|NCT01759290|521859387|FG000|Overall Study|Physician Decision|2|||
144728200|NCT01759290|521859387|FG000|Overall Study|Death|17|||
144728201|NCT01759290|521859387|FG000|Overall Study|Lost to Follow-up|53|||
144728202|NCT01759290|521859387|FG000|Overall Study|Unknown reason|4|||
144728203|NCT00841100|521859388|FG000|Phase 1 (28 Days)|Adverse Event|1|||
144728204|NCT00841100|521859388|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
144728205|NCT03338972|521859389|FG000|Overall Study|Death|1|||
144728206|NCT03338972|521859390|FG001|Overall Study|Death|1|||
144728207|NCT03338972|521859391|FG002|Overall Study|Death|0|||
144728208|NCT03338972|521859392|FG003|Overall Study|Death|0|||
144728209|NCT03338972|521859389|FG000|Overall Study|Withdrawal by Subject|1|||
144728210|NCT03338972|521859390|FG001|Overall Study|Withdrawal by Subject|0|||
144728211|NCT03338972|521859391|FG002|Overall Study|Withdrawal by Subject|0|||
144728212|NCT03338972|521859392|FG003|Overall Study|Withdrawal by Subject|0|||
144728213|NCT03629249|521859393|FG000|Overall Study|Study terminated by sponsor|197|||
144728214|NCT03629249|521859394|FG001|Overall Study|Study terminated by sponsor|197|||
144728215|NCT03629249|521859395|FG002|Overall Study|Study terminated by sponsor|194|||
144203553|NCT03893565|519940358|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144203554|NCT03893565|519940359|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144203555|NCT03893565|519940360|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144203556|NCT03893565|519940361|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144203557|NCT03893565|519940362|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144203558|NCT03893565|519940363|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144203559|NCT03893565|519940364|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
144203560|NCT03893565|519940365|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144560525|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
144560526|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
144560527|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144560528|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144560529|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144560530|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
144560531|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
144560532|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
144560533|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
144560534|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
144560535|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
144560536|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
144560537|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
144560538|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
144560539|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
144560540|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
144560541|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
144560542|NCT01187407|521252161|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
144560543|NCT01187407|521252162|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
144728216|NCT03629249|521859393|FG000|Overall Study|Protocol deviation|0|||
144728217|NCT03629249|521859394|FG001|Overall Study|Protocol deviation|2|||
144203561|NCT03893565|519940366|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
144728218|NCT03629249|521859395|FG002|Overall Study|Protocol deviation|5|||
144728219|NCT03629249|521859393|FG000|Overall Study|Subject decision|1|||
144728220|NCT03629249|521859394|FG001|Overall Study|Subject decision|1|||
144728221|NCT03629249|521859395|FG002|Overall Study|Subject decision|3|||
144728222|NCT03629249|521859393|FG000|Overall Study|Adverse Event|1|||
144728223|NCT03629249|521859394|FG001|Overall Study|Adverse Event|1|||
144262493|NCT01566604|520161450|FG000|Overall Study|Lack of Efficacy|1|||
144560544|NCT01187407|521252163|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
144560545|NCT01187407|521252164|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
144560546|NCT01187407|521252165|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
144560547|NCT02201771|521252166|FG000|Overall Study|Death|3|||
144560548|NCT02201771|521252167|FG001|Overall Study|Death|2|||
144560549|NCT02201771|521252168|FG002|Overall Study|Death|0|||
144560550|NCT02201771|521252166|FG000|Overall Study|Protocol Violation|10|||
144560551|NCT02201771|521252167|FG001|Overall Study|Protocol Violation|8|||
144560552|NCT02201771|521252168|FG002|Overall Study|Protocol Violation|10|||
144560553|NCT01713998|521252169|FG000|Overall Study|Lost to Follow-up|2|||
144560554|NCT01713998|521252170|FG001|Overall Study|Lost to Follow-up|0|||
144560555|NCT01713998|521252171|FG002|Overall Study|Lost to Follow-up|2|||
144560556|NCT01713998|521252169|FG000|Overall Study|Withdrawal by Subject|1|||
144560557|NCT01713998|521252170|FG001|Overall Study|Withdrawal by Subject|0|||
144560558|NCT01713998|521252171|FG002|Overall Study|Withdrawal by Subject|0|||
144560559|NCT03638258|521252172|FG000|Overall Study|Adverse Event|1|||
144560560|NCT03638258|521252173|FG001|Overall Study|Adverse Event|0|||
144560561|NCT03638258|521252174|FG002|Overall Study|Adverse Event|2|||
144560562|NCT03638258|521252172|FG000|Overall Study|Lost to Follow-up|2|||
144560563|NCT03638258|521252173|FG001|Overall Study|Lost to Follow-up|4|||
144560564|NCT03638258|521252174|FG002|Overall Study|Lost to Follow-up|5|||
144560565|NCT03638258|521252172|FG000|Overall Study|Pregnancy|0|||
144560566|NCT03638258|521252173|FG001|Overall Study|Pregnancy|0|||
144560567|NCT03638258|521252174|FG002|Overall Study|Pregnancy|1|||
144560568|NCT03638258|521252172|FG000|Overall Study|Protocol Violation|0|||
144560569|NCT03638258|521252173|FG001|Overall Study|Protocol Violation|0|||
144560570|NCT03638258|521252174|FG002|Overall Study|Protocol Violation|1|||
144560571|NCT03638258|521252172|FG000|Overall Study|Withdrawal by Subject|4|||
144560572|NCT03638258|521252173|FG001|Overall Study|Withdrawal by Subject|5|||
144560573|NCT03638258|521252174|FG002|Overall Study|Withdrawal by Subject|12|||
144560574|NCT03638258|521252172|FG000|Overall Study|Lack of Efficacy|0|||
144560575|NCT03638258|521252173|FG001|Overall Study|Lack of Efficacy|0|||
144560576|NCT03638258|521252174|FG002|Overall Study|Lack of Efficacy|2|||
144560577|NCT01919398|521252175|FG000|Overall Study|Progressive Disease|0|||
144560578|NCT01919398|521252176|FG001|Overall Study|Progressive Disease|0|||
144560579|NCT01919398|521252177|FG002|Overall Study|Progressive Disease|4|||
144560580|NCT02383927|521252181|FG000|Overall Study|Disease Progression|8|||
144560581|NCT02383927|521252182|FG001|Overall Study|Disease Progression|8|||
144560582|NCT02383927|521252183|FG002|Overall Study|Disease Progression|15|||
144560583|NCT02383927|521252184|FG003|Overall Study|Disease Progression|4|||
144560584|NCT02383927|521252181|FG000|Overall Study|Physician Decision|0|||
144560585|NCT02383927|521252182|FG001|Overall Study|Physician Decision|0|||
144560586|NCT02383927|521252183|FG002|Overall Study|Physician Decision|2|||
144560587|NCT02383927|521252184|FG003|Overall Study|Physician Decision|0|||
144560588|NCT02383927|521252181|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
144560589|NCT02383927|521252182|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
144560590|NCT02383927|521252183|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
144560591|NCT02383927|521252184|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
144560592|NCT02383927|521252181|FG000|Overall Study|Adverse Event|4|||
144560593|NCT02383927|521252182|FG001|Overall Study|Adverse Event|1|||
144560594|NCT02383927|521252183|FG002|Overall Study|Adverse Event|3|||
144262494|NCT01566604|520161451|FG001|Overall Study|Lack of Efficacy|2|||
144560595|NCT02383927|521252184|FG003|Overall Study|Adverse Event|5|||
144560596|NCT02383927|521252181|FG000|Overall Study|Miscellaneous|1|||
144560597|NCT02383927|521252182|FG001|Overall Study|Miscellaneous|0|||
144560598|NCT02383927|521252183|FG002|Overall Study|Miscellaneous|0|||
144560599|NCT02383927|521252184|FG003|Overall Study|Miscellaneous|1|||
144560600|NCT02383927|521252181|FG000|Overall Study|Withdrawal by Subject|0|||
144560601|NCT02383927|521252182|FG001|Overall Study|Withdrawal by Subject|1|||
144560602|NCT02383927|521252183|FG002|Overall Study|Withdrawal by Subject|4|||
144560603|NCT02383927|521252184|FG003|Overall Study|Withdrawal by Subject|0|||
144560604|NCT02865135|521252185|FG000|Overall Study|Death|0|||
144262495|NCT01566604|520161450|FG000|Overall Study|Protocol deviation|2|||
144560605|NCT02865135|521252186|FG001|Overall Study|Death|1|||
144560606|NCT02865135|521252187|FG002|Overall Study|Death|0|||
144560607|NCT02865135|521252185|FG000|Overall Study|Progression|6|||
144560608|NCT02865135|521252186|FG001|Overall Study|Progression|2|||
144560609|NCT02865135|521252187|FG002|Overall Study|Progression|2|||
144560610|NCT04783519|521252190|FG000|Overall Study|Withdrawal by Subject|2|||
144560611|NCT04783519|521252191|FG001|Overall Study|Withdrawal by Subject|7|||
144560612|NCT04783519|521252192|FG002|Overall Study|Withdrawal by Subject|3|||
144262496|NCT01566604|520161451|FG001|Overall Study|Protocol deviation|0|||
144560613|NCT04783519|521252190|FG000|Overall Study|Lost to Follow-up|9|||
144560614|NCT04783519|521252191|FG001|Overall Study|Lost to Follow-up|7|||
144560615|NCT04783519|521252192|FG002|Overall Study|Lost to Follow-up|6|||
144560616|NCT00645099|521252193|FG000|Overall Study|Lack of Efficacy|15|||
144560617|NCT00645099|521252194|FG001|Overall Study|Lack of Efficacy|6|||
144560618|NCT00645099|521252193|FG000|Overall Study|Withdrawal by Subject|30|||
144560619|NCT00645099|521252194|FG001|Overall Study|Withdrawal by Subject|22|||
144560620|NCT00645099|521252193|FG000|Overall Study|Lost to Follow-up|6|||
144560621|NCT00645099|521252194|FG001|Overall Study|Lost to Follow-up|4|||
144560622|NCT00645099|521252193|FG000|Overall Study|Adverse Event|11|||
144617680|NCT00440947|521459764|FG002|48-Week Randomization Phase|Pregnancy|1|||
144617681|NCT00440947|521459765|FG003|48-Week Randomization Phase|Pregnancy|0|||
144617682|NCT00440947|521459766|FG004|48-Week Randomization Phase|Pregnancy|0|||
144617683|NCT00440947|521459762|FG000|48-Week Randomization Phase|Incarceration|0|||
144617684|NCT00440947|521459763|FG001|48-Week Randomization Phase|Incarceration|3|||
144617685|NCT00440947|521459764|FG002|48-Week Randomization Phase|Incarceration|0|||
144617686|NCT00440947|521459765|FG003|48-Week Randomization Phase|Incarceration|0|||
144617687|NCT00440947|521459766|FG004|48-Week Randomization Phase|Incarceration|0|||
144617688|NCT00440947|521459762|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
144617689|NCT00440947|521459763|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
144617690|NCT00440947|521459764|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
144617691|NCT00440947|521459765|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
144617692|NCT00440947|521459766|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
144617693|NCT00440947|521459762|FG000|48-Week Randomization Phase|Physician Decision|0|||
144617694|NCT00440947|521459763|FG001|48-Week Randomization Phase|Physician Decision|2|||
144617695|NCT00440947|521459764|FG002|48-Week Randomization Phase|Physician Decision|0|||
144728224|NCT03629249|521859395|FG002|Overall Study|Adverse Event|0|||
144728225|NCT03629249|521859393|FG000|Overall Study|Death|1|||
144560623|NCT00645099|521252194|FG001|Overall Study|Adverse Event|5|||
144560624|NCT00645099|521252193|FG000|Overall Study|Other|9|||
144560625|NCT00645099|521252194|FG001|Overall Study|Other|5|||
144560626|NCT01201915|521252195|FG000|Overall Study|Adverse Event|2|||
144560627|NCT01201915|521252196|FG001|Overall Study|Adverse Event|1|||
144560628|NCT01201915|521252197|FG002|Overall Study|Adverse Event|1|||
144560629|NCT01201915|521252195|FG000|Overall Study|Lost to Follow-up|0|||
144560630|NCT01201915|521252196|FG001|Overall Study|Lost to Follow-up|4|||
144560631|NCT01201915|521252197|FG002|Overall Study|Lost to Follow-up|0|||
144560632|NCT01201915|521252195|FG000|Overall Study|Physician Decision|3|||
144560633|NCT01201915|521252196|FG001|Overall Study|Physician Decision|0|||
144560634|NCT01201915|521252197|FG002|Overall Study|Physician Decision|0|||
144560635|NCT01201915|521252195|FG000|Overall Study|Subject Decision|3|||
144560636|NCT01201915|521252196|FG001|Overall Study|Subject Decision|3|||
144560637|NCT01201915|521252197|FG002|Overall Study|Subject Decision|5|||
144560638|NCT01201915|521252195|FG000|Overall Study|Target Lesion Progression|0|||
144560639|NCT01201915|521252196|FG001|Overall Study|Target Lesion Progression|3|||
144560640|NCT01201915|521252197|FG002|Overall Study|Target Lesion Progression|0|||
144560641|NCT03406507|521252198|FG000|Extension Period|Lack of Efficacy|0|||
144560642|NCT03406507|521252199|FG001|Extension Period|Lack of Efficacy|1|||
144560643|NCT02316171|521252200|FG000|Overall Study|difficulties with urinary catheter|1|||
144560644|NCT02316171|521252201|FG001|Overall Study|difficulties with urinary catheter|0|||
144560645|NCT02316171|521252202|FG002|Overall Study|difficulties with urinary catheter|0|||
144560646|NCT02316171|521252203|FG003|Overall Study|difficulties with urinary catheter|0|||
144560647|NCT02329223|521253231|FG000|Overall Study|Withdrawal by Subject|1|||
144560648|NCT02329223|521253232|FG001|Overall Study|Withdrawal by Subject|2|||
144560649|NCT02329223|521253233|FG002|Overall Study|Withdrawal by Subject|5|||
144560650|NCT02329223|521253231|FG000|Overall Study|Physician Decision|0|||
144560651|NCT02329223|521253232|FG001|Overall Study|Physician Decision|0|||
144560652|NCT02329223|521253233|FG002|Overall Study|Physician Decision|1|||
144560653|NCT02329223|521253231|FG000|Overall Study|Adverse Event|0|||
144560654|NCT02329223|521253232|FG001|Overall Study|Adverse Event|1|||
144560655|NCT02329223|521253233|FG002|Overall Study|Adverse Event|0|||
144560656|NCT04150341|521253244|FG000|Overall Study|Physician Decision|0|||
144560657|NCT04150341|521253245|FG001|Overall Study|Physician Decision|0|||
144560658|NCT04150341|521253246|FG002|Overall Study|Physician Decision|1|||
144560659|NCT04150341|521253247|FG003|Overall Study|Physician Decision|0|||
144560660|NCT04150341|521253248|FG004|Overall Study|Physician Decision|0|||
144560661|NCT04150341|521253249|FG005|Overall Study|Physician Decision|0|||
144560662|NCT04150341|521253244|FG000|Overall Study|Adverse Event|0|||
144560663|NCT04150341|521253245|FG001|Overall Study|Adverse Event|0|||
144560664|NCT04150341|521253246|FG002|Overall Study|Adverse Event|0|||
144560665|NCT04150341|521253247|FG003|Overall Study|Adverse Event|0|||
144560666|NCT04150341|521253248|FG004|Overall Study|Adverse Event|1|||
144560667|NCT04150341|521253249|FG005|Overall Study|Adverse Event|0|||
144560668|NCT03712449|521253250|FG000|Overall Study|Withdraw Consent|0|||
144560669|NCT03712449|521253251|FG001|Overall Study|Withdraw Consent|1|||
144560670|NCT03168425|521253252|FG000|Overall Study|Lost to Follow-up|5|||
144560671|NCT03168425|521253253|FG001|Overall Study|Lost to Follow-up|8|||
144560672|NCT03168425|521253252|FG000|Overall Study|unable to confirm post op opioids|2|||
144560673|NCT03168425|521253253|FG001|Overall Study|unable to confirm post op opioids|3|||
144560674|NCT04491006|521253254|FG000|Overall Study|Adverse Event|0|||
144560675|NCT04491006|521253255|FG001|Overall Study|Adverse Event|3|||
144560676|NCT04491006|521253256|FG002|Overall Study|Adverse Event|5|||
144617696|NCT00440947|521459765|FG003|48-Week Randomization Phase|Physician Decision|0|||
144728226|NCT03629249|521859394|FG001|Overall Study|Death|0|||
144203562|NCT03893565|519940358|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144203563|NCT03893565|519940359|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144203564|NCT03893565|519940360|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144203565|NCT03893565|519940361|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144203566|NCT03893565|519940362|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144203567|NCT03893565|519940363|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
144560677|NCT04491006|521253254|FG000|Overall Study|Withdrawal by Subject|1|||
144560678|NCT04491006|521253255|FG001|Overall Study|Withdrawal by Subject|0|||
144560679|NCT04491006|521253256|FG002|Overall Study|Withdrawal by Subject|2|||
144560680|NCT01960114|521253261|FG000|Overall Study|Adverse Event|1|||
144560681|NCT01960114|521253262|FG001|Overall Study|Adverse Event|0|||
144560682|NCT01960114|521253261|FG000|Overall Study|Could not swallow study medication|0|||
144560683|NCT01960114|521253262|FG001|Overall Study|Could not swallow study medication|1|||
144560684|NCT02490878|521253266|FG000|Overall Study|deemed ineligible|0|||
144560685|NCT02490878|521253267|FG001|Overall Study|deemed ineligible|1|||
144560686|NCT02490878|521253266|FG000|Overall Study|progression prior to treatment|0|||
144560687|NCT02490878|521253267|FG001|Overall Study|progression prior to treatment|1|||
144560688|NCT02490878|521253266|FG000|Overall Study|only submitted baseline QOL|0|||
144560689|NCT02490878|521253267|FG001|Overall Study|only submitted baseline QOL|1|||
144560690|NCT00451555|521253268|FG000|Overall Study|Protocol Violation|2|||
144560691|NCT00451555|521253269|FG001|Overall Study|Protocol Violation|2|||
144560692|NCT00451555|521253268|FG000|Overall Study|Adverse Event|3|||
144560693|NCT00451555|521253269|FG001|Overall Study|Adverse Event|1|||
144560694|NCT00451555|521253268|FG000|Overall Study|Withdrawal by Subject|6|||
144560695|NCT00451555|521253269|FG001|Overall Study|Withdrawal by Subject|0|||
144560696|NCT00451555|521253268|FG000|Overall Study|Physician Decision|2|||
144560697|NCT00451555|521253269|FG001|Overall Study|Physician Decision|1|||
144560698|NCT00922441|521253270|FG000|Overall Study|Protocol Violation|0|||
144560699|NCT00922441|521253271|FG001|Overall Study|Protocol Violation|0|||
144560700|NCT00922441|521253272|FG002|Overall Study|Protocol Violation|2|||
144560701|NCT00922441|521253270|FG000|Overall Study|Withdrawal by Subject|0|||
144560702|NCT00922441|521253271|FG001|Overall Study|Withdrawal by Subject|0|||
144560703|NCT00922441|521253272|FG002|Overall Study|Withdrawal by Subject|1|||
144560704|NCT02959177|521253273|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
144560705|NCT02959177|521253274|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
144560706|NCT02959177|521253275|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
144560707|NCT02959177|521253273|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
144560708|NCT02959177|521253274|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
144560709|NCT02959177|521253275|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
144560710|NCT02959177|521253273|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
144560711|NCT02959177|521253274|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
144560712|NCT02959177|521253275|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
144560713|NCT02959177|521253273|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
144560714|NCT02959177|521253274|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144560715|NCT02959177|521253275|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
144560716|NCT02959177|521253273|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
144560717|NCT02959177|521253274|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
144560718|NCT02959177|521253275|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
144617697|NCT00440947|521459766|FG004|48-Week Randomization Phase|Physician Decision|0|||
144617698|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
144617699|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
144617700|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
144617701|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
144617702|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
144617703|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
144617704|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
144617705|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
144617706|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
144617707|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
144617708|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
144617709|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
144617710|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
144617711|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
144617712|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
144617713|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
144560719|NCT02959177|521253273|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
144560720|NCT02959177|521253274|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
144560721|NCT02959177|521253275|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
144560722|NCT02959177|521253273|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
144560723|NCT02959177|521253274|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
144560724|NCT02959177|521253275|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
144560725|NCT00677092|521253277|FG000|Overall Study|Adverse Event|1|||
144560726|NCT00677092|521253277|FG000|Overall Study|Lost to Follow-up|1|||
144560727|NCT00677092|521253277|FG000|Overall Study|Withdrawal by Subject|3|||
144560728|NCT00677092|521253277|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
144560729|NCT00187135|521253278|FG000|Visit One|Withdrawal by Subject|1|||
144560730|NCT00187135|521253279|FG001|Visit One|Withdrawal by Subject|0|||
144560731|NCT00187135|521253280|FG002|Visit One|Withdrawal by Subject|0|||
144560732|NCT00187135|521253281|FG003|Visit One|Withdrawal by Subject|0|||
144560733|NCT00187135|521253282|FG004|Visit One|Withdrawal by Subject|0|||
144560734|NCT00187135|521253283|FG005|Visit One|Withdrawal by Subject|1|||
144560735|NCT00187135|521253278|FG000|Visit One|Physician Decision|3|||
144560736|NCT00187135|521253279|FG001|Visit One|Physician Decision|1|||
144560737|NCT00187135|521253280|FG002|Visit One|Physician Decision|0|||
144560738|NCT00187135|521253281|FG003|Visit One|Physician Decision|0|||
144560739|NCT00187135|521253282|FG004|Visit One|Physician Decision|0|||
144560740|NCT00187135|521253283|FG005|Visit One|Physician Decision|1|||
144560741|NCT00187135|521253278|FG000|Visit Two|Death|0|||
144560742|NCT00187135|521253279|FG001|Visit Two|Death|0|||
144560743|NCT00187135|521253280|FG002|Visit Two|Death|0|||
144560744|NCT00187135|521253281|FG003|Visit Two|Death|1|||
144728227|NCT03629249|521859395|FG002|Overall Study|Death|0|||
144728228|NCT03629249|521859393|FG000|Overall Study|Physician Decision|1|||
144560745|NCT00187135|521253282|FG004|Visit Two|Death|0|||
144560746|NCT00187135|521253283|FG005|Visit Two|Death|1|||
144560747|NCT00187135|521253278|FG000|Visit Two|Physician Decision|1|||
144560748|NCT00187135|521253279|FG001|Visit Two|Physician Decision|0|||
144560749|NCT00187135|521253280|FG002|Visit Two|Physician Decision|0|||
144560750|NCT00187135|521253281|FG003|Visit Two|Physician Decision|0|||
144560751|NCT00187135|521253282|FG004|Visit Two|Physician Decision|0|||
144560752|NCT00187135|521253283|FG005|Visit Two|Physician Decision|0|||
144560753|NCT00187135|521253278|FG000|Visit Two|Withdrawal by Subject|1|||
144560754|NCT00187135|521253279|FG001|Visit Two|Withdrawal by Subject|1|||
144560755|NCT00187135|521253280|FG002|Visit Two|Withdrawal by Subject|1|||
144560756|NCT00187135|521253281|FG003|Visit Two|Withdrawal by Subject|0|||
144560757|NCT00187135|521253282|FG004|Visit Two|Withdrawal by Subject|1|||
144560758|NCT00187135|521253283|FG005|Visit Two|Withdrawal by Subject|1|||
144560759|NCT00187135|521253278|FG000|Visit Two|Study Discontinued|3|||
144560760|NCT00187135|521253279|FG001|Visit Two|Study Discontinued|2|||
144560761|NCT00187135|521253280|FG002|Visit Two|Study Discontinued|1|||
144560762|NCT00187135|521253281|FG003|Visit Two|Study Discontinued|7|||
144560763|NCT00187135|521253282|FG004|Visit Two|Study Discontinued|5|||
144560764|NCT00187135|521253283|FG005|Visit Two|Study Discontinued|6|||
144560765|NCT00187135|521253278|FG000|Visit Three|Death|0|||
144560766|NCT00187135|521253279|FG001|Visit Three|Death|0|||
144560767|NCT00187135|521253280|FG002|Visit Three|Death|1|||
144560768|NCT00187135|521253281|FG003|Visit Three|Death|0|||
144560769|NCT00187135|521253282|FG004|Visit Three|Death|1|||
144560770|NCT00187135|521253283|FG005|Visit Three|Death|0|||
144560771|NCT00187135|521253278|FG000|Visit Three|Withdrawal by Subject|0|||
144560772|NCT00187135|521253279|FG001|Visit Three|Withdrawal by Subject|1|||
144560773|NCT00187135|521253280|FG002|Visit Three|Withdrawal by Subject|1|||
144560774|NCT00187135|521253281|FG003|Visit Three|Withdrawal by Subject|2|||
144560775|NCT00187135|521253282|FG004|Visit Three|Withdrawal by Subject|0|||
144560776|NCT00187135|521253283|FG005|Visit Three|Withdrawal by Subject|0|||
144560777|NCT00187135|521253278|FG000|Visit Three|Study Discontinued|7|||
144728229|NCT03629249|521859394|FG001|Overall Study|Physician Decision|0|||
144728230|NCT03629249|521859395|FG002|Overall Study|Physician Decision|0|||
144728231|NCT03633721|521859396|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
144728232|NCT03633721|521859397|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
144728233|NCT03633721|521859398|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
144560778|NCT00187135|521253279|FG001|Visit Three|Study Discontinued|6|||
144560779|NCT00187135|521253280|FG002|Visit Three|Study Discontinued|7|||
144560780|NCT00187135|521253281|FG003|Visit Three|Study Discontinued|7|||
144560781|NCT00187135|521253282|FG004|Visit Three|Study Discontinued|7|||
144560782|NCT00187135|521253283|FG005|Visit Three|Study Discontinued|6|||
144560783|NCT01951261|521253284|FG000|Overall Study|Death|1|||
144560784|NCT01951261|521253285|FG001|Overall Study|Death|0|||
144560785|NCT01951261|521253284|FG000|Overall Study|Lost to Follow-up|4|||
144560786|NCT01951261|521253285|FG001|Overall Study|Lost to Follow-up|3|||
144560787|NCT01951261|521253284|FG000|Overall Study|Protocol Violation|4|||
144560788|NCT01951261|521253285|FG001|Overall Study|Protocol Violation|3|||
144560789|NCT02996097|521253286|FG000|Overall Study|Lost to Follow-up|11|||
144728234|NCT03633721|521859399|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
144560790|NCT02996097|521253287|FG001|Overall Study|Lost to Follow-up|11|||
144560791|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
144728235|NCT03069937|521859400|FG000|Overall Study|Second primary malignancy noted|1|||
144560792|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
144560793|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
144560794|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
144560795|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
144560796|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
144560797|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
144560798|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
144560799|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
144560800|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
144560801|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
144560802|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
144560803|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
144560804|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
144560805|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
144560806|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
144560807|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
144560808|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
144560809|NCT03569475|521253288|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
144560810|NCT03569475|521253289|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
144560811|NCT03569475|521253290|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
144560812|NCT03569475|521253288|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
144560813|NCT03569475|521253289|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
144560814|NCT03569475|521253290|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
144560815|NCT03569475|521253288|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
144560816|NCT03569475|521253289|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
144560817|NCT03569475|521253290|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
144560818|NCT01287416|521253291|FG000|Pre-post Training|Withdrawal by Subject|17|||
144560819|NCT01287416|521253292|FG001|Pre-post Training|Withdrawal by Subject|24|||
144560820|NCT01287416|521253291|FG000|Pre-post Training|Lost to Follow-up|5|||
144560821|NCT01287416|521253292|FG001|Pre-post Training|Lost to Follow-up|1|||
144560822|NCT01287416|521253291|FG000|6 Month Follow-up|Lost to Follow-up|3|||
144560823|NCT01287416|521253292|FG001|6 Month Follow-up|Lost to Follow-up|2|||
144560824|NCT02109107|521253295|FG000|Overall Study|Lost to Follow-up|2|||
144560825|NCT03078751|521253297|FG000|Overall Study|Adverse Event|4|||
144560826|NCT03078751|521253298|FG001|Overall Study|Adverse Event|0|||
144560827|NCT03078751|521253297|FG000|Overall Study|Physician Decision|1|||
144560828|NCT03078751|521253298|FG001|Overall Study|Physician Decision|0|||
144560829|NCT03078751|521253297|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
144560830|NCT03078751|521253298|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
144560831|NCT03078751|521253297|FG000|Overall Study|Subject/guardian decision|8|||
144560832|NCT03078751|521253298|FG001|Overall Study|Subject/guardian decision|1|||
144560833|NCT03078751|521253297|FG000|Overall Study|Untreated|0|||
144560834|NCT03078751|521253298|FG001|Overall Study|Untreated|4|||
144560835|NCT00607789|521253303|FG000|Overall Study|Adverse Event|3|||
144560836|NCT00607789|521253304|FG001|Overall Study|Adverse Event|0|||
144560837|NCT00607789|521253303|FG000|Overall Study|Lack of Efficacy|0|||
144560838|NCT00607789|521253304|FG001|Overall Study|Lack of Efficacy|1|||
144560839|NCT00607789|521253303|FG000|Overall Study|Inadequate adherence|3|||
144560840|NCT00607789|521253304|FG001|Overall Study|Inadequate adherence|0|||
144560841|NCT00607789|521253303|FG000|Overall Study|Lost to Follow-up|0|||
144560842|NCT00607789|521253304|FG001|Overall Study|Lost to Follow-up|5|||
144560843|NCT00607789|521253303|FG000|Overall Study|Withdrawal by Subject|1|||
144560844|NCT00607789|521253304|FG001|Overall Study|Withdrawal by Subject|0|||
144560845|NCT01313299|521253305|FG000|Overall Study|Adverse Event|3|||
144560846|NCT01313299|521253306|FG001|Overall Study|Adverse Event|1|||
144560847|NCT01313299|521253307|FG002|Overall Study|Adverse Event|1|||
144560848|NCT01313299|521253305|FG000|Overall Study|Lost to Follow-up|1|||
144560849|NCT01313299|521253306|FG001|Overall Study|Lost to Follow-up|0|||
144560850|NCT01313299|521253307|FG002|Overall Study|Lost to Follow-up|0|||
144560851|NCT01313299|521253305|FG000|Overall Study|Protocol Violation|2|||
144560852|NCT01313299|521253306|FG001|Overall Study|Protocol Violation|0|||
144560853|NCT01313299|521253307|FG002|Overall Study|Protocol Violation|0|||
144560854|NCT01313299|521253305|FG000|Overall Study|Withdrawal by Subject|1|||
144560855|NCT01313299|521253306|FG001|Overall Study|Withdrawal by Subject|0|||
144560856|NCT01313299|521253307|FG002|Overall Study|Withdrawal by Subject|2|||
144560857|NCT01313299|521253305|FG000|Overall Study|Family reason and moved out of state|0|||
144560858|NCT01313299|521253306|FG001|Overall Study|Family reason and moved out of state|2|||
144728236|NCT01046253|521859401|FG000|Second Intervention|Adverse Event|0|||
144560859|NCT01313299|521253307|FG002|Overall Study|Family reason and moved out of state|0|||
144560860|NCT01313299|521253305|FG000|Overall Study|Lack of subject compliance|0|||
144560861|NCT01313299|521253306|FG001|Overall Study|Lack of subject compliance|0|||
144728237|NCT01046253|521859402|FG001|Second Intervention|Adverse Event|1|||
144560862|NCT01313299|521253307|FG002|Overall Study|Lack of subject compliance|1|||
144560863|NCT01222078|521253308|FG000|Overall Study|Early termination of the study|1|||
144262497|NCT01566604|520161450|FG000|Overall Study|Abnormal laboratory value|2|||
144262498|NCT01566604|520161451|FG001|Overall Study|Abnormal laboratory value|0|||
144262499|NCT01566604|520161450|FG000|Overall Study|Death|4|||
144262500|NCT01566604|520161451|FG001|Overall Study|Death|1|||
144262501|NCT01566604|520161450|FG000|Overall Study|Adverse Event|4|||
144262502|NCT01566604|520161451|FG001|Overall Study|Adverse Event|2|||
144262503|NCT01566604|520161450|FG000|Overall Study|Withdrawal by Subject|9|||
144262504|NCT01566604|520161451|FG001|Overall Study|Withdrawal by Subject|6|||
144560864|NCT02515097|521253309|FG000|Overall Study|Lost to Follow-up|4|||
144560865|NCT02515097|521253310|FG001|Overall Study|Lost to Follow-up|2|||
144560866|NCT02515097|521253309|FG000|Overall Study|Withdrawal by Subject|1|||
144560867|NCT02515097|521253310|FG001|Overall Study|Withdrawal by Subject|3|||
144560868|NCT02515097|521253309|FG000|Overall Study|Adverse Event|2|||
144560869|NCT02515097|521253310|FG001|Overall Study|Adverse Event|1|||
144560870|NCT00853021|521253311|FG000|Overall Study|Adverse Event|2|||
144560871|NCT00853021|521253311|FG000|Overall Study|Withdrawal by Subject|2|||
144560872|NCT00853021|521253311|FG000|Overall Study|Death|1|||
144560873|NCT00981578|521253312|FG000|Overall Study|Death|1|||
144560874|NCT00981578|521253312|FG000|Overall Study|Withdrawal by Subject|2|||
144560875|NCT03613454|521253313|FG000|Overall Study|Protocol Violation|1|||
144560876|NCT03613454|521253314|FG001|Overall Study|Protocol Violation|0|||
144560877|NCT03613454|521253313|FG000|Overall Study|Protocol Violation|0|||
144560878|NCT03613454|521253314|FG001|Overall Study|Protocol Violation|1|||
144560879|NCT01180790|521253315|FG000|Overall Study|Adverse Event|1|||
144560880|NCT01180790|521253316|FG001|Overall Study|Adverse Event|1|||
144560881|NCT01180790|521253317|FG002|Overall Study|Adverse Event|2|||
144560882|NCT01180790|521253318|FG003|Overall Study|Adverse Event|0|||
144560883|NCT01180790|521253319|FG004|Overall Study|Adverse Event|1|||
144560884|NCT01180790|521253320|FG005|Overall Study|Adverse Event|3|||
144560885|NCT01180790|521253321|FG006|Overall Study|Adverse Event|0|||
144560886|NCT01180790|521253315|FG000|Overall Study|Withdrawal by Subject|3|||
144560887|NCT01180790|521253316|FG001|Overall Study|Withdrawal by Subject|0|||
144560888|NCT01180790|521253317|FG002|Overall Study|Withdrawal by Subject|5|||
144560889|NCT01180790|521253318|FG003|Overall Study|Withdrawal by Subject|0|||
144560890|NCT01180790|521253319|FG004|Overall Study|Withdrawal by Subject|2|||
144560891|NCT01180790|521253320|FG005|Overall Study|Withdrawal by Subject|1|||
144560892|NCT01180790|521253321|FG006|Overall Study|Withdrawal by Subject|0|||
144560893|NCT01180790|521253315|FG000|Overall Study|Lost to Follow-up|3|||
144560894|NCT01180790|521253316|FG001|Overall Study|Lost to Follow-up|1|||
144560895|NCT01180790|521253317|FG002|Overall Study|Lost to Follow-up|0|||
144560896|NCT01180790|521253318|FG003|Overall Study|Lost to Follow-up|2|||
144560897|NCT01180790|521253319|FG004|Overall Study|Lost to Follow-up|1|||
144560898|NCT01180790|521253320|FG005|Overall Study|Lost to Follow-up|0|||
144560899|NCT01180790|521253321|FG006|Overall Study|Lost to Follow-up|1|||
144560900|NCT01180790|521253315|FG000|Overall Study|Physician Decision|1|||
144560901|NCT01180790|521253316|FG001|Overall Study|Physician Decision|0|||
144560902|NCT01180790|521253317|FG002|Overall Study|Physician Decision|0|||
144560903|NCT01180790|521253318|FG003|Overall Study|Physician Decision|1|||
144560904|NCT01180790|521253319|FG004|Overall Study|Physician Decision|0|||
144560905|NCT01180790|521253320|FG005|Overall Study|Physician Decision|0|||
144560906|NCT01180790|521253321|FG006|Overall Study|Physician Decision|0|||
144560907|NCT01180790|521253315|FG000|Overall Study|Lack of Efficacy|1|||
144560908|NCT01180790|521253316|FG001|Overall Study|Lack of Efficacy|2|||
144560909|NCT01180790|521253317|FG002|Overall Study|Lack of Efficacy|5|||
144560910|NCT01180790|521253318|FG003|Overall Study|Lack of Efficacy|6|||
144560911|NCT01180790|521253319|FG004|Overall Study|Lack of Efficacy|1|||
144560912|NCT01180790|521253320|FG005|Overall Study|Lack of Efficacy|3|||
144560913|NCT01180790|521253321|FG006|Overall Study|Lack of Efficacy|0|||
144560914|NCT01180790|521253315|FG000|Overall Study|compliance|0|||
144560915|NCT01180790|521253316|FG001|Overall Study|compliance|1|||
144560916|NCT01180790|521253317|FG002|Overall Study|compliance|0|||
144560917|NCT01180790|521253318|FG003|Overall Study|compliance|0|||
144560918|NCT01180790|521253319|FG004|Overall Study|compliance|0|||
144560919|NCT01180790|521253320|FG005|Overall Study|compliance|0|||
144560920|NCT01180790|521253321|FG006|Overall Study|compliance|0|||
144560921|NCT01180790|521253315|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
144560922|NCT01180790|521253316|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
144560923|NCT01180790|521253317|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
144560924|NCT01180790|521253318|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
144560925|NCT01180790|521253319|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
144560926|NCT01180790|521253320|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
144560927|NCT01180790|521253321|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
144560928|NCT01064856|521253325|FG000|Double-blind (DB) Period|Adverse Event|1|||
144560929|NCT01064856|521253326|FG001|Double-blind (DB) Period|Adverse Event|0|||
144560930|NCT01064856|521253327|FG002|Double-blind (DB) Period|Adverse Event|0|||
144262505|NCT00661089|520161452|FG000|Overall Study|1 subject withdrawal|0|||
144262506|NCT00661089|520161453|FG001|Overall Study|1 subject withdrawal|1|||
144560931|NCT01064856|521253328|FG003|Double-blind (DB) Period|Adverse Event|0|||
144560932|NCT01064856|521253325|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
144560933|NCT01064856|521253326|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
144560934|NCT01064856|521253327|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
144560935|NCT01064856|521253328|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
144560936|NCT01064856|521253325|FG000|Open-label (OL) Period|Adverse Event|0|||
144560937|NCT01064856|521253326|FG001|Open-label (OL) Period|Adverse Event|0|||
144560938|NCT01064856|521253327|FG002|Open-label (OL) Period|Adverse Event|12|||
144560939|NCT01064856|521253328|FG003|Open-label (OL) Period|Adverse Event|6|||
144560940|NCT01064856|521253325|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
144560941|NCT01064856|521253326|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
144560942|NCT01064856|521253327|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
144560943|NCT01064856|521253328|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
144560944|NCT01064856|521253325|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
144560945|NCT01064856|521253326|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
144560946|NCT01064856|521253327|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
144560947|NCT01064856|521253328|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
144560948|NCT01064856|521253325|FG000|Open-label (OL) Period|Other|0|||
144560949|NCT01064856|521253326|FG001|Open-label (OL) Period|Other|0|||
144560950|NCT01064856|521253327|FG002|Open-label (OL) Period|Other|7|||
144560951|NCT01064856|521253328|FG003|Open-label (OL) Period|Other|7|||
144560952|NCT02273180|521253332|FG000|Overall Study|Adverse Event|2|||
144560953|NCT02273180|521253333|FG001|Overall Study|Adverse Event|2|||
144560954|NCT02273180|521253332|FG000|Overall Study|Lack of Efficacy|1|||
144560955|NCT02273180|521253333|FG001|Overall Study|Lack of Efficacy|0|||
144560956|NCT02273180|521253332|FG000|Overall Study|Protocol Violation|1|||
144560957|NCT02273180|521253333|FG001|Overall Study|Protocol Violation|7|||
144560958|NCT02273180|521253332|FG000|Overall Study|Randomized but not treated|1|||
144560959|NCT02273180|521253333|FG001|Overall Study|Randomized but not treated|0|||
144560960|NCT02273180|521253332|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
144560961|NCT02273180|521253333|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
144560962|NCT02273180|521253332|FG000|Overall Study|Other than specified above|21|||
144560963|NCT02273180|521253333|FG001|Overall Study|Other than specified above|10|||
144560964|NCT02154516|521253334|FG000|Overall Study|Withdrawal by Subject|0|||
144560965|NCT02154516|521253335|FG001|Overall Study|Withdrawal by Subject|1|||
144560966|NCT02154516|521253334|FG000|Overall Study|Lost to Follow-up|1|||
144560967|NCT02154516|521253335|FG001|Overall Study|Lost to Follow-up|0|||
144560968|NCT02154516|521253334|FG000|Overall Study|Removal/revision of device|1|||
144560969|NCT02154516|521253335|FG001|Overall Study|Removal/revision of device|0|||
144560970|NCT02154516|521253334|FG000|Overall Study|Death|2|||
144560971|NCT02154516|521253335|FG001|Overall Study|Death|1|||
144560972|NCT02965599|521253339|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
144560973|NCT02965599|521253340|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
144560974|NCT04435522|521253344|FG000|Overall Study|Withdrawal by Subject|2|||
144560975|NCT02799745|521253345|FG000|Overall Study|Participant moved out of state|1|||
144560976|NCT02799745|521253346|FG001|Overall Study|Participant moved out of state|0|||
144560977|NCT02799745|521253345|FG000|Overall Study|Discontinued due to planned surgery|1|||
144560978|NCT02799745|521253346|FG001|Overall Study|Discontinued due to planned surgery|0|||
144560979|NCT02799745|521253345|FG000|Overall Study|Withdrawal by Subject|16|||
144560980|NCT02799745|521253346|FG001|Overall Study|Withdrawal by Subject|25|||
144560981|NCT02799745|521253345|FG000|Overall Study|Protocol Deviation|4|||
144560982|NCT02799745|521253346|FG001|Overall Study|Protocol Deviation|5|||
144560983|NCT02799745|521253345|FG000|Overall Study|Progressive Disease|28|||
144560984|NCT02799745|521253346|FG001|Overall Study|Progressive Disease|38|||
144560985|NCT02799745|521253345|FG000|Overall Study|Lost to Follow-up|3|||
144560986|NCT02799745|521253346|FG001|Overall Study|Lost to Follow-up|2|||
144560987|NCT02799745|521253345|FG000|Overall Study|Death|3|||
144560988|NCT02799745|521253346|FG001|Overall Study|Death|0|||
144560989|NCT02799745|521253345|FG000|Overall Study|Adverse Event|0|||
144560990|NCT02799745|521253346|FG001|Overall Study|Adverse Event|1|||
144560991|NCT02517528|521254723|FG000|Overall Study|Withdrawal by Subject|1|||
144560992|NCT01093599|521254726|FG000|Overall Study|Lost to Follow-up|32|||
144560993|NCT01093599|521254727|FG001|Overall Study|Lost to Follow-up|46|||
144560994|NCT01703845|521254728|FG000|Overall Study|Adverse Event|1|||
144560995|NCT01703845|521254729|FG001|Overall Study|Adverse Event|0|||
144560996|NCT01703845|521254728|FG000|Overall Study|Protocol Violation|1|||
144560997|NCT01703845|521254729|FG001|Overall Study|Protocol Violation|0|||
144560998|NCT01703845|521254728|FG000|Overall Study|other than stated above|1|||
144560999|NCT01703845|521254729|FG001|Overall Study|other than stated above|0|||
144561000|NCT01644188|521254730|FG000|Overall Study|Adverse Event|44|||
144561001|NCT01644188|521254731|FG001|Overall Study|Adverse Event|20|||
144561002|NCT01644188|521254730|FG000|Overall Study|Poor compliance to protocol|26|||
144561003|NCT01644188|521254731|FG001|Overall Study|Poor compliance to protocol|14|||
144561004|NCT01644188|521254730|FG000|Overall Study|Physician Decision|1|||
144561005|NCT01644188|521254731|FG001|Overall Study|Physician Decision|3|||
144561006|NCT01644188|521254730|FG000|Overall Study|Participant moved|7|||
144561007|NCT01644188|521254731|FG001|Overall Study|Participant moved|2|||
144561008|NCT01644188|521254730|FG000|Overall Study|Related to auto-injector administration|2|||
144561009|NCT01644188|521254731|FG001|Overall Study|Related to auto-injector administration|2|||
144561010|NCT01644188|521254730|FG000|Overall Study|Consent withdrawn by participant|14|||
144561011|NCT01644188|521254731|FG001|Overall Study|Consent withdrawn by participant|7|||
144561012|NCT01644188|521254730|FG000|Overall Study|Selection criteria finally not met|2|||
144561013|NCT01644188|521254731|FG001|Overall Study|Selection criteria finally not met|0|||
144561014|NCT01644188|521254730|FG000|Overall Study|Lost to Follow-up|1|||
144561015|NCT01644188|521254731|FG001|Overall Study|Lost to Follow-up|0|||
144561016|NCT01644188|521254730|FG000|Overall Study|Death|4|||
144561017|NCT01644188|521254731|FG001|Overall Study|Death|3|||
144561018|NCT01644188|521254730|FG000|Overall Study|Last visit outside protocol visit window|14|||
144561019|NCT01644188|521254731|FG001|Overall Study|Last visit outside protocol visit window|16|||
144561020|NCT01644188|521254730|FG000|Overall Study|Site closure|1|||
144561021|NCT01644188|521254731|FG001|Overall Study|Site closure|1|||
144561022|NCT01644188|521254730|FG000|Overall Study|Other than specified above|6|||
144561023|NCT01644188|521254731|FG001|Overall Study|Other than specified above|7|||
144561024|NCT03991988|521254734|FG000|Overall Study|Withdrawal by Subject|2|||
144561025|NCT03991988|521254735|FG001|Overall Study|Withdrawal by Subject|2|||
144561026|NCT00966979|521254736|FG000|Overall Study|Death|1|||
144561027|NCT00966979|521254736|FG000|Overall Study|Lost to Follow-up|6|||
144561028|NCT00966979|521254736|FG000|Overall Study|Withdrawal by Subject|14|||
144561029|NCT00966979|521254736|FG000|Overall Study|Adverse Event|5|||
144561030|NCT00966979|521254736|FG000|Overall Study|Sponsor terminated early|49|||
144561031|NCT00966979|521254736|FG000|Overall Study|Censored because surgery not done|2|||
144561032|NCT00966979|521254736|FG000|Overall Study|Censored because study device was not implanted|14|||
144561033|NCT00966979|521254736|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
144561034|NCT00630552|521254740|FG000|Overall Study|Adverse Event|0|||
144561035|NCT00630552|521254741|FG001|Overall Study|Adverse Event|1|||
144561036|NCT00630552|521254742|FG002|Overall Study|Adverse Event|5|||
144561037|NCT00630552|521254743|FG003|Overall Study|Adverse Event|4|||
144561038|NCT00630552|521254744|FG004|Overall Study|Adverse Event|2|||
144561039|NCT00630552|521254740|FG000|Overall Study|Disease progression|5|||
144561040|NCT00630552|521254741|FG001|Overall Study|Disease progression|6|||
144561041|NCT00630552|521254742|FG002|Overall Study|Disease progression|27|||
144561042|NCT00630552|521254743|FG003|Overall Study|Disease progression|22|||
144561043|NCT00630552|521254744|FG004|Overall Study|Disease progression|31|||
144561044|NCT00630552|521254740|FG000|Overall Study|Never received IP|0|||
144561045|NCT00630552|521254741|FG001|Overall Study|Never received IP|0|||
144561046|NCT00630552|521254742|FG002|Overall Study|Never received IP|0|||
144561047|NCT00630552|521254743|FG003|Overall Study|Never received IP|2|||
144561048|NCT00630552|521254744|FG004|Overall Study|Never received IP|2|||
144561049|NCT00630552|521254740|FG000|Overall Study|Ineligibility determined|0|||
144561050|NCT00630552|521254741|FG001|Overall Study|Ineligibility determined|0|||
144561051|NCT00630552|521254742|FG002|Overall Study|Ineligibility determined|0|||
144561052|NCT00630552|521254743|FG003|Overall Study|Ineligibility determined|0|||
144561053|NCT00630552|521254744|FG004|Overall Study|Ineligibility determined|1|||
144561054|NCT00630552|521254740|FG000|Overall Study|Protocol Violation|0|||
144561055|NCT00630552|521254741|FG001|Overall Study|Protocol Violation|0|||
144561056|NCT00630552|521254742|FG002|Overall Study|Protocol Violation|0|||
144561057|NCT00630552|521254743|FG003|Overall Study|Protocol Violation|1|||
144561058|NCT00630552|521254744|FG004|Overall Study|Protocol Violation|0|||
144561059|NCT00630552|521254740|FG000|Overall Study|Physician Decision|0|||
144561060|NCT00630552|521254741|FG001|Overall Study|Physician Decision|0|||
144561061|NCT00630552|521254742|FG002|Overall Study|Physician Decision|0|||
144561062|NCT00630552|521254743|FG003|Overall Study|Physician Decision|0|||
144561063|NCT00630552|521254744|FG004|Overall Study|Physician Decision|1|||
144561064|NCT00630552|521254740|FG000|Overall Study|Death|0|||
144561065|NCT00630552|521254741|FG001|Overall Study|Death|0|||
144561066|NCT00630552|521254742|FG002|Overall Study|Death|1|||
144561067|NCT00630552|521254743|FG003|Overall Study|Death|2|||
144561068|NCT00630552|521254744|FG004|Overall Study|Death|2|||
144561069|NCT00630552|521254740|FG000|Overall Study|Withdrawal by Subject|0|||
144561070|NCT00630552|521254741|FG001|Overall Study|Withdrawal by Subject|0|||
144561071|NCT00630552|521254742|FG002|Overall Study|Withdrawal by Subject|0|||
144561072|NCT00630552|521254743|FG003|Overall Study|Withdrawal by Subject|1|||
144561073|NCT00630552|521254744|FG004|Overall Study|Withdrawal by Subject|0|||
144561074|NCT00630552|521254740|FG000|Overall Study|Other|0|||
144561075|NCT00630552|521254741|FG001|Overall Study|Other|0|||
144561076|NCT00630552|521254742|FG002|Overall Study|Other|4|||
144617714|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
144561077|NCT00630552|521254743|FG003|Overall Study|Other|2|||
144561078|NCT00630552|521254744|FG004|Overall Study|Other|0|||
144561079|NCT03226106|521254745|FG000|Overall Study|Withdrawal by Subject|2|||
144561080|NCT03226106|521254746|FG001|Overall Study|Withdrawal by Subject|0|||
144561081|NCT03226106|521254745|FG000|Overall Study|Adverse Event|1|||
144561082|NCT03226106|521254746|FG001|Overall Study|Adverse Event|0|||
144561083|NCT03226106|521254745|FG000|Overall Study|Lost to Follow-up|2|||
144561084|NCT03226106|521254746|FG001|Overall Study|Lost to Follow-up|0|||
144561085|NCT01084239|521254747|FG000|28-Day Follow-up|Lost to Follow-up|4|||
144561086|NCT01084239|521254748|FG001|28-Day Follow-up|Lost to Follow-up|9|||
144561087|NCT00721214|521254749|FG000|Overall Study|Chose another center for transplant|1|||
144561088|NCT00721214|521254749|FG000|Overall Study|Death|3|||
144561089|NCT00983905|521254750|FG000|Theophylline Alone|Adverse Event|1|||
144561090|NCT00983905|521254750|FG000|Colchicine Alone|Adverse Event|2|||
144561091|NCT02396953|521254751|FG000|Overall Study|Withdrawal by Subject|0|||
144561092|NCT02396953|521254752|FG001|Overall Study|Withdrawal by Subject|0|||
144561093|NCT02396953|521254753|FG002|Overall Study|Withdrawal by Subject|1|||
144561094|NCT02396953|521254751|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
144561095|NCT02396953|521254752|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
144561096|NCT02396953|521254753|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
144561097|NCT02396953|521254751|FG000|Overall Study|Personal Reasons|1|||
144561098|NCT02396953|521254752|FG001|Overall Study|Personal Reasons|1|||
144561099|NCT02396953|521254753|FG002|Overall Study|Personal Reasons|0|||
144561100|NCT00488319|521254754|FG000|Overall Study|Adverse Event|1|||
144561101|NCT00488319|521254755|FG001|Overall Study|Adverse Event|2|||
144561102|NCT00488319|521254756|FG002|Overall Study|Adverse Event|23|||
144561103|NCT00488319|521254754|FG000|Overall Study|Lack of Efficacy|6|||
144561104|NCT00488319|521254755|FG001|Overall Study|Lack of Efficacy|12|||
144561105|NCT00488319|521254756|FG002|Overall Study|Lack of Efficacy|27|||
144561106|NCT00488319|521254754|FG000|Overall Study|Lost to Follow-up|3|||
144561107|NCT00488319|521254755|FG001|Overall Study|Lost to Follow-up|5|||
144561108|NCT00488319|521254756|FG002|Overall Study|Lost to Follow-up|16|||
144561109|NCT00488319|521254754|FG000|Overall Study|Withdrawal by Subject|5|||
144561110|NCT00488319|521254755|FG001|Overall Study|Withdrawal by Subject|20|||
144561111|NCT00488319|521254756|FG002|Overall Study|Withdrawal by Subject|44|||
144561112|NCT00488319|521254754|FG000|Overall Study|Other reasons for withdrawal|0|||
144561113|NCT00488319|521254755|FG001|Overall Study|Other reasons for withdrawal|4|||
144561114|NCT00488319|521254756|FG002|Overall Study|Other reasons for withdrawal|12|||
144561115|NCT00875615|521254761|FG000|Overall Study|Withdrawal by Subject|1|||
144561116|NCT00405912|521254763|FG000|Overall Study|Withdrawal by Subject|12|||
144561117|NCT00405912|521254764|FG001|Overall Study|Withdrawal by Subject|11|||
144561118|NCT00405912|521254765|FG002|Overall Study|Withdrawal by Subject|12|||
144561119|NCT00405912|521254763|FG000|Overall Study|Lost to Follow-up|4|||
144561120|NCT00405912|521254764|FG001|Overall Study|Lost to Follow-up|8|||
144561121|NCT00405912|521254765|FG002|Overall Study|Lost to Follow-up|4|||
144561122|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
144561123|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
144561124|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
144561125|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
144561126|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
144561127|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
144561128|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
144561129|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
144561130|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Death|6|||
144561131|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Death|2|||
144561132|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Death|2|||
144561133|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Death|9|||
144561134|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
144561135|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
144561136|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
144561137|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
144561138|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
144561139|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
144561140|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
144561141|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
144561142|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
144561143|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
144561144|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
144561145|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
144561146|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
144561147|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
144561148|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
144561149|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
144561150|NCT03730662|521254766|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
144561151|NCT03730662|521254767|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
144561152|NCT03730662|521254768|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
144561153|NCT03730662|521254769|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
144561154|NCT03730662|521254766|FG000|Variable Treatment Period|Adverse Event|1|||
144561155|NCT03730662|521254767|FG001|Variable Treatment Period|Adverse Event|2|||
144561156|NCT03730662|521254768|FG002|Variable Treatment Period|Adverse Event|0|||
144561157|NCT03730662|521254769|FG003|Variable Treatment Period|Adverse Event|7|||
144561158|NCT03730662|521254766|FG000|Variable Treatment Period|Death|9|||
144203568|NCT03893565|519940364|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
144203569|NCT03893565|519940365|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144561159|NCT03730662|521254767|FG001|Variable Treatment Period|Death|0|||
144561160|NCT03730662|521254768|FG002|Variable Treatment Period|Death|6|||
144561161|NCT03730662|521254769|FG003|Variable Treatment Period|Death|26|||
144203570|NCT03893565|519940366|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
144203571|NCT03893565|519940358|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
144203572|NCT03893565|519940359|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
144203573|NCT03893565|519940360|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
144203574|NCT03893565|519940361|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
144203575|NCT03893565|519940362|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
144203576|NCT03893565|519940363|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
144203577|NCT03893565|519940364|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
144203578|NCT03893565|519940365|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
144203579|NCT03893565|519940366|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
144203580|NCT03893565|519940358|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203581|NCT03893565|519940359|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203582|NCT03893565|519940360|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203583|NCT03893565|519940361|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203584|NCT03893565|519940362|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203585|NCT03893565|519940363|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203586|NCT03893565|519940364|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203587|NCT03893565|519940365|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
144203588|NCT03893565|519940366|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
144203589|NCT03893565|519940358|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203590|NCT03893565|519940359|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203591|NCT03893565|519940360|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203592|NCT03893565|519940361|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203593|NCT03893565|519940362|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203594|NCT03893565|519940363|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203595|NCT03893565|519940364|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203596|NCT03893565|519940365|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
144203597|NCT03893565|519940366|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
144203598|NCT03893565|519940358|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203599|NCT03893565|519940359|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144561162|NCT03730662|521254766|FG000|Variable Treatment Period|Lost to Follow-up|2|||
144561163|NCT03730662|521254767|FG001|Variable Treatment Period|Lost to Follow-up|1|||
144561164|NCT03730662|521254768|FG002|Variable Treatment Period|Lost to Follow-up|4|||
144561165|NCT03730662|521254769|FG003|Variable Treatment Period|Lost to Follow-up|11|||
144561166|NCT03730662|521254766|FG000|Variable Treatment Period|Personal Reason|0|||
144561167|NCT03730662|521254767|FG001|Variable Treatment Period|Personal Reason|2|||
144561168|NCT03730662|521254768|FG002|Variable Treatment Period|Personal Reason|1|||
144561169|NCT03730662|521254769|FG003|Variable Treatment Period|Personal Reason|6|||
144561170|NCT03730662|521254766|FG000|Variable Treatment Period|Physician Decision|0|||
144561171|NCT03730662|521254767|FG001|Variable Treatment Period|Physician Decision|0|||
144728238|NCT01046253|521859401|FG000|Second Intervention|Protocol Violation|0|||
144728239|NCT01046253|521859402|FG001|Second Intervention|Protocol Violation|1|||
144728240|NCT02339909|521859403|FG000|Overall Study|Became ineligible after randomisation|89|||
144728241|NCT02339909|521859404|FG001|Overall Study|Became ineligible after randomisation|63|||
144728242|NCT02339909|521859405|FG002|Overall Study|Became ineligible after randomisation|71|||
144561172|NCT03730662|521254768|FG002|Variable Treatment Period|Physician Decision|0|||
144561173|NCT03730662|521254769|FG003|Variable Treatment Period|Physician Decision|3|||
144561174|NCT03730662|521254766|FG000|Variable Treatment Period|Protocol Violation|0|||
144561175|NCT03730662|521254767|FG001|Variable Treatment Period|Protocol Violation|1|||
144561176|NCT03730662|521254768|FG002|Variable Treatment Period|Protocol Violation|1|||
144561177|NCT03730662|521254769|FG003|Variable Treatment Period|Protocol Violation|1|||
144561178|NCT03730662|521254766|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
144561179|NCT03730662|521254767|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
144561180|NCT03730662|521254768|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
144561181|NCT03730662|521254769|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
144561182|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
144561183|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
144561184|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
144561185|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
144561186|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Death|0|||
144561187|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Death|1|||
144728243|NCT01471522|521859406|FG000|Overall Study|Withdrawal by Subject|28|||
144203600|NCT03893565|519940360|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203601|NCT03893565|519940361|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203602|NCT03893565|519940362|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203603|NCT03893565|519940363|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203604|NCT03893565|519940364|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203605|NCT03893565|519940365|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
144203606|NCT03893565|519940366|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
144203607|NCT03893565|519940358|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203608|NCT03893565|519940359|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203609|NCT03893565|519940360|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203610|NCT03893565|519940361|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203611|NCT03893565|519940362|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203612|NCT03893565|519940363|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144262507|NCT00661089|520161452|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
144262508|NCT00661089|520161453|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
144262509|NCT01443858|520161460|FG000|Overall Study|Withdrawal by Subject|9|||
144561188|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
144561189|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
144561190|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
144561191|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
144561192|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
144561193|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
144561194|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
144561195|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
144561196|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
144561197|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
144561198|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
144561199|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
144561200|NCT01309243|521254770|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
144561201|NCT01309243|521254771|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
144561202|NCT01309243|521254770|FG000|Extension Phase|Lost to Follow-up|6|||
144561203|NCT01309243|521254771|FG001|Extension Phase|Lost to Follow-up|0|||
144561204|NCT00632931|521254772|FG000|Part 1, Period 1|Protocol Violation|1|||
144561205|NCT00632931|521254773|FG001|Part 1, Period 1|Protocol Violation|0|||
144561206|NCT00632931|521254774|FG002|Part 1, Period 1|Protocol Violation|0|||
144561207|NCT00632931|521254772|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
144561208|NCT00632931|521254773|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
144561209|NCT00632931|521254774|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
144561210|NCT00632931|521254772|FG000|Part 2|Adverse Event|0|||
144561211|NCT00632931|521254773|FG001|Part 2|Adverse Event|0|||
144561212|NCT00632931|521254774|FG002|Part 2|Adverse Event|3|||
144561213|NCT00632931|521254772|FG000|Part 2|Death|0|||
144561214|NCT00632931|521254773|FG001|Part 2|Death|0|||
144561215|NCT00632931|521254774|FG002|Part 2|Death|1|||
144561216|NCT00632931|521254772|FG000|Part 2|Lack of Efficacy|0|||
144561217|NCT00632931|521254773|FG001|Part 2|Lack of Efficacy|0|||
144561218|NCT00632931|521254774|FG002|Part 2|Lack of Efficacy|17|||
144617715|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
144617716|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
144617717|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
144617718|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
144617719|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
144617720|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
144561219|NCT00632931|521254772|FG000|Part 2|Withdrawal by Subject|0|||
144561220|NCT00632931|521254773|FG001|Part 2|Withdrawal by Subject|0|||
144561221|NCT00632931|521254774|FG002|Part 2|Withdrawal by Subject|3|||
144561222|NCT01402063|521254777|FG000|Overall Study|Withdrawal by Subject|3|||
144561223|NCT01402063|521254778|FG001|Overall Study|Withdrawal by Subject|3|||
144561224|NCT05153499|521254784|FG000|Overall Study|Withdrawal by Subject|1|||
144561225|NCT05153499|521254785|FG001|Overall Study|Withdrawal by Subject|0|||
144561226|NCT05153499|521254784|FG000|Overall Study|Clinical Hold|1|||
144561227|NCT05153499|521254785|FG001|Overall Study|Clinical Hold|0|||
144561228|NCT05153499|521254784|FG000|Overall Study|Study Termination|6|||
144561229|NCT05153499|521254785|FG001|Overall Study|Study Termination|5|||
144561230|NCT00468858|521254793|FG000|Overall Study|Adverse Event|0|||
144561231|NCT00468858|521254794|FG001|Overall Study|Adverse Event|1|||
144561232|NCT00468858|521254795|FG002|Overall Study|Adverse Event|0|||
144561233|NCT00468858|521254793|FG000|Overall Study|Withdrawal by Subject|7|||
144561234|NCT00468858|521254794|FG001|Overall Study|Withdrawal by Subject|4|||
144561235|NCT00468858|521254795|FG002|Overall Study|Withdrawal by Subject|5|||
144561236|NCT00468858|521254793|FG000|Overall Study|Relocation|1|||
144561237|NCT00468858|521254794|FG001|Overall Study|Relocation|3|||
144561238|NCT00468858|521254795|FG002|Overall Study|Relocation|3|||
144561239|NCT00468858|521254793|FG000|Overall Study|Lost to Follow-up|1|||
144561240|NCT00468858|521254794|FG001|Overall Study|Lost to Follow-up|2|||
144561241|NCT00468858|521254795|FG002|Overall Study|Lost to Follow-up|5|||
144561242|NCT00468858|521254793|FG000|Overall Study|Other|0|||
144561243|NCT00468858|521254794|FG001|Overall Study|Other|0|||
144561244|NCT00468858|521254795|FG002|Overall Study|Other|1|||
144561245|NCT01885936|521254798|FG000|Overall Study|Withdrawal by Subject|1|||
144561246|NCT01885936|521254799|FG001|Overall Study|Withdrawal by Subject|0|||
144561247|NCT00317603|521254800|FG000|Overall Study|Progressive Disease|3|||
144561248|NCT00523549|521254803|FG000|Overall Study|Adverse Event|6|||
144561249|NCT00523549|521254804|FG001|Overall Study|Adverse Event|3|||
144561250|NCT00523549|521254803|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144561251|NCT00523549|521254804|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144561252|NCT00523549|521254803|FG000|Overall Study|Protocol Deviation|3|||
144561253|NCT00523549|521254804|FG001|Overall Study|Protocol Deviation|1|||
144561254|NCT00523549|521254803|FG000|Overall Study|Patient withdrew consent|7|||
144561255|NCT00523549|521254804|FG001|Overall Study|Patient withdrew consent|6|||
144561256|NCT00523549|521254803|FG000|Overall Study|Lost to Follow-up|3|||
144561257|NCT00523549|521254804|FG001|Overall Study|Lost to Follow-up|5|||
144561258|NCT00427778|521254809|FG000|First Intervention (4 Weeks)|no longer interested|1|||
144561259|NCT00427778|521254810|FG001|First Intervention (4 Weeks)|no longer interested|0|||
144561260|NCT00427778|521254809|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
144561261|NCT00427778|521254810|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
144561262|NCT00427778|521254809|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
144561263|NCT00427778|521254810|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
144561264|NCT00427778|521254809|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
144561265|NCT00427778|521254810|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
144561266|NCT00439647|521254812|FG000|Overall Study|Withdrawal by Subject|25|||
144561267|NCT00439647|521254813|FG001|Overall Study|Withdrawal by Subject|22|||
144561268|NCT00439647|521254812|FG000|Overall Study|Death|15|||
144561269|NCT00439647|521254813|FG001|Overall Study|Death|18|||
144561270|NCT00439647|521254812|FG000|Overall Study|Adverse Event|11|||
144561271|NCT00439647|521254813|FG001|Overall Study|Adverse Event|11|||
144561272|NCT00439647|521254812|FG000|Overall Study|Lost to Follow-up|4|||
144561273|NCT00439647|521254813|FG001|Overall Study|Lost to Follow-up|12|||
144561274|NCT00439647|521254812|FG000|Overall Study|Protocol Violation|3|||
144561275|NCT00439647|521254813|FG001|Overall Study|Protocol Violation|4|||
144561276|NCT00439647|521254812|FG000|Overall Study|Lack of Efficacy|0|||
144561277|NCT00439647|521254813|FG001|Overall Study|Lack of Efficacy|4|||
144561278|NCT00843115|521254814|FG000|Overall Study|Death|4|||
144561279|NCT00843115|521254814|FG000|Overall Study|Adverse Event|30|||
144561280|NCT00843115|521254814|FG000|Overall Study|Lost to Follow-up|4|||
144561281|NCT00843115|521254814|FG000|Overall Study|Withdrawal by Subject|17|||
144561282|NCT00843115|521254814|FG000|Overall Study|Family wanted meds stopped|1|||
144561283|NCT00843115|521254814|FG000|Overall Study|Family does not want continuation|1|||
144561284|NCT00843115|521254814|FG000|Overall Study|Patient forgot to take meds|1|||
144561285|NCT00843115|521254814|FG000|Overall Study|Does not meet entrance criteria|1|||
144561286|NCT00843115|521254814|FG000|Overall Study|Physician Decision|1|||
144561287|NCT00843115|521254814|FG000|Overall Study|Family discontinued meds|1|||
144561288|NCT00843115|521254814|FG000|Overall Study|patient took for 2 days then stopped|1|||
144561289|NCT00843115|521254814|FG000|Overall Study|patient never took the medication|1|||
144561290|NCT00843115|521254814|FG000|Overall Study|hospitalized due to deterioration|1|||
144561291|NCT00843115|521254814|FG000|Overall Study|week 12 not done|1|||
144561292|NCT00843115|521254814|FG000|Overall Study|Syndrome De Glissement|1|||
144203613|NCT03893565|519940364|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203614|NCT03893565|519940365|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
144203615|NCT03893565|519940366|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
144203616|NCT00851318|519940367|FG000|Overall Study|Withdrawal by Subject|7|||
144203617|NCT00851318|519940368|FG001|Overall Study|Withdrawal by Subject|1|||
144203618|NCT00851318|519940369|FG002|Overall Study|Withdrawal by Subject|5|||
144203619|NCT00851318|519940370|FG003|Overall Study|Withdrawal by Subject|3|||
144203620|NCT00851318|519940367|FG000|Overall Study|Adverse Event|13|||
144561293|NCT00225277|521254815|FG000|Overall Study|Adverse Event|30|||
144561294|NCT00225277|521254816|FG001|Overall Study|Adverse Event|34|||
144561295|NCT00225277|521254815|FG000|Overall Study|Lack of Efficacy|4|||
144561296|NCT00225277|521254816|FG001|Overall Study|Lack of Efficacy|1|||
144561297|NCT00225277|521254815|FG000|Overall Study|Lost to Follow-up|4|||
144561298|NCT00225277|521254816|FG001|Overall Study|Lost to Follow-up|6|||
144203621|NCT00851318|519940368|FG001|Overall Study|Adverse Event|2|||
144561299|NCT00225277|521254815|FG000|Overall Study|Physician Decision|6|||
144561300|NCT00225277|521254816|FG001|Overall Study|Physician Decision|8|||
144561301|NCT00225277|521254815|FG000|Overall Study|Protocol Violation|6|||
144561302|NCT00225277|521254816|FG001|Overall Study|Protocol Violation|3|||
144561303|NCT00225277|521254815|FG000|Overall Study|Withdrawal by Subject|40|||
144561304|NCT00225277|521254816|FG001|Overall Study|Withdrawal by Subject|34|||
144728244|NCT01471522|521859407|FG001|Overall Study|Withdrawal by Subject|22|||
144728245|NCT01471522|521859406|FG000|Overall Study|Lost to Follow-up|36|||
144728246|NCT01471522|521859407|FG001|Overall Study|Lost to Follow-up|26|||
144728247|NCT01101022|521861177|FG000|Overall Study|Adverse Event|6|||
144728248|NCT01101022|521861178|FG001|Overall Study|Adverse Event|2|||
144728249|NCT01101022|521861177|FG000|Overall Study|Protocol Violation|4|||
144728250|NCT01101022|521861178|FG001|Overall Study|Protocol Violation|3|||
144728251|NCT01101022|521861177|FG000|Overall Study|Withdrawal by Subject|3|||
144561305|NCT00225277|521254815|FG000|Overall Study|Other|7|||
144561306|NCT00225277|521254816|FG001|Overall Study|Other|9|||
144561307|NCT03891641|521254821|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
144561308|NCT03891641|521254822|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
144561309|NCT00784277|521254823|FG000|IR Treatment|Adverse Event|4|||
144561310|NCT00784277|521254824|FG001|IR Treatment|Adverse Event|8|||
144561311|NCT00784277|521254825|FG002|IR Treatment|Adverse Event|19|||
144561312|NCT00784277|521254826|FG003|IR Treatment|Adverse Event|35|||
144561313|NCT00784277|521254827|FG004|IR Treatment|Adverse Event|0|||
144561314|NCT00784277|521254828|FG005|IR Treatment|Adverse Event|0|||
144561315|NCT00784277|521254829|FG006|IR Treatment|Adverse Event|0|||
144561316|NCT00784277|521254823|FG000|IR Treatment|Lack of Efficacy|4|||
144561317|NCT00784277|521254824|FG001|IR Treatment|Lack of Efficacy|4|||
144561318|NCT00784277|521254825|FG002|IR Treatment|Lack of Efficacy|1|||
144561319|NCT00784277|521254826|FG003|IR Treatment|Lack of Efficacy|0|||
144561320|NCT00784277|521254827|FG004|IR Treatment|Lack of Efficacy|0|||
144561321|NCT00784277|521254828|FG005|IR Treatment|Lack of Efficacy|0|||
144561322|NCT00784277|521254829|FG006|IR Treatment|Lack of Efficacy|0|||
144561323|NCT00784277|521254823|FG000|IR Treatment|Lost to Follow-up|1|||
144561324|NCT00784277|521254824|FG001|IR Treatment|Lost to Follow-up|0|||
144561325|NCT00784277|521254825|FG002|IR Treatment|Lost to Follow-up|1|||
144561326|NCT00784277|521254826|FG003|IR Treatment|Lost to Follow-up|0|||
144561327|NCT00784277|521254827|FG004|IR Treatment|Lost to Follow-up|0|||
144561328|NCT00784277|521254828|FG005|IR Treatment|Lost to Follow-up|0|||
144561329|NCT00784277|521254829|FG006|IR Treatment|Lost to Follow-up|0|||
144561330|NCT00784277|521254823|FG000|IR Treatment|Withdrawal by Subject|5|||
144561331|NCT00784277|521254824|FG001|IR Treatment|Withdrawal by Subject|1|||
144561332|NCT00784277|521254825|FG002|IR Treatment|Withdrawal by Subject|4|||
144561333|NCT00784277|521254826|FG003|IR Treatment|Withdrawal by Subject|6|||
144561334|NCT00784277|521254827|FG004|IR Treatment|Withdrawal by Subject|0|||
144561335|NCT00784277|521254828|FG005|IR Treatment|Withdrawal by Subject|0|||
144561336|NCT00784277|521254829|FG006|IR Treatment|Withdrawal by Subject|0|||
144728252|NCT01101022|521861178|FG001|Overall Study|Withdrawal by Subject|8|||
144728253|NCT01101022|521861177|FG000|Overall Study|Lost to Follow-up|1|||
144561337|NCT00784277|521254823|FG000|IR Treatment|Resolution Of Pain|0|||
144561338|NCT00784277|521254824|FG001|IR Treatment|Resolution Of Pain|1|||
144561339|NCT00784277|521254825|FG002|IR Treatment|Resolution Of Pain|0|||
144561340|NCT00784277|521254826|FG003|IR Treatment|Resolution Of Pain|0|||
144561341|NCT00784277|521254827|FG004|IR Treatment|Resolution Of Pain|0|||
144561342|NCT00784277|521254828|FG005|IR Treatment|Resolution Of Pain|0|||
144561343|NCT00784277|521254829|FG006|IR Treatment|Resolution Of Pain|0|||
144561344|NCT00784277|521254823|FG000|IR Treatment|Other|2|||
144561345|NCT00784277|521254824|FG001|IR Treatment|Other|3|||
144561346|NCT00784277|521254825|FG002|IR Treatment|Other|3|||
144561347|NCT00784277|521254826|FG003|IR Treatment|Other|2|||
144561348|NCT00784277|521254827|FG004|IR Treatment|Other|0|||
144561349|NCT00784277|521254828|FG005|IR Treatment|Other|0|||
144561350|NCT00784277|521254829|FG006|IR Treatment|Other|0|||
144561351|NCT00784277|521254823|FG000|ER Treatment|Adverse Event|0|||
144561352|NCT00784277|521254824|FG001|ER Treatment|Adverse Event|0|||
144561353|NCT00784277|521254825|FG002|ER Treatment|Adverse Event|0|||
144561354|NCT00784277|521254826|FG003|ER Treatment|Adverse Event|0|||
144561355|NCT00784277|521254827|FG004|ER Treatment|Adverse Event|1|||
144561356|NCT00784277|521254828|FG005|ER Treatment|Adverse Event|7|||
144561357|NCT00784277|521254829|FG006|ER Treatment|Adverse Event|7|||
144561358|NCT00784277|521254823|FG000|ER Treatment|Lack of Efficacy|0|||
144561359|NCT00784277|521254824|FG001|ER Treatment|Lack of Efficacy|0|||
144561360|NCT00784277|521254825|FG002|ER Treatment|Lack of Efficacy|0|||
144561361|NCT00784277|521254826|FG003|ER Treatment|Lack of Efficacy|0|||
144561362|NCT00784277|521254827|FG004|ER Treatment|Lack of Efficacy|3|||
144561363|NCT00784277|521254828|FG005|ER Treatment|Lack of Efficacy|4|||
144561364|NCT00784277|521254829|FG006|ER Treatment|Lack of Efficacy|0|||
144561365|NCT00784277|521254823|FG000|ER Treatment|Lost to Follow-up|0|||
144561366|NCT00784277|521254824|FG001|ER Treatment|Lost to Follow-up|0|||
144561367|NCT00784277|521254825|FG002|ER Treatment|Lost to Follow-up|0|||
144561368|NCT00784277|521254826|FG003|ER Treatment|Lost to Follow-up|0|||
144203622|NCT00851318|519940369|FG002|Overall Study|Adverse Event|9|||
144561369|NCT00784277|521254827|FG004|ER Treatment|Lost to Follow-up|0|||
144728254|NCT01101022|521861178|FG001|Overall Study|Lost to Follow-up|4|||
144728255|NCT01101022|521861177|FG000|Overall Study|Lack of Efficacy|0|||
144561370|NCT00784277|521254828|FG005|ER Treatment|Lost to Follow-up|2|||
144561371|NCT00784277|521254829|FG006|ER Treatment|Lost to Follow-up|0|||
144561372|NCT00784277|521254823|FG000|ER Treatment|Withdrawal by Subject|0|||
144561373|NCT00784277|521254824|FG001|ER Treatment|Withdrawal by Subject|0|||
144561374|NCT00784277|521254825|FG002|ER Treatment|Withdrawal by Subject|0|||
144561375|NCT00784277|521254826|FG003|ER Treatment|Withdrawal by Subject|0|||
144561376|NCT00784277|521254827|FG004|ER Treatment|Withdrawal by Subject|2|||
144561377|NCT00784277|521254828|FG005|ER Treatment|Withdrawal by Subject|5|||
144561378|NCT00784277|521254829|FG006|ER Treatment|Withdrawal by Subject|3|||
144561379|NCT00784277|521254823|FG000|ER Treatment|Study Medication Non-Compliant|0|||
144561380|NCT00784277|521254824|FG001|ER Treatment|Study Medication Non-Compliant|0|||
144561381|NCT00784277|521254825|FG002|ER Treatment|Study Medication Non-Compliant|0|||
144561382|NCT00784277|521254826|FG003|ER Treatment|Study Medication Non-Compliant|0|||
144561383|NCT00784277|521254827|FG004|ER Treatment|Study Medication Non-Compliant|2|||
144561384|NCT00784277|521254828|FG005|ER Treatment|Study Medication Non-Compliant|3|||
144561385|NCT00784277|521254829|FG006|ER Treatment|Study Medication Non-Compliant|3|||
144561386|NCT00784277|521254823|FG000|ER Treatment|Other|0|||
144561387|NCT00784277|521254824|FG001|ER Treatment|Other|0|||
144561388|NCT00784277|521254825|FG002|ER Treatment|Other|0|||
144561389|NCT00784277|521254826|FG003|ER Treatment|Other|0|||
144561390|NCT00784277|521254827|FG004|ER Treatment|Other|1|||
144561391|NCT00784277|521254828|FG005|ER Treatment|Other|3|||
144561392|NCT00784277|521254829|FG006|ER Treatment|Other|2|||
144561393|NCT01093222|521254830|FG000|Overall Study|Ineligible|6|||
144561394|NCT01093222|521254830|FG000|Overall Study|Adverse Event|7|||
144561395|NCT01093222|521254830|FG000|Overall Study|Progression/relapse|24|||
144561396|NCT01093222|521254830|FG000|Overall Study|Death|2|||
144561397|NCT01093222|521254830|FG000|Overall Study|Not protocol specified|1|||
144561398|NCT03927222|521254836|FG000|Overall Study|Progression|3|||
144561399|NCT03927222|521254836|FG000|Overall Study|CMV testing results inconclusive|1|||
144561400|NCT03927222|521254836|FG000|Overall Study|Unable to generate enough vaccines|1|||
144561401|NCT03927222|521254836|FG000|Overall Study|Early study termination|1|||
144561402|NCT04414397|521254837|FG000|Control Period|Withdrawal by Subject|2|||
144561403|NCT04414397|521254838|FG001|Control Period|Withdrawal by Subject|2|||
144561404|NCT04414397|521254837|FG000|Control Period|Lost to Follow-up|0|||
144561405|NCT04414397|521254838|FG001|Control Period|Lost to Follow-up|4|||
144561406|NCT04414397|521254837|FG000|Control Period|Protocol deviation|0|||
144561407|NCT04414397|521254838|FG001|Control Period|Protocol deviation|1|||
144561408|NCT04414397|521254837|FG000|Post-Control Period|Withdrawal by Subject|3|||
144561409|NCT04414397|521254838|FG001|Post-Control Period|Withdrawal by Subject|6|||
144561410|NCT04414397|521254837|FG000|Post-Control Period|Lost to Follow-up|4|||
144561411|NCT04414397|521254838|FG001|Post-Control Period|Lost to Follow-up|9|||
144561412|NCT04414397|521254837|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
144561413|NCT04414397|521254838|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
144561414|NCT04414397|521254837|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
144561415|NCT04414397|521254838|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
144561416|NCT01204775|521254840|FG000|Overall Study|Poor/non-compliance|0|||
144561417|NCT01204775|521254841|FG001|Overall Study|Poor/non-compliance|1|||
144561418|NCT01204775|521254840|FG000|Overall Study|Withdrawal by Subject|1|||
144561419|NCT01204775|521254841|FG001|Overall Study|Withdrawal by Subject|0|||
144561420|NCT01679613|521254842|FG000|Overall Study|other than stated above|0|||
144561421|NCT01679613|521254843|FG001|Overall Study|other than stated above|1|||
144561422|NCT01679613|521254844|FG002|Overall Study|other than stated above|2|||
144561423|NCT01679613|521254845|FG003|Overall Study|other than stated above|2|||
144561424|NCT01374971|521254846|FG000|Overall Study|Withdrawal by Subject|1|||
144561425|NCT00509925|521254848|FG000|Overall Study|Personal reasons|0|||
144561426|NCT00509925|521254849|FG001|Overall Study|Personal reasons|1|||
144561427|NCT00919061|521254850|FG000|Overall Study|Adverse Event|1|||
144561428|NCT00919061|521254850|FG000|Overall Study|Withdrawal by Subject|1|||
144561429|NCT00560313|521256349|FG000|Overall Study|Adverse Events or Death|2|||
144561430|NCT00560313|521256349|FG000|Overall Study|Withdrawal by Subject|2|||
144561431|NCT00560313|521256349|FG000|Overall Study|Lost to Follow-up|1|||
144561432|NCT00560313|521256349|FG000|Overall Study|Protocol Violation|1|||
144561433|NCT00113269|521256350|FG000|Overall Study|Not transplanted, donor issues|4|||
144561434|NCT00113269|521256351|FG001|Overall Study|Not transplanted, donor issues|0|||
144561435|NCT00113269|521256352|FG002|Overall Study|Not transplanted, donor issues|2|||
144561436|NCT00113269|521256353|FG003|Overall Study|Not transplanted, donor issues|2|||
144561437|NCT00113269|521256350|FG000|Overall Study|Not transplanted, recipient issues|2|||
144561438|NCT00113269|521256351|FG001|Overall Study|Not transplanted, recipient issues|1|||
144561439|NCT00113269|521256352|FG002|Overall Study|Not transplanted, recipient issues|7|||
144561440|NCT00113269|521256353|FG003|Overall Study|Not transplanted, recipient issues|4|||
144561441|NCT00113269|521256350|FG000|Overall Study|Early graft loss, technical|0|||
144561442|NCT00113269|521256351|FG001|Overall Study|Early graft loss, technical|0|||
144561443|NCT00113269|521256352|FG002|Overall Study|Early graft loss, technical|2|||
144561444|NCT00113269|521256353|FG003|Overall Study|Early graft loss, technical|0|||
144561445|NCT00113269|521256350|FG000|Overall Study|Death in operating room|0|||
144561446|NCT00113269|521256351|FG001|Overall Study|Death in operating room|0|||
144561447|NCT00113269|521256352|FG002|Overall Study|Death in operating room|0|||
144728256|NCT01101022|521861178|FG001|Overall Study|Lack of Efficacy|7|||
144203623|NCT00851318|519940370|FG003|Overall Study|Adverse Event|12|||
144561448|NCT00113269|521256353|FG003|Overall Study|Death in operating room|1|||
144561449|NCT00113269|521256350|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
144561450|NCT00113269|521256351|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
144561451|NCT00113269|521256352|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
144561452|NCT00113269|521256353|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
144561453|NCT00113269|521256350|FG000|Overall Study|Adverse Event|2|||
144561454|NCT00113269|521256351|FG001|Overall Study|Adverse Event|7|||
144561455|NCT00113269|521256352|FG002|Overall Study|Adverse Event|11|||
144561456|NCT00113269|521256353|FG003|Overall Study|Adverse Event|7|||
144561457|NCT00113269|521256350|FG000|Overall Study|Withdrawal by Subject|4|||
144203624|NCT00851318|519940367|FG000|Overall Study|Pregnancy|0|||
144203625|NCT00851318|519940368|FG001|Overall Study|Pregnancy|0|||
144203626|NCT00851318|519940369|FG002|Overall Study|Pregnancy|1|||
144203627|NCT00851318|519940370|FG003|Overall Study|Pregnancy|1|||
144561458|NCT00113269|521256351|FG001|Overall Study|Withdrawal by Subject|3|||
144203628|NCT00851318|519940367|FG000|Overall Study|Lack of Efficacy|8|||
144203629|NCT00851318|519940368|FG001|Overall Study|Lack of Efficacy|2|||
144203630|NCT00851318|519940369|FG002|Overall Study|Lack of Efficacy|4|||
144203631|NCT00851318|519940370|FG003|Overall Study|Lack of Efficacy|2|||
144203632|NCT00851318|519940367|FG000|Overall Study|Non-compliance with Study Procedures|2|||
144203633|NCT00851318|519940368|FG001|Overall Study|Non-compliance with Study Procedures|0|||
144203634|NCT00851318|519940369|FG002|Overall Study|Non-compliance with Study Procedures|1|||
144203635|NCT00851318|519940370|FG003|Overall Study|Non-compliance with Study Procedures|0|||
144203636|NCT00851318|519940367|FG000|Overall Study|Physician Decision|0|||
144203637|NCT00851318|519940368|FG001|Overall Study|Physician Decision|0|||
144203638|NCT00851318|519940369|FG002|Overall Study|Physician Decision|1|||
144203639|NCT00851318|519940370|FG003|Overall Study|Physician Decision|1|||
144203640|NCT02695537|519940371|FG000|Overall Study|Adverse Event|3|||
144203641|NCT02695537|519940371|FG000|Overall Study|Lack of Efficacy|28|||
144203642|NCT02695537|519940371|FG000|Overall Study|Withdrawal by Subject|4|||
144203643|NCT02695537|519940371|FG000|Overall Study|Protocol Violation|3|||
144203644|NCT00809159|519940372|FG000|Part 1|Adverse Event|1|||
144203645|NCT00809159|519940373|FG001|Part 1|Adverse Event|1|||
144203646|NCT00809159|519940374|FG002|Part 1|Adverse Event|0|||
144203647|NCT00809159|519940375|FG003|Part 1|Adverse Event|0|||
144203648|NCT00809159|519940376|FG004|Part 1|Adverse Event|0|||
144203649|NCT00809159|519940377|FG005|Part 1|Adverse Event|0|||
144203650|NCT00809159|519940372|FG000|Part 1|Lost to Follow-up|1|||
144203651|NCT00809159|519940373|FG001|Part 1|Lost to Follow-up|0|||
144203652|NCT00809159|519940374|FG002|Part 1|Lost to Follow-up|0|||
144203653|NCT00809159|519940375|FG003|Part 1|Lost to Follow-up|0|||
144203654|NCT00809159|519940376|FG004|Part 1|Lost to Follow-up|0|||
144203655|NCT00809159|519940377|FG005|Part 1|Lost to Follow-up|0|||
144203656|NCT00809159|519940372|FG000|Part 1|Withdrawal by Subject|3|||
144203657|NCT00809159|519940373|FG001|Part 1|Withdrawal by Subject|1|||
144203658|NCT00809159|519940374|FG002|Part 1|Withdrawal by Subject|0|||
144203659|NCT00809159|519940375|FG003|Part 1|Withdrawal by Subject|0|||
144203660|NCT00809159|519940376|FG004|Part 1|Withdrawal by Subject|0|||
144561459|NCT00113269|521256352|FG002|Overall Study|Withdrawal by Subject|4|||
144561460|NCT00113269|521256353|FG003|Overall Study|Withdrawal by Subject|2|||
144561461|NCT00113269|521256350|FG000|Overall Study|Graft loss|6|||
144561462|NCT00113269|521256351|FG001|Overall Study|Graft loss|6|||
144561463|NCT00113269|521256352|FG002|Overall Study|Graft loss|4|||
144561464|NCT00113269|521256353|FG003|Overall Study|Graft loss|9|||
144561465|NCT00113269|521256350|FG000|Overall Study|Protocol Violation|1|||
144561466|NCT00113269|521256351|FG001|Overall Study|Protocol Violation|0|||
144561467|NCT00113269|521256352|FG002|Overall Study|Protocol Violation|4|||
144561468|NCT00113269|521256353|FG003|Overall Study|Protocol Violation|2|||
144561469|NCT00113269|521256350|FG000|Overall Study|Lost to Follow-up|2|||
144561470|NCT00113269|521256351|FG001|Overall Study|Lost to Follow-up|3|||
144561471|NCT00113269|521256352|FG002|Overall Study|Lost to Follow-up|6|||
144561472|NCT00113269|521256353|FG003|Overall Study|Lost to Follow-up|3|||
144203661|NCT00809159|519940377|FG005|Part 1|Withdrawal by Subject|0|||
144203662|NCT00809159|519940372|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
144203663|NCT00809159|519940373|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
144561473|NCT00113269|521256350|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
144561474|NCT00113269|521256351|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
144728257|NCT01101022|521861177|FG000|Overall Study|Sponsor decision|1|||
144203664|NCT00809159|519940374|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
144203665|NCT00809159|519940375|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
144203666|NCT00809159|519940376|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
144203667|NCT00809159|519940377|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
144203668|NCT00809159|519940372|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
144203669|NCT00809159|519940373|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
144203670|NCT00809159|519940374|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
144203671|NCT00809159|519940375|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
144203672|NCT00809159|519940376|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
144728258|NCT01101022|521861178|FG001|Overall Study|Sponsor decision|1|||
144561475|NCT00113269|521256352|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
144561476|NCT00113269|521256353|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
144561477|NCT00113269|521256350|FG000|Overall Study|Discontinued due to rejection|0|||
144561478|NCT00113269|521256351|FG001|Overall Study|Discontinued due to rejection|0|||
144561479|NCT00113269|521256352|FG002|Overall Study|Discontinued due to rejection|1|||
144561480|NCT00113269|521256353|FG003|Overall Study|Discontinued due to rejection|0|||
144561481|NCT00113269|521256350|FG000|Overall Study|Moved|0|||
144561482|NCT00113269|521256351|FG001|Overall Study|Moved|1|||
144561483|NCT00113269|521256352|FG002|Overall Study|Moved|0|||
144561484|NCT00113269|521256353|FG003|Overall Study|Moved|3|||
144561485|NCT00113269|521256350|FG000|Overall Study|Received pancreas transplant|0|||
144561486|NCT00113269|521256351|FG001|Overall Study|Received pancreas transplant|0|||
144561487|NCT00113269|521256352|FG002|Overall Study|Received pancreas transplant|0|||
144561488|NCT00113269|521256353|FG003|Overall Study|Received pancreas transplant|2|||
144561489|NCT00113269|521256350|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
144561490|NCT00113269|521256351|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
144561491|NCT00113269|521256352|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
144561492|NCT00113269|521256353|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
144561493|NCT00113269|521256350|FG000|Overall Study|Did not meet eligibility criteria|1|||
144561494|NCT00113269|521256351|FG001|Overall Study|Did not meet eligibility criteria|0|||
144561495|NCT00113269|521256352|FG002|Overall Study|Did not meet eligibility criteria|0|||
144561496|NCT00113269|521256353|FG003|Overall Study|Did not meet eligibility criteria|1|||
144561497|NCT00113269|521256350|FG000|Overall Study|Unable to return for follow up|2|||
144561498|NCT00113269|521256351|FG001|Overall Study|Unable to return for follow up|1|||
144561499|NCT00113269|521256352|FG002|Overall Study|Unable to return for follow up|0|||
144561500|NCT00113269|521256353|FG003|Overall Study|Unable to return for follow up|0|||
144561501|NCT00853372|521256358|FG000|Overall Study|Death|30|||
144561502|NCT00853372|521256359|FG001|Overall Study|Death|26|||
144561503|NCT00853372|521256358|FG000|Overall Study|Lost to Follow-up|1|||
144561504|NCT00853372|521256359|FG001|Overall Study|Lost to Follow-up|2|||
144561505|NCT00853372|521256358|FG000|Overall Study|Full Consent Withdrawn|1|||
144561506|NCT00853372|521256359|FG001|Overall Study|Full Consent Withdrawn|1|||
144561507|NCT01268098|521256360|FG000|Overall Study|Adverse Event|1|||
144561508|NCT01268098|521256361|FG001|Overall Study|Adverse Event|0|||
144561509|NCT01845649|521256363|FG000|Overall Study|Adverse Event|7|||
144561510|NCT01845649|521256364|FG001|Overall Study|Adverse Event|10|||
144561511|NCT01845649|521256363|FG000|Overall Study|Lack of Efficacy|1|||
144561512|NCT01845649|521256364|FG001|Overall Study|Lack of Efficacy|1|||
144561513|NCT01845649|521256363|FG000|Overall Study|Lost to Follow-up|2|||
144561514|NCT01845649|521256364|FG001|Overall Study|Lost to Follow-up|2|||
144561515|NCT01845649|521256363|FG000|Overall Study|Withdrew Consent|12|||
144561516|NCT01845649|521256364|FG001|Overall Study|Withdrew Consent|4|||
144561517|NCT01845649|521256363|FG000|Overall Study|Protocol Deviation|7|||
144561518|NCT01845649|521256364|FG001|Overall Study|Protocol Deviation|4|||
144561519|NCT01845649|521256363|FG000|Overall Study|Reason not Specified|2|||
144561520|NCT01845649|521256364|FG001|Overall Study|Reason not Specified|1|||
144561521|NCT01222533|521256366|FG000|Overall Study|Adverse Event|5|||
144561522|NCT01222533|521256366|FG000|Overall Study|Withdrawal by Subject|5|||
144561523|NCT01222533|521256366|FG000|Overall Study|Other|4|||
144561524|NCT01947517|521256367|FG000|Overall Study|Withdrawal by Subject|1|||
144561525|NCT01947517|521256368|FG001|Overall Study|Withdrawal by Subject|1|||
144561526|NCT03418493|521256369|FG000|Overall Study|Adverse Event|1|||
144561527|NCT03418493|521256370|FG001|Overall Study|Adverse Event|0|||
144561528|NCT03418493|521256371|FG002|Overall Study|Adverse Event|0|||
144561529|NCT03418493|521256372|FG003|Overall Study|Adverse Event|0|||
144561530|NCT03418493|521256373|FG004|Overall Study|Adverse Event|0|||
144561531|NCT03418493|521256374|FG005|Overall Study|Adverse Event|0|||
144561532|NCT03418493|521256375|FG006|Overall Study|Adverse Event|0|||
144561533|NCT03418493|521256376|FG007|Overall Study|Adverse Event|0|||
144561534|NCT03418493|521256377|FG008|Overall Study|Adverse Event|0|||
144561535|NCT03418493|521256378|FG009|Overall Study|Adverse Event|0|||
144561536|NCT03418493|521256379|FG010|Overall Study|Adverse Event|0|||
144561537|NCT03418493|521256369|FG000|Overall Study|Protocol Violation|0|||
144561538|NCT03418493|521256370|FG001|Overall Study|Protocol Violation|0|||
144561539|NCT03418493|521256371|FG002|Overall Study|Protocol Violation|0|||
144561540|NCT03418493|521256372|FG003|Overall Study|Protocol Violation|0|||
144561541|NCT03418493|521256373|FG004|Overall Study|Protocol Violation|0|||
144561542|NCT03418493|521256374|FG005|Overall Study|Protocol Violation|0|||
144561543|NCT03418493|521256375|FG006|Overall Study|Protocol Violation|0|||
144561544|NCT03418493|521256376|FG007|Overall Study|Protocol Violation|0|||
144561545|NCT03418493|521256377|FG008|Overall Study|Protocol Violation|0|||
144561546|NCT03418493|521256378|FG009|Overall Study|Protocol Violation|1|||
144561547|NCT03418493|521256379|FG010|Overall Study|Protocol Violation|0|||
144561548|NCT05446714|521256383|FG000|Overall Study|Lost to Follow-up|1|||
144561549|NCT05446714|521256384|FG001|Overall Study|Lost to Follow-up|3|||
144561550|NCT05446714|521256385|FG002|Overall Study|Lost to Follow-up|2|||
144561551|NCT05446714|521256383|FG000|Overall Study|Protocol Violation|2|||
144561552|NCT05446714|521256384|FG001|Overall Study|Protocol Violation|0|||
144561553|NCT05446714|521256385|FG002|Overall Study|Protocol Violation|0|||
144561554|NCT00943618|521256391|FG000|Overall Study|Lost to Follow-up|38|||
144561555|NCT00943618|521256392|FG001|Overall Study|Lost to Follow-up|48|||
144561556|NCT00943618|521256393|FG002|Overall Study|Lost to Follow-up|20|||
144561557|NCT00943618|521256391|FG000|Overall Study|Discontinued Medication|17|||
144561558|NCT00943618|521256392|FG001|Overall Study|Discontinued Medication|29|||
144561559|NCT00943618|521256393|FG002|Overall Study|Discontinued Medication|11|||
144561560|NCT00053352|521256394|FG000|Overall Study|Lost to Follow-up|0|||
144561561|NCT00053352|521256395|FG001|Overall Study|Lost to Follow-up|1|||
144561562|NCT00053352|521256394|FG000|Overall Study|Physician Decision|11|||
144561563|NCT00053352|521256395|FG001|Overall Study|Physician Decision|1|||
144561564|NCT00053352|521256394|FG000|Overall Study|Withdrawal by Subject|1|||
144561565|NCT00053352|521256395|FG001|Overall Study|Withdrawal by Subject|0|||
144561566|NCT00053352|521256394|FG000|Overall Study|Ineligible|8|||
144561567|NCT00053352|521256395|FG001|Overall Study|Ineligible|8|||
144561568|NCT00053352|521256394|FG000|Overall Study|Disease at new site|1|||
144561569|NCT00053352|521256395|FG001|Overall Study|Disease at new site|0|||
144561570|NCT01388478|521256396|FG000|Overall Study|Adverse Event|4|||
144561571|NCT01388478|521256396|FG000|Overall Study|Withdrawal by Subject|1|||
144561572|NCT01037413|521256397|FG000|Part A: Skin Testing|Adverse Event|1|||
144561573|NCT01037413|521256398|FG001|Part A: Skin Testing|Adverse Event|0|||
144561574|NCT01037413|521256397|FG000|Part A: Skin Testing|Protocol Violation|1|||
144561575|NCT01037413|521256398|FG001|Part A: Skin Testing|Protocol Violation|0|||
144561576|NCT01037413|521256397|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
144561577|NCT01037413|521256398|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
144561578|NCT01037413|521256397|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
144561579|NCT01037413|521256398|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
144561580|NCT01990664|521256399|FG000|Overall Study|Lost to Follow-up|2|||
144561581|NCT01990664|521256400|FG001|Overall Study|Lost to Follow-up|6|||
144561582|NCT01990664|521256399|FG000|Overall Study|Withdrawal by Subject|2|||
144561583|NCT01990664|521256400|FG001|Overall Study|Withdrawal by Subject|3|||
144561584|NCT01990664|521256399|FG000|Overall Study|Protocol Violation|1|||
144561585|NCT01990664|521256400|FG001|Overall Study|Protocol Violation|0|||
144561586|NCT01990664|521256399|FG000|Overall Study|Lens Discomfort|1|||
144561587|NCT01990664|521256400|FG001|Overall Study|Lens Discomfort|1|||
144561588|NCT01990664|521256399|FG000|Overall Study|Lens Handling Difficulties|1|||
144561589|NCT01990664|521256400|FG001|Overall Study|Lens Handling Difficulties|0|||
144561590|NCT01990664|521256399|FG000|Overall Study|Unsatisfactory Visual Response|0|||
144561591|NCT01990664|521256400|FG001|Overall Study|Unsatisfactory Visual Response|1|||
144561592|NCT00931918|521256404|FG000|Overall Study|Adverse Event|4|||
144561593|NCT00931918|521256405|FG001|Overall Study|Adverse Event|6|||
144561594|NCT00931918|521256404|FG000|Overall Study|Progressive Disease|2|||
144561595|NCT00931918|521256405|FG001|Overall Study|Progressive Disease|1|||
144561596|NCT00931918|521256404|FG000|Overall Study|Symptomatic Deterioration|1|||
144561597|NCT00931918|521256405|FG001|Overall Study|Symptomatic Deterioration|0|||
144561598|NCT00931918|521256404|FG000|Overall Study|Withdrawal by Patient|3|||
144561599|NCT00931918|521256405|FG001|Overall Study|Withdrawal by Patient|4|||
144561600|NCT00931918|521256404|FG000|Overall Study|Other Reason not Specified|4|||
144561601|NCT00931918|521256405|FG001|Overall Study|Other Reason not Specified|4|||
144561602|NCT00931918|521256404|FG000|Overall Study|Did not receive study drug|3|||
144561603|NCT00931918|521256405|FG001|Overall Study|Did not receive study drug|2|||
144561604|NCT00809341|521256406|FG000|Overall Study|Physician Decision|0|||
144561605|NCT00809341|521256407|FG001|Overall Study|Physician Decision|1|||
144561606|NCT00745121|521256418|FG000|Overall Study|Death|3|||
144561607|NCT00745121|521256419|FG001|Overall Study|Death|0|||
144561608|NCT00745121|521256418|FG000|Overall Study|Adverse Event|1|||
144561609|NCT00745121|521256419|FG001|Overall Study|Adverse Event|0|||
144561610|NCT00745121|521256418|FG000|Overall Study|Lost to Follow-up|1|||
144561611|NCT00745121|521256419|FG001|Overall Study|Lost to Follow-up|0|||
144561612|NCT00745121|521256418|FG000|Overall Study|Withdrawal by Subject|4|||
144561613|NCT00745121|521256419|FG001|Overall Study|Withdrawal by Subject|2|||
144561614|NCT03723915|521256421|FG000|Screening|Failed to meet screening requirements.|2|||
144203673|NCT00809159|519940377|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
144203674|NCT00809159|519940372|FG000|Part 1 and 2|Administrative problems|0|||
144561615|NCT03723915|521256421|FG000|On Treatment|Failed to meet treatment requirements|2|||
144561616|NCT01281917|521256432|FG000|Overall Study|Withdrawal by Subject|1|||
144561617|NCT04016805|521256433|FG000|Overall Study|Sponsor's Discretion|30|||
144561618|NCT04016805|521256434|FG001|Overall Study|Sponsor's Discretion|6|||
144561619|NCT04016805|521256435|FG002|Overall Study|Sponsor's Discretion|5|||
144561620|NCT00740870|521256438|FG000|Overall Study|Not Catheterized|4|||
144561621|NCT00740870|521256438|FG000|Overall Study|Further testing contraindicated implant|17|||
144561622|NCT00819013|521256439|FG000|Overall Study|Not meeting continuing study eligibility|2|||
144561623|NCT00819013|521256440|FG001|Overall Study|Not meeting continuing study eligibility|1|||
144561624|NCT00819013|521256441|FG002|Overall Study|Not meeting continuing study eligibility|2|||
144561625|NCT00819013|521256442|FG003|Overall Study|Not meeting continuing study eligibility|1|||
144203675|NCT00809159|519940373|FG001|Part 1 and 2|Administrative problems|0|||
144561626|NCT00819013|521256439|FG000|Overall Study|Adverse Event|0|||
144561627|NCT00819013|521256440|FG001|Overall Study|Adverse Event|0|||
144561628|NCT00819013|521256441|FG002|Overall Study|Adverse Event|1|||
144561629|NCT00819013|521256442|FG003|Overall Study|Adverse Event|0|||
144561630|NCT00819013|521256439|FG000|Overall Study|Withdrawal by Subject|1|||
144561631|NCT00819013|521256440|FG001|Overall Study|Withdrawal by Subject|0|||
144561632|NCT00819013|521256441|FG002|Overall Study|Withdrawal by Subject|1|||
144561633|NCT00819013|521256442|FG003|Overall Study|Withdrawal by Subject|0|||
144561634|NCT00819013|521256439|FG000|Overall Study|Lost to Follow-up|0|||
144561635|NCT00819013|521256440|FG001|Overall Study|Lost to Follow-up|0|||
144561636|NCT00819013|521256441|FG002|Overall Study|Lost to Follow-up|1|||
144561637|NCT00819013|521256442|FG003|Overall Study|Lost to Follow-up|2|||
144561638|NCT00819013|521256439|FG000|Overall Study|Death|0|||
144561639|NCT00819013|521256440|FG001|Overall Study|Death|0|||
144561640|NCT00819013|521256441|FG002|Overall Study|Death|0|||
144561641|NCT00819013|521256442|FG003|Overall Study|Death|1|||
144561642|NCT00607997|521256443|FG000|Overall Study|Lack of Efficacy|6|||
144561643|NCT00607997|521256444|FG001|Overall Study|Lack of Efficacy|20|||
144561644|NCT00607997|521256445|FG002|Overall Study|Lack of Efficacy|14|||
144561645|NCT00607997|521256446|FG003|Overall Study|Lack of Efficacy|10|||
144561646|NCT00607997|521256443|FG000|Overall Study|Death|8|||
144561647|NCT00607997|521256444|FG001|Overall Study|Death|5|||
144561648|NCT00607997|521256445|FG002|Overall Study|Death|2|||
144561649|NCT00607997|521256446|FG003|Overall Study|Death|5|||
144561650|NCT00607997|521256443|FG000|Overall Study|Adverse Event|3|||
144561651|NCT00607997|521256444|FG001|Overall Study|Adverse Event|1|||
144561652|NCT00607997|521256445|FG002|Overall Study|Adverse Event|2|||
144561653|NCT00607997|521256446|FG003|Overall Study|Adverse Event|0|||
144561654|NCT00607997|521256443|FG000|Overall Study|Physician Decision|4|||
144561655|NCT00607997|521256444|FG001|Overall Study|Physician Decision|1|||
144561656|NCT00607997|521256445|FG002|Overall Study|Physician Decision|0|||
144561657|NCT00607997|521256446|FG003|Overall Study|Physician Decision|0|||
144561658|NCT00607997|521256443|FG000|Overall Study|Relapse, recurrent illness|4|||
144561659|NCT00607997|521256444|FG001|Overall Study|Relapse, recurrent illness|0|||
144561660|NCT00607997|521256445|FG002|Overall Study|Relapse, recurrent illness|2|||
144561661|NCT00607997|521256446|FG003|Overall Study|Relapse, recurrent illness|0|||
144561662|NCT00607997|521256443|FG000|Overall Study|Other without explanation|2|||
144561663|NCT00607997|521256444|FG001|Overall Study|Other without explanation|0|||
144561664|NCT00607997|521256445|FG002|Overall Study|Other without explanation|4|||
144561665|NCT00607997|521256446|FG003|Overall Study|Other without explanation|1|||
144561666|NCT00839332|521256450|FG000|Phase 1|Disease Progression|38|||
144561667|NCT00839332|521256451|FG001|Phase 1|Disease Progression|0|||
144561668|NCT00839332|521256452|FG002|Phase 1|Disease Progression|0|||
144561669|NCT00839332|521256450|FG000|Phase 1|Adverse Event|6|||
144561670|NCT00839332|521256451|FG001|Phase 1|Adverse Event|0|||
144561671|NCT00839332|521256452|FG002|Phase 1|Adverse Event|0|||
144561672|NCT00839332|521256450|FG000|Phase 1|Withdrawal by Subject|4|||
144561673|NCT00839332|521256451|FG001|Phase 1|Withdrawal by Subject|0|||
144561674|NCT00839332|521256452|FG002|Phase 1|Withdrawal by Subject|0|||
144561675|NCT00839332|521256450|FG000|Phase 1|Physician Decision|2|||
144561676|NCT00839332|521256451|FG001|Phase 1|Physician Decision|0|||
144561677|NCT00839332|521256452|FG002|Phase 1|Physician Decision|0|||
144561678|NCT00839332|521256450|FG000|Phase 2|Protocol Violation|0|||
144561679|NCT00839332|521256451|FG001|Phase 2|Protocol Violation|1|||
144561680|NCT00839332|521256452|FG002|Phase 2|Protocol Violation|0|||
144561681|NCT00839332|521256450|FG000|Phase 2|Disease Progression|0|||
144561682|NCT00839332|521256451|FG001|Phase 2|Disease Progression|46|||
144561683|NCT00839332|521256452|FG002|Phase 2|Disease Progression|21|||
144561684|NCT00839332|521256450|FG000|Phase 2|Adverse Event|0|||
144561685|NCT00839332|521256451|FG001|Phase 2|Adverse Event|8|||
144561686|NCT00839332|521256452|FG002|Phase 2|Adverse Event|6|||
144617721|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
144203676|NCT00809159|519940374|FG002|Part 1 and 2|Administrative problems|0|||
144203677|NCT00809159|519940375|FG003|Part 1 and 2|Administrative problems|1|||
144203678|NCT00809159|519940376|FG004|Part 1 and 2|Administrative problems|0|||
144561687|NCT00839332|521256450|FG000|Phase 2|Death|0|||
144561688|NCT00839332|521256451|FG001|Phase 2|Death|4|||
144561689|NCT00839332|521256452|FG002|Phase 2|Death|2|||
144561690|NCT00839332|521256450|FG000|Phase 2|Withdrawal by Subject|0|||
144561691|NCT00839332|521256451|FG001|Phase 2|Withdrawal by Subject|5|||
144561692|NCT00839332|521256452|FG002|Phase 2|Withdrawal by Subject|8|||
144561693|NCT00839332|521256450|FG000|Phase 2|Physician Decision|0|||
144561694|NCT00839332|521256451|FG001|Phase 2|Physician Decision|4|||
144561695|NCT00839332|521256452|FG002|Phase 2|Physician Decision|1|||
144561696|NCT00839332|521256450|FG000|Phase 2|Lost to Follow-up|0|||
144561697|NCT00839332|521256451|FG001|Phase 2|Lost to Follow-up|0|||
144561698|NCT00839332|521256452|FG002|Phase 2|Lost to Follow-up|1|||
144561699|NCT01200485|521256453|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
144561700|NCT01200485|521256454|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
144561701|NCT01200485|521256455|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
144561702|NCT01200485|521256453|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
144561703|NCT01200485|521256454|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
144561704|NCT01200485|521256455|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
144561705|NCT06080438|521256457|FG000|Overall Study|Lost to Follow-up|2|||
144561706|NCT03589300|521256459|FG000|Overall Study|Adverse Event|2|||
144561707|NCT03589300|521256459|FG000|Overall Study|Death|4|||
144561708|NCT03589300|521256459|FG000|Overall Study|Lost to Follow-up|12|||
144561709|NCT03589300|521256459|FG000|Overall Study|Withdrawal by Subject|5|||
144561710|NCT01678898|521256464|FG000|PB-102-F01|Adverse Event|0|||
144561711|NCT01678898|521256465|FG001|PB-102-F01|Adverse Event|1|||
144561712|NCT01678898|521256466|FG002|PB-102-F01|Adverse Event|0|||
144561713|NCT01678898|521256464|FG000|PB-102-F01|Physician Decision|0|||
144561714|NCT01678898|521256465|FG001|PB-102-F01|Physician Decision|1|||
144561715|NCT01678898|521256466|FG002|PB-102-F01|Physician Decision|0|||
144561716|NCT00640042|521256467|FG000|Enrollment|Did not receive study drug|83|||
144561717|NCT01592383|521256481|FG000|Overall Study|Adverse Event|1|||
144561718|NCT04167085|521256482|FG000|Baseline|Withdrawal by Subject|2|||
144561719|NCT04167085|521256483|FG001|Baseline|Withdrawal by Subject|1|||
144561720|NCT04167085|521256482|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
144561721|NCT04167085|521256483|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
144561722|NCT03640754|521256484|FG000|Overall Study|Withdrawal by Subject|1|||
144561723|NCT03640754|521256485|FG001|Overall Study|Withdrawal by Subject|0|||
144561724|NCT03640754|521256484|FG000|Overall Study|Lost to Follow-up|0|||
144561725|NCT03640754|521256485|FG001|Overall Study|Lost to Follow-up|1|||
144561726|NCT00276016|521256490|FG000|Intervention 1|Withdrawal by Subject|0|||
144561727|NCT00276016|521256491|FG001|Intervention 1|Withdrawal by Subject|1|||
144728259|NCT01101022|521861177|FG000|Overall Study|Non-compliance|1|||
144728260|NCT01101022|521861178|FG001|Overall Study|Non-compliance|0|||
144728261|NCT01101022|521861177|FG000|Overall Study|Work schedule|1|||
144728262|NCT01101022|521861178|FG001|Overall Study|Work schedule|1|||
144728263|NCT01101022|521861177|FG000|Overall Study|Vacation|0|||
144728264|NCT01101022|521861178|FG001|Overall Study|Vacation|1|||
144728265|NCT01519661|521861179|FG000|Overall Study|Protocol deviation|6|||
144728266|NCT01519661|521861179|FG000|Overall Study|Lost to Follow-up|3|||
144728267|NCT01519661|521861179|FG000|Overall Study|Withdrawal by Subject|17|||
144728268|NCT01519661|521861179|FG000|Overall Study|Lack of Efficacy|6|||
144728269|NCT01519661|521861179|FG000|Overall Study|Adverse Event|29|||
144728270|NCT01139047|521861180|FG000|Overall Study|Withdrawal by Subject|1|||
144728271|NCT00420303|521861181|FG000|Overall Study|Serious Adverse Event|1|||
144728272|NCT00420303|521861182|FG001|Overall Study|Serious Adverse Event|0|||
144728273|NCT00420303|521861181|FG000|Overall Study|Lack of Efficacy|0|||
144728274|NCT00420303|521861182|FG001|Overall Study|Lack of Efficacy|3|||
144728275|NCT00420303|521861181|FG000|Overall Study|Physician Decision|0|||
144728276|NCT00420303|521861182|FG001|Overall Study|Physician Decision|1|||
144728277|NCT05628675|521861183|FG000|Overall Study|Lost to Follow-up|2|||
144728278|NCT05628675|521861183|FG000|Overall Study|Withdrawal by Subject|1|||
144728279|NCT01941095|521861186|FG000|Overall Study|Insufficient therapeutic response|13|||
144728280|NCT01941095|521861186|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
144728281|NCT01941095|521861186|FG000|Overall Study|Adverse Event|11|||
144728282|NCT01941095|521861186|FG000|Overall Study|Physician Decision|3|||
144728283|NCT01941095|521861186|FG000|Overall Study|Withdrawal by Subject|17|||
144728284|NCT01941095|521861186|FG000|Overall Study|Lost to Follow-up|10|||
144203679|NCT00809159|519940377|FG005|Part 1 and 2|Administrative problems|0|||
144561728|NCT00276016|521256492|FG002|Intervention 1|Withdrawal by Subject|0|||
144561729|NCT00276016|521256493|FG003|Intervention 1|Withdrawal by Subject|0|||
144561730|NCT00276016|521256494|FG004|Intervention 1|Withdrawal by Subject|0|||
144561731|NCT00276016|521256495|FG005|Intervention 1|Withdrawal by Subject|0|||
144561732|NCT00230971|521256496|FG000|Randomization|No study drug administered|3|||
144561733|NCT00230971|521256497|FG001|Randomization|No study drug administered|3|||
144728285|NCT02918877|521861196|FG000|Overall Study|Withdrawal by Subject|2|||
144728286|NCT02918877|521861197|FG001|Overall Study|Withdrawal by Subject|2|||
144728287|NCT02918877|521861196|FG000|Overall Study|Surgery cancelled|1|||
144728288|NCT02918877|521861197|FG001|Overall Study|Surgery cancelled|0|||
144728289|NCT02918877|521861196|FG000|Overall Study|Physician Decision|1|||
144728290|NCT02918877|521861197|FG001|Overall Study|Physician Decision|0|||
144728291|NCT02918877|521861196|FG000|Overall Study|Received intraoperative steroids|1|||
144728292|NCT02918877|521861197|FG001|Overall Study|Received intraoperative steroids|0|||
144203680|NCT00809159|519940372|FG000|Part 1 and 2|Adverse Event|0|||
144203681|NCT00809159|519940373|FG001|Part 1 and 2|Adverse Event|0|||
144203682|NCT00809159|519940374|FG002|Part 1 and 2|Adverse Event|1|||
144561734|NCT00230971|521256496|FG000|Baseline Participants|Lost to Follow-up|5|||
144561735|NCT00230971|521256497|FG001|Baseline Participants|Lost to Follow-up|12|||
144561736|NCT00230971|521256496|FG000|Baseline Participants|Death|6|||
144561737|NCT00230971|521256497|FG001|Baseline Participants|Death|5|||
144561738|NCT00230971|521256496|FG000|Baseline Participants|Withdrawal by Subject|7|||
144561739|NCT00230971|521256497|FG001|Baseline Participants|Withdrawal by Subject|1|||
144561740|NCT00230971|521256496|FG000|Baseline Participants|Adverse Event|1|||
144203683|NCT00809159|519940375|FG003|Part 1 and 2|Adverse Event|0|||
144203684|NCT00809159|519940376|FG004|Part 1 and 2|Adverse Event|1|||
144203685|NCT00809159|519940377|FG005|Part 1 and 2|Adverse Event|1|||
144203686|NCT00809159|519940372|FG000|Part 1 and 2|Lost to Follow-up|0|||
144203687|NCT00809159|519940373|FG001|Part 1 and 2|Lost to Follow-up|0|||
144203688|NCT00809159|519940374|FG002|Part 1 and 2|Lost to Follow-up|1|||
144203689|NCT00809159|519940375|FG003|Part 1 and 2|Lost to Follow-up|1|||
144203690|NCT00809159|519940376|FG004|Part 1 and 2|Lost to Follow-up|0|||
144203691|NCT00809159|519940377|FG005|Part 1 and 2|Lost to Follow-up|0|||
144203692|NCT00809159|519940372|FG000|Part 1 and 2|Withdrawal by Subject|0|||
144203693|NCT00809159|519940373|FG001|Part 1 and 2|Withdrawal by Subject|0|||
144203694|NCT00809159|519940374|FG002|Part 1 and 2|Withdrawal by Subject|4|||
144203695|NCT00809159|519940375|FG003|Part 1 and 2|Withdrawal by Subject|0|||
144561741|NCT00230971|521256497|FG001|Baseline Participants|Adverse Event|0|||
144561742|NCT00230971|521256496|FG000|Baseline Participants|No bacteria observed|1|||
144561743|NCT00230971|521256497|FG001|Baseline Participants|No bacteria observed|0|||
144561744|NCT00230971|521256496|FG000|Baseline Participants|Failure to return|1|||
144561745|NCT00230971|521256497|FG001|Baseline Participants|Failure to return|1|||
144561746|NCT00230971|521256496|FG000|Baseline Participants|Reintervention|1|||
144561747|NCT00230971|521256497|FG001|Baseline Participants|Reintervention|0|||
144561748|NCT04380688|521256499|FG000|Overall Study|Death|2|||
144561749|NCT04380688|521256500|FG001|Overall Study|Death|2|||
144561750|NCT04380688|521256499|FG000|Overall Study|Lost to Follow-up|2|||
144561751|NCT04380688|521256500|FG001|Overall Study|Lost to Follow-up|4|||
144561752|NCT04380688|521256499|FG000|Overall Study|Withdrawal by Subject|3|||
144561753|NCT04380688|521256500|FG001|Overall Study|Withdrawal by Subject|3|||
144561754|NCT00951171|521256504|FG000|Overall Study|Adverse Event|2|||
144561755|NCT00951171|521256505|FG001|Overall Study|Adverse Event|0|||
144561756|NCT05294328|521256508|FG000|Overall Study|Adverse Event|1|||
144561757|NCT05294328|521256509|FG001|Overall Study|Adverse Event|0|||
144561758|NCT05294328|521256510|FG002|Overall Study|Adverse Event|0|||
144561759|NCT05294328|521256508|FG000|Overall Study|Physician Decision|1|||
144561760|NCT05294328|521256509|FG001|Overall Study|Physician Decision|1|||
144561761|NCT05294328|521256510|FG002|Overall Study|Physician Decision|0|||
144561762|NCT05294328|521256508|FG000|Overall Study|Withdrawal by Subject|0|||
144561763|NCT05294328|521256509|FG001|Overall Study|Withdrawal by Subject|2|||
144561764|NCT05294328|521256510|FG002|Overall Study|Withdrawal by Subject|1|||
144561765|NCT05294328|521256508|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
144561766|NCT05294328|521256509|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
144561767|NCT05294328|521256510|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
144561768|NCT04267393|521256511|FG000|Randomization|Adverse Event|1|||
144561769|NCT04267393|521256512|FG001|Randomization|Adverse Event|0|||
144561770|NCT04267393|521256513|FG002|Randomization|Adverse Event|0|||
144561771|NCT04267393|521256511|FG000|Randomization|Administrative Reasons by Sponsor|0|||
144561772|NCT04267393|521256512|FG001|Randomization|Administrative Reasons by Sponsor|1|||
144561773|NCT04267393|521256513|FG002|Randomization|Administrative Reasons by Sponsor|0|||
144561774|NCT04267393|521256511|FG000|Treatment Period|Adverse Event|0|||
144561775|NCT04267393|521256512|FG001|Treatment Period|Adverse Event|2|||
144561776|NCT04267393|521256513|FG002|Treatment Period|Adverse Event|3|||
144561777|NCT04267393|521256511|FG000|Treatment Period|Participant Withdrew Consent|0|||
144561778|NCT04267393|521256512|FG001|Treatment Period|Participant Withdrew Consent|0|||
144561779|NCT04267393|521256513|FG002|Treatment Period|Participant Withdrew Consent|1|||
144561780|NCT04267393|521256511|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
144561781|NCT04267393|521256512|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
144561782|NCT04267393|521256513|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
144561783|NCT02056873|521256514|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
144203696|NCT00809159|519940376|FG004|Part 1 and 2|Withdrawal by Subject|0|||
144203697|NCT00809159|519940377|FG005|Part 1 and 2|Withdrawal by Subject|1|||
144203698|NCT04568031|519940383|FG000|Overall Study|Lost to Follow-up|1|||
144203699|NCT04568031|519940384|FG001|Overall Study|Lost to Follow-up|0|||
144203700|NCT04568031|519940385|FG002|Overall Study|Lost to Follow-up|0|||
144203701|NCT04568031|519940386|FG003|Overall Study|Lost to Follow-up|0|||
144203702|NCT04568031|519940383|FG000|Overall Study|Physician Decision|1|||
144203703|NCT04568031|519940384|FG001|Overall Study|Physician Decision|0|||
144203704|NCT04568031|519940385|FG002|Overall Study|Physician Decision|1|||
144203705|NCT04568031|519940386|FG003|Overall Study|Physician Decision|0|||
144203706|NCT04568031|519940383|FG000|Overall Study|Withdrawal by Subject|1|||
144203707|NCT04568031|519940384|FG001|Overall Study|Withdrawal by Subject|0|||
144203708|NCT04568031|519940385|FG002|Overall Study|Withdrawal by Subject|4|||
144561784|NCT01929876|521258633|FG000|Period 2|Non-Compliance|1|||
144561785|NCT00526097|521258636|FG000|Overall Study|Adverse Event|6|||
144561786|NCT00526097|521258637|FG001|Overall Study|Adverse Event|44|||
144561787|NCT00526097|521258636|FG000|Overall Study|Protocol Violation|4|||
144561788|NCT00526097|521258637|FG001|Overall Study|Protocol Violation|10|||
144561789|NCT00526097|521258636|FG000|Overall Study|Withdrawal by Subject|3|||
144561790|NCT00526097|521258637|FG001|Overall Study|Withdrawal by Subject|1|||
144561791|NCT00526097|521258636|FG000|Overall Study|Other|2|||
144561792|NCT00526097|521258637|FG001|Overall Study|Other|1|||
144561793|NCT03713281|521258642|FG000|Overall Study|Lens handling difficuluties|2|||
144561794|NCT03713281|521258642|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
144617722|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
144617723|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
144617724|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
144617725|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
144617726|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
144617727|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
144617728|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
144617729|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
144617730|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
144617731|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
144617732|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
144617733|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
144617734|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
144617735|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
144617736|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
144617737|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
144617738|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
144617739|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
144617740|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
144617741|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
144617742|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
144617743|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
144617744|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
144617745|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
144617746|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
144617747|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
144617748|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
144617749|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
144617750|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
144617751|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
144617752|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
144617753|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Other|0|||
144617754|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Other|0|||
144617755|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Other|0|||
144617756|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Other|1|||
144617757|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Other|0|||
144617758|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
144617759|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
144617760|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
144617761|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
144728293|NCT02918877|521861196|FG000|Overall Study|Unable to obtain lab samples|1|||
144728294|NCT02918877|521861197|FG001|Overall Study|Unable to obtain lab samples|0|||
144728295|NCT02918877|521861196|FG000|Overall Study|Unsafe to perform BAL|0|||
144728296|NCT02918877|521861197|FG001|Overall Study|Unsafe to perform BAL|1|||
144728297|NCT00088829|521861198|FG000|Overall Study|PI left institution and study was close|22|||
144728298|NCT05818137|521861199|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
144728299|NCT05818137|521861199|FG000|Extension Treatment Period|Ongoing participants|44|||
144728300|NCT01367275|521861200|FG000|Overall Study|Ineligible|1|||
144561795|NCT02412111|521258644|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
144561796|NCT02412111|521258645|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
144561797|NCT02412111|521258646|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
144561798|NCT02412111|521258644|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
144561799|NCT02412111|521258645|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
144561800|NCT02412111|521258646|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
144561801|NCT02412111|521258644|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
144561802|NCT02412111|521258645|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
144561803|NCT02412111|521258646|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
144561804|NCT02412111|521258644|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
144561805|NCT02412111|521258645|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
144561806|NCT02412111|521258646|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
144561807|NCT02412111|521258644|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
144561808|NCT02412111|521258645|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
144561809|NCT02412111|521258646|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
144561810|NCT02412111|521258644|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
144561811|NCT02412111|521258645|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
144561812|NCT02412111|521258646|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
144561813|NCT02412111|521258644|FG000|Active Comparator Period (8 Weeks)|Other|0|||
144561814|NCT02412111|521258645|FG001|Active Comparator Period (8 Weeks)|Other|0|||
144561815|NCT02412111|521258646|FG002|Active Comparator Period (8 Weeks)|Other|2|||
144561816|NCT00487552|521258647|FG000|Overall Study|Unsuccessful magnet placements|3|||
144561817|NCT00487552|521258647|FG000|Overall Study|Death due to progressive malignancy|2|||
144561818|NCT00487552|521258647|FG000|Overall Study|Stent not placed|1|||
144561819|NCT04349644|521258649|FG000|Allocation/Pretest|Lost to pretest|0|||
144561820|NCT04349644|521258650|FG001|Allocation/Pretest|Lost to pretest|3|||
144561821|NCT04349644|521258649|FG000|Posttest|Lost to posttest|0|||
144561822|NCT04349644|521258650|FG001|Posttest|Lost to posttest|8|||
144561823|NCT04349644|521258649|FG000|Posttest|Discontinued intervention|6|||
144561824|NCT04349644|521258650|FG001|Posttest|Discontinued intervention|0|||
144561825|NCT04349644|521258649|FG000|Follow-up|Lost to Follow-up|0|||
144561826|NCT04349644|521258650|FG001|Follow-up|Lost to Follow-up|2|||
144561827|NCT05006417|521258651|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
144561828|NCT01169636|521258652|FG000|Overall Study|Adverse Event|0|||
144561829|NCT01169636|521258653|FG001|Overall Study|Adverse Event|0|||
144561830|NCT01169636|521258654|FG002|Overall Study|Adverse Event|1|||
144561831|NCT01169636|521258655|FG003|Overall Study|Adverse Event|1|||
144561832|NCT01169636|521258656|FG004|Overall Study|Adverse Event|0|||
144561833|NCT01169636|521258652|FG000|Overall Study|Screen failure|0|||
144561834|NCT01169636|521258653|FG001|Overall Study|Screen failure|0|||
144561835|NCT01169636|521258654|FG002|Overall Study|Screen failure|2|||
144561836|NCT01169636|521258655|FG003|Overall Study|Screen failure|0|||
144561837|NCT01169636|521258656|FG004|Overall Study|Screen failure|0|||
144561838|NCT01169636|521258652|FG000|Overall Study|Withdrawal by Subject|0|||
144561839|NCT01169636|521258653|FG001|Overall Study|Withdrawal by Subject|0|||
144561840|NCT01169636|521258654|FG002|Overall Study|Withdrawal by Subject|0|||
144561841|NCT01169636|521258655|FG003|Overall Study|Withdrawal by Subject|0|||
144561842|NCT01169636|521258656|FG004|Overall Study|Withdrawal by Subject|3|||
144561843|NCT00510198|521258657|FG000|Overall Study|Withdrawal by Subject|5|||
144561844|NCT00510198|521258658|FG001|Overall Study|Withdrawal by Subject|4|||
144561845|NCT02994784|521258659|FG000|6 Months Follow-up|Lost to Follow-up|3|||
144561846|NCT00494026|521258660|FG000|Overall Study|Sponsor Decision|4|||
144561847|NCT02466243|521258661|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
144561848|NCT02466243|521258662|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
144561849|NCT02466243|521258661|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
144561850|NCT02466243|521258662|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
144561851|NCT02466243|521258661|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
144561852|NCT02466243|521258662|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
144561853|NCT02466243|521258661|FG000|Part B Open-label Treatment Period|Missing|2|||
144561854|NCT02466243|521258662|FG001|Part B Open-label Treatment Period|Missing|2|||
144561855|NCT01649557|521258666|FG000|Overall Study|Lost to Follow-up|5|||
144561856|NCT01649557|521258667|FG001|Overall Study|Lost to Follow-up|0|||
144561857|NCT01649557|521258668|FG002|Overall Study|Lost to Follow-up|3|||
144561858|NCT01649557|521258666|FG000|Overall Study|Adverse Event|7|||
144561859|NCT01649557|521258667|FG001|Overall Study|Adverse Event|5|||
144561860|NCT01649557|521258668|FG002|Overall Study|Adverse Event|1|||
144561861|NCT01649557|521258666|FG000|Overall Study|Met withdrawal criteria|4|||
144561862|NCT01649557|521258667|FG001|Overall Study|Met withdrawal criteria|0|||
144561863|NCT01649557|521258668|FG002|Overall Study|Met withdrawal criteria|0|||
144561864|NCT01649557|521258666|FG000|Overall Study|Physician Decision|8|||
144262510|NCT01443858|520161461|FG001|Overall Study|Withdrawal by Subject|8|||
144262511|NCT01443858|520161462|FG002|Overall Study|Withdrawal by Subject|5|||
144262512|NCT01443858|520161460|FG000|Overall Study|Lack of Efficacy|1|||
144262513|NCT01443858|520161461|FG001|Overall Study|Lack of Efficacy|0|||
144262514|NCT01443858|520161462|FG002|Overall Study|Lack of Efficacy|0|||
144262515|NCT01443858|520161460|FG000|Overall Study|Lost to Follow-up|5|||
144262516|NCT01443858|520161461|FG001|Overall Study|Lost to Follow-up|5|||
144262517|NCT01443858|520161462|FG002|Overall Study|Lost to Follow-up|2|||
144262518|NCT03361306|520161466|FG000|Overall Study|Death|6|||
144262519|NCT01272908|520161468|FG000|Initial Treatment Period|Adverse Event|1|||
144262520|NCT01272908|520161468|FG000|Initial Treatment Period|Lack of Efficacy|5|||
144728301|NCT01367275|521861200|FG000|Overall Study|Disease Progression|2|||
144262521|NCT01272908|520161468|FG000|Initial Treatment Period|Protocol Violation|1|||
144262522|NCT01272908|520161468|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
144561865|NCT01649557|521258667|FG001|Overall Study|Physician Decision|2|||
144561866|NCT01649557|521258668|FG002|Overall Study|Physician Decision|1|||
144561867|NCT01649557|521258666|FG000|Overall Study|Withdrawal by Subject|15|||
144561868|NCT01649557|521258667|FG001|Overall Study|Withdrawal by Subject|5|||
144561869|NCT01649557|521258668|FG002|Overall Study|Withdrawal by Subject|4|||
144561870|NCT01649557|521258666|FG000|Overall Study|Protocol deviation|0|||
144561871|NCT01649557|521258667|FG001|Overall Study|Protocol deviation|2|||
144561872|NCT01649557|521258668|FG002|Overall Study|Protocol deviation|0|||
144561873|NCT01649557|521258666|FG000|Overall Study|Lack of Efficacy|5|||
144561874|NCT01649557|521258667|FG001|Overall Study|Lack of Efficacy|0|||
144561875|NCT01649557|521258668|FG002|Overall Study|Lack of Efficacy|0|||
144561876|NCT03029234|521258669|FG000|Overall Study|Sponsor Decision|1|||
144561877|NCT03029234|521258669|FG000|Overall Study|Withdrawal by Subject|5|||
144561878|NCT03029234|521258669|FG000|Overall Study|Death|91|||
144561879|NCT03029234|521258669|FG000|Overall Study|Lost to Follow-up|2|||
144561880|NCT02544113|521258672|FG000|Overall Study|Death|3|||
144561881|NCT02544113|521258673|FG001|Overall Study|Death|4|||
144561882|NCT02847637|521258675|FG000|Overall Study|Withdrawal by Subject|0|||
144561883|NCT02847637|521258676|FG001|Overall Study|Withdrawal by Subject|1|||
144561884|NCT02847637|521258677|FG002|Overall Study|Withdrawal by Subject|1|||
144561885|NCT02847637|521258678|FG003|Overall Study|Withdrawal by Subject|0|||
144561886|NCT02847637|521258675|FG000|Overall Study|Lost to Follow-up|1|||
144561887|NCT02847637|521258676|FG001|Overall Study|Lost to Follow-up|1|||
144561888|NCT02847637|521258677|FG002|Overall Study|Lost to Follow-up|0|||
144561889|NCT02847637|521258678|FG003|Overall Study|Lost to Follow-up|0|||
144561890|NCT01746108|521258683|FG000|Overall Study|Migrated /moved from study area|0|||
144561891|NCT01746108|521258684|FG001|Overall Study|Migrated /moved from study area|1|||
144561892|NCT01746108|521258685|FG002|Overall Study|Migrated /moved from study area|0|||
144561893|NCT01746108|521258683|FG000|Overall Study|Adverse event, non-fatal|0|||
144561894|NCT01746108|521258684|FG001|Overall Study|Adverse event, non-fatal|1|||
144561895|NCT01746108|521258685|FG002|Overall Study|Adverse event, non-fatal|0|||
144561896|NCT01746108|521258683|FG000|Overall Study|Withdrawal by Subject|0|||
144561897|NCT01746108|521258684|FG001|Overall Study|Withdrawal by Subject|1|||
144561898|NCT01746108|521258685|FG002|Overall Study|Withdrawal by Subject|0|||
144561899|NCT01746108|521258683|FG000|Overall Study|Lost to Follow-up|0|||
144561900|NCT01746108|521258684|FG001|Overall Study|Lost to Follow-up|1|||
144561901|NCT01746108|521258685|FG002|Overall Study|Lost to Follow-up|0|||
144561902|NCT01040403|521258687|FG000|Overall Study|Adverse Event|10|||
144561903|NCT01040403|521258687|FG000|Overall Study|Protocol Violation|2|||
144561904|NCT01040403|521258687|FG000|Overall Study|Lost to Follow-up|1|||
144561905|NCT01040403|521258687|FG000|Overall Study|Not treated|1|||
144561906|NCT01040403|521258687|FG000|Overall Study|Other reason not defined above|6|||
144561907|NCT00797511|521258688|FG000|Overall Study|Withdrawal by Subject|1|||
144561908|NCT03036150|521258689|FG000|Overall Study|Withdrawal by Subject|8|||
144561909|NCT03036150|521258690|FG001|Overall Study|Withdrawal by Subject|3|||
144561910|NCT03036150|521258689|FG000|Overall Study|Lost to Follow-up|2|||
144561911|NCT03036150|521258690|FG001|Overall Study|Lost to Follow-up|2|||
144561912|NCT02741713|521258696|FG000|Overall Study|Surgery type changed intra-operatively|2|||
144561913|NCT02741713|521258697|FG001|Overall Study|Surgery type changed intra-operatively|1|||
144561914|NCT00619983|521258700|FG000|Test Drug Alone|Withdrawal by Subject|1|||
144561915|NCT00619983|521258701|FG001|Test Drug Alone|Withdrawal by Subject|0|||
144561916|NCT00619983|521258702|FG002|Test Drug Alone|Withdrawal by Subject|0|||
144561917|NCT00619983|521258703|FG003|Test Drug Alone|Withdrawal by Subject|1|||
144561918|NCT00619983|521258700|FG000|Test Drug Alone|Failure of daily diary device|1|||
144561919|NCT00619983|521258701|FG001|Test Drug Alone|Failure of daily diary device|1|||
144561920|NCT00619983|521258702|FG002|Test Drug Alone|Failure of daily diary device|2|||
144561921|NCT00619983|521258703|FG003|Test Drug Alone|Failure of daily diary device|2|||
144561922|NCT00570921|521258705|FG000|Overall Study|Protocol Violation|1|||
144561923|NCT00570921|521258705|FG000|Overall Study|Physician Decision|1|||
144561924|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
144561925|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
144561926|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
144561927|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
144561928|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
144561929|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
144617762|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
144617763|NCT00440947|521459762|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
144617764|NCT00440947|521459763|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
144617765|NCT00440947|521459764|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
144617766|NCT00440947|521459765|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
144561930|NCT03201900|521258708|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
144203709|NCT04568031|519940386|FG003|Overall Study|Withdrawal by Subject|1|||
144561931|NCT03201900|521258708|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
144561932|NCT03201900|521258708|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
144561933|NCT03201900|521258708|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
144561934|NCT03201900|521258708|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
144561935|NCT03201900|521258708|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
144561936|NCT03201900|521258708|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
144561937|NCT02971228|521258709|FG000|Overall Study|Withdrawal by Subject|1|||
144561938|NCT02971228|521258710|FG001|Overall Study|Withdrawal by Subject|1|||
144561939|NCT02971228|521258711|FG002|Overall Study|Withdrawal by Subject|0|||
144561940|NCT02971228|521258712|FG003|Overall Study|Withdrawal by Subject|0|||
144561941|NCT02971228|521258713|FG004|Overall Study|Withdrawal by Subject|0|||
144561942|NCT02971228|521258709|FG000|Overall Study|Logistical challenges|0|||
144561943|NCT02971228|521258710|FG001|Overall Study|Logistical challenges|1|||
144561944|NCT02971228|521258711|FG002|Overall Study|Logistical challenges|0|||
144561945|NCT02971228|521258712|FG003|Overall Study|Logistical challenges|0|||
144561946|NCT02971228|521258713|FG004|Overall Study|Logistical challenges|0|||
144561947|NCT02560389|521258714|FG000|Overall Study|Lost to Follow-up|1|||
144561948|NCT02560389|521258715|FG001|Overall Study|Lost to Follow-up|2|||
144561949|NCT02560389|521258716|FG002|Overall Study|Lost to Follow-up|2|||
144561950|NCT02560389|521258714|FG000|Overall Study|Tested positive for illicit substance|0|||
144561951|NCT02560389|521258715|FG001|Overall Study|Tested positive for illicit substance|1|||
144561952|NCT02560389|521258716|FG002|Overall Study|Tested positive for illicit substance|0|||
144561953|NCT00550446|521258717|FG000|Up To Week 12|Adverse Event|2|||
144561954|NCT00550446|521258718|FG001|Up To Week 12|Adverse Event|2|||
144561955|NCT00550446|521258719|FG002|Up To Week 12|Adverse Event|0|||
144561956|NCT00550446|521258720|FG003|Up To Week 12|Adverse Event|0|||
144561957|NCT00550446|521258721|FG004|Up To Week 12|Adverse Event|2|||
144617767|NCT00440947|521459766|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
144617768|NCT02898259|521459767|FG000|Overall Study|Adverse Event|0|||
144617769|NCT02898259|521459768|FG001|Overall Study|Adverse Event|0|||
144617770|NCT02898259|521459769|FG002|Overall Study|Adverse Event|1|||
144617771|NCT02898259|521459770|FG003|Overall Study|Adverse Event|0|||
144617772|NCT02898259|521459771|FG004|Overall Study|Adverse Event|0|||
144617773|NCT02898259|521459767|FG000|Overall Study|Lack of Efficacy|1|||
144617774|NCT02898259|521459768|FG001|Overall Study|Lack of Efficacy|1|||
144617775|NCT02898259|521459769|FG002|Overall Study|Lack of Efficacy|3|||
144617776|NCT02898259|521459770|FG003|Overall Study|Lack of Efficacy|0|||
144617777|NCT02898259|521459771|FG004|Overall Study|Lack of Efficacy|0|||
144617778|NCT02898259|521459767|FG000|Overall Study|Lost to Follow-up|0|||
144617779|NCT02898259|521459768|FG001|Overall Study|Lost to Follow-up|0|||
144617780|NCT02898259|521459769|FG002|Overall Study|Lost to Follow-up|1|||
144617781|NCT02898259|521459770|FG003|Overall Study|Lost to Follow-up|0|||
144617782|NCT02898259|521459771|FG004|Overall Study|Lost to Follow-up|0|||
144617783|NCT02898259|521459767|FG000|Overall Study|Transformation before study began|0|||
144617784|NCT02898259|521459768|FG001|Overall Study|Transformation before study began|0|||
144617785|NCT02898259|521459769|FG002|Overall Study|Transformation before study began|0|||
144617786|NCT02898259|521459770|FG003|Overall Study|Transformation before study began|1|||
144617787|NCT02898259|521459771|FG004|Overall Study|Transformation before study began|0|||
144617788|NCT01827670|521459776|FG000|Overall Study|Withdrawal of Consent|3|||
144617789|NCT01827670|521459777|FG001|Overall Study|Withdrawal of Consent|2|||
144617790|NCT01827670|521459776|FG000|Overall Study|Lost to Follow-up|0|||
144617791|NCT01827670|521459777|FG001|Overall Study|Lost to Follow-up|1|||
144617792|NCT03016325|521459782|FG000|Treatment Period|Participant withdrew consent|0|||
144617793|NCT03016325|521459783|FG001|Treatment Period|Participant withdrew consent|1|||
144617794|NCT03016325|521459784|FG002|Treatment Period|Participant withdrew consent|0|||
144617795|NCT03016325|521459785|FG003|Treatment Period|Participant withdrew consent|0|||
144617796|NCT03016325|521459786|FG004|Treatment Period|Participant withdrew consent|0|||
144617797|NCT03016325|521459787|FG005|Treatment Period|Participant withdrew consent|0|||
144617798|NCT03016325|521459788|FG006|Treatment Period|Participant withdrew consent|0|||
144617799|NCT03016325|521459789|FG007|Treatment Period|Participant withdrew consent|0|||
144617800|NCT03016325|521459782|FG000|Treatment Period|Death|0|||
144617801|NCT03016325|521459783|FG001|Treatment Period|Death|0|||
144617802|NCT03016325|521459784|FG002|Treatment Period|Death|0|||
144617803|NCT03016325|521459785|FG003|Treatment Period|Death|0|||
144617804|NCT03016325|521459786|FG004|Treatment Period|Death|2|||
144617805|NCT03016325|521459787|FG005|Treatment Period|Death|0|||
144203710|NCT04188301|519940387|FG000|Month 3|Lost to Follow-up|0|||
144203711|NCT04188301|519940388|FG001|Month 3|Lost to Follow-up|0|||
144203712|NCT04188301|519940389|FG002|Month 3|Lost to Follow-up|1|||
144617806|NCT03016325|521459788|FG006|Treatment Period|Death|0|||
144617807|NCT03016325|521459789|FG007|Treatment Period|Death|0|||
144617808|NCT03016325|521459782|FG000|Treatment Period|Participant refuses assessments|0|||
144617809|NCT03016325|521459783|FG001|Treatment Period|Participant refuses assessments|0|||
144617810|NCT03016325|521459784|FG002|Treatment Period|Participant refuses assessments|1|||
144617811|NCT03016325|521459785|FG003|Treatment Period|Participant refuses assessments|0|||
144617812|NCT03016325|521459786|FG004|Treatment Period|Participant refuses assessments|0|||
144617813|NCT03016325|521459787|FG005|Treatment Period|Participant refuses assessments|0|||
144617814|NCT03016325|521459788|FG006|Treatment Period|Participant refuses assessments|0|||
144617815|NCT03016325|521459789|FG007|Treatment Period|Participant refuses assessments|0|||
144617816|NCT03016325|521459782|FG000|32-Day Follow-Up Period|Death|2|||
144617817|NCT03016325|521459783|FG001|32-Day Follow-Up Period|Death|0|||
144203713|NCT04188301|519940387|FG000|Month 12|Lost to Follow-up|0|||
144203714|NCT04188301|519940388|FG001|Month 12|Lost to Follow-up|0|||
144561958|NCT00550446|521258722|FG005|Up To Week 12|Adverse Event|2|||
144561959|NCT00550446|521258723|FG006|Up To Week 12|Adverse Event|1|||
144561960|NCT00550446|521258724|FG007|Up To Week 12|Adverse Event|0|||
144561961|NCT00550446|521258725|FG008|Up To Week 12|Adverse Event|0|||
144561962|NCT00550446|521258726|FG009|Up To Week 12|Adverse Event|0|||
144561963|NCT00550446|521258727|FG010|Up To Week 12|Adverse Event|0|||
144561964|NCT00550446|521258717|FG000|Up To Week 12|Lack of Efficacy|3|||
144561965|NCT00550446|521258718|FG001|Up To Week 12|Lack of Efficacy|1|||
144561966|NCT00550446|521258719|FG002|Up To Week 12|Lack of Efficacy|0|||
144561967|NCT00550446|521258720|FG003|Up To Week 12|Lack of Efficacy|1|||
144561968|NCT00550446|521258721|FG004|Up To Week 12|Lack of Efficacy|0|||
144561969|NCT00550446|521258722|FG005|Up To Week 12|Lack of Efficacy|3|||
144561970|NCT00550446|521258723|FG006|Up To Week 12|Lack of Efficacy|3|||
144561971|NCT00550446|521258724|FG007|Up To Week 12|Lack of Efficacy|0|||
144561972|NCT00550446|521258725|FG008|Up To Week 12|Lack of Efficacy|0|||
144561973|NCT00550446|521258726|FG009|Up To Week 12|Lack of Efficacy|0|||
144561974|NCT00550446|521258727|FG010|Up To Week 12|Lack of Efficacy|0|||
144561975|NCT00550446|521258717|FG000|Up To Week 12|Lost to Follow-up|0|||
144561976|NCT00550446|521258718|FG001|Up To Week 12|Lost to Follow-up|1|||
144561977|NCT00550446|521258719|FG002|Up To Week 12|Lost to Follow-up|0|||
144561978|NCT00550446|521258720|FG003|Up To Week 12|Lost to Follow-up|0|||
144561979|NCT00550446|521258721|FG004|Up To Week 12|Lost to Follow-up|1|||
144561980|NCT00550446|521258722|FG005|Up To Week 12|Lost to Follow-up|1|||
144561981|NCT00550446|521258723|FG006|Up To Week 12|Lost to Follow-up|2|||
144561982|NCT00550446|521258724|FG007|Up To Week 12|Lost to Follow-up|0|||
144561983|NCT00550446|521258725|FG008|Up To Week 12|Lost to Follow-up|0|||
144561984|NCT00550446|521258726|FG009|Up To Week 12|Lost to Follow-up|0|||
144561985|NCT00550446|521258727|FG010|Up To Week 12|Lost to Follow-up|0|||
144561986|NCT00550446|521258717|FG000|Up To Week 12|Withdrawal by Subject|2|||
144561987|NCT00550446|521258718|FG001|Up To Week 12|Withdrawal by Subject|0|||
144561988|NCT00550446|521258719|FG002|Up To Week 12|Withdrawal by Subject|3|||
144561989|NCT00550446|521258720|FG003|Up To Week 12|Withdrawal by Subject|2|||
144561990|NCT00550446|521258721|FG004|Up To Week 12|Withdrawal by Subject|0|||
144561991|NCT00550446|521258722|FG005|Up To Week 12|Withdrawal by Subject|1|||
144561992|NCT00550446|521258723|FG006|Up To Week 12|Withdrawal by Subject|3|||
144561993|NCT00550446|521258724|FG007|Up To Week 12|Withdrawal by Subject|0|||
144561994|NCT00550446|521258725|FG008|Up To Week 12|Withdrawal by Subject|0|||
144561995|NCT00550446|521258726|FG009|Up To Week 12|Withdrawal by Subject|0|||
144561996|NCT00550446|521258727|FG010|Up To Week 12|Withdrawal by Subject|0|||
144561997|NCT00550446|521258717|FG000|Up To Week 12|Other|3|||
144561998|NCT00550446|521258718|FG001|Up To Week 12|Other|0|||
144561999|NCT00550446|521258719|FG002|Up To Week 12|Other|0|||
144562000|NCT00550446|521258720|FG003|Up To Week 12|Other|0|||
144562001|NCT00550446|521258721|FG004|Up To Week 12|Other|0|||
144562002|NCT00550446|521258722|FG005|Up To Week 12|Other|1|||
144562003|NCT00550446|521258723|FG006|Up To Week 12|Other|4|||
144562004|NCT00550446|521258724|FG007|Up To Week 12|Other|0|||
144562005|NCT00550446|521258725|FG008|Up To Week 12|Other|0|||
144562006|NCT00550446|521258726|FG009|Up To Week 12|Other|0|||
144562007|NCT00550446|521258727|FG010|Up To Week 12|Other|0|||
144562008|NCT00550446|521258717|FG000|Up To Week 12|Randomized not treated|0|||
144562009|NCT00550446|521258718|FG001|Up To Week 12|Randomized not treated|1|||
144562010|NCT00550446|521258719|FG002|Up To Week 12|Randomized not treated|1|||
144562011|NCT00550446|521258720|FG003|Up To Week 12|Randomized not treated|0|||
144562012|NCT00550446|521258721|FG004|Up To Week 12|Randomized not treated|0|||
144562013|NCT00550446|521258722|FG005|Up To Week 12|Randomized not treated|0|||
144562014|NCT00550446|521258723|FG006|Up To Week 12|Randomized not treated|0|||
144562015|NCT00550446|521258724|FG007|Up To Week 12|Randomized not treated|0|||
144562016|NCT00550446|521258725|FG008|Up To Week 12|Randomized not treated|0|||
144562017|NCT00550446|521258726|FG009|Up To Week 12|Randomized not treated|0|||
144562018|NCT00550446|521258727|FG010|Up To Week 12|Randomized not treated|0|||
144562019|NCT00550446|521258717|FG000|Post Week 12|Adverse Event|2|||
144562020|NCT00550446|521258718|FG001|Post Week 12|Adverse Event|1|||
144562021|NCT00550446|521258719|FG002|Post Week 12|Adverse Event|1|||
144562022|NCT00550446|521258720|FG003|Post Week 12|Adverse Event|1|||
144562023|NCT00550446|521258721|FG004|Post Week 12|Adverse Event|1|||
144562024|NCT00550446|521258722|FG005|Post Week 12|Adverse Event|1|||
144562025|NCT00550446|521258723|FG006|Post Week 12|Adverse Event|0|||
144562026|NCT00550446|521258724|FG007|Post Week 12|Adverse Event|0|||
144562027|NCT00550446|521258725|FG008|Post Week 12|Adverse Event|0|||
144562028|NCT00550446|521258726|FG009|Post Week 12|Adverse Event|4|||
144562029|NCT00550446|521258727|FG010|Post Week 12|Adverse Event|0|||
144562030|NCT00550446|521258717|FG000|Post Week 12|Lack of Efficacy|0|||
144562031|NCT00550446|521258718|FG001|Post Week 12|Lack of Efficacy|0|||
144562032|NCT00550446|521258719|FG002|Post Week 12|Lack of Efficacy|1|||
144562033|NCT00550446|521258720|FG003|Post Week 12|Lack of Efficacy|0|||
144562034|NCT00550446|521258721|FG004|Post Week 12|Lack of Efficacy|0|||
144562035|NCT00550446|521258722|FG005|Post Week 12|Lack of Efficacy|0|||
144562036|NCT00550446|521258723|FG006|Post Week 12|Lack of Efficacy|0|||
144562037|NCT00550446|521258724|FG007|Post Week 12|Lack of Efficacy|1|||
144562038|NCT00550446|521258725|FG008|Post Week 12|Lack of Efficacy|1|||
144562039|NCT00550446|521258726|FG009|Post Week 12|Lack of Efficacy|2|||
144562040|NCT00550446|521258727|FG010|Post Week 12|Lack of Efficacy|1|||
144203715|NCT04188301|519940389|FG002|Month 12|Lost to Follow-up|2|||
144203716|NCT04188301|519940387|FG000|Month 12|Death|1|||
144203717|NCT04188301|519940388|FG001|Month 12|Death|1|||
144203718|NCT04188301|519940389|FG002|Month 12|Death|0|||
144203719|NCT04188301|519940387|FG000|Month 18|Lost to Follow-up|6|||
144203720|NCT04188301|519940388|FG001|Month 18|Lost to Follow-up|0|||
144203721|NCT04188301|519940389|FG002|Month 18|Lost to Follow-up|0|||
144203722|NCT01770392|519940390|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
144203723|NCT03401450|519940391|FG000|Overall Study|Lost to Follow-up|4|||
144203724|NCT03401450|519940392|FG001|Overall Study|Lost to Follow-up|6|||
144203725|NCT03401450|519940391|FG000|Overall Study|Anesthesia plan changed|2|||
144203726|NCT03401450|519940392|FG001|Overall Study|Anesthesia plan changed|2|||
144203727|NCT03401450|519940391|FG000|Overall Study|Did not complete medication diary|4|||
144203728|NCT03401450|519940392|FG001|Overall Study|Did not complete medication diary|2|||
144203729|NCT03401450|519940391|FG000|Overall Study|post surgery medication change|2|||
144203730|NCT03401450|519940392|FG001|Overall Study|post surgery medication change|1|||
144203731|NCT03401450|519940391|FG000|Overall Study|Cancelled surgery|0|||
144203732|NCT03401450|519940392|FG001|Overall Study|Cancelled surgery|2|||
144203733|NCT03567382|519940412|FG000|Overall Study|Lost to Follow-up|1|||
144203734|NCT03567382|519940413|FG001|Overall Study|Lost to Follow-up|21|||
144203735|NCT03567382|519940414|FG002|Overall Study|Lost to Follow-up|1|||
144203736|NCT03567382|519940415|FG003|Overall Study|Lost to Follow-up|21|||
144203737|NCT03567382|519940412|FG000|Overall Study|Withdrawal by Subject|2|||
144203738|NCT03567382|519940413|FG001|Overall Study|Withdrawal by Subject|14|||
144203739|NCT03567382|519940414|FG002|Overall Study|Withdrawal by Subject|1|||
144203740|NCT03567382|519940415|FG003|Overall Study|Withdrawal by Subject|12|||
144562041|NCT00550446|521258717|FG000|Post Week 12|Lost to Follow-up|0|||
144562042|NCT00550446|521258718|FG001|Post Week 12|Lost to Follow-up|0|||
144562043|NCT00550446|521258719|FG002|Post Week 12|Lost to Follow-up|1|||
144562044|NCT00550446|521258720|FG003|Post Week 12|Lost to Follow-up|1|||
144562045|NCT00550446|521258721|FG004|Post Week 12|Lost to Follow-up|0|||
144203741|NCT01709838|519940416|FG000|Overall Study|Withdrawal by Subject|21|||
144203742|NCT01709838|519940416|FG000|Overall Study|Lost to Follow-up|16|||
144203743|NCT01709838|519940416|FG000|Overall Study|Pregnancy|10|||
144203744|NCT01709838|519940416|FG000|Overall Study|Subject/guardian decision|8|||
144203745|NCT01709838|519940416|FG000|Overall Study|Adverse Event|4|||
144203746|NCT01709838|519940416|FG000|Overall Study|Physician Decision|4|||
144203747|NCT01709838|519940416|FG000|Overall Study|Death|3|||
144203748|NCT01709838|519940416|FG000|Overall Study|Protocol Violation|1|||
144203749|NCT00620659|519940417|FG000|Treatment Period 1|Adverse Event|1|||
144203750|NCT00620659|519940418|FG001|Treatment Period 1|Adverse Event|0|||
144203751|NCT00620659|519940419|FG002|Treatment Period 1|Adverse Event|0|||
144203752|NCT00620659|519940420|FG003|Treatment Period 1|Adverse Event|3|||
144203753|NCT00620659|519940421|FG004|Treatment Period 1|Adverse Event|0|||
144203754|NCT00620659|519940422|FG005|Treatment Period 1|Adverse Event|0|||
144203755|NCT00620659|519940417|FG000|Treatment Period 1|Protocol Violation|1|||
144203756|NCT00620659|519940418|FG001|Treatment Period 1|Protocol Violation|0|||
144203757|NCT00620659|519940419|FG002|Treatment Period 1|Protocol Violation|0|||
144562046|NCT00550446|521258722|FG005|Post Week 12|Lost to Follow-up|0|||
144203758|NCT00620659|519940420|FG003|Treatment Period 1|Protocol Violation|0|||
144203759|NCT00620659|519940421|FG004|Treatment Period 1|Protocol Violation|0|||
144203760|NCT00620659|519940422|FG005|Treatment Period 1|Protocol Violation|0|||
144203761|NCT00620659|519940417|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144262523|NCT01272908|520161468|FG000|Re-Treatment Period|Adverse Event|2|||
144262524|NCT01272908|520161468|FG000|Re-Treatment Period|Lack of Efficacy|3|||
144262525|NCT01272908|520161468|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
144262526|NCT02221648|520161469|FG000|Overall Study|Withdrawal by Subject|3|||
144262527|NCT02221648|520161470|FG001|Overall Study|Withdrawal by Subject|3|||
144262528|NCT00149396|520161471|FG000|Overall Study|Death|15|||
144562047|NCT00550446|521258723|FG006|Post Week 12|Lost to Follow-up|1|||
144562048|NCT00550446|521258724|FG007|Post Week 12|Lost to Follow-up|0|||
144562049|NCT00550446|521258725|FG008|Post Week 12|Lost to Follow-up|0|||
144562050|NCT00550446|521258726|FG009|Post Week 12|Lost to Follow-up|0|||
144562051|NCT00550446|521258727|FG010|Post Week 12|Lost to Follow-up|0|||
144562052|NCT00550446|521258717|FG000|Post Week 12|Withdrawal by Subject|0|||
144562053|NCT00550446|521258718|FG001|Post Week 12|Withdrawal by Subject|0|||
144562054|NCT00550446|521258719|FG002|Post Week 12|Withdrawal by Subject|0|||
144562055|NCT00550446|521258720|FG003|Post Week 12|Withdrawal by Subject|0|||
144203762|NCT00620659|519940418|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144203763|NCT00620659|519940419|FG002|Treatment Period 1|Withdrawal by Subject|1|||
144203764|NCT00620659|519940420|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144203765|NCT00620659|519940421|FG004|Treatment Period 1|Withdrawal by Subject|1|||
144203766|NCT00620659|519940422|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144203767|NCT00620659|519940417|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
144203768|NCT00620659|519940418|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
144203769|NCT00620659|519940419|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
144203770|NCT00620659|519940420|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
144262529|NCT00149396|520161471|FG000|Overall Study|Withdrawal by Subject|1|||
144562056|NCT00550446|521258721|FG004|Post Week 12|Withdrawal by Subject|1|||
144562057|NCT00550446|521258722|FG005|Post Week 12|Withdrawal by Subject|0|||
144562058|NCT00550446|521258723|FG006|Post Week 12|Withdrawal by Subject|0|||
144562059|NCT00550446|521258724|FG007|Post Week 12|Withdrawal by Subject|0|||
144562060|NCT00550446|521258725|FG008|Post Week 12|Withdrawal by Subject|0|||
144562061|NCT00550446|521258726|FG009|Post Week 12|Withdrawal by Subject|0|||
144562062|NCT00550446|521258727|FG010|Post Week 12|Withdrawal by Subject|0|||
144562063|NCT00550446|521258717|FG000|Post Week 12|Other|1|||
144562064|NCT00550446|521258718|FG001|Post Week 12|Other|1|||
144562065|NCT00550446|521258719|FG002|Post Week 12|Other|0|||
144562066|NCT00550446|521258720|FG003|Post Week 12|Other|1|||
144562067|NCT00550446|521258721|FG004|Post Week 12|Other|0|||
144562068|NCT00550446|521258722|FG005|Post Week 12|Other|0|||
144562069|NCT00550446|521258723|FG006|Post Week 12|Other|1|||
144562070|NCT00550446|521258724|FG007|Post Week 12|Other|0|||
144562071|NCT00550446|521258725|FG008|Post Week 12|Other|1|||
144562072|NCT00550446|521258726|FG009|Post Week 12|Other|1|||
144562073|NCT00550446|521258727|FG010|Post Week 12|Other|0|||
144562074|NCT02716298|521258728|FG000|First Intervention (1 Month)|Lens discomfort|1|||
144562075|NCT02716298|521258729|FG001|First Intervention (1 Month)|Lens discomfort|1|||
144562076|NCT04081389|521258731|FG000|Overall Study|Withdrawal by Subject|0|||
144562077|NCT04081389|521258732|FG001|Overall Study|Withdrawal by Subject|0|||
144562078|NCT04081389|521258733|FG002|Overall Study|Withdrawal by Subject|1|||
144562079|NCT04081389|521258734|FG003|Overall Study|Withdrawal by Subject|0|||
144562080|NCT01670188|521258743|FG000|Overall Study|Death|0|||
144562081|NCT01670188|521258744|FG001|Overall Study|Death|1|||
144562082|NCT00866918|521258747|FG000|Overall Study|Death|1|||
144562083|NCT00866918|521258748|FG001|Overall Study|Death|5|||
144562084|NCT00866918|521258747|FG000|Overall Study|Lack of Efficacy|1|||
144562085|NCT00866918|521258748|FG001|Overall Study|Lack of Efficacy|1|||
144562086|NCT00866918|521258747|FG000|Overall Study|Physician Decision|10|||
144562087|NCT00866918|521258748|FG001|Overall Study|Physician Decision|2|||
144562088|NCT00866918|521258747|FG000|Overall Study|Ineligible|2|||
144562089|NCT00866918|521258748|FG001|Overall Study|Ineligible|4|||
144562090|NCT00866918|521258747|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
144562091|NCT00866918|521258748|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
144562092|NCT00866918|521258747|FG000|Overall Study|Secondary malignancy|1|||
144562093|NCT00866918|521258748|FG001|Overall Study|Secondary malignancy|0|||
144562094|NCT00802438|521258749|FG000|Overall Study|Screen Failure|20|||
144562095|NCT00802438|521258749|FG000|Overall Study|Withdrawal by Subject|7|||
144562096|NCT00802438|521258749|FG000|Overall Study|Physician Decision|1|||
144562097|NCT03175198|521258751|FG000|Overall Study|Adverse Event|480|||
144562098|NCT03175198|521258751|FG000|Overall Study|No actual visit|120|||
144562099|NCT03175198|521258751|FG000|Overall Study|Registration rule not followed|4|||
144562100|NCT03175198|521258751|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
144562101|NCT03175198|521258751|FG000|Overall Study|Other personal reason|509|||
144562102|NCT03175198|521258751|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
144562103|NCT03175198|521258751|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
144562104|NCT03175198|521258751|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
144562105|NCT03175198|521258751|FG000|Overall Study|To conduct invasive treatment of operation|53|||
144562106|NCT03175198|521258751|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
144562107|NCT02101268|521258753|FG000|Randomized Treatment Phase|Subject Decision|8|||
144562108|NCT02101268|521258754|FG001|Randomized Treatment Phase|Subject Decision|4|||
144562109|NCT02101268|521258755|FG002|Randomized Treatment Phase|Subject Decision|0|||
144562110|NCT02101268|521258756|FG003|Randomized Treatment Phase|Subject Decision|0|||
144562111|NCT02101268|521258753|FG000|Randomized Treatment Phase|Physician Decision|4|||
144562112|NCT02101268|521258754|FG001|Randomized Treatment Phase|Physician Decision|1|||
144562113|NCT02101268|521258755|FG002|Randomized Treatment Phase|Physician Decision|0|||
144562114|NCT02101268|521258756|FG003|Randomized Treatment Phase|Physician Decision|0|||
144562115|NCT02101268|521258753|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
144562116|NCT02101268|521258754|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
144562117|NCT02101268|521258755|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
144562118|NCT02101268|521258756|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
144562119|NCT02101268|521258753|FG000|Randomized Treatment Phase|Adverse Event|6|||
144562120|NCT02101268|521258754|FG001|Randomized Treatment Phase|Adverse Event|0|||
144562121|NCT02101268|521258755|FG002|Randomized Treatment Phase|Adverse Event|0|||
144562122|NCT02101268|521258756|FG003|Randomized Treatment Phase|Adverse Event|0|||
144562123|NCT02101268|521258753|FG000|Randomized Treatment Phase|Death|5|||
144617818|NCT03016325|521459784|FG002|32-Day Follow-Up Period|Death|5|||
144617819|NCT03016325|521459785|FG003|32-Day Follow-Up Period|Death|6|||
144562124|NCT02101268|521258754|FG001|Randomized Treatment Phase|Death|4|||
144562125|NCT02101268|521258755|FG002|Randomized Treatment Phase|Death|0|||
144562126|NCT02101268|521258756|FG003|Randomized Treatment Phase|Death|0|||
144562127|NCT02101268|521258753|FG000|Randomized Treatment Phase|Disease Progression|4|||
144562128|NCT02101268|521258754|FG001|Randomized Treatment Phase|Disease Progression|1|||
144617820|NCT03016325|521459786|FG004|32-Day Follow-Up Period|Death|3|||
144562129|NCT02101268|521258755|FG002|Randomized Treatment Phase|Disease Progression|0|||
144562130|NCT02101268|521258756|FG003|Randomized Treatment Phase|Disease Progression|0|||
144203771|NCT00620659|519940421|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
144203772|NCT00620659|519940422|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
144203773|NCT00620659|519940417|FG000|Treatment Period 2|Adverse Event|0|||
144562131|NCT02101268|521258753|FG000|Extended Treatment Phase|Subject Decision|0|||
144562132|NCT02101268|521258754|FG001|Extended Treatment Phase|Subject Decision|0|||
144562133|NCT02101268|521258755|FG002|Extended Treatment Phase|Subject Decision|3|||
144562134|NCT02101268|521258756|FG003|Extended Treatment Phase|Subject Decision|2|||
144562135|NCT02101268|521258753|FG000|Extended Treatment Phase|Physician Decision|0|||
144562136|NCT02101268|521258754|FG001|Extended Treatment Phase|Physician Decision|0|||
144562137|NCT02101268|521258755|FG002|Extended Treatment Phase|Physician Decision|5|||
144562138|NCT02101268|521258756|FG003|Extended Treatment Phase|Physician Decision|2|||
144562139|NCT02101268|521258753|FG000|Extended Treatment Phase|Adverse Event|0|||
144562140|NCT02101268|521258754|FG001|Extended Treatment Phase|Adverse Event|0|||
144562141|NCT02101268|521258755|FG002|Extended Treatment Phase|Adverse Event|14|||
144562142|NCT02101268|521258756|FG003|Extended Treatment Phase|Adverse Event|18|||
144562143|NCT02101268|521258753|FG000|Extended Treatment Phase|Death|0|||
144562144|NCT02101268|521258754|FG001|Extended Treatment Phase|Death|0|||
144562145|NCT02101268|521258755|FG002|Extended Treatment Phase|Death|5|||
144562146|NCT02101268|521258756|FG003|Extended Treatment Phase|Death|1|||
144562147|NCT02101268|521258753|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
144562148|NCT02101268|521258754|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
144562149|NCT02101268|521258755|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
144562150|NCT02101268|521258756|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
144562151|NCT02101268|521258753|FG000|Extended Treatment Phase|Disease Progression|0|||
144562152|NCT02101268|521258754|FG001|Extended Treatment Phase|Disease Progression|0|||
144562153|NCT02101268|521258755|FG002|Extended Treatment Phase|Disease Progression|13|||
144562154|NCT02101268|521258756|FG003|Extended Treatment Phase|Disease Progression|6|||
144562155|NCT02101268|521258753|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
144562156|NCT02101268|521258754|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
144562157|NCT02101268|521258755|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
144562158|NCT02101268|521258756|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
144562159|NCT02630706|521258758|FG000|Overall Study|Adverse Event|2|||
144562160|NCT02630706|521258759|FG001|Overall Study|Adverse Event|1|||
144562161|NCT02630706|521258760|FG002|Overall Study|Adverse Event|1|||
144562162|NCT02630706|521258758|FG000|Overall Study|Lost to Follow-up|0|||
144562163|NCT02630706|521258759|FG001|Overall Study|Lost to Follow-up|1|||
144562164|NCT02630706|521258760|FG002|Overall Study|Lost to Follow-up|2|||
144562165|NCT02630706|521258758|FG000|Overall Study|Physician Decision|1|||
144562166|NCT02630706|521258759|FG001|Overall Study|Physician Decision|1|||
144562167|NCT02630706|521258760|FG002|Overall Study|Physician Decision|0|||
144562168|NCT02630706|521258758|FG000|Overall Study|Pregnancy|0|||
144562169|NCT02630706|521258759|FG001|Overall Study|Pregnancy|1|||
144562170|NCT02630706|521258760|FG002|Overall Study|Pregnancy|0|||
144562171|NCT02630706|521258758|FG000|Overall Study|Withdrawal by Subject|4|||
144562172|NCT02630706|521258759|FG001|Overall Study|Withdrawal by Subject|5|||
144562173|NCT02630706|521258760|FG002|Overall Study|Withdrawal by Subject|7|||
144562174|NCT01544309|521258765|FG000|Overall Study|Withdrawal by Subject|12|||
144562175|NCT01544309|521258766|FG001|Overall Study|Withdrawal by Subject|7|||
144562176|NCT01544309|521258765|FG000|Overall Study|Protocol Violation|2|||
144562177|NCT01544309|521258766|FG001|Overall Study|Protocol Violation|1|||
144562178|NCT01544309|521258765|FG000|Overall Study|Physician Decision|4|||
144562179|NCT01544309|521258766|FG001|Overall Study|Physician Decision|1|||
144562180|NCT01544309|521258765|FG000|Overall Study|Not performed pre-dose examination|1|||
144562181|NCT01544309|521258766|FG001|Overall Study|Not performed pre-dose examination|2|||
144562182|NCT01544309|521258765|FG000|Overall Study|Administered prohibit prior medication|1|||
144562183|NCT01544309|521258766|FG001|Overall Study|Administered prohibit prior medication|0|||
144562184|NCT02551692|521258771|FG000|Overall Study|Lost to Follow-up|0|||
144562185|NCT02551692|521258772|FG001|Overall Study|Lost to Follow-up|1|||
144562186|NCT02551692|521258773|FG002|Overall Study|Lost to Follow-up|4|||
144562187|NCT02551692|521258771|FG000|Overall Study|Withdrawal by Subject|1|||
144562188|NCT02551692|521258772|FG001|Overall Study|Withdrawal by Subject|0|||
144203774|NCT00620659|519940418|FG001|Treatment Period 2|Adverse Event|3|||
144203775|NCT00620659|519940419|FG002|Treatment Period 2|Adverse Event|0|||
144562189|NCT02551692|521258773|FG002|Overall Study|Withdrawal by Subject|1|||
144562190|NCT01091519|521258774|FG000|Overall Study|Adverse Event|12|||
144562191|NCT01091519|521258775|FG001|Overall Study|Adverse Event|16|||
144562192|NCT01091519|521258774|FG000|Overall Study|Death|1|||
144562193|NCT01091519|521258775|FG001|Overall Study|Death|0|||
144203776|NCT00620659|519940420|FG003|Treatment Period 2|Adverse Event|0|||
144562194|NCT01091519|521258774|FG000|Overall Study|Lack of Efficacy|16|||
144562195|NCT01091519|521258775|FG001|Overall Study|Lack of Efficacy|19|||
144562196|NCT01091519|521258774|FG000|Overall Study|Lost to Follow-up|14|||
144562197|NCT01091519|521258775|FG001|Overall Study|Lost to Follow-up|24|||
144562198|NCT01091519|521258774|FG000|Overall Study|Withdrawal by Subject|2|||
144562199|NCT01091519|521258775|FG001|Overall Study|Withdrawal by Subject|2|||
144562200|NCT01091519|521258774|FG000|Overall Study|Other|6|||
144562201|NCT01091519|521258775|FG001|Overall Study|Other|8|||
144562202|NCT01091519|521258774|FG000|Overall Study|Randomized not treated|4|||
144562203|NCT01091519|521258775|FG001|Overall Study|Randomized not treated|4|||
144562204|NCT01196741|521258778|FG000|Overall Study|Disease progression|34|||
144562205|NCT01196741|521258779|FG001|Overall Study|Disease progression|14|||
144562206|NCT01196741|521258778|FG000|Overall Study|Adverse Event|10|||
144562207|NCT01196741|521258779|FG001|Overall Study|Adverse Event|6|||
144562208|NCT01196741|521258778|FG000|Overall Study|Serious Adverse Event|3|||
144562209|NCT01196741|521258779|FG001|Overall Study|Serious Adverse Event|1|||
144562210|NCT01196741|521258778|FG000|Overall Study|Dose limiting Adverse Event|2|||
144562211|NCT01196741|521258779|FG001|Overall Study|Dose limiting Adverse Event|1|||
144562212|NCT01196741|521258778|FG000|Overall Study|Withdrawal by Subject|3|||
144562213|NCT01196741|521258779|FG001|Overall Study|Withdrawal by Subject|0|||
144562214|NCT01196741|521258778|FG000|Overall Study|Other reason|3|||
144562215|NCT01196741|521258779|FG001|Overall Study|Other reason|3|||
144562216|NCT01196741|521258778|FG000|Overall Study|Other|3|||
144562217|NCT01196741|521258779|FG001|Overall Study|Other|2|||
144562218|NCT01196741|521258778|FG000|Overall Study|Protocol Violation|2|||
144562219|NCT01196741|521258779|FG001|Overall Study|Protocol Violation|1|||
144562220|NCT01227928|521258780|FG000|Overall Study|Lost to Follow-up|4|||
144562221|NCT01227928|521258781|FG001|Overall Study|Lost to Follow-up|2|||
144562222|NCT01227928|521258780|FG000|Overall Study|Withdrawal by Subject|4|||
144562223|NCT01227928|521258781|FG001|Overall Study|Withdrawal by Subject|3|||
144562224|NCT01227928|521258780|FG000|Overall Study|Death|14|||
144562225|NCT01227928|521258781|FG001|Overall Study|Death|12|||
144562226|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
144562227|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
144562228|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
144562229|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Other|1|||
144562230|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Other|0|||
144562231|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Other|0|||
144728302|NCT01648166|521861201|FG000|Overall Study|inadequate toenail samples|53|||
144728303|NCT01648166|521861202|FG001|Overall Study|inadequate toenail samples|100|||
144562232|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Physician Decision|3|||
144562233|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Physician Decision|0|||
144562234|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Physician Decision|0|||
144562235|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
144562236|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
144562237|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
144562238|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
144562239|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
144562240|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
144562241|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Adverse Event|18|||
144562242|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Adverse Event|0|||
144562243|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Adverse Event|0|||
144562244|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
144562245|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
144562246|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
144562247|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
144562248|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
144562249|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
144562250|NCT03030599|521258782|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
144562251|NCT03030599|521258783|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
144562252|NCT03030599|521258784|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
144562253|NCT03030599|521258782|FG000|Stable Dose|Protocol deviation|3|||
144562254|NCT03030599|521258783|FG001|Stable Dose|Protocol deviation|0|||
144562255|NCT03030599|521258784|FG002|Stable Dose|Protocol deviation|0|||
144562256|NCT03030599|521258782|FG000|Stable Dose|Adverse Event|1|||
144728304|NCT00883090|521861203|FG000|Overall Study|Sponsor's decision|1|||
144728305|NCT00883090|521861203|FG000|Overall Study|Withdrawal by Subject|1|||
144562257|NCT03030599|521258783|FG001|Stable Dose|Adverse Event|0|||
144562258|NCT03030599|521258784|FG002|Stable Dose|Adverse Event|0|||
144562259|NCT03030599|521258782|FG000|Stable Dose|Lost to Follow-up|1|||
144562260|NCT03030599|521258783|FG001|Stable Dose|Lost to Follow-up|0|||
144562261|NCT03030599|521258784|FG002|Stable Dose|Lost to Follow-up|0|||
144562262|NCT03030599|521258782|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
144562263|NCT03030599|521258783|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
144562264|NCT03030599|521258784|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
144562265|NCT03030599|521258782|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
144562266|NCT03030599|521258783|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
144728306|NCT02532764|521861204|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144562267|NCT03030599|521258784|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
144562268|NCT03030599|521258782|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
144562269|NCT03030599|521258783|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
144562270|NCT03030599|521258784|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
144562271|NCT03030599|521258782|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
144562272|NCT03030599|521258783|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
144562273|NCT03030599|521258784|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
144562274|NCT03030599|521258782|FG000|Open-label Extension|Adverse Event|3|||
144562275|NCT03030599|521258783|FG001|Open-label Extension|Adverse Event|0|||
144562276|NCT03030599|521258784|FG002|Open-label Extension|Adverse Event|0|||
144562277|NCT03030599|521258782|FG000|Open-label Extension|Lost to Follow-up|2|||
144562278|NCT03030599|521258783|FG001|Open-label Extension|Lost to Follow-up|0|||
144562279|NCT03030599|521258784|FG002|Open-label Extension|Lost to Follow-up|0|||
144562280|NCT03030599|521258782|FG000|Open-label Extension|Lack of Efficacy|1|||
144562281|NCT03030599|521258783|FG001|Open-label Extension|Lack of Efficacy|0|||
144562282|NCT03030599|521258784|FG002|Open-label Extension|Lack of Efficacy|0|||
144562283|NCT03030599|521258782|FG000|Open-label Extension|Other Reason|1|||
144562284|NCT03030599|521258783|FG001|Open-label Extension|Other Reason|0|||
144562285|NCT03030599|521258784|FG002|Open-label Extension|Other Reason|0|||
144562286|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
144562287|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
144562288|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
144562289|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
144562290|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
144562291|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
144562292|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
144562293|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
144562294|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
144562295|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
144562296|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
144562297|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
144562298|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
144562299|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
144562300|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
144562301|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
144562302|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
144562303|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
144562304|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
144562305|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
144562306|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
144617821|NCT03016325|521459787|FG005|32-Day Follow-Up Period|Death|0|||
144617822|NCT03016325|521459788|FG006|32-Day Follow-Up Period|Death|0|||
144617823|NCT03016325|521459789|FG007|32-Day Follow-Up Period|Death|0|||
144617824|NCT03016325|521459782|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
144617825|NCT03016325|521459783|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
144617826|NCT03016325|521459784|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
144617827|NCT03016325|521459785|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
144617828|NCT03016325|521459786|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
144617829|NCT03016325|521459787|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
144617830|NCT03016325|521459788|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
144617831|NCT03016325|521459789|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
144617832|NCT03016325|521459782|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
144617833|NCT03016325|521459783|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
144617834|NCT03016325|521459784|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
144617835|NCT03016325|521459785|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
144617836|NCT03016325|521459786|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
144617837|NCT03016325|521459787|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
144617838|NCT03016325|521459788|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
144617839|NCT03016325|521459789|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
144617840|NCT03016325|521459782|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
144617841|NCT03016325|521459783|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
144617842|NCT03016325|521459784|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
144617843|NCT03016325|521459785|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
144617844|NCT03016325|521459786|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
144617845|NCT03016325|521459787|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
144617846|NCT03016325|521459788|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
144617847|NCT03016325|521459789|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
144617848|NCT03016325|521459782|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
144617849|NCT03016325|521459783|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
144562307|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
144562308|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
144562309|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
144562310|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
144562311|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
144562312|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
144562313|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
144562314|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
144562315|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
144562316|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
144562317|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
144562318|NCT00092521|521260417|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
144562319|NCT00092521|521260418|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
144562320|NCT00092521|521260419|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
144562321|NCT00092521|521260420|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
144562322|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
144562323|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
144562324|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
144562325|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
144562326|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
144562327|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
144562328|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
144562329|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
144562330|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
144562331|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
144562332|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
144562333|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
144562334|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Death|2|||
144562335|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Death|0|||
144562336|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Death|1|||
144617850|NCT03016325|521459784|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
144617851|NCT03016325|521459785|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
144617852|NCT03016325|521459786|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
144617853|NCT03016325|521459787|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
144617854|NCT03016325|521459788|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
144617855|NCT03016325|521459789|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
144617856|NCT03016325|521459782|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617857|NCT03016325|521459783|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617858|NCT03016325|521459784|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
144617859|NCT03016325|521459785|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617860|NCT03016325|521459786|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617861|NCT03016325|521459787|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617862|NCT03016325|521459788|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617863|NCT03016325|521459789|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
144617864|NCT03016325|521459782|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617865|NCT03016325|521459783|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
144617866|NCT03016325|521459784|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617867|NCT03016325|521459785|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617868|NCT03016325|521459786|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617869|NCT03016325|521459787|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617870|NCT03016325|521459788|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617871|NCT03016325|521459789|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
144617872|NCT03016325|521459782|FG000|182-Day Follow-Up Period|Death|3|||
144617873|NCT03016325|521459783|FG001|182-Day Follow-Up Period|Death|3|||
144617874|NCT03016325|521459784|FG002|182-Day Follow-Up Period|Death|11|||
144617875|NCT03016325|521459785|FG003|182-Day Follow-Up Period|Death|12|||
144617876|NCT03016325|521459786|FG004|182-Day Follow-Up Period|Death|9|||
144617877|NCT03016325|521459787|FG005|182-Day Follow-Up Period|Death|0|||
144617878|NCT03016325|521459788|FG006|182-Day Follow-Up Period|Death|0|||
144617879|NCT03016325|521459789|FG007|182-Day Follow-Up Period|Death|1|||
144617880|NCT03016325|521459782|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
144617881|NCT03016325|521459783|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144617882|NCT03016325|521459784|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144617883|NCT03016325|521459785|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144617884|NCT03016325|521459786|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144562337|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Death|0|||
144562338|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
144562339|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
144562340|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
144562341|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
144562342|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
144562343|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
144562344|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
144562345|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
144562346|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
144562347|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
144562348|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
144562349|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
144562350|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Moved|32|||
144562351|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Moved|2|||
144562352|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Moved|28|||
144562353|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Moved|0|||
144562354|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
144562355|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
144562356|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
144562357|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
144562358|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Travel|2|||
144562359|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Travel|0|||
144562360|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Travel|0|||
144562361|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Travel|0|||
144562362|NCT00092521|521260417|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
144562363|NCT00092521|521260418|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
144562364|NCT00092521|521260419|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
144562365|NCT00092521|521260420|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
144562366|NCT00092521|521260417|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
144562367|NCT00092521|521260418|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
144562368|NCT00092521|521260419|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
144562369|NCT00092521|521260420|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
144562370|NCT00092521|521260417|FG000|Extension Study (Group 4)|Adverse Event|0|||
144562371|NCT00092521|521260418|FG001|Extension Study (Group 4)|Adverse Event|0|||
144562372|NCT00092521|521260419|FG002|Extension Study (Group 4)|Adverse Event|0|||
144562373|NCT00092521|521260420|FG003|Extension Study (Group 4)|Adverse Event|2|||
144562374|NCT00092521|521260417|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
144562375|NCT00092521|521260418|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
144562376|NCT00092521|521260419|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
144562377|NCT00092521|521260420|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
144562378|NCT00092521|521260417|FG000|Extension Study (Group 4)|Pregnancy|0|||
144562379|NCT00092521|521260418|FG001|Extension Study (Group 4)|Pregnancy|0|||
144562380|NCT00092521|521260419|FG002|Extension Study (Group 4)|Pregnancy|0|||
144562381|NCT00092521|521260420|FG003|Extension Study (Group 4)|Pregnancy|4|||
144562382|NCT00092521|521260417|FG000|Extension Study (Group 4)|Protocol Violation|0|||
144562383|NCT00092521|521260418|FG001|Extension Study (Group 4)|Protocol Violation|0|||
144562384|NCT00092521|521260419|FG002|Extension Study (Group 4)|Protocol Violation|0|||
144562385|NCT00092521|521260420|FG003|Extension Study (Group 4)|Protocol Violation|2|||
144562386|NCT00092521|521260417|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
144562387|NCT00092521|521260418|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
144562388|NCT00092521|521260419|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
144562389|NCT00092521|521260420|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
144562390|NCT00092521|521260417|FG000|Extension Study (Group 4)|Moved|0|||
144562391|NCT00092521|521260418|FG001|Extension Study (Group 4)|Moved|0|||
144562392|NCT00092521|521260419|FG002|Extension Study (Group 4)|Moved|0|||
144562393|NCT00092521|521260420|FG003|Extension Study (Group 4)|Moved|16|||
144562394|NCT00092521|521260417|FG000|Extension Study (Group 4)|Site Terminated|0|||
144562395|NCT00092521|521260418|FG001|Extension Study (Group 4)|Site Terminated|0|||
144562396|NCT00092521|521260419|FG002|Extension Study (Group 4)|Site Terminated|0|||
144562397|NCT00092521|521260420|FG003|Extension Study (Group 4)|Site Terminated|4|||
144562398|NCT00092521|521260417|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
144562399|NCT00092521|521260418|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
144562400|NCT00092521|521260419|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
144562401|NCT00092521|521260420|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
144562402|NCT01878383|521260421|FG000|Overall Study|Lost to Follow-up|0|||
144562403|NCT01878383|521260422|FG001|Overall Study|Lost to Follow-up|1499|||
144562404|NCT03464383|521260423|FG000|Overall Study|Lost to Follow-up|1|||
144562405|NCT03464383|521260424|FG001|Overall Study|Lost to Follow-up|0|||
144562406|NCT03464383|521260425|FG002|Overall Study|Lost to Follow-up|0|||
144562407|NCT03464383|521260423|FG000|Overall Study|Withdrawal by Subject|0|||
144562408|NCT03464383|521260424|FG001|Overall Study|Withdrawal by Subject|1|||
144562409|NCT03464383|521260425|FG002|Overall Study|Withdrawal by Subject|0|||
144562410|NCT03475056|521260426|FG000|Overall Study|Lost to Follow-up|0|||
144562411|NCT03475056|521260427|FG001|Overall Study|Lost to Follow-up|1|||
144562412|NCT03475056|521260426|FG000|Overall Study|Moved from Area|0|||
144562413|NCT03475056|521260427|FG001|Overall Study|Moved from Area|2|||
144562414|NCT01904136|521260431|FG000|Overall Study|Physician Decision|0|||
144562415|NCT01904136|521260432|FG001|Overall Study|Physician Decision|0|||
144562416|NCT01904136|521260433|FG002|Overall Study|Physician Decision|0|||
144562417|NCT01904136|521260434|FG003|Overall Study|Physician Decision|0|||
144562418|NCT01904136|521260435|FG004|Overall Study|Physician Decision|0|||
144562419|NCT01904136|521260436|FG005|Overall Study|Physician Decision|1|||
144562420|NCT01904136|521260437|FG006|Overall Study|Physician Decision|0|||
144562421|NCT01904136|521260438|FG007|Overall Study|Physician Decision|0|||
144562422|NCT01904136|521260439|FG008|Overall Study|Physician Decision|0|||
144562423|NCT02418845|521260442|FG000|Overall Study|Lost to Follow-up|7|||
144562424|NCT02418845|521260443|FG001|Overall Study|Lost to Follow-up|2|||
144562425|NCT02418845|521260442|FG000|Overall Study|Lack of Efficacy|0|||
144562426|NCT02418845|521260443|FG001|Overall Study|Lack of Efficacy|3|||
144562427|NCT02418845|521260442|FG000|Overall Study|Physician Decision|5|||
144562428|NCT02418845|521260443|FG001|Overall Study|Physician Decision|5|||
144562429|NCT02418845|521260442|FG000|Overall Study|Protocol Violation|1|||
144562430|NCT02418845|521260443|FG001|Overall Study|Protocol Violation|0|||
144562431|NCT02418845|521260442|FG000|Overall Study|Withdrawal by Subject|3|||
144562432|NCT02418845|521260443|FG001|Overall Study|Withdrawal by Subject|2|||
144562433|NCT00460564|521260444|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
144562434|NCT00460564|521260445|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
144562435|NCT00460564|521260446|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144562436|NCT00460564|521260447|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144562437|NCT00460564|521260448|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144562438|NCT00460564|521260449|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144562439|NCT00460564|521260450|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144562440|NCT00460564|521260451|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144562441|NCT00460564|521260444|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
144562442|NCT00460564|521260445|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562443|NCT00460564|521260446|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562444|NCT00460564|521260447|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562445|NCT00460564|521260448|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562446|NCT00460564|521260449|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562447|NCT00460564|521260450|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562448|NCT00460564|521260451|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144562449|NCT00460564|521260444|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144562450|NCT00460564|521260445|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144562451|NCT00460564|521260446|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144562452|NCT00460564|521260447|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144562453|NCT00460564|521260448|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
144562454|NCT00460564|521260449|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
144562455|NCT00460564|521260450|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
144562456|NCT00460564|521260451|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144562457|NCT00460564|521260444|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144562458|NCT00460564|521260445|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144562459|NCT00460564|521260446|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144562460|NCT00460564|521260447|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144562461|NCT00460564|521260448|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
144562462|NCT00460564|521260449|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
144562463|NCT00460564|521260450|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144562464|NCT00460564|521260451|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144562465|NCT00460564|521260444|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144617885|NCT03016325|521459787|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144617886|NCT03016325|521459788|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144617887|NCT03016325|521459789|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
144617888|NCT03016325|521459782|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
144617889|NCT03016325|521459783|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
144562466|NCT00460564|521260445|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144562467|NCT00460564|521260446|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144562468|NCT00460564|521260447|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144562469|NCT00460564|521260448|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
144562470|NCT00460564|521260449|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144562471|NCT00460564|521260450|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144562472|NCT00460564|521260451|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
144562473|NCT01990313|521260457|FG000|Overall Study|Lost to Follow-up|1|||
144562474|NCT02624869|521260458|FG000|Overall Study|Lost to Follow-up|0|||
144617890|NCT03016325|521459784|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
144617891|NCT03016325|521459785|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
144562475|NCT02624869|521260459|FG001|Overall Study|Lost to Follow-up|0|||
144562476|NCT02624869|521260460|FG002|Overall Study|Lost to Follow-up|1|||
144262530|NCT00149396|520161471|FG000|Overall Study|Subject noncompliance|2|||
144562477|NCT02624869|521260458|FG000|Overall Study|Withdrawal by Subject|1|||
144562478|NCT02624869|521260459|FG001|Overall Study|Withdrawal by Subject|3|||
144562479|NCT02624869|521260460|FG002|Overall Study|Withdrawal by Subject|1|||
144262531|NCT00149396|520161471|FG000|Overall Study|other treatment|5|||
144262532|NCT01158261|520161472|FG000|Overall Study|Lost to Follow-up|9|||
144262533|NCT01158261|520161472|FG000|Overall Study|Death|7|||
144262534|NCT01158261|520161472|FG000|Overall Study|Withdrawal by Subject|1|||
144262535|NCT02899065|520161475|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
144262536|NCT02899065|520161476|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
144262537|NCT02899065|520161475|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
144262538|NCT02899065|520161476|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
144262539|NCT02899065|520161475|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
144262540|NCT02899065|520161476|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
144262541|NCT00971867|520161477|FG000|Overall Study|Adverse Event|4|||
144262542|NCT00971867|520161477|FG000|Overall Study|Participant Withdrew Consent|1|||
144262543|NCT00971867|520161477|FG000|Overall Study|Disease Progression|6|||
144562480|NCT02705625|521260461|FG000|Overall Study|Protocol Violation|1|||
144562481|NCT02705625|521260462|FG001|Overall Study|Protocol Violation|0|||
144562482|NCT02705625|521260463|FG002|Overall Study|Protocol Violation|0|||
144562483|NCT02705625|521260461|FG000|Overall Study|Adverse Event|6|||
144562484|NCT02705625|521260462|FG001|Overall Study|Adverse Event|5|||
144562485|NCT02705625|521260463|FG002|Overall Study|Adverse Event|2|||
144562486|NCT02705625|521260461|FG000|Overall Study|Death|0|||
144562487|NCT02705625|521260462|FG001|Overall Study|Death|0|||
144562488|NCT02705625|521260463|FG002|Overall Study|Death|1|||
144562489|NCT02705625|521260461|FG000|Overall Study|Withdrawal by Subject|1|||
144562490|NCT02705625|521260462|FG001|Overall Study|Withdrawal by Subject|4|||
144562491|NCT02705625|521260463|FG002|Overall Study|Withdrawal by Subject|5|||
144562492|NCT02705625|521260461|FG000|Overall Study|Lost to Follow-up|0|||
144562493|NCT02705625|521260462|FG001|Overall Study|Lost to Follow-up|0|||
144562494|NCT02705625|521260463|FG002|Overall Study|Lost to Follow-up|1|||
144562495|NCT02705625|521260461|FG000|Overall Study|Non-compliance|0|||
144562496|NCT02705625|521260462|FG001|Overall Study|Non-compliance|1|||
144562497|NCT02705625|521260463|FG002|Overall Study|Non-compliance|1|||
144562498|NCT02705625|521260461|FG000|Overall Study|Overdosing|0|||
144562499|NCT02705625|521260462|FG001|Overall Study|Overdosing|0|||
144617892|NCT03016325|521459786|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
144617893|NCT03016325|521459787|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
144617894|NCT03016325|521459788|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
144617895|NCT03016325|521459789|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
144617896|NCT03016325|521459782|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144617897|NCT03016325|521459783|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144617898|NCT03016325|521459784|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144617899|NCT03016325|521459785|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144617900|NCT03016325|521459786|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
144617901|NCT03016325|521459787|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144728307|NCT02532764|521861205|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144728308|NCT02532764|521861206|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144728309|NCT02532764|521861207|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144728310|NCT02532764|521861208|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144203777|NCT00620659|519940421|FG004|Treatment Period 2|Adverse Event|2|||
144203778|NCT00620659|519940422|FG005|Treatment Period 2|Adverse Event|0|||
144203779|NCT00620659|519940417|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144203780|NCT00620659|519940418|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144203781|NCT00620659|519940419|FG002|Treatment Period 2|Withdrawal by Subject|1|||
144203782|NCT00620659|519940420|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144203783|NCT00620659|519940421|FG004|Treatment Period 2|Withdrawal by Subject|3|||
144203784|NCT00620659|519940422|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144203785|NCT00620659|519940417|FG000|Placebo Washout Period 2|Adverse Event|2|||
144203786|NCT00620659|519940418|FG001|Placebo Washout Period 2|Adverse Event|0|||
144203787|NCT00620659|519940419|FG002|Placebo Washout Period 2|Adverse Event|0|||
144562500|NCT02705625|521260463|FG002|Overall Study|Overdosing|1|||
144562501|NCT00863798|521260464|FG000|Overall Study|Adverse Event|5|||
144562502|NCT00863798|521260465|FG001|Overall Study|Adverse Event|2|||
144617902|NCT03016325|521459788|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144203788|NCT00620659|519940420|FG003|Placebo Washout Period 2|Adverse Event|0|||
144203789|NCT00620659|519940421|FG004|Placebo Washout Period 2|Adverse Event|0|||
144262544|NCT02983045|520161479|FG000|Overall Study|Withdrawal by Subject|0|||
144262545|NCT02983045|520161480|FG001|Overall Study|Withdrawal by Subject|1|||
144262546|NCT02983045|520161481|FG002|Overall Study|Withdrawal by Subject|0|||
144562503|NCT00863798|521260466|FG002|Overall Study|Adverse Event|4|||
144562504|NCT00863798|521260464|FG000|Overall Study|Participant failed to return|2|||
144562505|NCT00863798|521260465|FG001|Overall Study|Participant failed to return|1|||
144203790|NCT00620659|519940422|FG005|Placebo Washout Period 2|Adverse Event|0|||
144203791|NCT00620659|519940417|FG000|Treatment Period 3|Adverse Event|0|||
144203792|NCT00620659|519940418|FG001|Treatment Period 3|Adverse Event|2|||
144203793|NCT00620659|519940419|FG002|Treatment Period 3|Adverse Event|0|||
144203794|NCT00620659|519940420|FG003|Treatment Period 3|Adverse Event|0|||
144203795|NCT00620659|519940421|FG004|Treatment Period 3|Adverse Event|0|||
144203796|NCT00620659|519940422|FG005|Treatment Period 3|Adverse Event|0|||
144203797|NCT00620659|519940417|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144203798|NCT00620659|519940418|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144203799|NCT00620659|519940419|FG002|Treatment Period 3|Withdrawal by Subject|0|||
144203800|NCT00620659|519940420|FG003|Treatment Period 3|Withdrawal by Subject|1|||
144203801|NCT00620659|519940421|FG004|Treatment Period 3|Withdrawal by Subject|0|||
144203802|NCT00620659|519940422|FG005|Treatment Period 3|Withdrawal by Subject|0|||
144203803|NCT01193127|519940423|FG000|Randomized|Surgery Cancelled|0|||
144203804|NCT01193127|519940424|FG001|Randomized|Surgery Cancelled|0|||
144203805|NCT01193127|519940425|FG002|Randomized|Surgery Cancelled|0|||
144203806|NCT01193127|519940426|FG003|Randomized|Surgery Cancelled|1|||
144203807|NCT01193127|519940423|FG000|Treated|Withdrawal by Subject|0|||
144203808|NCT01193127|519940424|FG001|Treated|Withdrawal by Subject|0|||
144203809|NCT01193127|519940425|FG002|Treated|Withdrawal by Subject|0|||
144203810|NCT01193127|519940426|FG003|Treated|Withdrawal by Subject|1|||
144562506|NCT00863798|521260466|FG002|Overall Study|Participant failed to return|0|||
144562507|NCT00863798|521260464|FG000|Overall Study|Investigator request|1|||
144562508|NCT00863798|521260465|FG001|Overall Study|Investigator request|2|||
144562509|NCT00863798|521260466|FG002|Overall Study|Investigator request|1|||
144562510|NCT00863798|521260464|FG000|Overall Study|Lack of Efficacy|4|||
144562511|NCT00863798|521260465|FG001|Overall Study|Lack of Efficacy|3|||
144562512|NCT00863798|521260466|FG002|Overall Study|Lack of Efficacy|6|||
144562513|NCT00863798|521260464|FG000|Overall Study|Lost to Follow-up|6|||
144203811|NCT03246646|519940429|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
144203812|NCT03246646|519940430|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
144203813|NCT03246646|519940429|FG000|Overall Study|Withdrawal by Subject|3|||
144203814|NCT03246646|519940430|FG001|Overall Study|Withdrawal by Subject|0|||
144203815|NCT03246646|519940429|FG000|Overall Study|Lost to Follow-up|7|||
144203816|NCT03246646|519940430|FG001|Overall Study|Lost to Follow-up|0|||
144203817|NCT02352779|519940431|FG000|Overall Study|Personal Issues|1|||
144203818|NCT02352779|519940432|FG001|Overall Study|Personal Issues|1|||
144203819|NCT02352779|519940433|FG002|Overall Study|Personal Issues|0|||
144203820|NCT02352779|519940431|FG000|Overall Study|Too Many Forms|2|||
144203821|NCT02352779|519940432|FG001|Overall Study|Too Many Forms|0|||
144203822|NCT02352779|519940433|FG002|Overall Study|Too Many Forms|0|||
144203823|NCT02352779|519940431|FG000|Overall Study|Feeling Overwhelmed|1|||
144203824|NCT02352779|519940432|FG001|Overall Study|Feeling Overwhelmed|0|||
144203825|NCT02352779|519940433|FG002|Overall Study|Feeling Overwhelmed|0|||
144203826|NCT02352779|519940431|FG000|Overall Study|Disliked Intervention|1|||
144203827|NCT02352779|519940432|FG001|Overall Study|Disliked Intervention|0|||
144562514|NCT00863798|521260465|FG001|Overall Study|Lost to Follow-up|9|||
144562515|NCT00863798|521260466|FG002|Overall Study|Lost to Follow-up|5|||
144617903|NCT03016325|521459789|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
144617904|NCT03016325|521459782|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617905|NCT03016325|521459783|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617906|NCT03016325|521459784|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617907|NCT03016325|521459785|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617908|NCT03016325|521459786|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
144617909|NCT03016325|521459787|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617910|NCT03016325|521459788|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617911|NCT03016325|521459789|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
144617912|NCT03016325|521459782|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144617913|NCT03016325|521459783|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144617914|NCT03016325|521459784|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144617915|NCT03016325|521459785|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
144617916|NCT03016325|521459786|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144617917|NCT03016325|521459787|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144617918|NCT03016325|521459788|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144617919|NCT03016325|521459789|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
144203828|NCT02352779|519940433|FG002|Overall Study|Disliked Intervention|0|||
144203829|NCT02352779|519940431|FG000|Overall Study|Changed Mind|1|||
144203830|NCT02352779|519940432|FG001|Overall Study|Changed Mind|0|||
144562516|NCT00863798|521260464|FG000|Overall Study|Other|2|||
144203831|NCT02352779|519940433|FG002|Overall Study|Changed Mind|0|||
144203832|NCT02352779|519940431|FG000|Overall Study|Study Related Symptoms|1|||
144203833|NCT02352779|519940432|FG001|Overall Study|Study Related Symptoms|0|||
144203834|NCT02352779|519940433|FG002|Overall Study|Study Related Symptoms|0|||
144203835|NCT02352779|519940431|FG000|Overall Study|Absence of Symptoms|1|||
144562517|NCT00863798|521260465|FG001|Overall Study|Other|3|||
144562518|NCT00863798|521260466|FG002|Overall Study|Other|1|||
144562519|NCT00863798|521260464|FG000|Overall Study|Protocol Violation|0|||
144562520|NCT00863798|521260465|FG001|Overall Study|Protocol Violation|1|||
144562521|NCT00863798|521260466|FG002|Overall Study|Protocol Violation|1|||
144562522|NCT00863798|521260464|FG000|Overall Study|Withdrawal by Subject|8|||
144562523|NCT00863798|521260465|FG001|Overall Study|Withdrawal by Subject|7|||
144562524|NCT00863798|521260466|FG002|Overall Study|Withdrawal by Subject|4|||
144562525|NCT00863798|521260464|FG000|Overall Study|Randomized not treated|4|||
144562526|NCT00863798|521260465|FG001|Overall Study|Randomized not treated|2|||
144562527|NCT00863798|521260466|FG002|Overall Study|Randomized not treated|3|||
144562528|NCT04238520|521260468|FG000|Overall Study|Withdrawal by Subject|1|||
144562529|NCT04238520|521260469|FG001|Overall Study|Withdrawal by Subject|1|||
144562530|NCT04238520|521260468|FG000|Overall Study|Lost to Follow-up|1|||
144562531|NCT04238520|521260469|FG001|Overall Study|Lost to Follow-up|2|||
144562532|NCT04238520|521260468|FG000|Overall Study|Death|0|||
144562533|NCT04238520|521260469|FG001|Overall Study|Death|2|||
144562534|NCT04238520|521260468|FG000|Overall Study|Unsafe home environment for research staff|0|||
144562535|NCT04238520|521260469|FG001|Overall Study|Unsafe home environment for research staff|1|||
144562536|NCT01470599|521260470|FG000|Overall Study|Did not meet entrance criteria|1|||
144562537|NCT01470599|521260471|FG001|Overall Study|Did not meet entrance criteria|0|||
144562538|NCT01470599|521260470|FG000|Overall Study|Lost to Follow-up|2|||
144562539|NCT01470599|521260471|FG001|Overall Study|Lost to Follow-up|1|||
144562540|NCT01470599|521260470|FG000|Overall Study|Withdrawal by Subject|3|||
144562541|NCT01470599|521260471|FG001|Overall Study|Withdrawal by Subject|4|||
144562542|NCT01470599|521260470|FG000|Overall Study|Other|1|||
144562543|NCT01470599|521260471|FG001|Overall Study|Other|0|||
144562544|NCT01470599|521260470|FG000|Overall Study|Protocol Violation|3|||
144562545|NCT01470599|521260471|FG001|Overall Study|Protocol Violation|1|||
144562546|NCT01470599|521260470|FG000|Overall Study|Adverse event related to study drug|2|||
144562547|NCT01470599|521260471|FG001|Overall Study|Adverse event related to study drug|5|||
144562548|NCT01470599|521260470|FG000|Overall Study|Insufficient clinical response|6|||
144562549|NCT01470599|521260471|FG001|Overall Study|Insufficient clinical response|27|||
144562550|NCT01470599|521260470|FG000|Overall Study|Adverse event not related to study drug|1|||
144562551|NCT01470599|521260471|FG001|Overall Study|Adverse event not related to study drug|5|||
144203836|NCT02352779|519940432|FG001|Overall Study|Absence of Symptoms|0|||
144203837|NCT02352779|519940433|FG002|Overall Study|Absence of Symptoms|0|||
144203838|NCT02352779|519940431|FG000|Overall Study|Other Medical Reason|0|||
144203839|NCT02352779|519940432|FG001|Overall Study|Other Medical Reason|0|||
144203840|NCT02352779|519940433|FG002|Overall Study|Other Medical Reason|1|||
144203841|NCT02352779|519940431|FG000|Overall Study|No Reason|0|||
144203842|NCT02352779|519940432|FG001|Overall Study|No Reason|0|||
144203843|NCT02352779|519940433|FG002|Overall Study|No Reason|1|||
144203844|NCT00968799|519940434|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
144203845|NCT03753763|519940437|FG000|Overall Study|Adverse Event|2|||
144203846|NCT03753763|519940438|FG001|Overall Study|Adverse Event|0|||
144203847|NCT03753763|519940437|FG000|Overall Study|Withdrawal by Subject|3|||
144203848|NCT03753763|519940438|FG001|Overall Study|Withdrawal by Subject|1|||
144203849|NCT03753763|519940437|FG000|Overall Study|clinical deterioration|1|||
144203850|NCT03753763|519940438|FG001|Overall Study|clinical deterioration|0|||
144203851|NCT01104779|519940439|FG000|Overall Study|Protocol Violation|1|||
144203852|NCT01104779|519940440|FG001|Overall Study|Protocol Violation|2|||
144203853|NCT01104779|519940441|FG002|Overall Study|Protocol Violation|2|||
144203854|NCT01104779|519940439|FG000|Overall Study|Lack of Efficacy|26|||
144203855|NCT01104779|519940440|FG001|Overall Study|Lack of Efficacy|12|||
144203856|NCT01104779|519940441|FG002|Overall Study|Lack of Efficacy|13|||
144203857|NCT01104779|519940439|FG000|Overall Study|Adverse Event|13|||
144203858|NCT01104779|519940440|FG001|Overall Study|Adverse Event|14|||
144203859|NCT01104779|519940441|FG002|Overall Study|Adverse Event|13|||
144203860|NCT01104779|519940439|FG000|Overall Study|Did not meet inc/exc criteria|1|||
144203861|NCT01104779|519940440|FG001|Overall Study|Did not meet inc/exc criteria|1|||
144203862|NCT01104779|519940441|FG002|Overall Study|Did not meet inc/exc criteria|1|||
144262547|NCT02983045|520161482|FG003|Overall Study|Withdrawal by Subject|5|||
144562552|NCT00195442|521260472|FG000|Overall Study|Less than expected therapeutic effect|38|||
144562553|NCT00195442|521260472|FG000|Overall Study|Lost to Follow-up|27|||
144562554|NCT00195442|521260472|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
144562555|NCT00195442|521260472|FG000|Overall Study|Intermittent product shortage|21|||
144562556|NCT00195442|521260472|FG000|Overall Study|Death|7|||
144203863|NCT01104779|519940439|FG000|Overall Study|Other reasons|0|||
144203864|NCT01104779|519940440|FG001|Overall Study|Other reasons|1|||
144562557|NCT00195442|521260472|FG000|Overall Study|No reason specified|4|||
144203865|NCT01104779|519940441|FG002|Overall Study|Other reasons|0|||
144203866|NCT01104779|519940439|FG000|Overall Study|Lost to Follow-up|2|||
144203867|NCT01104779|519940440|FG001|Overall Study|Lost to Follow-up|0|||
144203868|NCT01104779|519940441|FG002|Overall Study|Lost to Follow-up|1|||
144203869|NCT01104779|519940439|FG000|Overall Study|Withdrawal by Subject|16|||
144203870|NCT01104779|519940440|FG001|Overall Study|Withdrawal by Subject|25|||
144203871|NCT01104779|519940441|FG002|Overall Study|Withdrawal by Subject|32|||
144562558|NCT00195442|521260472|FG000|Overall Study|Poor cooperation|2|||
144203872|NCT01372774|519940444|FG000|Overall Study|Withdrawal prior to treatment|4|||
144203873|NCT01372774|519940445|FG001|Overall Study|Withdrawal prior to treatment|5|||
144203874|NCT00389831|519940446|FG000|Overall Study|Lack of Efficacy|0|||
144203875|NCT00389831|519940447|FG001|Overall Study|Lack of Efficacy|2|||
144203876|NCT00389831|519940446|FG000|Overall Study|Did not receive treatment.|0|||
144203877|NCT00389831|519940447|FG001|Overall Study|Did not receive treatment.|2|||
144203878|NCT00389831|519940446|FG000|Overall Study|Other reasons|0|||
144203879|NCT00389831|519940447|FG001|Overall Study|Other reasons|2|||
144203880|NCT00389831|519940446|FG000|Overall Study|Lost to Follow-up|0|||
144203881|NCT00389831|519940447|FG001|Overall Study|Lost to Follow-up|1|||
144203882|NCT04639713|519940452|FG000|Overall Study|Protocol Noncompliance|2|||
144203883|NCT04639713|519940452|FG000|Overall Study|Withdrawal by Subject|1|||
144203884|NCT01167257|519942190|FG000|Overall Study|Lost to Follow-up|2|||
144203885|NCT01167257|519942191|FG001|Overall Study|Lost to Follow-up|2|||
144203886|NCT01167257|519942190|FG000|Overall Study|Withdrew consent|1|||
144203887|NCT01167257|519942191|FG001|Overall Study|Withdrew consent|1|||
144203888|NCT00721630|519942192|FG000|Overall Study|Participant found to be ineligible|1|||
144203889|NCT02213510|519942194|FG000|Overall Study|Death|0|||
144203890|NCT02213510|519942195|FG001|Overall Study|Death|1|||
144203891|NCT02213510|519942194|FG000|Overall Study|Lost to Follow-up|1|||
144203892|NCT02213510|519942195|FG001|Overall Study|Lost to Follow-up|0|||
144203893|NCT01570686|519942203|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144203894|NCT01570686|519942204|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144203895|NCT01570686|519942203|FG000|Overall Study|Administrative problems|0|||
144203896|NCT01570686|519942204|FG001|Overall Study|Administrative problems|1|||
144203897|NCT01570686|519942203|FG000|Overall Study|Adverse Event|8|||
144203898|NCT01570686|519942204|FG001|Overall Study|Adverse Event|6|||
144203899|NCT01570686|519942203|FG000|Overall Study|Lost to Follow-up|4|||
144203900|NCT01570686|519942204|FG001|Overall Study|Lost to Follow-up|3|||
144203901|NCT01570686|519942203|FG000|Overall Study|Protocol Deviation|3|||
144203902|NCT01570686|519942204|FG001|Overall Study|Protocol Deviation|0|||
144203903|NCT01570686|519942203|FG000|Overall Study|Withdrawal by Subject|4|||
144203904|NCT01570686|519942204|FG001|Overall Study|Withdrawal by Subject|4|||
144203905|NCT01570686|519942203|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144203906|NCT01570686|519942204|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144203907|NCT00754650|519942205|FG000|Overall Study|Disease Progression|2|||
144203908|NCT02771795|519942206|FG000|Overall Study|Withdrawal by Subject|47|||
144262548|NCT02983045|520161483|FG004|Overall Study|Withdrawal by Subject|0|||
144562559|NCT00195442|521260472|FG000|Overall Study|Other|14|||
144562560|NCT01917006|521260473|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
144562561|NCT01917006|521260474|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
144562562|NCT01917006|521260475|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
144562563|NCT01917006|521260476|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
144562564|NCT01917006|521260477|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
144562565|NCT01917006|521260478|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
144562566|NCT01917006|521260479|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
144562567|NCT01917006|521260480|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
144562568|NCT01917006|521260473|FG000|Randomized-treatment Period|Personal Reasons|0|||
144562569|NCT01917006|521260474|FG001|Randomized-treatment Period|Personal Reasons|0|||
144562570|NCT01917006|521260475|FG002|Randomized-treatment Period|Personal Reasons|0|||
144562571|NCT01917006|521260476|FG003|Randomized-treatment Period|Personal Reasons|0|||
144562572|NCT01917006|521260477|FG004|Randomized-treatment Period|Personal Reasons|0|||
144562573|NCT01917006|521260478|FG005|Randomized-treatment Period|Personal Reasons|1|||
144562574|NCT01917006|521260479|FG006|Randomized-treatment Period|Personal Reasons|0|||
144562575|NCT01917006|521260480|FG007|Randomized-treatment Period|Personal Reasons|0|||
144562576|NCT01917006|521260473|FG000|Randomized-treatment Period|Protocol Violation|1|||
144562577|NCT01917006|521260474|FG001|Randomized-treatment Period|Protocol Violation|0|||
144562578|NCT01917006|521260475|FG002|Randomized-treatment Period|Protocol Violation|0|||
144562579|NCT01917006|521260476|FG003|Randomized-treatment Period|Protocol Violation|0|||
144562580|NCT01917006|521260477|FG004|Randomized-treatment Period|Protocol Violation|0|||
144562581|NCT01917006|521260478|FG005|Randomized-treatment Period|Protocol Violation|0|||
144562582|NCT01917006|521260479|FG006|Randomized-treatment Period|Protocol Violation|0|||
144562583|NCT01917006|521260480|FG007|Randomized-treatment Period|Protocol Violation|0|||
144562584|NCT01917006|521260473|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144562585|NCT01917006|521260474|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144562586|NCT01917006|521260475|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144562587|NCT01917006|521260476|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144203909|NCT02771795|519942207|FG001|Overall Study|Withdrawal by Subject|37|||
144203910|NCT02771795|519942206|FG000|Overall Study|Termination by premature discontinuation of study|168|||
144203911|NCT02771795|519942207|FG001|Overall Study|Termination by premature discontinuation of study|185|||
144203912|NCT04715932|519942213|FG000|Overall Study|Lost to Follow-up|1|||
144203913|NCT04715932|519942214|FG001|Overall Study|Lost to Follow-up|0|||
144617920|NCT03016325|521459782|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617921|NCT03016325|521459783|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
144617922|NCT03016325|521459784|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617923|NCT03016325|521459785|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617924|NCT03016325|521459786|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617925|NCT03016325|521459787|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617926|NCT03016325|521459788|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617927|NCT03016325|521459789|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
144617928|NCT03016325|521459782|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
144617929|NCT03016325|521459783|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
144617930|NCT03016325|521459784|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
144617931|NCT03016325|521459785|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
144617932|NCT03016325|521459786|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
144617933|NCT03016325|521459787|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
144617934|NCT03016325|521459788|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
144617935|NCT03016325|521459789|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
144617936|NCT02970292|521459790|FG000|Overall Study|Physician Decision|1|||
144617937|NCT02970292|521459791|FG001|Overall Study|Physician Decision|1|||
144617938|NCT02970292|521459790|FG000|Overall Study|Withdrawal by Subject|11|||
144617939|NCT02970292|521459791|FG001|Overall Study|Withdrawal by Subject|5|||
144617940|NCT02970292|521459790|FG000|Overall Study|Noncompliance with study drug|2|||
144617941|NCT02970292|521459791|FG001|Overall Study|Noncompliance with study drug|2|||
144617942|NCT02970292|521459790|FG000|Overall Study|Adverse Event|5|||
144617943|NCT02970292|521459791|FG001|Overall Study|Adverse Event|0|||
144617944|NCT02970292|521459790|FG000|Overall Study|Lack of Efficacy|1|||
144617945|NCT02970292|521459791|FG001|Overall Study|Lack of Efficacy|0|||
144617946|NCT02970292|521459790|FG000|Overall Study|Lost to Follow-up|1|||
144617947|NCT02970292|521459791|FG001|Overall Study|Lost to Follow-up|0|||
144617948|NCT02970292|521459790|FG000|Overall Study|Protocol Violation|2|||
144617949|NCT02970292|521459791|FG001|Overall Study|Protocol Violation|0|||
144617950|NCT02970292|521459790|FG000|Overall Study|Other|1|||
144617951|NCT02970292|521459791|FG001|Overall Study|Other|0|||
144617952|NCT02941627|521459795|FG000|Overall Study|Death|1|||
144203914|NCT00699374|519942216|FG000|Overall Study|Death|93|||
144203915|NCT00699374|519942217|FG001|Overall Study|Death|83|||
144203916|NCT00699374|519942216|FG000|Overall Study|Adverse Event|70|||
144203917|NCT00699374|519942217|FG001|Overall Study|Adverse Event|67|||
144203918|NCT00699374|519942216|FG000|Overall Study|Global deterioration of health status|7|||
144203919|NCT00699374|519942217|FG001|Overall Study|Global deterioration of health status|8|||
144203920|NCT00699374|519942216|FG000|Overall Study|Lost to Follow-up|3|||
144203921|NCT00699374|519942217|FG001|Overall Study|Lost to Follow-up|5|||
144203922|NCT00699374|519942216|FG000|Overall Study|Withdrawal by Subject|34|||
144203923|NCT00699374|519942217|FG001|Overall Study|Withdrawal by Subject|44|||
144203924|NCT00699374|519942216|FG000|Overall Study|Objective progression or relapse|281|||
144203925|NCT00699374|519942217|FG001|Overall Study|Objective progression or relapse|277|||
144203926|NCT00699374|519942216|FG000|Overall Study|Other|18|||
144203927|NCT00699374|519942217|FG001|Overall Study|Other|15|||
144203928|NCT00699374|519942216|FG000|Overall Study|Protocol Violation|2|||
144203929|NCT00699374|519942217|FG001|Overall Study|Protocol Violation|6|||
144203930|NCT00699374|519942216|FG000|Overall Study|Study terminated by sponsor|13|||
144203931|NCT00699374|519942217|FG001|Overall Study|Study terminated by sponsor|28|||
144203932|NCT00699374|519942216|FG000|Overall Study|Randomized but not treated|4|||
144203933|NCT00699374|519942217|FG001|Overall Study|Randomized but not treated|2|||
144203934|NCT00699374|519942216|FG000|Overall Study|Died 28 days after last dose|5|||
144203935|NCT00699374|519942217|FG001|Overall Study|Died 28 days after last dose|9|||
144203936|NCT01359969|519942221|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
144203937|NCT02006693|519942230|FG000|Overall Study|No Reason Specified|6|||
144203938|NCT02006693|519942231|FG001|Overall Study|No Reason Specified|8|||
144203939|NCT02006693|519942230|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
144203940|NCT02006693|519942231|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
144203941|NCT02006693|519942230|FG000|Overall Study|XEN Implant Explantation|0|||
144203942|NCT02006693|519942231|FG001|Overall Study|XEN Implant Explantation|1|||
144203943|NCT02006693|519942230|FG000|Overall Study|Death|2|||
144203944|NCT02006693|519942231|FG001|Overall Study|Death|2|||
144203945|NCT02006693|519942230|FG000|Overall Study|Lost to Follow-up|4|||
144203946|NCT02006693|519942231|FG001|Overall Study|Lost to Follow-up|1|||
144203947|NCT02006693|519942230|FG000|Overall Study|Patient Decision|4|||
144203948|NCT02006693|519942231|FG001|Overall Study|Patient Decision|0|||
144262549|NCT02983045|520161484|FG005|Overall Study|Withdrawal by Subject|72|||
144617953|NCT02941627|521459795|FG000|Overall Study|Surgical failure|1|||
144617954|NCT02941627|521459795|FG000|Overall Study|cholesteatoma prevented implantation|1|||
144617955|NCT01087905|521459798|FG000|Overall Study|Lost to Follow-up|24|||
144617956|NCT01087905|521459799|FG001|Overall Study|Lost to Follow-up|28|||
144203949|NCT01119508|519942234|FG000|Overall Study|Adverse Event|56|||
144203950|NCT01119508|519942234|FG000|Overall Study|Withdrawal by Subject|2|||
144203951|NCT01119508|519942234|FG000|Overall Study|Died before tumor response evaluation|1|||
144203952|NCT00265395|519942235|FG000|Overall Study|Adverse Event|3|||
144203953|NCT00265395|519942236|FG001|Overall Study|Adverse Event|6|||
144203954|NCT00265395|519942235|FG000|Overall Study|Lost to Follow-up|2|||
144203955|NCT00265395|519942236|FG001|Overall Study|Lost to Follow-up|1|||
144203956|NCT00265395|519942235|FG000|Overall Study|Withdrawal by Subject|1|||
144203957|NCT00265395|519942236|FG001|Overall Study|Withdrawal by Subject|6|||
144203958|NCT00265395|519942235|FG000|Overall Study|Protocol Violation|2|||
144203959|NCT00265395|519942236|FG001|Overall Study|Protocol Violation|2|||
144203960|NCT00265395|519942235|FG000|Overall Study|Lack of Efficacy|0|||
144203961|NCT00265395|519942236|FG001|Overall Study|Lack of Efficacy|1|||
144203962|NCT00265395|519942235|FG000|Overall Study|Administrative|0|||
144203963|NCT00265395|519942236|FG001|Overall Study|Administrative|1|||
144203964|NCT00552578|519942244|FG000|Overall Study|Lost to Follow-up|1|||
144203965|NCT00552578|519942245|FG001|Overall Study|Lost to Follow-up|1|||
144203966|NCT00470067|519942246|FG000|Overall Study|Death|1|||
144203967|NCT00470067|519942246|FG000|Overall Study|Disease Progression|6|||
144203968|NCT02563106|519942247|FG000|Overall Study|Withdrawal by Subject|7|||
144203969|NCT02563106|519942248|FG001|Overall Study|Withdrawal by Subject|8|||
144203970|NCT02563106|519942247|FG000|Overall Study|Adverse Event|17|||
144203971|NCT02563106|519942248|FG001|Overall Study|Adverse Event|15|||
144203972|NCT02563106|519942247|FG000|Overall Study|Protocol Violation|1|||
144203973|NCT02563106|519942248|FG001|Overall Study|Protocol Violation|0|||
144203974|NCT02563106|519942247|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
144203975|NCT02563106|519942248|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
144203976|NCT02563106|519942247|FG000|Overall Study|Lost to Follow-up|3|||
144203977|NCT02563106|519942248|FG001|Overall Study|Lost to Follow-up|2|||
144203978|NCT02563106|519942247|FG000|Overall Study|Physician Decision|3|||
144203979|NCT02563106|519942248|FG001|Overall Study|Physician Decision|1|||
144203980|NCT02563106|519942247|FG000|Overall Study|Other reason - not specified|2|||
144203981|NCT02563106|519942248|FG001|Overall Study|Other reason - not specified|1|||
144203982|NCT01059539|519942249|FG000|Overall Study|Adverse Event|66|||
144203983|NCT01059539|519942249|FG000|Overall Study|Insufficient Therapeutic Response|26|||
144203984|NCT01059539|519942249|FG000|Overall Study|Protocol Violation|55|||
144203985|NCT01059539|519942249|FG000|Overall Study|Withdrawal of Consent|80|||
144203986|NCT01059539|519942249|FG000|Overall Study|Lost to Follow-up|42|||
144203987|NCT01059539|519942249|FG000|Overall Study|Reason Not Specified|2|||
144203988|NCT02085135|519942250|FG000|Overall Study|Adverse Event|4|||
144203989|NCT02085135|519942251|FG001|Overall Study|Adverse Event|7|||
144203990|NCT02085135|519942250|FG000|Overall Study|Lost to Follow-up|2|||
144203991|NCT02085135|519942251|FG001|Overall Study|Lost to Follow-up|2|||
144203992|NCT02085135|519942250|FG000|Overall Study|Withdrawal by Subject|3|||
144262550|NCT02983045|520161485|FG006|Overall Study|Withdrawal by Subject|0|||
144262551|NCT02983045|520161486|FG007|Overall Study|Withdrawal by Subject|0|||
144617957|NCT01087905|521459800|FG002|Overall Study|Lost to Follow-up|18|||
144617958|NCT01087905|521459801|FG003|Overall Study|Lost to Follow-up|31|||
144617959|NCT01087905|521459802|FG004|Overall Study|Lost to Follow-up|27|||
144617960|NCT01087905|521459803|FG005|Overall Study|Lost to Follow-up|25|||
144617961|NCT01087905|521459804|FG006|Overall Study|Lost to Follow-up|20|||
144617962|NCT01087905|521459805|FG007|Overall Study|Lost to Follow-up|24|||
144617963|NCT01087905|521459798|FG000|Overall Study|Withdrawal by Subject|5|||
144617964|NCT01087905|521459799|FG001|Overall Study|Withdrawal by Subject|4|||
144617965|NCT01087905|521459800|FG002|Overall Study|Withdrawal by Subject|4|||
144617966|NCT01087905|521459801|FG003|Overall Study|Withdrawal by Subject|5|||
144617967|NCT01087905|521459802|FG004|Overall Study|Withdrawal by Subject|4|||
144617968|NCT01087905|521459803|FG005|Overall Study|Withdrawal by Subject|3|||
144617969|NCT01087905|521459804|FG006|Overall Study|Withdrawal by Subject|3|||
144617970|NCT01087905|521459805|FG007|Overall Study|Withdrawal by Subject|5|||
144617971|NCT01618214|521459807|FG000|Overall Study|Adverse Event|3|||
144617972|NCT01618214|521459808|FG001|Overall Study|Adverse Event|1|||
144617973|NCT01618214|521459807|FG000|Overall Study|Lack of Efficacy|1|||
144617974|NCT01618214|521459808|FG001|Overall Study|Lack of Efficacy|1|||
144617975|NCT01618214|521459807|FG000|Overall Study|Protocol Violation|1|||
144617976|NCT01618214|521459808|FG001|Overall Study|Protocol Violation|4|||
144617977|NCT01618214|521459807|FG000|Overall Study|Withdrawal Criteria|1|||
144617978|NCT01618214|521459808|FG001|Overall Study|Withdrawal Criteria|2|||
144617979|NCT01618214|521459807|FG000|Overall Study|Unclassified|4|||
144617980|NCT01618214|521459808|FG001|Overall Study|Unclassified|5|||
144617981|NCT00606086|521459809|FG000|Overall Study|Adverse Event|1|||
144617982|NCT00606086|521459810|FG001|Overall Study|Adverse Event|1|||
144617983|NCT00606086|521459809|FG000|Overall Study|Lost to Follow-up|4|||
144617984|NCT00606086|521459810|FG001|Overall Study|Lost to Follow-up|8|||
144617985|NCT00606086|521459809|FG000|Overall Study|Protocol Violation|1|||
144617986|NCT00606086|521459810|FG001|Overall Study|Protocol Violation|0|||
144203993|NCT02085135|519942251|FG001|Overall Study|Withdrawal by Subject|0|||
144203994|NCT02085135|519942250|FG000|Overall Study|Lack of Efficacy|2|||
144203995|NCT02085135|519942251|FG001|Overall Study|Lack of Efficacy|0|||
144562588|NCT01917006|521260477|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144562589|NCT01917006|521260478|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144562590|NCT01917006|521260479|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
144562591|NCT01917006|521260480|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
144562592|NCT01917006|521260473|FG000|Open-label Period|Adverse Event|0|||
144562593|NCT01917006|521260474|FG001|Open-label Period|Adverse Event|0|||
144562594|NCT01917006|521260475|FG002|Open-label Period|Adverse Event|0|||
144562595|NCT01917006|521260476|FG003|Open-label Period|Adverse Event|0|||
144562596|NCT01917006|521260477|FG004|Open-label Period|Adverse Event|0|||
144562597|NCT01917006|521260478|FG005|Open-label Period|Adverse Event|0|||
144562598|NCT01917006|521260479|FG006|Open-label Period|Adverse Event|0|||
144562599|NCT01917006|521260480|FG007|Open-label Period|Adverse Event|1|||
144562600|NCT01917006|521260473|FG000|Open-label Period|Lost to Follow-up|0|||
144562601|NCT01917006|521260474|FG001|Open-label Period|Lost to Follow-up|0|||
144562602|NCT01917006|521260475|FG002|Open-label Period|Lost to Follow-up|0|||
144617987|NCT00606086|521459809|FG000|Overall Study|Withdrawal by Subject|5|||
144617988|NCT00606086|521459810|FG001|Overall Study|Withdrawal by Subject|3|||
144617989|NCT00606086|521459809|FG000|Overall Study|Non-compliance|0|||
144617990|NCT00606086|521459810|FG001|Overall Study|Non-compliance|1|||
144617991|NCT00606086|521459809|FG000|Overall Study|Randomized, not treated|1|||
144617992|NCT00606086|521459810|FG001|Overall Study|Randomized, not treated|2|||
144617993|NCT01929408|521459815|FG000|Overall Study|received HCT as initial treatment|8|||
144617994|NCT00391222|521459817|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
144617995|NCT00391222|521459818|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
144617996|NCT00391222|521459819|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
144617997|NCT00391222|521459820|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
144617998|NCT00391222|521459817|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
144617999|NCT00391222|521459818|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
144618000|NCT00391222|521459819|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
144618001|NCT00391222|521459820|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
144618002|NCT00391222|521459817|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
144618003|NCT00391222|521459818|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
144618004|NCT00391222|521459819|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
144618005|NCT00391222|521459820|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
144618006|NCT00391222|521459817|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
144618007|NCT00391222|521459818|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
144618008|NCT00391222|521459819|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
144618009|NCT00391222|521459820|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
144618010|NCT00391222|521459817|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
144618011|NCT00391222|521459818|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
144203996|NCT01212588|519942252|FG000|Overall Study|Physician Decision|0|||
144203997|NCT01212588|519942253|FG001|Overall Study|Physician Decision|1|||
144203998|NCT01212588|519942252|FG000|Overall Study|Protocol Violation|1|||
144618012|NCT00391222|521459819|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
144203999|NCT01212588|519942253|FG001|Overall Study|Protocol Violation|1|||
144204000|NCT02338193|519942254|FG000|Overall Study|Withdrawal by Subject|0|||
144204001|NCT02338193|519942255|FG001|Overall Study|Withdrawal by Subject|0|||
144204002|NCT02338193|519942256|FG002|Overall Study|Withdrawal by Subject|2|||
144204003|NCT02338193|519942254|FG000|Overall Study|Pregnancy|0|||
144204004|NCT02338193|519942255|FG001|Overall Study|Pregnancy|1|||
144204005|NCT02338193|519942256|FG002|Overall Study|Pregnancy|1|||
144204006|NCT02338193|519942254|FG000|Overall Study|Noncompliant with visits|2|||
144204007|NCT02338193|519942255|FG001|Overall Study|Noncompliant with visits|2|||
144204008|NCT02338193|519942256|FG002|Overall Study|Noncompliant with visits|7|||
144204009|NCT02338193|519942254|FG000|Overall Study|moved out of state|0|||
144204010|NCT02338193|519942255|FG001|Overall Study|moved out of state|1|||
144204011|NCT02338193|519942256|FG002|Overall Study|moved out of state|0|||
144204012|NCT02338193|519942254|FG000|Overall Study|intolerant of side effects|1|||
144204013|NCT02338193|519942255|FG001|Overall Study|intolerant of side effects|0|||
144204014|NCT02338193|519942256|FG002|Overall Study|intolerant of side effects|0|||
144204015|NCT01136967|519942261|FG000|Overall Study|Adverse Event|9|||
144204016|NCT01136967|519942262|FG001|Overall Study|Adverse Event|12|||
144204017|NCT01136967|519942261|FG000|Overall Study|Participant Choice|8|||
144204018|NCT01136967|519942262|FG001|Overall Study|Participant Choice|3|||
144204019|NCT01136967|519942261|FG000|Overall Study|Lost to Follow-up|0|||
144562603|NCT01917006|521260476|FG003|Open-label Period|Lost to Follow-up|0|||
144562604|NCT01917006|521260477|FG004|Open-label Period|Lost to Follow-up|0|||
144204020|NCT01136967|519942262|FG001|Overall Study|Lost to Follow-up|1|||
144204021|NCT01136967|519942261|FG000|Overall Study|Withdrawal by Subject|1|||
144204022|NCT01136967|519942262|FG001|Overall Study|Withdrawal by Subject|2|||
144204023|NCT01136967|519942261|FG000|Overall Study|Clinical Progression|3|||
144204024|NCT01136967|519942262|FG001|Overall Study|Clinical Progression|5|||
144204025|NCT01136967|519942261|FG000|Overall Study|Radiation|1|||
144204026|NCT01136967|519942262|FG001|Overall Study|Radiation|0|||
144562605|NCT01917006|521260478|FG005|Open-label Period|Lost to Follow-up|0|||
144562606|NCT01917006|521260479|FG006|Open-label Period|Lost to Follow-up|0|||
144562607|NCT01917006|521260480|FG007|Open-label Period|Lost to Follow-up|1|||
144562608|NCT02158247|521260481|FG000|Overall Study|Invisible vocal cords|5|||
144562609|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
144562610|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
144562611|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
144562612|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
144618013|NCT00391222|521459820|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
144618014|NCT00391222|521459817|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
144618015|NCT00391222|521459818|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
144618016|NCT00391222|521459819|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
144618017|NCT00391222|521459820|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
144618018|NCT00391222|521459817|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
144618019|NCT00391222|521459818|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
144204027|NCT01136967|519942261|FG000|Overall Study|Non-compliance|1|||
144204028|NCT01136967|519942262|FG001|Overall Study|Non-compliance|0|||
144204029|NCT01136967|519942261|FG000|Overall Study|Investigator's Choice|1|||
144204030|NCT01136967|519942262|FG001|Overall Study|Investigator's Choice|1|||
144204031|NCT01136967|519942261|FG000|Overall Study|Increase in Lesion Size|0|||
144204032|NCT01136967|519942262|FG001|Overall Study|Increase in Lesion Size|2|||
144204033|NCT01136967|519942261|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
144204034|NCT01136967|519942262|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
144204035|NCT02885181|519942263|FG000|Overall Study|Investigator's Discretion|0|||
144204036|NCT02885181|519942264|FG001|Overall Study|Investigator's Discretion|1|||
144204037|NCT02885181|519942265|FG002|Overall Study|Investigator's Discretion|0|||
144204038|NCT02885181|519942266|FG003|Overall Study|Investigator's Discretion|1|||
144204039|NCT02885181|519942263|FG000|Overall Study|Adverse Event|0|||
144204040|NCT02885181|519942264|FG001|Overall Study|Adverse Event|0|||
144204041|NCT02885181|519942265|FG002|Overall Study|Adverse Event|0|||
144204042|NCT02885181|519942266|FG003|Overall Study|Adverse Event|1|||
144204043|NCT02885181|519942263|FG000|Overall Study|Withdrawal by Subject|0|||
144204044|NCT02885181|519942264|FG001|Overall Study|Withdrawal by Subject|0|||
144204045|NCT02885181|519942265|FG002|Overall Study|Withdrawal by Subject|0|||
144204046|NCT02885181|519942266|FG003|Overall Study|Withdrawal by Subject|1|||
144204047|NCT01735955|519942267|FG000|Overall Study|Administrative problems|1|||
144204048|NCT01735955|519942267|FG000|Overall Study|Patient/guardian decision|1|||
144204049|NCT01735955|519942267|FG000|Overall Study|Patient withdrew consent|2|||
144204050|NCT01735955|519942267|FG000|Overall Study|Physician Decision|4|||
144204051|NCT01735955|519942267|FG000|Overall Study|Disease progression|24|||
144204052|NCT01735955|519942267|FG000|Overall Study|Adverse Event|5|||
144204053|NCT01716715|519942268|FG000|Overall Study|Never Treated|2|||
144204054|NCT01716715|519942269|FG001|Overall Study|Never Treated|4|||
144204055|NCT04228783|519942270|FG000|Overall Study|Adverse Event|1|||
144204056|NCT04228783|519942271|FG001|Overall Study|Adverse Event|0|||
144204057|NCT04228783|519942272|FG002|Overall Study|Adverse Event|2|||
144204058|NCT04228783|519942273|FG003|Overall Study|Adverse Event|0|||
144562613|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
144562614|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
144562615|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
144562616|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
144562617|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
144562618|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
144562619|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
144562620|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
144562621|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
144562622|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
144562623|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
144562624|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
144204059|NCT04228783|519942274|FG004|Overall Study|Adverse Event|0|||
144562625|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
144562626|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
144562627|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
144562628|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
144204060|NCT04228783|519942275|FG005|Overall Study|Adverse Event|1|||
144204061|NCT04228783|519942270|FG000|Overall Study|Death|0|||
144204062|NCT04228783|519942271|FG001|Overall Study|Death|0|||
144204063|NCT04228783|519942272|FG002|Overall Study|Death|0|||
144204064|NCT04228783|519942273|FG003|Overall Study|Death|0|||
144204065|NCT04228783|519942274|FG004|Overall Study|Death|1|||
144204066|NCT04228783|519942275|FG005|Overall Study|Death|0|||
144204067|NCT04228783|519942270|FG000|Overall Study|Lost to Follow-up|36|||
144204068|NCT04228783|519942271|FG001|Overall Study|Lost to Follow-up|36|||
144562629|NCT02637856|521260489|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
144562630|NCT02637856|521260490|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
144562631|NCT02637856|521260489|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
144562632|NCT02637856|521260490|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
144562633|NCT02637856|521260489|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
144562634|NCT02637856|521260490|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
144562635|NCT02509312|521260491|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
144562636|NCT02509312|521260492|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
144562637|NCT02509312|521260491|FG000|Overall Study|Obstetrician refusal|0|||
144562638|NCT02509312|521260492|FG001|Overall Study|Obstetrician refusal|1|||
144562639|NCT02509312|521260491|FG000|Overall Study|Patient elected for TOLAC|1|||
144562640|NCT02509312|521260492|FG001|Overall Study|Patient elected for TOLAC|0|||
144562641|NCT02509312|521260491|FG000|Overall Study|Cesarean deemed stat|1|||
144562642|NCT02509312|521260492|FG001|Overall Study|Cesarean deemed stat|0|||
144562643|NCT02509312|521260491|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
144562644|NCT02509312|521260492|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
144562645|NCT02815735|521260495|FG000|First Intervention (4 Weeks)|Discomfort|1|||
144562646|NCT02815735|521260496|FG001|First Intervention (4 Weeks)|Discomfort|0|||
144562647|NCT02815735|521260495|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
144562648|NCT02815735|521260496|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
144562649|NCT02815735|521260495|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
144562650|NCT02815735|521260496|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
144562651|NCT02815735|521260495|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
144562652|NCT02815735|521260496|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
144562653|NCT00702650|521260498|FG000|Overall Study|Withdrawal by Subject|9|||
144562654|NCT00702650|521260498|FG000|Overall Study|Non-Compliance of Study Drug|3|||
144562655|NCT00702650|521260498|FG000|Overall Study|Lost to Follow-up|2|||
144562656|NCT00702650|521260498|FG000|Overall Study|Non-Compliance with Site Directives|1|||
144562657|NCT00702650|521260498|FG000|Overall Study|Sponsor Request|1|||
144562658|NCT00702650|521260498|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
144562659|NCT00702650|521260498|FG000|Overall Study|Adverse Event|3|||
144562660|NCT00988533|521260499|FG000|Overall Study|Lost to Follow-up|3|||
144562661|NCT00943722|521260500|FG000|Base Study|Adverse Event|0|||
144562662|NCT00943722|521260501|FG001|Base Study|Adverse Event|0|||
144562663|NCT00943722|521260502|FG002|Base Study|Adverse Event|0|||
144562664|NCT00943722|521260503|FG003|Base Study|Adverse Event|1|||
144562665|NCT00943722|521260504|FG004|Base Study|Adverse Event|0|||
144562666|NCT00943722|521260505|FG005|Base Study|Adverse Event|0|||
144562667|NCT00943722|521260506|FG006|Base Study|Adverse Event|0|||
144562668|NCT00943722|521260500|FG000|Base Study|Lost to Follow-up|12|||
144562669|NCT00943722|521260501|FG001|Base Study|Lost to Follow-up|8|||
144562670|NCT00943722|521260502|FG002|Base Study|Lost to Follow-up|10|||
144562671|NCT00943722|521260503|FG003|Base Study|Lost to Follow-up|8|||
144562672|NCT00943722|521260504|FG004|Base Study|Lost to Follow-up|11|||
144562673|NCT00943722|521260505|FG005|Base Study|Lost to Follow-up|0|||
144562674|NCT00943722|521260506|FG006|Base Study|Lost to Follow-up|0|||
144562675|NCT00943722|521260500|FG000|Base Study|Physician Decision|1|||
144562676|NCT00943722|521260501|FG001|Base Study|Physician Decision|0|||
144562677|NCT00943722|521260502|FG002|Base Study|Physician Decision|0|||
144562678|NCT00943722|521260503|FG003|Base Study|Physician Decision|0|||
144562679|NCT00943722|521260504|FG004|Base Study|Physician Decision|1|||
144562680|NCT00943722|521260505|FG005|Base Study|Physician Decision|0|||
144562681|NCT00943722|521260506|FG006|Base Study|Physician Decision|0|||
144562682|NCT00943722|521260500|FG000|Base Study|Pregnancy|0|||
144562683|NCT00943722|521260501|FG001|Base Study|Pregnancy|0|||
144562684|NCT00943722|521260502|FG002|Base Study|Pregnancy|1|||
144562685|NCT00943722|521260503|FG003|Base Study|Pregnancy|0|||
144562686|NCT00943722|521260504|FG004|Base Study|Pregnancy|2|||
144562687|NCT00943722|521260505|FG005|Base Study|Pregnancy|0|||
144562688|NCT00943722|521260506|FG006|Base Study|Pregnancy|0|||
144562689|NCT00943722|521260500|FG000|Base Study|Protocol Violation|0|||
144562690|NCT00943722|521260501|FG001|Base Study|Protocol Violation|1|||
144562691|NCT00943722|521260502|FG002|Base Study|Protocol Violation|0|||
144562692|NCT00943722|521260503|FG003|Base Study|Protocol Violation|0|||
144562693|NCT00943722|521260504|FG004|Base Study|Protocol Violation|2|||
144562694|NCT00943722|521260505|FG005|Base Study|Protocol Violation|0|||
144562695|NCT00943722|521260506|FG006|Base Study|Protocol Violation|0|||
144562696|NCT00943722|521260500|FG000|Base Study|Withdrawal by Subject|12|||
144562697|NCT00943722|521260501|FG001|Base Study|Withdrawal by Subject|13|||
144562698|NCT00943722|521260502|FG002|Base Study|Withdrawal by Subject|2|||
144562699|NCT00943722|521260503|FG003|Base Study|Withdrawal by Subject|13|||
144618020|NCT00391222|521459819|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
144562700|NCT00943722|521260504|FG004|Base Study|Withdrawal by Subject|8|||
144562701|NCT00943722|521260505|FG005|Base Study|Withdrawal by Subject|0|||
144562702|NCT00943722|521260506|FG006|Base Study|Withdrawal by Subject|0|||
144618021|NCT00391222|521459820|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
144618022|NCT00391222|521459817|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
144618023|NCT00391222|521459818|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
144618024|NCT00391222|521459819|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
144618025|NCT00391222|521459820|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
144618026|NCT00391222|521459817|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
144618027|NCT00391222|521459818|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
144618028|NCT00391222|521459819|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
144618029|NCT00391222|521459820|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
144618030|NCT00391222|521459817|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
144618031|NCT00391222|521459818|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
144618032|NCT00391222|521459819|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
144618033|NCT00391222|521459820|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
144728311|NCT02532764|521861209|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144728312|NCT02532764|521861210|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
144204069|NCT04228783|519942272|FG002|Overall Study|Lost to Follow-up|28|||
144204070|NCT04228783|519942273|FG003|Overall Study|Lost to Follow-up|6|||
144204071|NCT04228783|519942274|FG004|Overall Study|Lost to Follow-up|14|||
144204072|NCT04228783|519942275|FG005|Overall Study|Lost to Follow-up|3|||
144204073|NCT04228783|519942270|FG000|Overall Study|Physician Decision|1|||
144204074|NCT04228783|519942271|FG001|Overall Study|Physician Decision|2|||
144204075|NCT04228783|519942272|FG002|Overall Study|Physician Decision|0|||
144204076|NCT04228783|519942273|FG003|Overall Study|Physician Decision|0|||
144204077|NCT04228783|519942274|FG004|Overall Study|Physician Decision|0|||
144204078|NCT04228783|519942275|FG005|Overall Study|Physician Decision|0|||
144204079|NCT04228783|519942270|FG000|Overall Study|Protocol Violation|0|||
144204080|NCT04228783|519942271|FG001|Overall Study|Protocol Violation|0|||
144204081|NCT04228783|519942272|FG002|Overall Study|Protocol Violation|0|||
144204082|NCT04228783|519942273|FG003|Overall Study|Protocol Violation|1|||
144204083|NCT04228783|519942274|FG004|Overall Study|Protocol Violation|0|||
144204084|NCT04228783|519942275|FG005|Overall Study|Protocol Violation|0|||
144204085|NCT04228783|519942270|FG000|Overall Study|Withdrawal by Subject|6|||
144204086|NCT04228783|519942271|FG001|Overall Study|Withdrawal by Subject|10|||
144204087|NCT04228783|519942272|FG002|Overall Study|Withdrawal by Subject|19|||
144204088|NCT04228783|519942273|FG003|Overall Study|Withdrawal by Subject|1|||
144204089|NCT04228783|519942274|FG004|Overall Study|Withdrawal by Subject|2|||
144204090|NCT04228783|519942275|FG005|Overall Study|Withdrawal by Subject|0|||
144204091|NCT04228783|519942270|FG000|Overall Study|Other|4|||
144204092|NCT04228783|519942271|FG001|Overall Study|Other|3|||
144204093|NCT04228783|519942272|FG002|Overall Study|Other|2|||
144204094|NCT04228783|519942273|FG003|Overall Study|Other|1|||
144204095|NCT04228783|519942274|FG004|Overall Study|Other|0|||
144204096|NCT04228783|519942275|FG005|Overall Study|Other|0|||
144204097|NCT00626392|519942276|FG000|Run-in Period|Adverse Event|0|||
144204098|NCT00626392|519942277|FG001|Run-in Period|Adverse Event|0|||
144204099|NCT00626392|519942278|FG002|Run-in Period|Adverse Event|1|||
144204100|NCT00626392|519942279|FG003|Run-in Period|Adverse Event|0|||
144204101|NCT00626392|519942280|FG004|Run-in Period|Adverse Event|1|||
144204102|NCT00626392|519942281|FG005|Run-in Period|Adverse Event|0|||
144204103|NCT00626392|519942276|FG000|Run-in Period|Withdrawal by Subject|0|||
144204104|NCT00626392|519942277|FG001|Run-in Period|Withdrawal by Subject|1|||
144204105|NCT00626392|519942278|FG002|Run-in Period|Withdrawal by Subject|1|||
144204106|NCT00626392|519942279|FG003|Run-in Period|Withdrawal by Subject|1|||
144204107|NCT00626392|519942280|FG004|Run-in Period|Withdrawal by Subject|3|||
144204108|NCT00626392|519942281|FG005|Run-in Period|Withdrawal by Subject|1|||
144618034|NCT00391222|521459817|FG000|Period III (Double-Blind Treatment)|Other|6|||
144618035|NCT00391222|521459818|FG001|Period III (Double-Blind Treatment)|Other|1|||
144618036|NCT00391222|521459819|FG002|Period III (Double-Blind Treatment)|Other|6|||
144618037|NCT00391222|521459820|FG003|Period III (Double-Blind Treatment)|Other|0|||
144618038|NCT00531752|521459821|FG000|First Double-blind Intervention Period|Adverse Event|2|||
144618039|NCT00531752|521459822|FG001|First Double-blind Intervention Period|Adverse Event|0|||
144618040|NCT00531752|521459823|FG002|First Double-blind Intervention Period|Adverse Event|1|||
144618041|NCT00531752|521459824|FG003|First Double-blind Intervention Period|Adverse Event|1|||
144618042|NCT00531752|521459821|FG000|First Double-blind Intervention Period|Other|1|||
144728313|NCT02532764|521861211|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
144728314|NCT02532764|521861212|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
144204109|NCT00626392|519942276|FG000|Run-in Period|Noncompliance|1|||
144204110|NCT00626392|519942277|FG001|Run-in Period|Noncompliance|0|||
144204111|NCT00626392|519942278|FG002|Run-in Period|Noncompliance|1|||
144204112|NCT00626392|519942279|FG003|Run-in Period|Noncompliance|0|||
144204113|NCT00626392|519942280|FG004|Run-in Period|Noncompliance|0|||
144204114|NCT00626392|519942281|FG005|Run-in Period|Noncompliance|0|||
144204115|NCT00626392|519942276|FG000|Coadministration Period|Adverse Event|3|||
144204116|NCT00626392|519942277|FG001|Coadministration Period|Adverse Event|1|||
144204117|NCT00626392|519942278|FG002|Coadministration Period|Adverse Event|7|||
144204118|NCT00626392|519942279|FG003|Coadministration Period|Adverse Event|4|||
144562703|NCT00943722|521260500|FG000|Base Study|Month 12 visit not completed|0|||
144562704|NCT00943722|521260501|FG001|Base Study|Month 12 visit not completed|0|||
144562705|NCT00943722|521260502|FG002|Base Study|Month 12 visit not completed|0|||
144562706|NCT00943722|521260503|FG003|Base Study|Month 12 visit not completed|0|||
144562707|NCT00943722|521260504|FG004|Base Study|Month 12 visit not completed|2|||
144562708|NCT00943722|521260505|FG005|Base Study|Month 12 visit not completed|0|||
144562709|NCT00943722|521260506|FG006|Base Study|Month 12 visit not completed|0|||
144562710|NCT00943722|521260500|FG000|First Extension Study: EXT 1|Adverse Event|0|||
144562711|NCT00943722|521260501|FG001|First Extension Study: EXT 1|Adverse Event|0|||
144562712|NCT00943722|521260502|FG002|First Extension Study: EXT 1|Adverse Event|0|||
144618043|NCT00531752|521459822|FG001|First Double-blind Intervention Period|Other|4|||
144618044|NCT00531752|521459823|FG002|First Double-blind Intervention Period|Other|4|||
144618045|NCT00531752|521459824|FG003|First Double-blind Intervention Period|Other|0|||
144618046|NCT00531752|521459821|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
144618047|NCT00531752|521459822|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
144618048|NCT00531752|521459823|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
144618049|NCT00531752|521459824|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
144618050|NCT00531752|521459821|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
144618051|NCT00531752|521459822|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
144618052|NCT00531752|521459823|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
144618053|NCT00531752|521459824|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
144618054|NCT00531752|521459821|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
144618055|NCT00531752|521459822|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
144618056|NCT00531752|521459823|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
144618057|NCT00531752|521459824|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
144618058|NCT00531752|521459821|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
144618059|NCT00531752|521459822|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
144618060|NCT00531752|521459823|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
144618061|NCT00531752|521459824|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
144618062|NCT00531752|521459821|FG000|Second Double-blind Intervention Period|Other|1|||
144618063|NCT00531752|521459822|FG001|Second Double-blind Intervention Period|Other|1|||
144618064|NCT00531752|521459823|FG002|Second Double-blind Intervention Period|Other|0|||
144618065|NCT00531752|521459824|FG003|Second Double-blind Intervention Period|Other|0|||
144618066|NCT00531752|521459821|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
144618067|NCT00531752|521459822|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
144618068|NCT00531752|521459823|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
144618069|NCT00531752|521459824|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
144618070|NCT00531752|521459821|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
144618071|NCT00531752|521459822|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
144618072|NCT00531752|521459823|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
144618073|NCT00531752|521459824|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
144618074|NCT00490451|521459825|FG000|Overall Study|Adverse Event|3|||
144618075|NCT00490451|521459826|FG001|Overall Study|Adverse Event|3|||
144618076|NCT00490451|521459825|FG000|Overall Study|Death|3|||
144618077|NCT00490451|521459826|FG001|Overall Study|Death|1|||
144618078|NCT00490451|521459825|FG000|Overall Study|Withdrawal by Subject|2|||
144618079|NCT00490451|521459826|FG001|Overall Study|Withdrawal by Subject|0|||
144618080|NCT00490451|521459825|FG000|Overall Study|Investigator Decision|1|||
144618081|NCT00490451|521459826|FG001|Overall Study|Investigator Decision|0|||
144618082|NCT00490451|521459825|FG000|Overall Study|Protocol Violation|1|||
144618083|NCT00490451|521459826|FG001|Overall Study|Protocol Violation|0|||
144618084|NCT00490451|521459825|FG000|Overall Study|Progressive Disease|53|||
144618085|NCT00490451|521459826|FG001|Overall Study|Progressive Disease|34|||
144618086|NCT04703075|521459827|FG000|Overall Study|Adverse Event|11|||
144618087|NCT04703075|521459828|FG001|Overall Study|Adverse Event|7|||
144618088|NCT04703075|521459827|FG000|Overall Study|Lost to Follow-up|6|||
144618089|NCT04703075|521459828|FG001|Overall Study|Lost to Follow-up|12|||
144618090|NCT04703075|521459827|FG000|Overall Study|Physician Decision|3|||
144618091|NCT04703075|521459828|FG001|Overall Study|Physician Decision|0|||
144618092|NCT04703075|521459827|FG000|Overall Study|Moved|0|||
144618093|NCT04703075|521459828|FG001|Overall Study|Moved|2|||
144618094|NCT04703075|521459827|FG000|Overall Study|Index INH Resistant|0|||
144204119|NCT00626392|519942280|FG004|Coadministration Period|Adverse Event|3|||
144204120|NCT00626392|519942281|FG005|Coadministration Period|Adverse Event|4|||
144562713|NCT00943722|521260503|FG003|First Extension Study: EXT 1|Adverse Event|0|||
144618095|NCT04703075|521459828|FG001|Overall Study|Index INH Resistant|1|||
144618096|NCT04703075|521459827|FG000|Overall Study|Lack of Efficacy|6|||
144618097|NCT04703075|521459828|FG001|Overall Study|Lack of Efficacy|18|||
144618098|NCT00254501|521459831|FG000|Overall Study|Lost to Follow-up|1|||
144618099|NCT00254501|521459832|FG001|Overall Study|Lost to Follow-up|1|||
144562714|NCT00943722|521260504|FG004|First Extension Study: EXT 1|Adverse Event|0|||
144618100|NCT01119248|521459833|FG000|Overall Study|Physician Decision|5|||
144562715|NCT00943722|521260505|FG005|First Extension Study: EXT 1|Adverse Event|1|||
144562716|NCT00943722|521260506|FG006|First Extension Study: EXT 1|Adverse Event|0|||
144562717|NCT00943722|521260500|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
144562718|NCT00943722|521260501|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
144562719|NCT00943722|521260502|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
144562720|NCT00943722|521260503|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
144562721|NCT00943722|521260504|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
144562722|NCT00943722|521260505|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
144562723|NCT00943722|521260506|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
144562724|NCT00943722|521260500|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
144562725|NCT00943722|521260501|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
144562726|NCT00943722|521260502|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
144562727|NCT00943722|521260503|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
144562728|NCT00943722|521260504|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
144562729|NCT00943722|521260505|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
144562730|NCT00943722|521260506|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
144562731|NCT00943722|521260500|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
144562732|NCT00943722|521260501|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
144562733|NCT00943722|521260502|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
144618101|NCT01967550|521459834|FG000|Overall Study|Withdrawal by Subject|1|||
144618102|NCT01967550|521459835|FG001|Overall Study|Withdrawal by Subject|0|||
144204121|NCT00626392|519942276|FG000|Coadministration Period|Withdrawal by Subject|1|||
144204122|NCT00626392|519942277|FG001|Coadministration Period|Withdrawal by Subject|1|||
144204123|NCT00626392|519942278|FG002|Coadministration Period|Withdrawal by Subject|0|||
144204124|NCT00626392|519942279|FG003|Coadministration Period|Withdrawal by Subject|1|||
144204125|NCT00626392|519942280|FG004|Coadministration Period|Withdrawal by Subject|0|||
144204126|NCT00626392|519942281|FG005|Coadministration Period|Withdrawal by Subject|1|||
144204127|NCT00626392|519942276|FG000|Coadministration Period|Protocol Violation|0|||
144204128|NCT00626392|519942277|FG001|Coadministration Period|Protocol Violation|1|||
144204129|NCT00626392|519942278|FG002|Coadministration Period|Protocol Violation|0|||
144204130|NCT00626392|519942279|FG003|Coadministration Period|Protocol Violation|1|||
144204131|NCT00626392|519942280|FG004|Coadministration Period|Protocol Violation|1|||
144204132|NCT00626392|519942281|FG005|Coadministration Period|Protocol Violation|0|||
144204133|NCT00626392|519942276|FG000|Coadministration Period|Other|0|||
144204134|NCT00626392|519942277|FG001|Coadministration Period|Other|2|||
144204135|NCT00626392|519942278|FG002|Coadministration Period|Other|3|||
144204136|NCT00626392|519942279|FG003|Coadministration Period|Other|1|||
144204137|NCT00626392|519942280|FG004|Coadministration Period|Other|1|||
144204138|NCT00626392|519942281|FG005|Coadministration Period|Other|1|||
144204139|NCT00742924|519942282|FG000|Overall Study|Adverse Event|0|||
144204140|NCT00742924|519942283|FG001|Overall Study|Adverse Event|0|||
144204141|NCT00742924|519942284|FG002|Overall Study|Adverse Event|1|||
144204142|NCT00742924|519942285|FG003|Overall Study|Adverse Event|1|||
144204143|NCT00742924|519942282|FG000|Overall Study|Lack of Efficacy|5|||
144204144|NCT00742924|519942283|FG001|Overall Study|Lack of Efficacy|1|||
144204145|NCT00742924|519942284|FG002|Overall Study|Lack of Efficacy|2|||
144204146|NCT00742924|519942285|FG003|Overall Study|Lack of Efficacy|4|||
144204147|NCT00742924|519942282|FG000|Overall Study|Physician Decision|0|||
144204148|NCT00742924|519942283|FG001|Overall Study|Physician Decision|0|||
144204149|NCT00742924|519942284|FG002|Overall Study|Physician Decision|0|||
144204150|NCT00742924|519942285|FG003|Overall Study|Physician Decision|1|||
144204151|NCT00742924|519942282|FG000|Overall Study|Withdrawal by Subject|0|||
144204152|NCT00742924|519942283|FG001|Overall Study|Withdrawal by Subject|1|||
144204153|NCT00742924|519942284|FG002|Overall Study|Withdrawal by Subject|1|||
144204154|NCT00742924|519942285|FG003|Overall Study|Withdrawal by Subject|0|||
144204155|NCT01777620|519942286|FG000|Overall Study|Subject Withdrawal|1|||
144204156|NCT01777620|519942287|FG001|Overall Study|Subject Withdrawal|0|||
144204157|NCT04562155|519942290|FG000|Overall Study|COVID-19 pandemic|0|||
144204158|NCT04562155|519942291|FG001|Overall Study|COVID-19 pandemic|0|||
144204159|NCT04562155|519942292|FG002|Overall Study|COVID-19 pandemic|0|||
144204160|NCT04562155|519942293|FG003|Overall Study|COVID-19 pandemic|1|||
144204161|NCT04562155|519942290|FG000|Overall Study|Adverse Event|7|||
144204162|NCT04562155|519942291|FG001|Overall Study|Adverse Event|3|||
144204163|NCT04562155|519942292|FG002|Overall Study|Adverse Event|8|||
144204164|NCT04562155|519942293|FG003|Overall Study|Adverse Event|1|||
144204165|NCT04562155|519942290|FG000|Overall Study|Withdrawal by Subject|3|||
144204166|NCT04562155|519942291|FG001|Overall Study|Withdrawal by Subject|6|||
144204167|NCT04562155|519942292|FG002|Overall Study|Withdrawal by Subject|3|||
144204168|NCT04562155|519942293|FG003|Overall Study|Withdrawal by Subject|3|||
144204169|NCT04562155|519942290|FG000|Overall Study|Participant personal reason|1|||
144204170|NCT04562155|519942291|FG001|Overall Study|Participant personal reason|0|||
144204171|NCT04562155|519942292|FG002|Overall Study|Participant personal reason|2|||
144204172|NCT04562155|519942293|FG003|Overall Study|Participant personal reason|1|||
144204173|NCT04005352|519942294|FG000|Overall Study|Adverse Event|4|||
144262552|NCT02983045|520161487|FG008|Overall Study|Withdrawal by Subject|0|||
144262553|NCT02983045|520161488|FG009|Overall Study|Withdrawal by Subject|2|||
144262554|NCT02983045|520161479|FG000|Overall Study|Lost to Follow-up|0|||
144262555|NCT02983045|520161480|FG001|Overall Study|Lost to Follow-up|0|||
144262556|NCT02983045|520161481|FG002|Overall Study|Lost to Follow-up|0|||
144262557|NCT02983045|520161482|FG003|Overall Study|Lost to Follow-up|0|||
144262558|NCT02983045|520161483|FG004|Overall Study|Lost to Follow-up|0|||
144262559|NCT02983045|520161484|FG005|Overall Study|Lost to Follow-up|10|||
144262560|NCT02983045|520161485|FG006|Overall Study|Lost to Follow-up|0|||
144618103|NCT01967550|521459834|FG000|Overall Study|Adverse Event|2|||
144618104|NCT01967550|521459835|FG001|Overall Study|Adverse Event|0|||
144618105|NCT01967550|521459834|FG000|Overall Study|Protocol Violation|2|||
144618106|NCT01967550|521459835|FG001|Overall Study|Protocol Violation|1|||
144618107|NCT01967550|521459834|FG000|Overall Study|Non Compliance|0|||
144618108|NCT01967550|521459835|FG001|Overall Study|Non Compliance|1|||
144618109|NCT01035905|521459841|FG000|Overall Study|Lack of Efficacy|1|||
144618110|NCT01035905|521459842|FG001|Overall Study|Lack of Efficacy|1|||
144618111|NCT04942925|521459843|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
144618112|NCT04942925|521459844|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
144204174|NCT04005352|519942295|FG001|Overall Study|Adverse Event|5|||
144204175|NCT04005352|519942294|FG000|Overall Study|Death|4|||
144204176|NCT04005352|519942295|FG001|Overall Study|Death|2|||
144204177|NCT04005352|519942294|FG000|Overall Study|Lost to Follow-up|6|||
144204178|NCT04005352|519942295|FG001|Overall Study|Lost to Follow-up|2|||
144204179|NCT04005352|519942294|FG000|Overall Study|Physician Decision|7|||
144204180|NCT04005352|519942295|FG001|Overall Study|Physician Decision|13|||
144204181|NCT04005352|519942294|FG000|Overall Study|Protocol Violation|0|||
144204182|NCT04005352|519942295|FG001|Overall Study|Protocol Violation|1|||
144204183|NCT04005352|519942294|FG000|Overall Study|Withdrawal by Subject|28|||
144204184|NCT04005352|519942295|FG001|Overall Study|Withdrawal by Subject|38|||
144204185|NCT01442688|519942296|FG000|First Intervention|Withdrawal by Subject|1|||
144204186|NCT01442688|519942297|FG001|First Intervention|Withdrawal by Subject|0|||
144204187|NCT01442688|519942296|FG000|First Intervention|subject incarcerated|1|||
144204188|NCT01442688|519942297|FG001|First Intervention|subject incarcerated|0|||
144204189|NCT01442688|519942296|FG000|Second Intervention|Adverse Event|1|||
144204190|NCT01442688|519942297|FG001|Second Intervention|Adverse Event|0|||
144204191|NCT02792699|519942311|FG000|Overall Study|Adverse Event|1|||
144204192|NCT02792699|519942312|FG001|Overall Study|Adverse Event|2|||
144204193|NCT02792699|519942313|FG002|Overall Study|Adverse Event|4|||
144204194|NCT02792699|519942311|FG000|Overall Study|Withdrawal by Subject|4|||
144204195|NCT02792699|519942312|FG001|Overall Study|Withdrawal by Subject|4|||
144204196|NCT02792699|519942313|FG002|Overall Study|Withdrawal by Subject|3|||
144204197|NCT02792699|519942311|FG000|Overall Study|Lost to Follow-up|0|||
144204198|NCT02792699|519942312|FG001|Overall Study|Lost to Follow-up|1|||
144204199|NCT02792699|519942313|FG002|Overall Study|Lost to Follow-up|2|||
144204200|NCT02792699|519942311|FG000|Overall Study|Physician Decision|2|||
144204201|NCT02792699|519942312|FG001|Overall Study|Physician Decision|0|||
144204202|NCT02792699|519942313|FG002|Overall Study|Physician Decision|0|||
144204203|NCT02792699|519942311|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
144204204|NCT02792699|519942312|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
144204205|NCT02792699|519942313|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
144204206|NCT02792699|519942311|FG000|Overall Study|Other|1|||
144204207|NCT02792699|519942312|FG001|Overall Study|Other|0|||
144204208|NCT02792699|519942313|FG002|Overall Study|Other|0|||
144618113|NCT04942925|521459843|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
144618114|NCT04942925|521459844|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
144618115|NCT04099251|521461187|FG000|Pre-Treatment|Other reasons|1|||
144618116|NCT04099251|521461188|FG001|Pre-Treatment|Other reasons|0|||
144618117|NCT04099251|521461187|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
144618118|NCT04099251|521461188|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
144618119|NCT04099251|521461187|FG000|Blinded Treatment Phase|Other reasons|16|||
144618120|NCT04099251|521461188|FG001|Blinded Treatment Phase|Other reasons|7|||
144204209|NCT04524364|519942314|FG000|Overall Study|Physician Decision|3|||
144204210|NCT04524364|519942315|FG001|Overall Study|Physician Decision|6|||
144618121|NCT04099251|521461187|FG000|Blinded Treatment Phase|Disease recurrence|26|||
144618122|NCT04099251|521461188|FG001|Blinded Treatment Phase|Disease recurrence|41|||
144204211|NCT04524364|519942314|FG000|Overall Study|Adverse Event|0|||
144204212|NCT04524364|519942315|FG001|Overall Study|Adverse Event|1|||
144204213|NCT04524364|519942314|FG000|Overall Study|Investigational device deficiency|0|||
144204214|NCT04524364|519942315|FG001|Overall Study|Investigational device deficiency|1|||
144204215|NCT04524364|519942314|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
144204216|NCT04524364|519942315|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
144204217|NCT04524364|519942314|FG000|Overall Study|Device unavailability|0|||
144204218|NCT04524364|519942315|FG001|Overall Study|Device unavailability|2|||
144262561|NCT02983045|520161486|FG007|Overall Study|Lost to Follow-up|0|||
144262562|NCT02983045|520161487|FG008|Overall Study|Lost to Follow-up|0|||
144618123|NCT04099251|521461187|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
144204219|NCT04524364|519942314|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
144562734|NCT00943722|521260503|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
144562735|NCT00943722|521260504|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
144562736|NCT00943722|521260505|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
144562737|NCT00943722|521260506|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
144562738|NCT00943722|521260500|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
144562739|NCT00943722|521260501|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
144562740|NCT00943722|521260502|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
144562741|NCT00943722|521260503|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
144562742|NCT00943722|521260504|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
144562743|NCT00943722|521260505|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
144562744|NCT00943722|521260506|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
144562745|NCT00943722|521260500|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
144562746|NCT00943722|521260501|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
144562747|NCT00943722|521260502|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
144562748|NCT00943722|521260503|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
144562749|NCT00943722|521260504|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
144562750|NCT00943722|521260505|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
144562751|NCT00943722|521260506|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
144562752|NCT00943722|521260500|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
144562753|NCT00943722|521260501|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
144562754|NCT00943722|521260502|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
144562755|NCT00943722|521260503|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
144562756|NCT00943722|521260504|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
144562757|NCT00943722|521260505|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
144562758|NCT00943722|521260506|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
144562759|NCT00943722|521260500|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
144562760|NCT00943722|521260501|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
144562761|NCT00943722|521260502|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
144562762|NCT00943722|521260503|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
144562763|NCT00943722|521260504|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
144562764|NCT00943722|521260505|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
144562765|NCT00943722|521260506|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
144562766|NCT00943722|521260500|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
144562767|NCT00943722|521260501|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
144562768|NCT00943722|521260502|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
144562769|NCT00943722|521260503|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
144562770|NCT00943722|521260504|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
144562771|NCT00943722|521260505|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
144562772|NCT00943722|521260506|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
144562773|NCT01036165|521260507|FG000|Overall Study|Adverse Event|6|||
144562774|NCT01036165|521260507|FG000|Overall Study|Lost to Follow-up|2|||
144562775|NCT01036165|521260507|FG000|Overall Study|Withdrawal by Subject|3|||
144562776|NCT01036165|521260507|FG000|Overall Study|Device Related Issues|3|||
144562777|NCT01036165|521260507|FG000|Overall Study|Problems finding proper area to inject|1|||
144562778|NCT00307164|521260512|FG000|Overall Study|Death|1|||
144562779|NCT00307164|521260513|FG001|Overall Study|Death|0|||
144562780|NCT00307164|521260512|FG000|Overall Study|Severe debilitation, unable to continue|1|||
144562781|NCT00307164|521260513|FG001|Overall Study|Severe debilitation, unable to continue|0|||
144562782|NCT00307164|521260512|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
144562783|NCT00307164|521260513|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
144562784|NCT00307164|521260512|FG000|Overall Study|Withdrawal by Subject|1|||
144562785|NCT00307164|521260513|FG001|Overall Study|Withdrawal by Subject|8|||
144562786|NCT00307164|521260512|FG000|Overall Study|Not compliant with requirements|4|||
144562787|NCT00307164|521260513|FG001|Overall Study|Not compliant with requirements|4|||
144562788|NCT00307164|521260512|FG000|Overall Study|Lost to Follow-up|6|||
144562789|NCT00307164|521260513|FG001|Overall Study|Lost to Follow-up|1|||
144562790|NCT01649297|521260515|FG000|Overall Study|Adverse Event|5|||
144562791|NCT01649297|521260516|FG001|Overall Study|Adverse Event|5|||
144562792|NCT01649297|521260517|FG002|Overall Study|Adverse Event|4|||
144562793|NCT01649297|521260518|FG003|Overall Study|Adverse Event|13|||
144562794|NCT01649297|521260519|FG004|Overall Study|Adverse Event|1|||
144562795|NCT01649297|521260515|FG000|Overall Study|Lack of Efficacy|0|||
144204220|NCT04524364|519942315|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
144562796|NCT01649297|521260516|FG001|Overall Study|Lack of Efficacy|0|||
144562797|NCT01649297|521260517|FG002|Overall Study|Lack of Efficacy|0|||
144562798|NCT01649297|521260518|FG003|Overall Study|Lack of Efficacy|0|||
144562799|NCT01649297|521260519|FG004|Overall Study|Lack of Efficacy|1|||
144562800|NCT01649297|521260515|FG000|Overall Study|Non compliant with Protocol|1|||
144562801|NCT01649297|521260516|FG001|Overall Study|Non compliant with Protocol|0|||
144562802|NCT01649297|521260517|FG002|Overall Study|Non compliant with Protocol|3|||
144562803|NCT01649297|521260518|FG003|Overall Study|Non compliant with Protocol|2|||
144562804|NCT01649297|521260519|FG004|Overall Study|Non compliant with Protocol|1|||
144562805|NCT01649297|521260515|FG000|Overall Study|Lost to Follow-up|1|||
144562806|NCT01649297|521260516|FG001|Overall Study|Lost to Follow-up|1|||
144562807|NCT01649297|521260517|FG002|Overall Study|Lost to Follow-up|4|||
144562808|NCT01649297|521260518|FG003|Overall Study|Lost to Follow-up|3|||
144562809|NCT01649297|521260519|FG004|Overall Study|Lost to Follow-up|0|||
144562810|NCT01649297|521260515|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
144562811|NCT01649297|521260516|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
144562812|NCT01649297|521260517|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
144562813|NCT01649297|521260518|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
144562814|NCT01649297|521260519|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
144562815|NCT01649297|521260515|FG000|Overall Study|For other reason|4|||
144562816|NCT01649297|521260516|FG001|Overall Study|For other reason|1|||
144562817|NCT01649297|521260517|FG002|Overall Study|For other reason|2|||
144562818|NCT01649297|521260518|FG003|Overall Study|For other reason|0|||
144562819|NCT01649297|521260519|FG004|Overall Study|For other reason|0|||
144562820|NCT01685047|521260520|FG000|Overall Study|Withdrawal by Subject|20|||
144562821|NCT01685047|521260520|FG000|Overall Study|Death|26|||
144562822|NCT01685047|521260520|FG000|Overall Study|Lost to Follow-up|8|||
144562823|NCT01685047|521260520|FG000|Overall Study|Physician Decision|25|||
144562824|NCT01685047|521260520|FG000|Overall Study|Adverse Event|5|||
144562825|NCT01685047|521260520|FG000|Overall Study|patient withdrawn by sponsor|1|||
144562826|NCT01049984|521260521|FG000|Overall Study|Withdrawal by Subject|1|||
144562827|NCT01049984|521260522|FG001|Overall Study|Withdrawal by Subject|5|||
144562828|NCT01049984|521260521|FG000|Overall Study|Protocol Violation|3|||
144562829|NCT01049984|521260522|FG001|Overall Study|Protocol Violation|4|||
144562830|NCT01049984|521260521|FG000|Overall Study|Lost to Follow-up|2|||
144562831|NCT01049984|521260522|FG001|Overall Study|Lost to Follow-up|1|||
144562832|NCT01049984|521260521|FG000|Overall Study|Adverse Event|13|||
144562833|NCT01049984|521260522|FG001|Overall Study|Adverse Event|7|||
144562834|NCT01049984|521260521|FG000|Overall Study|Treatment failure|0|||
144562835|NCT01049984|521260522|FG001|Overall Study|Treatment failure|2|||
144562836|NCT01233999|521260525|FG000|Overall Study|Withdrawal by Subject|1|||
144562837|NCT01233999|521260525|FG000|Overall Study|Lost to Follow-up|1|||
144562838|NCT02246218|521260526|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144562839|NCT02246218|521260527|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144562840|NCT02246218|521260526|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
144562841|NCT02246218|521260527|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
144562842|NCT02246218|521260526|FG000|Overall Study|Adverse Event|1|||
144562843|NCT02246218|521260527|FG001|Overall Study|Adverse Event|1|||
144562844|NCT02246218|521260526|FG000|Overall Study|Lost to Follow-up|1|||
144562845|NCT02246218|521260527|FG001|Overall Study|Lost to Follow-up|0|||
144562846|NCT01321723|521260528|FG000|Overall Study|Adverse Event|3|||
144562847|NCT01321723|521260529|FG001|Overall Study|Adverse Event|5|||
144562848|NCT01321723|521260530|FG002|Overall Study|Adverse Event|2|||
144562849|NCT01321723|521260528|FG000|Overall Study|Withdrawal by Subject|2|||
144562850|NCT01321723|521260529|FG001|Overall Study|Withdrawal by Subject|0|||
144562851|NCT01321723|521260530|FG002|Overall Study|Withdrawal by Subject|2|||
144562852|NCT04952701|521260531|FG000|Control Lens|Physician Decision|4|||
144562853|NCT04952701|521260531|FG000|Test Lens|Physician Decision|1|||
144562854|NCT00827775|521260532|FG000|Overall Study|Withdrawal by Subject|0|||
144562855|NCT00827775|521260533|FG001|Overall Study|Withdrawal by Subject|5|||
144562856|NCT02212301|521260534|FG000|Period 1|Lost to Follow-up|0|||
144562857|NCT02212301|521260535|FG001|Period 1|Lost to Follow-up|1|||
144562858|NCT00578318|521260538|FG000|Overall Study|Lost to Follow-up|2|||
144562859|NCT00578318|521260539|FG001|Overall Study|Lost to Follow-up|0|||
144562860|NCT00578318|521260538|FG000|Overall Study|Physician Decision|1|||
144562861|NCT00578318|521260539|FG001|Overall Study|Physician Decision|0|||
144562862|NCT02025985|521260540|FG000|Overall Study|Consent withdrawn|0|||
144562863|NCT02025985|521260541|FG001|Overall Study|Consent withdrawn|0|||
144562864|NCT02025985|521260542|FG002|Overall Study|Consent withdrawn|1|||
144562865|NCT02025985|521260543|FG003|Overall Study|Consent withdrawn|0|||
144562866|NCT02025985|521260544|FG004|Overall Study|Consent withdrawn|0|||
144562867|NCT02025985|521260540|FG000|Overall Study|Termination of study by Sponsor|4|||
144562868|NCT02025985|521260541|FG001|Overall Study|Termination of study by Sponsor|3|||
144562869|NCT02025985|521260542|FG002|Overall Study|Termination of study by Sponsor|1|||
144562870|NCT02025985|521260543|FG003|Overall Study|Termination of study by Sponsor|1|||
144562871|NCT02025985|521260544|FG004|Overall Study|Termination of study by Sponsor|3|||
144562872|NCT02025985|521260540|FG000|Overall Study|Death|21|||
144562873|NCT02025985|521260541|FG001|Overall Study|Death|20|||
144562874|NCT02025985|521260542|FG002|Overall Study|Death|23|||
144562875|NCT02025985|521260543|FG003|Overall Study|Death|20|||
144562876|NCT02025985|521260544|FG004|Overall Study|Death|17|||
144562877|NCT00527514|521260545|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
144562878|NCT00527514|521260545|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
144562879|NCT00527514|521260545|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
144562880|NCT00527514|521260545|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
144562881|NCT00527514|521260545|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
144562882|NCT00527514|521260545|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
144562883|NCT00527514|521260545|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
144562884|NCT03041701|521260546|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
144562885|NCT03041701|521260547|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
144562886|NCT03041701|521260548|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
144562887|NCT03041701|521260546|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
144562888|NCT03041701|521260547|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
144562889|NCT03041701|521260548|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
144562890|NCT00920699|521260551|FG000|Overall Study|Withdrawal by Subject|2|||
144204221|NCT04524364|519942314|FG000|Overall Study|Low International normalized ratio (INR)|1|||
144204222|NCT04524364|519942315|FG001|Overall Study|Low International normalized ratio (INR)|0|||
144204223|NCT00855803|519942323|FG000|Overall Study|Death|2|||
144204224|NCT00855803|519942323|FG000|Overall Study|Lost to Follow-up|2|||
144204225|NCT00855803|519942323|FG000|Overall Study|Technical inability to undergo procedure|2|||
144204226|NCT00855803|519942323|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
144204227|NCT00855803|519942323|FG000|Overall Study|Withdrawal by Subject|3|||
144618124|NCT04099251|521461188|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
144618125|NCT04099251|521461187|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
144618126|NCT04099251|521461188|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
144618127|NCT04099251|521461187|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
144204228|NCT00855803|519942323|FG000|Overall Study|Physician Decision|3|||
144204229|NCT04430855|519942324|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
144562891|NCT00920699|521260552|FG001|Overall Study|Withdrawal by Subject|0|||
144562892|NCT00920699|521260553|FG002|Overall Study|Withdrawal by Subject|2|||
144562893|NCT00920699|521260551|FG000|Overall Study|no longer met eligibility|0|||
144562894|NCT00920699|521260552|FG001|Overall Study|no longer met eligibility|1|||
144562895|NCT00920699|521260553|FG002|Overall Study|no longer met eligibility|0|||
144562896|NCT00920699|521260551|FG000|Overall Study|Lost to Follow-up|0|||
144562897|NCT00920699|521260552|FG001|Overall Study|Lost to Follow-up|0|||
144562898|NCT00920699|521260553|FG002|Overall Study|Lost to Follow-up|2|||
144562899|NCT00001941|521260554|FG000|Overall Study|not treated- rapidly progressing disease|0|||
144618128|NCT04099251|521461188|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
144618129|NCT04099251|521461187|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
144618130|NCT04099251|521461188|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
144618131|NCT04099251|521461187|FG000|Blinded Treatment Phase|Death|6|||
144618132|NCT04099251|521461188|FG001|Blinded Treatment Phase|Death|2|||
144618133|NCT04099251|521461187|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
144728315|NCT02532764|521861213|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
144728316|NCT01717976|521861214|FG000|Overall Study|Protocol Violation|0|||
144728317|NCT01717976|521861215|FG001|Overall Study|Protocol Violation|1|||
144728318|NCT00262223|521861218|FG000|Treatment Phase|Withdrawal by Subject|3|||
144728319|NCT00262223|521861219|FG001|Treatment Phase|Withdrawal by Subject|6|||
144728320|NCT00262223|521861218|FG000|Treatment Phase|Adverse Event|1|||
144728321|NCT00262223|521861219|FG001|Treatment Phase|Adverse Event|2|||
144728322|NCT00262223|521861218|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
144728323|NCT00262223|521861219|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
144728324|NCT00262223|521861218|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
144728325|NCT00262223|521861219|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
144728326|NCT00262223|521861218|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
144728327|NCT00262223|521861219|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
144728328|NCT00437658|521861220|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
144728329|NCT00437658|521861221|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
144728330|NCT00437658|521861222|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
144728331|NCT00437658|521861220|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
144728332|NCT00437658|521861221|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
144728333|NCT00437658|521861222|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
144728334|NCT00437658|521861220|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
144728335|NCT00437658|521861221|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
144728336|NCT00437658|521861222|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
144728337|NCT00437658|521861220|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
144728338|NCT00437658|521861221|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
144728339|NCT00437658|521861222|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
144728340|NCT00437658|521861220|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
144728341|NCT00437658|521861221|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
144728342|NCT00437658|521861222|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
144204230|NCT04430855|519942325|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
144204231|NCT04430855|519942324|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
144204232|NCT04430855|519942325|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
144204233|NCT04430855|519942324|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
144562900|NCT00001941|521260555|FG001|Overall Study|not treated- rapidly progressing disease|0|||
144562901|NCT00001941|521260556|FG002|Overall Study|not treated- rapidly progressing disease|0|||
144562902|NCT00001941|521260557|FG003|Overall Study|not treated- rapidly progressing disease|0|||
144562903|NCT00001941|521260558|FG004|Overall Study|not treated- rapidly progressing disease|1|||
144562904|NCT01527500|521260560|FG000|Part A|Administrative|11|||
144562905|NCT01527500|521260561|FG001|Part A|Administrative|7|||
144562906|NCT01527500|521260560|FG000|Part A|Adverse Event|4|||
144562907|NCT01527500|521260561|FG001|Part A|Adverse Event|2|||
144562908|NCT01527500|521260560|FG000|Part A|Death|4|||
144562909|NCT01527500|521260561|FG001|Part A|Death|1|||
144562910|NCT01527500|521260560|FG000|Part A|Lost to Follow-up|0|||
144562911|NCT01527500|521260561|FG001|Part A|Lost to Follow-up|1|||
144562912|NCT01527500|521260560|FG000|Part A|Protocol Deviation|9|||
144562913|NCT01527500|521260561|FG001|Part A|Protocol Deviation|2|||
144562914|NCT01527500|521260560|FG000|Part A|Withdrawal by Subject|2|||
144562915|NCT01527500|521260561|FG001|Part A|Withdrawal by Subject|0|||
144562916|NCT01527500|521260560|FG000|Part B|Adverse Event|1|||
144562917|NCT01527500|521260561|FG001|Part B|Adverse Event|0|||
144562918|NCT00776984|521260562|FG000|Overall Study|Adverse Event|8|||
144562919|NCT00776984|521260563|FG001|Overall Study|Adverse Event|2|||
144562920|NCT00776984|521260562|FG000|Overall Study|Protocol Violation|4|||
144562921|NCT00776984|521260563|FG001|Overall Study|Protocol Violation|2|||
144562922|NCT00776984|521260562|FG000|Overall Study|Lost to Follow-up|2|||
144562923|NCT00776984|521260563|FG001|Overall Study|Lost to Follow-up|0|||
144562924|NCT00776984|521260562|FG000|Overall Study|Withdrawal by Subject|12|||
144562925|NCT00776984|521260563|FG001|Overall Study|Withdrawal by Subject|7|||
144562926|NCT00776984|521260562|FG000|Overall Study|Lack of Efficacy|0|||
144562927|NCT00776984|521260563|FG001|Overall Study|Lack of Efficacy|1|||
144562928|NCT00776984|521260562|FG000|Overall Study|Other|5|||
144562929|NCT00776984|521260563|FG001|Overall Study|Other|9|||
144562930|NCT02864342|521260564|FG000|Overall Study|Eligibility Criteria Deviation|2|||
144562931|NCT02864342|521260565|FG001|Overall Study|Eligibility Criteria Deviation|3|||
144562932|NCT02864342|521260564|FG000|Overall Study|Withdrawal by Subject|4|||
144562933|NCT02864342|521260565|FG001|Overall Study|Withdrawal by Subject|2|||
144562934|NCT02864342|521260564|FG000|Overall Study|Device Technology Issue|6|||
144562935|NCT02864342|521260565|FG001|Overall Study|Device Technology Issue|7|||
144562936|NCT02864342|521260564|FG000|Overall Study|Death|0|||
144562937|NCT02864342|521260565|FG001|Overall Study|Death|1|||
144562938|NCT02864342|521260564|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
144562939|NCT02864342|521260565|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
144562940|NCT02864342|521260564|FG000|Overall Study|Lost to Follow-up|1|||
144562941|NCT02864342|521260565|FG001|Overall Study|Lost to Follow-up|5|||
144562942|NCT02864342|521260564|FG000|Overall Study|Lost Device|1|||
144562943|NCT02864342|521260565|FG001|Overall Study|Lost Device|0|||
144562944|NCT02864342|521260564|FG000|Overall Study|Adverse Event|1|||
144562945|NCT02864342|521260565|FG001|Overall Study|Adverse Event|0|||
144562946|NCT02573883|521260566|FG000|Six Month Follow Up|Lost to Follow-up|1|||
144562947|NCT02573883|521260567|FG001|Six Month Follow Up|Lost to Follow-up|0|||
144562948|NCT02573883|521260568|FG002|Six Month Follow Up|Lost to Follow-up|0|||
144562949|NCT02573883|521260569|FG003|Six Month Follow Up|Lost to Follow-up|0|||
144562950|NCT02573883|521260566|FG000|One Year Follow Up|Lost to Follow-up|2|||
144562951|NCT02573883|521260567|FG001|One Year Follow Up|Lost to Follow-up|1|||
144562952|NCT02573883|521260568|FG002|One Year Follow Up|Lost to Follow-up|0|||
144562953|NCT02573883|521260569|FG003|One Year Follow Up|Lost to Follow-up|0|||
144562954|NCT01560585|521260575|FG000|Overall Study|Physician Decision|3|||
144562955|NCT00519285|521260576|FG000|Overall Study|Adverse Event|127|||
144562956|NCT00519285|521260577|FG001|Overall Study|Adverse Event|266|||
144562957|NCT00519285|521260576|FG000|Overall Study|Disease progression|334|||
144562958|NCT00519285|521260577|FG001|Overall Study|Disease progression|186|||
144562959|NCT00519285|521260576|FG000|Overall Study|Physician Decision|75|||
144562960|NCT00519285|521260577|FG001|Overall Study|Physician Decision|47|||
144562961|NCT00519285|521260576|FG000|Overall Study|Participant's request|53|||
144562962|NCT00519285|521260577|FG001|Overall Study|Participant's request|84|||
144562963|NCT00519285|521260576|FG000|Overall Study|Consent withdrawn|4|||
144562964|NCT00519285|521260577|FG001|Overall Study|Consent withdrawn|5|||
144562965|NCT00519285|521260576|FG000|Overall Study|Poor compliance to protocol|5|||
144562966|NCT00519285|521260577|FG001|Overall Study|Poor compliance to protocol|7|||
144562967|NCT00519285|521260576|FG000|Overall Study|Reason unspecified|5|||
144562968|NCT00519285|521260577|FG001|Overall Study|Reason unspecified|8|||
144562969|NCT00519285|521260576|FG000|Overall Study|Not treated|8|||
144562970|NCT00519285|521260577|FG001|Overall Study|Not treated|7|||
144562971|NCT00519285|521260576|FG000|Overall Study|Treatment ongoing|1|||
144562972|NCT00519285|521260577|FG001|Overall Study|Treatment ongoing|2|||
144562973|NCT00988117|521260578|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
144562974|NCT00988117|521260578|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
144562975|NCT04088500|521260579|FG000|Overall Study|Reason unknown|1|||
144562976|NCT04088500|521260579|FG000|Overall Study|Participant withdrew consent|1|||
144562977|NCT04088500|521260579|FG000|Overall Study|Disease progression|3|||
144562978|NCT02930837|521260582|FG000|Overall Study|Adverse Event|6|||
144562979|NCT02930837|521260582|FG000|Overall Study|Lost to Follow-up|5|||
144562980|NCT02930837|521260582|FG000|Overall Study|Withdrawal by Subject|1|||
144562981|NCT04582864|521260583|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
144562982|NCT04582864|521260583|FG000|Overall Study|Death|1|||
144562983|NCT00006436|521260584|FG000|Overall Study|Refused further treatment|2|||
144562984|NCT00006436|521260584|FG000|Overall Study|Declined to participate (before treatment started)|1|||
144562985|NCT01071317|521260585|FG000|Overall Study|Lost to Follow-up|2|||
144562986|NCT01071317|521260586|FG001|Overall Study|Lost to Follow-up|2|||
144562987|NCT03119688|521262374|FG000|Overall Study|Adverse Event|4|||
144204234|NCT04430855|519942325|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
144204235|NCT04430855|519942324|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
144204236|NCT04430855|519942325|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
144204237|NCT04430855|519942324|FG000|Period 1 (Weeks 1-12)|Other|0|||
144204238|NCT04430855|519942325|FG001|Period 1 (Weeks 1-12)|Other|1|||
144204239|NCT04430855|519942324|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
144204240|NCT04430855|519942325|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
144204241|NCT04430855|519942324|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
144204242|NCT04430855|519942325|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
144204243|NCT04430855|519942324|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
144204244|NCT04430855|519942325|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
144204245|NCT01425723|519942326|FG000|Overall Study|Lack of Efficacy|0|||
144204246|NCT01425723|519942327|FG001|Overall Study|Lack of Efficacy|1|||
144204247|NCT01425723|519942326|FG000|Overall Study|Withdrawal by Subject|1|||
144204248|NCT01425723|519942327|FG001|Overall Study|Withdrawal by Subject|4|||
144204249|NCT01425723|519942326|FG000|Overall Study|Lost to Follow-up|0|||
144204250|NCT01425723|519942327|FG001|Overall Study|Lost to Follow-up|3|||
144204251|NCT01425723|519942326|FG000|Overall Study|Physician Decision|2|||
144204252|NCT01425723|519942327|FG001|Overall Study|Physician Decision|0|||
144204253|NCT01425723|519942326|FG000|Overall Study|Other|1|||
144204254|NCT01425723|519942327|FG001|Overall Study|Other|10|||
144204255|NCT00871741|519942334|FG000|Overall Study|Premature study termination|9|||
144204256|NCT00871741|519942335|FG001|Overall Study|Premature study termination|7|||
144204257|NCT01565850|519942336|FG000|Overall Study|Adverse Event|0|||
144204258|NCT01565850|519942337|FG001|Overall Study|Adverse Event|1|||
144204259|NCT01565850|519942336|FG000|Overall Study|Lost to Follow-up|12|||
144204260|NCT01565850|519942337|FG001|Overall Study|Lost to Follow-up|4|||
144204261|NCT01565850|519942336|FG000|Overall Study|Investigator's Discretion|2|||
144204262|NCT01565850|519942337|FG001|Overall Study|Investigator's Discretion|1|||
144204263|NCT01565850|519942336|FG000|Overall Study|Participant noncompliance|2|||
144204264|NCT01565850|519942337|FG001|Overall Study|Participant noncompliance|0|||
144204265|NCT01565850|519942336|FG000|Overall Study|Withdrew Consent|4|||
144204266|NCT01565850|519942337|FG001|Overall Study|Withdrew Consent|2|||
144204267|NCT05323123|519942338|FG000|Overall Study|Withdrawal by Subject|2|||
144204268|NCT05323123|519942339|FG001|Overall Study|Withdrawal by Subject|1|||
144204269|NCT05323123|519942338|FG000|Overall Study|Lost to Follow-up|4|||
144204270|NCT05323123|519942339|FG001|Overall Study|Lost to Follow-up|2|||
144204271|NCT05323123|519942338|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
144204272|NCT05323123|519942339|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
144204273|NCT05529472|519942340|FG000|Overall Study|Withdrawal by Subject|1|||
144204274|NCT05529472|519942341|FG001|Overall Study|Withdrawal by Subject|1|||
144204275|NCT03190330|519944379|FG000|Overall Study|Adverse Event|2|||
144204276|NCT03190330|519944379|FG000|Overall Study|Death|10|||
144204277|NCT03190330|519944379|FG000|Overall Study|Lost to Follow-up|1|||
144204278|NCT03190330|519944379|FG000|Overall Study|Withdrawal by Subject|6|||
144204279|NCT03190330|519944379|FG000|Overall Study|Progressive Disease|1|||
144204280|NCT02081209|519944380|FG000|Overall Study|Withdrawal by Subject|1|||
144204281|NCT02022748|519944384|FG000|Overall Study|Adverse Event|1|||
144204282|NCT02022748|519944385|FG001|Overall Study|Adverse Event|1|||
144204283|NCT02022748|519944386|FG002|Overall Study|Adverse Event|0|||
144204284|NCT02022748|519944384|FG000|Overall Study|Withdrawal by Subject|0|||
144204285|NCT02022748|519944385|FG001|Overall Study|Withdrawal by Subject|1|||
144204286|NCT02022748|519944386|FG002|Overall Study|Withdrawal by Subject|0|||
144204287|NCT00633243|519944387|FG000|Overall Study|Withdrawal by Subject|0|||
144204288|NCT00633243|519944388|FG001|Overall Study|Withdrawal by Subject|1|||
144204289|NCT00633243|519944387|FG000|Overall Study|incarceration|0|||
144204290|NCT00633243|519944388|FG001|Overall Study|incarceration|2|||
144204291|NCT00633243|519944387|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
144204292|NCT00633243|519944388|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
144204293|NCT00633243|519944387|FG000|Overall Study|Not comfortable with self-injecting|0|||
144204294|NCT00633243|519944388|FG001|Overall Study|Not comfortable with self-injecting|1|||
144204295|NCT00633243|519944387|FG000|Overall Study|Mental Health--Depression|0|||
144204296|NCT00633243|519944388|FG001|Overall Study|Mental Health--Depression|1|||
144204297|NCT00633243|519944387|FG000|Overall Study|Couldn't tolerate side-effects|1|||
144562988|NCT00320398|521262375|FG000|Overall Study|Adverse Event|1|||
144562989|NCT00320398|521262376|FG001|Overall Study|Adverse Event|4|||
144204298|NCT00633243|519944388|FG001|Overall Study|Couldn't tolerate side-effects|1|||
144204299|NCT00379340|519944390|FG000|Overall Study|Death|0|||
144204300|NCT00379340|519944391|FG001|Overall Study|Death|0|||
144204301|NCT00379340|519944392|FG002|Overall Study|Death|0|||
144204302|NCT00379340|519944393|FG003|Overall Study|Death|2|||
144204303|NCT00379340|519944394|FG004|Overall Study|Death|0|||
144204304|NCT00379340|519944390|FG000|Overall Study|Lack of Efficacy|6|||
144204305|NCT00379340|519944391|FG001|Overall Study|Lack of Efficacy|1|||
144204306|NCT00379340|519944392|FG002|Overall Study|Lack of Efficacy|0|||
144204307|NCT00379340|519944393|FG003|Overall Study|Lack of Efficacy|4|||
144204308|NCT00379340|519944394|FG004|Overall Study|Lack of Efficacy|3|||
144204309|NCT00379340|519944390|FG000|Overall Study|Physician Decision|6|||
144204310|NCT00379340|519944391|FG001|Overall Study|Physician Decision|2|||
144204311|NCT00379340|519944392|FG002|Overall Study|Physician Decision|1|||
144204312|NCT00379340|519944393|FG003|Overall Study|Physician Decision|2|||
144204313|NCT00379340|519944394|FG004|Overall Study|Physician Decision|3|||
144204314|NCT00379340|519944390|FG000|Overall Study|Withdrawal by Subject|0|||
144204315|NCT00379340|519944391|FG001|Overall Study|Withdrawal by Subject|0|||
144204316|NCT00379340|519944392|FG002|Overall Study|Withdrawal by Subject|0|||
144204317|NCT00379340|519944393|FG003|Overall Study|Withdrawal by Subject|1|||
144204318|NCT00379340|519944394|FG004|Overall Study|Withdrawal by Subject|0|||
144204319|NCT00379340|519944390|FG000|Overall Study|Refusal of further protocol therapy|1|||
144204320|NCT00379340|519944391|FG001|Overall Study|Refusal of further protocol therapy|0|||
144204321|NCT00379340|519944392|FG002|Overall Study|Refusal of further protocol therapy|1|||
144204322|NCT00379340|519944393|FG003|Overall Study|Refusal of further protocol therapy|1|||
144204323|NCT00379340|519944394|FG004|Overall Study|Refusal of further protocol therapy|7|||
144204324|NCT00379340|519944390|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
144204325|NCT00379340|519944391|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
144204326|NCT00379340|519944392|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
144204327|NCT00379340|519944393|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
144204328|NCT00379340|519944394|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
144204329|NCT00379340|519944390|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
144204330|NCT00379340|519944391|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
144204331|NCT00379340|519944392|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
144204332|NCT00379340|519944393|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
144204333|NCT00379340|519944394|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
144204334|NCT04347122|519944395|FG000|Overall Study|Physician Decision|0|||
144562990|NCT00320398|521262375|FG000|Overall Study|Other|1|||
144562991|NCT00320398|521262376|FG001|Overall Study|Other|0|||
144562992|NCT04190225|521262377|FG000|Overall Study|Lost to Follow-up|2|||
144562993|NCT04190225|521262378|FG001|Overall Study|Lost to Follow-up|3|||
144562994|NCT04190225|521262377|FG000|Overall Study|Withdrawal by Subject|3|||
144562995|NCT04190225|521262378|FG001|Overall Study|Withdrawal by Subject|2|||
144562996|NCT04190225|521262377|FG000|Overall Study|Unrelated health condition|2|||
144562997|NCT04190225|521262378|FG001|Overall Study|Unrelated health condition|0|||
144562998|NCT04544865|521262379|FG000|Overall Study|Death|0|||
144562999|NCT04544865|521262380|FG001|Overall Study|Death|2|||
144563000|NCT04544865|521262379|FG000|Overall Study|Lost to Follow-up|11|||
144563001|NCT04544865|521262380|FG001|Overall Study|Lost to Follow-up|7|||
144563002|NCT04544865|521262379|FG000|Overall Study|Withdrawal by Subject|0|||
144563003|NCT04544865|521262380|FG001|Overall Study|Withdrawal by Subject|1|||
144563004|NCT04544865|521262379|FG000|Overall Study|Other|0|||
144563005|NCT04544865|521262380|FG001|Overall Study|Other|1|||
144563006|NCT02973802|521262381|FG000|Overall Study|Lost to Follow-up|1|||
144563007|NCT02973802|521262381|FG000|Overall Study|Withdrawal by Subject|1|||
144563008|NCT01772823|521262383|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
144563009|NCT01772823|521262384|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
144563010|NCT01772823|521262383|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
144563011|NCT01772823|521262384|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
144563012|NCT01772823|521262383|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
144618134|NCT04099251|521461188|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
144204335|NCT04347122|519944396|FG001|Overall Study|Physician Decision|3|||
144204336|NCT04347122|519944397|FG002|Overall Study|Physician Decision|3|||
144618135|NCT04099251|521461187|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
144204337|NCT04347122|519944398|FG003|Overall Study|Physician Decision|6|||
144204338|NCT01502410|519944402|FG000|Overall Study|Adverse Event|1|||
144204339|NCT01502410|519944403|FG001|Overall Study|Adverse Event|2|||
144204340|NCT01502410|519944404|FG002|Overall Study|Adverse Event|0|||
144204341|NCT01502410|519944405|FG003|Overall Study|Adverse Event|0|||
144204342|NCT01502410|519944402|FG000|Overall Study|Lack of Efficacy|7|||
144204343|NCT01502410|519944403|FG001|Overall Study|Lack of Efficacy|7|||
144204344|NCT01502410|519944404|FG002|Overall Study|Lack of Efficacy|0|||
144204345|NCT01502410|519944405|FG003|Overall Study|Lack of Efficacy|0|||
144563013|NCT01772823|521262384|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
144204346|NCT01502410|519944402|FG000|Overall Study|Physician Decision|0|||
144563014|NCT01772823|521262383|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
144204347|NCT01502410|519944403|FG001|Overall Study|Physician Decision|1|||
144204348|NCT01502410|519944404|FG002|Overall Study|Physician Decision|0|||
144204349|NCT01502410|519944405|FG003|Overall Study|Physician Decision|0|||
144204350|NCT01502410|519944402|FG000|Overall Study|Withdrawal by Subject|2|||
144204351|NCT01502410|519944403|FG001|Overall Study|Withdrawal by Subject|0|||
144204352|NCT01502410|519944404|FG002|Overall Study|Withdrawal by Subject|0|||
144204353|NCT01502410|519944405|FG003|Overall Study|Withdrawal by Subject|0|||
144204354|NCT02903030|519944406|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
144204355|NCT02903030|519944407|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
144204356|NCT04345601|519944408|FG000|Overall Study|Death|0|||
144204357|NCT04345601|519944409|FG001|Overall Study|Death|3|||
144204358|NCT04345601|519944410|FG002|Overall Study|Death|2|||
144204359|NCT04345601|519944408|FG000|Overall Study|Lost to Follow-up|0|||
144204360|NCT04345601|519944409|FG001|Overall Study|Lost to Follow-up|0|||
144204361|NCT04345601|519944410|FG002|Overall Study|Lost to Follow-up|2|||
144204362|NCT03700385|519944411|FG000|Overall Study|Lost to Follow-up|1|||
144563015|NCT01772823|521262384|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
144563016|NCT01772823|521262383|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
144563017|NCT01772823|521262384|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
144563018|NCT01772823|521262383|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
144563019|NCT01772823|521262384|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
144563020|NCT01772823|521262383|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
144563021|NCT01772823|521262384|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
144563022|NCT01772823|521262383|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
144563023|NCT01772823|521262384|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
144563024|NCT01772823|521262383|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
144563025|NCT01772823|521262384|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
144563026|NCT01772823|521262383|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
144563027|NCT01772823|521262384|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
144563028|NCT01772823|521262383|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
144563029|NCT01772823|521262384|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
144563030|NCT01772823|521262383|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
144563031|NCT01772823|521262384|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
144563032|NCT01772823|521262383|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
144563033|NCT01772823|521262384|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
144563034|NCT01772823|521262383|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
144563035|NCT01772823|521262384|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
144563036|NCT01772823|521262383|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
144563037|NCT01772823|521262384|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
144563038|NCT01772823|521262383|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
144563039|NCT01772823|521262384|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
144563040|NCT02895360|521262389|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
144563041|NCT02895360|521262390|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
144563042|NCT02895360|521262391|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
144563043|NCT02895360|521262392|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
144563044|NCT02895360|521262393|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
144563045|NCT02895360|521262394|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
144563046|NCT02895360|521262389|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
144563047|NCT02895360|521262390|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
144563048|NCT02895360|521262391|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
144563049|NCT02895360|521262392|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
144563050|NCT02895360|521262393|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
144563051|NCT02895360|521262394|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
144563052|NCT02895360|521262389|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
144563053|NCT02895360|521262390|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
144563054|NCT02895360|521262391|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
144563055|NCT02895360|521262392|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
144563056|NCT02895360|521262393|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
144563057|NCT02895360|521262394|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
144563058|NCT02895360|521262389|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
144618136|NCT04099251|521461188|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
144618137|NCT04099251|521461187|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
144618138|NCT04099251|521461188|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
144618139|NCT04099251|521461187|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
144618140|NCT04099251|521461188|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
144204363|NCT01555671|519944416|FG000|Overall Study|Physician Decision|20|||
144204364|NCT01555671|519944417|FG001|Overall Study|Physician Decision|25|||
144204365|NCT00699283|519944418|FG000|Overall Study|Lack of Efficacy|15|||
144204366|NCT00699283|519944419|FG001|Overall Study|Lack of Efficacy|5|||
144563059|NCT02895360|521262390|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
144563060|NCT02895360|521262391|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
144563061|NCT02895360|521262392|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
144563062|NCT02895360|521262393|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
144563063|NCT02895360|521262394|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
144563064|NCT02895360|521262389|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
144563065|NCT02895360|521262390|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
144563066|NCT02895360|521262391|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
144563067|NCT02895360|521262392|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
144563068|NCT02895360|521262393|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
144204367|NCT00699283|519944418|FG000|Overall Study|Lost to Follow-up|2|||
144204368|NCT00699283|519944419|FG001|Overall Study|Lost to Follow-up|0|||
144204369|NCT00699283|519944418|FG000|Overall Study|Withdrawal by Subject|1|||
144204370|NCT00699283|519944419|FG001|Overall Study|Withdrawal by Subject|0|||
144204371|NCT00699283|519944418|FG000|Overall Study|Other Reason|5|||
144204372|NCT00699283|519944419|FG001|Overall Study|Other Reason|1|||
144204373|NCT00699283|519944418|FG000|Overall Study|SAE, non-fatal|1|||
144204374|NCT00699283|519944419|FG001|Overall Study|SAE, non-fatal|1|||
144204375|NCT00699283|519944418|FG000|Overall Study|AE, non-serious non-fatal|8|||
144204376|NCT00699283|519944419|FG001|Overall Study|AE, non-serious non-fatal|1|||
144204377|NCT00699283|519944418|FG000|Overall Study|AE of unknown type|1|||
144204378|NCT00699283|519944419|FG001|Overall Study|AE of unknown type|0|||
144204379|NCT04590040|519944420|FG000|Treatment Period|Lost to Follow-up|2|||
144204380|NCT04590040|519944421|FG001|Treatment Period|Lost to Follow-up|5|||
144204381|NCT04590040|519944422|FG002|Treatment Period|Lost to Follow-up|0|||
144204382|NCT04590040|519944420|FG000|Treatment Period|Physician Decision|0|||
144204383|NCT04590040|519944421|FG001|Treatment Period|Physician Decision|0|||
144204384|NCT04590040|519944422|FG002|Treatment Period|Physician Decision|2|||
144204385|NCT00631657|519944427|FG000|6-Month Treatment Period|Adverse Event|47|||
144204386|NCT00631657|519944428|FG001|6-Month Treatment Period|Adverse Event|0|||
144204387|NCT00631657|519944429|FG002|6-Month Treatment Period|Adverse Event|7|||
144204388|NCT00631657|519944427|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
144204389|NCT00631657|519944428|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
144204390|NCT00631657|519944429|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
144204391|NCT00631657|519944427|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
144204392|NCT00631657|519944428|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
144204393|NCT00631657|519944429|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
144204394|NCT00631657|519944427|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
144204395|NCT00631657|519944428|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
144204396|NCT00631657|519944429|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
144204397|NCT00631657|519944427|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
144204398|NCT00631657|519944428|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
144204399|NCT00631657|519944429|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
144204400|NCT00631657|519944427|FG000|6-Month Treatment Period|Other|16|||
144204401|NCT00631657|519944428|FG001|6-Month Treatment Period|Other|0|||
144204402|NCT00631657|519944429|FG002|6-Month Treatment Period|Other|4|||
144204403|NCT00631657|519944427|FG000|6-Month Treatment Period|Not Treated|2|||
144204404|NCT00631657|519944428|FG001|6-Month Treatment Period|Not Treated|0|||
144204405|NCT00631657|519944429|FG002|6-Month Treatment Period|Not Treated|1|||
144204406|NCT00631657|519944427|FG000|7-Day Discontinuation Period|Not Treated|1|||
144204407|NCT00631657|519944428|FG001|7-Day Discontinuation Period|Not Treated|1|||
144204408|NCT00631657|519944429|FG002|7-Day Discontinuation Period|Not Treated|1|||
144204409|NCT00631657|519944427|FG000|7-Day Discontinuation Period|Other|1|||
144204410|NCT00631657|519944428|FG001|7-Day Discontinuation Period|Other|0|||
144204411|NCT00631657|519944429|FG002|7-Day Discontinuation Period|Other|0|||
144204412|NCT01284361|519944434|FG000|Overall Study|Withdrawal by Subject|1|||
144204413|NCT01284361|519944434|FG000|Overall Study|Protocol Violation|5|||
144204414|NCT01284361|519944434|FG000|Overall Study|Adverse Event|1|||
144204415|NCT01284361|519944434|FG000|Overall Study|Lost to Follow-up|2|||
144204416|NCT03537599|519944435|FG000|Overall Study|Disease Progression|2|||
144204417|NCT03537599|519944436|FG001|Overall Study|Disease Progression|1|||
144204418|NCT03537599|519944435|FG000|Overall Study|Death|0|||
144204419|NCT03537599|519944436|FG001|Overall Study|Death|1|||
144204420|NCT00622466|519944437|FG000|Overall Study|Death|1|||
144618141|NCT04099251|521461187|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
144204421|NCT00622466|519944437|FG000|Overall Study|Adverse Event|1|||
144204422|NCT00622466|519944437|FG000|Overall Study|Withdrawal by Subject|2|||
144204423|NCT01007942|519944438|FG000|Overall Study|Adverse Event|29|||
144204424|NCT01007942|519944439|FG001|Overall Study|Adverse Event|14|||
144204425|NCT01007942|519944438|FG000|Overall Study|Abnormal test procedure|0|||
144204426|NCT01007942|519944439|FG001|Overall Study|Abnormal test procedure|1|||
144204427|NCT01007942|519944438|FG000|Overall Study|Disease progression|217|||
144204428|NCT01007942|519944439|FG001|Overall Study|Disease progression|242|||
144563069|NCT02895360|521262394|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
144563070|NCT02895360|521262389|FG000|Phase 2a|Adverse Event|0|||
144204429|NCT01007942|519944438|FG000|Overall Study|New cancer therapy|5|||
144204430|NCT01007942|519944439|FG001|Overall Study|New cancer therapy|1|||
144204431|NCT01007942|519944438|FG000|Overall Study|Protocol Violation|1|||
144204432|NCT01007942|519944439|FG001|Overall Study|Protocol Violation|1|||
144204433|NCT01007942|519944438|FG000|Overall Study|Withdrawal by Subject|19|||
144204434|NCT01007942|519944439|FG001|Overall Study|Withdrawal by Subject|14|||
144204435|NCT01007942|519944438|FG000|Overall Study|Lost to Follow-up|1|||
144204436|NCT01007942|519944439|FG001|Overall Study|Lost to Follow-up|0|||
144204437|NCT01007942|519944438|FG000|Overall Study|Administrative problems|2|||
144204438|NCT01007942|519944439|FG001|Overall Study|Administrative problems|0|||
144204439|NCT01007942|519944438|FG000|Overall Study|Death|3|||
144204440|NCT01007942|519944439|FG001|Overall Study|Death|2|||
144204441|NCT01007942|519944438|FG000|Overall Study|Patients untreated|4|||
144204442|NCT01007942|519944439|FG001|Overall Study|Patients untreated|3|||
144204443|NCT05083585|519944440|FG000|Overall Study|Death|1|||
144204444|NCT05083585|519944441|FG001|Overall Study|Death|1|||
144204445|NCT05083585|519944440|FG000|Overall Study|Lost to Follow-up|1|||
144204446|NCT05083585|519944441|FG001|Overall Study|Lost to Follow-up|1|||
144204447|NCT05083585|519944440|FG000|Overall Study|Withdrawal by Subject|2|||
144204448|NCT05083585|519944441|FG001|Overall Study|Withdrawal by Subject|0|||
144204449|NCT05083585|519944440|FG000|Overall Study|Randomized but not vaccinated|2|||
144204450|NCT05083585|519944441|FG001|Overall Study|Randomized but not vaccinated|0|||
144204451|NCT03929757|519944442|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
144204452|NCT03929757|519944443|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
144204453|NCT03929757|519944444|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
144204454|NCT03929757|519944442|FG000|Main Study: Up to Day 365|Other|1|||
144204455|NCT03929757|519944443|FG001|Main Study: Up to Day 365|Other|0|||
144204456|NCT03929757|519944444|FG002|Main Study: Up to Day 365|Other|0|||
144204457|NCT03929757|519944442|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
144204458|NCT03929757|519944443|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
144204459|NCT03929757|519944444|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
144204460|NCT03400943|519944445|FG000|Treatment Period 1|Adverse Event|0|||
144204461|NCT03400943|519944446|FG001|Treatment Period 1|Adverse Event|0|||
144204462|NCT03400943|519944447|FG002|Treatment Period 1|Adverse Event|0|||
144204463|NCT03400943|519944448|FG003|Treatment Period 1|Adverse Event|1|||
144204464|NCT03400943|519944445|FG000|Treatment Period 1|Lost to Follow-up|1|||
144204465|NCT03400943|519944446|FG001|Treatment Period 1|Lost to Follow-up|0|||
144204466|NCT03400943|519944447|FG002|Treatment Period 1|Lost to Follow-up|0|||
144204467|NCT03400943|519944448|FG003|Treatment Period 1|Lost to Follow-up|0|||
144204468|NCT03400943|519944445|FG000|Treatment Period 1|Protocol Violation|0|||
144204469|NCT03400943|519944446|FG001|Treatment Period 1|Protocol Violation|1|||
144204470|NCT03400943|519944447|FG002|Treatment Period 1|Protocol Violation|1|||
144204471|NCT03400943|519944448|FG003|Treatment Period 1|Protocol Violation|0|||
144204472|NCT03400943|519944445|FG000|Treatment Period 1|Study terminated by sponsor|2|||
144204473|NCT03400943|519944446|FG001|Treatment Period 1|Study terminated by sponsor|0|||
144204474|NCT03400943|519944447|FG002|Treatment Period 1|Study terminated by sponsor|0|||
144204475|NCT03400943|519944448|FG003|Treatment Period 1|Study terminated by sponsor|1|||
144204476|NCT03400943|519944445|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144204477|NCT03400943|519944446|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144204478|NCT03400943|519944447|FG002|Treatment Period 1|Withdrawal by Subject|3|||
144204479|NCT03400943|519944448|FG003|Treatment Period 1|Withdrawal by Subject|1|||
144204480|NCT03400943|519944445|FG000|Treatment Period 1|Other|2|||
144204481|NCT03400943|519944446|FG001|Treatment Period 1|Other|1|||
144204482|NCT03400943|519944447|FG002|Treatment Period 1|Other|2|||
144204483|NCT03400943|519944448|FG003|Treatment Period 1|Other|2|||
144204484|NCT03400943|519944445|FG000|Post-treatment Period 1|Adverse Event|2|||
144204485|NCT03400943|519944446|FG001|Post-treatment Period 1|Adverse Event|0|||
144204486|NCT03400943|519944447|FG002|Post-treatment Period 1|Adverse Event|0|||
144204487|NCT03400943|519944448|FG003|Post-treatment Period 1|Adverse Event|0|||
144204488|NCT03400943|519944445|FG000|Post-treatment Period 1|Protocol Violation|1|||
144204489|NCT03400943|519944446|FG001|Post-treatment Period 1|Protocol Violation|0|||
144563071|NCT02895360|521262390|FG001|Phase 2a|Adverse Event|0|||
144563072|NCT02895360|521262391|FG002|Phase 2a|Adverse Event|0|||
144204490|NCT03400943|519944447|FG002|Post-treatment Period 1|Protocol Violation|0|||
144204491|NCT03400943|519944448|FG003|Post-treatment Period 1|Protocol Violation|0|||
144204492|NCT03400943|519944445|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
144204493|NCT03400943|519944446|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
144204494|NCT03400943|519944447|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
144204495|NCT03400943|519944448|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
144204496|NCT03400943|519944445|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
144204497|NCT03400943|519944446|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
144563073|NCT02895360|521262392|FG003|Phase 2a|Adverse Event|0|||
144563074|NCT02895360|521262393|FG004|Phase 2a|Adverse Event|0|||
144204498|NCT03400943|519944447|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
144262563|NCT02983045|520161488|FG009|Overall Study|Lost to Follow-up|0|||
144563075|NCT02895360|521262394|FG005|Phase 2a|Adverse Event|1|||
144563076|NCT02895360|521262389|FG000|Phase 2a|Progressive disease|0|||
144618142|NCT04099251|521461188|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
144618143|NCT04099251|521461187|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
144618144|NCT04099251|521461188|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
144618145|NCT04099251|521461187|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
144618146|NCT04099251|521461188|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
144618147|NCT04099251|521461187|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
144618148|NCT04099251|521461188|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
144618149|NCT04099251|521461187|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
144618150|NCT04099251|521461188|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
144563077|NCT02895360|521262390|FG001|Phase 2a|Progressive disease|0|||
144563078|NCT02895360|521262391|FG002|Phase 2a|Progressive disease|0|||
144563079|NCT02895360|521262392|FG003|Phase 2a|Progressive disease|0|||
144563080|NCT02895360|521262393|FG004|Phase 2a|Progressive disease|11|||
144563081|NCT02895360|521262394|FG005|Phase 2a|Progressive disease|11|||
144563082|NCT01732926|521262395|FG000|Overall Study|Study Terminated by Sponsor|168|||
144563083|NCT01732926|521262396|FG001|Overall Study|Study Terminated by Sponsor|80|||
144563084|NCT01732926|521262395|FG000|Overall Study|Withdrawal by Subject|46|||
144563085|NCT01732926|521262396|FG001|Overall Study|Withdrawal by Subject|8|||
144563086|NCT01732926|521262395|FG000|Overall Study|Physician Decision|24|||
144563087|NCT01732926|521262396|FG001|Overall Study|Physician Decision|11|||
144563088|NCT01732926|521262395|FG000|Overall Study|Other Reason|21|||
144618151|NCT02068547|521461189|FG000|Overall Study|Lost to Follow-up|3|||
144618152|NCT02068547|521461190|FG001|Overall Study|Lost to Follow-up|3|||
144618153|NCT02068547|521461189|FG000|Overall Study|Physician Decision|1|||
144728343|NCT00437658|521861220|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
144728344|NCT00437658|521861221|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
144728345|NCT00437658|521861222|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
144728346|NCT00437658|521861220|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
144728347|NCT00437658|521861221|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
144728348|NCT00437658|521861222|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
144728349|NCT00437658|521861220|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
144728350|NCT00437658|521861221|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
144728351|NCT00437658|521861222|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
144728352|NCT00437658|521861220|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
144728353|NCT00437658|521861221|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
144728354|NCT00437658|521861222|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
144728355|NCT00437658|521861220|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
144728356|NCT00437658|521861221|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
144728357|NCT00437658|521861222|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
144728358|NCT00437658|521861220|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
144728359|NCT00437658|521861221|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
144728360|NCT00437658|521861222|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
144728361|NCT00437658|521861220|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
144728362|NCT00437658|521861221|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
144728363|NCT00437658|521861222|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
144728364|NCT03952143|521861223|FG000|Lead-In Period|Adverse Event|2|||
144728365|NCT03952143|521861224|FG001|Lead-In Period|Adverse Event|0|||
144728366|NCT03952143|521861225|FG002|Lead-In Period|Adverse Event|0|||
144728367|NCT03952143|521861223|FG000|Lead-In Period|Lack of Efficacy|2|||
144728368|NCT03952143|521861224|FG001|Lead-In Period|Lack of Efficacy|0|||
144728369|NCT03952143|521861225|FG002|Lead-In Period|Lack of Efficacy|0|||
144728370|NCT03952143|521861223|FG000|Lead-In Period|Physician Decision|5|||
144728371|NCT03952143|521861224|FG001|Lead-In Period|Physician Decision|0|||
144728372|NCT03952143|521861225|FG002|Lead-In Period|Physician Decision|0|||
144728373|NCT03952143|521861223|FG000|Lead-In Period|Protocol Violation|5|||
144728374|NCT03952143|521861224|FG001|Lead-In Period|Protocol Violation|0|||
144728375|NCT03952143|521861225|FG002|Lead-In Period|Protocol Violation|0|||
144728376|NCT03952143|521861223|FG000|Lead-In Period|Withdrawal by Subject|19|||
144728377|NCT03952143|521861224|FG001|Lead-In Period|Withdrawal by Subject|0|||
144728378|NCT03952143|521861225|FG002|Lead-In Period|Withdrawal by Subject|0|||
144728379|NCT03952143|521861223|FG000|Treatment Period|Adverse Event|0|||
144728380|NCT03952143|521861224|FG001|Treatment Period|Adverse Event|0|||
144728381|NCT03952143|521861225|FG002|Treatment Period|Adverse Event|1|||
144262564|NCT00905424|520161491|FG000|Overall Study|Lost to Follow-up|3|||
144563089|NCT01732926|521262396|FG001|Overall Study|Other Reason|4|||
144563090|NCT01732926|521262395|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
144563091|NCT01732926|521262396|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
144728382|NCT03952143|521861223|FG000|Treatment Period|Lost to Follow-up|0|||
144728383|NCT03952143|521861224|FG001|Treatment Period|Lost to Follow-up|2|||
144563092|NCT01732926|521262395|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
144618154|NCT02068547|521461190|FG001|Overall Study|Physician Decision|0|||
144618155|NCT02627495|521461191|FG000|Overall Study|Withdrawal by Subject|4|||
144618156|NCT01496885|521461193|FG000|Overall Study|Lost to Follow-up|13|||
144618157|NCT01496885|521461193|FG000|Overall Study|Withdrawal by Subject|7|||
144618158|NCT01496885|521461193|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
144618159|NCT01496885|521461193|FG000|Overall Study|Death|1|||
144618160|NCT02669017|521461195|FG000|Overall Study|Death|1|||
144618161|NCT02669017|521461196|FG001|Overall Study|Death|2|||
144204499|NCT03400943|519944448|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
144204500|NCT03400943|519944445|FG000|Post-treatment Period 1|Other|2|||
144204501|NCT03400943|519944446|FG001|Post-treatment Period 1|Other|0|||
144204502|NCT03400943|519944447|FG002|Post-treatment Period 1|Other|4|||
144204503|NCT03400943|519944448|FG003|Post-treatment Period 1|Other|5|||
144204504|NCT03400943|519944445|FG000|Treatment Period 2|Study terminated by sponsor|0|||
144204505|NCT03400943|519944446|FG001|Treatment Period 2|Study terminated by sponsor|1|||
144204506|NCT03400943|519944447|FG002|Treatment Period 2|Study terminated by sponsor|0|||
144204507|NCT03400943|519944448|FG003|Treatment Period 2|Study terminated by sponsor|0|||
144204508|NCT03400943|519944445|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144204509|NCT03400943|519944446|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144204510|NCT03400943|519944447|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144204511|NCT03400943|519944448|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144204512|NCT03400943|519944445|FG000|Treatment Period 2|Other|1|||
144204513|NCT03400943|519944446|FG001|Treatment Period 2|Other|6|||
144204514|NCT03400943|519944447|FG002|Treatment Period 2|Other|0|||
144563093|NCT01732926|521262396|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
144563094|NCT02262364|521262399|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
144563095|NCT00337285|521262402|FG000|Overall Study|Withdrawal by Subject|42|||
144563096|NCT00337285|521262402|FG000|Overall Study|Lost to Follow-up|41|||
144563097|NCT00337285|521262402|FG000|Overall Study|Adverse Event|28|||
144563098|NCT00337285|521262402|FG000|Overall Study|Protocol Violation|27|||
144563099|NCT00337285|521262402|FG000|Overall Study|Lack of Efficacy|11|||
144563100|NCT00337285|521262402|FG000|Overall Study|Death|1|||
144563101|NCT00337285|521262402|FG000|Overall Study|Physician Decision|1|||
144563102|NCT00337285|521262402|FG000|Overall Study|Lack of protocol compliance|7|||
144563103|NCT03214250|521262404|FG000|Overall Study|Death|5|||
144563104|NCT03214250|521262405|FG001|Overall Study|Death|5|||
144563105|NCT03214250|521262406|FG002|Overall Study|Death|7|||
144563106|NCT03214250|521262407|FG003|Overall Study|Death|4|||
144563107|NCT03214250|521262408|FG004|Overall Study|Death|23|||
144563108|NCT03214250|521262409|FG005|Overall Study|Death|23|||
144563109|NCT03214250|521262410|FG006|Overall Study|Death|24|||
144563110|NCT03214250|521262404|FG000|Overall Study|Lost to Follow-up|0|||
144563111|NCT03214250|521262405|FG001|Overall Study|Lost to Follow-up|0|||
144563112|NCT03214250|521262406|FG002|Overall Study|Lost to Follow-up|0|||
144563113|NCT03214250|521262407|FG003|Overall Study|Lost to Follow-up|1|||
144563114|NCT03214250|521262408|FG004|Overall Study|Lost to Follow-up|1|||
144563115|NCT03214250|521262409|FG005|Overall Study|Lost to Follow-up|2|||
144563116|NCT03214250|521262410|FG006|Overall Study|Lost to Follow-up|0|||
144563117|NCT03214250|521262404|FG000|Overall Study|Other|0|||
144563118|NCT03214250|521262405|FG001|Overall Study|Other|0|||
144563119|NCT03214250|521262406|FG002|Overall Study|Other|0|||
144563120|NCT03214250|521262407|FG003|Overall Study|Other|0|||
144563121|NCT03214250|521262408|FG004|Overall Study|Other|1|||
144563122|NCT03214250|521262409|FG005|Overall Study|Other|1|||
144563123|NCT03214250|521262410|FG006|Overall Study|Other|2|||
144563124|NCT03214250|521262404|FG000|Overall Study|Remains on Study|2|||
144563125|NCT03214250|521262405|FG001|Overall Study|Remains on Study|2|||
144563126|NCT03214250|521262406|FG002|Overall Study|Remains on Study|0|||
144563127|NCT03214250|521262407|FG003|Overall Study|Remains on Study|1|||
144563128|NCT03214250|521262408|FG004|Overall Study|Remains on Study|7|||
144563129|NCT03214250|521262409|FG005|Overall Study|Remains on Study|5|||
144563130|NCT03214250|521262410|FG006|Overall Study|Remains on Study|3|||
144262565|NCT00905424|520161492|FG001|Overall Study|Lost to Follow-up|3|||
144563131|NCT03214250|521262404|FG000|Overall Study|Withdrawal by Subject|0|||
144563132|NCT03214250|521262405|FG001|Overall Study|Withdrawal by Subject|0|||
144563133|NCT03214250|521262406|FG002|Overall Study|Withdrawal by Subject|1|||
144563134|NCT03214250|521262407|FG003|Overall Study|Withdrawal by Subject|2|||
144563135|NCT03214250|521262408|FG004|Overall Study|Withdrawal by Subject|5|||
144563136|NCT03214250|521262409|FG005|Overall Study|Withdrawal by Subject|0|||
144204515|NCT03400943|519944448|FG003|Treatment Period 2|Other|0|||
144204516|NCT03400943|519944445|FG000|Follow-up Period|Withdrawal by Subject|1|||
144563137|NCT03214250|521262410|FG006|Overall Study|Withdrawal by Subject|2|||
144563138|NCT00292981|521262411|FG000|Overall Study|Adverse Event|1|||
144618162|NCT02669017|521461197|FG002|Overall Study|Death|2|||
144618163|NCT02669017|521461198|FG003|Overall Study|Death|3|||
144563139|NCT00292981|521262411|FG000|Overall Study|Lost to Follow-up|13|||
144563140|NCT00292981|521262411|FG000|Overall Study|Withdrawal by Subject|22|||
144563141|NCT00292981|521262411|FG000|Overall Study|Other|3|||
144563142|NCT04582669|521262417|FG000|Overall Study|Subject missed appointment(s).|1|||
144563143|NCT04582669|521262418|FG001|Overall Study|Subject missed appointment(s).|0|||
144563144|NCT04582669|521262419|FG002|Overall Study|Subject missed appointment(s).|1|||
144563145|NCT04582669|521262420|FG003|Overall Study|Subject missed appointment(s).|2|||
144563146|NCT04582669|521262417|FG000|Overall Study|Protocol Violation|0|||
144563147|NCT04582669|521262418|FG001|Overall Study|Protocol Violation|1|||
144563148|NCT04582669|521262419|FG002|Overall Study|Protocol Violation|1|||
144563149|NCT04582669|521262420|FG003|Overall Study|Protocol Violation|0|||
144563150|NCT01274559|521262423|FG000|Overall Study|Adverse Event|57|||
144563151|NCT01274559|521262424|FG001|Overall Study|Adverse Event|13|||
144563152|NCT01274559|521262423|FG000|Overall Study|Death|1|||
144563153|NCT01274559|521262424|FG001|Overall Study|Death|1|||
144563154|NCT01274559|521262423|FG000|Overall Study|Lost to Follow-up|3|||
144563155|NCT01274559|521262424|FG001|Overall Study|Lost to Follow-up|3|||
144563156|NCT01274559|521262423|FG000|Overall Study|Non-compliance with Study Drug|2|||
144563157|NCT01274559|521262424|FG001|Overall Study|Non-compliance with Study Drug|4|||
144563158|NCT01274559|521262423|FG000|Overall Study|Physician Decision|2|||
144563159|NCT01274559|521262424|FG001|Overall Study|Physician Decision|1|||
144563160|NCT01274559|521262423|FG000|Overall Study|Protocol Violation|28|||
144563161|NCT01274559|521262424|FG001|Overall Study|Protocol Violation|23|||
144563162|NCT01274559|521262423|FG000|Overall Study|Study Terminated by Sponsor|79|||
144563163|NCT01274559|521262424|FG001|Overall Study|Study Terminated by Sponsor|87|||
144563164|NCT01274559|521262423|FG000|Overall Study|Withdrawal by Subject|25|||
144563165|NCT01274559|521262424|FG001|Overall Study|Withdrawal by Subject|13|||
144563166|NCT03245619|521262425|FG000|Part A (Up to Day 22)|Physician Decision|4|||
144563167|NCT03245619|521262426|FG001|Part A (Up to Day 22)|Physician Decision|6|||
144563168|NCT03245619|521262427|FG002|Part A (Up to Day 22)|Physician Decision|6|||
144563169|NCT03245619|521262428|FG003|Part A (Up to Day 22)|Physician Decision|0|||
144563170|NCT03245619|521262429|FG004|Part A (Up to Day 22)|Physician Decision|0|||
144563171|NCT03245619|521262430|FG005|Part A (Up to Day 22)|Physician Decision|0|||
144563172|NCT03245619|521262431|FG006|Part A (Up to Day 22)|Physician Decision|0|||
144563173|NCT03245619|521262432|FG007|Part A (Up to Day 22)|Physician Decision|0|||
144563174|NCT03245619|521262433|FG008|Part A (Up to Day 22)|Physician Decision|0|||
144563175|NCT03245619|521262434|FG009|Part A (Up to Day 22)|Physician Decision|0|||
144563176|NCT03245619|521262435|FG010|Part A (Up to Day 22)|Physician Decision|0|||
144563177|NCT03245619|521262436|FG011|Part A (Up to Day 22)|Physician Decision|0|||
144563178|NCT03245619|521262437|FG012|Part A (Up to Day 22)|Physician Decision|0|||
144563179|NCT03245619|521262438|FG013|Part A (Up to Day 22)|Physician Decision|0|||
144204517|NCT03400943|519944446|FG001|Follow-up Period|Withdrawal by Subject|0|||
144204518|NCT03400943|519944447|FG002|Follow-up Period|Withdrawal by Subject|0|||
144204519|NCT03400943|519944448|FG003|Follow-up Period|Withdrawal by Subject|0|||
144204520|NCT04729309|519944449|FG000|Period 1|Subject unable to return for Period 2|3|||
144204521|NCT04729309|519944450|FG001|Period 1|Subject unable to return for Period 2|0|||
144204522|NCT04729309|519944449|FG000|Period 1|Lost to Follow-up|1|||
144204523|NCT04729309|519944450|FG001|Period 1|Lost to Follow-up|0|||
144204524|NCT03151811|519944455|FG000|Overall Study|Randomized But Not Treated|18|||
144204525|NCT03151811|519944456|FG001|Overall Study|Randomized But Not Treated|3|||
144204526|NCT03151811|519944455|FG000|Overall Study|Progressive Disease|130|||
144204527|NCT03151811|519944456|FG001|Overall Study|Progressive Disease|170|||
144204528|NCT03151811|519944455|FG000|Overall Study|Adverse Event|49|||
144204529|NCT03151811|519944456|FG001|Overall Study|Adverse Event|40|||
144204530|NCT03151811|519944455|FG000|Overall Study|Lack of Efficacy|6|||
144204531|NCT03151811|519944456|FG001|Overall Study|Lack of Efficacy|8|||
144204532|NCT03151811|519944455|FG000|Overall Study|Physician Decision|21|||
144204533|NCT03151811|519944456|FG001|Overall Study|Physician Decision|9|||
144204534|NCT03151811|519944455|FG000|Overall Study|Withdrawal by Subject|17|||
144204535|NCT03151811|519944456|FG001|Overall Study|Withdrawal by Subject|7|||
144204536|NCT03151811|519944455|FG000|Overall Study|Lost to Follow-up|0|||
144204537|NCT03151811|519944456|FG001|Overall Study|Lost to Follow-up|1|||
144204538|NCT03151811|519944455|FG000|Overall Study|Study Terminated by Sponsor|5|||
144204539|NCT03151811|519944456|FG001|Overall Study|Study Terminated by Sponsor|11|||
144563180|NCT03245619|521262439|FG014|Part A (Up to Day 22)|Physician Decision|0|||
144563181|NCT03245619|521262440|FG015|Part A (Up to Day 22)|Physician Decision|0|||
144204540|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
144204541|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
144204542|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
144204543|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
144204544|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
144204545|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
144563182|NCT03245619|521262441|FG016|Part A (Up to Day 22)|Physician Decision|0|||
144563183|NCT00776659|521262458|FG000|Overall Study|Lost to Follow-up|15|||
144563184|NCT00776659|521262458|FG000|Overall Study|Withdrawal by Subject|10|||
144563185|NCT00776659|521262458|FG000|Overall Study|Study Terminated by Sponsor|1|||
144563186|NCT01167192|521262461|FG000|Overall Study|Adverse Event|1|||
144563187|NCT01167192|521262461|FG000|Overall Study|Death|1|||
144563188|NCT01167192|521262461|FG000|Overall Study|Withdrawal by Subject|1|||
144563189|NCT01167192|521262461|FG000|Overall Study|Insurance denial|1|||
144563190|NCT01336205|521262462|FG000|Overall Study|Other|22|||
144563191|NCT01336205|521262463|FG001|Overall Study|Other|9|||
144563192|NCT01336205|521262462|FG000|Overall Study|Lost to Follow-up|40|||
144563193|NCT01336205|521262463|FG001|Overall Study|Lost to Follow-up|20|||
144204546|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
144204547|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
144204548|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
144204549|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
144563194|NCT01336205|521262462|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
144563195|NCT01336205|521262463|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
144563196|NCT01336205|521262462|FG000|Overall Study|Lack of Efficacy|4|||
144563197|NCT01336205|521262463|FG001|Overall Study|Lack of Efficacy|0|||
144563198|NCT01336205|521262462|FG000|Overall Study|Severe noncompliance with protocol|9|||
144563199|NCT01336205|521262463|FG001|Overall Study|Severe noncompliance with protocol|2|||
144563200|NCT01336205|521262462|FG000|Overall Study|Adverse Event|56|||
144563201|NCT01336205|521262463|FG001|Overall Study|Adverse Event|6|||
144563202|NCT01336205|521262462|FG000|Overall Study|Death|1|||
144563203|NCT01336205|521262463|FG001|Overall Study|Death|1|||
144563204|NCT01336205|521262462|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
144563205|NCT01336205|521262463|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
144563206|NCT01336205|521262462|FG000|Overall Study|Withdrawal by Subject|72|||
144563207|NCT01336205|521262463|FG001|Overall Study|Withdrawal by Subject|38|||
144563208|NCT01336205|521262462|FG000|Overall Study|Did not receive treatment|4|||
144563209|NCT01336205|521262463|FG001|Overall Study|Did not receive treatment|0|||
144563210|NCT00129649|521262479|FG000|Overall Study|Withdrawal by Subject|76|||
144563211|NCT00129649|521262480|FG001|Overall Study|Withdrawal by Subject|65|||
144563212|NCT02482935|521262481|FG000|Period 1|Withdrawal by Subject|1|||
144563213|NCT02482935|521262482|FG001|Period 1|Withdrawal by Subject|0|||
144563214|NCT03503162|521262483|FG000|Overall Study|did not meet eligibility|1|||
144563215|NCT02835092|521262484|FG000|Overall Study|Withdrawal by Subject|3|||
144563216|NCT02835092|521262485|FG001|Overall Study|Withdrawal by Subject|6|||
144563217|NCT02835092|521262486|FG002|Overall Study|Withdrawal by Subject|3|||
144563218|NCT02835092|521262484|FG000|Overall Study|Lost to Follow-up|0|||
144563219|NCT02835092|521262485|FG001|Overall Study|Lost to Follow-up|2|||
144563220|NCT02835092|521262486|FG002|Overall Study|Lost to Follow-up|0|||
144563221|NCT00025506|521262487|FG000|Overall Study|Ineligible: clerical error|1|||
144563222|NCT00025506|521262487|FG000|Overall Study|Ineligible: wrong cell type|5|||
144563223|NCT00025506|521262487|FG000|Overall Study|Ineligible: inadequate pathology|2|||
144563224|NCT00025506|521262487|FG000|Overall Study|Never Treated|2|||
144563225|NCT00713206|521262488|FG000|Overall Study|Lost to Follow-up|4|||
144563226|NCT00713206|521262489|FG001|Overall Study|Lost to Follow-up|4|||
144563227|NCT00713206|521262488|FG000|Overall Study|Death|1|||
144563228|NCT00713206|521262489|FG001|Overall Study|Death|0|||
144563229|NCT02561806|521262490|FG000|Induction Period|Adverse Event|0|||
144563230|NCT02561806|521262491|FG001|Induction Period|Adverse Event|2|||
144563231|NCT02561806|521262490|FG000|Induction Period|Lack of Efficacy|1|||
144563232|NCT02561806|521262491|FG001|Induction Period|Lack of Efficacy|0|||
144563233|NCT02561806|521262490|FG000|Induction Period|Withdrawal by Subject|0|||
144563234|NCT02561806|521262491|FG001|Induction Period|Withdrawal by Subject|2|||
144563235|NCT02561806|521262490|FG000|Induction Period|Site staff became unblinded|1|||
144563236|NCT02561806|521262491|FG001|Induction Period|Site staff became unblinded|0|||
144563237|NCT02561806|521262490|FG000|Induction Period|Randomized but not treated|0|||
144563238|NCT02561806|521262491|FG001|Induction Period|Randomized but not treated|1|||
144563239|NCT02561806|521262490|FG000|Maintenance Period|Adverse Event|2|||
144563240|NCT02561806|521262491|FG001|Maintenance Period|Adverse Event|1|||
144563241|NCT02561806|521262490|FG000|Maintenance Period|Lack of Efficacy|3|||
144563242|NCT02561806|521262491|FG001|Maintenance Period|Lack of Efficacy|1|||
144204550|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Death|1|||
144204551|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Death|0|||
144204552|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Death|0|||
144204553|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Death|0|||
144563243|NCT02561806|521262490|FG000|Maintenance Period|Lost to Follow-up|2|||
144563244|NCT02561806|521262491|FG001|Maintenance Period|Lost to Follow-up|2|||
144563245|NCT02561806|521262490|FG000|Maintenance Period|Protocol Violation|1|||
144563246|NCT02561806|521262491|FG001|Maintenance Period|Protocol Violation|0|||
144563247|NCT02561806|521262490|FG000|Maintenance Period|Withdrawal by Subject|5|||
144563248|NCT02561806|521262491|FG001|Maintenance Period|Withdrawal by Subject|3|||
144563249|NCT02561806|521262490|FG000|Maintenance Period|Site staff became unblinded|0|||
144563250|NCT02561806|521262491|FG001|Maintenance Period|Site staff became unblinded|1|||
144563251|NCT02561806|521262490|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
144563252|NCT02561806|521262491|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
144563253|NCT02561806|521262490|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
144563254|NCT02561806|521262491|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
144563255|NCT02547441|521262492|FG000|Double-Blind Study Period|Adverse Event|4|||
144563256|NCT02547441|521262493|FG001|Double-Blind Study Period|Adverse Event|9|||
144563257|NCT02547441|521262492|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
144563258|NCT02547441|521262493|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
144204554|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Death|0|||
144204555|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
144204556|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
144204557|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
144204558|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
144204559|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
144204560|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
144204561|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
144204562|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
144204563|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
144204564|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
144204565|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
144204566|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
144204567|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
144204568|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
144204569|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
144204570|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
144204571|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
144204572|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
144204573|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
144204574|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144204575|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
144204576|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144204577|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144204578|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144204579|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144204580|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Other|4|||
144563259|NCT02547441|521262492|FG000|Double-Blind Study Period|Physician Decision|1|||
144563260|NCT02547441|521262493|FG001|Double-Blind Study Period|Physician Decision|0|||
144563261|NCT02547441|521262492|FG000|Double-Blind Study Period|Protocol Violation|1|||
144563262|NCT02547441|521262493|FG001|Double-Blind Study Period|Protocol Violation|2|||
144563263|NCT02547441|521262492|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
144563264|NCT02547441|521262493|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
144563265|NCT02547441|521262492|FG000|Double-Blind Study Period|Sponsor Decision|1|||
144563266|NCT02547441|521262493|FG001|Double-Blind Study Period|Sponsor Decision|0|||
144563267|NCT02547441|521262492|FG000|Open-Label Study Period|Adverse Event|10|||
144563268|NCT02547441|521262493|FG001|Open-Label Study Period|Adverse Event|11|||
144563269|NCT02547441|521262492|FG000|Open-Label Study Period|Lack of Efficacy|3|||
144563270|NCT02547441|521262493|FG001|Open-Label Study Period|Lack of Efficacy|2|||
144563271|NCT02547441|521262492|FG000|Open-Label Study Period|Lost to Follow-up|7|||
144563272|NCT02547441|521262493|FG001|Open-Label Study Period|Lost to Follow-up|8|||
144563273|NCT02547441|521262492|FG000|Open-Label Study Period|Physician Decision|1|||
144563274|NCT02547441|521262493|FG001|Open-Label Study Period|Physician Decision|0|||
144563275|NCT02547441|521262492|FG000|Open-Label Study Period|Protocol Violation|2|||
144563276|NCT02547441|521262493|FG001|Open-Label Study Period|Protocol Violation|0|||
144563277|NCT02547441|521262492|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
144563278|NCT02547441|521262493|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
144563279|NCT02547441|521262492|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
144563280|NCT02547441|521262493|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
144563281|NCT01322009|521262494|FG000|Overall Study|Death|0|||
144563282|NCT01322009|521262495|FG001|Overall Study|Death|1|||
144563283|NCT01322009|521262494|FG000|Overall Study|Adverse Event|0|||
144563284|NCT01322009|521262495|FG001|Overall Study|Adverse Event|1|||
144563285|NCT01322009|521262494|FG000|Overall Study|ng tube discontinued|0|||
144563286|NCT01322009|521262495|FG001|Overall Study|ng tube discontinued|1|||
144563287|NCT01657877|521262496|FG000|Overall Study|Withdrawal by Subject|4|||
144563288|NCT01657877|521262496|FG000|Overall Study|Protocol Violation|6|||
144563289|NCT01657877|521262496|FG000|Overall Study|Adverse Event|2|||
144563290|NCT01657877|521262496|FG000|Overall Study|Other Reason|2|||
144563291|NCT00394589|521262498|FG000|Overall Study|Adverse Event|2|||
144563292|NCT00394589|521262499|FG001|Overall Study|Adverse Event|1|||
144563293|NCT00394589|521262500|FG002|Overall Study|Adverse Event|2|||
144563294|NCT00394589|521262498|FG000|Overall Study|Lack of Efficacy|2|||
144563295|NCT00394589|521262499|FG001|Overall Study|Lack of Efficacy|2|||
144563296|NCT00394589|521262500|FG002|Overall Study|Lack of Efficacy|3|||
144563297|NCT00394589|521262498|FG000|Overall Study|Protocol Violation|4|||
144618164|NCT02669017|521461199|FG004|Overall Study|Death|8|||
144563298|NCT00394589|521262499|FG001|Overall Study|Protocol Violation|0|||
144563299|NCT00394589|521262500|FG002|Overall Study|Protocol Violation|2|||
144563300|NCT03409731|521262501|FG000|Overall Study|Withdrawal by Subject|17|||
144563301|NCT03409731|521262501|FG000|Overall Study|Death|4|||
144563302|NCT01710800|521262502|FG000|Overall Study|Withdrawal by Subject|21|||
144563303|NCT01710800|521262502|FG000|Overall Study|Protocol Violation|1|||
144563304|NCT02427958|521262503|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
144563305|NCT02427958|521262503|FG000|Overall Study|Lost to Follow-up|6|||
144563306|NCT02427958|521262503|FG000|Overall Study|Withdrawal by Subject|14|||
144563307|NCT02427958|521262503|FG000|Overall Study|Lack of Efficacy|1|||
144563308|NCT02287883|521262507|FG000|Overall Study|Death|8|||
144563309|NCT02287883|521262508|FG001|Overall Study|Death|7|||
144563310|NCT02287883|521262507|FG000|Overall Study|No longer eligible|222|||
144563311|NCT02287883|521262508|FG001|Overall Study|No longer eligible|182|||
144563312|NCT02287883|521262507|FG000|Overall Study|Non-response to survey|229|||
144563313|NCT02287883|521262508|FG001|Overall Study|Non-response to survey|237|||
144563314|NCT01978236|521262509|FG000|Overall Study|Discontinued due to study close|2|||
144563315|NCT00634920|521262511|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
144563316|NCT00634920|521262512|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
144563317|NCT00634920|521262513|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
144563318|NCT00634920|521262511|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
144563319|NCT00634920|521262512|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
144563320|NCT00634920|521262513|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
144563321|NCT00634920|521262511|FG000|Period 1 - Pre-Randomization|Rejections|0|||
144563322|NCT00634920|521262512|FG001|Period 1 - Pre-Randomization|Rejections|0|||
144563323|NCT00634920|521262513|FG002|Period 1 - Pre-Randomization|Rejections|55|||
144563324|NCT00634920|521262511|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
144563325|NCT00634920|521262512|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
144563326|NCT00634920|521262513|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
144563327|NCT00634920|521262511|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
144563328|NCT00634920|521262512|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
144563329|NCT00634920|521262513|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
144563330|NCT00634920|521262511|FG000|Period 1 - Pre-Randomization|Other issues|0|||
144563331|NCT00634920|521262512|FG001|Period 1 - Pre-Randomization|Other issues|0|||
144563332|NCT00634920|521262513|FG002|Period 1 - Pre-Randomization|Other issues|6|||
144563333|NCT00634920|521262511|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
144563334|NCT00634920|521262512|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
144563335|NCT00634920|521262513|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
144563336|NCT00634920|521262511|FG000|Period 2 - Post-Randomization|Rejection|11|||
144563337|NCT00634920|521262512|FG001|Period 2 - Post-Randomization|Rejection|5|||
144563338|NCT00634920|521262513|FG002|Period 2 - Post-Randomization|Rejection|0|||
144563339|NCT00634920|521262511|FG000|Period 2 - Post-Randomization|Death|2|||
144563340|NCT00634920|521262512|FG001|Period 2 - Post-Randomization|Death|5|||
144563341|NCT00634920|521262513|FG002|Period 2 - Post-Randomization|Death|0|||
144563342|NCT00634920|521262511|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
144563343|NCT00634920|521262512|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
144563344|NCT00634920|521262513|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
144563345|NCT00634920|521262511|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
144563346|NCT00634920|521262512|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
144563347|NCT00634920|521262513|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
144563348|NCT01193218|521262514|FG000|0-12 Weeks|Adverse Event|6|||
144563349|NCT01193218|521262515|FG001|0-12 Weeks|Adverse Event|0|||
144563350|NCT01193218|521262516|FG002|0-12 Weeks|Adverse Event|1|||
144618165|NCT02669017|521461200|FG005|Overall Study|Death|18|||
144618166|NCT02669017|521461201|FG006|Overall Study|Death|10|||
144618167|NCT02669017|521461202|FG007|Overall Study|Death|47|||
144618168|NCT02669017|521461203|FG008|Overall Study|Death|20|||
144618169|NCT02669017|521461195|FG000|Overall Study|Withdrawal by Subject|0|||
144618170|NCT02669017|521461196|FG001|Overall Study|Withdrawal by Subject|0|||
144618171|NCT02669017|521461197|FG002|Overall Study|Withdrawal by Subject|0|||
144618172|NCT02669017|521461198|FG003|Overall Study|Withdrawal by Subject|1|||
144618173|NCT02669017|521461199|FG004|Overall Study|Withdrawal by Subject|2|||
144618174|NCT02669017|521461200|FG005|Overall Study|Withdrawal by Subject|0|||
144618175|NCT02669017|521461201|FG006|Overall Study|Withdrawal by Subject|0|||
144618176|NCT02669017|521461202|FG007|Overall Study|Withdrawal by Subject|2|||
144618177|NCT02669017|521461203|FG008|Overall Study|Withdrawal by Subject|2|||
144618178|NCT02669017|521461195|FG000|Overall Study|Lost to Follow-up|0|||
144618179|NCT02669017|521461196|FG001|Overall Study|Lost to Follow-up|0|||
144563351|NCT01193218|521262517|FG003|0-12 Weeks|Adverse Event|0|||
144563352|NCT01193218|521262518|FG004|0-12 Weeks|Adverse Event|0|||
144563353|NCT01193218|521262519|FG005|0-12 Weeks|Adverse Event|2|||
144563354|NCT01193218|521262520|FG006|0-12 Weeks|Adverse Event|2|||
144618180|NCT02669017|521461197|FG002|Overall Study|Lost to Follow-up|0|||
144563355|NCT01193218|521262521|FG007|0-12 Weeks|Adverse Event|0|||
144563356|NCT01193218|521262514|FG000|0-12 Weeks|Protocol Violation|0|||
144618181|NCT02669017|521461198|FG003|Overall Study|Lost to Follow-up|0|||
144618182|NCT02669017|521461199|FG004|Overall Study|Lost to Follow-up|0|||
144618183|NCT02669017|521461200|FG005|Overall Study|Lost to Follow-up|0|||
144618184|NCT02669017|521461201|FG006|Overall Study|Lost to Follow-up|0|||
144204581|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Other|4|||
144204582|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Other|3|||
144204583|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Other|1|||
144204584|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Other|0|||
144204585|NCT01081834|519944457|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
144204586|NCT01081834|519944458|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
144204587|NCT01081834|519944459|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
144563357|NCT01193218|521262515|FG001|0-12 Weeks|Protocol Violation|0|||
144563358|NCT01193218|521262516|FG002|0-12 Weeks|Protocol Violation|0|||
144563359|NCT01193218|521262517|FG003|0-12 Weeks|Protocol Violation|0|||
144563360|NCT01193218|521262518|FG004|0-12 Weeks|Protocol Violation|1|||
144563361|NCT01193218|521262519|FG005|0-12 Weeks|Protocol Violation|1|||
144563362|NCT01193218|521262520|FG006|0-12 Weeks|Protocol Violation|0|||
144563363|NCT01193218|521262521|FG007|0-12 Weeks|Protocol Violation|0|||
144563364|NCT01193218|521262514|FG000|0-12 Weeks|Withdrawal by Subject|3|||
144563365|NCT01193218|521262515|FG001|0-12 Weeks|Withdrawal by Subject|0|||
144563366|NCT01193218|521262516|FG002|0-12 Weeks|Withdrawal by Subject|2|||
144563367|NCT01193218|521262517|FG003|0-12 Weeks|Withdrawal by Subject|0|||
144563368|NCT01193218|521262518|FG004|0-12 Weeks|Withdrawal by Subject|0|||
144563369|NCT01193218|521262519|FG005|0-12 Weeks|Withdrawal by Subject|0|||
144563370|NCT01193218|521262520|FG006|0-12 Weeks|Withdrawal by Subject|1|||
144563371|NCT01193218|521262521|FG007|0-12 Weeks|Withdrawal by Subject|0|||
144563372|NCT01193218|521262514|FG000|12-52 Weeks|Adverse Event|1|||
144563373|NCT01193218|521262515|FG001|12-52 Weeks|Adverse Event|0|||
144563374|NCT01193218|521262516|FG002|12-52 Weeks|Adverse Event|1|||
144563375|NCT01193218|521262517|FG003|12-52 Weeks|Adverse Event|2|||
144563376|NCT01193218|521262518|FG004|12-52 Weeks|Adverse Event|3|||
144563377|NCT01193218|521262519|FG005|12-52 Weeks|Adverse Event|3|||
144563378|NCT01193218|521262520|FG006|12-52 Weeks|Adverse Event|1|||
144563379|NCT01193218|521262521|FG007|12-52 Weeks|Adverse Event|2|||
144563380|NCT01193218|521262514|FG000|12-52 Weeks|Lack of Efficacy|0|||
144563381|NCT01193218|521262515|FG001|12-52 Weeks|Lack of Efficacy|0|||
144563382|NCT01193218|521262516|FG002|12-52 Weeks|Lack of Efficacy|0|||
144563383|NCT01193218|521262517|FG003|12-52 Weeks|Lack of Efficacy|0|||
144563384|NCT01193218|521262518|FG004|12-52 Weeks|Lack of Efficacy|0|||
144563385|NCT01193218|521262519|FG005|12-52 Weeks|Lack of Efficacy|0|||
144563386|NCT01193218|521262520|FG006|12-52 Weeks|Lack of Efficacy|1|||
144563387|NCT01193218|521262521|FG007|12-52 Weeks|Lack of Efficacy|0|||
144563388|NCT01193218|521262514|FG000|12-52 Weeks|Withdrawal by Subject|3|||
144563389|NCT01193218|521262515|FG001|12-52 Weeks|Withdrawal by Subject|0|||
144563390|NCT01193218|521262516|FG002|12-52 Weeks|Withdrawal by Subject|3|||
144563391|NCT01193218|521262517|FG003|12-52 Weeks|Withdrawal by Subject|0|||
144563392|NCT01193218|521262518|FG004|12-52 Weeks|Withdrawal by Subject|0|||
144563393|NCT01193218|521262519|FG005|12-52 Weeks|Withdrawal by Subject|2|||
144563394|NCT01193218|521262520|FG006|12-52 Weeks|Withdrawal by Subject|1|||
144563395|NCT01193218|521262521|FG007|12-52 Weeks|Withdrawal by Subject|2|||
144563396|NCT01193218|521262514|FG000|12-52 Weeks|Other reason than above|1|||
144563397|NCT01193218|521262515|FG001|12-52 Weeks|Other reason than above|0|||
144563398|NCT01193218|521262516|FG002|12-52 Weeks|Other reason than above|0|||
144563399|NCT01193218|521262517|FG003|12-52 Weeks|Other reason than above|1|||
144563400|NCT01193218|521262518|FG004|12-52 Weeks|Other reason than above|1|||
144563401|NCT01193218|521262519|FG005|12-52 Weeks|Other reason than above|0|||
144563402|NCT01193218|521262520|FG006|12-52 Weeks|Other reason than above|0|||
144563403|NCT01193218|521262521|FG007|12-52 Weeks|Other reason than above|0|||
144563404|NCT00363649|521262522|FG000|Overall Study|Withdrawal by Subject|1|||
144563405|NCT00363649|521262523|FG001|Overall Study|Withdrawal by Subject|1|||
144563406|NCT00363649|521262522|FG000|Overall Study|Adverse Event|6|||
144563407|NCT00363649|521262523|FG001|Overall Study|Adverse Event|0|||
144563408|NCT01013740|521262524|FG000|Overall Study|Lost to Follow-up|3|||
144563409|NCT01013740|521262525|FG001|Overall Study|Lost to Follow-up|5|||
144563410|NCT01013740|521262524|FG000|Overall Study|Physician Decision|2|||
144563411|NCT01013740|521262525|FG001|Overall Study|Physician Decision|0|||
144563412|NCT01013740|521262524|FG000|Overall Study|Withdrawal by Subject|2|||
144204588|NCT01081834|519944460|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
144563413|NCT01013740|521262525|FG001|Overall Study|Withdrawal by Subject|10|||
144563414|NCT01013740|521262524|FG000|Overall Study|study close / terminated : done in error|2|||
144563415|NCT01013740|521262525|FG001|Overall Study|study close / terminated : done in error|1|||
144563416|NCT01013740|521262524|FG000|Overall Study|Missing|2|||
144563417|NCT01013740|521262525|FG001|Overall Study|Missing|1|||
144563418|NCT01013740|521262524|FG000|Overall Study|Ongoing: Study records not completed|0|||
144563419|NCT01013740|521262525|FG001|Overall Study|Ongoing: Study records not completed|2|||
144563420|NCT02970305|521262528|FG000|Overall Study|Adverse Event|10|||
144563421|NCT02970305|521262529|FG001|Overall Study|Adverse Event|6|||
144618185|NCT02669017|521461202|FG007|Overall Study|Lost to Follow-up|0|||
144618186|NCT02669017|521461203|FG008|Overall Study|Lost to Follow-up|1|||
144563422|NCT02970305|521262528|FG000|Overall Study|Lack of Efficacy|1|||
144563423|NCT02970305|521262529|FG001|Overall Study|Lack of Efficacy|1|||
144563424|NCT02970305|521262528|FG000|Overall Study|Noncompliance with study drug|2|||
144563425|NCT02970305|521262529|FG001|Overall Study|Noncompliance with study drug|4|||
144563426|NCT02970305|521262528|FG000|Overall Study|Protocol Violation|2|||
144563427|NCT02970305|521262529|FG001|Overall Study|Protocol Violation|2|||
144563428|NCT02970305|521262528|FG000|Overall Study|Withdrawal by Subject|12|||
144563429|NCT02970305|521262529|FG001|Overall Study|Withdrawal by Subject|11|||
144563430|NCT02970305|521262528|FG000|Overall Study|Not further specified|1|||
144563431|NCT02970305|521262529|FG001|Overall Study|Not further specified|2|||
144563432|NCT02970305|521262528|FG000|Overall Study|Lost to Follow-up|1|||
144563433|NCT02970305|521262529|FG001|Overall Study|Lost to Follow-up|2|||
144563434|NCT01813305|521262531|FG000|Overall Study|Withdrawal by Subject|12|||
144563435|NCT01813305|521262532|FG001|Overall Study|Withdrawal by Subject|5|||
144563436|NCT01813305|521262531|FG000|Overall Study|Safety Concern|4|||
144563437|NCT01813305|521262532|FG001|Overall Study|Safety Concern|0|||
144563438|NCT01813305|521262531|FG000|Overall Study|Ulcer became worse|4|||
144728384|NCT03952143|521861225|FG002|Treatment Period|Lost to Follow-up|0|||
144563439|NCT01813305|521262532|FG001|Overall Study|Ulcer became worse|0|||
144563440|NCT01813305|521262531|FG000|Overall Study|Physician Decision|4|||
144563441|NCT01813305|521262532|FG001|Overall Study|Physician Decision|0|||
144563442|NCT01813305|521262531|FG000|Overall Study|Lost to Follow-up|3|||
144563443|NCT01813305|521262532|FG001|Overall Study|Lost to Follow-up|1|||
144563444|NCT01813305|521262531|FG000|Overall Study|Protocol Violation|1|||
144563445|NCT01813305|521262532|FG001|Overall Study|Protocol Violation|0|||
144563446|NCT01813305|521262531|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
144563447|NCT01813305|521262532|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
144563448|NCT01502371|521262540|FG000|Overall Study|Withdrawal by Subject|1|||
144563449|NCT01502371|521262541|FG001|Overall Study|Withdrawal by Subject|2|||
144563450|NCT01502371|521262542|FG002|Overall Study|Withdrawal by Subject|1|||
144563451|NCT01502371|521262543|FG003|Overall Study|Withdrawal by Subject|1|||
144563452|NCT01502371|521262544|FG004|Overall Study|Withdrawal by Subject|1|||
144563453|NCT01502371|521262540|FG000|Overall Study|Adverse Event|2|||
144563454|NCT01502371|521262541|FG001|Overall Study|Adverse Event|1|||
144563455|NCT01502371|521262542|FG002|Overall Study|Adverse Event|0|||
144563456|NCT01502371|521262543|FG003|Overall Study|Adverse Event|4|||
144563457|NCT01502371|521262544|FG004|Overall Study|Adverse Event|3|||
144563458|NCT01502371|521262540|FG000|Overall Study|Treatment Failure|22|||
144563459|NCT01502371|521262541|FG001|Overall Study|Treatment Failure|20|||
144563460|NCT01502371|521262542|FG002|Overall Study|Treatment Failure|12|||
144563461|NCT01502371|521262543|FG003|Overall Study|Treatment Failure|19|||
144563462|NCT01502371|521262544|FG004|Overall Study|Treatment Failure|30|||
144563463|NCT01502371|521262540|FG000|Overall Study|Lack of Efficacy|3|||
144563464|NCT01502371|521262541|FG001|Overall Study|Lack of Efficacy|3|||
144563465|NCT01502371|521262542|FG002|Overall Study|Lack of Efficacy|2|||
144563466|NCT01502371|521262543|FG003|Overall Study|Lack of Efficacy|2|||
144563467|NCT01502371|521262544|FG004|Overall Study|Lack of Efficacy|4|||
144563468|NCT01502371|521262540|FG000|Overall Study|Physician Decision|3|||
144563469|NCT01502371|521262541|FG001|Overall Study|Physician Decision|0|||
144563470|NCT01502371|521262542|FG002|Overall Study|Physician Decision|0|||
144563471|NCT01502371|521262543|FG003|Overall Study|Physician Decision|0|||
144563472|NCT01502371|521262544|FG004|Overall Study|Physician Decision|1|||
144563473|NCT01502371|521262540|FG000|Overall Study|Noncompliance with Study Drug|0|||
144563474|NCT01502371|521262541|FG001|Overall Study|Noncompliance with Study Drug|0|||
144563475|NCT01502371|521262542|FG002|Overall Study|Noncompliance with Study Drug|1|||
144563476|NCT01502371|521262543|FG003|Overall Study|Noncompliance with Study Drug|2|||
144563477|NCT01502371|521262544|FG004|Overall Study|Noncompliance with Study Drug|1|||
144563478|NCT01502371|521262540|FG000|Overall Study|Technical Problems|1|||
144563479|NCT01502371|521262541|FG001|Overall Study|Technical Problems|0|||
144563480|NCT01502371|521262542|FG002|Overall Study|Technical Problems|2|||
144563481|NCT01502371|521262543|FG003|Overall Study|Technical Problems|4|||
144563482|NCT01502371|521262544|FG004|Overall Study|Technical Problems|1|||
144563483|NCT01502371|521262540|FG000|Overall Study|Protocol Violation|9|||
144563484|NCT01502371|521262541|FG001|Overall Study|Protocol Violation|5|||
144563485|NCT01502371|521262542|FG002|Overall Study|Protocol Violation|6|||
144563486|NCT01502371|521262543|FG003|Overall Study|Protocol Violation|5|||
144563487|NCT01502371|521262544|FG004|Overall Study|Protocol Violation|10|||
144563488|NCT01502371|521262540|FG000|Overall Study|Excluded Medication|0|||
144563489|NCT01502371|521262541|FG001|Overall Study|Excluded Medication|1|||
144563490|NCT01502371|521262542|FG002|Overall Study|Excluded Medication|1|||
144563491|NCT01502371|521262543|FG003|Overall Study|Excluded Medication|0|||
144563492|NCT01502371|521262544|FG004|Overall Study|Excluded Medication|1|||
144728385|NCT03952143|521861223|FG000|Treatment Period|Physician Decision|0|||
144563493|NCT02598934|521262550|FG000|Overall Study|Adverse Event|11|||
144563494|NCT02598934|521262551|FG001|Overall Study|Adverse Event|13|||
144563495|NCT02598934|521262550|FG000|Overall Study|Failure to Return|3|||
144563496|NCT02598934|521262551|FG001|Overall Study|Failure to Return|3|||
144563497|NCT02598934|521262550|FG000|Overall Study|Withdrawal by Subject|2|||
144563498|NCT02598934|521262551|FG001|Overall Study|Withdrawal by Subject|3|||
144563499|NCT02598934|521262550|FG000|Overall Study|Administrative|2|||
144563500|NCT02598934|521262551|FG001|Overall Study|Administrative|1|||
144563501|NCT02598934|521262550|FG000|Overall Study|Protocol Violation|1|||
144563502|NCT02598934|521262551|FG001|Overall Study|Protocol Violation|2|||
144563503|NCT02481934|521262552|FG000|Overall Study|Death|2|||
144563504|NCT03749616|521262553|FG000|Overall Study|Lost to Follow-up|4|||
144563505|NCT03749616|521262554|FG001|Overall Study|Lost to Follow-up|7|||
144563506|NCT03749616|521262553|FG000|Overall Study|Screen Failure|1|||
144563507|NCT03749616|521262554|FG001|Overall Study|Screen Failure|1|||
144563508|NCT03749616|521262553|FG000|Overall Study|Withdrawal by Subject|2|||
144563509|NCT03749616|521262554|FG001|Overall Study|Withdrawal by Subject|0|||
144563510|NCT03302559|521262557|FG000|Overall Study|Adverse Event|2|||
144563511|NCT03302559|521262557|FG000|Overall Study|Lost to Follow-up|1|||
144563512|NCT03302559|521262557|FG000|Overall Study|Withdrew Consent|3|||
144563513|NCT00847132|521264343|FG000|Overall Study|Death|1|||
144563514|NCT00847132|521264344|FG001|Overall Study|Death|1|||
144563515|NCT01057251|521264345|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
144563516|NCT01057251|521264346|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
144563517|NCT01057251|521264345|FG000|Overall Study|Adverse Event|4|||
144563518|NCT01057251|521264346|FG001|Overall Study|Adverse Event|2|||
144563519|NCT01057251|521264345|FG000|Overall Study|Lack of Efficacy|2|||
144563520|NCT01057251|521264346|FG001|Overall Study|Lack of Efficacy|11|||
144563521|NCT01057251|521264345|FG000|Overall Study|Protocol Violation|6|||
144563522|NCT01057251|521264346|FG001|Overall Study|Protocol Violation|2|||
144563523|NCT01057251|521264345|FG000|Overall Study|Withdrawal by Subject|4|||
144563524|NCT01057251|521264346|FG001|Overall Study|Withdrawal by Subject|5|||
144563525|NCT01057251|521264345|FG000|Overall Study|Lost to Follow-up|7|||
144563526|NCT01057251|521264346|FG001|Overall Study|Lost to Follow-up|6|||
144563527|NCT01057251|521264345|FG000|Overall Study|Other Reason|1|||
144563528|NCT01057251|521264346|FG001|Overall Study|Other Reason|1|||
144563529|NCT01850823|521264347|FG000|Overall Study|Early Visit Window|0|||
144563530|NCT01850823|521264348|FG001|Overall Study|Early Visit Window|1|||
144563531|NCT01850823|521264349|FG002|Overall Study|Early Visit Window|4|||
144563532|NCT01850823|521264347|FG000|Overall Study|Enrolled in Error|0|||
144563533|NCT01850823|521264348|FG001|Overall Study|Enrolled in Error|1|||
144563534|NCT01850823|521264349|FG002|Overall Study|Enrolled in Error|2|||
144563535|NCT01850823|521264347|FG000|Overall Study|Lack of Efficacy|1|||
144563536|NCT01850823|521264348|FG001|Overall Study|Lack of Efficacy|0|||
144563537|NCT01850823|521264349|FG002|Overall Study|Lack of Efficacy|0|||
144563538|NCT01850823|521264347|FG000|Overall Study|Lost to Follow-up|0|||
144563539|NCT01850823|521264348|FG001|Overall Study|Lost to Follow-up|0|||
144563540|NCT01850823|521264349|FG002|Overall Study|Lost to Follow-up|1|||
144563541|NCT01850823|521264347|FG000|Overall Study|Restricted Medication|0|||
144563542|NCT01850823|521264348|FG001|Overall Study|Restricted Medication|0|||
144563543|NCT01850823|521264349|FG002|Overall Study|Restricted Medication|2|||
144563544|NCT01850823|521264347|FG000|Overall Study|Significant worstening of SAR|0|||
144563545|NCT01850823|521264348|FG001|Overall Study|Significant worstening of SAR|1|||
144563546|NCT01850823|521264349|FG002|Overall Study|Significant worstening of SAR|0|||
144563547|NCT01850823|521264347|FG000|Overall Study|Withdrawal by Subject|2|||
144563548|NCT01850823|521264348|FG001|Overall Study|Withdrawal by Subject|0|||
144563549|NCT01850823|521264349|FG002|Overall Study|Withdrawal by Subject|1|||
144563550|NCT01751165|521264350|FG000|Overall Study|Adverse event, serious fatal|1|||
144563551|NCT01751165|521264351|FG001|Overall Study|Adverse event, serious fatal|0|||
144563552|NCT01751165|521264352|FG002|Overall Study|Adverse event, serious fatal|1|||
144563553|NCT01751165|521264350|FG000|Overall Study|Withdrawal by Subject|0|||
144563554|NCT01751165|521264351|FG001|Overall Study|Withdrawal by Subject|0|||
144563555|NCT01751165|521264352|FG002|Overall Study|Withdrawal by Subject|1|||
144563556|NCT01751165|521264350|FG000|Overall Study|Serious adverse event|0|||
144563557|NCT01751165|521264351|FG001|Overall Study|Serious adverse event|2|||
144563558|NCT01751165|521264352|FG002|Overall Study|Serious adverse event|0|||
144563559|NCT01751165|521264350|FG000|Overall Study|Lost to Follow-up|1|||
144563560|NCT01751165|521264351|FG001|Overall Study|Lost to Follow-up|1|||
144563561|NCT01751165|521264352|FG002|Overall Study|Lost to Follow-up|1|||
144563562|NCT00913523|521264356|FG000|Overall Study|Withdrawal by Subject|3|||
144563563|NCT00913523|521264357|FG001|Overall Study|Withdrawal by Subject|2|||
144563564|NCT00913523|521264358|FG002|Overall Study|Withdrawal by Subject|2|||
144563565|NCT00913523|521264356|FG000|Overall Study|Lost to Follow-up|1|||
144563566|NCT00913523|521264357|FG001|Overall Study|Lost to Follow-up|1|||
144563567|NCT00913523|521264358|FG002|Overall Study|Lost to Follow-up|1|||
144563568|NCT00913523|521264356|FG000|Overall Study|Adverse Event|1|||
144563569|NCT00913523|521264357|FG001|Overall Study|Adverse Event|0|||
144563570|NCT00913523|521264358|FG002|Overall Study|Adverse Event|0|||
144563571|NCT00913523|521264356|FG000|Overall Study|Protocol Violation|5|||
144563572|NCT00913523|521264357|FG001|Overall Study|Protocol Violation|8|||
144563573|NCT00913523|521264358|FG002|Overall Study|Protocol Violation|8|||
144563574|NCT00913523|521264356|FG000|Overall Study|Pregnancy|1|||
144563575|NCT00913523|521264357|FG001|Overall Study|Pregnancy|3|||
144563576|NCT00913523|521264358|FG002|Overall Study|Pregnancy|0|||
144563577|NCT00913523|521264356|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
144563578|NCT00913523|521264357|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
144563579|NCT00913523|521264358|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
144563580|NCT01202409|521264360|FG000|Overall Study|Adverse Event|1|||
144563581|NCT01202409|521264360|FG000|Overall Study|Ineligible - KRAS mutants|7|||
144563582|NCT01774019|521264363|FG000|Overall Study|No longer meets protocol criteria|2|||
144563583|NCT01774019|521264364|FG001|Overall Study|No longer meets protocol criteria|0|||
144563584|NCT01774019|521264363|FG000|Overall Study|Withdrawal by Subject|1|||
144563585|NCT01774019|521264364|FG001|Overall Study|Withdrawal by Subject|0|||
144563586|NCT01774019|521264363|FG000|Overall Study|Surgery delayed > 120 days|1|||
144563587|NCT01774019|521264364|FG001|Overall Study|Surgery delayed > 120 days|0|||
144563588|NCT01774019|521264363|FG000|Overall Study|Patient refused surgery|1|||
144563589|NCT01774019|521264364|FG001|Overall Study|Patient refused surgery|1|||
144563590|NCT01774019|521264363|FG000|Overall Study|Unable to implant study device|1|||
144563591|NCT01774019|521264364|FG001|Overall Study|Unable to implant study device|0|||
144563592|NCT01774019|521264363|FG000|Overall Study|Lost to Follow-up|0|||
144563593|NCT01774019|521264364|FG001|Overall Study|Lost to Follow-up|3|||
144563594|NCT00553605|521264365|FG000|Overall Study|Did not meet entrance criteria|1|||
144563595|NCT00553605|521264366|FG001|Overall Study|Did not meet entrance criteria|3|||
144563596|NCT00553605|521264365|FG000|Overall Study|Did not receive full dose|1|||
144563597|NCT00553605|521264366|FG001|Overall Study|Did not receive full dose|0|||
144563598|NCT00553605|521264365|FG000|Overall Study|Randomized but not treated|2|||
144563599|NCT00553605|521264366|FG001|Overall Study|Randomized but not treated|0|||
144563600|NCT01004185|521264369|FG000|Overall Study|Adverse Event|1|||
144563601|NCT01004185|521264370|FG001|Overall Study|Adverse Event|1|||
144563602|NCT01004185|521264369|FG000|Overall Study|Lost to Follow-up|0|||
144563603|NCT01004185|521264370|FG001|Overall Study|Lost to Follow-up|1|||
144563604|NCT01004185|521264369|FG000|Overall Study|Lack of Efficacy|2|||
144563605|NCT01004185|521264370|FG001|Overall Study|Lack of Efficacy|1|||
144563606|NCT01004185|521264369|FG000|Overall Study|Sponsor Terminated Study|4|||
144563607|NCT01004185|521264370|FG001|Overall Study|Sponsor Terminated Study|5|||
144563608|NCT01004185|521264369|FG000|Overall Study|Withdrawal by Subject|2|||
144563609|NCT01004185|521264370|FG001|Overall Study|Withdrawal by Subject|1|||
144563610|NCT01085812|521264379|FG000|Open-Label Period|Adverse Event|0|||
144563611|NCT01085812|521264380|FG001|Open-Label Period|Adverse Event|80|||
144563612|NCT01085812|521264379|FG000|Open-Label Period|Lack of Efficacy|0|||
144563613|NCT01085812|521264380|FG001|Open-Label Period|Lack of Efficacy|26|||
144563614|NCT01085812|521264379|FG000|Open-Label Period|Protocol Violation|0|||
144563615|NCT01085812|521264380|FG001|Open-Label Period|Protocol Violation|39|||
144563616|NCT01085812|521264379|FG000|Open-Label Period|Withdrawal by Subject|0|||
144563617|NCT01085812|521264380|FG001|Open-Label Period|Withdrawal by Subject|53|||
144563618|NCT01085812|521264379|FG000|Open-Label Period|Lost to Follow-up|0|||
144563619|NCT01085812|521264380|FG001|Open-Label Period|Lost to Follow-up|42|||
144563620|NCT01085812|521264379|FG000|Double-Blind Period|Adverse Event|3|||
144563621|NCT01085812|521264380|FG001|Double-Blind Period|Adverse Event|8|||
144563622|NCT01085812|521264379|FG000|Double-Blind Period|Protocol Violation|2|||
144563623|NCT01085812|521264380|FG001|Double-Blind Period|Protocol Violation|7|||
144563624|NCT01085812|521264379|FG000|Double-Blind Period|Withdrawal by Subject|11|||
144563625|NCT01085812|521264380|FG001|Double-Blind Period|Withdrawal by Subject|24|||
144563626|NCT01085812|521264379|FG000|Double-Blind Period|Lost to Follow-up|5|||
144563627|NCT01085812|521264380|FG001|Double-Blind Period|Lost to Follow-up|17|||
144563628|NCT01085812|521264379|FG000|Double-Blind Period|Other Reasons|0|||
144563629|NCT01085812|521264380|FG001|Double-Blind Period|Other Reasons|2|||
144563630|NCT01085812|521264379|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
144563631|NCT01085812|521264380|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
144563632|NCT01085812|521264379|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
144618187|NCT02669017|521461195|FG000|Overall Study|Miscellaneous|0|||
144618188|NCT02669017|521461196|FG001|Overall Study|Miscellaneous|0|||
144618189|NCT02669017|521461197|FG002|Overall Study|Miscellaneous|0|||
144204589|NCT01081834|519944461|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
144563633|NCT01085812|521264380|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
144563634|NCT01085812|521264379|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
144618190|NCT02669017|521461198|FG003|Overall Study|Miscellaneous|0|||
144204590|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
144618191|NCT02669017|521461199|FG004|Overall Study|Miscellaneous|2|||
144618192|NCT02669017|521461200|FG005|Overall Study|Miscellaneous|1|||
144618193|NCT02669017|521461201|FG006|Overall Study|Miscellaneous|1|||
144618194|NCT02669017|521461202|FG007|Overall Study|Miscellaneous|13|||
144563635|NCT01085812|521264380|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
144563636|NCT01085812|521264379|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
144563637|NCT01085812|521264380|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
144563638|NCT01085812|521264379|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
144563639|NCT01085812|521264380|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
144563640|NCT00594178|521264383|FG000|Overall Study|Physician Decision|5|||
144563641|NCT00496626|521264384|FG000|Overall Study|Lost to Follow-up|0|||
144618195|NCT02669017|521461203|FG008|Overall Study|Miscellaneous|2|||
144563642|NCT00496626|521264385|FG001|Overall Study|Lost to Follow-up|1|||
144563643|NCT00496626|521264384|FG000|Overall Study|Protocol Violation|1|||
144563644|NCT00496626|521264385|FG001|Overall Study|Protocol Violation|0|||
144563645|NCT00496626|521264384|FG000|Overall Study|Withdrawal by Subject|5|||
144563646|NCT00496626|521264385|FG001|Overall Study|Withdrawal by Subject|4|||
144563647|NCT00496626|521264384|FG000|Overall Study|Relocated|0|||
144563648|NCT00496626|521264385|FG001|Overall Study|Relocated|1|||
144563649|NCT04191148|521264386|FG000|Overall Study|Withdrawal by Subject|1|||
144563650|NCT04191148|521264387|FG001|Overall Study|Withdrawal by Subject|0|||
144563651|NCT04191148|521264386|FG000|Overall Study|Adverse Event|1|||
144563652|NCT04191148|521264387|FG001|Overall Study|Adverse Event|0|||
144563653|NCT01874665|521264388|FG000|Overall Study|Adverse Event|6|||
144563654|NCT01874665|521264389|FG001|Overall Study|Adverse Event|2|||
144563655|NCT01874665|521264388|FG000|Overall Study|Withdrawal by Subject|4|||
144563656|NCT01874665|521264389|FG001|Overall Study|Withdrawal by Subject|1|||
144563657|NCT01874665|521264388|FG000|Overall Study|Physician Decision|3|||
144563658|NCT01874665|521264389|FG001|Overall Study|Physician Decision|0|||
144563659|NCT01874665|521264388|FG000|Overall Study|Clinical Progressive Disease|4|||
144563660|NCT01874665|521264389|FG001|Overall Study|Clinical Progressive Disease|3|||
144563661|NCT01874665|521264388|FG000|Overall Study|Study Terminated by Sponsor|0|||
144563662|NCT01874665|521264389|FG001|Overall Study|Study Terminated by Sponsor|2|||
144563663|NCT01874665|521264388|FG000|Overall Study|Documented Progressive Disease|11|||
144563664|NCT01874665|521264389|FG001|Overall Study|Documented Progressive Disease|7|||
144563665|NCT01874665|521264388|FG000|Overall Study|Other|2|||
144563666|NCT01874665|521264389|FG001|Overall Study|Other|0|||
144563667|NCT02647788|521264390|FG000|Overall Study|Lost to Follow-up|13|||
144563668|NCT02647788|521264391|FG001|Overall Study|Lost to Follow-up|11|||
144563669|NCT02647788|521264390|FG000|Overall Study|Did not want opiate|0|||
144563670|NCT02647788|521264391|FG001|Overall Study|Did not want opiate|1|||
144563671|NCT02647788|521264390|FG000|Overall Study|Withdrawal by Subject|1|||
144563672|NCT02647788|521264391|FG001|Overall Study|Withdrawal by Subject|0|||
144563673|NCT02647788|521264390|FG000|Overall Study|Felt itchy with assigned medication|1|||
144563674|NCT02647788|521264391|FG001|Overall Study|Felt itchy with assigned medication|0|||
144563675|NCT02647788|521264390|FG000|Overall Study|Felt nauseous with assigned medication|1|||
144563676|NCT02647788|521264391|FG001|Overall Study|Felt nauseous with assigned medication|1|||
144563677|NCT00905034|521264393|FG000|Overall Study|Withdrawal by Subject|1|||
144563678|NCT01114672|521264394|FG000|Overall Study|Death|0|||
144563679|NCT01114672|521264395|FG001|Overall Study|Death|1|||
144618196|NCT01289015|521461204|FG000|Overall Study|Protocol Violation|12|||
144618197|NCT01289015|521461205|FG001|Overall Study|Protocol Violation|9|||
144618198|NCT01289015|521461204|FG000|Overall Study|Adverse Event|3|||
144618199|NCT01289015|521461205|FG001|Overall Study|Adverse Event|0|||
144618200|NCT01289015|521461204|FG000|Overall Study|Lost to Follow-up|33|||
144618201|NCT01289015|521461205|FG001|Overall Study|Lost to Follow-up|17|||
144618202|NCT01289015|521461204|FG000|Overall Study|Withdrawal by Subject|17|||
144618203|NCT01289015|521461205|FG001|Overall Study|Withdrawal by Subject|8|||
144618204|NCT01289015|521461204|FG000|Overall Study|Disease progression|1|||
144618205|NCT01289015|521461205|FG001|Overall Study|Disease progression|0|||
144618206|NCT01289015|521461204|FG000|Overall Study|Negative baseline culture and others|33|||
144618207|NCT01289015|521461205|FG001|Overall Study|Negative baseline culture and others|20|||
144618208|NCT03031301|521461213|FG000|Overall Study|Protocol Violation|4|||
144618209|NCT03031301|521461214|FG001|Overall Study|Protocol Violation|8|||
144618210|NCT03031301|521461213|FG000|Overall Study|Withdrawal by Subject|7|||
144618211|NCT03031301|521461214|FG001|Overall Study|Withdrawal by Subject|4|||
144618212|NCT03031301|521461213|FG000|Overall Study|Lost to Follow-up|4|||
144618213|NCT03031301|521461214|FG001|Overall Study|Lost to Follow-up|12|||
144618214|NCT03031301|521461213|FG000|Overall Study|Noncompliance|1|||
144618215|NCT03031301|521461214|FG001|Overall Study|Noncompliance|3|||
144618216|NCT03031301|521461213|FG000|Overall Study|Technical issue|1|||
144618217|NCT03031301|521461214|FG001|Overall Study|Technical issue|1|||
144563680|NCT01114672|521264394|FG000|Overall Study|Withdrawal by Subject|2|||
144563681|NCT01114672|521264395|FG001|Overall Study|Withdrawal by Subject|1|||
144618218|NCT03031301|521461213|FG000|Overall Study|Adverse Event|1|||
144618219|NCT03031301|521461214|FG001|Overall Study|Adverse Event|0|||
144618220|NCT02599961|521461216|FG000|Overall Study|Withdrawal by Subject|1|||
144618221|NCT02599961|521461216|FG000|Overall Study|Subject Non-Compliance|2|||
144618222|NCT02599961|521461216|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
144618223|NCT02599961|521461216|FG000|Overall Study|Other, Not Specified|3|||
144618224|NCT02111993|521461219|FG000|Overall Study|Physician Decision|5|||
144618225|NCT02111993|521461220|FG001|Overall Study|Physician Decision|4|||
144618226|NCT00796315|521461221|FG000|Overall Study|Protocol Violation|0|||
144618227|NCT00796315|521461222|FG001|Overall Study|Protocol Violation|1|||
144618228|NCT00796315|521461223|FG002|Overall Study|Protocol Violation|0|||
144563682|NCT01114672|521264394|FG000|Overall Study|Lost to Follow-up|1|||
144563683|NCT01114672|521264395|FG001|Overall Study|Lost to Follow-up|0|||
144563684|NCT01114672|521264394|FG000|Overall Study|transplanted|1|||
144563685|NCT01114672|521264395|FG001|Overall Study|transplanted|0|||
144618229|NCT00960843|521461228|FG000|Overall Study|Lost to Follow-up|2|||
144563686|NCT00545571|521264403|FG000|Overall Study|Administrative Reasons|1|||
144563687|NCT00545571|521264403|FG000|Overall Study|Adverse Event|2|||
144563688|NCT00545571|521264403|FG000|Overall Study|Death|5|||
144563689|NCT00545571|521264403|FG000|Overall Study|Lack of Efficacy|1|||
144563690|NCT00545571|521264403|FG000|Overall Study|Protocol Violation|2|||
144563691|NCT00545571|521264403|FG000|Overall Study|Refused Treatment|1|||
144563692|NCT00545571|521264403|FG000|Overall Study|Screen Failure|16|||
144563693|NCT00545571|521264403|FG000|Overall Study|Transfusion|12|||
144563694|NCT00545571|521264403|FG000|Overall Study|Early Termination of Study|24|||
144563695|NCT00545571|521264403|FG000|Overall Study|Kidney Transplantation|3|||
144728386|NCT03952143|521861224|FG001|Treatment Period|Physician Decision|0|||
144728387|NCT03952143|521861225|FG002|Treatment Period|Physician Decision|2|||
144728388|NCT03952143|521861223|FG000|Treatment Period|Protocol Violation|0|||
144563696|NCT03811834|521264404|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
144563697|NCT00576823|521264405|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
144563698|NCT00576823|521264406|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
144563699|NCT00576823|521264407|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
144563700|NCT00576823|521264405|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
144563701|NCT00576823|521264406|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
144563702|NCT00576823|521264407|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
144563703|NCT01242371|521264408|FG000|Overall Study|Withdrawal by Subject|2|||
144563704|NCT01242371|521264409|FG001|Overall Study|Withdrawal by Subject|2|||
144563705|NCT01242371|521264408|FG000|Overall Study|Protocol Violation|0|||
144563706|NCT01242371|521264409|FG001|Overall Study|Protocol Violation|3|||
144563707|NCT00510146|521264410|FG000|Double-Blind Treatment|Adverse Event|30|||
144563708|NCT00510146|521264411|FG001|Double-Blind Treatment|Adverse Event|13|||
144563709|NCT00510146|521264410|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
144563710|NCT00510146|521264411|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
144563711|NCT00510146|521264410|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
144563712|NCT00510146|521264411|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
144563713|NCT00510146|521264410|FG000|Double-Blind Treatment|Physician Decision|6|||
144563714|NCT00510146|521264411|FG001|Double-Blind Treatment|Physician Decision|0|||
144563715|NCT00510146|521264410|FG000|Double-Blind Treatment|Protocol Violation|1|||
144563716|NCT00510146|521264411|FG001|Double-Blind Treatment|Protocol Violation|2|||
144563717|NCT00510146|521264410|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
144563718|NCT00510146|521264411|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
144563719|NCT00510146|521264410|FG000|Double-Blind Treatment|Clinical Relapse|0|||
144563720|NCT00510146|521264411|FG001|Double-Blind Treatment|Clinical Relapse|1|||
144563721|NCT00510146|521264410|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
144563722|NCT00510146|521264411|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
144563723|NCT00510146|521264410|FG000|Open-Label Treatment|Adverse Event|22|||
144563724|NCT00510146|521264411|FG001|Open-Label Treatment|Adverse Event|8|||
144563725|NCT00510146|521264410|FG000|Open-Label Treatment|Death|1|||
144563726|NCT00510146|521264411|FG001|Open-Label Treatment|Death|1|||
144563727|NCT00510146|521264410|FG000|Open-Label Treatment|Lack of Efficacy|4|||
144563728|NCT00510146|521264411|FG001|Open-Label Treatment|Lack of Efficacy|0|||
144563729|NCT00510146|521264410|FG000|Open-Label Treatment|Lost to Follow-up|10|||
144563730|NCT00510146|521264411|FG001|Open-Label Treatment|Lost to Follow-up|1|||
144563731|NCT00510146|521264410|FG000|Open-Label Treatment|Physician Decision|3|||
144563732|NCT00510146|521264411|FG001|Open-Label Treatment|Physician Decision|1|||
144563733|NCT00510146|521264410|FG000|Open-Label Treatment|Protocol Violation|4|||
144563734|NCT00510146|521264411|FG001|Open-Label Treatment|Protocol Violation|2|||
144563735|NCT00510146|521264410|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
144563736|NCT00510146|521264411|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
144563737|NCT00510146|521264410|FG000|Open-Label Treatment|Clinical Relapse|1|||
144563738|NCT00510146|521264411|FG001|Open-Label Treatment|Clinical Relapse|1|||
144563739|NCT00510146|521264410|FG000|Open-Label Treatment|Sponsor Decision|2|||
144563740|NCT00510146|521264411|FG001|Open-Label Treatment|Sponsor Decision|0|||
144563741|NCT03188536|521264414|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
144563742|NCT03188536|521264414|FG000|Overall Study|Not participated/met inclusion criteria|1|||
144563743|NCT01930214|521264415|FG000|Overall Study|Death|4|||
144563744|NCT01930214|521264416|FG001|Overall Study|Death|4|||
144563745|NCT01930214|521264417|FG002|Overall Study|Death|11|||
144563746|NCT01930214|521264415|FG000|Overall Study|Lost to Follow-up|12|||
144563747|NCT01930214|521264416|FG001|Overall Study|Lost to Follow-up|13|||
144563748|NCT01930214|521264417|FG002|Overall Study|Lost to Follow-up|12|||
144563749|NCT01930214|521264415|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
144728389|NCT03952143|521861224|FG001|Treatment Period|Protocol Violation|0|||
144563750|NCT01930214|521264416|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
144563751|NCT01930214|521264417|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
144563752|NCT01930214|521264415|FG000|Overall Study|Physician Decision|2|||
144563753|NCT01930214|521264416|FG001|Overall Study|Physician Decision|0|||
144563754|NCT01930214|521264417|FG002|Overall Study|Physician Decision|0|||
144563755|NCT00025662|521264418|FG000|Overall Study|Withdrawal by Subject|2|||
144563756|NCT00025662|521264418|FG000|Overall Study|Technical failure of manipulation|1|||
144262566|NCT00905424|520161491|FG000|Overall Study|Withdrawal by Subject|1|||
144262567|NCT00905424|520161492|FG001|Overall Study|Withdrawal by Subject|2|||
144262568|NCT00905424|520161491|FG000|Overall Study|Adverse Event|4|||
144262569|NCT00905424|520161492|FG001|Overall Study|Adverse Event|2|||
144262570|NCT00905424|520161491|FG000|Overall Study|Non-compliance with study medication|2|||
144262571|NCT00905424|520161492|FG001|Overall Study|Non-compliance with study medication|0|||
144262572|NCT00905424|520161491|FG000|Overall Study|Sponsor decision|1|||
144262573|NCT00905424|520161492|FG001|Overall Study|Sponsor decision|0|||
144262574|NCT00905424|520161491|FG000|Overall Study|Positive urine drug screen|0|||
144262575|NCT00905424|520161492|FG001|Overall Study|Positive urine drug screen|1|||
144262576|NCT00905424|520161491|FG000|Overall Study|Non-adherence to visit schedule|0|||
144262577|NCT00905424|520161492|FG001|Overall Study|Non-adherence to visit schedule|1|||
144262578|NCT00379899|520161493|FG000|Overall Study|Adverse Event|7|||
144262579|NCT00379899|520161494|FG001|Overall Study|Adverse Event|3|||
144262580|NCT00379899|520161493|FG000|Overall Study|Death|10|||
144262581|NCT00379899|520161494|FG001|Overall Study|Death|10|||
144262582|NCT00379899|520161493|FG000|Overall Study|Lost to Follow-up|2|||
144262583|NCT00379899|520161494|FG001|Overall Study|Lost to Follow-up|4|||
144262584|NCT00379899|520161493|FG000|Overall Study|Physician Decision|3|||
144262585|NCT00379899|520161494|FG001|Overall Study|Physician Decision|4|||
144262586|NCT00379899|520161493|FG000|Overall Study|Withdrawal by Subject|5|||
144262587|NCT00379899|520161494|FG001|Overall Study|Withdrawal by Subject|5|||
144262588|NCT00379899|520161493|FG000|Overall Study|Ineligibility determined|0|||
144262589|NCT00379899|520161494|FG001|Overall Study|Ineligibility determined|1|||
144262590|NCT00379899|520161493|FG000|Overall Study|Noncompliance|1|||
144262591|NCT00379899|520161494|FG001|Overall Study|Noncompliance|1|||
144262592|NCT00379899|520161493|FG000|Overall Study|Parathyroidectomy|0|||
144262593|NCT00379899|520161494|FG001|Overall Study|Parathyroidectomy|2|||
144563757|NCT02132117|521264421|FG000|Overall Study|Adverse Event|6|||
144563758|NCT02132117|521264422|FG001|Overall Study|Adverse Event|1|||
144563759|NCT02132117|521264421|FG000|Overall Study|Lost to Follow-up|2|||
144563760|NCT02132117|521264422|FG001|Overall Study|Lost to Follow-up|2|||
144563761|NCT02132117|521264421|FG000|Overall Study|Personal Reasons|1|||
144563762|NCT02132117|521264422|FG001|Overall Study|Personal Reasons|2|||
144563763|NCT02132117|521264421|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144563764|NCT02132117|521264422|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144563765|NCT04947436|521264423|FG000|Overall Study|Lost to Follow-up|3|||
144563766|NCT04947436|521264424|FG001|Overall Study|Lost to Follow-up|7|||
144563767|NCT04947436|521264425|FG002|Overall Study|Lost to Follow-up|5|||
144563768|NCT04947436|521264423|FG000|Overall Study|Death|1|||
144563769|NCT04947436|521264424|FG001|Overall Study|Death|1|||
144563770|NCT04947436|521264425|FG002|Overall Study|Death|1|||
144563771|NCT02161185|521264429|FG000|Treatment Phase|Administrative/Other|7|||
144563772|NCT00372255|521264430|FG000|Overall Study|Withdrawn for other reasons|2|||
144563773|NCT00372255|521264431|FG001|Overall Study|Withdrawn for other reasons|1|||
144563774|NCT00582114|521264435|FG000|Overall Study|Death|4|||
144563775|NCT00582114|521264436|FG001|Overall Study|Death|4|||
144563776|NCT00582114|521264435|FG000|Overall Study|Kidney Transplant|3|||
144563777|NCT00582114|521264436|FG001|Overall Study|Kidney Transplant|1|||
144563778|NCT00582114|521264435|FG000|Overall Study|Lost to Follow-up|7|||
144563779|NCT00582114|521264436|FG001|Overall Study|Lost to Follow-up|6|||
144563780|NCT00582114|521264435|FG000|Overall Study|Withdrawal by Subject|8|||
144563781|NCT00582114|521264436|FG001|Overall Study|Withdrawal by Subject|16|||
144563782|NCT00582114|521264435|FG000|Overall Study|Adverse Event|1|||
144563783|NCT00582114|521264436|FG001|Overall Study|Adverse Event|1|||
144563784|NCT00582114|521264435|FG000|Overall Study|Physician Decision|0|||
144563785|NCT00582114|521264436|FG001|Overall Study|Physician Decision|6|||
144563786|NCT00582114|521264435|FG000|Overall Study|Stopped by data safety monitoring board|19|||
144563787|NCT00582114|521264436|FG001|Overall Study|Stopped by data safety monitoring board|20|||
144563788|NCT00118703|521264437|FG000|Overall Study|Protocol Violation|1|||
144563789|NCT00118703|521264438|FG001|Overall Study|Protocol Violation|0|||
144563790|NCT00118703|521264437|FG000|Overall Study|Adverse Event|1|||
144563791|NCT00118703|521264438|FG001|Overall Study|Adverse Event|1|||
144563792|NCT00118703|521264437|FG000|Overall Study|Participant took two different treatment|0|||
144563793|NCT00118703|521264438|FG001|Overall Study|Participant took two different treatment|1|||
144563794|NCT00118703|521264437|FG000|Overall Study|Withdrawal by Subject|2|||
144618230|NCT00960843|521461229|FG001|Overall Study|Lost to Follow-up|0|||
144618231|NCT00960843|521461228|FG000|Overall Study|Protocol Violation|0|||
144618232|NCT00960843|521461229|FG001|Overall Study|Protocol Violation|4|||
144618233|NCT00960843|521461228|FG000|Overall Study|Repeated needle dislodgment|0|||
144618234|NCT00960843|521461229|FG001|Overall Study|Repeated needle dislodgment|1|||
144618235|NCT00652366|521461230|FG000|Overall Study|Adverse Event|8|||
144618236|NCT00652366|521461231|FG001|Overall Study|Adverse Event|4|||
144262594|NCT00379899|520161493|FG000|Overall Study|Renal transplantation|5|||
144563795|NCT00118703|521264438|FG001|Overall Study|Withdrawal by Subject|5|||
144563796|NCT00118703|521264437|FG000|Overall Study|Lost to Follow-up|1|||
144563797|NCT00118703|521264438|FG001|Overall Study|Lost to Follow-up|2|||
144618237|NCT00652366|521461232|FG002|Overall Study|Adverse Event|7|||
144563798|NCT00130728|521264443|FG000|Overall Study|Death|258|||
144563799|NCT00130728|521264444|FG001|Overall Study|Death|258|||
144563800|NCT00130728|521264443|FG000|Overall Study|Lost to Follow-up|4|||
144563801|NCT00130728|521264444|FG001|Overall Study|Lost to Follow-up|0|||
144563802|NCT00130728|521264443|FG000|Overall Study|Withdrawal by Subject|0|||
144563803|NCT00130728|521264444|FG001|Overall Study|Withdrawal by Subject|2|||
144563804|NCT01209286|521264445|FG000|Overall Study|Adverse Event|4|||
144563805|NCT01209286|521264446|FG001|Overall Study|Adverse Event|3|||
144563806|NCT01209286|521264447|FG002|Overall Study|Adverse Event|1|||
144563807|NCT01209286|521264445|FG000|Overall Study|Hematological Relapse After Remission|0|||
144563808|NCT01209286|521264446|FG001|Overall Study|Hematological Relapse After Remission|1|||
144563809|NCT01209286|521264447|FG002|Overall Study|Hematological Relapse After Remission|1|||
144563810|NCT01209286|521264445|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
144563811|NCT01209286|521264446|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
144563812|NCT01209286|521264447|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
144563813|NCT01209286|521264445|FG000|Overall Study|Physician Decision|0|||
144563814|NCT01209286|521264446|FG001|Overall Study|Physician Decision|2|||
144563815|NCT01209286|521264447|FG002|Overall Study|Physician Decision|0|||
144563816|NCT01209286|521264445|FG000|Overall Study|Other|0|||
144563817|NCT01209286|521264446|FG001|Overall Study|Other|1|||
144563818|NCT01209286|521264447|FG002|Overall Study|Other|0|||
144563819|NCT01349036|521264448|FG000|Overall Study|Disease progression|13|||
144563820|NCT01349036|521264449|FG001|Overall Study|Disease progression|22|||
144563821|NCT01349036|521264448|FG000|Overall Study|Other|1|||
144563822|NCT01349036|521264449|FG001|Overall Study|Other|0|||
144563823|NCT01349036|521264448|FG000|Overall Study|Withdrawal by Subject|0|||
144563824|NCT01349036|521264449|FG001|Overall Study|Withdrawal by Subject|2|||
144563825|NCT03796208|521264450|FG000|Overall Study|Withdrawal by Subject|3|||
144563826|NCT03796208|521264451|FG001|Overall Study|Withdrawal by Subject|0|||
144563827|NCT03796208|521264450|FG000|Overall Study|Loss of pregnancy|1|||
144563828|NCT03796208|521264451|FG001|Overall Study|Loss of pregnancy|1|||
144563829|NCT03796208|521264450|FG000|Overall Study|Changed prenatal clinics|0|||
144563830|NCT03796208|521264451|FG001|Overall Study|Changed prenatal clinics|5|||
144563831|NCT03796208|521264450|FG000|Overall Study|Lost to Follow-up|20|||
144563832|NCT03796208|521264451|FG001|Overall Study|Lost to Follow-up|16|||
144563833|NCT01215032|521264453|FG000|Overall Study|Adverse Event|3|||
144563834|NCT01215032|521264453|FG000|Overall Study|Lack of Efficacy|17|||
144563835|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
144563836|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
144563837|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
144563838|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
144563839|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
144563840|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
144563841|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
144563842|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
144563843|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
144563844|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
144563845|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
144563846|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
144563847|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
144563848|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
144563849|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
144563850|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
144563851|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
144563852|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
144563853|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
144563854|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
144563855|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
144563856|NCT01125566|521264454|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
144563857|NCT01125566|521264455|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
144563858|NCT01125566|521264456|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
144563859|NCT01125566|521264454|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
144563860|NCT01125566|521264455|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
144563861|NCT01125566|521264456|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
144563862|NCT01125566|521264454|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
144563863|NCT01125566|521264455|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
144563864|NCT01125566|521264456|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
144728390|NCT03952143|521861225|FG002|Treatment Period|Protocol Violation|1|||
144728391|NCT03952143|521861223|FG000|Treatment Period|Withdrawal by Subject|0|||
144563865|NCT01125566|521264454|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
144563866|NCT01125566|521264455|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
144563867|NCT01125566|521264456|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
144563868|NCT01125566|521264454|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
144563869|NCT01125566|521264455|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
144563870|NCT01125566|521264456|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
144563871|NCT02725008|521264457|FG000|Overall Study|Lost to Follow-up|7|||
144563872|NCT02725008|521264458|FG001|Overall Study|Lost to Follow-up|9|||
144563873|NCT02725008|521264457|FG000|Overall Study|Withdrawal by Subject|2|||
144563874|NCT02725008|521264458|FG001|Overall Study|Withdrawal by Subject|2|||
144563875|NCT02725008|521264457|FG000|Overall Study|Admitted to hospital|0|||
144563876|NCT02725008|521264458|FG001|Overall Study|Admitted to hospital|1|||
144563877|NCT04688086|521264464|FG000|Overall Study|Lost to Follow-up|164|||
144563878|NCT04688086|521264464|FG000|Overall Study|Imaging error;|64|||
144563879|NCT01329419|521264467|FG000|Overall Study|Protocol Violation|235|||
144563880|NCT00069277|521264468|FG000|Overall Study|Adverse Event|3|||
144563881|NCT00069277|521264468|FG000|Overall Study|Withdrawal by Subject|1|||
144563882|NCT00069277|521264468|FG000|Overall Study|Progressive Disease|15|||
144563883|NCT00069277|521264468|FG000|Overall Study|Physician Decision|2|||
144563884|NCT03512288|521264470|FG000|Overall Study|Adverse Event|1|||
144563885|NCT03512288|521264471|FG001|Overall Study|Adverse Event|0|||
144563886|NCT03512288|521264470|FG000|Overall Study|Lost to Follow-up|12|||
144563887|NCT03512288|521264471|FG001|Overall Study|Lost to Follow-up|15|||
144563888|NCT03512288|521264470|FG000|Overall Study|Physician Decision|0|||
144563889|NCT03512288|521264471|FG001|Overall Study|Physician Decision|2|||
144563890|NCT03512288|521264470|FG000|Overall Study|Protocol Violation|6|||
144563891|NCT03512288|521264471|FG001|Overall Study|Protocol Violation|4|||
144563892|NCT03512288|521264470|FG000|Overall Study|Medication error without associated adverse event|1|||
144563893|NCT03512288|521264471|FG001|Overall Study|Medication error without associated adverse event|0|||
144563894|NCT03512288|521264470|FG000|Overall Study|No longer met eligibility criteria|5|||
144563895|NCT03512288|521264471|FG001|Overall Study|No longer met eligibility criteria|2|||
144563896|NCT03512288|521264470|FG000|Overall Study|Withdrawal by parent/guardian|14|||
144563897|NCT03512288|521264471|FG001|Overall Study|Withdrawal by parent/guardian|18|||
144563898|NCT03512288|521264470|FG000|Overall Study|Other|1|||
144563899|NCT03512288|521264471|FG001|Overall Study|Other|1|||
144563900|NCT03512288|521264470|FG000|Overall Study|Randomized but not treated|1|||
144563901|NCT03512288|521264471|FG001|Overall Study|Randomized but not treated|1|||
144563902|NCT01078584|521264472|FG000|Overall Study|Final Status Unknown|1073|||
144563903|NCT01078584|521264472|FG000|Overall Study|Lost to Follow-up|670|||
144563904|NCT01078584|521264472|FG000|Overall Study|Non-serious Adverse Event|577|||
144563905|NCT01078584|521264472|FG000|Overall Study|Withdrawal of Consent|244|||
144563906|NCT01078584|521264472|FG000|Overall Study|Physician Withdrew from Study|90|||
144563907|NCT01078584|521264472|FG000|Overall Study|Non-compliance|67|||
144563908|NCT01078584|521264472|FG000|Overall Study|Blood Pressure Controlled|49|||
144563909|NCT01078584|521264472|FG000|Overall Study|Physician Switched Medication|26|||
144563910|NCT01078584|521264472|FG000|Overall Study|Physician Discontinued Patient|12|||
144563911|NCT01078584|521264472|FG000|Overall Study|Lack of Efficacy|98|||
144563912|NCT01078584|521264472|FG000|Overall Study|Protocol Violation|75|||
144563913|NCT01078584|521264472|FG000|Overall Study|Serious Adverse Event|27|||
144563914|NCT01078584|521264472|FG000|Overall Study|Multiple Reasons|2|||
144563915|NCT01208870|521264473|FG000|Overall Study|Lost to Follow-up|2|||
144563916|NCT01208870|521264474|FG001|Overall Study|Lost to Follow-up|8|||
144563917|NCT01121185|521264475|FG000|Overall Study|Not infused|0|||
144563918|NCT01121185|521264476|FG001|Overall Study|Not infused|1|||
144563919|NCT01121185|521264475|FG000|Overall Study|Not transplanted|1|||
144563920|NCT01121185|521264476|FG001|Overall Study|Not transplanted|0|||
144563921|NCT00424177|521264477|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
144563922|NCT00424177|521264477|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
144563923|NCT00424177|521264477|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
144563924|NCT00424177|521264477|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
144563925|NCT00424177|521264477|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
144563926|NCT00424177|521264477|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
144563927|NCT00424177|521264477|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
144563928|NCT00424177|521264477|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
144563929|NCT00424177|521264477|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
144563930|NCT00424177|521264477|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
144563931|NCT00316589|521264478|FG000|Overall Study|Withdrawal by Subject|0|||
144563932|NCT00316589|521264479|FG001|Overall Study|Withdrawal by Subject|5|||
144563933|NCT00316589|521264480|FG002|Overall Study|Withdrawal by Subject|0|||
144563934|NCT00316589|521264481|FG003|Overall Study|Withdrawal by Subject|1|||
144563935|NCT00316589|521264478|FG000|Overall Study|Subject unwilling/unable to comply|0|||
144618238|NCT00652366|521461233|FG003|Overall Study|Adverse Event|17|||
144563936|NCT00316589|521264479|FG001|Overall Study|Subject unwilling/unable to comply|6|||
144563937|NCT00316589|521264480|FG002|Overall Study|Subject unwilling/unable to comply|0|||
144563938|NCT00316589|521264481|FG003|Overall Study|Subject unwilling/unable to comply|2|||
144563939|NCT00316589|521264478|FG000|Overall Study|Adverse Event|1|||
144563940|NCT00316589|521264479|FG001|Overall Study|Adverse Event|0|||
144563941|NCT00316589|521264480|FG002|Overall Study|Adverse Event|0|||
144563942|NCT00316589|521264481|FG003|Overall Study|Adverse Event|1|||
144563943|NCT00316589|521264478|FG000|Overall Study|Physician Decision|0|||
144563944|NCT00316589|521264479|FG001|Overall Study|Physician Decision|1|||
144563945|NCT00316589|521264480|FG002|Overall Study|Physician Decision|0|||
144563946|NCT00316589|521264481|FG003|Overall Study|Physician Decision|0|||
144563947|NCT00316589|521264478|FG000|Overall Study|Other reason|0|||
144563948|NCT00316589|521264479|FG001|Overall Study|Other reason|12|||
144563949|NCT00316589|521264480|FG002|Overall Study|Other reason|1|||
144563950|NCT00316589|521264481|FG003|Overall Study|Other reason|1|||
144563951|NCT01283971|521264484|FG000|Overall Study|Adverse Event|3|||
144563952|NCT01283971|521264485|FG001|Overall Study|Adverse Event|5|||
144563953|NCT01283971|521264484|FG000|Overall Study|Insufficient therapeutic responses|3|||
144563954|NCT01283971|521264485|FG001|Overall Study|Insufficient therapeutic responses|3|||
144563955|NCT01283971|521264484|FG000|Overall Study|Protocol Violation|5|||
144563956|NCT01283971|521264485|FG001|Overall Study|Protocol Violation|1|||
144563957|NCT01283971|521264484|FG000|Overall Study|Refused treatment|3|||
144563958|NCT01283971|521264485|FG001|Overall Study|Refused treatment|1|||
144563959|NCT01283971|521264484|FG000|Overall Study|Failure to return|0|||
144563960|NCT01283971|521264485|FG001|Overall Study|Failure to return|1|||
144563961|NCT01283971|521264484|FG000|Overall Study|Administrative reasons|1|||
144563962|NCT01283971|521264485|FG001|Overall Study|Administrative reasons|1|||
144563963|NCT00605566|521265941|FG000|Overall Study|Adverse Event|1|||
144563964|NCT00605566|521265941|FG000|Overall Study|Clinical deterioration|1|||
144563965|NCT00605566|521265941|FG000|Overall Study|Poor compliance in run-in period|1|||
144563966|NCT03864341|521265944|FG000|Overall Study|Withdrawal by Subject|1|||
144563967|NCT01066936|521265945|FG000|Overall Study|Death|2|||
144563968|NCT01066936|521265945|FG000|Overall Study|Device revised/removed|1|||
144563969|NCT01066936|521265945|FG000|Overall Study|Lost to Follow-up|3|||
144563970|NCT01066936|521265945|FG000|Overall Study|Withdrawal by Subject|4|||
144563971|NCT00695136|521265946|FG000|Overall Study|Withdrawal by Subject|1|||
144563972|NCT00695136|521265946|FG000|Overall Study|unrelated adverse event|1|||
144563973|NCT01726049|521265948|FG000|Overall Study|Death|1|||
144563974|NCT01726049|521265949|FG001|Overall Study|Death|1|||
144563975|NCT01726049|521265948|FG000|Overall Study|Adverse Event|4|||
144563976|NCT01726049|521265949|FG001|Overall Study|Adverse Event|1|||
144563977|NCT01726049|521265948|FG000|Overall Study|refused second HC|0|||
144563978|NCT01726049|521265949|FG001|Overall Study|refused second HC|2|||
144563979|NCT02202109|521265952|FG000|Overall Study|Lost to Follow-up|88|||
144563980|NCT02202109|521265953|FG001|Overall Study|Lost to Follow-up|87|||
144563981|NCT02202109|521265952|FG000|Overall Study|Withdrawal by Subject|2|||
144563982|NCT02202109|521265953|FG001|Overall Study|Withdrawal by Subject|0|||
144563983|NCT04156399|521265960|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
144563984|NCT04156399|521265960|FG000|Overall Study|study suspension due to COVID pandemic|3|||
144563985|NCT01333111|521265963|FG000|Overall Study|patient undergoing major surgery|0|||
144563986|NCT01333111|521265964|FG001|Overall Study|patient undergoing major surgery|2|||
144563987|NCT01333111|521265965|FG002|Overall Study|patient undergoing major surgery|0|||
144563988|NCT01333111|521265963|FG000|Overall Study|personal reasons|0|||
144563989|NCT01333111|521265964|FG001|Overall Study|personal reasons|0|||
144563990|NCT01333111|521265965|FG002|Overall Study|personal reasons|1|||
144563991|NCT01333111|521265963|FG000|Overall Study|unclassified|1|||
144563992|NCT01333111|521265964|FG001|Overall Study|unclassified|0|||
144563993|NCT01333111|521265965|FG002|Overall Study|unclassified|0|||
144563994|NCT01333111|521265963|FG000|Overall Study|withdrawal criteria|0|||
144563995|NCT01333111|521265964|FG001|Overall Study|withdrawal criteria|1|||
144563996|NCT01333111|521265965|FG002|Overall Study|withdrawal criteria|0|||
144563997|NCT01333111|521265963|FG000|Overall Study|Non-compliance|1|||
144563998|NCT01333111|521265964|FG001|Overall Study|Non-compliance|0|||
144563999|NCT01333111|521265965|FG002|Overall Study|Non-compliance|0|||
144564000|NCT01333111|521265963|FG000|Overall Study|Ineffective therapy|0|||
144564001|NCT01333111|521265964|FG001|Overall Study|Ineffective therapy|0|||
144564002|NCT01333111|521265965|FG002|Overall Study|Ineffective therapy|1|||
144564003|NCT00664105|521265966|FG000|Overall Study|Death|3|||
144564004|NCT00664105|521265966|FG000|Overall Study|Withdrawal by Subject|5|||
144564005|NCT00664105|521265966|FG000|Overall Study|Adverse Event|9|||
144564006|NCT00664105|521265966|FG000|Overall Study|Disease progression|7|||
144564007|NCT03834623|521265967|FG000|Overall Study|Progression|0|||
144564008|NCT03834623|521265968|FG001|Overall Study|Progression|1|||
144564009|NCT00478647|521265969|FG000|Overall Study|Adverse Event|1|||
144564010|NCT00478647|521265969|FG000|Overall Study|Withdrawal by Subject|1|||
144564011|NCT00477464|521265973|FG000|Overall Study|Lost to Follow-up|1|||
144564012|NCT00477464|521265973|FG000|Overall Study|Death|36|||
144564013|NCT00477464|521265973|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
144564014|NCT00639769|521265974|FG000|Overall Study|Death|2|||
144564015|NCT00639769|521265974|FG000|Overall Study|Adverse Event|7|||
144618239|NCT00652366|521461234|FG004|Overall Study|Adverse Event|13|||
144618240|NCT00652366|521461230|FG000|Overall Study|Death|5|||
144618241|NCT00652366|521461231|FG001|Overall Study|Death|4|||
144204591|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
144204592|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
144204593|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
144204594|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
144204595|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Death|1|||
144204596|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Death|0|||
144564016|NCT00639769|521265974|FG000|Overall Study|Lack of Efficacy|1|||
144564017|NCT00639769|521265974|FG000|Overall Study|Disease progression|26|||
144564018|NCT00639769|521265974|FG000|Overall Study|Withdrawal by Subject|4|||
144564019|NCT00784147|521265975|FG000|Overall Study|Lost to Follow-up|2|||
144564020|NCT00784147|521265976|FG001|Overall Study|Lost to Follow-up|4|||
144564021|NCT00784147|521265975|FG000|Overall Study|Withdrawal by Subject|1|||
144564022|NCT00784147|521265976|FG001|Overall Study|Withdrawal by Subject|3|||
144564023|NCT00784147|521265975|FG000|Overall Study|Physician Decision|2|||
144564024|NCT00784147|521265976|FG001|Overall Study|Physician Decision|1|||
144564025|NCT00784147|521265975|FG000|Overall Study|Protocol Violation|1|||
144564026|NCT00784147|521265976|FG001|Overall Study|Protocol Violation|1|||
144564027|NCT00784147|521265975|FG000|Overall Study|Death|2|||
144564028|NCT00784147|521265976|FG001|Overall Study|Death|0|||
144564029|NCT01475461|521265981|FG000|Run-in Period|Not meet eligibility criteria|16|||
144564030|NCT01475461|521265982|FG001|Run-in Period|Not meet eligibility criteria|0|||
144564031|NCT01475461|521265983|FG002|Run-in Period|Not meet eligibility criteria|0|||
144564032|NCT01475461|521265984|FG003|Run-in Period|Not meet eligibility criteria|0|||
144564033|NCT01475461|521265985|FG004|Run-in Period|Not meet eligibility criteria|0|||
144564034|NCT01475461|521265986|FG005|Run-in Period|Not meet eligibility criteria|0|||
144564035|NCT01475461|521265987|FG006|Run-in Period|Not meet eligibility criteria|0|||
144564036|NCT01475461|521265981|FG000|Run-in Period|Lost to Follow-up|7|||
144564037|NCT01475461|521265982|FG001|Run-in Period|Lost to Follow-up|0|||
144564038|NCT01475461|521265983|FG002|Run-in Period|Lost to Follow-up|0|||
144564039|NCT01475461|521265984|FG003|Run-in Period|Lost to Follow-up|0|||
144564040|NCT01475461|521265985|FG004|Run-in Period|Lost to Follow-up|0|||
144564041|NCT01475461|521265986|FG005|Run-in Period|Lost to Follow-up|0|||
144564042|NCT01475461|521265987|FG006|Run-in Period|Lost to Follow-up|0|||
144564043|NCT01475461|521265981|FG000|Run-in Period|Withdrawal by Subject|11|||
144564044|NCT01475461|521265982|FG001|Run-in Period|Withdrawal by Subject|0|||
144564045|NCT01475461|521265983|FG002|Run-in Period|Withdrawal by Subject|0|||
144564046|NCT01475461|521265984|FG003|Run-in Period|Withdrawal by Subject|0|||
144564047|NCT01475461|521265985|FG004|Run-in Period|Withdrawal by Subject|0|||
144564048|NCT01475461|521265986|FG005|Run-in Period|Withdrawal by Subject|0|||
144564049|NCT01475461|521265987|FG006|Run-in Period|Withdrawal by Subject|0|||
144564050|NCT01475461|521265981|FG000|Run-in Period|Other|3|||
144564051|NCT01475461|521265982|FG001|Run-in Period|Other|0|||
144564052|NCT01475461|521265983|FG002|Run-in Period|Other|0|||
144564053|NCT01475461|521265984|FG003|Run-in Period|Other|0|||
144564054|NCT01475461|521265985|FG004|Run-in Period|Other|0|||
144564055|NCT01475461|521265986|FG005|Run-in Period|Other|0|||
144564056|NCT01475461|521265987|FG006|Run-in Period|Other|0|||
144564057|NCT01475461|521265981|FG000|Run-in Period|Protocol Violation|4|||
144564058|NCT01475461|521265982|FG001|Run-in Period|Protocol Violation|0|||
144564059|NCT01475461|521265983|FG002|Run-in Period|Protocol Violation|0|||
144564060|NCT01475461|521265984|FG003|Run-in Period|Protocol Violation|0|||
144564061|NCT01475461|521265985|FG004|Run-in Period|Protocol Violation|0|||
144564062|NCT01475461|521265986|FG005|Run-in Period|Protocol Violation|0|||
144564063|NCT01475461|521265987|FG006|Run-in Period|Protocol Violation|0|||
144564064|NCT01475461|521265981|FG000|Treatment Period|Death|0|||
144564065|NCT01475461|521265982|FG001|Treatment Period|Death|0|||
144564066|NCT01475461|521265983|FG002|Treatment Period|Death|0|||
144564067|NCT01475461|521265984|FG003|Treatment Period|Death|1|||
144564068|NCT01475461|521265985|FG004|Treatment Period|Death|0|||
144564069|NCT01475461|521265986|FG005|Treatment Period|Death|0|||
144204597|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Death|0|||
144204598|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Death|0|||
144204599|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Death|0|||
144204600|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
144564070|NCT01475461|521265987|FG006|Treatment Period|Death|0|||
144564071|NCT01475461|521265981|FG000|Treatment Period|Lost to Follow-up|0|||
144564072|NCT01475461|521265982|FG001|Treatment Period|Lost to Follow-up|3|||
144204601|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
144564073|NCT01475461|521265983|FG002|Treatment Period|Lost to Follow-up|2|||
144564074|NCT01475461|521265984|FG003|Treatment Period|Lost to Follow-up|3|||
144564075|NCT01475461|521265985|FG004|Treatment Period|Lost to Follow-up|1|||
144564076|NCT01475461|521265986|FG005|Treatment Period|Lost to Follow-up|2|||
144564077|NCT01475461|521265987|FG006|Treatment Period|Lost to Follow-up|1|||
144618242|NCT00652366|521461232|FG002|Overall Study|Death|1|||
144618243|NCT00652366|521461233|FG003|Overall Study|Death|8|||
144564078|NCT01475461|521265981|FG000|Treatment Period|Withdrawal by Subject|0|||
144564079|NCT01475461|521265982|FG001|Treatment Period|Withdrawal by Subject|2|||
144564080|NCT01475461|521265983|FG002|Treatment Period|Withdrawal by Subject|2|||
144564081|NCT01475461|521265984|FG003|Treatment Period|Withdrawal by Subject|0|||
144564082|NCT01475461|521265985|FG004|Treatment Period|Withdrawal by Subject|2|||
144564083|NCT01475461|521265986|FG005|Treatment Period|Withdrawal by Subject|2|||
144564084|NCT01475461|521265987|FG006|Treatment Period|Withdrawal by Subject|0|||
144564085|NCT01475461|521265981|FG000|Treatment Period|Other|0|||
144564086|NCT01475461|521265982|FG001|Treatment Period|Other|1|||
144564087|NCT01475461|521265983|FG002|Treatment Period|Other|0|||
144564088|NCT01475461|521265984|FG003|Treatment Period|Other|0|||
144564089|NCT01475461|521265985|FG004|Treatment Period|Other|0|||
144564090|NCT01475461|521265986|FG005|Treatment Period|Other|0|||
144564091|NCT01475461|521265987|FG006|Treatment Period|Other|0|||
144564092|NCT01475461|521265981|FG000|Treatment Period|Protocol Violation|0|||
144564093|NCT01475461|521265982|FG001|Treatment Period|Protocol Violation|1|||
144564094|NCT01475461|521265983|FG002|Treatment Period|Protocol Violation|0|||
144564095|NCT01475461|521265984|FG003|Treatment Period|Protocol Violation|0|||
144564096|NCT01475461|521265985|FG004|Treatment Period|Protocol Violation|0|||
144564097|NCT01475461|521265986|FG005|Treatment Period|Protocol Violation|0|||
144564098|NCT01475461|521265987|FG006|Treatment Period|Protocol Violation|1|||
144564099|NCT01475461|521265981|FG000|Treatment Period|Lack of Efficacy|0|||
144618244|NCT00652366|521461234|FG004|Overall Study|Death|5|||
144618245|NCT00652366|521461230|FG000|Overall Study|Lack of Efficacy|84|||
144618246|NCT00652366|521461231|FG001|Overall Study|Lack of Efficacy|58|||
144618247|NCT00652366|521461232|FG002|Overall Study|Lack of Efficacy|53|||
144618248|NCT00652366|521461233|FG003|Overall Study|Lack of Efficacy|133|||
144618249|NCT00652366|521461234|FG004|Overall Study|Lack of Efficacy|13|||
144262595|NCT00379899|520161494|FG001|Overall Study|Renal transplantation|4|||
144262596|NCT00379899|520161493|FG000|Overall Study|Coronary artery bypass graft|1|||
144618250|NCT00652366|521461230|FG000|Overall Study|Violation of Selection Criteria|0|||
144618251|NCT00652366|521461231|FG001|Overall Study|Violation of Selection Criteria|0|||
144618252|NCT00652366|521461232|FG002|Overall Study|Violation of Selection Criteria|1|||
144618253|NCT00652366|521461233|FG003|Overall Study|Violation of Selection Criteria|0|||
144618254|NCT00652366|521461234|FG004|Overall Study|Violation of Selection Criteria|0|||
144618255|NCT00652366|521461230|FG000|Overall Study|Protocol Violation|1|||
144204602|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144204603|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144204604|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144204605|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144204606|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
144204607|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144204608|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144204609|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144204610|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144204611|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
144618256|NCT00652366|521461231|FG001|Overall Study|Protocol Violation|0|||
144618257|NCT00652366|521461232|FG002|Overall Study|Protocol Violation|0|||
144618258|NCT00652366|521461233|FG003|Overall Study|Protocol Violation|0|||
144618259|NCT00652366|521461234|FG004|Overall Study|Protocol Violation|0|||
144618260|NCT00652366|521461230|FG000|Overall Study|Refused treatment|3|||
144618261|NCT00652366|521461231|FG001|Overall Study|Refused treatment|7|||
144618262|NCT00652366|521461232|FG002|Overall Study|Refused treatment|6|||
144618263|NCT00652366|521461233|FG003|Overall Study|Refused treatment|17|||
144618264|NCT00652366|521461234|FG004|Overall Study|Refused treatment|5|||
144618265|NCT00652366|521461230|FG000|Overall Study|Other|5|||
144204612|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
144564100|NCT01475461|521265982|FG001|Treatment Period|Lack of Efficacy|2|||
144564101|NCT01475461|521265983|FG002|Treatment Period|Lack of Efficacy|0|||
144204613|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
144564102|NCT01475461|521265984|FG003|Treatment Period|Lack of Efficacy|2|||
144564103|NCT01475461|521265985|FG004|Treatment Period|Lack of Efficacy|1|||
144564104|NCT01475461|521265986|FG005|Treatment Period|Lack of Efficacy|1|||
144564105|NCT01475461|521265987|FG006|Treatment Period|Lack of Efficacy|0|||
144564106|NCT01475461|521265981|FG000|Treatment Period|Medication Error|0|||
144564107|NCT01475461|521265982|FG001|Treatment Period|Medication Error|0|||
144564108|NCT01475461|521265983|FG002|Treatment Period|Medication Error|0|||
144618266|NCT00652366|521461231|FG001|Overall Study|Other|2|||
144564109|NCT01475461|521265984|FG003|Treatment Period|Medication Error|1|||
144564110|NCT01475461|521265985|FG004|Treatment Period|Medication Error|0|||
144618267|NCT00652366|521461232|FG002|Overall Study|Other|3|||
144618268|NCT00652366|521461233|FG003|Overall Study|Other|4|||
144618269|NCT00652366|521461234|FG004|Overall Study|Other|0|||
144618270|NCT00889265|521461235|FG000|Overall Study|Adverse Event|1|||
144618271|NCT00889265|521461235|FG000|Overall Study|Lost to Follow-up|5|||
144618272|NCT00889265|521461235|FG000|Overall Study|Protocol Violation|1|||
144618273|NCT03028870|521461238|FG000|Overall Study|Adverse Event|7|||
144564111|NCT01475461|521265986|FG005|Treatment Period|Medication Error|0|||
144564112|NCT01475461|521265987|FG006|Treatment Period|Medication Error|0|||
144564113|NCT01475461|521265981|FG000|Treatment Period|Adverse Event|0|||
144564114|NCT01475461|521265982|FG001|Treatment Period|Adverse Event|0|||
144564115|NCT01475461|521265983|FG002|Treatment Period|Adverse Event|0|||
144564116|NCT01475461|521265984|FG003|Treatment Period|Adverse Event|1|||
144564117|NCT01475461|521265985|FG004|Treatment Period|Adverse Event|0|||
144564118|NCT01475461|521265986|FG005|Treatment Period|Adverse Event|0|||
144564119|NCT01475461|521265987|FG006|Treatment Period|Adverse Event|0|||
144564120|NCT04051242|521265990|FG000|Overall Study|Withdrawal by Subject|1|||
144564121|NCT04051242|521265990|FG000|Overall Study|Physician Decision|1|||
144564122|NCT03029819|521265995|FG000|Overall Study|Lost to Follow-up|3|||
144564123|NCT03029819|521265996|FG001|Overall Study|Lost to Follow-up|5|||
144564124|NCT03029819|521265995|FG000|Overall Study|Removed due to disruptive behavior|0|||
144564125|NCT03029819|521265996|FG001|Overall Study|Removed due to disruptive behavior|1|||
144564126|NCT01020747|521266003|FG000|Overall Study|Withdrawal by Subject|1|||
144564127|NCT02175745|521266004|FG000|Overall Study|Not Eligible|1|||
144564128|NCT00983892|521266005|FG000|Overall Study|Withdrawal by Subject|10|||
144564129|NCT00983892|521266006|FG001|Overall Study|Withdrawal by Subject|12|||
144564130|NCT00808899|521266007|FG000|Overall Study|Death|1|||
144564131|NCT00808899|521266007|FG000|Overall Study|Physician Decision|3|||
144564132|NCT03028012|521266008|FG000|Overall Study|Lost to Follow-up|2|||
144564133|NCT03028012|521266009|FG001|Overall Study|Lost to Follow-up|3|||
144564134|NCT03028012|521266010|FG002|Overall Study|Lost to Follow-up|3|||
144564135|NCT01424189|521266019|FG000|Overall Study|Adverse Event|1|||
144564136|NCT01424189|521266020|FG001|Overall Study|Adverse Event|0|||
144564137|NCT01424189|521266019|FG000|Overall Study|Lost to Follow-up|4|||
144564138|NCT01424189|521266020|FG001|Overall Study|Lost to Follow-up|1|||
144564139|NCT01424189|521266019|FG000|Overall Study|Withdrawal by Subject|4|||
144564140|NCT01424189|521266020|FG001|Overall Study|Withdrawal by Subject|4|||
144564141|NCT01424189|521266019|FG000|Overall Study|Subject moved|1|||
144564142|NCT01424189|521266020|FG001|Overall Study|Subject moved|0|||
144564143|NCT01424189|521266019|FG000|Overall Study|Death|3|||
144564144|NCT01424189|521266020|FG001|Overall Study|Death|1|||
144564145|NCT03120949|521266021|FG000|Overall Study|randomized in error|1|||
144564146|NCT03120949|521266022|FG001|Overall Study|randomized in error|0|||
144564147|NCT03120949|521266021|FG000|Overall Study|Death|13|||
144564148|NCT03120949|521266022|FG001|Overall Study|Death|13|||
144564149|NCT03120949|521266021|FG000|Overall Study|Lost to Follow-up|23|||
144564150|NCT03120949|521266022|FG001|Overall Study|Lost to Follow-up|13|||
144564151|NCT03120949|521266021|FG000|Overall Study|Withdrawal by Subject|139|||
144564152|NCT03120949|521266022|FG001|Overall Study|Withdrawal by Subject|124|||
144564153|NCT03120949|521266021|FG000|Overall Study|Covid-19|43|||
144564154|NCT03120949|521266022|FG001|Overall Study|Covid-19|34|||
144564155|NCT03120949|521266021|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
144564156|NCT03120949|521266022|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
144564157|NCT03120949|521266021|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
144564158|NCT03120949|521266022|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
144564159|NCT03120949|521266021|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
144564160|NCT03120949|521266022|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
144564161|NCT03120949|521266021|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
144564162|NCT03120949|521266022|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
144564163|NCT03120949|521266021|FG000|Overall Study|Site was closed|2|||
144564164|NCT03120949|521266022|FG001|Overall Study|Site was closed|3|||
144564165|NCT03120949|521266021|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
144564166|NCT03120949|521266022|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
144564167|NCT03120949|521266021|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
144564168|NCT03120949|521266022|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
144564169|NCT03120949|521266021|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
144564170|NCT03120949|521266022|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
144564171|NCT03120949|521266021|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
144564172|NCT03120949|521266022|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
144564173|NCT03120949|521266021|FG000|Overall Study|Other: Adverse Event|0|||
144564174|NCT03120949|521266022|FG001|Overall Study|Other: Adverse Event|1|||
144618274|NCT03028870|521461239|FG001|Overall Study|Adverse Event|4|||
144564175|NCT03120949|521266021|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
144564176|NCT03120949|521266022|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
144564177|NCT03120949|521266021|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
144564178|NCT03120949|521266022|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
144564179|NCT03120949|521266021|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
144564180|NCT03120949|521266022|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
144564181|NCT03120949|521266021|FG000|Overall Study|Personal Reasons|0|||
144564182|NCT03120949|521266022|FG001|Overall Study|Personal Reasons|1|||
144564183|NCT03120949|521266021|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
144564184|NCT03120949|521266022|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
144564185|NCT03120949|521266021|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
144564186|NCT03120949|521266022|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
144564187|NCT03120949|521266021|FG000|Overall Study|Compliance With Medication|0|||
144564188|NCT03120949|521266022|FG001|Overall Study|Compliance With Medication|1|||
144564189|NCT03120949|521266021|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
144564190|NCT03120949|521266022|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
144564191|NCT03120949|521266021|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
144564192|NCT03120949|521266022|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
144564193|NCT03120949|521266021|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
144564194|NCT03120949|521266022|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
144564195|NCT01705145|521266023|FG000|Part B|Adverse Event|1|||
144564196|NCT01203956|521266026|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
144564197|NCT01203956|521266027|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
144564198|NCT04522778|521266028|FG000|Overall Study|Patient did not want to wear the device|1|||
144564199|NCT04522778|521266029|FG001|Overall Study|Patient did not want to wear the device|0|||
144564200|NCT04522778|521266028|FG000|Overall Study|Lost to Follow-up|0|||
144564201|NCT04522778|521266029|FG001|Overall Study|Lost to Follow-up|1|||
144564202|NCT02230306|521266032|FG000|Overall Study|Did not receive study treatment|1|||
144564203|NCT00312845|521266035|FG000|Overall Study|Adverse Event|19|||
144564204|NCT00312845|521266036|FG001|Overall Study|Adverse Event|5|||
144564205|NCT00312845|521266035|FG000|Overall Study|Death|2|||
144564206|NCT00312845|521266036|FG001|Overall Study|Death|2|||
144564207|NCT00312845|521266035|FG000|Overall Study|Withdrawal by Subject|14|||
144564208|NCT00312845|521266036|FG001|Overall Study|Withdrawal by Subject|6|||
144564209|NCT00312845|521266035|FG000|Overall Study|Disease Progression|56|||
144564210|NCT00312845|521266036|FG001|Overall Study|Disease Progression|77|||
144564211|NCT00312845|521266035|FG000|Overall Study|Lost to Follow-up|2|||
144564212|NCT00312845|521266036|FG001|Overall Study|Lost to Follow-up|0|||
144564213|NCT00312845|521266035|FG000|Overall Study|Other|6|||
144564214|NCT00312845|521266036|FG001|Overall Study|Other|5|||
144564215|NCT01220856|521266039|FG000|Overall Study|graft loss|3|||
144564216|NCT01220856|521266040|FG001|Overall Study|graft loss|3|||
144564217|NCT01220856|521266039|FG000|Overall Study|Lost to Follow-up|1|||
144564218|NCT01220856|521266040|FG001|Overall Study|Lost to Follow-up|0|||
144564219|NCT00361842|521266041|FG000|Overall Study|Withdrawal by Subject|2|||
144564220|NCT00361842|521266042|FG001|Overall Study|Withdrawal by Subject|3|||
144564221|NCT00361842|521266041|FG000|Overall Study|Death|2|||
144564222|NCT00361842|521266042|FG001|Overall Study|Death|1|||
144564223|NCT00361842|521266041|FG000|Overall Study|Disease progression|19|||
144564224|NCT00361842|521266042|FG001|Overall Study|Disease progression|20|||
144564225|NCT00361842|521266041|FG000|Overall Study|Adverse Event|2|||
144564226|NCT00361842|521266042|FG001|Overall Study|Adverse Event|3|||
144564227|NCT00361842|521266041|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
144564228|NCT00361842|521266042|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
144564229|NCT00361842|521266041|FG000|Overall Study|Other|1|||
144564230|NCT00361842|521266042|FG001|Overall Study|Other|0|||
144564231|NCT00361842|521266041|FG000|Overall Study|Other|0|||
144564232|NCT00361842|521266042|FG001|Overall Study|Other|2|||
144564233|NCT04206384|521266043|FG000|Overall Study|Withdrawal by Subject|8|||
144564234|NCT04206384|521266043|FG000|Overall Study|Adverse Event|2|||
144564235|NCT02212197|521266044|FG000|Overall Study|Need for radiotherapy|1|||
144564236|NCT02212197|521266045|FG001|Overall Study|Need for radiotherapy|0|||
144618275|NCT03028870|521461240|FG002|Overall Study|Adverse Event|3|||
144618276|NCT03028870|521461241|FG003|Overall Study|Adverse Event|3|||
144618277|NCT03028870|521461238|FG000|Overall Study|Withdrawal by Subject|1|||
144262597|NCT00379899|520161494|FG001|Overall Study|Coronary artery bypass graft|1|||
144564237|NCT02212197|521266046|FG002|Overall Study|Need for radiotherapy|0|||
144564238|NCT03015181|521266047|FG000|Overall Study|Enrolled, but product never administered|1|||
144618278|NCT03028870|521461239|FG001|Overall Study|Withdrawal by Subject|1|||
144564239|NCT03015181|521266048|FG001|Overall Study|Enrolled, but product never administered|0|||
144564240|NCT03015181|521266049|FG002|Overall Study|Enrolled, but product never administered|0|||
144564241|NCT03015181|521266050|FG003|Overall Study|Enrolled, but product never administered|0|||
144564242|NCT03015181|521266051|FG004|Overall Study|Enrolled, but product never administered|0|||
144564243|NCT03015181|521266052|FG005|Overall Study|Enrolled, but product never administered|0|||
144564244|NCT03015181|521266053|FG006|Overall Study|Enrolled, but product never administered|0|||
144564245|NCT03015181|521266047|FG000|Overall Study|Withdrawal by Subject|0|||
144564246|NCT03015181|521266048|FG001|Overall Study|Withdrawal by Subject|0|||
144564247|NCT03015181|521266049|FG002|Overall Study|Withdrawal by Subject|0|||
144564248|NCT03015181|521266050|FG003|Overall Study|Withdrawal by Subject|0|||
144564249|NCT03015181|521266051|FG004|Overall Study|Withdrawal by Subject|0|||
144564250|NCT03015181|521266052|FG005|Overall Study|Withdrawal by Subject|1|||
144564251|NCT03015181|521266053|FG006|Overall Study|Withdrawal by Subject|0|||
144564252|NCT03015181|521266047|FG000|Overall Study|Physician Decision|0|||
144564253|NCT03015181|521266048|FG001|Overall Study|Physician Decision|0|||
144564254|NCT03015181|521266049|FG002|Overall Study|Physician Decision|0|||
144564255|NCT03015181|521266050|FG003|Overall Study|Physician Decision|0|||
144564256|NCT03015181|521266051|FG004|Overall Study|Physician Decision|0|||
144564257|NCT03015181|521266052|FG005|Overall Study|Physician Decision|0|||
144564258|NCT03015181|521266053|FG006|Overall Study|Physician Decision|1|||
144564259|NCT01260142|521266055|FG000|Treatment Period 1|Study on hold|1|||
144564260|NCT01260142|521266056|FG001|Treatment Period 1|Study on hold|1|||
144564261|NCT01260142|521266057|FG002|Treatment Period 1|Study on hold|0|||
144564262|NCT01260142|521266058|FG003|Treatment Period 1|Study on hold|0|||
144564263|NCT01260142|521266059|FG004|Treatment Period 1|Study on hold|1|||
144564264|NCT01260142|521266060|FG005|Treatment Period 1|Study on hold|2|||
144564265|NCT01260142|521266055|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
144564266|NCT01260142|521266056|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
144564267|NCT01260142|521266057|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
144564268|NCT01260142|521266058|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
144564269|NCT01260142|521266059|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
144564270|NCT01260142|521266060|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
144564271|NCT01260142|521266055|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144564272|NCT01260142|521266056|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144564273|NCT01260142|521266057|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144564274|NCT01260142|521266058|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144564275|NCT01260142|521266059|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144564276|NCT01260142|521266060|FG005|Treatment Period 1|Withdrawal by Subject|1|||
144564277|NCT01503164|521266069|FG000|Overall Study|Withdrawal by Subject|2|||
144564278|NCT01503164|521266070|FG001|Overall Study|Withdrawal by Subject|1|||
144564279|NCT00474383|521266073|FG000|Main Study|Adverse Event|11|||
144564280|NCT00474383|521266074|FG001|Main Study|Adverse Event|0|||
144618279|NCT03028870|521461240|FG002|Overall Study|Withdrawal by Subject|1|||
144618280|NCT03028870|521461241|FG003|Overall Study|Withdrawal by Subject|2|||
144618281|NCT03028870|521461238|FG000|Overall Study|Lost to Follow-up|1|||
144618282|NCT03028870|521461239|FG001|Overall Study|Lost to Follow-up|0|||
144618283|NCT03028870|521461240|FG002|Overall Study|Lost to Follow-up|0|||
144204614|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
144204615|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
144204616|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144204617|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
144204618|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144204619|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144204620|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
144564281|NCT00474383|521266073|FG000|Main Study|Symptomatic Deterioration|1|||
144564282|NCT00474383|521266074|FG001|Main Study|Symptomatic Deterioration|0|||
144564283|NCT00474383|521266073|FG000|Main Study|Progressive Disease|23|||
144618284|NCT03028870|521461241|FG003|Overall Study|Lost to Follow-up|0|||
144618285|NCT03028870|521461238|FG000|Overall Study|Lack of Efficacy|3|||
144618286|NCT03028870|521461239|FG001|Overall Study|Lack of Efficacy|0|||
144618287|NCT03028870|521461240|FG002|Overall Study|Lack of Efficacy|0|||
144618288|NCT03028870|521461241|FG003|Overall Study|Lack of Efficacy|0|||
144618289|NCT03028870|521461238|FG000|Overall Study|Administrative|5|||
144618290|NCT03028870|521461239|FG001|Overall Study|Administrative|5|||
144618291|NCT03028870|521461240|FG002|Overall Study|Administrative|12|||
144618292|NCT03028870|521461241|FG003|Overall Study|Administrative|4|||
144618293|NCT02069899|521461244|FG000|Overall Study|Adverse Event|6|||
144204621|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
144564284|NCT00474383|521266074|FG001|Main Study|Progressive Disease|0|||
144564285|NCT00474383|521266073|FG000|Main Study|Other|1|||
144564286|NCT00474383|521266074|FG001|Main Study|Other|0|||
144564287|NCT00474383|521266073|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
144564288|NCT00474383|521266074|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
144564289|NCT00474383|521266073|FG000|Extension|Progressive Disease|0|||
144564290|NCT00474383|521266074|FG001|Extension|Progressive Disease|5|||
144618294|NCT02069899|521461245|FG001|Overall Study|Adverse Event|0|||
144564291|NCT01482819|521266076|FG000|Overall Study|Lost to Follow-up|2|||
144618295|NCT02069899|521461246|FG002|Overall Study|Adverse Event|1|||
144618296|NCT02069899|521461244|FG000|Overall Study|Withdrawal by Participant|2|||
144618297|NCT02069899|521461245|FG001|Overall Study|Withdrawal by Participant|0|||
144618298|NCT02069899|521461246|FG002|Overall Study|Withdrawal by Participant|0|||
144204622|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
144204623|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
144204624|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
144564292|NCT00562484|521266079|FG000|Overall Study|Adverse Event|6|||
144564293|NCT00562484|521266080|FG001|Overall Study|Adverse Event|1|||
144564294|NCT00562484|521266079|FG000|Overall Study|Protocol Violation|11|||
144564295|NCT00562484|521266080|FG001|Overall Study|Protocol Violation|2|||
144564296|NCT00562484|521266079|FG000|Overall Study|Withdrawal by Subject|12|||
144564297|NCT00562484|521266080|FG001|Overall Study|Withdrawal by Subject|9|||
144564298|NCT00562484|521266079|FG000|Overall Study|Moved away from the study area|20|||
144564299|NCT00562484|521266080|FG001|Overall Study|Moved away from the study area|9|||
144564300|NCT00562484|521266079|FG000|Overall Study|Lost to Follow-up|132|||
144564301|NCT00562484|521266080|FG001|Overall Study|Lost to Follow-up|71|||
144564302|NCT00562484|521266079|FG000|Overall Study|Reason not provided or not specified|25|||
144564303|NCT00562484|521266080|FG001|Overall Study|Reason not provided or not specified|12|||
144564304|NCT03325608|521266081|FG000|Overall Study|Lost to Follow-up|23|||
144564305|NCT03325608|521266082|FG001|Overall Study|Lost to Follow-up|23|||
144564306|NCT03325608|521266083|FG002|Overall Study|Lost to Follow-up|30|||
144564307|NCT03325608|521266084|FG003|Overall Study|Lost to Follow-up|30|||
144564308|NCT03325608|521266081|FG000|Overall Study|Death of Caregiver|0|||
144564309|NCT03325608|521266082|FG001|Overall Study|Death of Caregiver|0|||
144564310|NCT03325608|521266083|FG002|Overall Study|Death of Caregiver|2|||
144564311|NCT03325608|521266084|FG003|Overall Study|Death of Caregiver|2|||
144564312|NCT03325608|521266081|FG000|Overall Study|Death of Care Recipient|34|||
144564313|NCT03325608|521266082|FG001|Overall Study|Death of Care Recipient|34|||
144564314|NCT03325608|521266083|FG002|Overall Study|Death of Care Recipient|28|||
144564315|NCT03325608|521266084|FG003|Overall Study|Death of Care Recipient|28|||
144564316|NCT03325608|521266081|FG000|Overall Study|Withdrawal by Subject|49|||
144564317|NCT03325608|521266082|FG001|Overall Study|Withdrawal by Subject|49|||
144564318|NCT03325608|521266083|FG002|Overall Study|Withdrawal by Subject|35|||
144564319|NCT03325608|521266084|FG003|Overall Study|Withdrawal by Subject|35|||
144564320|NCT03325608|521266081|FG000|Overall Study|Ineligible|7|||
144564321|NCT03325608|521266082|FG001|Overall Study|Ineligible|7|||
144564322|NCT03325608|521266083|FG002|Overall Study|Ineligible|5|||
144564323|NCT03325608|521266084|FG003|Overall Study|Ineligible|5|||
144564324|NCT02154347|521266085|FG000|Double-blind Period|Adverse Event|1|||
144564325|NCT02154347|521266086|FG001|Double-blind Period|Adverse Event|2|||
144564326|NCT02154347|521266085|FG000|Double-blind Period|Lack of Efficacy|1|||
144564327|NCT02154347|521266086|FG001|Double-blind Period|Lack of Efficacy|0|||
144564328|NCT02154347|521266085|FG000|Double-blind Period|Physician Decision|0|||
144564329|NCT02154347|521266086|FG001|Double-blind Period|Physician Decision|1|||
144564330|NCT02154347|521266085|FG000|Double-blind Period|Withdrawal by Subject|1|||
144564331|NCT02154347|521266086|FG001|Double-blind Period|Withdrawal by Subject|1|||
144564332|NCT02154347|521266085|FG000|Open-label Period|Adverse Event|3|||
144564333|NCT02154347|521266086|FG001|Open-label Period|Adverse Event|4|||
144564334|NCT02154347|521266085|FG000|Open-label Period|Lack of Efficacy|4|||
144564335|NCT02154347|521266086|FG001|Open-label Period|Lack of Efficacy|19|||
144564336|NCT02154347|521266085|FG000|Open-label Period|Protocol Violation|0|||
144564337|NCT02154347|521266086|FG001|Open-label Period|Protocol Violation|1|||
144564338|NCT02154347|521266085|FG000|Open-label Period|Withdrawal by Subject|0|||
144564339|NCT02154347|521266086|FG001|Open-label Period|Withdrawal by Subject|1|||
144564340|NCT02188784|521266087|FG000|Overall Study|Death|3|||
144564341|NCT02188784|521266088|FG001|Overall Study|Death|1|||
144564342|NCT02188784|521266087|FG000|Overall Study|Lost to Follow-up|1|||
144564343|NCT02188784|521266088|FG001|Overall Study|Lost to Follow-up|0|||
144564344|NCT02188784|521266087|FG000|Overall Study|Withdrawal by Subject|3|||
144564345|NCT02188784|521266088|FG001|Overall Study|Withdrawal by Subject|9|||
144564346|NCT02188784|521266087|FG000|Overall Study|Physician Decision|2|||
144564347|NCT02188784|521266088|FG001|Overall Study|Physician Decision|3|||
144564348|NCT05041439|521266089|FG000|Overall Study|Withdrawal by Subject|1|||
144728392|NCT03952143|521861224|FG001|Treatment Period|Withdrawal by Subject|5|||
144204625|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Other|4|||
144564349|NCT05041439|521266090|FG001|Overall Study|Withdrawal by Subject|1|||
144564350|NCT05041439|521266089|FG000|Overall Study|Death|1|||
144564351|NCT05041439|521266090|FG001|Overall Study|Death|0|||
144564352|NCT02250183|521266091|FG000|Overall Study|Withdrawal by Subject|2|||
144564353|NCT02250183|521266091|FG000|Overall Study|Adverse Event|5|||
144564354|NCT02250183|521266091|FG000|Overall Study|Lost to Follow-up|1|||
144564355|NCT03282799|521266092|FG000|Overall Study|Pregnancy|1|||
144564356|NCT03282799|521266093|FG001|Overall Study|Pregnancy|0|||
144564357|NCT03282799|521266092|FG000|Overall Study|Physician Decision|1|||
144564358|NCT03282799|521266093|FG001|Overall Study|Physician Decision|0|||
144564359|NCT01932762|521267668|FG000|Overall Study|Withdrawal by Subject|1|||
144564360|NCT01932762|521267669|FG001|Overall Study|Withdrawal by Subject|2|||
144564361|NCT01932762|521267670|FG002|Overall Study|Withdrawal by Subject|0|||
144564362|NCT01932762|521267671|FG003|Overall Study|Withdrawal by Subject|0|||
144564363|NCT01932762|521267668|FG000|Overall Study|Lost to Follow-up|4|||
144564364|NCT01932762|521267669|FG001|Overall Study|Lost to Follow-up|0|||
144564365|NCT01932762|521267670|FG002|Overall Study|Lost to Follow-up|0|||
144618299|NCT02069899|521461244|FG000|Overall Study|Lost to Follow-up|1|||
144618300|NCT02069899|521461245|FG001|Overall Study|Lost to Follow-up|0|||
144618301|NCT02069899|521461246|FG002|Overall Study|Lost to Follow-up|1|||
144618302|NCT02069899|521461244|FG000|Overall Study|Other|4|||
144618303|NCT02069899|521461245|FG001|Overall Study|Other|0|||
144618304|NCT02069899|521461246|FG002|Overall Study|Other|0|||
144618305|NCT02069899|521461244|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
144618306|NCT02069899|521461245|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
144618307|NCT02069899|521461246|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
144618308|NCT02069899|521461244|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
144618309|NCT02069899|521461245|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
144618310|NCT02069899|521461246|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
144618311|NCT01181011|521461249|FG000|Overall Study|Adverse Event|2|||
144618312|NCT01181011|521461249|FG000|Overall Study|Lost to Follow-up|1|||
144618313|NCT02788747|521461250|FG000|Overall Study|Adverse Event|1|||
144618314|NCT02788747|521461251|FG001|Overall Study|Adverse Event|0|||
144618315|NCT02788747|521461252|FG002|Overall Study|Adverse Event|0|||
144618316|NCT00879697|521461253|FG000|Overall Study|Physician Decision|2|||
144618317|NCT00879697|521461254|FG001|Overall Study|Physician Decision|2|||
144618318|NCT02500121|521461255|FG000|Overall Study|Lost to Follow-up|0|||
144618319|NCT02500121|521461256|FG001|Overall Study|Lost to Follow-up|1|||
144618320|NCT02500121|521461255|FG000|Overall Study|Withdrawal by Subject|1|||
144618321|NCT02500121|521461256|FG001|Overall Study|Withdrawal by Subject|1|||
144618322|NCT02500121|521461255|FG000|Overall Study|Death|26|||
144618323|NCT02500121|521461256|FG001|Overall Study|Death|24|||
144618324|NCT01836783|521461258|FG000|Overall Study|Withdrawal by Subject|0|||
144618325|NCT01836783|521461259|FG001|Overall Study|Withdrawal by Subject|2|||
144618326|NCT01273883|521461261|FG000|First Intervention|Adverse Event|2|||
144564366|NCT01932762|521267671|FG003|Overall Study|Lost to Follow-up|1|||
144564367|NCT01932762|521267668|FG000|Overall Study|Physician Decision|1|||
144564368|NCT01932762|521267669|FG001|Overall Study|Physician Decision|0|||
144564369|NCT01932762|521267670|FG002|Overall Study|Physician Decision|0|||
144564370|NCT01932762|521267671|FG003|Overall Study|Physician Decision|0|||
144564371|NCT01468077|521267678|FG000|Overall Study|Adverse Event|2|||
144564372|NCT01468077|521267679|FG001|Overall Study|Adverse Event|2|||
144564373|NCT01468077|521267678|FG000|Overall Study|Lack of Efficacy|1|||
144564374|NCT01468077|521267679|FG001|Overall Study|Lack of Efficacy|1|||
144564375|NCT01468077|521267678|FG000|Overall Study|Physician Decision|1|||
144564376|NCT01468077|521267679|FG001|Overall Study|Physician Decision|0|||
144564377|NCT04843579|521267680|FG000|Overall Study|Adverse Event|1|||
144564378|NCT04843579|521267680|FG000|Overall Study|Disease Progression|1|||
144564379|NCT03024996|521267682|FG000|Overall Study|Death|57|||
144564380|NCT03024996|521267683|FG001|Overall Study|Death|55|||
144564381|NCT03024996|521267682|FG000|Overall Study|Disease relapse|1|||
144564382|NCT03024996|521267683|FG001|Overall Study|Disease relapse|0|||
144564383|NCT03024996|521267682|FG000|Overall Study|Lost to Follow-up|5|||
144564384|NCT03024996|521267683|FG001|Overall Study|Lost to Follow-up|10|||
144564385|NCT03024996|521267682|FG000|Overall Study|Other|3|||
144564386|NCT03024996|521267683|FG001|Overall Study|Other|3|||
144564387|NCT03024996|521267682|FG000|Overall Study|Physician Decision|0|||
144564388|NCT03024996|521267683|FG001|Overall Study|Physician Decision|1|||
144564389|NCT03024996|521267682|FG000|Overall Study|Study terminated by sponsor|303|||
144564390|NCT03024996|521267683|FG001|Overall Study|Study terminated by sponsor|283|||
144564391|NCT03024996|521267682|FG000|Overall Study|Withdrawal by Subject|21|||
144564392|NCT03024996|521267683|FG001|Overall Study|Withdrawal by Subject|36|||
144564393|NCT04606199|521267684|FG000|Overall Study|Withdrawal by Subject|2|||
144564394|NCT03596242|521267685|FG000|Overall Study|Lost to Follow-up|2|||
144564395|NCT03596242|521267686|FG001|Overall Study|Lost to Follow-up|2|||
144564396|NCT03357471|521267687|FG000|Overall Study|Adverse Event|1|||
144564397|NCT03357471|521267688|FG001|Overall Study|Adverse Event|0|||
144564398|NCT03357471|521267687|FG000|Overall Study|Lost to Follow-up|1|||
144564399|NCT03357471|521267688|FG001|Overall Study|Lost to Follow-up|0|||
144618327|NCT01273883|521461262|FG001|First Intervention|Adverse Event|1|||
144618328|NCT01273883|521461261|FG000|Second Intervention|Lost to Follow-up|1|||
144618329|NCT01273883|521461262|FG001|Second Intervention|Lost to Follow-up|1|||
144618330|NCT01273883|521461261|FG000|Second Intervention|Lack of Efficacy|1|||
144618331|NCT01273883|521461262|FG001|Second Intervention|Lack of Efficacy|0|||
144564400|NCT03294941|521267689|FG000|Overall Study|Withdrawal by Subject|0|||
144564401|NCT03294941|521267690|FG001|Overall Study|Withdrawal by Subject|2|||
144564402|NCT00916305|521267691|FG000|Overall Study|Lost to Follow-up|21|||
144564403|NCT00916305|521267692|FG001|Overall Study|Lost to Follow-up|27|||
144564404|NCT00916305|521267691|FG000|Overall Study|Withdrawal by Subject|0|||
144564405|NCT00916305|521267692|FG001|Overall Study|Withdrawal by Subject|1|||
144564406|NCT02512861|521267695|FG000|Overall Study|Protocol Violation|3|||
144618332|NCT04489888|521461268|FG000|Overall Study|Death|75|||
144564407|NCT02512861|521267696|FG001|Overall Study|Protocol Violation|7|||
144564408|NCT02512861|521267695|FG000|Overall Study|Physician Decision|3|||
144564409|NCT02512861|521267696|FG001|Overall Study|Physician Decision|1|||
144564410|NCT02512861|521267695|FG000|Overall Study|Withdrawal by Subject|0|||
144564411|NCT02512861|521267696|FG001|Overall Study|Withdrawal by Subject|1|||
144564412|NCT01585298|521267699|FG000|Overall Study|Study completion was not documented.|1|||
144564413|NCT01585298|521267699|FG000|Overall Study|Protocol deviation|1|||
144564414|NCT01585298|521267699|FG000|Overall Study|Administrative problems|4|||
144564415|NCT01585298|521267699|FG000|Overall Study|Lost to Follow-up|2|||
144564416|NCT01585298|521267699|FG000|Overall Study|Withdrawal by Subject|4|||
144564417|NCT01585298|521267699|FG000|Overall Study|Abnormal test procedure results|1|||
144564418|NCT01585298|521267699|FG000|Overall Study|Adverse Event|24|||
144564419|NCT04545476|521267700|FG000|Overall Study|Lost to Follow-up|1|||
144564420|NCT04545476|521267701|FG001|Overall Study|Lost to Follow-up|1|||
144564421|NCT04545476|521267702|FG002|Overall Study|Lost to Follow-up|0|||
144564422|NCT04545476|521267703|FG003|Overall Study|Lost to Follow-up|0|||
144564423|NCT04035577|521267717|FG000|Overall Study|Lost to Follow-up|1|||
144564424|NCT04035577|521267717|FG000|Overall Study|Withdrawal by Subject|1|||
144564425|NCT00505414|521267719|FG000|Titration Phase|Adverse Event|0|||
144564426|NCT00505414|521267720|FG001|Titration Phase|Adverse Event|0|||
144564427|NCT00505414|521267721|FG002|Titration Phase|Adverse Event|0|||
144564428|NCT00505414|521267722|FG003|Titration Phase|Adverse Event|8|||
144564429|NCT00505414|521267723|FG004|Titration Phase|Adverse Event|3|||
144564430|NCT00505414|521267719|FG000|Titration Phase|Death|0|||
144564431|NCT00505414|521267720|FG001|Titration Phase|Death|0|||
144564432|NCT00505414|521267721|FG002|Titration Phase|Death|0|||
144564433|NCT00505414|521267722|FG003|Titration Phase|Death|2|||
144564434|NCT00505414|521267723|FG004|Titration Phase|Death|0|||
144564435|NCT00505414|521267719|FG000|Titration Phase|Lack of Efficacy|0|||
144564436|NCT00505414|521267720|FG001|Titration Phase|Lack of Efficacy|0|||
144564437|NCT00505414|521267721|FG002|Titration Phase|Lack of Efficacy|0|||
144564438|NCT00505414|521267722|FG003|Titration Phase|Lack of Efficacy|10|||
144564439|NCT00505414|521267723|FG004|Titration Phase|Lack of Efficacy|1|||
144564440|NCT00505414|521267719|FG000|Titration Phase|Protocol Violation|0|||
144564441|NCT00505414|521267720|FG001|Titration Phase|Protocol Violation|0|||
144564442|NCT00505414|521267721|FG002|Titration Phase|Protocol Violation|0|||
144564443|NCT00505414|521267722|FG003|Titration Phase|Protocol Violation|0|||
144564444|NCT00505414|521267723|FG004|Titration Phase|Protocol Violation|1|||
144564445|NCT00505414|521267719|FG000|Titration Phase|Withdrawal by Subject|0|||
144564446|NCT00505414|521267720|FG001|Titration Phase|Withdrawal by Subject|0|||
144564447|NCT00505414|521267721|FG002|Titration Phase|Withdrawal by Subject|0|||
144564448|NCT00505414|521267722|FG003|Titration Phase|Withdrawal by Subject|3|||
144564449|NCT00505414|521267723|FG004|Titration Phase|Withdrawal by Subject|4|||
144564450|NCT00505414|521267719|FG000|Titration Phase|Underlying disease and therapy required|0|||
144564451|NCT00505414|521267720|FG001|Titration Phase|Underlying disease and therapy required|0|||
144564452|NCT00505414|521267721|FG002|Titration Phase|Underlying disease and therapy required|0|||
144564453|NCT00505414|521267722|FG003|Titration Phase|Underlying disease and therapy required|7|||
144564454|NCT00505414|521267723|FG004|Titration Phase|Underlying disease and therapy required|3|||
144564455|NCT00505414|521267719|FG000|Maintenance Phase|Adverse Event|2|||
144564456|NCT00505414|521267720|FG001|Maintenance Phase|Adverse Event|2|||
144564457|NCT00505414|521267721|FG002|Maintenance Phase|Adverse Event|3|||
144564458|NCT00505414|521267722|FG003|Maintenance Phase|Adverse Event|0|||
144564459|NCT00505414|521267723|FG004|Maintenance Phase|Adverse Event|0|||
144564460|NCT00505414|521267719|FG000|Maintenance Phase|Death|2|||
144564461|NCT00505414|521267720|FG001|Maintenance Phase|Death|0|||
144564462|NCT00505414|521267721|FG002|Maintenance Phase|Death|1|||
144564463|NCT00505414|521267722|FG003|Maintenance Phase|Death|0|||
144564464|NCT00505414|521267723|FG004|Maintenance Phase|Death|0|||
144564465|NCT00505414|521267719|FG000|Maintenance Phase|Lack of Efficacy|2|||
144564466|NCT00505414|521267720|FG001|Maintenance Phase|Lack of Efficacy|1|||
144564467|NCT00505414|521267721|FG002|Maintenance Phase|Lack of Efficacy|1|||
144564468|NCT00505414|521267722|FG003|Maintenance Phase|Lack of Efficacy|0|||
144564469|NCT00505414|521267723|FG004|Maintenance Phase|Lack of Efficacy|0|||
144564470|NCT00505414|521267719|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144564471|NCT00505414|521267720|FG001|Maintenance Phase|Withdrawal by Subject|0|||
144564472|NCT00505414|521267721|FG002|Maintenance Phase|Withdrawal by Subject|1|||
144564473|NCT00505414|521267722|FG003|Maintenance Phase|Withdrawal by Subject|0|||
144564474|NCT00505414|521267723|FG004|Maintenance Phase|Withdrawal by Subject|0|||
144618333|NCT04489888|521461268|FG000|Overall Study|Sponsor Decision|26|||
144564475|NCT00505414|521267719|FG000|Maintenance Phase|underlying disease and therapy required|0|||
144564476|NCT00505414|521267720|FG001|Maintenance Phase|underlying disease and therapy required|2|||
144564477|NCT00505414|521267721|FG002|Maintenance Phase|underlying disease and therapy required|2|||
144564478|NCT00505414|521267722|FG003|Maintenance Phase|underlying disease and therapy required|0|||
144564479|NCT00505414|521267723|FG004|Maintenance Phase|underlying disease and therapy required|0|||
144564480|NCT00846768|521267724|FG000|Overall Study|Adverse Event|0|||
144564481|NCT00846768|521267725|FG001|Overall Study|Adverse Event|1|||
144564482|NCT00846768|521267726|FG002|Overall Study|Adverse Event|0|||
144204626|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Other|5|||
144204627|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Other|4|||
144204628|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Other|0|||
144204629|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Other|0|||
144204630|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
144204631|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
144564483|NCT00846768|521267727|FG003|Overall Study|Adverse Event|0|||
144564484|NCT00644878|521267728|FG000|Overall Study|Adverse Event|2|||
144564485|NCT00644878|521267728|FG000|Overall Study|Abnormal laboratory value|3|||
144564486|NCT00644878|521267728|FG000|Overall Study|Protocol deviation|2|||
144564487|NCT00644878|521267728|FG000|Overall Study|Treatment duration completed as per protocol|11|||
144564488|NCT04358068|521267729|FG000|Overall Study|Did not initiate study treatment|2|||
144564489|NCT04358068|521267730|FG001|Overall Study|Did not initiate study treatment|2|||
144564490|NCT04353817|521267731|FG000|Overall Study|Adverse Event|0|||
144564491|NCT04353817|521267732|FG001|Overall Study|Adverse Event|1|||
144564492|NCT00770588|521267733|FG000|Overall Study|Adverse Event|9|||
144564493|NCT00770588|521267734|FG001|Overall Study|Adverse Event|2|||
144564494|NCT00770588|521267733|FG000|Overall Study|Death caused by progression of disease|70|||
144564495|NCT00770588|521267734|FG001|Overall Study|Death caused by progression of disease|91|||
144564496|NCT00770588|521267733|FG000|Overall Study|Lost to Follow-up|1|||
144564497|NCT00770588|521267734|FG001|Overall Study|Lost to Follow-up|1|||
144564498|NCT00770588|521267733|FG000|Overall Study|Withdrawal by Subject|1|||
144564499|NCT00770588|521267734|FG001|Overall Study|Withdrawal by Subject|1|||
144564500|NCT00338949|521267735|FG000|Subject Screening|Screen failures|11|||
144564501|NCT00338949|521267736|FG001|Subject Screening|Screen failures|11|||
144564502|NCT00338949|521267735|FG000|Randomization|Withdrawal by Subject|1|||
144564503|NCT00338949|521267736|FG001|Randomization|Withdrawal by Subject|0|||
144564504|NCT00338949|521267735|FG000|Randomization|Adverse Event|0|||
144564505|NCT00338949|521267736|FG001|Randomization|Adverse Event|5|||
144564506|NCT01841112|521267738|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
144564507|NCT01841112|521267739|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
144564508|NCT01841112|521267740|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
144564509|NCT01841112|521267741|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
144564510|NCT01841112|521267742|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
144564511|NCT02143063|521267743|FG000|Overall Study|Lost to Follow-up|16|||
144564512|NCT02143063|521267744|FG001|Overall Study|Lost to Follow-up|28|||
144564513|NCT02143063|521267745|FG002|Overall Study|Lost to Follow-up|29|||
144564514|NCT02143063|521267743|FG000|Overall Study|Withdrawal by Subject|0|||
144564515|NCT02143063|521267744|FG001|Overall Study|Withdrawal by Subject|1|||
144564516|NCT02143063|521267745|FG002|Overall Study|Withdrawal by Subject|0|||
144564517|NCT02143063|521267743|FG000|Overall Study|Death|0|||
144564518|NCT02143063|521267744|FG001|Overall Study|Death|1|||
144564519|NCT02143063|521267745|FG002|Overall Study|Death|1|||
144564520|NCT00878553|521267746|FG000|Sleep Study|Withdrawal by Subject|2|||
144564521|NCT00878553|521267747|FG001|Sleep Study|Withdrawal by Subject|0|||
144564522|NCT00878553|521267748|FG002|Sleep Study|Withdrawal by Subject|0|||
144564523|NCT00878553|521267749|FG003|Sleep Study|Withdrawal by Subject|0|||
144564524|NCT00878553|521267750|FG004|Sleep Study|Withdrawal by Subject|0|||
144564525|NCT00878553|521267746|FG000|Sleep Study|Lost to Follow-up|1|||
144564526|NCT00878553|521267747|FG001|Sleep Study|Lost to Follow-up|0|||
144564527|NCT00878553|521267748|FG002|Sleep Study|Lost to Follow-up|0|||
144564528|NCT00878553|521267749|FG003|Sleep Study|Lost to Follow-up|0|||
144564529|NCT00878553|521267750|FG004|Sleep Study|Lost to Follow-up|0|||
144564530|NCT00878553|521267746|FG000|Sleep Study|car accident|1|||
144564531|NCT00878553|521267747|FG001|Sleep Study|car accident|0|||
144564532|NCT00878553|521267748|FG002|Sleep Study|car accident|0|||
144564533|NCT00878553|521267749|FG003|Sleep Study|car accident|0|||
144564534|NCT00878553|521267750|FG004|Sleep Study|car accident|0|||
144564535|NCT00878553|521267746|FG000|Sleep Study|family emergency|1|||
144618334|NCT02043548|521461271|FG000|Overall Study|Lack of Efficacy|1|||
144618335|NCT02043548|521461272|FG001|Overall Study|Lack of Efficacy|0|||
144618336|NCT02043548|521461271|FG000|Overall Study|Adverse Event|0|||
144204632|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
144262598|NCT00379899|520161493|FG000|Overall Study|Other protocol-specified criteria|3|||
144618337|NCT02043548|521461272|FG001|Overall Study|Adverse Event|1|||
144564536|NCT00878553|521267747|FG001|Sleep Study|family emergency|0|||
144564537|NCT00878553|521267748|FG002|Sleep Study|family emergency|0|||
144564538|NCT00878553|521267749|FG003|Sleep Study|family emergency|0|||
144564539|NCT00878553|521267750|FG004|Sleep Study|family emergency|0|||
144564540|NCT00878553|521267746|FG000|PK Study|Withdrawal by Subject|0|||
144564541|NCT00878553|521267747|FG001|PK Study|Withdrawal by Subject|0|||
144564542|NCT00878553|521267748|FG002|PK Study|Withdrawal by Subject|0|||
144564543|NCT00878553|521267749|FG003|PK Study|Withdrawal by Subject|1|||
144564544|NCT00878553|521267750|FG004|PK Study|Withdrawal by Subject|0|||
144564545|NCT00912223|521267751|FG000|Overall Study|Withdrawal by Subject|1|||
144564546|NCT00912223|521267751|FG000|Overall Study|Not transplanted|1|||
144564547|NCT00912223|521267751|FG000|Overall Study|Transformed disease|1|||
144564548|NCT00461123|521267752|FG000|Overall Study|Adverse Event|1|||
144564549|NCT00461123|521267753|FG001|Overall Study|Adverse Event|0|||
144564550|NCT00461123|521267752|FG000|Overall Study|Lost to Follow-up|1|||
144564551|NCT00461123|521267753|FG001|Overall Study|Lost to Follow-up|1|||
144564552|NCT00461123|521267752|FG000|Overall Study|Protocol Violation|3|||
144564553|NCT00461123|521267753|FG001|Overall Study|Protocol Violation|2|||
144564554|NCT00461123|521267752|FG000|Overall Study|Withdrawal by Subject|1|||
144564555|NCT00461123|521267753|FG001|Overall Study|Withdrawal by Subject|3|||
144564556|NCT02604342|521267754|FG000|Overall Study|Death|32|||
144564557|NCT02604342|521267755|FG001|Overall Study|Death|16|||
144564558|NCT02604342|521267754|FG000|Overall Study|Progression of disease|1|||
144564559|NCT02604342|521267755|FG001|Overall Study|Progression of disease|0|||
144564560|NCT02604342|521267754|FG000|Overall Study|Withdrawal by Subject|5|||
144564561|NCT02604342|521267755|FG001|Overall Study|Withdrawal by Subject|6|||
144564562|NCT02604342|521267754|FG000|Overall Study|Other|1|||
144564563|NCT02604342|521267755|FG001|Overall Study|Other|0|||
144564564|NCT02604342|521267754|FG000|Overall Study|Study Termination by Sponsor|1|||
144564565|NCT02604342|521267755|FG001|Overall Study|Study Termination by Sponsor|0|||
144564566|NCT02604342|521267754|FG000|Overall Study|Lost to Follow-up|1|||
144564567|NCT02604342|521267755|FG001|Overall Study|Lost to Follow-up|1|||
144564568|NCT02604342|521267754|FG000|Overall Study|Physician Decision|2|||
144564569|NCT02604342|521267755|FG001|Overall Study|Physician Decision|0|||
144564570|NCT02024750|521267756|FG000|Overall Study|Withdrawal by Subject|2|||
144564571|NCT02024750|521267757|FG001|Overall Study|Withdrawal by Subject|1|||
144564572|NCT02261285|521267758|FG000|Overall Study|Disease progression|0|||
144564573|NCT02261285|521267759|FG001|Overall Study|Disease progression|0|||
144564574|NCT02261285|521267760|FG002|Overall Study|Disease progression|1|||
144564575|NCT01702519|521267761|FG000|Washout Period|Lost to Follow-up|1|||
144564576|NCT01702519|521267762|FG001|Washout Period|Lost to Follow-up|0|||
144564577|NCT01702519|521267761|FG000|Washout Period|Withdrawal by Subject|0|||
144564578|NCT01702519|521267762|FG001|Washout Period|Withdrawal by Subject|2|||
144564579|NCT00746356|521267769|FG000|Overall Study|Withdrawal by Subject|2|||
144564580|NCT00746356|521267770|FG001|Overall Study|Withdrawal by Subject|3|||
144564581|NCT00746356|521267769|FG000|Overall Study|Death|7|||
144564582|NCT00746356|521267770|FG001|Overall Study|Death|3|||
144564583|NCT00746356|521267769|FG000|Overall Study|Lost to Follow-up|1|||
144564584|NCT00746356|521267770|FG001|Overall Study|Lost to Follow-up|0|||
144564585|NCT00746356|521267769|FG000|Overall Study|Removal of Device|0|||
144564586|NCT00746356|521267770|FG001|Overall Study|Removal of Device|1|||
144564587|NCT00746356|521267769|FG000|Overall Study|Patient relocated|1|||
144564588|NCT00746356|521267770|FG001|Overall Study|Patient relocated|0|||
144564589|NCT01263925|521267771|FG000|Overall Study|Protocol Violation|1|||
144564590|NCT01263925|521267772|FG001|Overall Study|Protocol Violation|0|||
144564591|NCT01263925|521267771|FG000|Overall Study|Lack of Efficacy|0|||
144564592|NCT01263925|521267772|FG001|Overall Study|Lack of Efficacy|1|||
144564593|NCT01263925|521267771|FG000|Overall Study|Adverse Event|23|||
144564594|NCT01263925|521267772|FG001|Overall Study|Adverse Event|22|||
144564595|NCT01263925|521267771|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
144564596|NCT01263925|521267772|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
144564597|NCT01263925|521267771|FG000|Overall Study|Withdrawal by Subject|6|||
144564598|NCT01263925|521267772|FG001|Overall Study|Withdrawal by Subject|8|||
144564599|NCT01263925|521267771|FG000|Overall Study|Other|4|||
144564600|NCT01263925|521267772|FG001|Overall Study|Other|4|||
144564601|NCT01263925|521267771|FG000|Overall Study|Lost to Follow-up|3|||
144564602|NCT01263925|521267772|FG001|Overall Study|Lost to Follow-up|1|||
144564603|NCT01263925|521267771|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
144564604|NCT01263925|521267772|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
144564605|NCT01263925|521267771|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
144564606|NCT01263925|521267772|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
144564607|NCT01263925|521267771|FG000|Overall Study|AE/ Withdrawal|1|||
144564608|NCT01263925|521267772|FG001|Overall Study|AE/ Withdrawal|4|||
144564609|NCT01263925|521267771|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
144618338|NCT01430455|521461279|FG000|Overall Study|Withdrawal by Subject|1|||
144262599|NCT00379899|520161494|FG001|Overall Study|Other protocol-specified criteria|4|||
144262600|NCT00379899|520161493|FG000|Overall Study|Other|3|||
144262601|NCT00379899|520161494|FG001|Overall Study|Other|1|||
144262602|NCT01922258|520161495|FG000|Overall Study|Lost to Follow-up|1|||
144564610|NCT01263925|521267772|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
144564611|NCT01263925|521267771|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
144564612|NCT01263925|521267772|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
144564613|NCT01263925|521267771|FG000|Overall Study|Withdrawal/ Not specified|0|||
144564614|NCT01263925|521267772|FG001|Overall Study|Withdrawal/ Not specified|1|||
144564615|NCT02484547|521267773|FG000|Placebo-Controlled Period|Adverse Event|10|||
144564616|NCT02484547|521267774|FG001|Placebo-Controlled Period|Adverse Event|13|||
144564617|NCT02484547|521267775|FG002|Placebo-Controlled Period|Adverse Event|20|||
144564618|NCT02484547|521267776|FG003|Placebo-Controlled Period|Adverse Event|0|||
144564619|NCT02484547|521267777|FG004|Placebo-Controlled Period|Adverse Event|0|||
144564620|NCT02484547|521267778|FG005|Placebo-Controlled Period|Adverse Event|0|||
144564621|NCT02484547|521267779|FG006|Placebo-Controlled Period|Adverse Event|0|||
144564622|NCT02484547|521267773|FG000|Placebo-Controlled Period|Change of Treatment|0|||
144564623|NCT02484547|521267774|FG001|Placebo-Controlled Period|Change of Treatment|0|||
144564624|NCT02484547|521267775|FG002|Placebo-Controlled Period|Change of Treatment|1|||
144564625|NCT02484547|521267776|FG003|Placebo-Controlled Period|Change of Treatment|0|||
144564626|NCT02484547|521267777|FG004|Placebo-Controlled Period|Change of Treatment|0|||
144564627|NCT02484547|521267778|FG005|Placebo-Controlled Period|Change of Treatment|0|||
144564628|NCT02484547|521267779|FG006|Placebo-Controlled Period|Change of Treatment|0|||
144564629|NCT02484547|521267773|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
144564630|NCT02484547|521267774|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
144564631|NCT02484547|521267775|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
144564632|NCT02484547|521267776|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
144564633|NCT02484547|521267777|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
144564634|NCT02484547|521267778|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
144564635|NCT02484547|521267779|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
144564636|NCT02484547|521267773|FG000|Placebo-Controlled Period|Death|5|||
144564637|NCT02484547|521267774|FG001|Placebo-Controlled Period|Death|0|||
144564638|NCT02484547|521267775|FG002|Placebo-Controlled Period|Death|6|||
144564639|NCT02484547|521267776|FG003|Placebo-Controlled Period|Death|0|||
144564640|NCT02484547|521267777|FG004|Placebo-Controlled Period|Death|0|||
144564641|NCT02484547|521267778|FG005|Placebo-Controlled Period|Death|0|||
144564642|NCT02484547|521267779|FG006|Placebo-Controlled Period|Death|0|||
144564643|NCT02484547|521267773|FG000|Placebo-Controlled Period|Disease Progression|2|||
144564644|NCT02484547|521267774|FG001|Placebo-Controlled Period|Disease Progression|0|||
144564645|NCT02484547|521267775|FG002|Placebo-Controlled Period|Disease Progression|1|||
144564646|NCT02484547|521267776|FG003|Placebo-Controlled Period|Disease Progression|0|||
144564647|NCT02484547|521267777|FG004|Placebo-Controlled Period|Disease Progression|0|||
144564648|NCT02484547|521267778|FG005|Placebo-Controlled Period|Disease Progression|0|||
144564649|NCT02484547|521267779|FG006|Placebo-Controlled Period|Disease Progression|0|||
144564650|NCT02484547|521267773|FG000|Placebo-Controlled Period|Investigator Decision|2|||
144564651|NCT02484547|521267774|FG001|Placebo-Controlled Period|Investigator Decision|2|||
144564652|NCT02484547|521267775|FG002|Placebo-Controlled Period|Investigator Decision|5|||
144564653|NCT02484547|521267776|FG003|Placebo-Controlled Period|Investigator Decision|0|||
144564654|NCT02484547|521267777|FG004|Placebo-Controlled Period|Investigator Decision|0|||
144564655|NCT02484547|521267778|FG005|Placebo-Controlled Period|Investigator Decision|0|||
144564656|NCT02484547|521267779|FG006|Placebo-Controlled Period|Investigator Decision|0|||
144564657|NCT02484547|521267773|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
144564658|NCT02484547|521267774|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
144564659|NCT02484547|521267775|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
144564660|NCT02484547|521267776|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
144564661|NCT02484547|521267777|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
144564662|NCT02484547|521267778|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
144564663|NCT02484547|521267779|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
144564664|NCT02484547|521267773|FG000|Placebo-Controlled Period|Relocation|1|||
144564665|NCT02484547|521267774|FG001|Placebo-Controlled Period|Relocation|1|||
144564666|NCT02484547|521267775|FG002|Placebo-Controlled Period|Relocation|1|||
144564667|NCT02484547|521267776|FG003|Placebo-Controlled Period|Relocation|0|||
144564668|NCT02484547|521267777|FG004|Placebo-Controlled Period|Relocation|0|||
144564669|NCT02484547|521267778|FG005|Placebo-Controlled Period|Relocation|0|||
144564670|NCT02484547|521267779|FG006|Placebo-Controlled Period|Relocation|0|||
144564671|NCT02484547|521267773|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
144204633|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
144204634|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
144564672|NCT02484547|521267774|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
144564673|NCT02484547|521267775|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
144564674|NCT02484547|521267776|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
144564675|NCT02484547|521267777|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
144564676|NCT02484547|521267778|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
144564677|NCT02484547|521267779|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
144204635|NCT01081834|519944457|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144204636|NCT01081834|519944458|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
144204637|NCT01081834|519944459|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144204638|NCT01081834|519944460|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144564678|NCT02484547|521267773|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
144564679|NCT02484547|521267774|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
144564680|NCT02484547|521267775|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
144564681|NCT02484547|521267776|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144564682|NCT02484547|521267777|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144564683|NCT02484547|521267778|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144564684|NCT02484547|521267779|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144564685|NCT02484547|521267773|FG000|Placebo-Controlled Period|Reason not Specified|216|||
144564686|NCT02484547|521267774|FG001|Placebo-Controlled Period|Reason not Specified|194|||
144564687|NCT02484547|521267775|FG002|Placebo-Controlled Period|Reason not Specified|183|||
144564688|NCT02484547|521267776|FG003|Placebo-Controlled Period|Reason not Specified|0|||
144564689|NCT02484547|521267777|FG004|Placebo-Controlled Period|Reason not Specified|0|||
144564690|NCT02484547|521267778|FG005|Placebo-Controlled Period|Reason not Specified|0|||
144564691|NCT02484547|521267779|FG006|Placebo-Controlled Period|Reason not Specified|0|||
144564692|NCT02484547|521267773|FG000|Long-Term Extension Period|Adverse Event|0|||
144564693|NCT02484547|521267774|FG001|Long-Term Extension Period|Adverse Event|0|||
144564694|NCT02484547|521267775|FG002|Long-Term Extension Period|Adverse Event|0|||
144564695|NCT02484547|521267776|FG003|Long-Term Extension Period|Adverse Event|0|||
144564696|NCT02484547|521267777|FG004|Long-Term Extension Period|Adverse Event|1|||
144564697|NCT02484547|521267778|FG005|Long-Term Extension Period|Adverse Event|3|||
144564698|NCT02484547|521267779|FG006|Long-Term Extension Period|Adverse Event|2|||
144564699|NCT02484547|521267773|FG000|Long-Term Extension Period|Death|0|||
144564700|NCT02484547|521267774|FG001|Long-Term Extension Period|Death|0|||
144564701|NCT02484547|521267775|FG002|Long-Term Extension Period|Death|0|||
144564702|NCT02484547|521267776|FG003|Long-Term Extension Period|Death|0|||
144564703|NCT02484547|521267777|FG004|Long-Term Extension Period|Death|0|||
144564704|NCT02484547|521267778|FG005|Long-Term Extension Period|Death|3|||
144564705|NCT02484547|521267779|FG006|Long-Term Extension Period|Death|0|||
144564706|NCT02484547|521267773|FG000|Long-Term Extension Period|Disease Progression|0|||
144564707|NCT02484547|521267774|FG001|Long-Term Extension Period|Disease Progression|0|||
144564708|NCT02484547|521267775|FG002|Long-Term Extension Period|Disease Progression|0|||
144564709|NCT02484547|521267776|FG003|Long-Term Extension Period|Disease Progression|0|||
144564710|NCT02484547|521267777|FG004|Long-Term Extension Period|Disease Progression|2|||
144564711|NCT02484547|521267778|FG005|Long-Term Extension Period|Disease Progression|4|||
144564712|NCT02484547|521267779|FG006|Long-Term Extension Period|Disease Progression|0|||
144564713|NCT02484547|521267773|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
144564714|NCT02484547|521267774|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
144564715|NCT02484547|521267775|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
144564716|NCT02484547|521267776|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
144564717|NCT02484547|521267777|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
144564718|NCT02484547|521267778|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
144564719|NCT02484547|521267779|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
144564720|NCT02484547|521267773|FG000|Long-Term Extension Period|Loss of Capacity|0|||
144564721|NCT02484547|521267774|FG001|Long-Term Extension Period|Loss of Capacity|0|||
144564722|NCT02484547|521267775|FG002|Long-Term Extension Period|Loss of Capacity|0|||
144564723|NCT02484547|521267776|FG003|Long-Term Extension Period|Loss of Capacity|0|||
144564724|NCT02484547|521267777|FG004|Long-Term Extension Period|Loss of Capacity|1|||
144564725|NCT02484547|521267778|FG005|Long-Term Extension Period|Loss of Capacity|0|||
144564726|NCT02484547|521267779|FG006|Long-Term Extension Period|Loss of Capacity|0|||
144564727|NCT02484547|521267773|FG000|Long-Term Extension Period|Change of Treatment|0|||
144564728|NCT02484547|521267774|FG001|Long-Term Extension Period|Change of Treatment|0|||
144564729|NCT02484547|521267775|FG002|Long-Term Extension Period|Change of Treatment|0|||
144564730|NCT02484547|521267776|FG003|Long-Term Extension Period|Change of Treatment|0|||
144564731|NCT02484547|521267777|FG004|Long-Term Extension Period|Change of Treatment|0|||
144564732|NCT02484547|521267778|FG005|Long-Term Extension Period|Change of Treatment|0|||
144564733|NCT02484547|521267779|FG006|Long-Term Extension Period|Change of Treatment|1|||
144564734|NCT02484547|521267773|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
144564735|NCT02484547|521267774|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
144564736|NCT02484547|521267775|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
144564737|NCT02484547|521267776|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
144564738|NCT02484547|521267777|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
144564739|NCT02484547|521267778|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
144564740|NCT02484547|521267779|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
144564741|NCT02484547|521267773|FG000|Long-Term Extension Period|Investigator Decision|0|||
144564742|NCT02484547|521267774|FG001|Long-Term Extension Period|Investigator Decision|0|||
144564743|NCT02484547|521267775|FG002|Long-Term Extension Period|Investigator Decision|0|||
144564744|NCT02484547|521267776|FG003|Long-Term Extension Period|Investigator Decision|2|||
144564745|NCT02484547|521267777|FG004|Long-Term Extension Period|Investigator Decision|1|||
144564746|NCT02484547|521267778|FG005|Long-Term Extension Period|Investigator Decision|0|||
144564747|NCT02484547|521267779|FG006|Long-Term Extension Period|Investigator Decision|1|||
144564748|NCT02484547|521267773|FG000|Long-Term Extension Period|Relocation|0|||
144564749|NCT02484547|521267774|FG001|Long-Term Extension Period|Relocation|0|||
144564750|NCT02484547|521267775|FG002|Long-Term Extension Period|Relocation|0|||
144564751|NCT02484547|521267776|FG003|Long-Term Extension Period|Relocation|1|||
144564752|NCT02484547|521267777|FG004|Long-Term Extension Period|Relocation|1|||
144564753|NCT02484547|521267778|FG005|Long-Term Extension Period|Relocation|0|||
144564754|NCT02484547|521267779|FG006|Long-Term Extension Period|Relocation|0|||
144564755|NCT02484547|521267773|FG000|Long-Term Extension Period|Study Visit Burden|0|||
144564756|NCT02484547|521267774|FG001|Long-Term Extension Period|Study Visit Burden|0|||
144204639|NCT01081834|519944461|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144204640|NCT01475097|519944476|FG000|Overall Study|Protocol Violation|1|||
144204641|NCT01475097|519944477|FG001|Overall Study|Protocol Violation|1|||
144204642|NCT00936897|519944486|FG000|Overall Study|Withdrawal by Subject|9|||
144564757|NCT02484547|521267775|FG002|Long-Term Extension Period|Study Visit Burden|0|||
144564758|NCT02484547|521267776|FG003|Long-Term Extension Period|Study Visit Burden|2|||
144564759|NCT02484547|521267777|FG004|Long-Term Extension Period|Study Visit Burden|0|||
144564760|NCT02484547|521267778|FG005|Long-Term Extension Period|Study Visit Burden|0|||
144564761|NCT02484547|521267779|FG006|Long-Term Extension Period|Study Visit Burden|3|||
144564762|NCT02484547|521267773|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
144564763|NCT02484547|521267774|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
144564764|NCT02484547|521267775|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
144564765|NCT02484547|521267776|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
144564766|NCT02484547|521267777|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
144564767|NCT02484547|521267778|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
144564768|NCT02484547|521267779|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
144564769|NCT02484547|521267773|FG000|Long-Term Extension Period|Reason not Specified|0|||
144564770|NCT02484547|521267774|FG001|Long-Term Extension Period|Reason not Specified|0|||
144564771|NCT02484547|521267775|FG002|Long-Term Extension Period|Reason not Specified|0|||
144564772|NCT02484547|521267776|FG003|Long-Term Extension Period|Reason not Specified|119|||
144564773|NCT02484547|521267777|FG004|Long-Term Extension Period|Reason not Specified|117|||
144564774|NCT02484547|521267778|FG005|Long-Term Extension Period|Reason not Specified|223|||
144564775|NCT02484547|521267779|FG006|Long-Term Extension Period|Reason not Specified|231|||
144564776|NCT01665599|521267780|FG000|Overall Study|Adverse Event|1|||
144564777|NCT01665599|521267780|FG000|Overall Study|Consent Withdrawn|1|||
144564778|NCT01665599|521267780|FG000|Overall Study|Investigator/Sponsor decision|1|||
144564779|NCT01665599|521267780|FG000|Overall Study|Death|1|||
144564780|NCT01665599|521267780|FG000|Overall Study|Lost to Follow-up|2|||
144564781|NCT01665599|521267780|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
144564782|NCT01665599|521267780|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
144564783|NCT01225159|521267781|FG000|Overall Study|Change operation|1|||
144564784|NCT01225159|521267782|FG001|Overall Study|Change operation|0|||
144564785|NCT01077622|521267783|FG000|Overall Study|Physician Decision|2|||
144564786|NCT01077622|521267783|FG000|Overall Study|Withdrawal by Subject|1|||
144564787|NCT00496834|521267784|FG000|Overall Study|Withdrawal by Subject|4|||
144564788|NCT00496834|521267785|FG001|Overall Study|Withdrawal by Subject|6|||
144564789|NCT00496834|521267784|FG000|Overall Study|Contraindicated medication administered|0|||
144564790|NCT00496834|521267785|FG001|Overall Study|Contraindicated medication administered|1|||
144564791|NCT00496834|521267784|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
144564792|NCT00496834|521267785|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
144564793|NCT00496834|521267784|FG000|Overall Study|Adverse Event|5|||
144564794|NCT00496834|521267785|FG001|Overall Study|Adverse Event|3|||
144564795|NCT00496834|521267784|FG000|Overall Study|IP administration violation|2|||
144564796|NCT00496834|521267785|FG001|Overall Study|IP administration violation|0|||
144564797|NCT00496834|521267784|FG000|Overall Study|Lost to Follow-up|2|||
144564798|NCT00496834|521267785|FG001|Overall Study|Lost to Follow-up|0|||
144564799|NCT00496834|521267784|FG000|Overall Study|Blood Pressure control failure|2|||
144564800|NCT00496834|521267785|FG001|Overall Study|Blood Pressure control failure|1|||
144564801|NCT04088136|521267788|FG000|Overall Study|Withdrawal by Subject|5|||
144564802|NCT04088136|521267789|FG001|Overall Study|Withdrawal by Subject|0|||
144564803|NCT04088136|521267788|FG000|Overall Study|Lack of Efficacy|0|||
144564804|NCT04088136|521267789|FG001|Overall Study|Lack of Efficacy|1|||
144564805|NCT01177228|521267790|FG000|Overall Study|Positive tuberculosis test|0|||
144564806|NCT01177228|521267791|FG001|Overall Study|Positive tuberculosis test|1|||
144564807|NCT01177228|521267792|FG002|Overall Study|Positive tuberculosis test|0|||
144564808|NCT01177228|521267793|FG003|Overall Study|Positive tuberculosis test|0|||
144564809|NCT01177228|521267790|FG000|Overall Study|Worsening disease activity|1|||
144564810|NCT01177228|521267791|FG001|Overall Study|Worsening disease activity|0|||
144564811|NCT01177228|521267792|FG002|Overall Study|Worsening disease activity|0|||
144564812|NCT01177228|521267793|FG003|Overall Study|Worsening disease activity|0|||
144564813|NCT01177228|521267790|FG000|Overall Study|Withdrawal by Subject|0|||
144564814|NCT01177228|521267791|FG001|Overall Study|Withdrawal by Subject|1|||
144564815|NCT01177228|521267792|FG002|Overall Study|Withdrawal by Subject|0|||
144564816|NCT01177228|521267793|FG003|Overall Study|Withdrawal by Subject|0|||
144564817|NCT00356759|521267794|FG000|Overall Study|Death|5|||
144564818|NCT00356759|521267795|FG001|Overall Study|Death|2|||
144564819|NCT00356759|521267794|FG000|Overall Study|Withdrawal by Subject|2|||
144564820|NCT00356759|521267795|FG001|Overall Study|Withdrawal by Subject|2|||
144564821|NCT00356759|521267794|FG000|Overall Study|Adverse Event|1|||
144564822|NCT00356759|521267795|FG001|Overall Study|Adverse Event|3|||
144564823|NCT00356759|521267794|FG000|Overall Study|Lost to Follow-up|1|||
144564824|NCT00356759|521267795|FG001|Overall Study|Lost to Follow-up|1|||
144204643|NCT00936897|519944487|FG001|Overall Study|Withdrawal by Subject|19|||
144564825|NCT00356759|521267794|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
144262603|NCT01922258|520161496|FG001|Overall Study|Lost to Follow-up|1|||
144564826|NCT00356759|521267795|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
144564827|NCT01494298|521267796|FG000|Overall Study|Protocol Violation|2|||
144564828|NCT01494298|521267797|FG001|Overall Study|Protocol Violation|8|||
144564829|NCT04159805|521267798|FG000|Overall Study|Withdrawal by Subject|0|||
144564830|NCT04159805|521267799|FG001|Overall Study|Withdrawal by Subject|2|||
144564831|NCT04159805|521267800|FG002|Overall Study|Withdrawal by Subject|2|||
144564832|NCT01393613|521267801|FG000|Overall Study|Adverse Event|11|||
144564833|NCT01393613|521267802|FG001|Overall Study|Adverse Event|11|||
144564834|NCT01393613|521267803|FG002|Overall Study|Adverse Event|13|||
144564835|NCT01393613|521267804|FG003|Overall Study|Adverse Event|22|||
144564836|NCT01393613|521267801|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
144564837|NCT01393613|521267802|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
144564838|NCT01393613|521267803|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
144564839|NCT01393613|521267804|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
144564840|NCT01393613|521267801|FG000|Overall Study|Physician Decision|2|||
144564841|NCT01393613|521267802|FG001|Overall Study|Physician Decision|0|||
144564842|NCT01393613|521267803|FG002|Overall Study|Physician Decision|0|||
144564843|NCT01393613|521267804|FG003|Overall Study|Physician Decision|1|||
144564844|NCT01393613|521267801|FG000|Overall Study|Withdrawal by Subject|15|||
144564845|NCT01393613|521267802|FG001|Overall Study|Withdrawal by Subject|25|||
144564846|NCT01393613|521267803|FG002|Overall Study|Withdrawal by Subject|23|||
144564847|NCT01393613|521267804|FG003|Overall Study|Withdrawal by Subject|21|||
144564848|NCT01393613|521267801|FG000|Overall Study|Protocol Deviation|2|||
144564849|NCT01393613|521267802|FG001|Overall Study|Protocol Deviation|1|||
144564850|NCT01393613|521267803|FG002|Overall Study|Protocol Deviation|0|||
144564851|NCT01393613|521267804|FG003|Overall Study|Protocol Deviation|0|||
144564852|NCT01393613|521267801|FG000|Overall Study|Lack of Efficacy|9|||
144564853|NCT01393613|521267802|FG001|Overall Study|Lack of Efficacy|20|||
144564854|NCT01393613|521267803|FG002|Overall Study|Lack of Efficacy|16|||
144564855|NCT01393613|521267804|FG003|Overall Study|Lack of Efficacy|21|||
144564856|NCT03821064|521267805|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
144564857|NCT02998918|521267809|FG000|Overall Study|Withdrawal by Subject|1|||
144564858|NCT02998918|521267810|FG001|Overall Study|Withdrawal by Subject|0|||
144564859|NCT00702520|521267813|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
144564860|NCT00702520|521267814|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
144564861|NCT00702520|521267815|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
144564862|NCT00702520|521267816|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
144564863|NCT00702520|521267813|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
144564864|NCT00702520|521267814|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
144564865|NCT00702520|521267815|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
144564866|NCT00702520|521267816|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
144564867|NCT00702520|521267813|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
144564868|NCT00702520|521267814|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
144564869|NCT00702520|521267815|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
144564870|NCT00702520|521267816|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
144564871|NCT00942188|521267817|FG000|Overall Study|Adverse Event|0|||
144564872|NCT00942188|521267818|FG001|Overall Study|Adverse Event|3|||
144564873|NCT00942188|521267819|FG002|Overall Study|Adverse Event|2|||
144564874|NCT00942188|521267820|FG003|Overall Study|Adverse Event|0|||
144564875|NCT00942188|521267817|FG000|Overall Study|Lack of Efficacy|0|||
144564876|NCT00942188|521267818|FG001|Overall Study|Lack of Efficacy|0|||
144564877|NCT00942188|521267819|FG002|Overall Study|Lack of Efficacy|0|||
144564878|NCT00942188|521267820|FG003|Overall Study|Lack of Efficacy|1|||
144564879|NCT00942188|521267817|FG000|Overall Study|Protocol Violation|1|||
144564880|NCT00942188|521267818|FG001|Overall Study|Protocol Violation|1|||
144564881|NCT00942188|521267819|FG002|Overall Study|Protocol Violation|0|||
144564882|NCT00942188|521267820|FG003|Overall Study|Protocol Violation|0|||
144564883|NCT00942188|521267817|FG000|Overall Study|Lost to Follow-up|2|||
144564884|NCT00942188|521267818|FG001|Overall Study|Lost to Follow-up|1|||
144564885|NCT00942188|521267819|FG002|Overall Study|Lost to Follow-up|2|||
144564886|NCT00942188|521267820|FG003|Overall Study|Lost to Follow-up|0|||
144564887|NCT00942188|521267817|FG000|Overall Study|Withdrawal by Subject|1|||
144564888|NCT00942188|521267818|FG001|Overall Study|Withdrawal by Subject|3|||
144564889|NCT00942188|521267819|FG002|Overall Study|Withdrawal by Subject|4|||
144564890|NCT00942188|521267820|FG003|Overall Study|Withdrawal by Subject|2|||
144262604|NCT01922258|520161495|FG000|Overall Study|Adverse Event|9|||
144564891|NCT00942188|521267817|FG000|Overall Study|Physician Decision|0|||
144564892|NCT00942188|521267818|FG001|Overall Study|Physician Decision|0|||
144564893|NCT00942188|521267819|FG002|Overall Study|Physician Decision|1|||
144564894|NCT00942188|521267820|FG003|Overall Study|Physician Decision|0|||
144564895|NCT00942188|521267817|FG000|Overall Study|Sponsor Decision|0|||
144564896|NCT00942188|521267818|FG001|Overall Study|Sponsor Decision|2|||
144564897|NCT00942188|521267819|FG002|Overall Study|Sponsor Decision|0|||
144564898|NCT00942188|521267820|FG003|Overall Study|Sponsor Decision|1|||
144564899|NCT02473913|521267822|FG000|Overall Study|Lost to Follow-up|3|||
144564900|NCT02473913|521267823|FG001|Overall Study|Lost to Follow-up|3|||
144564901|NCT03614676|521269559|FG000|Overall Study|Delivery before planned visit|2|||
144564902|NCT03614676|521269560|FG001|Overall Study|Delivery before planned visit|0|||
144564903|NCT03614676|521269559|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
144564904|NCT03614676|521269560|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
144564905|NCT03614676|521269559|FG000|Overall Study|Migrated / moved from the study area|30|||
144564906|NCT03614676|521269560|FG001|Overall Study|Migrated / moved from the study area|22|||
144564907|NCT03614676|521269559|FG000|Overall Study|Lost to Follow-up|17|||
144564908|NCT03614676|521269560|FG001|Overall Study|Lost to Follow-up|42|||
144564909|NCT03614676|521269559|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
144564910|NCT03614676|521269560|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
144564911|NCT03614676|521269559|FG000|Overall Study|Other|16|||
144564912|NCT03614676|521269560|FG001|Overall Study|Other|47|||
144564913|NCT03614676|521269559|FG000|Overall Study|Protocol Violation|0|||
144564914|NCT03614676|521269560|FG001|Overall Study|Protocol Violation|2|||
144564915|NCT03614676|521269559|FG000|Overall Study|Neonatal event of interest|0|||
144564916|NCT03614676|521269560|FG001|Overall Study|Neonatal event of interest|6|||
144564917|NCT03614676|521269559|FG000|Overall Study|Death in infant greater than 28 days old|0|||
144564918|NCT03614676|521269560|FG001|Overall Study|Death in infant greater than 28 days old|12|||
144204644|NCT00936897|519944486|FG000|Overall Study|Adverse Event|4|||
144204645|NCT00936897|519944487|FG001|Overall Study|Adverse Event|13|||
144564919|NCT03614676|521269559|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
144564920|NCT03614676|521269560|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
144564921|NCT02080403|521269561|FG000|Overall Study|Adverse Event|5|||
144564922|NCT02080403|521269562|FG001|Overall Study|Adverse Event|1|||
144564923|NCT02080403|521269561|FG000|Overall Study|Death|0|||
144564924|NCT02080403|521269562|FG001|Overall Study|Death|2|||
144564925|NCT02080403|521269561|FG000|Overall Study|Lost to Follow-up|2|||
144564926|NCT02080403|521269562|FG001|Overall Study|Lost to Follow-up|0|||
144564927|NCT02080403|521269561|FG000|Overall Study|Pregnancy|0|||
144564928|NCT02080403|521269562|FG001|Overall Study|Pregnancy|1|||
144564929|NCT02080403|521269561|FG000|Overall Study|Protocol Violation|3|||
144564930|NCT02080403|521269562|FG001|Overall Study|Protocol Violation|7|||
144564931|NCT02080403|521269561|FG000|Overall Study|Withdrawal by Subject|5|||
144564932|NCT02080403|521269562|FG001|Overall Study|Withdrawal by Subject|1|||
144618339|NCT01430455|521461279|FG000|Overall Study|Switched to follow-up phase|1|||
144618340|NCT03829657|521461283|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
144618341|NCT03829657|521461284|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
144618342|NCT03829657|521461285|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
144618343|NCT03829657|521461286|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
144618344|NCT03829657|521461287|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
144618345|NCT03829657|521461283|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
144618346|NCT03829657|521461284|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144618347|NCT03829657|521461285|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144618348|NCT03829657|521461286|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144618349|NCT03829657|521461287|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
144618350|NCT03829657|521461283|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
144618351|NCT03829657|521461284|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
144618352|NCT03829657|521461285|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
144618353|NCT03829657|521461286|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
144618354|NCT03829657|521461287|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
144618355|NCT03829657|521461283|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
144618356|NCT03829657|521461284|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
144618357|NCT03829657|521461285|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
144618358|NCT03829657|521461286|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
144618359|NCT03829657|521461287|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
144618360|NCT03829657|521461283|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
144618361|NCT03829657|521461284|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
144618362|NCT03829657|521461285|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
144618363|NCT03829657|521461286|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
144618364|NCT03829657|521461287|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
144618365|NCT03829657|521461283|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
144618366|NCT03829657|521461284|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
144564933|NCT01999972|521269563|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
144204646|NCT00936897|519944486|FG000|Overall Study|Other|3|||
144564934|NCT01999972|521269564|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
144564935|NCT01999972|521269565|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
144564936|NCT01999972|521269566|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
144564937|NCT01999972|521269567|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
144564938|NCT01999972|521269568|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
144564939|NCT01999972|521269563|FG000|Dose Escalation Part|Death|0|||
144564940|NCT01999972|521269564|FG001|Dose Escalation Part|Death|1|||
144564941|NCT01999972|521269565|FG002|Dose Escalation Part|Death|0|||
144564942|NCT01999972|521269566|FG003|Dose Escalation Part|Death|0|||
144564943|NCT01999972|521269567|FG004|Dose Escalation Part|Death|0|||
144564944|NCT01999972|521269568|FG005|Dose Escalation Part|Death|0|||
144564945|NCT01999972|521269563|FG000|Dose Escalation Part|Enrolled but not treated|0|||
144564946|NCT01999972|521269564|FG001|Dose Escalation Part|Enrolled but not treated|0|||
144564947|NCT01999972|521269565|FG002|Dose Escalation Part|Enrolled but not treated|1|||
144564948|NCT01999972|521269566|FG003|Dose Escalation Part|Enrolled but not treated|1|||
144564949|NCT01999972|521269567|FG004|Dose Escalation Part|Enrolled but not treated|0|||
144564950|NCT01999972|521269568|FG005|Dose Escalation Part|Enrolled but not treated|0|||
144564951|NCT01999972|521269563|FG000|Dose Escalation Part|Disease progression|3|||
144728393|NCT03952143|521861225|FG002|Treatment Period|Withdrawal by Subject|26|||
144728394|NCT03952143|521861223|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
144564952|NCT01999972|521269564|FG001|Dose Escalation Part|Disease progression|2|||
144564953|NCT01999972|521269565|FG002|Dose Escalation Part|Disease progression|3|||
144564954|NCT01999972|521269566|FG003|Dose Escalation Part|Disease progression|6|||
144564955|NCT01999972|521269567|FG004|Dose Escalation Part|Disease progression|0|||
144564956|NCT01999972|521269568|FG005|Dose Escalation Part|Disease progression|0|||
144564957|NCT01999972|521269563|FG000|Dose Escalation Part|Adverse Event|0|||
144564958|NCT01999972|521269564|FG001|Dose Escalation Part|Adverse Event|0|||
144564959|NCT01999972|521269565|FG002|Dose Escalation Part|Adverse Event|0|||
144564960|NCT01999972|521269566|FG003|Dose Escalation Part|Adverse Event|2|||
144564961|NCT01999972|521269567|FG004|Dose Escalation Part|Adverse Event|0|||
144564962|NCT01999972|521269568|FG005|Dose Escalation Part|Adverse Event|0|||
144564963|NCT01999972|521269563|FG000|Dose Escalation Part|Global deterioration of health status|1|||
144564964|NCT01999972|521269564|FG001|Dose Escalation Part|Global deterioration of health status|0|||
144564965|NCT01999972|521269565|FG002|Dose Escalation Part|Global deterioration of health status|0|||
144564966|NCT01999972|521269566|FG003|Dose Escalation Part|Global deterioration of health status|1|||
144564967|NCT01999972|521269567|FG004|Dose Escalation Part|Global deterioration of health status|0|||
144564968|NCT01999972|521269568|FG005|Dose Escalation Part|Global deterioration of health status|0|||
144564969|NCT01999972|521269563|FG000|Dose Expansion Part|Death|0|||
144564970|NCT01999972|521269564|FG001|Dose Expansion Part|Death|0|||
144564971|NCT01999972|521269565|FG002|Dose Expansion Part|Death|0|||
144564972|NCT01999972|521269566|FG003|Dose Expansion Part|Death|0|||
144564973|NCT01999972|521269567|FG004|Dose Expansion Part|Death|2|||
144564974|NCT01999972|521269568|FG005|Dose Expansion Part|Death|1|||
144564975|NCT01999972|521269563|FG000|Dose Expansion Part|Disease progression|0|||
144564976|NCT01999972|521269564|FG001|Dose Expansion Part|Disease progression|0|||
144564977|NCT01999972|521269565|FG002|Dose Expansion Part|Disease progression|0|||
144564978|NCT01999972|521269566|FG003|Dose Expansion Part|Disease progression|0|||
144564979|NCT01999972|521269567|FG004|Dose Expansion Part|Disease progression|9|||
144564980|NCT01999972|521269568|FG005|Dose Expansion Part|Disease progression|3|||
144564981|NCT01999972|521269563|FG000|Dose Expansion Part|Sponsor decision|0|||
144564982|NCT01999972|521269564|FG001|Dose Expansion Part|Sponsor decision|0|||
144564983|NCT01999972|521269565|FG002|Dose Expansion Part|Sponsor decision|0|||
144564984|NCT01999972|521269566|FG003|Dose Expansion Part|Sponsor decision|0|||
144564985|NCT01999972|521269567|FG004|Dose Expansion Part|Sponsor decision|1|||
144564986|NCT01999972|521269568|FG005|Dose Expansion Part|Sponsor decision|0|||
144564987|NCT01999972|521269563|FG000|Dose Expansion Part|Adverse Event|0|||
144564988|NCT01999972|521269564|FG001|Dose Expansion Part|Adverse Event|0|||
144564989|NCT01999972|521269565|FG002|Dose Expansion Part|Adverse Event|0|||
144564990|NCT01999972|521269566|FG003|Dose Expansion Part|Adverse Event|0|||
144564991|NCT01999972|521269567|FG004|Dose Expansion Part|Adverse Event|4|||
144564992|NCT01999972|521269568|FG005|Dose Expansion Part|Adverse Event|2|||
144564993|NCT01999972|521269563|FG000|Dose Expansion Part|Participant's non-compliance|0|||
144564994|NCT01999972|521269564|FG001|Dose Expansion Part|Participant's non-compliance|0|||
144564995|NCT01999972|521269565|FG002|Dose Expansion Part|Participant's non-compliance|0|||
144564996|NCT01999972|521269566|FG003|Dose Expansion Part|Participant's non-compliance|0|||
144564997|NCT01999972|521269567|FG004|Dose Expansion Part|Participant's non-compliance|0|||
144564998|NCT01999972|521269568|FG005|Dose Expansion Part|Participant's non-compliance|1|||
144728395|NCT03952143|521861224|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
144728396|NCT03952143|521861225|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
144728397|NCT03952143|521861223|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
144564999|NCT01999972|521269563|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
144565000|NCT01999972|521269564|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
144565001|NCT01999972|521269565|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
144565002|NCT01999972|521269566|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
144565003|NCT01999972|521269567|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
144565004|NCT01999972|521269568|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
144565005|NCT01999972|521269563|FG000|Dose Expansion Part|Changed to standard of care|0|||
144565006|NCT01999972|521269564|FG001|Dose Expansion Part|Changed to standard of care|0|||
144565007|NCT01999972|521269565|FG002|Dose Expansion Part|Changed to standard of care|0|||
144565008|NCT01999972|521269566|FG003|Dose Expansion Part|Changed to standard of care|0|||
144565009|NCT01999972|521269567|FG004|Dose Expansion Part|Changed to standard of care|1|||
144565010|NCT01999972|521269568|FG005|Dose Expansion Part|Changed to standard of care|0|||
144565011|NCT02210208|521269569|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
144565012|NCT02210208|521269569|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
144565013|NCT02210208|521269569|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
144565014|NCT01171183|521269570|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
144565015|NCT01171183|521269571|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
144565016|NCT01171183|521269570|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
144565017|NCT01171183|521269571|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
144565018|NCT01171183|521269570|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
144565019|NCT01171183|521269571|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
144565020|NCT01171183|521269570|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
144565021|NCT01171183|521269571|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
144565022|NCT01171183|521269570|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
144565023|NCT01171183|521269571|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
144565024|NCT01171183|521269570|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
144565025|NCT01171183|521269571|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
144565026|NCT01101334|521269572|FG000|Overall Study|Adverse Event|9|||
144565027|NCT01101334|521269573|FG001|Overall Study|Adverse Event|4|||
144565028|NCT01101334|521269572|FG000|Overall Study|Death|7|||
144565029|NCT01101334|521269573|FG001|Overall Study|Death|1|||
144565030|NCT01101334|521269572|FG000|Overall Study|Withdrawal by Subject|4|||
144565031|NCT01101334|521269573|FG001|Overall Study|Withdrawal by Subject|3|||
144565032|NCT01101334|521269572|FG000|Overall Study|Withdrawal by Sponsor|1|||
144565033|NCT01101334|521269573|FG001|Overall Study|Withdrawal by Sponsor|1|||
144565034|NCT01101334|521269572|FG000|Overall Study|Progressive Disease|22|||
144565035|NCT01101334|521269573|FG001|Overall Study|Progressive Disease|35|||
144565036|NCT01101334|521269572|FG000|Overall Study|Other|2|||
144565037|NCT01101334|521269573|FG001|Overall Study|Other|1|||
144565038|NCT02826798|521269580|FG000|Overall Study|Withdrawal by Subject|0|||
144565039|NCT02826798|521269581|FG001|Overall Study|Withdrawal by Subject|1|||
144565040|NCT02826798|521269582|FG002|Overall Study|Withdrawal by Subject|0|||
144565041|NCT02826798|521269583|FG003|Overall Study|Withdrawal by Subject|1|||
144565042|NCT02826798|521269584|FG004|Overall Study|Withdrawal by Subject|0|||
144565043|NCT02806505|521269585|FG000|Overall Study|Adverse event/intercurrent illness|1|||
144565044|NCT02806505|521269586|FG001|Overall Study|Adverse event/intercurrent illness|3|||
144565045|NCT02806505|521269585|FG000|Overall Study|Death|4|||
144565046|NCT02806505|521269586|FG001|Overall Study|Death|0|||
144565047|NCT02806505|521269585|FG000|Overall Study|Did not cooperate/refused treatment|3|||
144618367|NCT03829657|521461285|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
144618368|NCT03829657|521461286|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
144618369|NCT03829657|521461287|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
144618370|NCT03829657|521461283|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
144618371|NCT03829657|521461284|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
144618372|NCT03829657|521461285|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
144618373|NCT03829657|521461286|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
144618374|NCT03829657|521461287|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
144618375|NCT03829657|521461283|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
144618376|NCT03829657|521461284|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
144618377|NCT03829657|521461285|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
144618378|NCT03829657|521461286|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
144618379|NCT03829657|521461287|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
144618380|NCT03829657|521461283|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
144618381|NCT03829657|521461284|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
144618382|NCT03829657|521461285|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
144618383|NCT03829657|521461286|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
144618384|NCT03829657|521461287|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
144618385|NCT03829657|521461283|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
144618386|NCT03829657|521461284|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
144565048|NCT02806505|521269586|FG001|Overall Study|Did not cooperate/refused treatment|3|||
144204647|NCT00936897|519944487|FG001|Overall Study|Other|9|||
144565049|NCT02806505|521269585|FG000|Overall Study|Failure to return|0|||
144565050|NCT02806505|521269586|FG001|Overall Study|Failure to return|1|||
144565051|NCT02806505|521269585|FG000|Overall Study|Insufficient therapeutic response|2|||
144565052|NCT02806505|521269586|FG001|Overall Study|Insufficient therapeutic response|4|||
144565053|NCT03440047|521269588|FG000|Overall Study|Withdrawal by Subject|2|||
144565054|NCT01181609|521269589|FG000|Overall Study|Adverse Event|1|||
144565055|NCT01181609|521269589|FG000|Overall Study|Withdrawal by Subject|1|||
144565056|NCT01181609|521269589|FG000|Overall Study|Lost to Follow-up|1|||
144565057|NCT01181609|521269589|FG000|Overall Study|Death|50|||
144565058|NCT01722045|521269590|FG000|Overall Study|Adverse Event|8|||
144565059|NCT01722045|521269590|FG000|Overall Study|Death|3|||
144565060|NCT01722045|521269590|FG000|Overall Study|Withdrawal by Subject|8|||
144565061|NCT01722045|521269590|FG000|Overall Study|Lost to Follow-up|4|||
144565062|NCT01722045|521269590|FG000|Overall Study|Protocol Deviation|1|||
144565063|NCT01722045|521269590|FG000|Overall Study|Physician Decision|3|||
144565064|NCT01722045|521269590|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
144565065|NCT00612352|521269591|FG000|Overall Study|Adverse Event|1|||
144565066|NCT00612352|521269592|FG001|Overall Study|Adverse Event|0|||
144565067|NCT00612352|521269591|FG000|Overall Study|Withdrawal by Subject|3|||
144565068|NCT00612352|521269592|FG001|Overall Study|Withdrawal by Subject|5|||
144565069|NCT00612352|521269591|FG000|Overall Study|moved out of state|1|||
144565070|NCT00612352|521269592|FG001|Overall Study|moved out of state|0|||
144565071|NCT00612352|521269591|FG000|Overall Study|didn't return calls/show up on test date|4|||
144565072|NCT00612352|521269592|FG001|Overall Study|didn't return calls/show up on test date|1|||
144565073|NCT02161406|521269593|FG000|Overall Study|Death|2|||
144565074|NCT02161406|521269594|FG001|Overall Study|Death|1|||
144565075|NCT02161406|521269593|FG000|Overall Study|Lost to Follow-up|2|||
144565076|NCT02161406|521269594|FG001|Overall Study|Lost to Follow-up|1|||
144565077|NCT02161406|521269593|FG000|Overall Study|Withdrawal by Subject|2|||
144565078|NCT02161406|521269594|FG001|Overall Study|Withdrawal by Subject|4|||
144565079|NCT02161406|521269593|FG000|Overall Study|investigator withdrew subject|3|||
144565080|NCT02161406|521269594|FG001|Overall Study|investigator withdrew subject|1|||
144565081|NCT02161406|521269593|FG000|Overall Study|Lack of Efficacy|1|||
144565082|NCT02161406|521269594|FG001|Overall Study|Lack of Efficacy|1|||
144565083|NCT02161406|521269593|FG000|Overall Study|relocation|0|||
144565084|NCT02161406|521269594|FG001|Overall Study|relocation|1|||
144565085|NCT04732871|521269597|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
144565086|NCT04732871|521269598|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
144565087|NCT04732871|521269599|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
144565088|NCT04732871|521269597|FG000|Overall Study|Lost to Follow-up|7|||
144565089|NCT04732871|521269598|FG001|Overall Study|Lost to Follow-up|4|||
144565090|NCT04732871|521269599|FG002|Overall Study|Lost to Follow-up|3|||
144565091|NCT04732871|521269597|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
144565092|NCT04732871|521269598|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
144565093|NCT04732871|521269599|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
144565094|NCT04732871|521269597|FG000|Overall Study|Migrated / moved from the study area|5|||
144565095|NCT04732871|521269598|FG001|Overall Study|Migrated / moved from the study area|0|||
144565096|NCT04732871|521269599|FG002|Overall Study|Migrated / moved from the study area|0|||
144565097|NCT04732871|521269597|FG000|Overall Study|Other|1|||
144565098|NCT04732871|521269598|FG001|Overall Study|Other|0|||
144565099|NCT04732871|521269599|FG002|Overall Study|Other|1|||
144565100|NCT04732871|521269597|FG000|Overall Study|Ongoing|6|||
144565101|NCT04732871|521269598|FG001|Overall Study|Ongoing|0|||
144565102|NCT04732871|521269599|FG002|Overall Study|Ongoing|1|||
144565103|NCT04732871|521269597|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
144565104|NCT04732871|521269598|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
144565105|NCT04732871|521269599|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
144565106|NCT00263211|521269600|FG000|Overall Study|Death|1|||
144565107|NCT00263211|521269601|FG001|Overall Study|Death|0|||
144565108|NCT00263211|521269600|FG000|Overall Study|Withdrawal by Subject|3|||
144565109|NCT00263211|521269601|FG001|Overall Study|Withdrawal by Subject|0|||
144565110|NCT00263211|521269600|FG000|Overall Study|Protocol Violation|1|||
144565111|NCT00263211|521269601|FG001|Overall Study|Protocol Violation|0|||
144565112|NCT00263211|521269600|FG000|Overall Study|Disease Progression|0|||
144565113|NCT00263211|521269601|FG001|Overall Study|Disease Progression|1|||
144565114|NCT02034162|521269602|FG000|Double-blind|Lost to Follow-up|3|||
144565115|NCT02034162|521269603|FG001|Double-blind|Lost to Follow-up|0|||
144565116|NCT02034162|521269604|FG002|Double-blind|Lost to Follow-up|0|||
144565117|NCT02034162|521269602|FG000|Double-blind|Physician Decision|1|||
144565118|NCT02034162|521269603|FG001|Double-blind|Physician Decision|0|||
144565119|NCT02034162|521269604|FG002|Double-blind|Physician Decision|0|||
144565120|NCT02034162|521269602|FG000|Double-blind|Protocol Violation|0|||
144565121|NCT02034162|521269603|FG001|Double-blind|Protocol Violation|1|||
144565122|NCT02034162|521269604|FG002|Double-blind|Protocol Violation|0|||
144204648|NCT00936897|519944486|FG000|Overall Study|Lost to Follow-up|1|||
144565123|NCT02034162|521269602|FG000|Double-blind|Withdrawal by Subject|5|||
144565124|NCT02034162|521269603|FG001|Double-blind|Withdrawal by Subject|7|||
144565125|NCT02034162|521269604|FG002|Double-blind|Withdrawal by Subject|0|||
144565126|NCT00760513|521269605|FG000|Overall Study|Withdrawal by Subject|5|||
144565127|NCT00760513|521269606|FG001|Overall Study|Withdrawal by Subject|7|||
144565128|NCT03458728|521269612|FG000|Overall Study|Adverse Event|1|||
144565129|NCT03458728|521269613|FG001|Overall Study|Adverse Event|0|||
144565130|NCT03458728|521269612|FG000|Overall Study|Physician Decision|1|||
144565131|NCT03458728|521269613|FG001|Overall Study|Physician Decision|0|||
144565132|NCT03458728|521269612|FG000|Overall Study|Progressive disease - clinical assessment|1|||
144565133|NCT03458728|521269613|FG001|Overall Study|Progressive disease - clinical assessment|0|||
144565134|NCT03458728|521269612|FG000|Overall Study|Progressive disease - radiological progression|21|||
144565135|NCT03458728|521269613|FG001|Overall Study|Progressive disease - radiological progression|6|||
144565136|NCT03458728|521269612|FG000|Overall Study|Withdrawal by Subject|0|||
144565137|NCT03458728|521269613|FG001|Overall Study|Withdrawal by Subject|1|||
144565138|NCT00908349|521269617|FG000|Overall Study|Adverse Event|10|||
144565139|NCT00908349|521269617|FG000|Overall Study|Withdrawal by Subject|9|||
144565140|NCT00908349|521269617|FG000|Overall Study|Physician Decision|5|||
144565141|NCT00908349|521269617|FG000|Overall Study|Lost to Follow-up|5|||
144565142|NCT00908349|521269617|FG000|Overall Study|Various|6|||
144565143|NCT00511836|521269623|FG000|Double-blind Period|Lost to Follow-up|1|||
144565144|NCT00511836|521269624|FG001|Double-blind Period|Lost to Follow-up|0|||
144565145|NCT01755546|521269627|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
144565146|NCT01755546|521269627|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
144565147|NCT01755546|521269627|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
144565148|NCT01755546|521269627|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
144565149|NCT01755546|521269627|FG000|Titration Phase|Adverse Event|11|||
144565150|NCT01755546|521269627|FG000|Titration Phase|Lack of Efficacy|18|||
144565151|NCT01755546|521269627|FG000|Titration Phase|Protocol Violation|9|||
144565152|NCT01755546|521269627|FG000|Titration Phase|Lost to Follow-up|2|||
144565153|NCT01755546|521269627|FG000|Titration Phase|Other and Continuing|22|||
144565154|NCT01755546|521269627|FG000|Titration Phase|Withdrawal by Subject|8|||
144565155|NCT01755546|521269627|FG000|Long Term Treatment|Adverse Event|12|||
144565156|NCT01755546|521269627|FG000|Long Term Treatment|Lack of Efficacy|6|||
144565157|NCT01755546|521269627|FG000|Long Term Treatment|Protocol Violation|10|||
144565158|NCT01755546|521269627|FG000|Long Term Treatment|Withdrawal by Subject|35|||
144565159|NCT01755546|521269627|FG000|Long Term Treatment|Lost to Follow-up|17|||
144565160|NCT01755546|521269627|FG000|Long Term Treatment|other and ongoing|41|||
144565161|NCT00891046|521269632|FG000|Overall Study|Protocol Violation|1|||
144565162|NCT00891046|521269633|FG001|Overall Study|Protocol Violation|1|||
144565163|NCT00891046|521269634|FG002|Overall Study|Protocol Violation|0|||
144565164|NCT00891046|521269635|FG003|Overall Study|Protocol Violation|0|||
144565165|NCT00891046|521269636|FG004|Overall Study|Protocol Violation|1|||
144565166|NCT00891046|521269632|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
144565167|NCT00891046|521269633|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144565168|NCT00891046|521269634|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
144565169|NCT00891046|521269635|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
144565170|NCT00891046|521269636|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
144565171|NCT00891046|521269632|FG000|Overall Study|Administrative problems|0|||
144565172|NCT00891046|521269633|FG001|Overall Study|Administrative problems|0|||
144565173|NCT00891046|521269634|FG002|Overall Study|Administrative problems|0|||
144565174|NCT00891046|521269635|FG003|Overall Study|Administrative problems|0|||
144565175|NCT00891046|521269636|FG004|Overall Study|Administrative problems|1|||
144565176|NCT00891046|521269632|FG000|Overall Study|Participant no longer required drug|0|||
144565177|NCT00891046|521269633|FG001|Overall Study|Participant no longer required drug|2|||
144565178|NCT00891046|521269634|FG002|Overall Study|Participant no longer required drug|0|||
144565179|NCT00891046|521269635|FG003|Overall Study|Participant no longer required drug|0|||
144565180|NCT00891046|521269636|FG004|Overall Study|Participant no longer required drug|1|||
144565181|NCT00891046|521269632|FG000|Overall Study|Adverse Event|4|||
144565182|NCT00891046|521269633|FG001|Overall Study|Adverse Event|3|||
144565183|NCT00891046|521269634|FG002|Overall Study|Adverse Event|2|||
144565184|NCT00891046|521269635|FG003|Overall Study|Adverse Event|0|||
144565185|NCT00891046|521269636|FG004|Overall Study|Adverse Event|14|||
144565186|NCT00891046|521269632|FG000|Overall Study|Withdrawal by Subject|2|||
144565187|NCT00891046|521269633|FG001|Overall Study|Withdrawal by Subject|1|||
144565188|NCT00891046|521269634|FG002|Overall Study|Withdrawal by Subject|2|||
144565189|NCT00891046|521269635|FG003|Overall Study|Withdrawal by Subject|1|||
144565190|NCT00891046|521269636|FG004|Overall Study|Withdrawal by Subject|1|||
144565191|NCT00891046|521269632|FG000|Overall Study|Lost to Follow-up|0|||
144565192|NCT00891046|521269633|FG001|Overall Study|Lost to Follow-up|0|||
144565193|NCT00891046|521269634|FG002|Overall Study|Lost to Follow-up|0|||
144565194|NCT00891046|521269635|FG003|Overall Study|Lost to Follow-up|0|||
144565195|NCT00891046|521269636|FG004|Overall Study|Lost to Follow-up|1|||
144565196|NCT04333147|521269637|FG000|Overall Study|Adverse Event|43|||
144565197|NCT04333147|521269638|FG001|Overall Study|Adverse Event|40|||
144565198|NCT04333147|521269637|FG000|Overall Study|Lack of Efficacy|49|||
144565199|NCT04333147|521269638|FG001|Overall Study|Lack of Efficacy|48|||
144565200|NCT04333147|521269637|FG000|Overall Study|Lost to Follow-up|19|||
144565201|NCT04333147|521269638|FG001|Overall Study|Lost to Follow-up|16|||
144565202|NCT04333147|521269637|FG000|Overall Study|Physician Decision|17|||
144565203|NCT04333147|521269638|FG001|Overall Study|Physician Decision|20|||
144565204|NCT04333147|521269637|FG000|Overall Study|Withdrawal by Subject|65|||
144565205|NCT04333147|521269638|FG001|Overall Study|Withdrawal by Subject|68|||
144565206|NCT04333147|521269637|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
144565207|NCT04333147|521269638|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
144565208|NCT04333147|521269637|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
144565209|NCT04333147|521269638|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
144565210|NCT04333147|521269637|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
144565211|NCT04333147|521269638|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
144565212|NCT00362375|521269639|FG000|Overall Study|Lost to Follow-up|40|||
144565213|NCT00362375|521269640|FG001|Overall Study|Lost to Follow-up|35|||
144565214|NCT04984239|521269641|FG000|Overall Study|Lost to Follow-up|1|||
144565215|NCT01114139|521269644|FG000|Overall Study|Adverse Event|3|||
144565216|NCT01114139|521269645|FG001|Overall Study|Adverse Event|2|||
144565217|NCT01114139|521269644|FG000|Overall Study|Lost to Follow-up|15|||
144565218|NCT01114139|521269645|FG001|Overall Study|Lost to Follow-up|3|||
144565219|NCT01114139|521269644|FG000|Overall Study|Withdrawal by Subject|17|||
144565220|NCT01114139|521269645|FG001|Overall Study|Withdrawal by Subject|6|||
144565221|NCT01114139|521269644|FG000|Overall Study|Other-Missed 1 visit|1|||
144565222|NCT01114139|521269645|FG001|Overall Study|Other-Missed 1 visit|0|||
144565223|NCT01114139|521269644|FG000|Overall Study|Other-Protocol Violation|1|||
144565224|NCT01114139|521269645|FG001|Overall Study|Other-Protocol Violation|0|||
144565225|NCT01114139|521269644|FG000|Overall Study|Other-Out of window for study drug dose|1|||
144565226|NCT01114139|521269645|FG001|Overall Study|Other-Out of window for study drug dose|0|||
144565227|NCT01114139|521269644|FG000|Overall Study|Other-Participant falsified records|0|||
144565228|NCT01114139|521269645|FG001|Overall Study|Other-Participant falsified records|1|||
144565229|NCT01114139|521269644|FG000|Overall Study|Other-Participant went on hospice|0|||
144565230|NCT01114139|521269645|FG001|Overall Study|Other-Participant went on hospice|1|||
144618387|NCT03829657|521461285|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
144618388|NCT03829657|521461286|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
144618389|NCT03829657|521461287|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
144618390|NCT04418076|521461289|FG000|Overall Study|Death|1|||
144618391|NCT04418076|521461290|FG001|Overall Study|Death|0|||
144618392|NCT04418076|521461291|FG002|Overall Study|Death|0|||
144618393|NCT04418076|521461292|FG003|Overall Study|Death|0|||
144618394|NCT04418076|521461289|FG000|Overall Study|Lost to Follow-up|2|||
144618395|NCT04418076|521461290|FG001|Overall Study|Lost to Follow-up|5|||
144618396|NCT04418076|521461291|FG002|Overall Study|Lost to Follow-up|1|||
144618397|NCT04418076|521461292|FG003|Overall Study|Lost to Follow-up|2|||
144618398|NCT04418076|521461289|FG000|Overall Study|Withdrawal by Subject|1|||
144618399|NCT04418076|521461290|FG001|Overall Study|Withdrawal by Subject|0|||
144618400|NCT04418076|521461291|FG002|Overall Study|Withdrawal by Subject|1|||
144618401|NCT04418076|521461292|FG003|Overall Study|Withdrawal by Subject|1|||
144618402|NCT04418076|521461289|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
144618403|NCT04418076|521461290|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
144618404|NCT04418076|521461291|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
144618405|NCT04418076|521461292|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
144618406|NCT01425008|521461293|FG000|Dose Escalation Phase|Progressive Disease|2|||
144618407|NCT01425008|521461294|FG001|Dose Escalation Phase|Progressive Disease|3|||
144618408|NCT01425008|521461295|FG002|Dose Escalation Phase|Progressive Disease|2|||
144618409|NCT01425008|521461296|FG003|Dose Escalation Phase|Progressive Disease|3|||
144618410|NCT01425008|521461297|FG004|Dose Escalation Phase|Progressive Disease|5|||
144618411|NCT01425008|521461298|FG005|Dose Escalation Phase|Progressive Disease|4|||
144618412|NCT01425008|521461299|FG006|Dose Escalation Phase|Progressive Disease|0|||
144618413|NCT01425008|521461300|FG007|Dose Escalation Phase|Progressive Disease|2|||
144618414|NCT01425008|521461301|FG008|Dose Escalation Phase|Progressive Disease|6|||
144618415|NCT01425008|521461302|FG009|Dose Escalation Phase|Progressive Disease|2|||
144618416|NCT01425008|521461303|FG010|Dose Escalation Phase|Progressive Disease|0|||
144565231|NCT01114139|521269644|FG000|Overall Study|Other-Physician changed treatment|1|||
144565232|NCT01114139|521269645|FG001|Overall Study|Other-Physician changed treatment|0|||
144565233|NCT01114139|521269644|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
144565234|NCT01114139|521269645|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
144565235|NCT02536742|521269647|FG000|Overall Study|Did not start protocol therapy|1|||
144565236|NCT02536742|521269647|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
144618417|NCT01425008|521461304|FG011|Dose Escalation Phase|Progressive Disease|0|||
144618418|NCT01425008|521461305|FG012|Dose Escalation Phase|Progressive Disease|0|||
144618419|NCT01425008|521461306|FG013|Dose Escalation Phase|Progressive Disease|0|||
144618420|NCT01425008|521461307|FG014|Dose Escalation Phase|Progressive Disease|0|||
144618421|NCT01425008|521461308|FG015|Dose Escalation Phase|Progressive Disease|0|||
144618422|NCT01425008|521461309|FG016|Dose Escalation Phase|Progressive Disease|0|||
144565237|NCT00706914|521269648|FG000|Overall Study|Lack of Efficacy|0|||
144565238|NCT00706914|521269649|FG001|Overall Study|Lack of Efficacy|1|||
144565239|NCT00706914|521269650|FG002|Overall Study|Lack of Efficacy|0|||
144565240|NCT00706914|521269648|FG000|Overall Study|Lost to Follow-up|1|||
144565241|NCT00706914|521269649|FG001|Overall Study|Lost to Follow-up|0|||
144565242|NCT00706914|521269650|FG002|Overall Study|Lost to Follow-up|0|||
144565243|NCT00706914|521269648|FG000|Overall Study|Adverse Event|2|||
144565244|NCT00706914|521269649|FG001|Overall Study|Adverse Event|2|||
144565245|NCT00706914|521269650|FG002|Overall Study|Adverse Event|0|||
144565246|NCT00706914|521269648|FG000|Overall Study|Protocol Violation|3|||
144565247|NCT00706914|521269649|FG001|Overall Study|Protocol Violation|1|||
144565248|NCT00706914|521269650|FG002|Overall Study|Protocol Violation|1|||
144565249|NCT04629443|521269651|FG000|Overall Study|Adverse Event|2|||
144565250|NCT04629443|521269652|FG001|Overall Study|Adverse Event|1|||
144204649|NCT00936897|519944487|FG001|Overall Study|Lost to Follow-up|10|||
144565251|NCT04629443|521269653|FG002|Overall Study|Adverse Event|2|||
144565252|NCT04629443|521269651|FG000|Overall Study|Progressive Disease|2|||
144565253|NCT04629443|521269652|FG001|Overall Study|Progressive Disease|3|||
144565254|NCT04629443|521269653|FG002|Overall Study|Progressive Disease|3|||
144565255|NCT04629443|521269651|FG000|Overall Study|Physician Decision|1|||
144565256|NCT04629443|521269652|FG001|Overall Study|Physician Decision|3|||
144565257|NCT04629443|521269653|FG002|Overall Study|Physician Decision|0|||
144565258|NCT00858247|521269660|FG000|Baseline Assessment|Withdrawal by Subject|1|||
144565259|NCT00858247|521269661|FG001|Baseline Assessment|Withdrawal by Subject|1|||
144565260|NCT00858247|521269660|FG000|Baseline Assessment|Poor IV access|1|||
144565261|NCT00858247|521269661|FG001|Baseline Assessment|Poor IV access|0|||
144565262|NCT00858247|521269660|FG000|Baseline Assessment|Protocol Violation|0|||
144565263|NCT00858247|521269661|FG001|Baseline Assessment|Protocol Violation|1|||
144565264|NCT00858247|521269660|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
144565265|NCT00858247|521269661|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
144565266|NCT01172639|521269662|FG000|Overall Study|Death|1|||
144565267|NCT01172639|521269663|FG001|Overall Study|Death|1|||
144565268|NCT01172639|521269664|FG002|Overall Study|Death|0|||
144565269|NCT01172639|521269665|FG003|Overall Study|Death|0|||
144565270|NCT01172639|521269666|FG004|Overall Study|Death|0|||
144565271|NCT01172639|521269662|FG000|Overall Study|Lost to Follow-up|9|||
144618423|NCT01425008|521461310|FG017|Dose Escalation Phase|Progressive Disease|0|||
144618424|NCT01425008|521461311|FG018|Dose Escalation Phase|Progressive Disease|0|||
144618425|NCT01425008|521461293|FG000|Dose Escalation Phase|Adverse Event|2|||
144618426|NCT01425008|521461294|FG001|Dose Escalation Phase|Adverse Event|0|||
144618427|NCT01425008|521461295|FG002|Dose Escalation Phase|Adverse Event|0|||
144618428|NCT01425008|521461296|FG003|Dose Escalation Phase|Adverse Event|0|||
144618429|NCT01425008|521461297|FG004|Dose Escalation Phase|Adverse Event|0|||
144618430|NCT01425008|521461298|FG005|Dose Escalation Phase|Adverse Event|2|||
144618431|NCT01425008|521461299|FG006|Dose Escalation Phase|Adverse Event|0|||
144618432|NCT01425008|521461300|FG007|Dose Escalation Phase|Adverse Event|0|||
144618433|NCT01425008|521461301|FG008|Dose Escalation Phase|Adverse Event|2|||
144618434|NCT01425008|521461302|FG009|Dose Escalation Phase|Adverse Event|0|||
144618435|NCT01425008|521461303|FG010|Dose Escalation Phase|Adverse Event|0|||
144618436|NCT01425008|521461304|FG011|Dose Escalation Phase|Adverse Event|0|||
144618437|NCT01425008|521461305|FG012|Dose Escalation Phase|Adverse Event|0|||
144618438|NCT01425008|521461306|FG013|Dose Escalation Phase|Adverse Event|0|||
144618439|NCT01425008|521461307|FG014|Dose Escalation Phase|Adverse Event|0|||
144618440|NCT01425008|521461308|FG015|Dose Escalation Phase|Adverse Event|0|||
144618441|NCT01425008|521461309|FG016|Dose Escalation Phase|Adverse Event|0|||
144618442|NCT01425008|521461310|FG017|Dose Escalation Phase|Adverse Event|0|||
144618443|NCT01425008|521461311|FG018|Dose Escalation Phase|Adverse Event|0|||
144204650|NCT00936897|519944486|FG000|Overall Study|Administrative Decision|1|||
144204651|NCT00936897|519944487|FG001|Overall Study|Administrative Decision|2|||
144204652|NCT00936897|519944486|FG000|Overall Study|Protocol Violation|1|||
144565272|NCT01172639|521269663|FG001|Overall Study|Lost to Follow-up|7|||
144565273|NCT01172639|521269664|FG002|Overall Study|Lost to Follow-up|11|||
144565274|NCT01172639|521269665|FG003|Overall Study|Lost to Follow-up|6|||
144565275|NCT01172639|521269666|FG004|Overall Study|Lost to Follow-up|6|||
144204653|NCT00936897|519944487|FG001|Overall Study|Protocol Violation|1|||
144565276|NCT01172639|521269662|FG000|Overall Study|Withdrawal by Subject|3|||
144565277|NCT01172639|521269663|FG001|Overall Study|Withdrawal by Subject|3|||
144565278|NCT01172639|521269664|FG002|Overall Study|Withdrawal by Subject|5|||
144565279|NCT01172639|521269665|FG003|Overall Study|Withdrawal by Subject|5|||
144565280|NCT01172639|521269666|FG004|Overall Study|Withdrawal by Subject|0|||
144565281|NCT02447432|521269667|FG000|Epoch 001|Adverse Event|1|||
144565282|NCT02447432|521269668|FG001|Epoch 001|Adverse Event|1|||
144565283|NCT02447432|521269667|FG000|Epoch 001|Withdrawal by Subject|0|||
144618444|NCT01425008|521461293|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618445|NCT01425008|521461294|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618446|NCT01425008|521461295|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618447|NCT01425008|521461296|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618448|NCT01425008|521461297|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
144565284|NCT02447432|521269668|FG001|Epoch 001|Withdrawal by Subject|4|||
144565285|NCT02447432|521269667|FG000|Epoch 001|Migrated/moved from study area|3|||
144565286|NCT02447432|521269668|FG001|Epoch 001|Migrated/moved from study area|5|||
144565287|NCT02447432|521269667|FG000|Epoch 001|Lost to Follow-up|1|||
144565288|NCT02447432|521269668|FG001|Epoch 001|Lost to Follow-up|3|||
144565289|NCT00002597|521269669|FG000|Overall Study|Protocol Violation|19|||
144565290|NCT00002597|521269670|FG001|Overall Study|Protocol Violation|17|||
144565291|NCT00002597|521269669|FG000|Overall Study|Withdrawal by Subject|7|||
144565292|NCT00002597|521269670|FG001|Overall Study|Withdrawal by Subject|6|||
144565293|NCT01891890|521269676|FG000|Overall Study|Lost to Follow-up|0|||
144565294|NCT01891890|521269677|FG001|Overall Study|Lost to Follow-up|0|||
144565295|NCT01891890|521269678|FG002|Overall Study|Lost to Follow-up|1|||
144565296|NCT01891890|521269676|FG000|Overall Study|Study ended before endpoint reached|7|||
144565297|NCT01891890|521269677|FG001|Overall Study|Study ended before endpoint reached|3|||
144565298|NCT01891890|521269678|FG002|Overall Study|Study ended before endpoint reached|6|||
144565299|NCT01161628|521269679|FG000|Overall Study|Death|6|||
144565300|NCT01161628|521269679|FG000|Overall Study|Lack of Efficacy|2|||
144565301|NCT03605368|521269685|FG000|Overall Study|Lost to Follow-up|2|||
144565302|NCT03605368|521269686|FG001|Overall Study|Lost to Follow-up|1|||
144565303|NCT03605368|521269687|FG002|Overall Study|Lost to Follow-up|3|||
144565304|NCT03605368|521269688|FG003|Overall Study|Lost to Follow-up|2|||
144565305|NCT03605368|521269685|FG000|Overall Study|Withdrawal by Subject|0|||
144565306|NCT03605368|521269686|FG001|Overall Study|Withdrawal by Subject|0|||
144565307|NCT03605368|521269687|FG002|Overall Study|Withdrawal by Subject|4|||
144565308|NCT03605368|521269688|FG003|Overall Study|Withdrawal by Subject|3|||
144565309|NCT01726517|521269689|FG000|Overall Study|Withdrawal by Subject|0|||
144565310|NCT01726517|521269690|FG001|Overall Study|Withdrawal by Subject|0|||
144565311|NCT01726517|521269691|FG002|Overall Study|Withdrawal by Subject|1|||
144565312|NCT01726517|521269692|FG003|Overall Study|Withdrawal by Subject|0|||
144565313|NCT01726517|521269693|FG004|Overall Study|Withdrawal by Subject|0|||
144565314|NCT03765164|521269694|FG000|Pre-intervention|Withdrawal by Subject|5|||
144565315|NCT03765164|521269695|FG001|Pre-intervention|Withdrawal by Subject|6|||
144565316|NCT03448536|521269696|FG000|Overall Study|Protocol Violation|2|||
144565317|NCT03448536|521269697|FG001|Overall Study|Protocol Violation|0|||
144565318|NCT03448536|521269696|FG000|Overall Study|Pregnancy|1|||
144565319|NCT03448536|521269697|FG001|Overall Study|Pregnancy|0|||
144565320|NCT03448536|521269696|FG000|Overall Study|Withdrawal by Subject|1|||
144565321|NCT03448536|521269697|FG001|Overall Study|Withdrawal by Subject|2|||
144565322|NCT03448536|521269696|FG000|Overall Study|Lost to Follow-up|3|||
144565323|NCT03448536|521269697|FG001|Overall Study|Lost to Follow-up|2|||
144565324|NCT03448536|521269696|FG000|Overall Study|Inadequate pain reporter|1|||
144565325|NCT03448536|521269697|FG001|Overall Study|Inadequate pain reporter|0|||
144618449|NCT01425008|521461298|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618450|NCT01425008|521461299|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
144618451|NCT01425008|521461300|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
144618452|NCT01425008|521461301|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
144618453|NCT01425008|521461302|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144565326|NCT03448536|521269696|FG000|Overall Study|Other|3|||
144618454|NCT01425008|521461303|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618455|NCT01425008|521461304|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618456|NCT01425008|521461305|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618457|NCT01425008|521461306|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618458|NCT01425008|521461307|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618459|NCT01425008|521461308|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618460|NCT01425008|521461309|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618461|NCT01425008|521461310|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618462|NCT01425008|521461311|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144618463|NCT01425008|521461293|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
144618464|NCT01425008|521461294|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
144618465|NCT01425008|521461295|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
144618466|NCT01425008|521461296|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144618467|NCT01425008|521461297|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
144618468|NCT01425008|521461298|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
144618469|NCT01425008|521461299|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
144618470|NCT01425008|521461300|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
144262605|NCT01922258|520161496|FG001|Overall Study|Adverse Event|2|||
144565327|NCT03448536|521269697|FG001|Overall Study|Other|0|||
144565328|NCT03448536|521269696|FG000|Overall Study|Physician Decision|1|||
144565329|NCT03448536|521269697|FG001|Overall Study|Physician Decision|0|||
144565330|NCT04814992|521269701|FG000|Overall Study|Withdrawal by Subject|6|||
144565331|NCT04814992|521269702|FG001|Overall Study|Withdrawal by Subject|3|||
144565332|NCT04814992|521269701|FG000|Overall Study|Lost to Follow-up|1|||
144565333|NCT04814992|521269702|FG001|Overall Study|Lost to Follow-up|4|||
144618471|NCT01425008|521461301|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
144204654|NCT00936897|519944486|FG000|Overall Study|Ineligibility Determined|0|||
144204655|NCT00936897|519944487|FG001|Overall Study|Ineligibility Determined|3|||
144204656|NCT00936897|519944486|FG000|Overall Study|Noncompliance|0|||
144204657|NCT00936897|519944487|FG001|Overall Study|Noncompliance|2|||
144204658|NCT00936897|519944486|FG000|Overall Study|Death|0|||
144204659|NCT00936897|519944487|FG001|Overall Study|Death|1|||
144204660|NCT00417170|519944488|FG000|Overall Study|Adverse Event|1|||
144204661|NCT00417170|519944489|FG001|Overall Study|Adverse Event|1|||
144204662|NCT00417170|519944488|FG000|Overall Study|Withdrawal by Subject|1|||
144204663|NCT00417170|519944489|FG001|Overall Study|Withdrawal by Subject|1|||
144204664|NCT00417170|519944488|FG000|Overall Study|Lost to Follow-up|0|||
144204665|NCT00417170|519944489|FG001|Overall Study|Lost to Follow-up|1|||
144204666|NCT04058067|519944490|FG000|Overall Study|Adverse Event|2|||
144204667|NCT04058067|519944491|FG001|Overall Study|Adverse Event|0|||
144204668|NCT04058067|519944490|FG000|Overall Study|Death|0|||
144204669|NCT04058067|519944491|FG001|Overall Study|Death|1|||
144204670|NCT04058067|519944490|FG000|Overall Study|Physician Decision|3|||
144204671|NCT04058067|519944491|FG001|Overall Study|Physician Decision|1|||
144204672|NCT04058067|519944490|FG000|Overall Study|Protocol Violation|0|||
144204673|NCT04058067|519944491|FG001|Overall Study|Protocol Violation|1|||
144204674|NCT04058067|519944490|FG000|Overall Study|Withdrawal by Subject|7|||
144204675|NCT04058067|519944491|FG001|Overall Study|Withdrawal by Subject|8|||
144204676|NCT05005312|519944492|FG000|Overall Study|Enrolled, but not treated|0|||
144204677|NCT05005312|519944493|FG001|Overall Study|Enrolled, but not treated|1|||
144204678|NCT01283035|519944494|FG000|Overall Study|Subject later found ineligible|1|||
144204679|NCT03597529|519944496|FG000|Overall Study|Lost to Follow-up|10|||
144204680|NCT03597529|519944497|FG001|Overall Study|Lost to Follow-up|12|||
144204681|NCT03597529|519944496|FG000|Overall Study|Physician Decision|3|||
144204682|NCT03597529|519944497|FG001|Overall Study|Physician Decision|1|||
144204683|NCT03597529|519944496|FG000|Overall Study|Withdrawal by Subject|6|||
144204684|NCT03597529|519944497|FG001|Overall Study|Withdrawal by Subject|3|||
144204685|NCT03597529|519944496|FG000|Overall Study|Non-compliant with study activities|1|||
144204686|NCT03597529|519944497|FG001|Overall Study|Non-compliant with study activities|2|||
144204687|NCT04623086|519944500|FG000|Overall Study|Withdrawal by Subject|0|||
144204688|NCT04623086|519944501|FG001|Overall Study|Withdrawal by Subject|0|||
144204689|NCT04623086|519944502|FG002|Overall Study|Withdrawal by Subject|10|||
144204690|NCT01755767|519944503|FG000|Overall Study|Progressive Disease|8|||
144204691|NCT01755767|519944504|FG001|Overall Study|Progressive Disease|7|||
144204692|NCT01755767|519944505|FG002|Overall Study|Progressive Disease|91|||
144204693|NCT01755767|519944506|FG003|Overall Study|Progressive Disease|43|||
144204694|NCT01755767|519944503|FG000|Overall Study|Clinical Disease Progression|4|||
144565334|NCT01831726|521269705|FG000|Overall Study|Adverse Event|16|||
144565335|NCT01831726|521269705|FG000|Overall Study|Death|7|||
144565336|NCT01831726|521269705|FG000|Overall Study|Disease Progression|49|||
144565337|NCT01831726|521269705|FG000|Overall Study|Physician Decision|1|||
144565338|NCT01831726|521269705|FG000|Overall Study|Subject/guardian decision|7|||
144565339|NCT04944784|521269708|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
144565340|NCT04944784|521269709|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
144565341|NCT04944784|521269710|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
144565342|NCT04944784|521269711|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
144565343|NCT04944784|521269708|FG000|Double-blind Period|Adverse Event|20|||
144565344|NCT04944784|521269709|FG001|Double-blind Period|Adverse Event|4|||
144565345|NCT04944784|521269710|FG002|Double-blind Period|Adverse Event|0|||
144565346|NCT04944784|521269711|FG003|Double-blind Period|Adverse Event|0|||
144565347|NCT04944784|521269708|FG000|Double-blind Period|Withdrawal by Subject|15|||
144565348|NCT04944784|521269709|FG001|Double-blind Period|Withdrawal by Subject|4|||
144565349|NCT04944784|521269710|FG002|Double-blind Period|Withdrawal by Subject|0|||
144204695|NCT01755767|519944504|FG001|Overall Study|Clinical Disease Progression|2|||
144204696|NCT01755767|519944505|FG002|Overall Study|Clinical Disease Progression|29|||
144204697|NCT01755767|519944506|FG003|Overall Study|Clinical Disease Progression|20|||
144204698|NCT01755767|519944503|FG000|Overall Study|Radiographic Disease Progression|9|||
144565350|NCT04944784|521269711|FG003|Double-blind Period|Withdrawal by Subject|0|||
144204699|NCT01755767|519944504|FG001|Overall Study|Radiographic Disease Progression|4|||
144204700|NCT01755767|519944505|FG002|Overall Study|Radiographic Disease Progression|44|||
144204701|NCT01755767|519944506|FG003|Overall Study|Radiographic Disease Progression|27|||
144204702|NCT01755767|519944503|FG000|Overall Study|Adverse Event|6|||
144204703|NCT01755767|519944504|FG001|Overall Study|Adverse Event|0|||
144204704|NCT01755767|519944505|FG002|Overall Study|Adverse Event|28|||
144204705|NCT01755767|519944506|FG003|Overall Study|Adverse Event|11|||
144204706|NCT01755767|519944503|FG000|Overall Study|Death|1|||
144204707|NCT01755767|519944504|FG001|Overall Study|Death|2|||
144204708|NCT01755767|519944505|FG002|Overall Study|Death|15|||
144204709|NCT01755767|519944506|FG003|Overall Study|Death|4|||
144204710|NCT01755767|519944503|FG000|Overall Study|Subject Decision|0|||
144565351|NCT04944784|521269708|FG000|Double-blind Period|Death|7|||
144565352|NCT04944784|521269709|FG001|Double-blind Period|Death|2|||
144565353|NCT04944784|521269710|FG002|Double-blind Period|Death|0|||
144565354|NCT04944784|521269711|FG003|Double-blind Period|Death|0|||
144565355|NCT04944784|521269708|FG000|Double-blind Period|Physician Decision|2|||
144565356|NCT04944784|521269709|FG001|Double-blind Period|Physician Decision|1|||
144204711|NCT01755767|519944504|FG001|Overall Study|Subject Decision|0|||
144204712|NCT01755767|519944505|FG002|Overall Study|Subject Decision|10|||
144204713|NCT01755767|519944506|FG003|Overall Study|Subject Decision|3|||
144565357|NCT04944784|521269710|FG002|Double-blind Period|Physician Decision|0|||
144565358|NCT04944784|521269711|FG003|Double-blind Period|Physician Decision|0|||
144565359|NCT04944784|521269708|FG000|Double-blind Period|Lack of Efficacy|0|||
144565360|NCT04944784|521269709|FG001|Double-blind Period|Lack of Efficacy|1|||
144565361|NCT04944784|521269710|FG002|Double-blind Period|Lack of Efficacy|0|||
144565362|NCT04944784|521269711|FG003|Double-blind Period|Lack of Efficacy|0|||
144565363|NCT04944784|521269708|FG000|Double-blind Period|Sponsor Request|2|||
144565364|NCT04944784|521269709|FG001|Double-blind Period|Sponsor Request|1|||
144565365|NCT04944784|521269710|FG002|Double-blind Period|Sponsor Request|0|||
144565366|NCT04944784|521269711|FG003|Double-blind Period|Sponsor Request|0|||
144565367|NCT04944784|521269708|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
144565368|NCT04944784|521269709|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
144565369|NCT04944784|521269710|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
144565370|NCT04944784|521269711|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
144565371|NCT04944784|521269708|FG000|Double-blind Period|Participant Choice|1|||
144565372|NCT04944784|521269709|FG001|Double-blind Period|Participant Choice|1|||
144565373|NCT04944784|521269710|FG002|Double-blind Period|Participant Choice|0|||
144565374|NCT04944784|521269711|FG003|Double-blind Period|Participant Choice|0|||
144565375|NCT04944784|521269708|FG000|Double-blind Period|Progressive Disease|2|||
144565376|NCT04944784|521269709|FG001|Double-blind Period|Progressive Disease|2|||
144565377|NCT04944784|521269710|FG002|Double-blind Period|Progressive Disease|0|||
144565378|NCT04944784|521269711|FG003|Double-blind Period|Progressive Disease|0|||
144565379|NCT04944784|521269708|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
144565380|NCT04944784|521269709|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
144204714|NCT01755767|519944503|FG000|Overall Study|Withdrawal by Subject|0|||
144204715|NCT01755767|519944504|FG001|Overall Study|Withdrawal by Subject|0|||
144204716|NCT01755767|519944505|FG002|Overall Study|Withdrawal by Subject|2|||
144204717|NCT01755767|519944506|FG003|Overall Study|Withdrawal by Subject|1|||
144204718|NCT01755767|519944503|FG000|Overall Study|Other|0|||
144565381|NCT04944784|521269710|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
144565382|NCT04944784|521269711|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
144565383|NCT04944784|521269708|FG000|Active Drug Period|Adverse Event|0|||
144565384|NCT04944784|521269709|FG001|Active Drug Period|Adverse Event|0|||
144565385|NCT04944784|521269710|FG002|Active Drug Period|Adverse Event|3|||
144565386|NCT04944784|521269711|FG003|Active Drug Period|Adverse Event|6|||
144565387|NCT04944784|521269708|FG000|Active Drug Period|Withdrawal by Subject|0|||
144565388|NCT04944784|521269709|FG001|Active Drug Period|Withdrawal by Subject|0|||
144565389|NCT04944784|521269710|FG002|Active Drug Period|Withdrawal by Subject|4|||
144565390|NCT04944784|521269711|FG003|Active Drug Period|Withdrawal by Subject|7|||
144565391|NCT04944784|521269708|FG000|Active Drug Period|Death|0|||
144565392|NCT04944784|521269709|FG001|Active Drug Period|Death|0|||
144565393|NCT04944784|521269710|FG002|Active Drug Period|Death|3|||
144565394|NCT04944784|521269711|FG003|Active Drug Period|Death|4|||
144565395|NCT04944784|521269708|FG000|Active Drug Period|Lack of Efficacy|0|||
144565396|NCT04944784|521269709|FG001|Active Drug Period|Lack of Efficacy|0|||
144565397|NCT04944784|521269710|FG002|Active Drug Period|Lack of Efficacy|2|||
144565398|NCT04944784|521269711|FG003|Active Drug Period|Lack of Efficacy|2|||
144565399|NCT04944784|521269708|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
144565400|NCT04944784|521269709|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
144204719|NCT01755767|519944504|FG001|Overall Study|Other|0|||
144565401|NCT04944784|521269710|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
144565402|NCT04944784|521269711|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
144565403|NCT04944784|521269708|FG000|Active Drug Period|Participant Choice|0|||
144565404|NCT04944784|521269709|FG001|Active Drug Period|Participant Choice|0|||
144565405|NCT04944784|521269710|FG002|Active Drug Period|Participant Choice|0|||
144565406|NCT04944784|521269711|FG003|Active Drug Period|Participant Choice|1|||
144204720|NCT01755767|519944505|FG002|Overall Study|Other|2|||
144204721|NCT01755767|519944506|FG003|Overall Study|Other|3|||
144204722|NCT01755767|519944503|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
144204723|NCT01755767|519944504|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
144565407|NCT04944784|521269708|FG000|Active Drug Period|Progressive Disease|0|||
144565408|NCT04944784|521269709|FG001|Active Drug Period|Progressive Disease|0|||
144565409|NCT04944784|521269710|FG002|Active Drug Period|Progressive Disease|4|||
144565410|NCT04944784|521269711|FG003|Active Drug Period|Progressive Disease|4|||
144565411|NCT04944784|521269708|FG000|Active Drug Period|Lost to Follow-up|0|||
144565412|NCT04944784|521269709|FG001|Active Drug Period|Lost to Follow-up|0|||
144565413|NCT04944784|521269710|FG002|Active Drug Period|Lost to Follow-up|0|||
144565414|NCT04944784|521269711|FG003|Active Drug Period|Lost to Follow-up|1|||
144565415|NCT00497874|521271323|FG000|Overall Study|Withdrawal by Subject|48|||
144204724|NCT01755767|519944505|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
144565416|NCT00497874|521271324|FG001|Overall Study|Withdrawal by Subject|17|||
144565417|NCT00497874|521271323|FG000|Overall Study|Illness|8|||
144565418|NCT00497874|521271324|FG001|Overall Study|Illness|4|||
144565419|NCT00497874|521271323|FG000|Overall Study|Death|2|||
144565420|NCT00497874|521271324|FG001|Overall Study|Death|4|||
144565421|NCT00497874|521271323|FG000|Overall Study|Unable to contact|52|||
144565422|NCT00497874|521271324|FG001|Overall Study|Unable to contact|67|||
144565423|NCT00497874|521271323|FG000|Overall Study|Unable to schedule|37|||
144565424|NCT00497874|521271324|FG001|Overall Study|Unable to schedule|24|||
144565425|NCT04009629|521271327|FG000|Overall Study|Withdrawal by Subject|2|||
144565426|NCT04009629|521271328|FG001|Overall Study|Withdrawal by Subject|0|||
144565427|NCT00761956|521271329|FG000|Overall Study|Lost to Follow-up|6|||
144565428|NCT00761956|521271330|FG001|Overall Study|Lost to Follow-up|11|||
144565429|NCT00761956|521271329|FG000|Overall Study|Withdrawal by Subject|3|||
144565430|NCT00761956|521271330|FG001|Overall Study|Withdrawal by Subject|8|||
144565431|NCT00761956|521271329|FG000|Overall Study|Death|0|||
144565432|NCT00761956|521271330|FG001|Overall Study|Death|1|||
144565433|NCT00761956|521271329|FG000|Overall Study|Adverse Event|26|||
144565434|NCT00761956|521271330|FG001|Overall Study|Adverse Event|34|||
144565435|NCT02808975|521271334|FG000|Overall Study|Adverse Event|3|||
144565436|NCT02808975|521271335|FG001|Overall Study|Adverse Event|4|||
144565437|NCT02808975|521271334|FG000|Overall Study|Withdrew consent|9|||
144565438|NCT02808975|521271335|FG001|Overall Study|Withdrew consent|8|||
144565439|NCT02808975|521271334|FG000|Overall Study|Lost to Follow-up|4|||
144565440|NCT02808975|521271335|FG001|Overall Study|Lost to Follow-up|6|||
144565441|NCT02808975|521271334|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
144565442|NCT02808975|521271335|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
144565443|NCT02808975|521271334|FG000|Overall Study|Other, not specified|5|||
144565444|NCT02808975|521271335|FG001|Overall Study|Other, not specified|1|||
144565445|NCT03602586|521271336|FG000|Overall Study|Withdrawal by Subject|3|||
144565446|NCT00030823|521271337|FG000|Overall Study|Withdrawal by Subject|1|||
144565447|NCT02106195|521271339|FG000|Overall Study|Adverse Event|2|||
144565448|NCT02106195|521271339|FG000|Overall Study|Protocol Violation|1|||
144565449|NCT01951378|521271340|FG000|Overall Study|Study Terminated-Not completed|23|||
144565450|NCT01951378|521271341|FG001|Overall Study|Study Terminated-Not completed|17|||
144565451|NCT00543062|521271342|FG000|Overall Study|Withdrawal by Subject|1|||
144565452|NCT00543062|521271343|FG001|Overall Study|Withdrawal by Subject|0|||
144565453|NCT00543062|521271344|FG002|Overall Study|Withdrawal by Subject|2|||
144565454|NCT00543062|521271345|FG003|Overall Study|Withdrawal by Subject|0|||
144565455|NCT00543062|521271342|FG000|Overall Study|Adverse Event|0|||
144565456|NCT00543062|521271343|FG001|Overall Study|Adverse Event|1|||
144565457|NCT00543062|521271344|FG002|Overall Study|Adverse Event|1|||
144565458|NCT00543062|521271345|FG003|Overall Study|Adverse Event|1|||
144565459|NCT00543062|521271342|FG000|Overall Study|Protocol Violation|1|||
144565460|NCT00543062|521271343|FG001|Overall Study|Protocol Violation|0|||
144565461|NCT00543062|521271344|FG002|Overall Study|Protocol Violation|0|||
144565462|NCT00543062|521271345|FG003|Overall Study|Protocol Violation|0|||
144565463|NCT03927690|521271348|FG000|Overall Study|Withdrawal by Subject|3|||
144565464|NCT03927690|521271349|FG001|Overall Study|Withdrawal by Subject|1|||
144565465|NCT03927690|521271350|FG002|Overall Study|Withdrawal by Subject|1|||
144565466|NCT03927690|521271348|FG000|Overall Study|Adverse Event|1|||
144565467|NCT03927690|521271349|FG001|Overall Study|Adverse Event|0|||
144565468|NCT03927690|521271350|FG002|Overall Study|Adverse Event|0|||
144565469|NCT03927690|521271348|FG000|Overall Study|Death|1|||
144565470|NCT03927690|521271349|FG001|Overall Study|Death|0|||
144565471|NCT03927690|521271350|FG002|Overall Study|Death|0|||
144565472|NCT03927690|521271348|FG000|Overall Study|Lost to Follow-up|2|||
144565473|NCT03927690|521271349|FG001|Overall Study|Lost to Follow-up|2|||
144565474|NCT03927690|521271350|FG002|Overall Study|Lost to Follow-up|1|||
144728398|NCT03952143|521861224|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
144728399|NCT03952143|521861225|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
144728400|NCT01866319|521861226|FG000|Overall Study|Adverse Event|12|||
144728401|NCT01866319|521861227|FG001|Overall Study|Adverse Event|5|||
144728402|NCT01866319|521861228|FG002|Overall Study|Adverse Event|9|||
144728403|NCT01866319|521861226|FG000|Overall Study|Clinical progression|3|||
144728404|NCT01866319|521861227|FG001|Overall Study|Clinical progression|2|||
144728405|NCT01866319|521861228|FG002|Overall Study|Clinical progression|2|||
144262606|NCT01922258|520161495|FG000|Overall Study|Met Withdrawal Criteria|0|||
144565475|NCT01844726|521271357|FG000|Overall Study|Withdrawal by Subject|0|||
144565476|NCT01844726|521271358|FG001|Overall Study|Withdrawal by Subject|1|||
144565477|NCT01844726|521271357|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
144565478|NCT01844726|521271358|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
144565479|NCT03898960|521271361|FG000|Overall Study|Death|10|||
144565480|NCT00548847|521271362|FG000|Overall Study|Disease progression|7|||
144565481|NCT01898442|521271373|FG000|Overall Study|Hemolysis/technical problems|1|||
144565482|NCT01898442|521271374|FG001|Overall Study|Hemolysis/technical problems|2|||
144565483|NCT01898442|521271375|FG002|Overall Study|Hemolysis/technical problems|2|||
144565484|NCT01898442|521271373|FG000|Overall Study|Patient vomited pills|0|||
144565485|NCT01898442|521271374|FG001|Overall Study|Patient vomited pills|0|||
144565486|NCT01898442|521271375|FG002|Overall Study|Patient vomited pills|1|||
144565487|NCT03974100|521271376|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
144565488|NCT03974100|521271377|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
144565489|NCT03974100|521271378|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
144565490|NCT03974100|521271379|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
144565491|NCT03974100|521271380|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
144565492|NCT03974100|521271376|FG000|TP1 - Day 1 to Week 52|Death|1|||
144565493|NCT03974100|521271377|FG001|TP1 - Day 1 to Week 52|Death|0|||
144565494|NCT03974100|521271378|FG002|TP1 - Day 1 to Week 52|Death|0|||
144565495|NCT03974100|521271379|FG003|TP1 - Day 1 to Week 52|Death|0|||
144565496|NCT03974100|521271380|FG004|TP1 - Day 1 to Week 52|Death|0|||
144565497|NCT03974100|521271376|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
144565498|NCT03974100|521271377|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
144565499|NCT03974100|521271378|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
144565500|NCT03974100|521271379|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
144565501|NCT03974100|521271380|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
144565502|NCT03974100|521271376|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
144565503|NCT03974100|521271377|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
144565504|NCT03974100|521271378|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
144565505|NCT03974100|521271379|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
144565506|NCT03974100|521271380|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
144565507|NCT03974100|521271376|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
144565508|NCT03974100|521271377|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
144565509|NCT03974100|521271378|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
144565510|NCT03974100|521271379|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
144565511|NCT03974100|521271380|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
144565512|NCT03974100|521271376|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
144565513|NCT03974100|521271377|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
144565514|NCT03974100|521271378|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
144565515|NCT03974100|521271379|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
144565516|NCT03974100|521271380|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
144565517|NCT03974100|521271376|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
144565518|NCT03974100|521271377|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
144565519|NCT03974100|521271378|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
144565520|NCT03974100|521271379|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
144565521|NCT03974100|521271380|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
144565522|NCT00874497|521271381|FG000|Overall Study|Lost to Follow-up|2|||
144565523|NCT00874497|521271382|FG001|Overall Study|Lost to Follow-up|4|||
144565524|NCT00874497|521271381|FG000|Overall Study|Adverse Event|9|||
144565525|NCT00874497|521271382|FG001|Overall Study|Adverse Event|4|||
144565526|NCT00874497|521271381|FG000|Overall Study|Sponsor Discontinued Trial|7|||
144565527|NCT00874497|521271382|FG001|Overall Study|Sponsor Discontinued Trial|3|||
144565528|NCT00874497|521271381|FG000|Overall Study|Met Withdrawal Criteria|4|||
144565529|NCT00874497|521271382|FG001|Overall Study|Met Withdrawal Criteria|2|||
144565530|NCT00874497|521271381|FG000|Overall Study|Physician Decision|1|||
144565531|NCT00874497|521271382|FG001|Overall Study|Physician Decision|1|||
144565532|NCT00874497|521271381|FG000|Overall Study|Withdrawal by Subject|5|||
144565533|NCT00874497|521271382|FG001|Overall Study|Withdrawal by Subject|4|||
144565534|NCT01721746|521271383|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
144565535|NCT01721746|521271384|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
144565536|NCT01721746|521271383|FG000|Pre-Treatment|Withdrawal by Subject|1|||
144565537|NCT01721746|521271384|FG001|Pre-Treatment|Withdrawal by Subject|16|||
144565538|NCT01721746|521271383|FG000|Pre-Treatment|Poor/Non-compliance|1|||
144565539|NCT01721746|521271384|FG001|Pre-Treatment|Poor/Non-compliance|0|||
144565540|NCT01721746|521271383|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
144565541|NCT01721746|521271384|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
144565542|NCT01721746|521271383|FG000|Treatment|Disease Progression|192|||
144565543|NCT01721746|521271384|FG001|Treatment|Disease Progression|74|||
144565544|NCT01721746|521271383|FG000|Treatment|Study Drug Toxicity|19|||
144565545|NCT01721746|521271384|FG001|Treatment|Study Drug Toxicity|11|||
144565546|NCT01721746|521271383|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
144565547|NCT01721746|521271384|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
144565548|NCT01721746|521271383|FG000|Treatment|Participant request to discontinue Study treatment|26|||
144565549|NCT01721746|521271384|FG001|Treatment|Participant request to discontinue Study treatment|7|||
144565550|NCT01721746|521271383|FG000|Treatment|Participant withdrew consent|4|||
144565551|NCT01721746|521271384|FG001|Treatment|Participant withdrew consent|2|||
144565552|NCT01721746|521271383|FG000|Treatment|Maximum Clinical Benefit|9|||
144565553|NCT01721746|521271384|FG001|Treatment|Maximum Clinical Benefit|3|||
144565554|NCT01721746|521271383|FG000|Treatment|Poor/Non-compliance|2|||
144565555|NCT01721746|521271384|FG001|Treatment|Poor/Non-compliance|0|||
144565556|NCT01721746|521271383|FG000|Treatment|Participant no longer met Study criteria|4|||
144565557|NCT01721746|521271384|FG001|Treatment|Participant no longer met Study criteria|0|||
144565558|NCT01721746|521271383|FG000|Treatment|Other reasons|6|||
144565559|NCT01721746|521271384|FG001|Treatment|Other reasons|2|||
144565560|NCT00665223|521271387|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
144565561|NCT00665223|521271388|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
144565562|NCT00665223|521271389|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
144565563|NCT00665223|521271387|FG000|Randomized Phase (26 Weeks)|Death|0|||
144565564|NCT00665223|521271388|FG001|Randomized Phase (26 Weeks)|Death|0|||
144565565|NCT00665223|521271389|FG002|Randomized Phase (26 Weeks)|Death|1|||
144565566|NCT00665223|521271387|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
144565567|NCT00665223|521271388|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
144565568|NCT00665223|521271389|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
144565569|NCT00665223|521271387|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
144565570|NCT00665223|521271388|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
144565571|NCT00665223|521271389|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
144565572|NCT00665223|521271387|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
144565573|NCT00665223|521271388|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
144565574|NCT00665223|521271389|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
144565575|NCT00665223|521271387|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
144565576|NCT00665223|521271388|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
144565577|NCT00665223|521271389|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
144565578|NCT00665223|521271387|FG000|Open-Label Period (26 Weeks)|Death|0|||
144565579|NCT00665223|521271388|FG001|Open-Label Period (26 Weeks)|Death|1|||
144565580|NCT00665223|521271389|FG002|Open-Label Period (26 Weeks)|Death|0|||
144565581|NCT00665223|521271387|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
144565582|NCT00665223|521271388|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
144565583|NCT00665223|521271389|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
144565584|NCT00665223|521271387|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
144565585|NCT00665223|521271388|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
144565586|NCT00665223|521271389|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
144565587|NCT00665223|521271387|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
144565588|NCT00665223|521271388|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
144565589|NCT00665223|521271389|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
144565590|NCT00665223|521271387|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
144565591|NCT00665223|521271388|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
144565592|NCT00665223|521271389|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
144565593|NCT00591591|521271390|FG000|Overall Study|Withdrawal by Subject|1|||
144565594|NCT00591591|521271391|FG001|Overall Study|Withdrawal by Subject|37|||
144565595|NCT00591591|521271390|FG000|Overall Study|Lack of Efficacy|10|||
144565596|NCT00591591|521271391|FG001|Overall Study|Lack of Efficacy|2|||
144565597|NCT01426113|521271392|FG000|Overall Study|Study Discontinued|1|||
144565598|NCT01426113|521271393|FG001|Overall Study|Study Discontinued|1|||
144565599|NCT01426113|521271392|FG000|Overall Study|Adverse Event|0|||
144565600|NCT01426113|521271393|FG001|Overall Study|Adverse Event|1|||
144565601|NCT00468130|521271395|FG000|Overall Study|Adverse Event|2|||
144565602|NCT00468130|521271396|FG001|Overall Study|Adverse Event|1|||
144565603|NCT00468130|521271395|FG000|Overall Study|Withdrawal by Subject|0|||
144565604|NCT00468130|521271396|FG001|Overall Study|Withdrawal by Subject|1|||
144565605|NCT02485899|521271397|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
144565606|NCT02485899|521271398|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144565607|NCT02485899|521271397|FG000|Overall Study|Withdrawal by Subject|1|||
144565608|NCT02485899|521271398|FG001|Overall Study|Withdrawal by Subject|0|||
144565609|NCT02485899|521271397|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
144565610|NCT02485899|521271398|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
144565611|NCT00436956|521271399|FG000|Overall Study|Not evaluable|1|||
144565612|NCT00436956|521271400|FG001|Overall Study|Not evaluable|0|||
144565613|NCT03517111|521271401|FG000|Enrolled|Withdrawal by Subject|0|||
144565614|NCT03517111|521271402|FG001|Enrolled|Withdrawal by Subject|1|||
144565615|NCT03517111|521271403|FG002|Enrolled|Withdrawal by Subject|0|||
144204725|NCT01755767|519944506|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
144204726|NCT03464630|519944507|FG000|Overall Study|Lost to Follow-up|62|||
144204727|NCT03464630|519944508|FG001|Overall Study|Lost to Follow-up|52|||
144204728|NCT03464630|519944507|FG000|Overall Study|Withdrawal by Subject|16|||
144204729|NCT03464630|519944508|FG001|Overall Study|Withdrawal by Subject|10|||
144204730|NCT03464630|519944507|FG000|Overall Study|Passive Disengagement|8|||
144204731|NCT03464630|519944508|FG001|Overall Study|Passive Disengagement|4|||
144565616|NCT03517111|521271401|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
144565617|NCT03517111|521271402|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
144565618|NCT03517111|521271403|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
144565619|NCT03517111|521271401|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
144565620|NCT03517111|521271402|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
144565621|NCT03517111|521271403|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
144565622|NCT03517111|521271401|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
144618472|NCT01425008|521461302|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
144204732|NCT06077149|519944511|FG000|Overall Study|Death|1|||
144565623|NCT03517111|521271402|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
144565624|NCT03517111|521271403|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
144565625|NCT03517111|521271401|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
144565626|NCT03517111|521271402|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
144565627|NCT03517111|521271403|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
144565628|NCT00623363|521271404|FG000|Overall Study|Adverse Event|2|||
144565629|NCT00623363|521271405|FG001|Overall Study|Adverse Event|2|||
144565630|NCT02719743|521271406|FG000|Overall Study|Consent withdrawal|0|||
144565631|NCT02719743|521271407|FG001|Overall Study|Consent withdrawal|2|||
144565632|NCT02719743|521271408|FG002|Overall Study|Consent withdrawal|0|||
144565633|NCT02719743|521271409|FG003|Overall Study|Consent withdrawal|1|||
144565634|NCT02719743|521271410|FG004|Overall Study|Consent withdrawal|0|||
144565635|NCT02719743|521271406|FG000|Overall Study|Migrated/moved from study area|0|||
144565636|NCT02719743|521271407|FG001|Overall Study|Migrated/moved from study area|0|||
144565637|NCT02719743|521271408|FG002|Overall Study|Migrated/moved from study area|0|||
144565638|NCT02719743|521271409|FG003|Overall Study|Migrated/moved from study area|0|||
144565639|NCT02719743|521271410|FG004|Overall Study|Migrated/moved from study area|2|||
144565640|NCT02719743|521271406|FG000|Overall Study|Lost to Follow-up|1|||
144565641|NCT02719743|521271407|FG001|Overall Study|Lost to Follow-up|1|||
144565642|NCT02719743|521271408|FG002|Overall Study|Lost to Follow-up|0|||
144565643|NCT02719743|521271409|FG003|Overall Study|Lost to Follow-up|0|||
144565644|NCT02719743|521271410|FG004|Overall Study|Lost to Follow-up|0|||
144565645|NCT01438840|521271411|FG000|Core Study|Adverse Event|0|||
144565646|NCT01438840|521271412|FG001|Core Study|Adverse Event|3|||
144565647|NCT01438840|521271413|FG002|Core Study|Adverse Event|0|||
144565648|NCT01438840|521271411|FG000|Core Study|Lack of Efficacy|15|||
144565649|NCT01438840|521271412|FG001|Core Study|Lack of Efficacy|7|||
144565650|NCT01438840|521271413|FG002|Core Study|Lack of Efficacy|0|||
144565651|NCT01438840|521271411|FG000|Core Study|Withdrawal of consent|1|||
144565652|NCT01438840|521271412|FG001|Core Study|Withdrawal of consent|0|||
144565653|NCT01438840|521271413|FG002|Core Study|Withdrawal of consent|0|||
144565654|NCT01438840|521271411|FG000|Extension Phase|Adverse Event|0|||
144565655|NCT01438840|521271412|FG001|Extension Phase|Adverse Event|0|||
144565656|NCT01438840|521271413|FG002|Extension Phase|Adverse Event|3|||
144565657|NCT01438840|521271411|FG000|Extension Phase|Lost to Follow-up|0|||
144565658|NCT01438840|521271412|FG001|Extension Phase|Lost to Follow-up|0|||
144565659|NCT01438840|521271413|FG002|Extension Phase|Lost to Follow-up|1|||
144565660|NCT01438840|521271411|FG000|Extension Phase|Withdrawal by Subject|0|||
144565661|NCT01438840|521271412|FG001|Extension Phase|Withdrawal by Subject|0|||
144565662|NCT01438840|521271413|FG002|Extension Phase|Withdrawal by Subject|3|||
144565663|NCT01438840|521271411|FG000|Extension Phase|Lack of Efficacy|0|||
144565664|NCT01438840|521271412|FG001|Extension Phase|Lack of Efficacy|0|||
144565665|NCT01438840|521271413|FG002|Extension Phase|Lack of Efficacy|2|||
144565666|NCT01438840|521271411|FG000|Extension Phase|Other|0|||
144565667|NCT01438840|521271412|FG001|Extension Phase|Other|0|||
144565668|NCT01438840|521271413|FG002|Extension Phase|Other|1|||
144565669|NCT02062645|521271419|FG000|Overall Study|Adverse Event|2|||
144565670|NCT02062645|521271419|FG000|Overall Study|Protocol Violation|8|||
144565671|NCT02062645|521271419|FG000|Overall Study|Lost to Follow-up|5|||
144565672|NCT00927901|521271422|FG000|Treatment Period 1|Subject withdrew consent|0|||
144565673|NCT00927901|521271423|FG001|Treatment Period 1|Subject withdrew consent|0|||
144565674|NCT00927901|521271424|FG002|Treatment Period 1|Subject withdrew consent|1|||
144565675|NCT00927901|521271425|FG003|Treatment Period 1|Subject withdrew consent|0|||
144565676|NCT00927901|521271422|FG000|Treatment Period 4|Adverse Event|0|||
144565677|NCT00927901|521271423|FG001|Treatment Period 4|Adverse Event|0|||
144565678|NCT00927901|521271424|FG002|Treatment Period 4|Adverse Event|0|||
144565679|NCT00927901|521271425|FG003|Treatment Period 4|Adverse Event|1|||
144565680|NCT00927901|521271422|FG000|Treatment Period 4|Subject withdrew consent|0|||
144565681|NCT00927901|521271423|FG001|Treatment Period 4|Subject withdrew consent|0|||
144565682|NCT00927901|521271424|FG002|Treatment Period 4|Subject withdrew consent|1|||
144565683|NCT00927901|521271425|FG003|Treatment Period 4|Subject withdrew consent|0|||
144565684|NCT02344173|521271426|FG000|Procedure|Ablation Procedure Not Performed|7|||
144565685|NCT02344173|521271426|FG000|12-month Visit|Death|8|||
144565686|NCT02344173|521271426|FG000|12-month Visit|Withdrawal by Subject|30|||
144565687|NCT02344173|521271426|FG000|12-month Visit|Lost to Follow-up|58|||
144565688|NCT03738397|521271427|FG000|Overall Study|Adverse Event|3|||
144565689|NCT03738397|521271428|FG001|Overall Study|Adverse Event|7|||
144565690|NCT03738397|521271427|FG000|Overall Study|Withdrawal by Subject|8|||
144565691|NCT03738397|521271428|FG001|Overall Study|Withdrawal by Subject|11|||
144565692|NCT03738397|521271427|FG000|Overall Study|Lost to Follow-up|7|||
144565693|NCT03738397|521271428|FG001|Overall Study|Lost to Follow-up|5|||
144565694|NCT03738397|521271427|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
144565695|NCT03738397|521271428|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
144565696|NCT03738397|521271427|FG000|Overall Study|Other|4|||
144565697|NCT03738397|521271428|FG001|Overall Study|Other|6|||
144565698|NCT01185171|521271429|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
144565699|NCT01185171|521271429|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
144565700|NCT01185171|521271429|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
144565701|NCT01185171|521271429|FG000|Maintenance|Elevated liver transaminases|3|||
144565702|NCT01185171|521271429|FG000|Maintenance|Rush|2|||
144565703|NCT01185171|521271429|FG000|Maintenance|Diarrhea|1|||
144565704|NCT01185171|521271429|FG000|Maintenance|Xerostomia|1|||
144565705|NCT01185171|521271429|FG000|Maintenance|Nausea|1|||
144565706|NCT01185171|521271429|FG000|Maintenance|Comorbid Illness|2|||
144565707|NCT01185171|521271429|FG000|Maintenance|Withdrawal by Subject|1|||
144565708|NCT01185171|521271429|FG000|Maintenance|Disease Recurrence|1|||
144565709|NCT02881047|521271430|FG000|Overall Study|Adverse Event|1|||
144565710|NCT02881047|521271430|FG000|Overall Study|Withdrawal by Subject|1|||
144565711|NCT00573651|521271434|FG000|Overall Study|Lost to Follow-up|3|||
144565712|NCT00573651|521271434|FG000|Overall Study|Withdrawal by Subject|1|||
144565713|NCT01837797|521271437|FG000|Period 1|Adverse Event|9|||
144565714|NCT01837797|521271438|FG001|Period 1|Adverse Event|0|||
144565715|NCT01837797|521271439|FG002|Period 1|Adverse Event|0|||
144565716|NCT01837797|521271440|FG003|Period 1|Adverse Event|0|||
144565717|NCT01837797|521271441|FG004|Period 1|Adverse Event|0|||
144565718|NCT01837797|521271437|FG000|Period 1|Withdrawal by Subject|6|||
144565719|NCT01837797|521271438|FG001|Period 1|Withdrawal by Subject|0|||
144565720|NCT01837797|521271439|FG002|Period 1|Withdrawal by Subject|0|||
144565721|NCT01837797|521271440|FG003|Period 1|Withdrawal by Subject|0|||
144565722|NCT01837797|521271441|FG004|Period 1|Withdrawal by Subject|0|||
144565723|NCT01837797|521271437|FG000|Period 1|Administrative reasons|76|||
144565724|NCT01837797|521271438|FG001|Period 1|Administrative reasons|0|||
144565725|NCT01837797|521271439|FG002|Period 1|Administrative reasons|0|||
144565726|NCT01837797|521271440|FG003|Period 1|Administrative reasons|0|||
144565727|NCT01837797|521271441|FG004|Period 1|Administrative reasons|0|||
144565728|NCT01837797|521271437|FG000|Period 1|Withdrawal of consent before treatment|1|||
144565729|NCT01837797|521271438|FG001|Period 1|Withdrawal of consent before treatment|0|||
144565730|NCT01837797|521271439|FG002|Period 1|Withdrawal of consent before treatment|0|||
144565731|NCT01837797|521271440|FG003|Period 1|Withdrawal of consent before treatment|0|||
144565732|NCT01837797|521271441|FG004|Period 1|Withdrawal of consent before treatment|0|||
144565733|NCT01837797|521271437|FG000|Period 1|Other|10|||
144565734|NCT01837797|521271438|FG001|Period 1|Other|0|||
144565735|NCT01837797|521271439|FG002|Period 1|Other|0|||
144565736|NCT01837797|521271440|FG003|Period 1|Other|0|||
144565737|NCT01837797|521271441|FG004|Period 1|Other|0|||
144565738|NCT01837797|521271437|FG000|Period 2|Administrative or other reasons|0|||
144565739|NCT01837797|521271438|FG001|Period 2|Administrative or other reasons|5|||
144565740|NCT01837797|521271439|FG002|Period 2|Administrative or other reasons|2|||
144565741|NCT01837797|521271440|FG003|Period 2|Administrative or other reasons|4|||
144565742|NCT01837797|521271441|FG004|Period 2|Administrative or other reasons|0|||
144565743|NCT01837797|521271437|FG000|Period 2|Adverse Event|0|||
144565744|NCT01837797|521271438|FG001|Period 2|Adverse Event|0|||
144565745|NCT01837797|521271439|FG002|Period 2|Adverse Event|0|||
144565746|NCT01837797|521271440|FG003|Period 2|Adverse Event|1|||
144565747|NCT01837797|521271441|FG004|Period 2|Adverse Event|0|||
144565748|NCT01837797|521271437|FG000|Period 3|Adverse Event|0|||
144565749|NCT01837797|521271438|FG001|Period 3|Adverse Event|0|||
144565750|NCT01837797|521271439|FG002|Period 3|Adverse Event|0|||
144565751|NCT01837797|521271440|FG003|Period 3|Adverse Event|0|||
144565752|NCT01837797|521271441|FG004|Period 3|Adverse Event|1|||
144565753|NCT01837797|521271437|FG000|Period 3|Administrative reasons|0|||
144618473|NCT01425008|521461303|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
144728406|NCT01866319|521861226|FG000|Overall Study|Death|153|||
144204733|NCT06077149|519944512|FG001|Overall Study|Death|0|||
144204734|NCT06077149|519944511|FG000|Overall Study|Withdrawal by Subject|2|||
144204735|NCT06077149|519944512|FG001|Overall Study|Withdrawal by Subject|0|||
144204736|NCT06077149|519944511|FG000|Overall Study|RSV infection before vaccination|3|||
144204737|NCT06077149|519944512|FG001|Overall Study|RSV infection before vaccination|0|||
144204738|NCT04154631|519944513|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
144204739|NCT04154631|519944514|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
144204740|NCT02238795|519944515|FG000|Overall Study|Patient without purpura fulminans|1|||
144565754|NCT01837797|521271438|FG001|Period 3|Administrative reasons|0|||
144565755|NCT01837797|521271439|FG002|Period 3|Administrative reasons|0|||
144565756|NCT01837797|521271440|FG003|Period 3|Administrative reasons|0|||
144565757|NCT01837797|521271441|FG004|Period 3|Administrative reasons|20|||
144565758|NCT01837797|521271437|FG000|Period 3|Other|0|||
144565759|NCT01837797|521271438|FG001|Period 3|Other|0|||
144565760|NCT01837797|521271439|FG002|Period 3|Other|0|||
144565761|NCT01837797|521271440|FG003|Period 3|Other|0|||
144565762|NCT01837797|521271441|FG004|Period 3|Other|2|||
144565763|NCT03797989|521271442|FG000|VAC069A|Withdrawal by Subject|0|||
144565764|NCT03797989|521271443|FG001|VAC069A|Withdrawal by Subject|0|||
144565765|NCT03797989|521271444|FG002|VAC069A|Withdrawal by Subject|1|||
144565766|NCT03797989|521271445|FG003|VAC069A|Withdrawal by Subject|0|||
144565767|NCT03797989|521271446|FG004|VAC069A|Withdrawal by Subject|0|||
144565768|NCT03797989|521271447|FG005|VAC069A|Withdrawal by Subject|0|||
144565769|NCT03797989|521271448|FG006|VAC069A|Withdrawal by Subject|0|||
144565770|NCT03797989|521271449|FG007|VAC069A|Withdrawal by Subject|0|||
144565771|NCT03797989|521271450|FG008|VAC069A|Withdrawal by Subject|0|||
144565772|NCT03797989|521271451|FG009|VAC069A|Withdrawal by Subject|0|||
144565773|NCT03797989|521271452|FG010|VAC069A|Withdrawal by Subject|0|||
144565774|NCT03797989|521271453|FG011|VAC069A|Withdrawal by Subject|0|||
144565775|NCT04052997|521271454|FG000|Overall Study|Withdrawal by Subject|17|||
144565776|NCT04052997|521271454|FG000|Overall Study|Physician Decision|50|||
144565777|NCT04052997|521271454|FG000|Overall Study|Death|43|||
144565778|NCT04052997|521271454|FG000|Overall Study|Lost to Follow-up|5|||
144565779|NCT04052997|521271454|FG000|Overall Study|Progression of Disease|1|||
144565780|NCT00514813|521271465|FG000|Overall Study|Study terminated|14|||
144565781|NCT00514813|521271466|FG001|Overall Study|Study terminated|74|||
144565782|NCT00514813|521271467|FG002|Overall Study|Study terminated|40|||
144565783|NCT00514813|521271468|FG003|Overall Study|Study terminated|2|||
144565784|NCT00514813|521271465|FG000|Overall Study|Adverse Event|0|||
144565785|NCT00514813|521271466|FG001|Overall Study|Adverse Event|2|||
144565786|NCT00514813|521271467|FG002|Overall Study|Adverse Event|2|||
144565787|NCT00514813|521271468|FG003|Overall Study|Adverse Event|0|||
144565788|NCT00514813|521271465|FG000|Overall Study|Protocol Violation|1|||
144565789|NCT00514813|521271466|FG001|Overall Study|Protocol Violation|0|||
144565790|NCT00514813|521271467|FG002|Overall Study|Protocol Violation|0|||
144565791|NCT00514813|521271468|FG003|Overall Study|Protocol Violation|0|||
144565792|NCT00514813|521271465|FG000|Overall Study|Withdrawal by Subject|0|||
144565793|NCT00514813|521271466|FG001|Overall Study|Withdrawal by Subject|1|||
144565794|NCT00514813|521271467|FG002|Overall Study|Withdrawal by Subject|0|||
144565795|NCT00514813|521271468|FG003|Overall Study|Withdrawal by Subject|0|||
144565796|NCT00514813|521271465|FG000|Overall Study|Lack of Efficacy|0|||
144565797|NCT00514813|521271466|FG001|Overall Study|Lack of Efficacy|1|||
144565798|NCT00514813|521271467|FG002|Overall Study|Lack of Efficacy|0|||
144565799|NCT00514813|521271468|FG003|Overall Study|Lack of Efficacy|0|||
144565800|NCT00514813|521271465|FG000|Overall Study|Kidney transplant|0|||
144565801|NCT00514813|521271466|FG001|Overall Study|Kidney transplant|6|||
144565802|NCT00514813|521271467|FG002|Overall Study|Kidney transplant|2|||
144565803|NCT00514813|521271468|FG003|Overall Study|Kidney transplant|0|||
144565804|NCT00514813|521271465|FG000|Overall Study|Death|0|||
144565805|NCT00514813|521271466|FG001|Overall Study|Death|2|||
144565806|NCT00514813|521271467|FG002|Overall Study|Death|3|||
144565807|NCT00514813|521271468|FG003|Overall Study|Death|2|||
144565808|NCT02979613|521271469|FG000|Double-Blind Phase|Withdrew Consent|2|||
144565809|NCT02979613|521271470|FG001|Double-Blind Phase|Withdrew Consent|4|||
144565810|NCT02979613|521271469|FG000|Double-Blind Phase|Pregnancy|2|||
144565811|NCT02979613|521271470|FG001|Double-Blind Phase|Pregnancy|2|||
144565812|NCT02979613|521271469|FG000|Double-Blind Phase|Adverse Event|2|||
144565813|NCT02979613|521271470|FG001|Double-Blind Phase|Adverse Event|0|||
144565814|NCT02979613|521271469|FG000|Double-Blind Phase|Lost to Follow-up|1|||
144565815|NCT02979613|521271470|FG001|Double-Blind Phase|Lost to Follow-up|1|||
144565816|NCT02979613|521271469|FG000|Double-Blind Phase|Protocol Violation|1|||
144565817|NCT02979613|521271470|FG001|Double-Blind Phase|Protocol Violation|1|||
144565818|NCT02979613|521271469|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
144565819|NCT02979613|521271470|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
144565820|NCT02979613|521271469|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
144565821|NCT02979613|521271470|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
144565822|NCT02979613|521271469|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
144565823|NCT02979613|521271470|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
144565824|NCT02979613|521271469|FG000|Open-Label Extension (OLE) Phase|Death|0|||
144565825|NCT02979613|521271470|FG001|Open-Label Extension (OLE) Phase|Death|1|||
144565826|NCT02979613|521271469|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
144565827|NCT02979613|521271470|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
144565828|NCT01075100|521271473|FG000|Overall Study|Adverse Event|15|||
144565829|NCT01075100|521271474|FG001|Overall Study|Adverse Event|18|||
144565830|NCT01075100|521271473|FG000|Overall Study|Patient Request|4|||
144565831|NCT01075100|521271474|FG001|Overall Study|Patient Request|4|||
144565832|NCT01075100|521271473|FG000|Overall Study|Investigator Request|2|||
144565833|NCT01075100|521271474|FG001|Overall Study|Investigator Request|1|||
144565834|NCT01075100|521271473|FG000|Overall Study|Disease Progression|25|||
144565835|NCT01075100|521271474|FG001|Overall Study|Disease Progression|29|||
144728407|NCT01866319|521861227|FG001|Overall Study|Death|154|||
144728408|NCT01866319|521861228|FG002|Overall Study|Death|147|||
144728409|NCT01866319|521861226|FG000|Overall Study|Lost to Follow-up|6|||
144565836|NCT01075100|521271473|FG000|Overall Study|Other|3|||
144565837|NCT01075100|521271474|FG001|Overall Study|Other|1|||
144565838|NCT01568112|521271477|FG000|Overall Study|Randomized But Not Treated|0|||
144565839|NCT01568112|521271478|FG001|Overall Study|Randomized But Not Treated|1|||
144565840|NCT01568112|521271479|FG002|Overall Study|Randomized But Not Treated|0|||
144565841|NCT01568112|521271480|FG003|Overall Study|Randomized But Not Treated|0|||
144565842|NCT01568112|521271477|FG000|Overall Study|Withdrew due to Adverse Event|2|||
144565843|NCT01568112|521271478|FG001|Overall Study|Withdrew due to Adverse Event|4|||
144565844|NCT01568112|521271479|FG002|Overall Study|Withdrew due to Adverse Event|6|||
144565845|NCT01568112|521271480|FG003|Overall Study|Withdrew due to Adverse Event|3|||
144565846|NCT01568112|521271477|FG000|Overall Study|Lost to Follow-up|0|||
144565847|NCT01568112|521271478|FG001|Overall Study|Lost to Follow-up|0|||
144565848|NCT01568112|521271479|FG002|Overall Study|Lost to Follow-up|0|||
144565849|NCT01568112|521271480|FG003|Overall Study|Lost to Follow-up|1|||
144565850|NCT01568112|521271477|FG000|Overall Study|Withdrawal by Subject|2|||
144565851|NCT01568112|521271478|FG001|Overall Study|Withdrawal by Subject|3|||
144565852|NCT01568112|521271479|FG002|Overall Study|Withdrawal by Subject|0|||
144565853|NCT01568112|521271480|FG003|Overall Study|Withdrawal by Subject|7|||
144565854|NCT01568112|521271477|FG000|Overall Study|Withdrawal by Physician|1|||
144565855|NCT01568112|521271478|FG001|Overall Study|Withdrawal by Physician|0|||
144565856|NCT01568112|521271479|FG002|Overall Study|Withdrawal by Physician|1|||
144565857|NCT01568112|521271480|FG003|Overall Study|Withdrawal by Physician|1|||
144565858|NCT02820597|521273585|FG000|Overall Study|Lost to Follow-up|12|||
144565859|NCT01053247|521273586|FG000|Overall Study|Withdrawal by Subject|9|||
144565860|NCT01053247|521273587|FG001|Overall Study|Withdrawal by Subject|4|||
144565861|NCT01053247|521273588|FG002|Overall Study|Withdrawal by Subject|15|||
144565862|NCT01053247|521273586|FG000|Overall Study|Lack of Efficacy|1|||
144565863|NCT01053247|521273587|FG001|Overall Study|Lack of Efficacy|0|||
144565864|NCT01053247|521273588|FG002|Overall Study|Lack of Efficacy|1|||
144565865|NCT01053247|521273586|FG000|Overall Study|Protocol Violation|2|||
144565866|NCT01053247|521273587|FG001|Overall Study|Protocol Violation|1|||
144565867|NCT01053247|521273588|FG002|Overall Study|Protocol Violation|2|||
144565868|NCT01053247|521273586|FG000|Overall Study|Lost to Follow-up|8|||
144565869|NCT01053247|521273587|FG001|Overall Study|Lost to Follow-up|5|||
144565870|NCT01053247|521273588|FG002|Overall Study|Lost to Follow-up|7|||
144565871|NCT01053247|521273586|FG000|Overall Study|Adverse Event|0|||
144565872|NCT01053247|521273587|FG001|Overall Study|Adverse Event|9|||
144565873|NCT01053247|521273588|FG002|Overall Study|Adverse Event|3|||
144565874|NCT03898700|521273589|FG000|Overall Study|Withdrawal by Subject|2|||
144565875|NCT00701909|521273590|FG000|Overall Study|Withdrawal by Subject|0|||
144565876|NCT00701909|521273591|FG001|Overall Study|Withdrawal by Subject|1|||
144262607|NCT01922258|520161496|FG001|Overall Study|Met Withdrawal Criteria|4|||
144262608|NCT01922258|520161495|FG000|Overall Study|Withdrawn by the Investigator|1|||
144262609|NCT01922258|520161496|FG001|Overall Study|Withdrawn by the Investigator|4|||
144262610|NCT01922258|520161495|FG000|Overall Study|Withdrawal by participant|5|||
144262611|NCT01922258|520161496|FG001|Overall Study|Withdrawal by participant|5|||
144262612|NCT04552132|520161497|FG000|Overall Study|Lost to Follow-up|4|||
144262613|NCT04552132|520161498|FG001|Overall Study|Lost to Follow-up|3|||
144262614|NCT04552132|520161497|FG000|Overall Study|Protocol Violation|1|||
144262615|NCT04552132|520161498|FG001|Overall Study|Protocol Violation|0|||
144262616|NCT01657162|520161499|FG000|Overall Study|Adverse Event|26|||
144262617|NCT01657162|520161500|FG001|Overall Study|Adverse Event|36|||
144262618|NCT01657162|520161499|FG000|Overall Study|Withdrawal by Subject|13|||
144262619|NCT01657162|520161500|FG001|Overall Study|Withdrawal by Subject|13|||
144618474|NCT01425008|521461304|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
144618475|NCT01425008|521461305|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
144618476|NCT01425008|521461306|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
144262620|NCT01657162|520161499|FG000|Overall Study|Continuing Significant Deterioration|9|||
144262621|NCT01657162|520161500|FG001|Overall Study|Continuing Significant Deterioration|3|||
144565877|NCT00971997|521273592|FG000|Overall Study|Adverse Event|2|||
144565878|NCT00971997|521273592|FG000|Overall Study|Death|1|||
144565879|NCT00971997|521273592|FG000|Overall Study|Protocol Violation|4|||
144565880|NCT00971997|521273592|FG000|Overall Study|Withdrawal by Subject|5|||
144565881|NCT00971997|521273592|FG000|Overall Study|Physician Decision|7|||
144565882|NCT04523207|521273595|FG000|Overall Study|Adverse Event|5|||
144565883|NCT04523207|521273596|FG001|Overall Study|Adverse Event|1|||
144565884|NCT04523207|521273595|FG000|Overall Study|Lost to Follow-up|2|||
144565885|NCT04523207|521273596|FG001|Overall Study|Lost to Follow-up|0|||
144565886|NCT04523207|521273595|FG000|Overall Study|Withdrawal by Subject|2|||
144565887|NCT04523207|521273596|FG001|Overall Study|Withdrawal by Subject|0|||
144618477|NCT01425008|521461307|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
144618478|NCT01425008|521461308|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
144618479|NCT01425008|521461309|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
144565888|NCT04523207|521273595|FG000|Overall Study|Progressive Disease|2|||
144565889|NCT04523207|521273596|FG001|Overall Study|Progressive Disease|1|||
144618480|NCT01425008|521461310|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
144728410|NCT01866319|521861227|FG001|Overall Study|Lost to Follow-up|3|||
144262622|NCT01657162|520161499|FG000|Overall Study|Refusal of Treatment|4|||
144565890|NCT04523207|521273595|FG000|Overall Study|Other|7|||
144565891|NCT04523207|521273596|FG001|Overall Study|Other|1|||
144565892|NCT03113383|521273597|FG000|Overall Study|Death|4|||
144565893|NCT03113383|521273598|FG001|Overall Study|Death|0|||
144565894|NCT03062449|521273599|FG000|Overall Study|Withdrawal by Subject|7|||
144565895|NCT03062449|521273600|FG001|Overall Study|Withdrawal by Subject|1|||
144565896|NCT04702893|521273602|FG000|Overall Study|Other reasons than listed|11|||
144565897|NCT04702893|521273602|FG000|Overall Study|Withdrawal by Subject|3|||
144565898|NCT04702893|521273602|FG000|Overall Study|Lost to Follow-up|7|||
144565899|NCT04702893|521273602|FG000|Overall Study|Death|10|||
144565900|NCT04702893|521273602|FG000|Overall Study|Not treated|6|||
144565901|NCT00408928|521273603|FG000|Overall Study|Withdrawal by Subject|1|||
144565902|NCT00408928|521273603|FG000|Overall Study|Death|1|||
144565903|NCT00408928|521273603|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
144565904|NCT03568812|521273605|FG000|Overall Study|Physician Decision|0|||
144565905|NCT03568812|521273606|FG001|Overall Study|Physician Decision|1|||
144565906|NCT03194867|521273610|FG000|Overall Study|Incorrect completion of end of study form|0|||
144565907|NCT03194867|521273611|FG001|Overall Study|Incorrect completion of end of study form|0|||
144565908|NCT03194867|521273612|FG002|Overall Study|Incorrect completion of end of study form|1|||
144565909|NCT03194867|521273613|FG003|Overall Study|Incorrect completion of end of study form|0|||
144565910|NCT00464945|521273614|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
144565911|NCT00464945|521273615|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
144565912|NCT00464945|521273614|FG000|Infant Series|Protocol Violation|1|||
144565913|NCT00464945|521273615|FG001|Infant Series|Protocol Violation|0|||
144565914|NCT00464945|521273614|FG000|Infant Series|Lost to Follow-up|1|||
144565915|NCT00464945|521273615|FG001|Infant Series|Lost to Follow-up|0|||
144565916|NCT00464945|521273614|FG000|After Infant Series|Withdrawal by Subject|0|||
144565917|NCT00464945|521273615|FG001|After Infant Series|Withdrawal by Subject|2|||
144565918|NCT00464945|521273614|FG000|Toddler Dose|Lost to Follow-up|0|||
144565919|NCT00464945|521273615|FG001|Toddler Dose|Lost to Follow-up|1|||
144565920|NCT03546816|521273616|FG000|Overall Study|Adverse Event|5|||
144565921|NCT03546816|521273617|FG001|Overall Study|Adverse Event|3|||
144565922|NCT03546816|521273616|FG000|Overall Study|Lack of Efficacy|2|||
144565923|NCT03546816|521273617|FG001|Overall Study|Lack of Efficacy|4|||
144565924|NCT03546816|521273616|FG000|Overall Study|Pregnancy|1|||
144565925|NCT03546816|521273617|FG001|Overall Study|Pregnancy|0|||
144565926|NCT03546816|521273616|FG000|Overall Study|Physician Decision|2|||
144565927|NCT03546816|521273617|FG001|Overall Study|Physician Decision|0|||
144565928|NCT03546816|521273616|FG000|Overall Study|Withdrawal by Subject|8|||
144204741|NCT03384654|519944519|FG000|Overall Study|Withdrawal by Subject|0|||
144204742|NCT03384654|519944520|FG001|Overall Study|Withdrawal by Subject|0|||
144204743|NCT03384654|519944521|FG002|Overall Study|Withdrawal by Subject|1|||
144204744|NCT03384654|519944522|FG003|Overall Study|Withdrawal by Subject|0|||
144565929|NCT03546816|521273617|FG001|Overall Study|Withdrawal by Subject|10|||
144565930|NCT03546816|521273616|FG000|Overall Study|Lost to Follow-up|3|||
144565931|NCT03546816|521273617|FG001|Overall Study|Lost to Follow-up|2|||
144565932|NCT02438371|521273618|FG000|Overall Study|Lost to Follow-up|3|||
144565933|NCT02438371|521273619|FG001|Overall Study|Lost to Follow-up|2|||
144565934|NCT02438371|521273618|FG000|Overall Study|Withdrawal by Subject|1|||
144565935|NCT02438371|521273619|FG001|Overall Study|Withdrawal by Subject|1|||
144565936|NCT03065933|521273622|FG000|Overall Study|study terminated|5|||
144565937|NCT03021551|521273624|FG000|Overall Study|Equipment Issues|2|||
144565938|NCT03021551|521273624|FG000|Overall Study|Protocol Violation|1|||
144565939|NCT00551135|521273629|FG000|Overall Study|Adverse Event|1|||
144565940|NCT00551135|521273630|FG001|Overall Study|Adverse Event|0|||
144565941|NCT00551135|521273631|FG002|Overall Study|Adverse Event|1|||
144565942|NCT00551135|521273632|FG003|Overall Study|Adverse Event|1|||
144565943|NCT00551135|521273629|FG000|Overall Study|Lost to Follow-up|0|||
144565944|NCT00551135|521273630|FG001|Overall Study|Lost to Follow-up|0|||
144565945|NCT00551135|521273631|FG002|Overall Study|Lost to Follow-up|0|||
144565946|NCT00551135|521273632|FG003|Overall Study|Lost to Follow-up|1|||
144565947|NCT00551135|521273629|FG000|Overall Study|Other|3|||
144565948|NCT00551135|521273630|FG001|Overall Study|Other|2|||
144565949|NCT00551135|521273631|FG002|Overall Study|Other|1|||
144565950|NCT00551135|521273632|FG003|Overall Study|Other|2|||
144565951|NCT00551135|521273629|FG000|Overall Study|Withdrawal by Subject|1|||
144565952|NCT00551135|521273630|FG001|Overall Study|Withdrawal by Subject|0|||
144565953|NCT00551135|521273631|FG002|Overall Study|Withdrawal by Subject|3|||
144565954|NCT00551135|521273632|FG003|Overall Study|Withdrawal by Subject|1|||
144565955|NCT04799418|521273633|FG000|Overall Study|Death|1|||
144565956|NCT04799418|521273634|FG001|Overall Study|Death|1|||
144565957|NCT04799418|521273633|FG000|Overall Study|Lack of Efficacy|14|||
144204745|NCT03233230|519944525|FG000|Overall Study|Adverse Event|6|||
144204746|NCT03233230|519944526|FG001|Overall Study|Adverse Event|3|||
144204747|NCT03233230|519944527|FG002|Overall Study|Adverse Event|6|||
144204748|NCT03233230|519944528|FG003|Overall Study|Adverse Event|3|||
144565958|NCT04799418|521273634|FG001|Overall Study|Lack of Efficacy|14|||
144565959|NCT04799418|521273633|FG000|Overall Study|Withdrawal by Subject|10|||
144565960|NCT04799418|521273634|FG001|Overall Study|Withdrawal by Subject|7|||
144565961|NCT04799418|521273633|FG000|Overall Study|Adverse Event|3|||
144565962|NCT04799418|521273634|FG001|Overall Study|Adverse Event|2|||
144565963|NCT01379703|521273635|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
144565964|NCT01379703|521273636|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
144565965|NCT01379703|521273637|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
144565966|NCT01379703|521273635|FG000|Study Start Through 9 Months|Adverse Event|0|||
144565967|NCT01379703|521273636|FG001|Study Start Through 9 Months|Adverse Event|14|||
144565968|NCT01379703|521273637|FG002|Study Start Through 9 Months|Adverse Event|10|||
144565969|NCT01379703|521273635|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
144728411|NCT01866319|521861228|FG002|Overall Study|Lost to Follow-up|8|||
144618481|NCT01425008|521461311|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
144204749|NCT03233230|519944525|FG000|Overall Study|Protocol Violation|1|||
144204750|NCT03233230|519944526|FG001|Overall Study|Protocol Violation|2|||
144204751|NCT03233230|519944527|FG002|Overall Study|Protocol Violation|1|||
144204752|NCT03233230|519944528|FG003|Overall Study|Protocol Violation|1|||
144204753|NCT03233230|519944525|FG000|Overall Study|Lack of Efficacy|1|||
144204754|NCT03233230|519944526|FG001|Overall Study|Lack of Efficacy|0|||
144204755|NCT03233230|519944527|FG002|Overall Study|Lack of Efficacy|0|||
144204756|NCT03233230|519944528|FG003|Overall Study|Lack of Efficacy|0|||
144204757|NCT03233230|519944525|FG000|Overall Study|Other|5|||
144565970|NCT01379703|521273636|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
144565971|NCT01379703|521273637|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
144565972|NCT01379703|521273635|FG000|Study Start Through 9 Months|Treatment Failure|0|||
144565973|NCT01379703|521273636|FG001|Study Start Through 9 Months|Treatment Failure|2|||
144565974|NCT01379703|521273637|FG002|Study Start Through 9 Months|Treatment Failure|2|||
144565975|NCT01379703|521273635|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
144565976|NCT01379703|521273636|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
144565977|NCT01379703|521273637|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
144565978|NCT01379703|521273635|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
144565979|NCT01379703|521273636|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
144565980|NCT01379703|521273637|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
144565981|NCT01379703|521273635|FG000|Study Start Through 9 Months|Medication not available|0|||
144565982|NCT01379703|521273636|FG001|Study Start Through 9 Months|Medication not available|2|||
144565983|NCT01379703|521273637|FG002|Study Start Through 9 Months|Medication not available|1|||
144565984|NCT01379703|521273635|FG000|Study Start Through 9 Months|Poor general condition|0|||
144565985|NCT01379703|521273636|FG001|Study Start Through 9 Months|Poor general condition|1|||
144565986|NCT01379703|521273637|FG002|Study Start Through 9 Months|Poor general condition|0|||
144565987|NCT01379703|521273635|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
144565988|NCT01379703|521273636|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
144565989|NCT01379703|521273637|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
144565990|NCT01379703|521273635|FG000|Study Start Through 9 Months|Reason unknown|2|||
144565991|NCT01379703|521273636|FG001|Study Start Through 9 Months|Reason unknown|31|||
144565992|NCT01379703|521273637|FG002|Study Start Through 9 Months|Reason unknown|24|||
144565993|NCT01379703|521273635|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
144565994|NCT01379703|521273636|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
144565995|NCT01379703|521273637|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
144565996|NCT01379703|521273635|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
144565997|NCT01379703|521273636|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
144565998|NCT01379703|521273637|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
144565999|NCT01379703|521273635|FG000|9 Months Through 18 Months|Adverse Event|0|||
144566000|NCT01379703|521273636|FG001|9 Months Through 18 Months|Adverse Event|6|||
144566001|NCT01379703|521273637|FG002|9 Months Through 18 Months|Adverse Event|0|||
144566002|NCT01379703|521273635|FG000|9 Months Through 18 Months|Treatment failure|0|||
144566003|NCT01379703|521273636|FG001|9 Months Through 18 Months|Treatment failure|5|||
144566004|NCT01379703|521273637|FG002|9 Months Through 18 Months|Treatment failure|0|||
144566005|NCT01379703|521273635|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
144566006|NCT01379703|521273636|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
144566007|NCT01379703|521273637|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
144566008|NCT01379703|521273635|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
144566009|NCT01379703|521273636|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
144566010|NCT01379703|521273637|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
144566011|NCT01379703|521273635|FG000|9 Months Through 18 Months|Fatigue|0|||
144566012|NCT01379703|521273636|FG001|9 Months Through 18 Months|Fatigue|1|||
144566013|NCT01379703|521273637|FG002|9 Months Through 18 Months|Fatigue|0|||
144566014|NCT01379703|521273635|FG000|9 Months Through 18 Months|Reason Unknown|0|||
144566015|NCT01379703|521273636|FG001|9 Months Through 18 Months|Reason Unknown|23|||
144566016|NCT01379703|521273637|FG002|9 Months Through 18 Months|Reason Unknown|0|||
144566017|NCT03463577|521273638|FG000|Overall Study|Lost to Follow-up|238|||
144566018|NCT03463577|521273639|FG001|Overall Study|Lost to Follow-up|435|||
144204758|NCT03233230|519944526|FG001|Overall Study|Other|5|||
144566019|NCT03463577|521273640|FG002|Overall Study|Lost to Follow-up|0|||
144566020|NCT03463577|521273641|FG003|Overall Study|Lost to Follow-up|0|||
144566021|NCT03463577|521273642|FG004|Overall Study|Lost to Follow-up|0|||
144566022|NCT03463577|521273643|FG005|Overall Study|Lost to Follow-up|0|||
144618482|NCT01425008|521461293|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618483|NCT01425008|521461294|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618484|NCT01425008|521461295|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
144566023|NCT03463577|521273638|FG000|Overall Study|With unknown pregnancy outcome|0|||
144618485|NCT01425008|521461296|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618486|NCT01425008|521461297|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
144204759|NCT03233230|519944527|FG002|Overall Study|Other|5|||
144204760|NCT03233230|519944528|FG003|Overall Study|Other|3|||
144204761|NCT03233230|519944525|FG000|Overall Study|Withdrawal by Subject|2|||
144204762|NCT03233230|519944526|FG001|Overall Study|Withdrawal by Subject|2|||
144204763|NCT03233230|519944527|FG002|Overall Study|Withdrawal by Subject|0|||
144204764|NCT03233230|519944528|FG003|Overall Study|Withdrawal by Subject|1|||
144204765|NCT03233230|519944525|FG000|Overall Study|Lost to Follow-up|0|||
144204766|NCT03233230|519944526|FG001|Overall Study|Lost to Follow-up|3|||
144204767|NCT03233230|519944527|FG002|Overall Study|Lost to Follow-up|0|||
144204768|NCT03233230|519944528|FG003|Overall Study|Lost to Follow-up|0|||
144204769|NCT01584843|519944529|FG000|First Treatment Period|Adverse Event|0|||
144204770|NCT01584843|519944530|FG001|First Treatment Period|Adverse Event|0|||
144204771|NCT01584843|519944531|FG002|First Treatment Period|Adverse Event|1|||
144204772|NCT01584843|519944532|FG003|First Treatment Period|Adverse Event|0|||
144204773|NCT01584843|519944533|FG004|First Treatment Period|Adverse Event|0|||
144204774|NCT01584843|519944534|FG005|First Treatment Period|Adverse Event|0|||
144204775|NCT01584843|519944529|FG000|First Treatment Period|Protocol Violation|0|||
144204776|NCT01584843|519944530|FG001|First Treatment Period|Protocol Violation|0|||
144204777|NCT01584843|519944531|FG002|First Treatment Period|Protocol Violation|0|||
144204778|NCT01584843|519944532|FG003|First Treatment Period|Protocol Violation|0|||
144204779|NCT01584843|519944533|FG004|First Treatment Period|Protocol Violation|0|||
144204780|NCT01584843|519944534|FG005|First Treatment Period|Protocol Violation|1|||
144204781|NCT01584843|519944529|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
144204782|NCT01584843|519944530|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
144204783|NCT01584843|519944531|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
144204784|NCT01584843|519944532|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
144204785|NCT01584843|519944533|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
144204786|NCT01584843|519944534|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
144204787|NCT01584843|519944529|FG000|Second Treatment Period|Withdrawal by Subject|0|||
144204788|NCT01584843|519944530|FG001|Second Treatment Period|Withdrawal by Subject|0|||
144204789|NCT01584843|519944531|FG002|Second Treatment Period|Withdrawal by Subject|0|||
144204790|NCT01584843|519944532|FG003|Second Treatment Period|Withdrawal by Subject|0|||
144204791|NCT01584843|519944533|FG004|Second Treatment Period|Withdrawal by Subject|0|||
144204792|NCT01584843|519944534|FG005|Second Treatment Period|Withdrawal by Subject|1|||
144204793|NCT04126213|519944537|FG000|Overall Study|Lost to Follow-up|9|||
144204794|NCT04126213|519944538|FG001|Overall Study|Lost to Follow-up|1|||
144204795|NCT04126213|519944539|FG002|Overall Study|Lost to Follow-up|5|||
144204796|NCT04126213|519944540|FG003|Overall Study|Lost to Follow-up|10|||
144204797|NCT04126213|519944541|FG004|Overall Study|Lost to Follow-up|4|||
144204798|NCT04126213|519944542|FG005|Overall Study|Lost to Follow-up|7|||
144204799|NCT04126213|519944537|FG000|Overall Study|Withdrawal by Subject|3|||
144204800|NCT04126213|519944538|FG001|Overall Study|Withdrawal by Subject|2|||
144204801|NCT04126213|519944539|FG002|Overall Study|Withdrawal by Subject|1|||
144204802|NCT04126213|519944540|FG003|Overall Study|Withdrawal by Subject|1|||
144204803|NCT04126213|519944541|FG004|Overall Study|Withdrawal by Subject|1|||
144204804|NCT04126213|519944542|FG005|Overall Study|Withdrawal by Subject|1|||
144204805|NCT04126213|519944537|FG000|Overall Study|Other|0|||
144204806|NCT04126213|519944538|FG001|Overall Study|Other|0|||
144204807|NCT04126213|519944539|FG002|Overall Study|Other|2|||
144204808|NCT04126213|519944540|FG003|Overall Study|Other|2|||
144204809|NCT04126213|519944541|FG004|Overall Study|Other|0|||
144204810|NCT04126213|519944542|FG005|Overall Study|Other|1|||
144204811|NCT04126213|519944537|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144204812|NCT04126213|519944538|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
144204813|NCT04126213|519944539|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144204814|NCT04126213|519944540|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144204815|NCT04126213|519944541|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144204816|NCT04126213|519944542|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
144204817|NCT02853370|519944543|FG000|Overall Study|Physician Decision|1|||
144204818|NCT02853370|519944543|FG000|Overall Study|Lack of Efficacy|2|||
144204819|NCT02853370|519944543|FG000|Overall Study|Death|1|||
144204820|NCT02853370|519944543|FG000|Overall Study|Adverse Event|4|||
144204821|NCT02853370|519944543|FG000|Overall Study|Withdrawal by Subject|3|||
144204822|NCT02196701|519944544|FG000|Overall Study|Adverse Event|1|||
144204823|NCT02196701|519944544|FG000|Overall Study|Lost to Follow-up|1|||
144204824|NCT02196701|519944544|FG000|Overall Study|Non-adherence to Protocol|1|||
144204825|NCT03275064|519944545|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
144204826|NCT03275064|519944546|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
144204827|NCT03275064|519944547|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
144204828|NCT03275064|519944548|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
144204829|NCT03275064|519944549|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
144204830|NCT03275064|519944545|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
144204831|NCT03275064|519944546|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
144728412|NCT01866319|521861226|FG000|Overall Study|Physician Decision|1|||
144728413|NCT01866319|521861227|FG001|Overall Study|Physician Decision|0|||
144728414|NCT01866319|521861228|FG002|Overall Study|Physician Decision|1|||
144728415|NCT01866319|521861226|FG000|Overall Study|Protocol Violation|0|||
144728416|NCT01866319|521861227|FG001|Overall Study|Protocol Violation|0|||
144728417|NCT01866319|521861228|FG002|Overall Study|Protocol Violation|1|||
144728418|NCT01866319|521861226|FG000|Overall Study|Withdrawal by Subject|32|||
144728419|NCT01866319|521861227|FG001|Overall Study|Withdrawal by Subject|14|||
144728420|NCT01866319|521861228|FG002|Overall Study|Withdrawal by Subject|12|||
144728421|NCT00623779|521861232|FG000|Overall Study|Adverse Event|1|||
144728422|NCT00623779|521861233|FG001|Overall Study|Adverse Event|3|||
144728423|NCT00623779|521861234|FG002|Overall Study|Adverse Event|0|||
144728424|NCT00623779|521861232|FG000|Overall Study|Criteria from CSR|2|||
144728425|NCT00623779|521861233|FG001|Overall Study|Criteria from CSR|0|||
144728426|NCT00623779|521861234|FG002|Overall Study|Criteria from CSR|1|||
144728427|NCT01856309|521861235|FG000|Overall Study|Death|4|||
144728428|NCT01856309|521861236|FG001|Overall Study|Death|6|||
144728429|NCT01856309|521861237|FG002|Overall Study|Death|11|||
144728430|NCT01856309|521861238|FG003|Overall Study|Death|6|||
144728431|NCT01856309|521861235|FG000|Overall Study|Lost to Follow-up|6|||
144728432|NCT01856309|521861236|FG001|Overall Study|Lost to Follow-up|2|||
144728433|NCT01856309|521861237|FG002|Overall Study|Lost to Follow-up|4|||
144728434|NCT01856309|521861238|FG003|Overall Study|Lost to Follow-up|8|||
144728435|NCT01856309|521861235|FG000|Overall Study|Withdrawal by Subject|11|||
144728436|NCT01856309|521861236|FG001|Overall Study|Withdrawal by Subject|13|||
144566024|NCT03463577|521273639|FG001|Overall Study|With unknown pregnancy outcome|5|||
144566025|NCT03463577|521273640|FG002|Overall Study|With unknown pregnancy outcome|0|||
144566026|NCT03463577|521273641|FG003|Overall Study|With unknown pregnancy outcome|0|||
144566027|NCT03463577|521273642|FG004|Overall Study|With unknown pregnancy outcome|0|||
144566028|NCT03463577|521273643|FG005|Overall Study|With unknown pregnancy outcome|0|||
144566029|NCT03463577|521273638|FG000|Overall Study|Maternal death|2|||
144566030|NCT03463577|521273639|FG001|Overall Study|Maternal death|0|||
144566031|NCT03463577|521273640|FG002|Overall Study|Maternal death|0|||
144566032|NCT03463577|521273641|FG003|Overall Study|Maternal death|0|||
144566033|NCT03463577|521273642|FG004|Overall Study|Maternal death|0|||
144566034|NCT03463577|521273643|FG005|Overall Study|Maternal death|0|||
144566035|NCT03463577|521273638|FG000|Overall Study|Neonatal death|0|||
144566036|NCT03463577|521273639|FG001|Overall Study|Neonatal death|0|||
144566037|NCT03463577|521273640|FG002|Overall Study|Neonatal death|0|||
144566038|NCT03463577|521273641|FG003|Overall Study|Neonatal death|15|||
144566039|NCT03463577|521273642|FG004|Overall Study|Neonatal death|17|||
144566040|NCT03463577|521273643|FG005|Overall Study|Neonatal death|0|||
144566041|NCT00236184|521273644|FG000|Overall Study|Adverse Event|5|||
144566042|NCT00236184|521273645|FG001|Overall Study|Adverse Event|2|||
144566043|NCT00236184|521273644|FG000|Overall Study|Lack of Efficacy|0|||
144566044|NCT00236184|521273645|FG001|Overall Study|Lack of Efficacy|1|||
144566045|NCT00236184|521273644|FG000|Overall Study|Lost to Follow-up|3|||
144566046|NCT00236184|521273645|FG001|Overall Study|Lost to Follow-up|4|||
144566047|NCT00236184|521273644|FG000|Overall Study|Physician Decision|1|||
144566048|NCT00236184|521273645|FG001|Overall Study|Physician Decision|1|||
144566049|NCT00236184|521273644|FG000|Overall Study|Withdrawal by Subject|3|||
144566050|NCT00236184|521273645|FG001|Overall Study|Withdrawal by Subject|0|||
144566051|NCT00236184|521273644|FG000|Overall Study|Protocol Violation|3|||
144618487|NCT01425008|521461298|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618488|NCT01425008|521461299|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618489|NCT01425008|521461300|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618490|NCT01425008|521461301|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
144618491|NCT01425008|521461302|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
144618492|NCT01425008|521461303|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618493|NCT01425008|521461304|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618494|NCT01425008|521461305|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618495|NCT01425008|521461306|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618496|NCT01425008|521461307|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
144728437|NCT01856309|521861237|FG002|Overall Study|Withdrawal by Subject|28|||
144204832|NCT03275064|519944547|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
144204833|NCT03275064|519944548|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
144262623|NCT01657162|520161500|FG001|Overall Study|Refusal of Treatment|6|||
144566052|NCT00236184|521273645|FG001|Overall Study|Protocol Violation|0|||
144566053|NCT00236184|521273644|FG000|Overall Study|non-compliance with study drug|2|||
144566054|NCT00236184|521273645|FG001|Overall Study|non-compliance with study drug|1|||
144566055|NCT00236184|521273644|FG000|Overall Study|other|1|||
144566056|NCT00236184|521273645|FG001|Overall Study|other|2|||
144566057|NCT02669407|521273646|FG000|Overall Study|Physician Decision|3|||
144566058|NCT00704171|521273649|FG000|Overall Study|Withdrawal by Subject|1|||
144566059|NCT00704171|521273650|FG001|Overall Study|Withdrawal by Subject|0|||
144728438|NCT01856309|521861238|FG003|Overall Study|Withdrawal by Subject|26|||
144728439|NCT01856309|521861235|FG000|Overall Study|Other|227|||
144728440|NCT01856309|521861236|FG001|Overall Study|Other|225|||
144566060|NCT03634839|521273651|FG000|First Intervention (2 Hours)|Adverse Event|0|||
144566061|NCT03634839|521273652|FG001|First Intervention (2 Hours)|Adverse Event|2|||
144566062|NCT00719043|521273660|FG000|Overall Study|Adverse Event|5|||
144566063|NCT00719043|521273661|FG001|Overall Study|Adverse Event|1|||
144566064|NCT00719043|521273662|FG002|Overall Study|Adverse Event|2|||
144566065|NCT00719043|521273663|FG003|Overall Study|Adverse Event|2|||
144566066|NCT00719043|521273664|FG004|Overall Study|Adverse Event|1|||
144618497|NCT01425008|521461308|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618498|NCT01425008|521461309|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618499|NCT01425008|521461310|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618500|NCT01425008|521461311|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
144618501|NCT01425008|521461293|FG000|Dose Escalation Phase|Other|0|||
144618502|NCT01425008|521461294|FG001|Dose Escalation Phase|Other|0|||
144618503|NCT01425008|521461295|FG002|Dose Escalation Phase|Other|0|||
144618504|NCT01425008|521461296|FG003|Dose Escalation Phase|Other|0|||
144618505|NCT01425008|521461297|FG004|Dose Escalation Phase|Other|0|||
144618506|NCT01425008|521461298|FG005|Dose Escalation Phase|Other|0|||
144618507|NCT01425008|521461299|FG006|Dose Escalation Phase|Other|0|||
144618508|NCT01425008|521461300|FG007|Dose Escalation Phase|Other|0|||
144618509|NCT01425008|521461301|FG008|Dose Escalation Phase|Other|1|||
144618510|NCT01425008|521461302|FG009|Dose Escalation Phase|Other|0|||
144618511|NCT01425008|521461303|FG010|Dose Escalation Phase|Other|0|||
144618512|NCT01425008|521461304|FG011|Dose Escalation Phase|Other|0|||
144618513|NCT01425008|521461305|FG012|Dose Escalation Phase|Other|0|||
144618514|NCT01425008|521461306|FG013|Dose Escalation Phase|Other|0|||
144618515|NCT01425008|521461307|FG014|Dose Escalation Phase|Other|0|||
144618516|NCT01425008|521461308|FG015|Dose Escalation Phase|Other|0|||
144618517|NCT01425008|521461309|FG016|Dose Escalation Phase|Other|0|||
144618518|NCT01425008|521461310|FG017|Dose Escalation Phase|Other|0|||
144618519|NCT01425008|521461311|FG018|Dose Escalation Phase|Other|0|||
144618520|NCT01425008|521461293|FG000|Dose Expansion Phase|Progressive Disease|0|||
144618521|NCT01425008|521461294|FG001|Dose Expansion Phase|Progressive Disease|0|||
144618522|NCT01425008|521461295|FG002|Dose Expansion Phase|Progressive Disease|0|||
144618523|NCT01425008|521461296|FG003|Dose Expansion Phase|Progressive Disease|0|||
144618524|NCT01425008|521461297|FG004|Dose Expansion Phase|Progressive Disease|0|||
144618525|NCT01425008|521461298|FG005|Dose Expansion Phase|Progressive Disease|0|||
144566067|NCT00719043|521273665|FG005|Overall Study|Adverse Event|4|||
144566068|NCT00719043|521273666|FG006|Overall Study|Adverse Event|4|||
144566069|NCT00719043|521273660|FG000|Overall Study|Lost to Follow-up|14|||
144566070|NCT00719043|521273661|FG001|Overall Study|Lost to Follow-up|10|||
144566071|NCT00719043|521273662|FG002|Overall Study|Lost to Follow-up|8|||
144566072|NCT00719043|521273663|FG003|Overall Study|Lost to Follow-up|9|||
144618526|NCT01425008|521461299|FG006|Dose Expansion Phase|Progressive Disease|0|||
144618527|NCT01425008|521461300|FG007|Dose Expansion Phase|Progressive Disease|0|||
144618528|NCT01425008|521461301|FG008|Dose Expansion Phase|Progressive Disease|0|||
144618529|NCT01425008|521461302|FG009|Dose Expansion Phase|Progressive Disease|0|||
144618530|NCT01425008|521461303|FG010|Dose Expansion Phase|Progressive Disease|10|||
144618531|NCT01425008|521461304|FG011|Dose Expansion Phase|Progressive Disease|4|||
144618532|NCT01425008|521461305|FG012|Dose Expansion Phase|Progressive Disease|12|||
144618533|NCT01425008|521461306|FG013|Dose Expansion Phase|Progressive Disease|1|||
144618534|NCT01425008|521461307|FG014|Dose Expansion Phase|Progressive Disease|5|||
144618535|NCT01425008|521461308|FG015|Dose Expansion Phase|Progressive Disease|8|||
144618536|NCT01425008|521461309|FG016|Dose Expansion Phase|Progressive Disease|9|||
144618537|NCT01425008|521461310|FG017|Dose Expansion Phase|Progressive Disease|2|||
144618538|NCT01425008|521461311|FG018|Dose Expansion Phase|Progressive Disease|10|||
144618539|NCT01425008|521461293|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
144618540|NCT01425008|521461294|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
144618541|NCT01425008|521461295|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
144618542|NCT01425008|521461296|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
144618543|NCT01425008|521461297|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
144618544|NCT01425008|521461298|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
144618545|NCT01425008|521461299|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
144618546|NCT01425008|521461300|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
144618547|NCT01425008|521461301|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
144618548|NCT01425008|521461302|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
144618549|NCT01425008|521461303|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
144618550|NCT01425008|521461304|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
144728441|NCT01856309|521861237|FG002|Overall Study|Other|447|||
144728442|NCT01856309|521861238|FG003|Overall Study|Other|469|||
144728443|NCT01856309|521861235|FG000|Overall Study|Lack of Efficacy|14|||
144566073|NCT00719043|521273664|FG004|Overall Study|Lost to Follow-up|10|||
144566074|NCT00719043|521273665|FG005|Overall Study|Lost to Follow-up|9|||
144566075|NCT00719043|521273666|FG006|Overall Study|Lost to Follow-up|9|||
144618551|NCT01425008|521461305|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
144618552|NCT01425008|521461306|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
144728444|NCT01856309|521861236|FG001|Overall Study|Lack of Efficacy|9|||
144728445|NCT01856309|521861237|FG002|Overall Study|Lack of Efficacy|40|||
144566076|NCT00719043|521273660|FG000|Overall Study|Protocol Violation|0|||
144566077|NCT00719043|521273661|FG001|Overall Study|Protocol Violation|0|||
144566078|NCT00719043|521273662|FG002|Overall Study|Protocol Violation|0|||
144566079|NCT00719043|521273663|FG003|Overall Study|Protocol Violation|0|||
144566080|NCT00719043|521273664|FG004|Overall Study|Protocol Violation|0|||
144566081|NCT00719043|521273665|FG005|Overall Study|Protocol Violation|1|||
144566082|NCT00719043|521273666|FG006|Overall Study|Protocol Violation|0|||
144566083|NCT00719043|521273660|FG000|Overall Study|Other|1|||
144566084|NCT00719043|521273661|FG001|Overall Study|Other|0|||
144566085|NCT00719043|521273662|FG002|Overall Study|Other|1|||
144566086|NCT00719043|521273663|FG003|Overall Study|Other|2|||
144566087|NCT00719043|521273664|FG004|Overall Study|Other|0|||
144566088|NCT00719043|521273665|FG005|Overall Study|Other|2|||
144566089|NCT00719043|521273666|FG006|Overall Study|Other|1|||
144566090|NCT00719043|521273660|FG000|Overall Study|Withdrawal by Subject|12|||
144566091|NCT00719043|521273661|FG001|Overall Study|Withdrawal by Subject|14|||
144566092|NCT00719043|521273662|FG002|Overall Study|Withdrawal by Subject|9|||
144566093|NCT00719043|521273663|FG003|Overall Study|Withdrawal by Subject|10|||
144566094|NCT00719043|521273664|FG004|Overall Study|Withdrawal by Subject|16|||
144566095|NCT00719043|521273665|FG005|Overall Study|Withdrawal by Subject|18|||
144566096|NCT00719043|521273666|FG006|Overall Study|Withdrawal by Subject|14|||
144566097|NCT01588366|521273667|FG000|Overall Study|Adverse Event|0|||
144566098|NCT01588366|521273668|FG001|Overall Study|Adverse Event|1|||
144566099|NCT01588366|521273669|FG002|Overall Study|Adverse Event|0|||
144618553|NCT01425008|521461307|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
144618554|NCT01425008|521461308|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
144204834|NCT03275064|519944549|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
144618555|NCT01425008|521461309|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
144618556|NCT01425008|521461310|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
144204835|NCT03275064|519944545|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
144204836|NCT03275064|519944546|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
144204837|NCT03275064|519944547|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
144204838|NCT03275064|519944548|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
144204839|NCT03275064|519944549|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
144204840|NCT03275064|519944545|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
144204841|NCT03275064|519944546|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
144204842|NCT03275064|519944547|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
144204843|NCT03275064|519944548|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
144204844|NCT03275064|519944549|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
144204845|NCT03275064|519944545|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
144204846|NCT03275064|519944546|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
144204847|NCT03275064|519944547|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
144204848|NCT03275064|519944548|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
144204849|NCT03275064|519944549|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
144204850|NCT01341782|519944550|FG000|Overall Study|Adverse Event|1|||
144204851|NCT01341782|519944551|FG001|Overall Study|Adverse Event|1|||
144204852|NCT01341782|519944550|FG000|Overall Study|Withdrawal by Subject|6|||
144204853|NCT01341782|519944551|FG001|Overall Study|Withdrawal by Subject|5|||
144204854|NCT01341782|519944550|FG000|Overall Study|Missed 3 consecutive doses|0|||
144204855|NCT01341782|519944551|FG001|Overall Study|Missed 3 consecutive doses|4|||
144204856|NCT01341782|519944550|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
144204857|NCT01341782|519944551|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
144204858|NCT01341782|519944550|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
144204859|NCT01341782|519944551|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
144204860|NCT01341782|519944550|FG000|Overall Study|Other|5|||
144204861|NCT01341782|519944551|FG001|Overall Study|Other|0|||
144204862|NCT00620555|519944552|FG000|Overall Study|Adverse Event|4|||
144204863|NCT00620555|519944552|FG000|Overall Study|Protocol Violation|2|||
144204864|NCT00620555|519944552|FG000|Overall Study|Lack of Efficacy|12|||
144204865|NCT00620555|519944552|FG000|Overall Study|Withdrawal by Subject|1|||
144204866|NCT00620555|519944552|FG000|Overall Study|Choice of other treatment|1|||
144204867|NCT00620555|519944552|FG000|Overall Study|Visit failure against planned|1|||
144262624|NCT01657162|520161499|FG000|Overall Study|Lost to Follow-up|3|||
144566100|NCT01588366|521273670|FG003|Overall Study|Adverse Event|1|||
144566101|NCT01588366|521273671|FG004|Overall Study|Adverse Event|0|||
144566102|NCT01588366|521273672|FG005|Overall Study|Adverse Event|2|||
144566103|NCT00302159|521273673|FG000|Overall Study|pt declined before treatment started|1|||
144566104|NCT00302159|521273673|FG000|Overall Study|pt started Avastin|1|||
144566105|NCT00813098|521273674|FG000|Overall Study|Adverse Event|2|||
144566106|NCT00813098|521273675|FG001|Overall Study|Adverse Event|4|||
144566107|NCT00813098|521273676|FG002|Overall Study|Adverse Event|1|||
144566108|NCT00813098|521273674|FG000|Overall Study|Withdrawal by Subject|0|||
144566109|NCT00813098|521273675|FG001|Overall Study|Withdrawal by Subject|1|||
144566110|NCT00813098|521273676|FG002|Overall Study|Withdrawal by Subject|0|||
144566111|NCT00813098|521273674|FG000|Overall Study|Inability to complete study procedures|1|||
144566112|NCT00813098|521273675|FG001|Overall Study|Inability to complete study procedures|0|||
144566113|NCT00813098|521273676|FG002|Overall Study|Inability to complete study procedures|0|||
144566114|NCT00813098|521273674|FG000|Overall Study|Lost to Follow-up|0|||
144566115|NCT00813098|521273675|FG001|Overall Study|Lost to Follow-up|1|||
144566116|NCT00813098|521273676|FG002|Overall Study|Lost to Follow-up|0|||
144566117|NCT00813098|521273674|FG000|Overall Study|Protocol Violation|0|||
144566118|NCT00813098|521273675|FG001|Overall Study|Protocol Violation|0|||
144566119|NCT00813098|521273676|FG002|Overall Study|Protocol Violation|1|||
144566120|NCT00813098|521273674|FG000|Overall Study|Principal Investigator decision|0|||
144566121|NCT00813098|521273675|FG001|Overall Study|Principal Investigator decision|1|||
144566122|NCT00813098|521273676|FG002|Overall Study|Principal Investigator decision|0|||
144566123|NCT00813098|521273674|FG000|Overall Study|Withdrew Consent|0|||
144566124|NCT00813098|521273675|FG001|Overall Study|Withdrew Consent|1|||
144566125|NCT00813098|521273676|FG002|Overall Study|Withdrew Consent|0|||
144566126|NCT04962698|521273677|FG000|Motor Imagery|Technical difficulty|1|||
144566127|NCT04962698|521273678|FG001|Motor Imagery|Technical difficulty|0|||
144566128|NCT04962698|521273677|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
144566129|NCT04962698|521273678|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
144566130|NCT04962698|521273677|FG000|Kinesthetic MI|Technical difficulty|1|||
144566131|NCT04962698|521273678|FG001|Kinesthetic MI|Technical difficulty|0|||
144566132|NCT04962698|521273677|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
144566133|NCT04962698|521273678|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
144566134|NCT04962698|521273677|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
144566135|NCT04962698|521273678|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
144566136|NCT04962698|521273677|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
144566137|NCT04962698|521273678|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
144566138|NCT04962698|521273677|FG000|Virtual-hand Interaction|Technical difficulty|1|||
144566139|NCT04962698|521273678|FG001|Virtual-hand Interaction|Technical difficulty|0|||
144566140|NCT04962698|521273677|FG000|Robotic Action Observation|Technical difficulty|1|||
144566141|NCT04962698|521273678|FG001|Robotic Action Observation|Technical difficulty|0|||
144566142|NCT04962698|521273677|FG000|Rest|Technical difficulty|1|||
144566143|NCT04962698|521273678|FG001|Rest|Technical difficulty|0|||
144566144|NCT04962698|521273677|FG000|Rest|Exclusion criteria met after enrollment|0|||
144566145|NCT04962698|521273678|FG001|Rest|Exclusion criteria met after enrollment|2|||
144566146|NCT00853229|521273679|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
144566147|NCT00853229|521273680|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
144566148|NCT03470545|521273681|FG000|Overall Study|Death|0|||
144566149|NCT03470545|521273682|FG001|Overall Study|Death|1|||
144566150|NCT03470545|521273681|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
144566151|NCT03470545|521273682|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
144566152|NCT03470545|521273681|FG000|Overall Study|Adverse Event|2|||
144566153|NCT03470545|521273682|FG001|Overall Study|Adverse Event|0|||
144566154|NCT03470545|521273681|FG000|Overall Study|Withdrawal by Subject|1|||
144566155|NCT03470545|521273682|FG001|Overall Study|Withdrawal by Subject|1|||
144566156|NCT03470545|521273681|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
144566157|NCT03470545|521273682|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
144566158|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
144566159|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
144566160|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
144566161|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
144566162|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
144566163|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
144566164|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
144566165|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
144566166|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
144566167|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
144566168|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
144566169|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
144566170|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
144566171|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
144566172|NCT01664923|521273683|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
144566173|NCT01664923|521273684|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
144566174|NCT01664923|521273683|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
144566175|NCT01664923|521273684|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
144566176|NCT01664923|521273683|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
144566177|NCT01664923|521273684|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
144566178|NCT01664923|521273683|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
144728446|NCT01856309|521861238|FG003|Overall Study|Lack of Efficacy|25|||
144728447|NCT01856309|521861235|FG000|Overall Study|Adverse Event|31|||
144728448|NCT01856309|521861236|FG001|Overall Study|Adverse Event|31|||
144728449|NCT01856309|521861237|FG002|Overall Study|Adverse Event|55|||
144728450|NCT01856309|521861238|FG003|Overall Study|Adverse Event|65|||
144728451|NCT01856309|521861235|FG000|Overall Study|Pregnancy|0|||
144728452|NCT01856309|521861236|FG001|Overall Study|Pregnancy|0|||
144566179|NCT01664923|521273684|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
144728453|NCT01856309|521861237|FG002|Overall Study|Pregnancy|0|||
144728454|NCT01856309|521861238|FG003|Overall Study|Pregnancy|1|||
144728455|NCT01856309|521861235|FG000|Overall Study|Physician Decision|6|||
144728456|NCT01856309|521861236|FG001|Overall Study|Physician Decision|1|||
144728457|NCT01856309|521861237|FG002|Overall Study|Physician Decision|6|||
144566180|NCT01664923|521273683|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
144566181|NCT01664923|521273684|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
144566182|NCT01664923|521273683|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
144566183|NCT01664923|521273684|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
144566184|NCT01664923|521273683|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
144566185|NCT01664923|521273684|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
144566186|NCT03672175|521273687|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
144566187|NCT03672175|521273688|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
144566188|NCT03672175|521273689|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
144566189|NCT03672175|521273687|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
144566190|NCT03672175|521273688|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
144566191|NCT03672175|521273689|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
144566192|NCT03672175|521273687|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
144566193|NCT03672175|521273688|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
144566194|NCT03672175|521273689|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
144728458|NCT01856309|521861238|FG003|Overall Study|Physician Decision|8|||
144728459|NCT01856309|521861235|FG000|Overall Study|Noncompliance With Study Drug|0|||
144728460|NCT01856309|521861236|FG001|Overall Study|Noncompliance With Study Drug|1|||
144728461|NCT01856309|521861237|FG002|Overall Study|Noncompliance With Study Drug|4|||
144728462|NCT01856309|521861238|FG003|Overall Study|Noncompliance With Study Drug|1|||
144728463|NCT00220337|521861239|FG000|Overall Study|Adverse Event|70|||
144728464|NCT00220337|521861239|FG000|Overall Study|Lack of Efficacy|17|||
144728465|NCT00220337|521861239|FG000|Overall Study|Withdrawal by Subject|68|||
144728466|NCT00220337|521861239|FG000|Overall Study|Protocol Violation|2|||
144728467|NCT00220337|521861239|FG000|Overall Study|Lost to Follow-up|5|||
144728468|NCT00220337|521861239|FG000|Overall Study|Other|12|||
144728469|NCT00220337|521861239|FG000|Overall Study|Unsatisfactory compliance|5|||
144728470|NCT00832377|521861240|FG000|Overall Study|Protocol Violation|1|||
144728471|NCT01273181|521861241|FG000|Phase I, Dose 1|Study termination|1|||
144728472|NCT01273181|521861242|FG001|Phase I, Dose 1|Study termination|0|||
144728473|NCT01273181|521861243|FG002|Phase I, Dose 1|Study termination|0|||
144728474|NCT01273181|521861244|FG003|Phase I, Dose 1|Study termination|0|||
144728475|NCT01273181|521861241|FG000|Phase I, Dose 2|Death during treatment|0|||
144728476|NCT01273181|521861242|FG001|Phase I, Dose 2|Death during treatment|1|||
144728477|NCT01273181|521861243|FG002|Phase I, Dose 2|Death during treatment|0|||
144728478|NCT01273181|521861244|FG003|Phase I, Dose 2|Death during treatment|0|||
144566195|NCT03672175|521273687|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
144566196|NCT03672175|521273688|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
144566197|NCT03672175|521273689|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
144566198|NCT03672175|521273687|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
144566199|NCT03672175|521273688|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
144566200|NCT03672175|521273689|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
144566201|NCT03672175|521273687|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
144728479|NCT01273181|521861241|FG000|Phase 2, Dose 1|Study termination|0|||
144728480|NCT01273181|521861242|FG001|Phase 2, Dose 1|Study termination|0|||
144204868|NCT02036775|519944553|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
144204869|NCT02036775|519944554|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
144204870|NCT02036775|519944555|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
144204871|NCT02036775|519944556|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
144204872|NCT02036775|519944557|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
144204873|NCT02036775|519944558|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
144566202|NCT03672175|521273688|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
144566203|NCT03672175|521273689|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
144566204|NCT03672175|521273687|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
144566205|NCT03672175|521273688|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
144566206|NCT03672175|521273689|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
144566207|NCT03672175|521273687|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
144566208|NCT03672175|521273688|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
144728481|NCT01273181|521861243|FG002|Phase 2, Dose 1|Study termination|1|||
144728482|NCT01273181|521861244|FG003|Phase 2, Dose 1|Study termination|0|||
144566209|NCT03672175|521273689|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
144566210|NCT03672175|521273687|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
144566211|NCT03672175|521273688|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
144566212|NCT03672175|521273689|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
144566213|NCT03672175|521273687|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
144566214|NCT03672175|521273688|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
144566215|NCT03672175|521273689|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
144566216|NCT03672175|521273687|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
144566217|NCT03672175|521273688|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
144566218|NCT03672175|521273689|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
144566219|NCT03672175|521273687|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
144566220|NCT03672175|521273688|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
144566221|NCT03672175|521273689|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
144566222|NCT01772563|521273693|FG000|Cycle 1|Dose limiting toxicity|2|||
144566223|NCT01772563|521273693|FG000|Cycle 1|Progressive disease|2|||
144566224|NCT01772563|521273693|FG000|Cycle 2 and Beyond|Progressive disease|17|||
144566225|NCT01772563|521273693|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
144566226|NCT01772563|521273693|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
144566227|NCT01192776|521273695|FG000|Overall Study|Death|8|||
144566228|NCT01192776|521273696|FG001|Overall Study|Death|15|||
144566229|NCT01192776|521273697|FG002|Overall Study|Death|18|||
144566230|NCT01192776|521273698|FG003|Overall Study|Death|15|||
144566231|NCT01192776|521273695|FG000|Overall Study|Lost to Follow-up|3|||
144566232|NCT01192776|521273696|FG001|Overall Study|Lost to Follow-up|6|||
144566233|NCT01192776|521273697|FG002|Overall Study|Lost to Follow-up|3|||
144566234|NCT01192776|521273698|FG003|Overall Study|Lost to Follow-up|5|||
144566235|NCT01086384|521273699|FG000|2-week Run-in Period|Adverse Event|1|||
144566236|NCT01086384|521273700|FG001|2-week Run-in Period|Adverse Event|0|||
144566237|NCT01086384|521273701|FG002|2-week Run-in Period|Adverse Event|0|||
144566238|NCT01086384|521273699|FG000|2-week Run-in Period|Protocol Violation|1|||
144566239|NCT01086384|521273700|FG001|2-week Run-in Period|Protocol Violation|0|||
144566240|NCT01086384|521273701|FG002|2-week Run-in Period|Protocol Violation|0|||
144566241|NCT01086384|521273699|FG000|2-week Run-in Period|Lost to Follow-up|1|||
144566242|NCT01086384|521273700|FG001|2-week Run-in Period|Lost to Follow-up|0|||
144566243|NCT01086384|521273701|FG002|2-week Run-in Period|Lost to Follow-up|0|||
144566244|NCT01086384|521273699|FG000|2-week Run-in Period|Physician Decision|6|||
144566245|NCT01086384|521273700|FG001|2-week Run-in Period|Physician Decision|0|||
144566246|NCT01086384|521273701|FG002|2-week Run-in Period|Physician Decision|0|||
144566247|NCT01086384|521273699|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
144566248|NCT01086384|521273700|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144566249|NCT01086384|521273701|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144566250|NCT01086384|521273699|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
144566251|NCT01086384|521273700|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
144566252|NCT01086384|521273701|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
144566253|NCT01086384|521273699|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
144566254|NCT01086384|521273700|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
144566255|NCT01086384|521273701|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
144566256|NCT01086384|521273699|FG000|2-week Run-in Period|Randomized in Error|1|||
144566257|NCT01086384|521273700|FG001|2-week Run-in Period|Randomized in Error|0|||
144566258|NCT01086384|521273701|FG002|2-week Run-in Period|Randomized in Error|0|||
144618557|NCT01425008|521461311|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
144618558|NCT01425008|521461293|FG000|Dose Expansion Phase|Other|0|||
144618559|NCT01425008|521461294|FG001|Dose Expansion Phase|Other|0|||
144618560|NCT01425008|521461295|FG002|Dose Expansion Phase|Other|0|||
144618561|NCT01425008|521461296|FG003|Dose Expansion Phase|Other|0|||
144618562|NCT01425008|521461297|FG004|Dose Expansion Phase|Other|0|||
144618563|NCT01425008|521461298|FG005|Dose Expansion Phase|Other|0|||
144618564|NCT01425008|521461299|FG006|Dose Expansion Phase|Other|0|||
144618565|NCT01425008|521461300|FG007|Dose Expansion Phase|Other|0|||
144566259|NCT01086384|521273699|FG000|Treatment Period|Withdrawal by Subject|0|||
144566260|NCT01086384|521273700|FG001|Treatment Period|Withdrawal by Subject|53|||
144566261|NCT01086384|521273701|FG002|Treatment Period|Withdrawal by Subject|55|||
144566262|NCT01086384|521273699|FG000|Treatment Period|Protocol Violation|0|||
144566263|NCT01086384|521273700|FG001|Treatment Period|Protocol Violation|26|||
144566264|NCT01086384|521273701|FG002|Treatment Period|Protocol Violation|17|||
144566265|NCT01086384|521273699|FG000|Treatment Period|Lack of Efficacy|0|||
144566266|NCT01086384|521273700|FG001|Treatment Period|Lack of Efficacy|22|||
144566267|NCT01086384|521273701|FG002|Treatment Period|Lack of Efficacy|13|||
144566268|NCT01086384|521273699|FG000|Treatment Period|Adverse Event|0|||
144566269|NCT01086384|521273700|FG001|Treatment Period|Adverse Event|19|||
144566270|NCT01086384|521273701|FG002|Treatment Period|Adverse Event|15|||
144566271|NCT01086384|521273699|FG000|Treatment Period|Lost to Follow-up|0|||
144618566|NCT01425008|521461301|FG008|Dose Expansion Phase|Other|0|||
144618567|NCT01425008|521461302|FG009|Dose Expansion Phase|Other|0|||
144566272|NCT01086384|521273700|FG001|Treatment Period|Lost to Follow-up|11|||
144566273|NCT01086384|521273701|FG002|Treatment Period|Lost to Follow-up|9|||
144566274|NCT01086384|521273699|FG000|Treatment Period|Physician Decision|0|||
144566275|NCT01086384|521273700|FG001|Treatment Period|Physician Decision|9|||
144566276|NCT01086384|521273701|FG002|Treatment Period|Physician Decision|6|||
144566277|NCT01086384|521273699|FG000|Treatment Period|Study Closed/Terminated|0|||
144566278|NCT01086384|521273700|FG001|Treatment Period|Study Closed/Terminated|7|||
144566279|NCT01086384|521273701|FG002|Treatment Period|Study Closed/Terminated|8|||
144566280|NCT01086384|521273699|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
144566281|NCT01086384|521273700|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
144566282|NCT01086384|521273701|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
144566283|NCT01086384|521273699|FG000|Treatment Period|Received Treatment in Error|0|||
144566284|NCT01086384|521273700|FG001|Treatment Period|Received Treatment in Error|1|||
144566285|NCT01086384|521273701|FG002|Treatment Period|Received Treatment in Error|0|||
144566286|NCT02586415|521273706|FG000|Overall Study|Death|13|||
144566287|NCT02586415|521273707|FG001|Overall Study|Death|23|||
144566288|NCT02586415|521273706|FG000|Overall Study|Lost to Follow-up|1|||
144566289|NCT02586415|521273707|FG001|Overall Study|Lost to Follow-up|2|||
144566290|NCT00832000|521273708|FG000|Overall Study|Adverse Event|2|||
144566291|NCT00832000|521273709|FG001|Overall Study|Adverse Event|0|||
144566292|NCT00832000|521273708|FG000|Overall Study|Withdrawal by Subject|1|||
144566293|NCT00832000|521273709|FG001|Overall Study|Withdrawal by Subject|0|||
144566294|NCT00832000|521273708|FG000|Overall Study|No calls to IVR in either period|1|||
144566295|NCT00832000|521273709|FG001|Overall Study|No calls to IVR in either period|1|||
144566296|NCT00832000|521273708|FG000|Overall Study|No calls to IVR in period 2|2|||
144566297|NCT00832000|521273709|FG001|Overall Study|No calls to IVR in period 2|0|||
144566298|NCT02872311|521273710|FG000|Overall Study|Death|2|||
144566299|NCT02872311|521273711|FG001|Overall Study|Death|0|||
144566300|NCT02872311|521273712|FG002|Overall Study|Death|0|||
144566301|NCT02872311|521273713|FG003|Overall Study|Death|0|||
144566302|NCT02872311|521273714|FG004|Overall Study|Death|0|||
144566303|NCT02872311|521273710|FG000|Overall Study|Lost to Follow-up|2|||
144566304|NCT02872311|521273711|FG001|Overall Study|Lost to Follow-up|0|||
144566305|NCT02872311|521273712|FG002|Overall Study|Lost to Follow-up|0|||
144566306|NCT02872311|521273713|FG003|Overall Study|Lost to Follow-up|0|||
144566307|NCT02872311|521273714|FG004|Overall Study|Lost to Follow-up|0|||
144566308|NCT02872311|521273710|FG000|Overall Study|Protocol Violation|0|||
144566309|NCT02872311|521273711|FG001|Overall Study|Protocol Violation|2|||
144566310|NCT02872311|521273712|FG002|Overall Study|Protocol Violation|1|||
144566311|NCT02872311|521273713|FG003|Overall Study|Protocol Violation|0|||
144566312|NCT02872311|521273714|FG004|Overall Study|Protocol Violation|0|||
144566313|NCT02725567|521273716|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
144566314|NCT02725567|521273717|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
144566315|NCT02725567|521273716|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
144566316|NCT02725567|521273717|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
144566317|NCT02725567|521273716|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
144566318|NCT02725567|521273717|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
144566319|NCT02777242|521273718|FG000|Overall Study|Other|2|||
144566320|NCT02777242|521273718|FG000|Overall Study|Lost to Follow-up|1|||
144566321|NCT02777242|521273718|FG000|Overall Study|Multiple|1|||
144566322|NCT02777242|521273718|FG000|Overall Study|Sponsor's request|1|||
144566323|NCT02777242|521273718|FG000|Overall Study|Withdrawal by Subject|1|||
144566324|NCT05178979|521273719|FG000|Overall Study|Death|0|||
144566325|NCT05178979|521273720|FG001|Overall Study|Death|5|||
144566326|NCT05178979|521273721|FG002|Overall Study|Death|0|||
144566327|NCT05178979|521273722|FG003|Overall Study|Death|3|||
144566328|NCT05178979|521273719|FG000|Overall Study|Adverse Event|0|||
144566329|NCT05178979|521273720|FG001|Overall Study|Adverse Event|1|||
144566330|NCT05178979|521273721|FG002|Overall Study|Adverse Event|0|||
144566331|NCT05178979|521273722|FG003|Overall Study|Adverse Event|0|||
144566332|NCT05178979|521273719|FG000|Overall Study|Lost to Follow-up|1|||
144618568|NCT01425008|521461303|FG010|Dose Expansion Phase|Other|0|||
144618569|NCT01425008|521461304|FG011|Dose Expansion Phase|Other|0|||
144618570|NCT01425008|521461305|FG012|Dose Expansion Phase|Other|1|||
144618571|NCT01425008|521461306|FG013|Dose Expansion Phase|Other|0|||
144566333|NCT05178979|521273720|FG001|Overall Study|Lost to Follow-up|8|||
144566334|NCT05178979|521273721|FG002|Overall Study|Lost to Follow-up|3|||
144566335|NCT05178979|521273722|FG003|Overall Study|Lost to Follow-up|8|||
144566336|NCT00255944|521273723|FG000|Overall Study|Lost to Follow-up|797|||
144566337|NCT00255944|521273724|FG001|Overall Study|Lost to Follow-up|834|||
144566338|NCT01129115|521273726|FG000|Overall Study|Adverse Event|1|||
144566339|NCT01129115|521273727|FG001|Overall Study|Adverse Event|2|||
144566340|NCT01129115|521273728|FG002|Overall Study|Adverse Event|3|||
144566341|NCT01129115|521273729|FG003|Overall Study|Adverse Event|3|||
144566342|NCT01129115|521273726|FG000|Overall Study|Withdrawal by Subject|1|||
144566343|NCT01129115|521273727|FG001|Overall Study|Withdrawal by Subject|3|||
144566344|NCT01129115|521273728|FG002|Overall Study|Withdrawal by Subject|1|||
144618572|NCT01425008|521461307|FG014|Dose Expansion Phase|Other|0|||
144566345|NCT01129115|521273729|FG003|Overall Study|Withdrawal by Subject|4|||
144566346|NCT01129115|521273726|FG000|Overall Study|Protocol Violation|0|||
144566347|NCT01129115|521273727|FG001|Overall Study|Protocol Violation|2|||
144566348|NCT01129115|521273728|FG002|Overall Study|Protocol Violation|2|||
144566349|NCT01129115|521273729|FG003|Overall Study|Protocol Violation|2|||
144566350|NCT01747837|521273731|FG000|Overall Study|Lost to Follow-up|5|||
144566351|NCT01747837|521273732|FG001|Overall Study|Lost to Follow-up|2|||
144566352|NCT01747837|521273731|FG000|Overall Study|Death|4|||
144566353|NCT01747837|521273732|FG001|Overall Study|Death|4|||
144566354|NCT00817336|521273734|FG000|Overall Study|Withdrawal by Subject|1|||
144566355|NCT00817336|521273735|FG001|Overall Study|Withdrawal by Subject|1|||
144566356|NCT01435798|521273736|FG000|Overall Study|Withdrawal by Subject|1|||
144566357|NCT00690378|521273737|FG000|Overall Study|Adverse Event|1|||
144566358|NCT00690378|521273738|FG001|Overall Study|Adverse Event|0|||
144566359|NCT00690378|521273737|FG000|Overall Study|Withdrawal by Subject|2|||
144566360|NCT00690378|521273738|FG001|Overall Study|Withdrawal by Subject|0|||
144566361|NCT00690378|521273737|FG000|Overall Study|Protocol Violation|1|||
144566362|NCT00690378|521273738|FG001|Overall Study|Protocol Violation|0|||
144566363|NCT00690378|521273737|FG000|Overall Study|Lost to Follow-up|2|||
144566364|NCT00690378|521273738|FG001|Overall Study|Lost to Follow-up|3|||
144566365|NCT00690378|521273737|FG000|Overall Study|Did not meet inc/exc criteria|13|||
144566366|NCT00690378|521273738|FG001|Overall Study|Did not meet inc/exc criteria|11|||
144566367|NCT00690378|521273737|FG000|Overall Study|Social problem|1|||
144566368|NCT00690378|521273738|FG001|Overall Study|Social problem|0|||
144566369|NCT02019641|521273745|FG000|10-Week Follow up|Withdrawal by investigator|2|||
144566370|NCT02019641|521273746|FG001|10-Week Follow up|Withdrawal by investigator|0|||
144566371|NCT02019641|521273747|FG002|10-Week Follow up|Withdrawal by investigator|0|||
144566372|NCT02019641|521273745|FG000|10-Week Follow up|Withdrawal by Subject|1|||
144566373|NCT02019641|521273746|FG001|10-Week Follow up|Withdrawal by Subject|1|||
144566374|NCT02019641|521273747|FG002|10-Week Follow up|Withdrawal by Subject|0|||
144566375|NCT02019641|521273745|FG000|20-Week Follow up|Withdrawal by investigator|0|||
144566376|NCT02019641|521273746|FG001|20-Week Follow up|Withdrawal by investigator|0|||
144566377|NCT02019641|521273747|FG002|20-Week Follow up|Withdrawal by investigator|1|||
144566378|NCT00935259|521273748|FG000|Period 1|Administrative (scheduling conflict)|1|||
144566379|NCT00935259|521273749|FG001|Period 1|Administrative (scheduling conflict)|1|||
144566380|NCT03318783|521273750|FG000|Overall Study|Withdrawal by Subject|0|||
144566381|NCT03318783|521273751|FG001|Overall Study|Withdrawal by Subject|1|||
144566382|NCT03318783|521273750|FG000|Overall Study|Death|0|||
144566383|NCT03318783|521273751|FG001|Overall Study|Death|1|||
144566384|NCT03410108|521273754|FG000|Overall Study|Ongoing|41|||
144566385|NCT03410108|521273754|FG000|Overall Study|Adverse Event|4|||
144566386|NCT03410108|521273754|FG000|Overall Study|Progressive Disease|58|||
144566387|NCT03410108|521273754|FG000|Overall Study|Withdrawal by Subject|1|||
144566388|NCT03856047|521273755|FG000|Overall Study|Withdrawal by Subject|0|||
144566389|NCT03856047|521273756|FG001|Overall Study|Withdrawal by Subject|1|||
144204874|NCT03734666|519944560|FG000|Overall Study|Other|7|||
144566390|NCT03856047|521273757|FG002|Overall Study|Withdrawal by Subject|1|||
144566391|NCT03856047|521273758|FG003|Overall Study|Withdrawal by Subject|0|||
144566392|NCT03856047|521273759|FG004|Overall Study|Withdrawal by Subject|3|||
144566393|NCT03856047|521273760|FG005|Overall Study|Withdrawal by Subject|0|||
144566394|NCT03856047|521273761|FG006|Overall Study|Withdrawal by Subject|2|||
144566395|NCT03856047|521273755|FG000|Overall Study|Lost to Follow-up|4|||
144566396|NCT03856047|521273756|FG001|Overall Study|Lost to Follow-up|2|||
144566397|NCT03856047|521273757|FG002|Overall Study|Lost to Follow-up|3|||
144566398|NCT03856047|521273758|FG003|Overall Study|Lost to Follow-up|1|||
144566399|NCT03856047|521273759|FG004|Overall Study|Lost to Follow-up|4|||
144566400|NCT03856047|521273760|FG005|Overall Study|Lost to Follow-up|4|||
144566401|NCT03856047|521273761|FG006|Overall Study|Lost to Follow-up|4|||
144618573|NCT01425008|521461308|FG015|Dose Expansion Phase|Other|0|||
144204875|NCT03734666|519944561|FG001|Overall Study|Other|4|||
144204876|NCT03734666|519944560|FG000|Overall Study|Lost to Follow-up|12|||
144204877|NCT03734666|519944561|FG001|Overall Study|Lost to Follow-up|12|||
144566402|NCT01209598|521273765|FG000|Overall Study|Withdrawal by Subject|1|||
144566403|NCT01209598|521273766|FG001|Overall Study|Withdrawal by Subject|0|||
144566404|NCT00934700|521273773|FG000|Overall Study|missing scan|5|||
144566405|NCT00934700|521273774|FG001|Overall Study|missing scan|9|||
144566406|NCT00934700|521273773|FG000|Overall Study|Death|8|||
144566407|NCT00934700|521273774|FG001|Overall Study|Death|3|||
144566408|NCT03049306|521273777|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
144566409|NCT03049306|521273778|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
144566410|NCT03151551|521273779|FG000|Open-Label Treatment Period|Adverse Event|0|||
144566411|NCT03151551|521273780|FG001|Open-Label Treatment Period|Adverse Event|2|||
144566412|NCT03151551|521273779|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
144566413|NCT03151551|521273780|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
144566414|NCT03151551|521273779|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
144566415|NCT03151551|521273780|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
144204878|NCT01910389|519944564|FG000|Overall Study|Withdrawal by Subject|2|||
144566416|NCT03151551|521273779|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
144566417|NCT03151551|521273780|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
144566418|NCT03151551|521273779|FG000|Open-Label Treatment Period|Physician Decision|3|||
144566419|NCT03151551|521273780|FG001|Open-Label Treatment Period|Physician Decision|0|||
144566420|NCT03151551|521273779|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
144566421|NCT03151551|521273780|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
144566422|NCT03151551|521273779|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
144618574|NCT01425008|521461309|FG016|Dose Expansion Phase|Other|2|||
144566423|NCT03151551|521273780|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
144566424|NCT03151551|521273779|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
144566425|NCT03151551|521273780|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
144566426|NCT03151551|521273779|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
144566427|NCT03151551|521273780|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
144566428|NCT03151551|521273779|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
144566429|NCT03151551|521273780|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
144618575|NCT01425008|521461310|FG017|Dose Expansion Phase|Other|0|||
144618576|NCT01425008|521461311|FG018|Dose Expansion Phase|Other|4|||
144618577|NCT01425008|521461293|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618578|NCT01425008|521461294|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618579|NCT01425008|521461295|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618580|NCT01425008|521461296|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618581|NCT01425008|521461297|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618582|NCT01425008|521461298|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618583|NCT01425008|521461299|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618584|NCT01425008|521461300|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618585|NCT01425008|521461301|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618586|NCT01425008|521461302|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618587|NCT01425008|521461303|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
144618588|NCT01425008|521461304|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
144618589|NCT01425008|521461305|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618590|NCT01425008|521461306|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618591|NCT01425008|521461307|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618592|NCT01425008|521461308|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
144618593|NCT01425008|521461309|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
144618594|NCT01425008|521461310|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
144618595|NCT01425008|521461311|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
144618596|NCT01425008|521461293|FG000|Dose Expansion Phase|Adverse Event|0|||
144618597|NCT01425008|521461294|FG001|Dose Expansion Phase|Adverse Event|0|||
144618598|NCT01425008|521461295|FG002|Dose Expansion Phase|Adverse Event|0|||
144618599|NCT01425008|521461296|FG003|Dose Expansion Phase|Adverse Event|0|||
144618600|NCT01425008|521461297|FG004|Dose Expansion Phase|Adverse Event|0|||
144618601|NCT01425008|521461298|FG005|Dose Expansion Phase|Adverse Event|0|||
144618602|NCT01425008|521461299|FG006|Dose Expansion Phase|Adverse Event|0|||
144618603|NCT01425008|521461300|FG007|Dose Expansion Phase|Adverse Event|0|||
144618604|NCT01425008|521461301|FG008|Dose Expansion Phase|Adverse Event|0|||
144618605|NCT01425008|521461302|FG009|Dose Expansion Phase|Adverse Event|0|||
144618606|NCT01425008|521461303|FG010|Dose Expansion Phase|Adverse Event|2|||
144618607|NCT01425008|521461304|FG011|Dose Expansion Phase|Adverse Event|3|||
144618608|NCT01425008|521461305|FG012|Dose Expansion Phase|Adverse Event|3|||
144618609|NCT01425008|521461306|FG013|Dose Expansion Phase|Adverse Event|0|||
144618610|NCT01425008|521461307|FG014|Dose Expansion Phase|Adverse Event|1|||
144618611|NCT01425008|521461308|FG015|Dose Expansion Phase|Adverse Event|1|||
144618612|NCT01425008|521461309|FG016|Dose Expansion Phase|Adverse Event|5|||
144618613|NCT01425008|521461310|FG017|Dose Expansion Phase|Adverse Event|0|||
144618614|NCT01425008|521461311|FG018|Dose Expansion Phase|Adverse Event|3|||
144618615|NCT01425008|521461293|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
144618616|NCT01425008|521461294|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
144618617|NCT01425008|521461295|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
144618618|NCT01425008|521461296|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
144618619|NCT01425008|521461297|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
144618620|NCT01425008|521461298|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
144618621|NCT01425008|521461299|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
144618622|NCT01425008|521461300|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
144566430|NCT05896696|521273781|FG000|Overall Study|Screening Failure|7|||
144566431|NCT05896696|521273781|FG000|Overall Study|Withdrawal by Subject|2|||
144566432|NCT00143598|521273782|FG000|Overall Study|Lost to Follow-up|23|||
144566433|NCT00143598|521273783|FG001|Overall Study|Lost to Follow-up|21|||
144618623|NCT01425008|521461301|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
144618624|NCT01425008|521461302|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
144618625|NCT01425008|521461303|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
144618626|NCT01425008|521461304|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
144618627|NCT01425008|521461305|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
144618628|NCT01425008|521461306|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
144618629|NCT01425008|521461307|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
144566434|NCT00143598|521273782|FG000|Overall Study|Withdrawal by Subject|33|||
144566435|NCT00143598|521273783|FG001|Overall Study|Withdrawal by Subject|37|||
144566436|NCT00143598|521273782|FG000|Overall Study|Death|36|||
144566437|NCT00143598|521273783|FG001|Overall Study|Death|36|||
144566438|NCT03900715|521273784|FG000|Overall Study|Protocol Deviation|1|||
144566439|NCT03900715|521273784|FG000|Overall Study|Lack of Efficacy|1|||
144566440|NCT03900715|521273784|FG000|Overall Study|Progressive Disease|6|||
144566441|NCT03900715|521273784|FG000|Overall Study|Adverse Event|2|||
144566442|NCT03900715|521273784|FG000|Overall Study|Other reasons|11|||
144566443|NCT00634842|521275532|FG000|Overall Study|Adverse Event|2|||
144566444|NCT00634842|521275533|FG001|Overall Study|Adverse Event|3|||
144566445|NCT00634842|521275532|FG000|Overall Study|Protocol Violation|8|||
144566446|NCT00634842|521275533|FG001|Overall Study|Protocol Violation|4|||
144566447|NCT00634842|521275532|FG000|Overall Study|Move to another state|1|||
144618630|NCT01425008|521461308|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
144618631|NCT01425008|521461309|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
144618632|NCT01425008|521461310|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
144618633|NCT01425008|521461311|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
144618634|NCT01425008|521461293|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618635|NCT01425008|521461294|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618636|NCT01425008|521461295|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618637|NCT01425008|521461296|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618638|NCT01425008|521461297|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618639|NCT01425008|521461298|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618640|NCT01425008|521461299|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618641|NCT01425008|521461300|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618642|NCT01425008|521461301|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618643|NCT01425008|521461302|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618644|NCT01425008|521461303|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618645|NCT01425008|521461304|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618646|NCT01425008|521461305|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618647|NCT01425008|521461306|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618648|NCT01425008|521461307|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618649|NCT01425008|521461308|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618650|NCT01425008|521461309|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618651|NCT01425008|521461310|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144618652|NCT01425008|521461311|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
144618653|NCT00264238|521461312|FG000|Overall Study|Protocol Violation|1|||
144618654|NCT00562588|521461315|FG000|Overall Study|Adverse Event|40|||
144618655|NCT00562588|521461316|FG001|Overall Study|Adverse Event|58|||
144618656|NCT00562588|521461315|FG000|Overall Study|Protocol Violation|30|||
144618657|NCT00562588|521461316|FG001|Overall Study|Protocol Violation|26|||
144618658|NCT00562588|521461315|FG000|Overall Study|Lost to Follow-up|12|||
144618659|NCT00562588|521461316|FG001|Overall Study|Lost to Follow-up|4|||
144618660|NCT00562588|521461315|FG000|Overall Study|Withdrawal by Subject|10|||
144618661|NCT00562588|521461316|FG001|Overall Study|Withdrawal by Subject|9|||
144618662|NCT00562588|521461315|FG000|Overall Study|Other|0|||
144618663|NCT00562588|521461316|FG001|Overall Study|Other|2|||
144618664|NCT01452152|521461317|FG000|Overall Study|Study termination by sponsor|5|||
144618665|NCT01452152|521461318|FG001|Overall Study|Study termination by sponsor|0|||
144618666|NCT01452152|521461319|FG002|Overall Study|Study termination by sponsor|4|||
144618667|NCT02867995|521461322|FG000|Overall Study|Withdrawal by Subject|0|||
144618668|NCT02867995|521461323|FG001|Overall Study|Withdrawal by Subject|1|||
144618669|NCT02867995|521461322|FG000|Overall Study|Lost to Follow-up|0|||
144618670|NCT02867995|521461323|FG001|Overall Study|Lost to Follow-up|2|||
144618671|NCT03315871|521461324|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
144618672|NCT03315871|521461325|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
144618673|NCT03315871|521461326|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
144618674|NCT03315871|521461324|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
144618675|NCT03315871|521461325|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
144618676|NCT03315871|521461326|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
144566448|NCT00634842|521275533|FG001|Overall Study|Move to another state|0|||
144566449|NCT00634842|521275532|FG000|Overall Study|Inclusion criteria were not met|1|||
144566450|NCT00634842|521275533|FG001|Overall Study|Inclusion criteria were not met|0|||
144566451|NCT00634842|521275532|FG000|Overall Study|Lost to Follow-up|1|||
144566452|NCT00634842|521275533|FG001|Overall Study|Lost to Follow-up|2|||
144566453|NCT00634842|521275532|FG000|Overall Study|Physician Decision|1|||
144566454|NCT00634842|521275533|FG001|Overall Study|Physician Decision|0|||
144566455|NCT00634842|521275532|FG000|Overall Study|Withdrawal by Subject|1|||
144618677|NCT03315871|521461324|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
144618678|NCT03315871|521461325|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
144618679|NCT03315871|521461326|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
144700085|NCT03759340|521754506|FG000|Overall Study|Withdrawal by Subject|15|||
144566456|NCT00634842|521275533|FG001|Overall Study|Withdrawal by Subject|3|||
144566457|NCT00634842|521275532|FG000|Overall Study|Lack of time and intolerance to drug|0|||
144566458|NCT00634842|521275533|FG001|Overall Study|Lack of time and intolerance to drug|1|||
144566459|NCT00634842|521275532|FG000|Overall Study|Discontinued due to injection|0|||
144566460|NCT00634842|521275533|FG001|Overall Study|Discontinued due to injection|2|||
144566461|NCT00634842|521275532|FG000|Overall Study|No need of study drug to treat diabetes|0|||
144566462|NCT00634842|521275533|FG001|Overall Study|No need of study drug to treat diabetes|1|||
144566463|NCT00634842|521275532|FG000|Overall Study|No wish to keep taking Avandia|0|||
144566464|NCT00634842|521275533|FG001|Overall Study|No wish to keep taking Avandia|1|||
144566465|NCT00634842|521275532|FG000|Overall Study|Subject off study drug for too long|0|||
144566466|NCT00634842|521275533|FG001|Overall Study|Subject off study drug for too long|1|||
144566467|NCT00328562|521275536|FG000|Overall Study|Disease progression|1|||
144566468|NCT03305809|521275537|FG000|Overall Study|Adverse Event|2|||
144566469|NCT03305809|521275538|FG001|Overall Study|Adverse Event|2|||
144566470|NCT03305809|521275539|FG002|Overall Study|Adverse Event|6|||
144566471|NCT03305809|521275540|FG003|Overall Study|Adverse Event|6|||
144566472|NCT03305809|521275537|FG000|Overall Study|Death|0|||
144566473|NCT03305809|521275538|FG001|Overall Study|Death|0|||
144566474|NCT03305809|521275539|FG002|Overall Study|Death|1|||
144566475|NCT03305809|521275540|FG003|Overall Study|Death|1|||
144566476|NCT03305809|521275537|FG000|Overall Study|Lost to Follow-up|1|||
144566477|NCT03305809|521275538|FG001|Overall Study|Lost to Follow-up|2|||
144566478|NCT03305809|521275539|FG002|Overall Study|Lost to Follow-up|0|||
144566479|NCT03305809|521275540|FG003|Overall Study|Lost to Follow-up|0|||
144566480|NCT03305809|521275537|FG000|Overall Study|Sponsor Decision|1|||
144566481|NCT03305809|521275538|FG001|Overall Study|Sponsor Decision|0|||
144566482|NCT03305809|521275539|FG002|Overall Study|Sponsor Decision|1|||
144566483|NCT03305809|521275540|FG003|Overall Study|Sponsor Decision|8|||
144566484|NCT03305809|521275537|FG000|Overall Study|Physician Decision|0|||
144566485|NCT03305809|521275538|FG001|Overall Study|Physician Decision|0|||
144566486|NCT03305809|521275539|FG002|Overall Study|Physician Decision|2|||
144566487|NCT03305809|521275540|FG003|Overall Study|Physician Decision|4|||
144566488|NCT03305809|521275537|FG000|Overall Study|Progressive Disease|0|||
144566489|NCT03305809|521275538|FG001|Overall Study|Progressive Disease|0|||
144566490|NCT03305809|521275539|FG002|Overall Study|Progressive Disease|1|||
144566491|NCT03305809|521275540|FG003|Overall Study|Progressive Disease|0|||
144566492|NCT03305809|521275537|FG000|Overall Study|Protocol Violation|1|||
144566493|NCT03305809|521275538|FG001|Overall Study|Protocol Violation|0|||
144566494|NCT03305809|521275539|FG002|Overall Study|Protocol Violation|2|||
144566495|NCT03305809|521275540|FG003|Overall Study|Protocol Violation|3|||
144566496|NCT03305809|521275537|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
144566497|NCT03305809|521275538|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
144566498|NCT03305809|521275539|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
144566499|NCT03305809|521275540|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
144566500|NCT03305809|521275537|FG000|Overall Study|Withdrawal by Subject|2|||
144566501|NCT03305809|521275538|FG001|Overall Study|Withdrawal by Subject|4|||
144566502|NCT03305809|521275539|FG002|Overall Study|Withdrawal by Subject|5|||
144566503|NCT03305809|521275540|FG003|Overall Study|Withdrawal by Subject|2|||
144566504|NCT03305809|521275537|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
144566505|NCT03305809|521275538|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
144566506|NCT03305809|521275539|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
144566507|NCT03305809|521275540|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
144566508|NCT04014790|521275541|FG000|Overall Study|Death|4|||
144566509|NCT04014790|521275541|FG000|Overall Study|Adverse Event|1|||
144566510|NCT04014790|521275541|FG000|Overall Study|Withdrawal by Subject|1|||
144566511|NCT01161446|521275542|FG000|Overall Study|Lost to Follow-up|18|||
144566512|NCT01161446|521275543|FG001|Overall Study|Lost to Follow-up|14|||
144566513|NCT01161446|521275542|FG000|Overall Study|Withdrawal by Subject|0|||
144566514|NCT01161446|521275543|FG001|Overall Study|Withdrawal by Subject|1|||
144566515|NCT01010204|521275544|FG000|Overall Study|Lost to Follow-up|2|||
144566516|NCT01010204|521275545|FG001|Overall Study|Lost to Follow-up|2|||
144566517|NCT01010204|521275544|FG000|Overall Study|Adverse Event|1|||
144566518|NCT01010204|521275545|FG001|Overall Study|Adverse Event|3|||
144566519|NCT01010204|521275544|FG000|Overall Study|Withdrawal by Subject|2|||
144566520|NCT01010204|521275545|FG001|Overall Study|Withdrawal by Subject|3|||
144566521|NCT01010204|521275544|FG000|Overall Study|psychiatric hospitalization|2|||
144566522|NCT01010204|521275545|FG001|Overall Study|psychiatric hospitalization|1|||
144566523|NCT01513330|521275546|FG000|SenSura Mio First,|Adverse Event|2|||
144566524|NCT01513330|521275547|FG001|SenSura Mio First,|Adverse Event|0|||
144566525|NCT01513330|521275546|FG000|SenSura Mio First,|Lack of Efficacy|0|||
144566526|NCT01513330|521275547|FG001|SenSura Mio First,|Lack of Efficacy|1|||
144566527|NCT01513330|521275546|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
144566528|NCT01513330|521275547|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
144566529|NCT01513330|521275546|FG000|SenSura Mio First,|Other|1|||
144566530|NCT01513330|521275547|FG001|SenSura Mio First,|Other|0|||
144566531|NCT01513330|521275546|FG000|Standard Care First,|Lack of Efficacy|2|||
144618680|NCT03315871|521461324|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
144618681|NCT03315871|521461325|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
144618682|NCT03315871|521461326|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
144618683|NCT03315871|521461324|FG000|PROSTVAC + CV301|Progressive disease|0|||
144618684|NCT03315871|521461325|FG001|PROSTVAC + CV301|Progressive disease|0|||
144618685|NCT03315871|521461326|FG002|PROSTVAC + CV301|Progressive disease|1|||
144618686|NCT03315871|521461324|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
144618687|NCT03315871|521461325|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
144566532|NCT01513330|521275547|FG001|Standard Care First,|Lack of Efficacy|2|||
144566533|NCT01513330|521275546|FG000|Standard Care First,|Withdrawal by Subject|1|||
144566534|NCT01513330|521275547|FG001|Standard Care First,|Withdrawal by Subject|2|||
144566535|NCT01513330|521275546|FG000|Standard Care First,|Other|1|||
144566536|NCT01513330|521275547|FG001|Standard Care First,|Other|0|||
144566537|NCT01519778|521275548|FG000|Overall Study|Withdrawal by Subject|3|||
144566538|NCT01519778|521275548|FG000|Overall Study|Lost to Follow-up|10|||
144566539|NCT01519778|521275548|FG000|Overall Study|Physician Decision|1|||
144566540|NCT02330562|521275549|FG000|Overall Study|Adverse Event|0|||
144566541|NCT02330562|521275550|FG001|Overall Study|Adverse Event|0|||
144566542|NCT02330562|521275551|FG002|Overall Study|Adverse Event|3|||
144566543|NCT02330562|521275552|FG003|Overall Study|Adverse Event|0|||
144566544|NCT02330562|521275553|FG004|Overall Study|Adverse Event|3|||
144566545|NCT02330562|521275554|FG005|Overall Study|Adverse Event|1|||
144566546|NCT02330562|521275555|FG006|Overall Study|Adverse Event|0|||
144566547|NCT02330562|521275556|FG007|Overall Study|Adverse Event|0|||
144566548|NCT02330562|521275557|FG008|Overall Study|Adverse Event|0|||
144566549|NCT02330562|521275558|FG009|Overall Study|Adverse Event|1|||
144566550|NCT02330562|521275559|FG010|Overall Study|Adverse Event|1|||
144566551|NCT02330562|521275549|FG000|Overall Study|Participant decision|1|||
144566552|NCT02330562|521275550|FG001|Overall Study|Participant decision|0|||
144566553|NCT02330562|521275551|FG002|Overall Study|Participant decision|4|||
144566554|NCT02330562|521275552|FG003|Overall Study|Participant decision|1|||
144566555|NCT02330562|521275553|FG004|Overall Study|Participant decision|5|||
144566556|NCT02330562|521275554|FG005|Overall Study|Participant decision|2|||
144618688|NCT03315871|521461326|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
144618689|NCT02164981|521462968|FG000|Started|Withdrawal by Subject|2|||
144618690|NCT02164981|521462969|FG001|Started|Withdrawal by Subject|1|||
144618691|NCT02164981|521462970|FG002|Started|Withdrawal by Subject|0|||
144618692|NCT02164981|521462968|FG000|Started|Protocol Violation|2|||
144618693|NCT02164981|521462969|FG001|Started|Protocol Violation|0|||
144618694|NCT02164981|521462970|FG002|Started|Protocol Violation|0|||
144618695|NCT02164981|521462968|FG000|Started|Adverse Event|1|||
144618696|NCT02164981|521462969|FG001|Started|Adverse Event|2|||
144618697|NCT02164981|521462970|FG002|Started|Adverse Event|0|||
144618698|NCT02164981|521462968|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
144618699|NCT02164981|521462969|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
144618700|NCT02164981|521462970|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
144618701|NCT02164981|521462968|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
144618702|NCT02164981|521462969|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
144618703|NCT02164981|521462970|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
144618704|NCT02164981|521462968|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
144618705|NCT02164981|521462969|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
144618706|NCT02164981|521462970|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
144618707|NCT01736579|521462971|FG000|Overall Study|Termination of Study by Sponsor|2|||
144618708|NCT01736579|521462972|FG001|Overall Study|Termination of Study by Sponsor|2|||
144618709|NCT01995071|521462975|FG000|Overall Study|Adverse Event|0|||
144618710|NCT01995071|521462976|FG001|Overall Study|Adverse Event|0|||
144618711|NCT01995071|521462977|FG002|Overall Study|Adverse Event|0|||
144618712|NCT01995071|521462978|FG003|Overall Study|Adverse Event|0|||
144618713|NCT01995071|521462979|FG004|Overall Study|Adverse Event|0|||
144618714|NCT01995071|521462980|FG005|Overall Study|Adverse Event|0|||
144618715|NCT01995071|521462981|FG006|Overall Study|Adverse Event|1|||
144618716|NCT01995071|521462982|FG007|Overall Study|Adverse Event|0|||
144566557|NCT02330562|521275555|FG006|Overall Study|Participant decision|0|||
144566558|NCT02330562|521275556|FG007|Overall Study|Participant decision|0|||
144566559|NCT02330562|521275557|FG008|Overall Study|Participant decision|0|||
144566560|NCT02330562|521275558|FG009|Overall Study|Participant decision|3|||
144618717|NCT01995071|521462983|FG008|Overall Study|Adverse Event|0|||
144618718|NCT01995071|521462984|FG009|Overall Study|Adverse Event|0|||
144618719|NCT01995071|521462985|FG010|Overall Study|Adverse Event|0|||
144566561|NCT02330562|521275559|FG010|Overall Study|Participant decision|0|||
144566562|NCT02330562|521275549|FG000|Overall Study|Disease progression|5|||
144566563|NCT02330562|521275550|FG001|Overall Study|Disease progression|3|||
144566564|NCT02330562|521275551|FG002|Overall Study|Disease progression|20|||
144566565|NCT02330562|521275552|FG003|Overall Study|Disease progression|28|||
144566566|NCT02330562|521275553|FG004|Overall Study|Disease progression|23|||
144566567|NCT02330562|521275554|FG005|Overall Study|Disease progression|7|||
144566568|NCT02330562|521275555|FG006|Overall Study|Disease progression|1|||
144566569|NCT02330562|521275556|FG007|Overall Study|Disease progression|1|||
144566570|NCT02330562|521275557|FG008|Overall Study|Disease progression|1|||
144566571|NCT02330562|521275558|FG009|Overall Study|Disease progression|0|||
144566572|NCT02330562|521275559|FG010|Overall Study|Disease progression|5|||
144566573|NCT02330562|521275549|FG000|Overall Study|Other reasons|0|||
144566574|NCT02330562|521275550|FG001|Overall Study|Other reasons|0|||
144566575|NCT02330562|521275551|FG002|Overall Study|Other reasons|0|||
144566576|NCT02330562|521275552|FG003|Overall Study|Other reasons|1|||
144566577|NCT02330562|521275553|FG004|Overall Study|Other reasons|0|||
144566578|NCT02330562|521275554|FG005|Overall Study|Other reasons|0|||
144566579|NCT02330562|521275555|FG006|Overall Study|Other reasons|0|||
144566580|NCT02330562|521275556|FG007|Overall Study|Other reasons|0|||
144566581|NCT02330562|521275557|FG008|Overall Study|Other reasons|0|||
144566582|NCT02330562|521275558|FG009|Overall Study|Other reasons|0|||
144566583|NCT02330562|521275559|FG010|Overall Study|Other reasons|0|||
144566584|NCT02330562|521275549|FG000|Overall Study|Withdrawal by Subject|0|||
144566585|NCT02330562|521275550|FG001|Overall Study|Withdrawal by Subject|0|||
144566586|NCT02330562|521275551|FG002|Overall Study|Withdrawal by Subject|0|||
144566587|NCT02330562|521275552|FG003|Overall Study|Withdrawal by Subject|0|||
144566588|NCT02330562|521275553|FG004|Overall Study|Withdrawal by Subject|0|||
144566589|NCT02330562|521275554|FG005|Overall Study|Withdrawal by Subject|0|||
144566590|NCT02330562|521275555|FG006|Overall Study|Withdrawal by Subject|0|||
144566591|NCT02330562|521275556|FG007|Overall Study|Withdrawal by Subject|0|||
144566592|NCT02330562|521275557|FG008|Overall Study|Withdrawal by Subject|0|||
144566593|NCT02330562|521275558|FG009|Overall Study|Withdrawal by Subject|1|||
144566594|NCT02330562|521275559|FG010|Overall Study|Withdrawal by Subject|0|||
144566595|NCT01547117|521275561|FG000|Overall Study|Physician Decision|0|||
144566596|NCT01547117|521275562|FG001|Overall Study|Physician Decision|1|||
144566597|NCT01547117|521275563|FG002|Overall Study|Physician Decision|1|||
144566598|NCT01547117|521275564|FG003|Overall Study|Physician Decision|3|||
144566599|NCT01547117|521275561|FG000|Overall Study|Withdrawal by Subject|1|||
144566600|NCT01547117|521275562|FG001|Overall Study|Withdrawal by Subject|2|||
144566601|NCT01547117|521275563|FG002|Overall Study|Withdrawal by Subject|1|||
144566602|NCT01547117|521275564|FG003|Overall Study|Withdrawal by Subject|2|||
144566603|NCT02706951|521275569|FG000|Period 1|Adverse Event|1|||
144566604|NCT02706951|521275570|FG001|Period 1|Adverse Event|5|||
144566605|NCT02706951|521275571|FG002|Period 1|Adverse Event|3|||
144566606|NCT02706951|521275572|FG003|Period 1|Adverse Event|0|||
144566607|NCT02706951|521275573|FG004|Period 1|Adverse Event|0|||
144566608|NCT02706951|521275569|FG000|Period 1|Withdrawal by Subject|10|||
144566609|NCT02706951|521275570|FG001|Period 1|Withdrawal by Subject|6|||
144566610|NCT02706951|521275571|FG002|Period 1|Withdrawal by Subject|6|||
144566611|NCT02706951|521275572|FG003|Period 1|Withdrawal by Subject|0|||
144566612|NCT02706951|521275573|FG004|Period 1|Withdrawal by Subject|0|||
144566613|NCT02706951|521275569|FG000|Period 1|Lost to Follow-up|0|||
144566614|NCT02706951|521275570|FG001|Period 1|Lost to Follow-up|4|||
144566615|NCT02706951|521275571|FG002|Period 1|Lost to Follow-up|1|||
144566616|NCT02706951|521275572|FG003|Period 1|Lost to Follow-up|0|||
144566617|NCT02706951|521275573|FG004|Period 1|Lost to Follow-up|0|||
144566618|NCT02706951|521275569|FG000|Period 1|Other|2|||
144566619|NCT02706951|521275570|FG001|Period 1|Other|1|||
144566620|NCT02706951|521275571|FG002|Period 1|Other|0|||
144566621|NCT02706951|521275572|FG003|Period 1|Other|0|||
144566622|NCT02706951|521275573|FG004|Period 1|Other|0|||
144566623|NCT02706951|521275569|FG000|Period 2|Adverse Event|0|||
144566624|NCT02706951|521275570|FG001|Period 2|Adverse Event|0|||
144566625|NCT02706951|521275571|FG002|Period 2|Adverse Event|0|||
144566626|NCT02706951|521275572|FG003|Period 2|Adverse Event|25|||
144566627|NCT02706951|521275573|FG004|Period 2|Adverse Event|34|||
144566628|NCT02706951|521275569|FG000|Period 2|Withdrawal by Subject|0|||
144566629|NCT02706951|521275570|FG001|Period 2|Withdrawal by Subject|0|||
144566630|NCT02706951|521275571|FG002|Period 2|Withdrawal by Subject|0|||
144566631|NCT02706951|521275572|FG003|Period 2|Withdrawal by Subject|38|||
144566632|NCT02706951|521275573|FG004|Period 2|Withdrawal by Subject|44|||
144566633|NCT02706951|521275569|FG000|Period 2|Lost to Follow-up|0|||
144566634|NCT02706951|521275570|FG001|Period 2|Lost to Follow-up|0|||
144566635|NCT02706951|521275571|FG002|Period 2|Lost to Follow-up|0|||
144566636|NCT02706951|521275572|FG003|Period 2|Lost to Follow-up|17|||
144566637|NCT02706951|521275573|FG004|Period 2|Lost to Follow-up|9|||
144566638|NCT02706951|521275569|FG000|Period 2|COVID-19 Related|0|||
144566639|NCT02706951|521275570|FG001|Period 2|COVID-19 Related|0|||
144618720|NCT01995071|521462986|FG011|Overall Study|Adverse Event|0|||
144566640|NCT02706951|521275571|FG002|Period 2|COVID-19 Related|0|||
144566641|NCT02706951|521275572|FG003|Period 2|COVID-19 Related|1|||
144566642|NCT02706951|521275573|FG004|Period 2|COVID-19 Related|2|||
144566643|NCT02706951|521275569|FG000|Period 2|Other|0|||
144566644|NCT02706951|521275570|FG001|Period 2|Other|0|||
144566645|NCT02706951|521275571|FG002|Period 2|Other|0|||
144566646|NCT02706951|521275572|FG003|Period 2|Other|37|||
144566647|NCT02706951|521275573|FG004|Period 2|Other|31|||
144566648|NCT02165397|521275576|FG000|Overall Study|Death|7|||
144566649|NCT02165397|521275577|FG001|Overall Study|Death|10|||
144566650|NCT02165397|521275578|FG002|Overall Study|Death|8|||
144566651|NCT02165397|521275576|FG000|Overall Study|Lost to Follow-up|1|||
144566652|NCT02165397|521275577|FG001|Overall Study|Lost to Follow-up|3|||
144566653|NCT02165397|521275578|FG002|Overall Study|Lost to Follow-up|0|||
144566654|NCT02165397|521275576|FG000|Overall Study|Withdrawal by Subject|6|||
144566655|NCT02165397|521275577|FG001|Overall Study|Withdrawal by Subject|6|||
144566656|NCT02165397|521275578|FG002|Overall Study|Withdrawal by Subject|1|||
144566657|NCT02165397|521275576|FG000|Overall Study|Other, Not Specified|0|||
144566658|NCT02165397|521275577|FG001|Overall Study|Other, Not Specified|0|||
144566659|NCT02165397|521275578|FG002|Overall Study|Other, Not Specified|1|||
144566660|NCT01101997|521275581|FG000|Overall Study|Withdrawal by Subject|2|||
144566661|NCT00469456|521275582|FG000|Overall Study|Adverse Event|4|||
144566662|NCT00469456|521275583|FG001|Overall Study|Adverse Event|3|||
144566663|NCT00469456|521275582|FG000|Overall Study|Protocol Violation|1|||
144566664|NCT00469456|521275583|FG001|Overall Study|Protocol Violation|0|||
144566665|NCT00469456|521275582|FG000|Overall Study|Withdrawal by Subject|4|||
144566666|NCT00469456|521275583|FG001|Overall Study|Withdrawal by Subject|1|||
144566667|NCT00611715|521275584|FG000|Overall Study|Disease Progression|24|||
144566668|NCT00611715|521275585|FG001|Overall Study|Disease Progression|4|||
144566669|NCT00611715|521275584|FG000|Overall Study|Withdrawal by Subject|5|||
144566670|NCT00611715|521275585|FG001|Overall Study|Withdrawal by Subject|1|||
144566671|NCT00611715|521275584|FG000|Overall Study|Adverse Event|9|||
144566672|NCT00611715|521275585|FG001|Overall Study|Adverse Event|1|||
144566673|NCT00611715|521275584|FG000|Overall Study|Death|1|||
144566674|NCT00611715|521275585|FG001|Overall Study|Death|0|||
144566675|NCT00611715|521275584|FG000|Overall Study|two patients are still on treatment|2|||
144566676|NCT00611715|521275585|FG001|Overall Study|two patients are still on treatment|0|||
144566677|NCT00107978|521275586|FG000|Overall Study|Adverse Event|1|||
144566678|NCT00107978|521275587|FG001|Overall Study|Adverse Event|5|||
144566679|NCT00107978|521275586|FG000|Overall Study|Death|3|||
144566680|NCT00107978|521275587|FG001|Overall Study|Death|3|||
144566681|NCT00107978|521275586|FG000|Overall Study|Lost to Follow-up|20|||
144566682|NCT00107978|521275587|FG001|Overall Study|Lost to Follow-up|28|||
144566683|NCT00107978|521275586|FG000|Overall Study|Withdrawal by Subject|4|||
144566684|NCT00107978|521275587|FG001|Overall Study|Withdrawal by Subject|9|||
144566685|NCT00107978|521275586|FG000|Overall Study|Protocol Violation|0|||
144566686|NCT00107978|521275587|FG001|Overall Study|Protocol Violation|1|||
144566687|NCT00107978|521275586|FG000|Overall Study|Other|5|||
144566688|NCT00107978|521275587|FG001|Overall Study|Other|4|||
144566689|NCT00350298|521275590|FG000|Overall Study|Death|7|||
144566690|NCT00350298|521275591|FG001|Overall Study|Death|8|||
144566691|NCT00350298|521275590|FG000|Overall Study|Lost to Follow-up|1|||
144566692|NCT00350298|521275591|FG001|Overall Study|Lost to Follow-up|2|||
144566693|NCT00350298|521275590|FG000|Overall Study|Withdrawal by Subject|1|||
144566694|NCT00350298|521275591|FG001|Overall Study|Withdrawal by Subject|3|||
144566695|NCT00233389|521275594|FG000|Overall Study|Adverse Event|5|||
144566696|NCT00233389|521275595|FG001|Overall Study|Adverse Event|5|||
144566697|NCT00233389|521275594|FG000|Overall Study|Lack of Efficacy|11|||
144566698|NCT00233389|521275595|FG001|Overall Study|Lack of Efficacy|8|||
144566699|NCT00233389|521275594|FG000|Overall Study|Lost to Follow-up|1|||
144566700|NCT00233389|521275595|FG001|Overall Study|Lost to Follow-up|1|||
144566701|NCT00233389|521275594|FG000|Overall Study|Physician Decision|1|||
144566702|NCT00233389|521275595|FG001|Overall Study|Physician Decision|0|||
144566703|NCT00233389|521275594|FG000|Overall Study|Protocol Violation|0|||
144566704|NCT00233389|521275595|FG001|Overall Study|Protocol Violation|1|||
144566705|NCT00233389|521275594|FG000|Overall Study|Withdrawal by Subject|0|||
144566706|NCT00233389|521275595|FG001|Overall Study|Withdrawal by Subject|1|||
144566707|NCT02312206|521275604|FG000|Overall Study|Adverse Event|3|||
144566708|NCT02312206|521275605|FG001|Overall Study|Adverse Event|6|||
144566709|NCT02312206|521275604|FG000|Overall Study|Withdrawal by Subject|6|||
144566710|NCT02312206|521275605|FG001|Overall Study|Withdrawal by Subject|6|||
144566711|NCT02312206|521275604|FG000|Overall Study|Physician Decision|7|||
144566712|NCT02312206|521275605|FG001|Overall Study|Physician Decision|6|||
144566713|NCT02312206|521275604|FG000|Overall Study|Death|31|||
144566714|NCT02312206|521275605|FG001|Overall Study|Death|36|||
144566715|NCT02312206|521275604|FG000|Overall Study|Study Terminated by Sponsor|81|||
144566716|NCT02312206|521275605|FG001|Overall Study|Study Terminated by Sponsor|74|||
144618721|NCT01995071|521462975|FG000|Overall Study|Moved|0|||
144618722|NCT01995071|521462976|FG001|Overall Study|Moved|0|||
144618723|NCT01995071|521462977|FG002|Overall Study|Moved|1|||
144618724|NCT01995071|521462978|FG003|Overall Study|Moved|0|||
144618725|NCT01995071|521462979|FG004|Overall Study|Moved|1|||
144618726|NCT01995071|521462980|FG005|Overall Study|Moved|0|||
144618727|NCT01995071|521462981|FG006|Overall Study|Moved|0|||
144618728|NCT01995071|521462982|FG007|Overall Study|Moved|0|||
144618729|NCT01995071|521462983|FG008|Overall Study|Moved|0|||
144618730|NCT01995071|521462984|FG009|Overall Study|Moved|0|||
144618731|NCT01995071|521462985|FG010|Overall Study|Moved|1|||
144618732|NCT01995071|521462986|FG011|Overall Study|Moved|0|||
144618733|NCT01995071|521462975|FG000|Overall Study|Lost to Follow-up|1|||
144618734|NCT01995071|521462976|FG001|Overall Study|Lost to Follow-up|0|||
144262625|NCT01657162|520161500|FG001|Overall Study|Lost to Follow-up|4|||
144262626|NCT01657162|520161499|FG000|Overall Study|Death|2|||
144262627|NCT01657162|520161500|FG001|Overall Study|Death|3|||
144262628|NCT01657162|520161499|FG000|Overall Study|Inability to Complete Study Procedures|1|||
144618735|NCT01995071|521462977|FG002|Overall Study|Lost to Follow-up|0|||
144618736|NCT01995071|521462978|FG003|Overall Study|Lost to Follow-up|0|||
144618737|NCT01995071|521462979|FG004|Overall Study|Lost to Follow-up|0|||
144618738|NCT01995071|521462980|FG005|Overall Study|Lost to Follow-up|0|||
144618739|NCT01995071|521462981|FG006|Overall Study|Lost to Follow-up|0|||
144618740|NCT01995071|521462982|FG007|Overall Study|Lost to Follow-up|1|||
144618741|NCT01995071|521462983|FG008|Overall Study|Lost to Follow-up|1|||
144618742|NCT01995071|521462984|FG009|Overall Study|Lost to Follow-up|0|||
144618743|NCT01995071|521462985|FG010|Overall Study|Lost to Follow-up|0|||
144618744|NCT01995071|521462986|FG011|Overall Study|Lost to Follow-up|0|||
144618745|NCT01995071|521462975|FG000|Overall Study|Incarcerated|0|||
144618746|NCT01995071|521462976|FG001|Overall Study|Incarcerated|0|||
144618747|NCT01995071|521462977|FG002|Overall Study|Incarcerated|0|||
144618748|NCT01995071|521462978|FG003|Overall Study|Incarcerated|0|||
144618749|NCT01995071|521462979|FG004|Overall Study|Incarcerated|0|||
144618750|NCT01995071|521462980|FG005|Overall Study|Incarcerated|0|||
144618751|NCT01995071|521462981|FG006|Overall Study|Incarcerated|0|||
144618752|NCT01995071|521462982|FG007|Overall Study|Incarcerated|1|||
144618753|NCT01995071|521462983|FG008|Overall Study|Incarcerated|0|||
144618754|NCT01995071|521462984|FG009|Overall Study|Incarcerated|0|||
144618755|NCT01995071|521462985|FG010|Overall Study|Incarcerated|0|||
144618756|NCT01995071|521462986|FG011|Overall Study|Incarcerated|0|||
144618757|NCT02404103|521462987|FG000|Overall Study|Adverse Event|1|||
144618758|NCT02404103|521462988|FG001|Overall Study|Adverse Event|0|||
144618759|NCT02404103|521462987|FG000|Overall Study|Lost to Follow-up|3|||
144618760|NCT02404103|521462988|FG001|Overall Study|Lost to Follow-up|3|||
144618761|NCT02543528|521462994|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
144618762|NCT02543528|521462995|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
144618763|NCT02543528|521462996|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
144618764|NCT02543528|521462997|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
144618765|NCT02543528|521462998|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
144618766|NCT02543528|521462994|FG000|Adaptation Period|Lens Handling Difficultes|0|||
144618767|NCT02543528|521462995|FG001|Adaptation Period|Lens Handling Difficultes|0|||
144618768|NCT02543528|521462996|FG002|Adaptation Period|Lens Handling Difficultes|0|||
144618769|NCT02543528|521462997|FG003|Adaptation Period|Lens Handling Difficultes|0|||
144618770|NCT02543528|521462998|FG004|Adaptation Period|Lens Handling Difficultes|8|||
144262629|NCT01657162|520161500|FG001|Overall Study|Inability to Complete Study Procedures|7|||
144262630|NCT01657162|520161499|FG000|Overall Study|Protocol Violation|1|||
144262631|NCT01657162|520161500|FG001|Overall Study|Protocol Violation|0|||
144262632|NCT01657162|520161499|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
144262633|NCT01657162|520161500|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
144262634|NCT01657162|520161499|FG000|Overall Study|Other than Specified|0|||
144262635|NCT01657162|520161500|FG001|Overall Study|Other than Specified|2|||
144262636|NCT03360019|520161503|FG000|Overall Study|Withdrawal by Subject|2|||
144262637|NCT03360019|520161504|FG001|Overall Study|Withdrawal by Subject|0|||
144262638|NCT03360019|520161505|FG002|Overall Study|Withdrawal by Subject|0|||
144262639|NCT03360019|520161503|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
144262640|NCT03360019|520161504|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
144262641|NCT03360019|520161505|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
144262642|NCT00096538|520161508|FG000|Overall Study|Withdrawal by Subject|1|||
144262643|NCT02686164|520161510|FG000|Overall Study|Adverse Event|1|||
144618771|NCT02543528|521462994|FG000|Adaptation Period|Lost to Follow-up|0|||
144618772|NCT02543528|521462995|FG001|Adaptation Period|Lost to Follow-up|0|||
144618773|NCT02543528|521462996|FG002|Adaptation Period|Lost to Follow-up|0|||
144618774|NCT02543528|521462997|FG003|Adaptation Period|Lost to Follow-up|0|||
144618775|NCT02543528|521462998|FG004|Adaptation Period|Lost to Follow-up|14|||
144618776|NCT02543528|521462994|FG000|Adaptation Period|Adverse Event|0|||
144618777|NCT02543528|521462995|FG001|Adaptation Period|Adverse Event|0|||
144618778|NCT02543528|521462996|FG002|Adaptation Period|Adverse Event|0|||
144618779|NCT02543528|521462997|FG003|Adaptation Period|Adverse Event|0|||
144618780|NCT02543528|521462998|FG004|Adaptation Period|Adverse Event|2|||
144618781|NCT02543528|521462994|FG000|Extended Wear Period|Adverse Event|17|||
144618782|NCT02543528|521462995|FG001|Extended Wear Period|Adverse Event|11|||
144618783|NCT02543528|521462996|FG002|Extended Wear Period|Adverse Event|16|||
144618784|NCT02543528|521462997|FG003|Extended Wear Period|Adverse Event|3|||
144618785|NCT02543528|521462998|FG004|Extended Wear Period|Adverse Event|0|||
144618786|NCT02543528|521462994|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
144618787|NCT02543528|521462995|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
144618788|NCT02543528|521462996|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
144618789|NCT02543528|521462997|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
144618790|NCT02543528|521462998|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
144618791|NCT02543528|521462994|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
144618792|NCT02543528|521462995|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
144618793|NCT02543528|521462996|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
144618794|NCT02543528|521462997|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
144618795|NCT02543528|521462998|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
144618796|NCT02543528|521462994|FG000|Extended Wear Period|Lost to Follow-up|0|||
144618797|NCT02543528|521462995|FG001|Extended Wear Period|Lost to Follow-up|1|||
144618798|NCT02543528|521462996|FG002|Extended Wear Period|Lost to Follow-up|2|||
144618799|NCT02543528|521462997|FG003|Extended Wear Period|Lost to Follow-up|1|||
144204879|NCT01910389|519944565|FG001|Overall Study|Withdrawal by Subject|0|||
144204880|NCT01910389|519944564|FG000|Overall Study|Study Closed|13|||
144204881|NCT01910389|519944565|FG001|Overall Study|Study Closed|8|||
144566717|NCT02312206|521275604|FG000|Overall Study|Patient transferred to hospice|0|||
144566718|NCT02312206|521275605|FG001|Overall Study|Patient transferred to hospice|1|||
144566719|NCT02312206|521275604|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
144566720|NCT02312206|521275605|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
144566721|NCT02312206|521275604|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
144566722|NCT02312206|521275605|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
144566723|NCT02312206|521275604|FG000|Overall Study|Disease Progression|1|||
144566724|NCT02312206|521275605|FG001|Overall Study|Disease Progression|0|||
144566725|NCT03082612|521275606|FG000|Overall Study|Lost to Follow-up|2|||
144566726|NCT03082612|521275607|FG001|Overall Study|Lost to Follow-up|0|||
144566727|NCT01006616|521275608|FG000|Period 1 (6 Months)|Adverse Event|10|||
144566728|NCT01006616|521275609|FG001|Period 1 (6 Months)|Adverse Event|31|||
144566729|NCT01006616|521275610|FG002|Period 1 (6 Months)|Adverse Event|37|||
144566730|NCT01006616|521275611|FG003|Period 1 (6 Months)|Adverse Event|9|||
144566731|NCT01006616|521275608|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
144566732|NCT01006616|521275609|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
144566733|NCT01006616|521275610|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
144566734|NCT01006616|521275611|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
144566735|NCT01006616|521275608|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
144566736|NCT01006616|521275609|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
144566737|NCT01006616|521275610|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
144566738|NCT01006616|521275611|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
144566739|NCT01006616|521275608|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
144566740|NCT01006616|521275609|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
144566741|NCT01006616|521275610|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
144566742|NCT01006616|521275611|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
144566743|NCT01006616|521275608|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
144566744|NCT01006616|521275609|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
144566745|NCT01006616|521275610|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
144566746|NCT01006616|521275611|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
144566747|NCT01006616|521275608|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
144566748|NCT01006616|521275609|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
144566749|NCT01006616|521275610|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
144566750|NCT01006616|521275611|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
144566751|NCT01006616|521275608|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
144566752|NCT01006616|521275609|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
144566753|NCT01006616|521275610|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
144566754|NCT01006616|521275611|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
144566755|NCT01006616|521275608|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
144566756|NCT01006616|521275609|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
144566757|NCT01006616|521275610|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
144566758|NCT01006616|521275611|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
144566759|NCT01006616|521275608|FG000|Period 1 (6 Months)|Not Treated|0|||
144618800|NCT02543528|521462998|FG004|Extended Wear Period|Lost to Follow-up|0|||
144204882|NCT01898650|519944566|FG000|Overall Study|the subject would not lie still for imaging|1|||
144566760|NCT01006616|521275609|FG001|Period 1 (6 Months)|Not Treated|0|||
144566761|NCT01006616|521275610|FG002|Period 1 (6 Months)|Not Treated|1|||
144204883|NCT05896202|519944568|FG000|Overall Study|Lost to Follow-up|2|||
144204884|NCT05896202|519944569|FG001|Overall Study|Lost to Follow-up|2|||
144204885|NCT04874636|519944570|FG000|Overall Study|Adverse Event|17|||
144204886|NCT04874636|519944571|FG001|Overall Study|Adverse Event|7|||
144566762|NCT01006616|521275611|FG003|Period 1 (6 Months)|Not Treated|1|||
144566763|NCT01006616|521275608|FG000|Period 2 (18 Months)|Adverse Event|6|||
144566764|NCT01006616|521275609|FG001|Period 2 (18 Months)|Adverse Event|6|||
144566765|NCT01006616|521275610|FG002|Period 2 (18 Months)|Adverse Event|6|||
144566766|NCT01006616|521275611|FG003|Period 2 (18 Months)|Adverse Event|4|||
144566767|NCT01006616|521275608|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
144566768|NCT01006616|521275609|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
144566769|NCT01006616|521275610|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
144204887|NCT04874636|519944570|FG000|Overall Study|Lost to Follow-up|1|||
144566770|NCT01006616|521275611|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
144566771|NCT01006616|521275608|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
144566772|NCT01006616|521275609|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
144566773|NCT01006616|521275610|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
144566774|NCT01006616|521275611|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
144566775|NCT01006616|521275608|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
144566776|NCT01006616|521275609|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
144566777|NCT01006616|521275610|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
144566778|NCT01006616|521275611|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
144566779|NCT01006616|521275608|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
144566780|NCT01006616|521275609|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
144566781|NCT01006616|521275610|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
144566782|NCT01006616|521275611|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
144566783|NCT01006616|521275608|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
144566784|NCT01006616|521275609|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
144566785|NCT01006616|521275610|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
144566786|NCT01006616|521275611|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
144566787|NCT01006616|521275608|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
144566788|NCT01006616|521275609|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
144566789|NCT01006616|521275610|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
144566790|NCT01006616|521275611|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
144566791|NCT01006616|521275608|FG000|Period 2 (18 Months)|Study Terminated|63|||
144566792|NCT01006616|521275609|FG001|Period 2 (18 Months)|Study Terminated|46|||
144566793|NCT01006616|521275610|FG002|Period 2 (18 Months)|Study Terminated|44|||
144566794|NCT01006616|521275611|FG003|Period 2 (18 Months)|Study Terminated|70|||
144566795|NCT00952848|521275616|FG000|Overall Study|Withdrawal by Subject|4|||
144566796|NCT02250534|521275617|FG000|Overall Study|Lost to Follow-up|18|||
144566797|NCT02250534|521275618|FG001|Overall Study|Lost to Follow-up|28|||
144566798|NCT02250534|521275619|FG002|Overall Study|Lost to Follow-up|33|||
144566799|NCT02250534|521275617|FG000|Overall Study|Personal reasons|7|||
144566800|NCT02250534|521275618|FG001|Overall Study|Personal reasons|8|||
144566801|NCT02250534|521275619|FG002|Overall Study|Personal reasons|14|||
144566802|NCT02250534|521275617|FG000|Overall Study|Adverse Event|6|||
144566803|NCT02250534|521275618|FG001|Overall Study|Adverse Event|3|||
144566804|NCT02250534|521275619|FG002|Overall Study|Adverse Event|8|||
144566805|NCT02250534|521275617|FG000|Overall Study|incarcerated|2|||
144566806|NCT02250534|521275618|FG001|Overall Study|incarcerated|1|||
144566807|NCT02250534|521275619|FG002|Overall Study|incarcerated|2|||
144566808|NCT02250534|521275617|FG000|Overall Study|Withdrawal by Subject|0|||
144566809|NCT02250534|521275618|FG001|Overall Study|Withdrawal by Subject|1|||
144566810|NCT02250534|521275619|FG002|Overall Study|Withdrawal by Subject|2|||
144566811|NCT02250534|521275617|FG000|Overall Study|Death|0|||
144566812|NCT02250534|521275618|FG001|Overall Study|Death|1|||
144566813|NCT02250534|521275619|FG002|Overall Study|Death|1|||
144566814|NCT02250534|521275617|FG000|Overall Study|Physician Decision|1|||
144566815|NCT02250534|521275618|FG001|Overall Study|Physician Decision|3|||
144566816|NCT02250534|521275619|FG002|Overall Study|Physician Decision|1|||
144566817|NCT02250534|521275617|FG000|Overall Study|Protocol Violation|1|||
144566818|NCT02250534|521275618|FG001|Overall Study|Protocol Violation|0|||
144566819|NCT02250534|521275619|FG002|Overall Study|Protocol Violation|1|||
144566820|NCT02250534|521275617|FG000|Overall Study|Reason unknown|1|||
144566821|NCT02250534|521275618|FG001|Overall Study|Reason unknown|0|||
144566822|NCT02250534|521275619|FG002|Overall Study|Reason unknown|0|||
144566823|NCT00458393|521275620|FG000|Overall Study|Withdrawal by Subject|67|||
144566824|NCT00458393|521275621|FG001|Overall Study|Withdrawal by Subject|80|||
144566825|NCT00458393|521275620|FG000|Overall Study|Physician Decision|31|||
144566826|NCT00458393|521275621|FG001|Overall Study|Physician Decision|22|||
144566827|NCT00458393|521275620|FG000|Overall Study|Relocated|77|||
144566828|NCT00458393|521275621|FG001|Overall Study|Relocated|81|||
144566829|NCT00458393|521275620|FG000|Overall Study|Lost to Follow-up|115|||
144566830|NCT00458393|521275621|FG001|Overall Study|Lost to Follow-up|92|||
144566831|NCT00458393|521275620|FG000|Overall Study|Sites marked other on the form.|19|||
144566832|NCT00458393|521275621|FG001|Overall Study|Sites marked other on the form.|20|||
144566833|NCT01253447|521275623|FG000|Overall Study|Adverse Event|2|||
144566834|NCT02299427|521275624|FG000|Overall Study|Withdrawal by Subject|1|||
144566835|NCT02299427|521275625|FG001|Overall Study|Withdrawal by Subject|0|||
144566836|NCT02299427|521275624|FG000|Overall Study|Lost to Follow-up|1|||
144566837|NCT02299427|521275625|FG001|Overall Study|Lost to Follow-up|3|||
144566838|NCT02299427|521275624|FG000|Overall Study|not adherent to dog website use|21|||
144566839|NCT02299427|521275625|FG001|Overall Study|not adherent to dog website use|0|||
144566840|NCT01121913|521275628|FG000|First Intervention Period|Adverse Event|0|||
144566841|NCT01121913|521275629|FG001|First Intervention Period|Adverse Event|0|||
144566842|NCT01121913|521275630|FG002|First Intervention Period|Adverse Event|1|||
144566843|NCT01121913|521275631|FG003|First Intervention Period|Adverse Event|0|||
144566844|NCT01121913|521275628|FG000|First Washout Period|Withdrawal by Subject|1|||
144204888|NCT04874636|519944571|FG001|Overall Study|Lost to Follow-up|0|||
144204889|NCT04874636|519944570|FG000|Overall Study|Non-Compliance with Study Drug|2|||
144204890|NCT04874636|519944571|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144204891|NCT04874636|519944570|FG000|Overall Study|Physician Decision|1|||
144204892|NCT04874636|519944571|FG001|Overall Study|Physician Decision|0|||
144204893|NCT04874636|519944570|FG000|Overall Study|Withdrawal by Subject|6|||
144204894|NCT04874636|519944571|FG001|Overall Study|Withdrawal by Subject|5|||
144204895|NCT00390221|519944572|FG000|Overall Study|Lost to Follow-up|0|||
144204896|NCT00390221|519944573|FG001|Overall Study|Lost to Follow-up|3|||
144204897|NCT00390221|519944574|FG002|Overall Study|Lost to Follow-up|0|||
144566845|NCT01121913|521275629|FG001|First Washout Period|Withdrawal by Subject|0|||
144566846|NCT01121913|521275630|FG002|First Washout Period|Withdrawal by Subject|0|||
144566847|NCT01121913|521275631|FG003|First Washout Period|Withdrawal by Subject|0|||
144566848|NCT01121913|521275628|FG000|Second Intervention Period|Adverse Event|0|||
144566849|NCT01121913|521275629|FG001|Second Intervention Period|Adverse Event|0|||
144566850|NCT01121913|521275630|FG002|Second Intervention Period|Adverse Event|1|||
144566851|NCT01121913|521275631|FG003|Second Intervention Period|Adverse Event|0|||
144566852|NCT01121913|521275628|FG000|Second Washout Period|Withdrawal by Subject|0|||
144566853|NCT01121913|521275629|FG001|Second Washout Period|Withdrawal by Subject|0|||
144566854|NCT01121913|521275630|FG002|Second Washout Period|Withdrawal by Subject|1|||
144566855|NCT01121913|521275631|FG003|Second Washout Period|Withdrawal by Subject|0|||
144566856|NCT01121913|521275628|FG000|Third Washout Period|Adverse Event|1|||
144566857|NCT01121913|521275629|FG001|Third Washout Period|Adverse Event|0|||
144566858|NCT01121913|521275630|FG002|Third Washout Period|Adverse Event|0|||
144566859|NCT01121913|521275631|FG003|Third Washout Period|Adverse Event|0|||
144566860|NCT00937521|521275632|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
144566861|NCT00937521|521275633|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
144566862|NCT00937521|521275634|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
144566863|NCT00937521|521275635|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
144566864|NCT00937521|521275636|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
144566865|NCT00937521|521275637|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
144566866|NCT00937521|521275638|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
144566867|NCT00937521|521275639|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
144566868|NCT00937521|521275632|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
144566869|NCT00937521|521275633|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
144566870|NCT00937521|521275634|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
144566871|NCT00937521|521275635|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
144566872|NCT00937521|521275636|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
144566873|NCT00937521|521275637|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
144566874|NCT00937521|521275638|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
144566875|NCT00937521|521275639|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
144566876|NCT00937521|521275632|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
144566877|NCT00937521|521275633|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
144566878|NCT00937521|521275634|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
144566879|NCT00937521|521275635|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
144566880|NCT00937521|521275636|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
144566881|NCT00937521|521275637|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
144618801|NCT02543528|521462994|FG000|Extended Wear Period|Withdrawal by Subject|10|||
144618802|NCT02543528|521462995|FG001|Extended Wear Period|Withdrawal by Subject|9|||
144618803|NCT02543528|521462996|FG002|Extended Wear Period|Withdrawal by Subject|4|||
144618804|NCT02543528|521462997|FG003|Extended Wear Period|Withdrawal by Subject|5|||
144618805|NCT02543528|521462998|FG004|Extended Wear Period|Withdrawal by Subject|0|||
144618806|NCT01408147|521462999|FG000|Overall Study|Withdrawal by Subject|0|||
144618807|NCT01408147|521463000|FG001|Overall Study|Withdrawal by Subject|1|||
144204898|NCT00390221|519944572|FG000|Overall Study|Adverse Event|1|||
144566882|NCT00937521|521275638|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
144566883|NCT00937521|521275639|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
144566884|NCT00937521|521275632|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
144566885|NCT00937521|521275633|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
144566886|NCT00937521|521275634|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
144566887|NCT00937521|521275635|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
144618808|NCT01042600|521463001|FG000|Overall Study|Ineligible|1|||
144618809|NCT01042600|521463002|FG001|Overall Study|Ineligible|0|||
144618810|NCT05048719|521463003|FG000|Overall Study|Withdrawal by Subject|2|||
144618811|NCT05048719|521463004|FG001|Overall Study|Withdrawal by Subject|1|||
144618812|NCT05048719|521463005|FG002|Overall Study|Withdrawal by Subject|3|||
144204899|NCT00390221|519944573|FG001|Overall Study|Adverse Event|4|||
144618813|NCT05048719|521463006|FG003|Overall Study|Withdrawal by Subject|1|||
144204900|NCT00390221|519944574|FG002|Overall Study|Adverse Event|3|||
144204901|NCT00390221|519944572|FG000|Overall Study|Investigator Decision|0|||
144566888|NCT00937521|521275636|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
144566889|NCT00937521|521275637|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
144566890|NCT00937521|521275638|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
144566891|NCT00937521|521275639|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
144566892|NCT00937521|521275632|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
144566893|NCT00937521|521275633|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
144566894|NCT00937521|521275634|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
144566895|NCT00937521|521275635|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
144566896|NCT00937521|521275636|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
144566897|NCT00937521|521275637|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
144566898|NCT00937521|521275638|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
144566899|NCT00937521|521275639|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
144566900|NCT00937521|521275632|FG000|Booster Phase|Adverse Event|0|||
144566901|NCT00937521|521275633|FG001|Booster Phase|Adverse Event|0|||
144566902|NCT00937521|521275634|FG002|Booster Phase|Adverse Event|0|||
144566903|NCT00937521|521275635|FG003|Booster Phase|Adverse Event|0|||
144566904|NCT00937521|521275636|FG004|Booster Phase|Adverse Event|0|||
144566905|NCT00937521|521275637|FG005|Booster Phase|Adverse Event|0|||
144566906|NCT00937521|521275638|FG006|Booster Phase|Adverse Event|1|||
144566907|NCT00937521|521275639|FG007|Booster Phase|Adverse Event|0|||
144566908|NCT00937521|521275632|FG000|Booster Phase|Withdrawal by Subject|1|||
144566909|NCT00937521|521275633|FG001|Booster Phase|Withdrawal by Subject|0|||
144566910|NCT00937521|521275634|FG002|Booster Phase|Withdrawal by Subject|0|||
144566911|NCT00937521|521275635|FG003|Booster Phase|Withdrawal by Subject|1|||
144566912|NCT00937521|521275636|FG004|Booster Phase|Withdrawal by Subject|0|||
144566913|NCT00937521|521275637|FG005|Booster Phase|Withdrawal by Subject|0|||
144566914|NCT00937521|521275638|FG006|Booster Phase|Withdrawal by Subject|0|||
144566915|NCT00937521|521275639|FG007|Booster Phase|Withdrawal by Subject|2|||
144566916|NCT00937521|521275632|FG000|Booster Phase|Lost to Follow-up|2|||
144566917|NCT00937521|521275633|FG001|Booster Phase|Lost to Follow-up|2|||
144566918|NCT00937521|521275634|FG002|Booster Phase|Lost to Follow-up|4|||
144566919|NCT00937521|521275635|FG003|Booster Phase|Lost to Follow-up|2|||
144566920|NCT00937521|521275636|FG004|Booster Phase|Lost to Follow-up|4|||
144566921|NCT00937521|521275637|FG005|Booster Phase|Lost to Follow-up|4|||
144566922|NCT00937521|521275638|FG006|Booster Phase|Lost to Follow-up|3|||
144566923|NCT00937521|521275639|FG007|Booster Phase|Lost to Follow-up|0|||
144566924|NCT00937521|521275632|FG000|Booster Phase|Administrative Reason|0|||
144566925|NCT00937521|521275633|FG001|Booster Phase|Administrative Reason|0|||
144566926|NCT00937521|521275634|FG002|Booster Phase|Administrative Reason|1|||
144566927|NCT00937521|521275635|FG003|Booster Phase|Administrative Reason|0|||
144566928|NCT00937521|521275636|FG004|Booster Phase|Administrative Reason|1|||
144566929|NCT00937521|521275637|FG005|Booster Phase|Administrative Reason|1|||
144566930|NCT00937521|521275638|FG006|Booster Phase|Administrative Reason|0|||
144566931|NCT00937521|521275639|FG007|Booster Phase|Administrative Reason|0|||
144566932|NCT00937521|521275632|FG000|Booster Phase|Protocol Deviation|0|||
144566933|NCT00937521|521275633|FG001|Booster Phase|Protocol Deviation|0|||
144566934|NCT00937521|521275634|FG002|Booster Phase|Protocol Deviation|0|||
144566935|NCT00937521|521275635|FG003|Booster Phase|Protocol Deviation|0|||
144566936|NCT00937521|521275636|FG004|Booster Phase|Protocol Deviation|0|||
144566937|NCT00937521|521275637|FG005|Booster Phase|Protocol Deviation|0|||
144566938|NCT00937521|521275638|FG006|Booster Phase|Protocol Deviation|1|||
144566939|NCT00937521|521275639|FG007|Booster Phase|Protocol Deviation|0|||
144566940|NCT03269695|521275645|FG000|Overall Study|Adverse Event|2|||
144566941|NCT03269695|521275646|FG001|Overall Study|Adverse Event|1|||
144618814|NCT05048719|521463007|FG004|Overall Study|Withdrawal by Subject|0|||
144618815|NCT05048719|521463008|FG005|Overall Study|Withdrawal by Subject|2|||
144618816|NCT05048719|521463009|FG006|Overall Study|Withdrawal by Subject|1|||
144618817|NCT05048719|521463010|FG007|Overall Study|Withdrawal by Subject|1|||
144618818|NCT05048719|521463011|FG008|Overall Study|Withdrawal by Subject|0|||
144566942|NCT03269695|521275645|FG000|Overall Study|Lack of Efficacy|0|||
144566943|NCT03269695|521275646|FG001|Overall Study|Lack of Efficacy|1|||
144566944|NCT03269695|521275645|FG000|Overall Study|Withdrawal by Subject|0|||
144618819|NCT05048719|521463003|FG000|Overall Study|Death|1|||
144618820|NCT05048719|521463004|FG001|Overall Study|Death|0|||
144618821|NCT05048719|521463005|FG002|Overall Study|Death|0|||
144618822|NCT05048719|521463006|FG003|Overall Study|Death|0|||
144566945|NCT03269695|521275646|FG001|Overall Study|Withdrawal by Subject|1|||
144566946|NCT01313624|521275647|FG000|Double-Blind Phase|Adverse Event|27|||
144566947|NCT01313624|521275648|FG001|Double-Blind Phase|Adverse Event|4|||
144566948|NCT01313624|521275647|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
144566949|NCT01313624|521275648|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
144566950|NCT01313624|521275647|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144566951|NCT01313624|521275648|FG001|Double-Blind Phase|Lost to Follow-up|2|||
144566952|NCT01313624|521275647|FG000|Double-Blind Phase|Physician Decision|1|||
144566953|NCT01313624|521275648|FG001|Double-Blind Phase|Physician Decision|0|||
144566954|NCT01313624|521275647|FG000|Double-Blind Phase|Lack of Efficacy|1|||
144204902|NCT00390221|519944573|FG001|Overall Study|Investigator Decision|0|||
144204903|NCT00390221|519944574|FG002|Overall Study|Investigator Decision|1|||
144204904|NCT00390221|519944572|FG000|Overall Study|Withdrawal by Subject|13|||
144204905|NCT00390221|519944573|FG001|Overall Study|Withdrawal by Subject|9|||
144204906|NCT00390221|519944574|FG002|Overall Study|Withdrawal by Subject|7|||
144204907|NCT00390221|519944572|FG000|Overall Study|Subject Non-compliance|1|||
144204908|NCT00390221|519944573|FG001|Overall Study|Subject Non-compliance|0|||
144204909|NCT00390221|519944574|FG002|Overall Study|Subject Non-compliance|2|||
144204910|NCT00390221|519944572|FG000|Overall Study|Other|3|||
144204911|NCT00390221|519944573|FG001|Overall Study|Other|4|||
144204912|NCT00390221|519944574|FG002|Overall Study|Other|2|||
144204913|NCT02582866|519944575|FG000|Overall Study|Death|1|||
144204914|NCT02582866|519944575|FG000|Overall Study|Lack of Efficacy|2|||
144204915|NCT02582866|519944575|FG000|Overall Study|Lost to Follow-up|2|||
144204916|NCT02582866|519944575|FG000|Overall Study|Withdrawal by Subject|7|||
144204917|NCT02582866|519944575|FG000|Overall Study|Investigator decision|5|||
144204918|NCT02582866|519944575|FG000|Overall Study|Participant wants to get pregnant|1|||
144204919|NCT02582866|519944575|FG000|Overall Study|Pregnancy|2|||
144204920|NCT02582866|519944575|FG000|Overall Study|Sponsor decision|1|||
144204921|NCT02582866|519944575|FG000|Overall Study|Withdrawal due to personal reasons|1|||
144204922|NCT03258853|519944576|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
144204923|NCT03258853|519944577|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
144204924|NCT02011386|519944582|FG000|Overall Study|Non-compliance|2|||
144204925|NCT02011386|519944582|FG000|Overall Study|Lack of Efficacy|3|||
144204926|NCT04994483|519946806|FG000|Overall Study|Adverse Event|26|||
144204927|NCT04994483|519946807|FG001|Overall Study|Adverse Event|17|||
144204928|NCT04994483|519946806|FG000|Overall Study|Lost to Follow-up|6|||
144204929|NCT04994483|519946807|FG001|Overall Study|Lost to Follow-up|10|||
144204930|NCT04994483|519946806|FG000|Overall Study|Noncompliance with study drug|8|||
144204931|NCT04994483|519946807|FG001|Overall Study|Noncompliance with study drug|5|||
144204932|NCT04994483|519946806|FG000|Overall Study|Physician Decision|5|||
144204933|NCT04994483|519946807|FG001|Overall Study|Physician Decision|0|||
144204934|NCT04994483|519946806|FG000|Overall Study|Withdrawal by Subject|41|||
144204935|NCT04994483|519946807|FG001|Overall Study|Withdrawal by Subject|38|||
144204936|NCT04994483|519946806|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
144204937|NCT04994483|519946807|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
144204938|NCT04994483|519946806|FG000|Overall Study|Met stopping criteria|1|||
144204939|NCT04994483|519946807|FG001|Overall Study|Met stopping criteria|0|||
144204940|NCT04994483|519946806|FG000|Overall Study|Randomized in error, not treated|4|||
144204941|NCT04994483|519946807|FG001|Overall Study|Randomized in error, not treated|3|||
144204942|NCT04994483|519946806|FG000|Overall Study|Lack of a reliable study partner|0|||
144204943|NCT04994483|519946807|FG001|Overall Study|Lack of a reliable study partner|1|||
144204944|NCT04994483|519946806|FG000|Overall Study|Met MRI exclusion criteria|0|||
144204945|NCT04994483|519946807|FG001|Overall Study|Met MRI exclusion criteria|1|||
144204946|NCT00112866|519946808|FG000|Overall Study|Protocol Violation|1|||
144204947|NCT00112866|519946809|FG001|Overall Study|Protocol Violation|0|||
144204948|NCT00112866|519946808|FG000|Overall Study|did not start treatment post-op|1|||
144204949|NCT00112866|519946809|FG001|Overall Study|did not start treatment post-op|2|||
144204950|NCT00554190|519946810|FG000|Overall Study|Termination forms not completed|10|||
144204951|NCT01957397|519946819|FG000|Test Period 1|sudden leakage/small bag|1|||
144204952|NCT01957397|519946820|FG001|Test Period 1|sudden leakage/small bag|1|||
144204953|NCT01957397|519946819|FG000|Test Period 1|Withdrawal by Subject|1|||
144204954|NCT01957397|519946820|FG001|Test Period 1|Withdrawal by Subject|0|||
144204955|NCT01957397|519946819|FG000|Test Period 2|Adverse Event|0|||
144204956|NCT01957397|519946820|FG001|Test Period 2|Adverse Event|1|||
144204957|NCT01957397|519946819|FG000|Test Period 3|Adverse Event|1|||
144204958|NCT01957397|519946820|FG001|Test Period 3|Adverse Event|2|||
144204959|NCT01957397|519946819|FG000|Test Period 3|the adhesive did not work|1|||
144204960|NCT01957397|519946820|FG001|Test Period 3|the adhesive did not work|0|||
144204961|NCT00540293|519946821|FG000|Overall Study|Adverse event related to study drug|10|||
144204962|NCT00540293|519946821|FG000|Overall Study|Adverse event not related to study drug|7|||
144204963|NCT00540293|519946821|FG000|Overall Study|Withdrawal by Subject|6|||
144204964|NCT00540293|519946821|FG000|Overall Study|Protocol violation, & subject schedule|12|||
144204965|NCT00325195|519946824|FG000|Randomized|Not dosed|5|||
144204966|NCT00325195|519946825|FG001|Randomized|Not dosed|5|||
144204967|NCT00325195|519946826|FG002|Randomized|Not dosed|3|||
144204968|NCT00325195|519946824|FG000|Received Intervention: ITT Population|Adverse Event|15|||
144204969|NCT00325195|519946825|FG001|Received Intervention: ITT Population|Adverse Event|17|||
144204970|NCT00325195|519946826|FG002|Received Intervention: ITT Population|Adverse Event|1|||
144618823|NCT05048719|521463007|FG004|Overall Study|Death|0|||
144204971|NCT00325195|519946824|FG000|Received Intervention: ITT Population|Death|3|||
144204972|NCT00325195|519946825|FG001|Received Intervention: ITT Population|Death|1|||
144204973|NCT00325195|519946826|FG002|Received Intervention: ITT Population|Death|0|||
144204974|NCT00325195|519946824|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
144204975|NCT00325195|519946825|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
144566955|NCT01313624|521275648|FG001|Double-Blind Phase|Lack of Efficacy|0|||
144566956|NCT01313624|521275647|FG000|Open-Label Phase|Adverse Event|1|||
144566957|NCT01313624|521275648|FG001|Open-Label Phase|Adverse Event|10|||
144566958|NCT01313624|521275647|FG000|Open-Label Phase|Withdrawal by Subject|2|||
144566959|NCT01313624|521275648|FG001|Open-Label Phase|Withdrawal by Subject|2|||
144566960|NCT01313624|521275647|FG000|Open-Label Phase|Lost to Follow-up|1|||
144566961|NCT01313624|521275648|FG001|Open-Label Phase|Lost to Follow-up|1|||
144566962|NCT00104637|521275649|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
144566963|NCT00104637|521275650|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
144566964|NCT00239681|521275653|FG000|Overall Study|Adverse Event|100|||
144566965|NCT00239681|521275654|FG001|Overall Study|Adverse Event|99|||
144566966|NCT00239681|521275653|FG000|Overall Study|Withdrawal by Subject|458|||
144566967|NCT00239681|521275654|FG001|Overall Study|Withdrawal by Subject|489|||
144566968|NCT00239681|521275653|FG000|Overall Study|Lost to Follow-up|28|||
144566969|NCT00239681|521275654|FG001|Overall Study|Lost to Follow-up|22|||
144566970|NCT00239681|521275653|FG000|Overall Study|Protocol Violation|4|||
144566971|NCT00239681|521275654|FG001|Overall Study|Protocol Violation|4|||
144566972|NCT00239681|521275653|FG000|Overall Study|Physician Decision|13|||
144566973|NCT00239681|521275654|FG001|Overall Study|Physician Decision|17|||
144566974|NCT00239681|521275653|FG000|Overall Study|No information chacked on CaseReportForm|90|||
144566975|NCT00239681|521275654|FG001|Overall Study|No information chacked on CaseReportForm|84|||
144566976|NCT02447718|521275655|FG000|Overall Study|Lost to Follow-up|8|||
144566977|NCT02447718|521275656|FG001|Overall Study|Lost to Follow-up|0|||
144566978|NCT02447718|521275655|FG000|Overall Study|Withdrawal by Subject|3|||
144566979|NCT02447718|521275656|FG001|Overall Study|Withdrawal by Subject|0|||
144566980|NCT02447718|521275655|FG000|Overall Study|Screen Failure|1|||
144566981|NCT02447718|521275656|FG001|Overall Study|Screen Failure|0|||
144566982|NCT02654132|521275657|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
144566983|NCT02654132|521275658|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
144566984|NCT02654132|521275657|FG000|Treatment Period|Disease progression|43|||
144566985|NCT02654132|521275658|FG001|Treatment Period|Disease progression|38|||
144566986|NCT02654132|521275657|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
144566987|NCT02654132|521275658|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
144566988|NCT02654132|521275657|FG000|Treatment Period|Other reasons|4|||
144566989|NCT02654132|521275658|FG001|Treatment Period|Other reasons|2|||
144566990|NCT02654132|521275657|FG000|Treatment Period|Study drug toxicity|2|||
144566991|NCT02654132|521275658|FG001|Treatment Period|Study drug toxicity|2|||
144618824|NCT05048719|521463008|FG005|Overall Study|Death|0|||
144618825|NCT05048719|521463009|FG006|Overall Study|Death|0|||
144618826|NCT05048719|521463010|FG007|Overall Study|Death|0|||
144262644|NCT02686164|520161510|FG000|Overall Study|Withdrawal of consent|1|||
144262645|NCT02686164|520161510|FG000|Overall Study|Clinical progression|1|||
144262646|NCT01691378|520161511|FG000|Overall Study|Withdrawal by Subject|2|||
144262647|NCT01691378|520161512|FG001|Overall Study|Withdrawal by Subject|0|||
144262648|NCT01691378|520161511|FG000|Overall Study|Lost to Follow-up|5|||
144262649|NCT01691378|520161512|FG001|Overall Study|Lost to Follow-up|2|||
144262650|NCT02324361|520161515|FG000|Overall Study|Lost to Follow-up|5|||
144262651|NCT02324361|520161516|FG001|Overall Study|Lost to Follow-up|2|||
144262652|NCT04235504|520161522|FG000|Study Phase|Withdrawal by Subject|5|||
144262653|NCT04235504|520161523|FG001|Study Phase|Withdrawal by Subject|2|||
144262654|NCT04235504|520161524|FG002|Study Phase|Withdrawal by Subject|0|||
144262655|NCT04235504|520161525|FG003|Study Phase|Withdrawal by Subject|0|||
144262656|NCT04235504|520161522|FG000|Continuation Phase|Withdrawal by Subject|0|||
144262657|NCT04235504|520161523|FG001|Continuation Phase|Withdrawal by Subject|4|||
144262658|NCT04235504|520161524|FG002|Continuation Phase|Withdrawal by Subject|0|||
144262659|NCT04235504|520161525|FG003|Continuation Phase|Withdrawal by Subject|0|||
144262660|NCT04235504|520161522|FG000|Continuation Phase|Adverse Event|0|||
144262661|NCT04235504|520161523|FG001|Continuation Phase|Adverse Event|1|||
144262662|NCT04235504|520161524|FG002|Continuation Phase|Adverse Event|0|||
144566992|NCT02654132|521275657|FG000|Treatment Period|Withdrawal by Subject|2|||
144566993|NCT02654132|521275658|FG001|Treatment Period|Withdrawal by Subject|1|||
144566994|NCT02654132|521275657|FG000|Treatment Period|Maximum Clinical Benefit|0|||
144618827|NCT05048719|521463011|FG008|Overall Study|Death|0|||
144618828|NCT05048719|521463003|FG000|Overall Study|Adverse Event|0|||
144618829|NCT05048719|521463004|FG001|Overall Study|Adverse Event|1|||
144618830|NCT05048719|521463005|FG002|Overall Study|Adverse Event|2|||
144262663|NCT04235504|520161525|FG003|Continuation Phase|Adverse Event|0|||
144262664|NCT04235504|520161522|FG000|Continuation Phase|Physician Decision|1|||
144262665|NCT04235504|520161523|FG001|Continuation Phase|Physician Decision|2|||
144262666|NCT04235504|520161524|FG002|Continuation Phase|Physician Decision|1|||
144566995|NCT02654132|521275658|FG001|Treatment Period|Maximum Clinical Benefit|2|||
144566996|NCT02654132|521275657|FG000|Treatment Period|Participant request to discontinue|2|||
144566997|NCT02654132|521275658|FG001|Treatment Period|Participant request to discontinue|0|||
144566998|NCT02654132|521275657|FG000|Treatment Period|Administrative reasons by sponsor|0|||
144566999|NCT02654132|521275658|FG001|Treatment Period|Administrative reasons by sponsor|1|||
144618831|NCT05048719|521463006|FG003|Overall Study|Adverse Event|0|||
144618832|NCT05048719|521463007|FG004|Overall Study|Adverse Event|1|||
144204976|NCT00325195|519946826|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
144204977|NCT00325195|519946824|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
144204978|NCT00325195|519946825|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
144204979|NCT00325195|519946826|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
144204980|NCT00325195|519946824|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
144204981|NCT00325195|519946825|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
144204982|NCT00325195|519946826|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
144204983|NCT00806286|519946827|FG000|Overall Study|Adverse Event|5|||
144204984|NCT00806286|519946828|FG001|Overall Study|Adverse Event|2|||
144567000|NCT02654132|521275657|FG000|Treatment Period|Death|1|||
144567001|NCT02654132|521275658|FG001|Treatment Period|Death|0|||
144567002|NCT01880437|521275661|FG000|Overall Study|Death|12|||
144567003|NCT01880437|521275662|FG001|Overall Study|Death|4|||
144567004|NCT01880437|521275663|FG002|Overall Study|Death|17|||
144567005|NCT01880437|521275661|FG000|Overall Study|Study terminated by Sponsor|3|||
144567006|NCT01880437|521275662|FG001|Overall Study|Study terminated by Sponsor|0|||
144567007|NCT01880437|521275663|FG002|Overall Study|Study terminated by Sponsor|2|||
144567008|NCT03713320|521275664|FG000|Randomized Period|Adverse Event|1|||
144567009|NCT03713320|521275665|FG001|Randomized Period|Adverse Event|5|||
144567010|NCT03713320|521275666|FG002|Randomized Period|Adverse Event|0|||
144567011|NCT03713320|521275664|FG000|Randomized Period|Physician Decision|1|||
144567012|NCT03713320|521275665|FG001|Randomized Period|Physician Decision|1|||
144567013|NCT03713320|521275666|FG002|Randomized Period|Physician Decision|0|||
144567014|NCT03713320|521275664|FG000|Randomized Period|Withdrawal by Subject|4|||
144567015|NCT03713320|521275665|FG001|Randomized Period|Withdrawal by Subject|0|||
144567016|NCT03713320|521275666|FG002|Randomized Period|Withdrawal by Subject|0|||
144567017|NCT03713320|521275664|FG000|Randomized Period|Participant decision|3|||
144567018|NCT03713320|521275665|FG001|Randomized Period|Participant decision|1|||
144567019|NCT03713320|521275666|FG002|Randomized Period|Participant decision|0|||
144567020|NCT03713320|521275664|FG000|Randomized Period|Study terminated by sponsor|6|||
144567021|NCT03713320|521275665|FG001|Randomized Period|Study terminated by sponsor|3|||
144567022|NCT03713320|521275666|FG002|Randomized Period|Study terminated by sponsor|0|||
144567023|NCT03713320|521275664|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
144567024|NCT03713320|521275665|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
144567025|NCT03713320|521275666|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
144567026|NCT03713320|521275664|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
144567027|NCT03713320|521275665|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
144567028|NCT03713320|521275666|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
144567029|NCT00909532|521275667|FG000|Overall Study|Adverse Event|4|||
144567030|NCT00909532|521275668|FG001|Overall Study|Adverse Event|1|||
144567031|NCT00909532|521275667|FG000|Overall Study|Pregnancy|0|||
144567032|NCT00909532|521275668|FG001|Overall Study|Pregnancy|1|||
144567033|NCT00909532|521275667|FG000|Overall Study|Prohibited Medication|2|||
144567034|NCT00909532|521275668|FG001|Overall Study|Prohibited Medication|1|||
144567035|NCT00909532|521275667|FG000|Overall Study|Withdrawal of Consent|1|||
144567036|NCT00909532|521275668|FG001|Overall Study|Withdrawal of Consent|1|||
144567037|NCT00909532|521275667|FG000|Overall Study|Noncompliance with Study Requirements|0|||
144567038|NCT00909532|521275668|FG001|Overall Study|Noncompliance with Study Requirements|2|||
144567039|NCT00909532|521275667|FG000|Overall Study|Physician Decision|1|||
144567040|NCT00909532|521275668|FG001|Overall Study|Physician Decision|0|||
144567041|NCT00909532|521275667|FG000|Overall Study|Wrong Genotype|1|||
144567042|NCT00909532|521275668|FG001|Overall Study|Wrong Genotype|0|||
144567043|NCT00909532|521275667|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
144567044|NCT00909532|521275668|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
144567045|NCT02287233|521275669|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
144567046|NCT02287233|521275670|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
144567047|NCT02287233|521275671|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
144567048|NCT02287233|521275669|FG000|Overall Study|Adverse Event Related to Progression|0|||
144567049|NCT02287233|521275670|FG001|Overall Study|Adverse Event Related to Progression|2|||
144567050|NCT02287233|521275671|FG002|Overall Study|Adverse Event Related to Progression|8|||
144567051|NCT02287233|521275669|FG000|Overall Study|Physician Decision|1|||
144567052|NCT02287233|521275670|FG001|Overall Study|Physician Decision|2|||
144567053|NCT02287233|521275671|FG002|Overall Study|Physician Decision|4|||
144567054|NCT02287233|521275669|FG000|Overall Study|Progressive Disease with Death|0|||
144567055|NCT02287233|521275670|FG001|Overall Study|Progressive Disease with Death|0|||
144567056|NCT02287233|521275671|FG002|Overall Study|Progressive Disease with Death|10|||
144567057|NCT02287233|521275669|FG000|Overall Study|Progressive Disease Without Death|2|||
144567058|NCT02287233|521275670|FG001|Overall Study|Progressive Disease Without Death|3|||
144567059|NCT02287233|521275671|FG002|Overall Study|Progressive Disease Without Death|20|||
144567060|NCT02287233|521275669|FG000|Overall Study|Withdrawal by Subject|1|||
144567061|NCT02287233|521275670|FG001|Overall Study|Withdrawal by Subject|1|||
144567062|NCT02287233|521275671|FG002|Overall Study|Withdrawal by Subject|7|||
144204985|NCT00806286|519946829|FG002|Overall Study|Adverse Event|0|||
144728483|NCT01273181|521861241|FG000|Phase 2, Dose 2|Death during treatment|0|||
144728484|NCT01273181|521861242|FG001|Phase 2, Dose 2|Death during treatment|0|||
144728485|NCT01273181|521861243|FG002|Phase 2, Dose 2|Death during treatment|0|||
144728486|NCT01273181|521861244|FG003|Phase 2, Dose 2|Death during treatment|1|||
144728487|NCT00944697|521861245|FG000|Overall Study|Withdrawal by Subject|1|||
144728488|NCT00944697|521861246|FG001|Overall Study|Withdrawal by Subject|1|||
144728489|NCT00944697|521861245|FG000|Overall Study|Adverse Event|0|||
144728490|NCT00944697|521861246|FG001|Overall Study|Adverse Event|3|||
144728491|NCT00944697|521861245|FG000|Overall Study|Administrative|1|||
144728492|NCT00944697|521861246|FG001|Overall Study|Administrative|1|||
144728493|NCT03661528|521861247|FG000|Overall Study|Death|1|||
144728494|NCT03661528|521861248|FG001|Overall Study|Death|0|||
144728495|NCT03661528|521861247|FG000|Overall Study|Physician Decision|3|||
144728496|NCT03661528|521861248|FG001|Overall Study|Physician Decision|1|||
144728497|NCT03661528|521861247|FG000|Overall Study|Other than Specified|5|||
144728498|NCT03661528|521861248|FG001|Overall Study|Other than Specified|2|||
144728499|NCT03661528|521861247|FG000|Overall Study|Withdrawal by Subject|5|||
144728500|NCT03661528|521861248|FG001|Overall Study|Withdrawal by Subject|3|||
144728501|NCT03661528|521861247|FG000|Overall Study|Disease Progression|8|||
144728502|NCT03661528|521861248|FG001|Overall Study|Disease Progression|13|||
144728503|NCT03661528|521861247|FG000|Overall Study|Adverse Event|61|||
144728504|NCT03661528|521861248|FG001|Overall Study|Adverse Event|55|||
144728505|NCT02732210|521861249|FG000|Overall Study|Site Closed|0|||
144728506|NCT02732210|521861250|FG001|Overall Study|Site Closed|11|||
144728507|NCT02732210|521861249|FG000|Overall Study|Study Ended|13|||
144728508|NCT02732210|521861250|FG001|Overall Study|Study Ended|13|||
144728509|NCT02732210|521861249|FG000|Overall Study|Withdrawal by Subject|28|||
144728510|NCT02732210|521861250|FG001|Overall Study|Withdrawal by Subject|87|||
144728511|NCT02732210|521861249|FG000|Overall Study|Lost to Follow-up|5|||
144728512|NCT02732210|521861250|FG001|Overall Study|Lost to Follow-up|57|||
144728513|NCT02732210|521861249|FG000|Overall Study|Death|4|||
144728514|NCT02732210|521861250|FG001|Overall Study|Death|15|||
144728515|NCT02732210|521861249|FG000|Overall Study|Other|35|||
144728516|NCT02732210|521861250|FG001|Overall Study|Other|103|||
144728517|NCT02732210|521861249|FG000|Overall Study|Missing|0|||
144728518|NCT02732210|521861250|FG001|Overall Study|Missing|8|||
144728519|NCT01062256|521861252|FG000|Overall Study|Adverse Event|1|||
144728520|NCT01062256|521861253|FG001|Overall Study|Adverse Event|0|||
144728521|NCT01062256|521861254|FG002|Overall Study|Adverse Event|0|||
144728522|NCT01062256|521861252|FG000|Overall Study|Withdrawal by Subject|1|||
144728523|NCT01062256|521861253|FG001|Overall Study|Withdrawal by Subject|1|||
144728524|NCT01062256|521861254|FG002|Overall Study|Withdrawal by Subject|1|||
144728525|NCT01062256|521861252|FG000|Overall Study|Ineligible|1|||
144728526|NCT01062256|521861253|FG001|Overall Study|Ineligible|4|||
144728527|NCT01062256|521861254|FG002|Overall Study|Ineligible|3|||
144728528|NCT01062256|521861252|FG000|Overall Study|Administrative|0|||
144728529|NCT01062256|521861253|FG001|Overall Study|Administrative|2|||
144728530|NCT01062256|521861254|FG002|Overall Study|Administrative|0|||
144728531|NCT03049488|521861255|FG000|Overall Study|Lost to Follow-up|1|||
144728532|NCT03049488|521861256|FG001|Overall Study|Lost to Follow-up|1|||
144728533|NCT03049488|521861257|FG002|Overall Study|Lost to Follow-up|0|||
144728534|NCT03049488|521861258|FG003|Overall Study|Lost to Follow-up|0|||
144728535|NCT03049488|521861259|FG004|Overall Study|Lost to Follow-up|0|||
144728536|NCT03049488|521861260|FG005|Overall Study|Lost to Follow-up|0|||
144728537|NCT03049488|521861255|FG000|Overall Study|Moved from Area|1|||
144728538|NCT03049488|521861256|FG001|Overall Study|Moved from Area|0|||
144728539|NCT03049488|521861257|FG002|Overall Study|Moved from Area|0|||
144728540|NCT03049488|521861258|FG003|Overall Study|Moved from Area|1|||
144728541|NCT03049488|521861259|FG004|Overall Study|Moved from Area|1|||
144728542|NCT03049488|521861260|FG005|Overall Study|Moved from Area|0|||
144728543|NCT03049488|521861255|FG000|Overall Study|Physician Decision|0|||
144728544|NCT03049488|521861256|FG001|Overall Study|Physician Decision|1|||
144728545|NCT03049488|521861257|FG002|Overall Study|Physician Decision|0|||
144728546|NCT03049488|521861258|FG003|Overall Study|Physician Decision|0|||
144728547|NCT03049488|521861259|FG004|Overall Study|Physician Decision|0|||
144728548|NCT03049488|521861260|FG005|Overall Study|Physician Decision|0|||
144728549|NCT03049488|521861255|FG000|Overall Study|Withdrawal by Subject|0|||
144728550|NCT03049488|521861256|FG001|Overall Study|Withdrawal by Subject|0|||
144728551|NCT03049488|521861257|FG002|Overall Study|Withdrawal by Subject|0|||
144728552|NCT03049488|521861258|FG003|Overall Study|Withdrawal by Subject|1|||
144728553|NCT03049488|521861259|FG004|Overall Study|Withdrawal by Subject|1|||
144262667|NCT04235504|520161525|FG003|Continuation Phase|Physician Decision|0|||
144728554|NCT03049488|521861260|FG005|Overall Study|Withdrawal by Subject|0|||
144728555|NCT00891293|521861261|FG000|Overall Study|Adverse Event|2|||
144728556|NCT00891293|521861261|FG000|Overall Study|Protocol Violation|2|||
144728557|NCT00891293|521861261|FG000|Overall Study|Laboratory abnormality|4|||
144728558|NCT00891293|521861261|FG000|Overall Study|Lost to Follow-up|7|||
144728559|NCT00891293|521861261|FG000|Overall Study|Subject withdrew consent|7|||
144728560|NCT00891293|521861261|FG000|Overall Study|Sponsor termination|62|||
144728561|NCT01448057|521861262|FG000|Overall Study|Protocol Violation|3|||
144567063|NCT02287233|521275669|FG000|Overall Study|Other|3|||
144567064|NCT02287233|521275670|FG001|Overall Study|Other|0|||
144567065|NCT02287233|521275671|FG002|Overall Study|Other|15|||
144567066|NCT02287233|521275669|FG000|Overall Study|Did Not Receive Treatment|0|||
144567067|NCT02287233|521275670|FG001|Overall Study|Did Not Receive Treatment|0|||
144567068|NCT02287233|521275671|FG002|Overall Study|Did Not Receive Treatment|2|||
144567069|NCT00085566|521275672|FG000|Overall Study|Adverse Event|0|||
144567070|NCT00085566|521275673|FG001|Overall Study|Adverse Event|0|||
144567071|NCT00085566|521275674|FG002|Overall Study|Adverse Event|10|||
144567072|NCT00085566|521275672|FG000|Overall Study|Patient Not treated|0|||
144618833|NCT05048719|521463008|FG005|Overall Study|Adverse Event|0|||
144618834|NCT05048719|521463009|FG006|Overall Study|Adverse Event|0|||
144618835|NCT05048719|521463010|FG007|Overall Study|Adverse Event|0|||
144618836|NCT05048719|521463011|FG008|Overall Study|Adverse Event|0|||
144618837|NCT05048719|521463003|FG000|Overall Study|Lost to Follow-up|0|||
144618838|NCT05048719|521463004|FG001|Overall Study|Lost to Follow-up|0|||
144618839|NCT05048719|521463005|FG002|Overall Study|Lost to Follow-up|1|||
144618840|NCT05048719|521463006|FG003|Overall Study|Lost to Follow-up|3|||
144618841|NCT05048719|521463007|FG004|Overall Study|Lost to Follow-up|1|||
144618842|NCT05048719|521463008|FG005|Overall Study|Lost to Follow-up|1|||
144618843|NCT05048719|521463009|FG006|Overall Study|Lost to Follow-up|1|||
144618844|NCT05048719|521463010|FG007|Overall Study|Lost to Follow-up|1|||
144618845|NCT05048719|521463011|FG008|Overall Study|Lost to Follow-up|0|||
144618846|NCT05048719|521463003|FG000|Overall Study|Physician Decision|0|||
144618847|NCT05048719|521463004|FG001|Overall Study|Physician Decision|0|||
144618848|NCT05048719|521463005|FG002|Overall Study|Physician Decision|0|||
144618849|NCT05048719|521463006|FG003|Overall Study|Physician Decision|0|||
144618850|NCT05048719|521463007|FG004|Overall Study|Physician Decision|0|||
144618851|NCT05048719|521463008|FG005|Overall Study|Physician Decision|0|||
144618852|NCT05048719|521463009|FG006|Overall Study|Physician Decision|0|||
144618853|NCT05048719|521463010|FG007|Overall Study|Physician Decision|1|||
144618854|NCT05048719|521463011|FG008|Overall Study|Physician Decision|1|||
144618855|NCT05048719|521463003|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
144618856|NCT05048719|521463004|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618857|NCT05048719|521463005|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618858|NCT05048719|521463006|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618859|NCT05048719|521463007|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618860|NCT05048719|521463008|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618861|NCT05048719|521463009|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618862|NCT05048719|521463010|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618863|NCT05048719|521463011|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
144618864|NCT05048719|521463003|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618865|NCT05048719|521463004|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
144618866|NCT05048719|521463005|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618867|NCT05048719|521463006|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618868|NCT05048719|521463007|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618869|NCT05048719|521463008|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618870|NCT05048719|521463009|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618871|NCT05048719|521463010|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618872|NCT05048719|521463011|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
144618873|NCT05048719|521463003|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618874|NCT05048719|521463004|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
144618875|NCT05048719|521463005|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618876|NCT05048719|521463006|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618877|NCT05048719|521463007|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618878|NCT05048719|521463008|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618879|NCT05048719|521463009|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618880|NCT05048719|521463010|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618881|NCT05048719|521463011|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
144618882|NCT05048719|521463003|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144728562|NCT01448057|521861263|FG001|Overall Study|Protocol Violation|2|||
144728563|NCT01448057|521861262|FG000|Overall Study|Lost to Follow-up|3|||
144728564|NCT01448057|521861263|FG001|Overall Study|Lost to Follow-up|0|||
144567073|NCT00085566|521275673|FG001|Overall Study|Patient Not treated|0|||
144567074|NCT00085566|521275674|FG002|Overall Study|Patient Not treated|3|||
144567075|NCT00085566|521275672|FG000|Overall Study|Clinical progression|0|||
144567076|NCT00085566|521275673|FG001|Overall Study|Clinical progression|0|||
144567077|NCT00085566|521275674|FG002|Overall Study|Clinical progression|1|||
144567078|NCT02601209|521275675|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
144204986|NCT00806286|519946827|FG000|Overall Study|Disease progression|31|||
144204987|NCT00806286|519946828|FG001|Overall Study|Disease progression|38|||
144567079|NCT02601209|521275676|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
144567080|NCT02601209|521275677|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
144567081|NCT02601209|521275678|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
144567082|NCT02601209|521275679|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
144567083|NCT02601209|521275680|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
144567084|NCT02601209|521275681|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
144567085|NCT02601209|521275682|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
144567086|NCT02601209|521275683|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
144567087|NCT02601209|521275675|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
144567088|NCT02601209|521275676|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
144618883|NCT05048719|521463004|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618884|NCT05048719|521463005|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618885|NCT05048719|521463006|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
144618886|NCT05048719|521463007|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618887|NCT05048719|521463008|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618888|NCT05048719|521463009|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618889|NCT05048719|521463010|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618890|NCT05048719|521463011|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
144618891|NCT05048719|521463003|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144618892|NCT05048719|521463004|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144618893|NCT05048719|521463005|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144618894|NCT05048719|521463006|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144618895|NCT05048719|521463007|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144618896|NCT05048719|521463008|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
144618897|NCT05048719|521463009|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144618898|NCT05048719|521463010|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144204988|NCT00806286|519946829|FG002|Overall Study|Disease progression|1|||
144204989|NCT00806286|519946827|FG000|Overall Study|Death|1|||
144204990|NCT00806286|519946828|FG001|Overall Study|Death|6|||
144204991|NCT00806286|519946829|FG002|Overall Study|Death|0|||
144204992|NCT00806286|519946827|FG000|Overall Study|Lost to Follow-up|0|||
144204993|NCT00806286|519946828|FG001|Overall Study|Lost to Follow-up|1|||
144204994|NCT00806286|519946829|FG002|Overall Study|Lost to Follow-up|0|||
144204995|NCT00806286|519946827|FG000|Overall Study|Withdrawal by Subject|8|||
144204996|NCT00806286|519946828|FG001|Overall Study|Withdrawal by Subject|3|||
144204997|NCT00806286|519946829|FG002|Overall Study|Withdrawal by Subject|1|||
144204998|NCT00806286|519946827|FG000|Overall Study|Physician Decision|2|||
144204999|NCT00806286|519946828|FG001|Overall Study|Physician Decision|2|||
144205000|NCT00806286|519946829|FG002|Overall Study|Physician Decision|0|||
144205001|NCT00806286|519946827|FG000|Overall Study|Due to a variety of reasons|7|||
144205002|NCT00806286|519946828|FG001|Overall Study|Due to a variety of reasons|2|||
144205003|NCT00806286|519946829|FG002|Overall Study|Due to a variety of reasons|1|||
144205004|NCT03469336|519946830|FG000|Overall Study|Adverse Event|1|||
144205005|NCT00686075|519946832|FG000|Overall Study|Withdrawal by Subject|4|||
144205006|NCT00686075|519946833|FG001|Overall Study|Withdrawal by Subject|3|||
144205007|NCT00686075|519946834|FG002|Overall Study|Withdrawal by Subject|3|||
144205008|NCT00686075|519946835|FG003|Overall Study|Withdrawal by Subject|7|||
144205009|NCT00686075|519946836|FG004|Overall Study|Withdrawal by Subject|1|||
144205010|NCT00686075|519946837|FG005|Overall Study|Withdrawal by Subject|0|||
144205011|NCT00686075|519946838|FG006|Overall Study|Withdrawal by Subject|0|||
144205012|NCT00686075|519946839|FG007|Overall Study|Withdrawal by Subject|2|||
144205013|NCT00686075|519946840|FG008|Overall Study|Withdrawal by Subject|4|||
144205014|NCT00686075|519946841|FG009|Overall Study|Withdrawal by Subject|6|||
144205015|NCT00686075|519946832|FG000|Overall Study|Lost to Follow-up|3|||
144205016|NCT00686075|519946833|FG001|Overall Study|Lost to Follow-up|6|||
144205017|NCT00686075|519946834|FG002|Overall Study|Lost to Follow-up|3|||
144618899|NCT05048719|521463011|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
144262668|NCT04001803|520161532|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
144205018|NCT00686075|519946835|FG003|Overall Study|Lost to Follow-up|2|||
144205019|NCT00686075|519946836|FG004|Overall Study|Lost to Follow-up|3|||
144205020|NCT00686075|519946837|FG005|Overall Study|Lost to Follow-up|3|||
144205021|NCT00686075|519946838|FG006|Overall Study|Lost to Follow-up|0|||
144205022|NCT00686075|519946839|FG007|Overall Study|Lost to Follow-up|0|||
144205023|NCT00686075|519946840|FG008|Overall Study|Lost to Follow-up|2|||
144205024|NCT00686075|519946841|FG009|Overall Study|Lost to Follow-up|3|||
144567089|NCT02601209|521275677|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
144567090|NCT02601209|521275678|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
144567091|NCT02601209|521275679|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
144567092|NCT02601209|521275680|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
144567093|NCT02601209|521275681|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
144567094|NCT02601209|521275682|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
144567095|NCT02601209|521275683|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
144567096|NCT02804399|521275684|FG000|Period 2|Adverse Event|0|||
144567097|NCT02804399|521275685|FG001|Period 2|Adverse Event|1|||
144567098|NCT01174264|521275686|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
144567099|NCT01174264|521275687|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
144567100|NCT01174264|521275688|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
144567101|NCT01174264|521275686|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
144567102|NCT01174264|521275687|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
144567103|NCT01174264|521275688|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
144567104|NCT01174264|521275686|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
144262669|NCT04001803|520161532|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
144567105|NCT01174264|521275687|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
144567106|NCT01174264|521275688|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
144567107|NCT01774305|521275690|FG000|Overall Study|Physician Decision|1|||
144567108|NCT01774305|521275691|FG001|Overall Study|Physician Decision|0|||
144567109|NCT01157377|521275693|FG000|Overall Study|Lost to Follow-up|0|||
144567110|NCT01157377|521275694|FG001|Overall Study|Lost to Follow-up|0|||
144567111|NCT01157377|521275695|FG002|Overall Study|Lost to Follow-up|1|||
144567112|NCT01157377|521275696|FG003|Overall Study|Lost to Follow-up|0|||
144567113|NCT01157377|521275697|FG004|Overall Study|Lost to Follow-up|1|||
144567114|NCT01157377|521275698|FG005|Overall Study|Lost to Follow-up|1|||
144567115|NCT01157377|521275699|FG006|Overall Study|Lost to Follow-up|0|||
144567116|NCT01157377|521275693|FG000|Overall Study|Personal Reasons|2|||
144567117|NCT01157377|521275694|FG001|Overall Study|Personal Reasons|1|||
144567118|NCT01157377|521275695|FG002|Overall Study|Personal Reasons|0|||
144567119|NCT01157377|521275696|FG003|Overall Study|Personal Reasons|1|||
144567120|NCT01157377|521275697|FG004|Overall Study|Personal Reasons|0|||
144567121|NCT01157377|521275698|FG005|Overall Study|Personal Reasons|0|||
144567122|NCT01157377|521275699|FG006|Overall Study|Personal Reasons|0|||
144567123|NCT01157377|521275693|FG000|Overall Study|Protocol Violation|0|||
144567124|NCT01157377|521275694|FG001|Overall Study|Protocol Violation|0|||
144567125|NCT01157377|521275695|FG002|Overall Study|Protocol Violation|0|||
144567126|NCT01157377|521275696|FG003|Overall Study|Protocol Violation|0|||
144567127|NCT01157377|521275697|FG004|Overall Study|Protocol Violation|0|||
144567128|NCT01157377|521275698|FG005|Overall Study|Protocol Violation|1|||
144567129|NCT01157377|521275699|FG006|Overall Study|Protocol Violation|0|||
144567130|NCT01157377|521275693|FG000|Overall Study|Lack of Efficacy|0|||
144567131|NCT01157377|521275694|FG001|Overall Study|Lack of Efficacy|0|||
144567132|NCT01157377|521275695|FG002|Overall Study|Lack of Efficacy|0|||
144567133|NCT01157377|521275696|FG003|Overall Study|Lack of Efficacy|0|||
144567134|NCT01157377|521275697|FG004|Overall Study|Lack of Efficacy|0|||
144567135|NCT01157377|521275698|FG005|Overall Study|Lack of Efficacy|0|||
144567136|NCT01157377|521275699|FG006|Overall Study|Lack of Efficacy|1|||
144567137|NCT01157377|521275693|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144567138|NCT01157377|521275694|FG001|Overall Study|Other Miscellaneous Reasons|2|||
144567139|NCT01157377|521275695|FG002|Overall Study|Other Miscellaneous Reasons|0|||
144567140|NCT01157377|521275696|FG003|Overall Study|Other Miscellaneous Reasons|0|||
144567141|NCT01157377|521275697|FG004|Overall Study|Other Miscellaneous Reasons|1|||
144567142|NCT01157377|521275698|FG005|Overall Study|Other Miscellaneous Reasons|1|||
144567143|NCT01157377|521275699|FG006|Overall Study|Other Miscellaneous Reasons|1|||
144567144|NCT00087555|521275700|FG000|Overall Study|Adverse Event|3|||
144567145|NCT00087555|521275701|FG001|Overall Study|Adverse Event|6|||
144567146|NCT00087555|521275702|FG002|Overall Study|Adverse Event|14|||
144567147|NCT00087555|521275700|FG000|Overall Study|Lost to Follow-up|0|||
144567148|NCT00087555|521275701|FG001|Overall Study|Lost to Follow-up|1|||
144567149|NCT00087555|521275702|FG002|Overall Study|Lost to Follow-up|1|||
144567150|NCT00087555|521275700|FG000|Overall Study|Non - Compliance|1|||
144567151|NCT00087555|521275701|FG001|Overall Study|Non - Compliance|0|||
144567152|NCT00087555|521275702|FG002|Overall Study|Non - Compliance|0|||
144567153|NCT00087555|521275700|FG000|Overall Study|Protocol Violation|0|||
144567154|NCT00087555|521275701|FG001|Overall Study|Protocol Violation|0|||
144567155|NCT00087555|521275702|FG002|Overall Study|Protocol Violation|2|||
144567156|NCT00087555|521275700|FG000|Overall Study|Screen Failure|1|||
144567157|NCT00087555|521275701|FG001|Overall Study|Screen Failure|1|||
144567158|NCT00087555|521275702|FG002|Overall Study|Screen Failure|0|||
144567159|NCT00087555|521275700|FG000|Overall Study|Pregnancy|0|||
144567160|NCT00087555|521275701|FG001|Overall Study|Pregnancy|1|||
144567161|NCT00087555|521275702|FG002|Overall Study|Pregnancy|1|||
144567162|NCT00087555|521275700|FG000|Overall Study|Withdrawal by Subject|3|||
144567163|NCT00087555|521275701|FG001|Overall Study|Withdrawal by Subject|2|||
144205025|NCT00686075|519946832|FG000|Overall Study|Other|1|||
144205026|NCT00686075|519946833|FG001|Overall Study|Other|1|||
144205027|NCT00686075|519946834|FG002|Overall Study|Other|0|||
144205028|NCT00686075|519946835|FG003|Overall Study|Other|0|||
144567164|NCT00087555|521275702|FG002|Overall Study|Withdrawal by Subject|1|||
144567165|NCT00087555|521275700|FG000|Overall Study|Lack of Efficacy|2|||
144567166|NCT00087555|521275701|FG001|Overall Study|Lack of Efficacy|0|||
144567167|NCT00087555|521275702|FG002|Overall Study|Lack of Efficacy|1|||
144567168|NCT00087555|521275700|FG000|Overall Study|Non Compliance|0|||
144567169|NCT00087555|521275701|FG001|Overall Study|Non Compliance|0|||
144567170|NCT00087555|521275702|FG002|Overall Study|Non Compliance|1|||
144567171|NCT00087555|521275700|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
144567172|NCT00087555|521275701|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
144567173|NCT00087555|521275702|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
144567174|NCT00087555|521275700|FG000|Overall Study|Patient wanted to go back on Med|1|||
144567175|NCT00087555|521275701|FG001|Overall Study|Patient wanted to go back on Med|0|||
144567176|NCT00087555|521275702|FG002|Overall Study|Patient wanted to go back on Med|0|||
144567177|NCT05523219|521275703|FG000|Overall Study|Wrong inclusion|1|||
144567178|NCT05523219|521275703|FG000|Overall Study|Lost to Follow-up|7|||
144567179|NCT03772613|521275704|FG000|Overall Study|Lost to Follow-up|0|||
144567180|NCT03772613|521275705|FG001|Overall Study|Lost to Follow-up|1|||
144567181|NCT03772613|521275706|FG002|Overall Study|Lost to Follow-up|1|||
144567182|NCT00661713|521275707|FG000|Overall Study|Death|1|||
144567183|NCT00661713|521275708|FG001|Overall Study|Death|0|||
144567184|NCT00661713|521275709|FG002|Overall Study|Death|0|||
144567185|NCT00661713|521275710|FG003|Overall Study|Death|0|||
144567186|NCT00661713|521275711|FG004|Overall Study|Death|1|||
144567187|NCT00661713|521275712|FG005|Overall Study|Death|0|||
144567188|NCT00661713|521275713|FG006|Overall Study|Death|0|||
144567189|NCT00661713|521275714|FG007|Overall Study|Death|0|||
144567190|NCT00661713|521275707|FG000|Overall Study|Unable to Classify|1|||
144567191|NCT00661713|521275708|FG001|Overall Study|Unable to Classify|0|||
144567192|NCT00661713|521275709|FG002|Overall Study|Unable to Classify|0|||
144567193|NCT00661713|521275710|FG003|Overall Study|Unable to Classify|0|||
144567194|NCT00661713|521275711|FG004|Overall Study|Unable to Classify|0|||
144567195|NCT00661713|521275712|FG005|Overall Study|Unable to Classify|0|||
144567196|NCT00661713|521275713|FG006|Overall Study|Unable to Classify|0|||
144567197|NCT00661713|521275714|FG007|Overall Study|Unable to Classify|0|||
144567198|NCT00661713|521275707|FG000|Overall Study|Protocol Violation|1|||
144567199|NCT00661713|521275708|FG001|Overall Study|Protocol Violation|6|||
144567200|NCT00661713|521275709|FG002|Overall Study|Protocol Violation|3|||
144567201|NCT00661713|521275710|FG003|Overall Study|Protocol Violation|3|||
144567202|NCT00661713|521275711|FG004|Overall Study|Protocol Violation|0|||
144567203|NCT00661713|521275712|FG005|Overall Study|Protocol Violation|2|||
144567204|NCT00661713|521275713|FG006|Overall Study|Protocol Violation|2|||
144567205|NCT00661713|521275714|FG007|Overall Study|Protocol Violation|1|||
144567206|NCT00661713|521275707|FG000|Overall Study|Withdrawal by Subject|11|||
144567207|NCT00661713|521275708|FG001|Overall Study|Withdrawal by Subject|25|||
144567208|NCT00661713|521275709|FG002|Overall Study|Withdrawal by Subject|12|||
144205029|NCT00686075|519946836|FG004|Overall Study|Other|0|||
144205030|NCT00686075|519946837|FG005|Overall Study|Other|0|||
144567209|NCT00661713|521275710|FG003|Overall Study|Withdrawal by Subject|21|||
144567210|NCT00661713|521275711|FG004|Overall Study|Withdrawal by Subject|12|||
144567211|NCT00661713|521275712|FG005|Overall Study|Withdrawal by Subject|26|||
144567212|NCT00661713|521275713|FG006|Overall Study|Withdrawal by Subject|45|||
144567213|NCT00661713|521275714|FG007|Overall Study|Withdrawal by Subject|9|||
144567214|NCT00661713|521275707|FG000|Overall Study|Lost to Follow-up|2|||
144567215|NCT00661713|521275708|FG001|Overall Study|Lost to Follow-up|7|||
144567216|NCT00661713|521275709|FG002|Overall Study|Lost to Follow-up|2|||
144567217|NCT00661713|521275710|FG003|Overall Study|Lost to Follow-up|2|||
144567218|NCT00661713|521275711|FG004|Overall Study|Lost to Follow-up|5|||
144567219|NCT00661713|521275712|FG005|Overall Study|Lost to Follow-up|7|||
144567220|NCT00661713|521275713|FG006|Overall Study|Lost to Follow-up|14|||
144567221|NCT00661713|521275714|FG007|Overall Study|Lost to Follow-up|1|||
144618900|NCT03257267|521463012|FG000|Overall Study|Adverse Event|17|||
144618901|NCT03257267|521463013|FG001|Overall Study|Adverse Event|7|||
144205031|NCT00686075|519946838|FG006|Overall Study|Other|0|||
144205032|NCT00686075|519946839|FG007|Overall Study|Other|0|||
144567222|NCT00661713|521275707|FG000|Overall Study|Administrative Reason|0|||
144567223|NCT00661713|521275708|FG001|Overall Study|Administrative Reason|1|||
144567224|NCT00661713|521275709|FG002|Overall Study|Administrative Reason|0|||
144567225|NCT00661713|521275710|FG003|Overall Study|Administrative Reason|2|||
144567226|NCT00661713|521275711|FG004|Overall Study|Administrative Reason|2|||
144567227|NCT00661713|521275712|FG005|Overall Study|Administrative Reason|2|||
144567228|NCT00661713|521275713|FG006|Overall Study|Administrative Reason|1|||
144567229|NCT00661713|521275714|FG007|Overall Study|Administrative Reason|0|||
144567230|NCT00661713|521275707|FG000|Overall Study|Adverse Event|0|||
144567231|NCT00661713|521275708|FG001|Overall Study|Adverse Event|0|||
144567232|NCT00661713|521275709|FG002|Overall Study|Adverse Event|0|||
144567233|NCT00661713|521275710|FG003|Overall Study|Adverse Event|0|||
144567234|NCT00661713|521275711|FG004|Overall Study|Adverse Event|0|||
144567235|NCT00661713|521275712|FG005|Overall Study|Adverse Event|0|||
144567236|NCT00661713|521275713|FG006|Overall Study|Adverse Event|1|||
144567237|NCT00661713|521275714|FG007|Overall Study|Adverse Event|0|||
144567238|NCT00661713|521275707|FG000|Overall Study|Inappropriate Enrollment|0|||
144567239|NCT00661713|521275708|FG001|Overall Study|Inappropriate Enrollment|0|||
144567240|NCT00661713|521275709|FG002|Overall Study|Inappropriate Enrollment|0|||
144567241|NCT00661713|521275710|FG003|Overall Study|Inappropriate Enrollment|0|||
144567242|NCT00661713|521275711|FG004|Overall Study|Inappropriate Enrollment|0|||
144567243|NCT00661713|521275712|FG005|Overall Study|Inappropriate Enrollment|0|||
144567244|NCT00661713|521275713|FG006|Overall Study|Inappropriate Enrollment|1|||
144567245|NCT00661713|521275714|FG007|Overall Study|Inappropriate Enrollment|0|||
144567246|NCT01190449|521275715|FG000|Overall Study|Ineligible|0|||
144567247|NCT01190449|521275716|FG001|Overall Study|Ineligible|4|||
144567248|NCT04811339|521275717|FG000|Overall Study|lack of transportation not wanting to return|4|||
144567249|NCT04811339|521275718|FG001|Overall Study|lack of transportation not wanting to return|8|||
144567250|NCT04811339|521275719|FG002|Overall Study|lack of transportation not wanting to return|0|||
144567251|NCT04811339|521275717|FG000|Overall Study|Adverse Event|3|||
144567252|NCT04811339|521275718|FG001|Overall Study|Adverse Event|0|||
144567253|NCT04811339|521275719|FG002|Overall Study|Adverse Event|0|||
144567254|NCT04811339|521275717|FG000|Overall Study|Lost to Follow-up|1|||
144567255|NCT04811339|521275718|FG001|Overall Study|Lost to Follow-up|0|||
144567256|NCT04811339|521275719|FG002|Overall Study|Lost to Follow-up|0|||
144567257|NCT04811339|521275717|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
144567258|NCT04811339|521275718|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
144567259|NCT04811339|521275719|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
144567260|NCT04811339|521275717|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
144567261|NCT04811339|521275718|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
144567262|NCT04811339|521275719|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
144567263|NCT04811339|521275717|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
144567264|NCT04811339|521275718|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
144567265|NCT04811339|521275719|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
144567266|NCT04811339|521275717|FG000|Overall Study|Withdrawal by Subject|0|||
144567267|NCT04811339|521275718|FG001|Overall Study|Withdrawal by Subject|3|||
144567268|NCT04811339|521275719|FG002|Overall Study|Withdrawal by Subject|0|||
144567269|NCT04811339|521275717|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
144567270|NCT04811339|521275718|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
144567271|NCT04811339|521275719|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
144567272|NCT04811339|521275717|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
144567273|NCT04811339|521275718|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
144567274|NCT04811339|521275719|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
144567275|NCT02388347|521278486|FG000|Overall Study|Withdrawal by Subject|0|||
144567276|NCT02388347|521278487|FG001|Overall Study|Withdrawal by Subject|0|||
144567277|NCT02388347|521278488|FG002|Overall Study|Withdrawal by Subject|1|||
144567278|NCT02388347|521278489|FG003|Overall Study|Withdrawal by Subject|0|||
144567279|NCT02388347|521278490|FG004|Overall Study|Withdrawal by Subject|0|||
144567280|NCT01639742|521278491|FG000|Overall Study|Study Ongoing|17|||
144567281|NCT01639742|521278491|FG000|Overall Study|Lost to Follow-up|1|||
144567282|NCT04398368|521278494|FG000|Overall Study|Withdrawal by Subject|2|||
144567283|NCT02370251|521278496|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
144567284|NCT02370251|521278496|FG000|Overall Study|Death|4|||
144567285|NCT04469465|521278497|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
144567286|NCT04469465|521278498|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
144618902|NCT03257267|521463012|FG000|Overall Study|Death|96|||
144618903|NCT03257267|521463013|FG001|Overall Study|Death|98|||
144618904|NCT03257267|521463012|FG000|Overall Study|Lost to Follow-up|2|||
144618905|NCT03257267|521463013|FG001|Overall Study|Lost to Follow-up|2|||
144618906|NCT03257267|521463012|FG000|Overall Study|Non-compliance with Study Drug|0|||
144618907|NCT03257267|521463013|FG001|Overall Study|Non-compliance with Study Drug|2|||
144618908|NCT03257267|521463012|FG000|Overall Study|Participant Decision|35|||
144618909|NCT03257267|521463013|FG001|Overall Study|Participant Decision|43|||
144567287|NCT04469465|521278497|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
144567288|NCT04469465|521278498|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
144567289|NCT04469465|521278497|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
144567290|NCT04469465|521278498|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
144567291|NCT04469465|521278497|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
144618910|NCT03257267|521463012|FG000|Overall Study|Sponsor Decision|1|||
144618911|NCT03257267|521463013|FG001|Overall Study|Sponsor Decision|0|||
144262670|NCT04001803|520161532|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
144567292|NCT04469465|521278498|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
144567293|NCT04469465|521278497|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
144205033|NCT00686075|519946840|FG008|Overall Study|Other|0|||
144205034|NCT00686075|519946841|FG009|Overall Study|Other|1|||
144205035|NCT02740699|519946842|FG000|Overall Study|Lost to Follow-up|5|||
144205036|NCT02740699|519946842|FG000|Overall Study|Withdrawal by Subject|14|||
144205037|NCT02740699|519946842|FG000|Overall Study|Physician Decision|5|||
144205038|NCT02585934|519946844|FG000|Overall Study|Lost to Follow-up|2|||
144205039|NCT02585934|519946845|FG001|Overall Study|Lost to Follow-up|2|||
144205040|NCT02585934|519946844|FG000|Overall Study|Protocol Violation|14|||
144205041|NCT02585934|519946845|FG001|Overall Study|Protocol Violation|11|||
144205042|NCT02585934|519946844|FG000|Overall Study|Adverse Event|21|||
144567294|NCT04469465|521278498|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
144205043|NCT02585934|519946845|FG001|Overall Study|Adverse Event|22|||
144205044|NCT02585934|519946844|FG000|Overall Study|Physician Decision|3|||
144205045|NCT02585934|519946845|FG001|Overall Study|Physician Decision|2|||
144205046|NCT02585934|519946844|FG000|Overall Study|Withdrawal by Subject|7|||
144205047|NCT02585934|519946845|FG001|Overall Study|Withdrawal by Subject|21|||
144205048|NCT02585934|519946844|FG000|Overall Study|Lack of Efficacy|2|||
144205049|NCT02585934|519946845|FG001|Overall Study|Lack of Efficacy|1|||
144205050|NCT02585934|519946844|FG000|Overall Study|Death|2|||
144205051|NCT02585934|519946845|FG001|Overall Study|Death|0|||
144205052|NCT02585934|519946844|FG000|Overall Study|Caregiver Withdrew Consent|7|||
144205053|NCT02585934|519946845|FG001|Overall Study|Caregiver Withdrew Consent|7|||
144205054|NCT02585934|519946844|FG000|Overall Study|Sponsor Termination|1|||
144205055|NCT02585934|519946845|FG001|Overall Study|Sponsor Termination|2|||
144205056|NCT02585934|519946844|FG000|Overall Study|Another Reason|10|||
144205057|NCT02585934|519946845|FG001|Overall Study|Another Reason|5|||
144205058|NCT04713553|519946846|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
144205059|NCT04713553|519946847|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
144205060|NCT04713553|519946848|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
144205061|NCT04713553|519946849|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
144205062|NCT04713553|519946850|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
144205063|NCT04713553|519946851|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
144205064|NCT04713553|519946852|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
144205065|NCT04713553|519946846|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
144205066|NCT04713553|519946847|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
144205067|NCT04713553|519946848|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
144205068|NCT04713553|519946849|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
144205069|NCT04713553|519946850|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
144205070|NCT04713553|519946851|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
144205071|NCT04713553|519946852|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
144205072|NCT04713553|519946846|FG000|Primary Study (2 Months)|Other|1|||
144205073|NCT04713553|519946847|FG001|Primary Study (2 Months)|Other|2|||
144205074|NCT04713553|519946848|FG002|Primary Study (2 Months)|Other|0|||
144205075|NCT04713553|519946849|FG003|Primary Study (2 Months)|Other|0|||
144205076|NCT04713553|519946850|FG004|Primary Study (2 Months)|Other|1|||
144567295|NCT04469465|521278497|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
144567296|NCT04469465|521278498|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
144567297|NCT04469465|521278497|FG000|Long-Term Extension (LTE)|Death|0|||
144205077|NCT04713553|519946851|FG005|Primary Study (2 Months)|Other|0|||
144205078|NCT04713553|519946852|FG006|Primary Study (2 Months)|Other|0|||
144205079|NCT04713553|519946846|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
144205080|NCT04713553|519946847|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
144205081|NCT04713553|519946848|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
144567298|NCT04469465|521278498|FG001|Long-Term Extension (LTE)|Death|1|||
144567299|NCT04469465|521278497|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
144567300|NCT04469465|521278498|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
144567301|NCT04120376|521278499|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
144567302|NCT04120376|521278500|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
144567303|NCT02053610|521278501|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
144567304|NCT02053610|521278502|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
144618912|NCT03257267|521463012|FG000|Overall Study|Physician Decision|1|||
144618913|NCT03257267|521463013|FG001|Overall Study|Physician Decision|3|||
144618914|NCT03257267|521463012|FG000|Overall Study|Disease Progression|109|||
144618915|NCT03257267|521463013|FG001|Overall Study|Disease Progression|121|||
144567305|NCT02053610|521278501|FG000|Overall Study|Withdrew Consent|2|||
144567306|NCT02053610|521278502|FG001|Overall Study|Withdrew Consent|9|||
144618916|NCT03257267|521463012|FG000|Overall Study|Withdrawal by Subject|8|||
144618917|NCT03257267|521463013|FG001|Overall Study|Withdrawal by Subject|26|||
144618918|NCT03257267|521463012|FG000|Overall Study|Other|0|||
144618919|NCT03257267|521463013|FG001|Overall Study|Other|2|||
144205082|NCT04713553|519946849|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
144205083|NCT04713553|519946850|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
144205084|NCT04713553|519946851|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
144567307|NCT02053610|521278501|FG000|Overall Study|Death|5|||
144618920|NCT02229552|521463014|FG000|Baseline|Withdrawal by Subject|6|||
144567308|NCT02053610|521278502|FG001|Overall Study|Death|5|||
144567309|NCT02053610|521278501|FG000|Overall Study|Administrative/Other|1|||
144567310|NCT02053610|521278502|FG001|Overall Study|Administrative/Other|1|||
144567311|NCT02053610|521278501|FG000|Overall Study|Disease Progression|2|||
144567312|NCT02053610|521278502|FG001|Overall Study|Disease Progression|3|||
144567313|NCT02053610|521278501|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
144567314|NCT02053610|521278502|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
144567315|NCT02053610|521278501|FG000|Overall Study|Did not Receive Treatment|4|||
144567316|NCT02053610|521278502|FG001|Overall Study|Did not Receive Treatment|2|||
144567317|NCT02053610|521278501|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144567318|NCT02053610|521278502|FG001|Overall Study|Insufficient Therapeutic Response|1|||
144567319|NCT02053610|521278501|FG000|Overall Study|Violation of Selection Criteria|1|||
144567320|NCT02053610|521278502|FG001|Overall Study|Violation of Selection Criteria|0|||
144567321|NCT02641587|521278503|FG000|Confinement Period|Adverse Event|1|||
144205085|NCT04713553|519946852|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
144205086|NCT04713553|519946846|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
144205087|NCT04713553|519946847|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
144205088|NCT04713553|519946848|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
144205089|NCT04713553|519946849|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
144205090|NCT04713553|519946850|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
144205091|NCT04713553|519946851|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
144205092|NCT04713553|519946852|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
144205093|NCT03783039|519946854|FG000|Overall Study|Death|2|||
144205094|NCT03783039|519946855|FG001|Overall Study|Death|1|||
144205095|NCT00918138|519946856|FG000|Overall Study|Subject withdrew consent|1|||
144205096|NCT00918138|519946857|FG001|Overall Study|Subject withdrew consent|1|||
144205097|NCT00918138|519946856|FG000|Overall Study|Death|1|||
144205098|NCT00918138|519946857|FG001|Overall Study|Death|0|||
144205099|NCT02315196|519946858|FG000|Overall Study|Withdrew consent|9|||
144205100|NCT03839823|519946859|FG000|Overall Study|Adverse Event|8|||
144205101|NCT03839823|519946860|FG001|Overall Study|Adverse Event|4|||
144205102|NCT03839823|519946859|FG000|Overall Study|Death|1|||
144205103|NCT03839823|519946860|FG001|Overall Study|Death|0|||
144205104|NCT03839823|519946859|FG000|Overall Study|Physician Decision|1|||
144205105|NCT03839823|519946860|FG001|Overall Study|Physician Decision|5|||
144205106|NCT03839823|519946859|FG000|Overall Study|Progressive Disease (PD)|65|||
144205107|NCT03839823|519946860|FG001|Overall Study|Progressive Disease (PD)|65|||
144205108|NCT03839823|519946859|FG000|Overall Study|Subject Decision|2|||
144205109|NCT03839823|519946860|FG001|Overall Study|Subject Decision|9|||
144205110|NCT03839823|519946859|FG000|Overall Study|Not Treated|0|||
144205111|NCT03839823|519946860|FG001|Overall Study|Not Treated|10|||
144205112|NCT03327792|519946861|FG000|Overall Study|Adverse Event|4|||
144205113|NCT03327792|519946862|FG001|Overall Study|Adverse Event|0|||
144205114|NCT03327792|519946861|FG000|Overall Study|Family/Personal issues|3|||
144205115|NCT03327792|519946862|FG001|Overall Study|Family/Personal issues|2|||
144205116|NCT03327792|519946861|FG000|Overall Study|Lost to Follow-up|0|||
144205117|NCT03327792|519946862|FG001|Overall Study|Lost to Follow-up|1|||
144205118|NCT01001988|519946863|FG000|Overall Study|Protocol Violation|84|||
144205119|NCT01001988|519946863|FG000|Overall Study|Withdrawal by Subject|18|||
144205120|NCT01001988|519946863|FG000|Overall Study|Lost to Follow-up|15|||
144205121|NCT01844856|519946864|FG000|Overall Study|Lost to Follow-up|15|||
144205122|NCT01844856|519946865|FG001|Overall Study|Lost to Follow-up|3|||
144205123|NCT01844856|519946864|FG000|Overall Study|Adverse Event|3|||
144205124|NCT01844856|519946865|FG001|Overall Study|Adverse Event|6|||
144205125|NCT01844856|519946864|FG000|Overall Study|Withdrawal by Subject|3|||
144205126|NCT01844856|519946865|FG001|Overall Study|Withdrawal by Subject|2|||
144205127|NCT01844856|519946864|FG000|Overall Study|Noncompliance|2|||
144567322|NCT02641587|521278504|FG001|Confinement Period|Adverse Event|0|||
144567323|NCT02641587|521278503|FG000|Confinement Period|Withdrawal by Subject|2|||
144567324|NCT02641587|521278504|FG001|Confinement Period|Withdrawal by Subject|1|||
144567325|NCT02641587|521278503|FG000|Ambulatory Period|Withdrawal by Subject|1|||
144567326|NCT02641587|521278504|FG001|Ambulatory Period|Withdrawal by Subject|0|||
144567327|NCT01165177|521278505|FG000|Overall Study|Serious Adverse Event|227|||
144567328|NCT01165177|521278506|FG001|Overall Study|Serious Adverse Event|235|||
144567329|NCT01165177|521278505|FG000|Overall Study|Withdrawal by Subject|368|||
144567330|NCT01165177|521278506|FG001|Overall Study|Withdrawal by Subject|354|||
144567331|NCT01165177|521278505|FG000|Overall Study|Protocol Violation|19|||
144567332|NCT01165177|521278506|FG001|Overall Study|Protocol Violation|21|||
144567333|NCT01165177|521278505|FG000|Overall Study|Non-serious adverse event|30|||
144567334|NCT01165177|521278506|FG001|Overall Study|Non-serious adverse event|18|||
144567335|NCT01165177|521278505|FG000|Overall Study|Other unspecified reasons|47|||
144567336|NCT01165177|521278506|FG001|Overall Study|Other unspecified reasons|35|||
144567337|NCT01165177|521278505|FG000|Overall Study|Suspected HZ episode|0|||
144567338|NCT01165177|521278506|FG001|Overall Study|Suspected HZ episode|2|||
144567339|NCT01165177|521278505|FG000|Overall Study|Lost to Follow-up|183|||
144567340|NCT01165177|521278506|FG001|Overall Study|Lost to Follow-up|194|||
144567341|NCT01165177|521278505|FG000|Overall Study|Migrated/ moved from study area|48|||
144728565|NCT01448057|521861262|FG000|Overall Study|Adverse Event|0|||
144728566|NCT01448057|521861263|FG001|Overall Study|Adverse Event|2|||
144728567|NCT01448057|521861262|FG000|Overall Study|Withdrawal by Subject|2|||
144728568|NCT01448057|521861263|FG001|Overall Study|Withdrawal by Subject|0|||
144728569|NCT00537030|521861275|FG000|Overall Study|Physician Decision|2|||
144728570|NCT00537030|521861275|FG000|Overall Study|Withdrawal by Subject|2|||
144728571|NCT00537030|521861275|FG000|Overall Study|≥ Grade 2 allergy|7|||
144728572|NCT00537030|521861275|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
144728573|NCT00537030|521861275|FG000|Overall Study|Ineligible|2|||
144728574|NCT00537030|521861275|FG000|Overall Study|Inevaluable|2|||
144728575|NCT01496183|521861277|FG000|Overall Study|Physician Decision|3|||
144728576|NCT01496183|521861278|FG001|Overall Study|Physician Decision|1|||
144728577|NCT01496183|521861277|FG000|Overall Study|Withdrawal by Subject|0|||
144728578|NCT01496183|521861278|FG001|Overall Study|Withdrawal by Subject|1|||
144728579|NCT03130699|521861279|FG000|Overall Study|Lost to Follow-up|34|||
144728580|NCT03130699|521861280|FG001|Overall Study|Lost to Follow-up|37|||
144728581|NCT03130699|521861281|FG002|Overall Study|Lost to Follow-up|26|||
144728582|NCT03130699|521861279|FG000|Overall Study|Withdrawal by Subject|5|||
144567342|NCT01165177|521278506|FG001|Overall Study|Migrated/ moved from study area|43|||
144567343|NCT00781937|521278512|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
144567344|NCT00781937|521278513|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
144567345|NCT00781937|521278512|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
144567346|NCT00781937|521278513|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
144567347|NCT00781937|521278512|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
144567348|NCT00781937|521278513|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
144567349|NCT00781937|521278512|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
144567350|NCT00781937|521278513|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
144567351|NCT00781937|521278512|FG000|Main Trial Period Through Week 56|Unclassified|10|||
144567352|NCT00781937|521278513|FG001|Main Trial Period Through Week 56|Unclassified|15|||
144567353|NCT00781937|521278512|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
144728583|NCT03130699|521861280|FG001|Overall Study|Withdrawal by Subject|1|||
144728584|NCT03130699|521861281|FG002|Overall Study|Withdrawal by Subject|0|||
144567354|NCT00781937|521278513|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
144567355|NCT00781937|521278512|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
144567356|NCT00781937|521278513|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
144567357|NCT01150045|521278514|FG000|Overall Study|Protocol Violation|0|||
144567358|NCT01150045|521278515|FG001|Overall Study|Protocol Violation|1|||
144567359|NCT01150045|521278516|FG002|Overall Study|Protocol Violation|0|||
144567360|NCT01150045|521278517|FG003|Overall Study|Protocol Violation|1|||
144728585|NCT03130699|521861279|FG000|Overall Study|Withdrawal by PI|1|||
144728586|NCT03130699|521861280|FG001|Overall Study|Withdrawal by PI|2|||
144728587|NCT03130699|521861281|FG002|Overall Study|Withdrawal by PI|5|||
144728588|NCT03130699|521861279|FG000|Overall Study|Death|0|||
144728589|NCT03130699|521861280|FG001|Overall Study|Death|0|||
144728590|NCT03130699|521861281|FG002|Overall Study|Death|1|||
144728591|NCT00669864|521861284|FG000|Overall Study|Lost to Follow-up|2|||
144728592|NCT00669864|521861284|FG000|Overall Study|Protocol Violation|2|||
144728593|NCT00669864|521861284|FG000|Overall Study|Withdrawal by Subject|3|||
144728594|NCT00669864|521861284|FG000|Overall Study|Other|2|||
144728595|NCT06354270|521861287|FG000|Overall Study|Withdrawal by Subject|1|||
144728596|NCT06354270|521861288|FG001|Overall Study|Withdrawal by Subject|0|||
144728597|NCT00680121|521861289|FG000|Overall Study|Lost to Follow-up|27|||
144728598|NCT00680121|521861290|FG001|Overall Study|Lost to Follow-up|23|||
144728599|NCT00162123|521861291|FG000|Overall Study|Disease progression|27|||
144728600|NCT00162123|521861292|FG001|Overall Study|Disease progression|19|||
144728601|NCT00162123|521861293|FG002|Overall Study|Disease progression|10|||
144728602|NCT00162123|521861294|FG003|Overall Study|Disease progression|4|||
144728603|NCT00162123|521861295|FG004|Overall Study|Disease progression|8|||
144728604|NCT00162123|521861296|FG005|Overall Study|Disease progression|3|||
144728605|NCT00162123|521861297|FG006|Overall Study|Disease progression|1|||
144728606|NCT00162123|521861298|FG007|Overall Study|Disease progression|0|||
144728607|NCT00162123|521861291|FG000|Overall Study|Study drug toxicity|6|||
144567361|NCT01663506|521278519|FG000|Overall Study|Lack of Efficacy|3|||
144567362|NCT01663506|521278519|FG000|Overall Study|Consent Withdrawal by Subject|1|||
144567363|NCT01663506|521278519|FG000|Overall Study|Lost to Follow-up|1|||
144567364|NCT01663506|521278519|FG000|Overall Study|Adverse Event|1|||
144728608|NCT00162123|521861292|FG001|Overall Study|Study drug toxicity|1|||
144728609|NCT00162123|521861293|FG002|Overall Study|Study drug toxicity|5|||
144728610|NCT00162123|521861294|FG003|Overall Study|Study drug toxicity|0|||
144728611|NCT00162123|521861295|FG004|Overall Study|Study drug toxicity|4|||
144728612|NCT00162123|521861296|FG005|Overall Study|Study drug toxicity|1|||
144728613|NCT00162123|521861297|FG006|Overall Study|Study drug toxicity|1|||
144728614|NCT00162123|521861298|FG007|Overall Study|Study drug toxicity|0|||
144728615|NCT00162123|521861291|FG000|Overall Study|Death|3|||
144728616|NCT00162123|521861292|FG001|Overall Study|Death|3|||
144728617|NCT00162123|521861293|FG002|Overall Study|Death|1|||
144728618|NCT00162123|521861294|FG003|Overall Study|Death|1|||
144728619|NCT00162123|521861295|FG004|Overall Study|Death|1|||
144567365|NCT01663506|521278519|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
144567366|NCT02094898|521278525|FG000|Overall Study|Clinical Worsening|2|||
144567367|NCT02094898|521278525|FG000|Overall Study|Adverse Event|2|||
144567368|NCT02094898|521278525|FG000|Overall Study|Lack of Efficacy|1|||
144567369|NCT03520075|521278526|FG000|Phase 1 (Dose Escalation)|Death|2|||
144567370|NCT03520075|521278527|FG001|Phase 1 (Dose Escalation)|Death|2|||
144567371|NCT03520075|521278528|FG002|Phase 1 (Dose Escalation)|Death|3|||
144567372|NCT03520075|521278529|FG003|Phase 1 (Dose Escalation)|Death|2|||
144567373|NCT03520075|521278530|FG004|Phase 1 (Dose Escalation)|Death|6|||
144567374|NCT03520075|521278531|FG005|Phase 1 (Dose Escalation)|Death|5|||
144567375|NCT03520075|521278532|FG006|Phase 1 (Dose Escalation)|Death|3|||
144567376|NCT03520075|521278533|FG007|Phase 1 (Dose Escalation)|Death|2|||
144618921|NCT02229552|521463014|FG000|1-year Follow up|Withdrawal by Subject|7|||
144618922|NCT02229552|521463014|FG000|1-year Follow up|Lost to Follow-up|18|||
144618923|NCT02229552|521463014|FG000|2-Year Follow up|Withdrawal by Subject|9|||
144618924|NCT02229552|521463014|FG000|2-Year Follow up|Lost to Follow-up|17|||
144618925|NCT01982292|521463015|FG000|Overall Study|Adverse Event|2|||
144618926|NCT01982292|521463016|FG001|Overall Study|Adverse Event|0|||
144618927|NCT01982292|521463015|FG000|Overall Study|Death|1|||
144618928|NCT01982292|521463016|FG001|Overall Study|Death|0|||
144618929|NCT01982292|521463015|FG000|Overall Study|Lost to Follow-up|2|||
144618930|NCT01982292|521463016|FG001|Overall Study|Lost to Follow-up|0|||
144618931|NCT01982292|521463015|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
144618932|NCT01982292|521463016|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
144618933|NCT01982292|521463015|FG000|Overall Study|Protocol Deviation|1|||
144618934|NCT01982292|521463016|FG001|Overall Study|Protocol Deviation|0|||
144618935|NCT01982292|521463015|FG000|Overall Study|Patient/Guardian Decision|3|||
144618936|NCT01982292|521463016|FG001|Overall Study|Patient/Guardian Decision|1|||
144618937|NCT01982292|521463015|FG000|Overall Study|Technical Problems|2|||
144618938|NCT01982292|521463016|FG001|Overall Study|Technical Problems|0|||
144618939|NCT00971945|521463018|FG000|Overall Study|Progressive Disease|3|||
144618940|NCT00971945|521463018|FG000|Overall Study|Change in treatment policy|1|||
144618941|NCT00971945|521463018|FG000|Overall Study|Other reasons|2|||
144618942|NCT03354663|521463019|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
144618943|NCT03354663|521463019|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
144618944|NCT03354663|521463019|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
144618945|NCT03354663|521463019|FG000|Completed 30-day Visit|Missed Visit|1|||
144618946|NCT00746252|521463022|FG000|Overall Study|weight gain >7.5 %|1|||
144618947|NCT00746252|521463023|FG001|Overall Study|weight gain >7.5 %|2|||
144618948|NCT01391000|521463024|FG000|Overall Study|Lost to Follow-up|2|||
144618949|NCT01391000|521463025|FG001|Overall Study|Lost to Follow-up|0|||
144618950|NCT00082888|521463026|FG000|Overall Study|Ineligible|1|||
144205128|NCT01844856|519946865|FG001|Overall Study|Noncompliance|3|||
144205129|NCT01844856|519946864|FG000|Overall Study|Enterococcus Resistant|0|||
144205130|NCT01844856|519946865|FG001|Overall Study|Enterococcus Resistant|1|||
144205131|NCT01844856|519946864|FG000|Overall Study|Inadvertently Not Scheduled|1|||
144205132|NCT01844856|519946865|FG001|Overall Study|Inadvertently Not Scheduled|0|||
144567377|NCT03520075|521278534|FG008|Phase 1 (Dose Escalation)|Death|3|||
144567378|NCT03520075|521278535|FG009|Phase 1 (Dose Escalation)|Death|1|||
144567379|NCT03520075|521278536|FG010|Phase 1 (Dose Escalation)|Death|5|||
144567380|NCT03520075|521278537|FG011|Phase 1 (Dose Escalation)|Death|7|||
144567381|NCT03520075|521278538|FG012|Phase 1 (Dose Escalation)|Death|11|||
144618951|NCT00082888|521463027|FG001|Overall Study|Ineligible|0|||
144205133|NCT01844856|519946864|FG000|Overall Study|Randomized but was a Screen Failure|0|||
144618952|NCT00082888|521463028|FG002|Overall Study|Ineligible|0|||
144618953|NCT02684981|521463029|FG000|Overall Study|Permanently discontinued the treatment|157|||
144618954|NCT02684981|521463030|FG001|Overall Study|Permanently discontinued the treatment|161|||
144618955|NCT02684981|521463031|FG002|Overall Study|Permanently discontinued the treatment|110|||
144205134|NCT01844856|519946865|FG001|Overall Study|Randomized but was a Screen Failure|1|||
144205135|NCT00927394|519946868|FG000|Overall Study|Adverse Event|14|||
144205136|NCT00927394|519946869|FG001|Overall Study|Adverse Event|9|||
144205137|NCT00927394|519946868|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
144205138|NCT00927394|519946869|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
144567382|NCT03520075|521278539|FG013|Phase 1 (Dose Escalation)|Death|0|||
144567383|NCT03520075|521278540|FG014|Phase 1 (Dose Escalation)|Death|0|||
144567384|NCT03520075|521278541|FG015|Phase 1 (Dose Escalation)|Death|0|||
144205139|NCT00927394|519946868|FG000|Overall Study|Withdrawal by Subject|20|||
144205140|NCT00927394|519946869|FG001|Overall Study|Withdrawal by Subject|24|||
144567385|NCT03520075|521278542|FG016|Phase 1 (Dose Escalation)|Death|0|||
144567386|NCT03520075|521278543|FG017|Phase 1 (Dose Escalation)|Death|0|||
144567387|NCT03520075|521278544|FG018|Phase 1 (Dose Escalation)|Death|0|||
144567388|NCT03520075|521278526|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
144618956|NCT02684981|521463029|FG000|Overall Study|Other|83|||
144618957|NCT02684981|521463030|FG001|Overall Study|Other|49|||
144618958|NCT02684981|521463031|FG002|Overall Study|Other|17|||
144618959|NCT00820898|521463034|FG000|Overall Study|Inelgible - wrong primary site|1|||
144618960|NCT00356278|521463039|FG000|Overall Study|Withdrawal by Subject|25|||
144618961|NCT00356278|521463040|FG001|Overall Study|Withdrawal by Subject|15|||
144205141|NCT00927394|519946868|FG000|Overall Study|Lost to Follow-up|8|||
144205142|NCT00927394|519946869|FG001|Overall Study|Lost to Follow-up|14|||
144205143|NCT00927394|519946868|FG000|Overall Study|Administrative Problem|1|||
144205144|NCT00927394|519946869|FG001|Overall Study|Administrative Problem|0|||
144205145|NCT00927394|519946868|FG000|Overall Study|Death|1|||
144205146|NCT00927394|519946869|FG001|Overall Study|Death|1|||
144205147|NCT00927394|519946868|FG000|Overall Study|Protocol deviation|16|||
144205148|NCT00927394|519946869|FG001|Overall Study|Protocol deviation|13|||
144205149|NCT00927394|519946868|FG000|Overall Study|Randomized in error|0|||
144205150|NCT00927394|519946869|FG001|Overall Study|Randomized in error|1|||
144205151|NCT01221363|519946870|FG000|Overall Study|Pregnancy|1|||
144205152|NCT01221363|519946871|FG001|Overall Study|Pregnancy|0|||
144205153|NCT01221363|519946870|FG000|Overall Study|Withdrawal by Subject|11|||
144205154|NCT01221363|519946871|FG001|Overall Study|Withdrawal by Subject|5|||
144205155|NCT01329549|519946874|FG000|Overall Study|Withdrawal by Subject|1|||
144205156|NCT01329549|519946874|FG000|Overall Study|Adverse Event|1|||
144205157|NCT00191165|519946875|FG000|Overall Study|Adverse Event|2|||
144205158|NCT00191165|519946876|FG001|Overall Study|Adverse Event|0|||
144205159|NCT00191165|519946875|FG000|Overall Study|Protocol Violation|0|||
144205160|NCT00191165|519946876|FG001|Overall Study|Protocol Violation|1|||
144205161|NCT00191165|519946875|FG000|Overall Study|Participant Moved Away|0|||
144205162|NCT00191165|519946876|FG001|Overall Study|Participant Moved Away|1|||
144205163|NCT00715624|519946877|FG000|Overall Study|Adverse Event|12|||
144205164|NCT00715624|519946878|FG001|Overall Study|Adverse Event|37|||
144205165|NCT00715624|519946877|FG000|Overall Study|Lack of Efficacy|11|||
144205166|NCT00715624|519946878|FG001|Overall Study|Lack of Efficacy|11|||
144205167|NCT00715624|519946877|FG000|Overall Study|Lost to Follow-up|1|||
144205168|NCT00715624|519946878|FG001|Overall Study|Lost to Follow-up|2|||
144205169|NCT00715624|519946877|FG000|Overall Study|Protocol Violation|1|||
144205170|NCT00715624|519946878|FG001|Overall Study|Protocol Violation|0|||
144205171|NCT00715624|519946877|FG000|Overall Study|Withdrawal by Subject|11|||
144205172|NCT00715624|519946878|FG001|Overall Study|Withdrawal by Subject|25|||
144205173|NCT00715624|519946877|FG000|Overall Study|Familial and personal reasons|10|||
144205174|NCT00715624|519946878|FG001|Overall Study|Familial and personal reasons|22|||
144205175|NCT00715624|519946877|FG000|Overall Study|Poor compliance|6|||
144205176|NCT00715624|519946878|FG001|Overall Study|Poor compliance|13|||
144205177|NCT00715624|519946877|FG000|Overall Study|Sponsor decision|0|||
144205178|NCT00715624|519946878|FG001|Overall Study|Sponsor decision|4|||
144205179|NCT00715624|519946877|FG000|Overall Study|Incorrect randomization (not treated)|0|||
144205180|NCT00715624|519946878|FG001|Overall Study|Incorrect randomization (not treated)|1|||
144205181|NCT00715624|519946877|FG000|Overall Study|Other|0|||
144205182|NCT00715624|519946878|FG001|Overall Study|Other|1|||
144205183|NCT03196635|519946880|FG000|Overall Study|Withdrawal by Subject|1|||
144205184|NCT00735397|519946889|FG000|Overall Study|Adverse Event|194|||
144205185|NCT00735397|519946889|FG000|Overall Study|Lost to Follow-up|33|||
144205186|NCT00735397|519946889|FG000|Overall Study|Participant choice|252|||
144205187|NCT00735397|519946889|FG000|Overall Study|Inadequate therapeutic effect|202|||
144205188|NCT00735397|519946889|FG000|Overall Study|Administrative/Other|502|||
144205189|NCT02865460|519946892|FG000|Overall Study|Adverse Event|1|||
144205190|NCT02865460|519946893|FG001|Overall Study|Adverse Event|0|||
144205191|NCT02865460|519946892|FG000|Overall Study|Withdrawal by Subject|1|||
144205192|NCT02865460|519946893|FG001|Overall Study|Withdrawal by Subject|1|||
144205193|NCT02865460|519946892|FG000|Overall Study|Lost to Follow-up|7|||
144205194|NCT02865460|519946893|FG001|Overall Study|Lost to Follow-up|4|||
144205195|NCT02865460|519946892|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
144205196|NCT02865460|519946893|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
144567389|NCT03520075|521278527|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567390|NCT03520075|521278528|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144205197|NCT00380744|519946894|FG000|Overall Study|Death|0|||
144205198|NCT00380744|519946895|FG001|Overall Study|Death|0|||
144205199|NCT00380744|519946896|FG002|Overall Study|Death|0|||
144205200|NCT00380744|519946897|FG003|Overall Study|Death|0|||
144205201|NCT00380744|519946898|FG004|Overall Study|Death|0|||
144205202|NCT00380744|519946899|FG005|Overall Study|Death|0|||
144205203|NCT00380744|519946900|FG006|Overall Study|Death|1|||
144205204|NCT00380744|519946894|FG000|Overall Study|Withdrawal by Subject|1|||
144205205|NCT00380744|519946895|FG001|Overall Study|Withdrawal by Subject|0|||
144567391|NCT03520075|521278529|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
144567392|NCT03520075|521278530|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
144205206|NCT00380744|519946896|FG002|Overall Study|Withdrawal by Subject|0|||
144205207|NCT00380744|519946897|FG003|Overall Study|Withdrawal by Subject|0|||
144205208|NCT00380744|519946898|FG004|Overall Study|Withdrawal by Subject|0|||
144205209|NCT00380744|519946899|FG005|Overall Study|Withdrawal by Subject|0|||
144205210|NCT00380744|519946900|FG006|Overall Study|Withdrawal by Subject|0|||
144205211|NCT01844505|519946904|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
144205212|NCT01844505|519946905|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
144205213|NCT01844505|519946906|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
144618962|NCT00356278|521463041|FG002|Overall Study|Withdrawal by Subject|19|||
144618963|NCT00527605|521463042|FG000|Overall Study|Adverse Event|3|||
144618964|NCT00527605|521463043|FG001|Overall Study|Adverse Event|0|||
144618965|NCT00527605|521463042|FG000|Overall Study|Withdrawal by Subject|3|||
144618966|NCT00527605|521463043|FG001|Overall Study|Withdrawal by Subject|7|||
144618967|NCT00527605|521463042|FG000|Overall Study|Lost to Follow-up|6|||
144618968|NCT00527605|521463043|FG001|Overall Study|Lost to Follow-up|2|||
144618969|NCT00527605|521463042|FG000|Overall Study|Protocol Violation|1|||
144618970|NCT00527605|521463043|FG001|Overall Study|Protocol Violation|2|||
144618971|NCT03468309|521463044|FG000|Overall Study|Lost to Follow-up|4|||
144618972|NCT03468309|521463044|FG000|Overall Study|Withdrawal by Subject|2|||
144618973|NCT00179309|521463045|FG000|Treatment|Toxicity|2|||
144618974|NCT00179309|521463046|FG001|Treatment|Toxicity|3|||
144618975|NCT00179309|521463045|FG000|Treatment|Withdrawal by Subject|1|||
144618976|NCT00179309|521463046|FG001|Treatment|Withdrawal by Subject|2|||
144618977|NCT00179309|521463045|FG000|Treatment|Allergy|1|||
144618978|NCT00179309|521463046|FG001|Treatment|Allergy|0|||
144618979|NCT00488982|521463047|FG000|Course 1|Physician Decision|0|||
144618980|NCT00488982|521463048|FG001|Course 1|Physician Decision|2|||
144618981|NCT00488982|521463049|FG002|Course 1|Physician Decision|4|||
144618982|NCT00488982|521463047|FG000|Course 1|Withdrawal by Subject|0|||
144618983|NCT00488982|521463048|FG001|Course 1|Withdrawal by Subject|8|||
144618984|NCT00488982|521463049|FG002|Course 1|Withdrawal by Subject|2|||
144618985|NCT00488982|521463047|FG000|Course 1|nonprotocol therapy|0|||
144618986|NCT00488982|521463048|FG001|Course 1|nonprotocol therapy|2|||
144618987|NCT00488982|521463049|FG002|Course 1|nonprotocol therapy|2|||
144618988|NCT00488982|521463047|FG000|Course 1|Adverse Event|0|||
144618989|NCT00488982|521463048|FG001|Course 1|Adverse Event|0|||
144618990|NCT00488982|521463049|FG002|Course 1|Adverse Event|6|||
144618991|NCT01777152|521463053|FG000|Overall Study|Withdrawal by Subject|22|||
144618992|NCT01777152|521463054|FG001|Overall Study|Withdrawal by Subject|16|||
144618993|NCT01777152|521463053|FG000|Overall Study|Lost to Follow-up|3|||
144618994|NCT01777152|521463054|FG001|Overall Study|Lost to Follow-up|5|||
144567393|NCT03520075|521278531|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
144618995|NCT01777152|521463053|FG000|Overall Study|Death|68|||
144618996|NCT01777152|521463054|FG001|Overall Study|Death|89|||
144618997|NCT01777152|521463053|FG000|Overall Study|Not eligible, no study drug received|1|||
144618998|NCT01777152|521463054|FG001|Overall Study|Not eligible, no study drug received|0|||
144567394|NCT03520075|521278532|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567395|NCT03520075|521278533|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
144567396|NCT03520075|521278534|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567397|NCT03520075|521278535|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
144567398|NCT03520075|521278536|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567399|NCT03520075|521278537|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567400|NCT03520075|521278538|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
144567401|NCT03520075|521278539|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567402|NCT03520075|521278540|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567403|NCT03520075|521278541|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567404|NCT03520075|521278542|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567405|NCT03520075|521278543|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144567406|NCT03520075|521278544|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
144618999|NCT01777152|521463053|FG000|Overall Study|Change of diagnosis|1|||
144619000|NCT01777152|521463054|FG001|Overall Study|Change of diagnosis|0|||
144619001|NCT03548558|521463055|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
144619002|NCT03548558|521463056|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
144619003|NCT03548558|521463057|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
144619004|NCT03548558|521463058|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
144619005|NCT03548558|521463059|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
144619006|NCT03548558|521463060|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
144619007|NCT03548558|521463061|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
144619008|NCT03548558|521463055|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
144619009|NCT03548558|521463056|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
144619010|NCT03548558|521463057|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
144619011|NCT03548558|521463058|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
144619012|NCT03548558|521463059|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
144619013|NCT03548558|521463060|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
144619014|NCT03548558|521463061|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
144619015|NCT03548558|521463055|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
144619016|NCT03548558|521463056|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
144619017|NCT03548558|521463057|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
144619018|NCT03548558|521463058|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
144619019|NCT03548558|521463059|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
144619020|NCT03548558|521463060|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
144205214|NCT01844505|519946904|FG000|Treatment Period|Other Reasons|120|||
144205215|NCT01844505|519946905|FG001|Treatment Period|Other Reasons|136|||
144205216|NCT01844505|519946906|FG002|Treatment Period|Other Reasons|58|||
144205217|NCT01844505|519946904|FG000|Treatment Period|Lost to Follow-up|9|||
144205218|NCT01844505|519946905|FG001|Treatment Period|Lost to Follow-up|11|||
144205219|NCT01844505|519946906|FG002|Treatment Period|Lost to Follow-up|6|||
144205220|NCT01844505|519946904|FG000|Treatment Period|Death|175|||
144205221|NCT01844505|519946905|FG001|Treatment Period|Death|154|||
144205222|NCT01844505|519946906|FG002|Treatment Period|Death|228|||
144205223|NCT00311402|519946907|FG000|Overall Study|Adverse Event|118|||
144205224|NCT00311402|519946908|FG001|Overall Study|Adverse Event|105|||
144205225|NCT00311402|519946907|FG000|Overall Study|Lost to Follow-up|0|||
144205226|NCT00311402|519946908|FG001|Overall Study|Lost to Follow-up|3|||
144205227|NCT00311402|519946907|FG000|Overall Study|Withdrawal by Subject|17|||
144205228|NCT00311402|519946908|FG001|Overall Study|Withdrawal by Subject|18|||
144205229|NCT00311402|519946907|FG000|Overall Study|Lack of Efficacy|58|||
144205230|NCT00311402|519946908|FG001|Overall Study|Lack of Efficacy|42|||
144205231|NCT00311402|519946907|FG000|Overall Study|Protocol Violation|7|||
144205232|NCT00311402|519946908|FG001|Overall Study|Protocol Violation|6|||
144205233|NCT00311402|519946907|FG000|Overall Study|IRB's rejection etc.|10|||
144205234|NCT00311402|519946908|FG001|Overall Study|IRB's rejection etc.|3|||
144205235|NCT04159935|519946909|FG000|Overall Study|Study terminated due to COVID-19|1|||
144205236|NCT04159935|519946910|FG001|Overall Study|Study terminated due to COVID-19|3|||
144205237|NCT01140503|519946912|FG000|Overall Study|Withdrawal by Subject|1|||
144205238|NCT00724048|519946913|FG000|Overall Study|Adverse Event|1|||
144205239|NCT00724048|519946914|FG001|Overall Study|Adverse Event|1|||
144205240|NCT00724048|519946915|FG002|Overall Study|Adverse Event|1|||
144205241|NCT00724048|519946916|FG003|Overall Study|Adverse Event|0|||
144205242|NCT00724048|519946913|FG000|Overall Study|Lost to Follow-up|0|||
144205243|NCT00724048|519946914|FG001|Overall Study|Lost to Follow-up|1|||
144205244|NCT00724048|519946915|FG002|Overall Study|Lost to Follow-up|0|||
144205245|NCT00724048|519946916|FG003|Overall Study|Lost to Follow-up|0|||
144205246|NCT00724048|519946913|FG000|Overall Study|Withdrawal by Subject|1|||
144205247|NCT00724048|519946914|FG001|Overall Study|Withdrawal by Subject|2|||
144205248|NCT00724048|519946915|FG002|Overall Study|Withdrawal by Subject|1|||
144205249|NCT00724048|519946916|FG003|Overall Study|Withdrawal by Subject|2|||
144205250|NCT00724048|519946913|FG000|Overall Study|Investigator decision|0|||
144205251|NCT00724048|519946914|FG001|Overall Study|Investigator decision|0|||
144205252|NCT00724048|519946915|FG002|Overall Study|Investigator decision|1|||
144262671|NCT04001803|520161532|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
144262672|NCT04001803|520161532|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
144262673|NCT04001803|520161532|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
144567407|NCT03520075|521278526|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567408|NCT03520075|521278527|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
144567409|NCT03520075|521278528|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567410|NCT03520075|521278529|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
144567411|NCT03520075|521278530|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
144567412|NCT03520075|521278531|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567413|NCT03520075|521278532|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567414|NCT03520075|521278533|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567415|NCT03520075|521278534|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567416|NCT03520075|521278535|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567417|NCT03520075|521278536|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
144567418|NCT03520075|521278537|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567419|NCT03520075|521278538|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
144567420|NCT03520075|521278539|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567421|NCT03520075|521278540|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567422|NCT03520075|521278541|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144205253|NCT00724048|519946916|FG003|Overall Study|Investigator decision|0|||
144567423|NCT03520075|521278542|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567424|NCT03520075|521278543|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567425|NCT03520075|521278544|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
144567426|NCT03520075|521278526|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567427|NCT03520075|521278527|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144205254|NCT00724048|519946913|FG000|Overall Study|Did not tolerate study drug|0|||
144205255|NCT00724048|519946914|FG001|Overall Study|Did not tolerate study drug|0|||
144205256|NCT00724048|519946915|FG002|Overall Study|Did not tolerate study drug|0|||
144205257|NCT00724048|519946916|FG003|Overall Study|Did not tolerate study drug|1|||
144205258|NCT00724048|519946913|FG000|Overall Study|Other than specified|1|||
144205259|NCT00724048|519946914|FG001|Overall Study|Other than specified|1|||
144205260|NCT00724048|519946915|FG002|Overall Study|Other than specified|0|||
144205261|NCT00724048|519946916|FG003|Overall Study|Other than specified|0|||
144262674|NCT04001803|520161532|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
144205262|NCT00206323|519946919|FG000|Overall Study|Lack of Efficacy|4|||
144205263|NCT00206323|519946920|FG001|Overall Study|Lack of Efficacy|1|||
144205264|NCT00206323|519946919|FG000|Overall Study|Adverse Event|1|||
144205265|NCT00206323|519946920|FG001|Overall Study|Adverse Event|1|||
144205266|NCT00206323|519946919|FG000|Overall Study|Lost to Follow-up|1|||
144205267|NCT00206323|519946920|FG001|Overall Study|Lost to Follow-up|1|||
144205268|NCT03334617|519946921|FG000|Overall Study|Adverse Event|0|||
144205269|NCT03334617|519946922|FG001|Overall Study|Adverse Event|0|||
144205270|NCT03334617|519946923|FG002|Overall Study|Adverse Event|0|||
144205271|NCT03334617|519946924|FG003|Overall Study|Adverse Event|0|||
144205272|NCT03334617|519946925|FG004|Overall Study|Adverse Event|0|||
144205273|NCT03334617|519946926|FG005|Overall Study|Adverse Event|0|||
144205274|NCT03334617|519946927|FG006|Overall Study|Adverse Event|0|||
144205275|NCT03334617|519946928|FG007|Overall Study|Adverse Event|0|||
144262675|NCT04001803|520161532|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
144262676|NCT04001803|520161532|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
144567428|NCT03520075|521278528|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567429|NCT03520075|521278529|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567430|NCT03520075|521278530|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567431|NCT03520075|521278531|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567432|NCT03520075|521278532|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567433|NCT03520075|521278533|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567434|NCT03520075|521278534|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567435|NCT03520075|521278535|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
144567436|NCT03520075|521278536|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567437|NCT03520075|521278537|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567438|NCT03520075|521278538|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
144567439|NCT03520075|521278539|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567440|NCT03520075|521278540|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567441|NCT03520075|521278541|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567442|NCT03520075|521278542|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567443|NCT03520075|521278543|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567444|NCT03520075|521278544|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
144567445|NCT03520075|521278526|FG000|Phase 2 (Dose Expansion)|Death|0|||
144567446|NCT03520075|521278527|FG001|Phase 2 (Dose Expansion)|Death|0|||
144567447|NCT03520075|521278528|FG002|Phase 2 (Dose Expansion)|Death|0|||
144567448|NCT03520075|521278529|FG003|Phase 2 (Dose Expansion)|Death|0|||
144567449|NCT03520075|521278530|FG004|Phase 2 (Dose Expansion)|Death|0|||
144567450|NCT03520075|521278531|FG005|Phase 2 (Dose Expansion)|Death|0|||
144567451|NCT03520075|521278532|FG006|Phase 2 (Dose Expansion)|Death|0|||
144567452|NCT03520075|521278533|FG007|Phase 2 (Dose Expansion)|Death|0|||
144567453|NCT03520075|521278534|FG008|Phase 2 (Dose Expansion)|Death|0|||
144567454|NCT03520075|521278535|FG009|Phase 2 (Dose Expansion)|Death|0|||
144567455|NCT03520075|521278536|FG010|Phase 2 (Dose Expansion)|Death|0|||
144567456|NCT03520075|521278537|FG011|Phase 2 (Dose Expansion)|Death|0|||
144567457|NCT03520075|521278538|FG012|Phase 2 (Dose Expansion)|Death|0|||
144567458|NCT03520075|521278539|FG013|Phase 2 (Dose Expansion)|Death|20|||
144567459|NCT03520075|521278540|FG014|Phase 2 (Dose Expansion)|Death|13|||
144567460|NCT03520075|521278541|FG015|Phase 2 (Dose Expansion)|Death|9|||
144567461|NCT03520075|521278542|FG016|Phase 2 (Dose Expansion)|Death|5|||
144567462|NCT03520075|521278543|FG017|Phase 2 (Dose Expansion)|Death|14|||
144567463|NCT03520075|521278544|FG018|Phase 2 (Dose Expansion)|Death|12|||
144567464|NCT03520075|521278526|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567465|NCT03520075|521278527|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567466|NCT03520075|521278528|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567467|NCT03520075|521278529|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144619021|NCT03548558|521463061|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
144619022|NCT03548558|521463055|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
144619023|NCT03548558|521463056|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
144619024|NCT03548558|521463057|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
144619025|NCT03548558|521463058|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
144619026|NCT03548558|521463059|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
144619027|NCT03548558|521463060|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
144619028|NCT03548558|521463061|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
144567468|NCT03520075|521278530|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567469|NCT03520075|521278531|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567470|NCT03520075|521278532|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567471|NCT03520075|521278533|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567472|NCT03520075|521278534|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567473|NCT03520075|521278535|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567474|NCT03520075|521278536|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144205276|NCT03334617|519946929|FG008|Overall Study|Adverse Event|1|||
144205277|NCT03334617|519946930|FG009|Overall Study|Adverse Event|0|||
144205278|NCT03334617|519946931|FG010|Overall Study|Adverse Event|0|||
144619029|NCT03548558|521463055|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
144619030|NCT03548558|521463056|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
144619031|NCT03548558|521463057|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
144619032|NCT03548558|521463058|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
144619033|NCT03548558|521463059|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
144619034|NCT03548558|521463060|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
144619035|NCT03548558|521463061|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
144619036|NCT03548558|521463055|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
144619037|NCT03548558|521463056|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
144619038|NCT03548558|521463057|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
144619039|NCT03548558|521463058|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
144619040|NCT03548558|521463059|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
144619041|NCT03548558|521463060|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
144619042|NCT03548558|521463061|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
144619043|NCT01485627|521463068|FG000|Overall Study|Patient withdrew|6|||
144619044|NCT01485627|521463069|FG001|Overall Study|Patient withdrew|5|||
144619045|NCT01485627|521463068|FG000|Overall Study|Patient died|3|||
144619046|NCT01485627|521463069|FG001|Overall Study|Patient died|1|||
144619047|NCT01485627|521463068|FG000|Overall Study|Patient lost to followup|0|||
144619048|NCT01485627|521463069|FG001|Overall Study|Patient lost to followup|1|||
144619049|NCT01485627|521463068|FG000|Overall Study|Caregiver withdrew|3|||
144619050|NCT01485627|521463069|FG001|Overall Study|Caregiver withdrew|3|||
144619051|NCT01485627|521463068|FG000|Overall Study|Caregiver lost to follow up|11|||
144619052|NCT01485627|521463069|FG001|Overall Study|Caregiver lost to follow up|12|||
144619053|NCT01485627|521463068|FG000|Overall Study|Caregiver died|1|||
144619054|NCT01485627|521463069|FG001|Overall Study|Caregiver died|0|||
144619055|NCT01485627|521463068|FG000|Overall Study|caregiver was not bereaved|42|||
144567475|NCT03520075|521278537|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567476|NCT03520075|521278538|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567477|NCT03520075|521278539|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
144567478|NCT03520075|521278540|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
144567479|NCT03520075|521278541|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
144567480|NCT03520075|521278542|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
144567481|NCT03520075|521278543|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
144567482|NCT03520075|521278544|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
144567483|NCT03520075|521278526|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567484|NCT03520075|521278527|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567485|NCT03520075|521278528|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567486|NCT03520075|521278529|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567487|NCT03520075|521278530|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144619056|NCT01485627|521463069|FG001|Overall Study|caregiver was not bereaved|35|||
144619057|NCT01709149|521463073|FG000|Open-label Lead-in Phase|Adverse Event|109|||
144619058|NCT01709149|521463074|FG001|Open-label Lead-in Phase|Adverse Event|0|||
144619059|NCT01709149|521463075|FG002|Open-label Lead-in Phase|Adverse Event|0|||
144619060|NCT01709149|521463073|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
144619061|NCT01709149|521463074|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
144619062|NCT01709149|521463075|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
144619063|NCT01709149|521463073|FG000|Open-label Lead-in Phase|Death|1|||
144619064|NCT01709149|521463074|FG001|Open-label Lead-in Phase|Death|0|||
144205279|NCT03334617|519946932|FG011|Overall Study|Adverse Event|0|||
144205280|NCT03334617|519946933|FG012|Overall Study|Adverse Event|1|||
144205281|NCT03334617|519946934|FG013|Overall Study|Adverse Event|0|||
144205282|NCT03334617|519946935|FG014|Overall Study|Adverse Event|0|||
144205283|NCT03334617|519946936|FG015|Overall Study|Adverse Event|0|||
144205284|NCT03334617|519946937|FG016|Overall Study|Adverse Event|0|||
144205285|NCT03334617|519946938|FG017|Overall Study|Adverse Event|0|||
144205286|NCT03334617|519946939|FG018|Overall Study|Adverse Event|0|||
144205287|NCT03334617|519946940|FG019|Overall Study|Adverse Event|0|||
144205288|NCT03334617|519946941|FG020|Overall Study|Adverse Event|0|||
144205289|NCT03334617|519946942|FG021|Overall Study|Adverse Event|0|||
144205290|NCT03334617|519946921|FG000|Overall Study|Death|18|||
144205291|NCT03334617|519946922|FG001|Overall Study|Death|18|||
144205292|NCT03334617|519946923|FG002|Overall Study|Death|20|||
144205293|NCT03334617|519946924|FG003|Overall Study|Death|21|||
144205294|NCT03334617|519946925|FG004|Overall Study|Death|20|||
144205295|NCT03334617|519946926|FG005|Overall Study|Death|16|||
144205296|NCT03334617|519946927|FG006|Overall Study|Death|28|||
144205297|NCT03334617|519946928|FG007|Overall Study|Death|35|||
144205298|NCT03334617|519946929|FG008|Overall Study|Death|47|||
144205299|NCT03334617|519946930|FG009|Overall Study|Death|0|||
144205300|NCT03334617|519946931|FG010|Overall Study|Death|19|||
144205301|NCT03334617|519946932|FG011|Overall Study|Death|6|||
144205302|NCT03334617|519946933|FG012|Overall Study|Death|20|||
144205303|NCT03334617|519946934|FG013|Overall Study|Death|22|||
144567488|NCT03520075|521278531|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567489|NCT03520075|521278532|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567490|NCT03520075|521278533|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567491|NCT03520075|521278534|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567492|NCT03520075|521278535|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567493|NCT03520075|521278536|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567494|NCT03520075|521278537|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567495|NCT03520075|521278538|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567496|NCT03520075|521278539|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567497|NCT03520075|521278540|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
144567498|NCT03520075|521278541|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
144567499|NCT03520075|521278542|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567500|NCT03520075|521278543|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
144567501|NCT03520075|521278544|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
144567502|NCT03520075|521278526|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567503|NCT03520075|521278527|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567504|NCT03520075|521278528|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567505|NCT03520075|521278529|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567506|NCT03520075|521278530|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567507|NCT03520075|521278531|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567508|NCT03520075|521278532|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567509|NCT03520075|521278533|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567510|NCT03520075|521278534|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567511|NCT03520075|521278535|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567512|NCT03520075|521278536|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567513|NCT03520075|521278537|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567514|NCT03520075|521278538|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567515|NCT03520075|521278539|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
144567516|NCT03520075|521278540|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567517|NCT03520075|521278541|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567518|NCT03520075|521278542|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
144567519|NCT03520075|521278543|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
144567520|NCT03520075|521278544|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
144567521|NCT00816556|521278545|FG000|Overall Study|Adverse Event|1|||
144567522|NCT00816556|521278546|FG001|Overall Study|Adverse Event|1|||
144567523|NCT00816556|521278547|FG002|Overall Study|Adverse Event|1|||
144567524|NCT00816556|521278545|FG000|Overall Study|Withdrawal by Subject|1|||
144567525|NCT00816556|521278546|FG001|Overall Study|Withdrawal by Subject|1|||
144567526|NCT00816556|521278547|FG002|Overall Study|Withdrawal by Subject|1|||
144567527|NCT00816556|521278545|FG000|Overall Study|Lost to Follow-up|0|||
144567528|NCT00816556|521278546|FG001|Overall Study|Lost to Follow-up|0|||
144567529|NCT00816556|521278547|FG002|Overall Study|Lost to Follow-up|1|||
144567530|NCT00810342|521278548|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
144567531|NCT00810342|521278549|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
144567532|NCT00810342|521278548|FG000|Month 1 Follow-up|Pregnancy|1|||
144567533|NCT00810342|521278549|FG001|Month 1 Follow-up|Pregnancy|0|||
144567534|NCT00810342|521278548|FG000|6-month Follow-up|Lost to Follow-up|18|||
144567535|NCT00810342|521278549|FG001|6-month Follow-up|Lost to Follow-up|6|||
144567536|NCT00810342|521278548|FG000|6-month Follow-up|Pregnancy|6|||
144567537|NCT00810342|521278549|FG001|6-month Follow-up|Pregnancy|2|||
144567538|NCT00810342|521278548|FG000|12-month Followup|Pregnancy|9|||
144567539|NCT00810342|521278549|FG001|12-month Followup|Pregnancy|10|||
144567540|NCT00810342|521278548|FG000|12-month Followup|Lost to Follow-up|3|||
144567541|NCT00810342|521278549|FG001|12-month Followup|Lost to Follow-up|1|||
144567542|NCT00412880|521278554|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
144567543|NCT00412880|521278554|FG000|Overall Study|Consent withdrawn|1|||
144567544|NCT00412880|521278554|FG000|Overall Study|Adverse Event|1|||
144567545|NCT00412880|521278554|FG000|Overall Study|Progressive disease|20|||
144567546|NCT01496365|521278555|FG000|Overall Study|Adverse Event|2|||
144567547|NCT01496365|521278556|FG001|Overall Study|Adverse Event|3|||
144567548|NCT01496365|521278557|FG002|Overall Study|Adverse Event|3|||
144567549|NCT01496365|521278558|FG003|Overall Study|Adverse Event|2|||
144567550|NCT01496365|521278559|FG004|Overall Study|Adverse Event|5|||
144567551|NCT01496365|521278560|FG005|Overall Study|Adverse Event|6|||
144567552|NCT01496365|521278561|FG006|Overall Study|Adverse Event|4|||
144567553|NCT01496365|521278555|FG000|Overall Study|Withdrawal by Subject|6|||
144567554|NCT01496365|521278556|FG001|Overall Study|Withdrawal by Subject|6|||
144567555|NCT01496365|521278557|FG002|Overall Study|Withdrawal by Subject|0|||
144567556|NCT01496365|521278558|FG003|Overall Study|Withdrawal by Subject|1|||
144567557|NCT01496365|521278559|FG004|Overall Study|Withdrawal by Subject|3|||
144567558|NCT01496365|521278560|FG005|Overall Study|Withdrawal by Subject|2|||
144567559|NCT01496365|521278561|FG006|Overall Study|Withdrawal by Subject|1|||
144567560|NCT01496365|521278555|FG000|Overall Study|Protocol Violation|2|||
144567561|NCT01496365|521278556|FG001|Overall Study|Protocol Violation|1|||
144567562|NCT01496365|521278557|FG002|Overall Study|Protocol Violation|1|||
144567563|NCT01496365|521278558|FG003|Overall Study|Protocol Violation|0|||
144567564|NCT01496365|521278559|FG004|Overall Study|Protocol Violation|0|||
144567565|NCT01496365|521278560|FG005|Overall Study|Protocol Violation|1|||
144567566|NCT01496365|521278561|FG006|Overall Study|Protocol Violation|0|||
144567567|NCT01496365|521278555|FG000|Overall Study|Lack of Efficacy|1|||
144567568|NCT01496365|521278556|FG001|Overall Study|Lack of Efficacy|0|||
144567569|NCT01496365|521278557|FG002|Overall Study|Lack of Efficacy|0|||
144567570|NCT01496365|521278558|FG003|Overall Study|Lack of Efficacy|0|||
144567571|NCT01496365|521278559|FG004|Overall Study|Lack of Efficacy|0|||
144567572|NCT01496365|521278560|FG005|Overall Study|Lack of Efficacy|1|||
144567573|NCT01496365|521278561|FG006|Overall Study|Lack of Efficacy|0|||
144567574|NCT01496365|521278555|FG000|Overall Study|Lost to Follow-up|0|||
144567575|NCT01496365|521278556|FG001|Overall Study|Lost to Follow-up|1|||
144567576|NCT01496365|521278557|FG002|Overall Study|Lost to Follow-up|0|||
144567577|NCT01496365|521278558|FG003|Overall Study|Lost to Follow-up|0|||
144567578|NCT01496365|521278559|FG004|Overall Study|Lost to Follow-up|2|||
144567579|NCT01496365|521278560|FG005|Overall Study|Lost to Follow-up|0|||
144567580|NCT01496365|521278561|FG006|Overall Study|Lost to Follow-up|0|||
144567581|NCT01496365|521278555|FG000|Overall Study|Other|4|||
144567582|NCT01496365|521278556|FG001|Overall Study|Other|4|||
144567583|NCT01496365|521278557|FG002|Overall Study|Other|2|||
144567584|NCT01496365|521278558|FG003|Overall Study|Other|1|||
144567585|NCT01496365|521278559|FG004|Overall Study|Other|3|||
144567586|NCT01496365|521278560|FG005|Overall Study|Other|0|||
144567587|NCT01496365|521278561|FG006|Overall Study|Other|1|||
144567588|NCT01288209|521278562|FG000|Overall Study|Withdrawal by Subject|1|||
144567589|NCT01288209|521278563|FG001|Overall Study|Withdrawal by Subject|3|||
144567590|NCT01288209|521278562|FG000|Overall Study|Other|1|||
144567591|NCT01288209|521278563|FG001|Overall Study|Other|0|||
144567592|NCT01015677|521278564|FG000|Overall Study|Adverse Event|0|||
144567593|NCT01015677|521278565|FG001|Overall Study|Adverse Event|1|||
144567594|NCT01015677|521278566|FG002|Overall Study|Adverse Event|0|||
144567595|NCT01015677|521278564|FG000|Overall Study|Lack of Efficacy|0|||
144567596|NCT01015677|521278565|FG001|Overall Study|Lack of Efficacy|1|||
144567597|NCT01015677|521278566|FG002|Overall Study|Lack of Efficacy|0|||
144567598|NCT01015677|521278564|FG000|Overall Study|Protocol Violation|0|||
144567599|NCT01015677|521278565|FG001|Overall Study|Protocol Violation|1|||
144567600|NCT01015677|521278566|FG002|Overall Study|Protocol Violation|0|||
144567601|NCT01015677|521278564|FG000|Overall Study|Withdrawal by Subject|1|||
144567602|NCT01015677|521278565|FG001|Overall Study|Withdrawal by Subject|1|||
144567603|NCT01015677|521278566|FG002|Overall Study|Withdrawal by Subject|0|||
144567604|NCT02232399|521278567|FG000|Overall Study|Adverse Event|1|||
144567605|NCT02232399|521278568|FG001|Overall Study|Adverse Event|0|||
144567606|NCT02232399|521278567|FG000|Overall Study|Withdrawal by Subject|0|||
144567607|NCT02232399|521278568|FG001|Overall Study|Withdrawal by Subject|1|||
144567608|NCT03491215|521278569|FG000|Overall Study|Death|6|||
144567609|NCT03491215|521278570|FG001|Overall Study|Death|2|||
144567610|NCT03491215|521278571|FG002|Overall Study|Death|1|||
144205304|NCT03334617|519946935|FG014|Overall Study|Death|17|||
144205305|NCT03334617|519946936|FG015|Overall Study|Death|18|||
144205306|NCT03334617|519946937|FG016|Overall Study|Death|12|||
144567611|NCT03491215|521278572|FG003|Overall Study|Death|0|||
144567612|NCT03491215|521278569|FG000|Overall Study|Physician Decision|1|||
144567613|NCT03491215|521278570|FG001|Overall Study|Physician Decision|0|||
144567614|NCT03491215|521278571|FG002|Overall Study|Physician Decision|0|||
144567615|NCT03491215|521278572|FG003|Overall Study|Physician Decision|0|||
144567616|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
144567617|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
144567618|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
144567619|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
144567620|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
144567621|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
144567622|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
144567623|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
144619065|NCT01709149|521463075|FG002|Open-label Lead-in Phase|Death|0|||
144619066|NCT01709149|521463073|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
144619067|NCT01709149|521463074|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
144619068|NCT01709149|521463075|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
144619069|NCT01709149|521463073|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
144619070|NCT01709149|521463074|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
144619071|NCT01709149|521463075|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
144619072|NCT01709149|521463073|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
144619073|NCT01709149|521463074|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
144619074|NCT01709149|521463075|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
144619075|NCT01709149|521463073|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
144567624|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
144567625|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
144567626|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
144567627|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
144567628|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
144567629|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
144567630|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
144567631|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
144567632|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
144567633|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
144567634|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
144567635|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
144567636|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
144567637|NCT04599855|521278573|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
144567638|NCT04599855|521278574|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
144567639|NCT04599855|521278575|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
144567640|NCT04599855|521278573|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
144567641|NCT04599855|521278574|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
144567642|NCT04599855|521278575|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
144567643|NCT04599855|521278573|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
144567644|NCT04599855|521278574|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
144567645|NCT04599855|521278575|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
144567646|NCT04599855|521278573|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
144567647|NCT04599855|521278574|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
144567648|NCT04599855|521278575|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
144567649|NCT04599855|521278573|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
144567650|NCT04599855|521278574|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
144567651|NCT04599855|521278575|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
144567652|NCT04599855|521278573|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
144567653|NCT04599855|521278574|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
144567654|NCT04599855|521278575|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
144567655|NCT04599855|521278573|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
144567656|NCT04599855|521278574|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
144567657|NCT04599855|521278575|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
144567658|NCT04294667|521278576|FG000|Overall Study|Lack of Efficacy|4|||
144567659|NCT04294667|521278577|FG001|Overall Study|Lack of Efficacy|4|||
144567660|NCT04294667|521278576|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
144567661|NCT04294667|521278577|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
144567662|NCT04294667|521278576|FG000|Overall Study|Patient has a Renal Flare|1|||
144567663|NCT04294667|521278577|FG001|Overall Study|Patient has a Renal Flare|0|||
144567664|NCT04294667|521278576|FG000|Overall Study|SLE Worsening|0|||
144567665|NCT04294667|521278577|FG001|Overall Study|SLE Worsening|1|||
144567666|NCT04294667|521278576|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
144567667|NCT04294667|521278577|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
144567668|NCT04294667|521278576|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
144567669|NCT04294667|521278577|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
144567670|NCT04294667|521278576|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
144619076|NCT01709149|521463074|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
144619077|NCT01709149|521463075|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
144619078|NCT01709149|521463073|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
144619079|NCT01709149|521463074|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
144619080|NCT01709149|521463075|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
144619081|NCT01709149|521463073|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
144619082|NCT01709149|521463074|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
144619083|NCT01709149|521463075|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
144619084|NCT01709149|521463073|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144619085|NCT01709149|521463074|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
144619086|NCT01709149|521463075|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
144619087|NCT01425203|521463076|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
144619088|NCT01425203|521463077|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
144619089|NCT01425203|521463078|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
144619090|NCT01425203|521463076|FG000|Treatment Phase|Failure at futility timepoint|8|||
144619091|NCT01425203|521463077|FG001|Treatment Phase|Failure at futility timepoint|27|||
144619092|NCT01425203|521463078|FG002|Treatment Phase|Failure at futility timepoint|0|||
144619093|NCT01425203|521463076|FG000|Treatment Phase|Other virologic failure criteria|5|||
144619094|NCT01425203|521463077|FG001|Treatment Phase|Other virologic failure criteria|3|||
144728620|NCT00162123|521861296|FG005|Overall Study|Death|1|||
144728621|NCT00162123|521861297|FG006|Overall Study|Death|0|||
144567671|NCT04294667|521278577|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
144567672|NCT04294667|521278576|FG000|Overall Study|Subject Moved to Another State|0|||
144567673|NCT04294667|521278577|FG001|Overall Study|Subject Moved to Another State|1|||
144567674|NCT04294667|521278576|FG000|Overall Study|Adverse event, serious fatal|0|||
144567675|NCT04294667|521278577|FG001|Overall Study|Adverse event, serious fatal|1|||
144567676|NCT04294667|521278576|FG000|Overall Study|Adverse event, non-fatal|3|||
144567677|NCT04294667|521278577|FG001|Overall Study|Adverse event, non-fatal|4|||
144567678|NCT03297398|521278578|FG000|Overall Study|Sponsor's decision|6|||
144567679|NCT03297398|521278579|FG001|Overall Study|Sponsor's decision|9|||
144567680|NCT03297398|521278580|FG002|Overall Study|Sponsor's decision|7|||
144567681|NCT03297398|521278578|FG000|Overall Study|Adverse Event|1|||
144567682|NCT03297398|521278579|FG001|Overall Study|Adverse Event|4|||
144567683|NCT03297398|521278580|FG002|Overall Study|Adverse Event|4|||
144567684|NCT03297398|521278578|FG000|Overall Study|Withdrawal by Subject|1|||
144567685|NCT03297398|521278579|FG001|Overall Study|Withdrawal by Subject|2|||
144567686|NCT03297398|521278580|FG002|Overall Study|Withdrawal by Subject|2|||
144567687|NCT03297398|521278578|FG000|Overall Study|Protocol Violation|0|||
144728622|NCT00162123|521861298|FG007|Overall Study|Death|0|||
144205307|NCT03334617|519946938|FG017|Overall Study|Death|15|||
144205308|NCT03334617|519946939|FG018|Overall Study|Death|16|||
144205309|NCT03334617|519946940|FG019|Overall Study|Death|27|||
144205310|NCT03334617|519946941|FG020|Overall Study|Death|14|||
144205311|NCT03334617|519946942|FG021|Overall Study|Death|27|||
144205312|NCT03334617|519946921|FG000|Overall Study|Lost to Follow-up|0|||
144205313|NCT03334617|519946922|FG001|Overall Study|Lost to Follow-up|0|||
144205314|NCT03334617|519946923|FG002|Overall Study|Lost to Follow-up|0|||
144205315|NCT03334617|519946924|FG003|Overall Study|Lost to Follow-up|1|||
144205316|NCT03334617|519946925|FG004|Overall Study|Lost to Follow-up|0|||
144205317|NCT03334617|519946926|FG005|Overall Study|Lost to Follow-up|1|||
144205318|NCT03334617|519946927|FG006|Overall Study|Lost to Follow-up|0|||
144205319|NCT03334617|519946928|FG007|Overall Study|Lost to Follow-up|0|||
144205320|NCT03334617|519946929|FG008|Overall Study|Lost to Follow-up|1|||
144205321|NCT03334617|519946930|FG009|Overall Study|Lost to Follow-up|0|||
144205322|NCT03334617|519946931|FG010|Overall Study|Lost to Follow-up|0|||
144205323|NCT03334617|519946932|FG011|Overall Study|Lost to Follow-up|0|||
144205324|NCT03334617|519946933|FG012|Overall Study|Lost to Follow-up|0|||
144205325|NCT03334617|519946934|FG013|Overall Study|Lost to Follow-up|0|||
144205326|NCT03334617|519946935|FG014|Overall Study|Lost to Follow-up|0|||
144205327|NCT03334617|519946936|FG015|Overall Study|Lost to Follow-up|0|||
144205328|NCT03334617|519946937|FG016|Overall Study|Lost to Follow-up|0|||
144205329|NCT03334617|519946938|FG017|Overall Study|Lost to Follow-up|0|||
144205330|NCT03334617|519946939|FG018|Overall Study|Lost to Follow-up|0|||
144205331|NCT03334617|519946940|FG019|Overall Study|Lost to Follow-up|0|||
144205332|NCT03334617|519946941|FG020|Overall Study|Lost to Follow-up|0|||
144205333|NCT03334617|519946942|FG021|Overall Study|Lost to Follow-up|0|||
144205334|NCT03334617|519946921|FG000|Overall Study|Withdrawal by Subject|0|||
144205335|NCT03334617|519946922|FG001|Overall Study|Withdrawal by Subject|1|||
144205336|NCT03334617|519946923|FG002|Overall Study|Withdrawal by Subject|0|||
144205337|NCT03334617|519946924|FG003|Overall Study|Withdrawal by Subject|0|||
144205338|NCT03334617|519946925|FG004|Overall Study|Withdrawal by Subject|1|||
144205339|NCT03334617|519946926|FG005|Overall Study|Withdrawal by Subject|1|||
144205340|NCT03334617|519946927|FG006|Overall Study|Withdrawal by Subject|1|||
144205341|NCT03334617|519946928|FG007|Overall Study|Withdrawal by Subject|2|||
144205342|NCT03334617|519946929|FG008|Overall Study|Withdrawal by Subject|0|||
144205343|NCT03334617|519946930|FG009|Overall Study|Withdrawal by Subject|0|||
144205344|NCT03334617|519946931|FG010|Overall Study|Withdrawal by Subject|0|||
144205345|NCT03334617|519946932|FG011|Overall Study|Withdrawal by Subject|1|||
144205346|NCT03334617|519946933|FG012|Overall Study|Withdrawal by Subject|1|||
144205347|NCT03334617|519946934|FG013|Overall Study|Withdrawal by Subject|0|||
144205348|NCT03334617|519946935|FG014|Overall Study|Withdrawal by Subject|2|||
144205349|NCT03334617|519946936|FG015|Overall Study|Withdrawal by Subject|1|||
144205350|NCT03334617|519946937|FG016|Overall Study|Withdrawal by Subject|0|||
144205351|NCT03334617|519946938|FG017|Overall Study|Withdrawal by Subject|1|||
144567688|NCT03297398|521278579|FG001|Overall Study|Protocol Violation|2|||
144205352|NCT03334617|519946939|FG018|Overall Study|Withdrawal by Subject|1|||
144205353|NCT03334617|519946940|FG019|Overall Study|Withdrawal by Subject|1|||
144567689|NCT03297398|521278580|FG002|Overall Study|Protocol Violation|0|||
144205354|NCT03334617|519946941|FG020|Overall Study|Withdrawal by Subject|0|||
144205355|NCT03334617|519946942|FG021|Overall Study|Withdrawal by Subject|1|||
144205356|NCT03334617|519946921|FG000|Overall Study|Other|1|||
144205357|NCT03334617|519946922|FG001|Overall Study|Other|2|||
144205358|NCT03334617|519946923|FG002|Overall Study|Other|0|||
144205359|NCT03334617|519946924|FG003|Overall Study|Other|1|||
144205360|NCT03334617|519946925|FG004|Overall Study|Other|1|||
144205361|NCT03334617|519946926|FG005|Overall Study|Other|0|||
144205362|NCT03334617|519946927|FG006|Overall Study|Other|2|||
144205363|NCT03334617|519946928|FG007|Overall Study|Other|1|||
144205364|NCT03334617|519946929|FG008|Overall Study|Other|8|||
144567690|NCT03297398|521278578|FG000|Overall Study|Physician Decision|0|||
144205365|NCT03334617|519946930|FG009|Overall Study|Other|0|||
144205366|NCT03334617|519946931|FG010|Overall Study|Other|3|||
144205367|NCT03334617|519946932|FG011|Overall Study|Other|1|||
144205368|NCT03334617|519946933|FG012|Overall Study|Other|3|||
144205369|NCT03334617|519946934|FG013|Overall Study|Other|1|||
144205370|NCT03334617|519946935|FG014|Overall Study|Other|1|||
144205371|NCT03334617|519946936|FG015|Overall Study|Other|3|||
144205372|NCT03334617|519946937|FG016|Overall Study|Other|3|||
144205373|NCT03334617|519946938|FG017|Overall Study|Other|3|||
144205374|NCT03334617|519946939|FG018|Overall Study|Other|7|||
144205375|NCT03334617|519946940|FG019|Overall Study|Other|4|||
144205376|NCT03334617|519946941|FG020|Overall Study|Other|1|||
144205377|NCT03334617|519946942|FG021|Overall Study|Other|4|||
144205378|NCT03334617|519946921|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
144205379|NCT03334617|519946922|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
144205380|NCT03334617|519946923|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
144205381|NCT03334617|519946924|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
144205382|NCT03334617|519946925|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
144205383|NCT03334617|519946926|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
144205384|NCT03334617|519946927|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
144205385|NCT03334617|519946928|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
144205386|NCT03334617|519946929|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
144205387|NCT03334617|519946930|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
144205388|NCT03334617|519946931|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
144205389|NCT03334617|519946932|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
144205390|NCT03334617|519946933|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
144205391|NCT03334617|519946934|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
144205392|NCT03334617|519946935|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
144205393|NCT03334617|519946936|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
144205394|NCT03334617|519946937|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
144205395|NCT03334617|519946938|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
144205396|NCT03334617|519946939|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
144205397|NCT03334617|519946940|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
144205398|NCT03334617|519946941|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
144205399|NCT03334617|519946942|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
144205400|NCT02329847|519946943|FG000|Overall Study|Death|4|||
144205401|NCT02329847|519946944|FG001|Overall Study|Death|4|||
144205402|NCT02329847|519946945|FG002|Overall Study|Death|22|||
144205403|NCT02329847|519946946|FG003|Overall Study|Death|12|||
144205404|NCT02329847|519946947|FG004|Overall Study|Death|20|||
144205405|NCT02329847|519946948|FG005|Overall Study|Death|13|||
144205406|NCT02329847|519946943|FG000|Overall Study|Lost to Follow-up|0|||
144619095|NCT01425203|521463078|FG002|Treatment Phase|Other virologic failure criteria|0|||
144619096|NCT01425203|521463076|FG000|Treatment Phase|Unidentified reasons|11|||
144619097|NCT01425203|521463077|FG001|Treatment Phase|Unidentified reasons|5|||
144619098|NCT01425203|521463078|FG002|Treatment Phase|Unidentified reasons|0|||
144619099|NCT01425203|521463076|FG000|Treatment Phase|Did not receive treatment|0|||
144619100|NCT01425203|521463077|FG001|Treatment Phase|Did not receive treatment|1|||
144619101|NCT01425203|521463078|FG002|Treatment Phase|Did not receive treatment|0|||
144205407|NCT02329847|519946944|FG001|Overall Study|Lost to Follow-up|0|||
144205408|NCT02329847|519946945|FG002|Overall Study|Lost to Follow-up|2|||
144205409|NCT02329847|519946946|FG003|Overall Study|Lost to Follow-up|3|||
144205410|NCT02329847|519946947|FG004|Overall Study|Lost to Follow-up|0|||
144205411|NCT02329847|519946948|FG005|Overall Study|Lost to Follow-up|1|||
144205412|NCT02329847|519946943|FG000|Overall Study|Physician Decision|0|||
144205413|NCT02329847|519946944|FG001|Overall Study|Physician Decision|0|||
144205414|NCT02329847|519946945|FG002|Overall Study|Physician Decision|0|||
144205415|NCT02329847|519946946|FG003|Overall Study|Physician Decision|0|||
144205416|NCT02329847|519946947|FG004|Overall Study|Physician Decision|1|||
144619102|NCT01425203|521463076|FG000|Crossover Phase|Failure at futility timepoint|0|||
144619103|NCT01425203|521463077|FG001|Crossover Phase|Failure at futility timepoint|0|||
144205417|NCT02329847|519946948|FG005|Overall Study|Physician Decision|0|||
144205418|NCT02329847|519946943|FG000|Overall Study|Withdrawal by Subject|2|||
144205419|NCT02329847|519946944|FG001|Overall Study|Withdrawal by Subject|1|||
144205420|NCT02329847|519946945|FG002|Overall Study|Withdrawal by Subject|5|||
144205421|NCT02329847|519946946|FG003|Overall Study|Withdrawal by Subject|7|||
144205422|NCT02329847|519946947|FG004|Overall Study|Withdrawal by Subject|8|||
144205423|NCT02329847|519946948|FG005|Overall Study|Withdrawal by Subject|3|||
144205424|NCT02329847|519946943|FG000|Overall Study|Other|1|||
144205425|NCT02329847|519946944|FG001|Overall Study|Other|2|||
144205426|NCT02329847|519946945|FG002|Overall Study|Other|6|||
144205427|NCT02329847|519946946|FG003|Overall Study|Other|13|||
144205428|NCT02329847|519946947|FG004|Overall Study|Other|10|||
144619104|NCT01425203|521463078|FG002|Crossover Phase|Failure at futility timepoint|3|||
144567691|NCT03297398|521278579|FG001|Overall Study|Physician Decision|0|||
144567692|NCT03297398|521278580|FG002|Overall Study|Physician Decision|1|||
144567693|NCT03297398|521278578|FG000|Overall Study|Lost to Follow-up|0|||
144567694|NCT03297398|521278579|FG001|Overall Study|Lost to Follow-up|0|||
144567695|NCT03297398|521278580|FG002|Overall Study|Lost to Follow-up|1|||
144567696|NCT03481556|521278583|FG000|Overall Study|Adverse Event|1|||
144567697|NCT03481556|521278584|FG001|Overall Study|Adverse Event|0|||
144567698|NCT03481556|521278585|FG002|Overall Study|Adverse Event|0|||
144567699|NCT03481556|521278586|FG003|Overall Study|Adverse Event|0|||
144567700|NCT03481556|521278583|FG000|Overall Study|Death|4|||
144567701|NCT03481556|521278584|FG001|Overall Study|Death|2|||
144567702|NCT03481556|521278585|FG002|Overall Study|Death|3|||
144567703|NCT03481556|521278586|FG003|Overall Study|Death|16|||
144205429|NCT02329847|519946948|FG005|Overall Study|Other|3|||
144205430|NCT03657342|519946949|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
144205431|NCT03657342|519946950|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
144205432|NCT03657342|519946949|FG000|Overall Study|Withdrawal by Subject|4|||
144205433|NCT03657342|519946950|FG001|Overall Study|Withdrawal by Subject|4|||
144567704|NCT03481556|521278583|FG000|Overall Study|Study Terminated by Sponsor|10|||
144567705|NCT03481556|521278584|FG001|Overall Study|Study Terminated by Sponsor|5|||
144567706|NCT03481556|521278585|FG002|Overall Study|Study Terminated by Sponsor|2|||
144567707|NCT03481556|521278586|FG003|Overall Study|Study Terminated by Sponsor|9|||
144567708|NCT00992992|521278587|FG000|Overall Study|Lost to Follow-up|3|||
144567709|NCT00992992|521278587|FG000|Overall Study|Death|16|||
144567710|NCT00992992|521278587|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
144567711|NCT00992992|521278587|FG000|Overall Study|Sponsor Closed the Study|4|||
144567712|NCT00217022|521278589|FG000|Overall Study|Withdrawal by Subject|1|||
144567713|NCT00217022|521278590|FG001|Overall Study|Withdrawal by Subject|1|||
144567714|NCT02108652|521278591|FG000|Overall Study|Death|253|||
144567715|NCT02108652|521278591|FG000|Overall Study|Lost to Follow-up|2|||
144567716|NCT02108652|521278591|FG000|Overall Study|Withdrawal by Subject|16|||
144567717|NCT02108652|521278591|FG000|Overall Study|Study Terminated By Sponsor|31|||
144567718|NCT02108652|521278591|FG000|Overall Study|Non-Compliance|1|||
144567719|NCT02108652|521278591|FG000|Overall Study|Physician Decision|6|||
144567720|NCT02108652|521278591|FG000|Overall Study|Progression Of Disease|1|||
144567721|NCT01017263|521278592|FG000|Overall Study|not eligible|12|||
144567722|NCT01560871|521278593|FG000|Overall Study|transportation issues|2|||
144567723|NCT01560871|521278594|FG001|Overall Study|transportation issues|1|||
144567724|NCT01560871|521278593|FG000|Overall Study|relocation|1|||
144567725|NCT01560871|521278594|FG001|Overall Study|relocation|0|||
144567726|NCT01560871|521278593|FG000|Overall Study|readmission to a hospital|2|||
144567727|NCT01560871|521278594|FG001|Overall Study|readmission to a hospital|1|||
144567728|NCT01560871|521278593|FG000|Overall Study|Lost to Follow-up|1|||
144567729|NCT01560871|521278594|FG001|Overall Study|Lost to Follow-up|0|||
144567730|NCT05043883|521278595|FG000|Overall Study|Minimum required measurements could not be taken|4|||
144567731|NCT02980705|521278596|FG000|Overall Study|Adverse Event|0|||
144567732|NCT02980705|521278597|FG001|Overall Study|Adverse Event|1|||
144567733|NCT02980705|521278596|FG000|Overall Study|Withdrawal by Subject|6|||
144567734|NCT02980705|521278597|FG001|Overall Study|Withdrawal by Subject|9|||
144567735|NCT02980705|521278596|FG000|Overall Study|withdrew participation|0|||
144567736|NCT02980705|521278597|FG001|Overall Study|withdrew participation|1|||
144567737|NCT02980705|521278596|FG000|Overall Study|Lost to Follow-up|2|||
144567738|NCT02980705|521278597|FG001|Overall Study|Lost to Follow-up|0|||
144567739|NCT00263575|521278598|FG000|Titration Period|Adverse Event|14|||
144567740|NCT00263575|521278598|FG000|Titration Period|Withdrawal by Subject|10|||
144567741|NCT00263575|521278598|FG000|Titration Period|Protocol Violation|9|||
144567742|NCT00263575|521278598|FG000|Titration Period|Sponsor Decision|2|||
144567743|NCT00263575|521278598|FG000|Titration Period|Other|2|||
144567744|NCT00263575|521278598|FG000|Titration Period|Lack of Efficacy|6|||
144567745|NCT00263575|521278598|FG000|Maintence Period|Adverse Event|23|||
144567746|NCT00263575|521278598|FG000|Maintence Period|Withdrawal by Subject|8|||
144567747|NCT00263575|521278598|FG000|Maintence Period|Protocol Violation|4|||
144567748|NCT00263575|521278598|FG000|Maintence Period|Lack of Efficacy|4|||
144567749|NCT00263575|521278598|FG000|Maintence Period|Physician Decision|6|||
144567750|NCT00263575|521278598|FG000|Maintence Period|Lost to Follow-up|1|||
144567751|NCT00263575|521278598|FG000|Maintence Period|Sponsor Decision|24|||
144567752|NCT00263575|521278598|FG000|Maintence Period|Other|7|||
144567753|NCT00537329|521278599|FG000|Overall Study|Death|10|||
144567754|NCT00537329|521278599|FG000|Overall Study|Adverse Event|3|||
144567755|NCT00537329|521278599|FG000|Overall Study|Lack of Efficacy|2|||
144567756|NCT00537329|521278599|FG000|Overall Study|Lost to Follow-up|6|||
144567757|NCT00537329|521278599|FG000|Overall Study|Withdrawal by Subject|4|||
144567758|NCT00537329|521278599|FG000|Overall Study|Other|1|||
144567759|NCT01278615|521278600|FG000|Overall Study|Withdrawal by Subject|2|||
144567760|NCT00905359|521278601|FG000|Overall Study|Lost to Follow-up|17|||
144567761|NCT00905359|521278602|FG001|Overall Study|Lost to Follow-up|10|||
144567762|NCT00905359|521278601|FG000|Overall Study|Death|2|||
144567763|NCT00905359|521278602|FG001|Overall Study|Death|0|||
144567764|NCT00905359|521278601|FG000|Overall Study|Withdrawal consent|5|||
144205434|NCT03657342|519946949|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
144205435|NCT03657342|519946950|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
144205436|NCT03657342|519946949|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
144205437|NCT03657342|519946950|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
144205438|NCT00827632|519946951|FG000|Overall Study|Lost to Follow-up|8|||
144205439|NCT00827632|519946952|FG001|Overall Study|Lost to Follow-up|12|||
144205440|NCT00827632|519946951|FG000|Overall Study|Early withdrawal|14|||
144205441|NCT00827632|519946952|FG001|Overall Study|Early withdrawal|11|||
144205442|NCT05330468|519946953|FG000|Overall Study|Death|6|||
144205443|NCT05330468|519946953|FG000|Overall Study|Withdrawal by Subject|4|||
144205444|NCT05330468|519946953|FG000|Overall Study|Lost to Follow-up|4|||
144205445|NCT03923530|519946954|FG000|Overall Study|Withdrawal by Subject|1|||
144205446|NCT03923530|519946954|FG000|Overall Study|screen failure|3|||
144205447|NCT00407758|519946955|FG000|Overall Study|ineligible -improper prior treatment|1|||
144205448|NCT04669691|519946966|FG000|Overall Study|Death|0|||
144205449|NCT04669691|519946967|FG001|Overall Study|Death|1|||
144205450|NCT04669691|519946968|FG002|Overall Study|Death|0|||
144205451|NCT04669691|519946969|FG003|Overall Study|Death|0|||
144205452|NCT04669691|519946970|FG004|Overall Study|Death|0|||
144205453|NCT04669691|519946971|FG005|Overall Study|Death|0|||
144205454|NCT01822275|519946973|FG000|Overall Study|Withdrawal by Subject|3|||
144205455|NCT01822275|519946973|FG000|Overall Study|Adverse Event|3|||
144205456|NCT01822275|519946973|FG000|Overall Study|Progression|14|||
144205457|NCT01822275|519946973|FG000|Overall Study|Physician Decision|2|||
144205458|NCT02722148|519946975|FG000|Overall Study|Lost to Follow-up|2|||
144205459|NCT02722148|519946975|FG000|Overall Study|Non compliant with treatment regimen|3|||
144567765|NCT00905359|521278602|FG001|Overall Study|Withdrawal consent|6|||
144567766|NCT02138253|521278603|FG000|Overall Study|Adverse Event|3|||
144567767|NCT02138253|521278604|FG001|Overall Study|Adverse Event|3|||
144567768|NCT02138253|521278603|FG000|Overall Study|Lost to Follow-up|2|||
144619105|NCT01425203|521463076|FG000|Crossover Phase|Other virologic failure criteria|0|||
144619106|NCT01425203|521463077|FG001|Crossover Phase|Other virologic failure criteria|0|||
144619107|NCT01425203|521463078|FG002|Crossover Phase|Other virologic failure criteria|3|||
144619108|NCT01903837|521463084|FG000|Part A|Withdrawal by Subject|4|||
144619109|NCT01903837|521463085|FG001|Part A|Withdrawal by Subject|9|||
144619110|NCT01903837|521463086|FG002|Part A|Withdrawal by Subject|8|||
144619111|NCT01903837|521463087|FG003|Part A|Withdrawal by Subject|5|||
144619112|NCT01903837|521463084|FG000|Part A|Adverse Event|3|||
144728623|NCT00162123|521861291|FG000|Overall Study|Withdrawal by Subject|2|||
144567769|NCT02138253|521278604|FG001|Overall Study|Lost to Follow-up|1|||
144567770|NCT02138253|521278603|FG000|Overall Study|Physician Decision|2|||
144567771|NCT02138253|521278604|FG001|Overall Study|Physician Decision|0|||
144567772|NCT02138253|521278603|FG000|Overall Study|Non compliance|1|||
144567773|NCT02138253|521278604|FG001|Overall Study|Non compliance|0|||
144567774|NCT02138253|521278603|FG000|Overall Study|Withdrawal by Subject|1|||
144567775|NCT02138253|521278604|FG001|Overall Study|Withdrawal by Subject|0|||
144567776|NCT01006889|521278605|FG000|Overall Study|Withdrawal by Subject|3|||
144567777|NCT00243022|521278606|FG000|Overall Study|Withdrawal by Subject|1|||
144728624|NCT00162123|521861292|FG001|Overall Study|Withdrawal by Subject|0|||
144728625|NCT00162123|521861293|FG002|Overall Study|Withdrawal by Subject|2|||
144728626|NCT00162123|521861294|FG003|Overall Study|Withdrawal by Subject|1|||
144728627|NCT00162123|521861295|FG004|Overall Study|Withdrawal by Subject|1|||
144728628|NCT00162123|521861296|FG005|Overall Study|Withdrawal by Subject|2|||
144728629|NCT00162123|521861297|FG006|Overall Study|Withdrawal by Subject|1|||
144728630|NCT00162123|521861298|FG007|Overall Study|Withdrawal by Subject|0|||
144728631|NCT00162123|521861291|FG000|Overall Study|Deterioration without progression|2|||
144728632|NCT00162123|521861292|FG001|Overall Study|Deterioration without progression|2|||
144728633|NCT00162123|521861293|FG002|Overall Study|Deterioration without progression|3|||
144205460|NCT00911807|519946976|FG000|Overall Study|Adverse Event|2|||
144205461|NCT00911807|519946977|FG001|Overall Study|Adverse Event|1|||
144205462|NCT00911807|519946978|FG002|Overall Study|Adverse Event|5|||
144205463|NCT00911807|519946976|FG000|Overall Study|Death|0|||
144205464|NCT00911807|519946977|FG001|Overall Study|Death|0|||
144205465|NCT00911807|519946978|FG002|Overall Study|Death|1|||
144205466|NCT00911807|519946976|FG000|Overall Study|Protocol Violation|6|||
144205467|NCT00911807|519946977|FG001|Overall Study|Protocol Violation|4|||
144205468|NCT00911807|519946978|FG002|Overall Study|Protocol Violation|9|||
144205469|NCT00911807|519946976|FG000|Overall Study|Withdrawal by Subject|8|||
144567778|NCT00243022|521278607|FG001|Overall Study|Withdrawal by Subject|0|||
144567779|NCT00243022|521278606|FG000|Overall Study|Death|1|||
144567780|NCT00243022|521278607|FG001|Overall Study|Death|0|||
144567781|NCT00243022|521278606|FG000|Overall Study|Difficult Travel Distance|0|||
144567782|NCT00243022|521278607|FG001|Overall Study|Difficult Travel Distance|1|||
144619113|NCT01903837|521463085|FG001|Part A|Adverse Event|6|||
144728634|NCT00162123|521861294|FG003|Overall Study|Deterioration without progression|0|||
144205470|NCT00911807|519946977|FG001|Overall Study|Withdrawal by Subject|10|||
144728635|NCT00162123|521861295|FG004|Overall Study|Deterioration without progression|1|||
144619114|NCT01903837|521463086|FG002|Part A|Adverse Event|9|||
144567783|NCT01390441|521278612|FG000|Treatment Period|Protocol Violation|0|||
144567784|NCT01390441|521278613|FG001|Treatment Period|Protocol Violation|1|||
144567785|NCT01390441|521278614|FG002|Treatment Period|Protocol Violation|0|||
144567786|NCT01390441|521278615|FG003|Treatment Period|Protocol Violation|0|||
144567787|NCT01390441|521278616|FG004|Treatment Period|Protocol Violation|0|||
144567788|NCT01390441|521278612|FG000|Treatment Period|Physician Decision|0|||
144567789|NCT01390441|521278613|FG001|Treatment Period|Physician Decision|0|||
144567790|NCT01390441|521278614|FG002|Treatment Period|Physician Decision|0|||
144567791|NCT01390441|521278615|FG003|Treatment Period|Physician Decision|1|||
144567792|NCT01390441|521278616|FG004|Treatment Period|Physician Decision|0|||
144567793|NCT01390441|521278612|FG000|Treatment Period|Lack of Efficacy|0|||
144567794|NCT01390441|521278613|FG001|Treatment Period|Lack of Efficacy|0|||
144567795|NCT01390441|521278614|FG002|Treatment Period|Lack of Efficacy|0|||
144567796|NCT01390441|521278615|FG003|Treatment Period|Lack of Efficacy|0|||
144567797|NCT01390441|521278616|FG004|Treatment Period|Lack of Efficacy|1|||
144567798|NCT01390441|521278612|FG000|Treatment Period|Unknown due to early stopping of study|0|||
144567799|NCT01390441|521278613|FG001|Treatment Period|Unknown due to early stopping of study|0|||
144567800|NCT01390441|521278614|FG002|Treatment Period|Unknown due to early stopping of study|8|||
144567801|NCT01390441|521278615|FG003|Treatment Period|Unknown due to early stopping of study|11|||
144567802|NCT01390441|521278616|FG004|Treatment Period|Unknown due to early stopping of study|7|||
144567803|NCT01390441|521278612|FG000|Treatment Period|Adverse Event|0|||
144567804|NCT01390441|521278613|FG001|Treatment Period|Adverse Event|0|||
144567805|NCT01390441|521278614|FG002|Treatment Period|Adverse Event|1|||
144567806|NCT01390441|521278615|FG003|Treatment Period|Adverse Event|1|||
144567807|NCT01390441|521278616|FG004|Treatment Period|Adverse Event|2|||
144567808|NCT01390441|521278612|FG000|Treatment Period|Withdrawal by Subject|0|||
144567809|NCT01390441|521278613|FG001|Treatment Period|Withdrawal by Subject|0|||
144567810|NCT01390441|521278614|FG002|Treatment Period|Withdrawal by Subject|1|||
144567811|NCT01390441|521278615|FG003|Treatment Period|Withdrawal by Subject|0|||
144567812|NCT01390441|521278616|FG004|Treatment Period|Withdrawal by Subject|1|||
144567813|NCT01390441|521278612|FG000|Treatment Period|Lost to Follow-up|1|||
144567814|NCT01390441|521278613|FG001|Treatment Period|Lost to Follow-up|0|||
144567815|NCT01390441|521278614|FG002|Treatment Period|Lost to Follow-up|0|||
144567816|NCT01390441|521278615|FG003|Treatment Period|Lost to Follow-up|0|||
144567817|NCT01390441|521278616|FG004|Treatment Period|Lost to Follow-up|0|||
144567818|NCT01390441|521278612|FG000|Extension Period|Protocol Violation|3|||
144567819|NCT01390441|521278613|FG001|Extension Period|Protocol Violation|1|||
144567820|NCT01390441|521278614|FG002|Extension Period|Protocol Violation|0|||
144567821|NCT01390441|521278615|FG003|Extension Period|Protocol Violation|1|||
144567822|NCT01390441|521278616|FG004|Extension Period|Protocol Violation|0|||
144567823|NCT00823836|521278617|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
144567824|NCT00823836|521278618|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
144567825|NCT00823836|521278617|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
144619115|NCT01903837|521463087|FG003|Part A|Adverse Event|6|||
144619116|NCT01903837|521463084|FG000|Part A|Lost to Follow-up|9|||
144619117|NCT01903837|521463085|FG001|Part A|Lost to Follow-up|7|||
144619118|NCT01903837|521463086|FG002|Part A|Lost to Follow-up|7|||
144619119|NCT01903837|521463087|FG003|Part A|Lost to Follow-up|2|||
144619120|NCT01903837|521463084|FG000|Part A|Non-compliance with study drug|1|||
144619121|NCT01903837|521463085|FG001|Part A|Non-compliance with study drug|4|||
144619122|NCT01903837|521463086|FG002|Part A|Non-compliance with study drug|4|||
144619123|NCT01903837|521463087|FG003|Part A|Non-compliance with study drug|0|||
144619124|NCT01903837|521463084|FG000|Part A|Physician Decision|1|||
144619125|NCT01903837|521463085|FG001|Part A|Physician Decision|1|||
144619126|NCT01903837|521463086|FG002|Part A|Physician Decision|0|||
144205471|NCT00911807|519946978|FG002|Overall Study|Withdrawal by Subject|7|||
144205472|NCT00911807|519946976|FG000|Overall Study|Organizational reasons|1|||
144205473|NCT00911807|519946977|FG001|Overall Study|Organizational reasons|3|||
144567826|NCT00823836|521278618|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
144567827|NCT00823836|521278617|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
144567828|NCT00823836|521278618|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
144567829|NCT00823836|521278617|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
144567830|NCT00823836|521278618|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
144567831|NCT00823836|521278617|FG000|Long-term Phase|Adverse Event|3|||
144567832|NCT00823836|521278618|FG001|Long-term Phase|Adverse Event|2|||
144205474|NCT00911807|519946978|FG002|Overall Study|Organizational reasons|1|||
144567833|NCT00823836|521278617|FG000|Long-term Phase|Physician Decision|1|||
144567834|NCT00823836|521278618|FG001|Long-term Phase|Physician Decision|2|||
144567835|NCT00823836|521278617|FG000|Long-term Phase|Withdrawal by Subject|1|||
144567836|NCT00823836|521278618|FG001|Long-term Phase|Withdrawal by Subject|1|||
144567837|NCT01099579|521278619|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
144619127|NCT01903837|521463087|FG003|Part A|Physician Decision|0|||
144619128|NCT01903837|521463084|FG000|Part A|Protocol Violation|1|||
144619129|NCT01903837|521463085|FG001|Part A|Protocol Violation|1|||
144619130|NCT01903837|521463086|FG002|Part A|Protocol Violation|0|||
144619131|NCT01903837|521463087|FG003|Part A|Protocol Violation|0|||
144262677|NCT04001803|520161532|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
144567838|NCT01099579|521278620|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
144567839|NCT01099579|521278621|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
144567840|NCT01099579|521278619|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
144567841|NCT01099579|521278620|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
144567842|NCT01099579|521278621|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
144567843|NCT01099579|521278619|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
144567844|NCT01099579|521278620|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
144567845|NCT01099579|521278621|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
144567846|NCT01099579|521278619|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
144567847|NCT01099579|521278620|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
144567848|NCT01099579|521278621|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
144567849|NCT01099579|521278619|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
144567850|NCT01099579|521278620|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
144567851|NCT01099579|521278621|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
144567852|NCT01099579|521278619|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
144567853|NCT01099579|521278620|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
144567854|NCT01099579|521278621|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
144567855|NCT01099579|521278619|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
144567856|NCT01099579|521278620|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
144567857|NCT01099579|521278621|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
144567858|NCT01099579|521278619|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
144567859|NCT01099579|521278620|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
144567860|NCT01099579|521278621|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
144567861|NCT01099579|521278619|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
144567862|NCT01099579|521278620|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
144567863|NCT01099579|521278621|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
144567864|NCT01099579|521278619|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
144567865|NCT01099579|521278620|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
144567866|NCT01099579|521278621|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
144567867|NCT02725528|521278622|FG000|Overall Study|Lost to Follow-up|1|||
144567868|NCT02725528|521278623|FG001|Overall Study|Lost to Follow-up|4|||
144567869|NCT02725528|521278622|FG000|Overall Study|Withdrawal by Subject|0|||
144567870|NCT02725528|521278623|FG001|Overall Study|Withdrawal by Subject|1|||
144567871|NCT00904722|521278626|FG000|Overall Study|Physician Decision|1|||
144567872|NCT00727506|521278630|FG000|Overall Study|Adverse Event|0|||
144567873|NCT00727506|521278631|FG001|Overall Study|Adverse Event|0|||
144567874|NCT00727506|521278632|FG002|Overall Study|Adverse Event|4|||
144567875|NCT00727506|521278633|FG003|Overall Study|Adverse Event|4|||
144567876|NCT00727506|521278634|FG004|Overall Study|Adverse Event|1|||
144567877|NCT00727506|521278635|FG005|Overall Study|Adverse Event|8|||
144567878|NCT00727506|521278630|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
144567879|NCT00727506|521278631|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144567880|NCT00727506|521278632|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
144567881|NCT00727506|521278633|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144567882|NCT00727506|521278634|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144567883|NCT00727506|521278635|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144567884|NCT00727506|521278630|FG000|Overall Study|Progressive disease|4|||
144567885|NCT00727506|521278631|FG001|Overall Study|Progressive disease|7|||
144567886|NCT00727506|521278632|FG002|Overall Study|Progressive disease|9|||
144567887|NCT00727506|521278633|FG003|Overall Study|Progressive disease|28|||
144567888|NCT00727506|521278634|FG004|Overall Study|Progressive disease|38|||
144567889|NCT00727506|521278635|FG005|Overall Study|Progressive disease|28|||
144567890|NCT00727506|521278630|FG000|Overall Study|Refused to continue medication|0|||
144567891|NCT00727506|521278631|FG001|Overall Study|Refused to continue medication|1|||
144567892|NCT00727506|521278632|FG002|Overall Study|Refused to continue medication|2|||
144567893|NCT00727506|521278633|FG003|Overall Study|Refused to continue medication|3|||
144567894|NCT00727506|521278634|FG004|Overall Study|Refused to continue medication|1|||
144567895|NCT00727506|521278635|FG005|Overall Study|Refused to continue medication|2|||
144567896|NCT00727506|521278630|FG000|Overall Study|Other reason not described above|0|||
144567897|NCT00727506|521278631|FG001|Overall Study|Other reason not described above|0|||
144567898|NCT00727506|521278632|FG002|Overall Study|Other reason not described above|1|||
144262678|NCT01931397|520161533|FG000|Overall Study|Physician Decision|2|||
144567899|NCT00727506|521278633|FG003|Overall Study|Other reason not described above|4|||
144567900|NCT00727506|521278634|FG004|Overall Study|Other reason not described above|1|||
144567901|NCT00727506|521278635|FG005|Overall Study|Other reason not described above|1|||
144567902|NCT04887506|521278636|FG000|Overall Study|Death|1|||
144567903|NCT04887506|521278637|FG001|Overall Study|Death|1|||
144567904|NCT04887506|521278636|FG000|Overall Study|Withdrawal by Subject|0|||
144567905|NCT04887506|521278637|FG001|Overall Study|Withdrawal by Subject|3|||
144567906|NCT04887506|521278636|FG000|Overall Study|Adverse Event|4|||
144567907|NCT04887506|521278637|FG001|Overall Study|Adverse Event|3|||
144567908|NCT04887506|521278636|FG000|Overall Study|Other - Not Reported|1|||
144567909|NCT04887506|521278637|FG001|Overall Study|Other - Not Reported|1|||
144567910|NCT02636608|521278638|FG000|Overall Study|Failure to Return|4|||
144567911|NCT02636608|521278638|FG000|Overall Study|Insufficient Virological Response|1|||
144567912|NCT02636608|521278638|FG000|Overall Study|Death|3|||
144567913|NCT02636608|521278638|FG000|Overall Study|Other|2|||
144567914|NCT02636608|521278638|FG000|Overall Study|Did Not Receive Treatment|1|||
144567915|NCT04594733|521278662|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
144567916|NCT04594733|521278663|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
144567917|NCT04594733|521278662|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
144567918|NCT04594733|521278663|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
144567919|NCT04594733|521278662|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
144567920|NCT04594733|521278663|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
144567921|NCT01024036|521278666|FG000|Blinded Treatment|Adverse Event|1|||
144567922|NCT01024036|521278667|FG001|Blinded Treatment|Adverse Event|1|||
144567923|NCT01024036|521278666|FG000|Blinded Treatment|Lack of Efficacy|16|||
144567924|NCT01024036|521278667|FG001|Blinded Treatment|Lack of Efficacy|14|||
144567925|NCT01024036|521278666|FG000|Blinded Treatment|Physician Decision|1|||
144567926|NCT01024036|521278667|FG001|Blinded Treatment|Physician Decision|0|||
144567927|NCT01024036|521278666|FG000|Blinded Treatment|Death|0|||
144567928|NCT01024036|521278667|FG001|Blinded Treatment|Death|2|||
144567929|NCT01024036|521278666|FG000|Blinded Treatment|Withdrawal by Subject|4|||
144567930|NCT01024036|521278667|FG001|Blinded Treatment|Withdrawal by Subject|3|||
144567931|NCT01024036|521278666|FG000|Unblinded Treatment|Adverse Event|0|||
144567932|NCT01024036|521278667|FG001|Unblinded Treatment|Adverse Event|1|||
144567933|NCT01024036|521278666|FG000|Unblinded Treatment|Lack of Efficacy|0|||
144567934|NCT01024036|521278667|FG001|Unblinded Treatment|Lack of Efficacy|2|||
144567935|NCT01024036|521278666|FG000|Follow-Up Period|Lost to Follow-up|1|||
144567936|NCT01024036|521278667|FG001|Follow-Up Period|Lost to Follow-up|1|||
144567937|NCT01024036|521278666|FG000|Follow-Up Period|Withdrawal by Subject|0|||
144567938|NCT01024036|521278667|FG001|Follow-Up Period|Withdrawal by Subject|1|||
144567939|NCT01024036|521278666|FG000|Follow-Up Period|Adverse Event|4|||
144567940|NCT01024036|521278667|FG001|Follow-Up Period|Adverse Event|1|||
144567941|NCT04680637|521278673|FG000|Overall Study|Lost to Follow-up|0|||
144567942|NCT04680637|521278674|FG001|Overall Study|Lost to Follow-up|1|||
144567943|NCT04680637|521278675|FG002|Overall Study|Lost to Follow-up|0|||
144567944|NCT04680637|521278676|FG003|Overall Study|Lost to Follow-up|1|||
144619132|NCT01903837|521463084|FG000|Part B|Lost to Follow-up|0|||
144619133|NCT01903837|521463085|FG001|Part B|Lost to Follow-up|3|||
144619134|NCT01903837|521463086|FG002|Part B|Lost to Follow-up|3|||
144619135|NCT01903837|521463087|FG003|Part B|Lost to Follow-up|4|||
144619136|NCT01903837|521463084|FG000|Part B|Withdrawal by Subject|1|||
144619137|NCT01903837|521463085|FG001|Part B|Withdrawal by Subject|2|||
144619138|NCT01903837|521463086|FG002|Part B|Withdrawal by Subject|0|||
144619139|NCT01903837|521463087|FG003|Part B|Withdrawal by Subject|3|||
144619140|NCT01903837|521463084|FG000|Part B|Adverse Event|3|||
144619141|NCT01903837|521463085|FG001|Part B|Adverse Event|0|||
144619142|NCT01903837|521463086|FG002|Part B|Adverse Event|2|||
144728636|NCT00162123|521861296|FG005|Overall Study|Deterioration without progression|0|||
144205475|NCT01672970|519946980|FG000|Overall Study|Lack of Efficacy|12|||
144205476|NCT01672970|519946980|FG000|Overall Study|Adverse Event|18|||
144205477|NCT01672970|519946980|FG000|Overall Study|Withdrawal by Subject|2|||
144205478|NCT01672970|519946980|FG000|Overall Study|Lost to Follow-up|5|||
144205479|NCT01672970|519946980|FG000|Overall Study|Other|9|||
144205480|NCT01672970|519946980|FG000|Overall Study|Enrolled but not treated|1|||
144205481|NCT03918109|519946981|FG000|Overall Study|Withdrawal by Subject|0|||
144205482|NCT03918109|519946982|FG001|Overall Study|Withdrawal by Subject|0|||
144205483|NCT03918109|519946983|FG002|Overall Study|Withdrawal by Subject|2|||
144205484|NCT03918109|519946984|FG003|Overall Study|Withdrawal by Subject|1|||
144205485|NCT03918109|519946981|FG000|Overall Study|Lost to Follow-up|0|||
144205486|NCT03918109|519946982|FG001|Overall Study|Lost to Follow-up|0|||
144205487|NCT03918109|519946983|FG002|Overall Study|Lost to Follow-up|0|||
144205488|NCT03918109|519946984|FG003|Overall Study|Lost to Follow-up|1|||
144567945|NCT04680637|521278673|FG000|Overall Study|Death|1|||
144567946|NCT04680637|521278674|FG001|Overall Study|Death|0|||
144205489|NCT03276780|519946991|FG000|Overall Study|Withdrawal by Subject|5|||
144205490|NCT03276780|519946992|FG001|Overall Study|Withdrawal by Subject|3|||
144205491|NCT03276780|519946991|FG000|Overall Study|Lost to Follow-up|3|||
144205492|NCT03276780|519946992|FG001|Overall Study|Lost to Follow-up|5|||
144619143|NCT01903837|521463087|FG003|Part B|Adverse Event|0|||
144619144|NCT01903837|521463084|FG000|Part B|Non-compliance with study drug|2|||
144728637|NCT00162123|521861297|FG006|Overall Study|Deterioration without progression|0|||
144205493|NCT03276780|519946991|FG000|Overall Study|Moved out of state|1|||
144205494|NCT03276780|519946992|FG001|Overall Study|Moved out of state|1|||
144262679|NCT01931397|520161533|FG000|Overall Study|Withdrawal by Subject|8|||
144567947|NCT04680637|521278675|FG002|Overall Study|Death|0|||
144567948|NCT04680637|521278676|FG003|Overall Study|Death|0|||
144567949|NCT04680637|521278673|FG000|Overall Study|Withdrawal by Subject|7|||
144619145|NCT01903837|521463085|FG001|Part B|Non-compliance with study drug|0|||
144262680|NCT01931397|520161533|FG000|Overall Study|moved out of state|1|||
144567950|NCT04680637|521278674|FG001|Overall Study|Withdrawal by Subject|10|||
144567951|NCT04680637|521278675|FG002|Overall Study|Withdrawal by Subject|17|||
144567952|NCT04680637|521278676|FG003|Overall Study|Withdrawal by Subject|15|||
144567953|NCT04680637|521278673|FG000|Overall Study|Decision by Sponsor|21|||
144728638|NCT00162123|521861298|FG007|Overall Study|Deterioration without progression|0|||
144728639|NCT00162123|521861291|FG000|Overall Study|Adverse Event|1|||
144728640|NCT00162123|521861292|FG001|Overall Study|Adverse Event|2|||
144728641|NCT00162123|521861293|FG002|Overall Study|Adverse Event|0|||
144728642|NCT00162123|521861294|FG003|Overall Study|Adverse Event|2|||
144728643|NCT00162123|521861295|FG004|Overall Study|Adverse Event|1|||
144728644|NCT00162123|521861296|FG005|Overall Study|Adverse Event|0|||
144728645|NCT00162123|521861297|FG006|Overall Study|Adverse Event|0|||
144728646|NCT00162123|521861298|FG007|Overall Study|Adverse Event|0|||
144728647|NCT00162123|521861291|FG000|Overall Study|Not specified (before treatment)|2|||
144728648|NCT00162123|521861292|FG001|Overall Study|Not specified (before treatment)|0|||
144728649|NCT00162123|521861293|FG002|Overall Study|Not specified (before treatment)|0|||
144728650|NCT00162123|521861294|FG003|Overall Study|Not specified (before treatment)|0|||
144728651|NCT00162123|521861295|FG004|Overall Study|Not specified (before treatment)|12|||
144728652|NCT00162123|521861296|FG005|Overall Study|Not specified (before treatment)|1|||
144728653|NCT00162123|521861297|FG006|Overall Study|Not specified (before treatment)|0|||
144728654|NCT00162123|521861298|FG007|Overall Study|Not specified (before treatment)|0|||
144728655|NCT00162123|521861291|FG000|Overall Study|Not specified (after start of treatment)|0|||
144728656|NCT00162123|521861292|FG001|Overall Study|Not specified (after start of treatment)|0|||
144728657|NCT00162123|521861293|FG002|Overall Study|Not specified (after start of treatment)|0|||
144728658|NCT00162123|521861294|FG003|Overall Study|Not specified (after start of treatment)|0|||
144728659|NCT00162123|521861295|FG004|Overall Study|Not specified (after start of treatment)|3|||
144728660|NCT00162123|521861296|FG005|Overall Study|Not specified (after start of treatment)|0|||
144728661|NCT00162123|521861297|FG006|Overall Study|Not specified (after start of treatment)|0|||
144728662|NCT00162123|521861298|FG007|Overall Study|Not specified (after start of treatment)|0|||
144728663|NCT00162123|521861291|FG000|Overall Study|Physician Decision|1|||
144728664|NCT00162123|521861292|FG001|Overall Study|Physician Decision|2|||
144728665|NCT00162123|521861293|FG002|Overall Study|Physician Decision|0|||
144728666|NCT00162123|521861294|FG003|Overall Study|Physician Decision|0|||
144728667|NCT00162123|521861295|FG004|Overall Study|Physician Decision|0|||
144728668|NCT00162123|521861296|FG005|Overall Study|Physician Decision|1|||
144728669|NCT00162123|521861297|FG006|Overall Study|Physician Decision|1|||
144728670|NCT00162123|521861298|FG007|Overall Study|Physician Decision|0|||
144728671|NCT00162123|521861291|FG000|Overall Study|Tumor assessment only (not treated)|0|||
144728672|NCT00162123|521861292|FG001|Overall Study|Tumor assessment only (not treated)|0|||
144728673|NCT00162123|521861293|FG002|Overall Study|Tumor assessment only (not treated)|0|||
144728674|NCT00162123|521861294|FG003|Overall Study|Tumor assessment only (not treated)|0|||
144728675|NCT00162123|521861295|FG004|Overall Study|Tumor assessment only (not treated)|0|||
144728676|NCT00162123|521861296|FG005|Overall Study|Tumor assessment only (not treated)|0|||
144728677|NCT00162123|521861297|FG006|Overall Study|Tumor assessment only (not treated)|0|||
144728678|NCT00162123|521861298|FG007|Overall Study|Tumor assessment only (not treated)|1|||
144205495|NCT03276780|519946991|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
144205496|NCT03276780|519946992|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
144205497|NCT03276780|519946991|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
144205498|NCT03276780|519946992|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
144205499|NCT00186043|519946993|FG000|Overall Study|Lack of Efficacy|1|||
144205500|NCT00186043|519946994|FG001|Overall Study|Lack of Efficacy|3|||
144205501|NCT00186043|519946993|FG000|Overall Study|Lost to Follow-up|4|||
144205502|NCT00186043|519946994|FG001|Overall Study|Lost to Follow-up|6|||
144205503|NCT00186043|519946993|FG000|Overall Study|Withdrawal by Subject|1|||
144205504|NCT00186043|519946994|FG001|Overall Study|Withdrawal by Subject|0|||
144205505|NCT00186043|519946993|FG000|Overall Study|Adverse Event|7|||
144205506|NCT00186043|519946994|FG001|Overall Study|Adverse Event|3|||
144205507|NCT00186043|519946993|FG000|Overall Study|Protocol Violation|2|||
144205508|NCT00186043|519946994|FG001|Overall Study|Protocol Violation|1|||
144205509|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
144205510|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
144205511|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205512|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205513|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144728679|NCT00162123|521861291|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
144728680|NCT00162123|521861292|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
144728681|NCT00162123|521861293|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
144205514|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205515|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205516|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144567954|NCT04680637|521278674|FG001|Overall Study|Decision by Sponsor|15|||
144567955|NCT04680637|521278675|FG002|Overall Study|Decision by Sponsor|7|||
144205517|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205518|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205519|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205520|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205521|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205522|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
144205523|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
144205524|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
144205525|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205526|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205527|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205528|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205529|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205530|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205531|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144619146|NCT01903837|521463086|FG002|Part B|Non-compliance with study drug|0|||
144619147|NCT01903837|521463087|FG003|Part B|Non-compliance with study drug|1|||
144619148|NCT01903837|521463084|FG000|Part B|Incarceration|2|||
144619149|NCT01903837|521463085|FG001|Part B|Incarceration|0|||
144619150|NCT01903837|521463086|FG002|Part B|Incarceration|0|||
144619151|NCT01903837|521463087|FG003|Part B|Incarceration|1|||
144205532|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205533|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205534|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205535|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205536|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
144205537|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
144205538|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
144205539|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144619152|NCT01903837|521463084|FG000|Part B|Physician Decision|1|||
144619153|NCT01903837|521463085|FG001|Part B|Physician Decision|0|||
144619154|NCT01903837|521463086|FG002|Part B|Physician Decision|0|||
144619155|NCT01903837|521463087|FG003|Part B|Physician Decision|2|||
144619156|NCT01903837|521463084|FG000|Part B|Lack of Efficacy|0|||
144619157|NCT01903837|521463085|FG001|Part B|Lack of Efficacy|1|||
144619158|NCT01903837|521463086|FG002|Part B|Lack of Efficacy|0|||
144619159|NCT01903837|521463087|FG003|Part B|Lack of Efficacy|0|||
144619160|NCT02275338|521463088|FG000|Overall Study|Adverse Event|15|||
144619161|NCT02275338|521463088|FG000|Overall Study|Lack of Efficacy|3|||
144619162|NCT02275338|521463088|FG000|Overall Study|Withdrawal by Subject|4|||
144619163|NCT02275338|521463088|FG000|Overall Study|Disease progression (death)|1|||
144619164|NCT02275338|521463088|FG000|Overall Study|Ineligible to start Phase 2|4|||
144619165|NCT02275338|521463088|FG000|Overall Study|Reason not specified|5|||
144619166|NCT02275338|521463088|FG000|Overall Study|Does not meet entry criteria|1|||
144619167|NCT01857869|521463093|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
144619168|NCT01857869|521463094|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
144619169|NCT01857869|521463095|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
144619170|NCT01857869|521463096|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
144619171|NCT01857869|521463097|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
144619172|NCT01857869|521463098|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
144619173|NCT01857869|521463099|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
144619174|NCT01857869|521463100|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
144619175|NCT01857869|521463101|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
144619176|NCT01857869|521463102|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
144619177|NCT01857869|521463093|FG000|Primary/Challenge Phase|Pregnancy|1|||
144619178|NCT01857869|521463094|FG001|Primary/Challenge Phase|Pregnancy|0|||
144619179|NCT01857869|521463095|FG002|Primary/Challenge Phase|Pregnancy|0|||
144619180|NCT01857869|521463096|FG003|Primary/Challenge Phase|Pregnancy|0|||
144619181|NCT01857869|521463097|FG004|Primary/Challenge Phase|Pregnancy|0|||
144619182|NCT01857869|521463098|FG005|Primary/Challenge Phase|Pregnancy|0|||
144619183|NCT01857869|521463099|FG006|Primary/Challenge Phase|Pregnancy|0|||
144619184|NCT01857869|521463100|FG007|Primary/Challenge Phase|Pregnancy|0|||
144619185|NCT01857869|521463101|FG008|Primary/Challenge Phase|Pregnancy|0|||
144619186|NCT01857869|521463102|FG009|Primary/Challenge Phase|Pregnancy|0|||
144205540|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205541|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144619187|NCT01857869|521463093|FG000|Primary/Challenge Phase|Protocol Violation|1|||
144619188|NCT01857869|521463094|FG001|Primary/Challenge Phase|Protocol Violation|0|||
144619189|NCT01857869|521463095|FG002|Primary/Challenge Phase|Protocol Violation|0|||
144619190|NCT01857869|521463096|FG003|Primary/Challenge Phase|Protocol Violation|0|||
144619191|NCT01857869|521463097|FG004|Primary/Challenge Phase|Protocol Violation|0|||
144619192|NCT01857869|521463098|FG005|Primary/Challenge Phase|Protocol Violation|0|||
144619193|NCT01857869|521463099|FG006|Primary/Challenge Phase|Protocol Violation|0|||
144619194|NCT01857869|521463100|FG007|Primary/Challenge Phase|Protocol Violation|0|||
144619195|NCT01857869|521463101|FG008|Primary/Challenge Phase|Protocol Violation|0|||
144619196|NCT01857869|521463102|FG009|Primary/Challenge Phase|Protocol Violation|0|||
144619197|NCT01857869|521463093|FG000|Primary/Challenge Phase|Other|1|||
144619198|NCT01857869|521463094|FG001|Primary/Challenge Phase|Other|1|||
144619199|NCT01857869|521463095|FG002|Primary/Challenge Phase|Other|0|||
144619200|NCT01857869|521463096|FG003|Primary/Challenge Phase|Other|0|||
144619201|NCT01857869|521463097|FG004|Primary/Challenge Phase|Other|0|||
144619202|NCT01857869|521463098|FG005|Primary/Challenge Phase|Other|0|||
144619203|NCT01857869|521463099|FG006|Primary/Challenge Phase|Other|0|||
144619204|NCT01857869|521463100|FG007|Primary/Challenge Phase|Other|0|||
144619205|NCT01857869|521463101|FG008|Primary/Challenge Phase|Other|0|||
144619206|NCT01857869|521463102|FG009|Primary/Challenge Phase|Other|0|||
144619207|NCT01857869|521463093|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619208|NCT01857869|521463094|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619209|NCT01857869|521463095|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619210|NCT01857869|521463096|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
144619211|NCT01857869|521463097|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619212|NCT01857869|521463098|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619213|NCT01857869|521463099|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619214|NCT01857869|521463100|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619215|NCT01857869|521463101|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619216|NCT01857869|521463102|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
144619217|NCT01857869|521463093|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619218|NCT01857869|521463094|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619219|NCT01857869|521463095|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619220|NCT01857869|521463096|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
144619221|NCT01857869|521463097|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619222|NCT01857869|521463098|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619223|NCT01857869|521463099|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619224|NCT01857869|521463100|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619225|NCT01857869|521463101|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619226|NCT01857869|521463102|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
144619227|NCT04607733|521463109|FG000|Overall Study|Lost to Follow-up|1|||
144619228|NCT04607733|521463110|FG001|Overall Study|Lost to Follow-up|0|||
144619229|NCT04607733|521463111|FG002|Overall Study|Lost to Follow-up|0|||
144205542|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205543|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205544|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205545|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205546|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205547|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205548|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205549|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205550|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
144205551|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
144205552|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
144205553|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205554|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205555|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205556|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205557|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205558|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205559|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205560|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205561|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205562|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205563|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144205564|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
144619230|NCT04607733|521463112|FG003|Overall Study|Lost to Follow-up|1|||
144619231|NCT04607733|521463113|FG004|Overall Study|Lost to Follow-up|1|||
144619232|NCT04607733|521463114|FG005|Overall Study|Lost to Follow-up|0|||
144619233|NCT04607733|521463109|FG000|Overall Study|Withdrawal by Subject|0|||
144619234|NCT04607733|521463110|FG001|Overall Study|Withdrawal by Subject|0|||
144619235|NCT04607733|521463111|FG002|Overall Study|Withdrawal by Subject|0|||
144619236|NCT04607733|521463112|FG003|Overall Study|Withdrawal by Subject|0|||
144619237|NCT04607733|521463113|FG004|Overall Study|Withdrawal by Subject|1|||
144619238|NCT04607733|521463114|FG005|Overall Study|Withdrawal by Subject|0|||
144205565|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
144205566|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
144567956|NCT04680637|521278676|FG003|Overall Study|Decision by Sponsor|32|||
144567957|NCT00691678|521278677|FG000|Overall Study|Adverse Event|5|||
144567958|NCT00691678|521278677|FG000|Overall Study|life events, pain|11|||
144567959|NCT00903760|521280252|FG000|Overall Study|Disease Progression/Death|8|||
144567960|NCT00903760|521280253|FG001|Overall Study|Disease Progression/Death|6|||
144567961|NCT00903760|521280252|FG000|Overall Study|Stem Cell Transplant|8|||
144567962|NCT00903760|521280253|FG001|Overall Study|Stem Cell Transplant|4|||
144567963|NCT00903760|521280252|FG000|Overall Study|Physician Decision|1|||
144567964|NCT00903760|521280253|FG001|Overall Study|Physician Decision|2|||
144567965|NCT00903760|521280252|FG000|Overall Study|Death|0|||
144619239|NCT01665807|521463115|FG000|Overall Study|Withdrawal by Subject|2|||
144619240|NCT01665807|521463116|FG001|Overall Study|Withdrawal by Subject|0|||
144619241|NCT01665807|521463117|FG002|Overall Study|Withdrawal by Subject|1|||
144619242|NCT03603496|521463119|FG000|Overall Study|Death|19|||
144619243|NCT03603496|521463120|FG001|Overall Study|Death|24|||
144619244|NCT03603496|521463119|FG000|Overall Study|Lost to Follow-up|141|||
144619245|NCT03603496|521463120|FG001|Overall Study|Lost to Follow-up|141|||
144619246|NCT03603496|521463119|FG000|Overall Study|Withdrawal by Subject|26|||
144619247|NCT03603496|521463120|FG001|Overall Study|Withdrawal by Subject|20|||
144728682|NCT00162123|521861294|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
144205567|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205568|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205569|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205570|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205571|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205572|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205573|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205574|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205575|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205576|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205577|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205578|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
144205579|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
144205580|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
144205581|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205582|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205583|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205584|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205585|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205586|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205587|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205588|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205589|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205590|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205591|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205592|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
144205593|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
144205594|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
144205595|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205596|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205597|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205598|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205599|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205600|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205601|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205602|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205603|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205604|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205605|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205606|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
144205607|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
144205608|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
144205609|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205610|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205611|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205612|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144567966|NCT00903760|521280253|FG001|Overall Study|Death|1|||
144567967|NCT00903760|521280252|FG000|Overall Study|Lost to Follow-up|1|||
144567968|NCT00903760|521280253|FG001|Overall Study|Lost to Follow-up|0|||
144619248|NCT03594227|521463121|FG000|Overall Study|Adverse Event|2|||
144567969|NCT00903760|521280252|FG000|Overall Study|Withdrawal by Subject|1|||
144567970|NCT00903760|521280253|FG001|Overall Study|Withdrawal by Subject|2|||
144567971|NCT00903760|521280252|FG000|Overall Study|Off treatment for long period|0|||
144567972|NCT00903760|521280253|FG001|Overall Study|Off treatment for long period|1|||
144567973|NCT01256671|521280258|FG000|Overall Study|Adverse Event|29|||
144567974|NCT01256671|521280258|FG000|Overall Study|Lost to Follow-up|16|||
144567975|NCT01256671|521280258|FG000|Overall Study|Withdrawal by Subject|31|||
144567976|NCT01256671|521280258|FG000|Overall Study|Physician Decision|3|||
144567977|NCT01256671|521280258|FG000|Overall Study|Lack of Efficacy|4|||
144567978|NCT01256671|521280258|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
144567979|NCT04411186|521280259|FG000|Overall Study|Withdrawn due to protocol violation|0|||
144567980|NCT04411186|521280260|FG001|Overall Study|Withdrawn due to protocol violation|1|||
144567981|NCT04367480|521280263|FG000|Overall Study|Adverse Event|1|||
144567982|NCT04367480|521280264|FG001|Overall Study|Adverse Event|1|||
144567983|NCT04367480|521280263|FG000|Overall Study|Death|1|||
144567984|NCT04367480|521280264|FG001|Overall Study|Death|0|||
144567985|NCT04367480|521280263|FG000|Overall Study|Lost to Follow-up|1|||
144567986|NCT04367480|521280264|FG001|Overall Study|Lost to Follow-up|1|||
144567987|NCT04367480|521280263|FG000|Overall Study|Withdrawal by Subject|0|||
144567988|NCT04367480|521280264|FG001|Overall Study|Withdrawal by Subject|3|||
144567989|NCT04367480|521280263|FG000|Overall Study|App glitch during the study|1|||
144567990|NCT04367480|521280264|FG001|Overall Study|App glitch during the study|0|||
144567991|NCT04367480|521280263|FG000|Overall Study|Device Distribution Error|0|||
144567992|NCT04367480|521280264|FG001|Overall Study|Device Distribution Error|2|||
144567993|NCT04367480|521280263|FG000|Overall Study|Ineligible after Randomization|0|||
144567994|NCT04367480|521280264|FG001|Overall Study|Ineligible after Randomization|1|||
144567995|NCT04367480|521280263|FG000|Overall Study|Other Medical Reasons|0|||
144567996|NCT04367480|521280264|FG001|Overall Study|Other Medical Reasons|2|||
144567997|NCT05382039|521280266|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
144567998|NCT05382039|521280267|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
144567999|NCT05382039|521280268|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
144568000|NCT05382039|521280266|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
144568001|NCT05382039|521280267|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
144568002|NCT05382039|521280268|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
144568003|NCT05382039|521280266|FG000|Overall Study|waiting for confirmation|0|||
144568004|NCT05382039|521280267|FG001|Overall Study|waiting for confirmation|0|||
144568005|NCT05382039|521280268|FG002|Overall Study|waiting for confirmation|1|||
144568006|NCT01432626|521280269|FG000|Overall Study|LV function recovered|2|||
144568007|NCT01432626|521280269|FG000|Overall Study|Withdrawal by Subject|2|||
144568008|NCT01432626|521280269|FG000|Overall Study|Only 1 image competed|2|||
144568009|NCT01432626|521280269|FG000|Overall Study|Imaging agent not available|1|||
144568010|NCT04504630|521280275|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
144568011|NCT04504630|521280276|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
144568012|NCT04504630|521280275|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
144568013|NCT04504630|521280276|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
144568014|NCT01660256|521280278|FG000|Overall Study|Adverse Event|4|||
144568015|NCT01660256|521280279|FG001|Overall Study|Adverse Event|0|||
144568016|NCT01660256|521280280|FG002|Overall Study|Adverse Event|2|||
144568017|NCT01660256|521280278|FG000|Overall Study|Withdrawal by Subject|1|||
144568018|NCT01660256|521280279|FG001|Overall Study|Withdrawal by Subject|0|||
144568019|NCT01660256|521280280|FG002|Overall Study|Withdrawal by Subject|2|||
144568020|NCT01777334|521280284|FG000|Overall Study|Adverse Event|18|||
144568021|NCT01777334|521280285|FG001|Overall Study|Adverse Event|14|||
144568022|NCT01777334|521280284|FG000|Overall Study|Lack of Efficacy|15|||
144568023|NCT01777334|521280285|FG001|Overall Study|Lack of Efficacy|29|||
144568024|NCT01777334|521280284|FG000|Overall Study|Protocol Violation|3|||
144728683|NCT00162123|521861295|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
144568025|NCT01777334|521280285|FG001|Overall Study|Protocol Violation|7|||
144568026|NCT01777334|521280284|FG000|Overall Study|Lost to Follow-up|3|||
144568027|NCT01777334|521280285|FG001|Overall Study|Lost to Follow-up|2|||
144568028|NCT01777334|521280284|FG000|Overall Study|Withdrawal by Subject|14|||
144568029|NCT01777334|521280285|FG001|Overall Study|Withdrawal by Subject|11|||
144568030|NCT01316887|521280293|FG000|Overall Study|Adverse Event|13|||
144568031|NCT01316887|521280294|FG001|Overall Study|Adverse Event|21|||
144568032|NCT01316887|521280295|FG002|Overall Study|Adverse Event|17|||
144728684|NCT00162123|521861296|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
144728685|NCT00162123|521861297|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
144568033|NCT01316887|521280293|FG000|Overall Study|Lack of Efficacy|9|||
144568034|NCT01316887|521280294|FG001|Overall Study|Lack of Efficacy|3|||
144568035|NCT01316887|521280295|FG002|Overall Study|Lack of Efficacy|1|||
144568036|NCT01316887|521280293|FG000|Overall Study|Protocol Violation|2|||
144568037|NCT01316887|521280294|FG001|Overall Study|Protocol Violation|6|||
144728686|NCT00162123|521861298|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
144568038|NCT01316887|521280295|FG002|Overall Study|Protocol Violation|6|||
144568039|NCT01316887|521280293|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
144568040|NCT01316887|521280294|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
144568041|NCT01316887|521280295|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
144568042|NCT01316887|521280293|FG000|Overall Study|Study Closed/Terminated|2|||
144568043|NCT01316887|521280294|FG001|Overall Study|Study Closed/Terminated|4|||
144568044|NCT01316887|521280295|FG002|Overall Study|Study Closed/Terminated|3|||
144205613|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205614|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205615|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205616|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205617|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205618|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205619|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205620|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
144205621|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
144205622|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
144205623|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205624|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205625|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205626|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205627|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205628|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205629|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205630|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205631|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205632|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205633|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205634|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
144205635|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
144205636|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
144205637|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205638|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205639|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205640|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205641|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205642|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205643|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205644|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205645|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205646|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205647|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205648|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
144205649|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
144205650|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
144205651|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205652|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205653|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205654|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205655|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205656|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205657|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205658|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205659|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205660|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205661|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205662|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
144205663|NCT03982199|519946995|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
144205664|NCT03982199|519946996|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
144205665|NCT03982199|519946997|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205666|NCT03982199|519946998|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205667|NCT03982199|519946999|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205668|NCT03982199|519947000|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144262681|NCT01367249|520161537|FG000|Overall Study|Withdrawal by Subject|6|||
144568045|NCT01316887|521280293|FG000|Overall Study|Lost to Follow-up|1|||
144568046|NCT01316887|521280294|FG001|Overall Study|Lost to Follow-up|7|||
144568047|NCT01316887|521280295|FG002|Overall Study|Lost to Follow-up|5|||
144568048|NCT01316887|521280293|FG000|Overall Study|Withdrawal by Subject|8|||
144568049|NCT01316887|521280294|FG001|Overall Study|Withdrawal by Subject|16|||
144568050|NCT01316887|521280295|FG002|Overall Study|Withdrawal by Subject|15|||
144568051|NCT02172950|521280296|FG000|Overall Study|Physician Decision|3|||
144568052|NCT02172950|521280297|FG001|Overall Study|Physician Decision|3|||
144568053|NCT02172950|521280296|FG000|Overall Study|Lack of Efficacy|1|||
144568054|NCT02172950|521280297|FG001|Overall Study|Lack of Efficacy|0|||
144568055|NCT02172950|521280296|FG000|Overall Study|Adverse Event|4|||
144568056|NCT02172950|521280297|FG001|Overall Study|Adverse Event|1|||
144568057|NCT02172950|521280296|FG000|Overall Study|Withdrawal by Subject|10|||
144568058|NCT02172950|521280297|FG001|Overall Study|Withdrawal by Subject|0|||
144568059|NCT02172950|521280296|FG000|Overall Study|Protocol Violation|1|||
144568060|NCT02172950|521280297|FG001|Overall Study|Protocol Violation|0|||
144568061|NCT02172950|521280296|FG000|Overall Study|Lost to Follow-up|1|||
144568062|NCT02172950|521280297|FG001|Overall Study|Lost to Follow-up|0|||
144568063|NCT02172950|521280296|FG000|Overall Study|Death|1|||
144568064|NCT02172950|521280297|FG001|Overall Study|Death|0|||
144568065|NCT02172950|521280296|FG000|Overall Study|Patient traveling|1|||
144568066|NCT02172950|521280297|FG001|Overall Study|Patient traveling|0|||
144568067|NCT02172950|521280296|FG000|Overall Study|Patient went to other country|1|||
144568068|NCT02172950|521280297|FG001|Overall Study|Patient went to other country|0|||
144205669|NCT03982199|519947001|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144568069|NCT02172950|521280296|FG000|Overall Study|Patient relocated overseas|1|||
144568070|NCT02172950|521280297|FG001|Overall Study|Patient relocated overseas|1|||
144568071|NCT02172950|521280296|FG000|Overall Study|Patient moving|1|||
144568072|NCT02172950|521280297|FG001|Overall Study|Patient moving|0|||
144568073|NCT00585975|521280301|FG000|Overall Study|Withdrawal by Subject|3|||
144568074|NCT00585975|521280302|FG001|Overall Study|Withdrawal by Subject|3|||
144568075|NCT00585975|521280301|FG000|Overall Study|Lost to Follow-up|2|||
144568076|NCT00585975|521280302|FG001|Overall Study|Lost to Follow-up|1|||
144205670|NCT03982199|519947002|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144568077|NCT00585975|521280301|FG000|Overall Study|Enrollment met/over-enrolled|10|||
144568078|NCT00585975|521280302|FG001|Overall Study|Enrollment met/over-enrolled|9|||
144568079|NCT03414047|521280303|FG000|Overall Study|Adverse Event|0|||
144568080|NCT03414047|521280304|FG001|Overall Study|Adverse Event|0|||
144568081|NCT03414047|521280305|FG002|Overall Study|Adverse Event|1|||
144568082|NCT03414047|521280306|FG003|Overall Study|Adverse Event|1|||
144568083|NCT03414047|521280303|FG000|Overall Study|Physician Decision|1|||
144205671|NCT03982199|519947003|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205672|NCT03982199|519947004|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205673|NCT03982199|519947005|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205674|NCT03982199|519947006|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205675|NCT03982199|519947007|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205676|NCT03982199|519947008|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
144205677|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205678|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205679|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205680|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
144205681|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205682|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205683|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205684|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205685|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205686|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205687|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205688|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205689|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205690|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
144205691|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144568084|NCT03414047|521280304|FG001|Overall Study|Physician Decision|0|||
144568085|NCT03414047|521280305|FG002|Overall Study|Physician Decision|0|||
144205692|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144568086|NCT03414047|521280306|FG003|Overall Study|Physician Decision|1|||
144568087|NCT03414047|521280303|FG000|Overall Study|Withdrawal by Subject|1|||
144568088|NCT03414047|521280304|FG001|Overall Study|Withdrawal by Subject|0|||
144568089|NCT03414047|521280305|FG002|Overall Study|Withdrawal by Subject|2|||
144568090|NCT03414047|521280306|FG003|Overall Study|Withdrawal by Subject|0|||
144568091|NCT00511797|521280315|FG000|Overall Study|Adverse Event|1|||
144568092|NCT00511797|521280316|FG001|Overall Study|Adverse Event|2|||
144568093|NCT00511797|521280317|FG002|Overall Study|Adverse Event|2|||
144568094|NCT00511797|521280318|FG003|Overall Study|Adverse Event|2|||
144568095|NCT00511797|521280315|FG000|Overall Study|Lost to Follow-up|1|||
144568096|NCT00511797|521280316|FG001|Overall Study|Lost to Follow-up|0|||
144568097|NCT00511797|521280317|FG002|Overall Study|Lost to Follow-up|0|||
144568098|NCT00511797|521280318|FG003|Overall Study|Lost to Follow-up|1|||
144568099|NCT00511797|521280315|FG000|Overall Study|Pregnancy|0|||
144568100|NCT00511797|521280316|FG001|Overall Study|Pregnancy|0|||
144568101|NCT00511797|521280317|FG002|Overall Study|Pregnancy|0|||
144568102|NCT00511797|521280318|FG003|Overall Study|Pregnancy|1|||
144568103|NCT00511797|521280315|FG000|Overall Study|Protocol Violation|0|||
144568104|NCT00511797|521280316|FG001|Overall Study|Protocol Violation|2|||
144568105|NCT00511797|521280317|FG002|Overall Study|Protocol Violation|2|||
144568106|NCT00511797|521280318|FG003|Overall Study|Protocol Violation|3|||
144568107|NCT00511797|521280315|FG000|Overall Study|Withdrawal by Subject|3|||
144568108|NCT00511797|521280316|FG001|Overall Study|Withdrawal by Subject|3|||
144568109|NCT00511797|521280317|FG002|Overall Study|Withdrawal by Subject|4|||
144568110|NCT00511797|521280318|FG003|Overall Study|Withdrawal by Subject|2|||
144568111|NCT00511797|521280315|FG000|Overall Study|Never dispensed|1|||
144568112|NCT00511797|521280316|FG001|Overall Study|Never dispensed|0|||
144568113|NCT00511797|521280317|FG002|Overall Study|Never dispensed|1|||
144568114|NCT00511797|521280318|FG003|Overall Study|Never dispensed|3|||
144568115|NCT00511797|521280315|FG000|Overall Study|Study drug not taken|0|||
144568116|NCT00511797|521280316|FG001|Overall Study|Study drug not taken|1|||
144568117|NCT00511797|521280317|FG002|Overall Study|Study drug not taken|0|||
144568118|NCT00511797|521280318|FG003|Overall Study|Study drug not taken|1|||
144568119|NCT00511797|521280315|FG000|Overall Study|Partially missing diary|0|||
144568120|NCT00511797|521280316|FG001|Overall Study|Partially missing diary|0|||
144205693|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
144205694|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205695|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205696|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205697|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205698|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205699|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205700|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205701|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205702|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205703|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205704|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
144205705|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205706|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205707|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
144205708|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205709|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205710|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205711|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205712|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205713|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205714|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205715|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205716|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205717|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205718|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
144205719|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205720|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205721|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
144205722|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
144205723|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205724|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144568121|NCT00511797|521280317|FG002|Overall Study|Partially missing diary|1|||
144568122|NCT00511797|521280318|FG003|Overall Study|Partially missing diary|0|||
144568123|NCT00511797|521280315|FG000|Overall Study|Other (moving etc)|1|||
144568124|NCT00511797|521280316|FG001|Overall Study|Other (moving etc)|0|||
144568125|NCT00511797|521280317|FG002|Overall Study|Other (moving etc)|1|||
144568126|NCT00511797|521280318|FG003|Overall Study|Other (moving etc)|2|||
144568127|NCT02564718|521280319|FG000|Overall Study|Withdrew from treatment|0|||
144568128|NCT02564718|521280320|FG001|Overall Study|Withdrew from treatment|1|||
144568129|NCT03845075|521280321|FG000|Part 1 - DB|Withdrawal by Subject|1|||
144568130|NCT03845075|521280322|FG001|Part 1 - DB|Withdrawal by Subject|1|||
144568131|NCT03845075|521280323|FG002|Part 1 - DB|Withdrawal by Subject|0|||
144568132|NCT03845075|521280324|FG003|Part 1 - DB|Withdrawal by Subject|0|||
144568133|NCT03845075|521280321|FG000|Part 1 - DB|Adverse Event|0|||
144728687|NCT02016170|521861299|FG000|Overall Study|Adverse Event|1|||
144728688|NCT02016170|521861300|FG001|Overall Study|Adverse Event|1|||
144205725|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205726|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205727|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205728|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205729|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205730|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205731|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205732|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
144205733|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205734|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205735|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205736|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
144205737|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205738|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205739|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205740|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205741|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205742|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205743|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205744|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205745|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205746|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
144205747|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205748|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205749|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
144205750|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
144205751|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205752|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205753|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205754|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205755|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205756|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205757|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205758|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205759|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205760|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
144205761|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205762|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205763|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205764|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205765|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205766|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205767|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205768|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205769|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
144205770|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205771|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205772|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205773|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205774|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
144205775|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205776|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205777|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205778|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205779|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205780|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205781|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205782|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205783|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
144205784|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205785|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205786|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205787|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144619249|NCT03594227|521463122|FG001|Overall Study|Adverse Event|1|||
144619250|NCT03594227|521463123|FG002|Overall Study|Adverse Event|0|||
144619251|NCT03594227|521463124|FG003|Overall Study|Adverse Event|2|||
144619252|NCT03594227|521463121|FG000|Overall Study|Lost to Follow-up|1|||
144619253|NCT03594227|521463122|FG001|Overall Study|Lost to Follow-up|1|||
144619254|NCT03594227|521463123|FG002|Overall Study|Lost to Follow-up|1|||
144619255|NCT03594227|521463124|FG003|Overall Study|Lost to Follow-up|0|||
144619256|NCT03594227|521463121|FG000|Overall Study|Withdrawal by Subject|1|||
144619257|NCT03594227|521463122|FG001|Overall Study|Withdrawal by Subject|1|||
144619258|NCT03594227|521463123|FG002|Overall Study|Withdrawal by Subject|1|||
144619259|NCT03594227|521463124|FG003|Overall Study|Withdrawal by Subject|1|||
144619260|NCT03594227|521463121|FG000|Overall Study|Pregnancy|0|||
144619261|NCT03594227|521463122|FG001|Overall Study|Pregnancy|1|||
144619262|NCT03594227|521463123|FG002|Overall Study|Pregnancy|0|||
144619263|NCT03594227|521463124|FG003|Overall Study|Pregnancy|0|||
144619264|NCT03594227|521463121|FG000|Overall Study|Sponsor Decision|0|||
144619265|NCT03594227|521463122|FG001|Overall Study|Sponsor Decision|0|||
144619266|NCT03594227|521463123|FG002|Overall Study|Sponsor Decision|0|||
144619267|NCT03594227|521463124|FG003|Overall Study|Sponsor Decision|1|||
144619268|NCT03594227|521463121|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
144619269|NCT03594227|521463122|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
144619270|NCT03594227|521463123|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
144619271|NCT03594227|521463124|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
144619272|NCT00790907|521463125|FG000|Overall Study|Adverse Event|9|||
144619273|NCT00790907|521463126|FG001|Overall Study|Adverse Event|7|||
144619274|NCT00790907|521463127|FG002|Overall Study|Adverse Event|6|||
144619275|NCT00790907|521463125|FG000|Overall Study|Physician Decision|304|||
144619276|NCT00790907|521463126|FG001|Overall Study|Physician Decision|271|||
144619277|NCT00790907|521463127|FG002|Overall Study|Physician Decision|255|||
144619278|NCT00790907|521463125|FG000|Overall Study|Withdrawal by Subject|1|||
144619279|NCT00790907|521463126|FG001|Overall Study|Withdrawal by Subject|7|||
144619280|NCT00790907|521463127|FG002|Overall Study|Withdrawal by Subject|5|||
144619281|NCT00790907|521463125|FG000|Overall Study|Bleeding Event|11|||
144619282|NCT00790907|521463126|FG001|Overall Study|Bleeding Event|16|||
144619283|NCT00790907|521463127|FG002|Overall Study|Bleeding Event|21|||
144619284|NCT00790907|521463125|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
144619285|NCT00790907|521463126|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
144619286|NCT00790907|521463127|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
144619287|NCT00790907|521463125|FG000|Overall Study|Qualifying Condition Not Present|29|||
144619288|NCT00790907|521463126|FG001|Overall Study|Qualifying Condition Not Present|14|||
144619289|NCT00790907|521463127|FG002|Overall Study|Qualifying Condition Not Present|16|||
144619290|NCT00790907|521463125|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
144619291|NCT00790907|521463126|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
144619292|NCT00790907|521463127|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
144619293|NCT00790907|521463125|FG000|Overall Study|Did Not Receive Study Drug|10|||
144619294|NCT00790907|521463126|FG001|Overall Study|Did Not Receive Study Drug|0|||
144619295|NCT00790907|521463127|FG002|Overall Study|Did Not Receive Study Drug|0|||
144619296|NCT00075504|521463128|FG000|Overall Study|Withdrawal by Subject|9|||
144619297|NCT00075504|521463129|FG001|Overall Study|Withdrawal by Subject|7|||
144619298|NCT02228590|521463130|FG000|Overall Study|Withdrawal by Subject|1|||
144619299|NCT01097863|521463131|FG000|Overall Study|Discomfort|1|||
144619300|NCT01097863|521463132|FG001|Overall Study|Discomfort|0|||
144619301|NCT01097863|521463133|FG002|Overall Study|Discomfort|1|||
144619302|NCT01097863|521463131|FG000|Overall Study|Did not return for final visit|0|||
144619303|NCT01097863|521463132|FG001|Overall Study|Did not return for final visit|0|||
144619304|NCT01097863|521463133|FG002|Overall Study|Did not return for final visit|1|||
144619305|NCT01400451|521463140|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
144619306|NCT01400451|521463141|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
144619307|NCT01400451|521463142|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
144619308|NCT01400451|521463140|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
144619309|NCT01400451|521463141|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
144619310|NCT01400451|521463142|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
144619311|NCT01400451|521463140|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
144262682|NCT01367249|520161538|FG001|Overall Study|Withdrawal by Subject|6|||
144619312|NCT01400451|521463141|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
144619313|NCT01400451|521463142|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
144619314|NCT01400451|521463140|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
144619315|NCT01400451|521463141|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
144619316|NCT01400451|521463142|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
144619317|NCT01400451|521463140|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
144619318|NCT01400451|521463141|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
144619319|NCT01400451|521463142|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
144619320|NCT03861559|521463151|FG000|Overall Study|Adverse Event|0|||
144262683|NCT01367249|520161537|FG000|Overall Study|Other|3|||
144262684|NCT01367249|520161538|FG001|Overall Study|Other|10|||
144262685|NCT02493517|520161539|FG000|Overall Study|Protocol Violation|1|||
144262686|NCT02493517|520161540|FG001|Overall Study|Protocol Violation|2|||
144262687|NCT02493517|520161539|FG000|Overall Study|Withdrawal by Subject|1|||
144262688|NCT02493517|520161540|FG001|Overall Study|Withdrawal by Subject|2|||
144262689|NCT02493517|520161539|FG000|Overall Study|Adverse Event|0|||
144262690|NCT02493517|520161540|FG001|Overall Study|Adverse Event|2|||
144262691|NCT02493517|520161539|FG000|Overall Study|Missed study visit|0|||
144262692|NCT02493517|520161540|FG001|Overall Study|Missed study visit|1|||
144262693|NCT05404711|520161541|FG000|Completed Study Visit|Withdrawal by Subject|1|||
144262694|NCT05404711|520161541|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
144262695|NCT05404711|520161541|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
144262696|NCT05404711|520161541|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
144262697|NCT05404711|520161541|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
144262698|NCT05404711|520161541|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
144262699|NCT02058589|520161542|FG000|Overall Study|Serious Adverse Event|1|||
144262700|NCT02058589|520161543|FG001|Overall Study|Serious Adverse Event|1|||
144262701|NCT02058589|520161542|FG000|Overall Study|Non-Serious Adverse Event|1|||
144262702|NCT02058589|520161543|FG001|Overall Study|Non-Serious Adverse Event|0|||
144262703|NCT02058589|520161542|FG000|Overall Study|Withdrawal by Subject|0|||
144262704|NCT02058589|520161543|FG001|Overall Study|Withdrawal by Subject|1|||
144262705|NCT02346877|520161544|FG000|Overall Study|Adverse Event|1|||
144262706|NCT02346877|520161545|FG001|Overall Study|Adverse Event|0|||
144262707|NCT02346877|520161544|FG000|Overall Study|Administrative Decision|1|||
144262708|NCT02346877|520161545|FG001|Overall Study|Administrative Decision|0|||
144262709|NCT02346877|520161544|FG000|Overall Study|Sponsor Decision|12|||
144262710|NCT02346877|520161545|FG001|Overall Study|Sponsor Decision|0|||
144262711|NCT02346877|520161544|FG000|Overall Study|Missing|5|||
144262712|NCT02346877|520161545|FG001|Overall Study|Missing|0|||
144568134|NCT03845075|521280322|FG001|Part 1 - DB|Adverse Event|1|||
144568135|NCT03845075|521280323|FG002|Part 1 - DB|Adverse Event|0|||
144568136|NCT03845075|521280324|FG003|Part 1 - DB|Adverse Event|0|||
144568137|NCT03845075|521280321|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
144568138|NCT03845075|521280322|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
144568139|NCT03845075|521280323|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
144568140|NCT03845075|521280324|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
144568141|NCT03599622|521280325|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
144568142|NCT03599622|521280326|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
144568143|NCT03599622|521280327|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
144568144|NCT03599622|521280328|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
144568145|NCT03599622|521280325|FG000|Pre-Treatment Period|Other reasons|1|||
144568146|NCT03599622|521280326|FG001|Pre-Treatment Period|Other reasons|1|||
144568147|NCT03599622|521280327|FG002|Pre-Treatment Period|Other reasons|1|||
144568148|NCT03599622|521280328|FG003|Pre-Treatment Period|Other reasons|0|||
144568149|NCT03599622|521280325|FG000|Treatment Period|Adverse Event|11|||
144568150|NCT03599622|521280326|FG001|Treatment Period|Adverse Event|20|||
144568151|NCT03599622|521280327|FG002|Treatment Period|Adverse Event|18|||
144205788|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
144205789|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205790|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205791|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205792|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205793|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205794|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205795|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205796|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205797|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
144205798|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205799|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205800|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205801|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205802|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
144205803|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144262713|NCT00490971|520161547|FG000|Acute/Continuation|Adverse Event|62|||
144262714|NCT00490971|520161548|FG001|Acute/Continuation|Adverse Event|13|||
144262715|NCT00490971|520161549|FG002|Acute/Continuation|Adverse Event|0|||
144568152|NCT03599622|521280328|FG003|Treatment Period|Adverse Event|2|||
144262716|NCT00490971|520161550|FG003|Acute/Continuation|Adverse Event|0|||
144568153|NCT03599622|521280325|FG000|Treatment Period|Lack of Efficacy|18|||
144568154|NCT03599622|521280326|FG001|Treatment Period|Lack of Efficacy|12|||
144619321|NCT03861559|521463152|FG001|Overall Study|Adverse Event|2|||
144619322|NCT03861559|521463151|FG000|Overall Study|Treatment failure|0|||
144619323|NCT03861559|521463152|FG001|Overall Study|Treatment failure|2|||
144619324|NCT03861559|521463151|FG000|Overall Study|Noncompliance|1|||
144619325|NCT03861559|521463152|FG001|Overall Study|Noncompliance|1|||
144619326|NCT03861559|521463151|FG000|Overall Study|Did not meet eligibility requirements|1|||
144619327|NCT03861559|521463152|FG001|Overall Study|Did not meet eligibility requirements|0|||
144619328|NCT01437397|521463156|FG000|Overall Study|Lost to Follow-up|9|||
144619329|NCT01437397|521463157|FG001|Overall Study|Lost to Follow-up|4|||
144619330|NCT01437397|521463158|FG002|Overall Study|Lost to Follow-up|2|||
144619331|NCT01437397|521463159|FG003|Overall Study|Lost to Follow-up|4|||
144619332|NCT01437397|521463160|FG004|Overall Study|Lost to Follow-up|5|||
144619333|NCT01437397|521463156|FG000|Overall Study|Withdrawal by Subject|11|||
144619334|NCT01437397|521463157|FG001|Overall Study|Withdrawal by Subject|12|||
144619335|NCT01437397|521463158|FG002|Overall Study|Withdrawal by Subject|24|||
144619336|NCT01437397|521463159|FG003|Overall Study|Withdrawal by Subject|11|||
144205804|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205805|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205806|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205807|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205808|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205809|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205810|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205811|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
144205812|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205813|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205814|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205815|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205816|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
144205817|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205818|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205819|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205820|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205821|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205822|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205823|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205824|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205825|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
144205826|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205827|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205828|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205829|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205830|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
144205831|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205832|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205833|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205834|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205835|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205836|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
144205837|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205838|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
144205839|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
144205840|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205841|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205842|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205843|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205844|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
144205845|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205846|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205847|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205848|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205849|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144262717|NCT00490971|520161551|FG004|Acute/Continuation|Adverse Event|0|||
144262718|NCT00490971|520161547|FG000|Acute/Continuation|Death|2|||
144262719|NCT00490971|520161548|FG001|Acute/Continuation|Death|0|||
144619337|NCT01437397|521463160|FG004|Overall Study|Withdrawal by Subject|22|||
144619338|NCT01437397|521463156|FG000|Overall Study|Protocol Violation|10|||
144619339|NCT01437397|521463157|FG001|Overall Study|Protocol Violation|12|||
144619340|NCT01437397|521463158|FG002|Overall Study|Protocol Violation|13|||
144619341|NCT01437397|521463159|FG003|Overall Study|Protocol Violation|21|||
144619342|NCT01437397|521463160|FG004|Overall Study|Protocol Violation|19|||
144619343|NCT01437397|521463156|FG000|Overall Study|Lack of Efficacy|5|||
144619344|NCT01437397|521463157|FG001|Overall Study|Lack of Efficacy|4|||
144619345|NCT01437397|521463158|FG002|Overall Study|Lack of Efficacy|8|||
144619346|NCT01437397|521463159|FG003|Overall Study|Lack of Efficacy|10|||
144619347|NCT01437397|521463160|FG004|Overall Study|Lack of Efficacy|20|||
144619348|NCT01437397|521463156|FG000|Overall Study|Adverse Event|21|||
144619349|NCT01437397|521463157|FG001|Overall Study|Adverse Event|22|||
144619350|NCT01437397|521463158|FG002|Overall Study|Adverse Event|16|||
144619351|NCT01437397|521463159|FG003|Overall Study|Adverse Event|14|||
144619352|NCT01437397|521463160|FG004|Overall Study|Adverse Event|21|||
144619353|NCT01437397|521463156|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
144619354|NCT01437397|521463157|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
144619355|NCT01437397|521463158|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
144619356|NCT01437397|521463159|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
144619357|NCT01437397|521463160|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
144619358|NCT00903175|521463161|FG000|Period 1 - First Line|Adverse Event|36|||
144619359|NCT00903175|521463162|FG001|Period 1 - First Line|Adverse Event|50|||
144619360|NCT00903175|521463161|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
144619361|NCT00903175|521463162|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
144619362|NCT00903175|521463161|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
144619363|NCT00903175|521463162|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
144619364|NCT00903175|521463161|FG000|Period 1 - First Line|Protocol Violation|3|||
144619365|NCT00903175|521463162|FG001|Period 1 - First Line|Protocol Violation|3|||
144619366|NCT00903175|521463161|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
144619367|NCT00903175|521463162|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
144619368|NCT00903175|521463161|FG000|Period 1 - First Line|Administrative problems|12|||
144619369|NCT00903175|521463162|FG001|Period 1 - First Line|Administrative problems|13|||
144619370|NCT00903175|521463161|FG000|Period 1 - First Line|Death|17|||
144619371|NCT00903175|521463162|FG001|Period 1 - First Line|Death|10|||
144619372|NCT00903175|521463161|FG000|Period 2 - Second Line|Missing|1|||
144619373|NCT00903175|521463162|FG001|Period 2 - Second Line|Missing|0|||
144619374|NCT00903175|521463161|FG000|Period 2 - Second Line|Adverse Event|16|||
144619375|NCT00903175|521463162|FG001|Period 2 - Second Line|Adverse Event|20|||
144619376|NCT00903175|521463161|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
144619377|NCT00903175|521463162|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
144619378|NCT00903175|521463161|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
144619379|NCT00903175|521463162|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
144619380|NCT00903175|521463161|FG000|Period 2 - Second Line|Administrative problems|19|||
144619381|NCT00903175|521463162|FG001|Period 2 - Second Line|Administrative problems|9|||
144619382|NCT00903175|521463161|FG000|Period 2 - Second Line|Death|5|||
144619383|NCT00903175|521463162|FG001|Period 2 - Second Line|Death|2|||
144619384|NCT03074474|521463165|FG000|Overall Study|Lost to Follow-up|10|||
144619385|NCT03074474|521463165|FG000|Overall Study|Withdrawal by Subject|10|||
144619386|NCT03074474|521463165|FG000|Overall Study|Death|4|||
144619387|NCT03074474|521463165|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
144619388|NCT02124564|521463171|FG000|Treatment Period|Adverse Event|2|||
144619389|NCT02124564|521463171|FG000|Treatment Period|Lack of Efficacy|3|||
144619390|NCT02124564|521463171|FG000|Treatment Period|Withdrawal by Subject|2|||
144619391|NCT03368170|521465981|FG000|Overall Study|Adverse Event|2|||
144619392|NCT03368170|521465982|FG001|Overall Study|Adverse Event|1|||
144619393|NCT00328627|521465990|FG000|Overall Study|Hyperglycemic Rescue|41|||
144619394|NCT00328627|521465991|FG001|Overall Study|Hyperglycemic Rescue|18|||
144619395|NCT00328627|521465992|FG002|Overall Study|Hyperglycemic Rescue|16|||
144619396|NCT00328627|521465993|FG003|Overall Study|Hyperglycemic Rescue|13|||
144205850|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205851|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205852|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205853|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
144205854|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205855|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205856|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205857|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205858|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
144205859|NCT03982199|519946995|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205860|NCT03982199|519946996|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205861|NCT03982199|519946997|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144619397|NCT00328627|521465994|FG004|Overall Study|Hyperglycemic Rescue|6|||
144619398|NCT00328627|521465995|FG005|Overall Study|Hyperglycemic Rescue|5|||
144619399|NCT00328627|521465996|FG006|Overall Study|Hyperglycemic Rescue|19|||
144619400|NCT00328627|521465997|FG007|Overall Study|Hyperglycemic Rescue|6|||
144205862|NCT03982199|519946998|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205863|NCT03982199|519946999|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205864|NCT03982199|519947000|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
144205865|NCT03982199|519947001|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205866|NCT03982199|519947002|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
144205867|NCT03982199|519947003|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
144205868|NCT03982199|519947004|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205869|NCT03982199|519947005|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205870|NCT03982199|519947006|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205871|NCT03982199|519947007|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205872|NCT03982199|519947008|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
144205873|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205874|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205875|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205876|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205877|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205878|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205879|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205880|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205881|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
144205882|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
144205883|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
144205884|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
144205885|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
144205886|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
144205887|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205888|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205889|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205890|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205891|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205892|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205893|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205894|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205895|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205896|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
144205897|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205898|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205899|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205900|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
144205901|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205902|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205903|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205904|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205905|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205906|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205907|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205908|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205909|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205910|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205911|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205912|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205913|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
144205914|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
144205915|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205916|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205917|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205918|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205919|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144568155|NCT03599622|521280327|FG002|Treatment Period|Lack of Efficacy|13|||
144568156|NCT03599622|521280328|FG003|Treatment Period|Lack of Efficacy|2|||
144568157|NCT03599622|521280325|FG000|Treatment Period|Withdrawal by Subject|5|||
144568158|NCT03599622|521280326|FG001|Treatment Period|Withdrawal by Subject|11|||
144619401|NCT00328627|521465998|FG008|Overall Study|Hyperglycemic Rescue|6|||
144619402|NCT00328627|521465999|FG009|Overall Study|Hyperglycemic Rescue|11|||
144619403|NCT00328627|521466000|FG010|Overall Study|Hyperglycemic Rescue|3|||
144619404|NCT00328627|521466001|FG011|Overall Study|Hyperglycemic Rescue|2|||
144619405|NCT00328627|521465990|FG000|Overall Study|Adverse Event|3|||
144619406|NCT00328627|521465991|FG001|Overall Study|Adverse Event|1|||
144619407|NCT00328627|521465992|FG002|Overall Study|Adverse Event|2|||
144619408|NCT00328627|521465993|FG003|Overall Study|Adverse Event|3|||
144619409|NCT00328627|521465994|FG004|Overall Study|Adverse Event|1|||
144619410|NCT00328627|521465995|FG005|Overall Study|Adverse Event|2|||
144205920|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205921|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205922|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205923|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205924|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205925|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
144205926|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
144205927|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
144205928|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
144205929|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205930|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205931|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205932|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205933|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205934|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205935|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205936|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205937|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205938|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205939|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205940|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205941|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
144205942|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
144205943|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205944|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205945|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205946|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205947|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205948|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205949|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205950|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205951|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205952|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205953|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205954|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
144205955|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
144205956|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
144205957|NCT03982199|519946995|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205958|NCT03982199|519946996|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205959|NCT03982199|519946997|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205960|NCT03982199|519946998|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205961|NCT03982199|519946999|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205962|NCT03982199|519947000|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205963|NCT03982199|519947001|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205964|NCT03982199|519947002|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205965|NCT03982199|519947003|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144619411|NCT00328627|521465996|FG006|Overall Study|Adverse Event|1|||
144619412|NCT00328627|521465997|FG007|Overall Study|Adverse Event|2|||
144619413|NCT00328627|521465998|FG008|Overall Study|Adverse Event|0|||
144619414|NCT00328627|521465999|FG009|Overall Study|Adverse Event|7|||
144728689|NCT02016170|521861301|FG002|Overall Study|Adverse Event|0|||
144205966|NCT03982199|519947004|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205967|NCT03982199|519947005|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205968|NCT03982199|519947006|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144262720|NCT00490971|520161549|FG002|Acute/Continuation|Death|0|||
144262721|NCT00490971|520161550|FG003|Acute/Continuation|Death|0|||
144728690|NCT02016170|521861299|FG000|Overall Study|Protocol Violation|1|||
144568159|NCT03599622|521280327|FG002|Treatment Period|Withdrawal by Subject|16|||
144568160|NCT03599622|521280328|FG003|Treatment Period|Withdrawal by Subject|1|||
144568161|NCT03599622|521280325|FG000|Treatment Period|Other reasons|4|||
144568162|NCT03599622|521280326|FG001|Treatment Period|Other reasons|6|||
144728691|NCT02016170|521861300|FG001|Overall Study|Protocol Violation|0|||
144728692|NCT02016170|521861301|FG002|Overall Study|Protocol Violation|0|||
144728693|NCT01936948|521861305|FG000|Overall Study|no 30-day follow-up data|0|||
144205969|NCT03982199|519947007|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
144568163|NCT03599622|521280327|FG002|Treatment Period|Other reasons|7|||
144568164|NCT03599622|521280328|FG003|Treatment Period|Other reasons|0|||
144568165|NCT03599622|521280325|FG000|Treatment Period|Lost to Follow-up|1|||
144568166|NCT03599622|521280326|FG001|Treatment Period|Lost to Follow-up|0|||
144568167|NCT03599622|521280327|FG002|Treatment Period|Lost to Follow-up|0|||
144568168|NCT03599622|521280328|FG003|Treatment Period|Lost to Follow-up|0|||
144568169|NCT03599622|521280325|FG000|Treatment Period|Study terminated by sponsor|7|||
144568170|NCT03599622|521280326|FG001|Treatment Period|Study terminated by sponsor|20|||
144568171|NCT03599622|521280327|FG002|Treatment Period|Study terminated by sponsor|15|||
144568172|NCT03599622|521280328|FG003|Treatment Period|Study terminated by sponsor|0|||
144568173|NCT03599622|521280325|FG000|Treatment Period|Site terminated by sponsor|0|||
144568174|NCT03599622|521280326|FG001|Treatment Period|Site terminated by sponsor|1|||
144568175|NCT03599622|521280327|FG002|Treatment Period|Site terminated by sponsor|0|||
144568176|NCT03599622|521280328|FG003|Treatment Period|Site terminated by sponsor|0|||
144568177|NCT01918371|521280333|FG000|Overall Study|Missing Data|1|||
144568178|NCT01918371|521280334|FG001|Overall Study|Missing Data|1|||
144568179|NCT00621192|521280335|FG000|Overall Study|Withdrawal by Subject|0|||
144568180|NCT00621192|521280336|FG001|Overall Study|Withdrawal by Subject|0|||
144568181|NCT00621192|521280337|FG002|Overall Study|Withdrawal by Subject|2|||
144568182|NCT00621192|521280338|FG003|Overall Study|Withdrawal by Subject|0|||
144568183|NCT00621192|521280335|FG000|Overall Study|Physician Decision|1|||
144568184|NCT00621192|521280336|FG001|Overall Study|Physician Decision|3|||
144568185|NCT00621192|521280337|FG002|Overall Study|Physician Decision|0|||
144568186|NCT00621192|521280338|FG003|Overall Study|Physician Decision|0|||
144568187|NCT00621192|521280335|FG000|Overall Study|Protocol Violation|1|||
144568188|NCT00621192|521280336|FG001|Overall Study|Protocol Violation|0|||
144568189|NCT00621192|521280337|FG002|Overall Study|Protocol Violation|0|||
144568190|NCT00621192|521280338|FG003|Overall Study|Protocol Violation|1|||
144568191|NCT00621192|521280335|FG000|Overall Study|Adverse Event|0|||
144568192|NCT00621192|521280336|FG001|Overall Study|Adverse Event|1|||
144568193|NCT00621192|521280337|FG002|Overall Study|Adverse Event|0|||
144568194|NCT00621192|521280338|FG003|Overall Study|Adverse Event|1|||
144568195|NCT00621192|521280335|FG000|Overall Study|Death|2|||
144568196|NCT00621192|521280336|FG001|Overall Study|Death|5|||
144568197|NCT00621192|521280337|FG002|Overall Study|Death|0|||
144568198|NCT00621192|521280338|FG003|Overall Study|Death|0|||
144568199|NCT00621192|521280335|FG000|Overall Study|Final Assessments not Completed|0|||
144568200|NCT00621192|521280336|FG001|Overall Study|Final Assessments not Completed|0|||
144568201|NCT00621192|521280337|FG002|Overall Study|Final Assessments not Completed|3|||
144568202|NCT00621192|521280338|FG003|Overall Study|Final Assessments not Completed|1|||
144568203|NCT04706793|521280339|FG000|Treatment|Disease worsening|10|||
144568204|NCT04706793|521280340|FG001|Treatment|Disease worsening|10|||
144728694|NCT01936948|521861306|FG001|Overall Study|no 30-day follow-up data|3|||
144728695|NCT01936948|521861307|FG002|Overall Study|no 30-day follow-up data|3|||
144205970|NCT03982199|519947008|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
144205971|NCT03433755|519947009|FG000|Overall Study|Lost to Follow-up|1|||
144205972|NCT03433755|519947010|FG001|Overall Study|Lost to Follow-up|0|||
144205973|NCT03433755|519947011|FG002|Overall Study|Lost to Follow-up|0|||
144205974|NCT03433755|519947012|FG003|Overall Study|Lost to Follow-up|0|||
144205975|NCT03433755|519947009|FG000|Overall Study|Decision by Sponsor|1|||
144205976|NCT03433755|519947010|FG001|Overall Study|Decision by Sponsor|0|||
144205977|NCT03433755|519947011|FG002|Overall Study|Decision by Sponsor|0|||
144205978|NCT03433755|519947012|FG003|Overall Study|Decision by Sponsor|0|||
144205979|NCT04240392|519949383|FG000|Overall Study|Withdrawal by Subject|13|||
144205980|NCT04240392|519949384|FG001|Overall Study|Withdrawal by Subject|4|||
144205981|NCT04240392|519949383|FG000|Overall Study|Lost to Follow-up|11|||
144205982|NCT04240392|519949384|FG001|Overall Study|Lost to Follow-up|12|||
144205983|NCT03589768|519949385|FG000|Overall Study|Death|1|||
144205984|NCT03589768|519949386|FG001|Overall Study|Death|0|||
144728696|NCT01936948|521861308|FG003|Overall Study|no 30-day follow-up data|3|||
144205985|NCT03589768|519949387|FG002|Overall Study|Death|8|||
144205986|NCT03589768|519949388|FG003|Overall Study|Death|3|||
144262722|NCT00490971|520161551|FG004|Acute/Continuation|Death|0|||
144568205|NCT04706793|521280339|FG000|Follow-up|Lack of Efficacy|1|||
144568206|NCT04706793|521280340|FG001|Follow-up|Lack of Efficacy|0|||
144568207|NCT04706793|521280339|FG000|Follow-up|Disease worsening|8|||
144568208|NCT04706793|521280340|FG001|Follow-up|Disease worsening|10|||
144568209|NCT04706793|521280339|FG000|Follow-up|Adverse Event|1|||
144568210|NCT04706793|521280340|FG001|Follow-up|Adverse Event|0|||
144568211|NCT01130168|521280348|FG000|Period 1|Withdrawal by Subject|0|||
144568212|NCT01130168|521280349|FG001|Period 1|Withdrawal by Subject|1|||
144728697|NCT02365207|521861309|FG000|Overall Study|Withdrawal by Subject|1|||
144728698|NCT02365207|521861309|FG000|Overall Study|Physician Decision|1|||
144728699|NCT01395030|521861310|FG000|Overall Study|Did not complete FCH PET/CT|7|||
144728700|NCT02327130|521861311|FG000|Overall Study|Discharged in less than 5 days|5|||
144728701|NCT02327130|521861311|FG000|Overall Study|Physician Decision|2|||
144728702|NCT02327130|521861311|FG000|Overall Study|Unable to provide breath sample|1|||
144728703|NCT02327130|521861311|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
144728704|NCT02327130|521861311|FG000|Overall Study|Met exclusion criteria|3|||
144728705|NCT05214560|521861313|FG000|Overall Study|Screening Failure|1|||
144568213|NCT01130168|521280350|FG002|Period 1|Withdrawal by Subject|0|||
144568214|NCT01130168|521280351|FG003|Period 1|Withdrawal by Subject|1|||
144568215|NCT01130168|521280352|FG004|Period 1|Withdrawal by Subject|0|||
144568216|NCT01130168|521280353|FG005|Period 1|Withdrawal by Subject|0|||
144568217|NCT01130168|521280348|FG000|Period 1|Discontinued For Other Reason|0|||
144568218|NCT01130168|521280349|FG001|Period 1|Discontinued For Other Reason|0|||
144568219|NCT01130168|521280350|FG002|Period 1|Discontinued For Other Reason|1|||
144568220|NCT01130168|521280351|FG003|Period 1|Discontinued For Other Reason|1|||
144568221|NCT01130168|521280352|FG004|Period 1|Discontinued For Other Reason|0|||
144568222|NCT01130168|521280353|FG005|Period 1|Discontinued For Other Reason|0|||
144568223|NCT01130168|521280348|FG000|Period 1|Adverse Event|0|||
144568224|NCT01130168|521280349|FG001|Period 1|Adverse Event|0|||
144568225|NCT01130168|521280350|FG002|Period 1|Adverse Event|0|||
144728706|NCT05214560|521861313|FG000|Overall Study|Physician Decision|4|||
144728707|NCT05214560|521861313|FG000|Overall Study|Withdrawal by Subject|1|||
144728708|NCT05214560|521861313|FG000|Overall Study|Lost to Follow-up|2|||
144728709|NCT05214560|521861313|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
144728710|NCT05214560|521861313|FG000|Overall Study|Study physician not available for the anesthesia|3|||
144728711|NCT05214560|521861313|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
144728712|NCT05214560|521861313|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
144728713|NCT05214560|521861313|FG000|Overall Study|Surgery not performed|3|||
144728714|NCT02672553|521861314|FG000|Overall Study|Death|3|||
144728715|NCT02672553|521861315|FG001|Overall Study|Death|5|||
144728716|NCT02672553|521861314|FG000|Overall Study|Valve Explant|1|||
144568226|NCT01130168|521280351|FG003|Period 1|Adverse Event|1|||
144568227|NCT01130168|521280352|FG004|Period 1|Adverse Event|0|||
144568228|NCT01130168|521280353|FG005|Period 1|Adverse Event|0|||
144568229|NCT02569957|521280355|FG000|Overall Study|Withdrawal by Subject|0|||
144568230|NCT02569957|521280356|FG001|Overall Study|Withdrawal by Subject|1|||
144568231|NCT04354168|521280358|FG000|Overall Study|Lost to Follow-up|22|||
144568232|NCT02635386|521280359|FG000|Overall Study|Pregnancy|2|||
144568233|NCT02635386|521280360|FG001|Overall Study|Pregnancy|0|||
144568234|NCT02635386|521280361|FG002|Overall Study|Pregnancy|0|||
144568235|NCT02635386|521280362|FG003|Overall Study|Pregnancy|0|||
144568236|NCT02635386|521280363|FG004|Overall Study|Pregnancy|2|||
144568237|NCT02635386|521280359|FG000|Overall Study|Withdrawal by Subject|1|||
144568238|NCT02635386|521280360|FG001|Overall Study|Withdrawal by Subject|1|||
144568239|NCT02635386|521280361|FG002|Overall Study|Withdrawal by Subject|0|||
144568240|NCT02635386|521280362|FG003|Overall Study|Withdrawal by Subject|1|||
144568241|NCT02635386|521280363|FG004|Overall Study|Withdrawal by Subject|0|||
144568242|NCT02635386|521280359|FG000|Overall Study|Physician Decision|0|||
144568243|NCT02635386|521280360|FG001|Overall Study|Physician Decision|1|||
144568244|NCT02635386|521280361|FG002|Overall Study|Physician Decision|0|||
144568245|NCT02635386|521280362|FG003|Overall Study|Physician Decision|0|||
144568246|NCT02635386|521280363|FG004|Overall Study|Physician Decision|0|||
144568247|NCT02635386|521280359|FG000|Overall Study|Moved Out of State|0|||
144568248|NCT02635386|521280360|FG001|Overall Study|Moved Out of State|1|||
144568249|NCT02635386|521280361|FG002|Overall Study|Moved Out of State|0|||
144568250|NCT02635386|521280362|FG003|Overall Study|Moved Out of State|0|||
144568251|NCT02635386|521280363|FG004|Overall Study|Moved Out of State|0|||
144568252|NCT02635386|521280359|FG000|Overall Study|Noncompliant|0|||
144568253|NCT02635386|521280360|FG001|Overall Study|Noncompliant|2|||
144568254|NCT02635386|521280361|FG002|Overall Study|Noncompliant|1|||
144568255|NCT02635386|521280362|FG003|Overall Study|Noncompliant|1|||
144728717|NCT02672553|521861315|FG001|Overall Study|Valve Explant|0|||
144728718|NCT02672553|521861314|FG000|Overall Study|Conversion to Commercial Valve|3|||
144728719|NCT02672553|521861315|FG001|Overall Study|Conversion to Commercial Valve|0|||
144262723|NCT00490971|520161547|FG000|Acute/Continuation|Lack of Efficacy|106|||
144568256|NCT02635386|521280363|FG004|Overall Study|Noncompliant|1|||
144568257|NCT02635386|521280359|FG000|Overall Study|side effects|0|||
144568258|NCT02635386|521280360|FG001|Overall Study|side effects|0|||
144568259|NCT02635386|521280361|FG002|Overall Study|side effects|1|||
144568260|NCT02635386|521280362|FG003|Overall Study|side effects|4|||
144568261|NCT02635386|521280363|FG004|Overall Study|side effects|6|||
144568262|NCT02635386|521280359|FG000|Overall Study|needed other major surgery|0|||
144568263|NCT02635386|521280360|FG001|Overall Study|needed other major surgery|1|||
144568264|NCT02635386|521280361|FG002|Overall Study|needed other major surgery|0|||
144568265|NCT02635386|521280362|FG003|Overall Study|needed other major surgery|0|||
144568266|NCT02635386|521280363|FG004|Overall Study|needed other major surgery|0|||
144205987|NCT03589768|519949385|FG000|Overall Study|Withdrawal by Subject|2|||
144205988|NCT03589768|519949386|FG001|Overall Study|Withdrawal by Subject|0|||
144205989|NCT03589768|519949387|FG002|Overall Study|Withdrawal by Subject|0|||
144205990|NCT03589768|519949388|FG003|Overall Study|Withdrawal by Subject|0|||
144205991|NCT03589768|519949385|FG000|Overall Study|Protocol Violation|1|||
144205992|NCT03589768|519949386|FG001|Overall Study|Protocol Violation|0|||
144205993|NCT03589768|519949387|FG002|Overall Study|Protocol Violation|0|||
144205994|NCT03589768|519949388|FG003|Overall Study|Protocol Violation|0|||
144205995|NCT04663295|519949389|FG000|Run-in Period|Withdrawal by Subject|3|||
144205996|NCT04663295|519949389|FG000|Overall Study Period|Pregnancy|1|||
144205997|NCT04663295|519949389|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
144205998|NCT03665441|519949397|FG000|Overall Study|survival follow up ongoing|23|||
144205999|NCT03665441|519949398|FG001|Overall Study|survival follow up ongoing|0|||
144206000|NCT03665441|519949397|FG000|Overall Study|Patients ongoing on treatment|9|||
144206001|NCT03665441|519949398|FG001|Overall Study|Patients ongoing on treatment|6|||
144206002|NCT03665441|519949397|FG000|Overall Study|Randomized but not treated|7|||
144206003|NCT03665441|519949398|FG001|Overall Study|Randomized but not treated|11|||
144206004|NCT00191113|519949399|FG000|Core Study|Withdrawal by Subject|25|||
144206005|NCT00191113|519949400|FG001|Core Study|Withdrawal by Subject|9|||
144206006|NCT00191113|519949399|FG000|Core Study|Protocol Violation|6|||
144206007|NCT00191113|519949400|FG001|Core Study|Protocol Violation|2|||
144206008|NCT00191113|519949399|FG000|Core Study|Lost to Follow-up|3|||
144206009|NCT00191113|519949400|FG001|Core Study|Lost to Follow-up|0|||
144206010|NCT00191113|519949399|FG000|Core Study|Adverse Event|0|||
144206011|NCT00191113|519949400|FG001|Core Study|Adverse Event|2|||
144206012|NCT00191113|519949399|FG000|Core Study|Lack of Efficacy|0|||
144206013|NCT00191113|519949400|FG001|Core Study|Lack of Efficacy|2|||
144206014|NCT00191113|519949399|FG000|Core Study|Death|1|||
144568267|NCT02635386|521280359|FG000|Overall Study|Other medical problems not drug related|0|||
144568268|NCT02635386|521280360|FG001|Overall Study|Other medical problems not drug related|0|||
144568269|NCT02635386|521280361|FG002|Overall Study|Other medical problems not drug related|0|||
144568270|NCT02635386|521280362|FG003|Overall Study|Other medical problems not drug related|1|||
144568271|NCT02635386|521280363|FG004|Overall Study|Other medical problems not drug related|0|||
144568272|NCT01781832|521280364|FG000|Overall Study|Withdrawal by Subject|1|||
144568273|NCT02706847|521280369|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
144568274|NCT02706847|521280370|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
144568275|NCT02706847|521280371|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
144568276|NCT02706847|521280372|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
144568277|NCT02706847|521280369|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
144568278|NCT02706847|521280370|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
144568279|NCT02706847|521280371|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
144568280|NCT02706847|521280372|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
144568281|NCT02706847|521280369|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
144568282|NCT02706847|521280370|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
144568283|NCT02706847|521280371|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
144568284|NCT02706847|521280372|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
144568285|NCT02706847|521280369|FG000|Period 1: Day 1 to Week 12|Other|4|||
144568286|NCT02706847|521280370|FG001|Period 1: Day 1 to Week 12|Other|4|||
144568287|NCT02706847|521280371|FG002|Period 1: Day 1 to Week 12|Other|2|||
144568288|NCT02706847|521280372|FG003|Period 1: Day 1 to Week 12|Other|2|||
144568289|NCT02706847|521280369|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
144568290|NCT02706847|521280370|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
144568291|NCT02706847|521280371|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
144568292|NCT02706847|521280372|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
144568293|NCT02706847|521280369|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
144568294|NCT02706847|521280370|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
144568295|NCT02706847|521280371|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
144619415|NCT00328627|521466000|FG010|Overall Study|Adverse Event|5|||
144619416|NCT00328627|521466001|FG011|Overall Study|Adverse Event|4|||
144619417|NCT00328627|521465990|FG000|Overall Study|Protocol Violation|2|||
144619418|NCT00328627|521465991|FG001|Overall Study|Protocol Violation|2|||
144619419|NCT00328627|521465992|FG002|Overall Study|Protocol Violation|2|||
144619420|NCT00328627|521465993|FG003|Overall Study|Protocol Violation|8|||
144206015|NCT00191113|519949400|FG001|Core Study|Death|0|||
144206016|NCT04241315|519949402|FG000|Overall Study|Withdrawal by Subject|0|||
144568296|NCT02706847|521280372|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
144206017|NCT04241315|519949403|FG001|Overall Study|Withdrawal by Subject|1|||
144206018|NCT03047330|519949404|FG000|Sleep Block 1|Withdrawal by Subject|3|||
144206019|NCT00000378|519949405|FG000|Overall Study|Lack of Efficacy|16|||
144206020|NCT00000378|519949406|FG001|Overall Study|Lack of Efficacy|14|||
144206021|NCT00663026|519949412|FG000|Overall Study|Lost to Follow-up|1|||
144206022|NCT00663026|519949413|FG001|Overall Study|Lost to Follow-up|0|||
144206023|NCT00663026|519949414|FG002|Overall Study|Lost to Follow-up|0|||
144568297|NCT02706847|521280369|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
144568298|NCT02706847|521280370|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
144619421|NCT00328627|521465994|FG004|Overall Study|Protocol Violation|5|||
144619422|NCT00328627|521465995|FG005|Overall Study|Protocol Violation|5|||
144619423|NCT00328627|521465996|FG006|Overall Study|Protocol Violation|6|||
144619424|NCT00328627|521465997|FG007|Overall Study|Protocol Violation|2|||
144619425|NCT00328627|521465998|FG008|Overall Study|Protocol Violation|1|||
144619426|NCT00328627|521465999|FG009|Overall Study|Protocol Violation|4|||
144619427|NCT00328627|521466000|FG010|Overall Study|Protocol Violation|6|||
144619428|NCT00328627|521466001|FG011|Overall Study|Protocol Violation|2|||
144619429|NCT00328627|521465990|FG000|Overall Study|Lost to Follow-up|4|||
144619430|NCT00328627|521465991|FG001|Overall Study|Lost to Follow-up|2|||
144619431|NCT00328627|521465992|FG002|Overall Study|Lost to Follow-up|2|||
144619432|NCT00328627|521465993|FG003|Overall Study|Lost to Follow-up|4|||
144619433|NCT00328627|521465994|FG004|Overall Study|Lost to Follow-up|0|||
144619434|NCT00328627|521465995|FG005|Overall Study|Lost to Follow-up|2|||
144619435|NCT00328627|521465996|FG006|Overall Study|Lost to Follow-up|3|||
144619436|NCT00328627|521465997|FG007|Overall Study|Lost to Follow-up|0|||
144619437|NCT00328627|521465998|FG008|Overall Study|Lost to Follow-up|3|||
144619438|NCT00328627|521465999|FG009|Overall Study|Lost to Follow-up|2|||
144619439|NCT00328627|521466000|FG010|Overall Study|Lost to Follow-up|0|||
144619440|NCT00328627|521466001|FG011|Overall Study|Lost to Follow-up|1|||
144619441|NCT00328627|521465990|FG000|Overall Study|Withdrawal by Subject|5|||
144619442|NCT00328627|521465991|FG001|Overall Study|Withdrawal by Subject|4|||
144619443|NCT00328627|521465992|FG002|Overall Study|Withdrawal by Subject|5|||
144619444|NCT00328627|521465993|FG003|Overall Study|Withdrawal by Subject|6|||
144619445|NCT00328627|521465994|FG004|Overall Study|Withdrawal by Subject|2|||
144619446|NCT00328627|521465995|FG005|Overall Study|Withdrawal by Subject|5|||
144619447|NCT00328627|521465996|FG006|Overall Study|Withdrawal by Subject|4|||
144619448|NCT00328627|521465997|FG007|Overall Study|Withdrawal by Subject|4|||
144619449|NCT00328627|521465998|FG008|Overall Study|Withdrawal by Subject|4|||
144619450|NCT00328627|521465999|FG009|Overall Study|Withdrawal by Subject|5|||
144619451|NCT00328627|521466000|FG010|Overall Study|Withdrawal by Subject|2|||
144619452|NCT00328627|521466001|FG011|Overall Study|Withdrawal by Subject|7|||
144619453|NCT00328627|521465990|FG000|Overall Study|Pregnancy|0|||
144619454|NCT00328627|521465991|FG001|Overall Study|Pregnancy|1|||
144619455|NCT00328627|521465992|FG002|Overall Study|Pregnancy|0|||
144619456|NCT00328627|521465993|FG003|Overall Study|Pregnancy|0|||
144619457|NCT00328627|521465994|FG004|Overall Study|Pregnancy|0|||
144619458|NCT00328627|521465995|FG005|Overall Study|Pregnancy|0|||
144619459|NCT00328627|521465996|FG006|Overall Study|Pregnancy|0|||
144619460|NCT00328627|521465997|FG007|Overall Study|Pregnancy|0|||
144619461|NCT00328627|521465998|FG008|Overall Study|Pregnancy|0|||
144619462|NCT00328627|521465999|FG009|Overall Study|Pregnancy|0|||
144619463|NCT00328627|521466000|FG010|Overall Study|Pregnancy|0|||
144619464|NCT00328627|521466001|FG011|Overall Study|Pregnancy|0|||
144619465|NCT00328627|521465990|FG000|Overall Study|Physician Decision|4|||
144619466|NCT00328627|521465991|FG001|Overall Study|Physician Decision|3|||
144619467|NCT00328627|521465992|FG002|Overall Study|Physician Decision|1|||
144619468|NCT00328627|521465993|FG003|Overall Study|Physician Decision|2|||
144619469|NCT00328627|521465994|FG004|Overall Study|Physician Decision|1|||
144619470|NCT00328627|521465995|FG005|Overall Study|Physician Decision|1|||
144619471|NCT00328627|521465996|FG006|Overall Study|Physician Decision|1|||
144619472|NCT00328627|521465997|FG007|Overall Study|Physician Decision|0|||
144619473|NCT00328627|521465998|FG008|Overall Study|Physician Decision|3|||
144619474|NCT00328627|521465999|FG009|Overall Study|Physician Decision|2|||
144619475|NCT00328627|521466000|FG010|Overall Study|Physician Decision|1|||
144619476|NCT00328627|521466001|FG011|Overall Study|Physician Decision|0|||
144619477|NCT00328627|521465990|FG000|Overall Study|Other|0|||
144619478|NCT00328627|521465991|FG001|Overall Study|Other|0|||
144619479|NCT00328627|521465992|FG002|Overall Study|Other|0|||
144619480|NCT00328627|521465993|FG003|Overall Study|Other|1|||
144619481|NCT00328627|521465994|FG004|Overall Study|Other|0|||
144619482|NCT00328627|521465995|FG005|Overall Study|Other|0|||
144619483|NCT00328627|521465996|FG006|Overall Study|Other|1|||
144619484|NCT00328627|521465997|FG007|Overall Study|Other|0|||
144619485|NCT00328627|521465998|FG008|Overall Study|Other|0|||
144619486|NCT00328627|521465999|FG009|Overall Study|Other|1|||
144619487|NCT00328627|521466000|FG010|Overall Study|Other|1|||
144619488|NCT00328627|521466001|FG011|Overall Study|Other|0|||
144619489|NCT01761266|521466002|FG000|Overall Study|Death|415|||
144619490|NCT01761266|521466003|FG001|Overall Study|Death|402|||
144619491|NCT01761266|521466002|FG000|Overall Study|Lost to Follow-up|8|||
144619492|NCT01761266|521466003|FG001|Overall Study|Lost to Follow-up|12|||
144619493|NCT01761266|521466002|FG000|Overall Study|Withdrawal by Subject|14|||
144619494|NCT01761266|521466003|FG001|Overall Study|Withdrawal by Subject|10|||
144619495|NCT01761266|521466002|FG000|Overall Study|Sponsor Decision|41|||
144728720|NCT02672553|521861314|FG000|Overall Study|Withdrawal by Subject|3|||
144619496|NCT01761266|521466003|FG001|Overall Study|Sponsor Decision|52|||
144619497|NCT03445000|521466006|FG000|Overall Study|Disease progression|8|||
144619498|NCT03445000|521466006|FG000|Overall Study|Adverse Event|3|||
144619499|NCT03445000|521466006|FG000|Overall Study|Death|2|||
144619500|NCT03445000|521466006|FG000|Overall Study|Physician Decision|1|||
144619501|NCT00706134|521466007|FG000|Overall Study|Adverse Event|8|||
144619502|NCT00706134|521466008|FG001|Overall Study|Adverse Event|7|||
144568299|NCT02706847|521280371|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
144568300|NCT02706847|521280372|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
144568301|NCT02706847|521280369|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
144568302|NCT02706847|521280370|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
144568303|NCT02706847|521280371|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
144568304|NCT02706847|521280372|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
144568305|NCT02706847|521280369|FG000|Period 1: Week 12 to Week 24|Other|1|||
144568306|NCT02706847|521280370|FG001|Period 1: Week 12 to Week 24|Other|0|||
144568307|NCT02706847|521280371|FG002|Period 1: Week 12 to Week 24|Other|1|||
144568308|NCT02706847|521280372|FG003|Period 1: Week 12 to Week 24|Other|4|||
144619503|NCT00706134|521466009|FG002|Overall Study|Adverse Event|2|||
144619504|NCT00706134|521466010|FG003|Overall Study|Adverse Event|3|||
144619505|NCT00706134|521466007|FG000|Overall Study|Lost to Follow-up|0|||
144206024|NCT00663026|519949412|FG000|Overall Study|Other|1|||
144206025|NCT00663026|519949413|FG001|Overall Study|Other|2|||
144206026|NCT00663026|519949414|FG002|Overall Study|Other|0|||
144206027|NCT00663026|519949412|FG000|Overall Study|Adverse Event|0|||
144206028|NCT00663026|519949413|FG001|Overall Study|Adverse Event|2|||
144206029|NCT00663026|519949414|FG002|Overall Study|Adverse Event|3|||
144206030|NCT00663026|519949412|FG000|Overall Study|Caregiver Request|0|||
144206031|NCT00663026|519949413|FG001|Overall Study|Caregiver Request|2|||
144206032|NCT00663026|519949414|FG002|Overall Study|Caregiver Request|0|||
144206033|NCT00663026|519949412|FG000|Overall Study|Withdrawal by Subject|0|||
144206034|NCT00663026|519949413|FG001|Overall Study|Withdrawal by Subject|0|||
144206035|NCT00663026|519949414|FG002|Overall Study|Withdrawal by Subject|1|||
144206036|NCT01682863|519949426|FG000|Overall Study|Subject/guardian decision|19|||
144206037|NCT01682863|519949427|FG001|Overall Study|Subject/guardian decision|12|||
144206038|NCT01682863|519949428|FG002|Overall Study|Subject/guardian decision|10|||
144206039|NCT01682863|519949426|FG000|Overall Study|Lost to Follow-up|5|||
144206040|NCT01682863|519949427|FG001|Overall Study|Lost to Follow-up|1|||
144206041|NCT01682863|519949428|FG002|Overall Study|Lost to Follow-up|6|||
144206042|NCT01682863|519949426|FG000|Overall Study|Death|1|||
144206043|NCT01682863|519949427|FG001|Overall Study|Death|3|||
144206044|NCT01682863|519949428|FG002|Overall Study|Death|4|||
144206045|NCT01682863|519949426|FG000|Overall Study|Protocol deviation|1|||
144206046|NCT01682863|519949427|FG001|Overall Study|Protocol deviation|0|||
144206047|NCT01682863|519949428|FG002|Overall Study|Protocol deviation|1|||
144206048|NCT01682863|519949426|FG000|Overall Study|Technical problems|1|||
144206049|NCT01682863|519949427|FG001|Overall Study|Technical problems|0|||
144206050|NCT01682863|519949428|FG002|Overall Study|Technical problems|0|||
144206051|NCT01682863|519949426|FG000|Overall Study|Adverse Event|0|||
144206052|NCT01682863|519949427|FG001|Overall Study|Adverse Event|1|||
144206053|NCT01682863|519949428|FG002|Overall Study|Adverse Event|2|||
144206054|NCT01682863|519949426|FG000|Overall Study|Physician Decision|0|||
144206055|NCT01682863|519949427|FG001|Overall Study|Physician Decision|0|||
144206056|NCT01682863|519949428|FG002|Overall Study|Physician Decision|1|||
144206057|NCT03972163|519949429|FG000|Overall Study|Death|0|||
144206058|NCT03972163|519949430|FG001|Overall Study|Death|1|||
144206059|NCT04516759|519949432|FG000|Overall Study|Withdrawal by Subject|1|||
144206060|NCT04516759|519949433|FG001|Overall Study|Withdrawal by Subject|1|||
144206061|NCT04516759|519949432|FG000|Overall Study|Other|0|||
144206062|NCT04516759|519949433|FG001|Overall Study|Other|1|||
144206063|NCT01756079|519949436|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
144206064|NCT01756079|519949436|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
144206065|NCT01756079|519949436|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
144206066|NCT01756079|519949436|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
144206067|NCT01756079|519949436|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
144206068|NCT04015908|519949437|FG000|Overall Study|Lost to Follow-up|0|||
144206069|NCT04015908|519949438|FG001|Overall Study|Lost to Follow-up|1|||
144206070|NCT01775189|519949439|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144568309|NCT02706847|521280369|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
144568310|NCT02706847|521280370|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
144568311|NCT02706847|521280371|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
144568312|NCT02706847|521280372|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
144568313|NCT02706847|521280369|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
144568314|NCT02706847|521280370|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
144619506|NCT00706134|521466008|FG001|Overall Study|Lost to Follow-up|1|||
144206071|NCT01775189|519949440|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
144206072|NCT01775189|519949441|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144206073|NCT01775189|519949442|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144206074|NCT01775189|519949443|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144206075|NCT01775189|519949444|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144206076|NCT01775189|519949445|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
144206077|NCT01775189|519949439|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144568315|NCT02706847|521280371|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
144619507|NCT00706134|521466009|FG002|Overall Study|Lost to Follow-up|0|||
144619508|NCT00706134|521466010|FG003|Overall Study|Lost to Follow-up|0|||
144619509|NCT00706134|521466007|FG000|Overall Study|Protocol Violation|0|||
144619510|NCT00706134|521466008|FG001|Overall Study|Protocol Violation|6|||
144619511|NCT00706134|521466009|FG002|Overall Study|Protocol Violation|0|||
144619512|NCT00706134|521466010|FG003|Overall Study|Protocol Violation|3|||
144619513|NCT00706134|521466007|FG000|Overall Study|Withdrawal by Subject|1|||
144619514|NCT00706134|521466008|FG001|Overall Study|Withdrawal by Subject|2|||
144619515|NCT00706134|521466009|FG002|Overall Study|Withdrawal by Subject|1|||
144619516|NCT00706134|521466010|FG003|Overall Study|Withdrawal by Subject|0|||
144619517|NCT00706134|521466007|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
144619518|NCT00706134|521466008|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144619519|NCT00706134|521466009|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
144619520|NCT00706134|521466010|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
144619521|NCT00706134|521466007|FG000|Overall Study|Did not meet study criteria|2|||
144619522|NCT00706134|521466008|FG001|Overall Study|Did not meet study criteria|0|||
144619523|NCT00706134|521466009|FG002|Overall Study|Did not meet study criteria|0|||
144619524|NCT00706134|521466010|FG003|Overall Study|Did not meet study criteria|0|||
144619525|NCT00452699|521466015|FG000|Overall Study|Adverse Event|10|||
144619526|NCT00452699|521466016|FG001|Overall Study|Adverse Event|3|||
144619527|NCT00452699|521466015|FG000|Overall Study|Lack of Efficacy|6|||
144619528|NCT00452699|521466016|FG001|Overall Study|Lack of Efficacy|4|||
144619529|NCT00452699|521466015|FG000|Overall Study|Lost to Follow-up|6|||
144619530|NCT00452699|521466016|FG001|Overall Study|Lost to Follow-up|9|||
144619531|NCT00452699|521466015|FG000|Overall Study|Protocol Violation|21|||
144619532|NCT00452699|521466016|FG001|Overall Study|Protocol Violation|25|||
144619533|NCT00452699|521466015|FG000|Overall Study|Withdrawal by Subject|26|||
144619534|NCT00452699|521466016|FG001|Overall Study|Withdrawal by Subject|25|||
144619535|NCT00452699|521466015|FG000|Overall Study|Other|12|||
144619536|NCT00452699|521466016|FG001|Overall Study|Other|7|||
144619537|NCT02921971|521466017|FG000|Overall Study|Adverse Event|1|||
144619538|NCT02921971|521466018|FG001|Overall Study|Adverse Event|2|||
144619539|NCT02921971|521466017|FG000|Overall Study|Lack of Efficacy|3|||
144619540|NCT02921971|521466018|FG001|Overall Study|Lack of Efficacy|1|||
144619541|NCT02921971|521466017|FG000|Overall Study|Other than specified above|2|||
144619542|NCT02921971|521466018|FG001|Overall Study|Other than specified above|1|||
144619543|NCT00272038|521466019|FG000|Overall Study|withdrew before they received 2 cycles|7|||
144619544|NCT04986202|521466024|FG000|Overall Study|Death|10|||
144619545|NCT04986202|521466025|FG001|Overall Study|Death|3|||
144619546|NCT04986202|521466026|FG002|Overall Study|Death|10|||
144619547|NCT04986202|521466024|FG000|Overall Study|Physician Decision|3|||
144619548|NCT04986202|521466025|FG001|Overall Study|Physician Decision|1|||
144619549|NCT04986202|521466026|FG002|Overall Study|Physician Decision|2|||
144619550|NCT04986202|521466024|FG000|Overall Study|Withdrawal by Subject|4|||
144619551|NCT04986202|521466025|FG001|Overall Study|Withdrawal by Subject|2|||
144206078|NCT01775189|519949440|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
144206079|NCT01775189|519949441|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144568316|NCT02706847|521280372|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
144568317|NCT02706847|521280369|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
144568318|NCT02706847|521280370|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
144568319|NCT02706847|521280371|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
144568320|NCT02706847|521280372|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
144568321|NCT02706847|521280369|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
144568322|NCT02706847|521280370|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
144568323|NCT02706847|521280371|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
144568324|NCT02706847|521280372|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
144568325|NCT02706847|521280369|FG000|Period 2: Week 24 to Week 260|Other|8|||
144619552|NCT04986202|521466026|FG002|Overall Study|Withdrawal by Subject|4|||
144619553|NCT02118792|521466027|FG000|Overall Study|Withdrawal by Subject|6|||
144619554|NCT02118792|521466028|FG001|Overall Study|Withdrawal by Subject|3|||
144619555|NCT02118792|521466027|FG000|Overall Study|Lost to Follow-up|4|||
144619556|NCT02118792|521466028|FG001|Overall Study|Lost to Follow-up|4|||
144619557|NCT02118792|521466027|FG000|Overall Study|Adverse Event|5|||
144619558|NCT02118792|521466028|FG001|Overall Study|Adverse Event|4|||
144619559|NCT02118792|521466027|FG000|Overall Study|Withdrawal by parent/guardian|14|||
144619560|NCT02118792|521466028|FG001|Overall Study|Withdrawal by parent/guardian|20|||
144728721|NCT02672553|521861315|FG001|Overall Study|Withdrawal by Subject|3|||
144619561|NCT02118792|521466027|FG000|Overall Study|Other|1|||
144619562|NCT02118792|521466028|FG001|Overall Study|Other|6|||
144619563|NCT02118792|521466027|FG000|Overall Study|Randomised but not treated|1|||
144206080|NCT01775189|519949442|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144568326|NCT02706847|521280370|FG001|Period 2: Week 24 to Week 260|Other|5|||
144568327|NCT02706847|521280371|FG002|Period 2: Week 24 to Week 260|Other|15|||
144568328|NCT02706847|521280372|FG003|Period 2: Week 24 to Week 260|Other|15|||
144568329|NCT03432390|521280373|FG000|Apnea Period|Protocol Violation|2|||
144568330|NCT03432390|521280374|FG001|Apnea Period|Protocol Violation|2|||
144568331|NCT05314374|521280375|FG000|Overall Study|Adverse Event|2|||
144568332|NCT05314374|521280376|FG001|Overall Study|Adverse Event|2|||
144568333|NCT02658175|521280377|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
144568334|NCT02658175|521280378|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
144568335|NCT02658175|521280379|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
144568336|NCT02658175|521280377|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
144568337|NCT02658175|521280378|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
144568338|NCT02658175|521280379|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
144568339|NCT02658175|521280377|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
144568340|NCT02658175|521280378|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
144568341|NCT02658175|521280379|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
144568342|NCT02658175|521280377|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
144568343|NCT02658175|521280378|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
144568344|NCT02658175|521280379|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
144568345|NCT02658175|521280377|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
144568346|NCT02658175|521280378|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
144568347|NCT02658175|521280379|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
144568348|NCT02658175|521280377|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
144568349|NCT02658175|521280378|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
144568350|NCT02658175|521280379|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
144568351|NCT02658175|521280377|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
144568352|NCT02658175|521280378|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
144568353|NCT02658175|521280379|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
144568354|NCT02658175|521280377|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
144568355|NCT02658175|521280378|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
144568356|NCT02658175|521280379|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
144568357|NCT02658175|521280377|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
144568358|NCT02658175|521280378|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
144568359|NCT02658175|521280379|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
144568360|NCT02658175|521280377|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
144568361|NCT02658175|521280378|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
144568362|NCT02658175|521280379|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
144568363|NCT02918292|521280380|FG000|Study Enrollment Prior to Transplant|Death|1|||
144568364|NCT02918292|521280380|FG000|Study Follow up After Transplant|Death|6|||
144568365|NCT01801982|521280381|FG000|Overall Study|Lost to Follow-up|1|||
144568366|NCT01482429|521280384|FG000|Care Usual|Protocol Violation|0|||
144568367|NCT01482429|521280385|FG001|Care Usual|Protocol Violation|172|||
144568368|NCT01482429|521280384|FG000|Care Usual|Lost to Follow-up|0|||
144568369|NCT01482429|521280385|FG001|Care Usual|Lost to Follow-up|1|||
144568370|NCT01482429|521280384|FG000|Protocol|Protocol Violation|275|||
144568371|NCT01482429|521280385|FG001|Protocol|Protocol Violation|0|||
144568372|NCT02650466|521280386|FG000|Overall Study|Physician Decision|1|||
144568373|NCT02650466|521280386|FG000|Overall Study|Withdrawal by Subject|5|||
144568374|NCT02650466|521280386|FG000|Overall Study|Lost to Follow-up|1|||
144568375|NCT03561597|521280387|FG000|Overall Study|Lost to Follow-up|20|||
144568376|NCT01214421|521280388|FG000|Overall Study|Lost to Follow-up|7|||
144568377|NCT01214421|521280389|FG001|Overall Study|Lost to Follow-up|3|||
144568378|NCT01214421|521280390|FG002|Overall Study|Lost to Follow-up|7|||
144568379|NCT01214421|521280391|FG003|Overall Study|Lost to Follow-up|3|||
144568380|NCT01214421|521280388|FG000|Overall Study|Adverse Event|16|||
144568381|NCT01214421|521280389|FG001|Overall Study|Adverse Event|35|||
144568382|NCT01214421|521280390|FG002|Overall Study|Adverse Event|14|||
144568383|NCT01214421|521280391|FG003|Overall Study|Adverse Event|3|||
144568384|NCT01214421|521280388|FG000|Overall Study|Sponsor Discontinued Site|1|||
144568385|NCT01214421|521280389|FG001|Overall Study|Sponsor Discontinued Site|2|||
144568386|NCT01214421|521280390|FG002|Overall Study|Sponsor Discontinued Site|0|||
144568387|NCT01214421|521280391|FG003|Overall Study|Sponsor Discontinued Site|0|||
144568388|NCT01214421|521280388|FG000|Overall Study|Withdrawal Criteria Met|3|||
144619564|NCT02118792|521466028|FG001|Overall Study|Randomised but not treated|0|||
144619565|NCT00290433|521466039|FG000|Overall Study|Disease Progression|13|||
144619566|NCT00290433|521466039|FG000|Overall Study|Adverse Event|14|||
144619567|NCT00290433|521466039|FG000|Overall Study|Withdrawal by Subject|1|||
144619568|NCT00290433|521466039|FG000|Overall Study|Non-Compliance|1|||
144619569|NCT00290433|521466039|FG000|Overall Study|Congestive Heart Failure|1|||
144619570|NCT00290433|521466039|FG000|Overall Study|Transplant in CR|5|||
144619571|NCT00290433|521466039|FG000|Overall Study|Unrelated Infection/Death|1|||
144619572|NCT00252057|521466042|FG000|Overall Study|Withdrawal by Subject|2|||
144619573|NCT00252057|521466043|FG001|Overall Study|Withdrawal by Subject|5|||
144568389|NCT01214421|521280389|FG001|Overall Study|Withdrawal Criteria Met|0|||
144568390|NCT01214421|521280390|FG002|Overall Study|Withdrawal Criteria Met|2|||
144619574|NCT00252057|521466042|FG000|Overall Study|Death|1|||
144568391|NCT01214421|521280391|FG003|Overall Study|Withdrawal Criteria Met|1|||
144568392|NCT01214421|521280388|FG000|Overall Study|Physician Decision|2|||
144568393|NCT01214421|521280389|FG001|Overall Study|Physician Decision|0|||
144568394|NCT01214421|521280390|FG002|Overall Study|Physician Decision|4|||
144568395|NCT01214421|521280391|FG003|Overall Study|Physician Decision|0|||
144568396|NCT01214421|521280388|FG000|Overall Study|Withdrawal by Subject|21|||
144568397|NCT01214421|521280389|FG001|Overall Study|Withdrawal by Subject|18|||
144568398|NCT01214421|521280390|FG002|Overall Study|Withdrawal by Subject|11|||
144568399|NCT01214421|521280391|FG003|Overall Study|Withdrawal by Subject|2|||
144568400|NCT03783689|521280393|FG000|Overall Study|Adverse Event|2|||
144568401|NCT03783689|521280394|FG001|Overall Study|Adverse Event|0|||
144568402|NCT03783689|521280393|FG000|Overall Study|Lost to Follow-up|2|||
144568403|NCT03783689|521280394|FG001|Overall Study|Lost to Follow-up|1|||
144568404|NCT03783689|521280393|FG000|Overall Study|Physician Decision|2|||
144568405|NCT03783689|521280394|FG001|Overall Study|Physician Decision|1|||
144568406|NCT03783689|521280393|FG000|Overall Study|Withdrawal by Subject|3|||
144568407|NCT03783689|521280394|FG001|Overall Study|Withdrawal by Subject|3|||
144568408|NCT01266018|521282056|FG000|Overall Study|Physician Decision|1|||
144568409|NCT01266018|521282057|FG001|Overall Study|Physician Decision|0|||
144568410|NCT01266018|521282056|FG000|Overall Study|Progressive disease|0|||
144568411|NCT01266018|521282057|FG001|Overall Study|Progressive disease|1|||
144568412|NCT03167151|521282058|FG000|Overall Study|Withdrawal by Subject|1|||
144568413|NCT03167151|521282059|FG001|Overall Study|Withdrawal by Subject|0|||
144568414|NCT03167151|521282060|FG002|Overall Study|Withdrawal by Subject|0|||
144568415|NCT03167151|521282058|FG000|Overall Study|No evidence of tumour at surgery|0|||
144568416|NCT03167151|521282059|FG001|Overall Study|No evidence of tumour at surgery|1|||
144568417|NCT03167151|521282060|FG002|Overall Study|No evidence of tumour at surgery|1|||
144568418|NCT01458522|521282061|FG000|Overall Study|Withdrawal by Subject|2|||
144568419|NCT01458522|521282062|FG001|Overall Study|Withdrawal by Subject|2|||
144568420|NCT01458522|521282061|FG000|Overall Study|Physician Decision|1|||
144568421|NCT01458522|521282062|FG001|Overall Study|Physician Decision|9|||
144568422|NCT00516139|521282063|FG000|Overall Study|Adverse Event|27|||
144568423|NCT00516139|521282063|FG000|Overall Study|Lost to Follow-up|1|||
144568424|NCT00516139|521282063|FG000|Overall Study|Protocol Violation|1|||
144568425|NCT00516139|521282063|FG000|Overall Study|Withdrawal by Subject|8|||
144619575|NCT00252057|521466043|FG001|Overall Study|Death|2|||
144619576|NCT00252057|521466042|FG000|Overall Study|Participant previously enrolled|0|||
144619577|NCT00252057|521466043|FG001|Overall Study|Participant previously enrolled|1|||
144619578|NCT01098071|521466044|FG000|Overall Study|Surgery (adenoidectomy)|2|||
144619579|NCT01098071|521466044|FG000|Overall Study|Lost to Follow-up|13|||
144619580|NCT00705939|521466046|FG000|Overall Study|Protocol Violation|0|||
144206081|NCT01775189|519949443|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144206082|NCT01775189|519949444|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144262724|NCT00490971|520161548|FG001|Acute/Continuation|Lack of Efficacy|12|||
144262725|NCT00490971|520161549|FG002|Acute/Continuation|Lack of Efficacy|0|||
144262726|NCT00490971|520161550|FG003|Acute/Continuation|Lack of Efficacy|0|||
144262727|NCT00490971|520161551|FG004|Acute/Continuation|Lack of Efficacy|0|||
144206083|NCT01775189|519949445|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
144206084|NCT01775189|519949439|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
144206085|NCT01775189|519949440|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
144206086|NCT01775189|519949441|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
144206087|NCT01775189|519949442|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
144206088|NCT01775189|519949443|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
144206089|NCT01775189|519949444|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
144206090|NCT01775189|519949445|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
144206091|NCT01775189|519949439|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
144206092|NCT01775189|519949440|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
144206093|NCT01775189|519949441|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
144206094|NCT01775189|519949442|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
144206095|NCT01775189|519949443|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
144206096|NCT01775189|519949444|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
144206097|NCT01775189|519949445|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
144262728|NCT00490971|520161547|FG000|Acute/Continuation|Lost to Follow-up|23|||
144568426|NCT00516139|521282063|FG000|Overall Study|Lack of Efficacy|1|||
144568427|NCT00416598|521282064|FG000|Induction & Intensification|Adverse Event|38|||
144568428|NCT00416598|521282064|FG000|Induction & Intensification|Death|32|||
144568429|NCT00416598|521282064|FG000|Induction & Intensification|Withdrawal by Subject|46|||
144568430|NCT00416598|521282064|FG000|Induction & Intensification|Alternative Treatment|135|||
144568431|NCT00416598|521282064|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
144568432|NCT00416598|521282064|FG000|Induction & Intensification|Relapse/progression|29|||
144568433|NCT00416598|521282064|FG000|Induction & Intensification|Failed induction|87|||
144568434|NCT00416598|521282064|FG000|Decitabine Maintenance|Adverse Event|5|||
144568435|NCT00416598|521282064|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
144568436|NCT00416598|521282064|FG000|Decitabine Maintenance|Progression/relapse|38|||
144568437|NCT00416598|521282064|FG000|Decitabine Maintenance|Alternative treatment|2|||
144568438|NCT00416598|521282064|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
144568439|NCT02166476|521282071|FG000|Overall Study|Withdrawal by Subject|5|||
144568440|NCT02166476|521282072|FG001|Overall Study|Withdrawal by Subject|7|||
144568441|NCT02166476|521282071|FG000|Overall Study|Adverse Event|3|||
144568442|NCT02166476|521282072|FG001|Overall Study|Adverse Event|3|||
144568443|NCT02166476|521282071|FG000|Overall Study|Lost to Follow-up|5|||
144568444|NCT02166476|521282072|FG001|Overall Study|Lost to Follow-up|10|||
144568445|NCT02166476|521282071|FG000|Overall Study|Physician Decision|1|||
144568446|NCT02166476|521282072|FG001|Overall Study|Physician Decision|0|||
144568447|NCT02166476|521282071|FG000|Overall Study|Unable to Come for Visit|0|||
144568448|NCT02166476|521282072|FG001|Overall Study|Unable to Come for Visit|3|||
144568449|NCT03382561|521282077|FG000|Overall Study|Disease progression|47|||
144568450|NCT03382561|521282078|FG001|Overall Study|Disease progression|6|||
144568451|NCT03382561|521282077|FG000|Overall Study|Adverse Event|10|||
144568452|NCT03382561|521282078|FG001|Overall Study|Adverse Event|2|||
144568453|NCT03382561|521282077|FG000|Overall Study|Death|8|||
144568454|NCT03382561|521282078|FG001|Overall Study|Death|3|||
144568455|NCT03382561|521282077|FG000|Overall Study|Withdrawal by Subject|6|||
144568456|NCT03382561|521282078|FG001|Overall Study|Withdrawal by Subject|5|||
144568457|NCT03382561|521282077|FG000|Overall Study|Alternative therapy|2|||
144568458|NCT03382561|521282078|FG001|Overall Study|Alternative therapy|8|||
144568459|NCT03382561|521282077|FG000|Overall Study|Never started treatment|3|||
144568460|NCT03382561|521282078|FG001|Overall Study|Never started treatment|6|||
144568461|NCT03382561|521282077|FG000|Overall Study|Lack of Efficacy|0|||
144568462|NCT03382561|521282078|FG001|Overall Study|Lack of Efficacy|1|||
144568463|NCT03382561|521282077|FG000|Overall Study|Physician Decision|0|||
144568464|NCT03382561|521282078|FG001|Overall Study|Physician Decision|1|||
144568465|NCT03382561|521282077|FG000|Overall Study|Other complicating disease|0|||
144568466|NCT03382561|521282078|FG001|Overall Study|Other complicating disease|1|||
144568467|NCT01131104|521282079|FG000|Overall Study|Withdrawal by Subject|3|||
144619581|NCT00705939|521466047|FG001|Overall Study|Protocol Violation|0|||
144619582|NCT00705939|521466048|FG002|Overall Study|Protocol Violation|1|||
144206098|NCT01775189|519949439|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
144206099|NCT01775189|519949440|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
144206100|NCT01775189|519949441|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
144206101|NCT01775189|519949442|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
144206102|NCT01775189|519949443|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
144206103|NCT01775189|519949444|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
144206104|NCT01775189|519949445|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
144206105|NCT01775189|519949439|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
144206106|NCT01775189|519949440|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
144206107|NCT01775189|519949441|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
144206108|NCT01775189|519949442|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
144206109|NCT01775189|519949443|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
144206110|NCT01775189|519949444|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
144206111|NCT01775189|519949445|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
144206112|NCT00998309|519949446|FG000|Overall Study|Protocol Violation|4|||
144206113|NCT00901576|519949455|FG000|Second Intervention|Withdrawal by Subject|0|||
144206114|NCT00901576|519949456|FG001|Second Intervention|Withdrawal by Subject|0|||
144206115|NCT00901576|519949457|FG002|Second Intervention|Withdrawal by Subject|0|||
144206116|NCT00901576|519949458|FG003|Second Intervention|Withdrawal by Subject|1|||
144206117|NCT00901576|519949459|FG004|Second Intervention|Withdrawal by Subject|0|||
144206118|NCT00901576|519949460|FG005|Second Intervention|Withdrawal by Subject|1|||
144206119|NCT00901576|519949455|FG000|Second Intervention|Physician Decision|1|||
144206120|NCT00901576|519949456|FG001|Second Intervention|Physician Decision|0|||
144206121|NCT00901576|519949457|FG002|Second Intervention|Physician Decision|0|||
144206122|NCT00901576|519949458|FG003|Second Intervention|Physician Decision|0|||
144206123|NCT00901576|519949459|FG004|Second Intervention|Physician Decision|0|||
144206124|NCT00901576|519949460|FG005|Second Intervention|Physician Decision|0|||
144206125|NCT01559389|519949461|FG000|Overall Study|Withdrawal by Subject|20|||
144206126|NCT01559389|519949462|FG001|Overall Study|Withdrawal by Subject|20|||
144206127|NCT02871492|519949463|FG000|Overall Study|Lost to Follow-up|6|||
144206128|NCT02871492|519949464|FG001|Overall Study|Lost to Follow-up|3|||
144206129|NCT02871492|519949465|FG002|Overall Study|Lost to Follow-up|5|||
144206130|NCT02871492|519949463|FG000|Overall Study|Withdrawal by Subject|0|||
144206131|NCT02871492|519949464|FG001|Overall Study|Withdrawal by Subject|0|||
144568468|NCT01131104|521282079|FG000|Overall Study|Physician Decision|4|||
144568469|NCT01131104|521282079|FG000|Overall Study|Information Not Available|5|||
144568470|NCT01131104|521282079|FG000|Overall Study|No Information on Index Date of Onset|1|||
144568471|NCT04836559|521282080|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
144568472|NCT04836559|521282081|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
144568473|NCT04836559|521282082|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
144568474|NCT04836559|521282083|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
144568475|NCT04836559|521282084|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
144568476|NCT04836559|521282085|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
144568477|NCT04836559|521282086|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
144568478|NCT04836559|521282087|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
144568479|NCT04836559|521282080|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
144568480|NCT04836559|521282081|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
144568481|NCT04836559|521282082|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
144568482|NCT04836559|521282083|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
144568483|NCT04836559|521282084|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
144568484|NCT04836559|521282085|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
144568485|NCT04836559|521282086|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
144568486|NCT04836559|521282087|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
144568487|NCT04836559|521282080|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
144568488|NCT04836559|521282081|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568489|NCT04836559|521282082|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568490|NCT04836559|521282083|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568491|NCT04836559|521282084|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568492|NCT04836559|521282085|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568493|NCT04836559|521282086|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568494|NCT04836559|521282087|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
144568495|NCT04836559|521282080|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
144568496|NCT04836559|521282081|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
144568497|NCT04836559|521282082|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
144568498|NCT04836559|521282083|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
144568499|NCT04836559|521282084|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
144728722|NCT02672553|521861314|FG000|Overall Study|Intraoperative screen failure|2|||
144728723|NCT02672553|521861315|FG001|Overall Study|Intraoperative screen failure|0|||
144728724|NCT01606306|521861316|FG000|Overall Study|Lack of Efficacy|2|||
144728725|NCT01606306|521861317|FG001|Overall Study|Lack of Efficacy|1|||
144728726|NCT01606306|521861318|FG002|Overall Study|Lack of Efficacy|4|||
144728727|NCT01606306|521861319|FG003|Overall Study|Lack of Efficacy|4|||
144728728|NCT01606306|521861320|FG004|Overall Study|Lack of Efficacy|1|||
144728729|NCT01606306|521861321|FG005|Overall Study|Lack of Efficacy|2|||
144728730|NCT01606306|521861316|FG000|Overall Study|Adverse Event|1|||
144728731|NCT01606306|521861317|FG001|Overall Study|Adverse Event|0|||
144728732|NCT01606306|521861318|FG002|Overall Study|Adverse Event|1|||
144728733|NCT01606306|521861319|FG003|Overall Study|Adverse Event|1|||
144568500|NCT04836559|521282085|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
144728734|NCT01606306|521861320|FG004|Overall Study|Adverse Event|2|||
144728735|NCT01606306|521861321|FG005|Overall Study|Adverse Event|0|||
144728736|NCT01606306|521861316|FG000|Overall Study|Lost to Follow-up|7|||
144728737|NCT01606306|521861317|FG001|Overall Study|Lost to Follow-up|4|||
144728738|NCT01606306|521861318|FG002|Overall Study|Lost to Follow-up|5|||
144728739|NCT01606306|521861319|FG003|Overall Study|Lost to Follow-up|4|||
144728740|NCT01606306|521861320|FG004|Overall Study|Lost to Follow-up|3|||
144728741|NCT01606306|521861321|FG005|Overall Study|Lost to Follow-up|5|||
144728742|NCT01606306|521861316|FG000|Overall Study|Withdrawal by Subject|4|||
144728743|NCT01606306|521861317|FG001|Overall Study|Withdrawal by Subject|3|||
144728744|NCT01606306|521861318|FG002|Overall Study|Withdrawal by Subject|4|||
144728745|NCT01606306|521861319|FG003|Overall Study|Withdrawal by Subject|4|||
144728746|NCT01606306|521861320|FG004|Overall Study|Withdrawal by Subject|5|||
144728747|NCT01606306|521861321|FG005|Overall Study|Withdrawal by Subject|4|||
144728748|NCT01606306|521861316|FG000|Overall Study|Physician Decision|1|||
144728749|NCT01606306|521861317|FG001|Overall Study|Physician Decision|2|||
144728750|NCT01606306|521861318|FG002|Overall Study|Physician Decision|0|||
144728751|NCT01606306|521861319|FG003|Overall Study|Physician Decision|0|||
144728752|NCT01606306|521861320|FG004|Overall Study|Physician Decision|0|||
144728753|NCT01606306|521861321|FG005|Overall Study|Physician Decision|0|||
144728754|NCT00950872|521861322|FG000|Overall Study|Withdrawal by Subject|1|||
144728755|NCT00950872|521861322|FG000|Overall Study|Did not have surgery|2|||
144728756|NCT00970281|521861325|FG000|Overall Study|Lack of Efficacy|1|||
144206132|NCT02871492|519949465|FG002|Overall Study|Withdrawal by Subject|1|||
144206133|NCT04546724|519949466|FG000|Overall Study|Withdrawal by Subject|145|||
144206134|NCT04546724|519949467|FG001|Overall Study|Withdrawal by Subject|41|||
144568501|NCT04836559|521282086|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
144568502|NCT04836559|521282087|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
144206135|NCT04546724|519949466|FG000|Overall Study|Adverse Event|1|||
144728757|NCT00970281|521861326|FG001|Overall Study|Lack of Efficacy|14|||
144728758|NCT00970281|521861325|FG000|Overall Study|Withdrawal by Subject|0|||
144728759|NCT00970281|521861326|FG001|Overall Study|Withdrawal by Subject|1|||
144728760|NCT00970281|521861325|FG000|Overall Study|Physician Decision|1|||
144728761|NCT00970281|521861326|FG001|Overall Study|Physician Decision|1|||
144206136|NCT04546724|519949467|FG001|Overall Study|Adverse Event|1|||
144206137|NCT04546724|519949466|FG000|Overall Study|Lost to Follow-up|186|||
144206138|NCT04546724|519949467|FG001|Overall Study|Lost to Follow-up|63|||
144206139|NCT04546724|519949466|FG000|Overall Study|Physician Decision|8|||
144206140|NCT04546724|519949467|FG001|Overall Study|Physician Decision|2|||
144206141|NCT04546724|519949466|FG000|Overall Study|Death|2|||
144206142|NCT04546724|519949467|FG001|Overall Study|Death|1|||
144206143|NCT04546724|519949466|FG000|Overall Study|subject has been out of town|1|||
144206144|NCT04546724|519949467|FG001|Overall Study|subject has been out of town|0|||
144206145|NCT04546724|519949466|FG000|Overall Study|subject is incarcerated|2|||
144206146|NCT04546724|519949467|FG001|Overall Study|subject is incarcerated|0|||
144206147|NCT04546724|519949466|FG000|Overall Study|subject is relocating|12|||
144206148|NCT04546724|519949467|FG001|Overall Study|subject is relocating|4|||
144206149|NCT04546724|519949466|FG000|Overall Study|Subject in another study|1|||
144206150|NCT04546724|519949467|FG001|Overall Study|Subject in another study|1|||
144206151|NCT02256436|519949470|FG000|Overall Study|Adverse Event|9|||
144206152|NCT02256436|519949471|FG001|Overall Study|Adverse Event|14|||
144568503|NCT04836559|521282080|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144568504|NCT04836559|521282081|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144568505|NCT04836559|521282082|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144568506|NCT04836559|521282083|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
144568507|NCT04836559|521282084|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144206153|NCT02256436|519949470|FG000|Overall Study|Death|216|||
144206154|NCT02256436|519949471|FG001|Overall Study|Death|208|||
144206155|NCT02256436|519949470|FG000|Overall Study|Lost to Follow-up|1|||
144206156|NCT02256436|519949471|FG001|Overall Study|Lost to Follow-up|2|||
144206157|NCT02256436|519949470|FG000|Overall Study|Physician Decision|1|||
144206158|NCT02256436|519949471|FG001|Overall Study|Physician Decision|0|||
144206159|NCT02256436|519949470|FG000|Overall Study|Protocol Violation|0|||
144206160|NCT02256436|519949471|FG001|Overall Study|Protocol Violation|1|||
144206161|NCT02256436|519949470|FG000|Overall Study|Withdrawal by Subject|26|||
144568508|NCT04836559|521282085|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144568509|NCT04836559|521282086|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144568510|NCT04836559|521282087|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
144568511|NCT04836559|521282080|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
144568512|NCT04836559|521282081|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
144568513|NCT04836559|521282082|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
144568514|NCT04836559|521282083|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
144568515|NCT04836559|521282084|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
144568516|NCT04836559|521282085|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
144568517|NCT04836559|521282086|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
144568518|NCT04836559|521282087|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
144568519|NCT04836559|521282080|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
144568520|NCT04836559|521282081|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
144568521|NCT04836559|521282082|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
144568522|NCT04836559|521282083|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
144568523|NCT04836559|521282084|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
144619583|NCT00705939|521466046|FG000|Overall Study|Withdrawal by Subject|0|||
144619584|NCT00705939|521466047|FG001|Overall Study|Withdrawal by Subject|1|||
144619585|NCT00705939|521466048|FG002|Overall Study|Withdrawal by Subject|3|||
144619586|NCT00705939|521466046|FG000|Overall Study|Physician Decision|0|||
144619587|NCT00705939|521466047|FG001|Overall Study|Physician Decision|1|||
144619588|NCT00705939|521466048|FG002|Overall Study|Physician Decision|0|||
144619589|NCT05048342|521466049|FG000|Overall Study|Adverse Event|1|||
144619590|NCT05048342|521466049|FG000|Overall Study|Subject decision|2|||
144619591|NCT00797732|521466050|FG000|Overall Study|Withdrawal by Subject|3|||
144568524|NCT04836559|521282085|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
144568525|NCT04836559|521282086|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
144568526|NCT04836559|521282087|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
144568527|NCT04836559|521282080|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
144568528|NCT04836559|521282081|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
144619592|NCT00797732|521466051|FG001|Overall Study|Withdrawal by Subject|3|||
144619593|NCT00797732|521466052|FG002|Overall Study|Withdrawal by Subject|0|||
144619594|NCT00797732|521466050|FG000|Overall Study|Lost to Follow-up|1|||
144619595|NCT00797732|521466051|FG001|Overall Study|Lost to Follow-up|0|||
144206162|NCT02256436|519949471|FG001|Overall Study|Withdrawal by Subject|10|||
144206163|NCT02256436|519949470|FG000|Overall Study|Transferred to Extension Study|11|||
144206164|NCT02256436|519949471|FG001|Overall Study|Transferred to Extension Study|23|||
144206165|NCT02256436|519949470|FG000|Overall Study|Did Not Continue on Extension Study|8|||
144206166|NCT02256436|519949471|FG001|Overall Study|Did Not Continue on Extension Study|12|||
144206167|NCT03583086|519949472|FG000|Overall Study|Death|2|||
144206168|NCT03583086|519949473|FG001|Overall Study|Death|6|||
144206169|NCT03583086|519949474|FG002|Overall Study|Death|12|||
144206170|NCT03583086|519949475|FG003|Overall Study|Death|10|||
144206171|NCT03583086|519949476|FG004|Overall Study|Death|14|||
144206172|NCT03583086|519949477|FG005|Overall Study|Death|14|||
144206173|NCT03583086|519949478|FG006|Overall Study|Death|4|||
144206174|NCT03583086|519949472|FG000|Overall Study|Withdrawal by Subject|0|||
144206175|NCT03583086|519949473|FG001|Overall Study|Withdrawal by Subject|0|||
144206176|NCT03583086|519949474|FG002|Overall Study|Withdrawal by Subject|1|||
144206177|NCT03583086|519949475|FG003|Overall Study|Withdrawal by Subject|0|||
144206178|NCT03583086|519949476|FG004|Overall Study|Withdrawal by Subject|0|||
144206179|NCT03583086|519949477|FG005|Overall Study|Withdrawal by Subject|0|||
144206180|NCT03583086|519949478|FG006|Overall Study|Withdrawal by Subject|1|||
144206181|NCT03583086|519949472|FG000|Overall Study|Refused follow-up|0|||
144206182|NCT03583086|519949473|FG001|Overall Study|Refused follow-up|0|||
144206183|NCT03583086|519949474|FG002|Overall Study|Refused follow-up|1|||
144206184|NCT03583086|519949475|FG003|Overall Study|Refused follow-up|0|||
144206185|NCT03583086|519949476|FG004|Overall Study|Refused follow-up|1|||
144206186|NCT03583086|519949477|FG005|Overall Study|Refused follow-up|0|||
144206187|NCT03583086|519949478|FG006|Overall Study|Refused follow-up|0|||
144206188|NCT03583086|519949472|FG000|Overall Study|Declining Performance Status|0|||
144206189|NCT03583086|519949473|FG001|Overall Study|Declining Performance Status|0|||
144206190|NCT03583086|519949474|FG002|Overall Study|Declining Performance Status|1|||
144206191|NCT03583086|519949475|FG003|Overall Study|Declining Performance Status|0|||
144206192|NCT03583086|519949476|FG004|Overall Study|Declining Performance Status|0|||
144206193|NCT03583086|519949477|FG005|Overall Study|Declining Performance Status|0|||
144206194|NCT03583086|519949478|FG006|Overall Study|Declining Performance Status|0|||
144206195|NCT03583086|519949472|FG000|Overall Study|Still on study|0|||
144206196|NCT03583086|519949473|FG001|Overall Study|Still on study|0|||
144206197|NCT03583086|519949474|FG002|Overall Study|Still on study|0|||
144206198|NCT03583086|519949475|FG003|Overall Study|Still on study|1|||
144206199|NCT03583086|519949476|FG004|Overall Study|Still on study|0|||
144206200|NCT03583086|519949477|FG005|Overall Study|Still on study|0|||
144206201|NCT03583086|519949478|FG006|Overall Study|Still on study|1|||
144206202|NCT03583086|519949472|FG000|Overall Study|Disease progression|0|||
144568529|NCT04836559|521282082|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
144568530|NCT04836559|521282083|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
144568531|NCT04836559|521282084|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
144568532|NCT04836559|521282085|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
144568533|NCT04836559|521282086|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
144568534|NCT04836559|521282087|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
144568535|NCT04836559|521282080|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568536|NCT04836559|521282081|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568537|NCT04836559|521282082|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568538|NCT04836559|521282083|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568539|NCT04836559|521282084|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568540|NCT04836559|521282085|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568541|NCT04836559|521282086|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
144568542|NCT04836559|521282087|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
144568543|NCT00730015|521282088|FG000|Overall Study|Adverse Event|11|||
144568544|NCT00730015|521282089|FG001|Overall Study|Adverse Event|10|||
144568545|NCT00730015|521282090|FG002|Overall Study|Adverse Event|8|||
144568546|NCT00730015|521282088|FG000|Overall Study|Protocol Violation|2|||
144568547|NCT00730015|521282089|FG001|Overall Study|Protocol Violation|6|||
144568548|NCT00730015|521282090|FG002|Overall Study|Protocol Violation|4|||
144568549|NCT00730015|521282088|FG000|Overall Study|Withdrawal by Subject|12|||
144568550|NCT00730015|521282089|FG001|Overall Study|Withdrawal by Subject|12|||
144568551|NCT00730015|521282090|FG002|Overall Study|Withdrawal by Subject|8|||
144568552|NCT00730015|521282088|FG000|Overall Study|Lost to Follow-up|4|||
144568553|NCT00730015|521282089|FG001|Overall Study|Lost to Follow-up|10|||
144568554|NCT00730015|521282090|FG002|Overall Study|Lost to Follow-up|3|||
144568555|NCT00730015|521282088|FG000|Overall Study|Lack of Efficacy|1|||
144568556|NCT00730015|521282089|FG001|Overall Study|Lack of Efficacy|2|||
144568557|NCT00730015|521282090|FG002|Overall Study|Lack of Efficacy|8|||
144206203|NCT03583086|519949473|FG001|Overall Study|Disease progression|0|||
144206204|NCT03583086|519949474|FG002|Overall Study|Disease progression|0|||
144206205|NCT03583086|519949475|FG003|Overall Study|Disease progression|0|||
144206206|NCT03583086|519949476|FG004|Overall Study|Disease progression|0|||
144206207|NCT03583086|519949477|FG005|Overall Study|Disease progression|0|||
144206208|NCT03583086|519949478|FG006|Overall Study|Disease progression|1|||
144568558|NCT00730015|521282088|FG000|Overall Study|Other Reason|1|||
144568559|NCT00730015|521282089|FG001|Overall Study|Other Reason|0|||
144568560|NCT00730015|521282090|FG002|Overall Study|Other Reason|1|||
144206209|NCT03583086|519949472|FG000|Overall Study|Undergoing radiation therapy|0|||
144206210|NCT03583086|519949473|FG001|Overall Study|Undergoing radiation therapy|0|||
144206211|NCT03583086|519949474|FG002|Overall Study|Undergoing radiation therapy|0|||
144206212|NCT03583086|519949475|FG003|Overall Study|Undergoing radiation therapy|0|||
144262729|NCT00490971|520161548|FG001|Acute/Continuation|Lost to Follow-up|7|||
144262730|NCT00490971|520161549|FG002|Acute/Continuation|Lost to Follow-up|0|||
144262731|NCT00490971|520161550|FG003|Acute/Continuation|Lost to Follow-up|0|||
144262732|NCT00490971|520161551|FG004|Acute/Continuation|Lost to Follow-up|0|||
144262733|NCT00490971|520161547|FG000|Acute/Continuation|Protocol Violation|10|||
144262734|NCT00490971|520161548|FG001|Acute/Continuation|Protocol Violation|2|||
144262735|NCT00490971|520161549|FG002|Acute/Continuation|Protocol Violation|0|||
144262736|NCT00490971|520161550|FG003|Acute/Continuation|Protocol Violation|0|||
144262737|NCT00490971|520161551|FG004|Acute/Continuation|Protocol Violation|0|||
144262738|NCT00490971|520161547|FG000|Acute/Continuation|Withdrawal by Subject|92|||
144262739|NCT00490971|520161548|FG001|Acute/Continuation|Withdrawal by Subject|24|||
144262740|NCT00490971|520161549|FG002|Acute/Continuation|Withdrawal by Subject|0|||
144262741|NCT00490971|520161550|FG003|Acute/Continuation|Withdrawal by Subject|0|||
144262742|NCT00490971|520161551|FG004|Acute/Continuation|Withdrawal by Subject|0|||
144262743|NCT00490971|520161547|FG000|Acute/Continuation|Other|11|||
144262744|NCT00490971|520161548|FG001|Acute/Continuation|Other|4|||
144262745|NCT00490971|520161549|FG002|Acute/Continuation|Other|0|||
144262746|NCT00490971|520161550|FG003|Acute/Continuation|Other|0|||
144262747|NCT00490971|520161551|FG004|Acute/Continuation|Other|0|||
144262748|NCT00490971|520161547|FG000|Maintenance|Adverse Event|0|||
144262749|NCT00490971|520161548|FG001|Maintenance|Adverse Event|0|||
144206213|NCT03583086|519949476|FG004|Overall Study|Undergoing radiation therapy|0|||
144206214|NCT03583086|519949477|FG005|Overall Study|Undergoing radiation therapy|0|||
144206215|NCT03583086|519949478|FG006|Overall Study|Undergoing radiation therapy|1|||
144206216|NCT03583086|519949472|FG000|Overall Study|Lost to Follow-up|0|||
144206217|NCT03583086|519949473|FG001|Overall Study|Lost to Follow-up|0|||
144206218|NCT03583086|519949474|FG002|Overall Study|Lost to Follow-up|0|||
144206219|NCT03583086|519949475|FG003|Overall Study|Lost to Follow-up|0|||
144206220|NCT03583086|519949476|FG004|Overall Study|Lost to Follow-up|0|||
144206221|NCT03583086|519949477|FG005|Overall Study|Lost to Follow-up|1|||
144206222|NCT03583086|519949478|FG006|Overall Study|Lost to Follow-up|0|||
144206223|NCT03583086|519949472|FG000|Overall Study|Adverse Event|0|||
144206224|NCT03583086|519949473|FG001|Overall Study|Adverse Event|0|||
144206225|NCT03583086|519949474|FG002|Overall Study|Adverse Event|0|||
144206226|NCT03583086|519949475|FG003|Overall Study|Adverse Event|0|||
144206227|NCT03583086|519949476|FG004|Overall Study|Adverse Event|0|||
144206228|NCT03583086|519949477|FG005|Overall Study|Adverse Event|1|||
144206229|NCT03583086|519949478|FG006|Overall Study|Adverse Event|0|||
144206230|NCT01696279|519949479|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
144206231|NCT01696279|519949480|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
144206232|NCT01696279|519949481|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
144206233|NCT01696279|519949482|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
144206234|NCT01696279|519949479|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
144206235|NCT01696279|519949480|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
144206236|NCT01696279|519949481|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
144206237|NCT01696279|519949482|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
144206238|NCT01696279|519949479|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
144206239|NCT01696279|519949480|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
144206240|NCT01696279|519949481|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
144206241|NCT01696279|519949482|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
144206242|NCT01696279|519949479|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
144206243|NCT01696279|519949480|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
144206244|NCT01696279|519949481|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
144206245|NCT01696279|519949482|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
144206246|NCT01696279|519949479|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
144206247|NCT01696279|519949480|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
144262750|NCT00490971|520161549|FG002|Maintenance|Adverse Event|4|||
144262751|NCT00490971|520161550|FG003|Maintenance|Adverse Event|5|||
144262752|NCT00490971|520161551|FG004|Maintenance|Adverse Event|7|||
144568561|NCT03210519|521282091|FG000|Overall Study|Adverse Event|2|||
144206248|NCT01696279|519949481|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
144206249|NCT01696279|519949482|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
144206250|NCT01696279|519949479|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
144206251|NCT01696279|519949480|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
144262753|NCT00490971|520161547|FG000|Maintenance|Death|0|||
144262754|NCT00490971|520161548|FG001|Maintenance|Death|0|||
144262755|NCT00490971|520161549|FG002|Maintenance|Death|0|||
144262756|NCT00490971|520161550|FG003|Maintenance|Death|2|||
144262757|NCT00490971|520161551|FG004|Maintenance|Death|0|||
144262758|NCT00490971|520161547|FG000|Maintenance|Lost to Follow-up|0|||
144262759|NCT00490971|520161548|FG001|Maintenance|Lost to Follow-up|0|||
144262760|NCT00490971|520161549|FG002|Maintenance|Lost to Follow-up|5|||
144206252|NCT01696279|519949481|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
144206253|NCT01696279|519949482|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
144206254|NCT01696279|519949479|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
144206255|NCT01696279|519949480|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
144206256|NCT01696279|519949481|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
144206257|NCT01696279|519949482|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
144568562|NCT03210519|521282092|FG001|Overall Study|Adverse Event|0|||
144568563|NCT02270671|521282093|FG000|Overall Study|Withdrawal by Subject|1|||
144568564|NCT02270671|521282094|FG001|Overall Study|Withdrawal by Subject|1|||
144568565|NCT02270671|521282093|FG000|Overall Study|Protocol Violation|0|||
144568566|NCT02270671|521282094|FG001|Overall Study|Protocol Violation|1|||
144568567|NCT02270671|521282093|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
144206258|NCT01696279|519949479|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
144206259|NCT01696279|519949480|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
144206260|NCT01696279|519949481|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
144206261|NCT01696279|519949482|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
144206262|NCT01696279|519949479|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
144206263|NCT01696279|519949480|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
144206264|NCT01696279|519949481|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
144206265|NCT01696279|519949482|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
144206266|NCT01696279|519949479|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
144206267|NCT01696279|519949480|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
144206268|NCT01696279|519949481|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
144206269|NCT01696279|519949482|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
144206270|NCT01696279|519949479|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
144206271|NCT01696279|519949480|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
144206272|NCT01696279|519949481|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
144206273|NCT01696279|519949482|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
144206274|NCT00171951|519949484|FG000|Overall Study|Adverse Event|1|||
144206275|NCT00171951|519949484|FG000|Overall Study|Abnormal Laboratory Values|2|||
144206276|NCT00171951|519949484|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144206277|NCT00171951|519949484|FG000|Overall Study|Participants Withdrew Consent|3|||
144206278|NCT00171951|519949484|FG000|Overall Study|New Cancer Therapy|5|||
144206279|NCT00171951|519949484|FG000|Overall Study|Reason not Specified|2|||
144206280|NCT00396812|519949485|FG000|Overall Study|Physician Decision|1|||
144206281|NCT03201445|519949489|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
144206282|NCT03201445|519949490|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
144206283|NCT03201445|519949489|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
144206284|NCT03201445|519949490|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
144206285|NCT03201445|519949489|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
144206286|NCT03201445|519949490|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
144206287|NCT03201445|519949489|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
144206288|NCT03201445|519949490|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
144206289|NCT03201445|519949489|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
144206290|NCT03201445|519949490|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
144206291|NCT03201445|519949489|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
144206292|NCT03201445|519949490|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
144206293|NCT03201445|519949489|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
144206294|NCT03201445|519949490|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
144206295|NCT03201445|519949489|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
144206296|NCT03201445|519949490|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
144206297|NCT03201445|519949489|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
144206298|NCT03201445|519949490|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
144206299|NCT03201445|519949489|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
144206300|NCT03201445|519949490|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
144206301|NCT03201445|519949489|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
144206302|NCT03201445|519949490|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
144206303|NCT03201445|519949489|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
144206304|NCT03201445|519949490|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
144568568|NCT02270671|521282094|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
144568569|NCT02270671|521282093|FG000|Overall Study|Lost to Follow-up|2|||
144568570|NCT02270671|521282094|FG001|Overall Study|Lost to Follow-up|1|||
144206305|NCT03201445|519949489|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
144206306|NCT03201445|519949490|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
144206307|NCT03201445|519949489|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
144206308|NCT03201445|519949490|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
144206309|NCT03201445|519949489|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
144619596|NCT00797732|521466052|FG002|Overall Study|Lost to Follow-up|0|||
144206310|NCT03201445|519949490|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
144568571|NCT01657799|521282097|FG000|Overall Study|Adverse Event Related to progression|6|||
144568572|NCT01657799|521282098|FG001|Overall Study|Adverse Event Related to progression|8|||
144568573|NCT01657799|521282099|FG002|Overall Study|Adverse Event Related to progression|12|||
144568574|NCT01657799|521282097|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
144568575|NCT01657799|521282098|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
144568576|NCT01657799|521282099|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
144568577|NCT01657799|521282097|FG000|Overall Study|Withdrawal by Subject|13|||
144568578|NCT01657799|521282098|FG001|Overall Study|Withdrawal by Subject|10|||
144568579|NCT01657799|521282099|FG002|Overall Study|Withdrawal by Subject|10|||
144206311|NCT03201445|519949489|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
144206312|NCT03201445|519949490|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
144206313|NCT03201445|519949489|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
144206314|NCT03201445|519949490|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
144206315|NCT03201445|519949489|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
144206316|NCT03201445|519949490|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
144206317|NCT03201445|519949489|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
144206318|NCT03201445|519949490|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
144206319|NCT03201445|519949489|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
144206320|NCT03201445|519949490|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
144206321|NCT03201445|519949489|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
144206322|NCT03201445|519949490|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
144206323|NCT01346293|519949493|FG000|Overall Study|Protocol Violation|30|||
144206324|NCT01346293|519949494|FG001|Overall Study|Protocol Violation|9|||
144206325|NCT01346293|519949493|FG000|Overall Study|Lost to Follow-up|21|||
144206326|NCT01346293|519949494|FG001|Overall Study|Lost to Follow-up|8|||
144206327|NCT01346293|519949493|FG000|Overall Study|Withdrawal by Subject|15|||
144206328|NCT01346293|519949494|FG001|Overall Study|Withdrawal by Subject|4|||
144206329|NCT01346293|519949493|FG000|Overall Study|Other|1|||
144206330|NCT01346293|519949494|FG001|Overall Study|Other|0|||
144206331|NCT01441947|519949495|FG000|Overall Study|Withdrawal by Subject|3|||
144206332|NCT01441947|519949496|FG001|Overall Study|Withdrawal by Subject|0|||
144206333|NCT02730351|519949499|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
144206334|NCT02730351|519949500|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
144206335|NCT02730351|519949499|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
144206336|NCT02730351|519949500|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
144206337|NCT02730351|519949499|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
144206338|NCT02730351|519949500|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
144206339|NCT02730351|519949499|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
144206340|NCT02730351|519949500|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
144206341|NCT02730351|519949499|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
144206342|NCT02730351|519949500|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
144206343|NCT03796039|519949501|FG000|Overall Study|Death|2|||
144206344|NCT03796039|519949502|FG001|Overall Study|Death|1|||
144206345|NCT03796039|519949501|FG000|Overall Study|Withdrawal by Subject|7|||
144206346|NCT03796039|519949502|FG001|Overall Study|Withdrawal by Subject|4|||
144206347|NCT02927366|519949504|FG000|Overall Study|Adverse Event|1|||
144206348|NCT02927366|519949505|FG001|Overall Study|Adverse Event|0|||
144206349|NCT02927366|519949504|FG000|Overall Study|Patient schedule|1|||
144206350|NCT02927366|519949505|FG001|Overall Study|Patient schedule|0|||
144206351|NCT00587990|519949510|FG000|Overall Study|Death|0|||
144206352|NCT00587990|519949511|FG001|Overall Study|Death|0|||
144206353|NCT00587990|519949512|FG002|Overall Study|Death|1|||
144206354|NCT02754856|519949513|FG000|Overall Study|Withdrawal by Subject|1|||
144206355|NCT04874155|519949514|FG000|Overall Study|Lost to Follow-up|1|||
144206356|NCT04874155|519949515|FG001|Overall Study|Lost to Follow-up|1|||
144206357|NCT04874155|519949514|FG000|Overall Study|Withdrawal by Subject|2|||
144206358|NCT04874155|519949515|FG001|Overall Study|Withdrawal by Subject|2|||
144206359|NCT00530218|519949518|FG000|Overall Study|CMV Not Detected|13|||
144206360|NCT00530218|519949518|FG000|Overall Study|Death|12|||
144206361|NCT00678886|519949521|FG000|Overall Study|Withdrawal by Subject|0|||
144206362|NCT00678886|519949522|FG001|Overall Study|Withdrawal by Subject|0|||
144568580|NCT01657799|521282097|FG000|Overall Study|Lost to Follow-up|1|||
144568581|NCT01657799|521282098|FG001|Overall Study|Lost to Follow-up|0|||
144206363|NCT00678886|519949523|FG002|Overall Study|Withdrawal by Subject|4|||
144206364|NCT00678886|519949524|FG003|Overall Study|Withdrawal by Subject|6|||
144206365|NCT00678886|519949521|FG000|Overall Study|Physician Decision|0|||
144206366|NCT00678886|519949522|FG001|Overall Study|Physician Decision|0|||
144206367|NCT00678886|519949523|FG002|Overall Study|Physician Decision|1|||
144206368|NCT00678886|519949524|FG003|Overall Study|Physician Decision|1|||
144206369|NCT00678886|519949521|FG000|Overall Study|Lost to Follow-up|0|||
144206370|NCT00678886|519949522|FG001|Overall Study|Lost to Follow-up|0|||
144206371|NCT00678886|519949523|FG002|Overall Study|Lost to Follow-up|3|||
144728762|NCT02003183|521861327|FG000|Overall Study|Lost to Follow-up|0|||
144728763|NCT02003183|521861328|FG001|Overall Study|Lost to Follow-up|2|||
144568582|NCT01657799|521282099|FG002|Overall Study|Lost to Follow-up|1|||
144568583|NCT01657799|521282097|FG000|Overall Study|Disease Progression|2|||
144568584|NCT01657799|521282098|FG001|Overall Study|Disease Progression|4|||
144568585|NCT01657799|521282099|FG002|Overall Study|Disease Progression|4|||
144568586|NCT01657799|521282097|FG000|Overall Study|Progressive Disease Clinical|7|||
144568587|NCT01657799|521282098|FG001|Overall Study|Progressive Disease Clinical|4|||
144568588|NCT01657799|521282099|FG002|Overall Study|Progressive Disease Clinical|7|||
144568589|NCT01657799|521282097|FG000|Overall Study|Radiographic & Clinical Progression|16|||
144568590|NCT01657799|521282098|FG001|Overall Study|Radiographic & Clinical Progression|11|||
144568591|NCT01657799|521282099|FG002|Overall Study|Radiographic & Clinical Progression|15|||
144568592|NCT01657799|521282097|FG000|Overall Study|Other|52|||
144568593|NCT01657799|521282098|FG001|Overall Study|Other|62|||
144568594|NCT01657799|521282099|FG002|Overall Study|Other|49|||
144568595|NCT03865953|521282106|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
144568596|NCT03865953|521282107|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
144568597|NCT03865953|521282106|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
144568598|NCT03865953|521282107|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
144568599|NCT03865953|521282106|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
144568600|NCT03865953|521282107|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
144728764|NCT00352690|521861331|FG000|Overall Study|Determined to be ineligible|2|||
144728765|NCT00352690|521861332|FG001|Overall Study|Determined to be ineligible|0|||
144206372|NCT00678886|519949524|FG003|Overall Study|Lost to Follow-up|2|||
144206373|NCT00678886|519949521|FG000|Overall Study|Other|0|||
144206374|NCT00678886|519949522|FG001|Overall Study|Other|0|||
144206375|NCT00678886|519949523|FG002|Overall Study|Other|1|||
144206376|NCT00678886|519949524|FG003|Overall Study|Other|0|||
144206377|NCT03477903|519949525|FG000|Overall Study|Study Terminated by Sponsor|1|||
144206378|NCT01147107|519949526|FG000|Overall Study|Lack of Efficacy|5|||
144206379|NCT01147107|519949527|FG001|Overall Study|Lack of Efficacy|0|||
144206380|NCT01147107|519949526|FG000|Overall Study|Withdrawal by Subject|1|||
144206381|NCT01147107|519949527|FG001|Overall Study|Withdrawal by Subject|1|||
144206382|NCT03496610|519949528|FG000|Overall Study|Lost to Follow-up|3|||
144206383|NCT03496610|519949529|FG001|Overall Study|Lost to Follow-up|2|||
144206384|NCT03496610|519949528|FG000|Overall Study|Physician Decision|1|||
144206385|NCT03496610|519949529|FG001|Overall Study|Physician Decision|0|||
144206386|NCT03496610|519949528|FG000|Overall Study|Withdrawal by Subject|1|||
144206387|NCT03496610|519949529|FG001|Overall Study|Withdrawal by Subject|0|||
144206388|NCT01458106|519949530|FG000|Overall Study|Withdrawal by Subject|2|||
144206389|NCT01458106|519949531|FG001|Overall Study|Withdrawal by Subject|0|||
144206390|NCT01458106|519949530|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
144206391|NCT01458106|519949531|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
144206392|NCT01458106|519949530|FG000|Overall Study|Withdrawn Per Protocol|0|||
144206393|NCT01458106|519949531|FG001|Overall Study|Withdrawn Per Protocol|1|||
144206394|NCT00477295|519949532|FG000|Overall Study|Adverse Event|31|||
144206395|NCT00477295|519949533|FG001|Overall Study|Adverse Event|35|||
144206396|NCT00477295|519949532|FG000|Overall Study|Withdrawal by Subject|35|||
144206397|NCT00477295|519949533|FG001|Overall Study|Withdrawal by Subject|24|||
144206398|NCT00477295|519949532|FG000|Overall Study|Lack of Efficacy|23|||
144206399|NCT00477295|519949533|FG001|Overall Study|Lack of Efficacy|23|||
144206400|NCT00477295|519949532|FG000|Overall Study|Protocol Violation|3|||
144206401|NCT00477295|519949533|FG001|Overall Study|Protocol Violation|8|||
144206402|NCT00477295|519949532|FG000|Overall Study|Physician Decision|4|||
144206403|NCT00477295|519949533|FG001|Overall Study|Physician Decision|5|||
144206404|NCT00477295|519949532|FG000|Overall Study|Lost to Follow-up|21|||
144206405|NCT00477295|519949533|FG001|Overall Study|Lost to Follow-up|11|||
144206406|NCT00477295|519949532|FG000|Overall Study|Other|4|||
144206407|NCT00477295|519949533|FG001|Overall Study|Other|3|||
144206408|NCT03050060|519949534|FG000|Overall Study|Adverse Event|7|||
144206409|NCT03050060|519949534|FG000|Overall Study|Withdrawal by Subject|1|||
144206410|NCT03050060|519949534|FG000|Overall Study|Progression|7|||
144206411|NCT02304458|519949535|FG000|Overall Study|Adverse Event|0|||
144206412|NCT02304458|519949536|FG001|Overall Study|Adverse Event|0|||
144206413|NCT02304458|519949537|FG002|Overall Study|Adverse Event|7|||
144206414|NCT02304458|519949538|FG003|Overall Study|Adverse Event|0|||
144262761|NCT00490971|520161550|FG003|Maintenance|Lost to Follow-up|8|||
144206415|NCT02304458|519949539|FG004|Overall Study|Adverse Event|0|||
144206416|NCT02304458|519949540|FG005|Overall Study|Adverse Event|0|||
144206417|NCT02304458|519949541|FG006|Overall Study|Adverse Event|3|||
144206418|NCT02304458|519949542|FG007|Overall Study|Adverse Event|4|||
144206419|NCT02304458|519949535|FG000|Overall Study|Death|0|||
144206420|NCT02304458|519949536|FG001|Overall Study|Death|0|||
144206421|NCT02304458|519949537|FG002|Overall Study|Death|2|||
144206422|NCT02304458|519949538|FG003|Overall Study|Death|0|||
144206423|NCT02304458|519949539|FG004|Overall Study|Death|0|||
144206424|NCT02304458|519949540|FG005|Overall Study|Death|0|||
144206425|NCT02304458|519949541|FG006|Overall Study|Death|1|||
144568601|NCT01271504|521282118|FG000|Overall Study|Death|7|||
144568602|NCT01271504|521282119|FG001|Overall Study|Death|6|||
144568603|NCT01271504|521282120|FG002|Overall Study|Death|32|||
144568604|NCT01271504|521282121|FG003|Overall Study|Death|32|||
144568605|NCT01271504|521282118|FG000|Overall Study|Lost to Follow-up|0|||
144568606|NCT01271504|521282119|FG001|Overall Study|Lost to Follow-up|1|||
144568607|NCT01271504|521282120|FG002|Overall Study|Lost to Follow-up|3|||
144568608|NCT01271504|521282121|FG003|Overall Study|Lost to Follow-up|1|||
144568609|NCT01271504|521282118|FG000|Overall Study|Protocol Violation|0|||
144568610|NCT01271504|521282119|FG001|Overall Study|Protocol Violation|0|||
144619597|NCT00797732|521466050|FG000|Overall Study|Death|1|||
144619598|NCT00797732|521466051|FG001|Overall Study|Death|0|||
144619599|NCT00797732|521466052|FG002|Overall Study|Death|0|||
144619600|NCT00797732|521466050|FG000|Overall Study|Not meet inclusion criteria|0|||
144206426|NCT02304458|519949542|FG007|Overall Study|Death|0|||
144206427|NCT02304458|519949535|FG000|Overall Study|Lack of Efficacy|4|||
144206428|NCT02304458|519949536|FG001|Overall Study|Lack of Efficacy|6|||
144206429|NCT02304458|519949537|FG002|Overall Study|Lack of Efficacy|38|||
144206430|NCT02304458|519949538|FG003|Overall Study|Lack of Efficacy|5|||
144206431|NCT02304458|519949539|FG004|Overall Study|Lack of Efficacy|6|||
144206432|NCT02304458|519949540|FG005|Overall Study|Lack of Efficacy|6|||
144206433|NCT02304458|519949541|FG006|Overall Study|Lack of Efficacy|21|||
144206434|NCT02304458|519949542|FG007|Overall Study|Lack of Efficacy|4|||
144206435|NCT02304458|519949535|FG000|Overall Study|Physician Decision|2|||
144206436|NCT02304458|519949536|FG001|Overall Study|Physician Decision|0|||
144206437|NCT02304458|519949537|FG002|Overall Study|Physician Decision|16|||
144206438|NCT02304458|519949538|FG003|Overall Study|Physician Decision|1|||
144206439|NCT02304458|519949539|FG004|Overall Study|Physician Decision|0|||
144206440|NCT02304458|519949540|FG005|Overall Study|Physician Decision|0|||
144206441|NCT02304458|519949541|FG006|Overall Study|Physician Decision|3|||
144206442|NCT02304458|519949542|FG007|Overall Study|Physician Decision|0|||
144206443|NCT02304458|519949535|FG000|Overall Study|Protocol Violation|0|||
144206444|NCT02304458|519949536|FG001|Overall Study|Protocol Violation|0|||
144206445|NCT02304458|519949537|FG002|Overall Study|Protocol Violation|1|||
144206446|NCT02304458|519949538|FG003|Overall Study|Protocol Violation|0|||
144206447|NCT02304458|519949539|FG004|Overall Study|Protocol Violation|0|||
144206448|NCT02304458|519949540|FG005|Overall Study|Protocol Violation|0|||
144206449|NCT02304458|519949541|FG006|Overall Study|Protocol Violation|0|||
144206450|NCT02304458|519949542|FG007|Overall Study|Protocol Violation|0|||
144206451|NCT02304458|519949535|FG000|Overall Study|Withdrawal by Subject|1|||
144206452|NCT02304458|519949536|FG001|Overall Study|Withdrawal by Subject|0|||
144206453|NCT02304458|519949537|FG002|Overall Study|Withdrawal by Subject|7|||
144568611|NCT01271504|521282120|FG002|Overall Study|Protocol Violation|0|||
144568612|NCT01271504|521282121|FG003|Overall Study|Protocol Violation|2|||
144619601|NCT00797732|521466051|FG001|Overall Study|Not meet inclusion criteria|0|||
144619602|NCT00797732|521466052|FG002|Overall Study|Not meet inclusion criteria|7|||
144619603|NCT00797732|521466050|FG000|Overall Study|Excluded due to time constraints|0|||
144619604|NCT00797732|521466051|FG001|Overall Study|Excluded due to time constraints|0|||
144619605|NCT00797732|521466052|FG002|Overall Study|Excluded due to time constraints|24|||
144619606|NCT00797732|521466050|FG000|Overall Study|Refused to Participate|0|||
144619607|NCT00797732|521466051|FG001|Overall Study|Refused to Participate|0|||
144619608|NCT00797732|521466052|FG002|Overall Study|Refused to Participate|123|||
144619609|NCT01888640|521466062|FG000|Overall Study|Lost to Follow-up|1|||
144619610|NCT01888640|521466063|FG001|Overall Study|Lost to Follow-up|2|||
144619611|NCT01888640|521466064|FG002|Overall Study|Lost to Follow-up|0|||
144619612|NCT01888640|521466062|FG000|Overall Study|Withdrawal by Subject|15|||
144619613|NCT01888640|521466063|FG001|Overall Study|Withdrawal by Subject|11|||
144619614|NCT01888640|521466064|FG002|Overall Study|Withdrawal by Subject|4|||
144619615|NCT01888640|521466062|FG000|Overall Study|Minimum dose not met|10|||
144619616|NCT01888640|521466063|FG001|Overall Study|Minimum dose not met|16|||
144619617|NCT01888640|521466064|FG002|Overall Study|Minimum dose not met|0|||
144619618|NCT01888640|521466062|FG000|Overall Study|Given wrong unit (placebo)|1|||
144619619|NCT01888640|521466063|FG001|Overall Study|Given wrong unit (placebo)|0|||
144619620|NCT01888640|521466064|FG002|Overall Study|Given wrong unit (placebo)|0|||
144619621|NCT01888640|521466062|FG000|Overall Study|Excluded for prior TENS|0|||
144619622|NCT01888640|521466063|FG001|Overall Study|Excluded for prior TENS|1|||
144619623|NCT01888640|521466064|FG002|Overall Study|Excluded for prior TENS|0|||
144619624|NCT01888640|521466062|FG000|Overall Study|Researcher Termination of Participant|0|||
144206454|NCT02304458|519949538|FG003|Overall Study|Withdrawal by Subject|0|||
144206455|NCT02304458|519949539|FG004|Overall Study|Withdrawal by Subject|0|||
144206456|NCT02304458|519949540|FG005|Overall Study|Withdrawal by Subject|0|||
144206457|NCT02304458|519949541|FG006|Overall Study|Withdrawal by Subject|1|||
144206458|NCT02304458|519949542|FG007|Overall Study|Withdrawal by Subject|0|||
144206459|NCT01197755|519949543|FG000|Overall Study|Adverse Event|8|||
144206460|NCT01197755|519949544|FG001|Overall Study|Adverse Event|10|||
144206461|NCT01197755|519949545|FG002|Overall Study|Adverse Event|10|||
144206462|NCT01197755|519949543|FG000|Overall Study|Study-specific discontinuation criteria|2|||
144262762|NCT00490971|520161551|FG004|Maintenance|Lost to Follow-up|10|||
144568613|NCT01271504|521282118|FG000|Overall Study|Administrative Reasons|0|||
144568614|NCT01271504|521282119|FG001|Overall Study|Administrative Reasons|0|||
144568615|NCT01271504|521282120|FG002|Overall Study|Administrative Reasons|6|||
144568616|NCT01271504|521282121|FG003|Overall Study|Administrative Reasons|5|||
144568617|NCT01271504|521282118|FG000|Overall Study|Withdrawal by Subject|0|||
144568618|NCT01271504|521282119|FG001|Overall Study|Withdrawal by Subject|0|||
144568619|NCT01271504|521282120|FG002|Overall Study|Withdrawal by Subject|1|||
144568620|NCT01271504|521282121|FG003|Overall Study|Withdrawal by Subject|3|||
144568621|NCT01271504|521282118|FG000|Overall Study|Other|0|||
144568622|NCT01271504|521282119|FG001|Overall Study|Other|1|||
144568623|NCT01271504|521282120|FG002|Overall Study|Other|2|||
144568624|NCT01271504|521282121|FG003|Overall Study|Other|0|||
144568625|NCT00882115|521282122|FG000|Overall Study|Withdrawal by Subject|3|||
144568626|NCT00882115|521282122|FG000|Overall Study|did not respond to DEP challe|6|||
144568627|NCT00940875|521282127|FG000|Treatment Phase|Adverse Event|9|||
144568628|NCT00940875|521282128|FG001|Treatment Phase|Adverse Event|3|||
144568629|NCT00940875|521282127|FG000|Treatment Phase|Death|3|||
144568630|NCT00940875|521282128|FG001|Treatment Phase|Death|5|||
144568631|NCT00940875|521282127|FG000|Treatment Phase|Lack of Efficacy|1|||
144568632|NCT00940875|521282128|FG001|Treatment Phase|Lack of Efficacy|0|||
144568633|NCT00940875|521282127|FG000|Treatment Phase|Withdrawal by Subject|3|||
144568634|NCT00940875|521282128|FG001|Treatment Phase|Withdrawal by Subject|0|||
144568635|NCT00940875|521282127|FG000|Treatment Phase|Disease progression|9|||
144568636|NCT00940875|521282128|FG001|Treatment Phase|Disease progression|11|||
144568637|NCT00940875|521282127|FG000|Treatment Phase|Physician Decision|1|||
144568638|NCT00940875|521282128|FG001|Treatment Phase|Physician Decision|0|||
144568639|NCT00940875|521282127|FG000|Post-Study Treatment|Death|0|||
144568640|NCT00940875|521282128|FG001|Post-Study Treatment|Death|1|||
144568641|NCT00940875|521282127|FG000|Post-Study Treatment|Disease Progression|0|||
144568642|NCT00940875|521282128|FG001|Post-Study Treatment|Disease Progression|2|||
144568643|NCT00490945|521282129|FG000|Overall Study|Adverse Event|0|||
144568644|NCT00490945|521282130|FG001|Overall Study|Adverse Event|1|||
144568645|NCT00490945|521282131|FG002|Overall Study|Adverse Event|0|||
144568646|NCT00490945|521282132|FG003|Overall Study|Adverse Event|0|||
144568647|NCT00490945|521282133|FG004|Overall Study|Adverse Event|0|||
144568648|NCT01646385|521282136|FG000|Overall Study|Death|202|||
144568649|NCT01646385|521282137|FG001|Overall Study|Death|222|||
144568650|NCT01646385|521282136|FG000|Overall Study|Switched to alternate biologic|636|||
144568651|NCT01646385|521282137|FG001|Overall Study|Switched to alternate biologic|649|||
144568652|NCT01841697|521282138|FG000|Overall Study|Death|0|||
144568653|NCT01841697|521282139|FG001|Overall Study|Death|1|||
144568654|NCT01841697|521282138|FG000|Overall Study|Lost to Follow-up|4|||
144619625|NCT01888640|521466063|FG001|Overall Study|Researcher Termination of Participant|1|||
144619626|NCT01888640|521466064|FG002|Overall Study|Researcher Termination of Participant|1|||
144619627|NCT00774345|521466065|FG000|Pre-treatment|Other reasons|2|||
144619628|NCT00774345|521466066|FG001|Pre-treatment|Other reasons|0|||
144619629|NCT00774345|521466065|FG000|Treatment|Adverse Event|61|||
144619630|NCT00774345|521466066|FG001|Treatment|Adverse Event|15|||
144206463|NCT01197755|519949544|FG001|Overall Study|Study-specific discontinuation criteria|1|||
144206464|NCT01197755|519949545|FG002|Overall Study|Study-specific discontinuation criteria|0|||
144206465|NCT01197755|519949543|FG000|Overall Study|Entered the long-term extension study|18|||
144206466|NCT01197755|519949544|FG001|Overall Study|Entered the long-term extension study|21|||
144206467|NCT01197755|519949545|FG002|Overall Study|Entered the long-term extension study|35|||
144206468|NCT01197755|519949543|FG000|Overall Study|Lack of therapeutic response|0|||
144206469|NCT01197755|519949544|FG001|Overall Study|Lack of therapeutic response|7|||
144206470|NCT01197755|519949545|FG002|Overall Study|Lack of therapeutic response|4|||
144206471|NCT01197755|519949543|FG000|Overall Study|Severe non-compliance to the protocol|2|||
144206472|NCT01197755|519949544|FG001|Overall Study|Severe non-compliance to the protocol|1|||
144206473|NCT01197755|519949545|FG002|Overall Study|Severe non-compliance to the protocol|2|||
144206474|NCT01197755|519949543|FG000|Overall Study|Withdrawal by Subject|1|||
144206475|NCT01197755|519949544|FG001|Overall Study|Withdrawal by Subject|0|||
144206476|NCT01197755|519949545|FG002|Overall Study|Withdrawal by Subject|0|||
144206477|NCT01197755|519949543|FG000|Overall Study|Lost to Follow-up|0|||
144206478|NCT01197755|519949544|FG001|Overall Study|Lost to Follow-up|0|||
144206479|NCT01197755|519949545|FG002|Overall Study|Lost to Follow-up|1|||
144206480|NCT01197755|519949543|FG000|Overall Study|eg, change in circumstances|7|||
144206481|NCT01197755|519949544|FG001|Overall Study|eg, change in circumstances|3|||
144568655|NCT01841697|521282139|FG001|Overall Study|Lost to Follow-up|1|||
144568656|NCT01841697|521282138|FG000|Overall Study|Withdrawal by Subject|16|||
144619631|NCT00774345|521466065|FG000|Treatment|Progressive Disease without histologic transformation|51|||
144619632|NCT00774345|521466066|FG001|Treatment|Progressive Disease without histologic transformation|111|||
144206482|NCT01197755|519949545|FG002|Overall Study|eg, change in circumstances|2|||
144206483|NCT03365011|519949546|FG000|Overall Study|Withdrawal by Subject|1|||
144568657|NCT01841697|521282139|FG001|Overall Study|Withdrawal by Subject|16|||
144568658|NCT00727415|521282140|FG000|Phase I|Dose Limiting Toxicity|2|||
144568659|NCT00756457|521282141|FG000|Overall Study|Lost to Follow-up|1|||
144568660|NCT00756457|521282142|FG001|Overall Study|Lost to Follow-up|2|||
144568661|NCT01777490|521282144|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
144206484|NCT03365011|519949547|FG001|Overall Study|Withdrawal by Subject|2|||
144206485|NCT00499174|519949548|FG000|Overall Study|Physician Decision|78|||
144206486|NCT00499174|519949549|FG001|Overall Study|Physician Decision|9|||
144206487|NCT03582826|519949550|FG000|Overall Study|Lost to Follow-up|39|||
144206488|NCT03582826|519949551|FG001|Overall Study|Lost to Follow-up|0|||
144206489|NCT03582826|519949550|FG000|Overall Study|Withdrawal by Subject|2|||
144206490|NCT03582826|519949551|FG001|Overall Study|Withdrawal by Subject|0|||
144206491|NCT01214915|519949553|FG000|Overall Study|Adverse Event|8|||
144206492|NCT01214915|519949553|FG000|Overall Study|Lack of Efficacy|3|||
144206493|NCT00761865|519949554|FG000|Overall Study|Lost to Follow-up|8|||
144206494|NCT00761865|519949555|FG001|Overall Study|Lost to Follow-up|7|||
144206495|NCT01094886|519949556|FG000|Overall Study|Adverse Event|2|||
144206496|NCT01094886|519949556|FG000|Overall Study|Withdrawal by Subject|5|||
144206497|NCT03866902|519949558|FG000|Overall Study|Lost to Follow-up|98|||
144206498|NCT03866902|519949559|FG001|Overall Study|Lost to Follow-up|82|||
144206499|NCT03866902|519949558|FG000|Overall Study|Pregnancy|18|||
144568662|NCT01777490|521282145|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
144568663|NCT01777490|521282146|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
144568664|NCT01777490|521282147|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
144568665|NCT02947100|521282150|FG000|Overall Study|study terminated early|3|||
144568666|NCT02947100|521282150|FG000|Overall Study|did not meet inclusion criteria|1|||
144568667|NCT00822770|521282151|FG000|Overall Study|Not treated|1|||
144568668|NCT00822770|521282152|FG001|Overall Study|Not treated|0|||
144568669|NCT00822770|521282151|FG000|Overall Study|Complication/Incomplete treatment|1|||
144568670|NCT00822770|521282152|FG001|Overall Study|Complication/Incomplete treatment|0|||
144568671|NCT00822770|521282151|FG000|Overall Study|Death|1|||
144568672|NCT00822770|521282152|FG001|Overall Study|Death|1|||
144568673|NCT02402322|521282153|FG000|Pretreatment|Withdrawal by Subject|3|||
144568674|NCT02402322|521282154|FG001|Pretreatment|Withdrawal by Subject|1|||
144568675|NCT02402322|521282155|FG002|Pretreatment|Withdrawal by Subject|1|||
144568676|NCT02402322|521282153|FG000|Follow-up|Withdrawal by Subject|6|||
144568677|NCT02402322|521282154|FG001|Follow-up|Withdrawal by Subject|3|||
144568678|NCT02402322|521282155|FG002|Follow-up|Withdrawal by Subject|24|||
144568679|NCT04593823|521282159|FG000|Overall Study|Withdrawal by Subject|1|||
144568680|NCT04593823|521282160|FG001|Overall Study|Withdrawal by Subject|1|||
144568681|NCT04593823|521282159|FG000|Overall Study|Lost to Follow-up|0|||
144568682|NCT04593823|521282160|FG001|Overall Study|Lost to Follow-up|1|||
144568683|NCT01080326|521282161|FG000|Overall Study|Patient deterioration prior to procedure|3|||
144568684|NCT01080326|521282161|FG000|Overall Study|Surgeon decision|1|||
144568685|NCT01704547|521282162|FG000|Overall Study|Physician Decision|4|||
144568686|NCT01704547|521282162|FG000|Overall Study|Withdrawal by Subject|1|||
144568687|NCT02058836|521282163|FG000|Overall Study|Withdrawal by Subject|1|||
144568688|NCT02058836|521282164|FG001|Overall Study|Withdrawal by Subject|1|||
144568689|NCT00267098|521282165|FG000|Overall Study|Death|0|||
144568690|NCT00267098|521282166|FG001|Overall Study|Death|0|||
144568691|NCT00267098|521282167|FG002|Overall Study|Death|57|||
144568692|NCT00267098|521282168|FG003|Overall Study|Death|66|||
144568693|NCT00267098|521282169|FG004|Overall Study|Death|14|||
144568694|NCT00267098|521282170|FG005|Overall Study|Death|23|||
144568695|NCT00267098|521282171|FG006|Overall Study|Death|28|||
144568696|NCT00267098|521282172|FG007|Overall Study|Death|9|||
144568697|NCT00267098|521282165|FG000|Overall Study|Lost to Follow-up|0|||
144568698|NCT00267098|521282166|FG001|Overall Study|Lost to Follow-up|0|||
144568699|NCT00267098|521282167|FG002|Overall Study|Lost to Follow-up|6|||
144568700|NCT00267098|521282168|FG003|Overall Study|Lost to Follow-up|5|||
144568701|NCT00267098|521282169|FG004|Overall Study|Lost to Follow-up|2|||
144568702|NCT00267098|521282170|FG005|Overall Study|Lost to Follow-up|3|||
144568703|NCT00267098|521282171|FG006|Overall Study|Lost to Follow-up|1|||
144568704|NCT00267098|521282172|FG007|Overall Study|Lost to Follow-up|1|||
144568705|NCT00267098|521282165|FG000|Overall Study|Withdrawal by Subject|8|||
144568706|NCT00267098|521282166|FG001|Overall Study|Withdrawal by Subject|0|||
144568707|NCT00267098|521282167|FG002|Overall Study|Withdrawal by Subject|24|||
144206500|NCT03866902|519949559|FG001|Overall Study|Pregnancy|24|||
144568708|NCT00267098|521282168|FG003|Overall Study|Withdrawal by Subject|21|||
144568709|NCT00267098|521282169|FG004|Overall Study|Withdrawal by Subject|12|||
144568710|NCT00267098|521282170|FG005|Overall Study|Withdrawal by Subject|9|||
144568711|NCT00267098|521282171|FG006|Overall Study|Withdrawal by Subject|12|||
144568712|NCT00267098|521282172|FG007|Overall Study|Withdrawal by Subject|5|||
144568713|NCT00267098|521282165|FG000|Overall Study|Physician Decision|5|||
144568714|NCT00267098|521282166|FG001|Overall Study|Physician Decision|0|||
144568715|NCT00267098|521282167|FG002|Overall Study|Physician Decision|7|||
144568716|NCT00267098|521282168|FG003|Overall Study|Physician Decision|11|||
144206501|NCT04730349|519949560|FG000|Overall Study|Participant withdrew consent|1|||
144206502|NCT04730349|519949561|FG001|Overall Study|Participant withdrew consent|0|||
144206503|NCT04730349|519949560|FG000|Overall Study|Disease progression|6|||
144206504|NCT04730349|519949561|FG001|Overall Study|Disease progression|4|||
144206505|NCT04730349|519949560|FG000|Overall Study|Study drug toxicity|0|||
144206506|NCT04730349|519949561|FG001|Overall Study|Study drug toxicity|1|||
144568717|NCT00267098|521282169|FG004|Overall Study|Physician Decision|5|||
144206507|NCT03155945|519949562|FG000|Overall Study|Lost to Follow-up|0|||
144206508|NCT03155945|519949563|FG001|Overall Study|Lost to Follow-up|1|||
144206509|NCT03155945|519949562|FG000|Overall Study|Withdrawal by Subject|0|||
144206510|NCT03155945|519949563|FG001|Overall Study|Withdrawal by Subject|1|||
144206511|NCT03155945|519949562|FG000|Overall Study|Other Reason|0|||
144206512|NCT03155945|519949563|FG001|Overall Study|Other Reason|1|||
144206513|NCT02013674|519949565|FG000|Overall Study|Death|0|||
144206514|NCT02013674|519949566|FG001|Overall Study|Death|1|||
144206515|NCT02013674|519949565|FG000|Overall Study|Lost to Follow-up|1|||
144206516|NCT02013674|519949566|FG001|Overall Study|Lost to Follow-up|0|||
144206517|NCT05065567|519949571|FG000|Overall Study|Lost to Follow-up|10|||
144206518|NCT05065567|519949572|FG001|Overall Study|Lost to Follow-up|9|||
144206519|NCT05065567|519949573|FG002|Overall Study|Lost to Follow-up|6|||
144206520|NCT05307510|519950692|FG000|Overall Study|Lost to Follow-up|3|||
144568718|NCT00267098|521282170|FG005|Overall Study|Physician Decision|4|||
144568719|NCT00267098|521282171|FG006|Overall Study|Physician Decision|3|||
144568720|NCT00267098|521282172|FG007|Overall Study|Physician Decision|0|||
144568721|NCT00267098|521282165|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
144568722|NCT00267098|521282166|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144568723|NCT00267098|521282167|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144568724|NCT00267098|521282168|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144568725|NCT00267098|521282169|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
144568726|NCT00267098|521282170|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144568727|NCT00267098|521282171|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144568728|NCT00267098|521282172|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144568729|NCT00267098|521282165|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568730|NCT00267098|521282166|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
144568731|NCT00267098|521282167|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568732|NCT00267098|521282168|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568733|NCT00267098|521282169|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568734|NCT00267098|521282170|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568735|NCT00267098|521282171|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568736|NCT00267098|521282172|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
144568737|NCT00267098|521282165|FG000|Overall Study|Site closure|0|||
144568738|NCT00267098|521282166|FG001|Overall Study|Site closure|0|||
144568739|NCT00267098|521282167|FG002|Overall Study|Site closure|0|||
144568740|NCT00267098|521282168|FG003|Overall Study|Site closure|1|||
144568741|NCT00267098|521282169|FG004|Overall Study|Site closure|0|||
144568742|NCT00267098|521282170|FG005|Overall Study|Site closure|1|||
144568743|NCT00267098|521282171|FG006|Overall Study|Site closure|1|||
144568744|NCT00267098|521282172|FG007|Overall Study|Site closure|0|||
144568745|NCT00267098|521282165|FG000|Overall Study|Explanted Medtronic device|0|||
144568746|NCT00267098|521282166|FG001|Overall Study|Explanted Medtronic device|0|||
144568747|NCT00267098|521282167|FG002|Overall Study|Explanted Medtronic device|0|||
144568748|NCT00267098|521282168|FG003|Overall Study|Explanted Medtronic device|1|||
144568749|NCT00267098|521282169|FG004|Overall Study|Explanted Medtronic device|0|||
144568750|NCT00267098|521282170|FG005|Overall Study|Explanted Medtronic device|0|||
144568751|NCT00267098|521282171|FG006|Overall Study|Explanted Medtronic device|0|||
144568752|NCT00267098|521282172|FG007|Overall Study|Explanted Medtronic device|0|||
144568753|NCT00267098|521282165|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568754|NCT00267098|521282166|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568755|NCT00267098|521282167|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568756|NCT00267098|521282168|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568757|NCT00267098|521282169|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
144568758|NCT00267098|521282170|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568759|NCT00267098|521282171|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568760|NCT00267098|521282172|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
144568761|NCT00267098|521282165|FG000|Overall Study|Subject listed for heart transplant|0|||
144568762|NCT00267098|521282166|FG001|Overall Study|Subject listed for heart transplant|0|||
144568763|NCT00267098|521282167|FG002|Overall Study|Subject listed for heart transplant|0|||
144568764|NCT00267098|521282168|FG003|Overall Study|Subject listed for heart transplant|0|||
144568765|NCT00267098|521282169|FG004|Overall Study|Subject listed for heart transplant|0|||
144568766|NCT00267098|521282170|FG005|Overall Study|Subject listed for heart transplant|0|||
144568767|NCT00267098|521282171|FG006|Overall Study|Subject listed for heart transplant|1|||
144568768|NCT00267098|521282172|FG007|Overall Study|Subject listed for heart transplant|0|||
144206521|NCT05307510|519950693|FG001|Overall Study|Lost to Follow-up|6|||
144568769|NCT00267098|521282165|FG000|Overall Study|Sponsor withdrew subject|0|||
144568770|NCT00267098|521282166|FG001|Overall Study|Sponsor withdrew subject|0|||
144206522|NCT05307510|519950692|FG000|Overall Study|Withdrawal by Subject|0|||
144206523|NCT05307510|519950693|FG001|Overall Study|Withdrawal by Subject|1|||
144206524|NCT03610516|519950694|FG000|Treatment Epoch|Adverse Event|3|||
144206525|NCT03610516|519950695|FG001|Treatment Epoch|Adverse Event|1|||
144206526|NCT03610516|519950694|FG000|Treatment Epoch|Death|1|||
144568771|NCT00267098|521282167|FG002|Overall Study|Sponsor withdrew subject|0|||
144568772|NCT00267098|521282168|FG003|Overall Study|Sponsor withdrew subject|1|||
144206527|NCT03610516|519950695|FG001|Treatment Epoch|Death|0|||
144206528|NCT03610516|519950694|FG000|Treatment Epoch|Lack of Efficacy|0|||
144206529|NCT03610516|519950695|FG001|Treatment Epoch|Lack of Efficacy|1|||
144206530|NCT03610516|519950694|FG000|Treatment Epoch|No longer requires treatment|1|||
144206531|NCT03610516|519950695|FG001|Treatment Epoch|No longer requires treatment|0|||
144206532|NCT03610516|519950694|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
144206533|NCT03610516|519950695|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
144206534|NCT03610516|519950694|FG000|Treatment Epoch|Physician Decision|8|||
144206535|NCT03610516|519950695|FG001|Treatment Epoch|Physician Decision|5|||
144206536|NCT03610516|519950694|FG000|Treatment Epoch|Protocol Deviation|1|||
144206537|NCT03610516|519950695|FG001|Treatment Epoch|Protocol Deviation|0|||
144206538|NCT03610516|519950694|FG000|Treatment Epoch|Withdrawal by Subject|3|||
144206539|NCT03610516|519950695|FG001|Treatment Epoch|Withdrawal by Subject|1|||
144206540|NCT03610516|519950694|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
144206541|NCT03610516|519950695|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
144206542|NCT03610516|519950694|FG000|Post-Treatment Follow-up|Death|1|||
144206543|NCT03610516|519950695|FG001|Post-Treatment Follow-up|Death|0|||
144206544|NCT04003896|519950703|FG000|Overall Study|Withdrawal by Subject|3|||
144206545|NCT04003896|519950703|FG000|Overall Study|Physician Decision|1|||
144206546|NCT00537303|519950704|FG000|Overall Study|Adverse Event|1|||
144206547|NCT00537303|519950705|FG001|Overall Study|Adverse Event|4|||
144206548|NCT00537303|519950704|FG000|Overall Study|Lack of Efficacy|6|||
144206549|NCT00537303|519950705|FG001|Overall Study|Lack of Efficacy|7|||
144206550|NCT00537303|519950704|FG000|Overall Study|Protocol Violation|8|||
144206551|NCT00537303|519950705|FG001|Overall Study|Protocol Violation|4|||
144206552|NCT00537303|519950704|FG000|Overall Study|Withdrawal criteria|3|||
144206553|NCT00537303|519950705|FG001|Overall Study|Withdrawal criteria|3|||
144206554|NCT00537303|519950704|FG000|Overall Study|Unclassified|8|||
144206555|NCT00537303|519950705|FG001|Overall Study|Unclassified|7|||
144568773|NCT00267098|521282169|FG004|Overall Study|Sponsor withdrew subject|0|||
144568774|NCT00267098|521282170|FG005|Overall Study|Sponsor withdrew subject|0|||
144568775|NCT00267098|521282171|FG006|Overall Study|Sponsor withdrew subject|0|||
144568776|NCT00267098|521282172|FG007|Overall Study|Sponsor withdrew subject|0|||
144568777|NCT00763451|521282176|FG000|Overall Study|Adverse Event|4|||
144568778|NCT00763451|521282177|FG001|Overall Study|Adverse Event|6|||
144568779|NCT00763451|521282178|FG002|Overall Study|Adverse Event|19|||
144568780|NCT00763451|521282179|FG003|Overall Study|Adverse Event|14|||
144568781|NCT00763451|521282176|FG000|Overall Study|Lack of Efficacy|1|||
144568782|NCT00763451|521282177|FG001|Overall Study|Lack of Efficacy|4|||
144568783|NCT00763451|521282178|FG002|Overall Study|Lack of Efficacy|3|||
144568784|NCT00763451|521282179|FG003|Overall Study|Lack of Efficacy|2|||
144568785|NCT00763451|521282176|FG000|Overall Study|Withdrawal by Subject|1|||
144568786|NCT00763451|521282177|FG001|Overall Study|Withdrawal by Subject|6|||
144568787|NCT00763451|521282178|FG002|Overall Study|Withdrawal by Subject|9|||
144568788|NCT00763451|521282179|FG003|Overall Study|Withdrawal by Subject|7|||
144568789|NCT00763451|521282176|FG000|Overall Study|Protocol Violation|0|||
144568790|NCT00763451|521282177|FG001|Overall Study|Protocol Violation|0|||
144568791|NCT00763451|521282178|FG002|Overall Study|Protocol Violation|1|||
144568792|NCT00763451|521282179|FG003|Overall Study|Protocol Violation|0|||
144568793|NCT00763451|521282176|FG000|Overall Study|Poor Compliance to Protocol|1|||
144568794|NCT00763451|521282177|FG001|Overall Study|Poor Compliance to Protocol|1|||
144568795|NCT00763451|521282178|FG002|Overall Study|Poor Compliance to Protocol|2|||
144568796|NCT00763451|521282179|FG003|Overall Study|Poor Compliance to Protocol|2|||
144619633|NCT00774345|521466065|FG000|Treatment|Progressive Disease with histologic transformation|4|||
144619634|NCT00774345|521466066|FG001|Treatment|Progressive Disease with histologic transformation|2|||
144619635|NCT00774345|521466065|FG000|Treatment|Withdrawal by Subject|5|||
144619636|NCT00774345|521466066|FG001|Treatment|Withdrawal by Subject|2|||
144619637|NCT00774345|521466065|FG000|Treatment|Lost to Follow-up|1|||
144206556|NCT01161407|519950706|FG000|Overall Study|Protocol Violation|3|||
144206557|NCT01161407|519950707|FG001|Overall Study|Protocol Violation|1|||
144206558|NCT00867503|519950709|FG000|Overall Study|Withdrawal by Subject|1|||
144568797|NCT00763451|521282176|FG000|Overall Study|Familial and Personal Reasons|5|||
144568798|NCT00763451|521282177|FG001|Overall Study|Familial and Personal Reasons|3|||
144568799|NCT00763451|521282178|FG002|Overall Study|Familial and Personal Reasons|5|||
144619638|NCT00774345|521466066|FG001|Treatment|Lost to Follow-up|1|||
144619639|NCT00774345|521466065|FG000|Treatment|Death|4|||
144206559|NCT02704403|519950710|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
144568800|NCT00763451|521282179|FG003|Overall Study|Familial and Personal Reasons|4|||
144568801|NCT00763451|521282176|FG000|Overall Study|Randomized but not Treated|1|||
144568802|NCT00763451|521282177|FG001|Overall Study|Randomized but not Treated|1|||
144619640|NCT00774345|521466066|FG001|Treatment|Death|0|||
144206560|NCT02704403|519950711|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
144206561|NCT02704403|519950710|FG000|Overall Study|Administrative reasons by sponsor|1251|||
144206562|NCT02704403|519950711|FG001|Overall Study|Administrative reasons by sponsor|616|||
144206563|NCT02704403|519950710|FG000|Overall Study|Death|4|||
144206564|NCT02704403|519950711|FG001|Overall Study|Death|3|||
144206565|NCT02704403|519950710|FG000|Overall Study|Endpoint event|52|||
144206566|NCT02704403|519950711|FG001|Overall Study|Endpoint event|24|||
144206567|NCT02704403|519950710|FG000|Overall Study|Lost to Follow-up|22|||
144206568|NCT02704403|519950711|FG001|Overall Study|Lost to Follow-up|11|||
144206569|NCT02704403|519950710|FG000|Overall Study|Protocol Violation|15|||
144206570|NCT02704403|519950711|FG001|Overall Study|Protocol Violation|15|||
144206571|NCT02704403|519950710|FG000|Overall Study|Adverse Event|2|||
144206572|NCT02704403|519950711|FG001|Overall Study|Adverse Event|0|||
144206573|NCT02704403|519950710|FG000|Overall Study|Withdrawal by Subject|85|||
144206574|NCT02704403|519950711|FG001|Overall Study|Withdrawal by Subject|45|||
144206575|NCT02704403|519950710|FG000|Overall Study|Investigator decision|1|||
144206576|NCT02704403|519950711|FG001|Overall Study|Investigator decision|1|||
144206577|NCT02704403|519950710|FG000|Overall Study|Follow-up not possible|1|||
144206578|NCT02704403|519950711|FG001|Overall Study|Follow-up not possible|2|||
144206579|NCT02677714|519950720|FG000|Overall Study|Withdrawal by Subject|2|||
144206580|NCT02677714|519950721|FG001|Overall Study|Withdrawal by Subject|0|||
144206581|NCT02227446|519950723|FG000|Overall Study|not eligible post randomization|18|||
144206582|NCT02227446|519950724|FG001|Overall Study|not eligible post randomization|29|||
144206583|NCT02227446|519950723|FG000|Overall Study|Withdrawal by Subject|4|||
144206584|NCT02227446|519950724|FG001|Overall Study|Withdrawal by Subject|5|||
144206585|NCT01352416|519950725|FG000|Overall Study|Physician Decision|1|||
144206586|NCT01352416|519950726|FG001|Overall Study|Physician Decision|2|||
144206587|NCT01352416|519950727|FG002|Overall Study|Physician Decision|2|||
144206588|NCT01352416|519950728|FG003|Overall Study|Physician Decision|1|||
144206589|NCT03200912|519950729|FG000|Overall Study|Adverse Event|3|||
144206590|NCT03200912|519950730|FG001|Overall Study|Adverse Event|0|||
144206591|NCT03200912|519950731|FG002|Overall Study|Adverse Event|0|||
144206592|NCT03200912|519950729|FG000|Overall Study|Withdrawal by Subject|1|||
144206593|NCT03200912|519950730|FG001|Overall Study|Withdrawal by Subject|2|||
144206594|NCT03200912|519950731|FG002|Overall Study|Withdrawal by Subject|4|||
144206595|NCT03200912|519950729|FG000|Overall Study|Non-compliance with study drug|0|||
144206596|NCT03200912|519950730|FG001|Overall Study|Non-compliance with study drug|1|||
144206597|NCT03200912|519950731|FG002|Overall Study|Non-compliance with study drug|0|||
144206598|NCT00229723|519950732|FG000|Concomitant Phase|Adverse Event|4|||
144206599|NCT00229723|519950733|FG001|Concomitant Phase|Adverse Event|2|||
144206600|NCT00229723|519950734|FG002|Concomitant Phase|Adverse Event|5|||
144206601|NCT00229723|519950735|FG003|Concomitant Phase|Adverse Event|2|||
144206602|NCT00229723|519950736|FG004|Concomitant Phase|Adverse Event|0|||
144206603|NCT00229723|519950737|FG005|Concomitant Phase|Adverse Event|1|||
144206604|NCT00229723|519950738|FG006|Concomitant Phase|Adverse Event|2|||
144206605|NCT00229723|519950732|FG000|Concomitant Phase|Objective disease progression|0|||
144206606|NCT00229723|519950733|FG001|Concomitant Phase|Objective disease progression|0|||
144206607|NCT00229723|519950734|FG002|Concomitant Phase|Objective disease progression|0|||
144206608|NCT00229723|519950735|FG003|Concomitant Phase|Objective disease progression|0|||
144206609|NCT00229723|519950736|FG004|Concomitant Phase|Objective disease progression|0|||
144206610|NCT00229723|519950737|FG005|Concomitant Phase|Objective disease progression|0|||
144206611|NCT00229723|519950738|FG006|Concomitant Phase|Objective disease progression|0|||
144206612|NCT00229723|519950732|FG000|Concomitant Phase|Clinical progression|0|||
144206613|NCT00229723|519950733|FG001|Concomitant Phase|Clinical progression|0|||
144206614|NCT00229723|519950734|FG002|Concomitant Phase|Clinical progression|0|||
144206615|NCT00229723|519950735|FG003|Concomitant Phase|Clinical progression|0|||
144206616|NCT00229723|519950736|FG004|Concomitant Phase|Clinical progression|0|||
144206617|NCT00229723|519950737|FG005|Concomitant Phase|Clinical progression|0|||
144206618|NCT00229723|519950738|FG006|Concomitant Phase|Clinical progression|1|||
144206619|NCT00229723|519950732|FG000|Concomitant Phase|Lost to Follow-up|0|||
144206620|NCT00229723|519950733|FG001|Concomitant Phase|Lost to Follow-up|0|||
144206621|NCT00229723|519950734|FG002|Concomitant Phase|Lost to Follow-up|0|||
144262763|NCT00490971|520161547|FG000|Maintenance|Pregnancy|0|||
144262764|NCT00490971|520161548|FG001|Maintenance|Pregnancy|0|||
144262765|NCT00490971|520161549|FG002|Maintenance|Pregnancy|1|||
144568803|NCT00763451|521282178|FG002|Overall Study|Randomized but not Treated|0|||
144568804|NCT00763451|521282179|FG003|Overall Study|Randomized but not Treated|0|||
144568805|NCT00763451|521282176|FG000|Overall Study|Study Site Reason|0|||
144262766|NCT00490971|520161550|FG003|Maintenance|Pregnancy|0|||
144568806|NCT00763451|521282177|FG001|Overall Study|Study Site Reason|1|||
144568807|NCT00763451|521282178|FG002|Overall Study|Study Site Reason|1|||
144568808|NCT00763451|521282179|FG003|Overall Study|Study Site Reason|1|||
144206622|NCT00229723|519950735|FG003|Concomitant Phase|Lost to Follow-up|0|||
144206623|NCT00229723|519950736|FG004|Concomitant Phase|Lost to Follow-up|1|||
144206624|NCT00229723|519950737|FG005|Concomitant Phase|Lost to Follow-up|0|||
144206625|NCT00229723|519950738|FG006|Concomitant Phase|Lost to Follow-up|0|||
144206626|NCT00229723|519950732|FG000|Concomitant Phase|Informed consent withdrawn|3|||
144206627|NCT00229723|519950733|FG001|Concomitant Phase|Informed consent withdrawn|2|||
144206628|NCT00229723|519950734|FG002|Concomitant Phase|Informed consent withdrawn|0|||
144262767|NCT00490971|520161551|FG004|Maintenance|Pregnancy|0|||
144262768|NCT00490971|520161547|FG000|Maintenance|Protocol Violation|0|||
144262769|NCT00490971|520161548|FG001|Maintenance|Protocol Violation|0|||
144262770|NCT00490971|520161549|FG002|Maintenance|Protocol Violation|4|||
144262771|NCT00490971|520161550|FG003|Maintenance|Protocol Violation|1|||
144262772|NCT00490971|520161551|FG004|Maintenance|Protocol Violation|1|||
144262773|NCT00490971|520161547|FG000|Maintenance|Withdrawal by Subject|0|||
144262774|NCT00490971|520161548|FG001|Maintenance|Withdrawal by Subject|0|||
144262775|NCT00490971|520161549|FG002|Maintenance|Withdrawal by Subject|26|||
144262776|NCT00490971|520161550|FG003|Maintenance|Withdrawal by Subject|28|||
144262777|NCT00490971|520161551|FG004|Maintenance|Withdrawal by Subject|18|||
144262778|NCT00490971|520161547|FG000|Maintenance|Other|0|||
144262779|NCT00490971|520161548|FG001|Maintenance|Other|0|||
144262780|NCT00490971|520161549|FG002|Maintenance|Other|11|||
144262781|NCT00490971|520161550|FG003|Maintenance|Other|9|||
144262782|NCT00490971|520161551|FG004|Maintenance|Other|3|||
144568809|NCT00725543|521282183|FG000|Overall Study|Adverse Event|10|||
144568810|NCT00725543|521282183|FG000|Overall Study|Lack of Efficacy|3|||
144568811|NCT00725543|521282183|FG000|Overall Study|Withdrawal by Subject|10|||
144568812|NCT00725543|521282183|FG000|Overall Study|Physician Decision|5|||
144568813|NCT00725543|521282183|FG000|Overall Study|Lost to Follow-up|4|||
144568814|NCT00725543|521282183|FG000|Overall Study|Non-compliance|2|||
144568815|NCT00725543|521282183|FG000|Overall Study|Other|119|||
144568816|NCT01062971|521282185|FG000|Overall Study|Protocol Violation|1|||
144568817|NCT01062971|521282186|FG001|Overall Study|Protocol Violation|3|||
144568818|NCT01062971|521282185|FG000|Overall Study|Lost to Follow-up|3|||
144568819|NCT01062971|521282186|FG001|Overall Study|Lost to Follow-up|4|||
144568820|NCT01087814|521282187|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
144568821|NCT01087814|521282188|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
144568822|NCT01087814|521282187|FG000|Second Intervention (5 Days)|Physician Decision|1|||
144568823|NCT01087814|521282188|FG001|Second Intervention (5 Days)|Physician Decision|0|||
144568824|NCT01427738|521282189|FG000|Overall Study|Death|12|||
144568825|NCT01427738|521282190|FG001|Overall Study|Death|9|||
144568826|NCT01427738|521282189|FG000|Overall Study|Severe debilitation, unable to continue|0|||
144568827|NCT01427738|521282190|FG001|Overall Study|Severe debilitation, unable to continue|1|||
144568828|NCT01427738|521282189|FG000|Overall Study|Subject unable to get to clinic|5|||
144568829|NCT01427738|521282190|FG001|Overall Study|Subject unable to get to clinic|2|||
144568830|NCT01427738|521282189|FG000|Overall Study|Withdrawal by Subject|0|||
144568831|NCT01427738|521282190|FG001|Overall Study|Withdrawal by Subject|2|||
144568832|NCT01427738|521282189|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
144568833|NCT01427738|521282190|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
144568834|NCT01427738|521282189|FG000|Overall Study|Lost to Follow-up|1|||
144568835|NCT01427738|521282190|FG001|Overall Study|Lost to Follow-up|5|||
144262783|NCT00565604|520161562|FG000|Overall Study|Failure to treat|2|||
144568836|NCT02392104|521282195|FG000|Overall Study|discontinuation of warfarin|3|||
144568837|NCT02392104|521282195|FG000|Overall Study|bleeding event|1|||
144568838|NCT02392104|521282195|FG000|Overall Study|transferred care to another doctor|2|||
144568839|NCT02392104|521282195|FG000|Overall Study|INR goal range changed|1|||
144568840|NCT02392104|521282195|FG000|Overall Study|admitted to skilled nursing facility|3|||
144568841|NCT02392104|521282195|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
144568842|NCT02581059|521282196|FG000|Study Treatment|Disease Progression|1|||
144568843|NCT02581059|521282197|FG001|Study Treatment|Disease Progression|1|||
144568844|NCT02581059|521282196|FG000|Study Treatment|Adverse Event|2|||
144568845|NCT02581059|521282197|FG001|Study Treatment|Adverse Event|1|||
144568846|NCT02581059|521282196|FG000|Study Treatment|Death|1|||
144568847|NCT02581059|521282197|FG001|Study Treatment|Death|1|||
144568848|NCT02581059|521282196|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
144568849|NCT02581059|521282197|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
144568850|NCT02581059|521282196|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
144568851|NCT02581059|521282197|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
144568852|NCT02581059|521282196|FG000|Follow up|Death|1|||
144568853|NCT02581059|521282197|FG001|Follow up|Death|3|||
144568854|NCT02581059|521282196|FG000|Follow up|study terminated|1|||
144568855|NCT02581059|521282197|FG001|Follow up|study terminated|1|||
144568856|NCT02581059|521282196|FG000|Follow up|screen failure|0|||
144568857|NCT02581059|521282197|FG001|Follow up|screen failure|1|||
144728766|NCT01475474|521861340|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
144262784|NCT00565604|520161562|FG000|Overall Study|Lost to Follow-up|2|||
144568858|NCT02581059|521282196|FG000|Follow up|Patient started new clinical trial|1|||
144568859|NCT02581059|521282197|FG001|Follow up|Patient started new clinical trial|0|||
144568860|NCT03912532|521282201|FG000|Overall Study|Adverse Event|3|||
144568861|NCT03912532|521282202|FG001|Overall Study|Adverse Event|3|||
144728767|NCT01475474|521861340|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
144262785|NCT04754542|520161563|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
144262786|NCT04754542|520161564|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
144262787|NCT00715559|520163737|FG000|Overall Study|medication not tolerated - nausea|1|||
144568862|NCT03912532|521282203|FG002|Overall Study|Adverse Event|2|||
144568863|NCT03912532|521282204|FG003|Overall Study|Adverse Event|2|||
144568864|NCT03912532|521282201|FG000|Overall Study|Lost to Follow-up|3|||
144568865|NCT03912532|521282202|FG001|Overall Study|Lost to Follow-up|2|||
144568866|NCT03912532|521282203|FG002|Overall Study|Lost to Follow-up|1|||
144568867|NCT03912532|521282204|FG003|Overall Study|Lost to Follow-up|2|||
144568868|NCT03912532|521282201|FG000|Overall Study|Withdrawal by Subject|1|||
144568869|NCT03912532|521282202|FG001|Overall Study|Withdrawal by Subject|1|||
144568870|NCT03912532|521282203|FG002|Overall Study|Withdrawal by Subject|2|||
144568871|NCT03912532|521282204|FG003|Overall Study|Withdrawal by Subject|0|||
144568872|NCT03912532|521282201|FG000|Overall Study|Physician Decision|1|||
144568873|NCT03912532|521282202|FG001|Overall Study|Physician Decision|0|||
144568874|NCT03912532|521282203|FG002|Overall Study|Physician Decision|0|||
144568875|NCT03912532|521282204|FG003|Overall Study|Physician Decision|3|||
144568876|NCT03912532|521282201|FG000|Overall Study|Other|0|||
144568877|NCT03912532|521282202|FG001|Overall Study|Other|1|||
144568878|NCT03912532|521282203|FG002|Overall Study|Other|1|||
144568879|NCT03912532|521282204|FG003|Overall Study|Other|0|||
144568880|NCT04913948|521282205|FG000|Overall Study|Withdrawal by Subject|2|||
144568881|NCT04913948|521282205|FG000|Overall Study|Sample processing issues|1|||
144568882|NCT04913948|521282205|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
144568883|NCT03783871|521282208|FG000|Overall Study|Withdrawal by Subject|15|||
144568884|NCT03783871|521282208|FG000|Overall Study|Death|13|||
144568885|NCT03783871|521282208|FG000|Overall Study|Lost to Follow-up|2|||
144568886|NCT03569891|521282210|FG000|Lead-in|Ineligible during lead-in|8|||
144568887|NCT03569891|521282210|FG000|Lead-in|Withdrawal by Subject|3|||
144568888|NCT03569891|521282210|FG000|Lead-in|Risks related to COVID-19|2|||
144568889|NCT03569891|521282210|FG000|AMT-061|Adverse Event|1|||
144568890|NCT05990387|521282211|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
144568891|NCT05990387|521282212|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
144568892|NCT00815919|521282213|FG000|Overall Study|Unrelated Fungal Infection|1|||
144568893|NCT00815919|521282213|FG000|Overall Study|AML Relapse|1|||
144568894|NCT00815919|521282213|FG000|Overall Study|Lack of Efficacy|2|||
144568895|NCT03522389|521282214|FG000|Overall Study|Lost to Follow-up|1|||
144568896|NCT03522389|521282215|FG001|Overall Study|Lost to Follow-up|1|||
144568897|NCT03522389|521282216|FG002|Overall Study|Lost to Follow-up|2|||
144568898|NCT03522389|521282214|FG000|Overall Study|had herniated nucleus pulposus|0|||
144568899|NCT03522389|521282215|FG001|Overall Study|had herniated nucleus pulposus|1|||
144568900|NCT03522389|521282216|FG002|Overall Study|had herniated nucleus pulposus|0|||
144568901|NCT03522389|521282214|FG000|Overall Study|go to work in other province|1|||
144568902|NCT03522389|521282215|FG001|Overall Study|go to work in other province|0|||
144568903|NCT03522389|521282216|FG002|Overall Study|go to work in other province|0|||
144568904|NCT04750577|521282217|FG000|Overall Study|Adverse Event|2|||
144568905|NCT04750577|521282218|FG001|Overall Study|Adverse Event|10|||
144568906|NCT04750577|521282219|FG002|Overall Study|Adverse Event|8|||
144568907|NCT04750577|521282220|FG003|Overall Study|Adverse Event|1|||
144568908|NCT04750577|521282217|FG000|Overall Study|Change of residence|0|||
144568909|NCT04750577|521282218|FG001|Overall Study|Change of residence|0|||
144568910|NCT04750577|521282219|FG002|Overall Study|Change of residence|1|||
144568911|NCT04750577|521282220|FG003|Overall Study|Change of residence|0|||
144568912|NCT04750577|521282217|FG000|Overall Study|Burden of study procedures|0|||
144568913|NCT04750577|521282218|FG001|Overall Study|Burden of study procedures|2|||
144568914|NCT04750577|521282219|FG002|Overall Study|Burden of study procedures|2|||
144206629|NCT00229723|519950735|FG003|Concomitant Phase|Informed consent withdrawn|2|||
144206630|NCT00229723|519950736|FG004|Concomitant Phase|Informed consent withdrawn|0|||
144206631|NCT00229723|519950737|FG005|Concomitant Phase|Informed consent withdrawn|0|||
144568915|NCT04750577|521282220|FG003|Overall Study|Burden of study procedures|0|||
144568916|NCT04750577|521282217|FG000|Overall Study|Prematurely discontinued|0|||
144568917|NCT04750577|521282218|FG001|Overall Study|Prematurely discontinued|0|||
144568918|NCT04750577|521282219|FG002|Overall Study|Prematurely discontinued|0|||
144568919|NCT04750577|521282220|FG003|Overall Study|Prematurely discontinued|2|||
144568920|NCT04750577|521282217|FG000|Overall Study|Protocol deviation|1|||
144568921|NCT04750577|521282218|FG001|Overall Study|Protocol deviation|1|||
144568922|NCT04750577|521282219|FG002|Overall Study|Protocol deviation|1|||
144568923|NCT04750577|521282220|FG003|Overall Study|Protocol deviation|1|||
144568924|NCT04750577|521282217|FG000|Overall Study|Other than listed|3|||
144206632|NCT00229723|519950738|FG006|Concomitant Phase|Informed consent withdrawn|0|||
144206633|NCT00229723|519950732|FG000|Concomitant Phase|Severe non-compliance|0|||
144568925|NCT04750577|521282218|FG001|Overall Study|Other than listed|2|||
144568926|NCT04750577|521282219|FG002|Overall Study|Other than listed|2|||
144568927|NCT04750577|521282220|FG003|Overall Study|Other than listed|1|||
144568928|NCT04750577|521282217|FG000|Overall Study|Not treated|0|||
144568929|NCT04750577|521282218|FG001|Overall Study|Not treated|0|||
144568930|NCT04750577|521282219|FG002|Overall Study|Not treated|0|||
144568931|NCT04750577|521282220|FG003|Overall Study|Not treated|2|||
144568932|NCT00604188|521282225|FG000|Overall Study|Adverse Event|1|||
144568933|NCT00604188|521282226|FG001|Overall Study|Adverse Event|4|||
144568934|NCT00604188|521282225|FG000|Overall Study|Lost to Follow-up|17|||
144568935|NCT00604188|521282226|FG001|Overall Study|Lost to Follow-up|15|||
144206634|NCT00229723|519950733|FG001|Concomitant Phase|Severe non-compliance|1|||
144206635|NCT00229723|519950734|FG002|Concomitant Phase|Severe non-compliance|0|||
144206636|NCT00229723|519950735|FG003|Concomitant Phase|Severe non-compliance|0|||
144206637|NCT00229723|519950736|FG004|Concomitant Phase|Severe non-compliance|1|||
144206638|NCT00229723|519950737|FG005|Concomitant Phase|Severe non-compliance|0|||
144206639|NCT00229723|519950738|FG006|Concomitant Phase|Severe non-compliance|0|||
144206640|NCT00229723|519950732|FG000|Concomitant Phase|Other|3|||
144206641|NCT00229723|519950733|FG001|Concomitant Phase|Other|0|||
144206642|NCT00229723|519950734|FG002|Concomitant Phase|Other|1|||
144206643|NCT00229723|519950735|FG003|Concomitant Phase|Other|1|||
144206644|NCT00229723|519950736|FG004|Concomitant Phase|Other|0|||
144206645|NCT00229723|519950737|FG005|Concomitant Phase|Other|2|||
144206646|NCT00229723|519950738|FG006|Concomitant Phase|Other|0|||
144568936|NCT00604188|521282225|FG000|Overall Study|Withdrawal by Subject|5|||
144568937|NCT00604188|521282226|FG001|Overall Study|Withdrawal by Subject|1|||
144568938|NCT00604188|521282225|FG000|Overall Study|Non-compliance with protocol|4|||
144568939|NCT00604188|521282226|FG001|Overall Study|Non-compliance with protocol|4|||
144568940|NCT00604188|521282225|FG000|Overall Study|Did not receive study drug|0|||
144568941|NCT00604188|521282226|FG001|Overall Study|Did not receive study drug|1|||
144568942|NCT01251887|521282228|FG000|Overall Study|Scheduling conflict|1|||
144568943|NCT01251887|521282229|FG001|Overall Study|Scheduling conflict|2|||
144568944|NCT01251887|521282230|FG002|Overall Study|Scheduling conflict|2|||
144568945|NCT01251887|521282228|FG000|Overall Study|Physician Decision|0|||
144568946|NCT01251887|521282229|FG001|Overall Study|Physician Decision|1|||
144568947|NCT01251887|521282230|FG002|Overall Study|Physician Decision|0|||
144568948|NCT03668223|521282231|FG000|Overall Study|Death|10|||
144568949|NCT03668223|521282232|FG001|Overall Study|Death|5|||
144568950|NCT03668223|521282231|FG000|Overall Study|Lost to Follow-up|12|||
144568951|NCT03668223|521282232|FG001|Overall Study|Lost to Follow-up|12|||
144568952|NCT03668223|521282231|FG000|Overall Study|Withdrawal by Subject|8|||
144568953|NCT03668223|521282232|FG001|Overall Study|Withdrawal by Subject|3|||
144568954|NCT00443599|521282236|FG000|Overall Study|Physician Decision|2|||
144568955|NCT00443599|521282237|FG001|Overall Study|Physician Decision|1|||
144568956|NCT00443599|521282236|FG000|Overall Study|Death|1|||
144568957|NCT00443599|521282237|FG001|Overall Study|Death|1|||
144568958|NCT00443599|521282236|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
144568959|NCT00443599|521282237|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
144568960|NCT00826228|521283889|FG000|Overall Study|Withdrawal by Subject|1|||
144568961|NCT00487825|521283891|FG000|Overall Study|Adverse Event|2|||
144568962|NCT00487825|521283892|FG001|Overall Study|Adverse Event|2|||
144568963|NCT00487825|521283891|FG000|Overall Study|Lack of Efficacy|1|||
144568964|NCT00487825|521283892|FG001|Overall Study|Lack of Efficacy|1|||
144206647|NCT00229723|519950732|FG000|Maintenance Phase|Adverse Event|7|||
144206648|NCT00229723|519950733|FG001|Maintenance Phase|Adverse Event|2|||
144206649|NCT00229723|519950734|FG002|Maintenance Phase|Adverse Event|1|||
144206650|NCT00229723|519950735|FG003|Maintenance Phase|Adverse Event|4|||
144206651|NCT00229723|519950736|FG004|Maintenance Phase|Adverse Event|7|||
144206652|NCT00229723|519950737|FG005|Maintenance Phase|Adverse Event|5|||
144206653|NCT00229723|519950738|FG006|Maintenance Phase|Adverse Event|2|||
144206654|NCT00229723|519950732|FG000|Maintenance Phase|Objective disease progression|5|||
144206655|NCT00229723|519950733|FG001|Maintenance Phase|Objective disease progression|5|||
144206656|NCT00229723|519950734|FG002|Maintenance Phase|Objective disease progression|3|||
144206657|NCT00229723|519950735|FG003|Maintenance Phase|Objective disease progression|6|||
144568965|NCT00487825|521283891|FG000|Overall Study|Other|3|||
144568966|NCT00487825|521283892|FG001|Overall Study|Other|2|||
144568967|NCT00575042|521283893|FG000|Overall Study|Adverse Event|2|||
144568968|NCT00575042|521283893|FG000|Overall Study|Lost to Follow-up|1|||
144568969|NCT04978350|521283894|FG000|Overall Study|Lost to Follow-up|6|||
144568970|NCT02577003|521283895|FG000|Overall Study|Adverse Event|2|||
144568971|NCT02577003|521283896|FG001|Overall Study|Adverse Event|4|||
144568972|NCT02577003|521283895|FG000|Overall Study|Withdrawal by Subject|0|||
144568973|NCT02577003|521283896|FG001|Overall Study|Withdrawal by Subject|1|||
144568974|NCT04486313|521283897|FG000|Overall Study|Lost to Follow-up|7|||
144568975|NCT04486313|521283898|FG001|Overall Study|Lost to Follow-up|9|||
144568976|NCT04486313|521283897|FG000|Overall Study|Withdrawal by Subject|8|||
144206658|NCT00229723|519950736|FG004|Maintenance Phase|Objective disease progression|2|||
144568977|NCT04486313|521283898|FG001|Overall Study|Withdrawal by Subject|6|||
144568978|NCT04486313|521283897|FG000|Overall Study|Physician Decision|1|||
144619641|NCT00774345|521466065|FG000|Treatment|Other Reasons|32|||
144568979|NCT04486313|521283898|FG001|Overall Study|Physician Decision|1|||
144568980|NCT04486313|521283897|FG000|Overall Study|Death|2|||
144568981|NCT04486313|521283898|FG001|Overall Study|Death|0|||
144568982|NCT04486313|521283897|FG000|Overall Study|Protocol Violation|1|||
144206659|NCT00229723|519950737|FG005|Maintenance Phase|Objective disease progression|9|||
144206660|NCT00229723|519950738|FG006|Maintenance Phase|Objective disease progression|5|||
144206661|NCT00229723|519950732|FG000|Maintenance Phase|Clinical progression|4|||
144206662|NCT00229723|519950733|FG001|Maintenance Phase|Clinical progression|1|||
144206663|NCT00229723|519950734|FG002|Maintenance Phase|Clinical progression|2|||
144206664|NCT00229723|519950735|FG003|Maintenance Phase|Clinical progression|2|||
144568983|NCT04486313|521283898|FG001|Overall Study|Protocol Violation|1|||
144568984|NCT00126659|521283899|FG000|Overall Study|Adverse Event|0|||
144568985|NCT00126659|521283900|FG001|Overall Study|Adverse Event|0|||
144568986|NCT00126659|521283901|FG002|Overall Study|Adverse Event|2|||
144568987|NCT00174447|521283902|FG000|Overall Study|Adverse Event|19|||
144568988|NCT00174447|521283902|FG000|Overall Study|Withdrawal by Subject|15|||
144568989|NCT00174447|521283902|FG000|Overall Study|Protocol Violation|1|||
144568990|NCT00174447|521283902|FG000|Overall Study|Lack of Efficacy|1|||
144568991|NCT00174447|521283902|FG000|Overall Study|Administrative reason/Other|2|||
144568992|NCT02229578|521283905|FG000|Overall Study|Withdrawal by Subject|1|||
144568993|NCT02229578|521283906|FG001|Overall Study|Withdrawal by Subject|3|||
144568994|NCT02229578|521283905|FG000|Overall Study|Protocol Violation|2|||
144568995|NCT02229578|521283906|FG001|Overall Study|Protocol Violation|0|||
144568996|NCT00943787|521283908|FG000|Overall Study|Physician Decision|4|||
144568997|NCT00943787|521283908|FG000|Overall Study|Withdrawal by Subject|3|||
144568998|NCT04071301|521283909|FG000|Overall Study|Withdrawal by Subject|6|||
144568999|NCT04071301|521283909|FG000|Overall Study|Death|1|||
144569000|NCT01850589|521283915|FG000|Overall Study|Withdrawal by Subject|8|||
144569001|NCT01850589|521283916|FG001|Overall Study|Withdrawal by Subject|0|||
144569002|NCT03721705|521283920|FG000|Overall Study|Adverse Event|2|||
144569003|NCT03721705|521283921|FG001|Overall Study|Adverse Event|0|||
144569004|NCT03721705|521283920|FG000|Overall Study|Withdrawal by Subject|4|||
144569005|NCT03721705|521283921|FG001|Overall Study|Withdrawal by Subject|10|||
144569006|NCT03721705|521283920|FG000|Overall Study|No Suitable Study Partner|1|||
144569007|NCT03721705|521283921|FG001|Overall Study|No Suitable Study Partner|0|||
144569008|NCT03721705|521283920|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
144569009|NCT03721705|521283921|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
144569010|NCT03721705|521283920|FG000|Overall Study|Death|0|||
144569011|NCT03721705|521283921|FG001|Overall Study|Death|1|||
144569012|NCT01843777|521283922|FG000|Overall Study|Withdrawal by Subject|1|||
144569013|NCT01843777|521283923|FG001|Overall Study|Withdrawal by Subject|0|||
144569014|NCT03721172|521283925|FG000|Placebo-controlled Phase|Adverse Event|7|||
144569015|NCT03721172|521283926|FG001|Placebo-controlled Phase|Adverse Event|7|||
144569016|NCT03721172|521283927|FG002|Placebo-controlled Phase|Adverse Event|0|||
144569017|NCT03721172|521283925|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
144569018|NCT03721172|521283926|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
144569019|NCT03721172|521283927|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
144569020|NCT03721172|521283925|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
144569021|NCT03721172|521283926|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
144569022|NCT03721172|521283927|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
144569023|NCT03721172|521283925|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
144569024|NCT03721172|521283926|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
144569025|NCT03721172|521283927|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
144569026|NCT03721172|521283925|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
144569027|NCT03721172|521283926|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
144569028|NCT03721172|521283927|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
144569029|NCT03721172|521283925|FG000|Placebo-controlled Phase|Other|3|||
144569030|NCT03721172|521283926|FG001|Placebo-controlled Phase|Other|0|||
144569031|NCT03721172|521283927|FG002|Placebo-controlled Phase|Other|0|||
144569032|NCT03721172|521283925|FG000|Apremilast Extension Phase|Adverse Event|0|||
144569033|NCT03721172|521283926|FG001|Apremilast Extension Phase|Adverse Event|0|||
144569034|NCT03721172|521283927|FG002|Apremilast Extension Phase|Adverse Event|10|||
144569035|NCT03721172|521283925|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
144569036|NCT03721172|521283926|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
144569037|NCT03721172|521283927|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
144569038|NCT03721172|521283925|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
144569039|NCT03721172|521283926|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
144569040|NCT03721172|521283927|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
144569041|NCT03721172|521283925|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
144569042|NCT03721172|521283926|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
144619642|NCT00774345|521466066|FG001|Treatment|Other Reasons|26|||
144619643|NCT01277549|521466067|FG000|Overall Study|Failed to meet eligibility criteria|13|||
144619644|NCT01277549|521466068|FG001|Overall Study|Failed to meet eligibility criteria|9|||
144619645|NCT01277549|521466067|FG000|Overall Study|Withdrawal by Subject|1|||
144619646|NCT01277549|521466068|FG001|Overall Study|Withdrawal by Subject|3|||
144619647|NCT01277549|521466067|FG000|Overall Study|Protocol Violation|10|||
144619648|NCT01277549|521466068|FG001|Overall Study|Protocol Violation|1|||
144619649|NCT01277549|521466067|FG000|Overall Study|Physician Decision|2|||
144619650|NCT01277549|521466068|FG001|Overall Study|Physician Decision|1|||
144619651|NCT00623428|521466069|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
144728768|NCT05277389|521861341|FG000|Overall Study|Lost to Follow-up|1|||
144728769|NCT05277389|521861342|FG001|Overall Study|Lost to Follow-up|4|||
144569043|NCT03721172|521283927|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
144569044|NCT03721172|521283925|FG000|Apremilast Extension Phase|Protocol Violation|0|||
144569045|NCT03721172|521283926|FG001|Apremilast Extension Phase|Protocol Violation|0|||
144619652|NCT00623428|521466070|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
144619653|NCT00623428|521466069|FG000|Treatment Period|Death|0|||
144619654|NCT00623428|521466070|FG001|Treatment Period|Death|1|||
144619655|NCT00623428|521466069|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
144619656|NCT00623428|521466070|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
144619657|NCT00623428|521466069|FG000|Treatment Period|Insufficient therapeutic response|0|||
144569046|NCT03721172|521283927|FG002|Apremilast Extension Phase|Protocol Violation|1|||
144569047|NCT03721172|521283925|FG000|Apremilast Extension Phase|Physician Decision|0|||
144569048|NCT03721172|521283926|FG001|Apremilast Extension Phase|Physician Decision|0|||
144569049|NCT03721172|521283927|FG002|Apremilast Extension Phase|Physician Decision|1|||
144569050|NCT03721172|521283925|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
144569051|NCT03721172|521283926|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
144569052|NCT03721172|521283927|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
144569053|NCT03721172|521283925|FG000|Apremilast Extension Phase|Other|0|||
144569054|NCT03721172|521283926|FG001|Apremilast Extension Phase|Other|0|||
144569055|NCT03721172|521283927|FG002|Apremilast Extension Phase|Other|3|||
144569056|NCT03721172|521283925|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
144569057|NCT03721172|521283926|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
144569058|NCT03721172|521283927|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
144569059|NCT01162135|521283929|FG000|Overall Study|Withdrawal by Subject|1|||
144569060|NCT01162135|521283929|FG000|Overall Study|Severe back pain|1|||
144569061|NCT01162135|521283929|FG000|Overall Study|Ineligible|1|||
144569062|NCT03603639|521283930|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
144569063|NCT03603639|521283931|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
144569064|NCT03603639|521283932|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
144569065|NCT03603639|521283933|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
144569066|NCT03603639|521283934|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
144569067|NCT03603639|521283935|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
144569068|NCT03603639|521283930|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
144569069|NCT03603639|521283931|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
144569070|NCT03603639|521283932|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
144569071|NCT03603639|521283933|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
144569072|NCT03603639|521283934|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
144569073|NCT03603639|521283935|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
144569074|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
144569075|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
144569076|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
144569077|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
144569078|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
144569079|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
144569080|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
144569081|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
144569082|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
144569083|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
144569084|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
144569085|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
144569086|NCT01216072|521283938|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
144569087|NCT01216072|521283939|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
144569088|NCT01216072|521283938|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
144569089|NCT01216072|521283939|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
144569090|NCT01216072|521283938|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
144569091|NCT01216072|521283939|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
144569092|NCT01216072|521283938|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
144569093|NCT01216072|521283939|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
144569094|NCT02818998|521283946|FG000|Overall Study|Adverse Event|3|||
144569095|NCT02818998|521283947|FG001|Overall Study|Adverse Event|2|||
144569096|NCT02818998|521283948|FG002|Overall Study|Adverse Event|1|||
144569097|NCT02818998|521283946|FG000|Overall Study|Lost to Follow-up|4|||
144569098|NCT02818998|521283947|FG001|Overall Study|Lost to Follow-up|1|||
144569099|NCT02818998|521283948|FG002|Overall Study|Lost to Follow-up|2|||
144619658|NCT00623428|521466070|FG001|Treatment Period|Insufficient therapeutic response|2|||
144619659|NCT00623428|521466069|FG000|Treatment Period|Other|0|||
144619660|NCT00623428|521466070|FG001|Treatment Period|Other|1|||
144619661|NCT00623428|521466069|FG000|Treatment Period|Withdrawal by Subject|0|||
144619662|NCT00623428|521466070|FG001|Treatment Period|Withdrawal by Subject|1|||
144619663|NCT00623428|521466069|FG000|Follow-up Period|Relapse post-treatment|11|||
144569100|NCT02818998|521283946|FG000|Overall Study|Withdrawal by sponsor|0|||
144569101|NCT02818998|521283947|FG001|Overall Study|Withdrawal by sponsor|1|||
144569102|NCT02818998|521283948|FG002|Overall Study|Withdrawal by sponsor|1|||
144728770|NCT06096168|521861343|FG000|Overall Study|Death|30|||
144569103|NCT02818998|521283946|FG000|Overall Study|Death|3|||
144569104|NCT02818998|521283947|FG001|Overall Study|Death|6|||
144569105|NCT02818998|521283948|FG002|Overall Study|Death|8|||
144569106|NCT02818998|521283946|FG000|Overall Study|Withdrawal by Subject|7|||
144569107|NCT02818998|521283947|FG001|Overall Study|Withdrawal by Subject|6|||
144569108|NCT02818998|521283948|FG002|Overall Study|Withdrawal by Subject|6|||
144569109|NCT02818998|521283946|FG000|Overall Study|Physician Decision|1|||
144619664|NCT00623428|521466070|FG001|Follow-up Period|Relapse post-treatment|3|||
144619665|NCT00623428|521466069|FG000|Follow-up Period|Failure to return|10|||
144619666|NCT00623428|521466070|FG001|Follow-up Period|Failure to return|2|||
144619667|NCT00623428|521466069|FG000|Follow-up Period|Patient withdrew consent|5|||
144619668|NCT00623428|521466070|FG001|Follow-up Period|Patient withdrew consent|4|||
144619669|NCT00623428|521466069|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
144619670|NCT00623428|521466070|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
144619671|NCT00623428|521466069|FG000|Follow-up Period|Did not cooperate|0|||
144619672|NCT00623428|521466070|FG001|Follow-up Period|Did not cooperate|3|||
144619673|NCT00623428|521466069|FG000|Follow-up Period|Reason not specified|1|||
144619674|NCT00623428|521466070|FG001|Follow-up Period|Reason not specified|1|||
144619675|NCT00623428|521466069|FG000|Follow-up Period|Death|0|||
144619676|NCT00623428|521466070|FG001|Follow-up Period|Death|1|||
144619677|NCT02109484|521466072|FG000|Overall Study|Lost to Follow-up|0|||
144619678|NCT02109484|521466073|FG001|Overall Study|Lost to Follow-up|0|||
144619679|NCT02109484|521466074|FG002|Overall Study|Lost to Follow-up|0|||
144619680|NCT02109484|521466075|FG003|Overall Study|Lost to Follow-up|1|||
144619681|NCT02109484|521466076|FG004|Overall Study|Lost to Follow-up|1|||
144619682|NCT02109484|521466077|FG005|Overall Study|Lost to Follow-up|0|||
144619683|NCT02109484|521466078|FG006|Overall Study|Lost to Follow-up|1|||
144619684|NCT02109484|521466079|FG007|Overall Study|Lost to Follow-up|0|||
144619685|NCT02109484|521466072|FG000|Overall Study|Withdrawal by Subject|0|||
144619686|NCT02109484|521466073|FG001|Overall Study|Withdrawal by Subject|0|||
144619687|NCT02109484|521466074|FG002|Overall Study|Withdrawal by Subject|0|||
144619688|NCT02109484|521466075|FG003|Overall Study|Withdrawal by Subject|0|||
144619689|NCT02109484|521466076|FG004|Overall Study|Withdrawal by Subject|1|||
144619690|NCT02109484|521466077|FG005|Overall Study|Withdrawal by Subject|1|||
144619691|NCT02109484|521466078|FG006|Overall Study|Withdrawal by Subject|1|||
144619692|NCT02109484|521466079|FG007|Overall Study|Withdrawal by Subject|0|||
144619693|NCT02109484|521466072|FG000|Overall Study|Physician Decision|0|||
144619694|NCT02109484|521466073|FG001|Overall Study|Physician Decision|0|||
144619695|NCT02109484|521466074|FG002|Overall Study|Physician Decision|0|||
144619696|NCT02109484|521466075|FG003|Overall Study|Physician Decision|0|||
144619697|NCT02109484|521466076|FG004|Overall Study|Physician Decision|2|||
144619698|NCT02109484|521466077|FG005|Overall Study|Physician Decision|0|||
144619699|NCT02109484|521466078|FG006|Overall Study|Physician Decision|0|||
144619700|NCT02109484|521466079|FG007|Overall Study|Physician Decision|0|||
144619701|NCT02109484|521466072|FG000|Overall Study|Death|0|||
144619702|NCT02109484|521466073|FG001|Overall Study|Death|0|||
144619703|NCT02109484|521466074|FG002|Overall Study|Death|0|||
144619704|NCT02109484|521466075|FG003|Overall Study|Death|0|||
144569110|NCT02818998|521283947|FG001|Overall Study|Physician Decision|0|||
144619705|NCT02109484|521466076|FG004|Overall Study|Death|0|||
144619706|NCT02109484|521466077|FG005|Overall Study|Death|0|||
144619707|NCT02109484|521466078|FG006|Overall Study|Death|0|||
144619708|NCT02109484|521466079|FG007|Overall Study|Death|2|||
144619709|NCT02109484|521466072|FG000|Overall Study|Moved away from study area|0|||
144619710|NCT02109484|521466073|FG001|Overall Study|Moved away from study area|0|||
144619711|NCT02109484|521466074|FG002|Overall Study|Moved away from study area|0|||
144619712|NCT02109484|521466075|FG003|Overall Study|Moved away from study area|0|||
144619713|NCT02109484|521466076|FG004|Overall Study|Moved away from study area|0|||
144619714|NCT02109484|521466077|FG005|Overall Study|Moved away from study area|0|||
144619715|NCT02109484|521466078|FG006|Overall Study|Moved away from study area|1|||
144619716|NCT02109484|521466079|FG007|Overall Study|Moved away from study area|1|||
144619717|NCT00419380|521466080|FG000|Overall Study|Lack of Efficacy|1|||
144569111|NCT02818998|521283948|FG002|Overall Study|Physician Decision|0|||
144619718|NCT00419380|521466081|FG001|Overall Study|Lack of Efficacy|7|||
144619719|NCT00419380|521466080|FG000|Overall Study|Physician Decision|0|||
144619720|NCT00419380|521466081|FG001|Overall Study|Physician Decision|1|||
144619721|NCT00419380|521466080|FG000|Overall Study|Lost to Follow-up|0|||
144619722|NCT00419380|521466081|FG001|Overall Study|Lost to Follow-up|1|||
144569112|NCT02472145|521283949|FG000|Overall Study|Death|10|||
144569113|NCT02472145|521283950|FG001|Overall Study|Death|101|||
144619723|NCT00419380|521466080|FG000|Overall Study|Withdrawal by Subject|0|||
144619724|NCT00419380|521466081|FG001|Overall Study|Withdrawal by Subject|1|||
144619725|NCT03099707|521466082|FG000|Overall Study|Withdrawal by Subject|0|||
144619726|NCT03099707|521466083|FG001|Overall Study|Withdrawal by Subject|3|||
144619727|NCT03099707|521466082|FG000|Overall Study|Lost to Follow-up|0|||
144619728|NCT03099707|521466083|FG001|Overall Study|Lost to Follow-up|1|||
144262788|NCT02019550|520163738|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
144619729|NCT03215771|521466092|FG000|Overall Study|Withdrawal by Subject|2|||
144569114|NCT02472145|521283951|FG002|Overall Study|Death|99|||
144619730|NCT03215771|521466092|FG000|Overall Study|Physician Decision|1|||
144619731|NCT00574275|521466097|FG000|Overall Study|Randomized but not treated|2|||
144619732|NCT00574275|521466098|FG001|Overall Study|Randomized but not treated|3|||
144619733|NCT00574275|521466097|FG000|Overall Study|Adverse Event|32|||
144619734|NCT00574275|521466098|FG001|Overall Study|Adverse Event|76|||
144619735|NCT00574275|521466097|FG000|Overall Study|Disease progression|160|||
144619736|NCT00574275|521466098|FG001|Overall Study|Disease progression|146|||
144619737|NCT00574275|521466097|FG000|Overall Study|Lost to Follow-up|2|||
144619738|NCT00574275|521466098|FG001|Overall Study|Lost to Follow-up|1|||
144619739|NCT00574275|521466097|FG000|Overall Study|Study stopped based on DMC decision|62|||
144728771|NCT06096168|521861343|FG000|Overall Study|Revision|2|||
144728772|NCT01766778|521861350|FG000|Overall Study|Adverse Event|4|||
144728773|NCT01766778|521861351|FG001|Overall Study|Adverse Event|4|||
144728774|NCT01766778|521861350|FG000|Overall Study|Withdrawal by Subject|1|||
144728775|NCT01766778|521861351|FG001|Overall Study|Withdrawal by Subject|0|||
144728776|NCT01411332|521861352|FG000|Enrollment|Protocol Violation|0|||
144728777|NCT01411332|521861353|FG001|Enrollment|Protocol Violation|1|||
144728778|NCT01411332|521861352|FG000|Enrollment|Withdrawal by Subject|0|||
144728779|NCT01411332|521861353|FG001|Enrollment|Withdrawal by Subject|1|||
144728780|NCT01411332|521861352|FG000|Treatment|Lost to Follow-up|1|||
144728781|NCT01411332|521861353|FG001|Treatment|Lost to Follow-up|0|||
144728782|NCT01432171|521861354|FG000|Overall Study|Death|1|||
144728783|NCT01432171|521861355|FG001|Overall Study|Death|2|||
144728784|NCT01432171|521861354|FG000|Overall Study|Lost to Follow-up|6|||
144728785|NCT01432171|521861355|FG001|Overall Study|Lost to Follow-up|5|||
144569115|NCT02472145|521283949|FG000|Overall Study|Lost to Follow-up|0|||
144619740|NCT00574275|521466098|FG001|Overall Study|Study stopped based on DMC decision|23|||
144619741|NCT00574275|521466097|FG000|Overall Study|Withdrawal by Subject|15|||
144619742|NCT00574275|521466098|FG001|Overall Study|Withdrawal by Subject|17|||
144619743|NCT00574275|521466097|FG000|Overall Study|Error calculating tumor measurement|1|||
144619744|NCT00574275|521466098|FG001|Overall Study|Error calculating tumor measurement|0|||
144619745|NCT00574275|521466097|FG000|Overall Study|Physician Decision|1|||
144619746|NCT00574275|521466098|FG001|Overall Study|Physician Decision|1|||
144619747|NCT00574275|521466097|FG000|Overall Study|Protocol Violation|0|||
144619748|NCT00574275|521466098|FG001|Overall Study|Protocol Violation|1|||
144619749|NCT00574275|521466097|FG000|Overall Study|Patient and Investigator decision|0|||
144619750|NCT00574275|521466098|FG001|Overall Study|Patient and Investigator decision|1|||
144619751|NCT00574275|521466097|FG000|Overall Study|Insurance change|0|||
144619752|NCT00574275|521466098|FG001|Overall Study|Insurance change|1|||
144619753|NCT00574275|521466097|FG000|Overall Study|Operation for curative intent|0|||
144619754|NCT00574275|521466098|FG001|Overall Study|Operation for curative intent|1|||
144619755|NCT02703311|521466099|FG000|Overall Study|Death|5|||
144619756|NCT02703311|521466099|FG000|Overall Study|Withdrawal by Subject|3|||
144619757|NCT01967537|521466100|FG000|Overall Study|Withdrawal by Subject|52|||
144569116|NCT02472145|521283950|FG001|Overall Study|Lost to Follow-up|1|||
144569117|NCT02472145|521283951|FG002|Overall Study|Lost to Follow-up|0|||
144569118|NCT02472145|521283949|FG000|Overall Study|Withdrawal by Subject|0|||
144569119|NCT02472145|521283950|FG001|Overall Study|Withdrawal by Subject|9|||
144569120|NCT02472145|521283951|FG002|Overall Study|Withdrawal by Subject|13|||
144569121|NCT02472145|521283949|FG000|Overall Study|Sponsor decision|0|||
144569122|NCT02472145|521283950|FG001|Overall Study|Sponsor decision|3|||
144569123|NCT02472145|521283951|FG002|Overall Study|Sponsor decision|2|||
144569124|NCT02472145|521283949|FG000|Overall Study|Other|0|||
144569125|NCT02472145|521283950|FG001|Overall Study|Other|45|||
144569126|NCT02472145|521283951|FG002|Overall Study|Other|43|||
144569127|NCT01296555|521283952|FG000|Overall Study|Adverse Event|0|||
144569128|NCT01296555|521283953|FG001|Overall Study|Adverse Event|0|||
144569129|NCT01296555|521283954|FG002|Overall Study|Adverse Event|1|||
144569130|NCT01296555|521283955|FG003|Overall Study|Adverse Event|1|||
144569131|NCT01296555|521283956|FG004|Overall Study|Adverse Event|2|||
144619758|NCT01967537|521466100|FG000|Overall Study|Refuse treatment|2|||
144619759|NCT01967537|521466100|FG000|Overall Study|Lost to Follow-up|6|||
144619760|NCT00137111|521466101|FG000|Total Therapy|Death|35|||
144619761|NCT00137111|521466102|FG001|Total Therapy|Death|0|||
144619762|NCT00137111|521466103|FG002|Total Therapy|Death|0|||
144619763|NCT00137111|521466104|FG003|Total Therapy|Death|0|||
144569132|NCT01296555|521283957|FG005|Overall Study|Adverse Event|4|||
144619764|NCT00137111|521466101|FG000|Total Therapy|Non Compliance|5|||
144619765|NCT00137111|521466102|FG001|Total Therapy|Non Compliance|0|||
144619766|NCT00137111|521466103|FG002|Total Therapy|Non Compliance|0|||
144569133|NCT01296555|521283958|FG006|Overall Study|Adverse Event|1|||
144569134|NCT01296555|521283959|FG007|Overall Study|Adverse Event|4|||
144619767|NCT00137111|521466104|FG003|Total Therapy|Non Compliance|0|||
144619768|NCT00562354|521466105|FG000|Overall Study|Physician Decision|0|||
144619769|NCT00562354|521466106|FG001|Overall Study|Physician Decision|1|||
144619770|NCT00562354|521466105|FG000|Overall Study|Lost to Follow-up|0|||
144728786|NCT01432171|521861354|FG000|Overall Study|Withdrawal by Subject|3|||
144728787|NCT01432171|521861355|FG001|Overall Study|Withdrawal by Subject|1|||
144728788|NCT01432171|521861354|FG000|Overall Study|Noncompliance|2|||
144728789|NCT01432171|521861355|FG001|Overall Study|Noncompliance|3|||
144206665|NCT00229723|519950736|FG004|Maintenance Phase|Clinical progression|1|||
144206666|NCT00229723|519950737|FG005|Maintenance Phase|Clinical progression|1|||
144206667|NCT00229723|519950738|FG006|Maintenance Phase|Clinical progression|1|||
144206668|NCT00229723|519950732|FG000|Maintenance Phase|Lost to Follow-up|0|||
144206669|NCT00229723|519950733|FG001|Maintenance Phase|Lost to Follow-up|1|||
144206670|NCT00229723|519950734|FG002|Maintenance Phase|Lost to Follow-up|2|||
144206671|NCT00229723|519950735|FG003|Maintenance Phase|Lost to Follow-up|2|||
144206672|NCT00229723|519950736|FG004|Maintenance Phase|Lost to Follow-up|0|||
144206673|NCT00229723|519950737|FG005|Maintenance Phase|Lost to Follow-up|0|||
144206674|NCT00229723|519950738|FG006|Maintenance Phase|Lost to Follow-up|1|||
144206675|NCT00229723|519950732|FG000|Maintenance Phase|Informed consent withdrawn|1|||
144206676|NCT00229723|519950733|FG001|Maintenance Phase|Informed consent withdrawn|0|||
144206677|NCT00229723|519950734|FG002|Maintenance Phase|Informed consent withdrawn|0|||
144206678|NCT00229723|519950735|FG003|Maintenance Phase|Informed consent withdrawn|1|||
144206679|NCT00229723|519950736|FG004|Maintenance Phase|Informed consent withdrawn|1|||
144206680|NCT00229723|519950737|FG005|Maintenance Phase|Informed consent withdrawn|1|||
144206681|NCT00229723|519950738|FG006|Maintenance Phase|Informed consent withdrawn|0|||
144206682|NCT00229723|519950732|FG000|Maintenance Phase|Severe non-compliance|3|||
144206683|NCT00229723|519950733|FG001|Maintenance Phase|Severe non-compliance|1|||
144206684|NCT00229723|519950734|FG002|Maintenance Phase|Severe non-compliance|0|||
144206685|NCT00229723|519950735|FG003|Maintenance Phase|Severe non-compliance|0|||
144206686|NCT00229723|519950736|FG004|Maintenance Phase|Severe non-compliance|1|||
144206687|NCT00229723|519950737|FG005|Maintenance Phase|Severe non-compliance|0|||
144206688|NCT00229723|519950738|FG006|Maintenance Phase|Severe non-compliance|0|||
144206689|NCT00229723|519950732|FG000|Maintenance Phase|Other|5|||
144206690|NCT00229723|519950733|FG001|Maintenance Phase|Other|4|||
144206691|NCT00229723|519950734|FG002|Maintenance Phase|Other|1|||
144206692|NCT00229723|519950735|FG003|Maintenance Phase|Other|2|||
144206693|NCT00229723|519950736|FG004|Maintenance Phase|Other|3|||
144206694|NCT00229723|519950737|FG005|Maintenance Phase|Other|3|||
144206695|NCT00229723|519950738|FG006|Maintenance Phase|Other|1|||
144206696|NCT02309138|519950739|FG000|Overall Study|Withdrawal by Subject|44|||
144206697|NCT02309138|519950740|FG001|Overall Study|Withdrawal by Subject|15|||
144206698|NCT02309138|519950739|FG000|Overall Study|Protocol Violation|4|||
144206699|NCT02309138|519950740|FG001|Overall Study|Protocol Violation|2|||
144206700|NCT02309138|519950739|FG000|Overall Study|delivered before visit 2|0|||
144206701|NCT02309138|519950740|FG001|Overall Study|delivered before visit 2|1|||
144206702|NCT03421730|519950743|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206703|NCT03421730|519950744|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
144206704|NCT03421730|519950745|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206705|NCT03421730|519950746|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206706|NCT03421730|519950747|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206707|NCT03421730|519950748|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206708|NCT03421730|519950749|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206709|NCT03421730|519950750|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206710|NCT03421730|519950751|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144569135|NCT01296555|521283960|FG008|Overall Study|Adverse Event|3|||
144569136|NCT01296555|521283961|FG009|Overall Study|Adverse Event|1|||
144569137|NCT01296555|521283962|FG010|Overall Study|Adverse Event|0|||
144569138|NCT01296555|521283963|FG011|Overall Study|Adverse Event|4|||
144569139|NCT01296555|521283964|FG012|Overall Study|Adverse Event|1|||
144569140|NCT01296555|521283965|FG013|Overall Study|Adverse Event|4|||
144569141|NCT01296555|521283966|FG014|Overall Study|Adverse Event|0|||
144569142|NCT01296555|521283967|FG015|Overall Study|Adverse Event|0|||
144569143|NCT01296555|521283968|FG016|Overall Study|Adverse Event|0|||
144569144|NCT01296555|521283969|FG017|Overall Study|Adverse Event|0|||
144569145|NCT01296555|521283970|FG018|Overall Study|Adverse Event|0|||
144569146|NCT01296555|521283971|FG019|Overall Study|Adverse Event|1|||
144569147|NCT01296555|521283972|FG020|Overall Study|Adverse Event|0|||
144206711|NCT03421730|519950752|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144262789|NCT02019550|520163739|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
144206712|NCT03421730|519950753|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144262790|NCT02787304|520163742|FG000|Overall Study|Adverse Event|9|||
144262791|NCT02787304|520163743|FG001|Overall Study|Adverse Event|3|||
144569148|NCT01296555|521283973|FG021|Overall Study|Adverse Event|0|||
144569149|NCT01296555|521283974|FG022|Overall Study|Adverse Event|0|||
144569150|NCT01296555|521283975|FG023|Overall Study|Adverse Event|0|||
144206713|NCT03421730|519950754|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
144206714|NCT03421730|519950743|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206715|NCT03421730|519950744|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206716|NCT03421730|519950745|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206717|NCT03421730|519950746|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144569151|NCT01296555|521283976|FG024|Overall Study|Adverse Event|0|||
144569152|NCT01296555|521283977|FG025|Overall Study|Adverse Event|0|||
144569153|NCT01296555|521283978|FG026|Overall Study|Adverse Event|0|||
144569154|NCT01296555|521283979|FG027|Overall Study|Adverse Event|0|||
144569155|NCT01296555|521283980|FG028|Overall Study|Adverse Event|0|||
144569156|NCT01296555|521283952|FG000|Overall Study|Reason Not Specified|0|||
144569157|NCT01296555|521283953|FG001|Overall Study|Reason Not Specified|0|||
144569158|NCT01296555|521283954|FG002|Overall Study|Reason Not Specified|0|||
144569159|NCT01296555|521283955|FG003|Overall Study|Reason Not Specified|0|||
144569160|NCT01296555|521283956|FG004|Overall Study|Reason Not Specified|0|||
144569161|NCT01296555|521283957|FG005|Overall Study|Reason Not Specified|0|||
144569162|NCT01296555|521283958|FG006|Overall Study|Reason Not Specified|0|||
144569163|NCT01296555|521283959|FG007|Overall Study|Reason Not Specified|0|||
144569164|NCT01296555|521283960|FG008|Overall Study|Reason Not Specified|0|||
144569165|NCT01296555|521283961|FG009|Overall Study|Reason Not Specified|0|||
144569166|NCT01296555|521283962|FG010|Overall Study|Reason Not Specified|0|||
144569167|NCT01296555|521283963|FG011|Overall Study|Reason Not Specified|0|||
144569168|NCT01296555|521283964|FG012|Overall Study|Reason Not Specified|0|||
144569169|NCT01296555|521283965|FG013|Overall Study|Reason Not Specified|1|||
144569170|NCT01296555|521283966|FG014|Overall Study|Reason Not Specified|2|||
144569171|NCT01296555|521283967|FG015|Overall Study|Reason Not Specified|3|||
144569172|NCT01296555|521283968|FG016|Overall Study|Reason Not Specified|7|||
144569173|NCT01296555|521283969|FG017|Overall Study|Reason Not Specified|4|||
144569174|NCT01296555|521283970|FG018|Overall Study|Reason Not Specified|3|||
144569175|NCT01296555|521283971|FG019|Overall Study|Reason Not Specified|7|||
144569176|NCT01296555|521283972|FG020|Overall Study|Reason Not Specified|11|||
144569177|NCT01296555|521283973|FG021|Overall Study|Reason Not Specified|5|||
144569178|NCT01296555|521283974|FG022|Overall Study|Reason Not Specified|5|||
144569179|NCT01296555|521283975|FG023|Overall Study|Reason Not Specified|7|||
144569180|NCT01296555|521283976|FG024|Overall Study|Reason Not Specified|2|||
144569181|NCT01296555|521283977|FG025|Overall Study|Reason Not Specified|2|||
144569182|NCT01296555|521283978|FG026|Overall Study|Reason Not Specified|19|||
144569183|NCT01296555|521283979|FG027|Overall Study|Reason Not Specified|11|||
144569184|NCT01296555|521283980|FG028|Overall Study|Reason Not Specified|9|||
144569185|NCT01296555|521283952|FG000|Overall Study|Physician Decision|0|||
144206718|NCT03421730|519950747|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
144206719|NCT03421730|519950748|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206720|NCT03421730|519950749|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206721|NCT03421730|519950750|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206722|NCT03421730|519950751|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206723|NCT03421730|519950752|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206724|NCT03421730|519950753|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206725|NCT03421730|519950754|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
144206726|NCT03016975|519950761|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
144206727|NCT03016975|519950762|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
144206728|NCT03016975|519950763|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
144206729|NCT03016975|519950761|FG000|At 6 Months Follow-up|Death|2|||
144206730|NCT03016975|519950762|FG001|At 6 Months Follow-up|Death|0|||
144206731|NCT03016975|519950763|FG002|At 6 Months Follow-up|Death|0|||
144206732|NCT03016975|519950761|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
144206733|NCT03016975|519950762|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
144206734|NCT03016975|519950763|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
144206735|NCT03016975|519950761|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
144206736|NCT03016975|519950762|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
144206737|NCT03016975|519950763|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
144206738|NCT03016975|519950761|FG000|At 6 Months Follow-up|Aborted implant|1|||
144206739|NCT03016975|519950762|FG001|At 6 Months Follow-up|Aborted implant|0|||
144206740|NCT03016975|519950763|FG002|At 6 Months Follow-up|Aborted implant|0|||
144206741|NCT03016975|519950761|FG000|At 2 Year Follow-up|Death|1|||
144569186|NCT01296555|521283953|FG001|Overall Study|Physician Decision|0|||
144569187|NCT01296555|521283954|FG002|Overall Study|Physician Decision|0|||
144569188|NCT01296555|521283955|FG003|Overall Study|Physician Decision|0|||
144569189|NCT01296555|521283956|FG004|Overall Study|Physician Decision|1|||
144569190|NCT01296555|521283957|FG005|Overall Study|Physician Decision|0|||
144569191|NCT01296555|521283958|FG006|Overall Study|Physician Decision|0|||
144206742|NCT03016975|519950762|FG001|At 2 Year Follow-up|Death|0|||
144569192|NCT01296555|521283959|FG007|Overall Study|Physician Decision|0|||
144569193|NCT01296555|521283960|FG008|Overall Study|Physician Decision|0|||
144569194|NCT01296555|521283961|FG009|Overall Study|Physician Decision|0|||
144569195|NCT01296555|521283962|FG010|Overall Study|Physician Decision|0|||
144569196|NCT01296555|521283963|FG011|Overall Study|Physician Decision|0|||
144569197|NCT01296555|521283964|FG012|Overall Study|Physician Decision|0|||
144569198|NCT01296555|521283965|FG013|Overall Study|Physician Decision|1|||
144569199|NCT01296555|521283966|FG014|Overall Study|Physician Decision|0|||
144569200|NCT01296555|521283967|FG015|Overall Study|Physician Decision|0|||
144206743|NCT03016975|519950763|FG002|At 2 Year Follow-up|Death|0|||
144206744|NCT03016975|519950761|FG000|At 3 Year Follow-up|Death|1|||
144206745|NCT03016975|519950762|FG001|At 3 Year Follow-up|Death|0|||
144206746|NCT03016975|519950763|FG002|At 3 Year Follow-up|Death|0|||
144206747|NCT03016975|519950761|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
144206748|NCT03016975|519950762|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
144206749|NCT03016975|519950763|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
144206750|NCT03016975|519950761|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
144206751|NCT03016975|519950762|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
144206752|NCT03016975|519950763|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
144206753|NCT02901548|519950764|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
144206754|NCT01338870|519950772|FG000|Overall Study|Lost to Follow-up|0|||
144206755|NCT01338870|519950773|FG001|Overall Study|Lost to Follow-up|0|||
144206756|NCT01338870|519950774|FG002|Overall Study|Lost to Follow-up|1|||
144206757|NCT01338870|519950775|FG003|Overall Study|Lost to Follow-up|0|||
144206758|NCT01338870|519950776|FG004|Overall Study|Lost to Follow-up|1|||
144206759|NCT01338870|519950777|FG005|Overall Study|Lost to Follow-up|0|||
144206760|NCT01338870|519950772|FG000|Overall Study|Withdrawal by Subject|2|||
144206761|NCT01338870|519950773|FG001|Overall Study|Withdrawal by Subject|3|||
144206762|NCT01338870|519950774|FG002|Overall Study|Withdrawal by Subject|4|||
144206763|NCT01338870|519950775|FG003|Overall Study|Withdrawal by Subject|0|||
144206764|NCT01338870|519950776|FG004|Overall Study|Withdrawal by Subject|0|||
144206765|NCT01338870|519950777|FG005|Overall Study|Withdrawal by Subject|2|||
144206766|NCT01338870|519950772|FG000|Overall Study|Other|3|||
144206767|NCT01338870|519950773|FG001|Overall Study|Other|3|||
144206768|NCT01338870|519950774|FG002|Overall Study|Other|3|||
144206769|NCT01338870|519950775|FG003|Overall Study|Other|2|||
144206770|NCT01338870|519950776|FG004|Overall Study|Other|0|||
144206771|NCT01338870|519950777|FG005|Overall Study|Other|2|||
144206772|NCT01338870|519950772|FG000|Overall Study|Protocol Violation|0|||
144569201|NCT01296555|521283968|FG016|Overall Study|Physician Decision|0|||
144569202|NCT01296555|521283969|FG017|Overall Study|Physician Decision|0|||
144569203|NCT01296555|521283970|FG018|Overall Study|Physician Decision|0|||
144569204|NCT01296555|521283971|FG019|Overall Study|Physician Decision|1|||
144569205|NCT01296555|521283972|FG020|Overall Study|Physician Decision|0|||
144569206|NCT01296555|521283973|FG021|Overall Study|Physician Decision|0|||
144569207|NCT01296555|521283974|FG022|Overall Study|Physician Decision|0|||
144569208|NCT01296555|521283975|FG023|Overall Study|Physician Decision|0|||
144569209|NCT01296555|521283976|FG024|Overall Study|Physician Decision|0|||
144569210|NCT01296555|521283977|FG025|Overall Study|Physician Decision|0|||
144569211|NCT01296555|521283978|FG026|Overall Study|Physician Decision|0|||
144569212|NCT01296555|521283979|FG027|Overall Study|Physician Decision|0|||
144569213|NCT01296555|521283980|FG028|Overall Study|Physician Decision|0|||
144569214|NCT01296555|521283952|FG000|Overall Study|Progressive Disease|6|||
144569215|NCT01296555|521283953|FG001|Overall Study|Progressive Disease|3|||
144569216|NCT01296555|521283954|FG002|Overall Study|Progressive Disease|3|||
144569217|NCT01296555|521283955|FG003|Overall Study|Progressive Disease|7|||
144569218|NCT01296555|521283956|FG004|Overall Study|Progressive Disease|6|||
144569219|NCT01296555|521283957|FG005|Overall Study|Progressive Disease|16|||
144569220|NCT01296555|521283958|FG006|Overall Study|Progressive Disease|16|||
144569221|NCT01296555|521283959|FG007|Overall Study|Progressive Disease|8|||
144206773|NCT01338870|519950773|FG001|Overall Study|Protocol Violation|2|||
144206774|NCT01338870|519950774|FG002|Overall Study|Protocol Violation|2|||
144206775|NCT01338870|519950775|FG003|Overall Study|Protocol Violation|2|||
144206776|NCT01338870|519950776|FG004|Overall Study|Protocol Violation|1|||
144206777|NCT01338870|519950777|FG005|Overall Study|Protocol Violation|1|||
144206778|NCT01338870|519950772|FG000|Overall Study|Adverse Event|4|||
144206779|NCT01338870|519950773|FG001|Overall Study|Adverse Event|4|||
144206780|NCT01338870|519950774|FG002|Overall Study|Adverse Event|1|||
144569222|NCT01296555|521283960|FG008|Overall Study|Progressive Disease|7|||
144569223|NCT01296555|521283961|FG009|Overall Study|Progressive Disease|18|||
144569224|NCT01296555|521283962|FG010|Overall Study|Progressive Disease|7|||
144206781|NCT01338870|519950775|FG003|Overall Study|Adverse Event|5|||
144206782|NCT01338870|519950776|FG004|Overall Study|Adverse Event|4|||
144206783|NCT01338870|519950777|FG005|Overall Study|Adverse Event|1|||
144206784|NCT01955083|519950782|FG000|Overall Study|Lost to Follow-up|1|||
144569225|NCT01296555|521283963|FG011|Overall Study|Progressive Disease|14|||
144206785|NCT01955083|519950783|FG001|Overall Study|Lost to Follow-up|1|||
144206786|NCT00128830|519950784|FG000|Overall Study|Adverse Event|10|||
144262792|NCT02787304|520163744|FG002|Overall Study|Adverse Event|8|||
144569226|NCT01296555|521283964|FG012|Overall Study|Progressive Disease|5|||
144569227|NCT01296555|521283965|FG013|Overall Study|Progressive Disease|12|||
144569228|NCT01296555|521283966|FG014|Overall Study|Progressive Disease|1|||
144569229|NCT01296555|521283967|FG015|Overall Study|Progressive Disease|1|||
144569230|NCT01296555|521283968|FG016|Overall Study|Progressive Disease|0|||
144206787|NCT00128830|519950784|FG000|Overall Study|Withdrawal by Subject|14|||
144206788|NCT00128830|519950784|FG000|Overall Study|Lost to Follow-up|4|||
144206789|NCT00128830|519950784|FG000|Overall Study|Reached a virologic endpoint|29|||
144569231|NCT01296555|521283969|FG017|Overall Study|Progressive Disease|0|||
144569232|NCT01296555|521283970|FG018|Overall Study|Progressive Disease|0|||
144569233|NCT01296555|521283971|FG019|Overall Study|Progressive Disease|1|||
144569234|NCT01296555|521283972|FG020|Overall Study|Progressive Disease|0|||
144569235|NCT01296555|521283973|FG021|Overall Study|Progressive Disease|0|||
144569236|NCT01296555|521283974|FG022|Overall Study|Progressive Disease|0|||
144569237|NCT01296555|521283975|FG023|Overall Study|Progressive Disease|0|||
144569238|NCT01296555|521283976|FG024|Overall Study|Progressive Disease|1|||
144569239|NCT01296555|521283977|FG025|Overall Study|Progressive Disease|0|||
144569240|NCT01296555|521283978|FG026|Overall Study|Progressive Disease|5|||
144569241|NCT01296555|521283979|FG027|Overall Study|Progressive Disease|1|||
144569242|NCT01296555|521283980|FG028|Overall Study|Progressive Disease|0|||
144569243|NCT01296555|521283952|FG000|Overall Study|Protocol Violation|0|||
144569244|NCT01296555|521283953|FG001|Overall Study|Protocol Violation|0|||
144569245|NCT01296555|521283954|FG002|Overall Study|Protocol Violation|0|||
144569246|NCT01296555|521283955|FG003|Overall Study|Protocol Violation|0|||
144569247|NCT01296555|521283956|FG004|Overall Study|Protocol Violation|0|||
144569248|NCT01296555|521283957|FG005|Overall Study|Protocol Violation|0|||
144569249|NCT01296555|521283958|FG006|Overall Study|Protocol Violation|0|||
144569250|NCT01296555|521283959|FG007|Overall Study|Protocol Violation|0|||
144569251|NCT01296555|521283960|FG008|Overall Study|Protocol Violation|0|||
144569252|NCT01296555|521283961|FG009|Overall Study|Protocol Violation|0|||
144569253|NCT01296555|521283962|FG010|Overall Study|Protocol Violation|0|||
144569254|NCT01296555|521283963|FG011|Overall Study|Protocol Violation|0|||
144569255|NCT01296555|521283964|FG012|Overall Study|Protocol Violation|0|||
144569256|NCT01296555|521283965|FG013|Overall Study|Protocol Violation|1|||
144569257|NCT01296555|521283966|FG014|Overall Study|Protocol Violation|0|||
144569258|NCT01296555|521283967|FG015|Overall Study|Protocol Violation|0|||
144569259|NCT01296555|521283968|FG016|Overall Study|Protocol Violation|0|||
144569260|NCT01296555|521283969|FG017|Overall Study|Protocol Violation|0|||
144569261|NCT01296555|521283970|FG018|Overall Study|Protocol Violation|0|||
144569262|NCT01296555|521283971|FG019|Overall Study|Protocol Violation|0|||
144569263|NCT01296555|521283972|FG020|Overall Study|Protocol Violation|0|||
144569264|NCT01296555|521283973|FG021|Overall Study|Protocol Violation|0|||
144569265|NCT01296555|521283974|FG022|Overall Study|Protocol Violation|0|||
144569266|NCT01296555|521283975|FG023|Overall Study|Protocol Violation|0|||
144569267|NCT01296555|521283976|FG024|Overall Study|Protocol Violation|0|||
144569268|NCT01296555|521283977|FG025|Overall Study|Protocol Violation|0|||
144569269|NCT01296555|521283978|FG026|Overall Study|Protocol Violation|0|||
144569270|NCT01296555|521283979|FG027|Overall Study|Protocol Violation|0|||
144569271|NCT01296555|521283980|FG028|Overall Study|Protocol Violation|0|||
144569272|NCT01296555|521283952|FG000|Overall Study|Study Terminated By Sponsor|0|||
144569273|NCT01296555|521283953|FG001|Overall Study|Study Terminated By Sponsor|0|||
144569274|NCT01296555|521283954|FG002|Overall Study|Study Terminated By Sponsor|0|||
144569275|NCT01296555|521283955|FG003|Overall Study|Study Terminated By Sponsor|0|||
144569276|NCT01296555|521283956|FG004|Overall Study|Study Terminated By Sponsor|0|||
144569277|NCT01296555|521283957|FG005|Overall Study|Study Terminated By Sponsor|0|||
144569278|NCT01296555|521283958|FG006|Overall Study|Study Terminated By Sponsor|0|||
144569279|NCT01296555|521283959|FG007|Overall Study|Study Terminated By Sponsor|0|||
144569280|NCT01296555|521283960|FG008|Overall Study|Study Terminated By Sponsor|0|||
144569281|NCT01296555|521283961|FG009|Overall Study|Study Terminated By Sponsor|0|||
144569282|NCT01296555|521283962|FG010|Overall Study|Study Terminated By Sponsor|0|||
144569283|NCT01296555|521283963|FG011|Overall Study|Study Terminated By Sponsor|0|||
144206790|NCT00128830|519950784|FG000|Overall Study|Non-compliant|4|||
144206791|NCT00128830|519950784|FG000|Overall Study|Discontinued or ineligible for study|2|||
144206792|NCT00128830|519950784|FG000|Overall Study|Other|9|||
144206793|NCT00838435|519950785|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
144569284|NCT01296555|521283964|FG012|Overall Study|Study Terminated By Sponsor|0|||
144569285|NCT01296555|521283965|FG013|Overall Study|Study Terminated By Sponsor|0|||
144569286|NCT01296555|521283966|FG014|Overall Study|Study Terminated By Sponsor|0|||
144569287|NCT01296555|521283967|FG015|Overall Study|Study Terminated By Sponsor|0|||
144206794|NCT00838435|519950785|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
144206795|NCT00838435|519950785|FG000|Part 2 (7 Years)|Adverse Event|2|||
144206796|NCT00838435|519950785|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
144569288|NCT01296555|521283968|FG016|Overall Study|Study Terminated By Sponsor|0|||
144569289|NCT01296555|521283969|FG017|Overall Study|Study Terminated By Sponsor|0|||
144569290|NCT01296555|521283970|FG018|Overall Study|Study Terminated By Sponsor|0|||
144569291|NCT01296555|521283971|FG019|Overall Study|Study Terminated By Sponsor|0|||
144569292|NCT01296555|521283972|FG020|Overall Study|Study Terminated By Sponsor|0|||
144569293|NCT01296555|521283973|FG021|Overall Study|Study Terminated By Sponsor|0|||
144569294|NCT01296555|521283974|FG022|Overall Study|Study Terminated By Sponsor|0|||
144569295|NCT01296555|521283975|FG023|Overall Study|Study Terminated By Sponsor|0|||
144569296|NCT01296555|521283976|FG024|Overall Study|Study Terminated By Sponsor|0|||
144569297|NCT01296555|521283977|FG025|Overall Study|Study Terminated By Sponsor|1|||
144569298|NCT01296555|521283978|FG026|Overall Study|Study Terminated By Sponsor|0|||
144569299|NCT01296555|521283979|FG027|Overall Study|Study Terminated By Sponsor|0|||
144569300|NCT01296555|521283980|FG028|Overall Study|Study Terminated By Sponsor|0|||
144569301|NCT01296555|521283952|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569302|NCT01296555|521283953|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569303|NCT01296555|521283954|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569304|NCT01296555|521283955|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569305|NCT01296555|521283956|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569306|NCT01296555|521283957|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569307|NCT01296555|521283958|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569308|NCT01296555|521283959|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569309|NCT01296555|521283960|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569310|NCT01296555|521283961|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569311|NCT01296555|521283962|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569312|NCT01296555|521283963|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569313|NCT01296555|521283964|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569314|NCT01296555|521283965|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569315|NCT01296555|521283966|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569316|NCT01296555|521283967|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569317|NCT01296555|521283968|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569318|NCT01296555|521283969|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569319|NCT01296555|521283970|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569320|NCT01296555|521283971|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
144569321|NCT01296555|521283972|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569322|NCT01296555|521283973|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569323|NCT01296555|521283974|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569324|NCT01296555|521283975|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569325|NCT01296555|521283976|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569326|NCT01296555|521283977|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569327|NCT01296555|521283978|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569328|NCT01296555|521283979|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569329|NCT01296555|521283980|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
144569330|NCT01296555|521283952|FG000|Overall Study|Death|0|||
144569331|NCT01296555|521283953|FG001|Overall Study|Death|0|||
144569332|NCT01296555|521283954|FG002|Overall Study|Death|0|||
144569333|NCT01296555|521283955|FG003|Overall Study|Death|2|||
144569334|NCT01296555|521283956|FG004|Overall Study|Death|1|||
144569335|NCT01296555|521283957|FG005|Overall Study|Death|0|||
144569336|NCT01296555|521283958|FG006|Overall Study|Death|2|||
144569337|NCT01296555|521283959|FG007|Overall Study|Death|0|||
144569338|NCT01296555|521283960|FG008|Overall Study|Death|0|||
144569339|NCT01296555|521283961|FG009|Overall Study|Death|1|||
144569340|NCT01296555|521283962|FG010|Overall Study|Death|0|||
144569341|NCT01296555|521283963|FG011|Overall Study|Death|1|||
144569342|NCT01296555|521283964|FG012|Overall Study|Death|0|||
144569343|NCT01296555|521283965|FG013|Overall Study|Death|2|||
144569344|NCT01296555|521283966|FG014|Overall Study|Death|27|||
144569345|NCT01296555|521283967|FG015|Overall Study|Death|15|||
144569346|NCT01296555|521283968|FG016|Overall Study|Death|11|||
144569347|NCT01296555|521283969|FG017|Overall Study|Death|11|||
144569348|NCT01296555|521283970|FG018|Overall Study|Death|17|||
144569349|NCT01296555|521283971|FG019|Overall Study|Death|12|||
144569350|NCT01296555|521283972|FG020|Overall Study|Death|13|||
144569351|NCT01296555|521283973|FG021|Overall Study|Death|12|||
144569352|NCT01296555|521283974|FG022|Overall Study|Death|12|||
144569353|NCT01296555|521283975|FG023|Overall Study|Death|13|||
144569354|NCT01296555|521283976|FG024|Overall Study|Death|7|||
144569355|NCT01296555|521283977|FG025|Overall Study|Death|7|||
144569356|NCT01296555|521283978|FG026|Overall Study|Death|35|||
144569357|NCT01296555|521283979|FG027|Overall Study|Death|92|||
144569358|NCT01296555|521283980|FG028|Overall Study|Death|44|||
144569359|NCT01296555|521283952|FG000|Overall Study|Lost to Follow-up|0|||
144569360|NCT01296555|521283953|FG001|Overall Study|Lost to Follow-up|0|||
144728790|NCT01432171|521861354|FG000|Overall Study|Insurance denial trial coverage|1|||
144728791|NCT01432171|521861355|FG001|Overall Study|Insurance denial trial coverage|0|||
144569361|NCT01296555|521283954|FG002|Overall Study|Lost to Follow-up|0|||
144728792|NCT01432171|521861354|FG000|Overall Study|Patient moved to palliative care|1|||
144728793|NCT01432171|521861355|FG001|Overall Study|Patient moved to palliative care|0|||
144569362|NCT01296555|521283955|FG003|Overall Study|Lost to Follow-up|0|||
144569363|NCT01296555|521283956|FG004|Overall Study|Lost to Follow-up|0|||
144569364|NCT01296555|521283957|FG005|Overall Study|Lost to Follow-up|0|||
144569365|NCT01296555|521283958|FG006|Overall Study|Lost to Follow-up|0|||
144569366|NCT01296555|521283959|FG007|Overall Study|Lost to Follow-up|0|||
144569367|NCT01296555|521283960|FG008|Overall Study|Lost to Follow-up|0|||
144569368|NCT01296555|521283961|FG009|Overall Study|Lost to Follow-up|0|||
144569369|NCT01296555|521283962|FG010|Overall Study|Lost to Follow-up|0|||
144569370|NCT01296555|521283963|FG011|Overall Study|Lost to Follow-up|0|||
144569371|NCT01296555|521283964|FG012|Overall Study|Lost to Follow-up|0|||
144569372|NCT01296555|521283965|FG013|Overall Study|Lost to Follow-up|0|||
144569373|NCT01296555|521283966|FG014|Overall Study|Lost to Follow-up|2|||
144569374|NCT01296555|521283967|FG015|Overall Study|Lost to Follow-up|1|||
144569375|NCT01296555|521283968|FG016|Overall Study|Lost to Follow-up|0|||
144569376|NCT01296555|521283969|FG017|Overall Study|Lost to Follow-up|2|||
144569377|NCT01296555|521283970|FG018|Overall Study|Lost to Follow-up|0|||
144728794|NCT04455633|521863120|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
144569378|NCT01296555|521283971|FG019|Overall Study|Lost to Follow-up|2|||
144569379|NCT01296555|521283972|FG020|Overall Study|Lost to Follow-up|3|||
144569380|NCT01296555|521283973|FG021|Overall Study|Lost to Follow-up|2|||
144569381|NCT01296555|521283974|FG022|Overall Study|Lost to Follow-up|0|||
144569382|NCT01296555|521283975|FG023|Overall Study|Lost to Follow-up|0|||
144569383|NCT01296555|521283976|FG024|Overall Study|Lost to Follow-up|0|||
144569384|NCT01296555|521283977|FG025|Overall Study|Lost to Follow-up|0|||
144569385|NCT01296555|521283978|FG026|Overall Study|Lost to Follow-up|3|||
144569386|NCT01296555|521283979|FG027|Overall Study|Lost to Follow-up|13|||
144569387|NCT01296555|521283980|FG028|Overall Study|Lost to Follow-up|5|||
144569388|NCT01296555|521283952|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144569389|NCT01296555|521283953|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144569390|NCT01296555|521283954|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144569391|NCT01296555|521283955|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144569392|NCT01296555|521283956|FG004|Overall Study|Non-Compliance With Study Drug|0|||
144569393|NCT01296555|521283957|FG005|Overall Study|Non-Compliance With Study Drug|0|||
144569394|NCT01296555|521283958|FG006|Overall Study|Non-Compliance With Study Drug|0|||
144569395|NCT01296555|521283959|FG007|Overall Study|Non-Compliance With Study Drug|1|||
144569396|NCT01296555|521283960|FG008|Overall Study|Non-Compliance With Study Drug|0|||
144569397|NCT01296555|521283961|FG009|Overall Study|Non-Compliance With Study Drug|0|||
144569398|NCT01296555|521283962|FG010|Overall Study|Non-Compliance With Study Drug|0|||
144569399|NCT01296555|521283963|FG011|Overall Study|Non-Compliance With Study Drug|0|||
144569400|NCT01296555|521283964|FG012|Overall Study|Non-Compliance With Study Drug|0|||
144569401|NCT01296555|521283965|FG013|Overall Study|Non-Compliance With Study Drug|0|||
144569402|NCT01296555|521283966|FG014|Overall Study|Non-Compliance With Study Drug|0|||
144569403|NCT01296555|521283967|FG015|Overall Study|Non-Compliance With Study Drug|0|||
144569404|NCT01296555|521283968|FG016|Overall Study|Non-Compliance With Study Drug|0|||
144569405|NCT01296555|521283969|FG017|Overall Study|Non-Compliance With Study Drug|0|||
144569406|NCT01296555|521283970|FG018|Overall Study|Non-Compliance With Study Drug|0|||
144569407|NCT01296555|521283971|FG019|Overall Study|Non-Compliance With Study Drug|0|||
144569408|NCT01296555|521283972|FG020|Overall Study|Non-Compliance With Study Drug|0|||
144569409|NCT01296555|521283973|FG021|Overall Study|Non-Compliance With Study Drug|0|||
144569410|NCT01296555|521283974|FG022|Overall Study|Non-Compliance With Study Drug|0|||
144569411|NCT01296555|521283975|FG023|Overall Study|Non-Compliance With Study Drug|0|||
144569412|NCT01296555|521283976|FG024|Overall Study|Non-Compliance With Study Drug|0|||
144569413|NCT01296555|521283977|FG025|Overall Study|Non-Compliance With Study Drug|0|||
144569414|NCT01296555|521283978|FG026|Overall Study|Non-Compliance With Study Drug|0|||
144569415|NCT01296555|521283979|FG027|Overall Study|Non-Compliance With Study Drug|0|||
144569416|NCT01296555|521283980|FG028|Overall Study|Non-Compliance With Study Drug|0|||
144569417|NCT01296555|521283952|FG000|Overall Study|Withdrawal by Subject|0|||
144569418|NCT01296555|521283953|FG001|Overall Study|Withdrawal by Subject|0|||
144569419|NCT01296555|521283954|FG002|Overall Study|Withdrawal by Subject|0|||
144569420|NCT01296555|521283955|FG003|Overall Study|Withdrawal by Subject|0|||
144569421|NCT01296555|521283956|FG004|Overall Study|Withdrawal by Subject|1|||
144569422|NCT01296555|521283957|FG005|Overall Study|Withdrawal by Subject|0|||
144569423|NCT01296555|521283958|FG006|Overall Study|Withdrawal by Subject|1|||
144569424|NCT01296555|521283959|FG007|Overall Study|Withdrawal by Subject|0|||
144569425|NCT01296555|521283960|FG008|Overall Study|Withdrawal by Subject|0|||
144569426|NCT01296555|521283961|FG009|Overall Study|Withdrawal by Subject|0|||
144569427|NCT01296555|521283962|FG010|Overall Study|Withdrawal by Subject|1|||
144569428|NCT01296555|521283963|FG011|Overall Study|Withdrawal by Subject|1|||
144569429|NCT01296555|521283964|FG012|Overall Study|Withdrawal by Subject|0|||
144569430|NCT01296555|521283965|FG013|Overall Study|Withdrawal by Subject|0|||
144569431|NCT01296555|521283966|FG014|Overall Study|Withdrawal by Subject|3|||
144569432|NCT01296555|521283967|FG015|Overall Study|Withdrawal by Subject|0|||
144569433|NCT01296555|521283968|FG016|Overall Study|Withdrawal by Subject|2|||
144206797|NCT00838435|519950785|FG000|Part 2 (7 Years)|Physician Decision|1|||
144206798|NCT00838435|519950785|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
144206799|NCT00838435|519950785|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
144206800|NCT02640053|519950786|FG000|Overall Study|Withdrawal by Subject|2|||
144569434|NCT01296555|521283969|FG017|Overall Study|Withdrawal by Subject|1|||
144569435|NCT01296555|521283970|FG018|Overall Study|Withdrawal by Subject|0|||
144619771|NCT00562354|521466106|FG001|Overall Study|Lost to Follow-up|1|||
144569436|NCT01296555|521283971|FG019|Overall Study|Withdrawal by Subject|1|||
144619772|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
144569437|NCT01296555|521283972|FG020|Overall Study|Withdrawal by Subject|1|||
144569438|NCT01296555|521283973|FG021|Overall Study|Withdrawal by Subject|1|||
144569439|NCT01296555|521283974|FG022|Overall Study|Withdrawal by Subject|3|||
144569440|NCT01296555|521283975|FG023|Overall Study|Withdrawal by Subject|0|||
144569441|NCT01296555|521283976|FG024|Overall Study|Withdrawal by Subject|0|||
144569442|NCT01296555|521283977|FG025|Overall Study|Withdrawal by Subject|0|||
144569443|NCT01296555|521283978|FG026|Overall Study|Withdrawal by Subject|8|||
144569444|NCT01296555|521283979|FG027|Overall Study|Withdrawal by Subject|4|||
144569445|NCT01296555|521283980|FG028|Overall Study|Withdrawal by Subject|2|||
144569446|NCT01182181|521283981|FG000|First Intervention|Adverse Event|1|||
144569447|NCT01182181|521283982|FG001|First Intervention|Adverse Event|0|||
144569448|NCT01182181|521283981|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
144569449|NCT01182181|521283982|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
144569450|NCT02413593|521283985|FG000|Overall Study|Lost to Follow-up|3|||
144569451|NCT02413593|521283985|FG000|Overall Study|Adverse Event|1|||
144569452|NCT01101061|521283986|FG000|Overall Study|Adverse Event|0|||
144569453|NCT01101061|521283987|FG001|Overall Study|Adverse Event|0|||
144569454|NCT01101061|521283988|FG002|Overall Study|Adverse Event|1|||
144569455|NCT01101061|521283989|FG003|Overall Study|Adverse Event|0|||
144569456|NCT01101061|521283990|FG004|Overall Study|Adverse Event|0|||
144569457|NCT01101061|521283991|FG005|Overall Study|Adverse Event|0|||
144569458|NCT00857233|521283992|FG000|Overall Study|Adverse Event|24|||
144569459|NCT00857233|521283992|FG000|Overall Study|Lack of Efficacy|1|||
144569460|NCT00857233|521283992|FG000|Overall Study|Non-compliance|1|||
144569461|NCT00857233|521283992|FG000|Overall Study|Withdrawal of Consent|9|||
144569462|NCT00857233|521283992|FG000|Overall Study|Lost to Follow-up|4|||
144569463|NCT00857233|521283992|FG000|Overall Study|Nursing Home Placement|14|||
144569464|NCT00857233|521283992|FG000|Overall Study|Other Reasons|2|||
144569465|NCT01587118|521283993|FG000|Overall Study|Adverse Event|3|||
144569466|NCT01587118|521283993|FG000|Overall Study|Lost to Follow-up|2|||
144569467|NCT01587118|521283993|FG000|Overall Study|Relocation|1|||
144569468|NCT01587118|521283993|FG000|Overall Study|nonresponse|1|||
144569469|NCT00409409|521283994|FG000|Overall Study|Adverse Event|7|||
144569470|NCT00409409|521283995|FG001|Overall Study|Adverse Event|2|||
144569471|NCT00409409|521283994|FG000|Overall Study|Withdrawal by Subject|1|||
144569472|NCT00409409|521283995|FG001|Overall Study|Withdrawal by Subject|1|||
144569473|NCT00409409|521283994|FG000|Overall Study|Any other reason not above-mentioned|0|||
144569474|NCT00409409|521283995|FG001|Overall Study|Any other reason not above-mentioned|1|||
144569475|NCT02872012|521283996|FG000|Overall Study|Withdrawal by Subject|1|||
144569476|NCT02872012|521283997|FG001|Overall Study|Withdrawal by Subject|0|||
144569477|NCT02872012|521283998|FG002|Overall Study|Withdrawal by Subject|0|||
144569478|NCT02872012|521283999|FG003|Overall Study|Withdrawal by Subject|0|||
144569479|NCT02872012|521284000|FG004|Overall Study|Withdrawal by Subject|0|||
144569480|NCT01728623|521284001|FG000|Overall Study|Disease progression|26|||
144569481|NCT01728623|521284001|FG000|Overall Study|Adverse Event|1|||
144569482|NCT01728623|521284001|FG000|Overall Study|Withdrawal by Subject|1|||
144569483|NCT03000348|521284002|FG000|Overall Study|Adverse Event|1|||
144569484|NCT03000348|521284003|FG001|Overall Study|Adverse Event|1|||
144569485|NCT03000348|521284004|FG002|Overall Study|Adverse Event|1|||
144569486|NCT03000348|521284005|FG003|Overall Study|Adverse Event|1|||
144569487|NCT03000348|521284006|FG004|Overall Study|Adverse Event|1|||
144569488|NCT03000348|521284007|FG005|Overall Study|Adverse Event|1|||
144569489|NCT03000348|521284002|FG000|Overall Study|Lost to Follow-up|0|||
144569490|NCT03000348|521284003|FG001|Overall Study|Lost to Follow-up|0|||
144569491|NCT03000348|521284004|FG002|Overall Study|Lost to Follow-up|1|||
144206801|NCT02640053|519950787|FG001|Overall Study|Withdrawal by Subject|1|||
144569492|NCT03000348|521284005|FG003|Overall Study|Lost to Follow-up|0|||
144569493|NCT03000348|521284006|FG004|Overall Study|Lost to Follow-up|0|||
144569494|NCT03000348|521284007|FG005|Overall Study|Lost to Follow-up|0|||
144569495|NCT03000348|521284002|FG000|Overall Study|Withdrawal by Subject|0|||
144569496|NCT03000348|521284003|FG001|Overall Study|Withdrawal by Subject|1|||
144569497|NCT03000348|521284004|FG002|Overall Study|Withdrawal by Subject|0|||
144569498|NCT03000348|521284005|FG003|Overall Study|Withdrawal by Subject|0|||
144569499|NCT03000348|521284006|FG004|Overall Study|Withdrawal by Subject|0|||
144569500|NCT03000348|521284007|FG005|Overall Study|Withdrawal by Subject|0|||
144569501|NCT03000348|521284002|FG000|Overall Study|Consent|0|||
144569502|NCT03000348|521284003|FG001|Overall Study|Consent|0|||
144569503|NCT03000348|521284004|FG002|Overall Study|Consent|0|||
144569504|NCT03000348|521284005|FG003|Overall Study|Consent|0|||
144569505|NCT03000348|521284006|FG004|Overall Study|Consent|1|||
144728795|NCT04455633|521863121|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
144206802|NCT02640053|519950786|FG000|Overall Study|Adverse Event|1|||
144262793|NCT02787304|520163745|FG003|Overall Study|Adverse Event|1|||
144569506|NCT03000348|521284007|FG005|Overall Study|Consent|0|||
144569507|NCT03000348|521284002|FG000|Overall Study|Failure to expectorate sputum|1|||
144569508|NCT03000348|521284003|FG001|Overall Study|Failure to expectorate sputum|0|||
144569509|NCT03000348|521284004|FG002|Overall Study|Failure to expectorate sputum|1|||
144569510|NCT03000348|521284005|FG003|Overall Study|Failure to expectorate sputum|0|||
144569511|NCT03000348|521284006|FG004|Overall Study|Failure to expectorate sputum|1|||
144569512|NCT03000348|521284007|FG005|Overall Study|Failure to expectorate sputum|0|||
144569513|NCT03000348|521284002|FG000|Overall Study|No gram negative|1|||
144569514|NCT03000348|521284003|FG001|Overall Study|No gram negative|2|||
144569515|NCT03000348|521284004|FG002|Overall Study|No gram negative|1|||
144569516|NCT03000348|521284005|FG003|Overall Study|No gram negative|1|||
144569517|NCT03000348|521284006|FG004|Overall Study|No gram negative|1|||
144569518|NCT03000348|521284007|FG005|Overall Study|No gram negative|1|||
144569519|NCT03000348|521284002|FG000|Overall Study|Patient had no transport|0|||
144569520|NCT03000348|521284003|FG001|Overall Study|Patient had no transport|0|||
144569521|NCT03000348|521284004|FG002|Overall Study|Patient had no transport|0|||
144569522|NCT03000348|521284005|FG003|Overall Study|Patient had no transport|1|||
144569523|NCT03000348|521284006|FG004|Overall Study|Patient had no transport|0|||
144569524|NCT03000348|521284007|FG005|Overall Study|Patient had no transport|0|||
144569525|NCT03000348|521284002|FG000|Overall Study|Dosing|0|||
144569526|NCT03000348|521284003|FG001|Overall Study|Dosing|0|||
144569527|NCT03000348|521284004|FG002|Overall Study|Dosing|0|||
144569528|NCT03000348|521284005|FG003|Overall Study|Dosing|0|||
144569529|NCT03000348|521284006|FG004|Overall Study|Dosing|1|||
144569530|NCT03000348|521284007|FG005|Overall Study|Dosing|0|||
144569531|NCT00745498|521284009|FG000|Overall Study|Lost to Follow-up|1|||
144569532|NCT00745498|521284010|FG001|Overall Study|Lost to Follow-up|1|||
144569533|NCT00745498|521284011|FG002|Overall Study|Lost to Follow-up|3|||
144569534|NCT00745498|521284009|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
144569535|NCT00745498|521284010|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
144569536|NCT00745498|521284011|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
144569537|NCT00745498|521284009|FG000|Overall Study|Non-PDR related VH|0|||
144569538|NCT00745498|521284010|FG001|Overall Study|Non-PDR related VH|1|||
144569539|NCT00745498|521284011|FG002|Overall Study|Non-PDR related VH|1|||
144569540|NCT00745498|521284009|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
144569541|NCT00745498|521284010|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
144569542|NCT00745498|521284011|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
144569543|NCT03174782|521284012|FG000|Overall Study|Protocol Violation|1|||
144569544|NCT03174782|521284013|FG001|Overall Study|Protocol Violation|0|||
144569545|NCT03174782|521284012|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
144569546|NCT03174782|521284013|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
144569547|NCT03636373|521284014|FG000|Overall Study|Study closure due to Covid-19|1|||
144569548|NCT03636373|521284015|FG001|Overall Study|Study closure due to Covid-19|0|||
144569549|NCT00572533|521284018|FG000|Overall Study|Death|4|||
144569550|NCT00572533|521284019|FG001|Overall Study|Death|1|||
144569551|NCT00572533|521284018|FG000|Overall Study|Received Kidney Transplant|2|||
144569552|NCT00572533|521284019|FG001|Overall Study|Received Kidney Transplant|1|||
144569553|NCT00572533|521284018|FG000|Overall Study|Social Issues|1|||
144569554|NCT00572533|521284019|FG001|Overall Study|Social Issues|0|||
144569555|NCT00572533|521284018|FG000|Overall Study|Transfer out of Facility|0|||
144569556|NCT00572533|521284019|FG001|Overall Study|Transfer out of Facility|1|||
144569557|NCT00798304|521284020|FG000|Overall Study|Adverse Event|0|||
144569558|NCT00798304|521284021|FG001|Overall Study|Adverse Event|1|||
144569559|NCT00798304|521284022|FG002|Overall Study|Adverse Event|1|||
144569560|NCT00798304|521284020|FG000|Overall Study|Discontinuation by Sponsor|14|||
144569561|NCT00798304|521284021|FG001|Overall Study|Discontinuation by Sponsor|21|||
144569562|NCT00798304|521284022|FG002|Overall Study|Discontinuation by Sponsor|9|||
144569563|NCT04211389|521284023|FG000|Overall Study|Adverse Event|1|||
144569564|NCT04211389|521284024|FG001|Overall Study|Adverse Event|2|||
144569565|NCT04211389|521284023|FG000|Overall Study|Lost to Follow-up|15|||
144569566|NCT04211389|521284024|FG001|Overall Study|Lost to Follow-up|7|||
144569567|NCT04211389|521284023|FG000|Overall Study|Protocol Violation|0|||
144569568|NCT04211389|521284024|FG001|Overall Study|Protocol Violation|1|||
144569569|NCT04211389|521284023|FG000|Overall Study|Withdrawal by Subject|10|||
144569570|NCT04211389|521284024|FG001|Overall Study|Withdrawal by Subject|11|||
144569571|NCT00547534|521284027|FG000|Overall Study|Adverse Event|7|||
144262794|NCT02787304|520163742|FG000|Overall Study|Withdrawal by Subject|1|||
144262795|NCT02787304|520163743|FG001|Overall Study|Withdrawal by Subject|4|||
144569572|NCT00547534|521284027|FG000|Overall Study|Disease Progression|4|||
144569573|NCT02688530|521284036|FG000|Overall Study|Withdrawal by Subject|0|||
144569574|NCT02688530|521284037|FG001|Overall Study|Withdrawal by Subject|1|||
144569575|NCT02688530|521284038|FG002|Overall Study|Withdrawal by Subject|0|||
144569576|NCT02688530|521284039|FG003|Overall Study|Withdrawal by Subject|0|||
144569577|NCT02688530|521284036|FG000|Overall Study|Lost to Follow-up|0|||
144569578|NCT02688530|521284037|FG001|Overall Study|Lost to Follow-up|0|||
144569579|NCT02688530|521284038|FG002|Overall Study|Lost to Follow-up|2|||
144569580|NCT02688530|521284039|FG003|Overall Study|Lost to Follow-up|0|||
144569581|NCT01658020|521284040|FG000|Overall Study|Adverse Event|3|||
144569582|NCT01658020|521284041|FG001|Overall Study|Adverse Event|3|||
144569583|NCT01658020|521284040|FG000|Overall Study|Lost to Follow-up|1|||
144569584|NCT01658020|521284041|FG001|Overall Study|Lost to Follow-up|0|||
144569585|NCT01658020|521284040|FG000|Overall Study|Withdrawal by Subject|4|||
144569586|NCT01658020|521284041|FG001|Overall Study|Withdrawal by Subject|5|||
144569587|NCT01658020|521284040|FG000|Overall Study|Protocol Violation|0|||
144569588|NCT01658020|521284041|FG001|Overall Study|Protocol Violation|1|||
144569589|NCT04206085|521284042|FG000|Overall Study|Lost to Follow-up|0|||
144569590|NCT04206085|521284043|FG001|Overall Study|Lost to Follow-up|1|||
144569591|NCT04206085|521284044|FG002|Overall Study|Lost to Follow-up|0|||
144262796|NCT02787304|520163744|FG002|Overall Study|Withdrawal by Subject|0|||
144569592|NCT04206085|521284042|FG000|Overall Study|Lost to Follow-up|0|||
144569593|NCT04206085|521284043|FG001|Overall Study|Lost to Follow-up|0|||
144728796|NCT04455633|521863122|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
144728797|NCT04455633|521863120|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
144206803|NCT02640053|519950787|FG001|Overall Study|Adverse Event|1|||
144569594|NCT04206085|521284044|FG002|Overall Study|Lost to Follow-up|1|||
144569595|NCT05594589|521284047|FG000|Overall Study|Other|0|||
144569596|NCT05594589|521284048|FG001|Overall Study|Other|1|||
144569597|NCT05594589|521284049|FG002|Overall Study|Other|0|||
144569598|NCT02168478|521284056|FG000|Overall Study|Withdrawal by Subject|1|||
144569599|NCT02168478|521284056|FG000|Overall Study|Did Not Consent to Participation|2|||
144569600|NCT02168478|521284056|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
144569601|NCT01530087|521284057|FG000|Overall Study|Physician Decision|2|||
144569602|NCT02760485|521284066|FG000|Phase 1|Death|3|||
144569603|NCT02760485|521284067|FG001|Phase 1|Death|6|||
144569604|NCT02760485|521284068|FG002|Phase 1|Death|0|||
144569605|NCT02760485|521284066|FG000|Phase 1|Withdrawal by Subject|2|||
144569606|NCT02760485|521284067|FG001|Phase 1|Withdrawal by Subject|0|||
144569607|NCT02760485|521284068|FG002|Phase 1|Withdrawal by Subject|0|||
144569608|NCT02760485|521284066|FG000|Phase 1|Progressive Disease|1|||
144569609|NCT02760485|521284067|FG001|Phase 1|Progressive Disease|0|||
144569610|NCT02760485|521284068|FG002|Phase 1|Progressive Disease|0|||
144569611|NCT02760485|521284066|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
144569612|NCT02760485|521284067|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
144569613|NCT02760485|521284068|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
144569614|NCT02760485|521284066|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
144569615|NCT02760485|521284067|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
144569616|NCT02760485|521284068|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
144569617|NCT02760485|521284066|FG000|Phase 2|Death|0|||
144569618|NCT02760485|521284067|FG001|Phase 2|Death|0|||
144569619|NCT02760485|521284068|FG002|Phase 2|Death|12|||
144569620|NCT02760485|521284066|FG000|Phase 2|Withdrawal by Subject|0|||
144569621|NCT02760485|521284067|FG001|Phase 2|Withdrawal by Subject|0|||
144569622|NCT02760485|521284068|FG002|Phase 2|Withdrawal by Subject|3|||
144569623|NCT02760485|521284066|FG000|Phase 2|Progressive Disease|0|||
144569624|NCT02760485|521284067|FG001|Phase 2|Progressive Disease|0|||
144569625|NCT02760485|521284068|FG002|Phase 2|Progressive Disease|1|||
144569626|NCT02760485|521284066|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
144569627|NCT02760485|521284067|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
144569628|NCT02760485|521284068|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
144569629|NCT01182207|521284069|FG000|First Intervention|Positive Hepatitis Results|0|||
144569630|NCT01182207|521284070|FG001|First Intervention|Positive Hepatitis Results|1|||
144569631|NCT01182207|521284069|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
144569632|NCT01182207|521284070|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
144569633|NCT02647645|521284073|FG000|Overall Study|Lost to Follow-up|2|||
144569634|NCT02647645|521284074|FG001|Overall Study|Lost to Follow-up|1|||
144569635|NCT02037256|521284075|FG000|Overall Study|Protocol Violation|0|||
144569636|NCT02037256|521284076|FG001|Overall Study|Protocol Violation|1|||
144569637|NCT02037256|521284075|FG000|Overall Study|Withdrawn prior to Velcade|0|||
144569638|NCT02037256|521284076|FG001|Overall Study|Withdrawn prior to Velcade|2|||
144569639|NCT04599907|521284079|FG000|Overall Study|Withdrawal by Subject|1|||
144569640|NCT04599907|521284080|FG001|Overall Study|Withdrawal by Subject|7|||
144569641|NCT04599907|521284081|FG002|Overall Study|Withdrawal by Subject|6|||
144569642|NCT04599907|521284079|FG000|Overall Study|Lost to Follow-up|0|||
144569643|NCT04599907|521284080|FG001|Overall Study|Lost to Follow-up|1|||
144569644|NCT04599907|521284081|FG002|Overall Study|Lost to Follow-up|0|||
144569645|NCT01466790|521284084|FG000|Overall Study|Adverse Event|1|||
144569646|NCT01466790|521284085|FG001|Overall Study|Adverse Event|0|||
144569647|NCT01466790|521284086|FG002|Overall Study|Adverse Event|0|||
144569648|NCT01466790|521284087|FG003|Overall Study|Adverse Event|0|||
144569649|NCT01466790|521284088|FG004|Overall Study|Adverse Event|2|||
144569650|NCT01466790|521284089|FG005|Overall Study|Adverse Event|0|||
144569651|NCT01466790|521284090|FG006|Overall Study|Adverse Event|0|||
144569652|NCT01466790|521284091|FG007|Overall Study|Adverse Event|0|||
144569653|NCT01466790|521284084|FG000|Overall Study|Lost to Follow-up|2|||
144569654|NCT01466790|521284085|FG001|Overall Study|Lost to Follow-up|0|||
144569655|NCT01466790|521284086|FG002|Overall Study|Lost to Follow-up|0|||
144569656|NCT01466790|521284087|FG003|Overall Study|Lost to Follow-up|0|||
144569657|NCT01466790|521284088|FG004|Overall Study|Lost to Follow-up|0|||
144569658|NCT01466790|521284089|FG005|Overall Study|Lost to Follow-up|0|||
144728798|NCT04455633|521863121|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
144569659|NCT01466790|521284090|FG006|Overall Study|Lost to Follow-up|0|||
144569660|NCT01466790|521284091|FG007|Overall Study|Lost to Follow-up|0|||
144569661|NCT01466790|521284084|FG000|Overall Study|Withdrawal by Subject|1|||
144569662|NCT01466790|521284085|FG001|Overall Study|Withdrawal by Subject|1|||
144569663|NCT01466790|521284086|FG002|Overall Study|Withdrawal by Subject|0|||
144569664|NCT01466790|521284087|FG003|Overall Study|Withdrawal by Subject|0|||
144569665|NCT01466790|521284088|FG004|Overall Study|Withdrawal by Subject|1|||
144569666|NCT01466790|521284089|FG005|Overall Study|Withdrawal by Subject|0|||
144569667|NCT01466790|521284090|FG006|Overall Study|Withdrawal by Subject|1|||
144569668|NCT01466790|521284091|FG007|Overall Study|Withdrawal by Subject|1|||
144569669|NCT00356811|521284093|FG000|Overall Study|Death|35|||
144569670|NCT00356811|521284093|FG000|Overall Study|Lost to Follow-up|2|||
144569671|NCT00356811|521284093|FG000|Overall Study|Withdrawal by Subject|6|||
144569672|NCT00356811|521284093|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
144569673|NCT00356811|521284093|FG000|Overall Study|Study Is Terminating|3|||
144569674|NCT00356811|521284093|FG000|Overall Study|Site Closed during Follow-up|2|||
144569675|NCT02386839|521284094|FG000|Overall Study|Death|1|||
144569676|NCT02386839|521284095|FG001|Overall Study|Death|0|||
144569677|NCT02386839|521284094|FG000|Overall Study|Withdrawal by Subject|9|||
144569678|NCT02386839|521284095|FG001|Overall Study|Withdrawal by Subject|10|||
144569679|NCT02386839|521284094|FG000|Overall Study|Lost to Follow-up|4|||
144569680|NCT02386839|521284095|FG001|Overall Study|Lost to Follow-up|4|||
144569681|NCT02386839|521284094|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
144569682|NCT02386839|521284095|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
144569683|NCT02386839|521284094|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
144569684|NCT02386839|521284095|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
144569685|NCT02386839|521284094|FG000|Overall Study|Other (unspecified)|1|||
144569686|NCT02386839|521284095|FG001|Overall Study|Other (unspecified)|0|||
144569687|NCT02242643|521284098|FG000|Overall Study|Protocol Violation|1|||
144569688|NCT02242643|521284099|FG001|Overall Study|Protocol Violation|2|||
144569689|NCT02242643|521284098|FG000|Overall Study|Withdrawal by Subject|15|||
144569690|NCT02242643|521284099|FG001|Overall Study|Withdrawal by Subject|10|||
144569691|NCT02242643|521284098|FG000|Overall Study|Migrated/moved from study area|1|||
144569692|NCT02242643|521284099|FG001|Overall Study|Migrated/moved from study area|3|||
144569693|NCT02242643|521284098|FG000|Overall Study|Lost to Follow-up|54|||
144569694|NCT02242643|521284099|FG001|Overall Study|Lost to Follow-up|61|||
144569695|NCT02242643|521284098|FG000|Overall Study|Child placed in foster care by family|0|||
144569696|NCT02242643|521284099|FG001|Overall Study|Child placed in foster care by family|1|||
144569697|NCT02242643|521284098|FG000|Overall Study|Non-compliance|1|||
144619773|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
144619774|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
144619775|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
144619776|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
144619777|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
144619778|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
144619779|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
144619780|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
144619781|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
144619782|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
144619783|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
144619784|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
144619785|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
144619786|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
144619787|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
144619788|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
144619789|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
144619790|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
144619791|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
144619792|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
144619793|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
144619794|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
144619795|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
144619796|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
144619797|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
144619798|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
144619799|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
144619800|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
144619801|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
144619802|NCT00784654|521466107|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
144619803|NCT00784654|521466108|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
144569698|NCT02242643|521284099|FG001|Overall Study|Non-compliance|0|||
144569699|NCT02242643|521284098|FG000|Overall Study|Consent withdrawal by parent|1|||
144569700|NCT02242643|521284099|FG001|Overall Study|Consent withdrawal by parent|0|||
144619804|NCT00784654|521466109|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
144619805|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
144206804|NCT02640053|519950786|FG000|Overall Study|Alternative Therapy|1|||
144619806|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
144619807|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
144619808|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
144619809|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
144619810|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
144619811|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144619812|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
144619813|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
144619814|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
144619815|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
144619816|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
144619817|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Adverse Event|0|||
144619818|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Adverse Event|1|||
144619819|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Adverse Event|1|||
144619820|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
144619821|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
144619822|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
144619823|NCT00784654|521466107|FG000|Randomized Withdrawal Period|Family reasons|0|||
144619824|NCT00784654|521466108|FG001|Randomized Withdrawal Period|Family reasons|0|||
144619825|NCT00784654|521466109|FG002|Randomized Withdrawal Period|Family reasons|1|||
144619826|NCT00317109|521466110|FG000|Overall Study|Withdrawal by Subject|2|||
144619827|NCT00317109|521466111|FG001|Overall Study|Withdrawal by Subject|0|||
144619828|NCT00317109|521466110|FG000|Overall Study|Migated/moved from study area|1|||
144619829|NCT00317109|521466111|FG001|Overall Study|Migated/moved from study area|0|||
144619830|NCT01026831|521466112|FG000|Overall Study|Adverse Event|4|||
144619831|NCT01026831|521466113|FG001|Overall Study|Adverse Event|3|||
144619832|NCT01026831|521466112|FG000|Overall Study|Lost to Follow-up|2|||
144619833|NCT01026831|521466113|FG001|Overall Study|Lost to Follow-up|0|||
144619834|NCT01026831|521466112|FG000|Overall Study|Physician Decision|1|||
144619835|NCT01026831|521466113|FG001|Overall Study|Physician Decision|1|||
144619836|NCT01026831|521466112|FG000|Overall Study|Protocol Violation|0|||
144619837|NCT01026831|521466113|FG001|Overall Study|Protocol Violation|2|||
144619838|NCT01026831|521466112|FG000|Overall Study|Withdrawal by Subject|7|||
144619839|NCT01026831|521466113|FG001|Overall Study|Withdrawal by Subject|5|||
144619840|NCT01079182|521466114|FG000|Overall Study|Lost to Follow-up|1634|||
144619841|NCT01079182|521466114|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
144619842|NCT01079182|521466114|FG000|Overall Study|Lack of Efficacy|514|||
144619843|NCT01079182|521466114|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
144619844|NCT01079182|521466114|FG000|Overall Study|Reasons not Evaluated|271|||
144619845|NCT04417894|521466116|FG000|Overall Study|Lost to Follow-up|3|||
144619846|NCT04417894|521466117|FG001|Overall Study|Lost to Follow-up|0|||
144619847|NCT04417894|521466116|FG000|Overall Study|Withdrawal by Subject|7|||
144619848|NCT04417894|521466117|FG001|Overall Study|Withdrawal by Subject|6|||
144619849|NCT04417894|521466116|FG000|Overall Study|Lack of Efficacy|3|||
144619850|NCT04417894|521466117|FG001|Overall Study|Lack of Efficacy|1|||
144619851|NCT01508702|521466118|FG000|Overall Study|Adverse Event|7|||
144619852|NCT01508702|521466119|FG001|Overall Study|Adverse Event|3|||
144619853|NCT01508702|521466118|FG000|Overall Study|Gout flare|2|||
144619854|NCT01508702|521466119|FG001|Overall Study|Gout flare|0|||
144619855|NCT01508702|521466118|FG000|Overall Study|Protocol Violation|2|||
144619856|NCT01508702|521466119|FG001|Overall Study|Protocol Violation|1|||
144619857|NCT01508702|521466118|FG000|Overall Study|Lost to Follow-up|1|||
144619858|NCT01508702|521466119|FG001|Overall Study|Lost to Follow-up|2|||
144619859|NCT01508702|521466118|FG000|Overall Study|Withdrawal by Subject|11|||
144619860|NCT01508702|521466119|FG001|Overall Study|Withdrawal by Subject|7|||
144619861|NCT03461757|521466120|FG000|Overall Study|Adverse Event|1|||
144619862|NCT03461757|521466121|FG001|Overall Study|Adverse Event|0|||
144619863|NCT03461757|521466120|FG000|Overall Study|Lost to Follow-up|13|||
144619864|NCT03461757|521466121|FG001|Overall Study|Lost to Follow-up|7|||
144619865|NCT03461757|521466120|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
144206805|NCT02640053|519950787|FG001|Overall Study|Alternative Therapy|1|||
144206806|NCT02640053|519950786|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
144619866|NCT03461757|521466121|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
144619867|NCT03461757|521466120|FG000|Overall Study|Non-compliance with study treatment|0|||
144619868|NCT03461757|521466121|FG001|Overall Study|Non-compliance with study treatment|1|||
144619869|NCT03461757|521466120|FG000|Overall Study|Pregnancy|2|||
144619870|NCT03461757|521466121|FG001|Overall Study|Pregnancy|0|||
144619871|NCT03461757|521466120|FG000|Overall Study|Protocol Violation|1|||
144619872|NCT03461757|521466121|FG001|Overall Study|Protocol Violation|1|||
144619873|NCT03461757|521466120|FG000|Overall Study|Withdrawal by Subject|7|||
144619874|NCT03461757|521466121|FG001|Overall Study|Withdrawal by Subject|7|||
144619875|NCT03461757|521466120|FG000|Overall Study|Other Reasons|1|||
144619876|NCT03461757|521466121|FG001|Overall Study|Other Reasons|4|||
144619877|NCT02425826|521466122|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
144569701|NCT02242643|521284098|FG000|Overall Study|Protocol requirements not followed|1|||
144569702|NCT02242643|521284099|FG001|Overall Study|Protocol requirements not followed|0|||
144569703|NCT02242643|521284098|FG000|Overall Study|Language barrier|1|||
144569704|NCT02242643|521284099|FG001|Overall Study|Language barrier|0|||
144569705|NCT02242643|521284098|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
144569706|NCT02242643|521284099|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
144569707|NCT02101983|521284103|FG000|Overall Study|Physician Decision|1|||
144569708|NCT02101983|521284104|FG001|Overall Study|Physician Decision|0|||
144569709|NCT01103232|521284105|FG000|Overall Study|Withdrawal by Subject|1|||
144569710|NCT01103232|521284106|FG001|Overall Study|Withdrawal by Subject|1|||
144569711|NCT01103232|521284105|FG000|Overall Study|Protocol Violation|0|||
144569712|NCT01103232|521284106|FG001|Overall Study|Protocol Violation|1|||
144569713|NCT03733899|521284107|FG000|Period 1|Protocol Violation|0|||
144569714|NCT03733899|521284108|FG001|Period 1|Protocol Violation|0|||
144569715|NCT03733899|521284109|FG002|Period 1|Protocol Violation|0|||
144569716|NCT03733899|521284110|FG003|Period 1|Protocol Violation|0|||
144206807|NCT02640053|519950787|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
144206808|NCT02348723|519950789|FG000|Overall Study|No ablation|21|||
144206809|NCT02348723|519950790|FG001|Overall Study|No ablation|20|||
144206810|NCT02348723|519950789|FG000|Overall Study|Non-compliant with Protocol|1|||
144569717|NCT03733899|521284111|FG004|Period 1|Protocol Violation|0|||
144569718|NCT03733899|521284112|FG005|Period 1|Protocol Violation|1|||
144569719|NCT03733899|521284107|FG000|Period 2|Unscuccessful Treatment|0|||
144569720|NCT03733899|521284108|FG001|Period 2|Unscuccessful Treatment|1|||
144206811|NCT02348723|519950790|FG001|Overall Study|Non-compliant with Protocol|0|||
144206812|NCT02348723|519950789|FG000|Overall Study|Lost to Follow-up|1|||
144206813|NCT02348723|519950790|FG001|Overall Study|Lost to Follow-up|1|||
144206814|NCT02348723|519950789|FG000|Overall Study|Consent withdrawn|1|||
144206815|NCT02348723|519950790|FG001|Overall Study|Consent withdrawn|3|||
144206816|NCT02348723|519950789|FG000|Overall Study|Reason other than specified|1|||
144206817|NCT02348723|519950790|FG001|Overall Study|Reason other than specified|1|||
144206818|NCT02348723|519950789|FG000|Overall Study|Adverse Event|3|||
144206819|NCT02348723|519950790|FG001|Overall Study|Adverse Event|1|||
144262797|NCT02787304|520163745|FG003|Overall Study|Withdrawal by Subject|0|||
144262798|NCT02787304|520163742|FG000|Overall Study|Lost to Follow-up|1|||
144569721|NCT03733899|521284109|FG002|Period 2|Unscuccessful Treatment|0|||
144569722|NCT03733899|521284110|FG003|Period 2|Unscuccessful Treatment|0|||
144569723|NCT03733899|521284111|FG004|Period 2|Unscuccessful Treatment|0|||
144569724|NCT03733899|521284112|FG005|Period 2|Unscuccessful Treatment|0|||
144569725|NCT03733899|521284107|FG000|Period 3|Withdrawal by Subject|1|||
144569726|NCT03733899|521284108|FG001|Period 3|Withdrawal by Subject|0|||
144569727|NCT03733899|521284109|FG002|Period 3|Withdrawal by Subject|0|||
144569728|NCT03733899|521284110|FG003|Period 3|Withdrawal by Subject|0|||
144569729|NCT03733899|521284111|FG004|Period 3|Withdrawal by Subject|0|||
144569730|NCT03733899|521284112|FG005|Period 3|Withdrawal by Subject|0|||
144569731|NCT02035696|521286203|FG000|Overall Study|Lost to Follow-up|0|||
144569732|NCT02035696|521286204|FG001|Overall Study|Lost to Follow-up|3|||
144569733|NCT02035696|521286205|FG002|Overall Study|Lost to Follow-up|1|||
144569734|NCT02035696|521286206|FG003|Overall Study|Lost to Follow-up|2|||
144569735|NCT02035696|521286203|FG000|Overall Study|Withdrawal by Subject|3|||
144569736|NCT02035696|521286204|FG001|Overall Study|Withdrawal by Subject|0|||
144569737|NCT02035696|521286205|FG002|Overall Study|Withdrawal by Subject|2|||
144569738|NCT02035696|521286206|FG003|Overall Study|Withdrawal by Subject|1|||
144569739|NCT00966264|521286208|FG000|Overall Study|Lost to Follow-up|4|||
144569740|NCT00966264|521286209|FG001|Overall Study|Lost to Follow-up|3|||
144569741|NCT01246999|521286210|FG000|Overall Study|Lost to Follow-up|0|||
144569742|NCT01246999|521286211|FG001|Overall Study|Lost to Follow-up|1|||
144569743|NCT01246999|521286212|FG002|Overall Study|Lost to Follow-up|0|||
144569744|NCT01246999|521286213|FG003|Overall Study|Lost to Follow-up|0|||
144569745|NCT01246999|521286210|FG000|Overall Study|Withdrawal by Subject|0|||
144569746|NCT01246999|521286211|FG001|Overall Study|Withdrawal by Subject|0|||
144569747|NCT01246999|521286212|FG002|Overall Study|Withdrawal by Subject|0|||
144206820|NCT01268501|519950791|FG000|Overall Study|Lost to Follow-up|1|||
144206821|NCT01268501|519950791|FG000|Overall Study|Withdrawal by Subject|3|||
144262799|NCT02787304|520163743|FG001|Overall Study|Lost to Follow-up|0|||
144569748|NCT01246999|521286213|FG003|Overall Study|Withdrawal by Subject|2|||
144569749|NCT01867047|521286214|FG000|Overall Study|Lost to Follow-up|3|||
144569750|NCT01867047|521286215|FG001|Overall Study|Lost to Follow-up|3|||
144569751|NCT01867047|521286214|FG000|Overall Study|Withdrawal by Subject|2|||
144569752|NCT01867047|521286215|FG001|Overall Study|Withdrawal by Subject|0|||
144569753|NCT01867047|521286214|FG000|Overall Study|Physician Decision|2|||
144569754|NCT01867047|521286215|FG001|Overall Study|Physician Decision|0|||
144569755|NCT01867047|521286214|FG000|Overall Study|surgery not indicated in protocol|1|||
144569756|NCT01867047|521286215|FG001|Overall Study|surgery not indicated in protocol|2|||
144569757|NCT01090011|521286216|FG000|Overall Study|Progressive disease|128|||
144569758|NCT01090011|521286216|FG000|Overall Study|Adverse Event|32|||
144569759|NCT01090011|521286216|FG000|Overall Study|Protocol Violation|1|||
144569760|NCT01090011|521286216|FG000|Overall Study|Refusal to start/continue medication|5|||
144728799|NCT04455633|521863122|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
144728800|NCT04455633|521863120|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
144728801|NCT04455633|521863121|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
144728802|NCT04455633|521863122|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
144728803|NCT04455633|521863120|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
144728804|NCT04455633|521863121|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
144728805|NCT04455633|521863122|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
144728806|NCT03527745|521863123|FG000|Overall Study|Lost to Follow-up|3|||
144728807|NCT03527745|521863124|FG001|Overall Study|Lost to Follow-up|6|||
144728808|NCT03527745|521863125|FG002|Overall Study|Lost to Follow-up|7|||
144728809|NCT03527745|521863126|FG003|Overall Study|Lost to Follow-up|9|||
144728810|NCT03527745|521863127|FG004|Overall Study|Lost to Follow-up|0|||
144728811|NCT03527745|521863128|FG005|Overall Study|Lost to Follow-up|2|||
144728812|NCT03527745|521863129|FG006|Overall Study|Lost to Follow-up|3|||
144728813|NCT03527745|521863130|FG007|Overall Study|Lost to Follow-up|2|||
144728814|NCT03527745|521863131|FG008|Overall Study|Lost to Follow-up|3|||
144728815|NCT03527745|521863132|FG009|Overall Study|Lost to Follow-up|2|||
144728816|NCT03527745|521863133|FG010|Overall Study|Lost to Follow-up|1|||
144728817|NCT03527745|521863134|FG011|Overall Study|Lost to Follow-up|1|||
144728818|NCT03527745|521863135|FG012|Overall Study|Lost to Follow-up|0|||
144728819|NCT03527745|521863136|FG013|Overall Study|Lost to Follow-up|0|||
144728820|NCT03527745|521863137|FG014|Overall Study|Lost to Follow-up|0|||
144728821|NCT03527745|521863138|FG015|Overall Study|Lost to Follow-up|0|||
144728822|NCT03527745|521863139|FG016|Overall Study|Lost to Follow-up|1|||
144728823|NCT03527745|521863140|FG017|Overall Study|Lost to Follow-up|0|||
144728824|NCT03527745|521863141|FG018|Overall Study|Lost to Follow-up|0|||
144728825|NCT03527745|521863142|FG019|Overall Study|Lost to Follow-up|1|||
144619878|NCT02425826|521466123|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
144619879|NCT02425826|521466124|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
144619880|NCT02425826|521466122|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
144619881|NCT02425826|521466123|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
144619882|NCT02425826|521466124|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
144619883|NCT02425826|521466122|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
144619884|NCT02425826|521466123|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
144619885|NCT02425826|521466124|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
144619886|NCT02425826|521466122|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
144619887|NCT02425826|521466123|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
144619888|NCT02425826|521466124|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
144619889|NCT02425826|521466122|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
144619890|NCT02425826|521466123|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
144619891|NCT02425826|521466124|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
144619892|NCT02425826|521466122|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
144619893|NCT02425826|521466123|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
144728826|NCT03527745|521863143|FG020|Overall Study|Lost to Follow-up|1|||
144728827|NCT03527745|521863144|FG021|Overall Study|Lost to Follow-up|5|||
144728828|NCT03527745|521863145|FG022|Overall Study|Lost to Follow-up|6|||
144728829|NCT03527745|521863146|FG023|Overall Study|Lost to Follow-up|8|||
144728830|NCT03527745|521863147|FG024|Overall Study|Lost to Follow-up|1|||
144728831|NCT03527745|521863148|FG025|Overall Study|Lost to Follow-up|3|||
144728832|NCT01475838|521863152|FG000|Randomized Phase|Randomized but Not Treated|0|||
144728833|NCT01475838|521863153|FG001|Randomized Phase|Randomized but Not Treated|5|||
144728834|NCT01475838|521863152|FG000|Randomized Phase|Adverse Event|6|||
144728835|NCT01475838|521863153|FG001|Randomized Phase|Adverse Event|1|||
144728836|NCT01475838|521863152|FG000|Randomized Phase|Pregnancy|0|||
144728837|NCT01475838|521863153|FG001|Randomized Phase|Pregnancy|1|||
144728838|NCT01475838|521863152|FG000|Randomized Phase|Investigators Discretion|1|||
144728839|NCT01475838|521863153|FG001|Randomized Phase|Investigators Discretion|2|||
144728840|NCT01475838|521863152|FG000|Randomized Phase|Withdrew Consent|10|||
144728841|NCT01475838|521863153|FG001|Randomized Phase|Withdrew Consent|14|||
144619894|NCT02425826|521466124|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
144728842|NCT01475838|521863152|FG000|Randomized Phase|Lost to Follow-up|3|||
144728843|NCT01475838|521863153|FG001|Randomized Phase|Lost to Follow-up|4|||
144728844|NCT01475838|521863152|FG000|Randomized Phase|Participant Noncompliance|1|||
144728845|NCT01475838|521863153|FG001|Randomized Phase|Participant Noncompliance|5|||
144728846|NCT01475838|521863152|FG000|Randomized Phase|Protocol Violation|9|||
144728847|NCT01475838|521863153|FG001|Randomized Phase|Protocol Violation|4|||
144728848|NCT01475838|521863152|FG000|Extension Phase|Participant Noncompliance|1|||
144728849|NCT01475838|521863153|FG001|Extension Phase|Participant Noncompliance|0|||
144728850|NCT00048568|521863159|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
144728851|NCT00048568|521863160|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
144728852|NCT00048568|521863161|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
144206822|NCT01268501|519950791|FG000|Overall Study|Unacceptable Subjective Vision|3|||
144206823|NCT01268501|519950791|FG000|Overall Study|Handling Difficulties|2|||
144206824|NCT02828241|519950794|FG000|Overall Study|Adverse Event|7|||
144206825|NCT02828241|519950795|FG001|Overall Study|Adverse Event|2|||
144206826|NCT02828241|519950794|FG000|Overall Study|Protocol Violation|1|||
144206827|NCT02828241|519950795|FG001|Overall Study|Protocol Violation|0|||
144206828|NCT00073021|519950802|FG000|Overall Study|Protocol Violation|2|||
144206829|NCT00073021|519950803|FG001|Overall Study|Protocol Violation|1|||
144206830|NCT00073021|519950802|FG000|Overall Study|Adverse Event|4|||
144206831|NCT00073021|519950803|FG001|Overall Study|Adverse Event|4|||
144206832|NCT00073021|519950802|FG000|Overall Study|Withdrawal by Subject|6|||
144206833|NCT00073021|519950803|FG001|Overall Study|Withdrawal by Subject|5|||
144206834|NCT00073021|519950802|FG000|Overall Study|Physician Decision|3|||
144206835|NCT00073021|519950803|FG001|Overall Study|Physician Decision|1|||
144206836|NCT00073021|519950802|FG000|Overall Study|Lack of Efficacy|11|||
144206837|NCT00073021|519950803|FG001|Overall Study|Lack of Efficacy|5|||
144206838|NCT03835221|519950804|FG000|Methafilcon A|Withdrawal by Subject|1|||
144206839|NCT02288182|519950810|FG000|Overall Study|Adverse Event|0|||
144206840|NCT02288182|519950811|FG001|Overall Study|Adverse Event|1|||
144206841|NCT02288182|519950810|FG000|Overall Study|Lost to Follow-up|0|||
144206842|NCT02288182|519950811|FG001|Overall Study|Lost to Follow-up|1|||
144206843|NCT02823652|519950815|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
144206844|NCT02823652|519950816|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
144206845|NCT02823652|519950817|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
144206846|NCT02823652|519950815|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
144206847|NCT02823652|519950816|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
144206848|NCT02823652|519950817|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
144206849|NCT02823652|519950815|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
144206850|NCT02823652|519950816|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
144206851|NCT02823652|519950817|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
144206852|NCT02823652|519950815|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
144206853|NCT02823652|519950816|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
144206854|NCT02823652|519950817|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
144206855|NCT03510598|519952368|FG000|Overall Study|Withdrawal by Subject|1|||
144206856|NCT05776862|519952369|FG000|Overall Study|Adverse Event|0|||
144206857|NCT05776862|519952370|FG001|Overall Study|Adverse Event|1|||
144206858|NCT05776862|519952369|FG000|Overall Study|non-compliance|1|||
144206859|NCT05776862|519952370|FG001|Overall Study|non-compliance|0|||
144206860|NCT00837473|519952371|FG000|Overall Study|Lost to Follow-up|1|||
144206861|NCT00837473|519952371|FG000|Overall Study|Withdrawal by Subject|2|||
144206862|NCT03262038|519952372|FG000|Overall Study|Withdrawal by Subject|0|||
144206863|NCT03262038|519952373|FG001|Overall Study|Withdrawal by Subject|1|||
144206864|NCT04933968|519952374|FG000|Overall Study|Adverse Event|0|||
144206865|NCT04933968|519952375|FG001|Overall Study|Adverse Event|0|||
144206866|NCT04933968|519952376|FG002|Overall Study|Adverse Event|1|||
144206867|NCT04933968|519952377|FG003|Overall Study|Adverse Event|1|||
144206868|NCT04933968|519952378|FG004|Overall Study|Adverse Event|0|||
144206869|NCT04933968|519952379|FG005|Overall Study|Adverse Event|0|||
144206870|NCT04933968|519952374|FG000|Overall Study|Lost to Follow-up|1|||
144206871|NCT04933968|519952375|FG001|Overall Study|Lost to Follow-up|0|||
144206872|NCT04933968|519952376|FG002|Overall Study|Lost to Follow-up|1|||
144206873|NCT04933968|519952377|FG003|Overall Study|Lost to Follow-up|0|||
144206874|NCT04933968|519952378|FG004|Overall Study|Lost to Follow-up|0|||
144206875|NCT04933968|519952379|FG005|Overall Study|Lost to Follow-up|0|||
144206876|NCT04933968|519952374|FG000|Overall Study|Randomized not treated|1|||
144206877|NCT04933968|519952375|FG001|Overall Study|Randomized not treated|0|||
144206878|NCT04933968|519952376|FG002|Overall Study|Randomized not treated|0|||
144206879|NCT04933968|519952377|FG003|Overall Study|Randomized not treated|0|||
144206880|NCT04933968|519952378|FG004|Overall Study|Randomized not treated|0|||
144206881|NCT04933968|519952379|FG005|Overall Study|Randomized not treated|0|||
144206882|NCT04933968|519952374|FG000|Overall Study|Sponsor terminated study|0|||
144206883|NCT04933968|519952375|FG001|Overall Study|Sponsor terminated study|0|||
144206884|NCT04933968|519952376|FG002|Overall Study|Sponsor terminated study|0|||
144206885|NCT04933968|519952377|FG003|Overall Study|Sponsor terminated study|1|||
144206886|NCT04933968|519952378|FG004|Overall Study|Sponsor terminated study|2|||
144206887|NCT04933968|519952379|FG005|Overall Study|Sponsor terminated study|0|||
144206888|NCT04933968|519952374|FG000|Overall Study|Other|0|||
144206889|NCT04933968|519952375|FG001|Overall Study|Other|0|||
144206890|NCT04933968|519952376|FG002|Overall Study|Other|0|||
144206891|NCT04933968|519952377|FG003|Overall Study|Other|1|||
144206892|NCT04933968|519952378|FG004|Overall Study|Other|0|||
144206893|NCT04933968|519952379|FG005|Overall Study|Other|0|||
144206894|NCT04933968|519952374|FG000|Overall Study|Missing|1|||
144206895|NCT04933968|519952375|FG001|Overall Study|Missing|3|||
144206896|NCT04933968|519952376|FG002|Overall Study|Missing|2|||
144206897|NCT04933968|519952377|FG003|Overall Study|Missing|1|||
144262800|NCT02787304|520163744|FG002|Overall Study|Lost to Follow-up|0|||
144262801|NCT02787304|520163745|FG003|Overall Study|Lost to Follow-up|1|||
144206898|NCT04933968|519952378|FG004|Overall Study|Missing|1|||
144206899|NCT04933968|519952379|FG005|Overall Study|Missing|0|||
144206900|NCT01724489|519952380|FG000|Overall Study|Adverse Event|8|||
144206901|NCT01724489|519952381|FG001|Overall Study|Adverse Event|3|||
144206902|NCT01724489|519952380|FG000|Overall Study|Surgery, medication|1|||
144206903|NCT01724489|519952381|FG001|Overall Study|Surgery, medication|1|||
144206904|NCT01724489|519952380|FG000|Overall Study|Lost to Follow-up|1|||
144206905|NCT01724489|519952381|FG001|Overall Study|Lost to Follow-up|2|||
144206906|NCT01724489|519952380|FG000|Overall Study|Withdrawal by Subject|6|||
144206907|NCT01724489|519952381|FG001|Overall Study|Withdrawal by Subject|6|||
144569761|NCT01090011|521286216|FG000|Overall Study|Other reason not defined above|5|||
144569762|NCT00307047|521286217|FG000|Overall Study|Lost to Follow-up|35|||
144569763|NCT00307047|521286218|FG001|Overall Study|Lost to Follow-up|24|||
144569764|NCT00307047|521286217|FG000|Overall Study|Withdrawal by Subject|6|||
144569765|NCT00307047|521286218|FG001|Overall Study|Withdrawal by Subject|6|||
144569766|NCT00307047|521286217|FG000|Overall Study|Physician Decision|1|||
144569767|NCT00307047|521286218|FG001|Overall Study|Physician Decision|2|||
144569768|NCT00307047|521286217|FG000|Overall Study|Lost to follow-up for other reasons|0|||
144569769|NCT00307047|521286218|FG001|Overall Study|Lost to follow-up for other reasons|1|||
144206908|NCT04576923|519952382|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
144206909|NCT01664130|519952385|FG000|Overall Study|competing secondary disease|2|||
144206910|NCT00554606|519952388|FG000|Overall Study|Adverse Event|3|||
144206911|NCT00554606|519952388|FG000|Overall Study|Abnormal laboratory values|1|||
144206912|NCT00554606|519952388|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
144206913|NCT00554606|519952388|FG000|Overall Study|Subject withdrew consent|2|||
144206914|NCT00554606|519952388|FG000|Overall Study|Lost to Follow-up|2|||
144206915|NCT00554606|519952388|FG000|Overall Study|Administrative problems|60|||
144206916|NCT00554606|519952388|FG000|Overall Study|Death|1|||
144206917|NCT00554606|519952388|FG000|Overall Study|Protocol deviation|2|||
144206918|NCT03323437|519952390|FG000|Overall Study|Withdrawal by Subject|0|||
144206919|NCT03323437|519952391|FG001|Overall Study|Withdrawal by Subject|4|||
144569770|NCT00307047|521286217|FG000|Overall Study|All death, all MI, all Revascularization|27|||
144569771|NCT00307047|521286218|FG001|Overall Study|All death, all MI, all Revascularization|16|||
144569772|NCT00379769|521286219|FG000|Main Study|Death|57|||
144569773|NCT00379769|521286220|FG001|Main Study|Death|67|||
144569774|NCT00379769|521286221|FG002|Main Study|Death|54|||
144569775|NCT00379769|521286222|FG003|Main Study|Death|72|||
144569776|NCT00379769|521286223|FG004|Main Study|Death|0|||
144569777|NCT00379769|521286224|FG005|Main Study|Death|0|||
144569778|NCT00379769|521286219|FG000|Main Study|Adverse Event|5|||
144569779|NCT00379769|521286220|FG001|Main Study|Adverse Event|8|||
144569780|NCT00379769|521286221|FG002|Main Study|Adverse Event|10|||
144569781|NCT00379769|521286222|FG003|Main Study|Adverse Event|11|||
144206920|NCT01635283|519952392|FG000|Overall Study|Tumor Progression|3|||
144206921|NCT01635283|519952392|FG000|Overall Study|Lost to Follow-up|1|||
144206922|NCT03511326|519952395|FG000|Overall Study|Withdrawal by Subject|1|||
144206923|NCT01305044|519952398|FG000|Overall Study|Withdrawal by Subject|3|||
144206924|NCT01305044|519952399|FG001|Overall Study|Withdrawal by Subject|6|||
144206925|NCT00849186|519952402|FG000|Overall Study|Adverse Event|2|||
144206926|NCT00849186|519952402|FG000|Overall Study|Withdrawal by Subject|1|||
144206927|NCT00849186|519952402|FG000|Overall Study|not treated|6|||
144206928|NCT00849186|519952402|FG000|Overall Study|Other|1|||
144206929|NCT00492024|519952403|FG000|Treatment|Adverse Event|3|||
144206930|NCT00492024|519952404|FG001|Treatment|Adverse Event|1|||
144206931|NCT00492024|519952403|FG000|Treatment|Lack of Efficacy|21|||
144206932|NCT00492024|519952404|FG001|Treatment|Lack of Efficacy|20|||
144206933|NCT00492024|519952403|FG000|Treatment|Lost to Follow-up|3|||
144206934|NCT00492024|519952404|FG001|Treatment|Lost to Follow-up|1|||
144206935|NCT00492024|519952403|FG000|Treatment|Withdrawal by Subject|2|||
144206936|NCT00492024|519952404|FG001|Treatment|Withdrawal by Subject|0|||
144569782|NCT00379769|521286223|FG004|Main Study|Adverse Event|0|||
144569783|NCT00379769|521286224|FG005|Main Study|Adverse Event|0|||
144569784|NCT00379769|521286219|FG000|Main Study|Lost to Follow-up|29|||
144569785|NCT00379769|521286220|FG001|Main Study|Lost to Follow-up|29|||
144569786|NCT00379769|521286221|FG002|Main Study|Lost to Follow-up|25|||
144728853|NCT00048568|521863159|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
144206937|NCT00492024|519952403|FG000|Follow up|Lack of Efficacy|0|||
144206938|NCT00492024|519952404|FG001|Follow up|Lack of Efficacy|1|||
144206939|NCT00492024|519952403|FG000|Follow up|Lost to Follow-up|1|||
144206940|NCT00492024|519952404|FG001|Follow up|Lost to Follow-up|1|||
144206941|NCT04628793|519952412|FG000|Overall Study|Study terminated by sponsor|0|||
144206942|NCT04628793|519952413|FG001|Overall Study|Study terminated by sponsor|0|||
144206943|NCT04628793|519952414|FG002|Overall Study|Study terminated by sponsor|8|||
144206944|NCT04628793|519952412|FG000|Overall Study|Withdrawal by Subject|2|||
144569787|NCT00379769|521286222|FG003|Main Study|Lost to Follow-up|26|||
144569788|NCT00379769|521286223|FG004|Main Study|Lost to Follow-up|0|||
144206945|NCT04628793|519952413|FG001|Overall Study|Withdrawal by Subject|3|||
144206946|NCT04628793|519952414|FG002|Overall Study|Withdrawal by Subject|0|||
144569789|NCT00379769|521286224|FG005|Main Study|Lost to Follow-up|0|||
144569790|NCT00379769|521286219|FG000|Main Study|Withdrawal by Subject|46|||
144569791|NCT00379769|521286220|FG001|Main Study|Withdrawal by Subject|56|||
144262802|NCT02787304|520163742|FG000|Overall Study|Noncompliance with study drug|0|||
144262803|NCT02787304|520163743|FG001|Overall Study|Noncompliance with study drug|0|||
144262804|NCT02787304|520163744|FG002|Overall Study|Noncompliance with study drug|1|||
144262805|NCT02787304|520163745|FG003|Overall Study|Noncompliance with study drug|0|||
144262806|NCT02787304|520163742|FG000|Overall Study|Physician Decision|0|||
144262807|NCT02787304|520163743|FG001|Overall Study|Physician Decision|0|||
144262808|NCT02787304|520163744|FG002|Overall Study|Physician Decision|1|||
144569792|NCT00379769|521286221|FG002|Main Study|Withdrawal by Subject|72|||
144569793|NCT00379769|521286222|FG003|Main Study|Withdrawal by Subject|70|||
144569794|NCT00379769|521286223|FG004|Main Study|Withdrawal by Subject|0|||
144569795|NCT00379769|521286224|FG005|Main Study|Withdrawal by Subject|0|||
144569796|NCT00379769|521286219|FG000|Main Study|Moved to survival status follow-up only|27|||
144569797|NCT00379769|521286220|FG001|Main Study|Moved to survival status follow-up only|25|||
144569798|NCT00379769|521286221|FG002|Main Study|Moved to survival status follow-up only|32|||
144569799|NCT00379769|521286222|FG003|Main Study|Moved to survival status follow-up only|36|||
144569800|NCT00379769|521286223|FG004|Main Study|Moved to survival status follow-up only|0|||
144569801|NCT00379769|521286224|FG005|Main Study|Moved to survival status follow-up only|0|||
144569802|NCT00379769|521286219|FG000|Main Study|Participant moved|3|||
144569803|NCT00379769|521286220|FG001|Main Study|Participant moved|2|||
144569804|NCT00379769|521286221|FG002|Main Study|Participant moved|3|||
144569805|NCT00379769|521286222|FG003|Main Study|Participant moved|3|||
144569806|NCT00379769|521286223|FG004|Main Study|Participant moved|0|||
144569807|NCT00379769|521286224|FG005|Main Study|Participant moved|0|||
144569808|NCT00379769|521286219|FG000|Main Study|Poor compliance|3|||
144569809|NCT00379769|521286220|FG001|Main Study|Poor compliance|2|||
144569810|NCT00379769|521286221|FG002|Main Study|Poor compliance|2|||
144569811|NCT00379769|521286222|FG003|Main Study|Poor compliance|1|||
144569812|NCT00379769|521286223|FG004|Main Study|Poor compliance|0|||
144569813|NCT00379769|521286224|FG005|Main Study|Poor compliance|0|||
144569814|NCT00379769|521286219|FG000|Main Study|Prohibited glucose lowering medication|0|||
144569815|NCT00379769|521286220|FG001|Main Study|Prohibited glucose lowering medication|3|||
144569816|NCT00379769|521286221|FG002|Main Study|Prohibited glucose lowering medication|0|||
144569817|NCT00379769|521286222|FG003|Main Study|Prohibited glucose lowering medication|1|||
144569818|NCT00379769|521286223|FG004|Main Study|Prohibited glucose lowering medication|0|||
144569819|NCT00379769|521286224|FG005|Main Study|Prohibited glucose lowering medication|0|||
144569820|NCT00379769|521286219|FG000|Main Study|Site closed|4|||
144569821|NCT00379769|521286220|FG001|Main Study|Site closed|4|||
144569822|NCT00379769|521286221|FG002|Main Study|Site closed|4|||
144569823|NCT00379769|521286222|FG003|Main Study|Site closed|8|||
144569824|NCT00379769|521286223|FG004|Main Study|Site closed|0|||
144569825|NCT00379769|521286224|FG005|Main Study|Site closed|0|||
144569826|NCT00379769|521286219|FG000|Main Study|Entry criteria violation|0|||
144569827|NCT00379769|521286220|FG001|Main Study|Entry criteria violation|0|||
144569828|NCT00379769|521286221|FG002|Main Study|Entry criteria violation|1|||
144569829|NCT00379769|521286222|FG003|Main Study|Entry criteria violation|1|||
144569830|NCT00379769|521286223|FG004|Main Study|Entry criteria violation|0|||
144569831|NCT00379769|521286224|FG005|Main Study|Entry criteria violation|0|||
144569832|NCT00379769|521286219|FG000|Main Study|Participant did not take study drug|0|||
144569833|NCT00379769|521286220|FG001|Main Study|Participant did not take study drug|0|||
144569834|NCT00379769|521286221|FG002|Main Study|Participant did not take study drug|1|||
144569835|NCT00379769|521286222|FG003|Main Study|Participant did not take study drug|0|||
144569836|NCT00379769|521286223|FG004|Main Study|Participant did not take study drug|0|||
144569837|NCT00379769|521286224|FG005|Main Study|Participant did not take study drug|0|||
144569838|NCT00379769|521286219|FG000|Main Study|Physician Decision|2|||
144569839|NCT00379769|521286220|FG001|Main Study|Physician Decision|2|||
144569840|NCT00379769|521286221|FG002|Main Study|Physician Decision|1|||
144569841|NCT00379769|521286222|FG003|Main Study|Physician Decision|1|||
144569842|NCT00379769|521286223|FG004|Main Study|Physician Decision|0|||
144569843|NCT00379769|521286224|FG005|Main Study|Physician Decision|0|||
144569844|NCT00379769|521286219|FG000|Main Study|Participant completed study at visit 27|1|||
144569845|NCT00379769|521286220|FG001|Main Study|Participant completed study at visit 27|0|||
144569846|NCT00379769|521286221|FG002|Main Study|Participant completed study at visit 27|0|||
144569847|NCT00379769|521286222|FG003|Main Study|Participant completed study at visit 27|0|||
144569848|NCT00379769|521286223|FG004|Main Study|Participant completed study at visit 27|0|||
144619895|NCT02425826|521466122|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
144569849|NCT00379769|521286224|FG005|Main Study|Participant completed study at visit 27|0|||
144569850|NCT00379769|521286219|FG000|Main Study|Personal reasons|1|||
144569851|NCT00379769|521286220|FG001|Main Study|Personal reasons|0|||
144569852|NCT00379769|521286221|FG002|Main Study|Personal reasons|0|||
144569853|NCT00379769|521286222|FG003|Main Study|Personal reasons|0|||
144569854|NCT00379769|521286223|FG004|Main Study|Personal reasons|0|||
144569855|NCT00379769|521286224|FG005|Main Study|Personal reasons|0|||
144569856|NCT00379769|521286219|FG000|Main Study|Risk of heart failure|0|||
144262809|NCT02787304|520163745|FG003|Overall Study|Physician Decision|0|||
144262810|NCT02787304|520163742|FG000|Overall Study|Study terminated by sponsor|25|||
144206947|NCT04628793|519952412|FG000|Overall Study|Lost to Follow-up|0|||
144206948|NCT04628793|519952413|FG001|Overall Study|Lost to Follow-up|1|||
144206949|NCT04628793|519952414|FG002|Overall Study|Lost to Follow-up|0|||
144206950|NCT02278055|519952416|FG000|Overall Study|Adverse Event|1|||
144206951|NCT02278055|519952416|FG000|Overall Study|Lost to Follow-up|1|||
144206952|NCT02278055|519952416|FG000|Overall Study|Withdrawal by Subject|2|||
144206953|NCT02278055|519952416|FG000|Overall Study|Progressive Disease|4|||
144206954|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
144206955|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
144206956|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
144206957|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
144206958|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
144206959|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
144206960|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
144206961|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
144206962|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
144206963|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
144206964|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
144206965|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
144206966|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
144206967|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
144206968|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
144206969|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
144206970|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
144206971|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
144206972|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
144206973|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
144206974|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
144206975|NCT04040192|519952417|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
144206976|NCT04040192|519952418|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
144206977|NCT04040192|519952419|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
144569857|NCT00379769|521286220|FG001|Main Study|Risk of heart failure|1|||
144569858|NCT00379769|521286221|FG002|Main Study|Risk of heart failure|0|||
144569859|NCT00379769|521286222|FG003|Main Study|Risk of heart failure|0|||
144569860|NCT00379769|521286223|FG004|Main Study|Risk of heart failure|0|||
144569861|NCT00379769|521286224|FG005|Main Study|Risk of heart failure|0|||
144569862|NCT00379769|521286219|FG000|Main Study|Investigator refused to log temperature|0|||
144569863|NCT00379769|521286220|FG001|Main Study|Investigator refused to log temperature|0|||
144569864|NCT00379769|521286221|FG002|Main Study|Investigator refused to log temperature|1|||
144569865|NCT00379769|521286222|FG003|Main Study|Investigator refused to log temperature|0|||
144569866|NCT00379769|521286223|FG004|Main Study|Investigator refused to log temperature|0|||
144569867|NCT00379769|521286224|FG005|Main Study|Investigator refused to log temperature|0|||
144569868|NCT00379769|521286219|FG000|Main Study|Reason unspecified|0|||
144569869|NCT00379769|521286220|FG001|Main Study|Reason unspecified|0|||
144569870|NCT00379769|521286221|FG002|Main Study|Reason unspecified|1|||
144569871|NCT00379769|521286222|FG003|Main Study|Reason unspecified|0|||
144569872|NCT00379769|521286223|FG004|Main Study|Reason unspecified|0|||
144569873|NCT00379769|521286224|FG005|Main Study|Reason unspecified|0|||
144569874|NCT00379769|521286219|FG000|Observational Follow-up|Death|0|||
144569875|NCT00379769|521286220|FG001|Observational Follow-up|Death|0|||
144569876|NCT00379769|521286221|FG002|Observational Follow-up|Death|0|||
144569877|NCT00379769|521286222|FG003|Observational Follow-up|Death|0|||
144569878|NCT00379769|521286223|FG004|Observational Follow-up|Death|78|||
144569879|NCT00379769|521286224|FG005|Observational Follow-up|Death|70|||
144569880|NCT00379769|521286219|FG000|Observational Follow-up|Adverse Event|0|||
144569881|NCT00379769|521286220|FG001|Observational Follow-up|Adverse Event|0|||
144569882|NCT00379769|521286221|FG002|Observational Follow-up|Adverse Event|0|||
144569883|NCT00379769|521286222|FG003|Observational Follow-up|Adverse Event|0|||
144569884|NCT00379769|521286223|FG004|Observational Follow-up|Adverse Event|1|||
144569885|NCT00379769|521286224|FG005|Observational Follow-up|Adverse Event|0|||
144569886|NCT00379769|521286219|FG000|Observational Follow-up|Lost to Follow-up|0|||
144569887|NCT00379769|521286220|FG001|Observational Follow-up|Lost to Follow-up|0|||
144569888|NCT00379769|521286221|FG002|Observational Follow-up|Lost to Follow-up|0|||
144569889|NCT00379769|521286222|FG003|Observational Follow-up|Lost to Follow-up|0|||
144206978|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
144569890|NCT00379769|521286223|FG004|Observational Follow-up|Lost to Follow-up|25|||
144569891|NCT00379769|521286224|FG005|Observational Follow-up|Lost to Follow-up|27|||
144569892|NCT00379769|521286219|FG000|Observational Follow-up|Withdrawal by Subject|0|||
144569893|NCT00379769|521286220|FG001|Observational Follow-up|Withdrawal by Subject|0|||
144569894|NCT00379769|521286221|FG002|Observational Follow-up|Withdrawal by Subject|0|||
144619896|NCT02425826|521466123|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
144619897|NCT02425826|521466124|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
144619898|NCT02425826|521466122|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
144619899|NCT02425826|521466123|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
144619900|NCT02425826|521466124|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
144619901|NCT02425826|521466122|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
144206979|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
144206980|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
144206981|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
144206982|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
144206983|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
144206984|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
144206985|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
144206986|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
144206987|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
144206988|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
144206989|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
144206990|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
144206991|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
144206992|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
144206993|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
144206994|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
144206995|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
144206996|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
144206997|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
144206998|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
144206999|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
144207000|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
144207001|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
144207002|NCT04040192|519952417|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
144207003|NCT04040192|519952418|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
144207004|NCT04040192|519952419|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
144207005|NCT00469144|519952420|FG000|Overall Study|Death|0|||
144207006|NCT00469144|519952421|FG001|Overall Study|Death|1|||
144207007|NCT00469144|519952420|FG000|Overall Study|No Response|5|||
144207008|NCT00469144|519952421|FG001|Overall Study|No Response|5|||
144207009|NCT00469144|519952420|FG000|Overall Study|Progressive Disease|1|||
144207010|NCT00469144|519952421|FG001|Overall Study|Progressive Disease|0|||
144207011|NCT01994291|519952422|FG000|Overall Study|Adverse Event|4|||
144207012|NCT01994291|519952423|FG001|Overall Study|Adverse Event|1|||
144207013|NCT01994291|519952424|FG002|Overall Study|Adverse Event|3|||
144207014|NCT01994291|519952422|FG000|Overall Study|Lost to Follow-up|1|||
144207015|NCT01994291|519952423|FG001|Overall Study|Lost to Follow-up|1|||
144207016|NCT01994291|519952424|FG002|Overall Study|Lost to Follow-up|0|||
144207017|NCT01994291|519952422|FG000|Overall Study|Does not meet entrance criteria|1|||
144207018|NCT01994291|519952423|FG001|Overall Study|Does not meet entrance criteria|0|||
144207019|NCT01994291|519952424|FG002|Overall Study|Does not meet entrance criteria|0|||
144207020|NCT01994291|519952422|FG000|Overall Study|Medication error without associated AE|1|||
144207021|NCT01994291|519952423|FG001|Overall Study|Medication error without associated AE|0|||
144207022|NCT01994291|519952424|FG002|Overall Study|Medication error without associated AE|1|||
144207023|NCT01994291|519952422|FG000|Overall Study|Protocol Violation|1|||
144207024|NCT01994291|519952423|FG001|Overall Study|Protocol Violation|0|||
144207025|NCT01994291|519952424|FG002|Overall Study|Protocol Violation|0|||
144207026|NCT01994291|519952422|FG000|Overall Study|Withdrawal by Subject|6|||
144207027|NCT01994291|519952423|FG001|Overall Study|Withdrawal by Subject|3|||
144207028|NCT01994291|519952424|FG002|Overall Study|Withdrawal by Subject|5|||
144207029|NCT01994291|519952422|FG000|Overall Study|Other|1|||
144207030|NCT01994291|519952423|FG001|Overall Study|Other|2|||
144207031|NCT01994291|519952424|FG002|Overall Study|Other|0|||
144207032|NCT00856375|519952425|FG000|Overall Study|Other|0|||
144207033|NCT00856375|519952426|FG001|Overall Study|Other|1|||
144207034|NCT00856375|519952425|FG000|Overall Study|Death|32|||
144207035|NCT00856375|519952426|FG001|Overall Study|Death|30|||
144207036|NCT00856375|519952425|FG000|Overall Study|Sponsor Terminated Study|7|||
144207037|NCT00856375|519952426|FG001|Overall Study|Sponsor Terminated Study|7|||
144207038|NCT00856375|519952425|FG000|Overall Study|Withdrawal by Subject|2|||
144207039|NCT00856375|519952426|FG001|Overall Study|Withdrawal by Subject|1|||
144207040|NCT00856375|519952425|FG000|Overall Study|Lost to Follow-up|1|||
144207041|NCT00856375|519952426|FG001|Overall Study|Lost to Follow-up|2|||
144207042|NCT02121392|519952427|FG000|Prior to Intervention|Protocol Violation|40|||
144207043|NCT02121392|519952428|FG001|Prior to Intervention|Protocol Violation|35|||
144207044|NCT02121392|519952427|FG000|Prior to Intervention|Withdrawal by Subject|8|||
144569895|NCT00379769|521286222|FG003|Observational Follow-up|Withdrawal by Subject|0|||
144569896|NCT00379769|521286223|FG004|Observational Follow-up|Withdrawal by Subject|12|||
144569897|NCT00379769|521286224|FG005|Observational Follow-up|Withdrawal by Subject|12|||
144569898|NCT00379769|521286219|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
144569899|NCT00379769|521286220|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
144569900|NCT00379769|521286221|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
144569901|NCT00379769|521286222|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
144569902|NCT00379769|521286223|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
144569903|NCT00379769|521286224|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
144569904|NCT00379769|521286219|FG000|Observational Follow-up|Physician Decision|0|||
144569905|NCT00379769|521286220|FG001|Observational Follow-up|Physician Decision|0|||
144569906|NCT00379769|521286221|FG002|Observational Follow-up|Physician Decision|0|||
144569907|NCT00379769|521286222|FG003|Observational Follow-up|Physician Decision|0|||
144569908|NCT00379769|521286223|FG004|Observational Follow-up|Physician Decision|8|||
144569909|NCT00379769|521286224|FG005|Observational Follow-up|Physician Decision|8|||
144569910|NCT00379769|521286219|FG000|Observational Follow-up|Site Closed Early|0|||
144619902|NCT02425826|521466123|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
144619903|NCT02425826|521466124|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
144619904|NCT02425826|521466122|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
144619905|NCT02425826|521466123|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
144619906|NCT02425826|521466124|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
144619907|NCT02049944|521467624|FG000|Overall Study|Protocol Violation|2|||
144619908|NCT01765673|521467625|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
144619909|NCT01284114|521467626|FG000|Overall Study|viral infection|1|||
144619910|NCT01284114|521467626|FG000|Overall Study|From the results of ALLTITUDE study|1|||
144619911|NCT01284114|521467626|FG000|Overall Study|Symptomatic hypotension|1|||
144619912|NCT01284114|521467626|FG000|Overall Study|dizziness|1|||
144619913|NCT03409744|521467627|FG000|Overall Study|Death|2|||
144619914|NCT03409744|521467627|FG000|Overall Study|Physician Decision|5|||
144619915|NCT03409744|521467627|FG000|Overall Study|Pregnancy|1|||
144619916|NCT03409744|521467627|FG000|Overall Study|Lost to Follow-up|1|||
144619917|NCT03409744|521467627|FG000|Overall Study|Protocol Violation|1|||
144619918|NCT04872101|521467629|FG000|Overall Study|Withdrawal by Subject|10|||
144619919|NCT04872101|521467630|FG001|Overall Study|Withdrawal by Subject|16|||
144619920|NCT04872101|521467629|FG000|Overall Study|Lack of Efficacy|6|||
144619921|NCT04872101|521467630|FG001|Overall Study|Lack of Efficacy|14|||
144619922|NCT04872101|521467629|FG000|Overall Study|Adverse Event|1|||
144619923|NCT04872101|521467630|FG001|Overall Study|Adverse Event|6|||
144619924|NCT04872101|521467629|FG000|Overall Study|Lost to Follow-up|2|||
144619925|NCT04872101|521467630|FG001|Overall Study|Lost to Follow-up|1|||
144619926|NCT04872101|521467629|FG000|Overall Study|Pregnancy|2|||
144619927|NCT04872101|521467630|FG001|Overall Study|Pregnancy|0|||
144619928|NCT04872101|521467629|FG000|Overall Study|Prohibited Medication|1|||
144619929|NCT04872101|521467630|FG001|Overall Study|Prohibited Medication|0|||
144619930|NCT04872101|521467629|FG000|Overall Study|Not dosed|1|||
144619931|NCT04872101|521467630|FG001|Overall Study|Not dosed|0|||
144619932|NCT00264004|521467631|FG000|Overall Study|Adverse Event|2|||
144619933|NCT00264004|521467632|FG001|Overall Study|Adverse Event|3|||
144619934|NCT00264004|521467633|FG002|Overall Study|Adverse Event|6|||
144619935|NCT00264004|521467634|FG003|Overall Study|Adverse Event|4|||
144619936|NCT00264004|521467631|FG000|Overall Study|Withdrawal by Subject|0|||
144569911|NCT00379769|521286220|FG001|Observational Follow-up|Site Closed Early|0|||
144619937|NCT00264004|521467632|FG001|Overall Study|Withdrawal by Subject|1|||
144619938|NCT00264004|521467633|FG002|Overall Study|Withdrawal by Subject|2|||
144569912|NCT00379769|521286221|FG002|Observational Follow-up|Site Closed Early|0|||
144569913|NCT00379769|521286222|FG003|Observational Follow-up|Site Closed Early|0|||
144569914|NCT00379769|521286223|FG004|Observational Follow-up|Site Closed Early|6|||
144569915|NCT00379769|521286224|FG005|Observational Follow-up|Site Closed Early|7|||
144569916|NCT00379769|521286219|FG000|Observational Follow-up|Participant Moved|0|||
144619939|NCT00264004|521467634|FG003|Overall Study|Withdrawal by Subject|2|||
144619940|NCT00264004|521467631|FG000|Overall Study|Other|2|||
144619941|NCT00264004|521467632|FG001|Overall Study|Other|2|||
144619942|NCT00264004|521467633|FG002|Overall Study|Other|0|||
144207045|NCT02121392|519952428|FG001|Prior to Intervention|Withdrawal by Subject|6|||
144569917|NCT00379769|521286220|FG001|Observational Follow-up|Participant Moved|0|||
144569918|NCT00379769|521286221|FG002|Observational Follow-up|Participant Moved|0|||
144569919|NCT00379769|521286222|FG003|Observational Follow-up|Participant Moved|0|||
144619943|NCT00264004|521467634|FG003|Overall Study|Other|3|||
144619944|NCT00264004|521467631|FG000|Overall Study|Development study specific disc. crit.|1|||
144619945|NCT00264004|521467632|FG001|Overall Study|Development study specific disc. crit.|0|||
144619946|NCT00264004|521467633|FG002|Overall Study|Development study specific disc. crit.|1|||
144619947|NCT00264004|521467634|FG003|Overall Study|Development study specific disc. crit.|0|||
144619948|NCT00264004|521467631|FG000|Overall Study|Cond. under inv. worsened|9|||
144619949|NCT00264004|521467632|FG001|Overall Study|Cond. under inv. worsened|5|||
144262811|NCT02787304|520163743|FG001|Overall Study|Study terminated by sponsor|31|||
144262812|NCT02787304|520163744|FG002|Overall Study|Study terminated by sponsor|31|||
144262813|NCT02787304|520163745|FG003|Overall Study|Study terminated by sponsor|32|||
144262814|NCT04771013|520163746|FG000|Overall Study|Withdrawal by Subject|2|||
144262815|NCT04771013|520163747|FG001|Overall Study|Withdrawal by Subject|0|||
144262816|NCT04771013|520163746|FG000|Overall Study|Death|0|||
144262817|NCT04771013|520163747|FG001|Overall Study|Death|5|||
144262818|NCT04771013|520163746|FG000|Overall Study|Referred to another hospital before day 20|0|||
144262819|NCT04771013|520163747|FG001|Overall Study|Referred to another hospital before day 20|1|||
144262820|NCT00419757|520163752|FG000|Overall Study|Adverse Event|1|||
144262821|NCT00419757|520163753|FG001|Overall Study|Adverse Event|4|||
144619950|NCT00264004|521467633|FG002|Overall Study|Cond. under inv. worsened|3|||
144619951|NCT00264004|521467634|FG003|Overall Study|Cond. under inv. worsened|4|||
144619952|NCT00264004|521467631|FG000|Overall Study|Not treated|3|||
144619953|NCT00264004|521467632|FG001|Overall Study|Not treated|0|||
144619954|NCT00264004|521467633|FG002|Overall Study|Not treated|2|||
144619955|NCT00264004|521467634|FG003|Overall Study|Not treated|2|||
144619956|NCT03691974|521467635|FG000|Overall Study|Physician Decision|1|||
144619957|NCT03691974|521467636|FG001|Overall Study|Physician Decision|0|||
144619958|NCT03691974|521467635|FG000|Overall Study|Adverse Event|1|||
144619959|NCT03691974|521467636|FG001|Overall Study|Adverse Event|0|||
144619960|NCT03691974|521467635|FG000|Overall Study|Withdrawal by Subject|11|||
144619961|NCT03691974|521467636|FG001|Overall Study|Withdrawal by Subject|9|||
144619962|NCT03691974|521467635|FG000|Overall Study|Protocol Violation|1|||
144619963|NCT03691974|521467636|FG001|Overall Study|Protocol Violation|0|||
144619964|NCT03691974|521467635|FG000|Overall Study|Lost to Follow-up|8|||
144619965|NCT03691974|521467636|FG001|Overall Study|Lost to Follow-up|7|||
144619966|NCT00691483|521467637|FG000|Overall Study|Adverse Event|14|||
144619967|NCT00691483|521467638|FG001|Overall Study|Adverse Event|6|||
144619968|NCT00691483|521467637|FG000|Overall Study|Lost to Follow-up|17|||
144619969|NCT00691483|521467638|FG001|Overall Study|Lost to Follow-up|10|||
144619970|NCT00691483|521467637|FG000|Overall Study|Withdrawal by Subject|24|||
144619971|NCT00691483|521467638|FG001|Overall Study|Withdrawal by Subject|7|||
144619972|NCT00691483|521467637|FG000|Overall Study|Other known cause|6|||
144619973|NCT00691483|521467638|FG001|Overall Study|Other known cause|1|||
144619974|NCT00691483|521467637|FG000|Overall Study|Randomized by not treated|7|||
144619975|NCT00691483|521467638|FG001|Overall Study|Randomized by not treated|1|||
144619976|NCT03860961|521467640|FG000|Overall Study|Withdrawal by Subject|6|||
144619977|NCT03860961|521467641|FG001|Overall Study|Withdrawal by Subject|11|||
144619978|NCT03860961|521467640|FG000|Overall Study|Death|10|||
144619979|NCT03860961|521467641|FG001|Overall Study|Death|6|||
144619980|NCT03860961|521467640|FG000|Overall Study|Incomplete two-year data|4|||
144619981|NCT03860961|521467641|FG001|Overall Study|Incomplete two-year data|0|||
144619982|NCT02475681|521467642|FG000|Overall Study|Death|16|||
144619983|NCT02475681|521467643|FG001|Overall Study|Death|6|||
144619984|NCT02475681|521467644|FG002|Overall Study|Death|9|||
144619985|NCT02475681|521467642|FG000|Overall Study|Physician Decision|0|||
144619986|NCT02475681|521467643|FG001|Overall Study|Physician Decision|3|||
144619987|NCT02475681|521467644|FG002|Overall Study|Physician Decision|1|||
144619988|NCT02475681|521467642|FG000|Overall Study|Withdrawal by Subject|12|||
144619989|NCT02475681|521467643|FG001|Overall Study|Withdrawal by Subject|6|||
144262822|NCT00419757|520163752|FG000|Overall Study|Lost to Follow-up|1|||
144262823|NCT00419757|520163753|FG001|Overall Study|Lost to Follow-up|4|||
144262824|NCT00419757|520163752|FG000|Overall Study|Withdrawal by Subject|7|||
144569920|NCT00379769|521286223|FG004|Observational Follow-up|Participant Moved|0|||
144569921|NCT00379769|521286224|FG005|Observational Follow-up|Participant Moved|1|||
144569922|NCT00379769|521286219|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
144569923|NCT00379769|521286220|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
144569924|NCT00379769|521286221|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
144569925|NCT00379769|521286222|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
144569926|NCT00379769|521286223|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
144569927|NCT00379769|521286224|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
144569928|NCT03778294|521286225|FG000|Overall Study|Death|1|||
144569929|NCT03778294|521286225|FG000|Overall Study|Issues with insurance|1|||
144569930|NCT03778294|521286225|FG000|Overall Study|disease progression before treatment|2|||
144569931|NCT02825251|521286226|FG000|Overall Study|Adverse Event|0|||
144569932|NCT02825251|521286227|FG001|Overall Study|Adverse Event|1|||
144569933|NCT02825251|521286226|FG000|Overall Study|Lost to Follow-up|0|||
144619990|NCT02475681|521467644|FG002|Overall Study|Withdrawal by Subject|9|||
144619991|NCT02475681|521467642|FG000|Overall Study|Lost to Follow-up|2|||
144619992|NCT02475681|521467643|FG001|Overall Study|Lost to Follow-up|1|||
144619993|NCT02475681|521467644|FG002|Overall Study|Lost to Follow-up|3|||
144619994|NCT02475681|521467642|FG000|Overall Study|Ongoing in Study|0|||
144619995|NCT02475681|521467643|FG001|Overall Study|Ongoing in Study|163|||
144619996|NCT02475681|521467644|FG002|Overall Study|Ongoing in Study|157|||
144619997|NCT02475681|521467642|FG000|Overall Study|Reasons other than above listed|2|||
144619998|NCT02475681|521467643|FG001|Overall Study|Reasons other than above listed|0|||
144619999|NCT02475681|521467644|FG002|Overall Study|Reasons other than above listed|0|||
144728854|NCT00048568|521863160|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
144728855|NCT00048568|521863161|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
144728856|NCT00048568|521863159|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
144728857|NCT00048568|521863160|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
144728858|NCT00048568|521863161|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
144728859|NCT00048568|521863159|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
144728860|NCT00048568|521863160|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
144728861|NCT00048568|521863161|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
144728862|NCT00048568|521863159|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
144728863|NCT00048568|521863160|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
144728864|NCT00048568|521863161|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
144728865|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|Death|1|||
144728866|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|Death|1|||
144728867|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|Death|0|||
144728868|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
144728869|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
144728870|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
144728871|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
144728872|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
144728873|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
144728874|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
144728875|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
144728876|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
144728877|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
144728878|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
144728879|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
144728880|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
144728881|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
144728882|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
144728883|NCT00048568|521863159|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
144728884|NCT00048568|521863160|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
144728885|NCT00048568|521863161|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
144728886|NCT00048568|521863159|FG000|Open-Label Period|Death|0|||
144728887|NCT00048568|521863160|FG001|Open-Label Period|Death|0|||
144728888|NCT00048568|521863161|FG002|Open-Label Period|Death|13|||
144728889|NCT00048568|521863159|FG000|Open-Label Period|Adverse Event|0|||
144728890|NCT00048568|521863160|FG001|Open-Label Period|Adverse Event|0|||
144728891|NCT00048568|521863161|FG002|Open-Label Period|Adverse Event|49|||
144728892|NCT00048568|521863159|FG000|Open-Label Period|Lack of Efficacy|0|||
144728893|NCT00048568|521863160|FG001|Open-Label Period|Lack of Efficacy|0|||
144728894|NCT00048568|521863161|FG002|Open-Label Period|Lack of Efficacy|32|||
144728895|NCT00048568|521863159|FG000|Open-Label Period|Withdrawal by Subject|0|||
144728896|NCT00048568|521863160|FG001|Open-Label Period|Withdrawal by Subject|0|||
144728897|NCT00048568|521863161|FG002|Open-Label Period|Withdrawal by Subject|26|||
144728898|NCT00048568|521863159|FG000|Open-Label Period|Pregnancy|0|||
144728899|NCT00048568|521863160|FG001|Open-Label Period|Pregnancy|0|||
144728900|NCT00048568|521863161|FG002|Open-Label Period|Pregnancy|5|||
144728901|NCT00048568|521863159|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
144728902|NCT00048568|521863160|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
144728903|NCT00048568|521863161|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
144728904|NCT00048568|521863159|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
144728905|NCT00048568|521863160|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
144728906|NCT00048568|521863161|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
144728907|NCT00048568|521863159|FG000|Open-Label Period|Unknown Reasons|0|||
144728908|NCT00048568|521863160|FG001|Open-Label Period|Unknown Reasons|0|||
144728909|NCT00048568|521863161|FG002|Open-Label Period|Unknown Reasons|25|||
144728910|NCT00048568|521863159|FG000|Open-Label Period|Lost to Follow-up|0|||
144728911|NCT00048568|521863160|FG001|Open-Label Period|Lost to Follow-up|0|||
144728912|NCT00048568|521863161|FG002|Open-Label Period|Lost to Follow-up|7|||
144728913|NCT03831048|521863162|FG000|Overall Study|Protocol Violation|9|||
144728914|NCT03831048|521863163|FG001|Overall Study|Protocol Violation|3|||
144728915|NCT03831048|521863162|FG000|Overall Study|Death|4|||
144728916|NCT03831048|521863163|FG001|Overall Study|Death|9|||
144728917|NCT03831048|521863162|FG000|Overall Study|Re-transplant|0|||
144207046|NCT02121392|519952427|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
144207047|NCT02121392|519952428|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
144207048|NCT02121392|519952427|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
144207049|NCT02121392|519952428|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
144728918|NCT03831048|521863163|FG001|Overall Study|Re-transplant|2|||
144728919|NCT03831048|521863162|FG000|Overall Study|Protocol violation and death|1|||
144728920|NCT03831048|521863163|FG001|Overall Study|Protocol violation and death|1|||
144728921|NCT01315249|521863168|FG000|Overall Study|Adverse Event|22|||
144620000|NCT02105454|521467657|FG000|Overall Study|Withdrawal by Subject|1|||
144620001|NCT00493870|521467658|FG000|Overall Study|Lost to Follow-up|12|||
144620002|NCT00493870|521467659|FG001|Overall Study|Lost to Follow-up|15|||
144620003|NCT02721355|521467660|FG000|Overall Study|Lost to Follow-up|6|||
144620004|NCT02721355|521467661|FG001|Overall Study|Lost to Follow-up|1|||
144620005|NCT00883337|521467664|FG000|Core Treatment Period|Adverse Event|9|||
144620006|NCT00883337|521467665|FG001|Core Treatment Period|Adverse Event|12|||
144620007|NCT00883337|521467666|FG002|Core Treatment Period|Adverse Event|22|||
144620008|NCT00883337|521467664|FG000|Core Treatment Period|Lack of Efficacy|7|||
144620009|NCT00883337|521467665|FG001|Core Treatment Period|Lack of Efficacy|4|||
144620010|NCT00883337|521467666|FG002|Core Treatment Period|Lack of Efficacy|2|||
144620011|NCT00883337|521467664|FG000|Core Treatment Period|Lost to Follow-up|1|||
144620012|NCT00883337|521467665|FG001|Core Treatment Period|Lost to Follow-up|1|||
144620013|NCT00883337|521467666|FG002|Core Treatment Period|Lost to Follow-up|0|||
144620014|NCT00883337|521467664|FG000|Core Treatment Period|Withdrawal by Subject|2|||
144620015|NCT00883337|521467665|FG001|Core Treatment Period|Withdrawal by Subject|2|||
144620016|NCT00883337|521467666|FG002|Core Treatment Period|Withdrawal by Subject|6|||
144620017|NCT00883337|521467664|FG000|Core Treatment Period|Wish to be pregnant|1|||
144620018|NCT00883337|521467665|FG001|Core Treatment Period|Wish to be pregnant|2|||
144620019|NCT00883337|521467666|FG002|Core Treatment Period|Wish to be pregnant|1|||
144620020|NCT00883337|521467664|FG000|Core Treatment Period|Poor compliance to protocol|0|||
144620021|NCT00883337|521467665|FG001|Core Treatment Period|Poor compliance to protocol|0|||
144620022|NCT00883337|521467666|FG002|Core Treatment Period|Poor compliance to protocol|1|||
144620023|NCT00883337|521467664|FG000|Core Treatment Period|Other than above|0|||
144620024|NCT00883337|521467665|FG001|Core Treatment Period|Other than above|1|||
144620025|NCT00883337|521467666|FG002|Core Treatment Period|Other than above|1|||
144620026|NCT00883337|521467664|FG000|Extension Treatment Period|Adverse Event|8|||
144620027|NCT00883337|521467665|FG001|Extension Treatment Period|Adverse Event|5|||
144620028|NCT00883337|521467666|FG002|Extension Treatment Period|Adverse Event|5|||
144620029|NCT00883337|521467664|FG000|Extension Treatment Period|Lack of Efficacy|8|||
144620030|NCT00883337|521467665|FG001|Extension Treatment Period|Lack of Efficacy|8|||
144620031|NCT00883337|521467666|FG002|Extension Treatment Period|Lack of Efficacy|8|||
144620032|NCT00883337|521467664|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
144620033|NCT00883337|521467665|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
144620034|NCT00883337|521467666|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
144620035|NCT00883337|521467664|FG000|Extension Treatment Period|Lost to Follow-up|1|||
144620036|NCT00883337|521467665|FG001|Extension Treatment Period|Lost to Follow-up|0|||
144620037|NCT00883337|521467666|FG002|Extension Treatment Period|Lost to Follow-up|0|||
144620038|NCT00883337|521467664|FG000|Extension Treatment Period|Other than above|10|||
144620039|NCT00883337|521467665|FG001|Extension Treatment Period|Other than above|9|||
144620040|NCT00883337|521467666|FG002|Extension Treatment Period|Other than above|5|||
144620041|NCT01652287|521467667|FG000|Overall Study|Withdrawal by Subject|2|||
144620042|NCT01652287|521467668|FG001|Overall Study|Withdrawal by Subject|0|||
144620043|NCT00763139|521467675|FG000|Overall Study|Adverse Event|4|||
144620044|NCT00763139|521467676|FG001|Overall Study|Adverse Event|2|||
144569934|NCT02825251|521286227|FG001|Overall Study|Lost to Follow-up|1|||
144569935|NCT02825251|521286226|FG000|Overall Study|Withdrawal by Subject|1|||
144569936|NCT02825251|521286227|FG001|Overall Study|Withdrawal by Subject|4|||
144569937|NCT02825251|521286226|FG000|Overall Study|Unclassified|2|||
144728922|NCT01315249|521863169|FG001|Overall Study|Adverse Event|26|||
144728923|NCT01315249|521863168|FG000|Overall Study|Withdrawal by Subject|11|||
144728924|NCT01315249|521863169|FG001|Overall Study|Withdrawal by Subject|10|||
144569938|NCT02825251|521286227|FG001|Overall Study|Unclassified|0|||
144569939|NCT01689363|521286236|FG000|Overall Study|Protocol Violation|0|||
144569940|NCT01689363|521286237|FG001|Overall Study|Protocol Violation|1|||
144569941|NCT01689363|521286238|FG002|Overall Study|Protocol Violation|0|||
144569942|NCT01689363|521286239|FG003|Overall Study|Protocol Violation|0|||
144569943|NCT01689363|521286240|FG004|Overall Study|Protocol Violation|0|||
144569944|NCT01689363|521286241|FG005|Overall Study|Protocol Violation|0|||
144569945|NCT01689363|521286242|FG006|Overall Study|Protocol Violation|0|||
144569946|NCT01689363|521286243|FG007|Overall Study|Protocol Violation|0|||
144569947|NCT02104505|521286244|FG000|First Intervention (14 Days)|Adverse Event|2|||
144569948|NCT02104505|521286245|FG001|First Intervention (14 Days)|Adverse Event|0|||
144569949|NCT02104505|521286244|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
144569950|NCT02104505|521286245|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
144569951|NCT02104505|521286244|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
144569952|NCT02104505|521286245|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
144569953|NCT02104505|521286244|FG000|First Intervention (14 Days)|exclusionary condition|0|||
144569954|NCT02104505|521286245|FG001|First Intervention (14 Days)|exclusionary condition|1|||
144569955|NCT02104505|521286244|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
144569956|NCT02104505|521286245|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
144569957|NCT02104505|521286244|FG000|Second Intervention (14 Days)|Adverse Event|2|||
144569958|NCT02104505|521286245|FG001|Second Intervention (14 Days)|Adverse Event|0|||
144620045|NCT00763139|521467675|FG000|Overall Study|Withdrawal by Subject|0|||
144620046|NCT00763139|521467676|FG001|Overall Study|Withdrawal by Subject|1|||
144620047|NCT00763139|521467675|FG000|Overall Study|med change not allowed by protocol|1|||
144620048|NCT00763139|521467676|FG001|Overall Study|med change not allowed by protocol|0|||
144620049|NCT01592760|521467677|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
144620050|NCT01592760|521467678|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
144620051|NCT01592760|521467679|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
144620052|NCT04312009|521467680|FG000|Overall Study|Withdrawal by Subject|2|||
144620053|NCT04312009|521467681|FG001|Overall Study|Withdrawal by Subject|1|||
144620054|NCT01363986|521467684|FG000|Overall Study|Disease progression|1|||
144620055|NCT01637142|521467685|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
144620056|NCT02354703|521467686|FG000|Overall Study|Withdrawal by Subject|1|||
144620057|NCT02354703|521467687|FG001|Overall Study|Withdrawal by Subject|1|||
144620058|NCT02354703|521467688|FG002|Overall Study|Withdrawal by Subject|1|||
144620059|NCT02354703|521467689|FG003|Overall Study|Withdrawal by Subject|1|||
144620060|NCT02354703|521467686|FG000|Overall Study|Lost to Follow-up|2|||
144620061|NCT02354703|521467687|FG001|Overall Study|Lost to Follow-up|7|||
144620062|NCT02354703|521467688|FG002|Overall Study|Lost to Follow-up|9|||
144620063|NCT02354703|521467689|FG003|Overall Study|Lost to Follow-up|2|||
144620064|NCT02354703|521467686|FG000|Overall Study|Adverse Event|0|||
144620065|NCT02354703|521467687|FG001|Overall Study|Adverse Event|0|||
144620066|NCT02354703|521467688|FG002|Overall Study|Adverse Event|1|||
144620067|NCT02354703|521467689|FG003|Overall Study|Adverse Event|0|||
144620068|NCT04681170|521467694|FG000|Stratified Enrolment & run-in|Death|1|||
144620069|NCT04681170|521467695|FG001|Stratified Enrolment & run-in|Death|0|||
144620070|NCT04681170|521467694|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
144620071|NCT04681170|521467695|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
144620072|NCT04681170|521467694|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
144620073|NCT04681170|521467695|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
144620074|NCT04681170|521467694|FG000|Open Label Efficacy Phase|Adverse Event|0|||
144620075|NCT04681170|521467695|FG001|Open Label Efficacy Phase|Adverse Event|2|||
144620076|NCT04681170|521467694|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
144620077|NCT04681170|521467695|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
144620078|NCT04681170|521467694|FG000|Open Label Safety Phase|AEs and none compliance|0|||
144620079|NCT04681170|521467695|FG001|Open Label Safety Phase|AEs and none compliance|1|||
144620080|NCT02468648|521467696|FG000|Overall Study|Death|1|||
144620081|NCT05131204|521467697|FG000|Overall Study|Sponsor request|2|||
144620082|NCT05131204|521467698|FG001|Overall Study|Sponsor request|1|||
144620083|NCT04232696|521467699|FG000|Overall Study|Implant attempted but not completed|5|||
144620084|NCT04232696|521467700|FG001|Overall Study|Implant attempted but not completed|2|||
144620085|NCT04232696|521467699|FG000|Overall Study|Not satisfied with therapy outcome|0|||
144620086|NCT04232696|521467700|FG001|Overall Study|Not satisfied with therapy outcome|8|||
144620087|NCT04232696|521467699|FG000|Overall Study|Adverse Event|0|||
144620088|NCT04232696|521467700|FG001|Overall Study|Adverse Event|3|||
144620089|NCT04232696|521467699|FG000|Overall Study|Withdrawal by Subject|0|||
144620090|NCT04232696|521467700|FG001|Overall Study|Withdrawal by Subject|3|||
144620091|NCT04232696|521467699|FG000|Overall Study|Missed Visit|0|||
144620092|NCT04232696|521467700|FG001|Overall Study|Missed Visit|2|||
144620093|NCT04232696|521467699|FG000|Overall Study|Other reason|0|||
144620094|NCT04232696|521467700|FG001|Overall Study|Other reason|1|||
144728925|NCT01315249|521863168|FG000|Overall Study|Protocol Violation|8|||
144728926|NCT01315249|521863169|FG001|Overall Study|Protocol Violation|5|||
144207050|NCT01228019|519952433|FG000|Overall Study|Dose Violation|70|||
144207051|NCT01228019|519952433|FG000|Overall Study|Duplicate enrollment|1|||
144207052|NCT01228019|519952433|FG000|Overall Study|Missing pre-treatment data|72|||
144620095|NCT02787863|521467701|FG000|Overall Study|Death|1|||
144620096|NCT02787863|521467702|FG001|Overall Study|Death|0|||
144620097|NCT02787863|521467703|FG002|Overall Study|Death|1|||
144207053|NCT01228019|519952433|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
144207054|NCT01228019|519952433|FG000|Overall Study|Violation of Entry Criterion|9|||
144207055|NCT01292226|519952436|FG000|Overall Study|Adverse Event|5|||
144207056|NCT01292226|519952436|FG000|Overall Study|Death|1|||
144207057|NCT01292226|519952436|FG000|Overall Study|Graft loss|1|||
144207058|NCT01292226|519952436|FG000|Overall Study|Protocol Violation|3|||
144207059|NCT01292226|519952436|FG000|Overall Study|Withdrawal by Subject|1|||
144620098|NCT02787863|521467704|FG003|Overall Study|Death|0|||
144620099|NCT02787863|521467705|FG004|Overall Study|Death|0|||
144620100|NCT02787863|521467706|FG005|Overall Study|Death|0|||
144620101|NCT02787863|521467707|FG006|Overall Study|Death|0|||
144620102|NCT02787863|521467708|FG007|Overall Study|Death|0|||
144620103|NCT02787863|521467701|FG000|Overall Study|Withdrawal by Subject|0|||
144620104|NCT02787863|521467702|FG001|Overall Study|Withdrawal by Subject|1|||
144620105|NCT02787863|521467703|FG002|Overall Study|Withdrawal by Subject|1|||
144620106|NCT02787863|521467704|FG003|Overall Study|Withdrawal by Subject|0|||
144620107|NCT02787863|521467705|FG004|Overall Study|Withdrawal by Subject|0|||
144620108|NCT02787863|521467706|FG005|Overall Study|Withdrawal by Subject|0|||
144620109|NCT02787863|521467707|FG006|Overall Study|Withdrawal by Subject|0|||
144620110|NCT02787863|521467708|FG007|Overall Study|Withdrawal by Subject|0|||
144620111|NCT01368835|521467709|FG000|Overall Study|Inclusion criteria/photography quality|22|||
144620112|NCT01368835|521467709|FG000|Overall Study|Lost to Follow-up|11|||
144620113|NCT01678144|521467710|FG000|Stage 1: MAR Classic|Adverse Event|1|||
144620114|NCT03118297|521467711|FG000|Overall Study|Lost to Follow-up|0|||
144620115|NCT03118297|521467712|FG001|Overall Study|Lost to Follow-up|2|||
144569959|NCT01845805|521286246|FG000|Overall Study|Withdrawal by Subject|1|||
144569960|NCT01845805|521286247|FG001|Overall Study|Withdrawal by Subject|2|||
144569961|NCT01845805|521286246|FG000|Overall Study|Disease Progression|13|||
144569962|NCT01845805|521286247|FG001|Overall Study|Disease Progression|14|||
144569963|NCT01845805|521286246|FG000|Overall Study|Drug-related Toxicity|4|||
144569964|NCT01845805|521286247|FG001|Overall Study|Drug-related Toxicity|0|||
144569965|NCT00321685|521286250|FG000|Overall Study|Adverse Event|18|||
144569966|NCT00321685|521286250|FG000|Overall Study|Death|2|||
144620116|NCT02754726|521467713|FG000|Overall Study|Progressive Disease by RECIST|13|||
144620117|NCT02754726|521467713|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
144620118|NCT02754726|521467713|FG000|Overall Study|Clinical Disease Progression|5|||
144620119|NCT02754726|521467713|FG000|Overall Study|Adverse Event|3|||
144620120|NCT02754726|521467713|FG000|Overall Study|Withdrawal by Subject|1|||
144620121|NCT02754726|521467713|FG000|Overall Study|Tolerability|1|||
144620122|NCT01885000|521467714|FG000|Overall Study|Adverse Event|1|||
144620123|NCT01885000|521467715|FG001|Overall Study|Adverse Event|0|||
144620124|NCT01885000|521467714|FG000|Overall Study|Withdrawal by Subject|1|||
144620125|NCT01885000|521467715|FG001|Overall Study|Withdrawal by Subject|1|||
144620126|NCT01885000|521467714|FG000|Overall Study|Protocol Violation|0|||
144620127|NCT01885000|521467715|FG001|Overall Study|Protocol Violation|1|||
144620128|NCT02162732|521467716|FG000|Overall Study|Biopsy not performed.|18|||
144620129|NCT02363686|521467717|FG000|Overall Study|Withdrawal by Subject|22|||
144620130|NCT02363686|521467717|FG000|Overall Study|incomplete FEES examinations|13|||
144620131|NCT03446885|521467726|FG000|Overall Study|Lost to Follow-up|1|||
144620132|NCT03446885|521467727|FG001|Overall Study|Lost to Follow-up|0|||
144620133|NCT03446885|521467726|FG000|Overall Study|Did not complete entire visit|1|||
144620134|NCT03446885|521467727|FG001|Overall Study|Did not complete entire visit|0|||
144620135|NCT05882318|521467733|FG000|Overall Study|Withdrawal by Subject|1|||
144620136|NCT05882318|521467734|FG001|Overall Study|Withdrawal by Subject|0|||
144620137|NCT05882318|521467733|FG000|Overall Study|Protocol Violation|0|||
144620138|NCT05882318|521467734|FG001|Overall Study|Protocol Violation|1|||
144620139|NCT04735653|521467737|FG000|Overall Study|Lost to Follow-up|17|||
144620140|NCT04735653|521467738|FG001|Overall Study|Lost to Follow-up|7|||
144620141|NCT04735653|521467737|FG000|Overall Study|Withdrawal by Subject|8|||
144620142|NCT04735653|521467738|FG001|Overall Study|Withdrawal by Subject|2|||
144620143|NCT04735653|521467737|FG000|Overall Study|Death|0|||
144620144|NCT04735653|521467738|FG001|Overall Study|Death|2|||
144620145|NCT04735653|521467737|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
144620146|NCT04735653|521467738|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
144620147|NCT03557359|521467739|FG000|Dose 1: 240 mg|Adverse Event|1|||
144620148|NCT03557359|521467740|FG001|Dose 1: 240 mg|Adverse Event|0|||
144620149|NCT03092726|521467741|FG000|Overall Study|Adverse Event|3|||
144620150|NCT03092726|521467742|FG001|Overall Study|Adverse Event|10|||
144620151|NCT03092726|521467741|FG000|Overall Study|Lack of Efficacy|0|||
144620152|NCT03092726|521467742|FG001|Overall Study|Lack of Efficacy|1|||
144620153|NCT03092726|521467741|FG000|Overall Study|Lost to Follow-up|1|||
144620154|NCT03092726|521467742|FG001|Overall Study|Lost to Follow-up|0|||
144620155|NCT03092726|521467741|FG000|Overall Study|Withdrawal by Subject|5|||
144620156|NCT03092726|521467742|FG001|Overall Study|Withdrawal by Subject|3|||
144620157|NCT05980299|521467743|FG000|Overall Study|Death|28|||
144620158|NCT05980299|521467744|FG001|Overall Study|Death|0|||
144620159|NCT05980299|521467743|FG000|Overall Study|Discharged from Nursing Home|9|||
144620160|NCT05980299|521467744|FG001|Overall Study|Discharged from Nursing Home|0|||
144620161|NCT05980299|521467743|FG000|Overall Study|Lost to Follow-up|0|||
144620162|NCT05980299|521467744|FG001|Overall Study|Lost to Follow-up|10|||
144620163|NCT02264990|521467745|FG000|Overall Study|Death|255|||
144620164|NCT02264990|521467746|FG001|Overall Study|Death|250|||
144620165|NCT02264990|521467745|FG000|Overall Study|Withdrawal by Subject|4|||
144620166|NCT02264990|521467746|FG001|Overall Study|Withdrawal by Subject|5|||
144620167|NCT02264990|521467745|FG000|Overall Study|Lost to Follow-up|1|||
144620168|NCT02264990|521467746|FG001|Overall Study|Lost to Follow-up|3|||
144620169|NCT02264990|521467745|FG000|Overall Study|Other|0|||
144620170|NCT02264990|521467746|FG001|Overall Study|Other|1|||
144620171|NCT01294800|521467748|FG000|Overall Study|Adverse Event|7|||
144620172|NCT01294800|521467749|FG001|Overall Study|Adverse Event|6|||
144620173|NCT01294800|521467750|FG002|Overall Study|Adverse Event|12|||
144620174|NCT01294800|521467751|FG003|Overall Study|Adverse Event|5|||
144620175|NCT01294800|521467748|FG000|Overall Study|Subject Withdrew Consent|2|||
144620176|NCT01294800|521467749|FG001|Overall Study|Subject Withdrew Consent|2|||
144569967|NCT00321685|521286250|FG000|Overall Study|Withdrawal by Subject|8|||
144620177|NCT01294800|521467750|FG002|Overall Study|Subject Withdrew Consent|2|||
144569968|NCT00321685|521286250|FG000|Overall Study|Alternative therapy|1|||
144569969|NCT00321685|521286250|FG000|Overall Study|Complicating disese|1|||
144569970|NCT00321685|521286250|FG000|Overall Study|Other|5|||
144569971|NCT00321685|521286250|FG000|Overall Study|Not start protocol therapy|2|||
144569972|NCT00321685|521286250|FG000|Overall Study|Ineligible|2|||
144569973|NCT01986114|521286251|FG000|Overall Study|Adverse Event|59|||
144569974|NCT01986114|521286251|FG000|Overall Study|Lack of Efficacy|23|||
144569975|NCT01986114|521286251|FG000|Overall Study|Withdrawal by Subject|58|||
144569976|NCT01986114|521286251|FG000|Overall Study|Noncompliance|3|||
144569977|NCT01986114|521286251|FG000|Overall Study|Protocol Violation|1|||
144620178|NCT01294800|521467751|FG003|Overall Study|Subject Withdrew Consent|11|||
144620179|NCT01294800|521467748|FG000|Overall Study|Lost to Follow-up|0|||
144620180|NCT01294800|521467749|FG001|Overall Study|Lost to Follow-up|0|||
144620181|NCT01294800|521467750|FG002|Overall Study|Lost to Follow-up|1|||
144620182|NCT01294800|521467751|FG003|Overall Study|Lost to Follow-up|0|||
144620183|NCT01294800|521467748|FG000|Overall Study|Non-compliance With Protocol|0|||
144620184|NCT01294800|521467749|FG001|Overall Study|Non-compliance With Protocol|1|||
144620185|NCT01294800|521467750|FG002|Overall Study|Non-compliance With Protocol|1|||
144620186|NCT01294800|521467751|FG003|Overall Study|Non-compliance With Protocol|0|||
144620187|NCT01294800|521467748|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
144620188|NCT01294800|521467749|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
144620189|NCT01294800|521467750|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
144620190|NCT01294800|521467751|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
144620191|NCT01662895|521467758|FG000|Overall Study|Lost to Follow-up|0|||
144620192|NCT01662895|521467759|FG001|Overall Study|Lost to Follow-up|1|||
144620193|NCT01441063|521467760|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
144620194|NCT01441063|521467760|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
144620195|NCT00293579|521467769|FG000|Overall Study|Withdrawal by Subject|1|||
144620196|NCT01344876|521467771|FG000|Overall Study|Adverse Event|0|||
144620197|NCT01344876|521467772|FG001|Overall Study|Adverse Event|0|||
144620198|NCT01344876|521467773|FG002|Overall Study|Adverse Event|0|||
144620199|NCT01344876|521467774|FG003|Overall Study|Adverse Event|0|||
144620200|NCT01344876|521467775|FG004|Overall Study|Adverse Event|1|||
144620201|NCT01344876|521467771|FG000|Overall Study|Withdrawal by Subject|0|||
144620202|NCT01344876|521467772|FG001|Overall Study|Withdrawal by Subject|0|||
144620203|NCT01344876|521467773|FG002|Overall Study|Withdrawal by Subject|1|||
144620204|NCT01344876|521467774|FG003|Overall Study|Withdrawal by Subject|0|||
144620205|NCT01344876|521467775|FG004|Overall Study|Withdrawal by Subject|0|||
144620206|NCT01344876|521467771|FG000|Overall Study|Definite progression of primary disease|1|||
144620207|NCT01344876|521467772|FG001|Overall Study|Definite progression of primary disease|0|||
144620208|NCT01344876|521467773|FG002|Overall Study|Definite progression of primary disease|0|||
144620209|NCT01344876|521467774|FG003|Overall Study|Definite progression of primary disease|3|||
144620210|NCT01344876|521467775|FG004|Overall Study|Definite progression of primary disease|0|||
144620211|NCT04428424|521467776|FG000|Overall Study|Does not meet entrance criteria|132|||
144620212|NCT04428424|521467776|FG000|Overall Study|Lost to Follow-up|115|||
144620213|NCT05107765|521467777|FG000|Overall Study|Lost to Follow-up|4|||
144620214|NCT05107765|521467778|FG001|Overall Study|Lost to Follow-up|1|||
144620215|NCT05107765|521467777|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
144620216|NCT05107765|521467778|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
144620217|NCT05107765|521467777|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
144620218|NCT05107765|521467778|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
144620219|NCT01662440|521469568|FG000|Overall Study|Adverse Event|1|||
144620220|NCT01662440|521469569|FG001|Overall Study|Adverse Event|0|||
144620221|NCT01662440|521469570|FG002|Overall Study|Adverse Event|0|||
144620222|NCT01662440|521469571|FG003|Overall Study|Adverse Event|1|||
144620223|NCT01662440|521469568|FG000|Overall Study|Death|0|||
144620224|NCT01662440|521469569|FG001|Overall Study|Death|1|||
144620225|NCT01662440|521469570|FG002|Overall Study|Death|0|||
144620226|NCT01662440|521469571|FG003|Overall Study|Death|0|||
144620227|NCT01662440|521469568|FG000|Overall Study|Lost to Follow-up|2|||
144728927|NCT01315249|521863168|FG000|Overall Study|Abnormal test results|1|||
144569978|NCT01986114|521286251|FG000|Overall Study|Lost to Follow-up|5|||
144569979|NCT01986114|521286251|FG000|Overall Study|Other reason|7|||
144569980|NCT01190644|521286252|FG000|Overall Study|Death|2|||
144569981|NCT01190644|521286252|FG000|Overall Study|Disease progression|1|||
144620228|NCT01662440|521469569|FG001|Overall Study|Lost to Follow-up|2|||
144620229|NCT01662440|521469570|FG002|Overall Study|Lost to Follow-up|4|||
144620230|NCT01662440|521469571|FG003|Overall Study|Lost to Follow-up|1|||
144620231|NCT01662440|521469568|FG000|Overall Study|Subject moved to another country.|0|||
144620232|NCT01662440|521469569|FG001|Overall Study|Subject moved to another country.|1|||
144620233|NCT01662440|521469570|FG002|Overall Study|Subject moved to another country.|0|||
144620234|NCT01662440|521469571|FG003|Overall Study|Subject moved to another country.|0|||
144620235|NCT01662440|521469568|FG000|Overall Study|Protocol Violation|1|||
144620236|NCT01662440|521469569|FG001|Overall Study|Protocol Violation|0|||
144620237|NCT01662440|521469570|FG002|Overall Study|Protocol Violation|0|||
144569982|NCT02366143|521286253|FG000|Overall Study|Death|307|||
144620238|NCT01662440|521469571|FG003|Overall Study|Protocol Violation|0|||
144620239|NCT01662440|521469568|FG000|Overall Study|Withdrawal by Subject|5|||
144620240|NCT01662440|521469569|FG001|Overall Study|Withdrawal by Subject|2|||
144620241|NCT01662440|521469570|FG002|Overall Study|Withdrawal by Subject|2|||
144620242|NCT01662440|521469571|FG003|Overall Study|Withdrawal by Subject|2|||
144620243|NCT01745146|521469572|FG000|Overall Study|Withdrawal by Subject|1|||
144620244|NCT01745146|521469573|FG001|Overall Study|Withdrawal by Subject|3|||
144620245|NCT01745146|521469572|FG000|Overall Study|Lost to Follow-up|2|||
144620246|NCT01745146|521469573|FG001|Overall Study|Lost to Follow-up|0|||
144620247|NCT04623242|521469574|FG000|Overall Study|Withdrawal by Subject|7|||
144620248|NCT04623242|521469575|FG001|Overall Study|Withdrawal by Subject|12|||
144620249|NCT04623242|521469576|FG002|Overall Study|Withdrawal by Subject|5|||
144620250|NCT04623242|521469577|FG003|Overall Study|Withdrawal by Subject|7|||
144620251|NCT04623242|521469578|FG004|Overall Study|Withdrawal by Subject|0|||
144620252|NCT04623242|521469574|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
144620253|NCT04623242|521469575|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
144620254|NCT04623242|521469576|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
144620255|NCT04623242|521469577|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
144620256|NCT04623242|521469578|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
144620257|NCT04623242|521469574|FG000|Overall Study|Subject unblinded to mutation status|0|||
144620258|NCT04623242|521469575|FG001|Overall Study|Subject unblinded to mutation status|0|||
144620259|NCT04623242|521469576|FG002|Overall Study|Subject unblinded to mutation status|0|||
144620260|NCT04623242|521469577|FG003|Overall Study|Subject unblinded to mutation status|13|||
144620261|NCT04623242|521469578|FG004|Overall Study|Subject unblinded to mutation status|0|||
144620262|NCT00326898|521469579|FG000|Overall Study|Disease progression|52|||
144620263|NCT00326898|521469580|FG001|Overall Study|Disease progression|54|||
144620264|NCT00326898|521469581|FG002|Overall Study|Disease progression|102|||
144620265|NCT00326898|521469579|FG000|Overall Study|Adverse Event|124|||
144620266|NCT00326898|521469580|FG001|Overall Study|Adverse Event|128|||
144620267|NCT00326898|521469581|FG002|Overall Study|Adverse Event|33|||
144620268|NCT00326898|521469579|FG000|Overall Study|Death|2|||
144620269|NCT00326898|521469580|FG001|Overall Study|Death|0|||
144620270|NCT00326898|521469581|FG002|Overall Study|Death|0|||
144620271|NCT00326898|521469579|FG000|Overall Study|Withdrawal by Subject|134|||
144620272|NCT00326898|521469580|FG001|Overall Study|Withdrawal by Subject|128|||
144620273|NCT00326898|521469581|FG002|Overall Study|Withdrawal by Subject|32|||
144620274|NCT00326898|521469579|FG000|Overall Study|Alternative therapy|1|||
144620275|NCT00326898|521469580|FG001|Overall Study|Alternative therapy|0|||
144620276|NCT00326898|521469581|FG002|Overall Study|Alternative therapy|0|||
144620277|NCT00326898|521469579|FG000|Overall Study|Other complicating disease|5|||
144620278|NCT00326898|521469580|FG001|Overall Study|Other complicating disease|5|||
144620279|NCT00326898|521469581|FG002|Overall Study|Other complicating disease|4|||
144620280|NCT00326898|521469579|FG000|Overall Study|Other/Missing/Unknown|33|||
144620281|NCT00326898|521469580|FG001|Overall Study|Other/Missing/Unknown|28|||
144569983|NCT02366143|521286254|FG001|Overall Study|Death|278|||
144569984|NCT02366143|521286255|FG002|Overall Study|Death|280|||
144569985|NCT02366143|521286253|FG000|Overall Study|Lost to Follow-up|2|||
144569986|NCT02366143|521286254|FG001|Overall Study|Lost to Follow-up|4|||
144569987|NCT02366143|521286255|FG002|Overall Study|Lost to Follow-up|2|||
144569988|NCT02366143|521286253|FG000|Overall Study|Physician Decision|1|||
144569989|NCT02366143|521286254|FG001|Overall Study|Physician Decision|2|||
144569990|NCT02366143|521286255|FG002|Overall Study|Physician Decision|1|||
144569991|NCT02366143|521286253|FG000|Overall Study|Protocol Violation|0|||
144569992|NCT02366143|521286254|FG001|Overall Study|Protocol Violation|0|||
144569993|NCT02366143|521286255|FG002|Overall Study|Protocol Violation|2|||
144569994|NCT02366143|521286253|FG000|Overall Study|Withdrawal by Subject|16|||
144569995|NCT02366143|521286254|FG001|Overall Study|Withdrawal by Subject|17|||
144620282|NCT00326898|521469581|FG002|Overall Study|Other/Missing/Unknown|32|||
144620283|NCT03847987|521469582|FG000|Overall Study|Lost to Follow-up|1|||
144620284|NCT03847987|521469583|FG001|Overall Study|Lost to Follow-up|0|||
144569996|NCT02366143|521286255|FG002|Overall Study|Withdrawal by Subject|22|||
144569997|NCT02366143|521286253|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
144569998|NCT02366143|521286254|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
144569999|NCT02366143|521286255|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
144570000|NCT02366143|521286253|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
144570001|NCT02366143|521286254|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
144620285|NCT03847987|521469582|FG000|Overall Study|Adverse Event|2|||
144620286|NCT03847987|521469583|FG001|Overall Study|Adverse Event|0|||
144620287|NCT02111564|521469584|FG000|Overall Study|Death|109|||
144620288|NCT02111564|521469585|FG001|Overall Study|Death|120|||
144620289|NCT02111564|521469584|FG000|Overall Study|Lost to Follow-up|2|||
144620290|NCT02111564|521469585|FG001|Overall Study|Lost to Follow-up|3|||
144620291|NCT02111564|521469584|FG000|Overall Study|Withdrawal by Subject|20|||
144620292|NCT02111564|521469585|FG001|Overall Study|Withdrawal by Subject|20|||
144570002|NCT02366143|521286255|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
144570003|NCT02366143|521286253|FG000|Overall Study|Randomization Error|1|||
144570004|NCT02366143|521286254|FG001|Overall Study|Randomization Error|0|||
144570005|NCT02366143|521286255|FG002|Overall Study|Randomization Error|0|||
144570006|NCT02366143|521286253|FG000|Overall Study|PI Move and Site Closure|1|||
144570007|NCT02366143|521286254|FG001|Overall Study|PI Move and Site Closure|0|||
144570008|NCT02366143|521286255|FG002|Overall Study|PI Move and Site Closure|1|||
144620293|NCT00687362|521469586|FG000|Overall Study|Protocol Violation|2|||
144620294|NCT00687362|521469586|FG000|Overall Study|Withdrawal by Subject|1|||
144620295|NCT02469090|521469592|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
144620296|NCT02469090|521469593|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
144620297|NCT02469090|521469594|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
144620298|NCT02469090|521469592|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
144620299|NCT02469090|521469593|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
144620300|NCT02469090|521469594|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
144620301|NCT02469090|521469592|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
144620302|NCT02469090|521469593|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
144620303|NCT02469090|521469594|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
144620304|NCT02469090|521469592|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
144620305|NCT02469090|521469593|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
144620306|NCT02469090|521469594|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
144620307|NCT02469090|521469592|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
144620308|NCT02469090|521469593|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
144620309|NCT02469090|521469594|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
144620310|NCT02469090|521469592|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
144620311|NCT02469090|521469593|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
144620312|NCT02469090|521469594|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
144620313|NCT02469090|521469592|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
144620314|NCT02469090|521469593|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
144620315|NCT02469090|521469594|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
144620316|NCT02469090|521469592|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
144620317|NCT02469090|521469593|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
144620318|NCT02469090|521469594|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
144620319|NCT03823391|521469599|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
144620320|NCT03823391|521469600|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
144620321|NCT03823391|521469599|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
144620322|NCT03823391|521469600|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
144620323|NCT05030311|521469601|FG000|Overall Study|Technical problems|0|||
144620324|NCT05030311|521469602|FG001|Overall Study|Technical problems|1|||
144620325|NCT05030311|521469601|FG000|Overall Study|Withdrawal by Subject|31|||
144620326|NCT05030311|521469602|FG001|Overall Study|Withdrawal by Subject|17|||
144620327|NCT05030311|521469601|FG000|Overall Study|Adverse Event|13|||
144620328|NCT05030311|521469602|FG001|Overall Study|Adverse Event|5|||
144620329|NCT05030311|521469601|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144620330|NCT05030311|521469602|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144620331|NCT05030311|521469601|FG000|Overall Study|Physician Decision|5|||
144620332|NCT05030311|521469602|FG001|Overall Study|Physician Decision|2|||
144620333|NCT05030311|521469601|FG000|Overall Study|Lost to Follow-up|5|||
144620334|NCT05030311|521469602|FG001|Overall Study|Lost to Follow-up|1|||
144620335|NCT05030311|521469601|FG000|Overall Study|Protocol Violation|4|||
144620336|NCT05030311|521469602|FG001|Overall Study|Protocol Violation|4|||
144620337|NCT03042468|521469604|FG000|Overall Study|Death|0|||
144620338|NCT03042468|521469605|FG001|Overall Study|Death|1|||
144620339|NCT03042468|521469606|FG002|Overall Study|Death|1|||
144620340|NCT03042468|521469607|FG003|Overall Study|Death|0|||
144620341|NCT03042468|521469608|FG004|Overall Study|Death|0|||
144620342|NCT03042468|521469609|FG005|Overall Study|Death|0|||
144620343|NCT03042468|521469604|FG000|Overall Study|Withdrawal by Subject|0|||
144620344|NCT03042468|521469605|FG001|Overall Study|Withdrawal by Subject|0|||
144620345|NCT03042468|521469606|FG002|Overall Study|Withdrawal by Subject|0|||
144620346|NCT03042468|521469607|FG003|Overall Study|Withdrawal by Subject|0|||
144620347|NCT03042468|521469608|FG004|Overall Study|Withdrawal by Subject|0|||
144728928|NCT01315249|521863169|FG001|Overall Study|Abnormal test results|2|||
144728929|NCT01315249|521863168|FG000|Overall Study|Administrative problems|1|||
144728930|NCT01315249|521863169|FG001|Overall Study|Administrative problems|0|||
144570009|NCT02366143|521286253|FG000|Overall Study|Study Terminated By Sponsor|0|||
144570010|NCT02366143|521286254|FG001|Overall Study|Study Terminated By Sponsor|0|||
144620348|NCT03042468|521469609|FG005|Overall Study|Withdrawal by Subject|1|||
144620349|NCT03042468|521469604|FG000|Overall Study|Lost to Follow-up|0|||
144620350|NCT03042468|521469605|FG001|Overall Study|Lost to Follow-up|0|||
144620351|NCT03042468|521469606|FG002|Overall Study|Lost to Follow-up|0|||
144620352|NCT03042468|521469607|FG003|Overall Study|Lost to Follow-up|0|||
144620353|NCT03042468|521469608|FG004|Overall Study|Lost to Follow-up|1|||
144620354|NCT03042468|521469609|FG005|Overall Study|Lost to Follow-up|1|||
144728931|NCT01315249|521863168|FG000|Overall Study|inability to use device|1|||
144728932|NCT01315249|521863169|FG001|Overall Study|inability to use device|0|||
144728933|NCT01315249|521863168|FG000|Overall Study|Lack of Efficacy|0|||
144728934|NCT01315249|521863169|FG001|Overall Study|Lack of Efficacy|1|||
144728935|NCT01315249|521863168|FG000|Overall Study|Lost to Follow-up|0|||
144728936|NCT01315249|521863169|FG001|Overall Study|Lost to Follow-up|2|||
144728937|NCT01315249|521863168|FG000|Overall Study|Death|0|||
144728938|NCT01315249|521863169|FG001|Overall Study|Death|1|||
144728939|NCT03227445|521863170|FG000|Period 1 (28 Days)|Adverse Event|1|||
144728940|NCT03227445|521863171|FG001|Period 1 (28 Days)|Adverse Event|2|||
144728941|NCT03227445|521863172|FG002|Period 1 (28 Days)|Adverse Event|0|||
144728942|NCT03227445|521863173|FG003|Period 1 (28 Days)|Adverse Event|1|||
144728943|NCT03227445|521863170|FG000|Period 1 (28 Days)|Protocol Violation|1|||
144728944|NCT03227445|521863171|FG001|Period 1 (28 Days)|Protocol Violation|0|||
144728945|NCT03227445|521863172|FG002|Period 1 (28 Days)|Protocol Violation|0|||
144728946|NCT03227445|521863173|FG003|Period 1 (28 Days)|Protocol Violation|0|||
144728947|NCT03227445|521863170|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
144728948|NCT03227445|521863171|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
144728949|NCT03227445|521863172|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
144728950|NCT03227445|521863173|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
144728951|NCT03227445|521863170|FG000|Period 2 (28 Days)|Adverse Event|1|||
144728952|NCT03227445|521863171|FG001|Period 2 (28 Days)|Adverse Event|0|||
144728953|NCT03227445|521863172|FG002|Period 2 (28 Days)|Adverse Event|2|||
144728954|NCT03227445|521863173|FG003|Period 2 (28 Days)|Adverse Event|1|||
144728955|NCT03227445|521863170|FG000|Period 2 (28 Days)|Protocol Violation|0|||
144728956|NCT03227445|521863171|FG001|Period 2 (28 Days)|Protocol Violation|0|||
144728957|NCT03227445|521863172|FG002|Period 2 (28 Days)|Protocol Violation|0|||
144728958|NCT03227445|521863173|FG003|Period 2 (28 Days)|Protocol Violation|1|||
144728959|NCT03227445|521863170|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
144728960|NCT03227445|521863171|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
144728961|NCT03227445|521863172|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
144728962|NCT03227445|521863173|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
144728963|NCT00365300|521863176|FG000|Open-label Phase|Adverse Event|4|||
144728964|NCT00365300|521863177|FG001|Open-label Phase|Adverse Event|0|||
144728965|NCT00365300|521863176|FG000|Open-label Phase|Failed to Return|1|||
144728966|NCT00365300|521863177|FG001|Open-label Phase|Failed to Return|0|||
144728967|NCT00365300|521863176|FG000|Open-label Phase|Physician Decision|1|||
144728968|NCT00365300|521863177|FG001|Open-label Phase|Physician Decision|0|||
144728969|NCT00365300|521863176|FG000|Open-label Phase|Noncompliance|9|||
144728970|NCT00365300|521863177|FG001|Open-label Phase|Noncompliance|0|||
144728971|NCT00365300|521863176|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
144728972|NCT00365300|521863177|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
144728973|NCT00365300|521863176|FG000|Open-label Phase|Protocol Violation|1|||
144728974|NCT00365300|521863177|FG001|Open-label Phase|Protocol Violation|0|||
144728975|NCT00365300|521863176|FG000|Open-label Phase|Lack of Efficacy|1|||
144728976|NCT00365300|521863177|FG001|Open-label Phase|Lack of Efficacy|0|||
144728977|NCT00365300|521863176|FG000|Open-label Phase|Patient skipped open label phase|1|||
144728978|NCT00365300|521863177|FG001|Open-label Phase|Patient skipped open label phase|0|||
144728979|NCT00365300|521863176|FG000|Double-blind Phase|Failed to return|1|||
144728980|NCT00365300|521863177|FG001|Double-blind Phase|Failed to return|0|||
144728981|NCT00365300|521863176|FG000|Double-blind Phase|Noncompliance|1|||
144728982|NCT00365300|521863177|FG001|Double-blind Phase|Noncompliance|1|||
144728983|NCT00365300|521863176|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144728984|NCT00365300|521863177|FG001|Double-blind Phase|Withdrawal by Subject|1|||
144728985|NCT00365300|521863176|FG000|Double-blind Phase|Protocol Violation|3|||
144728986|NCT00365300|521863177|FG001|Double-blind Phase|Protocol Violation|1|||
144728987|NCT00365300|521863176|FG000|Double-blind Phase|Lack of Efficacy|6|||
144728988|NCT00365300|521863177|FG001|Double-blind Phase|Lack of Efficacy|6|||
144728989|NCT01991470|521863178|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
144728990|NCT01991470|521863178|FG000|Enlite 1 Period|Adverse Event|1|||
144728991|NCT01991470|521863178|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
144728992|NCT01991470|521863178|FG000|Enlite 3 Period|Lost to Follow-up|1|||
144728993|NCT01991470|521863178|FG000|Enlite 3 Period|Physician Decision|2|||
144728994|NCT01991470|521863178|FG000|Enlite 3 Period|Physician Decision|8|||
144728995|NCT01991470|521863178|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
144728996|NCT02896361|521863195|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
144728997|NCT02896361|521863196|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
144262825|NCT00419757|520163753|FG001|Overall Study|Withdrawal by Subject|1|||
144262826|NCT00419757|520163752|FG000|Overall Study|Protocol Violation|2|||
144728998|NCT02896361|521863197|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
144728999|NCT02896361|521863195|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
144729000|NCT02896361|521863196|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
144729001|NCT02896361|521863197|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
144729002|NCT03164772|521863199|FG000|Overall Study|Death|4|||
144729003|NCT03164772|521863200|FG001|Overall Study|Death|2|||
144729004|NCT03164772|521863199|FG000|Overall Study|Adverse Event|1|||
144570011|NCT02366143|521286255|FG002|Overall Study|Study Terminated By Sponsor|2|||
144570012|NCT02366143|521286253|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
144570013|NCT02366143|521286254|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
144570014|NCT02366143|521286255|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
144570015|NCT02366143|521286253|FG000|Overall Study|Patient moved to roll-over study|1|||
144570016|NCT02366143|521286254|FG001|Overall Study|Patient moved to roll-over study|19|||
144570017|NCT02366143|521286255|FG002|Overall Study|Patient moved to roll-over study|28|||
144570018|NCT02366143|521286253|FG000|Overall Study|Patient moved to commercial stock|0|||
144570019|NCT02366143|521286254|FG001|Overall Study|Patient moved to commercial stock|0|||
144570020|NCT02366143|521286255|FG002|Overall Study|Patient moved to commercial stock|1|||
144570021|NCT02366143|521286253|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
144570022|NCT02366143|521286254|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
144570023|NCT02366143|521286255|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
144570024|NCT02366143|521286253|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
144570025|NCT02366143|521286254|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
144570026|NCT02366143|521286255|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
144570027|NCT02366143|521286253|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
144570028|NCT02366143|521286254|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
144570029|NCT02366143|521286255|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
144570030|NCT02366143|521286253|FG000|Overall Study|Requester's instructions|1|||
144262827|NCT00419757|520163753|FG001|Overall Study|Protocol Violation|3|||
144570031|NCT02366143|521286254|FG001|Overall Study|Requester's instructions|1|||
144570032|NCT02366143|521286255|FG002|Overall Study|Requester's instructions|1|||
144570033|NCT02366143|521286253|FG000|Overall Study|Uneligible|0|||
144570034|NCT02366143|521286254|FG001|Overall Study|Uneligible|1|||
144570035|NCT02366143|521286255|FG002|Overall Study|Uneligible|0|||
144570036|NCT02366143|521286253|FG000|Overall Study|Post Trial Migration|0|||
144570037|NCT02366143|521286254|FG001|Overall Study|Post Trial Migration|1|||
144570038|NCT02366143|521286255|FG002|Overall Study|Post Trial Migration|0|||
144570039|NCT02366143|521286253|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
144570040|NCT02366143|521286254|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
144570041|NCT02366143|521286255|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
144570042|NCT02366143|521286253|FG000|Overall Study|Patient switched to PTAP|0|||
144570043|NCT02366143|521286254|FG001|Overall Study|Patient switched to PTAP|1|||
144570044|NCT02366143|521286255|FG002|Overall Study|Patient switched to PTAP|0|||
144570045|NCT02366143|521286253|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
144570046|NCT02366143|521286254|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
144570047|NCT02366143|521286255|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
144570048|NCT02172911|521286256|FG000|Overall Study|Serious Adverse Event|0|||
144570049|NCT02172911|521286257|FG001|Overall Study|Serious Adverse Event|1|||
144570050|NCT02172911|521286256|FG000|Overall Study|Progression of Disease|0|||
144570051|NCT02172911|521286257|FG001|Overall Study|Progression of Disease|1|||
144570052|NCT02172911|521286256|FG000|Overall Study|Loss of insurance coverage|1|||
144570053|NCT02172911|521286257|FG001|Overall Study|Loss of insurance coverage|0|||
144570054|NCT04795336|521286260|FG000|Overall Study|Withdrawal by Subject|3|||
144570055|NCT04795336|521286261|FG001|Overall Study|Withdrawal by Subject|4|||
144570056|NCT04795336|521286262|FG002|Overall Study|Withdrawal by Subject|3|||
144570057|NCT04795336|521286263|FG003|Overall Study|Withdrawal by Subject|12|||
144570058|NCT04795336|521286260|FG000|Overall Study|Lost study logs|0|||
144570059|NCT04795336|521286261|FG001|Overall Study|Lost study logs|1|||
144570060|NCT04795336|521286262|FG002|Overall Study|Lost study logs|0|||
144570061|NCT04795336|521286263|FG003|Overall Study|Lost study logs|2|||
144570062|NCT04795336|521286260|FG000|Overall Study|Did not take study medication|2|||
144570063|NCT04795336|521286261|FG001|Overall Study|Did not take study medication|0|||
144570064|NCT04795336|521286262|FG002|Overall Study|Did not take study medication|0|||
144570065|NCT04795336|521286263|FG003|Overall Study|Did not take study medication|0|||
144570066|NCT01638390|521286264|FG000|Overall Study|screening failures|21|||
144570067|NCT01536587|521286271|FG000|Overall Study|Adverse Event|2|||
144570068|NCT03023722|521286272|FG000|Overall Study|No follow-up assessment|4|||
144570069|NCT02666664|521286273|FG000|Overall Study|Physician Decision|0|||
144570070|NCT02666664|521286274|FG001|Overall Study|Physician Decision|1|||
144570071|NCT02666664|521286273|FG000|Overall Study|Protocol Violation|0|||
144570072|NCT02666664|521286274|FG001|Overall Study|Protocol Violation|2|||
144570073|NCT02666664|521286273|FG000|Overall Study|Other|0|||
144570074|NCT02666664|521286274|FG001|Overall Study|Other|1|||
144570075|NCT02666664|521286273|FG000|Overall Study|Adverse Event|12|||
144570076|NCT02666664|521286274|FG001|Overall Study|Adverse Event|37|||
144570077|NCT02666664|521286273|FG000|Overall Study|Withdrawal by participant|23|||
144570078|NCT02666664|521286274|FG001|Overall Study|Withdrawal by participant|40|||
144570079|NCT02666664|521286273|FG000|Overall Study|Sponsor decision|0|||
144207060|NCT01292226|519952436|FG000|Overall Study|Other|2|||
144570080|NCT02666664|521286274|FG001|Overall Study|Sponsor decision|1|||
144570081|NCT02666664|521286273|FG000|Overall Study|Lost to Follow-up|1|||
144570082|NCT02666664|521286274|FG001|Overall Study|Lost to Follow-up|2|||
144570083|NCT03616964|521286275|FG000|Overall Study|Adverse Event|15|||
144570084|NCT03616964|521286276|FG001|Overall Study|Adverse Event|10|||
144570085|NCT03616964|521286277|FG002|Overall Study|Adverse Event|16|||
144570086|NCT03616964|521286275|FG000|Overall Study|Death|3|||
144570087|NCT03616964|521286276|FG001|Overall Study|Death|0|||
144570088|NCT03616964|521286277|FG002|Overall Study|Death|4|||
144570089|NCT03616964|521286275|FG000|Overall Study|Lack of Efficacy|4|||
144570090|NCT03616964|521286276|FG001|Overall Study|Lack of Efficacy|8|||
144570091|NCT03616964|521286277|FG002|Overall Study|Lack of Efficacy|8|||
144570092|NCT03616964|521286275|FG000|Overall Study|Lost to Follow-up|2|||
144570093|NCT03616964|521286276|FG001|Overall Study|Lost to Follow-up|1|||
144570094|NCT03616964|521286277|FG002|Overall Study|Lost to Follow-up|3|||
144570095|NCT03616964|521286275|FG000|Overall Study|Withdrawal by Subject|18|||
144570096|NCT03616964|521286276|FG001|Overall Study|Withdrawal by Subject|14|||
144570097|NCT03616964|521286277|FG002|Overall Study|Withdrawal by Subject|21|||
144570098|NCT03616964|521286275|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
144570099|NCT03616964|521286276|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
144570100|NCT03616964|521286277|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
144570101|NCT03616964|521286275|FG000|Overall Study|Sponsor's Decision|1|||
144570102|NCT03616964|521286276|FG001|Overall Study|Sponsor's Decision|0|||
144570103|NCT03616964|521286277|FG002|Overall Study|Sponsor's Decision|0|||
144570104|NCT03616964|521286275|FG000|Overall Study|Physician Decision|0|||
144570105|NCT03616964|521286276|FG001|Overall Study|Physician Decision|2|||
144570106|NCT03616964|521286277|FG002|Overall Study|Physician Decision|0|||
144570107|NCT03616964|521286275|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
144570108|NCT03616964|521286276|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
144570109|NCT03616964|521286277|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
144570110|NCT03616964|521286275|FG000|Overall Study|Protocol Violation|0|||
144570111|NCT03616964|521286276|FG001|Overall Study|Protocol Violation|1|||
144570112|NCT03616964|521286277|FG002|Overall Study|Protocol Violation|0|||
144570113|NCT03616964|521286275|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
144570114|NCT03616964|521286276|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
144570115|NCT03616964|521286277|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
144570116|NCT03616964|521286275|FG000|Overall Study|Randomized but Never Treated|1|||
144570117|NCT03616964|521286276|FG001|Overall Study|Randomized but Never Treated|1|||
144207061|NCT04106661|519952437|FG000|Overall Study|Protocol Violation|3|||
144570118|NCT03616964|521286277|FG002|Overall Study|Randomized but Never Treated|1|||
144570119|NCT04596995|521286278|FG000|Overall Study|Lack of Efficacy|8|||
144570120|NCT04596995|521286278|FG000|Overall Study|Lost to Follow-up|3|||
144570121|NCT04596995|521286278|FG000|Overall Study|Withdrawal by Subject|12|||
144570122|NCT04596995|521286278|FG000|Overall Study|Sponsor decision|3|||
144570123|NCT04596995|521286278|FG000|Overall Study|Enrolled in managed access program|3|||
144570124|NCT00129935|521286279|FG000|Overall Study|Adverse Event|18|||
144570125|NCT00129935|521286280|FG001|Overall Study|Adverse Event|56|||
144570126|NCT00129935|521286279|FG000|Overall Study|Death|1|||
144570127|NCT00129935|521286280|FG001|Overall Study|Death|1|||
144570128|NCT00129935|521286279|FG000|Overall Study|Withdrawal by Subject|7|||
144570129|NCT00129935|521286280|FG001|Overall Study|Withdrawal by Subject|20|||
144570130|NCT00129935|521286279|FG000|Overall Study|Protocol Violation|0|||
144570131|NCT00129935|521286280|FG001|Overall Study|Protocol Violation|4|||
144570132|NCT00129935|521286279|FG000|Overall Study|Physician Decision|3|||
144570133|NCT00129935|521286280|FG001|Overall Study|Physician Decision|4|||
144570134|NCT00129935|521286279|FG000|Overall Study|Recurrence|1|||
144570135|NCT00129935|521286280|FG001|Overall Study|Recurrence|3|||
144570136|NCT00129935|521286279|FG000|Overall Study|Second primary|0|||
144570137|NCT00129935|521286280|FG001|Overall Study|Second primary|1|||
144570138|NCT00129935|521286279|FG000|Overall Study|Other|3|||
144570139|NCT00129935|521286280|FG001|Overall Study|Other|2|||
144570140|NCT00129935|521286279|FG000|Overall Study|Crossed to the other arm|2|||
144570141|NCT00129935|521286280|FG001|Overall Study|Crossed to the other arm|1|||
144570142|NCT00129935|521286279|FG000|Overall Study|Incorrect study treatment|1|||
144570143|NCT00129935|521286280|FG001|Overall Study|Incorrect study treatment|0|||
144570144|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
144570145|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
144207062|NCT04106661|519952438|FG001|Overall Study|Protocol Violation|0|||
144570146|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
144570147|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Death|4|||
144570148|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Death|2|||
144570149|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Death|3|||
144570150|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
144570151|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
144570152|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
144620355|NCT00493038|521469612|FG000|Treatment|Adverse Event|8|||
144729005|NCT03164772|521863200|FG001|Overall Study|Adverse Event|4|||
144729006|NCT03164772|521863199|FG000|Overall Study|Progressive Disease|11|||
144729007|NCT03164772|521863200|FG001|Overall Study|Progressive Disease|21|||
144570153|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
144570154|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
144570155|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
144570156|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
144570157|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
144729008|NCT03164772|521863199|FG000|Overall Study|Physician Decision|2|||
144729009|NCT03164772|521863200|FG001|Overall Study|Physician Decision|0|||
144729010|NCT03164772|521863199|FG000|Overall Study|Withdrawal by Subject|0|||
144729011|NCT03164772|521863200|FG001|Overall Study|Withdrawal by Subject|4|||
144729012|NCT01029353|521863202|FG000|Overall Study|Lost to Follow-up|4|||
144729013|NCT01029353|521863203|FG001|Overall Study|Lost to Follow-up|5|||
144729014|NCT01029353|521863204|FG002|Overall Study|Lost to Follow-up|5|||
144729015|NCT01029353|521863205|FG003|Overall Study|Lost to Follow-up|4|||
144729016|NCT01029353|521863202|FG000|Overall Study|Consent Withdrawn|2|||
144729017|NCT01029353|521863203|FG001|Overall Study|Consent Withdrawn|0|||
144729018|NCT01029353|521863204|FG002|Overall Study|Consent Withdrawn|0|||
144729019|NCT01029353|521863205|FG003|Overall Study|Consent Withdrawn|0|||
144729020|NCT01029353|521863202|FG000|Overall Study|Primary Outcome Indeterminate|1|||
144729021|NCT01029353|521863203|FG001|Overall Study|Primary Outcome Indeterminate|3|||
144729022|NCT01029353|521863204|FG002|Overall Study|Primary Outcome Indeterminate|2|||
144729023|NCT01029353|521863205|FG003|Overall Study|Primary Outcome Indeterminate|0|||
144729024|NCT02932878|521863207|FG000|Overall Study|Due to Lab Results|2|||
144729025|NCT02932878|521863208|FG001|Overall Study|Due to Lab Results|1|||
144729026|NCT00849901|521863209|FG000|Acute Treatment Phase|Adverse Event|9|||
144729027|NCT00849901|521863210|FG001|Acute Treatment Phase|Adverse Event|1|||
144729028|NCT00849901|521863211|FG002|Acute Treatment Phase|Adverse Event|3|||
144729029|NCT00849901|521863209|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
144729030|NCT00849901|521863210|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
144729031|NCT00849901|521863211|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
144729032|NCT00849901|521863209|FG000|Acute Treatment Phase|Protocol Violation|0|||
144729033|NCT00849901|521863210|FG001|Acute Treatment Phase|Protocol Violation|2|||
144729034|NCT00849901|521863211|FG002|Acute Treatment Phase|Protocol Violation|1|||
144729035|NCT00849901|521863209|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
144729036|NCT00849901|521863210|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
144729037|NCT00849901|521863211|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
144729038|NCT00849901|521863209|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
144729039|NCT00849901|521863210|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
144729040|NCT00849901|521863211|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
144729041|NCT00849901|521863209|FG000|Acute Treatment Phase|Physician Decision|1|||
144729042|NCT00849901|521863210|FG001|Acute Treatment Phase|Physician Decision|1|||
144729043|NCT00849901|521863211|FG002|Acute Treatment Phase|Physician Decision|1|||
144729044|NCT00849901|521863209|FG000|Acute Treatment Phase|Sponsor Decision|1|||
144729045|NCT00849901|521863210|FG001|Acute Treatment Phase|Sponsor Decision|0|||
144729046|NCT00849901|521863211|FG002|Acute Treatment Phase|Sponsor Decision|0|||
144729047|NCT00849901|521863209|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
144729048|NCT00849901|521863210|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
144729049|NCT00849901|521863211|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
144729050|NCT00849901|521863209|FG000|Extension Phase|Adverse Event|2|||
144729051|NCT00849901|521863210|FG001|Extension Phase|Adverse Event|8|||
144729052|NCT00849901|521863211|FG002|Extension Phase|Adverse Event|4|||
144729053|NCT00849901|521863209|FG000|Extension Phase|Lost to Follow-up|3|||
144729054|NCT00849901|521863210|FG001|Extension Phase|Lost to Follow-up|0|||
144729055|NCT00849901|521863211|FG002|Extension Phase|Lost to Follow-up|1|||
144729056|NCT00849901|521863209|FG000|Extension Phase|Protocol Violation|2|||
144729057|NCT00849901|521863210|FG001|Extension Phase|Protocol Violation|2|||
144729058|NCT00849901|521863211|FG002|Extension Phase|Protocol Violation|4|||
144729059|NCT00849901|521863209|FG000|Extension Phase|Withdrawal by Subject|7|||
144729060|NCT00849901|521863210|FG001|Extension Phase|Withdrawal by Subject|6|||
144729061|NCT00849901|521863211|FG002|Extension Phase|Withdrawal by Subject|3|||
144729062|NCT00849901|521863209|FG000|Extension Phase|Parent or Caregiver Decision|10|||
144729063|NCT00849901|521863210|FG001|Extension Phase|Parent or Caregiver Decision|4|||
144729064|NCT00849901|521863211|FG002|Extension Phase|Parent or Caregiver Decision|4|||
144570158|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
144729065|NCT00849901|521863209|FG000|Extension Phase|Physician Decision|1|||
144729066|NCT00849901|521863210|FG001|Extension Phase|Physician Decision|2|||
144729067|NCT00849901|521863211|FG002|Extension Phase|Physician Decision|0|||
144729068|NCT00849901|521863209|FG000|Extension Phase|Lack of Efficacy|2|||
144729069|NCT00849901|521863210|FG001|Extension Phase|Lack of Efficacy|4|||
144729070|NCT00849901|521863211|FG002|Extension Phase|Lack of Efficacy|1|||
144729071|NCT02731157|521863216|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
144729072|NCT00760266|521863219|FG000|Overall Study|Adverse Event|13|||
144729073|NCT00760266|521863220|FG001|Overall Study|Adverse Event|7|||
144570159|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
144570160|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
144207063|NCT04106661|519952437|FG000|Overall Study|Scheduling difficulties|1|||
144207064|NCT04106661|519952438|FG001|Overall Study|Scheduling difficulties|1|||
144207065|NCT00233402|519952439|FG000|Overall Study|No pathology data|12|||
144570161|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
144570162|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
144570163|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
144570164|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
144570165|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
144570166|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
144570167|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
144570168|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
144570169|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
144620356|NCT00493038|521469613|FG001|Treatment|Adverse Event|4|||
144620357|NCT00493038|521469612|FG000|Treatment|Lost to Follow-up|5|||
144262828|NCT00419757|520163752|FG000|Overall Study|Study specific discontinuation criteria|4|||
144620358|NCT00493038|521469613|FG001|Treatment|Lost to Follow-up|3|||
144207066|NCT00233402|519952440|FG001|Overall Study|No pathology data|9|||
144207067|NCT00233402|519952439|FG000|Overall Study|No Ta/T1|89|||
144207068|NCT00233402|519952440|FG001|Overall Study|No Ta/T1|94|||
144207069|NCT00233402|519952439|FG000|Overall Study|Lost to follow up etc|3|||
144207070|NCT00233402|519952440|FG001|Overall Study|Lost to follow up etc|21|||
144207071|NCT00423319|519952443|FG000|Overall Study|Death|2|||
144207072|NCT00423319|519952444|FG001|Overall Study|Death|0|||
144207073|NCT00423319|519952443|FG000|Overall Study|Adverse Event|93|||
144207074|NCT00423319|519952444|FG001|Overall Study|Adverse Event|112|||
144207075|NCT00423319|519952443|FG000|Overall Study|Withdrawal by Subject|86|||
144207076|NCT00423319|519952444|FG001|Overall Study|Withdrawal by Subject|99|||
144207077|NCT00423319|519952443|FG000|Overall Study|Lost to Follow-up|4|||
144207078|NCT00423319|519952444|FG001|Overall Study|Lost to Follow-up|3|||
144207079|NCT00423319|519952443|FG000|Overall Study|Poor compliance or noncompliance|1|||
144207080|NCT00423319|519952444|FG001|Overall Study|Poor compliance or noncompliance|1|||
144207081|NCT00423319|519952443|FG000|Overall Study|No longer meets study criteria|15|||
144262829|NCT00419757|520163753|FG001|Overall Study|Study specific discontinuation criteria|8|||
144262830|NCT00419757|520163752|FG000|Overall Study|Multiple reasons|3|||
144262831|NCT00419757|520163753|FG001|Overall Study|Multiple reasons|1|||
144262832|NCT00379834|520163758|FG000|Overall Study|Time constraints|2|||
144620359|NCT00493038|521469612|FG000|Treatment|Withdrawal by Subject|11|||
144620360|NCT00493038|521469613|FG001|Treatment|Withdrawal by Subject|12|||
144620361|NCT00493038|521469612|FG000|Treatment|Other|0|||
144620362|NCT00493038|521469613|FG001|Treatment|Other|1|||
144620363|NCT00493038|521469612|FG000|Follow-up|Lost to Follow-up|1|||
144620364|NCT00493038|521469613|FG001|Follow-up|Lost to Follow-up|0|||
144620365|NCT03345472|521469615|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
144620366|NCT03345472|521469615|FG000|Implant to 3 Months|Physician Decision|1|||
144620367|NCT03345472|521469615|FG000|Implant to 3 Months|Adverse Event|1|||
144620368|NCT03345472|521469615|FG000|3 Months to 12 Months|Physician Decision|3|||
144620369|NCT03345472|521469615|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
144620370|NCT03345472|521469615|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
144620371|NCT03345472|521469615|FG000|3 Months to 12 Months|Adverse Event|1|||
144620372|NCT03345472|521469615|FG000|3 Months to 12 Months|Death|1|||
144620373|NCT02728830|521469646|FG000|Overall Study|Exclusionary Surgery|9|||
144620374|NCT02728830|521469646|FG000|Overall Study|Exclusionary Pathology|6|||
144620375|NCT02728830|521469646|FG000|Overall Study|Physician Decision|3|||
144620376|NCT02728830|521469646|FG000|Overall Study|Withdrawal by Subject|2|||
144620377|NCT02728830|521469646|FG000|Overall Study|Lost to Follow-up|1|||
144620378|NCT02728830|521469646|FG000|Overall Study|Exclusionary Lab Values|1|||
144620379|NCT02728830|521469646|FG000|Overall Study|Contraindicated Illness|1|||
144620380|NCT02728830|521469646|FG000|Overall Study|Language Barrier|1|||
144620381|NCT03504397|521469647|FG000|Overall Study|Progressive Disease|151|||
144620382|NCT03504397|521469648|FG001|Overall Study|Progressive Disease|199|||
144620383|NCT03504397|521469647|FG000|Overall Study|Withdrawal by Subject|29|||
144620384|NCT03504397|521469648|FG001|Overall Study|Withdrawal by Subject|17|||
144620385|NCT03504397|521469647|FG000|Overall Study|Lost to Follow-up|1|||
144620386|NCT03504397|521469648|FG001|Overall Study|Lost to Follow-up|0|||
144620387|NCT03504397|521469647|FG000|Overall Study|Death|14|||
144620388|NCT03504397|521469648|FG001|Overall Study|Death|16|||
144207082|NCT00423319|519952444|FG001|Overall Study|No longer meets study criteria|15|||
144262833|NCT01519817|520163759|FG000|Overall Study|Withdrawal by Subject|1|||
144620389|NCT03504397|521469647|FG000|Overall Study|Adverse Event|40|||
144620390|NCT03504397|521469648|FG001|Overall Study|Adverse Event|14|||
144620391|NCT03504397|521469647|FG000|Overall Study|miscellaneous|17|||
144620392|NCT03504397|521469648|FG001|Overall Study|miscellaneous|15|||
144620393|NCT03504397|521469647|FG000|Overall Study|Protocol deviation|1|||
144620394|NCT03504397|521469648|FG001|Overall Study|Protocol deviation|0|||
144570170|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
144570171|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
144570172|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
144570173|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
144570174|NCT02783573|521286282|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
144570175|NCT02783573|521286283|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
144570176|NCT02783573|521286284|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
144570177|NCT02783573|521286282|FG000|Delayed-Start Period|Sponsor Decision|0|||
144570178|NCT02783573|521286283|FG001|Delayed-Start Period|Sponsor Decision|17|||
144570179|NCT02783573|521286284|FG002|Delayed-Start Period|Sponsor Decision|12|||
144570180|NCT01434680|521286291|FG000|Overall Study|Withdrawal by Subject|1|||
144570181|NCT01434680|521286292|FG001|Overall Study|Withdrawal by Subject|0|||
144570182|NCT01434680|521286293|FG002|Overall Study|Withdrawal by Subject|2|||
144570183|NCT01434680|521286294|FG003|Overall Study|Withdrawal by Subject|0|||
144570184|NCT01434680|521286291|FG000|Overall Study|Lost to Follow-up|1|||
144570185|NCT01434680|521286292|FG001|Overall Study|Lost to Follow-up|1|||
144570186|NCT01434680|521286293|FG002|Overall Study|Lost to Follow-up|0|||
144570187|NCT01434680|521286294|FG003|Overall Study|Lost to Follow-up|0|||
144570188|NCT01434680|521286291|FG000|Overall Study|Protocol Violation|1|||
144570189|NCT01434680|521286292|FG001|Overall Study|Protocol Violation|1|||
144570190|NCT01434680|521286293|FG002|Overall Study|Protocol Violation|0|||
144570191|NCT01434680|521286294|FG003|Overall Study|Protocol Violation|0|||
144570192|NCT00725712|521286295|FG000|Overall Study|Withdrawal by Subject|2|||
144570193|NCT00725712|521286296|FG001|Overall Study|Withdrawal by Subject|1|||
144570194|NCT00725712|521286295|FG000|Overall Study|Protocol Violation|1|||
144570195|NCT00725712|521286296|FG001|Overall Study|Protocol Violation|0|||
144570196|NCT00725712|521286295|FG000|Overall Study|Progressive disease|37|||
144570197|NCT00725712|521286296|FG001|Overall Study|Progressive disease|16|||
144570198|NCT00725712|521286295|FG000|Overall Study|Clinical progression not based on RECIST|0|||
144570199|NCT00725712|521286296|FG001|Overall Study|Clinical progression not based on RECIST|3|||
144570200|NCT00725712|521286295|FG000|Overall Study|Adverse Event|5|||
144570201|NCT00725712|521286296|FG001|Overall Study|Adverse Event|5|||
144570202|NCT00725712|521286295|FG000|Overall Study|Death|2|||
144570203|NCT00725712|521286296|FG001|Overall Study|Death|0|||
144570204|NCT00725712|521286295|FG000|Overall Study|Other: Death|1|||
144570205|NCT00725712|521286296|FG001|Overall Study|Other: Death|0|||
144570206|NCT00725712|521286295|FG000|Overall Study|Hospitalized, unable to continue|0|||
144570207|NCT00725712|521286296|FG001|Overall Study|Hospitalized, unable to continue|1|||
144570208|NCT03020069|521286300|FG000|Overall Study|Lost to Follow-up|0|||
144570209|NCT03020069|521286301|FG001|Overall Study|Lost to Follow-up|1|||
144570210|NCT00589303|521286302|FG000|Overall Study|Withdrawal by Subject|2|||
144570211|NCT00589303|521286303|FG001|Overall Study|Withdrawal by Subject|1|||
144570212|NCT02056626|521286304|FG000|Overall Study|patient did not follow directions|3|||
144570213|NCT02056626|521286305|FG001|Overall Study|patient did not follow directions|1|||
144570214|NCT02056626|521286306|FG002|Overall Study|patient did not follow directions|0|||
144570215|NCT02056626|521286307|FG003|Overall Study|patient did not follow directions|0|||
144570216|NCT01952847|521286310|FG000|Overall Study|Ineligible|1|||
144570217|NCT01952847|521286311|FG001|Overall Study|Ineligible|0|||
144570218|NCT01952847|521286312|FG002|Overall Study|Ineligible|0|||
144570219|NCT01952847|521286313|FG003|Overall Study|Ineligible|0|||
144570220|NCT01952847|521286310|FG000|Overall Study|Lack of Insurance Coverage|0|||
144570221|NCT01952847|521286311|FG001|Overall Study|Lack of Insurance Coverage|1|||
144570222|NCT01952847|521286312|FG002|Overall Study|Lack of Insurance Coverage|0|||
144570223|NCT01952847|521286313|FG003|Overall Study|Lack of Insurance Coverage|0|||
144570224|NCT01952847|521286310|FG000|Overall Study|Withdrawal by Subject|1|||
144570225|NCT01952847|521286311|FG001|Overall Study|Withdrawal by Subject|1|||
144570226|NCT01952847|521286312|FG002|Overall Study|Withdrawal by Subject|0|||
144570227|NCT01952847|521286313|FG003|Overall Study|Withdrawal by Subject|1|||
144570228|NCT00013611|521286314|FG000|Overall Study|Lost to Follow-up|91|||
144570229|NCT00013611|521286315|FG001|Overall Study|Lost to Follow-up|100|||
144570230|NCT02786004|521286316|FG000|Overall Study|Withdrawal by Subject|0|||
144570231|NCT02786004|521286317|FG001|Overall Study|Withdrawal by Subject|1|||
144620395|NCT03504397|521469647|FG000|Overall Study|Participants who did not take the study drug|4|||
144570232|NCT01234883|521286318|FG000|Overall Study|Early treatment release|8|||
144570233|NCT01234883|521286319|FG001|Overall Study|Early treatment release|10|||
144570234|NCT01234883|521286318|FG000|Overall Study|Parent/guardian withdrew consent|1|||
144570235|NCT01234883|521286319|FG001|Overall Study|Parent/guardian withdrew consent|2|||
144570236|NCT01234883|521286318|FG000|Overall Study|Technical difficulties with IV infusion|0|||
144570237|NCT01234883|521286319|FG001|Overall Study|Technical difficulties with IV infusion|1|||
144570238|NCT01234883|521286318|FG000|Overall Study|Inclusion/exclusion failure|1|||
144570239|NCT01234883|521286319|FG001|Overall Study|Inclusion/exclusion failure|0|||
144570240|NCT01628692|521286324|FG000|Overall Study|Lack of Efficacy|4|||
144570241|NCT01628692|521286325|FG001|Overall Study|Lack of Efficacy|4|||
144570242|NCT01628692|521286326|FG002|Overall Study|Lack of Efficacy|5|||
144207083|NCT00423319|519952443|FG000|Overall Study|Other|23|||
144207084|NCT00423319|519952444|FG001|Overall Study|Other|22|||
144207085|NCT02639052|519952445|FG000|Overall Study|Lost to Follow-up|1|||
144207086|NCT02910063|519952450|FG000|Phase 2|Withdrawal by Subject|3|||
144207087|NCT02910063|519952451|FG001|Phase 2|Withdrawal by Subject|0|||
144207088|NCT02910063|519952452|FG002|Phase 2|Withdrawal by Subject|0|||
144207089|NCT02910063|519952450|FG000|Phase 2|Lost to Follow-up|1|||
144207090|NCT02910063|519952451|FG001|Phase 2|Lost to Follow-up|0|||
144207091|NCT02910063|519952452|FG002|Phase 2|Lost to Follow-up|0|||
144207092|NCT02910063|519952450|FG000|Phase 2|Death|24|||
144207093|NCT02910063|519952451|FG001|Phase 2|Death|0|||
144207094|NCT02910063|519952452|FG002|Phase 2|Death|0|||
144207095|NCT04435184|519952453|FG000|Overall Study|follow-up blood draws missing|3|||
144207096|NCT04435184|519952454|FG001|Overall Study|follow-up blood draws missing|5|||
144207097|NCT02774642|519952456|FG000|Overall Study|Lost to Follow-up|9|||
144207098|NCT02774642|519952457|FG001|Overall Study|Lost to Follow-up|7|||
144570243|NCT01628692|521286327|FG003|Overall Study|Lack of Efficacy|1|||
144570244|NCT01628692|521286328|FG004|Overall Study|Lack of Efficacy|4|||
144570245|NCT01628692|521286329|FG005|Overall Study|Lack of Efficacy|7|||
144570246|NCT01628692|521286324|FG000|Overall Study|Adverse Event|2|||
144570247|NCT01628692|521286325|FG001|Overall Study|Adverse Event|0|||
144570248|NCT01628692|521286326|FG002|Overall Study|Adverse Event|2|||
144570249|NCT01628692|521286327|FG003|Overall Study|Adverse Event|0|||
144570250|NCT01628692|521286328|FG004|Overall Study|Adverse Event|0|||
144570251|NCT01628692|521286329|FG005|Overall Study|Adverse Event|0|||
144570252|NCT01628692|521286324|FG000|Overall Study|Withdrawal by Subject|0|||
144570253|NCT01628692|521286325|FG001|Overall Study|Withdrawal by Subject|1|||
144620396|NCT03504397|521469648|FG001|Overall Study|Participants who did not take the study drug|4|||
144207111|NCT02365558|519952464|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
144207112|NCT02365558|519952465|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
144207113|NCT02365558|519952464|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
144207114|NCT02365558|519952465|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
144207115|NCT00510289|519952473|FG000|Overall Study|Withdrawal by Subject|7|||
144207116|NCT00510289|519952473|FG000|Overall Study|Refused bone marrow biopsy|2|||
144207117|NCT00510289|519952473|FG000|Overall Study|Lost to Follow-up|1|||
144207118|NCT00510289|519952473|FG000|Overall Study|Progressed prior to starting drug|2|||
144207119|NCT00861198|519952474|FG000|Overall Study|SpyGlass Failed|5|||
144207120|NCT00638027|519952485|FG000|Overall Study|Adverse Event|0|||
144207121|NCT00638027|519952486|FG001|Overall Study|Adverse Event|2|||
144207122|NCT00371397|519952487|FG000|Session 1|Withdrawal by Subject|1|||
144207123|NCT00371397|519952488|FG001|Session 1|Withdrawal by Subject|0|||
144207124|NCT00371397|519952489|FG002|Session 1|Withdrawal by Subject|0|||
144207125|NCT00371397|519952490|FG003|Session 1|Withdrawal by Subject|0|||
144207126|NCT00371397|519952491|FG004|Session 1|Withdrawal by Subject|0|||
144207127|NCT00371397|519952492|FG005|Session 1|Withdrawal by Subject|0|||
144207128|NCT00371397|519952493|FG006|Session 1|Withdrawal by Subject|0|||
144207129|NCT00371397|519952494|FG007|Session 1|Withdrawal by Subject|1|||
144207130|NCT00371397|519952495|FG008|Session 1|Withdrawal by Subject|0|||
144207131|NCT00371397|519952496|FG009|Session 1|Withdrawal by Subject|0|||
144207132|NCT00371397|519952497|FG010|Session 1|Withdrawal by Subject|0|||
144207133|NCT00371397|519952498|FG011|Session 1|Withdrawal by Subject|0|||
144207134|NCT03014180|519952499|FG000|Overall Study|Protocol Violation|2|||
144207135|NCT01284621|519952500|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
144207136|NCT01284621|519952501|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
144207137|NCT01284621|519952502|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
144207138|NCT01284621|519952503|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
144207139|NCT01284621|519952504|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
144207140|NCT01284621|519952505|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
144207141|NCT02099682|519952508|FG000|Overall Study|Data Not Available|51|||
144207142|NCT02099682|519952508|FG000|Overall Study|Lost to Follow-up|31|||
144207143|NCT02099682|519952508|FG000|Overall Study|Other|29|||
144207144|NCT02802631|519952509|FG000|Overall Study|Withdrawal by Subject|1|||
144620397|NCT01692301|521469651|FG000|Overall Study|Adverse Event|15|||
144620398|NCT01692301|521469652|FG001|Overall Study|Adverse Event|12|||
144620399|NCT01692301|521469651|FG000|Overall Study|Death|1|||
144620400|NCT01692301|521469652|FG001|Overall Study|Death|2|||
144620401|NCT01692301|521469651|FG000|Overall Study|Lack of Efficacy|0|||
144620402|NCT01692301|521469652|FG001|Overall Study|Lack of Efficacy|5|||
144620403|NCT01692301|521469651|FG000|Overall Study|Non-compliance with study treatment|1|||
144620404|NCT01692301|521469652|FG001|Overall Study|Non-compliance with study treatment|2|||
144620405|NCT01692301|521469651|FG000|Overall Study|Protocol deviation|9|||
144620406|NCT01692301|521469652|FG001|Overall Study|Protocol deviation|2|||
144620407|NCT01692301|521469651|FG000|Overall Study|Patient/guardian decision|16|||
144620408|NCT01692301|521469652|FG001|Overall Study|Patient/guardian decision|15|||
144620409|NCT01692301|521469651|FG000|Overall Study|Technical problems|0|||
144207145|NCT02802631|519952510|FG001|Overall Study|Withdrawal by Subject|0|||
144207146|NCT02802631|519952511|FG002|Overall Study|Withdrawal by Subject|0|||
144207147|NCT02802631|519952512|FG003|Overall Study|Withdrawal by Subject|0|||
144207148|NCT02802631|519952513|FG004|Overall Study|Withdrawal by Subject|0|||
144207149|NCT02802631|519952514|FG005|Overall Study|Withdrawal by Subject|0|||
144207150|NCT02802631|519952515|FG006|Overall Study|Withdrawal by Subject|0|||
144570254|NCT01628692|521286326|FG002|Overall Study|Withdrawal by Subject|1|||
144570255|NCT01628692|521286327|FG003|Overall Study|Withdrawal by Subject|0|||
144570256|NCT01628692|521286328|FG004|Overall Study|Withdrawal by Subject|0|||
144570257|NCT01628692|521286329|FG005|Overall Study|Withdrawal by Subject|0|||
144570258|NCT01628692|521286324|FG000|Overall Study|Death|0|||
144570259|NCT01628692|521286325|FG001|Overall Study|Death|1|||
144570260|NCT01628692|521286326|FG002|Overall Study|Death|0|||
144570261|NCT01628692|521286327|FG003|Overall Study|Death|0|||
144570262|NCT01628692|521286328|FG004|Overall Study|Death|0|||
144570263|NCT01628692|521286329|FG005|Overall Study|Death|0|||
144570264|NCT01628692|521286324|FG000|Overall Study|Poor compliance/noncompliance|1|||
144570265|NCT01628692|521286325|FG001|Overall Study|Poor compliance/noncompliance|0|||
144570266|NCT01628692|521286326|FG002|Overall Study|Poor compliance/noncompliance|0|||
144570267|NCT01628692|521286327|FG003|Overall Study|Poor compliance/noncompliance|0|||
144570268|NCT01628692|521286328|FG004|Overall Study|Poor compliance/noncompliance|0|||
144570269|NCT01628692|521286329|FG005|Overall Study|Poor compliance/noncompliance|0|||
144570270|NCT01628692|521286324|FG000|Overall Study|Administrative reason by sponsor|0|||
144570271|NCT01628692|521286325|FG001|Overall Study|Administrative reason by sponsor|0|||
144570272|NCT01628692|521286326|FG002|Overall Study|Administrative reason by sponsor|0|||
144570273|NCT01628692|521286327|FG003|Overall Study|Administrative reason by sponsor|0|||
144570274|NCT01628692|521286328|FG004|Overall Study|Administrative reason by sponsor|0|||
144570275|NCT01628692|521286329|FG005|Overall Study|Administrative reason by sponsor|1|||
144570276|NCT01628692|521286324|FG000|Overall Study|Completed 12 Week only|0|||
144570277|NCT01628692|521286325|FG001|Overall Study|Completed 12 Week only|0|||
144570278|NCT01628692|521286326|FG002|Overall Study|Completed 12 Week only|0|||
144570279|NCT01628692|521286327|FG003|Overall Study|Completed 12 Week only|0|||
144570280|NCT01628692|521286328|FG004|Overall Study|Completed 12 Week only|0|||
144570281|NCT01628692|521286329|FG005|Overall Study|Completed 12 Week only|1|||
144570282|NCT02049515|521286330|FG000|Overall Study|Adverse Event|46|||
144570283|NCT02049515|521286331|FG001|Overall Study|Adverse Event|2|||
144620410|NCT01692301|521469652|FG001|Overall Study|Technical problems|1|||
144620411|NCT01692301|521469651|FG000|Overall Study|Physician Decision|2|||
144620412|NCT01692301|521469652|FG001|Overall Study|Physician Decision|2|||
144620413|NCT01692301|521469651|FG000|Overall Study|Lost to Follow-up|1|||
144620414|NCT01692301|521469652|FG001|Overall Study|Lost to Follow-up|1|||
144620415|NCT01142726|521469653|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
144620416|NCT01142726|521469654|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
144620417|NCT01142726|521469655|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
144620418|NCT01142726|521469653|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
144620419|NCT01142726|521469654|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
144620420|NCT01142726|521469655|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
144620421|NCT01142726|521469653|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
144620422|NCT01142726|521469654|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
144620423|NCT01142726|521469655|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
144620424|NCT01142726|521469653|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
144620425|NCT01142726|521469654|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
144620426|NCT01142726|521469655|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
144620427|NCT01142726|521469653|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
144620428|NCT01142726|521469654|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
144620429|NCT01142726|521469655|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
144620430|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
144620431|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
144620432|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
144620433|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
144620434|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
144620435|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
144620436|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
144570284|NCT02049515|521286330|FG000|Overall Study|Protocol-specified Disease Progression|23|||
144570285|NCT02049515|521286331|FG001|Overall Study|Protocol-specified Disease Progression|2|||
144570286|NCT02049515|521286330|FG000|Overall Study|Death|6|||
144570287|NCT02049515|521286331|FG001|Overall Study|Death|0|||
144570288|NCT02049515|521286330|FG000|Overall Study|Physician Decision|5|||
144570289|NCT02049515|521286331|FG001|Overall Study|Physician Decision|1|||
144570290|NCT02049515|521286330|FG000|Overall Study|Withdrawal by Subject|3|||
144570291|NCT02049515|521286331|FG001|Overall Study|Withdrawal by Subject|0|||
144620437|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
144620438|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
144207151|NCT02802631|519952516|FG007|Overall Study|Withdrawal by Subject|0|||
144729074|NCT00760266|521863219|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144729075|NCT00760266|521863220|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144729076|NCT00760266|521863219|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144729077|NCT00760266|521863220|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144729078|NCT00760266|521863219|FG000|Overall Study|Lack of Efficacy|2|||
144729079|NCT00760266|521863220|FG001|Overall Study|Lack of Efficacy|2|||
144729080|NCT00760266|521863219|FG000|Overall Study|Protocol deviation|2|||
144729081|NCT00760266|521863220|FG001|Overall Study|Protocol deviation|4|||
144729082|NCT00760266|521863219|FG000|Overall Study|Patient withdrew consent|3|||
144729083|NCT00760266|521863220|FG001|Overall Study|Patient withdrew consent|3|||
144729084|NCT00760266|521863219|FG000|Overall Study|Lost to Follow-up|2|||
144729085|NCT00760266|521863220|FG001|Overall Study|Lost to Follow-up|1|||
144729086|NCT00760266|521863219|FG000|Overall Study|Administrative Problems|0|||
144729087|NCT00760266|521863220|FG001|Overall Study|Administrative Problems|1|||
144729088|NCT01239121|521863221|FG000|Overall Study|Withdrawal by Subject|2|||
144729089|NCT01239121|521863222|FG001|Overall Study|Withdrawal by Subject|4|||
144729090|NCT01239121|521863223|FG002|Overall Study|Withdrawal by Subject|0|||
144729091|NCT03018249|521863233|FG000|Overall Study|Withdrawal by Subject|2|||
144729092|NCT03018249|521863234|FG001|Overall Study|Withdrawal by Subject|2|||
144729093|NCT02343120|521863235|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
144729094|NCT02343120|521863236|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
144729095|NCT02343120|521863237|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
144729096|NCT02343120|521863238|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
144729097|NCT02343120|521863239|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
144729098|NCT02343120|521863235|FG000|Part 1: Dose Escalation|Death|1|||
144729099|NCT02343120|521863236|FG001|Part 1: Dose Escalation|Death|2|||
144729100|NCT02343120|521863237|FG002|Part 1: Dose Escalation|Death|2|||
144729101|NCT02343120|521863238|FG003|Part 1: Dose Escalation|Death|2|||
144729102|NCT02343120|521863239|FG004|Part 1: Dose Escalation|Death|1|||
144729103|NCT02343120|521863235|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
144729104|NCT02343120|521863236|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
144729105|NCT02343120|521863237|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
144729106|NCT02343120|521863238|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
144729107|NCT02343120|521863239|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
144729108|NCT02343120|521863235|FG000|Part 2: Expansion|Sponsor decision|0|||
144729109|NCT02343120|521863236|FG001|Part 2: Expansion|Sponsor decision|0|||
144729110|NCT02343120|521863237|FG002|Part 2: Expansion|Sponsor decision|0|||
144729111|NCT02343120|521863238|FG003|Part 2: Expansion|Sponsor decision|165|||
144729112|NCT02343120|521863239|FG004|Part 2: Expansion|Sponsor decision|67|||
144729113|NCT02343120|521863235|FG000|Part 2: Expansion|Death|0|||
144729114|NCT02343120|521863236|FG001|Part 2: Expansion|Death|0|||
144729115|NCT02343120|521863237|FG002|Part 2: Expansion|Death|0|||
144729116|NCT02343120|521863238|FG003|Part 2: Expansion|Death|74|||
144729117|NCT02343120|521863239|FG004|Part 2: Expansion|Death|17|||
144729118|NCT02343120|521863235|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
144729119|NCT02343120|521863236|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
144729120|NCT02343120|521863237|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
144729121|NCT02343120|521863238|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
144729122|NCT02343120|521863239|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
144729123|NCT02343120|521863235|FG000|Part 2: Expansion|Lost to Follow-up|0|||
144729124|NCT02343120|521863236|FG001|Part 2: Expansion|Lost to Follow-up|0|||
144729125|NCT02343120|521863237|FG002|Part 2: Expansion|Lost to Follow-up|0|||
144729126|NCT02343120|521863238|FG003|Part 2: Expansion|Lost to Follow-up|5|||
144729127|NCT02343120|521863239|FG004|Part 2: Expansion|Lost to Follow-up|2|||
144729128|NCT02343120|521863235|FG000|Part 2: Expansion|Other|0|||
144729129|NCT02343120|521863236|FG001|Part 2: Expansion|Other|0|||
144729130|NCT02343120|521863237|FG002|Part 2: Expansion|Other|0|||
144729131|NCT02343120|521863238|FG003|Part 2: Expansion|Other|1|||
144729132|NCT02343120|521863239|FG004|Part 2: Expansion|Other|5|||
144729133|NCT02343120|521863235|FG000|Part 2: Expansion|Adverse Event|0|||
144207152|NCT02802631|519952509|FG000|Overall Study|Physician Decision|1|||
144729134|NCT02343120|521863236|FG001|Part 2: Expansion|Adverse Event|0|||
144729135|NCT02343120|521863237|FG002|Part 2: Expansion|Adverse Event|0|||
144729136|NCT02343120|521863238|FG003|Part 2: Expansion|Adverse Event|1|||
144729137|NCT02343120|521863239|FG004|Part 2: Expansion|Adverse Event|1|||
144729138|NCT01030965|521863241|FG000|Overall Study|Lack of Efficacy|3|||
144729139|NCT01030965|521863242|FG001|Overall Study|Lack of Efficacy|2|||
144729140|NCT01030965|521863243|FG002|Overall Study|Lack of Efficacy|0|||
144729141|NCT01030965|521863244|FG003|Overall Study|Lack of Efficacy|3|||
144729142|NCT01030965|521863241|FG000|Overall Study|Protocol Violation|1|||
144729143|NCT01030965|521863242|FG001|Overall Study|Protocol Violation|1|||
144729144|NCT01030965|521863243|FG002|Overall Study|Protocol Violation|1|||
144729145|NCT01030965|521863244|FG003|Overall Study|Protocol Violation|1|||
144729146|NCT01030965|521863241|FG000|Overall Study|Adverse Event|0|||
144729147|NCT01030965|521863242|FG001|Overall Study|Adverse Event|1|||
144729148|NCT01030965|521863243|FG002|Overall Study|Adverse Event|2|||
144207153|NCT02802631|519952510|FG001|Overall Study|Physician Decision|0|||
144729149|NCT01030965|521863244|FG003|Overall Study|Adverse Event|1|||
144729150|NCT01030965|521863241|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
144729151|NCT01030965|521863242|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
144729152|NCT01030965|521863243|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
144729153|NCT01030965|521863244|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
144729154|NCT01030965|521863241|FG000|Overall Study|Withdrawal by Subject|0|||
144729155|NCT01030965|521863242|FG001|Overall Study|Withdrawal by Subject|1|||
144729156|NCT01030965|521863243|FG002|Overall Study|Withdrawal by Subject|0|||
144729157|NCT01030965|521863244|FG003|Overall Study|Withdrawal by Subject|2|||
144729158|NCT02097290|521863245|FG000|Overall Study|Death|6|||
144729159|NCT02097290|521863245|FG000|Overall Study|Total Withdrawals|3|||
144729160|NCT02097290|521863245|FG000|Overall Study|Attempt|8|||
144729161|NCT02534493|521863248|FG000|Overall Study|Lost to Follow-up|1|||
144729162|NCT02534493|521863248|FG000|Overall Study|Withdrawal by Subject|1|||
144729163|NCT01054599|521863254|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
144729164|NCT01054599|521863255|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
144729165|NCT01054599|521863254|FG000|Overall Study|Protocol Violation|1|||
144729166|NCT01054599|521863255|FG001|Overall Study|Protocol Violation|0|||
144729167|NCT01054599|521863254|FG000|Overall Study|Spells/seizure-like episodes|1|||
144729168|NCT01054599|521863255|FG001|Overall Study|Spells/seizure-like episodes|1|||
144729169|NCT01054599|521863254|FG000|Overall Study|Timing/scheduling difficulties|1|||
144729170|NCT01054599|521863255|FG001|Overall Study|Timing/scheduling difficulties|1|||
144729171|NCT01054599|521863254|FG000|Overall Study|Visual impairment, WTAR <80|0|||
144729172|NCT01054599|521863255|FG001|Overall Study|Visual impairment, WTAR <80|1|||
144729173|NCT01054599|521863254|FG000|Overall Study|Lost to Follow-up|0|||
144729174|NCT01054599|521863255|FG001|Overall Study|Lost to Follow-up|2|||
144729175|NCT01054599|521863254|FG000|Overall Study|Adverse Event|0|||
144729176|NCT01054599|521863255|FG001|Overall Study|Adverse Event|1|||
144729177|NCT01054599|521863254|FG000|Overall Study|Withdrawal by Subject|0|||
144729178|NCT01054599|521863255|FG001|Overall Study|Withdrawal by Subject|1|||
144729179|NCT00743197|521863256|FG000|Overall Study|Study terminated due to departure of PI.|1|||
144729180|NCT00743197|521863257|FG001|Overall Study|Study terminated due to departure of PI.|2|||
144729181|NCT01104662|521863258|FG000|Overall Study|Adverse Event|2|||
144729182|NCT01104662|521863259|FG001|Overall Study|Adverse Event|2|||
144729183|NCT01104662|521863260|FG002|Overall Study|Adverse Event|0|||
144729184|NCT01104662|521863261|FG003|Overall Study|Adverse Event|1|||
144729185|NCT01104662|521863262|FG004|Overall Study|Adverse Event|1|||
144729186|NCT01104662|521863263|FG005|Overall Study|Adverse Event|1|||
144729187|NCT01104662|521863264|FG006|Overall Study|Adverse Event|0|||
144729188|NCT01104662|521863265|FG007|Overall Study|Adverse Event|0|||
144729189|NCT01104662|521863258|FG000|Overall Study|Clinical Failure|1|||
144729190|NCT01104662|521863259|FG001|Overall Study|Clinical Failure|0|||
144729191|NCT01104662|521863260|FG002|Overall Study|Clinical Failure|0|||
144729192|NCT01104662|521863261|FG003|Overall Study|Clinical Failure|0|||
144729193|NCT01104662|521863262|FG004|Overall Study|Clinical Failure|0|||
144729194|NCT01104662|521863263|FG005|Overall Study|Clinical Failure|1|||
144729195|NCT01104662|521863264|FG006|Overall Study|Clinical Failure|0|||
144729196|NCT01104662|521863265|FG007|Overall Study|Clinical Failure|0|||
144729197|NCT01104662|521863258|FG000|Overall Study|Participant left investigator's care|1|||
144729198|NCT01104662|521863259|FG001|Overall Study|Participant left investigator's care|1|||
144729199|NCT01104662|521863260|FG002|Overall Study|Participant left investigator's care|0|||
144729200|NCT01104662|521863261|FG003|Overall Study|Participant left investigator's care|0|||
144729201|NCT01104662|521863262|FG004|Overall Study|Participant left investigator's care|0|||
144729202|NCT01104662|521863263|FG005|Overall Study|Participant left investigator's care|0|||
144729203|NCT01104662|521863264|FG006|Overall Study|Participant left investigator's care|0|||
144729204|NCT01104662|521863265|FG007|Overall Study|Participant left investigator's care|0|||
144729205|NCT01104662|521863258|FG000|Overall Study|Reason not specified|3|||
144729206|NCT01104662|521863259|FG001|Overall Study|Reason not specified|3|||
144729207|NCT01104662|521863260|FG002|Overall Study|Reason not specified|0|||
144729208|NCT01104662|521863261|FG003|Overall Study|Reason not specified|0|||
144729209|NCT01104662|521863262|FG004|Overall Study|Reason not specified|0|||
144729210|NCT01104662|521863263|FG005|Overall Study|Reason not specified|1|||
144729211|NCT01104662|521863264|FG006|Overall Study|Reason not specified|0|||
144729212|NCT01104662|521863265|FG007|Overall Study|Reason not specified|0|||
144729213|NCT01104662|521863258|FG000|Overall Study|Randomized but not treated|3|||
144729214|NCT01104662|521863259|FG001|Overall Study|Randomized but not treated|4|||
144729215|NCT01104662|521863260|FG002|Overall Study|Randomized but not treated|1|||
144729216|NCT01104662|521863261|FG003|Overall Study|Randomized but not treated|0|||
144729217|NCT01104662|521863262|FG004|Overall Study|Randomized but not treated|0|||
144729218|NCT01104662|521863263|FG005|Overall Study|Randomized but not treated|1|||
144729219|NCT01104662|521863264|FG006|Overall Study|Randomized but not treated|0|||
144729220|NCT01104662|521863265|FG007|Overall Study|Randomized but not treated|0|||
144729221|NCT01478620|521863266|FG000|Overall Study|Lost to Follow-up|6|||
144729222|NCT02170688|521863269|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
144729223|NCT02170688|521863270|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
144729224|NCT02170688|521863271|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
144570292|NCT02049515|521286330|FG000|Overall Study|Termination of the Study by Sponsor|2|||
144570293|NCT02049515|521286331|FG001|Overall Study|Termination of the Study by Sponsor|0|||
144570294|NCT02049515|521286330|FG000|Overall Study|Protocol Violation|1|||
144570295|NCT02049515|521286331|FG001|Overall Study|Protocol Violation|1|||
144570296|NCT02049515|521286330|FG000|Overall Study|Clinical Deterioration|1|||
144570297|NCT02049515|521286331|FG001|Overall Study|Clinical Deterioration|0|||
144570298|NCT02049515|521286330|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
144570299|NCT02049515|521286331|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
144570300|NCT02049515|521286330|FG000|Overall Study|Treatment Interruption >42 Days|1|||
144570301|NCT02049515|521286331|FG001|Overall Study|Treatment Interruption >42 Days|0|||
144570302|NCT02049515|521286330|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
144570303|NCT02049515|521286331|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
144570304|NCT00224029|521286338|FG000|Overall Study|Lost to Follow-up|1|||
144570305|NCT00224029|521286338|FG000|Overall Study|Withdrawal by Subject|4|||
144570306|NCT00224029|521286338|FG000|Overall Study|Other|1|||
144620439|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
144620440|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
144620441|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
144620442|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
144620443|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
144620444|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
144620445|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
144620446|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
144620447|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
144620448|NCT01142726|521469653|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
144620449|NCT01142726|521469654|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
144620450|NCT01142726|521469655|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
144620451|NCT01142726|521469653|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
144620452|NCT01142726|521469654|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
144620453|NCT01142726|521469655|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
144620454|NCT01142726|521469653|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
144620455|NCT01142726|521469654|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
144620456|NCT01142726|521469655|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
144620457|NCT01142726|521469653|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
144620458|NCT01142726|521469654|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
144620459|NCT01142726|521469655|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
144620460|NCT01142726|521469653|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
144620461|NCT01142726|521469654|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
144620462|NCT01142726|521469655|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
144620463|NCT01568593|521469656|FG000|Overall Study|Lack of Efficacy|4|||
144620464|NCT01568593|521469657|FG001|Overall Study|Lack of Efficacy|1|||
144620465|NCT01568593|521469656|FG000|Overall Study|Adverse Event|3|||
144620466|NCT01568593|521469657|FG001|Overall Study|Adverse Event|2|||
144620467|NCT02780648|521469658|FG000|Overall Study|Disease Progression|1|||
144620468|NCT02780648|521469659|FG001|Overall Study|Disease Progression|0|||
144620469|NCT03167073|521469664|FG000|Overall Study|Stillbirth|1|||
144620470|NCT03167073|521469665|FG001|Overall Study|Stillbirth|0|||
144620471|NCT01276236|521469666|FG000|Overall Study|Lack of Efficacy|2|||
144620472|NCT01276236|521469666|FG000|Overall Study|Withdrawal by Subject|4|||
144620473|NCT03127384|521469668|FG000|Overall Study|Lost to Follow-up|4|||
144620474|NCT03127384|521469668|FG000|Overall Study|Subject request|2|||
144620475|NCT01294579|521469669|FG000|Overall Study|Disease progression|12|||
144620476|NCT01294579|521469669|FG000|Overall Study|Adverse Event|11|||
144620477|NCT01294579|521469669|FG000|Overall Study|Study closed/terminated|3|||
144620478|NCT01294579|521469669|FG000|Overall Study|Lost to Follow-up|1|||
144620479|NCT01294579|521469669|FG000|Overall Study|Physician Decision|3|||
144620480|NCT01294579|521469669|FG000|Overall Study|Withdrawal by Subject|5|||
144620481|NCT01180660|521469672|FG000|Overall Study|Changed to open surgery|1|||
144570307|NCT00778921|521286339|FG000|Overall Study|Adverse Event|9|||
144570308|NCT00778921|521286340|FG001|Overall Study|Adverse Event|10|||
144570309|NCT00778921|521286341|FG002|Overall Study|Adverse Event|14|||
144570310|NCT00778921|521286339|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
144620482|NCT01180660|521469673|FG001|Overall Study|Changed to open surgery|0|||
144620483|NCT00262873|521469674|FG000|Overall Study|Adverse Event|3|||
144570311|NCT00778921|521286340|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
144570312|NCT00778921|521286341|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
144620484|NCT00262873|521469674|FG000|Overall Study|Withdrawal by Subject|5|||
144620485|NCT00844753|521469675|FG000|Overall Study|Lack of Efficacy|1|||
144620486|NCT00844753|521469676|FG001|Overall Study|Lack of Efficacy|0|||
144620487|NCT00844753|521469677|FG002|Overall Study|Lack of Efficacy|2|||
144620488|NCT00844753|521469678|FG003|Overall Study|Lack of Efficacy|2|||
144570313|NCT00778921|521286339|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
144729225|NCT02170688|521863272|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
144262834|NCT01519817|520163760|FG001|Overall Study|Withdrawal by Subject|0|||
144262835|NCT01519817|520163761|FG002|Overall Study|Withdrawal by Subject|0|||
144262836|NCT01519817|520163762|FG003|Overall Study|Withdrawal by Subject|0|||
144570314|NCT00778921|521286340|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
144570315|NCT00778921|521286341|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
144570316|NCT00778921|521286339|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
144570317|NCT00778921|521286340|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
144570318|NCT00778921|521286341|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
144570319|NCT00778921|521286339|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
144570320|NCT00778921|521286340|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
144570321|NCT00778921|521286341|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
144570322|NCT00778921|521286339|FG000|Overall Study|Patient withdrew request|3|||
144570323|NCT00778921|521286340|FG001|Overall Study|Patient withdrew request|1|||
144570324|NCT00778921|521286341|FG002|Overall Study|Patient withdrew request|6|||
144570325|NCT00778921|521286339|FG000|Overall Study|Lost to Follow-up|0|||
144570326|NCT00778921|521286340|FG001|Overall Study|Lost to Follow-up|2|||
144570327|NCT00778921|521286341|FG002|Overall Study|Lost to Follow-up|1|||
144570328|NCT00778921|521286339|FG000|Overall Study|Administrative Problems|1|||
144620489|NCT00844753|521469675|FG000|Overall Study|Adverse Event|3|||
144620490|NCT00844753|521469676|FG001|Overall Study|Adverse Event|2|||
144620491|NCT00844753|521469677|FG002|Overall Study|Adverse Event|5|||
144620492|NCT00844753|521469678|FG003|Overall Study|Adverse Event|5|||
144620493|NCT00844753|521469675|FG000|Overall Study|Lost to Follow-up|1|||
144620494|NCT00844753|521469676|FG001|Overall Study|Lost to Follow-up|1|||
144620495|NCT00844753|521469677|FG002|Overall Study|Lost to Follow-up|0|||
144620496|NCT00844753|521469678|FG003|Overall Study|Lost to Follow-up|1|||
144620497|NCT00844753|521469675|FG000|Overall Study|could not swallow medication|2|||
144620498|NCT00844753|521469676|FG001|Overall Study|could not swallow medication|0|||
144620499|NCT00844753|521469677|FG002|Overall Study|could not swallow medication|0|||
144620500|NCT00844753|521469678|FG003|Overall Study|could not swallow medication|0|||
144620501|NCT00844753|521469675|FG000|Overall Study|Withdrawal by Subject|1|||
144620502|NCT00844753|521469676|FG001|Overall Study|Withdrawal by Subject|0|||
144620503|NCT00844753|521469677|FG002|Overall Study|Withdrawal by Subject|0|||
144620504|NCT00844753|521469678|FG003|Overall Study|Withdrawal by Subject|3|||
144620505|NCT03440814|521469681|FG000|Overall Study|Adverse Event|2|||
144620506|NCT03440814|521469682|FG001|Overall Study|Adverse Event|1|||
144620507|NCT03440814|521469681|FG000|Overall Study|Lost to Follow-up|2|||
144620508|NCT03440814|521469682|FG001|Overall Study|Lost to Follow-up|0|||
144620509|NCT03440814|521469681|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
144620510|NCT03440814|521469682|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
144620511|NCT00088374|521469683|FG000|Overall Study|patient did not receive any 17AAG|1|||
144620512|NCT00088374|521469683|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
144620513|NCT00852995|521469684|FG000|Overall Study|Adverse Event|1|||
144620514|NCT00852995|521469685|FG001|Overall Study|Adverse Event|0|||
144620515|NCT00852995|521469686|FG002|Overall Study|Adverse Event|4|||
144620516|NCT00852995|521469687|FG003|Overall Study|Adverse Event|0|||
144620517|NCT00852995|521469688|FG004|Overall Study|Adverse Event|0|||
144620518|NCT00852995|521469684|FG000|Overall Study|Lost to Follow-up|0|||
144620519|NCT00852995|521469685|FG001|Overall Study|Lost to Follow-up|1|||
144620520|NCT00852995|521469686|FG002|Overall Study|Lost to Follow-up|1|||
144620521|NCT00852995|521469687|FG003|Overall Study|Lost to Follow-up|0|||
144620522|NCT00852995|521469688|FG004|Overall Study|Lost to Follow-up|0|||
144620523|NCT00852995|521469684|FG000|Overall Study|Withdrawal by Subject|4|||
144620524|NCT00852995|521469685|FG001|Overall Study|Withdrawal by Subject|0|||
144620525|NCT00852995|521469686|FG002|Overall Study|Withdrawal by Subject|0|||
144620526|NCT00852995|521469687|FG003|Overall Study|Withdrawal by Subject|1|||
144620527|NCT00852995|521469688|FG004|Overall Study|Withdrawal by Subject|2|||
144620528|NCT00852995|521469684|FG000|Overall Study|Non-Compliance|0|||
144620529|NCT00852995|521469685|FG001|Overall Study|Non-Compliance|0|||
144620530|NCT00852995|521469686|FG002|Overall Study|Non-Compliance|0|||
144620531|NCT00852995|521469687|FG003|Overall Study|Non-Compliance|2|||
144620532|NCT00852995|521469688|FG004|Overall Study|Non-Compliance|0|||
144620533|NCT00852995|521469684|FG000|Overall Study|Progressive Disease|1|||
144620534|NCT00852995|521469685|FG001|Overall Study|Progressive Disease|0|||
144620535|NCT00852995|521469686|FG002|Overall Study|Progressive Disease|0|||
144620536|NCT00852995|521469687|FG003|Overall Study|Progressive Disease|2|||
144620537|NCT00852995|521469688|FG004|Overall Study|Progressive Disease|1|||
144620538|NCT00852995|521469684|FG000|Overall Study|Physician Decision|1|||
144620539|NCT00852995|521469685|FG001|Overall Study|Physician Decision|0|||
144620540|NCT00852995|521469686|FG002|Overall Study|Physician Decision|0|||
144620541|NCT00852995|521469687|FG003|Overall Study|Physician Decision|0|||
144620542|NCT00852995|521469688|FG004|Overall Study|Physician Decision|0|||
144620543|NCT00852995|521469684|FG000|Overall Study|Protocol Violation|0|||
144620544|NCT00852995|521469685|FG001|Overall Study|Protocol Violation|0|||
144620545|NCT00852995|521469686|FG002|Overall Study|Protocol Violation|0|||
144620546|NCT00852995|521469687|FG003|Overall Study|Protocol Violation|0|||
144570329|NCT00778921|521286340|FG001|Overall Study|Administrative Problems|2|||
144570330|NCT00778921|521286341|FG002|Overall Study|Administrative Problems|0|||
144570331|NCT00778921|521286339|FG000|Overall Study|Protocol Violation|3|||
144570332|NCT00778921|521286340|FG001|Overall Study|Protocol Violation|0|||
144570333|NCT00778921|521286341|FG002|Overall Study|Protocol Violation|2|||
144570334|NCT00778921|521286339|FG000|Overall Study|Not treated|0|||
144570335|NCT00778921|521286340|FG001|Overall Study|Not treated|2|||
144570336|NCT00778921|521286341|FG002|Overall Study|Not treated|2|||
144570337|NCT01575873|521286345|FG000|Overall Study|Withdrawal by Subject|15|||
144570338|NCT01575873|521286346|FG001|Overall Study|Withdrawal by Subject|20|||
144570339|NCT01575873|521286347|FG002|Overall Study|Withdrawal by Subject|34|||
144570340|NCT01575873|521286348|FG003|Overall Study|Withdrawal by Subject|34|||
144570341|NCT01575873|521286345|FG000|Overall Study|Adverse Event|7|||
144570342|NCT01575873|521286346|FG001|Overall Study|Adverse Event|7|||
144570343|NCT01575873|521286347|FG002|Overall Study|Adverse Event|9|||
144570344|NCT01575873|521286348|FG003|Overall Study|Adverse Event|12|||
144570345|NCT01575873|521286345|FG000|Overall Study|Lost to Follow-up|1|||
144570346|NCT01575873|521286346|FG001|Overall Study|Lost to Follow-up|3|||
144570347|NCT01575873|521286347|FG002|Overall Study|Lost to Follow-up|13|||
144570348|NCT01575873|521286348|FG003|Overall Study|Lost to Follow-up|5|||
144570349|NCT01575873|521286345|FG000|Overall Study|Death|3|||
144570350|NCT01575873|521286346|FG001|Overall Study|Death|2|||
144570351|NCT01575873|521286347|FG002|Overall Study|Death|8|||
144570352|NCT01575873|521286348|FG003|Overall Study|Death|9|||
144570353|NCT01575873|521286345|FG000|Overall Study|Noncompliance|1|||
144570354|NCT01575873|521286346|FG001|Overall Study|Noncompliance|2|||
144570355|NCT01575873|521286347|FG002|Overall Study|Noncompliance|4|||
144570356|NCT01575873|521286348|FG003|Overall Study|Noncompliance|3|||
144570357|NCT01575873|521286345|FG000|Overall Study|Administrative decision|1|||
144570358|NCT01575873|521286346|FG001|Overall Study|Administrative decision|1|||
144570359|NCT01575873|521286347|FG002|Overall Study|Administrative decision|1|||
144570360|NCT01575873|521286348|FG003|Overall Study|Administrative decision|0|||
144570361|NCT01575873|521286345|FG000|Overall Study|Protocol deviation|0|||
144570362|NCT01575873|521286346|FG001|Overall Study|Protocol deviation|1|||
144570363|NCT01575873|521286347|FG002|Overall Study|Protocol deviation|0|||
144570364|NCT01575873|521286348|FG003|Overall Study|Protocol deviation|1|||
144570365|NCT01575873|521286345|FG000|Overall Study|Requirement for Alternative Therapy|0|||
144570366|NCT01575873|521286346|FG001|Overall Study|Requirement for Alternative Therapy|0|||
144570367|NCT01575873|521286347|FG002|Overall Study|Requirement for Alternative Therapy|1|||
144570368|NCT01575873|521286348|FG003|Overall Study|Requirement for Alternative Therapy|1|||
144570369|NCT01575873|521286345|FG000|Overall Study|Other|0|||
144570370|NCT01575873|521286346|FG001|Overall Study|Other|0|||
144570371|NCT01575873|521286347|FG002|Overall Study|Other|4|||
144570372|NCT01575873|521286348|FG003|Overall Study|Other|2|||
144570373|NCT02031536|521286349|FG000|Overall Study|ineligible|1|||
144570374|NCT02031536|521286350|FG001|Overall Study|ineligible|0|||
144570375|NCT03845023|521286352|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
144570376|NCT03845023|521286353|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
144570377|NCT03845023|521286354|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
144570378|NCT03845023|521286355|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
144570379|NCT03845023|521286352|FG000|Follow-Up (14 Days)|Adverse Event|0|||
144570380|NCT03845023|521286353|FG001|Follow-Up (14 Days)|Adverse Event|0|||
144570381|NCT03845023|521286354|FG002|Follow-Up (14 Days)|Adverse Event|1|||
144570382|NCT03845023|521286355|FG003|Follow-Up (14 Days)|Adverse Event|1|||
144570383|NCT02353871|521286356|FG000|Overall Study|Protocol deviation|0|||
144570384|NCT02353871|521286357|FG001|Overall Study|Protocol deviation|1|||
144570385|NCT02353871|521286356|FG000|Overall Study|Consent withdrawn|1|||
144570386|NCT02353871|521286357|FG001|Overall Study|Consent withdrawn|8|||
144570387|NCT02353871|521286356|FG000|Overall Study|Lost to Follow-up|2|||
144570388|NCT02353871|521286357|FG001|Overall Study|Lost to Follow-up|0|||
144570389|NCT00115336|521286358|FG000|Overall Study|Hospital discharge before study drug|0|||
144570390|NCT00115336|521286359|FG001|Overall Study|Hospital discharge before study drug|1|||
144570391|NCT02554383|521286360|FG000|Overall Study|Ineligible|3|||
144570392|NCT02554383|521286361|FG001|Overall Study|Ineligible|2|||
144570393|NCT02554383|521286360|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
144570394|NCT02554383|521286361|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
144570395|NCT02554383|521286360|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
144570396|NCT02554383|521286361|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
144570397|NCT02554383|521286360|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
144570398|NCT02554383|521286361|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
144570399|NCT02394665|521286364|FG000|Overall Study|Physician Decision|1|||
144570400|NCT02394665|521286365|FG001|Overall Study|Physician Decision|0|||
144570401|NCT02394665|521286366|FG002|Overall Study|Physician Decision|0|||
144570402|NCT05093504|521286369|FG000|Overall Study|Death|0|||
144262837|NCT01519817|520163759|FG000|Overall Study|Off study due to infection|0|||
144570403|NCT05093504|521286370|FG001|Overall Study|Death|1|||
144570404|NCT04650698|521288063|FG000|Overall Study|Protocol Violation|2|||
144207154|NCT02802631|519952511|FG002|Overall Study|Physician Decision|0|||
144207155|NCT02802631|519952512|FG003|Overall Study|Physician Decision|0|||
144570405|NCT04650698|521288064|FG001|Overall Study|Protocol Violation|1|||
144570406|NCT04650698|521288063|FG000|Overall Study|Withdrawal by Subject|0|||
144570407|NCT04650698|521288064|FG001|Overall Study|Withdrawal by Subject|1|||
144570408|NCT02859064|521288065|FG000|Overall Study|Progressive Disease|3|||
144570409|NCT02859064|521288065|FG000|Overall Study|Physician Decision|1|||
144570410|NCT02859064|521288065|FG000|Overall Study|Withdrawal by Subject|1|||
144570411|NCT02859064|521288065|FG000|Overall Study|Death|1|||
144570412|NCT01385748|521288071|FG000|Overall Study|Withdrawal by Subject|7|||
144570413|NCT01385748|521288072|FG001|Overall Study|Withdrawal by Subject|4|||
144570414|NCT01385748|521288073|FG002|Overall Study|Withdrawal by Subject|5|||
144570415|NCT01385748|521288071|FG000|Overall Study|Noncompliance|3|||
144570416|NCT01385748|521288072|FG001|Overall Study|Noncompliance|1|||
144570417|NCT01385748|521288073|FG002|Overall Study|Noncompliance|6|||
144570418|NCT01385748|521288071|FG000|Overall Study|Other|1|||
144570419|NCT01385748|521288072|FG001|Overall Study|Other|7|||
144570420|NCT01385748|521288073|FG002|Overall Study|Other|1|||
144570421|NCT01385748|521288071|FG000|Overall Study|Adverse Event|4|||
144570422|NCT01385748|521288072|FG001|Overall Study|Adverse Event|2|||
144570423|NCT01385748|521288073|FG002|Overall Study|Adverse Event|1|||
144570424|NCT02354651|521288074|FG000|Overall Study|Withdrawal by Subject|2|||
144570425|NCT02354651|521288074|FG000|Overall Study|Physician Decision|1|||
144570426|NCT00590564|521288075|FG000|Overall Study|Withdrawal by Subject|4|||
144570427|NCT00590564|521288075|FG000|Overall Study|Lost to Follow-up|6|||
144570428|NCT00590564|521288075|FG000|Overall Study|Protocol Violation|1|||
144570429|NCT00590564|521288075|FG000|Overall Study|Patient Found to be Ineligible|1|||
144570430|NCT00590564|521288075|FG000|Overall Study|Patient Non-compliance|6|||
144570431|NCT01377389|521288078|FG000|Overall Study|Withdrawal by Subject|1|||
144570432|NCT01377389|521288078|FG000|Overall Study|Screen failure|2|||
144570433|NCT02037477|521288080|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
144570434|NCT02037477|521288081|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
144570435|NCT02037477|521288082|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
144570436|NCT02037477|521288083|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
144570437|NCT00983749|521288084|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
144570438|NCT00983749|521288085|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
144570439|NCT05765435|521288086|FG000|Overall Study|Lost to Follow-up|0|||
144570440|NCT05765435|521288087|FG001|Overall Study|Lost to Follow-up|1|||
144570441|NCT05765435|521288088|FG002|Overall Study|Lost to Follow-up|0|||
144570442|NCT05765435|521288086|FG000|Overall Study|Withdrawal by Subject|0|||
144570443|NCT05765435|521288087|FG001|Overall Study|Withdrawal by Subject|0|||
144620547|NCT00852995|521469688|FG004|Overall Study|Protocol Violation|1|||
144620548|NCT00852995|521469684|FG000|Overall Study|Moved Out of Area|1|||
144620549|NCT00852995|521469685|FG001|Overall Study|Moved Out of Area|0|||
144620550|NCT00852995|521469686|FG002|Overall Study|Moved Out of Area|0|||
144620551|NCT00852995|521469687|FG003|Overall Study|Moved Out of Area|0|||
144620552|NCT00852995|521469688|FG004|Overall Study|Moved Out of Area|0|||
144620553|NCT03595553|521469689|FG000|Overall Study|Withdrawal by Subject|20|||
144620554|NCT03595553|521469690|FG001|Overall Study|Withdrawal by Subject|8|||
144620555|NCT03595553|521469689|FG000|Overall Study|Physician Decision|3|||
144620556|NCT03595553|521469690|FG001|Overall Study|Physician Decision|2|||
144620557|NCT03595553|521469689|FG000|Overall Study|Adverse Event|2|||
144620558|NCT03595553|521469690|FG001|Overall Study|Adverse Event|5|||
144620559|NCT03595553|521469689|FG000|Overall Study|Death|24|||
144620560|NCT03595553|521469690|FG001|Overall Study|Death|22|||
144620561|NCT03595553|521469689|FG000|Overall Study|Lost to Follow-up|6|||
144620562|NCT03595553|521469690|FG001|Overall Study|Lost to Follow-up|7|||
144620563|NCT03595553|521469689|FG000|Overall Study|Other as indicated in CSR|3|||
144620564|NCT03595553|521469690|FG001|Overall Study|Other as indicated in CSR|3|||
144620565|NCT03595553|521469689|FG000|Overall Study|Sponsor Decision|0|||
144620566|NCT03595553|521469690|FG001|Overall Study|Sponsor Decision|1|||
144620567|NCT00371865|521469697|FG000|Overall Study|Lack of Efficacy|0|||
144620568|NCT00371865|521469698|FG001|Overall Study|Lack of Efficacy|2|||
144620569|NCT00371865|521469697|FG000|Overall Study|Protocol Violation|3|||
144620570|NCT00371865|521469698|FG001|Overall Study|Protocol Violation|2|||
144620571|NCT00371865|521469697|FG000|Overall Study|Withdrawal by Subject|12|||
144620572|NCT00371865|521469698|FG001|Overall Study|Withdrawal by Subject|10|||
144620573|NCT01632566|521469702|FG000|Overall Study|Withdrawal by Subject|0|||
144207156|NCT02802631|519952513|FG004|Overall Study|Physician Decision|0|||
144570444|NCT05765435|521288088|FG002|Overall Study|Withdrawal by Subject|1|||
144570445|NCT04351269|521288089|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
144570446|NCT04351269|521288090|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
144570447|NCT04351269|521288091|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
144620574|NCT01632566|521469703|FG001|Overall Study|Withdrawal by Subject|1|||
144620575|NCT01632566|521469704|FG002|Overall Study|Withdrawal by Subject|0|||
144207157|NCT02802631|519952514|FG005|Overall Study|Physician Decision|0|||
144207158|NCT02802631|519952515|FG006|Overall Study|Physician Decision|1|||
144207159|NCT02802631|519952516|FG007|Overall Study|Physician Decision|0|||
144207160|NCT02802631|519952509|FG000|Overall Study|Adverse Event|0|||
144207161|NCT02802631|519952510|FG001|Overall Study|Adverse Event|2|||
144207162|NCT02802631|519952511|FG002|Overall Study|Adverse Event|0|||
144207163|NCT02802631|519952512|FG003|Overall Study|Adverse Event|1|||
144207164|NCT02802631|519952513|FG004|Overall Study|Adverse Event|6|||
144207165|NCT02802631|519952514|FG005|Overall Study|Adverse Event|1|||
144207166|NCT02802631|519952515|FG006|Overall Study|Adverse Event|4|||
144207167|NCT02802631|519952516|FG007|Overall Study|Adverse Event|0|||
144262838|NCT01519817|520163760|FG001|Overall Study|Off study due to infection|0|||
144262839|NCT01519817|520163761|FG002|Overall Study|Off study due to infection|0|||
144570448|NCT04351269|521288089|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
144570449|NCT04351269|521288090|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
144570450|NCT04351269|521288091|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
144570451|NCT04351269|521288089|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
144570452|NCT04351269|521288090|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
144570453|NCT04351269|521288091|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
144570454|NCT04351269|521288089|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
144570455|NCT04351269|521288090|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
144570456|NCT04351269|521288091|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
144570457|NCT04351269|521288089|FG000|Overall Study|Lost to Follow-up|1|||
144570458|NCT04351269|521288090|FG001|Overall Study|Lost to Follow-up|3|||
144570459|NCT04351269|521288091|FG002|Overall Study|Lost to Follow-up|0|||
144570460|NCT02367352|521288099|FG000|Overall Study|Progressive disease|7|||
144570461|NCT02367352|521288100|FG001|Overall Study|Progressive disease|0|||
144570462|NCT02367352|521288101|FG002|Overall Study|Progressive disease|0|||
144570463|NCT02367352|521288099|FG000|Overall Study|Participant Received Alternative Therapy|1|||
144570464|NCT02367352|521288100|FG001|Overall Study|Participant Received Alternative Therapy|0|||
144570465|NCT02367352|521288101|FG002|Overall Study|Participant Received Alternative Therapy|0|||
144570466|NCT02367352|521288099|FG000|Overall Study|Adverse Event|1|||
144570467|NCT02367352|521288100|FG001|Overall Study|Adverse Event|0|||
144570468|NCT02367352|521288101|FG002|Overall Study|Adverse Event|0|||
144570469|NCT01013961|521288102|FG000|Overall Study|Adverse Event|2|||
144570470|NCT01013961|521288103|FG001|Overall Study|Adverse Event|2|||
144570471|NCT01013961|521288102|FG000|Overall Study|Withdrawal by Subject|1|||
144570472|NCT01013961|521288103|FG001|Overall Study|Withdrawal by Subject|0|||
144570473|NCT01013961|521288102|FG000|Overall Study|Physician Decision|0|||
144620576|NCT01632566|521469705|FG003|Overall Study|Withdrawal by Subject|0|||
144620577|NCT01632566|521469706|FG004|Overall Study|Withdrawal by Subject|0|||
144620578|NCT01632566|521469702|FG000|Overall Study|Sponsor Decision|0|||
144620579|NCT01632566|521469703|FG001|Overall Study|Sponsor Decision|2|||
144620580|NCT01632566|521469704|FG002|Overall Study|Sponsor Decision|9|||
144620581|NCT01632566|521469705|FG003|Overall Study|Sponsor Decision|2|||
144620582|NCT01632566|521469706|FG004|Overall Study|Sponsor Decision|2|||
144620583|NCT05073458|521469707|FG000|24-week Double-blind Period|Adverse Event|1|||
144620584|NCT05073458|521469708|FG001|24-week Double-blind Period|Adverse Event|0|||
144620585|NCT05073458|521469707|FG000|24-week Double-blind Period|Physician Decision|1|||
144620586|NCT05073458|521469708|FG001|24-week Double-blind Period|Physician Decision|0|||
144620587|NCT05073458|521469707|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
144620588|NCT05073458|521469708|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
144620589|NCT05073458|521469707|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
144620590|NCT05073458|521469708|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
144620591|NCT05073458|521469707|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
144620592|NCT05073458|521469708|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
144620593|NCT05073458|521469707|FG000|24-week Open-label Period|Adverse Event|1|||
144620594|NCT05073458|521469708|FG001|24-week Open-label Period|Adverse Event|2|||
144620595|NCT02158091|521469716|FG000|Overall Study|DLT|2|||
144620596|NCT02158091|521469717|FG001|Overall Study|DLT|1|||
144620597|NCT02158091|521469718|FG002|Overall Study|DLT|0|||
144207168|NCT02802631|519952509|FG000|Overall Study|Sponsor Decision|0|||
144570474|NCT01013961|521288103|FG001|Overall Study|Physician Decision|1|||
144570475|NCT01437423|521288108|FG000|Overall Study|Lost to Follow-up|12|||
144570476|NCT01437423|521288108|FG000|Overall Study|Off label usage|3|||
144570477|NCT01375751|521288109|FG000|Overall Study|Other|0|||
144570478|NCT01375751|521288110|FG001|Overall Study|Other|1|||
144570479|NCT01375751|521288111|FG002|Overall Study|Other|0|||
144620598|NCT04982250|521469726|FG000|Overall Study|Lost to Follow-up|0|||
144620599|NCT04982250|521469727|FG001|Overall Study|Lost to Follow-up|26|||
144620600|NCT04982250|521469728|FG002|Overall Study|Lost to Follow-up|0|||
144620601|NCT04982250|521469729|FG003|Overall Study|Lost to Follow-up|0|||
144620602|NCT04982250|521469730|FG004|Overall Study|Lost to Follow-up|72|||
144620603|NCT04982250|521469731|FG005|Overall Study|Lost to Follow-up|69|||
144207169|NCT02802631|519952510|FG001|Overall Study|Sponsor Decision|0|||
144207170|NCT02802631|519952511|FG002|Overall Study|Sponsor Decision|6|||
144729226|NCT02170688|521863273|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
144729227|NCT02170688|521863269|FG000|Overall Study|Full dose not received|0|||
144729228|NCT02170688|521863270|FG001|Overall Study|Full dose not received|1|||
144729229|NCT02170688|521863271|FG002|Overall Study|Full dose not received|0|||
144729230|NCT02170688|521863272|FG003|Overall Study|Full dose not received|0|||
144729231|NCT02170688|521863273|FG004|Overall Study|Full dose not received|0|||
144729232|NCT02170688|521863269|FG000|Overall Study|Physician Decision|0|||
144729233|NCT02170688|521863270|FG001|Overall Study|Physician Decision|0|||
144729234|NCT02170688|521863271|FG002|Overall Study|Physician Decision|1|||
144729235|NCT02170688|521863272|FG003|Overall Study|Physician Decision|0|||
144729236|NCT02170688|521863273|FG004|Overall Study|Physician Decision|0|||
144729237|NCT02079532|521863276|FG000|Overall Study|Adverse Event|7|||
144729238|NCT02079532|521863276|FG000|Overall Study|Additional or changed therapy|2|||
144207171|NCT02802631|519952512|FG003|Overall Study|Sponsor Decision|0|||
144207172|NCT02802631|519952513|FG004|Overall Study|Sponsor Decision|2|||
144570480|NCT05878873|521288112|FG000|Overall Study|Lost to Follow-up|2|||
144570481|NCT05878873|521288113|FG001|Overall Study|Lost to Follow-up|0|||
144570482|NCT02980523|521288114|FG000|Overall Study|Lost to Follow-up|1|||
144570483|NCT02980523|521288115|FG001|Overall Study|Lost to Follow-up|4|||
144570484|NCT02980523|521288116|FG002|Overall Study|Lost to Follow-up|1|||
144570485|NCT02980523|521288117|FG003|Overall Study|Lost to Follow-up|2|||
144570486|NCT02980523|521288118|FG004|Overall Study|Lost to Follow-up|1|||
144570487|NCT02980523|521288114|FG000|Overall Study|Excluded from analysis|1|||
144570488|NCT02980523|521288115|FG001|Overall Study|Excluded from analysis|3|||
144570489|NCT02980523|521288116|FG002|Overall Study|Excluded from analysis|1|||
144570490|NCT02980523|521288117|FG003|Overall Study|Excluded from analysis|1|||
144570491|NCT02980523|521288118|FG004|Overall Study|Excluded from analysis|1|||
144570492|NCT02980523|521288114|FG000|Overall Study|Lack of Efficacy|1|||
144570493|NCT02980523|521288115|FG001|Overall Study|Lack of Efficacy|4|||
144570494|NCT02980523|521288116|FG002|Overall Study|Lack of Efficacy|4|||
144570495|NCT02980523|521288117|FG003|Overall Study|Lack of Efficacy|5|||
144570496|NCT02980523|521288118|FG004|Overall Study|Lack of Efficacy|8|||
144570497|NCT02980523|521288114|FG000|Overall Study|Did not receive intervention|0|||
144570498|NCT02980523|521288115|FG001|Overall Study|Did not receive intervention|0|||
144570499|NCT02980523|521288116|FG002|Overall Study|Did not receive intervention|0|||
144570500|NCT02980523|521288117|FG003|Overall Study|Did not receive intervention|1|||
144570501|NCT02980523|521288118|FG004|Overall Study|Did not receive intervention|0|||
144570502|NCT00633945|521288119|FG000|Overall Study|Physician Decision|2|||
144570503|NCT02552147|521288120|FG000|First Intervention (7 Days)|Protocol Violation|1|||
144570504|NCT02552147|521288121|FG001|First Intervention (7 Days)|Protocol Violation|0|||
144570505|NCT02552147|521288120|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
144570506|NCT02552147|521288121|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
144570507|NCT00559377|521288123|FG000|Overall Study|Withdrawal by Subject|9|||
144570508|NCT00872001|521288128|FG000|Overall Study|Adverse Event|34|||
144570509|NCT00872001|521288129|FG001|Overall Study|Adverse Event|23|||
144570510|NCT00872001|521288128|FG000|Overall Study|Protocol Defined Clinical Event|5|||
144570511|NCT00872001|521288129|FG001|Overall Study|Protocol Defined Clinical Event|7|||
144570512|NCT00872001|521288128|FG000|Overall Study|Lost to Follow-up|13|||
144570513|NCT00872001|521288129|FG001|Overall Study|Lost to Follow-up|12|||
144570514|NCT00872001|521288128|FG000|Overall Study|Withdrawal by Subject|18|||
144570515|NCT00872001|521288129|FG001|Overall Study|Withdrawal by Subject|30|||
144570516|NCT00872001|521288128|FG000|Overall Study|Protocol Violation|5|||
144570517|NCT00872001|521288129|FG001|Overall Study|Protocol Violation|8|||
144570518|NCT00872001|521288128|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
144570519|NCT00872001|521288129|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
144570520|NCT00872001|521288128|FG000|Overall Study|Administrative|23|||
144570521|NCT00872001|521288129|FG001|Overall Study|Administrative|15|||
144570522|NCT01453023|521288132|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
144570523|NCT01453023|521288133|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
144570524|NCT01453023|521288132|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
144729239|NCT02079532|521863276|FG000|Overall Study|Lack of Efficacy|9|||
144729240|NCT02079532|521863276|FG000|Overall Study|Protocol Violation|3|||
144729241|NCT02079532|521863276|FG000|Overall Study|Withdrawal by Subject|1|||
144729242|NCT02079532|521863276|FG000|Overall Study|Administrative problems|1|||
144570525|NCT01453023|521288133|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
144570526|NCT01453023|521288132|FG000|Treatment Period 2|Protocol Violation|0|||
144570527|NCT01453023|521288133|FG001|Treatment Period 2|Protocol Violation|1|||
144570528|NCT04468230|521288137|FG000|Overall Study|Adverse Event|2|||
144570529|NCT01790295|521288138|FG000|Overall Study|Adverse Event|1|||
144207173|NCT02802631|519952514|FG005|Overall Study|Sponsor Decision|0|||
144207174|NCT02802631|519952515|FG006|Overall Study|Sponsor Decision|0|||
144570530|NCT01790295|521288138|FG000|Overall Study|Death|4|||
144570531|NCT01790295|521288138|FG000|Overall Study|Lack of Efficacy|2|||
144570532|NCT01790295|521288138|FG000|Overall Study|Study closure|4|||
144570533|NCT00420784|521288141|FG000|Overall Study|Adverse Event|11|||
144570534|NCT00420784|521288142|FG001|Overall Study|Adverse Event|29|||
144620604|NCT04982250|521469726|FG000|Overall Study|Not Eligible to Enroll|0|||
144620605|NCT04982250|521469727|FG001|Overall Study|Not Eligible to Enroll|0|||
144620606|NCT04982250|521469728|FG002|Overall Study|Not Eligible to Enroll|0|||
144620607|NCT04982250|521469729|FG003|Overall Study|Not Eligible to Enroll|0|||
144620608|NCT04982250|521469730|FG004|Overall Study|Not Eligible to Enroll|10|||
144620609|NCT04982250|521469731|FG005|Overall Study|Not Eligible to Enroll|7|||
144620610|NCT01358864|521469734|FG000|Overall Study|Adverse Event|0|||
144620611|NCT01358864|521469735|FG001|Overall Study|Adverse Event|6|||
144620612|NCT01358864|521469736|FG002|Overall Study|Adverse Event|9|||
144620613|NCT01358864|521469737|FG003|Overall Study|Adverse Event|0|||
144620614|NCT01358864|521469738|FG004|Overall Study|Adverse Event|4|||
144620615|NCT01358864|521469739|FG005|Overall Study|Adverse Event|8|||
144620616|NCT01358864|521469740|FG006|Overall Study|Adverse Event|12|||
144620617|NCT01358864|521469741|FG007|Overall Study|Adverse Event|7|||
144620618|NCT01358864|521469734|FG000|Overall Study|Lack of Efficacy|26|||
144620619|NCT01358864|521469735|FG001|Overall Study|Lack of Efficacy|3|||
144620620|NCT01358864|521469736|FG002|Overall Study|Lack of Efficacy|4|||
144620621|NCT01358864|521469737|FG003|Overall Study|Lack of Efficacy|19|||
144620622|NCT01358864|521469738|FG004|Overall Study|Lack of Efficacy|7|||
144620623|NCT01358864|521469739|FG005|Overall Study|Lack of Efficacy|4|||
144620624|NCT01358864|521469740|FG006|Overall Study|Lack of Efficacy|49|||
144620625|NCT01358864|521469741|FG007|Overall Study|Lack of Efficacy|44|||
144620626|NCT01358864|521469734|FG000|Overall Study|Lost to Follow-up|0|||
144620627|NCT01358864|521469735|FG001|Overall Study|Lost to Follow-up|0|||
144620628|NCT01358864|521469736|FG002|Overall Study|Lost to Follow-up|1|||
144620629|NCT01358864|521469737|FG003|Overall Study|Lost to Follow-up|0|||
144620630|NCT01358864|521469738|FG004|Overall Study|Lost to Follow-up|0|||
144620631|NCT01358864|521469739|FG005|Overall Study|Lost to Follow-up|0|||
144620632|NCT01358864|521469740|FG006|Overall Study|Lost to Follow-up|0|||
144620633|NCT01358864|521469741|FG007|Overall Study|Lost to Follow-up|1|||
144620634|NCT01358864|521469734|FG000|Overall Study|Withdrawal by Subject|3|||
144620635|NCT01358864|521469735|FG001|Overall Study|Withdrawal by Subject|4|||
144620636|NCT01358864|521469736|FG002|Overall Study|Withdrawal by Subject|2|||
144620637|NCT01358864|521469737|FG003|Overall Study|Withdrawal by Subject|0|||
144620638|NCT01358864|521469738|FG004|Overall Study|Withdrawal by Subject|0|||
144729243|NCT02079532|521863276|FG000|Overall Study|Inclusion into ReFIRST|3|||
144729244|NCT02079532|521863276|FG000|Overall Study|Other|3|||
144570535|NCT00420784|521288143|FG002|Overall Study|Adverse Event|10|||
144570536|NCT00420784|521288144|FG003|Overall Study|Adverse Event|5|||
144570537|NCT00420784|521288141|FG000|Overall Study|Withdrawal by Subject|0|||
144570538|NCT00420784|521288142|FG001|Overall Study|Withdrawal by Subject|1|||
144570539|NCT00420784|521288143|FG002|Overall Study|Withdrawal by Subject|0|||
144570540|NCT00420784|521288144|FG003|Overall Study|Withdrawal by Subject|0|||
144570541|NCT00420784|521288141|FG000|Overall Study|Lost to Follow-up|0|||
144570542|NCT00420784|521288142|FG001|Overall Study|Lost to Follow-up|0|||
144570543|NCT00420784|521288143|FG002|Overall Study|Lost to Follow-up|2|||
144570544|NCT00420784|521288144|FG003|Overall Study|Lost to Follow-up|1|||
144570545|NCT00420784|521288141|FG000|Overall Study|Virologic Stopping Rule|17|||
144570546|NCT00420784|521288142|FG001|Overall Study|Virologic Stopping Rule|26|||
144570547|NCT00420784|521288143|FG002|Overall Study|Virologic Stopping Rule|41|||
144570548|NCT00420784|521288144|FG003|Overall Study|Virologic Stopping Rule|67|||
144570549|NCT00420784|521288141|FG000|Overall Study|Other|1|||
144570550|NCT00420784|521288142|FG001|Overall Study|Other|2|||
144570551|NCT00420784|521288143|FG002|Overall Study|Other|0|||
144570552|NCT00420784|521288144|FG003|Overall Study|Other|5|||
144570553|NCT02417441|521288147|FG000|Overall Study|Inconclusive due to missing data|52|||
144570554|NCT02417441|521288148|FG001|Overall Study|Inconclusive due to missing data|19|||
144570555|NCT00983853|521288149|FG000|Overall Study|Lost to Follow-up|1|||
144570556|NCT00983853|521288150|FG001|Overall Study|Lost to Follow-up|1|||
144570557|NCT00983853|521288151|FG002|Overall Study|Lost to Follow-up|2|||
144570558|NCT00983853|521288152|FG003|Overall Study|Lost to Follow-up|2|||
144570559|NCT00983853|521288153|FG004|Overall Study|Lost to Follow-up|2|||
144570560|NCT00983853|521288154|FG005|Overall Study|Lost to Follow-up|1|||
144570561|NCT00983853|521288149|FG000|Overall Study|Withdrawal by Subject|0|||
144570562|NCT00983853|521288150|FG001|Overall Study|Withdrawal by Subject|0|||
144570563|NCT00983853|521288151|FG002|Overall Study|Withdrawal by Subject|1|||
144620639|NCT01358864|521469739|FG005|Overall Study|Withdrawal by Subject|1|||
144620640|NCT01358864|521469740|FG006|Overall Study|Withdrawal by Subject|1|||
144620641|NCT01358864|521469741|FG007|Overall Study|Withdrawal by Subject|3|||
144620642|NCT01358864|521469734|FG000|Overall Study|Other reason not defined above|2|||
144620643|NCT01358864|521469735|FG001|Overall Study|Other reason not defined above|0|||
144620644|NCT01358864|521469736|FG002|Overall Study|Other reason not defined above|0|||
144620645|NCT01358864|521469737|FG003|Overall Study|Other reason not defined above|0|||
144620646|NCT01358864|521469738|FG004|Overall Study|Other reason not defined above|0|||
144620647|NCT01358864|521469739|FG005|Overall Study|Other reason not defined above|0|||
144620648|NCT01358864|521469740|FG006|Overall Study|Other reason not defined above|2|||
144570564|NCT00983853|521288152|FG003|Overall Study|Withdrawal by Subject|0|||
144570565|NCT00983853|521288153|FG004|Overall Study|Withdrawal by Subject|1|||
144620649|NCT01358864|521469741|FG007|Overall Study|Other reason not defined above|0|||
144620650|NCT01358864|521469734|FG000|Overall Study|Not treated|0|||
144620651|NCT01358864|521469735|FG001|Overall Study|Not treated|0|||
144620652|NCT01358864|521469736|FG002|Overall Study|Not treated|0|||
144620653|NCT01358864|521469737|FG003|Overall Study|Not treated|0|||
144620654|NCT01358864|521469738|FG004|Overall Study|Not treated|0|||
144620655|NCT01358864|521469739|FG005|Overall Study|Not treated|0|||
144620656|NCT01358864|521469740|FG006|Overall Study|Not treated|1|||
144620657|NCT01358864|521469741|FG007|Overall Study|Not treated|0|||
144620658|NCT04042103|521469743|FG000|Overall Study|Lost to Follow-up|1|||
144620659|NCT04042103|521469743|FG000|Overall Study|Withdrawal by Subject|1|||
144620660|NCT04518462|521469745|FG000|Overall Study|Withdrawal by Subject|0|||
144620661|NCT04518462|521469746|FG001|Overall Study|Withdrawal by Subject|0|||
144620662|NCT04518462|521469747|FG002|Overall Study|Withdrawal by Subject|1|||
144620663|NCT04518462|521469745|FG000|Overall Study|Physician Decision|1|||
144620664|NCT04518462|521469746|FG001|Overall Study|Physician Decision|1|||
144620665|NCT04518462|521469747|FG002|Overall Study|Physician Decision|0|||
144620666|NCT01003210|521469748|FG000|Overall Study|Lost to Follow-up|1|||
144620667|NCT01003210|521469749|FG001|Overall Study|Lost to Follow-up|3|||
144620668|NCT00271817|521469750|FG000|Part 1|Adverse Event|68|||
144620669|NCT00271817|521469751|FG001|Part 1|Adverse Event|25|||
144620670|NCT00271817|521469752|FG002|Part 1|Adverse Event|156|||
144620671|NCT00271817|521469750|FG000|Part 1|Lost to Follow-up|6|||
144620672|NCT00271817|521469751|FG001|Part 1|Lost to Follow-up|8|||
144620673|NCT00271817|521469752|FG002|Part 1|Lost to Follow-up|24|||
144620674|NCT00271817|521469750|FG000|Part 1|Protocol Violation|5|||
144620675|NCT00271817|521469751|FG001|Part 1|Protocol Violation|4|||
144620676|NCT00271817|521469752|FG002|Part 1|Protocol Violation|7|||
144620677|NCT00271817|521469750|FG000|Part 1|Patient Moved|3|||
144620678|NCT00271817|521469751|FG001|Part 1|Patient Moved|1|||
144620679|NCT00271817|521469752|FG002|Part 1|Patient Moved|5|||
144620680|NCT00271817|521469750|FG000|Part 1|Withdrawal by Subject|23|||
144620681|NCT00271817|521469751|FG001|Part 1|Withdrawal by Subject|17|||
144620682|NCT00271817|521469752|FG002|Part 1|Withdrawal by Subject|45|||
144620683|NCT00271817|521469750|FG000|Part 1|LDL < 50 mg/dL|1|||
144620684|NCT00271817|521469751|FG001|Part 1|LDL < 50 mg/dL|4|||
144620685|NCT00271817|521469752|FG002|Part 1|LDL < 50 mg/dL|48|||
144620686|NCT00271817|521469750|FG000|Part 2|Adverse Event|0|||
144620687|NCT00271817|521469751|FG001|Part 2|Adverse Event|17|||
144620688|NCT00271817|521469752|FG002|Part 2|Adverse Event|33|||
144620689|NCT00271817|521469750|FG000|Part 2|Lack of Efficacy|0|||
144620690|NCT00271817|521469751|FG001|Part 2|Lack of Efficacy|1|||
144620691|NCT00271817|521469752|FG002|Part 2|Lack of Efficacy|6|||
144620692|NCT00271817|521469750|FG000|Part 2|Lost to Follow-up|0|||
144620693|NCT00271817|521469751|FG001|Part 2|Lost to Follow-up|6|||
144620694|NCT00271817|521469752|FG002|Part 2|Lost to Follow-up|18|||
144620695|NCT00271817|521469750|FG000|Part 2|Protocol Violation|0|||
144620696|NCT00271817|521469751|FG001|Part 2|Protocol Violation|3|||
144620697|NCT00271817|521469752|FG002|Part 2|Protocol Violation|5|||
144620698|NCT00271817|521469750|FG000|Part 2|Patient Moved|0|||
144620699|NCT00271817|521469751|FG001|Part 2|Patient Moved|0|||
144620700|NCT00271817|521469752|FG002|Part 2|Patient Moved|5|||
144620701|NCT00271817|521469750|FG000|Part 2|Withdrawal by Subject|0|||
144620702|NCT00271817|521469751|FG001|Part 2|Withdrawal by Subject|2|||
144620703|NCT00271817|521469752|FG002|Part 2|Withdrawal by Subject|13|||
144620704|NCT00271817|521469750|FG000|Part 2|LDL < 50 mg/dL|0|||
144620705|NCT00271817|521469751|FG001|Part 2|LDL < 50 mg/dL|3|||
144620706|NCT00271817|521469752|FG002|Part 2|LDL < 50 mg/dL|4|||
144620707|NCT01471782|521469753|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
144620708|NCT01471782|521469754|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
144620709|NCT01471782|521469755|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
144620710|NCT01471782|521469756|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
144620711|NCT01471782|521469757|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
144620712|NCT01471782|521469758|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
144620713|NCT01471782|521469753|FG000|Overall Study|Lack of Efficacy|1|||
144620714|NCT01471782|521469754|FG001|Overall Study|Lack of Efficacy|2|||
144620715|NCT01471782|521469755|FG002|Overall Study|Lack of Efficacy|1|||
144620716|NCT01471782|521469756|FG003|Overall Study|Lack of Efficacy|1|||
144620717|NCT01471782|521469757|FG004|Overall Study|Lack of Efficacy|5|||
144620718|NCT01471782|521469758|FG005|Overall Study|Lack of Efficacy|18|||
144620719|NCT01471782|521469753|FG000|Overall Study|Adverse Event|1|||
144620720|NCT01471782|521469754|FG001|Overall Study|Adverse Event|1|||
144620721|NCT01471782|521469755|FG002|Overall Study|Adverse Event|2|||
144620722|NCT01471782|521469756|FG003|Overall Study|Adverse Event|2|||
144620723|NCT01471782|521469757|FG004|Overall Study|Adverse Event|3|||
144620724|NCT01471782|521469758|FG005|Overall Study|Adverse Event|1|||
144620725|NCT01471782|521469753|FG000|Overall Study|Other|0|||
144620726|NCT01471782|521469754|FG001|Overall Study|Other|0|||
144620727|NCT01471782|521469755|FG002|Overall Study|Other|1|||
144620728|NCT01471782|521469756|FG003|Overall Study|Other|1|||
144620729|NCT01471782|521469757|FG004|Overall Study|Other|6|||
144620730|NCT01471782|521469758|FG005|Overall Study|Other|5|||
144620731|NCT01471782|521469753|FG000|Overall Study|Change of Chemotherapy|1|||
144570566|NCT00983853|521288154|FG005|Overall Study|Withdrawal by Subject|0|||
144570567|NCT00983853|521288149|FG000|Overall Study|Unable to come to study follow-up visits|0|||
144570568|NCT00983853|521288150|FG001|Overall Study|Unable to come to study follow-up visits|1|||
144570569|NCT00983853|521288151|FG002|Overall Study|Unable to come to study follow-up visits|0|||
144570570|NCT00983853|521288152|FG003|Overall Study|Unable to come to study follow-up visits|0|||
144570571|NCT00983853|521288153|FG004|Overall Study|Unable to come to study follow-up visits|0|||
144570572|NCT00983853|521288154|FG005|Overall Study|Unable to come to study follow-up visits|0|||
144570573|NCT03016598|521288159|FG000|Overall Study|Lost to Follow-up|0|||
144570574|NCT03016598|521288160|FG001|Overall Study|Lost to Follow-up|2|||
144570575|NCT00632021|521288164|FG000|Overall Study|Withdrawal/death|4|||
144570576|NCT00632021|521288165|FG001|Overall Study|Withdrawal/death|7|||
144570577|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
144570578|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
144570579|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
144570580|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
144570581|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
144570582|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
144570583|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
144570584|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
144570585|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
144570586|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
144570587|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
144570588|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
144570589|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
144570590|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
144570591|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
144570592|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
144570593|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
144570594|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
144570595|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Missing|2|||
144570596|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Missing|1|||
144570597|NCT00443209|521288166|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
144570598|NCT00443209|521288167|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
144570599|NCT00443209|521288166|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
144570600|NCT00443209|521288167|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
144570601|NCT00443209|521288166|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
144570602|NCT00443209|521288167|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
144570603|NCT00443209|521288166|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
144207175|NCT02802631|519952516|FG007|Overall Study|Sponsor Decision|4|||
144207176|NCT02377427|519952517|FG000|Part A (Up to Week 20)|Physician Decision|1|||
144207177|NCT02377427|519952518|FG001|Part A (Up to Week 20)|Physician Decision|0|||
144570604|NCT00443209|521288167|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
144570605|NCT00443209|521288166|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
144570606|NCT00443209|521288167|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
144570607|NCT00443209|521288166|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
144570608|NCT00443209|521288167|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
144570609|NCT00443209|521288166|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
144570610|NCT00443209|521288167|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
144570611|NCT01318876|521288168|FG000|Day 8 Survey|email address invalid|96|||
144570612|NCT01318876|521288168|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
144570613|NCT01318876|521288168|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
144570614|NCT01807182|521288169|FG000|Overall Study|Death|1|||
144570615|NCT01807182|521288169|FG000|Overall Study|New therapy|1|||
144570616|NCT01807182|521288169|FG000|Overall Study|Moved to hospice care|1|||
144570617|NCT03513068|521288170|FG000|Overall Study|Death|1|||
144570618|NCT03513068|521288171|FG001|Overall Study|Death|0|||
144570619|NCT03513068|521288170|FG000|Overall Study|Withdrawal by Subject|4|||
144570620|NCT03513068|521288171|FG001|Overall Study|Withdrawal by Subject|6|||
144570621|NCT01791413|521288172|FG000|Overall Study|Lost to Follow-up|5|||
144570622|NCT01791413|521288173|FG001|Overall Study|Lost to Follow-up|1|||
144570623|NCT03178045|521288174|FG000|Overall Study|Withdrawal by Subject|5|||
144570624|NCT03178045|521288175|FG001|Overall Study|Withdrawal by Subject|7|||
144570625|NCT03178045|521288174|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
144570626|NCT03178045|521288175|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
144570627|NCT03178045|521288174|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
144570628|NCT03178045|521288175|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
144570629|NCT01078922|521288186|FG000|Overall Study|Adverse Event|1|||
144570630|NCT00003477|521288187|FG000|Overall Study|Not evalauable|4|||
144570631|NCT01236352|521288188|FG000|Overall Study|Death|0|||
144570632|NCT01236352|521288189|FG001|Overall Study|Death|0|||
144620732|NCT01471782|521469754|FG001|Overall Study|Change of Chemotherapy|1|||
144620733|NCT01471782|521469755|FG002|Overall Study|Change of Chemotherapy|0|||
144729245|NCT01706926|521863279|FG000|Overall Study|Lost to Follow-up|0|||
144729246|NCT01706926|521863280|FG001|Overall Study|Lost to Follow-up|0|||
144729247|NCT01706926|521863281|FG002|Overall Study|Lost to Follow-up|1|||
144729248|NCT01706926|521863282|FG003|Overall Study|Lost to Follow-up|0|||
144729249|NCT01706926|521863279|FG000|Overall Study|Withdrawal by Subject|2|||
144729250|NCT01706926|521863280|FG001|Overall Study|Withdrawal by Subject|0|||
144729251|NCT01706926|521863281|FG002|Overall Study|Withdrawal by Subject|1|||
144729252|NCT01706926|521863282|FG003|Overall Study|Withdrawal by Subject|2|||
144729253|NCT01706926|521863279|FG000|Overall Study|Other|4|||
144729254|NCT01706926|521863280|FG001|Overall Study|Other|4|||
144729255|NCT01706926|521863281|FG002|Overall Study|Other|4|||
144729256|NCT01706926|521863282|FG003|Overall Study|Other|3|||
144620734|NCT01471782|521469756|FG003|Overall Study|Change of Chemotherapy|0|||
144620735|NCT01471782|521469757|FG004|Overall Study|Change of Chemotherapy|1|||
144620736|NCT01471782|521469758|FG005|Overall Study|Change of Chemotherapy|4|||
144620737|NCT01471782|521469753|FG000|Overall Study|Disease Relapse|0|||
144620738|NCT01471782|521469754|FG001|Overall Study|Disease Relapse|0|||
144620739|NCT01471782|521469755|FG002|Overall Study|Disease Relapse|0|||
144207178|NCT02377427|519952519|FG002|Part A (Up to Week 20)|Physician Decision|0|||
144620740|NCT01471782|521469756|FG003|Overall Study|Disease Relapse|1|||
144620741|NCT01471782|521469757|FG004|Overall Study|Disease Relapse|2|||
144620742|NCT01471782|521469758|FG005|Overall Study|Disease Relapse|1|||
144620743|NCT01471782|521469753|FG000|Overall Study|Physician Decision|0|||
144620744|NCT01471782|521469754|FG001|Overall Study|Physician Decision|0|||
144620745|NCT01471782|521469755|FG002|Overall Study|Physician Decision|0|||
144620746|NCT01471782|521469756|FG003|Overall Study|Physician Decision|0|||
144620747|NCT01471782|521469757|FG004|Overall Study|Physician Decision|3|||
144620748|NCT01471782|521469758|FG005|Overall Study|Physician Decision|8|||
144620749|NCT01471782|521469753|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144620750|NCT01471782|521469754|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144620751|NCT01471782|521469755|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144620752|NCT01471782|521469756|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144620753|NCT01471782|521469757|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
144620754|NCT01471782|521469758|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144620755|NCT01471782|521469753|FG000|Overall Study|Death|0|||
144620756|NCT01471782|521469754|FG001|Overall Study|Death|0|||
144620757|NCT01471782|521469755|FG002|Overall Study|Death|0|||
144620758|NCT01471782|521469756|FG003|Overall Study|Death|0|||
144207179|NCT02377427|519952520|FG003|Part A (Up to Week 20)|Physician Decision|0|||
144207180|NCT02377427|519952521|FG004|Part A (Up to Week 20)|Physician Decision|0|||
144207181|NCT02377427|519952517|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
144207182|NCT02377427|519952518|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
144570633|NCT01236352|521288190|FG002|Overall Study|Death|0|||
144570634|NCT01236352|521288191|FG003|Overall Study|Death|0|||
144570635|NCT01236352|521288192|FG004|Overall Study|Death|0|||
144570636|NCT01236352|521288193|FG005|Overall Study|Death|0|||
144570637|NCT01236352|521288194|FG006|Overall Study|Death|0|||
144570638|NCT01236352|521288195|FG007|Overall Study|Death|1|||
144570639|NCT01236352|521288196|FG008|Overall Study|Death|0|||
144570640|NCT01236352|521288197|FG009|Overall Study|Death|0|||
144570641|NCT01236352|521288198|FG010|Overall Study|Death|0|||
144570642|NCT01236352|521288188|FG000|Overall Study|Withdrawal by Subject|0|||
144570643|NCT01236352|521288189|FG001|Overall Study|Withdrawal by Subject|0|||
144570644|NCT01236352|521288190|FG002|Overall Study|Withdrawal by Subject|0|||
144570645|NCT01236352|521288191|FG003|Overall Study|Withdrawal by Subject|0|||
144570646|NCT01236352|521288192|FG004|Overall Study|Withdrawal by Subject|0|||
144570647|NCT01236352|521288193|FG005|Overall Study|Withdrawal by Subject|0|||
144620759|NCT01471782|521469757|FG004|Overall Study|Death|0|||
144620760|NCT01471782|521469758|FG005|Overall Study|Death|1|||
144620761|NCT00936208|521469759|FG000|Overall Study|Protocol Violation|37|||
144620762|NCT00936208|521469760|FG001|Overall Study|Protocol Violation|22|||
144620763|NCT00861744|521469761|FG000|Overall Study|Adverse Event|0|||
144620764|NCT00861744|521469762|FG001|Overall Study|Adverse Event|0|||
144570648|NCT01236352|521288194|FG006|Overall Study|Withdrawal by Subject|0|||
144570649|NCT01236352|521288195|FG007|Overall Study|Withdrawal by Subject|0|||
144570650|NCT01236352|521288196|FG008|Overall Study|Withdrawal by Subject|0|||
144570651|NCT01236352|521288197|FG009|Overall Study|Withdrawal by Subject|2|||
144570652|NCT01236352|521288198|FG010|Overall Study|Withdrawal by Subject|1|||
144570653|NCT01236352|521288188|FG000|Overall Study|Adverse Event|0|||
144570654|NCT01236352|521288189|FG001|Overall Study|Adverse Event|0|||
144570655|NCT01236352|521288190|FG002|Overall Study|Adverse Event|0|||
144570656|NCT01236352|521288191|FG003|Overall Study|Adverse Event|0|||
144570657|NCT01236352|521288192|FG004|Overall Study|Adverse Event|0|||
144570658|NCT01236352|521288193|FG005|Overall Study|Adverse Event|0|||
144570659|NCT01236352|521288194|FG006|Overall Study|Adverse Event|2|||
144570660|NCT01236352|521288195|FG007|Overall Study|Adverse Event|0|||
144570661|NCT01236352|521288196|FG008|Overall Study|Adverse Event|0|||
144570662|NCT01236352|521288197|FG009|Overall Study|Adverse Event|4|||
144570663|NCT01236352|521288198|FG010|Overall Study|Adverse Event|1|||
144570664|NCT01236352|521288188|FG000|Overall Study|Study drug toxicity|0|||
144570665|NCT01236352|521288189|FG001|Overall Study|Study drug toxicity|0|||
144570666|NCT01236352|521288190|FG002|Overall Study|Study drug toxicity|0|||
144570667|NCT01236352|521288191|FG003|Overall Study|Study drug toxicity|0|||
144570668|NCT01236352|521288192|FG004|Overall Study|Study drug toxicity|0|||
144620765|NCT00861744|521469763|FG002|Overall Study|Adverse Event|0|||
144620766|NCT00861744|521469764|FG003|Overall Study|Adverse Event|1|||
144620767|NCT00861744|521469761|FG000|Overall Study|Lost to Follow-up|7|||
144620768|NCT00861744|521469762|FG001|Overall Study|Lost to Follow-up|19|||
144620769|NCT00861744|521469763|FG002|Overall Study|Lost to Follow-up|17|||
144620770|NCT00861744|521469764|FG003|Overall Study|Lost to Follow-up|12|||
144620771|NCT00861744|521469761|FG000|Overall Study|Withdrawal by Subject|10|||
144620772|NCT00861744|521469762|FG001|Overall Study|Withdrawal by Subject|6|||
144620773|NCT00861744|521469763|FG002|Overall Study|Withdrawal by Subject|6|||
144620774|NCT00861744|521469764|FG003|Overall Study|Withdrawal by Subject|19|||
144620775|NCT00861744|521469761|FG000|Overall Study|Protocol Violation|0|||
144620776|NCT00861744|521469762|FG001|Overall Study|Protocol Violation|1|||
144620777|NCT00861744|521469763|FG002|Overall Study|Protocol Violation|0|||
144620778|NCT00861744|521469764|FG003|Overall Study|Protocol Violation|0|||
144620779|NCT00861744|521469761|FG000|Overall Study|Migration from study area|0|||
144620780|NCT00861744|521469762|FG001|Overall Study|Migration from study area|3|||
144620781|NCT00861744|521469763|FG002|Overall Study|Migration from study area|1|||
144620782|NCT00861744|521469764|FG003|Overall Study|Migration from study area|0|||
144620783|NCT00861744|521469761|FG000|Overall Study|Blood draws|0|||
144620784|NCT00861744|521469762|FG001|Overall Study|Blood draws|0|||
144620785|NCT00861744|521469763|FG002|Overall Study|Blood draws|0|||
144620786|NCT00861744|521469764|FG003|Overall Study|Blood draws|1|||
144620787|NCT01411085|521469765|FG000|Overall Study|Physician Decision|1|||
144620788|NCT01411085|521469765|FG000|Overall Study|Protocol Violation|1|||
144620789|NCT01411085|521469765|FG000|Overall Study|Adverse Event|1|||
144620790|NCT04818593|521469766|FG000|Overall Study|Low Oocyte Yield|8|||
144620791|NCT04818593|521469767|FG001|Overall Study|Low Oocyte Yield|8|||
144620792|NCT04818593|521469766|FG000|Overall Study|Not ICSI Insemination|7|||
144620793|NCT04818593|521469767|FG001|Overall Study|Not ICSI Insemination|7|||
144620794|NCT04818593|521469766|FG000|Overall Study|Poor Sperm Quality|2|||
144620795|NCT04818593|521469767|FG001|Overall Study|Poor Sperm Quality|2|||
144620796|NCT04818593|521469766|FG000|Overall Study|Withdrawal by Subject|2|||
144620797|NCT04818593|521469767|FG001|Overall Study|Withdrawal by Subject|2|||
144620798|NCT04818593|521469766|FG000|Overall Study|Conversion to IUI due to low response|1|||
144620799|NCT04818593|521469767|FG001|Overall Study|Conversion to IUI due to low response|1|||
144620800|NCT01564862|521469768|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
144620801|NCT01564862|521469769|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
144620802|NCT01564862|521469770|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
144620803|NCT01564862|521469768|FG000|Overall Study|Major Protocol Deviation|3|||
144620804|NCT01564862|521469769|FG001|Overall Study|Major Protocol Deviation|3|||
144620805|NCT01564862|521469770|FG002|Overall Study|Major Protocol Deviation|4|||
144620806|NCT01564862|521469768|FG000|Overall Study|Lost to Follow-up|10|||
144620807|NCT01564862|521469769|FG001|Overall Study|Lost to Follow-up|8|||
144620808|NCT01564862|521469770|FG002|Overall Study|Lost to Follow-up|6|||
144620809|NCT01564862|521469768|FG000|Overall Study|Voluntary Withdrawal|9|||
144620810|NCT01564862|521469769|FG001|Overall Study|Voluntary Withdrawal|6|||
144620811|NCT01564862|521469770|FG002|Overall Study|Voluntary Withdrawal|8|||
144620812|NCT01564862|521469768|FG000|Overall Study|Lack of Efficacy|1|||
144620813|NCT01564862|521469769|FG001|Overall Study|Lack of Efficacy|5|||
144620814|NCT01564862|521469770|FG002|Overall Study|Lack of Efficacy|6|||
144620815|NCT01564862|521469768|FG000|Overall Study|Other reason(s)|1|||
144620816|NCT01564862|521469769|FG001|Overall Study|Other reason(s)|0|||
144620817|NCT01564862|521469770|FG002|Overall Study|Other reason(s)|0|||
144620818|NCT03809611|521469771|FG000|Overall Study|Withdrawal by Subject|1|||
144620819|NCT03809611|521469772|FG001|Overall Study|Withdrawal by Subject|1|||
144620820|NCT02193074|521469775|FG000|Overall Study|Withdrawal by Subject|1|||
144620821|NCT02193074|521469776|FG001|Overall Study|Withdrawal by Subject|2|||
144570669|NCT01236352|521288193|FG005|Overall Study|Study drug toxicity|1|||
144620822|NCT02193074|521469775|FG000|Overall Study|Adverse Event|16|||
144620823|NCT02193074|521469776|FG001|Overall Study|Adverse Event|13|||
144570670|NCT01236352|521288194|FG006|Overall Study|Study drug toxicity|1|||
144570671|NCT01236352|521288195|FG007|Overall Study|Study drug toxicity|0|||
144570672|NCT01236352|521288196|FG008|Overall Study|Study drug toxicity|0|||
144570673|NCT01236352|521288197|FG009|Overall Study|Study drug toxicity|2|||
144570674|NCT01236352|521288198|FG010|Overall Study|Study drug toxicity|2|||
144570675|NCT01236352|521288188|FG000|Overall Study|Disease progression|1|||
144570676|NCT01236352|521288189|FG001|Overall Study|Disease progression|2|||
144570677|NCT01236352|521288190|FG002|Overall Study|Disease progression|1|||
144570678|NCT01236352|521288191|FG003|Overall Study|Disease progression|2|||
144570679|NCT01236352|521288192|FG004|Overall Study|Disease progression|2|||
144570680|NCT01236352|521288193|FG005|Overall Study|Disease progression|2|||
144570681|NCT01236352|521288194|FG006|Overall Study|Disease progression|1|||
144570682|NCT01236352|521288195|FG007|Overall Study|Disease progression|3|||
144570683|NCT01236352|521288196|FG008|Overall Study|Disease progression|2|||
144570684|NCT01236352|521288197|FG009|Overall Study|Disease progression|2|||
144570685|NCT01236352|521288198|FG010|Overall Study|Disease progression|2|||
144570686|NCT01236352|521288188|FG000|Overall Study|Poor/Non-compliance|1|||
144570687|NCT01236352|521288189|FG001|Overall Study|Poor/Non-compliance|0|||
144570688|NCT01236352|521288190|FG002|Overall Study|Poor/Non-compliance|0|||
144570689|NCT01236352|521288191|FG003|Overall Study|Poor/Non-compliance|0|||
144570690|NCT01236352|521288192|FG004|Overall Study|Poor/Non-compliance|0|||
144570691|NCT01236352|521288193|FG005|Overall Study|Poor/Non-compliance|0|||
144570692|NCT01236352|521288194|FG006|Overall Study|Poor/Non-compliance|0|||
144570693|NCT01236352|521288195|FG007|Overall Study|Poor/Non-compliance|0|||
144570694|NCT01236352|521288196|FG008|Overall Study|Poor/Non-compliance|0|||
144570695|NCT01236352|521288197|FG009|Overall Study|Poor/Non-compliance|0|||
144570696|NCT01236352|521288198|FG010|Overall Study|Poor/Non-compliance|0|||
144570697|NCT01236352|521288188|FG000|Overall Study|Maximum clinical benefit|1|||
144570698|NCT01236352|521288189|FG001|Overall Study|Maximum clinical benefit|1|||
144570699|NCT01236352|521288190|FG002|Overall Study|Maximum clinical benefit|1|||
144570700|NCT01236352|521288191|FG003|Overall Study|Maximum clinical benefit|0|||
144570701|NCT01236352|521288192|FG004|Overall Study|Maximum clinical benefit|2|||
144570702|NCT01236352|521288193|FG005|Overall Study|Maximum clinical benefit|0|||
144570703|NCT01236352|521288194|FG006|Overall Study|Maximum clinical benefit|3|||
144570704|NCT01236352|521288195|FG007|Overall Study|Maximum clinical benefit|1|||
144570705|NCT01236352|521288196|FG008|Overall Study|Maximum clinical benefit|1|||
144570706|NCT01236352|521288197|FG009|Overall Study|Maximum clinical benefit|4|||
144570707|NCT01236352|521288198|FG010|Overall Study|Maximum clinical benefit|2|||
144570708|NCT01236352|521288188|FG000|Overall Study|Subject request to discontinue treatment|0|||
144570709|NCT01236352|521288189|FG001|Overall Study|Subject request to discontinue treatment|0|||
144570710|NCT01236352|521288190|FG002|Overall Study|Subject request to discontinue treatment|1|||
144570711|NCT01236352|521288191|FG003|Overall Study|Subject request to discontinue treatment|1|||
144570712|NCT01236352|521288192|FG004|Overall Study|Subject request to discontinue treatment|0|||
144570713|NCT01236352|521288193|FG005|Overall Study|Subject request to discontinue treatment|1|||
144570714|NCT01236352|521288194|FG006|Overall Study|Subject request to discontinue treatment|0|||
144570715|NCT01236352|521288195|FG007|Overall Study|Subject request to discontinue treatment|0|||
144570716|NCT01236352|521288196|FG008|Overall Study|Subject request to discontinue treatment|0|||
144570717|NCT01236352|521288197|FG009|Overall Study|Subject request to discontinue treatment|1|||
144570718|NCT01236352|521288198|FG010|Overall Study|Subject request to discontinue treatment|4|||
144570719|NCT01236352|521288188|FG000|Overall Study|Subject to receive drug via EAP|1|||
144570720|NCT01236352|521288189|FG001|Overall Study|Subject to receive drug via EAP|1|||
144570721|NCT01236352|521288190|FG002|Overall Study|Subject to receive drug via EAP|1|||
144570722|NCT01236352|521288191|FG003|Overall Study|Subject to receive drug via EAP|0|||
144570723|NCT01236352|521288192|FG004|Overall Study|Subject to receive drug via EAP|0|||
144570724|NCT01236352|521288193|FG005|Overall Study|Subject to receive drug via EAP|0|||
144570725|NCT01236352|521288194|FG006|Overall Study|Subject to receive drug via EAP|0|||
144570726|NCT01236352|521288195|FG007|Overall Study|Subject to receive drug via EAP|2|||
144570727|NCT01236352|521288196|FG008|Overall Study|Subject to receive drug via EAP|0|||
144570728|NCT01236352|521288197|FG009|Overall Study|Subject to receive drug via EAP|4|||
144570729|NCT01236352|521288198|FG010|Overall Study|Subject to receive drug via EAP|0|||
144570730|NCT01236352|521288188|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
144570731|NCT01236352|521288189|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
144570732|NCT01236352|521288190|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
144570733|NCT01236352|521288191|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
144570734|NCT01236352|521288192|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
144570735|NCT01236352|521288193|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
144729257|NCT00745420|521864594|FG000|Overall Study|Ineligible|1|||
144570736|NCT01236352|521288194|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
144570737|NCT01236352|521288195|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
144570738|NCT01236352|521288196|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
144570739|NCT01236352|521288197|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
144570740|NCT01236352|521288198|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
144570741|NCT01236352|521288188|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144207183|NCT02377427|519952519|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
144620824|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
144620825|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
144620826|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
144620827|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
144620828|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
144570742|NCT01236352|521288189|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570743|NCT01236352|521288190|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144620829|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
144620830|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
144620831|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
144620832|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
144620833|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
144620834|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
144570744|NCT01236352|521288191|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570745|NCT01236352|521288192|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570746|NCT01236352|521288193|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570747|NCT01236352|521288194|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570748|NCT01236352|521288195|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570749|NCT01236352|521288196|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570750|NCT01236352|521288197|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
144570751|NCT01236352|521288198|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
144570752|NCT01236352|521288188|FG000|Overall Study|Lack of response to drug|0|||
144570753|NCT01236352|521288189|FG001|Overall Study|Lack of response to drug|0|||
144570754|NCT01236352|521288190|FG002|Overall Study|Lack of response to drug|0|||
144570755|NCT01236352|521288191|FG003|Overall Study|Lack of response to drug|0|||
144570756|NCT01236352|521288192|FG004|Overall Study|Lack of response to drug|0|||
144570757|NCT01236352|521288193|FG005|Overall Study|Lack of response to drug|0|||
144570758|NCT01236352|521288194|FG006|Overall Study|Lack of response to drug|0|||
144570759|NCT01236352|521288195|FG007|Overall Study|Lack of response to drug|0|||
144570760|NCT01236352|521288196|FG008|Overall Study|Lack of response to drug|0|||
144570761|NCT01236352|521288197|FG009|Overall Study|Lack of response to drug|1|||
144570762|NCT01236352|521288198|FG010|Overall Study|Lack of response to drug|1|||
144570763|NCT01236352|521288188|FG000|Overall Study|Patient transferred to IST|0|||
144570764|NCT01236352|521288189|FG001|Overall Study|Patient transferred to IST|0|||
144570765|NCT01236352|521288190|FG002|Overall Study|Patient transferred to IST|0|||
144570766|NCT01236352|521288191|FG003|Overall Study|Patient transferred to IST|0|||
144570767|NCT01236352|521288192|FG004|Overall Study|Patient transferred to IST|0|||
144570768|NCT01236352|521288193|FG005|Overall Study|Patient transferred to IST|0|||
144570769|NCT01236352|521288194|FG006|Overall Study|Patient transferred to IST|0|||
144570770|NCT01236352|521288195|FG007|Overall Study|Patient transferred to IST|0|||
144570771|NCT01236352|521288196|FG008|Overall Study|Patient transferred to IST|0|||
144570772|NCT01236352|521288197|FG009|Overall Study|Patient transferred to IST|2|||
144570773|NCT01236352|521288198|FG010|Overall Study|Patient transferred to IST|6|||
144570774|NCT01850030|521288199|FG000|Overall Study|Adverse Event|64|||
144570775|NCT01850030|521288200|FG001|Overall Study|Adverse Event|82|||
144570776|NCT01850030|521288199|FG000|Overall Study|Lack of Efficacy|3|||
144570777|NCT01850030|521288200|FG001|Overall Study|Lack of Efficacy|1|||
144570778|NCT01850030|521288199|FG000|Overall Study|Lost to Follow-up|5|||
144570779|NCT01850030|521288200|FG001|Overall Study|Lost to Follow-up|5|||
144570780|NCT01850030|521288199|FG000|Overall Study|Withdrawal by Subject|3|||
144570781|NCT01850030|521288200|FG001|Overall Study|Withdrawal by Subject|4|||
144570782|NCT01850030|521288199|FG000|Overall Study|Protocol Violation|24|||
144570783|NCT01850030|521288200|FG001|Overall Study|Protocol Violation|28|||
144570784|NCT01850030|521288199|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
144570785|NCT01850030|521288200|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
144570786|NCT00246090|521288201|FG000|Overall Study|Adverse Event|25|||
144570787|NCT00246090|521288201|FG000|Overall Study|Withdrawal by Subject|7|||
144570788|NCT00246090|521288201|FG000|Overall Study|Progressive Disease|212|||
144570789|NCT00246090|521288201|FG000|Overall Study|Clinical Progression|30|||
144620835|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
144620836|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
144620837|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
144620838|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
144620839|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
144729258|NCT02152566|521864595|FG000|Overall Study|Lost to Follow-up|1|||
144570790|NCT00246090|521288201|FG000|Overall Study|Physician Decision|11|||
144570791|NCT00246090|521288201|FG000|Overall Study|Not Otherwise Specified|10|||
144570792|NCT00715117|521288208|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
144570793|NCT00715117|521288209|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
144570794|NCT01191008|521288213|FG000|Overall Study|Protocol Violation|7|||
144570795|NCT01191008|521288213|FG000|Overall Study|Lost to Follow-up|8|||
144729259|NCT02152566|521864595|FG000|Overall Study|Withdrawal by Subject|2|||
144570796|NCT00978562|521288214|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
144570797|NCT03371823|521288217|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
144570798|NCT03371823|521288218|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
144570799|NCT00926575|521288219|FG000|Overall Study|Adverse Event|1|||
144570800|NCT00926575|521288220|FG001|Overall Study|Adverse Event|1|||
144570801|NCT00926575|521288219|FG000|Overall Study|Death|4|||
144570802|NCT00926575|521288220|FG001|Overall Study|Death|4|||
144570803|NCT00926575|521288219|FG000|Overall Study|Lost to Follow-up|1|||
144570804|NCT00926575|521288220|FG001|Overall Study|Lost to Follow-up|1|||
144570805|NCT00926575|521288219|FG000|Overall Study|Physician Decision|1|||
144570806|NCT00926575|521288220|FG001|Overall Study|Physician Decision|2|||
144570807|NCT00926575|521288219|FG000|Overall Study|Protocol Violation|1|||
144570808|NCT00926575|521288220|FG001|Overall Study|Protocol Violation|0|||
144570809|NCT00926575|521288219|FG000|Overall Study|Withdrawal by Subject|8|||
144570810|NCT00926575|521288220|FG001|Overall Study|Withdrawal by Subject|9|||
144570811|NCT02559310|521288226|FG000|Overall Study|Death|4|||
144570812|NCT02559310|521288227|FG001|Overall Study|Death|3|||
144570813|NCT02559310|521288226|FG000|Overall Study|Lost to Follow-up|5|||
144570814|NCT02559310|521288227|FG001|Overall Study|Lost to Follow-up|3|||
144570815|NCT02559310|521288226|FG000|Overall Study|Physician Decision|2|||
144570816|NCT02559310|521288227|FG001|Overall Study|Physician Decision|1|||
144570817|NCT02559310|521288226|FG000|Overall Study|Withdrawal by Subject|13|||
144570818|NCT02559310|521288227|FG001|Overall Study|Withdrawal by Subject|9|||
144570819|NCT02559310|521288226|FG000|Overall Study|Sponsor Decision|0|||
144570820|NCT02559310|521288227|FG001|Overall Study|Sponsor Decision|1|||
144570821|NCT02559310|521288226|FG000|Overall Study|Randomized but not treated|3|||
144570822|NCT02559310|521288227|FG001|Overall Study|Randomized but not treated|2|||
144570823|NCT03595878|521288229|FG000|Overall Study|Death|2|||
144570824|NCT03595878|521288230|FG001|Overall Study|Death|1|||
144570825|NCT03595878|521288231|FG002|Overall Study|Death|0|||
144570826|NCT03595878|521288229|FG000|Overall Study|Disease progression|2|||
144570827|NCT03595878|521288230|FG001|Overall Study|Disease progression|1|||
144570828|NCT03595878|521288231|FG002|Overall Study|Disease progression|2|||
144570829|NCT03494985|521288232|FG000|Overall Study|Adverse Event|3|||
144570830|NCT03494985|521288233|FG001|Overall Study|Adverse Event|2|||
144570831|NCT03494985|521288234|FG002|Overall Study|Adverse Event|3|||
144570832|NCT03494985|521288235|FG003|Overall Study|Adverse Event|0|||
144570833|NCT03494985|521288232|FG000|Overall Study|Other (Withdrawal of consent)|2|||
144570834|NCT03494985|521288233|FG001|Overall Study|Other (Withdrawal of consent)|3|||
144570835|NCT03494985|521288234|FG002|Overall Study|Other (Withdrawal of consent)|2|||
144570836|NCT03494985|521288235|FG003|Overall Study|Other (Withdrawal of consent)|5|||
144570837|NCT03494985|521288232|FG000|Overall Study|Other (Not specified)|0|||
144570838|NCT03494985|521288233|FG001|Overall Study|Other (Not specified)|1|||
144570839|NCT03494985|521288234|FG002|Overall Study|Other (Not specified)|1|||
144570840|NCT03494985|521288235|FG003|Overall Study|Other (Not specified)|0|||
144570841|NCT04124471|521288236|FG000|Overall Study|screen failure|1|||
144570842|NCT03036124|521288237|FG000|Overall Study|Lost to Follow-up|0|||
144570843|NCT03036124|521288238|FG001|Overall Study|Lost to Follow-up|2|||
144570844|NCT03036124|521288237|FG000|Overall Study|Withdrawal by Subject|5|||
144570845|NCT03036124|521288238|FG001|Overall Study|Withdrawal by Subject|4|||
144570846|NCT02282059|521288239|FG000|Overall Study|Other|15|||
144570847|NCT02282059|521288240|FG001|Overall Study|Other|3|||
144570848|NCT02282059|521288239|FG000|Overall Study|Participant refused further follow-up|8|||
144570849|NCT02282059|521288240|FG001|Overall Study|Participant refused further follow-up|4|||
144570850|NCT02282059|521288239|FG000|Overall Study|Lost to Follow-up|19|||
144570851|NCT02282059|521288240|FG001|Overall Study|Lost to Follow-up|3|||
144570852|NCT02282059|521288239|FG000|Overall Study|Death|40|||
144570853|NCT02282059|521288240|FG001|Overall Study|Death|8|||
144570854|NCT02394925|521288241|FG000|Overall Study|Adverse Event|1|||
144570855|NCT02394925|521288241|FG000|Overall Study|Lens Discomfort|3|||
144570856|NCT02394925|521288241|FG000|Overall Study|Lens handling difficulities|5|||
144570857|NCT02394925|521288241|FG000|Overall Study|Lost to Follow-up|9|||
144570858|NCT02394925|521288241|FG000|Overall Study|Protocol Violation|5|||
144570859|NCT02394925|521288241|FG000|Overall Study|No longer meet eligibility criteria|1|||
144570860|NCT02394925|521288241|FG000|Overall Study|Unsatisfactory Visual Response|5|||
144570861|NCT05347485|521288247|FG000|Overall Study|Death|14|||
144620840|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
144570862|NCT05347485|521288247|FG000|Overall Study|Lost to Follow-up|2|||
144570863|NCT05347485|521288247|FG000|Overall Study|Withdrawal by Subject|13|||
144570864|NCT05347485|521288247|FG000|Overall Study|Progressive Disease|1|||
144570865|NCT05347485|521288247|FG000|Overall Study|Study Terminated by Sponsor|49|||
144570866|NCT05347485|521288247|FG000|Overall Study|Other|1|||
144570867|NCT05347485|521288247|FG000|Overall Study|Enrolled (consented) but not treated|4|||
144570868|NCT05347485|521288247|FG000|Overall Study|Disease Relapse|2|||
144570869|NCT04886518|521288248|FG000|Overall Study|Noncompliance with study drug|1|||
144570870|NCT04886518|521288249|FG001|Overall Study|Noncompliance with study drug|0|||
144570871|NCT04886518|521288250|FG002|Overall Study|Noncompliance with study drug|0|||
144729260|NCT02942264|521864597|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729261|NCT02942264|521864598|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
144729262|NCT02942264|521864599|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729263|NCT02942264|521864600|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729264|NCT02942264|521864601|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729265|NCT02942264|521864602|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729266|NCT02942264|521864603|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
144729267|NCT02942264|521864604|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729268|NCT02942264|521864605|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
144729269|NCT02942264|521864597|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729270|NCT02942264|521864598|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729271|NCT02942264|521864599|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729272|NCT02942264|521864600|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729273|NCT02942264|521864601|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729274|NCT02942264|521864602|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729275|NCT02942264|521864603|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729276|NCT02942264|521864604|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
144729277|NCT02942264|521864605|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
144729278|NCT01328093|521864606|FG000|Double-Blind Phase|Adverse Event|78|||
144729279|NCT01328093|521864607|FG001|Double-Blind Phase|Adverse Event|15|||
144729280|NCT01328093|521864606|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
144729281|NCT01328093|521864607|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
144570872|NCT04886518|521288248|FG000|Overall Study|Adverse Event|0|||
144570873|NCT04886518|521288249|FG001|Overall Study|Adverse Event|1|||
144570874|NCT04886518|521288250|FG002|Overall Study|Adverse Event|0|||
144570875|NCT04886518|521288248|FG000|Overall Study|Withdrawal by Subject|1|||
144570876|NCT04886518|521288249|FG001|Overall Study|Withdrawal by Subject|0|||
144570877|NCT04886518|521288250|FG002|Overall Study|Withdrawal by Subject|0|||
144570878|NCT00127842|521289778|FG000|Overall Study|Adverse Event|15|||
144570879|NCT00127842|521289778|FG000|Overall Study|Withdrawal by Subject|3|||
144570880|NCT00127842|521289778|FG000|Overall Study|Lost to Follow-up|1|||
144570881|NCT00127842|521289778|FG000|Overall Study|Lack of Efficacy|12|||
144570882|NCT00127842|521289778|FG000|Overall Study|Noncompliance|2|||
144570883|NCT00127842|521289778|FG000|Overall Study|Protocol Violation|1|||
144570884|NCT00127842|521289778|FG000|Overall Study|Other|5|||
144570885|NCT01730950|521289779|FG000|Overall Study|Protocol Violation|6|||
144570886|NCT01730950|521289780|FG001|Overall Study|Protocol Violation|6|||
144570887|NCT00667459|521289781|FG000|Overall Study|Death|0|||
144570888|NCT00667459|521289782|FG001|Overall Study|Death|2|||
144570889|NCT00667459|521289781|FG000|Overall Study|Lost to Follow-up|8|||
144570890|NCT00667459|521289782|FG001|Overall Study|Lost to Follow-up|43|||
144570891|NCT02568397|521289783|FG000|Period 2|Withdrawal by Subject|0|||
144570892|NCT02568397|521289784|FG001|Period 2|Withdrawal by Subject|1|||
144570893|NCT02568397|521289783|FG000|Period 2|Physician Decision|0|||
144570894|NCT02568397|521289784|FG001|Period 2|Physician Decision|1|||
144570895|NCT00581893|521289785|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
144570896|NCT00581893|521289786|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
144570897|NCT02684123|521289787|FG000|Phase 1|Lack of Efficacy|5|||
144570898|NCT02684123|521289788|FG001|Phase 1|Lack of Efficacy|0|||
144570899|NCT02684123|521289787|FG000|Phase 1|Adverse Event|3|||
144570900|NCT02684123|521289788|FG001|Phase 1|Adverse Event|0|||
144570901|NCT02684123|521289787|FG000|Phase 1|Lost to Follow-up|0|||
144570902|NCT02684123|521289788|FG001|Phase 1|Lost to Follow-up|1|||
144570903|NCT02684123|521289787|FG000|Phase 2|Lack of Efficacy|1|||
144570904|NCT02684123|521289788|FG001|Phase 2|Lack of Efficacy|8|||
144570905|NCT01245140|521289796|FG000|Overall Study|Adverse Event|1|||
144570906|NCT01245140|521289797|FG001|Overall Study|Adverse Event|3|||
144570907|NCT01245140|521289796|FG000|Overall Study|Lack of Efficacy|2|||
144570908|NCT01245140|521289797|FG001|Overall Study|Lack of Efficacy|4|||
144570909|NCT01245140|521289796|FG000|Overall Study|Protocol Violation|0|||
144570910|NCT01245140|521289797|FG001|Overall Study|Protocol Violation|1|||
144570911|NCT01245140|521289796|FG000|Overall Study|Withdrawal by Subject|0|||
144570912|NCT01245140|521289797|FG001|Overall Study|Withdrawal by Subject|1|||
144570913|NCT01245140|521289796|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
144570914|NCT01245140|521289797|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
144570915|NCT02635360|521289798|FG000|Overall Study|Adverse Event|0|||
144570916|NCT02635360|521289799|FG001|Overall Study|Adverse Event|3|||
144570917|NCT02635360|521289798|FG000|Overall Study|Withdrawal by Subject|2|||
144729282|NCT01328093|521864606|FG000|Double-Blind Phase|Lost to Follow-up|39|||
144570918|NCT02635360|521289799|FG001|Overall Study|Withdrawal by Subject|0|||
144570919|NCT02635360|521289798|FG000|Overall Study|Non-Compliance|3|||
144570920|NCT02635360|521289799|FG001|Overall Study|Non-Compliance|1|||
144570921|NCT02635360|521289798|FG000|Overall Study|Disease Progression|0|||
144570922|NCT02635360|521289799|FG001|Overall Study|Disease Progression|2|||
144570923|NCT02635360|521289798|FG000|Overall Study|Lost to Follow-up|1|||
144570924|NCT02635360|521289799|FG001|Overall Study|Lost to Follow-up|1|||
144570925|NCT00334542|521289800|FG000|Overall Study|Adverse Event|3|||
144570926|NCT00334542|521289800|FG000|Overall Study|Withdrawal by Subject|1|||
144570927|NCT00334542|521289800|FG000|Overall Study|New cancer diagnosis|1|||
144570928|NCT01454739|521289805|FG000|Overall Study|Protocol Violation|2|||
144570929|NCT01454739|521289806|FG001|Overall Study|Protocol Violation|3|||
144570930|NCT01454739|521289805|FG000|Overall Study|Withdrawal by Subject|2|||
144570931|NCT01454739|521289806|FG001|Overall Study|Withdrawal by Subject|6|||
144570932|NCT01454739|521289805|FG000|Overall Study|Other|3|||
144570933|NCT01454739|521289806|FG001|Overall Study|Other|5|||
144570934|NCT01454739|521289805|FG000|Overall Study|Physician Decision|0|||
144570935|NCT01454739|521289806|FG001|Overall Study|Physician Decision|5|||
144570936|NCT01454739|521289805|FG000|Overall Study|Lost to Follow-up|0|||
144570937|NCT01454739|521289806|FG001|Overall Study|Lost to Follow-up|1|||
144570938|NCT01454739|521289805|FG000|Overall Study|Adverse Event|0|||
144570939|NCT01454739|521289806|FG001|Overall Study|Adverse Event|1|||
144570940|NCT02375347|521289821|FG000|Overall Study|Protocol Violation|1|||
144570941|NCT00193479|521289822|FG000|Induction Chemotherapy|Adverse Event|2|||
144570942|NCT00193479|521289822|FG000|Induction Chemotherapy|Disease Progression|1|||
144570943|NCT00193479|521289822|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
144570944|NCT00193479|521289822|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
144570945|NCT01547598|521289824|FG000|Overall Study|Withdrew consent|1|||
144570946|NCT01547598|521289825|FG001|Overall Study|Withdrew consent|1|||
144570947|NCT01547598|521289824|FG000|Overall Study|Lost to Follow-up|1|||
144570948|NCT01547598|521289825|FG001|Overall Study|Lost to Follow-up|1|||
144570949|NCT01547598|521289824|FG000|Overall Study|Adverse Event|1|||
144570950|NCT01547598|521289825|FG001|Overall Study|Adverse Event|1|||
144570951|NCT01547598|521289824|FG000|Overall Study|Protocol Violation|1|||
144570952|NCT01547598|521289825|FG001|Overall Study|Protocol Violation|1|||
144570953|NCT01547598|521289824|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144570954|NCT01547598|521289825|FG001|Overall Study|Other Miscellaneous Reasons|1|||
144570955|NCT02229227|521289829|FG000|Overall Study|Adverse Event|14|||
144570956|NCT02229227|521289830|FG001|Overall Study|Adverse Event|9|||
144570957|NCT02229227|521289829|FG000|Overall Study|Lack of Efficacy|3|||
144570958|NCT02229227|521289830|FG001|Overall Study|Lack of Efficacy|3|||
144570959|NCT02229227|521289829|FG000|Overall Study|Protocol Violation|6|||
144570960|NCT02229227|521289830|FG001|Overall Study|Protocol Violation|8|||
144570961|NCT02229227|521289829|FG000|Overall Study|Protocol defined stopping criteria|1|||
144570962|NCT02229227|521289830|FG001|Overall Study|Protocol defined stopping criteria|3|||
144570963|NCT02229227|521289829|FG000|Overall Study|Lost to Follow-up|3|||
144570964|NCT02229227|521289830|FG001|Overall Study|Lost to Follow-up|3|||
144570965|NCT02229227|521289829|FG000|Overall Study|Study terminated by sponsor|11|||
144570966|NCT02229227|521289830|FG001|Overall Study|Study terminated by sponsor|11|||
144570967|NCT02229227|521289829|FG000|Overall Study|Withdrawal by Subject|8|||
144570968|NCT02229227|521289830|FG001|Overall Study|Withdrawal by Subject|12|||
144570969|NCT02229227|521289829|FG000|Overall Study|Other|0|||
144570970|NCT02229227|521289830|FG001|Overall Study|Other|1|||
144570971|NCT02229227|521289829|FG000|Overall Study|Physician Decision|5|||
144570972|NCT02229227|521289830|FG001|Overall Study|Physician Decision|12|||
144570973|NCT00340704|521289831|FG000|PK Study|Adverse Event|0|||
144570974|NCT00340704|521289832|FG001|PK Study|Adverse Event|1|||
144570975|NCT00340704|521289833|FG002|PK Study|Adverse Event|0|||
144570976|NCT00340704|521289834|FG003|PK Study|Adverse Event|0|||
144570977|NCT00340704|521289835|FG004|PK Study|Adverse Event|0|||
144570978|NCT00340704|521289836|FG005|PK Study|Adverse Event|0|||
144570979|NCT00340704|521289837|FG006|PK Study|Adverse Event|0|||
144570980|NCT00340704|521289838|FG007|PK Study|Adverse Event|0|||
144570981|NCT00340704|521289839|FG008|PK Study|Adverse Event|0|||
144570982|NCT00340704|521289831|FG000|PK Study|Not treated|0|||
144570983|NCT00340704|521289832|FG001|PK Study|Not treated|0|||
144570984|NCT00340704|521289833|FG002|PK Study|Not treated|1|||
144570985|NCT00340704|521289834|FG003|PK Study|Not treated|0|||
144570986|NCT00340704|521289835|FG004|PK Study|Not treated|0|||
144570987|NCT00340704|521289836|FG005|PK Study|Not treated|0|||
144620841|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
144620842|NCT02600494|521469777|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
144700086|NCT03759340|521754506|FG000|Overall Study|Study Terminated by Sponsor|38|||
144570988|NCT00340704|521289837|FG006|PK Study|Not treated|0|||
144570989|NCT00340704|521289838|FG007|PK Study|Not treated|0|||
144570990|NCT00340704|521289839|FG008|PK Study|Not treated|0|||
144570991|NCT00340704|521289831|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
144570992|NCT00340704|521289832|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
144570993|NCT00340704|521289833|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
144570994|NCT00340704|521289834|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
144570995|NCT00340704|521289835|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
144570996|NCT00340704|521289836|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
144570997|NCT00340704|521289837|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
144570998|NCT00340704|521289838|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
144570999|NCT00340704|521289839|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
144571000|NCT00340704|521289831|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144620843|NCT02600494|521469778|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
144571001|NCT00340704|521289832|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571002|NCT00340704|521289833|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571003|NCT00340704|521289834|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571004|NCT00340704|521289835|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571005|NCT00340704|521289836|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
144571006|NCT00340704|521289837|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571007|NCT00340704|521289838|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571008|NCT00340704|521289839|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
144571009|NCT00340704|521289831|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571010|NCT00340704|521289832|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571011|NCT00340704|521289833|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571012|NCT00340704|521289834|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571013|NCT00340704|521289835|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
144571014|NCT00340704|521289836|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
144571015|NCT00340704|521289837|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571016|NCT00340704|521289838|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571017|NCT00340704|521289839|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
144571018|NCT00340704|521289831|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
144571019|NCT00340704|521289832|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
144571020|NCT00340704|521289833|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
144571021|NCT00340704|521289834|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
144571022|NCT00340704|521289835|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
144571023|NCT00340704|521289836|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
144571024|NCT00340704|521289837|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
144571025|NCT00340704|521289838|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
144571026|NCT00340704|521289839|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
144571027|NCT00121667|521289840|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
144571028|NCT00121667|521289841|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
144571029|NCT00121667|521289842|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
144571030|NCT00121667|521289843|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
144571031|NCT00121667|521289840|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
144571032|NCT00121667|521289841|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
144571033|NCT00121667|521289842|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
144571034|NCT00121667|521289843|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
144571035|NCT00121667|521289840|FG000|Short Term (ST) Period|Adverse Event|5|||
144571036|NCT00121667|521289841|FG001|Short Term (ST) Period|Adverse Event|6|||
144571037|NCT00121667|521289842|FG002|Short Term (ST) Period|Adverse Event|5|||
144571038|NCT00121667|521289843|FG003|Short Term (ST) Period|Adverse Event|3|||
144571039|NCT00121667|521289840|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
144571040|NCT00121667|521289841|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
144571041|NCT00121667|521289842|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
144571042|NCT00121667|521289843|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
144571043|NCT00121667|521289840|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
144571044|NCT00121667|521289841|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
144571045|NCT00121667|521289842|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
144571046|NCT00121667|521289843|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
144571047|NCT00121667|521289840|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
144571048|NCT00121667|521289841|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
144571049|NCT00121667|521289842|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
144571050|NCT00121667|521289843|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
144571051|NCT00121667|521289840|FG000|Short Term (ST) Period|Other Reason|3|||
144571052|NCT00121667|521289841|FG001|Short Term (ST) Period|Other Reason|0|||
144571053|NCT00121667|521289842|FG002|Short Term (ST) Period|Other Reason|0|||
144571054|NCT00121667|521289843|FG003|Short Term (ST) Period|Other Reason|0|||
144571055|NCT00121667|521289840|FG000|Short Term (ST) Period|Death|0|||
144571056|NCT00121667|521289841|FG001|Short Term (ST) Period|Death|0|||
144571057|NCT00121667|521289842|FG002|Short Term (ST) Period|Death|0|||
144571058|NCT00121667|521289843|FG003|Short Term (ST) Period|Death|1|||
144571059|NCT00121667|521289840|FG000|Short Term (ST) Period|Pregnancy|0|||
144571060|NCT00121667|521289841|FG001|Short Term (ST) Period|Pregnancy|0|||
144571061|NCT00121667|521289842|FG002|Short Term (ST) Period|Pregnancy|0|||
144571062|NCT00121667|521289843|FG003|Short Term (ST) Period|Pregnancy|1|||
144571063|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
144571064|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
144571065|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
144620844|NCT02600494|521469779|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
144207184|NCT02377427|519952520|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
144571066|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
144571067|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
144571068|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
144571069|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
144571070|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
144571071|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
144571072|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
144571073|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
144571074|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
144571075|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
144571076|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
144571077|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
144571078|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
144571079|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
144571080|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
144571081|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
144571082|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
144571083|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
144571084|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
144571085|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
144620845|NCT02600494|521469777|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
144620846|NCT02600494|521469778|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
144620847|NCT02600494|521469779|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
144620848|NCT02600494|521469777|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
144620849|NCT02600494|521469778|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
144620850|NCT02600494|521469779|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
144620851|NCT02600494|521469777|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
144620852|NCT02600494|521469778|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
144620853|NCT02600494|521469779|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
144620854|NCT02600494|521469777|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
144620855|NCT02600494|521469778|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
144620856|NCT02600494|521469779|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
144620857|NCT02600494|521469777|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
144620858|NCT02600494|521469778|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
144620859|NCT02600494|521469779|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
144620860|NCT02600494|521469777|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
144620861|NCT02600494|521469778|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
144620862|NCT02600494|521469779|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
144620863|NCT03124563|521469780|FG000|Overall Study|Lost to Follow-up|1|||
144620864|NCT03124563|521469781|FG001|Overall Study|Lost to Follow-up|1|||
144620865|NCT03124563|521469780|FG000|Overall Study|Withdrawal by Subject|1|||
144620866|NCT03124563|521469781|FG001|Overall Study|Withdrawal by Subject|1|||
144620867|NCT02605642|521472123|FG000|Overall Study|Other|11|||
144620868|NCT02605642|521472124|FG001|Overall Study|Other|1|||
144620869|NCT02605642|521472123|FG000|Overall Study|Participant non-compliance|2|||
144620870|NCT02605642|521472124|FG001|Overall Study|Participant non-compliance|4|||
144620871|NCT02605642|521472123|FG000|Overall Study|Physician Decision|10|||
144620872|NCT02605642|521472124|FG001|Overall Study|Physician Decision|0|||
144620873|NCT02605642|521472123|FG000|Overall Study|Lost to Follow-up|12|||
144620874|NCT02605642|521472124|FG001|Overall Study|Lost to Follow-up|1|||
144620875|NCT02605642|521472123|FG000|Overall Study|Adverse Event|14|||
144620876|NCT02605642|521472124|FG001|Overall Study|Adverse Event|2|||
144620877|NCT02605642|521472123|FG000|Overall Study|Withdrawal by Subject|23|||
144620878|NCT02605642|521472124|FG001|Overall Study|Withdrawal by Subject|2|||
144620879|NCT02605642|521472123|FG000|Overall Study|Lack of response|24|||
144620880|NCT02605642|521472124|FG001|Overall Study|Lack of response|11|||
144620881|NCT00699348|521472134|FG000|Overall Study|Death|6|||
144620882|NCT00699348|521472134|FG000|Overall Study|Adverse Event|15|||
144620883|NCT00699348|521472134|FG000|Overall Study|Withdrawal by Subject|11|||
144620884|NCT00699348|521472134|FG000|Overall Study|Protocol Violation|10|||
144620885|NCT00699348|521472134|FG000|Overall Study|Lack of Efficacy|8|||
144620886|NCT00699348|521472134|FG000|Overall Study|Failure to return|1|||
144207185|NCT02377427|519952521|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
144620887|NCT00699348|521472134|FG000|Overall Study|Blood transfusion|24|||
144620888|NCT00699348|521472134|FG000|Overall Study|Renal transplantation|10|||
144207186|NCT02377427|519952517|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
144207187|NCT02377427|519952518|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
144207188|NCT02377427|519952519|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
144729283|NCT01328093|521864607|FG001|Double-Blind Phase|Lost to Follow-up|14|||
144729284|NCT01328093|521864606|FG000|Double-Blind Phase|Protocol Violation|30|||
144729285|NCT01328093|521864607|FG001|Double-Blind Phase|Protocol Violation|10|||
144729286|NCT01328093|521864606|FG000|Double-Blind Phase|Lack of Efficacy|55|||
144729287|NCT01328093|521864607|FG001|Double-Blind Phase|Lack of Efficacy|13|||
144729288|NCT01328093|521864606|FG000|Double-Blind Phase|Sponsor Decision|17|||
144729289|NCT01328093|521864607|FG001|Double-Blind Phase|Sponsor Decision|3|||
144729290|NCT01328093|521864606|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
144729291|NCT01328093|521864607|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
144729292|NCT01328093|521864606|FG000|Double-Blind Phase|Scheduling conflict|8|||
144729293|NCT01328093|521864607|FG001|Double-Blind Phase|Scheduling conflict|3|||
144729294|NCT01328093|521864606|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
144729295|NCT01328093|521864607|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
144729296|NCT01328093|521864606|FG000|Double-Blind Phase|Death|1|||
144729297|NCT01328093|521864607|FG001|Double-Blind Phase|Death|0|||
144729298|NCT01328093|521864606|FG000|Open-Label Phase|Sponsor Decision|98|||
144729299|NCT01328093|521864607|FG001|Open-Label Phase|Sponsor Decision|34|||
144729300|NCT01328093|521864606|FG000|Open-Label Phase|Protocol Violation|8|||
144729301|NCT01328093|521864607|FG001|Open-Label Phase|Protocol Violation|3|||
144729302|NCT01328093|521864606|FG000|Open-Label Phase|Lost to Follow-up|10|||
144729303|NCT01328093|521864607|FG001|Open-Label Phase|Lost to Follow-up|1|||
144729304|NCT01328093|521864606|FG000|Open-Label Phase|Adverse Event|10|||
144729305|NCT01328093|521864607|FG001|Open-Label Phase|Adverse Event|4|||
144729306|NCT01328093|521864606|FG000|Open-Label Phase|Lack of Efficacy|5|||
144729307|NCT01328093|521864607|FG001|Open-Label Phase|Lack of Efficacy|6|||
144729308|NCT01328093|521864606|FG000|Open-Label Phase|Withdrawal by Subject|4|||
144729309|NCT01328093|521864607|FG001|Open-Label Phase|Withdrawal by Subject|1|||
144729310|NCT01328093|521864606|FG000|Open-Label Phase|Scheduling conflict|2|||
144729311|NCT01328093|521864607|FG001|Open-Label Phase|Scheduling conflict|1|||
144729312|NCT01328093|521864606|FG000|Open-Label Phase|Subject is moving or has moved|2|||
144729313|NCT01328093|521864607|FG001|Open-Label Phase|Subject is moving or has moved|0|||
144729314|NCT01328093|521864606|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
144729315|NCT01328093|521864607|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
144729316|NCT03980483|521864608|FG000|Overall Study|Adverse Event|13|||
144729317|NCT03980483|521864609|FG001|Overall Study|Adverse Event|29|||
144729318|NCT03980483|521864610|FG002|Overall Study|Adverse Event|11|||
144729319|NCT03980483|521864611|FG003|Overall Study|Adverse Event|2|||
144729320|NCT03980483|521864612|FG004|Overall Study|Adverse Event|2|||
144729321|NCT03980483|521864613|FG005|Overall Study|Adverse Event|2|||
144729322|NCT03980483|521864608|FG000|Overall Study|Lack of Efficacy|7|||
144729323|NCT03980483|521864609|FG001|Overall Study|Lack of Efficacy|6|||
144729324|NCT03980483|521864610|FG002|Overall Study|Lack of Efficacy|0|||
144729325|NCT03980483|521864611|FG003|Overall Study|Lack of Efficacy|3|||
144729326|NCT03980483|521864612|FG004|Overall Study|Lack of Efficacy|1|||
144729327|NCT03980483|521864613|FG005|Overall Study|Lack of Efficacy|1|||
144729328|NCT03980483|521864608|FG000|Overall Study|Lost to Follow-up|2|||
144729329|NCT03980483|521864609|FG001|Overall Study|Lost to Follow-up|4|||
144729330|NCT03980483|521864610|FG002|Overall Study|Lost to Follow-up|2|||
144729331|NCT03980483|521864611|FG003|Overall Study|Lost to Follow-up|1|||
144729332|NCT03980483|521864612|FG004|Overall Study|Lost to Follow-up|2|||
144729333|NCT03980483|521864613|FG005|Overall Study|Lost to Follow-up|0|||
144729334|NCT03980483|521864608|FG000|Overall Study|Protocol Violation|4|||
144729335|NCT03980483|521864609|FG001|Overall Study|Protocol Violation|2|||
144729336|NCT03980483|521864610|FG002|Overall Study|Protocol Violation|1|||
144729337|NCT03980483|521864611|FG003|Overall Study|Protocol Violation|1|||
144729338|NCT03980483|521864612|FG004|Overall Study|Protocol Violation|0|||
144729339|NCT03980483|521864613|FG005|Overall Study|Protocol Violation|0|||
144729340|NCT03980483|521864608|FG000|Overall Study|Physician Decision|14|||
144729341|NCT03980483|521864609|FG001|Overall Study|Physician Decision|10|||
144729342|NCT03980483|521864610|FG002|Overall Study|Physician Decision|7|||
144729343|NCT03980483|521864611|FG003|Overall Study|Physician Decision|4|||
144729344|NCT03980483|521864612|FG004|Overall Study|Physician Decision|4|||
144729345|NCT03980483|521864613|FG005|Overall Study|Physician Decision|2|||
144729346|NCT03980483|521864608|FG000|Overall Study|Withdrawal by Subject|38|||
144729347|NCT03980483|521864609|FG001|Overall Study|Withdrawal by Subject|21|||
144729348|NCT03980483|521864610|FG002|Overall Study|Withdrawal by Subject|15|||
144729349|NCT03980483|521864611|FG003|Overall Study|Withdrawal by Subject|5|||
144729350|NCT03980483|521864612|FG004|Overall Study|Withdrawal by Subject|3|||
144729351|NCT03980483|521864613|FG005|Overall Study|Withdrawal by Subject|4|||
144729352|NCT03980483|521864608|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
144729353|NCT03980483|521864609|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
144729354|NCT03980483|521864610|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144729355|NCT03980483|521864611|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
144729356|NCT03980483|521864612|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144729357|NCT03980483|521864613|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
144729358|NCT03980483|521864608|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
144729359|NCT03980483|521864609|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
144571086|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
144571087|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
144571088|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
144571089|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
144571090|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
144571091|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
144571092|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
144571093|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
144571094|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
144571095|NCT00121667|521289840|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
144571096|NCT00121667|521289841|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
144571097|NCT00121667|521289842|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
144571098|NCT00121667|521289843|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
144571099|NCT02879383|521289844|FG000|First 24 Weeks|Physician Decision|0|||
144571100|NCT02879383|521289845|FG001|First 24 Weeks|Physician Decision|1|||
144571101|NCT02879383|521289846|FG002|First 24 Weeks|Physician Decision|0|||
144571102|NCT02879383|521289847|FG003|First 24 Weeks|Physician Decision|0|||
144571103|NCT05186311|521289848|FG000|Part A: Serum|Withdrawal by Subject|1|||
144571104|NCT02125279|521289849|FG000|Overall Study|Lack of Efficacy|2|||
144571105|NCT02125279|521289849|FG000|Overall Study|Withdrawal by Subject|6|||
144571106|NCT02125279|521289849|FG000|Overall Study|Protocol Violation|1|||
144571107|NCT02125279|521289849|FG000|Overall Study|Lost to Follow-up|4|||
144571108|NCT01080300|521289855|FG000|Overall Study|Adverse Event|49|||
144571109|NCT01080300|521289856|FG001|Overall Study|Adverse Event|35|||
144571110|NCT01080300|521289855|FG000|Overall Study|Lack of Efficacy|12|||
144571111|NCT01080300|521289856|FG001|Overall Study|Lack of Efficacy|15|||
144571112|NCT01080300|521289855|FG000|Overall Study|Protocol Violation|7|||
144571113|NCT01080300|521289856|FG001|Overall Study|Protocol Violation|13|||
144571114|NCT01080300|521289855|FG000|Overall Study|Lost to Follow-up|10|||
144571115|NCT01080300|521289856|FG001|Overall Study|Lost to Follow-up|6|||
144571116|NCT01080300|521289855|FG000|Overall Study|Death|0|||
144571117|NCT01080300|521289856|FG001|Overall Study|Death|1|||
144571118|NCT01080300|521289855|FG000|Overall Study|Withdrawal by Subject|12|||
144571119|NCT01080300|521289856|FG001|Overall Study|Withdrawal by Subject|28|||
144571120|NCT01080300|521289855|FG000|Overall Study|Reasons not specified|4|||
144571121|NCT01080300|521289856|FG001|Overall Study|Reasons not specified|6|||
144571122|NCT00478205|521289858|FG000|Overall Study|Adverse Event|182|||
144571123|NCT00478205|521289859|FG001|Overall Study|Adverse Event|39|||
144571124|NCT00478205|521289858|FG000|Overall Study|Medication Non-compliance|9|||
144571125|NCT00478205|521289859|FG001|Overall Study|Medication Non-compliance|4|||
144571126|NCT00478205|521289858|FG000|Overall Study|Protocol Violation|15|||
144571127|NCT00478205|521289859|FG001|Overall Study|Protocol Violation|5|||
144571128|NCT00478205|521289858|FG000|Overall Study|Request of Investigator or Sponsor|4|||
144571129|NCT00478205|521289859|FG001|Overall Study|Request of Investigator or Sponsor|5|||
144571130|NCT00478205|521289858|FG000|Overall Study|Withdrawal by Subject|61|||
144571131|NCT00478205|521289859|FG001|Overall Study|Withdrawal by Subject|22|||
144571132|NCT00478205|521289858|FG000|Overall Study|Lack of Efficacy|1|||
144571133|NCT00478205|521289859|FG001|Overall Study|Lack of Efficacy|0|||
144571134|NCT00478205|521289858|FG000|Overall Study|Other|24|||
144571135|NCT00478205|521289859|FG001|Overall Study|Other|12|||
144571136|NCT04016272|521289861|FG000|Overall Study|Withdrawal by Subject|1|||
144571137|NCT04016272|521289862|FG001|Overall Study|Withdrawal by Subject|2|||
144571138|NCT00825305|521289863|FG000|Overall Study|Adverse Event|1|||
144571139|NCT00825305|521289864|FG001|Overall Study|Adverse Event|1|||
144571140|NCT00825305|521289863|FG000|Overall Study|Withdrawal by Subject|6|||
144571141|NCT00825305|521289864|FG001|Overall Study|Withdrawal by Subject|12|||
144571142|NCT00825305|521289863|FG000|Overall Study|Inappropriate inclusion|1|||
144571143|NCT00825305|521289864|FG001|Overall Study|Inappropriate inclusion|0|||
144571144|NCT00825305|521289863|FG000|Overall Study|Protocol Violation|9|||
144571145|NCT00825305|521289864|FG001|Overall Study|Protocol Violation|9|||
144571146|NCT00825305|521289863|FG000|Overall Study|Can not be classified|0|||
144571147|NCT00825305|521289864|FG001|Overall Study|Can not be classified|1|||
144571148|NCT02353468|521289867|FG000|Overall Study|Study terminated|3|||
144571149|NCT01536171|521289874|FG000|Overall Study|Withdrawal by Subject|1|||
144571150|NCT00585078|521289875|FG000|Overall Study|Withdrawal by Subject|4|||
144571151|NCT00585078|521289875|FG000|Overall Study|Poor performance status|1|||
144571152|NCT00585078|521289875|FG000|Overall Study|Disease Progression|24|||
144571153|NCT00585078|521289875|FG000|Overall Study|Adverse Event|10|||
144571154|NCT00585078|521289875|FG000|Overall Study|Death|1|||
144571155|NCT01018732|521289876|FG000|Overall Study|Lost to Follow-up|0|||
144571156|NCT01018732|521289877|FG001|Overall Study|Lost to Follow-up|0|||
144571157|NCT01018732|521289878|FG002|Overall Study|Lost to Follow-up|3|||
144620889|NCT00699348|521472134|FG000|Overall Study|Other|5|||
144571158|NCT01018732|521289876|FG000|Overall Study|Protocol Violation|1|||
144620890|NCT01268293|521472135|FG000|Overall Study|Disease progression|7|||
144620891|NCT01268293|521472135|FG000|Overall Study|Adverse Event|1|||
144620892|NCT01268293|521472135|FG000|Overall Study|Subject choice|1|||
144729360|NCT03980483|521864610|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
144729361|NCT03980483|521864611|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
144729362|NCT03980483|521864612|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
144729363|NCT03980483|521864613|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
144729364|NCT03980483|521864608|FG000|Overall Study|Other|0|||
144729365|NCT03980483|521864609|FG001|Overall Study|Other|1|||
144729366|NCT03980483|521864610|FG002|Overall Study|Other|0|||
144729367|NCT03980483|521864611|FG003|Overall Study|Other|0|||
144729368|NCT03980483|521864612|FG004|Overall Study|Other|0|||
144729369|NCT03980483|521864613|FG005|Overall Study|Other|0|||
144729370|NCT03657160|521864614|FG000|Overall Study|Adverse Event|5|||
144729371|NCT03657160|521864615|FG001|Overall Study|Adverse Event|6|||
144729372|NCT03657160|521864614|FG000|Overall Study|Protocol Deviation|3|||
144729373|NCT03657160|521864615|FG001|Overall Study|Protocol Deviation|0|||
144729374|NCT03657160|521864614|FG000|Overall Study|Withdrawal by Subject|18|||
144729375|NCT03657160|521864615|FG001|Overall Study|Withdrawal by Subject|16|||
144729376|NCT03657160|521864614|FG000|Overall Study|Site Termination|1|||
144729377|NCT03657160|521864615|FG001|Overall Study|Site Termination|0|||
144729378|NCT03657160|521864614|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
144729379|NCT03657160|521864615|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
144729380|NCT03657160|521864614|FG000|Overall Study|Death|33|||
144729381|NCT03657160|521864615|FG001|Overall Study|Death|26|||
144729382|NCT03657160|521864614|FG000|Overall Study|Death (COVID-19-Related)|1|||
144729383|NCT03657160|521864615|FG001|Overall Study|Death (COVID-19-Related)|0|||
144729384|NCT03657160|521864614|FG000|Overall Study|Reason Not Specified|5|||
144729385|NCT03657160|521864615|FG001|Overall Study|Reason Not Specified|5|||
144729386|NCT03657160|521864614|FG000|Overall Study|Other (COVID-19-Related)|0|||
144729387|NCT03657160|521864615|FG001|Overall Study|Other (COVID-19-Related)|1|||
144729388|NCT00686959|521864617|FG000|Overall Study|Participants censored (no death events)|124|||
144729389|NCT00686959|521864618|FG001|Overall Study|Participants censored (no death events)|117|||
144729390|NCT01449630|521864619|FG000|Period 1|Physician Decision|1|||
144729391|NCT01449630|521864620|FG001|Period 1|Physician Decision|0|||
144729392|NCT01449630|521864621|FG002|Period 1|Physician Decision|0|||
144729393|NCT01449630|521864622|FG003|Period 1|Physician Decision|1|||
144729394|NCT01449630|521864623|FG004|Period 1|Physician Decision|0|||
144729395|NCT01449630|521864624|FG005|Period 1|Physician Decision|0|||
144729396|NCT01449630|521864625|FG006|Period 1|Physician Decision|0|||
144729397|NCT01449630|521864626|FG007|Period 1|Physician Decision|0|||
144729398|NCT01449630|521864627|FG008|Period 1|Physician Decision|0|||
144729399|NCT01449630|521864619|FG000|Period 1|Sponsor Decision|0|||
144729400|NCT01449630|521864620|FG001|Period 1|Sponsor Decision|0|||
144729401|NCT01449630|521864621|FG002|Period 1|Sponsor Decision|0|||
144729402|NCT01449630|521864622|FG003|Period 1|Sponsor Decision|0|||
144729403|NCT01449630|521864623|FG004|Period 1|Sponsor Decision|0|||
144729404|NCT01449630|521864624|FG005|Period 1|Sponsor Decision|1|||
144729405|NCT01449630|521864625|FG006|Period 1|Sponsor Decision|0|||
144729406|NCT01449630|521864626|FG007|Period 1|Sponsor Decision|0|||
144729407|NCT01449630|521864627|FG008|Period 1|Sponsor Decision|0|||
144729408|NCT01449630|521864619|FG000|Period 2|Sponsor Decision|0|||
144729409|NCT01449630|521864620|FG001|Period 2|Sponsor Decision|0|||
144729410|NCT01449630|521864621|FG002|Period 2|Sponsor Decision|0|||
144729411|NCT01449630|521864622|FG003|Period 2|Sponsor Decision|0|||
144729412|NCT01449630|521864623|FG004|Period 2|Sponsor Decision|0|||
144729413|NCT01449630|521864624|FG005|Period 2|Sponsor Decision|0|||
144729414|NCT01449630|521864625|FG006|Period 2|Sponsor Decision|1|||
144729415|NCT01449630|521864626|FG007|Period 2|Sponsor Decision|0|||
144729416|NCT01449630|521864627|FG008|Period 2|Sponsor Decision|0|||
144729417|NCT01735630|521864629|FG000|Overall Study|Adverse Event|8|||
144207189|NCT02377427|519952520|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
144207190|NCT02377427|519952521|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
144207191|NCT02377427|519952517|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
144207192|NCT02377427|519952518|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
144207193|NCT02377427|519952519|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
144207194|NCT02377427|519952520|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
144207195|NCT02377427|519952521|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
144207196|NCT03395405|519954253|FG000|Overall Study|Death|0|||
144729418|NCT01735630|521864630|FG001|Overall Study|Adverse Event|7|||
144729419|NCT01735630|521864629|FG000|Overall Study|Lost to Follow-up|1|||
144729420|NCT01735630|521864630|FG001|Overall Study|Lost to Follow-up|0|||
144729421|NCT01735630|521864629|FG000|Overall Study|Physician Decision|0|||
144729422|NCT01735630|521864630|FG001|Overall Study|Physician Decision|1|||
144729423|NCT01735630|521864629|FG000|Overall Study|Sponsor Decision|2|||
144729424|NCT01735630|521864630|FG001|Overall Study|Sponsor Decision|1|||
144729425|NCT01735630|521864629|FG000|Overall Study|Withdrawal by Subject|7|||
144729426|NCT01735630|521864630|FG001|Overall Study|Withdrawal by Subject|9|||
144729427|NCT01572948|521864631|FG000|Overall Study|Lost to Follow-up|1|||
144729428|NCT01572948|521864632|FG001|Overall Study|Lost to Follow-up|0|||
144729429|NCT01572948|521864631|FG000|Overall Study|unable to contact|0|||
144729430|NCT01572948|521864632|FG001|Overall Study|unable to contact|1|||
144729431|NCT01126736|521864638|FG000|Overall Study|Death|2|||
144729432|NCT01126736|521864639|FG001|Overall Study|Death|2|||
144729433|NCT01126736|521864640|FG002|Overall Study|Death|1|||
144729434|NCT01126736|521864641|FG003|Overall Study|Death|19|||
144729435|NCT01126736|521864642|FG004|Overall Study|Death|19|||
144729436|NCT01126736|521864638|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
144729437|NCT01126736|521864639|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
144729438|NCT01126736|521864640|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
144729439|NCT01126736|521864641|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
144729440|NCT01126736|521864642|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
144729441|NCT01126736|521864638|FG000|Overall Study|Lost to Follow-up|0|||
144729442|NCT01126736|521864639|FG001|Overall Study|Lost to Follow-up|0|||
144729443|NCT01126736|521864640|FG002|Overall Study|Lost to Follow-up|0|||
144729444|NCT01126736|521864641|FG003|Overall Study|Lost to Follow-up|1|||
144729445|NCT01126736|521864642|FG004|Overall Study|Lost to Follow-up|1|||
144729446|NCT01126736|521864638|FG000|Overall Study|Administrative reasons|0|||
144729447|NCT01126736|521864639|FG001|Overall Study|Administrative reasons|0|||
144729448|NCT01126736|521864640|FG002|Overall Study|Administrative reasons|0|||
144729449|NCT01126736|521864641|FG003|Overall Study|Administrative reasons|0|||
144729450|NCT01126736|521864642|FG004|Overall Study|Administrative reasons|1|||
144729451|NCT01126736|521864638|FG000|Overall Study|Progressive disease|0|||
144729452|NCT01126736|521864639|FG001|Overall Study|Progressive disease|0|||
144729453|NCT01126736|521864640|FG002|Overall Study|Progressive disease|0|||
144729454|NCT01126736|521864641|FG003|Overall Study|Progressive disease|2|||
144729455|NCT01126736|521864642|FG004|Overall Study|Progressive disease|1|||
144207197|NCT03395405|519954254|FG001|Overall Study|Death|2|||
144207198|NCT03395405|519954253|FG000|Overall Study|Lost to Follow-up|0|||
144207199|NCT03395405|519954254|FG001|Overall Study|Lost to Follow-up|1|||
144207200|NCT03395405|519954253|FG000|Overall Study|Protocol Violation|0|||
144207201|NCT03395405|519954254|FG001|Overall Study|Protocol Violation|1|||
144207202|NCT03395405|519954253|FG000|Overall Study|Withdrawal by Subject|3|||
144207203|NCT03395405|519954254|FG001|Overall Study|Withdrawal by Subject|1|||
144207204|NCT03395405|519954253|FG000|Overall Study|COVID-19 Pandemic|1|||
144729456|NCT01126736|521864638|FG000|Overall Study|Withdrawal by Subject|0|||
144729457|NCT01126736|521864639|FG001|Overall Study|Withdrawal by Subject|0|||
144729458|NCT01126736|521864640|FG002|Overall Study|Withdrawal by Subject|0|||
144729459|NCT01126736|521864641|FG003|Overall Study|Withdrawal by Subject|1|||
144729460|NCT01126736|521864642|FG004|Overall Study|Withdrawal by Subject|1|||
144729461|NCT01126736|521864638|FG000|Overall Study|Other|2|||
144729462|NCT01126736|521864639|FG001|Overall Study|Other|4|||
144729463|NCT01126736|521864640|FG002|Overall Study|Other|4|||
144729464|NCT01126736|521864641|FG003|Overall Study|Other|16|||
144729465|NCT01126736|521864642|FG004|Overall Study|Other|15|||
144729466|NCT01720264|521864647|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
144729467|NCT01720264|521864647|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
144729468|NCT01720264|521864647|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
144729469|NCT02107092|521864650|FG000|Overall Study|Miscellaneous|3|||
144729470|NCT02107092|521864650|FG000|Overall Study|Subject compliance|3|||
144729471|NCT02107092|521864650|FG000|Overall Study|Hypo-or hyperkalemia|2|||
144729472|NCT02107092|521864650|FG000|Overall Study|Met ECG withdrawal criteria|3|||
144729473|NCT02107092|521864650|FG000|Overall Study|Physician Decision|3|||
144729474|NCT02107092|521864650|FG000|Overall Study|Lost to Follow-up|2|||
144729475|NCT02107092|521864650|FG000|Overall Study|Withdrawal by Subject|9|||
144729476|NCT02107092|521864650|FG000|Overall Study|Adverse Event|7|||
144729477|NCT02107092|521864650|FG000|Overall Study|Expected progression of CKD|12|||
144729478|NCT04213326|521864655|FG000|Overall Study|Consent withdrawn|51|||
144729479|NCT04213326|521864656|FG001|Overall Study|Consent withdrawn|241|||
144729480|NCT04213326|521864655|FG000|Overall Study|Lost to Follow-up|50|||
144729481|NCT04213326|521864656|FG001|Overall Study|Lost to Follow-up|902|||
144729482|NCT04213326|521864655|FG000|Overall Study|Protocol Violation|3|||
144729483|NCT04213326|521864656|FG001|Overall Study|Protocol Violation|25|||
144207205|NCT03395405|519954254|FG001|Overall Study|COVID-19 Pandemic|0|||
144207206|NCT00213135|519954257|FG000|Overall Study|Adverse Event|9|||
144207207|NCT00213135|519954258|FG001|Overall Study|Adverse Event|5|||
144262840|NCT01519817|520163762|FG003|Overall Study|Off study due to infection|1|||
144262841|NCT01325350|520163767|FG000|Overall Study|Adverse Event|3|||
144262842|NCT01325350|520163768|FG001|Overall Study|Adverse Event|3|||
144729484|NCT04213326|521864655|FG000|Overall Study|Participant eligibility changed|106|||
144729485|NCT04213326|521864656|FG001|Overall Study|Participant eligibility changed|19|||
144729486|NCT04213326|521864655|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
144729487|NCT04213326|521864656|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
144207208|NCT00213135|519954259|FG002|Overall Study|Adverse Event|5|||
144207209|NCT00213135|519954257|FG000|Overall Study|Lost to Follow-up|11|||
144207210|NCT00213135|519954258|FG001|Overall Study|Lost to Follow-up|8|||
144729488|NCT04213326|521864655|FG000|Overall Study|Incomplete study visit|0|||
144729489|NCT04213326|521864656|FG001|Overall Study|Incomplete study visit|367|||
144729490|NCT02549092|521864657|FG000|Treatment Period|Adverse Event|2|||
144729491|NCT02549092|521864658|FG001|Treatment Period|Adverse Event|2|||
144729492|NCT02549092|521864657|FG000|Treatment Period|Withdrawal by Subject|1|||
144729493|NCT02549092|521864658|FG001|Treatment Period|Withdrawal by Subject|3|||
144729494|NCT02549092|521864657|FG000|Treatment Period|Lack of Efficacy|0|||
144729495|NCT02549092|521864658|FG001|Treatment Period|Lack of Efficacy|2|||
144729496|NCT02549092|521864657|FG000|Extension/Transition Period|Adverse Event|1|||
144729497|NCT02549092|521864658|FG001|Extension/Transition Period|Adverse Event|1|||
144729498|NCT02549092|521864657|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
144729499|NCT02549092|521864658|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
144729500|NCT02549092|521864657|FG000|Extension/Transition Period|Other, Not Specified|4|||
144729501|NCT02549092|521864658|FG001|Extension/Transition Period|Other, Not Specified|2|||
144729502|NCT00906347|521864669|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
144729503|NCT00906347|521864670|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
144729504|NCT00906347|521864669|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
144729505|NCT00906347|521864670|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
144729506|NCT00906347|521864669|FG000|Received Study Drug|Refused study drug|1|||
144729507|NCT00906347|521864670|FG001|Received Study Drug|Refused study drug|0|||
144729508|NCT00906347|521864669|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
144729509|NCT00906347|521864670|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
144729510|NCT00472290|521864675|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
144729511|NCT00472290|521864675|FG000|Overall Study|Protocol Specified Criteria|7|||
144729512|NCT00472290|521864675|FG000|Overall Study|Administrative Decision|37|||
144729513|NCT00472290|521864675|FG000|Overall Study|Death|3|||
144729514|NCT00472290|521864675|FG000|Overall Study|Lost to Follow-up|1|||
144729515|NCT00472290|521864675|FG000|Overall Study|Lack of Efficacy|1|||
144729516|NCT00472290|521864675|FG000|Overall Study|Disease Progression|4|||
144729517|NCT00472290|521864675|FG000|Overall Study|Withdrawal by Subject|5|||
144729518|NCT00472290|521864675|FG000|Overall Study|Adverse Event|6|||
144729519|NCT00472290|521864675|FG000|Overall Study|Requirement for alternative therapy|7|||
144729520|NCT00777829|521864676|FG000|Overall Study|Withdrawal by Subject|0|||
144729521|NCT00777829|521864677|FG001|Overall Study|Withdrawal by Subject|2|||
144729522|NCT00745095|521864686|FG000|Overall Study|Declined to participate|1|||
144729523|NCT00745095|521864687|FG001|Overall Study|Declined to participate|0|||
144729524|NCT00745095|521864688|FG002|Overall Study|Declined to participate|0|||
144729525|NCT00745095|521864689|FG003|Overall Study|Declined to participate|0|||
144729526|NCT00745095|521864690|FG004|Overall Study|Declined to participate|92|||
144729527|NCT00745095|521864691|FG005|Overall Study|Declined to participate|95|||
144729528|NCT00745095|521864686|FG000|Overall Study|Ineligible due to GFR criteria|0|||
144729529|NCT00745095|521864687|FG001|Overall Study|Ineligible due to GFR criteria|2|||
144729530|NCT00745095|521864688|FG002|Overall Study|Ineligible due to GFR criteria|3|||
144729531|NCT00745095|521864689|FG003|Overall Study|Ineligible due to GFR criteria|3|||
144729532|NCT00745095|521864690|FG004|Overall Study|Ineligible due to GFR criteria|30|||
144729533|NCT00745095|521864691|FG005|Overall Study|Ineligible due to GFR criteria|28|||
144729534|NCT01479439|521864692|FG000|Overall Study|Adverse Event|1|||
144729535|NCT01479439|521864693|FG001|Overall Study|Adverse Event|0|||
144729536|NCT01479439|521864694|FG002|Overall Study|Adverse Event|0|||
144729537|NCT01479439|521864692|FG000|Overall Study|Lost to Follow-up|0|||
144729538|NCT01479439|521864693|FG001|Overall Study|Lost to Follow-up|1|||
144729539|NCT01479439|521864694|FG002|Overall Study|Lost to Follow-up|0|||
144207211|NCT00213135|519954259|FG002|Overall Study|Lost to Follow-up|4|||
144207212|NCT00213135|519954257|FG000|Overall Study|Protocol Violation|4|||
144207213|NCT00213135|519954258|FG001|Overall Study|Protocol Violation|4|||
144207214|NCT00213135|519954259|FG002|Overall Study|Protocol Violation|10|||
144207215|NCT00213135|519954257|FG000|Overall Study|Death|1|||
144207216|NCT00213135|519954258|FG001|Overall Study|Death|1|||
144207217|NCT00213135|519954259|FG002|Overall Study|Death|2|||
144207218|NCT00213135|519954257|FG000|Overall Study|Disease progression|4|||
144207219|NCT00213135|519954258|FG001|Overall Study|Disease progression|5|||
144207220|NCT00213135|519954259|FG002|Overall Study|Disease progression|21|||
144207221|NCT00213135|519954257|FG000|Overall Study|Other|21|||
144207222|NCT00213135|519954258|FG001|Overall Study|Other|12|||
144207223|NCT00213135|519954259|FG002|Overall Study|Other|15|||
144207224|NCT00660907|519954263|FG000|Overall Study|Incorrect Enrollment|1|||
144207225|NCT00660907|519954264|FG001|Overall Study|Incorrect Enrollment|1|||
144207226|NCT00660907|519954263|FG000|Overall Study|Adverse Event|33|||
144207227|NCT00660907|519954264|FG001|Overall Study|Adverse Event|19|||
144207228|NCT00660907|519954263|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
144207229|NCT00660907|519954264|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
144729540|NCT01479439|521864692|FG000|Overall Study|Protocol Violation|0|||
144729541|NCT01479439|521864693|FG001|Overall Study|Protocol Violation|0|||
144729542|NCT01479439|521864694|FG002|Overall Study|Protocol Violation|2|||
144729543|NCT02079766|521864695|FG000|Overall Study|Physician Decision|1|||
144729544|NCT02079766|521864696|FG001|Overall Study|Physician Decision|0|||
144729545|NCT02079766|521864695|FG000|Overall Study|Withdrawal by Subject|1|||
144729546|NCT02079766|521864696|FG001|Overall Study|Withdrawal by Subject|0|||
144729547|NCT00683293|521864701|FG000|Overall Study|Withdrawal by Subject|2|||
144729548|NCT00683293|521864702|FG001|Overall Study|Withdrawal by Subject|3|||
144729549|NCT00824265|521864707|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
144571159|NCT01018732|521289877|FG001|Overall Study|Protocol Violation|1|||
144571160|NCT01018732|521289878|FG002|Overall Study|Protocol Violation|0|||
144571161|NCT01018732|521289876|FG000|Overall Study|Inappropriate Enrollment|0|||
144571162|NCT01018732|521289877|FG001|Overall Study|Inappropriate Enrollment|1|||
144571163|NCT01018732|521289878|FG002|Overall Study|Inappropriate Enrollment|0|||
144571164|NCT01018732|521289876|FG000|Overall Study|Unable to Classify|0|||
144571165|NCT01018732|521289877|FG001|Overall Study|Unable to Classify|0|||
144571166|NCT01018732|521289878|FG002|Overall Study|Unable to Classify|1|||
144571167|NCT02781311|521289881|FG000|Overall Study|Adverse Event|2|||
144571168|NCT02781311|521289882|FG001|Overall Study|Adverse Event|6|||
144571169|NCT02781311|521289883|FG002|Overall Study|Adverse Event|1|||
144571170|NCT02781311|521289881|FG000|Overall Study|Withdrawal of Consent|11|||
144571171|NCT02781311|521289882|FG001|Overall Study|Withdrawal of Consent|12|||
144571172|NCT02781311|521289883|FG002|Overall Study|Withdrawal of Consent|2|||
144571173|NCT02781311|521289881|FG000|Overall Study|Lost to Follow-up|11|||
144571174|NCT02781311|521289882|FG001|Overall Study|Lost to Follow-up|8|||
144571175|NCT02781311|521289883|FG002|Overall Study|Lost to Follow-up|1|||
144571176|NCT02781311|521289881|FG000|Overall Study|Non-Compliance with Study Drug|2|||
144571177|NCT02781311|521289882|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144571178|NCT02781311|521289883|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144571179|NCT02165826|521289884|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
144571180|NCT02165826|521289885|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
144571181|NCT02165826|521289886|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
144571182|NCT02165826|521289884|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
144571183|NCT02165826|521289885|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
144571184|NCT02165826|521289886|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
144571185|NCT02165826|521289884|FG000|Main Treatment Period|Lost to Follow-up|4|||
144571186|NCT02165826|521289885|FG001|Main Treatment Period|Lost to Follow-up|2|||
144571187|NCT02165826|521289886|FG002|Main Treatment Period|Lost to Follow-up|1|||
144571188|NCT02165826|521289884|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
144620893|NCT02597855|521472136|FG000|Overall Study|Lost to Follow-up|2|||
144620894|NCT02597855|521472137|FG001|Overall Study|Lost to Follow-up|1|||
144571189|NCT02165826|521289885|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
144571190|NCT02165826|521289886|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
144571191|NCT02165826|521289884|FG000|Main Treatment Period|Lack of Efficacy|2|||
144571192|NCT02165826|521289885|FG001|Main Treatment Period|Lack of Efficacy|0|||
144571193|NCT02165826|521289886|FG002|Main Treatment Period|Lack of Efficacy|0|||
144571194|NCT02165826|521289884|FG000|Main Treatment Period|Reason Not Specified|8|||
144571195|NCT02165826|521289885|FG001|Main Treatment Period|Reason Not Specified|5|||
144571196|NCT02165826|521289886|FG002|Main Treatment Period|Reason Not Specified|16|||
144571197|NCT02165826|521289884|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
144571198|NCT02165826|521289885|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
144571199|NCT02165826|521289886|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
144571200|NCT02165826|521289884|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
144620895|NCT00925015|521472145|FG000|Overall Study|Adverse Event|1|||
144620896|NCT00925015|521472146|FG001|Overall Study|Adverse Event|2|||
144620897|NCT00925015|521472147|FG002|Overall Study|Adverse Event|1|||
144620898|NCT00925015|521472145|FG000|Overall Study|Physician Decision|0|||
144620899|NCT00925015|521472146|FG001|Overall Study|Physician Decision|1|||
144620900|NCT00925015|521472147|FG002|Overall Study|Physician Decision|0|||
144620901|NCT00925015|521472145|FG000|Overall Study|Progressive Disease|7|||
144620902|NCT00925015|521472146|FG001|Overall Study|Progressive Disease|3|||
144620903|NCT00925015|521472147|FG002|Overall Study|Progressive Disease|4|||
144620904|NCT00925015|521472145|FG000|Overall Study|Withdrawal by Subject|0|||
144620905|NCT00925015|521472146|FG001|Overall Study|Withdrawal by Subject|0|||
144620906|NCT00925015|521472147|FG002|Overall Study|Withdrawal by Subject|1|||
144620907|NCT01407926|521472148|FG000|Overall Study|Lost to Follow-up|55|||
144620908|NCT02814565|521472149|FG000|Overall Study|Lack of Efficacy|0|||
144620909|NCT02814565|521472150|FG001|Overall Study|Lack of Efficacy|1|||
144620910|NCT02814565|521472149|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
144620911|NCT02814565|521472150|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
144620912|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
144620913|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
144620914|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
144620915|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
144620916|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
144620917|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
144620918|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
144620919|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
144620920|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
144620921|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
144620922|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
144571201|NCT02165826|521289885|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
144620923|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
144620924|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
144620925|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
144620926|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
144620927|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
144620928|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
144620929|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
144620930|NCT04418765|521472155|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
144620931|NCT04418765|521472156|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
144620932|NCT04418765|521472157|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
144620933|NCT04418765|521472155|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
144620934|NCT04418765|521472156|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
144620935|NCT04418765|521472157|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
144571202|NCT02165826|521289886|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
144571203|NCT02165826|521289884|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
144571204|NCT02165826|521289885|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
144571205|NCT02165826|521289886|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
144571206|NCT02165826|521289884|FG000|Down-Titration Period|Reason Not Specified|1|||
144571207|NCT02165826|521289885|FG001|Down-Titration Period|Reason Not Specified|0|||
144571208|NCT02165826|521289886|FG002|Down-Titration Period|Reason Not Specified|2|||
144571209|NCT00250432|521289889|FG000|Overall Study|Adverse Event|25|||
144571210|NCT00250432|521289890|FG001|Overall Study|Adverse Event|29|||
144571211|NCT00250432|521289889|FG000|Overall Study|Lack of Efficacy|2|||
144571212|NCT00250432|521289890|FG001|Overall Study|Lack of Efficacy|1|||
144571213|NCT00250432|521289889|FG000|Overall Study|Lost to Follow-up|6|||
144571214|NCT00250432|521289890|FG001|Overall Study|Lost to Follow-up|5|||
144571215|NCT00250432|521289889|FG000|Overall Study|Patient Moved|0|||
144620936|NCT04418765|521472155|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
144620937|NCT04418765|521472156|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
144620938|NCT04418765|521472157|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
144620939|NCT04418765|521472155|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
144620940|NCT04418765|521472156|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
144620941|NCT04418765|521472157|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
144620942|NCT04418765|521472155|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
144620943|NCT04418765|521472156|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
144620944|NCT04418765|521472157|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
144620945|NCT04418765|521472155|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
144620946|NCT04418765|521472156|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
144620947|NCT04418765|521472157|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
144620948|NCT04418765|521472155|FG000|Extension Period (48 Weeks)|Other than specified|0|||
144620949|NCT04418765|521472156|FG001|Extension Period (48 Weeks)|Other than specified|5|||
144620950|NCT04418765|521472157|FG002|Extension Period (48 Weeks)|Other than specified|2|||
144620951|NCT01926782|521472158|FG000|Overall Study|Participant moved|2|||
144620952|NCT01926782|521472159|FG001|Overall Study|Participant moved|0|||
144620953|NCT01926782|521472160|FG002|Overall Study|Participant moved|1|||
144620954|NCT01926782|521472161|FG003|Overall Study|Participant moved|1|||
144620955|NCT01926782|521472162|FG004|Overall Study|Participant moved|0|||
144620956|NCT01926782|521472163|FG005|Overall Study|Participant moved|3|||
144620957|NCT01926782|521472158|FG000|Overall Study|Physician Decision|0|||
144620958|NCT01926782|521472159|FG001|Overall Study|Physician Decision|2|||
144620959|NCT01926782|521472160|FG002|Overall Study|Physician Decision|1|||
144620960|NCT01926782|521472161|FG003|Overall Study|Physician Decision|1|||
144620961|NCT01926782|521472162|FG004|Overall Study|Physician Decision|0|||
144620962|NCT01926782|521472163|FG005|Overall Study|Physician Decision|0|||
144620963|NCT01926782|521472158|FG000|Overall Study|Other than specified|2|||
144620964|NCT01926782|521472159|FG001|Overall Study|Other than specified|3|||
144620965|NCT01926782|521472160|FG002|Overall Study|Other than specified|5|||
144620966|NCT01926782|521472161|FG003|Overall Study|Other than specified|12|||
144620967|NCT01926782|521472162|FG004|Overall Study|Other than specified|4|||
144729550|NCT00824265|521864708|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
144207230|NCT00660907|519954263|FG000|Overall Study|Withdrawal by Subject|23|||
144207231|NCT00660907|519954264|FG001|Overall Study|Withdrawal by Subject|32|||
144571216|NCT00250432|521289890|FG001|Overall Study|Patient Moved|1|||
144571217|NCT00250432|521289889|FG000|Overall Study|Protocol Violation|0|||
144571218|NCT00250432|521289890|FG001|Overall Study|Protocol Violation|3|||
144571219|NCT00250432|521289889|FG000|Overall Study|Withdrawal by Subject|6|||
144571220|NCT00250432|521289890|FG001|Overall Study|Withdrawal by Subject|2|||
144207232|NCT00660907|519954263|FG000|Overall Study|Lost to Follow-up|3|||
144571221|NCT00250432|521289889|FG000|Overall Study|Pt died out of posttherapy report period|6|||
144571222|NCT00250432|521289890|FG001|Overall Study|Pt died out of posttherapy report period|5|||
144620968|NCT01926782|521472163|FG005|Overall Study|Other than specified|11|||
144620969|NCT01926782|521472158|FG000|Overall Study|Adverse Event|13|||
144620970|NCT01926782|521472159|FG001|Overall Study|Adverse Event|4|||
144620971|NCT01926782|521472160|FG002|Overall Study|Adverse Event|17|||
144620972|NCT01926782|521472161|FG003|Overall Study|Adverse Event|4|||
144620973|NCT01926782|521472162|FG004|Overall Study|Adverse Event|3|||
144620974|NCT01926782|521472163|FG005|Overall Study|Adverse Event|14|||
144620975|NCT01926782|521472158|FG000|Overall Study|Poor compliance to protocol|5|||
144620976|NCT01926782|521472159|FG001|Overall Study|Poor compliance to protocol|3|||
144620977|NCT01926782|521472160|FG002|Overall Study|Poor compliance to protocol|8|||
144620978|NCT01926782|521472161|FG003|Overall Study|Poor compliance to protocol|0|||
144620979|NCT01926782|521472162|FG004|Overall Study|Poor compliance to protocol|1|||
144620980|NCT01926782|521472163|FG005|Overall Study|Poor compliance to protocol|6|||
144620981|NCT01926782|521472158|FG000|Overall Study|Randomized and not treated|0|||
144620982|NCT01926782|521472159|FG001|Overall Study|Randomized and not treated|0|||
144620983|NCT01926782|521472160|FG002|Overall Study|Randomized and not treated|0|||
144620984|NCT01926782|521472161|FG003|Overall Study|Randomized and not treated|1|||
144620985|NCT01926782|521472162|FG004|Overall Study|Randomized and not treated|0|||
144620986|NCT01926782|521472163|FG005|Overall Study|Randomized and not treated|0|||
144620987|NCT01926782|521472158|FG000|Overall Study|Withdrawal by Subject|6|||
144620988|NCT01926782|521472159|FG001|Overall Study|Withdrawal by Subject|1|||
144620989|NCT01926782|521472160|FG002|Overall Study|Withdrawal by Subject|8|||
144620990|NCT01926782|521472161|FG003|Overall Study|Withdrawal by Subject|1|||
144620991|NCT01926782|521472162|FG004|Overall Study|Withdrawal by Subject|0|||
144620992|NCT01926782|521472163|FG005|Overall Study|Withdrawal by Subject|5|||
144620993|NCT01926782|521472158|FG000|Overall Study|Related to study drug administration|0|||
144620994|NCT01926782|521472159|FG001|Overall Study|Related to study drug administration|0|||
144620995|NCT01926782|521472160|FG002|Overall Study|Related to study drug administration|0|||
144620996|NCT01926782|521472161|FG003|Overall Study|Related to study drug administration|0|||
144620997|NCT01926782|521472162|FG004|Overall Study|Related to study drug administration|0|||
144620998|NCT01926782|521472163|FG005|Overall Study|Related to study drug administration|2|||
144620999|NCT01100944|521472164|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
144621000|NCT01100944|521472165|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
144621001|NCT01100944|521472166|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
144621002|NCT01100944|521472164|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
144621003|NCT01100944|521472165|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
144621004|NCT01100944|521472166|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
144621005|NCT01100944|521472164|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
144621006|NCT01100944|521472165|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
144621007|NCT01100944|521472166|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
144621008|NCT01100944|521472164|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
144621009|NCT01100944|521472165|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
144621010|NCT01100944|521472166|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
144621011|NCT00577993|521472167|FG000|Overall Study|Adverse Event|1|||
144621012|NCT00577993|521472168|FG001|Overall Study|Adverse Event|0|||
144621013|NCT00577993|521472169|FG002|Overall Study|Adverse Event|0|||
144621014|NCT00577993|521472167|FG000|Overall Study|Death|0|||
144621015|NCT00577993|521472168|FG001|Overall Study|Death|1|||
144621016|NCT00577993|521472169|FG002|Overall Study|Death|1|||
144621017|NCT00577993|521472167|FG000|Overall Study|Lack of Efficacy|0|||
144621018|NCT00577993|521472168|FG001|Overall Study|Lack of Efficacy|1|||
144621019|NCT00577993|521472169|FG002|Overall Study|Lack of Efficacy|0|||
144621020|NCT00577993|521472167|FG000|Overall Study|Protocol Violation|2|||
144621021|NCT00577993|521472168|FG001|Overall Study|Protocol Violation|3|||
144621022|NCT00577993|521472169|FG002|Overall Study|Protocol Violation|0|||
144621023|NCT00577993|521472167|FG000|Overall Study|Withdrawal by Subject|1|||
144621024|NCT00577993|521472168|FG001|Overall Study|Withdrawal by Subject|0|||
144621025|NCT00577993|521472169|FG002|Overall Study|Withdrawal by Subject|2|||
144621026|NCT00577993|521472167|FG000|Overall Study|Conversion|2|||
144621027|NCT00577993|521472168|FG001|Overall Study|Conversion|5|||
144621028|NCT00577993|521472169|FG002|Overall Study|Conversion|0|||
144621029|NCT00577993|521472167|FG000|Overall Study|Uninsured|1|||
144621030|NCT00577993|521472168|FG001|Overall Study|Uninsured|0|||
144621031|NCT00577993|521472169|FG002|Overall Study|Uninsured|0|||
144621032|NCT02296242|521472170|FG000|Overall Study|Death|1|||
144621033|NCT02296242|521472171|FG001|Overall Study|Death|1|||
144621034|NCT02296242|521472172|FG002|Overall Study|Death|1|||
144621035|NCT02296242|521472173|FG003|Overall Study|Death|1|||
144621036|NCT02296242|521472174|FG004|Overall Study|Death|1|||
144621037|NCT02296242|521472170|FG000|Overall Study|Withdrawal by Subject|0|||
144621038|NCT02296242|521472171|FG001|Overall Study|Withdrawal by Subject|0|||
144621039|NCT02296242|521472172|FG002|Overall Study|Withdrawal by Subject|1|||
144621040|NCT02296242|521472173|FG003|Overall Study|Withdrawal by Subject|1|||
144621041|NCT02296242|521472174|FG004|Overall Study|Withdrawal by Subject|3|||
144621042|NCT02296242|521472170|FG000|Overall Study|Disease Progression|1|||
144621043|NCT02296242|521472171|FG001|Overall Study|Disease Progression|3|||
144621044|NCT02296242|521472172|FG002|Overall Study|Disease Progression|2|||
144621045|NCT02296242|521472173|FG003|Overall Study|Disease Progression|8|||
144729551|NCT00824265|521864707|FG000|Treatment Phase|Protocol Violation|1|||
144729552|NCT00824265|521864708|FG001|Treatment Phase|Protocol Violation|0|||
144729553|NCT00824265|521864707|FG000|Treatment Phase|Lost to Follow-up|1|||
144729554|NCT00824265|521864708|FG001|Treatment Phase|Lost to Follow-up|1|||
144729555|NCT00824265|521864707|FG000|Treatment Phase|Physician Decision|6|||
144729556|NCT00824265|521864708|FG001|Treatment Phase|Physician Decision|12|||
144729557|NCT00824265|521864707|FG000|Treatment Phase|Withdrawal by Subject|6|||
144729558|NCT00824265|521864708|FG001|Treatment Phase|Withdrawal by Subject|15|||
144729559|NCT00824265|521864707|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
144729560|NCT00824265|521864708|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
144729561|NCT00824265|521864707|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
144729562|NCT00824265|521864708|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
144729563|NCT02888171|521864711|FG000|Overall Study|Lost to Follow-up|2|||
144729564|NCT02888171|521864712|FG001|Overall Study|Lost to Follow-up|1|||
144729565|NCT02888171|521864711|FG000|Overall Study|Withdrawal by Subject|3|||
144729566|NCT02888171|521864712|FG001|Overall Study|Withdrawal by Subject|2|||
144729567|NCT02888171|521864711|FG000|Overall Study|Adverse Event|0|||
144729568|NCT02888171|521864712|FG001|Overall Study|Adverse Event|1|||
144729569|NCT02920996|521864713|FG000|Overall Study|Adverse Event|8|||
144729570|NCT02920996|521864714|FG001|Overall Study|Adverse Event|0|||
144729571|NCT02920996|521864713|FG000|Overall Study|Physician Decision|1|||
144729572|NCT02920996|521864714|FG001|Overall Study|Physician Decision|0|||
144729573|NCT02920996|521864713|FG000|Overall Study|Death|1|||
144729574|NCT02920996|521864714|FG001|Overall Study|Death|0|||
144729575|NCT02920996|521864713|FG000|Overall Study|Missing|1|||
144729576|NCT02920996|521864714|FG001|Overall Study|Missing|0|||
144729577|NCT02920996|521864713|FG000|Overall Study|Subject Non-Compliance|1|||
144729578|NCT02920996|521864714|FG001|Overall Study|Subject Non-Compliance|0|||
144729579|NCT01402947|521864715|FG000|First Intervention|Adverse Event|0|||
144729580|NCT01402947|521864716|FG001|First Intervention|Adverse Event|1|||
144729581|NCT00591630|521864717|FG000|Overall Study|Death|0|||
144729582|NCT00591630|521864718|FG001|Overall Study|Death|0|||
144729583|NCT00591630|521864719|FG002|Overall Study|Death|1|||
144729584|NCT00591630|521864720|FG003|Overall Study|Death|0|||
144571223|NCT00250432|521289889|FG000|Overall Study|Pt was considered untreatable|0|||
144571224|NCT00250432|521289890|FG001|Overall Study|Pt was considered untreatable|1|||
144571225|NCT01056263|521289891|FG000|Overall Study|Adverse Event|12|||
144729585|NCT02158936|521864723|FG000|Overall Study|Study closed/ terminated|57|||
144729586|NCT02158936|521864724|FG001|Overall Study|Study closed/ terminated|77|||
144729587|NCT02158936|521864723|FG000|Overall Study|Azacitidine tx discontinued|53|||
144729588|NCT02158936|521864724|FG001|Overall Study|Azacitidine tx discontinued|46|||
144729589|NCT02158936|521864723|FG000|Overall Study|Adverse Event|39|||
144729590|NCT02158936|521864724|FG001|Overall Study|Adverse Event|24|||
144729591|NCT02158936|521864723|FG000|Overall Study|Withdrawal by Subject|15|||
144729592|NCT02158936|521864724|FG001|Overall Study|Withdrawal by Subject|16|||
144729593|NCT02158936|521864723|FG000|Overall Study|Physician Decision|15|||
144729594|NCT02158936|521864724|FG001|Overall Study|Physician Decision|13|||
144729595|NCT02158936|521864723|FG000|Overall Study|Lost to Follow-up|0|||
144729596|NCT02158936|521864724|FG001|Overall Study|Lost to Follow-up|1|||
144729597|NCT00522457|521864725|FG000|Overall Study|Due to disease progression|16|||
144729598|NCT00522457|521864725|FG000|Overall Study|Adverse Event|2|||
144729599|NCT04349917|521866074|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
144729600|NCT04349917|521866075|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
144729601|NCT04349917|521866074|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
144729602|NCT04349917|521866075|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
144729603|NCT04188106|521866076|FG000|Overall Study|Lost to Follow-up|5|||
144729604|NCT04188106|521866076|FG000|Overall Study|Non-Compliance|1|||
144729605|NCT00441467|521866077|FG000|Overall Study|Adverse Event|6|||
144207233|NCT00660907|519954264|FG001|Overall Study|Lost to Follow-up|3|||
144207234|NCT00660907|519954263|FG000|Overall Study|Poor/Non-Compliance|5|||
144207235|NCT00660907|519954264|FG001|Overall Study|Poor/Non-Compliance|1|||
144207236|NCT00660907|519954263|FG000|Overall Study|Safety|1|||
144571226|NCT01056263|521289891|FG000|Overall Study|Death|1|||
144729606|NCT00441467|521866077|FG000|Overall Study|Withdrawal by Subject|3|||
144729607|NCT00441467|521866077|FG000|Overall Study|Progressive disease|9|||
144729608|NCT02289963|521866078|FG000|Overall Study|Adverse Event|1|||
144729609|NCT02289963|521866079|FG001|Overall Study|Adverse Event|2|||
144729610|NCT02289963|521866078|FG000|Overall Study|Poor compliance to protocol|1|||
144729611|NCT02289963|521866079|FG001|Overall Study|Poor compliance to protocol|0|||
144729612|NCT02289963|521866078|FG000|Overall Study|Withdrawal by Subject|1|||
144729613|NCT02289963|521866079|FG001|Overall Study|Withdrawal by Subject|0|||
144729614|NCT02289963|521866078|FG000|Overall Study|Last injection missed|2|||
144729615|NCT02289963|521866079|FG001|Overall Study|Last injection missed|2|||
144207237|NCT00660907|519954264|FG001|Overall Study|Safety|0|||
144571227|NCT01056263|521289891|FG000|Overall Study|Withdrawal by Subject|1|||
144729616|NCT02289963|521866078|FG000|Overall Study|End treatment visit outside visit window|0|||
144207238|NCT00660907|519954263|FG000|Overall Study|Death|1|||
144207239|NCT00660907|519954264|FG001|Overall Study|Death|3|||
144207240|NCT00660907|519954263|FG000|Overall Study|Various|11|||
144571228|NCT01056263|521289891|FG000|Overall Study|Lack of Efficacy|29|||
144571229|NCT01056263|521289891|FG000|Overall Study|Progressive disease|2|||
144571230|NCT01056263|521289891|FG000|Overall Study|Neoplasm progression|1|||
144571231|NCT01056263|521289891|FG000|Overall Study|Objective progression or relapse|1|||
144571232|NCT01056263|521289891|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
144571233|NCT00658606|521289894|FG000|Overall Study|Adverse Event|2|||
144571234|NCT00658606|521289895|FG001|Overall Study|Adverse Event|1|||
144571235|NCT00658606|521289894|FG000|Overall Study|Lack of Efficacy|6|||
144571236|NCT00658606|521289895|FG001|Overall Study|Lack of Efficacy|3|||
144571237|NCT00658606|521289894|FG000|Overall Study|Lost to Follow-up|1|||
144571238|NCT00658606|521289895|FG001|Overall Study|Lost to Follow-up|0|||
144571239|NCT00658606|521289894|FG000|Overall Study|Withdrawal by Subject|7|||
144571240|NCT00658606|521289895|FG001|Overall Study|Withdrawal by Subject|16|||
144571241|NCT00658606|521289894|FG000|Overall Study|Lack of Compliance|0|||
144571242|NCT00658606|521289895|FG001|Overall Study|Lack of Compliance|3|||
144571243|NCT04905849|521289896|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
144571244|NCT04905849|521289897|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
144571245|NCT00838929|521289902|FG000|Overall Study|Protocol Violation|0|||
144571246|NCT00838929|521289903|FG001|Overall Study|Protocol Violation|1|||
144571247|NCT00838929|521289904|FG002|Overall Study|Protocol Violation|0|||
144571248|NCT00838929|521289902|FG000|Overall Study|Disease progression|0|||
144571249|NCT00838929|521289903|FG001|Overall Study|Disease progression|2|||
144571250|NCT00838929|521289904|FG002|Overall Study|Disease progression|1|||
144571251|NCT01068210|521289909|FG000|Overall Study|Lost to Follow-up|1|||
144571252|NCT01068210|521289910|FG001|Overall Study|Lost to Follow-up|2|||
144571253|NCT01068210|521289911|FG002|Overall Study|Lost to Follow-up|2|||
144571254|NCT01068210|521289912|FG003|Overall Study|Lost to Follow-up|1|||
144571255|NCT01068210|521289909|FG000|Overall Study|Second cancer|0|||
144571256|NCT01068210|521289910|FG001|Overall Study|Second cancer|1|||
144571257|NCT01068210|521289911|FG002|Overall Study|Second cancer|0|||
144571258|NCT01068210|521289912|FG003|Overall Study|Second cancer|0|||
144571259|NCT01068210|521289909|FG000|Overall Study|Disease progression|0|||
144571260|NCT01068210|521289910|FG001|Overall Study|Disease progression|0|||
144571261|NCT01068210|521289911|FG002|Overall Study|Disease progression|0|||
144571262|NCT01068210|521289912|FG003|Overall Study|Disease progression|2|||
144571263|NCT00699842|521289913|FG000|Overall Study|Death|0|||
144571264|NCT00699842|521289914|FG001|Overall Study|Death|1|||
144207241|NCT00660907|519954264|FG001|Overall Study|Various|8|||
144571265|NCT00699842|521289915|FG002|Overall Study|Death|0|||
144571266|NCT01806389|521289920|FG000|Overall Study|Withdrawal by Subject|4|||
144571267|NCT01310699|521289924|FG000|Overall Study|Patients did not complete tandem.|4|||
144571268|NCT01310699|521289925|FG001|Overall Study|Patients did not complete tandem.|6|||
144571269|NCT02201901|521289926|FG000|Overall Study|Randomized but never treated|0|||
144571270|NCT02201901|521289927|FG001|Overall Study|Randomized but never treated|1|||
144571271|NCT02201901|521289928|FG002|Overall Study|Randomized but never treated|0|||
144571272|NCT02201901|521289926|FG000|Overall Study|Lack of Efficacy|7|||
144571273|NCT02201901|521289927|FG001|Overall Study|Lack of Efficacy|1|||
144571274|NCT02201901|521289928|FG002|Overall Study|Lack of Efficacy|6|||
144571275|NCT02201901|521289926|FG000|Overall Study|Death|3|||
144571276|NCT02201901|521289927|FG001|Overall Study|Death|3|||
144571277|NCT02201901|521289928|FG002|Overall Study|Death|3|||
144571278|NCT02201901|521289926|FG000|Overall Study|Lost to Follow-up|2|||
144571279|NCT02201901|521289927|FG001|Overall Study|Lost to Follow-up|3|||
144571280|NCT02201901|521289928|FG002|Overall Study|Lost to Follow-up|2|||
144571281|NCT02201901|521289926|FG000|Overall Study|Withdrew Consent|2|||
144571282|NCT02201901|521289927|FG001|Overall Study|Withdrew Consent|0|||
144571283|NCT02201901|521289928|FG002|Overall Study|Withdrew Consent|2|||
144571284|NCT02201901|521289926|FG000|Overall Study|Adverse Event|1|||
144571285|NCT02201901|521289927|FG001|Overall Study|Adverse Event|1|||
144571286|NCT02201901|521289928|FG002|Overall Study|Adverse Event|0|||
144571287|NCT00490698|521289929|FG000|Overall Study|Withdrawal by Subject|1|||
144621046|NCT02296242|521472174|FG004|Overall Study|Disease Progression|11|||
144621047|NCT02296242|521472170|FG000|Overall Study|Unacceptable Toxicity|0|||
144571288|NCT00490698|521289929|FG000|Overall Study|Disease Progression|7|||
144571289|NCT00490698|521289929|FG000|Overall Study|Physician Decision|2|||
144571290|NCT00738283|521289932|FG000|Overall Study|Death|1|||
144571291|NCT00738283|521289932|FG000|Overall Study|Transfer to another facility|2|||
144571292|NCT00738283|521289932|FG000|Overall Study|Discharge home prior to end of study|1|||
144571293|NCT02633397|521289933|FG000|Overall Study|Adverse Event|8|||
144571294|NCT02633397|521289934|FG001|Overall Study|Adverse Event|8|||
144571295|NCT02633397|521289933|FG000|Overall Study|Study Burden|4|||
144571296|NCT02633397|521289934|FG001|Overall Study|Study Burden|1|||
144571297|NCT02633397|521289933|FG000|Overall Study|Treatment interruption|2|||
144571298|NCT02633397|521289934|FG001|Overall Study|Treatment interruption|5|||
144571299|NCT02633397|521289933|FG000|Overall Study|Death|2|||
144207242|NCT01908907|519954265|FG000|Overall Study|Physician Decision|1|||
144729617|NCT02289963|521866079|FG001|Overall Study|End treatment visit outside visit window|4|||
144729618|NCT02289963|521866078|FG000|Overall Study|Other than specified above|0|||
144729619|NCT02289963|521866079|FG001|Overall Study|Other than specified above|2|||
144729620|NCT01042522|521866080|FG000|Overall Study|Adverse Event|1|||
144729621|NCT01042522|521866081|FG001|Overall Study|Adverse Event|2|||
144729622|NCT01042522|521866080|FG000|Overall Study|Disease Progression|5|||
144729623|NCT01042522|521866081|FG001|Overall Study|Disease Progression|0|||
144207243|NCT01908907|519954266|FG001|Overall Study|Physician Decision|0|||
144207244|NCT01908907|519954265|FG000|Overall Study|Protocol Violation|1|||
144571300|NCT02633397|521289934|FG001|Overall Study|Death|2|||
144571301|NCT02633397|521289933|FG000|Overall Study|Physician Decision|0|||
144729624|NCT01042522|521866080|FG000|Overall Study|Death|1|||
144729625|NCT01042522|521866081|FG001|Overall Study|Death|0|||
144729626|NCT01042522|521866080|FG000|Overall Study|Patient Refused|0|||
144729627|NCT01042522|521866081|FG001|Overall Study|Patient Refused|3|||
144729628|NCT01042522|521866080|FG000|Overall Study|Withdrawal by Subject|1|||
144729629|NCT01042522|521866081|FG001|Overall Study|Withdrawal by Subject|1|||
144729630|NCT01746017|521866084|FG000|Period 1|Withdrawal by Subject|0|||
144729631|NCT01746017|521866085|FG001|Period 1|Withdrawal by Subject|0|||
144729632|NCT01746017|521866086|FG002|Period 1|Withdrawal by Subject|0|||
144729633|NCT01746017|521866087|FG003|Period 1|Withdrawal by Subject|0|||
144729634|NCT01746017|521866088|FG004|Period 1|Withdrawal by Subject|0|||
144729635|NCT01746017|521866089|FG005|Period 1|Withdrawal by Subject|0|||
144729636|NCT01746017|521866090|FG006|Period 1|Withdrawal by Subject|1|||
144729637|NCT01746017|521866091|FG007|Period 1|Withdrawal by Subject|0|||
144729638|NCT01746017|521866092|FG008|Period 1|Withdrawal by Subject|0|||
144729639|NCT01746017|521866093|FG009|Period 1|Withdrawal by Subject|0|||
144729640|NCT01746017|521866094|FG010|Period 1|Withdrawal by Subject|0|||
144729641|NCT01746017|521866084|FG000|Period 3|Withdrawal by Subject|0|||
144729642|NCT01746017|521866085|FG001|Period 3|Withdrawal by Subject|0|||
144729643|NCT01746017|521866086|FG002|Period 3|Withdrawal by Subject|0|||
144729644|NCT01746017|521866087|FG003|Period 3|Withdrawal by Subject|0|||
144729645|NCT01746017|521866088|FG004|Period 3|Withdrawal by Subject|0|||
144729646|NCT01746017|521866089|FG005|Period 3|Withdrawal by Subject|1|||
144729647|NCT01746017|521866090|FG006|Period 3|Withdrawal by Subject|0|||
144729648|NCT01746017|521866091|FG007|Period 3|Withdrawal by Subject|0|||
144729649|NCT01746017|521866092|FG008|Period 3|Withdrawal by Subject|0|||
144729650|NCT01746017|521866093|FG009|Period 3|Withdrawal by Subject|0|||
144729651|NCT01746017|521866094|FG010|Period 3|Withdrawal by Subject|0|||
144729652|NCT01507051|521866095|FG000|Overall Study|Withdrawal by Subject|1|||
144729653|NCT01507051|521866096|FG001|Overall Study|Withdrawal by Subject|3|||
144729654|NCT01507051|521866097|FG002|Overall Study|Withdrawal by Subject|1|||
144729655|NCT01507051|521866098|FG003|Overall Study|Withdrawal by Subject|6|||
144729656|NCT01507051|521866095|FG000|Overall Study|Physician Decision|0|||
144729657|NCT01507051|521866096|FG001|Overall Study|Physician Decision|0|||
144729658|NCT01507051|521866097|FG002|Overall Study|Physician Decision|0|||
144729659|NCT01507051|521866098|FG003|Overall Study|Physician Decision|1|||
144729660|NCT01507051|521866095|FG000|Overall Study|Adverse Event|1|||
144729661|NCT01507051|521866096|FG001|Overall Study|Adverse Event|0|||
144729662|NCT01507051|521866097|FG002|Overall Study|Adverse Event|0|||
144729663|NCT01507051|521866098|FG003|Overall Study|Adverse Event|0|||
144729664|NCT01675622|521866099|FG000|Overall Study|Withdrawal by Subject|2|||
144729665|NCT01675622|521866100|FG001|Overall Study|Withdrawal by Subject|2|||
144729666|NCT01675622|521866099|FG000|Overall Study|Adverse Event|12|||
144729667|NCT01675622|521866100|FG001|Overall Study|Adverse Event|10|||
144729668|NCT01675622|521866099|FG000|Overall Study|Protocol Violation|4|||
144729669|NCT01675622|521866100|FG001|Overall Study|Protocol Violation|1|||
144729670|NCT01675622|521866099|FG000|Overall Study|Lack of Efficacy|2|||
144571302|NCT02633397|521289934|FG001|Overall Study|Physician Decision|1|||
144571303|NCT00469859|521289935|FG000|Overall Study|Inevaluable|0|||
144571304|NCT00469859|521289936|FG001|Overall Study|Inevaluable|2|||
144571305|NCT01240551|521291653|FG000|Overall Study|Refused further treatment|3|||
144571306|NCT01240551|521291654|FG001|Overall Study|Refused further treatment|2|||
144571307|NCT01240551|521291653|FG000|Overall Study|Lost to Follow-up|1|||
144729671|NCT01675622|521866100|FG001|Overall Study|Lack of Efficacy|4|||
144207245|NCT01908907|519954266|FG001|Overall Study|Protocol Violation|0|||
144571308|NCT01240551|521291654|FG001|Overall Study|Lost to Follow-up|1|||
144571309|NCT02737826|521291657|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
144571310|NCT02737826|521291658|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
144729672|NCT01675622|521866099|FG000|Overall Study|Lost to Follow-up|1|||
144729673|NCT01675622|521866100|FG001|Overall Study|Lost to Follow-up|3|||
144571311|NCT02737826|521291659|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
144571312|NCT00078377|521291660|FG000|Overall Study|Adverse Event|2|||
144729674|NCT01675622|521866099|FG000|Overall Study|Other|5|||
144571313|NCT00078377|521291661|FG001|Overall Study|Adverse Event|5|||
144729675|NCT01675622|521866100|FG001|Overall Study|Other|4|||
144729676|NCT02311361|521866101|FG000|Overall Study|Did not receive treatment|0|||
144729677|NCT02311361|521866102|FG001|Overall Study|Did not receive treatment|1|||
144729678|NCT02311361|521866103|FG002|Overall Study|Did not receive treatment|0|||
144729679|NCT02311361|521866104|FG003|Overall Study|Did not receive treatment|1|||
144571314|NCT00078377|521291662|FG002|Overall Study|Adverse Event|1|||
144571315|NCT00078377|521291660|FG000|Overall Study|Lack of Efficacy|2|||
144571316|NCT00078377|521291661|FG001|Overall Study|Lack of Efficacy|0|||
144571317|NCT00078377|521291662|FG002|Overall Study|Lack of Efficacy|2|||
144571318|NCT00078377|521291660|FG000|Overall Study|Lost to Follow-up|0|||
144571319|NCT00078377|521291661|FG001|Overall Study|Lost to Follow-up|1|||
144571320|NCT00078377|521291662|FG002|Overall Study|Lost to Follow-up|1|||
144571321|NCT00078377|521291660|FG000|Overall Study|Physician Decision|2|||
144571322|NCT00078377|521291661|FG001|Overall Study|Physician Decision|0|||
144571323|NCT00078377|521291662|FG002|Overall Study|Physician Decision|0|||
144571324|NCT00078377|521291660|FG000|Overall Study|Withdrawal by Subject|3|||
144571325|NCT00078377|521291661|FG001|Overall Study|Withdrawal by Subject|4|||
144571326|NCT00078377|521291662|FG002|Overall Study|Withdrawal by Subject|4|||
144571327|NCT00078377|521291660|FG000|Overall Study|Miscellaneous|2|||
144571328|NCT00078377|521291661|FG001|Overall Study|Miscellaneous|6|||
144571329|NCT00078377|521291662|FG002|Overall Study|Miscellaneous|1|||
144571330|NCT04546217|521291663|FG000|Overall Study|Withdrawal by Subject|2|||
144571331|NCT04546217|521291664|FG001|Overall Study|Withdrawal by Subject|0|||
144571332|NCT04546217|521291663|FG000|Overall Study|Uncontrolled hypertension|1|||
144571333|NCT04546217|521291664|FG001|Overall Study|Uncontrolled hypertension|0|||
144571334|NCT00863512|521291665|FG000|Overall Study|Adverse Event|2|||
144571335|NCT00863512|521291666|FG001|Overall Study|Adverse Event|0|||
144571336|NCT00863512|521291665|FG000|Overall Study|Withdrawal by Subject|11|||
144571337|NCT00863512|521291666|FG001|Overall Study|Withdrawal by Subject|0|||
144571338|NCT00863512|521291665|FG000|Overall Study|Physician Decision|1|||
144571339|NCT00863512|521291666|FG001|Overall Study|Physician Decision|0|||
144571340|NCT04292470|521291669|FG000|Overall Study|Withdrawal by Subject|0|||
144571341|NCT04292470|521291670|FG001|Overall Study|Withdrawal by Subject|1|||
144571342|NCT02906020|521291671|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
144571343|NCT02906020|521291672|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
144571344|NCT02906020|521291673|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
144571345|NCT02906020|521291674|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
144571346|NCT02906020|521291675|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
144571347|NCT02906020|521291676|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
144571348|NCT02906020|521291677|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
144571349|NCT02906020|521291678|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
144571350|NCT02906020|521291679|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
144571351|NCT02906020|521291680|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
144571352|NCT02906020|521291681|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
144571353|NCT02906020|521291682|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
144571354|NCT02906020|521291683|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
144571355|NCT02906020|521291684|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
144571356|NCT02906020|521291685|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
144571357|NCT02906020|521291686|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
144571358|NCT02906020|521291671|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571359|NCT02906020|521291672|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571360|NCT02906020|521291673|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571361|NCT02906020|521291674|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571362|NCT02906020|521291675|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571363|NCT02906020|521291676|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571364|NCT02906020|521291677|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571365|NCT02906020|521291678|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571366|NCT02906020|521291679|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
144571367|NCT02906020|521291680|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
144571368|NCT02906020|521291681|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571369|NCT02906020|521291682|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571370|NCT02906020|521291683|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571371|NCT02906020|521291684|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571372|NCT02906020|521291685|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571373|NCT02906020|521291686|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
144571374|NCT02906020|521291671|FG000|Part 2: Double-blind Treatment Period|Other|0|||
144571375|NCT02906020|521291672|FG001|Part 2: Double-blind Treatment Period|Other|0|||
144571376|NCT02906020|521291673|FG002|Part 2: Double-blind Treatment Period|Other|0|||
144621048|NCT02296242|521472171|FG001|Overall Study|Unacceptable Toxicity|0|||
144621049|NCT02296242|521472172|FG002|Overall Study|Unacceptable Toxicity|0|||
144621050|NCT02296242|521472173|FG003|Overall Study|Unacceptable Toxicity|0|||
144621051|NCT02296242|521472174|FG004|Overall Study|Unacceptable Toxicity|1|||
144571377|NCT02906020|521291674|FG003|Part 2: Double-blind Treatment Period|Other|0|||
144571378|NCT02906020|521291675|FG004|Part 2: Double-blind Treatment Period|Other|0|||
144571379|NCT02906020|521291676|FG005|Part 2: Double-blind Treatment Period|Other|0|||
144571380|NCT02906020|521291677|FG006|Part 2: Double-blind Treatment Period|Other|0|||
144571381|NCT02906020|521291678|FG007|Part 2: Double-blind Treatment Period|Other|0|||
144571382|NCT02906020|521291679|FG008|Part 2: Double-blind Treatment Period|Other|6|||
144571383|NCT02906020|521291680|FG009|Part 2: Double-blind Treatment Period|Other|10|||
144571384|NCT02906020|521291681|FG010|Part 2: Double-blind Treatment Period|Other|0|||
144571385|NCT02906020|521291682|FG011|Part 2: Double-blind Treatment Period|Other|0|||
144571386|NCT02906020|521291683|FG012|Part 2: Double-blind Treatment Period|Other|0|||
144571387|NCT02906020|521291684|FG013|Part 2: Double-blind Treatment Period|Other|0|||
144571388|NCT02906020|521291685|FG014|Part 2: Double-blind Treatment Period|Other|0|||
144571389|NCT02906020|521291686|FG015|Part 2: Double-blind Treatment Period|Other|0|||
144729680|NCT00485472|521866106|FG000|Overall Study|Adverse Event|8|||
144729681|NCT00485472|521866107|FG001|Overall Study|Adverse Event|5|||
144729682|NCT00485472|521866106|FG000|Overall Study|Lack of Efficacy|5|||
144729683|NCT00485472|521866107|FG001|Overall Study|Lack of Efficacy|4|||
144729684|NCT00485472|521866106|FG000|Overall Study|Withdrawal by Subject|1|||
144729685|NCT00485472|521866107|FG001|Overall Study|Withdrawal by Subject|0|||
144729686|NCT00485472|521866106|FG000|Overall Study|Protocol Violation|0|||
144729687|NCT00485472|521866107|FG001|Overall Study|Protocol Violation|1|||
144729688|NCT00485472|521866106|FG000|Overall Study|Other|2|||
144729689|NCT00485472|521866107|FG001|Overall Study|Other|1|||
144729690|NCT00485472|521866106|FG000|Overall Study|Lost to Follow-up|0|||
144729691|NCT00485472|521866107|FG001|Overall Study|Lost to Follow-up|1|||
144729692|NCT01492361|521866108|FG000|Overall Study|Withdrawal by Subject|281|||
144729693|NCT01492361|521866109|FG001|Overall Study|Withdrawal by Subject|297|||
144729694|NCT01492361|521866108|FG000|Overall Study|Physician Decision|12|||
144729695|NCT01492361|521866109|FG001|Overall Study|Physician Decision|12|||
144729696|NCT01492361|521866108|FG000|Overall Study|Lost to Follow-up|6|||
144729697|NCT01492361|521866109|FG001|Overall Study|Lost to Follow-up|13|||
144729698|NCT01492361|521866108|FG000|Overall Study|Other than specified above|106|||
144729699|NCT01492361|521866109|FG001|Overall Study|Other than specified above|138|||
144729700|NCT00560235|521866113|FG000|Phase 1|Discontinued|8|||
144729701|NCT00560235|521866114|FG001|Phase 1|Discontinued|0|||
144729702|NCT00560235|521866115|FG002|Phase 1|Discontinued|0|||
144729703|NCT00560235|521866113|FG000|Phase 1B|Discontinued|0|||
144729704|NCT00560235|521866114|FG001|Phase 1B|Discontinued|19|||
144729705|NCT00560235|521866115|FG002|Phase 1B|Discontinued|0|||
144729706|NCT00560235|521866113|FG000|Phase 2|Discontinued|0|||
144729707|NCT00560235|521866114|FG001|Phase 2|Discontinued|0|||
144729708|NCT00560235|521866115|FG002|Phase 2|Discontinued|96|||
144729709|NCT00560235|521866113|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
144729710|NCT00560235|521866114|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
144729711|NCT00560235|521866115|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
144729712|NCT04015232|521866116|FG000|Overall Study|Withdrawal by Subject|7|||
144729713|NCT04015232|521866117|FG001|Overall Study|Withdrawal by Subject|4|||
144729714|NCT04015232|521866116|FG000|Overall Study|Protocol Violation|1|||
144729715|NCT04015232|521866117|FG001|Overall Study|Protocol Violation|0|||
144729716|NCT04015232|521866116|FG000|Overall Study|Medical Grounds|3|||
144729717|NCT04015232|521866117|FG001|Overall Study|Medical Grounds|3|||
144729718|NCT05150964|521866123|FG000|Overall Study|Lost to Follow-up|2|||
144729719|NCT02017964|521866129|FG000|Overall Study|Patient deemed ineligible|1|||
144729720|NCT00569374|521866133|FG000|Overall Study|Withdrawal by Subject|4|||
144729721|NCT04006171|521866134|FG000|Overall Study|Withdrawal by Subject|8|||
144729722|NCT04006171|521866135|FG001|Overall Study|Withdrawal by Subject|7|||
144729723|NCT04006171|521866134|FG000|Overall Study|missing serum samples|2|||
144729724|NCT04006171|521866135|FG001|Overall Study|missing serum samples|2|||
144729725|NCT04006171|521866134|FG000|Overall Study|insufficient sample volume|2|||
144729726|NCT04006171|521866135|FG001|Overall Study|insufficient sample volume|3|||
144729727|NCT03099538|521866142|FG000|Overall Study|Lack of Efficacy|3|||
144729728|NCT00440557|521866143|FG000|Overall Study|Withdrawal by Subject|10|||
144729729|NCT00440557|521866144|FG001|Overall Study|Withdrawal by Subject|5|||
144729730|NCT00440557|521866145|FG002|Overall Study|Withdrawal by Subject|11|||
144729731|NCT00440557|521866143|FG000|Overall Study|Lost to Follow-up|1|||
144729732|NCT00440557|521866144|FG001|Overall Study|Lost to Follow-up|2|||
144729733|NCT00440557|521866145|FG002|Overall Study|Lost to Follow-up|6|||
144729734|NCT00440557|521866143|FG000|Overall Study|Adverse Event|3|||
144729735|NCT00440557|521866144|FG001|Overall Study|Adverse Event|3|||
144729736|NCT00440557|521866145|FG002|Overall Study|Adverse Event|5|||
144729737|NCT00440557|521866143|FG000|Overall Study|Death|2|||
144729738|NCT00440557|521866144|FG001|Overall Study|Death|6|||
144729739|NCT00440557|521866145|FG002|Overall Study|Death|3|||
144729740|NCT00440557|521866143|FG000|Overall Study|Began Dialysis|4|||
144729741|NCT00440557|521866144|FG001|Overall Study|Began Dialysis|1|||
144729742|NCT00440557|521866145|FG002|Overall Study|Began Dialysis|4|||
144729743|NCT00440557|521866143|FG000|Overall Study|Principal Investigator decision|0|||
144729744|NCT00440557|521866144|FG001|Overall Study|Principal Investigator decision|3|||
144729745|NCT00440557|521866145|FG002|Overall Study|Principal Investigator decision|1|||
144729746|NCT00440557|521866143|FG000|Overall Study|Patient moved|1|||
144729747|NCT00440557|521866144|FG001|Overall Study|Patient moved|2|||
144729748|NCT00440557|521866145|FG002|Overall Study|Patient moved|1|||
144729749|NCT00440557|521866143|FG000|Overall Study|Principal Investigator's office closed|3|||
144621052|NCT02296242|521472170|FG000|Overall Study|Patient Condition Changed|0|||
144621053|NCT02296242|521472171|FG001|Overall Study|Patient Condition Changed|0|||
144621054|NCT02296242|521472172|FG002|Overall Study|Patient Condition Changed|2|||
144621055|NCT02296242|521472173|FG003|Overall Study|Patient Condition Changed|0|||
144621056|NCT02296242|521472174|FG004|Overall Study|Patient Condition Changed|1|||
144621057|NCT02296242|521472170|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
144621058|NCT02296242|521472171|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
144621059|NCT02296242|521472172|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
144621060|NCT02296242|521472173|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
144621061|NCT02296242|521472174|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
144621062|NCT02296242|521472170|FG000|Overall Study|Lost to Follow-up|1|||
144621063|NCT02296242|521472171|FG001|Overall Study|Lost to Follow-up|0|||
144621064|NCT02296242|521472172|FG002|Overall Study|Lost to Follow-up|0|||
144621065|NCT02296242|521472173|FG003|Overall Study|Lost to Follow-up|0|||
144621066|NCT02296242|521472174|FG004|Overall Study|Lost to Follow-up|0|||
144621067|NCT02296242|521472170|FG000|Overall Study|Need for Hydroxyurea|2|||
144621068|NCT02296242|521472171|FG001|Overall Study|Need for Hydroxyurea|0|||
144621069|NCT02296242|521472172|FG002|Overall Study|Need for Hydroxyurea|0|||
144621070|NCT02296242|521472173|FG003|Overall Study|Need for Hydroxyurea|0|||
144621071|NCT02296242|521472174|FG004|Overall Study|Need for Hydroxyurea|0|||
144621072|NCT02296242|521472170|FG000|Overall Study|Screened for Other Protocol|0|||
144621073|NCT02296242|521472171|FG001|Overall Study|Screened for Other Protocol|1|||
144621074|NCT02296242|521472172|FG002|Overall Study|Screened for Other Protocol|0|||
144621075|NCT02296242|521472173|FG003|Overall Study|Screened for Other Protocol|0|||
144621076|NCT02296242|521472174|FG004|Overall Study|Screened for Other Protocol|0|||
144621077|NCT02296242|521472170|FG000|Overall Study|Physician Decision|0|||
144621078|NCT02296242|521472171|FG001|Overall Study|Physician Decision|1|||
144729750|NCT00440557|521866144|FG001|Overall Study|Principal Investigator's office closed|6|||
144729751|NCT00440557|521866145|FG002|Overall Study|Principal Investigator's office closed|4|||
144729752|NCT00440557|521866143|FG000|Overall Study|Patient transferred to nursing home|0|||
144621079|NCT02296242|521472172|FG002|Overall Study|Physician Decision|0|||
144621080|NCT02296242|521472173|FG003|Overall Study|Physician Decision|1|||
144621081|NCT02296242|521472174|FG004|Overall Study|Physician Decision|0|||
144621082|NCT02296242|521472170|FG000|Overall Study|Alternative Treatment|0|||
144621083|NCT02296242|521472171|FG001|Overall Study|Alternative Treatment|0|||
144621084|NCT02296242|521472172|FG002|Overall Study|Alternative Treatment|0|||
144621085|NCT02296242|521472173|FG003|Overall Study|Alternative Treatment|1|||
144621086|NCT02296242|521472174|FG004|Overall Study|Alternative Treatment|0|||
144621087|NCT02296242|521472170|FG000|Overall Study|Adverse Event|0|||
144621088|NCT02296242|521472171|FG001|Overall Study|Adverse Event|0|||
144621089|NCT02296242|521472172|FG002|Overall Study|Adverse Event|0|||
144729753|NCT00440557|521866144|FG001|Overall Study|Patient transferred to nursing home|1|||
144729754|NCT00440557|521866145|FG002|Overall Study|Patient transferred to nursing home|0|||
144729755|NCT00440557|521866143|FG000|Overall Study|Patient had surgery|1|||
144729756|NCT00440557|521866144|FG001|Overall Study|Patient had surgery|0|||
144729757|NCT00440557|521866145|FG002|Overall Study|Patient had surgery|0|||
144729758|NCT00877032|521866146|FG000|Overall Study|Did not meet entrance criteria|0|||
144729759|NCT00877032|521866147|FG001|Overall Study|Did not meet entrance criteria|0|||
144729760|NCT00877032|521866148|FG002|Overall Study|Did not meet entrance criteria|0|||
144729761|NCT00877032|521866149|FG003|Overall Study|Did not meet entrance criteria|1|||
144729762|NCT00877032|521866150|FG004|Overall Study|Did not meet entrance criteria|0|||
144729763|NCT00877032|521866151|FG005|Overall Study|Did not meet entrance criteria|0|||
144729764|NCT00877032|521866152|FG006|Overall Study|Did not meet entrance criteria|2|||
144729765|NCT03752528|521866153|FG000|Part A|Lost to Follow-up|1|||
144729766|NCT03752528|521866153|FG000|Part A|Protocol Violation|1|||
144621090|NCT02296242|521472173|FG003|Overall Study|Adverse Event|1|||
144621091|NCT02296242|521472174|FG004|Overall Study|Adverse Event|0|||
144621092|NCT02296242|521472170|FG000|Overall Study|Lack of Efficacy|0|||
144621093|NCT02296242|521472171|FG001|Overall Study|Lack of Efficacy|0|||
144621094|NCT02296242|521472172|FG002|Overall Study|Lack of Efficacy|0|||
144621095|NCT02296242|521472173|FG003|Overall Study|Lack of Efficacy|0|||
144621096|NCT02296242|521472174|FG004|Overall Study|Lack of Efficacy|3|||
144621097|NCT02217566|521472175|FG000|Overall Study|Lost to Follow-up|2|||
144621098|NCT02217566|521472175|FG000|Overall Study|Death|3|||
144621099|NCT02217566|521472175|FG000|Overall Study|Early study termination|6|||
144621100|NCT01639833|521472176|FG000|Overall Study|Death|4|||
144621101|NCT01639833|521472177|FG001|Overall Study|Death|2|||
144621102|NCT01639833|521472176|FG000|Overall Study|Withdrawal by Subject|2|||
144621103|NCT01639833|521472177|FG001|Overall Study|Withdrawal by Subject|2|||
144621104|NCT00070941|521472179|FG000|Overall Study|Adverse Event|10|||
144621105|NCT00070941|521472180|FG001|Overall Study|Adverse Event|8|||
144621106|NCT00070941|521472181|FG002|Overall Study|Adverse Event|4|||
144621107|NCT02064387|521472182|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144729767|NCT03752528|521866153|FG000|Part B|Protocol Violation|1|||
144729768|NCT03752528|521866153|FG000|Part B|Study terminated by sponsor|3|||
144729769|NCT04625114|521866154|FG000|Overall Study|Adverse Event|3|||
144729770|NCT04625114|521866155|FG001|Overall Study|Adverse Event|1|||
144207246|NCT02886624|519954269|FG000|12-week Post Treatment Follow-up|Death|1|||
144207247|NCT02886624|519954269|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
144207248|NCT00359801|519954276|FG000|Overall Study|Lost to Follow-up|72|||
144207249|NCT00359801|519954277|FG001|Overall Study|Lost to Follow-up|58|||
144207250|NCT00359801|519954276|FG000|Overall Study|Withdrawal by Subject|143|||
144571390|NCT02906020|521291671|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571391|NCT02906020|521291672|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571392|NCT02906020|521291673|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571393|NCT02906020|521291674|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571394|NCT02906020|521291675|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571395|NCT02906020|521291676|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571396|NCT02906020|521291677|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571397|NCT02906020|521291678|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571398|NCT02906020|521291679|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571399|NCT02906020|521291680|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571400|NCT02906020|521291681|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571401|NCT02906020|521291682|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571402|NCT02906020|521291683|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
144571403|NCT02906020|521291684|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
144571404|NCT02906020|521291685|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571405|NCT02906020|521291686|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
144571406|NCT02906020|521291671|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144207251|NCT00359801|519954277|FG001|Overall Study|Withdrawal by Subject|96|||
144207252|NCT00359801|519954276|FG000|Overall Study|Other|66|||
144207253|NCT00359801|519954277|FG001|Overall Study|Other|46|||
144207254|NCT00359801|519954276|FG000|Overall Study|Final Status Unknown: missing data|7|||
144571407|NCT02906020|521291672|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571408|NCT02906020|521291673|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571409|NCT02906020|521291674|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571410|NCT02906020|521291675|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571411|NCT02906020|521291676|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571412|NCT02906020|521291677|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571413|NCT02906020|521291678|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571414|NCT02906020|521291679|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571415|NCT02906020|521291680|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571416|NCT02906020|521291681|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571417|NCT02906020|521291682|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571418|NCT02906020|521291683|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
144571419|NCT02906020|521291684|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
144571420|NCT02906020|521291685|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
144571421|NCT02906020|521291686|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
144571422|NCT02906020|521291671|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571423|NCT02906020|521291672|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571424|NCT02906020|521291673|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571425|NCT02906020|521291674|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571426|NCT02906020|521291675|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571427|NCT02906020|521291676|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571428|NCT02906020|521291677|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571429|NCT02906020|521291678|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571430|NCT02906020|521291679|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571431|NCT02906020|521291680|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571432|NCT02906020|521291681|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571433|NCT02906020|521291682|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571434|NCT02906020|521291683|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
144571435|NCT02906020|521291684|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
144571436|NCT02906020|521291685|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571437|NCT02906020|521291686|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
144571438|NCT02906020|521291671|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571439|NCT02906020|521291672|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571440|NCT02906020|521291673|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571441|NCT02906020|521291674|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571442|NCT02906020|521291675|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571443|NCT02906020|521291676|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571444|NCT02906020|521291677|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571445|NCT02906020|521291678|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571446|NCT02906020|521291679|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571447|NCT02906020|521291680|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571448|NCT02906020|521291681|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571449|NCT02906020|521291682|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571450|NCT02906020|521291683|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
144571451|NCT02906020|521291684|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
144571452|NCT02906020|521291685|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571453|NCT02906020|521291686|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
144571454|NCT02906020|521291671|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571455|NCT02906020|521291672|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571456|NCT02906020|521291673|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571457|NCT02906020|521291674|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571458|NCT02906020|521291675|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571459|NCT02906020|521291676|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571460|NCT02906020|521291677|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571461|NCT02906020|521291678|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571462|NCT02906020|521291679|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571463|NCT02906020|521291680|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571464|NCT02906020|521291681|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144571465|NCT02906020|521291682|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
144621108|NCT02064387|521472183|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621109|NCT02064387|521472184|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621110|NCT02064387|521472185|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621111|NCT02064387|521472186|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144571466|NCT02906020|521291683|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
144571467|NCT02906020|521291684|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
144571468|NCT02906020|521291685|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
144571469|NCT02906020|521291686|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
144571470|NCT02906020|521291671|FG000|Part 2: Long-term Follow-up Period|Other|0|||
144571471|NCT02906020|521291672|FG001|Part 2: Long-term Follow-up Period|Other|0|||
144571472|NCT02906020|521291673|FG002|Part 2: Long-term Follow-up Period|Other|0|||
144571473|NCT02906020|521291674|FG003|Part 2: Long-term Follow-up Period|Other|0|||
144571474|NCT02906020|521291675|FG004|Part 2: Long-term Follow-up Period|Other|0|||
144571475|NCT02906020|521291676|FG005|Part 2: Long-term Follow-up Period|Other|0|||
144571476|NCT02906020|521291677|FG006|Part 2: Long-term Follow-up Period|Other|0|||
144571477|NCT02906020|521291678|FG007|Part 2: Long-term Follow-up Period|Other|0|||
144571478|NCT02906020|521291679|FG008|Part 2: Long-term Follow-up Period|Other|0|||
144571479|NCT02906020|521291680|FG009|Part 2: Long-term Follow-up Period|Other|0|||
144571480|NCT02906020|521291681|FG010|Part 2: Long-term Follow-up Period|Other|0|||
144571481|NCT02906020|521291682|FG011|Part 2: Long-term Follow-up Period|Other|0|||
144571482|NCT02906020|521291683|FG012|Part 2: Long-term Follow-up Period|Other|13|||
144571483|NCT02906020|521291684|FG013|Part 2: Long-term Follow-up Period|Other|8|||
144571484|NCT02906020|521291685|FG014|Part 2: Long-term Follow-up Period|Other|3|||
144571485|NCT02906020|521291686|FG015|Part 2: Long-term Follow-up Period|Other|2|||
144571486|NCT04698915|521291687|FG000|Overall Study|Adverse Event|2|||
144571487|NCT04698915|521291688|FG001|Overall Study|Adverse Event|0|||
144571488|NCT04698915|521291687|FG000|Overall Study|Death|23|||
144571489|NCT04698915|521291688|FG001|Overall Study|Death|20|||
144571490|NCT04698915|521291687|FG000|Overall Study|Physician Decision|1|||
144621112|NCT02064387|521472187|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621113|NCT02064387|521472188|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621114|NCT02064387|521472189|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
144621115|NCT02064387|521472190|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621116|NCT02064387|521472191|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
144621117|NCT02064387|521472192|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621118|NCT02064387|521472193|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
144621119|NCT02064387|521472182|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621120|NCT02064387|521472183|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621121|NCT02064387|521472184|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621122|NCT02064387|521472185|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621123|NCT02064387|521472186|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621124|NCT02064387|521472187|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621125|NCT02064387|521472188|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621126|NCT02064387|521472189|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
144621127|NCT02064387|521472190|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621128|NCT02064387|521472191|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621129|NCT02064387|521472192|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144571491|NCT04698915|521291688|FG001|Overall Study|Physician Decision|1|||
144571492|NCT04698915|521291687|FG000|Overall Study|Lost to Follow-up|1|||
144571493|NCT04698915|521291688|FG001|Overall Study|Lost to Follow-up|0|||
144571494|NCT04698915|521291687|FG000|Overall Study|Study Terminated by Sponsor|55|||
144571495|NCT04698915|521291688|FG001|Overall Study|Study Terminated by Sponsor|60|||
144571496|NCT04698915|521291687|FG000|Overall Study|Withdrawal by Subject|2|||
144571497|NCT04698915|521291688|FG001|Overall Study|Withdrawal by Subject|3|||
144571498|NCT00979953|521291689|FG000|Overall Study|Adverse Event|5|||
144571499|NCT00979953|521291690|FG001|Overall Study|Adverse Event|2|||
144571500|NCT00979953|521291691|FG002|Overall Study|Adverse Event|17|||
144571501|NCT00979953|521291692|FG003|Overall Study|Adverse Event|4|||
144621130|NCT02064387|521472193|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
144621131|NCT02064387|521472182|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621132|NCT02064387|521472183|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621133|NCT02064387|521472184|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621134|NCT02064387|521472185|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621135|NCT02064387|521472186|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621136|NCT02064387|521472187|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621137|NCT02064387|521472188|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621138|NCT02064387|521472189|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621139|NCT02064387|521472190|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
144621140|NCT02064387|521472191|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621141|NCT02064387|521472192|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621142|NCT02064387|521472193|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
144621143|NCT02064387|521472182|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
144621144|NCT02064387|521472183|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
144621145|NCT02064387|521472184|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
144621146|NCT02064387|521472185|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
144621147|NCT02064387|521472186|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
144621148|NCT02064387|521472187|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
144621149|NCT02064387|521472188|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
144621150|NCT02064387|521472189|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
144621151|NCT02064387|521472190|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
144621152|NCT02064387|521472191|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
144621153|NCT02064387|521472192|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
144621154|NCT02064387|521472193|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
144621155|NCT02064387|521472182|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621156|NCT02064387|521472183|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621157|NCT02064387|521472184|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621158|NCT02064387|521472185|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621159|NCT02064387|521472186|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621160|NCT02064387|521472187|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621161|NCT02064387|521472188|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621162|NCT02064387|521472189|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621163|NCT02064387|521472190|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621164|NCT02064387|521472191|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621165|NCT02064387|521472192|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
144621166|NCT02064387|521472193|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
144621167|NCT02499029|521472194|FG000|Overall Study|Lost to Follow-up|2|||
144621168|NCT02499029|521472195|FG001|Overall Study|Lost to Follow-up|2|||
144621169|NCT02499029|521472194|FG000|Overall Study|Physician Decision|2|||
144621170|NCT02499029|521472195|FG001|Overall Study|Physician Decision|1|||
144621171|NCT02499029|521472194|FG000|Overall Study|Death|1|||
144621172|NCT02499029|521472195|FG001|Overall Study|Death|0|||
144621173|NCT01707693|521472196|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
144621174|NCT01707693|521472197|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
144621175|NCT01707693|521472196|FG000|Overall Study Allocation|Protocol Violation|4|||
144621176|NCT01707693|521472197|FG001|Overall Study Allocation|Protocol Violation|3|||
144621177|NCT01707693|521472196|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
144621178|NCT01707693|521472197|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
144621179|NCT01707693|521472196|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
144621180|NCT01707693|521472197|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
144621181|NCT03847610|521472198|FG000|Overall Study|Withdrawal by Subject|1|||
144621182|NCT03298022|521472199|FG000|Overall Study|Lack of Efficacy|4|||
144621183|NCT03298022|521472199|FG000|Overall Study|Withdrawal by Subject|7|||
144621184|NCT03298022|521472199|FG000|Overall Study|Adverse Event|1|||
144621185|NCT03298022|521472199|FG000|Overall Study|disease relapse|1|||
144621186|NCT01445769|521472200|FG000|Overall Study|Consent Withdrawn|2|||
144621187|NCT01445769|521472200|FG000|Overall Study|Disease Progression|1|||
144621188|NCT01445769|521472200|FG000|Overall Study|Lost to Follow-up|5|||
144621189|NCT00343889|521472208|FG000|Overall Study|Lost to Follow-up|2|||
144621190|NCT00343889|521472209|FG001|Overall Study|Lost to Follow-up|0|||
144571502|NCT00979953|521291689|FG000|Overall Study|Lack of Efficacy|1|||
144571503|NCT00979953|521291690|FG001|Overall Study|Lack of Efficacy|2|||
144571504|NCT00979953|521291691|FG002|Overall Study|Lack of Efficacy|0|||
144571505|NCT00979953|521291692|FG003|Overall Study|Lack of Efficacy|0|||
144571506|NCT00979953|521291689|FG000|Overall Study|Lost to Follow-up|1|||
144571507|NCT00979953|521291690|FG001|Overall Study|Lost to Follow-up|1|||
144571508|NCT00979953|521291691|FG002|Overall Study|Lost to Follow-up|1|||
144571509|NCT00979953|521291692|FG003|Overall Study|Lost to Follow-up|0|||
144571510|NCT00979953|521291689|FG000|Overall Study|Withdrawal by Subject|0|||
144571511|NCT00979953|521291690|FG001|Overall Study|Withdrawal by Subject|0|||
144571512|NCT00979953|521291691|FG002|Overall Study|Withdrawal by Subject|2|||
144571513|NCT00979953|521291692|FG003|Overall Study|Withdrawal by Subject|1|||
144571514|NCT00979953|521291689|FG000|Overall Study|Protocol Violation|1|||
144571515|NCT00979953|521291690|FG001|Overall Study|Protocol Violation|0|||
144571516|NCT00979953|521291691|FG002|Overall Study|Protocol Violation|2|||
144571517|NCT00979953|521291692|FG003|Overall Study|Protocol Violation|2|||
144571518|NCT01124097|521291693|FG000|Overall Study|Withdrawal by Subject|4|||
144571519|NCT01124097|521291694|FG001|Overall Study|Withdrawal by Subject|3|||
144571520|NCT01124097|521291695|FG002|Overall Study|Withdrawal by Subject|2|||
144571521|NCT01124097|521291696|FG003|Overall Study|Withdrawal by Subject|3|||
144571522|NCT01124097|521291693|FG000|Overall Study|Lack of Efficacy|2|||
144571523|NCT01124097|521291694|FG001|Overall Study|Lack of Efficacy|3|||
144571524|NCT01124097|521291695|FG002|Overall Study|Lack of Efficacy|1|||
144571525|NCT01124097|521291696|FG003|Overall Study|Lack of Efficacy|3|||
144571526|NCT01124097|521291693|FG000|Overall Study|Adverse Event|24|||
144571527|NCT01124097|521291694|FG001|Overall Study|Adverse Event|15|||
144571528|NCT01124097|521291695|FG002|Overall Study|Adverse Event|15|||
144571529|NCT01124097|521291696|FG003|Overall Study|Adverse Event|7|||
144571530|NCT01124097|521291693|FG000|Overall Study|Protocol Violation|2|||
144571531|NCT01124097|521291694|FG001|Overall Study|Protocol Violation|0|||
144571532|NCT01124097|521291695|FG002|Overall Study|Protocol Violation|2|||
144571533|NCT01124097|521291696|FG003|Overall Study|Protocol Violation|1|||
144571534|NCT01124097|521291693|FG000|Overall Study|Physician Decision|2|||
144571535|NCT01124097|521291694|FG001|Overall Study|Physician Decision|1|||
144571536|NCT01124097|521291695|FG002|Overall Study|Physician Decision|0|||
144571537|NCT01124097|521291696|FG003|Overall Study|Physician Decision|0|||
144571538|NCT00079339|521291701|FG000|Overall Study|Adverse Event|1|||
144571539|NCT00079339|521291702|FG001|Overall Study|Adverse Event|7|||
144571540|NCT00079339|521291703|FG002|Overall Study|Adverse Event|2|||
144571541|NCT00079339|521291701|FG000|Overall Study|Death|1|||
144571542|NCT00079339|521291702|FG001|Overall Study|Death|0|||
144571543|NCT00079339|521291703|FG002|Overall Study|Death|0|||
144571544|NCT00079339|521291701|FG000|Overall Study|Non-compliance|0|||
144571545|NCT00079339|521291702|FG001|Overall Study|Non-compliance|0|||
144571546|NCT00079339|521291703|FG002|Overall Study|Non-compliance|1|||
144571547|NCT00079339|521291701|FG000|Overall Study|Withdrawal by Subject|0|||
144571548|NCT00079339|521291702|FG001|Overall Study|Withdrawal by Subject|4|||
144571549|NCT00079339|521291703|FG002|Overall Study|Withdrawal by Subject|1|||
144571550|NCT00079339|521291701|FG000|Overall Study|Disease progression|3|||
144571551|NCT00079339|521291702|FG001|Overall Study|Disease progression|28|||
144571552|NCT00079339|521291703|FG002|Overall Study|Disease progression|2|||
144571553|NCT01592045|521291710|FG000|Overall Study|Disease Progression|1|||
144571554|NCT01592045|521291711|FG001|Overall Study|Disease Progression|1|||
144571555|NCT01592045|521291710|FG000|Overall Study|Adverse Event|1|||
144571556|NCT01592045|521291711|FG001|Overall Study|Adverse Event|1|||
144571557|NCT01592045|521291710|FG000|Overall Study|Withdrawal by Subject|1|||
144571558|NCT01592045|521291711|FG001|Overall Study|Withdrawal by Subject|0|||
144571559|NCT01592045|521291710|FG000|Overall Study|Moved out of country|2|||
144571560|NCT01592045|521291711|FG001|Overall Study|Moved out of country|0|||
144571561|NCT02599688|521291721|FG000|Overall Study|Lack of Efficacy|1|||
144571562|NCT02599688|521291721|FG000|Overall Study|Withdrawal by Subject|1|||
144571563|NCT02599688|521291721|FG000|Overall Study|Termination by Sponsor|2|||
144571564|NCT00742326|521291723|FG000|Overall Study|Physician Decision|0|||
144571565|NCT00742326|521291724|FG001|Overall Study|Physician Decision|1|||
144571566|NCT03635086|521291736|FG000|Overall Study|Withdrawal of consent|0|||
144571567|NCT03635086|521291737|FG001|Overall Study|Withdrawal of consent|0|||
144571568|NCT03635086|521291738|FG002|Overall Study|Withdrawal of consent|1|||
144571569|NCT03635086|521291739|FG003|Overall Study|Withdrawal of consent|0|||
144571570|NCT03635086|521291740|FG004|Overall Study|Withdrawal of consent|0|||
144571571|NCT03635086|521291736|FG000|Overall Study|Adverse Event|0|||
144571572|NCT03635086|521291737|FG001|Overall Study|Adverse Event|1|||
144571573|NCT03635086|521291738|FG002|Overall Study|Adverse Event|0|||
144571574|NCT03635086|521291739|FG003|Overall Study|Adverse Event|0|||
144571575|NCT03635086|521291740|FG004|Overall Study|Adverse Event|0|||
144571576|NCT03635086|521291736|FG000|Overall Study|Lost to Follow-up|1|||
144571577|NCT03635086|521291737|FG001|Overall Study|Lost to Follow-up|0|||
144571578|NCT03635086|521291738|FG002|Overall Study|Lost to Follow-up|0|||
144571579|NCT03635086|521291739|FG003|Overall Study|Lost to Follow-up|0|||
144571580|NCT03635086|521291740|FG004|Overall Study|Lost to Follow-up|0|||
144571581|NCT00723125|521291741|FG000|Overall Study|Met Dx|1|||
144571582|NCT00723125|521291742|FG001|Overall Study|Met Dx|0|||
144571583|NCT00723125|521291741|FG000|Overall Study|Withdrawal by Subject|15|||
144571584|NCT00723125|521291742|FG001|Overall Study|Withdrawal by Subject|6|||
144571585|NCT00723125|521291741|FG000|Overall Study|Adverse Event|2|||
144571586|NCT00723125|521291742|FG001|Overall Study|Adverse Event|0|||
144571587|NCT02196077|521291743|FG000|Overall Study|Adverse Event|4|||
144571588|NCT02196077|521291743|FG000|Overall Study|Lack of Efficacy|1|||
144571589|NCT02196077|521291743|FG000|Overall Study|Withdrawal by Subject|14|||
144571590|NCT02196077|521291743|FG000|Overall Study|Physician Decision|1|||
144571591|NCT02196077|521291743|FG000|Overall Study|Lost to Follow-up|3|||
144571592|NCT02196077|521291743|FG000|Overall Study|Protocol Violation|24|||
144571593|NCT04042077|521291746|FG000|Overall Study|Adverse Event|0|||
144571594|NCT04042077|521291747|FG001|Overall Study|Adverse Event|1|||
144571595|NCT04042077|521291746|FG000|Overall Study|Death|2|||
144571596|NCT04042077|521291747|FG001|Overall Study|Death|1|||
144571597|NCT04042077|521291746|FG000|Overall Study|Physician Decision|2|||
144571598|NCT04042077|521291747|FG001|Overall Study|Physician Decision|0|||
144571599|NCT04042077|521291746|FG000|Overall Study|Withdrawal by Subject|3|||
144571600|NCT04042077|521291747|FG001|Overall Study|Withdrawal by Subject|2|||
144571601|NCT04042077|521291746|FG000|Overall Study|Lack of Efficacy|0|||
144571602|NCT04042077|521291747|FG001|Overall Study|Lack of Efficacy|1|||
144571603|NCT01667549|521291748|FG000|Overall Study|Withdrawal by Subject|3|||
144571604|NCT01667549|521291749|FG001|Overall Study|Withdrawal by Subject|5|||
144571605|NCT01667549|521291750|FG002|Overall Study|Withdrawal by Subject|7|||
144571606|NCT01667549|521291751|FG003|Overall Study|Withdrawal by Subject|6|||
144571607|NCT01667549|521291752|FG004|Overall Study|Withdrawal by Subject|1|||
144571608|NCT01407276|521291753|FG000|Overall Study|Withdrawal by Subject|0|||
144571609|NCT01407276|521291754|FG001|Overall Study|Withdrawal by Subject|0|||
144571610|NCT01407276|521291755|FG002|Overall Study|Withdrawal by Subject|0|||
144571611|NCT01407276|521291756|FG003|Overall Study|Withdrawal by Subject|0|||
144571612|NCT01407276|521291757|FG004|Overall Study|Withdrawal by Subject|0|||
144571613|NCT01407276|521291758|FG005|Overall Study|Withdrawal by Subject|0|||
144571614|NCT01407276|521291759|FG006|Overall Study|Withdrawal by Subject|0|||
144571615|NCT01407276|521291760|FG007|Overall Study|Withdrawal by Subject|1|||
144571616|NCT03482752|521291763|FG000|Overall Study|Withdrawal by Subject|2|||
144571617|NCT03482752|521291763|FG000|Overall Study|Lost to Follow-up|1|||
144571618|NCT03482752|521291763|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
144571619|NCT02844777|521291765|FG000|Overall Study|Withdrawal by Subject|2|||
144571620|NCT02844777|521291766|FG001|Overall Study|Withdrawal by Subject|0|||
144571621|NCT02844777|521291767|FG002|Overall Study|Withdrawal by Subject|0|||
144571622|NCT01776008|521291768|FG000|Overall Study|ineligible|2|||
144571623|NCT04092452|521291770|FG000|Overall Study|Adverse Event|1|||
144571624|NCT04092452|521291771|FG001|Overall Study|Adverse Event|3|||
144571625|NCT04092452|521291772|FG002|Overall Study|Adverse Event|3|||
144571626|NCT04092452|521291773|FG003|Overall Study|Adverse Event|7|||
144571627|NCT04092452|521291770|FG000|Overall Study|Lack of Efficacy|1|||
144571628|NCT04092452|521291771|FG001|Overall Study|Lack of Efficacy|1|||
144571629|NCT04092452|521291772|FG002|Overall Study|Lack of Efficacy|1|||
144571630|NCT04092452|521291773|FG003|Overall Study|Lack of Efficacy|0|||
144571631|NCT04092452|521291770|FG000|Overall Study|Lost to Follow-up|4|||
144571632|NCT04092452|521291771|FG001|Overall Study|Lost to Follow-up|3|||
144621191|NCT00343889|521472208|FG000|Overall Study|Withdrawal by Subject|0|||
144621192|NCT00343889|521472209|FG001|Overall Study|Withdrawal by Subject|1|||
144621193|NCT00343889|521472208|FG000|Overall Study|Protocol Violation|1|||
144621194|NCT00343889|521472209|FG001|Overall Study|Protocol Violation|0|||
144621195|NCT04472429|521472212|FG000|Randomized Period|Ongoing|90|||
144571633|NCT04092452|521291772|FG002|Overall Study|Lost to Follow-up|5|||
144571634|NCT04092452|521291773|FG003|Overall Study|Lost to Follow-up|1|||
144571635|NCT04092452|521291770|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144571636|NCT04092452|521291771|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144571637|NCT04092452|521291772|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144571638|NCT04092452|521291773|FG003|Overall Study|Non-Compliance With Study Drug|1|||
144571639|NCT04092452|521291770|FG000|Overall Study|Physician Decision|1|||
144571640|NCT04092452|521291771|FG001|Overall Study|Physician Decision|0|||
144571641|NCT04092452|521291772|FG002|Overall Study|Physician Decision|1|||
144571642|NCT04092452|521291773|FG003|Overall Study|Physician Decision|0|||
144262843|NCT01325350|520163769|FG002|Overall Study|Adverse Event|3|||
144571643|NCT04092452|521291770|FG000|Overall Study|Pregnancy|2|||
144571644|NCT04092452|521291771|FG001|Overall Study|Pregnancy|0|||
144571645|NCT04092452|521291772|FG002|Overall Study|Pregnancy|0|||
144571646|NCT04092452|521291773|FG003|Overall Study|Pregnancy|0|||
144571647|NCT04092452|521291770|FG000|Overall Study|Protocol Deviation|1|||
144571648|NCT04092452|521291771|FG001|Overall Study|Protocol Deviation|0|||
144571649|NCT04092452|521291772|FG002|Overall Study|Protocol Deviation|0|||
144571650|NCT04092452|521291773|FG003|Overall Study|Protocol Deviation|0|||
144571651|NCT04092452|521291770|FG000|Overall Study|Withdrawal by Subject|3|||
144571652|NCT04092452|521291771|FG001|Overall Study|Withdrawal by Subject|10|||
144571653|NCT04092452|521291772|FG002|Overall Study|Withdrawal by Subject|3|||
144621196|NCT04472429|521472213|FG001|Randomized Period|Ongoing|40|||
144571654|NCT04092452|521291773|FG003|Overall Study|Withdrawal by Subject|5|||
144571655|NCT04092452|521291770|FG000|Overall Study|Other|0|||
144571656|NCT04092452|521291771|FG001|Overall Study|Other|0|||
144571657|NCT04092452|521291772|FG002|Overall Study|Other|1|||
144571658|NCT04092452|521291773|FG003|Overall Study|Other|2|||
144571659|NCT02127125|521291781|FG000|Overall Study|Lost to Follow-up|0|||
144571660|NCT02127125|521291782|FG001|Overall Study|Lost to Follow-up|0|||
144571661|NCT02127125|521291783|FG002|Overall Study|Lost to Follow-up|0|||
144571662|NCT02127125|521291784|FG003|Overall Study|Lost to Follow-up|0|||
144571663|NCT02127125|521291785|FG004|Overall Study|Lost to Follow-up|2|||
144571664|NCT02127125|521291786|FG005|Overall Study|Lost to Follow-up|1|||
144571665|NCT02127125|521291787|FG006|Overall Study|Lost to Follow-up|0|||
144571666|NCT02127125|521291788|FG007|Overall Study|Lost to Follow-up|0|||
144571667|NCT02127125|521291789|FG008|Overall Study|Lost to Follow-up|0|||
144571668|NCT02127125|521291781|FG000|Overall Study|Withdrawal by Subject|0|||
144571669|NCT02127125|521291782|FG001|Overall Study|Withdrawal by Subject|0|||
144571670|NCT02127125|521291783|FG002|Overall Study|Withdrawal by Subject|0|||
144571671|NCT02127125|521291784|FG003|Overall Study|Withdrawal by Subject|1|||
144571672|NCT02127125|521291785|FG004|Overall Study|Withdrawal by Subject|0|||
144571673|NCT02127125|521291786|FG005|Overall Study|Withdrawal by Subject|0|||
144571674|NCT02127125|521291787|FG006|Overall Study|Withdrawal by Subject|0|||
144571675|NCT02127125|521291788|FG007|Overall Study|Withdrawal by Subject|0|||
144571676|NCT02127125|521291789|FG008|Overall Study|Withdrawal by Subject|0|||
144571677|NCT02127125|521291781|FG000|Overall Study|Physician Decision|0|||
144571678|NCT02127125|521291782|FG001|Overall Study|Physician Decision|0|||
144571679|NCT02127125|521291783|FG002|Overall Study|Physician Decision|1|||
144571680|NCT02127125|521291784|FG003|Overall Study|Physician Decision|0|||
144571681|NCT02127125|521291785|FG004|Overall Study|Physician Decision|1|||
144571682|NCT02127125|521291786|FG005|Overall Study|Physician Decision|2|||
144571683|NCT02127125|521291787|FG006|Overall Study|Physician Decision|0|||
144571684|NCT02127125|521291788|FG007|Overall Study|Physician Decision|0|||
144571685|NCT02127125|521291789|FG008|Overall Study|Physician Decision|0|||
144571686|NCT02493946|521291795|FG000|DB Period|Withdrawal by Subject|8|||
144571687|NCT02493946|521291796|FG001|DB Period|Withdrawal by Subject|5|||
144571688|NCT02493946|521291797|FG002|DB Period|Withdrawal by Subject|0|||
144571689|NCT02493946|521291795|FG000|Open Label Period|Withdrawal by Subject|0|||
144571690|NCT02493946|521291796|FG001|Open Label Period|Withdrawal by Subject|0|||
144571691|NCT02493946|521291797|FG002|Open Label Period|Withdrawal by Subject|74|||
144571692|NCT02493946|521291795|FG000|Open Label Period|Adverse Event|0|||
144571693|NCT02493946|521291796|FG001|Open Label Period|Adverse Event|0|||
144571694|NCT02493946|521291797|FG002|Open Label Period|Adverse Event|4|||
144571695|NCT02493946|521291795|FG000|Open Label Period|Lost to Follow-up|0|||
144571696|NCT02493946|521291796|FG001|Open Label Period|Lost to Follow-up|0|||
144571697|NCT02493946|521291797|FG002|Open Label Period|Lost to Follow-up|1|||
144571698|NCT02493946|521291795|FG000|Open Label Period|Investigator decision, non-compliance|0|||
144571699|NCT02493946|521291796|FG001|Open Label Period|Investigator decision, non-compliance|0|||
144571700|NCT02493946|521291797|FG002|Open Label Period|Investigator decision, non-compliance|2|||
144571701|NCT02493946|521291795|FG000|Open Label Period|Investigator decision, non-availability|0|||
144571702|NCT02493946|521291796|FG001|Open Label Period|Investigator decision, non-availability|0|||
144571703|NCT02493946|521291797|FG002|Open Label Period|Investigator decision, non-availability|1|||
144571704|NCT02493946|521291795|FG000|Open Label Period|Pregnancy|0|||
144571705|NCT02493946|521291796|FG001|Open Label Period|Pregnancy|0|||
144571706|NCT02493946|521291797|FG002|Open Label Period|Pregnancy|3|||
144571707|NCT02493946|521291795|FG000|Open Label Period|Site error|0|||
144571708|NCT02493946|521291796|FG001|Open Label Period|Site error|0|||
144571709|NCT02493946|521291797|FG002|Open Label Period|Site error|1|||
144571710|NCT00965497|521291799|FG000|Overall Study|Physician Decision|1|||
144571711|NCT02689453|521291801|FG000|Overall Study|Progressive disease|0|||
144571712|NCT02689453|521291802|FG001|Overall Study|Progressive disease|1|||
144571713|NCT02689453|521291803|FG002|Overall Study|Progressive disease|1|||
144571714|NCT02638103|521291805|FG000|Overall Study|Adverse Event|13|||
144571715|NCT02638103|521291806|FG001|Overall Study|Adverse Event|12|||
144571716|NCT02638103|521291807|FG002|Overall Study|Adverse Event|19|||
144571717|NCT02638103|521291808|FG003|Overall Study|Adverse Event|12|||
144621197|NCT04472429|521472214|FG002|Randomized Period|Ongoing|0|||
144621198|NCT04472429|521472212|FG000|Randomized Period|Death|52|||
144207255|NCT00359801|519954277|FG001|Overall Study|Final Status Unknown: missing data|4|||
144207256|NCT00359801|519954276|FG000|Overall Study|Sponsor Decision|17|||
144571718|NCT02638103|521291805|FG000|Overall Study|Withdrawal by Subject|43|||
144571719|NCT02638103|521291806|FG001|Overall Study|Withdrawal by Subject|53|||
144571720|NCT02638103|521291807|FG002|Overall Study|Withdrawal by Subject|30|||
144571721|NCT02638103|521291808|FG003|Overall Study|Withdrawal by Subject|61|||
144571722|NCT02638103|521291805|FG000|Overall Study|Protocol Violation|1|||
144571723|NCT02638103|521291806|FG001|Overall Study|Protocol Violation|2|||
144571724|NCT02638103|521291807|FG002|Overall Study|Protocol Violation|1|||
144571725|NCT02638103|521291808|FG003|Overall Study|Protocol Violation|4|||
144571726|NCT02638103|521291805|FG000|Overall Study|Pregnancy|2|||
144571727|NCT02638103|521291806|FG001|Overall Study|Pregnancy|3|||
144621199|NCT04472429|521472213|FG001|Randomized Period|Death|37|||
144571728|NCT02638103|521291807|FG002|Overall Study|Pregnancy|0|||
144571729|NCT02638103|521291808|FG003|Overall Study|Pregnancy|1|||
144571730|NCT02638103|521291805|FG000|Overall Study|Non-compliance to Study Procedures|2|||
144571731|NCT02638103|521291806|FG001|Overall Study|Non-compliance to Study Procedures|1|||
144571732|NCT02638103|521291807|FG002|Overall Study|Non-compliance to Study Procedures|1|||
144571733|NCT02638103|521291808|FG003|Overall Study|Non-compliance to Study Procedures|1|||
144571734|NCT02638103|521291805|FG000|Overall Study|Lost to Follow-up|26|||
144571735|NCT02638103|521291806|FG001|Overall Study|Lost to Follow-up|33|||
144571736|NCT02638103|521291807|FG002|Overall Study|Lost to Follow-up|20|||
144571737|NCT02638103|521291808|FG003|Overall Study|Lost to Follow-up|37|||
144571738|NCT02638103|521291805|FG000|Overall Study|Lack of Efficacy|14|||
144571739|NCT02638103|521291806|FG001|Overall Study|Lack of Efficacy|10|||
144571740|NCT02638103|521291807|FG002|Overall Study|Lack of Efficacy|12|||
144571741|NCT02638103|521291808|FG003|Overall Study|Lack of Efficacy|22|||
144571742|NCT02638103|521291805|FG000|Overall Study|Other than specified|5|||
144571743|NCT02638103|521291806|FG001|Overall Study|Other than specified|4|||
144571744|NCT02638103|521291807|FG002|Overall Study|Other than specified|2|||
144571745|NCT02638103|521291808|FG003|Overall Study|Other than specified|4|||
144571746|NCT00794924|521291816|FG000|Overall Study|Lost to Follow-up|6|||
144571747|NCT00794924|521291817|FG001|Overall Study|Lost to Follow-up|8|||
144571748|NCT00794924|521291816|FG000|Overall Study|Withdrawal by Subject|48|||
144571749|NCT00794924|521291817|FG001|Overall Study|Withdrawal by Subject|60|||
144571750|NCT00794924|521291816|FG000|Overall Study|Adverse Event|6|||
144571751|NCT00794924|521291817|FG001|Overall Study|Adverse Event|2|||
144571752|NCT00953615|521291818|FG000|Overall Study|Adverse Event|1|||
144571753|NCT01827046|521291821|FG000|Overall Study|Lost to Follow-up|1|||
144571754|NCT01827046|521291822|FG001|Overall Study|Lost to Follow-up|5|||
144571755|NCT01827046|521291821|FG000|Overall Study|Withdrawal by Subject|0|||
144571756|NCT01827046|521291822|FG001|Overall Study|Withdrawal by Subject|4|||
144571757|NCT01294436|521291824|FG000|Overall Study|Adverse Event|10|||
144571758|NCT01294436|521291825|FG001|Overall Study|Adverse Event|17|||
144571759|NCT01294436|521291824|FG000|Overall Study|Withdrawal by Subject|11|||
144571760|NCT01294436|521291825|FG001|Overall Study|Withdrawal by Subject|28|||
144571761|NCT01294436|521291824|FG000|Overall Study|subject no longer meets study criteria|5|||
144571762|NCT01294436|521291825|FG001|Overall Study|subject no longer meets study criteria|20|||
144571763|NCT01294436|521291824|FG000|Overall Study|poor/non-compliance|2|||
144571764|NCT01294436|521291825|FG001|Overall Study|poor/non-compliance|5|||
144571765|NCT02389764|521291826|FG000|Overall Study|Lack of Efficacy|9|||
144571766|NCT01255761|521291835|FG000|Overall Study|Adverse Event|29|||
144571767|NCT01255761|521291836|FG001|Overall Study|Adverse Event|43|||
144571768|NCT01255761|521291835|FG000|Overall Study|Lack of Efficacy|86|||
144571769|NCT01255761|521291836|FG001|Overall Study|Lack of Efficacy|74|||
144571770|NCT01255761|521291835|FG000|Overall Study|Protocol Violation|9|||
144571771|NCT01255761|521291836|FG001|Overall Study|Protocol Violation|5|||
144571772|NCT01255761|521291835|FG000|Overall Study|Lost to Follow-up|10|||
144571773|NCT01255761|521291836|FG001|Overall Study|Lost to Follow-up|8|||
144571774|NCT01255761|521291835|FG000|Overall Study|Withdrawal by Subject|11|||
144571775|NCT01255761|521291836|FG001|Overall Study|Withdrawal by Subject|27|||
144571776|NCT01255761|521291835|FG000|Overall Study|Other Reasons|37|||
144571777|NCT01255761|521291836|FG001|Overall Study|Other Reasons|18|||
144571778|NCT03170518|521291840|FG000|Overall Study|Lost to Follow-up|4|||
144571779|NCT03170518|521291841|FG001|Overall Study|Lost to Follow-up|1|||
144571780|NCT03170518|521291842|FG002|Overall Study|Lost to Follow-up|0|||
144571781|NCT03170518|521291840|FG000|Overall Study|Physician Decision|1|||
144571782|NCT03170518|521291841|FG001|Overall Study|Physician Decision|0|||
144571783|NCT03170518|521291842|FG002|Overall Study|Physician Decision|0|||
144571784|NCT03170518|521291840|FG000|Overall Study|Withdrawal by Subject|4|||
144571785|NCT03170518|521291841|FG001|Overall Study|Withdrawal by Subject|5|||
144571786|NCT03170518|521291842|FG002|Overall Study|Withdrawal by Subject|2|||
144571787|NCT03170518|521291840|FG000|Overall Study|Site terminated by sponsor|0|||
144571788|NCT03170518|521291841|FG001|Overall Study|Site terminated by sponsor|1|||
144571789|NCT03170518|521291842|FG002|Overall Study|Site terminated by sponsor|0|||
144571790|NCT03170518|521291840|FG000|Overall Study|Non-compliance with study drug|1|||
144571791|NCT03170518|521291841|FG001|Overall Study|Non-compliance with study drug|0|||
144571792|NCT03170518|521291842|FG002|Overall Study|Non-compliance with study drug|1|||
144621200|NCT04472429|521472214|FG002|Randomized Period|Death|0|||
144571793|NCT03170518|521291840|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144571794|NCT03170518|521291841|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144571795|NCT03170518|521291842|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144571796|NCT03842436|521291843|FG000|Overall Study|Lost to Follow-up|1|||
144571797|NCT01263054|521291846|FG000|Overall Study|Death|1|||
144571798|NCT01263054|521291847|FG001|Overall Study|Death|0|||
144571799|NCT01263054|521291846|FG000|Overall Study|Lost to Follow-up|2|||
144571800|NCT01263054|521291847|FG001|Overall Study|Lost to Follow-up|2|||
144571801|NCT01263054|521291846|FG000|Overall Study|Withdrawal by Subject|1|||
144571802|NCT01263054|521291847|FG001|Overall Study|Withdrawal by Subject|3|||
144571803|NCT01263054|521291846|FG000|Overall Study|Qualification Violation|1|||
144621201|NCT04472429|521472212|FG000|Randomized Period|Lost to Follow-up|4|||
144621202|NCT04472429|521472213|FG001|Randomized Period|Lost to Follow-up|0|||
144621203|NCT04472429|521472214|FG002|Randomized Period|Lost to Follow-up|0|||
144621204|NCT04472429|521472212|FG000|Randomized Period|Physician Decision|1|||
144621205|NCT04472429|521472213|FG001|Randomized Period|Physician Decision|2|||
144621206|NCT04472429|521472214|FG002|Randomized Period|Physician Decision|0|||
144621207|NCT04472429|521472212|FG000|Randomized Period|Withdrawal by Subject|6|||
144621208|NCT04472429|521472213|FG001|Randomized Period|Withdrawal by Subject|5|||
144621209|NCT04472429|521472214|FG002|Randomized Period|Withdrawal by Subject|0|||
144621210|NCT04472429|521472212|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
144621211|NCT04472429|521472213|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
144621212|NCT04472429|521472214|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
144729771|NCT04625114|521866154|FG000|Overall Study|Withdrawal by Subject|2|||
144571804|NCT01263054|521291847|FG001|Overall Study|Qualification Violation|0|||
144571805|NCT01263054|521291846|FG000|Overall Study|Other|0|||
144571806|NCT01263054|521291847|FG001|Overall Study|Other|1|||
144571807|NCT00936598|521291848|FG000|Overall Study|Withdrawal by Subject|1|||
144571808|NCT00936598|521291849|FG001|Overall Study|Withdrawal by Subject|0|||
144571809|NCT00936598|521291848|FG000|Overall Study|Ineligible after consent|1|||
144571810|NCT00936598|521291849|FG001|Overall Study|Ineligible after consent|0|||
144571811|NCT03358238|521291850|FG000|Overall Study|Withdrawal by Subject|0|||
144571812|NCT03358238|521291851|FG001|Overall Study|Withdrawal by Subject|1|||
144571813|NCT02358668|521293977|FG000|Overall Study|Adverse Event|2|||
144571814|NCT02358668|521293978|FG001|Overall Study|Adverse Event|0|||
144571815|NCT02358668|521293979|FG002|Overall Study|Adverse Event|0|||
144571816|NCT02358668|521293977|FG000|Overall Study|Withdrawal by Subject|0|||
144571817|NCT02358668|521293978|FG001|Overall Study|Withdrawal by Subject|1|||
144571818|NCT02358668|521293979|FG002|Overall Study|Withdrawal by Subject|0|||
144571819|NCT01317875|521293985|FG000|Overall Study|Other|0|||
144571820|NCT01317875|521293986|FG001|Overall Study|Other|0|||
144571821|NCT01317875|521293987|FG002|Overall Study|Other|1|||
144571822|NCT01317875|521293988|FG003|Overall Study|Other|0|||
144571823|NCT01317875|521293989|FG004|Overall Study|Other|0|||
144571824|NCT01317875|521293990|FG005|Overall Study|Other|0|||
144571825|NCT01317875|521293991|FG006|Overall Study|Other|0|||
144571826|NCT01317875|521293992|FG007|Overall Study|Other|0|||
144571827|NCT01317875|521293993|FG008|Overall Study|Other|0|||
144571828|NCT01317875|521293994|FG009|Overall Study|Other|0|||
144571829|NCT01317875|521293985|FG000|Overall Study|Noncompliance with study drug|0|||
144571830|NCT01317875|521293986|FG001|Overall Study|Noncompliance with study drug|0|||
144571831|NCT01317875|521293987|FG002|Overall Study|Noncompliance with study drug|1|||
144571832|NCT01317875|521293988|FG003|Overall Study|Noncompliance with study drug|0|||
144571833|NCT01317875|521293989|FG004|Overall Study|Noncompliance with study drug|0|||
144621213|NCT04472429|521472212|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
144621214|NCT04472429|521472213|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
144621215|NCT04472429|521472214|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
144729772|NCT04625114|521866155|FG001|Overall Study|Withdrawal by Subject|0|||
144729773|NCT01629381|521866156|FG000|Overall Study|Withdrawal by Subject|2|||
144729774|NCT01629381|521866157|FG001|Overall Study|Withdrawal by Subject|5|||
144729775|NCT02849652|521866163|FG000|Overall Study|Lost to Follow-up|104|||
144729776|NCT02849652|521866164|FG001|Overall Study|Lost to Follow-up|35|||
144729777|NCT02849652|521866165|FG002|Overall Study|Lost to Follow-up|116|||
144729778|NCT02849652|521866166|FG003|Overall Study|Lost to Follow-up|22|||
144729779|NCT02849652|521866163|FG000|Overall Study|Withdrawal by Subject|10|||
144729780|NCT02849652|521866164|FG001|Overall Study|Withdrawal by Subject|2|||
144729781|NCT02849652|521866165|FG002|Overall Study|Withdrawal by Subject|8|||
144729782|NCT02849652|521866166|FG003|Overall Study|Withdrawal by Subject|4|||
144729783|NCT00854308|521866167|FG000|Overall Study|Disease progression|42|||
144729784|NCT00854308|521866168|FG001|Overall Study|Disease progression|50|||
144207257|NCT00359801|519954277|FG001|Overall Study|Sponsor Decision|16|||
144207258|NCT01056289|519954279|FG000|Open-label Phase|Adverse Event|29|||
144207259|NCT01056289|519954280|FG001|Open-label Phase|Adverse Event|0|||
144207260|NCT01056289|519954281|FG002|Open-label Phase|Adverse Event|0|||
144571834|NCT01317875|521293990|FG005|Overall Study|Noncompliance with study drug|0|||
144571835|NCT01317875|521293991|FG006|Overall Study|Noncompliance with study drug|0|||
144621216|NCT04472429|521472212|FG000|Open-label Monotherapy Period|Ongoing|0|||
144621217|NCT04472429|521472213|FG001|Open-label Monotherapy Period|Ongoing|0|||
144571836|NCT01317875|521293992|FG007|Overall Study|Noncompliance with study drug|0|||
144571837|NCT01317875|521293993|FG008|Overall Study|Noncompliance with study drug|0|||
144571838|NCT01317875|521293994|FG009|Overall Study|Noncompliance with study drug|0|||
144571839|NCT01317875|521293985|FG000|Overall Study|Progressive Disease|1|||
144571840|NCT01317875|521293986|FG001|Overall Study|Progressive Disease|0|||
144621218|NCT04472429|521472214|FG002|Open-label Monotherapy Period|Ongoing|32|||
144729785|NCT00854308|521866167|FG000|Overall Study|Adverse Event|8|||
144571841|NCT01317875|521293987|FG002|Overall Study|Progressive Disease|2|||
144729786|NCT00854308|521866168|FG001|Overall Study|Adverse Event|3|||
144729787|NCT00854308|521866167|FG000|Overall Study|Death|2|||
144207261|NCT01056289|519954282|FG003|Open-label Phase|Adverse Event|0|||
144571842|NCT01317875|521293988|FG003|Overall Study|Progressive Disease|0|||
144571843|NCT01317875|521293989|FG004|Overall Study|Progressive Disease|1|||
144571844|NCT01317875|521293990|FG005|Overall Study|Progressive Disease|0|||
144571845|NCT01317875|521293991|FG006|Overall Study|Progressive Disease|0|||
144571846|NCT01317875|521293992|FG007|Overall Study|Progressive Disease|1|||
144571847|NCT01317875|521293993|FG008|Overall Study|Progressive Disease|0|||
144571848|NCT01317875|521293994|FG009|Overall Study|Progressive Disease|0|||
144571849|NCT01317875|521293985|FG000|Overall Study|Withdrawal by Subject|0|||
144571850|NCT01317875|521293986|FG001|Overall Study|Withdrawal by Subject|0|||
144571851|NCT01317875|521293987|FG002|Overall Study|Withdrawal by Subject|0|||
144571852|NCT01317875|521293988|FG003|Overall Study|Withdrawal by Subject|0|||
144571853|NCT01317875|521293989|FG004|Overall Study|Withdrawal by Subject|1|||
144571854|NCT01317875|521293990|FG005|Overall Study|Withdrawal by Subject|0|||
144571855|NCT01317875|521293991|FG006|Overall Study|Withdrawal by Subject|0|||
144571856|NCT01317875|521293992|FG007|Overall Study|Withdrawal by Subject|3|||
144571857|NCT01317875|521293993|FG008|Overall Study|Withdrawal by Subject|0|||
144571858|NCT01317875|521293994|FG009|Overall Study|Withdrawal by Subject|0|||
144571859|NCT01317875|521293985|FG000|Overall Study|Physician Decision|0|||
144571860|NCT01317875|521293986|FG001|Overall Study|Physician Decision|1|||
144571861|NCT01317875|521293987|FG002|Overall Study|Physician Decision|1|||
144571862|NCT01317875|521293988|FG003|Overall Study|Physician Decision|0|||
144571863|NCT01317875|521293989|FG004|Overall Study|Physician Decision|2|||
144571864|NCT01317875|521293990|FG005|Overall Study|Physician Decision|0|||
144571865|NCT01317875|521293991|FG006|Overall Study|Physician Decision|0|||
144571866|NCT01317875|521293992|FG007|Overall Study|Physician Decision|2|||
144571867|NCT01317875|521293993|FG008|Overall Study|Physician Decision|0|||
144571868|NCT01317875|521293994|FG009|Overall Study|Physician Decision|0|||
144571869|NCT01317875|521293985|FG000|Overall Study|Death|0|||
144571870|NCT01317875|521293986|FG001|Overall Study|Death|0|||
144571871|NCT01317875|521293987|FG002|Overall Study|Death|2|||
144571872|NCT01317875|521293988|FG003|Overall Study|Death|1|||
144621219|NCT04472429|521472212|FG000|Open-label Monotherapy Period|Death|0|||
144621220|NCT04472429|521472213|FG001|Open-label Monotherapy Period|Death|0|||
144621221|NCT04472429|521472214|FG002|Open-label Monotherapy Period|Death|35|||
144621222|NCT04472429|521472212|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
144621223|NCT04472429|521472213|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
144621224|NCT04472429|521472214|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
144621225|NCT05130463|521472215|FG000|Overall Study|Unspecified reasons|2|||
144621226|NCT05130463|521472215|FG000|Overall Study|off-label indication dose|435|||
144621227|NCT03652662|521472216|FG000|Overall Study|Withdrawal by Subject|2|||
144621228|NCT03652662|521472217|FG001|Overall Study|Withdrawal by Subject|1|||
144621229|NCT03652662|521472216|FG000|Overall Study|Lost to Follow-up|1|||
144621230|NCT03652662|521472217|FG001|Overall Study|Lost to Follow-up|0|||
144621231|NCT02695628|521472218|FG000|Overall Study|Withdrawal by Subject|1|||
144621232|NCT02678390|521472219|FG000|AE (1 Day)|Withdrawal by Subject|0|||
144621233|NCT02678390|521472220|FG001|AE (1 Day)|Withdrawal by Subject|1|||
144621234|NCT01687712|521472221|FG000|Cycle 1|Not Biochemically Pregnant|386|||
144621235|NCT01687712|521472222|FG001|Cycle 1|Not Biochemically Pregnant|348|||
144621236|NCT01687712|521472221|FG000|Cycle 1|Early Pregnancy Loss|43|||
144621237|NCT01687712|521472222|FG001|Cycle 1|Early Pregnancy Loss|60|||
144621238|NCT01687712|521472221|FG000|Cycle 1|Ectopic Pregnancy|5|||
144729788|NCT00854308|521866168|FG001|Overall Study|Death|5|||
144729789|NCT00854308|521866167|FG000|Overall Study|Physician Decision|6|||
144729790|NCT00854308|521866168|FG001|Overall Study|Physician Decision|6|||
144729791|NCT00854308|521866167|FG000|Overall Study|Withdrawal by Subject|4|||
144621239|NCT01687712|521472222|FG001|Cycle 1|Ectopic Pregnancy|5|||
144621240|NCT01687712|521472221|FG000|Cycle 1|Heterotropic Pregnancy|1|||
144621241|NCT01687712|521472222|FG001|Cycle 1|Heterotropic Pregnancy|0|||
144729792|NCT00854308|521866168|FG001|Overall Study|Withdrawal by Subject|2|||
144729793|NCT00854308|521866167|FG000|Overall Study|Sponsor's decision to terminate study|0|||
144729794|NCT00854308|521866168|FG001|Overall Study|Sponsor's decision to terminate study|1|||
144729795|NCT01390844|521866169|FG000|Treatment Phase|Adverse Event|12|||
144207262|NCT01056289|519954279|FG000|Open-label Phase|Lost to Follow-up|30|||
144571873|NCT01317875|521293989|FG004|Overall Study|Death|0|||
144571874|NCT01317875|521293990|FG005|Overall Study|Death|1|||
144571875|NCT01317875|521293991|FG006|Overall Study|Death|0|||
144571876|NCT01317875|521293992|FG007|Overall Study|Death|4|||
144571877|NCT01317875|521293993|FG008|Overall Study|Death|0|||
144571878|NCT01317875|521293994|FG009|Overall Study|Death|0|||
144571879|NCT01317875|521293985|FG000|Overall Study|Adverse Event|2|||
144571880|NCT01317875|521293986|FG001|Overall Study|Adverse Event|1|||
144571881|NCT01317875|521293987|FG002|Overall Study|Adverse Event|2|||
144571882|NCT01317875|521293988|FG003|Overall Study|Adverse Event|1|||
144571883|NCT01317875|521293989|FG004|Overall Study|Adverse Event|5|||
144621242|NCT01687712|521472221|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
144729796|NCT01390844|521866170|FG001|Treatment Phase|Adverse Event|2|||
144729797|NCT01390844|521866171|FG002|Treatment Phase|Adverse Event|3|||
144729798|NCT01390844|521866172|FG003|Treatment Phase|Adverse Event|2|||
144571884|NCT01317875|521293990|FG005|Overall Study|Adverse Event|1|||
144207263|NCT01056289|519954280|FG001|Open-label Phase|Lost to Follow-up|0|||
144571885|NCT01317875|521293991|FG006|Overall Study|Adverse Event|2|||
144571886|NCT01317875|521293992|FG007|Overall Study|Adverse Event|5|||
144571887|NCT01317875|521293993|FG008|Overall Study|Adverse Event|0|||
144571888|NCT01317875|521293994|FG009|Overall Study|Adverse Event|0|||
144571889|NCT00233480|521293995|FG000|Overall Study|Underwent status II heart transplant|0|||
144571890|NCT00233480|521293996|FG001|Overall Study|Underwent status II heart transplant|1|||
144571891|NCT00592293|521294001|FG000|Overall Study|Withdrawal by Subject|1|||
144571892|NCT01606319|521294002|FG000|Overall Study|Lost to Follow-up|17|||
144571893|NCT01606319|521294003|FG001|Overall Study|Lost to Follow-up|14|||
144571894|NCT01606319|521294002|FG000|Overall Study|Withdrawal by Subject|9|||
144571895|NCT01606319|521294003|FG001|Overall Study|Withdrawal by Subject|12|||
144571896|NCT01606319|521294002|FG000|Overall Study|Physician Decision|1|||
144571897|NCT01606319|521294003|FG001|Overall Study|Physician Decision|2|||
144571898|NCT01606319|521294002|FG000|Overall Study|Lack of Efficacy|6|||
144571899|NCT01606319|521294003|FG001|Overall Study|Lack of Efficacy|8|||
144571900|NCT01606319|521294002|FG000|Overall Study|Adverse Event|1|||
144571901|NCT01606319|521294003|FG001|Overall Study|Adverse Event|4|||
144571902|NCT00022659|521294008|FG000|Overall Study|Ineligible: wrong primary|1|||
144571903|NCT00022659|521294008|FG000|Overall Study|Never treated|1|||
144571904|NCT01821937|521294015|FG000|Overall Study|Adverse Event|0|||
144571905|NCT01821937|521294016|FG001|Overall Study|Adverse Event|3|||
144571906|NCT04829747|521294019|FG000|Overall Study|Protocol Violation|1|||
144571907|NCT02153905|521294024|FG000|Overall Study|Death|1|||
144571908|NCT02153905|521294025|FG001|Overall Study|Death|0|||
144571909|NCT00425607|521294030|FG000|Overall Study|Death|1|||
144571910|NCT00425607|521294030|FG000|Overall Study|Withdrawal by Subject|1|||
144571911|NCT02563548|521294031|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
144571912|NCT02563548|521294032|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
144571913|NCT02563548|521294033|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
144571914|NCT02563548|521294034|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
144571915|NCT02563548|521294035|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
144571916|NCT02563548|521294036|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
144571917|NCT02563548|521294031|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
144621243|NCT01687712|521472222|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
144621244|NCT01687712|521472221|FG000|Cycle 1|Abortion|3|||
144621245|NCT01687712|521472222|FG001|Cycle 1|Abortion|0|||
144621246|NCT01687712|521472221|FG000|Cycle 1|Intrauterine Fetal Death|0|||
144621247|NCT01687712|521472222|FG001|Cycle 1|Intrauterine Fetal Death|1|||
144621248|NCT01687712|521472221|FG000|Cycle 1|Lost to Follow-up|1|||
144621249|NCT01687712|521472222|FG001|Cycle 1|Lost to Follow-up|1|||
144621250|NCT01687712|521472221|FG000|Cycle 2|Not Biochemically Pregnant|74|||
144621251|NCT01687712|521472222|FG001|Cycle 2|Not Biochemically Pregnant|77|||
144621252|NCT01687712|521472221|FG000|Cycle 2|Early Pregnancy Loss|18|||
144621253|NCT01687712|521472222|FG001|Cycle 2|Early Pregnancy Loss|16|||
144621254|NCT01687712|521472221|FG000|Cycle 2|Ectopic Pregnancy|0|||
144621255|NCT01687712|521472222|FG001|Cycle 2|Ectopic Pregnancy|1|||
144621256|NCT01687712|521472221|FG000|Cycle 2|Still Birth|1|||
144621257|NCT01687712|521472222|FG001|Cycle 2|Still Birth|0|||
144621258|NCT01687712|521472221|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
144621259|NCT01687712|521472222|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
144621260|NCT01687712|521472221|FG000|Cycle 3|Not Biochemically Pregnant|21|||
144621261|NCT01687712|521472222|FG001|Cycle 3|Not Biochemically Pregnant|22|||
144621262|NCT01687712|521472221|FG000|Cycle 3|Early Pregnancy Loss|1|||
144621263|NCT01687712|521472222|FG001|Cycle 3|Early Pregnancy Loss|2|||
144621264|NCT01687712|521472221|FG000|Cycle 3|Ectopic Pregnancy|1|||
144621265|NCT01687712|521472222|FG001|Cycle 3|Ectopic Pregnancy|0|||
144621266|NCT01687712|521472221|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
144621267|NCT01687712|521472222|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
144621268|NCT02573155|521472223|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
144621269|NCT02573155|521472224|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
144571918|NCT02563548|521294032|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
144571919|NCT02563548|521294033|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
144571920|NCT02563548|521294034|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
144571921|NCT02563548|521294035|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
144571922|NCT02563548|521294036|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
144571923|NCT02563548|521294031|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
144621270|NCT02573155|521472223|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
144621271|NCT02573155|521472224|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
144621272|NCT02573155|521472223|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
144621273|NCT02573155|521472224|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
144621274|NCT02573155|521472223|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
144621275|NCT02573155|521472224|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
144621276|NCT02573155|521472223|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
144621277|NCT02573155|521472224|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
144571924|NCT02563548|521294032|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
144571925|NCT02563548|521294033|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
144571926|NCT02563548|521294034|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
144571927|NCT02563548|521294035|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
144571928|NCT02563548|521294036|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
144571929|NCT02563548|521294031|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
144571930|NCT02563548|521294032|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
144571931|NCT02563548|521294033|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
144571932|NCT02563548|521294034|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
144571933|NCT02563548|521294035|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
144571934|NCT02563548|521294036|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
144571935|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
144571936|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
144571937|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
144571938|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
144571939|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
144571940|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
144571941|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
144571942|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
144571943|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
144571944|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
144571945|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
144571946|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
144571947|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
144571948|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
144571949|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
144571950|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
144571951|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
144571952|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
144571953|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
144571954|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
144571955|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
144571956|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
144571957|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
144571958|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
144571959|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
144571960|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
144571961|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
144571962|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
144571963|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
144571964|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
144571965|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
144571966|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
144621278|NCT02573155|521472223|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
144621279|NCT02573155|521472224|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
144621280|NCT02573155|521472223|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
144621281|NCT02573155|521472224|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
144621282|NCT02573155|521472223|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
144621283|NCT02573155|521472224|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
144571967|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
144571968|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
144571969|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
144621284|NCT01681433|521472225|FG000|Overall Study|Lack of Efficacy|23|||
144621285|NCT01681433|521472226|FG001|Overall Study|Lack of Efficacy|23|||
144621286|NCT01681433|521472225|FG000|Overall Study|Withdrawal by Subject|5|||
144621287|NCT01681433|521472226|FG001|Overall Study|Withdrawal by Subject|5|||
144621288|NCT01681433|521472225|FG000|Overall Study|Protocol Violation|2|||
144621289|NCT01681433|521472226|FG001|Overall Study|Protocol Violation|0|||
144621290|NCT01681433|521472225|FG000|Overall Study|Adverse Event|2|||
144621291|NCT01681433|521472226|FG001|Overall Study|Adverse Event|4|||
144621292|NCT01681433|521472225|FG000|Overall Study|Lost to Follow-up|0|||
144621293|NCT01681433|521472226|FG001|Overall Study|Lost to Follow-up|1|||
144621294|NCT05913232|521472227|FG000|Overall Study|Adverse Event|0|||
144621295|NCT05913232|521472228|FG001|Overall Study|Adverse Event|2|||
144621296|NCT05913232|521472229|FG002|Overall Study|Adverse Event|1|||
144621297|NCT05913232|521472230|FG003|Overall Study|Adverse Event|1|||
144621298|NCT01318109|521472231|FG000|Overall Study|Adverse Event|0|||
144621299|NCT01318109|521472232|FG001|Overall Study|Adverse Event|2|||
144571970|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
144571971|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
144571972|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
144571973|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
144571974|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
144571975|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
144571976|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
144571977|NCT02563548|521294031|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
144571978|NCT02563548|521294032|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
144571979|NCT02563548|521294033|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
144571980|NCT02563548|521294034|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
144571981|NCT02563548|521294035|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
144571982|NCT02563548|521294036|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
144571983|NCT00203047|521294037|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
144571984|NCT00203047|521294038|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
144571985|NCT00203047|521294037|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
144571986|NCT00203047|521294038|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
144571987|NCT00203047|521294037|FG000|Overall Study|Withdrawal by Subject|13|||
144571988|NCT00203047|521294038|FG001|Overall Study|Withdrawal by Subject|47|||
144571989|NCT00203047|521294037|FG000|Overall Study|Teva requested participant withdrawal|1|||
144571990|NCT00203047|521294038|FG001|Overall Study|Teva requested participant withdrawal|1|||
144571991|NCT00203047|521294037|FG000|Overall Study|Physician Decision|8|||
144571992|NCT00203047|521294038|FG001|Overall Study|Physician Decision|7|||
144571993|NCT00203047|521294037|FG000|Overall Study|Non-compliance|4|||
144571994|NCT00203047|521294038|FG001|Overall Study|Non-compliance|8|||
144571995|NCT00203047|521294037|FG000|Overall Study|Protocol Violation|1|||
144571996|NCT00203047|521294038|FG001|Overall Study|Protocol Violation|0|||
144571997|NCT00203047|521294037|FG000|Overall Study|Lost to Follow-up|11|||
144571998|NCT00203047|521294038|FG001|Overall Study|Lost to Follow-up|5|||
144571999|NCT00203047|521294037|FG000|Overall Study|Adverse Event|8|||
144572000|NCT00203047|521294038|FG001|Overall Study|Adverse Event|18|||
144572001|NCT00203047|521294037|FG000|Overall Study|Death|1|||
144572002|NCT00203047|521294038|FG001|Overall Study|Death|2|||
144572003|NCT00203047|521294037|FG000|Overall Study|Pregnancy|3|||
144572004|NCT00203047|521294038|FG001|Overall Study|Pregnancy|0|||
144572005|NCT00203047|521294037|FG000|Overall Study|Other|5|||
144572006|NCT00203047|521294038|FG001|Overall Study|Other|5|||
144572007|NCT00351377|521294039|FG000|Overall Study|Adverse Event|5|||
144572008|NCT00351377|521294039|FG000|Overall Study|Death|1|||
144572009|NCT00351377|521294039|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144572010|NCT01607879|521294042|FG000|Overall Study|Death|1|||
144572011|NCT01607879|521294043|FG001|Overall Study|Death|0|||
144572012|NCT03845140|521294044|FG000|Overall Study|Participant travelled outside study area|0|||
144572013|NCT03845140|521294045|FG001|Overall Study|Participant travelled outside study area|1|||
144572014|NCT03845140|521294046|FG002|Overall Study|Participant travelled outside study area|0|||
144572015|NCT03845140|521294047|FG003|Overall Study|Participant travelled outside study area|0|||
144572016|NCT03845140|521294048|FG004|Overall Study|Participant travelled outside study area|0|||
144572017|NCT03845140|521294049|FG005|Overall Study|Participant travelled outside study area|0|||
144572018|NCT00150618|521294059|FG000|Overall Study|Adverse Event|2|||
144572019|NCT00150618|521294060|FG001|Overall Study|Adverse Event|2|||
144572020|NCT00150618|521294061|FG002|Overall Study|Adverse Event|6|||
144572021|NCT00150618|521294062|FG003|Overall Study|Adverse Event|9|||
144572022|NCT00150618|521294063|FG004|Overall Study|Adverse Event|5|||
144572023|NCT00150618|521294059|FG000|Overall Study|Withdrawal by Subject|6|||
144572024|NCT00150618|521294060|FG001|Overall Study|Withdrawal by Subject|8|||
144572025|NCT00150618|521294061|FG002|Overall Study|Withdrawal by Subject|8|||
144572026|NCT00150618|521294062|FG003|Overall Study|Withdrawal by Subject|4|||
144572027|NCT00150618|521294063|FG004|Overall Study|Withdrawal by Subject|5|||
144572028|NCT00150618|521294059|FG000|Overall Study|Lost to Follow-up|4|||
144572029|NCT00150618|521294060|FG001|Overall Study|Lost to Follow-up|1|||
144572030|NCT00150618|521294061|FG002|Overall Study|Lost to Follow-up|5|||
144621300|NCT01318109|521472233|FG002|Overall Study|Adverse Event|0|||
144621301|NCT01318109|521472231|FG000|Overall Study|Withdrawal by Subject|1|||
144621302|NCT01318109|521472232|FG001|Overall Study|Withdrawal by Subject|0|||
144572031|NCT00150618|521294062|FG003|Overall Study|Lost to Follow-up|8|||
144572032|NCT00150618|521294063|FG004|Overall Study|Lost to Follow-up|4|||
144572033|NCT00150618|521294059|FG000|Overall Study|Protocol Violation|1|||
144572034|NCT00150618|521294060|FG001|Overall Study|Protocol Violation|0|||
144572035|NCT00150618|521294061|FG002|Overall Study|Protocol Violation|0|||
144572036|NCT00150618|521294062|FG003|Overall Study|Protocol Violation|0|||
144572037|NCT00150618|521294063|FG004|Overall Study|Protocol Violation|1|||
144572038|NCT00150618|521294059|FG000|Overall Study|Lack of Efficacy|1|||
144572039|NCT00150618|521294060|FG001|Overall Study|Lack of Efficacy|4|||
144572040|NCT00150618|521294061|FG002|Overall Study|Lack of Efficacy|7|||
144572041|NCT00150618|521294062|FG003|Overall Study|Lack of Efficacy|4|||
144572042|NCT00150618|521294063|FG004|Overall Study|Lack of Efficacy|6|||
144572043|NCT00150618|521294059|FG000|Overall Study|No study meds|0|||
144572044|NCT00150618|521294060|FG001|Overall Study|No study meds|0|||
144572045|NCT00150618|521294061|FG002|Overall Study|No study meds|0|||
144572046|NCT00150618|521294062|FG003|Overall Study|No study meds|0|||
144572047|NCT00150618|521294063|FG004|Overall Study|No study meds|2|||
144572048|NCT00150618|521294059|FG000|Overall Study|Physician Decision|0|||
144572049|NCT00150618|521294060|FG001|Overall Study|Physician Decision|2|||
144572050|NCT00150618|521294061|FG002|Overall Study|Physician Decision|0|||
144572051|NCT00150618|521294062|FG003|Overall Study|Physician Decision|0|||
144572052|NCT00150618|521294063|FG004|Overall Study|Physician Decision|1|||
144572053|NCT00150618|521294059|FG000|Overall Study|Lack of compliance|2|||
144572054|NCT00150618|521294060|FG001|Overall Study|Lack of compliance|1|||
144572055|NCT00150618|521294061|FG002|Overall Study|Lack of compliance|1|||
144572056|NCT00150618|521294062|FG003|Overall Study|Lack of compliance|0|||
144572057|NCT00150618|521294063|FG004|Overall Study|Lack of compliance|1|||
144572058|NCT00150618|521294059|FG000|Overall Study|Abnormal ECG|1|||
144572059|NCT00150618|521294060|FG001|Overall Study|Abnormal ECG|0|||
144572060|NCT00150618|521294061|FG002|Overall Study|Abnormal ECG|0|||
144572061|NCT00150618|521294062|FG003|Overall Study|Abnormal ECG|0|||
144572062|NCT00150618|521294063|FG004|Overall Study|Abnormal ECG|0|||
144572063|NCT00150618|521294059|FG000|Overall Study|Sponsor's decision|0|||
144572064|NCT00150618|521294060|FG001|Overall Study|Sponsor's decision|0|||
144572065|NCT00150618|521294061|FG002|Overall Study|Sponsor's decision|0|||
144572066|NCT00150618|521294062|FG003|Overall Study|Sponsor's decision|1|||
144572067|NCT00150618|521294063|FG004|Overall Study|Sponsor's decision|0|||
144572068|NCT01012947|521294064|FG000|Overall Study|Lost to Follow-up|131|||
144572069|NCT01012947|521294065|FG001|Overall Study|Lost to Follow-up|135|||
144572070|NCT01012947|521294066|FG002|Overall Study|Lost to Follow-up|130|||
144572071|NCT01012947|521294067|FG003|Overall Study|Lost to Follow-up|118|||
144572072|NCT01012947|521294068|FG004|Overall Study|Lost to Follow-up|142|||
144572073|NCT01163474|521294069|FG000|Overall Study|Withdrawal by Subject|1|||
144572074|NCT01163474|521294069|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
144572075|NCT01163474|521294069|FG000|Overall Study|Lost to Follow-up|3|||
144572076|NCT00762476|521294070|FG000|Overall Study|Adverse Event|7|||
144572077|NCT00762476|521294071|FG001|Overall Study|Adverse Event|1|||
144572078|NCT00762476|521294070|FG000|Overall Study|Lost to Follow-up|2|||
144572079|NCT00762476|521294071|FG001|Overall Study|Lost to Follow-up|0|||
144572080|NCT00762476|521294070|FG000|Overall Study|Protocol Violation|5|||
144572081|NCT00762476|521294071|FG001|Overall Study|Protocol Violation|6|||
144572082|NCT00762476|521294070|FG000|Overall Study|Physician Decision|2|||
144572083|NCT00762476|521294071|FG001|Overall Study|Physician Decision|14|||
144572084|NCT00762476|521294070|FG000|Overall Study|Withdrawal by Subject|6|||
144572085|NCT00762476|521294071|FG001|Overall Study|Withdrawal by Subject|12|||
144572086|NCT00762476|521294070|FG000|Overall Study|antibiotic use|0|||
144572087|NCT00762476|521294071|FG001|Overall Study|antibiotic use|1|||
144572088|NCT00762476|521294070|FG000|Overall Study|non-compliance with study visits|0|||
144572089|NCT00762476|521294071|FG001|Overall Study|non-compliance with study visits|2|||
144572090|NCT00762476|521294070|FG000|Overall Study|Seasonal allergies|1|||
144572091|NCT00762476|521294071|FG001|Overall Study|Seasonal allergies|0|||
144572092|NCT02878603|521294072|FG000|Overall Study|Lost to Follow-up|4|||
144572093|NCT02878603|521294073|FG001|Overall Study|Lost to Follow-up|1|||
144572094|NCT02878603|521294072|FG000|Overall Study|Withdrawal by Subject|1|||
144572095|NCT02878603|521294073|FG001|Overall Study|Withdrawal by Subject|1|||
144572096|NCT02878603|521294072|FG000|Overall Study|Death|1|||
144572097|NCT02878603|521294073|FG001|Overall Study|Death|0|||
144572098|NCT02878603|521294072|FG000|Overall Study|Physician Decision|0|||
144572099|NCT02878603|521294073|FG001|Overall Study|Physician Decision|3|||
144572100|NCT01358331|521294074|FG000|Overall Study|Lost to Follow-up|0|||
144572101|NCT01358331|521294075|FG001|Overall Study|Lost to Follow-up|0|||
144572102|NCT01358331|521294076|FG002|Overall Study|Lost to Follow-up|0|||
144572103|NCT01358331|521294077|FG003|Overall Study|Lost to Follow-up|1|||
144572104|NCT01358331|521294078|FG004|Overall Study|Lost to Follow-up|0|||
144572105|NCT01358331|521294079|FG005|Overall Study|Lost to Follow-up|0|||
144572106|NCT01358331|521294074|FG000|Overall Study|Withdrawal by Subject|0|||
144621303|NCT01318109|521472233|FG002|Overall Study|Withdrawal by Subject|0|||
144207264|NCT01056289|519954281|FG002|Open-label Phase|Lost to Follow-up|0|||
144207265|NCT01056289|519954282|FG003|Open-label Phase|Lost to Follow-up|0|||
144207266|NCT01056289|519954279|FG000|Open-label Phase|Other|9|||
144207267|NCT01056289|519954280|FG001|Open-label Phase|Other|0|||
144572107|NCT01358331|521294075|FG001|Overall Study|Withdrawal by Subject|0|||
144572108|NCT01358331|521294076|FG002|Overall Study|Withdrawal by Subject|0|||
144572109|NCT01358331|521294077|FG003|Overall Study|Withdrawal by Subject|1|||
144572110|NCT01358331|521294078|FG004|Overall Study|Withdrawal by Subject|1|||
144572111|NCT01358331|521294079|FG005|Overall Study|Withdrawal by Subject|1|||
144572112|NCT01358331|521294074|FG000|Overall Study|Adverse Events|1|||
144572113|NCT01358331|521294075|FG001|Overall Study|Adverse Events|1|||
144572114|NCT01358331|521294076|FG002|Overall Study|Adverse Events|1|||
144572115|NCT01358331|521294077|FG003|Overall Study|Adverse Events|0|||
144572116|NCT01358331|521294078|FG004|Overall Study|Adverse Events|1|||
144572117|NCT01358331|521294079|FG005|Overall Study|Adverse Events|5|||
144572118|NCT01358331|521294074|FG000|Overall Study|Symptomatic Deterioration|0|||
144572119|NCT01358331|521294075|FG001|Overall Study|Symptomatic Deterioration|0|||
144572120|NCT01358331|521294076|FG002|Overall Study|Symptomatic Deterioration|0|||
144572121|NCT01358331|521294077|FG003|Overall Study|Symptomatic Deterioration|0|||
144572122|NCT01358331|521294078|FG004|Overall Study|Symptomatic Deterioration|1|||
144572123|NCT01358331|521294079|FG005|Overall Study|Symptomatic Deterioration|0|||
144572124|NCT01358331|521294074|FG000|Overall Study|Participants did not wish to continue|0|||
144572125|NCT01358331|521294075|FG001|Overall Study|Participants did not wish to continue|0|||
144572126|NCT01358331|521294076|FG002|Overall Study|Participants did not wish to continue|0|||
144572127|NCT01358331|521294077|FG003|Overall Study|Participants did not wish to continue|0|||
144572128|NCT01358331|521294078|FG004|Overall Study|Participants did not wish to continue|1|||
144572129|NCT01358331|521294079|FG005|Overall Study|Participants did not wish to continue|0|||
144572130|NCT01358331|521294074|FG000|Overall Study|Progress of disease under investigation|1|||
144572131|NCT01358331|521294075|FG001|Overall Study|Progress of disease under investigation|2|||
144572132|NCT01358331|521294076|FG002|Overall Study|Progress of disease under investigation|3|||
144572133|NCT01358331|521294077|FG003|Overall Study|Progress of disease under investigation|1|||
144572134|NCT01358331|521294078|FG004|Overall Study|Progress of disease under investigation|3|||
144572135|NCT01358331|521294079|FG005|Overall Study|Progress of disease under investigation|0|||
144572136|NCT04674189|521294080|FG000|Overall Study|Adverse Event|0|||
144572137|NCT04674189|521294081|FG001|Overall Study|Adverse Event|0|||
144572138|NCT04674189|521294082|FG002|Overall Study|Adverse Event|1|||
144572139|NCT04674189|521294080|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
144572140|NCT04674189|521294081|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
144572141|NCT04674189|521294082|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
144572142|NCT04674189|521294080|FG000|Overall Study|Physician Decision|1|||
144572143|NCT04674189|521294081|FG001|Overall Study|Physician Decision|0|||
144572144|NCT04674189|521294082|FG002|Overall Study|Physician Decision|0|||
144572145|NCT04674189|521294080|FG000|Overall Study|Withdrawal by Participant|83|||
144572146|NCT04674189|521294081|FG001|Overall Study|Withdrawal by Participant|71|||
144572147|NCT04674189|521294082|FG002|Overall Study|Withdrawal by Participant|142|||
144572148|NCT04674189|521294080|FG000|Overall Study|Lost to Follow-up|55|||
144572149|NCT04674189|521294081|FG001|Overall Study|Lost to Follow-up|53|||
144572150|NCT04674189|521294082|FG002|Overall Study|Lost to Follow-up|44|||
144572151|NCT04674189|521294080|FG000|Overall Study|Miscellaneous|27|||
144572152|NCT04674189|521294081|FG001|Overall Study|Miscellaneous|23|||
144572153|NCT04674189|521294082|FG002|Overall Study|Miscellaneous|207|||
144572154|NCT04674189|521294080|FG000|Overall Study|Did Not Receive Treatment|3|||
144572155|NCT04674189|521294081|FG001|Overall Study|Did Not Receive Treatment|1|||
144572156|NCT04674189|521294082|FG002|Overall Study|Did Not Receive Treatment|2|||
144572157|NCT02838134|521294083|FG000|Overall Study|Lost to Follow-up|1|||
144572158|NCT02838134|521294084|FG001|Overall Study|Lost to Follow-up|2|||
144572159|NCT02838134|521294083|FG000|Overall Study|logistic problems|1|||
144572160|NCT02838134|521294084|FG001|Overall Study|logistic problems|1|||
144572161|NCT01637077|521294085|FG000|Overall Study|Cancel|1|||
144572162|NCT01637077|521294086|FG001|Overall Study|Cancel|1|||
144572163|NCT01637077|521294085|FG000|Overall Study|Withdrawal by Subject|1|||
144572164|NCT01637077|521294086|FG001|Overall Study|Withdrawal by Subject|0|||
144572165|NCT01637077|521294085|FG000|Overall Study|No cycle 1 questionnaire data|2|||
144572166|NCT01637077|521294086|FG001|Overall Study|No cycle 1 questionnaire data|0|||
144572167|NCT01969851|521294092|FG000|Overall Study|Adverse Event|0|||
144572168|NCT01969851|521294093|FG001|Overall Study|Adverse Event|0|||
144621304|NCT01318109|521472231|FG000|Overall Study|Schedule Conflict|0|||
144621305|NCT01318109|521472232|FG001|Overall Study|Schedule Conflict|1|||
144621306|NCT01318109|521472233|FG002|Overall Study|Schedule Conflict|0|||
144621307|NCT01328951|521472234|FG000|Overall Study|Disease Progression|17|||
144621308|NCT01328951|521472235|FG001|Overall Study|Disease Progression|14|||
144621309|NCT01328951|521472234|FG000|Overall Study|Adverse Event|2|||
144621310|NCT01328951|521472235|FG001|Overall Study|Adverse Event|0|||
144621311|NCT01328951|521472234|FG000|Overall Study|Death|243|||
144621312|NCT01328951|521472235|FG001|Overall Study|Death|258|||
144729799|NCT01390844|521866169|FG000|Treatment Phase|Treatment Failure|23|||
144572169|NCT01969851|521294094|FG002|Overall Study|Adverse Event|3|||
144621313|NCT01328951|521472234|FG000|Overall Study|Lost to Follow-up|6|||
144572170|NCT01969851|521294092|FG000|Overall Study|Lack of Efficacy|0|||
144572171|NCT01969851|521294093|FG001|Overall Study|Lack of Efficacy|3|||
144572172|NCT01969851|521294094|FG002|Overall Study|Lack of Efficacy|1|||
144572173|NCT01969851|521294092|FG000|Overall Study|Withdrawal by Subject|1|||
144572174|NCT01969851|521294093|FG001|Overall Study|Withdrawal by Subject|0|||
144572175|NCT01969851|521294094|FG002|Overall Study|Withdrawal by Subject|1|||
144572176|NCT01969851|521294092|FG000|Overall Study|No effective dose in Titration period|0|||
144572177|NCT01969851|521294093|FG001|Overall Study|No effective dose in Titration period|0|||
144729800|NCT01390844|521866170|FG001|Treatment Phase|Treatment Failure|25|||
144207268|NCT01056289|519954281|FG002|Open-label Phase|Other|0|||
144621314|NCT01328951|521472235|FG001|Overall Study|Lost to Follow-up|7|||
144621315|NCT01328951|521472234|FG000|Overall Study|Withdrawal by Subject|6|||
144572178|NCT01969851|521294094|FG002|Overall Study|No effective dose in Titration period|1|||
144572179|NCT01969851|521294092|FG000|Overall Study|Sponsor decision|0|||
144572180|NCT01969851|521294093|FG001|Overall Study|Sponsor decision|0|||
144572181|NCT01969851|521294094|FG002|Overall Study|Sponsor decision|1|||
144572182|NCT01011868|521294099|FG000|After Week 18 Follow-up|Adverse Event|8|||
144572183|NCT01011868|521294100|FG001|After Week 18 Follow-up|Adverse Event|6|||
144572184|NCT01011868|521294101|FG002|After Week 18 Follow-up|Adverse Event|13|||
144572185|NCT01011868|521294099|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
144572186|NCT01011868|521294100|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
144572187|NCT01011868|521294101|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
144572188|NCT01011868|521294099|FG000|After Week 18 Follow-up|Protocol Violation|1|||
144572189|NCT01011868|521294100|FG001|After Week 18 Follow-up|Protocol Violation|1|||
144572190|NCT01011868|521294101|FG002|After Week 18 Follow-up|Protocol Violation|1|||
144572191|NCT01011868|521294099|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
144572192|NCT01011868|521294100|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
144572193|NCT01011868|521294101|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
144572194|NCT01011868|521294099|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
144572195|NCT01011868|521294100|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
144572196|NCT01011868|521294101|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
144572197|NCT01011868|521294099|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
144572198|NCT01011868|521294100|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
144572199|NCT01011868|521294101|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
144572200|NCT01011868|521294099|FG000|After Week 78 Follow-up|Adverse Event|14|||
144572201|NCT01011868|521294100|FG001|After Week 78 Follow-up|Adverse Event|18|||
144572202|NCT01011868|521294101|FG002|After Week 78 Follow-up|Adverse Event|21|||
144572203|NCT01011868|521294099|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
144572204|NCT01011868|521294100|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
144572205|NCT01011868|521294101|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
144572206|NCT01011868|521294099|FG000|After Week 78 Follow-up|Protocol Violation|9|||
144572207|NCT01011868|521294100|FG001|After Week 78 Follow-up|Protocol Violation|1|||
144572208|NCT01011868|521294101|FG002|After Week 78 Follow-up|Protocol Violation|2|||
144572209|NCT01011868|521294099|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
144572210|NCT01011868|521294100|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
144572211|NCT01011868|521294101|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
144572212|NCT01011868|521294099|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
144572213|NCT01011868|521294100|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
144572214|NCT01011868|521294101|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
144572215|NCT01011868|521294099|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
144572216|NCT01011868|521294100|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
144572217|NCT01011868|521294101|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
144572218|NCT01262092|521294102|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
144572219|NCT01262092|521294103|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
144572220|NCT01262092|521294102|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
144572221|NCT01262092|521294103|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
144572222|NCT01262092|521294102|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
144572223|NCT01262092|521294103|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
144572224|NCT01262092|521294102|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
144572225|NCT01262092|521294103|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
144572226|NCT03784820|521294104|FG000|Overall Study|Lost to Follow-up|5|||
144572227|NCT03784820|521294105|FG001|Overall Study|Lost to Follow-up|5|||
144572228|NCT03784820|521294106|FG002|Overall Study|Lost to Follow-up|3|||
144572229|NCT03784820|521294107|FG003|Overall Study|Lost to Follow-up|3|||
144572230|NCT04147858|521294109|FG000|Overall Study|Adverse Event|6|||
144621316|NCT01328951|521472235|FG001|Overall Study|Withdrawal by Subject|6|||
144621317|NCT01328951|521472234|FG000|Overall Study|Study Closed by the Sponsor|36|||
144621318|NCT01328951|521472235|FG001|Overall Study|Study Closed by the Sponsor|31|||
144621319|NCT01328951|521472234|FG000|Overall Study|Other|11|||
144621320|NCT01328951|521472235|FG001|Overall Study|Other|6|||
144621321|NCT01627899|521472236|FG000|Overall Study|Study terminated early by sponsor.|5|||
144621322|NCT05103332|521472237|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621323|NCT05103332|521472238|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
144621324|NCT05103332|521472239|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
144621325|NCT05103332|521472240|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144572231|NCT04147858|521294110|FG001|Overall Study|Adverse Event|6|||
144572232|NCT04147858|521294111|FG002|Overall Study|Adverse Event|6|||
144621326|NCT05103332|521472241|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621327|NCT05103332|521472242|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
144621328|NCT05103332|521472243|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621329|NCT05103332|521472244|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144207269|NCT01056289|519954282|FG003|Open-label Phase|Other|0|||
144572233|NCT04147858|521294109|FG000|Overall Study|Lack of Efficacy|3|||
144572234|NCT04147858|521294110|FG001|Overall Study|Lack of Efficacy|3|||
144572235|NCT04147858|521294111|FG002|Overall Study|Lack of Efficacy|1|||
144572236|NCT04147858|521294109|FG000|Overall Study|Lost to Follow-up|1|||
144572237|NCT04147858|521294110|FG001|Overall Study|Lost to Follow-up|6|||
144572238|NCT04147858|521294111|FG002|Overall Study|Lost to Follow-up|2|||
144572239|NCT04147858|521294109|FG000|Overall Study|Withdrawal by Subject|3|||
144572240|NCT04147858|521294110|FG001|Overall Study|Withdrawal by Subject|4|||
144729801|NCT01390844|521866171|FG002|Treatment Phase|Treatment Failure|10|||
144572241|NCT04147858|521294111|FG002|Overall Study|Withdrawal by Subject|10|||
144572242|NCT04147858|521294109|FG000|Overall Study|Subject Noncompliance, Other|4|||
144572243|NCT04147858|521294110|FG001|Overall Study|Subject Noncompliance, Other|3|||
144572244|NCT04147858|521294111|FG002|Overall Study|Subject Noncompliance, Other|1|||
144572245|NCT02336425|521294112|FG000|Overall Study|Study terminated.|2|||
144572246|NCT02336425|521294113|FG001|Overall Study|Study terminated.|2|||
144572247|NCT02336425|521294114|FG002|Overall Study|Study terminated.|3|||
144572248|NCT02336425|521294115|FG003|Overall Study|Study terminated.|3|||
144572249|NCT04907357|521294119|FG000|Overall Study|Death|0|||
144572250|NCT04907357|521294120|FG001|Overall Study|Death|1|||
144572251|NCT04907357|521294119|FG000|Overall Study|Lost to Follow-up|9|||
144572252|NCT04907357|521294120|FG001|Overall Study|Lost to Follow-up|18|||
144572253|NCT04907357|521294119|FG000|Overall Study|Physician Decision|1|||
144572254|NCT04907357|521294120|FG001|Overall Study|Physician Decision|0|||
144572255|NCT04907357|521294119|FG000|Overall Study|Withdrawal by Subject|0|||
144572256|NCT04907357|521294120|FG001|Overall Study|Withdrawal by Subject|1|||
144572257|NCT04907357|521294119|FG000|Overall Study|Unable to attend visits|1|||
144572258|NCT04907357|521294120|FG001|Overall Study|Unable to attend visits|0|||
144572259|NCT04907357|521294119|FG000|Overall Study|Incarcerated|1|||
144572260|NCT04907357|521294120|FG001|Overall Study|Incarcerated|1|||
144572261|NCT00365547|521294121|FG000|Overall Study|Insurance did not cover Avastin|1|||
144572262|NCT00365547|521294121|FG000|Overall Study|Screen failure|1|||
144572263|NCT00365547|521294121|FG000|Overall Study|Withdrawal by Subject|1|||
144572264|NCT00546078|521294122|FG000|Overall Study|Lost to Follow-up|1|||
144572265|NCT00546078|521294123|FG001|Overall Study|Lost to Follow-up|3|||
144572266|NCT00546078|521294122|FG000|Overall Study|Withdrawal by Subject|2|||
144572267|NCT00546078|521294123|FG001|Overall Study|Withdrawal by Subject|3|||
144572268|NCT00546078|521294122|FG000|Overall Study|Other reason|1|||
144572269|NCT00546078|521294123|FG001|Overall Study|Other reason|1|||
144572270|NCT02257918|521294124|FG000|Overall Study|Lost to Follow-up|4|||
144729802|NCT01390844|521866172|FG003|Treatment Phase|Treatment Failure|13|||
144729803|NCT01390844|521866169|FG000|Treatment Phase|Non-Medical Reasons|5|||
144729804|NCT01390844|521866170|FG001|Treatment Phase|Non-Medical Reasons|1|||
144729805|NCT01390844|521866171|FG002|Treatment Phase|Non-Medical Reasons|8|||
144729806|NCT01390844|521866172|FG003|Treatment Phase|Non-Medical Reasons|1|||
144207270|NCT01056289|519954279|FG000|Open-label Phase|Protocol Violation|6|||
144207271|NCT01056289|519954280|FG001|Open-label Phase|Protocol Violation|0|||
144207272|NCT01056289|519954281|FG002|Open-label Phase|Protocol Violation|0|||
144572271|NCT02257918|521294125|FG001|Overall Study|Lost to Follow-up|1|||
144572272|NCT02257918|521294126|FG002|Overall Study|Lost to Follow-up|0|||
144572273|NCT02257918|521294124|FG000|Overall Study|Withdrawal by Subject|0|||
144572274|NCT02257918|521294125|FG001|Overall Study|Withdrawal by Subject|0|||
144572275|NCT02257918|521294126|FG002|Overall Study|Withdrawal by Subject|1|||
144572276|NCT02257918|521294124|FG000|Overall Study|Pregnancy|0|||
144572277|NCT02257918|521294125|FG001|Overall Study|Pregnancy|0|||
144572278|NCT02257918|521294126|FG002|Overall Study|Pregnancy|1|||
144572279|NCT03023423|521294127|FG000|Overall Study|Death|5|||
144572280|NCT03023423|521294128|FG001|Overall Study|Death|12|||
144572281|NCT03023423|521294129|FG002|Overall Study|Death|20|||
144572282|NCT03023423|521294127|FG000|Overall Study|Other|0|||
144572283|NCT03023423|521294128|FG001|Overall Study|Other|2|||
144572284|NCT03023423|521294129|FG002|Overall Study|Other|2|||
144572285|NCT03023423|521294127|FG000|Overall Study|Ongoing|2|||
144572286|NCT03023423|521294128|FG001|Overall Study|Ongoing|32|||
144572287|NCT03023423|521294129|FG002|Overall Study|Ongoing|24|||
144572288|NCT03512197|521294130|FG000|Overall Study|Guardian decision|1|||
144572289|NCT03512197|521294131|FG001|Overall Study|Guardian decision|1|||
144572290|NCT03512197|521294130|FG000|Overall Study|Lack of Efficacy|19|||
144572291|NCT03512197|521294131|FG001|Overall Study|Lack of Efficacy|11|||
144572292|NCT03512197|521294130|FG000|Overall Study|New Therapy for Study Indication|16|||
144572293|NCT03512197|521294131|FG001|Overall Study|New Therapy for Study Indication|16|||
144729807|NCT01390844|521866169|FG000|Treatment Phase|Non-GCP Compliant|0|||
144572294|NCT03512197|521294130|FG000|Overall Study|Physician Decision|60|||
144572295|NCT03512197|521294131|FG001|Overall Study|Physician Decision|60|||
144572296|NCT03512197|521294130|FG000|Overall Study|Protocol Violation|0|||
144572297|NCT03512197|521294131|FG001|Overall Study|Protocol Violation|2|||
144572298|NCT03512197|521294130|FG000|Overall Study|Terminated by Sponsored|46|||
144572299|NCT03512197|521294131|FG001|Overall Study|Terminated by Sponsored|50|||
144572300|NCT03512197|521294130|FG000|Overall Study|Subject Decision|15|||
144572301|NCT03512197|521294131|FG001|Overall Study|Subject Decision|12|||
144572302|NCT03512197|521294130|FG000|Overall Study|Withdrawal of informed consent|20|||
144572303|NCT03512197|521294131|FG001|Overall Study|Withdrawal of informed consent|14|||
144729808|NCT01390844|521866170|FG001|Treatment Phase|Non-GCP Compliant|0|||
144621330|NCT05103332|521472245|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621331|NCT05103332|521472246|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621332|NCT05103332|521472247|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621333|NCT05103332|521472248|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621334|NCT05103332|521472249|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621335|NCT05103332|521472250|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621336|NCT05103332|521472251|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621337|NCT05103332|521472252|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621338|NCT05103332|521472253|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144572304|NCT03512197|521294130|FG000|Overall Study|Adverse Event|30|||
144572305|NCT03512197|521294131|FG001|Overall Study|Adverse Event|34|||
144572306|NCT03512197|521294130|FG000|Overall Study|Death|14|||
144572307|NCT03512197|521294131|FG001|Overall Study|Death|9|||
144572308|NCT03512197|521294130|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
144572309|NCT03512197|521294131|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
144572310|NCT03512197|521294130|FG000|Overall Study|Missing|3|||
144572311|NCT03512197|521294131|FG001|Overall Study|Missing|13|||
144572312|NCT04277507|521294133|FG000|Overall Study|Lost to Follow-up|17|||
144572313|NCT04277507|521294133|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
144572314|NCT04277507|521294133|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
144572315|NCT04277507|521294133|FG000|Overall Study|Withdrawal by Subject|3|||
144572316|NCT04277507|521294133|FG000|Overall Study|Death due to COVID-19|1|||
144572317|NCT04277507|521294133|FG000|Overall Study|Data missing for full evaluation|5|||
144572318|NCT01431950|521294134|FG000|Overall Study|Study Site Closed/Terminated|7|||
144572319|NCT01431950|521294135|FG001|Overall Study|Study Site Closed/Terminated|3|||
144572320|NCT01431950|521294134|FG000|Overall Study|Withdrawal by Subject|4|||
144572321|NCT01431950|521294135|FG001|Overall Study|Withdrawal by Subject|3|||
144572322|NCT01431950|521294134|FG000|Overall Study|Protocol Violation|2|||
144572323|NCT01431950|521294135|FG001|Overall Study|Protocol Violation|3|||
144572324|NCT01431950|521294134|FG000|Overall Study|Adverse Event|2|||
144572325|NCT01431950|521294135|FG001|Overall Study|Adverse Event|2|||
144572326|NCT01431950|521294134|FG000|Overall Study|Physician Decision|2|||
144572327|NCT01431950|521294135|FG001|Overall Study|Physician Decision|1|||
144572328|NCT01431950|521294134|FG000|Overall Study|Lack of Efficacy|2|||
144572329|NCT01431950|521294135|FG001|Overall Study|Lack of Efficacy|1|||
144572330|NCT01431950|521294134|FG000|Overall Study|Lost to Follow-up|0|||
144572331|NCT01431950|521294135|FG001|Overall Study|Lost to Follow-up|1|||
144572332|NCT01431950|521294134|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144572333|NCT01431950|521294135|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144572334|NCT01210651|521294137|FG000|Overall Study|Lost to Follow-up|1|||
144572335|NCT01210651|521294138|FG001|Overall Study|Lost to Follow-up|1|||
144572336|NCT01210651|521294137|FG000|Overall Study|schedule conflicts|1|||
144572337|NCT01210651|521294138|FG001|Overall Study|schedule conflicts|5|||
144572338|NCT01210651|521294137|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
144572339|NCT01210651|521294138|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
144572340|NCT01210651|521294137|FG000|Overall Study|Withdrawal by Subject|1|||
144572341|NCT01210651|521294138|FG001|Overall Study|Withdrawal by Subject|1|||
144572342|NCT01210651|521294137|FG000|Overall Study|Injury outside study|2|||
144572343|NCT01210651|521294138|FG001|Overall Study|Injury outside study|0|||
144207273|NCT01056289|519954282|FG003|Open-label Phase|Protocol Violation|0|||
144207274|NCT01056289|519954279|FG000|Open-label Phase|Withdrawal by Subject|26|||
144207275|NCT01056289|519954280|FG001|Open-label Phase|Withdrawal by Subject|0|||
144207276|NCT01056289|519954281|FG002|Open-label Phase|Withdrawal by Subject|0|||
144207277|NCT01056289|519954282|FG003|Open-label Phase|Withdrawal by Subject|0|||
144207278|NCT01056289|519954279|FG000|Open-label Phase|Lack of Efficacy|18|||
144207279|NCT01056289|519954280|FG001|Open-label Phase|Lack of Efficacy|0|||
144207280|NCT01056289|519954281|FG002|Open-label Phase|Lack of Efficacy|0|||
144207281|NCT01056289|519954282|FG003|Open-label Phase|Lack of Efficacy|0|||
144207282|NCT01056289|519954279|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
144207283|NCT01056289|519954280|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
144207284|NCT01056289|519954281|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
144207285|NCT01056289|519954282|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
144572344|NCT01261247|521294139|FG000|Overall Study|Ineligible|2|||
144572345|NCT01740154|521294140|FG000|Overall Study|Adverse Event|1|||
144572346|NCT05226130|521294141|FG000|Overall Study|Lost to Follow-up|0|||
144572347|NCT05226130|521294142|FG001|Overall Study|Lost to Follow-up|1|||
144572348|NCT05226130|521294141|FG000|Overall Study|Not treatment adherent|0|||
144572349|NCT05226130|521294142|FG001|Overall Study|Not treatment adherent|2|||
144572350|NCT04013971|521294143|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
144572351|NCT04013971|521294144|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
144572352|NCT04013971|521294143|FG000|Overall Study|Missing biomechanical data|0|||
144621339|NCT05103332|521472254|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621340|NCT05103332|521472237|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621341|NCT05103332|521472238|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
144207286|NCT01056289|519954279|FG000|Double-blind Phase|Adverse Event|0|||
144207287|NCT01056289|519954280|FG001|Double-blind Phase|Adverse Event|1|||
144207288|NCT01056289|519954281|FG002|Double-blind Phase|Adverse Event|2|||
144207289|NCT01056289|519954282|FG003|Double-blind Phase|Adverse Event|1|||
144207290|NCT01056289|519954279|FG000|Double-blind Phase|Lost to Follow-up|0|||
144207291|NCT01056289|519954280|FG001|Double-blind Phase|Lost to Follow-up|2|||
144207292|NCT01056289|519954281|FG002|Double-blind Phase|Lost to Follow-up|2|||
144207293|NCT01056289|519954282|FG003|Double-blind Phase|Lost to Follow-up|2|||
144207294|NCT01056289|519954279|FG000|Double-blind Phase|Other|0|||
144572353|NCT04013971|521294144|FG001|Overall Study|Missing biomechanical data|1|||
144572354|NCT01340014|521294147|FG000|Period 1, First 7 Days|Adverse Event|1|||
144572355|NCT01340014|521294148|FG001|Period 1, First 7 Days|Adverse Event|0|||
144572356|NCT01340014|521294147|FG000|Period 1, First 7 Days|Personal Reasons|1|||
144572357|NCT01340014|521294148|FG001|Period 1, First 7 Days|Personal Reasons|0|||
144572358|NCT01340014|521294147|FG000|Period 2, Second 7 Days|Adverse Event|0|||
144572359|NCT01340014|521294148|FG001|Period 2, Second 7 Days|Adverse Event|1|||
144572360|NCT05101993|521294149|FG000|Overall Study|Withdrawal by Subject|1|||
144572361|NCT04577573|521294150|FG000|Overall Study|Technical - invalid protocol|0|||
144572362|NCT04577573|521294151|FG001|Overall Study|Technical - invalid protocol|2|||
144572363|NCT04577573|521294152|FG002|Overall Study|Technical - invalid protocol|0|||
144572364|NCT01124838|521294153|FG000|Overall Study|Miscellaneous|4|||
144572365|NCT01124838|521294154|FG001|Overall Study|Miscellaneous|2|||
144572366|NCT01124838|521294153|FG000|Overall Study|Adverse Event|7|||
144572367|NCT01124838|521294154|FG001|Overall Study|Adverse Event|11|||
144572368|NCT01124838|521294153|FG000|Overall Study|Lack of Efficacy|2|||
144572369|NCT01124838|521294154|FG001|Overall Study|Lack of Efficacy|0|||
144572370|NCT01124838|521294153|FG000|Overall Study|Withdrawal by Subject|3|||
144572371|NCT01124838|521294154|FG001|Overall Study|Withdrawal by Subject|2|||
144572372|NCT01124838|521294153|FG000|Overall Study|Lost to Follow-up|2|||
144572373|NCT01124838|521294154|FG001|Overall Study|Lost to Follow-up|0|||
144572374|NCT04297618|521294155|FG000|Overall Study|Adverse Event|1|||
144572375|NCT04297618|521294155|FG000|Overall Study|Withdrawal by Subject|1|||
144572376|NCT02065882|521294156|FG000|Part I: PK/PD|Screening failure|5|||
144572377|NCT02065882|521294156|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
144572378|NCT02065882|521294156|FG000|Part I: PK/PD|Adverse Event|1|||
144572379|NCT02065882|521294156|FG000|Part II: Clinical Efficacy|Screening failure|7|||
144572380|NCT02065882|521294156|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
144572381|NCT02065882|521294156|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
144572382|NCT02065882|521294156|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
144572383|NCT02065882|521294156|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
144572384|NCT02065882|521294156|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
144572385|NCT04949802|521296410|FG000|Overall Study|Lost to Follow-up|3|||
144572386|NCT02419417|521296411|FG000|Overall Study|Disease progression|5|||
144572387|NCT02419417|521296412|FG001|Overall Study|Disease progression|4|||
144572388|NCT02419417|521296413|FG002|Overall Study|Disease progression|13|||
144572389|NCT02419417|521296414|FG003|Overall Study|Disease progression|10|||
144572390|NCT02419417|521296415|FG004|Overall Study|Disease progression|10|||
144572391|NCT02419417|521296416|FG005|Overall Study|Disease progression|3|||
144572392|NCT02419417|521296417|FG006|Overall Study|Disease progression|4|||
144572393|NCT02419417|521296418|FG007|Overall Study|Disease progression|5|||
144572394|NCT02419417|521296419|FG008|Overall Study|Disease progression|13|||
144572395|NCT02419417|521296420|FG009|Overall Study|Disease progression|9|||
144572396|NCT02419417|521296421|FG010|Overall Study|Disease progression|0|||
144572397|NCT02419417|521296411|FG000|Overall Study|Study drug toxicity|0|||
144572398|NCT02419417|521296412|FG001|Overall Study|Study drug toxicity|0|||
144572399|NCT02419417|521296413|FG002|Overall Study|Study drug toxicity|0|||
144572400|NCT02419417|521296414|FG003|Overall Study|Study drug toxicity|0|||
144572401|NCT02419417|521296415|FG004|Overall Study|Study drug toxicity|1|||
144572402|NCT02419417|521296416|FG005|Overall Study|Study drug toxicity|0|||
144572403|NCT02419417|521296417|FG006|Overall Study|Study drug toxicity|0|||
144572404|NCT02419417|521296418|FG007|Overall Study|Study drug toxicity|0|||
144572405|NCT02419417|521296419|FG008|Overall Study|Study drug toxicity|0|||
144572406|NCT02419417|521296420|FG009|Overall Study|Study drug toxicity|0|||
144572407|NCT02419417|521296421|FG010|Overall Study|Study drug toxicity|0|||
144572408|NCT02419417|521296411|FG000|Overall Study|Adverse event unrelated to study drug|0|||
144572409|NCT02419417|521296412|FG001|Overall Study|Adverse event unrelated to study drug|0|||
144572410|NCT02419417|521296413|FG002|Overall Study|Adverse event unrelated to study drug|0|||
144207295|NCT01056289|519954280|FG001|Double-blind Phase|Other|0|||
144572411|NCT02419417|521296414|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144572412|NCT02419417|521296415|FG004|Overall Study|Adverse event unrelated to study drug|2|||
144572413|NCT02419417|521296416|FG005|Overall Study|Adverse event unrelated to study drug|1|||
144572414|NCT02419417|521296417|FG006|Overall Study|Adverse event unrelated to study drug|0|||
144572415|NCT02419417|521296418|FG007|Overall Study|Adverse event unrelated to study drug|1|||
144572416|NCT02419417|521296419|FG008|Overall Study|Adverse event unrelated to study drug|0|||
144207296|NCT01056289|519954281|FG002|Double-blind Phase|Other|1|||
144572417|NCT02419417|521296420|FG009|Overall Study|Adverse event unrelated to study drug|0|||
144572418|NCT02419417|521296421|FG010|Overall Study|Adverse event unrelated to study drug|0|||
144572419|NCT02419417|521296411|FG000|Overall Study|Participant request to discontinue|0|||
144572420|NCT02419417|521296412|FG001|Overall Study|Participant request to discontinue|0|||
144572421|NCT02419417|521296413|FG002|Overall Study|Participant request to discontinue|0|||
144572422|NCT02419417|521296414|FG003|Overall Study|Participant request to discontinue|0|||
144572423|NCT02419417|521296415|FG004|Overall Study|Participant request to discontinue|0|||
144572424|NCT02419417|521296416|FG005|Overall Study|Participant request to discontinue|0|||
144572425|NCT02419417|521296417|FG006|Overall Study|Participant request to discontinue|0|||
144572426|NCT02419417|521296418|FG007|Overall Study|Participant request to discontinue|0|||
144572427|NCT02419417|521296419|FG008|Overall Study|Participant request to discontinue|0|||
144572428|NCT02419417|521296420|FG009|Overall Study|Participant request to discontinue|1|||
144572429|NCT02419417|521296421|FG010|Overall Study|Participant request to discontinue|0|||
144572430|NCT02419417|521296411|FG000|Overall Study|Withdrawal by Subject|0|||
144572431|NCT02419417|521296412|FG001|Overall Study|Withdrawal by Subject|0|||
144572432|NCT02419417|521296413|FG002|Overall Study|Withdrawal by Subject|0|||
144572433|NCT02419417|521296414|FG003|Overall Study|Withdrawal by Subject|0|||
144572434|NCT02419417|521296415|FG004|Overall Study|Withdrawal by Subject|0|||
144572435|NCT02419417|521296416|FG005|Overall Study|Withdrawal by Subject|0|||
144572436|NCT02419417|521296417|FG006|Overall Study|Withdrawal by Subject|0|||
144572437|NCT02419417|521296418|FG007|Overall Study|Withdrawal by Subject|0|||
144572438|NCT02419417|521296419|FG008|Overall Study|Withdrawal by Subject|0|||
144572439|NCT02419417|521296420|FG009|Overall Study|Withdrawal by Subject|0|||
144572440|NCT02419417|521296421|FG010|Overall Study|Withdrawal by Subject|1|||
144572441|NCT01381575|521296422|FG000|Overall Study|Serious Adverse Event|1|||
144572442|NCT01381575|521296423|FG001|Overall Study|Serious Adverse Event|0|||
144572443|NCT01381575|521296424|FG002|Overall Study|Serious Adverse Event|0|||
144572444|NCT01381575|521296422|FG000|Overall Study|Non-Serious Adverse Event|0|||
144572445|NCT01381575|521296423|FG001|Overall Study|Non-Serious Adverse Event|0|||
144572446|NCT01381575|521296424|FG002|Overall Study|Non-Serious Adverse Event|1|||
144572447|NCT01381575|521296422|FG000|Overall Study|Protocol Violation|0|||
144572448|NCT01381575|521296423|FG001|Overall Study|Protocol Violation|1|||
144572449|NCT01381575|521296424|FG002|Overall Study|Protocol Violation|1|||
144572450|NCT01381575|521296422|FG000|Overall Study|Withdrawal by Subject|15|||
144572451|NCT01381575|521296423|FG001|Overall Study|Withdrawal by Subject|9|||
144572452|NCT01381575|521296424|FG002|Overall Study|Withdrawal by Subject|7|||
144572453|NCT01381575|521296422|FG000|Overall Study|Migrated/moved from study area|2|||
144572454|NCT01381575|521296423|FG001|Overall Study|Migrated/moved from study area|12|||
144572455|NCT01381575|521296424|FG002|Overall Study|Migrated/moved from study area|2|||
144572456|NCT01381575|521296422|FG000|Overall Study|Lost to Follow-up|8|||
144572457|NCT01381575|521296423|FG001|Overall Study|Lost to Follow-up|17|||
144572458|NCT01381575|521296424|FG002|Overall Study|Lost to Follow-up|9|||
144572459|NCT01200342|521296425|FG000|Overall Study|Disease Progression|1|||
144572460|NCT02550938|521296426|FG000|Overall Study|Lost to Follow-up|8|||
144572461|NCT02550938|521296427|FG001|Overall Study|Lost to Follow-up|7|||
144572462|NCT02550938|521296428|FG002|Overall Study|Lost to Follow-up|12|||
144572463|NCT02550938|521296429|FG003|Overall Study|Lost to Follow-up|11|||
144572464|NCT01367847|521296430|FG000|Overall Study|Withdrawal by Subject|2|||
144572465|NCT01367847|521296431|FG001|Overall Study|Withdrawal by Subject|2|||
144572466|NCT01439867|521296432|FG000|Overall Study|Non-compliance|0|||
144572467|NCT01439867|521296433|FG001|Overall Study|Non-compliance|1|||
144572468|NCT01439867|521296432|FG000|Overall Study|Withdrawal by Subject|1|||
144572469|NCT01439867|521296433|FG001|Overall Study|Withdrawal by Subject|2|||
144572470|NCT01439867|521296432|FG000|Overall Study|Administrative Decision|4|||
144572471|NCT01439867|521296433|FG001|Overall Study|Administrative Decision|5|||
144572472|NCT01439867|521296432|FG000|Overall Study|Protocol-specified Criteria|1|||
144572473|NCT01439867|521296433|FG001|Overall Study|Protocol-specified Criteria|0|||
144572474|NCT02763215|521296434|FG000|Overall Study|Participants withdrew from study|3|||
144572475|NCT02763215|521296434|FG000|Overall Study|Missed visit|1|||
144572476|NCT02763215|521296434|FG000|Overall Study|Visit outside visit-window|1|||
144572477|NCT02763215|521296434|FG000|Overall Study|Death|1|||
144572478|NCT02763215|521296434|FG000|Overall Study|Lost to Follow-up|1|||
144572479|NCT03258723|521296435|FG000|Overall Study|COVID Interruption of study|54|||
144572480|NCT03258723|521296435|FG000|Overall Study|Lost to Follow-up|8|||
144572481|NCT01107899|521296436|FG000|Overall Study|Physician Decision|5|||
144572482|NCT01107899|521296437|FG001|Overall Study|Physician Decision|0|||
144572483|NCT01107899|521296438|FG002|Overall Study|Physician Decision|3|||
144572484|NCT01107899|521296436|FG000|Overall Study|Withdrawal by Subject|0|||
144572485|NCT01107899|521296437|FG001|Overall Study|Withdrawal by Subject|0|||
144572486|NCT01107899|521296438|FG002|Overall Study|Withdrawal by Subject|1|||
144572487|NCT00953771|521296439|FG000|Overall Study|Death|1|||
144572488|NCT00953771|521296440|FG001|Overall Study|Death|0|||
144572489|NCT00974259|521296441|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
144572490|NCT00974259|521296442|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
144572491|NCT01375673|521296449|FG000|Overall Study|Withdrawal by Subject|0|||
144572492|NCT01375673|521296450|FG001|Overall Study|Withdrawal by Subject|1|||
144572493|NCT01784523|521296453|FG000|Overall Study|Study closed early|7|||
144572494|NCT01784523|521296454|FG001|Overall Study|Study closed early|4|||
144572495|NCT04340947|521296457|FG000|7-day Washout Period|Lost to Follow-up|5|||
144572496|NCT04340947|521296458|FG001|7-day Washout Period|Lost to Follow-up|4|||
144572497|NCT01907906|521296461|FG000|Overall Study|Withdrawal by Subject|1|||
144572498|NCT01907906|521296462|FG001|Overall Study|Withdrawal by Subject|0|||
144572499|NCT01907906|521296461|FG000|Overall Study|Physician Decision|3|||
144572500|NCT01907906|521296462|FG001|Overall Study|Physician Decision|1|||
144572501|NCT00884650|521296463|FG000|Overall Study|Did not return complete pain diaries|7|||
144572502|NCT00884650|521296464|FG001|Overall Study|Did not return complete pain diaries|7|||
144572503|NCT00884650|521296463|FG000|Overall Study|Admitted Post-Op|1|||
144572504|NCT00884650|521296464|FG001|Overall Study|Admitted Post-Op|0|||
144572505|NCT00884650|521296463|FG000|Overall Study|Femoral Stress Fracture|1|||
144572506|NCT00884650|521296464|FG001|Overall Study|Femoral Stress Fracture|0|||
144572507|NCT00884650|521296463|FG000|Overall Study|Pain Pump Complication|0|||
144572508|NCT00884650|521296464|FG001|Overall Study|Pain Pump Complication|1|||
144572509|NCT04334278|521296467|FG000|Overall Study|Lost to Follow-up|0|||
144572510|NCT04334278|521296468|FG001|Overall Study|Lost to Follow-up|3|||
144572511|NCT04334278|521296467|FG000|Overall Study|Withdrawal by Subject|4|||
144572512|NCT04334278|521296468|FG001|Overall Study|Withdrawal by Subject|2|||
144572513|NCT02030002|521296469|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
144572514|NCT02030002|521296469|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
144572515|NCT02030002|521296469|FG000|Follow-up|Lost to Follow-up|2|||
144572516|NCT03994731|521296470|FG000|Pegloticase + IMM Period|Death|2|||
144572517|NCT03994731|521296471|FG001|Pegloticase + IMM Period|Death|0|||
144572518|NCT03994731|521296470|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
144572519|NCT03994731|521296471|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
144572520|NCT03994731|521296470|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
144572521|NCT03994731|521296471|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
144572522|NCT02406248|521296472|FG000|Overall Study|Death|7|||
144572523|NCT02406248|521296472|FG000|Overall Study|Withdrawal by Subject|2|||
144572524|NCT04805073|521296479|FG000|Overall Study|study personnel not available|2|||
144572525|NCT04805073|521296480|FG001|Overall Study|study personnel not available|0|||
144572526|NCT04805073|521296479|FG000|Overall Study|spinal anesthesia failure|0|||
144572527|NCT04805073|521296480|FG001|Overall Study|spinal anesthesia failure|1|||
144572528|NCT04805073|521296479|FG000|Overall Study|Lost to Follow-up|0|||
144572529|NCT04805073|521296480|FG001|Overall Study|Lost to Follow-up|2|||
144572530|NCT02975102|521296483|FG000|Overall Study|Adverse Event|2|||
144572531|NCT02975102|521296484|FG001|Overall Study|Adverse Event|1|||
144572532|NCT01162486|521296485|FG000|Overall Study|low ANC|1|||
144572533|NCT01162486|521296486|FG001|Overall Study|low ANC|0|||
144572534|NCT01162486|521296487|FG002|Overall Study|low ANC|0|||
144572535|NCT01162486|521296488|FG003|Overall Study|low ANC|0|||
144572536|NCT01162486|521296489|FG004|Overall Study|low ANC|0|||
144572537|NCT01162486|521296485|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
144572538|NCT01162486|521296486|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
144572539|NCT01162486|521296487|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
144572540|NCT01162486|521296488|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
144572541|NCT01162486|521296489|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
144572542|NCT01162486|521296485|FG000|Overall Study|elevated LFTs|0|||
144572543|NCT01162486|521296486|FG001|Overall Study|elevated LFTs|0|||
144572544|NCT01162486|521296487|FG002|Overall Study|elevated LFTs|1|||
144572545|NCT01162486|521296488|FG003|Overall Study|elevated LFTs|0|||
144572546|NCT01162486|521296489|FG004|Overall Study|elevated LFTs|0|||
144572547|NCT01162486|521296485|FG000|Overall Study|Pregnancy|0|||
144572548|NCT01162486|521296486|FG001|Overall Study|Pregnancy|0|||
144572549|NCT01162486|521296487|FG002|Overall Study|Pregnancy|0|||
144572550|NCT01162486|521296488|FG003|Overall Study|Pregnancy|1|||
144572551|NCT01162486|521296489|FG004|Overall Study|Pregnancy|0|||
144572552|NCT03274895|521296490|FG000|Overall Study|Lack of Efficacy|1|||
144572553|NCT03274895|521296491|FG001|Overall Study|Lack of Efficacy|0|||
144572554|NCT03274895|521296490|FG000|Overall Study|Adverse Event|8|||
144572555|NCT03274895|521296491|FG001|Overall Study|Adverse Event|7|||
144572556|NCT03274895|521296490|FG000|Overall Study|Lost to Follow-up|1|||
144572557|NCT03274895|521296491|FG001|Overall Study|Lost to Follow-up|0|||
144572558|NCT03274895|521296490|FG000|Overall Study|Diagnosis not confirmed|3|||
144207297|NCT01056289|519954282|FG003|Double-blind Phase|Other|2|||
144572559|NCT03274895|521296491|FG001|Overall Study|Diagnosis not confirmed|4|||
144572560|NCT03332784|521296492|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572561|NCT03332784|521296493|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
144572562|NCT03332784|521296494|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572563|NCT03332784|521296495|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572564|NCT03332784|521296496|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572565|NCT03332784|521296497|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572566|NCT03332784|521296498|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572567|NCT03332784|521296499|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572568|NCT03332784|521296500|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572569|NCT03332784|521296501|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572570|NCT03332784|521296502|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572571|NCT03332784|521296503|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572572|NCT03332784|521296504|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572573|NCT03332784|521296505|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572574|NCT03332784|521296506|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
144572575|NCT03332784|521296507|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572576|NCT03332784|521296508|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572577|NCT03332784|521296509|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572578|NCT03332784|521296510|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572579|NCT03332784|521296511|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
144572580|NCT02498236|521296512|FG000|Overall Study|Did not show for testing|1|||
144572581|NCT02498236|521296513|FG001|Overall Study|Did not show for testing|0|||
144572582|NCT02498236|521296514|FG002|Overall Study|Did not show for testing|0|||
144572583|NCT02498236|521296515|FG003|Overall Study|Did not show for testing|0|||
144572584|NCT02498236|521296516|FG004|Overall Study|Did not show for testing|0|||
144572585|NCT02498236|521296517|FG005|Overall Study|Did not show for testing|0|||
144572586|NCT02498236|521296518|FG006|Overall Study|Did not show for testing|0|||
144572587|NCT02498236|521296519|FG007|Overall Study|Did not show for testing|1|||
144572588|NCT02498236|521296512|FG000|Overall Study|Equipment failure|0|||
144572589|NCT02498236|521296513|FG001|Overall Study|Equipment failure|0|||
144572590|NCT02498236|521296514|FG002|Overall Study|Equipment failure|0|||
144572591|NCT02498236|521296515|FG003|Overall Study|Equipment failure|0|||
144572592|NCT02498236|521296516|FG004|Overall Study|Equipment failure|0|||
144572593|NCT02498236|521296517|FG005|Overall Study|Equipment failure|0|||
144572594|NCT02498236|521296518|FG006|Overall Study|Equipment failure|1|||
144572595|NCT02498236|521296519|FG007|Overall Study|Equipment failure|0|||
144572596|NCT02498236|521296512|FG000|Overall Study|Withdrawal by Subject|0|||
144572597|NCT02498236|521296513|FG001|Overall Study|Withdrawal by Subject|0|||
144572598|NCT02498236|521296514|FG002|Overall Study|Withdrawal by Subject|0|||
144572599|NCT02498236|521296515|FG003|Overall Study|Withdrawal by Subject|0|||
144572600|NCT02498236|521296516|FG004|Overall Study|Withdrawal by Subject|1|||
144572601|NCT02498236|521296517|FG005|Overall Study|Withdrawal by Subject|0|||
144572602|NCT02498236|521296518|FG006|Overall Study|Withdrawal by Subject|0|||
144572603|NCT02498236|521296519|FG007|Overall Study|Withdrawal by Subject|0|||
144572604|NCT02296892|521296520|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
144572605|NCT02296892|521296521|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
144572606|NCT02296892|521296522|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
144572607|NCT02296892|521296520|FG000|Overall Study|Lost to Follow-up|5|||
144572608|NCT02296892|521296521|FG001|Overall Study|Lost to Follow-up|0|||
144572609|NCT02296892|521296522|FG002|Overall Study|Lost to Follow-up|1|||
144572610|NCT01814072|521296525|FG000|Overall Study|Lost to Follow-up|2|||
144572611|NCT01814072|521296526|FG001|Overall Study|Lost to Follow-up|2|||
144572612|NCT01814072|521296527|FG002|Overall Study|Lost to Follow-up|2|||
144572613|NCT01814072|521296528|FG003|Overall Study|Lost to Follow-up|0|||
144572614|NCT01814072|521296529|FG004|Overall Study|Lost to Follow-up|2|||
144572615|NCT01814072|521296530|FG005|Overall Study|Lost to Follow-up|3|||
144572616|NCT01814072|521296531|FG006|Overall Study|Lost to Follow-up|3|||
144572617|NCT01814072|521296532|FG007|Overall Study|Lost to Follow-up|1|||
144572618|NCT01814072|521296533|FG008|Overall Study|Lost to Follow-up|2|||
144572619|NCT01814072|521296534|FG009|Overall Study|Lost to Follow-up|3|||
144572620|NCT01814072|521296535|FG010|Overall Study|Lost to Follow-up|1|||
144572621|NCT01814072|521296536|FG011|Overall Study|Lost to Follow-up|2|||
144572622|NCT01814072|521296537|FG012|Overall Study|Lost to Follow-up|2|||
144621342|NCT05103332|521472239|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621343|NCT05103332|521472240|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
144621344|NCT05103332|521472241|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
144572623|NCT01814072|521296538|FG013|Overall Study|Lost to Follow-up|1|||
144572624|NCT01814072|521296539|FG014|Overall Study|Lost to Follow-up|2|||
144572625|NCT01814072|521296540|FG015|Overall Study|Lost to Follow-up|1|||
144572626|NCT01814072|521296541|FG016|Overall Study|Lost to Follow-up|3|||
144572627|NCT01814072|521296542|FG017|Overall Study|Lost to Follow-up|1|||
144572628|NCT01814072|521296543|FG018|Overall Study|Lost to Follow-up|3|||
144572629|NCT01814072|521296544|FG019|Overall Study|Lost to Follow-up|3|||
144621345|NCT05103332|521472242|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621346|NCT05103332|521472243|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621347|NCT05103332|521472244|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
144572630|NCT01814072|521296545|FG020|Overall Study|Lost to Follow-up|2|||
144572631|NCT01814072|521296546|FG021|Overall Study|Lost to Follow-up|1|||
144572632|NCT01814072|521296547|FG022|Overall Study|Lost to Follow-up|3|||
144572633|NCT01814072|521296548|FG023|Overall Study|Lost to Follow-up|1|||
144572634|NCT01814072|521296549|FG024|Overall Study|Lost to Follow-up|4|||
144572635|NCT01814072|521296550|FG025|Overall Study|Lost to Follow-up|1|||
144621348|NCT05103332|521472245|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621349|NCT05103332|521472246|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
144572636|NCT01814072|521296551|FG026|Overall Study|Lost to Follow-up|1|||
144572637|NCT01814072|521296552|FG027|Overall Study|Lost to Follow-up|2|||
144572638|NCT01814072|521296553|FG028|Overall Study|Lost to Follow-up|3|||
144572639|NCT01814072|521296554|FG029|Overall Study|Lost to Follow-up|3|||
144572640|NCT01814072|521296555|FG030|Overall Study|Lost to Follow-up|2|||
144572641|NCT01814072|521296556|FG031|Overall Study|Lost to Follow-up|0|||
144572642|NCT01814072|521296525|FG000|Overall Study|Withdrawal by Subject|2|||
144572643|NCT01814072|521296526|FG001|Overall Study|Withdrawal by Subject|0|||
144572644|NCT01814072|521296527|FG002|Overall Study|Withdrawal by Subject|1|||
144572645|NCT01814072|521296528|FG003|Overall Study|Withdrawal by Subject|0|||
144572646|NCT01814072|521296529|FG004|Overall Study|Withdrawal by Subject|2|||
144572647|NCT01814072|521296530|FG005|Overall Study|Withdrawal by Subject|3|||
144572648|NCT01814072|521296531|FG006|Overall Study|Withdrawal by Subject|1|||
144572649|NCT01814072|521296532|FG007|Overall Study|Withdrawal by Subject|0|||
144572650|NCT01814072|521296533|FG008|Overall Study|Withdrawal by Subject|1|||
144572651|NCT01814072|521296534|FG009|Overall Study|Withdrawal by Subject|2|||
144572652|NCT01814072|521296535|FG010|Overall Study|Withdrawal by Subject|0|||
144572653|NCT01814072|521296536|FG011|Overall Study|Withdrawal by Subject|0|||
144572654|NCT01814072|521296537|FG012|Overall Study|Withdrawal by Subject|1|||
144572655|NCT01814072|521296538|FG013|Overall Study|Withdrawal by Subject|1|||
144572656|NCT01814072|521296539|FG014|Overall Study|Withdrawal by Subject|1|||
144572657|NCT01814072|521296540|FG015|Overall Study|Withdrawal by Subject|1|||
144572658|NCT01814072|521296541|FG016|Overall Study|Withdrawal by Subject|0|||
144572659|NCT01814072|521296542|FG017|Overall Study|Withdrawal by Subject|0|||
144572660|NCT01814072|521296543|FG018|Overall Study|Withdrawal by Subject|0|||
144572661|NCT01814072|521296544|FG019|Overall Study|Withdrawal by Subject|2|||
144572662|NCT01814072|521296545|FG020|Overall Study|Withdrawal by Subject|0|||
144572663|NCT01814072|521296546|FG021|Overall Study|Withdrawal by Subject|0|||
144572664|NCT01814072|521296547|FG022|Overall Study|Withdrawal by Subject|1|||
144572665|NCT01814072|521296548|FG023|Overall Study|Withdrawal by Subject|0|||
144572666|NCT01814072|521296549|FG024|Overall Study|Withdrawal by Subject|2|||
144572667|NCT01814072|521296550|FG025|Overall Study|Withdrawal by Subject|1|||
144572668|NCT01814072|521296551|FG026|Overall Study|Withdrawal by Subject|1|||
144572669|NCT01814072|521296552|FG027|Overall Study|Withdrawal by Subject|2|||
144572670|NCT01814072|521296553|FG028|Overall Study|Withdrawal by Subject|1|||
144572671|NCT01814072|521296554|FG029|Overall Study|Withdrawal by Subject|0|||
144572672|NCT01814072|521296555|FG030|Overall Study|Withdrawal by Subject|0|||
144572673|NCT01814072|521296556|FG031|Overall Study|Withdrawal by Subject|0|||
144572674|NCT00383123|521296557|FG000|Overall Study|Adverse Event|1|||
144572675|NCT00383123|521296558|FG001|Overall Study|Adverse Event|0|||
144572676|NCT00383123|521296557|FG000|Overall Study|Lost to Follow-up|68|||
144621350|NCT05103332|521472247|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621351|NCT05103332|521472248|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621352|NCT05103332|521472249|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621353|NCT05103332|521472250|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621354|NCT05103332|521472251|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621355|NCT05103332|521472252|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621356|NCT05103332|521472253|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621357|NCT05103332|521472254|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
144621358|NCT05103332|521472237|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
144621359|NCT05103332|521472238|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
144621360|NCT05103332|521472239|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
144621361|NCT05103332|521472240|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
144621362|NCT05103332|521472241|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
144621363|NCT05103332|521472242|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
144621364|NCT05103332|521472243|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621365|NCT05103332|521472244|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621366|NCT05103332|521472245|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621367|NCT05103332|521472246|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621368|NCT05103332|521472247|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621369|NCT05103332|521472248|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621370|NCT05103332|521472249|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144572677|NCT00383123|521296558|FG001|Overall Study|Lost to Follow-up|61|||
144572678|NCT00383123|521296557|FG000|Overall Study|Protocol Violation|5|||
144572679|NCT00383123|521296558|FG001|Overall Study|Protocol Violation|1|||
144621371|NCT05103332|521472250|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144572680|NCT00383123|521296557|FG000|Overall Study|Withdrawal by Subject|27|||
144572681|NCT00383123|521296558|FG001|Overall Study|Withdrawal by Subject|18|||
144572682|NCT00383123|521296557|FG000|Overall Study|Other reason|10|||
144572683|NCT00383123|521296558|FG001|Overall Study|Other reason|6|||
144572684|NCT03566979|521296559|FG000|Overall Study|Withdrawal by Subject|2|||
144572685|NCT03566979|521296560|FG001|Overall Study|Withdrawal by Subject|0|||
144621372|NCT05103332|521472251|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621373|NCT05103332|521472252|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621374|NCT05103332|521472253|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621375|NCT05103332|521472254|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621376|NCT05103332|521472237|FG000|DB Period (6 Months=168 Days)|Other|0|||
144621377|NCT05103332|521472238|FG001|DB Period (6 Months=168 Days)|Other|0|||
144621378|NCT05103332|521472239|FG002|DB Period (6 Months=168 Days)|Other|0|||
144621379|NCT05103332|521472240|FG003|DB Period (6 Months=168 Days)|Other|1|||
144621380|NCT05103332|521472241|FG004|DB Period (6 Months=168 Days)|Other|0|||
144621381|NCT05103332|521472242|FG005|DB Period (6 Months=168 Days)|Other|0|||
144621382|NCT05103332|521472243|FG006|DB Period (6 Months=168 Days)|Other|0|||
144621383|NCT05103332|521472244|FG007|DB Period (6 Months=168 Days)|Other|0|||
144621384|NCT05103332|521472245|FG008|DB Period (6 Months=168 Days)|Other|0|||
144621385|NCT05103332|521472246|FG009|DB Period (6 Months=168 Days)|Other|0|||
144621386|NCT05103332|521472247|FG010|DB Period (6 Months=168 Days)|Other|0|||
144621387|NCT05103332|521472248|FG011|DB Period (6 Months=168 Days)|Other|0|||
144621388|NCT05103332|521472249|FG012|DB Period (6 Months=168 Days)|Other|0|||
144621389|NCT05103332|521472250|FG013|DB Period (6 Months=168 Days)|Other|0|||
144621390|NCT05103332|521472251|FG014|DB Period (6 Months=168 Days)|Other|0|||
144621391|NCT05103332|521472252|FG015|DB Period (6 Months=168 Days)|Other|0|||
144621392|NCT05103332|521472253|FG016|DB Period (6 Months=168 Days)|Other|0|||
144621393|NCT05103332|521472254|FG017|DB Period (6 Months=168 Days)|Other|0|||
144621394|NCT05103332|521472237|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621395|NCT05103332|521472238|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621396|NCT05103332|521472239|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621397|NCT05103332|521472240|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621398|NCT05103332|521472241|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621399|NCT05103332|521472242|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621400|NCT05103332|521472243|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621401|NCT05103332|521472244|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621402|NCT05103332|521472245|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621403|NCT05103332|521472246|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621404|NCT05103332|521472247|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
144621405|NCT05103332|521472248|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621406|NCT05103332|521472249|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144572686|NCT03566979|521296561|FG002|Overall Study|Withdrawal by Subject|1|||
144572687|NCT03566979|521296562|FG003|Overall Study|Withdrawal by Subject|1|||
144572688|NCT03566979|521296559|FG000|Overall Study|Lost to Follow-up|2|||
144572689|NCT03566979|521296560|FG001|Overall Study|Lost to Follow-up|7|||
144572690|NCT03566979|521296561|FG002|Overall Study|Lost to Follow-up|9|||
144572691|NCT03566979|521296562|FG003|Overall Study|Lost to Follow-up|5|||
144572692|NCT03566979|521296559|FG000|Overall Study|Adverse Event|1|||
144572693|NCT03566979|521296560|FG001|Overall Study|Adverse Event|0|||
144572694|NCT03566979|521296561|FG002|Overall Study|Adverse Event|0|||
144572695|NCT03566979|521296562|FG003|Overall Study|Adverse Event|0|||
144572696|NCT04547023|521296567|FG000|Overall Study|Did Not Receive Intervention|3|||
144572697|NCT04547023|521296568|FG001|Overall Study|Did Not Receive Intervention|2|||
144572698|NCT04547023|521296567|FG000|Overall Study|Lost to Follow-up|1|||
144572699|NCT04547023|521296568|FG001|Overall Study|Lost to Follow-up|1|||
144572700|NCT04946942|521296569|FG000|Overall Study|Lost to Follow-up|6|||
144572701|NCT04946942|521296570|FG001|Overall Study|Lost to Follow-up|2|||
144572702|NCT04946942|521296571|FG002|Overall Study|Lost to Follow-up|0|||
144621407|NCT05103332|521472250|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621408|NCT05103332|521472251|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621409|NCT05103332|521472252|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621410|NCT05103332|521472253|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621411|NCT05103332|521472254|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
144621412|NCT05103332|521472237|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621413|NCT05103332|521472238|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144572703|NCT00583947|521296575|FG000|Cross-over Period|Adverse Event|2|||
144572704|NCT00583947|521296576|FG001|Cross-over Period|Adverse Event|0|||
144621414|NCT05103332|521472239|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621415|NCT05103332|521472240|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621416|NCT05103332|521472241|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621417|NCT05103332|521472242|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621418|NCT05103332|521472243|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621419|NCT05103332|521472244|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144572705|NCT00583947|521296575|FG000|Cross-over Period|Withdrawal by Subject|2|||
144621420|NCT05103332|521472245|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
144572706|NCT00583947|521296576|FG001|Cross-over Period|Withdrawal by Subject|0|||
144572707|NCT00583947|521296575|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
144572708|NCT00583947|521296576|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
144572709|NCT00583947|521296575|FG000|Cross-over Period|Other|1|||
144572710|NCT00583947|521296576|FG001|Cross-over Period|Other|1|||
144572711|NCT00486252|521296577|FG000|Overall Study|Adverse Event|7|||
144572712|NCT00486252|521296577|FG000|Overall Study|Lack of Efficacy|9|||
144572713|NCT00486252|521296577|FG000|Overall Study|Lost to Follow-up|24|||
144572714|NCT00486252|521296577|FG000|Overall Study|Other|18|||
144572715|NCT02520310|521296578|FG000|At 6 Months Clinical Follow-up|Death|1|||
144572716|NCT02520310|521296578|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
144572717|NCT02520310|521296578|FG000|AT 3 Year Clinical Follow-up|Death|2|||
144572718|NCT02520310|521296578|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
144572719|NCT02520310|521296578|FG000|AT 4 Year Clinical Follow-up|Death|1|||
144572720|NCT02520310|521296578|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
144572721|NCT06719986|521296581|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
144572722|NCT06719986|521296582|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
144572723|NCT06719986|521296583|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
144572724|NCT06719986|521296581|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
144572725|NCT06719986|521296582|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
144572726|NCT06719986|521296583|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
144572727|NCT02600897|521296584|FG000|Overall Study|Death|1|||
144572728|NCT02600897|521296585|FG001|Overall Study|Death|2|||
144572729|NCT02600897|521296586|FG002|Overall Study|Death|1|||
144572730|NCT02600897|521296587|FG003|Overall Study|Death|2|||
144572731|NCT02600897|521296588|FG004|Overall Study|Death|3|||
144572732|NCT02600897|521296589|FG005|Overall Study|Death|2|||
144572733|NCT02600897|521296590|FG006|Overall Study|Death|10|||
144572734|NCT02600897|521296591|FG007|Overall Study|Death|7|||
144572735|NCT02600897|521296592|FG008|Overall Study|Death|20|||
144572736|NCT02600897|521296584|FG000|Overall Study|Lost to Follow-up|1|||
144572737|NCT02600897|521296585|FG001|Overall Study|Lost to Follow-up|0|||
144572738|NCT02600897|521296586|FG002|Overall Study|Lost to Follow-up|0|||
144572739|NCT02600897|521296587|FG003|Overall Study|Lost to Follow-up|0|||
144572740|NCT02600897|521296588|FG004|Overall Study|Lost to Follow-up|0|||
144572741|NCT02600897|521296589|FG005|Overall Study|Lost to Follow-up|0|||
144572742|NCT02600897|521296590|FG006|Overall Study|Lost to Follow-up|0|||
144572743|NCT02600897|521296591|FG007|Overall Study|Lost to Follow-up|1|||
144572744|NCT02600897|521296592|FG008|Overall Study|Lost to Follow-up|0|||
144572745|NCT02600897|521296584|FG000|Overall Study|Withdrawal by Subject|0|||
144572746|NCT02600897|521296585|FG001|Overall Study|Withdrawal by Subject|0|||
144572747|NCT02600897|521296586|FG002|Overall Study|Withdrawal by Subject|0|||
144572748|NCT02600897|521296587|FG003|Overall Study|Withdrawal by Subject|0|||
144572749|NCT02600897|521296588|FG004|Overall Study|Withdrawal by Subject|0|||
144572750|NCT02600897|521296589|FG005|Overall Study|Withdrawal by Subject|0|||
144572751|NCT02600897|521296590|FG006|Overall Study|Withdrawal by Subject|0|||
144572752|NCT02600897|521296591|FG007|Overall Study|Withdrawal by Subject|4|||
144572753|NCT02600897|521296592|FG008|Overall Study|Withdrawal by Subject|2|||
144572754|NCT02600897|521296584|FG000|Overall Study|Reason Not Specified|0|||
144572755|NCT02600897|521296585|FG001|Overall Study|Reason Not Specified|0|||
144572756|NCT02600897|521296586|FG002|Overall Study|Reason Not Specified|0|||
144572757|NCT02600897|521296587|FG003|Overall Study|Reason Not Specified|0|||
144572758|NCT02600897|521296588|FG004|Overall Study|Reason Not Specified|0|||
144572759|NCT02600897|521296589|FG005|Overall Study|Reason Not Specified|0|||
144572760|NCT02600897|521296590|FG006|Overall Study|Reason Not Specified|0|||
144572761|NCT02600897|521296591|FG007|Overall Study|Reason Not Specified|0|||
144207298|NCT01056289|519954279|FG000|Double-blind Phase|Protocol Violation|0|||
144572762|NCT02600897|521296592|FG008|Overall Study|Reason Not Specified|1|||
144572763|NCT03816761|521298763|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
144572764|NCT03816761|521298764|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
144572765|NCT03816761|521298765|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
144572766|NCT03816761|521298766|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
144572767|NCT03816761|521298767|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
144572768|NCT03816761|521298768|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
144572769|NCT03816761|521298763|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
144572770|NCT03816761|521298764|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
144572771|NCT03816761|521298765|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
144572772|NCT03816761|521298766|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
144572773|NCT03816761|521298767|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
144207299|NCT01056289|519954280|FG001|Double-blind Phase|Protocol Violation|0|||
144207300|NCT01056289|519954281|FG002|Double-blind Phase|Protocol Violation|1|||
144207301|NCT01056289|519954282|FG003|Double-blind Phase|Protocol Violation|1|||
144572774|NCT03816761|521298768|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
144572775|NCT01443403|521298769|FG000|Overall Study|Adverse Event|1|||
144572776|NCT01443403|521298770|FG001|Overall Study|Adverse Event|1|||
144572777|NCT01443403|521298771|FG002|Overall Study|Adverse Event|4|||
144572778|NCT01443403|521298772|FG003|Overall Study|Adverse Event|5|||
144572779|NCT01443403|521298769|FG000|Overall Study|Withdrawal by Subject|0|||
144572780|NCT01443403|521298770|FG001|Overall Study|Withdrawal by Subject|1|||
144729809|NCT01390844|521866171|FG002|Treatment Phase|Non-GCP Compliant|10|||
144572781|NCT01443403|521298771|FG002|Overall Study|Withdrawal by Subject|2|||
144572782|NCT01443403|521298772|FG003|Overall Study|Withdrawal by Subject|1|||
144572783|NCT01443403|521298769|FG000|Overall Study|Lost to Follow-up|0|||
144572784|NCT01443403|521298770|FG001|Overall Study|Lost to Follow-up|0|||
144572785|NCT01443403|521298771|FG002|Overall Study|Lost to Follow-up|0|||
144572786|NCT01443403|521298772|FG003|Overall Study|Lost to Follow-up|1|||
144572787|NCT01443403|521298769|FG000|Overall Study|Protocol Violation|2|||
144572788|NCT01443403|521298770|FG001|Overall Study|Protocol Violation|1|||
144572789|NCT01443403|521298771|FG002|Overall Study|Protocol Violation|1|||
144572790|NCT01443403|521298772|FG003|Overall Study|Protocol Violation|1|||
144572791|NCT01443403|521298769|FG000|Overall Study|Use of Prohibited Treatment|2|||
144572792|NCT01443403|521298770|FG001|Overall Study|Use of Prohibited Treatment|3|||
144572793|NCT01443403|521298771|FG002|Overall Study|Use of Prohibited Treatment|0|||
144572794|NCT01443403|521298772|FG003|Overall Study|Use of Prohibited Treatment|0|||
144572795|NCT01443403|521298769|FG000|Overall Study|Other - Miscellaneous|1|||
144572796|NCT01443403|521298770|FG001|Overall Study|Other - Miscellaneous|0|||
144572797|NCT01443403|521298771|FG002|Overall Study|Other - Miscellaneous|0|||
144572798|NCT01443403|521298772|FG003|Overall Study|Other - Miscellaneous|1|||
144572799|NCT00474526|521298773|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
144572800|NCT00474526|521298774|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
144572801|NCT00474526|521298775|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
144572802|NCT00474526|521298776|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
144572803|NCT00474526|521298777|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
144572804|NCT00474526|521298778|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
144572805|NCT00474526|521298779|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
144572806|NCT00474526|521298780|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
144572807|NCT00474526|521298781|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
144572808|NCT00474526|521298782|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
144572809|NCT00474526|521298783|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
144572810|NCT00474526|521298784|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
144572811|NCT00474526|521298785|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
144572812|NCT00474526|521298786|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
144572813|NCT00474526|521298787|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
144572814|NCT00474526|521298788|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
144572815|NCT00474526|521298789|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
144572816|NCT00474526|521298773|FG000|Overall Study|Adverse Event|2|||
144572817|NCT00474526|521298774|FG001|Overall Study|Adverse Event|0|||
144572818|NCT00474526|521298775|FG002|Overall Study|Adverse Event|2|||
144572819|NCT00474526|521298776|FG003|Overall Study|Adverse Event|4|||
144729810|NCT01390844|521866172|FG003|Treatment Phase|Non-GCP Compliant|3|||
144729811|NCT01390844|521866169|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
144729812|NCT01390844|521866170|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
144729813|NCT01390844|521866171|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
144729814|NCT01390844|521866172|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
144207302|NCT01056289|519954279|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144572820|NCT00474526|521298777|FG004|Overall Study|Adverse Event|2|||
144729815|NCT02781727|521866175|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
144572821|NCT00474526|521298778|FG005|Overall Study|Adverse Event|1|||
144572822|NCT00474526|521298779|FG006|Overall Study|Adverse Event|1|||
144572823|NCT00474526|521298780|FG007|Overall Study|Adverse Event|0|||
144572824|NCT00474526|521298781|FG008|Overall Study|Adverse Event|0|||
144572825|NCT00474526|521298782|FG009|Overall Study|Adverse Event|0|||
144572826|NCT00474526|521298783|FG010|Overall Study|Adverse Event|0|||
144572827|NCT00474526|521298784|FG011|Overall Study|Adverse Event|0|||
144572828|NCT00474526|521298785|FG012|Overall Study|Adverse Event|0|||
144572829|NCT00474526|521298786|FG013|Overall Study|Adverse Event|0|||
144572830|NCT00474526|521298787|FG014|Overall Study|Adverse Event|1|||
144729816|NCT02781727|521866176|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
144572831|NCT00474526|521298788|FG015|Overall Study|Adverse Event|1|||
144572832|NCT00474526|521298789|FG016|Overall Study|Adverse Event|0|||
144572833|NCT00474526|521298773|FG000|Overall Study|Death|0|||
144572834|NCT00474526|521298774|FG001|Overall Study|Death|0|||
144572835|NCT00474526|521298775|FG002|Overall Study|Death|0|||
144572836|NCT00474526|521298776|FG003|Overall Study|Death|0|||
144572837|NCT00474526|521298777|FG004|Overall Study|Death|0|||
144572838|NCT00474526|521298778|FG005|Overall Study|Death|0|||
144729817|NCT02781727|521866175|FG000|Treatment Period|Withdrawal by Subject|1|||
144729818|NCT02781727|521866176|FG001|Treatment Period|Withdrawal by Subject|0|||
144729819|NCT02781727|521866175|FG000|Treatment Period|Lost to Follow-up|0|||
144572839|NCT00474526|521298779|FG006|Overall Study|Death|0|||
144572840|NCT00474526|521298780|FG007|Overall Study|Death|0|||
144572841|NCT00474526|521298781|FG008|Overall Study|Death|0|||
144572842|NCT00474526|521298782|FG009|Overall Study|Death|0|||
144572843|NCT00474526|521298783|FG010|Overall Study|Death|0|||
144572844|NCT00474526|521298784|FG011|Overall Study|Death|0|||
144729820|NCT02781727|521866176|FG001|Treatment Period|Lost to Follow-up|1|||
144729821|NCT01044732|521866178|FG000|Overall Study|Lost to Follow-up|2|||
144572845|NCT00474526|521298785|FG012|Overall Study|Death|0|||
144572846|NCT00474526|521298786|FG013|Overall Study|Death|3|||
144572847|NCT00474526|521298787|FG014|Overall Study|Death|0|||
144572848|NCT00474526|521298788|FG015|Overall Study|Death|0|||
144572849|NCT00474526|521298789|FG016|Overall Study|Death|0|||
144572850|NCT00474526|521298773|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572851|NCT00474526|521298774|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
144572852|NCT00474526|521298775|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572853|NCT00474526|521298776|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
144572854|NCT00474526|521298777|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
144572855|NCT00474526|521298778|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572856|NCT00474526|521298779|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572857|NCT00474526|521298780|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572858|NCT00474526|521298781|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572859|NCT00474526|521298782|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572860|NCT00474526|521298783|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572861|NCT00474526|521298784|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572862|NCT00474526|521298785|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572863|NCT00474526|521298786|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
144572864|NCT00474526|521298787|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
144572865|NCT00474526|521298788|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572866|NCT00474526|521298789|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
144572867|NCT00474526|521298773|FG000|Overall Study|Lost to Follow-up|8|||
144572868|NCT00474526|521298774|FG001|Overall Study|Lost to Follow-up|6|||
144572869|NCT00474526|521298775|FG002|Overall Study|Lost to Follow-up|13|||
144572870|NCT00474526|521298776|FG003|Overall Study|Lost to Follow-up|29|||
144572871|NCT00474526|521298777|FG004|Overall Study|Lost to Follow-up|11|||
144572872|NCT00474526|521298778|FG005|Overall Study|Lost to Follow-up|5|||
144572873|NCT00474526|521298779|FG006|Overall Study|Lost to Follow-up|8|||
144572874|NCT00474526|521298780|FG007|Overall Study|Lost to Follow-up|1|||
144572875|NCT00474526|521298781|FG008|Overall Study|Lost to Follow-up|0|||
144572876|NCT00474526|521298782|FG009|Overall Study|Lost to Follow-up|6|||
144572877|NCT00474526|521298783|FG010|Overall Study|Lost to Follow-up|2|||
144572878|NCT00474526|521298784|FG011|Overall Study|Lost to Follow-up|4|||
144572879|NCT00474526|521298785|FG012|Overall Study|Lost to Follow-up|6|||
144572880|NCT00474526|521298786|FG013|Overall Study|Lost to Follow-up|74|||
144572881|NCT00474526|521298787|FG014|Overall Study|Lost to Follow-up|29|||
144572882|NCT00474526|521298788|FG015|Overall Study|Lost to Follow-up|4|||
144572883|NCT00474526|521298789|FG016|Overall Study|Lost to Follow-up|5|||
144572884|NCT00474526|521298773|FG000|Overall Study|Protocol Violation|2|||
144572885|NCT00474526|521298774|FG001|Overall Study|Protocol Violation|6|||
144572886|NCT00474526|521298775|FG002|Overall Study|Protocol Violation|4|||
144572887|NCT00474526|521298776|FG003|Overall Study|Protocol Violation|12|||
144572888|NCT00474526|521298777|FG004|Overall Study|Protocol Violation|3|||
144572889|NCT00474526|521298778|FG005|Overall Study|Protocol Violation|1|||
144572890|NCT00474526|521298779|FG006|Overall Study|Protocol Violation|3|||
144572891|NCT00474526|521298780|FG007|Overall Study|Protocol Violation|0|||
144572892|NCT00474526|521298781|FG008|Overall Study|Protocol Violation|0|||
144572893|NCT00474526|521298782|FG009|Overall Study|Protocol Violation|4|||
144572894|NCT00474526|521298783|FG010|Overall Study|Protocol Violation|2|||
144572895|NCT00474526|521298784|FG011|Overall Study|Protocol Violation|2|||
144572896|NCT00474526|521298785|FG012|Overall Study|Protocol Violation|4|||
144572897|NCT00474526|521298786|FG013|Overall Study|Protocol Violation|19|||
144572898|NCT00474526|521298787|FG014|Overall Study|Protocol Violation|9|||
144572899|NCT00474526|521298788|FG015|Overall Study|Protocol Violation|6|||
144572900|NCT00474526|521298789|FG016|Overall Study|Protocol Violation|2|||
144572901|NCT00474526|521298773|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
144572902|NCT00474526|521298774|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
144572903|NCT00474526|521298775|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
144572904|NCT00474526|521298776|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
144572905|NCT00474526|521298777|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
144572906|NCT00474526|521298778|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
144572907|NCT00474526|521298779|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
144572908|NCT00474526|521298780|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
144621421|NCT05103332|521472246|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621422|NCT05103332|521472247|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621423|NCT05103332|521472248|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144572909|NCT00474526|521298781|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
144572910|NCT00474526|521298782|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
144572911|NCT00474526|521298783|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
144572912|NCT00474526|521298784|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
144572913|NCT00474526|521298785|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
144572914|NCT00474526|521298786|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
144572915|NCT00474526|521298787|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
144572916|NCT00474526|521298788|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
144572917|NCT00474526|521298789|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
144572918|NCT00474526|521298773|FG000|Overall Study|Withdrawal by Subject|9|||
144572919|NCT00474526|521298774|FG001|Overall Study|Withdrawal by Subject|24|||
144572920|NCT00474526|521298775|FG002|Overall Study|Withdrawal by Subject|21|||
144572921|NCT00474526|521298776|FG003|Overall Study|Withdrawal by Subject|52|||
144572922|NCT00474526|521298777|FG004|Overall Study|Withdrawal by Subject|38|||
144572923|NCT00474526|521298778|FG005|Overall Study|Withdrawal by Subject|6|||
144572924|NCT00474526|521298779|FG006|Overall Study|Withdrawal by Subject|12|||
144572925|NCT00474526|521298780|FG007|Overall Study|Withdrawal by Subject|4|||
144572926|NCT00474526|521298781|FG008|Overall Study|Withdrawal by Subject|4|||
144572927|NCT00474526|521298782|FG009|Overall Study|Withdrawal by Subject|13|||
144572928|NCT00474526|521298783|FG010|Overall Study|Withdrawal by Subject|5|||
144572929|NCT00474526|521298784|FG011|Overall Study|Withdrawal by Subject|4|||
144572930|NCT00474526|521298785|FG012|Overall Study|Withdrawal by Subject|4|||
144572931|NCT00474526|521298786|FG013|Overall Study|Withdrawal by Subject|37|||
144572932|NCT00474526|521298787|FG014|Overall Study|Withdrawal by Subject|22|||
144572933|NCT00474526|521298788|FG015|Overall Study|Withdrawal by Subject|1|||
144572934|NCT00474526|521298789|FG016|Overall Study|Withdrawal by Subject|1|||
144572935|NCT02797522|521298790|FG000|Overall Study|Study Terminated by Sponsor|0|||
144572936|NCT02797522|521298791|FG001|Overall Study|Study Terminated by Sponsor|0|||
144572937|NCT02797522|521298792|FG002|Overall Study|Study Terminated by Sponsor|0|||
144572938|NCT02797522|521298793|FG003|Overall Study|Study Terminated by Sponsor|0|||
144572939|NCT02797522|521298794|FG004|Overall Study|Study Terminated by Sponsor|0|||
144572940|NCT02797522|521298795|FG005|Overall Study|Study Terminated by Sponsor|0|||
144572941|NCT02797522|521298796|FG006|Overall Study|Study Terminated by Sponsor|0|||
144572942|NCT02797522|521298797|FG007|Overall Study|Study Terminated by Sponsor|4|||
144572943|NCT02797522|521298798|FG008|Overall Study|Study Terminated by Sponsor|2|||
144572944|NCT02797522|521298799|FG009|Overall Study|Study Terminated by Sponsor|4|||
144572945|NCT02797522|521298800|FG010|Overall Study|Study Terminated by Sponsor|1|||
144572946|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
144572947|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
144572948|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
144572949|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
144572950|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
144572951|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
144572952|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
144572953|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
144572954|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
144572955|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
144572956|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
144572957|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
144572958|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
144572959|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
144572960|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
144572961|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
144572962|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
144572963|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
144572964|NCT00132678|521298805|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
144572965|NCT00132678|521298806|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
144572966|NCT00132678|521298807|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
144572967|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Death|2|||
144572968|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Death|0|||
144572969|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Death|0|||
144572970|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
144572971|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
144572972|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
144572973|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
144572974|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
144572975|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
144572976|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
144572977|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
144572978|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
144572979|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
144572980|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
144572981|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
144572982|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
144572983|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
144572984|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
144572985|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
144572986|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
144729822|NCT01044732|521866179|FG001|Overall Study|Lost to Follow-up|1|||
144729823|NCT01044732|521866178|FG000|Overall Study|Physician Decision|5|||
144572987|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
144572988|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
144572989|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
144572990|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
144572991|NCT00132678|521298805|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
144572992|NCT00132678|521298806|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
144572993|NCT00132678|521298807|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
144572994|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
144572995|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
144572996|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
144572997|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
144572998|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
144572999|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
144573000|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
144573001|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
144573002|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
144573003|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
144573004|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
144573005|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
144573006|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
144573007|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
144573008|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
144573009|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
144573010|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
144573011|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
144573012|NCT00132678|521298805|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
144573013|NCT00132678|521298806|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
144573014|NCT00132678|521298807|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
144573015|NCT00953147|521298808|FG000|Overall Study|Adverse Event|8|||
144573016|NCT00953147|521298809|FG001|Overall Study|Adverse Event|16|||
144573017|NCT00953147|521298810|FG002|Overall Study|Adverse Event|6|||
144573018|NCT00953147|521298808|FG000|Overall Study|Protocol Violation|2|||
144573019|NCT00953147|521298809|FG001|Overall Study|Protocol Violation|8|||
144573020|NCT00953147|521298810|FG002|Overall Study|Protocol Violation|4|||
144573021|NCT00953147|521298808|FG000|Overall Study|Withdrawal by Subject|13|||
144573022|NCT00953147|521298809|FG001|Overall Study|Withdrawal by Subject|15|||
144573023|NCT00953147|521298810|FG002|Overall Study|Withdrawal by Subject|12|||
144573024|NCT00953147|521298808|FG000|Overall Study|Lost to Follow-up|8|||
144573025|NCT00953147|521298809|FG001|Overall Study|Lost to Follow-up|9|||
144573026|NCT00953147|521298810|FG002|Overall Study|Lost to Follow-up|4|||
144573027|NCT00953147|521298808|FG000|Overall Study|Physician Decision|2|||
144573028|NCT00953147|521298809|FG001|Overall Study|Physician Decision|7|||
144573029|NCT00953147|521298810|FG002|Overall Study|Physician Decision|3|||
144573030|NCT00953147|521298808|FG000|Overall Study|Other|4|||
144573031|NCT00953147|521298809|FG001|Overall Study|Other|11|||
144621424|NCT05103332|521472249|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621425|NCT05103332|521472250|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621426|NCT05103332|521472251|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621427|NCT05103332|521472252|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621428|NCT05103332|521472253|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621429|NCT05103332|521472254|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
144621430|NCT05103332|521472237|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621431|NCT05103332|521472238|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621432|NCT05103332|521472239|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621433|NCT05103332|521472240|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621434|NCT05103332|521472241|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621435|NCT05103332|521472242|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621436|NCT05103332|521472243|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621437|NCT05103332|521472244|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621438|NCT05103332|521472245|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621439|NCT05103332|521472246|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144573032|NCT00953147|521298810|FG002|Overall Study|Other|13|||
144573033|NCT01484431|521298811|FG000|Period 1: High Dose|Physician Decision|0|||
144573034|NCT01484431|521298812|FG001|Period 1: High Dose|Physician Decision|1|||
144573035|NCT01484431|521298813|FG002|Period 1: High Dose|Physician Decision|0|||
144573036|NCT01484431|521298811|FG000|Period 2|Death|0|||
144621440|NCT05103332|521472247|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621441|NCT05103332|521472248|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
144621442|NCT05103332|521472249|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144573037|NCT01484431|521298812|FG001|Period 2|Death|1|||
144573038|NCT01484431|521298813|FG002|Period 2|Death|1|||
144573039|NCT01484431|521298811|FG000|Period 2|Physician Decision|0|||
144573040|NCT01484431|521298812|FG001|Period 2|Physician Decision|0|||
144573041|NCT01484431|521298813|FG002|Period 2|Physician Decision|1|||
144573042|NCT01484431|521298811|FG000|Period 2|Non-Compliance with Study Drug|1|||
144573043|NCT01484431|521298812|FG001|Period 2|Non-Compliance with Study Drug|0|||
144573044|NCT01484431|521298813|FG002|Period 2|Non-Compliance with Study Drug|0|||
144573045|NCT01251770|521298814|FG000|Overall Study|Protocol Violation|13|||
144573046|NCT01251770|521298815|FG001|Overall Study|Protocol Violation|7|||
144573047|NCT02514239|521298816|FG000|Overall Study|Refused to continue trial medication|0|||
144573048|NCT02514239|521298817|FG001|Overall Study|Refused to continue trial medication|0|||
144573049|NCT02514239|521298818|FG002|Overall Study|Refused to continue trial medication|0|||
144573050|NCT02514239|521298819|FG003|Overall Study|Refused to continue trial medication|0|||
144573051|NCT02514239|521298820|FG004|Overall Study|Refused to continue trial medication|0|||
144573052|NCT02514239|521298821|FG005|Overall Study|Refused to continue trial medication|0|||
144573053|NCT02514239|521298822|FG006|Overall Study|Refused to continue trial medication|0|||
144573054|NCT02514239|521298823|FG007|Overall Study|Refused to continue trial medication|0|||
144573055|NCT02514239|521298824|FG008|Overall Study|Refused to continue trial medication|0|||
144573056|NCT02514239|521298825|FG009|Overall Study|Refused to continue trial medication|1|||
144573057|NCT02514239|521298816|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573058|NCT02514239|521298817|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573059|NCT02514239|521298818|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573060|NCT02514239|521298819|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573061|NCT02514239|521298820|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573062|NCT02514239|521298821|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573063|NCT02514239|521298822|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573064|NCT02514239|521298823|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
144573065|NCT02514239|521298824|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
144573066|NCT02514239|521298825|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
144573067|NCT02514239|521298816|FG000|Overall Study|Not treated|0|||
144573068|NCT02514239|521298817|FG001|Overall Study|Not treated|1|||
144573069|NCT02514239|521298818|FG002|Overall Study|Not treated|0|||
144573070|NCT02514239|521298819|FG003|Overall Study|Not treated|0|||
144573071|NCT02514239|521298820|FG004|Overall Study|Not treated|0|||
144573072|NCT02514239|521298821|FG005|Overall Study|Not treated|0|||
144573073|NCT02514239|521298822|FG006|Overall Study|Not treated|0|||
144573074|NCT02514239|521298823|FG007|Overall Study|Not treated|0|||
144573075|NCT02514239|521298824|FG008|Overall Study|Not treated|0|||
144573076|NCT02514239|521298825|FG009|Overall Study|Not treated|0|||
144573077|NCT02514239|521298816|FG000|Overall Study|Other Adverse Events|2|||
144573078|NCT02514239|521298817|FG001|Overall Study|Other Adverse Events|0|||
144573079|NCT02514239|521298818|FG002|Overall Study|Other Adverse Events|0|||
144573080|NCT02514239|521298819|FG003|Overall Study|Other Adverse Events|1|||
144573081|NCT02514239|521298820|FG004|Overall Study|Other Adverse Events|0|||
144573082|NCT02514239|521298821|FG005|Overall Study|Other Adverse Events|1|||
144573083|NCT02514239|521298822|FG006|Overall Study|Other Adverse Events|0|||
144573084|NCT02514239|521298823|FG007|Overall Study|Other Adverse Events|1|||
144573085|NCT02514239|521298824|FG008|Overall Study|Other Adverse Events|2|||
144573086|NCT02514239|521298825|FG009|Overall Study|Other Adverse Events|0|||
144573087|NCT02514239|521298816|FG000|Overall Study|Progressive disease|3|||
144573088|NCT02514239|521298817|FG001|Overall Study|Progressive disease|3|||
144573089|NCT02514239|521298818|FG002|Overall Study|Progressive disease|2|||
144573090|NCT02514239|521298819|FG003|Overall Study|Progressive disease|2|||
144573091|NCT02514239|521298820|FG004|Overall Study|Progressive disease|3|||
144573092|NCT02514239|521298821|FG005|Overall Study|Progressive disease|3|||
144573093|NCT02514239|521298822|FG006|Overall Study|Progressive disease|4|||
144573094|NCT02514239|521298823|FG007|Overall Study|Progressive disease|2|||
144573095|NCT02514239|521298824|FG008|Overall Study|Progressive disease|5|||
144573096|NCT02514239|521298825|FG009|Overall Study|Progressive disease|0|||
144573097|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
144573098|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
144573099|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
144573100|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
144573101|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
144573102|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
144573103|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
144573104|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
144573105|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
144573106|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
144573107|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
144573108|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
144573109|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
144573110|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
144262844|NCT01325350|520163770|FG003|Overall Study|Adverse Event|1|||
144262845|NCT01325350|520163771|FG004|Overall Study|Adverse Event|2|||
144729824|NCT01044732|521866179|FG001|Overall Study|Physician Decision|3|||
144573111|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
144573112|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
144573113|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
144573114|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
144573115|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
144573116|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
144573117|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
144573118|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
144573119|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
144573120|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
144573121|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
144573122|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
144573123|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
144573124|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
144573125|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144573126|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144573127|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144573128|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144573129|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
144573130|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144573131|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144573132|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
144573133|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
144573134|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
144573135|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
144573136|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
144573137|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
144573138|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
144573139|NCT01888874|521298826|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
144573140|NCT01888874|521298827|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
144573141|NCT01888874|521298828|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
144573142|NCT01888874|521298829|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
144573143|NCT01888874|521298830|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
144573144|NCT01888874|521298831|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
144573145|NCT01888874|521298832|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
144573146|NCT01888874|521298826|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
144573147|NCT01888874|521298827|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
144573148|NCT01888874|521298828|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
144573149|NCT01888874|521298829|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
144573150|NCT01888874|521298830|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
144573151|NCT01888874|521298831|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
144573152|NCT01888874|521298832|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
144573153|NCT01888874|521298826|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
144573154|NCT01888874|521298827|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
144573155|NCT01888874|521298828|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
144573156|NCT01888874|521298829|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
144573157|NCT01888874|521298830|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
144573158|NCT01888874|521298831|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
144573159|NCT01888874|521298832|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
144573160|NCT01888874|521298826|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
144573161|NCT01888874|521298827|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
144621443|NCT05103332|521472250|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621444|NCT05103332|521472251|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621445|NCT05103332|521472252|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621446|NCT05103332|521472253|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621447|NCT05103332|521472254|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
144621448|NCT05103332|521472237|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621449|NCT05103332|521472238|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621450|NCT05103332|521472239|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621451|NCT05103332|521472240|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621452|NCT05103332|521472241|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144729825|NCT01044732|521866178|FG000|Overall Study|Protocol Violation|11|||
144729826|NCT01044732|521866179|FG001|Overall Study|Protocol Violation|12|||
144573162|NCT01888874|521298828|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
144573163|NCT01888874|521298829|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
144573164|NCT01888874|521298830|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
144573165|NCT01888874|521298831|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
144573166|NCT01888874|521298832|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
144573167|NCT01888874|521298826|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
144573168|NCT01888874|521298827|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
144573169|NCT01888874|521298828|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
144573170|NCT01888874|521298829|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
144573171|NCT01888874|521298830|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
144573172|NCT01888874|521298831|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
144573173|NCT01888874|521298832|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
144573174|NCT01888874|521298826|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
144573175|NCT01888874|521298827|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
144573176|NCT01888874|521298828|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
144573177|NCT01888874|521298829|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
144573178|NCT01888874|521298830|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
144573179|NCT01888874|521298831|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
144573180|NCT01888874|521298832|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
144573181|NCT01888874|521298826|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
144573182|NCT01888874|521298827|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
144573183|NCT01888874|521298828|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
144573184|NCT01888874|521298829|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
144573185|NCT01888874|521298830|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
144573186|NCT01888874|521298831|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
144573187|NCT01888874|521298832|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
144573188|NCT02980042|521298835|FG000|Overall Study|Lost to Follow-up|5|||
144573189|NCT02980042|521298836|FG001|Overall Study|Lost to Follow-up|0|||
144573190|NCT02980042|521298835|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
144573191|NCT02980042|521298836|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
144573192|NCT01020877|521298839|FG000|Second Intervention|Withdrawal by Subject|1|||
144573193|NCT01020877|521298840|FG001|Second Intervention|Withdrawal by Subject|0|||
144573194|NCT01483144|521298841|FG000|Overall Study|Adverse Event|9|||
144573195|NCT01483144|521298842|FG001|Overall Study|Adverse Event|4|||
144573196|NCT01483144|521298843|FG002|Overall Study|Adverse Event|6|||
144573197|NCT01483144|521298841|FG000|Overall Study|Withdrawal by Subject|0|||
144573198|NCT01483144|521298842|FG001|Overall Study|Withdrawal by Subject|2|||
144573199|NCT01483144|521298843|FG002|Overall Study|Withdrawal by Subject|5|||
144573200|NCT01483144|521298841|FG000|Overall Study|Physician Decision|1|||
144573201|NCT01483144|521298842|FG001|Overall Study|Physician Decision|0|||
144573202|NCT01483144|521298843|FG002|Overall Study|Physician Decision|0|||
144573203|NCT01483144|521298841|FG000|Overall Study|Lost to Follow-up|2|||
144573204|NCT01483144|521298842|FG001|Overall Study|Lost to Follow-up|4|||
144573205|NCT01483144|521298843|FG002|Overall Study|Lost to Follow-up|1|||
144573206|NCT01483144|521298841|FG000|Overall Study|Protocol Violation|3|||
144573207|NCT01483144|521298842|FG001|Overall Study|Protocol Violation|3|||
144573208|NCT01483144|521298843|FG002|Overall Study|Protocol Violation|3|||
144573209|NCT00944229|521298844|FG000|Overall Study|Withdrawal by Subject|11|||
144573210|NCT00944229|521298844|FG000|Overall Study|Physician Decision|14|||
144573211|NCT02179177|521298845|FG000|Overall Study|Lost to Follow-up|1|||
144573212|NCT02179177|521298846|FG001|Overall Study|Lost to Follow-up|1|||
144573213|NCT02179177|521298845|FG000|Overall Study|Withdrawal by Subject|1|||
144573214|NCT02179177|521298846|FG001|Overall Study|Withdrawal by Subject|1|||
144573215|NCT04400487|521298847|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
144573216|NCT04400487|521298847|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
144207303|NCT01056289|519954280|FG001|Double-blind Phase|Withdrawal by Subject|0|||
144573217|NCT04400487|521298847|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
144573218|NCT04052425|521298848|FG000|24-Week Double-blind Period|Adverse Event|0|||
144573219|NCT04052425|521298849|FG001|24-Week Double-blind Period|Adverse Event|1|||
144573220|NCT04052425|521298850|FG002|24-Week Double-blind Period|Adverse Event|0|||
144573221|NCT04052425|521298851|FG003|24-Week Double-blind Period|Adverse Event|0|||
144573222|NCT04052425|521298848|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
144573223|NCT04052425|521298849|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
144573224|NCT04052425|521298850|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
144573225|NCT04052425|521298851|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
144573226|NCT04052425|521298848|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
144573227|NCT04052425|521298849|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
144573228|NCT04052425|521298850|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
144573229|NCT04052425|521298851|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
144573230|NCT04052425|521298848|FG000|24-Week Double-blind Period|Physician Decision|1|||
144207304|NCT01056289|519954281|FG002|Double-blind Phase|Withdrawal by Subject|4|||
144207305|NCT01056289|519954282|FG003|Double-blind Phase|Withdrawal by Subject|2|||
144573231|NCT04052425|521298849|FG001|24-Week Double-blind Period|Physician Decision|0|||
144573232|NCT04052425|521298850|FG002|24-Week Double-blind Period|Physician Decision|0|||
144573233|NCT04052425|521298851|FG003|24-Week Double-blind Period|Physician Decision|0|||
144573234|NCT04052425|521298848|FG000|24-Week Double-blind Period|Protocol Violation|1|||
144573235|NCT04052425|521298849|FG001|24-Week Double-blind Period|Protocol Violation|0|||
144573236|NCT04052425|521298850|FG002|24-Week Double-blind Period|Protocol Violation|0|||
144573237|NCT04052425|521298851|FG003|24-Week Double-blind Period|Protocol Violation|0|||
144573238|NCT04052425|521298848|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
144573239|NCT04052425|521298849|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
144573240|NCT04052425|521298850|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
144573241|NCT04052425|521298851|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
144573242|NCT04052425|521298848|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
144573243|NCT04052425|521298849|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
144573244|NCT04052425|521298850|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
144573245|NCT04052425|521298851|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
144573246|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
144573247|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
144573248|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
144573249|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
144573250|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
144573251|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
144573252|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
144573253|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
144573254|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
144573255|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
144573256|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
144573257|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
144573258|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
144573259|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
144573260|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
144573261|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
144573262|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
144573263|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
144573264|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
144573265|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
144573266|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
144573267|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
144573268|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
144573269|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
144573270|NCT04052425|521298848|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
144573271|NCT04052425|521298849|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
144573272|NCT04052425|521298850|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
144573273|NCT04052425|521298851|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
144573274|NCT01677299|521298852|FG000|Overall Study|Adverse Event|0|||
144573275|NCT01677299|521298853|FG001|Overall Study|Adverse Event|2|||
144573276|NCT01677299|521298854|FG002|Overall Study|Adverse Event|1|||
144573277|NCT01677299|521298855|FG003|Overall Study|Adverse Event|0|||
144573278|NCT01677299|521298852|FG000|Overall Study|Withdrawal by Subject|0|||
144573279|NCT01677299|521298853|FG001|Overall Study|Withdrawal by Subject|1|||
144573280|NCT01677299|521298854|FG002|Overall Study|Withdrawal by Subject|0|||
144573281|NCT01677299|521298855|FG003|Overall Study|Withdrawal by Subject|1|||
144573282|NCT00520845|521298856|FG000|Overall Study|Death|3|||
144573283|NCT00520845|521298856|FG000|Overall Study|Adverse Event|4|||
144573284|NCT00520845|521298856|FG000|Overall Study|Disease Progression, relapse|13|||
144573285|NCT00520845|521298856|FG000|Overall Study|Withdrawal by Subject|1|||
144573286|NCT00520845|521298856|FG000|Overall Study|Alternative Therapy|1|||
144573287|NCT03334253|521298859|FG000|Overall Study|Withdrawal by Subject|1|||
144573288|NCT03334253|521298860|FG001|Overall Study|Withdrawal by Subject|0|||
144573289|NCT03334253|521298859|FG000|Overall Study|Lost to Follow-up|4|||
144573290|NCT03334253|521298860|FG001|Overall Study|Lost to Follow-up|3|||
144573291|NCT03334253|521298859|FG000|Overall Study|Moved residence|2|||
144573292|NCT03334253|521298860|FG001|Overall Study|Moved residence|2|||
144573293|NCT01732549|521298861|FG000|Overall Study|Adverse Event|13|||
144573294|NCT01732549|521298862|FG001|Overall Study|Adverse Event|3|||
144621453|NCT05103332|521472242|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144573295|NCT01732549|521298861|FG000|Overall Study|Consent withdrawn|13|||
144573296|NCT01732549|521298862|FG001|Overall Study|Consent withdrawn|6|||
144573297|NCT01732549|521298861|FG000|Overall Study|Disease progression|37|||
144621454|NCT05103332|521472243|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
144573298|NCT01732549|521298862|FG001|Overall Study|Disease progression|50|||
144573299|NCT01732549|521298861|FG000|Overall Study|Other|8|||
144573300|NCT01732549|521298862|FG001|Overall Study|Other|14|||
144573301|NCT01516749|521298863|FG000|Active Therapy|Lost to Follow-up|1|||
144573302|NCT01516749|521298863|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
144573303|NCT00945672|521298865|FG000|Overall Study|Withdrawal by Subject|0|||
144573304|NCT00945672|521298866|FG001|Overall Study|Withdrawal by Subject|0|||
144573305|NCT00945672|521298867|FG002|Overall Study|Withdrawal by Subject|0|||
144573306|NCT00945672|521298868|FG003|Overall Study|Withdrawal by Subject|1|||
144573307|NCT01681992|521298873|FG000|Overall Study|Adverse Event|3|||
144573308|NCT01681992|521298874|FG001|Overall Study|Adverse Event|2|||
144573309|NCT01681992|521298875|FG002|Overall Study|Adverse Event|3|||
144573310|NCT01681992|521298873|FG000|Overall Study|Lost to Follow-up|36|||
144573311|NCT01681992|521298874|FG001|Overall Study|Lost to Follow-up|38|||
144573312|NCT01681992|521298875|FG002|Overall Study|Lost to Follow-up|53|||
144573313|NCT01681992|521298873|FG000|Overall Study|As Per Sponsor Decision|0|||
144573314|NCT01681992|521298874|FG001|Overall Study|As Per Sponsor Decision|0|||
144573315|NCT01681992|521298875|FG002|Overall Study|As Per Sponsor Decision|1|||
144573316|NCT01681992|521298873|FG000|Overall Study|Protocol Violation|0|||
144573317|NCT01681992|521298874|FG001|Overall Study|Protocol Violation|0|||
144573318|NCT01681992|521298875|FG002|Overall Study|Protocol Violation|1|||
144573319|NCT01681992|521298873|FG000|Overall Study|Withdrawal by Subject|27|||
144573320|NCT01681992|521298874|FG001|Overall Study|Withdrawal by Subject|30|||
144573321|NCT01681992|521298875|FG002|Overall Study|Withdrawal by Subject|25|||
144573322|NCT00447590|521298882|FG000|Overall Study|Withdrawal by Subject|26|||
144573323|NCT00447590|521298882|FG000|Overall Study|Lost to Follow-up|24|||
144573324|NCT00447590|521298882|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
144573325|NCT05569421|521298885|FG000|Overall Study|Withdrawal by Subject|1|||
144573326|NCT05569421|521298886|FG001|Overall Study|Withdrawal by Subject|0|||
144573327|NCT05569421|521298887|FG002|Overall Study|Withdrawal by Subject|0|||
144573328|NCT00504075|521298888|FG000|Overall Study|Adverse Event|1|||
144573329|NCT00504075|521298888|FG000|Overall Study|Lost to Follow-up|5|||
144573330|NCT00504075|521298888|FG000|Overall Study|Withdrawal by Subject|1|||
144573331|NCT00504075|521298888|FG000|Overall Study|Required other therapeutic intervention|1|||
144573332|NCT03812029|521298891|FG000|Overall Study|Protocol Violation|1|||
144573333|NCT03812029|521298892|FG001|Overall Study|Protocol Violation|0|||
144573334|NCT03812029|521298893|FG002|Overall Study|Protocol Violation|0|||
144573335|NCT03812029|521298894|FG003|Overall Study|Protocol Violation|1|||
144573336|NCT03812029|521298895|FG004|Overall Study|Protocol Violation|0|||
144573337|NCT03812029|521298891|FG000|Overall Study|Withdrawal by Subject|1|||
144573338|NCT03812029|521298892|FG001|Overall Study|Withdrawal by Subject|0|||
144573339|NCT03812029|521298893|FG002|Overall Study|Withdrawal by Subject|0|||
144573340|NCT03812029|521298894|FG003|Overall Study|Withdrawal by Subject|2|||
144573341|NCT03812029|521298895|FG004|Overall Study|Withdrawal by Subject|2|||
144573342|NCT03812029|521298891|FG000|Overall Study|Stopping rules|0|||
144573343|NCT03812029|521298892|FG001|Overall Study|Stopping rules|1|||
144573344|NCT03812029|521298893|FG002|Overall Study|Stopping rules|0|||
144573345|NCT03812029|521298894|FG003|Overall Study|Stopping rules|0|||
144573346|NCT03812029|521298895|FG004|Overall Study|Stopping rules|0|||
144573347|NCT03812029|521298891|FG000|Overall Study|Adverse Event|0|||
144573348|NCT03812029|521298892|FG001|Overall Study|Adverse Event|9|||
144573349|NCT03812029|521298893|FG002|Overall Study|Adverse Event|0|||
144573350|NCT03812029|521298894|FG003|Overall Study|Adverse Event|3|||
144573351|NCT03812029|521298895|FG004|Overall Study|Adverse Event|5|||
144573352|NCT03812029|521298891|FG000|Overall Study|Lost to Follow-up|0|||
144573353|NCT03812029|521298892|FG001|Overall Study|Lost to Follow-up|0|||
144573354|NCT03812029|521298893|FG002|Overall Study|Lost to Follow-up|0|||
144573355|NCT03812029|521298894|FG003|Overall Study|Lost to Follow-up|0|||
144573356|NCT03812029|521298895|FG004|Overall Study|Lost to Follow-up|3|||
144573357|NCT03149042|521298896|FG000|Overall Study|Invasive FFR not performed|21|||
144573358|NCT03149042|521298896|FG000|Overall Study|Poor CT Image Quality|1|||
144621455|NCT05103332|521472244|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
144621456|NCT05103332|521472245|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144573359|NCT03149042|521298896|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
144573360|NCT00790205|521298897|FG000|Overall Study|Lost to Follow-up|61|||
144573361|NCT00790205|521298898|FG001|Overall Study|Lost to Follow-up|71|||
144573362|NCT00790205|521298897|FG000|Overall Study|Withdrawal by Subject|299|||
144573363|NCT00790205|521298898|FG001|Overall Study|Withdrawal by Subject|363|||
144573364|NCT02643628|521298899|FG000|Overall Study|Lost to Follow-up|1|||
144573365|NCT02643628|521298900|FG001|Overall Study|Lost to Follow-up|4|||
144573366|NCT02643628|521298899|FG000|Overall Study|Withdrawal by Subject|0|||
144573367|NCT02643628|521298900|FG001|Overall Study|Withdrawal by Subject|1|||
144573368|NCT02643628|521298899|FG000|Overall Study|Relocated out of state|0|||
144573369|NCT02643628|521298900|FG001|Overall Study|Relocated out of state|1|||
144573370|NCT00732992|521298901|FG000|Overall Study|Adverse Event|1|||
144573371|NCT00732992|521298902|FG001|Overall Study|Adverse Event|1|||
144573372|NCT00732992|521298901|FG000|Overall Study|Objective Progression or Relapse|3|||
144573373|NCT00732992|521298902|FG001|Overall Study|Objective Progression or Relapse|5|||
144573374|NCT00732992|521298901|FG000|Overall Study|Global Deterioration of Health Status|1|||
144573375|NCT00732992|521298902|FG001|Overall Study|Global Deterioration of Health Status|0|||
144573376|NCT00732992|521298901|FG000|Overall Study|Withdrawal by Subject|1|||
144573377|NCT00732992|521298902|FG001|Overall Study|Withdrawal by Subject|0|||
144573378|NCT03017742|521298909|FG000|Overall Study|Protocol Violation|36|||
144573379|NCT03017742|521298909|FG000|Overall Study|Withdrawal by Subject|37|||
144573380|NCT01441635|521298913|FG000|Overall Study|Adverse Event|4|||
144573381|NCT01441635|521298914|FG001|Overall Study|Adverse Event|3|||
144573382|NCT01441635|521298915|FG002|Overall Study|Adverse Event|1|||
144573383|NCT01441635|521298916|FG003|Overall Study|Adverse Event|5|||
144573384|NCT01441635|521298917|FG004|Overall Study|Adverse Event|1|||
144573385|NCT01441635|521298918|FG005|Overall Study|Adverse Event|2|||
144573386|NCT01441635|521298919|FG006|Overall Study|Adverse Event|2|||
144573387|NCT01441635|521298920|FG007|Overall Study|Adverse Event|2|||
144573388|NCT01441635|521298921|FG008|Overall Study|Adverse Event|1|||
144573389|NCT01441635|521298922|FG009|Overall Study|Adverse Event|0|||
144573390|NCT01441635|521298913|FG000|Overall Study|Withdrawal by Subject|1|||
144573391|NCT01441635|521298914|FG001|Overall Study|Withdrawal by Subject|1|||
144573392|NCT01441635|521298915|FG002|Overall Study|Withdrawal by Subject|0|||
144573393|NCT01441635|521298916|FG003|Overall Study|Withdrawal by Subject|1|||
144573394|NCT01441635|521298917|FG004|Overall Study|Withdrawal by Subject|0|||
144573395|NCT01441635|521298918|FG005|Overall Study|Withdrawal by Subject|0|||
144573396|NCT01441635|521298919|FG006|Overall Study|Withdrawal by Subject|2|||
144573397|NCT01441635|521298920|FG007|Overall Study|Withdrawal by Subject|0|||
144573398|NCT01441635|521298921|FG008|Overall Study|Withdrawal by Subject|1|||
144573399|NCT01441635|521298922|FG009|Overall Study|Withdrawal by Subject|1|||
144573400|NCT01441635|521298913|FG000|Overall Study|Lost to Follow-up|0|||
144573401|NCT01441635|521298914|FG001|Overall Study|Lost to Follow-up|1|||
144573402|NCT01441635|521298915|FG002|Overall Study|Lost to Follow-up|1|||
144573403|NCT01441635|521298916|FG003|Overall Study|Lost to Follow-up|1|||
144573404|NCT01441635|521298917|FG004|Overall Study|Lost to Follow-up|1|||
144573405|NCT01441635|521298918|FG005|Overall Study|Lost to Follow-up|3|||
144573406|NCT01441635|521298919|FG006|Overall Study|Lost to Follow-up|1|||
144573407|NCT01441635|521298920|FG007|Overall Study|Lost to Follow-up|1|||
144573408|NCT01441635|521298921|FG008|Overall Study|Lost to Follow-up|0|||
144573409|NCT01441635|521298922|FG009|Overall Study|Lost to Follow-up|1|||
144573410|NCT01441635|521298913|FG000|Overall Study|Noncompliance|0|||
144573411|NCT01441635|521298914|FG001|Overall Study|Noncompliance|1|||
144573412|NCT01441635|521298915|FG002|Overall Study|Noncompliance|0|||
144573413|NCT01441635|521298916|FG003|Overall Study|Noncompliance|0|||
144573414|NCT01441635|521298917|FG004|Overall Study|Noncompliance|0|||
144573415|NCT01441635|521298918|FG005|Overall Study|Noncompliance|0|||
144573416|NCT01441635|521298919|FG006|Overall Study|Noncompliance|1|||
144573417|NCT01441635|521298920|FG007|Overall Study|Noncompliance|0|||
144573418|NCT01441635|521298921|FG008|Overall Study|Noncompliance|0|||
144573419|NCT01441635|521298922|FG009|Overall Study|Noncompliance|0|||
144573420|NCT01441635|521298913|FG000|Overall Study|Surgery or Invasive Intervention|0|||
144573421|NCT01441635|521298914|FG001|Overall Study|Surgery or Invasive Intervention|0|||
144573422|NCT01441635|521298915|FG002|Overall Study|Surgery or Invasive Intervention|1|||
144573423|NCT01441635|521298916|FG003|Overall Study|Surgery or Invasive Intervention|0|||
144573424|NCT01441635|521298917|FG004|Overall Study|Surgery or Invasive Intervention|0|||
144573425|NCT01441635|521298918|FG005|Overall Study|Surgery or Invasive Intervention|0|||
144573426|NCT01441635|521298919|FG006|Overall Study|Surgery or Invasive Intervention|0|||
144573427|NCT01441635|521298920|FG007|Overall Study|Surgery or Invasive Intervention|0|||
144573428|NCT01441635|521298921|FG008|Overall Study|Surgery or Invasive Intervention|0|||
144573429|NCT01441635|521298922|FG009|Overall Study|Surgery or Invasive Intervention|0|||
144573430|NCT01441635|521298913|FG000|Overall Study|Received Exclusionary Medication|1|||
144573431|NCT01441635|521298914|FG001|Overall Study|Received Exclusionary Medication|0|||
144573432|NCT01441635|521298915|FG002|Overall Study|Received Exclusionary Medication|0|||
144573433|NCT01441635|521298916|FG003|Overall Study|Received Exclusionary Medication|0|||
144573434|NCT01441635|521298917|FG004|Overall Study|Received Exclusionary Medication|0|||
144573435|NCT01441635|521298918|FG005|Overall Study|Received Exclusionary Medication|0|||
144573436|NCT01441635|521298919|FG006|Overall Study|Received Exclusionary Medication|0|||
144573437|NCT01441635|521298920|FG007|Overall Study|Received Exclusionary Medication|0|||
144573438|NCT01441635|521298921|FG008|Overall Study|Received Exclusionary Medication|0|||
144573439|NCT01441635|521298922|FG009|Overall Study|Received Exclusionary Medication|0|||
144573440|NCT01441635|521298913|FG000|Overall Study|Other|0|||
144573441|NCT01441635|521298914|FG001|Overall Study|Other|0|||
144573442|NCT01441635|521298915|FG002|Overall Study|Other|0|||
144573443|NCT01441635|521298916|FG003|Overall Study|Other|0|||
144573444|NCT01441635|521298917|FG004|Overall Study|Other|0|||
144573445|NCT01441635|521298918|FG005|Overall Study|Other|0|||
144573446|NCT01441635|521298919|FG006|Overall Study|Other|0|||
144573447|NCT01441635|521298920|FG007|Overall Study|Other|1|||
144573448|NCT01441635|521298921|FG008|Overall Study|Other|0|||
144573449|NCT01441635|521298922|FG009|Overall Study|Other|0|||
144573450|NCT01825577|521298923|FG000|Overall Study|Physician Decision|2|||
144573451|NCT01825577|521298923|FG000|Overall Study|Withdrawal by Subject|1|||
144573452|NCT01825577|521298923|FG000|Overall Study|Withdrawn by family members|2|||
144573453|NCT01825577|521298923|FG000|Overall Study|Lack of Efficacy|3|||
144573454|NCT00358644|521298924|FG000|Overall Study|Progressive Disease|21|||
144573455|NCT00358644|521298924|FG000|Overall Study|Adverse Event|7|||
144573456|NCT00358644|521298924|FG000|Overall Study|Death|11|||
144573457|NCT00358644|521298924|FG000|Overall Study|Withdrawal by Subject|4|||
144573458|NCT00358644|521298924|FG000|Overall Study|Physician Decision|6|||
144573459|NCT00358644|521298924|FG000|Overall Study|Patient not eligible for study|1|||
144573460|NCT00513708|521298925|FG000|Overall Study|Lost to Follow-up|4|||
144573461|NCT00513708|521298926|FG001|Overall Study|Lost to Follow-up|4|||
144573462|NCT00513708|521298927|FG002|Overall Study|Lost to Follow-up|4|||
144573463|NCT00368875|521298928|FG000|Overall Study|Adverse Event|0|||
144573464|NCT00368875|521298929|FG001|Overall Study|Adverse Event|12|||
144573465|NCT00368875|521298928|FG000|Overall Study|Progressive disease|3|||
144573466|NCT00368875|521298929|FG001|Overall Study|Progressive disease|27|||
144573467|NCT00368875|521298928|FG000|Overall Study|Withdrawal by Subject|2|||
144573468|NCT00368875|521298929|FG001|Overall Study|Withdrawal by Subject|6|||
144573469|NCT00368875|521298928|FG000|Overall Study|Other Reason|0|||
144573470|NCT00368875|521298929|FG001|Overall Study|Other Reason|2|||
144573471|NCT00368875|521298928|FG000|Overall Study|Alternative Therapy|1|||
144573472|NCT00368875|521298929|FG001|Overall Study|Alternative Therapy|1|||
144573473|NCT03327831|521298930|FG000|Overall Study|Lost to Follow-up|2|||
144573474|NCT01564277|521298931|FG000|Overall Study|Protocol Violation|0|||
144573475|NCT01564277|521298932|FG001|Overall Study|Protocol Violation|1|||
144573476|NCT01564277|521298931|FG000|Overall Study|Physician Decision|1|||
144573477|NCT01564277|521298932|FG001|Overall Study|Physician Decision|0|||
144573478|NCT02595372|521298933|FG000|Overall Study|Adverse Event|6|||
144573479|NCT02595372|521298933|FG000|Overall Study|Physician Decision|2|||
144573480|NCT02595372|521298933|FG000|Overall Study|Disease Progression|1|||
144573481|NCT05992922|521298940|FG000|Overall Study|Adverse Event|6|||
144573482|NCT05992922|521298941|FG001|Overall Study|Adverse Event|0|||
144573483|NCT05992922|521298940|FG000|Overall Study|Sponsor Termination of Study|14|||
144573484|NCT05992922|521298941|FG001|Overall Study|Sponsor Termination of Study|20|||
144573485|NCT02473965|521300296|FG000|Overall Study|Adverse Event|6|||
144573486|NCT02473965|521300297|FG001|Overall Study|Adverse Event|4|||
144573487|NCT02473965|521300296|FG000|Overall Study|MG worsening|4|||
144573488|NCT02473965|521300297|FG001|Overall Study|MG worsening|1|||
144573489|NCT02473965|521300296|FG000|Overall Study|Withdrawal by Subject|2|||
144573490|NCT02473965|521300297|FG001|Overall Study|Withdrawal by Subject|3|||
144573491|NCT02473965|521300296|FG000|Overall Study|Physician Decision|0|||
144573492|NCT02473965|521300297|FG001|Overall Study|Physician Decision|2|||
144573493|NCT01183390|521300298|FG000|First Intervention|Adverse Event|0|||
144573494|NCT01183390|521300299|FG001|First Intervention|Adverse Event|1|||
144573495|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Adverse Event|2|||
144573496|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Adverse Event|0|||
144573497|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Adverse Event|0|||
144573498|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Adverse Event|0|||
144573499|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
144573500|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
144573501|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
144573502|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
144573503|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
144573504|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
144573505|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
144621457|NCT05103332|521472246|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
144621458|NCT05103332|521472247|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
144621459|NCT05103332|521472248|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
144621460|NCT05103332|521472249|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621461|NCT05103332|521472250|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621462|NCT05103332|521472251|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144573506|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
144621463|NCT05103332|521472252|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621464|NCT05103332|521472253|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144621465|NCT05103332|521472254|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
144573507|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Physician Decision|1|||
144573508|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Physician Decision|0|||
144573509|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Physician Decision|0|||
144573510|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Physician Decision|0|||
144573511|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Pregnancy|1|||
144573512|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Pregnancy|0|||
144573513|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Pregnancy|0|||
144573514|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Pregnancy|0|||
144573515|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
144729827|NCT01044732|521866178|FG000|Overall Study|Withdrawal by Subject|0|||
144573516|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
144573517|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
144573518|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
144573519|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
144573520|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
144573521|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
144573522|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
144573523|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
144573524|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
144573525|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
144573526|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
144573527|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
144573528|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
144573529|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
144573530|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
144573531|NCT04057573|521300300|FG000|24-Week Double-Blind Period|Not Treated|1|||
144573532|NCT04057573|521300301|FG001|24-Week Double-Blind Period|Not Treated|0|||
144573533|NCT04057573|521300302|FG002|24-Week Double-Blind Period|Not Treated|0|||
144573534|NCT04057573|521300303|FG003|24-Week Double-Blind Period|Not Treated|0|||
144573535|NCT04057573|521300300|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
144573536|NCT04057573|521300301|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
144573537|NCT04057573|521300302|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
144573538|NCT04057573|521300303|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
144573539|NCT04057573|521300300|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
144573540|NCT04057573|521300301|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
144729828|NCT01044732|521866179|FG001|Overall Study|Withdrawal by Subject|1|||
144573541|NCT04057573|521300302|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
144573542|NCT04057573|521300303|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
144573543|NCT04057573|521300300|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
144573544|NCT04057573|521300301|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
144573545|NCT04057573|521300302|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
144573546|NCT04057573|521300303|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
144573547|NCT04057573|521300300|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
144573548|NCT04057573|521300301|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
144573549|NCT04057573|521300302|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
144573550|NCT04057573|521300303|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
144573551|NCT04057573|521300300|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
144573552|NCT04057573|521300301|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
144573553|NCT04057573|521300302|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
144573554|NCT04057573|521300303|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
144573555|NCT03299049|521300310|FG000|Overall Study|On-going|486|||
144573556|NCT03299049|521300311|FG001|Overall Study|On-going|481|||
144573557|NCT03299049|521300310|FG000|Overall Study|Withdrawal by Subject|6|||
144573558|NCT03299049|521300311|FG001|Overall Study|Withdrawal by Subject|21|||
144573559|NCT03299049|521300310|FG000|Overall Study|Physician Decision|5|||
144573560|NCT03299049|521300311|FG001|Overall Study|Physician Decision|1|||
144573561|NCT03299049|521300310|FG000|Overall Study|Lost to Follow-up|2|||
144573562|NCT03299049|521300311|FG001|Overall Study|Lost to Follow-up|0|||
144573563|NCT03299049|521300310|FG000|Overall Study|Pregnancy|1|||
144573564|NCT03299049|521300311|FG001|Overall Study|Pregnancy|3|||
144573565|NCT03299049|521300310|FG000|Overall Study|Protocol Violation|1|||
144573566|NCT03299049|521300311|FG001|Overall Study|Protocol Violation|1|||
144573567|NCT03299049|521300310|FG000|Overall Study|Lack of Efficacy|9|||
144573568|NCT03299049|521300311|FG001|Overall Study|Lack of Efficacy|3|||
144573569|NCT03299049|521300310|FG000|Overall Study|Adverse Event|12|||
144573570|NCT03299049|521300311|FG001|Overall Study|Adverse Event|13|||
144573571|NCT00475644|521300313|FG000|Overall Study|Protocol Violation|13|||
144573572|NCT01411241|521300314|FG000|Overall Study|Protocol Violation|0|||
144573573|NCT01411241|521300315|FG001|Overall Study|Protocol Violation|5|||
144573574|NCT01411241|521300314|FG000|Overall Study|Withdrawal by Subject|9|||
144573575|NCT01411241|521300315|FG001|Overall Study|Withdrawal by Subject|10|||
144573576|NCT01411241|521300314|FG000|Overall Study|Serious Adverse Event|0|||
144573577|NCT01411241|521300315|FG001|Overall Study|Serious Adverse Event|3|||
144573578|NCT01411241|521300314|FG000|Overall Study|Lost to Follow-up|2|||
144573579|NCT01411241|521300315|FG001|Overall Study|Lost to Follow-up|4|||
144573580|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
144573581|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
144262846|NCT01325350|520163767|FG000|Overall Study|Pregnancy|0|||
144573582|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
144573583|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
144573584|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
144573585|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
144573586|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
144573587|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
144573588|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
144573589|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
144573590|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
144573591|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
144573592|NCT00790400|521300322|FG000|Double-blind Period (Core Phase)|Death|1|||
144573593|NCT00790400|521300323|FG001|Double-blind Period (Core Phase)|Death|0|||
144573594|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
144573595|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
144573596|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
144573597|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
144573598|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
144573599|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
144573600|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
144573601|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
144573602|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
144573603|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
144573604|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Death|1|||
144573605|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Death|0|||
144573606|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
144573607|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
144573608|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
144573609|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
144573610|NCT00790400|521300322|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
144573611|NCT00790400|521300323|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
144573612|NCT00078338|521300325|FG000|Overall Study|Adverse Event|31|||
144573613|NCT00078338|521300326|FG001|Overall Study|Adverse Event|24|||
144573614|NCT00078338|521300325|FG000|Overall Study|Lost to Follow-up|17|||
144573615|NCT00078338|521300326|FG001|Overall Study|Lost to Follow-up|2|||
144573616|NCT00078338|521300325|FG000|Overall Study|Protocol Violation|2|||
144573617|NCT00078338|521300326|FG001|Overall Study|Protocol Violation|2|||
144573618|NCT00078338|521300325|FG000|Overall Study|Disease Progression|4|||
144573619|NCT00078338|521300326|FG001|Overall Study|Disease Progression|7|||
144573620|NCT00078338|521300325|FG000|Overall Study|Other|28|||
144573621|NCT00078338|521300326|FG001|Overall Study|Other|16|||
144573622|NCT00078338|521300325|FG000|Overall Study|Subjects randomized, but not treated|3|||
144573623|NCT00078338|521300326|FG001|Overall Study|Subjects randomized, but not treated|3|||
144573624|NCT02460575|521300327|FG000|Overall Study|Lost to Follow-up|1|||
144573625|NCT02460575|521300328|FG001|Overall Study|Lost to Follow-up|0|||
144573626|NCT04307940|521300329|FG000|Overall Study|Adverse Event|1|||
144573627|NCT04307940|521300330|FG001|Overall Study|Adverse Event|0|||
144573628|NCT04307940|521300331|FG002|Overall Study|Adverse Event|0|||
144262847|NCT01325350|520163768|FG001|Overall Study|Pregnancy|0|||
144262848|NCT01325350|520163769|FG002|Overall Study|Pregnancy|1|||
144262849|NCT01325350|520163770|FG003|Overall Study|Pregnancy|0|||
144573629|NCT04307940|521300329|FG000|Overall Study|Withdrawal by Subject|2|||
144573630|NCT04307940|521300330|FG001|Overall Study|Withdrawal by Subject|3|||
144573631|NCT04307940|521300331|FG002|Overall Study|Withdrawal by Subject|1|||
144573632|NCT04307940|521300329|FG000|Overall Study|Lost to Follow-up|2|||
144573633|NCT04307940|521300330|FG001|Overall Study|Lost to Follow-up|0|||
144573634|NCT04307940|521300331|FG002|Overall Study|Lost to Follow-up|1|||
144573635|NCT02521363|521300332|FG000|Overall Study|Withdrawal by Subject|1|||
144573636|NCT02521363|521300333|FG001|Overall Study|Withdrawal by Subject|2|||
144573637|NCT05543174|521300334|FG000|Overall Study|Ongoing|7|||
144573638|NCT03104075|521300337|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
144573639|NCT03104075|521300338|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
144573640|NCT04024462|521300339|FG000|Overall Study|Withdrawal by Subject|6|||
144573641|NCT04024462|521300340|FG001|Overall Study|Withdrawal by Subject|7|||
144573642|NCT04024462|521300339|FG000|Overall Study|Progressive Disease|0|||
144573643|NCT04024462|521300340|FG001|Overall Study|Progressive Disease|1|||
144573644|NCT04024462|521300339|FG000|Overall Study|Adverse Event|0|||
144573645|NCT04024462|521300340|FG001|Overall Study|Adverse Event|1|||
144573646|NCT04024462|521300339|FG000|Overall Study|Death|0|||
144573647|NCT04024462|521300340|FG001|Overall Study|Death|1|||
144573648|NCT04024462|521300339|FG000|Overall Study|Lost to Follow-up|1|||
144573649|NCT04024462|521300340|FG001|Overall Study|Lost to Follow-up|0|||
144573650|NCT04024462|521300339|FG000|Overall Study|Ongoing in the Study|94|||
144573651|NCT04024462|521300340|FG001|Overall Study|Ongoing in the Study|89|||
144573652|NCT04896008|521300341|FG000|Overall Study|Ongoing|70|||
144573653|NCT04896008|521300342|FG001|Overall Study|Ongoing|38|||
144573654|NCT04896008|521300341|FG000|Overall Study|Adverse Event|0|||
144573655|NCT04896008|521300342|FG001|Overall Study|Adverse Event|2|||
144573656|NCT04896008|521300341|FG000|Overall Study|Death|5|||
144573657|NCT04896008|521300342|FG001|Overall Study|Death|10|||
144573658|NCT04896008|521300341|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
144573659|NCT04896008|521300342|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
144573660|NCT04896008|521300341|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
144573661|NCT04896008|521300342|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
144573662|NCT04896008|521300341|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
144573663|NCT04896008|521300342|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
144573664|NCT04896008|521300341|FG000|Overall Study|Withdrawal by Subject|1|||
144573665|NCT04896008|521300342|FG001|Overall Study|Withdrawal by Subject|4|||
144573666|NCT04896008|521300341|FG000|Overall Study|Investigator Decision|2|||
144573667|NCT04896008|521300342|FG001|Overall Study|Investigator Decision|0|||
144573668|NCT04896008|521300341|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
144573669|NCT04896008|521300342|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
144573670|NCT01270828|521300347|FG000|Pregabalin CR SB|Reason Unspecified|0|||
144573671|NCT01270828|521300348|FG001|Pregabalin CR SB|Reason Unspecified|0|||
144573672|NCT01270828|521300349|FG002|Pregabalin CR SB|Reason Unspecified|8|||
144573673|NCT01270828|521300347|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
144573674|NCT01270828|521300348|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
144573675|NCT01270828|521300349|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
144573676|NCT01270828|521300347|FG000|Pregabalin CR SB|Related adverse event|0|||
144573677|NCT01270828|521300348|FG001|Pregabalin CR SB|Related adverse event|0|||
144573678|NCT01270828|521300349|FG002|Pregabalin CR SB|Related adverse event|46|||
144573679|NCT01270828|521300347|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
144573680|NCT01270828|521300348|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
144573681|NCT01270828|521300349|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
144573682|NCT01270828|521300347|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
144573683|NCT01270828|521300348|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
144573684|NCT01270828|521300349|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
144573685|NCT01270828|521300347|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
144573686|NCT01270828|521300348|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
144573687|NCT01270828|521300349|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
144573688|NCT01270828|521300347|FG000|Pregabalin CR SB|Unrelated AE|0|||
144573689|NCT01270828|521300348|FG001|Pregabalin CR SB|Unrelated AE|0|||
144573690|NCT01270828|521300349|FG002|Pregabalin CR SB|Unrelated AE|8|||
144573691|NCT01270828|521300347|FG000|Pregabalin CR SB|Protocol Violation|0|||
144573692|NCT01270828|521300348|FG001|Pregabalin CR SB|Protocol Violation|0|||
144573693|NCT01270828|521300349|FG002|Pregabalin CR SB|Protocol Violation|8|||
144573694|NCT01270828|521300347|FG000|Double Blind Phase|Death|0|||
144573695|NCT01270828|521300348|FG001|Double Blind Phase|Death|1|||
144573696|NCT01270828|521300349|FG002|Double Blind Phase|Death|0|||
144573697|NCT01270828|521300347|FG000|Double Blind Phase|Protocol Violation|0|||
144573698|NCT01270828|521300348|FG001|Double Blind Phase|Protocol Violation|1|||
144573699|NCT01270828|521300349|FG002|Double Blind Phase|Protocol Violation|0|||
144573700|NCT01270828|521300347|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
144573701|NCT01270828|521300348|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
144573702|NCT01270828|521300349|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
144573703|NCT01270828|521300347|FG000|Double Blind Phase|Reason Unspecified|7|||
144573704|NCT01270828|521300348|FG001|Double Blind Phase|Reason Unspecified|4|||
144573705|NCT01270828|521300349|FG002|Double Blind Phase|Reason Unspecified|0|||
144573706|NCT01270828|521300347|FG000|Double Blind Phase|Withdrawal by Subject|6|||
144573707|NCT01270828|521300348|FG001|Double Blind Phase|Withdrawal by Subject|15|||
144573708|NCT01270828|521300349|FG002|Double Blind Phase|Withdrawal by Subject|0|||
144573709|NCT01270828|521300347|FG000|Double Blind Phase|Lost to Follow-up|1|||
144573710|NCT01270828|521300348|FG001|Double Blind Phase|Lost to Follow-up|2|||
144573711|NCT01270828|521300349|FG002|Double Blind Phase|Lost to Follow-up|0|||
144573712|NCT01270828|521300347|FG000|Double Blind Phase|Lack of Efficacy|2|||
144573713|NCT01270828|521300348|FG001|Double Blind Phase|Lack of Efficacy|11|||
144573714|NCT01270828|521300349|FG002|Double Blind Phase|Lack of Efficacy|0|||
144573715|NCT01270828|521300347|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
144573716|NCT01270828|521300348|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
144262850|NCT01325350|520163771|FG004|Overall Study|Pregnancy|1|||
144573717|NCT01270828|521300349|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
144573718|NCT01270828|521300347|FG000|Double Blind Phase|Adverse event related to study drug|5|||
144573719|NCT01270828|521300348|FG001|Double Blind Phase|Adverse event related to study drug|7|||
144573720|NCT01270828|521300349|FG002|Double Blind Phase|Adverse event related to study drug|0|||
144573721|NCT01810939|521300350|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
144573722|NCT01810939|521300351|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
144573723|NCT01810939|521300352|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
144573724|NCT01810939|521300350|FG000|Part A Treatment Period|Protocol Violation|2|||
144573725|NCT01810939|521300351|FG001|Part A Treatment Period|Protocol Violation|0|||
144573726|NCT01810939|521300352|FG002|Part A Treatment Period|Protocol Violation|0|||
144573727|NCT01810939|521300350|FG000|Part A Treatment Period|Adverse Event|10|||
144573728|NCT01810939|521300351|FG001|Part A Treatment Period|Adverse Event|0|||
144573729|NCT01810939|521300352|FG002|Part A Treatment Period|Adverse Event|0|||
144573730|NCT01810939|521300350|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
144573731|NCT01810939|521300351|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
144573732|NCT01810939|521300352|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
144621466|NCT05103332|521472237|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621467|NCT05103332|521472238|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621468|NCT05103332|521472239|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621469|NCT05103332|521472240|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621470|NCT05103332|521472241|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621471|NCT05103332|521472242|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621472|NCT05103332|521472243|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621473|NCT05103332|521472244|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621474|NCT05103332|521472245|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621475|NCT05103332|521472246|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144573733|NCT01810939|521300350|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
144573734|NCT01810939|521300351|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
144573735|NCT01810939|521300352|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
144573736|NCT01810939|521300350|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
144573737|NCT01810939|521300351|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
144573738|NCT01810939|521300352|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
144573739|NCT01810939|521300350|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
144573740|NCT01810939|521300351|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
144573741|NCT01810939|521300352|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
144573742|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
144573743|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
144573744|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
144573745|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
144729829|NCT01044732|521866178|FG000|Overall Study|Inadequate bowel preparation|11|||
144729830|NCT01044732|521866179|FG001|Overall Study|Inadequate bowel preparation|17|||
144729831|NCT01044732|521866178|FG000|Overall Study|Inability to reach cecum|5|||
144729832|NCT01044732|521866179|FG001|Overall Study|Inability to reach cecum|2|||
144729833|NCT01044732|521866178|FG000|Overall Study|Technical error or malfunction|15|||
144573746|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
144573747|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
144573748|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
144573749|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
144573750|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
144573751|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
144573752|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
144573753|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
144573754|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
144573755|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
144573756|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
144573757|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
144573758|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
144573759|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
144573760|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
144573761|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
144573762|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
144573763|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
144573764|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
144573765|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
144573766|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
144621476|NCT05103332|521472247|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621477|NCT05103332|521472248|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
144621478|NCT05103332|521472249|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
144573767|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
144621479|NCT05103332|521472250|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
144621480|NCT05103332|521472251|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
144621481|NCT05103332|521472252|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
144729834|NCT01044732|521866179|FG001|Overall Study|Technical error or malfunction|14|||
144573768|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
144573769|NCT01810939|521300350|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
144573770|NCT01810939|521300351|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
144573771|NCT01810939|521300352|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
144573772|NCT00709228|521300353|FG000|Overall Study|Not treated|14|||
144573773|NCT00709228|521300353|FG000|Overall Study|Eligibility criteria not met|281|||
144573774|NCT00709228|521300353|FG000|Overall Study|Adverse events|2|||
144573775|NCT00709228|521300353|FG000|Overall Study|Discontinued treatment|14|||
144573776|NCT00709228|521300353|FG000|Overall Study|Did not enter follow-up|4|||
144573777|NCT00709228|521300353|FG000|Overall Study|Discontinued follow-up|5|||
144573778|NCT00709228|521300353|FG000|Overall Study|Disease progression|1|||
144573779|NCT00709228|521300353|FG000|Overall Study|Lost to Follow-up|6|||
144573780|NCT00709228|521300353|FG000|Overall Study|Non-compliance|5|||
144573781|NCT01594827|521300355|FG000|Overall Study|Adverse Event|1|||
144573782|NCT01594827|521300356|FG001|Overall Study|Adverse Event|0|||
144573783|NCT01594827|521300355|FG000|Overall Study|Physician Decision|3|||
144573784|NCT01594827|521300356|FG001|Overall Study|Physician Decision|0|||
144573785|NCT00609947|521300358|FG000|Overall Study|Death|1|||
144573786|NCT04148651|521300362|FG000|Overall Study|Lost to Follow-up|2|||
144573787|NCT03690427|521300365|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
144573788|NCT03690427|521300366|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
144573789|NCT01721954|521300372|FG000|Overall Study|Death|58|||
144573790|NCT01721954|521300373|FG001|Overall Study|Death|64|||
144573791|NCT01721954|521300372|FG000|Overall Study|Withdrawal by Subject|8|||
144573792|NCT01721954|521300373|FG001|Overall Study|Withdrawal by Subject|4|||
144573793|NCT01721954|521300372|FG000|Overall Study|Adverse Event|2|||
144573794|NCT01721954|521300373|FG001|Overall Study|Adverse Event|0|||
144573795|NCT01721954|521300372|FG000|Overall Study|Lost to Follow-up|2|||
144573796|NCT01721954|521300373|FG001|Overall Study|Lost to Follow-up|1|||
144573797|NCT03519204|521300374|FG000|Overall Study|Lost to Follow-up|3|||
144573798|NCT03519204|521300375|FG001|Overall Study|Lost to Follow-up|8|||
144729835|NCT03991494|521866186|FG000|Overall Study|Progressive Disease|4|||
144729836|NCT02507375|521866197|FG000|Overall Study|Progressive Disease|4|||
144729837|NCT02507375|521866198|FG001|Overall Study|Progressive Disease|5|||
144573799|NCT03519204|521300374|FG000|Overall Study|Withdrawal by Subject|9|||
144573800|NCT03519204|521300375|FG001|Overall Study|Withdrawal by Subject|7|||
144573801|NCT03519204|521300374|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144573802|NCT03519204|521300375|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144573803|NCT02609672|521300376|FG000|Overall Study|Lost to Follow-up|3|||
144573804|NCT02609672|521300377|FG001|Overall Study|Lost to Follow-up|1|||
144573805|NCT02956837|521300379|FG000|Overall Study|Serious Adverse Events|0|||
144573806|NCT02956837|521300380|FG001|Overall Study|Serious Adverse Events|1|||
144573807|NCT02956837|521300381|FG002|Overall Study|Serious Adverse Events|0|||
144573808|NCT02956837|521300382|FG003|Overall Study|Serious Adverse Events|0|||
144573809|NCT02956837|521300379|FG000|Overall Study|Withdrawal by Subject|0|||
144573810|NCT02956837|521300380|FG001|Overall Study|Withdrawal by Subject|1|||
144573811|NCT02956837|521300381|FG002|Overall Study|Withdrawal by Subject|0|||
144573812|NCT02956837|521300382|FG003|Overall Study|Withdrawal by Subject|3|||
144573813|NCT02956837|521300379|FG000|Overall Study|Lost to Follow-up|0|||
144573814|NCT02956837|521300380|FG001|Overall Study|Lost to Follow-up|1|||
144573815|NCT02956837|521300381|FG002|Overall Study|Lost to Follow-up|2|||
144573816|NCT02956837|521300382|FG003|Overall Study|Lost to Follow-up|0|||
144729838|NCT02507375|521866197|FG000|Overall Study|Death|0|||
144573817|NCT02637323|521300387|FG000|Overall Study|Lost to Follow-up|2|||
144573818|NCT02637323|521300388|FG001|Overall Study|Lost to Follow-up|0|||
144573819|NCT02637323|521300387|FG000|Overall Study|Protocol Violation|0|||
144573820|NCT02637323|521300388|FG001|Overall Study|Protocol Violation|1|||
144573821|NCT00401258|521300389|FG000|Overall Study|Adverse Event|7|||
144573822|NCT01305239|521300391|FG000|Overall Study|Adverse Event|22|||
144573823|NCT01305239|521300391|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
144573824|NCT01245374|521300396|FG000|Overall Study|Protocol Violation|1|||
144573825|NCT01245374|521300396|FG000|Overall Study|Withdrawal by Subject|3|||
144573826|NCT01782690|521300398|FG000|Overall Study|Not reported|7|||
144573827|NCT01782690|521300398|FG000|Overall Study|Toxicity of gemcitabine|1|||
144573828|NCT01782690|521300398|FG000|Overall Study|Toxicity of erlotinib|1|||
144729839|NCT02507375|521866198|FG001|Overall Study|Death|1|||
144573829|NCT01782690|521300398|FG000|Overall Study|Lost to Follow-up|31|||
144573830|NCT01782690|521300398|FG000|Overall Study|Withdrawal of informed consent|2|||
144573831|NCT01782690|521300398|FG000|Overall Study|Absent rash|9|||
144573832|NCT01782690|521300398|FG000|Overall Study|Physician Decision|13|||
144573833|NCT01782690|521300398|FG000|Overall Study|Patient's wish|21|||
144573834|NCT01782690|521300398|FG000|Overall Study|Tumor progression|74|||
144573835|NCT01782690|521300398|FG000|Overall Study|Death|133|||
144573836|NCT01782690|521300398|FG000|Overall Study|Study completion unknown|7|||
144573837|NCT04199052|521300401|FG000|Overall Study|Lost to Follow-up|11|||
144573838|NCT04199052|521300402|FG001|Overall Study|Lost to Follow-up|18|||
144262851|NCT01325350|520163767|FG000|Overall Study|Lost to Follow-up|1|||
144729840|NCT02507375|521866197|FG000|Overall Study|Refused treatment|0|||
144573839|NCT01948076|521300403|FG000|Overall Study|Withdrawal by Subject|0|||
144573840|NCT01948076|521300404|FG001|Overall Study|Withdrawal by Subject|1|||
144573841|NCT01151423|521300405|FG000|Overall Study|Study terminated by Sponsor|9|||
144573842|NCT01151423|521300406|FG001|Overall Study|Study terminated by Sponsor|10|||
144573843|NCT01151423|521300405|FG000|Overall Study|Protocol Violation|0|||
144573844|NCT01151423|521300406|FG001|Overall Study|Protocol Violation|1|||
144573845|NCT01151423|521300405|FG000|Overall Study|Physician Decision|1|||
144573846|NCT01151423|521300406|FG001|Overall Study|Physician Decision|1|||
144573847|NCT01151423|521300405|FG000|Overall Study|Pregnancy|0|||
144573848|NCT01151423|521300406|FG001|Overall Study|Pregnancy|1|||
144573849|NCT01151423|521300405|FG000|Overall Study|Death|0|||
144573850|NCT01151423|521300406|FG001|Overall Study|Death|1|||
144573851|NCT01151423|521300405|FG000|Overall Study|Adverse Event|3|||
144573852|NCT01151423|521300406|FG001|Overall Study|Adverse Event|0|||
144573853|NCT01151423|521300405|FG000|Overall Study|Withdrawal by Subject|1|||
144573854|NCT01151423|521300406|FG001|Overall Study|Withdrawal by Subject|3|||
144573855|NCT01151423|521300405|FG000|Overall Study|Lost to Follow-up|1|||
144573856|NCT01151423|521300406|FG001|Overall Study|Lost to Follow-up|0|||
144573857|NCT01151423|521300405|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
144573858|NCT01151423|521300406|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
144573859|NCT01151423|521300405|FG000|Overall Study|Participated in other clinical trial|1|||
144573860|NCT01151423|521300406|FG001|Overall Study|Participated in other clinical trial|0|||
144573861|NCT00681668|521300407|FG000|Overall Study|Protocol Violation|1|||
144573862|NCT00681668|521300407|FG000|Overall Study|Withdrawal by Subject|1|||
144573863|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
144573864|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
144573865|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
144573866|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
144573867|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Death|13|||
144573868|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Death|12|||
144573869|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Progression|257|||
144573870|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Progression|218|||
144573871|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
144573872|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
144573873|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
144573874|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
144573875|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
144573876|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
144573877|NCT01006980|521302667|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
144573878|NCT01006980|521302668|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
144573879|NCT01006980|521302667|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
144573880|NCT01006980|521302668|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
144573881|NCT01006980|521302667|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
144573882|NCT01006980|521302668|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
144207306|NCT01056289|519954279|FG000|Double-blind Phase|Discontinuation symptom|0|||
144207307|NCT01056289|519954280|FG001|Double-blind Phase|Discontinuation symptom|1|||
144207308|NCT01056289|519954281|FG002|Double-blind Phase|Discontinuation symptom|2|||
144207309|NCT01056289|519954282|FG003|Double-blind Phase|Discontinuation symptom|2|||
144207310|NCT01056289|519954279|FG000|Double-blind Phase|Physician Decision|0|||
144207311|NCT01056289|519954280|FG001|Double-blind Phase|Physician Decision|0|||
144207312|NCT01056289|519954281|FG002|Double-blind Phase|Physician Decision|1|||
144207313|NCT01056289|519954282|FG003|Double-blind Phase|Physician Decision|0|||
144207314|NCT02856555|519954283|FG000|Overall Study|Adverse Event|1|||
144207315|NCT02856555|519954284|FG001|Overall Study|Adverse Event|0|||
144573883|NCT01006980|521302667|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
144573884|NCT01006980|521302668|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
144573885|NCT01006980|521302667|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
144573886|NCT01006980|521302668|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
144573887|NCT01006980|521302667|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
144573888|NCT01006980|521302668|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
144573889|NCT02963090|521302671|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
144573890|NCT02963090|521302672|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
144573891|NCT02870972|521302676|FG000|Overall Study|Adverse Event|1|||
144573892|NCT02870972|521302677|FG001|Overall Study|Adverse Event|0|||
144621482|NCT05103332|521472253|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
144621483|NCT05103332|521472254|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
144207316|NCT02856555|519954285|FG002|Overall Study|Adverse Event|0|||
144573893|NCT02870972|521302678|FG002|Overall Study|Adverse Event|0|||
144573894|NCT02870972|521302679|FG003|Overall Study|Adverse Event|0|||
144573895|NCT02870972|521302680|FG004|Overall Study|Adverse Event|0|||
144573896|NCT03559062|521302681|FG000|Overall Study|Other|0|||
144207317|NCT02856555|519954283|FG000|Overall Study|Lost to Follow-up|1|||
144207318|NCT02856555|519954284|FG001|Overall Study|Lost to Follow-up|3|||
144729841|NCT02507375|521866198|FG001|Overall Study|Refused treatment|1|||
144207319|NCT02856555|519954285|FG002|Overall Study|Lost to Follow-up|0|||
144207320|NCT02856555|519954283|FG000|Overall Study|Withdrawal by Subject|3|||
144207321|NCT02856555|519954284|FG001|Overall Study|Withdrawal by Subject|0|||
144207322|NCT02856555|519954285|FG002|Overall Study|Withdrawal by Subject|0|||
144207323|NCT02856555|519954283|FG000|Overall Study|Randomized but Never Treated|0|||
144207324|NCT02856555|519954284|FG001|Overall Study|Randomized but Never Treated|1|||
144207325|NCT02856555|519954285|FG002|Overall Study|Randomized but Never Treated|0|||
144207326|NCT01564537|519954289|FG000|Overall Study|Site Terminated by Sponsor|1|||
144207327|NCT01564537|519954290|FG001|Overall Study|Site Terminated by Sponsor|0|||
144207328|NCT01564537|519954289|FG000|Overall Study|Withdrawal by Subject|12|||
144207329|NCT01564537|519954290|FG001|Overall Study|Withdrawal by Subject|14|||
144207330|NCT01564537|519954289|FG000|Overall Study|Lost to Follow-up|7|||
144207331|NCT01564537|519954290|FG001|Overall Study|Lost to Follow-up|3|||
144207332|NCT01564537|519954289|FG000|Overall Study|Reason not specified|81|||
144207333|NCT01564537|519954290|FG001|Overall Study|Reason not specified|82|||
144207334|NCT02448706|519954291|FG000|Overall Study|Withdrawal by Subject|4|||
144207335|NCT02448706|519954292|FG001|Overall Study|Withdrawal by Subject|3|||
144207336|NCT02448706|519954291|FG000|Overall Study|Protocol Violation|1|||
144573897|NCT03559062|521302682|FG001|Overall Study|Other|1|||
144573898|NCT03559062|521302683|FG002|Overall Study|Other|0|||
144573899|NCT03054337|521302686|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
144573900|NCT03054337|521302687|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
144573901|NCT03054337|521302688|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
144573902|NCT03054337|521302689|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
144573903|NCT03054337|521302690|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
144573904|NCT03054337|521302691|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
144573905|NCT01967069|521302693|FG000|Overall Study|Adverse Event|2|||
144573906|NCT01967069|521302694|FG001|Overall Study|Adverse Event|2|||
144573907|NCT01967069|521302693|FG000|Overall Study|Lost to Follow-up|5|||
144573908|NCT01967069|521302694|FG001|Overall Study|Lost to Follow-up|2|||
144573909|NCT01967069|521302693|FG000|Overall Study|Withdrawal by Subject|1|||
144573910|NCT01967069|521302694|FG001|Overall Study|Withdrawal by Subject|3|||
144573911|NCT01967069|521302693|FG000|Overall Study|Lack of Efficacy|0|||
144573912|NCT01967069|521302694|FG001|Overall Study|Lack of Efficacy|1|||
144573913|NCT00874731|521302696|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
144573914|NCT00874731|521302697|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
144573915|NCT00874731|521302698|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
144573916|NCT00874731|521302696|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
144573917|NCT00874731|521302697|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
144573918|NCT00874731|521302698|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
144573919|NCT00874731|521302696|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
144573920|NCT00874731|521302697|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
144573921|NCT00874731|521302698|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
144573922|NCT01016262|521302699|FG000|Double-blind Phase|Adverse Event|0|||
144573923|NCT01016262|521302700|FG001|Double-blind Phase|Adverse Event|0|||
144573924|NCT01016262|521302701|FG002|Double-blind Phase|Adverse Event|1|||
144573925|NCT01016262|521302702|FG003|Double-blind Phase|Adverse Event|0|||
144573926|NCT01016262|521302703|FG004|Double-blind Phase|Adverse Event|0|||
144573927|NCT01016262|521302704|FG005|Double-blind Phase|Adverse Event|0|||
144573928|NCT01016262|521302699|FG000|Double-blind Phase|Lack of Efficacy|1|||
144573929|NCT01016262|521302700|FG001|Double-blind Phase|Lack of Efficacy|0|||
144573930|NCT01016262|521302701|FG002|Double-blind Phase|Lack of Efficacy|5|||
144573931|NCT01016262|521302702|FG003|Double-blind Phase|Lack of Efficacy|0|||
144573932|NCT01016262|521302703|FG004|Double-blind Phase|Lack of Efficacy|0|||
144621484|NCT05103332|521472237|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621485|NCT05103332|521472238|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621486|NCT05103332|521472239|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621487|NCT05103332|521472240|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621488|NCT05103332|521472241|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144573933|NCT01016262|521302704|FG005|Double-blind Phase|Lack of Efficacy|0|||
144621489|NCT05103332|521472242|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144207337|NCT02448706|519954292|FG001|Overall Study|Protocol Violation|1|||
144207338|NCT02065700|519954293|FG000|Overall Study|Adverse Event|165|||
144207339|NCT02065700|519954294|FG001|Overall Study|Adverse Event|101|||
144573934|NCT01016262|521302699|FG000|Double-blind Phase|Disease Progression|0|||
144573935|NCT01016262|521302700|FG001|Double-blind Phase|Disease Progression|1|||
144573936|NCT01016262|521302701|FG002|Double-blind Phase|Disease Progression|2|||
144573937|NCT01016262|521302702|FG003|Double-blind Phase|Disease Progression|0|||
144573938|NCT01016262|521302703|FG004|Double-blind Phase|Disease Progression|0|||
144573939|NCT01016262|521302704|FG005|Double-blind Phase|Disease Progression|0|||
144573940|NCT01016262|521302699|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
144573941|NCT01016262|521302700|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
144573942|NCT01016262|521302701|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
144621490|NCT05103332|521472243|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144573943|NCT01016262|521302702|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
144573944|NCT01016262|521302703|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
144573945|NCT01016262|521302704|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
144573946|NCT01016262|521302699|FG000|Open-Label Phase|Adverse Event|0|||
144573947|NCT01016262|521302700|FG001|Open-Label Phase|Adverse Event|0|||
144573948|NCT01016262|521302701|FG002|Open-Label Phase|Adverse Event|0|||
144573949|NCT01016262|521302702|FG003|Open-Label Phase|Adverse Event|1|||
144573950|NCT01016262|521302703|FG004|Open-Label Phase|Adverse Event|0|||
144573951|NCT01016262|521302704|FG005|Open-Label Phase|Adverse Event|0|||
144573952|NCT01016262|521302699|FG000|Open-Label Phase|Lost to Follow-up|0|||
144573953|NCT01016262|521302700|FG001|Open-Label Phase|Lost to Follow-up|0|||
144573954|NCT01016262|521302701|FG002|Open-Label Phase|Lost to Follow-up|0|||
144573955|NCT01016262|521302702|FG003|Open-Label Phase|Lost to Follow-up|0|||
144573956|NCT01016262|521302703|FG004|Open-Label Phase|Lost to Follow-up|1|||
144573957|NCT01016262|521302704|FG005|Open-Label Phase|Lost to Follow-up|0|||
144573958|NCT01016262|521302699|FG000|Open-Label Phase|Lack of Efficacy|0|||
144573959|NCT01016262|521302700|FG001|Open-Label Phase|Lack of Efficacy|0|||
144573960|NCT01016262|521302701|FG002|Open-Label Phase|Lack of Efficacy|0|||
144573961|NCT01016262|521302702|FG003|Open-Label Phase|Lack of Efficacy|1|||
144573962|NCT01016262|521302703|FG004|Open-Label Phase|Lack of Efficacy|0|||
144573963|NCT01016262|521302704|FG005|Open-Label Phase|Lack of Efficacy|0|||
144573964|NCT01016262|521302699|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
144573965|NCT01016262|521302700|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
144573966|NCT01016262|521302701|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
144573967|NCT01016262|521302702|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
144573968|NCT01016262|521302703|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
144573969|NCT01016262|521302704|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
144573970|NCT01736540|521302705|FG000|Overall Study|Did not complete scan within 45 days|2|||
144573971|NCT01736540|521302705|FG000|Overall Study|Death|1|||
144573972|NCT01736540|521302705|FG000|Overall Study|Abnormal test procedure|1|||
144573973|NCT01736540|521302705|FG000|Overall Study|Withdrawal by Subject|5|||
144573974|NCT01736540|521302705|FG000|Overall Study|Protocol Violation|1|||
144573975|NCT01736540|521302705|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
144573976|NCT01736540|521302705|FG000|Overall Study|No show for MRI appointment|1|||
144573977|NCT01736540|521302705|FG000|Overall Study|Unable to make MRI appointment|3|||
144573978|NCT00581477|521302706|FG000|Overall Study|Physician Decision|2|||
144573979|NCT03106753|521302707|FG000|Overall Study|Withdrawal by Subject|0|||
144573980|NCT03106753|521302708|FG001|Overall Study|Withdrawal by Subject|1|||
144573981|NCT01643044|521302712|FG000|Overall Study|Lost to Follow-up|1|||
144573982|NCT01643044|521302713|FG001|Overall Study|Lost to Follow-up|1|||
144573983|NCT01643044|521302712|FG000|Overall Study|Miscarried baby|2|||
144573984|NCT01643044|521302713|FG001|Overall Study|Miscarried baby|2|||
144573985|NCT01643044|521302712|FG000|Overall Study|Delivered outside of hospital|1|||
144573986|NCT01643044|521302713|FG001|Overall Study|Delivered outside of hospital|2|||
144573987|NCT01031628|521302719|FG000|Overall Study|Study terminated early|0|||
144573988|NCT01031628|521302720|FG001|Overall Study|Study terminated early|1|||
144621491|NCT05103332|521472244|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621492|NCT05103332|521472245|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621493|NCT05103332|521472246|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621494|NCT05103332|521472247|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621495|NCT05103332|521472248|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621496|NCT05103332|521472249|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621497|NCT05103332|521472250|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621498|NCT05103332|521472251|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621499|NCT05103332|521472252|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621500|NCT05103332|521472253|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
144621501|NCT05103332|521472254|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
144621502|NCT05103332|521472237|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621503|NCT05103332|521472238|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621504|NCT05103332|521472239|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621505|NCT05103332|521472240|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621506|NCT05103332|521472241|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144207340|NCT02065700|519954293|FG000|Overall Study|Withdrawal by Subject|90|||
144621507|NCT05103332|521472242|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621508|NCT05103332|521472243|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144207341|NCT02065700|519954294|FG001|Overall Study|Withdrawal by Subject|29|||
144207342|NCT02065700|519954293|FG000|Overall Study|Lost to Follow-up|12|||
144207343|NCT02065700|519954294|FG001|Overall Study|Lost to Follow-up|9|||
144573989|NCT01031628|521302721|FG002|Overall Study|Study terminated early|3|||
144573990|NCT01031628|521302722|FG003|Overall Study|Study terminated early|0|||
144573991|NCT02362503|521302723|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
144573992|NCT02362503|521302724|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
144573993|NCT02362503|521302725|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
144573994|NCT02362503|521302723|FG000|Double-blind Period-Up to 8 Days|Death|1|||
144573995|NCT02362503|521302724|FG001|Double-blind Period-Up to 8 Days|Death|0|||
144573996|NCT02362503|521302725|FG002|Double-blind Period-Up to 8 Days|Death|0|||
144573997|NCT02362503|521302723|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
144573998|NCT02362503|521302724|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
144573999|NCT02362503|521302725|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
144574000|NCT02362503|521302723|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
144574001|NCT02362503|521302724|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
144574002|NCT02362503|521302725|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
144574003|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
144574004|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
144574005|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
144574006|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
144574007|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
144574008|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
144574009|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
144574010|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
144574011|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
144574012|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
144574013|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
144574014|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
144574015|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
144574016|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
144574017|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
144574018|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
144574019|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
144574020|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
144574021|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
144574022|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
144574023|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
144574024|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
144574025|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
144574026|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
144574027|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
144574028|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
144574029|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
144574030|NCT02362503|521302723|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
144574031|NCT02362503|521302724|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
144574032|NCT02362503|521302725|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
144574033|NCT02803593|521302726|FG000|Overall Study|Lost to Follow-up|17|||
144574034|NCT02803593|521302727|FG001|Overall Study|Lost to Follow-up|35|||
144574035|NCT05143138|521302728|FG000|Overall Study|Death|5|||
144574036|NCT05143138|521302729|FG001|Overall Study|Death|35|||
144574037|NCT05143138|521302730|FG002|Overall Study|Death|1|||
144574038|NCT05143138|521302728|FG000|Overall Study|Lost to Follow-up|2|||
144574039|NCT05143138|521302729|FG001|Overall Study|Lost to Follow-up|4|||
144574040|NCT05143138|521302730|FG002|Overall Study|Lost to Follow-up|0|||
144574041|NCT05143138|521302728|FG000|Overall Study|withdrawal|1|||
144574042|NCT05143138|521302729|FG001|Overall Study|withdrawal|1|||
144574043|NCT05143138|521302730|FG002|Overall Study|withdrawal|0|||
144574044|NCT04245345|521302741|FG000|Overall Study|Death|1|||
144574045|NCT04245345|521302741|FG000|Overall Study|Exited prior to implant|5|||
144574046|NCT04245345|521302741|FG000|Overall Study|Exited prior to 1-month|9|||
144574047|NCT04245345|521302741|FG000|Overall Study|Missed 1-month visit|3|||
144574048|NCT04245345|521302741|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
144621509|NCT05103332|521472244|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621510|NCT05103332|521472245|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621511|NCT05103332|521472246|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621512|NCT05103332|521472247|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144207344|NCT02065700|519954293|FG000|Overall Study|Physician Decision|2|||
144574049|NCT04245345|521302741|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
144574050|NCT01834586|521302742|FG000|Overall Study|Adverse Event|1|||
144574051|NCT03004404|521302745|FG000|Period 2|Adverse Event|0|||
144574052|NCT03004404|521302746|FG001|Period 2|Adverse Event|0|||
144574053|NCT03004404|521302747|FG002|Period 2|Adverse Event|0|||
144574054|NCT03004404|521302748|FG003|Period 2|Adverse Event|0|||
144574055|NCT03004404|521302749|FG004|Period 2|Adverse Event|0|||
144574056|NCT03004404|521302750|FG005|Period 2|Adverse Event|0|||
144574057|NCT03004404|521302751|FG006|Period 2|Adverse Event|0|||
144574058|NCT03004404|521302752|FG007|Period 2|Adverse Event|0|||
144574059|NCT03004404|521302753|FG008|Period 2|Adverse Event|1|||
144729842|NCT02507375|521866197|FG000|Overall Study|Adverse Event|0|||
144729843|NCT02507375|521866198|FG001|Overall Study|Adverse Event|1|||
144729844|NCT01387737|521868075|FG000|Overall Study|Adverse Event|20|||
144729845|NCT01387737|521868076|FG001|Overall Study|Adverse Event|30|||
144729846|NCT01387737|521868075|FG000|Overall Study|Lack of Efficacy|1|||
144729847|NCT01387737|521868076|FG001|Overall Study|Lack of Efficacy|0|||
144729848|NCT01387737|521868075|FG000|Overall Study|Physician Decision|3|||
144729849|NCT01387737|521868076|FG001|Overall Study|Physician Decision|10|||
144729850|NCT01387737|521868075|FG000|Overall Study|Withdrawal by Subject|27|||
144729851|NCT01387737|521868076|FG001|Overall Study|Withdrawal by Subject|31|||
144729852|NCT01387737|521868075|FG000|Overall Study|Clearly not eligible for the study|1|||
144729853|NCT01387737|521868076|FG001|Overall Study|Clearly not eligible for the study|3|||
144729854|NCT01248247|521868078|FG000|Overall Study|Adverse Event|2|||
144729855|NCT01248247|521868079|FG001|Overall Study|Adverse Event|4|||
144729856|NCT01248247|521868080|FG002|Overall Study|Adverse Event|4|||
144729857|NCT01248247|521868081|FG003|Overall Study|Adverse Event|2|||
144729858|NCT01248247|521868078|FG000|Overall Study|Death|0|||
144207345|NCT02065700|519954294|FG001|Overall Study|Physician Decision|0|||
144574060|NCT03004404|521302754|FG009|Period 2|Adverse Event|0|||
144574061|NCT03004404|521302755|FG010|Period 2|Adverse Event|0|||
144574062|NCT03004404|521302756|FG011|Period 2|Adverse Event|0|||
144574063|NCT03004404|521302757|FG012|Period 2|Adverse Event|0|||
144574064|NCT03004404|521302758|FG013|Period 2|Adverse Event|0|||
144574065|NCT03004404|521302759|FG014|Period 2|Adverse Event|0|||
144574066|NCT03004404|521302760|FG015|Period 2|Adverse Event|1|||
144574067|NCT03933462|521302763|FG000|Overall Study|Adverse Event|2|||
144574068|NCT03933462|521302764|FG001|Overall Study|Adverse Event|0|||
144574069|NCT02522728|521302768|FG000|Overall Study|Withdrawal by Subject|6|||
144574070|NCT02522728|521302769|FG001|Overall Study|Withdrawal by Subject|6|||
144574071|NCT02522728|521302768|FG000|Overall Study|Death|4|||
144574072|NCT02522728|521302769|FG001|Overall Study|Death|3|||
144574073|NCT02522728|521302768|FG000|Overall Study|Adverse Event|2|||
144574074|NCT02522728|521302769|FG001|Overall Study|Adverse Event|1|||
144574075|NCT02522728|521302768|FG000|Overall Study|Did not receive randomized study device|0|||
144574076|NCT02522728|521302769|FG001|Overall Study|Did not receive randomized study device|1|||
144574077|NCT01266161|521302777|FG000|Overall Study|Ineligible|1|||
144574078|NCT01266161|521302778|FG001|Overall Study|Ineligible|0|||
144574079|NCT01266161|521302777|FG000|Overall Study|Lack of Efficacy|0|||
144574080|NCT01266161|521302778|FG001|Overall Study|Lack of Efficacy|1|||
144574081|NCT01266161|521302777|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
144574082|NCT01266161|521302778|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
144574083|NCT02990468|521302779|FG000|Phase 2: MTD|Change in treatment|0|||
144574084|NCT02990468|521302780|FG001|Phase 2: MTD|Change in treatment|0|||
144574085|NCT02990468|521302781|FG002|Phase 2: MTD|Change in treatment|1|||
144574086|NCT01436305|521302783|FG000|Overall Study|Death|1|||
144574087|NCT01436305|521302784|FG001|Overall Study|Death|0|||
144574088|NCT01436305|521302785|FG002|Overall Study|Death|0|||
144574089|NCT01436305|521302783|FG000|Overall Study|Lost to Follow-up|0|||
144574090|NCT01436305|521302784|FG001|Overall Study|Lost to Follow-up|1|||
144574091|NCT01436305|521302785|FG002|Overall Study|Lost to Follow-up|0|||
144574092|NCT01436305|521302783|FG000|Overall Study|Withdrawal by Subject|1|||
144574093|NCT01436305|521302784|FG001|Overall Study|Withdrawal by Subject|3|||
144574094|NCT01436305|521302785|FG002|Overall Study|Withdrawal by Subject|0|||
144574095|NCT03392168|521302794|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
144574096|NCT03392168|521302795|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
144574097|NCT03392168|521302796|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
144574098|NCT03392168|521302797|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
144574099|NCT03392168|521302794|FG000|Period 2: Cohort 2|Other|0|||
144574100|NCT03392168|521302795|FG001|Period 2: Cohort 2|Other|1|||
144729859|NCT01248247|521868079|FG001|Overall Study|Death|1|||
144729860|NCT01248247|521868080|FG002|Overall Study|Death|4|||
144729861|NCT01248247|521868081|FG003|Overall Study|Death|7|||
144729862|NCT01248247|521868078|FG000|Overall Study|Lost to Follow-up|0|||
144729863|NCT01248247|521868079|FG001|Overall Study|Lost to Follow-up|1|||
144729864|NCT01248247|521868080|FG002|Overall Study|Lost to Follow-up|1|||
144574101|NCT03392168|521302796|FG002|Period 2: Cohort 2|Other|0|||
144574102|NCT03392168|521302797|FG003|Period 2: Cohort 2|Other|0|||
144574103|NCT02597712|521302798|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
144574104|NCT02597712|521302799|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
144574105|NCT02597712|521302798|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
144574106|NCT02597712|521302799|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
144574107|NCT02597712|521302798|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
144574108|NCT02597712|521302799|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
144574109|NCT01727505|521302800|FG000|First 24 Hours|Adverse Event|0|||
144729865|NCT01248247|521868081|FG003|Overall Study|Lost to Follow-up|0|||
144729866|NCT01248247|521868078|FG000|Overall Study|Alternative treatment|0|||
144729867|NCT01248247|521868079|FG001|Overall Study|Alternative treatment|1|||
144729868|NCT01248247|521868080|FG002|Overall Study|Alternative treatment|0|||
144729869|NCT01248247|521868081|FG003|Overall Study|Alternative treatment|0|||
144574110|NCT01727505|521302801|FG001|First 24 Hours|Adverse Event|1|||
144574111|NCT01727505|521302800|FG000|Second 24 Hours|Missing data|0|||
144574112|NCT01727505|521302801|FG001|Second 24 Hours|Missing data|1|||
144574113|NCT01594970|521302802|FG000|Overall Study|Non-Adverse Event Related|4|||
144574114|NCT01594970|521302803|FG001|Overall Study|Non-Adverse Event Related|5|||
144574115|NCT01594970|521302804|FG002|Overall Study|Non-Adverse Event Related|6|||
144574116|NCT01594970|521302802|FG000|Overall Study|Adverse Event|17|||
144574117|NCT01594970|521302803|FG001|Overall Study|Adverse Event|23|||
144574118|NCT01594970|521302804|FG002|Overall Study|Adverse Event|23|||
144574119|NCT01594970|521302802|FG000|Overall Study|Lost to Follow-up|54|||
144574120|NCT01594970|521302803|FG001|Overall Study|Lost to Follow-up|54|||
144574121|NCT01594970|521302804|FG002|Overall Study|Lost to Follow-up|37|||
144574122|NCT01299480|521302805|FG000|Overall Study|No longer willing to participate|19|||
144574123|NCT01299480|521302806|FG001|Overall Study|No longer willing to participate|17|||
144574124|NCT01299480|521302807|FG002|Overall Study|No longer willing to participate|14|||
144574125|NCT01299480|521302808|FG003|Overall Study|No longer willing to participate|13|||
144574126|NCT01299480|521302809|FG004|Overall Study|No longer willing to participate|10|||
144574127|NCT01299480|521302805|FG000|Overall Study|Protocol Violation|7|||
144574128|NCT01299480|521302806|FG001|Overall Study|Protocol Violation|5|||
144574129|NCT01299480|521302807|FG002|Overall Study|Protocol Violation|8|||
144574130|NCT01299480|521302808|FG003|Overall Study|Protocol Violation|1|||
144574131|NCT01299480|521302809|FG004|Overall Study|Protocol Violation|1|||
144574132|NCT01299480|521302805|FG000|Overall Study|Withdrawal by Subject|3|||
144574133|NCT01299480|521302806|FG001|Overall Study|Withdrawal by Subject|4|||
144574134|NCT01299480|521302807|FG002|Overall Study|Withdrawal by Subject|7|||
144574135|NCT01299480|521302808|FG003|Overall Study|Withdrawal by Subject|3|||
144574136|NCT01299480|521302809|FG004|Overall Study|Withdrawal by Subject|4|||
144574137|NCT01299480|521302805|FG000|Overall Study|Adverse Event|6|||
144574138|NCT01299480|521302806|FG001|Overall Study|Adverse Event|4|||
144574139|NCT01299480|521302807|FG002|Overall Study|Adverse Event|5|||
144574140|NCT01299480|521302808|FG003|Overall Study|Adverse Event|4|||
144574141|NCT01299480|521302809|FG004|Overall Study|Adverse Event|0|||
144574142|NCT01299480|521302805|FG000|Overall Study|Withdrawal due to pregnancy|0|||
144574143|NCT01299480|521302806|FG001|Overall Study|Withdrawal due to pregnancy|1|||
144574144|NCT01299480|521302807|FG002|Overall Study|Withdrawal due to pregnancy|1|||
144574145|NCT01299480|521302808|FG003|Overall Study|Withdrawal due to pregnancy|0|||
144574146|NCT01299480|521302809|FG004|Overall Study|Withdrawal due to pregnancy|0|||
144574147|NCT01299480|521302805|FG000|Overall Study|Physician Decision|1|||
144574148|NCT01299480|521302806|FG001|Overall Study|Physician Decision|1|||
144574149|NCT01299480|521302807|FG002|Overall Study|Physician Decision|0|||
144574150|NCT01299480|521302808|FG003|Overall Study|Physician Decision|2|||
144574151|NCT01299480|521302809|FG004|Overall Study|Physician Decision|0|||
144574152|NCT01299480|521302805|FG000|Overall Study|Lost to Follow-up|3|||
144574153|NCT01299480|521302806|FG001|Overall Study|Lost to Follow-up|1|||
144574154|NCT01299480|521302807|FG002|Overall Study|Lost to Follow-up|2|||
144574155|NCT01299480|521302808|FG003|Overall Study|Lost to Follow-up|1|||
144574156|NCT01299480|521302809|FG004|Overall Study|Lost to Follow-up|2|||
144574157|NCT01299480|521302805|FG000|Overall Study|Other|3|||
144574158|NCT01299480|521302806|FG001|Overall Study|Other|2|||
144574159|NCT01299480|521302807|FG002|Overall Study|Other|3|||
144574160|NCT01299480|521302808|FG003|Overall Study|Other|0|||
144621513|NCT05103332|521472248|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
144621514|NCT05103332|521472249|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
144621515|NCT05103332|521472250|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
144621516|NCT05103332|521472251|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
144621517|NCT05103332|521472252|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
144621518|NCT05103332|521472253|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
144621519|NCT05103332|521472254|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
144621520|NCT05103332|521472237|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621521|NCT05103332|521472238|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621522|NCT05103332|521472239|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144574161|NCT01299480|521302809|FG004|Overall Study|Other|3|||
144574162|NCT01299480|521302805|FG000|Overall Study|Started, but not vaccinated|0|||
144574163|NCT01299480|521302806|FG001|Overall Study|Started, but not vaccinated|0|||
144574164|NCT01299480|521302807|FG002|Overall Study|Started, but not vaccinated|1|||
144574165|NCT01299480|521302808|FG003|Overall Study|Started, but not vaccinated|1|||
144574166|NCT01299480|521302809|FG004|Overall Study|Started, but not vaccinated|0|||
144574167|NCT01430468|521302816|FG000|Overall Study|Physician Decision|2|||
144574168|NCT01430468|521302817|FG001|Overall Study|Physician Decision|1|||
144574169|NCT01430468|521302816|FG000|Overall Study|Withdrawal by Subject|5|||
144574170|NCT01430468|521302817|FG001|Overall Study|Withdrawal by Subject|5|||
144574171|NCT03229486|521302818|FG000|Overall Study|Protocol Violation|0|||
144574172|NCT03229486|521302819|FG001|Overall Study|Protocol Violation|1|||
144574173|NCT00455741|521302823|FG000|Overall Study|Physician Decision|0|||
144574174|NCT00455741|521302824|FG001|Overall Study|Physician Decision|1|||
144621523|NCT05103332|521472240|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621524|NCT05103332|521472241|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621525|NCT05103332|521472242|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621526|NCT05103332|521472243|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621527|NCT05103332|521472244|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621528|NCT05103332|521472245|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621529|NCT05103332|521472246|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621530|NCT05103332|521472247|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144729870|NCT01248247|521868078|FG000|Overall Study|Other|2|||
144729871|NCT01248247|521868079|FG001|Overall Study|Other|8|||
144729872|NCT01248247|521868080|FG002|Overall Study|Other|8|||
144729873|NCT01248247|521868081|FG003|Overall Study|Other|5|||
144729874|NCT01248247|521868078|FG000|Overall Study|Progression|18|||
144729875|NCT01248247|521868079|FG001|Overall Study|Progression|27|||
144729876|NCT01248247|521868080|FG002|Overall Study|Progression|56|||
144729877|NCT01248247|521868081|FG003|Overall Study|Progression|44|||
144729878|NCT01248247|521868078|FG000|Overall Study|Refuse further treatment|0|||
144729879|NCT01248247|521868079|FG001|Overall Study|Refuse further treatment|0|||
144729880|NCT01248247|521868080|FG002|Overall Study|Refuse further treatment|1|||
144729881|NCT01248247|521868081|FG003|Overall Study|Refuse further treatment|2|||
144729882|NCT01248247|521868078|FG000|Overall Study|Complicating disease|0|||
144574175|NCT04855734|521302829|FG000|Overall Study|Lost to Follow-up|2|||
144729883|NCT01248247|521868079|FG001|Overall Study|Complicating disease|0|||
144729884|NCT01248247|521868080|FG002|Overall Study|Complicating disease|1|||
144729885|NCT01248247|521868081|FG003|Overall Study|Complicating disease|1|||
144729886|NCT00705536|521868082|FG000|Start Period 1|Withdrawal by Subject|0|||
144729887|NCT00705536|521868083|FG001|Start Period 1|Withdrawal by Subject|0|||
144729888|NCT00705536|521868084|FG002|Start Period 1|Withdrawal by Subject|0|||
144729889|NCT00705536|521868085|FG003|Start Period 1|Withdrawal by Subject|1|||
144729890|NCT00549718|521868086|FG000|Overall Study|Insufficient clinical response|20|||
144729891|NCT00549718|521868087|FG001|Overall Study|Insufficient clinical response|7|||
144729892|NCT00549718|521868088|FG002|Overall Study|Insufficient clinical response|18|||
144729893|NCT00549718|521868089|FG003|Overall Study|Insufficient clinical response|32|||
144729894|NCT00549718|521868086|FG000|Overall Study|Adverse Event|6|||
144729895|NCT00549718|521868087|FG001|Overall Study|Adverse Event|8|||
144729896|NCT00549718|521868088|FG002|Overall Study|Adverse Event|7|||
144729897|NCT00549718|521868089|FG003|Overall Study|Adverse Event|3|||
144729898|NCT00549718|521868086|FG000|Overall Study|Lost to Follow-up|4|||
144729899|NCT00549718|521868087|FG001|Overall Study|Lost to Follow-up|2|||
144729900|NCT00549718|521868088|FG002|Overall Study|Lost to Follow-up|0|||
144729901|NCT00549718|521868089|FG003|Overall Study|Lost to Follow-up|6|||
144207346|NCT02065700|519954293|FG000|Overall Study|Sponsor Request|38|||
144207347|NCT02065700|519954294|FG001|Overall Study|Sponsor Request|15|||
144574176|NCT04855734|521302830|FG001|Overall Study|Lost to Follow-up|2|||
144574177|NCT03358472|521302831|FG000|Overall Study|Death|6|||
144574178|NCT03358472|521302832|FG001|Overall Study|Death|3|||
144574179|NCT03358472|521302833|FG002|Overall Study|Death|10|||
144574180|NCT03358472|521302831|FG000|Overall Study|Physician Decision|0|||
144574181|NCT03358472|521302832|FG001|Overall Study|Physician Decision|1|||
144574182|NCT03358472|521302833|FG002|Overall Study|Physician Decision|0|||
144574183|NCT03358472|521302831|FG000|Overall Study|Withdrawal by Subject|0|||
144574184|NCT03358472|521302832|FG001|Overall Study|Withdrawal by Subject|0|||
144574185|NCT03358472|521302833|FG002|Overall Study|Withdrawal by Subject|1|||
144574186|NCT03358472|521302831|FG000|Overall Study|On-going at clinical cut off date|9|||
144574187|NCT03358472|521302832|FG001|Overall Study|On-going at clinical cut off date|6|||
144621531|NCT05103332|521472248|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621532|NCT05103332|521472249|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621533|NCT05103332|521472250|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621534|NCT05103332|521472251|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
144729902|NCT00549718|521868086|FG000|Overall Study|Withdrawal by Subject|9|||
144729903|NCT00549718|521868087|FG001|Overall Study|Withdrawal by Subject|18|||
144729904|NCT00549718|521868088|FG002|Overall Study|Withdrawal by Subject|12|||
144729905|NCT00549718|521868089|FG003|Overall Study|Withdrawal by Subject|13|||
144207348|NCT02065700|519954293|FG000|Overall Study|Treatment Failure|3|||
144207349|NCT02065700|519954294|FG001|Overall Study|Treatment Failure|2|||
144207350|NCT02065700|519954293|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
144574188|NCT03358472|521302833|FG002|Overall Study|On-going at clinical cut off date|5|||
144574189|NCT04535544|521302836|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
144729906|NCT00549718|521868086|FG000|Overall Study|Administrative|2|||
144729907|NCT00549718|521868087|FG001|Overall Study|Administrative|2|||
144729908|NCT00549718|521868088|FG002|Overall Study|Administrative|2|||
144729909|NCT00549718|521868089|FG003|Overall Study|Administrative|1|||
144729910|NCT04032977|521868090|FG000|Overall Study|Withdrawal by Subject|6|||
144729911|NCT04032977|521868091|FG001|Overall Study|Withdrawal by Subject|1|||
144729912|NCT04032977|521868090|FG000|Overall Study|Lost to Follow-up|2|||
144729913|NCT04032977|521868091|FG001|Overall Study|Lost to Follow-up|7|||
144729914|NCT04032977|521868090|FG000|Overall Study|Pregnancy|1|||
144729915|NCT04032977|521868091|FG001|Overall Study|Pregnancy|0|||
144729916|NCT03075761|521868093|FG000|Overall Study|Lost to Follow-up|1|||
144729917|NCT03075761|521868094|FG001|Overall Study|Lost to Follow-up|6|||
144729918|NCT02880761|521868095|FG000|Overall Study|Death|6|||
144574190|NCT04535544|521302837|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
144574191|NCT04535544|521302838|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
144574192|NCT04535544|521302839|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
144574193|NCT04535544|521302836|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
144574194|NCT04535544|521302837|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
144574195|NCT04535544|521302838|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
144574196|NCT04535544|521302839|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
144574197|NCT04535544|521302836|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
144574198|NCT04535544|521302837|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
144574199|NCT04535544|521302838|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
144574200|NCT04535544|521302839|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
144574201|NCT04535544|521302836|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
144574202|NCT04535544|521302837|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
144574203|NCT04535544|521302838|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
144574204|NCT04535544|521302839|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
144574205|NCT04535544|521302836|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
144574206|NCT04535544|521302837|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
144574207|NCT04535544|521302838|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
144574208|NCT04535544|521302839|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
144574209|NCT04535544|521302836|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
144729919|NCT02880761|521868096|FG001|Overall Study|Death|8|||
144729920|NCT02880761|521868095|FG000|Overall Study|Withdrawal by Subject|3|||
144729921|NCT02880761|521868096|FG001|Overall Study|Withdrawal by Subject|6|||
144729922|NCT02880761|521868095|FG000|Overall Study|Protocol Violation|4|||
144207351|NCT02065700|519954294|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
144207352|NCT02065700|519954293|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
144207353|NCT02065700|519954294|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
144207354|NCT02065700|519954293|FG000|Overall Study|Non-compliance with Study Procedures|2|||
144207355|NCT02065700|519954294|FG001|Overall Study|Non-compliance with Study Procedures|0|||
144207356|NCT02065700|519954293|FG000|Overall Study|Not Defined|21|||
144207357|NCT02065700|519954294|FG001|Overall Study|Not Defined|3|||
144207358|NCT03151408|519954295|FG000|Overall Study|Adverse Event|24|||
144207359|NCT03151408|519954296|FG001|Overall Study|Adverse Event|23|||
144207360|NCT03151408|519954295|FG000|Overall Study|Death|46|||
144207361|NCT03151408|519954296|FG001|Overall Study|Death|26|||
144207362|NCT03151408|519954295|FG000|Overall Study|Physician Decision|13|||
144207363|NCT03151408|519954296|FG001|Overall Study|Physician Decision|19|||
144207364|NCT03151408|519954295|FG000|Overall Study|Withdrawal by Subject|16|||
144207365|NCT03151408|519954296|FG001|Overall Study|Withdrawal by Subject|20|||
144207366|NCT03151408|519954295|FG000|Overall Study|Progressive disease|45|||
144207367|NCT03151408|519954296|FG001|Overall Study|Progressive disease|61|||
144207368|NCT03151408|519954295|FG000|Overall Study|non-compliance by patient|1|||
144207369|NCT03151408|519954296|FG001|Overall Study|non-compliance by patient|0|||
144207370|NCT03151408|519954295|FG000|Overall Study|other reasons|56|||
144207371|NCT03151408|519954296|FG001|Overall Study|other reasons|52|||
144207372|NCT03151408|519954295|FG000|Overall Study|randomized and not treated|2|||
144207373|NCT03151408|519954296|FG001|Overall Study|randomized and not treated|2|||
144207374|NCT01635218|519954297|FG000|Overall Study|Lost to Follow-up|3|||
144207375|NCT01635218|519954298|FG001|Overall Study|Lost to Follow-up|7|||
144207376|NCT01635218|519954299|FG002|Overall Study|Lost to Follow-up|6|||
144207377|NCT03146962|519954306|FG000|Overall Study|Lost to Follow-up|1|||
144207378|NCT03146962|519954307|FG001|Overall Study|Lost to Follow-up|1|||
144207379|NCT03146962|519954308|FG002|Overall Study|Lost to Follow-up|0|||
144207380|NCT03146962|519954309|FG003|Overall Study|Lost to Follow-up|0|||
144207381|NCT03146962|519954310|FG004|Overall Study|Lost to Follow-up|0|||
144207382|NCT03146962|519954311|FG005|Overall Study|Lost to Follow-up|0|||
144207383|NCT03146962|519954312|FG006|Overall Study|Lost to Follow-up|0|||
144207384|NCT03146962|519954313|FG007|Overall Study|Lost to Follow-up|0|||
144207385|NCT03146962|519954314|FG008|Overall Study|Lost to Follow-up|0|||
144207386|NCT03146962|519954315|FG009|Overall Study|Lost to Follow-up|0|||
144207387|NCT03146962|519954306|FG000|Overall Study|Adverse Event|0|||
144207388|NCT03146962|519954307|FG001|Overall Study|Adverse Event|3|||
144574210|NCT04535544|521302837|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
144574211|NCT04535544|521302838|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
144207389|NCT03146962|519954308|FG002|Overall Study|Adverse Event|0|||
144574212|NCT04535544|521302839|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
144574213|NCT04535544|521302836|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
144729923|NCT02880761|521868096|FG001|Overall Study|Protocol Violation|3|||
144729924|NCT02880761|521868095|FG000|Overall Study|Lost to Follow-up|3|||
144729925|NCT02880761|521868096|FG001|Overall Study|Lost to Follow-up|4|||
144574214|NCT04535544|521302837|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
144574215|NCT04535544|521302838|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
144574216|NCT04535544|521302839|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
144574217|NCT04535544|521302836|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
144574218|NCT04535544|521302837|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
144574219|NCT04535544|521302838|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
144574220|NCT04535544|521302839|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
144574221|NCT00344032|521302842|FG000|Overall Study|Adverse Event|0|||
144574222|NCT00344032|521302843|FG001|Overall Study|Adverse Event|1|||
144574223|NCT00344032|521302842|FG000|Overall Study|Withdrawal by Subject|6|||
144574224|NCT00344032|521302843|FG001|Overall Study|Withdrawal by Subject|2|||
144574225|NCT00344032|521302842|FG000|Overall Study|Lost to Follow-up|4|||
144574226|NCT00344032|521302843|FG001|Overall Study|Lost to Follow-up|6|||
144574227|NCT00344032|521302842|FG000|Overall Study|Physician Decision|4|||
144574228|NCT00344032|521302843|FG001|Overall Study|Physician Decision|1|||
144574229|NCT05131477|521302850|FG000|PART 1|Withdrawal by Subject|2|||
144574230|NCT05131477|521302851|FG001|PART 1|Withdrawal by Subject|9|||
144574231|NCT05131477|521302852|FG002|PART 1|Withdrawal by Subject|6|||
144574232|NCT05131477|521302853|FG003|PART 1|Withdrawal by Subject|2|||
144574233|NCT05131477|521302854|FG004|PART 1|Withdrawal by Subject|8|||
144574234|NCT05131477|521302855|FG005|PART 1|Withdrawal by Subject|0|||
144574235|NCT05131477|521302856|FG006|PART 1|Withdrawal by Subject|0|||
144574236|NCT05131477|521302857|FG007|PART 1|Withdrawal by Subject|0|||
144574237|NCT05131477|521302858|FG008|PART 1|Withdrawal by Subject|0|||
144574238|NCT05131477|521302859|FG009|PART 1|Withdrawal by Subject|0|||
144574239|NCT05131477|521302860|FG010|PART 1|Withdrawal by Subject|0|||
144574240|NCT05131477|521302861|FG011|PART 1|Withdrawal by Subject|0|||
144574241|NCT05131477|521302862|FG012|PART 1|Withdrawal by Subject|0|||
144574242|NCT05131477|521302863|FG013|PART 1|Withdrawal by Subject|0|||
144574243|NCT05131477|521302850|FG000|PART 1|Physician Decision|1|||
144621535|NCT05103332|521472252|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
144621536|NCT05103332|521472253|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
144621537|NCT05103332|521472254|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
144621538|NCT05103332|521472237|FG000|SFU Period (6 Months=168 Days)|Death|0|||
144621539|NCT05103332|521472238|FG001|SFU Period (6 Months=168 Days)|Death|0|||
144621540|NCT05103332|521472239|FG002|SFU Period (6 Months=168 Days)|Death|0|||
144621541|NCT05103332|521472240|FG003|SFU Period (6 Months=168 Days)|Death|0|||
144621542|NCT05103332|521472241|FG004|SFU Period (6 Months=168 Days)|Death|0|||
144621543|NCT05103332|521472242|FG005|SFU Period (6 Months=168 Days)|Death|0|||
144621544|NCT05103332|521472243|FG006|SFU Period (6 Months=168 Days)|Death|0|||
144621545|NCT05103332|521472244|FG007|SFU Period (6 Months=168 Days)|Death|0|||
144621546|NCT05103332|521472245|FG008|SFU Period (6 Months=168 Days)|Death|0|||
144621547|NCT05103332|521472246|FG009|SFU Period (6 Months=168 Days)|Death|0|||
144621548|NCT05103332|521472247|FG010|SFU Period (6 Months=168 Days)|Death|0|||
144621549|NCT05103332|521472248|FG011|SFU Period (6 Months=168 Days)|Death|0|||
144621550|NCT05103332|521472249|FG012|SFU Period (6 Months=168 Days)|Death|0|||
144621551|NCT05103332|521472250|FG013|SFU Period (6 Months=168 Days)|Death|0|||
144621552|NCT05103332|521472251|FG014|SFU Period (6 Months=168 Days)|Death|1|||
144621553|NCT05103332|521472252|FG015|SFU Period (6 Months=168 Days)|Death|0|||
144621554|NCT05103332|521472253|FG016|SFU Period (6 Months=168 Days)|Death|0|||
144621555|NCT05103332|521472254|FG017|SFU Period (6 Months=168 Days)|Death|1|||
144621556|NCT04428476|521472255|FG000|Overall Study|Withdrawal by Subject|1|||
144621557|NCT04428476|521472255|FG000|Overall Study|Still on treatment|12|||
144621558|NCT04209855|521472269|FG000|Overall Study|Death|161|||
144621559|NCT04209855|521472270|FG001|Overall Study|Death|177|||
144621560|NCT04209855|521472269|FG000|Overall Study|PI Discretion|1|||
144621561|NCT04209855|521472270|FG001|Overall Study|PI Discretion|1|||
144621562|NCT04209855|521472269|FG000|Overall Study|Lost to Follow-up|5|||
144621563|NCT04209855|521472270|FG001|Overall Study|Lost to Follow-up|2|||
144621564|NCT04209855|521472269|FG000|Overall Study|Withdrew consent|10|||
144729926|NCT03597256|521868097|FG000|Overall Study|Lost to Follow-up|3|||
144574244|NCT05131477|521302851|FG001|PART 1|Physician Decision|0|||
144574245|NCT05131477|521302852|FG002|PART 1|Physician Decision|0|||
144621565|NCT04209855|521472270|FG001|Overall Study|Withdrew consent|24|||
144621566|NCT04209855|521472269|FG000|Overall Study|Sponsor decision|44|||
144621567|NCT04209855|521472270|FG001|Overall Study|Sponsor decision|18|||
144621568|NCT04209855|521472269|FG000|Overall Study|Other than specified|6|||
144621569|NCT04209855|521472270|FG001|Overall Study|Other than specified|4|||
144621570|NCT02289950|521472271|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
144262852|NCT01325350|520163768|FG001|Overall Study|Lost to Follow-up|0|||
144574246|NCT05131477|521302853|FG003|PART 1|Physician Decision|0|||
144574247|NCT05131477|521302854|FG004|PART 1|Physician Decision|0|||
144574248|NCT05131477|521302855|FG005|PART 1|Physician Decision|0|||
144574249|NCT05131477|521302856|FG006|PART 1|Physician Decision|0|||
144574250|NCT05131477|521302857|FG007|PART 1|Physician Decision|0|||
144729927|NCT03597256|521868098|FG001|Overall Study|Lost to Follow-up|1|||
144574251|NCT05131477|521302858|FG008|PART 1|Physician Decision|0|||
144574252|NCT05131477|521302859|FG009|PART 1|Physician Decision|0|||
144574253|NCT05131477|521302860|FG010|PART 1|Physician Decision|0|||
144574254|NCT05131477|521302861|FG011|PART 1|Physician Decision|0|||
144574255|NCT05131477|521302862|FG012|PART 1|Physician Decision|0|||
144574256|NCT05131477|521302863|FG013|PART 1|Physician Decision|0|||
144574257|NCT05131477|521302850|FG000|PART 1|Adverse Event|3|||
144574258|NCT05131477|521302851|FG001|PART 1|Adverse Event|5|||
144574259|NCT05131477|521302852|FG002|PART 1|Adverse Event|1|||
144574260|NCT05131477|521302853|FG003|PART 1|Adverse Event|6|||
144574261|NCT05131477|521302854|FG004|PART 1|Adverse Event|4|||
144574262|NCT05131477|521302855|FG005|PART 1|Adverse Event|0|||
144574263|NCT05131477|521302856|FG006|PART 1|Adverse Event|0|||
144574264|NCT05131477|521302857|FG007|PART 1|Adverse Event|0|||
144574265|NCT05131477|521302858|FG008|PART 1|Adverse Event|0|||
144574266|NCT05131477|521302859|FG009|PART 1|Adverse Event|0|||
144574267|NCT05131477|521302860|FG010|PART 1|Adverse Event|0|||
144574268|NCT05131477|521302861|FG011|PART 1|Adverse Event|0|||
144574269|NCT05131477|521302862|FG012|PART 1|Adverse Event|0|||
144574270|NCT05131477|521302863|FG013|PART 1|Adverse Event|0|||
144574271|NCT05131477|521302850|FG000|PART 1|unclassified|1|||
144574272|NCT05131477|521302851|FG001|PART 1|unclassified|1|||
144574273|NCT05131477|521302852|FG002|PART 1|unclassified|0|||
144574274|NCT05131477|521302853|FG003|PART 1|unclassified|0|||
144574275|NCT05131477|521302854|FG004|PART 1|unclassified|4|||
144574276|NCT05131477|521302855|FG005|PART 1|unclassified|0|||
144574277|NCT05131477|521302856|FG006|PART 1|unclassified|0|||
144574278|NCT05131477|521302857|FG007|PART 1|unclassified|0|||
144574279|NCT05131477|521302858|FG008|PART 1|unclassified|0|||
144574280|NCT05131477|521302859|FG009|PART 1|unclassified|0|||
144574281|NCT05131477|521302860|FG010|PART 1|unclassified|0|||
144574282|NCT05131477|521302861|FG011|PART 1|unclassified|0|||
144574283|NCT05131477|521302862|FG012|PART 1|unclassified|0|||
144574284|NCT05131477|521302863|FG013|PART 1|unclassified|0|||
144574285|NCT05131477|521302850|FG000|PART 1|Randomized and not treated|0|||
144574286|NCT05131477|521302851|FG001|PART 1|Randomized and not treated|0|||
144574287|NCT05131477|521302852|FG002|PART 1|Randomized and not treated|0|||
144574288|NCT05131477|521302853|FG003|PART 1|Randomized and not treated|1|||
144574289|NCT05131477|521302854|FG004|PART 1|Randomized and not treated|1|||
144574290|NCT05131477|521302855|FG005|PART 1|Randomized and not treated|0|||
144574291|NCT05131477|521302856|FG006|PART 1|Randomized and not treated|0|||
144574292|NCT05131477|521302857|FG007|PART 1|Randomized and not treated|0|||
144574293|NCT05131477|521302858|FG008|PART 1|Randomized and not treated|0|||
144574294|NCT05131477|521302859|FG009|PART 1|Randomized and not treated|0|||
144574295|NCT05131477|521302860|FG010|PART 1|Randomized and not treated|0|||
144574296|NCT05131477|521302861|FG011|PART 1|Randomized and not treated|0|||
144574297|NCT05131477|521302862|FG012|PART 1|Randomized and not treated|0|||
144574298|NCT05131477|521302863|FG013|PART 1|Randomized and not treated|0|||
144574299|NCT05131477|521302850|FG000|PART 1|Protocol Violation|2|||
144574300|NCT05131477|521302851|FG001|PART 1|Protocol Violation|0|||
144574301|NCT05131477|521302852|FG002|PART 1|Protocol Violation|0|||
144574302|NCT05131477|521302853|FG003|PART 1|Protocol Violation|1|||
144574303|NCT05131477|521302854|FG004|PART 1|Protocol Violation|0|||
144574304|NCT05131477|521302855|FG005|PART 1|Protocol Violation|0|||
144574305|NCT05131477|521302856|FG006|PART 1|Protocol Violation|0|||
144574306|NCT05131477|521302857|FG007|PART 1|Protocol Violation|0|||
144574307|NCT05131477|521302858|FG008|PART 1|Protocol Violation|0|||
144574308|NCT05131477|521302859|FG009|PART 1|Protocol Violation|0|||
144574309|NCT05131477|521302860|FG010|PART 1|Protocol Violation|0|||
144574310|NCT05131477|521302861|FG011|PART 1|Protocol Violation|0|||
144574311|NCT05131477|521302862|FG012|PART 1|Protocol Violation|0|||
144574312|NCT05131477|521302863|FG013|PART 1|Protocol Violation|0|||
144574313|NCT05131477|521302850|FG000|PART 1|Lack of Efficacy|0|||
144574314|NCT05131477|521302851|FG001|PART 1|Lack of Efficacy|1|||
144574315|NCT05131477|521302852|FG002|PART 1|Lack of Efficacy|1|||
144574316|NCT05131477|521302853|FG003|PART 1|Lack of Efficacy|2|||
144207390|NCT03146962|519954309|FG003|Overall Study|Adverse Event|0|||
144207391|NCT03146962|519954310|FG004|Overall Study|Adverse Event|0|||
144207392|NCT03146962|519954311|FG005|Overall Study|Adverse Event|0|||
144207393|NCT03146962|519954312|FG006|Overall Study|Adverse Event|0|||
144207394|NCT03146962|519954313|FG007|Overall Study|Adverse Event|1|||
144574317|NCT05131477|521302854|FG004|PART 1|Lack of Efficacy|5|||
144574318|NCT05131477|521302855|FG005|PART 1|Lack of Efficacy|0|||
144574319|NCT05131477|521302856|FG006|PART 1|Lack of Efficacy|0|||
144574320|NCT05131477|521302857|FG007|PART 1|Lack of Efficacy|0|||
144574321|NCT05131477|521302858|FG008|PART 1|Lack of Efficacy|0|||
144574322|NCT05131477|521302859|FG009|PART 1|Lack of Efficacy|0|||
144574323|NCT05131477|521302860|FG010|PART 1|Lack of Efficacy|0|||
144574324|NCT05131477|521302861|FG011|PART 1|Lack of Efficacy|0|||
144574325|NCT05131477|521302862|FG012|PART 1|Lack of Efficacy|0|||
144574326|NCT05131477|521302863|FG013|PART 1|Lack of Efficacy|0|||
144574327|NCT05131477|521302850|FG000|PART 2|Withdrawal by Subject|0|||
144574328|NCT05131477|521302851|FG001|PART 2|Withdrawal by Subject|0|||
144574329|NCT05131477|521302852|FG002|PART 2|Withdrawal by Subject|0|||
144574330|NCT05131477|521302853|FG003|PART 2|Withdrawal by Subject|0|||
144574331|NCT05131477|521302854|FG004|PART 2|Withdrawal by Subject|0|||
144574332|NCT05131477|521302855|FG005|PART 2|Withdrawal by Subject|0|||
144574333|NCT05131477|521302856|FG006|PART 2|Withdrawal by Subject|2|||
144574334|NCT05131477|521302857|FG007|PART 2|Withdrawal by Subject|0|||
144729928|NCT03597256|521868097|FG000|Overall Study|Withdrawal by Subject|0|||
144729929|NCT03597256|521868098|FG001|Overall Study|Withdrawal by Subject|1|||
144729930|NCT03597256|521868097|FG000|Overall Study|Could not return for treatment|0|||
144729931|NCT03597256|521868098|FG001|Overall Study|Could not return for treatment|1|||
144729932|NCT03597256|521868097|FG000|Overall Study|Moved from location|0|||
144729933|NCT03597256|521868098|FG001|Overall Study|Moved from location|1|||
144729934|NCT03597256|521868097|FG000|Overall Study|Not accepted the treatment|0|||
144729935|NCT03597256|521868098|FG001|Overall Study|Not accepted the treatment|1|||
144729936|NCT02106156|521868099|FG000|Overall Study|Patient Died|19|||
144574335|NCT05131477|521302858|FG008|PART 2|Withdrawal by Subject|0|||
144574336|NCT05131477|521302859|FG009|PART 2|Withdrawal by Subject|0|||
144574337|NCT05131477|521302860|FG010|PART 2|Withdrawal by Subject|2|||
144574338|NCT05131477|521302861|FG011|PART 2|Withdrawal by Subject|0|||
144574339|NCT05131477|521302862|FG012|PART 2|Withdrawal by Subject|2|||
144574340|NCT05131477|521302863|FG013|PART 2|Withdrawal by Subject|2|||
144574341|NCT05131477|521302850|FG000|PART 2|Other|0|||
144574342|NCT05131477|521302851|FG001|PART 2|Other|0|||
144574343|NCT05131477|521302852|FG002|PART 2|Other|0|||
144574344|NCT05131477|521302853|FG003|PART 2|Other|0|||
144574345|NCT05131477|521302854|FG004|PART 2|Other|0|||
144574346|NCT05131477|521302855|FG005|PART 2|Other|0|||
144574347|NCT05131477|521302856|FG006|PART 2|Other|0|||
144574348|NCT05131477|521302857|FG007|PART 2|Other|0|||
144574349|NCT05131477|521302858|FG008|PART 2|Other|1|||
144574350|NCT05131477|521302859|FG009|PART 2|Other|1|||
144574351|NCT05131477|521302860|FG010|PART 2|Other|0|||
144574352|NCT05131477|521302861|FG011|PART 2|Other|0|||
144574353|NCT05131477|521302862|FG012|PART 2|Other|1|||
144574354|NCT05131477|521302863|FG013|PART 2|Other|0|||
144574355|NCT05131477|521302850|FG000|PART 2|Lack of Efficacy|0|||
144574356|NCT05131477|521302851|FG001|PART 2|Lack of Efficacy|0|||
144574357|NCT05131477|521302852|FG002|PART 2|Lack of Efficacy|0|||
144574358|NCT05131477|521302853|FG003|PART 2|Lack of Efficacy|0|||
144574359|NCT05131477|521302854|FG004|PART 2|Lack of Efficacy|0|||
144574360|NCT05131477|521302855|FG005|PART 2|Lack of Efficacy|1|||
144574361|NCT05131477|521302856|FG006|PART 2|Lack of Efficacy|1|||
144574362|NCT05131477|521302857|FG007|PART 2|Lack of Efficacy|0|||
144574363|NCT05131477|521302858|FG008|PART 2|Lack of Efficacy|3|||
144574364|NCT05131477|521302859|FG009|PART 2|Lack of Efficacy|0|||
144574365|NCT05131477|521302860|FG010|PART 2|Lack of Efficacy|1|||
144574366|NCT05131477|521302861|FG011|PART 2|Lack of Efficacy|0|||
144574367|NCT05131477|521302862|FG012|PART 2|Lack of Efficacy|2|||
144574368|NCT05131477|521302863|FG013|PART 2|Lack of Efficacy|0|||
144574369|NCT05131477|521302850|FG000|PART 2|Unclassified|0|||
144574370|NCT05131477|521302851|FG001|PART 2|Unclassified|0|||
144574371|NCT05131477|521302852|FG002|PART 2|Unclassified|0|||
144574372|NCT05131477|521302853|FG003|PART 2|Unclassified|0|||
144574373|NCT05131477|521302854|FG004|PART 2|Unclassified|0|||
144574374|NCT05131477|521302855|FG005|PART 2|Unclassified|0|||
144574375|NCT05131477|521302856|FG006|PART 2|Unclassified|0|||
144574376|NCT05131477|521302857|FG007|PART 2|Unclassified|0|||
144574377|NCT05131477|521302858|FG008|PART 2|Unclassified|0|||
144574378|NCT05131477|521302859|FG009|PART 2|Unclassified|0|||
144574379|NCT05131477|521302860|FG010|PART 2|Unclassified|1|||
144574380|NCT05131477|521302861|FG011|PART 2|Unclassified|0|||
144574381|NCT05131477|521302862|FG012|PART 2|Unclassified|0|||
144574382|NCT05131477|521302863|FG013|PART 2|Unclassified|0|||
144574383|NCT05131477|521302850|FG000|PART 2|Re-randomized and not treated|0|||
144574384|NCT05131477|521302851|FG001|PART 2|Re-randomized and not treated|0|||
144574385|NCT05131477|521302852|FG002|PART 2|Re-randomized and not treated|0|||
144574386|NCT05131477|521302853|FG003|PART 2|Re-randomized and not treated|0|||
144574387|NCT05131477|521302854|FG004|PART 2|Re-randomized and not treated|0|||
144574388|NCT05131477|521302855|FG005|PART 2|Re-randomized and not treated|0|||
144574389|NCT05131477|521302856|FG006|PART 2|Re-randomized and not treated|0|||
144574390|NCT05131477|521302857|FG007|PART 2|Re-randomized and not treated|1|||
144574391|NCT05131477|521302858|FG008|PART 2|Re-randomized and not treated|0|||
144729937|NCT02106156|521868100|FG001|Overall Study|Patient Died|0|||
144574392|NCT05131477|521302859|FG009|PART 2|Re-randomized and not treated|0|||
144574393|NCT05131477|521302860|FG010|PART 2|Re-randomized and not treated|1|||
144574394|NCT05131477|521302861|FG011|PART 2|Re-randomized and not treated|0|||
144574395|NCT05131477|521302862|FG012|PART 2|Re-randomized and not treated|1|||
144574396|NCT05131477|521302863|FG013|PART 2|Re-randomized and not treated|1|||
144574397|NCT02194829|521302864|FG000|Overall Study|Adverse Event|2|||
144574398|NCT02194829|521302865|FG001|Overall Study|Adverse Event|2|||
144574399|NCT02194829|521302864|FG000|Overall Study|Death|0|||
144729938|NCT02106156|521868101|FG002|Overall Study|Patient Died|0|||
144574400|NCT02194829|521302865|FG001|Overall Study|Death|1|||
144574401|NCT02194829|521302864|FG000|Overall Study|Disease progression|0|||
144574402|NCT02194829|521302865|FG001|Overall Study|Disease progression|1|||
144574403|NCT02194829|521302864|FG000|Overall Study|Withdrawal by Subject|0|||
144574404|NCT02194829|521302865|FG001|Overall Study|Withdrawal by Subject|1|||
144574405|NCT02194829|521302864|FG000|Overall Study|Never started protocol therapy|0|||
144574406|NCT02194829|521302865|FG001|Overall Study|Never started protocol therapy|1|||
144574407|NCT06840769|521302866|FG000|Overall Study|Withdrawal by Subject|1|||
144574408|NCT06840769|521302867|FG001|Overall Study|Withdrawal by Subject|0|||
144574409|NCT06840769|521302868|FG002|Overall Study|Withdrawal by Subject|0|||
144574410|NCT06840769|521302869|FG003|Overall Study|Withdrawal by Subject|0|||
144574411|NCT06840769|521302870|FG004|Overall Study|Withdrawal by Subject|0|||
144574412|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Adverse Event|10|||
144574413|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Adverse Event|9|||
144574414|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Adverse Event|7|||
144574415|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
144574416|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
144574417|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
144574418|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
144574419|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
144574420|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
144574421|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Physician Decision|7|||
144574422|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Physician Decision|3|||
144574423|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Physician Decision|2|||
144574424|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Pregnancy|2|||
144574425|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Pregnancy|1|||
144574426|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Pregnancy|3|||
144574427|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
144574428|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
144574429|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
144574430|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
144574431|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
144574432|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
144574433|NCT02614183|521302873|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
144574434|NCT02614183|521302874|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
144574435|NCT02614183|521302875|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
144574436|NCT02614183|521302873|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
144574437|NCT02614183|521302874|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
144574438|NCT02614183|521302875|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
144574439|NCT02614183|521302873|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
144574440|NCT02614183|521302874|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
144574441|NCT02614183|521302875|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
144574442|NCT02614183|521302873|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
144574443|NCT02614183|521302874|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
144574444|NCT02614183|521302875|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
144574445|NCT02614183|521302873|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
144574446|NCT02614183|521302874|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
144574447|NCT02614183|521302875|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
144574448|NCT02726945|521302876|FG000|Overall Study|Withdrawal by Subject|0|||
144574449|NCT02726945|521302877|FG001|Overall Study|Withdrawal by Subject|0|||
144574450|NCT02726945|521302878|FG002|Overall Study|Withdrawal by Subject|1|||
144574451|NCT02726945|521302876|FG000|Overall Study|Elected to have total knee replacement|0|||
144574452|NCT02726945|521302877|FG001|Overall Study|Elected to have total knee replacement|1|||
144574453|NCT02726945|521302878|FG002|Overall Study|Elected to have total knee replacement|0|||
144574454|NCT04991753|521305130|FG000|Overall Study|Withdrawal by Subject|0|||
144574455|NCT04991753|521305131|FG001|Overall Study|Withdrawal by Subject|1|||
144574456|NCT02113124|521305132|FG000|Overall Study|Unable to retrieve blood sample|1|||
144574457|NCT02113124|521305133|FG001|Overall Study|Unable to retrieve blood sample|1|||
144574458|NCT01901419|521305134|FG000|Overall Study|Protocol Violation|2|||
144574459|NCT01901419|521305135|FG001|Overall Study|Protocol Violation|6|||
144574460|NCT01901419|521305134|FG000|Overall Study|unavailable researchers|6|||
144574461|NCT01901419|521305135|FG001|Overall Study|unavailable researchers|3|||
144574462|NCT00699153|521305136|FG000|Overall Study|Lost to Follow-up|1|||
144574463|NCT00699153|521305137|FG001|Overall Study|Lost to Follow-up|0|||
144574464|NCT00699153|521305136|FG000|Overall Study|Adverse Event|0|||
144574465|NCT00699153|521305137|FG001|Overall Study|Adverse Event|2|||
144574466|NCT00699153|521305136|FG000|Overall Study|Protocol Violation|1|||
144574467|NCT00699153|521305137|FG001|Overall Study|Protocol Violation|0|||
144574468|NCT00699153|521305136|FG000|Overall Study|Travel Problem|1|||
144207395|NCT03146962|519954314|FG008|Overall Study|Adverse Event|0|||
144574469|NCT00699153|521305137|FG001|Overall Study|Travel Problem|0|||
144574470|NCT02412735|521305140|FG000|Overall Study|Adverse Event|0|||
144574471|NCT02412735|521305141|FG001|Overall Study|Adverse Event|1|||
144574472|NCT02412735|521305142|FG002|Overall Study|Adverse Event|2|||
144574473|NCT02412735|521305140|FG000|Overall Study|Withdrawal by Subject|23|||
144574474|NCT02412735|521305141|FG001|Overall Study|Withdrawal by Subject|27|||
144574475|NCT02412735|521305142|FG002|Overall Study|Withdrawal by Subject|22|||
144574476|NCT02412735|521305140|FG000|Overall Study|Investigator Decision|3|||
144574477|NCT02412735|521305141|FG001|Overall Study|Investigator Decision|3|||
144574478|NCT02412735|521305142|FG002|Overall Study|Investigator Decision|2|||
144574479|NCT02412735|521305140|FG000|Overall Study|Lost to Follow-up|17|||
144574480|NCT02412735|521305141|FG001|Overall Study|Lost to Follow-up|11|||
144574481|NCT02412735|521305142|FG002|Overall Study|Lost to Follow-up|18|||
144574482|NCT02412735|521305140|FG000|Overall Study|Reason not Specified|3|||
144574483|NCT02412735|521305141|FG001|Overall Study|Reason not Specified|2|||
144574484|NCT02412735|521305142|FG002|Overall Study|Reason not Specified|2|||
144574485|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
144574486|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
144574487|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144574488|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
144574489|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144574490|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144574491|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
144574492|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
144574493|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144574494|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144574495|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
144574496|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144574497|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
144574498|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
144574499|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144574500|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
144574501|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
144574502|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
144574503|NCT00603525|521305144|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
144574504|NCT00603525|521305145|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
144574505|NCT00603525|521305146|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
144574506|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
144574507|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
144574508|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
144574509|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
144574510|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
144574511|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
144574512|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
144574513|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
144574514|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
144574515|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
144574516|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
144574517|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
144574518|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
144574519|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
144574520|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
144574521|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
144574522|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
144574523|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
144574524|NCT00603525|521305144|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
144574525|NCT00603525|521305145|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
144574526|NCT00603525|521305146|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
144574527|NCT00603525|521305144|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
144574528|NCT00603525|521305145|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
144574529|NCT00603525|521305146|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
144574530|NCT04043143|521305147|FG000|Overall Study|Lost to Follow-up|5|||
144574531|NCT04043143|521305148|FG001|Overall Study|Lost to Follow-up|5|||
144574532|NCT04043143|521305147|FG000|Overall Study|screen failure|1|||
144574533|NCT04043143|521305148|FG001|Overall Study|screen failure|0|||
144574534|NCT04201288|521305160|FG000|Overall Study|Death|1|||
144574535|NCT04201288|521305161|FG001|Overall Study|Death|1|||
144574536|NCT04201288|521305160|FG000|Overall Study|Lost to Follow-up|5|||
144574537|NCT04201288|521305161|FG001|Overall Study|Lost to Follow-up|3|||
144574538|NCT04201288|521305160|FG000|Overall Study|Withdrawal by Subject|1|||
144574539|NCT04201288|521305161|FG001|Overall Study|Withdrawal by Subject|0|||
144574540|NCT04497389|521305164|FG000|Overall Study|Withdrawal by Subject|1|||
144574541|NCT04497389|521305165|FG001|Overall Study|Withdrawal by Subject|0|||
144574542|NCT00789360|521305168|FG000|Overall Study|Protocol Violation|3|||
144574543|NCT00789360|521305169|FG001|Overall Study|Protocol Violation|1|||
144574544|NCT03322540|521305174|FG000|Overall Study|Death|21|||
144574545|NCT03322540|521305175|FG001|Overall Study|Death|28|||
144574546|NCT03322540|521305174|FG000|Overall Study|Lost to Follow-up|0|||
144574547|NCT03322540|521305175|FG001|Overall Study|Lost to Follow-up|1|||
144574548|NCT03322540|521305174|FG000|Overall Study|Physician Decision|7|||
144574549|NCT03322540|521305175|FG001|Overall Study|Physician Decision|6|||
144574550|NCT03322540|521305174|FG000|Overall Study|Withdrawal by Subject|3|||
144574551|NCT03322540|521305175|FG001|Overall Study|Withdrawal by Subject|1|||
144574552|NCT03322540|521305174|FG000|Overall Study|Study terminated by sponsor|0|||
144574553|NCT03322540|521305175|FG001|Overall Study|Study terminated by sponsor|1|||
144574554|NCT03445533|521305176|FG000|Overall Study|Progressive Disease|48|||
144574555|NCT03445533|521305177|FG001|Overall Study|Progressive Disease|81|||
144574556|NCT03445533|521305176|FG000|Overall Study|Adverse Event|60|||
144574557|NCT03445533|521305177|FG001|Overall Study|Adverse Event|64|||
144574558|NCT03445533|521305176|FG000|Overall Study|Death|9|||
144574559|NCT03445533|521305177|FG001|Overall Study|Death|19|||
144574560|NCT03445533|521305176|FG000|Overall Study|Miscellaneous|0|||
144574561|NCT03445533|521305177|FG001|Overall Study|Miscellaneous|16|||
144574562|NCT03445533|521305176|FG000|Overall Study|Withdrawal by Subject|3|||
144574563|NCT03445533|521305177|FG001|Overall Study|Withdrawal by Subject|4|||
144574564|NCT03445533|521305176|FG000|Overall Study|Physician Decision|1|||
144574565|NCT03445533|521305177|FG001|Overall Study|Physician Decision|3|||
144574566|NCT03445533|521305176|FG000|Overall Study|Sponsor Decision|0|||
144574567|NCT03445533|521305177|FG001|Overall Study|Sponsor Decision|1|||
144574568|NCT03445533|521305176|FG000|Overall Study|Lost to Follow-up|0|||
144574569|NCT03445533|521305177|FG001|Overall Study|Lost to Follow-up|1|||
144574570|NCT03445533|521305176|FG000|Overall Study|Never Received any Study Treatment|7|||
144574571|NCT03445533|521305177|FG001|Overall Study|Never Received any Study Treatment|4|||
144574572|NCT02615509|521305178|FG000|Overall Study|Lost to Follow-up|134|||
144574573|NCT02615509|521305178|FG000|Overall Study|Death|4|||
144574574|NCT02615509|521305178|FG000|Overall Study|Withdrawal by Subject|8|||
144574575|NCT03274453|521305179|FG000|Overall Study|Lost to Follow-up|2|||
144574576|NCT03274453|521305180|FG001|Overall Study|Lost to Follow-up|5|||
144574577|NCT03274453|521305181|FG002|Overall Study|Lost to Follow-up|4|||
144574578|NCT03274453|521305182|FG003|Overall Study|Lost to Follow-up|1|||
144574579|NCT03274453|521305179|FG000|Overall Study|Physician Decision|2|||
144574580|NCT03274453|521305180|FG001|Overall Study|Physician Decision|0|||
144574581|NCT03274453|521305181|FG002|Overall Study|Physician Decision|0|||
144574582|NCT03274453|521305182|FG003|Overall Study|Physician Decision|3|||
144574583|NCT03274453|521305179|FG000|Overall Study|Surgery Cancelled|0|||
144574584|NCT03274453|521305180|FG001|Overall Study|Surgery Cancelled|1|||
144574585|NCT03274453|521305181|FG002|Overall Study|Surgery Cancelled|0|||
144574586|NCT03274453|521305182|FG003|Overall Study|Surgery Cancelled|0|||
144574587|NCT00968526|521305184|FG000|Overall Study|Adverse Event|2|||
144574588|NCT00968526|521305185|FG001|Overall Study|Adverse Event|0|||
144574589|NCT00968526|521305184|FG000|Overall Study|Migrated/moved from study area|1|||
144574590|NCT00968526|521305185|FG001|Overall Study|Migrated/moved from study area|0|||
144574591|NCT04703192|521305189|FG000|Overall Study|Withdrawal by Subject|2|||
144574592|NCT04703192|521305190|FG001|Overall Study|Withdrawal by Subject|0|||
144574593|NCT04703192|521305189|FG000|Overall Study|Death|3|||
144574594|NCT04703192|521305190|FG001|Overall Study|Death|1|||
144574595|NCT04703192|521305189|FG000|Overall Study|Adverse Event|13|||
144574596|NCT04703192|521305190|FG001|Overall Study|Adverse Event|2|||
144574597|NCT04703192|521305189|FG000|Overall Study|Progressive or Relapsed Disease|46|||
144574598|NCT04703192|521305190|FG001|Overall Study|Progressive or Relapsed Disease|7|||
144574599|NCT04703192|521305189|FG000|Overall Study|Clinical Progression|19|||
144621571|NCT02289950|521472272|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
144621572|NCT02289950|521472271|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
144621573|NCT02289950|521472272|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
144621574|NCT02289950|521472271|FG000|Overall Study|Lost to Follow-up|1|||
144621575|NCT02289950|521472272|FG001|Overall Study|Lost to Follow-up|0|||
144621576|NCT02289950|521472271|FG000|Overall Study|Physician Decision|9|||
144621577|NCT02289950|521472272|FG001|Overall Study|Physician Decision|3|||
144621578|NCT02289950|521472271|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
144621579|NCT02289950|521472272|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
144621580|NCT02289950|521472271|FG000|Overall Study|Withdrawal by Subject|1|||
144621581|NCT02289950|521472272|FG001|Overall Study|Withdrawal by Subject|3|||
144574600|NCT04703192|521305190|FG001|Overall Study|Clinical Progression|8|||
144621582|NCT02289950|521472271|FG000|Overall Study|Test article held for greater than 28 days|0|||
144574601|NCT04703192|521305189|FG000|Overall Study|Lost to Follow-up|1|||
144574602|NCT04703192|521305190|FG001|Overall Study|Lost to Follow-up|0|||
144574603|NCT04703192|521305189|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
144574604|NCT04703192|521305190|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
144574605|NCT04703192|521305189|FG000|Overall Study|Other|5|||
144574606|NCT04703192|521305190|FG001|Overall Study|Other|1|||
144574607|NCT02493062|521305191|FG000|Overall Study|Physician Decision|12|||
144574608|NCT03926195|521305192|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
144574609|NCT03926195|521305193|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
144574610|NCT03926195|521305192|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
144574611|NCT03926195|521305193|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
144621583|NCT02289950|521472272|FG001|Overall Study|Test article held for greater than 28 days|1|||
144574612|NCT03926195|521305192|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
144574613|NCT03926195|521305193|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
144574614|NCT03926195|521305192|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
144574615|NCT03926195|521305193|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
144574616|NCT03926195|521305192|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
144574617|NCT03926195|521305193|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
144574618|NCT03926195|521305192|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
144574619|NCT03926195|521305193|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
144574620|NCT01327612|521305194|FG000|Overall Study|Withdrawal by Subject|0|||
144574621|NCT01327612|521305195|FG001|Overall Study|Withdrawal by Subject|0|||
144574622|NCT01327612|521305196|FG002|Overall Study|Withdrawal by Subject|0|||
144574623|NCT01327612|521305197|FG003|Overall Study|Withdrawal by Subject|0|||
144574624|NCT01327612|521305198|FG004|Overall Study|Withdrawal by Subject|0|||
144574625|NCT01327612|521305199|FG005|Overall Study|Withdrawal by Subject|1|||
144574626|NCT01327612|521305200|FG006|Overall Study|Withdrawal by Subject|0|||
144574627|NCT01327612|521305194|FG000|Overall Study|Disease Progression|1|||
144574628|NCT01327612|521305195|FG001|Overall Study|Disease Progression|1|||
144574629|NCT01327612|521305196|FG002|Overall Study|Disease Progression|1|||
144574630|NCT01327612|521305197|FG003|Overall Study|Disease Progression|0|||
144574631|NCT01327612|521305198|FG004|Overall Study|Disease Progression|1|||
144574632|NCT01327612|521305199|FG005|Overall Study|Disease Progression|2|||
144574633|NCT01327612|521305200|FG006|Overall Study|Disease Progression|2|||
144574634|NCT01327612|521305194|FG000|Overall Study|Administrative Decision|0|||
144574635|NCT01327612|521305195|FG001|Overall Study|Administrative Decision|0|||
144574636|NCT01327612|521305196|FG002|Overall Study|Administrative Decision|0|||
144574637|NCT01327612|521305197|FG003|Overall Study|Administrative Decision|1|||
144574638|NCT01327612|521305198|FG004|Overall Study|Administrative Decision|0|||
144574639|NCT01327612|521305199|FG005|Overall Study|Administrative Decision|0|||
144574640|NCT01327612|521305200|FG006|Overall Study|Administrative Decision|0|||
144574641|NCT01327612|521305194|FG000|Overall Study|Death|0|||
144574642|NCT01327612|521305195|FG001|Overall Study|Death|0|||
144574643|NCT01327612|521305196|FG002|Overall Study|Death|0|||
144574644|NCT01327612|521305197|FG003|Overall Study|Death|0|||
144574645|NCT01327612|521305198|FG004|Overall Study|Death|1|||
144574646|NCT01327612|521305199|FG005|Overall Study|Death|0|||
144574647|NCT01327612|521305200|FG006|Overall Study|Death|0|||
144574648|NCT01661205|521305201|FG000|Overall Study|Physician Decision|2|||
144574649|NCT00426127|521305202|FG000|Overall Study|Adverse Event|1|||
144574650|NCT00426127|521305202|FG000|Overall Study|Removed due to disease progression|1|||
144574651|NCT03111095|521305206|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
144574652|NCT03111095|521305207|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
144574653|NCT03111095|521305206|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
144574654|NCT03111095|521305207|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
144574655|NCT01689857|521305209|FG000|Overall Study|Lost to Follow-up|5|||
144574656|NCT01689857|521305210|FG001|Overall Study|Lost to Follow-up|2|||
144574657|NCT01730378|521305211|FG000|Overall Study|Lost to Follow-up|1|||
144574658|NCT01730378|521305212|FG001|Overall Study|Lost to Follow-up|0|||
144574659|NCT00955708|521305215|FG000|Overall Study|Death|269|||
144574660|NCT00955708|521305215|FG000|Overall Study|Lost to Follow-up|72|||
144574661|NCT00955708|521305215|FG000|Overall Study|Physician Decision|36|||
144574662|NCT00955708|521305215|FG000|Overall Study|Protocol Violation|134|||
144574663|NCT00955708|521305215|FG000|Overall Study|Registry Conclusion|186|||
144574664|NCT00955708|521305215|FG000|Overall Study|Product removed from service|94|||
144574665|NCT00955708|521305215|FG000|Overall Study|Patient Refused to participate further|116|||
144574666|NCT00955708|521305215|FG000|Overall Study|Closure of study location|60|||
144574667|NCT00955708|521305215|FG000|Overall Study|Patient changed care provider/moved|91|||
144574668|NCT05105087|521305216|FG000|Overall Study|Withdrawal by Subject|2|||
144574669|NCT05105087|521305216|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
144574670|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
144574671|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
144574672|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
144574673|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
144574674|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
144574675|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
144574676|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
144574677|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
144574678|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
144574679|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
144574680|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
144574681|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
144574682|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
144574683|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
144574684|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
144574685|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
144574686|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
144574687|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
144574688|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
144574689|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
144574690|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
144574691|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
144574692|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
144574693|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
144574694|NCT00479882|521305219|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
144574695|NCT00479882|521305220|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
144574696|NCT00479882|521305221|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
144574697|NCT00479882|521305222|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
144574698|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
144574699|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
144574700|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
144574701|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
144574702|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
144574703|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
144574704|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
144574705|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
144574706|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
144574707|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
144574708|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
144574709|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
144574710|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
144574711|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
144574712|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
144574713|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
144574714|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
144574715|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
144574716|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
144574717|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
144574718|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
144574719|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
144574720|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
144574721|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
144574722|NCT00479882|521305219|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
144574723|NCT00479882|521305220|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
144574724|NCT00479882|521305221|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
144574725|NCT00479882|521305222|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
144574726|NCT03738475|521305223|FG000|Overall Study|Participant Non-Compliance|1|||
144574727|NCT03738475|521305224|FG001|Overall Study|Participant Non-Compliance|0|||
144574728|NCT00737477|521305225|FG000|Overall Study|Adverse Event|9|||
144574729|NCT00737477|521305225|FG000|Overall Study|Death|9|||
144574730|NCT00737477|521305225|FG000|Overall Study|Treatment Refusal|1|||
144574731|NCT00737477|521305225|FG000|Overall Study|Withdrawal by Subject|1|||
144574732|NCT00737477|521305225|FG000|Overall Study|Renal Transplantation|10|||
144574733|NCT00737477|521305225|FG000|Overall Study|Other|4|||
144574734|NCT01132820|521305226|FG000|Overall Study|Ineligible: wrong cell type|1|||
144574735|NCT01132820|521305226|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
144574736|NCT01132820|521305226|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
144574737|NCT01132820|521305226|FG000|Overall Study|Never treated|1|||
144574738|NCT01132820|521305226|FG000|Overall Study|Inadequate data|1|||
144574739|NCT01370655|521305229|FG000|Period 1|Adverse Event|2|||
144574740|NCT01370655|521305230|FG001|Period 1|Adverse Event|0|||
144574741|NCT01370655|521305231|FG002|Period 1|Adverse Event|0|||
144574742|NCT01370655|521305232|FG003|Period 1|Adverse Event|0|||
144574743|NCT01370655|521305233|FG004|Period 1|Adverse Event|0|||
144574744|NCT01370655|521305234|FG005|Period 1|Adverse Event|0|||
144574745|NCT01370655|521305235|FG006|Period 1|Adverse Event|1|||
144574746|NCT01370655|521305236|FG007|Period 1|Adverse Event|0|||
144574747|NCT01370655|521305237|FG008|Period 1|Adverse Event|0|||
144574748|NCT01370655|521305238|FG009|Period 1|Adverse Event|0|||
144574749|NCT01370655|521305239|FG010|Period 1|Adverse Event|0|||
144574750|NCT01370655|521305240|FG011|Period 1|Adverse Event|0|||
144574751|NCT01370655|521305229|FG000|Period 2|Adverse Event|0|||
144574752|NCT01370655|521305230|FG001|Period 2|Adverse Event|0|||
144574753|NCT01370655|521305231|FG002|Period 2|Adverse Event|1|||
144574754|NCT01370655|521305232|FG003|Period 2|Adverse Event|0|||
144574755|NCT01370655|521305233|FG004|Period 2|Adverse Event|1|||
144574756|NCT01370655|521305234|FG005|Period 2|Adverse Event|0|||
144621584|NCT02289950|521472271|FG000|Overall Study|Adverse Event|11|||
144621585|NCT02289950|521472272|FG001|Overall Study|Adverse Event|3|||
144621586|NCT02289950|521472271|FG000|Overall Study|Death|1|||
144621587|NCT02289950|521472272|FG001|Overall Study|Death|1|||
144574757|NCT01370655|521305235|FG006|Period 2|Adverse Event|0|||
144574758|NCT01370655|521305236|FG007|Period 2|Adverse Event|1|||
144574759|NCT01370655|521305237|FG008|Period 2|Adverse Event|0|||
144574760|NCT01370655|521305238|FG009|Period 2|Adverse Event|0|||
144574761|NCT01370655|521305239|FG010|Period 2|Adverse Event|0|||
144574762|NCT01370655|521305240|FG011|Period 2|Adverse Event|0|||
144574763|NCT01370655|521305229|FG000|Period 2|met protocol specified stopping criteria|0|||
144574764|NCT01370655|521305230|FG001|Period 2|met protocol specified stopping criteria|0|||
144574765|NCT01370655|521305231|FG002|Period 2|met protocol specified stopping criteria|1|||
144574766|NCT01370655|521305232|FG003|Period 2|met protocol specified stopping criteria|0|||
144574767|NCT01370655|521305233|FG004|Period 2|met protocol specified stopping criteria|0|||
144574768|NCT01370655|521305234|FG005|Period 2|met protocol specified stopping criteria|0|||
144574769|NCT01370655|521305235|FG006|Period 2|met protocol specified stopping criteria|1|||
144574770|NCT01370655|521305236|FG007|Period 2|met protocol specified stopping criteria|0|||
144574771|NCT01370655|521305237|FG008|Period 2|met protocol specified stopping criteria|1|||
144574772|NCT01370655|521305238|FG009|Period 2|met protocol specified stopping criteria|0|||
144574773|NCT01370655|521305239|FG010|Period 2|met protocol specified stopping criteria|1|||
144574774|NCT01370655|521305240|FG011|Period 2|met protocol specified stopping criteria|0|||
144574775|NCT01370655|521305229|FG000|Period 2|Withdrawal by Subject|0|||
144574776|NCT01370655|521305230|FG001|Period 2|Withdrawal by Subject|0|||
144574777|NCT01370655|521305231|FG002|Period 2|Withdrawal by Subject|0|||
144574778|NCT01370655|521305232|FG003|Period 2|Withdrawal by Subject|0|||
144574779|NCT01370655|521305233|FG004|Period 2|Withdrawal by Subject|0|||
144574780|NCT01370655|521305234|FG005|Period 2|Withdrawal by Subject|0|||
144574781|NCT01370655|521305235|FG006|Period 2|Withdrawal by Subject|0|||
144574782|NCT01370655|521305236|FG007|Period 2|Withdrawal by Subject|0|||
144574783|NCT01370655|521305237|FG008|Period 2|Withdrawal by Subject|1|||
144574784|NCT01370655|521305238|FG009|Period 2|Withdrawal by Subject|0|||
144574785|NCT01370655|521305239|FG010|Period 2|Withdrawal by Subject|0|||
144574786|NCT01370655|521305240|FG011|Period 2|Withdrawal by Subject|0|||
144574787|NCT00659880|521305245|FG000|Overall Study|Lost to Follow-up|5|||
144574788|NCT01853475|521305246|FG000|Overall Study|Withdrawal by Subject|0|||
144574789|NCT01853475|521305247|FG001|Overall Study|Withdrawal by Subject|1|||
144574790|NCT01853475|521305248|FG002|Overall Study|Withdrawal by Subject|0|||
144574791|NCT01023958|521305253|FG000|Overall Study|Progressive disease|48|||
144574792|NCT01023958|521305253|FG000|Overall Study|Other adverse event|1|||
144574793|NCT01023958|521305253|FG000|Overall Study|Refused to continue medication|1|||
144574794|NCT02159040|521305254|FG000|Overall Study|Death|1|||
144574795|NCT01304498|521305255|FG000|Overall Study|Adverse Event|1|||
144574796|NCT01304498|521305256|FG001|Overall Study|Adverse Event|1|||
144574797|NCT01304498|521305255|FG000|Overall Study|Withdrawal by Subject|2|||
144574798|NCT01304498|521305256|FG001|Overall Study|Withdrawal by Subject|3|||
144574799|NCT01304498|521305255|FG000|Overall Study|Protocol Violation|1|||
144574800|NCT01304498|521305256|FG001|Overall Study|Protocol Violation|0|||
144574801|NCT01304498|521305255|FG000|Overall Study|Lost to Follow-up|2|||
144621588|NCT02289950|521472271|FG000|Overall Study|Other|5|||
144621589|NCT02289950|521472272|FG001|Overall Study|Other|2|||
144574802|NCT01304498|521305256|FG001|Overall Study|Lost to Follow-up|1|||
144574803|NCT03080493|521305257|FG000|Overall Study|Did not provide NRS pain results|1|||
144574804|NCT03080493|521305258|FG001|Overall Study|Did not provide NRS pain results|0|||
144574805|NCT03080493|521305257|FG000|Overall Study|Adverse Event|0|||
144574806|NCT03080493|521305258|FG001|Overall Study|Adverse Event|1|||
144574807|NCT03080493|521305257|FG000|Overall Study|Randomization error (parity group)|0|||
144574808|NCT03080493|521305258|FG001|Overall Study|Randomization error (parity group)|1|||
144574809|NCT00755417|521305259|FG000|Overall Study|Adverse Event|28|||
144574810|NCT00755417|521305260|FG001|Overall Study|Adverse Event|20|||
144574811|NCT00755417|521305261|FG002|Overall Study|Adverse Event|7|||
144574812|NCT00755417|521305259|FG000|Overall Study|Lack of Efficacy|8|||
144574813|NCT00755417|521305260|FG001|Overall Study|Lack of Efficacy|4|||
144574814|NCT00755417|521305261|FG002|Overall Study|Lack of Efficacy|9|||
144574815|NCT00755417|521305259|FG000|Overall Study|Protocol Violation|2|||
144574816|NCT00755417|521305260|FG001|Overall Study|Protocol Violation|1|||
144574817|NCT00755417|521305261|FG002|Overall Study|Protocol Violation|1|||
144574818|NCT00755417|521305259|FG000|Overall Study|Lost to Follow-up|3|||
144574819|NCT00755417|521305260|FG001|Overall Study|Lost to Follow-up|0|||
144574820|NCT00755417|521305261|FG002|Overall Study|Lost to Follow-up|1|||
144574821|NCT00755417|521305259|FG000|Overall Study|Withdrawal by Subject|12|||
144574822|NCT00755417|521305260|FG001|Overall Study|Withdrawal by Subject|12|||
144574823|NCT00755417|521305261|FG002|Overall Study|Withdrawal by Subject|12|||
144621590|NCT02289950|521472271|FG000|Overall Study|Not Treated|2|||
144621591|NCT02289950|521472272|FG001|Overall Study|Not Treated|1|||
144574824|NCT00755417|521305259|FG000|Overall Study|Not specified or missing data|9|||
144574825|NCT00755417|521305260|FG001|Overall Study|Not specified or missing data|18|||
144621592|NCT04153188|521472277|FG000|Overall Study|Lost to Follow-up|1|||
144574826|NCT00755417|521305261|FG002|Overall Study|Not specified or missing data|12|||
144574827|NCT03325777|521305264|FG000|Overall Study|Lost to Follow-up|9|||
144574828|NCT03325777|521305265|FG001|Overall Study|Lost to Follow-up|12|||
144574829|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
144574830|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
144574831|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
144574832|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
144574833|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
144574834|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
144574835|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
144574836|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
144574837|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
144574838|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
144574839|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
144574840|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
144574841|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
144574842|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
144574843|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
144574844|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
144574845|NCT04210843|521305267|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
144574846|NCT04210843|521305268|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
144574847|NCT04210843|521305267|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
144574848|NCT04210843|521305268|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
144574849|NCT04210843|521305267|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
144574850|NCT04210843|521305268|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
144574851|NCT04210843|521305267|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
144574852|NCT04210843|521305268|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
144574853|NCT04210843|521305267|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
144574854|NCT04210843|521305268|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
144574855|NCT04210843|521305267|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
144574856|NCT04210843|521305268|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
144574857|NCT04210843|521305267|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
144574858|NCT04210843|521305268|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
144574859|NCT04210843|521305267|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
144574860|NCT04210843|521305268|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
144574861|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
144574862|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
144574863|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
144574864|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
144574865|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
144574866|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
144574867|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
144574868|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
144574869|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
144574870|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
144574871|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
144574872|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
144574873|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
144574874|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
144574875|NCT04210843|521305267|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
144574876|NCT04210843|521305268|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
144574877|NCT01099917|521305269|FG000|Overall Study|Adverse Event|3|||
144574878|NCT01099917|521305269|FG000|Overall Study|Not Treated|24|||
144574879|NCT01485120|521305270|FG000|Overall Study|Withdrawal by Subject|2|||
144574880|NCT00422734|521305271|FG000|Overall Study|Physician Decision|1|||
144574881|NCT00422734|521305272|FG001|Overall Study|Physician Decision|1|||
144574882|NCT00422734|521305271|FG000|Overall Study|Protocol Violation|1|||
144574883|NCT00422734|521305272|FG001|Overall Study|Protocol Violation|6|||
144574884|NCT00422734|521305271|FG000|Overall Study|Withdrawal by Subject|12|||
144574885|NCT00422734|521305272|FG001|Overall Study|Withdrawal by Subject|8|||
144574886|NCT00422734|521305271|FG000|Overall Study|Adverse Event|0|||
144574887|NCT00422734|521305272|FG001|Overall Study|Adverse Event|3|||
144574888|NCT00422734|521305271|FG000|Overall Study|Partner Decision|0|||
144574889|NCT00422734|521305272|FG001|Overall Study|Partner Decision|3|||
144207396|NCT03146962|519954315|FG009|Overall Study|Adverse Event|0|||
144207397|NCT03146962|519954306|FG000|Overall Study|Withdrawal by Subject|0|||
144207398|NCT03146962|519954307|FG001|Overall Study|Withdrawal by Subject|0|||
144207399|NCT03146962|519954308|FG002|Overall Study|Withdrawal by Subject|0|||
144574890|NCT02344342|521305273|FG000|Overall Study|Industry partner dropped out|11|||
144574891|NCT02344342|521305274|FG001|Overall Study|Industry partner dropped out|9|||
144574892|NCT02344342|521305275|FG002|Overall Study|Industry partner dropped out|14|||
144574893|NCT02344342|521305276|FG003|Overall Study|Industry partner dropped out|10|||
144574894|NCT00848484|521305277|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
144574895|NCT00848484|521305278|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
144574896|NCT00848484|521305277|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
144574897|NCT00848484|521305278|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
144574898|NCT00848484|521305277|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
144574899|NCT00848484|521305278|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
144574900|NCT00848484|521305277|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
144574901|NCT00848484|521305278|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
144574902|NCT00848484|521305277|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
144574903|NCT00848484|521305278|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
144574904|NCT03355209|521305282|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
144574905|NCT03355209|521305283|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
144574906|NCT03355209|521305284|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
144574907|NCT03355209|521305285|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
144574908|NCT03355209|521305286|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
144574909|NCT03355209|521305287|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
144574910|NCT03355209|521305282|FG000|Part 1: Double-Blind Period|Death|0|||
144574911|NCT03355209|521305283|FG001|Part 1: Double-Blind Period|Death|0|||
144574912|NCT03355209|521305284|FG002|Part 1: Double-Blind Period|Death|1|||
144574913|NCT03355209|521305285|FG003|Part 1: Double-Blind Period|Death|0|||
144574914|NCT03355209|521305286|FG004|Part 1: Double-Blind Period|Death|0|||
144574915|NCT03355209|521305287|FG005|Part 1: Double-Blind Period|Death|0|||
144574916|NCT03355209|521305282|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
144574917|NCT03355209|521305283|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
144574918|NCT03355209|521305284|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
144574919|NCT03355209|521305285|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
144574920|NCT03355209|521305286|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
144574921|NCT03355209|521305287|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
144574922|NCT03355209|521305282|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
144574923|NCT03355209|521305283|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
144574924|NCT03355209|521305284|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
144574925|NCT03355209|521305285|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
144574926|NCT03355209|521305286|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
144574927|NCT03355209|521305287|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
144574928|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
144574929|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
144574930|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
144574931|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
144574932|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
144574933|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
144574934|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
144574935|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
144574936|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
144621593|NCT04153188|521472278|FG001|Overall Study|Lost to Follow-up|1|||
144621594|NCT04153188|521472277|FG000|Overall Study|Withdrawal by Subject|2|||
144574937|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
144574938|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
144574939|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
144574940|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
144574941|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
144574942|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
144574943|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
144574944|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
144574945|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
144621595|NCT04153188|521472278|FG001|Overall Study|Withdrawal by Subject|0|||
144621596|NCT04153188|521472277|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
144621597|NCT04153188|521472278|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
144621598|NCT01314716|521472280|FG000|Double-Blind Phase|Randomized but not treated|1|||
144574946|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
144621599|NCT01314716|521472281|FG001|Double-Blind Phase|Randomized but not treated|1|||
144621600|NCT01314716|521472280|FG000|Double-Blind Phase|Adverse Event|10|||
144574947|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
144621601|NCT01314716|521472281|FG001|Double-Blind Phase|Adverse Event|4|||
144574948|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
144621602|NCT01314716|521472280|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
144574949|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
144574950|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
144574951|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
144574952|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
144574953|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
144574954|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
144574955|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144574956|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
144574957|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144574958|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
144574959|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
144574960|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
144574961|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
144574962|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
144574963|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
144574964|NCT03355209|521305282|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
144574965|NCT03355209|521305283|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
144574966|NCT03355209|521305284|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
144574967|NCT03355209|521305285|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
144574968|NCT03355209|521305286|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
144574969|NCT03355209|521305287|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
144574970|NCT01081886|521305288|FG000|Overall Study|Study termination|11|||
144574971|NCT01081886|521305289|FG001|Overall Study|Study termination|13|||
144574972|NCT02567708|521305290|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
144574973|NCT02567708|521305291|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
144574974|NCT02567708|521305290|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
144574975|NCT02567708|521305291|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
144574976|NCT02567708|521305290|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
144574977|NCT02567708|521305291|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
144574978|NCT02567708|521305290|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
144574979|NCT02567708|521305291|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
144574980|NCT00706654|521305292|FG000|Conversion Phase|Lost to Follow-up|4|||
144574981|NCT00706654|521305293|FG001|Conversion Phase|Lost to Follow-up|0|||
144574982|NCT00706654|521305294|FG002|Conversion Phase|Lost to Follow-up|0|||
144574983|NCT00706654|521305295|FG003|Conversion Phase|Lost to Follow-up|0|||
144574984|NCT00706654|521305292|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
144574985|NCT00706654|521305293|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
144574986|NCT00706654|521305294|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
144574987|NCT00706654|521305295|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
144574988|NCT00706654|521305292|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
144574989|NCT00706654|521305293|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
144574990|NCT00706654|521305294|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
144574991|NCT00706654|521305295|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
144574992|NCT00706654|521305292|FG000|Conversion Phase|Withdrawn by Investigator|14|||
144574993|NCT00706654|521305293|FG001|Conversion Phase|Withdrawn by Investigator|0|||
144574994|NCT00706654|521305294|FG002|Conversion Phase|Withdrawn by Investigator|0|||
144574995|NCT00706654|521305295|FG003|Conversion Phase|Withdrawn by Investigator|0|||
144574996|NCT00706654|521305292|FG000|Conversion Phase|Withdrew Consent|38|||
144574997|NCT00706654|521305293|FG001|Conversion Phase|Withdrew Consent|0|||
144574998|NCT00706654|521305294|FG002|Conversion Phase|Withdrew Consent|0|||
144574999|NCT00706654|521305295|FG003|Conversion Phase|Withdrew Consent|0|||
144621603|NCT01314716|521472281|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
144621604|NCT01314716|521472280|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144621605|NCT01314716|521472281|FG001|Double-Blind Phase|Lost to Follow-up|1|||
144621606|NCT01314716|521472280|FG000|Double-Blind Phase|Sponsor request|1|||
144621607|NCT01314716|521472281|FG001|Double-Blind Phase|Sponsor request|2|||
144621608|NCT01314716|521472280|FG000|Double-Blind Phase|Physician Decision|0|||
144621609|NCT01314716|521472281|FG001|Double-Blind Phase|Physician Decision|1|||
144621610|NCT01314716|521472280|FG000|Open-Label Phase|Adverse Event|4|||
144621611|NCT01314716|521472281|FG001|Open-Label Phase|Adverse Event|6|||
144621612|NCT01314716|521472280|FG000|Open-Label Phase|Withdrawal by Subject|1|||
144621613|NCT01314716|521472281|FG001|Open-Label Phase|Withdrawal by Subject|2|||
144621614|NCT01314716|521472280|FG000|Open-Label Phase|Physician Decision|5|||
144621615|NCT01314716|521472281|FG001|Open-Label Phase|Physician Decision|4|||
144575000|NCT00706654|521305292|FG000|Conversion Phase|Adverse Event|18|||
144621616|NCT00700271|521472282|FG000|Overall Study|Adverse Event|4|||
144621617|NCT00700271|521472283|FG001|Overall Study|Adverse Event|6|||
144621618|NCT00700271|521472282|FG000|Overall Study|Protocol Violation|1|||
144621619|NCT00700271|521472283|FG001|Overall Study|Protocol Violation|0|||
144575001|NCT00706654|521305293|FG001|Conversion Phase|Adverse Event|0|||
144575002|NCT00706654|521305294|FG002|Conversion Phase|Adverse Event|0|||
144575003|NCT00706654|521305295|FG003|Conversion Phase|Adverse Event|0|||
144575004|NCT00706654|521305292|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
144575005|NCT00706654|521305293|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
144575006|NCT00706654|521305294|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
144575007|NCT00706654|521305295|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
144575008|NCT00706654|521305292|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
144575009|NCT00706654|521305293|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
144575010|NCT00706654|521305294|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
144575011|NCT00706654|521305295|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
144575012|NCT00706654|521305292|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
144575013|NCT00706654|521305293|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
144575014|NCT00706654|521305294|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
144575015|NCT00706654|521305295|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
144575016|NCT00706654|521305292|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
144575017|NCT00706654|521305293|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
144575018|NCT00706654|521305294|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
144575019|NCT00706654|521305295|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
144575020|NCT00706654|521305292|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
144575021|NCT00706654|521305293|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
144575022|NCT00706654|521305294|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
144575023|NCT00706654|521305295|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
144575024|NCT00706654|521305292|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
144575025|NCT00706654|521305293|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
144575026|NCT00706654|521305294|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
144575027|NCT00706654|521305295|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
144575028|NCT00706654|521305292|FG000|Oral Stabilization Phase|Withdrew consent|55|||
144575029|NCT00706654|521305293|FG001|Oral Stabilization Phase|Withdrew consent|0|||
144575030|NCT00706654|521305294|FG002|Oral Stabilization Phase|Withdrew consent|0|||
144575031|NCT00706654|521305295|FG003|Oral Stabilization Phase|Withdrew consent|0|||
144575032|NCT00706654|521305292|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
144575033|NCT00706654|521305293|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
144575034|NCT00706654|521305294|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
144575035|NCT00706654|521305295|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
144575036|NCT00706654|521305292|FG000|Oral Stabilization Phase|Adverse Event|21|||
144575037|NCT00706654|521305293|FG001|Oral Stabilization Phase|Adverse Event|0|||
144575038|NCT00706654|521305294|FG002|Oral Stabilization Phase|Adverse Event|0|||
144575039|NCT00706654|521305295|FG003|Oral Stabilization Phase|Adverse Event|0|||
144575040|NCT00706654|521305292|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
144575041|NCT00706654|521305293|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144575042|NCT00706654|521305294|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144575043|NCT00706654|521305295|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
144575044|NCT00706654|521305292|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
144575045|NCT00706654|521305293|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144575046|NCT00706654|521305294|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144575047|NCT00706654|521305295|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
144575048|NCT00706654|521305292|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
144575049|NCT00706654|521305293|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
144575050|NCT00706654|521305294|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
144575051|NCT00706654|521305295|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
144575052|NCT00706654|521305292|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
144575053|NCT00706654|521305293|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
144575054|NCT00706654|521305294|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
144575055|NCT00706654|521305295|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
144575056|NCT00706654|521305292|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
144575057|NCT00706654|521305293|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
144621620|NCT00700271|521472282|FG000|Overall Study|Administrative Reasons|1|||
144621621|NCT00700271|521472283|FG001|Overall Study|Administrative Reasons|0|||
144621622|NCT00700271|521472282|FG000|Overall Study|Withdrawal by Subject|6|||
144621623|NCT00700271|521472283|FG001|Overall Study|Withdrawal by Subject|4|||
144621624|NCT00700271|521472282|FG000|Overall Study|Lost to Follow-up|2|||
144575058|NCT00706654|521305294|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
144575059|NCT00706654|521305295|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
144262853|NCT01325350|520163769|FG002|Overall Study|Lost to Follow-up|5|||
144575060|NCT00706654|521305292|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
144575061|NCT00706654|521305293|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
144575062|NCT00706654|521305294|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
144621625|NCT00700271|521472283|FG001|Overall Study|Lost to Follow-up|2|||
144700087|NCT00948896|521754507|FG000|Randomization to 24 Months of Age|Death|1|||
144575063|NCT00706654|521305295|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
144575064|NCT00706654|521305292|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
144575065|NCT00706654|521305293|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
144575066|NCT00706654|521305294|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
144575067|NCT00706654|521305295|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
144575068|NCT00706654|521305292|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
144575069|NCT00706654|521305293|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
144575070|NCT00706654|521305294|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
144575071|NCT00706654|521305295|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
144575072|NCT00706654|521305292|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
144575073|NCT00706654|521305293|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
144575074|NCT00706654|521305294|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
144575075|NCT00706654|521305295|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
144575076|NCT00706654|521305292|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
144575077|NCT00706654|521305293|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
144575078|NCT00706654|521305294|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
144575079|NCT00706654|521305295|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
144575080|NCT05262751|521305296|FG000|Washout Period 2|Adverse Event|1|||
144575081|NCT05262751|521305297|FG001|Washout Period 2|Adverse Event|0|||
144575082|NCT05262751|521305298|FG002|Washout Period 2|Adverse Event|0|||
144575083|NCT05262751|521305299|FG003|Washout Period 2|Adverse Event|0|||
144575084|NCT05262751|521305300|FG004|Washout Period 2|Adverse Event|0|||
144575085|NCT05262751|521305301|FG005|Washout Period 2|Adverse Event|0|||
144575086|NCT05262751|521305296|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
144575087|NCT05262751|521305297|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
144575088|NCT05262751|521305298|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
144575089|NCT05262751|521305299|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
144575090|NCT05262751|521305300|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
144575091|NCT05262751|521305301|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
144575092|NCT01151215|521305302|FG000|Overall Study|Worsening of condition under study|1|||
144621626|NCT02028455|521472293|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
144621627|NCT02028455|521472294|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
144621628|NCT02028455|521472295|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
144621629|NCT02028455|521472296|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
144621630|NCT02028455|521472297|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
144621631|NCT02028455|521472298|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
144621632|NCT02028455|521472299|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
144621633|NCT02028455|521472300|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
144621634|NCT02028455|521472293|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
144621635|NCT02028455|521472294|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
144621636|NCT02028455|521472295|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
144621637|NCT02028455|521472296|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
144621638|NCT02028455|521472297|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
144621639|NCT02028455|521472298|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
144621640|NCT02028455|521472299|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
144621641|NCT02028455|521472300|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
144621642|NCT02028455|521472293|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
144621643|NCT02028455|521472294|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
144621644|NCT02028455|521472295|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
144621645|NCT02028455|521472296|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
144621646|NCT02028455|521472297|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
144621647|NCT02028455|521472298|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
144621648|NCT02028455|521472299|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
144621649|NCT02028455|521472300|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
144621650|NCT02028455|521472293|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
144621651|NCT02028455|521472294|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
144621652|NCT02028455|521472295|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
144621653|NCT02028455|521472296|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
144575093|NCT01151215|521305303|FG001|Overall Study|Worsening of condition under study|1|||
144575094|NCT01151215|521305304|FG002|Overall Study|Worsening of condition under study|1|||
144207400|NCT03146962|519954309|FG003|Overall Study|Withdrawal by Subject|0|||
144207401|NCT03146962|519954310|FG004|Overall Study|Withdrawal by Subject|1|||
144207402|NCT03146962|519954311|FG005|Overall Study|Withdrawal by Subject|0|||
144729939|NCT02106156|521868099|FG000|Overall Study|Lack of Tolerability|305|||
144575095|NCT01151215|521305302|FG000|Overall Study|Death|16|||
144575096|NCT01151215|521305303|FG001|Overall Study|Death|20|||
144575097|NCT01151215|521305304|FG002|Overall Study|Death|11|||
144575098|NCT01151215|521305302|FG000|Overall Study|Lost to Follow-up|0|||
144575099|NCT01151215|521305303|FG001|Overall Study|Lost to Follow-up|0|||
144575100|NCT01151215|521305304|FG002|Overall Study|Lost to Follow-up|3|||
144575101|NCT01151215|521305302|FG000|Overall Study|Withdrawal by Subject|3|||
144575102|NCT01151215|521305303|FG001|Overall Study|Withdrawal by Subject|1|||
144575103|NCT01151215|521305304|FG002|Overall Study|Withdrawal by Subject|2|||
144575104|NCT01151215|521305302|FG000|Overall Study|Disease progression|0|||
144575105|NCT01151215|521305303|FG001|Overall Study|Disease progression|1|||
144575106|NCT01151215|521305304|FG002|Overall Study|Disease progression|1|||
144575107|NCT01151215|521305302|FG000|Overall Study|Safety as judged by the investigator|0|||
144575108|NCT01151215|521305303|FG001|Overall Study|Safety as judged by the investigator|0|||
144575109|NCT01151215|521305304|FG002|Overall Study|Safety as judged by the investigator|1|||
144575110|NCT01427725|521305305|FG000|Overall Study|Lost to Follow-up|17|||
144575111|NCT01427725|521305305|FG000|Overall Study|Protocol Violation|1|||
144575112|NCT01427725|521305305|FG000|Overall Study|Drug not administered|1|||
144575113|NCT01427725|521305305|FG000|Overall Study|Failure to visit|7|||
144575114|NCT01427725|521305305|FG000|Overall Study|Adverse Event|46|||
144575115|NCT01427725|521305305|FG000|Overall Study|Failure to visit after administration|40|||
144575116|NCT01427725|521305305|FG000|Overall Study|Patient's rejection|27|||
144575117|NCT01427725|521305305|FG000|Overall Study|Transfer to a different hospital|17|||
144575118|NCT01427725|521305305|FG000|Overall Study|Lack of Efficacy|8|||
144575119|NCT01427725|521305305|FG000|Overall Study|Death|7|||
144575120|NCT01427725|521305305|FG000|Overall Study|Symptom improvement|6|||
144575121|NCT01427725|521305305|FG000|Overall Study|AE and Patient's rejection|5|||
144575122|NCT01427725|521305305|FG000|Overall Study|Physician Decision|5|||
144575123|NCT01427725|521305305|FG000|Overall Study|Exacerbation of underlying disease|5|||
144575124|NCT01427725|521305305|FG000|Overall Study|Oral feeding difficulty|5|||
144575125|NCT01427725|521305305|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
144575126|NCT01427725|521305305|FG000|Overall Study|Forgetting prescription|1|||
144575127|NCT01427725|521305305|FG000|Overall Study|Other|2|||
144575128|NCT01281839|521305306|FG000|Overall Study|Lost to Follow-up|6|||
144575129|NCT01281839|521305307|FG001|Overall Study|Lost to Follow-up|3|||
144575130|NCT01281839|521305306|FG000|Overall Study|Withdrawal by Subject|4|||
144575131|NCT01281839|521305307|FG001|Overall Study|Withdrawal by Subject|10|||
144575132|NCT01281839|521305306|FG000|Overall Study|Reason not specified|0|||
144575133|NCT01281839|521305307|FG001|Overall Study|Reason not specified|1|||
144575134|NCT01754753|521305308|FG000|Overall Study|Study close|43|||
144575135|NCT01754753|521305309|FG001|Overall Study|Study close|44|||
144575136|NCT01754753|521305308|FG000|Overall Study|Lost to Follow-up|9|||
144575137|NCT01754753|521305309|FG001|Overall Study|Lost to Follow-up|5|||
144575138|NCT00617929|521305310|FG000|Overall Study|Physician Decision|1|||
144575139|NCT00760747|521305315|FG000|Study Period II|Adverse Event|3|||
144575140|NCT00760747|521305316|FG001|Study Period II|Adverse Event|4|||
144575141|NCT00760747|521305315|FG000|Study Period II|Lack of Efficacy|0|||
144575142|NCT00760747|521305316|FG001|Study Period II|Lack of Efficacy|6|||
144575143|NCT00760747|521305315|FG000|Study Period II|Parent/Caregiver Decision|3|||
144575144|NCT00760747|521305316|FG001|Study Period II|Parent/Caregiver Decision|0|||
144575145|NCT00760747|521305315|FG000|Study Period II|Protocol Violation|6|||
144575146|NCT00760747|521305316|FG001|Study Period II|Protocol Violation|3|||
144729940|NCT02106156|521868100|FG001|Overall Study|Lack of Tolerability|3|||
144262854|NCT01325350|520163770|FG003|Overall Study|Lost to Follow-up|1|||
144575147|NCT00760747|521305315|FG000|Study Period II|Withdrawal by Subject|1|||
144575148|NCT00760747|521305316|FG001|Study Period II|Withdrawal by Subject|0|||
144575149|NCT00760747|521305315|FG000|Study Period II|No drug administered|0|||
144575150|NCT00760747|521305316|FG001|Study Period II|No drug administered|1|||
144575151|NCT00760747|521305315|FG000|Study Period III|Adverse Event|1|||
144575152|NCT00760747|521305316|FG001|Study Period III|Adverse Event|0|||
144575153|NCT00760747|521305315|FG000|Study Period III|Lack of Efficacy|1|||
144575154|NCT00760747|521305316|FG001|Study Period III|Lack of Efficacy|0|||
144575155|NCT00760747|521305315|FG000|Study Period III|Parent/Caregiver Decision|0|||
144575156|NCT00760747|521305316|FG001|Study Period III|Parent/Caregiver Decision|1|||
144575157|NCT00760747|521305315|FG000|Study Period III|Protocol Violation|1|||
144575158|NCT00760747|521305316|FG001|Study Period III|Protocol Violation|1|||
144575159|NCT00760747|521305315|FG000|Study Period III|Physician Decision|0|||
144575160|NCT00760747|521305316|FG001|Study Period III|Physician Decision|1|||
144575161|NCT00844597|521305317|FG000|Overall Study|Adverse Event|0|||
144575162|NCT00844597|521305318|FG001|Overall Study|Adverse Event|0|||
144575163|NCT00844597|521305319|FG002|Overall Study|Adverse Event|0|||
144575164|NCT00844597|521305320|FG003|Overall Study|Adverse Event|1|||
144575165|NCT00844597|521305321|FG004|Overall Study|Adverse Event|0|||
144575166|NCT00844597|521305322|FG005|Overall Study|Adverse Event|0|||
144575167|NCT04160988|521305323|FG000|Overall Study|poor image quality|28|||
144575168|NCT01426347|521305327|FG000|Overall Study|Lost to Follow-up|0|||
144575169|NCT01426347|521305328|FG001|Overall Study|Lost to Follow-up|3|||
144575170|NCT01426347|521305327|FG000|Overall Study|Protocol Violation|2|||
144575171|NCT01426347|521305328|FG001|Overall Study|Protocol Violation|0|||
144575172|NCT01426347|521305327|FG000|Overall Study|Withdrawal by Subject|5|||
144575173|NCT01426347|521305328|FG001|Overall Study|Withdrawal by Subject|0|||
144575174|NCT02592707|521305329|FG000|Overall Study|Consent Withdrawn|0|||
144575175|NCT02592707|521305330|FG001|Overall Study|Consent Withdrawn|1|||
144575176|NCT02592707|521305331|FG002|Overall Study|Consent Withdrawn|2|||
144575177|NCT02592707|521305332|FG003|Overall Study|Consent Withdrawn|0|||
144575178|NCT02592707|521305329|FG000|Overall Study|Death|1|||
144575179|NCT02592707|521305330|FG001|Overall Study|Death|0|||
144575180|NCT02592707|521305331|FG002|Overall Study|Death|0|||
144575181|NCT02592707|521305332|FG003|Overall Study|Death|0|||
144575182|NCT02592707|521305329|FG000|Overall Study|Progressive Disease|4|||
144575183|NCT02592707|521305330|FG001|Overall Study|Progressive Disease|4|||
144575184|NCT02592707|521305331|FG002|Overall Study|Progressive Disease|3|||
144575185|NCT02592707|521305332|FG003|Overall Study|Progressive Disease|3|||
144575186|NCT02592707|521305329|FG000|Overall Study|Other|0|||
144575187|NCT02592707|521305330|FG001|Overall Study|Other|0|||
144575188|NCT02592707|521305331|FG002|Overall Study|Other|1|||
144575189|NCT02592707|521305332|FG003|Overall Study|Other|2|||
144575190|NCT02592707|521305329|FG000|Overall Study|Never entered LTFU period|1|||
144575191|NCT02592707|521305330|FG001|Overall Study|Never entered LTFU period|0|||
144575192|NCT02592707|521305331|FG002|Overall Study|Never entered LTFU period|0|||
144575193|NCT02592707|521305332|FG003|Overall Study|Never entered LTFU period|2|||
144575194|NCT02124811|521307152|FG000|Overall Study|Early termination|2|||
144575195|NCT02124811|521307153|FG001|Overall Study|Early termination|2|||
144575196|NCT02124811|521307152|FG000|Overall Study|Withdrawal by Subject|1|||
144575197|NCT02124811|521307153|FG001|Overall Study|Withdrawal by Subject|0|||
144575198|NCT03480932|521307154|FG000|Overall Study|Death|1|||
144575199|NCT03480932|521307155|FG001|Overall Study|Death|1|||
144575200|NCT03480932|521307156|FG002|Overall Study|Death|0|||
144575201|NCT03480932|521307154|FG000|Overall Study|Lost to Follow-up|0|||
144575202|NCT03480932|521307155|FG001|Overall Study|Lost to Follow-up|2|||
144575203|NCT03480932|521307156|FG002|Overall Study|Lost to Follow-up|3|||
144575204|NCT03480932|521307154|FG000|Overall Study|Incarcerated|2|||
144575205|NCT03480932|521307155|FG001|Overall Study|Incarcerated|2|||
144575206|NCT03480932|521307156|FG002|Overall Study|Incarcerated|2|||
144575207|NCT04624243|521307157|FG000|Overall Study|Death|0|||
144575208|NCT04624243|521307158|FG001|Overall Study|Death|1|||
144575209|NCT04624243|521307159|FG002|Overall Study|Death|0|||
144575210|NCT04624243|521307160|FG003|Overall Study|Death|0|||
144575211|NCT04624243|521307161|FG004|Overall Study|Death|0|||
144575212|NCT04624243|521307157|FG000|Overall Study|Lost to Follow-up|2|||
144575213|NCT04624243|521307158|FG001|Overall Study|Lost to Follow-up|3|||
144575214|NCT04624243|521307159|FG002|Overall Study|Lost to Follow-up|7|||
144575215|NCT04624243|521307160|FG003|Overall Study|Lost to Follow-up|1|||
144575216|NCT04624243|521307161|FG004|Overall Study|Lost to Follow-up|3|||
144575217|NCT04624243|521307157|FG000|Overall Study|Physician Decision|3|||
144575218|NCT04624243|521307158|FG001|Overall Study|Physician Decision|8|||
144575219|NCT04624243|521307159|FG002|Overall Study|Physician Decision|15|||
144575220|NCT04624243|521307160|FG003|Overall Study|Physician Decision|2|||
144575221|NCT04624243|521307161|FG004|Overall Study|Physician Decision|11|||
144575222|NCT04624243|521307157|FG000|Overall Study|Withdrawal by Subject|19|||
144575223|NCT04624243|521307158|FG001|Overall Study|Withdrawal by Subject|44|||
144575224|NCT04624243|521307159|FG002|Overall Study|Withdrawal by Subject|40|||
144575225|NCT04624243|521307160|FG003|Overall Study|Withdrawal by Subject|21|||
144575226|NCT04624243|521307161|FG004|Overall Study|Withdrawal by Subject|39|||
144575227|NCT04624243|521307157|FG000|Overall Study|Miscellaneous|3|||
144575228|NCT04624243|521307158|FG001|Overall Study|Miscellaneous|12|||
144621654|NCT02028455|521472297|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
144621655|NCT02028455|521472298|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
144621656|NCT02028455|521472299|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
144621657|NCT02028455|521472300|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
144575229|NCT04624243|521307159|FG002|Overall Study|Miscellaneous|9|||
144575230|NCT04624243|521307160|FG003|Overall Study|Miscellaneous|4|||
144575231|NCT04624243|521307161|FG004|Overall Study|Miscellaneous|6|||
144575232|NCT04079868|521307162|FG000|Overall Study|Lost to Follow-up|100|||
144575233|NCT04079868|521307163|FG001|Overall Study|Lost to Follow-up|200|||
144575234|NCT04079868|521307162|FG000|Overall Study|Physician Decision|100|||
144575235|NCT04079868|521307163|FG001|Overall Study|Physician Decision|0|||
144575236|NCT03374488|521307164|FG000|Overall Study|Death|13|||
144575237|NCT03374488|521307165|FG001|Overall Study|Death|13|||
144575238|NCT03374488|521307164|FG000|Overall Study|Withdrawal by Subject|3|||
144575239|NCT03374488|521307165|FG001|Overall Study|Withdrawal by Subject|1|||
144575240|NCT03374488|521307164|FG000|Overall Study|Physician Decision|3|||
144575241|NCT03374488|521307165|FG001|Overall Study|Physician Decision|0|||
144575242|NCT01294397|521307166|FG000|Overall Study|Withdrawal by Subject|1|||
144575243|NCT01294397|521307166|FG000|Overall Study|Administrative Decision|1|||
144575244|NCT02057575|521307173|FG000|Overall Study|Adverse Event|0|||
144575245|NCT02057575|521307174|FG001|Overall Study|Adverse Event|2|||
144575246|NCT02057575|521307175|FG002|Overall Study|Adverse Event|0|||
144575247|NCT02057575|521307176|FG003|Overall Study|Adverse Event|1|||
144575248|NCT02057575|521307173|FG000|Overall Study|Withdrawal by Subject|1|||
144575249|NCT02057575|521307174|FG001|Overall Study|Withdrawal by Subject|0|||
144575250|NCT02057575|521307175|FG002|Overall Study|Withdrawal by Subject|0|||
144575251|NCT02057575|521307176|FG003|Overall Study|Withdrawal by Subject|0|||
144575252|NCT02057575|521307173|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
144575253|NCT02057575|521307174|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
144575254|NCT02057575|521307175|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
144575255|NCT02057575|521307176|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
144575256|NCT02057575|521307173|FG000|Overall Study|Protocol Violation|0|||
144575257|NCT02057575|521307174|FG001|Overall Study|Protocol Violation|1|||
144575258|NCT02057575|521307175|FG002|Overall Study|Protocol Violation|0|||
144575259|NCT02057575|521307176|FG003|Overall Study|Protocol Violation|0|||
144575260|NCT00332462|521307177|FG000|Overall Study|Adverse Event|5|||
144575261|NCT00332462|521307177|FG000|Overall Study|Abnormal Lab Value|1|||
144575262|NCT00332462|521307177|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144575263|NCT00332462|521307177|FG000|Overall Study|no longer requires study drug|1|||
144575264|NCT00332462|521307177|FG000|Overall Study|Death|3|||
144575265|NCT00332462|521307177|FG000|Overall Study|Graft Loss|2|||
144575266|NCT00863681|521307178|FG000|Overall Study|Other|2|||
144575267|NCT00863681|521307179|FG001|Overall Study|Other|0|||
144575268|NCT00863681|521307180|FG002|Overall Study|Other|0|||
144575269|NCT00863681|521307178|FG000|Overall Study|Missing|1|||
144575270|NCT00863681|521307179|FG001|Overall Study|Missing|0|||
144575271|NCT00863681|521307180|FG002|Overall Study|Missing|0|||
144575272|NCT00863681|521307178|FG000|Overall Study|Death|40|||
144575273|NCT00863681|521307179|FG001|Overall Study|Death|23|||
144575274|NCT00863681|521307180|FG002|Overall Study|Death|6|||
144575275|NCT00863681|521307178|FG000|Overall Study|Withdrawal by Subject|12|||
144575276|NCT00863681|521307179|FG001|Overall Study|Withdrawal by Subject|5|||
144575277|NCT00863681|521307180|FG002|Overall Study|Withdrawal by Subject|2|||
144575278|NCT00863681|521307178|FG000|Overall Study|Protocol Violation|2|||
144575279|NCT00863681|521307179|FG001|Overall Study|Protocol Violation|0|||
144575280|NCT00863681|521307180|FG002|Overall Study|Protocol Violation|0|||
144575281|NCT00863681|521307178|FG000|Overall Study|Lost to Follow-up|3|||
144575282|NCT00863681|521307179|FG001|Overall Study|Lost to Follow-up|0|||
144575283|NCT00863681|521307180|FG002|Overall Study|Lost to Follow-up|3|||
144575284|NCT00863681|521307178|FG000|Overall Study|Adverse Event|28|||
144575285|NCT00863681|521307179|FG001|Overall Study|Adverse Event|10|||
144575286|NCT00863681|521307180|FG002|Overall Study|Adverse Event|6|||
144575287|NCT00863681|521307178|FG000|Overall Study|Lack of Efficacy|2|||
144575288|NCT00863681|521307179|FG001|Overall Study|Lack of Efficacy|2|||
144575289|NCT00863681|521307180|FG002|Overall Study|Lack of Efficacy|1|||
144575290|NCT00863681|521307178|FG000|Overall Study|Non-compliance with study drug|1|||
144575291|NCT00863681|521307179|FG001|Overall Study|Non-compliance with study drug|3|||
144575292|NCT00863681|521307180|FG002|Overall Study|Non-compliance with study drug|0|||
144575293|NCT02922023|521307181|FG000|Overall Study|Lost to Follow-up|2|||
144575294|NCT02922023|521307182|FG001|Overall Study|Lost to Follow-up|0|||
144575295|NCT01735175|521307183|FG000|Overall Study|Withdrawal by Subject|9|||
144575296|NCT01735175|521307184|FG001|Overall Study|Withdrawal by Subject|2|||
144575297|NCT01735175|521307183|FG000|Overall Study|Lost to Follow-up|4|||
144575298|NCT01735175|521307184|FG001|Overall Study|Lost to Follow-up|2|||
144575299|NCT01735175|521307183|FG000|Overall Study|Death|3|||
144575300|NCT01735175|521307184|FG001|Overall Study|Death|2|||
144575301|NCT01735175|521307183|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
144575302|NCT01735175|521307184|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
144575303|NCT03199469|521307185|FG000|Overall Study|Randomized, not treated|0|||
144575304|NCT03199469|521307186|FG001|Overall Study|Randomized, not treated|3|||
144575305|NCT03199469|521307185|FG000|Overall Study|Withdrawal by Subject|1|||
144575306|NCT03199469|521307186|FG001|Overall Study|Withdrawal by Subject|0|||
144575307|NCT03199469|521307185|FG000|Overall Study|Death|1|||
144621658|NCT04179175|521473576|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
144621659|NCT04179175|521473577|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
144621660|NCT04179175|521473578|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
144207403|NCT03146962|519954312|FG006|Overall Study|Withdrawal by Subject|0|||
144207404|NCT03146962|519954313|FG007|Overall Study|Withdrawal by Subject|0|||
144207405|NCT03146962|519954314|FG008|Overall Study|Withdrawal by Subject|0|||
144207406|NCT03146962|519954315|FG009|Overall Study|Withdrawal by Subject|0|||
144575308|NCT03199469|521307186|FG001|Overall Study|Death|3|||
144575309|NCT03199469|521307185|FG000|Overall Study|Ongoing|5|||
144575310|NCT03199469|521307186|FG001|Overall Study|Ongoing|14|||
144575311|NCT03443414|521307187|FG000|Overall Study|Adverse Event|6|||
144575312|NCT03443414|521307188|FG001|Overall Study|Adverse Event|0|||
144575313|NCT03443414|521307189|FG002|Overall Study|Adverse Event|4|||
144575314|NCT03443414|521307190|FG003|Overall Study|Adverse Event|2|||
144575315|NCT03443414|521307191|FG004|Overall Study|Adverse Event|3|||
144575316|NCT03443414|521307187|FG000|Overall Study|Withdrawal by Subject|3|||
144575317|NCT03443414|521307188|FG001|Overall Study|Withdrawal by Subject|2|||
144575318|NCT03443414|521307189|FG002|Overall Study|Withdrawal by Subject|2|||
144575319|NCT03443414|521307190|FG003|Overall Study|Withdrawal by Subject|2|||
144575320|NCT03443414|521307191|FG004|Overall Study|Withdrawal by Subject|1|||
144575321|NCT03443414|521307187|FG000|Overall Study|Death|0|||
144575322|NCT03443414|521307188|FG001|Overall Study|Death|1|||
144575323|NCT03443414|521307189|FG002|Overall Study|Death|0|||
144575324|NCT03443414|521307190|FG003|Overall Study|Death|1|||
144575325|NCT03443414|521307191|FG004|Overall Study|Death|0|||
144575326|NCT03443414|521307187|FG000|Overall Study|Reason not specified|2|||
144575327|NCT03443414|521307188|FG001|Overall Study|Reason not specified|0|||
144575328|NCT03443414|521307189|FG002|Overall Study|Reason not specified|0|||
144575329|NCT03443414|521307190|FG003|Overall Study|Reason not specified|0|||
144575330|NCT03443414|521307191|FG004|Overall Study|Reason not specified|1|||
144575331|NCT04276051|521307195|FG000|Overall Study|Lost to Follow-up|0|||
144575332|NCT04276051|521307196|FG001|Overall Study|Lost to Follow-up|1|||
144575333|NCT04276051|521307195|FG000|Overall Study|Physician Decision|0|||
144575334|NCT04276051|521307196|FG001|Overall Study|Physician Decision|1|||
144575335|NCT04276051|521307195|FG000|Overall Study|Withdrawal by Subject|1|||
144575336|NCT04276051|521307196|FG001|Overall Study|Withdrawal by Subject|1|||
144575337|NCT01912404|521307197|FG000|Overall Study|Due to personal reasons|1|||
144575338|NCT01912404|521307198|FG001|Overall Study|Due to personal reasons|0|||
144575339|NCT02269423|521307202|FG000|Overall Study|Discontinued due to change in residence|0|||
144575340|NCT02269423|521307203|FG001|Overall Study|Discontinued due to change in residence|1|||
144575341|NCT02269423|521307204|FG002|Overall Study|Discontinued due to change in residence|0|||
144575342|NCT02269423|521307205|FG003|Overall Study|Discontinued due to change in residence|1|||
144575343|NCT00856245|521307208|FG000|Overall Study|Was not transplanted|5|||
144575344|NCT02670122|521307209|FG000|Overall Study|Lost to Follow-up|4|||
144575345|NCT02762903|521307212|FG000|Overall Study|Lost to Follow-up|0|||
144575346|NCT02762903|521307213|FG001|Overall Study|Lost to Follow-up|1|||
144575347|NCT01889069|521307214|FG000|Overall Study|Death|18|||
144575348|NCT01889069|521307214|FG000|Overall Study|Progression of Disease|14|||
144575349|NCT01889069|521307214|FG000|Overall Study|Lost to Follow-up|6|||
144575350|NCT01889069|521307214|FG000|Overall Study|Other|4|||
144575351|NCT01889069|521307214|FG000|Overall Study|Consent Withdrawal|3|||
144575352|NCT00108745|521307215|FG000|Overall Study|Withdrawal by Subject|19|||
144575353|NCT00108745|521307216|FG001|Overall Study|Withdrawal by Subject|12|||
144575354|NCT00108745|521307217|FG002|Overall Study|Withdrawal by Subject|12|||
144575355|NCT00108745|521307215|FG000|Overall Study|Never Treated|8|||
144575356|NCT00108745|521307216|FG001|Overall Study|Never Treated|10|||
144575357|NCT00108745|521307217|FG002|Overall Study|Never Treated|12|||
144575358|NCT00108745|521307215|FG000|Overall Study|Ineligible|7|||
144575359|NCT00108745|521307216|FG001|Overall Study|Ineligible|13|||
144575360|NCT00108745|521307217|FG002|Overall Study|Ineligible|13|||
144575361|NCT00243074|521307221|FG000|Overall Study|Ineligible|6|||
144575362|NCT00243074|521307221|FG000|Overall Study|Adverse Event|6|||
144575363|NCT00243074|521307221|FG000|Overall Study|Withdrawal by Subject|2|||
144575364|NCT00243074|521307221|FG000|Overall Study|Lack of Efficacy|36|||
144575365|NCT00243074|521307221|FG000|Overall Study|Death|2|||
144575366|NCT00243074|521307221|FG000|Overall Study|not protocol specified|1|||
144575367|NCT00243074|521307221|FG000|Overall Study|Did not receive any treatment|1|||
144621661|NCT04179175|521473579|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
144621662|NCT04179175|521473580|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
144621663|NCT04179175|521473581|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
144621664|NCT04179175|521473576|FG000|Overall Study|Adverse Event|5|||
144621665|NCT04179175|521473577|FG001|Overall Study|Adverse Event|3|||
144621666|NCT04179175|521473578|FG002|Overall Study|Adverse Event|3|||
144621667|NCT04179175|521473579|FG003|Overall Study|Adverse Event|4|||
144621668|NCT04179175|521473580|FG004|Overall Study|Adverse Event|6|||
144621669|NCT04179175|521473581|FG005|Overall Study|Adverse Event|6|||
144621670|NCT04179175|521473576|FG000|Overall Study|Lack of Efficacy|5|||
144621671|NCT04179175|521473577|FG001|Overall Study|Lack of Efficacy|1|||
144621672|NCT04179175|521473578|FG002|Overall Study|Lack of Efficacy|3|||
144621673|NCT04179175|521473579|FG003|Overall Study|Lack of Efficacy|2|||
144621674|NCT04179175|521473580|FG004|Overall Study|Lack of Efficacy|18|||
144621675|NCT04179175|521473581|FG005|Overall Study|Lack of Efficacy|7|||
144621676|NCT04179175|521473576|FG000|Overall Study|Lost to Follow-up|5|||
144729941|NCT02106156|521868101|FG002|Overall Study|Lack of Tolerability|0|||
144575368|NCT01371708|521307226|FG000|Overall Study|Insufficient clinical response|3|||
144621677|NCT04179175|521473577|FG001|Overall Study|Lost to Follow-up|3|||
144575369|NCT01371708|521307227|FG001|Overall Study|Insufficient clinical response|2|||
144575370|NCT01371708|521307228|FG002|Overall Study|Insufficient clinical response|0|||
144575371|NCT01371708|521307226|FG000|Overall Study|Lost to Follow-up|5|||
144575372|NCT01371708|521307227|FG001|Overall Study|Lost to Follow-up|9|||
144575373|NCT01371708|521307228|FG002|Overall Study|Lost to Follow-up|7|||
144575374|NCT01371708|521307226|FG000|Overall Study|Protocol Violation|2|||
144575375|NCT01371708|521307227|FG001|Overall Study|Protocol Violation|1|||
144621678|NCT04179175|521473578|FG002|Overall Study|Lost to Follow-up|2|||
144575376|NCT01371708|521307228|FG002|Overall Study|Protocol Violation|2|||
144575377|NCT01371708|521307226|FG000|Overall Study|No longer willing to participate|7|||
144575378|NCT01371708|521307227|FG001|Overall Study|No longer willing to participate|7|||
144575379|NCT01371708|521307228|FG002|Overall Study|No longer willing to participate|13|||
144575380|NCT01371708|521307226|FG000|Overall Study|Medication error/not related to AE|0|||
144575381|NCT01371708|521307227|FG001|Overall Study|Medication error/not related to AE|1|||
144575382|NCT01371708|521307228|FG002|Overall Study|Medication error/not related to AE|0|||
144575383|NCT01371708|521307226|FG000|Overall Study|Other|3|||
144575384|NCT01371708|521307227|FG001|Overall Study|Other|2|||
144575385|NCT01371708|521307228|FG002|Overall Study|Other|4|||
144575386|NCT01371708|521307226|FG000|Overall Study|Adverse Event|5|||
144575387|NCT01371708|521307227|FG001|Overall Study|Adverse Event|8|||
144575388|NCT01371708|521307228|FG002|Overall Study|Adverse Event|12|||
144621679|NCT04179175|521473579|FG003|Overall Study|Lost to Follow-up|2|||
144621680|NCT04179175|521473580|FG004|Overall Study|Lost to Follow-up|4|||
144621681|NCT04179175|521473581|FG005|Overall Study|Lost to Follow-up|5|||
144621682|NCT04179175|521473576|FG000|Overall Study|Physician Decision|2|||
144621683|NCT04179175|521473577|FG001|Overall Study|Physician Decision|0|||
144729942|NCT02106156|521868099|FG000|Overall Study|Lack of Virological Response|1044|||
144729943|NCT02106156|521868100|FG001|Overall Study|Lack of Virological Response|8|||
144729944|NCT02106156|521868101|FG002|Overall Study|Lack of Virological Response|0|||
144729945|NCT02106156|521868099|FG000|Overall Study|Concomitant Disease|74|||
144729946|NCT02106156|521868100|FG001|Overall Study|Concomitant Disease|2|||
144729947|NCT02106156|521868101|FG002|Overall Study|Concomitant Disease|0|||
144729948|NCT02106156|521868099|FG000|Overall Study|Lack of Compliance|211|||
144729949|NCT02106156|521868100|FG001|Overall Study|Lack of Compliance|7|||
144729950|NCT02106156|521868101|FG002|Overall Study|Lack of Compliance|0|||
144729951|NCT02106156|521868099|FG000|Overall Study|Patients Request|307|||
144729952|NCT02106156|521868100|FG001|Overall Study|Patients Request|9|||
144729953|NCT02106156|521868101|FG002|Overall Study|Patients Request|0|||
144729954|NCT02106156|521868099|FG000|Overall Study|Lost to Follow-up|451|||
144729955|NCT02106156|521868100|FG001|Overall Study|Lost to Follow-up|8|||
144729956|NCT02106156|521868101|FG002|Overall Study|Lost to Follow-up|0|||
144729957|NCT02106156|521868099|FG000|Overall Study|Unplanned Event|82|||
144729958|NCT02106156|521868100|FG001|Overall Study|Unplanned Event|2|||
144729959|NCT02106156|521868101|FG002|Overall Study|Unplanned Event|0|||
144729960|NCT02106156|521868099|FG000|Overall Study|Change of Laboratory Parameter|10|||
144729961|NCT02106156|521868100|FG001|Overall Study|Change of Laboratory Parameter|0|||
144729962|NCT02106156|521868101|FG002|Overall Study|Change of Laboratory Parameter|0|||
144729963|NCT02106156|521868099|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
144729964|NCT02106156|521868100|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
144729965|NCT02106156|521868101|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
144729966|NCT02106156|521868099|FG000|Overall Study|Relocation/Change of Physician|40|||
144729967|NCT02106156|521868100|FG001|Overall Study|Relocation/Change of Physician|1|||
144729968|NCT02106156|521868101|FG002|Overall Study|Relocation/Change of Physician|0|||
144729969|NCT05017480|521868111|FG000|Stage 1 Study|Withdrawal by Subject|8|||
144729970|NCT05017480|521868112|FG001|Stage 1 Study|Withdrawal by Subject|6|||
144729971|NCT05017480|521868113|FG002|Stage 1 Study|Withdrawal by Subject|0|||
144729972|NCT05017480|521868114|FG003|Stage 1 Study|Withdrawal by Subject|0|||
144729973|NCT05017480|521868115|FG004|Stage 1 Study|Withdrawal by Subject|0|||
144729974|NCT05017480|521868111|FG000|Stage 1 Study|Adverse Event|1|||
144729975|NCT05017480|521868112|FG001|Stage 1 Study|Adverse Event|1|||
144729976|NCT05017480|521868113|FG002|Stage 1 Study|Adverse Event|0|||
144729977|NCT05017480|521868114|FG003|Stage 1 Study|Adverse Event|0|||
144729978|NCT05017480|521868115|FG004|Stage 1 Study|Adverse Event|0|||
144729979|NCT05017480|521868111|FG000|Stage 1 Study|Poor Compliance|1|||
144621684|NCT04179175|521473578|FG002|Overall Study|Physician Decision|2|||
144621685|NCT04179175|521473579|FG003|Overall Study|Physician Decision|3|||
144621686|NCT04179175|521473580|FG004|Overall Study|Physician Decision|1|||
144621687|NCT04179175|521473581|FG005|Overall Study|Physician Decision|1|||
144621688|NCT04179175|521473576|FG000|Overall Study|Pregnancy|3|||
144262855|NCT01325350|520163771|FG004|Overall Study|Lost to Follow-up|5|||
144575389|NCT01371708|521307226|FG000|Overall Study|Started but did not receive treatment|1|||
144729980|NCT05017480|521868112|FG001|Stage 1 Study|Poor Compliance|1|||
144729981|NCT05017480|521868113|FG002|Stage 1 Study|Poor Compliance|0|||
144729982|NCT05017480|521868114|FG003|Stage 1 Study|Poor Compliance|0|||
144729983|NCT05017480|521868115|FG004|Stage 1 Study|Poor Compliance|0|||
144729984|NCT05017480|521868111|FG000|Stage 1 Study|Physician Decision|0|||
144729985|NCT05017480|521868112|FG001|Stage 1 Study|Physician Decision|1|||
144729986|NCT05017480|521868113|FG002|Stage 1 Study|Physician Decision|0|||
144729987|NCT05017480|521868114|FG003|Stage 1 Study|Physician Decision|0|||
144621689|NCT04179175|521473577|FG001|Overall Study|Pregnancy|0|||
144621690|NCT04179175|521473578|FG002|Overall Study|Pregnancy|3|||
144621691|NCT04179175|521473579|FG003|Overall Study|Pregnancy|0|||
144729988|NCT05017480|521868115|FG004|Stage 1 Study|Physician Decision|0|||
144621692|NCT04179175|521473580|FG004|Overall Study|Pregnancy|1|||
144621693|NCT04179175|521473581|FG005|Overall Study|Pregnancy|2|||
144621694|NCT04179175|521473576|FG000|Overall Study|Withdrawal by Subject|22|||
144575390|NCT01371708|521307227|FG001|Overall Study|Started but did not receive treatment|0|||
144575391|NCT01371708|521307228|FG002|Overall Study|Started but did not receive treatment|1|||
144575392|NCT00996606|521307239|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
144575393|NCT00996606|521307239|FG000|Overall Study|Insufficient Therapeutic Response|2|||
144575394|NCT00996606|521307239|FG000|Overall Study|Protocol Violation|1|||
144575395|NCT00996606|521307239|FG000|Overall Study|Withdrawal by Subject|3|||
144575396|NCT00632502|521307241|FG000|Overall Study|Adverse Event|0|||
144575397|NCT00632502|521307242|FG001|Overall Study|Adverse Event|1|||
144575398|NCT00632502|521307241|FG000|Overall Study|Randomized not treated|3|||
144575399|NCT00632502|521307242|FG001|Overall Study|Randomized not treated|0|||
144575400|NCT04954326|521307243|FG000|Overall Study|Protocol Violation|0|||
144575401|NCT04954326|521307244|FG001|Overall Study|Protocol Violation|1|||
144575402|NCT04954326|521307243|FG000|Overall Study|Death|0|||
144575403|NCT04954326|521307244|FG001|Overall Study|Death|2|||
144575404|NCT04954326|521307243|FG000|Overall Study|Physician Decision|0|||
144575405|NCT04954326|521307244|FG001|Overall Study|Physician Decision|1|||
144575406|NCT01213524|521307245|FG000|Baseline|Withdrawal by Subject|5|||
144575407|NCT01213524|521307245|FG000|Baseline|high breath alcohol levels|1|||
144575408|NCT01213524|521307245|FG000|Baseline|Physician Decision|1|||
144575409|NCT01213524|521307245|FG000|Session 2|Withdrawal by Subject|5|||
144575410|NCT01213524|521307245|FG000|Session 3|Withdrawal by Subject|4|||
144575411|NCT01213524|521307245|FG000|Session 4|Physician Decision|1|||
144575412|NCT01213524|521307245|FG000|Session 4|Withdrawal by Subject|2|||
144575413|NCT02519348|521307249|FG000|Overall Study|Death|31|||
144575414|NCT02519348|521307250|FG001|Overall Study|Death|74|||
144575415|NCT02519348|521307251|FG002|Overall Study|Death|47|||
144575416|NCT02519348|521307252|FG003|Overall Study|Death|54|||
144575417|NCT02519348|521307253|FG004|Overall Study|Death|63|||
144575418|NCT02519348|521307254|FG005|Overall Study|Death|18|||
144575419|NCT02519348|521307255|FG006|Overall Study|Death|2|||
144575420|NCT02519348|521307256|FG007|Overall Study|Death|5|||
144575421|NCT02519348|521307257|FG008|Overall Study|Death|5|||
144575422|NCT02519348|521307249|FG000|Overall Study|Withdrawal by Subject|4|||
144575423|NCT02519348|521307250|FG001|Overall Study|Withdrawal by Subject|7|||
144729989|NCT05017480|521868111|FG000|Stage 2 Study|Withdrawal by Subject|0|||
144729990|NCT05017480|521868112|FG001|Stage 2 Study|Withdrawal by Subject|0|||
144729991|NCT05017480|521868113|FG002|Stage 2 Study|Withdrawal by Subject|6|||
144729992|NCT05017480|521868114|FG003|Stage 2 Study|Withdrawal by Subject|9|||
144729993|NCT05017480|521868115|FG004|Stage 2 Study|Withdrawal by Subject|11|||
144729994|NCT05017480|521868111|FG000|Stage 2 Study|Lost to Follow-up|0|||
144729995|NCT05017480|521868112|FG001|Stage 2 Study|Lost to Follow-up|0|||
144729996|NCT05017480|521868113|FG002|Stage 2 Study|Lost to Follow-up|0|||
144729997|NCT05017480|521868114|FG003|Stage 2 Study|Lost to Follow-up|2|||
144575424|NCT02519348|521307251|FG002|Overall Study|Withdrawal by Subject|4|||
144575425|NCT02519348|521307252|FG003|Overall Study|Withdrawal by Subject|3|||
144621695|NCT04179175|521473577|FG001|Overall Study|Withdrawal by Subject|10|||
144621696|NCT04179175|521473578|FG002|Overall Study|Withdrawal by Subject|12|||
144621697|NCT04179175|521473579|FG003|Overall Study|Withdrawal by Subject|8|||
144621698|NCT04179175|521473580|FG004|Overall Study|Withdrawal by Subject|23|||
144621699|NCT04179175|521473581|FG005|Overall Study|Withdrawal by Subject|31|||
144621700|NCT04179175|521473576|FG000|Overall Study|Technical problems|0|||
144621701|NCT04179175|521473577|FG001|Overall Study|Technical problems|0|||
144621702|NCT04179175|521473578|FG002|Overall Study|Technical problems|1|||
144621703|NCT04179175|521473579|FG003|Overall Study|Technical problems|1|||
144621704|NCT04179175|521473580|FG004|Overall Study|Technical problems|0|||
144621705|NCT04179175|521473581|FG005|Overall Study|Technical problems|0|||
144621706|NCT05593016|521473582|FG000|Overall Study|Death|1|||
144621707|NCT05593016|521473583|FG001|Overall Study|Death|1|||
144621708|NCT05593016|521473584|FG002|Overall Study|Death|1|||
144621709|NCT05593016|521473585|FG003|Overall Study|Death|0|||
144621710|NCT05593016|521473586|FG004|Overall Study|Death|0|||
144575426|NCT02519348|521307253|FG004|Overall Study|Withdrawal by Subject|3|||
144621711|NCT05593016|521473582|FG000|Overall Study|Lost to Follow-up|1|||
144621712|NCT05593016|521473583|FG001|Overall Study|Lost to Follow-up|1|||
144621713|NCT05593016|521473584|FG002|Overall Study|Lost to Follow-up|1|||
144729998|NCT05017480|521868115|FG004|Stage 2 Study|Lost to Follow-up|1|||
144575427|NCT02519348|521307254|FG005|Overall Study|Withdrawal by Subject|2|||
144575428|NCT02519348|521307255|FG006|Overall Study|Withdrawal by Subject|0|||
144207407|NCT03146962|519954306|FG000|Overall Study|Death|0|||
144575429|NCT02519348|521307256|FG007|Overall Study|Withdrawal by Subject|0|||
144575430|NCT02519348|521307257|FG008|Overall Study|Withdrawal by Subject|1|||
144575431|NCT02519348|521307249|FG000|Overall Study|Lost to Follow-up|0|||
144621714|NCT05593016|521473585|FG003|Overall Study|Lost to Follow-up|2|||
144621715|NCT05593016|521473586|FG004|Overall Study|Lost to Follow-up|0|||
144575432|NCT02519348|521307250|FG001|Overall Study|Lost to Follow-up|0|||
144575433|NCT02519348|521307251|FG002|Overall Study|Lost to Follow-up|1|||
144575434|NCT02519348|521307252|FG003|Overall Study|Lost to Follow-up|0|||
144621716|NCT04705051|521473587|FG000|Overall Study|Enrolled but not treated|1|||
144729999|NCT05017480|521868111|FG000|Stage 2 Study|Adverse Event|0|||
144730000|NCT05017480|521868112|FG001|Stage 2 Study|Adverse Event|0|||
144730001|NCT05017480|521868113|FG002|Stage 2 Study|Adverse Event|0|||
144730002|NCT05017480|521868114|FG003|Stage 2 Study|Adverse Event|1|||
144730003|NCT05017480|521868115|FG004|Stage 2 Study|Adverse Event|0|||
144730004|NCT05017480|521868111|FG000|Stage 2 Study|COVID-19|0|||
144730005|NCT05017480|521868112|FG001|Stage 2 Study|COVID-19|0|||
144730006|NCT05017480|521868113|FG002|Stage 2 Study|COVID-19|0|||
144575435|NCT02519348|521307253|FG004|Overall Study|Lost to Follow-up|2|||
144575436|NCT02519348|521307254|FG005|Overall Study|Lost to Follow-up|1|||
144575437|NCT02519348|521307255|FG006|Overall Study|Lost to Follow-up|1|||
144575438|NCT02519348|521307256|FG007|Overall Study|Lost to Follow-up|0|||
144575439|NCT02519348|521307257|FG008|Overall Study|Lost to Follow-up|0|||
144575440|NCT02519348|521307249|FG000|Overall Study|Other|0|||
144575441|NCT02519348|521307250|FG001|Overall Study|Other|3|||
144575442|NCT02519348|521307251|FG002|Overall Study|Other|0|||
144575443|NCT02519348|521307252|FG003|Overall Study|Other|0|||
144575444|NCT02519348|521307253|FG004|Overall Study|Other|1|||
144575445|NCT02519348|521307254|FG005|Overall Study|Other|0|||
144575446|NCT02519348|521307255|FG006|Overall Study|Other|0|||
144575447|NCT02519348|521307256|FG007|Overall Study|Other|0|||
144575448|NCT02519348|521307257|FG008|Overall Study|Other|0|||
144575449|NCT02519348|521307249|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
144575450|NCT02519348|521307250|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
144575451|NCT02519348|521307251|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
144575452|NCT02519348|521307252|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
144575453|NCT02519348|521307253|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
144575454|NCT02519348|521307254|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
144575455|NCT02519348|521307255|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
144575456|NCT02519348|521307256|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
144575457|NCT02519348|521307257|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
144575458|NCT05415748|521307261|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
144575459|NCT05415748|521307262|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
144575460|NCT05415748|521307263|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
144575461|NCT05415748|521307264|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
144575462|NCT05415748|521307261|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
144575463|NCT05415748|521307262|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
144575464|NCT05415748|521307263|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
144575465|NCT05415748|521307264|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
144575466|NCT03075527|521307265|FG000|Overall Study|Death|1|||
144575467|NCT03075527|521307265|FG000|Overall Study|Withdrawal by Subject|1|||
144575468|NCT03075527|521307265|FG000|Overall Study|Physician Decision|3|||
144575469|NCT03075527|521307265|FG000|Overall Study|Progression/Relapse|14|||
144575470|NCT00281320|521307270|FG000|Overall Study|Adverse Event|12|||
144575471|NCT00281320|521307271|FG001|Overall Study|Adverse Event|9|||
144575472|NCT00281320|521307270|FG000|Overall Study|Lack of Efficacy|4|||
144575473|NCT00281320|521307271|FG001|Overall Study|Lack of Efficacy|3|||
144575474|NCT00281320|521307270|FG000|Overall Study|Withdrawal by Subject|5|||
144575475|NCT00281320|521307271|FG001|Overall Study|Withdrawal by Subject|6|||
144575476|NCT00281320|521307270|FG000|Overall Study|Lost to Follow-up|1|||
144575477|NCT00281320|521307271|FG001|Overall Study|Lost to Follow-up|2|||
144575478|NCT00281320|521307270|FG000|Overall Study|Other|3|||
144575479|NCT00281320|521307271|FG001|Overall Study|Other|1|||
144575480|NCT00475228|521307272|FG000|Overall Study|Lost to Follow-up|17|||
144575481|NCT00475228|521307273|FG001|Overall Study|Lost to Follow-up|17|||
144575482|NCT00975676|521307275|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
144575483|NCT00975676|521307276|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
144575484|NCT02209181|521307277|FG000|Overall Study|Adverse Event|1|||
144575485|NCT02209181|521307278|FG001|Overall Study|Adverse Event|0|||
144575486|NCT02209181|521307279|FG002|Overall Study|Adverse Event|1|||
144575487|NCT02209181|521307280|FG003|Overall Study|Adverse Event|0|||
144575488|NCT02209181|521307277|FG000|Overall Study|Withdrawal by Subject|0|||
144575489|NCT02209181|521307278|FG001|Overall Study|Withdrawal by Subject|1|||
144575490|NCT02209181|521307279|FG002|Overall Study|Withdrawal by Subject|0|||
144575491|NCT02209181|521307280|FG003|Overall Study|Withdrawal by Subject|0|||
144575492|NCT02548078|521307281|FG000|Overall Study|Serious adverse event/Adverse event|1|||
144575493|NCT02548078|521307282|FG001|Overall Study|Serious adverse event/Adverse event|0|||
144575494|NCT02548078|521307281|FG000|Overall Study|Moved from study area|3|||
144575495|NCT02548078|521307282|FG001|Overall Study|Moved from study area|3|||
144575496|NCT02548078|521307281|FG000|Overall Study|Lost to Follow-up|1|||
144575497|NCT02548078|521307282|FG001|Overall Study|Lost to Follow-up|3|||
144575498|NCT02579772|521307283|FG000|Overall Study|Withdrawal by Subject|0|||
144575499|NCT02579772|521307284|FG001|Overall Study|Withdrawal by Subject|1|||
144575500|NCT02579772|521307283|FG000|Overall Study|Usage of additional antioxidants|1|||
144730007|NCT05017480|521868114|FG003|Stage 2 Study|COVID-19|1|||
144730008|NCT05017480|521868115|FG004|Stage 2 Study|COVID-19|0|||
144575501|NCT02579772|521307284|FG001|Overall Study|Usage of additional antioxidants|0|||
144730009|NCT05017480|521868111|FG000|Stage 2 Study|Pregnancy|0|||
144730010|NCT05017480|521868112|FG001|Stage 2 Study|Pregnancy|0|||
144575502|NCT02579772|521307283|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
144575503|NCT02579772|521307284|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
144575504|NCT03128671|521307285|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
144575505|NCT03128671|521307286|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
144575506|NCT03128671|521307285|FG000|Allocation|Death|1|||
144575507|NCT03128671|521307286|FG001|Allocation|Death|0|||
144575508|NCT03128671|521307285|FG000|Allocation|Withdrawal by Subject|4|||
144575509|NCT03128671|521307286|FG001|Allocation|Withdrawal by Subject|0|||
144575510|NCT03128671|521307285|FG000|Intervention|Withdrawal by Subject|11|||
144575511|NCT03128671|521307286|FG001|Intervention|Withdrawal by Subject|10|||
144575512|NCT03128671|521307285|FG000|Intervention|Palliative/hospice care initiated|9|||
144575513|NCT03128671|521307286|FG001|Intervention|Palliative/hospice care initiated|10|||
144575514|NCT03128671|521307285|FG000|Intervention|Death|13|||
144575515|NCT03128671|521307286|FG001|Intervention|Death|11|||
144575516|NCT03128671|521307285|FG000|Intervention|Interrupted by hurricane|1|||
144575517|NCT03128671|521307286|FG001|Intervention|Interrupted by hurricane|0|||
144621717|NCT04705051|521473587|FG000|Overall Study|Study terminated by sponsor|23|||
144621718|NCT01241708|521473588|FG000|Overall Study|Withdrawal by Subject|6|||
144621719|NCT01241708|521473588|FG000|Overall Study|Screen Failure|6|||
144621720|NCT01241708|521473588|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
144207408|NCT03146962|519954307|FG001|Overall Study|Death|1|||
144207409|NCT03146962|519954308|FG002|Overall Study|Death|0|||
144207410|NCT03146962|519954309|FG003|Overall Study|Death|0|||
144207411|NCT03146962|519954310|FG004|Overall Study|Death|0|||
144207412|NCT03146962|519954311|FG005|Overall Study|Death|0|||
144207413|NCT03146962|519954312|FG006|Overall Study|Death|0|||
144207414|NCT03146962|519954313|FG007|Overall Study|Death|0|||
144207415|NCT03146962|519954314|FG008|Overall Study|Death|0|||
144207416|NCT03146962|519954315|FG009|Overall Study|Death|0|||
144575518|NCT03128671|521307285|FG000|Intervention|Physician Decision|2|||
144575519|NCT03128671|521307286|FG001|Intervention|Physician Decision|3|||
144575520|NCT04641962|521307288|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
144575521|NCT04641962|521307289|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
144621721|NCT01241708|521473588|FG000|Overall Study|Lost to Follow-up|5|||
144621722|NCT02968810|521473591|FG000|Overall Study|Lost to Follow-up|1|||
144621723|NCT02968810|521473592|FG001|Overall Study|Lost to Follow-up|0|||
144621724|NCT02968810|521473591|FG000|Overall Study|Physician Decision|1|||
144621725|NCT02968810|521473592|FG001|Overall Study|Physician Decision|0|||
144621726|NCT02968810|521473591|FG000|Overall Study|Withdrawal by Subject|1|||
144621727|NCT02968810|521473592|FG001|Overall Study|Withdrawal by Subject|3|||
144621728|NCT02968810|521473591|FG000|Overall Study|Disease Progression|0|||
144621729|NCT02968810|521473592|FG001|Overall Study|Disease Progression|1|||
144621730|NCT01790503|521473595|FG000|Overall Study|Adverse Event|1|||
144621731|NCT01790503|521473596|FG001|Overall Study|Adverse Event|0|||
144621732|NCT01790503|521473597|FG002|Overall Study|Adverse Event|0|||
144621733|NCT01790503|521473598|FG003|Overall Study|Adverse Event|0|||
144621734|NCT01790503|521473599|FG004|Overall Study|Adverse Event|0|||
144621735|NCT01790503|521473600|FG005|Overall Study|Adverse Event|2|||
144621736|NCT01790503|521473601|FG006|Overall Study|Adverse Event|0|||
144621737|NCT01790503|521473602|FG007|Overall Study|Adverse Event|0|||
144621738|NCT01790503|521473603|FG008|Overall Study|Adverse Event|2|||
144621739|NCT01790503|521473604|FG009|Overall Study|Adverse Event|4|||
144621740|NCT01790503|521473605|FG010|Overall Study|Adverse Event|7|||
144621741|NCT01790503|521473595|FG000|Overall Study|Withdrawal by Subject|0|||
144621742|NCT01790503|521473596|FG001|Overall Study|Withdrawal by Subject|0|||
144621743|NCT01790503|521473597|FG002|Overall Study|Withdrawal by Subject|1|||
144621744|NCT01790503|521473598|FG003|Overall Study|Withdrawal by Subject|1|||
144621745|NCT01790503|521473599|FG004|Overall Study|Withdrawal by Subject|1|||
144621746|NCT01790503|521473600|FG005|Overall Study|Withdrawal by Subject|2|||
144621747|NCT01790503|521473601|FG006|Overall Study|Withdrawal by Subject|1|||
144621748|NCT01790503|521473602|FG007|Overall Study|Withdrawal by Subject|0|||
144621749|NCT01790503|521473603|FG008|Overall Study|Withdrawal by Subject|0|||
144621750|NCT01790503|521473604|FG009|Overall Study|Withdrawal by Subject|0|||
144621751|NCT01790503|521473605|FG010|Overall Study|Withdrawal by Subject|1|||
144621752|NCT01790503|521473595|FG000|Overall Study|Disease progression|2|||
144621753|NCT01790503|521473596|FG001|Overall Study|Disease progression|1|||
144621754|NCT01790503|521473597|FG002|Overall Study|Disease progression|0|||
144621755|NCT01790503|521473598|FG003|Overall Study|Disease progression|1|||
144621756|NCT01790503|521473599|FG004|Overall Study|Disease progression|2|||
144207417|NCT03146962|519954306|FG000|Overall Study|COVID Precautions|1|||
144207418|NCT03146962|519954307|FG001|Overall Study|COVID Precautions|0|||
144207419|NCT03146962|519954308|FG002|Overall Study|COVID Precautions|0|||
144207420|NCT03146962|519954309|FG003|Overall Study|COVID Precautions|0|||
144207421|NCT03146962|519954310|FG004|Overall Study|COVID Precautions|0|||
144575522|NCT04641962|521307290|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
144575523|NCT04641962|521307291|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
144575524|NCT04641962|521307292|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
144621757|NCT01790503|521473600|FG005|Overall Study|Disease progression|1|||
144207422|NCT03146962|519954311|FG005|Overall Study|COVID Precautions|0|||
144575525|NCT04641962|521307288|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
144575526|NCT04641962|521307289|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
144575527|NCT04641962|521307290|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
144575528|NCT04641962|521307291|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
144575529|NCT04641962|521307292|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
144575530|NCT04641962|521307288|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
144575531|NCT04641962|521307289|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
144575532|NCT04641962|521307290|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
144575533|NCT04641962|521307291|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
144575534|NCT04641962|521307292|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
144575535|NCT04641962|521307288|FG000|DBT Period: Up to 52 Weeks|Death|1|||
144575536|NCT04641962|521307289|FG001|DBT Period: Up to 52 Weeks|Death|0|||
144575537|NCT04641962|521307290|FG002|DBT Period: Up to 52 Weeks|Death|0|||
144575538|NCT04641962|521307291|FG003|DBT Period: Up to 52 Weeks|Death|0|||
144575539|NCT04641962|521307292|FG004|DBT Period: Up to 52 Weeks|Death|0|||
144575540|NCT04641962|521307288|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
144575541|NCT04641962|521307289|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
144575542|NCT04641962|521307290|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
144575543|NCT04641962|521307291|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
144575544|NCT04641962|521307292|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
144575545|NCT04641962|521307288|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
144575546|NCT04641962|521307289|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
144575547|NCT04641962|521307290|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
144575548|NCT04641962|521307291|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
144575549|NCT04641962|521307292|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
144575550|NCT04641962|521307288|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
144575551|NCT04641962|521307289|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
144575552|NCT04641962|521307290|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
144575553|NCT04641962|521307291|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
144575554|NCT04641962|521307292|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
144575555|NCT00862836|521307294|FG000|Overall Study|Withdrawal by Subject|1|||
144575556|NCT04463680|521307297|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
144575557|NCT04463680|521307297|FG000|Overall Study|Not eligible due to implant duration of use|1|||
144575558|NCT04463680|521307297|FG000|Overall Study|Withdrawal by Subject|3|||
144575559|NCT03832595|521307302|FG000|Overall Study|Death|142|||
144575560|NCT03832595|521307303|FG001|Overall Study|Death|130|||
144575561|NCT03832595|521307302|FG000|Overall Study|Medical management without dialysis|37|||
144575562|NCT03832595|521307303|FG001|Overall Study|Medical management without dialysis|1|||
144575563|NCT03277352|521307304|FG000|Overall Study|Study Terminated By Sponsor|2|||
144575564|NCT03277352|521307304|FG000|Overall Study|Withdrawal by Subject|4|||
144575565|NCT03277352|521307304|FG000|Overall Study|Death|4|||
144575566|NCT04147195|521307305|FG000|Overall Study|Adverse Event|0|||
144575567|NCT04147195|521307306|FG001|Overall Study|Adverse Event|3|||
144575568|NCT04147195|521307305|FG000|Overall Study|Study Terminated by Sponsor|4|||
144575569|NCT04147195|521307306|FG001|Overall Study|Study Terminated by Sponsor|2|||
144575570|NCT04147195|521307305|FG000|Overall Study|Withdrawal by Subject|0|||
144575571|NCT04147195|521307306|FG001|Overall Study|Withdrawal by Subject|1|||
144575572|NCT04427280|521309301|FG000|Overall Study|Withdrawal by Subject|0|||
144575573|NCT04427280|521309302|FG001|Overall Study|Withdrawal by Subject|2|||
144575574|NCT01667926|521309311|FG000|Overall Study|Withdrawal by Subject|1|||
144575575|NCT01667926|521309312|FG001|Overall Study|Withdrawal by Subject|2|||
144575576|NCT01667926|521309313|FG002|Overall Study|Withdrawal by Subject|2|||
144575577|NCT01667926|521309311|FG000|Overall Study|Physician Decision|0|||
144575578|NCT01667926|521309312|FG001|Overall Study|Physician Decision|0|||
144575579|NCT01667926|521309313|FG002|Overall Study|Physician Decision|1|||
144575580|NCT01667926|521309311|FG000|Overall Study|Time committment|0|||
144575581|NCT01667926|521309312|FG001|Overall Study|Time committment|0|||
144575582|NCT01667926|521309313|FG002|Overall Study|Time committment|2|||
144575583|NCT01667926|521309311|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
144575584|NCT01667926|521309312|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
144575585|NCT01667926|521309313|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
144575586|NCT01667926|521309311|FG000|Overall Study|Lost to Follow-up|1|||
144575587|NCT01667926|521309312|FG001|Overall Study|Lost to Follow-up|2|||
144575588|NCT01667926|521309313|FG002|Overall Study|Lost to Follow-up|1|||
144575589|NCT01667926|521309311|FG000|Overall Study|Side effects|3|||
144575590|NCT01667926|521309312|FG001|Overall Study|Side effects|0|||
144575591|NCT01667926|521309313|FG002|Overall Study|Side effects|0|||
144575592|NCT02271984|521309314|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575593|NCT02271984|521309315|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575594|NCT02271984|521309316|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575595|NCT02271984|521309317|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575596|NCT02271984|521309318|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575597|NCT02271984|521309319|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
144575598|NCT02271984|521309320|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575599|NCT02271984|521309321|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
144575600|NCT02271984|521309322|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575601|NCT02271984|521309323|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575602|NCT02271984|521309324|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575603|NCT02271984|521309325|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
144575604|NCT01088984|521309326|FG000|Phase 1|Death|2|||
144575605|NCT01088984|521309327|FG001|Phase 1|Death|1|||
144575606|NCT01088984|521309326|FG000|Phase 1|Disease Progression|2|||
144575607|NCT01088984|521309327|FG001|Phase 1|Disease Progression|4|||
144575608|NCT01088984|521309326|FG000|Phase 1|Other|1|||
144575609|NCT01088984|521309327|FG001|Phase 1|Other|1|||
144575610|NCT01088984|521309326|FG000|Phase 2|Death|0|||
144575611|NCT01088984|521309327|FG001|Phase 2|Death|5|||
144575612|NCT01088984|521309326|FG000|Phase 2|Withdrawal by Subject|0|||
144575613|NCT01088984|521309327|FG001|Phase 2|Withdrawal by Subject|1|||
144575614|NCT01088984|521309326|FG000|Phase 2|DIsease Progression|0|||
144575615|NCT01088984|521309327|FG001|Phase 2|DIsease Progression|25|||
144575616|NCT01088984|521309326|FG000|Phase 2|Other|0|||
144575617|NCT01088984|521309327|FG001|Phase 2|Other|1|||
144575618|NCT01228318|521309332|FG000|Overall Study|Clinic no show to receive intervention|1|||
144575619|NCT01228318|521309333|FG001|Overall Study|Clinic no show to receive intervention|0|||
144575620|NCT01228318|521309332|FG000|Overall Study|Unable to contact|2|||
144575621|NCT01228318|521309333|FG001|Overall Study|Unable to contact|5|||
144575622|NCT01228318|521309332|FG000|Overall Study|Moved|0|||
144575623|NCT01228318|521309333|FG001|Overall Study|Moved|2|||
144575624|NCT01228318|521309332|FG000|Overall Study|Incarcerated|1|||
144575625|NCT01228318|521309333|FG001|Overall Study|Incarcerated|0|||
144575626|NCT00770029|521309338|FG000|Overall Study|Lost to Follow-up|2|||
144575627|NCT00770029|521309339|FG001|Overall Study|Lost to Follow-up|0|||
144575628|NCT00770029|521309338|FG000|Overall Study|Withdrawal by Subject|3|||
144575629|NCT00770029|521309339|FG001|Overall Study|Withdrawal by Subject|3|||
144575630|NCT00770029|521309338|FG000|Overall Study|Adverse Event|1|||
144575631|NCT00770029|521309339|FG001|Overall Study|Adverse Event|0|||
144575632|NCT02088957|521309340|FG000|Overall Study|Lack of Efficacy|1|||
144575633|NCT02088957|521309341|FG001|Overall Study|Lack of Efficacy|0|||
144575634|NCT01923662|521309342|FG000|Overall Study|Withdrawal by Subject|1|||
144575635|NCT05000216|521309343|FG000|Stage 1|Lost to Follow-up|0|||
144575636|NCT05000216|521309344|FG001|Stage 1|Lost to Follow-up|0|||
144575637|NCT05000216|521309345|FG002|Stage 1|Lost to Follow-up|0|||
144575638|NCT05000216|521309346|FG003|Stage 1|Lost to Follow-up|0|||
144575639|NCT05000216|521309347|FG004|Stage 1|Lost to Follow-up|0|||
144575640|NCT05000216|521309348|FG005|Stage 1|Lost to Follow-up|0|||
144575641|NCT05000216|521309349|FG006|Stage 1|Lost to Follow-up|1|||
144575642|NCT05000216|521309350|FG007|Stage 1|Lost to Follow-up|1|||
144575643|NCT05000216|521309351|FG008|Stage 1|Lost to Follow-up|0|||
144621758|NCT01790503|521473601|FG006|Overall Study|Disease progression|0|||
144621759|NCT01790503|521473602|FG007|Overall Study|Disease progression|1|||
144621760|NCT01790503|521473603|FG008|Overall Study|Disease progression|0|||
144621761|NCT01790503|521473604|FG009|Overall Study|Disease progression|17|||
144621762|NCT01790503|521473605|FG010|Overall Study|Disease progression|7|||
144621763|NCT01790503|521473595|FG000|Overall Study|Protocol Violation|0|||
144621764|NCT01790503|521473596|FG001|Overall Study|Protocol Violation|0|||
144621765|NCT01790503|521473597|FG002|Overall Study|Protocol Violation|0|||
144621766|NCT01790503|521473598|FG003|Overall Study|Protocol Violation|0|||
144621767|NCT01790503|521473599|FG004|Overall Study|Protocol Violation|0|||
144621768|NCT01790503|521473600|FG005|Overall Study|Protocol Violation|0|||
144621769|NCT01790503|521473601|FG006|Overall Study|Protocol Violation|0|||
144621770|NCT01790503|521473602|FG007|Overall Study|Protocol Violation|0|||
144621771|NCT01790503|521473603|FG008|Overall Study|Protocol Violation|0|||
144621772|NCT01790503|521473604|FG009|Overall Study|Protocol Violation|1|||
144621773|NCT01790503|521473605|FG010|Overall Study|Protocol Violation|0|||
144621774|NCT01790503|521473595|FG000|Overall Study|Physician Decision|0|||
144621775|NCT01790503|521473596|FG001|Overall Study|Physician Decision|0|||
144621776|NCT01790503|521473597|FG002|Overall Study|Physician Decision|0|||
144575644|NCT05000216|521309352|FG009|Stage 1|Lost to Follow-up|2|||
144575645|NCT05000216|521309353|FG010|Stage 1|Lost to Follow-up|3|||
144575646|NCT05000216|521309354|FG011|Stage 1|Lost to Follow-up|0|||
144575647|NCT05000216|521309355|FG012|Stage 1|Lost to Follow-up|0|||
144621777|NCT01790503|521473598|FG003|Overall Study|Physician Decision|0|||
144621778|NCT01790503|521473599|FG004|Overall Study|Physician Decision|0|||
144621779|NCT01790503|521473600|FG005|Overall Study|Physician Decision|0|||
144621780|NCT01790503|521473601|FG006|Overall Study|Physician Decision|0|||
144621781|NCT01790503|521473602|FG007|Overall Study|Physician Decision|0|||
144575648|NCT05000216|521309356|FG013|Stage 1|Lost to Follow-up|0|||
144575649|NCT05000216|521309357|FG014|Stage 1|Lost to Follow-up|0|||
144575650|NCT05000216|521309358|FG015|Stage 1|Lost to Follow-up|0|||
144575651|NCT05000216|521309359|FG016|Stage 1|Lost to Follow-up|0|||
144575652|NCT05000216|521309360|FG017|Stage 1|Lost to Follow-up|0|||
144575653|NCT05000216|521309361|FG018|Stage 1|Lost to Follow-up|0|||
144575654|NCT05000216|521309362|FG019|Stage 1|Lost to Follow-up|0|||
144575655|NCT05000216|521309363|FG020|Stage 1|Lost to Follow-up|0|||
144621782|NCT01790503|521473603|FG008|Overall Study|Physician Decision|0|||
144621783|NCT01790503|521473604|FG009|Overall Study|Physician Decision|1|||
144575656|NCT05000216|521309364|FG021|Stage 1|Lost to Follow-up|0|||
144575657|NCT05000216|521309343|FG000|Stage 1|Physician Decision|0|||
144575658|NCT05000216|521309344|FG001|Stage 1|Physician Decision|0|||
144575659|NCT05000216|521309345|FG002|Stage 1|Physician Decision|0|||
144575660|NCT05000216|521309346|FG003|Stage 1|Physician Decision|0|||
144575661|NCT05000216|521309347|FG004|Stage 1|Physician Decision|0|||
144575662|NCT05000216|521309348|FG005|Stage 1|Physician Decision|0|||
144575663|NCT05000216|521309349|FG006|Stage 1|Physician Decision|0|||
144575664|NCT05000216|521309350|FG007|Stage 1|Physician Decision|1|||
144575665|NCT05000216|521309351|FG008|Stage 1|Physician Decision|1|||
144575666|NCT05000216|521309352|FG009|Stage 1|Physician Decision|0|||
144575667|NCT05000216|521309353|FG010|Stage 1|Physician Decision|0|||
144575668|NCT05000216|521309354|FG011|Stage 1|Physician Decision|0|||
144575669|NCT05000216|521309355|FG012|Stage 1|Physician Decision|0|||
144575670|NCT05000216|521309356|FG013|Stage 1|Physician Decision|0|||
144575671|NCT05000216|521309357|FG014|Stage 1|Physician Decision|0|||
144575672|NCT05000216|521309358|FG015|Stage 1|Physician Decision|0|||
144575673|NCT05000216|521309359|FG016|Stage 1|Physician Decision|0|||
144575674|NCT05000216|521309360|FG017|Stage 1|Physician Decision|0|||
144575675|NCT05000216|521309361|FG018|Stage 1|Physician Decision|0|||
144575676|NCT05000216|521309362|FG019|Stage 1|Physician Decision|0|||
144575677|NCT05000216|521309363|FG020|Stage 1|Physician Decision|0|||
144575678|NCT05000216|521309364|FG021|Stage 1|Physician Decision|0|||
144575679|NCT05000216|521309343|FG000|Stage 1|Withdrawal by Subject|0|||
144575680|NCT05000216|521309344|FG001|Stage 1|Withdrawal by Subject|1|||
144575681|NCT05000216|521309345|FG002|Stage 1|Withdrawal by Subject|0|||
144621784|NCT01790503|521473605|FG010|Overall Study|Physician Decision|1|||
144621785|NCT01790503|521473595|FG000|Overall Study|Death|0|||
144621786|NCT01790503|521473596|FG001|Overall Study|Death|0|||
144575682|NCT05000216|521309346|FG003|Stage 1|Withdrawal by Subject|0|||
144575683|NCT05000216|521309347|FG004|Stage 1|Withdrawal by Subject|0|||
144575684|NCT05000216|521309348|FG005|Stage 1|Withdrawal by Subject|0|||
144575685|NCT05000216|521309349|FG006|Stage 1|Withdrawal by Subject|0|||
144575686|NCT05000216|521309350|FG007|Stage 1|Withdrawal by Subject|0|||
144575687|NCT05000216|521309351|FG008|Stage 1|Withdrawal by Subject|0|||
144575688|NCT05000216|521309352|FG009|Stage 1|Withdrawal by Subject|3|||
144575689|NCT05000216|521309353|FG010|Stage 1|Withdrawal by Subject|10|||
144575690|NCT05000216|521309354|FG011|Stage 1|Withdrawal by Subject|0|||
144575691|NCT05000216|521309355|FG012|Stage 1|Withdrawal by Subject|0|||
144575692|NCT05000216|521309356|FG013|Stage 1|Withdrawal by Subject|0|||
144575693|NCT05000216|521309357|FG014|Stage 1|Withdrawal by Subject|0|||
144575694|NCT05000216|521309358|FG015|Stage 1|Withdrawal by Subject|0|||
144575695|NCT05000216|521309359|FG016|Stage 1|Withdrawal by Subject|0|||
144575696|NCT05000216|521309360|FG017|Stage 1|Withdrawal by Subject|0|||
144575697|NCT05000216|521309361|FG018|Stage 1|Withdrawal by Subject|0|||
144575698|NCT05000216|521309362|FG019|Stage 1|Withdrawal by Subject|0|||
144575699|NCT05000216|521309363|FG020|Stage 1|Withdrawal by Subject|0|||
144575700|NCT05000216|521309364|FG021|Stage 1|Withdrawal by Subject|0|||
144575701|NCT05000216|521309343|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
144575702|NCT05000216|521309344|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
144575703|NCT05000216|521309345|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
144575704|NCT05000216|521309346|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
144575705|NCT05000216|521309347|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
144575706|NCT05000216|521309348|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
144575707|NCT05000216|521309349|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
144575708|NCT05000216|521309350|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
144575709|NCT05000216|521309351|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
144575710|NCT05000216|521309352|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
144621787|NCT01790503|521473597|FG002|Overall Study|Death|0|||
144621788|NCT01790503|521473598|FG003|Overall Study|Death|0|||
144621789|NCT01790503|521473599|FG004|Overall Study|Death|0|||
144621790|NCT01790503|521473600|FG005|Overall Study|Death|0|||
144621791|NCT01790503|521473601|FG006|Overall Study|Death|0|||
144575711|NCT05000216|521309353|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
144621792|NCT01790503|521473602|FG007|Overall Study|Death|0|||
144621793|NCT01790503|521473603|FG008|Overall Study|Death|0|||
144621794|NCT01790503|521473604|FG009|Overall Study|Death|1|||
144621795|NCT01790503|521473605|FG010|Overall Study|Death|0|||
144621796|NCT01790503|521473595|FG000|Overall Study|Non Compliance|0|||
144621797|NCT01790503|521473596|FG001|Overall Study|Non Compliance|0|||
144730011|NCT05017480|521868113|FG002|Stage 2 Study|Pregnancy|0|||
144575712|NCT05000216|521309354|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
144575713|NCT05000216|521309355|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
144575714|NCT05000216|521309356|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
144575715|NCT05000216|521309357|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
144575716|NCT05000216|521309358|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
144575717|NCT05000216|521309359|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
144575718|NCT05000216|521309360|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
144621798|NCT01790503|521473597|FG002|Overall Study|Non Compliance|0|||
144621799|NCT01790503|521473598|FG003|Overall Study|Non Compliance|0|||
144730012|NCT05017480|521868114|FG003|Stage 2 Study|Pregnancy|0|||
144730013|NCT05017480|521868115|FG004|Stage 2 Study|Pregnancy|1|||
144730014|NCT01136382|521868116|FG000|Overall Study|Other|8|||
144730015|NCT01136382|521868117|FG001|Overall Study|Other|3|||
144730016|NCT01136382|521868116|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
144730017|NCT01136382|521868117|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
144730018|NCT01136382|521868116|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
144730019|NCT01136382|521868117|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
144730020|NCT01136382|521868116|FG000|Overall Study|Withdrawal by Subject|4|||
144575719|NCT05000216|521309361|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
144575720|NCT05000216|521309362|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
144575721|NCT05000216|521309363|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
144575722|NCT05000216|521309364|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
144575723|NCT05000216|521309343|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575724|NCT05000216|521309344|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575725|NCT05000216|521309345|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575726|NCT05000216|521309346|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575727|NCT05000216|521309347|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575728|NCT05000216|521309348|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575729|NCT05000216|521309349|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575730|NCT05000216|521309350|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575731|NCT05000216|521309351|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
144575732|NCT05000216|521309352|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575733|NCT05000216|521309353|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575734|NCT05000216|521309354|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575735|NCT05000216|521309355|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575736|NCT05000216|521309356|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575737|NCT05000216|521309357|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575738|NCT05000216|521309358|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575739|NCT05000216|521309359|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575740|NCT05000216|521309360|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575741|NCT05000216|521309361|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575742|NCT05000216|521309362|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575743|NCT05000216|521309363|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575744|NCT05000216|521309364|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
144575745|NCT05000216|521309343|FG000|Stage 1|Other|0|||
144575746|NCT05000216|521309344|FG001|Stage 1|Other|0|||
144575747|NCT05000216|521309345|FG002|Stage 1|Other|0|||
144575748|NCT05000216|521309346|FG003|Stage 1|Other|0|||
144575749|NCT05000216|521309347|FG004|Stage 1|Other|1|||
144575750|NCT05000216|521309348|FG005|Stage 1|Other|0|||
144575751|NCT05000216|521309349|FG006|Stage 1|Other|0|||
144575752|NCT05000216|521309350|FG007|Stage 1|Other|2|||
144575753|NCT05000216|521309351|FG008|Stage 1|Other|0|||
144575754|NCT05000216|521309352|FG009|Stage 1|Other|0|||
144575755|NCT05000216|521309353|FG010|Stage 1|Other|1|||
144575756|NCT05000216|521309354|FG011|Stage 1|Other|1|||
144575757|NCT05000216|521309355|FG012|Stage 1|Other|0|||
144575758|NCT05000216|521309356|FG013|Stage 1|Other|0|||
144575759|NCT05000216|521309357|FG014|Stage 1|Other|0|||
144575760|NCT05000216|521309358|FG015|Stage 1|Other|0|||
144575761|NCT05000216|521309359|FG016|Stage 1|Other|0|||
144575762|NCT05000216|521309360|FG017|Stage 1|Other|0|||
144621800|NCT01790503|521473599|FG004|Overall Study|Non Compliance|1|||
144621801|NCT01790503|521473600|FG005|Overall Study|Non Compliance|0|||
144621802|NCT01790503|521473601|FG006|Overall Study|Non Compliance|0|||
144621803|NCT01790503|521473602|FG007|Overall Study|Non Compliance|0|||
144621804|NCT01790503|521473603|FG008|Overall Study|Non Compliance|0|||
144621805|NCT01790503|521473604|FG009|Overall Study|Non Compliance|0|||
144621806|NCT01790503|521473605|FG010|Overall Study|Non Compliance|0|||
144621807|NCT01790503|521473595|FG000|Overall Study|Other|0|||
144730021|NCT01136382|521868117|FG001|Overall Study|Withdrawal by Subject|1|||
144730022|NCT02653664|521868125|FG000|Post-Treatment|Withdrawal by Subject|6|||
144730023|NCT02653664|521868126|FG001|Post-Treatment|Withdrawal by Subject|5|||
144207423|NCT03146962|519954312|FG006|Overall Study|COVID Precautions|0|||
144575763|NCT05000216|521309361|FG018|Stage 1|Other|0|||
144621808|NCT01790503|521473596|FG001|Overall Study|Other|0|||
144621809|NCT01790503|521473597|FG002|Overall Study|Other|0|||
144621810|NCT01790503|521473598|FG003|Overall Study|Other|0|||
144621811|NCT01790503|521473599|FG004|Overall Study|Other|1|||
144730024|NCT02653664|521868127|FG002|Post-Treatment|Withdrawal by Subject|7|||
144207424|NCT03146962|519954313|FG007|Overall Study|COVID Precautions|0|||
144575764|NCT05000216|521309362|FG019|Stage 1|Other|0|||
144575765|NCT05000216|521309363|FG020|Stage 1|Other|0|||
144575766|NCT05000216|521309364|FG021|Stage 1|Other|0|||
144575767|NCT05000216|521309343|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
144575768|NCT05000216|521309344|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
144575769|NCT05000216|521309345|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
144575770|NCT05000216|521309346|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
144730025|NCT02653664|521868125|FG000|Post-Treatment|Lost to Follow-up|8|||
144621812|NCT01790503|521473600|FG005|Overall Study|Other|0|||
144575771|NCT05000216|521309347|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
144575772|NCT05000216|521309348|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
144575773|NCT05000216|521309349|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
144575774|NCT05000216|521309350|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
144575775|NCT05000216|521309351|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
144575776|NCT05000216|521309352|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
144575777|NCT05000216|521309353|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
144730026|NCT02653664|521868126|FG001|Post-Treatment|Lost to Follow-up|1|||
144730027|NCT02653664|521868127|FG002|Post-Treatment|Lost to Follow-up|7|||
144730028|NCT02653664|521868125|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
144730029|NCT02653664|521868126|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
144730030|NCT02653664|521868127|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
144730031|NCT02653664|521868125|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
144730032|NCT02653664|521868126|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
144730033|NCT02653664|521868127|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
144730034|NCT02653664|521868125|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
144730035|NCT02653664|521868126|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
144730036|NCT02653664|521868127|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
144730037|NCT02653664|521868125|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
144730038|NCT02653664|521868126|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
144730039|NCT02653664|521868127|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
144730040|NCT02653664|521868125|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
144730041|NCT02653664|521868126|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
144730042|NCT02653664|521868127|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
144730043|NCT02653664|521868125|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
144575778|NCT05000216|521309354|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
144575779|NCT05000216|521309355|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
144730044|NCT02653664|521868126|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
144575780|NCT05000216|521309356|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
144575781|NCT05000216|521309357|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
144575782|NCT05000216|521309358|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
144575783|NCT05000216|521309359|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
144575784|NCT05000216|521309360|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
144575785|NCT05000216|521309361|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
144575786|NCT05000216|521309362|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
144575787|NCT05000216|521309363|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
144575788|NCT05000216|521309364|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
144575789|NCT05000216|521309343|FG000|Stage 2|Lost to Follow-up|0|||
144575790|NCT05000216|521309344|FG001|Stage 2|Lost to Follow-up|0|||
144575791|NCT05000216|521309345|FG002|Stage 2|Lost to Follow-up|0|||
144575792|NCT05000216|521309346|FG003|Stage 2|Lost to Follow-up|0|||
144575793|NCT05000216|521309347|FG004|Stage 2|Lost to Follow-up|0|||
144575794|NCT05000216|521309348|FG005|Stage 2|Lost to Follow-up|0|||
144575795|NCT05000216|521309349|FG006|Stage 2|Lost to Follow-up|0|||
144575796|NCT05000216|521309350|FG007|Stage 2|Lost to Follow-up|0|||
144575797|NCT05000216|521309351|FG008|Stage 2|Lost to Follow-up|0|||
144575798|NCT05000216|521309352|FG009|Stage 2|Lost to Follow-up|0|||
144575799|NCT05000216|521309353|FG010|Stage 2|Lost to Follow-up|0|||
144575800|NCT05000216|521309354|FG011|Stage 2|Lost to Follow-up|0|||
144575801|NCT05000216|521309355|FG012|Stage 2|Lost to Follow-up|0|||
144575802|NCT05000216|521309356|FG013|Stage 2|Lost to Follow-up|0|||
144575803|NCT05000216|521309357|FG014|Stage 2|Lost to Follow-up|0|||
144575804|NCT05000216|521309358|FG015|Stage 2|Lost to Follow-up|0|||
144575805|NCT05000216|521309359|FG016|Stage 2|Lost to Follow-up|4|||
144575806|NCT05000216|521309360|FG017|Stage 2|Lost to Follow-up|0|||
144575807|NCT05000216|521309361|FG018|Stage 2|Lost to Follow-up|0|||
144575808|NCT05000216|521309362|FG019|Stage 2|Lost to Follow-up|0|||
144575809|NCT05000216|521309363|FG020|Stage 2|Lost to Follow-up|0|||
144575810|NCT05000216|521309364|FG021|Stage 2|Lost to Follow-up|0|||
144730045|NCT02653664|521868127|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
144730046|NCT02653664|521868125|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
144730047|NCT02653664|521868126|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
144730048|NCT02653664|521868127|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
144575811|NCT05000216|521309343|FG000|Stage 2|Physician Decision|0|||
144575812|NCT05000216|521309344|FG001|Stage 2|Physician Decision|0|||
144575813|NCT05000216|521309345|FG002|Stage 2|Physician Decision|0|||
144575814|NCT05000216|521309346|FG003|Stage 2|Physician Decision|0|||
144575815|NCT05000216|521309347|FG004|Stage 2|Physician Decision|0|||
144575816|NCT05000216|521309348|FG005|Stage 2|Physician Decision|0|||
144575817|NCT05000216|521309349|FG006|Stage 2|Physician Decision|0|||
144575818|NCT05000216|521309350|FG007|Stage 2|Physician Decision|0|||
144575819|NCT05000216|521309351|FG008|Stage 2|Physician Decision|0|||
144575820|NCT05000216|521309352|FG009|Stage 2|Physician Decision|0|||
144575821|NCT05000216|521309353|FG010|Stage 2|Physician Decision|0|||
144575822|NCT05000216|521309354|FG011|Stage 2|Physician Decision|0|||
144575823|NCT05000216|521309355|FG012|Stage 2|Physician Decision|1|||
144575824|NCT05000216|521309356|FG013|Stage 2|Physician Decision|0|||
144575825|NCT05000216|521309357|FG014|Stage 2|Physician Decision|0|||
144575826|NCT05000216|521309358|FG015|Stage 2|Physician Decision|0|||
144575827|NCT05000216|521309359|FG016|Stage 2|Physician Decision|0|||
144575828|NCT05000216|521309360|FG017|Stage 2|Physician Decision|0|||
144575829|NCT05000216|521309361|FG018|Stage 2|Physician Decision|0|||
144575830|NCT05000216|521309362|FG019|Stage 2|Physician Decision|0|||
144575831|NCT05000216|521309363|FG020|Stage 2|Physician Decision|0|||
144575832|NCT05000216|521309364|FG021|Stage 2|Physician Decision|0|||
144575833|NCT05000216|521309343|FG000|Stage 2|Withdrawal by Subject|0|||
144575834|NCT05000216|521309344|FG001|Stage 2|Withdrawal by Subject|0|||
144575835|NCT05000216|521309345|FG002|Stage 2|Withdrawal by Subject|0|||
144575836|NCT05000216|521309346|FG003|Stage 2|Withdrawal by Subject|0|||
144575837|NCT05000216|521309347|FG004|Stage 2|Withdrawal by Subject|0|||
144575838|NCT05000216|521309348|FG005|Stage 2|Withdrawal by Subject|0|||
144575839|NCT05000216|521309349|FG006|Stage 2|Withdrawal by Subject|0|||
144575840|NCT05000216|521309350|FG007|Stage 2|Withdrawal by Subject|0|||
144575841|NCT05000216|521309351|FG008|Stage 2|Withdrawal by Subject|0|||
144575842|NCT05000216|521309352|FG009|Stage 2|Withdrawal by Subject|0|||
144575843|NCT05000216|521309353|FG010|Stage 2|Withdrawal by Subject|0|||
144575844|NCT05000216|521309354|FG011|Stage 2|Withdrawal by Subject|0|||
144575845|NCT05000216|521309355|FG012|Stage 2|Withdrawal by Subject|0|||
144575846|NCT05000216|521309356|FG013|Stage 2|Withdrawal by Subject|0|||
144575847|NCT05000216|521309357|FG014|Stage 2|Withdrawal by Subject|2|||
144575848|NCT05000216|521309358|FG015|Stage 2|Withdrawal by Subject|0|||
144575849|NCT05000216|521309359|FG016|Stage 2|Withdrawal by Subject|9|||
144575850|NCT05000216|521309360|FG017|Stage 2|Withdrawal by Subject|0|||
144575851|NCT05000216|521309361|FG018|Stage 2|Withdrawal by Subject|0|||
144575852|NCT05000216|521309362|FG019|Stage 2|Withdrawal by Subject|0|||
144575853|NCT05000216|521309363|FG020|Stage 2|Withdrawal by Subject|0|||
144575854|NCT05000216|521309364|FG021|Stage 2|Withdrawal by Subject|0|||
144575855|NCT05000216|521309343|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
144575856|NCT05000216|521309344|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
144575857|NCT05000216|521309345|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
144575858|NCT05000216|521309346|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
144575859|NCT05000216|521309347|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
144575860|NCT05000216|521309348|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
144575861|NCT05000216|521309349|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
144575862|NCT05000216|521309350|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
144575863|NCT05000216|521309351|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
144575864|NCT05000216|521309352|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
144575865|NCT05000216|521309353|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
144575866|NCT05000216|521309354|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
144575867|NCT05000216|521309355|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
144575868|NCT05000216|521309356|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
144575869|NCT05000216|521309357|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
144575870|NCT05000216|521309358|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
144575871|NCT05000216|521309359|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
144575872|NCT05000216|521309360|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
144575873|NCT05000216|521309361|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
144575874|NCT05000216|521309362|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
144575875|NCT05000216|521309363|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
144575876|NCT05000216|521309364|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
144575877|NCT05000216|521309343|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575878|NCT05000216|521309344|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575879|NCT05000216|521309345|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575880|NCT05000216|521309346|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575881|NCT05000216|521309347|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575882|NCT05000216|521309348|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575883|NCT05000216|521309349|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575884|NCT05000216|521309350|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575885|NCT05000216|521309351|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575886|NCT05000216|521309352|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575887|NCT05000216|521309353|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575888|NCT05000216|521309354|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575889|NCT05000216|521309355|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575890|NCT05000216|521309356|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575891|NCT05000216|521309357|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
144575892|NCT05000216|521309358|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575893|NCT05000216|521309359|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
144575894|NCT05000216|521309360|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575895|NCT05000216|521309361|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575896|NCT05000216|521309362|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575897|NCT05000216|521309363|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575898|NCT05000216|521309364|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
144575899|NCT05000216|521309343|FG000|Stage 2|Other reason|0|||
144575900|NCT05000216|521309344|FG001|Stage 2|Other reason|0|||
144575901|NCT05000216|521309345|FG002|Stage 2|Other reason|0|||
144575902|NCT05000216|521309346|FG003|Stage 2|Other reason|0|||
144575903|NCT05000216|521309347|FG004|Stage 2|Other reason|0|||
144575904|NCT05000216|521309348|FG005|Stage 2|Other reason|0|||
144575905|NCT05000216|521309349|FG006|Stage 2|Other reason|0|||
144575906|NCT05000216|521309350|FG007|Stage 2|Other reason|0|||
144575907|NCT05000216|521309351|FG008|Stage 2|Other reason|0|||
144575908|NCT05000216|521309352|FG009|Stage 2|Other reason|0|||
144575909|NCT05000216|521309353|FG010|Stage 2|Other reason|0|||
144575910|NCT05000216|521309354|FG011|Stage 2|Other reason|0|||
144575911|NCT05000216|521309355|FG012|Stage 2|Other reason|0|||
144575912|NCT05000216|521309356|FG013|Stage 2|Other reason|0|||
144575913|NCT05000216|521309357|FG014|Stage 2|Other reason|0|||
144575914|NCT05000216|521309358|FG015|Stage 2|Other reason|0|||
144575915|NCT05000216|521309359|FG016|Stage 2|Other reason|1|||
144575916|NCT05000216|521309360|FG017|Stage 2|Other reason|0|||
144575917|NCT05000216|521309361|FG018|Stage 2|Other reason|0|||
144575918|NCT05000216|521309362|FG019|Stage 2|Other reason|0|||
144575919|NCT05000216|521309363|FG020|Stage 2|Other reason|0|||
144575920|NCT05000216|521309364|FG021|Stage 2|Other reason|0|||
144575921|NCT05000216|521309343|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
144575922|NCT05000216|521309344|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
144575923|NCT05000216|521309345|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
144575924|NCT05000216|521309346|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
144575925|NCT05000216|521309347|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
144575926|NCT05000216|521309348|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
144575927|NCT05000216|521309349|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
144575928|NCT05000216|521309350|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
144575929|NCT05000216|521309351|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
144575930|NCT05000216|521309352|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
144575931|NCT05000216|521309353|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
144575932|NCT05000216|521309354|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
144575933|NCT05000216|521309355|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
144575934|NCT05000216|521309356|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
144575935|NCT05000216|521309357|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
144575936|NCT05000216|521309358|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
144575937|NCT05000216|521309359|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
144575938|NCT05000216|521309360|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
144575939|NCT05000216|521309361|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
144575940|NCT05000216|521309362|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
144575941|NCT05000216|521309363|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
144575942|NCT05000216|521309364|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
144575943|NCT05000216|521309343|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575944|NCT05000216|521309344|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575945|NCT05000216|521309345|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575946|NCT05000216|521309346|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575947|NCT05000216|521309347|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575948|NCT05000216|521309348|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575949|NCT05000216|521309349|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575950|NCT05000216|521309350|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575951|NCT05000216|521309351|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575952|NCT05000216|521309352|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575953|NCT05000216|521309353|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575954|NCT05000216|521309354|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575955|NCT05000216|521309355|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575956|NCT05000216|521309356|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575957|NCT05000216|521309357|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575958|NCT05000216|521309358|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
144575959|NCT05000216|521309359|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575960|NCT05000216|521309360|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575961|NCT05000216|521309361|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575962|NCT05000216|521309362|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575963|NCT05000216|521309363|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575964|NCT05000216|521309364|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
144575965|NCT05000216|521309343|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575966|NCT05000216|521309344|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575967|NCT05000216|521309345|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575968|NCT05000216|521309346|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575969|NCT05000216|521309347|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575970|NCT05000216|521309348|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575971|NCT05000216|521309349|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575972|NCT05000216|521309350|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575973|NCT05000216|521309351|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575974|NCT05000216|521309352|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575975|NCT05000216|521309353|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575976|NCT05000216|521309354|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575977|NCT05000216|521309355|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575978|NCT05000216|521309356|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
144575979|NCT05000216|521309357|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575980|NCT05000216|521309358|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
144575981|NCT05000216|521309359|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575982|NCT05000216|521309360|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575983|NCT05000216|521309361|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
144575984|NCT05000216|521309362|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575985|NCT05000216|521309363|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575986|NCT05000216|521309364|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
144575987|NCT03842228|521309365|FG000|Overall Study|Adverse Event|1|||
144575988|NCT03842228|521309366|FG001|Overall Study|Adverse Event|1|||
144575989|NCT03842228|521309367|FG002|Overall Study|Adverse Event|1|||
144575990|NCT03842228|521309368|FG003|Overall Study|Adverse Event|0|||
144575991|NCT03842228|521309369|FG004|Overall Study|Adverse Event|0|||
144575992|NCT03842228|521309370|FG005|Overall Study|Adverse Event|0|||
144575993|NCT03842228|521309371|FG006|Overall Study|Adverse Event|0|||
144575994|NCT03842228|521309365|FG000|Overall Study|Death|0|||
144575995|NCT03842228|521309366|FG001|Overall Study|Death|1|||
144575996|NCT03842228|521309367|FG002|Overall Study|Death|0|||
144575997|NCT03842228|521309368|FG003|Overall Study|Death|0|||
144575998|NCT03842228|521309369|FG004|Overall Study|Death|0|||
144575999|NCT03842228|521309370|FG005|Overall Study|Death|0|||
144576000|NCT03842228|521309371|FG006|Overall Study|Death|0|||
144576001|NCT03842228|521309365|FG000|Overall Study|Withdrawal by Subject|0|||
144576002|NCT03842228|521309366|FG001|Overall Study|Withdrawal by Subject|0|||
144576003|NCT03842228|521309367|FG002|Overall Study|Withdrawal by Subject|2|||
144576004|NCT03842228|521309368|FG003|Overall Study|Withdrawal by Subject|1|||
144576005|NCT03842228|521309369|FG004|Overall Study|Withdrawal by Subject|0|||
144576006|NCT03842228|521309370|FG005|Overall Study|Withdrawal by Subject|0|||
144576007|NCT03842228|521309371|FG006|Overall Study|Withdrawal by Subject|2|||
144576008|NCT03842228|521309365|FG000|Overall Study|Progression|8|||
144576009|NCT03842228|521309366|FG001|Overall Study|Progression|1|||
144576010|NCT03842228|521309367|FG002|Overall Study|Progression|7|||
144576011|NCT03842228|521309368|FG003|Overall Study|Progression|5|||
144576012|NCT03842228|521309369|FG004|Overall Study|Progression|4|||
144576013|NCT03842228|521309370|FG005|Overall Study|Progression|2|||
144576014|NCT03842228|521309371|FG006|Overall Study|Progression|3|||
144576015|NCT01263509|521309372|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
144576016|NCT01263509|521309373|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
144576017|NCT01263509|521309374|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
144576018|NCT01263509|521309375|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
144576019|NCT01263509|521309372|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
144576020|NCT01263509|521309373|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
144576021|NCT01263509|521309374|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
144576022|NCT01263509|521309375|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
144576023|NCT01263509|521309372|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144576024|NCT01263509|521309373|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144576025|NCT01263509|521309374|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144576026|NCT01263509|521309375|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144576027|NCT01263509|521309372|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
144576028|NCT01263509|521309373|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
144576029|NCT01263509|521309374|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144576030|NCT01263509|521309375|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
144576031|NCT01263509|521309372|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
144576032|NCT01263509|521309373|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
144576033|NCT01263509|521309374|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
144576034|NCT01263509|521309375|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
144576035|NCT01261000|521309376|FG000|Overall Study|Screen failure|1|||
144576036|NCT01154140|521309377|FG000|Overall Study|Death|71|||
144576037|NCT01154140|521309378|FG001|Overall Study|Death|81|||
144576038|NCT01154140|521309377|FG000|Overall Study|Lost to Follow-up|4|||
144576039|NCT01154140|521309378|FG001|Overall Study|Lost to Follow-up|5|||
144576040|NCT01154140|521309377|FG000|Overall Study|Withdrawal by Subject|12|||
144576041|NCT01154140|521309378|FG001|Overall Study|Withdrawal by Subject|13|||
144576042|NCT01154140|521309377|FG000|Overall Study|Other|3|||
144576043|NCT01154140|521309378|FG001|Overall Study|Other|1|||
144576044|NCT01154140|521309377|FG000|Overall Study|Randomized but not treated|1|||
144576045|NCT01154140|521309378|FG001|Overall Study|Randomized but not treated|2|||
144576046|NCT01374568|521309385|FG000|Overall Study|Lab unable to analyze BTM|0|||
144576047|NCT01374568|521309386|FG001|Overall Study|Lab unable to analyze BTM|2|||
144576048|NCT04916730|521309387|FG000|Overall Study|Withdrawal by Subject|4|||
144576049|NCT04916730|521309388|FG001|Overall Study|Withdrawal by Subject|2|||
144576050|NCT04916730|521309387|FG000|Overall Study|Lost to Follow-up|0|||
144621813|NCT01790503|521473601|FG006|Overall Study|Other|0|||
144621814|NCT01790503|521473602|FG007|Overall Study|Other|0|||
144621815|NCT01790503|521473603|FG008|Overall Study|Other|1|||
144621816|NCT01790503|521473604|FG009|Overall Study|Other|2|||
144621817|NCT01790503|521473605|FG010|Overall Study|Other|0|||
144621818|NCT00049673|521473606|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
144621819|NCT00049673|521473607|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
144621820|NCT01535729|521473608|FG000|Overall Study|Withdrawal by Subject|2|||
144621821|NCT01535729|521473608|FG000|Overall Study|Disease progression|230|||
144262856|NCT01325350|520163767|FG000|Overall Study|Personal Reasons|2|||
144576051|NCT04916730|521309388|FG001|Overall Study|Lost to Follow-up|2|||
144576052|NCT04916730|521309387|FG000|Overall Study|Physician Decision|1|||
144576053|NCT04916730|521309388|FG001|Overall Study|Physician Decision|0|||
144576054|NCT01443923|521309394|FG000|Overall Study|Adverse Event|1|||
144576055|NCT01443923|521309395|FG001|Overall Study|Adverse Event|0|||
144576056|NCT01250509|521309398|FG000|Overall Study|Lost to Follow-up|5|||
144576057|NCT01250509|521309399|FG001|Overall Study|Lost to Follow-up|2|||
144576058|NCT01228175|521309400|FG000|Overall Study|Lost to Follow-up|64|||
144576059|NCT01228175|521309401|FG001|Overall Study|Lost to Follow-up|50|||
144576060|NCT01228175|521309400|FG000|Overall Study|Withdrawal by Subject|1|||
144576061|NCT01228175|521309401|FG001|Overall Study|Withdrawal by Subject|2|||
144576062|NCT01228175|521309400|FG000|Overall Study|Physician Decision|1|||
144576063|NCT01228175|521309401|FG001|Overall Study|Physician Decision|1|||
144576064|NCT00600613|521309402|FG000|Overall Study|Protocol Deviation|1|||
144576065|NCT00664534|521309405|FG000|Overall Study|Adverse Event|2|||
144576066|NCT00664534|521309406|FG001|Overall Study|Adverse Event|3|||
144576067|NCT00664534|521309405|FG000|Overall Study|Lost to Follow-up|6|||
144576068|NCT00664534|521309406|FG001|Overall Study|Lost to Follow-up|10|||
144576069|NCT00664534|521309405|FG000|Overall Study|Protocol Violation|10|||
144576070|NCT00664534|521309406|FG001|Overall Study|Protocol Violation|8|||
144576071|NCT00664534|521309405|FG000|Overall Study|Withdrawal by Subject|7|||
144576072|NCT00664534|521309406|FG001|Overall Study|Withdrawal by Subject|6|||
144576073|NCT00664534|521309405|FG000|Overall Study|Physician Decision|8|||
144576074|NCT00664534|521309406|FG001|Overall Study|Physician Decision|0|||
144576075|NCT00664534|521309405|FG000|Overall Study|Sponsor decision|8|||
144576076|NCT00664534|521309406|FG001|Overall Study|Sponsor decision|6|||
144576077|NCT03041792|521309407|FG000|Overall Study|Adverse Event|4|||
144576078|NCT03041792|521309408|FG001|Overall Study|Adverse Event|0|||
144576079|NCT03041792|521309407|FG000|Overall Study|Death in the family|0|||
144576080|NCT03041792|521309408|FG001|Overall Study|Death in the family|2|||
144576081|NCT03041792|521309407|FG000|Overall Study|Randomized but not treated|0|||
144576082|NCT03041792|521309408|FG001|Overall Study|Randomized but not treated|1|||
144576083|NCT04978090|521309411|FG000|Overall Study|unable to adequately fit device|2|||
144576084|NCT02227992|521309414|FG000|Overall Study|Lost to Follow-up|1|||
144576085|NCT02227992|521309415|FG001|Overall Study|Lost to Follow-up|1|||
144576086|NCT00935532|521309418|FG000|Overall Study|Adverse Event|11|||
144576087|NCT00935532|521309419|FG001|Overall Study|Adverse Event|6|||
144576088|NCT00935532|521309418|FG000|Overall Study|Death|1|||
144576089|NCT00935532|521309419|FG001|Overall Study|Death|0|||
144576090|NCT00935532|521309418|FG000|Overall Study|Lost to Follow-up|1|||
144576091|NCT00935532|521309419|FG001|Overall Study|Lost to Follow-up|0|||
144576092|NCT00935532|521309418|FG000|Overall Study|Physician Decision|1|||
144576093|NCT00935532|521309419|FG001|Overall Study|Physician Decision|2|||
144576094|NCT00935532|521309418|FG000|Overall Study|Protocol Violation|2|||
144576095|NCT00935532|521309419|FG001|Overall Study|Protocol Violation|1|||
144576096|NCT00935532|521309418|FG000|Overall Study|Subject Decision|2|||
144576097|NCT00935532|521309419|FG001|Overall Study|Subject Decision|1|||
144576098|NCT00935532|521309418|FG000|Overall Study|Sponsor Decision|0|||
144576099|NCT00935532|521309419|FG001|Overall Study|Sponsor Decision|1|||
144576100|NCT00935532|521309418|FG000|Overall Study|Loss Glucose Control|4|||
144576101|NCT00935532|521309419|FG001|Overall Study|Loss Glucose Control|0|||
144576102|NCT01509547|521309420|FG000|Overall Study|Lost to Follow-up|24|||
144576103|NCT01509547|521309421|FG001|Overall Study|Lost to Follow-up|14|||
144576104|NCT01509547|521309420|FG000|Overall Study|Withdrawal by Subject|11|||
144576105|NCT01509547|521309421|FG001|Overall Study|Withdrawal by Subject|24|||
144576106|NCT01509547|521309420|FG000|Overall Study|Physician Decision|0|||
144576107|NCT01509547|521309421|FG001|Overall Study|Physician Decision|1|||
144576108|NCT00402051|521309424|FG000|Overall Study|Progressive Disease|13|||
144576109|NCT00402051|521309425|FG001|Overall Study|Progressive Disease|20|||
144576110|NCT00402051|521309424|FG000|Overall Study|Adverse Event|11|||
144576111|NCT00402051|521309425|FG001|Overall Study|Adverse Event|4|||
144576112|NCT00402051|521309424|FG000|Overall Study|Physician Decision|7|||
144576113|NCT00402051|521309425|FG001|Overall Study|Physician Decision|3|||
144576114|NCT00402051|521309424|FG000|Overall Study|Withdrawal by Subject|3|||
144576115|NCT00402051|521309425|FG001|Overall Study|Withdrawal by Subject|3|||
144576116|NCT00402051|521309424|FG000|Overall Study|Death - Related to Study Drug|1|||
144576117|NCT00402051|521309425|FG001|Overall Study|Death - Related to Study Drug|2|||
144621822|NCT01535729|521473608|FG000|Overall Study|Discontinued treatment|25|||
144621823|NCT01535729|521473608|FG000|Overall Study|Lost to Follow-up|8|||
144576118|NCT00402051|521309424|FG000|Overall Study|Death Due to Study Disease|2|||
144576119|NCT00402051|521309425|FG001|Overall Study|Death Due to Study Disease|1|||
144576120|NCT00402051|521309424|FG000|Overall Study|Death Due to Adverse Event|0|||
144576121|NCT00402051|521309425|FG001|Overall Study|Death Due to Adverse Event|2|||
144576122|NCT00402051|521309424|FG000|Overall Study|Lost to Follow-up|1|||
144576123|NCT00402051|521309425|FG001|Overall Study|Lost to Follow-up|0|||
144576124|NCT02514551|521309426|FG000|Overall Study|Lost to Follow-up|0|||
144576125|NCT02514551|521309427|FG001|Overall Study|Lost to Follow-up|1|||
144576126|NCT02514551|521309426|FG000|Overall Study|Participant Never Treated|0|||
144576127|NCT02514551|521309427|FG001|Overall Study|Participant Never Treated|2|||
144576128|NCT00570908|521309431|FG000|Overall Study|Adverse Event|5|||
144576129|NCT00570908|521309431|FG000|Overall Study|Withdrawal by Subject|2|||
144576130|NCT00277095|521309432|FG000|Overall Study|Death|2|||
144576131|NCT00277095|521309432|FG000|Overall Study|Explanted|7|||
144576132|NCT00277095|521309432|FG000|Overall Study|Lost to Follow-up|2|||
144576133|NCT00277095|521309432|FG000|Overall Study|Missed Follow-up|9|||
144576134|NCT00277095|521309432|FG000|Overall Study|Physician Decision|1|||
144576135|NCT01447576|521309438|FG000|Overall Study|Lost to Follow-up|52|||
144576136|NCT01447576|521309438|FG000|Overall Study|Adverse Event|127|||
144576137|NCT01447576|521309438|FG000|Overall Study|Participant met withdrawal criteria|40|||
144576138|NCT01447576|521309438|FG000|Overall Study|Withdrawal by Subject|100|||
144576139|NCT01447576|521309438|FG000|Overall Study|Protocol deviation|83|||
144576140|NCT01447576|521309438|FG000|Overall Study|Lack of Efficacy|68|||
144576141|NCT01447576|521309438|FG000|Overall Study|Physician Decision|6|||
144576142|NCT05239598|521309439|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
144621824|NCT01535729|521473608|FG000|Overall Study|Death|52|||
144621825|NCT01535729|521473608|FG000|Overall Study|Other|19|||
144621826|NCT01535729|521473608|FG000|Overall Study|Did not sign informed consent|1|||
144621827|NCT01535729|521473608|FG000|Overall Study|No previous chemotherapy|33|||
144621828|NCT01535729|521473608|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
144621829|NCT01535729|521473608|FG000|Overall Study|Protocol Violation|11|||
144621830|NCT01535729|521473608|FG000|Overall Study|Screening failure|1|||
144621831|NCT01535729|521473608|FG000|Overall Study|Not treated|9|||
144621832|NCT01535729|521473608|FG000|Overall Study|No participant record available|5|||
144621833|NCT01262365|521473611|FG000|Overall Study|Lack of Efficacy|35|||
144621834|NCT01262365|521473612|FG001|Overall Study|Lack of Efficacy|30|||
144621835|NCT01262365|521473613|FG002|Overall Study|Lack of Efficacy|47|||
144621836|NCT01262365|521473611|FG000|Overall Study|Protocol Violation|3|||
144621837|NCT01262365|521473612|FG001|Overall Study|Protocol Violation|1|||
144621838|NCT01262365|521473613|FG002|Overall Study|Protocol Violation|1|||
144621839|NCT01262365|521473611|FG000|Overall Study|Lost to Follow-up|3|||
144621840|NCT01262365|521473612|FG001|Overall Study|Lost to Follow-up|7|||
144621841|NCT01262365|521473613|FG002|Overall Study|Lost to Follow-up|6|||
144621842|NCT01262365|521473611|FG000|Overall Study|Withdrawal by Subject|17|||
144621843|NCT01262365|521473612|FG001|Overall Study|Withdrawal by Subject|22|||
144621844|NCT01262365|521473613|FG002|Overall Study|Withdrawal by Subject|22|||
144621845|NCT01262365|521473611|FG000|Overall Study|Death|1|||
144621846|NCT01262365|521473612|FG001|Overall Study|Death|2|||
144621847|NCT01262365|521473613|FG002|Overall Study|Death|1|||
144621848|NCT01262365|521473611|FG000|Overall Study|Adverse Event|26|||
144621849|NCT01262365|521473612|FG001|Overall Study|Adverse Event|16|||
144621850|NCT01262365|521473613|FG002|Overall Study|Adverse Event|11|||
144621851|NCT01262365|521473611|FG000|Overall Study|sponsor decision|1|||
144621852|NCT01262365|521473612|FG001|Overall Study|sponsor decision|1|||
144621853|NCT01262365|521473613|FG002|Overall Study|sponsor decision|0|||
144621854|NCT01262365|521473611|FG000|Overall Study|Randomization error|1|||
144621855|NCT01262365|521473612|FG001|Overall Study|Randomization error|0|||
144621856|NCT01262365|521473613|FG002|Overall Study|Randomization error|2|||
144621857|NCT01262365|521473611|FG000|Overall Study|Non-compliance|1|||
144621858|NCT01262365|521473612|FG001|Overall Study|Non-compliance|0|||
144621859|NCT01262365|521473613|FG002|Overall Study|Non-compliance|2|||
144207425|NCT03146962|519954314|FG008|Overall Study|COVID Precautions|0|||
144576143|NCT05239598|521309440|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
144576144|NCT05239598|521309439|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
144576145|NCT05239598|521309440|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
144576146|NCT02998476|521309443|FG000|Overall Study|Lost to Follow-up|1|||
144576147|NCT02998476|521309444|FG001|Overall Study|Lost to Follow-up|0|||
144576148|NCT02998476|521309443|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
144576149|NCT02998476|521309444|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
144621860|NCT01262365|521473611|FG000|Overall Study|Suspected pregnancy|1|||
144621861|NCT01262365|521473612|FG001|Overall Study|Suspected pregnancy|0|||
144621862|NCT01262365|521473613|FG002|Overall Study|Suspected pregnancy|0|||
144621863|NCT01262365|521473611|FG000|Overall Study|Patient pregnant|1|||
144621864|NCT01262365|521473612|FG001|Overall Study|Patient pregnant|0|||
144621865|NCT01262365|521473613|FG002|Overall Study|Patient pregnant|1|||
144621866|NCT01262365|521473611|FG000|Overall Study|Toxicity related to study drug|0|||
144621867|NCT01262365|521473612|FG001|Overall Study|Toxicity related to study drug|1|||
144621868|NCT01262365|521473613|FG002|Overall Study|Toxicity related to study drug|0|||
144207426|NCT03146962|519954315|FG009|Overall Study|COVID Precautions|0|||
144621869|NCT01262365|521473611|FG000|Overall Study|Cannot tolerate the protocol|0|||
144576150|NCT02998476|521309443|FG000|Overall Study|Withdrawal by Subject|1|||
144576151|NCT02998476|521309444|FG001|Overall Study|Withdrawal by Subject|2|||
144576152|NCT02998476|521309443|FG000|Overall Study|Death|45|||
144576153|NCT02998476|521309444|FG001|Overall Study|Death|2|||
144576154|NCT02998476|521309443|FG000|Overall Study|Other|6|||
144576155|NCT02998476|521309444|FG001|Overall Study|Other|1|||
144576156|NCT05855967|521309445|FG000|Overall Study|Withdrawal by Subject|7|||
144576157|NCT05855967|521309446|FG001|Overall Study|Withdrawal by Subject|5|||
144576158|NCT05855967|521309445|FG000|Overall Study|Lost to Follow-up|2|||
144576159|NCT05855967|521309446|FG001|Overall Study|Lost to Follow-up|1|||
144576160|NCT01435772|521309448|FG000|Overall Study|Adverse Event|1|||
144576161|NCT01435772|521309449|FG001|Overall Study|Adverse Event|0|||
144576162|NCT01435772|521309450|FG002|Overall Study|Adverse Event|2|||
144576163|NCT01435772|521309448|FG000|Overall Study|Withdrawal by Subject|0|||
144576164|NCT01435772|521309449|FG001|Overall Study|Withdrawal by Subject|1|||
144576165|NCT01435772|521309450|FG002|Overall Study|Withdrawal by Subject|3|||
144576166|NCT01435772|521309448|FG000|Overall Study|Other - study termination|2|||
144576167|NCT01435772|521309449|FG001|Overall Study|Other - study termination|2|||
144576168|NCT01435772|521309450|FG002|Overall Study|Other - study termination|10|||
144576169|NCT03238963|521309451|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
144576170|NCT03238963|521309452|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
144576171|NCT03238963|521309451|FG000|Overall Study|Withdrawal by Subject|1|||
144576172|NCT03238963|521309452|FG001|Overall Study|Withdrawal by Subject|1|||
144576173|NCT03238963|521309451|FG000|Overall Study|Lost to Follow-up|1|||
144576174|NCT03238963|521309452|FG001|Overall Study|Lost to Follow-up|0|||
144576175|NCT03238963|521309451|FG000|Overall Study|Protocol Violation|1|||
144576176|NCT03238963|521309452|FG001|Overall Study|Protocol Violation|1|||
144576177|NCT03238963|521309451|FG000|Overall Study|Adverse Event|1|||
144576178|NCT03238963|521309452|FG001|Overall Study|Adverse Event|0|||
144576179|NCT06926673|521309453|FG000|Overall Study|Lost to Follow-up|0|||
144576180|NCT06926673|521309454|FG001|Overall Study|Lost to Follow-up|0|||
144576181|NCT06926673|521309455|FG002|Overall Study|Lost to Follow-up|0|||
144576182|NCT06926673|521309456|FG003|Overall Study|Lost to Follow-up|1|||
144576183|NCT06926673|521309457|FG004|Overall Study|Lost to Follow-up|0|||
144621870|NCT01262365|521473612|FG001|Overall Study|Cannot tolerate the protocol|1|||
144621871|NCT01262365|521473613|FG002|Overall Study|Cannot tolerate the protocol|0|||
144621872|NCT01262365|521473611|FG000|Overall Study|Patient unavailable|0|||
144621873|NCT01262365|521473612|FG001|Overall Study|Patient unavailable|0|||
144621874|NCT01262365|521473613|FG002|Overall Study|Patient unavailable|1|||
144621875|NCT02787850|521473614|FG000|Overall Study|Withdrawal by Subject|0|||
144621876|NCT02787850|521473615|FG001|Overall Study|Withdrawal by Subject|1|||
144621877|NCT00494091|521473616|FG000|Overall Study|Death|5|||
144621878|NCT00494091|521473617|FG001|Overall Study|Death|54|||
144621879|NCT00494091|521473616|FG000|Overall Study|Lost to Follow-up|0|||
144621880|NCT00494091|521473617|FG001|Overall Study|Lost to Follow-up|4|||
144621881|NCT00494091|521473616|FG000|Overall Study|Other|1|||
144621882|NCT00494091|521473617|FG001|Overall Study|Other|11|||
144621883|NCT00494091|521473616|FG000|Overall Study|Withdrawal by Subject|0|||
144621884|NCT00494091|521473617|FG001|Overall Study|Withdrawal by Subject|7|||
144621885|NCT02322710|521473620|FG000|Overall Study|No efficacy assessment post-baseline|0|||
144621886|NCT02322710|521473621|FG001|Overall Study|No efficacy assessment post-baseline|1|||
144621887|NCT02322710|521473620|FG000|Overall Study|Protocol Violation|20|||
144621888|NCT02322710|521473621|FG001|Overall Study|Protocol Violation|25|||
144621889|NCT04161131|521473622|FG000|Overall Study|Ineligible|2|||
144621890|NCT04161131|521473622|FG000|Overall Study|Lost to Follow-up|4|||
144621891|NCT03733392|521473626|FG000|Overall Study|Withdrawal by Subject|11|||
144621892|NCT03733392|521473627|FG001|Overall Study|Withdrawal by Subject|1|||
144730049|NCT02653664|521868125|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
144730050|NCT02653664|521868126|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
144730051|NCT02653664|521868127|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
144730052|NCT04657770|521868128|FG000|Overall Study|Withdrawal by Subject|3|||
144730053|NCT04657770|521868128|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
144576184|NCT06926673|521309458|FG005|Overall Study|Lost to Follow-up|0|||
144576185|NCT06926673|521309459|FG006|Overall Study|Lost to Follow-up|0|||
144576186|NCT06926673|521309453|FG000|Overall Study|Physician Decision|0|||
144730054|NCT00746798|521868129|FG000|Overall Study|Protocol Violation|0|||
144730055|NCT00746798|521868130|FG001|Overall Study|Protocol Violation|1|||
144576187|NCT06926673|521309454|FG001|Overall Study|Physician Decision|0|||
144576188|NCT06926673|521309455|FG002|Overall Study|Physician Decision|0|||
144576189|NCT06926673|521309456|FG003|Overall Study|Physician Decision|0|||
144576190|NCT06926673|521309457|FG004|Overall Study|Physician Decision|0|||
144621893|NCT03733392|521473626|FG000|Overall Study|Death|1|||
144621894|NCT03733392|521473627|FG001|Overall Study|Death|0|||
144621895|NCT03733392|521473626|FG000|Overall Study|Lost to Follow-up|5|||
144576191|NCT06926673|521309458|FG005|Overall Study|Physician Decision|0|||
144621896|NCT03733392|521473627|FG001|Overall Study|Lost to Follow-up|0|||
144576192|NCT06926673|521309459|FG006|Overall Study|Physician Decision|1|||
144576193|NCT06926673|521309453|FG000|Overall Study|Withdrawal by Subject|0|||
144576194|NCT06926673|521309454|FG001|Overall Study|Withdrawal by Subject|3|||
144576195|NCT06926673|521309455|FG002|Overall Study|Withdrawal by Subject|2|||
144576196|NCT06926673|521309456|FG003|Overall Study|Withdrawal by Subject|1|||
144576197|NCT06926673|521309457|FG004|Overall Study|Withdrawal by Subject|0|||
144576198|NCT06926673|521309458|FG005|Overall Study|Withdrawal by Subject|2|||
144576199|NCT06926673|521309459|FG006|Overall Study|Withdrawal by Subject|0|||
144576200|NCT01424813|521309460|FG000|Overall Study|Withdrawal by Subject|3|||
144576201|NCT01424813|521309461|FG001|Overall Study|Withdrawal by Subject|0|||
144576202|NCT01424813|521309460|FG000|Overall Study|Protocol Violation|1|||
144576203|NCT01424813|521309461|FG001|Overall Study|Protocol Violation|0|||
144576204|NCT01424813|521309460|FG000|Overall Study|Other|1|||
144576205|NCT01424813|521309461|FG001|Overall Study|Other|2|||
144576206|NCT03939689|521311652|FG000|Overall Study|Radiographic progression|14|||
144576207|NCT03939689|521311653|FG001|Overall Study|Radiographic progression|17|||
144576208|NCT03939689|521311652|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
144576209|NCT03939689|521311653|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
144576210|NCT03939689|521311652|FG000|Overall Study|Adverse Event|1|||
144576211|NCT03939689|521311653|FG001|Overall Study|Adverse Event|8|||
144576212|NCT03939689|521311652|FG000|Overall Study|Unequivocal clinical progression|2|||
144576213|NCT03939689|521311653|FG001|Overall Study|Unequivocal clinical progression|5|||
144576214|NCT03939689|521311652|FG000|Overall Study|Other|1|||
144576215|NCT03939689|521311653|FG001|Overall Study|Other|4|||
144576216|NCT03939689|521311652|FG000|Overall Study|Death|0|||
144576217|NCT03939689|521311653|FG001|Overall Study|Death|3|||
144576218|NCT03939689|521311652|FG000|Overall Study|Participant decision|0|||
144576219|NCT03939689|521311653|FG001|Overall Study|Participant decision|3|||
144576220|NCT03939689|521311652|FG000|Overall Study|Withdrawal of consent|2|||
144576221|NCT03939689|521311653|FG001|Overall Study|Withdrawal of consent|1|||
144576222|NCT03939689|521311652|FG000|Overall Study|Investigator decision|1|||
144576223|NCT03939689|521311653|FG001|Overall Study|Investigator decision|0|||
144576224|NCT01920477|521311656|FG000|Overall Study|Adverse Event|0|||
144576225|NCT01920477|521311657|FG001|Overall Study|Adverse Event|1|||
144576226|NCT01920477|521311656|FG000|Overall Study|Lack of Efficacy|1|||
144576227|NCT01920477|521311657|FG001|Overall Study|Lack of Efficacy|0|||
144576228|NCT01920477|521311656|FG000|Overall Study|Study closed/terminated|14|||
144576229|NCT01920477|521311657|FG001|Overall Study|Study closed/terminated|15|||
144576230|NCT01920477|521311656|FG000|Overall Study|Withdrawal by Subject|0|||
144576231|NCT01920477|521311657|FG001|Overall Study|Withdrawal by Subject|1|||
144576232|NCT01681277|521311658|FG000|Overall Study|Adverse Event|1|||
144576233|NCT01681277|521311659|FG001|Overall Study|Adverse Event|0|||
144576234|NCT01681277|521311660|FG002|Overall Study|Adverse Event|0|||
144576235|NCT01681277|521311661|FG003|Overall Study|Adverse Event|0|||
144576236|NCT01681277|521311662|FG004|Overall Study|Adverse Event|0|||
144576237|NCT03838731|521311663|FG000|Overall Study|Pregnancy|0|||
144576238|NCT03838731|521311664|FG001|Overall Study|Pregnancy|1|||
144576239|NCT03838731|521311663|FG000|Overall Study|Withdrawal of consent|1|||
144576240|NCT03838731|521311664|FG001|Overall Study|Withdrawal of consent|0|||
144576241|NCT04707664|521311665|FG000|Overall Study|Adverse Event|2|||
144576242|NCT04707664|521311666|FG001|Overall Study|Adverse Event|0|||
144576243|NCT04707664|521311665|FG000|Overall Study|Death|1|||
144576244|NCT04707664|521311666|FG001|Overall Study|Death|2|||
144576245|NCT04707664|521311665|FG000|Overall Study|Withdrawal by Subject|13|||
144576246|NCT04707664|521311666|FG001|Overall Study|Withdrawal by Subject|21|||
144576247|NCT04707664|521311665|FG000|Overall Study|Lost to Follow-up|11|||
144576248|NCT04707664|521311666|FG001|Overall Study|Lost to Follow-up|13|||
144576249|NCT04707664|521311665|FG000|Overall Study|Not treated|2|||
144576250|NCT04707664|521311666|FG001|Overall Study|Not treated|0|||
144576251|NCT01182441|521311667|FG000|Overall Study|Patient Still in Follow-up|152|||
144576252|NCT01182441|521311668|FG001|Overall Study|Patient Still in Follow-up|72|||
144576253|NCT01182441|521311667|FG000|Overall Study|Death|37|||
144576254|NCT01182441|521311668|FG001|Overall Study|Death|25|||
144207427|NCT03146962|519954306|FG000|Overall Study|Physician Decision|0|||
144207428|NCT03146962|519954307|FG001|Overall Study|Physician Decision|0|||
144207429|NCT03146962|519954308|FG002|Overall Study|Physician Decision|0|||
144576255|NCT01182441|521311667|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
144576256|NCT01182441|521311668|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
144576257|NCT01182441|521311667|FG000|Overall Study|Lost to Follow-up|5|||
144576258|NCT01182441|521311668|FG001|Overall Study|Lost to Follow-up|8|||
144576259|NCT01182441|521311667|FG000|Overall Study|Withdrawal by Subject|6|||
144576260|NCT01182441|521311668|FG001|Overall Study|Withdrawal by Subject|13|||
144576261|NCT01182441|521311667|FG000|Overall Study|Implant Not Attempted|4|||
144576262|NCT01182441|521311668|FG001|Overall Study|Implant Not Attempted|0|||
144576263|NCT01182441|521311667|FG000|Overall Study|Adverse Event|2|||
144207430|NCT03146962|519954309|FG003|Overall Study|Physician Decision|0|||
144576264|NCT01182441|521311668|FG001|Overall Study|Adverse Event|0|||
144576265|NCT01182441|521311667|FG000|Overall Study|Physician Decision|1|||
144576266|NCT01182441|521311668|FG001|Overall Study|Physician Decision|1|||
144576267|NCT02304705|521311669|FG000|Overall Study|Withdrawal by Subject|2|||
144576268|NCT02304705|521311670|FG001|Overall Study|Withdrawal by Subject|0|||
144576269|NCT02304705|521311669|FG000|Overall Study|Physician Decision|2|||
144576270|NCT02304705|521311670|FG001|Overall Study|Physician Decision|4|||
144576271|NCT02304705|521311669|FG000|Overall Study|Death|0|||
144576272|NCT02304705|521311670|FG001|Overall Study|Death|1|||
144576273|NCT02304705|521311669|FG000|Overall Study|Lost to Follow-up|0|||
144576274|NCT02304705|521311670|FG001|Overall Study|Lost to Follow-up|2|||
144576275|NCT01195948|521311671|FG000|Overall Study|Lost to Follow-up|0|||
144576276|NCT01195948|521311672|FG001|Overall Study|Lost to Follow-up|1|||
144576277|NCT01195948|521311673|FG002|Overall Study|Lost to Follow-up|2|||
144576278|NCT04996004|521311674|FG000|Phase I|Death|1|||
144576279|NCT04996004|521311675|FG001|Phase I|Death|2|||
144576280|NCT04996004|521311676|FG002|Phase I|Death|1|||
144576281|NCT04996004|521311677|FG003|Phase I|Death|0|||
144576282|NCT04996004|521311678|FG004|Phase I|Death|0|||
144576283|NCT04996004|521311679|FG005|Phase I|Death|0|||
144576284|NCT04996004|521311674|FG000|Phase I|Study terminated by sponsor|2|||
144576285|NCT04996004|521311675|FG001|Phase I|Study terminated by sponsor|1|||
144576286|NCT04996004|521311676|FG002|Phase I|Study terminated by sponsor|2|||
144576287|NCT04996004|521311677|FG003|Phase I|Study terminated by sponsor|0|||
144576288|NCT04996004|521311678|FG004|Phase I|Study terminated by sponsor|0|||
144576289|NCT04996004|521311679|FG005|Phase I|Study terminated by sponsor|0|||
144576290|NCT04996004|521311674|FG000|Phase II|Study terminated by sponsor|0|||
144576291|NCT04996004|521311675|FG001|Phase II|Study terminated by sponsor|0|||
144576292|NCT04996004|521311676|FG002|Phase II|Study terminated by sponsor|0|||
144576293|NCT04996004|521311677|FG003|Phase II|Study terminated by sponsor|20|||
144576294|NCT04996004|521311678|FG004|Phase II|Study terminated by sponsor|10|||
144576295|NCT04996004|521311679|FG005|Phase II|Study terminated by sponsor|10|||
144576296|NCT04996004|521311674|FG000|Phase II|Withdrawal by Subject|0|||
144576297|NCT04996004|521311675|FG001|Phase II|Withdrawal by Subject|0|||
144576298|NCT04996004|521311676|FG002|Phase II|Withdrawal by Subject|0|||
144576299|NCT04996004|521311677|FG003|Phase II|Withdrawal by Subject|0|||
144576300|NCT04996004|521311678|FG004|Phase II|Withdrawal by Subject|1|||
144576301|NCT04996004|521311679|FG005|Phase II|Withdrawal by Subject|2|||
144576302|NCT04996004|521311674|FG000|Phase II|Death|0|||
144576303|NCT04996004|521311675|FG001|Phase II|Death|0|||
144576304|NCT04996004|521311676|FG002|Phase II|Death|0|||
144576305|NCT04996004|521311677|FG003|Phase II|Death|12|||
144576306|NCT04996004|521311678|FG004|Phase II|Death|2|||
144576307|NCT04996004|521311679|FG005|Phase II|Death|9|||
144576308|NCT04996004|521311674|FG000|Phase II|Other|0|||
144576309|NCT04996004|521311675|FG001|Phase II|Other|0|||
144576310|NCT04996004|521311676|FG002|Phase II|Other|0|||
144576311|NCT04996004|521311677|FG003|Phase II|Other|0|||
144576312|NCT04996004|521311678|FG004|Phase II|Other|0|||
144576313|NCT04996004|521311679|FG005|Phase II|Other|1|||
144576314|NCT05620108|521311680|FG000|Overall Study|Physician Decision|1|||
144576315|NCT05620108|521311681|FG001|Overall Study|Physician Decision|2|||
144576316|NCT02038842|521311682|FG000|Overall Study|Withdrawal by Subject|2|||
144576317|NCT02038842|521311683|FG001|Overall Study|Withdrawal by Subject|2|||
144576318|NCT02038842|521311684|FG002|Overall Study|Withdrawal by Subject|0|||
144576319|NCT02038842|521311685|FG003|Overall Study|Withdrawal by Subject|0|||
144576320|NCT02038842|521311682|FG000|Overall Study|Participant decision|0|||
144576321|NCT02038842|521311683|FG001|Overall Study|Participant decision|0|||
144576322|NCT02038842|521311684|FG002|Overall Study|Participant decision|2|||
144576323|NCT02038842|521311685|FG003|Overall Study|Participant decision|1|||
144576324|NCT02038842|521311682|FG000|Overall Study|Adverse Event|0|||
144576325|NCT02038842|521311683|FG001|Overall Study|Adverse Event|0|||
144576326|NCT02038842|521311684|FG002|Overall Study|Adverse Event|3|||
144576327|NCT02038842|521311685|FG003|Overall Study|Adverse Event|1|||
144576328|NCT02038842|521311682|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
144576329|NCT02038842|521311683|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
144576330|NCT02038842|521311684|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
144576331|NCT02038842|521311685|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
144576332|NCT01757197|521311688|FG000|Overall Study|Death|2|||
144576333|NCT05332912|521311689|FG000|Overall Study|Withdrawal by Subject|0|||
144576334|NCT05332912|521311690|FG001|Overall Study|Withdrawal by Subject|1|||
144576335|NCT05332912|521311691|FG002|Overall Study|Withdrawal by Subject|2|||
144576336|NCT05332912|521311692|FG003|Overall Study|Withdrawal by Subject|0|||
144576337|NCT05332912|521311689|FG000|Overall Study|Lost to Follow-up|0|||
144576338|NCT05332912|521311690|FG001|Overall Study|Lost to Follow-up|0|||
144576339|NCT05332912|521311691|FG002|Overall Study|Lost to Follow-up|1|||
144576340|NCT05332912|521311692|FG003|Overall Study|Lost to Follow-up|0|||
144576341|NCT01174446|521311693|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
144576342|NCT01174446|521311694|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
144576343|NCT01174446|521311695|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
144576344|NCT01174446|521311696|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
144576345|NCT01174446|521311693|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
144621897|NCT03733392|521473626|FG000|Overall Study|Protocol Violation|0|||
144576346|NCT01174446|521311694|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
144576347|NCT01174446|521311695|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
144576348|NCT01174446|521311696|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
144576349|NCT01174446|521311693|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
144576350|NCT01174446|521311694|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
144576351|NCT01174446|521311695|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
144576352|NCT01174446|521311696|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
144576353|NCT01174446|521311693|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
144576354|NCT01174446|521311694|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
144576355|NCT01174446|521311695|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
144576356|NCT01174446|521311696|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
144576357|NCT03057847|521311697|FG000|Overall Study|Lost to Follow-up|16|||
144576358|NCT02942004|521311699|FG000|Overall Study|Withdrawal by Subject|0|||
144576359|NCT02942004|521311700|FG001|Overall Study|Withdrawal by Subject|2|||
144576360|NCT02942004|521311701|FG002|Overall Study|Withdrawal by Subject|3|||
144576361|NCT02942004|521311699|FG000|Overall Study|Lost to Follow-up|1|||
144576362|NCT02942004|521311700|FG001|Overall Study|Lost to Follow-up|1|||
144576363|NCT02942004|521311701|FG002|Overall Study|Lost to Follow-up|2|||
144576364|NCT02942004|521311699|FG000|Overall Study|Randomized but not dosed|3|||
144576365|NCT02942004|521311700|FG001|Overall Study|Randomized but not dosed|9|||
144576366|NCT02942004|521311701|FG002|Overall Study|Randomized but not dosed|4|||
144576367|NCT04517669|521311702|FG000|Overall Study|Lost to Follow-up|2|||
144576368|NCT04517669|521311702|FG000|Overall Study|Withdrawal by Subject|3|||
144576369|NCT04517669|521311702|FG000|Overall Study|Drug withdrawn|44|||
144576370|NCT04517669|521311702|FG000|Overall Study|Other|1|||
144576371|NCT04517669|521311702|FG000|Overall Study|Eligibility criteria not met|4|||
144576372|NCT04517669|521311702|FG000|Overall Study|Did not receive treatment|3|||
144576373|NCT02138786|521311703|FG000|Overall Study|Adverse Event|0|||
144576374|NCT02138786|521311704|FG001|Overall Study|Adverse Event|2|||
144576375|NCT02138786|521311705|FG002|Overall Study|Adverse Event|1|||
144576376|NCT02138786|521311703|FG000|Overall Study|Death|1|||
144576377|NCT02138786|521311704|FG001|Overall Study|Death|7|||
144576378|NCT02138786|521311705|FG002|Overall Study|Death|2|||
144576379|NCT02138786|521311703|FG000|Overall Study|Disease Progression|1|||
144576380|NCT02138786|521311704|FG001|Overall Study|Disease Progression|1|||
144576381|NCT02138786|521311705|FG002|Overall Study|Disease Progression|3|||
144576382|NCT02138786|521311703|FG000|Overall Study|Withdrawal by Subject|1|||
144576383|NCT02138786|521311704|FG001|Overall Study|Withdrawal by Subject|2|||
144576384|NCT02138786|521311705|FG002|Overall Study|Withdrawal by Subject|0|||
144576385|NCT02138786|521311703|FG000|Overall Study|Patient's Wish|0|||
144576386|NCT02138786|521311704|FG001|Overall Study|Patient's Wish|2|||
144576387|NCT02138786|521311705|FG002|Overall Study|Patient's Wish|0|||
144576388|NCT02138786|521311703|FG000|Overall Study|Sponsor Terminated Study|0|||
144576389|NCT02138786|521311704|FG001|Overall Study|Sponsor Terminated Study|1|||
144576390|NCT02138786|521311705|FG002|Overall Study|Sponsor Terminated Study|1|||
144576391|NCT02138786|521311703|FG000|Overall Study|Non-Compliance|0|||
144576392|NCT02138786|521311704|FG001|Overall Study|Non-Compliance|0|||
144576393|NCT02138786|521311705|FG002|Overall Study|Non-Compliance|1|||
144576394|NCT01199068|521311706|FG000|Overall Study|Unacceptable toxicity|0|||
144576395|NCT01199068|521311707|FG001|Overall Study|Unacceptable toxicity|0|||
144576396|NCT01199068|521311708|FG002|Overall Study|Unacceptable toxicity|2|||
144576397|NCT01199068|521311706|FG000|Overall Study|Progressive disease|3|||
144576398|NCT01199068|521311707|FG001|Overall Study|Progressive disease|3|||
144576399|NCT01199068|521311708|FG002|Overall Study|Progressive disease|6|||
144576400|NCT01199068|521311706|FG000|Overall Study|Withdrawal by Subject|0|||
144576401|NCT01199068|521311707|FG001|Overall Study|Withdrawal by Subject|0|||
144576402|NCT01199068|521311708|FG002|Overall Study|Withdrawal by Subject|1|||
144576403|NCT01250925|521311709|FG000|Overall Study|Lost to Follow-up|1|||
144576404|NCT01250925|521311710|FG001|Overall Study|Lost to Follow-up|1|||
144576405|NCT01250925|521311711|FG002|Overall Study|Lost to Follow-up|0|||
144576406|NCT01250925|521311709|FG000|Overall Study|Withdrawal by Subject|2|||
144576407|NCT01250925|521311710|FG001|Overall Study|Withdrawal by Subject|0|||
144576408|NCT01250925|521311711|FG002|Overall Study|Withdrawal by Subject|0|||
144576409|NCT01250925|521311709|FG000|Overall Study|Protocol Violation|2|||
144576410|NCT01250925|521311710|FG001|Overall Study|Protocol Violation|0|||
144576411|NCT01250925|521311711|FG002|Overall Study|Protocol Violation|0|||
144576412|NCT01250925|521311709|FG000|Overall Study|Physician Decision|0|||
144576413|NCT01250925|521311710|FG001|Overall Study|Physician Decision|2|||
144576414|NCT01250925|521311711|FG002|Overall Study|Physician Decision|1|||
144576415|NCT01250925|521311709|FG000|Overall Study|Adverse Event|0|||
144576416|NCT01250925|521311710|FG001|Overall Study|Adverse Event|0|||
144576417|NCT01250925|521311711|FG002|Overall Study|Adverse Event|1|||
144576418|NCT00677534|521311716|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
144621898|NCT03733392|521473627|FG001|Overall Study|Protocol Violation|1|||
144576419|NCT00677534|521311716|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
144576420|NCT00677534|521311716|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
144576421|NCT02687035|521311717|FG000|Overall Study|Withdrawal by Subject|1|||
144576422|NCT02687035|521311717|FG000|Overall Study|Death|87|||
144576423|NCT02687035|521311717|FG000|Overall Study|Lost to Follow-up|1|||
144576424|NCT02687035|521311717|FG000|Overall Study|Missed Visit|87|||
144576425|NCT02687035|521311717|FG000|Overall Study|Did not receive Study Device|8|||
144576426|NCT00667394|521311720|FG000|Overall Study|Adverse Event|3|||
144576427|NCT00667394|521311721|FG001|Overall Study|Adverse Event|0|||
144576428|NCT00667394|521311720|FG000|Overall Study|Progressive disease|1|||
144576429|NCT00667394|521311721|FG001|Overall Study|Progressive disease|0|||
144576430|NCT04638660|521311723|FG000|Overall Study|Withdrawal by Subject|2|||
144576431|NCT04638660|521311724|FG001|Overall Study|Withdrawal by Subject|0|||
144576432|NCT04638660|521311723|FG000|Overall Study|Lost to Follow-up|1|||
144576433|NCT04638660|521311724|FG001|Overall Study|Lost to Follow-up|0|||
144576434|NCT04481373|521311729|FG000|Overall Study|Protocol Violation|1|||
144576435|NCT04481373|521311730|FG001|Overall Study|Protocol Violation|0|||
144576436|NCT04481373|521311729|FG000|Overall Study|Viral load in hospital not over 1000|2|||
144576437|NCT04481373|521311730|FG001|Overall Study|Viral load in hospital not over 1000|1|||
144576438|NCT04481373|521311729|FG000|Overall Study|Death before hospital discharge|1|||
144576439|NCT04481373|521311730|FG001|Overall Study|Death before hospital discharge|0|||
144576440|NCT02224703|521311732|FG000|Overall Study|Adverse Event|0|||
144576441|NCT02224703|521311733|FG001|Overall Study|Adverse Event|5|||
144576442|NCT02224703|521311734|FG002|Overall Study|Adverse Event|0|||
144576443|NCT02224703|521311732|FG000|Overall Study|Withdrawn by investigator|1|||
144576444|NCT02224703|521311733|FG001|Overall Study|Withdrawn by investigator|0|||
144576445|NCT02224703|521311734|FG002|Overall Study|Withdrawn by investigator|0|||
144576446|NCT02224703|521311732|FG000|Overall Study|Advised by medical monitor|1|||
144576447|NCT02224703|521311733|FG001|Overall Study|Advised by medical monitor|0|||
144576448|NCT02224703|521311734|FG002|Overall Study|Advised by medical monitor|0|||
144576449|NCT02224703|521311732|FG000|Overall Study|Withdrawn by parent/guardian|0|||
144576450|NCT02224703|521311733|FG001|Overall Study|Withdrawn by parent/guardian|1|||
144576451|NCT02224703|521311734|FG002|Overall Study|Withdrawn by parent/guardian|0|||
144576452|NCT02224703|521311732|FG000|Overall Study|Lack of Efficacy|1|||
144576453|NCT02224703|521311733|FG001|Overall Study|Lack of Efficacy|0|||
144576454|NCT02224703|521311734|FG002|Overall Study|Lack of Efficacy|0|||
144576455|NCT01886287|521311744|FG000|Overall Study|Radiographic disease progression|1|||
144576456|NCT01886287|521311744|FG000|Overall Study|Clinical progression due to disease|1|||
144576457|NCT03596762|521311745|FG000|Overall Study|Protocol Violation|0|||
144576458|NCT03596762|521311746|FG001|Overall Study|Protocol Violation|0|||
144576459|NCT03596762|521311747|FG002|Overall Study|Protocol Violation|0|||
144576460|NCT03596762|521311748|FG003|Overall Study|Protocol Violation|0|||
144576461|NCT03596762|521311749|FG004|Overall Study|Protocol Violation|1|||
144576462|NCT03596762|521311745|FG000|Overall Study|Adverse Event|2|||
144576463|NCT03596762|521311746|FG001|Overall Study|Adverse Event|0|||
144576464|NCT03596762|521311747|FG002|Overall Study|Adverse Event|1|||
144576465|NCT03596762|521311748|FG003|Overall Study|Adverse Event|0|||
144576466|NCT03596762|521311749|FG004|Overall Study|Adverse Event|5|||
144576467|NCT03596762|521311745|FG000|Overall Study|Withdrawal by Subject|2|||
144576468|NCT03596762|521311746|FG001|Overall Study|Withdrawal by Subject|1|||
144576469|NCT03596762|521311747|FG002|Overall Study|Withdrawal by Subject|0|||
144576470|NCT03596762|521311748|FG003|Overall Study|Withdrawal by Subject|1|||
144576471|NCT03596762|521311749|FG004|Overall Study|Withdrawal by Subject|1|||
144576472|NCT02195479|521311750|FG000|Overall Study|Lost to Follow-up|18|||
144576473|NCT02195479|521311751|FG001|Overall Study|Lost to Follow-up|15|||
144576474|NCT02195479|521311750|FG000|Overall Study|Death|217|||
144576475|NCT02195479|521311751|FG001|Overall Study|Death|171|||
144576476|NCT02195479|521311750|FG000|Overall Study|Physician Decision|1|||
144576477|NCT02195479|521311751|FG001|Overall Study|Physician Decision|0|||
144576478|NCT02195479|521311750|FG000|Overall Study|Withdrawal by Subject|30|||
144576479|NCT02195479|521311751|FG001|Overall Study|Withdrawal by Subject|30|||
144576480|NCT02195479|521311750|FG000|Overall Study|Other|3|||
144576481|NCT02195479|521311751|FG001|Overall Study|Other|4|||
144576482|NCT02195479|521311750|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
144576483|NCT02195479|521311751|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
144576484|NCT05071053|521311752|FG000|Overall Study|Progressive disease|30|||
144576485|NCT05071053|521311752|FG000|Overall Study|Adverse Event|5|||
144576486|NCT02593123|521311753|FG000|Overall Study|Physician Decision|2|||
144576487|NCT02593123|521311754|FG001|Overall Study|Physician Decision|1|||
144576488|NCT02593123|521311753|FG000|Overall Study|Relapse|1|||
144576489|NCT02593123|521311754|FG001|Overall Study|Relapse|1|||
144576490|NCT01602510|521311762|FG000|Open Label Phase|Adverse Event|46|||
144576491|NCT01602510|521311763|FG001|Open Label Phase|Adverse Event|0|||
144576492|NCT01602510|521311764|FG002|Open Label Phase|Adverse Event|0|||
144576493|NCT01602510|521311762|FG000|Open Label Phase|Lack of Efficacy|22|||
144576494|NCT01602510|521311763|FG001|Open Label Phase|Lack of Efficacy|0|||
144576495|NCT01602510|521311764|FG002|Open Label Phase|Lack of Efficacy|0|||
144576496|NCT01602510|521311762|FG000|Open Label Phase|Protocol Violation|15|||
144576497|NCT01602510|521311763|FG001|Open Label Phase|Protocol Violation|0|||
144576498|NCT01602510|521311764|FG002|Open Label Phase|Protocol Violation|0|||
144576499|NCT01602510|521311762|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
144576500|NCT01602510|521311763|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
144576501|NCT01602510|521311764|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
144576502|NCT01602510|521311762|FG000|Open Label Phase|Lost to Follow-up|22|||
144576503|NCT01602510|521311763|FG001|Open Label Phase|Lost to Follow-up|0|||
144576504|NCT01602510|521311764|FG002|Open Label Phase|Lost to Follow-up|0|||
144576505|NCT01602510|521311762|FG000|Open Label Phase|Physician Decision|19|||
144576506|NCT01602510|521311763|FG001|Open Label Phase|Physician Decision|0|||
144576507|NCT01602510|521311764|FG002|Open Label Phase|Physician Decision|0|||
144576508|NCT01602510|521311762|FG000|Open Label Phase|Withdrawal by Subject|57|||
144576509|NCT01602510|521311763|FG001|Open Label Phase|Withdrawal by Subject|0|||
144576510|NCT01602510|521311764|FG002|Open Label Phase|Withdrawal by Subject|0|||
144576511|NCT01602510|521311762|FG000|Randomized Phase|Adverse Event|0|||
144576512|NCT01602510|521311763|FG001|Randomized Phase|Adverse Event|2|||
144576513|NCT01602510|521311764|FG002|Randomized Phase|Adverse Event|6|||
144576514|NCT01602510|521311762|FG000|Randomized Phase|Lack of Efficacy|0|||
144576515|NCT01602510|521311763|FG001|Randomized Phase|Lack of Efficacy|4|||
144576516|NCT01602510|521311764|FG002|Randomized Phase|Lack of Efficacy|4|||
144576517|NCT01602510|521311762|FG000|Randomized Phase|Protocol Violation|0|||
144576518|NCT01602510|521311763|FG001|Randomized Phase|Protocol Violation|3|||
144576519|NCT01602510|521311764|FG002|Randomized Phase|Protocol Violation|3|||
144576520|NCT01602510|521311762|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
144576521|NCT01602510|521311763|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
144576522|NCT01602510|521311764|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
144576523|NCT01602510|521311762|FG000|Randomized Phase|Lost to Follow-up|0|||
144576524|NCT01602510|521311763|FG001|Randomized Phase|Lost to Follow-up|1|||
144576525|NCT01602510|521311764|FG002|Randomized Phase|Lost to Follow-up|3|||
144576526|NCT01602510|521311762|FG000|Randomized Phase|Physician Decision|0|||
144576527|NCT01602510|521311763|FG001|Randomized Phase|Physician Decision|0|||
144576528|NCT01602510|521311764|FG002|Randomized Phase|Physician Decision|2|||
144576529|NCT01602510|521311762|FG000|Randomized Phase|Withdrawal by Subject|0|||
144576530|NCT01602510|521311763|FG001|Randomized Phase|Withdrawal by Subject|6|||
144576531|NCT01602510|521311764|FG002|Randomized Phase|Withdrawal by Subject|7|||
144576532|NCT01001390|521311765|FG000|Overall Study|Failure to wear AFO device|2|||
144576533|NCT01001390|521311766|FG001|Overall Study|Failure to wear AFO device|0|||
144576534|NCT00504777|521311767|FG000|Overall Study|Adverse Event|1|||
144576535|NCT01195623|521311768|FG000|Overall Study|Lost to Follow-up|35|||
144576536|NCT01195623|521311769|FG001|Overall Study|Lost to Follow-up|37|||
144576537|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
144576538|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
144576539|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
144576540|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
144576541|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
144576542|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
144576543|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
144576544|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
144576545|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
144576546|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
144621899|NCT03733392|521473626|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
144621900|NCT03733392|521473627|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
144621901|NCT03733392|521473626|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
144576547|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
144576548|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
144576549|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
144576550|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
144576551|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
144621902|NCT03733392|521473627|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
144576552|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
144576553|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
144576554|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
144576555|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
144576556|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
144576557|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
144576558|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
144576559|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
144576560|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
144621903|NCT03733392|521473626|FG000|Overall Study|Patient Non-Compliance|2|||
144576561|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
144576562|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
144576563|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
144576564|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
144576565|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
144576566|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
144576567|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
144576568|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
144576569|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
144576570|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
144576571|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
144576572|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
144576573|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
144576574|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
144576575|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
144576576|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
144576577|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
144576578|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
144576579|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
144576580|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
144576581|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
144576582|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
144576583|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
144576584|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
144576585|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
144576586|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
144576587|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
144576588|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
144576589|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
144576590|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
144576591|NCT00477490|521311773|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
144576592|NCT00477490|521311774|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
144576593|NCT00477490|521311775|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
144576594|NCT00477490|521311776|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
144576595|NCT00477490|521311777|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
144576596|NCT00477490|521311778|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
144576597|NCT00477490|521311779|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
144576598|NCT00477490|521311780|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
144576599|NCT00477490|521311781|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
144576600|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
144576601|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
144576602|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
144576603|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
144576604|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
144576605|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
144576606|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
144576607|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
144576608|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
144576609|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
144576610|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
144576611|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
144576612|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
144576613|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
144576614|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
144576615|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
144576616|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
144576617|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
144576618|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
144576619|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
144576620|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
144576621|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
144576622|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
144576623|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
144576624|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
144576625|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
144576626|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
144576627|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
144576628|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
144576629|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
144576630|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
144576631|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
144576632|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
144576633|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
144576634|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
144576635|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
144576636|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576637|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
144576638|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576639|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576640|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576641|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576642|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576643|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576644|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
144576645|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
144576646|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
144576647|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
144576648|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
144576649|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
144576650|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
144576651|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
144576652|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
144576653|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
144576654|NCT00477490|521311773|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
144576655|NCT00477490|521311774|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
144576656|NCT00477490|521311775|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
144576657|NCT00477490|521311776|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
144576658|NCT00477490|521311777|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
144576659|NCT00477490|521311778|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
144576660|NCT00477490|521311779|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
144576661|NCT00477490|521311780|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
144576662|NCT00477490|521311781|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
144576663|NCT00669877|521311784|FG000|Overall Study|Disease Progression/Death|4|||
144207431|NCT03146962|519954310|FG004|Overall Study|Physician Decision|0|||
144207432|NCT03146962|519954311|FG005|Overall Study|Physician Decision|0|||
144576664|NCT01110408|521311785|FG000|Overall Study|Protocol Violation|1|||
144576665|NCT01110408|521311786|FG001|Overall Study|Protocol Violation|0|||
144576666|NCT01646177|521311787|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
144576667|NCT01646177|521311788|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
144576668|NCT01646177|521311789|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
144576669|NCT01646177|521311790|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
144576670|NCT01646177|521311791|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576671|NCT01646177|521311792|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576672|NCT01646177|521311793|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576673|NCT01646177|521311794|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576674|NCT01646177|521311795|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576675|NCT01646177|521311796|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576676|NCT01646177|521311797|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576677|NCT01646177|521311798|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
144576678|NCT01646177|521311787|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
144576679|NCT01646177|521311788|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
144576680|NCT01646177|521311789|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
144576681|NCT01646177|521311790|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
144576682|NCT01646177|521311791|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576683|NCT01646177|521311792|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576684|NCT01646177|521311793|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576685|NCT01646177|521311794|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576686|NCT01646177|521311795|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576687|NCT01646177|521311796|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576688|NCT01646177|521311797|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576689|NCT01646177|521311798|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
144576690|NCT01646177|521311787|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
144576691|NCT01646177|521311788|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
144576692|NCT01646177|521311789|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
144576693|NCT01646177|521311790|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
144576694|NCT01646177|521311791|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576695|NCT01646177|521311792|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144207433|NCT03146962|519954312|FG006|Overall Study|Physician Decision|0|||
144576696|NCT01646177|521311793|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576697|NCT01646177|521311794|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576698|NCT01646177|521311795|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576699|NCT01646177|521311796|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576700|NCT01646177|521311797|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576701|NCT01646177|521311798|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
144576702|NCT01646177|521311787|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
144576703|NCT01646177|521311788|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
144576704|NCT01646177|521311789|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
144576705|NCT01646177|521311790|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
144576706|NCT01646177|521311791|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576707|NCT01646177|521311792|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576708|NCT01646177|521311793|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576709|NCT01646177|521311794|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144621904|NCT03733392|521473627|FG001|Overall Study|Patient Non-Compliance|1|||
144576710|NCT01646177|521311795|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576711|NCT01646177|521311796|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576712|NCT01646177|521311797|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576713|NCT01646177|521311798|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
144576714|NCT01646177|521311787|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576715|NCT01646177|521311788|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576716|NCT01646177|521311789|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
144576717|NCT01646177|521311790|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
144576718|NCT01646177|521311791|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576719|NCT01646177|521311792|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576720|NCT01646177|521311793|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576721|NCT01646177|521311794|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576722|NCT01646177|521311795|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576723|NCT01646177|521311796|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576724|NCT01646177|521311797|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576725|NCT01646177|521311798|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
144576726|NCT01646177|521311787|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
144576727|NCT01646177|521311788|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
144576728|NCT01646177|521311789|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
144576729|NCT01646177|521311790|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576730|NCT01646177|521311791|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576731|NCT01646177|521311792|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576732|NCT01646177|521311793|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576733|NCT01646177|521311794|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576734|NCT01646177|521311795|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576735|NCT01646177|521311796|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576736|NCT01646177|521311797|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576737|NCT01646177|521311798|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
144576738|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576739|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576740|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576741|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576742|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
144576743|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
144576744|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
144621905|NCT03733392|521473626|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
144621906|NCT03733392|521473627|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
144621907|NCT03733392|521473626|FG000|Overall Study|Withdrawal prior to procedure|5|||
144621908|NCT03733392|521473627|FG001|Overall Study|Withdrawal prior to procedure|2|||
144621909|NCT00130832|521473628|FG000|Overall Study|Adverse Event|1|||
144621910|NCT00130832|521473629|FG001|Overall Study|Adverse Event|1|||
144621911|NCT00130832|521473628|FG000|Overall Study|Lost to Follow-up|1|||
144576745|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
144576746|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576747|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576748|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144621912|NCT00130832|521473629|FG001|Overall Study|Lost to Follow-up|2|||
144621913|NCT00130832|521473628|FG000|Overall Study|Protocol Violation|6|||
144621914|NCT00130832|521473629|FG001|Overall Study|Protocol Violation|8|||
144621915|NCT00130832|521473628|FG000|Overall Study|Withdrawal by Subject|6|||
144621916|NCT00130832|521473629|FG001|Overall Study|Withdrawal by Subject|1|||
144262857|NCT01325350|520163768|FG001|Overall Study|Personal Reasons|1|||
144262858|NCT01325350|520163769|FG002|Overall Study|Personal Reasons|6|||
144262859|NCT01325350|520163770|FG003|Overall Study|Personal Reasons|5|||
144262860|NCT01325350|520163771|FG004|Overall Study|Personal Reasons|3|||
144262861|NCT01325350|520163767|FG000|Overall Study|Protocol Violation|0|||
144262862|NCT01325350|520163768|FG001|Overall Study|Protocol Violation|0|||
144262863|NCT01325350|520163769|FG002|Overall Study|Protocol Violation|0|||
144576749|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
144576750|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576751|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576752|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576753|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576754|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
144576755|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
144576756|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
144576757|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
144576758|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576759|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576760|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576761|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
144576762|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576763|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576764|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576765|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576766|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
144576767|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
144576768|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
144576769|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
144576770|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576771|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576772|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576773|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
144576774|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576775|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576776|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576777|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576778|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
144576779|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
144576780|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
144576781|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
144576782|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576783|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576784|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576785|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
144576786|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576787|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576788|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576789|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576790|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
144576791|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
144576792|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
144576793|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
144576794|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576795|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576796|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576797|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
144576798|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576799|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576800|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576801|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576802|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
144576803|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
144576804|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144262864|NCT01325350|520163770|FG003|Overall Study|Protocol Violation|1|||
144576805|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
144576806|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576807|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576808|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576809|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
144576810|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576811|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576812|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576813|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576814|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
144576815|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
144576816|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
144576817|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
144576818|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576819|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576820|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576821|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
144576822|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
144576823|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
144576824|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
144576825|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
144576826|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
144576827|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
144576828|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
144576829|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
144576830|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
144576831|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
144576832|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
144576833|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
144576834|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144576835|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144576836|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144576837|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144576838|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
144576839|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
144576840|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
144576841|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
144576842|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144576843|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144621917|NCT00130832|521473628|FG000|Overall Study|Moved|2|||
144621918|NCT00130832|521473629|FG001|Overall Study|Moved|2|||
144621919|NCT00130832|521473628|FG000|Overall Study|Other|0|||
144621920|NCT00130832|521473629|FG001|Overall Study|Other|3|||
144621921|NCT03905863|521473630|FG000|Overall Study|Adverse Event|2|||
144621922|NCT03905863|521473631|FG001|Overall Study|Adverse Event|4|||
144621923|NCT03905863|521473630|FG000|Overall Study|Withdrawal by Subject|2|||
144621924|NCT03905863|521473631|FG001|Overall Study|Withdrawal by Subject|2|||
144621925|NCT03905863|521473630|FG000|Overall Study|Physician Decision|0|||
144621926|NCT03905863|521473631|FG001|Overall Study|Physician Decision|3|||
144621927|NCT03905863|521473630|FG000|Overall Study|Lost to Follow-up|1|||
144621928|NCT03905863|521473631|FG001|Overall Study|Lost to Follow-up|0|||
144621929|NCT03905863|521473630|FG000|Overall Study|Protocol Violation|0|||
144621930|NCT03905863|521473631|FG001|Overall Study|Protocol Violation|2|||
144621931|NCT03905863|521473630|FG000|Overall Study|Death|0|||
144621932|NCT03905863|521473631|FG001|Overall Study|Death|1|||
144621933|NCT00984204|521473633|FG000|Overall Study|Death|1|||
144621934|NCT00984204|521473633|FG000|Overall Study|Lost to Follow-up|4|||
144621935|NCT00984204|521473633|FG000|Overall Study|Lack of Efficacy|10|||
144621936|NCT04401267|521473640|FG000|Overall Study|Death|0|||
144207434|NCT03146962|519954313|FG007|Overall Study|Physician Decision|0|||
144207435|NCT03146962|519954314|FG008|Overall Study|Physician Decision|0|||
144207436|NCT03146962|519954315|FG009|Overall Study|Physician Decision|1|||
144207437|NCT03146962|519954306|FG000|Overall Study|Started New Treatment|0|||
144207438|NCT03146962|519954307|FG001|Overall Study|Started New Treatment|1|||
144207439|NCT03146962|519954308|FG002|Overall Study|Started New Treatment|0|||
144207440|NCT03146962|519954309|FG003|Overall Study|Started New Treatment|0|||
144576844|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144621937|NCT04401267|521473641|FG001|Overall Study|Death|1|||
144621938|NCT04401267|521473640|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
144621939|NCT04401267|521473641|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
144621940|NCT04401267|521473640|FG000|Overall Study|Found to be Ineligible|1|||
144621941|NCT04401267|521473641|FG001|Overall Study|Found to be Ineligible|0|||
144576845|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
144576846|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576847|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576848|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576849|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576850|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576851|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576852|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576853|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
144576854|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576855|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576856|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576857|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
144576858|NCT01646177|521311787|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576859|NCT01646177|521311788|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576860|NCT01646177|521311789|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576861|NCT01646177|521311790|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576862|NCT01646177|521311791|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576863|NCT01646177|521311792|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
144576864|NCT01646177|521311793|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
144576865|NCT01646177|521311794|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
144576866|NCT01646177|521311795|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576867|NCT01646177|521311796|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576868|NCT01646177|521311797|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576869|NCT01646177|521311798|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
144576870|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576871|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576872|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576873|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576874|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576875|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576876|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576877|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
144576878|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
144576879|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
144576880|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
144576881|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
144576882|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576883|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576884|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576885|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576886|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576887|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576888|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576889|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
144576890|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
144576891|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
144576892|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
144576893|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
144576894|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576895|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576896|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576897|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576898|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576899|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576900|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576901|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
144576902|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
144576903|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
144576904|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
144576905|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
144262865|NCT01325350|520163771|FG004|Overall Study|Protocol Violation|0|||
144576906|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144621942|NCT03704194|521473645|FG000|Overall Study|Withdrawal by Subject|0|||
144621943|NCT03704194|521473646|FG001|Overall Study|Withdrawal by Subject|1|||
144621944|NCT01191697|521473653|FG000|Overall Study|Death|1|||
144621945|NCT01191697|521473653|FG000|Overall Study|Physician Decision|2|||
144621946|NCT01191697|521473653|FG000|Overall Study|Pursue chemoradiation|2|||
144621947|NCT01191697|521473653|FG000|Overall Study|Break from chemotherapy|2|||
144576907|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576908|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576909|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576910|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576911|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576912|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576913|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
144576914|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
144576915|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
144576916|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
144576917|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
144576918|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576919|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576920|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576921|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576922|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576923|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576924|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576925|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
144576926|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
144576927|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
144621948|NCT01191697|521473653|FG000|Overall Study|Withdrawal by Subject|1|||
144621949|NCT01191697|521473653|FG000|Overall Study|Surveillance|1|||
144621950|NCT01191697|521473653|FG000|Overall Study|Adverse Event|2|||
144621951|NCT01191697|521473653|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
144621952|NCT01191697|521473653|FG000|Overall Study|Not completed but analyzed|25|||
144621953|NCT04227899|521473656|FG000|Overall Study|Withdrawal by Subject|6|||
144621954|NCT04227899|521473657|FG001|Overall Study|Withdrawal by Subject|3|||
144621955|NCT04227899|521473656|FG000|Overall Study|Death|12|||
144621956|NCT04227899|521473657|FG001|Overall Study|Death|6|||
144621957|NCT04227899|521473656|FG000|Overall Study|Lost to Follow-up|2|||
144621958|NCT04227899|521473657|FG001|Overall Study|Lost to Follow-up|1|||
144621959|NCT02479802|521473658|FG000|Overall Study|Lost to Follow-up|1|||
144621960|NCT02479802|521473658|FG000|Overall Study|Adverse Event|1|||
144621961|NCT05702515|521473659|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
144621962|NCT02792842|521473662|FG000|Overall Study|Adverse Event|4|||
144621963|NCT02792842|521473663|FG001|Overall Study|Adverse Event|2|||
144621964|NCT02792842|521473664|FG002|Overall Study|Adverse Event|3|||
144621965|NCT02792842|521473662|FG000|Overall Study|Withdrawal by Subject|0|||
144621966|NCT02792842|521473663|FG001|Overall Study|Withdrawal by Subject|1|||
144621967|NCT02792842|521473664|FG002|Overall Study|Withdrawal by Subject|2|||
144621968|NCT02792842|521473662|FG000|Overall Study|Lost to Follow-up|0|||
144621969|NCT02792842|521473663|FG001|Overall Study|Lost to Follow-up|0|||
144621970|NCT02792842|521473664|FG002|Overall Study|Lost to Follow-up|1|||
144621971|NCT02792842|521473662|FG000|Overall Study|Schedule delay|0|||
144621972|NCT02792842|521473663|FG001|Overall Study|Schedule delay|1|||
144621973|NCT02792842|521473664|FG002|Overall Study|Schedule delay|1|||
144621974|NCT01847885|521473666|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
144621975|NCT01847885|521473667|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
144621976|NCT01847885|521473668|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
144621977|NCT01847885|521473666|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
144621978|NCT01847885|521473667|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
144621979|NCT01847885|521473668|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
144621980|NCT01847885|521473666|FG000|Initial Enrollment (Consented)|Screen failure|39|||
144621981|NCT01847885|521473667|FG001|Initial Enrollment (Consented)|Screen failure|0|||
144621982|NCT01847885|521473668|FG002|Initial Enrollment (Consented)|Screen failure|0|||
144621983|NCT01847885|521473666|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
144621984|NCT01847885|521473667|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
144621985|NCT01847885|521473668|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
144621986|NCT01847885|521473666|FG000|Randomization|Protocol Violation|0|||
144621987|NCT01847885|521473667|FG001|Randomization|Protocol Violation|1|||
144621988|NCT01847885|521473668|FG002|Randomization|Protocol Violation|0|||
144621989|NCT01847885|521473666|FG000|Randomization|Withdrawal by Subject|0|||
144730056|NCT00746798|521868131|FG002|Overall Study|Protocol Violation|0|||
144730057|NCT00746798|521868132|FG003|Overall Study|Protocol Violation|0|||
144576928|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
144576929|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
144576930|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576931|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576932|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576933|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576934|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576935|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576936|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576937|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
144576938|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
144576939|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
144576940|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
144576941|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
144576942|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576943|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576944|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576945|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576946|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576947|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576948|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576949|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576950|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
144576951|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
144730058|NCT00746798|521868129|FG000|Overall Study|Withdrawal by Subject|0|||
144730059|NCT00746798|521868130|FG001|Overall Study|Withdrawal by Subject|1|||
144730060|NCT00746798|521868131|FG002|Overall Study|Withdrawal by Subject|1|||
144730061|NCT00746798|521868132|FG003|Overall Study|Withdrawal by Subject|0|||
144730062|NCT00746798|521868129|FG000|Overall Study|Death|0|||
144730063|NCT00746798|521868130|FG001|Overall Study|Death|0|||
144730064|NCT00746798|521868131|FG002|Overall Study|Death|2|||
144730065|NCT00746798|521868132|FG003|Overall Study|Death|0|||
144730066|NCT00746798|521868129|FG000|Overall Study|Participant unable to return for visit|1|||
144730067|NCT00746798|521868130|FG001|Overall Study|Participant unable to return for visit|0|||
144730068|NCT00746798|521868131|FG002|Overall Study|Participant unable to return for visit|0|||
144730069|NCT00746798|521868132|FG003|Overall Study|Participant unable to return for visit|0|||
144730070|NCT00633594|521868135|FG000|Overall Study|Adverse Event|0|||
144730071|NCT00633594|521868136|FG001|Overall Study|Adverse Event|4|||
144730072|NCT00633594|521868137|FG002|Overall Study|Adverse Event|7|||
144730073|NCT00633594|521868135|FG000|Overall Study|Death|0|||
144730074|NCT00633594|521868136|FG001|Overall Study|Death|1|||
144730075|NCT00633594|521868137|FG002|Overall Study|Death|2|||
144576952|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
144576953|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
144576954|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576955|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576956|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576957|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576958|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576959|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576960|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576961|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576962|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
144576963|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
144576964|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
144576965|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
144576966|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576967|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576968|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576969|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576970|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576971|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576972|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576973|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144730076|NCT00633594|521868135|FG000|Overall Study|Disease Progression|0|||
144730077|NCT00633594|521868136|FG001|Overall Study|Disease Progression|0|||
144730078|NCT00633594|521868137|FG002|Overall Study|Disease Progression|1|||
144730079|NCT00727571|521868139|FG000|Overall Study|Ineligibility determined|1|||
144730080|NCT00727571|521868140|FG001|Overall Study|Ineligibility determined|1|||
144730081|NCT00727571|521868141|FG002|Overall Study|Ineligibility determined|1|||
144576974|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
144576975|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
144576976|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
144576977|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
144576978|NCT01646177|521311787|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576979|NCT01646177|521311788|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576980|NCT01646177|521311789|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576981|NCT01646177|521311790|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576982|NCT01646177|521311791|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576983|NCT01646177|521311792|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576984|NCT01646177|521311793|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576985|NCT01646177|521311794|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576986|NCT01646177|521311795|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576987|NCT01646177|521311796|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
144576988|NCT01646177|521311797|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
144576989|NCT01646177|521311798|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
144576990|NCT02920970|521311799|FG000|First Intervention|Protocol Violation|0|||
144576991|NCT02920970|521311800|FG001|First Intervention|Protocol Violation|1|||
144576992|NCT02920970|521311799|FG000|First Intervention|Adverse Event|0|||
144576993|NCT02920970|521311800|FG001|First Intervention|Adverse Event|1|||
144576994|NCT02920970|521311799|FG000|Second Intervention|Poor Lens Fit|1|||
144576995|NCT02920970|521311800|FG001|Second Intervention|Poor Lens Fit|0|||
144576996|NCT01711853|521311801|FG000|Overall Study|Not treated|3|||
144576997|NCT03945825|521311802|FG000|Overall Study|Enrolled but treatment not administered|0|||
144576998|NCT03945825|521311803|FG001|Overall Study|Enrolled but treatment not administered|0|||
144576999|NCT03945825|521311804|FG002|Overall Study|Enrolled but treatment not administered|0|||
144577000|NCT03945825|521311805|FG003|Overall Study|Enrolled but treatment not administered|0|||
144577001|NCT03945825|521311806|FG004|Overall Study|Enrolled but treatment not administered|1|||
144577002|NCT03945825|521311807|FG005|Overall Study|Enrolled but treatment not administered|0|||
144577003|NCT03945825|521311802|FG000|Overall Study|Lost to Follow-up|1|||
144577004|NCT03945825|521311803|FG001|Overall Study|Lost to Follow-up|5|||
144577005|NCT03945825|521311804|FG002|Overall Study|Lost to Follow-up|0|||
144577006|NCT03945825|521311805|FG003|Overall Study|Lost to Follow-up|1|||
144577007|NCT03945825|521311806|FG004|Overall Study|Lost to Follow-up|2|||
144577008|NCT03945825|521311807|FG005|Overall Study|Lost to Follow-up|2|||
144577009|NCT03945825|521311802|FG000|Overall Study|Withdrawal by Subject|1|||
144577010|NCT03945825|521311803|FG001|Overall Study|Withdrawal by Subject|0|||
144577011|NCT03945825|521311804|FG002|Overall Study|Withdrawal by Subject|1|||
144577012|NCT03945825|521311805|FG003|Overall Study|Withdrawal by Subject|1|||
144577013|NCT03945825|521311806|FG004|Overall Study|Withdrawal by Subject|0|||
144577014|NCT03945825|521311807|FG005|Overall Study|Withdrawal by Subject|1|||
144577015|NCT01461005|521311808|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
144577016|NCT07149155|521311812|FG000|Overall Study|Lost to Follow-up|10|||
144577017|NCT03345576|521311813|FG000|Overall Study|Withdrawal by Subject|2|||
144577018|NCT03345576|521311814|FG001|Overall Study|Withdrawal by Subject|2|||
144577019|NCT03345576|521311813|FG000|Overall Study|Adverse Event|1|||
144577020|NCT03345576|521311814|FG001|Overall Study|Adverse Event|0|||
144577021|NCT04942366|521313377|FG000|Overall Study|Withdrawal by Subject|5|||
144577022|NCT04942366|521313378|FG001|Overall Study|Withdrawal by Subject|5|||
144577023|NCT02706405|521313384|FG000|Overall Study|Death|3|||
144577024|NCT02706405|521313385|FG001|Overall Study|Death|2|||
144577025|NCT02706405|521313386|FG002|Overall Study|Death|0|||
144577026|NCT02706405|521313387|FG003|Overall Study|Death|1|||
144577027|NCT02706405|521313388|FG004|Overall Study|Death|0|||
144577028|NCT02706405|521313389|FG005|Overall Study|Death|0|||
144577029|NCT02706405|521313390|FG006|Overall Study|Death|3|||
144577030|NCT02706405|521313391|FG007|Overall Study|Death|4|||
144577031|NCT02706405|521313384|FG000|Overall Study|Disease progression|0|||
144577032|NCT02706405|521313385|FG001|Overall Study|Disease progression|0|||
144577033|NCT02706405|521313386|FG002|Overall Study|Disease progression|0|||
144577034|NCT02706405|521313387|FG003|Overall Study|Disease progression|0|||
144577035|NCT02706405|521313388|FG004|Overall Study|Disease progression|0|||
144577036|NCT02706405|521313389|FG005|Overall Study|Disease progression|0|||
144577037|NCT02706405|521313390|FG006|Overall Study|Disease progression|0|||
144577038|NCT02706405|521313391|FG007|Overall Study|Disease progression|1|||
144577039|NCT02706405|521313384|FG000|Overall Study|Pt moved to new therapy|0|||
144577040|NCT02706405|521313385|FG001|Overall Study|Pt moved to new therapy|0|||
144577041|NCT02706405|521313386|FG002|Overall Study|Pt moved to new therapy|0|||
144577042|NCT02706405|521313387|FG003|Overall Study|Pt moved to new therapy|0|||
144577043|NCT02706405|521313388|FG004|Overall Study|Pt moved to new therapy|0|||
144577044|NCT02706405|521313389|FG005|Overall Study|Pt moved to new therapy|1|||
144577045|NCT02706405|521313390|FG006|Overall Study|Pt moved to new therapy|0|||
144577046|NCT02706405|521313391|FG007|Overall Study|Pt moved to new therapy|1|||
144577047|NCT02706405|521313384|FG000|Overall Study|Physician Decision|1|||
144577048|NCT02706405|521313385|FG001|Overall Study|Physician Decision|0|||
144577049|NCT02706405|521313386|FG002|Overall Study|Physician Decision|0|||
144577050|NCT02706405|521313387|FG003|Overall Study|Physician Decision|0|||
144577051|NCT02706405|521313388|FG004|Overall Study|Physician Decision|0|||
144577052|NCT02706405|521313389|FG005|Overall Study|Physician Decision|0|||
144577053|NCT02706405|521313390|FG006|Overall Study|Physician Decision|0|||
144577054|NCT02706405|521313391|FG007|Overall Study|Physician Decision|0|||
144577055|NCT03140280|521313392|FG000|Overall Study|Physician Decision|5|||
144577056|NCT05577715|521313401|FG000|Overall Study|Withdrawal by Subject|1|||
144577057|NCT05577715|521313401|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
144577058|NCT05577715|521313401|FG000|Overall Study|Lost to Follow-up|1|||
144577059|NCT05577715|521313401|FG000|Overall Study|Death|6|||
144577060|NCT03412773|521313402|FG000|Overall Study|Lost to Follow-up|0|||
144577061|NCT03412773|521313403|FG001|Overall Study|Lost to Follow-up|7|||
144577062|NCT03412773|521313404|FG002|Overall Study|Lost to Follow-up|6|||
144577063|NCT03412773|521313402|FG000|Overall Study|Withdrawal by Subject|0|||
144577064|NCT03412773|521313403|FG001|Overall Study|Withdrawal by Subject|15|||
144577065|NCT03412773|521313404|FG002|Overall Study|Withdrawal by Subject|19|||
144577066|NCT03412773|521313402|FG000|Overall Study|Study Closed By Sponsor|3|||
144577067|NCT03412773|521313403|FG001|Overall Study|Study Closed By Sponsor|46|||
144577068|NCT03412773|521313404|FG002|Overall Study|Study Closed By Sponsor|33|||
144577069|NCT03412773|521313402|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
144577070|NCT03412773|521313403|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
144577071|NCT03412773|521313404|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
144577072|NCT03412773|521313402|FG000|Overall Study|Death|7|||
144577073|NCT03412773|521313403|FG001|Overall Study|Death|259|||
144577074|NCT03412773|521313404|FG002|Overall Study|Death|273|||
144577075|NCT03412773|521313402|FG000|Overall Study|Physician Decision|0|||
144577076|NCT03412773|521313403|FG001|Overall Study|Physician Decision|0|||
144577077|NCT03412773|521313404|FG002|Overall Study|Physician Decision|1|||
144577078|NCT01706705|521313413|FG000|Overall Study|Death|1|||
144577079|NCT01706705|521313413|FG000|Overall Study|Lack of Efficacy|13|||
144577080|NCT01706705|521313413|FG000|Overall Study|Non-clinical|6|||
144577081|NCT03510455|521313414|FG000|Overall Study|Physician Decision|1|||
144577082|NCT00384189|521313415|FG000|Overall Study|Reason Not Specified|50|||
144577083|NCT00384189|521313416|FG001|Overall Study|Reason Not Specified|57|||
144577084|NCT00384189|521313417|FG002|Overall Study|Reason Not Specified|58|||
144577085|NCT00384189|521313418|FG003|Overall Study|Reason Not Specified|40|||
144577086|NCT04958642|521313419|FG000|Overall Study|Transferred to OLEX program|3|||
144577087|NCT04958642|521313420|FG001|Overall Study|Transferred to OLEX program|0|||
144577088|NCT04958642|521313421|FG002|Overall Study|Transferred to OLEX program|5|||
144577089|NCT04958642|521313419|FG000|Overall Study|Death|0|||
144577090|NCT04958642|521313420|FG001|Overall Study|Death|0|||
144577091|NCT04958642|521313421|FG002|Overall Study|Death|1|||
144577092|NCT04958642|521313419|FG000|Overall Study|Withdrawal by Subject|4|||
144577093|NCT04958642|521313420|FG001|Overall Study|Withdrawal by Subject|9|||
144577094|NCT04958642|521313421|FG002|Overall Study|Withdrawal by Subject|13|||
144577095|NCT04958642|521313419|FG000|Overall Study|Investigator's Decision|0|||
144577096|NCT04958642|521313420|FG001|Overall Study|Investigator's Decision|0|||
144577097|NCT04958642|521313421|FG002|Overall Study|Investigator's Decision|1|||
144577098|NCT04958642|521313419|FG000|Overall Study|Adverse Event|1|||
144577099|NCT04958642|521313420|FG001|Overall Study|Adverse Event|0|||
144577100|NCT04958642|521313421|FG002|Overall Study|Adverse Event|1|||
144577101|NCT04958642|521313419|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
144577102|NCT04958642|521313420|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
144577103|NCT04958642|521313421|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
144577104|NCT04958642|521313419|FG000|Overall Study|Lost to Follow-up|1|||
144577105|NCT04958642|521313420|FG001|Overall Study|Lost to Follow-up|0|||
144577106|NCT04958642|521313421|FG002|Overall Study|Lost to Follow-up|0|||
144577107|NCT04958642|521313419|FG000|Overall Study|Transferred to EAP following study termination|0|||
144577108|NCT04958642|521313420|FG001|Overall Study|Transferred to EAP following study termination|0|||
144621990|NCT01847885|521473667|FG001|Randomization|Withdrawal by Subject|0|||
144621991|NCT01847885|521473668|FG002|Randomization|Withdrawal by Subject|2|||
144621992|NCT01847885|521473666|FG000|Randomization|Screen Failure|0|||
144621993|NCT01847885|521473667|FG001|Randomization|Screen Failure|3|||
144577109|NCT04958642|521313421|FG002|Overall Study|Transferred to EAP following study termination|1|||
144577110|NCT04958642|521313419|FG000|Overall Study|Transferred to Expanded Access Program|1|||
144577111|NCT04958642|521313420|FG001|Overall Study|Transferred to Expanded Access Program|0|||
144577112|NCT04958642|521313421|FG002|Overall Study|Transferred to Expanded Access Program|0|||
144577113|NCT05627258|521313422|FG000|Overall Study|Lost to Follow-up|1|||
144577114|NCT05627258|521313423|FG001|Overall Study|Lost to Follow-up|0|||
144621994|NCT01847885|521473668|FG002|Randomization|Screen Failure|0|||
144577115|NCT05627258|521313424|FG002|Overall Study|Lost to Follow-up|0|||
144577116|NCT05627258|521313425|FG003|Overall Study|Lost to Follow-up|0|||
144621995|NCT00094055|521473670|FG000|Overall Study|Adverse Event|11|||
144621996|NCT00094055|521473670|FG000|Overall Study|Death|4|||
144621997|NCT00094055|521473670|FG000|Overall Study|Lack of Efficacy|17|||
144621998|NCT00094055|521473670|FG000|Overall Study|Lost to Follow-up|2|||
144621999|NCT00094055|521473670|FG000|Overall Study|progressive disease|2|||
144622000|NCT00094055|521473670|FG000|Overall Study|clinical progression|1|||
144622001|NCT00094055|521473670|FG000|Overall Study|roll-over to another study|14|||
144622002|NCT00094055|521473670|FG000|Overall Study|Withdrawal by Subject|9|||
144622003|NCT02436876|521473671|FG000|Overall Study|Lost to Follow-up|0|||
144622004|NCT02436876|521473672|FG001|Overall Study|Lost to Follow-up|1|||
144622005|NCT02436876|521473673|FG002|Overall Study|Lost to Follow-up|1|||
144577117|NCT05627258|521313426|FG004|Overall Study|Lost to Follow-up|0|||
144577118|NCT05627258|521313427|FG005|Overall Study|Lost to Follow-up|0|||
144577119|NCT05627258|521313422|FG000|Overall Study|Withdrawal by Subject|0|||
144577120|NCT05627258|521313423|FG001|Overall Study|Withdrawal by Subject|0|||
144577121|NCT05627258|521313424|FG002|Overall Study|Withdrawal by Subject|0|||
144577122|NCT05627258|521313425|FG003|Overall Study|Withdrawal by Subject|0|||
144577123|NCT05627258|521313426|FG004|Overall Study|Withdrawal by Subject|2|||
144577124|NCT05627258|521313427|FG005|Overall Study|Withdrawal by Subject|0|||
144577125|NCT05627258|521313422|FG000|Overall Study|Enrolled, but product not administered|1|||
144577126|NCT05627258|521313423|FG001|Overall Study|Enrolled, but product not administered|0|||
144577127|NCT05627258|521313424|FG002|Overall Study|Enrolled, but product not administered|0|||
144577128|NCT05627258|521313425|FG003|Overall Study|Enrolled, but product not administered|0|||
144577129|NCT05627258|521313426|FG004|Overall Study|Enrolled, but product not administered|0|||
144577130|NCT05627258|521313427|FG005|Overall Study|Enrolled, but product not administered|0|||
144577131|NCT05627258|521313422|FG000|Overall Study|Other subject illness/injury|1|||
144577132|NCT05627258|521313423|FG001|Overall Study|Other subject illness/injury|0|||
144577133|NCT05627258|521313424|FG002|Overall Study|Other subject illness/injury|0|||
144577134|NCT05627258|521313425|FG003|Overall Study|Other subject illness/injury|0|||
144577135|NCT05627258|521313426|FG004|Overall Study|Other subject illness/injury|0|||
144577136|NCT05627258|521313427|FG005|Overall Study|Other subject illness/injury|0|||
144577137|NCT05627258|521313422|FG000|Overall Study|Subject moved from area|0|||
144577138|NCT05627258|521313423|FG001|Overall Study|Subject moved from area|0|||
144577139|NCT05627258|521313424|FG002|Overall Study|Subject moved from area|1|||
144577140|NCT05627258|521313425|FG003|Overall Study|Subject moved from area|0|||
144577141|NCT05627258|521313426|FG004|Overall Study|Subject moved from area|0|||
144577142|NCT05627258|521313427|FG005|Overall Study|Subject moved from area|0|||
144577143|NCT00678301|521313431|FG000|Overall Study|Non-compliance with study procedures|0|||
144577144|NCT00678301|521313432|FG001|Overall Study|Non-compliance with study procedures|1|||
144577145|NCT00678301|521313431|FG000|Overall Study|Adverse Event|1|||
144577146|NCT00678301|521313432|FG001|Overall Study|Adverse Event|0|||
144577147|NCT00678301|521313431|FG000|Overall Study|Withdrawal by Subject|4|||
144577148|NCT00678301|521313432|FG001|Overall Study|Withdrawal by Subject|0|||
144577149|NCT00678301|521313431|FG000|Overall Study|Lost to Follow-up|3|||
144577150|NCT00678301|521313432|FG001|Overall Study|Lost to Follow-up|1|||
144577151|NCT01939353|521313433|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
144577152|NCT01939353|521313433|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
144577153|NCT01939353|521313433|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
144577154|NCT01939353|521313433|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
144577155|NCT01939353|521313433|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
144577156|NCT05048238|521313437|FG000|Overall Study|Withdrawal by Subject|1|||
144577157|NCT04076943|521313440|FG000|Overall Study|Withdrawal by Subject|12|||
144577158|NCT04076943|521313440|FG000|Overall Study|Adverse Event|1|||
144577159|NCT04076943|521313440|FG000|Overall Study|Progressive Disease|2|||
144577160|NCT04076943|521313440|FG000|Overall Study|Death|13|||
144577161|NCT04076943|521313440|FG000|Overall Study|Other than specified|6|||
144622006|NCT02436876|521473674|FG003|Overall Study|Lost to Follow-up|1|||
144622007|NCT02436876|521473671|FG000|Overall Study|Withdrawal by Subject|1|||
144622008|NCT02436876|521473672|FG001|Overall Study|Withdrawal by Subject|0|||
144622009|NCT02436876|521473673|FG002|Overall Study|Withdrawal by Subject|0|||
144622010|NCT02436876|521473674|FG003|Overall Study|Withdrawal by Subject|1|||
144622011|NCT02436876|521473671|FG000|Overall Study|Physician Decision|0|||
144262866|NCT01325350|520163767|FG000|Overall Study|Withdrawal by Subject|0|||
144577162|NCT02964325|521313451|FG000|Overall Study|Lost to Follow-up|3|||
144577163|NCT02964325|521313452|FG001|Overall Study|Lost to Follow-up|3|||
144577164|NCT02964325|521313451|FG000|Overall Study|Physician Decision|5|||
144577165|NCT02964325|521313452|FG001|Overall Study|Physician Decision|4|||
144577166|NCT02964325|521313451|FG000|Overall Study|Death|1|||
144622012|NCT02436876|521473672|FG001|Overall Study|Physician Decision|2|||
144262867|NCT01325350|520163768|FG001|Overall Study|Withdrawal by Subject|0|||
144577167|NCT02964325|521313452|FG001|Overall Study|Death|3|||
144577168|NCT02964325|521313451|FG000|Overall Study|Withdrawal by Subject|2|||
144577169|NCT02964325|521313452|FG001|Overall Study|Withdrawal by Subject|1|||
144577170|NCT02964325|521313451|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
144622013|NCT02436876|521473673|FG002|Overall Study|Physician Decision|1|||
144622014|NCT02436876|521473674|FG003|Overall Study|Physician Decision|0|||
144577171|NCT02964325|521313452|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
144577172|NCT01371825|521313457|FG000|Overall Study|Death|4|||
144577173|NCT00895895|521313458|FG000|Period 1|Adverse Event|7|||
144577174|NCT00895895|521313459|FG001|Period 1|Adverse Event|6|||
144577175|NCT00895895|521313460|FG002|Period 1|Adverse Event|4|||
144577176|NCT00895895|521313461|FG003|Period 1|Adverse Event|6|||
144577177|NCT00895895|521313462|FG004|Period 1|Adverse Event|7|||
144577178|NCT00895895|521313458|FG000|Period 1|Death|0|||
144577179|NCT00895895|521313459|FG001|Period 1|Death|0|||
144577180|NCT00895895|521313460|FG002|Period 1|Death|0|||
144577181|NCT00895895|521313461|FG003|Period 1|Death|0|||
144577182|NCT00895895|521313462|FG004|Period 1|Death|1|||
144577183|NCT00895895|521313458|FG000|Period 1|discontinued by sponsor|2|||
144577184|NCT00895895|521313459|FG001|Period 1|discontinued by sponsor|1|||
144577185|NCT00895895|521313460|FG002|Period 1|discontinued by sponsor|2|||
144577186|NCT00895895|521313461|FG003|Period 1|discontinued by sponsor|1|||
144577187|NCT00895895|521313462|FG004|Period 1|discontinued by sponsor|1|||
144577188|NCT00895895|521313458|FG000|Period 1|failed to return|0|||
144577189|NCT00895895|521313459|FG001|Period 1|failed to return|0|||
144577190|NCT00895895|521313460|FG002|Period 1|failed to return|1|||
144577191|NCT00895895|521313461|FG003|Period 1|failed to return|0|||
144577192|NCT00895895|521313462|FG004|Period 1|failed to return|1|||
144577193|NCT00895895|521313458|FG000|Period 1|investigator request|0|||
144577194|NCT00895895|521313459|FG001|Period 1|investigator request|1|||
144577195|NCT00895895|521313460|FG002|Period 1|investigator request|0|||
144577196|NCT00895895|521313461|FG003|Period 1|investigator request|0|||
144577197|NCT00895895|521313462|FG004|Period 1|investigator request|0|||
144577198|NCT00895895|521313458|FG000|Period 1|Lost to Follow-up|2|||
144577199|NCT00895895|521313459|FG001|Period 1|Lost to Follow-up|1|||
144577200|NCT00895895|521313460|FG002|Period 1|Lost to Follow-up|3|||
144577201|NCT00895895|521313461|FG003|Period 1|Lost to Follow-up|2|||
144577202|NCT00895895|521313462|FG004|Period 1|Lost to Follow-up|3|||
144577203|NCT00895895|521313458|FG000|Period 1|Other|1|||
144577204|NCT00895895|521313459|FG001|Period 1|Other|2|||
144577205|NCT00895895|521313460|FG002|Period 1|Other|1|||
144577206|NCT00895895|521313461|FG003|Period 1|Other|1|||
144577207|NCT00895895|521313462|FG004|Period 1|Other|1|||
144577208|NCT00895895|521313458|FG000|Period 1|Protocol Violation|0|||
144577209|NCT00895895|521313459|FG001|Period 1|Protocol Violation|1|||
144577210|NCT00895895|521313460|FG002|Period 1|Protocol Violation|0|||
144577211|NCT00895895|521313461|FG003|Period 1|Protocol Violation|0|||
144577212|NCT00895895|521313462|FG004|Period 1|Protocol Violation|0|||
144622015|NCT02436876|521473671|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
144622016|NCT02436876|521473672|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
144622017|NCT02436876|521473673|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
144622018|NCT02436876|521473674|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
144622019|NCT03115151|521473677|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
144622020|NCT03115151|521473678|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
144622021|NCT03115151|521473677|FG000|Overall Study|Epidural catheter removal|1|||
144622022|NCT03115151|521473678|FG001|Overall Study|Epidural catheter removal|0|||
144622023|NCT03115151|521473677|FG000|Overall Study|Withdrawal by Subject|0|||
144622024|NCT03115151|521473678|FG001|Overall Study|Withdrawal by Subject|1|||
144622025|NCT03115151|521473677|FG000|Overall Study|Intervention not received according to the protocol.|1|||
144622026|NCT03115151|521473678|FG001|Overall Study|Intervention not received according to the protocol.|1|||
144622027|NCT03115151|521473677|FG000|Overall Study|Physician Decision|1|||
144622028|NCT03115151|521473678|FG001|Overall Study|Physician Decision|0|||
144622029|NCT03115151|521473677|FG000|Overall Study|Randomization not applied|1|||
144622030|NCT03115151|521473678|FG001|Overall Study|Randomization not applied|1|||
144622031|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
144622032|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
144730082|NCT00727571|521868142|FG003|Overall Study|Ineligibility determined|0|||
144622033|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
144730083|NCT00727571|521868139|FG000|Overall Study|Death|0|||
144622034|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
144730084|NCT00727571|521868140|FG001|Overall Study|Death|19|||
144577213|NCT00895895|521313458|FG000|Period 1|Withdrawal by Subject|6|||
144577214|NCT00895895|521313459|FG001|Period 1|Withdrawal by Subject|6|||
144577215|NCT00895895|521313460|FG002|Period 1|Withdrawal by Subject|8|||
144577216|NCT00895895|521313461|FG003|Period 1|Withdrawal by Subject|2|||
144577217|NCT00895895|521313462|FG004|Period 1|Withdrawal by Subject|4|||
144577218|NCT00895895|521313458|FG000|Period 1|unsatisfactory response-efficacy|2|||
144577219|NCT00895895|521313459|FG001|Period 1|unsatisfactory response-efficacy|0|||
144577220|NCT00895895|521313460|FG002|Period 1|unsatisfactory response-efficacy|0|||
144577221|NCT00895895|521313461|FG003|Period 1|unsatisfactory response-efficacy|0|||
144577222|NCT00895895|521313462|FG004|Period 1|unsatisfactory response-efficacy|0|||
144577223|NCT00895895|521313458|FG000|Period 1|randomized and not treated|1|||
144577224|NCT00895895|521313459|FG001|Period 1|randomized and not treated|3|||
144577225|NCT00895895|521313460|FG002|Period 1|randomized and not treated|1|||
144577226|NCT00895895|521313461|FG003|Period 1|randomized and not treated|1|||
144577227|NCT00895895|521313462|FG004|Period 1|randomized and not treated|2|||
144577228|NCT00895895|521313458|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
144577229|NCT00895895|521313459|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
144577230|NCT00895895|521313460|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
144577231|NCT00895895|521313461|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
144577232|NCT00895895|521313462|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
144577233|NCT00895895|521313458|FG000|After Period 1, Prior to Period 2|Other|0|||
144577234|NCT00895895|521313459|FG001|After Period 1, Prior to Period 2|Other|0|||
144577235|NCT00895895|521313460|FG002|After Period 1, Prior to Period 2|Other|1|||
144577236|NCT00895895|521313461|FG003|After Period 1, Prior to Period 2|Other|0|||
144577237|NCT00895895|521313462|FG004|After Period 1, Prior to Period 2|Other|0|||
144577238|NCT00895895|521313458|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
144207441|NCT03146962|519954310|FG004|Overall Study|Started New Treatment|0|||
144207442|NCT03146962|519954311|FG005|Overall Study|Started New Treatment|0|||
144207443|NCT03146962|519954312|FG006|Overall Study|Started New Treatment|0|||
144577239|NCT00895895|521313459|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
144577240|NCT00895895|521313460|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
144577241|NCT00895895|521313461|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
144577242|NCT00895895|521313462|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
144577243|NCT00895895|521313458|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
144577244|NCT00895895|521313459|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
144577245|NCT00895895|521313460|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
144577246|NCT00895895|521313461|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
144577247|NCT00895895|521313462|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
144577248|NCT00895895|521313458|FG000|Period 2|Adverse Event|3|||
144577249|NCT00895895|521313459|FG001|Period 2|Adverse Event|3|||
144577250|NCT00895895|521313460|FG002|Period 2|Adverse Event|5|||
144577251|NCT00895895|521313461|FG003|Period 2|Adverse Event|2|||
144577252|NCT00895895|521313462|FG004|Period 2|Adverse Event|5|||
144577253|NCT00895895|521313458|FG000|Period 2|Death|0|||
144577254|NCT00895895|521313459|FG001|Period 2|Death|0|||
144577255|NCT00895895|521313460|FG002|Period 2|Death|1|||
144577256|NCT00895895|521313461|FG003|Period 2|Death|0|||
144577257|NCT00895895|521313462|FG004|Period 2|Death|0|||
144577258|NCT00895895|521313458|FG000|Period 2|discontinued by sponsor|44|||
144577259|NCT00895895|521313459|FG001|Period 2|discontinued by sponsor|44|||
144577260|NCT00895895|521313460|FG002|Period 2|discontinued by sponsor|38|||
144577261|NCT00895895|521313461|FG003|Period 2|discontinued by sponsor|46|||
144577262|NCT00895895|521313462|FG004|Period 2|discontinued by sponsor|37|||
144577263|NCT00895895|521313458|FG000|Period 2|failed to return|2|||
144577264|NCT00895895|521313459|FG001|Period 2|failed to return|0|||
144577265|NCT00895895|521313460|FG002|Period 2|failed to return|0|||
144577266|NCT00895895|521313461|FG003|Period 2|failed to return|0|||
144577267|NCT00895895|521313462|FG004|Period 2|failed to return|0|||
144577268|NCT00895895|521313458|FG000|Period 2|investigator request|2|||
144577269|NCT00895895|521313459|FG001|Period 2|investigator request|0|||
144577270|NCT00895895|521313460|FG002|Period 2|investigator request|0|||
144577271|NCT00895895|521313461|FG003|Period 2|investigator request|0|||
144577272|NCT00895895|521313462|FG004|Period 2|investigator request|0|||
144577273|NCT00895895|521313458|FG000|Period 2|Lost to Follow-up|1|||
144577274|NCT00895895|521313459|FG001|Period 2|Lost to Follow-up|2|||
144577275|NCT00895895|521313460|FG002|Period 2|Lost to Follow-up|1|||
144577276|NCT00895895|521313461|FG003|Period 2|Lost to Follow-up|1|||
144577277|NCT00895895|521313462|FG004|Period 2|Lost to Follow-up|0|||
144577278|NCT00895895|521313458|FG000|Period 2|Other|1|||
144577279|NCT00895895|521313459|FG001|Period 2|Other|1|||
144577280|NCT00895895|521313460|FG002|Period 2|Other|3|||
144577281|NCT00895895|521313461|FG003|Period 2|Other|1|||
144207444|NCT03146962|519954313|FG007|Overall Study|Started New Treatment|0|||
144207445|NCT03146962|519954314|FG008|Overall Study|Started New Treatment|0|||
144207446|NCT03146962|519954315|FG009|Overall Study|Started New Treatment|0|||
144577282|NCT00895895|521313462|FG004|Period 2|Other|1|||
144577283|NCT00895895|521313458|FG000|Period 2|Protocol Violation|1|||
144577284|NCT00895895|521313459|FG001|Period 2|Protocol Violation|0|||
144577285|NCT00895895|521313460|FG002|Period 2|Protocol Violation|1|||
144577286|NCT00895895|521313461|FG003|Period 2|Protocol Violation|1|||
144577287|NCT00895895|521313462|FG004|Period 2|Protocol Violation|1|||
144622035|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144622036|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144577288|NCT00895895|521313458|FG000|Period 2|Withdrawal by Subject|0|||
144577289|NCT00895895|521313459|FG001|Period 2|Withdrawal by Subject|2|||
144577290|NCT00895895|521313460|FG002|Period 2|Withdrawal by Subject|0|||
144577291|NCT00895895|521313461|FG003|Period 2|Withdrawal by Subject|3|||
144577292|NCT00895895|521313462|FG004|Period 2|Withdrawal by Subject|5|||
144577293|NCT00895895|521313458|FG000|Period 2|unsatisfactory response-efficacy|2|||
144577294|NCT00895895|521313459|FG001|Period 2|unsatisfactory response-efficacy|1|||
144577295|NCT00895895|521313460|FG002|Period 2|unsatisfactory response-efficacy|0|||
144622037|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
144577296|NCT00895895|521313461|FG003|Period 2|unsatisfactory response-efficacy|0|||
144577297|NCT00895895|521313462|FG004|Period 2|unsatisfactory response-efficacy|0|||
144577298|NCT03019640|521313463|FG000|Overall Study|Screen Failures|4|||
144577299|NCT03019640|521313463|FG000|Overall Study|Adverse Event|3|||
144577300|NCT03019640|521313463|FG000|Overall Study|Participant Relapsed|1|||
144577301|NCT01277887|521313468|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
144577302|NCT01277887|521313469|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
144577303|NCT01277887|521313468|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
144577304|NCT01277887|521313469|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
144577305|NCT01277887|521313468|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
144577306|NCT01277887|521313469|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
144577307|NCT03651700|521313470|FG000|Overall Study|Withdrawal by Subject|1|||
144577308|NCT03651700|521313471|FG001|Overall Study|Withdrawal by Subject|0|||
144577309|NCT05479734|521313472|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
144577310|NCT05479734|521313473|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
144577311|NCT05479734|521313472|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
144577312|NCT05479734|521313473|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
144577313|NCT05479734|521313472|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
144577314|NCT05479734|521313473|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
144577315|NCT05479734|521313472|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
144577316|NCT05479734|521313473|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
144577317|NCT04844879|521313476|FG000|Overall Study|Death|1|||
144577318|NCT04844879|521313476|FG000|Overall Study|Withdrawal by Subject|1|||
144577319|NCT04844879|521313476|FG000|Overall Study|Adverse Event|1|||
144577320|NCT04520659|521313477|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
144577321|NCT04520659|521313478|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
144577322|NCT04520659|521313479|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
144577323|NCT04520659|521313480|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
144577324|NCT04879849|521313481|FG000|Overall Study|Lost to Follow-up|0|||
144577325|NCT04879849|521313482|FG001|Overall Study|Lost to Follow-up|0|||
144577326|NCT04879849|521313483|FG002|Overall Study|Lost to Follow-up|0|||
144577327|NCT04879849|521313484|FG003|Overall Study|Lost to Follow-up|1|||
144577328|NCT04879849|521313485|FG004|Overall Study|Lost to Follow-up|0|||
144577329|NCT04879849|521313486|FG005|Overall Study|Lost to Follow-up|0|||
144577330|NCT04879849|521313487|FG006|Overall Study|Lost to Follow-up|0|||
144622038|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144622039|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
144622040|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144622041|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144622042|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144622043|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
144622044|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
144622045|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
144622046|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
144622047|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
144622048|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
144622049|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
144622050|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
144622051|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
144622052|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
144622053|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
144622054|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
144622055|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
144622056|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
144622057|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
144622058|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
144622059|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
144622060|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
144622061|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
144577331|NCT04879849|521313488|FG007|Overall Study|Lost to Follow-up|0|||
144577332|NCT04879849|521313481|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
144622062|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
144622063|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
144622064|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
144622065|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
144577333|NCT04879849|521313482|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
144622066|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
144730085|NCT00727571|521868141|FG002|Overall Study|Death|5|||
144577334|NCT04879849|521313483|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
144577335|NCT04879849|521313484|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
144577336|NCT04879849|521313485|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
144577337|NCT04879849|521313486|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
144577338|NCT04879849|521313487|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
144577339|NCT04879849|521313488|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
144577340|NCT04879849|521313481|FG000|Overall Study|Withdrawal by Subject|0|||
144577341|NCT04879849|521313482|FG001|Overall Study|Withdrawal by Subject|0|||
144577342|NCT04879849|521313483|FG002|Overall Study|Withdrawal by Subject|0|||
144577343|NCT04879849|521313484|FG003|Overall Study|Withdrawal by Subject|0|||
144577344|NCT04879849|521313485|FG004|Overall Study|Withdrawal by Subject|2|||
144577345|NCT04879849|521313486|FG005|Overall Study|Withdrawal by Subject|0|||
144577346|NCT04879849|521313487|FG006|Overall Study|Withdrawal by Subject|1|||
144577347|NCT04879849|521313488|FG007|Overall Study|Withdrawal by Subject|0|||
144577348|NCT04879849|521313481|FG000|Overall Study|Progressive Disease|0|||
144577349|NCT04879849|521313482|FG001|Overall Study|Progressive Disease|0|||
144577350|NCT04879849|521313483|FG002|Overall Study|Progressive Disease|1|||
144577351|NCT04879849|521313484|FG003|Overall Study|Progressive Disease|0|||
144577352|NCT04879849|521313485|FG004|Overall Study|Progressive Disease|0|||
144577353|NCT04879849|521313486|FG005|Overall Study|Progressive Disease|0|||
144577354|NCT04879849|521313487|FG006|Overall Study|Progressive Disease|0|||
144577355|NCT04879849|521313488|FG007|Overall Study|Progressive Disease|0|||
144577356|NCT04879849|521313481|FG000|Overall Study|Death|0|||
144577357|NCT04879849|521313482|FG001|Overall Study|Death|0|||
144577358|NCT04879849|521313483|FG002|Overall Study|Death|1|||
144577359|NCT04879849|521313484|FG003|Overall Study|Death|1|||
144577360|NCT04879849|521313485|FG004|Overall Study|Death|1|||
144577361|NCT04879849|521313486|FG005|Overall Study|Death|2|||
144577362|NCT04879849|521313487|FG006|Overall Study|Death|1|||
144577363|NCT04879849|521313488|FG007|Overall Study|Death|2|||
144577364|NCT04879849|521313481|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
144577365|NCT04879849|521313482|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
144577366|NCT04879849|521313483|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
144577367|NCT04879849|521313484|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
144577368|NCT04879849|521313485|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
144577369|NCT04879849|521313486|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
144577370|NCT04879849|521313487|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
144577371|NCT04879849|521313488|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
144577372|NCT04879849|521313481|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577373|NCT04879849|521313482|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577374|NCT04879849|521313483|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577375|NCT04879849|521313484|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577376|NCT04879849|521313485|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577377|NCT04879849|521313486|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577378|NCT04879849|521313487|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
144577379|NCT04879849|521313488|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
144577380|NCT04879849|521313481|FG000|Overall Study|Reason Not Specified|1|||
144577381|NCT04879849|521313482|FG001|Overall Study|Reason Not Specified|0|||
144577382|NCT04879849|521313483|FG002|Overall Study|Reason Not Specified|0|||
144577383|NCT04879849|521313484|FG003|Overall Study|Reason Not Specified|0|||
144577384|NCT04879849|521313485|FG004|Overall Study|Reason Not Specified|0|||
144577385|NCT04879849|521313486|FG005|Overall Study|Reason Not Specified|0|||
144577386|NCT04879849|521313487|FG006|Overall Study|Reason Not Specified|0|||
144577387|NCT04879849|521313488|FG007|Overall Study|Reason Not Specified|0|||
144577388|NCT03361865|521313489|FG000|Overall Study|Death|17|||
144577389|NCT03361865|521313490|FG001|Overall Study|Death|18|||
144577390|NCT03361865|521313489|FG000|Overall Study|Physician Decision|1|||
144577391|NCT03361865|521313490|FG001|Overall Study|Physician Decision|9|||
144577392|NCT03361865|521313489|FG000|Overall Study|Withdrawal by Subject|1|||
144577393|NCT03361865|521313490|FG001|Overall Study|Withdrawal by Subject|0|||
144577394|NCT04201262|521313492|FG000|Primary Treatment Period|Adverse Event|1|||
144577395|NCT04201262|521313493|FG001|Primary Treatment Period|Adverse Event|2|||
144577396|NCT04201262|521313492|FG000|Primary Treatment Period|Physician Decision|1|||
144207447|NCT02861014|519954319|FG000|Primary Analysis|Adverse Event|7|||
144577397|NCT04201262|521313493|FG001|Primary Treatment Period|Physician Decision|1|||
144577398|NCT04201262|521313492|FG000|Long-term Extension Period|Death|1|||
144577399|NCT04201262|521313493|FG001|Long-term Extension Period|Death|0|||
144577400|NCT04103892|521313495|FG000|Overall Study|Adverse Event|0|||
144207448|NCT02861014|519954319|FG000|Primary Analysis|Death|1|||
144577401|NCT04103892|521313496|FG001|Overall Study|Adverse Event|0|||
144577402|NCT04103892|521313497|FG002|Overall Study|Adverse Event|0|||
144577403|NCT04103892|521313498|FG003|Overall Study|Adverse Event|3|||
144577404|NCT04103892|521313495|FG000|Overall Study|Lost to Follow-up|0|||
144577405|NCT04103892|521313496|FG001|Overall Study|Lost to Follow-up|0|||
144577406|NCT04103892|521313497|FG002|Overall Study|Lost to Follow-up|2|||
144577407|NCT04103892|521313498|FG003|Overall Study|Lost to Follow-up|0|||
144577408|NCT04103892|521313495|FG000|Overall Study|Protocol Violation|0|||
144577409|NCT04103892|521313496|FG001|Overall Study|Protocol Violation|0|||
144577410|NCT04103892|521313497|FG002|Overall Study|Protocol Violation|1|||
144577411|NCT04103892|521313498|FG003|Overall Study|Protocol Violation|1|||
144577412|NCT04103892|521313495|FG000|Overall Study|Withdrawal by Subject|1|||
144577413|NCT04103892|521313496|FG001|Overall Study|Withdrawal by Subject|0|||
144577414|NCT04103892|521313497|FG002|Overall Study|Withdrawal by Subject|2|||
144577415|NCT04103892|521313498|FG003|Overall Study|Withdrawal by Subject|5|||
144577416|NCT04103892|521313495|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
144577417|NCT04103892|521313496|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
144577418|NCT04103892|521313497|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
144577419|NCT04103892|521313498|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
144577420|NCT02819024|521313499|FG000|Overall Study|Withdrawal by Subject|1|||
144577421|NCT05576662|521313500|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
144577422|NCT05576662|521313501|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
144577423|NCT05576662|521313500|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
144577424|NCT05576662|521313501|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
144577425|NCT05576662|521313500|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
144577426|NCT05576662|521313501|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
144577427|NCT05576662|521313500|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
144577428|NCT05576662|521313501|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
144577429|NCT03008005|521313509|FG000|Overall Study|Physician Decision|1|||
144577430|NCT03008005|521313510|FG001|Overall Study|Physician Decision|0|||
144577431|NCT03008005|521313511|FG002|Overall Study|Physician Decision|0|||
144577432|NCT03008005|521313509|FG000|Overall Study|Withdrawal by Subject|1|||
144577433|NCT03008005|521313510|FG001|Overall Study|Withdrawal by Subject|0|||
144577434|NCT03008005|521313511|FG002|Overall Study|Withdrawal by Subject|0|||
144577435|NCT03008005|521313509|FG000|Overall Study|Ineligible|0|||
144577436|NCT03008005|521313510|FG001|Overall Study|Ineligible|1|||
144577437|NCT03008005|521313511|FG002|Overall Study|Ineligible|0|||
144577438|NCT05217641|521313512|FG000|Overall Study|Lost to Follow-up|1|||
144577439|NCT05217641|521313513|FG001|Overall Study|Lost to Follow-up|1|||
144577440|NCT05217641|521313514|FG002|Overall Study|Lost to Follow-up|0|||
144577441|NCT05217641|521313515|FG003|Overall Study|Lost to Follow-up|1|||
144577442|NCT05217641|521313516|FG004|Overall Study|Lost to Follow-up|1|||
144577443|NCT05217641|521313517|FG005|Overall Study|Lost to Follow-up|0|||
144577444|NCT05217641|521313512|FG000|Overall Study|Withdrawal by Subject|0|||
144577445|NCT05217641|521313513|FG001|Overall Study|Withdrawal by Subject|0|||
144577446|NCT05217641|521313514|FG002|Overall Study|Withdrawal by Subject|0|||
144577447|NCT05217641|521313515|FG003|Overall Study|Withdrawal by Subject|3|||
144577448|NCT05217641|521313516|FG004|Overall Study|Withdrawal by Subject|1|||
144577449|NCT05217641|521313517|FG005|Overall Study|Withdrawal by Subject|0|||
144577450|NCT05217641|521313512|FG000|Overall Study|Other: participant did not specify reason|0|||
144577451|NCT05217641|521313513|FG001|Overall Study|Other: participant did not specify reason|0|||
144577452|NCT05217641|521313514|FG002|Overall Study|Other: participant did not specify reason|0|||
144730086|NCT00727571|521868142|FG003|Overall Study|Death|1|||
144577453|NCT05217641|521313515|FG003|Overall Study|Other: participant did not specify reason|0|||
144577454|NCT05217641|521313516|FG004|Overall Study|Other: participant did not specify reason|1|||
144577455|NCT05217641|521313517|FG005|Overall Study|Other: participant did not specify reason|0|||
144577456|NCT05217641|521313512|FG000|Overall Study|Extended Follow up|1|||
144577457|NCT05217641|521313513|FG001|Overall Study|Extended Follow up|1|||
144577458|NCT05217641|521313514|FG002|Overall Study|Extended Follow up|0|||
144577459|NCT05217641|521313515|FG003|Overall Study|Extended Follow up|0|||
144577460|NCT05217641|521313516|FG004|Overall Study|Extended Follow up|1|||
144577461|NCT05217641|521313517|FG005|Overall Study|Extended Follow up|0|||
144577462|NCT03007420|521313520|FG000|Overall Study|Withdrawal by Subject|0|||
144577463|NCT03007420|521313521|FG001|Overall Study|Withdrawal by Subject|2|||
144577464|NCT03007420|521313520|FG000|Overall Study|Physician Decision|0|||
144577465|NCT03007420|521313521|FG001|Overall Study|Physician Decision|1|||
144577466|NCT05823012|521313522|FG000|Titration Period|Adverse Event|1|||
144577467|NCT05823012|521313522|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
144577468|NCT05823012|521313522|FG000|Maintenance Period|Adverse Event|1|||
144577469|NCT05823012|521313522|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
144730087|NCT00727571|521868139|FG000|Overall Study|Physician Decision|0|||
144577470|NCT05823012|521313522|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
144577471|NCT03301155|521314979|FG000|Overall Study|Сompliance with exclusion criteria|8|||
144577472|NCT03301155|521314980|FG001|Overall Study|Сompliance with exclusion criteria|7|||
144577473|NCT03338296|521314981|FG000|Overall Study|Adverse Event|0|||
144577474|NCT03338296|521314982|FG001|Overall Study|Adverse Event|1|||
144577475|NCT03338296|521314981|FG000|Overall Study|Withdrawal by Subject|14|||
144577476|NCT03338296|521314982|FG001|Overall Study|Withdrawal by Subject|13|||
144577477|NCT03338296|521314981|FG000|Overall Study|Lost to Follow-up|10|||
144577478|NCT03338296|521314982|FG001|Overall Study|Lost to Follow-up|10|||
144577479|NCT03338296|521314981|FG000|Overall Study|Study Terminated by Sponsor|77|||
144577480|NCT03338296|521314982|FG001|Overall Study|Study Terminated by Sponsor|76|||
144577481|NCT03338296|521314981|FG000|Overall Study|Other|2|||
144577482|NCT03338296|521314982|FG001|Overall Study|Other|7|||
144577483|NCT03338296|521314981|FG000|Overall Study|Missing|0|||
144577484|NCT03338296|521314982|FG001|Overall Study|Missing|1|||
144577485|NCT04421950|521314985|FG000|Overall Study|Dropped or lost to follow up|4|||
144577486|NCT04421950|521314986|FG001|Overall Study|Dropped or lost to follow up|2|||
144577487|NCT00335140|521314989|FG000|Overall Study|Ineligible|1|||
144577488|NCT04546425|521314990|FG000|Overall Study|Protocol Violation|1|||
144577489|NCT04546425|521314991|FG001|Overall Study|Protocol Violation|1|||
144577490|NCT04546425|521314992|FG002|Overall Study|Protocol Violation|0|||
144577491|NCT04546425|521314993|FG003|Overall Study|Protocol Violation|0|||
144577492|NCT04546425|521314990|FG000|Overall Study|Adverse Event|3|||
144577493|NCT04546425|521314991|FG001|Overall Study|Adverse Event|0|||
144577494|NCT04546425|521314992|FG002|Overall Study|Adverse Event|0|||
144577495|NCT04546425|521314993|FG003|Overall Study|Adverse Event|0|||
144577496|NCT04546425|521314990|FG000|Overall Study|Lost to Follow-up|5|||
144577497|NCT04546425|521314991|FG001|Overall Study|Lost to Follow-up|4|||
144577498|NCT04546425|521314992|FG002|Overall Study|Lost to Follow-up|0|||
144577499|NCT04546425|521314993|FG003|Overall Study|Lost to Follow-up|0|||
144577500|NCT04546425|521314990|FG000|Overall Study|No Longer met eligibility criteria|3|||
144577501|NCT04546425|521314991|FG001|Overall Study|No Longer met eligibility criteria|3|||
144577502|NCT04546425|521314992|FG002|Overall Study|No Longer met eligibility criteria|1|||
144577503|NCT04546425|521314993|FG003|Overall Study|No Longer met eligibility criteria|1|||
144577504|NCT04546425|521314990|FG000|Overall Study|Withdrawal by parent/guardian|6|||
144577505|NCT04546425|521314991|FG001|Overall Study|Withdrawal by parent/guardian|5|||
144577506|NCT04546425|521314992|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144577507|NCT04546425|521314993|FG003|Overall Study|Withdrawal by parent/guardian|1|||
144577508|NCT01125046|521315001|FG000|First 6 Months of Treatment|Death|1|||
144577509|NCT01125046|521315001|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
144577510|NCT01125046|521315001|FG000|First 6 Months of Treatment|Non-compliance|1|||
144577511|NCT01125046|521315001|FG000|First 6 Months of Treatment|Surgery|1|||
144577512|NCT01125046|521315001|FG000|First 6 Months of Treatment|Progressive Disease|7|||
144577513|NCT01125046|521315001|FG000|First 6 Months of Treatment|Adverse Event|2|||
144577514|NCT01125046|521315001|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
144577515|NCT01125046|521315001|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
144577516|NCT01125046|521315001|FG000|Follow-up/Data Cut Off Point|Death|29|||
144577517|NCT01125046|521315001|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
144577518|NCT01685229|521315002|FG000|Overall Study|Subjects missing Study Exit form|3|||
144577519|NCT01685229|521315003|FG001|Overall Study|Subjects missing Study Exit form|1|||
144577520|NCT01685229|521315002|FG000|Overall Study|Lost to Follow-up|16|||
144577521|NCT01685229|521315003|FG001|Overall Study|Lost to Follow-up|10|||
144577522|NCT01685229|521315002|FG000|Overall Study|Withdrawal by Subject|6|||
144577523|NCT01685229|521315003|FG001|Overall Study|Withdrawal by Subject|5|||
144577524|NCT01685229|521315002|FG000|Overall Study|Death|1|||
144577525|NCT01685229|521315003|FG001|Overall Study|Death|0|||
144577526|NCT02766777|521315004|FG000|Overall Study|Adverse Event|12|||
144577527|NCT02766777|521315004|FG000|Overall Study|Lost to Follow-up|16|||
144577528|NCT02766777|521315004|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144577529|NCT02766777|521315004|FG000|Overall Study|Protocol Violation|1|||
144577530|NCT02766777|521315004|FG000|Overall Study|Withdrawal by Subject|4|||
144577531|NCT00534495|521315005|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
144622067|NCT03403205|521473679|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
144622068|NCT03403205|521473680|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
144577532|NCT00534495|521315006|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
144577533|NCT00534495|521315007|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
144577534|NCT00534495|521315005|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
144577535|NCT00534495|521315006|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
144577536|NCT00534495|521315007|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
144577537|NCT00534495|521315005|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
144577538|NCT00534495|521315006|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
144577539|NCT00534495|521315007|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
144577540|NCT00534495|521315005|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
144577541|NCT00534495|521315006|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
144622069|NCT03403205|521473681|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
144622070|NCT03403205|521473682|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
144577542|NCT00534495|521315007|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
144577543|NCT00534495|521315005|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
144577544|NCT00534495|521315006|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
144577545|NCT00534495|521315007|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
144577546|NCT00534495|521315005|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
144577547|NCT00534495|521315006|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
144577548|NCT00534495|521315007|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
144577549|NCT00534495|521315005|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
144577550|NCT00534495|521315006|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
144577551|NCT00534495|521315007|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
144577552|NCT00534495|521315005|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
144577553|NCT00534495|521315006|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
144577554|NCT00534495|521315007|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
144577555|NCT00534495|521315005|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
144577556|NCT00534495|521315006|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
144577557|NCT00534495|521315007|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
144577558|NCT04868539|521315008|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
144577559|NCT04868539|521315009|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
144577560|NCT01572740|521315010|FG000|Overall Study|Adverse Event|1|||
144577561|NCT01572740|521315011|FG001|Overall Study|Adverse Event|1|||
144577562|NCT01572740|521315010|FG000|Overall Study|Withdrawal by Subject|1|||
144577563|NCT01572740|521315011|FG001|Overall Study|Withdrawal by Subject|1|||
144577564|NCT01572740|521315010|FG000|Overall Study|unclassified|4|||
144577565|NCT01572740|521315011|FG001|Overall Study|unclassified|3|||
144577566|NCT01401153|521315014|FG000|First Test Day|Learning disabilities; illness|1|||
144577567|NCT01401153|521315015|FG001|First Test Day|Learning disabilities; illness|10|||
144577568|NCT01401153|521315014|FG000|Second Test Day|illness|0|||
144577569|NCT01401153|521315015|FG001|Second Test Day|illness|5|||
144577570|NCT00214019|521315016|FG000|Overall Study|Lost to Follow-up|11|||
144577571|NCT00214019|521315016|FG000|Overall Study|Withdrawal by Subject|2|||
144577572|NCT00214019|521315016|FG000|Overall Study|Screen Failed prior to randomization|17|||
144577573|NCT01465763|521315017|FG000|Overall Study|Withdrawal by Subject|4|||
144577574|NCT01465763|521315018|FG001|Overall Study|Withdrawal by Subject|0|||
144577575|NCT01465763|521315019|FG002|Overall Study|Withdrawal by Subject|1|||
144577576|NCT01465763|521315017|FG000|Overall Study|Insufficient Clinical Response|11|||
144577577|NCT01465763|521315018|FG001|Overall Study|Insufficient Clinical Response|0|||
144577578|NCT01465763|521315019|FG002|Overall Study|Insufficient Clinical Response|1|||
144577579|NCT01465763|521315017|FG000|Overall Study|Adverse Event|9|||
144577580|NCT01465763|521315018|FG001|Overall Study|Adverse Event|0|||
144577581|NCT01465763|521315019|FG002|Overall Study|Adverse Event|1|||
144577582|NCT01465763|521315017|FG000|Overall Study|Other|2|||
144577583|NCT01465763|521315018|FG001|Overall Study|Other|0|||
144577584|NCT01465763|521315019|FG002|Overall Study|Other|0|||
144577585|NCT01465763|521315017|FG000|Overall Study|Protocol Violation|4|||
144577586|NCT01465763|521315018|FG001|Overall Study|Protocol Violation|1|||
144577587|NCT01465763|521315019|FG002|Overall Study|Protocol Violation|1|||
144577588|NCT01465763|521315017|FG000|Overall Study|Death|1|||
144577589|NCT01465763|521315018|FG001|Overall Study|Death|0|||
144577590|NCT01465763|521315019|FG002|Overall Study|Death|0|||
144577591|NCT03635099|521315020|FG000|Period 1|Adverse Event|1|||
144577592|NCT03635099|521315021|FG001|Period 1|Adverse Event|0|||
144577593|NCT03635099|521315022|FG002|Period 1|Adverse Event|0|||
144577594|NCT03635099|521315023|FG003|Period 1|Adverse Event|1|||
144577595|NCT03635099|521315024|FG004|Period 1|Adverse Event|0|||
144622071|NCT03403205|521473683|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
144622072|NCT03403205|521473684|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
144622073|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
144622074|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
144622075|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
144622076|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
144622077|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
144622078|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
144622079|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
144622080|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
144577596|NCT03635099|521315025|FG005|Period 1|Adverse Event|0|||
144577597|NCT03635099|521315026|FG006|Period 1|Adverse Event|0|||
144577598|NCT03635099|521315027|FG007|Period 1|Adverse Event|0|||
144577599|NCT03635099|521315020|FG000|Period 1|Protocol Violation|0|||
144622081|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
144577600|NCT03635099|521315021|FG001|Period 1|Protocol Violation|0|||
144577601|NCT03635099|521315022|FG002|Period 1|Protocol Violation|1|||
144577602|NCT03635099|521315023|FG003|Period 1|Protocol Violation|0|||
144577603|NCT03635099|521315024|FG004|Period 1|Protocol Violation|0|||
144577604|NCT03635099|521315025|FG005|Period 1|Protocol Violation|0|||
144577605|NCT03635099|521315026|FG006|Period 1|Protocol Violation|0|||
144577606|NCT03635099|521315027|FG007|Period 1|Protocol Violation|0|||
144577607|NCT03635099|521315020|FG000|Period 1|Lost to Follow-up|0|||
144577608|NCT03635099|521315021|FG001|Period 1|Lost to Follow-up|0|||
144577609|NCT03635099|521315022|FG002|Period 1|Lost to Follow-up|1|||
144577610|NCT03635099|521315023|FG003|Period 1|Lost to Follow-up|2|||
144577611|NCT03635099|521315024|FG004|Period 1|Lost to Follow-up|1|||
144577612|NCT03635099|521315025|FG005|Period 1|Lost to Follow-up|0|||
144577613|NCT03635099|521315026|FG006|Period 1|Lost to Follow-up|1|||
144577614|NCT03635099|521315027|FG007|Period 1|Lost to Follow-up|2|||
144577615|NCT03635099|521315020|FG000|Period 1|Withdrawal by Subject|3|||
144577616|NCT03635099|521315021|FG001|Period 1|Withdrawal by Subject|3|||
144577617|NCT03635099|521315022|FG002|Period 1|Withdrawal by Subject|5|||
144577618|NCT03635099|521315023|FG003|Period 1|Withdrawal by Subject|2|||
144577619|NCT03635099|521315024|FG004|Period 1|Withdrawal by Subject|2|||
144577620|NCT03635099|521315025|FG005|Period 1|Withdrawal by Subject|0|||
144577621|NCT03635099|521315026|FG006|Period 1|Withdrawal by Subject|3|||
144577622|NCT03635099|521315027|FG007|Period 1|Withdrawal by Subject|0|||
144577623|NCT03635099|521315020|FG000|Period 1|History of suicidal ideation|0|||
144577624|NCT03635099|521315021|FG001|Period 1|History of suicidal ideation|0|||
144577625|NCT03635099|521315022|FG002|Period 1|History of suicidal ideation|1|||
144577626|NCT03635099|521315023|FG003|Period 1|History of suicidal ideation|0|||
144577627|NCT03635099|521315024|FG004|Period 1|History of suicidal ideation|0|||
144577628|NCT03635099|521315025|FG005|Period 1|History of suicidal ideation|0|||
144577629|NCT03635099|521315026|FG006|Period 1|History of suicidal ideation|0|||
144577630|NCT03635099|521315027|FG007|Period 1|History of suicidal ideation|0|||
144577631|NCT03635099|521315020|FG000|Period 1|pursue other treatment options|0|||
144577632|NCT03635099|521315021|FG001|Period 1|pursue other treatment options|0|||
144577633|NCT03635099|521315022|FG002|Period 1|pursue other treatment options|0|||
144577634|NCT03635099|521315023|FG003|Period 1|pursue other treatment options|0|||
144577635|NCT03635099|521315024|FG004|Period 1|pursue other treatment options|0|||
144577636|NCT03635099|521315025|FG005|Period 1|pursue other treatment options|1|||
144577637|NCT03635099|521315026|FG006|Period 1|pursue other treatment options|0|||
144577638|NCT03635099|521315027|FG007|Period 1|pursue other treatment options|0|||
144577639|NCT03635099|521315020|FG000|Not Eligible for Period 2|Pregnancy|0|||
144577640|NCT03635099|521315021|FG001|Not Eligible for Period 2|Pregnancy|0|||
144577641|NCT03635099|521315022|FG002|Not Eligible for Period 2|Pregnancy|0|||
144577642|NCT03635099|521315023|FG003|Not Eligible for Period 2|Pregnancy|1|||
144577643|NCT03635099|521315024|FG004|Not Eligible for Period 2|Pregnancy|0|||
144577644|NCT03635099|521315025|FG005|Not Eligible for Period 2|Pregnancy|0|||
144577645|NCT03635099|521315026|FG006|Not Eligible for Period 2|Pregnancy|0|||
144577646|NCT03635099|521315027|FG007|Not Eligible for Period 2|Pregnancy|0|||
144577647|NCT03635099|521315020|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
144577648|NCT03635099|521315021|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577649|NCT03635099|521315022|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577650|NCT03635099|521315023|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577651|NCT03635099|521315024|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577652|NCT03635099|521315025|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577653|NCT03635099|521315026|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577654|NCT03635099|521315027|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
144577655|NCT03635099|521315020|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
144577656|NCT03635099|521315021|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
144577657|NCT03635099|521315022|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
144577658|NCT03635099|521315023|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
144622082|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
144622083|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
144622084|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
144622085|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Death|1|||
144622086|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Death|0|||
144622087|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Death|0|||
144577659|NCT03635099|521315024|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
144577660|NCT03635099|521315025|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
144577661|NCT03635099|521315026|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
144577662|NCT03635099|521315027|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
144577663|NCT03635099|521315020|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
144577664|NCT03635099|521315021|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
144577665|NCT03635099|521315022|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
144577666|NCT03635099|521315023|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
144577667|NCT03635099|521315024|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
144622088|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Death|0|||
144577668|NCT03635099|521315025|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
144577669|NCT03635099|521315026|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
144577670|NCT03635099|521315027|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
144577671|NCT03635099|521315020|FG000|Period 2|Adverse Event|0|||
144577672|NCT03635099|521315021|FG001|Period 2|Adverse Event|0|||
144577673|NCT03635099|521315022|FG002|Period 2|Adverse Event|1|||
144577674|NCT03635099|521315023|FG003|Period 2|Adverse Event|0|||
144577675|NCT03635099|521315024|FG004|Period 2|Adverse Event|1|||
144577676|NCT03635099|521315025|FG005|Period 2|Adverse Event|0|||
144577677|NCT03635099|521315026|FG006|Period 2|Adverse Event|0|||
144577678|NCT03635099|521315027|FG007|Period 2|Adverse Event|0|||
144577679|NCT03635099|521315020|FG000|Period 2|Lost to Follow-up|0|||
144577680|NCT03635099|521315021|FG001|Period 2|Lost to Follow-up|0|||
144577681|NCT03635099|521315022|FG002|Period 2|Lost to Follow-up|1|||
144577682|NCT03635099|521315023|FG003|Period 2|Lost to Follow-up|0|||
144577683|NCT03635099|521315024|FG004|Period 2|Lost to Follow-up|4|||
144577684|NCT03635099|521315025|FG005|Period 2|Lost to Follow-up|0|||
144577685|NCT03635099|521315026|FG006|Period 2|Lost to Follow-up|0|||
144577686|NCT03635099|521315027|FG007|Period 2|Lost to Follow-up|0|||
144577687|NCT03635099|521315020|FG000|Period 2|Withdrawal by Subject|0|||
144577688|NCT03635099|521315021|FG001|Period 2|Withdrawal by Subject|0|||
144577689|NCT03635099|521315022|FG002|Period 2|Withdrawal by Subject|7|||
144577690|NCT03635099|521315023|FG003|Period 2|Withdrawal by Subject|4|||
144577691|NCT03635099|521315024|FG004|Period 2|Withdrawal by Subject|7|||
144577692|NCT03635099|521315025|FG005|Period 2|Withdrawal by Subject|0|||
144577693|NCT03635099|521315026|FG006|Period 2|Withdrawal by Subject|0|||
144577694|NCT03635099|521315027|FG007|Period 2|Withdrawal by Subject|0|||
144577695|NCT01068665|521315028|FG000|Overall Study|Adverse Event|5|||
144577696|NCT01068665|521315029|FG001|Overall Study|Adverse Event|4|||
144577697|NCT01068665|521315028|FG000|Overall Study|Lack of Efficacy|0|||
144577698|NCT01068665|521315029|FG001|Overall Study|Lack of Efficacy|2|||
144577699|NCT01068665|521315028|FG000|Overall Study|Protocol Violation|5|||
144577700|NCT01068665|521315029|FG001|Overall Study|Protocol Violation|2|||
144577701|NCT01068665|521315028|FG000|Overall Study|Withdrawal Criteria|3|||
144577702|NCT01068665|521315029|FG001|Overall Study|Withdrawal Criteria|9|||
144577703|NCT01068665|521315028|FG000|Overall Study|Other|17|||
144577704|NCT01068665|521315029|FG001|Overall Study|Other|12|||
144577705|NCT02807272|521315033|FG000|Overall Study|Death|9|||
144577706|NCT02807272|521315034|FG001|Overall Study|Death|5|||
144577707|NCT02807272|521315035|FG002|Overall Study|Death|2|||
144577708|NCT02807272|521315036|FG003|Overall Study|Death|0|||
144577709|NCT02807272|521315037|FG004|Overall Study|Death|1|||
144577710|NCT02807272|521315033|FG000|Overall Study|Lost to Follow-up|1|||
144577711|NCT02807272|521315034|FG001|Overall Study|Lost to Follow-up|0|||
144577712|NCT02807272|521315035|FG002|Overall Study|Lost to Follow-up|0|||
144577713|NCT02807272|521315036|FG003|Overall Study|Lost to Follow-up|0|||
144577714|NCT02807272|521315037|FG004|Overall Study|Lost to Follow-up|0|||
144577715|NCT02807272|521315033|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
144622089|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Death|0|||
144622090|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Death|0|||
144622091|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
144622092|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
144622093|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
144622094|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
144622095|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
144622096|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
144622097|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
144622098|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
144622099|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
144622100|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
144622101|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
144622102|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
144577716|NCT02807272|521315034|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
144577717|NCT02807272|521315035|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
144577718|NCT02807272|521315036|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
144577719|NCT02807272|521315037|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
144577720|NCT02807272|521315033|FG000|Overall Study|Protocol-defined Disease Progression|0|||
144622103|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
144622104|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
144622105|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
144577721|NCT02807272|521315034|FG001|Overall Study|Protocol-defined Disease Progression|1|||
144577722|NCT02807272|521315035|FG002|Overall Study|Protocol-defined Disease Progression|0|||
144577723|NCT02807272|521315036|FG003|Overall Study|Protocol-defined Disease Progression|0|||
144577724|NCT02807272|521315037|FG004|Overall Study|Protocol-defined Disease Progression|1|||
144577725|NCT02807272|521315033|FG000|Overall Study|Study Terminated by Sponsor|1|||
144577726|NCT02807272|521315034|FG001|Overall Study|Study Terminated by Sponsor|0|||
144577727|NCT02807272|521315035|FG002|Overall Study|Study Terminated by Sponsor|0|||
144577728|NCT02807272|521315036|FG003|Overall Study|Study Terminated by Sponsor|1|||
144577729|NCT02807272|521315037|FG004|Overall Study|Study Terminated by Sponsor|0|||
144577730|NCT02807272|521315033|FG000|Overall Study|Other|1|||
144577731|NCT02807272|521315034|FG001|Overall Study|Other|0|||
144577732|NCT02807272|521315035|FG002|Overall Study|Other|0|||
144577733|NCT02807272|521315036|FG003|Overall Study|Other|0|||
144577734|NCT02807272|521315037|FG004|Overall Study|Other|1|||
144577735|NCT01038427|521315039|FG000|Overall Study|Lost to follow up|1|||
144577736|NCT01038427|521315040|FG001|Overall Study|Lost to follow up|1|||
144577737|NCT01038427|521315041|FG002|Overall Study|Lost to follow up|0|||
144577738|NCT01038427|521315039|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
144577739|NCT01038427|521315040|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
144577740|NCT01038427|521315041|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
144577741|NCT01038427|521315039|FG000|Overall Study|Withdrew consent|0|||
144577742|NCT01038427|521315040|FG001|Overall Study|Withdrew consent|0|||
144577743|NCT01038427|521315041|FG002|Overall Study|Withdrew consent|1|||
144577744|NCT01038427|521315039|FG000|Overall Study|Adverse Event|2|||
144577745|NCT01038427|521315040|FG001|Overall Study|Adverse Event|2|||
144577746|NCT01038427|521315041|FG002|Overall Study|Adverse Event|1|||
144577747|NCT01038427|521315039|FG000|Overall Study|Enrolled in error|0|||
144577748|NCT01038427|521315040|FG001|Overall Study|Enrolled in error|1|||
144577749|NCT01038427|521315041|FG002|Overall Study|Enrolled in error|1|||
144577750|NCT01038427|521315039|FG000|Overall Study|Other|0|||
144577751|NCT01038427|521315040|FG001|Overall Study|Other|2|||
144577752|NCT01038427|521315041|FG002|Overall Study|Other|0|||
144577753|NCT04191616|521315042|FG000|Pre-assignment Period|Did not receive study treatment|2|||
144577754|NCT04191616|521315042|FG000|Treatment Period|Death|37|||
144577755|NCT04191616|521315042|FG000|Treatment Period|Sponsor decision|11|||
144577756|NCT04191616|521315042|FG000|Treatment Period|Withdrawal by Subject|4|||
144577757|NCT01162863|521315043|FG000|Overall Study|Lack of Efficacy|1|||
144577758|NCT01162863|521315044|FG001|Overall Study|Lack of Efficacy|0|||
144577759|NCT01162863|521315045|FG002|Overall Study|Lack of Efficacy|0|||
144577760|NCT01162863|521315043|FG000|Overall Study|Adverse Event|0|||
144577761|NCT01162863|521315044|FG001|Overall Study|Adverse Event|1|||
144577762|NCT01162863|521315045|FG002|Overall Study|Adverse Event|0|||
144577763|NCT02992691|521315046|FG000|Overall Study|Adverse Event|2|||
144577764|NCT02992691|521315046|FG000|Overall Study|Withdrawal by Subject|1|||
144577765|NCT00588692|521315047|FG000|Overall Study|Withdrawal by Subject|4|||
144577766|NCT00588692|521315048|FG001|Overall Study|Withdrawal by Subject|2|||
144577767|NCT00588692|521315047|FG000|Overall Study|Hip Surgery|0|||
144577768|NCT00588692|521315048|FG001|Overall Study|Hip Surgery|1|||
144577769|NCT00588692|521315047|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
144577770|NCT00588692|521315048|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
144577771|NCT00588692|521315047|FG000|Overall Study|Cancer|1|||
144577772|NCT00588692|521315048|FG001|Overall Study|Cancer|0|||
144577773|NCT00588692|521315047|FG000|Overall Study|Death|1|||
144577774|NCT00588692|521315048|FG001|Overall Study|Death|0|||
144577775|NCT00392925|521315050|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
144577776|NCT00392925|521315051|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
144577777|NCT00392925|521315052|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
144577778|NCT00392925|521315053|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
144577779|NCT00392925|521315050|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
144577780|NCT00392925|521315051|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
144577781|NCT00392925|521315052|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
144577782|NCT00392925|521315053|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
144577783|NCT00392925|521315050|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
144577784|NCT00392925|521315051|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
144577785|NCT00392925|521315052|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
144577786|NCT00392925|521315053|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
144577787|NCT00392925|521315050|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
144577788|NCT00392925|521315051|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
144577789|NCT00392925|521315052|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
144577790|NCT00392925|521315053|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
144577791|NCT00392925|521315050|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
144577792|NCT00392925|521315051|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
144577793|NCT00392925|521315052|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
144577794|NCT00392925|521315053|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
144577795|NCT00392925|521315050|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
144577796|NCT00392925|521315051|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
144577797|NCT00392925|521315052|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
144577798|NCT00392925|521315053|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
144577799|NCT00392925|521315050|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
144622106|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
144577800|NCT00392925|521315051|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
144577801|NCT00392925|521315052|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
144577802|NCT00392925|521315053|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
144577803|NCT00392925|521315050|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
144577804|NCT00392925|521315051|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
144577805|NCT00392925|521315052|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
144577806|NCT00392925|521315053|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
144577807|NCT00392925|521315050|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
144577808|NCT00392925|521315051|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
144577809|NCT00392925|521315052|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
144577810|NCT00392925|521315053|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
144577811|NCT04230122|521315054|FG000|Overall Study|Lost to Follow-up|1|||
144577812|NCT04230122|521315055|FG001|Overall Study|Lost to Follow-up|0|||
144577813|NCT00820170|521315057|FG000|Overall Study|Adverse Event|0|||
144577814|NCT00820170|521315058|FG001|Overall Study|Adverse Event|0|||
144577815|NCT00820170|521315059|FG002|Overall Study|Adverse Event|0|||
144577816|NCT00820170|521315060|FG003|Overall Study|Adverse Event|0|||
144577817|NCT00820170|521315061|FG004|Overall Study|Adverse Event|2|||
144577818|NCT00820170|521315057|FG000|Overall Study|Progressive Disease|0|||
144577819|NCT00820170|521315058|FG001|Overall Study|Progressive Disease|0|||
144577820|NCT00820170|521315059|FG002|Overall Study|Progressive Disease|0|||
144577821|NCT00820170|521315060|FG003|Overall Study|Progressive Disease|0|||
144577822|NCT00820170|521315061|FG004|Overall Study|Progressive Disease|2|||
144577823|NCT03538938|521315064|FG000|Overall Study|Death|0|||
144577824|NCT03538938|521315065|FG001|Overall Study|Death|0|||
144577825|NCT03538938|521315066|FG002|Overall Study|Death|2|||
144577826|NCT03538938|521315067|FG003|Overall Study|Death|0|||
144730088|NCT00727571|521868140|FG001|Overall Study|Physician Decision|5|||
144730089|NCT00727571|521868141|FG002|Overall Study|Physician Decision|0|||
144730090|NCT00727571|521868142|FG003|Overall Study|Physician Decision|0|||
144730091|NCT00727571|521868139|FG000|Overall Study|Withdrawal by Subject|0|||
144730092|NCT00727571|521868140|FG001|Overall Study|Withdrawal by Subject|10|||
144730093|NCT00727571|521868141|FG002|Overall Study|Withdrawal by Subject|11|||
144730094|NCT00727571|521868142|FG003|Overall Study|Withdrawal by Subject|0|||
144730095|NCT00727571|521868139|FG000|Overall Study|Subject Non Compliance|0|||
144730096|NCT00727571|521868140|FG001|Overall Study|Subject Non Compliance|6|||
144730097|NCT00727571|521868141|FG002|Overall Study|Subject Non Compliance|0|||
144730098|NCT00727571|521868142|FG003|Overall Study|Subject Non Compliance|4|||
144730099|NCT00727571|521868139|FG000|Overall Study|Dismissed from nursing home|0|||
144730100|NCT00727571|521868140|FG001|Overall Study|Dismissed from nursing home|9|||
144730101|NCT00727571|521868141|FG002|Overall Study|Dismissed from nursing home|5|||
144730102|NCT00727571|521868142|FG003|Overall Study|Dismissed from nursing home|0|||
144730103|NCT00727571|521868139|FG000|Overall Study|Hospitalization|0|||
144730104|NCT00727571|521868140|FG001|Overall Study|Hospitalization|1|||
144730105|NCT00727571|521868141|FG002|Overall Study|Hospitalization|0|||
144730106|NCT00727571|521868142|FG003|Overall Study|Hospitalization|1|||
144730107|NCT00727571|521868139|FG000|Overall Study|AE not leading to hospitalization|0|||
144730108|NCT00727571|521868140|FG001|Overall Study|AE not leading to hospitalization|0|||
144730109|NCT00727571|521868141|FG002|Overall Study|AE not leading to hospitalization|2|||
144730110|NCT00727571|521868142|FG003|Overall Study|AE not leading to hospitalization|0|||
144730111|NCT00727571|521868139|FG000|Overall Study|Other|0|||
144730112|NCT00727571|521868140|FG001|Overall Study|Other|4|||
144730113|NCT00727571|521868141|FG002|Overall Study|Other|6|||
144730114|NCT00727571|521868142|FG003|Overall Study|Other|0|||
144730115|NCT01287013|521868143|FG000|Overall Study|Non-evaluable|3|||
144730116|NCT01287013|521868144|FG001|Overall Study|Non-evaluable|5|||
144730117|NCT01287013|521868145|FG002|Overall Study|Non-evaluable|21|||
144730118|NCT03247556|521868146|FG000|Overall Study|Adverse Event|1|||
144577827|NCT03538938|521315068|FG004|Overall Study|Death|0|||
144577828|NCT03538938|521315069|FG005|Overall Study|Death|1|||
144577829|NCT03538938|521315070|FG006|Overall Study|Death|0|||
144577830|NCT03538938|521315071|FG007|Overall Study|Death|1|||
144577831|NCT03538938|521315072|FG008|Overall Study|Death|1|||
144577832|NCT03538938|521315073|FG009|Overall Study|Death|1|||
144577833|NCT03538938|521315074|FG010|Overall Study|Death|0|||
144730119|NCT03247556|521868147|FG001|Overall Study|Adverse Event|4|||
144577834|NCT03538938|521315075|FG011|Overall Study|Death|0|||
144577835|NCT03538938|521315076|FG012|Overall Study|Death|1|||
144577836|NCT03538938|521315077|FG013|Overall Study|Death|1|||
144577837|NCT03538938|521315078|FG014|Overall Study|Death|0|||
144577838|NCT03538938|521315079|FG015|Overall Study|Death|1|||
144577839|NCT03538938|521315064|FG000|Overall Study|Withdrawal by Subject|4|||
144730120|NCT03247556|521868148|FG002|Overall Study|Adverse Event|5|||
144730121|NCT03247556|521868146|FG000|Overall Study|Lost to Follow-up|5|||
144730122|NCT03247556|521868147|FG001|Overall Study|Lost to Follow-up|5|||
144730123|NCT03247556|521868148|FG002|Overall Study|Lost to Follow-up|4|||
144730124|NCT03247556|521868146|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
144730125|NCT03247556|521868147|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
144577840|NCT03538938|521315065|FG001|Overall Study|Withdrawal by Subject|6|||
144577841|NCT03538938|521315066|FG002|Overall Study|Withdrawal by Subject|5|||
144577842|NCT03538938|521315067|FG003|Overall Study|Withdrawal by Subject|3|||
144577843|NCT03538938|521315068|FG004|Overall Study|Withdrawal by Subject|0|||
144577844|NCT03538938|521315069|FG005|Overall Study|Withdrawal by Subject|0|||
144577845|NCT03538938|521315070|FG006|Overall Study|Withdrawal by Subject|3|||
144577846|NCT03538938|521315071|FG007|Overall Study|Withdrawal by Subject|1|||
144577847|NCT03538938|521315072|FG008|Overall Study|Withdrawal by Subject|5|||
144577848|NCT03538938|521315073|FG009|Overall Study|Withdrawal by Subject|1|||
144577849|NCT03538938|521315074|FG010|Overall Study|Withdrawal by Subject|2|||
144577850|NCT03538938|521315075|FG011|Overall Study|Withdrawal by Subject|1|||
144577851|NCT03538938|521315076|FG012|Overall Study|Withdrawal by Subject|3|||
144577852|NCT03538938|521315077|FG013|Overall Study|Withdrawal by Subject|0|||
144577853|NCT03538938|521315078|FG014|Overall Study|Withdrawal by Subject|2|||
144577854|NCT03538938|521315079|FG015|Overall Study|Withdrawal by Subject|4|||
144577855|NCT03538938|521315064|FG000|Overall Study|Incarcerated|0|||
144577856|NCT03538938|521315065|FG001|Overall Study|Incarcerated|0|||
144577857|NCT03538938|521315066|FG002|Overall Study|Incarcerated|0|||
144577858|NCT03538938|521315067|FG003|Overall Study|Incarcerated|0|||
144577859|NCT03538938|521315068|FG004|Overall Study|Incarcerated|0|||
144577860|NCT03538938|521315069|FG005|Overall Study|Incarcerated|0|||
144577861|NCT03538938|521315070|FG006|Overall Study|Incarcerated|0|||
144577862|NCT03538938|521315071|FG007|Overall Study|Incarcerated|0|||
144577863|NCT03538938|521315072|FG008|Overall Study|Incarcerated|0|||
144577864|NCT03538938|521315073|FG009|Overall Study|Incarcerated|0|||
144577865|NCT03538938|521315074|FG010|Overall Study|Incarcerated|0|||
144577866|NCT03538938|521315075|FG011|Overall Study|Incarcerated|1|||
144577867|NCT03538938|521315076|FG012|Overall Study|Incarcerated|0|||
144577868|NCT03538938|521315077|FG013|Overall Study|Incarcerated|0|||
144577869|NCT03538938|521315078|FG014|Overall Study|Incarcerated|0|||
144577870|NCT03538938|521315079|FG015|Overall Study|Incarcerated|0|||
144577871|NCT03995316|521315081|FG000|Overall Study|Lost to Follow-up|10|||
144577872|NCT03995316|521315082|FG001|Overall Study|Lost to Follow-up|3|||
144577873|NCT01137578|521315083|FG000|Overall Study|Participant requested to Discontinue|3|||
144577874|NCT01137578|521315084|FG001|Overall Study|Participant requested to Discontinue|0|||
144577875|NCT01137578|521315085|FG002|Overall Study|Participant requested to Discontinue|0|||
144577876|NCT01137578|521315083|FG000|Overall Study|Withdrawal by Subject|1|||
144577877|NCT01137578|521315084|FG001|Overall Study|Withdrawal by Subject|0|||
144577878|NCT01137578|521315085|FG002|Overall Study|Withdrawal by Subject|0|||
144577879|NCT01137578|521315083|FG000|Overall Study|Other|12|||
144577880|NCT01137578|521315084|FG001|Overall Study|Other|2|||
144577881|NCT01137578|521315085|FG002|Overall Study|Other|6|||
144622107|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
144622108|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
144622109|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
144622110|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
144622111|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
144622112|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
144622113|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
144622114|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
144622115|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
144622116|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
144622117|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
144622118|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
144622119|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
144622120|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
144622121|NCT03403205|521473679|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
144622122|NCT03403205|521473680|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
144622123|NCT03403205|521473681|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
144622124|NCT03403205|521473682|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
144577882|NCT01361594|521315086|FG000|Overall Study|Withdrawal by Subject|1|||
144577883|NCT01361594|521315087|FG001|Overall Study|Withdrawal by Subject|2|||
144577884|NCT00415051|521315089|FG000|Overall Study|Protocol Violation|1|||
144577885|NCT01518153|521315092|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
144577886|NCT01518153|521315093|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
144577887|NCT01518153|521315094|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
144577888|NCT01518153|521315092|FG000|Stem Cell Transplant|Death|2|||
144577889|NCT01518153|521315093|FG001|Stem Cell Transplant|Death|0|||
144577890|NCT01518153|521315094|FG002|Stem Cell Transplant|Death|0|||
144577891|NCT01518153|521315092|FG000|Stem Cell Transplant|Secondary graft failure|1|||
144577892|NCT01518153|521315093|FG001|Stem Cell Transplant|Secondary graft failure|0|||
144577893|NCT01518153|521315094|FG002|Stem Cell Transplant|Secondary graft failure|0|||
144577894|NCT01518153|521315092|FG000|Stem Cell Transplant|Adverse Event|1|||
144730126|NCT03247556|521868148|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
144730127|NCT03247556|521868146|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
144730128|NCT03247556|521868147|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
144730129|NCT03247556|521868148|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
144730130|NCT03247556|521868146|FG000|Overall Study|Protocol Violation|2|||
144730131|NCT03247556|521868147|FG001|Overall Study|Protocol Violation|0|||
144730132|NCT03247556|521868148|FG002|Overall Study|Protocol Violation|1|||
144730133|NCT03247556|521868146|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
144207449|NCT02861014|519954319|FG000|Primary Analysis|Lack of Efficacy|3|||
144207450|NCT02861014|519954319|FG000|Primary Analysis|Physician Decision|2|||
144207451|NCT02861014|519954319|FG000|Primary Analysis|Pregnancy|4|||
144207452|NCT02861014|519954319|FG000|Primary Analysis|Protocol Violation|2|||
144577895|NCT01518153|521315093|FG001|Stem Cell Transplant|Adverse Event|0|||
144577896|NCT01518153|521315094|FG002|Stem Cell Transplant|Adverse Event|0|||
144577897|NCT01518153|521315092|FG000|Donor Lymphocyte Infusion|Death|0|||
144577898|NCT01518153|521315093|FG001|Donor Lymphocyte Infusion|Death|2|||
144577899|NCT01518153|521315094|FG002|Donor Lymphocyte Infusion|Death|1|||
144577900|NCT01399918|521315097|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
144577901|NCT03197766|521315098|FG000|Overall Study|Withdrawal by Subject|2|||
144577902|NCT03197766|521315099|FG001|Overall Study|Withdrawal by Subject|0|||
144577903|NCT01436253|521315100|FG000|Overall Study|Lost to Follow-up|182|||
144577904|NCT01436253|521315100|FG000|Overall Study|Not meeting all eligibility criteria|117|||
144577905|NCT03083665|521315102|FG000|Double-Blind Period|Adverse Event|5|||
144577906|NCT03083665|521315103|FG001|Double-Blind Period|Adverse Event|4|||
144577907|NCT03083665|521315104|FG002|Double-Blind Period|Adverse Event|5|||
144577908|NCT03083665|521315105|FG003|Double-Blind Period|Adverse Event|0|||
144577909|NCT03083665|521315106|FG004|Double-Blind Period|Adverse Event|0|||
144577910|NCT03083665|521315107|FG005|Double-Blind Period|Adverse Event|0|||
144207453|NCT02861014|519954319|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
144207454|NCT02861014|519954319|FG000|Primary Analysis|Withdrawal by Subject|14|||
144577911|NCT03083665|521315102|FG000|Double-Blind Period|Lack of Efficacy|0|||
144577912|NCT03083665|521315103|FG001|Double-Blind Period|Lack of Efficacy|0|||
144577913|NCT03083665|521315104|FG002|Double-Blind Period|Lack of Efficacy|1|||
144577914|NCT03083665|521315105|FG003|Double-Blind Period|Lack of Efficacy|0|||
144577915|NCT03083665|521315106|FG004|Double-Blind Period|Lack of Efficacy|0|||
144577916|NCT03083665|521315107|FG005|Double-Blind Period|Lack of Efficacy|0|||
144577917|NCT03083665|521315102|FG000|Double-Blind Period|Protocol Violation|1|||
144577918|NCT03083665|521315103|FG001|Double-Blind Period|Protocol Violation|0|||
144577919|NCT03083665|521315104|FG002|Double-Blind Period|Protocol Violation|1|||
144577920|NCT03083665|521315105|FG003|Double-Blind Period|Protocol Violation|0|||
144577921|NCT03083665|521315106|FG004|Double-Blind Period|Protocol Violation|0|||
144577922|NCT03083665|521315107|FG005|Double-Blind Period|Protocol Violation|0|||
144577923|NCT03083665|521315102|FG000|Double-Blind Period|Lost to Follow-up|1|||
144577924|NCT03083665|521315103|FG001|Double-Blind Period|Lost to Follow-up|0|||
144577925|NCT03083665|521315104|FG002|Double-Blind Period|Lost to Follow-up|1|||
144577926|NCT03083665|521315105|FG003|Double-Blind Period|Lost to Follow-up|0|||
144577927|NCT03083665|521315106|FG004|Double-Blind Period|Lost to Follow-up|0|||
144577928|NCT03083665|521315107|FG005|Double-Blind Period|Lost to Follow-up|0|||
144577929|NCT03083665|521315102|FG000|Double-Blind Period|Withdrawal by Subject|3|||
144577930|NCT03083665|521315103|FG001|Double-Blind Period|Withdrawal by Subject|0|||
144577931|NCT03083665|521315104|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144577932|NCT03083665|521315105|FG003|Double-Blind Period|Withdrawal by Subject|0|||
144577933|NCT03083665|521315106|FG004|Double-Blind Period|Withdrawal by Subject|0|||
144577934|NCT03083665|521315107|FG005|Double-Blind Period|Withdrawal by Subject|0|||
144577935|NCT03083665|521315102|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
144207455|NCT02861014|519954319|FG000|Primary Analysis|Commercial ocrelizumab|3|||
144207456|NCT02861014|519954319|FG000|Safety Follow-up|Adverse Event|1|||
144207457|NCT02861014|519954319|FG000|Safety Follow-up|Pregnancy|1|||
144577936|NCT03083665|521315103|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
144577937|NCT03083665|521315104|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
144577938|NCT03083665|521315105|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
144577939|NCT03083665|521315106|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
144577940|NCT03083665|521315107|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
144577941|NCT03083665|521315102|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
144577942|NCT03083665|521315103|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
144730134|NCT03247556|521868147|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
144207458|NCT02861014|519954319|FG000|Safety Follow-up|Withdrawal by Subject|9|||
144207459|NCT02861014|519954319|FG000|Safety Follow-up|Study terminated by sponsor|1|||
144577943|NCT03083665|521315104|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
144577944|NCT03083665|521315105|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
144577945|NCT03083665|521315106|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
144577946|NCT03083665|521315107|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
144207460|NCT02861014|519954319|FG000|Safety Follow-up|Physician Decision|1|||
144207461|NCT02861014|519954319|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
144207462|NCT02861014|519954319|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
144207463|NCT03247816|519954320|FG000|Overall Study|Adverse Event|12|||
144207464|NCT03247816|519954320|FG000|Overall Study|Physician Decision|3|||
144207465|NCT03247816|519954320|FG000|Overall Study|Lack of Efficacy|1|||
144207466|NCT03247816|519954320|FG000|Overall Study|Lost to Follow-up|10|||
144577947|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
144577948|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
144577949|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
144577950|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
144577951|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
144577952|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
144577953|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
144577954|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
144577955|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
144577956|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
144577957|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
144577958|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
144577959|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
144577960|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
144577961|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
144577962|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
144577963|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
144577964|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
144577965|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
144577966|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
144577967|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
144577968|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
144577969|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
144577970|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
144577971|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
144577972|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
144577973|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
144577974|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
144577975|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
144577976|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
144577977|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
144577978|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
144577979|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
144577980|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
144577981|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
144577982|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
144577983|NCT03083665|521315102|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
144577984|NCT03083665|521315103|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
144577985|NCT03083665|521315104|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
144577986|NCT03083665|521315105|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
144577987|NCT03083665|521315106|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
144577988|NCT03083665|521315107|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
144577989|NCT06285240|521315108|FG000|Overall Study|Withdrawal by Subject|2|||
144577990|NCT06285240|521315109|FG001|Overall Study|Withdrawal by Subject|0|||
144577991|NCT06285240|521315110|FG002|Overall Study|Withdrawal by Subject|0|||
144577992|NCT06285240|521315111|FG003|Overall Study|Withdrawal by Subject|0|||
144577993|NCT06285240|521315108|FG000|Overall Study|Serious Adverse Event|0|||
144577994|NCT06285240|521315109|FG001|Overall Study|Serious Adverse Event|0|||
144577995|NCT06285240|521315110|FG002|Overall Study|Serious Adverse Event|1|||
144577996|NCT06285240|521315111|FG003|Overall Study|Serious Adverse Event|0|||
144577997|NCT05140915|521315112|FG000|Overall Study|Lost to Follow-up|2|||
144577998|NCT05140915|521315113|FG001|Overall Study|Lost to Follow-up|1|||
144577999|NCT04485611|521315118|FG000|Prehabilitation|Physician Decision|1|||
144578000|NCT00350727|521315119|FG000|Phase I: Dose Escalation|Adverse Event|4|||
144578001|NCT00350727|521315120|FG001|Phase I: Dose Escalation|Adverse Event|0|||
144578002|NCT00350727|521315121|FG002|Phase I: Dose Escalation|Adverse Event|0|||
144578003|NCT00350727|521315119|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
144207467|NCT03247816|519954320|FG000|Overall Study|Missing Feraccru stop date|3|||
144578004|NCT00350727|521315120|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
144578005|NCT00350727|521315121|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
144578006|NCT00350727|521315119|FG000|Phase I: Dose Escalation|Death|1|||
144578007|NCT00350727|521315120|FG001|Phase I: Dose Escalation|Death|0|||
144578008|NCT00350727|521315121|FG002|Phase I: Dose Escalation|Death|0|||
144578009|NCT00350727|521315119|FG000|Phase I: Dose Escalation|Physician Decision|1|||
144578010|NCT00350727|521315120|FG001|Phase I: Dose Escalation|Physician Decision|0|||
144578011|NCT00350727|521315121|FG002|Phase I: Dose Escalation|Physician Decision|0|||
144578012|NCT00350727|521315119|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
144578013|NCT00350727|521315120|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
144578014|NCT00350727|521315121|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
144622125|NCT03403205|521473683|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
144622126|NCT03403205|521473684|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
144622127|NCT05779072|521473685|FG000|Overall Study|Lost to Follow-up|0|||
144622128|NCT05779072|521473686|FG001|Overall Study|Lost to Follow-up|1|||
144622129|NCT05779072|521473685|FG000|Overall Study|Withdrawal by Subject|1|||
144622130|NCT05779072|521473686|FG001|Overall Study|Withdrawal by Subject|5|||
144622131|NCT02682901|521473687|FG000|Overall Study|Adverse Event|10|||
144622132|NCT02682901|521473688|FG001|Overall Study|Adverse Event|3|||
144622133|NCT02682901|521473687|FG000|Overall Study|Lack of Efficacy|0|||
144622134|NCT02682901|521473688|FG001|Overall Study|Lack of Efficacy|1|||
144622135|NCT03713944|521473689|FG000|Study Treatment|Patient non-compliance|1|||
144622136|NCT03713944|521473689|FG000|Study Treatment|Alternative Cancer Therapy|3|||
144622137|NCT03713944|521473689|FG000|Study Treatment|Disease Progression|18|||
144622138|NCT03713944|521473689|FG000|Study Treatment|AE/Side Effects/Complications|2|||
144622139|NCT03713944|521473689|FG000|Study Treatment|Death|2|||
144622140|NCT03713944|521473689|FG000|Study Treatment|Withdrawal by Subject|1|||
144622141|NCT03713944|521473689|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
144622142|NCT03713944|521473689|FG000|Study Treatment|Symptomatic Deterioration|2|||
144622143|NCT03713944|521473689|FG000|Follow up|Withdrawal by Subject|2|||
144622144|NCT03713944|521473689|FG000|Follow up|Death|11|||
144622145|NCT03713944|521473689|FG000|Follow up|Study Terminated|3|||
144622146|NCT03694925|521473690|FG000|Overall Study|Inadequate laboratory testing|0|||
144622147|NCT03694925|521473691|FG001|Overall Study|Inadequate laboratory testing|3|||
144622148|NCT03694925|521473692|FG002|Overall Study|Inadequate laboratory testing|0|||
144622149|NCT00487539|521473695|FG000|Overall Study|Adverse Event|3|||
144622150|NCT00487539|521473696|FG001|Overall Study|Adverse Event|2|||
144622151|NCT00487539|521473697|FG002|Overall Study|Adverse Event|1|||
144622152|NCT00487539|521473698|FG003|Overall Study|Adverse Event|1|||
144622153|NCT00487539|521473695|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144622154|NCT00487539|521473696|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144622155|NCT00487539|521473697|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144622156|NCT00487539|521473698|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
144622157|NCT00487539|521473695|FG000|Overall Study|Other|3|||
144622158|NCT00487539|521473696|FG001|Overall Study|Other|1|||
144622159|NCT00487539|521473697|FG002|Overall Study|Other|2|||
144622160|NCT00487539|521473698|FG003|Overall Study|Other|2|||
144622161|NCT02751502|521473699|FG000|Overall Study|Lack of funding|4|||
144622162|NCT03499028|521473700|FG000|Overall Study|Lost to Follow-up|12|||
144622163|NCT03499028|521473701|FG001|Overall Study|Lost to Follow-up|9|||
144622164|NCT03499028|521473700|FG000|Overall Study|Withdrawal by Subject|5|||
144622165|NCT03499028|521473701|FG001|Overall Study|Withdrawal by Subject|8|||
144622166|NCT03499028|521473700|FG000|Overall Study|Unplanned SNF discharge|5|||
144622167|NCT03499028|521473701|FG001|Overall Study|Unplanned SNF discharge|8|||
144622168|NCT00720109|521473702|FG000|Induction Period|Did not meet eligibility criteria|3|||
144622169|NCT00720109|521473703|FG001|Induction Period|Did not meet eligibility criteria|0|||
144622170|NCT00720109|521473704|FG002|Induction Period|Did not meet eligibility criteria|0|||
144730135|NCT03247556|521868148|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
144730136|NCT00051025|521868152|FG000|Overall Study|Progressive Disease|1|||
144730137|NCT00051025|521868153|FG001|Overall Study|Progressive Disease|1|||
144730138|NCT00051025|521868152|FG000|Overall Study|Adverse Event|1|||
144730139|NCT00051025|521868153|FG001|Overall Study|Adverse Event|1|||
144730140|NCT00051025|521868152|FG000|Overall Study|Withdrawal by Subject|0|||
144578015|NCT00350727|521315119|FG000|Phase II|Disease Progression|0|||
144578016|NCT00350727|521315120|FG001|Phase II|Disease Progression|15|||
144622171|NCT00720109|521473702|FG000|Induction Period|Bone Marrow Transplant|2|||
144622172|NCT00720109|521473703|FG001|Induction Period|Bone Marrow Transplant|0|||
144622173|NCT00720109|521473704|FG002|Induction Period|Bone Marrow Transplant|0|||
144622174|NCT00720109|521473702|FG000|Induction Period|Physician Decision|1|||
144622175|NCT00720109|521473703|FG001|Induction Period|Physician Decision|0|||
144622176|NCT00720109|521473704|FG002|Induction Period|Physician Decision|0|||
144622177|NCT00720109|521473702|FG000|Risk Stratification Period|Adverse Event|0|||
144622178|NCT00720109|521473703|FG001|Risk Stratification Period|Adverse Event|1|||
144622179|NCT00720109|521473704|FG002|Risk Stratification Period|Adverse Event|0|||
144578017|NCT00350727|521315121|FG002|Phase II|Disease Progression|16|||
144578018|NCT00350727|521315119|FG000|Phase II|Clinical Deterioration|0|||
144578019|NCT00350727|521315120|FG001|Phase II|Clinical Deterioration|1|||
144578020|NCT00350727|521315121|FG002|Phase II|Clinical Deterioration|0|||
144578021|NCT00350727|521315119|FG000|Phase II|Withdrawal by Subject|0|||
144578022|NCT00350727|521315120|FG001|Phase II|Withdrawal by Subject|2|||
144578023|NCT00350727|521315121|FG002|Phase II|Withdrawal by Subject|1|||
144578024|NCT00350727|521315119|FG000|Phase II|Adverse Event|0|||
144578025|NCT00350727|521315120|FG001|Phase II|Adverse Event|1|||
144578026|NCT00350727|521315121|FG002|Phase II|Adverse Event|1|||
144578027|NCT00350727|521315119|FG000|Phase II|Death|0|||
144578028|NCT00350727|521315120|FG001|Phase II|Death|0|||
144578029|NCT00350727|521315121|FG002|Phase II|Death|2|||
144578030|NCT00350727|521315119|FG000|Phase II|Sponsor Terminated Study|0|||
144578031|NCT00350727|521315120|FG001|Phase II|Sponsor Terminated Study|0|||
144578032|NCT00350727|521315121|FG002|Phase II|Sponsor Terminated Study|1|||
144578033|NCT00350727|521315119|FG000|Phase II|Enrolled in Rollover Study|0|||
144578034|NCT00350727|521315120|FG001|Phase II|Enrolled in Rollover Study|0|||
144578035|NCT00350727|521315121|FG002|Phase II|Enrolled in Rollover Study|1|||
144578036|NCT03633799|521315129|FG000|Overall Study|Adverse Event|349|||
144578037|NCT03633799|521315129|FG000|Overall Study|Withdrawal by Subject|288|||
144578038|NCT03633799|521315129|FG000|Overall Study|Lost to Follow-up|97|||
144578039|NCT03633799|521315129|FG000|Overall Study|Physician Decision|9|||
144578040|NCT03633799|521315129|FG000|Overall Study|Protocol Violation|4|||
144578041|NCT03633799|521315129|FG000|Overall Study|Pregnancy|20|||
144578042|NCT03633799|521315129|FG000|Overall Study|other|39|||
144578043|NCT03633799|521315129|FG000|Overall Study|ongoing within third year of study|106|||
144578044|NCT03633799|521315129|FG000|Overall Study|unsuccessful study drug placement|19|||
144578045|NCT03829501|521317493|FG000|Overall Study|Withdrawal of Consent|2|||
144578046|NCT03829501|521317494|FG001|Overall Study|Withdrawal of Consent|0|||
144578047|NCT03829501|521317495|FG002|Overall Study|Withdrawal of Consent|3|||
144578048|NCT03829501|521317496|FG003|Overall Study|Withdrawal of Consent|0|||
144578049|NCT03829501|521317497|FG004|Overall Study|Withdrawal of Consent|1|||
144578050|NCT03829501|521317498|FG005|Overall Study|Withdrawal of Consent|1|||
144578051|NCT03829501|521317499|FG006|Overall Study|Withdrawal of Consent|0|||
144578052|NCT03829501|521317500|FG007|Overall Study|Withdrawal of Consent|10|||
144578053|NCT03829501|521317501|FG008|Overall Study|Withdrawal of Consent|10|||
144578054|NCT03829501|521317502|FG009|Overall Study|Withdrawal of Consent|3|||
144578055|NCT03829501|521317503|FG010|Overall Study|Withdrawal of Consent|4|||
144578056|NCT03829501|521317504|FG011|Overall Study|Withdrawal of Consent|4|||
144578057|NCT03829501|521317505|FG012|Overall Study|Withdrawal of Consent|4|||
144578058|NCT03829501|521317506|FG013|Overall Study|Withdrawal of Consent|0|||
144578059|NCT03829501|521317507|FG014|Overall Study|Withdrawal of Consent|3|||
144578060|NCT03829501|521317508|FG015|Overall Study|Withdrawal of Consent|0|||
144578061|NCT03829501|521317509|FG016|Overall Study|Withdrawal of Consent|1|||
144578062|NCT03829501|521317510|FG017|Overall Study|Withdrawal of Consent|1|||
144578063|NCT03829501|521317511|FG018|Overall Study|Withdrawal of Consent|0|||
144578064|NCT03829501|521317512|FG019|Overall Study|Withdrawal of Consent|0|||
144578065|NCT03829501|521317513|FG020|Overall Study|Withdrawal of Consent|3|||
144578066|NCT03829501|521317514|FG021|Overall Study|Withdrawal of Consent|0|||
144578067|NCT03829501|521317515|FG022|Overall Study|Withdrawal of Consent|1|||
144578068|NCT03829501|521317493|FG000|Overall Study|PD|0|||
144578069|NCT03829501|521317494|FG001|Overall Study|PD|0|||
144578070|NCT03829501|521317495|FG002|Overall Study|PD|0|||
144578071|NCT03829501|521317496|FG003|Overall Study|PD|2|||
144578072|NCT03829501|521317497|FG004|Overall Study|PD|0|||
144578073|NCT03829501|521317498|FG005|Overall Study|PD|0|||
144578074|NCT03829501|521317499|FG006|Overall Study|PD|0|||
144578075|NCT03829501|521317500|FG007|Overall Study|PD|0|||
144578076|NCT03829501|521317501|FG008|Overall Study|PD|0|||
144578077|NCT03829501|521317502|FG009|Overall Study|PD|0|||
144578078|NCT03829501|521317503|FG010|Overall Study|PD|0|||
144578079|NCT03829501|521317504|FG011|Overall Study|PD|0|||
144578080|NCT03829501|521317505|FG012|Overall Study|PD|0|||
144578081|NCT03829501|521317506|FG013|Overall Study|PD|0|||
144578082|NCT03829501|521317507|FG014|Overall Study|PD|0|||
144622180|NCT00720109|521473702|FG000|Risk Stratification Period|Physician Decision|0|||
144622181|NCT00720109|521473703|FG001|Risk Stratification Period|Physician Decision|2|||
144578083|NCT03829501|521317508|FG015|Overall Study|PD|1|||
144578084|NCT03829501|521317509|FG016|Overall Study|PD|0|||
144578085|NCT03829501|521317510|FG017|Overall Study|PD|0|||
144578086|NCT03829501|521317511|FG018|Overall Study|PD|0|||
144578087|NCT03829501|521317512|FG019|Overall Study|PD|0|||
144578088|NCT03829501|521317513|FG020|Overall Study|PD|1|||
144578089|NCT03829501|521317514|FG021|Overall Study|PD|0|||
144578090|NCT03829501|521317515|FG022|Overall Study|PD|0|||
144578091|NCT03829501|521317493|FG000|Overall Study|Study Terminated by Sponsor|0|||
144578092|NCT03829501|521317494|FG001|Overall Study|Study Terminated by Sponsor|0|||
144578093|NCT03829501|521317495|FG002|Overall Study|Study Terminated by Sponsor|0|||
144578094|NCT03829501|521317496|FG003|Overall Study|Study Terminated by Sponsor|0|||
144578095|NCT03829501|521317497|FG004|Overall Study|Study Terminated by Sponsor|0|||
144578096|NCT03829501|521317498|FG005|Overall Study|Study Terminated by Sponsor|0|||
144622182|NCT00720109|521473704|FG002|Risk Stratification Period|Physician Decision|1|||
144578097|NCT03829501|521317499|FG006|Overall Study|Study Terminated by Sponsor|0|||
144578098|NCT03829501|521317500|FG007|Overall Study|Study Terminated by Sponsor|3|||
144578099|NCT03829501|521317501|FG008|Overall Study|Study Terminated by Sponsor|1|||
144578100|NCT03829501|521317502|FG009|Overall Study|Study Terminated by Sponsor|0|||
144578101|NCT03829501|521317503|FG010|Overall Study|Study Terminated by Sponsor|0|||
144578102|NCT03829501|521317504|FG011|Overall Study|Study Terminated by Sponsor|0|||
144578103|NCT03829501|521317505|FG012|Overall Study|Study Terminated by Sponsor|0|||
144578104|NCT03829501|521317506|FG013|Overall Study|Study Terminated by Sponsor|0|||
144578105|NCT03829501|521317507|FG014|Overall Study|Study Terminated by Sponsor|3|||
144578106|NCT03829501|521317508|FG015|Overall Study|Study Terminated by Sponsor|2|||
144578107|NCT03829501|521317509|FG016|Overall Study|Study Terminated by Sponsor|2|||
144578108|NCT03829501|521317510|FG017|Overall Study|Study Terminated by Sponsor|0|||
144578109|NCT03829501|521317511|FG018|Overall Study|Study Terminated by Sponsor|0|||
144578110|NCT03829501|521317512|FG019|Overall Study|Study Terminated by Sponsor|0|||
144578111|NCT03829501|521317513|FG020|Overall Study|Study Terminated by Sponsor|1|||
144578112|NCT03829501|521317514|FG021|Overall Study|Study Terminated by Sponsor|0|||
144578113|NCT03829501|521317515|FG022|Overall Study|Study Terminated by Sponsor|3|||
144578114|NCT03829501|521317493|FG000|Overall Study|Lost to Follow Up|0|||
144578115|NCT03829501|521317494|FG001|Overall Study|Lost to Follow Up|0|||
144578116|NCT03829501|521317495|FG002|Overall Study|Lost to Follow Up|0|||
144578117|NCT03829501|521317496|FG003|Overall Study|Lost to Follow Up|0|||
144578118|NCT03829501|521317497|FG004|Overall Study|Lost to Follow Up|1|||
144578119|NCT03829501|521317498|FG005|Overall Study|Lost to Follow Up|0|||
144578120|NCT03829501|521317499|FG006|Overall Study|Lost to Follow Up|0|||
144578121|NCT03829501|521317500|FG007|Overall Study|Lost to Follow Up|2|||
144578122|NCT03829501|521317501|FG008|Overall Study|Lost to Follow Up|2|||
144578123|NCT03829501|521317502|FG009|Overall Study|Lost to Follow Up|0|||
144578124|NCT03829501|521317503|FG010|Overall Study|Lost to Follow Up|2|||
144578125|NCT03829501|521317504|FG011|Overall Study|Lost to Follow Up|1|||
144578126|NCT03829501|521317505|FG012|Overall Study|Lost to Follow Up|0|||
144578127|NCT03829501|521317506|FG013|Overall Study|Lost to Follow Up|1|||
144578128|NCT03829501|521317507|FG014|Overall Study|Lost to Follow Up|1|||
144578129|NCT03829501|521317508|FG015|Overall Study|Lost to Follow Up|0|||
144578130|NCT03829501|521317509|FG016|Overall Study|Lost to Follow Up|0|||
144578131|NCT03829501|521317510|FG017|Overall Study|Lost to Follow Up|0|||
144578132|NCT03829501|521317511|FG018|Overall Study|Lost to Follow Up|0|||
144578133|NCT03829501|521317512|FG019|Overall Study|Lost to Follow Up|0|||
144578134|NCT03829501|521317513|FG020|Overall Study|Lost to Follow Up|0|||
144578135|NCT03829501|521317514|FG021|Overall Study|Lost to Follow Up|0|||
144578136|NCT03829501|521317515|FG022|Overall Study|Lost to Follow Up|1|||
144578137|NCT03829501|521317493|FG000|Overall Study|Death|2|||
144578138|NCT03829501|521317494|FG001|Overall Study|Death|4|||
144578139|NCT03829501|521317495|FG002|Overall Study|Death|5|||
144578140|NCT03829501|521317496|FG003|Overall Study|Death|6|||
144578141|NCT03829501|521317497|FG004|Overall Study|Death|5|||
144578142|NCT03829501|521317498|FG005|Overall Study|Death|4|||
144578143|NCT03829501|521317499|FG006|Overall Study|Death|5|||
144578144|NCT03829501|521317500|FG007|Overall Study|Death|24|||
144578145|NCT03829501|521317501|FG008|Overall Study|Death|22|||
144578146|NCT03829501|521317502|FG009|Overall Study|Death|6|||
144578147|NCT03829501|521317503|FG010|Overall Study|Death|3|||
144578148|NCT03829501|521317504|FG011|Overall Study|Death|10|||
144578149|NCT03829501|521317505|FG012|Overall Study|Death|10|||
144578150|NCT03829501|521317506|FG013|Overall Study|Death|5|||
144578151|NCT03829501|521317507|FG014|Overall Study|Death|7|||
144578152|NCT03829501|521317508|FG015|Overall Study|Death|2|||
144578153|NCT03829501|521317509|FG016|Overall Study|Death|2|||
144578154|NCT03829501|521317510|FG017|Overall Study|Death|1|||
144730141|NCT00051025|521868153|FG001|Overall Study|Withdrawal by Subject|1|||
144730142|NCT00051025|521868152|FG000|Overall Study|Death|0|||
144578155|NCT03829501|521317511|FG018|Overall Study|Death|1|||
144578156|NCT03829501|521317512|FG019|Overall Study|Death|1|||
144578157|NCT03829501|521317513|FG020|Overall Study|Death|1|||
144578158|NCT03829501|521317514|FG021|Overall Study|Death|2|||
144578159|NCT03829501|521317515|FG022|Overall Study|Death|3|||
144578160|NCT03829501|521317493|FG000|Overall Study|Miscellaneous|0|||
144578161|NCT03829501|521317494|FG001|Overall Study|Miscellaneous|0|||
144578162|NCT03829501|521317495|FG002|Overall Study|Miscellaneous|1|||
144578163|NCT03829501|521317496|FG003|Overall Study|Miscellaneous|0|||
144578164|NCT03829501|521317497|FG004|Overall Study|Miscellaneous|0|||
144730143|NCT00051025|521868153|FG001|Overall Study|Death|1|||
144578165|NCT03829501|521317498|FG005|Overall Study|Miscellaneous|0|||
144578166|NCT03829501|521317499|FG006|Overall Study|Miscellaneous|0|||
144578167|NCT03829501|521317500|FG007|Overall Study|Miscellaneous|1|||
144578168|NCT03829501|521317501|FG008|Overall Study|Miscellaneous|0|||
144578169|NCT03829501|521317502|FG009|Overall Study|Miscellaneous|0|||
144578170|NCT03829501|521317503|FG010|Overall Study|Miscellaneous|0|||
144578171|NCT03829501|521317504|FG011|Overall Study|Miscellaneous|0|||
144578172|NCT03829501|521317505|FG012|Overall Study|Miscellaneous|0|||
144578173|NCT03829501|521317506|FG013|Overall Study|Miscellaneous|0|||
144578174|NCT03829501|521317507|FG014|Overall Study|Miscellaneous|0|||
144578175|NCT03829501|521317508|FG015|Overall Study|Miscellaneous|0|||
144622183|NCT00720109|521473702|FG000|Risk Stratification Period|Bone marrow transplant|0|||
144622184|NCT00720109|521473703|FG001|Risk Stratification Period|Bone marrow transplant|9|||
144622185|NCT00720109|521473704|FG002|Risk Stratification Period|Bone marrow transplant|7|||
144622186|NCT00720109|521473702|FG000|Risk Stratification Period|Disease progression or relapse|0|||
144622187|NCT00720109|521473703|FG001|Risk Stratification Period|Disease progression or relapse|2|||
144622188|NCT00720109|521473704|FG002|Risk Stratification Period|Disease progression or relapse|0|||
144622189|NCT00720109|521473702|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
144622190|NCT00720109|521473703|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
144622191|NCT00720109|521473704|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
144622192|NCT01110200|521473705|FG000|Overall Study|Adverse Event|28|||
144622193|NCT01110200|521473706|FG001|Overall Study|Adverse Event|28|||
144622194|NCT01110200|521473705|FG000|Overall Study|Withdrawal by Subject|25|||
144622195|NCT01110200|521473706|FG001|Overall Study|Withdrawal by Subject|32|||
144622196|NCT01110200|521473705|FG000|Overall Study|Lack of Efficacy|16|||
144622197|NCT01110200|521473706|FG001|Overall Study|Lack of Efficacy|25|||
144622198|NCT01110200|521473705|FG000|Overall Study|Protocol Violation|14|||
144622199|NCT01110200|521473706|FG001|Overall Study|Protocol Violation|12|||
144622200|NCT01110200|521473705|FG000|Overall Study|Physician Decision|13|||
144622201|NCT01110200|521473706|FG001|Overall Study|Physician Decision|17|||
144622202|NCT01110200|521473705|FG000|Overall Study|Lost to Follow-up|10|||
144622203|NCT01110200|521473706|FG001|Overall Study|Lost to Follow-up|7|||
144622204|NCT03467958|521473707|FG000|Overall Study|Adverse Event|20|||
144622205|NCT03467958|521473708|FG001|Overall Study|Adverse Event|32|||
144622206|NCT03467958|521473709|FG002|Overall Study|Adverse Event|5|||
144622207|NCT03467958|521473710|FG003|Overall Study|Adverse Event|3|||
144622208|NCT03467958|521473711|FG004|Overall Study|Adverse Event|3|||
144622209|NCT03467958|521473712|FG005|Overall Study|Adverse Event|3|||
144622210|NCT03467958|521473713|FG006|Overall Study|Adverse Event|6|||
144622211|NCT03467958|521473714|FG007|Overall Study|Adverse Event|5|||
144622212|NCT03467958|521473715|FG008|Overall Study|Adverse Event|0|||
144622213|NCT03467958|521473707|FG000|Overall Study|Lack of Efficacy|59|||
144622214|NCT03467958|521473708|FG001|Overall Study|Lack of Efficacy|120|||
144622215|NCT03467958|521473709|FG002|Overall Study|Lack of Efficacy|6|||
144622216|NCT03467958|521473710|FG003|Overall Study|Lack of Efficacy|9|||
144622217|NCT03467958|521473711|FG004|Overall Study|Lack of Efficacy|8|||
144622218|NCT03467958|521473712|FG005|Overall Study|Lack of Efficacy|9|||
144730144|NCT00150462|521868154|FG000|Overall Study|Disease Progression or Relapse|3|||
144730145|NCT00150462|521868155|FG001|Overall Study|Disease Progression or Relapse|1|||
144730146|NCT00150462|521868156|FG002|Overall Study|Disease Progression or Relapse|2|||
144730147|NCT00150462|521868157|FG003|Overall Study|Disease Progression or Relapse|1|||
144730148|NCT00150462|521868158|FG004|Overall Study|Disease Progression or Relapse|2|||
144730149|NCT00150462|521868159|FG005|Overall Study|Disease Progression or Relapse|2|||
144730150|NCT00150462|521868160|FG006|Overall Study|Disease Progression or Relapse|3|||
144730151|NCT00150462|521868161|FG007|Overall Study|Disease Progression or Relapse|5|||
144730152|NCT00150462|521868162|FG008|Overall Study|Disease Progression or Relapse|5|||
144730153|NCT00150462|521868163|FG009|Overall Study|Disease Progression or Relapse|3|||
144578176|NCT03829501|521317509|FG016|Overall Study|Miscellaneous|0|||
144578177|NCT03829501|521317510|FG017|Overall Study|Miscellaneous|0|||
144578178|NCT03829501|521317511|FG018|Overall Study|Miscellaneous|0|||
144578179|NCT03829501|521317512|FG019|Overall Study|Miscellaneous|0|||
144578180|NCT03829501|521317513|FG020|Overall Study|Miscellaneous|0|||
144578181|NCT03829501|521317514|FG021|Overall Study|Miscellaneous|0|||
144578182|NCT03829501|521317515|FG022|Overall Study|Miscellaneous|1|||
144578183|NCT02964013|521317516|FG000|Overall Study|Death|58|||
144578184|NCT02964013|521317517|FG001|Overall Study|Death|239|||
144578185|NCT02964013|521317518|FG002|Overall Study|Death|38|||
144730154|NCT00150462|521868164|FG010|Overall Study|Disease Progression or Relapse|2|||
144578186|NCT02964013|521317519|FG003|Overall Study|Death|10|||
144578187|NCT02964013|521317520|FG004|Overall Study|Death|33|||
144622219|NCT03467958|521473713|FG006|Overall Study|Lack of Efficacy|11|||
144622220|NCT03467958|521473714|FG007|Overall Study|Lack of Efficacy|9|||
144622221|NCT03467958|521473715|FG008|Overall Study|Lack of Efficacy|3|||
144622222|NCT03467958|521473707|FG000|Overall Study|Lost to Follow-up|1|||
144730155|NCT00150462|521868154|FG000|Overall Study|Withdrawal by Subject|0|||
144207468|NCT01439009|519954321|FG000|Overall Study|Physician Decision|5|||
144622223|NCT03467958|521473708|FG001|Overall Study|Lost to Follow-up|2|||
144207469|NCT01439009|519954322|FG001|Overall Study|Physician Decision|3|||
144578188|NCT02964013|521317516|FG000|Overall Study|Lost to Follow-up|1|||
144622224|NCT03467958|521473709|FG002|Overall Study|Lost to Follow-up|1|||
144730156|NCT00150462|521868155|FG001|Overall Study|Withdrawal by Subject|1|||
144207470|NCT01439009|519954321|FG000|Overall Study|Protocol Violation|2|||
144622225|NCT03467958|521473710|FG003|Overall Study|Lost to Follow-up|0|||
144622226|NCT03467958|521473711|FG004|Overall Study|Lost to Follow-up|4|||
144578189|NCT02964013|521317517|FG001|Overall Study|Lost to Follow-up|4|||
144578190|NCT02964013|521317518|FG002|Overall Study|Lost to Follow-up|2|||
144622227|NCT03467958|521473712|FG005|Overall Study|Lost to Follow-up|0|||
144622228|NCT03467958|521473713|FG006|Overall Study|Lost to Follow-up|0|||
144578191|NCT02964013|521317519|FG003|Overall Study|Lost to Follow-up|0|||
144578192|NCT02964013|521317520|FG004|Overall Study|Lost to Follow-up|0|||
144578193|NCT02964013|521317516|FG000|Overall Study|Physician Decision|0|||
144578194|NCT02964013|521317517|FG001|Overall Study|Physician Decision|1|||
144578195|NCT02964013|521317518|FG002|Overall Study|Physician Decision|0|||
144578196|NCT02964013|521317519|FG003|Overall Study|Physician Decision|0|||
144578197|NCT02964013|521317520|FG004|Overall Study|Physician Decision|0|||
144578198|NCT02964013|521317516|FG000|Overall Study|Sponsor Decision|3|||
144578199|NCT02964013|521317517|FG001|Overall Study|Sponsor Decision|22|||
144578200|NCT02964013|521317518|FG002|Overall Study|Sponsor Decision|11|||
144578201|NCT02964013|521317519|FG003|Overall Study|Sponsor Decision|0|||
144578202|NCT02964013|521317520|FG004|Overall Study|Sponsor Decision|7|||
144578203|NCT02964013|521317516|FG000|Overall Study|Withdrawal by Subject|6|||
144578204|NCT02964013|521317517|FG001|Overall Study|Withdrawal by Subject|27|||
144578205|NCT02964013|521317518|FG002|Overall Study|Withdrawal by Subject|9|||
144578206|NCT02964013|521317519|FG003|Overall Study|Withdrawal by Subject|0|||
144578207|NCT02964013|521317520|FG004|Overall Study|Withdrawal by Subject|0|||
144578208|NCT02964013|521317516|FG000|Overall Study|Not Treated|0|||
144578209|NCT02964013|521317517|FG001|Overall Study|Not Treated|2|||
144578210|NCT02964013|521317518|FG002|Overall Study|Not Treated|0|||
144578211|NCT02964013|521317519|FG003|Overall Study|Not Treated|1|||
144578212|NCT02964013|521317520|FG004|Overall Study|Not Treated|0|||
144578213|NCT00747227|521317527|FG000|Overall Study|Death|3|||
144578214|NCT00747227|521317528|FG001|Overall Study|Death|1|||
144578215|NCT00747227|521317527|FG000|Overall Study|Withdrawal by Subject|1|||
144578216|NCT00747227|521317528|FG001|Overall Study|Withdrawal by Subject|0|||
144578217|NCT00747227|521317527|FG000|Overall Study|Lost to Follow-up|1|||
144578218|NCT00747227|521317528|FG001|Overall Study|Lost to Follow-up|2|||
144578219|NCT00747227|521317527|FG000|Overall Study|Illness|1|||
144578220|NCT00747227|521317528|FG001|Overall Study|Illness|1|||
144578221|NCT03284229|521317529|FG000|Overall Study|Lost to Follow-up|3|||
144578222|NCT00663702|521317532|FG000|Overall Study|Adverse Event|8|||
144578223|NCT00663702|521317533|FG001|Overall Study|Adverse Event|4|||
144578224|NCT00663702|521317532|FG000|Overall Study|Withdrawal by Subject|3|||
144578225|NCT00663702|521317533|FG001|Overall Study|Withdrawal by Subject|1|||
144578226|NCT00663702|521317532|FG000|Overall Study|Pregnancy|0|||
144578227|NCT00663702|521317533|FG001|Overall Study|Pregnancy|1|||
144578228|NCT00663702|521317532|FG000|Overall Study|Lost to Follow-up|3|||
144578229|NCT00663702|521317533|FG001|Overall Study|Lost to Follow-up|0|||
144578230|NCT00663702|521317532|FG000|Overall Study|Death|1|||
144578231|NCT00663702|521317533|FG001|Overall Study|Death|1|||
144578232|NCT00663702|521317532|FG000|Overall Study|Lack of Efficacy|3|||
144578233|NCT00663702|521317533|FG001|Overall Study|Lack of Efficacy|3|||
144578234|NCT02993406|521317540|FG000|Overall Study|Withdrawal by Subject|170|||
144578235|NCT02993406|521317541|FG001|Overall Study|Withdrawal by Subject|196|||
144578236|NCT02993406|521317540|FG000|Overall Study|Physician Decision|3|||
144578237|NCT02993406|521317541|FG001|Overall Study|Physician Decision|5|||
144578238|NCT02993406|521317540|FG000|Overall Study|Lost to Follow-up|12|||
144578239|NCT02993406|521317541|FG001|Overall Study|Lost to Follow-up|13|||
144578240|NCT02993406|521317540|FG000|Overall Study|Unclassifiable Response|105|||
144578241|NCT02993406|521317541|FG001|Overall Study|Unclassifiable Response|139|||
144578242|NCT02993406|521317540|FG000|Overall Study|Administrative decision|1|||
144578243|NCT02993406|521317541|FG001|Overall Study|Administrative decision|0|||
144578244|NCT02993406|521317540|FG000|Overall Study|Sponsor decision|4|||
144578245|NCT02993406|521317541|FG001|Overall Study|Sponsor decision|5|||
144578246|NCT02248818|521317542|FG000|Screening|Protocol Violation|0|||
144578247|NCT02248818|521317543|FG001|Screening|Protocol Violation|0|||
144578248|NCT02248818|521317544|FG002|Screening|Protocol Violation|0|||
144578249|NCT02248818|521317545|FG003|Screening|Protocol Violation|0|||
144578250|NCT02248818|521317546|FG004|Screening|Protocol Violation|0|||
144578251|NCT02248818|521317547|FG005|Screening|Protocol Violation|0|||
144578252|NCT02248818|521317548|FG006|Screening|Protocol Violation|0|||
144578253|NCT02248818|521317549|FG007|Screening|Protocol Violation|0|||
144578254|NCT02248818|521317550|FG008|Screening|Protocol Violation|7|||
144578255|NCT02248818|521317542|FG000|Screening|Study fully enrolled|0|||
144578256|NCT02248818|521317543|FG001|Screening|Study fully enrolled|0|||
144578257|NCT02248818|521317544|FG002|Screening|Study fully enrolled|0|||
144578258|NCT02248818|521317545|FG003|Screening|Study fully enrolled|0|||
144578259|NCT02248818|521317546|FG004|Screening|Study fully enrolled|0|||
144578260|NCT02248818|521317547|FG005|Screening|Study fully enrolled|0|||
144578261|NCT02248818|521317548|FG006|Screening|Study fully enrolled|0|||
144578262|NCT02248818|521317549|FG007|Screening|Study fully enrolled|0|||
144578263|NCT02248818|521317550|FG008|Screening|Study fully enrolled|14|||
144578264|NCT02248818|521317542|FG000|Screening|Physician Decision|0|||
144578265|NCT02248818|521317543|FG001|Screening|Physician Decision|0|||
144578266|NCT02248818|521317544|FG002|Screening|Physician Decision|0|||
144578267|NCT02248818|521317545|FG003|Screening|Physician Decision|0|||
144207471|NCT01439009|519954322|FG001|Overall Study|Protocol Violation|0|||
144578268|NCT02248818|521317546|FG004|Screening|Physician Decision|0|||
144578269|NCT02248818|521317547|FG005|Screening|Physician Decision|0|||
144578270|NCT02248818|521317548|FG006|Screening|Physician Decision|0|||
144578271|NCT02248818|521317549|FG007|Screening|Physician Decision|0|||
144578272|NCT02248818|521317550|FG008|Screening|Physician Decision|73|||
144578273|NCT02248818|521317542|FG000|Screening|Withdrawal by Subject|0|||
144578274|NCT02248818|521317543|FG001|Screening|Withdrawal by Subject|0|||
144578275|NCT02248818|521317544|FG002|Screening|Withdrawal by Subject|0|||
144578276|NCT02248818|521317545|FG003|Screening|Withdrawal by Subject|0|||
144578277|NCT02248818|521317546|FG004|Screening|Withdrawal by Subject|0|||
144578278|NCT02248818|521317547|FG005|Screening|Withdrawal by Subject|0|||
144578279|NCT02248818|521317548|FG006|Screening|Withdrawal by Subject|0|||
144578280|NCT02248818|521317549|FG007|Screening|Withdrawal by Subject|0|||
144578281|NCT02248818|521317550|FG008|Screening|Withdrawal by Subject|6|||
144578282|NCT02248818|521317542|FG000|Screening|Lost to Follow-up|0|||
144578283|NCT02248818|521317543|FG001|Screening|Lost to Follow-up|0|||
144578284|NCT02248818|521317544|FG002|Screening|Lost to Follow-up|0|||
144578285|NCT02248818|521317545|FG003|Screening|Lost to Follow-up|0|||
144578286|NCT02248818|521317546|FG004|Screening|Lost to Follow-up|0|||
144578287|NCT02248818|521317547|FG005|Screening|Lost to Follow-up|0|||
144578288|NCT02248818|521317548|FG006|Screening|Lost to Follow-up|0|||
144578289|NCT02248818|521317549|FG007|Screening|Lost to Follow-up|0|||
144578290|NCT02248818|521317550|FG008|Screening|Lost to Follow-up|7|||
144578291|NCT02248818|521317542|FG000|Randomised Study|Administrative - randomization error|0|||
144578292|NCT02248818|521317543|FG001|Randomised Study|Administrative - randomization error|0|||
144578293|NCT02248818|521317544|FG002|Randomised Study|Administrative - randomization error|0|||
144578294|NCT02248818|521317545|FG003|Randomised Study|Administrative - randomization error|0|||
144578295|NCT02248818|521317546|FG004|Randomised Study|Administrative - randomization error|0|||
144578296|NCT02248818|521317547|FG005|Randomised Study|Administrative - randomization error|8|||
144578297|NCT02248818|521317548|FG006|Randomised Study|Administrative - randomization error|0|||
144578298|NCT02248818|521317549|FG007|Randomised Study|Administrative - randomization error|0|||
144578299|NCT02248818|521317550|FG008|Randomised Study|Administrative - randomization error|0|||
144578300|NCT01283152|521317551|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
144578301|NCT01283152|521317552|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
144578302|NCT01283152|521317551|FG000|Overall Study|Refused HESA|1|||
144578303|NCT01283152|521317552|FG001|Overall Study|Refused HESA|0|||
144578304|NCT00626197|521317555|FG000|Overall Study|Did not cooperate|2|||
144578305|NCT00626197|521317556|FG001|Overall Study|Did not cooperate|6|||
144578306|NCT00626197|521317557|FG002|Overall Study|Did not cooperate|1|||
144578307|NCT00626197|521317555|FG000|Overall Study|Failure to return|6|||
144578308|NCT00626197|521317556|FG001|Overall Study|Failure to return|5|||
144578309|NCT00626197|521317557|FG002|Overall Study|Failure to return|6|||
144578310|NCT00626197|521317555|FG000|Overall Study|Adverse event, serious fatal|3|||
144578311|NCT00626197|521317556|FG001|Overall Study|Adverse event, serious fatal|6|||
144578312|NCT00626197|521317557|FG002|Overall Study|Adverse event, serious fatal|6|||
144578313|NCT00626197|521317555|FG000|Overall Study|Adverse Event|1|||
144578314|NCT00626197|521317556|FG001|Overall Study|Adverse Event|1|||
144578315|NCT00626197|521317557|FG002|Overall Study|Adverse Event|2|||
144578316|NCT00626197|521317555|FG000|Overall Study|Withdrawal by Subject|17|||
144578317|NCT00626197|521317556|FG001|Overall Study|Withdrawal by Subject|17|||
144578318|NCT00626197|521317557|FG002|Overall Study|Withdrawal by Subject|7|||
144578319|NCT00626197|521317555|FG000|Overall Study|Administrative reasons|15|||
144578320|NCT00626197|521317556|FG001|Overall Study|Administrative reasons|19|||
144578321|NCT00626197|521317557|FG002|Overall Study|Administrative reasons|55|||
144578322|NCT00461981|521317564|FG000|Overall Study|Lost to Follow-up|9|||
144578323|NCT00461981|521317565|FG001|Overall Study|Lost to Follow-up|6|||
144578324|NCT00461981|521317564|FG000|Overall Study|Withdrawal by Subject|2|||
144578325|NCT00461981|521317565|FG001|Overall Study|Withdrawal by Subject|3|||
144578326|NCT01077128|521317571|FG000|Overall Study|Adverse Event|8|||
144578327|NCT01077128|521317571|FG000|Overall Study|Lack of Efficacy|1|||
144578328|NCT01077128|521317571|FG000|Overall Study|Disease exacerbation|1|||
144578329|NCT01077128|521317571|FG000|Overall Study|Adverse event and consent withdrawal|1|||
144578330|NCT01077128|521317571|FG000|Overall Study|Adverse event and disease exacerbation|1|||
144578331|NCT01077128|521317571|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
144578332|NCT01077128|521317571|FG000|Overall Study|Other|54|||
144578333|NCT00847626|521317572|FG000|Overall Study|Adverse Event|10|||
144578334|NCT00847626|521317573|FG001|Overall Study|Adverse Event|10|||
144578335|NCT00847626|521317574|FG002|Overall Study|Adverse Event|6|||
144578336|NCT00847626|521317575|FG003|Overall Study|Adverse Event|19|||
144578337|NCT00847626|521317576|FG004|Overall Study|Adverse Event|11|||
144578338|NCT00847626|521317577|FG005|Overall Study|Adverse Event|22|||
144578339|NCT00847626|521317578|FG006|Overall Study|Adverse Event|4|||
144578340|NCT00847626|521317579|FG007|Overall Study|Adverse Event|6|||
144578341|NCT00847626|521317580|FG008|Overall Study|Adverse Event|3|||
144578342|NCT00847626|521317581|FG009|Overall Study|Adverse Event|6|||
144578343|NCT00847626|521317582|FG010|Overall Study|Adverse Event|6|||
144578344|NCT00847626|521317572|FG000|Overall Study|Protocol Violation|2|||
144578345|NCT00847626|521317573|FG001|Overall Study|Protocol Violation|1|||
144578346|NCT00847626|521317574|FG002|Overall Study|Protocol Violation|2|||
144578347|NCT00847626|521317575|FG003|Overall Study|Protocol Violation|1|||
144622229|NCT03467958|521473714|FG007|Overall Study|Lost to Follow-up|0|||
144622230|NCT03467958|521473715|FG008|Overall Study|Lost to Follow-up|0|||
144622231|NCT03467958|521473707|FG000|Overall Study|Other reasons|8|||
144622232|NCT03467958|521473708|FG001|Overall Study|Other reasons|14|||
144622233|NCT03467958|521473709|FG002|Overall Study|Other reasons|2|||
144622234|NCT03467958|521473710|FG003|Overall Study|Other reasons|1|||
144622235|NCT03467958|521473711|FG004|Overall Study|Other reasons|4|||
144622236|NCT03467958|521473712|FG005|Overall Study|Other reasons|0|||
144622237|NCT03467958|521473713|FG006|Overall Study|Other reasons|1|||
144622238|NCT03467958|521473714|FG007|Overall Study|Other reasons|0|||
144622239|NCT03467958|521473715|FG008|Overall Study|Other reasons|1|||
144622240|NCT03467958|521473707|FG000|Overall Study|Pregnancy|1|||
144622241|NCT03467958|521473708|FG001|Overall Study|Pregnancy|0|||
144622242|NCT03467958|521473709|FG002|Overall Study|Pregnancy|0|||
144622243|NCT03467958|521473710|FG003|Overall Study|Pregnancy|0|||
144622244|NCT03467958|521473711|FG004|Overall Study|Pregnancy|0|||
144622245|NCT03467958|521473712|FG005|Overall Study|Pregnancy|1|||
144622246|NCT03467958|521473713|FG006|Overall Study|Pregnancy|0|||
144622247|NCT03467958|521473714|FG007|Overall Study|Pregnancy|0|||
144622248|NCT03467958|521473715|FG008|Overall Study|Pregnancy|0|||
144622249|NCT03467958|521473707|FG000|Overall Study|Study terminated by sponsor|65|||
144622250|NCT03467958|521473708|FG001|Overall Study|Study terminated by sponsor|117|||
144622251|NCT03467958|521473709|FG002|Overall Study|Study terminated by sponsor|45|||
144622252|NCT03467958|521473710|FG003|Overall Study|Study terminated by sponsor|64|||
144578348|NCT00847626|521317576|FG004|Overall Study|Protocol Violation|1|||
144578349|NCT00847626|521317577|FG005|Overall Study|Protocol Violation|1|||
144578350|NCT00847626|521317578|FG006|Overall Study|Protocol Violation|1|||
144578351|NCT00847626|521317579|FG007|Overall Study|Protocol Violation|1|||
144578352|NCT00847626|521317580|FG008|Overall Study|Protocol Violation|0|||
144578353|NCT00847626|521317581|FG009|Overall Study|Protocol Violation|1|||
144578354|NCT00847626|521317582|FG010|Overall Study|Protocol Violation|1|||
144578355|NCT00847626|521317572|FG000|Overall Study|Lost to Follow-up|0|||
144578356|NCT00847626|521317573|FG001|Overall Study|Lost to Follow-up|1|||
144578357|NCT00847626|521317574|FG002|Overall Study|Lost to Follow-up|1|||
144578358|NCT00847626|521317575|FG003|Overall Study|Lost to Follow-up|1|||
144578359|NCT00847626|521317576|FG004|Overall Study|Lost to Follow-up|0|||
144578360|NCT00847626|521317577|FG005|Overall Study|Lost to Follow-up|3|||
144578361|NCT00847626|521317578|FG006|Overall Study|Lost to Follow-up|1|||
144578362|NCT00847626|521317579|FG007|Overall Study|Lost to Follow-up|3|||
144578363|NCT00847626|521317580|FG008|Overall Study|Lost to Follow-up|1|||
144578364|NCT00847626|521317581|FG009|Overall Study|Lost to Follow-up|0|||
144578365|NCT00847626|521317582|FG010|Overall Study|Lost to Follow-up|1|||
144578366|NCT00847626|521317572|FG000|Overall Study|Withdrawal by Subject|5|||
144578367|NCT00847626|521317573|FG001|Overall Study|Withdrawal by Subject|5|||
144578368|NCT00847626|521317574|FG002|Overall Study|Withdrawal by Subject|3|||
144578369|NCT00847626|521317575|FG003|Overall Study|Withdrawal by Subject|8|||
144578370|NCT00847626|521317576|FG004|Overall Study|Withdrawal by Subject|12|||
144578371|NCT00847626|521317577|FG005|Overall Study|Withdrawal by Subject|9|||
144578372|NCT00847626|521317578|FG006|Overall Study|Withdrawal by Subject|8|||
144578373|NCT00847626|521317579|FG007|Overall Study|Withdrawal by Subject|4|||
144578374|NCT00847626|521317580|FG008|Overall Study|Withdrawal by Subject|4|||
144578375|NCT00847626|521317581|FG009|Overall Study|Withdrawal by Subject|5|||
144578376|NCT00847626|521317582|FG010|Overall Study|Withdrawal by Subject|2|||
144578377|NCT00847626|521317572|FG000|Overall Study|Lack of Efficacy|3|||
144578378|NCT00847626|521317573|FG001|Overall Study|Lack of Efficacy|1|||
144578379|NCT00847626|521317574|FG002|Overall Study|Lack of Efficacy|0|||
144622253|NCT03467958|521473711|FG004|Overall Study|Study terminated by sponsor|66|||
144622254|NCT03467958|521473712|FG005|Overall Study|Study terminated by sponsor|17|||
144622255|NCT03467958|521473713|FG006|Overall Study|Study terminated by sponsor|11|||
144622256|NCT03467958|521473714|FG007|Overall Study|Study terminated by sponsor|5|||
144622257|NCT03467958|521473715|FG008|Overall Study|Study terminated by sponsor|5|||
144622258|NCT03467958|521473707|FG000|Overall Study|Withdrawal by Subject|25|||
144622259|NCT03467958|521473708|FG001|Overall Study|Withdrawal by Subject|44|||
144622260|NCT03467958|521473709|FG002|Overall Study|Withdrawal by Subject|7|||
144578380|NCT00847626|521317575|FG003|Overall Study|Lack of Efficacy|1|||
144578381|NCT00847626|521317576|FG004|Overall Study|Lack of Efficacy|2|||
144578382|NCT00847626|521317577|FG005|Overall Study|Lack of Efficacy|0|||
144622261|NCT03467958|521473710|FG003|Overall Study|Withdrawal by Subject|8|||
144622262|NCT03467958|521473711|FG004|Overall Study|Withdrawal by Subject|6|||
144622263|NCT03467958|521473712|FG005|Overall Study|Withdrawal by Subject|8|||
144578383|NCT00847626|521317578|FG006|Overall Study|Lack of Efficacy|6|||
144578384|NCT00847626|521317579|FG007|Overall Study|Lack of Efficacy|2|||
144578385|NCT00847626|521317580|FG008|Overall Study|Lack of Efficacy|5|||
144578386|NCT00847626|521317581|FG009|Overall Study|Lack of Efficacy|1|||
144578387|NCT00847626|521317582|FG010|Overall Study|Lack of Efficacy|7|||
144622264|NCT03467958|521473713|FG006|Overall Study|Withdrawal by Subject|4|||
144622265|NCT03467958|521473714|FG007|Overall Study|Withdrawal by Subject|1|||
144622266|NCT03467958|521473715|FG008|Overall Study|Withdrawal by Subject|4|||
144622267|NCT00866307|521473716|FG000|Induction|Adverse Event|5|||
144622268|NCT00866307|521473717|FG001|Induction|Adverse Event|0|||
144578388|NCT00847626|521317572|FG000|Overall Study|Other|1|||
144578389|NCT00847626|521317573|FG001|Overall Study|Other|5|||
144578390|NCT00847626|521317574|FG002|Overall Study|Other|4|||
144578391|NCT00847626|521317575|FG003|Overall Study|Other|1|||
144578392|NCT00847626|521317576|FG004|Overall Study|Other|2|||
144578393|NCT00847626|521317577|FG005|Overall Study|Other|2|||
144578394|NCT00847626|521317578|FG006|Overall Study|Other|2|||
144578395|NCT00847626|521317579|FG007|Overall Study|Other|3|||
144578396|NCT00847626|521317580|FG008|Overall Study|Other|1|||
144578397|NCT00847626|521317581|FG009|Overall Study|Other|1|||
144578398|NCT00847626|521317582|FG010|Overall Study|Other|3|||
144578399|NCT03809039|521317583|FG000|Part 1|Withdrawal by Subject|1|||
144578400|NCT03809039|521317584|FG001|Part 1|Withdrawal by Subject|0|||
144578401|NCT03809039|521317585|FG002|Part 1|Withdrawal by Subject|0|||
144578402|NCT03809039|521317586|FG003|Part 1|Withdrawal by Subject|1|||
144578403|NCT03809039|521317587|FG004|Part 1|Withdrawal by Subject|0|||
144578404|NCT03809039|521317588|FG005|Part 1|Withdrawal by Subject|0|||
144578405|NCT03809039|521317589|FG006|Part 1|Withdrawal by Subject|0|||
144578406|NCT03809039|521317590|FG007|Part 1|Withdrawal by Subject|0|||
144578407|NCT03809039|521317591|FG008|Part 1|Withdrawal by Subject|0|||
144578408|NCT03809039|521317583|FG000|Part 3|Withdrawn by study termination|0|||
144578409|NCT03809039|521317584|FG001|Part 3|Withdrawn by study termination|0|||
144578410|NCT03809039|521317585|FG002|Part 3|Withdrawn by study termination|0|||
144578411|NCT03809039|521317586|FG003|Part 3|Withdrawn by study termination|0|||
144578412|NCT03809039|521317587|FG004|Part 3|Withdrawn by study termination|0|||
144578413|NCT03809039|521317588|FG005|Part 3|Withdrawn by study termination|0|||
144578414|NCT03809039|521317589|FG006|Part 3|Withdrawn by study termination|0|||
144578415|NCT03809039|521317590|FG007|Part 3|Withdrawn by study termination|2|||
144578416|NCT03809039|521317591|FG008|Part 3|Withdrawn by study termination|6|||
144578417|NCT02476175|521317596|FG000|Overall Study|Adverse Event|2|||
144578418|NCT03031496|521317597|FG000|Period 1|Adverse Event|2|||
144578419|NCT03031496|521317598|FG001|Period 1|Adverse Event|0|||
144578420|NCT03031496|521317597|FG000|Period 1|Withdrawal by Subject|0|||
144578421|NCT03031496|521317598|FG001|Period 1|Withdrawal by Subject|2|||
144578422|NCT02979249|521317600|FG000|Overall Study|Lost to Follow-up|2|||
144578423|NCT02979249|521317600|FG000|Overall Study|Withdrawal by Subject|4|||
144578424|NCT03868787|521317601|FG000|Overall Study|Withdrawal by Subject|2|||
144578425|NCT03868787|521317602|FG001|Overall Study|Withdrawal by Subject|1|||
144578426|NCT01399697|521317603|FG000|Overall Study|Adverse Event|13|||
144578427|NCT01399697|521317604|FG001|Overall Study|Adverse Event|3|||
144578428|NCT01399697|521317605|FG002|Overall Study|Adverse Event|1|||
144578429|NCT01399697|521317603|FG000|Overall Study|Lost to Follow-up|2|||
144578430|NCT01399697|521317604|FG001|Overall Study|Lost to Follow-up|0|||
144578431|NCT01399697|521317605|FG002|Overall Study|Lost to Follow-up|0|||
144578432|NCT01399697|521317603|FG000|Overall Study|Withdrawal by Subject|8|||
144578433|NCT01399697|521317604|FG001|Overall Study|Withdrawal by Subject|0|||
144578434|NCT01399697|521317605|FG002|Overall Study|Withdrawal by Subject|0|||
144578435|NCT01399697|521317603|FG000|Overall Study|Investigator Decisión|1|||
144578436|NCT01399697|521317604|FG001|Overall Study|Investigator Decisión|0|||
144578437|NCT01399697|521317605|FG002|Overall Study|Investigator Decisión|2|||
144578438|NCT01399697|521317603|FG000|Overall Study|Lack of Efficacy|9|||
144578439|NCT01399697|521317604|FG001|Overall Study|Lack of Efficacy|0|||
144578440|NCT01399697|521317605|FG002|Overall Study|Lack of Efficacy|1|||
144578441|NCT01399697|521317603|FG000|Overall Study|Protocol Violation|2|||
144578442|NCT01399697|521317604|FG001|Overall Study|Protocol Violation|0|||
144578443|NCT01399697|521317605|FG002|Overall Study|Protocol Violation|0|||
144578444|NCT01399697|521317603|FG000|Overall Study|Non-Compliant|1|||
144578445|NCT01399697|521317604|FG001|Overall Study|Non-Compliant|0|||
144578446|NCT01399697|521317605|FG002|Overall Study|Non-Compliant|0|||
144578447|NCT01399697|521317603|FG000|Overall Study|Inclusion Error|2|||
144578448|NCT01399697|521317604|FG001|Overall Study|Inclusion Error|0|||
144578449|NCT01399697|521317605|FG002|Overall Study|Inclusion Error|0|||
144578450|NCT01399697|521317603|FG000|Overall Study|Positive result for hepatitis B|1|||
144578451|NCT01399697|521317604|FG001|Overall Study|Positive result for hepatitis B|0|||
144578452|NCT01399697|521317605|FG002|Overall Study|Positive result for hepatitis B|0|||
144578453|NCT01399697|521317603|FG000|Overall Study|Clinical RA remission|1|||
144578454|NCT01399697|521317604|FG001|Overall Study|Clinical RA remission|0|||
144578455|NCT01399697|521317605|FG002|Overall Study|Clinical RA remission|0|||
144578456|NCT01399697|521317603|FG000|Overall Study|Sponsor Decision|1|||
144578457|NCT01399697|521317604|FG001|Overall Study|Sponsor Decision|0|||
144578458|NCT01399697|521317605|FG002|Overall Study|Sponsor Decision|0|||
144578459|NCT02510040|521317606|FG000|Overall Study|Deemed no longer eligible|18|||
144578460|NCT02510040|521317607|FG001|Overall Study|Deemed no longer eligible|3|||
144578461|NCT02510040|521317608|FG002|Overall Study|Deemed no longer eligible|1|||
144578462|NCT00967005|521317612|FG000|Overall Study|Lost to Follow-up|7|||
144578463|NCT00967005|521317613|FG001|Overall Study|Lost to Follow-up|10|||
144622269|NCT00866307|521473718|FG002|Induction|Adverse Event|0|||
144622270|NCT00866307|521473716|FG000|Induction|Death|2|||
144578464|NCT01289210|521317616|FG000|Overall Study|Adverse Event|1|||
144578465|NCT01818531|521317619|FG000|Overall Study|Withdrawn for case delay after block|1|||
144578466|NCT01818531|521317620|FG001|Overall Study|Withdrawn for case delay after block|0|||
144578467|NCT01818531|521317619|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
144578468|NCT01818531|521317620|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
144578469|NCT01818531|521317619|FG000|Overall Study|Withdrawn for failure to place block|0|||
144578470|NCT01818531|521317620|FG001|Overall Study|Withdrawn for failure to place block|1|||
144578471|NCT03552523|521317623|FG000|Overall Study|Withdrawal by Subject|1|||
144578472|NCT03552523|521317624|FG001|Overall Study|Withdrawal by Subject|1|||
144578473|NCT00604708|521317625|FG000|Overall Study|Withdrawal by Subject|9|||
144578474|NCT00604708|521317626|FG001|Overall Study|Withdrawal by Subject|10|||
144578475|NCT00604708|521317625|FG000|Overall Study|Protocol Violation|2|||
144578476|NCT00604708|521317626|FG001|Overall Study|Protocol Violation|8|||
144578477|NCT00604708|521317625|FG000|Overall Study|Lost to Follow-up|5|||
144578478|NCT00604708|521317626|FG001|Overall Study|Lost to Follow-up|5|||
144578479|NCT00604708|521317625|FG000|Overall Study|administrative reasons|9|||
144578480|NCT00604708|521317626|FG001|Overall Study|administrative reasons|11|||
144578481|NCT00604708|521317625|FG000|Overall Study|Adverse Event|6|||
144578482|NCT00604708|521317626|FG001|Overall Study|Adverse Event|6|||
144578483|NCT02202785|521317627|FG000|Overall Study|Study Terminated by Sponsor|1|||
144578484|NCT02202785|521317628|FG001|Overall Study|Study Terminated by Sponsor|6|||
144578485|NCT02202785|521317629|FG002|Overall Study|Study Terminated by Sponsor|4|||
144578486|NCT02202785|521317627|FG000|Overall Study|Withdrawal by Subject|0|||
144578487|NCT02202785|521317628|FG001|Overall Study|Withdrawal by Subject|1|||
144578488|NCT02202785|521317629|FG002|Overall Study|Withdrawal by Subject|0|||
144578489|NCT02202785|521317627|FG000|Overall Study|Lost to Follow-up|0|||
144578490|NCT02202785|521317628|FG001|Overall Study|Lost to Follow-up|1|||
144578491|NCT02202785|521317629|FG002|Overall Study|Lost to Follow-up|0|||
144578492|NCT02202785|521317627|FG000|Overall Study|Reason not Specified|10|||
144578493|NCT02202785|521317628|FG001|Overall Study|Reason not Specified|7|||
144578494|NCT02202785|521317629|FG002|Overall Study|Reason not Specified|13|||
144578495|NCT02180243|521317630|FG000|Overall Study|Withdrawal by Subject|12|||
144578496|NCT02180243|521317631|FG001|Overall Study|Withdrawal by Subject|12|||
144578497|NCT02180243|521317630|FG000|Overall Study|Lost to Follow-up|12|||
144578498|NCT02180243|521317631|FG001|Overall Study|Lost to Follow-up|2|||
144578499|NCT01647542|521317632|FG000|Overall Study|Major Protocol Deviation|1|||
144578500|NCT01647542|521317633|FG001|Overall Study|Major Protocol Deviation|0|||
144578501|NCT01647542|521317634|FG002|Overall Study|Major Protocol Deviation|0|||
144578502|NCT01647542|521317632|FG000|Overall Study|Adverse Event|4|||
144578503|NCT01647542|521317633|FG001|Overall Study|Adverse Event|5|||
144578504|NCT01647542|521317634|FG002|Overall Study|Adverse Event|4|||
144578505|NCT01647542|521317632|FG000|Overall Study|Lost to Follow-up|0|||
144578506|NCT01647542|521317633|FG001|Overall Study|Lost to Follow-up|2|||
144578507|NCT01647542|521317634|FG002|Overall Study|Lost to Follow-up|2|||
144578508|NCT01647542|521317632|FG000|Overall Study|Withdrawal by Subject|6|||
144578509|NCT01647542|521317633|FG001|Overall Study|Withdrawal by Subject|4|||
144578510|NCT01647542|521317634|FG002|Overall Study|Withdrawal by Subject|0|||
144578511|NCT01647542|521317632|FG000|Overall Study|Study Termination|64|||
144578512|NCT01647542|521317633|FG001|Overall Study|Study Termination|61|||
144578513|NCT01647542|521317634|FG002|Overall Study|Study Termination|65|||
144578514|NCT01647542|521317632|FG000|Overall Study|Lack of Efficacy|1|||
144578515|NCT01647542|521317633|FG001|Overall Study|Lack of Efficacy|1|||
144578516|NCT01647542|521317634|FG002|Overall Study|Lack of Efficacy|0|||
144578517|NCT01647542|521317632|FG000|Overall Study|Death|0|||
144578518|NCT01647542|521317633|FG001|Overall Study|Death|0|||
144578519|NCT01647542|521317634|FG002|Overall Study|Death|1|||
144578520|NCT05292586|521317635|FG000|Overall Study|Withdrawal by Subject|3|||
144578521|NCT05292586|521317636|FG001|Overall Study|Withdrawal by Subject|10|||
144578522|NCT05292586|521317635|FG000|Overall Study|Randomization error|3|||
144578523|NCT05292586|521317636|FG001|Overall Study|Randomization error|7|||
144578524|NCT05292586|521317635|FG000|Overall Study|Adverse Event|3|||
144578525|NCT05292586|521317636|FG001|Overall Study|Adverse Event|0|||
144578526|NCT05292586|521317635|FG000|Overall Study|Lost to Follow-up|0|||
144578527|NCT05292586|521317636|FG001|Overall Study|Lost to Follow-up|1|||
144578528|NCT05292586|521317635|FG000|Overall Study|Patient refused treatment|1|||
144578529|NCT05292586|521317636|FG001|Overall Study|Patient refused treatment|0|||
144578530|NCT05292586|521317635|FG000|Overall Study|Patient could not travel to the study site|1|||
144578531|NCT05292586|521317636|FG001|Overall Study|Patient could not travel to the study site|0|||
144578532|NCT05292586|521317635|FG000|Overall Study|Technical issues with the masterscope|0|||
144578533|NCT05292586|521317636|FG001|Overall Study|Technical issues with the masterscope|3|||
144578534|NCT05292586|521317635|FG000|Overall Study|Patient moved to a different state|0|||
144578535|NCT05292586|521317636|FG001|Overall Study|Patient moved to a different state|1|||
144578536|NCT01040169|521317650|FG000|Overall Study|Lost to Follow-up|3|||
144578537|NCT01040169|521317651|FG001|Overall Study|Lost to Follow-up|8|||
144578538|NCT03551691|521317652|FG000|Overall Study|Withdrawal by Subject|3|||
144578539|NCT03551691|521317653|FG001|Overall Study|Withdrawal by Subject|3|||
144578540|NCT02367040|521317654|FG000|Overall Study|Lost to Follow-up|1|||
144578541|NCT02367040|521317655|FG001|Overall Study|Lost to Follow-up|1|||
144578542|NCT02367040|521317654|FG000|Overall Study|Lack of Efficacy|1|||
144578543|NCT02367040|521317655|FG001|Overall Study|Lack of Efficacy|0|||
144578544|NCT02367040|521317654|FG000|Overall Study|Additional primary malignancy|1|||
144578545|NCT02367040|521317655|FG001|Overall Study|Additional primary malignancy|1|||
144578546|NCT02367040|521317654|FG000|Overall Study|AE not associated with clinical disease progression|117|||
144578547|NCT02367040|521317655|FG001|Overall Study|AE not associated with clinical disease progression|12|||
144578548|NCT02367040|521317654|FG000|Overall Study|AE associated with clinical disease progression|1|||
144578549|NCT02367040|521317655|FG001|Overall Study|AE associated with clinical disease progression|4|||
144578550|NCT02367040|521317654|FG000|Overall Study|Physician Decision|2|||
144578551|NCT02367040|521317655|FG001|Overall Study|Physician Decision|8|||
144578552|NCT02367040|521317654|FG000|Overall Study|Non-compliance to study drug|1|||
144578553|NCT02367040|521317655|FG001|Overall Study|Non-compliance to study drug|0|||
144578554|NCT02367040|521317654|FG000|Overall Study|Failure to meet continuation criteria|1|||
144578555|NCT02367040|521317655|FG001|Overall Study|Failure to meet continuation criteria|0|||
144578556|NCT02367040|521317654|FG000|Overall Study|Switching to other therapy|2|||
144578557|NCT02367040|521317655|FG001|Overall Study|Switching to other therapy|0|||
144578558|NCT02367040|521317654|FG000|Overall Study|Withdrawal by Subject|51|||
144578559|NCT02367040|521317655|FG001|Overall Study|Withdrawal by Subject|16|||
144578560|NCT02367040|521317654|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
144578561|NCT02367040|521317655|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144578562|NCT02367040|521317654|FG000|Overall Study|Patient decision|40|||
144578563|NCT02367040|521317655|FG001|Overall Study|Patient decision|14|||
144578564|NCT02367040|521317654|FG000|Overall Study|Required procedure failed|1|||
144578565|NCT02367040|521317655|FG001|Overall Study|Required procedure failed|0|||
144578566|NCT02367040|521317654|FG000|Overall Study|Randomized by mistake with study treatment|1|||
144578567|NCT02367040|521317655|FG001|Overall Study|Randomized by mistake with study treatment|0|||
144578568|NCT02367040|521317654|FG000|Overall Study|Protocol Violation|1|||
144578569|NCT02367040|521317655|FG001|Overall Study|Protocol Violation|0|||
144578570|NCT02367040|521317654|FG000|Overall Study|Progressive disease - radiological progression|54|||
144578571|NCT02367040|521317655|FG001|Overall Study|Progressive disease - radiological progression|80|||
144578572|NCT02367040|521317654|FG000|Overall Study|Progressive disease - clinical progression|6|||
144578573|NCT02367040|521317655|FG001|Overall Study|Progressive disease - clinical progression|6|||
144578574|NCT02367040|521317654|FG000|Overall Study|Drug not administered|3|||
144578575|NCT02367040|521317655|FG001|Overall Study|Drug not administered|2|||
144578576|NCT02367040|521317654|FG000|Overall Study|Progressive disease|0|||
144578577|NCT02367040|521317655|FG001|Overall Study|Progressive disease|1|||
144578578|NCT02367040|521317654|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
144578579|NCT02367040|521317655|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
144578580|NCT02367040|521317654|FG000|Overall Study|Death|2|||
144578581|NCT02367040|521317655|FG001|Overall Study|Death|0|||
144578582|NCT02367040|521317654|FG000|Overall Study|Study terminated by sponsor|19|||
144578583|NCT02367040|521317655|FG001|Overall Study|Study terminated by sponsor|2|||
144578584|NCT02477618|521317656|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
144578585|NCT02477618|521317657|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
144578586|NCT02477618|521317656|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
144578587|NCT02477618|521317657|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
144578588|NCT02477618|521317656|FG000|Overall Study|Adverse Event|1|||
144578589|NCT02477618|521317657|FG001|Overall Study|Adverse Event|1|||
144578590|NCT02477618|521317656|FG000|Overall Study|Transferred Away from Study Site|1|||
144578591|NCT02477618|521317657|FG001|Overall Study|Transferred Away from Study Site|0|||
144578592|NCT02477618|521317656|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
144578593|NCT02477618|521317657|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
144578594|NCT02446821|521317658|FG000|Overall Study|Adverse Event|28|||
144578595|NCT02446821|521317658|FG000|Overall Study|Withdrawal by Subject|6|||
144578596|NCT02446821|521317658|FG000|Overall Study|Lost to Follow-up|22|||
144578597|NCT02446821|521317658|FG000|Overall Study|other|9|||
144578598|NCT02446821|521317658|FG000|Overall Study|insertion failure|3|||
144578599|NCT02284009|521317662|FG000|Overall Study|Adverse Event|3|||
144578600|NCT02284009|521317663|FG001|Overall Study|Adverse Event|0|||
144578601|NCT02284009|521317662|FG000|Overall Study|Lost to Follow-up|1|||
144578602|NCT02284009|521317663|FG001|Overall Study|Lost to Follow-up|3|||
144622271|NCT00866307|521473717|FG001|Induction|Death|0|||
144622272|NCT00866307|521473718|FG002|Induction|Death|0|||
144578603|NCT02284009|521317662|FG000|Overall Study|Physician Decision|0|||
144578604|NCT02284009|521317663|FG001|Overall Study|Physician Decision|2|||
144578605|NCT02284009|521317662|FG000|Overall Study|Withdrawal by Subject|2|||
144578606|NCT02284009|521317663|FG001|Overall Study|Withdrawal by Subject|5|||
144578607|NCT02397447|521317664|FG000|Overall Study|Lost to Follow-up|2|||
144578608|NCT02397447|521317665|FG001|Overall Study|Lost to Follow-up|2|||
144578609|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
144578610|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
144578611|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
144578612|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
144578613|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
144578614|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
144578615|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
144578616|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
144578617|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
144578618|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
144578619|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
144578620|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
144578621|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
144578622|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
144578623|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
144578624|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
144578625|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
144578626|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
144578627|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
144578628|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
144578629|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
144578630|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
144578631|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
144578632|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
144578633|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
144578634|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
144578635|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
144578636|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
144578637|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
144578638|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
144578639|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
144207472|NCT01439009|519954321|FG000|Overall Study|Deviation of exclusion criteria|1|||
144578640|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
144578641|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
144578642|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
144578643|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
144578644|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
144578645|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
144578646|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
144578647|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
144578648|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
144578649|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
144578650|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
144578651|NCT03524092|521317666|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
144578652|NCT03524092|521317667|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
144578653|NCT03524092|521317668|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
144578654|NCT03524092|521317669|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
144578655|NCT03524092|521317670|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
144578656|NCT03524092|521317671|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
144578657|NCT03524092|521317666|FG000|Loss of Response Rescue Period|Adverse Event|0|||
144578658|NCT03524092|521317667|FG001|Loss of Response Rescue Period|Adverse Event|0|||
144578659|NCT03524092|521317668|FG002|Loss of Response Rescue Period|Adverse Event|0|||
144578660|NCT03524092|521317669|FG003|Loss of Response Rescue Period|Adverse Event|2|||
144578661|NCT03524092|521317670|FG004|Loss of Response Rescue Period|Adverse Event|0|||
144578662|NCT03524092|521317671|FG005|Loss of Response Rescue Period|Adverse Event|0|||
144578663|NCT03524092|521317666|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
144578664|NCT03524092|521317667|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
144578665|NCT03524092|521317668|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
144578666|NCT03524092|521317669|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
144578667|NCT03524092|521317670|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
144578668|NCT03524092|521317671|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
144622273|NCT00866307|521473716|FG000|Induction|Physician Decision|5|||
144622274|NCT00866307|521473717|FG001|Induction|Physician Decision|0|||
144622275|NCT00866307|521473718|FG002|Induction|Physician Decision|0|||
144622276|NCT00866307|521473716|FG000|Induction|Progressive Disease|1|||
144622277|NCT00866307|521473717|FG001|Induction|Progressive Disease|0|||
144622278|NCT00866307|521473718|FG002|Induction|Progressive Disease|0|||
144622279|NCT00866307|521473716|FG000|Induction|Identification of Patients with Day 29 M|3|||
144622280|NCT00866307|521473717|FG001|Induction|Identification of Patients with Day 29 M|0|||
144207473|NCT01439009|519954322|FG001|Overall Study|Deviation of exclusion criteria|0|||
144207474|NCT00926783|519954323|FG000|Overall Study|Incomplete CFAE Procedures|3|||
144622281|NCT00866307|521473718|FG002|Induction|Identification of Patients with Day 29 M|0|||
144578669|NCT03524092|521317666|FG000|Loss of Response Rescue Period|Pregnancy|0|||
144578670|NCT03524092|521317667|FG001|Loss of Response Rescue Period|Pregnancy|0|||
144578671|NCT03524092|521317668|FG002|Loss of Response Rescue Period|Pregnancy|0|||
144578672|NCT03524092|521317669|FG003|Loss of Response Rescue Period|Pregnancy|1|||
144578673|NCT03524092|521317670|FG004|Loss of Response Rescue Period|Pregnancy|0|||
144578674|NCT03524092|521317671|FG005|Loss of Response Rescue Period|Pregnancy|0|||
144578675|NCT03524092|521317666|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
144578676|NCT03524092|521317667|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
144578677|NCT03524092|521317668|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
144578678|NCT03524092|521317669|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
144578679|NCT03524092|521317670|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
144578680|NCT03524092|521317671|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
144578681|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
144578682|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
144578683|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
144578684|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
144578685|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
144578686|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
144578687|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
144578688|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
144578689|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
144578690|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
144578691|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
144578692|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
144578693|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
144578694|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
144578695|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
144578696|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
144578697|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
144578698|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
144578699|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
144578700|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
144578701|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
144578702|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
144578703|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
144578704|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
144578705|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
144578706|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
144578707|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
144578708|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
144578709|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
144578710|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
144578711|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
144578712|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
144578713|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
144578714|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
144578715|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
144578716|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
144578717|NCT03524092|521317666|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
144578718|NCT03524092|521317667|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
144578719|NCT03524092|521317668|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
144578720|NCT03524092|521317669|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
144578721|NCT03524092|521317670|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
144578722|NCT03524092|521317671|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
144578723|NCT03524092|521317666|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
144578724|NCT03524092|521317667|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
144578725|NCT03524092|521317668|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
144578726|NCT03524092|521317669|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
144578727|NCT03524092|521317670|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
144622282|NCT00866307|521473716|FG000|Induction|Inadequate cytognetic samples th|1|||
144622283|NCT00866307|521473717|FG001|Induction|Inadequate cytognetic samples th|0|||
144622284|NCT00866307|521473718|FG002|Induction|Inadequate cytognetic samples th|0|||
144622285|NCT00866307|521473716|FG000|Induction|Improper post-induction consent|2|||
144622286|NCT00866307|521473717|FG001|Induction|Improper post-induction consent|0|||
144730157|NCT00150462|521868156|FG002|Overall Study|Withdrawal by Subject|1|||
144730158|NCT00150462|521868157|FG003|Overall Study|Withdrawal by Subject|0|||
144730159|NCT00150462|521868158|FG004|Overall Study|Withdrawal by Subject|1|||
144730160|NCT00150462|521868159|FG005|Overall Study|Withdrawal by Subject|2|||
144730161|NCT00150462|521868160|FG006|Overall Study|Withdrawal by Subject|0|||
144730162|NCT00150462|521868161|FG007|Overall Study|Withdrawal by Subject|1|||
144730163|NCT00150462|521868162|FG008|Overall Study|Withdrawal by Subject|0|||
144730164|NCT00150462|521868163|FG009|Overall Study|Withdrawal by Subject|1|||
144730165|NCT00150462|521868164|FG010|Overall Study|Withdrawal by Subject|0|||
144730166|NCT00150462|521868154|FG000|Overall Study|Death|0|||
144730167|NCT00150462|521868155|FG001|Overall Study|Death|1|||
144730168|NCT00150462|521868156|FG002|Overall Study|Death|0|||
144730169|NCT00150462|521868157|FG003|Overall Study|Death|0|||
144730170|NCT00150462|521868158|FG004|Overall Study|Death|0|||
144730171|NCT00150462|521868159|FG005|Overall Study|Death|0|||
144730172|NCT00150462|521868160|FG006|Overall Study|Death|0|||
144730173|NCT00150462|521868161|FG007|Overall Study|Death|0|||
144730174|NCT00150462|521868162|FG008|Overall Study|Death|1|||
144730175|NCT00150462|521868163|FG009|Overall Study|Death|0|||
144730176|NCT00150462|521868164|FG010|Overall Study|Death|0|||
144730177|NCT00150462|521868154|FG000|Overall Study|Adverse Event|0|||
144730178|NCT00150462|521868155|FG001|Overall Study|Adverse Event|0|||
144730179|NCT00150462|521868156|FG002|Overall Study|Adverse Event|0|||
144730180|NCT00150462|521868157|FG003|Overall Study|Adverse Event|1|||
144730181|NCT00150462|521868158|FG004|Overall Study|Adverse Event|0|||
144730182|NCT00150462|521868159|FG005|Overall Study|Adverse Event|0|||
144730183|NCT00150462|521868160|FG006|Overall Study|Adverse Event|0|||
144730184|NCT00150462|521868161|FG007|Overall Study|Adverse Event|2|||
144730185|NCT00150462|521868162|FG008|Overall Study|Adverse Event|0|||
144730186|NCT00150462|521868163|FG009|Overall Study|Adverse Event|1|||
144730187|NCT00150462|521868164|FG010|Overall Study|Adverse Event|0|||
144730188|NCT00150462|521868154|FG000|Overall Study|Physician Decision|0|||
144730189|NCT00150462|521868155|FG001|Overall Study|Physician Decision|0|||
144730190|NCT00150462|521868156|FG002|Overall Study|Physician Decision|1|||
144730191|NCT00150462|521868157|FG003|Overall Study|Physician Decision|1|||
144730192|NCT00150462|521868158|FG004|Overall Study|Physician Decision|0|||
144730193|NCT00150462|521868159|FG005|Overall Study|Physician Decision|0|||
144730194|NCT00150462|521868160|FG006|Overall Study|Physician Decision|0|||
144730195|NCT00150462|521868161|FG007|Overall Study|Physician Decision|0|||
144730196|NCT00150462|521868162|FG008|Overall Study|Physician Decision|0|||
144730197|NCT00150462|521868163|FG009|Overall Study|Physician Decision|0|||
144730198|NCT00150462|521868164|FG010|Overall Study|Physician Decision|0|||
144730199|NCT00150462|521868154|FG000|Overall Study|Other|0|||
144730200|NCT00150462|521868155|FG001|Overall Study|Other|0|||
144730201|NCT00150462|521868156|FG002|Overall Study|Other|0|||
144578728|NCT03524092|521317671|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
144578729|NCT03524092|521317666|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
144578730|NCT03524092|521317667|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
144578731|NCT03524092|521317668|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
144578732|NCT03524092|521317669|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
144578733|NCT03524092|521317670|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
144578734|NCT03524092|521317671|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
144578735|NCT03524092|521317666|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
144578736|NCT03524092|521317667|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
144578737|NCT03524092|521317668|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
144578738|NCT03524092|521317669|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
144578739|NCT03524092|521317670|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
144730202|NCT00150462|521868157|FG003|Overall Study|Other|0|||
144730203|NCT00150462|521868158|FG004|Overall Study|Other|0|||
144730204|NCT00150462|521868159|FG005|Overall Study|Other|0|||
144207475|NCT00926783|519954324|FG001|Overall Study|Incomplete CFAE Procedures|3|||
144578740|NCT03524092|521317671|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
144578741|NCT03524092|521317666|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
144578742|NCT03524092|521317667|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
144730205|NCT00150462|521868160|FG006|Overall Study|Other|0|||
144730206|NCT00150462|521868161|FG007|Overall Study|Other|0|||
144730207|NCT00150462|521868162|FG008|Overall Study|Other|0|||
144730208|NCT00150462|521868163|FG009|Overall Study|Other|1|||
144730209|NCT00150462|521868164|FG010|Overall Study|Other|1|||
144730210|NCT04638153|521868167|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144730211|NCT04638153|521868168|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144730212|NCT04638153|521868169|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144730213|NCT04638153|521868167|FG000|Overall Study|Study terminated by sponsor|4|||
144730214|NCT04638153|521868168|FG001|Overall Study|Study terminated by sponsor|2|||
144730215|NCT04638153|521868169|FG002|Overall Study|Study terminated by sponsor|14|||
144730216|NCT01434693|521868172|FG000|Overall Study|Adverse Event|1|||
144578743|NCT03524092|521317668|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
144578744|NCT03524092|521317669|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
144578745|NCT03524092|521317670|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
144578746|NCT03524092|521317671|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
144578747|NCT01876082|521318730|FG000|Overall Study|Withdrawal by Subject|0|||
144578748|NCT01876082|521318731|FG001|Overall Study|Withdrawal by Subject|2|||
144578749|NCT01876082|521318730|FG000|Overall Study|Protocol Violation|1|||
144578750|NCT01876082|521318731|FG001|Overall Study|Protocol Violation|0|||
144578751|NCT01876082|521318730|FG000|Overall Study|Adverse Event|1|||
144578752|NCT01876082|521318731|FG001|Overall Study|Adverse Event|1|||
144578753|NCT01876082|521318730|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
144578754|NCT01876082|521318731|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
144578755|NCT03554629|521318732|FG000|Overall Study|Inadequate data|6|||
144578756|NCT01498887|521318735|FG000|Overall Study|Administrative problems|1|||
144578757|NCT01498887|521318736|FG001|Overall Study|Administrative problems|0|||
144578758|NCT01498887|521318735|FG000|Overall Study|Lost to Follow-up|1|||
144578759|NCT01498887|521318736|FG001|Overall Study|Lost to Follow-up|1|||
144578760|NCT01498887|521318735|FG000|Overall Study|Withdrawal by Subject|1|||
144578761|NCT01498887|521318736|FG001|Overall Study|Withdrawal by Subject|0|||
144578762|NCT01498887|521318735|FG000|Overall Study|Protocol Violation|1|||
144578763|NCT01498887|521318736|FG001|Overall Study|Protocol Violation|3|||
144578764|NCT01498887|521318735|FG000|Overall Study|Lack of Efficacy|5|||
144578765|NCT01498887|521318736|FG001|Overall Study|Lack of Efficacy|3|||
144578766|NCT01498887|521318735|FG000|Overall Study|Abnormal result from test procedure|1|||
144578767|NCT01498887|521318736|FG001|Overall Study|Abnormal result from test procedure|1|||
144578768|NCT01498887|521318735|FG000|Overall Study|Abnormal laboratory value|2|||
144578769|NCT01498887|521318736|FG001|Overall Study|Abnormal laboratory value|2|||
144578770|NCT01498887|521318735|FG000|Overall Study|Adverse Event|4|||
144578771|NCT01498887|521318736|FG001|Overall Study|Adverse Event|1|||
144578772|NCT00667225|521318739|FG000|Overall Study|Subject had no more lesions to treat.|1|||
144578773|NCT00667225|521318740|FG001|Overall Study|Subject had no more lesions to treat.|0|||
144578774|NCT00667225|521318739|FG000|Overall Study|Lost to Follow-up|0|||
144578775|NCT00667225|521318740|FG001|Overall Study|Lost to Follow-up|1|||
144578776|NCT03056300|521318741|FG000|Overall Study|Surgical reason per study protocol|3|||
144578777|NCT03563157|521318742|FG000|Overall Study|Progressive Disease|2|||
144578778|NCT05262517|521318743|FG000|Overall Study|Randomized but not treated|5|||
144578779|NCT05262517|521318744|FG001|Overall Study|Randomized but not treated|11|||
144578780|NCT02942277|521318745|FG000|Year 1|Withdrawal by Subject|0|||
144578781|NCT02942277|521318746|FG001|Year 1|Withdrawal by Subject|0|||
144578782|NCT02942277|521318747|FG002|Year 1|Withdrawal by Subject|0|||
144578783|NCT02942277|521318748|FG003|Year 1|Withdrawal by Subject|0|||
144578784|NCT02942277|521318749|FG004|Year 1|Withdrawal by Subject|1|||
144578785|NCT02942277|521318750|FG005|Year 1|Withdrawal by Subject|3|||
144578786|NCT02942277|521318751|FG006|Year 1|Withdrawal by Subject|0|||
144578787|NCT02942277|521318752|FG007|Year 1|Withdrawal by Subject|1|||
144578788|NCT02942277|521318753|FG008|Year 1|Withdrawal by Subject|0|||
144578789|NCT02942277|521318754|FG009|Year 1|Withdrawal by Subject|0|||
144578790|NCT02942277|521318755|FG010|Year 1|Withdrawal by Subject|3|||
144578791|NCT02942277|521318745|FG000|Year 1|Travel|0|||
144578792|NCT02942277|521318746|FG001|Year 1|Travel|1|||
144578793|NCT02942277|521318747|FG002|Year 1|Travel|0|||
144578794|NCT02942277|521318748|FG003|Year 1|Travel|0|||
144578795|NCT02942277|521318749|FG004|Year 1|Travel|4|||
144578796|NCT02942277|521318750|FG005|Year 1|Travel|5|||
144578797|NCT02942277|521318751|FG006|Year 1|Travel|0|||
144578798|NCT02942277|521318752|FG007|Year 1|Travel|0|||
144578799|NCT02942277|521318753|FG008|Year 1|Travel|0|||
144578800|NCT02942277|521318754|FG009|Year 1|Travel|0|||
144578801|NCT02942277|521318755|FG010|Year 1|Travel|8|||
144578802|NCT02942277|521318745|FG000|Year 1|Joined Army|0|||
144578803|NCT02942277|521318746|FG001|Year 1|Joined Army|1|||
144578804|NCT02942277|521318747|FG002|Year 1|Joined Army|0|||
144578805|NCT02942277|521318748|FG003|Year 1|Joined Army|0|||
144578806|NCT02942277|521318749|FG004|Year 1|Joined Army|0|||
144578807|NCT02942277|521318750|FG005|Year 1|Joined Army|0|||
144578808|NCT02942277|521318751|FG006|Year 1|Joined Army|0|||
144578809|NCT02942277|521318752|FG007|Year 1|Joined Army|0|||
144578810|NCT02942277|521318753|FG008|Year 1|Joined Army|0|||
144578811|NCT02942277|521318754|FG009|Year 1|Joined Army|0|||
144578812|NCT02942277|521318755|FG010|Year 1|Joined Army|0|||
144578813|NCT02942277|521318745|FG000|Year 1|Subject met withdrawal criteria|0|||
144578814|NCT02942277|521318746|FG001|Year 1|Subject met withdrawal criteria|0|||
144578815|NCT02942277|521318747|FG002|Year 1|Subject met withdrawal criteria|0|||
144578816|NCT02942277|521318748|FG003|Year 1|Subject met withdrawal criteria|1|||
144578817|NCT02942277|521318749|FG004|Year 1|Subject met withdrawal criteria|0|||
144578818|NCT02942277|521318750|FG005|Year 1|Subject met withdrawal criteria|0|||
144578819|NCT02942277|521318751|FG006|Year 1|Subject met withdrawal criteria|0|||
144578820|NCT02942277|521318752|FG007|Year 1|Subject met withdrawal criteria|0|||
144578821|NCT02942277|521318753|FG008|Year 1|Subject met withdrawal criteria|0|||
144578822|NCT02942277|521318754|FG009|Year 1|Subject met withdrawal criteria|0|||
144578823|NCT02942277|521318755|FG010|Year 1|Subject met withdrawal criteria|0|||
144578824|NCT02942277|521318745|FG000|Year 1|Lost to Follow-up|0|||
144578825|NCT02942277|521318746|FG001|Year 1|Lost to Follow-up|0|||
144578826|NCT02942277|521318747|FG002|Year 1|Lost to Follow-up|0|||
144578827|NCT02942277|521318748|FG003|Year 1|Lost to Follow-up|0|||
144578828|NCT02942277|521318749|FG004|Year 1|Lost to Follow-up|1|||
144578829|NCT02942277|521318750|FG005|Year 1|Lost to Follow-up|0|||
144578830|NCT02942277|521318751|FG006|Year 1|Lost to Follow-up|0|||
144578831|NCT02942277|521318752|FG007|Year 1|Lost to Follow-up|0|||
144578832|NCT02942277|521318753|FG008|Year 1|Lost to Follow-up|0|||
144578833|NCT02942277|521318754|FG009|Year 1|Lost to Follow-up|0|||
144578834|NCT02942277|521318755|FG010|Year 1|Lost to Follow-up|2|||
144578835|NCT02942277|521318745|FG000|Year 1|Protocol Violation|0|||
144578836|NCT02942277|521318746|FG001|Year 1|Protocol Violation|0|||
144578837|NCT02942277|521318747|FG002|Year 1|Protocol Violation|0|||
144578838|NCT02942277|521318748|FG003|Year 1|Protocol Violation|0|||
144578839|NCT02942277|521318749|FG004|Year 1|Protocol Violation|1|||
144578840|NCT02942277|521318750|FG005|Year 1|Protocol Violation|1|||
144578841|NCT02942277|521318751|FG006|Year 1|Protocol Violation|0|||
144578842|NCT02942277|521318752|FG007|Year 1|Protocol Violation|0|||
144578843|NCT02942277|521318753|FG008|Year 1|Protocol Violation|0|||
144578844|NCT02942277|521318754|FG009|Year 1|Protocol Violation|0|||
144578845|NCT02942277|521318755|FG010|Year 1|Protocol Violation|2|||
144578846|NCT02942277|521318745|FG000|Year 1|Pregnancy|0|||
144578847|NCT02942277|521318746|FG001|Year 1|Pregnancy|0|||
144578848|NCT02942277|521318747|FG002|Year 1|Pregnancy|0|||
144578849|NCT02942277|521318748|FG003|Year 1|Pregnancy|0|||
144578850|NCT02942277|521318749|FG004|Year 1|Pregnancy|0|||
144578851|NCT02942277|521318750|FG005|Year 1|Pregnancy|1|||
144578852|NCT02942277|521318751|FG006|Year 1|Pregnancy|0|||
144578853|NCT02942277|521318752|FG007|Year 1|Pregnancy|0|||
144578854|NCT02942277|521318753|FG008|Year 1|Pregnancy|0|||
144578855|NCT02942277|521318754|FG009|Year 1|Pregnancy|0|||
144578856|NCT02942277|521318755|FG010|Year 1|Pregnancy|0|||
144578857|NCT02942277|521318745|FG000|Year 2|Lost to Follow-up|0|||
144578858|NCT02942277|521318746|FG001|Year 2|Lost to Follow-up|0|||
144578859|NCT02942277|521318747|FG002|Year 2|Lost to Follow-up|0|||
144578860|NCT02942277|521318748|FG003|Year 2|Lost to Follow-up|0|||
144578861|NCT02942277|521318749|FG004|Year 2|Lost to Follow-up|2|||
144578862|NCT02942277|521318750|FG005|Year 2|Lost to Follow-up|1|||
144578863|NCT02942277|521318751|FG006|Year 2|Lost to Follow-up|0|||
144578864|NCT02942277|521318752|FG007|Year 2|Lost to Follow-up|0|||
144578865|NCT02942277|521318753|FG008|Year 2|Lost to Follow-up|0|||
144578866|NCT02942277|521318754|FG009|Year 2|Lost to Follow-up|0|||
144578867|NCT02942277|521318755|FG010|Year 2|Lost to Follow-up|0|||
144578868|NCT02942277|521318745|FG000|Year 2|Did not rescreen|0|||
144578869|NCT02942277|521318746|FG001|Year 2|Did not rescreen|0|||
144578870|NCT02942277|521318747|FG002|Year 2|Did not rescreen|1|||
144578871|NCT02942277|521318748|FG003|Year 2|Did not rescreen|1|||
144578872|NCT02942277|521318749|FG004|Year 2|Did not rescreen|9|||
144730217|NCT01434693|521868173|FG001|Overall Study|Adverse Event|0|||
144730218|NCT01434693|521868174|FG002|Overall Study|Adverse Event|0|||
144730219|NCT01434693|521868175|FG003|Overall Study|Adverse Event|0|||
144730220|NCT01434693|521868172|FG000|Overall Study|Withdrawal by Subject|1|||
144730221|NCT01434693|521868173|FG001|Overall Study|Withdrawal by Subject|0|||
144578873|NCT02942277|521318750|FG005|Year 2|Did not rescreen|6|||
144730222|NCT01434693|521868174|FG002|Overall Study|Withdrawal by Subject|1|||
144578874|NCT02942277|521318751|FG006|Year 2|Did not rescreen|0|||
144578875|NCT02942277|521318752|FG007|Year 2|Did not rescreen|1|||
144578876|NCT02942277|521318753|FG008|Year 2|Did not rescreen|0|||
144578877|NCT02942277|521318754|FG009|Year 2|Did not rescreen|0|||
144578878|NCT02942277|521318755|FG010|Year 2|Did not rescreen|21|||
144578879|NCT02942277|521318745|FG000|Year 2|Met withdrawal criteria|0|||
144578880|NCT02942277|521318746|FG001|Year 2|Met withdrawal criteria|0|||
144578881|NCT02942277|521318747|FG002|Year 2|Met withdrawal criteria|0|||
144578882|NCT02942277|521318748|FG003|Year 2|Met withdrawal criteria|0|||
144578883|NCT02942277|521318749|FG004|Year 2|Met withdrawal criteria|1|||
144578884|NCT02942277|521318750|FG005|Year 2|Met withdrawal criteria|2|||
144578885|NCT02942277|521318751|FG006|Year 2|Met withdrawal criteria|0|||
144578886|NCT02942277|521318752|FG007|Year 2|Met withdrawal criteria|0|||
144578887|NCT02942277|521318753|FG008|Year 2|Met withdrawal criteria|0|||
144578888|NCT02942277|521318754|FG009|Year 2|Met withdrawal criteria|0|||
144578889|NCT02942277|521318755|FG010|Year 2|Met withdrawal criteria|1|||
144730223|NCT01434693|521868175|FG003|Overall Study|Withdrawal by Subject|1|||
144578890|NCT02942277|521318745|FG000|Year 2|Travel|0|||
144578891|NCT02942277|521318746|FG001|Year 2|Travel|1|||
144578892|NCT02942277|521318747|FG002|Year 2|Travel|0|||
144578893|NCT02942277|521318748|FG003|Year 2|Travel|0|||
144578894|NCT02942277|521318749|FG004|Year 2|Travel|0|||
144578895|NCT02942277|521318750|FG005|Year 2|Travel|1|||
144578896|NCT02942277|521318751|FG006|Year 2|Travel|0|||
144578897|NCT02942277|521318752|FG007|Year 2|Travel|0|||
144578898|NCT02942277|521318753|FG008|Year 2|Travel|0|||
144578899|NCT02942277|521318754|FG009|Year 2|Travel|1|||
144578900|NCT02942277|521318755|FG010|Year 2|Travel|3|||
144578901|NCT02942277|521318745|FG000|Year 2|Non-compliant|0|||
144730224|NCT01434693|521868172|FG000|Overall Study|Lost to Follow-up|1|||
144578902|NCT02942277|521318746|FG001|Year 2|Non-compliant|0|||
144578903|NCT02942277|521318747|FG002|Year 2|Non-compliant|0|||
144578904|NCT02942277|521318748|FG003|Year 2|Non-compliant|0|||
144578905|NCT02942277|521318749|FG004|Year 2|Non-compliant|1|||
144578906|NCT02942277|521318750|FG005|Year 2|Non-compliant|1|||
144578907|NCT02942277|521318751|FG006|Year 2|Non-compliant|0|||
144578908|NCT02942277|521318752|FG007|Year 2|Non-compliant|0|||
144578909|NCT02942277|521318753|FG008|Year 2|Non-compliant|0|||
144578910|NCT02942277|521318754|FG009|Year 2|Non-compliant|0|||
144578911|NCT02942277|521318755|FG010|Year 2|Non-compliant|0|||
144578912|NCT02942277|521318745|FG000|Year 2|Withdrawal by Subject|0|||
144578913|NCT02942277|521318746|FG001|Year 2|Withdrawal by Subject|0|||
144578914|NCT02942277|521318747|FG002|Year 2|Withdrawal by Subject|0|||
144578915|NCT02942277|521318748|FG003|Year 2|Withdrawal by Subject|0|||
144578916|NCT02942277|521318749|FG004|Year 2|Withdrawal by Subject|0|||
144578917|NCT02942277|521318750|FG005|Year 2|Withdrawal by Subject|0|||
144578918|NCT02942277|521318751|FG006|Year 2|Withdrawal by Subject|1|||
144578919|NCT02942277|521318752|FG007|Year 2|Withdrawal by Subject|0|||
144578920|NCT02942277|521318753|FG008|Year 2|Withdrawal by Subject|0|||
144578921|NCT02942277|521318754|FG009|Year 2|Withdrawal by Subject|0|||
144578922|NCT02942277|521318755|FG010|Year 2|Withdrawal by Subject|0|||
144578923|NCT02187159|521318756|FG000|Overall Study|Protocol Violation|4|||
144578924|NCT02187159|521318757|FG001|Overall Study|Protocol Violation|6|||
144578925|NCT02187159|521318758|FG002|Overall Study|Protocol Violation|3|||
144578926|NCT02187159|521318759|FG003|Overall Study|Protocol Violation|4|||
144578927|NCT02187159|521318756|FG000|Overall Study|Lack of Efficacy|10|||
144578928|NCT02187159|521318757|FG001|Overall Study|Lack of Efficacy|5|||
144578929|NCT02187159|521318758|FG002|Overall Study|Lack of Efficacy|4|||
144578930|NCT02187159|521318759|FG003|Overall Study|Lack of Efficacy|7|||
144578931|NCT02187159|521318756|FG000|Overall Study|Adverse Event|28|||
144578932|NCT02187159|521318757|FG001|Overall Study|Adverse Event|33|||
144578933|NCT02187159|521318758|FG002|Overall Study|Adverse Event|42|||
144578934|NCT02187159|521318759|FG003|Overall Study|Adverse Event|50|||
144578935|NCT02187159|521318756|FG000|Overall Study|Withdrawal by Subject|24|||
144578936|NCT02187159|521318757|FG001|Overall Study|Withdrawal by Subject|28|||
144578937|NCT02187159|521318758|FG002|Overall Study|Withdrawal by Subject|25|||
144578938|NCT02187159|521318759|FG003|Overall Study|Withdrawal by Subject|26|||
144578939|NCT02187159|521318756|FG000|Overall Study|Other|3|||
144578940|NCT02187159|521318757|FG001|Overall Study|Other|7|||
144578941|NCT02187159|521318758|FG002|Overall Study|Other|3|||
144578942|NCT02187159|521318759|FG003|Overall Study|Other|9|||
144578943|NCT04325282|521318760|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
144578944|NCT04325282|521318761|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
144578945|NCT04325282|521318760|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
144578946|NCT04325282|521318761|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
144578947|NCT05282121|521318767|FG000|Overall Study|Adverse Event|1|||
144578948|NCT05282121|521318768|FG001|Overall Study|Adverse Event|1|||
144578949|NCT05282121|521318769|FG002|Overall Study|Adverse Event|4|||
144578950|NCT05282121|521318770|FG003|Overall Study|Adverse Event|1|||
144578951|NCT05282121|521318767|FG000|Overall Study|Study Terminated by Sponsor|1|||
144578952|NCT05282121|521318768|FG001|Overall Study|Study Terminated by Sponsor|2|||
144578953|NCT05282121|521318769|FG002|Overall Study|Study Terminated by Sponsor|2|||
144578954|NCT05282121|521318770|FG003|Overall Study|Study Terminated by Sponsor|2|||
144578955|NCT05282121|521318767|FG000|Overall Study|Other than listed|0|||
144578956|NCT05282121|521318768|FG001|Overall Study|Other than listed|0|||
144578957|NCT05282121|521318769|FG002|Overall Study|Other than listed|1|||
144578958|NCT05282121|521318770|FG003|Overall Study|Other than listed|0|||
144578959|NCT05282121|521318767|FG000|Overall Study|No reason available|0|||
144578960|NCT05282121|521318768|FG001|Overall Study|No reason available|0|||
144578961|NCT05282121|521318769|FG002|Overall Study|No reason available|1|||
144578962|NCT05282121|521318770|FG003|Overall Study|No reason available|0|||
144578963|NCT01736189|521318773|FG000|Overall Study|Violation of registration criteria|41|||
144578964|NCT01736189|521318773|FG000|Overall Study|Protocol Violation|4|||
144578965|NCT01736189|521318773|FG000|Overall Study|Criteria and protocol violations|1|||
144578966|NCT00608868|521318776|FG000|Overall Study|Withdrawal by Subject|7|||
144578967|NCT00608868|521318776|FG000|Overall Study|Protocol Violation|3|||
144578968|NCT00608868|521318776|FG000|Overall Study|Lost to Follow-up|2|||
144578969|NCT00608868|521318776|FG000|Overall Study|Adverse Event|1|||
144578970|NCT00608868|521318776|FG000|Overall Study|Physician Decision|2|||
144578971|NCT01712061|521318777|FG000|Overall Study|Adverse Event|4|||
144578972|NCT01712061|521318778|FG001|Overall Study|Adverse Event|9|||
144578973|NCT01712061|521318779|FG002|Overall Study|Adverse Event|5|||
144578974|NCT01712061|521318777|FG000|Overall Study|Death|0|||
144578975|NCT01712061|521318778|FG001|Overall Study|Death|0|||
144578976|NCT01712061|521318779|FG002|Overall Study|Death|1|||
144578977|NCT01712061|521318777|FG000|Overall Study|Lost to Follow-up|1|||
144578978|NCT01712061|521318778|FG001|Overall Study|Lost to Follow-up|0|||
144578979|NCT01712061|521318779|FG002|Overall Study|Lost to Follow-up|1|||
144578980|NCT01712061|521318777|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
144578981|NCT01712061|521318778|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
144730225|NCT01434693|521868173|FG001|Overall Study|Lost to Follow-up|0|||
144578982|NCT01712061|521318779|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
144578983|NCT01712061|521318777|FG000|Overall Study|Medication Error Without Associated AE|0|||
144578984|NCT01712061|521318778|FG001|Overall Study|Medication Error Without Associated AE|1|||
144578985|NCT01712061|521318779|FG002|Overall Study|Medication Error Without Associated AE|0|||
144578986|NCT01712061|521318777|FG000|Overall Study|Withdrawal by Subject|1|||
144578987|NCT01712061|521318778|FG001|Overall Study|Withdrawal by Subject|7|||
144578988|NCT01712061|521318779|FG002|Overall Study|Withdrawal by Subject|1|||
144578989|NCT01712061|521318777|FG000|Overall Study|Other|0|||
144578990|NCT01712061|521318778|FG001|Overall Study|Other|3|||
144578991|NCT01712061|521318779|FG002|Overall Study|Other|0|||
144578992|NCT00879775|521318782|FG000|Overall Study|Lost to Follow-up|2|||
144578993|NCT00879775|521318783|FG001|Overall Study|Lost to Follow-up|1|||
144578994|NCT01677767|521318784|FG000|Overall Study|Adverse Event|1|||
144578995|NCT01677767|521318784|FG000|Overall Study|Death|4|||
144578996|NCT01677767|521318784|FG000|Overall Study|Protocol Violation|4|||
144578997|NCT01677767|521318784|FG000|Overall Study|Withdrawal by Subject|10|||
144578998|NCT01677767|521318784|FG000|Overall Study|Non-compliance by the participants|3|||
144578999|NCT00755105|521318785|FG000|Overall Study|Withdrawal by Subject|9|||
144579000|NCT00755105|521318786|FG001|Overall Study|Withdrawal by Subject|11|||
144579001|NCT00755105|521318787|FG002|Overall Study|Withdrawal by Subject|4|||
144579002|NCT00818779|521318790|FG000|Overall Study|Protocol Violation|1|||
144579003|NCT00818779|521318791|FG001|Overall Study|Protocol Violation|0|||
144579004|NCT00818779|521318790|FG000|Overall Study|Lost to Follow-up|1|||
144579005|NCT00818779|521318791|FG001|Overall Study|Lost to Follow-up|0|||
144579006|NCT00818779|521318790|FG000|Overall Study|Adverse Event|4|||
144579007|NCT00818779|521318791|FG001|Overall Study|Adverse Event|1|||
144579008|NCT01840410|521318794|FG000|Overall Study|Physician Decision|1|||
144579009|NCT01840410|521318795|FG001|Overall Study|Physician Decision|2|||
144579010|NCT01840410|521318794|FG000|Overall Study|Pregnancy|1|||
144579011|NCT01840410|521318795|FG001|Overall Study|Pregnancy|0|||
144579012|NCT01840410|521318794|FG000|Overall Study|Protocol deviation|1|||
144579013|NCT01840410|521318795|FG001|Overall Study|Protocol deviation|0|||
144579014|NCT01840410|521318794|FG000|Overall Study|Lost to Follow-up|1|||
144579015|NCT01840410|521318795|FG001|Overall Study|Lost to Follow-up|0|||
144579016|NCT01840410|521318794|FG000|Overall Study|Withdrawal by Subject|2|||
144579017|NCT01840410|521318795|FG001|Overall Study|Withdrawal by Subject|1|||
144579018|NCT01840410|521318794|FG000|Overall Study|Adverse Event|1|||
144579019|NCT01840410|521318795|FG001|Overall Study|Adverse Event|1|||
144579020|NCT04343976|521318796|FG000|Overall Study|Withdrawal by Subject|0|||
144579021|NCT04343976|521318797|FG001|Overall Study|Withdrawal by Subject|1|||
144579022|NCT00839956|521318798|FG000|Overall Study|Adverse Event|2|||
144579023|NCT00839956|521318798|FG000|Overall Study|Lack of Efficacy|6|||
144579024|NCT00839956|521318798|FG000|Overall Study|Physician Decision|1|||
144579025|NCT00839956|521318798|FG000|Overall Study|Withdrawal by Subject|3|||
144579026|NCT02807883|521318799|FG000|Overall Study|Withdrawal by Subject|2|||
144579027|NCT00594880|521318800|FG000|Overall Study|Withdrawal by Subject|1|||
144579028|NCT00594880|521318801|FG001|Overall Study|Withdrawal by Subject|1|||
144579029|NCT00594880|521318800|FG000|Overall Study|Lost to Follow-up|1|||
144579030|NCT00594880|521318801|FG001|Overall Study|Lost to Follow-up|0|||
144579031|NCT00694109|521318802|FG000|Overall Study|Physician Decision|3|||
144579032|NCT00694109|521318802|FG000|Overall Study|Adverse Event|74|||
144579033|NCT00694109|521318802|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
144579034|NCT00694109|521318802|FG000|Overall Study|Lack of Efficacy|2|||
144579035|NCT00694109|521318802|FG000|Overall Study|Withdrawal by Subject|13|||
144579036|NCT00694109|521318802|FG000|Overall Study|Pregnancy|1|||
144579037|NCT00694109|521318802|FG000|Overall Study|Enrolled but not treated|1|||
144579038|NCT00694109|521318802|FG000|Overall Study|Other|2|||
144579039|NCT00694109|521318802|FG000|Overall Study|Consented but no additional treatment|3|||
144579040|NCT01077518|521318807|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
144579041|NCT01077518|521318808|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
144579042|NCT01077518|521318809|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
144579043|NCT01077518|521318807|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
144579044|NCT01077518|521318808|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
144579045|NCT01077518|521318809|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
144579046|NCT01077518|521318807|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
144579047|NCT01077518|521318808|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
144579048|NCT01077518|521318809|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
144579049|NCT01077518|521318807|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
144579050|NCT01077518|521318808|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
144579051|NCT01077518|521318809|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
144622287|NCT00866307|521473718|FG002|Induction|Improper post-induction consent|0|||
144579052|NCT01077518|521318807|FG000|Optional Ofa Phase|Physician Decision|0|||
144579053|NCT01077518|521318808|FG001|Optional Ofa Phase|Physician Decision|0|||
144579054|NCT01077518|521318809|FG002|Optional Ofa Phase|Physician Decision|1|||
144579055|NCT01077518|521318807|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
144730226|NCT01434693|521868174|FG002|Overall Study|Lost to Follow-up|0|||
144730227|NCT01434693|521868175|FG003|Overall Study|Lost to Follow-up|0|||
144730228|NCT00912288|521868176|FG000|Overall Study|Death|0|||
144730229|NCT00912288|521868177|FG001|Overall Study|Death|1|||
144730230|NCT00912288|521868176|FG000|Overall Study|Adverse Event|1|||
144579056|NCT01077518|521318808|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
144579057|NCT01077518|521318809|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
144579058|NCT01077518|521318807|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
144579059|NCT01077518|521318808|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
144579060|NCT01077518|521318809|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
144579061|NCT04958200|521318810|FG000|Overall Study|Withdrawal by Subject|0|||
144579062|NCT04958200|521318811|FG001|Overall Study|Withdrawal by Subject|2|||
144579063|NCT04958200|521318810|FG000|Overall Study|Lost to Follow-up|3|||
144579064|NCT04958200|521318811|FG001|Overall Study|Lost to Follow-up|2|||
144579065|NCT02387970|521318812|FG000|Overall Study|Did not complete 1-year follow up|1|||
144579066|NCT02387970|521318813|FG001|Overall Study|Did not complete 1-year follow up|2|||
144579067|NCT01495598|521318814|FG000|Overall Study|Death during follow up period|2|||
144579068|NCT01495598|521318814|FG000|Overall Study|Death on study|1|||
144579069|NCT01495598|521318814|FG000|Overall Study|Lost to Follow-up|3|||
144579070|NCT01495598|521318814|FG000|Overall Study|Physician Decision|8|||
144579071|NCT05511038|521318815|FG000|Overall|Withdrawal by Subject|5|||
144579072|NCT05511038|521318816|FG001|Overall|Withdrawal by Subject|3|||
144579073|NCT05511038|521318815|FG000|Overall|Screen Failure|20|||
144579074|NCT05511038|521318816|FG001|Overall|Screen Failure|1|||
144579075|NCT05511038|521318815|FG000|Overall|Physician Decision|3|||
144579076|NCT05511038|521318816|FG001|Overall|Physician Decision|0|||
144579077|NCT05511038|521318815|FG000|Overall|Lost to Follow-up|3|||
144579078|NCT05511038|521318816|FG001|Overall|Lost to Follow-up|0|||
144579079|NCT05511038|521318815|FG000|Overall|Death|1|||
144579080|NCT05511038|521318816|FG001|Overall|Death|0|||
144579081|NCT05511038|521318815|FG000|Screening|Withdrawal by Subject|1|||
144579082|NCT05511038|521318816|FG001|Screening|Withdrawal by Subject|0|||
144579083|NCT05511038|521318815|FG000|Screening|Lost to Follow Up (1 participant)|1|||
144579084|NCT05511038|521318816|FG001|Screening|Lost to Follow Up (1 participant)|0|||
144579085|NCT05511038|521318815|FG000|Screening|Screen Failure|3|||
144579086|NCT05511038|521318816|FG001|Screening|Screen Failure|0|||
144579087|NCT05511038|521318815|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
144579088|NCT05511038|521318816|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
144579089|NCT05511038|521318815|FG000|Treatment|Withdrawal by Subject|5|||
144579090|NCT05511038|521318816|FG001|Treatment|Withdrawal by Subject|3|||
144579091|NCT05511038|521318815|FG000|Treatment|Physician Decision|4|||
144579092|NCT05511038|521318816|FG001|Treatment|Physician Decision|0|||
144579093|NCT05511038|521318815|FG000|Treatment|Lost to Follow-up|2|||
144579094|NCT05511038|521318816|FG001|Treatment|Lost to Follow-up|0|||
144579095|NCT05511038|521318815|FG000|Treatment|Death|1|||
144579096|NCT05511038|521318816|FG001|Treatment|Death|0|||
144579097|NCT05511038|521318815|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
144579098|NCT05511038|521318816|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
144579099|NCT05511038|521318815|FG000|Treatment|Refuse by subject|1|||
144579100|NCT05511038|521318816|FG001|Treatment|Refuse by subject|0|||
144579101|NCT05511038|521318815|FG000|Treatment|Subject did not go to the site for visit|1|||
144579102|NCT05511038|521318816|FG001|Treatment|Subject did not go to the site for visit|0|||
144579103|NCT03852719|521318817|FG000|Overall Study|Withdrawal of consent|8|||
144579104|NCT03852719|521318818|FG001|Overall Study|Withdrawal of consent|8|||
144579105|NCT03852719|521318819|FG002|Overall Study|Withdrawal of consent|9|||
144579106|NCT03852719|521318817|FG000|Overall Study|Physician Decision|5|||
144579107|NCT03852719|521318818|FG001|Overall Study|Physician Decision|4|||
144579108|NCT03852719|521318819|FG002|Overall Study|Physician Decision|1|||
144730231|NCT00912288|521868177|FG001|Overall Study|Adverse Event|1|||
144730232|NCT00912288|521868176|FG000|Overall Study|Lost to Follow-up|1|||
144730233|NCT00912288|521868177|FG001|Overall Study|Lost to Follow-up|0|||
144730234|NCT00912288|521868176|FG000|Overall Study|Protocol Violation|1|||
144579109|NCT03852719|521318817|FG000|Overall Study|Pregnancy|2|||
144579110|NCT03852719|521318818|FG001|Overall Study|Pregnancy|1|||
144579111|NCT03852719|521318819|FG002|Overall Study|Pregnancy|0|||
144579112|NCT03852719|521318817|FG000|Overall Study|Death|1|||
144579113|NCT03852719|521318818|FG001|Overall Study|Death|0|||
144579114|NCT03852719|521318819|FG002|Overall Study|Death|0|||
144579115|NCT03852719|521318817|FG000|Overall Study|Reason not Specified|3|||
144579116|NCT03852719|521318818|FG001|Overall Study|Reason not Specified|3|||
144579117|NCT03852719|521318819|FG002|Overall Study|Reason not Specified|5|||
144579118|NCT03852719|521318817|FG000|Overall Study|Adverse Event|2|||
144730235|NCT00912288|521868177|FG001|Overall Study|Protocol Violation|0|||
144579119|NCT03852719|521318818|FG001|Overall Study|Adverse Event|1|||
144579120|NCT03852719|521318819|FG002|Overall Study|Adverse Event|4|||
144579121|NCT03852719|521318817|FG000|Overall Study|Progressive disease|1|||
144579122|NCT03852719|521318818|FG001|Overall Study|Progressive disease|4|||
144579123|NCT03852719|521318819|FG002|Overall Study|Progressive disease|1|||
144730236|NCT00912288|521868176|FG000|Overall Study|Withdrawal by Subject|3|||
144579124|NCT03852719|521318817|FG000|Overall Study|Lost to Follow-up|1|||
144579125|NCT03852719|521318818|FG001|Overall Study|Lost to Follow-up|0|||
144579126|NCT03852719|521318819|FG002|Overall Study|Lost to Follow-up|0|||
144579127|NCT05543187|521318822|FG000|Overall Study|Ongoing|3|||
144579128|NCT05543187|521318823|FG001|Overall Study|Ongoing|2|||
144579129|NCT04777864|521318824|FG000|Overall Study|Lost to Follow-up|8|||
144579130|NCT04777864|521318825|FG001|Overall Study|Lost to Follow-up|19|||
144579131|NCT03086655|521318828|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
144579132|NCT03086655|521318829|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
144579133|NCT03086655|521318828|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
144579134|NCT03086655|521318829|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
144579135|NCT03086655|521318828|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
144579136|NCT03086655|521318829|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
144579137|NCT03086655|521318828|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
144579138|NCT03086655|521318829|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
144579139|NCT03086655|521318828|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
144579140|NCT03086655|521318829|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
144579141|NCT03086655|521318828|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
144579142|NCT03086655|521318829|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
144579143|NCT03086655|521318828|FG000|12 Month Follow-up = Final Assessment|Death|0|||
144579144|NCT03086655|521318829|FG001|12 Month Follow-up = Final Assessment|Death|1|||
144579145|NCT03841526|521318831|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
144579146|NCT03841526|521318832|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
144579147|NCT03841526|521318833|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
144579148|NCT03841526|521318834|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
144579149|NCT03841526|521318835|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
144579150|NCT03841526|521318836|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
144579151|NCT03841526|521318831|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
144579152|NCT03841526|521318832|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
144579153|NCT03841526|521318833|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
144579154|NCT03841526|521318834|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
144579155|NCT03841526|521318835|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
144579156|NCT03841526|521318836|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
144579157|NCT03841526|521318831|FG000|Outpatient Phase Treatment|Physician Decision|0|||
144579158|NCT03841526|521318832|FG001|Outpatient Phase Treatment|Physician Decision|1|||
144579159|NCT03841526|521318833|FG002|Outpatient Phase Treatment|Physician Decision|0|||
144579160|NCT03841526|521318834|FG003|Outpatient Phase Treatment|Physician Decision|0|||
144579161|NCT03841526|521318835|FG004|Outpatient Phase Treatment|Physician Decision|0|||
144579162|NCT03841526|521318836|FG005|Outpatient Phase Treatment|Physician Decision|0|||
144579163|NCT03841526|521318831|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
144579164|NCT03841526|521318832|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
144579165|NCT03841526|521318833|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
144579166|NCT03841526|521318834|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
144579167|NCT03841526|521318835|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
144579168|NCT03841526|521318836|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
144579169|NCT02994069|521318837|FG000|Overall Study|Death|7|||
144579170|NCT02994069|521318838|FG001|Overall Study|Death|13|||
144579171|NCT02994069|521318837|FG000|Overall Study|Adverse Event|1|||
144579172|NCT02994069|521318838|FG001|Overall Study|Adverse Event|0|||
144579173|NCT02994069|521318837|FG000|Overall Study|Other|2|||
144579174|NCT02994069|521318838|FG001|Overall Study|Other|0|||
144579175|NCT02994069|521318837|FG000|Overall Study|still on follow up/treatment|5|||
144579176|NCT02994069|521318838|FG001|Overall Study|still on follow up/treatment|6|||
144579177|NCT04303780|521318841|FG000|Overall Study|Death|104|||
144579178|NCT04303780|521318842|FG001|Overall Study|Death|85|||
144579179|NCT04303780|521318841|FG000|Overall Study|Lost to Follow-up|5|||
144579180|NCT04303780|521318842|FG001|Overall Study|Lost to Follow-up|2|||
144579181|NCT04303780|521318841|FG000|Overall Study|Withdrawal by Subject|12|||
144579182|NCT04303780|521318842|FG001|Overall Study|Withdrawal by Subject|39|||
144579183|NCT04303780|521318841|FG000|Overall Study|Ongoing in study|50|||
144579184|NCT04303780|521318842|FG001|Overall Study|Ongoing in study|45|||
144579185|NCT04893460|521318843|FG000|Overall Study|Lost to Follow-up|18|||
144579186|NCT01123070|521320438|FG000|Part B Double Blind Period|Protocol Violation|0|||
144579187|NCT01123070|521320439|FG001|Part B Double Blind Period|Protocol Violation|0|||
144579188|NCT01123070|521320440|FG002|Part B Double Blind Period|Protocol Violation|0|||
144579189|NCT01123070|521320441|FG003|Part B Double Blind Period|Protocol Violation|1|||
144579190|NCT01123070|521320438|FG000|Part B Double Blind Period|Adverse Event|0|||
144579191|NCT01123070|521320439|FG001|Part B Double Blind Period|Adverse Event|0|||
144579192|NCT01123070|521320440|FG002|Part B Double Blind Period|Adverse Event|2|||
144579193|NCT01123070|521320441|FG003|Part B Double Blind Period|Adverse Event|0|||
144579194|NCT01123070|521320438|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
144579195|NCT01123070|521320439|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
144579196|NCT01123070|521320440|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
144579197|NCT01123070|521320441|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
144207476|NCT03503864|519954327|FG000|Overall Study|Protocol Violation|6|||
144207477|NCT03503864|519954327|FG000|Overall Study|Withdrawal by Subject|7|||
144579198|NCT01977677|521320442|FG000|Overall Study|Unrelated Adverse Event|0|||
144579199|NCT01977677|521320443|FG001|Overall Study|Unrelated Adverse Event|0|||
144579200|NCT01977677|521320444|FG002|Overall Study|Unrelated Adverse Event|1|||
144579201|NCT04020185|521320445|FG000|Overall Study|Death|0|||
144579202|NCT04020185|521320446|FG001|Overall Study|Death|0|||
144579203|NCT04020185|521320447|FG002|Overall Study|Death|1|||
144579204|NCT04020185|521320448|FG003|Overall Study|Death|2|||
144579205|NCT04020185|521320449|FG004|Overall Study|Death|1|||
144579206|NCT04020185|521320450|FG005|Overall Study|Death|0|||
144579207|NCT04020185|521320451|FG006|Overall Study|Death|1|||
144579208|NCT04020185|521320452|FG007|Overall Study|Death|0|||
144579209|NCT04020185|521320445|FG000|Overall Study|Consent withdrawn|1|||
144579210|NCT04020185|521320446|FG001|Overall Study|Consent withdrawn|0|||
144579211|NCT04020185|521320447|FG002|Overall Study|Consent withdrawn|0|||
144579212|NCT04020185|521320448|FG003|Overall Study|Consent withdrawn|0|||
144579213|NCT04020185|521320449|FG004|Overall Study|Consent withdrawn|2|||
144579214|NCT04020185|521320450|FG005|Overall Study|Consent withdrawn|0|||
144579215|NCT04020185|521320451|FG006|Overall Study|Consent withdrawn|1|||
144579216|NCT04020185|521320452|FG007|Overall Study|Consent withdrawn|1|||
144579217|NCT04020185|521320445|FG000|Overall Study|Patient in hospice|0|||
144579218|NCT04020185|521320446|FG001|Overall Study|Patient in hospice|1|||
144579219|NCT04020185|521320447|FG002|Overall Study|Patient in hospice|0|||
144579220|NCT04020185|521320448|FG003|Overall Study|Patient in hospice|0|||
144622288|NCT00866307|521473716|FG000|Induction|Study was closed at the time|1|||
144622289|NCT00866307|521473717|FG001|Induction|Study was closed at the time|0|||
144622290|NCT00866307|521473718|FG002|Induction|Study was closed at the time|0|||
144622291|NCT00866307|521473716|FG000|Consolidation/Maintenance|Adverse Event|0|||
144622292|NCT00866307|521473717|FG001|Consolidation/Maintenance|Adverse Event|0|||
144622293|NCT00866307|521473718|FG002|Consolidation/Maintenance|Adverse Event|8|||
144622294|NCT00866307|521473716|FG000|Consolidation/Maintenance|Death|0|||
144622295|NCT00866307|521473717|FG001|Consolidation/Maintenance|Death|0|||
144622296|NCT00866307|521473718|FG002|Consolidation/Maintenance|Death|1|||
144622297|NCT00866307|521473716|FG000|Consolidation/Maintenance|Physician Decision|0|||
144622298|NCT00866307|521473717|FG001|Consolidation/Maintenance|Physician Decision|3|||
144622299|NCT00866307|521473718|FG002|Consolidation/Maintenance|Physician Decision|2|||
144622300|NCT00866307|521473716|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
144622301|NCT00866307|521473717|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
144622302|NCT00866307|521473718|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
144622303|NCT00866307|521473716|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
144622304|NCT00866307|521473717|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
144622305|NCT00866307|521473718|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
144622306|NCT00866307|521473716|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
144622307|NCT00866307|521473717|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
144622308|NCT00866307|521473718|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
144622309|NCT00866307|521473716|FG000|Consolidation/Maintenance|Therapy error|0|||
144622310|NCT00866307|521473717|FG001|Consolidation/Maintenance|Therapy error|1|||
144622311|NCT00866307|521473718|FG002|Consolidation/Maintenance|Therapy error|0|||
144622312|NCT00866307|521473716|FG000|Consolidation/Maintenance|Non-compliance|0|||
144622313|NCT00866307|521473717|FG001|Consolidation/Maintenance|Non-compliance|0|||
144622314|NCT00866307|521473718|FG002|Consolidation/Maintenance|Non-compliance|1|||
144622315|NCT00866307|521473716|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
144622316|NCT00866307|521473717|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
144622317|NCT00866307|521473718|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
144622318|NCT00903929|521473719|FG000|Overall Study|Withdrawal by Subject|0|||
144622319|NCT00903929|521473720|FG001|Overall Study|Withdrawal by Subject|0|||
144622320|NCT00903929|521473721|FG002|Overall Study|Withdrawal by Subject|1|||
144622321|NCT00903929|521473722|FG003|Overall Study|Withdrawal by Subject|2|||
144622322|NCT00903929|521473719|FG000|Overall Study|Adverse Event|0|||
144622323|NCT00903929|521473720|FG001|Overall Study|Adverse Event|0|||
144622324|NCT00903929|521473721|FG002|Overall Study|Adverse Event|0|||
144622325|NCT00903929|521473722|FG003|Overall Study|Adverse Event|1|||
144622326|NCT04947800|521473723|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
144700088|NCT00948896|521754508|FG001|Randomization to 24 Months of Age|Death|0|||
144207478|NCT00468650|519954328|FG000|Overall Study|Lost to Follow-up|4|||
144579221|NCT04020185|521320449|FG004|Overall Study|Patient in hospice|0|||
144579222|NCT04020185|521320450|FG005|Overall Study|Patient in hospice|0|||
144207479|NCT00468650|519954328|FG000|Overall Study|Withdrawal by Subject|2|||
144207480|NCT00468650|519954328|FG000|Overall Study|Protocol Violation|1|||
144579223|NCT04020185|521320451|FG006|Overall Study|Patient in hospice|0|||
144579224|NCT04020185|521320452|FG007|Overall Study|Patient in hospice|0|||
144579225|NCT04020185|521320445|FG000|Overall Study|Continuing on expanded access|0|||
144579226|NCT04020185|521320446|FG001|Overall Study|Continuing on expanded access|0|||
144579227|NCT04020185|521320447|FG002|Overall Study|Continuing on expanded access|0|||
144579228|NCT04020185|521320448|FG003|Overall Study|Continuing on expanded access|0|||
144579229|NCT04020185|521320449|FG004|Overall Study|Continuing on expanded access|0|||
144579230|NCT04020185|521320450|FG005|Overall Study|Continuing on expanded access|0|||
144579231|NCT04020185|521320451|FG006|Overall Study|Continuing on expanded access|1|||
144579232|NCT04020185|521320452|FG007|Overall Study|Continuing on expanded access|1|||
144579233|NCT00527787|521320455|FG000|Overall Study|Adverse Event|14|||
144579234|NCT00527787|521320456|FG001|Overall Study|Adverse Event|24|||
144579235|NCT00527787|521320455|FG000|Overall Study|Withdrawal by Subject|13|||
144579236|NCT00527787|521320456|FG001|Overall Study|Withdrawal by Subject|25|||
144579237|NCT00527787|521320455|FG000|Overall Study|Lost to Follow-up|5|||
144579238|NCT00527787|521320456|FG001|Overall Study|Lost to Follow-up|2|||
144579239|NCT00527787|521320455|FG000|Overall Study|Duodenal Ulcer|1|||
144579240|NCT00527787|521320456|FG001|Overall Study|Duodenal Ulcer|10|||
144579241|NCT00527787|521320455|FG000|Overall Study|misc|5|||
144579242|NCT00527787|521320456|FG001|Overall Study|misc|2|||
144579243|NCT01499303|521320457|FG000|Overall Study|Ongoing|2|||
144579244|NCT01499303|521320458|FG001|Overall Study|Ongoing|1|||
144579245|NCT01499303|521320457|FG000|Overall Study|Withdrawal by Subject|0|||
144579246|NCT01499303|521320458|FG001|Overall Study|Withdrawal by Subject|1|||
144579247|NCT01499303|521320457|FG000|Overall Study|Adverse Event|1|||
144579248|NCT01499303|521320458|FG001|Overall Study|Adverse Event|4|||
144579249|NCT01499303|521320457|FG000|Overall Study|Other|0|||
144579250|NCT01499303|521320458|FG001|Overall Study|Other|1|||
144579251|NCT03435692|521320460|FG000|Overall Study|Lack of Efficacy|2|||
144579252|NCT03435692|521320461|FG001|Overall Study|Lack of Efficacy|2|||
144579253|NCT03435692|521320462|FG002|Overall Study|Lack of Efficacy|0|||
144579254|NCT04313608|521320463|FG000|Overall Study|Death|12|||
144579255|NCT04313608|521320464|FG001|Overall Study|Death|3|||
144579256|NCT01145898|521320465|FG000|3-year Treatment|medication change by treating physician|3|||
144579257|NCT01145898|521320466|FG001|3-year Treatment|medication change by treating physician|16|||
144579258|NCT02440425|521320467|FG000|Overall Study|Death likely due to disease progression|1|||
144579259|NCT02440425|521320467|FG000|Overall Study|Withdrawal by Subject|2|||
144579260|NCT02440425|521320467|FG000|Overall Study|Adverse Event|1|||
144579261|NCT02440425|521320467|FG000|Overall Study|Adverse Event/Ineligible|1|||
144579262|NCT00842244|521320468|FG000|Overall Study|Death|3|||
144579263|NCT00842244|521320468|FG000|Overall Study|Withdrawal by Subject|1|||
144579264|NCT00842244|521320468|FG000|Overall Study|Other|17|||
144579265|NCT04145700|521320469|FG000|Overall Study|Withdrawal by Subject|8|||
144579266|NCT04145700|521320470|FG001|Overall Study|Withdrawal by Subject|3|||
144579267|NCT00780559|521320471|FG000|Overall Study|Lost to Follow-up|2|||
144579268|NCT00780559|521320472|FG001|Overall Study|Lost to Follow-up|7|||
144579269|NCT00780559|521320471|FG000|Overall Study|Death|1|||
144579270|NCT00780559|521320472|FG001|Overall Study|Death|0|||
144579271|NCT01327846|521320474|FG000|Core Phase|Subject decision (vital status: missing)|1|||
144579272|NCT01327846|521320475|FG001|Core Phase|Subject decision (vital status: missing)|2|||
144579273|NCT01327846|521320476|FG002|Core Phase|Subject decision (vital status: missing)|2|||
144579274|NCT01327846|521320477|FG003|Core Phase|Subject decision (vital status: missing)|1|||
144579275|NCT01327846|521320474|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
144579276|NCT01327846|521320475|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
144579277|NCT01327846|521320476|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
144579278|NCT01327846|521320477|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
144579279|NCT01327846|521320474|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
144579280|NCT01327846|521320475|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
144579281|NCT01327846|521320476|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
144579282|NCT01327846|521320477|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
144579283|NCT01327846|521320474|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
144579284|NCT01327846|521320475|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
144579285|NCT01327846|521320476|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
144579286|NCT01327846|521320477|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
144579287|NCT01327846|521320474|FG000|Core Phase|Lost to Follow-up|3|||
144579288|NCT01327846|521320475|FG001|Core Phase|Lost to Follow-up|3|||
144579289|NCT01327846|521320476|FG002|Core Phase|Lost to Follow-up|4|||
144579290|NCT01327846|521320477|FG003|Core Phase|Lost to Follow-up|5|||
144579291|NCT01327846|521320474|FG000|Extension Phase|Study terminated by sponsor|1073|||
144579292|NCT01327846|521320475|FG001|Extension Phase|Study terminated by sponsor|1124|||
144579293|NCT01327846|521320476|FG002|Extension Phase|Study terminated by sponsor|1067|||
144579294|NCT01327846|521320477|FG003|Extension Phase|Study terminated by sponsor|1660|||
144730237|NCT00912288|521868177|FG001|Overall Study|Withdrawal by Subject|3|||
144579295|NCT01327846|521320474|FG000|Extension Phase|Withdrawal by Subject|20|||
144579296|NCT01327846|521320475|FG001|Extension Phase|Withdrawal by Subject|13|||
144579297|NCT01327846|521320476|FG002|Extension Phase|Withdrawal by Subject|19|||
144579298|NCT01327846|521320477|FG003|Extension Phase|Withdrawal by Subject|37|||
144579299|NCT01327846|521320474|FG000|Extension Phase|Lost to Follow-up|4|||
144579300|NCT01327846|521320475|FG001|Extension Phase|Lost to Follow-up|3|||
144579301|NCT01327846|521320476|FG002|Extension Phase|Lost to Follow-up|4|||
144579302|NCT01327846|521320477|FG003|Extension Phase|Lost to Follow-up|7|||
144579303|NCT01327846|521320474|FG000|Extension Phase|Technical Problems|2|||
144579304|NCT01327846|521320475|FG001|Extension Phase|Technical Problems|4|||
144579305|NCT01327846|521320476|FG002|Extension Phase|Technical Problems|2|||
144579306|NCT01327846|521320477|FG003|Extension Phase|Technical Problems|2|||
144579307|NCT00203268|521320483|FG000|Early Treatment|only treated one headache|2|||
144579308|NCT00203268|521320483|FG000|Early Treatment|Lost to Follow-up|1|||
144579309|NCT00203268|521320483|FG000|Early Treatment|Withdrawal by Subject|1|||
144579310|NCT01254747|521320486|FG000|Overall Study|Unacceptable subjective vision|0|||
144579311|NCT01254747|521320487|FG001|Overall Study|Unacceptable subjective vision|0|||
144579312|NCT01254747|521320488|FG002|Overall Study|Unacceptable subjective vision|0|||
144579313|NCT01254747|521320489|FG003|Overall Study|Unacceptable subjective vision|2|||
144579314|NCT01254747|521320486|FG000|Overall Study|Difficult removal handling|0|||
144579315|NCT01254747|521320487|FG001|Overall Study|Difficult removal handling|0|||
144579316|NCT01254747|521320488|FG002|Overall Study|Difficult removal handling|1|||
144579317|NCT01254747|521320489|FG003|Overall Study|Difficult removal handling|0|||
144579318|NCT01254747|521320486|FG000|Overall Study|Symptoms and problems|0|||
144579319|NCT01254747|521320487|FG001|Overall Study|Symptoms and problems|2|||
144579320|NCT01254747|521320488|FG002|Overall Study|Symptoms and problems|1|||
144579321|NCT01254747|521320489|FG003|Overall Study|Symptoms and problems|0|||
144579322|NCT01254747|521320486|FG000|Overall Study|Lost to Follow-up|0|||
144579323|NCT01254747|521320487|FG001|Overall Study|Lost to Follow-up|0|||
144579324|NCT01254747|521320488|FG002|Overall Study|Lost to Follow-up|1|||
144579325|NCT01254747|521320489|FG003|Overall Study|Lost to Follow-up|0|||
144579326|NCT01254747|521320486|FG000|Overall Study|Biomicroscopy|0|||
144579327|NCT01254747|521320487|FG001|Overall Study|Biomicroscopy|0|||
144579328|NCT01254747|521320488|FG002|Overall Study|Biomicroscopy|1|||
144579329|NCT01254747|521320489|FG003|Overall Study|Biomicroscopy|0|||
144579330|NCT01254747|521320486|FG000|Overall Study|Discomfort|0|||
144579331|NCT01254747|521320487|FG001|Overall Study|Discomfort|4|||
144579332|NCT01254747|521320488|FG002|Overall Study|Discomfort|0|||
144579333|NCT01254747|521320489|FG003|Overall Study|Discomfort|0|||
144579334|NCT00846807|521320490|FG000|Overall Study|Adverse Event|270|||
144579335|NCT00846807|521320490|FG000|Overall Study|Lost to Follow-up|94|||
144579336|NCT00846807|521320490|FG000|Overall Study|Withdrawal by Subject|56|||
144579337|NCT00846807|521320490|FG000|Overall Study|Non compliant with European label|7|||
144579338|NCT00846807|521320490|FG000|Overall Study|Switch to other anticoagulants|89|||
144579339|NCT00846807|521320490|FG000|Overall Study|No prescription after hospital discharge|56|||
144579340|NCT00846807|521320490|FG000|Overall Study|Other|60|||
144579341|NCT00245960|521320491|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
144579342|NCT00245960|521320492|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
144579343|NCT00245960|521320491|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
144579344|NCT00245960|521320492|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
144579345|NCT00245960|521320491|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
144579346|NCT00245960|521320492|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
144579347|NCT00245960|521320491|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
144579348|NCT00245960|521320492|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
144579349|NCT00245960|521320491|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
144579350|NCT00245960|521320492|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
144579351|NCT00245960|521320491|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
144579352|NCT00245960|521320492|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
144579353|NCT00245960|521320491|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
144579354|NCT00245960|521320492|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
144579355|NCT00245960|521320491|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
144579356|NCT00245960|521320492|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
144579357|NCT00245960|521320491|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
144579358|NCT00245960|521320492|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
144579359|NCT00245960|521320491|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
144579360|NCT00245960|521320492|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
144207481|NCT02087189|519954329|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
144579361|NCT00245960|521320491|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
144579362|NCT00245960|521320492|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
144579363|NCT00245960|521320491|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
144579364|NCT00245960|521320492|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
144579365|NCT00737698|521320493|FG000|Overall Study|Withdrawal by Subject|6|||
144579366|NCT00737698|521320494|FG001|Overall Study|Withdrawal by Subject|5|||
144579367|NCT00737698|521320495|FG002|Overall Study|Withdrawal by Subject|3|||
144579368|NCT00737698|521320493|FG000|Overall Study|Death|0|||
144579369|NCT00737698|521320494|FG001|Overall Study|Death|0|||
144579370|NCT00737698|521320495|FG002|Overall Study|Death|1|||
144579371|NCT01067846|521320496|FG000|Overall Study|Lost to Follow-up|17|||
144579372|NCT01067846|521320497|FG001|Overall Study|Lost to Follow-up|19|||
144207482|NCT04693416|519954330|FG000|Overall Study|Lost to Follow-up|13|||
144579373|NCT01067846|521320496|FG000|Overall Study|Withdrawal by Subject|1|||
144579374|NCT01067846|521320497|FG001|Overall Study|Withdrawal by Subject|0|||
144579375|NCT01067846|521320496|FG000|Overall Study|participation in other tx study|1|||
144579376|NCT01067846|521320497|FG001|Overall Study|participation in other tx study|0|||
144579377|NCT02817906|521320498|FG000|Overall Study|Adverse Event|3|||
144579378|NCT02817906|521320499|FG001|Overall Study|Adverse Event|0|||
144579379|NCT02817906|521320498|FG000|Overall Study|Lack of Efficacy|1|||
144579380|NCT02817906|521320499|FG001|Overall Study|Lack of Efficacy|0|||
144579381|NCT02817906|521320498|FG000|Overall Study|Protocol Violation|1|||
144579382|NCT02817906|521320499|FG001|Overall Study|Protocol Violation|1|||
144579383|NCT02817906|521320498|FG000|Overall Study|Study Terminated by Sponsor|2|||
144579384|NCT02817906|521320499|FG001|Overall Study|Study Terminated by Sponsor|2|||
144579385|NCT02817906|521320498|FG000|Overall Study|Withdrawal by Subject|7|||
144579386|NCT02817906|521320499|FG001|Overall Study|Withdrawal by Subject|0|||
144579387|NCT02817906|521320498|FG000|Overall Study|Other|2|||
144579388|NCT02817906|521320499|FG001|Overall Study|Other|2|||
144579389|NCT04608773|521320505|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
144579390|NCT04608773|521320506|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
144579391|NCT04608773|521320505|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
144579392|NCT04608773|521320506|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
144579393|NCT04608773|521320505|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
144579394|NCT04608773|521320506|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
144579395|NCT04608773|521320505|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
144579396|NCT04608773|521320506|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
144579397|NCT04608773|521320505|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
144579398|NCT04608773|521320506|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
144579399|NCT00972322|521320507|FG000|Overall Study|Adverse Event|2|||
144579400|NCT00972322|521320508|FG001|Overall Study|Adverse Event|1|||
144579401|NCT00972322|521320507|FG000|Overall Study|Positive drug screen|0|||
144579402|NCT00972322|521320508|FG001|Overall Study|Positive drug screen|1|||
144579403|NCT00972322|521320507|FG000|Overall Study|Lost to Follow-up|0|||
144579404|NCT00972322|521320508|FG001|Overall Study|Lost to Follow-up|1|||
144579405|NCT00972322|521320507|FG000|Overall Study|Consistently high glucose values|1|||
144579406|NCT00972322|521320508|FG001|Overall Study|Consistently high glucose values|0|||
144579407|NCT00316017|521320513|FG000|Overall Study|Protocol Violation|11|||
144579408|NCT00316017|521320514|FG001|Overall Study|Protocol Violation|13|||
144579409|NCT00316017|521320515|FG002|Overall Study|Protocol Violation|19|||
144579410|NCT05235269|521320533|FG000|Overall Study|Adverse Event|1|||
144579411|NCT05235269|521320533|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
144579412|NCT05235269|521320533|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
144579413|NCT03810235|521320534|FG000|Overall Study|Withdrawal by Subject|2|||
144579414|NCT03810235|521320535|FG001|Overall Study|Withdrawal by Subject|0|||
144579415|NCT00798434|521320536|FG000|Double-Blind|Adverse Event|22|||
144579416|NCT00798434|521320537|FG001|Double-Blind|Adverse Event|46|||
144579417|NCT00798434|521320536|FG000|Double-Blind|Death|0|||
144579418|NCT00798434|521320537|FG001|Double-Blind|Death|1|||
144579419|NCT00798434|521320536|FG000|Double-Blind|Lost to Follow-up|1|||
144579420|NCT00798434|521320537|FG001|Double-Blind|Lost to Follow-up|0|||
144579421|NCT00798434|521320536|FG000|Double-Blind|Lack of Efficacy|8|||
144579422|NCT00798434|521320537|FG001|Double-Blind|Lack of Efficacy|12|||
144579423|NCT00798434|521320536|FG000|Double-Blind|Withdrawal by Subject|17|||
144579424|NCT00798434|521320537|FG001|Double-Blind|Withdrawal by Subject|14|||
144579425|NCT00798434|521320536|FG000|Double-Blind|Protocol Violation|1|||
144579426|NCT00798434|521320537|FG001|Double-Blind|Protocol Violation|4|||
144579427|NCT00798434|521320536|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
144579428|NCT00798434|521320537|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
144579429|NCT00798434|521320536|FG000|Double-Blind|Other|1|||
144579430|NCT00798434|521320537|FG001|Double-Blind|Other|0|||
144579431|NCT00798434|521320536|FG000|Double-Blind|Not Treated|3|||
144579432|NCT00798434|521320537|FG001|Double-Blind|Not Treated|6|||
144579433|NCT00798434|521320536|FG000|Open-Label|Adverse Event|33|||
144579434|NCT00798434|521320537|FG001|Open-Label|Adverse Event|11|||
144579435|NCT00798434|521320536|FG000|Open-Label|Lack of Efficacy|5|||
144579436|NCT00798434|521320537|FG001|Open-Label|Lack of Efficacy|11|||
144579437|NCT00798434|521320536|FG000|Open-Label|Withdrawal by Subject|2|||
144579438|NCT00798434|521320537|FG001|Open-Label|Withdrawal by Subject|7|||
144579439|NCT00798434|521320536|FG000|Open-Label|Protocol Violation|1|||
144579440|NCT00798434|521320537|FG001|Open-Label|Protocol Violation|0|||
144579441|NCT00798434|521320536|FG000|Open-Label|Other|1|||
144579442|NCT00798434|521320537|FG001|Open-Label|Other|2|||
144579443|NCT00798434|521320536|FG000|Open-Label|Not Treated|0|||
144579444|NCT00798434|521320537|FG001|Open-Label|Not Treated|1|||
144579445|NCT03682185|521320541|FG000|Overall Study|Lost to Follow-up|4|||
144579446|NCT03682185|521320542|FG001|Overall Study|Lost to Follow-up|7|||
144579447|NCT03682185|521320543|FG002|Overall Study|Lost to Follow-up|4|||
144579448|NCT03682185|521320544|FG003|Overall Study|Lost to Follow-up|7|||
144579449|NCT03682185|521320545|FG004|Overall Study|Lost to Follow-up|1|||
144579450|NCT03682185|521320541|FG000|Overall Study|Withdrawal by Subject|7|||
144579451|NCT03682185|521320542|FG001|Overall Study|Withdrawal by Subject|3|||
144579452|NCT03682185|521320543|FG002|Overall Study|Withdrawal by Subject|7|||
144579453|NCT03682185|521320544|FG003|Overall Study|Withdrawal by Subject|3|||
144579454|NCT03682185|521320545|FG004|Overall Study|Withdrawal by Subject|0|||
144579455|NCT04908631|521320546|FG000|Overall Study|Lost to Follow-up|1|||
144579456|NCT04908631|521320546|FG000|Overall Study|Physician Decision|1|||
144579457|NCT04908631|521320546|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
144579458|NCT02336451|521320550|FG000|Overall Study|Adverse Event|1|||
144579459|NCT02336451|521320551|FG001|Overall Study|Adverse Event|2|||
144579460|NCT02336451|521320552|FG002|Overall Study|Adverse Event|0|||
144579461|NCT02336451|521320553|FG003|Overall Study|Adverse Event|6|||
144579462|NCT02336451|521320554|FG004|Overall Study|Adverse Event|4|||
144579463|NCT02336451|521320550|FG000|Overall Study|Death|6|||
144579464|NCT02336451|521320551|FG001|Overall Study|Death|2|||
144579465|NCT02336451|521320552|FG002|Overall Study|Death|3|||
144579466|NCT02336451|521320553|FG003|Overall Study|Death|6|||
144579467|NCT02336451|521320554|FG004|Overall Study|Death|6|||
144579468|NCT02336451|521320550|FG000|Overall Study|Physician Decision|9|||
144579469|NCT02336451|521320551|FG001|Overall Study|Physician Decision|6|||
144579470|NCT02336451|521320552|FG002|Overall Study|Physician Decision|7|||
144579471|NCT02336451|521320553|FG003|Overall Study|Physician Decision|16|||
144579472|NCT02336451|521320554|FG004|Overall Study|Physician Decision|3|||
144579473|NCT02336451|521320550|FG000|Overall Study|Progressive disease|23|||
144579474|NCT02336451|521320551|FG001|Overall Study|Progressive disease|26|||
144579475|NCT02336451|521320552|FG002|Overall Study|Progressive disease|2|||
144579476|NCT02336451|521320553|FG003|Overall Study|Progressive disease|14|||
144579477|NCT02336451|521320554|FG004|Overall Study|Progressive disease|4|||
144579478|NCT02336451|521320550|FG000|Overall Study|Protocol Violation|1|||
144579479|NCT02336451|521320551|FG001|Overall Study|Protocol Violation|0|||
144579480|NCT02336451|521320552|FG002|Overall Study|Protocol Violation|0|||
144579481|NCT02336451|521320553|FG003|Overall Study|Protocol Violation|0|||
144579482|NCT02336451|521320554|FG004|Overall Study|Protocol Violation|0|||
144579483|NCT02336451|521320550|FG000|Overall Study|Patient/guardian decision|2|||
144579484|NCT02336451|521320551|FG001|Overall Study|Patient/guardian decision|4|||
144579485|NCT02336451|521320552|FG002|Overall Study|Patient/guardian decision|0|||
144579486|NCT02336451|521320553|FG003|Overall Study|Patient/guardian decision|2|||
144579487|NCT02336451|521320554|FG004|Overall Study|Patient/guardian decision|1|||
144579488|NCT03520712|521320556|FG000|Overall Study|Early termination of the study by Sponsor|2|||
144579489|NCT02344290|521320567|FG000|Overall Study|Withdrawal by Subject|315|||
144579490|NCT02344290|521320568|FG001|Overall Study|Withdrawal by Subject|324|||
144579491|NCT02344290|521320567|FG000|Overall Study|Lost to Follow-up|258|||
144579492|NCT02344290|521320568|FG001|Overall Study|Lost to Follow-up|249|||
144579493|NCT02344290|521320567|FG000|Overall Study|Unable to get to clinic|69|||
144579494|NCT02344290|521320568|FG001|Overall Study|Unable to get to clinic|60|||
144579495|NCT02344290|521320567|FG000|Overall Study|Physician Decision|25|||
144579496|NCT02344290|521320568|FG001|Overall Study|Physician Decision|25|||
144579497|NCT02344290|521320567|FG000|Overall Study|Site Closure|15|||
144579498|NCT02344290|521320568|FG001|Overall Study|Site Closure|19|||
144579499|NCT02344290|521320567|FG000|Overall Study|Other|5|||
144579500|NCT02344290|521320568|FG001|Overall Study|Other|3|||
144579501|NCT04047862|521320572|FG000|Overall Study|Death|0|||
144579502|NCT04047862|521320573|FG001|Overall Study|Death|0|||
144579503|NCT04047862|521320574|FG002|Overall Study|Death|4|||
144579504|NCT04047862|521320575|FG003|Overall Study|Death|7|||
144579505|NCT04047862|521320576|FG004|Overall Study|Death|2|||
144579506|NCT04047862|521320577|FG005|Overall Study|Death|4|||
144579507|NCT04047862|521320578|FG006|Overall Study|Death|3|||
144579508|NCT04047862|521320579|FG007|Overall Study|Death|24|||
144579509|NCT04047862|521320580|FG008|Overall Study|Death|24|||
144579510|NCT04047862|521320581|FG009|Overall Study|Death|22|||
144579511|NCT04047862|521320582|FG010|Overall Study|Death|35|||
144579512|NCT04047862|521320583|FG011|Overall Study|Death|18|||
144579513|NCT04047862|521320584|FG012|Overall Study|Death|14|||
144579514|NCT04047862|521320585|FG013|Overall Study|Death|6|||
144579515|NCT04047862|521320586|FG014|Overall Study|Death|19|||
144579516|NCT04047862|521320587|FG015|Overall Study|Death|42|||
144579517|NCT04047862|521320588|FG016|Overall Study|Death|9|||
144579518|NCT04047862|521320589|FG017|Overall Study|Death|8|||
144579519|NCT04047862|521320590|FG018|Overall Study|Death|10|||
144579520|NCT04047862|521320572|FG000|Overall Study|Withdrawal by Subject|0|||
144579521|NCT04047862|521320573|FG001|Overall Study|Withdrawal by Subject|0|||
144579522|NCT04047862|521320574|FG002|Overall Study|Withdrawal by Subject|0|||
144579523|NCT04047862|521320575|FG003|Overall Study|Withdrawal by Subject|5|||
144579524|NCT04047862|521320576|FG004|Overall Study|Withdrawal by Subject|2|||
144579525|NCT04047862|521320577|FG005|Overall Study|Withdrawal by Subject|0|||
144579526|NCT04047862|521320578|FG006|Overall Study|Withdrawal by Subject|1|||
144579527|NCT04047862|521320579|FG007|Overall Study|Withdrawal by Subject|0|||
144579528|NCT04047862|521320580|FG008|Overall Study|Withdrawal by Subject|4|||
144579529|NCT04047862|521320581|FG009|Overall Study|Withdrawal by Subject|4|||
144579530|NCT04047862|521320582|FG010|Overall Study|Withdrawal by Subject|4|||
144579531|NCT04047862|521320583|FG011|Overall Study|Withdrawal by Subject|2|||
144730238|NCT00912288|521868176|FG000|Overall Study|Study terminated by sponsor|34|||
144730239|NCT00912288|521868177|FG001|Overall Study|Study terminated by sponsor|35|||
144730240|NCT00912288|521868176|FG000|Overall Study|Other|1|||
144730241|NCT00912288|521868177|FG001|Overall Study|Other|0|||
144730242|NCT01440283|521868178|FG000|Overall Study|Death|3|||
144730243|NCT01440283|521868178|FG000|Overall Study|Withdrawal by Subject|4|||
144207483|NCT04693416|519954331|FG001|Overall Study|Lost to Follow-up|0|||
144207484|NCT00474266|519954332|FG000|Overall Study|Withdrawal by Subject|7|||
144579532|NCT04047862|521320584|FG012|Overall Study|Withdrawal by Subject|3|||
144579533|NCT04047862|521320585|FG013|Overall Study|Withdrawal by Subject|0|||
144579534|NCT04047862|521320586|FG014|Overall Study|Withdrawal by Subject|9|||
144579535|NCT04047862|521320587|FG015|Overall Study|Withdrawal by Subject|5|||
144579536|NCT04047862|521320588|FG016|Overall Study|Withdrawal by Subject|1|||
144579537|NCT04047862|521320589|FG017|Overall Study|Withdrawal by Subject|3|||
144579538|NCT04047862|521320590|FG018|Overall Study|Withdrawal by Subject|1|||
144579539|NCT04047862|521320572|FG000|Overall Study|Lost to Follow-up|0|||
144579540|NCT04047862|521320573|FG001|Overall Study|Lost to Follow-up|0|||
144579541|NCT04047862|521320574|FG002|Overall Study|Lost to Follow-up|1|||
144579542|NCT04047862|521320575|FG003|Overall Study|Lost to Follow-up|0|||
144579543|NCT04047862|521320576|FG004|Overall Study|Lost to Follow-up|0|||
144579544|NCT04047862|521320577|FG005|Overall Study|Lost to Follow-up|0|||
144579545|NCT04047862|521320578|FG006|Overall Study|Lost to Follow-up|0|||
144579546|NCT04047862|521320579|FG007|Overall Study|Lost to Follow-up|1|||
144579547|NCT04047862|521320580|FG008|Overall Study|Lost to Follow-up|0|||
144579548|NCT04047862|521320581|FG009|Overall Study|Lost to Follow-up|1|||
144579549|NCT04047862|521320582|FG010|Overall Study|Lost to Follow-up|0|||
144579550|NCT04047862|521320583|FG011|Overall Study|Lost to Follow-up|3|||
144579551|NCT04047862|521320584|FG012|Overall Study|Lost to Follow-up|0|||
144579552|NCT04047862|521320585|FG013|Overall Study|Lost to Follow-up|0|||
144579553|NCT04047862|521320586|FG014|Overall Study|Lost to Follow-up|2|||
144579554|NCT04047862|521320587|FG015|Overall Study|Lost to Follow-up|2|||
144579555|NCT04047862|521320588|FG016|Overall Study|Lost to Follow-up|1|||
144579556|NCT04047862|521320589|FG017|Overall Study|Lost to Follow-up|0|||
144579557|NCT04047862|521320590|FG018|Overall Study|Lost to Follow-up|0|||
144579558|NCT04047862|521320572|FG000|Overall Study|Physician Decision|0|||
144579559|NCT04047862|521320573|FG001|Overall Study|Physician Decision|0|||
144579560|NCT04047862|521320574|FG002|Overall Study|Physician Decision|0|||
144579561|NCT04047862|521320575|FG003|Overall Study|Physician Decision|1|||
144622327|NCT04947800|521473724|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
144622328|NCT04947800|521473725|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
144622329|NCT03977467|521473726|FG000|Overall Study|Disease Progression|1|||
144622330|NCT03977467|521473727|FG001|Overall Study|Disease Progression|1|||
144622331|NCT03977467|521473728|FG002|Overall Study|Disease Progression|30|||
144622332|NCT03977467|521473729|FG003|Overall Study|Disease Progression|0|||
144622333|NCT03977467|521473726|FG000|Overall Study|Adverse Event|0|||
144622334|NCT03977467|521473727|FG001|Overall Study|Adverse Event|1|||
144622335|NCT03977467|521473728|FG002|Overall Study|Adverse Event|0|||
144622336|NCT03977467|521473729|FG003|Overall Study|Adverse Event|0|||
144622337|NCT03977467|521473726|FG000|Overall Study|Death|0|||
144622338|NCT03977467|521473727|FG001|Overall Study|Death|0|||
144622339|NCT03977467|521473728|FG002|Overall Study|Death|3|||
144622340|NCT03977467|521473729|FG003|Overall Study|Death|0|||
144622341|NCT03977467|521473726|FG000|Overall Study|Lack of Efficacy|0|||
144730244|NCT01440283|521868178|FG000|Overall Study|Physician Decision|3|||
144730245|NCT02087904|521868181|FG000|Overall Study|Did Not Receive Study Drug|0|||
144207485|NCT00474266|519954333|FG001|Overall Study|Withdrawal by Subject|20|||
144207486|NCT00474266|519954334|FG002|Overall Study|Withdrawal by Subject|4|||
144207487|NCT00474266|519954335|FG003|Overall Study|Withdrawal by Subject|7|||
144207488|NCT00369317|519954336|FG000|Overall Study|Adverse Event|3|||
144207489|NCT00369317|519954336|FG000|Overall Study|Death|1|||
144207490|NCT00369317|519954336|FG000|Overall Study|Lack of Efficacy|5|||
144207491|NCT00369317|519954336|FG000|Overall Study|Physician Decision|2|||
144207492|NCT00369317|519954336|FG000|Overall Study|Withdrawal by Subject|8|||
144207493|NCT00369317|519954336|FG000|Overall Study|Ineligible|1|||
144207494|NCT00426361|519954338|FG000|Overall Study|Lost to Follow-up|3|||
144579562|NCT04047862|521320576|FG004|Overall Study|Physician Decision|0|||
144579563|NCT04047862|521320577|FG005|Overall Study|Physician Decision|0|||
144579564|NCT04047862|521320578|FG006|Overall Study|Physician Decision|0|||
144579565|NCT04047862|521320579|FG007|Overall Study|Physician Decision|0|||
144579566|NCT04047862|521320580|FG008|Overall Study|Physician Decision|0|||
144579567|NCT04047862|521320581|FG009|Overall Study|Physician Decision|0|||
144579568|NCT04047862|521320582|FG010|Overall Study|Physician Decision|0|||
144579569|NCT04047862|521320583|FG011|Overall Study|Physician Decision|0|||
144579570|NCT04047862|521320584|FG012|Overall Study|Physician Decision|0|||
144579571|NCT04047862|521320585|FG013|Overall Study|Physician Decision|0|||
144579572|NCT04047862|521320586|FG014|Overall Study|Physician Decision|1|||
144579573|NCT04047862|521320587|FG015|Overall Study|Physician Decision|0|||
144207495|NCT00426361|519954339|FG001|Overall Study|Lost to Follow-up|2|||
144622342|NCT03977467|521473727|FG001|Overall Study|Lack of Efficacy|0|||
144579574|NCT04047862|521320588|FG016|Overall Study|Physician Decision|1|||
144579575|NCT04047862|521320589|FG017|Overall Study|Physician Decision|0|||
144579576|NCT04047862|521320590|FG018|Overall Study|Physician Decision|0|||
144579577|NCT04047862|521320572|FG000|Overall Study|Completed all Assessments|1|||
144579578|NCT04047862|521320573|FG001|Overall Study|Completed all Assessments|3|||
144579579|NCT04047862|521320574|FG002|Overall Study|Completed all Assessments|1|||
144579580|NCT04047862|521320575|FG003|Overall Study|Completed all Assessments|3|||
144579581|NCT04047862|521320576|FG004|Overall Study|Completed all Assessments|2|||
144579582|NCT04047862|521320577|FG005|Overall Study|Completed all Assessments|5|||
144579583|NCT04047862|521320578|FG006|Overall Study|Completed all Assessments|7|||
144579584|NCT04047862|521320579|FG007|Overall Study|Completed all Assessments|0|||
144579585|NCT04047862|521320580|FG008|Overall Study|Completed all Assessments|0|||
144579586|NCT04047862|521320581|FG009|Overall Study|Completed all Assessments|0|||
144579587|NCT04047862|521320582|FG010|Overall Study|Completed all Assessments|0|||
144579588|NCT04047862|521320583|FG011|Overall Study|Completed all Assessments|0|||
144579589|NCT04047862|521320584|FG012|Overall Study|Completed all Assessments|0|||
144579590|NCT04047862|521320585|FG013|Overall Study|Completed all Assessments|0|||
144579591|NCT04047862|521320586|FG014|Overall Study|Completed all Assessments|0|||
144579592|NCT04047862|521320587|FG015|Overall Study|Completed all Assessments|0|||
144579593|NCT04047862|521320588|FG016|Overall Study|Completed all Assessments|0|||
144579594|NCT04047862|521320589|FG017|Overall Study|Completed all Assessments|0|||
144579595|NCT04047862|521320590|FG018|Overall Study|Completed all Assessments|0|||
144579596|NCT04047862|521320572|FG000|Overall Study|Sponsor Decision|0|||
144579597|NCT04047862|521320573|FG001|Overall Study|Sponsor Decision|0|||
144579598|NCT04047862|521320574|FG002|Overall Study|Sponsor Decision|0|||
144579599|NCT04047862|521320575|FG003|Overall Study|Sponsor Decision|0|||
144579600|NCT04047862|521320576|FG004|Overall Study|Sponsor Decision|0|||
144579601|NCT04047862|521320577|FG005|Overall Study|Sponsor Decision|0|||
144579602|NCT04047862|521320578|FG006|Overall Study|Sponsor Decision|0|||
144579603|NCT04047862|521320579|FG007|Overall Study|Sponsor Decision|13|||
144579604|NCT04047862|521320580|FG008|Overall Study|Sponsor Decision|10|||
144579605|NCT04047862|521320581|FG009|Overall Study|Sponsor Decision|18|||
144579606|NCT04047862|521320582|FG010|Overall Study|Sponsor Decision|3|||
144579607|NCT04047862|521320583|FG011|Overall Study|Sponsor Decision|3|||
144579608|NCT04047862|521320584|FG012|Overall Study|Sponsor Decision|4|||
144579609|NCT04047862|521320585|FG013|Overall Study|Sponsor Decision|0|||
144579610|NCT04047862|521320586|FG014|Overall Study|Sponsor Decision|7|||
144579611|NCT04047862|521320587|FG015|Overall Study|Sponsor Decision|8|||
144579612|NCT04047862|521320588|FG016|Overall Study|Sponsor Decision|9|||
144579613|NCT04047862|521320589|FG017|Overall Study|Sponsor Decision|7|||
144579614|NCT04047862|521320590|FG018|Overall Study|Sponsor Decision|8|||
144579615|NCT04047862|521320572|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579616|NCT04047862|521320573|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579617|NCT04047862|521320574|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579618|NCT04047862|521320575|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579619|NCT04047862|521320576|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579620|NCT04047862|521320577|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579621|NCT04047862|521320578|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579622|NCT04047862|521320579|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
144579623|NCT04047862|521320580|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
144622343|NCT03977467|521473728|FG002|Overall Study|Lack of Efficacy|1|||
144622344|NCT03977467|521473729|FG003|Overall Study|Lack of Efficacy|0|||
144622345|NCT03977467|521473726|FG000|Overall Study|Withdrawal by Subject|2|||
144622346|NCT03977467|521473727|FG001|Overall Study|Withdrawal by Subject|1|||
144622347|NCT03977467|521473728|FG002|Overall Study|Withdrawal by Subject|4|||
144622348|NCT03977467|521473729|FG003|Overall Study|Withdrawal by Subject|0|||
144622349|NCT03977467|521473726|FG000|Overall Study|Study Terminated|1|||
144622350|NCT03977467|521473727|FG001|Overall Study|Study Terminated|0|||
144622351|NCT03977467|521473728|FG002|Overall Study|Study Terminated|0|||
144622352|NCT03977467|521473729|FG003|Overall Study|Study Terminated|1|||
144207496|NCT00426361|519954340|FG002|Overall Study|Lost to Follow-up|5|||
144207497|NCT00426361|519954338|FG000|Overall Study|Withdrawal by Subject|1|||
144207498|NCT00426361|519954339|FG001|Overall Study|Withdrawal by Subject|3|||
144207499|NCT00426361|519954340|FG002|Overall Study|Withdrawal by Subject|0|||
144207500|NCT06281171|519954353|FG000|Timepoint 2|Lost to Follow-up|6|||
144579624|NCT04047862|521320581|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579625|NCT04047862|521320582|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
144579626|NCT04047862|521320583|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579627|NCT04047862|521320584|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579628|NCT04047862|521320585|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
144579629|NCT04047862|521320586|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
144579630|NCT04047862|521320587|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
144622353|NCT04440592|521473732|FG000|Overall Study|Adverse Event|8|||
144622354|NCT04440592|521473733|FG001|Overall Study|Adverse Event|0|||
144730246|NCT02087904|521868182|FG001|Overall Study|Did Not Receive Study Drug|0|||
144730247|NCT02087904|521868183|FG002|Overall Study|Did Not Receive Study Drug|2|||
144730248|NCT02087904|521868184|FG003|Overall Study|Did Not Receive Study Drug|1|||
144730249|NCT02087904|521868181|FG000|Overall Study|Adverse Event|8|||
144730250|NCT02087904|521868182|FG001|Overall Study|Adverse Event|4|||
144730251|NCT02087904|521868183|FG002|Overall Study|Adverse Event|4|||
144730252|NCT02087904|521868184|FG003|Overall Study|Adverse Event|12|||
144730253|NCT02087904|521868181|FG000|Overall Study|Lack of Efficacy|3|||
144730254|NCT02087904|521868182|FG001|Overall Study|Lack of Efficacy|6|||
144730255|NCT02087904|521868183|FG002|Overall Study|Lack of Efficacy|3|||
144579631|NCT04047862|521320588|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
144579632|NCT04047862|521320589|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
144579633|NCT04047862|521320590|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
144579634|NCT04047862|521320572|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579635|NCT04047862|521320573|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579636|NCT04047862|521320574|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579637|NCT04047862|521320575|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579638|NCT04047862|521320576|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579639|NCT04047862|521320577|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579640|NCT04047862|521320578|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579641|NCT04047862|521320579|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579642|NCT04047862|521320580|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579643|NCT04047862|521320581|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579644|NCT04047862|521320582|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579645|NCT04047862|521320583|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579646|NCT04047862|521320584|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579647|NCT04047862|521320585|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579648|NCT04047862|521320586|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579649|NCT04047862|521320587|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
144579650|NCT04047862|521320588|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579651|NCT04047862|521320589|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
144579652|NCT04047862|521320590|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
144579653|NCT04047862|521320572|FG000|Overall Study|Other|0|||
144579654|NCT04047862|521320573|FG001|Overall Study|Other|0|||
144579655|NCT04047862|521320574|FG002|Overall Study|Other|0|||
144579656|NCT04047862|521320575|FG003|Overall Study|Other|0|||
144579657|NCT04047862|521320576|FG004|Overall Study|Other|0|||
144579658|NCT04047862|521320577|FG005|Overall Study|Other|0|||
144579659|NCT04047862|521320578|FG006|Overall Study|Other|0|||
144579660|NCT04047862|521320579|FG007|Overall Study|Other|0|||
144579661|NCT04047862|521320580|FG008|Overall Study|Other|0|||
144579662|NCT04047862|521320581|FG009|Overall Study|Other|0|||
144579663|NCT04047862|521320582|FG010|Overall Study|Other|0|||
144579664|NCT04047862|521320583|FG011|Overall Study|Other|0|||
144579665|NCT04047862|521320584|FG012|Overall Study|Other|0|||
144579666|NCT04047862|521320585|FG013|Overall Study|Other|0|||
144579667|NCT04047862|521320586|FG014|Overall Study|Other|2|||
144579668|NCT04047862|521320587|FG015|Overall Study|Other|1|||
144579669|NCT04047862|521320588|FG016|Overall Study|Other|1|||
144579670|NCT04047862|521320589|FG017|Overall Study|Other|1|||
144579671|NCT04047862|521320590|FG018|Overall Study|Other|0|||
144579672|NCT01901432|521321986|FG000|Overall Study|Adverse Event|0|||
144579673|NCT01901432|521321987|FG001|Overall Study|Adverse Event|1|||
144579674|NCT01901432|521321988|FG002|Overall Study|Adverse Event|1|||
144579675|NCT01901432|521321989|FG003|Overall Study|Adverse Event|0|||
144579676|NCT01901432|521321990|FG004|Overall Study|Adverse Event|1|||
144579677|NCT01901432|521321986|FG000|Overall Study|Withdrawal by Subject|0|||
144730256|NCT02087904|521868184|FG003|Overall Study|Lack of Efficacy|2|||
144730257|NCT02087904|521868181|FG000|Overall Study|Other|6|||
144730258|NCT02087904|521868182|FG001|Overall Study|Other|2|||
144730259|NCT02087904|521868183|FG002|Overall Study|Other|4|||
144207501|NCT06281171|519954354|FG001|Timepoint 2|Lost to Follow-up|4|||
144207502|NCT06281171|519954353|FG000|Timepoint 3|Lost to Follow-up|0|||
144207503|NCT06281171|519954354|FG001|Timepoint 3|Lost to Follow-up|5|||
144579678|NCT01901432|521321987|FG001|Overall Study|Withdrawal by Subject|0|||
144730260|NCT02087904|521868184|FG003|Overall Study|Other|4|||
144730261|NCT02087904|521868181|FG000|Overall Study|Withdrawal by Subject|8|||
144730262|NCT02087904|521868182|FG001|Overall Study|Withdrawal by Subject|3|||
144579679|NCT01901432|521321988|FG002|Overall Study|Withdrawal by Subject|1|||
144579680|NCT01901432|521321989|FG003|Overall Study|Withdrawal by Subject|0|||
144579681|NCT01901432|521321990|FG004|Overall Study|Withdrawal by Subject|5|||
144579682|NCT01901432|521321986|FG000|Overall Study|Physician Decision|0|||
144730263|NCT02087904|521868183|FG002|Overall Study|Withdrawal by Subject|7|||
144730264|NCT02087904|521868184|FG003|Overall Study|Withdrawal by Subject|4|||
144207504|NCT04572893|519954360|FG000|Part A|Adverse Event|1|||
144579683|NCT01901432|521321987|FG001|Overall Study|Physician Decision|0|||
144579684|NCT01901432|521321988|FG002|Overall Study|Physician Decision|0|||
144579685|NCT01901432|521321989|FG003|Overall Study|Physician Decision|0|||
144579686|NCT01901432|521321990|FG004|Overall Study|Physician Decision|2|||
144579687|NCT01901432|521321986|FG000|Overall Study|Patient decision to stop study drug|0|||
144579688|NCT01901432|521321987|FG001|Overall Study|Patient decision to stop study drug|0|||
144579689|NCT01901432|521321988|FG002|Overall Study|Patient decision to stop study drug|0|||
144579690|NCT01901432|521321989|FG003|Overall Study|Patient decision to stop study drug|0|||
144579691|NCT01901432|521321990|FG004|Overall Study|Patient decision to stop study drug|1|||
144579692|NCT00379288|521321991|FG000|Overall Study|Adverse Event|5|||
144579693|NCT00379288|521321992|FG001|Overall Study|Adverse Event|6|||
144579694|NCT00379288|521321993|FG002|Overall Study|Adverse Event|2|||
144207505|NCT04572893|519954361|FG001|Part A|Adverse Event|0|||
144207506|NCT04572893|519954362|FG002|Part A|Adverse Event|0|||
144207507|NCT04572893|519954363|FG003|Part A|Adverse Event|0|||
144207508|NCT04572893|519954364|FG004|Part A|Adverse Event|0|||
144207509|NCT04572893|519954365|FG005|Part A|Adverse Event|0|||
144207510|NCT04572893|519954366|FG006|Part A|Adverse Event|0|||
144207511|NCT04572893|519954360|FG000|Part B|Withdrawal by Subject|0|||
144207512|NCT04572893|519954361|FG001|Part B|Withdrawal by Subject|0|||
144207513|NCT04572893|519954362|FG002|Part B|Withdrawal by Subject|0|||
144207514|NCT04572893|519954363|FG003|Part B|Withdrawal by Subject|0|||
144207515|NCT04572893|519954364|FG004|Part B|Withdrawal by Subject|0|||
144207516|NCT04572893|519954365|FG005|Part B|Withdrawal by Subject|1|||
144207517|NCT04572893|519954366|FG006|Part B|Withdrawal by Subject|0|||
144207518|NCT04572893|519954360|FG000|Part B|Study terminated by sponsor|0|||
144207519|NCT04572893|519954361|FG001|Part B|Study terminated by sponsor|0|||
144207520|NCT04572893|519954362|FG002|Part B|Study terminated by sponsor|0|||
144207521|NCT04572893|519954363|FG003|Part B|Study terminated by sponsor|0|||
144207522|NCT04572893|519954364|FG004|Part B|Study terminated by sponsor|7|||
144207523|NCT04572893|519954365|FG005|Part B|Study terminated by sponsor|5|||
144207524|NCT04572893|519954366|FG006|Part B|Study terminated by sponsor|3|||
144207525|NCT04572893|519954360|FG000|Part B|Lost to Follow-up|0|||
144207526|NCT04572893|519954361|FG001|Part B|Lost to Follow-up|0|||
144207527|NCT04572893|519954362|FG002|Part B|Lost to Follow-up|0|||
144207528|NCT04572893|519954363|FG003|Part B|Lost to Follow-up|0|||
144207529|NCT04572893|519954364|FG004|Part B|Lost to Follow-up|0|||
144207530|NCT04572893|519954365|FG005|Part B|Lost to Follow-up|0|||
144207531|NCT04572893|519954366|FG006|Part B|Lost to Follow-up|1|||
144207532|NCT04572893|519954360|FG000|Part B|Adverse Event|0|||
144207533|NCT04572893|519954361|FG001|Part B|Adverse Event|0|||
144207534|NCT04572893|519954362|FG002|Part B|Adverse Event|0|||
144207535|NCT04572893|519954363|FG003|Part B|Adverse Event|0|||
144207536|NCT04572893|519954364|FG004|Part B|Adverse Event|1|||
144207537|NCT04572893|519954365|FG005|Part B|Adverse Event|1|||
144207538|NCT04572893|519954366|FG006|Part B|Adverse Event|0|||
144207539|NCT05038800|519954367|FG000|Overall Study|Death|1|||
144207540|NCT05038800|519954368|FG001|Overall Study|Death|1|||
144207541|NCT05038800|519954369|FG002|Overall Study|Death|5|||
144207542|NCT05038800|519954370|FG003|Overall Study|Death|3|||
144207543|NCT05038800|519954371|FG004|Overall Study|Death|1|||
144207544|NCT05038800|519954367|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144207545|NCT05038800|519954368|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144579695|NCT00379288|521321994|FG003|Overall Study|Adverse Event|0|||
144579696|NCT00379288|521321991|FG000|Overall Study|Treatment Failure|0|||
144579697|NCT00379288|521321992|FG001|Overall Study|Treatment Failure|1|||
144579698|NCT00379288|521321993|FG002|Overall Study|Treatment Failure|0|||
144579699|NCT00379288|521321994|FG003|Overall Study|Treatment Failure|1|||
144579700|NCT00379288|521321991|FG000|Overall Study|Lost to Follow-up|3|||
144579701|NCT00379288|521321992|FG001|Overall Study|Lost to Follow-up|3|||
144579702|NCT00379288|521321993|FG002|Overall Study|Lost to Follow-up|2|||
144579703|NCT00379288|521321994|FG003|Overall Study|Lost to Follow-up|0|||
144579704|NCT00379288|521321991|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
144579705|NCT00379288|521321992|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
144579706|NCT00379288|521321993|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
144579707|NCT00379288|521321994|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
144207546|NCT05038800|519954369|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144207547|NCT05038800|519954370|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144207548|NCT05038800|519954371|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144207549|NCT05038800|519954367|FG000|Overall Study|Lack of Efficacy|0|||
144207550|NCT05038800|519954368|FG001|Overall Study|Lack of Efficacy|0|||
144207551|NCT05038800|519954369|FG002|Overall Study|Lack of Efficacy|0|||
144579708|NCT00379288|521321991|FG000|Overall Study|Subject withdrew-related to study drug|1|||
144579709|NCT00379288|521321992|FG001|Overall Study|Subject withdrew-related to study drug|0|||
144622355|NCT04440592|521473732|FG000|Overall Study|Lost to Follow-up|1|||
144207552|NCT05038800|519954370|FG003|Overall Study|Lack of Efficacy|0|||
144207553|NCT05038800|519954371|FG004|Overall Study|Lack of Efficacy|1|||
144207554|NCT00121134|519954372|FG000|Overall Study|Progression of Disease|5|||
144207555|NCT00121134|519954373|FG001|Overall Study|Progression of Disease|3|||
144579710|NCT00379288|521321993|FG002|Overall Study|Subject withdrew-related to study drug|0|||
144579711|NCT00379288|521321994|FG003|Overall Study|Subject withdrew-related to study drug|1|||
144579712|NCT00379288|521321991|FG000|Overall Study|Noncompliance with protocol|8|||
144579713|NCT00379288|521321992|FG001|Overall Study|Noncompliance with protocol|6|||
144579714|NCT00379288|521321993|FG002|Overall Study|Noncompliance with protocol|2|||
144579715|NCT00379288|521321994|FG003|Overall Study|Noncompliance with protocol|1|||
144579716|NCT00379288|521321991|FG000|Overall Study|Did not meet protocol eligibility|0|||
144579717|NCT00379288|521321992|FG001|Overall Study|Did not meet protocol eligibility|1|||
144622356|NCT04440592|521473733|FG001|Overall Study|Lost to Follow-up|0|||
144207556|NCT00121134|519954374|FG002|Overall Study|Progression of Disease|4|||
144207557|NCT00121134|519954375|FG003|Overall Study|Progression of Disease|2|||
144207558|NCT00121134|519954372|FG000|Overall Study|Toxicity|4|||
144207559|NCT00121134|519954373|FG001|Overall Study|Toxicity|7|||
144207560|NCT00121134|519954374|FG002|Overall Study|Toxicity|13|||
144207561|NCT00121134|519954375|FG003|Overall Study|Toxicity|5|||
144207562|NCT00121134|519954372|FG000|Overall Study|Physician Decision|6|||
144207563|NCT00121134|519954373|FG001|Overall Study|Physician Decision|4|||
144207564|NCT00121134|519954374|FG002|Overall Study|Physician Decision|4|||
144207565|NCT00121134|519954375|FG003|Overall Study|Physician Decision|1|||
144207566|NCT00121134|519954372|FG000|Overall Study|Treatment Delay|1|||
144207567|NCT00121134|519954373|FG001|Overall Study|Treatment Delay|0|||
144207568|NCT00121134|519954374|FG002|Overall Study|Treatment Delay|0|||
144207569|NCT00121134|519954375|FG003|Overall Study|Treatment Delay|0|||
144207570|NCT00121134|519954372|FG000|Overall Study|Intercurrent Illness|0|||
144207571|NCT00121134|519954373|FG001|Overall Study|Intercurrent Illness|0|||
144207572|NCT00121134|519954374|FG002|Overall Study|Intercurrent Illness|0|||
144207573|NCT00121134|519954375|FG003|Overall Study|Intercurrent Illness|1|||
144207574|NCT00121134|519954372|FG000|Overall Study|Patient Personal Reasons|0|||
144207575|NCT00121134|519954373|FG001|Overall Study|Patient Personal Reasons|1|||
144207576|NCT00121134|519954374|FG002|Overall Study|Patient Personal Reasons|0|||
144207577|NCT00121134|519954375|FG003|Overall Study|Patient Personal Reasons|0|||
144207578|NCT02478320|519954378|FG000|Overall Study|Adverse Event|2|||
144207579|NCT02478320|519954379|FG001|Overall Study|Adverse Event|0|||
144207580|NCT02478320|519954378|FG000|Overall Study|Death|1|||
144207581|NCT02478320|519954379|FG001|Overall Study|Death|0|||
144207582|NCT02478320|519954378|FG000|Overall Study|Lack of Efficacy|4|||
144207583|NCT02478320|519954379|FG001|Overall Study|Lack of Efficacy|0|||
144207584|NCT02478320|519954378|FG000|Overall Study|Withdrawal by Subject|2|||
144207585|NCT02478320|519954379|FG001|Overall Study|Withdrawal by Subject|0|||
144207586|NCT02478320|519954378|FG000|Overall Study|Screen Failure|3|||
144207587|NCT02478320|519954379|FG001|Overall Study|Screen Failure|0|||
144207588|NCT04428333|519954380|FG000|Overall Study|Physician Decision|5|||
144207589|NCT04428333|519954381|FG001|Overall Study|Physician Decision|6|||
144207590|NCT04428333|519954380|FG000|Overall Study|Withdrawal by Subject|1|||
144207591|NCT04428333|519954381|FG001|Overall Study|Withdrawal by Subject|3|||
144207592|NCT04428333|519954380|FG000|Overall Study|Study Terminated By Sponsor|14|||
144207593|NCT04428333|519954381|FG001|Overall Study|Study Terminated By Sponsor|16|||
144207594|NCT04853992|519954382|FG000|Treatment Period A|Adverse Event|0|||
144207595|NCT04853992|519954383|FG001|Treatment Period A|Adverse Event|1|||
144207596|NCT04853992|519954382|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
144207597|NCT04853992|519954383|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
144207598|NCT02269163|519954384|FG000|Overall Study|Lost to Follow-up|1|||
144207599|NCT02269163|519954385|FG001|Overall Study|Lost to Follow-up|0|||
144207600|NCT02269163|519954384|FG000|Overall Study|Major protocol violation|0|||
144207601|NCT02269163|519954385|FG001|Overall Study|Major protocol violation|1|||
144207602|NCT02269163|519954384|FG000|Overall Study|Other|2|||
144207603|NCT02269163|519954385|FG001|Overall Study|Other|2|||
144207604|NCT02269163|519954384|FG000|Overall Study|Withdrawal by Subject|0|||
144207605|NCT02269163|519954385|FG001|Overall Study|Withdrawal by Subject|3|||
144207606|NCT02269163|519954384|FG000|Overall Study|Physician Decision|0|||
144207607|NCT02269163|519954385|FG001|Overall Study|Physician Decision|1|||
144207608|NCT00758680|519954386|FG000|Overall Study|Adverse Event|0|||
144207609|NCT00758680|519954387|FG001|Overall Study|Adverse Event|0|||
144207610|NCT00758680|519954388|FG002|Overall Study|Adverse Event|0|||
144207611|NCT00758680|519954389|FG003|Overall Study|Adverse Event|0|||
144207612|NCT00758680|519954390|FG004|Overall Study|Adverse Event|0|||
144207613|NCT00758680|519954391|FG005|Overall Study|Adverse Event|0|||
144207614|NCT00758680|519954392|FG006|Overall Study|Adverse Event|0|||
144207615|NCT00758680|519954393|FG007|Overall Study|Adverse Event|1|||
144207616|NCT00758680|519954394|FG008|Overall Study|Adverse Event|0|||
144579718|NCT00379288|521321993|FG002|Overall Study|Did not meet protocol eligibility|0|||
144579719|NCT00379288|521321994|FG003|Overall Study|Did not meet protocol eligibility|2|||
144207617|NCT00758680|519954395|FG009|Overall Study|Adverse Event|1|||
144207618|NCT00758680|519954386|FG000|Overall Study|Laboratory Adverse Event|0|||
144207619|NCT00758680|519954387|FG001|Overall Study|Laboratory Adverse Event|0|||
144207620|NCT00758680|519954388|FG002|Overall Study|Laboratory Adverse Event|0|||
144207621|NCT00758680|519954389|FG003|Overall Study|Laboratory Adverse Event|0|||
144622357|NCT04440592|521473732|FG000|Overall Study|Withdrawal by Subject|1|||
144207622|NCT00758680|519954390|FG004|Overall Study|Laboratory Adverse Event|0|||
144207623|NCT00758680|519954391|FG005|Overall Study|Laboratory Adverse Event|0|||
144207624|NCT00758680|519954392|FG006|Overall Study|Laboratory Adverse Event|0|||
144207625|NCT00758680|519954393|FG007|Overall Study|Laboratory Adverse Event|0|||
144207626|NCT00758680|519954394|FG008|Overall Study|Laboratory Adverse Event|1|||
144207627|NCT00758680|519954395|FG009|Overall Study|Laboratory Adverse Event|0|||
144207628|NCT00758680|519954386|FG000|Overall Study|Withdrawal by Subject|0|||
144207629|NCT00758680|519954387|FG001|Overall Study|Withdrawal by Subject|0|||
144207630|NCT00758680|519954388|FG002|Overall Study|Withdrawal by Subject|0|||
144207631|NCT00758680|519954389|FG003|Overall Study|Withdrawal by Subject|0|||
144207632|NCT00758680|519954390|FG004|Overall Study|Withdrawal by Subject|0|||
144207633|NCT00758680|519954391|FG005|Overall Study|Withdrawal by Subject|0|||
144207634|NCT00758680|519954392|FG006|Overall Study|Withdrawal by Subject|1|||
144207635|NCT00758680|519954393|FG007|Overall Study|Withdrawal by Subject|0|||
144207636|NCT00758680|519954394|FG008|Overall Study|Withdrawal by Subject|1|||
144207637|NCT00758680|519954395|FG009|Overall Study|Withdrawal by Subject|0|||
144207638|NCT02351960|519954398|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
144207639|NCT02351960|519954399|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
144207640|NCT02351960|519954398|FG000|Overall Study|Voluntary Withdrawal|5|||
144207641|NCT02351960|519954399|FG001|Overall Study|Voluntary Withdrawal|4|||
144207642|NCT02351960|519954398|FG000|Overall Study|Significant Protocol Deviation|0|||
144579720|NCT00379288|521321991|FG000|Overall Study|Administrative|2|||
144579721|NCT00379288|521321992|FG001|Overall Study|Administrative|2|||
144579722|NCT00379288|521321993|FG002|Overall Study|Administrative|0|||
144579723|NCT00379288|521321994|FG003|Overall Study|Administrative|1|||
144207643|NCT02351960|519954399|FG001|Overall Study|Significant Protocol Deviation|5|||
144207644|NCT00319982|519954400|FG000|Overall Study|Withdrawal by Subject|1|||
144207645|NCT00319982|519954401|FG001|Overall Study|Withdrawal by Subject|0|||
144579724|NCT00918879|521321995|FG000|Overall Study|Withdrawal by Subject|4|||
144207646|NCT03480386|519954402|FG000|Overall Study|Did not complete measures at 3-months|17|||
144207647|NCT03480386|519954403|FG001|Overall Study|Did not complete measures at 3-months|14|||
144207648|NCT03480386|519954402|FG000|Overall Study|No baseline measures|11|||
144207649|NCT03480386|519954403|FG001|Overall Study|No baseline measures|14|||
144207650|NCT03480386|519954402|FG000|Overall Study|Death|0|||
144207651|NCT03480386|519954403|FG001|Overall Study|Death|5|||
144207652|NCT03480386|519954402|FG000|Overall Study|Withdrawal by Subject|12|||
144207653|NCT03480386|519954403|FG001|Overall Study|Withdrawal by Subject|8|||
144207654|NCT03480386|519954402|FG000|Overall Study|Lost to Follow-up|2|||
144207655|NCT03480386|519954403|FG001|Overall Study|Lost to Follow-up|1|||
144207656|NCT03480386|519954402|FG000|Overall Study|Complicating disease|0|||
144207657|NCT03480386|519954403|FG001|Overall Study|Complicating disease|1|||
144207658|NCT03480386|519954402|FG000|Overall Study|Disease progression|3|||
144207659|NCT03480386|519954403|FG001|Overall Study|Disease progression|0|||
144207660|NCT03480386|519954402|FG000|Overall Study|Became ineligible|0|||
144207661|NCT03480386|519954403|FG001|Overall Study|Became ineligible|2|||
144207662|NCT00574912|519954404|FG000|Overall Study|Could not place IV lines.|3|||
144207663|NCT00574912|519954404|FG000|Overall Study|scheduling conflicts|3|||
144207664|NCT00574912|519954404|FG000|Overall Study|Physician Decision|2|||
144207665|NCT02342639|519954405|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
144207666|NCT02342639|519954406|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
144207667|NCT02342639|519954405|FG000|Overall Study|Protocol Violation|0|||
144207668|NCT02342639|519954406|FG001|Overall Study|Protocol Violation|2|||
144207669|NCT02293863|519954407|FG000|Overall Study|Death|4|||
144207670|NCT02293863|519954408|FG001|Overall Study|Death|6|||
144207671|NCT02293863|519954409|FG002|Overall Study|Death|4|||
144207672|NCT02293863|519954407|FG000|Overall Study|Lost to Follow-up|2|||
144207673|NCT02293863|519954408|FG001|Overall Study|Lost to Follow-up|2|||
144207674|NCT02293863|519954409|FG002|Overall Study|Lost to Follow-up|2|||
144207675|NCT02293863|519954407|FG000|Overall Study|Withdrawal by Subject|3|||
144207676|NCT02293863|519954408|FG001|Overall Study|Withdrawal by Subject|3|||
144207677|NCT02293863|519954409|FG002|Overall Study|Withdrawal by Subject|1|||
144207678|NCT02293863|519954407|FG000|Overall Study|Reason Not Specified|0|||
144579725|NCT00918879|521321996|FG001|Overall Study|Withdrawal by Subject|4|||
144579726|NCT00918879|521321995|FG000|Overall Study|Lost to Follow-up|1|||
144207679|NCT02293863|519954408|FG001|Overall Study|Reason Not Specified|2|||
144207680|NCT02293863|519954409|FG002|Overall Study|Reason Not Specified|2|||
144207681|NCT02212379|519954410|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
144207682|NCT02212379|519954410|FG000|From Baseline to Week 48|Adverse Event|7|||
144207683|NCT02212379|519954410|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
144207684|NCT02212379|519954410|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
144207685|NCT02212379|519954410|FG000|From Week 48 to Week 96|Adverse Event|1|||
144207686|NCT02212379|519954410|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
144207687|NCT00416884|519954413|FG000|Overall Study|Study terminated due to low accrual|1|||
144207688|NCT00704730|519954414|FG000|Overall Study|Adverse Event|35|||
144207689|NCT00704730|519954415|FG001|Overall Study|Adverse Event|9|||
144579727|NCT00918879|521321996|FG001|Overall Study|Lost to Follow-up|1|||
144207690|NCT00704730|519954414|FG000|Overall Study|Death|11|||
144207691|NCT00704730|519954415|FG001|Overall Study|Death|5|||
144207692|NCT00704730|519954414|FG000|Overall Study|Physician Decision|2|||
144207693|NCT00704730|519954415|FG001|Overall Study|Physician Decision|0|||
144207694|NCT00704730|519954414|FG000|Overall Study|Did not receive drug|5|||
144207695|NCT00704730|519954415|FG001|Overall Study|Did not receive drug|2|||
144207696|NCT00704730|519954414|FG000|Overall Study|Disease progression per PI|58|||
144207697|NCT00704730|519954415|FG001|Overall Study|Disease progression per PI|67|||
144207698|NCT00704730|519954414|FG000|Overall Study|data unavailable|1|||
144207699|NCT00704730|519954415|FG001|Overall Study|data unavailable|0|||
144207700|NCT00704730|519954414|FG000|Overall Study|Withdrawal by Subject|9|||
144207701|NCT00704730|519954415|FG001|Overall Study|Withdrawal by Subject|13|||
144207702|NCT04975191|519956096|FG000|Overall Study|Protocol Violation|1|||
144207703|NCT04975191|519956097|FG001|Overall Study|Protocol Violation|2|||
144207704|NCT04975191|519956098|FG002|Overall Study|Protocol Violation|2|||
144207705|NCT04975191|519956099|FG003|Overall Study|Protocol Violation|2|||
144207706|NCT04975191|519956096|FG000|Overall Study|Lost to Follow-up|13|||
144207707|NCT04975191|519956097|FG001|Overall Study|Lost to Follow-up|3|||
144207708|NCT04975191|519956098|FG002|Overall Study|Lost to Follow-up|8|||
144207709|NCT04975191|519956099|FG003|Overall Study|Lost to Follow-up|8|||
144207710|NCT00761657|519956102|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
144207711|NCT00761657|519956103|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
144207712|NCT00761657|519956104|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
144207713|NCT00761657|519956105|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
144207714|NCT00761657|519956106|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
144207715|NCT00761657|519956107|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
144207716|NCT00761657|519956108|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
144207717|NCT00761657|519956109|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
144207718|NCT00761657|519956110|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
144207719|NCT00761657|519956102|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207720|NCT00761657|519956103|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207721|NCT00761657|519956104|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
144207722|NCT00761657|519956105|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
144207723|NCT00761657|519956106|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207724|NCT00761657|519956107|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207725|NCT00761657|519956108|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207726|NCT00761657|519956109|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207727|NCT00761657|519956110|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
144207728|NCT00761657|519956102|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
144579728|NCT00918879|521321995|FG000|Overall Study|Severe non-compliance to protocol|1|||
144579729|NCT00918879|521321996|FG001|Overall Study|Severe non-compliance to protocol|1|||
144579730|NCT00357110|521321999|FG000|Overall Study|Early study termination|5|||
144579731|NCT00357110|521322000|FG001|Overall Study|Early study termination|5|||
144579732|NCT00515671|521322002|FG000|Overall Study|Lost to Follow-up|13|||
144579733|NCT00515671|521322003|FG001|Overall Study|Lost to Follow-up|10|||
144579734|NCT00515671|521322002|FG000|Overall Study|Withdrawal by Subject|3|||
144579735|NCT00515671|521322003|FG001|Overall Study|Withdrawal by Subject|5|||
144579736|NCT00515671|521322002|FG000|Overall Study|incarcerated|1|||
144579737|NCT00515671|521322003|FG001|Overall Study|incarcerated|2|||
144579738|NCT01014208|521322007|FG000|Overall Study|Lost to Follow-up|2|||
144579739|NCT01014208|521322008|FG001|Overall Study|Lost to Follow-up|5|||
144579740|NCT01014208|521322007|FG000|Overall Study|Participant Withdrew Consent|12|||
144579741|NCT01014208|521322008|FG001|Overall Study|Participant Withdrew Consent|12|||
144579742|NCT01014208|521322007|FG000|Overall Study|Did Not Receive Study Drug|2|||
144579743|NCT01014208|521322008|FG001|Overall Study|Did Not Receive Study Drug|0|||
144579744|NCT01014208|521322007|FG000|Overall Study|Study Closed/terminated|78|||
144579745|NCT01014208|521322008|FG001|Overall Study|Study Closed/terminated|83|||
144579746|NCT00414908|521322011|FG000|Overall Study|Protocol Violation|1|||
144579747|NCT00414908|521322012|FG001|Overall Study|Protocol Violation|1|||
144579748|NCT01076153|521322013|FG000|Overall Study|Symptoms improved/resolved|10|||
144579749|NCT01076153|521322013|FG000|Overall Study|Adverse Event|1|||
144579750|NCT04165031|521322014|FG000|Overall Study|Adverse Event|1|||
144579751|NCT04165031|521322015|FG001|Overall Study|Adverse Event|1|||
144579752|NCT04165031|521322016|FG002|Overall Study|Adverse Event|0|||
144579753|NCT04165031|521322017|FG003|Overall Study|Adverse Event|0|||
144579754|NCT04165031|521322018|FG004|Overall Study|Adverse Event|0|||
144579755|NCT04165031|521322019|FG005|Overall Study|Adverse Event|0|||
144622358|NCT04440592|521473733|FG001|Overall Study|Withdrawal by Subject|1|||
144622359|NCT04440592|521473732|FG000|Overall Study|Other therapy needed|0|||
144207729|NCT00761657|519956103|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
144207730|NCT00761657|519956104|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
144579756|NCT04165031|521322014|FG000|Overall Study|Withdrawal by Subject|0|||
144579757|NCT04165031|521322015|FG001|Overall Study|Withdrawal by Subject|0|||
144579758|NCT04165031|521322016|FG002|Overall Study|Withdrawal by Subject|1|||
144579759|NCT04165031|521322017|FG003|Overall Study|Withdrawal by Subject|0|||
144579760|NCT04165031|521322018|FG004|Overall Study|Withdrawal by Subject|0|||
144730265|NCT02087904|521868181|FG000|Overall Study|Lost to Follow-up|0|||
144207731|NCT00761657|519956105|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
144207732|NCT00761657|519956106|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
144207733|NCT00761657|519956107|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
144207734|NCT00761657|519956108|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
144207735|NCT00761657|519956109|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
144207736|NCT00761657|519956110|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
144579761|NCT04165031|521322019|FG005|Overall Study|Withdrawal by Subject|0|||
144579762|NCT01332630|521322020|FG000|Overall Study|Withdrawal by Subject|3|||
144579763|NCT05602727|521322026|FG000|Overall Study|Physician Decision|0|||
144579764|NCT05602727|521322027|FG001|Overall Study|Physician Decision|1|||
144579765|NCT05602727|521322028|FG002|Overall Study|Physician Decision|0|||
144579766|NCT05602727|521322026|FG000|Overall Study|Randomized by mistake without study medication|1|||
144579767|NCT05602727|521322027|FG001|Overall Study|Randomized by mistake without study medication|0|||
144579768|NCT05602727|521322028|FG002|Overall Study|Randomized by mistake without study medication|0|||
144579769|NCT05602727|521322026|FG000|Overall Study|Study termination by Sponsor|18|||
144579770|NCT05602727|521322027|FG001|Overall Study|Study termination by Sponsor|15|||
144579771|NCT05602727|521322028|FG002|Overall Study|Study termination by Sponsor|19|||
144579772|NCT05602727|521322026|FG000|Overall Study|Withdrawal by Subject|2|||
144579773|NCT05602727|521322027|FG001|Overall Study|Withdrawal by Subject|1|||
144579774|NCT05602727|521322028|FG002|Overall Study|Withdrawal by Subject|1|||
144579775|NCT05602727|521322026|FG000|Overall Study|Various reasons|1|||
144579776|NCT05602727|521322027|FG001|Overall Study|Various reasons|6|||
144579777|NCT05602727|521322028|FG002|Overall Study|Various reasons|1|||
144579778|NCT00567567|521322029|FG000|Overall Study|Adverse Event|0|||
144579779|NCT00567567|521322030|FG001|Overall Study|Adverse Event|2|||
144579780|NCT00567567|521322031|FG002|Overall Study|Adverse Event|5|||
144579781|NCT00567567|521322029|FG000|Overall Study|Death|8|||
144579782|NCT00567567|521322030|FG001|Overall Study|Death|1|||
144579783|NCT00567567|521322031|FG002|Overall Study|Death|5|||
144579784|NCT00567567|521322029|FG000|Overall Study|Lack of Efficacy|16|||
144579785|NCT00567567|521322030|FG001|Overall Study|Lack of Efficacy|17|||
144579786|NCT00567567|521322031|FG002|Overall Study|Lack of Efficacy|48|||
144579787|NCT00567567|521322029|FG000|Overall Study|Lost to Follow-up|0|||
144579788|NCT00567567|521322030|FG001|Overall Study|Lost to Follow-up|0|||
144579789|NCT00567567|521322031|FG002|Overall Study|Lost to Follow-up|1|||
144579790|NCT00567567|521322029|FG000|Overall Study|Physician Decision|16|||
144579791|NCT00567567|521322030|FG001|Overall Study|Physician Decision|18|||
144579792|NCT00567567|521322031|FG002|Overall Study|Physician Decision|84|||
144579793|NCT00567567|521322029|FG000|Overall Study|Withdrawal by Subject|0|||
144579794|NCT00567567|521322030|FG001|Overall Study|Withdrawal by Subject|0|||
144207737|NCT00761657|519956102|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
144207738|NCT00761657|519956103|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
144207739|NCT00761657|519956104|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
144207740|NCT00761657|519956105|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
144207741|NCT00761657|519956106|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
144207742|NCT00761657|519956107|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
144207743|NCT00761657|519956108|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
144207744|NCT00761657|519956109|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
144207745|NCT00761657|519956110|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
144207746|NCT02929056|519956122|FG000|Overall Study|Lost to Follow-up|0|||
144207747|NCT02929056|519956123|FG001|Overall Study|Lost to Follow-up|1|||
144207748|NCT02245412|519956124|FG000|Treatment Period|Death|1|||
144207749|NCT02245412|519956125|FG001|Treatment Period|Death|1|||
144207750|NCT02245412|519956126|FG002|Treatment Period|Death|0|||
144207751|NCT02245412|519956124|FG000|Treatment Period|Physician Decision|1|||
144207752|NCT02245412|519956125|FG001|Treatment Period|Physician Decision|1|||
144207753|NCT02245412|519956126|FG002|Treatment Period|Physician Decision|0|||
144207754|NCT02245412|519956124|FG000|Treatment Period|Withdrawal by Subject|2|||
144207755|NCT02245412|519956125|FG001|Treatment Period|Withdrawal by Subject|1|||
144207756|NCT02245412|519956126|FG002|Treatment Period|Withdrawal by Subject|0|||
144207757|NCT02245412|519956124|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
144207758|NCT02245412|519956125|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
144207759|NCT02245412|519956126|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
144207760|NCT02245412|519956124|FG000|Follow-Up Period|Death|4|||
144207761|NCT02245412|519956125|FG001|Follow-Up Period|Death|2|||
144207762|NCT02245412|519956126|FG002|Follow-Up Period|Death|1|||
144207763|NCT02245412|519956124|FG000|Follow-Up Period|Physician Decision|1|||
144207764|NCT02245412|519956125|FG001|Follow-Up Period|Physician Decision|0|||
144207765|NCT02245412|519956126|FG002|Follow-Up Period|Physician Decision|0|||
144579795|NCT00567567|521322031|FG002|Overall Study|Withdrawal by Subject|2|||
144579796|NCT00567567|521322029|FG000|Overall Study|Ineligible|4|||
144579797|NCT00567567|521322030|FG001|Overall Study|Ineligible|0|||
144579798|NCT00567567|521322031|FG002|Overall Study|Ineligible|9|||
144579799|NCT00567567|521322029|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
144579800|NCT00567567|521322030|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
144207766|NCT02245412|519956124|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
144579801|NCT00567567|521322031|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
144207767|NCT02245412|519956125|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
144207768|NCT02245412|519956126|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
144207769|NCT00402116|519956136|FG000|Overall Study|Jaw infection after surgery-other|1|||
144207770|NCT00402116|519956137|FG001|Overall Study|Jaw infection after surgery-other|0|||
144207771|NCT00402116|519956138|FG002|Overall Study|Jaw infection after surgery-other|0|||
144207772|NCT00402116|519956136|FG000|Overall Study|Withdrawal by Subject|1|||
144207773|NCT00402116|519956137|FG001|Overall Study|Withdrawal by Subject|0|||
144207774|NCT00402116|519956138|FG002|Overall Study|Withdrawal by Subject|5|||
144207775|NCT00402116|519956136|FG000|Overall Study|Treatment completed per protocol|1|||
144207776|NCT00402116|519956137|FG001|Overall Study|Treatment completed per protocol|1|||
144207777|NCT00402116|519956138|FG002|Overall Study|Treatment completed per protocol|2|||
144207778|NCT00402116|519956136|FG000|Overall Study|other complicating disease|0|||
144207779|NCT00402116|519956137|FG001|Overall Study|other complicating disease|0|||
144207780|NCT00402116|519956138|FG002|Overall Study|other complicating disease|2|||
144207781|NCT00402116|519956136|FG000|Overall Study|Disease Progression|0|||
144207782|NCT00402116|519956137|FG001|Overall Study|Disease Progression|4|||
144207783|NCT00402116|519956138|FG002|Overall Study|Disease Progression|38|||
144207784|NCT00402116|519956136|FG000|Overall Study|mistaken thrombocytopenia|0|||
144207785|NCT00402116|519956137|FG001|Overall Study|mistaken thrombocytopenia|0|||
144207786|NCT00402116|519956138|FG002|Overall Study|mistaken thrombocytopenia|1|||
144207787|NCT00402116|519956136|FG000|Overall Study|decline related hyponatremia/tumor|0|||
144207788|NCT00402116|519956137|FG001|Overall Study|decline related hyponatremia/tumor|0|||
144207789|NCT00402116|519956138|FG002|Overall Study|decline related hyponatremia/tumor|1|||
144207790|NCT00402116|519956136|FG000|Overall Study|Adverse Event|0|||
144207791|NCT00402116|519956137|FG001|Overall Study|Adverse Event|1|||
144207792|NCT00402116|519956138|FG002|Overall Study|Adverse Event|6|||
144207793|NCT00270855|519956139|FG000|Overall Study|Withdrawal by Subject|8|||
144207794|NCT00270855|519956140|FG001|Overall Study|Withdrawal by Subject|8|||
144207795|NCT00450801|519956145|FG000|Overall Study|Death|1|||
144207796|NCT05048329|519956146|FG000|Overall Study|Withdrawal by Subject|1|||
144207797|NCT05048329|519956146|FG000|Overall Study|Screenfail|1|||
144207798|NCT00324649|519956147|FG000|Overall Study|Adverse Event|1|||
144207799|NCT00324649|519956148|FG001|Overall Study|Adverse Event|4|||
144207800|NCT00324649|519956147|FG000|Overall Study|Withdrawal by Subject|0|||
144207801|NCT00324649|519956148|FG001|Overall Study|Withdrawal by Subject|1|||
144207802|NCT00324649|519956147|FG000|Overall Study|Noncompliance|1|||
144207803|NCT00324649|519956148|FG001|Overall Study|Noncompliance|0|||
144207804|NCT01396512|519956151|FG000|Overall Study|Withdrawal by Subject|0|||
144207805|NCT01396512|519956152|FG001|Overall Study|Withdrawal by Subject|1|||
144207806|NCT02618759|519956155|FG000|Overall Study|Lost to Follow-up|0|||
144207807|NCT02618759|519956156|FG001|Overall Study|Lost to Follow-up|1|||
144207808|NCT02618759|519956155|FG000|Overall Study|Withdrawal by Subject|1|||
144207809|NCT02618759|519956156|FG001|Overall Study|Withdrawal by Subject|0|||
144207810|NCT02618759|519956155|FG000|Overall Study|Other Reasons|1|||
144207811|NCT02618759|519956156|FG001|Overall Study|Other Reasons|4|||
144207812|NCT02152605|519956157|FG000|Overall Study|Adverse Event|6|||
144207813|NCT02152605|519956158|FG001|Overall Study|Adverse Event|8|||
144207814|NCT02152605|519956157|FG000|Overall Study|Lack of Efficacy|7|||
144207815|NCT02152605|519956158|FG001|Overall Study|Lack of Efficacy|4|||
144207816|NCT02152605|519956157|FG000|Overall Study|Protocol deviation|1|||
144207817|NCT02152605|519956158|FG001|Overall Study|Protocol deviation|4|||
144207818|NCT02152605|519956157|FG000|Overall Study|Lost to Follow-up|1|||
144207819|NCT02152605|519956158|FG001|Overall Study|Lost to Follow-up|0|||
144207820|NCT02152605|519956157|FG000|Overall Study|Withdrew consent|4|||
144207821|NCT02152605|519956158|FG001|Overall Study|Withdrew consent|2|||
144207822|NCT02500043|519956165|FG000|Overall Study|Randomized, but not Treated|2|||
144207823|NCT02500043|519956166|FG001|Overall Study|Randomized, but not Treated|2|||
144207824|NCT02500043|519956165|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
144207825|NCT02500043|519956166|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
144207826|NCT02500043|519956165|FG000|Overall Study|Adverse Event|33|||
144262868|NCT01325350|520163769|FG002|Overall Study|Withdrawal by Subject|1|||
144262869|NCT01325350|520163770|FG003|Overall Study|Withdrawal by Subject|1|||
144622360|NCT04440592|521473733|FG001|Overall Study|Other therapy needed|1|||
144622361|NCT02396589|521473734|FG000|Intervention|Lost to Follow-up|1|||
144622362|NCT02396589|521473735|FG001|Intervention|Lost to Follow-up|0|||
144622363|NCT02396589|521473734|FG000|6 Month Follow-up|change in health status|0|||
144207827|NCT02500043|519956166|FG001|Overall Study|Adverse Event|11|||
144207828|NCT02500043|519956165|FG000|Overall Study|Clinical Progression|54|||
144207829|NCT02500043|519956166|FG001|Overall Study|Clinical Progression|35|||
144262870|NCT01325350|520163771|FG004|Overall Study|Withdrawal by Subject|0|||
144262871|NCT01325350|520163767|FG000|Overall Study|Did Not Receive Treatment|0|||
144207830|NCT02500043|519956165|FG000|Overall Study|Radiological Progression|192|||
144207831|NCT02500043|519956166|FG001|Overall Study|Radiological Progression|110|||
144207832|NCT02500043|519956165|FG000|Overall Study|Physician's Decision|11|||
144207833|NCT02500043|519956166|FG001|Overall Study|Physician's Decision|3|||
144262872|NCT01325350|520163768|FG001|Overall Study|Did Not Receive Treatment|1|||
144622364|NCT02396589|521473735|FG001|6 Month Follow-up|change in health status|1|||
144730266|NCT02087904|521868182|FG001|Overall Study|Lost to Follow-up|4|||
144730267|NCT02087904|521868183|FG002|Overall Study|Lost to Follow-up|2|||
144730268|NCT02087904|521868184|FG003|Overall Study|Lost to Follow-up|2|||
144730269|NCT01196052|521868186|FG000|Overall Study|Adverse Event|9|||
144207834|NCT02500043|519956165|FG000|Overall Study|Withdrawal by Subject|14|||
144207835|NCT02500043|519956166|FG001|Overall Study|Withdrawal by Subject|4|||
144207836|NCT02500043|519956165|FG000|Overall Study|Death|11|||
144207837|NCT02500043|519956166|FG001|Overall Study|Death|2|||
144207838|NCT02500043|519956165|FG000|Overall Study|Protocol Deviation|1|||
144207839|NCT02500043|519956166|FG001|Overall Study|Protocol Deviation|0|||
144207840|NCT01371747|519956167|FG000|Overall Study|Adverse Event|4|||
144207841|NCT01371747|519956168|FG001|Overall Study|Adverse Event|2|||
144207842|NCT01371747|519956169|FG002|Overall Study|Adverse Event|7|||
144207843|NCT01371747|519956170|FG003|Overall Study|Adverse Event|2|||
144207844|NCT01371747|519956171|FG004|Overall Study|Adverse Event|2|||
144207845|NCT01371747|519956172|FG005|Overall Study|Adverse Event|2|||
144207846|NCT01371747|519956167|FG000|Overall Study|Death|1|||
144207847|NCT01371747|519956168|FG001|Overall Study|Death|0|||
144207848|NCT01371747|519956169|FG002|Overall Study|Death|4|||
144207849|NCT01371747|519956170|FG003|Overall Study|Death|1|||
144207850|NCT01371747|519956171|FG004|Overall Study|Death|2|||
144207851|NCT01371747|519956172|FG005|Overall Study|Death|0|||
144207852|NCT01371747|519956167|FG000|Overall Study|Abnormal Renal Function|0|||
144207853|NCT01371747|519956168|FG001|Overall Study|Abnormal Renal Function|2|||
144207854|NCT01371747|519956169|FG002|Overall Study|Abnormal Renal Function|0|||
144207855|NCT01371747|519956170|FG003|Overall Study|Abnormal Renal Function|1|||
144207856|NCT01371747|519956171|FG004|Overall Study|Abnormal Renal Function|0|||
144207857|NCT01371747|519956172|FG005|Overall Study|Abnormal Renal Function|1|||
144730270|NCT01196052|521868186|FG000|Overall Study|Lost to Follow-up|1|||
144730271|NCT01196052|521868186|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
144730272|NCT01196052|521868186|FG000|Overall Study|Reason not Specified|5|||
144730273|NCT01196052|521868186|FG000|Overall Study|Withdrawal by Subject|6|||
144730274|NCT02178722|521868187|FG000|Overall Study|Withdrawal by Subject|0|||
144730275|NCT02178722|521868188|FG001|Overall Study|Withdrawal by Subject|0|||
144730276|NCT02178722|521868189|FG002|Overall Study|Withdrawal by Subject|0|||
144730277|NCT02178722|521868190|FG003|Overall Study|Withdrawal by Subject|2|||
144730278|NCT02178722|521868191|FG004|Overall Study|Withdrawal by Subject|33|||
144730279|NCT02178722|521868187|FG000|Overall Study|Death|2|||
144730280|NCT02178722|521868188|FG001|Overall Study|Death|13|||
144730281|NCT02178722|521868189|FG002|Overall Study|Death|12|||
144730282|NCT02178722|521868190|FG003|Overall Study|Death|12|||
144730283|NCT02178722|521868191|FG004|Overall Study|Death|205|||
144207858|NCT01371747|519956167|FG000|Overall Study|High Serum Potassium Results|1|||
144207859|NCT01371747|519956168|FG001|Overall Study|High Serum Potassium Results|1|||
144207860|NCT01371747|519956169|FG002|Overall Study|High Serum Potassium Results|1|||
144730284|NCT02178722|521868187|FG000|Overall Study|Lost to Follow-up|0|||
144730285|NCT02178722|521868188|FG001|Overall Study|Lost to Follow-up|0|||
144730286|NCT02178722|521868189|FG002|Overall Study|Lost to Follow-up|0|||
144730287|NCT02178722|521868190|FG003|Overall Study|Lost to Follow-up|2|||
144730288|NCT02178722|521868191|FG004|Overall Study|Lost to Follow-up|11|||
144730289|NCT02178722|521868187|FG000|Overall Study|Study terminated by Sponsor|2|||
144730290|NCT02178722|521868188|FG001|Overall Study|Study terminated by Sponsor|7|||
144730291|NCT02178722|521868189|FG002|Overall Study|Study terminated by Sponsor|6|||
144730292|NCT02178722|521868190|FG003|Overall Study|Study terminated by Sponsor|4|||
144730293|NCT02178722|521868191|FG004|Overall Study|Study terminated by Sponsor|128|||
144730294|NCT02178722|521868187|FG000|Overall Study|Physician Decision|0|||
144730295|NCT02178722|521868188|FG001|Overall Study|Physician Decision|0|||
144730296|NCT02178722|521868189|FG002|Overall Study|Physician Decision|0|||
144730297|NCT02178722|521868190|FG003|Overall Study|Physician Decision|0|||
144730298|NCT02178722|521868191|FG004|Overall Study|Physician Decision|3|||
144730299|NCT02178722|521868187|FG000|Overall Study|Other|0|||
144207861|NCT01371747|519956170|FG003|Overall Study|High Serum Potassium Results|2|||
144207862|NCT01371747|519956171|FG004|Overall Study|High Serum Potassium Results|0|||
144207863|NCT01371747|519956172|FG005|Overall Study|High Serum Potassium Results|2|||
144207864|NCT01371747|519956167|FG000|Overall Study|Low Serum Potassium Results|1|||
144730300|NCT02178722|521868188|FG001|Overall Study|Other|0|||
144730301|NCT02178722|521868189|FG002|Overall Study|Other|0|||
144730302|NCT02178722|521868190|FG003|Overall Study|Other|0|||
144730303|NCT02178722|521868191|FG004|Overall Study|Other|2|||
144730304|NCT03340727|521868192|FG000|Overall Study|Death|1|||
144730305|NCT03340727|521868193|FG001|Overall Study|Death|0|||
144730306|NCT03340727|521868192|FG000|Overall Study|Lost to Follow-up|31|||
144207865|NCT01371747|519956168|FG001|Overall Study|Low Serum Potassium Results|1|||
144207866|NCT01371747|519956169|FG002|Overall Study|Low Serum Potassium Results|1|||
144207867|NCT01371747|519956170|FG003|Overall Study|Low Serum Potassium Results|1|||
144207868|NCT01371747|519956171|FG004|Overall Study|Low Serum Potassium Results|0|||
144207869|NCT01371747|519956172|FG005|Overall Study|Low Serum Potassium Results|3|||
144730307|NCT03340727|521868193|FG001|Overall Study|Lost to Follow-up|35|||
144730308|NCT03340727|521868192|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
144262873|NCT01325350|520163769|FG002|Overall Study|Did Not Receive Treatment|1|||
144262874|NCT01325350|520163770|FG003|Overall Study|Did Not Receive Treatment|0|||
144579802|NCT00567567|521322029|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
144579803|NCT00567567|521322030|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
144579804|NCT00567567|521322031|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
144579805|NCT00567567|521322029|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
144579806|NCT00567567|521322030|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
144579807|NCT00567567|521322031|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
144579808|NCT03330405|521322032|FG000|Overall Study|Other|1|||
144579809|NCT03330405|521322033|FG001|Overall Study|Other|3|||
144579810|NCT03330405|521322034|FG002|Overall Study|Other|1|||
144579811|NCT03330405|521322035|FG003|Overall Study|Other|0|||
144579812|NCT03330405|521322036|FG004|Overall Study|Other|2|||
144579813|NCT03330405|521322037|FG005|Overall Study|Other|0|||
144579814|NCT03330405|521322038|FG006|Overall Study|Other|1|||
144579815|NCT03330405|521322039|FG007|Overall Study|Other|0|||
144579816|NCT03330405|521322040|FG008|Overall Study|Other|0|||
144579817|NCT03330405|521322041|FG009|Overall Study|Other|0|||
144579818|NCT03330405|521322042|FG010|Overall Study|Other|0|||
144579819|NCT03330405|521322032|FG000|Overall Study|Progressive disease|8|||
144579820|NCT03330405|521322033|FG001|Overall Study|Progressive disease|27|||
144579821|NCT03330405|521322034|FG002|Overall Study|Progressive disease|4|||
144579822|NCT03330405|521322035|FG003|Overall Study|Progressive disease|18|||
144579823|NCT03330405|521322036|FG004|Overall Study|Progressive disease|16|||
144579824|NCT03330405|521322037|FG005|Overall Study|Progressive disease|14|||
144579825|NCT03330405|521322038|FG006|Overall Study|Progressive disease|7|||
144579826|NCT03330405|521322039|FG007|Overall Study|Progressive disease|29|||
144579827|NCT03330405|521322040|FG008|Overall Study|Progressive disease|9|||
144579828|NCT03330405|521322041|FG009|Overall Study|Progressive disease|11|||
144579829|NCT03330405|521322042|FG010|Overall Study|Progressive disease|5|||
144579830|NCT03330405|521322032|FG000|Overall Study|Withdrawal by Subject|1|||
144579831|NCT03330405|521322033|FG001|Overall Study|Withdrawal by Subject|4|||
144579832|NCT03330405|521322034|FG002|Overall Study|Withdrawal by Subject|0|||
144579833|NCT03330405|521322035|FG003|Overall Study|Withdrawal by Subject|1|||
144579834|NCT03330405|521322036|FG004|Overall Study|Withdrawal by Subject|1|||
144579835|NCT03330405|521322037|FG005|Overall Study|Withdrawal by Subject|1|||
144579836|NCT03330405|521322038|FG006|Overall Study|Withdrawal by Subject|0|||
144579837|NCT03330405|521322039|FG007|Overall Study|Withdrawal by Subject|2|||
144579838|NCT03330405|521322040|FG008|Overall Study|Withdrawal by Subject|2|||
144579839|NCT03330405|521322041|FG009|Overall Study|Withdrawal by Subject|1|||
144579840|NCT03330405|521322042|FG010|Overall Study|Withdrawal by Subject|1|||
144579841|NCT03330405|521322032|FG000|Overall Study|Global deterioration of health status|2|||
144579842|NCT03330405|521322033|FG001|Overall Study|Global deterioration of health status|3|||
144579843|NCT03330405|521322034|FG002|Overall Study|Global deterioration of health status|0|||
144579844|NCT03330405|521322035|FG003|Overall Study|Global deterioration of health status|2|||
144579845|NCT03330405|521322036|FG004|Overall Study|Global deterioration of health status|3|||
144579846|NCT03330405|521322037|FG005|Overall Study|Global deterioration of health status|3|||
144579847|NCT03330405|521322038|FG006|Overall Study|Global deterioration of health status|0|||
144579848|NCT03330405|521322039|FG007|Overall Study|Global deterioration of health status|2|||
144579849|NCT03330405|521322040|FG008|Overall Study|Global deterioration of health status|8|||
144579850|NCT03330405|521322041|FG009|Overall Study|Global deterioration of health status|4|||
144579851|NCT03330405|521322042|FG010|Overall Study|Global deterioration of health status|1|||
144579852|NCT03330405|521322032|FG000|Overall Study|Adverse Event|0|||
144579853|NCT03330405|521322033|FG001|Overall Study|Adverse Event|1|||
144579854|NCT03330405|521322034|FG002|Overall Study|Adverse Event|0|||
144579855|NCT03330405|521322035|FG003|Overall Study|Adverse Event|1|||
144579856|NCT03330405|521322036|FG004|Overall Study|Adverse Event|1|||
144579857|NCT03330405|521322037|FG005|Overall Study|Adverse Event|1|||
144579858|NCT03330405|521322038|FG006|Overall Study|Adverse Event|3|||
144579859|NCT03330405|521322039|FG007|Overall Study|Adverse Event|4|||
144579860|NCT03330405|521322040|FG008|Overall Study|Adverse Event|2|||
144579861|NCT03330405|521322041|FG009|Overall Study|Adverse Event|2|||
144579862|NCT03330405|521322042|FG010|Overall Study|Adverse Event|2|||
144579863|NCT03330405|521322032|FG000|Overall Study|Death|0|||
144579864|NCT03330405|521322033|FG001|Overall Study|Death|4|||
144579865|NCT03330405|521322034|FG002|Overall Study|Death|0|||
144579866|NCT03330405|521322035|FG003|Overall Study|Death|0|||
144579867|NCT03330405|521322036|FG004|Overall Study|Death|0|||
144579868|NCT03330405|521322037|FG005|Overall Study|Death|1|||
144579869|NCT03330405|521322038|FG006|Overall Study|Death|0|||
144579870|NCT03330405|521322039|FG007|Overall Study|Death|2|||
144579871|NCT03330405|521322040|FG008|Overall Study|Death|0|||
144579872|NCT03330405|521322041|FG009|Overall Study|Death|0|||
144579873|NCT03330405|521322042|FG010|Overall Study|Death|0|||
144579874|NCT03330405|521322032|FG000|Overall Study|Physician Decision|0|||
144579875|NCT03330405|521322033|FG001|Overall Study|Physician Decision|0|||
144579876|NCT03330405|521322034|FG002|Overall Study|Physician Decision|0|||
144622365|NCT02396589|521473734|FG000|9 Month Follow-up|Death|0|||
144622366|NCT02396589|521473735|FG001|9 Month Follow-up|Death|1|||
144622367|NCT02396589|521473734|FG000|12 Month Follow up|Lost to Follow-up|0|||
144622368|NCT02396589|521473735|FG001|12 Month Follow up|Lost to Follow-up|2|||
144622369|NCT03087955|521476191|FG000|Overall Study|Death|4|||
144622370|NCT03087955|521476192|FG001|Overall Study|Death|0|||
144622371|NCT03087955|521476191|FG000|Overall Study|Lack of Efficacy|2|||
144622372|NCT03087955|521476192|FG001|Overall Study|Lack of Efficacy|0|||
144622373|NCT03087955|521476191|FG000|Overall Study|Lost to Follow-up|1|||
144622374|NCT03087955|521476192|FG001|Overall Study|Lost to Follow-up|0|||
144622375|NCT04441905|521476193|FG000|Overall Study|Lost to Follow-up|1|||
144622376|NCT04441905|521476194|FG001|Overall Study|Lost to Follow-up|0|||
144622377|NCT04441905|521476195|FG002|Overall Study|Lost to Follow-up|0|||
144622378|NCT04441905|521476196|FG003|Overall Study|Lost to Follow-up|0|||
144622379|NCT04441905|521476197|FG004|Overall Study|Lost to Follow-up|0|||
144622380|NCT04441905|521476198|FG005|Overall Study|Lost to Follow-up|0|||
144622381|NCT04441905|521476193|FG000|Overall Study|Enrolled but treatment not administered|0|||
144622382|NCT04441905|521476194|FG001|Overall Study|Enrolled but treatment not administered|1|||
144622383|NCT04441905|521476195|FG002|Overall Study|Enrolled but treatment not administered|0|||
144622384|NCT04441905|521476196|FG003|Overall Study|Enrolled but treatment not administered|0|||
144622385|NCT04441905|521476197|FG004|Overall Study|Enrolled but treatment not administered|0|||
144622386|NCT04441905|521476198|FG005|Overall Study|Enrolled but treatment not administered|0|||
144622387|NCT04441905|521476193|FG000|Overall Study|Became ineligible after enrollment|0|||
144622388|NCT04441905|521476194|FG001|Overall Study|Became ineligible after enrollment|0|||
144622389|NCT04441905|521476195|FG002|Overall Study|Became ineligible after enrollment|0|||
144622390|NCT04441905|521476196|FG003|Overall Study|Became ineligible after enrollment|0|||
144622391|NCT04441905|521476197|FG004|Overall Study|Became ineligible after enrollment|1|||
144622392|NCT04441905|521476198|FG005|Overall Study|Became ineligible after enrollment|0|||
144622393|NCT02392429|521476199|FG000|Screening|Screen failure|15|||
144622394|NCT02392429|521476199|FG000|Enrolled Participants|Ineligible due to disease|3|||
144622395|NCT02392429|521476199|FG000|Enrolled Participants|Withdrawal by Subject|4|||
144622396|NCT02392429|521476199|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
144622397|NCT02392429|521476199|FG000|Evaluable|Death|5|||
144622398|NCT02392429|521476199|FG000|Evaluable|Withdrawal by Subject|1|||
144622399|NCT02392429|521476199|FG000|Evaluable|Adverse Event|1|||
144622400|NCT02392429|521476199|FG000|Evaluable|remission bone marrow biopsy|3|||
144622401|NCT00598975|521476200|FG000|Overall Study|Adverse Event|1|||
144622402|NCT00598975|521476201|FG001|Overall Study|Adverse Event|1|||
144622403|NCT00598975|521476200|FG000|Overall Study|Brain metastases|1|||
144622404|NCT00598975|521476201|FG001|Overall Study|Brain metastases|0|||
144622405|NCT00598975|521476200|FG000|Overall Study|Withdrawal by Subject|1|||
144622406|NCT00598975|521476201|FG001|Overall Study|Withdrawal by Subject|1|||
144622407|NCT00598975|521476200|FG000|Overall Study|Withdrawal of consent|0|||
144622408|NCT00598975|521476201|FG001|Overall Study|Withdrawal of consent|1|||
144622409|NCT00598975|521476200|FG000|Overall Study|Disease progression|8|||
144622410|NCT00598975|521476201|FG001|Overall Study|Disease progression|3|||
144622411|NCT00598975|521476200|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
144622412|NCT00598975|521476201|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
144622413|NCT01178138|521476202|FG000|Overall Study|Lost to Follow-up|8|||
144622414|NCT01178138|521476202|FG000|Overall Study|Withdrawal by Subject|7|||
144622415|NCT01178138|521476202|FG000|Overall Study|Physician Decision|8|||
144622416|NCT04183335|521476203|FG000|Overall Study|Adverse Event|1|||
144622417|NCT04183335|521476204|FG001|Overall Study|Adverse Event|0|||
144622418|NCT04183335|521476203|FG000|Overall Study|Withdrawal by Subject|12|||
144622419|NCT04183335|521476204|FG001|Overall Study|Withdrawal by Subject|3|||
144622420|NCT02944448|521476205|FG000|Overall Study|Adverse Event|37|||
144622421|NCT02944448|521476206|FG001|Overall Study|Adverse Event|6|||
144622422|NCT02944448|521476205|FG000|Overall Study|Lack of Efficacy|8|||
144622423|NCT02944448|521476206|FG001|Overall Study|Lack of Efficacy|5|||
144622424|NCT02944448|521476205|FG000|Overall Study|Lost to Follow-up|3|||
144622425|NCT02944448|521476206|FG001|Overall Study|Lost to Follow-up|1|||
144622426|NCT02944448|521476205|FG000|Overall Study|Protocol Violation|25|||
144622427|NCT02944448|521476206|FG001|Overall Study|Protocol Violation|7|||
144622428|NCT02944448|521476205|FG000|Overall Study|Withdrawal by Subject|14|||
144622429|NCT02944448|521476206|FG001|Overall Study|Withdrawal by Subject|4|||
144622430|NCT02944448|521476205|FG000|Overall Study|Sponsor did not supply drug in time|0|||
144622431|NCT02944448|521476206|FG001|Overall Study|Sponsor did not supply drug in time|1|||
144622432|NCT02944448|521476205|FG000|Overall Study|Noncompliant with dosing|1|||
144622433|NCT02944448|521476206|FG001|Overall Study|Noncompliant with dosing|0|||
144622434|NCT02944448|521476205|FG000|Overall Study|Abnormal laboratory values|1|||
144622435|NCT02944448|521476206|FG001|Overall Study|Abnormal laboratory values|0|||
144622436|NCT00618748|521476207|FG000|Overall Study|Adverse Event|4|||
144622437|NCT00618748|521476208|FG001|Overall Study|Adverse Event|3|||
144622438|NCT00618748|521476209|FG002|Overall Study|Adverse Event|8|||
144622439|NCT00618748|521476207|FG000|Overall Study|Physician Decision|3|||
144622440|NCT00618748|521476208|FG001|Overall Study|Physician Decision|1|||
144622441|NCT00618748|521476209|FG002|Overall Study|Physician Decision|1|||
144207870|NCT01371747|519956167|FG000|Overall Study|Protocol Violation|0|||
144207871|NCT01371747|519956168|FG001|Overall Study|Protocol Violation|0|||
144207872|NCT01371747|519956169|FG002|Overall Study|Protocol Violation|1|||
144207873|NCT01371747|519956170|FG003|Overall Study|Protocol Violation|0|||
144207874|NCT01371747|519956171|FG004|Overall Study|Protocol Violation|0|||
144207875|NCT01371747|519956172|FG005|Overall Study|Protocol Violation|0|||
144207876|NCT01371747|519956167|FG000|Overall Study|Non-Compliance|3|||
144207877|NCT01371747|519956168|FG001|Overall Study|Non-Compliance|4|||
144207878|NCT01371747|519956169|FG002|Overall Study|Non-Compliance|3|||
144207879|NCT01371747|519956170|FG003|Overall Study|Non-Compliance|0|||
144207880|NCT01371747|519956171|FG004|Overall Study|Non-Compliance|0|||
144207881|NCT01371747|519956172|FG005|Overall Study|Non-Compliance|1|||
144207882|NCT01371747|519956167|FG000|Overall Study|Physician Decision|0|||
144207883|NCT01371747|519956168|FG001|Overall Study|Physician Decision|0|||
144207884|NCT01371747|519956169|FG002|Overall Study|Physician Decision|0|||
144207885|NCT01371747|519956170|FG003|Overall Study|Physician Decision|0|||
144207886|NCT01371747|519956171|FG004|Overall Study|Physician Decision|1|||
144207887|NCT01371747|519956172|FG005|Overall Study|Physician Decision|0|||
144207888|NCT01371747|519956167|FG000|Overall Study|Withdrawal by Subject|6|||
144579877|NCT03330405|521322035|FG003|Overall Study|Physician Decision|0|||
144579878|NCT03330405|521322036|FG004|Overall Study|Physician Decision|0|||
144579879|NCT03330405|521322037|FG005|Overall Study|Physician Decision|0|||
144579880|NCT03330405|521322038|FG006|Overall Study|Physician Decision|0|||
144579881|NCT03330405|521322039|FG007|Overall Study|Physician Decision|1|||
144579882|NCT03330405|521322040|FG008|Overall Study|Physician Decision|0|||
144579883|NCT03330405|521322041|FG009|Overall Study|Physician Decision|0|||
144207889|NCT01371747|519956168|FG001|Overall Study|Withdrawal by Subject|12|||
144207890|NCT01371747|519956169|FG002|Overall Study|Withdrawal by Subject|5|||
144207891|NCT01371747|519956170|FG003|Overall Study|Withdrawal by Subject|2|||
144207892|NCT01371747|519956171|FG004|Overall Study|Withdrawal by Subject|2|||
144207893|NCT01371747|519956172|FG005|Overall Study|Withdrawal by Subject|4|||
144207894|NCT01371747|519956167|FG000|Overall Study|Other Reasons|2|||
144207895|NCT01371747|519956168|FG001|Overall Study|Other Reasons|1|||
144207896|NCT01371747|519956169|FG002|Overall Study|Other Reasons|2|||
144207897|NCT01371747|519956170|FG003|Overall Study|Other Reasons|0|||
144207898|NCT01371747|519956171|FG004|Overall Study|Other Reasons|0|||
144207899|NCT01371747|519956172|FG005|Overall Study|Other Reasons|1|||
144207900|NCT02094417|519956173|FG000|Overall Study|Adverse Event|0|||
144207901|NCT02094417|519956174|FG001|Overall Study|Adverse Event|0|||
144207902|NCT02094417|519956175|FG002|Overall Study|Adverse Event|0|||
144207903|NCT02094417|519956176|FG003|Overall Study|Adverse Event|1|||
144207904|NCT02094417|519956173|FG000|Overall Study|Eligibility criteria|0|||
144207905|NCT02094417|519956174|FG001|Overall Study|Eligibility criteria|1|||
144207906|NCT02094417|519956175|FG002|Overall Study|Eligibility criteria|0|||
144207907|NCT02094417|519956176|FG003|Overall Study|Eligibility criteria|0|||
144207908|NCT02094417|519956173|FG000|Overall Study|No responder|4|||
144207909|NCT02094417|519956174|FG001|Overall Study|No responder|4|||
144207910|NCT02094417|519956175|FG002|Overall Study|No responder|4|||
144207911|NCT02094417|519956176|FG003|Overall Study|No responder|3|||
144207912|NCT02094417|519956173|FG000|Overall Study|Unable to conduct observations or assess|0|||
144207913|NCT02094417|519956174|FG001|Overall Study|Unable to conduct observations or assess|1|||
144207914|NCT02094417|519956175|FG002|Overall Study|Unable to conduct observations or assess|0|||
144207915|NCT02094417|519956176|FG003|Overall Study|Unable to conduct observations or assess|0|||
144207916|NCT02094417|519956173|FG000|Overall Study|Withdrawal by Subject|1|||
144207917|NCT02094417|519956174|FG001|Overall Study|Withdrawal by Subject|2|||
144207918|NCT02094417|519956175|FG002|Overall Study|Withdrawal by Subject|1|||
144207919|NCT02094417|519956176|FG003|Overall Study|Withdrawal by Subject|3|||
144207920|NCT03333941|519956177|FG000|Overall Study|Lost to Follow-up|10|||
144207921|NCT03333941|519956177|FG000|Overall Study|Death|2|||
144207922|NCT03333941|519956177|FG000|Overall Study|Adverse Event|1|||
144207923|NCT01199471|519956178|FG000|Overall Study|Protocol Violation|4|||
144207924|NCT01199471|519956178|FG000|Overall Study|Withdrawal by Subject|1|||
144579884|NCT03330405|521322042|FG010|Overall Study|Physician Decision|0|||
144579885|NCT02643303|521322043|FG000|Overall Study|Progressive Disease|4|||
144579886|NCT02643303|521322044|FG001|Overall Study|Progressive Disease|4|||
144579887|NCT02643303|521322045|FG002|Overall Study|Progressive Disease|1|||
144579888|NCT02643303|521322046|FG003|Overall Study|Progressive Disease|12|||
144207925|NCT01199471|519956178|FG000|Overall Study|Physician Decision|1|||
144207926|NCT00049530|519956179|FG000|Overall Study|Lack of Efficacy|25|||
144207927|NCT00049530|519956179|FG000|Overall Study|Adverse Event|2|||
144207928|NCT00049530|519956179|FG000|Overall Study|Death|1|||
144207929|NCT00049530|519956179|FG000|Overall Study|symptomatic deterioration|1|||
144579889|NCT02643303|521322047|FG004|Overall Study|Progressive Disease|6|||
144579890|NCT02643303|521322048|FG005|Overall Study|Progressive Disease|4|||
144207930|NCT00049530|519956179|FG000|Overall Study|ineligible|3|||
144207931|NCT02383810|519956180|FG000|Overall Study|Physician Decision|1|||
144207932|NCT02383810|519956181|FG001|Overall Study|Physician Decision|1|||
144207933|NCT02383810|519956182|FG002|Overall Study|Physician Decision|0|||
144207934|NCT02383810|519956183|FG003|Overall Study|Physician Decision|0|||
144579891|NCT02643303|521322049|FG006|Overall Study|Progressive Disease|8|||
144579892|NCT02643303|521322050|FG007|Overall Study|Progressive Disease|2|||
144579893|NCT02643303|521322051|FG008|Overall Study|Progressive Disease|6|||
144579894|NCT02643303|521322043|FG000|Overall Study|Adverse Event|0|||
144579895|NCT02643303|521322044|FG001|Overall Study|Adverse Event|1|||
144579896|NCT02643303|521322045|FG002|Overall Study|Adverse Event|0|||
144579897|NCT02643303|521322046|FG003|Overall Study|Adverse Event|0|||
144579898|NCT02643303|521322047|FG004|Overall Study|Adverse Event|1|||
144579899|NCT02643303|521322048|FG005|Overall Study|Adverse Event|0|||
144579900|NCT02643303|521322049|FG006|Overall Study|Adverse Event|0|||
144579901|NCT02643303|521322050|FG007|Overall Study|Adverse Event|0|||
144579902|NCT02643303|521322051|FG008|Overall Study|Adverse Event|0|||
144622442|NCT00618748|521476207|FG000|Overall Study|Withdrawal by Subject|4|||
144622443|NCT00618748|521476208|FG001|Overall Study|Withdrawal by Subject|1|||
144622444|NCT00618748|521476209|FG002|Overall Study|Withdrawal by Subject|5|||
144622445|NCT00559507|521476216|FG000|Overall Study|Not treated, patient ineligible|3|||
144622446|NCT03124784|521476217|FG000|Overall Study|Adverse Event|1|||
144622447|NCT03124784|521476217|FG000|Overall Study|Computer/Equip Malfunction|1|||
144622448|NCT01784965|521476218|FG000|Overall Study|Withdrawal by Subject|6|||
144622449|NCT01784965|521476219|FG001|Overall Study|Withdrawal by Subject|3|||
144622450|NCT01784965|521476218|FG000|Overall Study|Adverse Event|0|||
144622451|NCT01784965|521476219|FG001|Overall Study|Adverse Event|8|||
144622452|NCT03757988|521476222|FG000|Overall Study|Withdrawal by Subject|1|||
144622453|NCT03806127|521476223|FG000|Overall Study|Withdrawal by Subject|4|||
144622454|NCT03806127|521476224|FG001|Overall Study|Withdrawal by Subject|5|||
144622455|NCT03806127|521476223|FG000|Overall Study|Protocol Violation|3|||
144622456|NCT03806127|521476224|FG001|Overall Study|Protocol Violation|1|||
144622457|NCT03806127|521476223|FG000|Overall Study|Adverse Event|3|||
144622458|NCT03806127|521476224|FG001|Overall Study|Adverse Event|0|||
144622459|NCT03806127|521476223|FG000|Overall Study|Unable to Complete Procedures|0|||
144622460|NCT03806127|521476224|FG001|Overall Study|Unable to Complete Procedures|1|||
144622461|NCT03806127|521476223|FG000|Overall Study|Pregnancy|0|||
144622462|NCT03806127|521476224|FG001|Overall Study|Pregnancy|1|||
144622463|NCT03806127|521476223|FG000|Overall Study|Lost to Follow-up|5|||
144622464|NCT03806127|521476224|FG001|Overall Study|Lost to Follow-up|1|||
144622465|NCT03806127|521476223|FG000|Overall Study|Physician Decision|1|||
144622466|NCT03806127|521476224|FG001|Overall Study|Physician Decision|1|||
144622467|NCT03806127|521476223|FG000|Overall Study|Could Not Come Due to Covid|1|||
144622468|NCT03806127|521476224|FG001|Overall Study|Could Not Come Due to Covid|0|||
144622469|NCT03806127|521476223|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
144622470|NCT03806127|521476224|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
144622471|NCT03806127|521476223|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
144622472|NCT03806127|521476224|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
144622473|NCT03806127|521476223|FG000|Overall Study|Covid 19 Restrictions|2|||
144622474|NCT03806127|521476224|FG001|Overall Study|Covid 19 Restrictions|0|||
144622475|NCT03806127|521476223|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
144622476|NCT03806127|521476224|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
144622477|NCT03806127|521476223|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
144622478|NCT03806127|521476224|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
144622479|NCT01467492|521476225|FG000|Overall Study|Withdrawal by Subject|6|||
144622480|NCT01467492|521476226|FG001|Overall Study|Withdrawal by Subject|4|||
144622481|NCT01467492|521476225|FG000|Overall Study|Study Terminated by Sponsor|6|||
144622482|NCT01467492|521476226|FG001|Overall Study|Study Terminated by Sponsor|4|||
144622483|NCT01467492|521476225|FG000|Overall Study|Adverse Event|4|||
144622484|NCT01467492|521476226|FG001|Overall Study|Adverse Event|3|||
144622485|NCT01467492|521476225|FG000|Overall Study|Lost to Follow-up|3|||
144622486|NCT01467492|521476226|FG001|Overall Study|Lost to Follow-up|2|||
144622487|NCT01467492|521476225|FG000|Overall Study|Undefined|2|||
144622488|NCT01467492|521476226|FG001|Overall Study|Undefined|0|||
144622489|NCT01467492|521476225|FG000|Overall Study|Enrolled But Not Treated|1|||
144622490|NCT01467492|521476226|FG001|Overall Study|Enrolled But Not Treated|0|||
144622491|NCT02450487|521476227|FG000|Overall Study|Lost to Follow-up|3|||
144622492|NCT03132636|521476228|FG000|Overall Study|Adverse Event|1|||
144622493|NCT03132636|521476229|FG001|Overall Study|Adverse Event|2|||
144622494|NCT03132636|521476228|FG000|Overall Study|Death|4|||
144622495|NCT03132636|521476229|FG001|Overall Study|Death|7|||
144579903|NCT02643303|521322043|FG000|Overall Study|Withdrawal by Subject|0|||
144622496|NCT03132636|521476228|FG000|Overall Study|Lost to Follow-up|3|||
144622497|NCT03132636|521476229|FG001|Overall Study|Lost to Follow-up|2|||
144622498|NCT03132636|521476228|FG000|Overall Study|Non compliance with protocol by participant|1|||
144622499|NCT03132636|521476229|FG001|Overall Study|Non compliance with protocol by participant|1|||
144622500|NCT03132636|521476228|FG000|Overall Study|Subject decision|1|||
144622501|NCT03132636|521476229|FG001|Overall Study|Subject decision|9|||
144579904|NCT02643303|521322044|FG001|Overall Study|Withdrawal by Subject|0|||
144579905|NCT02643303|521322045|FG002|Overall Study|Withdrawal by Subject|0|||
144207935|NCT02383810|519956184|FG004|Overall Study|Physician Decision|0|||
144579906|NCT02643303|521322046|FG003|Overall Study|Withdrawal by Subject|1|||
144207936|NCT02383810|519956185|FG005|Overall Study|Physician Decision|0|||
144207937|NCT02383810|519956186|FG006|Overall Study|Physician Decision|0|||
144207938|NCT02383810|519956187|FG007|Overall Study|Physician Decision|0|||
144207939|NCT02383810|519956180|FG000|Overall Study|Withdrawal by Subject|2|||
144207940|NCT02383810|519956181|FG001|Overall Study|Withdrawal by Subject|3|||
144207941|NCT02383810|519956182|FG002|Overall Study|Withdrawal by Subject|3|||
144207942|NCT02383810|519956183|FG003|Overall Study|Withdrawal by Subject|3|||
144207943|NCT02383810|519956184|FG004|Overall Study|Withdrawal by Subject|0|||
144207944|NCT02383810|519956185|FG005|Overall Study|Withdrawal by Subject|0|||
144207945|NCT02383810|519956186|FG006|Overall Study|Withdrawal by Subject|0|||
144207946|NCT02383810|519956187|FG007|Overall Study|Withdrawal by Subject|0|||
144207947|NCT02383810|519956180|FG000|Overall Study|Adverse Event|0|||
144207948|NCT02383810|519956181|FG001|Overall Study|Adverse Event|2|||
144207949|NCT02383810|519956182|FG002|Overall Study|Adverse Event|4|||
144207950|NCT02383810|519956183|FG003|Overall Study|Adverse Event|5|||
144207951|NCT02383810|519956184|FG004|Overall Study|Adverse Event|0|||
144622502|NCT03132636|521476228|FG000|Overall Study|Sponsor decision|0|||
144207952|NCT02383810|519956185|FG005|Overall Study|Adverse Event|1|||
144622503|NCT03132636|521476229|FG001|Overall Study|Sponsor decision|1|||
144622504|NCT03132636|521476228|FG000|Overall Study|Physician Decision|1|||
144622505|NCT03132636|521476229|FG001|Overall Study|Physician Decision|0|||
144622506|NCT03132636|521476228|FG000|Overall Study|Progressive disease|33|||
144622507|NCT03132636|521476229|FG001|Overall Study|Progressive disease|36|||
144622508|NCT03132636|521476228|FG000|Overall Study|Withdrawal of consent|2|||
144622509|NCT03132636|521476229|FG001|Overall Study|Withdrawal of consent|5|||
144622510|NCT03132636|521476228|FG000|Overall Study|Did not re-consent|1|||
144622511|NCT03132636|521476229|FG001|Overall Study|Did not re-consent|0|||
144622512|NCT03132636|521476228|FG000|Overall Study|Lost insurance coverage|1|||
144622513|NCT03132636|521476229|FG001|Overall Study|Lost insurance coverage|0|||
144622514|NCT03132636|521476228|FG000|Overall Study|Related to radiological outcomes|0|||
144622515|NCT03132636|521476229|FG001|Overall Study|Related to radiological outcomes|1|||
144622516|NCT03132636|521476228|FG000|Overall Study|Unable to come to site for continued visits|0|||
144622517|NCT03132636|521476229|FG001|Overall Study|Unable to come to site for continued visits|1|||
144622518|NCT03286842|521476230|FG000|Overall Study|Patients rolled over to another study|80|||
144622519|NCT01453855|521476234|FG000|Overall Study|Adverse Event|3|||
144622520|NCT01453855|521476235|FG001|Overall Study|Adverse Event|4|||
144622521|NCT01453855|521476234|FG000|Overall Study|Lost to Follow-up|2|||
144622522|NCT01453855|521476235|FG001|Overall Study|Lost to Follow-up|1|||
144622523|NCT01453855|521476234|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
144622524|NCT01453855|521476235|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
144622525|NCT01453855|521476234|FG000|Overall Study|Noncompliance|1|||
144622526|NCT01453855|521476235|FG001|Overall Study|Noncompliance|0|||
144622527|NCT01453855|521476234|FG000|Overall Study|Inadequate Control of IOP|1|||
144622528|NCT01453855|521476235|FG001|Overall Study|Inadequate Control of IOP|5|||
144622529|NCT01453855|521476234|FG000|Overall Study|Other|0|||
144622530|NCT01453855|521476235|FG001|Overall Study|Other|1|||
144622531|NCT01562548|521476238|FG000|Overall Study|Lost to Follow-up|0|||
144622532|NCT01562548|521476239|FG001|Overall Study|Lost to Follow-up|0|||
144622533|NCT01562548|521476240|FG002|Overall Study|Lost to Follow-up|1|||
144622534|NCT01562548|521476241|FG003|Overall Study|Lost to Follow-up|0|||
144622535|NCT02926209|521476243|FG000|Study Cohort|Poor Bowel Preparation|1|||
144622536|NCT02926209|521476244|FG001|Study Cohort|Poor Bowel Preparation|0|||
144622537|NCT01239160|521476245|FG000|Overall Study|Lost to Follow-up|3|||
144622538|NCT01239160|521476246|FG001|Overall Study|Lost to Follow-up|5|||
144622539|NCT01239160|521476247|FG002|Overall Study|Lost to Follow-up|0|||
144622540|NCT01239160|521476245|FG000|Overall Study|Withdrawal by Subject|17|||
144622541|NCT01239160|521476246|FG001|Overall Study|Withdrawal by Subject|6|||
144622542|NCT01239160|521476247|FG002|Overall Study|Withdrawal by Subject|2|||
144622543|NCT01239160|521476245|FG000|Overall Study|Physician Decision|5|||
144622544|NCT01239160|521476246|FG001|Overall Study|Physician Decision|7|||
144622545|NCT01239160|521476247|FG002|Overall Study|Physician Decision|2|||
144622546|NCT01239160|521476245|FG000|Overall Study|Early Termination Due to Study Closure|0|||
144622547|NCT01239160|521476246|FG001|Overall Study|Early Termination Due to Study Closure|1|||
144622548|NCT01239160|521476247|FG002|Overall Study|Early Termination Due to Study Closure|6|||
144622549|NCT01764633|521476248|FG000|Overall Study|Withdrawal by Subject|105|||
144622550|NCT01764633|521476249|FG001|Overall Study|Withdrawal by Subject|88|||
144622551|NCT01764633|521476248|FG000|Overall Study|Lost to Follow-up|13|||
144622552|NCT01764633|521476249|FG001|Overall Study|Lost to Follow-up|5|||
144622553|NCT04781816|521476255|FG000|Overall Study|Adverse Event|0|||
144622554|NCT04781816|521476256|FG001|Overall Study|Adverse Event|1|||
144622555|NCT04781816|521476255|FG000|Overall Study|Withdrawal by Subject|1|||
144622556|NCT04781816|521476256|FG001|Overall Study|Withdrawal by Subject|1|||
144622557|NCT04781816|521476255|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
144622558|NCT04781816|521476256|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
144579907|NCT02643303|521322047|FG004|Overall Study|Withdrawal by Subject|0|||
144579908|NCT02643303|521322048|FG005|Overall Study|Withdrawal by Subject|0|||
144579909|NCT02643303|521322049|FG006|Overall Study|Withdrawal by Subject|1|||
144579910|NCT02643303|521322050|FG007|Overall Study|Withdrawal by Subject|1|||
144579911|NCT02643303|521322051|FG008|Overall Study|Withdrawal by Subject|1|||
144579912|NCT04833127|521322056|FG000|Overall Study|Lost to Follow-up|1|||
144579913|NCT04833127|521322057|FG001|Overall Study|Lost to Follow-up|1|||
144579914|NCT04335591|521322058|FG000|Overall Study|Adverse Event|5|||
144579915|NCT04335591|521322059|FG001|Overall Study|Adverse Event|2|||
144622559|NCT02062658|521476257|FG000|Overall Study|Withdrawal by Subject|1|||
144622560|NCT02062658|521476257|FG000|Overall Study|Lack of Efficacy|1|||
144622561|NCT01121393|521476258|FG000|Overall Study|Progressive disease|201|||
144622562|NCT01121393|521476259|FG001|Overall Study|Progressive disease|20|||
144622563|NCT01121393|521476258|FG000|Overall Study|Other Adverse events|24|||
144207953|NCT02383810|519956186|FG006|Overall Study|Adverse Event|1|||
144207954|NCT02383810|519956187|FG007|Overall Study|Adverse Event|0|||
144207955|NCT02383810|519956180|FG000|Overall Study|Lost to Follow-up|0|||
144207956|NCT02383810|519956181|FG001|Overall Study|Lost to Follow-up|1|||
144207957|NCT02383810|519956182|FG002|Overall Study|Lost to Follow-up|0|||
144207958|NCT02383810|519956183|FG003|Overall Study|Lost to Follow-up|1|||
144207959|NCT02383810|519956184|FG004|Overall Study|Lost to Follow-up|0|||
144207960|NCT02383810|519956185|FG005|Overall Study|Lost to Follow-up|0|||
144207961|NCT02383810|519956186|FG006|Overall Study|Lost to Follow-up|0|||
144207962|NCT02383810|519956187|FG007|Overall Study|Lost to Follow-up|0|||
144207963|NCT02383810|519956180|FG000|Overall Study|other|0|||
144207964|NCT02383810|519956181|FG001|Overall Study|other|0|||
144207965|NCT02383810|519956182|FG002|Overall Study|other|0|||
144207966|NCT02383810|519956183|FG003|Overall Study|other|2|||
144207967|NCT02383810|519956184|FG004|Overall Study|other|0|||
144207968|NCT02383810|519956185|FG005|Overall Study|other|0|||
144207969|NCT02383810|519956186|FG006|Overall Study|other|0|||
144207970|NCT02383810|519956187|FG007|Overall Study|other|0|||
144207971|NCT02383810|519956180|FG000|Overall Study|subject did not receive study treatment|0|||
144207972|NCT02383810|519956181|FG001|Overall Study|subject did not receive study treatment|1|||
144207973|NCT02383810|519956182|FG002|Overall Study|subject did not receive study treatment|0|||
144207974|NCT02383810|519956183|FG003|Overall Study|subject did not receive study treatment|0|||
144207975|NCT02383810|519956184|FG004|Overall Study|subject did not receive study treatment|0|||
144207976|NCT02383810|519956185|FG005|Overall Study|subject did not receive study treatment|0|||
144207977|NCT02383810|519956186|FG006|Overall Study|subject did not receive study treatment|0|||
144207978|NCT02383810|519956187|FG007|Overall Study|subject did not receive study treatment|0|||
144207979|NCT03257865|519956188|FG000|Overall Study|Adverse Event|4|||
144207980|NCT03257865|519956189|FG001|Overall Study|Adverse Event|8|||
144207981|NCT03257865|519956188|FG000|Overall Study|Lack of Efficacy|1|||
144207982|NCT03257865|519956189|FG001|Overall Study|Lack of Efficacy|2|||
144207983|NCT03257865|519956188|FG000|Overall Study|Non-compliance with Study Drug|0|||
144207984|NCT03257865|519956189|FG001|Overall Study|Non-compliance with Study Drug|2|||
144207985|NCT03257865|519956188|FG000|Overall Study|Withdrawal by Subject|23|||
144207986|NCT03257865|519956189|FG001|Overall Study|Withdrawal by Subject|17|||
144207987|NCT03257865|519956188|FG000|Overall Study|Physician Decision|3|||
144207988|NCT03257865|519956189|FG001|Overall Study|Physician Decision|1|||
144207989|NCT03257865|519956188|FG000|Overall Study|Other|0|||
144207990|NCT03257865|519956189|FG001|Overall Study|Other|1|||
144207991|NCT03257865|519956188|FG000|Overall Study|Lost to Follow-up|4|||
144207992|NCT03257865|519956189|FG001|Overall Study|Lost to Follow-up|4|||
144207993|NCT01696058|519956192|FG000|Overall Study|Adverse Event|21|||
144207994|NCT01696058|519956193|FG001|Overall Study|Adverse Event|11|||
144207995|NCT01696058|519956192|FG000|Overall Study|Lack of Efficacy|2|||
144207996|NCT01696058|519956193|FG001|Overall Study|Lack of Efficacy|3|||
144207997|NCT01696058|519956192|FG000|Overall Study|Protocol Violation|9|||
144207998|NCT01696058|519956193|FG001|Overall Study|Protocol Violation|3|||
144207999|NCT01696058|519956192|FG000|Overall Study|Lost to Follow-up|2|||
144208000|NCT01696058|519956193|FG001|Overall Study|Lost to Follow-up|5|||
144208001|NCT01696058|519956192|FG000|Overall Study|Withdrawal by Subject|4|||
144208002|NCT01696058|519956193|FG001|Overall Study|Withdrawal by Subject|6|||
144208003|NCT01696058|519956192|FG000|Overall Study|Other reason prematurely discontinued|5|||
144579916|NCT04335591|521322060|FG002|Overall Study|Adverse Event|3|||
144579917|NCT04335591|521322061|FG003|Overall Study|Adverse Event|2|||
144579918|NCT04335591|521322058|FG000|Overall Study|Protocol Violation|1|||
144579919|NCT04335591|521322059|FG001|Overall Study|Protocol Violation|0|||
144208004|NCT01696058|519956193|FG001|Overall Study|Other reason prematurely discontinued|3|||
144208005|NCT01934335|519956195|FG000|Overall Study|Withdrawal by Subject|1|||
144208006|NCT01934335|519956196|FG001|Overall Study|Withdrawal by Subject|1|||
144208007|NCT01421511|519956197|FG000|Overall Study|Lost to Follow-up|11|||
144208008|NCT01421511|519956198|FG001|Overall Study|Lost to Follow-up|14|||
144208009|NCT01421511|519956197|FG000|Overall Study|Randomized but didn't receive study drug|1|||
144208010|NCT01421511|519956198|FG001|Overall Study|Randomized but didn't receive study drug|7|||
144208011|NCT01421511|519956197|FG000|Overall Study|Physician Decision|0|||
144622564|NCT01121393|521476259|FG001|Overall Study|Other Adverse events|45|||
144208012|NCT01421511|519956198|FG001|Overall Study|Physician Decision|1|||
144208013|NCT01421511|519956197|FG000|Overall Study|Withdrawal by Subject|6|||
144208014|NCT01421511|519956198|FG001|Overall Study|Withdrawal by Subject|5|||
144208015|NCT01421511|519956197|FG000|Overall Study|Death|1|||
144208016|NCT01421511|519956198|FG001|Overall Study|Death|1|||
144622565|NCT01121393|521476258|FG000|Overall Study|Non-compliant with protocol|0|||
144622566|NCT01121393|521476259|FG001|Overall Study|Non-compliant with protocol|3|||
144622567|NCT01121393|521476258|FG000|Overall Study|Lost to Follow-up|1|||
144622568|NCT01121393|521476259|FG001|Overall Study|Lost to Follow-up|0|||
144622569|NCT01121393|521476258|FG000|Overall Study|Refused cont. medication|7|||
144622570|NCT01121393|521476259|FG001|Overall Study|Refused cont. medication|7|||
144622571|NCT01121393|521476258|FG000|Overall Study|Not treated|3|||
144622572|NCT01121393|521476259|FG001|Overall Study|Not treated|9|||
144622573|NCT01121393|521476258|FG000|Overall Study|Other than listed|6|||
144622574|NCT01121393|521476259|FG001|Overall Study|Other than listed|0|||
144622575|NCT04372927|521476262|FG000|Overall Study|Death|1|||
144622576|NCT00608985|521476270|FG000|Overall Study|Adverse Event|2|||
144622577|NCT00608985|521476271|FG001|Overall Study|Adverse Event|7|||
144622578|NCT00608985|521476272|FG002|Overall Study|Adverse Event|4|||
144622579|NCT00608985|521476273|FG003|Overall Study|Adverse Event|6|||
144622580|NCT00608985|521476270|FG000|Overall Study|Administrative/Other|7|||
144622581|NCT00608985|521476271|FG001|Overall Study|Administrative/Other|4|||
144622582|NCT00608985|521476272|FG002|Overall Study|Administrative/Other|1|||
144622583|NCT00608985|521476273|FG003|Overall Study|Administrative/Other|2|||
144622584|NCT00608985|521476270|FG000|Overall Study|Withdrawal of Consent|5|||
144622585|NCT00608985|521476271|FG001|Overall Study|Withdrawal of Consent|1|||
144622586|NCT00608985|521476272|FG002|Overall Study|Withdrawal of Consent|1|||
144622587|NCT00608985|521476273|FG003|Overall Study|Withdrawal of Consent|1|||
144622588|NCT00608985|521476270|FG000|Overall Study|Lost to Follow-up|2|||
144622589|NCT00608985|521476271|FG001|Overall Study|Lost to Follow-up|1|||
144622590|NCT00608985|521476272|FG002|Overall Study|Lost to Follow-up|0|||
144622591|NCT00608985|521476273|FG003|Overall Study|Lost to Follow-up|0|||
144622592|NCT03033745|521476274|FG000|Overall Study|Protocol Violation|0|||
144622593|NCT03033745|521476275|FG001|Overall Study|Protocol Violation|0|||
144622594|NCT03033745|521476276|FG002|Overall Study|Protocol Violation|1|||
144622595|NCT03033745|521476274|FG000|Overall Study|Adverse Event|1|||
144622596|NCT03033745|521476275|FG001|Overall Study|Adverse Event|0|||
144622597|NCT03033745|521476276|FG002|Overall Study|Adverse Event|1|||
144622598|NCT03033745|521476274|FG000|Overall Study|Withdrawal by Subject|0|||
144622599|NCT03033745|521476275|FG001|Overall Study|Withdrawal by Subject|1|||
144622600|NCT03033745|521476276|FG002|Overall Study|Withdrawal by Subject|0|||
144622601|NCT02574637|521476277|FG000|Double-blind Period|Adverse Event|1|||
144622602|NCT02574637|521476278|FG001|Double-blind Period|Adverse Event|0|||
144622603|NCT02574637|521476279|FG002|Double-blind Period|Adverse Event|0|||
144622604|NCT02574637|521476280|FG003|Double-blind Period|Adverse Event|0|||
144622605|NCT02574637|521476281|FG004|Double-blind Period|Adverse Event|0|||
144622606|NCT02574637|521476282|FG005|Double-blind Period|Adverse Event|0|||
144622607|NCT02574637|521476283|FG006|Double-blind Period|Adverse Event|0|||
144622608|NCT02574637|521476284|FG007|Double-blind Period|Adverse Event|0|||
144622609|NCT02574637|521476285|FG008|Double-blind Period|Adverse Event|0|||
144622610|NCT02574637|521476286|FG009|Double-blind Period|Adverse Event|0|||
144622611|NCT02574637|521476277|FG000|Double-blind Period|Lack of Efficacy|0|||
144622612|NCT02574637|521476278|FG001|Double-blind Period|Lack of Efficacy|0|||
144622613|NCT02574637|521476279|FG002|Double-blind Period|Lack of Efficacy|2|||
144622614|NCT02574637|521476280|FG003|Double-blind Period|Lack of Efficacy|0|||
144622615|NCT02574637|521476281|FG004|Double-blind Period|Lack of Efficacy|0|||
144622616|NCT02574637|521476282|FG005|Double-blind Period|Lack of Efficacy|0|||
144622617|NCT02574637|521476283|FG006|Double-blind Period|Lack of Efficacy|0|||
144622618|NCT02574637|521476284|FG007|Double-blind Period|Lack of Efficacy|0|||
144622619|NCT02574637|521476285|FG008|Double-blind Period|Lack of Efficacy|0|||
144208017|NCT05384171|519956199|FG000|Overall Study|Lost to Follow-up|9|||
144208018|NCT05384171|519956200|FG001|Overall Study|Lost to Follow-up|9|||
144208019|NCT05384171|519956199|FG000|Overall Study|Withdrawal by Subject|3|||
144208020|NCT05384171|519956200|FG001|Overall Study|Withdrawal by Subject|0|||
144622620|NCT02574637|521476286|FG009|Double-blind Period|Lack of Efficacy|0|||
144622621|NCT02574637|521476277|FG000|Double-blind Period|Protocol Deviation|1|||
144622622|NCT02574637|521476278|FG001|Double-blind Period|Protocol Deviation|0|||
144622623|NCT02574637|521476279|FG002|Double-blind Period|Protocol Deviation|0|||
144622624|NCT02574637|521476280|FG003|Double-blind Period|Protocol Deviation|0|||
144622625|NCT02574637|521476281|FG004|Double-blind Period|Protocol Deviation|0|||
144622626|NCT02574637|521476282|FG005|Double-blind Period|Protocol Deviation|0|||
144622627|NCT02574637|521476283|FG006|Double-blind Period|Protocol Deviation|0|||
144622628|NCT02574637|521476284|FG007|Double-blind Period|Protocol Deviation|0|||
144622629|NCT02574637|521476285|FG008|Double-blind Period|Protocol Deviation|0|||
144622630|NCT02574637|521476286|FG009|Double-blind Period|Protocol Deviation|0|||
144622631|NCT02574637|521476277|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
144622632|NCT02574637|521476278|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
144622633|NCT02574637|521476279|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
144208021|NCT00749892|519956201|FG000|Overall Study|Withdrawal by Subject|3|||
144208022|NCT04581369|519956202|FG000|Overall Study|Death|7|||
144208023|NCT04581369|519956203|FG001|Overall Study|Death|6|||
144208024|NCT04581369|519956204|FG002|Overall Study|Death|0|||
144208025|NCT04581369|519956202|FG000|Overall Study|Lost to Follow-up|7|||
144208026|NCT04581369|519956203|FG001|Overall Study|Lost to Follow-up|3|||
144208027|NCT04581369|519956204|FG002|Overall Study|Lost to Follow-up|0|||
144208028|NCT04581369|519956202|FG000|Overall Study|liver transplant|2|||
144208029|NCT04581369|519956203|FG001|Overall Study|liver transplant|2|||
144208030|NCT04581369|519956204|FG002|Overall Study|liver transplant|0|||
144208031|NCT04581369|519956202|FG000|Overall Study|transitioned to hospice care|0|||
144208032|NCT04581369|519956203|FG001|Overall Study|transitioned to hospice care|5|||
144208033|NCT04581369|519956204|FG002|Overall Study|transitioned to hospice care|0|||
144208034|NCT00780910|519956205|FG000|Overall Study|Adverse Event|2|||
144208035|NCT01111825|519956207|FG000|Overall Study|Withdrawal by Subject|0|||
144208036|NCT01111825|519956208|FG001|Overall Study|Withdrawal by Subject|0|||
144208037|NCT01111825|519956209|FG002|Overall Study|Withdrawal by Subject|1|||
144208038|NCT01111825|519956210|FG003|Overall Study|Withdrawal by Subject|0|||
144579920|NCT04335591|521322060|FG002|Overall Study|Protocol Violation|0|||
144208039|NCT01111825|519956207|FG000|Overall Study|Lost to Follow-up|0|||
144208040|NCT01111825|519956208|FG001|Overall Study|Lost to Follow-up|0|||
144208041|NCT01111825|519956209|FG002|Overall Study|Lost to Follow-up|3|||
144208042|NCT01111825|519956210|FG003|Overall Study|Lost to Follow-up|1|||
144208043|NCT01111825|519956207|FG000|Overall Study|Adverse Event|2|||
144208044|NCT01111825|519956208|FG001|Overall Study|Adverse Event|1|||
144208045|NCT01111825|519956209|FG002|Overall Study|Adverse Event|4|||
144208046|NCT01111825|519956210|FG003|Overall Study|Adverse Event|0|||
144208047|NCT01111825|519956207|FG000|Overall Study|Disease Progression|1|||
144208048|NCT01111825|519956208|FG001|Overall Study|Disease Progression|0|||
144208049|NCT01111825|519956209|FG002|Overall Study|Disease Progression|0|||
144208050|NCT01111825|519956210|FG003|Overall Study|Disease Progression|0|||
144208051|NCT01111825|519956207|FG000|Overall Study|Discontinuation by Sponsor|0|||
144208052|NCT01111825|519956208|FG001|Overall Study|Discontinuation by Sponsor|0|||
144208053|NCT01111825|519956209|FG002|Overall Study|Discontinuation by Sponsor|0|||
144208054|NCT01111825|519956210|FG003|Overall Study|Discontinuation by Sponsor|20|||
144208055|NCT00314951|519956211|FG000|Treatment|Didn't meet criteria for mITT population|16|||
144208056|NCT00314951|519956212|FG001|Treatment|Didn't meet criteria for mITT population|11|||
144208057|NCT00314951|519956211|FG000|Follow-up|mITT failure|44|||
144208058|NCT00314951|519956212|FG001|Follow-up|mITT failure|34|||
144208059|NCT01661062|519956213|FG000|Overall Study|Completed Treatment Off Study|3|||
144208060|NCT01661062|519956213|FG000|Overall Study|Withdrawal by Subject|2|||
144208061|NCT00642278|519956216|FG000|Overall Study|Adverse Event|2|||
144208062|NCT00642278|519956217|FG001|Overall Study|Adverse Event|1|||
144208063|NCT00642278|519956218|FG002|Overall Study|Adverse Event|3|||
144208064|NCT00642278|519956219|FG003|Overall Study|Adverse Event|1|||
144208065|NCT00642278|519956220|FG004|Overall Study|Adverse Event|2|||
144208066|NCT00642278|519956221|FG005|Overall Study|Adverse Event|2|||
144208067|NCT00642278|519956222|FG006|Overall Study|Adverse Event|0|||
144208068|NCT00642278|519956216|FG000|Overall Study|Lack of Efficacy|0|||
144208069|NCT00642278|519956217|FG001|Overall Study|Lack of Efficacy|1|||
144208070|NCT00642278|519956218|FG002|Overall Study|Lack of Efficacy|0|||
144208071|NCT00642278|519956219|FG003|Overall Study|Lack of Efficacy|0|||
144208072|NCT00642278|519956220|FG004|Overall Study|Lack of Efficacy|0|||
144208073|NCT00642278|519956221|FG005|Overall Study|Lack of Efficacy|0|||
144208074|NCT00642278|519956222|FG006|Overall Study|Lack of Efficacy|0|||
144208075|NCT00642278|519956216|FG000|Overall Study|Lost to Follow-up|5|||
144208076|NCT00642278|519956217|FG001|Overall Study|Lost to Follow-up|1|||
144208077|NCT00642278|519956218|FG002|Overall Study|Lost to Follow-up|0|||
144208078|NCT00642278|519956219|FG003|Overall Study|Lost to Follow-up|1|||
144208079|NCT00642278|519956220|FG004|Overall Study|Lost to Follow-up|0|||
144208080|NCT00642278|519956221|FG005|Overall Study|Lost to Follow-up|1|||
144208081|NCT00642278|519956222|FG006|Overall Study|Lost to Follow-up|1|||
144208082|NCT00642278|519956216|FG000|Overall Study|Physician Decision|0|||
144208083|NCT00642278|519956217|FG001|Overall Study|Physician Decision|0|||
144208084|NCT00642278|519956218|FG002|Overall Study|Physician Decision|0|||
144208085|NCT00642278|519956219|FG003|Overall Study|Physician Decision|1|||
144208086|NCT00642278|519956220|FG004|Overall Study|Physician Decision|0|||
144208087|NCT00642278|519956221|FG005|Overall Study|Physician Decision|0|||
144208088|NCT00642278|519956222|FG006|Overall Study|Physician Decision|0|||
144208089|NCT00642278|519956216|FG000|Overall Study|Protocol Violation|0|||
144208090|NCT00642278|519956217|FG001|Overall Study|Protocol Violation|0|||
144208091|NCT00642278|519956218|FG002|Overall Study|Protocol Violation|1|||
144579921|NCT04335591|521322061|FG003|Overall Study|Protocol Violation|0|||
144208092|NCT00642278|519956219|FG003|Overall Study|Protocol Violation|1|||
144208093|NCT00642278|519956220|FG004|Overall Study|Protocol Violation|0|||
144208094|NCT00642278|519956221|FG005|Overall Study|Protocol Violation|1|||
144208095|NCT00642278|519956222|FG006|Overall Study|Protocol Violation|2|||
144208096|NCT00642278|519956216|FG000|Overall Study|Withdrawal by Subject|1|||
144579922|NCT04335591|521322058|FG000|Overall Study|Withdrawal by Subject|8|||
144730309|NCT03340727|521868193|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
144208097|NCT00642278|519956217|FG001|Overall Study|Withdrawal by Subject|1|||
144579923|NCT04335591|521322059|FG001|Overall Study|Withdrawal by Subject|4|||
144579924|NCT04335591|521322060|FG002|Overall Study|Withdrawal by Subject|4|||
144579925|NCT04335591|521322061|FG003|Overall Study|Withdrawal by Subject|5|||
144579926|NCT04335591|521322058|FG000|Overall Study|Subject planning pregnancy|0|||
144579927|NCT04335591|521322059|FG001|Overall Study|Subject planning pregnancy|1|||
144579928|NCT04335591|521322060|FG002|Overall Study|Subject planning pregnancy|0|||
144579929|NCT04335591|521322061|FG003|Overall Study|Subject planning pregnancy|0|||
144579930|NCT04335591|521322058|FG000|Overall Study|Ukrainian Russian war conflict|4|||
144579931|NCT04335591|521322059|FG001|Overall Study|Ukrainian Russian war conflict|5|||
144579932|NCT04335591|521322060|FG002|Overall Study|Ukrainian Russian war conflict|2|||
144208098|NCT00642278|519956218|FG002|Overall Study|Withdrawal by Subject|1|||
144208099|NCT00642278|519956219|FG003|Overall Study|Withdrawal by Subject|3|||
144208100|NCT00642278|519956220|FG004|Overall Study|Withdrawal by Subject|6|||
144208101|NCT00642278|519956221|FG005|Overall Study|Withdrawal by Subject|2|||
144208102|NCT00642278|519956222|FG006|Overall Study|Withdrawal by Subject|2|||
144208103|NCT00642278|519956216|FG000|Overall Study|Noncompliance with study drug regimen|0|||
144208104|NCT00642278|519956217|FG001|Overall Study|Noncompliance with study drug regimen|0|||
144208105|NCT00642278|519956218|FG002|Overall Study|Noncompliance with study drug regimen|0|||
144208106|NCT00642278|519956219|FG003|Overall Study|Noncompliance with study drug regimen|1|||
144208107|NCT00642278|519956220|FG004|Overall Study|Noncompliance with study drug regimen|0|||
144208108|NCT00642278|519956221|FG005|Overall Study|Noncompliance with study drug regimen|0|||
144208109|NCT00642278|519956222|FG006|Overall Study|Noncompliance with study drug regimen|0|||
144208110|NCT00642278|519956216|FG000|Overall Study|Other|2|||
144208111|NCT00642278|519956217|FG001|Overall Study|Other|1|||
144208112|NCT00642278|519956218|FG002|Overall Study|Other|0|||
144208113|NCT00642278|519956219|FG003|Overall Study|Other|1|||
144208114|NCT00642278|519956220|FG004|Overall Study|Other|0|||
144208115|NCT00642278|519956221|FG005|Overall Study|Other|1|||
144208116|NCT00642278|519956222|FG006|Overall Study|Other|0|||
144208117|NCT00090363|519956223|FG000|Overall Study|Lost to Follow-up|1|||
144208118|NCT00090363|519956224|FG001|Overall Study|Lost to Follow-up|2|||
144208119|NCT00090363|519956225|FG002|Overall Study|Lost to Follow-up|1|||
144208120|NCT00090363|519956223|FG000|Overall Study|Withdrawal by Subject|7|||
144208121|NCT00090363|519956224|FG001|Overall Study|Withdrawal by Subject|7|||
144208122|NCT00090363|519956225|FG002|Overall Study|Withdrawal by Subject|6|||
144208123|NCT00090363|519956223|FG000|Overall Study|Study-specific discontinuation criteria|75|||
144208124|NCT00090363|519956224|FG001|Overall Study|Study-specific discontinuation criteria|74|||
144208125|NCT00090363|519956225|FG002|Overall Study|Study-specific discontinuation criteria|62|||
144579933|NCT04335591|521322061|FG003|Overall Study|Ukrainian Russian war conflict|0|||
144579934|NCT00731133|521322064|FG000|Overall Study|Withdrawal by Subject|10|||
144579935|NCT03853551|521322068|FG000|Overall Study|Death|2|||
144579936|NCT03853551|521322068|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
144579937|NCT01252355|521322069|FG000|Overall Study|Adverse Event|9|||
144579938|NCT01252355|521322070|FG001|Overall Study|Adverse Event|17|||
144579939|NCT01252355|521322071|FG002|Overall Study|Adverse Event|22|||
144579940|NCT01252355|521322069|FG000|Overall Study|Lack of Efficacy|6|||
144579941|NCT01252355|521322070|FG001|Overall Study|Lack of Efficacy|4|||
144579942|NCT01252355|521322071|FG002|Overall Study|Lack of Efficacy|2|||
144579943|NCT01252355|521322069|FG000|Overall Study|Lost to Follow-up|0|||
144579944|NCT01252355|521322070|FG001|Overall Study|Lost to Follow-up|0|||
144579945|NCT01252355|521322071|FG002|Overall Study|Lost to Follow-up|1|||
144579946|NCT01252355|521322069|FG000|Overall Study|Poor Compliance to Protocol|1|||
144730310|NCT03340727|521868192|FG000|Overall Study|Transferred to another facility|10|||
144730311|NCT03340727|521868193|FG001|Overall Study|Transferred to another facility|7|||
144730312|NCT03340727|521868192|FG000|Overall Study|Withdrawal by Subject|28|||
144208126|NCT00090363|519956223|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144579947|NCT01252355|521322070|FG001|Overall Study|Poor Compliance to Protocol|1|||
144579948|NCT01252355|521322071|FG002|Overall Study|Poor Compliance to Protocol|1|||
144579949|NCT01252355|521322069|FG000|Overall Study|Progressive Disease|2|||
144579950|NCT01252355|521322070|FG001|Overall Study|Progressive Disease|0|||
144579951|NCT01252355|521322071|FG002|Overall Study|Progressive Disease|0|||
144579952|NCT01252355|521322069|FG000|Overall Study|Sponsor Early Termination of Study|149|||
144579953|NCT01252355|521322070|FG001|Overall Study|Sponsor Early Termination of Study|149|||
144579954|NCT01252355|521322071|FG002|Overall Study|Sponsor Early Termination of Study|146|||
144579955|NCT01252355|521322069|FG000|Overall Study|Randomized but not Treated|2|||
144579956|NCT01252355|521322070|FG001|Overall Study|Randomized but not Treated|0|||
144208127|NCT00090363|519956224|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144208128|NCT00090363|519956225|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
144208129|NCT00090363|519956223|FG000|Overall Study|Consent expired|7|||
144579957|NCT01252355|521322071|FG002|Overall Study|Randomized but not Treated|0|||
144579958|NCT01252355|521322069|FG000|Overall Study|Other Than Above|8|||
144579959|NCT01252355|521322070|FG001|Overall Study|Other Than Above|7|||
144579960|NCT01252355|521322071|FG002|Overall Study|Other Than Above|7|||
144579961|NCT01725126|521322072|FG000|Overall Study|Protocol Violation|0|||
144579962|NCT01725126|521322073|FG001|Overall Study|Protocol Violation|1|||
144579963|NCT01725126|521322074|FG002|Overall Study|Protocol Violation|0|||
144579964|NCT01725126|521322075|FG003|Overall Study|Protocol Violation|0|||
144208130|NCT00090363|519956224|FG001|Overall Study|Consent expired|10|||
144208131|NCT00090363|519956225|FG002|Overall Study|Consent expired|9|||
144208132|NCT00090363|519956223|FG000|Overall Study|Reasons not specified|2|||
144208133|NCT00090363|519956224|FG001|Overall Study|Reasons not specified|1|||
144208134|NCT00090363|519956225|FG002|Overall Study|Reasons not specified|1|||
144208135|NCT00090363|519956223|FG000|Overall Study|Continuing on study off treatment|14|||
144208136|NCT00090363|519956224|FG001|Overall Study|Continuing on study off treatment|13|||
144208137|NCT00090363|519956225|FG002|Overall Study|Continuing on study off treatment|16|||
144208138|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
144208139|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
144208140|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
144208141|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
144208142|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
144208143|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
144208144|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
144208145|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
144208146|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
144208147|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
144208148|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
144208149|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
144208150|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
144208151|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
144208152|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
144208153|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
144208154|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144730313|NCT03340727|521868193|FG001|Overall Study|Withdrawal by Subject|17|||
144730314|NCT02015390|521868194|FG000|Overall Study|Lost to Follow-up|1|||
144730315|NCT02015390|521868195|FG001|Overall Study|Lost to Follow-up|0|||
144730316|NCT02015390|521868194|FG000|Overall Study|Adverse Event|0|||
144208155|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144208156|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144208157|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144208158|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
144208159|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
144208160|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
144208161|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
144208162|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
144208163|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
144208164|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
144208165|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
144208166|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
144208167|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
144208168|NCT03713619|519956226|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
144208169|NCT03713619|519956227|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
144208170|NCT03713619|519956228|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
144208171|NCT03713619|519956229|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
144262875|NCT01325350|520163771|FG004|Overall Study|Did Not Receive Treatment|1|||
144262876|NCT01716806|520163776|FG000|Overall Study|Patient withdrawal of consent|4|||
144579965|NCT01725126|521322076|FG004|Overall Study|Protocol Violation|0|||
144579966|NCT01725126|521322077|FG005|Overall Study|Protocol Violation|0|||
144579967|NCT01725126|521322072|FG000|Overall Study|Withdrawal by Subject|0|||
144579968|NCT01725126|521322073|FG001|Overall Study|Withdrawal by Subject|0|||
144579969|NCT01725126|521322074|FG002|Overall Study|Withdrawal by Subject|0|||
144579970|NCT01725126|521322075|FG003|Overall Study|Withdrawal by Subject|1|||
144579971|NCT01725126|521322076|FG004|Overall Study|Withdrawal by Subject|0|||
144579972|NCT01725126|521322077|FG005|Overall Study|Withdrawal by Subject|0|||
144579973|NCT01876901|521322080|FG000|Overall Study|Protocol Violation|10|||
144579974|NCT01876901|521322081|FG001|Overall Study|Protocol Violation|2|||
144208172|NCT03713619|519956230|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
144208173|NCT03713619|519956226|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
144208174|NCT03713619|519956227|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
144208175|NCT03713619|519956228|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
144208176|NCT03713619|519956229|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
144579975|NCT01876901|521322080|FG000|Overall Study|No or other surgical intervention|7|||
144579976|NCT01876901|521322081|FG001|Overall Study|No or other surgical intervention|5|||
144579977|NCT02242097|521322084|FG000|Ibrutinib Treatment|Adverse Event|16|||
144579978|NCT02242097|521322084|FG000|Ibrutinib Treatment|Physician Decision|1|||
144208177|NCT03713619|519956230|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
144208178|NCT03713619|519956226|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
144208179|NCT03713619|519956227|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144579979|NCT02242097|521322084|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
144579980|NCT02242097|521322084|FG000|Ibrutinib Treatment|Death|1|||
144208180|NCT03713619|519956228|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144208181|NCT03713619|519956229|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
144208182|NCT03713619|519956230|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144208183|NCT03713619|519956226|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
144208184|NCT03713619|519956227|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
144208185|NCT03713619|519956228|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
144208186|NCT03713619|519956229|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
144208187|NCT03713619|519956230|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
144208188|NCT03713619|519956226|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
144208189|NCT03713619|519956227|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
144208190|NCT03713619|519956228|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
144208191|NCT03713619|519956229|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
144208192|NCT03713619|519956230|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
144208193|NCT03713619|519956226|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
144208194|NCT03713619|519956227|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
144579981|NCT02242097|521322084|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
144579982|NCT02242097|521322084|FG000|Post Therapy Follow Up|Death|3|||
144579983|NCT02242097|521322084|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
144579984|NCT02781090|521322086|FG000|3-Month Follow-Up|Missed Visit|20|||
144579985|NCT02781090|521322087|FG001|3-Month Follow-Up|Missed Visit|20|||
144579986|NCT02781090|521322086|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
144579987|NCT02781090|521322087|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
144579988|NCT02781090|521322086|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
144208195|NCT03713619|519956228|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
144208196|NCT03713619|519956229|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
144208197|NCT03713619|519956230|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
144208198|NCT03713619|519956226|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
144208199|NCT03713619|519956227|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
144208200|NCT03713619|519956228|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
144208201|NCT03713619|519956229|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
144208202|NCT03713619|519956230|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
144208203|NCT04642365|519956234|FG000|Overall Study|Death|3|||
144208204|NCT04642365|519956235|FG001|Overall Study|Death|2|||
144208205|NCT04642365|519956236|FG002|Overall Study|Death|4|||
144208206|NCT04642365|519956237|FG003|Overall Study|Death|5|||
144208207|NCT04642365|519956238|FG004|Overall Study|Death|5|||
144208208|NCT04642365|519956239|FG005|Overall Study|Death|3|||
144208209|NCT04642365|519956240|FG006|Overall Study|Death|2|||
144208210|NCT04642365|519956241|FG007|Overall Study|Death|1|||
144208211|NCT04642365|519956234|FG000|Overall Study|Physician Decision|1|||
144208212|NCT04642365|519956235|FG001|Overall Study|Physician Decision|0|||
144208213|NCT04642365|519956236|FG002|Overall Study|Physician Decision|0|||
144208214|NCT04642365|519956237|FG003|Overall Study|Physician Decision|0|||
144208215|NCT04642365|519956238|FG004|Overall Study|Physician Decision|0|||
144208216|NCT04642365|519956239|FG005|Overall Study|Physician Decision|0|||
144208217|NCT04642365|519956240|FG006|Overall Study|Physician Decision|0|||
144208218|NCT04642365|519956241|FG007|Overall Study|Physician Decision|0|||
144208219|NCT04642365|519956234|FG000|Overall Study|Progressive Disease|1|||
144208220|NCT04642365|519956235|FG001|Overall Study|Progressive Disease|1|||
144208221|NCT04642365|519956236|FG002|Overall Study|Progressive Disease|1|||
144579989|NCT02781090|521322087|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
144579990|NCT02781090|521322086|FG000|3-Month Follow-Up|Death|1|||
144579991|NCT02781090|521322087|FG001|3-Month Follow-Up|Death|0|||
144579992|NCT02781090|521322086|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
144579993|NCT02781090|521322087|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
144579994|NCT02781090|521322086|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
144622634|NCT02574637|521476280|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
144208222|NCT04642365|519956237|FG003|Overall Study|Progressive Disease|0|||
144208223|NCT04642365|519956238|FG004|Overall Study|Progressive Disease|0|||
144208224|NCT04642365|519956239|FG005|Overall Study|Progressive Disease|0|||
144208225|NCT04642365|519956240|FG006|Overall Study|Progressive Disease|1|||
144579995|NCT02781090|521322087|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
144579996|NCT02781090|521322086|FG000|6-Month Follow-Up|Death|0|||
144579997|NCT02781090|521322087|FG001|6-Month Follow-Up|Death|1|||
144622635|NCT02574637|521476281|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
144579998|NCT01867333|521322088|FG000|Overall Study|Withdrawal by Subject|1|||
144208226|NCT04642365|519956241|FG007|Overall Study|Progressive Disease|0|||
144208227|NCT04642365|519956234|FG000|Overall Study|Study Terminated By Sponsor|0|||
144208228|NCT04642365|519956235|FG001|Overall Study|Study Terminated By Sponsor|2|||
144208229|NCT04642365|519956236|FG002|Overall Study|Study Terminated By Sponsor|1|||
144579999|NCT01867333|521322089|FG001|Overall Study|Withdrawal by Subject|0|||
144580000|NCT01867333|521322088|FG000|Overall Study|Adverse Event|1|||
144580001|NCT01867333|521322089|FG001|Overall Study|Adverse Event|0|||
144580002|NCT01867333|521322088|FG000|Overall Study|Participant choice|1|||
144580003|NCT01867333|521322089|FG001|Overall Study|Participant choice|2|||
144580004|NCT01867333|521322088|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
144580005|NCT01867333|521322089|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
144580006|NCT01867333|521322088|FG000|Overall Study|Death|0|||
144580007|NCT01867333|521322089|FG001|Overall Study|Death|1|||
144730317|NCT02015390|521868195|FG001|Overall Study|Adverse Event|3|||
144730318|NCT02015390|521868194|FG000|Overall Study|Physician Decision|0|||
144730319|NCT02015390|521868195|FG001|Overall Study|Physician Decision|1|||
144730320|NCT00669942|521868196|FG000|Parts 2 and 3|Adverse Event|0|||
144730321|NCT00669942|521868197|FG001|Parts 2 and 3|Adverse Event|0|||
144730322|NCT00669942|521868198|FG002|Parts 2 and 3|Adverse Event|0|||
144730323|NCT00669942|521868199|FG003|Parts 2 and 3|Adverse Event|0|||
144730324|NCT00669942|521868200|FG004|Parts 2 and 3|Adverse Event|0|||
144730325|NCT00669942|521868201|FG005|Parts 2 and 3|Adverse Event|0|||
144580008|NCT01867333|521322088|FG000|Overall Study|Physician Decision|3|||
144580009|NCT01867333|521322089|FG001|Overall Study|Physician Decision|2|||
144580010|NCT01867333|521322088|FG000|Overall Study|Switched to alternative treatment|1|||
144580011|NCT01867333|521322089|FG001|Overall Study|Switched to alternative treatment|0|||
144580012|NCT02683785|521322090|FG000|Overall Study|Withdrawal by Subject|1|||
144580013|NCT02683785|521322091|FG001|Overall Study|Withdrawal by Subject|1|||
144580014|NCT02683785|521322090|FG000|Overall Study|Lost to Follow-up|0|||
144580015|NCT02683785|521322091|FG001|Overall Study|Lost to Follow-up|1|||
144580016|NCT02683785|521322090|FG000|Overall Study|Adverse Event|0|||
144580017|NCT02683785|521322091|FG001|Overall Study|Adverse Event|2|||
144580018|NCT04462289|521322098|FG000|Overall Study|Lost to Follow-up|4|||
144580019|NCT04462289|521322099|FG001|Overall Study|Lost to Follow-up|5|||
144580020|NCT04462289|521322098|FG000|Overall Study|Death|0|||
144580021|NCT04462289|521322099|FG001|Overall Study|Death|3|||
144580022|NCT04462289|521322098|FG000|Overall Study|Withdrawal by Subject|1|||
144580023|NCT04462289|521322099|FG001|Overall Study|Withdrawal by Subject|3|||
144580024|NCT02206061|521322100|FG000|Overall Study|Withdrawal by Subject|4|||
144580025|NCT02206061|521322101|FG001|Overall Study|Withdrawal by Subject|7|||
144580026|NCT02206061|521322102|FG002|Overall Study|Withdrawal by Subject|1|||
144580027|NCT02206061|521322100|FG000|Overall Study|Lost to Follow-up|14|||
144580028|NCT02206061|521322101|FG001|Overall Study|Lost to Follow-up|7|||
144580029|NCT02206061|521322102|FG002|Overall Study|Lost to Follow-up|20|||
144580030|NCT04187326|521322103|FG000|Overall Study|Lost to Follow-up|2|||
144580031|NCT04187326|521322104|FG001|Overall Study|Lost to Follow-up|1|||
144580032|NCT04187326|521322103|FG000|Overall Study|Computer error- task was only partially completed.|0|||
144580033|NCT04187326|521322104|FG001|Overall Study|Computer error- task was only partially completed.|1|||
144580034|NCT03686423|521322110|FG000|Overall Study|Withdrawal by Subject|9|||
144580035|NCT03686423|521322110|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
144580036|NCT02833077|521322111|FG000|Overall Study|Adverse Event|1|||
144580037|NCT02833077|521322112|FG001|Overall Study|Adverse Event|2|||
144580038|NCT02833077|521322111|FG000|Overall Study|Lost to Follow-up|10|||
144580039|NCT02833077|521322112|FG001|Overall Study|Lost to Follow-up|1|||
144580040|NCT02833077|521322111|FG000|Overall Study|Personal Reasons|6|||
144580041|NCT02833077|521322112|FG001|Overall Study|Personal Reasons|4|||
144580042|NCT02833077|521322111|FG000|Overall Study|Protocol Deviation|0|||
144580043|NCT02833077|521322112|FG001|Overall Study|Protocol Deviation|1|||
144580044|NCT05718466|521323552|FG000|Overall Study|Withdrawal by Subject|1|||
144580045|NCT05718466|521323553|FG001|Overall Study|Withdrawal by Subject|2|||
144580046|NCT05718466|521323552|FG000|Overall Study|Death|0|||
144580047|NCT05718466|521323553|FG001|Overall Study|Death|1|||
144580048|NCT00387426|521323554|FG000|Overall Study|Lack of Response|7|||
144580049|NCT00387426|521323554|FG000|Overall Study|Toxicities|4|||
144580050|NCT00387426|521323554|FG000|Overall Study|Disease Progression|3|||
144580051|NCT01253135|521323555|FG000|Original Protocol|Protocol Amendment|15|||
144580052|NCT01253135|521323555|FG000|Amended Protocol|Non-compliance|1|||
144580053|NCT01015560|521323556|FG000|Overall Study|Adverse Event|1|||
144580054|NCT01015560|521323556|FG000|Overall Study|Not protocol specified|1|||
144580055|NCT01015560|521323556|FG000|Overall Study|Withdrawal by Subject|1|||
144580056|NCT00288639|521323566|FG000|Overall Study|Adverse Event|5|||
144580057|NCT00288639|521323566|FG000|Overall Study|Lack of Efficacy|4|||
144580058|NCT00288639|521323566|FG000|Overall Study|Withdrawal by Subject|2|||
144580059|NCT00288639|521323566|FG000|Overall Study|Other|1|||
144580060|NCT02815579|521323572|FG000|Overall Study|Non-payment of loan down-payment|16|||
144580061|NCT02815579|521323573|FG001|Overall Study|Non-payment of loan down-payment|0|||
144580062|NCT02815579|521323572|FG000|Overall Study|Withdrawal by Subject|7|||
144580063|NCT02815579|521323573|FG001|Overall Study|Withdrawal by Subject|1|||
144580064|NCT02815579|521323572|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
144580065|NCT02815579|521323573|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
144580066|NCT02815579|521323572|FG000|Overall Study|Lost to Follow-up|7|||
144580067|NCT02815579|521323573|FG001|Overall Study|Lost to Follow-up|4|||
144580068|NCT02815579|521323572|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
144580069|NCT02815579|521323573|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
144580070|NCT02815579|521323572|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
144580071|NCT02815579|521323573|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
144580072|NCT02815579|521323572|FG000|Overall Study|Death|5|||
144580073|NCT02815579|521323573|FG001|Overall Study|Death|4|||
144580074|NCT02815579|521323572|FG000|Overall Study|Imprisoned|0|||
144580075|NCT02815579|521323573|FG001|Overall Study|Imprisoned|2|||
144580076|NCT02815579|521323572|FG000|Overall Study|Did not meet enrollment criteria|0|||
144580077|NCT02815579|521323573|FG001|Overall Study|Did not meet enrollment criteria|1|||
144580078|NCT02311673|521323574|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
144580079|NCT02311673|521323575|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
144580080|NCT02311673|521323576|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
144580081|NCT02311673|521323577|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
144580082|NCT04939701|521323580|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
144580083|NCT04939701|521323581|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
144580084|NCT04939701|521323582|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
144580085|NCT04939701|521323580|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
144580086|NCT04939701|521323581|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
144580087|NCT04939701|521323582|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
144580088|NCT04939701|521323580|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
144580089|NCT04939701|521323581|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
144580090|NCT04939701|521323582|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
144580091|NCT04939701|521323580|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
144580092|NCT04939701|521323581|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
144580093|NCT04939701|521323582|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
144580094|NCT04939701|521323580|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
144580095|NCT04939701|521323581|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
144580096|NCT04939701|521323582|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
144580097|NCT04939701|521323580|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
144580098|NCT04939701|521323581|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
144580099|NCT04939701|521323582|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
144580100|NCT04939701|521323580|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
144580101|NCT04939701|521323581|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
144580102|NCT04939701|521323582|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
144580103|NCT05487586|521323587|FG000|Overall Study|Death|22|||
144580104|NCT05487586|521323587|FG000|Overall Study|Physician Decision|1|||
144580105|NCT05487586|521323587|FG000|Overall Study|Transfer to another hospital|4|||
144580106|NCT05487586|521323587|FG000|Overall Study|Other|1|||
144580107|NCT01493427|521323588|FG000|Overall Study|Adverse Event|10|||
144730326|NCT00669942|521868202|FG006|Parts 2 and 3|Adverse Event|0|||
144580108|NCT01493427|521323588|FG000|Overall Study|Personal Reasons|4|||
144580109|NCT01493427|521323588|FG000|Overall Study|Lost to Follow-up|2|||
144580110|NCT01493427|521323588|FG000|Overall Study|Inability to Follow Instructions|2|||
144580111|NCT01493427|521323588|FG000|Overall Study|Other|2|||
144580112|NCT02574845|521323591|FG000|Overall Study|Consent withdrawn further participation|0|||
144580113|NCT02574845|521323592|FG001|Overall Study|Consent withdrawn further participation|0|||
144580114|NCT02574845|521323593|FG002|Overall Study|Consent withdrawn further participation|0|||
144580115|NCT02574845|521323594|FG003|Overall Study|Consent withdrawn further participation|0|||
144580116|NCT02574845|521323595|FG004|Overall Study|Consent withdrawn further participation|1|||
144580117|NCT02574845|521323596|FG005|Overall Study|Consent withdrawn further participation|0|||
144580118|NCT02574845|521323591|FG000|Overall Study|Adverse Event|0|||
144580119|NCT02574845|521323592|FG001|Overall Study|Adverse Event|1|||
144580120|NCT02574845|521323593|FG002|Overall Study|Adverse Event|0|||
144580121|NCT02574845|521323594|FG003|Overall Study|Adverse Event|0|||
144580122|NCT02574845|521323595|FG004|Overall Study|Adverse Event|0|||
144580123|NCT02574845|521323596|FG005|Overall Study|Adverse Event|1|||
144580124|NCT02233803|521323600|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
144580125|NCT02233803|521323601|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
144580126|NCT02233803|521323600|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
144580127|NCT02233803|521323601|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
144580128|NCT02233803|521323600|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
144580129|NCT02233803|521323601|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
144580130|NCT02233803|521323600|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
144580131|NCT02233803|521323601|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
144580132|NCT02233803|521323600|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
144580133|NCT02233803|521323601|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
144580134|NCT02233803|521323600|FG000|Washout Period (4-Wks)|Physician Decision|1|||
144580135|NCT02233803|521323601|FG001|Washout Period (4-Wks)|Physician Decision|0|||
144580136|NCT02233803|521323600|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
144580137|NCT02233803|521323601|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
144580138|NCT02233803|521323600|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
144580139|NCT02233803|521323601|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
144580140|NCT02233803|521323600|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
144580141|NCT02233803|521323601|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
144580142|NCT01559129|521323606|FG000|Treatment Phase|Adverse Event|0|||
144580143|NCT01559129|521323607|FG001|Treatment Phase|Adverse Event|2|||
144580144|NCT01559129|521323606|FG000|Treatment Phase|Progressive Disease|1|||
144580145|NCT01559129|521323607|FG001|Treatment Phase|Progressive Disease|1|||
144580146|NCT01559129|521323606|FG000|Treatment Phase|Lack of Efficacy|0|||
144208230|NCT04642365|519956237|FG003|Overall Study|Study Terminated By Sponsor|1|||
144208231|NCT04642365|519956238|FG004|Overall Study|Study Terminated By Sponsor|1|||
144208232|NCT04642365|519956239|FG005|Overall Study|Study Terminated By Sponsor|2|||
144580147|NCT01559129|521323607|FG001|Treatment Phase|Lack of Efficacy|1|||
144580148|NCT01559129|521323606|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
144580149|NCT01559129|521323607|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
144580150|NCT01559129|521323606|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
144580151|NCT01559129|521323607|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
144580152|NCT01559129|521323606|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
144580153|NCT01559129|521323607|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
144580154|NCT01559129|521323606|FG000|Open-label Extension Period|Adverse Event|1|||
144580155|NCT01559129|521323607|FG001|Open-label Extension Period|Adverse Event|0|||
144580156|NCT01559129|521323606|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
144580157|NCT01559129|521323607|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
144580158|NCT00368927|521323608|FG000|Overall Study|Lost to Follow-up|2|||
144580159|NCT00368927|521323609|FG001|Overall Study|Lost to Follow-up|0|||
144580160|NCT00368927|521323608|FG000|Overall Study|Adverse Event|1|||
144580161|NCT00368927|521323609|FG001|Overall Study|Adverse Event|1|||
144580162|NCT00368927|521323608|FG000|Overall Study|Withdrawal by Subject|1|||
144580163|NCT00368927|521323609|FG001|Overall Study|Withdrawal by Subject|2|||
144580164|NCT00368927|521323608|FG000|Overall Study|Physician Decision|1|||
144580165|NCT00368927|521323609|FG001|Overall Study|Physician Decision|0|||
144580166|NCT03525392|521323610|FG000|Overall Study|Adverse Event|1|||
144580167|NCT03525392|521323611|FG001|Overall Study|Adverse Event|0|||
144580168|NCT03525392|521323612|FG002|Overall Study|Adverse Event|2|||
144580169|NCT03525392|521323613|FG003|Overall Study|Adverse Event|0|||
144580170|NCT03525392|521323614|FG004|Overall Study|Adverse Event|0|||
144580171|NCT03525392|521323610|FG000|Overall Study|Progressive disease|0|||
144580172|NCT03525392|521323611|FG001|Overall Study|Progressive disease|1|||
144580173|NCT03525392|521323612|FG002|Overall Study|Progressive disease|1|||
144580174|NCT03525392|521323613|FG003|Overall Study|Progressive disease|3|||
144580175|NCT03525392|521323614|FG004|Overall Study|Progressive disease|1|||
144580176|NCT03284203|521323617|FG000|Overall Study|Lost to Follow-up|3|||
144580177|NCT03309813|521323618|FG000|Main Randomized Study|Withdrawal by Subject|1|||
144580178|NCT03309813|521323619|FG001|Main Randomized Study|Withdrawal by Subject|0|||
144580179|NCT04978493|521323620|FG000|Overall Study|No reason available|0|||
144580180|NCT04978493|521323621|FG001|Overall Study|No reason available|1|||
144580181|NCT04978493|521323620|FG000|Overall Study|Adverse Event|1|||
144580182|NCT04978493|521323621|FG001|Overall Study|Adverse Event|0|||
144580183|NCT01128114|521323622|FG000|Overall Study|Treatment Withdrawn|6|||
144580184|NCT01128114|521323622|FG000|Overall Study|Screening Failed|2|||
144580185|NCT00208325|521323623|FG000|Overall Study|Death|18|||
144580186|NCT00208325|521323624|FG001|Overall Study|Death|19|||
144208233|NCT04642365|519956240|FG006|Overall Study|Study Terminated By Sponsor|2|||
144208234|NCT04642365|519956241|FG007|Overall Study|Study Terminated By Sponsor|1|||
144208235|NCT04642365|519956234|FG000|Overall Study|Symptomatic Deterioration|1|||
144208236|NCT04642365|519956235|FG001|Overall Study|Symptomatic Deterioration|1|||
144208237|NCT04642365|519956236|FG002|Overall Study|Symptomatic Deterioration|0|||
144208238|NCT04642365|519956237|FG003|Overall Study|Symptomatic Deterioration|0|||
144208239|NCT04642365|519956238|FG004|Overall Study|Symptomatic Deterioration|0|||
144208240|NCT04642365|519956239|FG005|Overall Study|Symptomatic Deterioration|1|||
144208241|NCT04642365|519956240|FG006|Overall Study|Symptomatic Deterioration|0|||
144208242|NCT04642365|519956241|FG007|Overall Study|Symptomatic Deterioration|0|||
144208243|NCT04642365|519956234|FG000|Overall Study|Withdrawal by Subject|0|||
144208244|NCT04642365|519956235|FG001|Overall Study|Withdrawal by Subject|0|||
144580187|NCT00208325|521323625|FG002|Overall Study|Death|7|||
144580188|NCT00208325|521323626|FG003|Overall Study|Death|5|||
144580189|NCT00208325|521323623|FG000|Overall Study|Withdrawal by Subject|0|||
144580190|NCT00208325|521323624|FG001|Overall Study|Withdrawal by Subject|1|||
144580191|NCT00208325|521323625|FG002|Overall Study|Withdrawal by Subject|0|||
144580192|NCT00208325|521323626|FG003|Overall Study|Withdrawal by Subject|0|||
144580193|NCT00208325|521323623|FG000|Overall Study|Revision|4|||
144580194|NCT00208325|521323624|FG001|Overall Study|Revision|1|||
144580195|NCT00208325|521323625|FG002|Overall Study|Revision|0|||
144208245|NCT04642365|519956236|FG002|Overall Study|Withdrawal by Subject|1|||
144208246|NCT04642365|519956237|FG003|Overall Study|Withdrawal by Subject|1|||
144208247|NCT04642365|519956238|FG004|Overall Study|Withdrawal by Subject|0|||
144208248|NCT04642365|519956239|FG005|Overall Study|Withdrawal by Subject|0|||
144208249|NCT04642365|519956240|FG006|Overall Study|Withdrawal by Subject|2|||
144208250|NCT04642365|519956241|FG007|Overall Study|Withdrawal by Subject|0|||
144208251|NCT04642365|519956234|FG000|Overall Study|Adverse Event|0|||
144208252|NCT04642365|519956235|FG001|Overall Study|Adverse Event|0|||
144208253|NCT04642365|519956236|FG002|Overall Study|Adverse Event|0|||
144208254|NCT04642365|519956237|FG003|Overall Study|Adverse Event|0|||
144208255|NCT04642365|519956238|FG004|Overall Study|Adverse Event|0|||
144208256|NCT04642365|519956239|FG005|Overall Study|Adverse Event|0|||
144208257|NCT04642365|519956240|FG006|Overall Study|Adverse Event|0|||
144208258|NCT04642365|519956241|FG007|Overall Study|Adverse Event|1|||
144208259|NCT00673387|519956243|FG000|Overall Study|Withdrawal by Subject|15|||
144208260|NCT00673387|519956244|FG001|Overall Study|Withdrawal by Subject|16|||
144208261|NCT00673387|519956245|FG002|Overall Study|Withdrawal by Subject|20|||
144208262|NCT00673387|519956246|FG003|Overall Study|Withdrawal by Subject|16|||
144208263|NCT00673387|519956247|FG004|Overall Study|Withdrawal by Subject|18|||
144208264|NCT00673387|519956248|FG005|Overall Study|Withdrawal by Subject|21|||
144208265|NCT00673387|519956249|FG006|Overall Study|Withdrawal by Subject|15|||
144208266|NCT00673387|519956250|FG007|Overall Study|Withdrawal by Subject|21|||
144208267|NCT00673387|519956243|FG000|Overall Study|Adverse Event|3|||
144208268|NCT00673387|519956244|FG001|Overall Study|Adverse Event|1|||
144208269|NCT00673387|519956245|FG002|Overall Study|Adverse Event|5|||
144208270|NCT00673387|519956246|FG003|Overall Study|Adverse Event|2|||
144208271|NCT00673387|519956247|FG004|Overall Study|Adverse Event|6|||
144208272|NCT00673387|519956248|FG005|Overall Study|Adverse Event|2|||
144208273|NCT00673387|519956249|FG006|Overall Study|Adverse Event|5|||
144208274|NCT00673387|519956250|FG007|Overall Study|Adverse Event|5|||
144208275|NCT00673387|519956243|FG000|Overall Study|Physician Decision|0|||
144208276|NCT00673387|519956244|FG001|Overall Study|Physician Decision|0|||
144208277|NCT00673387|519956245|FG002|Overall Study|Physician Decision|0|||
144580196|NCT00208325|521323626|FG003|Overall Study|Revision|4|||
144580197|NCT00208325|521323623|FG000|Overall Study|Lost to Follow-up|1|||
144580198|NCT00208325|521323624|FG001|Overall Study|Lost to Follow-up|0|||
144580199|NCT00208325|521323625|FG002|Overall Study|Lost to Follow-up|2|||
144580200|NCT00208325|521323626|FG003|Overall Study|Lost to Follow-up|0|||
144580201|NCT00208325|521323623|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
144580202|NCT00208325|521323624|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
144580203|NCT00208325|521323625|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
144208278|NCT00673387|519956246|FG003|Overall Study|Physician Decision|0|||
144208279|NCT00673387|519956247|FG004|Overall Study|Physician Decision|0|||
144208280|NCT00673387|519956248|FG005|Overall Study|Physician Decision|5|||
144208281|NCT00673387|519956249|FG006|Overall Study|Physician Decision|1|||
144208282|NCT00673387|519956250|FG007|Overall Study|Physician Decision|1|||
144208283|NCT00673387|519956243|FG000|Overall Study|Protocol Violation|3|||
144208284|NCT00673387|519956244|FG001|Overall Study|Protocol Violation|0|||
144208285|NCT00673387|519956245|FG002|Overall Study|Protocol Violation|1|||
144208286|NCT00673387|519956246|FG003|Overall Study|Protocol Violation|2|||
144208287|NCT00673387|519956247|FG004|Overall Study|Protocol Violation|0|||
144208288|NCT00673387|519956248|FG005|Overall Study|Protocol Violation|1|||
144208289|NCT00673387|519956249|FG006|Overall Study|Protocol Violation|1|||
144208290|NCT00673387|519956250|FG007|Overall Study|Protocol Violation|3|||
144208291|NCT00673387|519956243|FG000|Overall Study|Lost to Follow-up|8|||
144208292|NCT00673387|519956244|FG001|Overall Study|Lost to Follow-up|6|||
144208293|NCT00673387|519956245|FG002|Overall Study|Lost to Follow-up|5|||
144208294|NCT00673387|519956246|FG003|Overall Study|Lost to Follow-up|6|||
144208295|NCT00673387|519956247|FG004|Overall Study|Lost to Follow-up|6|||
144208296|NCT00673387|519956248|FG005|Overall Study|Lost to Follow-up|5|||
144208297|NCT00673387|519956249|FG006|Overall Study|Lost to Follow-up|8|||
144208298|NCT00673387|519956250|FG007|Overall Study|Lost to Follow-up|5|||
144622636|NCT02574637|521476282|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
144622637|NCT02574637|521476283|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
144622638|NCT02574637|521476284|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
144622639|NCT02574637|521476285|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
144622640|NCT02574637|521476286|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
144622641|NCT02574637|521476277|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
144208299|NCT02533375|519956251|FG000|Overall Study|Lack of Efficacy|3|||
144208300|NCT02533375|519956251|FG000|Overall Study|Adverse Event|2|||
144208301|NCT00960115|519956252|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
144208302|NCT00960115|519956253|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
144208303|NCT00418821|519956254|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
144208304|NCT04619992|519956255|FG000|Overall Study|Withdrawal by Subject|1|||
144208305|NCT04619992|519956256|FG001|Overall Study|Withdrawal by Subject|0|||
144208306|NCT01806506|519956259|FG000|Overall Study|Lost to Follow-up|2|||
144208307|NCT01806506|519956260|FG001|Overall Study|Lost to Follow-up|1|||
144580204|NCT00208325|521323626|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
144580205|NCT00208325|521323623|FG000|Overall Study|Does not wish to Continue in Study|5|||
144730327|NCT00669942|521868203|FG007|Parts 2 and 3|Adverse Event|2|||
144730328|NCT00669942|521868204|FG008|Parts 2 and 3|Adverse Event|1|||
144730329|NCT00669942|521868205|FG009|Parts 2 and 3|Adverse Event|0|||
144730330|NCT00669942|521868206|FG010|Parts 2 and 3|Adverse Event|0|||
144730331|NCT00669942|521868207|FG011|Parts 2 and 3|Adverse Event|0|||
144730332|NCT00669942|521868196|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
144730333|NCT00669942|521868197|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
144208308|NCT04844762|519956261|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208309|NCT04844762|519956262|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208310|NCT04844762|519956263|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
144208311|NCT04844762|519956264|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208312|NCT04844762|519956265|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208313|NCT04844762|519956266|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208314|NCT04844762|519956261|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
144208315|NCT04844762|519956262|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
144208316|NCT04844762|519956263|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
144208317|NCT04844762|519956264|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
144208318|NCT04844762|519956265|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
144208319|NCT04844762|519956266|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
144208320|NCT04844762|519956261|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208321|NCT04844762|519956262|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208322|NCT04844762|519956263|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
144208323|NCT04844762|519956264|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
144208324|NCT04844762|519956265|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144580206|NCT00208325|521323624|FG001|Overall Study|Does not wish to Continue in Study|8|||
144580207|NCT00208325|521323625|FG002|Overall Study|Does not wish to Continue in Study|3|||
144580208|NCT00208325|521323626|FG003|Overall Study|Does not wish to Continue in Study|2|||
144580209|NCT00208325|521323623|FG000|Overall Study|Other|2|||
144580210|NCT00208325|521323624|FG001|Overall Study|Other|1|||
144580211|NCT00208325|521323625|FG002|Overall Study|Other|1|||
144580212|NCT00208325|521323626|FG003|Overall Study|Other|0|||
144580213|NCT00208325|521323623|FG000|Overall Study|Mis-Randomized|17|||
144580214|NCT00208325|521323624|FG001|Overall Study|Mis-Randomized|20|||
144580215|NCT00208325|521323625|FG002|Overall Study|Mis-Randomized|0|||
144580216|NCT00208325|521323626|FG003|Overall Study|Mis-Randomized|0|||
144580217|NCT00586612|521323627|FG000|Primary Phase|Protocol Violation|1|||
144208325|NCT04844762|519956266|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
144208326|NCT04844762|519956261|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144730334|NCT00669942|521868198|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
144730335|NCT00669942|521868199|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
144730336|NCT00669942|521868200|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
144730337|NCT00669942|521868201|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
144730338|NCT00669942|521868202|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
144730339|NCT00669942|521868203|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
144730340|NCT00669942|521868204|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
144730341|NCT00669942|521868205|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
144730342|NCT00669942|521868206|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
144730343|NCT00669942|521868207|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
144730344|NCT00669942|521868196|FG000|Parts 2 and 3|Protocol Violation|0|||
144730345|NCT00669942|521868197|FG001|Parts 2 and 3|Protocol Violation|0|||
144208327|NCT04844762|519956262|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208328|NCT04844762|519956263|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
144208329|NCT04844762|519956264|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
144208330|NCT04844762|519956265|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
144208331|NCT04844762|519956266|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208332|NCT04844762|519956261|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
144208333|NCT04844762|519956262|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
144208334|NCT04844762|519956263|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208335|NCT04844762|519956264|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208336|NCT04844762|519956265|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144580218|NCT00586612|521323628|FG001|Primary Phase|Protocol Violation|0|||
144580219|NCT00586612|521323627|FG000|Primary Phase|Lost to Follow-up|0|||
144580220|NCT00586612|521323628|FG001|Primary Phase|Lost to Follow-up|1|||
144580221|NCT00586612|521323627|FG000|Primary Phase|Withdrawal by Subject|0|||
144580222|NCT00586612|521323628|FG001|Primary Phase|Withdrawal by Subject|2|||
144730346|NCT00669942|521868198|FG002|Parts 2 and 3|Protocol Violation|0|||
144580223|NCT00586612|521323627|FG000|Booster Phase|Lost to Follow-up|3|||
144730347|NCT00669942|521868199|FG003|Parts 2 and 3|Protocol Violation|0|||
144730348|NCT00669942|521868200|FG004|Parts 2 and 3|Protocol Violation|0|||
144580224|NCT00586612|521323628|FG001|Booster Phase|Lost to Follow-up|1|||
144580225|NCT02738853|521323629|FG000|Enrollment|Inclusion/Exclusion not met|21|||
144580226|NCT02738853|521323629|FG000|Enrollment|Withdrawal by Subject|3|||
144580227|NCT02738853|521323629|FG000|Enrollment|Subject treated with commercially available device|6|||
144580228|NCT02738853|521323629|FG000|Enrollment|Study Enrollment Closed|3|||
144580229|NCT02738853|521323629|FG000|Procedure|Death|1|||
144208337|NCT04844762|519956266|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208338|NCT04844762|519956261|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
144208339|NCT04844762|519956262|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208340|NCT04844762|519956263|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208341|NCT04844762|519956264|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208342|NCT04844762|519956265|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208343|NCT04844762|519956266|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208344|NCT04844762|519956261|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208345|NCT04844762|519956262|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208346|NCT04844762|519956263|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208347|NCT04844762|519956264|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208348|NCT04844762|519956265|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
144208349|NCT04844762|519956266|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
144208350|NCT04844762|519956261|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
144208351|NCT04844762|519956262|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208352|NCT04844762|519956263|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208353|NCT04844762|519956264|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208354|NCT04844762|519956265|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208355|NCT04844762|519956266|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
144208356|NCT04844762|519956261|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
144208357|NCT04844762|519956262|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208358|NCT04844762|519956263|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208359|NCT04844762|519956264|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208360|NCT04844762|519956265|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
144208361|NCT04844762|519956266|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
144208362|NCT04844762|519956261|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
144208363|NCT04844762|519956262|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
144208364|NCT04844762|519956263|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
144208365|NCT04844762|519956264|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
144208366|NCT04844762|519956265|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
144208367|NCT04844762|519956266|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
144208368|NCT04844762|519956261|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
144208369|NCT04844762|519956262|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
144208370|NCT04844762|519956263|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
144208371|NCT04844762|519956264|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
144208372|NCT04844762|519956265|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
144208373|NCT04844762|519956266|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
144208374|NCT00805467|519958041|FG000|Overall Study|Lack of Efficacy|0|||
144208375|NCT00805467|519958042|FG001|Overall Study|Lack of Efficacy|8|||
144208376|NCT00805467|519958043|FG002|Overall Study|Lack of Efficacy|13|||
144208377|NCT00805467|519958044|FG003|Overall Study|Lack of Efficacy|86|||
144208378|NCT00805467|519958041|FG000|Overall Study|Lost to Follow-up|0|||
144208379|NCT00805467|519958042|FG001|Overall Study|Lost to Follow-up|1|||
144208380|NCT00805467|519958043|FG002|Overall Study|Lost to Follow-up|7|||
144208381|NCT00805467|519958044|FG003|Overall Study|Lost to Follow-up|21|||
144208382|NCT00805467|519958041|FG000|Overall Study|Withdrawal by Subject|0|||
144208383|NCT00805467|519958042|FG001|Overall Study|Withdrawal by Subject|6|||
144208384|NCT00805467|519958043|FG002|Overall Study|Withdrawal by Subject|45|||
144208385|NCT00805467|519958044|FG003|Overall Study|Withdrawal by Subject|50|||
144208386|NCT00805467|519958041|FG000|Overall Study|Protocol Violation|0|||
144208387|NCT00805467|519958042|FG001|Overall Study|Protocol Violation|3|||
144208388|NCT00805467|519958043|FG002|Overall Study|Protocol Violation|0|||
144208389|NCT00805467|519958044|FG003|Overall Study|Protocol Violation|5|||
144580230|NCT02738853|521323629|FG000|1 Month|Death|2|||
144580231|NCT02738853|521323629|FG000|6 Month|Death|4|||
144730349|NCT00669942|521868201|FG005|Parts 2 and 3|Protocol Violation|1|||
144208390|NCT00805467|519958041|FG000|Overall Study|Adverse Event|0|||
144208391|NCT00805467|519958042|FG001|Overall Study|Adverse Event|13|||
144580232|NCT02738853|521323629|FG000|6 Month|Withdrawal by Subject|2|||
144730350|NCT00669942|521868202|FG006|Parts 2 and 3|Protocol Violation|0|||
144208392|NCT00805467|519958043|FG002|Overall Study|Adverse Event|26|||
144208393|NCT00805467|519958044|FG003|Overall Study|Adverse Event|57|||
144208394|NCT00805467|519958041|FG000|Overall Study|Death|0|||
144208395|NCT00805467|519958042|FG001|Overall Study|Death|2|||
144580233|NCT02738853|521323629|FG000|1 Year|Death|6|||
144580234|NCT02738853|521323629|FG000|1 Year|Withdrawal by Subject|1|||
144580235|NCT02738853|521323629|FG000|2 Year|Death|2|||
144580236|NCT02738853|521323629|FG000|2 Year|Lost to Follow-up|1|||
144730351|NCT00669942|521868203|FG007|Parts 2 and 3|Protocol Violation|0|||
144208396|NCT00805467|519958043|FG002|Overall Study|Death|7|||
144580237|NCT02738853|521323629|FG000|3 Year|Death|2|||
144580238|NCT02738853|521323629|FG000|3 Year|Withdrawal by Subject|1|||
144208397|NCT00805467|519958044|FG003|Overall Study|Death|5|||
144208398|NCT00805467|519958041|FG000|Overall Study|Physician Decision|0|||
144208399|NCT00805467|519958042|FG001|Overall Study|Physician Decision|1|||
144208400|NCT00805467|519958043|FG002|Overall Study|Physician Decision|2|||
144580239|NCT02738853|521323629|FG000|4 Year|Death|9|||
144580240|NCT02738853|521323629|FG000|5 Year|Lost to Follow-up|4|||
144580241|NCT04157400|521323631|FG000|Overall Study|Withdrawal by Subject|1|||
144580242|NCT04157400|521323631|FG000|Overall Study|Lost to Follow-up|3|||
144580243|NCT00623805|521323632|FG000|Overall Study|Adverse Event|9|||
144580244|NCT00623805|521323633|FG001|Overall Study|Adverse Event|6|||
144580245|NCT00623805|521323632|FG000|Overall Study|Death|2|||
144580246|NCT00623805|521323633|FG001|Overall Study|Death|0|||
144580247|NCT00623805|521323632|FG000|Overall Study|Lack of Efficacy|3|||
144580248|NCT00623805|521323633|FG001|Overall Study|Lack of Efficacy|7|||
144580249|NCT00623805|521323632|FG000|Overall Study|Lost to Follow-up|2|||
144580250|NCT00623805|521323633|FG001|Overall Study|Lost to Follow-up|2|||
144580251|NCT00623805|521323632|FG000|Overall Study|Protocol Violation|1|||
144580252|NCT00623805|521323633|FG001|Overall Study|Protocol Violation|1|||
144580253|NCT00623805|521323632|FG000|Overall Study|Reason not Specified|3|||
144580254|NCT00623805|521323633|FG001|Overall Study|Reason not Specified|6|||
144580255|NCT01803282|521323637|FG000|Overall Study|Progressive Disease|4|||
144580256|NCT01803282|521323638|FG001|Overall Study|Progressive Disease|3|||
144580257|NCT01803282|521323639|FG002|Overall Study|Progressive Disease|6|||
144580258|NCT01803282|521323640|FG003|Overall Study|Progressive Disease|22|||
144580259|NCT01803282|521323641|FG004|Overall Study|Progressive Disease|5|||
144580260|NCT01803282|521323642|FG005|Overall Study|Progressive Disease|8|||
144580261|NCT01803282|521323643|FG006|Overall Study|Progressive Disease|23|||
144580262|NCT01803282|521323644|FG007|Overall Study|Progressive Disease|24|||
144580263|NCT01803282|521323645|FG008|Overall Study|Progressive Disease|3|||
144580264|NCT01803282|521323646|FG009|Overall Study|Progressive Disease|29|||
144580265|NCT01803282|521323647|FG010|Overall Study|Progressive Disease|6|||
144580266|NCT01803282|521323648|FG011|Overall Study|Progressive Disease|11|||
144580267|NCT01803282|521323637|FG000|Overall Study|Death|0|||
144580268|NCT01803282|521323638|FG001|Overall Study|Death|0|||
144580269|NCT01803282|521323639|FG002|Overall Study|Death|0|||
144580270|NCT01803282|521323640|FG003|Overall Study|Death|0|||
144580271|NCT01803282|521323641|FG004|Overall Study|Death|2|||
144580272|NCT01803282|521323642|FG005|Overall Study|Death|1|||
144580273|NCT01803282|521323643|FG006|Overall Study|Death|1|||
144580274|NCT01803282|521323644|FG007|Overall Study|Death|5|||
144580275|NCT01803282|521323645|FG008|Overall Study|Death|1|||
144580276|NCT01803282|521323646|FG009|Overall Study|Death|1|||
144580277|NCT01803282|521323647|FG010|Overall Study|Death|0|||
144580278|NCT01803282|521323648|FG011|Overall Study|Death|0|||
144580279|NCT01803282|521323637|FG000|Overall Study|Withdrew Consent|0|||
144580280|NCT01803282|521323638|FG001|Overall Study|Withdrew Consent|0|||
144580281|NCT01803282|521323639|FG002|Overall Study|Withdrew Consent|0|||
144580282|NCT01803282|521323640|FG003|Overall Study|Withdrew Consent|6|||
144580283|NCT01803282|521323641|FG004|Overall Study|Withdrew Consent|1|||
144580284|NCT01803282|521323642|FG005|Overall Study|Withdrew Consent|0|||
144208401|NCT00805467|519958044|FG003|Overall Study|Physician Decision|6|||
144208402|NCT00805467|519958041|FG000|Overall Study|Not reported|0|||
144208403|NCT00805467|519958042|FG001|Overall Study|Not reported|0|||
144208404|NCT00805467|519958043|FG002|Overall Study|Not reported|3|||
144208405|NCT00805467|519958044|FG003|Overall Study|Not reported|7|||
144208406|NCT03156504|519958048|FG000|Overall Study|Withdrawal by Subject|1|||
144580285|NCT01803282|521323643|FG006|Overall Study|Withdrew Consent|8|||
144580286|NCT01803282|521323644|FG007|Overall Study|Withdrew Consent|3|||
144580287|NCT01803282|521323645|FG008|Overall Study|Withdrew Consent|1|||
144580288|NCT01803282|521323646|FG009|Overall Study|Withdrew Consent|5|||
144580289|NCT01803282|521323647|FG010|Overall Study|Withdrew Consent|0|||
144580290|NCT01803282|521323648|FG011|Overall Study|Withdrew Consent|1|||
144580291|NCT01803282|521323637|FG000|Overall Study|Investigator's Discretion|0|||
144580292|NCT01803282|521323638|FG001|Overall Study|Investigator's Discretion|0|||
144208407|NCT02755649|519958049|FG000|Overall Study|Transitioned into OLE study|99|||
144208408|NCT02755649|519958050|FG001|Overall Study|Transitioned into OLE study|98|||
144580293|NCT01803282|521323639|FG002|Overall Study|Investigator's Discretion|0|||
144580294|NCT01803282|521323640|FG003|Overall Study|Investigator's Discretion|7|||
144208409|NCT02755649|519958051|FG002|Overall Study|Transitioned into OLE study|100|||
144208410|NCT02755649|519958049|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
144580295|NCT01803282|521323641|FG004|Overall Study|Investigator's Discretion|2|||
144580296|NCT01803282|521323642|FG005|Overall Study|Investigator's Discretion|1|||
144580297|NCT01803282|521323643|FG006|Overall Study|Investigator's Discretion|7|||
144580298|NCT01803282|521323644|FG007|Overall Study|Investigator's Discretion|10|||
144580299|NCT01803282|521323645|FG008|Overall Study|Investigator's Discretion|6|||
144580300|NCT01803282|521323646|FG009|Overall Study|Investigator's Discretion|7|||
144580301|NCT01803282|521323647|FG010|Overall Study|Investigator's Discretion|1|||
144580302|NCT01803282|521323648|FG011|Overall Study|Investigator's Discretion|0|||
144580303|NCT01803282|521323637|FG000|Overall Study|Adverse Event|0|||
144580304|NCT01803282|521323638|FG001|Overall Study|Adverse Event|0|||
144580305|NCT01803282|521323639|FG002|Overall Study|Adverse Event|0|||
144580306|NCT01803282|521323640|FG003|Overall Study|Adverse Event|0|||
144580307|NCT01803282|521323641|FG004|Overall Study|Adverse Event|0|||
144580308|NCT01803282|521323642|FG005|Overall Study|Adverse Event|0|||
144580309|NCT01803282|521323643|FG006|Overall Study|Adverse Event|1|||
144580310|NCT01803282|521323644|FG007|Overall Study|Adverse Event|2|||
144580311|NCT01803282|521323645|FG008|Overall Study|Adverse Event|0|||
144580312|NCT01803282|521323646|FG009|Overall Study|Adverse Event|1|||
144580313|NCT01803282|521323647|FG010|Overall Study|Adverse Event|0|||
144580314|NCT01803282|521323648|FG011|Overall Study|Adverse Event|3|||
144580315|NCT01803282|521323637|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144580316|NCT01803282|521323638|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144580317|NCT01803282|521323639|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144580318|NCT01803282|521323640|FG003|Overall Study|Non-Compliance with Study Drug|1|||
144580319|NCT01803282|521323641|FG004|Overall Study|Non-Compliance with Study Drug|0|||
144580320|NCT01803282|521323642|FG005|Overall Study|Non-Compliance with Study Drug|0|||
144580321|NCT01803282|521323643|FG006|Overall Study|Non-Compliance with Study Drug|0|||
144580322|NCT01803282|521323644|FG007|Overall Study|Non-Compliance with Study Drug|0|||
144580323|NCT01803282|521323645|FG008|Overall Study|Non-Compliance with Study Drug|0|||
144580324|NCT01803282|521323646|FG009|Overall Study|Non-Compliance with Study Drug|0|||
144622642|NCT02574637|521476278|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
144622643|NCT02574637|521476279|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
144622644|NCT02574637|521476280|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
144622645|NCT02574637|521476281|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
144622646|NCT02574637|521476282|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
144622647|NCT02574637|521476283|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
144622648|NCT02574637|521476284|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
144622649|NCT02574637|521476285|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
144622650|NCT02574637|521476286|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
144622651|NCT02574637|521476277|FG000|Double-blind Period|Reason Not Specified|0|||
144622652|NCT02574637|521476278|FG001|Double-blind Period|Reason Not Specified|0|||
144622653|NCT02574637|521476279|FG002|Double-blind Period|Reason Not Specified|0|||
144622654|NCT02574637|521476280|FG003|Double-blind Period|Reason Not Specified|1|||
144622655|NCT02574637|521476281|FG004|Double-blind Period|Reason Not Specified|0|||
144622656|NCT02574637|521476282|FG005|Double-blind Period|Reason Not Specified|0|||
144622657|NCT02574637|521476283|FG006|Double-blind Period|Reason Not Specified|0|||
144622658|NCT02574637|521476284|FG007|Double-blind Period|Reason Not Specified|0|||
144622659|NCT02574637|521476285|FG008|Double-blind Period|Reason Not Specified|0|||
144622660|NCT02574637|521476286|FG009|Double-blind Period|Reason Not Specified|0|||
144622661|NCT02574637|521476277|FG000|Open-label (OL) Period|Adverse Event|0|||
144622662|NCT02574637|521476278|FG001|Open-label (OL) Period|Adverse Event|0|||
144622663|NCT02574637|521476279|FG002|Open-label (OL) Period|Adverse Event|0|||
144622664|NCT02574637|521476280|FG003|Open-label (OL) Period|Adverse Event|0|||
144622665|NCT02574637|521476281|FG004|Open-label (OL) Period|Adverse Event|0|||
144622666|NCT02574637|521476282|FG005|Open-label (OL) Period|Adverse Event|0|||
144622667|NCT02574637|521476283|FG006|Open-label (OL) Period|Adverse Event|0|||
144622668|NCT02574637|521476284|FG007|Open-label (OL) Period|Adverse Event|0|||
144622669|NCT02574637|521476285|FG008|Open-label (OL) Period|Adverse Event|1|||
144622670|NCT02574637|521476286|FG009|Open-label (OL) Period|Adverse Event|0|||
144622671|NCT02574637|521476277|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
144622672|NCT02574637|521476278|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
144622673|NCT02574637|521476279|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
144622674|NCT02574637|521476280|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
144622675|NCT02574637|521476281|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
144622676|NCT02574637|521476282|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
144622677|NCT02574637|521476283|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
144622678|NCT02574637|521476284|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
144622679|NCT02574637|521476285|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
144622680|NCT02574637|521476286|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
144622681|NCT02574637|521476277|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
144622682|NCT02574637|521476278|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
144730352|NCT00669942|521868204|FG008|Parts 2 and 3|Protocol Violation|0|||
144580325|NCT01803282|521323647|FG010|Overall Study|Non-Compliance with Study Drug|0|||
144580326|NCT01803282|521323648|FG011|Overall Study|Non-Compliance with Study Drug|0|||
144580327|NCT01803282|521323637|FG000|Overall Study|Unknown Reason|0|||
144208411|NCT02755649|519958050|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
144208412|NCT02755649|519958051|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
144208413|NCT02755649|519958049|FG000|Overall Study|Physician Decision|0|||
144580328|NCT01803282|521323638|FG001|Overall Study|Unknown Reason|0|||
144580329|NCT01803282|521323639|FG002|Overall Study|Unknown Reason|0|||
144622683|NCT02574637|521476279|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
144730353|NCT00669942|521868205|FG009|Parts 2 and 3|Protocol Violation|0|||
144580330|NCT01803282|521323640|FG003|Overall Study|Unknown Reason|0|||
144580331|NCT01803282|521323641|FG004|Overall Study|Unknown Reason|0|||
144580332|NCT01803282|521323642|FG005|Overall Study|Unknown Reason|0|||
144580333|NCT01803282|521323643|FG006|Overall Study|Unknown Reason|0|||
144580334|NCT01803282|521323644|FG007|Overall Study|Unknown Reason|1|||
144580335|NCT01803282|521323645|FG008|Overall Study|Unknown Reason|0|||
144580336|NCT01803282|521323646|FG009|Overall Study|Unknown Reason|0|||
144580337|NCT01803282|521323647|FG010|Overall Study|Unknown Reason|0|||
144580338|NCT01803282|521323648|FG011|Overall Study|Unknown Reason|0|||
144580339|NCT01803282|521323637|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
144580340|NCT01803282|521323638|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
144580341|NCT01803282|521323639|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
144580342|NCT01803282|521323640|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
144580343|NCT01803282|521323641|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
144580344|NCT01803282|521323642|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
144580345|NCT01803282|521323643|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
144580346|NCT01803282|521323644|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
144580347|NCT01803282|521323645|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
144580348|NCT01803282|521323646|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
144580349|NCT01803282|521323647|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
144580350|NCT01803282|521323648|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
144580351|NCT01803282|521323637|FG000|Overall Study|Enrolled but Never Treated|0|||
144580352|NCT01803282|521323638|FG001|Overall Study|Enrolled but Never Treated|0|||
144580353|NCT01803282|521323639|FG002|Overall Study|Enrolled but Never Treated|0|||
144580354|NCT01803282|521323640|FG003|Overall Study|Enrolled but Never Treated|0|||
144622684|NCT02574637|521476280|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
144622685|NCT02574637|521476281|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
144208414|NCT02755649|519958050|FG001|Overall Study|Physician Decision|0|||
144208415|NCT02755649|519958051|FG002|Overall Study|Physician Decision|2|||
144622686|NCT02574637|521476282|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
144622687|NCT02574637|521476283|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
144622688|NCT02574637|521476284|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
144622689|NCT02574637|521476285|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
144622690|NCT02574637|521476286|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
144622691|NCT04016311|521476287|FG000|Overall Study|Withdrawal by Subject|1|||
144622692|NCT04016311|521476288|FG001|Overall Study|Withdrawal by Subject|0|||
144622693|NCT04029519|521476291|FG000|Overall Study|Protocol Violation|1|||
144622694|NCT04029519|521476291|FG000|Overall Study|Withdrawal by Subject|3|||
144622695|NCT04029519|521476291|FG000|Overall Study|Lost to Follow-up|1|||
144622696|NCT02706730|521476294|FG000|Overall Study|Adverse Event|3|||
144622697|NCT02706730|521476294|FG000|Overall Study|Lack of Efficacy|5|||
144622698|NCT02706730|521476294|FG000|Overall Study|Withdrawal by Subject|11|||
144622699|NCT02706730|521476294|FG000|Overall Study|Study Terminated by Sponsor|11|||
144622700|NCT02706730|521476294|FG000|Overall Study|Subject chose not to receive injection|3|||
144622701|NCT01999582|521476301|FG000|Overall Study|Withdrawal by Subject|0|||
144622702|NCT01999582|521476302|FG001|Overall Study|Withdrawal by Subject|0|||
144622703|NCT01999582|521476303|FG002|Overall Study|Withdrawal by Subject|0|||
144622704|NCT01999582|521476304|FG003|Overall Study|Withdrawal by Subject|1|||
144622705|NCT01999582|521476305|FG004|Overall Study|Withdrawal by Subject|0|||
144208416|NCT02755649|519958049|FG000|Overall Study|Withdrawal by Subject|0|||
144208417|NCT02755649|519958050|FG001|Overall Study|Withdrawal by Subject|1|||
144208418|NCT02755649|519958051|FG002|Overall Study|Withdrawal by Subject|0|||
144580355|NCT01803282|521323641|FG004|Overall Study|Enrolled but Never Treated|1|||
144580356|NCT01803282|521323642|FG005|Overall Study|Enrolled but Never Treated|0|||
144580357|NCT01803282|521323643|FG006|Overall Study|Enrolled but Never Treated|1|||
144580358|NCT01803282|521323644|FG007|Overall Study|Enrolled but Never Treated|1|||
144580359|NCT01803282|521323645|FG008|Overall Study|Enrolled but Never Treated|0|||
144580360|NCT01803282|521323646|FG009|Overall Study|Enrolled but Never Treated|1|||
144622706|NCT01999582|521476306|FG005|Overall Study|Withdrawal by Subject|0|||
144622707|NCT01999582|521476301|FG000|Overall Study|Adverse Event|0|||
144622708|NCT01999582|521476302|FG001|Overall Study|Adverse Event|0|||
144622709|NCT01999582|521476303|FG002|Overall Study|Adverse Event|3|||
144622710|NCT01999582|521476304|FG003|Overall Study|Adverse Event|0|||
144622711|NCT01999582|521476305|FG004|Overall Study|Adverse Event|1|||
144622712|NCT01999582|521476306|FG005|Overall Study|Adverse Event|0|||
144622713|NCT01999582|521476301|FG000|Overall Study|Other Reasons|1|||
144622714|NCT01999582|521476302|FG001|Overall Study|Other Reasons|0|||
144622715|NCT01999582|521476303|FG002|Overall Study|Other Reasons|3|||
144622716|NCT01999582|521476304|FG003|Overall Study|Other Reasons|1|||
144622717|NCT01999582|521476305|FG004|Overall Study|Other Reasons|1|||
144622718|NCT01999582|521476306|FG005|Overall Study|Other Reasons|2|||
144622719|NCT01999582|521476301|FG000|Overall Study|Protocol Violation|1|||
144730354|NCT00669942|521868206|FG010|Parts 2 and 3|Protocol Violation|0|||
144580361|NCT01803282|521323647|FG010|Overall Study|Enrolled but Never Treated|0|||
144208419|NCT02755649|519958049|FG000|Overall Study|Undecided|1|||
144580362|NCT01803282|521323648|FG011|Overall Study|Enrolled but Never Treated|0|||
144580363|NCT02671500|521323651|FG000|Overall Study|Lack of Efficacy|12|||
144580364|NCT02671500|521323651|FG000|Overall Study|Lost to Follow-up|2|||
144580365|NCT01217437|521323652|FG000|Overall Study|Adverse Event|0|||
144580366|NCT01217437|521323653|FG001|Overall Study|Adverse Event|8|||
144580367|NCT01217437|521323652|FG000|Overall Study|Death|5|||
144580368|NCT01217437|521323653|FG001|Overall Study|Death|0|||
144580369|NCT01217437|521323652|FG000|Overall Study|Lack of Efficacy|29|||
144580370|NCT01217437|521323653|FG001|Overall Study|Lack of Efficacy|25|||
144580371|NCT01217437|521323652|FG000|Overall Study|Physician Decision|8|||
144580372|NCT01217437|521323653|FG001|Overall Study|Physician Decision|5|||
144580373|NCT01217437|521323652|FG000|Overall Study|Withdrawal by Subject|0|||
144580374|NCT01217437|521323653|FG001|Overall Study|Withdrawal by Subject|2|||
144580375|NCT01217437|521323652|FG000|Overall Study|Ineligible|1|||
144580376|NCT01217437|521323653|FG001|Overall Study|Ineligible|1|||
144580377|NCT03548220|521323654|FG000|Overall Study|Lost to Follow-up|1|||
144580378|NCT03548220|521323655|FG001|Overall Study|Lost to Follow-up|0|||
144580379|NCT03548220|521323656|FG002|Overall Study|Lost to Follow-up|0|||
144580380|NCT03548220|521323657|FG003|Overall Study|Lost to Follow-up|0|||
144580381|NCT02906007|521323658|FG000|Overall Study|Physician Decision|0|||
144580382|NCT02906007|521323659|FG001|Overall Study|Physician Decision|0|||
144580383|NCT02906007|521323660|FG002|Overall Study|Physician Decision|1|||
144580384|NCT02906007|521323658|FG000|Overall Study|Died|1|||
144580385|NCT02906007|521323659|FG001|Overall Study|Died|0|||
144580386|NCT02906007|521323660|FG002|Overall Study|Died|0|||
144580387|NCT04531982|521323661|FG000|Overall Study|Withdrawal by Subject|10|||
144580388|NCT04531982|521323662|FG001|Overall Study|Withdrawal by Subject|11|||
144580389|NCT04531982|521323661|FG000|Overall Study|Adverse Event|6|||
144580390|NCT04531982|521323662|FG001|Overall Study|Adverse Event|14|||
144580391|NCT04531982|521323661|FG000|Overall Study|Protocol Violation|6|||
144580392|NCT04531982|521323662|FG001|Overall Study|Protocol Violation|9|||
144580393|NCT04531982|521323661|FG000|Overall Study|Non-compliance with study drug|3|||
144580394|NCT04531982|521323662|FG001|Overall Study|Non-compliance with study drug|2|||
144580395|NCT04531982|521323661|FG000|Overall Study|Use of prohibited medication|2|||
144580396|NCT04531982|521323662|FG001|Overall Study|Use of prohibited medication|0|||
144580397|NCT04531982|521323661|FG000|Overall Study|Lost to Follow-up|0|||
144580398|NCT04531982|521323662|FG001|Overall Study|Lost to Follow-up|1|||
144580399|NCT04531982|521323661|FG000|Overall Study|Geopolitical conflict|2|||
144580400|NCT04531982|521323662|FG001|Overall Study|Geopolitical conflict|0|||
144580401|NCT04531982|521323661|FG000|Overall Study|Lack of Efficacy|3|||
144580402|NCT04531982|521323662|FG001|Overall Study|Lack of Efficacy|1|||
144580403|NCT06655558|521323663|FG000|Overall Study|Protocol Violation|1|||
144580404|NCT04998812|521323667|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
144580405|NCT04998812|521323668|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
144580406|NCT04998812|521323667|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
144580407|NCT04998812|521323668|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
144580408|NCT04998812|521323667|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
144580409|NCT04998812|521323668|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
144580410|NCT04998812|521323667|FG000|Vaccination Period|Ongoing in study|23|||
144580411|NCT04998812|521323668|FG001|Vaccination Period|Ongoing in study|23|||
144580412|NCT06748729|521323671|FG000|Overall Study|Withdrawal by Subject|1|||
144580413|NCT00890695|521325394|FG000|Overall Study|Protocol Violation|1|||
144580414|NCT00890695|521325395|FG001|Overall Study|Protocol Violation|0|||
144580415|NCT00833261|521325404|FG000|Overall Study|Withdrawal by Subject|4|||
144580416|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
144580417|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
144580418|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
144580419|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
144580420|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
144580421|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
144580422|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
144580423|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
144580424|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
144580425|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
144622720|NCT01999582|521476302|FG001|Overall Study|Protocol Violation|0|||
144208420|NCT02755649|519958050|FG001|Overall Study|Undecided|0|||
144208421|NCT02755649|519958051|FG002|Overall Study|Undecided|0|||
144580426|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
144580427|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
144580428|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Death|1|||
144580429|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Death|2|||
144580430|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Death|2|||
144580431|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Death|0|||
144208422|NCT00580788|519958055|FG000|Overall Study|Adverse Event|0|||
144580432|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Death|0|||
144580433|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Death|0|||
144580434|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
144580435|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
144580436|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
144580437|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
144580438|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
144580439|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
144580440|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
144580441|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
144580442|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
144580443|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
144580444|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
144580445|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
144580446|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
144580447|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
144580448|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
144580449|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
144580450|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
144580451|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
144580452|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
144580453|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
144580454|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
144580455|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
144580456|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
144580457|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
144580458|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
144580459|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
144580460|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
144580461|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
144580462|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
144580463|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
144580464|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
144580465|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
144580466|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
144580467|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
144580468|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
144580469|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
144580470|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
144580471|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
144580472|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
144580473|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
144580474|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
144580475|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
144622721|NCT01999582|521476303|FG002|Overall Study|Protocol Violation|0|||
144622722|NCT01999582|521476304|FG003|Overall Study|Protocol Violation|0|||
144622723|NCT01999582|521476305|FG004|Overall Study|Protocol Violation|0|||
144622724|NCT01999582|521476306|FG005|Overall Study|Protocol Violation|1|||
144622725|NCT01999582|521476301|FG000|Overall Study|Lack of Efficacy|1|||
144622726|NCT01999582|521476302|FG001|Overall Study|Lack of Efficacy|3|||
144622727|NCT01999582|521476303|FG002|Overall Study|Lack of Efficacy|0|||
144622728|NCT01999582|521476304|FG003|Overall Study|Lack of Efficacy|1|||
144622729|NCT01999582|521476305|FG004|Overall Study|Lack of Efficacy|0|||
144622730|NCT01999582|521476306|FG005|Overall Study|Lack of Efficacy|0|||
144622731|NCT01081795|521476309|FG000|Overall Study|Adverse Event|18|||
144622732|NCT01081795|521476310|FG001|Overall Study|Adverse Event|23|||
144622733|NCT01081795|521476311|FG002|Overall Study|Adverse Event|6|||
144622734|NCT01081795|521476309|FG000|Overall Study|Lack of Efficacy|7|||
144622735|NCT01081795|521476310|FG001|Overall Study|Lack of Efficacy|5|||
144622736|NCT01081795|521476311|FG002|Overall Study|Lack of Efficacy|19|||
144622737|NCT01081795|521476309|FG000|Overall Study|Subject's schedule|1|||
144262877|NCT01716806|520163777|FG001|Overall Study|Patient withdrawal of consent|2|||
144622738|NCT01081795|521476310|FG001|Overall Study|Subject's schedule|1|||
144208423|NCT00580788|519958056|FG001|Overall Study|Adverse Event|0|||
144208424|NCT00580788|519958057|FG002|Overall Study|Adverse Event|0|||
144208425|NCT00580788|519958058|FG003|Overall Study|Adverse Event|1|||
144208426|NCT03301649|519958061|FG000|Overall Study|Need alternate therapy due to live lice|17|||
144208427|NCT03301649|519958062|FG001|Overall Study|Need alternate therapy due to live lice|25|||
144208428|NCT03301649|519958063|FG002|Overall Study|Need alternate therapy due to live lice|81|||
144208429|NCT03301649|519958061|FG000|Overall Study|Lost to Follow-up|11|||
144208430|NCT03301649|519958062|FG001|Overall Study|Lost to Follow-up|11|||
144208431|NCT03301649|519958063|FG002|Overall Study|Lost to Follow-up|3|||
144208432|NCT03301649|519958061|FG000|Overall Study|Protocol Violation|0|||
144208433|NCT03301649|519958062|FG001|Overall Study|Protocol Violation|1|||
144208434|NCT03301649|519958063|FG002|Overall Study|Protocol Violation|1|||
144208435|NCT03301649|519958061|FG000|Overall Study|Withdrawal by Subject|10|||
144208436|NCT03301649|519958062|FG001|Overall Study|Withdrawal by Subject|4|||
144208437|NCT03301649|519958063|FG002|Overall Study|Withdrawal by Subject|0|||
144208438|NCT03301649|519958061|FG000|Overall Study|Other than specified|5|||
144580476|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Site closure|0|||
144580477|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Site closure|0|||
144580478|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Site closure|1|||
144580479|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Site closure|0|||
144580480|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Site closure|0|||
144580481|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Site closure|0|||
144580482|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
144580483|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
144580484|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
144580485|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
144580486|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
144580487|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
144580488|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
144580489|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
144580490|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
144580491|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
144580492|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
144580493|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
144580494|NCT03439254|521325405|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
144580495|NCT03439254|521325406|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
144580496|NCT03439254|521325407|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
144580497|NCT03439254|521325408|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
144580498|NCT03439254|521325409|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
144580499|NCT03439254|521325410|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
144580500|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
144580501|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
144580502|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
144580503|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
144580504|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
144580505|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
144580506|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
144580507|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
144580508|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
144580509|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
144580510|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
144580511|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
144580512|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
144580513|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
144622739|NCT01081795|521476311|FG002|Overall Study|Subject's schedule|2|||
144622740|NCT01081795|521476309|FG000|Overall Study|Revocation of informed consent|2|||
144622741|NCT01081795|521476310|FG001|Overall Study|Revocation of informed consent|0|||
144580514|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
144580515|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
144580516|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
144622742|NCT01081795|521476311|FG002|Overall Study|Revocation of informed consent|0|||
144622743|NCT01081795|521476309|FG000|Overall Study|Ineligible for participation|1|||
144622744|NCT01081795|521476310|FG001|Overall Study|Ineligible for participation|0|||
144622745|NCT01081795|521476311|FG002|Overall Study|Ineligible for participation|0|||
144208439|NCT03301649|519958062|FG001|Overall Study|Other than specified|3|||
144208440|NCT03301649|519958063|FG002|Overall Study|Other than specified|0|||
144208441|NCT01403051|519958064|FG000|Overall Study|Protocol Violation|2|||
144208442|NCT01403051|519958065|FG001|Overall Study|Protocol Violation|0|||
144208443|NCT01403051|519958064|FG000|Overall Study|Death|1|||
144208444|NCT01403051|519958065|FG001|Overall Study|Death|0|||
144580517|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
144580518|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
144580519|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
144580520|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
144580521|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
144580522|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
144580523|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
144580524|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
144580525|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
144580526|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
144580527|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
144580528|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
144580529|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
144580530|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
144580531|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
144580532|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
144580533|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
144580534|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
144580535|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
144580536|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
144580537|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
144580538|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
144580539|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
144580540|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
144580541|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
144580542|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
144580543|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
144580544|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
144580545|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
144580546|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
144580547|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
144580548|NCT03439254|521325405|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
144580549|NCT03439254|521325406|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
144580550|NCT03439254|521325407|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
144580551|NCT03439254|521325408|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
144580552|NCT03439254|521325409|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
144580553|NCT03439254|521325410|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
144580554|NCT01255631|521325411|FG000|Overall Study|poor enrollment, no data analyzed|9|||
144580555|NCT01255631|521325412|FG001|Overall Study|poor enrollment, no data analyzed|6|||
144580556|NCT03339245|521325415|FG000|Overall Study|Adverse Event|1|||
144580557|NCT03339245|521325416|FG001|Overall Study|Adverse Event|1|||
144580558|NCT03339245|521325415|FG000|Overall Study|Withdrawal by Subject|1|||
144580559|NCT03339245|521325416|FG001|Overall Study|Withdrawal by Subject|0|||
144580560|NCT01531673|521325424|FG000|Overall Study|Non-Compliance|0|||
144580561|NCT01531673|521325425|FG001|Overall Study|Non-Compliance|0|||
144580562|NCT01531673|521325426|FG002|Overall Study|Non-Compliance|0|||
144580563|NCT01531673|521325427|FG003|Overall Study|Non-Compliance|0|||
144580564|NCT01531673|521325428|FG004|Overall Study|Non-Compliance|0|||
144580565|NCT01531673|521325429|FG005|Overall Study|Non-Compliance|1|||
144580566|NCT01531673|521325430|FG006|Overall Study|Non-Compliance|0|||
144580567|NCT01531673|521325431|FG007|Overall Study|Non-Compliance|0|||
144580568|NCT01531673|521325432|FG008|Overall Study|Non-Compliance|0|||
144580569|NCT01531673|521325433|FG009|Overall Study|Non-Compliance|0|||
144208445|NCT01403051|519958064|FG000|Overall Study|Withdrawal by Subject|2|||
144208446|NCT01403051|519958065|FG001|Overall Study|Withdrawal by Subject|1|||
144208447|NCT01403051|519958064|FG000|Overall Study|Lost to Follow-up|5|||
144208448|NCT01403051|519958065|FG001|Overall Study|Lost to Follow-up|5|||
144208449|NCT03559400|519958070|FG000|Overall Study|Lost to Follow-up|9|||
144208450|NCT03559400|519958071|FG001|Overall Study|Lost to Follow-up|7|||
144208451|NCT03559400|519958070|FG000|Overall Study|Death|0|||
144208452|NCT03559400|519958071|FG001|Overall Study|Death|2|||
144208453|NCT00509366|519958074|FG000|Overall Study|Not Treated (Screen Failure)|1|||
144208454|NCT00509366|519958075|FG001|Overall Study|Not Treated (Screen Failure)|1|||
144580570|NCT01531673|521325434|FG010|Overall Study|Non-Compliance|0|||
144580571|NCT01531673|521325435|FG011|Overall Study|Non-Compliance|0|||
144580572|NCT01531673|521325436|FG012|Overall Study|Non-Compliance|0|||
144580573|NCT01531673|521325424|FG000|Overall Study|Adverse Event|0|||
144580574|NCT01531673|521325425|FG001|Overall Study|Adverse Event|1|||
144208455|NCT00509366|519958076|FG002|Overall Study|Not Treated (Screen Failure)|1|||
144208456|NCT00509366|519958077|FG003|Overall Study|Not Treated (Screen Failure)|0|||
144208457|NCT00509366|519958078|FG004|Overall Study|Not Treated (Screen Failure)|0|||
144208458|NCT01473524|519958079|FG000|DB Phase|Adverse Event|4|||
144208459|NCT01473524|519958080|FG001|DB Phase|Adverse Event|8|||
144208460|NCT01473524|519958081|FG002|DB Phase|Adverse Event|2|||
144208461|NCT01473524|519958082|FG003|DB Phase|Adverse Event|0|||
144208462|NCT01473524|519958083|FG004|DB Phase|Adverse Event|0|||
144208463|NCT01473524|519958084|FG005|DB Phase|Adverse Event|0|||
144208464|NCT01473524|519958079|FG000|DB Phase|Death|1|||
144208465|NCT01473524|519958080|FG001|DB Phase|Death|0|||
144208466|NCT01473524|519958081|FG002|DB Phase|Death|0|||
144208467|NCT01473524|519958082|FG003|DB Phase|Death|0|||
144208468|NCT01473524|519958083|FG004|DB Phase|Death|0|||
144208469|NCT01473524|519958084|FG005|DB Phase|Death|0|||
144208470|NCT01473524|519958079|FG000|DB Phase|Withdrawal by Subject|2|||
144208471|NCT01473524|519958080|FG001|DB Phase|Withdrawal by Subject|1|||
144208472|NCT01473524|519958081|FG002|DB Phase|Withdrawal by Subject|1|||
144208473|NCT01473524|519958082|FG003|DB Phase|Withdrawal by Subject|0|||
144208474|NCT01473524|519958083|FG004|DB Phase|Withdrawal by Subject|0|||
144208475|NCT01473524|519958084|FG005|DB Phase|Withdrawal by Subject|0|||
144208476|NCT01473524|519958079|FG000|LTSE Phase|Withdrawal by Subject|0|||
144208477|NCT01473524|519958080|FG001|LTSE Phase|Withdrawal by Subject|0|||
144208478|NCT01473524|519958081|FG002|LTSE Phase|Withdrawal by Subject|0|||
144208479|NCT01473524|519958082|FG003|LTSE Phase|Withdrawal by Subject|3|||
144208480|NCT01473524|519958083|FG004|LTSE Phase|Withdrawal by Subject|3|||
144208481|NCT01473524|519958084|FG005|LTSE Phase|Withdrawal by Subject|6|||
144208482|NCT01473524|519958079|FG000|LTSE Phase|Death|0|||
144208483|NCT01473524|519958080|FG001|LTSE Phase|Death|0|||
144208484|NCT01473524|519958081|FG002|LTSE Phase|Death|0|||
144208485|NCT01473524|519958082|FG003|LTSE Phase|Death|0|||
144208486|NCT01473524|519958083|FG004|LTSE Phase|Death|1|||
144208487|NCT01473524|519958084|FG005|LTSE Phase|Death|0|||
144208488|NCT01473524|519958079|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
144208489|NCT01473524|519958080|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
144208490|NCT01473524|519958081|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
144208491|NCT01473524|519958082|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
144208492|NCT01473524|519958083|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
144208493|NCT01473524|519958084|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
144208494|NCT01473524|519958079|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
144208495|NCT01473524|519958080|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
144208496|NCT01473524|519958081|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
144208497|NCT01473524|519958082|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
144208498|NCT01473524|519958083|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
144622746|NCT01081795|521476309|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
144622747|NCT01081795|521476310|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
144208499|NCT01473524|519958084|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
144208500|NCT01473524|519958079|FG000|LTSE Phase|Lost to Follow-up|0|||
144208501|NCT01473524|519958080|FG001|LTSE Phase|Lost to Follow-up|0|||
144208502|NCT01473524|519958081|FG002|LTSE Phase|Lost to Follow-up|0|||
144208503|NCT01473524|519958082|FG003|LTSE Phase|Lost to Follow-up|1|||
144208504|NCT01473524|519958083|FG004|LTSE Phase|Lost to Follow-up|3|||
144208505|NCT01473524|519958084|FG005|LTSE Phase|Lost to Follow-up|2|||
144208506|NCT01473524|519958079|FG000|LTSE Phase|Principal Investigator Decision|0|||
144208507|NCT01473524|519958080|FG001|LTSE Phase|Principal Investigator Decision|0|||
144208508|NCT01473524|519958081|FG002|LTSE Phase|Principal Investigator Decision|0|||
144208509|NCT01473524|519958082|FG003|LTSE Phase|Principal Investigator Decision|1|||
144208510|NCT01473524|519958083|FG004|LTSE Phase|Principal Investigator Decision|1|||
144208511|NCT01473524|519958084|FG005|LTSE Phase|Principal Investigator Decision|3|||
144208512|NCT01473524|519958079|FG000|LTSE Phase|Liver Transplantation|0|||
144208513|NCT01473524|519958080|FG001|LTSE Phase|Liver Transplantation|0|||
144208514|NCT01473524|519958081|FG002|LTSE Phase|Liver Transplantation|0|||
144208515|NCT01473524|519958082|FG003|LTSE Phase|Liver Transplantation|0|||
144208516|NCT01473524|519958083|FG004|LTSE Phase|Liver Transplantation|0|||
144208517|NCT01473524|519958084|FG005|LTSE Phase|Liver Transplantation|1|||
144208518|NCT01473524|519958079|FG000|LTSE Phase|Pregnancy|0|||
144208519|NCT01473524|519958080|FG001|LTSE Phase|Pregnancy|0|||
144208520|NCT01473524|519958081|FG002|LTSE Phase|Pregnancy|0|||
144208521|NCT01473524|519958082|FG003|LTSE Phase|Pregnancy|1|||
144208522|NCT01473524|519958083|FG004|LTSE Phase|Pregnancy|0|||
144208523|NCT01473524|519958084|FG005|LTSE Phase|Pregnancy|0|||
144208524|NCT01473524|519958079|FG000|LTSE Phase|Protocol Violation|0|||
144208525|NCT01473524|519958080|FG001|LTSE Phase|Protocol Violation|0|||
144208526|NCT01473524|519958081|FG002|LTSE Phase|Protocol Violation|0|||
144208527|NCT01473524|519958082|FG003|LTSE Phase|Protocol Violation|0|||
144208528|NCT01473524|519958083|FG004|LTSE Phase|Protocol Violation|0|||
144208529|NCT01473524|519958084|FG005|LTSE Phase|Protocol Violation|1|||
144208530|NCT02119819|519958086|FG000|Overall Study|Adverse Event|3|||
144208531|NCT02119819|519958087|FG001|Overall Study|Adverse Event|1|||
144208532|NCT02119819|519958088|FG002|Overall Study|Adverse Event|2|||
144208533|NCT02119819|519958089|FG003|Overall Study|Adverse Event|3|||
144208534|NCT02119819|519958090|FG004|Overall Study|Adverse Event|0|||
144208535|NCT02119819|519958091|FG005|Overall Study|Adverse Event|1|||
144208536|NCT02119819|519958086|FG000|Overall Study|Lack of Efficacy|0|||
144208537|NCT02119819|519958087|FG001|Overall Study|Lack of Efficacy|0|||
144208538|NCT02119819|519958088|FG002|Overall Study|Lack of Efficacy|0|||
144208539|NCT02119819|519958089|FG003|Overall Study|Lack of Efficacy|0|||
144208540|NCT02119819|519958090|FG004|Overall Study|Lack of Efficacy|0|||
144208541|NCT02119819|519958091|FG005|Overall Study|Lack of Efficacy|1|||
144208542|NCT02119819|519958086|FG000|Overall Study|Lost to Follow-up|0|||
144208543|NCT02119819|519958087|FG001|Overall Study|Lost to Follow-up|0|||
144208544|NCT02119819|519958088|FG002|Overall Study|Lost to Follow-up|1|||
144208545|NCT02119819|519958089|FG003|Overall Study|Lost to Follow-up|2|||
144208546|NCT02119819|519958090|FG004|Overall Study|Lost to Follow-up|1|||
144208547|NCT02119819|519958091|FG005|Overall Study|Lost to Follow-up|2|||
144208548|NCT02119819|519958086|FG000|Overall Study|Physician Decision|1|||
144208549|NCT02119819|519958087|FG001|Overall Study|Physician Decision|1|||
144208550|NCT02119819|519958088|FG002|Overall Study|Physician Decision|0|||
144208551|NCT02119819|519958089|FG003|Overall Study|Physician Decision|0|||
144208552|NCT02119819|519958090|FG004|Overall Study|Physician Decision|0|||
144208553|NCT02119819|519958091|FG005|Overall Study|Physician Decision|1|||
144208554|NCT02119819|519958086|FG000|Overall Study|Withdrawal by Subject|5|||
144208555|NCT02119819|519958087|FG001|Overall Study|Withdrawal by Subject|3|||
144208556|NCT02119819|519958088|FG002|Overall Study|Withdrawal by Subject|0|||
144208557|NCT02119819|519958089|FG003|Overall Study|Withdrawal by Subject|0|||
144208558|NCT02119819|519958090|FG004|Overall Study|Withdrawal by Subject|6|||
144208559|NCT02119819|519958091|FG005|Overall Study|Withdrawal by Subject|10|||
144208560|NCT02119819|519958086|FG000|Overall Study|Jury Duty|0|||
144208561|NCT02119819|519958087|FG001|Overall Study|Jury Duty|0|||
144208562|NCT02119819|519958088|FG002|Overall Study|Jury Duty|1|||
144208563|NCT02119819|519958089|FG003|Overall Study|Jury Duty|0|||
144208564|NCT02119819|519958090|FG004|Overall Study|Jury Duty|0|||
144208565|NCT02119819|519958091|FG005|Overall Study|Jury Duty|0|||
144208566|NCT02119819|519958086|FG000|Overall Study|Protocol Violation|0|||
144208567|NCT02119819|519958087|FG001|Overall Study|Protocol Violation|0|||
144208568|NCT02119819|519958088|FG002|Overall Study|Protocol Violation|0|||
144208569|NCT02119819|519958089|FG003|Overall Study|Protocol Violation|1|||
144208570|NCT02119819|519958090|FG004|Overall Study|Protocol Violation|0|||
144208571|NCT02119819|519958091|FG005|Overall Study|Protocol Violation|0|||
144208572|NCT02119819|519958086|FG000|Overall Study|Left the city to get a job|0|||
144208573|NCT02119819|519958087|FG001|Overall Study|Left the city to get a job|0|||
144208574|NCT02119819|519958088|FG002|Overall Study|Left the city to get a job|0|||
144208575|NCT02119819|519958089|FG003|Overall Study|Left the city to get a job|1|||
144208576|NCT02119819|519958090|FG004|Overall Study|Left the city to get a job|0|||
144208577|NCT02119819|519958091|FG005|Overall Study|Left the city to get a job|0|||
144208578|NCT01544179|519958092|FG000|Overall Study|Death|50|||
144208579|NCT01544179|519958093|FG001|Overall Study|Death|37|||
144208580|NCT01544179|519958092|FG000|Overall Study|Lost to Follow-up|0|||
144208581|NCT01544179|519958093|FG001|Overall Study|Lost to Follow-up|1|||
144208582|NCT01544179|519958092|FG000|Overall Study|Adverse Event|0|||
144208583|NCT01544179|519958093|FG001|Overall Study|Adverse Event|1|||
144208584|NCT01544179|519958092|FG000|Overall Study|Withdrawal by Subject|12|||
144208585|NCT01544179|519958093|FG001|Overall Study|Withdrawal by Subject|7|||
144208586|NCT01544179|519958092|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
144208587|NCT01544179|519958093|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144208588|NCT02045147|519958094|FG000|Overall Study|Withdrawal by Subject|2|||
144208589|NCT02045147|519958095|FG001|Overall Study|Withdrawal by Subject|0|||
144208590|NCT02045147|519958096|FG002|Overall Study|Withdrawal by Subject|0|||
144208591|NCT02045147|519958097|FG003|Overall Study|Withdrawal by Subject|0|||
144208592|NCT02045147|519958098|FG004|Overall Study|Withdrawal by Subject|0|||
144208593|NCT02045147|519958099|FG005|Overall Study|Withdrawal by Subject|0|||
144208594|NCT02045147|519958100|FG006|Overall Study|Withdrawal by Subject|0|||
144208595|NCT02045147|519958101|FG007|Overall Study|Withdrawal by Subject|1|||
144208596|NCT02045147|519958094|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
144208597|NCT02045147|519958095|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
144208598|NCT02045147|519958096|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
144208599|NCT02045147|519958097|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
144208600|NCT02045147|519958098|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
144208601|NCT02045147|519958099|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
144208602|NCT02045147|519958100|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
144622748|NCT01081795|521476311|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
144622749|NCT01081795|521476309|FG000|Overall Study|Using drug with restricted days of use|2|||
144622750|NCT01081795|521476310|FG001|Overall Study|Using drug with restricted days of use|3|||
144208603|NCT02045147|519958101|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
144208604|NCT04839692|519958102|FG000|Overall Study|Withdrawal by Subject|0|||
144208605|NCT04839692|519958103|FG001|Overall Study|Withdrawal by Subject|3|||
144208606|NCT04839692|519958102|FG000|Overall Study|Physician Decision|1|||
144208607|NCT04839692|519958103|FG001|Overall Study|Physician Decision|0|||
144208608|NCT02549027|519958108|FG000|Washout After Period 4|Withdrawal by Subject|0|||
144208609|NCT02549027|519958109|FG001|Washout After Period 4|Withdrawal by Subject|1|||
144208610|NCT02549027|519958110|FG002|Washout After Period 4|Withdrawal by Subject|1|||
144208611|NCT02549027|519958111|FG003|Washout After Period 4|Withdrawal by Subject|1|||
144208612|NCT02549027|519958112|FG004|Washout After Period 4|Withdrawal by Subject|0|||
144208613|NCT02549027|519958113|FG005|Washout After Period 4|Withdrawal by Subject|0|||
144208614|NCT02549027|519958108|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
144208615|NCT02549027|519958109|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
144208616|NCT02549027|519958110|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
144208617|NCT02549027|519958111|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
144208618|NCT02549027|519958112|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
144208619|NCT02549027|519958113|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
144208620|NCT02186834|519958114|FG000|Dose Escalation|Death|0|||
144208621|NCT02186834|519958115|FG001|Dose Escalation|Death|0|||
144208622|NCT02186834|519958116|FG002|Dose Escalation|Death|0|||
144208623|NCT02186834|519958117|FG003|Dose Escalation|Death|1|||
144208624|NCT02186834|519958118|FG004|Dose Escalation|Death|0|||
144208625|NCT02186834|519958119|FG005|Dose Escalation|Death|0|||
144208626|NCT02186834|519958114|FG000|Treatment at RP2D|Died prior to treatment|0|||
144208627|NCT02186834|519958115|FG001|Treatment at RP2D|Died prior to treatment|0|||
144208628|NCT02186834|519958116|FG002|Treatment at RP2D|Died prior to treatment|0|||
144208629|NCT02186834|519958117|FG003|Treatment at RP2D|Died prior to treatment|0|||
144208630|NCT02186834|519958118|FG004|Treatment at RP2D|Died prior to treatment|0|||
144208631|NCT02186834|519958119|FG005|Treatment at RP2D|Died prior to treatment|1|||
144208632|NCT00106964|519958123|FG000|Overall Study|Lost to Follow-up|8|||
144208633|NCT00106964|519958124|FG001|Overall Study|Lost to Follow-up|6|||
144208634|NCT00106964|519958125|FG002|Overall Study|Lost to Follow-up|2|||
144208635|NCT00106964|519958123|FG000|Overall Study|Pregnancy|2|||
144208636|NCT00106964|519958124|FG001|Overall Study|Pregnancy|3|||
144208637|NCT00106964|519958125|FG002|Overall Study|Pregnancy|2|||
144208638|NCT00106964|519958123|FG000|Overall Study|Death|1|||
144208639|NCT00106964|519958124|FG001|Overall Study|Death|1|||
144208640|NCT00106964|519958125|FG002|Overall Study|Death|0|||
144208641|NCT00106964|519958123|FG000|Overall Study|Incarceration|0|||
144208642|NCT00106964|519958124|FG001|Overall Study|Incarceration|1|||
144208643|NCT00106964|519958125|FG002|Overall Study|Incarceration|0|||
144208644|NCT00106964|519958123|FG000|Overall Study|Site Funding Terminated|0|||
144208645|NCT00106964|519958124|FG001|Overall Study|Site Funding Terminated|1|||
144208646|NCT00106964|519958125|FG002|Overall Study|Site Funding Terminated|1|||
144208647|NCT00106964|519958123|FG000|Overall Study|Failure to adhere|2|||
144208648|NCT00106964|519958124|FG001|Overall Study|Failure to adhere|0|||
144208649|NCT00106964|519958125|FG002|Overall Study|Failure to adhere|0|||
144208650|NCT00106964|519958123|FG000|Overall Study|Did not meet eligibility criteria|0|||
144208651|NCT00106964|519958124|FG001|Overall Study|Did not meet eligibility criteria|2|||
144208652|NCT00106964|519958125|FG002|Overall Study|Did not meet eligibility criteria|2|||
144208653|NCT00106964|519958123|FG000|Overall Study|Required disallowed medication|0|||
144208654|NCT00106964|519958124|FG001|Overall Study|Required disallowed medication|1|||
144208655|NCT00106964|519958125|FG002|Overall Study|Required disallowed medication|0|||
144208656|NCT04746794|519958126|FG000|Overall Study|Did not complete any study assessment|50303|||
144208657|NCT04746794|519958127|FG001|Overall Study|Did not complete any study assessment|44997|||
144208658|NCT01422187|519958132|FG000|Overall Study|Personal reason|1|||
144208659|NCT01422187|519958133|FG001|Overall Study|Personal reason|0|||
144208660|NCT01422187|519958134|FG002|Overall Study|Personal reason|0|||
144208661|NCT01422187|519958132|FG000|Overall Study|Lost to Follow-up|0|||
144208662|NCT01422187|519958133|FG001|Overall Study|Lost to Follow-up|1|||
144208663|NCT01422187|519958134|FG002|Overall Study|Lost to Follow-up|0|||
144208664|NCT00168818|519958135|FG000|Overall Study|Adverse Event|23|||
144622751|NCT01081795|521476311|FG002|Overall Study|Using drug with restricted days of use|2|||
144622752|NCT01081795|521476309|FG000|Overall Study|Other|1|||
144622753|NCT01081795|521476310|FG001|Overall Study|Other|2|||
144622754|NCT01081795|521476311|FG002|Overall Study|Other|0|||
144622755|NCT02462473|521476312|FG000|Overall Study|Death|1|||
144622756|NCT02462473|521476312|FG000|Overall Study|Other|3|||
144208665|NCT00168818|519958136|FG001|Overall Study|Adverse Event|29|||
144208666|NCT00168818|519958137|FG002|Overall Study|Adverse Event|31|||
144622757|NCT00661271|521476313|FG000|Overall Study|Lost to Follow-up|28|||
144208667|NCT00168818|519958135|FG000|Overall Study|Protocol Violation|16|||
144208668|NCT00168818|519958136|FG001|Overall Study|Protocol Violation|11|||
144208669|NCT00168818|519958137|FG002|Overall Study|Protocol Violation|11|||
144208670|NCT00168818|519958135|FG000|Overall Study|Lost to Follow-up|13|||
144208671|NCT00168818|519958136|FG001|Overall Study|Lost to Follow-up|4|||
144208672|NCT00168818|519958137|FG002|Overall Study|Lost to Follow-up|15|||
144208673|NCT00168818|519958135|FG000|Overall Study|Withdrawal by Subject|43|||
144622758|NCT00661271|521476314|FG001|Overall Study|Lost to Follow-up|25|||
144622759|NCT03728309|521476319|FG000|Overall Study|Randomized but not Treated|0|||
144208674|NCT00168818|519958136|FG001|Overall Study|Withdrawal by Subject|41|||
144208675|NCT00168818|519958137|FG002|Overall Study|Withdrawal by Subject|37|||
144208676|NCT00168818|519958135|FG000|Overall Study|Other|22|||
144208677|NCT00168818|519958136|FG001|Overall Study|Other|24|||
144208678|NCT00168818|519958137|FG002|Overall Study|Other|30|||
144208679|NCT00168818|519958135|FG000|Treatment|Adverse Event|77|||
144208680|NCT00168818|519958136|FG001|Treatment|Adverse Event|89|||
144208681|NCT00168818|519958137|FG002|Treatment|Adverse Event|68|||
144208682|NCT00168818|519958135|FG000|Treatment|Protocol Violation|8|||
144208683|NCT00168818|519958136|FG001|Treatment|Protocol Violation|11|||
144208684|NCT00168818|519958137|FG002|Treatment|Protocol Violation|11|||
144208685|NCT00168818|519958135|FG000|Treatment|Lost to Follow-up|0|||
144208686|NCT00168818|519958136|FG001|Treatment|Lost to Follow-up|2|||
144208687|NCT00168818|519958137|FG002|Treatment|Lost to Follow-up|1|||
144208688|NCT00168818|519958135|FG000|Treatment|Withdrawal by Subject|25|||
144208689|NCT00168818|519958136|FG001|Treatment|Withdrawal by Subject|20|||
144208690|NCT00168818|519958137|FG002|Treatment|Withdrawal by Subject|22|||
144208691|NCT00168818|519958135|FG000|Treatment|Other|23|||
144208692|NCT00168818|519958136|FG001|Treatment|Other|29|||
144208693|NCT00168818|519958137|FG002|Treatment|Other|31|||
144208694|NCT02538965|519958144|FG000|Treatment Period|Other = Death due to disease progression|1|||
144208695|NCT02538965|519958144|FG000|Treatment Period|Adverse Event|2|||
144208696|NCT02538965|519958144|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
144208697|NCT02538965|519958144|FG000|Treatment Period|Treatment Failure|9|||
144208698|NCT02538965|519958144|FG000|Treatment Period|Disease Progression|1|||
144208699|NCT02538965|519958144|FG000|Treatment Period|Physician Decision|2|||
144208700|NCT02538965|519958144|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
144208701|NCT02538965|519958144|FG000|Follow-Up Period|Withdrawal by Parent|4|||
144208702|NCT00875797|519958145|FG000|Overall Study|Protocol Violation|6|||
144580575|NCT01531673|521325426|FG002|Overall Study|Adverse Event|0|||
144580576|NCT01531673|521325427|FG003|Overall Study|Adverse Event|0|||
144580577|NCT01531673|521325428|FG004|Overall Study|Adverse Event|0|||
144580578|NCT01531673|521325429|FG005|Overall Study|Adverse Event|0|||
144580579|NCT01531673|521325430|FG006|Overall Study|Adverse Event|0|||
144580580|NCT01531673|521325431|FG007|Overall Study|Adverse Event|0|||
144580581|NCT01531673|521325432|FG008|Overall Study|Adverse Event|0|||
144580582|NCT01531673|521325433|FG009|Overall Study|Adverse Event|0|||
144580583|NCT01531673|521325434|FG010|Overall Study|Adverse Event|0|||
144580584|NCT01531673|521325435|FG011|Overall Study|Adverse Event|0|||
144580585|NCT01531673|521325436|FG012|Overall Study|Adverse Event|0|||
144580586|NCT01531673|521325424|FG000|Overall Study|Lost to Follow-up|0|||
144580587|NCT01531673|521325425|FG001|Overall Study|Lost to Follow-up|0|||
144580588|NCT01531673|521325426|FG002|Overall Study|Lost to Follow-up|0|||
144580589|NCT01531673|521325427|FG003|Overall Study|Lost to Follow-up|0|||
144580590|NCT01531673|521325428|FG004|Overall Study|Lost to Follow-up|1|||
144580591|NCT01531673|521325429|FG005|Overall Study|Lost to Follow-up|0|||
144580592|NCT01531673|521325430|FG006|Overall Study|Lost to Follow-up|0|||
144580593|NCT01531673|521325431|FG007|Overall Study|Lost to Follow-up|0|||
144580594|NCT01531673|521325432|FG008|Overall Study|Lost to Follow-up|0|||
144622760|NCT03728309|521476320|FG001|Overall Study|Randomized but not Treated|1|||
144622761|NCT03728309|521476319|FG000|Overall Study|Adverse Event|0|||
144622762|NCT03728309|521476320|FG001|Overall Study|Adverse Event|1|||
144622763|NCT03728309|521476319|FG000|Overall Study|Withdrawal by Subject|2|||
144208703|NCT00875797|519958146|FG001|Overall Study|Protocol Violation|3|||
144208704|NCT01590797|519958151|FG000|Overall Study|Adverse Event|4|||
144208705|NCT01590797|519958152|FG001|Overall Study|Adverse Event|3|||
144208706|NCT01590797|519958151|FG000|Overall Study|Lack of Efficacy|0|||
144208707|NCT01590797|519958152|FG001|Overall Study|Lack of Efficacy|2|||
144208708|NCT01590797|519958151|FG000|Overall Study|Lost to Follow-up|0|||
144208709|NCT01590797|519958152|FG001|Overall Study|Lost to Follow-up|1|||
144208710|NCT01590797|519958151|FG000|Overall Study|Protocol Violation|4|||
144208711|NCT01590797|519958152|FG001|Overall Study|Protocol Violation|1|||
144580595|NCT01531673|521325433|FG009|Overall Study|Lost to Follow-up|0|||
144622764|NCT03728309|521476320|FG001|Overall Study|Withdrawal by Subject|8|||
144622765|NCT03728309|521476319|FG000|Overall Study|Lost to Follow-up|9|||
144622766|NCT03728309|521476320|FG001|Overall Study|Lost to Follow-up|10|||
144622767|NCT03728309|521476319|FG000|Overall Study|Protocol Deviation|0|||
144622768|NCT03728309|521476320|FG001|Overall Study|Protocol Deviation|1|||
144622769|NCT03728309|521476319|FG000|Overall Study|Due to COVID|1|||
144730355|NCT00669942|521868207|FG011|Parts 2 and 3|Protocol Violation|0|||
144580596|NCT01531673|521325434|FG010|Overall Study|Lost to Follow-up|0|||
144622770|NCT03728309|521476320|FG001|Overall Study|Due to COVID|3|||
144730356|NCT00259012|521868209|FG000|Overall Study|Adverse Event|0|||
144208712|NCT01590797|519958151|FG000|Overall Study|Withdrawal by Subject|7|||
144622771|NCT00953758|521476321|FG000|Overall Study|Death|2|||
144622772|NCT00953758|521476322|FG001|Overall Study|Death|0|||
144622773|NCT00953758|521476323|FG002|Overall Study|Death|1|||
144208713|NCT01590797|519958152|FG001|Overall Study|Withdrawal by Subject|5|||
144208714|NCT01590797|519958151|FG000|Overall Study|Other Protocol Specified Criteria|2|||
144580597|NCT01531673|521325435|FG011|Overall Study|Lost to Follow-up|0|||
144580598|NCT01531673|521325436|FG012|Overall Study|Lost to Follow-up|0|||
144580599|NCT01531673|521325424|FG000|Overall Study|Other|0|||
144208715|NCT01590797|519958152|FG001|Overall Study|Other Protocol Specified Criteria|4|||
144208716|NCT02842073|519958160|FG000|Overall Study|Withdrawal by Subject|1|||
144208717|NCT00195338|519958161|FG000|Overall Study|Lost to Follow-up|2|||
144208718|NCT00195338|519958161|FG000|Overall Study|Adverse Event|5|||
144208719|NCT00195338|519958161|FG000|Overall Study|Lack of Efficacy|1|||
144208720|NCT00195338|519958161|FG000|Overall Study|Early closure of the site|4|||
144208721|NCT00811928|519958162|FG000|Overall Study|AEs and SAEs Including Death|7|||
144208722|NCT00811928|519958163|FG001|Overall Study|AEs and SAEs Including Death|11|||
144208723|NCT00811928|519958162|FG000|Overall Study|Withdrawal by Subject|18|||
144208724|NCT00811928|519958163|FG001|Overall Study|Withdrawal by Subject|12|||
144208725|NCT00811928|519958162|FG000|Overall Study|Did Not Take Study Drug|3|||
144208726|NCT00811928|519958163|FG001|Overall Study|Did Not Take Study Drug|0|||
144208727|NCT00811928|519958162|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
144208728|NCT00811928|519958163|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
144208729|NCT00811928|519958162|FG000|Overall Study|Investigator Decision|2|||
144208730|NCT00811928|519958163|FG001|Overall Study|Investigator Decision|1|||
144208731|NCT00811928|519958162|FG000|Overall Study|Poor Compliance|2|||
144208732|NCT00811928|519958163|FG001|Overall Study|Poor Compliance|5|||
144208733|NCT01333397|519958164|FG000|Overall Study|Lost to Follow-up|1|||
144208734|NCT01333397|519958165|FG001|Overall Study|Lost to Follow-up|0|||
144208735|NCT01333397|519958166|FG002|Overall Study|Lost to Follow-up|0|||
144208736|NCT01333397|519958167|FG003|Overall Study|Lost to Follow-up|1|||
144208737|NCT01333397|519958168|FG004|Overall Study|Lost to Follow-up|0|||
144208738|NCT01085357|519958169|FG000|Overall Study|Adverse Event|1|||
144208739|NCT01085357|519958170|FG001|Overall Study|Adverse Event|1|||
144208740|NCT01085357|519958169|FG000|Overall Study|Subject Decision|4|||
144208741|NCT01085357|519958170|FG001|Overall Study|Subject Decision|3|||
144208742|NCT01085357|519958169|FG000|Overall Study|Investigator Decision|1|||
144208743|NCT01085357|519958170|FG001|Overall Study|Investigator Decision|1|||
144208744|NCT01085357|519958169|FG000|Overall Study|Death|11|||
144208745|NCT01085357|519958170|FG001|Overall Study|Death|1|||
144208746|NCT01085357|519958169|FG000|Overall Study|Lost to Follow-up|2|||
144208747|NCT01085357|519958170|FG001|Overall Study|Lost to Follow-up|0|||
144208748|NCT05320887|519958175|FG000|Overall Study|Lost to Follow-up|0|||
144208749|NCT05320887|519958176|FG001|Overall Study|Lost to Follow-up|3|||
144208750|NCT05320887|519958177|FG002|Overall Study|Lost to Follow-up|0|||
144208751|NCT05320887|519958178|FG003|Overall Study|Lost to Follow-up|0|||
144208752|NCT02910011|519958179|FG000|Overall Study|Physician Decision|2|||
144208753|NCT00920790|519958180|FG000|Overall Study|aggravation of general condition|14|||
144208754|NCT04411914|519958181|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
144208755|NCT04411914|519958182|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
144208756|NCT02015065|519958183|FG000|Overall Study|Death on study|1|||
144208757|NCT02015065|519958184|FG001|Overall Study|Death on study|2|||
144208758|NCT02015065|519958185|FG002|Overall Study|Death on study|1|||
144208759|NCT01860677|519958186|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
144208760|NCT01860677|519958187|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
144208761|NCT03553576|519958188|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
144208762|NCT03553576|519958189|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
144208763|NCT03553576|519958188|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
144208764|NCT03553576|519958189|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
144208765|NCT03553576|519958188|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
144208766|NCT03553576|519958189|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
144208767|NCT03553576|519958188|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
144208768|NCT03553576|519958189|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
144208769|NCT03553576|519958188|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
144208770|NCT03553576|519958189|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
144208771|NCT03553576|519958188|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
144208772|NCT03553576|519958189|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
144208773|NCT03553576|519958188|FG000|Overall Study|Physician Decision|2|||
144580600|NCT01531673|521325425|FG001|Overall Study|Other|0|||
144580601|NCT01531673|521325426|FG002|Overall Study|Other|0|||
144580602|NCT01531673|521325427|FG003|Overall Study|Other|1|||
144208774|NCT03553576|519958189|FG001|Overall Study|Physician Decision|5|||
144208775|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
144208776|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
144208777|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
144208778|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
144208779|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
144208780|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
144580603|NCT01531673|521325428|FG004|Overall Study|Other|0|||
144580604|NCT01531673|521325429|FG005|Overall Study|Other|0|||
144580605|NCT01531673|521325430|FG006|Overall Study|Other|0|||
144580606|NCT01531673|521325431|FG007|Overall Study|Other|0|||
144580607|NCT01531673|521325432|FG008|Overall Study|Other|0|||
144580608|NCT01531673|521325433|FG009|Overall Study|Other|1|||
144580609|NCT01531673|521325434|FG010|Overall Study|Other|0|||
144580610|NCT01531673|521325435|FG011|Overall Study|Other|0|||
144580611|NCT01531673|521325436|FG012|Overall Study|Other|0|||
144580612|NCT00568178|521325437|FG000|Double Blind Base Study|Adverse Event|0|||
144580613|NCT00568178|521325438|FG001|Double Blind Base Study|Adverse Event|2|||
144580614|NCT00568178|521325439|FG002|Double Blind Base Study|Adverse Event|1|||
144580615|NCT00568178|521325440|FG003|Double Blind Base Study|Adverse Event|2|||
144580616|NCT00568178|521325441|FG004|Double Blind Base Study|Adverse Event|0|||
144580617|NCT00568178|521325442|FG005|Double Blind Base Study|Adverse Event|0|||
144580618|NCT00568178|521325437|FG000|Double Blind Base Study|Lost to Follow-up|1|||
144580619|NCT00568178|521325438|FG001|Double Blind Base Study|Lost to Follow-up|0|||
144580620|NCT00568178|521325439|FG002|Double Blind Base Study|Lost to Follow-up|0|||
144580621|NCT00568178|521325440|FG003|Double Blind Base Study|Lost to Follow-up|1|||
144580622|NCT00568178|521325441|FG004|Double Blind Base Study|Lost to Follow-up|0|||
144580623|NCT00568178|521325442|FG005|Double Blind Base Study|Lost to Follow-up|0|||
144580624|NCT00568178|521325437|FG000|Double Blind Base Study|Physician Decision|1|||
144580625|NCT00568178|521325438|FG001|Double Blind Base Study|Physician Decision|1|||
144580626|NCT00568178|521325439|FG002|Double Blind Base Study|Physician Decision|0|||
144580627|NCT00568178|521325440|FG003|Double Blind Base Study|Physician Decision|1|||
144580628|NCT00568178|521325441|FG004|Double Blind Base Study|Physician Decision|0|||
144580629|NCT00568178|521325442|FG005|Double Blind Base Study|Physician Decision|0|||
144580630|NCT00568178|521325437|FG000|Double Blind Base Study|Protocol Violation|3|||
144580631|NCT00568178|521325438|FG001|Double Blind Base Study|Protocol Violation|2|||
144580632|NCT00568178|521325439|FG002|Double Blind Base Study|Protocol Violation|0|||
144580633|NCT00568178|521325440|FG003|Double Blind Base Study|Protocol Violation|0|||
144580634|NCT00568178|521325441|FG004|Double Blind Base Study|Protocol Violation|0|||
144580635|NCT00568178|521325442|FG005|Double Blind Base Study|Protocol Violation|0|||
144580636|NCT00568178|521325437|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
144580637|NCT00568178|521325438|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
144580638|NCT00568178|521325439|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
144580639|NCT00568178|521325440|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
144580640|NCT00568178|521325441|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
144580641|NCT00568178|521325442|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
144580642|NCT00568178|521325437|FG000|Double Blind Base Study|Progressive Disease|0|||
144580643|NCT00568178|521325438|FG001|Double Blind Base Study|Progressive Disease|0|||
144208781|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
144208782|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
144208783|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
144208784|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
144208785|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
144208786|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
144208787|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
144208788|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
144208789|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
144208790|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
144208791|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
144208792|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
144208793|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
144208794|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
144580644|NCT00568178|521325439|FG002|Double Blind Base Study|Progressive Disease|0|||
144580645|NCT00568178|521325440|FG003|Double Blind Base Study|Progressive Disease|1|||
144580646|NCT00568178|521325441|FG004|Double Blind Base Study|Progressive Disease|0|||
144580647|NCT00568178|521325442|FG005|Double Blind Base Study|Progressive Disease|0|||
144580648|NCT00568178|521325437|FG000|Open Label Extension|Adverse Event|0|||
144580649|NCT00568178|521325438|FG001|Open Label Extension|Adverse Event|0|||
144580650|NCT00568178|521325439|FG002|Open Label Extension|Adverse Event|0|||
144580651|NCT00568178|521325440|FG003|Open Label Extension|Adverse Event|0|||
144622774|NCT00953758|521476324|FG003|Overall Study|Death|1|||
144622775|NCT00953758|521476325|FG004|Overall Study|Death|1|||
144622776|NCT00953758|521476326|FG005|Overall Study|Death|1|||
144208795|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
144208796|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
144208797|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
144580652|NCT00568178|521325441|FG004|Open Label Extension|Adverse Event|11|||
144580653|NCT00568178|521325442|FG005|Open Label Extension|Adverse Event|8|||
144580654|NCT00568178|521325437|FG000|Open Label Extension|Protocol Violation|0|||
144580655|NCT00568178|521325438|FG001|Open Label Extension|Protocol Violation|0|||
144580656|NCT00568178|521325439|FG002|Open Label Extension|Protocol Violation|0|||
144208798|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
144208799|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
144208800|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
144208801|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
144208802|NCT02552212|519958190|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
144208803|NCT02552212|519958191|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
144208804|NCT02552212|519958192|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
144208805|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
144208806|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
144208807|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
144208808|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
144208809|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
144208810|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
144208811|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
144208812|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
144208813|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
144208814|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
144208815|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
144208816|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
144208817|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
144208818|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
144208819|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
144208820|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
144208821|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
144580657|NCT00568178|521325440|FG003|Open Label Extension|Protocol Violation|0|||
144580658|NCT00568178|521325441|FG004|Open Label Extension|Protocol Violation|1|||
144580659|NCT00568178|521325442|FG005|Open Label Extension|Protocol Violation|0|||
144580660|NCT00568178|521325437|FG000|Open Label Extension|Lost to Follow-up|0|||
144580661|NCT00568178|521325438|FG001|Open Label Extension|Lost to Follow-up|0|||
144580662|NCT00568178|521325439|FG002|Open Label Extension|Lost to Follow-up|0|||
144580663|NCT00568178|521325440|FG003|Open Label Extension|Lost to Follow-up|0|||
144622777|NCT00953758|521476327|FG006|Overall Study|Death|1|||
144622778|NCT00953758|521476328|FG007|Overall Study|Death|3|||
144622779|NCT00953758|521476329|FG008|Overall Study|Death|1|||
144622780|NCT00953758|521476330|FG009|Overall Study|Death|0|||
144622781|NCT00953758|521476321|FG000|Overall Study|Participant refused further follow-up|0|||
144622782|NCT00953758|521476322|FG001|Overall Study|Participant refused further follow-up|0|||
144622783|NCT00953758|521476323|FG002|Overall Study|Participant refused further follow-up|1|||
144622784|NCT00953758|521476324|FG003|Overall Study|Participant refused further follow-up|0|||
144622785|NCT00953758|521476325|FG004|Overall Study|Participant refused further follow-up|3|||
144622786|NCT00953758|521476326|FG005|Overall Study|Participant refused further follow-up|0|||
144622787|NCT00953758|521476327|FG006|Overall Study|Participant refused further follow-up|0|||
144622788|NCT00953758|521476328|FG007|Overall Study|Participant refused further follow-up|0|||
144622789|NCT00953758|521476329|FG008|Overall Study|Participant refused further follow-up|1|||
144622790|NCT00953758|521476330|FG009|Overall Study|Participant refused further follow-up|0|||
144622791|NCT00953758|521476321|FG000|Overall Study|Lost to Follow-up|0|||
144622792|NCT00953758|521476322|FG001|Overall Study|Lost to Follow-up|0|||
144622793|NCT00953758|521476323|FG002|Overall Study|Lost to Follow-up|0|||
144622794|NCT00953758|521476324|FG003|Overall Study|Lost to Follow-up|1|||
144622795|NCT00953758|521476325|FG004|Overall Study|Lost to Follow-up|0|||
144622796|NCT00953758|521476326|FG005|Overall Study|Lost to Follow-up|0|||
144622797|NCT00953758|521476327|FG006|Overall Study|Lost to Follow-up|0|||
144622798|NCT00953758|521476328|FG007|Overall Study|Lost to Follow-up|1|||
144622799|NCT00953758|521476329|FG008|Overall Study|Lost to Follow-up|0|||
144622800|NCT00953758|521476330|FG009|Overall Study|Lost to Follow-up|1|||
144622801|NCT00953758|521476321|FG000|Overall Study|Physician Decision|0|||
144622802|NCT00953758|521476322|FG001|Overall Study|Physician Decision|0|||
144622803|NCT00953758|521476323|FG002|Overall Study|Physician Decision|0|||
144622804|NCT00953758|521476324|FG003|Overall Study|Physician Decision|0|||
144622805|NCT00953758|521476325|FG004|Overall Study|Physician Decision|1|||
144622806|NCT00953758|521476326|FG005|Overall Study|Physician Decision|0|||
144622807|NCT00953758|521476327|FG006|Overall Study|Physician Decision|0|||
144622808|NCT00953758|521476328|FG007|Overall Study|Physician Decision|0|||
144622809|NCT00953758|521476329|FG008|Overall Study|Physician Decision|0|||
144622810|NCT00953758|521476330|FG009|Overall Study|Physician Decision|0|||
144622811|NCT00953758|521476321|FG000|Overall Study|Disease progression|0|||
144622812|NCT00953758|521476322|FG001|Overall Study|Disease progression|0|||
144208822|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
144208823|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
144580664|NCT00568178|521325441|FG004|Open Label Extension|Lost to Follow-up|6|||
144622813|NCT00953758|521476323|FG002|Overall Study|Disease progression|0|||
144622814|NCT00953758|521476324|FG003|Overall Study|Disease progression|0|||
144622815|NCT00953758|521476325|FG004|Overall Study|Disease progression|1|||
144622816|NCT00953758|521476326|FG005|Overall Study|Disease progression|0|||
144580665|NCT00568178|521325442|FG005|Open Label Extension|Lost to Follow-up|11|||
144208824|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
144208825|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
144208826|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
144208827|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
144208828|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
144208829|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
144208830|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
144208831|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
144208832|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
144208833|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
144208834|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
144208835|NCT02552212|519958190|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
144208836|NCT02552212|519958191|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
144208837|NCT02552212|519958192|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
144208838|NCT01671332|519958193|FG000|Overall Study|Withdrawal by Subject|1|||
144208839|NCT01671332|519958194|FG001|Overall Study|Withdrawal by Subject|1|||
144208840|NCT02728843|519958195|FG000|Overall Study|Adverse Event|0|||
144208841|NCT02728843|519958196|FG001|Overall Study|Adverse Event|2|||
144208842|NCT02728843|519958197|FG002|Overall Study|Adverse Event|3|||
144208843|NCT02728843|519958198|FG003|Overall Study|Adverse Event|1|||
144208844|NCT02728843|519958199|FG004|Overall Study|Adverse Event|2|||
144208845|NCT02728843|519958195|FG000|Overall Study|Lack of Efficacy|0|||
144208846|NCT02728843|519958196|FG001|Overall Study|Lack of Efficacy|1|||
144208847|NCT02728843|519958197|FG002|Overall Study|Lack of Efficacy|1|||
144208848|NCT02728843|519958198|FG003|Overall Study|Lack of Efficacy|0|||
144208849|NCT02728843|519958199|FG004|Overall Study|Lack of Efficacy|0|||
144208850|NCT02728843|519958195|FG000|Overall Study|Protocol Violation|2|||
144208851|NCT02728843|519958196|FG001|Overall Study|Protocol Violation|0|||
144208852|NCT02728843|519958197|FG002|Overall Study|Protocol Violation|4|||
144208853|NCT02728843|519958198|FG003|Overall Study|Protocol Violation|2|||
144208854|NCT02728843|519958199|FG004|Overall Study|Protocol Violation|2|||
144208855|NCT02728843|519958195|FG000|Overall Study|Withdrawal by Subject|1|||
144208856|NCT02728843|519958196|FG001|Overall Study|Withdrawal by Subject|0|||
144208857|NCT02728843|519958197|FG002|Overall Study|Withdrawal by Subject|0|||
144208858|NCT02728843|519958198|FG003|Overall Study|Withdrawal by Subject|1|||
144580666|NCT00568178|521325437|FG000|Open Label Extension|Physician Decision|0|||
144580667|NCT00568178|521325438|FG001|Open Label Extension|Physician Decision|0|||
144580668|NCT00568178|521325439|FG002|Open Label Extension|Physician Decision|0|||
144580669|NCT00568178|521325440|FG003|Open Label Extension|Physician Decision|0|||
144580670|NCT00568178|521325441|FG004|Open Label Extension|Physician Decision|9|||
144580671|NCT00568178|521325442|FG005|Open Label Extension|Physician Decision|8|||
144580672|NCT00568178|521325437|FG000|Open Label Extension|Pregnancy|0|||
144580673|NCT00568178|521325438|FG001|Open Label Extension|Pregnancy|0|||
144580674|NCT00568178|521325439|FG002|Open Label Extension|Pregnancy|0|||
144580675|NCT00568178|521325440|FG003|Open Label Extension|Pregnancy|0|||
144580676|NCT00568178|521325441|FG004|Open Label Extension|Pregnancy|0|||
144580677|NCT00568178|521325442|FG005|Open Label Extension|Pregnancy|1|||
144580678|NCT00568178|521325437|FG000|Open Label Extension|Progressive Disease|0|||
144580679|NCT00568178|521325438|FG001|Open Label Extension|Progressive Disease|0|||
144580680|NCT00568178|521325439|FG002|Open Label Extension|Progressive Disease|0|||
144580681|NCT00568178|521325440|FG003|Open Label Extension|Progressive Disease|0|||
144580682|NCT00568178|521325441|FG004|Open Label Extension|Progressive Disease|3|||
144580683|NCT00568178|521325442|FG005|Open Label Extension|Progressive Disease|1|||
144580684|NCT00568178|521325437|FG000|Open Label Extension|Termination of Trial|0|||
144580685|NCT00568178|521325438|FG001|Open Label Extension|Termination of Trial|0|||
144580686|NCT00568178|521325439|FG002|Open Label Extension|Termination of Trial|0|||
144580687|NCT00568178|521325440|FG003|Open Label Extension|Termination of Trial|0|||
144580688|NCT00568178|521325441|FG004|Open Label Extension|Termination of Trial|45|||
144580689|NCT00568178|521325442|FG005|Open Label Extension|Termination of Trial|47|||
144580690|NCT00568178|521325437|FG000|Open Label Extension|Withdrawal by Subject|0|||
144622817|NCT00953758|521476327|FG006|Overall Study|Disease progression|0|||
144622818|NCT00953758|521476328|FG007|Overall Study|Disease progression|0|||
144622819|NCT00953758|521476329|FG008|Overall Study|Disease progression|0|||
144622820|NCT00953758|521476330|FG009|Overall Study|Disease progression|0|||
144622821|NCT00953758|521476321|FG000|Overall Study|Participant went for transplant|0|||
144208859|NCT02728843|519958199|FG004|Overall Study|Withdrawal by Subject|0|||
144208860|NCT02728843|519958195|FG000|Overall Study|Use of rescue medication|0|||
144208861|NCT02728843|519958196|FG001|Overall Study|Use of rescue medication|2|||
144208862|NCT02728843|519958197|FG002|Overall Study|Use of rescue medication|0|||
144208863|NCT02728843|519958198|FG003|Overall Study|Use of rescue medication|2|||
144580691|NCT00568178|521325438|FG001|Open Label Extension|Withdrawal by Subject|0|||
144580692|NCT00568178|521325439|FG002|Open Label Extension|Withdrawal by Subject|0|||
144622822|NCT00953758|521476322|FG001|Overall Study|Participant went for transplant|0|||
144208864|NCT02728843|519958199|FG004|Overall Study|Use of rescue medication|1|||
144208865|NCT03185013|519958200|FG000|Overall Study|Withdrawal by Subject|5|||
144208866|NCT03185013|519958201|FG001|Overall Study|Withdrawal by Subject|3|||
144208867|NCT03185013|519958200|FG000|Overall Study|Adverse Event|1|||
144208868|NCT03185013|519958201|FG001|Overall Study|Adverse Event|0|||
144208869|NCT03185013|519958200|FG000|Overall Study|Progressive Disease|1|||
144208870|NCT03185013|519958201|FG001|Overall Study|Progressive Disease|0|||
144208871|NCT03185013|519958200|FG000|Overall Study|Lost to Follow-up|8|||
144208872|NCT03185013|519958201|FG001|Overall Study|Lost to Follow-up|2|||
144208873|NCT03185013|519958200|FG000|Overall Study|Physician Decision|1|||
144208874|NCT03185013|519958201|FG001|Overall Study|Physician Decision|0|||
144208875|NCT03185013|519958200|FG000|Overall Study|Protocol Deviation|2|||
144208876|NCT03185013|519958201|FG001|Overall Study|Protocol Deviation|0|||
144208877|NCT03185013|519958200|FG000|Overall Study|Reason not Specified|3|||
144208878|NCT03185013|519958201|FG001|Overall Study|Reason not Specified|2|||
144208879|NCT03185013|519958200|FG000|Overall Study|Death|1|||
144208880|NCT03185013|519958201|FG001|Overall Study|Death|0|||
144208881|NCT02092467|519958205|FG000|Overall Study|Death|49|||
144208882|NCT02092467|519958206|FG001|Overall Study|Death|66|||
144208883|NCT02092467|519958207|FG002|Overall Study|Death|38|||
144208884|NCT02092467|519958205|FG000|Overall Study|Lost to Follow-up|38|||
144208885|NCT02092467|519958206|FG001|Overall Study|Lost to Follow-up|35|||
144208886|NCT02092467|519958207|FG002|Overall Study|Lost to Follow-up|40|||
144208887|NCT02092467|519958205|FG000|Overall Study|Global Deterioration of Health Status|1|||
144208888|NCT02092467|519958206|FG001|Overall Study|Global Deterioration of Health Status|0|||
144208889|NCT02092467|519958207|FG002|Overall Study|Global Deterioration of Health Status|0|||
144208890|NCT02092467|519958205|FG000|Overall Study|Other|32|||
144208891|NCT02092467|519958206|FG001|Overall Study|Other|30|||
144622823|NCT00953758|521476323|FG002|Overall Study|Participant went for transplant|0|||
144622824|NCT00953758|521476324|FG003|Overall Study|Participant went for transplant|0|||
144622825|NCT00953758|521476325|FG004|Overall Study|Participant went for transplant|0|||
144622826|NCT00953758|521476326|FG005|Overall Study|Participant went for transplant|0|||
144622827|NCT00953758|521476327|FG006|Overall Study|Participant went for transplant|0|||
144622828|NCT00953758|521476328|FG007|Overall Study|Participant went for transplant|0|||
144622829|NCT00953758|521476329|FG008|Overall Study|Participant went for transplant|1|||
144622830|NCT00953758|521476330|FG009|Overall Study|Participant went for transplant|0|||
144622831|NCT01536860|521476331|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
144622832|NCT01536860|521476332|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
144622833|NCT01536860|521476333|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
144622834|NCT01164722|521476334|FG000|Overall Study|Adverse Event|0|||
144622835|NCT01164722|521476335|FG001|Overall Study|Adverse Event|1|||
144730357|NCT00259012|521868210|FG001|Overall Study|Adverse Event|1|||
144730358|NCT00259012|521868209|FG000|Overall Study|Withdrawal by Subject|1|||
144208892|NCT02092467|519958207|FG002|Overall Study|Other|24|||
144208893|NCT02092467|519958205|FG000|Overall Study|Withdrawal by Subject|282|||
144208894|NCT02092467|519958206|FG001|Overall Study|Withdrawal by Subject|327|||
144208895|NCT02092467|519958207|FG002|Overall Study|Withdrawal by Subject|289|||
144208896|NCT02092467|519958205|FG000|Overall Study|Randomized but not treated|2|||
144208897|NCT02092467|519958206|FG001|Overall Study|Randomized but not treated|1|||
144208898|NCT02092467|519958207|FG002|Overall Study|Randomized but not treated|7|||
144208899|NCT04400682|519958212|FG000|Period 1|Withdrawal by Subject|1|||
144208900|NCT04400682|519958213|FG001|Period 1|Withdrawal by Subject|4|||
144208901|NCT02105974|519958214|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
144208902|NCT02105974|519958215|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
144208903|NCT02105974|519958216|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
144208904|NCT02105974|519958214|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
144208905|NCT02105974|519958215|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
144208906|NCT02105974|519958216|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
144208907|NCT02105974|519958214|FG000|2 Week Run-in Period|Adverse Event|6|||
144730359|NCT00259012|521868210|FG001|Overall Study|Withdrawal by Subject|0|||
144730360|NCT00259012|521868209|FG000|Overall Study|Physician Decision|0|||
144208908|NCT02105974|519958215|FG001|2 Week Run-in Period|Adverse Event|0|||
144208909|NCT02105974|519958216|FG002|2 Week Run-in Period|Adverse Event|0|||
144208910|NCT02105974|519958214|FG000|2 Week Run-in Period|Study closed/terminated|1|||
144208911|NCT02105974|519958215|FG001|2 Week Run-in Period|Study closed/terminated|0|||
144208912|NCT02105974|519958216|FG002|2 Week Run-in Period|Study closed/terminated|0|||
144208913|NCT02105974|519958214|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
144208914|NCT02105974|519958215|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
144622836|NCT01164722|521476334|FG000|Overall Study|Withdrawal by Subject|3|||
144730361|NCT00259012|521868210|FG001|Overall Study|Physician Decision|1|||
144208915|NCT02105974|519958216|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
144208916|NCT02105974|519958214|FG000|2 Week Run-in Period|Withdrew consent|23|||
144208917|NCT02105974|519958215|FG001|2 Week Run-in Period|Withdrew consent|0|||
144208918|NCT02105974|519958216|FG002|2 Week Run-in Period|Withdrew consent|0|||
144208919|NCT02105974|519958214|FG000|2 Week Run-in Period|Investigator discretion|8|||
144208920|NCT02105974|519958215|FG001|2 Week Run-in Period|Investigator discretion|0|||
144208921|NCT02105974|519958216|FG002|2 Week Run-in Period|Investigator discretion|0|||
144208922|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
144208923|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
144208924|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
144208925|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
144208926|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
144208927|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
144208928|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
144208929|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
144208930|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
144208931|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
144208932|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
144208933|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
144622837|NCT01164722|521476335|FG001|Overall Study|Withdrawal by Subject|4|||
144622838|NCT01164722|521476334|FG000|Overall Study|Lost to Follow-up|3|||
144622839|NCT01164722|521476335|FG001|Overall Study|Lost to Follow-up|6|||
144622840|NCT01164722|521476334|FG000|Overall Study|met protocol criteria for non-treatment|11|||
144622841|NCT01164722|521476335|FG001|Overall Study|met protocol criteria for non-treatment|1|||
144622842|NCT01164722|521476334|FG000|Overall Study|enrolled on other study, concomitant med|1|||
144622843|NCT01164722|521476335|FG001|Overall Study|enrolled on other study, concomitant med|3|||
144622844|NCT00999908|521476336|FG000|Treatment Period 1|Subject withdrew consent|2|||
144622845|NCT00999908|521476337|FG001|Treatment Period 1|Subject withdrew consent|0|||
144622846|NCT00999908|521476338|FG002|Treatment Period 1|Subject withdrew consent|0|||
144622847|NCT00999908|521476336|FG000|Treatment Period 2|Protocol Violation|1|||
144622848|NCT00999908|521476337|FG001|Treatment Period 2|Protocol Violation|0|||
144622849|NCT00999908|521476338|FG002|Treatment Period 2|Protocol Violation|0|||
144622850|NCT00927095|521476340|FG000|Overall Study|Adverse Event|3|||
144622851|NCT00927095|521476341|FG001|Overall Study|Adverse Event|1|||
144622852|NCT00927095|521476342|FG002|Overall Study|Adverse Event|0|||
144622853|NCT00927095|521476340|FG000|Overall Study|Withdrawal by Subject|2|||
144622854|NCT00927095|521476341|FG001|Overall Study|Withdrawal by Subject|1|||
144622855|NCT00927095|521476342|FG002|Overall Study|Withdrawal by Subject|1|||
144622856|NCT00927095|521476340|FG000|Overall Study|Physician Decision|1|||
144622857|NCT00927095|521476341|FG001|Overall Study|Physician Decision|2|||
144622858|NCT00927095|521476342|FG002|Overall Study|Physician Decision|1|||
144622859|NCT01290692|521476347|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
144622860|NCT00706030|521476351|FG000|Overall Study|Disease Progression|4|||
144622861|NCT00706030|521476352|FG001|Overall Study|Disease Progression|6|||
144622862|NCT00706030|521476353|FG002|Overall Study|Disease Progression|46|||
144622863|NCT00706030|521476354|FG003|Overall Study|Disease Progression|12|||
144622864|NCT00706030|521476351|FG000|Overall Study|Adverse Event|1|||
144622865|NCT00706030|521476352|FG001|Overall Study|Adverse Event|0|||
144622866|NCT00706030|521476353|FG002|Overall Study|Adverse Event|4|||
144622867|NCT00706030|521476354|FG003|Overall Study|Adverse Event|2|||
144622868|NCT00706030|521476351|FG000|Overall Study|Withdrawal by Subject|1|||
144622869|NCT00706030|521476352|FG001|Overall Study|Withdrawal by Subject|0|||
144622870|NCT00706030|521476353|FG002|Overall Study|Withdrawal by Subject|2|||
144622871|NCT00706030|521476354|FG003|Overall Study|Withdrawal by Subject|0|||
144622872|NCT00706030|521476351|FG000|Overall Study|Physician Decision|0|||
144622873|NCT00706030|521476352|FG001|Overall Study|Physician Decision|0|||
144622874|NCT00706030|521476353|FG002|Overall Study|Physician Decision|2|||
144622875|NCT00706030|521476354|FG003|Overall Study|Physician Decision|0|||
144622876|NCT00706030|521476351|FG000|Overall Study|Not recorded|0|||
144622877|NCT00706030|521476352|FG001|Overall Study|Not recorded|0|||
144622878|NCT00706030|521476353|FG002|Overall Study|Not recorded|2|||
144622879|NCT00706030|521476354|FG003|Overall Study|Not recorded|0|||
144622880|NCT00706030|521476351|FG000|Overall Study|Protocol Violation|0|||
144622881|NCT00706030|521476352|FG001|Overall Study|Protocol Violation|0|||
144730362|NCT00259012|521868209|FG000|Overall Study|Lost to Follow-up|0|||
144622882|NCT00706030|521476353|FG002|Overall Study|Protocol Violation|1|||
144622883|NCT00706030|521476354|FG003|Overall Study|Protocol Violation|1|||
144622884|NCT00706030|521476351|FG000|Overall Study|Failed to return|0|||
144622885|NCT00706030|521476352|FG001|Overall Study|Failed to return|0|||
144622886|NCT00706030|521476353|FG002|Overall Study|Failed to return|1|||
144622887|NCT00706030|521476354|FG003|Overall Study|Failed to return|0|||
144622888|NCT00706030|521476351|FG000|Overall Study|Symptomatic Deterioration|0|||
144730363|NCT00259012|521868210|FG001|Overall Study|Lost to Follow-up|1|||
144208934|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
144622889|NCT00706030|521476352|FG001|Overall Study|Symptomatic Deterioration|0|||
144622890|NCT00706030|521476353|FG002|Overall Study|Symptomatic Deterioration|1|||
144622891|NCT00706030|521476354|FG003|Overall Study|Symptomatic Deterioration|0|||
144622892|NCT00706030|521476351|FG000|Overall Study|No treatment received|0|||
144622893|NCT00706030|521476352|FG001|Overall Study|No treatment received|0|||
144208935|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
144208936|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
144208937|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
144208938|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
144208939|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
144208940|NCT02105974|519958214|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
144208941|NCT02105974|519958215|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
144208942|NCT02105974|519958216|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
144208943|NCT00477633|519958217|FG000|Overall Study|Did not receive treatment|23|||
144208944|NCT00477633|519958217|FG000|Overall Study|Adverse Event|143|||
144208945|NCT00477633|519958217|FG000|Overall Study|Pregnancy|23|||
144208946|NCT00477633|519958217|FG000|Overall Study|Lost to Follow-up|271|||
144208947|NCT00477633|519958217|FG000|Overall Study|Withdrawal by Subject|149|||
144208948|NCT00477633|519958217|FG000|Overall Study|Protocol Violation|25|||
144208949|NCT00477633|519958217|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
144208950|NCT02968849|519958218|FG000|Overall Study|Death|8|||
144208951|NCT02968849|519958219|FG001|Overall Study|Death|10|||
144208952|NCT02968849|519958218|FG000|Overall Study|Lost to Follow-up|31|||
144208953|NCT02968849|519958219|FG001|Overall Study|Lost to Follow-up|29|||
144208954|NCT02968849|519958218|FG000|Overall Study|Withdrawal by Subject|73|||
144208955|NCT02968849|519958219|FG001|Overall Study|Withdrawal by Subject|64|||
144208956|NCT02968849|519958218|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
144208957|NCT02968849|519958219|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
144208958|NCT02968849|519958218|FG000|Overall Study|Physician Decision|6|||
144208959|NCT02968849|519958219|FG001|Overall Study|Physician Decision|9|||
144208960|NCT02968849|519958218|FG000|Overall Study|Other|16|||
144208961|NCT02968849|519958219|FG001|Overall Study|Other|10|||
144208962|NCT00478244|519960018|FG000|Overall Study|Did not receive transplant|1|||
144208963|NCT01392963|519960019|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
144208964|NCT01392963|519960020|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
144208965|NCT01392963|519960019|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
144208966|NCT01392963|519960020|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
144208967|NCT01392963|519960019|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
144208968|NCT01392963|519960020|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
144208969|NCT02899195|519960021|FG000|Concurrent Durvalumab|Adverse Event|4|||
144208970|NCT02899195|519960021|FG000|Concurrent Durvalumab|Physician Decision|1|||
144208971|NCT02899195|519960021|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
144208972|NCT02899195|519960021|FG000|Concurrent Durvalumab|Progressive Disease|5|||
144208973|NCT02899195|519960021|FG000|Maintenance Durvalumab|Adverse Event|1|||
144208974|NCT02899195|519960021|FG000|Maintenance Durvalumab|Physician Decision|1|||
144208975|NCT02899195|519960021|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
144208976|NCT02899195|519960021|FG000|Maintenance Durvalumab|Progressive Disease|31|||
144208977|NCT04778904|519960022|FG000|Overall Study|Protocol Violation|1|||
144208978|NCT04778904|519960023|FG001|Overall Study|Protocol Violation|0|||
144208979|NCT04778904|519960024|FG002|Overall Study|Protocol Violation|0|||
144208980|NCT04778904|519960025|FG003|Overall Study|Protocol Violation|0|||
144208981|NCT04778904|519960022|FG000|Overall Study|Withdrawal by Subject|0|||
144208982|NCT04778904|519960023|FG001|Overall Study|Withdrawal by Subject|0|||
144208983|NCT04778904|519960024|FG002|Overall Study|Withdrawal by Subject|1|||
144208984|NCT04778904|519960025|FG003|Overall Study|Withdrawal by Subject|0|||
144208985|NCT03452137|519960026|FG000|Overall Study|Death|67|||
144208986|NCT03452137|519960027|FG001|Overall Study|Death|70|||
144208987|NCT03452137|519960026|FG000|Overall Study|Lost to Follow-up|4|||
144208988|NCT03452137|519960027|FG001|Overall Study|Lost to Follow-up|2|||
144208989|NCT03452137|519960026|FG000|Overall Study|Physician Decision|0|||
144208990|NCT03452137|519960027|FG001|Overall Study|Physician Decision|1|||
144208991|NCT03452137|519960026|FG000|Overall Study|Study Terminated by Sponsor|120|||
144208992|NCT03452137|519960027|FG001|Overall Study|Study Terminated by Sponsor|121|||
144208993|NCT03452137|519960026|FG000|Overall Study|Withdrawal by Subject|12|||
144580693|NCT00568178|521325440|FG003|Open Label Extension|Withdrawal by Subject|0|||
144580694|NCT00568178|521325441|FG004|Open Label Extension|Withdrawal by Subject|4|||
144580695|NCT00568178|521325442|FG005|Open Label Extension|Withdrawal by Subject|4|||
144580696|NCT00264303|521325443|FG000|Overall Study|Adverse Event|4|||
144580697|NCT00264303|521325444|FG001|Overall Study|Adverse Event|3|||
144580698|NCT00264303|521325443|FG000|Overall Study|Lack of Efficacy|10|||
144580699|NCT00264303|521325444|FG001|Overall Study|Lack of Efficacy|13|||
144580700|NCT00264303|521325443|FG000|Overall Study|Lost to Follow-up|3|||
144580701|NCT00264303|521325444|FG001|Overall Study|Lost to Follow-up|3|||
144580702|NCT00264303|521325443|FG000|Overall Study|Withdrawal by Subject|2|||
144580703|NCT00264303|521325444|FG001|Overall Study|Withdrawal by Subject|3|||
144580704|NCT00264303|521325443|FG000|Overall Study|Various reasons listed in study report|6|||
144580705|NCT00264303|521325444|FG001|Overall Study|Various reasons listed in study report|7|||
144580706|NCT02389452|521325445|FG000|Overall Study|Lost to Follow-up|13|||
144580707|NCT02389452|521325445|FG000|Overall Study|Adverse Event|1|||
144580708|NCT02389452|521325445|FG000|Overall Study|Withdrawal by Subject|5|||
144208994|NCT03452137|519960027|FG001|Overall Study|Withdrawal by Subject|9|||
144208995|NCT04138043|519960028|FG000|Overall Study|Withdrawal by Subject|0|||
144208996|NCT04138043|519960029|FG001|Overall Study|Withdrawal by Subject|1|||
144208997|NCT02856802|519960030|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
144208998|NCT02856802|519960031|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
144208999|NCT02856802|519960030|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
144209000|NCT02856802|519960031|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
144209001|NCT02856802|519960030|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
144209002|NCT02856802|519960031|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
144209003|NCT02856802|519960030|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
144209004|NCT02856802|519960031|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
144209005|NCT02856802|519960030|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
144209006|NCT02856802|519960031|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
144209007|NCT02856802|519960030|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
144209008|NCT02856802|519960031|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
144209009|NCT03772717|519960032|FG000|Overall Study|Withdrawal by Subject|2|||
144209010|NCT00587860|519960033|FG000|Overall Study|Lost to Follow-up|2|||
144209011|NCT00587860|519960034|FG001|Overall Study|Lost to Follow-up|2|||
144209012|NCT00587860|519960033|FG000|Overall Study|Withdrawal by Subject|3|||
144209013|NCT00587860|519960034|FG001|Overall Study|Withdrawal by Subject|3|||
144209014|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
144209015|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
144209016|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
144209017|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
144209018|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
144209019|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
144209020|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
144209021|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
144209022|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
144209023|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
144209024|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
144209025|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
144209026|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
144209027|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
144209028|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
144209029|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
144209030|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
144209031|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
144209032|NCT00261443|519960035|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
144209033|NCT00261443|519960036|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
144209034|NCT00261443|519960037|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
144209035|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
144209036|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
144209037|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
144209038|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
144209039|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
144209040|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
144209041|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
144209042|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
144209043|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
144209044|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
144209045|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
144209046|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
144209047|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
144209048|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
144209049|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
144209050|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
144209051|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
144209052|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
144209053|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
144209054|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
144209055|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
144209056|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
144209057|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
144209058|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
144209059|NCT00261443|519960035|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
144209060|NCT00261443|519960036|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
144209061|NCT00261443|519960037|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
144209062|NCT00261443|519960035|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
144209063|NCT00261443|519960036|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
144209064|NCT00261443|519960037|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
144209065|NCT00261443|519960035|FG000|3: Assessment of Relapse|Adverse Event|0|||
144209066|NCT00261443|519960036|FG001|3: Assessment of Relapse|Adverse Event|15|||
144209067|NCT00261443|519960037|FG002|3: Assessment of Relapse|Adverse Event|19|||
144209068|NCT00261443|519960035|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
144209069|NCT00261443|519960036|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
144209070|NCT00261443|519960037|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
144209071|NCT00261443|519960035|FG000|3: Assessment of Relapse|Death|0|||
144209072|NCT00261443|519960036|FG001|3: Assessment of Relapse|Death|0|||
144209073|NCT00261443|519960037|FG002|3: Assessment of Relapse|Death|1|||
144209074|NCT00261443|519960035|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
144209075|NCT00261443|519960036|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
144209076|NCT00261443|519960037|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
144209077|NCT00261443|519960035|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
144209078|NCT00261443|519960036|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
144209079|NCT00261443|519960037|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
144209080|NCT00261443|519960035|FG000|3: Assessment of Relapse|Pregnancy|0|||
144209081|NCT00261443|519960036|FG001|3: Assessment of Relapse|Pregnancy|2|||
144209082|NCT00261443|519960037|FG002|3: Assessment of Relapse|Pregnancy|1|||
144580709|NCT02389452|521325445|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
144580710|NCT00837694|521325448|FG000|Overall Study|Lost to Follow-up|2|||
144580711|NCT00837694|521325449|FG001|Overall Study|Lost to Follow-up|0|||
144580712|NCT00837694|521325450|FG002|Overall Study|Lost to Follow-up|2|||
144580713|NCT00837694|521325451|FG003|Overall Study|Lost to Follow-up|1|||
144580714|NCT00837694|521325452|FG004|Overall Study|Lost to Follow-up|1|||
144580715|NCT00837694|521325453|FG005|Overall Study|Lost to Follow-up|1|||
144622894|NCT00706030|521476353|FG002|Overall Study|No treatment received|0|||
144209083|NCT00261443|519960035|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
144209084|NCT00261443|519960036|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
144209085|NCT00261443|519960037|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
144209086|NCT00261443|519960035|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
144209087|NCT00261443|519960036|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
144209088|NCT00261443|519960037|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
144209089|NCT00261443|519960035|FG000|3: Assessment of Relapse|Other Reasons|0|||
144209090|NCT00261443|519960036|FG001|3: Assessment of Relapse|Other Reasons|4|||
144209091|NCT00261443|519960037|FG002|3: Assessment of Relapse|Other Reasons|3|||
144209092|NCT00261443|519960035|FG000|4: Extension Phase|Adverse Event|0|||
144209093|NCT00261443|519960036|FG001|4: Extension Phase|Adverse Event|1|||
144209094|NCT00261443|519960037|FG002|4: Extension Phase|Adverse Event|0|||
144209095|NCT00261443|519960035|FG000|4: Extension Phase|Withdrawal by Subject|0|||
144209096|NCT00261443|519960036|FG001|4: Extension Phase|Withdrawal by Subject|1|||
144209097|NCT00261443|519960037|FG002|4: Extension Phase|Withdrawal by Subject|2|||
144209098|NCT00261443|519960035|FG000|4: Extension Phase|Lost to Follow-up|0|||
144209099|NCT00261443|519960036|FG001|4: Extension Phase|Lost to Follow-up|1|||
144209100|NCT00261443|519960037|FG002|4: Extension Phase|Lost to Follow-up|0|||
144209101|NCT01286753|519960038|FG000|Overall Study|Adverse Event|7|||
144209102|NCT01286753|519960039|FG001|Overall Study|Adverse Event|6|||
144209103|NCT01286753|519960038|FG000|Overall Study|Progression|11|||
144209104|NCT01286753|519960039|FG001|Overall Study|Progression|13|||
144209105|NCT01286753|519960038|FG000|Overall Study|Refused Treatment|1|||
144209106|NCT01286753|519960039|FG001|Overall Study|Refused Treatment|0|||
144209107|NCT01286753|519960038|FG000|Overall Study|Withdrawal of Consent|0|||
144209108|NCT01286753|519960039|FG001|Overall Study|Withdrawal of Consent|2|||
144209109|NCT01286753|519960038|FG000|Overall Study|Discontinued to Join Extension Study|6|||
144209110|NCT01286753|519960039|FG001|Overall Study|Discontinued to Join Extension Study|4|||
144209111|NCT01286753|519960038|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
144209112|NCT01286753|519960039|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
144209113|NCT00887289|519960041|FG000|Overall Study|Lack of Efficacy|14|||
144209114|NCT00887289|519960041|FG000|Overall Study|Adverse Event|27|||
144209115|NCT00887289|519960041|FG000|Overall Study|Withdrawal by Subject|26|||
144209116|NCT00887289|519960041|FG000|Overall Study|Lost to Follow-up|8|||
144580716|NCT00818168|521325463|FG000|Overall Study|Lack of Efficacy|18|||
144580717|NCT00818168|521325463|FG000|Overall Study|Pregnancy|2|||
144580718|NCT00818168|521325463|FG000|Overall Study|Withdrawal by Subject|16|||
144580719|NCT00818168|521325463|FG000|Overall Study|Lost to Follow-up|7|||
144580720|NCT00818168|521325463|FG000|Overall Study|Adverse Event|19|||
144580721|NCT00818168|521325463|FG000|Overall Study|Reason for Non-completion Not reported|6|||
144209117|NCT00887289|519960041|FG000|Overall Study|Other|20|||
144580722|NCT00818168|521325463|FG000|Overall Study|Participant Moved|2|||
144622895|NCT00706030|521476354|FG003|Overall Study|No treatment received|1|||
144209118|NCT03022084|519960044|FG000|Overall Study|Lost to Follow-up|2|||
144209119|NCT03022084|519960045|FG001|Overall Study|Lost to Follow-up|3|||
144209120|NCT02932306|519960049|FG000|Overall Study|Withdrawal by Subject|16|||
144209121|NCT02932306|519960050|FG001|Overall Study|Withdrawal by Subject|25|||
144209122|NCT02932306|519960049|FG000|Overall Study|Adverse Event|3|||
144209123|NCT02932306|519960050|FG001|Overall Study|Adverse Event|0|||
144209124|NCT02932306|519960049|FG000|Overall Study|Pregnancy|2|||
144209125|NCT02932306|519960050|FG001|Overall Study|Pregnancy|0|||
144209126|NCT02932306|519960049|FG000|Overall Study|Protocol Violation|1|||
144209127|NCT02932306|519960050|FG001|Overall Study|Protocol Violation|1|||
144209128|NCT02932306|519960049|FG000|Overall Study|Noncompliance with Study Drug|1|||
144209129|NCT02932306|519960050|FG001|Overall Study|Noncompliance with Study Drug|1|||
144209130|NCT02932306|519960049|FG000|Overall Study|Lost to Follow-up|36|||
144209131|NCT02932306|519960050|FG001|Overall Study|Lost to Follow-up|40|||
144209132|NCT02932306|519960049|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
144209133|NCT02932306|519960050|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
144622896|NCT00706030|521476351|FG000|Overall Study|Death|0|||
144622897|NCT00706030|521476352|FG001|Overall Study|Death|0|||
144622898|NCT00706030|521476353|FG002|Overall Study|Death|1|||
144622899|NCT00706030|521476354|FG003|Overall Study|Death|0|||
144622900|NCT04673786|521476355|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
144622901|NCT04673786|521476356|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
144622902|NCT04673786|521476357|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
144622903|NCT04673786|521476355|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
144622904|NCT04673786|521476356|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
144622905|NCT04673786|521476357|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
144622906|NCT04673786|521476355|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
144209134|NCT02932306|519960049|FG000|Overall Study|Lack of Efficacy|0|||
144209135|NCT02932306|519960050|FG001|Overall Study|Lack of Efficacy|2|||
144209136|NCT02932306|519960049|FG000|Overall Study|Worsening condition|2|||
144209137|NCT02932306|519960050|FG001|Overall Study|Worsening condition|0|||
144209138|NCT02932306|519960049|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
144209139|NCT02932306|519960050|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
144209140|NCT00923273|519960051|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
144209141|NCT00923273|519960052|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
144209142|NCT00923273|519960053|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
144209143|NCT00923273|519960054|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
144209144|NCT00923273|519960055|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
144209145|NCT00923273|519960051|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
144209146|NCT00923273|519960052|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
144209147|NCT00923273|519960053|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
144209148|NCT00923273|519960054|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
144209149|NCT00923273|519960055|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
144209150|NCT00605540|519960056|FG000|Overall Study|Death|15|||
144209151|NCT00605540|519960056|FG000|Overall Study|Lost to Follow-up|23|||
144209152|NCT01438996|519960059|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
144209153|NCT01438996|519960060|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
144209154|NCT01438996|519960061|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
144622907|NCT04673786|521476356|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
144622908|NCT04673786|521476357|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
144622909|NCT04673786|521476355|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
144209155|NCT04497948|519960062|FG000|Overall Study|Death|2|||
144209156|NCT03207243|519960069|FG000|Overall Study|Adverse Event|2|||
144209157|NCT03207243|519960070|FG001|Overall Study|Adverse Event|2|||
144209158|NCT03207243|519960069|FG000|Overall Study|Loss of Asthma Control|47|||
144209159|NCT03207243|519960070|FG001|Overall Study|Loss of Asthma Control|31|||
144209160|NCT03207243|519960069|FG000|Overall Study|Withdrawal by Subject|2|||
144209161|NCT03207243|519960070|FG001|Overall Study|Withdrawal by Subject|4|||
144209162|NCT03207243|519960069|FG000|Overall Study|Physician Decision|1|||
144209163|NCT03207243|519960070|FG001|Overall Study|Physician Decision|1|||
144730364|NCT00259012|521868209|FG000|Overall Study|Protocol Violation|1|||
144209164|NCT03207243|519960069|FG000|Overall Study|Lost to Follow-up|0|||
144209165|NCT03207243|519960070|FG001|Overall Study|Lost to Follow-up|1|||
144209166|NCT03207243|519960069|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
144209167|NCT03207243|519960070|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
144209168|NCT03207243|519960069|FG000|Overall Study|Protocol Violation|0|||
144209169|NCT03207243|519960070|FG001|Overall Study|Protocol Violation|3|||
144622910|NCT04673786|521476356|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
144622911|NCT04673786|521476357|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
144730365|NCT00259012|521868210|FG001|Overall Study|Protocol Violation|1|||
144730366|NCT03002077|521868211|FG000|Overall Study|Non-compliance with Study Drug|4|||
144730367|NCT03002077|521868211|FG000|Overall Study|Non-compliance w/Background ADT|1|||
144209170|NCT01377987|519960073|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
144209171|NCT01377987|519960074|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
144209172|NCT04611529|519960075|FG000|2-day Follow up|Lost to Follow-up|5|||
144209173|NCT04611529|519960076|FG001|2-day Follow up|Lost to Follow-up|6|||
144209174|NCT04611529|519960077|FG002|2-day Follow up|Lost to Follow-up|3|||
144209175|NCT00741286|519960083|FG000|Overall Study|Lost to Follow-up|15|||
144580723|NCT01008553|521325464|FG000|Period 1 (Titration Period)|Physician Decision|2|||
144580724|NCT01008553|521325465|FG001|Period 1 (Titration Period)|Physician Decision|0|||
144580725|NCT01008553|521325466|FG002|Period 1 (Titration Period)|Physician Decision|0|||
144580726|NCT01008553|521325464|FG000|Period 1 (Titration Period)|Adverse Event|33|||
144580727|NCT01008553|521325465|FG001|Period 1 (Titration Period)|Adverse Event|0|||
144580728|NCT01008553|521325466|FG002|Period 1 (Titration Period)|Adverse Event|0|||
144580729|NCT01008553|521325464|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
144580730|NCT01008553|521325465|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
144580731|NCT01008553|521325466|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
144580732|NCT01008553|521325464|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
144580733|NCT01008553|521325465|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
144580734|NCT01008553|521325466|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
144580735|NCT01008553|521325464|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
144580736|NCT01008553|521325465|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
144580737|NCT01008553|521325466|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
144580738|NCT01008553|521325464|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
144580739|NCT01008553|521325465|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
144580740|NCT01008553|521325466|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
144580741|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
144580742|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
144580743|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
144580744|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
144580745|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
144580746|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
144580747|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
144580748|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
144580749|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
144580750|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
144580751|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
144580752|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
144580753|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
144580754|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
144580755|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
144580756|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
144580757|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
144580758|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
144580759|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
144580760|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
144580761|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
144622912|NCT04673786|521476355|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
144622913|NCT04673786|521476356|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
144622914|NCT04673786|521476357|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
144622915|NCT04673786|521476355|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
144622916|NCT04673786|521476356|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
144622917|NCT04673786|521476357|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
144622918|NCT00044512|521476363|FG000|Follow Up|Lost to Follow-up|2|||
144622919|NCT02799069|521476364|FG000|Overall Study|Adverse Event|0|||
144622920|NCT02799069|521476365|FG001|Overall Study|Adverse Event|2|||
144730368|NCT03002077|521868211|FG000|Overall Study|Study Terminated by Sponsor|257|||
144580762|NCT01008553|521325464|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
144580763|NCT01008553|521325465|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
144580764|NCT01008553|521325466|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
144580765|NCT01008410|521325467|FG000|Overall Study|Adverse Event|13|||
144580766|NCT01008410|521325468|FG001|Overall Study|Adverse Event|7|||
144580767|NCT01008410|521325467|FG000|Overall Study|Withdrawal by Subject|6|||
144580768|NCT01008410|521325468|FG001|Overall Study|Withdrawal by Subject|2|||
144622921|NCT02799069|521476366|FG002|Overall Study|Adverse Event|2|||
144622922|NCT02799069|521476364|FG000|Overall Study|Lack of Efficacy|2|||
144209176|NCT00741286|519960084|FG001|Overall Study|Lost to Follow-up|10|||
144209177|NCT00741286|519960083|FG000|Overall Study|Adverse Event|1|||
144622923|NCT02799069|521476365|FG001|Overall Study|Lack of Efficacy|0|||
144622924|NCT02799069|521476366|FG002|Overall Study|Lack of Efficacy|0|||
144580769|NCT01008410|521325467|FG000|Overall Study|Lost to Follow-up|1|||
144580770|NCT01008410|521325468|FG001|Overall Study|Lost to Follow-up|0|||
144580771|NCT01008410|521325467|FG000|Overall Study|Noncompliance|1|||
144580772|NCT01008410|521325468|FG001|Overall Study|Noncompliance|0|||
144580773|NCT01008410|521325467|FG000|Overall Study|Low Cortisol|2|||
144580774|NCT01008410|521325468|FG001|Overall Study|Low Cortisol|0|||
144580775|NCT01008410|521325467|FG000|Overall Study|Lack of Efficacy|2|||
144580776|NCT01008410|521325468|FG001|Overall Study|Lack of Efficacy|6|||
144580777|NCT01008410|521325467|FG000|Overall Study|Met Exclusion Criterion|0|||
144580778|NCT01008410|521325468|FG001|Overall Study|Met Exclusion Criterion|1|||
144580779|NCT02787044|521325471|FG000|Overall Study|Lost to Follow-up|15|||
144580780|NCT02787044|521325472|FG001|Overall Study|Lost to Follow-up|19|||
144580781|NCT03433677|521325473|FG000|Period 1|Protocol Violation|1|||
144580782|NCT03433677|521325474|FG001|Period 1|Protocol Violation|0|||
144580783|NCT03433677|521325473|FG000|Period 2|Withdrawal by Subject|1|||
144580784|NCT03433677|521325474|FG001|Period 2|Withdrawal by Subject|1|||
144580785|NCT03889704|521325476|FG000|Overall Study|Study terminated due to pandemic|1|||
144580786|NCT03482466|521325477|FG000|Overall Study|Protocol Violation|2|||
144580787|NCT04552899|521325478|FG000|Overall Study|Adverse Event|4|||
144580788|NCT04552899|521325479|FG001|Overall Study|Adverse Event|3|||
144580789|NCT04552899|521325478|FG000|Overall Study|Death|4|||
144580790|NCT04552899|521325479|FG001|Overall Study|Death|4|||
144580791|NCT04552899|521325478|FG000|Overall Study|Lost to Follow-up|8|||
144580792|NCT04552899|521325479|FG001|Overall Study|Lost to Follow-up|13|||
144580793|NCT04552899|521325478|FG000|Overall Study|Lung Transplant|4|||
144580794|NCT04552899|521325479|FG001|Overall Study|Lung Transplant|3|||
144580795|NCT04552899|521325478|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
144580796|NCT04552899|521325479|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
144580797|NCT04552899|521325478|FG000|Overall Study|Physician Decision|3|||
144580798|NCT04552899|521325479|FG001|Overall Study|Physician Decision|4|||
144580799|NCT04552899|521325478|FG000|Overall Study|Study Terminated By Sponsor|237|||
144580800|NCT04552899|521325479|FG001|Overall Study|Study Terminated By Sponsor|239|||
144580801|NCT04552899|521325478|FG000|Overall Study|Withdrawal by Subject|15|||
144580802|NCT04552899|521325479|FG001|Overall Study|Withdrawal by Subject|17|||
144580803|NCT03268603|521325480|FG000|Overall Study|Withdrawal by Subject|6|||
144580804|NCT03268603|521325480|FG000|Overall Study|Physician Decision|1|||
144580805|NCT03268603|521325480|FG000|Overall Study|Withdrawn due to disease progression|2|||
144580806|NCT02591953|521325481|FG000|Overall Study|Lost to Follow-up|6|||
144580807|NCT02591953|521325482|FG001|Overall Study|Lost to Follow-up|6|||
144580808|NCT02060370|521325483|FG000|Overall Study|Physician Decision|1|||
144580809|NCT02383940|521325484|FG000|Overall Study|Adverse Event|1|||
144580810|NCT02383940|521325485|FG001|Overall Study|Adverse Event|0|||
144580811|NCT02383940|521325484|FG000|Overall Study|Lost to Follow-up|2|||
144580812|NCT02383940|521325485|FG001|Overall Study|Lost to Follow-up|2|||
144580813|NCT02383940|521325484|FG000|Overall Study|Physician Decision|2|||
144580814|NCT02383940|521325485|FG001|Overall Study|Physician Decision|0|||
144580815|NCT02383940|521325484|FG000|Overall Study|Withdrawal by Subject|1|||
144580816|NCT02383940|521325485|FG001|Overall Study|Withdrawal by Subject|1|||
144580817|NCT02383940|521325484|FG000|Overall Study|Randomized but not treated|2|||
144580818|NCT02383940|521325485|FG001|Overall Study|Randomized but not treated|0|||
144580819|NCT02383940|521325484|FG000|Overall Study|Other than specified above|1|||
144580820|NCT02383940|521325485|FG001|Overall Study|Other than specified above|0|||
144580821|NCT01517295|521325486|FG000|Overall Study|Physician Decision|1|||
144580822|NCT01517295|521325487|FG001|Overall Study|Physician Decision|0|||
144580823|NCT02672852|521325489|FG000|Part A1|Disease Worsening|1|||
144580824|NCT02672852|521325490|FG001|Part A1|Disease Worsening|0|||
144580825|NCT02672852|521325491|FG002|Part A1|Disease Worsening|0|||
144580826|NCT02672852|521325492|FG003|Part A1|Disease Worsening|0|||
144580827|NCT02672852|521325493|FG004|Part A1|Disease Worsening|0|||
144580828|NCT02672852|521325494|FG005|Part A1|Disease Worsening|0|||
144580829|NCT02672852|521325495|FG006|Part A1|Disease Worsening|0|||
144580830|NCT02672852|521325489|FG000|Part A1|Adverse Event|0|||
144580831|NCT02672852|521325490|FG001|Part A1|Adverse Event|1|||
144580832|NCT02672852|521325491|FG002|Part A1|Adverse Event|0|||
144580833|NCT02672852|521325492|FG003|Part A1|Adverse Event|0|||
144580834|NCT02672852|521325493|FG004|Part A1|Adverse Event|0|||
144580835|NCT02672852|521325494|FG005|Part A1|Adverse Event|0|||
144580836|NCT02672852|521325495|FG006|Part A1|Adverse Event|0|||
144580837|NCT02672852|521325489|FG000|Part A1|Lost to Follow-up|1|||
144580838|NCT02672852|521325490|FG001|Part A1|Lost to Follow-up|2|||
144580839|NCT02672852|521325491|FG002|Part A1|Lost to Follow-up|0|||
144580840|NCT02672852|521325492|FG003|Part A1|Lost to Follow-up|0|||
144580841|NCT02672852|521325493|FG004|Part A1|Lost to Follow-up|0|||
144580842|NCT02672852|521325494|FG005|Part A1|Lost to Follow-up|0|||
144580843|NCT02672852|521325495|FG006|Part A1|Lost to Follow-up|0|||
144580844|NCT02672852|521325489|FG000|Part A1|Withdrawal by Subject|1|||
144580845|NCT02672852|521325490|FG001|Part A1|Withdrawal by Subject|1|||
144580846|NCT02672852|521325491|FG002|Part A1|Withdrawal by Subject|0|||
144580847|NCT02672852|521325492|FG003|Part A1|Withdrawal by Subject|0|||
144580848|NCT02672852|521325493|FG004|Part A1|Withdrawal by Subject|0|||
144580849|NCT02672852|521325494|FG005|Part A1|Withdrawal by Subject|0|||
144209178|NCT00741286|519960084|FG001|Overall Study|Adverse Event|6|||
144209179|NCT00741286|519960083|FG000|Overall Study|Protocol Violation|3|||
144209180|NCT00741286|519960084|FG001|Overall Study|Protocol Violation|2|||
144209181|NCT00741286|519960083|FG000|Overall Study|Primary Outcome|1|||
144580850|NCT02672852|521325495|FG006|Part A1|Withdrawal by Subject|0|||
144580851|NCT02672852|521325489|FG000|Part A2|Disease worsening|0|||
144209182|NCT00741286|519960084|FG001|Overall Study|Primary Outcome|1|||
144580852|NCT02672852|521325490|FG001|Part A2|Disease worsening|0|||
144580853|NCT02672852|521325491|FG002|Part A2|Disease worsening|1|||
144580854|NCT02672852|521325492|FG003|Part A2|Disease worsening|0|||
144580855|NCT02672852|521325493|FG004|Part A2|Disease worsening|0|||
144580856|NCT02672852|521325494|FG005|Part A2|Disease worsening|0|||
144580857|NCT02672852|521325495|FG006|Part A2|Disease worsening|0|||
144580858|NCT02672852|521325489|FG000|Part A2|Adverse Event|0|||
144580859|NCT02672852|521325490|FG001|Part A2|Adverse Event|0|||
144580860|NCT02672852|521325491|FG002|Part A2|Adverse Event|3|||
144580861|NCT02672852|521325492|FG003|Part A2|Adverse Event|0|||
144580862|NCT02672852|521325493|FG004|Part A2|Adverse Event|0|||
144580863|NCT02672852|521325494|FG005|Part A2|Adverse Event|0|||
144580864|NCT02672852|521325495|FG006|Part A2|Adverse Event|0|||
144580865|NCT02672852|521325489|FG000|Part A2|Lost to Follow-up|0|||
144580866|NCT02672852|521325490|FG001|Part A2|Lost to Follow-up|0|||
144580867|NCT02672852|521325491|FG002|Part A2|Lost to Follow-up|2|||
144580868|NCT02672852|521325492|FG003|Part A2|Lost to Follow-up|0|||
144580869|NCT02672852|521325493|FG004|Part A2|Lost to Follow-up|0|||
144580870|NCT02672852|521325494|FG005|Part A2|Lost to Follow-up|0|||
144580871|NCT02672852|521325495|FG006|Part A2|Lost to Follow-up|0|||
144580872|NCT02672852|521325489|FG000|Part A2|Withdrawal by Subject|0|||
144580873|NCT02672852|521325490|FG001|Part A2|Withdrawal by Subject|0|||
144580874|NCT02672852|521325491|FG002|Part A2|Withdrawal by Subject|1|||
144580875|NCT02672852|521325492|FG003|Part A2|Withdrawal by Subject|0|||
144580876|NCT02672852|521325493|FG004|Part A2|Withdrawal by Subject|0|||
144580877|NCT02672852|521325494|FG005|Part A2|Withdrawal by Subject|0|||
144580878|NCT02672852|521325495|FG006|Part A2|Withdrawal by Subject|0|||
144580879|NCT02672852|521325489|FG000|Part A2|Other|0|||
144580880|NCT02672852|521325490|FG001|Part A2|Other|0|||
144580881|NCT02672852|521325491|FG002|Part A2|Other|3|||
144580882|NCT02672852|521325492|FG003|Part A2|Other|0|||
144580883|NCT02672852|521325493|FG004|Part A2|Other|0|||
144580884|NCT02672852|521325494|FG005|Part A2|Other|0|||
144580885|NCT02672852|521325495|FG006|Part A2|Other|0|||
144580886|NCT02672852|521325489|FG000|Part A2|Not entered in Part B|0|||
144580887|NCT02672852|521325490|FG001|Part A2|Not entered in Part B|0|||
144580888|NCT02672852|521325491|FG002|Part A2|Not entered in Part B|0|||
144580889|NCT02672852|521325492|FG003|Part A2|Not entered in Part B|4|||
144580890|NCT02672852|521325493|FG004|Part A2|Not entered in Part B|0|||
144580891|NCT02672852|521325494|FG005|Part A2|Not entered in Part B|0|||
144580892|NCT02672852|521325495|FG006|Part A2|Not entered in Part B|0|||
144580893|NCT02672852|521325489|FG000|Part B|Disease worsening|0|||
144580894|NCT02672852|521325490|FG001|Part B|Disease worsening|0|||
144580895|NCT02672852|521325491|FG002|Part B|Disease worsening|0|||
144580896|NCT02672852|521325492|FG003|Part B|Disease worsening|0|||
144580897|NCT02672852|521325493|FG004|Part B|Disease worsening|1|||
144580898|NCT02672852|521325494|FG005|Part B|Disease worsening|0|||
144580899|NCT02672852|521325495|FG006|Part B|Disease worsening|1|||
144580900|NCT02672852|521325489|FG000|Part B|Worsening pre-existing condition|0|||
144580901|NCT02672852|521325490|FG001|Part B|Worsening pre-existing condition|0|||
144580902|NCT02672852|521325491|FG002|Part B|Worsening pre-existing condition|0|||
144580903|NCT02672852|521325492|FG003|Part B|Worsening pre-existing condition|0|||
144580904|NCT02672852|521325493|FG004|Part B|Worsening pre-existing condition|0|||
144580905|NCT02672852|521325494|FG005|Part B|Worsening pre-existing condition|1|||
144580906|NCT02672852|521325495|FG006|Part B|Worsening pre-existing condition|0|||
144580907|NCT02672852|521325489|FG000|Part B|Other adverse event|0|||
144580908|NCT02672852|521325490|FG001|Part B|Other adverse event|0|||
144580909|NCT02672852|521325491|FG002|Part B|Other adverse event|0|||
144580910|NCT02672852|521325492|FG003|Part B|Other adverse event|0|||
144580911|NCT02672852|521325493|FG004|Part B|Other adverse event|3|||
144622925|NCT02799069|521476364|FG000|Overall Study|Lost to Follow-up|1|||
144209183|NCT01831258|519960085|FG000|Overall Study|Withdrawal by Subject|2|||
144209184|NCT01831258|519960086|FG001|Overall Study|Withdrawal by Subject|1|||
144209185|NCT01831258|519960085|FG000|Overall Study|Lost to Follow-up|3|||
144209186|NCT01831258|519960086|FG001|Overall Study|Lost to Follow-up|2|||
144580912|NCT02672852|521325494|FG005|Part B|Other adverse event|5|||
144580913|NCT02672852|521325495|FG006|Part B|Other adverse event|1|||
144580914|NCT02672852|521325489|FG000|Part B|Lost to Follow-up|0|||
144580915|NCT02672852|521325490|FG001|Part B|Lost to Follow-up|0|||
144580916|NCT02672852|521325491|FG002|Part B|Lost to Follow-up|0|||
144580917|NCT02672852|521325492|FG003|Part B|Lost to Follow-up|0|||
144580918|NCT02672852|521325493|FG004|Part B|Lost to Follow-up|3|||
144580919|NCT02672852|521325494|FG005|Part B|Lost to Follow-up|4|||
144580920|NCT02672852|521325495|FG006|Part B|Lost to Follow-up|1|||
144580921|NCT02672852|521325489|FG000|Part B|Withdrawal by Subject|0|||
144580922|NCT02672852|521325490|FG001|Part B|Withdrawal by Subject|0|||
144580923|NCT02672852|521325491|FG002|Part B|Withdrawal by Subject|0|||
144580924|NCT02672852|521325492|FG003|Part B|Withdrawal by Subject|0|||
144580925|NCT02672852|521325493|FG004|Part B|Withdrawal by Subject|5|||
144580926|NCT02672852|521325494|FG005|Part B|Withdrawal by Subject|0|||
144580927|NCT02672852|521325495|FG006|Part B|Withdrawal by Subject|7|||
144209187|NCT04893018|519960097|FG000|Overall Study|Lost to Follow-up|1|||
144209188|NCT04893018|519960098|FG001|Overall Study|Lost to Follow-up|0|||
144209189|NCT04893018|519960097|FG000|Overall Study|Withdrawal by Subject|2|||
144209190|NCT04893018|519960098|FG001|Overall Study|Withdrawal by Subject|0|||
144209191|NCT04893018|519960097|FG000|Overall Study|Study Terminated|1|||
144209192|NCT04893018|519960098|FG001|Overall Study|Study Terminated|2|||
144209193|NCT01189487|519960107|FG000|Overall Study|Lack of Efficacy|2|||
144209194|NCT01189487|519960107|FG000|Overall Study|Adverse Event|1|||
144209195|NCT04630158|519960108|FG000|Overall Study|Adverse Event|1|||
144209196|NCT04630158|519960109|FG001|Overall Study|Adverse Event|1|||
144209197|NCT04630158|519960110|FG002|Overall Study|Adverse Event|1|||
144209198|NCT04630158|519960108|FG000|Overall Study|Physician Decision|0|||
144209199|NCT04630158|519960109|FG001|Overall Study|Physician Decision|2|||
144209200|NCT04630158|519960110|FG002|Overall Study|Physician Decision|0|||
144209201|NCT04630158|519960108|FG000|Overall Study|Protocol Violation|1|||
144209202|NCT04630158|519960109|FG001|Overall Study|Protocol Violation|0|||
144209203|NCT04630158|519960110|FG002|Overall Study|Protocol Violation|1|||
144209204|NCT04630158|519960108|FG000|Overall Study|Withdrawal by Subject|2|||
144209205|NCT04630158|519960109|FG001|Overall Study|Withdrawal by Subject|1|||
144209206|NCT04630158|519960110|FG002|Overall Study|Withdrawal by Subject|2|||
144209207|NCT03136965|519960113|FG000|Overall Study|Lost to Follow-up|0|||
144209208|NCT03136965|519960114|FG001|Overall Study|Lost to Follow-up|1|||
144209209|NCT03136965|519960115|FG002|Overall Study|Lost to Follow-up|0|||
144209210|NCT05293639|519960117|FG000|Overall Study|Withdrawal by Subject|1|||
144209211|NCT05293639|519960118|FG001|Overall Study|Withdrawal by Subject|1|||
144209212|NCT05293639|519960119|FG002|Overall Study|Withdrawal by Subject|2|||
144209213|NCT05293639|519960117|FG000|Overall Study|Death|0|||
144209214|NCT05293639|519960118|FG001|Overall Study|Death|1|||
144209215|NCT05293639|519960119|FG002|Overall Study|Death|0|||
144209216|NCT05293639|519960117|FG000|Overall Study|Lost to Follow-up|0|||
144209217|NCT05293639|519960118|FG001|Overall Study|Lost to Follow-up|0|||
144209218|NCT05293639|519960119|FG002|Overall Study|Lost to Follow-up|5|||
144209219|NCT05293639|519960117|FG000|Overall Study|Other|0|||
144209220|NCT05293639|519960118|FG001|Overall Study|Other|0|||
144209221|NCT05293639|519960119|FG002|Overall Study|Other|1|||
144209222|NCT01144715|519960125|FG000|Overall Study|Lost to Follow-up|2|||
144209223|NCT01144715|519960126|FG001|Overall Study|Lost to Follow-up|1|||
144209224|NCT01144715|519960125|FG000|Overall Study|Withdrawal by Subject|2|||
144209225|NCT01144715|519960126|FG001|Overall Study|Withdrawal by Subject|1|||
144209226|NCT01144715|519960125|FG000|Overall Study|Adverse Event|0|||
144209227|NCT01144715|519960126|FG001|Overall Study|Adverse Event|1|||
144209228|NCT00351533|519960127|FG000|Overall Study|Extubated before first BAL|1|||
144209229|NCT00351533|519960128|FG001|Overall Study|Extubated before first BAL|0|||
144209230|NCT00351533|519960127|FG000|Overall Study|Lost to Follow-up|1|||
144209231|NCT00351533|519960128|FG001|Overall Study|Lost to Follow-up|3|||
144209232|NCT00351533|519960127|FG000|Overall Study|Physician Decision|0|||
144209233|NCT00351533|519960128|FG001|Overall Study|Physician Decision|1|||
144209234|NCT00351533|519960127|FG000|Overall Study|Withdrawal by Subject|0|||
144209235|NCT00351533|519960128|FG001|Overall Study|Withdrawal by Subject|1|||
144209236|NCT00197496|519960135|FG000|Baseline to Discharge|not interested|1|||
144209237|NCT00197496|519960136|FG001|Baseline to Discharge|not interested|0|||
144209238|NCT00197496|519960135|FG000|Baseline to Discharge|MRSA|1|||
144209239|NCT00197496|519960136|FG001|Baseline to Discharge|MRSA|0|||
144209240|NCT00197496|519960135|FG000|Baseline to Discharge|Physician Decision|0|||
144209241|NCT00197496|519960136|FG001|Baseline to Discharge|Physician Decision|1|||
144209242|NCT00197496|519960135|FG000|Baseline to Discharge|Protocol Violation|0|||
144209243|NCT00197496|519960136|FG001|Baseline to Discharge|Protocol Violation|1|||
144209244|NCT00197496|519960135|FG000|Follow-up|Lost to Follow-up|2|||
144209245|NCT00197496|519960136|FG001|Follow-up|Lost to Follow-up|1|||
144209246|NCT00857584|519960139|FG000|Overall Study|Lack of Efficacy|1|||
144209247|NCT00857584|519960140|FG001|Overall Study|Lack of Efficacy|2|||
144209248|NCT00857584|519960139|FG000|Overall Study|Adverse Event|2|||
144209249|NCT00857584|519960140|FG001|Overall Study|Adverse Event|2|||
144209250|NCT00857584|519960139|FG000|Overall Study|Physician Decision|1|||
144209251|NCT00857584|519960140|FG001|Overall Study|Physician Decision|1|||
144209252|NCT02056392|519960142|FG000|Overall Study|Lost to Follow-up|0|||
144209253|NCT02056392|519960143|FG001|Overall Study|Lost to Follow-up|1|||
144209254|NCT02056392|519960144|FG002|Overall Study|Lost to Follow-up|2|||
144209255|NCT02056392|519960145|FG003|Overall Study|Lost to Follow-up|0|||
144209256|NCT02056392|519960146|FG004|Overall Study|Lost to Follow-up|0|||
144209257|NCT02056392|519960147|FG005|Overall Study|Lost to Follow-up|0|||
144209258|NCT02056392|519960142|FG000|Overall Study|Protocol Violation|1|||
144209259|NCT02056392|519960143|FG001|Overall Study|Protocol Violation|0|||
144209260|NCT02056392|519960144|FG002|Overall Study|Protocol Violation|1|||
144580928|NCT02672852|521325489|FG000|Part B|Other|0|||
144580929|NCT02672852|521325490|FG001|Part B|Other|0|||
144580930|NCT02672852|521325491|FG002|Part B|Other|0|||
144209261|NCT02056392|519960145|FG003|Overall Study|Protocol Violation|0|||
144209262|NCT02056392|519960146|FG004|Overall Study|Protocol Violation|0|||
144209263|NCT02056392|519960147|FG005|Overall Study|Protocol Violation|0|||
144209264|NCT02056392|519960142|FG000|Overall Study|Withdrawal by Subject|1|||
144209265|NCT02056392|519960143|FG001|Overall Study|Withdrawal by Subject|0|||
144209266|NCT02056392|519960144|FG002|Overall Study|Withdrawal by Subject|0|||
144209267|NCT02056392|519960145|FG003|Overall Study|Withdrawal by Subject|0|||
144209268|NCT02056392|519960146|FG004|Overall Study|Withdrawal by Subject|1|||
144209269|NCT02056392|519960147|FG005|Overall Study|Withdrawal by Subject|0|||
144209270|NCT02952898|519960154|FG000|Overall Study|Withdrawal by Subject|10|||
144209271|NCT02952898|519960155|FG001|Overall Study|Withdrawal by Subject|8|||
144209272|NCT02952898|519960156|FG002|Overall Study|Withdrawal by Subject|8|||
144209273|NCT02952898|519960154|FG000|Overall Study|Adverse Event|8|||
144209274|NCT02952898|519960155|FG001|Overall Study|Adverse Event|8|||
144209275|NCT02952898|519960156|FG002|Overall Study|Adverse Event|3|||
144209276|NCT02952898|519960154|FG000|Overall Study|Lost to Follow-up|3|||
144209277|NCT02952898|519960155|FG001|Overall Study|Lost to Follow-up|2|||
144209278|NCT02952898|519960156|FG002|Overall Study|Lost to Follow-up|2|||
144209279|NCT02952898|519960154|FG000|Overall Study|Non-compliance with study drug|1|||
144209280|NCT02952898|519960155|FG001|Overall Study|Non-compliance with study drug|1|||
144209281|NCT02952898|519960156|FG002|Overall Study|Non-compliance with study drug|2|||
144209282|NCT02203331|519960160|FG000|Overall Study|Pregnancy|1|||
144209283|NCT02203331|519960161|FG001|Overall Study|Pregnancy|0|||
144209284|NCT02203331|519960162|FG002|Overall Study|Pregnancy|0|||
144209285|NCT02203331|519960163|FG003|Overall Study|Pregnancy|0|||
144209286|NCT02203331|519960164|FG004|Overall Study|Pregnancy|2|||
144209287|NCT02203331|519960165|FG005|Overall Study|Pregnancy|0|||
144209288|NCT02203331|519960160|FG000|Overall Study|Withdrawal by Subject|1|||
144209289|NCT02203331|519960161|FG001|Overall Study|Withdrawal by Subject|0|||
144209290|NCT02203331|519960162|FG002|Overall Study|Withdrawal by Subject|1|||
144209291|NCT02203331|519960163|FG003|Overall Study|Withdrawal by Subject|0|||
144209292|NCT02203331|519960164|FG004|Overall Study|Withdrawal by Subject|0|||
144209293|NCT02203331|519960165|FG005|Overall Study|Withdrawal by Subject|3|||
144209294|NCT02203331|519960160|FG000|Overall Study|Adverse Event|4|||
144209295|NCT02203331|519960161|FG001|Overall Study|Adverse Event|8|||
144209296|NCT02203331|519960162|FG002|Overall Study|Adverse Event|3|||
144209297|NCT02203331|519960163|FG003|Overall Study|Adverse Event|4|||
144209298|NCT02203331|519960164|FG004|Overall Study|Adverse Event|3|||
144209299|NCT02203331|519960165|FG005|Overall Study|Adverse Event|3|||
144209300|NCT02203331|519960160|FG000|Overall Study|Other Reasons|1|||
144209301|NCT02203331|519960161|FG001|Overall Study|Other Reasons|2|||
144209302|NCT02203331|519960162|FG002|Overall Study|Other Reasons|0|||
144209303|NCT02203331|519960163|FG003|Overall Study|Other Reasons|2|||
144209304|NCT02203331|519960164|FG004|Overall Study|Other Reasons|0|||
144209305|NCT02203331|519960165|FG005|Overall Study|Other Reasons|0|||
144209306|NCT02203331|519960160|FG000|Overall Study|Lack of Efficacy|0|||
144209307|NCT02203331|519960161|FG001|Overall Study|Lack of Efficacy|2|||
144209308|NCT02203331|519960162|FG002|Overall Study|Lack of Efficacy|1|||
144209309|NCT02203331|519960163|FG003|Overall Study|Lack of Efficacy|0|||
144209310|NCT02203331|519960164|FG004|Overall Study|Lack of Efficacy|0|||
144209311|NCT02203331|519960165|FG005|Overall Study|Lack of Efficacy|1|||
144209312|NCT02203331|519960160|FG000|Overall Study|Protocol Violation|0|||
144209313|NCT02203331|519960161|FG001|Overall Study|Protocol Violation|2|||
144209314|NCT02203331|519960162|FG002|Overall Study|Protocol Violation|0|||
144209315|NCT02203331|519960163|FG003|Overall Study|Protocol Violation|1|||
144209316|NCT02203331|519960164|FG004|Overall Study|Protocol Violation|1|||
144209317|NCT02203331|519960165|FG005|Overall Study|Protocol Violation|0|||
144209318|NCT02203331|519960160|FG000|Overall Study|Lost to Follow-up|0|||
144209319|NCT02203331|519960161|FG001|Overall Study|Lost to Follow-up|0|||
144209320|NCT02203331|519960162|FG002|Overall Study|Lost to Follow-up|0|||
144580931|NCT02672852|521325492|FG003|Part B|Other|0|||
144580932|NCT02672852|521325493|FG004|Part B|Other|4|||
144580933|NCT02672852|521325494|FG005|Part B|Other|1|||
144580934|NCT02672852|521325495|FG006|Part B|Other|2|||
144730369|NCT03002077|521868211|FG000|Overall Study|Site Terminated by Sponsor|5|||
144209321|NCT02203331|519960163|FG003|Overall Study|Lost to Follow-up|0|||
144209322|NCT02203331|519960164|FG004|Overall Study|Lost to Follow-up|1|||
144209323|NCT02203331|519960165|FG005|Overall Study|Lost to Follow-up|0|||
144209324|NCT03462459|519960166|FG000|Overall Study|Death|1|||
144209325|NCT03462459|519960167|FG001|Overall Study|Death|0|||
144209326|NCT03462459|519960166|FG000|Overall Study|Lack of Efficacy|2|||
144209327|NCT03462459|519960167|FG001|Overall Study|Lack of Efficacy|4|||
144209328|NCT03462459|519960166|FG000|Overall Study|Lost to Follow-up|1|||
144209329|NCT03462459|519960167|FG001|Overall Study|Lost to Follow-up|3|||
144209330|NCT03462459|519960166|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
144209331|NCT03462459|519960167|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
144209332|NCT03462459|519960166|FG000|Overall Study|Withdrawal by Subject|3|||
144580935|NCT03248882|521325496|FG000|Overall Study|Adverse Event|3|||
144580936|NCT03248882|521325497|FG001|Overall Study|Adverse Event|3|||
144580937|NCT03248882|521325498|FG002|Overall Study|Adverse Event|2|||
144209333|NCT03462459|519960167|FG001|Overall Study|Withdrawal by Subject|2|||
144209334|NCT03462459|519960166|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
144209335|NCT03462459|519960167|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
144209336|NCT01177059|519960169|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
144209337|NCT01177059|519960169|FG000|Overall Study|Withdrew consent|2|||
144209338|NCT01177059|519960169|FG000|Overall Study|Lost to Follow-up|18|||
144209339|NCT01200069|519961847|FG000|Overall Study|Withdrawal by Subject|0|||
144209340|NCT01200069|519961848|FG001|Overall Study|Withdrawal by Subject|1|||
144209341|NCT03408639|519961849|FG000|Overall Study|Death|5|||
144209342|NCT03408639|519961850|FG001|Overall Study|Death|5|||
144209343|NCT03408639|519961849|FG000|Overall Study|Lost to Follow-up|1|||
144209344|NCT03408639|519961850|FG001|Overall Study|Lost to Follow-up|4|||
144209345|NCT03408639|519961849|FG000|Overall Study|Withdrawal by Subject|2|||
144209346|NCT03408639|519961850|FG001|Overall Study|Withdrawal by Subject|7|||
144209347|NCT03408639|519961849|FG000|Overall Study|Physician Decision|3|||
144209348|NCT03408639|519961850|FG001|Overall Study|Physician Decision|6|||
144209349|NCT00070499|519961851|FG000|Overall Study|Adverse Event|6|||
144209350|NCT00070499|519961852|FG001|Overall Study|Adverse Event|6|||
144209351|NCT00070499|519961853|FG002|Overall Study|Adverse Event|19|||
144209352|NCT00070499|519961854|FG003|Overall Study|Adverse Event|15|||
144209353|NCT00070499|519961851|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
144209354|NCT00070499|519961852|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
144580938|NCT03248882|521325499|FG003|Overall Study|Adverse Event|6|||
144580939|NCT03248882|521325500|FG004|Overall Study|Adverse Event|9|||
144580940|NCT03248882|521325496|FG000|Overall Study|Lost to Follow-up|0|||
144580941|NCT03248882|521325497|FG001|Overall Study|Lost to Follow-up|0|||
144580942|NCT03248882|521325498|FG002|Overall Study|Lost to Follow-up|0|||
144580943|NCT03248882|521325499|FG003|Overall Study|Lost to Follow-up|0|||
144580944|NCT03248882|521325500|FG004|Overall Study|Lost to Follow-up|1|||
144580945|NCT03248882|521325496|FG000|Overall Study|Protocol Violation|2|||
144580946|NCT03248882|521325497|FG001|Overall Study|Protocol Violation|0|||
144580947|NCT03248882|521325498|FG002|Overall Study|Protocol Violation|2|||
144580948|NCT03248882|521325499|FG003|Overall Study|Protocol Violation|0|||
144580949|NCT03248882|521325500|FG004|Overall Study|Protocol Violation|1|||
144580950|NCT03248882|521325496|FG000|Overall Study|Withdrawal by Subject|2|||
144580951|NCT03248882|521325497|FG001|Overall Study|Withdrawal by Subject|2|||
144580952|NCT03248882|521325498|FG002|Overall Study|Withdrawal by Subject|3|||
144580953|NCT03248882|521325499|FG003|Overall Study|Withdrawal by Subject|4|||
144580954|NCT03248882|521325500|FG004|Overall Study|Withdrawal by Subject|2|||
144580955|NCT04308590|521325501|FG000|Overall Study|Adverse Event|12|||
144580956|NCT04308590|521325502|FG001|Overall Study|Adverse Event|2|||
144580957|NCT04308590|521325501|FG000|Overall Study|Withdrawal by Subject|10|||
144580958|NCT04308590|521325502|FG001|Overall Study|Withdrawal by Subject|4|||
144580959|NCT04308590|521325501|FG000|Overall Study|Death|1|||
144580960|NCT04308590|521325502|FG001|Overall Study|Death|0|||
144580961|NCT04308590|521325501|FG000|Overall Study|Lost to Follow-up|1|||
144580962|NCT04308590|521325502|FG001|Overall Study|Lost to Follow-up|1|||
144580963|NCT04308590|521325501|FG000|Overall Study|Physician Decision|1|||
144580964|NCT04308590|521325502|FG001|Overall Study|Physician Decision|0|||
144580965|NCT04308590|521325501|FG000|Overall Study|Subject does not want to continue with Pi|0|||
144580966|NCT04308590|521325502|FG001|Overall Study|Subject does not want to continue with Pi|1|||
144580967|NCT00356408|521325503|FG000|Overall Study|Adverse Event|9|||
144580968|NCT00356408|521325503|FG000|Overall Study|Lack of Efficacy|36|||
144580969|NCT00356408|521325503|FG000|Overall Study|Lost to Follow-up|2|||
144580970|NCT00356408|521325503|FG000|Overall Study|Withdrawal by Subject|6|||
144580971|NCT00356408|521325503|FG000|Overall Study|Other: Principal investigator discretion|3|||
144580972|NCT00356408|521325503|FG000|Overall Study|Other: Sponsor request|1|||
144580973|NCT00356408|521325503|FG000|Overall Study|Other: Azathioprine stopped|1|||
144580974|NCT00356408|521325503|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
144580975|NCT00356408|521325503|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
144580976|NCT01156376|521325505|FG000|Overall Study|Adverse Event|1|||
144580977|NCT01156376|521325506|FG001|Overall Study|Adverse Event|0|||
144580978|NCT01156376|521325507|FG002|Overall Study|Adverse Event|1|||
144580979|NCT01156376|521325505|FG000|Overall Study|Withdrawal by Subject|0|||
144580980|NCT01156376|521325506|FG001|Overall Study|Withdrawal by Subject|0|||
144580981|NCT01156376|521325507|FG002|Overall Study|Withdrawal by Subject|3|||
144580982|NCT00565773|521325508|FG000|Overall Study|Withdrawal by Subject|1|||
144580983|NCT00565773|521325508|FG000|Overall Study|Physician Decision|1|||
144209355|NCT00070499|519961853|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
144209356|NCT00070499|519961854|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
144580984|NCT05775991|521325509|FG000|Overall Study|Withdrawal by Subject|0|||
144580985|NCT05775991|521325510|FG001|Overall Study|Withdrawal by Subject|0|||
144580986|NCT05775991|521325511|FG002|Overall Study|Withdrawal by Subject|2|||
144209357|NCT00070499|519961851|FG000|Overall Study|Progression/relapse|4|||
144580987|NCT00702962|521325512|FG000|Overall Study|Progressive disease|0|||
144209358|NCT00070499|519961852|FG001|Overall Study|Progression/relapse|2|||
144209359|NCT00070499|519961853|FG002|Overall Study|Progression/relapse|1|||
144580988|NCT00702962|521325513|FG001|Overall Study|Progressive disease|1|||
144580989|NCT00702962|521325512|FG000|Overall Study|Hospitalized for other health disorder|1|||
144580990|NCT00702962|521325513|FG001|Overall Study|Hospitalized for other health disorder|0|||
144580991|NCT02175641|521325515|FG000|Overall Study|Death|3|||
144580992|NCT02175641|521325516|FG001|Overall Study|Death|4|||
144580993|NCT02175641|521325515|FG000|Overall Study|Lost to Follow-up|4|||
144580994|NCT02175641|521325516|FG001|Overall Study|Lost to Follow-up|4|||
144580995|NCT02175641|521325515|FG000|Overall Study|Withdrawal by Subject|7|||
144580996|NCT02175641|521325516|FG001|Overall Study|Withdrawal by Subject|4|||
144580997|NCT02175641|521325515|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
144580998|NCT02175641|521325516|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
144580999|NCT02175641|521325515|FG000|Overall Study|Developed Contraindicated Condition|8|||
144581000|NCT02175641|521325516|FG001|Overall Study|Developed Contraindicated Condition|0|||
144581001|NCT01923467|521325519|FG000|Overall Study|Lost to Follow-up|62|||
144581002|NCT01923467|521325519|FG000|Overall Study|Subject non-interest|479|||
144581003|NCT01075958|521325520|FG000|Overall Study|Blood sample could not be obtained|44|||
144581004|NCT01240915|521325521|FG000|Overall Study|Adverse Event|0|||
144581005|NCT01240915|521325522|FG001|Overall Study|Adverse Event|0|||
144581006|NCT01240915|521325523|FG002|Overall Study|Adverse Event|0|||
144581007|NCT01240915|521325524|FG003|Overall Study|Adverse Event|1|||
144581008|NCT01240915|521325525|FG004|Overall Study|Adverse Event|0|||
144581009|NCT01240915|521325526|FG005|Overall Study|Adverse Event|2|||
144581010|NCT01240915|521325527|FG006|Overall Study|Adverse Event|0|||
144581011|NCT01240915|521325528|FG007|Overall Study|Adverse Event|0|||
144581012|NCT01240915|521325529|FG008|Overall Study|Adverse Event|1|||
144581013|NCT01240915|521325521|FG000|Overall Study|Lost to Follow-up|0|||
144581014|NCT01240915|521325522|FG001|Overall Study|Lost to Follow-up|0|||
144581015|NCT01240915|521325523|FG002|Overall Study|Lost to Follow-up|0|||
144581016|NCT01240915|521325524|FG003|Overall Study|Lost to Follow-up|0|||
144581017|NCT01240915|521325525|FG004|Overall Study|Lost to Follow-up|1|||
144581018|NCT01240915|521325526|FG005|Overall Study|Lost to Follow-up|1|||
144581019|NCT01240915|521325527|FG006|Overall Study|Lost to Follow-up|0|||
144581020|NCT01240915|521325528|FG007|Overall Study|Lost to Follow-up|1|||
144581021|NCT01240915|521325529|FG008|Overall Study|Lost to Follow-up|1|||
144581022|NCT01240915|521325521|FG000|Overall Study|Withdrawal by Subject|2|||
144581023|NCT01240915|521325522|FG001|Overall Study|Withdrawal by Subject|1|||
144581024|NCT01240915|521325523|FG002|Overall Study|Withdrawal by Subject|0|||
144581025|NCT01240915|521325524|FG003|Overall Study|Withdrawal by Subject|2|||
144581026|NCT01240915|521325525|FG004|Overall Study|Withdrawal by Subject|0|||
144581027|NCT01240915|521325526|FG005|Overall Study|Withdrawal by Subject|4|||
144581028|NCT01240915|521325527|FG006|Overall Study|Withdrawal by Subject|2|||
144581029|NCT01240915|521325528|FG007|Overall Study|Withdrawal by Subject|3|||
144581030|NCT01240915|521325529|FG008|Overall Study|Withdrawal by Subject|3|||
144581031|NCT01240915|521325521|FG000|Overall Study|Other|0|||
144581032|NCT01240915|521325522|FG001|Overall Study|Other|0|||
144581033|NCT01240915|521325523|FG002|Overall Study|Other|0|||
144581034|NCT01240915|521325524|FG003|Overall Study|Other|0|||
144581035|NCT01240915|521325525|FG004|Overall Study|Other|2|||
144581036|NCT01240915|521325526|FG005|Overall Study|Other|0|||
144581037|NCT01240915|521325527|FG006|Overall Study|Other|0|||
144581038|NCT01240915|521325528|FG007|Overall Study|Other|0|||
144581039|NCT01240915|521325529|FG008|Overall Study|Other|0|||
144581040|NCT01240915|521325521|FG000|Overall Study|Insufficient Clinical Response|0|||
144581041|NCT01240915|521325522|FG001|Overall Study|Insufficient Clinical Response|0|||
144581042|NCT01240915|521325523|FG002|Overall Study|Insufficient Clinical Response|0|||
144581043|NCT01240915|521325524|FG003|Overall Study|Insufficient Clinical Response|0|||
144581044|NCT01240915|521325525|FG004|Overall Study|Insufficient Clinical Response|1|||
144581045|NCT01240915|521325526|FG005|Overall Study|Insufficient Clinical Response|3|||
144581046|NCT01240915|521325527|FG006|Overall Study|Insufficient Clinical Response|6|||
144581047|NCT01240915|521325528|FG007|Overall Study|Insufficient Clinical Response|0|||
144581048|NCT01240915|521325529|FG008|Overall Study|Insufficient Clinical Response|3|||
144581049|NCT01598662|521325531|FG000|Overall Study|Lost to Follow-up|10|||
144581050|NCT01598662|521325532|FG001|Overall Study|Lost to Follow-up|17|||
144581051|NCT01598662|521325531|FG000|Overall Study|Physician Decision|1|||
144581052|NCT01598662|521325532|FG001|Overall Study|Physician Decision|2|||
144581053|NCT01598662|521325531|FG000|Overall Study|IUD expelled before month 6|0|||
144581054|NCT01598662|521325532|FG001|Overall Study|IUD expelled before month 6|2|||
144581055|NCT00643617|521325533|FG000|Overall Study|Death|6|||
144581056|NCT00643617|521325534|FG001|Overall Study|Death|9|||
144581057|NCT00643617|521325533|FG000|Overall Study|Lost to Follow-up|42|||
144581058|NCT00643617|521325534|FG001|Overall Study|Lost to Follow-up|51|||
144581059|NCT02075073|521325535|FG000|Overall Study|Withdrawal by Subject|0|||
144581060|NCT02075073|521325536|FG001|Overall Study|Withdrawal by Subject|1|||
144581061|NCT02075073|521325537|FG002|Overall Study|Withdrawal by Subject|0|||
144581062|NCT00416195|521325553|FG000|Overall Study|Adverse Event|1|||
144581063|NCT00416195|521325554|FG001|Overall Study|Adverse Event|2|||
144581064|NCT00416195|521325553|FG000|Overall Study|Protocol Violation|1|||
144581065|NCT00416195|521325554|FG001|Overall Study|Protocol Violation|1|||
144581066|NCT00416195|521325553|FG000|Overall Study|Other|0|||
144581067|NCT00416195|521325554|FG001|Overall Study|Other|1|||
144581068|NCT03361605|521325559|FG000|Overall Study|Analyzable data not available|3|||
144581069|NCT00831129|521325562|FG000|Overall Study|Adverse Event|0|||
144581070|NCT00831129|521325563|FG001|Overall Study|Adverse Event|1|||
144581071|NCT00831129|521325562|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
144581072|NCT00831129|521325563|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
144581073|NCT01877239|521325565|FG000|Overall Study|Adverse Event|4|||
144581074|NCT01877239|521325565|FG000|Overall Study|Disease Remission|1|||
144581075|NCT01877239|521325565|FG000|Overall Study|Withdrawal by Subject|4|||
144581076|NCT01877239|521325565|FG000|Overall Study|Other|2|||
144581077|NCT01877239|521325565|FG000|Overall Study|Lack of Efficacy|4|||
144581078|NCT01877239|521325565|FG000|Overall Study|Data not available|35|||
144581079|NCT04531904|521325568|FG000|Overall Study|Lost to Follow-up|1|||
144581080|NCT04531904|521325568|FG000|Overall Study|Death|14|||
144581081|NCT04372121|521325569|FG000|Overall Study|Lost to Follow-up|0|||
144581082|NCT04372121|521325570|FG001|Overall Study|Lost to Follow-up|0|||
144581083|NCT04372121|521325571|FG002|Overall Study|Lost to Follow-up|0|||
144581084|NCT04372121|521325572|FG003|Overall Study|Lost to Follow-up|1|||
144581085|NCT04372121|521325569|FG000|Overall Study|Protocol Violation|0|||
144581086|NCT04372121|521325570|FG001|Overall Study|Protocol Violation|0|||
144581087|NCT04372121|521325571|FG002|Overall Study|Protocol Violation|1|||
144581088|NCT04372121|521325572|FG003|Overall Study|Protocol Violation|0|||
144581089|NCT04372121|521325569|FG000|Overall Study|Withdrawal by Subject|3|||
144581090|NCT04372121|521325570|FG001|Overall Study|Withdrawal by Subject|1|||
144581091|NCT04372121|521325571|FG002|Overall Study|Withdrawal by Subject|0|||
144581092|NCT04372121|521325572|FG003|Overall Study|Withdrawal by Subject|0|||
144581093|NCT04372121|521325569|FG000|Overall Study|Study termination|6|||
144581094|NCT04372121|521325570|FG001|Overall Study|Study termination|5|||
144581095|NCT04372121|521325571|FG002|Overall Study|Study termination|1|||
144581096|NCT04372121|521325572|FG003|Overall Study|Study termination|1|||
144581097|NCT04372121|521325569|FG000|Overall Study|Hysterectomy planned|1|||
144581098|NCT04372121|521325570|FG001|Overall Study|Hysterectomy planned|0|||
144581099|NCT04372121|521325571|FG002|Overall Study|Hysterectomy planned|0|||
144581100|NCT04372121|521325572|FG003|Overall Study|Hysterectomy planned|0|||
144581101|NCT01967147|521327116|FG000|Overall Study|Adverse Event|5|||
144581102|NCT01967147|521327117|FG001|Overall Study|Adverse Event|2|||
144581103|NCT01967147|521327116|FG000|Overall Study|Lack of Efficacy|1|||
144581104|NCT01967147|521327117|FG001|Overall Study|Lack of Efficacy|4|||
144581105|NCT01967147|521327116|FG000|Overall Study|Lost to Follow-up|1|||
144581106|NCT01967147|521327117|FG001|Overall Study|Lost to Follow-up|2|||
144581107|NCT01967147|521327116|FG000|Overall Study|Withdrawal by Subject|2|||
144581108|NCT01967147|521327117|FG001|Overall Study|Withdrawal by Subject|4|||
144581109|NCT01967147|521327116|FG000|Overall Study|Non-compliance with Study Drug|0|||
144581110|NCT01967147|521327117|FG001|Overall Study|Non-compliance with Study Drug|3|||
144581111|NCT01967147|521327116|FG000|Overall Study|Other|4|||
144581112|NCT01967147|521327117|FG001|Overall Study|Other|5|||
144581113|NCT03986944|521327120|FG000|Overall Study|Adverse Event|1|||
144581114|NCT03986944|521327121|FG001|Overall Study|Adverse Event|2|||
144581115|NCT03986944|521327122|FG002|Overall Study|Adverse Event|3|||
144581116|NCT03986944|521327120|FG000|Overall Study|Protocol Violation|0|||
144581117|NCT03986944|521327121|FG001|Overall Study|Protocol Violation|1|||
144581118|NCT03986944|521327122|FG002|Overall Study|Protocol Violation|1|||
144581119|NCT03986944|521327120|FG000|Overall Study|Withdrawal by Subject|3|||
144581120|NCT03986944|521327121|FG001|Overall Study|Withdrawal by Subject|5|||
144581121|NCT03986944|521327122|FG002|Overall Study|Withdrawal by Subject|5|||
144581122|NCT03986944|521327120|FG000|Overall Study|Study termination|10|||
144581123|NCT03986944|521327121|FG001|Overall Study|Study termination|10|||
144581124|NCT03986944|521327122|FG002|Overall Study|Study termination|10|||
144581125|NCT03986944|521327120|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
144581126|NCT03986944|521327121|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
144581127|NCT03986944|521327122|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
144581128|NCT03986944|521327120|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
144581129|NCT03986944|521327121|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
144581130|NCT03986944|521327122|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
144581131|NCT01302080|521327128|FG000|Overall Study|Withdrew Consent|92|||
144581132|NCT01302080|521327129|FG001|Overall Study|Withdrew Consent|39|||
144581133|NCT01302080|521327128|FG000|Overall Study|Patient/Family Moved|28|||
144581134|NCT01302080|521327129|FG001|Overall Study|Patient/Family Moved|3|||
144581135|NCT01302080|521327128|FG000|Overall Study|Lost to Follow-up|192|||
144581136|NCT01302080|521327129|FG001|Overall Study|Lost to Follow-up|93|||
144581137|NCT01302080|521327128|FG000|Overall Study|Death|1|||
144581138|NCT01302080|521327129|FG001|Overall Study|Death|0|||
144581139|NCT01302080|521327128|FG000|Overall Study|Other|52|||
144581140|NCT01302080|521327129|FG001|Overall Study|Other|8|||
144581141|NCT01302080|521327128|FG000|Overall Study|Reason Missing For Discontinuation|1|||
144581142|NCT01302080|521327129|FG001|Overall Study|Reason Missing For Discontinuation|0|||
144581143|NCT01305408|521327133|FG000|Overall Study|Adverse Event|10|||
144581144|NCT01305408|521327134|FG001|Overall Study|Adverse Event|7|||
144581145|NCT01305408|521327133|FG000|Overall Study|Lack of Efficacy|3|||
144581146|NCT01305408|521327134|FG001|Overall Study|Lack of Efficacy|4|||
144581147|NCT01305408|521327133|FG000|Overall Study|Withdrawal by Subject|9|||
144581148|NCT01305408|521327134|FG001|Overall Study|Withdrawal by Subject|9|||
144581149|NCT01305408|521327133|FG000|Overall Study|Protocol Violation|4|||
144581150|NCT01305408|521327134|FG001|Overall Study|Protocol Violation|6|||
144581151|NCT01305408|521327133|FG000|Overall Study|Lost to Follow-up|5|||
144581152|NCT01305408|521327134|FG001|Overall Study|Lost to Follow-up|3|||
144581153|NCT01305408|521327133|FG000|Overall Study|Noncompliance with study medication|0|||
144581154|NCT01305408|521327134|FG001|Overall Study|Noncompliance with study medication|1|||
144581155|NCT01305408|521327133|FG000|Overall Study|Noncompliance with study procedures|0|||
144581156|NCT01305408|521327134|FG001|Overall Study|Noncompliance with study procedures|1|||
144581157|NCT01305408|521327133|FG000|Overall Study|Other|1|||
144581158|NCT01305408|521327134|FG001|Overall Study|Other|0|||
144581159|NCT02530970|521327135|FG000|Overall Study|Adverse Event|8|||
144581160|NCT02530970|521327135|FG000|Overall Study|Lost to Follow-up|88|||
144581161|NCT02530970|521327135|FG000|Overall Study|Physician Decision|5|||
144581162|NCT02530970|521327135|FG000|Overall Study|Withdrawal by Subject|14|||
144581163|NCT02530970|521327135|FG000|Overall Study|Death|6|||
144581164|NCT02530970|521327135|FG000|Overall Study|Hospitalization|1|||
144581165|NCT02530970|521327135|FG000|Overall Study|Insurance|2|||
144581166|NCT02530970|521327135|FG000|Overall Study|Explant|2|||
144581167|NCT02530970|521327135|FG000|Overall Study|Change in Provider|5|||
144581168|NCT02530970|521327135|FG000|Overall Study|Relocation|3|||
144581169|NCT02770612|521327138|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
144581170|NCT01283516|521327141|FG000|Overall Study|Adverse Event|0|||
144581171|NCT01283516|521327142|FG001|Overall Study|Adverse Event|0|||
144581172|NCT01283516|521327143|FG002|Overall Study|Adverse Event|0|||
144581173|NCT01283516|521327144|FG003|Overall Study|Adverse Event|0|||
144581174|NCT01283516|521327145|FG004|Overall Study|Adverse Event|0|||
144581175|NCT01283516|521327146|FG005|Overall Study|Adverse Event|0|||
144581176|NCT01283516|521327147|FG006|Overall Study|Adverse Event|2|||
144581177|NCT01283516|521327148|FG007|Overall Study|Adverse Event|0|||
144622926|NCT02799069|521476365|FG001|Overall Study|Lost to Follow-up|1|||
144622927|NCT02799069|521476366|FG002|Overall Study|Lost to Follow-up|0|||
144622928|NCT02799069|521476364|FG000|Overall Study|Withdrawal by Subject|4|||
144622929|NCT02799069|521476365|FG001|Overall Study|Withdrawal by Subject|4|||
144622930|NCT02799069|521476366|FG002|Overall Study|Withdrawal by Subject|3|||
144622931|NCT02799069|521476364|FG000|Overall Study|Protocol Violation|1|||
144622932|NCT02799069|521476365|FG001|Overall Study|Protocol Violation|0|||
144622933|NCT02799069|521476366|FG002|Overall Study|Protocol Violation|2|||
144581178|NCT01283516|521327149|FG008|Overall Study|Adverse Event|28|||
144581179|NCT01283516|521327141|FG000|Overall Study|Death|0|||
144581180|NCT01283516|521327142|FG001|Overall Study|Death|0|||
144581181|NCT01283516|521327143|FG002|Overall Study|Death|0|||
144581182|NCT01283516|521327144|FG003|Overall Study|Death|0|||
144581183|NCT01283516|521327145|FG004|Overall Study|Death|0|||
144622934|NCT02925156|521476370|FG000|Overall Study|Lost to Follow-up|27|||
144622935|NCT02925156|521476371|FG001|Overall Study|Lost to Follow-up|53|||
144622936|NCT02925156|521476372|FG002|Overall Study|Lost to Follow-up|51|||
144622937|NCT02925156|521476373|FG003|Overall Study|Lost to Follow-up|59|||
144622938|NCT02925156|521476374|FG004|Overall Study|Lost to Follow-up|89|||
144622939|NCT02925156|521476375|FG005|Overall Study|Lost to Follow-up|107|||
144622940|NCT02925156|521476376|FG006|Overall Study|Lost to Follow-up|34|||
144622941|NCT02925156|521476377|FG007|Overall Study|Lost to Follow-up|36|||
144622942|NCT02925156|521476378|FG008|Overall Study|Lost to Follow-up|73|||
144622943|NCT02925156|521476379|FG009|Overall Study|Lost to Follow-up|34|||
144622944|NCT00730639|521476380|FG000|Overall Study|Adverse Event|3|||
144622945|NCT00730639|521476381|FG001|Overall Study|Adverse Event|0|||
144622946|NCT00730639|521476382|FG002|Overall Study|Adverse Event|9|||
144730370|NCT03002077|521868211|FG000|Overall Study|Miscellaneous Reasons|10|||
144581184|NCT01283516|521327146|FG005|Overall Study|Death|1|||
144581185|NCT01283516|521327147|FG006|Overall Study|Death|0|||
144581186|NCT01283516|521327148|FG007|Overall Study|Death|1|||
144581187|NCT01283516|521327149|FG008|Overall Study|Death|12|||
144581188|NCT01283516|521327141|FG000|Overall Study|Disease Progression|2|||
144622947|NCT00730639|521476383|FG003|Overall Study|Adverse Event|8|||
144622948|NCT00730639|521476384|FG004|Overall Study|Adverse Event|23|||
144622949|NCT00730639|521476380|FG000|Overall Study|Complete Response|0|||
144622950|NCT00730639|521476381|FG001|Overall Study|Complete Response|0|||
144622951|NCT00730639|521476382|FG002|Overall Study|Complete Response|2|||
144622952|NCT00730639|521476383|FG003|Overall Study|Complete Response|2|||
144622953|NCT00730639|521476384|FG004|Overall Study|Complete Response|1|||
144622954|NCT00730639|521476380|FG000|Overall Study|Completed Maximum Cycles|0|||
144622955|NCT00730639|521476381|FG001|Overall Study|Completed Maximum Cycles|0|||
144622956|NCT00730639|521476382|FG002|Overall Study|Completed Maximum Cycles|11|||
144622957|NCT00730639|521476383|FG003|Overall Study|Completed Maximum Cycles|3|||
144581189|NCT01283516|521327142|FG001|Overall Study|Disease Progression|2|||
144581190|NCT01283516|521327143|FG002|Overall Study|Disease Progression|3|||
144581191|NCT01283516|521327144|FG003|Overall Study|Disease Progression|3|||
144581192|NCT01283516|521327145|FG004|Overall Study|Disease Progression|13|||
144581193|NCT01283516|521327146|FG005|Overall Study|Disease Progression|8|||
144581194|NCT01283516|521327147|FG006|Overall Study|Disease Progression|6|||
144581195|NCT01283516|521327148|FG007|Overall Study|Disease Progression|3|||
144581196|NCT01283516|521327149|FG008|Overall Study|Disease Progression|139|||
144581197|NCT01283516|521327141|FG000|Overall Study|Withdrawal by Subject|0|||
144581198|NCT01283516|521327142|FG001|Overall Study|Withdrawal by Subject|0|||
144581199|NCT01283516|521327143|FG002|Overall Study|Withdrawal by Subject|0|||
144581200|NCT01283516|521327144|FG003|Overall Study|Withdrawal by Subject|0|||
144581201|NCT01283516|521327145|FG004|Overall Study|Withdrawal by Subject|1|||
144581202|NCT01283516|521327146|FG005|Overall Study|Withdrawal by Subject|0|||
144581203|NCT01283516|521327147|FG006|Overall Study|Withdrawal by Subject|1|||
144581204|NCT01283516|521327148|FG007|Overall Study|Withdrawal by Subject|0|||
144581205|NCT01283516|521327149|FG008|Overall Study|Withdrawal by Subject|36|||
144581206|NCT01283516|521327141|FG000|Overall Study|Administrative problems|0|||
144209360|NCT00070499|519961854|FG003|Overall Study|Progression/relapse|4|||
144581207|NCT01283516|521327142|FG001|Overall Study|Administrative problems|0|||
144581208|NCT01283516|521327143|FG002|Overall Study|Administrative problems|0|||
144581209|NCT01283516|521327144|FG003|Overall Study|Administrative problems|0|||
144581210|NCT01283516|521327145|FG004|Overall Study|Administrative problems|0|||
144581211|NCT01283516|521327146|FG005|Overall Study|Administrative problems|1|||
144581212|NCT01283516|521327147|FG006|Overall Study|Administrative problems|1|||
144581213|NCT01283516|521327148|FG007|Overall Study|Administrative problems|1|||
144581214|NCT01283516|521327149|FG008|Overall Study|Administrative problems|39|||
144581215|NCT01283516|521327141|FG000|Overall Study|Lost to Follow-up|0|||
144581216|NCT01283516|521327142|FG001|Overall Study|Lost to Follow-up|0|||
144581217|NCT01283516|521327143|FG002|Overall Study|Lost to Follow-up|0|||
144581218|NCT01283516|521327144|FG003|Overall Study|Lost to Follow-up|0|||
144581219|NCT01283516|521327145|FG004|Overall Study|Lost to Follow-up|0|||
144581220|NCT01283516|521327146|FG005|Overall Study|Lost to Follow-up|0|||
144581221|NCT01283516|521327147|FG006|Overall Study|Lost to Follow-up|0|||
144581222|NCT01283516|521327148|FG007|Overall Study|Lost to Follow-up|0|||
144581223|NCT01283516|521327149|FG008|Overall Study|Lost to Follow-up|1|||
144581224|NCT00132873|521327150|FG000|Overall Study|Adverse Event|3|||
144581225|NCT00132873|521327150|FG000|Overall Study|Lost to Follow-up|1|||
144581226|NCT00132873|521327150|FG000|Overall Study|Lack of Efficacy|1|||
144581227|NCT00132873|521327150|FG000|Overall Study|Withdrawal by Subject|3|||
144581228|NCT00132873|521327150|FG000|Overall Study|Planned Pregnancy|1|||
144581229|NCT01204710|521327154|FG000|Randomization Treatment|Lost to Follow-up|1|||
144581230|NCT01204710|521327155|FG001|Randomization Treatment|Lost to Follow-up|0|||
144581231|NCT01204710|521327154|FG000|Randomization Treatment|Withdrawal by Subject|6|||
144581232|NCT01204710|521327155|FG001|Randomization Treatment|Withdrawal by Subject|5|||
144581233|NCT01204710|521327154|FG000|Randomization Treatment|Physician Decision|3|||
144581234|NCT01204710|521327155|FG001|Randomization Treatment|Physician Decision|2|||
144581235|NCT01204710|521327154|FG000|Randomization Treatment|Entry criteria not met|0|||
144581236|NCT01204710|521327155|FG001|Randomization Treatment|Entry criteria not met|1|||
144581237|NCT01204710|521327154|FG000|Randomization Treatment|Adverse Event|4|||
144581238|NCT01204710|521327155|FG001|Randomization Treatment|Adverse Event|2|||
144581239|NCT01204710|521327154|FG000|Randomization Treatment|Sponsor Decision|0|||
144581240|NCT01204710|521327155|FG001|Randomization Treatment|Sponsor Decision|1|||
144581241|NCT01204710|521327154|FG000|Randomization Treatment|Worsening of General condition|0|||
144581242|NCT01204710|521327155|FG001|Randomization Treatment|Worsening of General condition|1|||
144581243|NCT01204710|521327154|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
144581244|NCT01204710|521327155|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
144581245|NCT01204710|521327154|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
144581246|NCT01204710|521327155|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
144581247|NCT01204710|521327154|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
144581248|NCT01204710|521327155|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
144581249|NCT01204710|521327154|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
144581250|NCT01204710|521327155|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
144581251|NCT00743431|521327156|FG000|Overall Study|Toxicity|6|||
144581252|NCT00743431|521327156|FG000|Overall Study|Tumor progression|56|||
144581253|NCT00743431|521327156|FG000|Overall Study|Withdrawal by Subject|13|||
144622958|NCT00730639|521476384|FG004|Overall Study|Completed Maximum Cycles|6|||
144581254|NCT00743431|521327156|FG000|Overall Study|Death|9|||
144581255|NCT00743431|521327156|FG000|Overall Study|Reason for discontinuation not specified|29|||
144581256|NCT00743431|521327156|FG000|Overall Study|No documentation available|13|||
144581257|NCT03291288|521327157|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
144581258|NCT03291288|521327158|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
144581259|NCT03291288|521327157|FG000|Drug-drug Interaction Phase|Disease progression|1|||
144581260|NCT03291288|521327158|FG001|Drug-drug Interaction Phase|Disease progression|0|||
144581261|NCT03291288|521327157|FG000|Drug-drug Interaction Phase|Other|3|||
144581262|NCT03291288|521327158|FG001|Drug-drug Interaction Phase|Other|0|||
144209361|NCT00070499|519961851|FG000|Overall Study|Death|1|||
144209362|NCT00070499|519961852|FG001|Overall Study|Death|1|||
144209363|NCT00070499|519961853|FG002|Overall Study|Death|1|||
144209364|NCT00070499|519961854|FG003|Overall Study|Death|2|||
144209365|NCT00070499|519961851|FG000|Overall Study|Other - not protocol specified|7|||
144209366|NCT00070499|519961852|FG001|Overall Study|Other - not protocol specified|3|||
144581263|NCT03291288|521327157|FG000|Pexidartinib Only|Ongoing|0|||
144581264|NCT03291288|521327158|FG001|Pexidartinib Only|Ongoing|2|||
144581265|NCT04276415|521327159|FG000|Overall Study|Adverse Event|0|||
144581266|NCT04276415|521327160|FG001|Overall Study|Adverse Event|0|||
144581267|NCT04276415|521327161|FG002|Overall Study|Adverse Event|0|||
144581268|NCT04276415|521327162|FG003|Overall Study|Adverse Event|3|||
144581269|NCT04276415|521327163|FG004|Overall Study|Adverse Event|0|||
144581270|NCT04276415|521327164|FG005|Overall Study|Adverse Event|0|||
144581271|NCT04276415|521327159|FG000|Overall Study|Clinical progression|1|||
144581272|NCT04276415|521327160|FG001|Overall Study|Clinical progression|1|||
144581273|NCT04276415|521327161|FG002|Overall Study|Clinical progression|0|||
144581274|NCT04276415|521327162|FG003|Overall Study|Clinical progression|0|||
144581275|NCT04276415|521327163|FG004|Overall Study|Clinical progression|1|||
144581276|NCT04276415|521327164|FG005|Overall Study|Clinical progression|0|||
144581277|NCT04276415|521327159|FG000|Overall Study|Other|0|||
144581278|NCT04276415|521327160|FG001|Overall Study|Other|0|||
144581279|NCT04276415|521327161|FG002|Overall Study|Other|0|||
144581280|NCT04276415|521327162|FG003|Overall Study|Other|1|||
144581281|NCT04276415|521327163|FG004|Overall Study|Other|0|||
144581282|NCT04276415|521327164|FG005|Overall Study|Other|0|||
144581283|NCT04276415|521327159|FG000|Overall Study|Physician Decision|0|||
144581284|NCT04276415|521327160|FG001|Overall Study|Physician Decision|0|||
144581285|NCT04276415|521327161|FG002|Overall Study|Physician Decision|1|||
144581286|NCT04276415|521327162|FG003|Overall Study|Physician Decision|3|||
144581287|NCT04276415|521327163|FG004|Overall Study|Physician Decision|2|||
144581288|NCT04276415|521327164|FG005|Overall Study|Physician Decision|0|||
144581289|NCT04276415|521327159|FG000|Overall Study|Progressive disease|3|||
144581290|NCT04276415|521327160|FG001|Overall Study|Progressive disease|3|||
144581291|NCT04276415|521327161|FG002|Overall Study|Progressive disease|4|||
144581292|NCT04276415|521327162|FG003|Overall Study|Progressive disease|5|||
144581293|NCT04276415|521327163|FG004|Overall Study|Progressive disease|1|||
144581294|NCT04276415|521327164|FG005|Overall Study|Progressive disease|2|||
144581295|NCT04276415|521327159|FG000|Overall Study|Withdrawal by patient|0|||
144581296|NCT04276415|521327160|FG001|Overall Study|Withdrawal by patient|0|||
144581297|NCT04276415|521327161|FG002|Overall Study|Withdrawal by patient|0|||
144581298|NCT04276415|521327162|FG003|Overall Study|Withdrawal by patient|1|||
144581299|NCT04276415|521327163|FG004|Overall Study|Withdrawal by patient|2|||
144581300|NCT04276415|521327164|FG005|Overall Study|Withdrawal by patient|0|||
144581301|NCT01896726|521327165|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
144581302|NCT01896726|521327165|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
144581303|NCT02406677|521327166|FG000|Overall Study|Death|16|||
144581304|NCT02406677|521327167|FG001|Overall Study|Death|8|||
144581305|NCT02406677|521327166|FG000|Overall Study|Discharged without P2Y12|1|||
144581306|NCT02406677|521327167|FG001|Overall Study|Discharged without P2Y12|3|||
144581307|NCT02406677|521327166|FG000|Overall Study|Discharged on prasugrel|283|||
144581308|NCT02406677|521327167|FG001|Overall Study|Discharged on prasugrel|587|||
144581309|NCT02406677|521327166|FG000|Overall Study|Withdrawal by Subject|1|||
144209367|NCT00070499|519961853|FG002|Overall Study|Other - not protocol specified|12|||
144209368|NCT00070499|519961854|FG003|Overall Study|Other - not protocol specified|20|||
144209369|NCT00070499|519961851|FG000|Overall Study|Still on protocol treatment|10|||
144209370|NCT00070499|519961852|FG001|Overall Study|Still on protocol treatment|4|||
144581310|NCT02406677|521327167|FG001|Overall Study|Withdrawal by Subject|0|||
144581311|NCT01114880|521327168|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
144581312|NCT01114880|521327169|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
144581313|NCT01114880|521327168|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
144581314|NCT01114880|521327169|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
144581315|NCT01114880|521327168|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
144581316|NCT01114880|521327169|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
144581317|NCT01114880|521327168|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
144581318|NCT01114880|521327169|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
144209371|NCT00070499|519961853|FG002|Overall Study|Still on protocol treatment|79|||
144581319|NCT01114880|521327168|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
144581320|NCT01114880|521327169|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
144581321|NCT01114880|521327168|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
144209372|NCT00070499|519961854|FG003|Overall Study|Still on protocol treatment|57|||
144581322|NCT01114880|521327169|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
144581323|NCT04531098|521327173|FG000|Stage I|Adverse Event|0|||
144581324|NCT04531098|521327174|FG001|Stage I|Adverse Event|0|||
144581325|NCT04531098|521327175|FG002|Stage I|Adverse Event|3|||
144581326|NCT04531098|521327173|FG000|Stage I|Protocol Violation|0|||
144581327|NCT04531098|521327174|FG001|Stage I|Protocol Violation|0|||
144581328|NCT04531098|521327175|FG002|Stage I|Protocol Violation|5|||
144581329|NCT04531098|521327173|FG000|Stage I|Withdrawal by Subject|0|||
144581330|NCT04531098|521327174|FG001|Stage I|Withdrawal by Subject|5|||
144581331|NCT04531098|521327175|FG002|Stage I|Withdrawal by Subject|10|||
144581332|NCT04531098|521327173|FG000|Stage II|Adverse Event|1|||
144581333|NCT04531098|521327174|FG001|Stage II|Adverse Event|2|||
144581334|NCT04531098|521327175|FG002|Stage II|Adverse Event|0|||
144581335|NCT04531098|521327173|FG000|Stage II|Protocol Violation|1|||
144581336|NCT04531098|521327174|FG001|Stage II|Protocol Violation|2|||
144581337|NCT04531098|521327175|FG002|Stage II|Protocol Violation|0|||
144581338|NCT04531098|521327173|FG000|Stage II|Withdrawal by Subject|3|||
144581339|NCT04531098|521327174|FG001|Stage II|Withdrawal by Subject|1|||
144581340|NCT04531098|521327175|FG002|Stage II|Withdrawal by Subject|0|||
144581341|NCT04531098|521327173|FG000|Stage II|Moved from study area|8|||
144581342|NCT04531098|521327174|FG001|Stage II|Moved from study area|5|||
144581343|NCT04531098|521327175|FG002|Stage II|Moved from study area|0|||
144581344|NCT00283244|521327176|FG000|Overall Study|Adverse Event|0|||
144581345|NCT00283244|521327177|FG001|Overall Study|Adverse Event|8|||
144581346|NCT00283244|521327178|FG002|Overall Study|Adverse Event|11|||
144581347|NCT00283244|521327176|FG000|Overall Study|Death|4|||
144581348|NCT00283244|521327177|FG001|Overall Study|Death|3|||
144581349|NCT00283244|521327178|FG002|Overall Study|Death|2|||
144581350|NCT00283244|521327176|FG000|Overall Study|Lack of Efficacy|8|||
144581351|NCT00283244|521327177|FG001|Overall Study|Lack of Efficacy|32|||
144581352|NCT00283244|521327178|FG002|Overall Study|Lack of Efficacy|26|||
144581353|NCT00283244|521327176|FG000|Overall Study|Withdrawal by Subject|1|||
144581354|NCT00283244|521327177|FG001|Overall Study|Withdrawal by Subject|2|||
144581355|NCT00283244|521327178|FG002|Overall Study|Withdrawal by Subject|2|||
144581356|NCT00283244|521327176|FG000|Overall Study|Physician Decision|0|||
144581357|NCT00283244|521327177|FG001|Overall Study|Physician Decision|0|||
144581358|NCT00283244|521327178|FG002|Overall Study|Physician Decision|1|||
144581359|NCT00283244|521327176|FG000|Overall Study|Medical illness (other complicating dz)|4|||
144581360|NCT00283244|521327177|FG001|Overall Study|Medical illness (other complicating dz)|3|||
144581361|NCT00283244|521327178|FG002|Overall Study|Medical illness (other complicating dz)|6|||
144581362|NCT00283244|521327176|FG000|Overall Study|Clinical deterioration|1|||
144581363|NCT00283244|521327177|FG001|Overall Study|Clinical deterioration|3|||
144581364|NCT00283244|521327178|FG002|Overall Study|Clinical deterioration|3|||
144581365|NCT02628028|521327179|FG000|Dosing Period|Withdrawal by Subject|0|||
144581366|NCT02628028|521327180|FG001|Dosing Period|Withdrawal by Subject|0|||
144581367|NCT02628028|521327181|FG002|Dosing Period|Withdrawal by Subject|1|||
144581368|NCT02628028|521327182|FG003|Dosing Period|Withdrawal by Subject|0|||
144581369|NCT02628028|521327183|FG004|Dosing Period|Withdrawal by Subject|2|||
144581370|NCT02628028|521327184|FG005|Dosing Period|Withdrawal by Subject|4|||
144581371|NCT02628028|521327185|FG006|Dosing Period|Withdrawal by Subject|1|||
144581372|NCT02628028|521327186|FG007|Dosing Period|Withdrawal by Subject|1|||
144581373|NCT02628028|521327179|FG000|Dosing Period|Adverse Event|0|||
144581374|NCT02628028|521327180|FG001|Dosing Period|Adverse Event|0|||
144581375|NCT02628028|521327181|FG002|Dosing Period|Adverse Event|0|||
144581376|NCT02628028|521327182|FG003|Dosing Period|Adverse Event|0|||
144581377|NCT02628028|521327183|FG004|Dosing Period|Adverse Event|2|||
144581378|NCT02628028|521327184|FG005|Dosing Period|Adverse Event|1|||
144581379|NCT02628028|521327185|FG006|Dosing Period|Adverse Event|3|||
144581380|NCT02628028|521327186|FG007|Dosing Period|Adverse Event|2|||
144581381|NCT02628028|521327179|FG000|Dosing Period|Death|0|||
144581382|NCT02628028|521327180|FG001|Dosing Period|Death|0|||
144581383|NCT02628028|521327181|FG002|Dosing Period|Death|0|||
144581384|NCT02628028|521327182|FG003|Dosing Period|Death|0|||
144581385|NCT02628028|521327183|FG004|Dosing Period|Death|0|||
144581386|NCT02628028|521327184|FG005|Dosing Period|Death|0|||
144581387|NCT02628028|521327185|FG006|Dosing Period|Death|0|||
144581388|NCT02628028|521327186|FG007|Dosing Period|Death|1|||
144622959|NCT00730639|521476380|FG000|Overall Study|Death|0|||
144622960|NCT00730639|521476381|FG001|Overall Study|Death|0|||
144581389|NCT02628028|521327179|FG000|Dosing Period|Lack of Efficacy|0|||
144581390|NCT02628028|521327180|FG001|Dosing Period|Lack of Efficacy|0|||
144581391|NCT02628028|521327181|FG002|Dosing Period|Lack of Efficacy|0|||
144581392|NCT02628028|521327182|FG003|Dosing Period|Lack of Efficacy|0|||
144581393|NCT02628028|521327183|FG004|Dosing Period|Lack of Efficacy|3|||
144581394|NCT02628028|521327184|FG005|Dosing Period|Lack of Efficacy|0|||
144581395|NCT02628028|521327185|FG006|Dosing Period|Lack of Efficacy|1|||
144581396|NCT02628028|521327186|FG007|Dosing Period|Lack of Efficacy|0|||
144581397|NCT02628028|521327179|FG000|Dosing Period|Study Terminated by Sponsor|0|||
144581398|NCT02628028|521327180|FG001|Dosing Period|Study Terminated by Sponsor|0|||
144581399|NCT02628028|521327181|FG002|Dosing Period|Study Terminated by Sponsor|0|||
144581400|NCT02628028|521327182|FG003|Dosing Period|Study Terminated by Sponsor|0|||
144581401|NCT02628028|521327183|FG004|Dosing Period|Study Terminated by Sponsor|7|||
144581402|NCT02628028|521327184|FG005|Dosing Period|Study Terminated by Sponsor|6|||
144581403|NCT02628028|521327185|FG006|Dosing Period|Study Terminated by Sponsor|7|||
144622961|NCT00730639|521476382|FG002|Overall Study|Death|0|||
144622962|NCT00730639|521476383|FG003|Overall Study|Death|0|||
144581404|NCT02628028|521327186|FG007|Dosing Period|Study Terminated by Sponsor|7|||
144581405|NCT02628028|521327179|FG000|Dosing Period|Physician Decision|0|||
144581406|NCT02628028|521327180|FG001|Dosing Period|Physician Decision|0|||
144581407|NCT02628028|521327181|FG002|Dosing Period|Physician Decision|0|||
144581408|NCT02628028|521327182|FG003|Dosing Period|Physician Decision|0|||
144581409|NCT02628028|521327183|FG004|Dosing Period|Physician Decision|0|||
144581410|NCT02628028|521327184|FG005|Dosing Period|Physician Decision|1|||
144581411|NCT02628028|521327185|FG006|Dosing Period|Physician Decision|0|||
144581412|NCT02628028|521327186|FG007|Dosing Period|Physician Decision|0|||
144581413|NCT02628028|521327179|FG000|Dosing Period|Site Terminated by Sponsor|0|||
144581414|NCT02628028|521327180|FG001|Dosing Period|Site Terminated by Sponsor|0|||
144581415|NCT02628028|521327181|FG002|Dosing Period|Site Terminated by Sponsor|0|||
144581416|NCT02628028|521327182|FG003|Dosing Period|Site Terminated by Sponsor|0|||
144581417|NCT02628028|521327183|FG004|Dosing Period|Site Terminated by Sponsor|0|||
144581418|NCT02628028|521327184|FG005|Dosing Period|Site Terminated by Sponsor|1|||
144581419|NCT02628028|521327185|FG006|Dosing Period|Site Terminated by Sponsor|1|||
144581420|NCT02628028|521327186|FG007|Dosing Period|Site Terminated by Sponsor|0|||
144581421|NCT02628028|521327179|FG000|Dosing Period|Lost to Follow-up|0|||
144581422|NCT02628028|521327180|FG001|Dosing Period|Lost to Follow-up|0|||
144581423|NCT02628028|521327181|FG002|Dosing Period|Lost to Follow-up|0|||
144581424|NCT02628028|521327182|FG003|Dosing Period|Lost to Follow-up|0|||
144581425|NCT02628028|521327183|FG004|Dosing Period|Lost to Follow-up|0|||
144581426|NCT02628028|521327184|FG005|Dosing Period|Lost to Follow-up|0|||
144581427|NCT02628028|521327185|FG006|Dosing Period|Lost to Follow-up|1|||
144581428|NCT02628028|521327186|FG007|Dosing Period|Lost to Follow-up|0|||
144581429|NCT02628028|521327179|FG000|Dosing Period|Other|0|||
144581430|NCT02628028|521327180|FG001|Dosing Period|Other|0|||
144581431|NCT02628028|521327181|FG002|Dosing Period|Other|0|||
144581432|NCT02628028|521327182|FG003|Dosing Period|Other|0|||
144581433|NCT02628028|521327183|FG004|Dosing Period|Other|2|||
144581434|NCT02628028|521327184|FG005|Dosing Period|Other|1|||
144581435|NCT02628028|521327185|FG006|Dosing Period|Other|2|||
144581436|NCT02628028|521327186|FG007|Dosing Period|Other|4|||
144581437|NCT02628028|521327179|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
144581438|NCT02628028|521327180|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
144581439|NCT02628028|521327181|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
144581440|NCT02628028|521327182|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
144581441|NCT02628028|521327183|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
144581442|NCT02628028|521327184|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
144581443|NCT02628028|521327185|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
144581444|NCT02628028|521327186|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
144581445|NCT02628028|521327179|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
144581446|NCT02628028|521327180|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
144581447|NCT02628028|521327181|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
144581448|NCT02628028|521327182|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
144581449|NCT02628028|521327183|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
144581450|NCT02628028|521327184|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
144581451|NCT02628028|521327185|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
144581452|NCT02628028|521327186|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
144581453|NCT02628028|521327179|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
144581454|NCT02628028|521327180|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
144581455|NCT02628028|521327181|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
144581456|NCT02628028|521327182|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
144581457|NCT02628028|521327183|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
144209373|NCT00070499|519961851|FG000|Overall Study|Did not start treatment|1|||
144209374|NCT00070499|519961852|FG001|Overall Study|Did not start treatment|0|||
144209375|NCT00070499|519961853|FG002|Overall Study|Did not start treatment|0|||
144209376|NCT00070499|519961854|FG003|Overall Study|Did not start treatment|2|||
144209377|NCT00070499|519961851|FG000|Overall Study|Not eligible|2|||
144209378|NCT00070499|519961852|FG001|Overall Study|Not eligible|5|||
144581458|NCT02628028|521327184|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
144581459|NCT02628028|521327185|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
144581460|NCT02628028|521327186|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
144581461|NCT02628028|521327179|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
144581462|NCT02628028|521327180|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
144581463|NCT02628028|521327181|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
144581464|NCT02628028|521327182|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
144581465|NCT02628028|521327183|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
144581466|NCT02628028|521327184|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
144581467|NCT02628028|521327185|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
144581468|NCT02628028|521327186|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
144581469|NCT02628028|521327179|FG000|Long-term Extension (LTE) Period|Other|0|||
144622963|NCT00730639|521476384|FG004|Overall Study|Death|2|||
144622964|NCT00730639|521476380|FG000|Overall Study|Disease Progression|12|||
144581470|NCT02628028|521327180|FG001|Long-term Extension (LTE) Period|Other|0|||
144581471|NCT02628028|521327181|FG002|Long-term Extension (LTE) Period|Other|0|||
144581472|NCT02628028|521327182|FG003|Long-term Extension (LTE) Period|Other|0|||
144581473|NCT02628028|521327183|FG004|Long-term Extension (LTE) Period|Other|0|||
144581474|NCT02628028|521327184|FG005|Long-term Extension (LTE) Period|Other|3|||
144581475|NCT02628028|521327185|FG006|Long-term Extension (LTE) Period|Other|4|||
144581476|NCT02628028|521327186|FG007|Long-term Extension (LTE) Period|Other|3|||
144581477|NCT02145468|521327187|FG000|Overall Study|Withdrawal by Subject|5|||
144581478|NCT02145468|521327188|FG001|Overall Study|Withdrawal by Subject|8|||
144581479|NCT00658788|521327195|FG000|Overall Study|Adverse Event|11|||
144581480|NCT00658788|521327195|FG000|Overall Study|Withdrawal by Subject|13|||
144581481|NCT00658788|521327195|FG000|Overall Study|Lost to Follow-up|18|||
144581482|NCT00658788|521327195|FG000|Overall Study|Treatment Discontinuation|32|||
144581483|NCT03519997|521327196|FG000|Overall Study|Adverse Event|4|||
144581484|NCT03519997|521327196|FG000|Overall Study|Withdrawal by Subject|2|||
144581485|NCT03519997|521327196|FG000|Overall Study|Protocol Violation|1|||
144581486|NCT03898167|521327197|FG000|Overall Study|Terminated phone call early|7|||
144581487|NCT03898167|521327198|FG001|Overall Study|Terminated phone call early|0|||
144581488|NCT03898167|521327199|FG002|Overall Study|Terminated phone call early|0|||
144581489|NCT03898167|521327197|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
144581490|NCT03898167|521327198|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
144581491|NCT03898167|521327199|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
144581492|NCT00384397|521327200|FG000|Overall Study|Adverse Event|0|||
144581493|NCT00384397|521327201|FG001|Overall Study|Adverse Event|1|||
144581494|NCT00384397|521327202|FG002|Overall Study|Adverse Event|2|||
144581495|NCT00384397|521327200|FG000|Overall Study|Protocol Violation|7|||
144581496|NCT00384397|521327201|FG001|Overall Study|Protocol Violation|15|||
144581497|NCT00384397|521327202|FG002|Overall Study|Protocol Violation|13|||
144581498|NCT00384397|521327200|FG000|Overall Study|Lost to Follow-up|11|||
144581499|NCT00384397|521327201|FG001|Overall Study|Lost to Follow-up|13|||
144581500|NCT00384397|521327202|FG002|Overall Study|Lost to Follow-up|3|||
144581501|NCT00384397|521327200|FG000|Overall Study|Withdrawal by Subject|14|||
144581502|NCT00384397|521327201|FG001|Overall Study|Withdrawal by Subject|17|||
144581503|NCT00384397|521327202|FG002|Overall Study|Withdrawal by Subject|15|||
144581504|NCT01214642|521327203|FG000|Overall Study|Progressive Disease|3|||
144581505|NCT01214642|521327204|FG001|Overall Study|Progressive Disease|2|||
144581506|NCT01214642|521327205|FG002|Overall Study|Progressive Disease|3|||
144581507|NCT01214642|521327206|FG003|Overall Study|Progressive Disease|5|||
144581508|NCT01214642|521327207|FG004|Overall Study|Progressive Disease|5|||
144581509|NCT01214642|521327208|FG005|Overall Study|Progressive Disease|3|||
144581510|NCT01214642|521327209|FG006|Overall Study|Progressive Disease|5|||
144581511|NCT01214642|521327210|FG007|Overall Study|Progressive Disease|3|||
144581512|NCT01214642|521327211|FG008|Overall Study|Progressive Disease|10|||
144581513|NCT01214642|521327212|FG009|Overall Study|Progressive Disease|2|||
144581514|NCT01214642|521327213|FG010|Overall Study|Progressive Disease|1|||
144581515|NCT01214642|521327214|FG011|Overall Study|Progressive Disease|4|||
144581516|NCT01214642|521327203|FG000|Overall Study|Adverse Event|0|||
144581517|NCT01214642|521327204|FG001|Overall Study|Adverse Event|1|||
144581518|NCT01214642|521327205|FG002|Overall Study|Adverse Event|0|||
144581519|NCT01214642|521327206|FG003|Overall Study|Adverse Event|0|||
144581520|NCT01214642|521327207|FG004|Overall Study|Adverse Event|0|||
144581521|NCT01214642|521327208|FG005|Overall Study|Adverse Event|0|||
144581522|NCT01214642|521327209|FG006|Overall Study|Adverse Event|1|||
144581523|NCT01214642|521327210|FG007|Overall Study|Adverse Event|0|||
144581524|NCT01214642|521327211|FG008|Overall Study|Adverse Event|0|||
144581525|NCT01214642|521327212|FG009|Overall Study|Adverse Event|1|||
144581526|NCT01214642|521327213|FG010|Overall Study|Adverse Event|1|||
144581527|NCT01214642|521327214|FG011|Overall Study|Adverse Event|0|||
144581528|NCT01214642|521327203|FG000|Overall Study|Death|0|||
144581529|NCT01214642|521327204|FG001|Overall Study|Death|0|||
144581530|NCT01214642|521327205|FG002|Overall Study|Death|1|||
144581531|NCT01214642|521327206|FG003|Overall Study|Death|0|||
144581532|NCT01214642|521327207|FG004|Overall Study|Death|0|||
144581533|NCT01214642|521327208|FG005|Overall Study|Death|0|||
144581534|NCT01214642|521327209|FG006|Overall Study|Death|0|||
144581535|NCT01214642|521327210|FG007|Overall Study|Death|0|||
144581536|NCT01214642|521327211|FG008|Overall Study|Death|0|||
144581537|NCT01214642|521327212|FG009|Overall Study|Death|0|||
144581538|NCT01214642|521327213|FG010|Overall Study|Death|1|||
144581539|NCT01214642|521327214|FG011|Overall Study|Death|0|||
144581540|NCT01214642|521327203|FG000|Overall Study|Withdrawal by Subject|0|||
144581541|NCT01214642|521327204|FG001|Overall Study|Withdrawal by Subject|0|||
144581542|NCT01214642|521327205|FG002|Overall Study|Withdrawal by Subject|1|||
144581543|NCT01214642|521327206|FG003|Overall Study|Withdrawal by Subject|0|||
144581544|NCT01214642|521327207|FG004|Overall Study|Withdrawal by Subject|0|||
144581545|NCT01214642|521327208|FG005|Overall Study|Withdrawal by Subject|0|||
144581546|NCT01214642|521327209|FG006|Overall Study|Withdrawal by Subject|0|||
144581547|NCT01214642|521327210|FG007|Overall Study|Withdrawal by Subject|0|||
144209379|NCT00070499|519961853|FG002|Overall Study|Not eligible|3|||
144581548|NCT01214642|521327211|FG008|Overall Study|Withdrawal by Subject|3|||
144581549|NCT01214642|521327212|FG009|Overall Study|Withdrawal by Subject|1|||
144581550|NCT01214642|521327213|FG010|Overall Study|Withdrawal by Subject|1|||
144581551|NCT01214642|521327214|FG011|Overall Study|Withdrawal by Subject|0|||
144581552|NCT01214642|521327203|FG000|Overall Study|Physician Decision|0|||
144581553|NCT01214642|521327204|FG001|Overall Study|Physician Decision|0|||
144581554|NCT01214642|521327205|FG002|Overall Study|Physician Decision|1|||
144581555|NCT01214642|521327206|FG003|Overall Study|Physician Decision|1|||
144581556|NCT01214642|521327207|FG004|Overall Study|Physician Decision|1|||
144581557|NCT01214642|521327208|FG005|Overall Study|Physician Decision|0|||
144581558|NCT01214642|521327209|FG006|Overall Study|Physician Decision|0|||
144581559|NCT01214642|521327210|FG007|Overall Study|Physician Decision|0|||
144581560|NCT01214642|521327211|FG008|Overall Study|Physician Decision|0|||
144581561|NCT01214642|521327212|FG009|Overall Study|Physician Decision|0|||
144581562|NCT01214642|521327213|FG010|Overall Study|Physician Decision|0|||
144581563|NCT01214642|521327214|FG011|Overall Study|Physician Decision|2|||
144581564|NCT01946529|521327217|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
144581565|NCT01946529|521327218|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
144581566|NCT01946529|521327219|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
144581567|NCT01946529|521327217|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
144581568|NCT01946529|521327218|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
144581569|NCT01946529|521327219|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
144581570|NCT03826030|521327224|FG000|Overall Study|Withdrawal by Subject|2|||
144581571|NCT03826030|521327225|FG001|Overall Study|Withdrawal by Subject|0|||
144581572|NCT03826030|521327226|FG002|Overall Study|Withdrawal by Subject|1|||
144581573|NCT03826030|521327224|FG000|Overall Study|Lost to Follow-up|1|||
144581574|NCT03826030|521327225|FG001|Overall Study|Lost to Follow-up|1|||
144581575|NCT03826030|521327226|FG002|Overall Study|Lost to Follow-up|1|||
144581576|NCT03826030|521327224|FG000|Overall Study|Too busy to return for visits|1|||
144581577|NCT03826030|521327225|FG001|Overall Study|Too busy to return for visits|0|||
144581578|NCT03826030|521327226|FG002|Overall Study|Too busy to return for visits|0|||
144581579|NCT03820947|521327229|FG000|Overall Study|Physician Decision|0|||
144581580|NCT03820947|521327230|FG001|Overall Study|Physician Decision|1|||
144581581|NCT03820947|521327231|FG002|Overall Study|Physician Decision|1|||
144581582|NCT03820947|521327232|FG003|Overall Study|Physician Decision|0|||
144581583|NCT03820947|521327233|FG004|Overall Study|Physician Decision|3|||
144581584|NCT03820947|521327229|FG000|Overall Study|Withdrawal by Subject|6|||
144581585|NCT03820947|521327230|FG001|Overall Study|Withdrawal by Subject|10|||
144581586|NCT03820947|521327231|FG002|Overall Study|Withdrawal by Subject|3|||
144581587|NCT03820947|521327232|FG003|Overall Study|Withdrawal by Subject|8|||
144581588|NCT03820947|521327233|FG004|Overall Study|Withdrawal by Subject|5|||
144581589|NCT03820947|521327229|FG000|Overall Study|Procedure Not Attempted|0|||
144581590|NCT03820947|521327230|FG001|Overall Study|Procedure Not Attempted|2|||
144581591|NCT03820947|521327231|FG002|Overall Study|Procedure Not Attempted|1|||
144581592|NCT03820947|521327232|FG003|Overall Study|Procedure Not Attempted|0|||
144581593|NCT03820947|521327233|FG004|Overall Study|Procedure Not Attempted|0|||
144581594|NCT03820947|521327229|FG000|Overall Study|Other Exit|1|||
144622965|NCT00730639|521476381|FG001|Overall Study|Disease Progression|13|||
144622966|NCT00730639|521476382|FG002|Overall Study|Disease Progression|48|||
144622967|NCT00730639|521476383|FG003|Overall Study|Disease Progression|32|||
144622968|NCT00730639|521476384|FG004|Overall Study|Disease Progression|88|||
144622969|NCT00730639|521476380|FG000|Overall Study|non-specified|0|||
144622970|NCT00730639|521476381|FG001|Overall Study|non-specified|0|||
144622971|NCT00730639|521476382|FG002|Overall Study|non-specified|4|||
144622972|NCT00730639|521476383|FG003|Overall Study|non-specified|2|||
144622973|NCT00730639|521476384|FG004|Overall Study|non-specified|3|||
144730371|NCT03002077|521868211|FG000|Overall Study|Adverse Event|23|||
144730372|NCT03002077|521868211|FG000|Overall Study|Lack of Efficacy|20|||
144730373|NCT03002077|521868211|FG000|Overall Study|Withdrawal by Subject|72|||
144730374|NCT03002077|521868211|FG000|Overall Study|Lost to Follow-up|21|||
144730375|NCT03002077|521868211|FG000|Overall Study|Pregnancy|4|||
144209380|NCT00070499|519961854|FG003|Overall Study|Not eligible|2|||
144622974|NCT00730639|521476380|FG000|Overall Study|Protocol Violation|0|||
144622975|NCT00730639|521476381|FG001|Overall Study|Protocol Violation|0|||
144622976|NCT00730639|521476382|FG002|Overall Study|Protocol Violation|1|||
144622977|NCT00730639|521476383|FG003|Overall Study|Protocol Violation|0|||
144209381|NCT01924754|519961855|FG000|Overall Study|Lost to Follow-up|1|||
144209382|NCT01924754|519961856|FG001|Overall Study|Lost to Follow-up|2|||
144581595|NCT03820947|521327230|FG001|Overall Study|Other Exit|3|||
144581596|NCT03820947|521327231|FG002|Overall Study|Other Exit|3|||
144622978|NCT00730639|521476384|FG004|Overall Study|Protocol Violation|0|||
144622979|NCT00730639|521476380|FG000|Overall Study|Withdrawal by Subject|0|||
144209383|NCT01924754|519961857|FG002|Overall Study|Lost to Follow-up|1|||
144581597|NCT03820947|521327232|FG003|Overall Study|Other Exit|3|||
144581598|NCT03820947|521327233|FG004|Overall Study|Other Exit|0|||
144581599|NCT03820947|521327229|FG000|Overall Study|Follow-up Not Done|10|||
144581600|NCT03820947|521327230|FG001|Overall Study|Follow-up Not Done|13|||
144730376|NCT03002077|521868211|FG000|Overall Study|Protocol Violation|21|||
144730377|NCT03048500|521868218|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
144730378|NCT03048500|521868218|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
144581601|NCT03820947|521327231|FG002|Overall Study|Follow-up Not Done|2|||
144581602|NCT03820947|521327232|FG003|Overall Study|Follow-up Not Done|3|||
144581603|NCT03820947|521327233|FG004|Overall Study|Follow-up Not Done|12|||
144581604|NCT03820947|521327229|FG000|Overall Study|Death|0|||
144581605|NCT03820947|521327230|FG001|Overall Study|Death|0|||
144581606|NCT03820947|521327231|FG002|Overall Study|Death|0|||
144581607|NCT03820947|521327232|FG003|Overall Study|Death|0|||
144581608|NCT03820947|521327233|FG004|Overall Study|Death|9|||
144581609|NCT03820947|521327229|FG000|Overall Study|Lost to Follow-up|4|||
144581610|NCT03820947|521327230|FG001|Overall Study|Lost to Follow-up|6|||
144581611|NCT03820947|521327231|FG002|Overall Study|Lost to Follow-up|0|||
144581612|NCT03820947|521327232|FG003|Overall Study|Lost to Follow-up|0|||
144581613|NCT03820947|521327233|FG004|Overall Study|Lost to Follow-up|9|||
144581614|NCT03578887|521327234|FG000|Overall Study|Withdrawal by Subject|7|||
144581615|NCT03578887|521327235|FG001|Overall Study|Withdrawal by Subject|2|||
144581616|NCT03578887|521327236|FG002|Overall Study|Withdrawal by Subject|1|||
144581617|NCT03578887|521327234|FG000|Overall Study|Lost to Follow-up|13|||
144581618|NCT03578887|521327235|FG001|Overall Study|Lost to Follow-up|1|||
144581619|NCT03578887|521327236|FG002|Overall Study|Lost to Follow-up|4|||
144581620|NCT03578887|521327234|FG000|Overall Study|Physician Decision|0|||
144581621|NCT03578887|521327235|FG001|Overall Study|Physician Decision|1|||
144581622|NCT03578887|521327236|FG002|Overall Study|Physician Decision|1|||
144581623|NCT04500769|521329136|FG000|Overall Study|Withdrawal by Subject|5|||
144581624|NCT03843554|521329137|FG000|Overall Study|Physician Decision|0|||
144581625|NCT03843554|521329138|FG001|Overall Study|Physician Decision|2|||
144581626|NCT01099215|521329139|FG000|Overall Study|Withdrawal by Subject|1|||
144581627|NCT01099215|521329140|FG001|Overall Study|Withdrawal by Subject|0|||
144581628|NCT01099215|521329139|FG000|Overall Study|Adverse Event|0|||
144581629|NCT01099215|521329140|FG001|Overall Study|Adverse Event|1|||
144581630|NCT03002220|521329141|FG000|Overall Study|Lack of Efficacy|2|||
144581631|NCT03002220|521329141|FG000|Overall Study|Withdrawal by Subject|3|||
144581632|NCT03002220|521329141|FG000|Overall Study|Adverse Event|2|||
144581633|NCT03002220|521329141|FG000|Overall Study|Disease progression|13|||
144581634|NCT03002220|521329141|FG000|Overall Study|Physician Decision|1|||
144581635|NCT00640133|521329142|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
144581636|NCT00640133|521329143|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
144581637|NCT00640133|521329142|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
144581638|NCT00640133|521329143|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
144581639|NCT00640133|521329142|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
144581640|NCT00640133|521329143|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
144581641|NCT01183260|521329144|FG000|Overall Study|Intraop screen failure|2|||
144581642|NCT01183260|521329145|FG001|Overall Study|Intraop screen failure|0|||
144581643|NCT01183260|521329144|FG000|Overall Study|Withdrawal by Subject|1|||
144730379|NCT03048500|521868218|FG000|Reached 1st Response/Continued Treatment|Death|1|||
144730380|NCT03048500|521868218|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
144730381|NCT03048500|521868218|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
144209384|NCT01924754|519961855|FG000|Overall Study|Pregnancy|0|||
144209385|NCT01924754|519961856|FG001|Overall Study|Pregnancy|1|||
144209386|NCT01924754|519961857|FG002|Overall Study|Pregnancy|2|||
144209387|NCT02925403|519961863|FG000|Overall Study|Lost to Follow-up|0|||
144209388|NCT02925403|519961864|FG001|Overall Study|Lost to Follow-up|1|||
144209389|NCT00459043|519961865|FG000|Overall Study|Withdrawal by Subject|1|||
144209390|NCT00459043|519961866|FG001|Overall Study|Withdrawal by Subject|0|||
144209391|NCT03743415|519961867|FG000|Overall Study|Death|5|||
144209392|NCT03743415|519961868|FG001|Overall Study|Death|3|||
144209393|NCT03743415|519961869|FG002|Overall Study|Death|1|||
144209394|NCT03743415|519961870|FG003|Overall Study|Death|4|||
144209395|NCT03743415|519961871|FG004|Overall Study|Death|0|||
144209396|NCT03743415|519961872|FG005|Overall Study|Death|0|||
144209397|NCT03743415|519961873|FG006|Overall Study|Death|0|||
144209398|NCT03743415|519961874|FG007|Overall Study|Death|0|||
144209399|NCT03743415|519961875|FG008|Overall Study|Death|1|||
144581644|NCT01183260|521329145|FG001|Overall Study|Withdrawal by Subject|1|||
144581645|NCT01183260|521329144|FG000|Overall Study|Revised within 30 days|0|||
144581646|NCT01183260|521329145|FG001|Overall Study|Revised within 30 days|1|||
144581647|NCT01183260|521329144|FG000|Overall Study|Death|1|||
144581648|NCT01183260|521329145|FG001|Overall Study|Death|0|||
144209400|NCT03743415|519961876|FG009|Overall Study|Death|0|||
144209401|NCT03743415|519961867|FG000|Overall Study|Withdrawal by Subject|1|||
144581649|NCT00128102|521329146|FG000|Overall Study|Site Discontinued|3|||
144581650|NCT00128102|521329147|FG001|Overall Study|Site Discontinued|6|||
144581651|NCT00128102|521329146|FG000|Overall Study|Other|0|||
144581652|NCT00128102|521329147|FG001|Overall Study|Other|1|||
144581653|NCT00128102|521329146|FG000|Overall Study|Progressive Disease|255|||
144581654|NCT00128102|521329147|FG001|Overall Study|Progressive Disease|285|||
144581655|NCT00128102|521329146|FG000|Overall Study|Adverse Event|34|||
144581656|NCT00128102|521329147|FG001|Overall Study|Adverse Event|11|||
144581657|NCT00128102|521329146|FG000|Overall Study|Death|12|||
144581658|NCT00128102|521329147|FG001|Overall Study|Death|13|||
144581659|NCT00128102|521329146|FG000|Overall Study|Physician Decision|3|||
144581660|NCT00128102|521329147|FG001|Overall Study|Physician Decision|3|||
144581661|NCT00128102|521329146|FG000|Overall Study|Withdrawal by Subject|19|||
144581662|NCT00128102|521329147|FG001|Overall Study|Withdrawal by Subject|11|||
144581663|NCT00128102|521329146|FG000|Overall Study|Protocol Violation|2|||
144581664|NCT00128102|521329147|FG001|Overall Study|Protocol Violation|2|||
144581665|NCT01202903|521329148|FG000|Overall Study|Administrative Probelms|1|||
144581666|NCT01202903|521329149|FG001|Overall Study|Administrative Probelms|4|||
144581667|NCT01202903|521329148|FG000|Overall Study|Protocol Violation|0|||
144581668|NCT01202903|521329149|FG001|Overall Study|Protocol Violation|1|||
144581669|NCT01202903|521329148|FG000|Overall Study|Death|1|||
144581670|NCT01202903|521329149|FG001|Overall Study|Death|0|||
144581671|NCT01202903|521329148|FG000|Overall Study|Lost to Follow-up|1|||
144581672|NCT01202903|521329149|FG001|Overall Study|Lost to Follow-up|1|||
144581673|NCT01202903|521329148|FG000|Overall Study|Lack of Efficacy|1|||
144581674|NCT01202903|521329149|FG001|Overall Study|Lack of Efficacy|3|||
144581675|NCT01202903|521329148|FG000|Overall Study|Adverse Event|3|||
144581676|NCT01202903|521329149|FG001|Overall Study|Adverse Event|3|||
144581677|NCT01202903|521329148|FG000|Overall Study|Withdrawal by Subject|4|||
144581678|NCT01202903|521329149|FG001|Overall Study|Withdrawal by Subject|4|||
144581679|NCT00996476|521329150|FG000|Overall Study|Withdrawal by Subject|1|||
144581680|NCT00996476|521329151|FG001|Overall Study|Withdrawal by Subject|2|||
144581681|NCT00996476|521329152|FG002|Overall Study|Withdrawal by Subject|1|||
144581682|NCT00996476|521329153|FG003|Overall Study|Withdrawal by Subject|0|||
144581683|NCT00996476|521329154|FG004|Overall Study|Withdrawal by Subject|1|||
144581684|NCT00996476|521329150|FG000|Overall Study|Adverse Event|0|||
144581685|NCT00996476|521329151|FG001|Overall Study|Adverse Event|1|||
144581686|NCT00996476|521329152|FG002|Overall Study|Adverse Event|0|||
144581687|NCT00996476|521329153|FG003|Overall Study|Adverse Event|0|||
144581688|NCT00996476|521329154|FG004|Overall Study|Adverse Event|1|||
144581689|NCT01896557|521329155|FG000|Clopidogrel Alone|Adverse Event|1|||
144581690|NCT01896557|521329156|FG001|Clopidogrel Alone|Adverse Event|0|||
144581691|NCT01896557|521329155|FG000|Clopidogrel + GI Protector|low adherence|1|||
144581692|NCT01896557|521329156|FG001|Clopidogrel + GI Protector|low adherence|1|||
144581693|NCT01896557|521329155|FG000|Clopidogrel + GI Protector|Reading error|1|||
144581694|NCT01896557|521329156|FG001|Clopidogrel + GI Protector|Reading error|3|||
144581695|NCT00734591|521329157|FG000|Screening for Prospective Period|Site did not participate|1604|||
144581696|NCT00734591|521329158|FG001|Screening for Prospective Period|Site did not participate|1488|||
144581697|NCT00734591|521329157|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
144209402|NCT03743415|519961868|FG001|Overall Study|Withdrawal by Subject|0|||
144209403|NCT03743415|519961869|FG002|Overall Study|Withdrawal by Subject|4|||
144209404|NCT03743415|519961870|FG003|Overall Study|Withdrawal by Subject|5|||
144209405|NCT03743415|519961871|FG004|Overall Study|Withdrawal by Subject|5|||
144209406|NCT03743415|519961872|FG005|Overall Study|Withdrawal by Subject|2|||
144209407|NCT03743415|519961873|FG006|Overall Study|Withdrawal by Subject|2|||
144209408|NCT03743415|519961874|FG007|Overall Study|Withdrawal by Subject|5|||
144209409|NCT03743415|519961875|FG008|Overall Study|Withdrawal by Subject|9|||
144209410|NCT03743415|519961876|FG009|Overall Study|Withdrawal by Subject|10|||
144209411|NCT03743415|519961867|FG000|Overall Study|Lost to Follow-up|2|||
144209412|NCT03743415|519961868|FG001|Overall Study|Lost to Follow-up|0|||
144209413|NCT03743415|519961869|FG002|Overall Study|Lost to Follow-up|2|||
144209414|NCT03743415|519961870|FG003|Overall Study|Lost to Follow-up|1|||
144209415|NCT03743415|519961871|FG004|Overall Study|Lost to Follow-up|1|||
144209416|NCT03743415|519961872|FG005|Overall Study|Lost to Follow-up|0|||
144209417|NCT03743415|519961873|FG006|Overall Study|Lost to Follow-up|1|||
144209418|NCT03743415|519961874|FG007|Overall Study|Lost to Follow-up|4|||
144209419|NCT03743415|519961875|FG008|Overall Study|Lost to Follow-up|13|||
144209420|NCT03743415|519961876|FG009|Overall Study|Lost to Follow-up|13|||
144209421|NCT02679235|519961877|FG000|Overall Study|Withdrawal by Subject|3|||
144581698|NCT00734591|521329158|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
144581699|NCT00734591|521329157|FG000|Prospective Period|Withdrawal by Subject|11|||
144581700|NCT00734591|521329158|FG001|Prospective Period|Withdrawal by Subject|9|||
144209422|NCT02679235|519961877|FG000|Overall Study|Adverse Event|1|||
144209423|NCT00094861|519961878|FG000|Overall Study|Adverse Event|5|||
144581701|NCT00734591|521329157|FG000|Prospective Period|Lost to Follow-up|37|||
144581702|NCT00734591|521329158|FG001|Prospective Period|Lost to Follow-up|33|||
144581703|NCT00734591|521329157|FG000|Prospective Period|Study Terminated|1|||
144581704|NCT00734591|521329158|FG001|Prospective Period|Study Terminated|0|||
144581705|NCT00734591|521329157|FG000|Prospective Period|Other|2|||
144581706|NCT00734591|521329158|FG001|Prospective Period|Other|2|||
144581707|NCT01656200|521329159|FG000|Overall Study|Withdrawal by Subject|1|||
144581708|NCT02236988|521329160|FG000|Overall Study|Lost to Follow-up|0|||
144581709|NCT02236988|521329161|FG001|Overall Study|Lost to Follow-up|0|||
144209424|NCT00094861|519961879|FG001|Overall Study|Adverse Event|2|||
144209425|NCT00094861|519961878|FG000|Overall Study|Withdrawal by Subject|5|||
144581710|NCT02236988|521329162|FG002|Overall Study|Lost to Follow-up|0|||
144581711|NCT02236988|521329163|FG003|Overall Study|Lost to Follow-up|1|||
144581712|NCT02236988|521329160|FG000|Overall Study|Unable to Comply with Study Visits|0|||
144581713|NCT02236988|521329161|FG001|Overall Study|Unable to Comply with Study Visits|0|||
144581714|NCT02236988|521329162|FG002|Overall Study|Unable to Comply with Study Visits|0|||
144581715|NCT02236988|521329163|FG003|Overall Study|Unable to Comply with Study Visits|2|||
144581716|NCT03015129|521329167|FG000|Overall Study|Death|2|||
144581717|NCT03015129|521329168|FG001|Overall Study|Death|2|||
144581718|NCT03015129|521329167|FG000|Overall Study|Lost to Follow-up|0|||
144581719|NCT03015129|521329168|FG001|Overall Study|Lost to Follow-up|1|||
144581720|NCT03015129|521329167|FG000|Overall Study|Progression of disease|38|||
144581721|NCT03015129|521329168|FG001|Overall Study|Progression of disease|33|||
144581722|NCT03015129|521329167|FG000|Overall Study|Adverse Event|0|||
144581723|NCT03015129|521329168|FG001|Overall Study|Adverse Event|4|||
144581724|NCT01072630|521329176|FG000|Overall Study|Adverse Event|11|||
144581725|NCT01072630|521329177|FG001|Overall Study|Adverse Event|19|||
144581726|NCT01072630|521329178|FG002|Overall Study|Adverse Event|2|||
144581727|NCT01072630|521329176|FG000|Overall Study|Lack of Efficacy|10|||
144581728|NCT01072630|521329177|FG001|Overall Study|Lack of Efficacy|10|||
144581729|NCT01072630|521329178|FG002|Overall Study|Lack of Efficacy|1|||
144581730|NCT01072630|521329176|FG000|Overall Study|Withdrawal by Subject|8|||
144581731|NCT01072630|521329177|FG001|Overall Study|Withdrawal by Subject|7|||
144581732|NCT01072630|521329178|FG002|Overall Study|Withdrawal by Subject|2|||
144581733|NCT01072630|521329176|FG000|Overall Study|Protocol Violation|10|||
144581734|NCT01072630|521329177|FG001|Overall Study|Protocol Violation|8|||
144581735|NCT01072630|521329178|FG002|Overall Study|Protocol Violation|4|||
144581736|NCT01072630|521329176|FG000|Overall Study|Lost to Follow-up|11|||
144581737|NCT01072630|521329177|FG001|Overall Study|Lost to Follow-up|11|||
144581738|NCT01072630|521329178|FG002|Overall Study|Lost to Follow-up|1|||
144581739|NCT01072630|521329176|FG000|Overall Study|Noncompliance with study medication|1|||
144581740|NCT01072630|521329177|FG001|Overall Study|Noncompliance with study medication|1|||
144581741|NCT01072630|521329178|FG002|Overall Study|Noncompliance with study medication|1|||
144581742|NCT01072630|521329176|FG000|Overall Study|Noncompliance with study procedures|1|||
144581743|NCT01072630|521329177|FG001|Overall Study|Noncompliance with study procedures|2|||
144581744|NCT01072630|521329178|FG002|Overall Study|Noncompliance with study procedures|1|||
144581745|NCT01072630|521329176|FG000|Overall Study|Other|3|||
144581746|NCT01072630|521329177|FG001|Overall Study|Other|2|||
144581747|NCT01072630|521329178|FG002|Overall Study|Other|1|||
144581748|NCT03046121|521329179|FG000|Overall Study|Death|32|||
144581749|NCT03046121|521329180|FG001|Overall Study|Death|60|||
144581750|NCT03046121|521329179|FG000|Overall Study|Withdrawal by Subject|14|||
144581751|NCT03046121|521329180|FG001|Overall Study|Withdrawal by Subject|12|||
144581752|NCT04514510|521329183|FG000|Overall Study|Lost to Follow-up|0|||
144581753|NCT04514510|521329184|FG001|Overall Study|Lost to Follow-up|1|||
144581754|NCT04514510|521329183|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
144581755|NCT04514510|521329184|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
144581756|NCT00821587|521329189|FG000|Overall Study|Physician Decision|0|||
144581757|NCT00821587|521329190|FG001|Overall Study|Physician Decision|1|||
144581758|NCT04488770|521329193|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581759|NCT04488770|521329194|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581760|NCT04488770|521329195|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581761|NCT04488770|521329196|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
144581762|NCT04488770|521329197|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581763|NCT04488770|521329198|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581764|NCT04488770|521329199|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581765|NCT04488770|521329200|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581766|NCT04488770|521329201|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581767|NCT04488770|521329202|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581768|NCT04488770|521329203|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581769|NCT04488770|521329204|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581770|NCT04488770|521329205|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
144581771|NCT04488770|521329193|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
144581772|NCT04488770|521329194|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144622980|NCT00730639|521476381|FG001|Overall Study|Withdrawal by Subject|0|||
144622981|NCT00730639|521476382|FG002|Overall Study|Withdrawal by Subject|6|||
144622982|NCT00730639|521476383|FG003|Overall Study|Withdrawal by Subject|3|||
144622983|NCT00730639|521476384|FG004|Overall Study|Withdrawal by Subject|4|||
144622984|NCT00730639|521476380|FG000|Overall Study|Treatment on-going|2|||
144581773|NCT04488770|521329195|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581774|NCT04488770|521329196|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581775|NCT04488770|521329197|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581776|NCT04488770|521329198|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581777|NCT04488770|521329199|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581778|NCT04488770|521329200|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144622985|NCT00730639|521476381|FG001|Overall Study|Treatment on-going|5|||
144581779|NCT04488770|521329201|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581780|NCT04488770|521329202|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581781|NCT04488770|521329203|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581782|NCT04488770|521329204|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581783|NCT04488770|521329205|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
144581784|NCT04488770|521329193|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581785|NCT04488770|521329194|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581786|NCT04488770|521329195|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581787|NCT04488770|521329196|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581788|NCT04488770|521329197|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581789|NCT04488770|521329198|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
144581790|NCT04488770|521329199|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
144581791|NCT04488770|521329200|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581792|NCT04488770|521329201|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581793|NCT04488770|521329202|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581794|NCT04488770|521329203|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581795|NCT04488770|521329204|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581796|NCT04488770|521329205|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
144581797|NCT04488770|521329193|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581798|NCT04488770|521329194|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581799|NCT04488770|521329195|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581800|NCT04488770|521329196|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581801|NCT04488770|521329197|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
144581802|NCT04488770|521329198|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581803|NCT04488770|521329199|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581804|NCT04488770|521329200|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581805|NCT04488770|521329201|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581806|NCT04488770|521329202|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581807|NCT04488770|521329203|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581808|NCT04488770|521329204|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581809|NCT04488770|521329205|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
144581810|NCT01208103|521329206|FG000|Overall Study|Adverse Event|1|||
144581811|NCT01208103|521329206|FG000|Overall Study|Withdrawal by Subject|1|||
144581812|NCT03101462|521329207|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
144581813|NCT03101462|521329208|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
144581814|NCT03846453|521329209|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
144581815|NCT03846453|521329210|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
144581816|NCT03846453|521329211|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
144581817|NCT03846453|521329209|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
144581818|NCT03846453|521329210|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
144581819|NCT03846453|521329211|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
144581820|NCT03846453|521329209|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
144581821|NCT03846453|521329210|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
144581822|NCT03846453|521329211|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
144581823|NCT03846453|521329209|FG000|Placebo Run-in (14 Days)|Other|2|||
144581824|NCT03846453|521329210|FG001|Placebo Run-in (14 Days)|Other|0|||
144581825|NCT03846453|521329211|FG002|Placebo Run-in (14 Days)|Other|0|||
144581826|NCT03846453|521329209|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
144581827|NCT03846453|521329210|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
144581828|NCT03846453|521329211|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
144581829|NCT03846453|521329209|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
144581830|NCT03846453|521329210|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
144581831|NCT03846453|521329211|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
144581832|NCT03846453|521329209|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
144622986|NCT00730639|521476382|FG002|Overall Study|Treatment on-going|5|||
144622987|NCT00730639|521476383|FG003|Overall Study|Treatment on-going|4|||
144209426|NCT00094861|519961879|FG001|Overall Study|Withdrawal by Subject|3|||
144209427|NCT00094861|519961878|FG000|Overall Study|Physician Decision|1|||
144209428|NCT00094861|519961879|FG001|Overall Study|Physician Decision|1|||
144209429|NCT00094861|519961878|FG000|Overall Study|Lost to Follow-up|0|||
144209430|NCT00094861|519961879|FG001|Overall Study|Lost to Follow-up|1|||
144209431|NCT00094861|519961878|FG000|Overall Study|Death|4|||
144209432|NCT00094861|519961879|FG001|Overall Study|Death|2|||
144209433|NCT00094861|519961878|FG000|Overall Study|Other|3|||
144622988|NCT00730639|521476384|FG004|Overall Study|Treatment on-going|4|||
144209434|NCT00094861|519961879|FG001|Overall Study|Other|0|||
144209435|NCT00282919|519961880|FG000|Overall Study|Lack of Efficacy|4|||
144209436|NCT00282919|519961880|FG000|Overall Study|Withdrawal by Subject|1|||
144581833|NCT03846453|521329210|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
144581834|NCT03846453|521329211|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
144581835|NCT03846453|521329209|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
144581836|NCT03846453|521329210|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
144581837|NCT03846453|521329211|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
144581838|NCT03846453|521329209|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
144581839|NCT03846453|521329210|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
144581840|NCT03846453|521329211|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
144581841|NCT00468143|521329212|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
144581842|NCT00468143|521329213|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
144581843|NCT00468143|521329212|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
144581844|NCT00468143|521329213|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
144581845|NCT01606670|521329214|FG000|Overall Study|Adverse Event|6|||
144581846|NCT01606670|521329214|FG000|Overall Study|Lack of Efficacy|2|||
144581847|NCT01606670|521329214|FG000|Overall Study|Lost to Follow-up|3|||
144581848|NCT01606670|521329214|FG000|Overall Study|Withdrawal by Subject|3|||
144581849|NCT01606670|521329214|FG000|Overall Study|Other Reason|2|||
144581850|NCT02636725|521329215|FG000|Overall Study|Adverse Event|1|||
144581851|NCT03653208|521329218|FG000|Overall Study|Withdrawal by Subject|0|||
144581852|NCT03653208|521329219|FG001|Overall Study|Withdrawal by Subject|0|||
144581853|NCT03653208|521329220|FG002|Overall Study|Withdrawal by Subject|0|||
144581854|NCT03653208|521329221|FG003|Overall Study|Withdrawal by Subject|0|||
144581855|NCT03653208|521329222|FG004|Overall Study|Withdrawal by Subject|1|||
144581856|NCT03653208|521329223|FG005|Overall Study|Withdrawal by Subject|0|||
144581857|NCT03653208|521329224|FG006|Overall Study|Withdrawal by Subject|0|||
144581858|NCT03653208|521329225|FG007|Overall Study|Withdrawal by Subject|1|||
144581859|NCT03653208|521329226|FG008|Overall Study|Withdrawal by Subject|1|||
144581860|NCT01696045|521329228|FG000|Overall Study|Study drug toxicity|1|||
144581861|NCT01696045|521329229|FG001|Overall Study|Study drug toxicity|5|||
144581862|NCT01696045|521329228|FG000|Overall Study|Disease progression|2|||
144581863|NCT01696045|521329229|FG001|Overall Study|Disease progression|2|||
144581864|NCT01152814|521329231|FG000|Overall Study|Lost to Follow-up|2|||
144581865|NCT00886795|521329232|FG000|Overall Study|Lack of Efficacy|1|||
144581866|NCT01669577|521329236|FG000|Overall Study|Death|22|||
144581867|NCT01669577|521329236|FG000|Overall Study|Lost to Follow-up|78|||
144581868|NCT01669577|521329236|FG000|Overall Study|Physician Decision|34|||
144581869|NCT03466073|521329237|FG000|Overall Study|Death|1|||
144581870|NCT03466073|521329238|FG001|Overall Study|Death|0|||
144581871|NCT03466073|521329239|FG002|Overall Study|Death|0|||
144581872|NCT03466073|521329240|FG003|Overall Study|Death|0|||
144581873|NCT03466073|521329241|FG004|Overall Study|Death|0|||
144581874|NCT03466073|521329242|FG005|Overall Study|Death|1|||
144581875|NCT02045875|521329246|FG000|Overall Study|Lost to Follow-up|3|||
144581876|NCT02045875|521329247|FG001|Overall Study|Lost to Follow-up|0|||
144581877|NCT02045875|521329246|FG000|Overall Study|Withdrawal by Subject|4|||
144581878|NCT02045875|521329247|FG001|Overall Study|Withdrawal by Subject|3|||
144581879|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
144581880|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
144581881|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
144622989|NCT01844895|521476386|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
144622990|NCT01844895|521476386|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
144622991|NCT01844895|521476386|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
144622992|NCT01844895|521476386|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
144622993|NCT01844895|521476386|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
144622994|NCT01844895|521476386|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
144622995|NCT01844895|521476386|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
144581882|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
144581883|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
144581884|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
144581885|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
144581886|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
144581887|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
144581888|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
144581889|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Adverse Event|0|||
144581890|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Adverse Event|0|||
144581891|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Adverse Event|3|||
144581892|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Adverse Event|2|||
144581893|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Adverse Event|13|||
144581894|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
144622996|NCT02508194|521476390|FG000|Overall Study|Death|5|||
144581895|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
144622997|NCT02508194|521476391|FG001|Overall Study|Death|3|||
144622998|NCT02508194|521476390|FG000|Overall Study|Lost to Follow-up|25|||
144581896|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
144581897|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
144581898|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
144581899|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Patient's wish|0|||
144581900|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Patient's wish|0|||
144581901|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Patient's wish|19|||
144581902|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Patient's wish|9|||
144581903|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Patient's wish|20|||
144581904|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
144581905|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
144581906|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
144581907|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
144581908|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
144581909|NCT00444275|521329248|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
144581910|NCT00444275|521329249|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
144581911|NCT00444275|521329250|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
144581912|NCT00444275|521329251|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
144581913|NCT00444275|521329252|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
144581914|NCT01276379|521329253|FG000|Overall Study|Screening failure|40|||
144581915|NCT00864253|521329254|FG000|Overall Study|Adverse Event|56|||
144622999|NCT02508194|521476391|FG001|Overall Study|Lost to Follow-up|18|||
144623000|NCT02508194|521476390|FG000|Overall Study|Withdrawal by Subject|20|||
144623001|NCT02508194|521476391|FG001|Overall Study|Withdrawal by Subject|18|||
144623002|NCT02508194|521476390|FG000|Overall Study|Error in Randomization|1|||
144623003|NCT02508194|521476391|FG001|Overall Study|Error in Randomization|3|||
144623004|NCT02508194|521476390|FG000|Overall Study|Principal Investigator Decision|1|||
144623005|NCT02508194|521476391|FG001|Overall Study|Principal Investigator Decision|2|||
144623006|NCT00511355|521476392|FG000|Overall Study|Adverse Event|4|||
144623007|NCT00511355|521476393|FG001|Overall Study|Adverse Event|4|||
144623008|NCT00511355|521476392|FG000|Overall Study|Pregnancy Wish|1|||
144623009|NCT00511355|521476393|FG001|Overall Study|Pregnancy Wish|0|||
144623010|NCT00511355|521476392|FG000|Overall Study|Lost to Follow-up|2|||
144623011|NCT00511355|521476393|FG001|Overall Study|Lost to Follow-up|1|||
144623012|NCT00511355|521476392|FG000|Overall Study|Other Reason|0|||
144623013|NCT00511355|521476393|FG001|Overall Study|Other Reason|1|||
144623014|NCT00511355|521476392|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
144623015|NCT00511355|521476393|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
144623016|NCT00511355|521476392|FG000|Overall Study|Withdrawal of informed consent|0|||
144623017|NCT00511355|521476393|FG001|Overall Study|Withdrawal of informed consent|1|||
144623018|NCT00511355|521476392|FG000|Overall Study|Other reason pre-treatment|0|||
144623019|NCT00511355|521476393|FG001|Overall Study|Other reason pre-treatment|1|||
144623020|NCT00454805|521476397|FG000|Overall Study|Withdrawal by Subject|9|||
144623021|NCT00454805|521476398|FG001|Overall Study|Withdrawal by Subject|2|||
144623022|NCT00454805|521476397|FG000|Overall Study|Death|0|||
144623023|NCT00454805|521476398|FG001|Overall Study|Death|2|||
144623024|NCT00454805|521476397|FG000|Overall Study|Disease progression|16|||
144623025|NCT00454805|521476398|FG001|Overall Study|Disease progression|19|||
144623026|NCT00454805|521476397|FG000|Overall Study|In order to begin radiotherapy|1|||
144623027|NCT00454805|521476398|FG001|Overall Study|In order to begin radiotherapy|0|||
144623028|NCT00217087|521476399|FG000|Overall Study|decided to have esophagectomy|1|||
144623029|NCT00217087|521476400|FG001|Overall Study|decided to have esophagectomy|2|||
144623030|NCT00217087|521476399|FG000|Overall Study|completed less than 12 months return|10|||
144623031|NCT00217087|521476400|FG001|Overall Study|completed less than 12 months return|18|||
144623032|NCT01250379|521476412|FG000|Overall Study|Death|141|||
144623033|NCT01250379|521476413|FG001|Overall Study|Death|148|||
144623034|NCT01250379|521476412|FG000|Overall Study|Withdrawal by Subject|32|||
144623035|NCT01250379|521476413|FG001|Overall Study|Withdrawal by Subject|20|||
144623036|NCT01250379|521476412|FG000|Overall Study|Physician Decision|11|||
144623037|NCT01250379|521476413|FG001|Overall Study|Physician Decision|3|||
144623038|NCT01250379|521476412|FG000|Overall Study|Protocol Violation|2|||
144623039|NCT01250379|521476413|FG001|Overall Study|Protocol Violation|8|||
144623040|NCT01250379|521476412|FG000|Overall Study|Lost to Follow-up|9|||
144623041|NCT01250379|521476413|FG001|Overall Study|Lost to Follow-up|6|||
144623042|NCT01250379|521476412|FG000|Overall Study|Adverse Event|5|||
144623043|NCT01250379|521476413|FG001|Overall Study|Adverse Event|4|||
144581916|NCT00864253|521329255|FG001|Overall Study|Adverse Event|11|||
144581917|NCT00864253|521329254|FG000|Overall Study|Unrelated Adverse Event|3|||
144623044|NCT01250379|521476412|FG000|Overall Study|Other|0|||
144623045|NCT01250379|521476413|FG001|Overall Study|Other|4|||
144623046|NCT01250379|521476412|FG000|Overall Study|Participant noncompliance|2|||
144623047|NCT01250379|521476413|FG001|Overall Study|Participant noncompliance|0|||
144623048|NCT01489527|521476414|FG000|Overall Study|Pregnancy|9|||
144623049|NCT01489527|521476415|FG001|Overall Study|Pregnancy|14|||
144623050|NCT01489527|521476414|FG000|Overall Study|Participant moved|6|||
144623051|NCT01489527|521476415|FG001|Overall Study|Participant moved|7|||
144581918|NCT00864253|521329255|FG001|Overall Study|Unrelated Adverse Event|1|||
144581919|NCT00864253|521329254|FG000|Overall Study|Physician Decision|11|||
144581920|NCT00864253|521329255|FG001|Overall Study|Physician Decision|15|||
144581921|NCT00864253|521329254|FG000|Overall Study|Protocol Violation|0|||
144581922|NCT00864253|521329255|FG001|Overall Study|Protocol Violation|2|||
144581923|NCT00864253|521329254|FG000|Overall Study|Lost to Follow-up|1|||
144581924|NCT00864253|521329255|FG001|Overall Study|Lost to Follow-up|1|||
144581925|NCT00864253|521329254|FG000|Overall Study|Withdrawal by Subject|18|||
144581926|NCT00864253|521329255|FG001|Overall Study|Withdrawal by Subject|18|||
144581927|NCT00864253|521329254|FG000|Overall Study|Death|1|||
144581928|NCT00864253|521329255|FG001|Overall Study|Death|0|||
144581929|NCT00864253|521329254|FG000|Overall Study|Ongoing|2|||
144730382|NCT03048500|521868218|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
144730383|NCT03048500|521868218|FG000|Follow up for 3 Years|Death|12|||
144730384|NCT01941030|521868221|FG000|Overall Study|Death|3|||
144730385|NCT01941030|521868222|FG001|Overall Study|Death|2|||
144730386|NCT01941030|521868221|FG000|Overall Study|Lost to Follow-up|6|||
144581930|NCT00864253|521329255|FG001|Overall Study|Ongoing|3|||
144581931|NCT00864253|521329254|FG000|Overall Study|Untreated|7|||
144581932|NCT00864253|521329255|FG001|Overall Study|Untreated|7|||
144581933|NCT01111240|521329258|FG000|Overall Study|Adverse Event|190|||
144581934|NCT01111240|521329258|FG000|Overall Study|Lack of Efficacy|545|||
144581935|NCT01111240|521329258|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
144581936|NCT01111240|521329258|FG000|Overall Study|Other|312|||
144581937|NCT04662931|521329259|FG000|Overall Study|Withdrawal by Subject|17|||
144581938|NCT04662931|521329259|FG000|Overall Study|Death|3|||
144581939|NCT04662931|521329259|FG000|Overall Study|Lost to Follow-up|3|||
144581940|NCT04662931|521329259|FG000|Overall Study|Guardian Decision|1|||
144581941|NCT01989169|521329260|FG000|Period 2|Adverse Event|0|||
144581942|NCT01989169|521329261|FG001|Period 2|Adverse Event|1|||
144581943|NCT01585155|521329262|FG000|Overall Study|Adverse Event|1|||
144581944|NCT01585155|521329262|FG000|Overall Study|Lack of Efficacy|2|||
144581945|NCT01585155|521329262|FG000|Overall Study|Worsening ulcerative colitis|2|||
144581946|NCT01743989|521329263|FG000|Treatment Phase|Unstable MR4.0|0|||
144581947|NCT01743989|521329264|FG001|Treatment Phase|Unstable MR4.0|6|||
144581948|NCT01743989|521329265|FG002|Treatment Phase|Unstable MR4.0|263|||
144581949|NCT01743989|521329263|FG000|Treatment Phase|Adverse Event|0|||
144581950|NCT01743989|521329264|FG001|Treatment Phase|Adverse Event|4|||
144581951|NCT01743989|521329265|FG002|Treatment Phase|Adverse Event|67|||
144581952|NCT01743989|521329263|FG000|Treatment Phase|Withdrawal by Subject|1|||
144581953|NCT01743989|521329264|FG001|Treatment Phase|Withdrawal by Subject|3|||
144581954|NCT01743989|521329265|FG002|Treatment Phase|Withdrawal by Subject|28|||
144581955|NCT01743989|521329263|FG000|Treatment Phase|Death|0|||
144581956|NCT01743989|521329264|FG001|Treatment Phase|Death|1|||
144581957|NCT01743989|521329265|FG002|Treatment Phase|Death|3|||
144581958|NCT01743989|521329263|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
144581959|NCT01743989|521329264|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
144581960|NCT01743989|521329265|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
144581961|NCT01743989|521329263|FG000|Treatment Phase|Protocol deviation|0|||
144581962|NCT01743989|521329264|FG001|Treatment Phase|Protocol deviation|0|||
144581963|NCT01743989|521329265|FG002|Treatment Phase|Protocol deviation|3|||
144581964|NCT01743989|521329263|FG000|Treatment Phase|Pregnancy|0|||
144581965|NCT01743989|521329264|FG001|Treatment Phase|Pregnancy|0|||
144581966|NCT01743989|521329265|FG002|Treatment Phase|Pregnancy|2|||
144581967|NCT01743989|521329263|FG000|Treatment Phase|Lost to Follow-up|0|||
144581968|NCT01743989|521329264|FG001|Treatment Phase|Lost to Follow-up|0|||
144581969|NCT01743989|521329265|FG002|Treatment Phase|Lost to Follow-up|2|||
144581970|NCT01743989|521329263|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
144581971|NCT01743989|521329264|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
144581972|NCT01743989|521329265|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
144581973|NCT01743989|521329263|FG000|Treatment Phase|Administrative problems|0|||
144730387|NCT01941030|521868222|FG001|Overall Study|Lost to Follow-up|5|||
144730388|NCT01941030|521868221|FG000|Overall Study|Withdrawal by Subject|4|||
144581974|NCT01743989|521329264|FG001|Treatment Phase|Administrative problems|0|||
144581975|NCT01743989|521329265|FG002|Treatment Phase|Administrative problems|1|||
144581976|NCT01743989|521329263|FG000|Treatment Phase|New cancer (CML) therapy|0|||
144581977|NCT01743989|521329264|FG001|Treatment Phase|New cancer (CML) therapy|1|||
144581978|NCT01743989|521329265|FG002|Treatment Phase|New cancer (CML) therapy|0|||
144581979|NCT01743989|521329263|FG000|Treatment Phase|Physician Decision|0|||
144581980|NCT01743989|521329264|FG001|Treatment Phase|Physician Decision|0|||
144581981|NCT01743989|521329265|FG002|Treatment Phase|Physician Decision|3|||
144581982|NCT01743989|521329263|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
144581983|NCT01743989|521329264|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
144581984|NCT01743989|521329265|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
144581985|NCT01743989|521329263|FG000|Treatment Phase|Not randomized by mistake|0|||
144581986|NCT01743989|521329264|FG001|Treatment Phase|Not randomized by mistake|0|||
144581987|NCT01743989|521329265|FG002|Treatment Phase|Not randomized by mistake|1|||
144581988|NCT01743989|521329263|FG000|Treatment Phase|Included by mistake|0|||
144581989|NCT01743989|521329264|FG001|Treatment Phase|Included by mistake|0|||
144581990|NCT01743989|521329265|FG002|Treatment Phase|Included by mistake|1|||
144581991|NCT01743989|521329263|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
144581992|NCT01743989|521329264|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
144581993|NCT01743989|521329265|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
144581994|NCT01743989|521329263|FG000|TFR Phase|Adverse Event|0|||
144581995|NCT01743989|521329264|FG001|TFR Phase|Adverse Event|1|||
144581996|NCT01743989|521329265|FG002|TFR Phase|Adverse Event|0|||
144581997|NCT01743989|521329263|FG000|TFR Phase|Lost to Follow-up|0|||
144581998|NCT01743989|521329264|FG001|TFR Phase|Lost to Follow-up|2|||
144581999|NCT01743989|521329265|FG002|TFR Phase|Lost to Follow-up|0|||
144582000|NCT01743989|521329263|FG000|TFR Phase|Physician Decision|0|||
144582001|NCT01743989|521329264|FG001|TFR Phase|Physician Decision|1|||
144582002|NCT01743989|521329265|FG002|TFR Phase|Physician Decision|0|||
144582003|NCT01743989|521329263|FG000|TFR Phase|Logistical problems|0|||
144582004|NCT01743989|521329264|FG001|TFR Phase|Logistical problems|2|||
144582005|NCT01743989|521329265|FG002|TFR Phase|Logistical problems|0|||
144582006|NCT01743989|521329263|FG000|TFR Phase|Protocol deviation|0|||
144582007|NCT01743989|521329264|FG001|TFR Phase|Protocol deviation|1|||
144582008|NCT01743989|521329265|FG002|TFR Phase|Protocol deviation|0|||
144582009|NCT01743989|521329263|FG000|TFR Phase|Withdrawal by Subject|0|||
144582010|NCT01743989|521329264|FG001|TFR Phase|Withdrawal by Subject|2|||
144582011|NCT01743989|521329265|FG002|TFR Phase|Withdrawal by Subject|0|||
144623052|NCT01489527|521476414|FG000|Overall Study|Withdrawal by Subject|0|||
144623053|NCT01489527|521476415|FG001|Overall Study|Withdrawal by Subject|4|||
144623054|NCT01489527|521476414|FG000|Overall Study|Lost to Follow-up|5|||
144623055|NCT01489527|521476415|FG001|Overall Study|Lost to Follow-up|1|||
144623056|NCT01489527|521476414|FG000|Overall Study|Procedures|1|||
144623057|NCT01489527|521476415|FG001|Overall Study|Procedures|0|||
144623058|NCT01489527|521476414|FG000|Overall Study|Not compliant|1|||
144623059|NCT01489527|521476415|FG001|Overall Study|Not compliant|0|||
144623060|NCT01984268|521476416|FG000|Overall Study|Study Terminated|15|||
144623061|NCT04899232|521476417|FG000|Screening Period|Physician Decision|1|||
144623062|NCT04899232|521476418|FG001|Screening Period|Physician Decision|0|||
144623063|NCT04899232|521476419|FG002|Screening Period|Physician Decision|0|||
144623064|NCT04899232|521476417|FG000|Screening Period|Withdrawal by Subject|1|||
144623065|NCT04899232|521476418|FG001|Screening Period|Withdrawal by Subject|0|||
144623066|NCT04899232|521476419|FG002|Screening Period|Withdrawal by Subject|0|||
144623067|NCT04899232|521476417|FG000|Screening Period|Participant discharged before receiving intervention|3|||
144623068|NCT04899232|521476418|FG001|Screening Period|Participant discharged before receiving intervention|0|||
144623069|NCT04899232|521476419|FG002|Screening Period|Participant discharged before receiving intervention|0|||
144623070|NCT05061719|521476423|FG000|Overall Study|Adverse Event|60|||
144623071|NCT05061719|521476423|FG000|Overall Study|Death|1|||
144623072|NCT05061719|521476423|FG000|Overall Study|Lack of Efficacy|7|||
144623073|NCT05061719|521476423|FG000|Overall Study|Lost to Follow-up|5|||
144623074|NCT05061719|521476423|FG000|Overall Study|Pregnancy|1|||
144623075|NCT05061719|521476423|FG000|Overall Study|Protocol Violation|8|||
144623076|NCT05061719|521476423|FG000|Overall Study|Withdrawal by Subject|41|||
144623077|NCT05061719|521476423|FG000|Overall Study|Site Closure|2|||
144623078|NCT04137887|521478554|FG000|Overall Study|Death|102|||
144623079|NCT04137887|521478555|FG001|Overall Study|Death|92|||
144623080|NCT04137887|521478554|FG000|Overall Study|Withdrawal by Subject|2|||
144623081|NCT04137887|521478555|FG001|Overall Study|Withdrawal by Subject|3|||
144623082|NCT04137887|521478554|FG000|Overall Study|Randomized but not treated|0|||
144623083|NCT04137887|521478555|FG001|Overall Study|Randomized but not treated|1|||
144623084|NCT02740478|521478557|FG000|Overall Study|Withdrawal by Subject|1|||
144623085|NCT01934140|521478559|FG000|Persistence Phase (Year 6-10)|Other|24|||
144623086|NCT01934140|521478560|FG001|Persistence Phase (Year 6-10)|Other|6|||
144623087|NCT01934140|521478559|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
144623088|NCT01934140|521478560|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
144623089|NCT01934140|521478559|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
144623090|NCT01934140|521478560|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
144623091|NCT01934140|521478559|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
144623092|NCT01934140|521478560|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
144582012|NCT01743989|521329263|FG000|Re-treatment Phase|Adverse Event|8|||
144582013|NCT01743989|521329264|FG001|Re-treatment Phase|Adverse Event|4|||
144582014|NCT01743989|521329265|FG002|Re-treatment Phase|Adverse Event|0|||
144582015|NCT01743989|521329263|FG000|Re-treatment Phase|Death|1|||
144582016|NCT01743989|521329264|FG001|Re-treatment Phase|Death|1|||
144582017|NCT01743989|521329265|FG002|Re-treatment Phase|Death|0|||
144623093|NCT01934140|521478559|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
144623094|NCT01934140|521478560|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
144623095|NCT01934140|521478559|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
144623096|NCT01934140|521478560|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
144582018|NCT01743989|521329263|FG000|Re-treatment Phase|Administrative problems|1|||
144582019|NCT01743989|521329264|FG001|Re-treatment Phase|Administrative problems|1|||
144582020|NCT01743989|521329265|FG002|Re-treatment Phase|Administrative problems|0|||
144582021|NCT01743989|521329263|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
144582022|NCT01743989|521329264|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
144582023|NCT01743989|521329265|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
144582024|NCT01743989|521329263|FG000|Re-treatment Phase|Unstable MR|1|||
144582025|NCT01743989|521329264|FG001|Re-treatment Phase|Unstable MR|0|||
144582026|NCT01743989|521329265|FG002|Re-treatment Phase|Unstable MR|0|||
144582027|NCT01743989|521329263|FG000|Re-treatment Phase|Physician Decision|0|||
144582028|NCT01743989|521329264|FG001|Re-treatment Phase|Physician Decision|1|||
144582029|NCT01743989|521329265|FG002|Re-treatment Phase|Physician Decision|0|||
144582030|NCT01743989|521329263|FG000|Re-treatment Phase|Lost to Follow-up|0|||
144582031|NCT01743989|521329264|FG001|Re-treatment Phase|Lost to Follow-up|1|||
144582032|NCT01743989|521329265|FG002|Re-treatment Phase|Lost to Follow-up|0|||
144582033|NCT02235311|521329272|FG000|Overall Study|Lost to Follow-up|0|||
144582034|NCT02235311|521329273|FG001|Overall Study|Lost to Follow-up|1|||
144582035|NCT02235311|521329272|FG000|Overall Study|Protocol Violation|0|||
144582036|NCT02235311|521329273|FG001|Overall Study|Protocol Violation|1|||
144582037|NCT04655027|521329274|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
144623097|NCT01934140|521478559|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
144623098|NCT01934140|521478560|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
144623099|NCT01934140|521478559|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
144623100|NCT01934140|521478560|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
144623101|NCT05499559|521478561|FG000|Overall Study|Lost to Follow-up|467|||
144623102|NCT02770326|521478564|FG000|Overall Study|Death|3|||
144623103|NCT02770326|521478564|FG000|Overall Study|Lost to Follow-up|1|||
144623104|NCT02889796|521478565|FG000|Overall Study|Withdrew Consent|18|||
144623105|NCT02889796|521478566|FG001|Overall Study|Withdrew Consent|29|||
144623106|NCT02889796|521478567|FG002|Overall Study|Withdrew Consent|20|||
144623107|NCT02889796|521478568|FG003|Overall Study|Withdrew Consent|1|||
144623108|NCT02889796|521478569|FG004|Overall Study|Withdrew Consent|2|||
144623109|NCT02889796|521478570|FG005|Overall Study|Withdrew Consent|35|||
144623110|NCT02889796|521478565|FG000|Overall Study|Investigator's Discretion|10|||
144623111|NCT02889796|521478566|FG001|Overall Study|Investigator's Discretion|9|||
144623112|NCT02889796|521478567|FG002|Overall Study|Investigator's Discretion|10|||
144623113|NCT02889796|521478568|FG003|Overall Study|Investigator's Discretion|3|||
144623114|NCT02889796|521478569|FG004|Overall Study|Investigator's Discretion|0|||
144623115|NCT02889796|521478570|FG005|Overall Study|Investigator's Discretion|15|||
144623116|NCT02889796|521478565|FG000|Overall Study|Adverse Event|17|||
144623117|NCT02889796|521478566|FG001|Overall Study|Adverse Event|8|||
144623118|NCT02889796|521478567|FG002|Overall Study|Adverse Event|8|||
144623119|NCT02889796|521478568|FG003|Overall Study|Adverse Event|4|||
144623120|NCT02889796|521478569|FG004|Overall Study|Adverse Event|1|||
144623121|NCT02889796|521478570|FG005|Overall Study|Adverse Event|7|||
144623122|NCT02889796|521478565|FG000|Overall Study|Lost to Follow-up|5|||
144623123|NCT02889796|521478566|FG001|Overall Study|Lost to Follow-up|7|||
144623124|NCT02889796|521478567|FG002|Overall Study|Lost to Follow-up|2|||
144623125|NCT02889796|521478568|FG003|Overall Study|Lost to Follow-up|0|||
144623126|NCT02889796|521478569|FG004|Overall Study|Lost to Follow-up|2|||
144623127|NCT02889796|521478570|FG005|Overall Study|Lost to Follow-up|6|||
144623128|NCT02889796|521478565|FG000|Overall Study|Protocol Violation|0|||
144623129|NCT02889796|521478566|FG001|Overall Study|Protocol Violation|1|||
144623130|NCT02889796|521478567|FG002|Overall Study|Protocol Violation|3|||
144623131|NCT02889796|521478568|FG003|Overall Study|Protocol Violation|0|||
144623132|NCT02889796|521478569|FG004|Overall Study|Protocol Violation|0|||
144623133|NCT02889796|521478570|FG005|Overall Study|Protocol Violation|4|||
144623134|NCT02889796|521478565|FG000|Overall Study|Non-compliance With Study Drug|0|||
144623135|NCT02889796|521478566|FG001|Overall Study|Non-compliance With Study Drug|2|||
144623136|NCT02889796|521478567|FG002|Overall Study|Non-compliance With Study Drug|0|||
144623137|NCT02889796|521478568|FG003|Overall Study|Non-compliance With Study Drug|0|||
144623138|NCT02889796|521478569|FG004|Overall Study|Non-compliance With Study Drug|1|||
144623139|NCT02889796|521478570|FG005|Overall Study|Non-compliance With Study Drug|2|||
144623140|NCT02889796|521478565|FG000|Overall Study|Death|1|||
144623141|NCT02889796|521478566|FG001|Overall Study|Death|1|||
144623142|NCT02889796|521478567|FG002|Overall Study|Death|0|||
144623143|NCT02889796|521478568|FG003|Overall Study|Death|1|||
144623144|NCT02889796|521478569|FG004|Overall Study|Death|0|||
144623145|NCT02889796|521478570|FG005|Overall Study|Death|1|||
144623146|NCT02889796|521478565|FG000|Overall Study|Pregnancy|0|||
144623147|NCT02889796|521478566|FG001|Overall Study|Pregnancy|1|||
144623148|NCT02889796|521478567|FG002|Overall Study|Pregnancy|1|||
144623149|NCT02889796|521478568|FG003|Overall Study|Pregnancy|0|||
144623150|NCT02889796|521478569|FG004|Overall Study|Pregnancy|0|||
144623151|NCT02889796|521478570|FG005|Overall Study|Pregnancy|0|||
144623152|NCT02889796|521478565|FG000|Overall Study|Randomized but not Dosed|2|||
144730389|NCT01941030|521868222|FG001|Overall Study|Withdrawal by Subject|6|||
144623153|NCT02889796|521478566|FG001|Overall Study|Randomized but not Dosed|0|||
144623154|NCT02889796|521478567|FG002|Overall Study|Randomized but not Dosed|0|||
144623155|NCT02889796|521478568|FG003|Overall Study|Randomized but not Dosed|0|||
144582038|NCT04655027|521329275|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
144582039|NCT00653523|521329276|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
144582040|NCT00653523|521329276|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
144582041|NCT00653523|521329276|FG000|Overall Study|Adverse Event|7|||
144582042|NCT00653523|521329276|FG000|Overall Study|Withdrawal by Subject|6|||
144582043|NCT00653523|521329276|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
144582044|NCT00653523|521329276|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
144582045|NCT05543707|521329279|FG000|Overall Study|Study drug non-compliance/|5|||
144582046|NCT05543707|521329280|FG001|Overall Study|Study drug non-compliance/|0|||
144582047|NCT05543707|521329279|FG000|Overall Study|Withdrawal by Subject|1|||
144582048|NCT05543707|521329280|FG001|Overall Study|Withdrawal by Subject|1|||
144582049|NCT05543707|521329279|FG000|Overall Study|Adverse Event|1|||
144582050|NCT05543707|521329280|FG001|Overall Study|Adverse Event|0|||
144582051|NCT05543707|521329279|FG000|Overall Study|concurrent illness|0|||
144582052|NCT05543707|521329280|FG001|Overall Study|concurrent illness|1|||
144582053|NCT05543707|521329279|FG000|Overall Study|Pregnancy|1|||
144582054|NCT05543707|521329280|FG001|Overall Study|Pregnancy|1|||
144582055|NCT00186888|521329281|FG000|Overall Study|Toxicity|0|||
144582056|NCT00186888|521329282|FG001|Overall Study|Toxicity|1|||
144582057|NCT00186888|521329283|FG002|Overall Study|Toxicity|0|||
144582058|NCT00186888|521329281|FG000|Overall Study|Relapse or progression of disease|4|||
144582059|NCT00186888|521329282|FG001|Overall Study|Relapse or progression of disease|2|||
144582060|NCT00186888|521329283|FG002|Overall Study|Relapse or progression of disease|0|||
144582061|NCT02108964|521329284|FG000|Overall Study|Progressive disease|15|||
144582062|NCT02108964|521329285|FG001|Overall Study|Progressive disease|31|||
144582063|NCT02108964|521329286|FG002|Overall Study|Progressive disease|54|||
144582064|NCT02108964|521329287|FG003|Overall Study|Progressive disease|7|||
144582065|NCT02108964|521329288|FG004|Overall Study|Progressive disease|20|||
144582066|NCT02108964|521329289|FG005|Overall Study|Progressive disease|4|||
144582067|NCT02108964|521329290|FG006|Overall Study|Progressive disease|6|||
144582068|NCT02108964|521329291|FG007|Overall Study|Progressive disease|33|||
144582069|NCT02108964|521329284|FG000|Overall Study|Physician Decision|1|||
144582070|NCT02108964|521329285|FG001|Overall Study|Physician Decision|5|||
144582071|NCT02108964|521329286|FG002|Overall Study|Physician Decision|7|||
144582072|NCT02108964|521329287|FG003|Overall Study|Physician Decision|1|||
144582073|NCT02108964|521329288|FG004|Overall Study|Physician Decision|2|||
144582074|NCT02108964|521329289|FG005|Overall Study|Physician Decision|1|||
144582075|NCT02108964|521329290|FG006|Overall Study|Physician Decision|1|||
144582076|NCT02108964|521329291|FG007|Overall Study|Physician Decision|3|||
144582077|NCT02108964|521329284|FG000|Overall Study|Adverse Event|0|||
144582078|NCT02108964|521329285|FG001|Overall Study|Adverse Event|0|||
144582079|NCT02108964|521329286|FG002|Overall Study|Adverse Event|4|||
144582080|NCT02108964|521329287|FG003|Overall Study|Adverse Event|0|||
144582081|NCT02108964|521329288|FG004|Overall Study|Adverse Event|1|||
144582082|NCT02108964|521329289|FG005|Overall Study|Adverse Event|0|||
144582083|NCT02108964|521329290|FG006|Overall Study|Adverse Event|3|||
144582084|NCT02108964|521329291|FG007|Overall Study|Adverse Event|2|||
144582085|NCT02108964|521329284|FG000|Overall Study|Death|1|||
144582086|NCT02108964|521329285|FG001|Overall Study|Death|1|||
144582087|NCT02108964|521329286|FG002|Overall Study|Death|4|||
144582088|NCT02108964|521329287|FG003|Overall Study|Death|0|||
144582089|NCT02108964|521329288|FG004|Overall Study|Death|3|||
144582090|NCT02108964|521329289|FG005|Overall Study|Death|0|||
144582091|NCT02108964|521329290|FG006|Overall Study|Death|0|||
144582092|NCT02108964|521329291|FG007|Overall Study|Death|2|||
144582093|NCT02108964|521329284|FG000|Overall Study|Subject/Guardian decision|0|||
144623156|NCT02889796|521478569|FG004|Overall Study|Randomized but not Dosed|0|||
144623157|NCT02889796|521478570|FG005|Overall Study|Randomized but not Dosed|2|||
144623158|NCT04294459|521478572|FG000|Overall Study|Adverse Event|0|||
144623159|NCT04294459|521478573|FG001|Overall Study|Adverse Event|1|||
144623160|NCT04033367|521478574|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
144209437|NCT00282919|519961880|FG000|Overall Study|Asymptomatic Parasitemia|2|||
144582094|NCT02108964|521329285|FG001|Overall Study|Subject/Guardian decision|1|||
144582095|NCT02108964|521329286|FG002|Overall Study|Subject/Guardian decision|4|||
144582096|NCT02108964|521329287|FG003|Overall Study|Subject/Guardian decision|0|||
144209438|NCT01433549|519961881|FG000|Phase 2: Second Study Product|Adverse Event|0|||
144209439|NCT01433549|519961882|FG001|Phase 2: Second Study Product|Adverse Event|1|||
144582097|NCT02108964|521329288|FG004|Overall Study|Subject/Guardian decision|2|||
144582098|NCT02108964|521329289|FG005|Overall Study|Subject/Guardian decision|0|||
144582099|NCT02108964|521329290|FG006|Overall Study|Subject/Guardian decision|1|||
144209440|NCT02540850|519961885|FG000|Overall Study|Lost to Follow-up|69|||
144582100|NCT02108964|521329291|FG007|Overall Study|Subject/Guardian decision|2|||
144582101|NCT02108964|521329284|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144582102|NCT02108964|521329285|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144582103|NCT02108964|521329286|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144623161|NCT04033367|521478575|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
144582104|NCT02108964|521329287|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144582105|NCT02108964|521329288|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144582106|NCT02108964|521329289|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144582107|NCT02108964|521329290|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
144582108|NCT02108964|521329291|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
144582109|NCT03006848|521329292|FG000|Overall Study|Adverse Event|1|||
144582110|NCT03006848|521329292|FG000|Overall Study|Physician Decision|1|||
144582111|NCT03006848|521329292|FG000|Overall Study|Lack of Efficacy|16|||
144582112|NCT05384938|521329293|FG000|Overall Study|Withdrawal by Subject|8|||
144582113|NCT05384938|521329293|FG000|Overall Study|Lost to Follow-up|6|||
144582114|NCT05384938|521329293|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
144582115|NCT04696653|521329295|FG000|Overall Study|left organization|18|||
144582116|NCT04696653|521329295|FG000|Overall Study|Lost to Follow-up|3|||
144582117|NCT02218606|521331669|FG000|Overall Study|Adverse Event|1|||
144582118|NCT02218606|521331670|FG001|Overall Study|Adverse Event|1|||
144582119|NCT02218606|521331669|FG000|Overall Study|Death|15|||
144582120|NCT02218606|521331670|FG001|Overall Study|Death|28|||
144582121|NCT02218606|521331669|FG000|Overall Study|Physician Decision|0|||
144582122|NCT02218606|521331670|FG001|Overall Study|Physician Decision|1|||
144582123|NCT02218606|521331669|FG000|Overall Study|Withdrawal by Subject|4|||
144582124|NCT02218606|521331670|FG001|Overall Study|Withdrawal by Subject|0|||
144582125|NCT02218606|521331669|FG000|Overall Study|Noncompliance|1|||
144582126|NCT02218606|521331670|FG001|Overall Study|Noncompliance|0|||
144582127|NCT02218606|521331669|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
144582128|NCT02218606|521331670|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
144582129|NCT02218606|521331669|FG000|Overall Study|Other|2|||
144623162|NCT04033367|521478574|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
144623163|NCT04033367|521478575|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
144623164|NCT04033367|521478574|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
144623165|NCT04033367|521478575|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
144623166|NCT04033367|521478574|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
144623167|NCT04033367|521478575|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
144623168|NCT02421887|521478576|FG000|Overall Study|Lost to Follow-up|5|||
144623169|NCT02421887|521478577|FG001|Overall Study|Lost to Follow-up|0|||
144623170|NCT02421887|521478576|FG000|Overall Study|Withdrawal by Subject|8|||
144623171|NCT02421887|521478577|FG001|Overall Study|Withdrawal by Subject|5|||
144623172|NCT02421887|521478576|FG000|Overall Study|Physician Decision|2|||
144623173|NCT02421887|521478577|FG001|Overall Study|Physician Decision|4|||
144623174|NCT02421887|521478576|FG000|Overall Study|Adverse Event|2|||
144582130|NCT02218606|521331670|FG001|Overall Study|Other|1|||
144582131|NCT02218606|521331669|FG000|Overall Study|Never started treatment|0|||
144582132|NCT02218606|521331670|FG001|Overall Study|Never started treatment|1|||
144582133|NCT03203473|521331671|FG000|Induction Phase|Never started primary treatment|2|||
144582134|NCT03203473|521331672|FG001|Induction Phase|Never started primary treatment|0|||
144582135|NCT03203473|521331673|FG002|Induction Phase|Never started primary treatment|0|||
144582136|NCT03203473|521331671|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
144582137|NCT03203473|521331672|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
144582138|NCT03203473|521331673|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
144582139|NCT03203473|521331671|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
144582140|NCT03203473|521331672|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
144582141|NCT03203473|521331673|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
144582142|NCT03203473|521331671|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
144582143|NCT03203473|521331672|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
144623175|NCT02421887|521478577|FG001|Overall Study|Adverse Event|0|||
144582144|NCT03203473|521331673|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
144623176|NCT01978093|521478578|FG000|Overall Study|Death|1|||
144623177|NCT01978093|521478579|FG001|Overall Study|Death|0|||
144623178|NCT01978093|521478578|FG000|Overall Study|Adverse Event|0|||
144623179|NCT01978093|521478579|FG001|Overall Study|Adverse Event|5|||
144623180|NCT01978093|521478578|FG000|Overall Study|Protocol Violation|8|||
144623181|NCT01978093|521478579|FG001|Overall Study|Protocol Violation|2|||
144623182|NCT01978093|521478578|FG000|Overall Study|Withdrawal by Subject|29|||
144582145|NCT03203473|521331671|FG000|Arm Allocation Phase|started salvage therapy|0|||
144623183|NCT01978093|521478579|FG001|Overall Study|Withdrawal by Subject|25|||
144623184|NCT01978093|521478578|FG000|Overall Study|Lost to Follow-up|11|||
144730390|NCT00304083|521868226|FG000|Overall Study|Withdrawal by Subject|4|||
144623185|NCT01978093|521478579|FG001|Overall Study|Lost to Follow-up|15|||
144623186|NCT01978093|521478578|FG000|Overall Study|Migrated/moved from study area|11|||
144623187|NCT01978093|521478579|FG001|Overall Study|Migrated/moved from study area|13|||
144623188|NCT01978093|521478578|FG000|Overall Study|Loss of kaiser coverage|4|||
144623189|NCT01978093|521478579|FG001|Overall Study|Loss of kaiser coverage|10|||
144582146|NCT03203473|521331672|FG001|Arm Allocation Phase|started salvage therapy|5|||
144582147|NCT03203473|521331673|FG002|Arm Allocation Phase|started salvage therapy|0|||
144582148|NCT03203473|521331671|FG000|Arm Allocation Phase|Disease progression|0|||
144582149|NCT03203473|521331672|FG001|Arm Allocation Phase|Disease progression|0|||
144582150|NCT03203473|521331673|FG002|Arm Allocation Phase|Disease progression|37|||
144582151|NCT03203473|521331671|FG000|Arm Allocation Phase|Adverse Event|0|||
144582152|NCT03203473|521331672|FG001|Arm Allocation Phase|Adverse Event|0|||
144582153|NCT03203473|521331673|FG002|Arm Allocation Phase|Adverse Event|11|||
144582154|NCT03203473|521331671|FG000|Arm Allocation Phase|Physician Decision|0|||
144582155|NCT03203473|521331672|FG001|Arm Allocation Phase|Physician Decision|0|||
144582156|NCT03203473|521331673|FG002|Arm Allocation Phase|Physician Decision|3|||
144582157|NCT03203473|521331671|FG000|Arm Allocation Phase|Death|0|||
144582158|NCT03203473|521331672|FG001|Arm Allocation Phase|Death|0|||
144582159|NCT03203473|521331673|FG002|Arm Allocation Phase|Death|1|||
144582160|NCT03203473|521331671|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
144582161|NCT03203473|521331672|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
144582162|NCT03203473|521331673|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
144582163|NCT03203473|521331671|FG000|Arm Allocation Phase|Intercurrent illness|0|||
144582164|NCT03203473|521331672|FG001|Arm Allocation Phase|Intercurrent illness|0|||
144582165|NCT03203473|521331673|FG002|Arm Allocation Phase|Intercurrent illness|1|||
144582166|NCT03203473|521331671|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
144582167|NCT03203473|521331672|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
144582168|NCT03203473|521331673|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
144582169|NCT02314780|521331680|FG000|Overall Study|organizational reasons|0|||
144582170|NCT02314780|521331681|FG001|Overall Study|organizational reasons|2|||
144582171|NCT02314780|521331682|FG002|Overall Study|organizational reasons|0|||
144582172|NCT02314780|521331680|FG000|Overall Study|Adverse Event|0|||
144582173|NCT02314780|521331681|FG001|Overall Study|Adverse Event|1|||
144582174|NCT02314780|521331682|FG002|Overall Study|Adverse Event|0|||
144582175|NCT01077271|521331683|FG000|Overall Study|Parental desire|8|||
144582176|NCT01077271|521331683|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
144582177|NCT01077271|521331683|FG000|Overall Study|Noncompliance|2|||
144582178|NCT01077271|521331683|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
144582179|NCT01077271|521331683|FG000|Overall Study|Changed doctors|2|||
144582180|NCT01077271|521331683|FG000|Overall Study|Parents thought too many injections|2|||
144582181|NCT01077271|521331683|FG000|Overall Study|End of RSV season nearly reached|1|||
144582182|NCT01077271|521331683|FG000|Overall Study|Mother unconvinced of the necessity|1|||
144582183|NCT00215137|521331684|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
144582184|NCT00215137|521331685|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
144582185|NCT00215137|521331686|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
144582186|NCT00215137|521331684|FG000|Randomization Period|Lost to Follow-up|0|||
144582187|NCT00215137|521331685|FG001|Randomization Period|Lost to Follow-up|1|||
144582188|NCT00215137|521331686|FG002|Randomization Period|Lost to Follow-up|0|||
144582189|NCT00215137|521331684|FG000|Randomization Period|Withdrawal by Subject|0|||
144582190|NCT00215137|521331685|FG001|Randomization Period|Withdrawal by Subject|1|||
144582191|NCT00215137|521331686|FG002|Randomization Period|Withdrawal by Subject|0|||
144582192|NCT03333876|521331687|FG000|Screening Period|Screen Failure|4|||
144582193|NCT03333876|521331687|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
144582194|NCT03333876|521331687|FG000|Mandibular Advancement|Adverse Event|2|||
144582195|NCT03333876|521331687|FG000|Mandibular Advancement|Product Damage|2|||
144582196|NCT00095498|521331691|FG000|Overall Study|Physician Decision|9|||
144582197|NCT00095498|521331692|FG001|Overall Study|Physician Decision|10|||
144582198|NCT00095498|521331693|FG002|Overall Study|Physician Decision|8|||
144582199|NCT00095498|521331691|FG000|Overall Study|Adverse Event|1|||
144582200|NCT00095498|521331692|FG001|Overall Study|Adverse Event|0|||
144582201|NCT00095498|521331693|FG002|Overall Study|Adverse Event|1|||
144582202|NCT00095498|521331691|FG000|Overall Study|Withdrawal by Subject|15|||
144582203|NCT00095498|521331692|FG001|Overall Study|Withdrawal by Subject|16|||
144582204|NCT00095498|521331693|FG002|Overall Study|Withdrawal by Subject|15|||
144582205|NCT00095498|521331691|FG000|Overall Study|Disease progression|0|||
144582206|NCT00095498|521331692|FG001|Overall Study|Disease progression|1|||
144582207|NCT00095498|521331693|FG002|Overall Study|Disease progression|1|||
144582208|NCT00095498|521331691|FG000|Overall Study|Ineligibility determined|3|||
144582209|NCT00095498|521331692|FG001|Overall Study|Ineligibility determined|0|||
144582210|NCT00095498|521331693|FG002|Overall Study|Ineligibility determined|2|||
144582211|NCT00095498|521331691|FG000|Overall Study|Lost to Follow-up|1|||
144582212|NCT00095498|521331692|FG001|Overall Study|Lost to Follow-up|1|||
144582213|NCT00095498|521331693|FG002|Overall Study|Lost to Follow-up|2|||
144582214|NCT00095498|521331691|FG000|Overall Study|Noncompliance|1|||
144582215|NCT00095498|521331692|FG001|Overall Study|Noncompliance|0|||
144582216|NCT00095498|521331693|FG002|Overall Study|Noncompliance|1|||
144582217|NCT00095498|521331691|FG000|Overall Study|Other|6|||
144582218|NCT00095498|521331692|FG001|Overall Study|Other|7|||
144582219|NCT00095498|521331693|FG002|Overall Study|Other|6|||
144582220|NCT00095498|521331691|FG000|Overall Study|Protocol Violation|0|||
144582221|NCT00095498|521331692|FG001|Overall Study|Protocol Violation|0|||
144582222|NCT00095498|521331693|FG002|Overall Study|Protocol Violation|1|||
144582223|NCT00095498|521331691|FG000|Overall Study|Requirement for alternative therapy|1|||
144623190|NCT01978093|521478578|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
144623191|NCT01978093|521478579|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
144623192|NCT01978093|521478578|FG000|Overall Study|Mother lost custody of child|0|||
144623193|NCT01978093|521478579|FG001|Overall Study|Mother lost custody of child|1|||
144582224|NCT00095498|521331692|FG001|Overall Study|Requirement for alternative therapy|0|||
144582225|NCT00095498|521331693|FG002|Overall Study|Requirement for alternative therapy|2|||
144582226|NCT04396366|521331694|FG000|Overall Study|Adverse Event|1|||
144582227|NCT04396366|521331695|FG001|Overall Study|Adverse Event|0|||
144582228|NCT00166712|521331697|FG000|Overall Study|Death|0|||
144582229|NCT00166712|521331698|FG001|Overall Study|Death|1|||
144582230|NCT00166712|521331697|FG000|Overall Study|Adverse Event|1|||
144582231|NCT00166712|521331698|FG001|Overall Study|Adverse Event|0|||
144582232|NCT00166712|521331697|FG000|Overall Study|Withdrawal by Subject|1|||
144582233|NCT00166712|521331698|FG001|Overall Study|Withdrawal by Subject|2|||
144582234|NCT00166712|521331697|FG000|Overall Study|Physician Decision|0|||
144582235|NCT00166712|521331698|FG001|Overall Study|Physician Decision|2|||
144582236|NCT04684394|521331699|FG000|Overall Study|Death|1|||
144582237|NCT04684394|521331700|FG001|Overall Study|Death|2|||
144582238|NCT04684394|521331699|FG000|Overall Study|Lost to Follow-up|1|||
144582239|NCT04684394|521331700|FG001|Overall Study|Lost to Follow-up|0|||
144582240|NCT04684394|521331699|FG000|Overall Study|Withdrawal by Subject|2|||
144582241|NCT04684394|521331700|FG001|Overall Study|Withdrawal by Subject|0|||
144582242|NCT04684394|521331699|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
144582243|NCT04684394|521331700|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
144582244|NCT00306670|521331702|FG000|Overall Study|patients recruited; Genentech, the st|0|||
144582245|NCT00306670|521331703|FG001|Overall Study|patients recruited; Genentech, the st|2|||
144582246|NCT04476251|521331707|FG000|Overall Study|Not treated|1|||
144582247|NCT00297427|521331715|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
144582248|NCT00297427|521331716|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
144582249|NCT00297427|521331715|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
144582250|NCT00297427|521331716|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
144582251|NCT00297427|521331715|FG000|Phase 1: Initial Intervention|Death|0|||
144582252|NCT00297427|521331716|FG001|Phase 1: Initial Intervention|Death|1|||
144582253|NCT00297427|521331715|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
144582254|NCT00297427|521331716|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
144582255|NCT00297427|521331715|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
144582256|NCT00297427|521331716|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
144582257|NCT00297427|521331715|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
144582258|NCT00297427|521331716|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
144582259|NCT00297427|521331715|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
144582260|NCT00297427|521331716|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
144582261|NCT00297427|521331715|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
144582262|NCT00297427|521331716|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
144582263|NCT01127893|521331717|FG000|Overall Study|Study Termination by the Sponsor|1|||
144582264|NCT01470001|521331718|FG000|Overall Study|Lost to Follow-up|1|||
144582265|NCT01470001|521331719|FG001|Overall Study|Lost to Follow-up|1|||
144582266|NCT01470001|521331718|FG000|Overall Study|Physician Decision|2|||
144582267|NCT01470001|521331719|FG001|Overall Study|Physician Decision|0|||
144582268|NCT01470001|521331718|FG000|Overall Study|Withdrawal by Subject|2|||
144582269|NCT01470001|521331719|FG001|Overall Study|Withdrawal by Subject|1|||
144582270|NCT01895101|521331720|FG000|Overall Study|OPCAB procedure|1|||
144623194|NCT01978093|521478578|FG000|Overall Study|Child was in care of grandmother|0|||
144623195|NCT01978093|521478579|FG001|Overall Study|Child was in care of grandmother|1|||
144623196|NCT01978093|521478578|FG000|Overall Study|N/A for vaccine administration|0|||
144623197|NCT01978093|521478579|FG001|Overall Study|N/A for vaccine administration|1|||
144582271|NCT01895101|521331721|FG001|Overall Study|OPCAB procedure|1|||
144582272|NCT01895101|521331722|FG002|Overall Study|OPCAB procedure|3|||
144582273|NCT01895101|521331720|FG000|Overall Study|Withdrawal by Subject|0|||
144582274|NCT01895101|521331721|FG001|Overall Study|Withdrawal by Subject|1|||
144582275|NCT01895101|521331722|FG002|Overall Study|Withdrawal by Subject|2|||
144582276|NCT01895101|521331720|FG000|Overall Study|another study, enrolled in other study|0|||
144582277|NCT01895101|521331721|FG001|Overall Study|another study, enrolled in other study|1|||
144582278|NCT01895101|521331722|FG002|Overall Study|another study, enrolled in other study|0|||
144582279|NCT01895101|521331720|FG000|Overall Study|Death|0|||
144582280|NCT01895101|521331721|FG001|Overall Study|Death|1|||
144582281|NCT01895101|521331722|FG002|Overall Study|Death|0|||
144582282|NCT01895101|521331720|FG000|Overall Study|coagulation disorder|0|||
144623198|NCT01491178|521478580|FG000|Overall Study|Adverse Event|1016|||
144623199|NCT01491178|521478580|FG000|Overall Study|Improvement of NVAF|210|||
144623200|NCT01491178|521478580|FG000|Overall Study|To conduct invasive treatment|59|||
144209441|NCT02540850|519961886|FG001|Overall Study|Lost to Follow-up|66|||
144582283|NCT01895101|521331721|FG001|Overall Study|coagulation disorder|1|||
144582284|NCT01895101|521331722|FG002|Overall Study|coagulation disorder|0|||
144582285|NCT03339583|521331725|FG000|First Intervention (14 Days)|Adverse Event|1|||
144582286|NCT03339583|521331726|FG001|First Intervention (14 Days)|Adverse Event|0|||
144582287|NCT03339583|521331725|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
144582288|NCT03339583|521331726|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
144582289|NCT03339583|521331725|FG000|Second Intervention (14 Days)|Adverse Event|0|||
144582290|NCT03339583|521331726|FG001|Second Intervention (14 Days)|Adverse Event|1|||
144582291|NCT03339583|521331725|FG000|Follow-up (14 Days)|Physician Decision|6|||
144582292|NCT03339583|521331726|FG001|Follow-up (14 Days)|Physician Decision|3|||
144582293|NCT02182947|521331727|FG000|Overall Study|Withdrawal by Subject|7|||
144582294|NCT02182947|521331727|FG000|Overall Study|Lost to Follow-up|3|||
144582295|NCT02182947|521331727|FG000|Overall Study|Failed screening activities|8|||
144582296|NCT00730275|521331728|FG000|Overall Study|Withdrawal by Subject|0|||
144582297|NCT00730275|521331729|FG001|Overall Study|Withdrawal by Subject|0|||
144582298|NCT00730275|521331730|FG002|Overall Study|Withdrawal by Subject|0|||
144582299|NCT00730275|521331731|FG003|Overall Study|Withdrawal by Subject|1|||
144582300|NCT03921723|521331734|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
144582301|NCT03921723|521331734|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
144582302|NCT01461811|521331735|FG000|Overall Study|Adverse Event|2|||
144582303|NCT01461811|521331736|FG001|Overall Study|Adverse Event|1|||
144582304|NCT01461811|521331735|FG000|Overall Study|Subject decision unrelated to an AE|1|||
144582305|NCT01461811|521331736|FG001|Overall Study|Subject decision unrelated to an AE|1|||
144582306|NCT01461811|521331735|FG000|Overall Study|Noncompliance|1|||
144582307|NCT01461811|521331736|FG001|Overall Study|Noncompliance|1|||
144582308|NCT00338962|521331737|FG000|Overall Study|Lost to Follow-up|3|||
144582309|NCT00338962|521331738|FG001|Overall Study|Lost to Follow-up|3|||
144582310|NCT00338962|521331739|FG002|Overall Study|Lost to Follow-up|2|||
144582311|NCT00338962|521331740|FG003|Overall Study|Lost to Follow-up|3|||
144582312|NCT00338962|521331737|FG000|Overall Study|Withdrawal by Subject|1|||
144582313|NCT00338962|521331738|FG001|Overall Study|Withdrawal by Subject|0|||
144582314|NCT00338962|521331739|FG002|Overall Study|Withdrawal by Subject|0|||
144582315|NCT00338962|521331740|FG003|Overall Study|Withdrawal by Subject|0|||
144582316|NCT00338962|521331737|FG000|Overall Study|No Transportation|2|||
144582317|NCT00338962|521331738|FG001|Overall Study|No Transportation|0|||
144582318|NCT00338962|521331739|FG002|Overall Study|No Transportation|0|||
144582319|NCT00338962|521331740|FG003|Overall Study|No Transportation|0|||
144582320|NCT00338962|521331737|FG000|Overall Study|Time Constraint|2|||
144582321|NCT00338962|521331738|FG001|Overall Study|Time Constraint|0|||
144582322|NCT00338962|521331739|FG002|Overall Study|Time Constraint|0|||
144582323|NCT00338962|521331740|FG003|Overall Study|Time Constraint|0|||
144582324|NCT00338962|521331737|FG000|Overall Study|Moved|0|||
144582325|NCT00338962|521331738|FG001|Overall Study|Moved|1|||
144582326|NCT00338962|521331739|FG002|Overall Study|Moved|0|||
144582327|NCT00338962|521331740|FG003|Overall Study|Moved|0|||
144582328|NCT00338962|521331737|FG000|Overall Study|Adverse Event|0|||
144582329|NCT00338962|521331738|FG001|Overall Study|Adverse Event|0|||
144582330|NCT00338962|521331739|FG002|Overall Study|Adverse Event|2|||
144582331|NCT00338962|521331740|FG003|Overall Study|Adverse Event|0|||
144582332|NCT00338962|521331737|FG000|Overall Study|Poor Compliance|0|||
144582333|NCT00338962|521331738|FG001|Overall Study|Poor Compliance|0|||
144582334|NCT00338962|521331739|FG002|Overall Study|Poor Compliance|2|||
144582335|NCT00338962|521331740|FG003|Overall Study|Poor Compliance|0|||
144582336|NCT03733314|521331741|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
144582337|NCT03733314|521331742|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
144262878|NCT01716806|520163778|FG002|Overall Study|Patient withdrawal of consent|4|||
144262879|NCT01716806|520163779|FG003|Overall Study|Patient withdrawal of consent|3|||
144262880|NCT01716806|520163780|FG004|Overall Study|Patient withdrawal of consent|2|||
144262881|NCT01716806|520163781|FG005|Overall Study|Patient withdrawal of consent|0|||
144262882|NCT01716806|520163776|FG000|Overall Study|Lost to Follow-up|3|||
144262883|NCT01716806|520163777|FG001|Overall Study|Lost to Follow-up|3|||
144262884|NCT01716806|520163778|FG002|Overall Study|Lost to Follow-up|0|||
144262885|NCT01716806|520163779|FG003|Overall Study|Lost to Follow-up|2|||
144262886|NCT01716806|520163780|FG004|Overall Study|Lost to Follow-up|1|||
144262887|NCT01716806|520163781|FG005|Overall Study|Lost to Follow-up|0|||
144262888|NCT01716806|520163776|FG000|Overall Study|Death|13|||
144262889|NCT01716806|520163777|FG001|Overall Study|Death|9|||
144262890|NCT01716806|520163778|FG002|Overall Study|Death|12|||
144262891|NCT01716806|520163779|FG003|Overall Study|Death|4|||
144262892|NCT01716806|520163780|FG004|Overall Study|Death|10|||
144262893|NCT01716806|520163781|FG005|Overall Study|Death|5|||
144582338|NCT03733314|521331741|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
144582339|NCT03733314|521331742|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
144582340|NCT03733314|521331741|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
144582341|NCT03733314|521331742|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
144582342|NCT03733314|521331741|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
144582343|NCT03733314|521331742|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
144582344|NCT03733314|521331741|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
144582345|NCT03733314|521331742|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
144582346|NCT03733314|521331741|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
144582347|NCT03733314|521331742|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
144582348|NCT03214640|521331743|FG000|Overall Study|Protocol Violation|1|||
144582349|NCT03214640|521331744|FG001|Overall Study|Protocol Violation|2|||
144582350|NCT03214640|521331745|FG002|Overall Study|Protocol Violation|1|||
144582351|NCT03214640|521331746|FG003|Overall Study|Protocol Violation|4|||
144582352|NCT00406692|521331747|FG000|Overall Study|Withdrawal by Subject|4|||
144582353|NCT00406692|521331747|FG000|Overall Study|Physician Decision|1|||
144582354|NCT00406692|521331747|FG000|Overall Study|Adverse Event|1|||
144582355|NCT00406692|521331747|FG000|Overall Study|Lack of Efficacy|1|||
144582356|NCT00635661|521331759|FG000|Overall Study|Withdrawal by Subject|4|||
144582357|NCT01641159|521331767|FG000|Overall Study|Lost to Follow-up|2|||
144582358|NCT01641159|521331768|FG001|Overall Study|Lost to Follow-up|1|||
144582359|NCT01641159|521331767|FG000|Overall Study|Withdrawal by Subject|0|||
144582360|NCT01641159|521331768|FG001|Overall Study|Withdrawal by Subject|1|||
144582361|NCT05330676|521331771|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
144582362|NCT05330676|521331772|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
144582363|NCT02229851|521331775|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
144582364|NCT02229851|521331776|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
144582365|NCT02229851|521331777|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
144582366|NCT02229851|521331778|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
144582367|NCT02229851|521331779|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
144582368|NCT02229851|521331780|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
144582369|NCT02229851|521331781|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
144582370|NCT02229851|521331775|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
144582371|NCT02229851|521331776|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
144582372|NCT02229851|521331777|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
144582373|NCT02229851|521331778|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
144582374|NCT02229851|521331779|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
144582375|NCT02229851|521331780|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
144582376|NCT02229851|521331781|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
144582377|NCT02229851|521331775|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
144582378|NCT02229851|521331776|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
144582379|NCT02229851|521331777|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
144582380|NCT02229851|521331778|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
144582381|NCT02229851|521331779|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
144582382|NCT02229851|521331780|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
144582383|NCT02229851|521331781|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
144582384|NCT02229851|521331775|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
144582385|NCT02229851|521331776|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
144582386|NCT02229851|521331777|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
144582387|NCT02229851|521331778|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
144582388|NCT02229851|521331779|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
144582389|NCT02229851|521331780|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
144582390|NCT02229851|521331781|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
144582391|NCT02229851|521331775|FG000|Main Phase (Double-blind Phase)|Death|1|||
144582392|NCT02229851|521331776|FG001|Main Phase (Double-blind Phase)|Death|1|||
144582393|NCT02229851|521331777|FG002|Main Phase (Double-blind Phase)|Death|0|||
144582394|NCT02229851|521331778|FG003|Main Phase (Double-blind Phase)|Death|0|||
144582395|NCT02229851|521331779|FG004|Main Phase (Double-blind Phase)|Death|0|||
144582396|NCT02229851|521331780|FG005|Main Phase (Double-blind Phase)|Death|0|||
144623201|NCT01491178|521478580|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
144623202|NCT01491178|521478580|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
144623203|NCT01491178|521478580|FG000|Overall Study|To take a contraindication|20|||
144623204|NCT01491178|521478580|FG000|Overall Study|Other than specified above|657|||
144623205|NCT01604512|521478581|FG000|Overall Study|Withdrawal by Subject|3|||
144582397|NCT02229851|521331781|FG006|Main Phase (Double-blind Phase)|Death|0|||
144582398|NCT02229851|521331775|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
144582399|NCT02229851|521331776|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
144582400|NCT02229851|521331777|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
144582401|NCT02229851|521331778|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
144209442|NCT02540850|519961887|FG002|Overall Study|Lost to Follow-up|34|||
144209443|NCT00264550|519961888|FG000|Overall Study|Death|0|||
144209444|NCT00264550|519961889|FG001|Overall Study|Death|3|||
144623206|NCT01604512|521478581|FG000|Overall Study|Not treated|4|||
144623207|NCT01415752|521478582|FG000|Induction (Step 1)|Ineligible|4|||
144623208|NCT01415752|521478583|FG001|Induction (Step 1)|Ineligible|3|||
144623209|NCT01415752|521478584|FG002|Induction (Step 1)|Ineligible|4|||
144623210|NCT01415752|521478585|FG003|Induction (Step 1)|Ineligible|4|||
144582402|NCT02229851|521331779|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
144582403|NCT02229851|521331780|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
144582404|NCT02229851|521331781|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
144582405|NCT02229851|521331775|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
144582406|NCT02229851|521331776|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
144582407|NCT02229851|521331777|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
144582408|NCT02229851|521331778|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
144582409|NCT02229851|521331779|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
144582410|NCT02229851|521331780|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
144582411|NCT02229851|521331781|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
144582412|NCT02229851|521331775|FG000|Extension Phase (Open-label Phase)|Death|0|||
144582413|NCT02229851|521331776|FG001|Extension Phase (Open-label Phase)|Death|0|||
144582414|NCT02229851|521331777|FG002|Extension Phase (Open-label Phase)|Death|0|||
144582415|NCT02229851|521331778|FG003|Extension Phase (Open-label Phase)|Death|1|||
144582416|NCT02229851|521331779|FG004|Extension Phase (Open-label Phase)|Death|0|||
144582417|NCT02229851|521331780|FG005|Extension Phase (Open-label Phase)|Death|1|||
144582418|NCT02229851|521331781|FG006|Extension Phase (Open-label Phase)|Death|1|||
144582419|NCT03541200|521331782|FG000|Overall Study|Adverse Event|19|||
144582420|NCT03541200|521331782|FG000|Overall Study|Death|1|||
144582421|NCT03541200|521331782|FG000|Overall Study|Lost to Follow-up|10|||
144582422|NCT03541200|521331782|FG000|Overall Study|Physician Decision|1|||
144582423|NCT03541200|521331782|FG000|Overall Study|Protocol Violation|51|||
144582424|NCT03541200|521331782|FG000|Overall Study|Withdrawal by Subject|23|||
144582425|NCT03541200|521331782|FG000|Overall Study|other|8|||
144582426|NCT01607476|521331785|FG000|Overall Study|Withdrawal by Subject|1|||
144582427|NCT01607476|521331786|FG001|Overall Study|Withdrawal by Subject|0|||
144582428|NCT01607476|521331787|FG002|Overall Study|Withdrawal by Subject|1|||
144582429|NCT01607476|521331785|FG000|Overall Study|Lost to Follow-up|0|||
144582430|NCT01607476|521331786|FG001|Overall Study|Lost to Follow-up|0|||
144582431|NCT01607476|521331787|FG002|Overall Study|Lost to Follow-up|2|||
144582432|NCT04445987|521331788|FG000|Overall Study|Adverse Event|0|||
144582433|NCT04445987|521331789|FG001|Overall Study|Adverse Event|0|||
144582434|NCT04445987|521331790|FG002|Overall Study|Adverse Event|1|||
144582435|NCT04445987|521331791|FG003|Overall Study|Adverse Event|0|||
144582436|NCT04445987|521331792|FG004|Overall Study|Adverse Event|4|||
144582437|NCT04445987|521331793|FG005|Overall Study|Adverse Event|0|||
144582438|NCT04445987|521331788|FG000|Overall Study|Lost to Follow-up|4|||
144582439|NCT04445987|521331789|FG001|Overall Study|Lost to Follow-up|3|||
144582440|NCT04445987|521331790|FG002|Overall Study|Lost to Follow-up|1|||
144582441|NCT04445987|521331791|FG003|Overall Study|Lost to Follow-up|1|||
144582442|NCT04445987|521331792|FG004|Overall Study|Lost to Follow-up|29|||
144582443|NCT04445987|521331793|FG005|Overall Study|Lost to Follow-up|0|||
144582444|NCT04445987|521331788|FG000|Overall Study|Physician Decision|0|||
144582445|NCT04445987|521331789|FG001|Overall Study|Physician Decision|0|||
144582446|NCT04445987|521331790|FG002|Overall Study|Physician Decision|0|||
144582447|NCT04445987|521331791|FG003|Overall Study|Physician Decision|0|||
144582448|NCT04445987|521331792|FG004|Overall Study|Physician Decision|1|||
144582449|NCT04445987|521331793|FG005|Overall Study|Physician Decision|0|||
144582450|NCT04445987|521331788|FG000|Overall Study|Protocol Violation|1|||
144582451|NCT04445987|521331789|FG001|Overall Study|Protocol Violation|0|||
144582452|NCT04445987|521331790|FG002|Overall Study|Protocol Violation|0|||
144582453|NCT04445987|521331791|FG003|Overall Study|Protocol Violation|0|||
144582454|NCT04445987|521331792|FG004|Overall Study|Protocol Violation|2|||
144582455|NCT04445987|521331793|FG005|Overall Study|Protocol Violation|0|||
144582456|NCT04445987|521331788|FG000|Overall Study|Withdrawal by Subject|4|||
144582457|NCT04445987|521331789|FG001|Overall Study|Withdrawal by Subject|0|||
144582458|NCT04445987|521331790|FG002|Overall Study|Withdrawal by Subject|1|||
144582459|NCT04445987|521331791|FG003|Overall Study|Withdrawal by Subject|0|||
144582460|NCT04445987|521331792|FG004|Overall Study|Withdrawal by Subject|18|||
144582461|NCT04445987|521331793|FG005|Overall Study|Withdrawal by Subject|1|||
144582462|NCT04445987|521331788|FG000|Overall Study|Other reason|0|||
144582463|NCT04445987|521331789|FG001|Overall Study|Other reason|0|||
144582464|NCT04445987|521331790|FG002|Overall Study|Other reason|1|||
144582465|NCT04445987|521331791|FG003|Overall Study|Other reason|0|||
144582466|NCT04445987|521331792|FG004|Overall Study|Other reason|2|||
144582467|NCT04445987|521331793|FG005|Overall Study|Other reason|0|||
144582468|NCT02001064|521331796|FG000|Overall Study|Withdrawal by Subject|2|||
144623211|NCT01415752|521478582|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
144582469|NCT02001064|521331797|FG001|Overall Study|Withdrawal by Subject|1|||
144582470|NCT02425904|521331798|FG000|Overall Study|Lost to Follow-up|1|||
144582471|NCT02425904|521331799|FG001|Overall Study|Lost to Follow-up|0|||
144582472|NCT02425904|521331798|FG000|Overall Study|Withdrawal by Subject|2|||
144582473|NCT02425904|521331799|FG001|Overall Study|Withdrawal by Subject|0|||
144582474|NCT02425904|521331798|FG000|Overall Study|Death|0|||
144582475|NCT02425904|521331799|FG001|Overall Study|Death|3|||
144582476|NCT05148962|521331800|FG000|Overall Study|Withdrawal by Subject|1|||
144623212|NCT01415752|521478583|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
144730391|NCT00304083|521868227|FG001|Overall Study|Withdrawal by Subject|2|||
144582477|NCT05148962|521331801|FG001|Overall Study|Withdrawal by Subject|1|||
144582478|NCT05148962|521331802|FG002|Overall Study|Withdrawal by Subject|0|||
144730392|NCT00304083|521868226|FG000|Overall Study|Physician Decision|8|||
144582479|NCT05148962|521331803|FG003|Overall Study|Withdrawal by Subject|1|||
144582480|NCT05148962|521331804|FG004|Overall Study|Withdrawal by Subject|0|||
144582481|NCT05148962|521331800|FG000|Overall Study|Participant was early terminated per protocol|0|||
144582482|NCT05148962|521331801|FG001|Overall Study|Participant was early terminated per protocol|0|||
144582483|NCT05148962|521331802|FG002|Overall Study|Participant was early terminated per protocol|3|||
144582484|NCT05148962|521331803|FG003|Overall Study|Participant was early terminated per protocol|5|||
144582485|NCT05148962|521331804|FG004|Overall Study|Participant was early terminated per protocol|2|||
144582486|NCT05148962|521331800|FG000|Overall Study|Miscellaneous|0|||
144582487|NCT05148962|521331801|FG001|Overall Study|Miscellaneous|0|||
144582488|NCT05148962|521331802|FG002|Overall Study|Miscellaneous|0|||
144582489|NCT05148962|521331803|FG003|Overall Study|Miscellaneous|1|||
144582490|NCT05148962|521331804|FG004|Overall Study|Miscellaneous|0|||
144582491|NCT01525238|521331806|FG000|Overall Study|Withdrawal by Subject|1|||
144582492|NCT01525238|521331807|FG001|Overall Study|Withdrawal by Subject|0|||
144582493|NCT01525238|521331808|FG002|Overall Study|Withdrawal by Subject|0|||
144582494|NCT01732822|521333845|FG000|Overall Study|Withdrawal by Subject|123|||
144582495|NCT01732822|521333846|FG001|Overall Study|Withdrawal by Subject|113|||
144582496|NCT05020327|521333850|FG000|Overall Study|Physician Decision|3|||
144582497|NCT05020327|521333851|FG001|Overall Study|Physician Decision|0|||
144582498|NCT05020327|521333852|FG002|Overall Study|Physician Decision|0|||
144582499|NCT05020327|521333850|FG000|Overall Study|Withdrawal by Subject|1|||
144582500|NCT05020327|521333851|FG001|Overall Study|Withdrawal by Subject|1|||
144582501|NCT05020327|521333852|FG002|Overall Study|Withdrawal by Subject|0|||
144582502|NCT05020327|521333850|FG000|Overall Study|personal/cultural, ineligible|12|||
144582503|NCT05020327|521333851|FG001|Overall Study|personal/cultural, ineligible|0|||
144582504|NCT05020327|521333852|FG002|Overall Study|personal/cultural, ineligible|0|||
144582505|NCT00591370|521333853|FG000|Overall Study|Not Treated|2|||
144582506|NCT00503139|521333857|FG000|Overall Study|Case Report Forms were not collected|4|||
144582507|NCT00503139|521333857|FG000|Overall Study|Protocol Violation|4|||
144582508|NCT00833833|521333858|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
144582509|NCT00833833|521333859|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
144582510|NCT00833833|521333860|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
144582511|NCT00833833|521333861|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
144582512|NCT00833833|521333862|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
144582513|NCT00833833|521333863|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
144582514|NCT00833833|521333858|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
144582515|NCT00833833|521333859|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
144582516|NCT00833833|521333860|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
144582517|NCT00833833|521333861|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
144582518|NCT00833833|521333862|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
144582519|NCT00833833|521333863|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
144582520|NCT00833833|521333858|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
144623213|NCT01415752|521478584|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
144623214|NCT01415752|521478585|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
144623215|NCT01415752|521478582|FG000|Maintenance (Step 2)|Adverse Event|3|||
144623216|NCT01415752|521478583|FG001|Maintenance (Step 2)|Adverse Event|4|||
144623217|NCT01415752|521478584|FG002|Maintenance (Step 2)|Adverse Event|9|||
144623218|NCT01415752|521478585|FG003|Maintenance (Step 2)|Adverse Event|6|||
144623219|NCT01415752|521478582|FG000|Maintenance (Step 2)|Death|1|||
144623220|NCT01415752|521478583|FG001|Maintenance (Step 2)|Death|1|||
144623221|NCT01415752|521478584|FG002|Maintenance (Step 2)|Death|2|||
144623222|NCT01415752|521478585|FG003|Maintenance (Step 2)|Death|0|||
144623223|NCT01415752|521478582|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
144730393|NCT00304083|521868227|FG001|Overall Study|Physician Decision|3|||
144730394|NCT00304083|521868226|FG000|Overall Study|Disease Progression|5|||
144730395|NCT00304083|521868227|FG001|Overall Study|Disease Progression|1|||
144582521|NCT00833833|521333859|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
144730396|NCT00304083|521868226|FG000|Overall Study|Other|5|||
144730397|NCT00304083|521868227|FG001|Overall Study|Other|2|||
144730398|NCT01378975|521868228|FG000|Overall Study|Death|77|||
144209445|NCT00264550|519961890|FG002|Overall Study|Death|0|||
144582522|NCT00833833|521333860|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
144582523|NCT00833833|521333861|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
144623224|NCT01415752|521478583|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
144623225|NCT01415752|521478584|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
144623226|NCT01415752|521478585|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
144623227|NCT01415752|521478582|FG000|Maintenance (Step 2)|Alternative therapy|0|||
144623228|NCT01415752|521478583|FG001|Maintenance (Step 2)|Alternative therapy|1|||
144730399|NCT01378975|521868229|FG001|Overall Study|Death|46|||
144730400|NCT01378975|521868228|FG000|Overall Study|Investigator Request|1|||
144730401|NCT01378975|521868229|FG001|Overall Study|Investigator Request|0|||
144730402|NCT01378975|521868228|FG000|Overall Study|Lost to Follow-up|4|||
144730403|NCT01378975|521868229|FG001|Overall Study|Lost to Follow-up|1|||
144730404|NCT01378975|521868228|FG000|Overall Study|Withdrew Consent|4|||
144730405|NCT01378975|521868229|FG001|Overall Study|Withdrew Consent|3|||
144582524|NCT00833833|521333862|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
144582525|NCT00833833|521333863|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
144582526|NCT00833833|521333858|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
144582527|NCT00833833|521333859|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
144582528|NCT00833833|521333860|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
144582529|NCT00833833|521333861|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
144582530|NCT00833833|521333862|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
144582531|NCT00833833|521333863|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
144582532|NCT00833833|521333858|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
144582533|NCT00833833|521333859|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582534|NCT00833833|521333860|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
144582535|NCT00833833|521333861|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582536|NCT00833833|521333862|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582537|NCT00833833|521333863|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582538|NCT00833833|521333858|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
144582539|NCT00833833|521333859|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
144582540|NCT00833833|521333860|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
144582541|NCT00833833|521333861|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
144582542|NCT00833833|521333862|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
144582543|NCT00833833|521333863|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
144582544|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
144582545|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
144582546|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
144582547|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
144582548|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
144582549|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
144582550|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
144582551|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
144582552|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
144582553|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
144582554|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
144582555|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
144582556|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
144582557|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
144582558|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
144582559|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
144582560|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
144582561|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
144582562|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582563|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582564|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582565|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
144582566|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
144582567|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
144582568|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
144582569|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
144582570|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
144582571|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
144582572|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
144582573|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
144582574|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
144582575|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
144582576|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
144582577|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
144582578|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
144582579|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
144582580|NCT00833833|521333858|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
144582581|NCT00833833|521333859|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
144582582|NCT00833833|521333860|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
144582583|NCT00833833|521333861|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
144582584|NCT00833833|521333862|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
144582585|NCT00833833|521333863|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
144582586|NCT02040259|521333866|FG000|Overall Study|Death|280|||
144582587|NCT02040259|521333866|FG000|Overall Study|Lost to Follow-up|76|||
144582588|NCT02040259|521333866|FG000|Overall Study|Assessment not completed|3|||
144582589|NCT02040259|521333866|FG000|Overall Study|Withdrawal by Subject|4|||
144582590|NCT00316602|521333870|FG000|Overall Study|Withdrawal by Subject|3|||
144582591|NCT00316602|521333871|FG001|Overall Study|Withdrawal by Subject|2|||
144582592|NCT00316602|521333870|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
144582593|NCT00316602|521333871|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
144582594|NCT00316602|521333870|FG000|Overall Study|Adverse Event|1|||
144582595|NCT00316602|521333871|FG001|Overall Study|Adverse Event|0|||
144582596|NCT00316602|521333870|FG000|Overall Study|Other|3|||
144582597|NCT00316602|521333871|FG001|Overall Study|Other|6|||
144582598|NCT01142232|521333872|FG000|Overall Study|Adverse Event|1|||
144582599|NCT01142232|521333873|FG001|Overall Study|Adverse Event|2|||
144582600|NCT01142232|521333874|FG002|Overall Study|Adverse Event|1|||
144582601|NCT01142232|521333875|FG003|Overall Study|Adverse Event|0|||
144582602|NCT01142232|521333876|FG004|Overall Study|Adverse Event|4|||
144582603|NCT01142232|521333872|FG000|Overall Study|Death|0|||
144582604|NCT01142232|521333873|FG001|Overall Study|Death|0|||
144582605|NCT01142232|521333874|FG002|Overall Study|Death|0|||
144582606|NCT01142232|521333875|FG003|Overall Study|Death|0|||
144582607|NCT01142232|521333876|FG004|Overall Study|Death|1|||
144582608|NCT01142232|521333872|FG000|Overall Study|Disease Progression|2|||
144582609|NCT01142232|521333873|FG001|Overall Study|Disease Progression|0|||
144582610|NCT01142232|521333874|FG002|Overall Study|Disease Progression|1|||
144582611|NCT01142232|521333875|FG003|Overall Study|Disease Progression|2|||
144582612|NCT01142232|521333876|FG004|Overall Study|Disease Progression|12|||
144582613|NCT01142232|521333872|FG000|Overall Study|Withdrawal by Subject|0|||
144582614|NCT01142232|521333873|FG001|Overall Study|Withdrawal by Subject|0|||
144582615|NCT01142232|521333874|FG002|Overall Study|Withdrawal by Subject|0|||
144582616|NCT01142232|521333875|FG003|Overall Study|Withdrawal by Subject|1|||
144582617|NCT01142232|521333876|FG004|Overall Study|Withdrawal by Subject|3|||
144582618|NCT01142232|521333872|FG000|Overall Study|Physician Decision|0|||
144582619|NCT01142232|521333873|FG001|Overall Study|Physician Decision|1|||
144582620|NCT01142232|521333874|FG002|Overall Study|Physician Decision|0|||
144582621|NCT01142232|521333875|FG003|Overall Study|Physician Decision|2|||
144582622|NCT01142232|521333876|FG004|Overall Study|Physician Decision|10|||
144582623|NCT01142232|521333872|FG000|Overall Study|Alternative Therapy|0|||
144582624|NCT01142232|521333873|FG001|Overall Study|Alternative Therapy|1|||
144582625|NCT01142232|521333874|FG002|Overall Study|Alternative Therapy|1|||
144582626|NCT01142232|521333875|FG003|Overall Study|Alternative Therapy|0|||
144582627|NCT01142232|521333876|FG004|Overall Study|Alternative Therapy|1|||
144582628|NCT01142232|521333872|FG000|Overall Study|Off Trt for other complicating disease|0|||
144582629|NCT01142232|521333873|FG001|Overall Study|Off Trt for other complicating disease|0|||
144582630|NCT01142232|521333874|FG002|Overall Study|Off Trt for other complicating disease|0|||
144582631|NCT01142232|521333875|FG003|Overall Study|Off Trt for other complicating disease|0|||
144582632|NCT01142232|521333876|FG004|Overall Study|Off Trt for other complicating disease|1|||
144582633|NCT01142232|521333872|FG000|Overall Study|Noncompliance|0|||
144582634|NCT01142232|521333873|FG001|Overall Study|Noncompliance|0|||
144582635|NCT01142232|521333874|FG002|Overall Study|Noncompliance|0|||
144582636|NCT01142232|521333875|FG003|Overall Study|Noncompliance|0|||
144623229|NCT01415752|521478584|FG002|Maintenance (Step 2)|Alternative therapy|0|||
144623230|NCT01415752|521478585|FG003|Maintenance (Step 2)|Alternative therapy|0|||
144623231|NCT01415752|521478582|FG000|Maintenance (Step 2)|Other reasons|3|||
144623232|NCT01415752|521478583|FG001|Maintenance (Step 2)|Other reasons|6|||
144623233|NCT01415752|521478584|FG002|Maintenance (Step 2)|Other reasons|4|||
144623234|NCT01415752|521478585|FG003|Maintenance (Step 2)|Other reasons|6|||
144623235|NCT01415752|521478582|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
144623236|NCT01415752|521478583|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
144582637|NCT01142232|521333876|FG004|Overall Study|Noncompliance|2|||
144582638|NCT00626990|521333877|FG000|Overall Study|Lack of Efficacy|6|||
144582639|NCT00626990|521333878|FG001|Overall Study|Lack of Efficacy|7|||
144582640|NCT00626990|521333879|FG002|Overall Study|Lack of Efficacy|49|||
144623237|NCT01415752|521478584|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
144623238|NCT01415752|521478585|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
144582641|NCT00626990|521333880|FG003|Overall Study|Lack of Efficacy|40|||
144582642|NCT00626990|521333877|FG000|Overall Study|Adverse Event|1|||
144582643|NCT00626990|521333878|FG001|Overall Study|Adverse Event|7|||
144582644|NCT00626990|521333879|FG002|Overall Study|Adverse Event|14|||
144582645|NCT00626990|521333880|FG003|Overall Study|Adverse Event|28|||
144582646|NCT00626990|521333877|FG000|Overall Study|Death|0|||
144582647|NCT00626990|521333878|FG001|Overall Study|Death|1|||
144582648|NCT00626990|521333879|FG002|Overall Study|Death|0|||
144582649|NCT00626990|521333880|FG003|Overall Study|Death|0|||
144582650|NCT00626990|521333877|FG000|Overall Study|Withdrawal by Subject|3|||
144582651|NCT00626990|521333878|FG001|Overall Study|Withdrawal by Subject|1|||
144582652|NCT00626990|521333879|FG002|Overall Study|Withdrawal by Subject|5|||
144623239|NCT01415752|521478582|FG000|Maintenance (Step 2)|ineligible|1|||
144623240|NCT01415752|521478583|FG001|Maintenance (Step 2)|ineligible|1|||
144623241|NCT01415752|521478584|FG002|Maintenance (Step 2)|ineligible|1|||
144582653|NCT00626990|521333880|FG003|Overall Study|Withdrawal by Subject|11|||
144582654|NCT00626990|521333877|FG000|Overall Study|Protocol Violation|0|||
144582655|NCT00626990|521333878|FG001|Overall Study|Protocol Violation|1|||
144582656|NCT00626990|521333879|FG002|Overall Study|Protocol Violation|1|||
144582657|NCT00626990|521333880|FG003|Overall Study|Protocol Violation|0|||
144582658|NCT00626990|521333877|FG000|Overall Study|Various different reasons/missing|4|||
144582659|NCT00626990|521333878|FG001|Overall Study|Various different reasons/missing|8|||
144623242|NCT01415752|521478585|FG003|Maintenance (Step 2)|ineligible|0|||
144623243|NCT01415752|521478582|FG000|Maintenance (Step 2)|Missing|4|||
144623244|NCT01415752|521478583|FG001|Maintenance (Step 2)|Missing|1|||
144623245|NCT01415752|521478584|FG002|Maintenance (Step 2)|Missing|4|||
144623246|NCT01415752|521478585|FG003|Maintenance (Step 2)|Missing|3|||
144623247|NCT01391507|521478586|FG000|Overall Study|Death|0|||
144623248|NCT01391507|521478587|FG001|Overall Study|Death|0|||
144623249|NCT01391507|521478588|FG002|Overall Study|Death|0|||
144623250|NCT01391507|521478589|FG003|Overall Study|Death|1|||
144623251|NCT01391507|521478586|FG000|Overall Study|Adverse Event|1|||
144623252|NCT01391507|521478587|FG001|Overall Study|Adverse Event|1|||
144582660|NCT00626990|521333879|FG002|Overall Study|Various different reasons/missing|8|||
144582661|NCT00626990|521333880|FG003|Overall Study|Various different reasons/missing|16|||
144582662|NCT04138576|521333885|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
144623253|NCT01391507|521478588|FG002|Overall Study|Adverse Event|2|||
144623254|NCT01391507|521478589|FG003|Overall Study|Adverse Event|2|||
144623255|NCT01391507|521478586|FG000|Overall Study|Withdrawal by Subject|1|||
144623256|NCT01391507|521478587|FG001|Overall Study|Withdrawal by Subject|2|||
144623257|NCT01391507|521478588|FG002|Overall Study|Withdrawal by Subject|1|||
144623258|NCT01391507|521478589|FG003|Overall Study|Withdrawal by Subject|1|||
144623259|NCT01391507|521478586|FG000|Overall Study|Lack of Efficacy|0|||
144623260|NCT01391507|521478587|FG001|Overall Study|Lack of Efficacy|0|||
144623261|NCT01391507|521478588|FG002|Overall Study|Lack of Efficacy|0|||
144623262|NCT01391507|521478589|FG003|Overall Study|Lack of Efficacy|1|||
144623263|NCT01391507|521478586|FG000|Overall Study|Protocol Violation|2|||
144623264|NCT01391507|521478587|FG001|Overall Study|Protocol Violation|1|||
144623265|NCT01391507|521478588|FG002|Overall Study|Protocol Violation|1|||
144623266|NCT01391507|521478589|FG003|Overall Study|Protocol Violation|2|||
144623267|NCT01285908|521478590|FG000|Baseline Measurement|unable to insert catheter|1|||
144623268|NCT01285908|521478591|FG001|Baseline Measurement|unable to insert catheter|0|||
144623269|NCT01285908|521478592|FG002|Baseline Measurement|unable to insert catheter|0|||
144623270|NCT01285908|521478590|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
144623271|NCT01285908|521478591|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
144623272|NCT01285908|521478592|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
144623273|NCT01285908|521478590|FG000|Baseline Measurement|unable to tolerate procedure|1|||
144623274|NCT01285908|521478591|FG001|Baseline Measurement|unable to tolerate procedure|0|||
144623275|NCT01285908|521478592|FG002|Baseline Measurement|unable to tolerate procedure|0|||
144623276|NCT03529773|521478593|FG000|Overall Study|Adverse Event|0|||
144623277|NCT03529773|521478594|FG001|Overall Study|Adverse Event|0|||
144623278|NCT03529773|521478595|FG002|Overall Study|Adverse Event|0|||
144623279|NCT03529773|521478596|FG003|Overall Study|Adverse Event|0|||
144623280|NCT03529773|521478597|FG004|Overall Study|Adverse Event|0|||
144623281|NCT03529773|521478598|FG005|Overall Study|Adverse Event|0|||
144623282|NCT03529773|521478599|FG006|Overall Study|Adverse Event|0|||
144623283|NCT03529773|521478600|FG007|Overall Study|Adverse Event|0|||
144582663|NCT01994837|521333886|FG000|Overall Study|Progressive disease per protocol|23|||
144623284|NCT03529773|521478601|FG008|Overall Study|Adverse Event|0|||
144623285|NCT03529773|521478602|FG009|Overall Study|Adverse Event|0|||
144623286|NCT03529773|521478603|FG010|Overall Study|Adverse Event|0|||
144623287|NCT03529773|521478604|FG011|Overall Study|Adverse Event|0|||
144623288|NCT03529773|521478605|FG012|Overall Study|Adverse Event|0|||
144623289|NCT03529773|521478606|FG013|Overall Study|Adverse Event|0|||
144623290|NCT03529773|521478607|FG014|Overall Study|Adverse Event|0|||
144623291|NCT03529773|521478608|FG015|Overall Study|Adverse Event|0|||
144623292|NCT03529773|521478609|FG016|Overall Study|Adverse Event|0|||
144623293|NCT03529773|521478610|FG017|Overall Study|Adverse Event|0|||
144623294|NCT03529773|521478611|FG018|Overall Study|Adverse Event|0|||
144623295|NCT03529773|521478612|FG019|Overall Study|Adverse Event|0|||
144623296|NCT03529773|521478613|FG020|Overall Study|Adverse Event|0|||
144623297|NCT03529773|521478614|FG021|Overall Study|Adverse Event|0|||
144582664|NCT01994837|521333886|FG000|Overall Study|Adv event related to progressive disease|3|||
144623298|NCT03529773|521478615|FG022|Overall Study|Adverse Event|0|||
144623299|NCT03529773|521478616|FG023|Overall Study|Adverse Event|0|||
144623300|NCT03529773|521478617|FG024|Overall Study|Adverse Event|0|||
144623301|NCT03529773|521478618|FG025|Overall Study|Adverse Event|0|||
144623302|NCT03529773|521478619|FG026|Overall Study|Adverse Event|0|||
144623303|NCT03529773|521478620|FG027|Overall Study|Adverse Event|0|||
144623304|NCT03529773|521478621|FG028|Overall Study|Adverse Event|0|||
144623305|NCT03529773|521478622|FG029|Overall Study|Adverse Event|0|||
144623306|NCT03529773|521478623|FG030|Overall Study|Adverse Event|1|||
144582665|NCT01994837|521333886|FG000|Overall Study|Fatal progressive disease|2|||
144582666|NCT01994837|521333886|FG000|Overall Study|Adverse event not related to progression|1|||
144582667|NCT01994837|521333886|FG000|Overall Study|Chose palliative care|1|||
144582668|NCT01994837|521333886|FG000|Overall Study|Proceeded to transplant|1|||
144582669|NCT01994837|521333886|FG000|Overall Study|Removed from study due to no response|1|||
144582670|NCT01262677|521333888|FG000|Overall Study|Does not meet entrance criteria|0|||
144582671|NCT01262677|521333889|FG001|Overall Study|Does not meet entrance criteria|2|||
144582672|NCT01262677|521333890|FG002|Overall Study|Does not meet entrance criteria|0|||
144582673|NCT01262677|521333888|FG000|Overall Study|Insufficient clinical response|0|||
144582674|NCT01262677|521333889|FG001|Overall Study|Insufficient clinical response|0|||
144582675|NCT01262677|521333890|FG002|Overall Study|Insufficient clinical response|1|||
144582676|NCT01262677|521333888|FG000|Overall Study|Lost to Follow-up|1|||
144582677|NCT01262677|521333889|FG001|Overall Study|Lost to Follow-up|0|||
144582678|NCT01262677|521333890|FG002|Overall Study|Lost to Follow-up|2|||
144582679|NCT01262677|521333888|FG000|Overall Study|No longer willing to participate|3|||
144582680|NCT01262677|521333889|FG001|Overall Study|No longer willing to participate|3|||
144582681|NCT01262677|521333890|FG002|Overall Study|No longer willing to participate|2|||
144582682|NCT01262677|521333888|FG000|Overall Study|Reason not provided|2|||
144582683|NCT01262677|521333889|FG001|Overall Study|Reason not provided|1|||
144582684|NCT01262677|521333890|FG002|Overall Study|Reason not provided|3|||
144582685|NCT01262677|521333888|FG000|Overall Study|Protocol Violation|0|||
144582686|NCT01262677|521333889|FG001|Overall Study|Protocol Violation|1|||
144582687|NCT01262677|521333890|FG002|Overall Study|Protocol Violation|1|||
144582688|NCT01262677|521333888|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
144582689|NCT01262677|521333889|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
144582690|NCT01262677|521333890|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
144582691|NCT00581555|521333894|FG000|Overall Study|Adverse Event|4|||
144582692|NCT00581555|521333895|FG001|Overall Study|Adverse Event|3|||
144582693|NCT00581555|521333894|FG000|Overall Study|Physician Decision|3|||
144582694|NCT00581555|521333895|FG001|Overall Study|Physician Decision|2|||
144582695|NCT00581555|521333894|FG000|Overall Study|Withdrawal by Subject|18|||
144582696|NCT00581555|521333895|FG001|Overall Study|Withdrawal by Subject|9|||
144582697|NCT00581555|521333894|FG000|Overall Study|Lost to Follow-up|2|||
144582698|NCT00581555|521333895|FG001|Overall Study|Lost to Follow-up|2|||
144582699|NCT00581555|521333894|FG000|Overall Study|Other reasons|16|||
144582700|NCT00581555|521333895|FG001|Overall Study|Other reasons|4|||
144582701|NCT05816330|521333901|FG000|Overall Study|Withdrawal by Subject|4|||
144582702|NCT05816330|521333902|FG001|Overall Study|Withdrawal by Subject|1|||
144582703|NCT03446781|521333905|FG000|Overall Study|Lost to Follow-up|11|||
144582704|NCT03446781|521333906|FG001|Overall Study|Lost to Follow-up|5|||
144582705|NCT03446781|521333905|FG000|Overall Study|Withdrawal by Subject|9|||
144582706|NCT03446781|521333906|FG001|Overall Study|Withdrawal by Subject|7|||
144582707|NCT03446781|521333905|FG000|Overall Study|Adverse Event|8|||
144582708|NCT03446781|521333906|FG001|Overall Study|Adverse Event|2|||
144582709|NCT03446781|521333905|FG000|Overall Study|Protocol Violation|0|||
144582710|NCT03446781|521333906|FG001|Overall Study|Protocol Violation|3|||
144582711|NCT03568318|521333913|FG000|Overall Study|Adverse Event|3|||
144582712|NCT03568318|521333914|FG001|Overall Study|Adverse Event|1|||
144582713|NCT03568318|521333915|FG002|Overall Study|Adverse Event|1|||
144582714|NCT03568318|521333916|FG003|Overall Study|Adverse Event|0|||
144582715|NCT03568318|521333917|FG004|Overall Study|Adverse Event|1|||
144582716|NCT03568318|521333918|FG005|Overall Study|Adverse Event|0|||
144582717|NCT03568318|521333913|FG000|Overall Study|Withdrawal by Subject|6|||
144582718|NCT03568318|521333914|FG001|Overall Study|Withdrawal by Subject|5|||
144582719|NCT03568318|521333915|FG002|Overall Study|Withdrawal by Subject|2|||
144582720|NCT03568318|521333916|FG003|Overall Study|Withdrawal by Subject|1|||
144582721|NCT03568318|521333917|FG004|Overall Study|Withdrawal by Subject|0|||
144582722|NCT03568318|521333918|FG005|Overall Study|Withdrawal by Subject|0|||
144582723|NCT03568318|521333913|FG000|Overall Study|Lost to Follow-up|3|||
144582724|NCT03568318|521333914|FG001|Overall Study|Lost to Follow-up|2|||
144582725|NCT03568318|521333915|FG002|Overall Study|Lost to Follow-up|2|||
144582726|NCT03568318|521333916|FG003|Overall Study|Lost to Follow-up|2|||
144582727|NCT03568318|521333917|FG004|Overall Study|Lost to Follow-up|1|||
144582728|NCT03568318|521333918|FG005|Overall Study|Lost to Follow-up|0|||
144582729|NCT03568318|521333913|FG000|Overall Study|Other|3|||
144582730|NCT03568318|521333914|FG001|Overall Study|Other|1|||
144582731|NCT03568318|521333915|FG002|Overall Study|Other|3|||
144582732|NCT03568318|521333916|FG003|Overall Study|Other|0|||
144582733|NCT03568318|521333917|FG004|Overall Study|Other|0|||
144582734|NCT03568318|521333918|FG005|Overall Study|Other|0|||
144582735|NCT03568318|521333913|FG000|Overall Study|Ongoing at Time of Analysis|5|||
144582736|NCT03568318|521333914|FG001|Overall Study|Ongoing at Time of Analysis|3|||
144582737|NCT03568318|521333915|FG002|Overall Study|Ongoing at Time of Analysis|2|||
144582738|NCT03568318|521333916|FG003|Overall Study|Ongoing at Time of Analysis|1|||
144582739|NCT03568318|521333917|FG004|Overall Study|Ongoing at Time of Analysis|0|||
144582740|NCT03568318|521333918|FG005|Overall Study|Ongoing at Time of Analysis|0|||
144730406|NCT03125200|521868230|FG000|Overall Study|Study Termination|0|||
144582741|NCT02898077|521333919|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
144582742|NCT02898077|521333920|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
144582743|NCT02898077|521333919|FG000|Overall Study|Lost to Follow-up|4|||
144582744|NCT02898077|521333920|FG001|Overall Study|Lost to Follow-up|3|||
144582745|NCT02898077|521333919|FG000|Overall Study|Physician Decision|0|||
144582746|NCT02898077|521333920|FG001|Overall Study|Physician Decision|2|||
144582747|NCT02898077|521333919|FG000|Overall Study|Sponsor Decision|32|||
144582748|NCT02898077|521333920|FG001|Overall Study|Sponsor Decision|13|||
144582749|NCT02898077|521333919|FG000|Overall Study|Withdrawal by Subject|6|||
144582750|NCT02898077|521333920|FG001|Overall Study|Withdrawal by Subject|3|||
144582751|NCT02898077|521333919|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
144582752|NCT02898077|521333920|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
144582753|NCT02898077|521333919|FG000|Overall Study|Ended extension period|3|||
144582754|NCT02898077|521333920|FG001|Overall Study|Ended extension period|0|||
144582755|NCT04410523|521333921|FG000|Overall Study|Study terminated by sponsor|1|||
144582756|NCT04410523|521333922|FG001|Overall Study|Study terminated by sponsor|3|||
144582757|NCT04410523|521333923|FG002|Overall Study|Study terminated by sponsor|2|||
144582758|NCT04410523|521333924|FG003|Overall Study|Study terminated by sponsor|6|||
144582759|NCT04410523|521333925|FG004|Overall Study|Study terminated by sponsor|3|||
144582760|NCT04410523|521333926|FG005|Overall Study|Study terminated by sponsor|4|||
144582761|NCT04410523|521333921|FG000|Overall Study|Adverse Event|1|||
144582762|NCT04410523|521333922|FG001|Overall Study|Adverse Event|0|||
144582763|NCT04410523|521333923|FG002|Overall Study|Adverse Event|0|||
144582764|NCT04410523|521333924|FG003|Overall Study|Adverse Event|0|||
144582765|NCT04410523|521333925|FG004|Overall Study|Adverse Event|0|||
144582766|NCT04410523|521333926|FG005|Overall Study|Adverse Event|2|||
144582767|NCT04410523|521333921|FG000|Overall Study|Lost to Follow-up|0|||
144582768|NCT04410523|521333922|FG001|Overall Study|Lost to Follow-up|1|||
144582769|NCT04410523|521333923|FG002|Overall Study|Lost to Follow-up|0|||
144582770|NCT04410523|521333924|FG003|Overall Study|Lost to Follow-up|0|||
144582771|NCT04410523|521333925|FG004|Overall Study|Lost to Follow-up|0|||
144582772|NCT04410523|521333926|FG005|Overall Study|Lost to Follow-up|0|||
144582773|NCT04410523|521333921|FG000|Overall Study|Physician Decision|0|||
144582774|NCT04410523|521333922|FG001|Overall Study|Physician Decision|1|||
144582775|NCT04410523|521333923|FG002|Overall Study|Physician Decision|0|||
144582776|NCT04410523|521333924|FG003|Overall Study|Physician Decision|0|||
144582777|NCT04410523|521333925|FG004|Overall Study|Physician Decision|0|||
144582778|NCT04410523|521333926|FG005|Overall Study|Physician Decision|0|||
144582779|NCT04410523|521333921|FG000|Overall Study|Pregnancy|0|||
144582780|NCT04410523|521333922|FG001|Overall Study|Pregnancy|0|||
144582781|NCT04410523|521333923|FG002|Overall Study|Pregnancy|0|||
144582782|NCT04410523|521333924|FG003|Overall Study|Pregnancy|0|||
144582783|NCT04410523|521333925|FG004|Overall Study|Pregnancy|0|||
144582784|NCT04410523|521333926|FG005|Overall Study|Pregnancy|1|||
144582785|NCT04410523|521333921|FG000|Overall Study|Protocol deviation|0|||
144582786|NCT04410523|521333922|FG001|Overall Study|Protocol deviation|0|||
144582787|NCT04410523|521333923|FG002|Overall Study|Protocol deviation|0|||
144582788|NCT04410523|521333924|FG003|Overall Study|Protocol deviation|0|||
144582789|NCT04410523|521333925|FG004|Overall Study|Protocol deviation|0|||
144582790|NCT04410523|521333926|FG005|Overall Study|Protocol deviation|2|||
144582791|NCT04410523|521333921|FG000|Overall Study|Subject decision|2|||
144582792|NCT04410523|521333922|FG001|Overall Study|Subject decision|0|||
144582793|NCT04410523|521333923|FG002|Overall Study|Subject decision|0|||
144582794|NCT04410523|521333924|FG003|Overall Study|Subject decision|1|||
144582795|NCT04410523|521333925|FG004|Overall Study|Subject decision|0|||
144582796|NCT04410523|521333926|FG005|Overall Study|Subject decision|1|||
144582797|NCT01638429|521333929|FG000|Overall Study|Withdrawal by Subject|1|||
144582798|NCT03207451|521333930|FG000|Overall Study|scheduling conflict|1|||
144582799|NCT03207451|521333931|FG001|Overall Study|scheduling conflict|0|||
144582800|NCT03207451|521333932|FG002|Overall Study|scheduling conflict|2|||
144582801|NCT03207451|521333933|FG003|Overall Study|scheduling conflict|2|||
144582802|NCT03207451|521333930|FG000|Overall Study|Adverse Event|0|||
144582803|NCT03207451|521333931|FG001|Overall Study|Adverse Event|0|||
144582804|NCT03207451|521333932|FG002|Overall Study|Adverse Event|0|||
144582805|NCT03207451|521333933|FG003|Overall Study|Adverse Event|1|||
144582806|NCT02040584|521333935|FG000|Overall Study|Adverse Event|13|||
144582807|NCT02040584|521333936|FG001|Overall Study|Adverse Event|6|||
144582808|NCT02040584|521333935|FG000|Overall Study|Protocol Violation|9|||
144582809|NCT02040584|521333936|FG001|Overall Study|Protocol Violation|11|||
144582810|NCT02040584|521333935|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144582811|NCT02040584|521333936|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144582812|NCT02040584|521333935|FG000|Overall Study|Death|6|||
144582813|NCT02040584|521333936|FG001|Overall Study|Death|3|||
144582814|NCT02040584|521333935|FG000|Overall Study|Transplant rejection/retransplant|0|||
144582815|NCT02040584|521333936|FG001|Overall Study|Transplant rejection/retransplant|1|||
144582816|NCT02040584|521333935|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
144582817|NCT02040584|521333936|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
144730407|NCT03125200|521868231|FG001|Overall Study|Study Termination|0|||
144582818|NCT01802567|521333937|FG000|Overall Study|Withdrawal by Subject|2|||
144582819|NCT01802567|521333937|FG000|Overall Study|Physician Decision|1|||
144582820|NCT01802567|521333937|FG000|Overall Study|Lack of Efficacy|7|||
144582821|NCT01802567|521333937|FG000|Overall Study|Consented but did not start therapy|7|||
144582822|NCT01802567|521333937|FG000|Overall Study|Protocol Violation|1|||
144582823|NCT01940939|521333938|FG000|Overall Study|Withdrawal by Subject|2|||
144582824|NCT01940939|521333939|FG001|Overall Study|Withdrawal by Subject|8|||
144582825|NCT00772330|521333943|FG000|Overall Study|Lost to Follow-up|3|||
144582826|NCT01519089|521333944|FG000|Overall Study|Adverse Event|4|||
144582827|NCT01519089|521333945|FG001|Overall Study|Adverse Event|4|||
144582828|NCT01519089|521333944|FG000|Overall Study|Lack of Efficacy|0|||
144582829|NCT01519089|521333945|FG001|Overall Study|Lack of Efficacy|2|||
144582830|NCT01519089|521333944|FG000|Overall Study|Lost to Follow-up|1|||
144582831|NCT01519089|521333945|FG001|Overall Study|Lost to Follow-up|0|||
144582832|NCT01519089|521333944|FG000|Overall Study|Withdrawal by Subject|0|||
144582833|NCT01519089|521333945|FG001|Overall Study|Withdrawal by Subject|2|||
144582834|NCT01519089|521333944|FG000|Overall Study|Other|2|||
144582835|NCT01519089|521333945|FG001|Overall Study|Other|6|||
144582836|NCT01519089|521333944|FG000|Overall Study|Not received study drug|0|||
144582837|NCT01519089|521333945|FG001|Overall Study|Not received study drug|1|||
144582838|NCT00127205|521333946|FG000|Overall Study|Adverse Event|228|||
144582839|NCT00127205|521333947|FG001|Overall Study|Adverse Event|387|||
144582840|NCT00127205|521333948|FG002|Overall Study|Adverse Event|273|||
144582841|NCT00127205|521333946|FG000|Overall Study|Death|8|||
144582842|NCT00127205|521333947|FG001|Overall Study|Death|6|||
144582843|NCT00127205|521333948|FG002|Overall Study|Death|5|||
144582844|NCT00127205|521333946|FG000|Overall Study|Withdrawal by Subject|318|||
144582845|NCT00127205|521333947|FG001|Overall Study|Withdrawal by Subject|310|||
144582846|NCT00127205|521333948|FG002|Overall Study|Withdrawal by Subject|172|||
144582847|NCT00127205|521333946|FG000|Overall Study|Other-non protocol specified|142|||
144582848|NCT00127205|521333947|FG001|Overall Study|Other-non protocol specified|129|||
144582849|NCT00127205|521333948|FG002|Overall Study|Other-non protocol specified|77|||
144582850|NCT00127205|521333946|FG000|Overall Study|Data not reported|6|||
144582851|NCT00127205|521333947|FG001|Overall Study|Data not reported|10|||
144582852|NCT00127205|521333948|FG002|Overall Study|Data not reported|1|||
144582853|NCT00127205|521333946|FG000|Overall Study|Progression|127|||
144582854|NCT00127205|521333947|FG001|Overall Study|Progression|131|||
144582855|NCT00127205|521333948|FG002|Overall Study|Progression|84|||
144582856|NCT05032872|521333949|FG000|Overall Study|Adverse Event|1|||
144582857|NCT05032872|521333950|FG001|Overall Study|Adverse Event|0|||
144582858|NCT05032872|521333949|FG000|Overall Study|Lost to Follow-up|2|||
144582859|NCT05032872|521333950|FG001|Overall Study|Lost to Follow-up|4|||
144582860|NCT05032872|521333949|FG000|Overall Study|Withdrawal by Subject|4|||
144582861|NCT05032872|521333950|FG001|Overall Study|Withdrawal by Subject|3|||
144582862|NCT00910039|521333951|FG000|Overall Study|Physician Decision|1|||
144582863|NCT04155047|521333955|FG000|Overall Study|Adverse Event|1|||
144582864|NCT04155047|521333956|FG001|Overall Study|Adverse Event|0|||
144582865|NCT04155047|521333955|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
144582866|NCT04155047|521333956|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
144582867|NCT00400725|521333957|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
144582868|NCT00400725|521333958|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
144582869|NCT00400725|521333959|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
144582870|NCT00400725|521333957|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
144582871|NCT00400725|521333958|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
144582872|NCT00400725|521333959|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
144582873|NCT00400725|521333957|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
144582874|NCT00400725|521333958|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
144582875|NCT00400725|521333959|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
144582876|NCT00400725|521333957|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
144582877|NCT00400725|521333958|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
144582878|NCT00400725|521333959|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
144582879|NCT00400725|521333957|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
144582880|NCT00400725|521333958|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
144582881|NCT00400725|521333959|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
144582882|NCT00400725|521333957|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
144582883|NCT00400725|521333958|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
144582884|NCT00400725|521333959|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
144582885|NCT00400725|521333957|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
144582886|NCT00400725|521333958|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
144582887|NCT00400725|521333959|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
144582888|NCT00400725|521333957|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
144582889|NCT00400725|521333958|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
144582890|NCT00400725|521333959|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
144582891|NCT00400725|521333957|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
144582892|NCT00400725|521333958|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
144582893|NCT00400725|521333959|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
144582894|NCT03547739|521333960|FG000|Overall Study|Death|0|||
144582895|NCT03547739|521333961|FG001|Overall Study|Death|1|||
144582896|NCT03547739|521333962|FG002|Overall Study|Death|5|||
144582897|NCT03547739|521333960|FG000|Overall Study|Adverse Event|24|||
144582898|NCT03547739|521333961|FG001|Overall Study|Adverse Event|11|||
144582899|NCT03547739|521333962|FG002|Overall Study|Adverse Event|13|||
144582900|NCT03547739|521333960|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
144582901|NCT03547739|521333961|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
144582902|NCT03547739|521333962|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
144582903|NCT03547739|521333960|FG000|Overall Study|Lost to Follow-up|80|||
144582904|NCT03547739|521333961|FG001|Overall Study|Lost to Follow-up|84|||
144582905|NCT03547739|521333962|FG002|Overall Study|Lost to Follow-up|116|||
144582906|NCT03192475|521333975|FG000|Overall Study|Death|0|||
144582907|NCT03192475|521333976|FG001|Overall Study|Death|1|||
144582908|NCT03192475|521333975|FG000|Overall Study|Lost to Follow-up|13|||
144582909|NCT03192475|521333976|FG001|Overall Study|Lost to Follow-up|8|||
144582910|NCT00798590|521333977|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
144582911|NCT00798590|521333978|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
144582912|NCT00436605|521333982|FG000|Overall Study|Protocol Violation|3|||
144582913|NCT03014011|521333983|FG000|First Intervention|Withdrawal by Subject|1|||
144582914|NCT03014011|521333984|FG001|First Intervention|Withdrawal by Subject|0|||
144582915|NCT03014011|521333983|FG000|Washout|Withdrawal by Subject|1|||
144582916|NCT03014011|521333984|FG001|Washout|Withdrawal by Subject|0|||
144582917|NCT00573859|521333985|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
144582918|NCT00573859|521333985|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
144582919|NCT00688870|521333992|FG000|Infant Series|Parent or legal guardian request|4|||
144582920|NCT00688870|521333993|FG001|Infant Series|Parent or legal guardian request|0|||
144582921|NCT03449901|521333996|FG000|Overall Study|Progression|57|||
144582922|NCT03449901|521333997|FG001|Overall Study|Progression|12|||
144582923|NCT03449901|521333996|FG000|Overall Study|Adverse Event|3|||
144582924|NCT03449901|521333997|FG001|Overall Study|Adverse Event|0|||
144582925|NCT03449901|521333996|FG000|Overall Study|Death|6|||
144582926|NCT03449901|521333997|FG001|Overall Study|Death|2|||
144582927|NCT03449901|521333996|FG000|Overall Study|Withdrawal by Subject|12|||
144582928|NCT03449901|521333997|FG001|Overall Study|Withdrawal by Subject|1|||
144582929|NCT03449901|521333996|FG000|Overall Study|Physician Decision|1|||
144582930|NCT03449901|521333997|FG001|Overall Study|Physician Decision|0|||
144582931|NCT03449901|521333996|FG000|Overall Study|Patient elected for surgical intervention|1|||
144582932|NCT03449901|521333997|FG001|Overall Study|Patient elected for surgical intervention|0|||
144582933|NCT03449901|521333996|FG000|Overall Study|Patient off for other complicating disease|1|||
144582934|NCT03449901|521333997|FG001|Overall Study|Patient off for other complicating disease|0|||
144582935|NCT03682302|521333998|FG000|Overall Study|Lost to Follow-up|1|||
144582936|NCT03682302|521333999|FG001|Overall Study|Lost to Follow-up|2|||
144582937|NCT03682302|521334000|FG002|Overall Study|Lost to Follow-up|0|||
144582938|NCT03682302|521334001|FG003|Overall Study|Lost to Follow-up|1|||
144582939|NCT03682302|521333998|FG000|Overall Study|Study drug was not administered|0|||
144582940|NCT03682302|521333999|FG001|Overall Study|Study drug was not administered|0|||
144582941|NCT03682302|521334000|FG002|Overall Study|Study drug was not administered|1|||
144582942|NCT03682302|521334001|FG003|Overall Study|Study drug was not administered|1|||
144582943|NCT00293059|521334003|FG000|Overall Study|Adverse Event|12|||
144582944|NCT00293059|521334004|FG001|Overall Study|Adverse Event|4|||
144582945|NCT00293059|521334003|FG000|Overall Study|Lack of Efficacy|2|||
144582946|NCT00293059|521334004|FG001|Overall Study|Lack of Efficacy|0|||
144582947|NCT00293059|521334003|FG000|Overall Study|Lost to Follow-up|2|||
144582948|NCT00293059|521334004|FG001|Overall Study|Lost to Follow-up|3|||
144582949|NCT00293059|521334003|FG000|Overall Study|Pregnancy|1|||
144582950|NCT00293059|521334004|FG001|Overall Study|Pregnancy|1|||
144582951|NCT00293059|521334003|FG000|Overall Study|Protocol Violation|2|||
144582952|NCT00293059|521334004|FG001|Overall Study|Protocol Violation|0|||
144582953|NCT00293059|521334003|FG000|Overall Study|Withdrawal by Subject|11|||
144582954|NCT00293059|521334004|FG001|Overall Study|Withdrawal by Subject|5|||
144582955|NCT00293059|521334003|FG000|Overall Study|Participant moved out of state|1|||
144582956|NCT00293059|521334004|FG001|Overall Study|Participant moved out of state|0|||
144582957|NCT00293059|521334003|FG000|Overall Study|Participant stopped study drug|1|||
144582958|NCT00293059|521334004|FG001|Overall Study|Participant stopped study drug|0|||
144582959|NCT00293059|521334003|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
144582960|NCT00293059|521334004|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
144582961|NCT00293059|521334003|FG000|Overall Study|missing|3|||
144582962|NCT00293059|521334004|FG001|Overall Study|missing|5|||
144730408|NCT03125200|521868232|FG002|Overall Study|Study Termination|0|||
144582963|NCT01609062|521334005|FG000|Extension Phase|Terminated by Sponsor|14|||
144582964|NCT01609062|521334006|FG001|Extension Phase|Terminated by Sponsor|9|||
144582965|NCT01609062|521334005|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
144582966|NCT01609062|521334006|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
144582967|NCT01609062|521334005|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
144582968|NCT01609062|521334006|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
144582969|NCT00680992|521334007|FG000|Overall Study|Complete Resection (as per protocol)|25|||
144582970|NCT00680992|521334008|FG001|Overall Study|Complete Resection (as per protocol)|121|||
144209446|NCT00264550|519961891|FG003|Overall Study|Death|0|||
144582971|NCT00680992|521334009|FG002|Overall Study|Complete Resection (as per protocol)|0|||
144582972|NCT00680992|521334007|FG000|Overall Study|Administrative Decision|83|||
144582973|NCT00680992|521334008|FG001|Overall Study|Administrative Decision|42|||
144582974|NCT00680992|521334009|FG002|Overall Study|Administrative Decision|5|||
144582975|NCT00680992|521334007|FG000|Overall Study|End of Trial|32|||
144582976|NCT00680992|521334008|FG001|Overall Study|End of Trial|12|||
144582977|NCT00680992|521334009|FG002|Overall Study|End of Trial|3|||
144582978|NCT00680992|521334007|FG000|Overall Study|Withdrawal by Subject|33|||
144582979|NCT00680992|521334008|FG001|Overall Study|Withdrawal by Subject|11|||
144582980|NCT00680992|521334009|FG002|Overall Study|Withdrawal by Subject|1|||
144582981|NCT00680992|521334007|FG000|Overall Study|Adverse Event|21|||
144582982|NCT00680992|521334008|FG001|Overall Study|Adverse Event|19|||
144582983|NCT00680992|521334009|FG002|Overall Study|Adverse Event|1|||
144582984|NCT00680992|521334007|FG000|Overall Study|Other|19|||
144582985|NCT00680992|521334008|FG001|Overall Study|Other|14|||
144582986|NCT00680992|521334009|FG002|Overall Study|Other|1|||
144582987|NCT00680992|521334007|FG000|Overall Study|Disease Progression|21|||
144582988|NCT00680992|521334008|FG001|Overall Study|Disease Progression|9|||
144582989|NCT00680992|521334009|FG002|Overall Study|Disease Progression|0|||
144582990|NCT00680992|521334007|FG000|Overall Study|Lost to Follow-up|12|||
144582991|NCT00680992|521334008|FG001|Overall Study|Lost to Follow-up|14|||
144582992|NCT00680992|521334009|FG002|Overall Study|Lost to Follow-up|0|||
144582993|NCT00680992|521334007|FG000|Overall Study|Noncompliance|4|||
144582994|NCT00680992|521334008|FG001|Overall Study|Noncompliance|6|||
144582995|NCT00680992|521334009|FG002|Overall Study|Noncompliance|0|||
144582996|NCT00680992|521334007|FG000|Overall Study|Requirement for Alternative Therapy|8|||
144582997|NCT00680992|521334008|FG001|Overall Study|Requirement for Alternative Therapy|2|||
144582998|NCT00680992|521334009|FG002|Overall Study|Requirement for Alternative Therapy|0|||
144582999|NCT00680992|521334007|FG000|Overall Study|Pregnancy|5|||
144583000|NCT00680992|521334008|FG001|Overall Study|Pregnancy|0|||
144583001|NCT00680992|521334009|FG002|Overall Study|Pregnancy|1|||
144583002|NCT00680992|521334007|FG000|Overall Study|Death|5|||
144583003|NCT00680992|521334008|FG001|Overall Study|Death|1|||
144583004|NCT00680992|521334009|FG002|Overall Study|Death|0|||
144583005|NCT00680992|521334007|FG000|Overall Study|Ineligibility Determined|0|||
144209447|NCT00264550|519961888|FG000|Overall Study|Lost to Follow-up|3|||
144583006|NCT00680992|521334008|FG001|Overall Study|Ineligibility Determined|1|||
144583007|NCT00680992|521334009|FG002|Overall Study|Ineligibility Determined|0|||
144583008|NCT03772587|521334010|FG000|Overall Study|COVID-19|0|||
144583009|NCT03772587|521334011|FG001|Overall Study|COVID-19|0|||
144583010|NCT03772587|521334012|FG002|Overall Study|COVID-19|1|||
144583011|NCT03772587|521334013|FG003|Overall Study|COVID-19|1|||
144209448|NCT00264550|519961889|FG001|Overall Study|Lost to Follow-up|1|||
144209449|NCT00264550|519961890|FG002|Overall Study|Lost to Follow-up|1|||
144209450|NCT00264550|519961891|FG003|Overall Study|Lost to Follow-up|1|||
144583012|NCT03772587|521334014|FG004|Overall Study|COVID-19|0|||
144583013|NCT03772587|521334010|FG000|Overall Study|Withdrawal by Subject|1|||
144583014|NCT03772587|521334011|FG001|Overall Study|Withdrawal by Subject|0|||
144583015|NCT03772587|521334012|FG002|Overall Study|Withdrawal by Subject|0|||
144583016|NCT03772587|521334013|FG003|Overall Study|Withdrawal by Subject|0|||
144209451|NCT00264550|519961888|FG000|Overall Study|Adverse Event|23|||
144583017|NCT03772587|521334014|FG004|Overall Study|Withdrawal by Subject|0|||
144583018|NCT00095056|521335591|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
144583019|NCT00095056|521335592|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
144583020|NCT00095056|521335591|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
144583021|NCT00095056|521335592|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
144583022|NCT00095056|521335591|FG000|Phase A (Weeks 0-12)|Death|1|||
144583023|NCT00095056|521335592|FG001|Phase A (Weeks 0-12)|Death|0|||
144583024|NCT00095056|521335591|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
144583025|NCT00095056|521335592|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
144583026|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
144583027|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
144583028|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
144583029|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
144583030|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
144583031|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
144583032|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
144583033|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
144583034|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Death|3|||
144583035|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Death|1|||
144583036|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
144583037|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
144583038|NCT00095056|521335591|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
144623307|NCT03529773|521478624|FG031|Overall Study|Adverse Event|0|||
144623308|NCT03529773|521478625|FG032|Overall Study|Adverse Event|0|||
144623309|NCT03529773|521478626|FG033|Overall Study|Adverse Event|0|||
144623310|NCT03529773|521478627|FG034|Overall Study|Adverse Event|0|||
144623311|NCT03529773|521478628|FG035|Overall Study|Adverse Event|1|||
144623312|NCT03529773|521478629|FG036|Overall Study|Adverse Event|0|||
144623313|NCT03529773|521478630|FG037|Overall Study|Adverse Event|0|||
144623314|NCT03529773|521478631|FG038|Overall Study|Adverse Event|1|||
144623315|NCT03529773|521478632|FG039|Overall Study|Adverse Event|1|||
144623316|NCT03529773|521478593|FG000|Overall Study|Death|0|||
144623317|NCT03529773|521478594|FG001|Overall Study|Death|0|||
144583039|NCT00095056|521335592|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
144583040|NCT00574873|521335594|FG000|Overall Study|Withdrawal by Subject|18|||
144583041|NCT00574873|521335595|FG001|Overall Study|Withdrawal by Subject|19|||
144583042|NCT00574873|521335594|FG000|Overall Study|Investigator request|18|||
144583043|NCT00574873|521335595|FG001|Overall Study|Investigator request|8|||
144583044|NCT00574873|521335594|FG000|Overall Study|Death|15|||
144583045|NCT00574873|521335595|FG001|Overall Study|Death|14|||
144583046|NCT00574873|521335594|FG000|Overall Study|Lost to Follow-up|14|||
144583047|NCT00574873|521335595|FG001|Overall Study|Lost to Follow-up|5|||
144583048|NCT00574873|521335594|FG000|Overall Study|Other|40|||
144583049|NCT00574873|521335595|FG001|Overall Study|Other|4|||
144583050|NCT00574873|521335594|FG000|Overall Study|Discontinuation of study by sponsor|5|||
144583051|NCT00574873|521335595|FG001|Overall Study|Discontinuation of study by sponsor|199|||
144583052|NCT00574873|521335594|FG000|Overall Study|Blank, site closed per local regulations|2|||
144583053|NCT00574873|521335595|FG001|Overall Study|Blank, site closed per local regulations|2|||
144583054|NCT00574873|521335594|FG000|Overall Study|Extension Study|126|||
144583055|NCT00574873|521335595|FG001|Overall Study|Extension Study|0|||
144583056|NCT00201643|521335596|FG000|Overall Study|Withdrawal by Subject|5|||
144583057|NCT00201643|521335597|FG001|Overall Study|Withdrawal by Subject|4|||
144583058|NCT03896152|521335598|FG000|Overall Study|Patient/guardian decision|1|||
144583059|NCT03896152|521335599|FG001|Overall Study|Patient/guardian decision|1|||
144623318|NCT03529773|521478595|FG002|Overall Study|Death|0|||
144623319|NCT03529773|521478596|FG003|Overall Study|Death|0|||
144623320|NCT03529773|521478597|FG004|Overall Study|Death|0|||
144623321|NCT03529773|521478598|FG005|Overall Study|Death|0|||
144623322|NCT03529773|521478599|FG006|Overall Study|Death|0|||
144623323|NCT03529773|521478600|FG007|Overall Study|Death|0|||
144623324|NCT03529773|521478601|FG008|Overall Study|Death|0|||
144623325|NCT03529773|521478602|FG009|Overall Study|Death|0|||
144623326|NCT03529773|521478603|FG010|Overall Study|Death|0|||
144623327|NCT03529773|521478604|FG011|Overall Study|Death|0|||
144623328|NCT03529773|521478605|FG012|Overall Study|Death|1|||
144623329|NCT03529773|521478606|FG013|Overall Study|Death|0|||
144623330|NCT03529773|521478607|FG014|Overall Study|Death|0|||
144623331|NCT03529773|521478608|FG015|Overall Study|Death|0|||
144623332|NCT03529773|521478609|FG016|Overall Study|Death|0|||
144623333|NCT03529773|521478610|FG017|Overall Study|Death|0|||
144623334|NCT03529773|521478611|FG018|Overall Study|Death|0|||
144623335|NCT03529773|521478612|FG019|Overall Study|Death|1|||
144623336|NCT03529773|521478613|FG020|Overall Study|Death|0|||
144623337|NCT03529773|521478614|FG021|Overall Study|Death|0|||
144623338|NCT03529773|521478615|FG022|Overall Study|Death|1|||
144623339|NCT03529773|521478616|FG023|Overall Study|Death|0|||
144623340|NCT03529773|521478617|FG024|Overall Study|Death|0|||
144623341|NCT03529773|521478618|FG025|Overall Study|Death|0|||
144623342|NCT03529773|521478619|FG026|Overall Study|Death|0|||
144623343|NCT03529773|521478620|FG027|Overall Study|Death|0|||
144623344|NCT03529773|521478621|FG028|Overall Study|Death|0|||
144623345|NCT03529773|521478622|FG029|Overall Study|Death|0|||
144623346|NCT03529773|521478623|FG030|Overall Study|Death|0|||
144623347|NCT03529773|521478624|FG031|Overall Study|Death|0|||
144623348|NCT03529773|521478625|FG032|Overall Study|Death|0|||
144583060|NCT03896152|521335598|FG000|Overall Study|Adverse Event|0|||
144583061|NCT03896152|521335599|FG001|Overall Study|Adverse Event|1|||
144583062|NCT03896152|521335598|FG000|Overall Study|Physician Decision|1|||
144583063|NCT03896152|521335599|FG001|Overall Study|Physician Decision|0|||
144583064|NCT03896152|521335598|FG000|Overall Study|Technical problems|1|||
144583065|NCT03896152|521335599|FG001|Overall Study|Technical problems|0|||
144583066|NCT00436852|521335600|FG000|Overall Study|Death|23|||
144623349|NCT03529773|521478626|FG033|Overall Study|Death|1|||
144730409|NCT03125200|521868233|FG003|Overall Study|Study Termination|1|||
144583067|NCT00436852|521335601|FG001|Overall Study|Death|34|||
144623350|NCT03529773|521478627|FG034|Overall Study|Death|1|||
144623351|NCT03529773|521478628|FG035|Overall Study|Death|0|||
144623352|NCT03529773|521478629|FG036|Overall Study|Death|1|||
144623353|NCT03529773|521478630|FG037|Overall Study|Death|0|||
144623354|NCT03529773|521478631|FG038|Overall Study|Death|0|||
144623355|NCT03529773|521478632|FG039|Overall Study|Death|0|||
144623356|NCT03529773|521478593|FG000|Overall Study|Lost to Follow-up|0|||
144623357|NCT03529773|521478594|FG001|Overall Study|Lost to Follow-up|0|||
144623358|NCT03529773|521478595|FG002|Overall Study|Lost to Follow-up|1|||
144623359|NCT03529773|521478596|FG003|Overall Study|Lost to Follow-up|0|||
144583068|NCT00436852|521335600|FG000|Overall Study|Lack of Efficacy|9|||
144583069|NCT00436852|521335601|FG001|Overall Study|Lack of Efficacy|7|||
144583070|NCT00436852|521335600|FG000|Overall Study|Withdrawal by Subject|2|||
144583071|NCT00436852|521335601|FG001|Overall Study|Withdrawal by Subject|4|||
144583072|NCT00436852|521335600|FG000|Overall Study|Ineligible|1|||
144583073|NCT00436852|521335601|FG001|Overall Study|Ineligible|0|||
144583074|NCT00370682|521335602|FG000|Overall Study|Moved from area|0|||
144583075|NCT00370682|521335603|FG001|Overall Study|Moved from area|2|||
144583076|NCT00370682|521335604|FG002|Overall Study|Moved from area|0|||
144583077|NCT00370682|521335602|FG000|Overall Study|Lost to Follow-up|0|||
144583078|NCT00370682|521335603|FG001|Overall Study|Lost to Follow-up|1|||
144583079|NCT00370682|521335604|FG002|Overall Study|Lost to Follow-up|1|||
144583080|NCT03167359|521335605|FG000|Overall Study|Physician Decision|1|||
144583081|NCT03167359|521335605|FG000|Overall Study|Lost to Follow-up|1|||
144583082|NCT00943852|521335606|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583083|NCT00943852|521335607|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583084|NCT00943852|521335608|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583085|NCT00943852|521335609|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
144583086|NCT00943852|521335610|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583087|NCT00943852|521335611|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583088|NCT00943852|521335612|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583089|NCT00943852|521335613|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583090|NCT00943852|521335614|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583091|NCT00943852|521335615|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
144583092|NCT00943852|521335606|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583093|NCT00943852|521335607|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583094|NCT00943852|521335608|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583095|NCT00943852|521335609|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583096|NCT00943852|521335610|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583097|NCT00943852|521335611|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
144583098|NCT00943852|521335612|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583099|NCT00943852|521335613|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583100|NCT00943852|521335614|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583101|NCT00943852|521335615|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
144583102|NCT00943852|521335606|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583103|NCT00943852|521335607|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583104|NCT00943852|521335608|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583105|NCT00943852|521335609|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583106|NCT00943852|521335610|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583107|NCT00943852|521335611|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583108|NCT00943852|521335612|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
144583109|NCT00943852|521335613|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583110|NCT00943852|521335614|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583111|NCT00943852|521335615|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
144583112|NCT00943852|521335606|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583113|NCT00943852|521335607|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583114|NCT00943852|521335608|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583115|NCT00943852|521335609|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583116|NCT00943852|521335610|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583117|NCT00943852|521335611|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583118|NCT00943852|521335612|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583119|NCT00943852|521335613|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
144583120|NCT00943852|521335614|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583121|NCT00943852|521335615|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
144583122|NCT00943852|521335606|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
144583123|NCT00943852|521335607|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
144583124|NCT00943852|521335608|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
144583125|NCT00943852|521335609|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
144583126|NCT00943852|521335610|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
144583127|NCT00943852|521335611|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
144583128|NCT00943852|521335612|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
144583129|NCT00943852|521335613|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
144583130|NCT00943852|521335614|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
144583131|NCT00943852|521335615|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
144583132|NCT03582943|521335618|FG000|Allocated to Groups|Withdrawal by Subject|1|||
144583133|NCT03582943|521335619|FG001|Allocated to Groups|Withdrawal by Subject|1|||
144583134|NCT03582943|521335618|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
144583135|NCT03582943|521335619|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
144583136|NCT03582943|521335618|FG000|Analyzed|Protocol Violation|4|||
144583137|NCT03582943|521335619|FG001|Analyzed|Protocol Violation|1|||
144583138|NCT04032613|521335620|FG000|Overall Study|Did not complete post-program assessment|5|||
144583139|NCT04032613|521335621|FG001|Overall Study|Did not complete post-program assessment|2|||
144583140|NCT01659853|521335622|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
144583141|NCT01659853|521335623|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
144583142|NCT01659853|521335622|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
144583143|NCT01659853|521335623|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
144583144|NCT03053518|521335626|FG000|Overall Study|Withdrawal by Subject|3|||
144583145|NCT03053518|521335626|FG000|Overall Study|Lost to Follow-up|2|||
144583146|NCT03053518|521335626|FG000|Overall Study|Ineligible|5|||
144583147|NCT02683876|521335627|FG000|Overall Study|samples damaged during shipping|2|||
144583148|NCT02683876|521335628|FG001|Overall Study|samples damaged during shipping|0|||
144583149|NCT00488475|521335632|FG000|Overall Study|Other|1754|||
144583150|NCT01744392|521335634|FG000|Overall Study|Physician Decision|1|||
144583151|NCT01365481|521335635|FG000|Overall Study|Adverse Event|6|||
144583152|NCT01365481|521335636|FG001|Overall Study|Adverse Event|9|||
144583153|NCT01365481|521335637|FG002|Overall Study|Adverse Event|0|||
144583154|NCT01365481|521335638|FG003|Overall Study|Adverse Event|2|||
144583155|NCT01365481|521335635|FG000|Overall Study|Withdrawal by Subject|0|||
144583156|NCT01365481|521335636|FG001|Overall Study|Withdrawal by Subject|2|||
144583157|NCT01365481|521335637|FG002|Overall Study|Withdrawal by Subject|1|||
144583158|NCT01365481|521335638|FG003|Overall Study|Withdrawal by Subject|1|||
144583159|NCT01365481|521335635|FG000|Overall Study|Lost to Follow-up|1|||
144583160|NCT01365481|521335636|FG001|Overall Study|Lost to Follow-up|1|||
144583161|NCT01365481|521335637|FG002|Overall Study|Lost to Follow-up|2|||
144583162|NCT01365481|521335638|FG003|Overall Study|Lost to Follow-up|3|||
144583163|NCT01365481|521335635|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144583164|NCT01365481|521335636|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144583165|NCT01365481|521335637|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144583166|NCT01365481|521335638|FG003|Overall Study|Abnormal laboratory value(s)|0|||
144583167|NCT01365481|521335635|FG000|Overall Study|Administrative problems|0|||
144583168|NCT01365481|521335636|FG001|Overall Study|Administrative problems|1|||
144583169|NCT01365481|521335637|FG002|Overall Study|Administrative problems|0|||
144583170|NCT01365481|521335638|FG003|Overall Study|Administrative problems|0|||
144583171|NCT01365481|521335635|FG000|Overall Study|Protocol deviation|0|||
144583172|NCT01365481|521335636|FG001|Overall Study|Protocol deviation|1|||
144583173|NCT01365481|521335637|FG002|Overall Study|Protocol deviation|0|||
144583174|NCT01365481|521335638|FG003|Overall Study|Protocol deviation|1|||
144583175|NCT01365481|521335635|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144583176|NCT01365481|521335636|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144583177|NCT01365481|521335637|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
144583178|NCT01365481|521335638|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
144583179|NCT00757627|521335639|FG000|Overall Study|Adverse Event|15|||
144583180|NCT00757627|521335639|FG000|Overall Study|Lack of Efficacy|10|||
144583181|NCT00757627|521335639|FG000|Overall Study|Lost to Follow-up|28|||
144583182|NCT00757627|521335639|FG000|Overall Study|Withdrawal by Subject|27|||
144583183|NCT00757627|521335639|FG000|Overall Study|Other|1|||
144583184|NCT00403767|521335642|FG000|Overall Study|Adverse Event|993|||
144583185|NCT00403767|521335643|FG001|Overall Study|Adverse Event|919|||
144583186|NCT00403767|521335642|FG000|Overall Study|Non-compliant with study medication|134|||
144583187|NCT00403767|521335643|FG001|Overall Study|Non-compliant with study medication|164|||
144583188|NCT00403767|521335642|FG000|Overall Study|Consent withdrawn|671|||
144583189|NCT00403767|521335643|FG001|Overall Study|Consent withdrawn|673|||
144583190|NCT00403767|521335642|FG000|Overall Study|Investigator dec./not protocol-related|191|||
144623360|NCT03529773|521478597|FG004|Overall Study|Lost to Follow-up|1|||
144623361|NCT03529773|521478598|FG005|Overall Study|Lost to Follow-up|1|||
144583191|NCT00403767|521335643|FG001|Overall Study|Investigator dec./not protocol-related|178|||
144583192|NCT00403767|521335642|FG000|Overall Study|Lost to Follow-up|6|||
144583193|NCT00403767|521335643|FG001|Overall Study|Lost to Follow-up|8|||
144583194|NCT00403767|521335642|FG000|Overall Study|Protocol Violation|142|||
144583195|NCT00403767|521335643|FG001|Overall Study|Protocol Violation|124|||
144583196|NCT00403767|521335642|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
144583197|NCT00403767|521335643|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
144583198|NCT00403767|521335642|FG000|Overall Study|Study terminated by sponsor|82|||
144583199|NCT00403767|521335643|FG001|Overall Study|Study terminated by sponsor|69|||
144583200|NCT00403767|521335642|FG000|Overall Study|Missing/incomplete data|1|||
144623362|NCT03529773|521478599|FG006|Overall Study|Lost to Follow-up|0|||
144583201|NCT00403767|521335643|FG001|Overall Study|Missing/incomplete data|1|||
144583202|NCT01696955|521335644|FG000|Main Study|Protocol Violation|1|||
144583203|NCT01696955|521335645|FG001|Main Study|Protocol Violation|0|||
144583204|NCT01696955|521335644|FG000|Main Study|Withdrawal by Subject|1|||
144583205|NCT01696955|521335645|FG001|Main Study|Withdrawal by Subject|1|||
144583206|NCT02416453|521335646|FG000|Overall Study|Adverse Event|0|||
144583207|NCT02416453|521335647|FG001|Overall Study|Adverse Event|0|||
144583208|NCT02416453|521335648|FG002|Overall Study|Adverse Event|0|||
144583209|NCT02416453|521335649|FG003|Overall Study|Adverse Event|2|||
144583210|NCT02416453|521335650|FG004|Overall Study|Adverse Event|0|||
144583211|NCT02416453|521335651|FG005|Overall Study|Adverse Event|1|||
144583212|NCT02416453|521335652|FG006|Overall Study|Adverse Event|0|||
144583213|NCT02416453|521335653|FG007|Overall Study|Adverse Event|0|||
144583214|NCT02416453|521335654|FG008|Overall Study|Adverse Event|0|||
144583215|NCT02416453|521335655|FG009|Overall Study|Adverse Event|0|||
144583216|NCT02416453|521335656|FG010|Overall Study|Adverse Event|0|||
144583217|NCT02416453|521335646|FG000|Overall Study|Lost to Follow-up|1|||
144583218|NCT02416453|521335647|FG001|Overall Study|Lost to Follow-up|3|||
144583219|NCT02416453|521335648|FG002|Overall Study|Lost to Follow-up|0|||
144583220|NCT02416453|521335649|FG003|Overall Study|Lost to Follow-up|8|||
144583221|NCT02416453|521335650|FG004|Overall Study|Lost to Follow-up|0|||
144583222|NCT02416453|521335651|FG005|Overall Study|Lost to Follow-up|5|||
144583223|NCT02416453|521335652|FG006|Overall Study|Lost to Follow-up|1|||
144583224|NCT02416453|521335653|FG007|Overall Study|Lost to Follow-up|3|||
144583225|NCT02416453|521335654|FG008|Overall Study|Lost to Follow-up|1|||
144583226|NCT02416453|521335655|FG009|Overall Study|Lost to Follow-up|0|||
144583227|NCT02416453|521335656|FG010|Overall Study|Lost to Follow-up|0|||
144583228|NCT02416453|521335646|FG000|Overall Study|Physician Decision|0|||
144583229|NCT02416453|521335647|FG001|Overall Study|Physician Decision|0|||
144583230|NCT02416453|521335648|FG002|Overall Study|Physician Decision|0|||
144583231|NCT02416453|521335649|FG003|Overall Study|Physician Decision|0|||
144583232|NCT02416453|521335650|FG004|Overall Study|Physician Decision|0|||
144583233|NCT02416453|521335651|FG005|Overall Study|Physician Decision|1|||
144583234|NCT02416453|521335652|FG006|Overall Study|Physician Decision|1|||
144583235|NCT02416453|521335653|FG007|Overall Study|Physician Decision|1|||
144583236|NCT02416453|521335654|FG008|Overall Study|Physician Decision|0|||
144583237|NCT02416453|521335655|FG009|Overall Study|Physician Decision|0|||
144583238|NCT02416453|521335656|FG010|Overall Study|Physician Decision|0|||
144583239|NCT02416453|521335646|FG000|Overall Study|Withdrawal by Subject|2|||
144583240|NCT02416453|521335647|FG001|Overall Study|Withdrawal by Subject|0|||
144583241|NCT02416453|521335648|FG002|Overall Study|Withdrawal by Subject|0|||
144583242|NCT02416453|521335649|FG003|Overall Study|Withdrawal by Subject|5|||
144583243|NCT02416453|521335650|FG004|Overall Study|Withdrawal by Subject|1|||
144583244|NCT02416453|521335651|FG005|Overall Study|Withdrawal by Subject|8|||
144583245|NCT02416453|521335652|FG006|Overall Study|Withdrawal by Subject|0|||
144583246|NCT02416453|521335653|FG007|Overall Study|Withdrawal by Subject|8|||
144583247|NCT02416453|521335654|FG008|Overall Study|Withdrawal by Subject|4|||
144583248|NCT02416453|521335655|FG009|Overall Study|Withdrawal by Subject|0|||
144583249|NCT02416453|521335656|FG010|Overall Study|Withdrawal by Subject|0|||
144583250|NCT02416453|521335646|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583251|NCT02416453|521335647|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583252|NCT02416453|521335648|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
144583253|NCT02416453|521335649|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583254|NCT02416453|521335650|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583255|NCT02416453|521335651|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583256|NCT02416453|521335652|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583257|NCT02416453|521335653|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144209452|NCT00264550|519961889|FG001|Overall Study|Adverse Event|18|||
144209453|NCT00264550|519961890|FG002|Overall Study|Adverse Event|9|||
144209454|NCT00264550|519961891|FG003|Overall Study|Adverse Event|14|||
144209455|NCT00264550|519961888|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144209456|NCT00264550|519961889|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
144583258|NCT02416453|521335654|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144730410|NCT03125200|521868234|FG004|Overall Study|Study Termination|1|||
144209457|NCT00264550|519961890|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
144209458|NCT00264550|519961891|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
144209459|NCT00264550|519961888|FG000|Overall Study|Discontinued oral study agent|0|||
144209460|NCT00264550|519961889|FG001|Overall Study|Discontinued oral study agent|1|||
144583259|NCT02416453|521335655|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583260|NCT02416453|521335656|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
144583261|NCT02416453|521335646|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583262|NCT02416453|521335647|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583263|NCT02416453|521335648|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583264|NCT02416453|521335649|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583265|NCT02416453|521335650|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583266|NCT02416453|521335651|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
144209461|NCT00264550|519961890|FG002|Overall Study|Discontinued oral study agent|0|||
144209462|NCT00264550|519961891|FG003|Overall Study|Discontinued oral study agent|0|||
144583267|NCT02416453|521335652|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583268|NCT02416453|521335653|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583269|NCT02416453|521335654|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583270|NCT02416453|521335655|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583271|NCT02416453|521335656|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
144583272|NCT01259089|521335664|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
144583273|NCT01259089|521335665|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
144583274|NCT01259089|521335666|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
144583275|NCT01259089|521335667|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
144583276|NCT01259089|521335668|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
144583277|NCT01259089|521335669|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
144583278|NCT01259089|521335664|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
144583279|NCT01259089|521335665|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
144583280|NCT01259089|521335666|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
144583281|NCT01259089|521335667|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
144583282|NCT01259089|521335668|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
144583283|NCT01259089|521335669|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
144583284|NCT01259089|521335664|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
144583285|NCT01259089|521335665|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
144583286|NCT01259089|521335666|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
144583287|NCT01259089|521335667|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
144583288|NCT01259089|521335668|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
144583289|NCT01259089|521335669|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
144583290|NCT01259089|521335664|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
144583291|NCT01259089|521335665|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
144583292|NCT01259089|521335666|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
144583293|NCT01259089|521335667|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
144583294|NCT01259089|521335668|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
144583295|NCT01259089|521335669|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
144583296|NCT01259089|521335664|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
144583297|NCT01259089|521335665|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
144583298|NCT01259089|521335666|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
144583299|NCT01259089|521335667|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
144583300|NCT01259089|521335668|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
144583301|NCT01259089|521335669|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
144583302|NCT01259089|521335664|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
144583303|NCT01259089|521335665|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
144583304|NCT01259089|521335666|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
144583305|NCT01259089|521335667|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
144583306|NCT01259089|521335668|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
144583307|NCT01259089|521335669|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
144583308|NCT01259089|521335664|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
144583309|NCT01259089|521335665|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
144583310|NCT01259089|521335666|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
144583311|NCT01259089|521335667|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
144583312|NCT01259089|521335668|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
144583313|NCT01259089|521335669|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
144583314|NCT01259089|521335664|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
144583315|NCT01259089|521335665|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
144583316|NCT01259089|521335666|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
144583317|NCT01259089|521335667|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
144583318|NCT01259089|521335668|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
144583319|NCT01259089|521335669|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
144583320|NCT01259089|521335664|FG000|Survival Follow up for Two Years|Death|3|||
144583321|NCT01259089|521335665|FG001|Survival Follow up for Two Years|Death|2|||
144583322|NCT01259089|521335666|FG002|Survival Follow up for Two Years|Death|2|||
144583323|NCT01259089|521335667|FG003|Survival Follow up for Two Years|Death|3|||
144583324|NCT01259089|521335668|FG004|Survival Follow up for Two Years|Death|6|||
144583325|NCT01259089|521335669|FG005|Survival Follow up for Two Years|Death|13|||
144583326|NCT01259089|521335664|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
144583327|NCT01259089|521335665|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
144583328|NCT01259089|521335666|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
144583329|NCT01259089|521335667|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
144583330|NCT01259089|521335668|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
144583331|NCT01259089|521335669|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
144209463|NCT00264550|519961888|FG000|Overall Study|Other|13|||
144583332|NCT01259089|521335664|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
144583333|NCT01259089|521335665|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
144583334|NCT01259089|521335666|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
144583335|NCT01259089|521335667|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
144583336|NCT01259089|521335668|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
144583337|NCT01259089|521335669|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
144583338|NCT02310100|521335674|FG000|Overall Study|Physician Decision|3|||
144583339|NCT02310100|521335674|FG000|Overall Study|Withdrawal by Subject|10|||
144583340|NCT02310100|521335674|FG000|Overall Study|Enrollment closure|1|||
144583341|NCT02310100|521335674|FG000|Overall Study|Unapproved ablation operator|1|||
144583342|NCT02310100|521335674|FG000|Overall Study|Visit compliance|1|||
144583343|NCT02310100|521335674|FG000|Overall Study|Lost to Follow-up|2|||
144583344|NCT01253018|521335678|FG000|Overall Study|Lost to Follow-up|1|||
144583345|NCT01253018|521335679|FG001|Overall Study|Lost to Follow-up|1|||
144583346|NCT01253018|521335678|FG000|Overall Study|Robot Repair Issues|2|||
144583347|NCT01253018|521335679|FG001|Overall Study|Robot Repair Issues|0|||
144583348|NCT01253018|521335678|FG000|Overall Study|Withdrawal by Subject|1|||
144583349|NCT01253018|521335679|FG001|Overall Study|Withdrawal by Subject|1|||
144583350|NCT00744757|521335680|FG000|Overall Study|Objective disease progression|7|||
144583351|NCT00744757|521335680|FG000|Overall Study|Physician Decision|5|||
144583352|NCT00744757|521335680|FG000|Overall Study|Withdrawal by Subject|1|||
144583353|NCT00744757|521335680|FG000|Overall Study|Death|6|||
144583354|NCT00744757|521335680|FG000|Overall Study|Adverse Event|2|||
144583355|NCT00532493|521335681|FG000|Overall Study|Death|1|||
144583356|NCT00532493|521335682|FG001|Overall Study|Death|1|||
144583357|NCT00532493|521335681|FG000|Overall Study|Lost to Follow-up|10|||
144583358|NCT00532493|521335682|FG001|Overall Study|Lost to Follow-up|7|||
144583359|NCT00532493|521335681|FG000|Overall Study|Withdrawal by Subject|7|||
144583360|NCT00532493|521335682|FG001|Overall Study|Withdrawal by Subject|9|||
144583361|NCT00532493|521335681|FG000|Overall Study|Physician Decision|1|||
144583362|NCT00532493|521335682|FG001|Overall Study|Physician Decision|6|||
144583363|NCT00532493|521335681|FG000|Overall Study|Adverse Event|6|||
144583364|NCT00532493|521335682|FG001|Overall Study|Adverse Event|5|||
144583365|NCT00532493|521335681|FG000|Overall Study|Protocol Deviation|1|||
144583366|NCT00532493|521335682|FG001|Overall Study|Protocol Deviation|0|||
144583367|NCT00532493|521335681|FG000|Overall Study|Subject Moved Away|3|||
144583368|NCT00532493|521335682|FG001|Overall Study|Subject Moved Away|1|||
144583369|NCT00532493|521335681|FG000|Overall Study|Contraindicative Medication|1|||
144583370|NCT00532493|521335682|FG001|Overall Study|Contraindicative Medication|0|||
144583371|NCT01769326|521335688|FG000|Overall Study|Lost to Follow-up|1|||
144583372|NCT01769326|521335689|FG001|Overall Study|Lost to Follow-up|2|||
144583373|NCT01769326|521335690|FG002|Overall Study|Lost to Follow-up|0|||
144583374|NCT01769326|521335691|FG003|Overall Study|Lost to Follow-up|0|||
144583375|NCT01769326|521335688|FG000|Overall Study|unrelated injry|1|||
144583376|NCT01769326|521335689|FG001|Overall Study|unrelated injry|1|||
144583377|NCT01769326|521335690|FG002|Overall Study|unrelated injry|0|||
144583378|NCT01769326|521335691|FG003|Overall Study|unrelated injry|0|||
144583379|NCT01769326|521335688|FG000|Overall Study|got a job|0|||
144583380|NCT01769326|521335689|FG001|Overall Study|got a job|1|||
144583381|NCT01769326|521335690|FG002|Overall Study|got a job|0|||
144583382|NCT01769326|521335691|FG003|Overall Study|got a job|0|||
144583383|NCT01769326|521335688|FG000|Overall Study|Got sick and could not complete study|0|||
144583384|NCT01769326|521335689|FG001|Overall Study|Got sick and could not complete study|0|||
144583385|NCT01769326|521335690|FG002|Overall Study|Got sick and could not complete study|1|||
144583386|NCT01769326|521335691|FG003|Overall Study|Got sick and could not complete study|0|||
144583387|NCT00888927|521335692|FG000|Overall Study|Adverse Event|0|||
144583388|NCT00888927|521335693|FG001|Overall Study|Adverse Event|0|||
144583389|NCT00888927|521335694|FG002|Overall Study|Adverse Event|0|||
144209464|NCT00264550|519961889|FG001|Overall Study|Other|7|||
144209465|NCT00264550|519961890|FG002|Overall Study|Other|3|||
144583390|NCT00888927|521335695|FG003|Overall Study|Adverse Event|1|||
144583391|NCT00888927|521335692|FG000|Overall Study|Withdrawal of consent|0|||
144583392|NCT00888927|521335693|FG001|Overall Study|Withdrawal of consent|0|||
144583393|NCT00888927|521335694|FG002|Overall Study|Withdrawal of consent|0|||
144583394|NCT00888927|521335695|FG003|Overall Study|Withdrawal of consent|1|||
144583395|NCT03459443|521335696|FG000|Overall Study|Lack of Efficacy|3|||
144583396|NCT03459443|521335696|FG000|Overall Study|Adverse Event|1|||
144583397|NCT03459443|521335696|FG000|Overall Study|Sponsor's decision to close the study|18|||
144623363|NCT03529773|521478600|FG007|Overall Study|Lost to Follow-up|0|||
144623364|NCT03529773|521478601|FG008|Overall Study|Lost to Follow-up|0|||
144623365|NCT03529773|521478602|FG009|Overall Study|Lost to Follow-up|0|||
144623366|NCT03529773|521478603|FG010|Overall Study|Lost to Follow-up|0|||
144623367|NCT03529773|521478604|FG011|Overall Study|Lost to Follow-up|0|||
144623368|NCT03529773|521478605|FG012|Overall Study|Lost to Follow-up|0|||
144623369|NCT03529773|521478606|FG013|Overall Study|Lost to Follow-up|1|||
144623370|NCT03529773|521478607|FG014|Overall Study|Lost to Follow-up|4|||
144623371|NCT03529773|521478608|FG015|Overall Study|Lost to Follow-up|1|||
144583398|NCT02153073|521335697|FG000|Overall Study|Case Report Forms Uncollected|230|||
144583399|NCT02153073|521335697|FG000|Overall Study|Protocol Deviation|68|||
144583400|NCT03702231|521335698|FG000|Overall Study|Withdrawal by Subject|1|||
144583401|NCT03702231|521335699|FG001|Overall Study|Withdrawal by Subject|0|||
144583402|NCT03702231|521335700|FG002|Overall Study|Withdrawal by Subject|0|||
144583403|NCT03702231|521335698|FG000|Overall Study|Protocol Violation|0|||
144583404|NCT03702231|521335699|FG001|Overall Study|Protocol Violation|0|||
144583405|NCT03702231|521335700|FG002|Overall Study|Protocol Violation|1|||
144583406|NCT03702231|521335698|FG000|Overall Study|Change in CLL Treatment|0|||
144583407|NCT03702231|521335699|FG001|Overall Study|Change in CLL Treatment|0|||
144583408|NCT03702231|521335700|FG002|Overall Study|Change in CLL Treatment|1|||
144583409|NCT03702231|521335698|FG000|Overall Study|COVID Pandemic|1|||
144583410|NCT03702231|521335699|FG001|Overall Study|COVID Pandemic|4|||
144583411|NCT03702231|521335700|FG002|Overall Study|COVID Pandemic|1|||
144583412|NCT03702231|521335698|FG000|Overall Study|Non-compliance|0|||
144583413|NCT03702231|521335699|FG001|Overall Study|Non-compliance|0|||
144583414|NCT03702231|521335700|FG002|Overall Study|Non-compliance|1|||
144583415|NCT05051462|521335704|FG000|Overall Study|Lost to Follow-up|1|||
144583416|NCT05051462|521335705|FG001|Overall Study|Lost to Follow-up|8|||
144583417|NCT05051462|521335704|FG000|Overall Study|Withdrawal by Subject|1|||
144583418|NCT05051462|521335705|FG001|Overall Study|Withdrawal by Subject|0|||
144583419|NCT05051462|521335704|FG000|Overall Study|Protocol Violation|0|||
144583420|NCT05051462|521335705|FG001|Overall Study|Protocol Violation|2|||
144583421|NCT05260021|521335710|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
144583422|NCT05260021|521335711|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
144583423|NCT05260021|521335712|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
144583424|NCT05260021|521335710|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
144583425|NCT05260021|521335711|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
144583426|NCT05260021|521335712|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
144583427|NCT05260021|521335710|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
144583428|NCT05260021|521335711|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
144583429|NCT05260021|521335712|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
144583430|NCT05260021|521335710|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
144583431|NCT05260021|521335711|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
144583432|NCT05260021|521335712|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
144583433|NCT05260021|521335710|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
144583434|NCT05260021|521335711|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
144583435|NCT05260021|521335712|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
144583436|NCT03842358|521335713|FG000|Overall Study|Poor DOT probe contact with breast|2|||
144583437|NCT03842358|521335713|FG000|Overall Study|DOT system problem|1|||
144583438|NCT03842358|521335713|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
144583439|NCT03842358|521335713|FG000|Overall Study|No biopsy after physician review|4|||
144583440|NCT03842358|521335713|FG000|Overall Study|Patient withdrew|2|||
144583441|NCT02626455|521335714|FG000|Overall Study|Other|1|||
144583442|NCT02626455|521335715|FG001|Overall Study|Other|1|||
144583443|NCT02626455|521335716|FG002|Overall Study|Other|0|||
144583444|NCT02626455|521335717|FG003|Overall Study|Other|0|||
144583445|NCT02626455|521335718|FG004|Overall Study|Other|0|||
144583446|NCT02626455|521335719|FG005|Overall Study|Other|17|||
144583447|NCT02626455|521335720|FG006|Overall Study|Other|23|||
144583448|NCT02626455|521335714|FG000|Overall Study|Withdrawal by Subject|1|||
144583449|NCT02626455|521335715|FG001|Overall Study|Withdrawal by Subject|0|||
144583450|NCT02626455|521335716|FG002|Overall Study|Withdrawal by Subject|0|||
144583451|NCT02626455|521335717|FG003|Overall Study|Withdrawal by Subject|0|||
144583452|NCT02626455|521335718|FG004|Overall Study|Withdrawal by Subject|0|||
144583453|NCT02626455|521335719|FG005|Overall Study|Withdrawal by Subject|10|||
144583454|NCT02626455|521335720|FG006|Overall Study|Withdrawal by Subject|6|||
144583455|NCT02626455|521335714|FG000|Overall Study|Physician Decision|0|||
144583456|NCT02626455|521335715|FG001|Overall Study|Physician Decision|2|||
144583457|NCT02626455|521335716|FG002|Overall Study|Physician Decision|2|||
144583458|NCT02626455|521335717|FG003|Overall Study|Physician Decision|2|||
144583459|NCT02626455|521335718|FG004|Overall Study|Physician Decision|1|||
144623372|NCT03529773|521478609|FG016|Overall Study|Lost to Follow-up|1|||
144583460|NCT02626455|521335719|FG005|Overall Study|Physician Decision|10|||
144623373|NCT03529773|521478610|FG017|Overall Study|Lost to Follow-up|0|||
144583461|NCT02626455|521335720|FG006|Overall Study|Physician Decision|3|||
144583462|NCT02626455|521335714|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144583463|NCT02626455|521335715|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144583464|NCT02626455|521335716|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144583465|NCT02626455|521335717|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144623374|NCT03529773|521478611|FG018|Overall Study|Lost to Follow-up|1|||
144623375|NCT03529773|521478612|FG019|Overall Study|Lost to Follow-up|1|||
144583466|NCT02626455|521335718|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144623376|NCT03529773|521478613|FG020|Overall Study|Lost to Follow-up|2|||
144623377|NCT03529773|521478614|FG021|Overall Study|Lost to Follow-up|4|||
144583467|NCT02626455|521335719|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
144583468|NCT02626455|521335720|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
144583469|NCT02626455|521335714|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
144583470|NCT02626455|521335715|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
144583471|NCT02626455|521335716|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
144583472|NCT02626455|521335717|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
144583473|NCT02626455|521335718|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
144583474|NCT02626455|521335719|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
144583475|NCT02626455|521335720|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
144583476|NCT02626455|521335714|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
144583477|NCT02626455|521335715|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
144583478|NCT02626455|521335716|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
144583479|NCT02626455|521335717|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
144583480|NCT02626455|521335718|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
144583481|NCT02626455|521335719|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
144583482|NCT02626455|521335720|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
144583483|NCT02626455|521335714|FG000|Overall Study|Patient decision|0|||
144583484|NCT02626455|521335715|FG001|Overall Study|Patient decision|1|||
144583485|NCT02626455|521335716|FG002|Overall Study|Patient decision|0|||
144583486|NCT02626455|521335717|FG003|Overall Study|Patient decision|0|||
144583487|NCT02626455|521335718|FG004|Overall Study|Patient decision|1|||
144583488|NCT02626455|521335719|FG005|Overall Study|Patient decision|36|||
144583489|NCT02626455|521335720|FG006|Overall Study|Patient decision|22|||
144583490|NCT02626455|521335714|FG000|Overall Study|Protocol Violation|0|||
144583491|NCT02626455|521335715|FG001|Overall Study|Protocol Violation|0|||
144583492|NCT02626455|521335716|FG002|Overall Study|Protocol Violation|0|||
144583493|NCT02626455|521335717|FG003|Overall Study|Protocol Violation|0|||
144583494|NCT02626455|521335718|FG004|Overall Study|Protocol Violation|0|||
144583495|NCT02626455|521335719|FG005|Overall Study|Protocol Violation|0|||
144583496|NCT02626455|521335720|FG006|Overall Study|Protocol Violation|1|||
144583497|NCT02626455|521335714|FG000|Overall Study|Progressive disease - radiological progression|0|||
144583498|NCT02626455|521335715|FG001|Overall Study|Progressive disease - radiological progression|0|||
144583499|NCT02626455|521335716|FG002|Overall Study|Progressive disease - radiological progression|0|||
144583500|NCT02626455|521335717|FG003|Overall Study|Progressive disease - radiological progression|0|||
144583501|NCT02626455|521335718|FG004|Overall Study|Progressive disease - radiological progression|0|||
144583502|NCT02626455|521335719|FG005|Overall Study|Progressive disease - radiological progression|11|||
144583503|NCT02626455|521335720|FG006|Overall Study|Progressive disease - radiological progression|22|||
144583504|NCT02626455|521335714|FG000|Overall Study|Progressive disease - clinical progression|0|||
144583505|NCT02626455|521335715|FG001|Overall Study|Progressive disease - clinical progression|0|||
144583506|NCT02626455|521335716|FG002|Overall Study|Progressive disease - clinical progression|0|||
144583507|NCT02626455|521335717|FG003|Overall Study|Progressive disease - clinical progression|0|||
144583508|NCT02626455|521335718|FG004|Overall Study|Progressive disease - clinical progression|0|||
144583509|NCT02626455|521335719|FG005|Overall Study|Progressive disease - clinical progression|1|||
144583510|NCT02626455|521335720|FG006|Overall Study|Progressive disease - clinical progression|2|||
144583511|NCT02626455|521335714|FG000|Overall Study|Lost to Follow-up|0|||
144583512|NCT02626455|521335715|FG001|Overall Study|Lost to Follow-up|0|||
144583513|NCT02626455|521335716|FG002|Overall Study|Lost to Follow-up|0|||
144583514|NCT02626455|521335717|FG003|Overall Study|Lost to Follow-up|0|||
144583515|NCT02626455|521335718|FG004|Overall Study|Lost to Follow-up|0|||
144583516|NCT02626455|521335719|FG005|Overall Study|Lost to Follow-up|1|||
144583517|NCT02626455|521335720|FG006|Overall Study|Lost to Follow-up|0|||
144583518|NCT02626455|521335714|FG000|Overall Study|AE not associated with clinical disease progression|1|||
144583519|NCT02626455|521335715|FG001|Overall Study|AE not associated with clinical disease progression|1|||
144583520|NCT02626455|521335716|FG002|Overall Study|AE not associated with clinical disease progression|0|||
144583521|NCT02626455|521335717|FG003|Overall Study|AE not associated with clinical disease progression|2|||
144583522|NCT02626455|521335718|FG004|Overall Study|AE not associated with clinical disease progression|1|||
144583523|NCT02626455|521335719|FG005|Overall Study|AE not associated with clinical disease progression|65|||
144583524|NCT02626455|521335720|FG006|Overall Study|AE not associated with clinical disease progression|21|||
144583525|NCT02626455|521335714|FG000|Overall Study|AE associated with clinical disease progression|0|||
144583526|NCT02626455|521335715|FG001|Overall Study|AE associated with clinical disease progression|0|||
144583527|NCT02626455|521335716|FG002|Overall Study|AE associated with clinical disease progression|0|||
144583528|NCT02626455|521335717|FG003|Overall Study|AE associated with clinical disease progression|0|||
144583529|NCT02626455|521335718|FG004|Overall Study|AE associated with clinical disease progression|0|||
144583530|NCT02626455|521335719|FG005|Overall Study|AE associated with clinical disease progression|1|||
144583531|NCT02626455|521335720|FG006|Overall Study|AE associated with clinical disease progression|2|||
144583532|NCT02626455|521335714|FG000|Overall Study|Study intervention never administered|0|||
144583533|NCT02626455|521335715|FG001|Overall Study|Study intervention never administered|0|||
144583534|NCT02626455|521335716|FG002|Overall Study|Study intervention never administered|0|||
144583535|NCT02626455|521335717|FG003|Overall Study|Study intervention never administered|0|||
144583536|NCT02626455|521335718|FG004|Overall Study|Study intervention never administered|0|||
144583537|NCT02626455|521335719|FG005|Overall Study|Study intervention never administered|1|||
144583538|NCT02626455|521335720|FG006|Overall Study|Study intervention never administered|3|||
144583539|NCT06665919|521335721|FG000|Overall Study|Withdrawal by Subject|4|||
144583540|NCT06665919|521335722|FG001|Overall Study|Withdrawal by Subject|4|||
144583541|NCT06665919|521335723|FG002|Overall Study|Withdrawal by Subject|4|||
144583542|NCT06665919|521335721|FG000|Overall Study|Non-compliance to Treatment|4|||
144583543|NCT06665919|521335722|FG001|Overall Study|Non-compliance to Treatment|1|||
144583544|NCT06665919|521335723|FG002|Overall Study|Non-compliance to Treatment|6|||
144583545|NCT06665919|521335721|FG000|Overall Study|Lost to Follow-up|3|||
144583546|NCT06665919|521335722|FG001|Overall Study|Lost to Follow-up|0|||
144583547|NCT06665919|521335723|FG002|Overall Study|Lost to Follow-up|2|||
144583548|NCT06665919|521335721|FG000|Overall Study|Physician Decision|4|||
144583549|NCT06665919|521335722|FG001|Overall Study|Physician Decision|0|||
144583550|NCT06665919|521335723|FG002|Overall Study|Physician Decision|1|||
144583551|NCT01200290|521335724|FG000|Treatment Period|Adverse Event|1|||
144583552|NCT01200290|521335724|FG000|Post-Treatment Follow-Up Period|Death|2|||
144583553|NCT01144377|521335725|FG000|52 Week Treatment Period|Adverse Event|0|||
144583554|NCT01144377|521335726|FG001|52 Week Treatment Period|Adverse Event|0|||
144583555|NCT01144377|521335727|FG002|52 Week Treatment Period|Adverse Event|3|||
144583556|NCT01144377|521335728|FG003|52 Week Treatment Period|Adverse Event|2|||
144583557|NCT01144377|521335729|FG004|52 Week Treatment Period|Adverse Event|1|||
144583558|NCT01144377|521335725|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
144583559|NCT01144377|521335726|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
144583560|NCT01144377|521335727|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
144583561|NCT01144377|521335728|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
144583562|NCT01144377|521335729|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
144583563|NCT01144377|521335725|FG000|52 Week Treatment Period|Protocol Violation|0|||
144583564|NCT01144377|521335726|FG001|52 Week Treatment Period|Protocol Violation|0|||
144583565|NCT01144377|521335727|FG002|52 Week Treatment Period|Protocol Violation|0|||
144583566|NCT01144377|521335728|FG003|52 Week Treatment Period|Protocol Violation|0|||
144583567|NCT01144377|521335729|FG004|52 Week Treatment Period|Protocol Violation|1|||
144583568|NCT01144377|521335725|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
144583569|NCT01144377|521335726|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
144583570|NCT01144377|521335727|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
144583571|NCT01144377|521335728|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
144583572|NCT01144377|521335729|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
144583573|NCT01144377|521335725|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
144583574|NCT01144377|521335726|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
144583575|NCT01144377|521335727|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
144583576|NCT01144377|521335728|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
144583577|NCT01144377|521335729|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
144583578|NCT01144377|521335725|FG000|52 Week Treatment Period|Sponsor Decision|0|||
144583579|NCT01144377|521335726|FG001|52 Week Treatment Period|Sponsor Decision|0|||
144583580|NCT01144377|521335727|FG002|52 Week Treatment Period|Sponsor Decision|0|||
144583581|NCT01144377|521335728|FG003|52 Week Treatment Period|Sponsor Decision|0|||
144583582|NCT01144377|521335729|FG004|52 Week Treatment Period|Sponsor Decision|1|||
144583583|NCT01144377|521335725|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
144583584|NCT01144377|521335726|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
144583585|NCT01144377|521335727|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
144583586|NCT01144377|521335728|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
144583587|NCT01144377|521335729|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
144583588|NCT01144377|521335725|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
144583589|NCT01144377|521335726|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
144583590|NCT01144377|521335727|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
144583591|NCT01144377|521335728|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
144583592|NCT01144377|521335729|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
144583593|NCT01144377|521335725|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
144583594|NCT01144377|521335726|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
144583595|NCT01144377|521335727|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
144583596|NCT01144377|521335728|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
144583597|NCT01144377|521335729|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
144583598|NCT00607724|521335730|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
144583599|NCT00607724|521335731|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
144583600|NCT00607724|521335732|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
144583601|NCT00607724|521335733|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
144209466|NCT00264550|519961891|FG003|Overall Study|Other|9|||
144209467|NCT02246114|519961894|FG000|Overall Study|miscarriage|1|||
144583602|NCT00607724|521335734|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
144583603|NCT00607724|521335735|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
144583604|NCT00607724|521335736|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
144583605|NCT00607724|521335730|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
144583606|NCT00607724|521335731|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
144583607|NCT00607724|521335732|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
144583608|NCT00607724|521335733|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
144583609|NCT00607724|521335734|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
144583610|NCT00607724|521335735|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
144583611|NCT00607724|521335736|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
144583612|NCT00607724|521335730|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
144583613|NCT00607724|521335731|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
144583614|NCT00607724|521335732|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
144583615|NCT00607724|521335733|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
144583616|NCT00607724|521335734|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
144583617|NCT00607724|521335735|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
144583618|NCT00607724|521335736|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
144583619|NCT00607724|521335730|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
144583620|NCT00607724|521335731|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
144583621|NCT00607724|521335732|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
144583622|NCT00607724|521335733|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
144583623|NCT00607724|521335734|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
144583624|NCT00607724|521335735|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
144583625|NCT00607724|521335736|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
144583626|NCT00607724|521335730|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
144583627|NCT00607724|521335731|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
144583628|NCT00607724|521335732|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
144583629|NCT00607724|521335733|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
144583630|NCT00607724|521335734|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
144583631|NCT00607724|521335735|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
144583632|NCT00607724|521335736|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
144583633|NCT00151281|521335737|FG000|Overall Study|Not evaluable|3|||
144583634|NCT01133418|521335740|FG000|Overall Study|Lost to Follow-up|5|||
144583635|NCT01133418|521335741|FG001|Overall Study|Lost to Follow-up|6|||
144583636|NCT04150068|521335742|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
144583637|NCT04150068|521335743|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
144583638|NCT04150068|521335744|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
144583639|NCT04150068|521335742|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
144583640|NCT04150068|521335743|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
144583641|NCT04150068|521335744|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
144583642|NCT05316701|521335745|FG000|Overall Study|Adverse Event|0|||
144583643|NCT05316701|521335746|FG001|Overall Study|Adverse Event|1|||
144583644|NCT05316701|521335745|FG000|Overall Study|Death|3|||
144583645|NCT05316701|521335746|FG001|Overall Study|Death|9|||
144583646|NCT05316701|521335745|FG000|Overall Study|Lost to Follow-up|1|||
144583647|NCT05316701|521335746|FG001|Overall Study|Lost to Follow-up|0|||
144583648|NCT05316701|521335745|FG000|Overall Study|Physician Decision|1|||
144583649|NCT05316701|521335746|FG001|Overall Study|Physician Decision|4|||
144583650|NCT05316701|521335745|FG000|Overall Study|Withdrawal by Subject|3|||
144583651|NCT05316701|521335746|FG001|Overall Study|Withdrawal by Subject|5|||
144583652|NCT05316701|521335745|FG000|Overall Study|Progression/Relapse|14|||
144583653|NCT05316701|521335746|FG001|Overall Study|Progression/Relapse|9|||
144583654|NCT05316701|521335745|FG000|Overall Study|Received Standard of Care|1|||
144583655|NCT05316701|521335746|FG001|Overall Study|Received Standard of Care|0|||
144583656|NCT05316701|521335745|FG000|Overall Study|Ongoing|70|||
144583657|NCT05316701|521335746|FG001|Overall Study|Ongoing|64|||
144583658|NCT04679935|521335747|FG000|Overall Study|Death|0|||
144262894|NCT01716806|520163776|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
144583659|NCT04679935|521335748|FG001|Overall Study|Death|1|||
144583660|NCT04362189|521335749|FG000|Overall Study|Lost to Follow-up|0|||
144583661|NCT04362189|521335750|FG001|Overall Study|Lost to Follow-up|1|||
144583662|NCT04362189|521335749|FG000|Overall Study|Withdrawal by Subject|1|||
144583663|NCT04362189|521335750|FG001|Overall Study|Withdrawal by Subject|0|||
144583664|NCT04362189|521335749|FG000|Overall Study|FDA Clinical Hold|7|||
144583665|NCT04362189|521335750|FG001|Overall Study|FDA Clinical Hold|2|||
144583666|NCT04362189|521335749|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
144730411|NCT03125200|521868235|FG005|Overall Study|Study Termination|2|||
144583667|NCT04362189|521335750|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
144583668|NCT04362189|521335749|FG000|Overall Study|Adverse Event|0|||
144583669|NCT04362189|521335750|FG001|Overall Study|Adverse Event|2|||
144583670|NCT04362189|521335749|FG000|Overall Study|Death|4|||
144583671|NCT04362189|521335750|FG001|Overall Study|Death|1|||
144583672|NCT02111681|521335751|FG000|Overall Study|Death|5|||
144583673|NCT02111681|521335751|FG000|Overall Study|Lack of Efficacy|2|||
144583674|NCT02111681|521335751|FG000|Overall Study|Progression of disease|4|||
144583675|NCT02735577|521337141|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
144583676|NCT02735577|521337141|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
144583677|NCT02731690|521337142|FG000|Overall Study|Adverse Event|1|||
144583678|NCT02731690|521337142|FG000|Overall Study|Withdrawal by Subject|3|||
144583679|NCT02731690|521337142|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
144583680|NCT03828747|521337149|FG000|Double-Blind Treatment Period|Adverse Event|6|||
144583681|NCT03828747|521337150|FG001|Double-Blind Treatment Period|Adverse Event|6|||
144583682|NCT03828747|521337149|FG000|Double-Blind Treatment Period|Death|1|||
144583683|NCT03828747|521337150|FG001|Double-Blind Treatment Period|Death|1|||
144583684|NCT03828747|521337149|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144583685|NCT03828747|521337150|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
144583686|NCT03828747|521337149|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
144583687|NCT03828747|521337150|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
144583688|NCT03828747|521337149|FG000|Double-Blind Treatment Period|Physician Decision|1|||
144583689|NCT03828747|521337150|FG001|Double-Blind Treatment Period|Physician Decision|4|||
144583690|NCT03828747|521337149|FG000|Double-Blind Treatment Period|Various reasons|5|||
144583691|NCT03828747|521337150|FG001|Double-Blind Treatment Period|Various reasons|3|||
144583692|NCT03828747|521337149|FG000|Open-Label Extension|Adverse Event|9|||
144583693|NCT03828747|521337150|FG001|Open-Label Extension|Adverse Event|7|||
144583694|NCT03828747|521337149|FG000|Open-Label Extension|Death|0|||
144583695|NCT03828747|521337150|FG001|Open-Label Extension|Death|2|||
144583696|NCT03828747|521337149|FG000|Open-Label Extension|Lost to Follow-up|4|||
144583697|NCT03828747|521337150|FG001|Open-Label Extension|Lost to Follow-up|0|||
144583698|NCT03828747|521337149|FG000|Open-Label Extension|Withdrawal by Subject|31|||
144583699|NCT03828747|521337150|FG001|Open-Label Extension|Withdrawal by Subject|30|||
144583700|NCT03828747|521337149|FG000|Open-Label Extension|Various reasons|4|||
144583701|NCT03828747|521337150|FG001|Open-Label Extension|Various reasons|4|||
144583702|NCT03828747|521337149|FG000|Open-Label Extension|Physician Decision|6|||
144623378|NCT03529773|521478615|FG022|Overall Study|Lost to Follow-up|3|||
144623379|NCT03529773|521478616|FG023|Overall Study|Lost to Follow-up|4|||
144623380|NCT03529773|521478617|FG024|Overall Study|Lost to Follow-up|3|||
144623381|NCT03529773|521478618|FG025|Overall Study|Lost to Follow-up|5|||
144623382|NCT03529773|521478619|FG026|Overall Study|Lost to Follow-up|5|||
144623383|NCT03529773|521478620|FG027|Overall Study|Lost to Follow-up|0|||
144623384|NCT03529773|521478621|FG028|Overall Study|Lost to Follow-up|0|||
144623385|NCT03529773|521478622|FG029|Overall Study|Lost to Follow-up|0|||
144623386|NCT03529773|521478623|FG030|Overall Study|Lost to Follow-up|1|||
144623387|NCT03529773|521478624|FG031|Overall Study|Lost to Follow-up|0|||
144623388|NCT03529773|521478625|FG032|Overall Study|Lost to Follow-up|0|||
144623389|NCT03529773|521478626|FG033|Overall Study|Lost to Follow-up|1|||
144623390|NCT03529773|521478627|FG034|Overall Study|Lost to Follow-up|1|||
144623391|NCT03529773|521478628|FG035|Overall Study|Lost to Follow-up|0|||
144623392|NCT03529773|521478629|FG036|Overall Study|Lost to Follow-up|0|||
144623393|NCT03529773|521478630|FG037|Overall Study|Lost to Follow-up|3|||
144623394|NCT03529773|521478631|FG038|Overall Study|Lost to Follow-up|1|||
144623395|NCT03529773|521478632|FG039|Overall Study|Lost to Follow-up|1|||
144623396|NCT03529773|521478593|FG000|Overall Study|No longer meets eligibility criteria|0|||
144623397|NCT03529773|521478594|FG001|Overall Study|No longer meets eligibility criteria|0|||
144623398|NCT03529773|521478595|FG002|Overall Study|No longer meets eligibility criteria|0|||
144623399|NCT03529773|521478596|FG003|Overall Study|No longer meets eligibility criteria|0|||
144623400|NCT03529773|521478597|FG004|Overall Study|No longer meets eligibility criteria|0|||
144623401|NCT03529773|521478598|FG005|Overall Study|No longer meets eligibility criteria|0|||
144623402|NCT03529773|521478599|FG006|Overall Study|No longer meets eligibility criteria|0|||
144583703|NCT03828747|521337150|FG001|Open-Label Extension|Physician Decision|2|||
144583704|NCT00836745|521337158|FG000|Overall Study|Death|2|||
144583705|NCT00836745|521337158|FG000|Overall Study|Lost to Follow-up|10|||
144583706|NCT00836745|521337158|FG000|Overall Study|Adverse Event|3|||
144583707|NCT00836745|521337158|FG000|Overall Study|Objective progression or relapse|4|||
144583708|NCT00836745|521337158|FG000|Overall Study|Other|2|||
144583709|NCT02366468|521337159|FG000|Overall Study|Adverse Event|2|||
144583710|NCT02366468|521337160|FG001|Overall Study|Adverse Event|0|||
144583711|NCT02366468|521337159|FG000|Overall Study|Withdrawal by Subject|1|||
144583712|NCT02366468|521337160|FG001|Overall Study|Withdrawal by Subject|5|||
144583713|NCT02366468|521337159|FG000|Overall Study|Lost to Follow-up|2|||
144583714|NCT02366468|521337160|FG001|Overall Study|Lost to Follow-up|0|||
144583715|NCT02366468|521337159|FG000|Overall Study|Death|1|||
144583716|NCT02366468|521337160|FG001|Overall Study|Death|2|||
144623403|NCT03529773|521478600|FG007|Overall Study|No longer meets eligibility criteria|0|||
144583717|NCT02366468|521337159|FG000|Overall Study|Other|0|||
144583718|NCT02366468|521337160|FG001|Overall Study|Other|2|||
144583719|NCT00490490|521337161|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
144623404|NCT03529773|521478601|FG008|Overall Study|No longer meets eligibility criteria|0|||
144623405|NCT03529773|521478602|FG009|Overall Study|No longer meets eligibility criteria|0|||
144623406|NCT03529773|521478603|FG010|Overall Study|No longer meets eligibility criteria|0|||
144623407|NCT03529773|521478604|FG011|Overall Study|No longer meets eligibility criteria|0|||
144583720|NCT00490490|521337161|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
144583721|NCT05540717|521337162|FG000|Overall Study|Lost to Follow-up|2|||
144583722|NCT05540717|521337163|FG001|Overall Study|Lost to Follow-up|5|||
144583723|NCT05540717|521337162|FG000|Overall Study|Withdrawal by Subject|6|||
144583724|NCT05540717|521337163|FG001|Overall Study|Withdrawal by Subject|6|||
144583725|NCT05540717|521337162|FG000|Overall Study|Sponsor request|1|||
144583726|NCT05540717|521337163|FG001|Overall Study|Sponsor request|0|||
144583727|NCT05540717|521337162|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
144583728|NCT05540717|521337163|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
144583729|NCT05540717|521337162|FG000|Overall Study|Other|0|||
144583730|NCT05540717|521337163|FG001|Overall Study|Other|1|||
144583731|NCT02141620|521337164|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
144583732|NCT02141620|521337165|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
144583733|NCT03651622|521337166|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
144583734|NCT03651622|521337167|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
144583735|NCT03651622|521337168|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
144583736|NCT03651622|521337166|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
144583737|NCT03651622|521337167|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
144583738|NCT03651622|521337168|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
144583739|NCT03651622|521337166|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
144583740|NCT03651622|521337167|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
144583741|NCT03651622|521337168|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
144583742|NCT03651622|521337166|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
144583743|NCT03651622|521337167|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
144583744|NCT03651622|521337168|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
144583745|NCT03651622|521337166|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
144583746|NCT03651622|521337167|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
144583747|NCT03651622|521337168|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
144583748|NCT00307684|521337169|FG000|Open Label Phase|Lack of Efficacy|0|||
144583749|NCT00307684|521337170|FG001|Open Label Phase|Lack of Efficacy|0|||
144583750|NCT00307684|521337171|FG002|Open Label Phase|Lack of Efficacy|3|||
144583751|NCT00307684|521337169|FG000|Open Label Phase|Adverse Event|0|||
144583752|NCT00307684|521337170|FG001|Open Label Phase|Adverse Event|0|||
144583753|NCT00307684|521337171|FG002|Open Label Phase|Adverse Event|16|||
144583754|NCT00307684|521337169|FG000|Open Label Phase|Withdrawal by Subject|0|||
144583755|NCT00307684|521337170|FG001|Open Label Phase|Withdrawal by Subject|0|||
144583756|NCT00307684|521337171|FG002|Open Label Phase|Withdrawal by Subject|15|||
144583757|NCT00307684|521337169|FG000|Open Label Phase|Lost to Follow-up|0|||
144583758|NCT00307684|521337170|FG001|Open Label Phase|Lost to Follow-up|0|||
144583759|NCT00307684|521337171|FG002|Open Label Phase|Lost to Follow-up|11|||
144583760|NCT00307684|521337169|FG000|Open Label Phase|non compliance|0|||
144583761|NCT00307684|521337170|FG001|Open Label Phase|non compliance|0|||
144583762|NCT00307684|521337171|FG002|Open Label Phase|non compliance|5|||
144583763|NCT00307684|521337169|FG000|Open Label Phase|other|0|||
144583764|NCT00307684|521337170|FG001|Open Label Phase|other|0|||
144583765|NCT00307684|521337171|FG002|Open Label Phase|other|6|||
144583766|NCT00307684|521337169|FG000|Double Blind Phase|Lack of Efficacy|2|||
144583767|NCT00307684|521337170|FG001|Double Blind Phase|Lack of Efficacy|5|||
144583768|NCT00307684|521337171|FG002|Double Blind Phase|Lack of Efficacy|0|||
144583769|NCT02580305|521337172|FG000|Overall Study|Adverse Event|15|||
144583770|NCT02580305|521337173|FG001|Overall Study|Adverse Event|19|||
144623408|NCT03529773|521478605|FG012|Overall Study|No longer meets eligibility criteria|0|||
144623409|NCT03529773|521478606|FG013|Overall Study|No longer meets eligibility criteria|0|||
144623410|NCT03529773|521478607|FG014|Overall Study|No longer meets eligibility criteria|0|||
144623411|NCT03529773|521478608|FG015|Overall Study|No longer meets eligibility criteria|0|||
144623412|NCT03529773|521478609|FG016|Overall Study|No longer meets eligibility criteria|0|||
144623413|NCT03529773|521478610|FG017|Overall Study|No longer meets eligibility criteria|0|||
144623414|NCT03529773|521478611|FG018|Overall Study|No longer meets eligibility criteria|0|||
144623415|NCT03529773|521478612|FG019|Overall Study|No longer meets eligibility criteria|0|||
144583771|NCT02580305|521337174|FG002|Overall Study|Adverse Event|10|||
144583772|NCT02580305|521337172|FG000|Overall Study|Lack of Efficacy|5|||
144583773|NCT02580305|521337173|FG001|Overall Study|Lack of Efficacy|0|||
144583774|NCT02580305|521337174|FG002|Overall Study|Lack of Efficacy|2|||
144583775|NCT02580305|521337172|FG000|Overall Study|Protocol Violation|4|||
144583776|NCT02580305|521337173|FG001|Overall Study|Protocol Violation|9|||
144583777|NCT02580305|521337174|FG002|Overall Study|Protocol Violation|6|||
144583778|NCT02580305|521337172|FG000|Overall Study|Lost to Follow-up|4|||
144583779|NCT02580305|521337173|FG001|Overall Study|Lost to Follow-up|4|||
144583780|NCT02580305|521337174|FG002|Overall Study|Lost to Follow-up|2|||
144623416|NCT03529773|521478613|FG020|Overall Study|No longer meets eligibility criteria|0|||
144623417|NCT03529773|521478614|FG021|Overall Study|No longer meets eligibility criteria|0|||
144583781|NCT02580305|521337172|FG000|Overall Study|Withdrawal by Subject|11|||
144583782|NCT02580305|521337173|FG001|Overall Study|Withdrawal by Subject|9|||
144583783|NCT02580305|521337174|FG002|Overall Study|Withdrawal by Subject|7|||
144583784|NCT02580305|521337172|FG000|Overall Study|Randomized in error and never treated|4|||
144583785|NCT02580305|521337173|FG001|Overall Study|Randomized in error and never treated|8|||
144583786|NCT02580305|521337174|FG002|Overall Study|Randomized in error and never treated|5|||
144583787|NCT00224887|521337175|FG000|Overall Study|Pregnancy|6|||
144583788|NCT00224887|521337176|FG001|Overall Study|Pregnancy|6|||
144583789|NCT01353859|521337177|FG000|Overall Study|Adverse Event|3|||
144583790|NCT01353859|521337177|FG000|Overall Study|Lack of Efficacy|1|||
144583791|NCT03527550|521337182|FG000|Overall Study|Lost to Follow-up|4|||
144583792|NCT03527550|521337183|FG001|Overall Study|Lost to Follow-up|2|||
144583793|NCT03527550|521337182|FG000|Overall Study|Withdrawal by Subject|4|||
144583794|NCT03527550|521337183|FG001|Overall Study|Withdrawal by Subject|1|||
144583795|NCT03527550|521337182|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
144583796|NCT03527550|521337183|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
144583797|NCT02071290|521337184|FG000|Overall Study|Death|1|||
144583798|NCT02071290|521337185|FG001|Overall Study|Death|0|||
144583799|NCT02071290|521337184|FG000|Overall Study|Withdrawal by Subject|0|||
144583800|NCT02071290|521337185|FG001|Overall Study|Withdrawal by Subject|1|||
144583801|NCT02071290|521337184|FG000|Overall Study|Protocol Violation|3|||
144583802|NCT02071290|521337185|FG001|Overall Study|Protocol Violation|5|||
144583803|NCT02071290|521337184|FG000|Overall Study|Physician Decision|0|||
144583804|NCT02071290|521337185|FG001|Overall Study|Physician Decision|1|||
144583805|NCT05560243|521337190|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
144583806|NCT00939822|521337191|FG000|Overall Study|Lost to Follow-up|1|||
144583807|NCT00939822|521337192|FG001|Overall Study|Lost to Follow-up|0|||
144583808|NCT00939822|521337191|FG000|Overall Study|withdrew from study due to busy schedule|1|||
144583809|NCT00939822|521337192|FG001|Overall Study|withdrew from study due to busy schedule|1|||
144583810|NCT00939822|521337191|FG000|Overall Study|Mental health issues|0|||
144583811|NCT00939822|521337192|FG001|Overall Study|Mental health issues|2|||
144583812|NCT01232738|521337193|FG000|Overall Study|Death|3|||
144583813|NCT01232738|521337193|FG000|Overall Study|Physician Decision|2|||
144583814|NCT01232738|521337193|FG000|Overall Study|Lost to Follow-up|1|||
144583815|NCT01232738|521337193|FG000|Overall Study|Withdrawal by Subject|2|||
144583816|NCT01232738|521337193|FG000|Overall Study|Adverse Event|5|||
144583817|NCT00859222|521337194|FG000|Overall Study|Adverse Event|2|||
144583818|NCT00859222|521337195|FG001|Overall Study|Adverse Event|3|||
144583819|NCT00859222|521337196|FG002|Overall Study|Adverse Event|6|||
144583820|NCT00859222|521337197|FG003|Overall Study|Adverse Event|24|||
144583821|NCT00859222|521337198|FG004|Overall Study|Adverse Event|15|||
144583822|NCT00859222|521337194|FG000|Overall Study|DLT|1|||
144583823|NCT00859222|521337195|FG001|Overall Study|DLT|0|||
144583824|NCT00859222|521337196|FG002|Overall Study|DLT|0|||
144583825|NCT00859222|521337197|FG003|Overall Study|DLT|0|||
144583826|NCT00859222|521337198|FG004|Overall Study|DLT|0|||
144583827|NCT00941070|521337199|FG000|Overall Study|Patient non-compliant|1|||
144583828|NCT02797080|521337200|FG000|Overall Study|Lost to Follow-up|1|||
144583829|NCT02797080|521337200|FG000|Overall Study|Withdrawal by Subject|1|||
144583830|NCT00951015|521337201|FG000|Randomization Phase 96 Week|Adverse Event|1|||
144583831|NCT00951015|521337202|FG001|Randomization Phase 96 Week|Adverse Event|1|||
144583832|NCT00951015|521337203|FG002|Randomization Phase 96 Week|Adverse Event|2|||
144583833|NCT00951015|521337204|FG003|Randomization Phase 96 Week|Adverse Event|5|||
144583834|NCT00951015|521337205|FG004|Randomization Phase 96 Week|Adverse Event|0|||
144583835|NCT00951015|521337201|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
144583836|NCT00951015|521337202|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
144583837|NCT00951015|521337203|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
144583838|NCT00951015|521337204|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
144583839|NCT00951015|521337205|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
144730412|NCT03125200|521868236|FG006|Overall Study|Study Termination|1|||
144730413|NCT03125200|521868230|FG000|Overall Study|Clinical Progression|0|||
144730414|NCT03125200|521868231|FG001|Overall Study|Clinical Progression|0|||
144730415|NCT03125200|521868232|FG002|Overall Study|Clinical Progression|0|||
144730416|NCT03125200|521868233|FG003|Overall Study|Clinical Progression|1|||
144583840|NCT00951015|521337201|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
144583841|NCT00951015|521337202|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
144730417|NCT03125200|521868234|FG004|Overall Study|Clinical Progression|0|||
144583842|NCT00951015|521337203|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
144583843|NCT00951015|521337204|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
144583844|NCT00951015|521337205|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
144583845|NCT00951015|521337201|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
144583846|NCT00951015|521337202|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
144583847|NCT00951015|521337203|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
144730418|NCT03125200|521868235|FG005|Overall Study|Clinical Progression|1|||
144730419|NCT03125200|521868236|FG006|Overall Study|Clinical Progression|0|||
144583848|NCT00951015|521337204|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
144583849|NCT00951015|521337205|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
144583850|NCT00951015|521337201|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
144583851|NCT00951015|521337202|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
144583852|NCT00951015|521337203|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
144583853|NCT00951015|521337204|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
144583854|NCT00951015|521337205|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
144583855|NCT00951015|521337201|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
144583856|NCT00951015|521337202|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
144583857|NCT00951015|521337203|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
144583858|NCT00951015|521337204|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
144583859|NCT00951015|521337205|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
144583860|NCT00951015|521337201|FG000|Open-label Phase|Adverse Event|0|||
144583861|NCT00951015|521337202|FG001|Open-label Phase|Adverse Event|0|||
144583862|NCT00951015|521337203|FG002|Open-label Phase|Adverse Event|0|||
144583863|NCT00951015|521337204|FG003|Open-label Phase|Adverse Event|0|||
144583864|NCT00951015|521337205|FG004|Open-label Phase|Adverse Event|3|||
144583865|NCT00951015|521337201|FG000|Open-label Phase|Lack of Efficacy|0|||
144583866|NCT00951015|521337202|FG001|Open-label Phase|Lack of Efficacy|0|||
144583867|NCT00951015|521337203|FG002|Open-label Phase|Lack of Efficacy|0|||
144583868|NCT00951015|521337204|FG003|Open-label Phase|Lack of Efficacy|0|||
144583869|NCT00951015|521337205|FG004|Open-label Phase|Lack of Efficacy|1|||
144583870|NCT00951015|521337201|FG000|Open-label Phase|Protocol Violation|0|||
144583871|NCT00951015|521337202|FG001|Open-label Phase|Protocol Violation|0|||
144583872|NCT00951015|521337203|FG002|Open-label Phase|Protocol Violation|0|||
144583873|NCT00951015|521337204|FG003|Open-label Phase|Protocol Violation|0|||
144583874|NCT00951015|521337205|FG004|Open-label Phase|Protocol Violation|12|||
144583875|NCT00951015|521337201|FG000|Open-label Phase|Lost to Follow-up|0|||
144583876|NCT00951015|521337202|FG001|Open-label Phase|Lost to Follow-up|0|||
144583877|NCT00951015|521337203|FG002|Open-label Phase|Lost to Follow-up|0|||
144583878|NCT00951015|521337204|FG003|Open-label Phase|Lost to Follow-up|0|||
144583879|NCT00951015|521337205|FG004|Open-label Phase|Lost to Follow-up|12|||
144583880|NCT00951015|521337201|FG000|Open-label Phase|Withdrawal by Subject|0|||
144583881|NCT00951015|521337202|FG001|Open-label Phase|Withdrawal by Subject|0|||
144583882|NCT00951015|521337203|FG002|Open-label Phase|Withdrawal by Subject|0|||
144583883|NCT00951015|521337204|FG003|Open-label Phase|Withdrawal by Subject|0|||
144583884|NCT00951015|521337205|FG004|Open-label Phase|Withdrawal by Subject|14|||
144583885|NCT00951015|521337201|FG000|Open-label Phase|Physician Decision|0|||
144583886|NCT00951015|521337202|FG001|Open-label Phase|Physician Decision|0|||
144583887|NCT00951015|521337203|FG002|Open-label Phase|Physician Decision|0|||
144583888|NCT00951015|521337204|FG003|Open-label Phase|Physician Decision|0|||
144583889|NCT00951015|521337205|FG004|Open-label Phase|Physician Decision|8|||
144583890|NCT00299494|521337206|FG000|Overall Study|Withdrawal by Subject|0|||
144583891|NCT00299494|521337207|FG001|Overall Study|Withdrawal by Subject|0|||
144583892|NCT00299494|521337208|FG002|Overall Study|Withdrawal by Subject|0|||
144583893|NCT00299494|521337209|FG003|Overall Study|Withdrawal by Subject|3|||
144583894|NCT00299494|521337210|FG004|Overall Study|Withdrawal by Subject|1|||
144583895|NCT00299494|521337211|FG005|Overall Study|Withdrawal by Subject|4|||
144583896|NCT00299494|521337206|FG000|Overall Study|Physician Decision|0|||
144583897|NCT00299494|521337207|FG001|Overall Study|Physician Decision|0|||
144583898|NCT00299494|521337208|FG002|Overall Study|Physician Decision|0|||
144583899|NCT00299494|521337209|FG003|Overall Study|Physician Decision|0|||
144583900|NCT00299494|521337210|FG004|Overall Study|Physician Decision|1|||
144583901|NCT00299494|521337211|FG005|Overall Study|Physician Decision|0|||
144583902|NCT00299494|521337206|FG000|Overall Study|Death|3|||
144583903|NCT00299494|521337207|FG001|Overall Study|Death|1|||
144583904|NCT00299494|521337208|FG002|Overall Study|Death|4|||
144583905|NCT00299494|521337209|FG003|Overall Study|Death|6|||
144583906|NCT00299494|521337210|FG004|Overall Study|Death|18|||
144583907|NCT00299494|521337211|FG005|Overall Study|Death|19|||
144583908|NCT00299494|521337206|FG000|Overall Study|Lost to Follow-up|0|||
144583909|NCT00299494|521337207|FG001|Overall Study|Lost to Follow-up|0|||
144262895|NCT01716806|520163777|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
144262896|NCT01716806|520163778|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
144583910|NCT00299494|521337208|FG002|Overall Study|Lost to Follow-up|0|||
144583911|NCT00299494|521337209|FG003|Overall Study|Lost to Follow-up|0|||
144583912|NCT00299494|521337210|FG004|Overall Study|Lost to Follow-up|3|||
144583913|NCT00299494|521337211|FG005|Overall Study|Lost to Follow-up|1|||
144583914|NCT00299494|521337206|FG000|Overall Study|Other - Unspecified|0|||
144583915|NCT00299494|521337207|FG001|Overall Study|Other - Unspecified|0|||
144583916|NCT00299494|521337208|FG002|Overall Study|Other - Unspecified|0|||
144583917|NCT00299494|521337209|FG003|Overall Study|Other - Unspecified|0|||
144583918|NCT00299494|521337210|FG004|Overall Study|Other - Unspecified|3|||
144583919|NCT00299494|521337211|FG005|Overall Study|Other - Unspecified|1|||
144583920|NCT00299494|521337206|FG000|Overall Study|Other - site closure|0|||
144583921|NCT00299494|521337207|FG001|Overall Study|Other - site closure|0|||
144209468|NCT02246114|519961895|FG001|Overall Study|miscarriage|0|||
144209469|NCT00696787|519961899|FG000|Overall Study|Adverse Event|1|||
144209470|NCT00696787|519961900|FG001|Overall Study|Adverse Event|0|||
144209471|NCT00696787|519961901|FG002|Overall Study|Adverse Event|6|||
144209472|NCT00696787|519961899|FG000|Overall Study|Discontinuation by Sponsor|9|||
144583922|NCT00299494|521337208|FG002|Overall Study|Other - site closure|0|||
144583923|NCT00299494|521337209|FG003|Overall Study|Other - site closure|1|||
144583924|NCT00299494|521337210|FG004|Overall Study|Other - site closure|1|||
144583925|NCT00299494|521337211|FG005|Overall Study|Other - site closure|1|||
144583926|NCT00958841|521337212|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144583927|NCT00958841|521337212|FG000|Overall Study|Abnormal test procedure result(s)|3|||
144583928|NCT00958841|521337212|FG000|Overall Study|Administrative problems|1|||
144583929|NCT00958841|521337212|FG000|Overall Study|Adverse Event|8|||
144583930|NCT00958841|521337212|FG000|Overall Study|New cancer therapy|5|||
144583931|NCT00958841|521337212|FG000|Overall Study|Withdrawal by Subject|1|||
144583932|NCT00958841|521337212|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
144583933|NCT00958841|521337212|FG000|Overall Study|Completed M6/did not enter extension|27|||
144583934|NCT00958841|521337212|FG000|Overall Study|Discontinued prior to M*|28|||
144583935|NCT02755818|521337214|FG000|Overall Study|Withdrawal by Subject|0|||
144583936|NCT02755818|521337215|FG001|Overall Study|Withdrawal by Subject|0|||
144583937|NCT02755818|521337216|FG002|Overall Study|Withdrawal by Subject|0|||
144583938|NCT02755818|521337217|FG003|Overall Study|Withdrawal by Subject|2|||
144583939|NCT02755818|521337214|FG000|Overall Study|withdrawal by PI|0|||
144583940|NCT02755818|521337215|FG001|Overall Study|withdrawal by PI|0|||
144583941|NCT02755818|521337216|FG002|Overall Study|withdrawal by PI|1|||
144583942|NCT02755818|521337217|FG003|Overall Study|withdrawal by PI|1|||
144583943|NCT01280357|521337220|FG000|Overall Study|Excluded no internal monitoring|14|||
144583944|NCT01280357|521337220|FG000|Overall Study|IInsufficient data/No data supplied|12|||
144583945|NCT00992225|521337221|FG000|Overall Study|Entry Criteria Not Met|8|||
144583946|NCT00992225|521337221|FG000|Overall Study|Adverse Event|2|||
144583947|NCT01036438|521337225|FG000|Overall Study|Adverse Event|7|||
144583948|NCT01036438|521337226|FG001|Overall Study|Adverse Event|8|||
144583949|NCT01036438|521337225|FG000|Overall Study|Death|0|||
144583950|NCT01036438|521337226|FG001|Overall Study|Death|1|||
144583951|NCT01036438|521337225|FG000|Overall Study|No effect of study treatment|3|||
144583952|NCT01036438|521337226|FG001|Overall Study|No effect of study treatment|1|||
144583953|NCT02729831|521337227|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
144583954|NCT02729831|521337228|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
144583955|NCT02729831|521337229|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
144583956|NCT02729831|521337230|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
144583957|NCT02729831|521337227|FG000|1 Week Post-visit|Lost to Follow-up|43|||
144583958|NCT02729831|521337228|FG001|1 Week Post-visit|Lost to Follow-up|40|||
144583959|NCT02729831|521337229|FG002|1 Week Post-visit|Lost to Follow-up|38|||
144583960|NCT02729831|521337230|FG003|1 Week Post-visit|Lost to Follow-up|36|||
144583961|NCT02729831|521337227|FG000|6 Month Follow-up|Lost to Follow-up|54|||
144583962|NCT02729831|521337228|FG001|6 Month Follow-up|Lost to Follow-up|51|||
144583963|NCT02729831|521337229|FG002|6 Month Follow-up|Lost to Follow-up|48|||
144583964|NCT02729831|521337230|FG003|6 Month Follow-up|Lost to Follow-up|42|||
144583965|NCT02729831|521337227|FG000|6 Month Follow-up|Death|1|||
144583966|NCT02729831|521337228|FG001|6 Month Follow-up|Death|3|||
144209473|NCT00696787|519961900|FG001|Overall Study|Discontinuation by Sponsor|13|||
144209474|NCT00696787|519961901|FG002|Overall Study|Discontinuation by Sponsor|14|||
144209475|NCT00696787|519961899|FG000|Overall Study|Lack of Efficacy|0|||
144209476|NCT00696787|519961900|FG001|Overall Study|Lack of Efficacy|1|||
144209477|NCT00696787|519961901|FG002|Overall Study|Lack of Efficacy|0|||
144209478|NCT00696787|519961899|FG000|Overall Study|Lost to Follow-up|4|||
144583967|NCT02729831|521337229|FG002|6 Month Follow-up|Death|0|||
144583968|NCT02729831|521337230|FG003|6 Month Follow-up|Death|1|||
144583969|NCT05597787|521337238|FG000|Overall Study|Withdrawal by Subject|0|||
144583970|NCT05597787|521337239|FG001|Overall Study|Withdrawal by Subject|0|||
144583971|NCT05597787|521337240|FG002|Overall Study|Withdrawal by Subject|1|||
144583972|NCT01241604|521337241|FG000|Screening Period|Screen Failure|3|||
144583973|NCT01241604|521337242|FG001|Screening Period|Screen Failure|0|||
144583974|NCT01241604|521337243|FG002|Screening Period|Screen Failure|0|||
144583975|NCT04349631|521337245|FG000|Overall Study|Lost to Follow-up|3|||
144583976|NCT04349631|521337245|FG000|Overall Study|Withdrawal by Subject|7|||
144583977|NCT00775463|521338275|FG000|Overall Study|Withdrawal by Subject|0|||
144583978|NCT00775463|521338276|FG001|Overall Study|Withdrawal by Subject|1|||
144583979|NCT00775463|521338275|FG000|Overall Study|Adverse Event|7|||
144209479|NCT00696787|519961900|FG001|Overall Study|Lost to Follow-up|0|||
144583980|NCT00775463|521338276|FG001|Overall Study|Adverse Event|9|||
144583981|NCT00775463|521338275|FG000|Overall Study|Protocol Violation|2|||
144583982|NCT00775463|521338276|FG001|Overall Study|Protocol Violation|2|||
144583983|NCT00775463|521338275|FG000|Overall Study|Lost to Follow-up|1|||
144583984|NCT00775463|521338276|FG001|Overall Study|Lost to Follow-up|0|||
144583985|NCT00775463|521338275|FG000|Overall Study|Lack of Efficacy|1|||
144209480|NCT00696787|519961901|FG002|Overall Study|Lost to Follow-up|3|||
144209481|NCT00696787|519961899|FG000|Overall Study|Withdrawal by Subject|0|||
144583986|NCT00775463|521338276|FG001|Overall Study|Lack of Efficacy|1|||
144583987|NCT05870228|521338277|FG000|Overall Study|Lost to Follow-up|2|||
144583988|NCT05870228|521338278|FG001|Overall Study|Lost to Follow-up|0|||
144583989|NCT05870228|521338277|FG000|Overall Study|Withdrawal by Subject|1|||
144583990|NCT05870228|521338278|FG001|Overall Study|Withdrawal by Subject|0|||
144583991|NCT03231800|521338279|FG000|Overall Study|Lost to Follow-up|0|||
144583992|NCT03231800|521338280|FG001|Overall Study|Lost to Follow-up|2|||
144583993|NCT03231800|521338279|FG000|Overall Study|Protocol Violation|1|||
144583994|NCT03231800|521338280|FG001|Overall Study|Protocol Violation|1|||
144583995|NCT03231800|521338279|FG000|Overall Study|reason not provided|2|||
144583996|NCT03231800|521338280|FG001|Overall Study|reason not provided|0|||
144583997|NCT03174431|521338292|FG000|Overall Study|Withdrawal by Subject|14|||
144583998|NCT03174431|521338293|FG001|Overall Study|Withdrawal by Subject|11|||
144583999|NCT03174431|521338292|FG000|Overall Study|alternative treatment|2|||
144584000|NCT03174431|521338293|FG001|Overall Study|alternative treatment|0|||
144584001|NCT03174431|521338292|FG000|Overall Study|Lost to Follow-up|1|||
144584002|NCT03174431|521338293|FG001|Overall Study|Lost to Follow-up|5|||
144584003|NCT04075994|521338294|FG000|Overall Study|Withdrawal by Subject|8|||
144584004|NCT04075994|521338295|FG001|Overall Study|Withdrawal by Subject|9|||
144584005|NCT04075994|521338294|FG000|Overall Study|Adverse Event|2|||
144584006|NCT04075994|521338295|FG001|Overall Study|Adverse Event|2|||
144584007|NCT04075994|521338294|FG000|Overall Study|Investigator withdrew|3|||
144584008|NCT04075994|521338295|FG001|Overall Study|Investigator withdrew|1|||
144584009|NCT01941719|521338303|FG000|Overall Study|Lost to Follow-up|20|||
144584010|NCT01941719|521338304|FG001|Overall Study|Lost to Follow-up|19|||
144584011|NCT00252577|521338305|FG000|Overall Study|Lost to Follow-up|20|||
144584012|NCT04035499|521338310|FG000|Overall Study|Death|2|||
144584013|NCT04035499|521338310|FG000|Overall Study|Withdrawal by Subject|1|||
144584014|NCT03819634|521338312|FG000|Overall Study|Physician Decision|2|||
144584015|NCT01417104|521338316|FG000|Overall Study|Withdrawal by Subject|5|||
144584016|NCT01417104|521338317|FG001|Overall Study|Withdrawal by Subject|1|||
144584017|NCT01417104|521338316|FG000|Overall Study|Failure to make contact|0|||
144584018|NCT01417104|521338317|FG001|Overall Study|Failure to make contact|1|||
144584019|NCT01417104|521338316|FG000|Overall Study|Adverse Event|1|||
144584020|NCT01417104|521338317|FG001|Overall Study|Adverse Event|0|||
144584021|NCT01416389|521338318|FG000|Overall Study|Lost to Follow-up|1|||
144584022|NCT01416389|521338319|FG001|Overall Study|Lost to Follow-up|0|||
144584023|NCT01416389|521338318|FG000|Overall Study|Started New Therapy|2|||
144584024|NCT01416389|521338319|FG001|Overall Study|Started New Therapy|0|||
144584025|NCT00858364|521338322|FG000|Overall Study|Administrative Decision|3|||
144584026|NCT00858364|521338323|FG001|Overall Study|Administrative Decision|2|||
144584027|NCT00858364|521338322|FG000|Overall Study|Adverse Event|5|||
144584028|NCT00858364|521338323|FG001|Overall Study|Adverse Event|2|||
144584029|NCT00858364|521338322|FG000|Overall Study|Withdrawal by Subject|44|||
144584030|NCT00858364|521338323|FG001|Overall Study|Withdrawal by Subject|118|||
144584031|NCT00858364|521338322|FG000|Overall Study|Ineligibility Determined|1|||
144584032|NCT00858364|521338323|FG001|Overall Study|Ineligibility Determined|10|||
144584033|NCT00858364|521338322|FG000|Overall Study|Lost to Follow-up|24|||
144584034|NCT00858364|521338323|FG001|Overall Study|Lost to Follow-up|54|||
144584035|NCT00858364|521338322|FG000|Overall Study|Noncompliance|3|||
144584036|NCT00858364|521338323|FG001|Overall Study|Noncompliance|4|||
144584037|NCT00858364|521338322|FG000|Overall Study|Protocol Deviation|0|||
144584038|NCT00858364|521338323|FG001|Overall Study|Protocol Deviation|2|||
144584039|NCT00858364|521338322|FG000|Overall Study|Other|9|||
144584040|NCT00858364|521338323|FG001|Overall Study|Other|17|||
144584041|NCT00858364|521338322|FG000|Overall Study|Missing|1|||
144584042|NCT00858364|521338323|FG001|Overall Study|Missing|1|||
144584043|NCT00858364|521338322|FG000|Overall Study|Still on-study|114|||
144584044|NCT00858364|521338323|FG001|Overall Study|Still on-study|247|||
144584045|NCT00929110|521338324|FG000|Overall Study|Adverse Event|40|||
144584046|NCT00929110|521338325|FG001|Overall Study|Adverse Event|29|||
144584047|NCT00929110|521338326|FG002|Overall Study|Adverse Event|18|||
144584048|NCT00929110|521338324|FG000|Overall Study|Subject withdrew consent|40|||
144584049|NCT00929110|521338325|FG001|Overall Study|Subject withdrew consent|23|||
144584050|NCT00929110|521338326|FG002|Overall Study|Subject withdrew consent|26|||
144584051|NCT00929110|521338324|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
144584052|NCT00929110|521338325|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
144584053|NCT00929110|521338326|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
144584054|NCT00929110|521338324|FG000|Overall Study|Lost to Follow-up|7|||
144584055|NCT00929110|521338325|FG001|Overall Study|Lost to Follow-up|7|||
144584056|NCT00929110|521338326|FG002|Overall Study|Lost to Follow-up|3|||
144584057|NCT00929110|521338324|FG000|Overall Study|Protocol deviation|5|||
144584058|NCT00929110|521338325|FG001|Overall Study|Protocol deviation|2|||
144209482|NCT00696787|519961900|FG001|Overall Study|Withdrawal by Subject|3|||
144584059|NCT00929110|521338326|FG002|Overall Study|Protocol deviation|4|||
144584060|NCT00929110|521338324|FG000|Overall Study|Administrative problems|4|||
144584061|NCT00929110|521338325|FG001|Overall Study|Administrative problems|1|||
144584062|NCT00929110|521338326|FG002|Overall Study|Administrative problems|2|||
144584063|NCT00929110|521338324|FG000|Overall Study|Death|2|||
144584064|NCT00929110|521338325|FG001|Overall Study|Death|2|||
144584065|NCT00929110|521338326|FG002|Overall Study|Death|2|||
144584066|NCT00929110|521338324|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144584067|NCT00929110|521338325|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144584068|NCT00929110|521338326|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144584069|NCT00929110|521338324|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144584070|NCT00929110|521338325|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144584071|NCT00929110|521338326|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144584072|NCT00929110|521338324|FG000|Overall Study|Patient inability to use the device|0|||
144584073|NCT00929110|521338325|FG001|Overall Study|Patient inability to use the device|1|||
144584074|NCT00929110|521338326|FG002|Overall Study|Patient inability to use the device|0|||
144584075|NCT01163292|521338329|FG000|Overall Study|Lack of Efficacy|9|||
144584076|NCT01163292|521338330|FG001|Overall Study|Lack of Efficacy|0|||
144584077|NCT01163292|521338329|FG000|Overall Study|Adverse Event|6|||
144584078|NCT01163292|521338330|FG001|Overall Study|Adverse Event|0|||
144584079|NCT01163292|521338329|FG000|Overall Study|Initiation of biological therapy|0|||
144584080|NCT01163292|521338330|FG001|Overall Study|Initiation of biological therapy|15|||
144584081|NCT01163292|521338329|FG000|Overall Study|Sufficient response to adalimumab|8|||
144584082|NCT01163292|521338330|FG001|Overall Study|Sufficient response to adalimumab|0|||
144584083|NCT01163292|521338329|FG000|Overall Study|Refusal to receive adalimumab|7|||
144584084|NCT01163292|521338330|FG001|Overall Study|Refusal to receive adalimumab|0|||
144584085|NCT01163292|521338329|FG000|Overall Study|Economic reasons|6|||
144584086|NCT01163292|521338330|FG001|Overall Study|Economic reasons|0|||
144584087|NCT01163292|521338329|FG000|Overall Study|No further visits|5|||
144584088|NCT01163292|521338330|FG001|Overall Study|No further visits|7|||
144584089|NCT01258595|521338331|FG000|Overall Study|Lost to Follow-up|1|||
144584090|NCT01258595|521338332|FG001|Overall Study|Lost to Follow-up|0|||
144584091|NCT01258595|521338331|FG000|Overall Study|Withdrawal by Subject|0|||
144584092|NCT01258595|521338332|FG001|Overall Study|Withdrawal by Subject|1|||
144584093|NCT01012414|521338333|FG000|Overall Study|Withdrawal by Subject|2|||
144584094|NCT01012414|521338333|FG000|Overall Study|Lost to Follow-up|1|||
144584095|NCT01012414|521338333|FG000|Overall Study|Trial was stopped before completed|7|||
144584096|NCT01215188|521338334|FG000|Overall Study|Lost to Follow-up|22|||
144584097|NCT01215188|521338335|FG001|Overall Study|Lost to Follow-up|22|||
144584098|NCT01215188|521338336|FG002|Overall Study|Lost to Follow-up|16|||
144584099|NCT01215188|521338334|FG000|Overall Study|Adverse Event|1|||
144584100|NCT01215188|521338335|FG001|Overall Study|Adverse Event|1|||
144584101|NCT01215188|521338336|FG002|Overall Study|Adverse Event|3|||
144584102|NCT01215188|521338334|FG000|Overall Study|Physician Decision|2|||
144584103|NCT01215188|521338335|FG001|Overall Study|Physician Decision|1|||
144584104|NCT01215188|521338336|FG002|Overall Study|Physician Decision|0|||
144584105|NCT01215188|521338334|FG000|Overall Study|Lack of Efficacy|0|||
144584106|NCT01215188|521338335|FG001|Overall Study|Lack of Efficacy|0|||
144584107|NCT01215188|521338336|FG002|Overall Study|Lack of Efficacy|1|||
144584108|NCT01215188|521338334|FG000|Overall Study|Protocol Violation|1|||
144584109|NCT01215188|521338335|FG001|Overall Study|Protocol Violation|1|||
144584110|NCT01215188|521338336|FG002|Overall Study|Protocol Violation|1|||
144584111|NCT01215188|521338334|FG000|Overall Study|Withdrawal by Subject|32|||
144584112|NCT01215188|521338335|FG001|Overall Study|Withdrawal by Subject|34|||
144584113|NCT01215188|521338336|FG002|Overall Study|Withdrawal by Subject|31|||
144584114|NCT02601300|521338337|FG000|Induction Phase|Lack of Efficacy|2|||
144584115|NCT02601300|521338337|FG000|Induction Phase|Protocol Violation|1|||
144584116|NCT02601300|521338337|FG000|Extension Phase|Withdrawal by Subject|3|||
144584117|NCT02601300|521338337|FG000|Extension Phase|Adverse Event|4|||
144584118|NCT02601300|521338337|FG000|Extension Phase|Lack of Efficacy|10|||
144584119|NCT01127763|521338338|FG000|Overall Study|Adverse Event|2|||
144584120|NCT01127763|521338338|FG000|Overall Study|Withdrawal by Subject|1|||
144584121|NCT01127763|521338338|FG000|Overall Study|Physician Decision|2|||
144584122|NCT00528931|521338339|FG000|Overall Study|Lost to Follow-up|1|||
144584123|NCT02285153|521338340|FG000|Overall Study|Adverse Event|1|||
144584124|NCT02285153|521338341|FG001|Overall Study|Adverse Event|0|||
144623418|NCT03529773|521478615|FG022|Overall Study|No longer meets eligibility criteria|1|||
144623419|NCT03529773|521478616|FG023|Overall Study|No longer meets eligibility criteria|0|||
144623420|NCT03529773|521478617|FG024|Overall Study|No longer meets eligibility criteria|0|||
144623421|NCT03529773|521478618|FG025|Overall Study|No longer meets eligibility criteria|0|||
144623422|NCT03529773|521478619|FG026|Overall Study|No longer meets eligibility criteria|0|||
144623423|NCT03529773|521478620|FG027|Overall Study|No longer meets eligibility criteria|0|||
144623424|NCT03529773|521478621|FG028|Overall Study|No longer meets eligibility criteria|0|||
144623425|NCT03529773|521478622|FG029|Overall Study|No longer meets eligibility criteria|0|||
144584125|NCT01489891|521338344|FG000|Overall Study|Endoscopy failure|1|||
144584126|NCT01489891|521338345|FG001|Overall Study|Endoscopy failure|0|||
144584127|NCT02576587|521338346|FG000|Baseline|Equipment failure|0|||
144584128|NCT02576587|521338347|FG001|Baseline|Equipment failure|1|||
144584129|NCT02576587|521338346|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
144584130|NCT02576587|521338347|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
144584131|NCT02576587|521338346|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
144584132|NCT02576587|521338347|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
144584133|NCT02576587|521338346|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
144584134|NCT02576587|521338347|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
144584135|NCT00777088|521338348|FG000|Overall Study|PED Treatment not attempted|1|||
144584136|NCT01278173|521338349|FG000|Overall Study|Lack of Efficacy|13|||
144584137|NCT01278173|521338349|FG000|Overall Study|Adverse Event|8|||
144584138|NCT01278173|521338349|FG000|Overall Study|Administrative or other reason|4|||
144584139|NCT01278173|521338349|FG000|Overall Study|Protocol Violation|1|||
144584140|NCT01278173|521338349|FG000|Overall Study|Withdrawal by Subject|1|||
144584141|NCT03592745|521338350|FG000|Overall Study|Adverse Event|0|||
144584142|NCT03592745|521338351|FG001|Overall Study|Adverse Event|2|||
144584143|NCT03592745|521338350|FG000|Overall Study|Lost to Follow-up|2|||
144584144|NCT03592745|521338351|FG001|Overall Study|Lost to Follow-up|0|||
144584145|NCT03592745|521338350|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
144584146|NCT03592745|521338351|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
144584147|NCT02546921|521338353|FG000|Overall Study|Adverse Event|0|||
144584148|NCT02546921|521338354|FG001|Overall Study|Adverse Event|5|||
144584149|NCT02546921|521338355|FG002|Overall Study|Adverse Event|2|||
144584150|NCT02546921|521338356|FG003|Overall Study|Adverse Event|0|||
144584151|NCT02546921|521338357|FG004|Overall Study|Adverse Event|0|||
144584152|NCT02546921|521338358|FG005|Overall Study|Adverse Event|0|||
144584153|NCT02546921|521338359|FG006|Overall Study|Adverse Event|0|||
144584154|NCT02546921|521338353|FG000|Overall Study|Evidence of Disease Progression|1|||
144584155|NCT02546921|521338354|FG001|Overall Study|Evidence of Disease Progression|0|||
144584156|NCT02546921|521338355|FG002|Overall Study|Evidence of Disease Progression|0|||
144584157|NCT02546921|521338356|FG003|Overall Study|Evidence of Disease Progression|0|||
144584158|NCT02546921|521338357|FG004|Overall Study|Evidence of Disease Progression|1|||
144584159|NCT02546921|521338358|FG005|Overall Study|Evidence of Disease Progression|0|||
144584160|NCT02546921|521338359|FG006|Overall Study|Evidence of Disease Progression|0|||
144584161|NCT02546921|521338353|FG000|Overall Study|Patient Choice|0|||
144584162|NCT02546921|521338354|FG001|Overall Study|Patient Choice|1|||
144584163|NCT02546921|521338355|FG002|Overall Study|Patient Choice|0|||
144584164|NCT02546921|521338356|FG003|Overall Study|Patient Choice|0|||
144584165|NCT02546921|521338357|FG004|Overall Study|Patient Choice|0|||
144584166|NCT02546921|521338358|FG005|Overall Study|Patient Choice|1|||
144584167|NCT02546921|521338359|FG006|Overall Study|Patient Choice|0|||
144584168|NCT01413503|521338360|FG000|Overall Study|Lost to Follow-up|1|||
144584169|NCT01373151|521338361|FG000|Period 1|Lack of Efficacy|3|||
144584170|NCT01373151|521338362|FG001|Period 1|Lack of Efficacy|0|||
144584171|NCT01373151|521338363|FG002|Period 1|Lack of Efficacy|0|||
144584172|NCT01373151|521338364|FG003|Period 1|Lack of Efficacy|0|||
144584173|NCT01373151|521338365|FG004|Period 1|Lack of Efficacy|1|||
144584174|NCT01373151|521338366|FG005|Period 1|Lack of Efficacy|0|||
144584175|NCT01373151|521338367|FG006|Period 1|Lack of Efficacy|0|||
144584176|NCT01373151|521338361|FG000|Period 1|Adverse Event|0|||
144584177|NCT01373151|521338362|FG001|Period 1|Adverse Event|0|||
144584178|NCT01373151|521338363|FG002|Period 1|Adverse Event|1|||
144584179|NCT01373151|521338364|FG003|Period 1|Adverse Event|0|||
144584180|NCT01373151|521338365|FG004|Period 1|Adverse Event|4|||
144584181|NCT01373151|521338366|FG005|Period 1|Adverse Event|3|||
144584182|NCT01373151|521338367|FG006|Period 1|Adverse Event|0|||
144584183|NCT01373151|521338361|FG000|Period 1|Withdrawal by Subject|2|||
144584184|NCT01373151|521338362|FG001|Period 1|Withdrawal by Subject|0|||
144584185|NCT01373151|521338363|FG002|Period 1|Withdrawal by Subject|3|||
144584186|NCT01373151|521338364|FG003|Period 1|Withdrawal by Subject|1|||
144584187|NCT01373151|521338365|FG004|Period 1|Withdrawal by Subject|0|||
144584188|NCT01373151|521338366|FG005|Period 1|Withdrawal by Subject|1|||
144584189|NCT01373151|521338367|FG006|Period 1|Withdrawal by Subject|0|||
144584190|NCT01373151|521338361|FG000|Period 2|Lack of Efficacy|9|||
144584191|NCT01373151|521338362|FG001|Period 2|Lack of Efficacy|0|||
144584192|NCT01373151|521338363|FG002|Period 2|Lack of Efficacy|0|||
144584193|NCT01373151|521338364|FG003|Period 2|Lack of Efficacy|1|||
144584194|NCT01373151|521338365|FG004|Period 2|Lack of Efficacy|2|||
144730420|NCT03125200|521868230|FG000|Overall Study|Progressive Disease|2|||
144584195|NCT01373151|521338366|FG005|Period 2|Lack of Efficacy|0|||
144584196|NCT01373151|521338367|FG006|Period 2|Lack of Efficacy|3|||
144584197|NCT01373151|521338361|FG000|Period 2|Adverse Event|0|||
144584198|NCT01373151|521338362|FG001|Period 2|Adverse Event|0|||
144584199|NCT01373151|521338363|FG002|Period 2|Adverse Event|3|||
144584200|NCT01373151|521338364|FG003|Period 2|Adverse Event|3|||
144584201|NCT01373151|521338365|FG004|Period 2|Adverse Event|0|||
144584202|NCT01373151|521338366|FG005|Period 2|Adverse Event|0|||
144584203|NCT01373151|521338367|FG006|Period 2|Adverse Event|1|||
144584204|NCT01373151|521338361|FG000|Period 2|subject request to discontinue|0|||
144584205|NCT01373151|521338362|FG001|Period 2|subject request to discontinue|1|||
144584206|NCT01373151|521338363|FG002|Period 2|subject request to discontinue|0|||
144584207|NCT01373151|521338364|FG003|Period 2|subject request to discontinue|0|||
144730421|NCT03125200|521868231|FG001|Overall Study|Progressive Disease|1|||
144584208|NCT01373151|521338365|FG004|Period 2|subject request to discontinue|0|||
144584209|NCT01373151|521338366|FG005|Period 2|subject request to discontinue|0|||
144584210|NCT01373151|521338367|FG006|Period 2|subject request to discontinue|0|||
144584211|NCT01373151|521338361|FG000|Period 2|Withdrawal by Subject|0|||
144584212|NCT01373151|521338362|FG001|Period 2|Withdrawal by Subject|0|||
144584213|NCT01373151|521338363|FG002|Period 2|Withdrawal by Subject|0|||
144584214|NCT01373151|521338364|FG003|Period 2|Withdrawal by Subject|1|||
144584215|NCT01373151|521338365|FG004|Period 2|Withdrawal by Subject|0|||
144584216|NCT01373151|521338366|FG005|Period 2|Withdrawal by Subject|0|||
144584217|NCT01373151|521338367|FG006|Period 2|Withdrawal by Subject|0|||
144584218|NCT01373151|521338361|FG000|Period 2|Other|0|||
144584219|NCT01373151|521338362|FG001|Period 2|Other|0|||
144584220|NCT01373151|521338363|FG002|Period 2|Other|1|||
144584221|NCT01373151|521338364|FG003|Period 2|Other|0|||
144584222|NCT01373151|521338365|FG004|Period 2|Other|0|||
144584223|NCT01373151|521338366|FG005|Period 2|Other|0|||
144584224|NCT01373151|521338367|FG006|Period 2|Other|1|||
144584225|NCT03026075|521338369|FG000|Overall Study|Physician Decision|1|||
144584226|NCT04927247|521338373|FG000|Overall Study|Other|2|||
144584227|NCT04927247|521338374|FG001|Overall Study|Other|1|||
144584228|NCT04927247|521338373|FG000|Overall Study|Physician Decision|0|||
144584229|NCT04927247|521338374|FG001|Overall Study|Physician Decision|1|||
144584230|NCT04927247|521338373|FG000|Overall Study|Adverse Event|1|||
144584231|NCT04927247|521338374|FG001|Overall Study|Adverse Event|0|||
144584232|NCT04828837|521338376|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
144584233|NCT04828837|521338377|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
144584234|NCT04828837|521338376|FG000|Overall Study|Lost to Follow-up|2|||
144584235|NCT04828837|521338377|FG001|Overall Study|Lost to Follow-up|6|||
144584236|NCT04828837|521338376|FG000|Overall Study|Lack of Efficacy|1|||
144584237|NCT04828837|521338377|FG001|Overall Study|Lack of Efficacy|0|||
144584238|NCT04828837|521338376|FG000|Overall Study|Admitted due to pneumothorax.|1|||
144584239|NCT04828837|521338377|FG001|Overall Study|Admitted due to pneumothorax.|0|||
144584240|NCT04828837|521338376|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
144584241|NCT04828837|521338377|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
144584242|NCT01397422|521338378|FG000|Overall Study|Adverse Event|0|||
144584243|NCT01397422|521338379|FG001|Overall Study|Adverse Event|3|||
144584244|NCT01397422|521338380|FG002|Overall Study|Adverse Event|3|||
144584245|NCT01397422|521338381|FG003|Overall Study|Adverse Event|8|||
144584246|NCT01397422|521338378|FG000|Overall Study|Withdrawal by Subject|1|||
144584247|NCT01397422|521338379|FG001|Overall Study|Withdrawal by Subject|0|||
144584248|NCT01397422|521338380|FG002|Overall Study|Withdrawal by Subject|0|||
144584249|NCT01397422|521338381|FG003|Overall Study|Withdrawal by Subject|0|||
144584250|NCT01397422|521338378|FG000|Overall Study|Increased bradykinesia related to PD|1|||
144584251|NCT01397422|521338379|FG001|Overall Study|Increased bradykinesia related to PD|0|||
144584252|NCT01397422|521338380|FG002|Overall Study|Increased bradykinesia related to PD|0|||
144584253|NCT01397422|521338381|FG003|Overall Study|Increased bradykinesia related to PD|0|||
144584254|NCT00545753|521338382|FG000|Overall Study|Withdrawal by Subject|0|||
144584255|NCT00545753|521338383|FG001|Overall Study|Withdrawal by Subject|1|||
144584256|NCT00545753|521338384|FG002|Overall Study|Withdrawal by Subject|10|||
144584257|NCT00545753|521338382|FG000|Overall Study|Lost to Follow-up|13|||
144584258|NCT00545753|521338383|FG001|Overall Study|Lost to Follow-up|3|||
144584259|NCT00545753|521338384|FG002|Overall Study|Lost to Follow-up|12|||
144584260|NCT00545753|521338382|FG000|Overall Study|Protocol Violation|3|||
144584261|NCT00545753|521338383|FG001|Overall Study|Protocol Violation|1|||
144584262|NCT00545753|521338384|FG002|Overall Study|Protocol Violation|4|||
144584263|NCT02489968|521338393|FG000|Open-label Treatment Period|Adverse Event|14|||
144584264|NCT02489968|521338394|FG001|Open-label Treatment Period|Adverse Event|7|||
144584265|NCT02489968|521338395|FG002|Open-label Treatment Period|Adverse Event|0|||
144584266|NCT02489968|521338396|FG003|Open-label Treatment Period|Adverse Event|0|||
144584267|NCT02489968|521338397|FG004|Open-label Treatment Period|Adverse Event|0|||
144584268|NCT02489968|521338398|FG005|Open-label Treatment Period|Adverse Event|0|||
144584269|NCT02489968|521338393|FG000|Open-label Treatment Period|Protocol Violation|2|||
144584270|NCT02489968|521338394|FG001|Open-label Treatment Period|Protocol Violation|2|||
144584271|NCT02489968|521338395|FG002|Open-label Treatment Period|Protocol Violation|0|||
144584272|NCT02489968|521338396|FG003|Open-label Treatment Period|Protocol Violation|0|||
144584273|NCT02489968|521338397|FG004|Open-label Treatment Period|Protocol Violation|0|||
144584274|NCT02489968|521338398|FG005|Open-label Treatment Period|Protocol Violation|0|||
144584275|NCT02489968|521338393|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
144584276|NCT02489968|521338394|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
144584277|NCT02489968|521338395|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
144584278|NCT02489968|521338396|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
144584279|NCT02489968|521338397|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
144584280|NCT02489968|521338398|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
144584281|NCT02489968|521338393|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
144584282|NCT02489968|521338394|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
144584283|NCT02489968|521338395|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
144730422|NCT03125200|521868232|FG002|Overall Study|Progressive Disease|2|||
144584284|NCT02489968|521338396|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
144584285|NCT02489968|521338397|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
144584286|NCT02489968|521338398|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
144584287|NCT02489968|521338393|FG000|Open-label Treatment Period|Other than specified above|204|||
144584288|NCT02489968|521338394|FG001|Open-label Treatment Period|Other than specified above|189|||
144584289|NCT02489968|521338395|FG002|Open-label Treatment Period|Other than specified above|0|||
144584290|NCT02489968|521338396|FG003|Open-label Treatment Period|Other than specified above|0|||
144584291|NCT02489968|521338397|FG004|Open-label Treatment Period|Other than specified above|0|||
144584292|NCT02489968|521338398|FG005|Open-label Treatment Period|Other than specified above|0|||
144584293|NCT02489968|521338393|FG000|Double-blind Treatment Period|Adverse Event|0|||
144584294|NCT02489968|521338394|FG001|Double-blind Treatment Period|Adverse Event|0|||
144584295|NCT02489968|521338395|FG002|Double-blind Treatment Period|Adverse Event|2|||
144584296|NCT02489968|521338396|FG003|Double-blind Treatment Period|Adverse Event|6|||
144584297|NCT02489968|521338397|FG004|Double-blind Treatment Period|Adverse Event|4|||
144584298|NCT02489968|521338398|FG005|Double-blind Treatment Period|Adverse Event|5|||
144584299|NCT02489968|521338393|FG000|Double-blind Treatment Period|Protocol Violation|0|||
144584300|NCT02489968|521338394|FG001|Double-blind Treatment Period|Protocol Violation|0|||
144584301|NCT02489968|521338395|FG002|Double-blind Treatment Period|Protocol Violation|0|||
144584302|NCT02489968|521338396|FG003|Double-blind Treatment Period|Protocol Violation|0|||
144584303|NCT02489968|521338397|FG004|Double-blind Treatment Period|Protocol Violation|1|||
144584304|NCT02489968|521338398|FG005|Double-blind Treatment Period|Protocol Violation|1|||
144584305|NCT02489968|521338393|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
144584306|NCT02489968|521338394|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
144584307|NCT02489968|521338395|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144584308|NCT02489968|521338396|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
144584309|NCT02489968|521338397|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
144584310|NCT02489968|521338398|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
144584311|NCT02489968|521338393|FG000|Double-blind Treatment Period|Other than specified above|0|||
144584312|NCT02489968|521338394|FG001|Double-blind Treatment Period|Other than specified above|0|||
144584313|NCT02489968|521338395|FG002|Double-blind Treatment Period|Other than specified above|0|||
144584314|NCT02489968|521338396|FG003|Double-blind Treatment Period|Other than specified above|0|||
144584315|NCT02489968|521338397|FG004|Double-blind Treatment Period|Other than specified above|1|||
144584316|NCT02489968|521338398|FG005|Double-blind Treatment Period|Other than specified above|0|||
144584317|NCT04577001|521338399|FG000|Overall Study|Subject became ineligible|0|||
144584318|NCT04577001|521338400|FG001|Overall Study|Subject became ineligible|1|||
144584319|NCT00969709|521339701|FG000|Overall Study|Adverse Event|3|||
144584320|NCT00969709|521339702|FG001|Overall Study|Adverse Event|13|||
144584321|NCT00969709|521339703|FG002|Overall Study|Adverse Event|26|||
144584322|NCT00969709|521339704|FG003|Overall Study|Adverse Event|12|||
144584323|NCT00969709|521339701|FG000|Overall Study|Lack of Efficacy|7|||
144584324|NCT00969709|521339702|FG001|Overall Study|Lack of Efficacy|4|||
144584325|NCT00969709|521339703|FG002|Overall Study|Lack of Efficacy|1|||
144584326|NCT00969709|521339704|FG003|Overall Study|Lack of Efficacy|3|||
144584327|NCT00969709|521339701|FG000|Overall Study|Protocol Violation|9|||
144584328|NCT00969709|521339702|FG001|Overall Study|Protocol Violation|5|||
144584329|NCT00969709|521339703|FG002|Overall Study|Protocol Violation|9|||
144584330|NCT00969709|521339704|FG003|Overall Study|Protocol Violation|10|||
144584331|NCT00969709|521339701|FG000|Overall Study|Withdrawal by Subject|9|||
144584332|NCT00969709|521339702|FG001|Overall Study|Withdrawal by Subject|12|||
144584333|NCT00969709|521339703|FG002|Overall Study|Withdrawal by Subject|11|||
144584334|NCT00969709|521339704|FG003|Overall Study|Withdrawal by Subject|23|||
144584335|NCT00969709|521339701|FG000|Overall Study|Lost to Follow-up|10|||
144584336|NCT00969709|521339702|FG001|Overall Study|Lost to Follow-up|14|||
144584337|NCT00969709|521339703|FG002|Overall Study|Lost to Follow-up|8|||
144584338|NCT00969709|521339704|FG003|Overall Study|Lost to Follow-up|15|||
144584339|NCT00969709|521339701|FG000|Overall Study|Other reasons|0|||
144584340|NCT00969709|521339702|FG001|Overall Study|Other reasons|0|||
144584341|NCT00969709|521339703|FG002|Overall Study|Other reasons|3|||
144584342|NCT00969709|521339704|FG003|Overall Study|Other reasons|0|||
144584343|NCT02980731|521339705|FG000|Overall Study|Death|63|||
144584344|NCT02980731|521339705|FG000|Overall Study|Withdrawal by Subject|6|||
144584345|NCT02980731|521339705|FG000|Overall Study|Lost to Follow-up|5|||
144584346|NCT02980731|521339705|FG000|Overall Study|Study terminated by Sponsor|4|||
144584347|NCT02980731|521339705|FG000|Overall Study|Completed survival follow-up period|65|||
144584348|NCT02980731|521339705|FG000|Overall Study|COVID-19 infection|1|||
144584349|NCT02980731|521339705|FG000|Overall Study|Other, not specified|66|||
144584350|NCT03037931|521339706|FG000|Overall Study|Death|354|||
144584351|NCT03037931|521339707|FG001|Overall Study|Death|367|||
144584352|NCT03037931|521339706|FG000|Overall Study|Lost to Follow-up|7|||
144584353|NCT03037931|521339707|FG001|Overall Study|Lost to Follow-up|4|||
144584354|NCT03037931|521339706|FG000|Overall Study|Withdrawal by Subject|48|||
144584355|NCT03037931|521339707|FG001|Overall Study|Withdrawal by Subject|41|||
144584356|NCT02075476|521339708|FG000|Overall Study|Death|2|||
144584357|NCT02075476|521339709|FG001|Overall Study|Death|2|||
144623426|NCT03529773|521478623|FG030|Overall Study|No longer meets eligibility criteria|0|||
144623427|NCT03529773|521478624|FG031|Overall Study|No longer meets eligibility criteria|0|||
144623428|NCT03529773|521478625|FG032|Overall Study|No longer meets eligibility criteria|0|||
144623429|NCT03529773|521478626|FG033|Overall Study|No longer meets eligibility criteria|0|||
144623430|NCT03529773|521478627|FG034|Overall Study|No longer meets eligibility criteria|0|||
144584358|NCT02075476|521339708|FG000|Overall Study|Lost to Follow-up|1|||
144584359|NCT02075476|521339709|FG001|Overall Study|Lost to Follow-up|3|||
144584360|NCT00091169|521339712|FG000|Overall Study|Disease progression|3|||
144584361|NCT00091169|521339713|FG001|Overall Study|Disease progression|1|||
144584362|NCT00091169|521339712|FG000|Overall Study|Adverse Event|11|||
144584363|NCT00091169|521339713|FG001|Overall Study|Adverse Event|17|||
144584364|NCT00091169|521339712|FG000|Overall Study|Death|4|||
144584365|NCT00091169|521339713|FG001|Overall Study|Death|1|||
144584366|NCT00091169|521339712|FG000|Overall Study|Withdrawal by Subject|10|||
144584367|NCT00091169|521339713|FG001|Overall Study|Withdrawal by Subject|13|||
144584368|NCT00091169|521339712|FG000|Overall Study|Other|3|||
144584369|NCT00091169|521339713|FG001|Overall Study|Other|4|||
144584370|NCT00091169|521339712|FG000|Overall Study|Not start protocol therapy|26|||
144584371|NCT00091169|521339713|FG001|Overall Study|Not start protocol therapy|17|||
144584372|NCT03809429|521339714|FG000|Overall Study|Withdrawal by Subject|7|||
144584373|NCT03809429|521339715|FG001|Overall Study|Withdrawal by Subject|3|||
144584374|NCT03809429|521339714|FG000|Overall Study|Adverse Event|6|||
144584375|NCT03809429|521339715|FG001|Overall Study|Adverse Event|9|||
144584376|NCT03809429|521339714|FG000|Overall Study|COVID-19|3|||
144584377|NCT03809429|521339715|FG001|Overall Study|COVID-19|1|||
144584378|NCT03809429|521339714|FG000|Overall Study|Participant was discontinued by investigator|12|||
144584379|NCT03809429|521339715|FG001|Overall Study|Participant was discontinued by investigator|7|||
144584380|NCT00901186|521339716|FG000|Overall Study|Lack of Efficacy|0|||
144584381|NCT00901186|521339717|FG001|Overall Study|Lack of Efficacy|1|||
144584382|NCT00901186|521339716|FG000|Overall Study|Abnormal laboratory values|0|||
144584383|NCT00901186|521339717|FG001|Overall Study|Abnormal laboratory values|1|||
144584384|NCT00901186|521339716|FG000|Overall Study|Lost to Follow-up|2|||
144584385|NCT00901186|521339717|FG001|Overall Study|Lost to Follow-up|0|||
144584386|NCT00901186|521339716|FG000|Overall Study|Adverse Event|2|||
144584387|NCT00901186|521339717|FG001|Overall Study|Adverse Event|4|||
144584388|NCT00901186|521339716|FG000|Overall Study|Administration problems|0|||
144584389|NCT00901186|521339717|FG001|Overall Study|Administration problems|1|||
144584390|NCT00901186|521339716|FG000|Overall Study|Protocol deviations|5|||
144584391|NCT00901186|521339717|FG001|Overall Study|Protocol deviations|4|||
144584392|NCT03377699|521339725|FG000|Overall Study|Withdrawal by Subject|2|||
144584393|NCT03377699|521339726|FG001|Overall Study|Withdrawal by Subject|9|||
144623431|NCT03529773|521478628|FG035|Overall Study|No longer meets eligibility criteria|0|||
144623432|NCT03529773|521478629|FG036|Overall Study|No longer meets eligibility criteria|0|||
144623433|NCT03529773|521478630|FG037|Overall Study|No longer meets eligibility criteria|0|||
144623434|NCT03529773|521478631|FG038|Overall Study|No longer meets eligibility criteria|1|||
144623435|NCT03529773|521478632|FG039|Overall Study|No longer meets eligibility criteria|0|||
144623436|NCT03529773|521478593|FG000|Overall Study|Other|0|||
144623437|NCT03529773|521478594|FG001|Overall Study|Other|0|||
144623438|NCT03529773|521478595|FG002|Overall Study|Other|0|||
144623439|NCT03529773|521478596|FG003|Overall Study|Other|0|||
144623440|NCT03529773|521478597|FG004|Overall Study|Other|0|||
144623441|NCT03529773|521478598|FG005|Overall Study|Other|0|||
144623442|NCT03529773|521478599|FG006|Overall Study|Other|0|||
144623443|NCT03529773|521478600|FG007|Overall Study|Other|0|||
144623444|NCT03529773|521478601|FG008|Overall Study|Other|0|||
144623445|NCT03529773|521478602|FG009|Overall Study|Other|0|||
144623446|NCT03529773|521478603|FG010|Overall Study|Other|0|||
144623447|NCT03529773|521478604|FG011|Overall Study|Other|0|||
144623448|NCT03529773|521478605|FG012|Overall Study|Other|1|||
144623449|NCT03529773|521478606|FG013|Overall Study|Other|0|||
144730423|NCT03125200|521868233|FG003|Overall Study|Progressive Disease|1|||
144730424|NCT03125200|521868234|FG004|Overall Study|Progressive Disease|2|||
144209483|NCT00696787|519961901|FG002|Overall Study|Withdrawal by Subject|2|||
144623450|NCT03529773|521478607|FG014|Overall Study|Other|2|||
144623451|NCT03529773|521478608|FG015|Overall Study|Other|0|||
144209484|NCT00696787|519961899|FG000|Overall Study|Failed to return|1|||
144623452|NCT03529773|521478609|FG016|Overall Study|Other|0|||
144730425|NCT03125200|521868235|FG005|Overall Study|Progressive Disease|0|||
144584394|NCT03377699|521339725|FG000|Overall Study|Lost to Follow-up|1|||
144584395|NCT03377699|521339726|FG001|Overall Study|Lost to Follow-up|1|||
144584396|NCT03377699|521339725|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
144584397|NCT03377699|521339726|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
144584398|NCT03377699|521339725|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
144584399|NCT03377699|521339726|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
144584400|NCT03377699|521339725|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
144623453|NCT03529773|521478610|FG017|Overall Study|Other|3|||
144209485|NCT00696787|519961900|FG001|Overall Study|Failed to return|3|||
144209486|NCT00696787|519961901|FG002|Overall Study|Failed to return|1|||
144209487|NCT00129389|519961902|FG000|Overall Study|Adverse Event|19|||
144209488|NCT00129389|519961903|FG001|Overall Study|Adverse Event|87|||
144209489|NCT00129389|519961902|FG000|Overall Study|Death|0|||
144584401|NCT03377699|521339726|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
144584402|NCT03377699|521339725|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
144584403|NCT03377699|521339726|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
144584404|NCT00774930|521339730|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
144584405|NCT00774930|521339731|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
144584406|NCT00774930|521339730|FG000|DB Phase|Adverse Event|1|||
144584407|NCT00774930|521339731|FG001|DB Phase|Adverse Event|2|||
144584408|NCT00774930|521339730|FG000|DB Phase|Subject Decision|1|||
144584409|NCT00774930|521339731|FG001|DB Phase|Subject Decision|5|||
144584410|NCT00774930|521339730|FG000|DB Phase|Sponsor Decision|0|||
144584411|NCT00774930|521339731|FG001|DB Phase|Sponsor Decision|1|||
144584412|NCT00774930|521339730|FG000|DB Phase|Disease Progression|1|||
144584413|NCT00774930|521339731|FG001|DB Phase|Disease Progression|1|||
144584414|NCT00774930|521339730|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
144584415|NCT00774930|521339731|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
144584416|NCT00774930|521339730|FG000|IOL Phase|Adverse Event|1|||
144584417|NCT00774930|521339731|FG001|IOL Phase|Adverse Event|1|||
144584418|NCT00774930|521339730|FG000|IOL Phase|Subject Decision|4|||
144584419|NCT00774930|521339731|FG001|IOL Phase|Subject Decision|3|||
144584420|NCT00774930|521339730|FG000|IOL Phase|Physician Decision|3|||
144584421|NCT00774930|521339731|FG001|IOL Phase|Physician Decision|2|||
144584422|NCT00774930|521339730|FG000|IOL Phase|Sponsor Decision|1|||
144584423|NCT00774930|521339731|FG001|IOL Phase|Sponsor Decision|0|||
144584424|NCT00774930|521339730|FG000|IOL Phase|Disease Progression|2|||
144584425|NCT00774930|521339731|FG001|IOL Phase|Disease Progression|1|||
144584426|NCT00774930|521339730|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
144584427|NCT00774930|521339731|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
144584428|NCT00774930|521339730|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
144584429|NCT00774930|521339731|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
144584430|NCT00774930|521339730|FG000|IOL Phase|Other|1|||
144584431|NCT00774930|521339731|FG001|IOL Phase|Other|0|||
144584432|NCT00774930|521339730|FG000|IOL Phase|Brain radiation|0|||
144584433|NCT00774930|521339731|FG001|IOL Phase|Brain radiation|1|||
144584434|NCT00774930|521339730|FG000|LTOLE Phase|Adverse Event|7|||
144584435|NCT00774930|521339731|FG001|LTOLE Phase|Adverse Event|3|||
144584436|NCT00774930|521339730|FG000|LTOLE Phase|Subject decision|0|||
144584437|NCT00774930|521339731|FG001|LTOLE Phase|Subject decision|5|||
144584438|NCT00774930|521339730|FG000|LTOLE Phase|Physician Decision|4|||
144584439|NCT00774930|521339731|FG001|LTOLE Phase|Physician Decision|1|||
144584440|NCT00774930|521339730|FG000|LTOLE Phase|Sponsor decision|2|||
144584441|NCT00774930|521339731|FG001|LTOLE Phase|Sponsor decision|1|||
144584442|NCT00774930|521339730|FG000|LTOLE Phase|Disease Progression|2|||
144584443|NCT00774930|521339731|FG001|LTOLE Phase|Disease Progression|5|||
144584444|NCT00774930|521339730|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
144584445|NCT00774930|521339731|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
144584446|NCT00774930|521339730|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
144584447|NCT00774930|521339731|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
144584448|NCT01153321|521339732|FG000|Overall Study|Development of study withdrawal criteria|0|||
144584449|NCT01153321|521339733|FG001|Overall Study|Development of study withdrawal criteria|1|||
144584450|NCT01153321|521339732|FG000|Overall Study|Withdrawal by Subject|0|||
144584451|NCT01153321|521339733|FG001|Overall Study|Withdrawal by Subject|1|||
144584452|NCT01153321|521339732|FG000|Overall Study|Adverse Event|1|||
144584453|NCT01153321|521339733|FG001|Overall Study|Adverse Event|1|||
144584454|NCT01177800|521339734|FG000|Overall Study|Adverse Event|9|||
144584455|NCT01177800|521339735|FG001|Overall Study|Adverse Event|3|||
144584456|NCT01177800|521339734|FG000|Overall Study|Protocol Violation|0|||
144584457|NCT01177800|521339735|FG001|Overall Study|Protocol Violation|1|||
144584458|NCT01177800|521339734|FG000|Overall Study|Physician Decision|1|||
144584459|NCT01177800|521339735|FG001|Overall Study|Physician Decision|0|||
144209490|NCT00129389|519961903|FG001|Overall Study|Death|1|||
144584460|NCT01177800|521339734|FG000|Overall Study|Withdrawal of informed consent|0|||
144584461|NCT01177800|521339735|FG001|Overall Study|Withdrawal of informed consent|1|||
144584462|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
144584463|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
144584464|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
144584465|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
144584466|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
144584467|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
144584468|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
144584469|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
144584470|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
144584471|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
144584472|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
144584473|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
144584474|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
144623454|NCT03529773|521478611|FG018|Overall Study|Other|0|||
144623455|NCT03529773|521478612|FG019|Overall Study|Other|0|||
144623456|NCT03529773|521478613|FG020|Overall Study|Other|1|||
144623457|NCT03529773|521478614|FG021|Overall Study|Other|0|||
144623458|NCT03529773|521478615|FG022|Overall Study|Other|1|||
144623459|NCT03529773|521478616|FG023|Overall Study|Other|0|||
144623460|NCT03529773|521478617|FG024|Overall Study|Other|3|||
144623461|NCT03529773|521478618|FG025|Overall Study|Other|2|||
144730426|NCT03125200|521868236|FG006|Overall Study|Progressive Disease|1|||
144730427|NCT03125200|521868230|FG000|Overall Study|Lack of Efficacy|0|||
144730428|NCT03125200|521868231|FG001|Overall Study|Lack of Efficacy|0|||
144730429|NCT03125200|521868232|FG002|Overall Study|Lack of Efficacy|0|||
144730430|NCT03125200|521868233|FG003|Overall Study|Lack of Efficacy|1|||
144730431|NCT03125200|521868234|FG004|Overall Study|Lack of Efficacy|0|||
144730432|NCT03125200|521868235|FG005|Overall Study|Lack of Efficacy|0|||
144730433|NCT03125200|521868236|FG006|Overall Study|Lack of Efficacy|0|||
144730434|NCT03125200|521868230|FG000|Overall Study|Toxicity|0|||
144730435|NCT03125200|521868231|FG001|Overall Study|Toxicity|0|||
144730436|NCT03125200|521868232|FG002|Overall Study|Toxicity|0|||
144730437|NCT03125200|521868233|FG003|Overall Study|Toxicity|1|||
144730438|NCT03125200|521868234|FG004|Overall Study|Toxicity|0|||
144730439|NCT03125200|521868235|FG005|Overall Study|Toxicity|0|||
144730440|NCT03125200|521868236|FG006|Overall Study|Toxicity|0|||
144730441|NCT03125200|521868230|FG000|Overall Study|Consent Withdrawn by Subject|0|||
144730442|NCT03125200|521868231|FG001|Overall Study|Consent Withdrawn by Subject|1|||
144730443|NCT03125200|521868232|FG002|Overall Study|Consent Withdrawn by Subject|0|||
144730444|NCT03125200|521868233|FG003|Overall Study|Consent Withdrawn by Subject|0|||
144730445|NCT03125200|521868234|FG004|Overall Study|Consent Withdrawn by Subject|1|||
144730446|NCT03125200|521868235|FG005|Overall Study|Consent Withdrawn by Subject|0|||
144730447|NCT03125200|521868236|FG006|Overall Study|Consent Withdrawn by Subject|1|||
144730448|NCT00694551|521868237|FG000|Overall Study|Disease Progression|1|||
144730449|NCT00694551|521868238|FG001|Overall Study|Disease Progression|0|||
144730450|NCT00694551|521868239|FG002|Overall Study|Disease Progression|1|||
144730451|NCT01937390|521868243|FG000|Overall Study|Death|2|||
144730452|NCT01937390|521868243|FG000|Overall Study|Lost to Follow-up|7|||
144730453|NCT01937390|521868243|FG000|Overall Study|Withdrawal by Subject|5|||
144584475|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
144584476|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
144584477|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
144584478|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
144584479|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
144584480|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
144584481|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
144584482|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
144584483|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
144584484|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
144584485|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
144584486|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
144584487|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
144584488|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
144584489|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
144584490|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
144584491|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
144623462|NCT03529773|521478619|FG026|Overall Study|Other|2|||
144730454|NCT01937390|521868243|FG000|Overall Study|Fail to return|21|||
144730455|NCT03544138|521868248|FG000|Overall Study|Lost to Follow-up|29|||
144730456|NCT03144687|521868255|FG000|Overall Study|Death|0|||
144623463|NCT03529773|521478620|FG027|Overall Study|Other|0|||
144623464|NCT03529773|521478621|FG028|Overall Study|Other|0|||
144730457|NCT03144687|521868256|FG001|Overall Study|Death|2|||
144730458|NCT03144687|521868255|FG000|Overall Study|Lost to Follow-up|0|||
144730459|NCT03144687|521868256|FG001|Overall Study|Lost to Follow-up|1|||
144730460|NCT03144687|521868255|FG000|Overall Study|Physician Decision|0|||
144623465|NCT03529773|521478622|FG029|Overall Study|Other|0|||
144623466|NCT03529773|521478623|FG030|Overall Study|Other|0|||
144623467|NCT03529773|521478624|FG031|Overall Study|Other|0|||
144730461|NCT03144687|521868256|FG001|Overall Study|Physician Decision|1|||
144730462|NCT03144687|521868255|FG000|Overall Study|Withdrawal by Subject|1|||
144730463|NCT03144687|521868256|FG001|Overall Study|Withdrawal by Subject|3|||
144730464|NCT03144687|521868255|FG000|Overall Study|Not Reported|2|||
144730465|NCT03144687|521868256|FG001|Overall Study|Not Reported|0|||
144209491|NCT00129389|519961902|FG000|Overall Study|Lost to Follow-up|2|||
144209492|NCT00129389|519961903|FG001|Overall Study|Lost to Follow-up|1|||
144209493|NCT00129389|519961902|FG000|Overall Study|Physician Decision|0|||
144209494|NCT00129389|519961903|FG001|Overall Study|Physician Decision|4|||
144209495|NCT00129389|519961902|FG000|Overall Study|Protocol Violation|0|||
144584492|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
144584493|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
144584494|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
144584495|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
144584496|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
144584497|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
144584498|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
144584499|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
144584500|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
144584501|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
144584502|NCT00700427|521339737|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
144584503|NCT00700427|521339738|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
144584504|NCT00700427|521339739|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
144584505|NCT00700427|521339740|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
144584506|NCT00700427|521339741|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
144584507|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
144584508|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
144584509|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
144584510|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
144584511|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
144584512|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
144584513|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
144584514|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
144584515|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
144584516|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
144584517|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
144584518|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
144584519|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
144584520|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
144584521|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
144584522|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
144584523|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
144584524|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
144584525|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
144584526|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
144584527|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
144584528|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
144584529|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
144584530|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
144584531|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
144584532|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
144584533|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
144584534|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
144584535|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
144584536|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
144584537|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
144584538|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
144584539|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
144584540|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
144584541|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
144584542|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
144584543|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
144584544|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
144584545|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
144584546|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
144584547|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
144584548|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
144730466|NCT01900730|521869785|FG000|Overall Study|Withdrawal by Subject|1|||
144730467|NCT01900730|521869786|FG001|Overall Study|Withdrawal by Subject|0|||
144209496|NCT00129389|519961903|FG001|Overall Study|Protocol Violation|6|||
144584549|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
144584550|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
144584551|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
144584552|NCT00700427|521339737|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
144584553|NCT00700427|521339738|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
144584554|NCT00700427|521339739|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
144584555|NCT00700427|521339740|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
144584556|NCT00700427|521339741|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
144584557|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
144584558|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
144584559|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
144584560|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
144584561|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
144584562|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
144584563|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
144584564|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
144584565|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
144584566|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
144584567|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
144584568|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
144584569|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
144584570|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
144584571|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
144584572|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
144584573|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
144584574|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
144584575|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
144584576|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
144584577|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
144584578|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
144584579|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
144584580|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
144584581|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
144584582|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
144584583|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
144584584|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
144584585|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
144584586|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
144584587|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
144584588|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
144584589|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
144584590|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
144584591|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
144584592|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
144584593|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
144584594|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
144584595|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
144584596|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
144584597|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
144584598|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
144584599|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
144584600|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
144584601|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
144584602|NCT00700427|521339737|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
144584603|NCT00700427|521339738|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
144584604|NCT00700427|521339739|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
144584605|NCT00700427|521339740|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
144584606|NCT00700427|521339741|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
144584607|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
144584608|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
144584609|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
144584610|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
144584611|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
144623468|NCT03529773|521478625|FG032|Overall Study|Other|0|||
144623469|NCT03529773|521478626|FG033|Overall Study|Other|0|||
144623470|NCT03529773|521478627|FG034|Overall Study|Other|1|||
144623471|NCT03529773|521478628|FG035|Overall Study|Other|1|||
144623472|NCT03529773|521478629|FG036|Overall Study|Other|0|||
144623473|NCT03529773|521478630|FG037|Overall Study|Other|0|||
144623474|NCT03529773|521478631|FG038|Overall Study|Other|0|||
144623475|NCT03529773|521478632|FG039|Overall Study|Other|0|||
144623476|NCT03529773|521478593|FG000|Overall Study|Physician Decision|0|||
144584612|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
144623477|NCT03529773|521478594|FG001|Overall Study|Physician Decision|0|||
144584613|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
144584614|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
144584615|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
144584616|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
144584617|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
144584618|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
144584619|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
144584620|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
144584621|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
144584622|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
144584623|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
144584624|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
144584625|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
144584626|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
144584627|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
144584628|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
144584629|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
144584630|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
144584631|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
144584632|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
144584633|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
144584634|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
144584635|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
144584636|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
144584637|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
144584638|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
144584639|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
144584640|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
144584641|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
144584642|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
144584643|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
144584644|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
144584645|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
144584646|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
144584647|NCT00700427|521339737|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
144584648|NCT00700427|521339738|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
144584649|NCT00700427|521339739|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
144584650|NCT00700427|521339740|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
144584651|NCT00700427|521339741|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
144584652|NCT00424385|521339742|FG000|Cohort 0|Withdrawal by Subject|5|||
144623478|NCT03529773|521478595|FG002|Overall Study|Physician Decision|0|||
144623479|NCT03529773|521478596|FG003|Overall Study|Physician Decision|0|||
144623480|NCT03529773|521478597|FG004|Overall Study|Physician Decision|0|||
144623481|NCT03529773|521478598|FG005|Overall Study|Physician Decision|0|||
144623482|NCT03529773|521478599|FG006|Overall Study|Physician Decision|0|||
144623483|NCT03529773|521478600|FG007|Overall Study|Physician Decision|0|||
144623484|NCT03529773|521478601|FG008|Overall Study|Physician Decision|0|||
144730468|NCT01900730|521869785|FG000|Overall Study|Screen Failure|1|||
144730469|NCT01900730|521869786|FG001|Overall Study|Screen Failure|0|||
144209497|NCT00129389|519961902|FG000|Overall Study|Withdrawal by Subject|9|||
144209498|NCT00129389|519961903|FG001|Overall Study|Withdrawal by Subject|23|||
144623485|NCT03529773|521478602|FG009|Overall Study|Physician Decision|0|||
144623486|NCT03529773|521478603|FG010|Overall Study|Physician Decision|0|||
144623487|NCT03529773|521478604|FG011|Overall Study|Physician Decision|0|||
144623488|NCT03529773|521478605|FG012|Overall Study|Physician Decision|0|||
144623489|NCT03529773|521478606|FG013|Overall Study|Physician Decision|0|||
144623490|NCT03529773|521478607|FG014|Overall Study|Physician Decision|0|||
144623491|NCT03529773|521478608|FG015|Overall Study|Physician Decision|0|||
144623492|NCT03529773|521478609|FG016|Overall Study|Physician Decision|0|||
144623493|NCT03529773|521478610|FG017|Overall Study|Physician Decision|0|||
144730470|NCT01179048|521869787|FG000|Overall Study|Withdrawn - does not allow contact|4|||
144623494|NCT03529773|521478611|FG018|Overall Study|Physician Decision|0|||
144584653|NCT00424385|521339742|FG000|Cohort 0|Physician Decision|1|||
144584654|NCT00424385|521339742|FG000|Cohort 1|Withdrawal by Subject|1|||
144584655|NCT01125514|521339751|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
144584656|NCT01125514|521339751|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
144584657|NCT01125514|521339751|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
144584658|NCT01125514|521339751|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
144584659|NCT01125514|521339751|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
144584660|NCT01125514|521339751|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
144584661|NCT03980808|521339752|FG000|Overall Study|Lost to Follow-up|2|||
144584662|NCT03980808|521339753|FG001|Overall Study|Lost to Follow-up|2|||
144584663|NCT01655693|521339754|FG000|Overall Study|Progression of Disease|92|||
144584664|NCT01655693|521339755|FG001|Overall Study|Progression of Disease|76|||
144584665|NCT01655693|521339756|FG002|Overall Study|Progression of Disease|58|||
144584666|NCT01655693|521339754|FG000|Overall Study|Death|8|||
144584667|NCT01655693|521339755|FG001|Overall Study|Death|9|||
144584668|NCT01655693|521339756|FG002|Overall Study|Death|12|||
144209499|NCT00129389|519961902|FG000|Overall Study|Relapse|1|||
144209500|NCT00129389|519961903|FG001|Overall Study|Relapse|0|||
144209501|NCT00129389|519961902|FG000|Overall Study|Not eligible|1|||
144584669|NCT01655693|521339754|FG000|Overall Study|Serious Adverse Event|3|||
144584670|NCT01655693|521339755|FG001|Overall Study|Serious Adverse Event|15|||
144584671|NCT01655693|521339756|FG002|Overall Study|Serious Adverse Event|11|||
144584672|NCT01655693|521339754|FG000|Overall Study|Withdrawal by Subject|3|||
144584673|NCT01655693|521339755|FG001|Overall Study|Withdrawal by Subject|2|||
144584674|NCT01655693|521339756|FG002|Overall Study|Withdrawal by Subject|20|||
144584675|NCT01655693|521339754|FG000|Overall Study|Adverse Event|3|||
144584676|NCT01655693|521339755|FG001|Overall Study|Adverse Event|11|||
144584677|NCT01655693|521339756|FG002|Overall Study|Adverse Event|3|||
144584678|NCT01655693|521339754|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
144584679|NCT01655693|521339755|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
144584680|NCT01655693|521339756|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
144584681|NCT01655693|521339754|FG000|Overall Study|Non-Compliance|0|||
144584682|NCT01655693|521339755|FG001|Overall Study|Non-Compliance|0|||
144584683|NCT01655693|521339756|FG002|Overall Study|Non-Compliance|7|||
144584684|NCT01655693|521339754|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
144584685|NCT01655693|521339755|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
144584686|NCT01655693|521339756|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
144584687|NCT01655693|521339754|FG000|Overall Study|Protocol Violation|1|||
144584688|NCT01655693|521339755|FG001|Overall Study|Protocol Violation|0|||
144584689|NCT01655693|521339756|FG002|Overall Study|Protocol Violation|3|||
144584690|NCT01655693|521339754|FG000|Overall Study|Lost to Follow-up|1|||
144584691|NCT01655693|521339755|FG001|Overall Study|Lost to Follow-up|0|||
144584692|NCT01655693|521339756|FG002|Overall Study|Lost to Follow-up|1|||
144584693|NCT01655693|521339754|FG000|Overall Study|Screening Failure|1|||
144584694|NCT01655693|521339755|FG001|Overall Study|Screening Failure|0|||
144584695|NCT01655693|521339756|FG002|Overall Study|Screening Failure|0|||
144584696|NCT01655693|521339754|FG000|Overall Study|Other|8|||
144584697|NCT01655693|521339755|FG001|Overall Study|Other|6|||
144584698|NCT01655693|521339756|FG002|Overall Study|Other|15|||
144623495|NCT03529773|521478612|FG019|Overall Study|Physician Decision|1|||
144623496|NCT03529773|521478613|FG020|Overall Study|Physician Decision|1|||
144623497|NCT03529773|521478614|FG021|Overall Study|Physician Decision|0|||
144623498|NCT03529773|521478615|FG022|Overall Study|Physician Decision|0|||
144623499|NCT03529773|521478616|FG023|Overall Study|Physician Decision|0|||
144623500|NCT03529773|521478617|FG024|Overall Study|Physician Decision|0|||
144623501|NCT03529773|521478618|FG025|Overall Study|Physician Decision|0|||
144209502|NCT00129389|519961903|FG001|Overall Study|Not eligible|2|||
144209503|NCT00129389|519961902|FG000|Overall Study|Crossed to the other arm|1|||
144584699|NCT02535091|521339760|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
144584700|NCT02535091|521339761|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
144584701|NCT02535091|521339762|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
144584702|NCT02535091|521339760|FG000|Overall Study|Withdrawal by Subject|14|||
144584703|NCT02535091|521339761|FG001|Overall Study|Withdrawal by Subject|5|||
144584704|NCT02535091|521339762|FG002|Overall Study|Withdrawal by Subject|121|||
144584705|NCT02535091|521339760|FG000|Overall Study|Adverse Event|9|||
144623502|NCT03529773|521478619|FG026|Overall Study|Physician Decision|0|||
144623503|NCT03529773|521478620|FG027|Overall Study|Physician Decision|0|||
144584706|NCT02535091|521339761|FG001|Overall Study|Adverse Event|4|||
144584707|NCT02535091|521339762|FG002|Overall Study|Adverse Event|170|||
144584708|NCT02535091|521339760|FG000|Overall Study|Other|4|||
144584709|NCT02535091|521339761|FG001|Overall Study|Other|3|||
144584710|NCT02535091|521339762|FG002|Overall Study|Other|81|||
144584711|NCT02535091|521339760|FG000|Overall Study|Lost to Follow-up|0|||
144584712|NCT02535091|521339761|FG001|Overall Study|Lost to Follow-up|1|||
144623504|NCT03529773|521478621|FG028|Overall Study|Physician Decision|0|||
144623505|NCT03529773|521478622|FG029|Overall Study|Physician Decision|0|||
144623506|NCT03529773|521478623|FG030|Overall Study|Physician Decision|0|||
144584713|NCT02535091|521339762|FG002|Overall Study|Lost to Follow-up|19|||
144584714|NCT02535091|521339760|FG000|Overall Study|Protocol Violation|0|||
144584715|NCT02535091|521339761|FG001|Overall Study|Protocol Violation|1|||
144584716|NCT02535091|521339762|FG002|Overall Study|Protocol Violation|11|||
144584717|NCT02535091|521339760|FG000|Overall Study|Pregnancy|0|||
144584718|NCT02535091|521339761|FG001|Overall Study|Pregnancy|0|||
144584719|NCT02535091|521339762|FG002|Overall Study|Pregnancy|7|||
144584720|NCT03223662|521339763|FG000|Overall Study|Physician Decision|1|||
144584721|NCT03223662|521339763|FG000|Overall Study|Study closure|1|||
144584722|NCT02643472|521339764|FG000|Overall Study|Death|2|||
144584723|NCT02643472|521339765|FG001|Overall Study|Death|5|||
144584724|NCT02643472|521339764|FG000|Overall Study|Withdrawal by Subject|3|||
144584725|NCT02643472|521339765|FG001|Overall Study|Withdrawal by Subject|2|||
144584726|NCT02643472|521339764|FG000|Overall Study|Protocol Violation|0|||
144584727|NCT02643472|521339765|FG001|Overall Study|Protocol Violation|1|||
144584728|NCT02643472|521339764|FG000|Overall Study|Lost to Follow-up|22|||
144584729|NCT02643472|521339765|FG001|Overall Study|Lost to Follow-up|26|||
144584730|NCT00506441|521339766|FG000|Period 1; Open-label Period|Adverse Event|21|||
144584731|NCT00506441|521339767|FG001|Period 1; Open-label Period|Adverse Event|0|||
144584732|NCT00506441|521339766|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
144584733|NCT00506441|521339767|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
144584734|NCT00506441|521339766|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
144584735|NCT00506441|521339767|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
144584736|NCT00506441|521339766|FG000|Period 1; Open-label Period|Physician Decision|5|||
144584737|NCT00506441|521339767|FG001|Period 1; Open-label Period|Physician Decision|0|||
144584738|NCT00506441|521339766|FG000|Period 1; Open-label Period|Protocol Violation|9|||
144584739|NCT00506441|521339767|FG001|Period 1; Open-label Period|Protocol Violation|0|||
144584740|NCT00506441|521339766|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
144584741|NCT00506441|521339767|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
144584742|NCT00506441|521339766|FG000|Period 1; Open-label Period|Other Reasons|13|||
144584743|NCT00506441|521339767|FG001|Period 1; Open-label Period|Other Reasons|0|||
144584744|NCT00506441|521339766|FG000|Period 2; Double-blind Period|Adverse Event|0|||
144584745|NCT00506441|521339767|FG001|Period 2; Double-blind Period|Adverse Event|1|||
144584746|NCT00506441|521339766|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
144584747|NCT00506441|521339767|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
144584748|NCT00506441|521339766|FG000|Period 2; Double-blind Period|Physician Decision|1|||
144584749|NCT00506441|521339767|FG001|Period 2; Double-blind Period|Physician Decision|1|||
144584750|NCT00506441|521339766|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
144584751|NCT00506441|521339767|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
144584752|NCT00506441|521339766|FG000|Period 2; Double-blind Period|Other Reason|1|||
144584753|NCT00506441|521339767|FG001|Period 2; Double-blind Period|Other Reason|1|||
144584754|NCT03122223|521339774|FG000|Overall Study|Withdrawal by Subject|2|||
144584755|NCT03122223|521339775|FG001|Overall Study|Withdrawal by Subject|2|||
144584756|NCT03122223|521339776|FG002|Overall Study|Withdrawal by Subject|1|||
144584757|NCT03122223|521339777|FG003|Overall Study|Withdrawal by Subject|0|||
144584758|NCT03122223|521339774|FG000|Overall Study|Lost to Follow-up|0|||
144584759|NCT03122223|521339775|FG001|Overall Study|Lost to Follow-up|2|||
144584760|NCT03122223|521339776|FG002|Overall Study|Lost to Follow-up|2|||
144584761|NCT03122223|521339777|FG003|Overall Study|Lost to Follow-up|0|||
144584762|NCT03122223|521339774|FG000|Overall Study|Participant unable to adhere|1|||
144584763|NCT03122223|521339775|FG001|Overall Study|Participant unable to adhere|1|||
144584764|NCT03122223|521339776|FG002|Overall Study|Participant unable to adhere|1|||
144584765|NCT03122223|521339777|FG003|Overall Study|Participant unable to adhere|0|||
144584766|NCT00291642|521339781|FG000|Overall Study|Adverse Event|1|||
144584767|NCT00291642|521339782|FG001|Overall Study|Adverse Event|0|||
144584768|NCT00291642|521339783|FG002|Overall Study|Adverse Event|1|||
144584769|NCT00291642|521339784|FG003|Overall Study|Adverse Event|0|||
144584770|NCT00291642|521339785|FG004|Overall Study|Adverse Event|1|||
144584771|NCT00291642|521339781|FG000|Overall Study|Patient missed visit|0|||
144584772|NCT00291642|521339782|FG001|Overall Study|Patient missed visit|0|||
144584773|NCT00291642|521339783|FG002|Overall Study|Patient missed visit|1|||
144584774|NCT00291642|521339784|FG003|Overall Study|Patient missed visit|0|||
144584775|NCT00291642|521339785|FG004|Overall Study|Patient missed visit|0|||
144584776|NCT00291642|521339781|FG000|Overall Study|Intake of prohibited medication|1|||
144584777|NCT00291642|521339782|FG001|Overall Study|Intake of prohibited medication|0|||
144584778|NCT00291642|521339783|FG002|Overall Study|Intake of prohibited medication|0|||
144584779|NCT00291642|521339784|FG003|Overall Study|Intake of prohibited medication|0|||
144584780|NCT00291642|521339785|FG004|Overall Study|Intake of prohibited medication|0|||
144584781|NCT01820585|521339786|FG000|Overall Study|Adverse Event|9|||
144584782|NCT01820585|521339787|FG001|Overall Study|Adverse Event|13|||
144209504|NCT00129389|519961903|FG001|Overall Study|Crossed to the other arm|16|||
144584783|NCT01820585|521339788|FG002|Overall Study|Adverse Event|23|||
144584784|NCT01820585|521339789|FG003|Overall Study|Adverse Event|34|||
144584785|NCT01820585|521339786|FG000|Overall Study|Lack of Efficacy|9|||
144209505|NCT02794246|519961907|FG000|Overall Study|Withdrawal by Subject|2|||
144209506|NCT02794246|519961907|FG000|Overall Study|Physician Decision|4|||
144209507|NCT00603837|519961908|FG000|Overall Study|Physician Decision|3|||
144209508|NCT00603837|519961909|FG001|Overall Study|Physician Decision|0|||
144209509|NCT00425373|519961971|FG000|Overall Study|Adverse Event|2|||
144584786|NCT01820585|521339787|FG001|Overall Study|Lack of Efficacy|7|||
144584787|NCT01820585|521339788|FG002|Overall Study|Lack of Efficacy|5|||
144584788|NCT01820585|521339789|FG003|Overall Study|Lack of Efficacy|1|||
144584789|NCT01820585|521339786|FG000|Overall Study|Withdrawal by Subject|3|||
144584790|NCT01820585|521339787|FG001|Overall Study|Withdrawal by Subject|7|||
144584791|NCT01820585|521339788|FG002|Overall Study|Withdrawal by Subject|3|||
144584792|NCT01820585|521339789|FG003|Overall Study|Withdrawal by Subject|8|||
144584793|NCT01820585|521339786|FG000|Overall Study|Lost to Follow-up|3|||
144584794|NCT01820585|521339787|FG001|Overall Study|Lost to Follow-up|3|||
144584795|NCT01820585|521339788|FG002|Overall Study|Lost to Follow-up|0|||
144584796|NCT01820585|521339789|FG003|Overall Study|Lost to Follow-up|3|||
144584797|NCT01820585|521339786|FG000|Overall Study|Protocol Violation|3|||
144584798|NCT01820585|521339787|FG001|Overall Study|Protocol Violation|1|||
144584799|NCT01820585|521339788|FG002|Overall Study|Protocol Violation|1|||
144584800|NCT01820585|521339789|FG003|Overall Study|Protocol Violation|1|||
144584801|NCT01820585|521339786|FG000|Overall Study|Subject non-compliance|0|||
144584802|NCT01820585|521339787|FG001|Overall Study|Subject non-compliance|0|||
144584803|NCT01820585|521339788|FG002|Overall Study|Subject non-compliance|1|||
144584804|NCT01820585|521339789|FG003|Overall Study|Subject non-compliance|2|||
144584805|NCT01820585|521339786|FG000|Overall Study|at sponsor request|0|||
144584806|NCT01820585|521339787|FG001|Overall Study|at sponsor request|0|||
144584807|NCT01820585|521339788|FG002|Overall Study|at sponsor request|1|||
144584808|NCT01820585|521339789|FG003|Overall Study|at sponsor request|0|||
144584809|NCT01820585|521339786|FG000|Overall Study|Pregnancy|0|||
144584810|NCT01820585|521339787|FG001|Overall Study|Pregnancy|1|||
144584811|NCT01820585|521339788|FG002|Overall Study|Pregnancy|0|||
144584812|NCT01820585|521339789|FG003|Overall Study|Pregnancy|0|||
144584813|NCT00548262|521339790|FG000|Overall Study|Death|21|||
144584814|NCT00548262|521339790|FG000|Overall Study|Adverse Event|2|||
144584815|NCT00548262|521339790|FG000|Overall Study|Lack of Efficacy|4|||
144584816|NCT00548262|521339790|FG000|Overall Study|Lost to Follow-up|1|||
144584817|NCT00548262|521339790|FG000|Overall Study|Other|3|||
144584818|NCT00548262|521339790|FG000|Overall Study|Withdrawal by Subject|1|||
144584819|NCT02544451|521339791|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
144584820|NCT02544451|521339792|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
144584821|NCT02544451|521339793|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
144584822|NCT02544451|521339794|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
144584823|NCT02544451|521339791|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
144584824|NCT02544451|521339792|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
144584825|NCT02544451|521339793|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
144584826|NCT02544451|521339794|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
144584827|NCT02544451|521339791|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
144584828|NCT02544451|521339792|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
144584829|NCT02544451|521339793|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
144584830|NCT02544451|521339794|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
144584831|NCT02544451|521339791|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
144584832|NCT02544451|521339792|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
144209510|NCT00425373|519961972|FG001|Overall Study|Adverse Event|2|||
144584833|NCT02544451|521339793|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
144584834|NCT02544451|521339794|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
144584835|NCT02544451|521339791|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
144584836|NCT02544451|521339792|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
144584837|NCT02544451|521339793|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
144584838|NCT02544451|521339794|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
144584839|NCT02544451|521339791|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
144584840|NCT02544451|521339792|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
144584841|NCT02544451|521339793|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
144584842|NCT02544451|521339794|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
144584843|NCT00948766|521339796|FG000|Core Study|Adverse Event|73|||
144584844|NCT00948766|521339797|FG001|Core Study|Adverse Event|51|||
144584845|NCT00948766|521339796|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
144584846|NCT00948766|521339797|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
144584847|NCT00948766|521339796|FG000|Core Study|Patient Withdrew Consent|27|||
144584848|NCT00948766|521339797|FG001|Core Study|Patient Withdrew Consent|46|||
144584849|NCT00948766|521339796|FG000|Core Study|Lost to Follow-up|3|||
144584850|NCT00948766|521339797|FG001|Core Study|Lost to Follow-up|2|||
144584851|NCT00948766|521339796|FG000|Core Study|Administrative Problems|2|||
144584852|NCT00948766|521339797|FG001|Core Study|Administrative Problems|2|||
144584853|NCT00948766|521339796|FG000|Core Study|Death|1|||
144209511|NCT00425373|519961973|FG002|Overall Study|Adverse Event|0|||
144209512|NCT00425373|519961974|FG003|Overall Study|Adverse Event|1|||
144584854|NCT00948766|521339797|FG001|Core Study|Death|1|||
144584855|NCT00948766|521339796|FG000|Core Study|Protocol Deviation|8|||
144584856|NCT00948766|521339797|FG001|Core Study|Protocol Deviation|10|||
144584857|NCT00948766|521339796|FG000|Extension Study|Adverse Event|43|||
144584858|NCT00948766|521339797|FG001|Extension Study|Adverse Event|0|||
144584859|NCT00948766|521339796|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
144584860|NCT00948766|521339797|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
144584861|NCT00948766|521339796|FG000|Extension Study|Study Drug No Longer Required|1|||
144584862|NCT00948766|521339797|FG001|Extension Study|Study Drug No Longer Required|0|||
144584863|NCT00948766|521339796|FG000|Extension Study|Patient Withdrew Consent|32|||
144584864|NCT00948766|521339797|FG001|Extension Study|Patient Withdrew Consent|0|||
144584865|NCT00948766|521339796|FG000|Extension Study|Lost to Follow-up|8|||
144584866|NCT00948766|521339797|FG001|Extension Study|Lost to Follow-up|0|||
144584867|NCT00948766|521339796|FG000|Extension Study|Administrative Problems|1|||
144584868|NCT00948766|521339797|FG001|Extension Study|Administrative Problems|0|||
144584869|NCT00948766|521339796|FG000|Extension Study|Death|4|||
144584870|NCT00948766|521339797|FG001|Extension Study|Death|0|||
144584871|NCT03590366|521339798|FG000|Overall Study|Adverse Event|0|||
144584872|NCT03590366|521339799|FG001|Overall Study|Adverse Event|3|||
144584873|NCT03590366|521339798|FG000|Overall Study|Lost to Follow-up|3|||
144584874|NCT03590366|521339799|FG001|Overall Study|Lost to Follow-up|3|||
144584875|NCT03590366|521339798|FG000|Overall Study|Withdrawal by Subject|0|||
144584876|NCT03590366|521339799|FG001|Overall Study|Withdrawal by Subject|2|||
144584877|NCT02656329|521339800|FG000|Overall Study|Lost to Follow-up|2|||
144584878|NCT02656329|521339801|FG001|Overall Study|Lost to Follow-up|3|||
144584879|NCT02656329|521339800|FG000|Overall Study|Withdrawal by Subject|7|||
144584880|NCT02656329|521339801|FG001|Overall Study|Withdrawal by Subject|6|||
144584881|NCT02656329|521339800|FG000|Overall Study|Study termination by Sponsor|150|||
144584882|NCT02656329|521339801|FG001|Overall Study|Study termination by Sponsor|142|||
144584883|NCT02656329|521339800|FG000|Overall Study|Other than specified above|5|||
144584884|NCT02656329|521339801|FG001|Overall Study|Other than specified above|6|||
144584885|NCT01081665|521339802|FG000|Overall Study|Death|41|||
144584886|NCT01081665|521339802|FG000|Overall Study|Lost to Follow-up|18|||
144584887|NCT01081665|521339802|FG000|Overall Study|Withdrawal by Subject|17|||
144584888|NCT01081665|521339802|FG000|Overall Study|Change of dialysis unit|10|||
144584889|NCT01081665|521339802|FG000|Overall Study|Regulation of iPTH|5|||
144584890|NCT01081665|521339802|FG000|Overall Study|Change in renal replacement therapy|2|||
144584891|NCT01081665|521339802|FG000|Overall Study|Adverse Event|1|||
144584892|NCT01081665|521339802|FG000|Overall Study|Lack of Efficacy|1|||
144584893|NCT03381339|521339814|FG000|Overall Study|Protocol Violation|4|||
144584894|NCT03381339|521339815|FG001|Overall Study|Protocol Violation|3|||
144584895|NCT03381339|521339814|FG000|Overall Study|Lost to Follow-up|0|||
144584896|NCT03381339|521339815|FG001|Overall Study|Lost to Follow-up|1|||
144584897|NCT01865747|521339818|FG000|Overall Study (ITT)|Adverse Event|32|||
144584898|NCT01865747|521339819|FG001|Overall Study (ITT)|Adverse Event|31|||
144584899|NCT01865747|521339818|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
144584900|NCT01865747|521339819|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
144584901|NCT01865747|521339818|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
144584902|NCT01865747|521339819|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
144584903|NCT01865747|521339818|FG000|Overall Study (ITT)|Protocol Violation|1|||
144584904|NCT01865747|521339819|FG001|Overall Study (ITT)|Protocol Violation|1|||
144584905|NCT01865747|521339818|FG000|Overall Study (ITT)|Physician Decision|5|||
144584906|NCT01865747|521339819|FG001|Overall Study (ITT)|Physician Decision|2|||
144584907|NCT01865747|521339818|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
144584908|NCT01865747|521339819|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
144584909|NCT01865747|521339818|FG000|Overall Study (ITT)|Sponsor Decision|0|||
144584910|NCT01865747|521339819|FG001|Overall Study (ITT)|Sponsor Decision|1|||
144623507|NCT03529773|521478624|FG031|Overall Study|Physician Decision|0|||
144623508|NCT03529773|521478625|FG032|Overall Study|Physician Decision|0|||
144623509|NCT03529773|521478626|FG033|Overall Study|Physician Decision|0|||
144623510|NCT03529773|521478627|FG034|Overall Study|Physician Decision|0|||
144623511|NCT03529773|521478628|FG035|Overall Study|Physician Decision|0|||
144584911|NCT01865747|521339818|FG000|Overall Study (ITT)|Progressive Disease|122|||
144584912|NCT01865747|521339819|FG001|Overall Study (ITT)|Progressive Disease|158|||
144584913|NCT01865747|521339818|FG000|Overall Study (ITT)|Reason Not Provided|0|||
144584914|NCT01865747|521339819|FG001|Overall Study (ITT)|Reason Not Provided|1|||
144584915|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
144623512|NCT03529773|521478629|FG036|Overall Study|Physician Decision|0|||
144623513|NCT03529773|521478630|FG037|Overall Study|Physician Decision|0|||
144623514|NCT03529773|521478631|FG038|Overall Study|Physician Decision|0|||
144584916|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
144584917|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
144584918|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
144584919|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
144584920|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
144584921|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
144623515|NCT03529773|521478632|FG039|Overall Study|Physician Decision|0|||
144209513|NCT00425373|519961975|FG004|Overall Study|Adverse Event|4|||
144209514|NCT00425373|519961976|FG005|Overall Study|Adverse Event|6|||
144209515|NCT00425373|519961977|FG006|Overall Study|Adverse Event|2|||
144209516|NCT00425373|519961978|FG007|Overall Study|Adverse Event|3|||
144209517|NCT00425373|519961979|FG008|Overall Study|Adverse Event|8|||
144209518|NCT00425373|519961971|FG000|Overall Study|Lost to Follow-up|0|||
144584922|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
144584923|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
144584924|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
144584925|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
144584926|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
144584927|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
144584928|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
144584929|NCT01865747|521339818|FG000|Primary Intent to Treat (PITT)|Other|0|||
144584930|NCT01865747|521339819|FG001|Primary Intent to Treat (PITT)|Other|1|||
144584931|NCT03973931|521339820|FG000|Overall Study|Lost to Follow-up|47|||
144584932|NCT03973931|521339821|FG001|Overall Study|Lost to Follow-up|63|||
144584933|NCT03973931|521339822|FG002|Overall Study|Lost to Follow-up|51|||
144584934|NCT03973931|521339823|FG003|Overall Study|Lost to Follow-up|54|||
144584935|NCT03973931|521339820|FG000|Overall Study|opted out|6|||
144584936|NCT03973931|521339821|FG001|Overall Study|opted out|5|||
144584937|NCT03973931|521339822|FG002|Overall Study|opted out|5|||
144584938|NCT03973931|521339823|FG003|Overall Study|opted out|1|||
144584939|NCT01022112|521339824|FG000|Overall Study|Adverse Event|1|||
144584940|NCT01022112|521339825|FG001|Overall Study|Adverse Event|2|||
144584941|NCT01022112|521339826|FG002|Overall Study|Adverse Event|0|||
144623516|NCT03529773|521478593|FG000|Overall Study|Protocol Violation|0|||
144584942|NCT01022112|521339827|FG003|Overall Study|Adverse Event|1|||
144584943|NCT01022112|521339828|FG004|Overall Study|Adverse Event|0|||
144584944|NCT01022112|521339824|FG000|Overall Study|Lack of Efficacy|1|||
144584945|NCT01022112|521339825|FG001|Overall Study|Lack of Efficacy|0|||
144584946|NCT01022112|521339826|FG002|Overall Study|Lack of Efficacy|0|||
144584947|NCT01022112|521339827|FG003|Overall Study|Lack of Efficacy|0|||
144584948|NCT01022112|521339828|FG004|Overall Study|Lack of Efficacy|1|||
144584949|NCT01022112|521339824|FG000|Overall Study|Physician Decision|0|||
144584950|NCT01022112|521339825|FG001|Overall Study|Physician Decision|0|||
144584951|NCT01022112|521339826|FG002|Overall Study|Physician Decision|1|||
144584952|NCT01022112|521339827|FG003|Overall Study|Physician Decision|0|||
144584953|NCT01022112|521339828|FG004|Overall Study|Physician Decision|1|||
144584954|NCT01022112|521339824|FG000|Overall Study|Withdrawal by Subject|0|||
144584955|NCT01022112|521339825|FG001|Overall Study|Withdrawal by Subject|1|||
144584956|NCT01022112|521339826|FG002|Overall Study|Withdrawal by Subject|2|||
144584957|NCT01022112|521339827|FG003|Overall Study|Withdrawal by Subject|2|||
144584958|NCT01022112|521339828|FG004|Overall Study|Withdrawal by Subject|1|||
144584959|NCT01022112|521339824|FG000|Overall Study|Fasting plasma glucose level increased|1|||
144584960|NCT01022112|521339825|FG001|Overall Study|Fasting plasma glucose level increased|0|||
144584961|NCT01022112|521339826|FG002|Overall Study|Fasting plasma glucose level increased|0|||
144584962|NCT01022112|521339827|FG003|Overall Study|Fasting plasma glucose level increased|0|||
144584963|NCT01022112|521339828|FG004|Overall Study|Fasting plasma glucose level increased|7|||
144584964|NCT01982448|521339829|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
144584965|NCT01982448|521339830|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
144584966|NCT01982448|521339829|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
144584967|NCT01982448|521339830|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
144584968|NCT01982448|521339829|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
144584969|NCT01982448|521339830|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
144584970|NCT01982448|521339829|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
144584971|NCT01982448|521339830|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
144584972|NCT04988867|521341205|FG000|Overall Study|Study terminated by Sponsor|12|||
144623517|NCT03529773|521478594|FG001|Overall Study|Protocol Violation|0|||
144209519|NCT00425373|519961972|FG001|Overall Study|Lost to Follow-up|1|||
144209520|NCT00425373|519961973|FG002|Overall Study|Lost to Follow-up|0|||
144209521|NCT00425373|519961974|FG003|Overall Study|Lost to Follow-up|0|||
144209522|NCT00425373|519961975|FG004|Overall Study|Lost to Follow-up|1|||
144584973|NCT04988867|521341205|FG000|Overall Study|Adverse Event|2|||
144584974|NCT04988867|521341205|FG000|Overall Study|Study drug noncompliance|1|||
144584975|NCT01327495|521341206|FG000|Overall Study|Adverse Event|2|||
144623518|NCT03529773|521478595|FG002|Overall Study|Protocol Violation|0|||
144209523|NCT00425373|519961976|FG005|Overall Study|Lost to Follow-up|0|||
144209524|NCT00425373|519961977|FG006|Overall Study|Lost to Follow-up|0|||
144209525|NCT00425373|519961978|FG007|Overall Study|Lost to Follow-up|0|||
144584976|NCT01327495|521341207|FG001|Overall Study|Adverse Event|1|||
144584977|NCT01327495|521341208|FG002|Overall Study|Adverse Event|1|||
144584978|NCT01327495|521341209|FG003|Overall Study|Adverse Event|0|||
144584979|NCT01327495|521341210|FG004|Overall Study|Adverse Event|0|||
144584980|NCT01327495|521341211|FG005|Overall Study|Adverse Event|2|||
144584981|NCT01327495|521341206|FG000|Overall Study|Withdrawal by Subject|0|||
144623519|NCT03529773|521478596|FG003|Overall Study|Protocol Violation|0|||
144623520|NCT03529773|521478597|FG004|Overall Study|Protocol Violation|0|||
144623521|NCT03529773|521478598|FG005|Overall Study|Protocol Violation|0|||
144623522|NCT03529773|521478599|FG006|Overall Study|Protocol Violation|0|||
144623523|NCT03529773|521478600|FG007|Overall Study|Protocol Violation|0|||
144623524|NCT03529773|521478601|FG008|Overall Study|Protocol Violation|0|||
144623525|NCT03529773|521478602|FG009|Overall Study|Protocol Violation|0|||
144623526|NCT03529773|521478603|FG010|Overall Study|Protocol Violation|0|||
144623527|NCT03529773|521478604|FG011|Overall Study|Protocol Violation|0|||
144623528|NCT03529773|521478605|FG012|Overall Study|Protocol Violation|0|||
144623529|NCT03529773|521478606|FG013|Overall Study|Protocol Violation|0|||
144623530|NCT03529773|521478607|FG014|Overall Study|Protocol Violation|0|||
144623531|NCT03529773|521478608|FG015|Overall Study|Protocol Violation|0|||
144623532|NCT03529773|521478609|FG016|Overall Study|Protocol Violation|0|||
144623533|NCT03529773|521478610|FG017|Overall Study|Protocol Violation|0|||
144623534|NCT03529773|521478611|FG018|Overall Study|Protocol Violation|0|||
144623535|NCT03529773|521478612|FG019|Overall Study|Protocol Violation|0|||
144623536|NCT03529773|521478613|FG020|Overall Study|Protocol Violation|0|||
144623537|NCT03529773|521478614|FG021|Overall Study|Protocol Violation|0|||
144584982|NCT01327495|521341207|FG001|Overall Study|Withdrawal by Subject|1|||
144584983|NCT01327495|521341208|FG002|Overall Study|Withdrawal by Subject|1|||
144584984|NCT01327495|521341209|FG003|Overall Study|Withdrawal by Subject|0|||
144584985|NCT01327495|521341210|FG004|Overall Study|Withdrawal by Subject|1|||
144584986|NCT01327495|521341211|FG005|Overall Study|Withdrawal by Subject|0|||
144584987|NCT01327495|521341206|FG000|Overall Study|Physician Decision|0|||
144584988|NCT01327495|521341207|FG001|Overall Study|Physician Decision|0|||
144584989|NCT01327495|521341208|FG002|Overall Study|Physician Decision|0|||
144584990|NCT01327495|521341209|FG003|Overall Study|Physician Decision|0|||
144584991|NCT01327495|521341210|FG004|Overall Study|Physician Decision|2|||
144584992|NCT01327495|521341211|FG005|Overall Study|Physician Decision|0|||
144584993|NCT01151410|521341214|FG000|Overall Study|Withdrawal by Subject|3|||
144584994|NCT01151410|521341215|FG001|Overall Study|Withdrawal by Subject|5|||
144584995|NCT01151410|521341214|FG000|Overall Study|Lost to Follow-up|3|||
144584996|NCT01151410|521341215|FG001|Overall Study|Lost to Follow-up|4|||
144584997|NCT01151410|521341214|FG000|Overall Study|Adverse Event|1|||
144584998|NCT01151410|521341215|FG001|Overall Study|Adverse Event|2|||
144584999|NCT01151410|521341214|FG000|Overall Study|Protocol deviation|2|||
144585000|NCT01151410|521341215|FG001|Overall Study|Protocol deviation|1|||
144585001|NCT01151410|521341214|FG000|Overall Study|Administrative problems|1|||
144585002|NCT01151410|521341215|FG001|Overall Study|Administrative problems|1|||
144585003|NCT01151410|521341214|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144585004|NCT01151410|521341215|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144585005|NCT01151410|521341214|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144585006|NCT01151410|521341215|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144585007|NCT00735475|521341216|FG000|Overall Study|Adverse Event|0|||
144585008|NCT00735475|521341217|FG001|Overall Study|Adverse Event|1|||
144585009|NCT00735475|521341216|FG000|Overall Study|Death|1|||
144585010|NCT00735475|521341217|FG001|Overall Study|Death|1|||
144585011|NCT00735475|521341216|FG000|Overall Study|Lost to Follow-up|3|||
144585012|NCT00735475|521341217|FG001|Overall Study|Lost to Follow-up|3|||
144585013|NCT00735475|521341216|FG000|Overall Study|Physician Decision|0|||
144585014|NCT00735475|521341217|FG001|Overall Study|Physician Decision|1|||
144585015|NCT00735475|521341216|FG000|Overall Study|Withdrawal by Subject|4|||
144585016|NCT00735475|521341217|FG001|Overall Study|Withdrawal by Subject|5|||
144585017|NCT01712659|521341218|FG000|Dose Escalation|Physician Decision|0|||
144585018|NCT01712659|521341219|FG001|Dose Escalation|Physician Decision|1|||
144585019|NCT01712659|521341220|FG002|Dose Escalation|Physician Decision|0|||
144585020|NCT01712659|521341221|FG003|Dose Escalation|Physician Decision|0|||
144623538|NCT03529773|521478615|FG022|Overall Study|Protocol Violation|0|||
144623539|NCT03529773|521478616|FG023|Overall Study|Protocol Violation|0|||
144623540|NCT03529773|521478617|FG024|Overall Study|Protocol Violation|0|||
144623541|NCT03529773|521478618|FG025|Overall Study|Protocol Violation|0|||
144623542|NCT03529773|521478619|FG026|Overall Study|Protocol Violation|0|||
144623543|NCT03529773|521478620|FG027|Overall Study|Protocol Violation|0|||
144623544|NCT03529773|521478621|FG028|Overall Study|Protocol Violation|0|||
144623545|NCT03529773|521478622|FG029|Overall Study|Protocol Violation|0|||
144585021|NCT01712659|521341222|FG004|Dose Escalation|Physician Decision|0|||
144585022|NCT01712659|521341218|FG000|Dose Escalation|Unable to take study drug|0|||
144623546|NCT03529773|521478623|FG030|Overall Study|Protocol Violation|1|||
144623547|NCT03529773|521478624|FG031|Overall Study|Protocol Violation|0|||
144623548|NCT03529773|521478625|FG032|Overall Study|Protocol Violation|0|||
144623549|NCT03529773|521478626|FG033|Overall Study|Protocol Violation|0|||
144623550|NCT03529773|521478627|FG034|Overall Study|Protocol Violation|0|||
144623551|NCT03529773|521478628|FG035|Overall Study|Protocol Violation|0|||
144585023|NCT01712659|521341219|FG001|Dose Escalation|Unable to take study drug|1|||
144585024|NCT01712659|521341220|FG002|Dose Escalation|Unable to take study drug|0|||
144585025|NCT01712659|521341221|FG003|Dose Escalation|Unable to take study drug|0|||
144585026|NCT01712659|521341222|FG004|Dose Escalation|Unable to take study drug|0|||
144623552|NCT03529773|521478629|FG036|Overall Study|Protocol Violation|0|||
144730471|NCT01179048|521869788|FG001|Overall Study|Withdrawn - does not allow contact|8|||
144730472|NCT01179048|521869787|FG000|Overall Study|Lost to Follow-up|8|||
144730473|NCT01179048|521869788|FG001|Overall Study|Lost to Follow-up|9|||
144730474|NCT01179048|521869787|FG000|Overall Study|Alive|127|||
144585027|NCT01712659|521341218|FG000|Dose Expansion|Early disease progression|1|||
144585028|NCT01712659|521341219|FG001|Dose Expansion|Early disease progression|0|||
144585029|NCT01712659|521341220|FG002|Dose Expansion|Early disease progression|0|||
144585030|NCT01712659|521341221|FG003|Dose Expansion|Early disease progression|0|||
144585031|NCT01712659|521341222|FG004|Dose Expansion|Early disease progression|0|||
144585032|NCT01712659|521341218|FG000|Dose Expansion|Physician Decision|1|||
144585033|NCT01712659|521341219|FG001|Dose Expansion|Physician Decision|0|||
144585034|NCT01712659|521341220|FG002|Dose Expansion|Physician Decision|0|||
144585035|NCT01712659|521341221|FG003|Dose Expansion|Physician Decision|0|||
144585036|NCT01712659|521341222|FG004|Dose Expansion|Physician Decision|0|||
144585037|NCT00844532|521341231|FG000|Overall Study|Death|16|||
144585038|NCT00844532|521341231|FG000|Overall Study|Withdrawal by Subject|16|||
144585039|NCT00844532|521341231|FG000|Overall Study|Lost to Follow-up|7|||
144585040|NCT03189745|521341232|FG000|Overall Study|Conflict in work schedule of participant|1|||
144585041|NCT03189745|521341233|FG001|Overall Study|Conflict in work schedule of participant|1|||
144585042|NCT05086276|521341234|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
144585043|NCT05086276|521341235|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
144585044|NCT00738894|521341237|FG000|Overall Study|Lost to Follow-up|23|||
144585045|NCT00738894|521341238|FG001|Overall Study|Lost to Follow-up|13|||
144585046|NCT00738894|521341237|FG000|Overall Study|Withdrawal by Subject|10|||
144585047|NCT00738894|521341238|FG001|Overall Study|Withdrawal by Subject|15|||
144585048|NCT00738894|521341237|FG000|Overall Study|Physician Decision|4|||
144585049|NCT00738894|521341238|FG001|Overall Study|Physician Decision|5|||
144585050|NCT00738894|521341237|FG000|Overall Study|Death|2|||
144585051|NCT00738894|521341238|FG001|Overall Study|Death|0|||
144585052|NCT05017103|521341239|FG000|Overall Study|Death|2|||
144585053|NCT01747551|521341243|FG000|Overall Study|Progressive Disease|24|||
144585054|NCT01747551|521341244|FG001|Overall Study|Progressive Disease|17|||
144585055|NCT01747551|521341243|FG000|Overall Study|Death|3|||
144585056|NCT01747551|521341244|FG001|Overall Study|Death|1|||
144585057|NCT01747551|521341243|FG000|Overall Study|Adverse Event|7|||
144585058|NCT01747551|521341244|FG001|Overall Study|Adverse Event|1|||
144585059|NCT01747551|521341243|FG000|Overall Study|Prolonged Treatment Delay|2|||
144585060|NCT01747551|521341244|FG001|Overall Study|Prolonged Treatment Delay|0|||
144585061|NCT01747551|521341243|FG000|Overall Study|Withdrawal by Subject|3|||
144585062|NCT01747551|521341244|FG001|Overall Study|Withdrawal by Subject|1|||
144730475|NCT01179048|521869788|FG001|Overall Study|Alive|142|||
144585063|NCT01747551|521341243|FG000|Overall Study|Physician Decision|2|||
144585064|NCT01747551|521341244|FG001|Overall Study|Physician Decision|1|||
144585065|NCT01747551|521341243|FG000|Overall Study|Other|2|||
144585066|NCT01747551|521341244|FG001|Overall Study|Other|0|||
144585067|NCT02091206|521341245|FG000|Treatment Period|Adverse Event|0|||
144585068|NCT02091206|521341246|FG001|Treatment Period|Adverse Event|1|||
144585069|NCT02091206|521341247|FG002|Treatment Period|Adverse Event|0|||
144585070|NCT02091206|521341248|FG003|Treatment Period|Adverse Event|0|||
144585071|NCT02091206|521341245|FG000|Treatment Period|Met withdrawal criteria|0|||
144585072|NCT02091206|521341246|FG001|Treatment Period|Met withdrawal criteria|0|||
144585073|NCT02091206|521341247|FG002|Treatment Period|Met withdrawal criteria|1|||
144585074|NCT02091206|521341248|FG003|Treatment Period|Met withdrawal criteria|0|||
144585075|NCT02091206|521341245|FG000|Taper Period|Participant refused study drug|1|||
144585076|NCT02091206|521341246|FG001|Taper Period|Participant refused study drug|0|||
144585077|NCT02091206|521341247|FG002|Taper Period|Participant refused study drug|0|||
144585078|NCT02091206|521341248|FG003|Taper Period|Participant refused study drug|1|||
144585079|NCT02091206|521341245|FG000|Taper Period|Lost to Follow-up|0|||
144585080|NCT02091206|521341246|FG001|Taper Period|Lost to Follow-up|0|||
144585081|NCT02091206|521341247|FG002|Taper Period|Lost to Follow-up|0|||
144585082|NCT02091206|521341248|FG003|Taper Period|Lost to Follow-up|1|||
144730476|NCT02109042|521869789|FG000|Overall Study|Sponsor Decision|15|||
144730477|NCT03203447|521869790|FG000|Overall Study|Withdrawal by Subject|2|||
144730478|NCT03203447|521869791|FG001|Overall Study|Withdrawal by Subject|1|||
144585083|NCT03117998|521341254|FG000|Overall Study|Adverse Event|1|||
144730479|NCT03203447|521869790|FG000|Overall Study|Lost to Follow-up|1|||
144585084|NCT03117998|521341255|FG001|Overall Study|Adverse Event|0|||
144585085|NCT03117998|521341256|FG002|Overall Study|Adverse Event|0|||
144585086|NCT03117998|521341257|FG003|Overall Study|Adverse Event|0|||
144585087|NCT03117998|521341258|FG004|Overall Study|Adverse Event|0|||
144585088|NCT03117998|521341259|FG005|Overall Study|Adverse Event|0|||
144730480|NCT03203447|521869791|FG001|Overall Study|Lost to Follow-up|10|||
144730481|NCT03203447|521869790|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
144585089|NCT03117998|521341254|FG000|Overall Study|Withdrawal by Subject|0|||
144585090|NCT03117998|521341255|FG001|Overall Study|Withdrawal by Subject|0|||
144585091|NCT03117998|521341256|FG002|Overall Study|Withdrawal by Subject|2|||
144585092|NCT03117998|521341257|FG003|Overall Study|Withdrawal by Subject|3|||
144585093|NCT03117998|521341258|FG004|Overall Study|Withdrawal by Subject|3|||
144585094|NCT03117998|521341259|FG005|Overall Study|Withdrawal by Subject|0|||
144585095|NCT03117998|521341254|FG000|Overall Study|Physician Decision|0|||
144585096|NCT03117998|521341255|FG001|Overall Study|Physician Decision|1|||
144585097|NCT03117998|521341256|FG002|Overall Study|Physician Decision|1|||
144585098|NCT03117998|521341257|FG003|Overall Study|Physician Decision|0|||
144585099|NCT03117998|521341258|FG004|Overall Study|Physician Decision|0|||
144585100|NCT03117998|521341259|FG005|Overall Study|Physician Decision|0|||
144585101|NCT03117998|521341254|FG000|Overall Study|Lost to Follow-up|0|||
144585102|NCT03117998|521341255|FG001|Overall Study|Lost to Follow-up|0|||
144585103|NCT03117998|521341256|FG002|Overall Study|Lost to Follow-up|0|||
144585104|NCT03117998|521341257|FG003|Overall Study|Lost to Follow-up|1|||
144585105|NCT03117998|521341258|FG004|Overall Study|Lost to Follow-up|4|||
144585106|NCT03117998|521341259|FG005|Overall Study|Lost to Follow-up|0|||
144585107|NCT03117998|521341254|FG000|Overall Study|Subject noncompliance|0|||
144585108|NCT03117998|521341255|FG001|Overall Study|Subject noncompliance|0|||
144585109|NCT03117998|521341256|FG002|Overall Study|Subject noncompliance|1|||
144585110|NCT03117998|521341257|FG003|Overall Study|Subject noncompliance|0|||
144585111|NCT03117998|521341258|FG004|Overall Study|Subject noncompliance|0|||
144585112|NCT03117998|521341259|FG005|Overall Study|Subject noncompliance|2|||
144585113|NCT03117998|521341254|FG000|Overall Study|Protocol Violation|0|||
144585114|NCT03117998|521341255|FG001|Overall Study|Protocol Violation|0|||
144585115|NCT03117998|521341256|FG002|Overall Study|Protocol Violation|0|||
144585116|NCT03117998|521341257|FG003|Overall Study|Protocol Violation|0|||
144585117|NCT03117998|521341258|FG004|Overall Study|Protocol Violation|0|||
144585118|NCT03117998|521341259|FG005|Overall Study|Protocol Violation|1|||
144585119|NCT01468181|521341260|FG000|Overall Study|Adverse Event|8|||
144585120|NCT01468181|521341261|FG001|Overall Study|Adverse Event|1|||
144585121|NCT01468181|521341262|FG002|Overall Study|Adverse Event|6|||
144585122|NCT01468181|521341263|FG003|Overall Study|Adverse Event|2|||
144585123|NCT01468181|521341264|FG004|Overall Study|Adverse Event|2|||
144585124|NCT01468181|521341260|FG000|Overall Study|Protocol Violation|2|||
144585125|NCT01468181|521341261|FG001|Overall Study|Protocol Violation|0|||
144585126|NCT01468181|521341262|FG002|Overall Study|Protocol Violation|1|||
144585127|NCT01468181|521341263|FG003|Overall Study|Protocol Violation|0|||
144585128|NCT01468181|521341264|FG004|Overall Study|Protocol Violation|1|||
144585129|NCT01468181|521341260|FG000|Overall Study|Physician Decision|0|||
144585130|NCT01468181|521341261|FG001|Overall Study|Physician Decision|0|||
144585131|NCT01468181|521341262|FG002|Overall Study|Physician Decision|0|||
144585132|NCT01468181|521341263|FG003|Overall Study|Physician Decision|1|||
144585133|NCT01468181|521341264|FG004|Overall Study|Physician Decision|1|||
144585134|NCT01468181|521341260|FG000|Overall Study|Lost to Follow-up|0|||
144585135|NCT01468181|521341261|FG001|Overall Study|Lost to Follow-up|0|||
144585136|NCT01468181|521341262|FG002|Overall Study|Lost to Follow-up|1|||
144585137|NCT01468181|521341263|FG003|Overall Study|Lost to Follow-up|0|||
144585138|NCT01468181|521341264|FG004|Overall Study|Lost to Follow-up|1|||
144585139|NCT01468181|521341260|FG000|Overall Study|Withdrawal by Subject|0|||
144585140|NCT01468181|521341261|FG001|Overall Study|Withdrawal by Subject|1|||
144585141|NCT01468181|521341262|FG002|Overall Study|Withdrawal by Subject|0|||
144585142|NCT01468181|521341263|FG003|Overall Study|Withdrawal by Subject|0|||
144585143|NCT01468181|521341264|FG004|Overall Study|Withdrawal by Subject|0|||
144585144|NCT04664400|521341265|FG000|Overall Study|Withdrawal by Subject|2|||
144585145|NCT01011153|521341268|FG000|Overall Study|Less than 78 cases completed|8|||
144585146|NCT01011153|521341269|FG001|Overall Study|Less than 78 cases completed|11|||
144585147|NCT01011153|521341270|FG002|Overall Study|Less than 78 cases completed|9|||
144585148|NCT01081132|521341273|FG000|Overall Study|Lack of Efficacy|25|||
144585149|NCT01081132|521341274|FG001|Overall Study|Lack of Efficacy|9|||
144585150|NCT01081132|521341273|FG000|Overall Study|Withdrawal by Subject|13|||
144585151|NCT01081132|521341274|FG001|Overall Study|Withdrawal by Subject|16|||
144585152|NCT01081132|521341273|FG000|Overall Study|Lost to Follow-up|4|||
144585153|NCT01081132|521341274|FG001|Overall Study|Lost to Follow-up|11|||
144585154|NCT01081132|521341273|FG000|Overall Study|Adverse Event|3|||
144730482|NCT03203447|521869791|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
144730483|NCT00324168|521869792|FG000|Overall Study|Lost to Follow-up|19|||
144730484|NCT00324168|521869793|FG001|Overall Study|Lost to Follow-up|18|||
144730485|NCT00324168|521869792|FG000|Overall Study|Death|3|||
144730486|NCT00324168|521869793|FG001|Overall Study|Death|3|||
144730487|NCT00324168|521869792|FG000|Overall Study|Patient did not visit in f/u window|6|||
144730488|NCT00324168|521869793|FG001|Overall Study|Patient did not visit in f/u window|9|||
144730489|NCT01203878|521869794|FG000|Overall Study|Withdrawal by Subject|0|||
144730490|NCT01203878|521869795|FG001|Overall Study|Withdrawal by Subject|0|||
144730491|NCT01203878|521869796|FG002|Overall Study|Withdrawal by Subject|1|||
144730492|NCT01203878|521869794|FG000|Overall Study|Adverse Event|0|||
144262897|NCT01716806|520163779|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
144730493|NCT01203878|521869795|FG001|Overall Study|Adverse Event|0|||
144585155|NCT01081132|521341274|FG001|Overall Study|Adverse Event|9|||
144585156|NCT01081132|521341273|FG000|Overall Study|Non Compliance|4|||
144585157|NCT01081132|521341274|FG001|Overall Study|Non Compliance|2|||
144585158|NCT01081132|521341273|FG000|Overall Study|Lack Of Compliance|0|||
144585159|NCT01081132|521341274|FG001|Overall Study|Lack Of Compliance|1|||
144585160|NCT01081132|521341273|FG000|Overall Study|Missed Visits|1|||
144585161|NCT01081132|521341274|FG001|Overall Study|Missed Visits|1|||
144585162|NCT01081132|521341273|FG000|Overall Study|Stopped Taking Meds|2|||
144585163|NCT01081132|521341274|FG001|Overall Study|Stopped Taking Meds|0|||
144585164|NCT01081132|521341273|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
144585165|NCT01081132|521341274|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
144585166|NCT01081132|521341273|FG000|Overall Study|Declined Taper Phase|0|||
144585167|NCT01081132|521341274|FG001|Overall Study|Declined Taper Phase|1|||
144585168|NCT01081132|521341273|FG000|Overall Study|Protocol Violation|3|||
144585169|NCT01081132|521341274|FG001|Overall Study|Protocol Violation|1|||
144585170|NCT02297139|521341275|FG000|Overall Study|Disease progression|0|||
144585171|NCT02297139|521341276|FG001|Overall Study|Disease progression|1|||
144585172|NCT02297139|521341275|FG000|Overall Study|Study drug toxicity|0|||
144585173|NCT02297139|521341276|FG001|Overall Study|Study drug toxicity|4|||
144585174|NCT02297139|521341275|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144585175|NCT02297139|521341276|FG001|Overall Study|Participant request to discontinue study treatment|1|||
144585176|NCT02297139|521341275|FG000|Overall Study|Maximum clinical benefit|1|||
144585177|NCT02297139|521341276|FG001|Overall Study|Maximum clinical benefit|0|||
144585178|NCT02297139|521341275|FG000|Overall Study|Administrative reason by sponsor|0|||
144585179|NCT02297139|521341276|FG001|Overall Study|Administrative reason by sponsor|2|||
144585180|NCT02297139|521341275|FG000|Overall Study|Other reasons|0|||
144585181|NCT02297139|521341276|FG001|Overall Study|Other reasons|8|||
144585182|NCT02101385|521341279|FG000|Study Treatment|Disease Progression|9|||
144585183|NCT02101385|521341280|FG001|Study Treatment|Disease Progression|3|||
144585184|NCT02101385|521341279|FG000|Study Treatment|Alternative therapy|0|||
144585185|NCT02101385|521341280|FG001|Study Treatment|Alternative therapy|1|||
144585186|NCT02101385|521341279|FG000|Study Treatment|No treatment, per protocol criteria|0|||
144585187|NCT02101385|521341280|FG001|Study Treatment|No treatment, per protocol criteria|4|||
144585188|NCT02101385|521341279|FG000|Study Treatment|Patient Non compliance|0|||
144585189|NCT02101385|521341280|FG001|Study Treatment|Patient Non compliance|2|||
144585190|NCT02101385|521341279|FG000|Study Treatment|Withdrawal by Subject|5|||
144585191|NCT02101385|521341280|FG001|Study Treatment|Withdrawal by Subject|2|||
144585192|NCT02101385|521341279|FG000|Study Treatment|screen failure|1|||
144585193|NCT02101385|521341280|FG001|Study Treatment|screen failure|0|||
144585194|NCT02101385|521341279|FG000|Study Treatment|AE/Side Effects/Complications|8|||
144585195|NCT02101385|521341280|FG001|Study Treatment|AE/Side Effects/Complications|0|||
144585196|NCT02101385|521341279|FG000|Study Treatment|Lost to Follow-up|1|||
144585197|NCT02101385|521341280|FG001|Study Treatment|Lost to Follow-up|0|||
144585198|NCT02101385|521341279|FG000|Study Treatment|Disease Progression before treatment|1|||
144585199|NCT02101385|521341280|FG001|Study Treatment|Disease Progression before treatment|0|||
144585200|NCT02101385|521341279|FG000|Study Treatment|Death|1|||
144585201|NCT02101385|521341280|FG001|Study Treatment|Death|0|||
144585202|NCT02101385|521341279|FG000|Follow up|Lost to Follow-up|4|||
144585203|NCT02101385|521341280|FG001|Follow up|Lost to Follow-up|9|||
144585204|NCT02101385|521341279|FG000|Follow up|Refused to follow up|5|||
144585205|NCT02101385|521341280|FG001|Follow up|Refused to follow up|4|||
144585206|NCT02101385|521341279|FG000|Follow up|Death|21|||
144585207|NCT02101385|521341280|FG001|Follow up|Death|39|||
144585208|NCT02101385|521341279|FG000|Follow up|study completed|33|||
144585209|NCT02101385|521341280|FG001|Follow up|study completed|52|||
144585210|NCT02101385|521341279|FG000|Follow up|screen failure|2|||
144585211|NCT02101385|521341280|FG001|Follow up|screen failure|0|||
144585212|NCT02101385|521341279|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
144585213|NCT02101385|521341280|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
144585214|NCT02101385|521341279|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
144585215|NCT02101385|521341280|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
144585216|NCT02101385|521341279|FG000|Follow up|Withdrawal by Subject|2|||
144585217|NCT02101385|521341280|FG001|Follow up|Withdrawal by Subject|2|||
144585218|NCT02101385|521341279|FG000|Follow up|PI requested closure of site|0|||
144585219|NCT02101385|521341280|FG001|Follow up|PI requested closure of site|5|||
144585220|NCT02432196|521341281|FG000|Overall Study|Exit - did not receive study device|1|||
144585221|NCT02432196|521341281|FG000|Overall Study|Death|2|||
144585222|NCT02432196|521341281|FG000|Overall Study|Reoperation|3|||
144585223|NCT01905150|521341283|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
144623553|NCT03529773|521478630|FG037|Overall Study|Protocol Violation|0|||
144585224|NCT01905150|521341284|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
144585225|NCT03738423|521341289|FG000|Overall Study|Withdrawal by Subject|9|||
144585226|NCT03738423|521341290|FG001|Overall Study|Withdrawal by Subject|12|||
144585227|NCT03738423|521341291|FG002|Overall Study|Withdrawal by Subject|9|||
144623554|NCT03529773|521478631|FG038|Overall Study|Protocol Violation|0|||
144585228|NCT03738423|521341292|FG003|Overall Study|Withdrawal by Subject|12|||
144585229|NCT03738423|521341293|FG004|Overall Study|Withdrawal by Subject|10|||
144585230|NCT03738423|521341289|FG000|Overall Study|Lack of Efficacy|3|||
144585231|NCT03738423|521341290|FG001|Overall Study|Lack of Efficacy|1|||
144585232|NCT03738423|521341291|FG002|Overall Study|Lack of Efficacy|1|||
144585233|NCT03738423|521341292|FG003|Overall Study|Lack of Efficacy|1|||
144585234|NCT03738423|521341293|FG004|Overall Study|Lack of Efficacy|2|||
144585235|NCT03738423|521341289|FG000|Overall Study|Lost to Follow-up|1|||
144585236|NCT03738423|521341290|FG001|Overall Study|Lost to Follow-up|0|||
144585237|NCT03738423|521341291|FG002|Overall Study|Lost to Follow-up|1|||
144585238|NCT03738423|521341292|FG003|Overall Study|Lost to Follow-up|1|||
144585239|NCT03738423|521341293|FG004|Overall Study|Lost to Follow-up|0|||
144585240|NCT03738423|521341289|FG000|Overall Study|Protocol Violation|1|||
144585241|NCT03738423|521341290|FG001|Overall Study|Protocol Violation|0|||
144585242|NCT03738423|521341291|FG002|Overall Study|Protocol Violation|0|||
144585243|NCT03738423|521341292|FG003|Overall Study|Protocol Violation|0|||
144585244|NCT03738423|521341293|FG004|Overall Study|Protocol Violation|1|||
144585245|NCT03738423|521341289|FG000|Overall Study|Physician Decision|0|||
144585246|NCT03738423|521341290|FG001|Overall Study|Physician Decision|0|||
144585247|NCT03738423|521341291|FG002|Overall Study|Physician Decision|1|||
144585248|NCT03738423|521341292|FG003|Overall Study|Physician Decision|0|||
144585249|NCT03738423|521341293|FG004|Overall Study|Physician Decision|1|||
144585250|NCT03738423|521341289|FG000|Overall Study|Death|0|||
144585251|NCT03738423|521341290|FG001|Overall Study|Death|0|||
144585252|NCT03738423|521341291|FG002|Overall Study|Death|0|||
144585253|NCT03738423|521341292|FG003|Overall Study|Death|0|||
144585254|NCT03738423|521341293|FG004|Overall Study|Death|1|||
144585255|NCT03738423|521341289|FG000|Overall Study|Randomized but never treated|0|||
144585256|NCT03738423|521341290|FG001|Overall Study|Randomized but never treated|0|||
144585257|NCT03738423|521341291|FG002|Overall Study|Randomized but never treated|1|||
144585258|NCT03738423|521341292|FG003|Overall Study|Randomized but never treated|1|||
144585259|NCT03738423|521341293|FG004|Overall Study|Randomized but never treated|0|||
144585260|NCT01593787|521341294|FG000|Overall Study|Adverse Event|1|||
144585261|NCT01593787|521341295|FG001|Overall Study|Adverse Event|0|||
144585262|NCT01593787|521341296|FG002|Overall Study|Adverse Event|0|||
144585263|NCT02592876|521341303|FG000|Overall Study|Withdrawal by Subject|3|||
144585264|NCT02592876|521341304|FG001|Overall Study|Withdrawal by Subject|3|||
144585265|NCT02592876|521341303|FG000|Overall Study|Study Termination by Sponsor|32|||
144585266|NCT02592876|521341304|FG001|Overall Study|Study Termination by Sponsor|27|||
144262898|NCT01716806|520163780|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
144585267|NCT02592876|521341303|FG000|Overall Study|Lost to Follow-up|0|||
144585268|NCT02592876|521341304|FG001|Overall Study|Lost to Follow-up|1|||
144585269|NCT02592876|521341303|FG000|Overall Study|Death|6|||
144585270|NCT02592876|521341304|FG001|Overall Study|Death|9|||
144585271|NCT00611975|521341307|FG000|Overall Study|Withdrawal by Subject|3|||
144585272|NCT00611975|521341308|FG001|Overall Study|Withdrawal by Subject|7|||
144585273|NCT00611975|521341307|FG000|Overall Study|Pregnancy|2|||
144585274|NCT00611975|521341308|FG001|Overall Study|Pregnancy|1|||
144585275|NCT03465904|521341309|FG000|Overall Study|Withdrawal by Subject|9|||
144585276|NCT03465904|521341310|FG001|Overall Study|Withdrawal by Subject|5|||
144585277|NCT03465904|521341309|FG000|Overall Study|Lost to Follow-up|11|||
144585278|NCT03465904|521341310|FG001|Overall Study|Lost to Follow-up|9|||
144585279|NCT03465904|521341309|FG000|Overall Study|Protocol Violation|20|||
144585280|NCT03465904|521341310|FG001|Overall Study|Protocol Violation|15|||
144585281|NCT04625413|521341311|FG000|Overall Study|Hospice|2|||
144585282|NCT04625413|521341311|FG000|Overall Study|Distress|1|||
144585283|NCT04625413|521341311|FG000|Overall Study|Not feeling well|1|||
144585284|NCT01305200|521341312|FG000|Overall Study|Physician Decision|4|||
144585285|NCT01305200|521341313|FG001|Overall Study|Physician Decision|6|||
144585286|NCT01305200|521341314|FG002|Overall Study|Physician Decision|1|||
144585287|NCT01305200|521341312|FG000|Overall Study|Withdrawal by Subject|24|||
144585288|NCT01305200|521341313|FG001|Overall Study|Withdrawal by Subject|21|||
144585289|NCT01305200|521341314|FG002|Overall Study|Withdrawal by Subject|1|||
144585290|NCT01305200|521341312|FG000|Overall Study|Ineligible|1|||
144585291|NCT01305200|521341313|FG001|Overall Study|Ineligible|2|||
144585292|NCT01305200|521341314|FG002|Overall Study|Ineligible|1|||
144585293|NCT01305200|521341312|FG000|Overall Study|Death|0|||
144585294|NCT01305200|521341313|FG001|Overall Study|Death|2|||
144585295|NCT01305200|521341314|FG002|Overall Study|Death|0|||
144585296|NCT03981861|521341315|FG000|Overall Study|Withdrawal by Subject|3|||
144585297|NCT05618912|521341316|FG000|Overall Study|Lost to Follow-up|14|||
144585298|NCT05618912|521341317|FG001|Overall Study|Lost to Follow-up|19|||
144585299|NCT00925353|521341318|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
144585300|NCT03695237|521343697|FG000|Overall Study|Withdrawal by Subject|1|||
144585301|NCT03695237|521343698|FG001|Overall Study|Withdrawal by Subject|3|||
144585302|NCT03695237|521343697|FG000|Overall Study|Lost to Follow-up|1|||
144585303|NCT03695237|521343698|FG001|Overall Study|Lost to Follow-up|2|||
144585304|NCT03695237|521343697|FG000|Overall Study|Other, Not Specified|8|||
144585305|NCT03695237|521343698|FG001|Overall Study|Other, Not Specified|2|||
144585306|NCT02516332|521343699|FG000|Overall Study|Withdrawal by Subject|2|||
144585307|NCT02516332|521343700|FG001|Overall Study|Withdrawal by Subject|1|||
144623555|NCT03529773|521478632|FG039|Overall Study|Protocol Violation|0|||
144623556|NCT03529773|521478593|FG000|Overall Study|Withdrawal by Subject|0|||
144623557|NCT03529773|521478594|FG001|Overall Study|Withdrawal by Subject|0|||
144623558|NCT03529773|521478595|FG002|Overall Study|Withdrawal by Subject|0|||
144623559|NCT03529773|521478596|FG003|Overall Study|Withdrawal by Subject|0|||
144623560|NCT03529773|521478597|FG004|Overall Study|Withdrawal by Subject|0|||
144623561|NCT03529773|521478598|FG005|Overall Study|Withdrawal by Subject|0|||
144623562|NCT03529773|521478599|FG006|Overall Study|Withdrawal by Subject|0|||
144623563|NCT03529773|521478600|FG007|Overall Study|Withdrawal by Subject|1|||
144623564|NCT03529773|521478601|FG008|Overall Study|Withdrawal by Subject|0|||
144623565|NCT03529773|521478602|FG009|Overall Study|Withdrawal by Subject|1|||
144623566|NCT03529773|521478603|FG010|Overall Study|Withdrawal by Subject|1|||
144623567|NCT03529773|521478604|FG011|Overall Study|Withdrawal by Subject|0|||
144623568|NCT03529773|521478605|FG012|Overall Study|Withdrawal by Subject|0|||
144623569|NCT03529773|521478606|FG013|Overall Study|Withdrawal by Subject|0|||
144623570|NCT03529773|521478607|FG014|Overall Study|Withdrawal by Subject|0|||
144623571|NCT03529773|521478608|FG015|Overall Study|Withdrawal by Subject|3|||
144623572|NCT03529773|521478609|FG016|Overall Study|Withdrawal by Subject|0|||
144623573|NCT03529773|521478610|FG017|Overall Study|Withdrawal by Subject|2|||
144623574|NCT03529773|521478611|FG018|Overall Study|Withdrawal by Subject|3|||
144623575|NCT03529773|521478612|FG019|Overall Study|Withdrawal by Subject|1|||
144623576|NCT03529773|521478613|FG020|Overall Study|Withdrawal by Subject|3|||
144623577|NCT03529773|521478614|FG021|Overall Study|Withdrawal by Subject|1|||
144623578|NCT03529773|521478615|FG022|Overall Study|Withdrawal by Subject|1|||
144623579|NCT03529773|521478616|FG023|Overall Study|Withdrawal by Subject|2|||
144623580|NCT03529773|521478617|FG024|Overall Study|Withdrawal by Subject|2|||
144623581|NCT03529773|521478618|FG025|Overall Study|Withdrawal by Subject|4|||
144623582|NCT03529773|521478619|FG026|Overall Study|Withdrawal by Subject|2|||
144585308|NCT02516332|521343701|FG002|Overall Study|Withdrawal by Subject|2|||
144585309|NCT00605215|521343704|FG000|Overall Study|Death|0|||
144585310|NCT00605215|521343705|FG001|Overall Study|Death|0|||
144585311|NCT00605215|521343706|FG002|Overall Study|Death|1|||
144585312|NCT00605215|521343704|FG000|Overall Study|Adverse Event|19|||
144585313|NCT00605215|521343705|FG001|Overall Study|Adverse Event|21|||
144585314|NCT00605215|521343706|FG002|Overall Study|Adverse Event|26|||
144585315|NCT00605215|521343704|FG000|Overall Study|Refusal to sign the re-consent form|8|||
144585316|NCT00605215|521343705|FG001|Overall Study|Refusal to sign the re-consent form|3|||
144585317|NCT00605215|521343706|FG002|Overall Study|Refusal to sign the re-consent form|3|||
144585318|NCT00605215|521343704|FG000|Overall Study|Withdrawal by Subject|39|||
144585319|NCT00605215|521343705|FG001|Overall Study|Withdrawal by Subject|37|||
144585320|NCT00605215|521343706|FG002|Overall Study|Withdrawal by Subject|27|||
144585321|NCT00605215|521343704|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
144585322|NCT00605215|521343705|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
144585323|NCT00605215|521343706|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
144585324|NCT00605215|521343704|FG000|Overall Study|Protocol Violation|3|||
144585325|NCT00605215|521343705|FG001|Overall Study|Protocol Violation|4|||
144585326|NCT00605215|521343706|FG002|Overall Study|Protocol Violation|1|||
144585327|NCT00605215|521343704|FG000|Overall Study|Pregnancy|8|||
144585328|NCT00605215|521343705|FG001|Overall Study|Pregnancy|5|||
144585329|NCT00605215|521343706|FG002|Overall Study|Pregnancy|4|||
144585330|NCT00605215|521343704|FG000|Overall Study|Lost to Follow-up|8|||
144585331|NCT00605215|521343705|FG001|Overall Study|Lost to Follow-up|5|||
144585332|NCT00605215|521343706|FG002|Overall Study|Lost to Follow-up|2|||
144585333|NCT00605215|521343704|FG000|Overall Study|Other than specified|0|||
144585334|NCT00605215|521343705|FG001|Overall Study|Other than specified|2|||
144585335|NCT00605215|521343706|FG002|Overall Study|Other than specified|1|||
144585336|NCT01789567|521343707|FG000|Overall Study|Death|6|||
144585337|NCT00872989|521343708|FG000|Overall Study|Adverse Event|7|||
144585338|NCT00872989|521343709|FG001|Overall Study|Adverse Event|15|||
144585339|NCT00872989|521343708|FG000|Overall Study|Withdrawal by Subject|8|||
144585340|NCT00872989|521343709|FG001|Overall Study|Withdrawal by Subject|5|||
144585341|NCT00872989|521343708|FG000|Overall Study|Progression/relapse|47|||
144585342|NCT00872989|521343709|FG001|Overall Study|Progression/relapse|35|||
144585343|NCT00872989|521343708|FG000|Overall Study|Not protocol specified|3|||
144623583|NCT03529773|521478620|FG027|Overall Study|Withdrawal by Subject|1|||
144623584|NCT03529773|521478621|FG028|Overall Study|Withdrawal by Subject|1|||
144623585|NCT03529773|521478622|FG029|Overall Study|Withdrawal by Subject|0|||
144623586|NCT03529773|521478623|FG030|Overall Study|Withdrawal by Subject|0|||
144623587|NCT03529773|521478624|FG031|Overall Study|Withdrawal by Subject|0|||
144623588|NCT03529773|521478625|FG032|Overall Study|Withdrawal by Subject|0|||
144623589|NCT03529773|521478626|FG033|Overall Study|Withdrawal by Subject|0|||
144623590|NCT03529773|521478627|FG034|Overall Study|Withdrawal by Subject|1|||
144623591|NCT03529773|521478628|FG035|Overall Study|Withdrawal by Subject|2|||
144623592|NCT03529773|521478629|FG036|Overall Study|Withdrawal by Subject|0|||
144585344|NCT00872989|521343709|FG001|Overall Study|Not protocol specified|8|||
144585345|NCT02407990|521343710|FG000|Overall Study|Death|2|||
144730494|NCT01203878|521869796|FG002|Overall Study|Adverse Event|2|||
144730495|NCT00274937|521869797|FG000|Overall Study|Physician Decision|10|||
144730496|NCT00274937|521869797|FG000|Overall Study|Withdrawal by Subject|6|||
144730497|NCT00274937|521869797|FG000|Overall Study|Progressive Disease|4|||
144730498|NCT02189941|521869798|FG000|Overall Study|Non-compliance|0|||
144730499|NCT02189941|521869799|FG001|Overall Study|Non-compliance|0|||
144209526|NCT00425373|519961979|FG008|Overall Study|Lost to Follow-up|0|||
144209527|NCT00425373|519961971|FG000|Overall Study|Protocol Violation|1|||
144209528|NCT00425373|519961972|FG001|Overall Study|Protocol Violation|0|||
144209529|NCT00425373|519961973|FG002|Overall Study|Protocol Violation|1|||
144209530|NCT00425373|519961974|FG003|Overall Study|Protocol Violation|0|||
144585346|NCT02407990|521343711|FG001|Overall Study|Death|22|||
144585347|NCT02407990|521343712|FG002|Overall Study|Death|23|||
144585348|NCT02407990|521343713|FG003|Overall Study|Death|7|||
144585349|NCT02407990|521343714|FG004|Overall Study|Death|17|||
144585350|NCT02407990|521343715|FG005|Overall Study|Death|16|||
144585351|NCT02407990|521343716|FG006|Overall Study|Death|10|||
144585352|NCT02407990|521343717|FG007|Overall Study|Death|248|||
144585353|NCT02407990|521343710|FG000|Overall Study|Lost to Follow-up|0|||
144585354|NCT02407990|521343711|FG001|Overall Study|Lost to Follow-up|1|||
144585355|NCT02407990|521343712|FG002|Overall Study|Lost to Follow-up|0|||
144585356|NCT02407990|521343713|FG003|Overall Study|Lost to Follow-up|0|||
144585357|NCT02407990|521343714|FG004|Overall Study|Lost to Follow-up|0|||
144585358|NCT02407990|521343715|FG005|Overall Study|Lost to Follow-up|0|||
144585359|NCT02407990|521343716|FG006|Overall Study|Lost to Follow-up|0|||
144585360|NCT02407990|521343717|FG007|Overall Study|Lost to Follow-up|17|||
144585361|NCT02407990|521343710|FG000|Overall Study|Progressive Disease|0|||
144585362|NCT02407990|521343711|FG001|Overall Study|Progressive Disease|0|||
144585363|NCT02407990|521343712|FG002|Overall Study|Progressive Disease|0|||
144585364|NCT02407990|521343713|FG003|Overall Study|Progressive Disease|0|||
144585365|NCT02407990|521343714|FG004|Overall Study|Progressive Disease|0|||
144585366|NCT02407990|521343715|FG005|Overall Study|Progressive Disease|0|||
144585367|NCT02407990|521343716|FG006|Overall Study|Progressive Disease|0|||
144585368|NCT02407990|521343717|FG007|Overall Study|Progressive Disease|1|||
144585369|NCT02407990|521343710|FG000|Overall Study|Withdrawal by Subject|0|||
144585370|NCT02407990|521343711|FG001|Overall Study|Withdrawal by Subject|0|||
144585371|NCT02407990|521343712|FG002|Overall Study|Withdrawal by Subject|0|||
144585372|NCT02407990|521343713|FG003|Overall Study|Withdrawal by Subject|0|||
144585373|NCT02407990|521343714|FG004|Overall Study|Withdrawal by Subject|1|||
144585374|NCT02407990|521343715|FG005|Overall Study|Withdrawal by Subject|0|||
144585375|NCT02407990|521343716|FG006|Overall Study|Withdrawal by Subject|0|||
144585376|NCT02407990|521343717|FG007|Overall Study|Withdrawal by Subject|30|||
144585377|NCT02407990|521343710|FG000|Overall Study|Study Terminated by Sponsor|1|||
144585378|NCT02407990|521343711|FG001|Overall Study|Study Terminated by Sponsor|3|||
144585379|NCT02407990|521343712|FG002|Overall Study|Study Terminated by Sponsor|3|||
144585380|NCT02407990|521343713|FG003|Overall Study|Study Terminated by Sponsor|0|||
144585381|NCT02407990|521343714|FG004|Overall Study|Study Terminated by Sponsor|3|||
144585382|NCT02407990|521343715|FG005|Overall Study|Study Terminated by Sponsor|4|||
144585383|NCT02407990|521343716|FG006|Overall Study|Study Terminated by Sponsor|3|||
144585384|NCT02407990|521343717|FG007|Overall Study|Study Terminated by Sponsor|37|||
144585385|NCT02407990|521343710|FG000|Overall Study|Logistics|0|||
144585386|NCT02407990|521343711|FG001|Overall Study|Logistics|0|||
144585387|NCT02407990|521343712|FG002|Overall Study|Logistics|0|||
144585388|NCT02407990|521343713|FG003|Overall Study|Logistics|0|||
144585389|NCT02407990|521343714|FG004|Overall Study|Logistics|0|||
144585390|NCT02407990|521343715|FG005|Overall Study|Logistics|0|||
144585391|NCT02407990|521343716|FG006|Overall Study|Logistics|0|||
144585392|NCT02407990|521343717|FG007|Overall Study|Logistics|1|||
144585393|NCT02407990|521343710|FG000|Overall Study|Rolled into long-term extension study|0|||
144585394|NCT02407990|521343711|FG001|Overall Study|Rolled into long-term extension study|0|||
144585395|NCT02407990|521343712|FG002|Overall Study|Rolled into long-term extension study|0|||
144585396|NCT02407990|521343713|FG003|Overall Study|Rolled into long-term extension study|0|||
144585397|NCT02407990|521343714|FG004|Overall Study|Rolled into long-term extension study|0|||
144585398|NCT02407990|521343715|FG005|Overall Study|Rolled into long-term extension study|0|||
144585399|NCT02407990|521343716|FG006|Overall Study|Rolled into long-term extension study|0|||
144585400|NCT02407990|521343717|FG007|Overall Study|Rolled into long-term extension study|1|||
144585401|NCT00923260|521343718|FG000|Overall Study|Lost to Follow-up|1|||
144730500|NCT02189941|521869800|FG002|Overall Study|Non-compliance|1|||
144209531|NCT00425373|519961975|FG004|Overall Study|Protocol Violation|0|||
144585402|NCT00923260|521343719|FG001|Overall Study|Lost to Follow-up|1|||
144585403|NCT01302067|521343722|FG000|Overall Study|Death|0|||
144730501|NCT00445003|521869801|FG000|Overall Study|Death|1|||
144209532|NCT00425373|519961976|FG005|Overall Study|Protocol Violation|0|||
144209533|NCT00425373|519961977|FG006|Overall Study|Protocol Violation|0|||
144585404|NCT01302067|521343723|FG001|Overall Study|Death|0|||
144585405|NCT01302067|521343724|FG002|Overall Study|Death|1|||
144585406|NCT01302067|521343722|FG000|Overall Study|Physician Decision|9|||
144585407|NCT01302067|521343723|FG001|Overall Study|Physician Decision|5|||
144585408|NCT01302067|521343724|FG002|Overall Study|Physician Decision|14|||
144730502|NCT00445003|521869802|FG001|Overall Study|Death|2|||
144623593|NCT03529773|521478630|FG037|Overall Study|Withdrawal by Subject|2|||
144623594|NCT03529773|521478631|FG038|Overall Study|Withdrawal by Subject|1|||
144623595|NCT03529773|521478632|FG039|Overall Study|Withdrawal by Subject|1|||
144623596|NCT03529773|521478593|FG000|Overall Study|Screen Failure|0|||
144623597|NCT03529773|521478594|FG001|Overall Study|Screen Failure|0|||
144623598|NCT03529773|521478595|FG002|Overall Study|Screen Failure|0|||
144623599|NCT03529773|521478596|FG003|Overall Study|Screen Failure|0|||
144623600|NCT03529773|521478597|FG004|Overall Study|Screen Failure|0|||
144623601|NCT03529773|521478598|FG005|Overall Study|Screen Failure|0|||
144623602|NCT03529773|521478599|FG006|Overall Study|Screen Failure|0|||
144623603|NCT03529773|521478600|FG007|Overall Study|Screen Failure|0|||
144730503|NCT00445003|521869803|FG002|Overall Study|Death|1|||
144730504|NCT00445003|521869801|FG000|Overall Study|Missed Visit|3|||
144730505|NCT00445003|521869802|FG001|Overall Study|Missed Visit|5|||
144730506|NCT00445003|521869803|FG002|Overall Study|Missed Visit|1|||
144730507|NCT00445003|521869801|FG000|Overall Study|Dropped|1|||
144730508|NCT00445003|521869802|FG001|Overall Study|Dropped|3|||
144730509|NCT00445003|521869803|FG002|Overall Study|Dropped|2|||
144730510|NCT00528606|521869804|FG000|Overall Study|Withdrew consent|4|||
144730511|NCT00528606|521869805|FG001|Overall Study|Withdrew consent|3|||
144730512|NCT00528606|521869804|FG000|Overall Study|Lost to Follow-up|4|||
144730513|NCT00528606|521869805|FG001|Overall Study|Lost to Follow-up|1|||
144730514|NCT00528606|521869804|FG000|Overall Study|Adverse Event|3|||
144730515|NCT00528606|521869805|FG001|Overall Study|Adverse Event|0|||
144585409|NCT01302067|521343722|FG000|Overall Study|Lack of Efficacy|8|||
144585410|NCT01302067|521343723|FG001|Overall Study|Lack of Efficacy|4|||
144585411|NCT01302067|521343724|FG002|Overall Study|Lack of Efficacy|2|||
144585412|NCT01302067|521343722|FG000|Overall Study|Lost to Follow-up|9|||
144585413|NCT01302067|521343723|FG001|Overall Study|Lost to Follow-up|4|||
144585414|NCT01302067|521343724|FG002|Overall Study|Lost to Follow-up|15|||
144585415|NCT01302067|521343722|FG000|Overall Study|Withdrawal by Subject|13|||
144585416|NCT01302067|521343723|FG001|Overall Study|Withdrawal by Subject|6|||
144585417|NCT01302067|521343724|FG002|Overall Study|Withdrawal by Subject|10|||
144585418|NCT01302067|521343722|FG000|Overall Study|Other|1|||
144585419|NCT01302067|521343723|FG001|Overall Study|Other|1|||
144585420|NCT01302067|521343724|FG002|Overall Study|Other|3|||
144585421|NCT01302067|521343722|FG000|Overall Study|Protocol Violation|11|||
144585422|NCT01302067|521343723|FG001|Overall Study|Protocol Violation|0|||
144585423|NCT01302067|521343724|FG002|Overall Study|Protocol Violation|8|||
144585424|NCT01302067|521343722|FG000|Overall Study|Adverse Event|27|||
144585425|NCT01302067|521343723|FG001|Overall Study|Adverse Event|14|||
144585426|NCT01302067|521343724|FG002|Overall Study|Adverse Event|45|||
144585427|NCT02738203|521343726|FG000|Overall Study|Failed IUD Insertion|2|||
144585428|NCT02738203|521343727|FG001|Overall Study|Failed IUD Insertion|2|||
144585429|NCT02738203|521343726|FG000|Overall Study|Protocol Violation|0|||
144585430|NCT02738203|521343727|FG001|Overall Study|Protocol Violation|1|||
144585431|NCT00266227|521343728|FG000|Initial Treatment|Adverse Event|0|||
144585432|NCT00266227|521343729|FG001|Initial Treatment|Adverse Event|0|||
144585433|NCT00266227|521343730|FG002|Initial Treatment|Adverse Event|13|||
144585434|NCT00266227|521343728|FG000|Initial Treatment|Lost to Follow-up|0|||
144585435|NCT00266227|521343729|FG001|Initial Treatment|Lost to Follow-up|0|||
144585436|NCT00266227|521343730|FG002|Initial Treatment|Lost to Follow-up|6|||
144585437|NCT00266227|521343728|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
144585438|NCT00266227|521343729|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
144585439|NCT00266227|521343730|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
144585440|NCT00266227|521343728|FG000|Initial Treatment|Physician decision to withdraw|0|||
144585441|NCT00266227|521343729|FG001|Initial Treatment|Physician decision to withdraw|0|||
144585442|NCT00266227|521343730|FG002|Initial Treatment|Physician decision to withdraw|12|||
144585443|NCT00266227|521343728|FG000|Initial Treatment|Pregnancy|0|||
144585444|NCT00266227|521343729|FG001|Initial Treatment|Pregnancy|0|||
144585445|NCT00266227|521343730|FG002|Initial Treatment|Pregnancy|1|||
144585446|NCT00266227|521343728|FG000|Retreatment: Up to Week 48|Death|1|||
144585447|NCT00266227|521343729|FG001|Retreatment: Up to Week 48|Death|0|||
144585448|NCT00266227|521343730|FG002|Retreatment: Up to Week 48|Death|0|||
144585449|NCT00266227|521343728|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
144585450|NCT00266227|521343729|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
144730516|NCT00528606|521869804|FG000|Overall Study|Other|2|||
144730517|NCT00528606|521869805|FG001|Overall Study|Other|0|||
144730518|NCT01471093|521869806|FG000|Overall Study|Adverse Event|1|||
144209534|NCT00425373|519961978|FG007|Overall Study|Protocol Violation|5|||
144209535|NCT00425373|519961979|FG008|Overall Study|Protocol Violation|3|||
144209536|NCT00425373|519961971|FG000|Overall Study|Withdrawal by Subject|2|||
144585451|NCT00266227|521343730|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
144585452|NCT00266227|521343728|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
144585453|NCT00266227|521343729|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
144623604|NCT03529773|521478601|FG008|Overall Study|Screen Failure|0|||
144623605|NCT03529773|521478602|FG009|Overall Study|Screen Failure|0|||
144623606|NCT03529773|521478603|FG010|Overall Study|Screen Failure|0|||
144730519|NCT01471093|521869807|FG001|Overall Study|Adverse Event|0|||
144585454|NCT00266227|521343730|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
144585455|NCT00266227|521343728|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
144585456|NCT00266227|521343729|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
144585457|NCT00266227|521343730|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
144585458|NCT00266227|521343728|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
144585459|NCT00266227|521343729|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
144585460|NCT00266227|521343730|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
144585461|NCT00266227|521343728|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
144585462|NCT00266227|521343729|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
144585463|NCT00266227|521343730|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
144585464|NCT00266227|521343728|FG000|Retreatment: Week 48 to Week 72|Death|1|||
144585465|NCT00266227|521343729|FG001|Retreatment: Week 48 to Week 72|Death|1|||
144585466|NCT00266227|521343730|FG002|Retreatment: Week 48 to Week 72|Death|0|||
144585467|NCT00266227|521343728|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
144585468|NCT00266227|521343729|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
144585469|NCT00266227|521343730|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
144585470|NCT00266227|521343728|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
144585471|NCT00266227|521343729|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
144585472|NCT00266227|521343730|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
144585473|NCT00266227|521343728|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
144585474|NCT00266227|521343729|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
144585475|NCT00266227|521343730|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
144585476|NCT00266227|521343728|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
144585477|NCT00266227|521343729|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
144585478|NCT00266227|521343730|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
144585479|NCT03241927|521343731|FG000|Overall Study|study terminated|1|||
144585480|NCT03241927|521343732|FG001|Overall Study|study terminated|0|||
144585481|NCT01198756|521343733|FG000|Overall Study|Adverse Event|0|||
144585482|NCT01198756|521343734|FG001|Overall Study|Adverse Event|0|||
144585483|NCT01198756|521343735|FG002|Overall Study|Adverse Event|0|||
144585484|NCT01198756|521343736|FG003|Overall Study|Adverse Event|1|||
144585485|NCT01198756|521343733|FG000|Overall Study|Protocol Violation|0|||
144585486|NCT01198756|521343734|FG001|Overall Study|Protocol Violation|0|||
144585487|NCT01198756|521343735|FG002|Overall Study|Protocol Violation|0|||
144585488|NCT01198756|521343736|FG003|Overall Study|Protocol Violation|2|||
144585489|NCT01198756|521343733|FG000|Overall Study|Withdrawal by Subject|9|||
144585490|NCT01198756|521343734|FG001|Overall Study|Withdrawal by Subject|4|||
144585491|NCT01198756|521343735|FG002|Overall Study|Withdrawal by Subject|7|||
144585492|NCT01198756|521343736|FG003|Overall Study|Withdrawal by Subject|5|||
144585493|NCT01198756|521343733|FG000|Overall Study|Lost to Follow-up|29|||
144585494|NCT01198756|521343734|FG001|Overall Study|Lost to Follow-up|36|||
144585495|NCT01198756|521343735|FG002|Overall Study|Lost to Follow-up|23|||
144585496|NCT01198756|521343736|FG003|Overall Study|Lost to Follow-up|18|||
144585497|NCT02915302|521343739|FG000|Overall Study|Adverse Event|3|||
144585498|NCT02915302|521343740|FG001|Overall Study|Adverse Event|0|||
144585499|NCT02915302|521343739|FG000|Overall Study|Protocol Violation|20|||
144585500|NCT02915302|521343740|FG001|Overall Study|Protocol Violation|27|||
144585501|NCT02915302|521343739|FG000|Overall Study|Lost to Follow-up|19|||
144585502|NCT02915302|521343740|FG001|Overall Study|Lost to Follow-up|22|||
144585503|NCT02915302|521343739|FG000|Overall Study|Withdrawal by Subject|22|||
144585504|NCT02915302|521343740|FG001|Overall Study|Withdrawal by Subject|29|||
144585505|NCT02915302|521343739|FG000|Overall Study|Other|1|||
144585506|NCT02915302|521343740|FG001|Overall Study|Other|0|||
144585507|NCT04343872|521343744|FG000|Overall Study|Lost to Follow-up|6|||
144585508|NCT04343872|521343745|FG001|Overall Study|Lost to Follow-up|3|||
144585509|NCT01850446|521343746|FG000|Overall Study|Lack of Efficacy|1|||
144585510|NCT01850446|521343747|FG001|Overall Study|Lack of Efficacy|0|||
144585511|NCT01850446|521343746|FG000|Overall Study|Withdrawal by Subject|4|||
144585512|NCT01850446|521343747|FG001|Overall Study|Withdrawal by Subject|0|||
144585513|NCT01850446|521343746|FG000|Overall Study|Protocol Violation|0|||
144585514|NCT01850446|521343747|FG001|Overall Study|Protocol Violation|2|||
144585515|NCT01290315|521343748|FG000|Overall Study|Adverse Event|0|||
144585516|NCT01290315|521343749|FG001|Overall Study|Adverse Event|0|||
144585517|NCT01290315|521343750|FG002|Overall Study|Adverse Event|0|||
144585518|NCT01290315|521343751|FG003|Overall Study|Adverse Event|3|||
144585519|NCT01290315|521343748|FG000|Overall Study|Selection criteria/compliance|2|||
144585520|NCT01290315|521343749|FG001|Overall Study|Selection criteria/compliance|1|||
144585521|NCT01290315|521343750|FG002|Overall Study|Selection criteria/compliance|0|||
144585522|NCT01290315|521343751|FG003|Overall Study|Selection criteria/compliance|2|||
144585523|NCT01290315|521343748|FG000|Overall Study|Lost to Follow-up|0|||
144585524|NCT01290315|521343749|FG001|Overall Study|Lost to Follow-up|1|||
144585525|NCT01290315|521343750|FG002|Overall Study|Lost to Follow-up|0|||
144585526|NCT01290315|521343751|FG003|Overall Study|Lost to Follow-up|0|||
144585527|NCT01290315|521343748|FG000|Overall Study|Withdrawal by Subject|1|||
144623607|NCT03529773|521478604|FG011|Overall Study|Screen Failure|0|||
144623608|NCT03529773|521478605|FG012|Overall Study|Screen Failure|0|||
144623609|NCT03529773|521478606|FG013|Overall Study|Screen Failure|0|||
144623610|NCT03529773|521478607|FG014|Overall Study|Screen Failure|0|||
144623611|NCT03529773|521478608|FG015|Overall Study|Screen Failure|0|||
144623612|NCT03529773|521478609|FG016|Overall Study|Screen Failure|0|||
144623613|NCT03529773|521478610|FG017|Overall Study|Screen Failure|0|||
144623614|NCT03529773|521478611|FG018|Overall Study|Screen Failure|0|||
144623615|NCT03529773|521478612|FG019|Overall Study|Screen Failure|0|||
144623616|NCT03529773|521478613|FG020|Overall Study|Screen Failure|0|||
144623617|NCT03529773|521478614|FG021|Overall Study|Screen Failure|0|||
144623618|NCT03529773|521478615|FG022|Overall Study|Screen Failure|0|||
144623619|NCT03529773|521478616|FG023|Overall Study|Screen Failure|0|||
144623620|NCT03529773|521478617|FG024|Overall Study|Screen Failure|0|||
144623621|NCT03529773|521478618|FG025|Overall Study|Screen Failure|0|||
144623622|NCT03529773|521478619|FG026|Overall Study|Screen Failure|0|||
144623623|NCT03529773|521478620|FG027|Overall Study|Screen Failure|0|||
144585528|NCT01290315|521343749|FG001|Overall Study|Withdrawal by Subject|1|||
144585529|NCT01290315|521343750|FG002|Overall Study|Withdrawal by Subject|0|||
144585530|NCT01290315|521343751|FG003|Overall Study|Withdrawal by Subject|0|||
144585531|NCT00591721|521343752|FG000|Overall Study|Withdrawal by Subject|10|||
144585532|NCT00591721|521343753|FG001|Overall Study|Withdrawal by Subject|10|||
144585533|NCT00591721|521343752|FG000|Overall Study|Lost to Follow-up|1|||
144585534|NCT00591721|521343753|FG001|Overall Study|Lost to Follow-up|4|||
144585535|NCT00591721|521343752|FG000|Overall Study|Intervention not received|10|||
144585536|NCT00591721|521343753|FG001|Overall Study|Intervention not received|8|||
144585537|NCT03725085|521343754|FG000|Overall Study|Lost to Follow-up|2|||
144585538|NCT02704754|521343755|FG000|Overall Study|Lost to Follow-up|1|||
144585539|NCT02704754|521343756|FG001|Overall Study|Lost to Follow-up|1|||
144585540|NCT02704754|521343755|FG000|Overall Study|Lack of Efficacy|1|||
144585541|NCT02704754|521343756|FG001|Overall Study|Lack of Efficacy|0|||
144585542|NCT02704754|521343755|FG000|Overall Study|Withdrawal by Subject|1|||
144585543|NCT02704754|521343756|FG001|Overall Study|Withdrawal by Subject|0|||
144585544|NCT00423943|521343757|FG000|Overall Study|Withdrawal by Subject|3|||
144585545|NCT00423943|521343758|FG001|Overall Study|Withdrawal by Subject|1|||
144585546|NCT02134977|521343759|FG000|Overall Study|Protocol Deviation|102|||
144585547|NCT02383056|521343768|FG000|Overall Study|Adverse Event|1|||
144585548|NCT02383056|521343769|FG001|Overall Study|Adverse Event|0|||
144585549|NCT02383056|521343768|FG000|Overall Study|Lost to Follow-up|0|||
144585550|NCT02383056|521343769|FG001|Overall Study|Lost to Follow-up|2|||
144585551|NCT04187989|521343770|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
144585552|NCT04187989|521343771|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
144585553|NCT04187989|521343770|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
144585554|NCT04187989|521343771|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
144585555|NCT03646656|521343772|FG000|Overall Study|Lost to Follow-up|1|||
144585556|NCT03646656|521343773|FG001|Overall Study|Lost to Follow-up|0|||
144585557|NCT03646656|521343772|FG000|Overall Study|Withdrawal by Subject|2|||
144585558|NCT03646656|521343773|FG001|Overall Study|Withdrawal by Subject|0|||
144585559|NCT03900416|521343774|FG000|Six Week Follow-up|Lost to Follow-up|1|||
144585560|NCT03900416|521343775|FG001|Six Week Follow-up|Lost to Follow-up|0|||
144585561|NCT03900416|521343774|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
144585562|NCT03900416|521343775|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
144585563|NCT03900416|521343774|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
144585564|NCT03900416|521343775|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
144585565|NCT03900416|521343774|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
144585566|NCT03900416|521343775|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
144585567|NCT03900416|521343774|FG000|Twelve Week Follow-up|Adverse Event|1|||
144585568|NCT03900416|521343775|FG001|Twelve Week Follow-up|Adverse Event|1|||
144585569|NCT03900416|521343774|FG000|Six Month Follow-up|Lost to Follow-up|4|||
144623624|NCT03529773|521478621|FG028|Overall Study|Screen Failure|0|||
144623625|NCT03529773|521478622|FG029|Overall Study|Screen Failure|0|||
144623626|NCT03529773|521478623|FG030|Overall Study|Screen Failure|0|||
144585570|NCT03900416|521343775|FG001|Six Month Follow-up|Lost to Follow-up|3|||
144585571|NCT03900416|521343774|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
144585572|NCT03900416|521343775|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
144585573|NCT03507777|521343776|FG000|Overall Study|Lost to Follow-up|5|||
144585574|NCT03507777|521343777|FG001|Overall Study|Lost to Follow-up|7|||
144585575|NCT03507777|521343776|FG000|Overall Study|Withdrawal by Subject|6|||
144585576|NCT03507777|521343777|FG001|Overall Study|Withdrawal by Subject|11|||
144585577|NCT03507777|521343776|FG000|Overall Study|Death|30|||
144585578|NCT03507777|521343777|FG001|Overall Study|Death|44|||
144585579|NCT03507777|521343776|FG000|Overall Study|Other Reasons|3|||
144623627|NCT03529773|521478624|FG031|Overall Study|Screen Failure|0|||
144623628|NCT03529773|521478625|FG032|Overall Study|Screen Failure|0|||
144623629|NCT03529773|521478626|FG033|Overall Study|Screen Failure|0|||
144623630|NCT03529773|521478627|FG034|Overall Study|Screen Failure|0|||
144623631|NCT03529773|521478628|FG035|Overall Study|Screen Failure|0|||
144623632|NCT03529773|521478629|FG036|Overall Study|Screen Failure|1|||
144623633|NCT03529773|521478630|FG037|Overall Study|Screen Failure|1|||
144623634|NCT03529773|521478631|FG038|Overall Study|Screen Failure|0|||
144623635|NCT03529773|521478632|FG039|Overall Study|Screen Failure|1|||
144623636|NCT03529773|521478593|FG000|Overall Study|Randomized but not vaccinated|0|||
144623637|NCT03529773|521478594|FG001|Overall Study|Randomized but not vaccinated|0|||
144623638|NCT03529773|521478595|FG002|Overall Study|Randomized but not vaccinated|0|||
144623639|NCT03529773|521478596|FG003|Overall Study|Randomized but not vaccinated|0|||
144623640|NCT03529773|521478597|FG004|Overall Study|Randomized but not vaccinated|0|||
144623641|NCT03529773|521478598|FG005|Overall Study|Randomized but not vaccinated|0|||
144623642|NCT03529773|521478599|FG006|Overall Study|Randomized but not vaccinated|0|||
144623643|NCT03529773|521478600|FG007|Overall Study|Randomized but not vaccinated|0|||
144623644|NCT03529773|521478601|FG008|Overall Study|Randomized but not vaccinated|0|||
144623645|NCT03529773|521478602|FG009|Overall Study|Randomized but not vaccinated|0|||
144623646|NCT03529773|521478603|FG010|Overall Study|Randomized but not vaccinated|0|||
144623647|NCT03529773|521478604|FG011|Overall Study|Randomized but not vaccinated|0|||
144623648|NCT03529773|521478605|FG012|Overall Study|Randomized but not vaccinated|0|||
144623649|NCT03529773|521478606|FG013|Overall Study|Randomized but not vaccinated|0|||
144623650|NCT03529773|521478607|FG014|Overall Study|Randomized but not vaccinated|0|||
144623651|NCT03529773|521478608|FG015|Overall Study|Randomized but not vaccinated|0|||
144623652|NCT03529773|521478609|FG016|Overall Study|Randomized but not vaccinated|0|||
144623653|NCT03529773|521478610|FG017|Overall Study|Randomized but not vaccinated|1|||
144623654|NCT03529773|521478611|FG018|Overall Study|Randomized but not vaccinated|0|||
144623655|NCT03529773|521478612|FG019|Overall Study|Randomized but not vaccinated|0|||
144623656|NCT03529773|521478613|FG020|Overall Study|Randomized but not vaccinated|0|||
144623657|NCT03529773|521478614|FG021|Overall Study|Randomized but not vaccinated|0|||
144623658|NCT03529773|521478615|FG022|Overall Study|Randomized but not vaccinated|0|||
144623659|NCT03529773|521478616|FG023|Overall Study|Randomized but not vaccinated|0|||
144623660|NCT03529773|521478617|FG024|Overall Study|Randomized but not vaccinated|0|||
144623661|NCT03529773|521478618|FG025|Overall Study|Randomized but not vaccinated|0|||
144623662|NCT03529773|521478619|FG026|Overall Study|Randomized but not vaccinated|0|||
144623663|NCT03529773|521478620|FG027|Overall Study|Randomized but not vaccinated|1|||
144623664|NCT03529773|521478621|FG028|Overall Study|Randomized but not vaccinated|0|||
144623665|NCT03529773|521478622|FG029|Overall Study|Randomized but not vaccinated|0|||
144623666|NCT03529773|521478623|FG030|Overall Study|Randomized but not vaccinated|0|||
144623667|NCT03529773|521478624|FG031|Overall Study|Randomized but not vaccinated|0|||
144623668|NCT03529773|521478625|FG032|Overall Study|Randomized but not vaccinated|0|||
144623669|NCT03529773|521478626|FG033|Overall Study|Randomized but not vaccinated|0|||
144623670|NCT03529773|521478627|FG034|Overall Study|Randomized but not vaccinated|0|||
144623671|NCT03529773|521478628|FG035|Overall Study|Randomized but not vaccinated|0|||
144623672|NCT03529773|521478629|FG036|Overall Study|Randomized but not vaccinated|0|||
144623673|NCT03529773|521478630|FG037|Overall Study|Randomized but not vaccinated|0|||
144623674|NCT03529773|521478631|FG038|Overall Study|Randomized but not vaccinated|0|||
144623675|NCT03529773|521478632|FG039|Overall Study|Randomized but not vaccinated|0|||
144623676|NCT01496066|521478633|FG000|Overall Study|Lost to Follow-up|8|||
144623677|NCT01496066|521478634|FG001|Overall Study|Lost to Follow-up|5|||
144623678|NCT01496066|521478633|FG000|Overall Study|Explant|3|||
144623679|NCT01496066|521478634|FG001|Overall Study|Explant|0|||
144623680|NCT01496066|521478633|FG000|Overall Study|Death|1|||
144623681|NCT01496066|521478634|FG001|Overall Study|Death|4|||
144623682|NCT00209339|521478635|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
144623683|NCT00209339|521478635|FG000|At 12 Months Follow-up|Death|1|||
144623684|NCT00209339|521478635|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
144623685|NCT00209339|521478635|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
144623686|NCT00209339|521478635|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
144623687|NCT00209339|521478635|FG000|At 24 Months Follow-up|Death|1|||
144623688|NCT00209339|521478635|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
144623689|NCT00209339|521478635|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
144623690|NCT00209339|521478635|FG000|At 4 Years Follow-up|Death|1|||
144623691|NCT00209339|521478635|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
144623692|NCT00209339|521478635|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
144623693|NCT00209339|521478635|FG000|At 5 Years Follow-up|Death|1|||
144623694|NCT00429858|521478636|FG000|Overall Study|Withdrawal by Subject|1|||
144623695|NCT00429858|521478636|FG000|Overall Study|Study Termination|1|||
144623696|NCT02268058|521478638|FG000|Overall Study|Protocol Violation|1|||
144623697|NCT02268058|521478639|FG001|Overall Study|Protocol Violation|0|||
144623698|NCT02268058|521478640|FG002|Overall Study|Protocol Violation|0|||
144623699|NCT02268058|521478641|FG003|Overall Study|Protocol Violation|0|||
144623700|NCT04142983|521478642|FG000|Overall Study|Lost to Follow-up|73|||
144623701|NCT04142983|521478642|FG000|Overall Study|Withdrawal by Subject|10|||
144623702|NCT04142983|521478642|FG000|Overall Study|Physician Decision|1|||
144623703|NCT04142983|521478642|FG000|Overall Study|Adverse Event|1|||
144623704|NCT04142983|521478642|FG000|Overall Study|No longer eligible|4|||
144623705|NCT04142983|521478642|FG000|Overall Study|Screen Failure|10|||
144585580|NCT03507777|521343777|FG001|Overall Study|Other Reasons|8|||
144585581|NCT02245737|521343778|FG000|Overall Study|Adverse Event|23|||
144585582|NCT02245737|521343779|FG001|Overall Study|Adverse Event|26|||
144585583|NCT02245737|521343780|FG002|Overall Study|Adverse Event|33|||
144585584|NCT02245737|521343778|FG000|Overall Study|Condition Worsened|9|||
144585585|NCT02245737|521343779|FG001|Overall Study|Condition Worsened|10|||
144585586|NCT02245737|521343780|FG002|Overall Study|Condition Worsened|9|||
144585587|NCT02245737|521343778|FG000|Overall Study|Death|2|||
144585588|NCT02245737|521343779|FG001|Overall Study|Death|4|||
144585589|NCT02245737|521343780|FG002|Overall Study|Death|4|||
144585590|NCT02245737|521343778|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
144585591|NCT02245737|521343779|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
144585592|NCT02245737|521343780|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
144585593|NCT02245737|521343778|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
144585594|NCT02245737|521343779|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
144585595|NCT02245737|521343780|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
144585596|NCT02245737|521343778|FG000|Overall Study|Lost to Follow-up|2|||
144585597|NCT02245737|521343779|FG001|Overall Study|Lost to Follow-up|5|||
144585598|NCT02245737|521343780|FG002|Overall Study|Lost to Follow-up|4|||
144585599|NCT02245737|521343778|FG000|Overall Study|Other-determined by Investigator|9|||
144585600|NCT02245737|521343779|FG001|Overall Study|Other-determined by Investigator|10|||
144585601|NCT02245737|521343780|FG002|Overall Study|Other-determined by Investigator|10|||
144585602|NCT02245737|521343778|FG000|Overall Study|Physician Decision|6|||
144585603|NCT02245737|521343779|FG001|Overall Study|Physician Decision|3|||
144585604|NCT02245737|521343780|FG002|Overall Study|Physician Decision|6|||
144585605|NCT02245737|521343778|FG000|Overall Study|Protocol Violation|3|||
144585606|NCT02245737|521343779|FG001|Overall Study|Protocol Violation|2|||
144585607|NCT02245737|521343780|FG002|Overall Study|Protocol Violation|3|||
144585608|NCT02245737|521343778|FG000|Overall Study|Withdrawal by Subject|40|||
144585609|NCT02245737|521343779|FG001|Overall Study|Withdrawal by Subject|41|||
144585610|NCT02245737|521343780|FG002|Overall Study|Withdrawal by Subject|44|||
144585611|NCT02245737|521343778|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
144585612|NCT02245737|521343779|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
144585613|NCT02245737|521343780|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
144585614|NCT02245737|521343778|FG000|Overall Study|Sponsor Decision|445|||
144585615|NCT02245737|521343779|FG001|Overall Study|Sponsor Decision|430|||
144585616|NCT02245737|521343780|FG002|Overall Study|Sponsor Decision|432|||
144585617|NCT00621777|521343783|FG000|Open Phase|Adverse Event|20|||
144585618|NCT00621777|521343784|FG001|Open Phase|Adverse Event|0|||
144585619|NCT00621777|521343783|FG000|Open Phase|Did not abstain during open phase|56|||
144585620|NCT00621777|521343784|FG001|Open Phase|Did not abstain during open phase|0|||
144585621|NCT00621777|521343783|FG000|Open Phase|Withdrawal by Subject|17|||
144585622|NCT00621777|521343784|FG001|Open Phase|Withdrawal by Subject|0|||
144585623|NCT00621777|521343783|FG000|Open Phase|administrative|13|||
144585624|NCT00621777|521343784|FG001|Open Phase|administrative|0|||
144585625|NCT00621777|521343783|FG000|Open Phase|Lost to Follow-up|10|||
144585626|NCT00621777|521343784|FG001|Open Phase|Lost to Follow-up|0|||
144585627|NCT00621777|521343783|FG000|Randomized Phase|Adverse Event|3|||
144585628|NCT00621777|521343784|FG001|Randomized Phase|Adverse Event|3|||
144585629|NCT00621777|521343783|FG000|Randomized Phase|Lost to Follow-up|3|||
144585630|NCT00621777|521343784|FG001|Randomized Phase|Lost to Follow-up|3|||
144585631|NCT00621777|521343783|FG000|Randomized Phase|Withdrawal by Subject|1|||
144585632|NCT00621777|521343784|FG001|Randomized Phase|Withdrawal by Subject|9|||
144585633|NCT00621777|521343783|FG000|Randomized Phase|administrative|0|||
144585634|NCT00621777|521343784|FG001|Randomized Phase|administrative|3|||
144585635|NCT00621777|521343783|FG000|Randomized Phase|Death|0|||
144585636|NCT00621777|521343784|FG001|Randomized Phase|Death|1|||
144585637|NCT00446043|521343785|FG000|Overall Study|Adverse Event|9|||
144585638|NCT00446043|521343785|FG000|Overall Study|Withdrawal by Subject|70|||
144585639|NCT00446043|521343785|FG000|Overall Study|Protocol Violation|2|||
144585640|NCT00446043|521343785|FG000|Overall Study|Lost to Follow-up|42|||
144585641|NCT00446043|521343785|FG000|Overall Study|Pregnancy|2|||
144585642|NCT01239043|521343786|FG000|Overall Study|Protocol Violation|2|||
144585643|NCT01239043|521343787|FG001|Overall Study|Protocol Violation|1|||
144585644|NCT02929329|521343790|FG000|Overall Study|Withdrawal by Subject|24|||
144585645|NCT02929329|521343791|FG001|Overall Study|Withdrawal by Subject|21|||
144585646|NCT02929329|521343790|FG000|Overall Study|Lost to Follow-up|26|||
144585647|NCT02929329|521343791|FG001|Overall Study|Lost to Follow-up|20|||
144585648|NCT02929329|521343790|FG000|Overall Study|Death|1054|||
144585649|NCT02929329|521343791|FG001|Overall Study|Death|1051|||
144585650|NCT02121301|521343792|FG000|Overall Study|Protocol Violation|1|||
144585651|NCT02121301|521343793|FG001|Overall Study|Protocol Violation|4|||
144585652|NCT02121301|521343794|FG002|Overall Study|Protocol Violation|1|||
144585653|NCT02663518|521343797|FG000|Part 1: Phase 1a Escalation|Death|0|||
144585654|NCT02663518|521343798|FG001|Part 1: Phase 1a Escalation|Death|0|||
144585655|NCT02663518|521343799|FG002|Part 1: Phase 1a Escalation|Death|1|||
144585656|NCT02663518|521343800|FG003|Part 1: Phase 1a Escalation|Death|0|||
144585657|NCT02663518|521343801|FG004|Part 1: Phase 1a Escalation|Death|0|||
144585658|NCT02663518|521343802|FG005|Part 1: Phase 1a Escalation|Death|0|||
144623706|NCT01789970|521478644|FG000|Open-label Titration Period|Adverse Event|68|||
144623707|NCT01789970|521478645|FG001|Open-label Titration Period|Adverse Event|0|||
144623708|NCT01789970|521478646|FG002|Open-label Titration Period|Adverse Event|0|||
144623709|NCT01789970|521478644|FG000|Open-label Titration Period|Lack of Efficacy|31|||
144623710|NCT01789970|521478645|FG001|Open-label Titration Period|Lack of Efficacy|0|||
144623711|NCT01789970|521478646|FG002|Open-label Titration Period|Lack of Efficacy|0|||
144623712|NCT01789970|521478644|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
144623713|NCT01789970|521478645|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
144623714|NCT01789970|521478646|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
144623715|NCT01789970|521478644|FG000|Open-label Titration Period|Protocol Violation|18|||
144623716|NCT01789970|521478645|FG001|Open-label Titration Period|Protocol Violation|0|||
144623717|NCT01789970|521478646|FG002|Open-label Titration Period|Protocol Violation|0|||
144623718|NCT01789970|521478644|FG000|Open-label Titration Period|Lost to Follow-up|5|||
144623719|NCT01789970|521478645|FG001|Open-label Titration Period|Lost to Follow-up|0|||
144623720|NCT01789970|521478646|FG002|Open-label Titration Period|Lost to Follow-up|0|||
144623721|NCT01789970|521478644|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
144623722|NCT01789970|521478645|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
144623723|NCT01789970|521478646|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
144623724|NCT01789970|521478644|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
144623725|NCT01789970|521478645|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
144623726|NCT01789970|521478646|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
144623727|NCT01789970|521478644|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
144623728|NCT01789970|521478645|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
144623729|NCT01789970|521478646|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
144623730|NCT01789970|521478644|FG000|Open-label Titration Period|Pregnancy|2|||
144623731|NCT01789970|521478645|FG001|Open-label Titration Period|Pregnancy|0|||
144623732|NCT01789970|521478646|FG002|Open-label Titration Period|Pregnancy|0|||
144623733|NCT01789970|521478644|FG000|Open-label Titration Period|Other|76|||
144623734|NCT01789970|521478645|FG001|Open-label Titration Period|Other|0|||
144623735|NCT01789970|521478646|FG002|Open-label Titration Period|Other|0|||
144623736|NCT01789970|521478644|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
144623737|NCT01789970|521478645|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
144623738|NCT01789970|521478646|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
144623739|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
144623740|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
144623741|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
144623742|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
144623743|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
144623744|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
144623745|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144623746|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
144623747|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
144623748|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
144623749|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
144623750|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
144623751|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
144623752|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
144623753|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
144623754|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
144623755|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
144623756|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
144623757|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144623758|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
144623759|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
144623760|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
144623761|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
144623762|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
144623763|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
144623764|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
144623765|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
144623766|NCT01789970|521478644|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
144623767|NCT01789970|521478645|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
144262899|NCT01716806|520163781|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
144262900|NCT01716806|520163776|FG000|Overall Study|PI decision|0|||
144262901|NCT01716806|520163777|FG001|Overall Study|PI decision|0|||
144623768|NCT01789970|521478646|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
144623769|NCT00643994|521478647|FG000|Overall Study|Death|24|||
144623770|NCT00643994|521478647|FG000|Overall Study|Lost to Follow-up|72|||
144623771|NCT02347176|521478657|FG000|Overall Study|Lost to Follow-up|2|||
144623772|NCT02347176|521478658|FG001|Overall Study|Lost to Follow-up|3|||
144623773|NCT02347176|521478659|FG002|Overall Study|Lost to Follow-up|1|||
144623774|NCT02347176|521478660|FG003|Overall Study|Lost to Follow-up|1|||
144623775|NCT02347176|521478657|FG000|Overall Study|Withdrawal by Subject|9|||
144623776|NCT02347176|521478658|FG001|Overall Study|Withdrawal by Subject|5|||
144623777|NCT02347176|521478659|FG002|Overall Study|Withdrawal by Subject|5|||
144623778|NCT02347176|521478660|FG003|Overall Study|Withdrawal by Subject|3|||
144623779|NCT02347176|521478657|FG000|Overall Study|Other|1|||
144623780|NCT02347176|521478658|FG001|Overall Study|Other|2|||
144623781|NCT02347176|521478659|FG002|Overall Study|Other|2|||
144623782|NCT02347176|521478660|FG003|Overall Study|Other|0|||
144623783|NCT00699907|521478665|FG000|Overall Study|Withdrawal by Subject|2|||
144623784|NCT00699907|521478666|FG001|Overall Study|Withdrawal by Subject|1|||
144623785|NCT00699907|521478667|FG002|Overall Study|Withdrawal by Subject|0|||
144623786|NCT00699907|521478665|FG000|Overall Study|No usable sample|0|||
144623787|NCT00699907|521478666|FG001|Overall Study|No usable sample|9|||
144623788|NCT00699907|521478667|FG002|Overall Study|No usable sample|8|||
144623789|NCT02161211|521478668|FG000|Overall Study|Lost to Follow-up|21|||
144623790|NCT02161211|521478669|FG001|Overall Study|Lost to Follow-up|27|||
144623791|NCT02161211|521478670|FG002|Overall Study|Lost to Follow-up|21|||
144623792|NCT02161211|521478668|FG000|Overall Study|Dropped|12|||
144623793|NCT02161211|521478669|FG001|Overall Study|Dropped|5|||
144623794|NCT02161211|521478670|FG002|Overall Study|Dropped|9|||
144623795|NCT00430508|521478672|FG000|Overall Study|Adverse Event|2|||
144623796|NCT00430508|521478673|FG001|Overall Study|Adverse Event|3|||
144623797|NCT00430508|521478674|FG002|Overall Study|Adverse Event|5|||
144623798|NCT00430508|521478675|FG003|Overall Study|Adverse Event|3|||
144623799|NCT00430508|521478672|FG000|Overall Study|Withdrawal by Subject|0|||
144623800|NCT00430508|521478673|FG001|Overall Study|Withdrawal by Subject|1|||
144623801|NCT00430508|521478674|FG002|Overall Study|Withdrawal by Subject|1|||
144623802|NCT00430508|521478675|FG003|Overall Study|Withdrawal by Subject|1|||
144623803|NCT00430508|521478672|FG000|Overall Study|responder at visit 4|0|||
144623804|NCT00430508|521478673|FG001|Overall Study|responder at visit 4|0|||
144623805|NCT00430508|521478674|FG002|Overall Study|responder at visit 4|2|||
144623806|NCT00430508|521478675|FG003|Overall Study|responder at visit 4|0|||
144623807|NCT00430508|521478672|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
144623808|NCT00430508|521478673|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
144623809|NCT00430508|521478674|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
144623810|NCT00430508|521478675|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
144623811|NCT00430508|521478672|FG000|Overall Study|Other|1|||
144623812|NCT00430508|521478673|FG001|Overall Study|Other|1|||
144623813|NCT00430508|521478674|FG002|Overall Study|Other|3|||
144623814|NCT00430508|521478675|FG003|Overall Study|Other|0|||
144623815|NCT01703858|521478677|FG000|Overall Study|Withdrawal by Subject|0|||
144209537|NCT00425373|519961972|FG001|Overall Study|Withdrawal by Subject|0|||
144209538|NCT00425373|519961973|FG002|Overall Study|Withdrawal by Subject|2|||
144209539|NCT00425373|519961974|FG003|Overall Study|Withdrawal by Subject|1|||
144623816|NCT01703858|521478678|FG001|Overall Study|Withdrawal by Subject|1|||
144623817|NCT01703858|521478679|FG002|Overall Study|Withdrawal by Subject|0|||
144623818|NCT01543087|521478681|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
144623819|NCT01543087|521478682|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
144623820|NCT01543087|521478683|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
144623821|NCT01543087|521478684|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
144623822|NCT01543087|521478685|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
144623823|NCT01543087|521478686|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
144623824|NCT01543087|521478681|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
144623825|NCT01543087|521478682|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
144623826|NCT01543087|521478683|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
144623827|NCT01543087|521478684|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
144623828|NCT01543087|521478685|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
144623829|NCT01543087|521478686|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
144623830|NCT01543087|521478681|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
144623831|NCT01543087|521478682|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
144623832|NCT01543087|521478683|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
144623833|NCT01543087|521478684|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
144623834|NCT01543087|521478685|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
144623835|NCT01543087|521478686|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
144209540|NCT00425373|519961975|FG004|Overall Study|Withdrawal by Subject|4|||
144209541|NCT00425373|519961976|FG005|Overall Study|Withdrawal by Subject|0|||
144209542|NCT00425373|519961977|FG006|Overall Study|Withdrawal by Subject|2|||
144209543|NCT00425373|519961978|FG007|Overall Study|Withdrawal by Subject|2|||
144730520|NCT01471093|521869808|FG002|Overall Study|Adverse Event|0|||
144730521|NCT01471093|521869809|FG003|Overall Study|Adverse Event|0|||
144623836|NCT01543087|521478681|FG000|Stage 1 (48 Months)|Other than specified|5|||
144623837|NCT01543087|521478682|FG001|Stage 1 (48 Months)|Other than specified|0|||
144623838|NCT01543087|521478683|FG002|Stage 1 (48 Months)|Other than specified|9|||
144623839|NCT01543087|521478684|FG003|Stage 1 (48 Months)|Other than specified|0|||
144623840|NCT01543087|521478685|FG004|Stage 1 (48 Months)|Other than specified|0|||
144623841|NCT01543087|521478686|FG005|Stage 1 (48 Months)|Other than specified|0|||
144623842|NCT01543087|521478681|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
144623843|NCT01543087|521478682|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
144623844|NCT01543087|521478683|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
144623845|NCT01543087|521478684|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
144623846|NCT01543087|521478685|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
144623847|NCT01543087|521478686|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
144623848|NCT01543087|521478681|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
144623849|NCT01543087|521478682|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
144730522|NCT02475954|521869810|FG000|Overall Study|Withdrawal by Subject|2|||
144730523|NCT02475954|521869811|FG001|Overall Study|Withdrawal by Subject|2|||
144209544|NCT00425373|519961979|FG008|Overall Study|Withdrawal by Subject|2|||
144585659|NCT02663518|521343803|FG006|Part 1: Phase 1a Escalation|Death|0|||
144585660|NCT02663518|521343804|FG007|Part 1: Phase 1a Escalation|Death|0|||
144585661|NCT02663518|521343805|FG008|Part 1: Phase 1a Escalation|Death|0|||
144585662|NCT02663518|521343806|FG009|Part 1: Phase 1a Escalation|Death|0|||
144585663|NCT02663518|521343807|FG010|Part 1: Phase 1a Escalation|Death|0|||
144585664|NCT02663518|521343808|FG011|Part 1: Phase 1a Escalation|Death|0|||
144585665|NCT02663518|521343809|FG012|Part 1: Phase 1a Escalation|Death|0|||
144585666|NCT02663518|521343810|FG013|Part 1: Phase 1a Escalation|Death|0|||
144585667|NCT02663518|521343797|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585668|NCT02663518|521343798|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585669|NCT02663518|521343799|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
144585670|NCT02663518|521343800|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585671|NCT02663518|521343801|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585672|NCT02663518|521343802|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585673|NCT02663518|521343803|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585674|NCT02663518|521343804|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585675|NCT02663518|521343805|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585676|NCT02663518|521343806|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585677|NCT02663518|521343807|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585678|NCT02663518|521343808|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585679|NCT02663518|521343809|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585680|NCT02663518|521343810|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
144585681|NCT02663518|521343797|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
144585682|NCT02663518|521343798|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
144585683|NCT02663518|521343799|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
144585684|NCT02663518|521343800|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
144585685|NCT02663518|521343801|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585686|NCT02663518|521343802|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585687|NCT02663518|521343803|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585688|NCT02663518|521343804|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585689|NCT02663518|521343805|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585690|NCT02663518|521343806|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585691|NCT02663518|521343807|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585692|NCT02663518|521343808|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585693|NCT02663518|521343809|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585694|NCT02663518|521343810|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
144585695|NCT02663518|521343797|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
144585696|NCT02663518|521343798|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585697|NCT02663518|521343799|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
144585698|NCT02663518|521343800|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
144585699|NCT02663518|521343801|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585700|NCT02663518|521343802|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585701|NCT02663518|521343803|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585702|NCT02663518|521343804|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585703|NCT02663518|521343805|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585704|NCT02663518|521343806|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585705|NCT02663518|521343807|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585706|NCT02663518|521343808|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585707|NCT02663518|521343809|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585708|NCT02663518|521343810|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
144585709|NCT02663518|521343797|FG000|Part 1: Phase 1a Escalation|Other|0|||
144623850|NCT01543087|521478683|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
144209545|NCT00425373|519961971|FG000|Overall Study|Lack of Efficacy|0|||
144209546|NCT00425373|519961972|FG001|Overall Study|Lack of Efficacy|0|||
144623851|NCT01543087|521478684|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
144209547|NCT00425373|519961973|FG002|Overall Study|Lack of Efficacy|0|||
144209548|NCT00425373|519961974|FG003|Overall Study|Lack of Efficacy|0|||
144209549|NCT00425373|519961975|FG004|Overall Study|Lack of Efficacy|1|||
144209550|NCT00425373|519961976|FG005|Overall Study|Lack of Efficacy|3|||
144209551|NCT00425373|519961977|FG006|Overall Study|Lack of Efficacy|3|||
144623852|NCT01543087|521478685|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
144623853|NCT01543087|521478686|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
144623854|NCT01543087|521478681|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
144623855|NCT01543087|521478682|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
144623856|NCT01543087|521478683|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
144623857|NCT01543087|521478684|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
144623858|NCT01543087|521478685|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
144623859|NCT01543087|521478686|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
144262902|NCT01716806|520163778|FG002|Overall Study|PI decision|0|||
144262903|NCT01716806|520163779|FG003|Overall Study|PI decision|0|||
144262904|NCT01716806|520163780|FG004|Overall Study|PI decision|1|||
144262905|NCT01716806|520163781|FG005|Overall Study|PI decision|0|||
144262906|NCT01716806|520163776|FG000|Overall Study|Change in performance status|1|||
144262907|NCT01716806|520163777|FG001|Overall Study|Change in performance status|0|||
144262908|NCT01716806|520163778|FG002|Overall Study|Change in performance status|0|||
144262909|NCT01716806|520163779|FG003|Overall Study|Change in performance status|0|||
144262910|NCT01716806|520163780|FG004|Overall Study|Change in performance status|0|||
144623860|NCT01325428|521478688|FG000|Part A|Progressive disease according to RECIST|9|||
144623861|NCT01325428|521478688|FG000|Part A|Clinical signs, symptoms of progression|2|||
144623862|NCT01325428|521478688|FG000|Part A|Other adverse event|1|||
144623863|NCT01325428|521478688|FG000|Part A|Refused continue taking trial medication|2|||
144623864|NCT01325428|521478688|FG000|Part A|Other reason not defined above|2|||
144623865|NCT01325428|521478688|FG000|Part B|Refused continue taking trial medication|2|||
144623866|NCT01325428|521478688|FG000|Part B|Other reason not defined above|1|||
144623867|NCT01422239|521478689|FG000|Overall Study|Lost to Follow-up|4|||
144623868|NCT01422239|521478690|FG001|Overall Study|Lost to Follow-up|3|||
144623869|NCT03208231|521478701|FG000|Overall Study|Death|1|||
144262911|NCT01716806|520163781|FG005|Overall Study|Change in performance status|0|||
144262912|NCT01716806|520163776|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
144262913|NCT01716806|520163777|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
144262914|NCT01716806|520163778|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
144262915|NCT01716806|520163779|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
144262916|NCT01716806|520163780|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
144262917|NCT01716806|520163781|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
144262918|NCT01716806|520163776|FG000|Overall Study|Sponsor direction|7|||
144262919|NCT01716806|520163777|FG001|Overall Study|Sponsor direction|8|||
144262920|NCT01716806|520163778|FG002|Overall Study|Sponsor direction|5|||
144262921|NCT01716806|520163779|FG003|Overall Study|Sponsor direction|12|||
144623870|NCT03208231|521478702|FG001|Overall Study|Death|2|||
144623871|NCT03208231|521478701|FG000|Overall Study|Moved and unable to get to clinic|1|||
144623872|NCT03208231|521478702|FG001|Overall Study|Moved and unable to get to clinic|0|||
144623873|NCT03208231|521478701|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
144623874|NCT03208231|521478702|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
144623875|NCT04158648|521478707|FG000|Overall Study|Ongoing in the Study|69|||
144623876|NCT04158648|521478707|FG000|Overall Study|Withdrawal by Subject|4|||
144623877|NCT02926950|521478708|FG000|Overall Study|Adverse Event|4|||
144623878|NCT02926950|521478709|FG001|Overall Study|Adverse Event|6|||
144623879|NCT02926950|521478708|FG000|Overall Study|At the participant's own request|21|||
144623880|NCT02926950|521478709|FG001|Overall Study|At the participant's own request|25|||
144623881|NCT02926950|521478708|FG000|Overall Study|Reason not Specified|17|||
144623882|NCT02926950|521478709|FG001|Overall Study|Reason not Specified|9|||
144623883|NCT02926950|521478708|FG000|Overall Study|Lost to Follow-up|7|||
144623884|NCT02926950|521478709|FG001|Overall Study|Lost to Follow-up|8|||
144623885|NCT05036083|521478710|FG000|Overall Study|Physician Decision|1|||
144623886|NCT05036083|521478710|FG000|Overall Study|Withdrawal by Subject|1|||
144623887|NCT05036083|521478710|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
144623888|NCT05036083|521478710|FG000|Overall Study|IV not sustainable|1|||
144623889|NCT04622046|521478711|FG000|Intervention Period|Adverse Event|1|||
144623890|NCT04622046|521478711|FG000|Intervention Period|Withdrawal by Subject|2|||
144209552|NCT00425373|519961978|FG007|Overall Study|Lack of Efficacy|0|||
144209553|NCT00425373|519961979|FG008|Overall Study|Lack of Efficacy|5|||
144262922|NCT01716806|520163780|FG004|Overall Study|Sponsor direction|16|||
144209554|NCT02564887|519961981|FG000|Overall Study|Lost to Follow-up|6|||
144209555|NCT02564887|519961982|FG001|Overall Study|Lost to Follow-up|0|||
144262923|NCT01716806|520163781|FG005|Overall Study|Sponsor direction|1|||
144262924|NCT02692586|520163782|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
144623891|NCT04622046|521478711|FG000|Extension Period|Ongoing in the Extension Period|21|||
144623892|NCT03505021|521478712|FG000|Overall Study|Protocol Violation|1|||
144623893|NCT03505021|521478713|FG001|Overall Study|Protocol Violation|0|||
144623894|NCT03505021|521478712|FG000|Overall Study|Death|9|||
144623895|NCT03505021|521478713|FG001|Overall Study|Death|8|||
144623896|NCT03505021|521478712|FG000|Overall Study|Consent withdrawn by subject|6|||
144623897|NCT03505021|521478713|FG001|Overall Study|Consent withdrawn by subject|1|||
144623898|NCT03505021|521478712|FG000|Overall Study|Lost to Follow-up|5|||
144623899|NCT03505021|521478713|FG001|Overall Study|Lost to Follow-up|3|||
144623900|NCT03505021|521478712|FG000|Overall Study|Adverse Event|26|||
144623901|NCT03505021|521478713|FG001|Overall Study|Adverse Event|9|||
144623902|NCT03505021|521478712|FG000|Overall Study|Disease progression|33|||
144623903|NCT03505021|521478713|FG001|Overall Study|Disease progression|17|||
144623904|NCT03505021|521478712|FG000|Overall Study|Other|11|||
144623905|NCT03505021|521478713|FG001|Overall Study|Other|5|||
144623906|NCT03505021|521478712|FG000|Overall Study|Personal reason|21|||
144623907|NCT03505021|521478713|FG001|Overall Study|Personal reason|12|||
144623908|NCT04341948|521478714|FG000|Overall Study|Adverse Event|0|||
144623909|NCT04341948|521478715|FG001|Overall Study|Adverse Event|1|||
144623910|NCT04341948|521478714|FG000|Overall Study|Lost to Follow-up|6|||
144623911|NCT04341948|521478715|FG001|Overall Study|Lost to Follow-up|1|||
144623912|NCT04341948|521478714|FG000|Overall Study|Physician Decision|1|||
144623913|NCT04341948|521478715|FG001|Overall Study|Physician Decision|2|||
144623914|NCT04341948|521478714|FG000|Overall Study|Withdrawal by Participant|6|||
144623915|NCT04341948|521478715|FG001|Overall Study|Withdrawal by Participant|3|||
144623916|NCT04341948|521478714|FG000|Overall Study|Lack of compliance by Participant|1|||
144623917|NCT04341948|521478715|FG001|Overall Study|Lack of compliance by Participant|0|||
144623918|NCT03266016|521480359|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
144623919|NCT03266016|521480360|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
144623920|NCT03266016|521480361|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
144623921|NCT03266016|521480362|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
144623922|NCT03266016|521480359|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
144623923|NCT03266016|521480360|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
144623924|NCT03266016|521480361|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
144623925|NCT03266016|521480362|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
144623926|NCT00482014|521480363|FG000|Overall Study|Withdrawal by Subject|1|||
144623927|NCT00482014|521480364|FG001|Overall Study|Withdrawal by Subject|2|||
144623928|NCT00482014|521480365|FG002|Overall Study|Withdrawal by Subject|3|||
144623929|NCT00482014|521480366|FG003|Overall Study|Withdrawal by Subject|4|||
144623930|NCT00482014|521480363|FG000|Overall Study|Adverse Event|3|||
144623931|NCT00482014|521480364|FG001|Overall Study|Adverse Event|0|||
144623932|NCT00482014|521480365|FG002|Overall Study|Adverse Event|2|||
144623933|NCT00482014|521480366|FG003|Overall Study|Adverse Event|8|||
144623934|NCT00482014|521480363|FG000|Overall Study|Death|1|||
144623935|NCT00482014|521480364|FG001|Overall Study|Death|2|||
144623936|NCT00482014|521480365|FG002|Overall Study|Death|1|||
144623937|NCT00482014|521480366|FG003|Overall Study|Death|4|||
144623938|NCT00482014|521480363|FG000|Overall Study|Lack of Efficacy|1|||
144623939|NCT00482014|521480364|FG001|Overall Study|Lack of Efficacy|0|||
144623940|NCT00482014|521480365|FG002|Overall Study|Lack of Efficacy|4|||
144623941|NCT00482014|521480366|FG003|Overall Study|Lack of Efficacy|6|||
144623942|NCT00482014|521480363|FG000|Overall Study|Sponsor Decision|1|||
144623943|NCT00482014|521480364|FG001|Overall Study|Sponsor Decision|2|||
144623944|NCT00482014|521480365|FG002|Overall Study|Sponsor Decision|1|||
144623945|NCT00482014|521480366|FG003|Overall Study|Sponsor Decision|1|||
144623946|NCT03686397|521480367|FG000|Overall Study|Lack of Efficacy|3|||
144623947|NCT03686397|521480368|FG001|Overall Study|Lack of Efficacy|5|||
144623948|NCT03686397|521480367|FG000|Overall Study|Adverse Event|0|||
144623949|NCT03686397|521480368|FG001|Overall Study|Adverse Event|1|||
144623950|NCT03686397|521480367|FG000|Overall Study|Protocol Violation|0|||
144623951|NCT03686397|521480368|FG001|Overall Study|Protocol Violation|1|||
144623952|NCT03686397|521480367|FG000|Overall Study|Withdrawal by Subject|0|||
144623953|NCT03686397|521480368|FG001|Overall Study|Withdrawal by Subject|1|||
144623954|NCT03686397|521480367|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
144623955|NCT03686397|521480368|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
144623956|NCT03718143|521480374|FG000|Overall Study|Death|1|||
144623957|NCT03718143|521480375|FG001|Overall Study|Death|0|||
144623958|NCT03718143|521480376|FG002|Overall Study|Death|0|||
144623959|NCT03718143|521480374|FG000|Overall Study|Progression of Disease|1|||
144623960|NCT03718143|521480375|FG001|Overall Study|Progression of Disease|0|||
144623961|NCT03718143|521480376|FG002|Overall Study|Progression of Disease|0|||
144623962|NCT03718143|521480374|FG000|Overall Study|Withdrawal of Informed Consent|1|||
144623963|NCT03718143|521480375|FG001|Overall Study|Withdrawal of Informed Consent|2|||
144623964|NCT03718143|521480376|FG002|Overall Study|Withdrawal of Informed Consent|1|||
144623965|NCT05064059|521480377|FG000|Overall Study|Death|199|||
144623966|NCT05064059|521480378|FG001|Overall Study|Death|196|||
144623967|NCT05064059|521480377|FG000|Overall Study|Physician Decision|4|||
144623968|NCT05064059|521480378|FG001|Overall Study|Physician Decision|2|||
144623969|NCT05064059|521480377|FG000|Overall Study|Sponsor Decision|14|||
144623970|NCT05064059|521480378|FG001|Overall Study|Sponsor Decision|11|||
144623971|NCT05064059|521480377|FG000|Overall Study|Withdrawal by Subject|4|||
144623972|NCT05064059|521480378|FG001|Overall Study|Withdrawal by Subject|11|||
144623973|NCT04316585|521480379|FG000|Overall Study|Adverse Event|2|||
144623974|NCT04316585|521480380|FG001|Overall Study|Adverse Event|1|||
144623975|NCT04316585|521480379|FG000|Overall Study|Lost to Follow-up|1|||
144623976|NCT04316585|521480380|FG001|Overall Study|Lost to Follow-up|0|||
144623977|NCT04316585|521480379|FG000|Overall Study|Withdrawal by Subject|2|||
144623978|NCT04316585|521480380|FG001|Overall Study|Withdrawal by Subject|3|||
144623979|NCT04316585|521480379|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
144623980|NCT04316585|521480380|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
144623981|NCT04316585|521480379|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
144623982|NCT04316585|521480380|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
144623983|NCT01072344|521480382|FG000|Overall Study|Relasped-reached end point|7|||
144623984|NCT01072344|521480383|FG001|Overall Study|Relasped-reached end point|12|||
144623985|NCT01072344|521480382|FG000|Overall Study|Protocol Violation|1|||
144623986|NCT01072344|521480383|FG001|Overall Study|Protocol Violation|2|||
144623987|NCT01072344|521480382|FG000|Overall Study|Lost to Follow-up|3|||
144623988|NCT01072344|521480383|FG001|Overall Study|Lost to Follow-up|4|||
144623989|NCT00808444|521480392|FG000|Overall Study|Withdrawal by Subject|1|||
144623990|NCT00808444|521480393|FG001|Overall Study|Withdrawal by Subject|0|||
144623991|NCT00808444|521480392|FG000|Overall Study|Lost to Follow-up|0|||
144623992|NCT00808444|521480393|FG001|Overall Study|Lost to Follow-up|1|||
144623993|NCT01461044|521480394|FG000|Overall Study|Death|58|||
144623994|NCT01461044|521480395|FG001|Overall Study|Death|35|||
144623995|NCT01461044|521480394|FG000|Overall Study|Lost to Follow-up|12|||
144623996|NCT01461044|521480395|FG001|Overall Study|Lost to Follow-up|5|||
144623997|NCT00122135|521480396|FG000|Overall Study|Withdrawal by Subject|3|||
144623998|NCT00122135|521480397|FG001|Overall Study|Withdrawal by Subject|0|||
144623999|NCT03269344|521480398|FG000|Overall Study|Protocol Violation|4|||
144624000|NCT03269344|521480399|FG001|Overall Study|Protocol Violation|3|||
144624001|NCT00805740|521480405|FG000|Overall Study|Death|7|||
144624002|NCT00805740|521480406|FG001|Overall Study|Death|4|||
144624003|NCT00805740|521480405|FG000|Overall Study|Withdrawal by Subject|1|||
144624004|NCT00805740|521480406|FG001|Overall Study|Withdrawal by Subject|0|||
144624005|NCT00805740|521480405|FG000|Overall Study|Lost to Follow-up|1|||
144624006|NCT00805740|521480406|FG001|Overall Study|Lost to Follow-up|0|||
144624007|NCT00805740|521480405|FG000|Overall Study|Randomized, but not treated|2|||
144624008|NCT00805740|521480406|FG001|Overall Study|Randomized, but not treated|0|||
144624009|NCT00200850|521480411|FG000|Overall Study|relocation|1|||
144624010|NCT00200850|521480412|FG001|Overall Study|relocation|0|||
144624011|NCT00200850|521480413|FG002|Overall Study|relocation|1|||
144624012|NCT00200850|521480411|FG000|Overall Study|too busy|1|||
144624013|NCT00200850|521480412|FG001|Overall Study|too busy|0|||
144624014|NCT00200850|521480413|FG002|Overall Study|too busy|0|||
144624015|NCT00200850|521480411|FG000|Overall Study|Pregnancy|0|||
144624016|NCT00200850|521480412|FG001|Overall Study|Pregnancy|0|||
144624017|NCT00200850|521480413|FG002|Overall Study|Pregnancy|1|||
144624018|NCT00200850|521480411|FG000|Overall Study|Poor adherence|0|||
144624019|NCT00200850|521480412|FG001|Overall Study|Poor adherence|0|||
144624020|NCT00200850|521480413|FG002|Overall Study|Poor adherence|1|||
144624021|NCT00200850|521480411|FG000|Overall Study|optic neuritis|0|||
144624022|NCT00200850|521480412|FG001|Overall Study|optic neuritis|0|||
144624023|NCT00200850|521480413|FG002|Overall Study|optic neuritis|1|||
144624024|NCT00200850|521480411|FG000|Overall Study|Adverse Event|1|||
144624025|NCT00200850|521480412|FG001|Overall Study|Adverse Event|1|||
144624026|NCT00200850|521480413|FG002|Overall Study|Adverse Event|2|||
144624027|NCT01449708|521480414|FG000|Overall Study|Protocol Violation|0|||
144624028|NCT01449708|521480415|FG001|Overall Study|Protocol Violation|1|||
144209556|NCT02648932|519961983|FG000|Overall Study|No transplant|3|||
144624029|NCT01449708|521480414|FG000|Overall Study|surgical complication|1|||
144624030|NCT01449708|521480415|FG001|Overall Study|surgical complication|2|||
144624031|NCT01449708|521480414|FG000|Overall Study|respiratory failure|1|||
144624032|NCT01449708|521480415|FG001|Overall Study|respiratory failure|0|||
144624033|NCT05227690|521480424|FG000|Overall Study|Adverse Event|5|||
144624034|NCT05227690|521480425|FG001|Overall Study|Adverse Event|6|||
144624035|NCT05227690|521480426|FG002|Overall Study|Adverse Event|10|||
144624036|NCT05227690|521480424|FG000|Overall Study|Lack of Efficacy|2|||
144624037|NCT05227690|521480425|FG001|Overall Study|Lack of Efficacy|4|||
144624038|NCT05227690|521480426|FG002|Overall Study|Lack of Efficacy|1|||
144624039|NCT05227690|521480424|FG000|Overall Study|Physician Decision|6|||
144624040|NCT05227690|521480425|FG001|Overall Study|Physician Decision|0|||
144624041|NCT05227690|521480426|FG002|Overall Study|Physician Decision|4|||
144624042|NCT05227690|521480424|FG000|Overall Study|Withdrawal of consent|28|||
144624043|NCT05227690|521480425|FG001|Overall Study|Withdrawal of consent|27|||
144624044|NCT05227690|521480426|FG002|Overall Study|Withdrawal of consent|21|||
144624045|NCT05227690|521480424|FG000|Overall Study|Other, not specified|2|||
144624046|NCT05227690|521480425|FG001|Overall Study|Other, not specified|2|||
144624047|NCT05227690|521480426|FG002|Overall Study|Other, not specified|1|||
144585710|NCT02663518|521343798|FG001|Part 1: Phase 1a Escalation|Other|0|||
144585711|NCT02663518|521343799|FG002|Part 1: Phase 1a Escalation|Other|2|||
144585712|NCT02663518|521343800|FG003|Part 1: Phase 1a Escalation|Other|0|||
144585713|NCT02663518|521343801|FG004|Part 1: Phase 1a Escalation|Other|0|||
144585714|NCT02663518|521343802|FG005|Part 1: Phase 1a Escalation|Other|0|||
144585715|NCT02663518|521343803|FG006|Part 1: Phase 1a Escalation|Other|0|||
144585716|NCT02663518|521343804|FG007|Part 1: Phase 1a Escalation|Other|0|||
144585717|NCT02663518|521343805|FG008|Part 1: Phase 1a Escalation|Other|0|||
144585718|NCT02663518|521343806|FG009|Part 1: Phase 1a Escalation|Other|0|||
144585719|NCT02663518|521343807|FG010|Part 1: Phase 1a Escalation|Other|0|||
144585720|NCT02663518|521343808|FG011|Part 1: Phase 1a Escalation|Other|0|||
144585721|NCT02663518|521343809|FG012|Part 1: Phase 1a Escalation|Other|0|||
144585722|NCT02663518|521343810|FG013|Part 1: Phase 1a Escalation|Other|0|||
144585723|NCT02663518|521343797|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585724|NCT02663518|521343798|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585725|NCT02663518|521343799|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585726|NCT02663518|521343800|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585727|NCT02663518|521343801|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
144585728|NCT02663518|521343802|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585729|NCT02663518|521343803|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
144585730|NCT02663518|521343804|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
144585731|NCT02663518|521343805|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585732|NCT02663518|521343806|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585733|NCT02663518|521343807|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585734|NCT02663518|521343808|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585735|NCT02663518|521343809|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585736|NCT02663518|521343810|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
144585737|NCT02663518|521343797|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585738|NCT02663518|521343798|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585739|NCT02663518|521343799|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585740|NCT02663518|521343800|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585741|NCT02663518|521343801|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
144585742|NCT02663518|521343802|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585743|NCT02663518|521343803|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
144585744|NCT02663518|521343804|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
144585745|NCT02663518|521343805|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585746|NCT02663518|521343806|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585747|NCT02663518|521343807|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585748|NCT02663518|521343808|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585749|NCT02663518|521343809|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585750|NCT02663518|521343810|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
144585751|NCT02663518|521343797|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585752|NCT02663518|521343798|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585753|NCT02663518|521343799|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585754|NCT02663518|521343800|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585755|NCT02663518|521343801|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
144585756|NCT02663518|521343802|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585757|NCT02663518|521343803|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585758|NCT02663518|521343804|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585759|NCT02663518|521343805|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585760|NCT02663518|521343806|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585761|NCT02663518|521343807|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585762|NCT02663518|521343808|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585763|NCT02663518|521343809|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585764|NCT02663518|521343810|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
144585765|NCT02663518|521343797|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585766|NCT02663518|521343798|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585767|NCT02663518|521343799|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585768|NCT02663518|521343800|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585769|NCT02663518|521343801|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
144585770|NCT02663518|521343802|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
144585771|NCT02663518|521343803|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
144585772|NCT02663518|521343804|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
144585773|NCT02663518|521343805|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585774|NCT02663518|521343806|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585775|NCT02663518|521343807|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585776|NCT02663518|521343808|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585777|NCT02663518|521343809|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144585778|NCT02663518|521343810|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
144624048|NCT00223496|521480427|FG000|Overall Study|screen failure|9|||
144624049|NCT00223496|521480427|FG000|Overall Study|Lost to Follow-up|4|||
144624050|NCT00223496|521480427|FG000|Overall Study|Lack of Efficacy|6|||
144624051|NCT00223496|521480427|FG000|Overall Study|Withdrawal by Subject|1|||
144624052|NCT00223496|521480427|FG000|Overall Study|Physician Decision|2|||
144624053|NCT02723201|521480430|FG000|Second Intervention Period|Protocol Violation|1|||
144624054|NCT02723201|521480431|FG001|Second Intervention Period|Protocol Violation|0|||
144624055|NCT02723201|521480432|FG002|Second Intervention Period|Protocol Violation|0|||
144624056|NCT02723201|521480430|FG000|Second Intervention Period|Adverse Event|1|||
144624057|NCT02723201|521480431|FG001|Second Intervention Period|Adverse Event|0|||
144624058|NCT02723201|521480432|FG002|Second Intervention Period|Adverse Event|0|||
144624059|NCT04656652|521480433|FG000|Overall Study|Lost to Follow-up|2|||
144624060|NCT04656652|521480434|FG001|Overall Study|Lost to Follow-up|2|||
144624061|NCT04656652|521480433|FG000|Overall Study|Death|213|||
144624062|NCT04656652|521480434|FG001|Overall Study|Death|212|||
144624063|NCT04656652|521480433|FG000|Overall Study|Other|1|||
144624064|NCT04656652|521480434|FG001|Overall Study|Other|0|||
144624065|NCT04656652|521480433|FG000|Overall Study|Withdrawal by Subject|15|||
144624066|NCT04656652|521480434|FG001|Overall Study|Withdrawal by Subject|29|||
144624067|NCT02908880|521480435|FG000|Overall Study|Lost to Follow-up|4|||
144624068|NCT02908880|521480435|FG000|Overall Study|Explantation of the device|1|||
144624069|NCT02908880|521480435|FG000|Overall Study|Withdrawal by Subject|17|||
144624070|NCT02908880|521480435|FG000|Overall Study|Death|5|||
144624071|NCT01882907|521480436|FG000|Overall Study|Adverse Event|3|||
144624072|NCT01882907|521480437|FG001|Overall Study|Adverse Event|1|||
144624073|NCT01882907|521480436|FG000|Overall Study|Lack of Efficacy|0|||
144624074|NCT01882907|521480437|FG001|Overall Study|Lack of Efficacy|3|||
144624075|NCT01882907|521480436|FG000|Overall Study|Lost to Follow-up|1|||
144624076|NCT01882907|521480437|FG001|Overall Study|Lost to Follow-up|4|||
144624077|NCT01882907|521480436|FG000|Overall Study|Protocol Violation|10|||
144624078|NCT01882907|521480437|FG001|Overall Study|Protocol Violation|14|||
144624079|NCT01882907|521480436|FG000|Overall Study|Withdrawal by Subject|0|||
144624080|NCT01882907|521480437|FG001|Overall Study|Withdrawal by Subject|6|||
144624081|NCT01396005|521480442|FG000|Overall Study|Withdrawal by Subject|0|||
144624082|NCT01396005|521480443|FG001|Overall Study|Withdrawal by Subject|1|||
144624083|NCT01396005|521480442|FG000|Overall Study|Non-compliance with protocol|0|||
144624084|NCT01396005|521480443|FG001|Overall Study|Non-compliance with protocol|1|||
144624085|NCT00424827|521480446|FG000|Overall Study|Adverse Event|1|||
144624086|NCT00491179|521480449|FG000|Overall Study|Adverse Event|5|||
144624087|NCT00491179|521480450|FG001|Overall Study|Adverse Event|1|||
144624088|NCT00491179|521480449|FG000|Overall Study|Withdrawal by Subject|2|||
144624089|NCT00491179|521480450|FG001|Overall Study|Withdrawal by Subject|1|||
144624090|NCT04269395|521480451|FG000|Overall Study|Lost to Follow-up|1|||
144624091|NCT04269395|521480452|FG001|Overall Study|Lost to Follow-up|0|||
144624092|NCT04269395|521480451|FG000|Overall Study|Study terminated by Sponsor|13|||
144624093|NCT04269395|521480452|FG001|Overall Study|Study terminated by Sponsor|10|||
144624094|NCT00584233|521480453|FG000|Overall Study|Withdrawal by Subject|5|||
144624095|NCT00584233|521480453|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
144624096|NCT00159432|521480454|FG000|Overall Study|Adverse Event|1|||
144624097|NCT00159432|521480454|FG000|Overall Study|Death|1|||
144624098|NCT00159432|521480454|FG000|Overall Study|Lack of Efficacy|8|||
144624099|NCT05689047|521480457|FG000|Overall Study|Lost to Follow-up|0|||
144624100|NCT05689047|521480458|FG001|Overall Study|Lost to Follow-up|1|||
144624101|NCT05689047|521480457|FG000|Overall Study|Protocol Deviation|1|||
144624102|NCT05689047|521480458|FG001|Overall Study|Protocol Deviation|0|||
144624103|NCT03083886|521480459|FG000|Overall Study|Withdrawal by Subject|51|||
144624104|NCT03083886|521480460|FG001|Overall Study|Withdrawal by Subject|73|||
144624105|NCT03083886|521480461|FG002|Overall Study|Withdrawal by Subject|104|||
144624106|NCT03083886|521480459|FG000|Overall Study|Missing Baseline data|43|||
144624107|NCT03083886|521480460|FG001|Overall Study|Missing Baseline data|42|||
144624108|NCT03083886|521480461|FG002|Overall Study|Missing Baseline data|31|||
144624109|NCT03083886|521480459|FG000|Overall Study|Investigator terminated|1|||
144624110|NCT03083886|521480460|FG001|Overall Study|Investigator terminated|6|||
144624111|NCT03083886|521480461|FG002|Overall Study|Investigator terminated|3|||
144624112|NCT01587079|521480468|FG000|Overall Study|Protocol-specified criteria|9|||
144624113|NCT01587079|521480468|FG000|Overall Study|Protocol Violation|5|||
144624114|NCT01587079|521480468|FG000|Overall Study|Lost to Follow-up|2|||
144624115|NCT01587079|521480468|FG000|Overall Study|Physician Decision|2|||
144624116|NCT01587079|521480468|FG000|Overall Study|Withdrawal by Subject|7|||
144624117|NCT01587079|521480468|FG000|Overall Study|Adverse Event|14|||
144624118|NCT02475655|521480469|FG000|Overall Study|Lost to Follow-up|0|||
144624119|NCT02475655|521480470|FG001|Overall Study|Lost to Follow-up|1|||
144624120|NCT00411554|521480471|FG000|Overall Study|Adverse Event|2|||
144624121|NCT00411554|521480472|FG001|Overall Study|Adverse Event|4|||
144624122|NCT00411554|521480471|FG000|Overall Study|Lack of Efficacy|2|||
144624123|NCT00411554|521480472|FG001|Overall Study|Lack of Efficacy|5|||
144624124|NCT00411554|521480471|FG000|Overall Study|Withdrawal by Subject|3|||
144624125|NCT00411554|521480472|FG001|Overall Study|Withdrawal by Subject|0|||
144624126|NCT00411554|521480471|FG000|Overall Study|Patient Moved|1|||
144624127|NCT00411554|521480472|FG001|Overall Study|Patient Moved|0|||
144209557|NCT02648932|519961984|FG001|Overall Study|No transplant|1|||
144209558|NCT01199016|519961985|FG000|Overall Study|No longer meets eligibility criteria|4|||
144209559|NCT01199016|519961985|FG000|Overall Study|Entrance criteria|5|||
144209560|NCT01199016|519961985|FG000|Overall Study|Protocol Violation|9|||
144209561|NCT01199016|519961985|FG000|Overall Study|Other|13|||
144209562|NCT01199016|519961985|FG000|Overall Study|Withdrawal by Subject|21|||
144624128|NCT03889639|521480475|FG000|Overall Study|Withdrawal by Subject|0|||
144624129|NCT03889639|521480476|FG001|Overall Study|Withdrawal by Subject|0|||
144624130|NCT03889639|521480477|FG002|Overall Study|Withdrawal by Subject|0|||
144624131|NCT03889639|521480478|FG003|Overall Study|Withdrawal by Subject|0|||
144624132|NCT03889639|521480479|FG004|Overall Study|Withdrawal by Subject|0|||
144624133|NCT03889639|521480480|FG005|Overall Study|Withdrawal by Subject|0|||
144624134|NCT03889639|521480481|FG006|Overall Study|Withdrawal by Subject|0|||
144624135|NCT03889639|521480482|FG007|Overall Study|Withdrawal by Subject|1|||
144624136|NCT00993031|521480483|FG000|Overall Study|Death|0|||
144624137|NCT00993031|521480484|FG001|Overall Study|Death|1|||
144624138|NCT00993031|521480483|FG000|Overall Study|Physician Decision|0|||
144624139|NCT00993031|521480484|FG001|Overall Study|Physician Decision|2|||
144624140|NCT00993031|521480483|FG000|Overall Study|Withdrawal by Subject|3|||
144624141|NCT00993031|521480484|FG001|Overall Study|Withdrawal by Subject|3|||
144624142|NCT00993031|521480483|FG000|Overall Study|Lost to Follow-up|19|||
144624143|NCT00993031|521480484|FG001|Overall Study|Lost to Follow-up|13|||
144624144|NCT01834729|521480489|FG000|Overall Study|Did not return bowel diaries|0|||
144624145|NCT01834729|521480490|FG001|Overall Study|Did not return bowel diaries|0|||
144624146|NCT01834729|521480491|FG002|Overall Study|Did not return bowel diaries|3|||
144624147|NCT01834729|521480492|FG003|Overall Study|Did not return bowel diaries|0|||
144624148|NCT01834729|521480489|FG000|Overall Study|Withdrawal by Subject|1|||
144624149|NCT01834729|521480490|FG001|Overall Study|Withdrawal by Subject|1|||
144624150|NCT01834729|521480491|FG002|Overall Study|Withdrawal by Subject|0|||
144624151|NCT01834729|521480492|FG003|Overall Study|Withdrawal by Subject|0|||
144624152|NCT01834729|521480489|FG000|Overall Study|Adverse Event|0|||
144624153|NCT01834729|521480490|FG001|Overall Study|Adverse Event|0|||
144624154|NCT01834729|521480491|FG002|Overall Study|Adverse Event|0|||
144624155|NCT01834729|521480492|FG003|Overall Study|Adverse Event|2|||
144624156|NCT00143455|521480493|FG000|Cohort 1|Adverse Event|8|||
144624157|NCT00143455|521480494|FG001|Cohort 1|Adverse Event|4|||
144624158|NCT00143455|521480495|FG002|Cohort 1|Adverse Event|0|||
144624159|NCT00143455|521480496|FG003|Cohort 1|Adverse Event|0|||
144624160|NCT00143455|521480493|FG000|Cohort 1|Death|5|||
144624161|NCT00143455|521480494|FG001|Cohort 1|Death|2|||
144624162|NCT00143455|521480495|FG002|Cohort 1|Death|0|||
144624163|NCT00143455|521480496|FG003|Cohort 1|Death|0|||
144624164|NCT00143455|521480493|FG000|Cohort 1|Progressive Disease|0|||
144624165|NCT00143455|521480494|FG001|Cohort 1|Progressive Disease|6|||
144624166|NCT00143455|521480495|FG002|Cohort 1|Progressive Disease|0|||
144624167|NCT00143455|521480496|FG003|Cohort 1|Progressive Disease|0|||
144624168|NCT00143455|521480493|FG000|Cohort 1|Withdrawal by Subject|1|||
144624169|NCT00143455|521480494|FG001|Cohort 1|Withdrawal by Subject|4|||
144624170|NCT00143455|521480495|FG002|Cohort 1|Withdrawal by Subject|0|||
144624171|NCT00143455|521480496|FG003|Cohort 1|Withdrawal by Subject|0|||
144624172|NCT00143455|521480493|FG000|Cohort 1|Randomized But Not Treated|0|||
144624173|NCT00143455|521480494|FG001|Cohort 1|Randomized But Not Treated|1|||
144624174|NCT00143455|521480495|FG002|Cohort 1|Randomized But Not Treated|0|||
144624175|NCT00143455|521480496|FG003|Cohort 1|Randomized But Not Treated|0|||
144624176|NCT00143455|521480493|FG000|Cohort 2|Adverse Event|0|||
144624177|NCT00143455|521480494|FG001|Cohort 2|Adverse Event|0|||
144624178|NCT00143455|521480495|FG002|Cohort 2|Adverse Event|42|||
144209563|NCT01199016|519961985|FG000|Overall Study|Lost to Follow-up|25|||
144209564|NCT02960490|519961994|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
144209565|NCT02960490|519961995|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
144209566|NCT02960490|519961996|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144209567|NCT02960490|519961997|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144209568|NCT02960490|519961998|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144624179|NCT00143455|521480496|FG003|Cohort 2|Adverse Event|30|||
144624180|NCT00143455|521480493|FG000|Cohort 2|No Longer Required Study Treatment|0|||
144624181|NCT00143455|521480494|FG001|Cohort 2|No Longer Required Study Treatment|0|||
144624182|NCT00143455|521480495|FG002|Cohort 2|No Longer Required Study Treatment|1|||
144624183|NCT00143455|521480496|FG003|Cohort 2|No Longer Required Study Treatment|0|||
144624184|NCT00143455|521480493|FG000|Cohort 2|Protocol Violation|0|||
144624185|NCT00143455|521480494|FG001|Cohort 2|Protocol Violation|0|||
144624186|NCT00143455|521480495|FG002|Cohort 2|Protocol Violation|1|||
144624187|NCT00143455|521480496|FG003|Cohort 2|Protocol Violation|1|||
144624188|NCT00143455|521480493|FG000|Cohort 2|Lost to Follow-up|0|||
144209569|NCT02960490|519961999|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144624189|NCT00143455|521480494|FG001|Cohort 2|Lost to Follow-up|0|||
144624190|NCT00143455|521480495|FG002|Cohort 2|Lost to Follow-up|1|||
144624191|NCT00143455|521480496|FG003|Cohort 2|Lost to Follow-up|4|||
144624192|NCT00143455|521480493|FG000|Cohort 2|Death|0|||
144624193|NCT00143455|521480494|FG001|Cohort 2|Death|0|||
144209570|NCT02960490|519962000|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144209571|NCT02960490|519962001|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144209572|NCT02960490|519962002|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144209573|NCT02960490|519962003|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
144624194|NCT00143455|521480495|FG002|Cohort 2|Death|20|||
144624195|NCT00143455|521480496|FG003|Cohort 2|Death|12|||
144624196|NCT00143455|521480493|FG000|Cohort 2|Progressive Disease|0|||
144624197|NCT00143455|521480494|FG001|Cohort 2|Progressive Disease|0|||
144624198|NCT00143455|521480495|FG002|Cohort 2|Progressive Disease|20|||
144624199|NCT00143455|521480496|FG003|Cohort 2|Progressive Disease|27|||
144624200|NCT00143455|521480493|FG000|Cohort 2|Withdrawal by Subject|0|||
144624201|NCT00143455|521480494|FG001|Cohort 2|Withdrawal by Subject|0|||
144624202|NCT00143455|521480495|FG002|Cohort 2|Withdrawal by Subject|13|||
144624203|NCT00143455|521480496|FG003|Cohort 2|Withdrawal by Subject|12|||
144624204|NCT00143455|521480493|FG000|Cohort 2|Other|0|||
144624205|NCT00143455|521480494|FG001|Cohort 2|Other|0|||
144624206|NCT00143455|521480495|FG002|Cohort 2|Other|7|||
144624207|NCT00143455|521480496|FG003|Cohort 2|Other|6|||
144624208|NCT00143455|521480493|FG000|Cohort 2|Randomized But Not Treated|0|||
144624209|NCT00143455|521480494|FG001|Cohort 2|Randomized But Not Treated|0|||
144624210|NCT00143455|521480495|FG002|Cohort 2|Randomized But Not Treated|1|||
144624211|NCT00143455|521480496|FG003|Cohort 2|Randomized But Not Treated|1|||
144624212|NCT01298492|521480497|FG000|Overall Study|Death|2|||
144624213|NCT01298492|521480497|FG000|Overall Study|Insufficient Clinical Response|22|||
144624214|NCT01298492|521480497|FG000|Overall Study|Lost to Follow-up|12|||
144624215|NCT01298492|521480497|FG000|Overall Study|Withdrawal by Subject|47|||
144624216|NCT01298492|521480497|FG000|Overall Study|Other (Unspecified)|7|||
144624217|NCT01298492|521480497|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
144624218|NCT01298492|521480497|FG000|Overall Study|Protocol Violation|2|||
144624219|NCT01298492|521480497|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
144624220|NCT01298492|521480497|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
144624221|NCT03870555|521480498|FG000|Period 3 (2 Days)|Adverse Event|1|||
144624222|NCT03870555|521480499|FG001|Period 3 (2 Days)|Adverse Event|0|||
144624223|NCT03870555|521480500|FG002|Period 3 (2 Days)|Adverse Event|0|||
144624224|NCT02902120|521480501|FG000|Overall Study|Lack of Efficacy|1|||
144624225|NCT02665286|521480522|FG000|Overall Study|Lost to Follow-up|3|||
144624226|NCT02665286|521480523|FG001|Overall Study|Lost to Follow-up|2|||
144624227|NCT02665286|521480524|FG002|Overall Study|Lost to Follow-up|1|||
144624228|NCT00516737|521480526|FG000|Overall Study|Lost to Follow-up|2|||
144624229|NCT00516737|521480527|FG001|Overall Study|Lost to Follow-up|0|||
144624230|NCT00516737|521480526|FG000|Overall Study|Physician Decision|0|||
144624231|NCT00516737|521480527|FG001|Overall Study|Physician Decision|1|||
144624232|NCT00516737|521480526|FG000|Overall Study|Withdrawal by Subject|0|||
144624233|NCT00516737|521480527|FG001|Overall Study|Withdrawal by Subject|1|||
144624234|NCT00516737|521480526|FG000|Overall Study|Lack of Qualifying Event|9|||
144624235|NCT00516737|521480527|FG001|Overall Study|Lack of Qualifying Event|6|||
144624236|NCT00512798|521480528|FG000|Overall Study|Death|0|||
144624237|NCT00512798|521480529|FG001|Overall Study|Death|3|||
144624238|NCT00512798|521480528|FG000|Overall Study|Adverse Event|2|||
144624239|NCT00512798|521480529|FG001|Overall Study|Adverse Event|4|||
144624240|NCT00512798|521480528|FG000|Overall Study|Progression of disease|14|||
144624241|NCT00512798|521480529|FG001|Overall Study|Progression of disease|20|||
144624242|NCT00512798|521480528|FG000|Overall Study|Withdrawal by Subject|3|||
144209574|NCT02960490|519961994|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144624243|NCT00512798|521480529|FG001|Overall Study|Withdrawal by Subject|0|||
144624244|NCT02775851|521481853|FG000|Overall Study|Adverse Event|1|||
144624245|NCT02775851|521481854|FG001|Overall Study|Adverse Event|10|||
144624246|NCT02775851|521481853|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
144624247|NCT02775851|521481854|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
144624248|NCT02775851|521481853|FG000|Overall Study|Progression/Relapse|0|||
144624249|NCT02775851|521481854|FG001|Overall Study|Progression/Relapse|4|||
144624250|NCT02775851|521481853|FG000|Overall Study|Other - Not Protocol Specified|0|||
144624251|NCT02775851|521481854|FG001|Overall Study|Other - Not Protocol Specified|7|||
144624252|NCT02775851|521481853|FG000|Overall Study|Withdrawal by Subject|1|||
144624253|NCT02775851|521481854|FG001|Overall Study|Withdrawal by Subject|0|||
144624254|NCT02615990|521481862|FG000|Overall Study|study terminated|1|||
144624255|NCT02615990|521481863|FG001|Overall Study|study terminated|1|||
144624256|NCT00716976|521481864|FG000|Overall Study|Adverse Event|2|||
144624257|NCT00716976|521481865|FG001|Overall Study|Adverse Event|0|||
144624258|NCT00716976|521481864|FG000|Overall Study|Death|1|||
144624259|NCT00716976|521481865|FG001|Overall Study|Death|0|||
144624260|NCT00716976|521481864|FG000|Overall Study|Physician Decision|2|||
144624261|NCT00716976|521481865|FG001|Overall Study|Physician Decision|2|||
144624262|NCT00716976|521481864|FG000|Overall Study|Withdrawal by Subject|5|||
144624263|NCT00716976|521481865|FG001|Overall Study|Withdrawal by Subject|1|||
144624264|NCT00716976|521481864|FG000|Overall Study|Premature discontinuation cisplatin|5|||
144624265|NCT00716976|521481865|FG001|Overall Study|Premature discontinuation cisplatin|4|||
144624266|NCT00716976|521481864|FG000|Overall Study|Radiation during protocol|1|||
144624267|NCT00716976|521481865|FG001|Overall Study|Radiation during protocol|0|||
144624268|NCT00716976|521481864|FG000|Overall Study|Ineligibles|4|||
144624269|NCT00716976|521481865|FG001|Overall Study|Ineligibles|2|||
144624270|NCT01414257|521481866|FG000|Overall Study|No Visit After First Day of Treatment|12|||
144624271|NCT01414257|521481866|FG000|Overall Study|Protocol Violation|10|||
144624272|NCT02634580|521481867|FG000|Double-blind Treatment Period|Subject Request|1|||
144730524|NCT02475954|521869810|FG000|Overall Study|Lost to Follow-up|11|||
144209575|NCT02960490|519961995|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
144209576|NCT02960490|519961996|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209577|NCT02960490|519961997|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209578|NCT02960490|519961998|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209579|NCT02960490|519961999|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209580|NCT02960490|519962000|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209581|NCT02960490|519962001|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209582|NCT02960490|519962002|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209583|NCT02960490|519962003|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
144209584|NCT02960490|519961994|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
144209585|NCT02960490|519961995|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
144585779|NCT02663518|521343797|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585780|NCT02663518|521343798|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585781|NCT02663518|521343799|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585782|NCT02663518|521343800|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585783|NCT02663518|521343801|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
144585784|NCT02663518|521343802|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585785|NCT02663518|521343803|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
144585786|NCT02663518|521343804|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585787|NCT02663518|521343805|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585788|NCT02663518|521343806|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585789|NCT02663518|521343807|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585790|NCT02663518|521343808|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585791|NCT02663518|521343809|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585792|NCT02663518|521343810|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
144585793|NCT02663518|521343797|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585794|NCT02663518|521343798|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585795|NCT02663518|521343799|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585796|NCT02663518|521343800|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585797|NCT02663518|521343801|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585798|NCT02663518|521343802|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585799|NCT02663518|521343803|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
144585800|NCT02663518|521343804|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585801|NCT02663518|521343805|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585802|NCT02663518|521343806|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585803|NCT02663518|521343807|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585804|NCT02663518|521343808|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585805|NCT02663518|521343809|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585806|NCT02663518|521343810|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
144585807|NCT02663518|521343797|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
144585808|NCT02663518|521343798|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
144585809|NCT02663518|521343799|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
144585810|NCT02663518|521343800|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
144585811|NCT02663518|521343801|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
144585812|NCT02663518|521343802|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
144585813|NCT02663518|521343803|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
144585814|NCT02663518|521343804|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
144585815|NCT02663518|521343805|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
144585816|NCT02663518|521343806|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
144585817|NCT02663518|521343807|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
144585818|NCT02663518|521343808|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
144585819|NCT02663518|521343809|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
144585820|NCT02663518|521343810|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
144585821|NCT02663518|521343797|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585822|NCT02663518|521343798|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585823|NCT02663518|521343799|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585824|NCT02663518|521343800|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144624273|NCT02634580|521481868|FG001|Double-blind Treatment Period|Subject Request|0|||
144624274|NCT02634580|521481869|FG002|Double-blind Treatment Period|Subject Request|1|||
144730525|NCT02475954|521869811|FG001|Overall Study|Lost to Follow-up|9|||
144730526|NCT02475954|521869810|FG000|Overall Study|Death|1|||
144624275|NCT02634580|521481870|FG003|Double-blind Treatment Period|Subject Request|1|||
144624276|NCT02634580|521481867|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
144624277|NCT02634580|521481868|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
144624278|NCT02634580|521481869|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
144624279|NCT02634580|521481870|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
144624280|NCT01790048|521481873|FG000|Overall Study|Incorrect Age|9|||
144624281|NCT01790048|521481874|FG001|Overall Study|Incorrect Age|14|||
144624282|NCT01790048|521481873|FG000|Overall Study|data entry error|0|||
144624283|NCT01790048|521481874|FG001|Overall Study|data entry error|1|||
144624284|NCT01790048|521481873|FG000|Overall Study|Other|0|||
144624285|NCT01790048|521481874|FG001|Overall Study|Other|2|||
144624286|NCT01790048|521481873|FG000|Overall Study|SAM at Enrollment|2|||
144624287|NCT01790048|521481874|FG001|Overall Study|SAM at Enrollment|0|||
144624288|NCT01790048|521481873|FG000|Overall Study|Measurement error|1|||
144624289|NCT01790048|521481874|FG001|Overall Study|Measurement error|0|||
144624290|NCT03178487|521481875|FG000|Period 1|Adverse Event|1|||
144624291|NCT03178487|521481876|FG001|Period 1|Adverse Event|2|||
144624292|NCT03178487|521481875|FG000|Period 1|Withdrawal by Subject|2|||
144624293|NCT03178487|521481876|FG001|Period 1|Withdrawal by Subject|1|||
144624294|NCT03178487|521481875|FG000|Period 1|Lost to Follow-up|1|||
144624295|NCT03178487|521481876|FG001|Period 1|Lost to Follow-up|0|||
144624296|NCT03178487|521481875|FG000|Period 1|Other|0|||
144624297|NCT03178487|521481876|FG001|Period 1|Other|1|||
144624298|NCT03178487|521481875|FG000|Period 2|Adverse Event|4|||
144624299|NCT03178487|521481876|FG001|Period 2|Adverse Event|4|||
144624300|NCT03178487|521481875|FG000|Period 2|Withdrawal by Subject|6|||
144624301|NCT03178487|521481876|FG001|Period 2|Withdrawal by Subject|6|||
144624302|NCT03178487|521481875|FG000|Period 2|Lost to Follow-up|2|||
144624303|NCT03178487|521481876|FG001|Period 2|Lost to Follow-up|2|||
144624304|NCT03178487|521481875|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
144624305|NCT03178487|521481876|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
144624306|NCT03178487|521481875|FG000|Period 2|Other|8|||
144624307|NCT03178487|521481876|FG001|Period 2|Other|7|||
144624308|NCT04161495|521481877|FG000|Overall Study|Withdrawal by Subject|3|||
144624309|NCT04161495|521481878|FG001|Overall Study|Withdrawal by Subject|0|||
144624310|NCT04161495|521481877|FG000|Overall Study|Protocol Violation|1|||
144624311|NCT04161495|521481878|FG001|Overall Study|Protocol Violation|0|||
144624312|NCT04161495|521481877|FG000|Overall Study|Prohibited concomitant medication|3|||
144624313|NCT04161495|521481878|FG001|Overall Study|Prohibited concomitant medication|0|||
144624314|NCT04161495|521481877|FG000|Overall Study|Adverse Event|1|||
144624315|NCT04161495|521481878|FG001|Overall Study|Adverse Event|0|||
144624316|NCT04161495|521481877|FG000|Overall Study|Other - Unspecified|1|||
144624317|NCT04161495|521481878|FG001|Overall Study|Other - Unspecified|0|||
144624318|NCT04161495|521481877|FG000|Overall Study|Death|0|||
144624319|NCT04161495|521481878|FG001|Overall Study|Death|1|||
144624320|NCT03655756|521481879|FG000|Overall Study|Death|1|||
144624321|NCT01340209|521481880|FG000|Overall Study|Adverse Event|1|||
144624322|NCT01340209|521481881|FG001|Overall Study|Adverse Event|1|||
144624323|NCT01340209|521481882|FG002|Overall Study|Adverse Event|2|||
144624324|NCT01340209|521481880|FG000|Overall Study|Protocol Violation|1|||
144624325|NCT01340209|521481881|FG001|Overall Study|Protocol Violation|2|||
144624326|NCT01340209|521481882|FG002|Overall Study|Protocol Violation|1|||
144624327|NCT01340209|521481880|FG000|Overall Study|Withdrawal by Subject|0|||
144624328|NCT01340209|521481881|FG001|Overall Study|Withdrawal by Subject|0|||
144624329|NCT01340209|521481882|FG002|Overall Study|Withdrawal by Subject|1|||
144624330|NCT01340209|521481880|FG000|Overall Study|Other reason not defined above|3|||
144624331|NCT01340209|521481881|FG001|Overall Study|Other reason not defined above|5|||
144624332|NCT01340209|521481882|FG002|Overall Study|Other reason not defined above|4|||
144624333|NCT00253630|521481883|FG000|Overall Study|ineligible|2|||
144624334|NCT00704964|521481885|FG000|Overall Study|Not completed on time|328|||
144624335|NCT02161562|521481886|FG000|Overall Study|Withdrawal by Subject|5|||
144624336|NCT02161562|521481887|FG001|Overall Study|Withdrawal by Subject|8|||
144624337|NCT02161562|521481886|FG000|Overall Study|Protocol Violation|9|||
144730527|NCT02475954|521869811|FG001|Overall Study|Death|1|||
144624338|NCT02161562|521481887|FG001|Overall Study|Protocol Violation|4|||
144624339|NCT02161562|521481886|FG000|Overall Study|Pregnancy|1|||
144624340|NCT02161562|521481887|FG001|Overall Study|Pregnancy|2|||
144730528|NCT01918397|521869816|FG000|Overall Study|Never started treatment|2|||
144624341|NCT02161562|521481886|FG000|Overall Study|Lost to Follow-up|3|||
144624342|NCT02161562|521481887|FG001|Overall Study|Lost to Follow-up|1|||
144624343|NCT02161562|521481886|FG000|Overall Study|Lack of Efficacy|4|||
144730529|NCT01918397|521869817|FG001|Overall Study|Never started treatment|1|||
144624344|NCT02161562|521481887|FG001|Overall Study|Lack of Efficacy|1|||
144624345|NCT02161562|521481886|FG000|Overall Study|Adverse Event|1|||
144624346|NCT02161562|521481887|FG001|Overall Study|Adverse Event|1|||
144730530|NCT01918397|521869818|FG002|Overall Study|Never started treatment|0|||
144624347|NCT02161562|521481886|FG000|Overall Study|Participant moved back to home country|1|||
144624348|NCT02161562|521481887|FG001|Overall Study|Participant moved back to home country|0|||
144624349|NCT02161562|521481886|FG000|Overall Study|Withdrew due to being out of the country|1|||
144624350|NCT02161562|521481887|FG001|Overall Study|Withdrew due to being out of the country|0|||
144624351|NCT02161562|521481886|FG000|Overall Study|Participant moved out of province|1|||
144624352|NCT02161562|521481887|FG001|Overall Study|Participant moved out of province|0|||
144624353|NCT00257010|521481900|FG000|Overall Study|Lack of Efficacy|11|||
144624354|NCT00257010|521481900|FG000|Overall Study|Lost to Follow-up|53|||
144624355|NCT00257010|521481900|FG000|Overall Study|Withdrawal by Subject|34|||
144624356|NCT00257010|521481900|FG000|Overall Study|Adverse Event|10|||
144624357|NCT00257010|521481900|FG000|Overall Study|various|11|||
144624358|NCT00257010|521481900|FG000|Overall Study|no headache reported|9|||
144624359|NCT01699087|521481902|FG000|Overall Study|Lost to Follow-up|7|||
144624360|NCT01699087|521481902|FG000|Overall Study|Screen failure (prior to treatment)|15|||
144624361|NCT01699087|521481902|FG000|Overall Study|Unable to make future visits|2|||
144624362|NCT00094757|521481903|FG000|Overall Study|Adverse Event|11|||
144624363|NCT00094757|521481904|FG001|Overall Study|Adverse Event|9|||
144624364|NCT00094757|521481905|FG002|Overall Study|Adverse Event|6|||
144624365|NCT00094757|521481903|FG000|Overall Study|Lack of Efficacy|11|||
144624366|NCT00094757|521481904|FG001|Overall Study|Lack of Efficacy|15|||
144624367|NCT00094757|521481905|FG002|Overall Study|Lack of Efficacy|8|||
144624368|NCT00094757|521481903|FG000|Overall Study|Lost to Follow-up|3|||
144624369|NCT00094757|521481904|FG001|Overall Study|Lost to Follow-up|5|||
144624370|NCT00094757|521481905|FG002|Overall Study|Lost to Follow-up|6|||
144624371|NCT00094757|521481903|FG000|Overall Study|Patient Moved|2|||
144624372|NCT00094757|521481904|FG001|Overall Study|Patient Moved|1|||
144624373|NCT00094757|521481905|FG002|Overall Study|Patient Moved|1|||
144624374|NCT00094757|521481903|FG000|Overall Study|Protocol Violation|8|||
144624375|NCT00094757|521481904|FG001|Overall Study|Protocol Violation|5|||
144624376|NCT00094757|521481905|FG002|Overall Study|Protocol Violation|3|||
144624377|NCT00094757|521481903|FG000|Overall Study|Withdrawal by Subject|14|||
144624378|NCT00094757|521481904|FG001|Overall Study|Withdrawal by Subject|21|||
144624379|NCT00094757|521481905|FG002|Overall Study|Withdrawal by Subject|5|||
144624380|NCT00094757|521481903|FG000|Overall Study|Other|3|||
144624381|NCT00094757|521481904|FG001|Overall Study|Other|3|||
144624382|NCT00094757|521481905|FG002|Overall Study|Other|1|||
144624383|NCT00094757|521481903|FG000|Overall Study|Protocol specified discontinuation|1|||
144624384|NCT00094757|521481904|FG001|Overall Study|Protocol specified discontinuation|3|||
144624385|NCT00094757|521481905|FG002|Overall Study|Protocol specified discontinuation|0|||
144624386|NCT04823949|521481906|FG000|Overall Study|Withdrawal by Subject|0|||
144624387|NCT04823949|521481907|FG001|Overall Study|Withdrawal by Subject|4|||
144624388|NCT04823949|521481906|FG000|Overall Study|Physician Decision|0|||
144624389|NCT04823949|521481907|FG001|Overall Study|Physician Decision|1|||
144624390|NCT00756938|521481908|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
144624391|NCT00756938|521481909|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
144624392|NCT00756938|521481910|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
144624393|NCT00756938|521481911|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
144262925|NCT02692586|520163782|FG000|Overall Study|Received adjunctive thrombolytics|2|||
144624394|NCT00756938|521481908|FG000|12-week Base Study|Protocol Violation|0|||
144624395|NCT00756938|521481909|FG001|12-week Base Study|Protocol Violation|0|||
144624396|NCT00756938|521481910|FG002|12-week Base Study|Protocol Violation|1|||
144624397|NCT00756938|521481911|FG003|12-week Base Study|Protocol Violation|0|||
144624398|NCT00756938|521481908|FG000|12-week Base Study|Lost to Follow-up|1|||
144624399|NCT00756938|521481909|FG001|12-week Base Study|Lost to Follow-up|0|||
144624400|NCT00756938|521481910|FG002|12-week Base Study|Lost to Follow-up|0|||
144624401|NCT00756938|521481911|FG003|12-week Base Study|Lost to Follow-up|0|||
144624402|NCT00756938|521481908|FG000|Optional Extension|Lack of Efficacy|0|||
144624403|NCT00756938|521481909|FG001|Optional Extension|Lack of Efficacy|0|||
144624404|NCT00756938|521481910|FG002|Optional Extension|Lack of Efficacy|0|||
144624405|NCT00756938|521481911|FG003|Optional Extension|Lack of Efficacy|1|||
144624406|NCT00756938|521481908|FG000|Optional Extension|End of Study|0|||
144624407|NCT00756938|521481909|FG001|Optional Extension|End of Study|0|||
144624408|NCT00756938|521481910|FG002|Optional Extension|End of Study|0|||
144624409|NCT00756938|521481911|FG003|Optional Extension|End of Study|11|||
144624410|NCT00756938|521481908|FG000|Optional Extension|Protocol-specific criteria met|0|||
144624411|NCT00756938|521481909|FG001|Optional Extension|Protocol-specific criteria met|0|||
144624412|NCT00756938|521481910|FG002|Optional Extension|Protocol-specific criteria met|0|||
144624413|NCT00756938|521481911|FG003|Optional Extension|Protocol-specific criteria met|9|||
144624414|NCT00756938|521481908|FG000|Optional Extension|Physician Decision|0|||
144624415|NCT00756938|521481909|FG001|Optional Extension|Physician Decision|0|||
144624416|NCT00756938|521481910|FG002|Optional Extension|Physician Decision|0|||
144624417|NCT00756938|521481911|FG003|Optional Extension|Physician Decision|3|||
144624418|NCT00756938|521481908|FG000|Optional Extension|Lost to Follow-up|0|||
144624419|NCT00756938|521481909|FG001|Optional Extension|Lost to Follow-up|0|||
144624420|NCT00756938|521481910|FG002|Optional Extension|Lost to Follow-up|0|||
144624421|NCT00756938|521481911|FG003|Optional Extension|Lost to Follow-up|1|||
144262926|NCT03506438|520163786|FG000|Overall Study|Lost to Follow-up|8|||
144624422|NCT00756938|521481908|FG000|Optional Extension|Protocol Violation|0|||
144624423|NCT00756938|521481909|FG001|Optional Extension|Protocol Violation|0|||
144624424|NCT00756938|521481910|FG002|Optional Extension|Protocol Violation|0|||
144624425|NCT00756938|521481911|FG003|Optional Extension|Protocol Violation|1|||
144624426|NCT00756938|521481908|FG000|Optional Extension|Withdrawal by Subject|0|||
144624427|NCT00756938|521481909|FG001|Optional Extension|Withdrawal by Subject|0|||
144624428|NCT00756938|521481910|FG002|Optional Extension|Withdrawal by Subject|0|||
144624429|NCT00756938|521481911|FG003|Optional Extension|Withdrawal by Subject|10|||
144624430|NCT00756938|521481908|FG000|Optional Extension|Adverse Event|0|||
144624431|NCT00756938|521481909|FG001|Optional Extension|Adverse Event|0|||
144624432|NCT00756938|521481910|FG002|Optional Extension|Adverse Event|0|||
144624433|NCT00756938|521481911|FG003|Optional Extension|Adverse Event|1|||
144624434|NCT00441545|521481913|FG000|First Intervention|Adverse Event|6|||
144624435|NCT00441545|521481914|FG001|First Intervention|Adverse Event|5|||
144624436|NCT00441545|521481913|FG000|First Intervention|Protocol Violation|2|||
144624437|NCT00441545|521481914|FG001|First Intervention|Protocol Violation|2|||
144624438|NCT00441545|521481913|FG000|First Intervention|Withdrawal by Subject|3|||
144624439|NCT00441545|521481914|FG001|First Intervention|Withdrawal by Subject|3|||
144624440|NCT00441545|521481913|FG000|First Intervention|Kidney transplant|1|||
144624441|NCT00441545|521481914|FG001|First Intervention|Kidney transplant|1|||
144624442|NCT00441545|521481913|FG000|First Intervention|Lack of Efficacy|2|||
144624443|NCT00441545|521481914|FG001|First Intervention|Lack of Efficacy|0|||
144624444|NCT00441545|521481913|FG000|First Intervention|Subject exceeded safety criteria|0|||
144624445|NCT00441545|521481914|FG001|First Intervention|Subject exceeded safety criteria|1|||
144624446|NCT00441545|521481913|FG000|First Intervention|Subject met an exclusionary criteria|1|||
144624447|NCT00441545|521481914|FG001|First Intervention|Subject met an exclusionary criteria|0|||
144624448|NCT00441545|521481913|FG000|First Intervention|Extended hospitalization|1|||
144624449|NCT00441545|521481914|FG001|First Intervention|Extended hospitalization|0|||
144624450|NCT00441545|521481913|FG000|First Intervention|Site error|1|||
144624451|NCT00441545|521481914|FG001|First Intervention|Site error|0|||
144624452|NCT00441545|521481913|FG000|First Intervention|Sponsor's request|1|||
144624453|NCT00441545|521481914|FG001|First Intervention|Sponsor's request|0|||
144624454|NCT00441545|521481913|FG000|Second Intervention|Adverse Event|5|||
144624455|NCT00441545|521481914|FG001|Second Intervention|Adverse Event|2|||
144624456|NCT00441545|521481913|FG000|Second Intervention|Protocol Violation|4|||
144624457|NCT00441545|521481914|FG001|Second Intervention|Protocol Violation|1|||
144624458|NCT00441545|521481913|FG000|Second Intervention|Withdrawal by Subject|1|||
144624459|NCT00441545|521481914|FG001|Second Intervention|Withdrawal by Subject|1|||
144624460|NCT00441545|521481913|FG000|Second Intervention|Kidney Transplant|1|||
144624461|NCT00441545|521481914|FG001|Second Intervention|Kidney Transplant|1|||
144624462|NCT00441545|521481913|FG000|Second Intervention|Lack of Efficacy|0|||
144624463|NCT00441545|521481914|FG001|Second Intervention|Lack of Efficacy|1|||
144624464|NCT00441545|521481913|FG000|Second Intervention|Subject exceeded safety criteria|1|||
144624465|NCT00441545|521481914|FG001|Second Intervention|Subject exceeded safety criteria|0|||
144624466|NCT00441545|521481913|FG000|Second Intervention|Subject moved|0|||
144624467|NCT00441545|521481914|FG001|Second Intervention|Subject moved|1|||
144624468|NCT00797823|521481915|FG000|First Period (Initial Randomization)|Physician Decision|1|||
144624469|NCT00797823|521481916|FG001|First Period (Initial Randomization)|Physician Decision|0|||
144624470|NCT00797823|521481917|FG002|First Period (Initial Randomization)|Physician Decision|0|||
144624471|NCT02556255|521481918|FG000|Overall Study|Lost to Follow-up|4|||
144624472|NCT00288080|521481920|FG000|Overall Study|Withdrawal by Subject|1|||
144624473|NCT00288080|521481921|FG001|Overall Study|Withdrawal by Subject|3|||
144624474|NCT00288080|521481920|FG000|Overall Study|Protocol Violation|25|||
144624475|NCT00288080|521481921|FG001|Overall Study|Protocol Violation|20|||
144624476|NCT03403192|521481922|FG000|Overall Study|Lost to Follow-up|1|||
144624477|NCT03403192|521481923|FG001|Overall Study|Lost to Follow-up|2|||
144624478|NCT03403192|521481924|FG002|Overall Study|Lost to Follow-up|0|||
144624479|NCT03403192|521481925|FG003|Overall Study|Lost to Follow-up|0|||
144624480|NCT03403192|521481922|FG000|Overall Study|Unable to respond|0|||
144624481|NCT03403192|521481923|FG001|Overall Study|Unable to respond|1|||
144624482|NCT03403192|521481924|FG002|Overall Study|Unable to respond|0|||
144624483|NCT03403192|521481925|FG003|Overall Study|Unable to respond|0|||
144624484|NCT03403192|521481922|FG000|Overall Study|Incomplete|3|||
144624485|NCT03403192|521481923|FG001|Overall Study|Incomplete|1|||
144624486|NCT03403192|521481924|FG002|Overall Study|Incomplete|3|||
144624487|NCT03403192|521481925|FG003|Overall Study|Incomplete|6|||
144624488|NCT02387580|521481929|FG000|Overall Study|Withdrawal by Subject|0|||
144624489|NCT02387580|521481930|FG001|Overall Study|Withdrawal by Subject|0|||
144624490|NCT02387580|521481931|FG002|Overall Study|Withdrawal by Subject|0|||
144624491|NCT02387580|521481932|FG003|Overall Study|Withdrawal by Subject|1|||
144624492|NCT02387580|521481933|FG004|Overall Study|Withdrawal by Subject|0|||
144624493|NCT02387580|521481934|FG005|Overall Study|Withdrawal by Subject|0|||
144209586|NCT02960490|519961996|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209587|NCT02960490|519961997|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209588|NCT02960490|519961998|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144624494|NCT00087646|521481935|FG000|Overall Study|Adverse Event|37|||
144624495|NCT00087646|521481936|FG001|Overall Study|Adverse Event|6|||
144624496|NCT00087646|521481937|FG002|Overall Study|Adverse Event|18|||
144209589|NCT02960490|519961999|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209590|NCT02960490|519962000|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209591|NCT02960490|519962001|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209592|NCT02960490|519962002|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209593|NCT02960490|519962003|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
144209594|NCT02960490|519961994|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
144209595|NCT02960490|519961995|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
144624497|NCT00087646|521481938|FG003|Overall Study|Adverse Event|20|||
144624498|NCT00087646|521481935|FG000|Overall Study|Death|0|||
144624499|NCT00087646|521481936|FG001|Overall Study|Death|1|||
144624500|NCT00087646|521481937|FG002|Overall Study|Death|0|||
144624501|NCT00087646|521481938|FG003|Overall Study|Death|0|||
144624502|NCT00087646|521481935|FG000|Overall Study|Withdrawal by Subject|6|||
144624503|NCT00087646|521481936|FG001|Overall Study|Withdrawal by Subject|1|||
144624504|NCT00087646|521481937|FG002|Overall Study|Withdrawal by Subject|2|||
144624505|NCT00087646|521481938|FG003|Overall Study|Withdrawal by Subject|2|||
144624506|NCT00087646|521481935|FG000|Overall Study|Insufficient therapeutic response|64|||
144624507|NCT00087646|521481936|FG001|Overall Study|Insufficient therapeutic response|24|||
144624508|NCT00087646|521481937|FG002|Overall Study|Insufficient therapeutic response|38|||
144624509|NCT00087646|521481938|FG003|Overall Study|Insufficient therapeutic response|51|||
144624510|NCT00087646|521481935|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
144624511|NCT00087646|521481936|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
144624512|NCT00087646|521481937|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
144624513|NCT00087646|521481938|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
144624514|NCT00087646|521481935|FG000|Overall Study|Failure to Return|5|||
144624515|NCT00087646|521481936|FG001|Overall Study|Failure to Return|2|||
144624516|NCT00087646|521481937|FG002|Overall Study|Failure to Return|2|||
144624517|NCT00087646|521481938|FG003|Overall Study|Failure to Return|3|||
144624518|NCT00087646|521481935|FG000|Overall Study|Administrative/Other|6|||
144624519|NCT00087646|521481936|FG001|Overall Study|Administrative/Other|1|||
144624520|NCT00087646|521481937|FG002|Overall Study|Administrative/Other|1|||
144624521|NCT00087646|521481938|FG003|Overall Study|Administrative/Other|2|||
144624522|NCT00087646|521481935|FG000|Overall Study|Other Protocol Violation|3|||
144624523|NCT00087646|521481936|FG001|Overall Study|Other Protocol Violation|1|||
144624524|NCT00087646|521481937|FG002|Overall Study|Other Protocol Violation|0|||
144624525|NCT00087646|521481938|FG003|Overall Study|Other Protocol Violation|0|||
144624526|NCT00087646|521481935|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
144624527|NCT00087646|521481936|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
144624528|NCT00087646|521481937|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
144624529|NCT00087646|521481938|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
144624530|NCT02004873|521481940|FG000|Overall Study|Implant unsuccessful|6|||
144624531|NCT02004873|521481940|FG000|Overall Study|Awaiting 6-month visit|390|||
144624532|NCT02004873|521481940|FG000|Overall Study|Missed 6-month visit|4|||
144624533|NCT02004873|521481940|FG000|Overall Study|Death|23|||
144624534|NCT02004873|521481940|FG000|Overall Study|Withdrawal by Subject|1|||
144624535|NCT00357500|521481941|FG000|Overall Study|Adverse Event|3|||
144624536|NCT00357500|521481941|FG000|Overall Study|Withdrawal by Subject|5|||
144624537|NCT00357500|521481941|FG000|Overall Study|Progressive Disease|65|||
144624538|NCT00357500|521481941|FG000|Overall Study|Not Started Protocol Therapy|4|||
144624539|NCT03033875|521481942|FG000|Overall Study|Withdrawal by Subject|5|||
144624540|NCT03033875|521481943|FG001|Overall Study|Withdrawal by Subject|9|||
144624541|NCT03033875|521481944|FG002|Overall Study|Withdrawal by Subject|4|||
144624542|NCT03033875|521481942|FG000|Overall Study|Other|14|||
144624543|NCT03033875|521481943|FG001|Overall Study|Other|15|||
144624544|NCT03033875|521481944|FG002|Overall Study|Other|8|||
144624545|NCT04925752|521481946|FG000|Overall Study|Still on Study|1826|||
144624546|NCT04925752|521481947|FG001|Overall Study|Still on Study|926|||
144624547|NCT04925752|521481946|FG000|Overall Study|Withdrew Consent|128|||
144624548|NCT04925752|521481947|FG001|Overall Study|Withdrew Consent|59|||
144624549|NCT04925752|521481946|FG000|Overall Study|Lost to Follow-up|73|||
144624550|NCT04925752|521481947|FG001|Overall Study|Lost to Follow-up|47|||
144209596|NCT02960490|519961996|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144209597|NCT02960490|519961997|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144209598|NCT02960490|519961998|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144624551|NCT04925752|521481946|FG000|Overall Study|Randomized but Never Treated|12|||
144624552|NCT04925752|521481947|FG001|Overall Study|Randomized but Never Treated|9|||
144624553|NCT04925752|521481946|FG000|Overall Study|Hiv-1 Infection|6|||
144624554|NCT04925752|521481947|FG001|Overall Study|Hiv-1 Infection|7|||
144730531|NCT01918397|521869819|FG003|Overall Study|Never started treatment|0|||
144624555|NCT04925752|521481946|FG000|Overall Study|Investigator's discretion|8|||
144624556|NCT04925752|521481947|FG001|Overall Study|Investigator's discretion|5|||
144730532|NCT01918397|521869816|FG000|Overall Study|Adverse Event|1|||
144624557|NCT04925752|521481946|FG000|Overall Study|Non-compliance with Study Drug|8|||
144730533|NCT01918397|521869817|FG001|Overall Study|Adverse Event|1|||
144624558|NCT04925752|521481947|FG001|Overall Study|Non-compliance with Study Drug|5|||
144624559|NCT04925752|521481946|FG000|Overall Study|Adverse Event|5|||
144624560|NCT04925752|521481947|FG001|Overall Study|Adverse Event|2|||
144624561|NCT04925752|521481946|FG000|Overall Study|Death|4|||
144624562|NCT04925752|521481947|FG001|Overall Study|Death|2|||
144624563|NCT04925752|521481946|FG000|Overall Study|Protocol Violation|1|||
144624564|NCT04925752|521481947|FG001|Overall Study|Protocol Violation|3|||
144624565|NCT04925752|521481946|FG000|Overall Study|Withdrew Assent|1|||
144624566|NCT04925752|521481947|FG001|Overall Study|Withdrew Assent|0|||
144624567|NCT03434977|521481953|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
144624568|NCT03434977|521481954|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
144624569|NCT01724528|521481963|FG000|Overall Study|Death|3|||
144624570|NCT01724528|521481964|FG001|Overall Study|Death|0|||
144624571|NCT01724528|521481963|FG000|Overall Study|Withdrawal by Subject|0|||
144624572|NCT01724528|521481964|FG001|Overall Study|Withdrawal by Subject|2|||
144624573|NCT01724528|521481963|FG000|Overall Study|Protocol Violation|0|||
144624574|NCT01724528|521481964|FG001|Overall Study|Protocol Violation|1|||
144624575|NCT01724528|521481963|FG000|Overall Study|Patient refused to attend last visit|1|||
144624576|NCT01724528|521481964|FG001|Overall Study|Patient refused to attend last visit|0|||
144624577|NCT05574062|521481968|FG000|Pre Run-In|Screening failure|3|||
144624578|NCT05574062|521481969|FG001|Pre Run-In|Screening failure|0|||
144624579|NCT05574062|521481970|FG002|Pre Run-In|Screening failure|0|||
144624580|NCT05574062|521481971|FG003|Pre Run-In|Screening failure|0|||
144624581|NCT05574062|521481972|FG004|Pre Run-In|Screening failure|0|||
144624582|NCT05574062|521481968|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
144624583|NCT05574062|521481969|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
144624584|NCT05574062|521481970|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
144624585|NCT05574062|521481971|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
144624586|NCT05574062|521481972|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
144624587|NCT05574062|521481968|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
144624588|NCT05574062|521481969|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
144624589|NCT05574062|521481970|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
144624590|NCT05574062|521481971|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
144624591|NCT05574062|521481972|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
144209599|NCT02960490|519961999|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144209600|NCT02960490|519962000|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144624592|NCT05574062|521481968|FG000|Continuation Phase Period 1|Physician Decision|1|||
144624593|NCT05574062|521481969|FG001|Continuation Phase Period 1|Physician Decision|0|||
144624594|NCT05574062|521481970|FG002|Continuation Phase Period 1|Physician Decision|0|||
144624595|NCT05574062|521481971|FG003|Continuation Phase Period 1|Physician Decision|0|||
144624596|NCT05574062|521481972|FG004|Continuation Phase Period 1|Physician Decision|0|||
144624597|NCT05574062|521481968|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
144624598|NCT05574062|521481969|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
144624599|NCT05574062|521481970|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
144624600|NCT05574062|521481971|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
144624601|NCT05574062|521481972|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
144624602|NCT05574062|521481968|FG000|Continuation Phase Period 1|Adverse Event|1|||
144624603|NCT05574062|521481969|FG001|Continuation Phase Period 1|Adverse Event|0|||
144624604|NCT05574062|521481970|FG002|Continuation Phase Period 1|Adverse Event|0|||
144624605|NCT05574062|521481971|FG003|Continuation Phase Period 1|Adverse Event|0|||
144624606|NCT05574062|521481972|FG004|Continuation Phase Period 1|Adverse Event|0|||
144624607|NCT05574062|521481968|FG000|Continuation Phase Period 1|Death|1|||
144624608|NCT05574062|521481969|FG001|Continuation Phase Period 1|Death|0|||
144624609|NCT05574062|521481970|FG002|Continuation Phase Period 1|Death|0|||
144624610|NCT05574062|521481971|FG003|Continuation Phase Period 1|Death|0|||
144624611|NCT05574062|521481972|FG004|Continuation Phase Period 1|Death|0|||
144624612|NCT05574062|521481968|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
144730534|NCT01918397|521869818|FG002|Overall Study|Adverse Event|1|||
144209601|NCT02960490|519962001|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144209602|NCT02960490|519962002|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144624613|NCT05574062|521481969|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
144624614|NCT05574062|521481970|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
144624615|NCT05574062|521481971|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
144624616|NCT05574062|521481972|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
144624617|NCT04820309|521481973|FG000|Overall Study|Adverse Event|96|||
144624618|NCT04820309|521481973|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
144624619|NCT04820309|521481973|FG000|Overall Study|Consent Withdrawn|93|||
144209603|NCT02960490|519962003|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
144209604|NCT02960490|519961994|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144624620|NCT04820309|521481973|FG000|Overall Study|failure to adhere to protocol|32|||
144624621|NCT04820309|521481973|FG000|Overall Study|alcohol or drug use|6|||
144624622|NCT04820309|521481973|FG000|Overall Study|Lost to Follow-up|46|||
144624623|NCT04820309|521481973|FG000|Overall Study|Death|2|||
144624624|NCT04820309|521481973|FG000|Overall Study|Pregnancy|1|||
144730535|NCT01918397|521869819|FG003|Overall Study|Adverse Event|0|||
144730536|NCT01918397|521869816|FG000|Overall Study|Lack of compliance|2|||
144730537|NCT01918397|521869817|FG001|Overall Study|Lack of compliance|2|||
144730538|NCT01918397|521869818|FG002|Overall Study|Lack of compliance|3|||
144624625|NCT04820309|521481973|FG000|Overall Study|Other reasons|12|||
144624626|NCT05902364|521481976|FG000|Overall Study|Adverse Event|1|||
144624627|NCT05902364|521481977|FG001|Overall Study|Adverse Event|0|||
144624628|NCT02270242|521481978|FG000|Overall Study|Withdrawal by Subject|18|||
144624629|NCT02270242|521481979|FG001|Overall Study|Withdrawal by Subject|25|||
144624630|NCT02270242|521481978|FG000|Overall Study|Lost to Follow-up|41|||
144624631|NCT02270242|521481979|FG001|Overall Study|Lost to Follow-up|27|||
144624632|NCT02270242|521481978|FG000|Overall Study|Physician Decision|0|||
144624633|NCT02270242|521481979|FG001|Overall Study|Physician Decision|1|||
144624634|NCT03864653|521481980|FG000|Overall Study|Withdrawal by Subject|1|||
144624635|NCT02482129|521481981|FG000|Overall Study|Adverse Event-prior to treatment|0|||
144624636|NCT02482129|521481982|FG001|Overall Study|Adverse Event-prior to treatment|1|||
144624637|NCT02482129|521481981|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
144624638|NCT02482129|521481982|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
144624639|NCT02482129|521481981|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
144624640|NCT02482129|521481982|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
144624641|NCT02482129|521481981|FG000|Overall Study|Criteria not met-prior to treatment|1|||
144624642|NCT02482129|521481982|FG001|Overall Study|Criteria not met-prior to treatment|0|||
144624643|NCT02482129|521481981|FG000|Overall Study|Adverse Event|1|||
144624644|NCT02482129|521481982|FG001|Overall Study|Adverse Event|0|||
144624645|NCT02482129|521481981|FG000|Overall Study|Withdrawal by Subject|2|||
144624646|NCT02482129|521481982|FG001|Overall Study|Withdrawal by Subject|0|||
144624647|NCT02482129|521481981|FG000|Overall Study|Criteria not met|1|||
144624648|NCT02482129|521481982|FG001|Overall Study|Criteria not met|0|||
144624649|NCT00429585|521481985|FG000|Overall Study|Death|1|||
144624650|NCT00429585|521481986|FG001|Overall Study|Death|0|||
144624651|NCT00429585|521481985|FG000|Overall Study|Lost to Follow-up|27|||
144624652|NCT00429585|521481986|FG001|Overall Study|Lost to Follow-up|20|||
144624653|NCT00429585|521481985|FG000|Overall Study|Physician Decision|2|||
144624654|NCT00429585|521481986|FG001|Overall Study|Physician Decision|0|||
144624655|NCT01299766|521483372|FG000|Overall Study|Death|5|||
144624656|NCT01299766|521483373|FG001|Overall Study|Death|4|||
144624657|NCT01299766|521483372|FG000|Overall Study|Withdrawal by Subject|29|||
144624658|NCT01299766|521483373|FG001|Overall Study|Withdrawal by Subject|19|||
144624659|NCT00403260|521483376|FG000|Overall Study|Adverse Event|5|||
144624660|NCT00403260|521483377|FG001|Overall Study|Adverse Event|4|||
144624661|NCT00403260|521483376|FG000|Overall Study|Withdrawal by Subject|5|||
144624662|NCT00403260|521483377|FG001|Overall Study|Withdrawal by Subject|6|||
144624663|NCT00403260|521483376|FG000|Overall Study|Lost to Follow-up|49|||
144624664|NCT00403260|521483377|FG001|Overall Study|Lost to Follow-up|25|||
144624665|NCT00403260|521483376|FG000|Overall Study|Re-appearance of P. falciparum|34|||
144624666|NCT00403260|521483377|FG001|Overall Study|Re-appearance of P. falciparum|25|||
144624667|NCT00403260|521483376|FG000|Overall Study|P. vivax infection|26|||
144624668|NCT00403260|521483377|FG001|Overall Study|P. vivax infection|4|||
144624669|NCT00403260|521483376|FG000|Overall Study|Mixed infection with P. vivax|2|||
144624670|NCT00403260|521483377|FG001|Overall Study|Mixed infection with P. vivax|0|||
144624671|NCT00403260|521483376|FG000|Overall Study|Mixed infection with P. falciparum|1|||
144624672|NCT00403260|521483377|FG001|Overall Study|Mixed infection with P. falciparum|0|||
144624673|NCT00403260|521483376|FG000|Overall Study|P. vivax infection at screening|1|||
144730539|NCT01918397|521869819|FG003|Overall Study|Lack of compliance|0|||
144730540|NCT01918397|521869816|FG000|Overall Study|Pregnancy|0|||
144624674|NCT00403260|521483377|FG001|Overall Study|P. vivax infection at screening|0|||
144624675|NCT00403260|521483376|FG000|Overall Study|P. ovale infection|1|||
144624676|NCT00403260|521483377|FG001|Overall Study|P. ovale infection|0|||
144624677|NCT00403260|521483376|FG000|Overall Study|Gametocyte re-appearance|1|||
144624678|NCT00403260|521483377|FG001|Overall Study|Gametocyte re-appearance|1|||
144624679|NCT00403260|521483376|FG000|Overall Study|Withdrawn from study accidentally|0|||
144624680|NCT00403260|521483377|FG001|Overall Study|Withdrawn from study accidentally|1|||
144624681|NCT02971202|521483382|FG000|Overall Study|Pregnancy|1|||
144624682|NCT02971202|521483383|FG001|Overall Study|Pregnancy|0|||
144624683|NCT02971202|521483384|FG002|Overall Study|Pregnancy|0|||
144624684|NCT02971202|521483382|FG000|Overall Study|screen fail after consent|1|||
144624685|NCT02971202|521483383|FG001|Overall Study|screen fail after consent|0|||
144624686|NCT02971202|521483384|FG002|Overall Study|screen fail after consent|1|||
144624687|NCT03472560|521483385|FG000|Overall Study|Subject transfer to continuation protocol|0|||
144624688|NCT03472560|521483386|FG001|Overall Study|Subject transfer to continuation protocol|1|||
144730541|NCT01918397|521869817|FG001|Overall Study|Pregnancy|1|||
144624689|NCT03472560|521483385|FG000|Overall Study|Withdrawal by Subject|4|||
144624690|NCT03472560|521483386|FG001|Overall Study|Withdrawal by Subject|0|||
144624691|NCT03472560|521483385|FG000|Overall Study|Progressive disease|24|||
144209605|NCT02960490|519961995|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144209606|NCT02960490|519961996|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
144624692|NCT03472560|521483386|FG001|Overall Study|Progressive disease|8|||
144624693|NCT03472560|521483385|FG000|Overall Study|Physician Decision|1|||
144624694|NCT03472560|521483386|FG001|Overall Study|Physician Decision|0|||
144624695|NCT03472560|521483385|FG000|Overall Study|Death|7|||
144624696|NCT03472560|521483386|FG001|Overall Study|Death|4|||
144624697|NCT03472560|521483385|FG000|Overall Study|Adverse Event|5|||
144624698|NCT03472560|521483386|FG001|Overall Study|Adverse Event|3|||
144624699|NCT03472560|521483385|FG000|Overall Study|Global deterioration of health status|0|||
144624700|NCT03472560|521483386|FG001|Overall Study|Global deterioration of health status|4|||
144624701|NCT01946178|521483387|FG000|Overall Study|Pregnancy|1|||
144624702|NCT01946178|521483387|FG000|Overall Study|Lost to Follow-up|1|||
144624703|NCT01534676|521483388|FG000|Overall Study|Study closed due to poor enrollment|2|||
144624704|NCT01534676|521483389|FG001|Overall Study|Study closed due to poor enrollment|1|||
144624705|NCT05425563|521483390|FG000|Overall Study|Withdrawal by Subject|17|||
144624706|NCT02222714|521483392|FG000|Overall Study|Death|0|||
144624707|NCT02222714|521483393|FG001|Overall Study|Death|2|||
144624708|NCT02222714|521483394|FG002|Overall Study|Death|3|||
144624709|NCT02222714|521483395|FG003|Overall Study|Death|4|||
144624710|NCT02222714|521483396|FG004|Overall Study|Death|6|||
144624711|NCT02222714|521483392|FG000|Overall Study|Withdrawal by Subject|0|||
144624712|NCT02222714|521483393|FG001|Overall Study|Withdrawal by Subject|0|||
144624713|NCT02222714|521483394|FG002|Overall Study|Withdrawal by Subject|1|||
144624714|NCT02222714|521483395|FG003|Overall Study|Withdrawal by Subject|0|||
144624715|NCT02222714|521483396|FG004|Overall Study|Withdrawal by Subject|1|||
144624716|NCT03237065|521483399|FG000|Overall Study|Adverse Event|0|||
144624717|NCT03237065|521483400|FG001|Overall Study|Adverse Event|2|||
144624718|NCT03237065|521483399|FG000|Overall Study|Protocol Violation|0|||
144624719|NCT03237065|521483400|FG001|Overall Study|Protocol Violation|1|||
144624720|NCT03237065|521483399|FG000|Overall Study|Withdrawal by Subject|3|||
144624721|NCT03237065|521483400|FG001|Overall Study|Withdrawal by Subject|0|||
144624722|NCT03237065|521483399|FG000|Overall Study|Lost to Follow-up|1|||
144624723|NCT03237065|521483400|FG001|Overall Study|Lost to Follow-up|0|||
144624724|NCT03237065|521483399|FG000|Overall Study|Unable to obtain venous access|0|||
144624725|NCT03237065|521483400|FG001|Overall Study|Unable to obtain venous access|1|||
144624726|NCT02474082|521483401|FG000|Overall Study|Adverse Event|2|||
144730542|NCT01918397|521869818|FG002|Overall Study|Pregnancy|0|||
144730543|NCT01918397|521869819|FG003|Overall Study|Pregnancy|0|||
144730544|NCT01918397|521869816|FG000|Overall Study|Rifampin susceptible|0|||
144624727|NCT02474082|521483402|FG001|Overall Study|Adverse Event|32|||
144624728|NCT02474082|521483401|FG000|Overall Study|Withdrawal of informed consent|1|||
144624729|NCT02474082|521483402|FG001|Overall Study|Withdrawal of informed consent|11|||
144624730|NCT02474082|521483401|FG000|Overall Study|Lost to Follow-up|2|||
144624731|NCT02474082|521483402|FG001|Overall Study|Lost to Follow-up|2|||
144624732|NCT02474082|521483401|FG000|Overall Study|Dose tapering not achieved|0|||
144624733|NCT02474082|521483402|FG001|Overall Study|Dose tapering not achieved|4|||
144624734|NCT02474082|521483401|FG000|Overall Study|Participant/guardian decision|1|||
144624735|NCT02474082|521483402|FG001|Overall Study|Participant/guardian decision|2|||
144624736|NCT02474082|521483401|FG000|Overall Study|Non-compliance with study treatment|0|||
144624737|NCT02474082|521483402|FG001|Overall Study|Non-compliance with study treatment|2|||
144624738|NCT02474082|521483401|FG000|Overall Study|Protocol deviation|0|||
144624739|NCT02474082|521483402|FG001|Overall Study|Protocol deviation|1|||
144624740|NCT00939692|521483409|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
144624741|NCT00939692|521483410|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
144624742|NCT00939692|521483409|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
144624743|NCT00939692|521483410|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
144624744|NCT04317274|521483411|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
144624745|NCT04317274|521483412|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
144624746|NCT04317274|521483413|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
144624747|NCT04317274|521483414|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
144624748|NCT04849780|521483426|FG000|Period 1|Covid-19 Related|1|||
144624749|NCT04849780|521483427|FG001|Period 1|Covid-19 Related|0|||
144624750|NCT04849780|521483426|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
144624751|NCT04849780|521483427|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
144730545|NCT01918397|521869817|FG001|Overall Study|Rifampin susceptible|0|||
144262927|NCT03506438|520163787|FG001|Overall Study|Lost to Follow-up|7|||
144730546|NCT01918397|521869818|FG002|Overall Study|Rifampin susceptible|0|||
144624752|NCT04849780|521483426|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
144624753|NCT04849780|521483427|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
144624754|NCT01580397|521483430|FG000|Overall Study|Lack of Efficacy|14|||
144624755|NCT01353703|521483431|FG000|Overall Study|Migrated/moved from study area|1|||
144624756|NCT01353703|521483432|FG001|Overall Study|Migrated/moved from study area|0|||
144624757|NCT02286947|521483438|FG000|Overall Study|Withdrawal by Subject|2|||
144730547|NCT01918397|521869819|FG003|Overall Study|Rifampin susceptible|2|||
144624758|NCT01614093|521483443|FG000|Overall Study|Withdrawal by Subject|1|||
144624759|NCT00848354|521483444|FG000|Phase 1|Adverse Event|5|||
144624760|NCT00848354|521483445|FG001|Phase 1|Adverse Event|4|||
144624761|NCT00848354|521483444|FG000|Phase 1|Discontinuation of study by sponsor|2|||
144624762|NCT00848354|521483445|FG001|Phase 1|Discontinuation of study by sponsor|1|||
144624763|NCT00848354|521483444|FG000|Phase 1|Failed to return|0|||
144624764|NCT00848354|521483445|FG001|Phase 1|Failed to return|1|||
144624765|NCT00848354|521483444|FG000|Phase 1|Lost to Follow-up|1|||
144624766|NCT00848354|521483445|FG001|Phase 1|Lost to Follow-up|1|||
144624767|NCT00848354|521483444|FG000|Phase 1|Unspecified Reason|1|||
144624768|NCT00848354|521483445|FG001|Phase 1|Unspecified Reason|1|||
144624769|NCT00848354|521483444|FG000|Phase 1|Protocol Violation|1|||
144624770|NCT00848354|521483445|FG001|Phase 1|Protocol Violation|1|||
144624771|NCT00848354|521483444|FG000|Phase 1|Withdrawal by Subject|2|||
144624772|NCT00848354|521483445|FG001|Phase 1|Withdrawal by Subject|4|||
144624773|NCT00848354|521483444|FG000|Phase 1|Lack of Efficacy|0|||
144624774|NCT00848354|521483445|FG001|Phase 1|Lack of Efficacy|1|||
144624775|NCT00848354|521483444|FG000|Phase 2 Year 1|Adverse Event|7|||
144624776|NCT00848354|521483445|FG001|Phase 2 Year 1|Adverse Event|2|||
144624777|NCT00848354|521483444|FG000|Phase 2 Year 1|Death|1|||
144624778|NCT00848354|521483445|FG001|Phase 2 Year 1|Death|0|||
144624779|NCT00848354|521483444|FG000|Phase 2 Year 1|Failed to Return|1|||
144624780|NCT00848354|521483445|FG001|Phase 2 Year 1|Failed to Return|1|||
144624781|NCT00848354|521483444|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
144624782|NCT00848354|521483445|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
144624783|NCT00848354|521483444|FG000|Phase 2 Year 1|Unspecified Reason|3|||
144624784|NCT00848354|521483445|FG001|Phase 2 Year 1|Unspecified Reason|0|||
144624785|NCT00848354|521483444|FG000|Phase 2 Year 1|Protocol Violation|4|||
144624786|NCT00848354|521483445|FG001|Phase 2 Year 1|Protocol Violation|1|||
144624787|NCT00848354|521483444|FG000|Phase 2 Year 1|Subject Request|1|||
144624788|NCT00848354|521483445|FG001|Phase 2 Year 1|Subject Request|2|||
144624789|NCT00848354|521483444|FG000|Phase 2 Year 2|Adverse Event|12|||
144624790|NCT00848354|521483445|FG001|Phase 2 Year 2|Adverse Event|2|||
144624791|NCT00848354|521483444|FG000|Phase 2 Year 2|Death|2|||
144624792|NCT00848354|521483445|FG001|Phase 2 Year 2|Death|0|||
144624793|NCT00848354|521483444|FG000|Phase 2 Year 2|Failed to return|3|||
144624794|NCT00848354|521483445|FG001|Phase 2 Year 2|Failed to return|0|||
144624795|NCT00848354|521483444|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
144624796|NCT00848354|521483445|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
144624797|NCT00848354|521483444|FG000|Phase 2 Year 2|Unspecified Reason|1|||
144624798|NCT00848354|521483445|FG001|Phase 2 Year 2|Unspecified Reason|0|||
144624799|NCT00848354|521483444|FG000|Phase 2 Year 2|Protocol Violation|1|||
144624800|NCT00848354|521483445|FG001|Phase 2 Year 2|Protocol Violation|1|||
144624801|NCT00848354|521483444|FG000|Phase 2 Year 2|Subject Request|1|||
144624802|NCT00848354|521483445|FG001|Phase 2 Year 2|Subject Request|1|||
144624803|NCT00848354|521483444|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
144624804|NCT00848354|521483445|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
144624805|NCT00915343|521483448|FG000|Part B - Open Label Period|Treatment switch|0|||
144624806|NCT00915343|521483449|FG001|Part B - Open Label Period|Treatment switch|0|||
144624807|NCT00915343|521483450|FG002|Part B - Open Label Period|Treatment switch|1|||
144624808|NCT00915343|521483448|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
144624809|NCT00915343|521483449|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
144624810|NCT00915343|521483450|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
144624811|NCT01972074|521483451|FG000|Overall Study|Adverse Event|4|||
144624812|NCT01972074|521483452|FG001|Overall Study|Adverse Event|1|||
144624813|NCT01972074|521483453|FG002|Overall Study|Adverse Event|0|||
144624814|NCT01972074|521483451|FG000|Overall Study|Lack of Efficacy|1|||
144624815|NCT01972074|521483452|FG001|Overall Study|Lack of Efficacy|1|||
144624816|NCT01972074|521483453|FG002|Overall Study|Lack of Efficacy|0|||
144624817|NCT01972074|521483451|FG000|Overall Study|Lost to Follow-up|0|||
144624818|NCT01972074|521483452|FG001|Overall Study|Lost to Follow-up|1|||
144624819|NCT01972074|521483453|FG002|Overall Study|Lost to Follow-up|1|||
144624820|NCT01972074|521483451|FG000|Overall Study|Withdrawal by Subject|1|||
144624821|NCT01972074|521483452|FG001|Overall Study|Withdrawal by Subject|1|||
144624822|NCT01972074|521483453|FG002|Overall Study|Withdrawal by Subject|1|||
144624823|NCT01972074|521483451|FG000|Overall Study|Scanner Unavailable|0|||
144624824|NCT01972074|521483452|FG001|Overall Study|Scanner Unavailable|0|||
144624825|NCT01972074|521483453|FG002|Overall Study|Scanner Unavailable|1|||
144624826|NCT02317562|521483454|FG000|Overall Study|Physician Decision|1|||
144624827|NCT02317562|521483454|FG000|Overall Study|early termination of the study|8|||
144624828|NCT02317562|521483454|FG000|Overall Study|Lack of Efficacy|4|||
144624829|NCT02317562|521483454|FG000|Overall Study|Withdrawal by Subject|1|||
144624830|NCT00911989|521483455|FG000|Overall Study|Adverse Event|1|||
144624831|NCT03064841|521483456|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
144624832|NCT03064841|521483456|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
144624833|NCT03064841|521483456|FG000|Overall Study|Screen failure|2|||
144624834|NCT01145066|521483457|FG000|Overall Study|To resume NSAIDs|2|||
144262928|NCT03506438|520163788|FG002|Overall Study|Lost to Follow-up|8|||
144624835|NCT01145066|521483458|FG001|Overall Study|To resume NSAIDs|2|||
144624836|NCT01145066|521483459|FG002|Overall Study|To resume NSAIDs|1|||
144624837|NCT01145066|521483457|FG000|Overall Study|Non-related surgery|0|||
144624838|NCT01145066|521483458|FG001|Overall Study|Non-related surgery|0|||
144624839|NCT01145066|521483459|FG002|Overall Study|Non-related surgery|1|||
144624840|NCT01145066|521483457|FG000|Overall Study|Withdrawal by Subject|0|||
144624841|NCT01145066|521483458|FG001|Overall Study|Withdrawal by Subject|0|||
144624842|NCT01145066|521483459|FG002|Overall Study|Withdrawal by Subject|2|||
144624843|NCT01145066|521483457|FG000|Overall Study|To start new med|1|||
144624844|NCT01145066|521483458|FG001|Overall Study|To start new med|0|||
144624845|NCT01145066|521483459|FG002|Overall Study|To start new med|0|||
144624846|NCT01145066|521483457|FG000|Overall Study|problems swallowing capsule|1|||
144624847|NCT01145066|521483458|FG001|Overall Study|problems swallowing capsule|0|||
144624848|NCT01145066|521483459|FG002|Overall Study|problems swallowing capsule|0|||
144624849|NCT01145066|521483457|FG000|Overall Study|Abdominal discomfort|0|||
144624850|NCT01145066|521483458|FG001|Overall Study|Abdominal discomfort|1|||
144624851|NCT01145066|521483459|FG002|Overall Study|Abdominal discomfort|0|||
144624852|NCT01145066|521483457|FG000|Overall Study|Low platelet count|0|||
144624853|NCT01145066|521483458|FG001|Overall Study|Low platelet count|1|||
144624854|NCT01145066|521483459|FG002|Overall Study|Low platelet count|0|||
144624855|NCT03920670|521483460|FG000|Overall Study|Protocol Violation|2|||
144624856|NCT03920670|521483461|FG001|Overall Study|Protocol Violation|2|||
144624857|NCT03920670|521483460|FG000|Overall Study|Adverse Event|1|||
144624858|NCT03920670|521483461|FG001|Overall Study|Adverse Event|0|||
144624859|NCT03687502|521483462|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
144624860|NCT03687502|521483462|FG000|Overall Study|Lumason not available|1|||
144624861|NCT01777581|521483463|FG000|Overall Study|Lost to Follow-up|1|||
144624862|NCT01777581|521483464|FG001|Overall Study|Lost to Follow-up|1|||
144624863|NCT01777581|521483463|FG000|Overall Study|Adverse Event|2|||
144624864|NCT01777581|521483464|FG001|Overall Study|Adverse Event|0|||
144624865|NCT01777581|521483463|FG000|Overall Study|Lack of Efficacy|0|||
144624866|NCT01777581|521483464|FG001|Overall Study|Lack of Efficacy|1|||
144624867|NCT04811716|521483469|FG000|Overall Study|Withdrawal by Subject|2|||
144624868|NCT04811716|521483470|FG001|Overall Study|Withdrawal by Subject|0|||
144624869|NCT04202679|521483471|FG000|Overall Study|Adverse Event|2|||
144624870|NCT04202679|521483472|FG001|Overall Study|Adverse Event|0|||
144624871|NCT04202679|521483471|FG000|Overall Study|Poor compliance to protocol|1|||
144624872|NCT04202679|521483472|FG001|Overall Study|Poor compliance to protocol|0|||
144624873|NCT04202679|521483471|FG000|Overall Study|Withdrawal by Subject|23|||
144624874|NCT04202679|521483472|FG001|Overall Study|Withdrawal by Subject|6|||
144624875|NCT02321436|521483473|FG000|Overall Study|Withdrawal by Subject|1|||
144624876|NCT02321436|521483474|FG001|Overall Study|Withdrawal by Subject|0|||
144624877|NCT02321436|521483473|FG000|Overall Study|Lost to Follow-up|0|||
144624878|NCT02321436|521483474|FG001|Overall Study|Lost to Follow-up|1|||
144624879|NCT03048422|521483477|FG000|Overall Study|Death|1|||
144624880|NCT03048422|521483478|FG001|Overall Study|Death|0|||
144624881|NCT03048422|521483479|FG002|Overall Study|Death|0|||
144624882|NCT03048422|521483477|FG000|Overall Study|Lost to Follow-up|5|||
144624883|NCT03048422|521483478|FG001|Overall Study|Lost to Follow-up|0|||
144624884|NCT03048422|521483479|FG002|Overall Study|Lost to Follow-up|1|||
144624885|NCT03048422|521483477|FG000|Overall Study|Withdrawal by Subject|5|||
144624886|NCT03048422|521483478|FG001|Overall Study|Withdrawal by Subject|7|||
144624887|NCT03048422|521483479|FG002|Overall Study|Withdrawal by Subject|4|||
144624888|NCT03048422|521483477|FG000|Overall Study|Moved|3|||
144624889|NCT03048422|521483478|FG001|Overall Study|Moved|2|||
144624890|NCT03048422|521483479|FG002|Overall Study|Moved|2|||
144624891|NCT03048422|521483477|FG000|Overall Study|Noncompliant with Study Requirements|2|||
144624892|NCT03048422|521483478|FG001|Overall Study|Noncompliant with Study Requirements|1|||
144624893|NCT03048422|521483479|FG002|Overall Study|Noncompliant with Study Requirements|2|||
144624894|NCT03048422|521483477|FG000|Overall Study|Not Able to Get to Clinic|1|||
144624895|NCT03048422|521483478|FG001|Overall Study|Not Able to Get to Clinic|0|||
144624896|NCT03048422|521483479|FG002|Overall Study|Not Able to Get to Clinic|0|||
144624897|NCT01928381|521483480|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
144624898|NCT01928381|521483481|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
144624899|NCT01928381|521483482|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
144262929|NCT03506438|520163789|FG003|Overall Study|Lost to Follow-up|7|||
144262930|NCT03506438|520163790|FG004|Overall Study|Lost to Follow-up|0|||
144262931|NCT03506438|520163791|FG005|Overall Study|Lost to Follow-up|0|||
144624900|NCT01928381|521483483|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
144624901|NCT01928381|521483484|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
144624902|NCT01928381|521483485|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
144624903|NCT01928381|521483486|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
144624904|NCT01928381|521483480|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
144624905|NCT01928381|521483481|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
144624906|NCT01928381|521483482|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
144730548|NCT01918397|521869816|FG000|Overall Study|Treatment failure|0|||
144730549|NCT01918397|521869817|FG001|Overall Study|Treatment failure|0|||
144624907|NCT01928381|521483483|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
144624908|NCT01928381|521483484|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
144624909|NCT01928381|521483485|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
144624910|NCT01928381|521483486|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
144624911|NCT01928381|521483480|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
144624912|NCT01928381|521483481|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
144624913|NCT01928381|521483482|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
144624914|NCT01928381|521483483|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
144624915|NCT01928381|521483484|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
144624916|NCT01928381|521483485|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
144624917|NCT01928381|521483486|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
144624918|NCT01928381|521483480|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
144624919|NCT01928381|521483481|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
144624920|NCT01928381|521483482|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
144624921|NCT01928381|521483483|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
144624922|NCT01928381|521483484|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
144624923|NCT01928381|521483485|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
144624924|NCT01928381|521483486|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
144624925|NCT01928381|521483480|FG000|Part 1 - Pain Training|Protocol Violation|1|||
144624926|NCT01928381|521483481|FG001|Part 1 - Pain Training|Protocol Violation|0|||
144624927|NCT01928381|521483482|FG002|Part 1 - Pain Training|Protocol Violation|0|||
144624928|NCT01928381|521483483|FG003|Part 1 - Pain Training|Protocol Violation|0|||
144624929|NCT01928381|521483484|FG004|Part 1 - Pain Training|Protocol Violation|0|||
144624930|NCT01928381|521483485|FG005|Part 1 - Pain Training|Protocol Violation|0|||
144624931|NCT01928381|521483486|FG006|Part 1 - Pain Training|Protocol Violation|0|||
144624932|NCT01928381|521483480|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
144624933|NCT01928381|521483481|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
144624934|NCT01928381|521483482|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
144624935|NCT01928381|521483483|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
144624936|NCT01928381|521483484|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
144624937|NCT01928381|521483485|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
144624938|NCT01928381|521483486|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
144624939|NCT01928381|521483480|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
144624940|NCT01928381|521483481|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
144624941|NCT01928381|521483482|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
144624942|NCT01928381|521483483|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
144624943|NCT01928381|521483484|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
144624944|NCT01928381|521483485|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
144624945|NCT01928381|521483486|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
144624946|NCT01928381|521483480|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
144624947|NCT01928381|521483481|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
144624948|NCT01928381|521483482|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
144624949|NCT01928381|521483483|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
144624950|NCT01928381|521483484|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
144624951|NCT01928381|521483485|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
144624952|NCT01928381|521483486|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
144624953|NCT01928381|521483480|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
144624954|NCT01928381|521483481|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
144624955|NCT01928381|521483482|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
144624956|NCT01928381|521483483|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
144624957|NCT01928381|521483484|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
144624958|NCT01928381|521483485|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
144624959|NCT01928381|521483486|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
144624960|NCT01928381|521483480|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
144624961|NCT01928381|521483481|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
144624962|NCT01928381|521483482|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
144624963|NCT01928381|521483483|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
144624964|NCT01928381|521483484|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
144624965|NCT01928381|521483485|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
144624966|NCT01928381|521483486|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
144624967|NCT01928381|521483480|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
144624968|NCT01928381|521483481|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
144624969|NCT01928381|521483482|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
144624970|NCT01928381|521483483|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
144624971|NCT01928381|521483484|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
144624972|NCT01928381|521483485|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
144624973|NCT01928381|521483486|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
144730550|NCT01918397|521869818|FG002|Overall Study|Treatment failure|0|||
144730551|NCT01918397|521869819|FG003|Overall Study|Treatment failure|1|||
144730552|NCT01918397|521869816|FG000|Overall Study|Withdrawal by Subject|3|||
144730553|NCT01918397|521869817|FG001|Overall Study|Withdrawal by Subject|2|||
144730554|NCT01918397|521869818|FG002|Overall Study|Withdrawal by Subject|1|||
144209607|NCT02960490|519961997|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
144585825|NCT02663518|521343801|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585826|NCT02663518|521343802|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585827|NCT02663518|521343803|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585828|NCT02663518|521343804|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585829|NCT02663518|521343805|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585830|NCT02663518|521343806|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585831|NCT02663518|521343807|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585832|NCT02663518|521343808|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585833|NCT02663518|521343809|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
144585834|NCT02663518|521343810|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
144585835|NCT02663518|521343797|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585836|NCT02663518|521343798|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585837|NCT02663518|521343799|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585838|NCT02663518|521343800|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585839|NCT02663518|521343801|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585840|NCT02663518|521343802|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585841|NCT02663518|521343803|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585842|NCT02663518|521343804|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585843|NCT02663518|521343805|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585844|NCT02663518|521343806|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585845|NCT02663518|521343807|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585846|NCT02663518|521343808|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
144585847|NCT02663518|521343809|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585848|NCT02663518|521343810|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
144585849|NCT02663518|521343797|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585850|NCT02663518|521343798|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585851|NCT02663518|521343799|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585852|NCT02663518|521343800|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585853|NCT02663518|521343801|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585854|NCT02663518|521343802|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585855|NCT02663518|521343803|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585856|NCT02663518|521343804|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585857|NCT02663518|521343805|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585858|NCT02663518|521343806|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
144585859|NCT02663518|521343807|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
144585860|NCT02663518|521343808|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
144585861|NCT02663518|521343809|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
144585862|NCT02663518|521343810|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
144585863|NCT02663518|521343797|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
144585864|NCT02663518|521343798|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
144585865|NCT02663518|521343799|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
144585866|NCT02663518|521343800|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
144585867|NCT02663518|521343801|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
144585868|NCT02663518|521343802|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
144585869|NCT02663518|521343803|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
144585870|NCT02663518|521343804|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
144585871|NCT02663518|521343805|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
144585872|NCT02663518|521343806|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
144585873|NCT02663518|521343807|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
144585874|NCT02663518|521343808|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
144585875|NCT02663518|521343809|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
144585876|NCT02663518|521343810|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
144585877|NCT02663518|521343797|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585878|NCT02663518|521343798|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585879|NCT02663518|521343799|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585880|NCT02663518|521343800|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585881|NCT02663518|521343801|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585882|NCT02663518|521343802|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585883|NCT02663518|521343803|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585884|NCT02663518|521343804|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144730555|NCT01918397|521869819|FG003|Overall Study|Withdrawal by Subject|1|||
144624974|NCT01928381|521483480|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
144624975|NCT01928381|521483481|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
144624976|NCT01928381|521483482|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
144624977|NCT01928381|521483483|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
144624978|NCT01928381|521483484|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
144624979|NCT01928381|521483485|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
144624980|NCT01928381|521483486|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
144624981|NCT01928381|521483480|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
144624982|NCT01928381|521483481|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
144624983|NCT01928381|521483482|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
144624984|NCT01928381|521483483|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
144624985|NCT01928381|521483484|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
144624986|NCT01928381|521483485|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
144624987|NCT01928381|521483486|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
144624988|NCT01928381|521483480|FG000|Washout First Intervention|Protocol Violation|0|||
144624989|NCT01928381|521483481|FG001|Washout First Intervention|Protocol Violation|0|||
144624990|NCT01928381|521483482|FG002|Washout First Intervention|Protocol Violation|0|||
144624991|NCT01928381|521483483|FG003|Washout First Intervention|Protocol Violation|0|||
144624992|NCT01928381|521483484|FG004|Washout First Intervention|Protocol Violation|1|||
144624993|NCT01928381|521483485|FG005|Washout First Intervention|Protocol Violation|0|||
144624994|NCT01928381|521483486|FG006|Washout First Intervention|Protocol Violation|0|||
144624995|NCT01928381|521483480|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
144624996|NCT01928381|521483481|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
144624997|NCT01928381|521483482|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
144624998|NCT01928381|521483483|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
144624999|NCT01928381|521483484|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
144625000|NCT01928381|521483485|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
144625001|NCT01928381|521483486|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
144625002|NCT01928381|521483480|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
144625003|NCT01928381|521483481|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
144625004|NCT01928381|521483482|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
144625005|NCT01928381|521483483|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
144625006|NCT01928381|521483484|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
144625007|NCT01928381|521483485|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
144625008|NCT01928381|521483486|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
144625009|NCT01877083|521483487|FG000|Treatment Phase|Disease Progression|10|||
144625010|NCT01877083|521483487|FG000|Treatment Phase|Clinical Progression|1|||
144625011|NCT01877083|521483487|FG000|Treatment Phase|Adverse Event|6|||
144625012|NCT01877083|521483487|FG000|Treatment Phase|Withdrawal by Subject|2|||
144625013|NCT01877083|521483487|FG000|Treatment Phase|Lost to Follow-up|1|||
144625014|NCT01877083|521483487|FG000|Extension Phase|Disease Progression|3|||
144625015|NCT01877083|521483487|FG000|Extension Phase|Adverse Event|2|||
144625016|NCT01582308|521483488|FG000|Period 1|Withdrawal by Subject|0|||
144625017|NCT01582308|521483489|FG001|Period 1|Withdrawal by Subject|0|||
144625018|NCT01582308|521483490|FG002|Period 1|Withdrawal by Subject|0|||
144625019|NCT01582308|521483491|FG003|Period 1|Withdrawal by Subject|0|||
144625020|NCT01582308|521483492|FG004|Period 1|Withdrawal by Subject|0|||
144625021|NCT01582308|521483493|FG005|Period 1|Withdrawal by Subject|0|||
144625022|NCT01582308|521483494|FG006|Period 1|Withdrawal by Subject|1|||
144625023|NCT01582308|521483495|FG007|Period 1|Withdrawal by Subject|0|||
144625024|NCT01582308|521483496|FG008|Period 1|Withdrawal by Subject|0|||
144625025|NCT01582308|521483497|FG009|Period 1|Withdrawal by Subject|0|||
144625026|NCT01582308|521483488|FG000|10-day Washout Following Period 1|Physician Decision|0|||
144625027|NCT01582308|521483489|FG001|10-day Washout Following Period 1|Physician Decision|0|||
144625028|NCT01582308|521483490|FG002|10-day Washout Following Period 1|Physician Decision|0|||
144625029|NCT01582308|521483491|FG003|10-day Washout Following Period 1|Physician Decision|0|||
144625030|NCT01582308|521483492|FG004|10-day Washout Following Period 1|Physician Decision|1|||
144625031|NCT01582308|521483493|FG005|10-day Washout Following Period 1|Physician Decision|0|||
144625032|NCT01582308|521483494|FG006|10-day Washout Following Period 1|Physician Decision|0|||
144625033|NCT01582308|521483495|FG007|10-day Washout Following Period 1|Physician Decision|0|||
144625034|NCT01582308|521483496|FG008|10-day Washout Following Period 1|Physician Decision|0|||
144625035|NCT01582308|521483497|FG009|10-day Washout Following Period 1|Physician Decision|0|||
144625036|NCT01582308|521483488|FG000|Period 4|Physician Decision|1|||
144625037|NCT01582308|521483489|FG001|Period 4|Physician Decision|0|||
144625038|NCT01582308|521483490|FG002|Period 4|Physician Decision|0|||
144625039|NCT01582308|521483491|FG003|Period 4|Physician Decision|0|||
144625040|NCT01582308|521483492|FG004|Period 4|Physician Decision|0|||
144625041|NCT01582308|521483493|FG005|Period 4|Physician Decision|1|||
144625042|NCT01582308|521483494|FG006|Period 4|Physician Decision|0|||
144625043|NCT01582308|521483495|FG007|Period 4|Physician Decision|0|||
144625044|NCT01582308|521483496|FG008|Period 4|Physician Decision|0|||
144625045|NCT01582308|521483497|FG009|Period 4|Physician Decision|1|||
144625046|NCT01844986|521483500|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
144625047|NCT01844986|521483501|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
144625048|NCT01844986|521483500|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
144625049|NCT01844986|521483501|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
144625050|NCT01844986|521483500|FG000|Overall Study (Global Cohort)|Death|55|||
144625051|NCT01844986|521483501|FG001|Overall Study (Global Cohort)|Death|26|||
144625052|NCT01844986|521483500|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
144625053|NCT01844986|521483501|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
144625054|NCT01844986|521483500|FG000|Overall Study (China Cohort)|Death|10|||
144625055|NCT01844986|521483501|FG001|Overall Study (China Cohort)|Death|6|||
144625056|NCT03406897|521483502|FG000|Overall Study|Lost to Follow-up|1|||
144625057|NCT03406897|521483503|FG001|Overall Study|Lost to Follow-up|2|||
144625058|NCT03406897|521483502|FG000|Overall Study|Withdrawal by Subject|4|||
144625059|NCT03406897|521483503|FG001|Overall Study|Withdrawal by Subject|4|||
144625060|NCT03406897|521483502|FG000|Overall Study|Physician Decision|0|||
144625061|NCT03406897|521483503|FG001|Overall Study|Physician Decision|1|||
144625062|NCT03160560|521485673|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
144625063|NCT03160560|521485674|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144625064|NCT03160560|521485675|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144625065|NCT03160560|521485676|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
144625066|NCT03160560|521485673|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
144625067|NCT03160560|521485674|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
144625068|NCT03160560|521485675|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
144625069|NCT03160560|521485676|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
144625070|NCT01354028|521485687|FG000|Overall Study|Physician Decision|0|||
144625071|NCT01354028|521485688|FG001|Overall Study|Physician Decision|2|||
144625072|NCT01354028|521485687|FG000|Overall Study|Discharged before study start|2|||
144625073|NCT01354028|521485688|FG001|Overall Study|Discharged before study start|2|||
144625074|NCT01354028|521485687|FG000|Overall Study|No quiet alert state|0|||
144625075|NCT01354028|521485688|FG001|Overall Study|No quiet alert state|1|||
144625076|NCT01777763|521485689|FG000|Overall Study|Adverse Event|2|||
144625077|NCT01777763|521485690|FG001|Overall Study|Adverse Event|32|||
144625078|NCT01777763|521485689|FG000|Overall Study|Protocol Violation|1|||
144625079|NCT01777763|521485690|FG001|Overall Study|Protocol Violation|7|||
144625080|NCT01777763|521485689|FG000|Overall Study|Withdrawal by Subject|0|||
144625081|NCT01777763|521485690|FG001|Overall Study|Withdrawal by Subject|2|||
144625082|NCT01777763|521485689|FG000|Overall Study|Treatment Failure|1|||
144625083|NCT01777763|521485690|FG001|Overall Study|Treatment Failure|6|||
144625084|NCT00935883|521485693|FG000|Treatment Period|Physician Decision|1|||
144625085|NCT00935883|521485694|FG001|Treatment Period|Physician Decision|0|||
144625086|NCT00935883|521485693|FG000|Treatment Period|Withdrawal by Subject|0|||
144625087|NCT00935883|521485694|FG001|Treatment Period|Withdrawal by Subject|2|||
144625088|NCT01641939|521485697|FG000|Overall Study|Death|90|||
144625089|NCT01641939|521485698|FG001|Overall Study|Death|187|||
144625090|NCT01641939|521485699|FG002|Overall Study|Death|61|||
144625091|NCT01641939|521485697|FG000|Overall Study|Lost to Follow-up|3|||
144625092|NCT01641939|521485698|FG001|Overall Study|Lost to Follow-up|2|||
144625093|NCT01641939|521485699|FG002|Overall Study|Lost to Follow-up|1|||
144625094|NCT01641939|521485697|FG000|Overall Study|Withdrawal by Subject|14|||
144625095|NCT01641939|521485698|FG001|Overall Study|Withdrawal by Subject|11|||
144625096|NCT01641939|521485699|FG002|Overall Study|Withdrawal by Subject|5|||
144625097|NCT01641939|521485697|FG000|Overall Study|Study Terminated by Sponsor|10|||
144625098|NCT01641939|521485698|FG001|Overall Study|Study Terminated by Sponsor|28|||
144625099|NCT01641939|521485699|FG002|Overall Study|Study Terminated by Sponsor|3|||
144625100|NCT02894840|521485700|FG000|Overall Study|Lost to Follow-up|1|||
144625101|NCT02894840|521485701|FG001|Overall Study|Lost to Follow-up|0|||
144625102|NCT02894840|521485702|FG002|Overall Study|Lost to Follow-up|3|||
144625103|NCT02894840|521485703|FG003|Overall Study|Lost to Follow-up|0|||
144625104|NCT00975156|521485707|FG000|Overall Study|Protocol Violation|0|||
144625105|NCT00975156|521485708|FG001|Overall Study|Protocol Violation|1|||
144625106|NCT01337973|521485711|FG000|Overall Study|Lost to Follow-up|2|||
144625107|NCT01337973|521485712|FG001|Overall Study|Lost to Follow-up|4|||
144625108|NCT01337973|521485713|FG002|Overall Study|Lost to Follow-up|3|||
144625109|NCT01337973|521485711|FG000|Overall Study|Death|1|||
144625110|NCT01337973|521485712|FG001|Overall Study|Death|2|||
144625111|NCT01337973|521485713|FG002|Overall Study|Death|1|||
144625112|NCT01337973|521485711|FG000|Overall Study|Withdrawal by Subject|10|||
144625113|NCT01337973|521485712|FG001|Overall Study|Withdrawal by Subject|8|||
144625114|NCT01337973|521485713|FG002|Overall Study|Withdrawal by Subject|4|||
144625115|NCT01337973|521485711|FG000|Overall Study|missing data on primary outcome|3|||
144625116|NCT01337973|521485712|FG001|Overall Study|missing data on primary outcome|1|||
144625117|NCT01337973|521485713|FG002|Overall Study|missing data on primary outcome|3|||
144625118|NCT02009878|521485718|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
144730556|NCT01918397|521869816|FG000|Overall Study|XDR at baseline|0|||
144625119|NCT02009878|521485719|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
144209608|NCT02960490|519961998|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144209609|NCT02960490|519961999|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
144209610|NCT02960490|519962000|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144209611|NCT02960490|519962001|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144209612|NCT02960490|519962002|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144209613|NCT02960490|519962003|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
144209614|NCT02960490|519961994|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209615|NCT02960490|519961995|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209616|NCT02960490|519961996|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
144209617|NCT02960490|519961997|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209618|NCT02960490|519961998|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
144209619|NCT02960490|519961999|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209620|NCT02960490|519962000|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144730557|NCT01918397|521869817|FG001|Overall Study|XDR at baseline|0|||
144730558|NCT01918397|521869818|FG002|Overall Study|XDR at baseline|1|||
144209621|NCT02960490|519962001|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209622|NCT02960490|519962002|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209623|NCT02960490|519962003|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
144209624|NCT02960490|519961994|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
144585885|NCT02663518|521343805|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585886|NCT02663518|521343806|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585887|NCT02663518|521343807|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585888|NCT02663518|521343808|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585889|NCT02663518|521343809|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
144585890|NCT02663518|521343810|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
144585891|NCT01144052|521343813|FG000|Overall Study|Withdrawal by Subject|1|||
144585892|NCT01144052|521343814|FG001|Overall Study|Withdrawal by Subject|1|||
144585893|NCT03836716|521343815|FG000|Overall Study|Adverse Event|3|||
144585894|NCT03836716|521343815|FG000|Overall Study|Death|22|||
144585895|NCT03836716|521343815|FG000|Overall Study|Withdrawal by Subject|8|||
144585896|NCT03836716|521343815|FG000|Overall Study|Study terminated by sponsor|87|||
144585897|NCT01879722|521343816|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144585898|NCT01879722|521343817|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
144585899|NCT01879722|521343818|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144585900|NCT01879722|521343819|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
144585901|NCT01879722|521343820|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
144585902|NCT01879722|521343821|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
144585903|NCT01879722|521343822|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
144585904|NCT01879722|521343823|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
144585905|NCT01879722|521343824|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
144585906|NCT01879722|521343825|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
144585907|NCT01879722|521343816|FG000|Overall Study|Voluntary Withdrawal|0|||
144585908|NCT01879722|521343817|FG001|Overall Study|Voluntary Withdrawal|0|||
144585909|NCT01879722|521343818|FG002|Overall Study|Voluntary Withdrawal|0|||
144585910|NCT01879722|521343819|FG003|Overall Study|Voluntary Withdrawal|0|||
144585911|NCT01879722|521343820|FG004|Overall Study|Voluntary Withdrawal|0|||
144585912|NCT01879722|521343821|FG005|Overall Study|Voluntary Withdrawal|0|||
144585913|NCT01879722|521343822|FG006|Overall Study|Voluntary Withdrawal|0|||
144585914|NCT01879722|521343823|FG007|Overall Study|Voluntary Withdrawal|0|||
144585915|NCT01879722|521343824|FG008|Overall Study|Voluntary Withdrawal|1|||
144585916|NCT01879722|521343825|FG009|Overall Study|Voluntary Withdrawal|0|||
144585917|NCT01983254|521343826|FG000|Overall Study|Death|6|||
144585918|NCT01983254|521343827|FG001|Overall Study|Death|6|||
144585919|NCT01983254|521343826|FG000|Overall Study|Lost to Follow-up|17|||
144585920|NCT01983254|521343827|FG001|Overall Study|Lost to Follow-up|16|||
144585921|NCT01983254|521343826|FG000|Overall Study|too ill|11|||
144585922|NCT01983254|521343827|FG001|Overall Study|too ill|8|||
144585923|NCT00037830|521343830|FG000|Overall Study|Adverse Event|2|||
144585924|NCT00037830|521343831|FG001|Overall Study|Adverse Event|0|||
144585925|NCT00037830|521343832|FG002|Overall Study|Adverse Event|0|||
144585926|NCT00037830|521343830|FG000|Overall Study|Withdrawal by Subject|4|||
144585927|NCT00037830|521343831|FG001|Overall Study|Withdrawal by Subject|5|||
144585928|NCT00037830|521343832|FG002|Overall Study|Withdrawal by Subject|1|||
144585929|NCT00037830|521343830|FG000|Overall Study|Protocol Violation|2|||
144585930|NCT00037830|521343831|FG001|Overall Study|Protocol Violation|2|||
144585931|NCT00037830|521343832|FG002|Overall Study|Protocol Violation|0|||
144585932|NCT00037830|521343830|FG000|Overall Study|Unrelated Medical Problem|2|||
144585933|NCT00037830|521343831|FG001|Overall Study|Unrelated Medical Problem|0|||
144585934|NCT00037830|521343832|FG002|Overall Study|Unrelated Medical Problem|0|||
144585935|NCT01253304|521343833|FG000|Overall Study|Adverse Event|0|||
144585936|NCT01253304|521343834|FG001|Overall Study|Adverse Event|0|||
144585937|NCT01253304|521343835|FG002|Overall Study|Adverse Event|0|||
144625120|NCT02009878|521485720|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
144625121|NCT04537208|521485725|FG000|Overall Study|Adverse Event|0|||
144625122|NCT04537208|521485726|FG001|Overall Study|Adverse Event|0|||
144625123|NCT04537208|521485727|FG002|Overall Study|Adverse Event|0|||
144625124|NCT04537208|521485728|FG003|Overall Study|Adverse Event|0|||
144625125|NCT04537208|521485729|FG004|Overall Study|Adverse Event|0|||
144625126|NCT04537208|521485730|FG005|Overall Study|Adverse Event|0|||
144625127|NCT04537208|521485731|FG006|Overall Study|Adverse Event|0|||
144625128|NCT04537208|521485732|FG007|Overall Study|Adverse Event|0|||
144625129|NCT04537208|521485733|FG008|Overall Study|Adverse Event|1|||
144625130|NCT04537208|521485734|FG009|Overall Study|Adverse Event|0|||
144625131|NCT04537208|521485735|FG010|Overall Study|Adverse Event|0|||
144625132|NCT04537208|521485725|FG000|Overall Study|Protocol deviation|0|||
144625133|NCT04537208|521485726|FG001|Overall Study|Protocol deviation|0|||
144625134|NCT04537208|521485727|FG002|Overall Study|Protocol deviation|2|||
144625135|NCT04537208|521485728|FG003|Overall Study|Protocol deviation|0|||
144625136|NCT04537208|521485729|FG004|Overall Study|Protocol deviation|0|||
144625137|NCT04537208|521485730|FG005|Overall Study|Protocol deviation|2|||
144625138|NCT04537208|521485731|FG006|Overall Study|Protocol deviation|4|||
144625139|NCT04537208|521485732|FG007|Overall Study|Protocol deviation|0|||
144625140|NCT04537208|521485733|FG008|Overall Study|Protocol deviation|1|||
144625141|NCT04537208|521485734|FG009|Overall Study|Protocol deviation|0|||
144625142|NCT04537208|521485735|FG010|Overall Study|Protocol deviation|2|||
144585938|NCT01253304|521343836|FG003|Overall Study|Adverse Event|1|||
144585939|NCT01699503|521343837|FG000|Overall Study|Death|31|||
144585940|NCT01699503|521343838|FG001|Overall Study|Death|40|||
144585941|NCT01699503|521343837|FG000|Overall Study|Withdrawal by Subject|65|||
144585942|NCT01699503|521343838|FG001|Overall Study|Withdrawal by Subject|57|||
144585943|NCT01699503|521343837|FG000|Overall Study|Lost to Follow-up|121|||
144585944|NCT01699503|521343838|FG001|Overall Study|Lost to Follow-up|117|||
144585945|NCT01699503|521343837|FG000|Overall Study|Excluded due to quality|783|||
144585946|NCT01699503|521343838|FG001|Overall Study|Excluded due to quality|791|||
144585947|NCT00006011|521343842|FG000|Overall Study|Disease progression|13|||
144585948|NCT00006011|521343843|FG001|Overall Study|Disease progression|6|||
144585949|NCT00006011|521343844|FG002|Overall Study|Disease progression|26|||
144585950|NCT00006011|521343842|FG000|Overall Study|Refused further treatment|15|||
144585951|NCT00006011|521343843|FG001|Overall Study|Refused further treatment|13|||
144585952|NCT00006011|521343844|FG002|Overall Study|Refused further treatment|26|||
144585953|NCT00006011|521343842|FG000|Overall Study|Adverse Event|15|||
144585954|NCT00006011|521343843|FG001|Overall Study|Adverse Event|39|||
144585955|NCT00006011|521343844|FG002|Overall Study|Adverse Event|5|||
144585956|NCT00006011|521343842|FG000|Overall Study|Death|0|||
144585957|NCT00006011|521343843|FG001|Overall Study|Death|1|||
144585958|NCT00006011|521343844|FG002|Overall Study|Death|2|||
144585959|NCT00006011|521343842|FG000|Overall Study|Other|4|||
144585960|NCT00006011|521343843|FG001|Overall Study|Other|2|||
144585961|NCT00006011|521343844|FG002|Overall Study|Other|5|||
144585962|NCT00006011|521343842|FG000|Overall Study|Ineligible|18|||
144585963|NCT00006011|521343843|FG001|Overall Study|Ineligible|16|||
144585964|NCT00006011|521343844|FG002|Overall Study|Ineligible|9|||
144585965|NCT03020576|521343858|FG000|Overall Study|Withdrawal by Subject|1|||
144585966|NCT03020576|521343859|FG001|Overall Study|Withdrawal by Subject|2|||
144585967|NCT00911937|521343861|FG000|Overall Study|Death|1|||
144585968|NCT00911937|521343862|FG001|Overall Study|Death|0|||
144585969|NCT00911937|521343861|FG000|Overall Study|Lost to Follow-up|8|||
144585970|NCT00911937|521343862|FG001|Overall Study|Lost to Follow-up|5|||
144585971|NCT00911937|521343861|FG000|Overall Study|Withdrawal by Subject|10|||
144585972|NCT00911937|521343862|FG001|Overall Study|Withdrawal by Subject|7|||
144585973|NCT00911937|521343861|FG000|Overall Study|Withdrawn due to pregnancy|1|||
144585974|NCT00911937|521343862|FG001|Overall Study|Withdrawn due to pregnancy|0|||
144585975|NCT00911937|521343861|FG000|Overall Study|Adverse Event|11|||
144585976|NCT00911937|521343862|FG001|Overall Study|Adverse Event|25|||
144585977|NCT00911937|521343861|FG000|Overall Study|Lack of Efficacy|11|||
144585978|NCT00911937|521343862|FG001|Overall Study|Lack of Efficacy|6|||
144585979|NCT00911937|521343861|FG000|Overall Study|Did not meet inclusion criteria|9|||
144585980|NCT00911937|521343862|FG001|Overall Study|Did not meet inclusion criteria|11|||
144585981|NCT00911937|521343861|FG000|Overall Study|Protocol Violation|14|||
144585982|NCT00911937|521343862|FG001|Overall Study|Protocol Violation|23|||
144585983|NCT00911937|521343861|FG000|Overall Study|Randomized but not treated|13|||
144625143|NCT04537208|521485725|FG000|Overall Study|Withdrawal by Subject|4|||
144625144|NCT04537208|521485726|FG001|Overall Study|Withdrawal by Subject|2|||
144585984|NCT00911937|521343862|FG001|Overall Study|Randomized but not treated|13|||
144585985|NCT00911937|521343861|FG000|Overall Study|Other|9|||
144585986|NCT00911937|521343862|FG001|Overall Study|Other|5|||
144585987|NCT03500159|521343868|FG000|Overall Study|Study Terminated|2|||
144625145|NCT04537208|521485727|FG002|Overall Study|Withdrawal by Subject|1|||
144625146|NCT04537208|521485728|FG003|Overall Study|Withdrawal by Subject|3|||
144625147|NCT04537208|521485729|FG004|Overall Study|Withdrawal by Subject|5|||
144625148|NCT04537208|521485730|FG005|Overall Study|Withdrawal by Subject|1|||
144625149|NCT04537208|521485731|FG006|Overall Study|Withdrawal by Subject|6|||
144625150|NCT04537208|521485732|FG007|Overall Study|Withdrawal by Subject|1|||
144625151|NCT04537208|521485733|FG008|Overall Study|Withdrawal by Subject|7|||
144625152|NCT04537208|521485734|FG009|Overall Study|Withdrawal by Subject|2|||
144625153|NCT04537208|521485735|FG010|Overall Study|Withdrawal by Subject|4|||
144625154|NCT04537208|521485725|FG000|Overall Study|Lost to Follow-up|4|||
144625155|NCT04537208|521485726|FG001|Overall Study|Lost to Follow-up|1|||
144625156|NCT04537208|521485727|FG002|Overall Study|Lost to Follow-up|3|||
144625157|NCT04537208|521485728|FG003|Overall Study|Lost to Follow-up|4|||
144625158|NCT04537208|521485729|FG004|Overall Study|Lost to Follow-up|3|||
144625159|NCT04537208|521485730|FG005|Overall Study|Lost to Follow-up|2|||
144625160|NCT04537208|521485731|FG006|Overall Study|Lost to Follow-up|3|||
144625161|NCT04537208|521485732|FG007|Overall Study|Lost to Follow-up|2|||
144625162|NCT04537208|521485733|FG008|Overall Study|Lost to Follow-up|7|||
144625163|NCT04537208|521485734|FG009|Overall Study|Lost to Follow-up|2|||
144625164|NCT04537208|521485735|FG010|Overall Study|Lost to Follow-up|2|||
144625165|NCT01537211|521485736|FG000|Overall Study|Lost to Follow-up|0|||
144625166|NCT01537211|521485737|FG001|Overall Study|Lost to Follow-up|1|||
144625167|NCT00343512|521485743|FG000|Overall Study|Withdrawal by Subject|2|||
144625168|NCT00323557|521485744|FG000|Overall Study|Physician Decision|1|||
144625169|NCT00323557|521485745|FG001|Overall Study|Physician Decision|0|||
144625170|NCT00197054|521485746|FG000|Overall Study|Withdrawal by Subject|9|||
144625171|NCT00197054|521485747|FG001|Overall Study|Withdrawal by Subject|3|||
144625172|NCT00197054|521485748|FG002|Overall Study|Withdrawal by Subject|3|||
144625173|NCT00197054|521485746|FG000|Overall Study|Moved from area|7|||
144625174|NCT00197054|521485747|FG001|Overall Study|Moved from area|14|||
144625175|NCT00197054|521485748|FG002|Overall Study|Moved from area|9|||
144625176|NCT00197054|521485746|FG000|Overall Study|Lost to Follow-up|1|||
144625177|NCT00197054|521485747|FG001|Overall Study|Lost to Follow-up|4|||
144625178|NCT00197054|521485748|FG002|Overall Study|Lost to Follow-up|0|||
144625179|NCT00684515|521485749|FG000|Overall Study|Adverse Event|3|||
144625180|NCT00684515|521485750|FG001|Overall Study|Adverse Event|3|||
144625181|NCT00684515|521485751|FG002|Overall Study|Adverse Event|1|||
144625182|NCT00684515|521485749|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
144625183|NCT00684515|521485750|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
144625184|NCT00684515|521485751|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
144625185|NCT02450578|521485752|FG000|Overall Study|ECG abnormality so not treated|1|||
144625186|NCT02450578|521485753|FG001|Overall Study|ECG abnormality so not treated|0|||
144625187|NCT02450578|521485754|FG002|Overall Study|ECG abnormality so not treated|0|||
144625188|NCT02450578|521485755|FG003|Overall Study|ECG abnormality so not treated|0|||
144625189|NCT04428411|521485758|FG000|Overall Study|Lost to Follow-up|114|||
144625190|NCT02918019|521485759|FG000|Overall Study|Death|0|||
144625191|NCT02918019|521485760|FG001|Overall Study|Death|0|||
144625192|NCT02918019|521485761|FG002|Overall Study|Death|1|||
144625193|NCT02918019|521485762|FG003|Overall Study|Death|0|||
144625194|NCT02918019|521485759|FG000|Overall Study|Lost to Follow-up|1|||
144625195|NCT02918019|521485760|FG001|Overall Study|Lost to Follow-up|1|||
144625196|NCT02918019|521485761|FG002|Overall Study|Lost to Follow-up|0|||
144625197|NCT02918019|521485762|FG003|Overall Study|Lost to Follow-up|1|||
144625198|NCT02918019|521485759|FG000|Overall Study|Principal investigator request|0|||
144625199|NCT02918019|521485760|FG001|Overall Study|Principal investigator request|0|||
144625200|NCT02918019|521485761|FG002|Overall Study|Principal investigator request|0|||
144625201|NCT02918019|521485762|FG003|Overall Study|Principal investigator request|1|||
144625202|NCT02918019|521485759|FG000|Overall Study|Physician Decision|1|||
144625203|NCT02918019|521485760|FG001|Overall Study|Physician Decision|3|||
144625204|NCT02918019|521485761|FG002|Overall Study|Physician Decision|2|||
144625205|NCT02918019|521485762|FG003|Overall Study|Physician Decision|0|||
144625206|NCT02918019|521485759|FG000|Overall Study|Protocol deviation|1|||
144625207|NCT02918019|521485760|FG001|Overall Study|Protocol deviation|1|||
144625208|NCT02918019|521485761|FG002|Overall Study|Protocol deviation|0|||
144625209|NCT02918019|521485762|FG003|Overall Study|Protocol deviation|2|||
144262932|NCT03934216|520163794|FG000|Overall Study|Other Reasons|5|||
144262933|NCT03934216|520163795|FG001|Overall Study|Other Reasons|5|||
144262934|NCT03934216|520163794|FG000|Overall Study|Adverse Event|22|||
144262935|NCT03934216|520163795|FG001|Overall Study|Adverse Event|11|||
144262936|NCT03934216|520163794|FG000|Overall Study|Lack of Efficacy|8|||
144625210|NCT02918019|521485759|FG000|Overall Study|Withdrawal by Subject|3|||
144625211|NCT02918019|521485760|FG001|Overall Study|Withdrawal by Subject|4|||
144262937|NCT03934216|520163795|FG001|Overall Study|Lack of Efficacy|7|||
144625212|NCT02918019|521485761|FG002|Overall Study|Withdrawal by Subject|6|||
144625213|NCT02918019|521485762|FG003|Overall Study|Withdrawal by Subject|4|||
144625214|NCT02918019|521485759|FG000|Overall Study|Adverse Event|0|||
144625215|NCT02918019|521485760|FG001|Overall Study|Adverse Event|1|||
144625216|NCT02918019|521485761|FG002|Overall Study|Adverse Event|0|||
144625217|NCT02918019|521485762|FG003|Overall Study|Adverse Event|1|||
144625218|NCT00662792|521485763|FG000|Period 1|Personal Reasons|0|||
144625219|NCT00662792|521485764|FG001|Period 1|Personal Reasons|0|||
144625220|NCT00662792|521485765|FG002|Period 1|Personal Reasons|1|||
144625221|NCT00662792|521485766|FG003|Period 1|Personal Reasons|0|||
144625222|NCT00662792|521485763|FG000|Period 1|Refused continuing medication|0|||
144209625|NCT02960490|519961995|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
144209626|NCT02960490|519961996|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
144209627|NCT02960490|519961997|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
144209628|NCT02960490|519961998|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
144209629|NCT02960490|519961999|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
144209630|NCT02960490|519962000|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
144209631|NCT02960490|519962001|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
144209632|NCT02960490|519962002|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
144209633|NCT02960490|519962003|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
144209634|NCT02960490|519961994|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209635|NCT02960490|519961995|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209636|NCT02960490|519961996|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209637|NCT02960490|519961997|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209638|NCT02960490|519961998|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209639|NCT02960490|519961999|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209640|NCT02960490|519962000|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
144209641|NCT02960490|519962001|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
144209642|NCT02960490|519962002|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
144209643|NCT02960490|519962003|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
144209644|NCT02960490|519961994|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144585988|NCT03500159|521343869|FG001|Overall Study|Study Terminated|1|||
144585989|NCT03484273|521343874|FG000|Overall Study|Equipment Malfunction|1|||
144585990|NCT03484273|521343874|FG000|Overall Study|Data excluded from analysis|1|||
144585991|NCT02217475|521343885|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
144585992|NCT02217475|521343886|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
144585993|NCT02217475|521343887|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
144585994|NCT02217475|521343885|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
144585995|NCT02217475|521343886|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
144585996|NCT02217475|521343887|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
144585997|NCT02217475|521343885|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
144585998|NCT02217475|521343886|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
144585999|NCT02217475|521343887|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
144586000|NCT02217475|521343885|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
144586001|NCT02217475|521343886|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
144586002|NCT02217475|521343887|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
144586003|NCT02217475|521343885|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
144586004|NCT02217475|521343886|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
144586005|NCT02217475|521343887|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
144586006|NCT02217475|521343885|FG000|Discontinued After Period 1|Adverse Event|1|||
144586007|NCT02217475|521343886|FG001|Discontinued After Period 1|Adverse Event|2|||
144586008|NCT02217475|521343887|FG002|Discontinued After Period 1|Adverse Event|0|||
144586009|NCT02217475|521343885|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
144586010|NCT02217475|521343886|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
144586011|NCT02217475|521343887|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
144586012|NCT02217475|521343885|FG000|Discontinued After Period 1|Physician Decision|0|||
144586013|NCT02217475|521343886|FG001|Discontinued After Period 1|Physician Decision|0|||
144586014|NCT02217475|521343887|FG002|Discontinued After Period 1|Physician Decision|1|||
144586015|NCT02217475|521343885|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
144586016|NCT02217475|521343886|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
144586017|NCT02217475|521343887|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
144586018|NCT02217475|521343885|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
144586019|NCT02217475|521343886|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
144586020|NCT02217475|521343887|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
144586021|NCT02217475|521343885|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
144586022|NCT02217475|521343886|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
144586023|NCT02217475|521343887|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
144586024|NCT02217475|521343885|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
144586025|NCT02217475|521343886|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
144586026|NCT02217475|521343887|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
144586027|NCT02217475|521343885|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
144586028|NCT02217475|521343886|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
144586029|NCT02217475|521343887|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
144586030|NCT04738292|521343892|FG000|Overall Study|Death|1|||
144586031|NCT03001076|521343893|FG000|Overall Study|Withdrawal by patient|2|||
144586032|NCT03001076|521343894|FG001|Overall Study|Withdrawal by patient|0|||
144586033|NCT03001076|521343893|FG000|Overall Study|Other|1|||
144586034|NCT03001076|521343894|FG001|Overall Study|Other|0|||
144586035|NCT03001076|521343893|FG000|Overall Study|Adverse Event|3|||
144262938|NCT03934216|520163794|FG000|Overall Study|Lost to Follow-up|2|||
144586036|NCT03001076|521343894|FG001|Overall Study|Adverse Event|3|||
144625223|NCT00662792|521485764|FG001|Period 1|Refused continuing medication|1|||
144625224|NCT00662792|521485765|FG002|Period 1|Refused continuing medication|1|||
144625225|NCT00662792|521485766|FG003|Period 1|Refused continuing medication|0|||
144625226|NCT00662792|521485763|FG000|Period 1|Lost to Follow-up|1|||
144625227|NCT00662792|521485764|FG001|Period 1|Lost to Follow-up|0|||
144730559|NCT01918397|521869819|FG003|Overall Study|XDR at baseline|0|||
144730560|NCT01918397|521869816|FG000|Overall Study|Lost to Follow-up|2|||
144730561|NCT01918397|521869817|FG001|Overall Study|Lost to Follow-up|1|||
144730562|NCT01918397|521869818|FG002|Overall Study|Lost to Follow-up|1|||
144730563|NCT01918397|521869819|FG003|Overall Study|Lost to Follow-up|1|||
144730564|NCT01918397|521869816|FG000|Overall Study|Increased QTc|1|||
144730565|NCT01918397|521869817|FG001|Overall Study|Increased QTc|0|||
144730566|NCT01918397|521869818|FG002|Overall Study|Increased QTc|0|||
144730567|NCT01918397|521869819|FG003|Overall Study|Increased QTc|1|||
144730568|NCT01918397|521869816|FG000|Overall Study|Death|0|||
144730569|NCT01918397|521869817|FG001|Overall Study|Death|0|||
144730570|NCT01918397|521869818|FG002|Overall Study|Death|1|||
144730571|NCT01918397|521869819|FG003|Overall Study|Death|0|||
144730572|NCT01918397|521869816|FG000|Overall Study|Involved in another investigative trial|0|||
144730573|NCT01918397|521869817|FG001|Overall Study|Involved in another investigative trial|0|||
144730574|NCT01918397|521869818|FG002|Overall Study|Involved in another investigative trial|0|||
144730575|NCT01918397|521869819|FG003|Overall Study|Involved in another investigative trial|1|||
144730576|NCT00880568|521869820|FG000|Overall Study|Disease progression|3|||
144730577|NCT00880568|521869821|FG001|Overall Study|Disease progression|3|||
144730578|NCT00880568|521869822|FG002|Overall Study|Disease progression|3|||
144730579|NCT00880568|521869823|FG003|Overall Study|Disease progression|1|||
144730580|NCT00880568|521869824|FG004|Overall Study|Disease progression|3|||
144730581|NCT00880568|521869825|FG005|Overall Study|Disease progression|3|||
144730582|NCT00880568|521869826|FG006|Overall Study|Disease progression|5|||
144730583|NCT00880568|521869827|FG007|Overall Study|Disease progression|0|||
144730584|NCT00880568|521869828|FG008|Overall Study|Disease progression|3|||
144730585|NCT00880568|521869820|FG000|Overall Study|Adverse Event|0|||
144730586|NCT00880568|521869821|FG001|Overall Study|Adverse Event|0|||
144730587|NCT00880568|521869822|FG002|Overall Study|Adverse Event|0|||
144209645|NCT02960490|519961995|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144209646|NCT02960490|519961996|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144209647|NCT02960490|519961997|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144209648|NCT02960490|519961998|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144209649|NCT02960490|519961999|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144209650|NCT02960490|519962000|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144625228|NCT00662792|521485765|FG002|Period 1|Lost to Follow-up|0|||
144625229|NCT00662792|521485766|FG003|Period 1|Lost to Follow-up|0|||
144625230|NCT00662792|521485763|FG000|Period 1|Other adverse event (AE)|0|||
144625231|NCT00662792|521485764|FG001|Period 1|Other adverse event (AE)|2|||
144625232|NCT00662792|521485765|FG002|Period 1|Other adverse event (AE)|0|||
144625233|NCT00662792|521485766|FG003|Period 1|Other adverse event (AE)|0|||
144625234|NCT00662792|521485763|FG000|Period 1|Worsening of disease under study (AE)|1|||
144625235|NCT00662792|521485764|FG001|Period 1|Worsening of disease under study (AE)|3|||
144625236|NCT00662792|521485765|FG002|Period 1|Worsening of disease under study (AE)|2|||
144625237|NCT00662792|521485766|FG003|Period 1|Worsening of disease under study (AE)|0|||
144625238|NCT00662792|521485763|FG000|Period 1|Not treated|0|||
144625239|NCT00662792|521485764|FG001|Period 1|Not treated|1|||
144625240|NCT00662792|521485765|FG002|Period 1|Not treated|0|||
144625241|NCT00662792|521485766|FG003|Period 1|Not treated|0|||
144209651|NCT02960490|519962001|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
144209652|NCT02960490|519962002|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144625242|NCT00662792|521485763|FG000|Period 2|Worsening of disease under study|1|||
144625243|NCT00662792|521485764|FG001|Period 2|Worsening of disease under study|0|||
144625244|NCT00662792|521485765|FG002|Period 2|Worsening of disease under study|0|||
144625245|NCT00662792|521485766|FG003|Period 2|Worsening of disease under study|3|||
144625246|NCT00662792|521485763|FG000|Period 3|Refused continuing medication|1|||
144625247|NCT00662792|521485764|FG001|Period 3|Refused continuing medication|0|||
144625248|NCT00662792|521485765|FG002|Period 3|Refused continuing medication|1|||
144625249|NCT00662792|521485766|FG003|Period 3|Refused continuing medication|0|||
144625250|NCT00662792|521485763|FG000|Period 3|Other adverse event (AE)|0|||
144730588|NCT00880568|521869823|FG003|Overall Study|Adverse Event|0|||
144730589|NCT00880568|521869824|FG004|Overall Study|Adverse Event|0|||
144730590|NCT00880568|521869825|FG005|Overall Study|Adverse Event|0|||
144730591|NCT00880568|521869826|FG006|Overall Study|Adverse Event|1|||
144625251|NCT00662792|521485764|FG001|Period 3|Other adverse event (AE)|0|||
144625252|NCT00662792|521485765|FG002|Period 3|Other adverse event (AE)|1|||
144625253|NCT00662792|521485766|FG003|Period 3|Other adverse event (AE)|1|||
144625254|NCT00662792|521485763|FG000|Period 4|Refused continuing medication|0|||
144625255|NCT00662792|521485764|FG001|Period 4|Refused continuing medication|1|||
144730592|NCT00880568|521869827|FG007|Overall Study|Adverse Event|1|||
144730593|NCT00880568|521869828|FG008|Overall Study|Adverse Event|0|||
144730594|NCT00880568|521869820|FG000|Overall Study|Withdrawal by Subject|0|||
144625256|NCT00662792|521485765|FG002|Period 4|Refused continuing medication|0|||
144625257|NCT00662792|521485766|FG003|Period 4|Refused continuing medication|0|||
144625258|NCT00662792|521485763|FG000|Period 4|Other adverse event (AE)|1|||
144625259|NCT00662792|521485764|FG001|Period 4|Other adverse event (AE)|0|||
144625260|NCT00662792|521485765|FG002|Period 4|Other adverse event (AE)|0|||
144625261|NCT00662792|521485766|FG003|Period 4|Other adverse event (AE)|0|||
144625262|NCT00662792|521485763|FG000|Period 4|Worsening of disease under study (AE)|0|||
144625263|NCT00662792|521485764|FG001|Period 4|Worsening of disease under study (AE)|0|||
144625264|NCT00662792|521485765|FG002|Period 4|Worsening of disease under study (AE)|0|||
144625265|NCT00662792|521485766|FG003|Period 4|Worsening of disease under study (AE)|1|||
144625266|NCT03021642|521485772|FG000|Washout Period (21 Days)|Adverse Event|1|||
144625267|NCT03021642|521485773|FG001|Washout Period (21 Days)|Adverse Event|1|||
144625268|NCT00090545|521485774|FG000|Overall Study|Disease progression on study|21|||
144625269|NCT00090545|521485775|FG001|Overall Study|Disease progression on study|17|||
144625270|NCT00090545|521485774|FG000|Overall Study|Refused further treatment|1|||
144625271|NCT00090545|521485775|FG001|Overall Study|Refused further treatment|4|||
144625272|NCT00090545|521485774|FG000|Overall Study|Death|0|||
144625273|NCT00090545|521485775|FG001|Overall Study|Death|1|||
144625274|NCT00090545|521485774|FG000|Overall Study|Adverse Event|0|||
144625275|NCT00090545|521485775|FG001|Overall Study|Adverse Event|2|||
144625276|NCT03433781|521485776|FG000|Overall Study|Progression of Disease|1|||
144625277|NCT03433781|521485777|FG001|Overall Study|Progression of Disease|0|||
144625278|NCT03433781|521485778|FG002|Overall Study|Progression of Disease|0|||
144625279|NCT03433781|521485776|FG000|Overall Study|Physician Decision|0|||
144625280|NCT03433781|521485777|FG001|Overall Study|Physician Decision|1|||
144625281|NCT03433781|521485778|FG002|Overall Study|Physician Decision|0|||
144625282|NCT02568046|521485779|FG000|Overall Study|Adverse Event|0|||
144625283|NCT02568046|521485780|FG001|Overall Study|Adverse Event|1|||
144625284|NCT02568046|521485779|FG000|Overall Study|Death|2|||
144625285|NCT02568046|521485780|FG001|Overall Study|Death|0|||
144625286|NCT02568046|521485779|FG000|Overall Study|Progressive Disease|1|||
144625287|NCT02568046|521485780|FG001|Overall Study|Progressive Disease|0|||
144625288|NCT02568046|521485779|FG000|Overall Study|Withdrawal by Subject|2|||
144625289|NCT02568046|521485780|FG001|Overall Study|Withdrawal by Subject|1|||
144625290|NCT02568046|521485779|FG000|Overall Study|Other Events|0|||
144625291|NCT02568046|521485780|FG001|Overall Study|Other Events|1|||
144625292|NCT00744874|521485781|FG000|Overall Study|Lost to Follow-up|1|||
144625293|NCT00744874|521485781|FG000|Overall Study|Withdrawal by Subject|1|||
144625294|NCT00744874|521485781|FG000|Overall Study|Study Device not available at procedure|1|||
144625295|NCT00744874|521485781|FG000|Overall Study|Unable to accomodate schedule|1|||
144625296|NCT02971670|521485784|FG000|Overall Study|Withdrawal by Subject|4|||
144625297|NCT02971670|521485785|FG001|Overall Study|Withdrawal by Subject|1|||
144625298|NCT02971670|521485786|FG002|Overall Study|Withdrawal by Subject|1|||
144625299|NCT02971670|521485787|FG003|Overall Study|Withdrawal by Subject|2|||
144625300|NCT02435849|521485788|FG000|Overall Study|Death|23|||
144625301|NCT02435849|521485789|FG001|Overall Study|Death|0|||
144625302|NCT02435849|521485788|FG000|Overall Study|Lack of Efficacy|10|||
144625303|NCT02435849|521485789|FG001|Overall Study|Lack of Efficacy|0|||
144625304|NCT02435849|521485788|FG000|Overall Study|New therapy for study indication|8|||
144625305|NCT02435849|521485789|FG001|Overall Study|New therapy for study indication|0|||
144625306|NCT02435849|521485788|FG000|Overall Study|Subject/guardian decision|5|||
144625307|NCT02435849|521485789|FG001|Overall Study|Subject/guardian decision|1|||
144625308|NCT02435849|521485788|FG000|Overall Study|Lost to Follow-up|1|||
144625309|NCT02435849|521485789|FG001|Overall Study|Lost to Follow-up|0|||
144625310|NCT02435849|521485788|FG000|Overall Study|Physician Decision|1|||
144730595|NCT00880568|521869821|FG001|Overall Study|Withdrawal by Subject|0|||
144730596|NCT00880568|521869822|FG002|Overall Study|Withdrawal by Subject|0|||
144730597|NCT00880568|521869823|FG003|Overall Study|Withdrawal by Subject|0|||
144730598|NCT00880568|521869824|FG004|Overall Study|Withdrawal by Subject|0|||
144730599|NCT00880568|521869825|FG005|Overall Study|Withdrawal by Subject|0|||
144625311|NCT02435849|521485789|FG001|Overall Study|Physician Decision|0|||
144625312|NCT03175549|521485790|FG000|Overall Study|Lost to Follow-up|2|||
144730600|NCT00880568|521869826|FG006|Overall Study|Withdrawal by Subject|0|||
144625313|NCT03175549|521485791|FG001|Overall Study|Lost to Follow-up|2|||
144625314|NCT03175549|521485790|FG000|Overall Study|Medication non-compliance|2|||
144730601|NCT00880568|521869827|FG007|Overall Study|Withdrawal by Subject|1|||
144730602|NCT00880568|521869828|FG008|Overall Study|Withdrawal by Subject|0|||
144730603|NCT00620022|521869829|FG000|Treatment Period 1|Adverse Event|4|||
144730604|NCT00620022|521869830|FG001|Treatment Period 1|Adverse Event|6|||
144730605|NCT00620022|521869829|FG000|Treatment Period 1|Subject withdrew consent|1|||
144625315|NCT03175549|521485791|FG001|Overall Study|Medication non-compliance|2|||
144625316|NCT02486757|521485792|FG000|Overall Study|Lost to Follow-up|1|||
144625317|NCT02793232|521485793|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625318|NCT02793232|521485794|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625319|NCT02793232|521485795|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625320|NCT02793232|521485796|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625321|NCT02793232|521485797|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
144625322|NCT02793232|521485798|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625323|NCT02793232|521485799|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
144625324|NCT02793232|521485800|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625325|NCT02793232|521485801|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
144625326|NCT00725075|521485802|FG000|Overall Study|Use of Excluded Medication|0|||
144625327|NCT00725075|521485803|FG001|Overall Study|Use of Excluded Medication|1|||
144625328|NCT00725075|521485804|FG002|Overall Study|Use of Excluded Medication|0|||
144625329|NCT00725075|521485802|FG000|Overall Study|Protocol Violation|0|||
144625330|NCT00725075|521485803|FG001|Overall Study|Protocol Violation|0|||
144625331|NCT00725075|521485804|FG002|Overall Study|Protocol Violation|1|||
144625332|NCT00725075|521485802|FG000|Overall Study|Lost to Follow-up|1|||
144625333|NCT00725075|521485803|FG001|Overall Study|Lost to Follow-up|0|||
144625334|NCT00725075|521485804|FG002|Overall Study|Lost to Follow-up|0|||
144625335|NCT00725075|521485802|FG000|Overall Study|Withdrawal by Subject|4|||
144625336|NCT00725075|521485803|FG001|Overall Study|Withdrawal by Subject|5|||
144625337|NCT00725075|521485804|FG002|Overall Study|Withdrawal by Subject|4|||
144625338|NCT00725075|521485802|FG000|Overall Study|Adverse Event|2|||
144625339|NCT00725075|521485803|FG001|Overall Study|Adverse Event|1|||
144625340|NCT00725075|521485804|FG002|Overall Study|Adverse Event|1|||
144625341|NCT00725075|521485802|FG000|Overall Study|Worsening of Disease|2|||
144625342|NCT00725075|521485803|FG001|Overall Study|Worsening of Disease|1|||
144625343|NCT00725075|521485804|FG002|Overall Study|Worsening of Disease|2|||
144625344|NCT00725075|521485802|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
144625345|NCT00725075|521485803|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
144625346|NCT00725075|521485804|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
144625347|NCT00725075|521485802|FG000|Overall Study|Other|1|||
144625348|NCT00725075|521485803|FG001|Overall Study|Other|0|||
144625349|NCT00725075|521485804|FG002|Overall Study|Other|0|||
144625350|NCT02340663|521485805|FG000|Overall Study|Lost to Follow-up|1|||
144625351|NCT02340663|521485806|FG001|Overall Study|Lost to Follow-up|0|||
144625352|NCT02340663|521485805|FG000|Overall Study|Protocol Violation|1|||
144625353|NCT02340663|521485806|FG001|Overall Study|Protocol Violation|0|||
144625354|NCT02340663|521485805|FG000|Overall Study|Withdrawal by Subject|3|||
144625355|NCT02340663|521485806|FG001|Overall Study|Withdrawal by Subject|1|||
144625356|NCT00352105|521485807|FG000|Overall Study|Death|5|||
144625357|NCT00352105|521485807|FG000|Overall Study|Withdrawal by Subject|5|||
144625358|NCT00352105|521485807|FG000|Overall Study|Lack of Efficacy|9|||
144625359|NCT00352105|521485807|FG000|Overall Study|Adverse Event|19|||
144625360|NCT00352105|521485807|FG000|Overall Study|Protocol Violation|2|||
144625361|NCT02979431|521485808|FG000|Overall Study|Parent/guardian withdrew consent|2|||
144625362|NCT02979431|521485809|FG001|Overall Study|Parent/guardian withdrew consent|1|||
144625363|NCT02979431|521485810|FG002|Overall Study|Parent/guardian withdrew consent|1|||
144625364|NCT02979431|521485811|FG003|Overall Study|Parent/guardian withdrew consent|1|||
144625365|NCT02979431|521485808|FG000|Overall Study|Randomized but received no study drug|1|||
144625366|NCT02979431|521485809|FG001|Overall Study|Randomized but received no study drug|1|||
144625367|NCT02979431|521485810|FG002|Overall Study|Randomized but received no study drug|0|||
144625368|NCT02979431|521485811|FG003|Overall Study|Randomized but received no study drug|0|||
144625369|NCT02979431|521485808|FG000|Overall Study|Adverse Event|0|||
144625370|NCT02979431|521485809|FG001|Overall Study|Adverse Event|0|||
144625371|NCT02979431|521485810|FG002|Overall Study|Adverse Event|1|||
144625372|NCT02979431|521485811|FG003|Overall Study|Adverse Event|0|||
144625373|NCT02979431|521485808|FG000|Overall Study|Subject left country after Day14|1|||
144625374|NCT02979431|521485809|FG001|Overall Study|Subject left country after Day14|0|||
144625375|NCT02979431|521485810|FG002|Overall Study|Subject left country after Day14|0|||
144625376|NCT02979431|521485811|FG003|Overall Study|Subject left country after Day14|0|||
144625377|NCT02301403|521485822|FG000|Overall Study|Withdrawal by Subject|28|||
144625378|NCT02301403|521485823|FG001|Overall Study|Withdrawal by Subject|41|||
144625379|NCT01060059|521485824|FG000|Overall Study|Adverse Event|1|||
144625380|NCT01060059|521485825|FG001|Overall Study|Adverse Event|1|||
144625381|NCT01060059|521485824|FG000|Overall Study|Death|2|||
144625382|NCT01060059|521485825|FG001|Overall Study|Death|3|||
144625383|NCT01060059|521485824|FG000|Overall Study|Lost to Follow-up|18|||
144625384|NCT01060059|521485825|FG001|Overall Study|Lost to Follow-up|34|||
144625385|NCT01060059|521485824|FG000|Overall Study|entry criteria not met|4|||
144625386|NCT01060059|521485825|FG001|Overall Study|entry criteria not met|3|||
144625387|NCT01060059|521485824|FG000|Overall Study|Withdrawal by Subject|35|||
144625388|NCT01060059|521485825|FG001|Overall Study|Withdrawal by Subject|23|||
144625389|NCT01060059|521485824|FG000|Overall Study|lack of glycemic control|2|||
144625390|NCT01060059|521485825|FG001|Overall Study|lack of glycemic control|1|||
144625391|NCT01060059|521485824|FG000|Overall Study|lack of compliance|5|||
144730606|NCT00620022|521869830|FG001|Treatment Period 1|Subject withdrew consent|0|||
144625392|NCT01060059|521485825|FG001|Overall Study|lack of compliance|2|||
144625393|NCT02319044|521485829|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
144625394|NCT02319044|521485830|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
144730607|NCT00620022|521869829|FG000|Treatment Period 2|Adverse Event|2|||
144625395|NCT02319044|521485831|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
144625396|NCT02319044|521485829|FG000|Overall Study|Withdrawal by Subject|3|||
144625397|NCT02319044|521485830|FG001|Overall Study|Withdrawal by Subject|3|||
144625398|NCT02319044|521485831|FG002|Overall Study|Withdrawal by Subject|6|||
144625399|NCT02319044|521485829|FG000|Overall Study|Condition under investigation worsened|100|||
144625400|NCT02319044|521485830|FG001|Overall Study|Condition under investigation worsened|50|||
144625401|NCT02319044|521485831|FG002|Overall Study|Condition under investigation worsened|46|||
144625402|NCT02319044|521485829|FG000|Overall Study|Adverse Event|17|||
144625403|NCT02319044|521485830|FG001|Overall Study|Adverse Event|2|||
144625404|NCT02319044|521485831|FG002|Overall Study|Adverse Event|8|||
144625405|NCT02319044|521485829|FG000|Overall Study|Study specific discontinuation criteria|2|||
144625406|NCT02319044|521485830|FG001|Overall Study|Study specific discontinuation criteria|2|||
144625407|NCT02319044|521485831|FG002|Overall Study|Study specific discontinuation criteria|1|||
144625408|NCT02319044|521485829|FG000|Overall Study|Not treated|0|||
144625409|NCT02319044|521485830|FG001|Overall Study|Not treated|2|||
144625410|NCT02319044|521485831|FG002|Overall Study|Not treated|2|||
144625411|NCT03551743|521485832|FG000|Overall Study|Adverse Event|1|||
144625412|NCT03551743|521485833|FG001|Overall Study|Adverse Event|0|||
144625413|NCT03551743|521485834|FG002|Overall Study|Adverse Event|0|||
144625414|NCT03551743|521485835|FG003|Overall Study|Adverse Event|0|||
144625415|NCT03551743|521485832|FG000|Overall Study|Withdrawal by Subject|1|||
144625416|NCT03551743|521485833|FG001|Overall Study|Withdrawal by Subject|0|||
144625417|NCT03551743|521485834|FG002|Overall Study|Withdrawal by Subject|0|||
144625418|NCT03551743|521485835|FG003|Overall Study|Withdrawal by Subject|0|||
144625419|NCT00626093|521485836|FG000|Overall Study|Lost to Follow-up|5|||
144625420|NCT00626093|521485836|FG000|Overall Study|Death|1|||
144625421|NCT00626093|521485836|FG000|Overall Study|Physician Decision|4|||
144625422|NCT00626093|521485836|FG000|Overall Study|Withdrawal by Subject|6|||
144625423|NCT00626093|521485836|FG000|Overall Study|Protocol Violation|1|||
144625424|NCT00626093|521485836|FG000|Overall Study|One of the required devices not implante|6|||
144625425|NCT00603915|521485837|FG000|Overall Study|Physician Decision|1|||
144625426|NCT00644787|521485848|FG000|Period 1: Titration Phase|Adverse Event|11|||
144625427|NCT00644787|521485849|FG001|Period 1: Titration Phase|Adverse Event|0|||
144625428|NCT00644787|521485850|FG002|Period 1: Titration Phase|Adverse Event|0|||
144625429|NCT00644787|521485848|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
144625430|NCT00644787|521485849|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
144625431|NCT00644787|521485850|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
144625432|NCT00644787|521485848|FG000|Period 1: Titration Phase|Physician Decision|1|||
144625433|NCT00644787|521485849|FG001|Period 1: Titration Phase|Physician Decision|0|||
144625434|NCT00644787|521485850|FG002|Period 1: Titration Phase|Physician Decision|0|||
144625435|NCT00644787|521485848|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
144625436|NCT00644787|521485849|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
144625437|NCT00644787|521485850|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
144625438|NCT00644787|521485848|FG000|Period 1: Titration Phase|Worsening of complications|1|||
144625439|NCT00644787|521485849|FG001|Period 1: Titration Phase|Worsening of complications|0|||
144625440|NCT00644787|521485850|FG002|Period 1: Titration Phase|Worsening of complications|0|||
144625441|NCT00644787|521485848|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
144625442|NCT00644787|521485849|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
144625443|NCT00644787|521485850|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
144625444|NCT00644787|521485848|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
144625445|NCT00644787|521485849|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
144625446|NCT00644787|521485850|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
144625447|NCT00644787|521485848|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
144625448|NCT00644787|521485849|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
144625449|NCT00644787|521485850|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
144625450|NCT00644787|521485848|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
144625451|NCT00644787|521485849|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
144625452|NCT00644787|521485850|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
144625453|NCT00644787|521485848|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
144625454|NCT00644787|521485849|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
144625455|NCT00644787|521485850|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
144262939|NCT03934216|520163795|FG001|Overall Study|Lost to Follow-up|0|||
144625456|NCT00644787|521485848|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
144625457|NCT00644787|521485849|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
144625458|NCT00644787|521485850|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
144625459|NCT00644787|521485848|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
144625460|NCT00644787|521485849|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
144625461|NCT00644787|521485850|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
144625462|NCT00772668|521485856|FG000|Overall Study|Physician Decision|3|||
144625463|NCT01227902|521487598|FG000|Overall Study|Adverse Event|12|||
144625464|NCT01227902|521487599|FG001|Overall Study|Adverse Event|8|||
144586037|NCT03001076|521343893|FG000|Overall Study|Sponsor decision|1|||
144586038|NCT03001076|521343894|FG001|Overall Study|Sponsor decision|0|||
144586039|NCT03001076|521343893|FG000|Overall Study|Lost to Follow-up|0|||
144586040|NCT03001076|521343894|FG001|Overall Study|Lost to Follow-up|2|||
144586041|NCT02270515|521343895|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
144586042|NCT02270515|521343895|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
144586043|NCT02270515|521343895|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
144586044|NCT02270515|521343895|FG000|Intervention Period 1: 0-6 Months|Death|7|||
144586045|NCT02270515|521343895|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
144586046|NCT02270515|521343895|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
144586047|NCT02270515|521343895|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
144586048|NCT02270515|521343895|FG000|Intervention Period 2: 6-12 Months|Death|5|||
144586049|NCT02270515|521343895|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
144586050|NCT02270515|521343895|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
144586051|NCT02270515|521343895|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
144586052|NCT02270515|521343895|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
144586053|NCT02270515|521343895|FG000|Intervention Period 3: 12-18 Months|Death|3|||
144586054|NCT02270515|521343895|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
144586055|NCT00760474|521343896|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
144586056|NCT00760474|521343897|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
144586057|NCT00760474|521343896|FG000|Placebo Washout Period|Other|0|||
144586058|NCT00760474|521343897|FG001|Placebo Washout Period|Other|1|||
144586059|NCT00760474|521343896|FG000|Period 2 (P2)|Lost to Follow-up|1|||
144586060|NCT00760474|521343897|FG001|Period 2 (P2)|Lost to Follow-up|0|||
144586061|NCT00760474|521343896|FG000|Period 2 (P2)|Adverse Event|0|||
144586062|NCT00760474|521343897|FG001|Period 2 (P2)|Adverse Event|1|||
144586063|NCT01934790|521343898|FG000|Treatment|Adverse Event|3|||
144586064|NCT01934790|521343898|FG000|Treatment|Clinical progression|6|||
144586065|NCT01934790|521343898|FG000|Treatment|Radiological progression|4|||
144586066|NCT01934790|521343898|FG000|Treatment|Withdrawal by Subject|2|||
144586067|NCT01934790|521343898|FG000|Treatment|Study drug never administered|1|||
144586068|NCT01934790|521343898|FG000|Active Follow up|Death|20|||
144586069|NCT01934790|521343898|FG000|Active Follow up|Physician Decision|2|||
144586070|NCT01934790|521343898|FG000|Active Follow up|Progressive disease|1|||
144586071|NCT01934790|521343898|FG000|Active Follow up|Other reason|1|||
144586072|NCT03541174|521345407|FG000|Part 1 Double-Blind|Adverse Event|6|||
144586073|NCT03541174|521345408|FG001|Part 1 Double-Blind|Adverse Event|5|||
144586074|NCT03541174|521345409|FG002|Part 1 Double-Blind|Adverse Event|2|||
144586075|NCT03541174|521345410|FG003|Part 1 Double-Blind|Adverse Event|0|||
144586076|NCT03541174|521345411|FG004|Part 1 Double-Blind|Adverse Event|0|||
144586077|NCT03541174|521345412|FG005|Part 1 Double-Blind|Adverse Event|0|||
144586078|NCT03541174|521345407|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
144586079|NCT03541174|521345408|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
144586080|NCT03541174|521345409|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
144586081|NCT03541174|521345410|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
144586082|NCT03541174|521345411|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
144586083|NCT03541174|521345412|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
144586084|NCT03541174|521345407|FG000|Part 1 Double-Blind|Other reasons|3|||
144586085|NCT03541174|521345408|FG001|Part 1 Double-Blind|Other reasons|2|||
144586086|NCT03541174|521345409|FG002|Part 1 Double-Blind|Other reasons|3|||
144586087|NCT03541174|521345410|FG003|Part 1 Double-Blind|Other reasons|0|||
144586088|NCT03541174|521345411|FG004|Part 1 Double-Blind|Other reasons|0|||
144586089|NCT03541174|521345412|FG005|Part 1 Double-Blind|Other reasons|0|||
144586090|NCT03541174|521345407|FG000|Part 2 Single-Blind|Adverse Event|0|||
144586091|NCT03541174|521345408|FG001|Part 2 Single-Blind|Adverse Event|0|||
144586092|NCT03541174|521345409|FG002|Part 2 Single-Blind|Adverse Event|0|||
144586093|NCT03541174|521345410|FG003|Part 2 Single-Blind|Adverse Event|25|||
144586094|NCT03541174|521345411|FG004|Part 2 Single-Blind|Adverse Event|0|||
144586095|NCT03541174|521345412|FG005|Part 2 Single-Blind|Adverse Event|0|||
144586096|NCT03541174|521345407|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
144586097|NCT03541174|521345408|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
144586098|NCT03541174|521345409|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
144586099|NCT03541174|521345410|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
144586100|NCT03541174|521345411|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
144586101|NCT03541174|521345412|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
144586102|NCT03541174|521345407|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
144586103|NCT03541174|521345408|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
144586104|NCT03541174|521345409|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
144586105|NCT03541174|521345410|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
144586106|NCT03541174|521345411|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
144586107|NCT03541174|521345412|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
144586108|NCT03541174|521345407|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
144586109|NCT03541174|521345408|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
144586110|NCT03541174|521345409|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
144586111|NCT03541174|521345410|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
144209653|NCT02960490|519962003|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
144209654|NCT02960490|519961994|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
144209655|NCT02960490|519961995|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
144209656|NCT02960490|519961996|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
144209657|NCT02960490|519961997|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
144209658|NCT02960490|519961998|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
144209659|NCT02960490|519961999|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
144209660|NCT02960490|519962000|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
144586112|NCT03541174|521345411|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
144586113|NCT03541174|521345412|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
144586114|NCT03541174|521345407|FG000|Part 2 Single-Blind|Death|0|||
144586115|NCT03541174|521345408|FG001|Part 2 Single-Blind|Death|0|||
144586116|NCT03541174|521345409|FG002|Part 2 Single-Blind|Death|0|||
144586117|NCT03541174|521345410|FG003|Part 2 Single-Blind|Death|5|||
144586118|NCT03541174|521345411|FG004|Part 2 Single-Blind|Death|0|||
144586119|NCT03541174|521345412|FG005|Part 2 Single-Blind|Death|0|||
144586120|NCT03541174|521345407|FG000|Part 2 Single-Blind|Pregnancy|0|||
144586121|NCT03541174|521345408|FG001|Part 2 Single-Blind|Pregnancy|0|||
144586122|NCT03541174|521345409|FG002|Part 2 Single-Blind|Pregnancy|0|||
144586123|NCT03541174|521345410|FG003|Part 2 Single-Blind|Pregnancy|1|||
144586124|NCT03541174|521345411|FG004|Part 2 Single-Blind|Pregnancy|0|||
144586125|NCT03541174|521345412|FG005|Part 2 Single-Blind|Pregnancy|0|||
144586126|NCT03541174|521345407|FG000|Part 2 Single-Blind|Other reasons|0|||
144586127|NCT03541174|521345408|FG001|Part 2 Single-Blind|Other reasons|0|||
144586128|NCT03541174|521345409|FG002|Part 2 Single-Blind|Other reasons|0|||
144586129|NCT03541174|521345410|FG003|Part 2 Single-Blind|Other reasons|32|||
144586130|NCT03541174|521345411|FG004|Part 2 Single-Blind|Other reasons|0|||
144586131|NCT03541174|521345412|FG005|Part 2 Single-Blind|Other reasons|0|||
144586132|NCT03541174|521345407|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
144586133|NCT03541174|521345408|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
144586134|NCT03541174|521345409|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
144586135|NCT03541174|521345410|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
144586136|NCT03541174|521345411|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
144586137|NCT03541174|521345412|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
144586138|NCT03541174|521345407|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
144586139|NCT03541174|521345408|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
144586140|NCT03541174|521345409|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
144586141|NCT03541174|521345410|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
144586142|NCT03541174|521345411|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
144586143|NCT03541174|521345412|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
144586144|NCT03541174|521345407|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
144586145|NCT03541174|521345408|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
144586146|NCT03541174|521345409|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
144586147|NCT03541174|521345410|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
144586148|NCT03541174|521345411|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
144586149|NCT03541174|521345412|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
144586150|NCT03541174|521345407|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
144586151|NCT03541174|521345408|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
144586152|NCT03541174|521345409|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
144586153|NCT03541174|521345410|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
144586154|NCT03541174|521345411|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
144586155|NCT03541174|521345412|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
144586156|NCT03541174|521345407|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
144586157|NCT03541174|521345408|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
144586158|NCT03541174|521345409|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
144586159|NCT03541174|521345410|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
144586160|NCT03541174|521345411|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
144586161|NCT03541174|521345412|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
144586162|NCT01342341|521345413|FG000|Overall Study|Lost to Follow-up|4|||
144586163|NCT01342341|521345414|FG001|Overall Study|Lost to Follow-up|4|||
144586164|NCT02914275|521345415|FG000|Overall Study|Lost to Follow-up|84|||
144586165|NCT02914275|521345416|FG001|Overall Study|Lost to Follow-up|29|||
144586166|NCT02914275|521345415|FG000|Overall Study|Withdrawal by Subject|26|||
144586167|NCT02914275|521345416|FG001|Overall Study|Withdrawal by Subject|10|||
144586168|NCT02914275|521345415|FG000|Overall Study|Protocol Violation|1|||
144586169|NCT02914275|521345416|FG001|Overall Study|Protocol Violation|1|||
144586170|NCT02914275|521345415|FG000|Overall Study|Physician Decision|3|||
144586171|NCT02914275|521345416|FG001|Overall Study|Physician Decision|1|||
144586172|NCT02914275|521345415|FG000|Overall Study|Other|4|||
144586173|NCT02914275|521345416|FG001|Overall Study|Other|1|||
144586174|NCT02914275|521345415|FG000|Overall Study|Excluded due to invalid informed consent|3|||
144586175|NCT02914275|521345416|FG001|Overall Study|Excluded due to invalid informed consent|0|||
144586176|NCT01238900|521345417|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
144586177|NCT01238900|521345417|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
144586178|NCT03573583|521345420|FG000|Overall Study|Lost to Follow-up|1|||
144586179|NCT03573583|521345421|FG001|Overall Study|Lost to Follow-up|0|||
144586180|NCT03573583|521345420|FG000|Overall Study|Withdrawal by Subject|1|||
144586181|NCT03573583|521345421|FG001|Overall Study|Withdrawal by Subject|1|||
144586182|NCT00434213|521345422|FG000|Overall Study|Adverse Event|12|||
144586183|NCT00434213|521345422|FG000|Overall Study|Lack of Efficacy|9|||
144586184|NCT00434213|521345422|FG000|Overall Study|Lost to Follow-up|14|||
144586185|NCT00434213|521345422|FG000|Overall Study|Withdrawal by Subject|7|||
144586186|NCT00434213|521345422|FG000|Overall Study|Protocol Violation|3|||
144586187|NCT00434213|521345422|FG000|Overall Study|Unable to comply with study visit window|2|||
144586188|NCT00434213|521345422|FG000|Overall Study|Application site reaction|1|||
144586189|NCT00434213|521345422|FG000|Overall Study|Non-compliant to study schedule|1|||
144586190|NCT01639560|521345423|FG000|Overall Study|Withdrawal by Subject|9|||
144586191|NCT01639560|521345424|FG001|Overall Study|Withdrawal by Subject|14|||
144586192|NCT01639560|521345423|FG000|Overall Study|Lack of Efficacy|1|||
144586193|NCT01639560|521345424|FG001|Overall Study|Lack of Efficacy|2|||
144586194|NCT01639560|521345423|FG000|Overall Study|Lost to Follow-up|9|||
144586195|NCT01639560|521345424|FG001|Overall Study|Lost to Follow-up|11|||
144586196|NCT01639560|521345423|FG000|Overall Study|Adverse Event|0|||
144586197|NCT01639560|521345424|FG001|Overall Study|Adverse Event|2|||
144586198|NCT00766363|521345425|FG000|Overall Study|Withdrawal by Subject|1|||
144586199|NCT00766363|521345426|FG001|Overall Study|Withdrawal by Subject|0|||
144586200|NCT00766363|521345427|FG002|Overall Study|Withdrawal by Subject|0|||
144586201|NCT00766363|521345428|FG003|Overall Study|Withdrawal by Subject|0|||
144586202|NCT00766363|521345425|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
144586203|NCT00766363|521345426|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
144586204|NCT00766363|521345427|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
144586205|NCT00766363|521345428|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
144586206|NCT03292432|521345429|FG000|Overall Study|Lost to Follow-up|11|||
144586207|NCT03292432|521345430|FG001|Overall Study|Lost to Follow-up|8|||
144586208|NCT03292432|521345429|FG000|Overall Study|Death|2|||
144586209|NCT03292432|521345430|FG001|Overall Study|Death|1|||
144586210|NCT03292432|521345429|FG000|Overall Study|Withdrawal by Subject|1|||
144586211|NCT03292432|521345430|FG001|Overall Study|Withdrawal by Subject|2|||
144586212|NCT03292432|521345429|FG000|Overall Study|Site closed before any data collected|1|||
144586213|NCT03292432|521345430|FG001|Overall Study|Site closed before any data collected|0|||
144586214|NCT01498679|521345434|FG000|Overall Study|Adverse Event|1|||
144586215|NCT01498679|521345435|FG001|Overall Study|Adverse Event|4|||
144586216|NCT01498679|521345434|FG000|Overall Study|Lack of Efficacy|72|||
144586217|NCT01498679|521345435|FG001|Overall Study|Lack of Efficacy|12|||
144586218|NCT01498679|521345434|FG000|Overall Study|Protocol Violation|4|||
144586219|NCT01498679|521345435|FG001|Overall Study|Protocol Violation|0|||
144586220|NCT01498679|521345434|FG000|Overall Study|Physician Decision|0|||
144586221|NCT01498679|521345435|FG001|Overall Study|Physician Decision|2|||
144586222|NCT01498679|521345434|FG000|Overall Study|Withdrawal by Subject|12|||
144586223|NCT01498679|521345435|FG001|Overall Study|Withdrawal by Subject|4|||
144586224|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
144586225|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
144586226|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
144586227|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
144586228|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
144586229|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
144586230|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
144586231|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
144586232|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
144586233|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
144586234|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
144586235|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
144586236|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
144586237|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
144586238|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
144586239|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
144586240|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
144586241|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
144586242|NCT03412747|521345437|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
144586243|NCT03412747|521345438|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
144586244|NCT03412747|521345439|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
144586245|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
144586246|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
144586247|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
144625465|NCT01227902|521487600|FG002|Overall Study|Adverse Event|11|||
144586248|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
144586249|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
144586250|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
144586251|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
144586252|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
144586253|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
144586254|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
144586255|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
144586256|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
144586257|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
144586258|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
144586259|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
144586260|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
144586261|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
144586262|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
144586263|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
144586264|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
144586265|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
144586266|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
144586267|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
144586268|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
144586269|NCT03412747|521345437|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
144586270|NCT03412747|521345438|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
144586271|NCT03412747|521345439|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
144586272|NCT01263665|521345442|FG000|Overall Study|Withdrew Consent|1|||
144586273|NCT01263665|521345442|FG000|Overall Study|Lost to Follow-up|3|||
144586274|NCT01263665|521345442|FG000|Overall Study|Death|2|||
144586275|NCT01263665|521345442|FG000|Overall Study|Amputation above the ankle|1|||
144586276|NCT01263665|521345442|FG000|Overall Study|Surgical Bypass|2|||
144586277|NCT00560066|521345445|FG000|Overall Study|Death|2|||
144586278|NCT00560066|521345446|FG001|Overall Study|Death|1|||
144586279|NCT00560066|521345445|FG000|Overall Study|Withdrawal by Subject|0|||
144586280|NCT00560066|521345446|FG001|Overall Study|Withdrawal by Subject|3|||
144586281|NCT00560066|521345445|FG000|Overall Study|Lost to Follow-up|4|||
144586282|NCT00560066|521345446|FG001|Overall Study|Lost to Follow-up|10|||
144586283|NCT00560066|521345445|FG000|Overall Study|Protocol Violation|0|||
144586284|NCT00560066|521345446|FG001|Overall Study|Protocol Violation|1|||
144586285|NCT00560066|521345445|FG000|Overall Study|Administrative reason|0|||
144586286|NCT00560066|521345446|FG001|Overall Study|Administrative reason|5|||
144586287|NCT00560066|521345445|FG000|Overall Study|Missing primary reason|0|||
144586288|NCT00560066|521345446|FG001|Overall Study|Missing primary reason|2|||
144586289|NCT01435616|521345447|FG000|Overall Study|Adverse Event|39|||
144586290|NCT01435616|521345448|FG001|Overall Study|Adverse Event|21|||
144586291|NCT01435616|521345447|FG000|Overall Study|Death|7|||
144586292|NCT01435616|521345448|FG001|Overall Study|Death|2|||
144586293|NCT01435616|521345447|FG000|Overall Study|Lost to Follow-up|22|||
144586294|NCT01435616|521345448|FG001|Overall Study|Lost to Follow-up|13|||
144586295|NCT01435616|521345447|FG000|Overall Study|Protocol Violation|16|||
144586296|NCT01435616|521345448|FG001|Overall Study|Protocol Violation|13|||
144586297|NCT01435616|521345447|FG000|Overall Study|Withdrawal by Subject|66|||
144586298|NCT01435616|521345448|FG001|Overall Study|Withdrawal by Subject|24|||
144586299|NCT01435616|521345447|FG000|Overall Study|Physician Decision|20|||
144586300|NCT01435616|521345448|FG001|Overall Study|Physician Decision|7|||
144586301|NCT01435616|521345447|FG000|Overall Study|Sponsor Decision|1|||
144586302|NCT01435616|521345448|FG001|Overall Study|Sponsor Decision|0|||
144586303|NCT02442336|521345456|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
144586304|NCT02442336|521345456|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
144586305|NCT02442336|521345456|FG000|Overall Study|Lost to Follow-up|11|||
144586306|NCT04602221|521345457|FG000|Overall Study|Discontinuation of trial treatment|0|||
144586307|NCT04602221|521345458|FG001|Overall Study|Discontinuation of trial treatment|0|||
144586308|NCT04602221|521345459|FG002|Overall Study|Discontinuation of trial treatment|1|||
144586309|NCT04602221|521345460|FG003|Overall Study|Discontinuation of trial treatment|0|||
144625466|NCT01227902|521487601|FG003|Overall Study|Adverse Event|4|||
144625467|NCT01227902|521487598|FG000|Overall Study|Lack of Efficacy|1|||
144625468|NCT01227902|521487599|FG001|Overall Study|Lack of Efficacy|2|||
144625469|NCT01227902|521487600|FG002|Overall Study|Lack of Efficacy|2|||
144262940|NCT03934216|520163794|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144586310|NCT04602221|521345461|FG004|Overall Study|Discontinuation of trial treatment|0|||
144625470|NCT01227902|521487601|FG003|Overall Study|Lack of Efficacy|1|||
144625471|NCT01227902|521487598|FG000|Overall Study|Protocol Violation|1|||
144625472|NCT01227902|521487599|FG001|Overall Study|Protocol Violation|0|||
144262941|NCT03934216|520163795|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144625473|NCT01227902|521487600|FG002|Overall Study|Protocol Violation|0|||
144625474|NCT01227902|521487601|FG003|Overall Study|Protocol Violation|0|||
144625475|NCT01227902|521487598|FG000|Overall Study|Lost to Follow-up|0|||
144625476|NCT01227902|521487599|FG001|Overall Study|Lost to Follow-up|0|||
144625477|NCT01227902|521487600|FG002|Overall Study|Lost to Follow-up|1|||
144625478|NCT01227902|521487601|FG003|Overall Study|Lost to Follow-up|2|||
144625479|NCT01227902|521487598|FG000|Overall Study|Physician Decision|0|||
144625480|NCT01227902|521487599|FG001|Overall Study|Physician Decision|1|||
144625481|NCT01227902|521487600|FG002|Overall Study|Physician Decision|1|||
144625482|NCT01227902|521487601|FG003|Overall Study|Physician Decision|0|||
144625483|NCT01227902|521487598|FG000|Overall Study|Withdrawal by Subject|4|||
144625484|NCT01227902|521487599|FG001|Overall Study|Withdrawal by Subject|2|||
144625485|NCT01227902|521487600|FG002|Overall Study|Withdrawal by Subject|4|||
144625486|NCT01227902|521487601|FG003|Overall Study|Withdrawal by Subject|3|||
144625487|NCT05280756|521487602|FG000|Overall Study|Lost to Follow-up|1|||
144625488|NCT05280756|521487603|FG001|Overall Study|Lost to Follow-up|1|||
144625489|NCT03064763|521487604|FG000|Overall Study|Lost to Follow-up|1|||
144625490|NCT03064763|521487604|FG000|Overall Study|Death|8|||
144625491|NCT00619502|521487605|FG000|Overall Study|Lost to Follow-up|8|||
144625492|NCT00619502|521487606|FG001|Overall Study|Lost to Follow-up|10|||
144625493|NCT02397473|521487609|FG000|Treatment Phase|Adverse Event|1|||
144625494|NCT02397473|521487610|FG001|Treatment Phase|Adverse Event|2|||
144625495|NCT02397473|521487609|FG000|Treatment Phase|Lack of Efficacy|8|||
144625496|NCT02397473|521487610|FG001|Treatment Phase|Lack of Efficacy|1|||
144625497|NCT02397473|521487609|FG000|Treatment Phase|Lost to Follow-up|1|||
144625498|NCT02397473|521487610|FG001|Treatment Phase|Lost to Follow-up|0|||
144625499|NCT02397473|521487609|FG000|Treatment Phase|Withdrawal by Subject|2|||
144625500|NCT02397473|521487610|FG001|Treatment Phase|Withdrawal by Subject|1|||
144625501|NCT02397473|521487609|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
144625502|NCT02397473|521487610|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
144625503|NCT02397473|521487609|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
144625504|NCT02397473|521487610|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
144625505|NCT02397473|521487609|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
144625506|NCT02397473|521487610|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
144625507|NCT02397473|521487609|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
144625508|NCT02397473|521487610|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
144625509|NCT02397473|521487609|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
144625510|NCT02397473|521487610|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
144625511|NCT01001702|521487612|FG000|Overall Study|Lost to Follow-up|7|||
144625512|NCT01001702|521487612|FG000|Overall Study|Adverse Event|7|||
144625513|NCT01001702|521487612|FG000|Overall Study|Sponsor Discontinued Study|4|||
144625514|NCT01001702|521487612|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
144625515|NCT01001702|521487612|FG000|Overall Study|Investigator withdrew Subject|10|||
144625516|NCT01001702|521487612|FG000|Overall Study|Withdrawal by Subject|19|||
144625517|NCT01001702|521487612|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
144625518|NCT02494596|521487615|FG000|Overall Study|Insufficient Therapeutic Response|3|||
144625519|NCT02494596|521487616|FG001|Overall Study|Insufficient Therapeutic Response|3|||
144625520|NCT02494596|521487617|FG002|Overall Study|Insufficient Therapeutic Response|1|||
144625521|NCT02494596|521487615|FG000|Overall Study|Adverse Event|0|||
144625522|NCT02494596|521487616|FG001|Overall Study|Adverse Event|1|||
144625523|NCT02494596|521487617|FG002|Overall Study|Adverse Event|0|||
144625524|NCT02494596|521487615|FG000|Overall Study|Refused Treatment|0|||
144625525|NCT02494596|521487616|FG001|Overall Study|Refused Treatment|1|||
144625526|NCT02494596|521487617|FG002|Overall Study|Refused Treatment|0|||
144625527|NCT00634569|521487620|FG000|Overall Study|Withdrawal by Subject|0|||
144625528|NCT00634569|521487621|FG001|Overall Study|Withdrawal by Subject|4|||
144625529|NCT00634569|521487620|FG000|Overall Study|Physician Decision|0|||
144625530|NCT00634569|521487621|FG001|Overall Study|Physician Decision|1|||
144625531|NCT01163786|521487622|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
144625532|NCT01163786|521487622|FG000|Treatment With Bortezomib|Adverse Event|2|||
144625533|NCT01163786|521487622|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
144625534|NCT01212185|521487623|FG000|Overall Study|Protocol Violation|2|||
144625535|NCT01212185|521487624|FG001|Overall Study|Protocol Violation|1|||
144625536|NCT01463098|521487625|FG000|Part A (11 Days)|Participant Choice|2|||
144625537|NCT01463098|521487626|FG001|Part A (11 Days)|Participant Choice|0|||
144625538|NCT01463098|521487627|FG002|Part A (11 Days)|Participant Choice|0|||
144625539|NCT01463098|521487628|FG003|Part A (11 Days)|Participant Choice|0|||
144625540|NCT01463098|521487629|FG004|Part A (11 Days)|Participant Choice|0|||
144625541|NCT01463098|521487630|FG005|Part A (11 Days)|Participant Choice|0|||
144625542|NCT01463098|521487631|FG006|Part A (11 Days)|Participant Choice|0|||
144625543|NCT01463098|521487632|FG007|Part A (11 Days)|Participant Choice|0|||
144625544|NCT01463098|521487633|FG008|Part A (11 Days)|Participant Choice|1|||
144625545|NCT01463098|521487634|FG009|Part A (11 Days)|Participant Choice|0|||
144625546|NCT01463098|521487635|FG010|Part A (11 Days)|Participant Choice|0|||
144625547|NCT01463098|521487636|FG011|Part A (11 Days)|Participant Choice|0|||
144625548|NCT01463098|521487637|FG012|Part A (11 Days)|Participant Choice|0|||
144625549|NCT01463098|521487638|FG013|Part A (11 Days)|Participant Choice|0|||
144625550|NCT01463098|521487625|FG000|Part A (11 Days)|Lost to Follow-up|0|||
144625551|NCT01463098|521487626|FG001|Part A (11 Days)|Lost to Follow-up|0|||
144625552|NCT01463098|521487627|FG002|Part A (11 Days)|Lost to Follow-up|0|||
144625553|NCT01463098|521487628|FG003|Part A (11 Days)|Lost to Follow-up|0|||
144625554|NCT01463098|521487629|FG004|Part A (11 Days)|Lost to Follow-up|1|||
144625555|NCT01463098|521487630|FG005|Part A (11 Days)|Lost to Follow-up|0|||
144625556|NCT01463098|521487631|FG006|Part A (11 Days)|Lost to Follow-up|0|||
144625557|NCT01463098|521487632|FG007|Part A (11 Days)|Lost to Follow-up|0|||
144625558|NCT01463098|521487633|FG008|Part A (11 Days)|Lost to Follow-up|0|||
144625559|NCT01463098|521487634|FG009|Part A (11 Days)|Lost to Follow-up|0|||
144625560|NCT01463098|521487635|FG010|Part A (11 Days)|Lost to Follow-up|0|||
144625561|NCT01463098|521487636|FG011|Part A (11 Days)|Lost to Follow-up|0|||
144625562|NCT01463098|521487637|FG012|Part A (11 Days)|Lost to Follow-up|0|||
144625563|NCT01463098|521487638|FG013|Part A (11 Days)|Lost to Follow-up|0|||
144625564|NCT01463098|521487625|FG000|Part B (11 Days)|Participant Choice|0|||
144625565|NCT01463098|521487626|FG001|Part B (11 Days)|Participant Choice|0|||
144625566|NCT01463098|521487627|FG002|Part B (11 Days)|Participant Choice|0|||
144625567|NCT01463098|521487628|FG003|Part B (11 Days)|Participant Choice|0|||
144625568|NCT01463098|521487629|FG004|Part B (11 Days)|Participant Choice|0|||
144625569|NCT01463098|521487630|FG005|Part B (11 Days)|Participant Choice|0|||
144625570|NCT01463098|521487631|FG006|Part B (11 Days)|Participant Choice|0|||
144625571|NCT01463098|521487632|FG007|Part B (11 Days)|Participant Choice|0|||
144625572|NCT01463098|521487633|FG008|Part B (11 Days)|Participant Choice|0|||
144625573|NCT01463098|521487634|FG009|Part B (11 Days)|Participant Choice|0|||
144625574|NCT01463098|521487635|FG010|Part B (11 Days)|Participant Choice|0|||
144625575|NCT01463098|521487636|FG011|Part B (11 Days)|Participant Choice|1|||
144625576|NCT01463098|521487637|FG012|Part B (11 Days)|Participant Choice|0|||
144625577|NCT01463098|521487638|FG013|Part B (11 Days)|Participant Choice|0|||
144625578|NCT01528787|521487641|FG000|Overall Study|Withdrawal by Subject|0|||
144625579|NCT01528787|521487642|FG001|Overall Study|Withdrawal by Subject|0|||
144625580|NCT01528787|521487643|FG002|Overall Study|Withdrawal by Subject|0|||
144625581|NCT01528787|521487644|FG003|Overall Study|Withdrawal by Subject|1|||
144625582|NCT01528787|521487641|FG000|Overall Study|Family Emergency|0|||
144625583|NCT01528787|521487642|FG001|Overall Study|Family Emergency|0|||
144625584|NCT01528787|521487643|FG002|Overall Study|Family Emergency|1|||
144625585|NCT01528787|521487644|FG003|Overall Study|Family Emergency|0|||
144625586|NCT02809833|521487645|FG000|Overall Study|Death|3|||
144625587|NCT02809833|521487645|FG000|Overall Study|Intolerance|54|||
144625588|NCT02809833|521487645|FG000|Overall Study|Lack of Efficacy|89|||
144625589|NCT02809833|521487645|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
144625590|NCT02809833|521487645|FG000|Overall Study|Noncompliance|1|||
144625591|NCT02809833|521487645|FG000|Overall Study|Withdrawal by Subject|34|||
144625592|NCT02809833|521487645|FG000|Overall Study|Lost to Follow-up|35|||
144625593|NCT02809833|521487645|FG000|Overall Study|Adverse Event (AE)|24|||
144625594|NCT02809833|521487645|FG000|Overall Study|Other|5|||
144625595|NCT02809833|521487645|FG000|Overall Study|Missing Information|52|||
144625596|NCT00523991|521487646|FG000|Overall Study|Adverse Event|6|||
144625597|NCT00523991|521487647|FG001|Overall Study|Adverse Event|5|||
144625598|NCT00523991|521487646|FG000|Overall Study|Protocol Violation|1|||
144625599|NCT00523991|521487647|FG001|Overall Study|Protocol Violation|4|||
144625600|NCT00523991|521487646|FG000|Overall Study|Lost to Follow-up|4|||
144625601|NCT00523991|521487647|FG001|Overall Study|Lost to Follow-up|1|||
144625602|NCT00523991|521487646|FG000|Overall Study|Withdrawal by Subject|7|||
144625603|NCT00523991|521487647|FG001|Overall Study|Withdrawal by Subject|17|||
144625604|NCT00523991|521487646|FG000|Overall Study|Other reason (not specified)|3|||
144625605|NCT00523991|521487647|FG001|Overall Study|Other reason (not specified)|0|||
144625606|NCT00193063|521487648|FG000|Overall Study|Lack of Efficacy|3|||
144625607|NCT00193063|521487648|FG000|Overall Study|Adverse Event|1|||
144625608|NCT01700192|521487649|FG000|Overall Study|Adverse Event|73|||
144625609|NCT01700192|521487650|FG001|Overall Study|Adverse Event|18|||
144625610|NCT01700192|521487649|FG000|Overall Study|Lack of Efficacy|1|||
144625611|NCT01700192|521487650|FG001|Overall Study|Lack of Efficacy|0|||
144625612|NCT01700192|521487649|FG000|Overall Study|Lost to Follow-up|42|||
144625613|NCT01700192|521487650|FG001|Overall Study|Lost to Follow-up|29|||
144625614|NCT01700192|521487649|FG000|Overall Study|Noncompliance with study drug|0|||
144625615|NCT01700192|521487650|FG001|Overall Study|Noncompliance with study drug|5|||
144625616|NCT01700192|521487649|FG000|Overall Study|Physician Decision|2|||
144625617|NCT01700192|521487650|FG001|Overall Study|Physician Decision|3|||
144625618|NCT01700192|521487649|FG000|Overall Study|Pregnancy|1|||
144625619|NCT01700192|521487650|FG001|Overall Study|Pregnancy|4|||
144625620|NCT01700192|521487649|FG000|Overall Study|Progressive disease|1|||
144730608|NCT00620022|521869830|FG001|Treatment Period 2|Adverse Event|2|||
144625621|NCT01700192|521487650|FG001|Overall Study|Progressive disease|0|||
144625622|NCT01700192|521487649|FG000|Overall Study|Protocol Violation|3|||
144625623|NCT01700192|521487650|FG001|Overall Study|Protocol Violation|4|||
144625624|NCT01700192|521487649|FG000|Overall Study|Technical problems|0|||
144625625|NCT01700192|521487650|FG001|Overall Study|Technical problems|1|||
144625626|NCT01700192|521487649|FG000|Overall Study|Withdrawal by Subject|56|||
144625627|NCT01700192|521487650|FG001|Overall Study|Withdrawal by Subject|64|||
144625628|NCT01700192|521487649|FG000|Overall Study|Never received study drug|1|||
144625629|NCT01700192|521487650|FG001|Overall Study|Never received study drug|0|||
144625630|NCT01127165|521487655|FG000|Overall Study|Adverse Event|2|||
144625631|NCT01127165|521487656|FG001|Overall Study|Adverse Event|2|||
144625632|NCT01127165|521487655|FG000|Overall Study|Lack of Efficacy|10|||
144625633|NCT01127165|521487656|FG001|Overall Study|Lack of Efficacy|8|||
144625634|NCT01127165|521487655|FG000|Overall Study|Lost to Follow-up|3|||
144625635|NCT01127165|521487656|FG001|Overall Study|Lost to Follow-up|5|||
144625636|NCT01127165|521487655|FG000|Overall Study|Withdrawal by Subject|1|||
144625637|NCT01127165|521487656|FG001|Overall Study|Withdrawal by Subject|3|||
144625638|NCT01127165|521487655|FG000|Overall Study|Protocol Violation|0|||
144625639|NCT01127165|521487656|FG001|Overall Study|Protocol Violation|1|||
144625640|NCT00379795|521487657|FG000|Overall Study|Death|31|||
144625641|NCT00379795|521487658|FG001|Overall Study|Death|8|||
144625642|NCT00379795|521487659|FG002|Overall Study|Death|6|||
144625643|NCT00379795|521487660|FG003|Overall Study|Death|4|||
144625644|NCT00379795|521487661|FG004|Overall Study|Death|7|||
144625645|NCT00379795|521487657|FG000|Overall Study|Adverse Event|17|||
144625646|NCT00379795|521487658|FG001|Overall Study|Adverse Event|3|||
144625647|NCT00379795|521487659|FG002|Overall Study|Adverse Event|3|||
144625648|NCT00379795|521487660|FG003|Overall Study|Adverse Event|1|||
144625649|NCT00379795|521487661|FG004|Overall Study|Adverse Event|4|||
144625650|NCT00379795|521487657|FG000|Overall Study|Lost to Follow-up|8|||
144625651|NCT00379795|521487658|FG001|Overall Study|Lost to Follow-up|1|||
144625652|NCT00379795|521487659|FG002|Overall Study|Lost to Follow-up|2|||
144625653|NCT00379795|521487660|FG003|Overall Study|Lost to Follow-up|1|||
144625654|NCT00379795|521487661|FG004|Overall Study|Lost to Follow-up|4|||
144625655|NCT00379795|521487657|FG000|Overall Study|Physician Decision|25|||
144625656|NCT00379795|521487658|FG001|Overall Study|Physician Decision|0|||
144625657|NCT00379795|521487659|FG002|Overall Study|Physician Decision|2|||
144625658|NCT00379795|521487660|FG003|Overall Study|Physician Decision|2|||
144625659|NCT00379795|521487661|FG004|Overall Study|Physician Decision|2|||
144625660|NCT00379795|521487657|FG000|Overall Study|Withdrawal by Subject|94|||
144625661|NCT00379795|521487658|FG001|Overall Study|Withdrawal by Subject|11|||
144625662|NCT00379795|521487659|FG002|Overall Study|Withdrawal by Subject|19|||
144625663|NCT00379795|521487660|FG003|Overall Study|Withdrawal by Subject|7|||
144625664|NCT00379795|521487661|FG004|Overall Study|Withdrawal by Subject|14|||
144625665|NCT00379795|521487657|FG000|Overall Study|Subject non-compliance|7|||
144625666|NCT00379795|521487658|FG001|Overall Study|Subject non-compliance|2|||
144625667|NCT00379795|521487659|FG002|Overall Study|Subject non-compliance|0|||
144625668|NCT00379795|521487660|FG003|Overall Study|Subject non-compliance|0|||
144625669|NCT00379795|521487661|FG004|Overall Study|Subject non-compliance|1|||
144625670|NCT00379795|521487657|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
144625671|NCT00379795|521487658|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
144625672|NCT00379795|521487659|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
144625673|NCT00379795|521487660|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
144625674|NCT00379795|521487661|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
144625675|NCT00379795|521487657|FG000|Overall Study|Subjects condition mandated intervention|34|||
144625676|NCT00379795|521487658|FG001|Overall Study|Subjects condition mandated intervention|9|||
144625677|NCT00379795|521487659|FG002|Overall Study|Subjects condition mandated intervention|7|||
144625678|NCT00379795|521487660|FG003|Overall Study|Subjects condition mandated intervention|5|||
144625679|NCT00379795|521487661|FG004|Overall Study|Subjects condition mandated intervention|7|||
144625680|NCT00379795|521487657|FG000|Overall Study|Sponsor's decision|257|||
144625681|NCT00379795|521487658|FG001|Overall Study|Sponsor's decision|17|||
144625682|NCT00379795|521487659|FG002|Overall Study|Sponsor's decision|54|||
144625683|NCT00379795|521487660|FG003|Overall Study|Sponsor's decision|47|||
144625684|NCT00379795|521487661|FG004|Overall Study|Sponsor's decision|10|||
144625685|NCT00763321|521487662|FG000|Open-label Period|Adverse Event|24|||
144625686|NCT00763321|521487663|FG001|Open-label Period|Adverse Event|0|||
144625687|NCT00763321|521487664|FG002|Open-label Period|Adverse Event|0|||
144625688|NCT00763321|521487662|FG000|Open-label Period|Lost to Follow-up|14|||
144625689|NCT00763321|521487663|FG001|Open-label Period|Lost to Follow-up|0|||
144625690|NCT00763321|521487664|FG002|Open-label Period|Lost to Follow-up|0|||
144625691|NCT00763321|521487662|FG000|Open-label Period|Withdrawal by Subject|7|||
144625692|NCT00763321|521487663|FG001|Open-label Period|Withdrawal by Subject|0|||
144625693|NCT00763321|521487664|FG002|Open-label Period|Withdrawal by Subject|0|||
144625694|NCT00763321|521487662|FG000|Open-label Period|Subject noncompliant|7|||
144625695|NCT00763321|521487663|FG001|Open-label Period|Subject noncompliant|0|||
144730609|NCT00358449|521869837|FG000|Overall Study|Adverse Event|1|||
144262942|NCT03934216|520163794|FG000|Overall Study|Pregnancy|1|||
144625696|NCT00763321|521487664|FG002|Open-label Period|Subject noncompliant|0|||
144625697|NCT00763321|521487662|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
144625698|NCT00763321|521487663|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
144625699|NCT00763321|521487664|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
144730610|NCT00358449|521869838|FG001|Overall Study|Adverse Event|0|||
144625700|NCT00763321|521487662|FG000|Open-label Period|Lack of Efficacy|2|||
144625701|NCT00763321|521487663|FG001|Open-label Period|Lack of Efficacy|0|||
144625702|NCT00763321|521487664|FG002|Open-label Period|Lack of Efficacy|0|||
144625703|NCT00763321|521487662|FG000|Open-label Period|Other|4|||
144625704|NCT00763321|521487663|FG001|Open-label Period|Other|0|||
144625705|NCT00763321|521487664|FG002|Open-label Period|Other|0|||
144625706|NCT00763321|521487662|FG000|Double-blind Period|Lack of Efficacy|0|||
144625707|NCT00763321|521487663|FG001|Double-blind Period|Lack of Efficacy|9|||
144625708|NCT00763321|521487664|FG002|Double-blind Period|Lack of Efficacy|17|||
144625709|NCT00763321|521487662|FG000|Double-blind Period|Adverse Event|0|||
144625710|NCT00763321|521487663|FG001|Double-blind Period|Adverse Event|4|||
144625711|NCT00763321|521487664|FG002|Double-blind Period|Adverse Event|4|||
144625712|NCT00763321|521487662|FG000|Double-blind Period|Lost to Follow-up|0|||
144625713|NCT00763321|521487663|FG001|Double-blind Period|Lost to Follow-up|4|||
144625714|NCT00763321|521487664|FG002|Double-blind Period|Lost to Follow-up|2|||
144625715|NCT00763321|521487662|FG000|Double-blind Period|Withdrawal by Subject|0|||
144625716|NCT00763321|521487663|FG001|Double-blind Period|Withdrawal by Subject|2|||
144625717|NCT00763321|521487664|FG002|Double-blind Period|Withdrawal by Subject|3|||
144625718|NCT00763321|521487662|FG000|Double-blind Period|Other|0|||
144625719|NCT00763321|521487663|FG001|Double-blind Period|Other|2|||
144625720|NCT00763321|521487664|FG002|Double-blind Period|Other|3|||
144625721|NCT01017952|521487665|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
144625722|NCT01017952|521487666|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144625723|NCT01017952|521487667|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144625724|NCT01017952|521487668|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144625725|NCT01017952|521487669|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144625726|NCT01017952|521487665|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
144625727|NCT01017952|521487666|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
144625728|NCT01017952|521487667|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
144625729|NCT01017952|521487668|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
144625730|NCT01017952|521487669|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
144625731|NCT01017952|521487665|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
144625732|NCT01017952|521487666|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
144625733|NCT01017952|521487667|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
144625734|NCT01017952|521487668|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
144625735|NCT01017952|521487669|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
144625736|NCT01017952|521487665|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
144625737|NCT01017952|521487666|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144625738|NCT01017952|521487667|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144625739|NCT01017952|521487668|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144625740|NCT01017952|521487669|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144625741|NCT01017952|521487665|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
144625742|NCT01017952|521487666|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
144625743|NCT01017952|521487667|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
144625744|NCT01017952|521487668|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
144625745|NCT01017952|521487669|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
144625746|NCT01017952|521487665|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
144625747|NCT01017952|521487666|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144625748|NCT01017952|521487667|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144625749|NCT01017952|521487668|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144625750|NCT01017952|521487669|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144625751|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
144625752|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
144625753|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
144625754|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
144625755|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
144625756|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144625757|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
144625758|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
144625759|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
144625760|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
144625761|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
144625762|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
144625763|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
144625764|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
144625765|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
144625766|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
144625767|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
144730611|NCT00358449|521869839|FG002|Overall Study|Adverse Event|1|||
144625768|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
144625769|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
144625770|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
144625771|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
144625772|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
144625773|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
144625774|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
144625775|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
144625776|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
144625777|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
144625778|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
144625779|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
144625780|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
144625781|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144625782|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
144625783|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
144625784|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
144625785|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
144625786|NCT01017952|521487665|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
144625787|NCT01017952|521487666|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
144625788|NCT01017952|521487667|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
144625789|NCT01017952|521487668|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
144625790|NCT01017952|521487669|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
144625791|NCT01064167|521487670|FG000|Overall Study|Protocol Violation|14|||
144625792|NCT01064167|521487671|FG001|Overall Study|Protocol Violation|15|||
144625793|NCT03984305|521487673|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
144625794|NCT03984305|521487674|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
144625795|NCT03984305|521487673|FG000|Overall Study|Withdrawal by Subject|3|||
144625796|NCT03984305|521487674|FG001|Overall Study|Withdrawal by Subject|3|||
144625797|NCT03984305|521487673|FG000|Overall Study|Lost to Follow-up|1|||
144625798|NCT03984305|521487674|FG001|Overall Study|Lost to Follow-up|0|||
144625799|NCT01656434|521487675|FG000|Overall Study|Adverse Event|199|||
144625800|NCT01656434|521487676|FG001|Overall Study|Adverse Event|63|||
144625801|NCT01656434|521487675|FG000|Overall Study|Enrollment terminated at trial site|2|||
144625802|NCT01656434|521487676|FG001|Overall Study|Enrollment terminated at trial site|0|||
144625803|NCT01656434|521487675|FG000|Overall Study|Lost to Follow-up|309|||
144625804|NCT01656434|521487676|FG001|Overall Study|Lost to Follow-up|76|||
144625805|NCT01656434|521487675|FG000|Overall Study|Site discontinued study participation|24|||
144625806|NCT01656434|521487676|FG001|Overall Study|Site discontinued study participation|9|||
144625807|NCT01656434|521487675|FG000|Overall Study|Screen failure|2|||
144625808|NCT01656434|521487676|FG001|Overall Study|Screen failure|0|||
144625809|NCT01656434|521487675|FG000|Overall Study|Protocol Violation|7|||
144625810|NCT01656434|521487676|FG001|Overall Study|Protocol Violation|0|||
144625811|NCT01656434|521487675|FG000|Overall Study|Pregnancy wish|18|||
144625812|NCT01656434|521487676|FG001|Overall Study|Pregnancy wish|6|||
144625813|NCT01656434|521487675|FG000|Overall Study|Pregnancy|45|||
144625814|NCT01656434|521487676|FG001|Overall Study|Pregnancy|10|||
144625815|NCT01656434|521487675|FG000|Overall Study|Physician Decision|7|||
144625816|NCT01656434|521487676|FG001|Overall Study|Physician Decision|2|||
144625817|NCT01656434|521487675|FG000|Overall Study|Non-compliance with study drug|48|||
144625818|NCT01656434|521487676|FG001|Overall Study|Non-compliance with study drug|9|||
144625819|NCT01656434|521487675|FG000|Overall Study|Study terminated by sponsor|1501|||
144625820|NCT01656434|521487676|FG001|Overall Study|Study terminated by sponsor|348|||
144625821|NCT01656434|521487675|FG000|Overall Study|Participant discontinued; drug related|13|||
144625822|NCT01656434|521487676|FG001|Overall Study|Participant discontinued; drug related|4|||
144625823|NCT01656434|521487675|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
144625824|NCT01656434|521487676|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
144625825|NCT01656434|521487675|FG000|Overall Study|Non-compliance with protocol|39|||
144625826|NCT01656434|521487676|FG001|Overall Study|Non-compliance with protocol|15|||
144209661|NCT02960490|519962001|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
144209662|NCT02960490|519962002|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
144209663|NCT02960490|519962003|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
144209664|NCT02960490|519961994|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144625827|NCT01656434|521487675|FG000|Overall Study|Participant moved|40|||
144209665|NCT02960490|519961995|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144209666|NCT02960490|519961996|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144209667|NCT02960490|519961997|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144625828|NCT01656434|521487676|FG001|Overall Study|Participant moved|12|||
144625829|NCT01656434|521487675|FG000|Overall Study|Participant withdrew consent|28|||
144625830|NCT01656434|521487676|FG001|Overall Study|Participant withdrew consent|9|||
144625831|NCT01656434|521487675|FG000|Overall Study|Withdrawal by Subject|64|||
144209668|NCT02960490|519961998|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144209669|NCT02960490|519961999|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144586311|NCT04602221|521345462|FG005|Overall Study|Discontinuation of trial treatment|0|||
144586312|NCT04602221|521345463|FG006|Overall Study|Discontinuation of trial treatment|0|||
144586313|NCT04602221|521345464|FG007|Overall Study|Discontinuation of trial treatment|0|||
144586314|NCT04602221|521345465|FG008|Overall Study|Discontinuation of trial treatment|0|||
144586315|NCT04602221|521345466|FG009|Overall Study|Discontinuation of trial treatment|0|||
144586316|NCT04602221|521345467|FG010|Overall Study|Discontinuation of trial treatment|0|||
144586317|NCT04602221|521345468|FG011|Overall Study|Discontinuation of trial treatment|0|||
144586318|NCT04602221|521345469|FG012|Overall Study|Discontinuation of trial treatment|0|||
144586319|NCT04602221|521345470|FG013|Overall Study|Discontinuation of trial treatment|0|||
144586320|NCT04602221|521345471|FG014|Overall Study|Discontinuation of trial treatment|0|||
144586321|NCT04602221|521345472|FG015|Overall Study|Discontinuation of trial treatment|0|||
144586322|NCT04602221|521345473|FG016|Overall Study|Discontinuation of trial treatment|0|||
144586323|NCT04602221|521345474|FG017|Overall Study|Discontinuation of trial treatment|0|||
144586324|NCT04602221|521345457|FG000|Overall Study|Other than listed|0|||
144586325|NCT04602221|521345458|FG001|Overall Study|Other than listed|0|||
144586326|NCT04602221|521345459|FG002|Overall Study|Other than listed|0|||
144586327|NCT04602221|521345460|FG003|Overall Study|Other than listed|0|||
144586328|NCT04602221|521345461|FG004|Overall Study|Other than listed|0|||
144586329|NCT04602221|521345462|FG005|Overall Study|Other than listed|0|||
144586330|NCT04602221|521345463|FG006|Overall Study|Other than listed|0|||
144586331|NCT04602221|521345464|FG007|Overall Study|Other than listed|0|||
144586332|NCT04602221|521345465|FG008|Overall Study|Other than listed|0|||
144586333|NCT04602221|521345466|FG009|Overall Study|Other than listed|0|||
144586334|NCT04602221|521345467|FG010|Overall Study|Other than listed|0|||
144586335|NCT04602221|521345468|FG011|Overall Study|Other than listed|0|||
144586336|NCT04602221|521345469|FG012|Overall Study|Other than listed|0|||
144586337|NCT04602221|521345470|FG013|Overall Study|Other than listed|0|||
144586338|NCT04602221|521345471|FG014|Overall Study|Other than listed|0|||
144586339|NCT04602221|521345472|FG015|Overall Study|Other than listed|1|||
144586340|NCT04602221|521345473|FG016|Overall Study|Other than listed|0|||
144586341|NCT04602221|521345474|FG017|Overall Study|Other than listed|1|||
144586342|NCT04602221|521345457|FG000|Overall Study|Withdrawal by Subject|0|||
144586343|NCT04602221|521345458|FG001|Overall Study|Withdrawal by Subject|0|||
144586344|NCT04602221|521345459|FG002|Overall Study|Withdrawal by Subject|0|||
144586345|NCT04602221|521345460|FG003|Overall Study|Withdrawal by Subject|0|||
144586346|NCT04602221|521345461|FG004|Overall Study|Withdrawal by Subject|0|||
144586347|NCT04602221|521345462|FG005|Overall Study|Withdrawal by Subject|0|||
144586348|NCT04602221|521345463|FG006|Overall Study|Withdrawal by Subject|0|||
144586349|NCT04602221|521345464|FG007|Overall Study|Withdrawal by Subject|0|||
144586350|NCT04602221|521345465|FG008|Overall Study|Withdrawal by Subject|0|||
144586351|NCT04602221|521345466|FG009|Overall Study|Withdrawal by Subject|0|||
144586352|NCT04602221|521345467|FG010|Overall Study|Withdrawal by Subject|0|||
144586353|NCT04602221|521345468|FG011|Overall Study|Withdrawal by Subject|0|||
144586354|NCT04602221|521345469|FG012|Overall Study|Withdrawal by Subject|1|||
144586355|NCT04602221|521345470|FG013|Overall Study|Withdrawal by Subject|0|||
144586356|NCT04602221|521345471|FG014|Overall Study|Withdrawal by Subject|0|||
144586357|NCT04602221|521345472|FG015|Overall Study|Withdrawal by Subject|0|||
144586358|NCT04602221|521345473|FG016|Overall Study|Withdrawal by Subject|0|||
144586359|NCT04602221|521345474|FG017|Overall Study|Withdrawal by Subject|0|||
144586360|NCT04602221|521345457|FG000|Overall Study|Lost to Follow-up|0|||
144586361|NCT04602221|521345458|FG001|Overall Study|Lost to Follow-up|0|||
144586362|NCT04602221|521345459|FG002|Overall Study|Lost to Follow-up|0|||
144586363|NCT04602221|521345460|FG003|Overall Study|Lost to Follow-up|0|||
144586364|NCT04602221|521345461|FG004|Overall Study|Lost to Follow-up|0|||
144586365|NCT04602221|521345462|FG005|Overall Study|Lost to Follow-up|1|||
144586366|NCT04602221|521345463|FG006|Overall Study|Lost to Follow-up|0|||
144586367|NCT04602221|521345464|FG007|Overall Study|Lost to Follow-up|0|||
144586368|NCT04602221|521345465|FG008|Overall Study|Lost to Follow-up|0|||
144586369|NCT04602221|521345466|FG009|Overall Study|Lost to Follow-up|0|||
144586370|NCT04602221|521345467|FG010|Overall Study|Lost to Follow-up|0|||
144586371|NCT04602221|521345468|FG011|Overall Study|Lost to Follow-up|0|||
144586372|NCT04602221|521345469|FG012|Overall Study|Lost to Follow-up|0|||
144586373|NCT04602221|521345470|FG013|Overall Study|Lost to Follow-up|0|||
144586374|NCT04602221|521345471|FG014|Overall Study|Lost to Follow-up|0|||
144586375|NCT04602221|521345472|FG015|Overall Study|Lost to Follow-up|0|||
144625832|NCT01656434|521487676|FG001|Overall Study|Withdrawal by Subject|7|||
144209670|NCT02960490|519962000|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
144209671|NCT02960490|519962001|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144209672|NCT02960490|519962002|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144209673|NCT02960490|519962003|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
144209674|NCT02960490|519961994|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209675|NCT02960490|519961995|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
144730612|NCT00358449|521869837|FG000|Overall Study|Lost to Follow-up|1|||
144730613|NCT00358449|521869838|FG001|Overall Study|Lost to Follow-up|0|||
144730614|NCT00358449|521869839|FG002|Overall Study|Lost to Follow-up|0|||
144730615|NCT00358449|521869837|FG000|Overall Study|Withdrawal by Subject|2|||
144730616|NCT00358449|521869838|FG001|Overall Study|Withdrawal by Subject|0|||
144730617|NCT00358449|521869839|FG002|Overall Study|Withdrawal by Subject|0|||
144730618|NCT00358449|521869837|FG000|Overall Study|Lack of Efficacy|0|||
144586376|NCT04602221|521345473|FG016|Overall Study|Lost to Follow-up|0|||
144586377|NCT04602221|521345474|FG017|Overall Study|Lost to Follow-up|0|||
144586378|NCT01056718|521345475|FG000|Overall Study|Withdrawal by Subject|2|||
144586379|NCT01056718|521345475|FG000|Overall Study|Ischemia on baseline stress test|1|||
144586380|NCT01011387|521345476|FG000|Overall Study|Withdrawal by Subject|3|||
144586381|NCT01011387|521345476|FG000|Overall Study|Adverse Event|2|||
144586382|NCT01011387|521345476|FG000|Overall Study|Protocol Violation|1|||
144586383|NCT01139580|521345477|FG000|Overall Study|Adverse Event|5|||
144586384|NCT01139580|521345478|FG001|Overall Study|Adverse Event|4|||
144586385|NCT01139580|521345477|FG000|Overall Study|Lost to Follow-up|9|||
144586386|NCT01139580|521345478|FG001|Overall Study|Lost to Follow-up|1|||
144586387|NCT01139580|521345477|FG000|Overall Study|Lack of Efficacy|0|||
144586388|NCT01139580|521345478|FG001|Overall Study|Lack of Efficacy|2|||
144586389|NCT01139580|521345477|FG000|Overall Study|Withdrawal by Subject|6|||
144586390|NCT01139580|521345478|FG001|Overall Study|Withdrawal by Subject|9|||
144586391|NCT01139580|521345477|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
144586392|NCT01139580|521345478|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
144586393|NCT01139580|521345477|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
144586394|NCT01139580|521345478|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
144586395|NCT01139580|521345477|FG000|Overall Study|Misrandomized|1|||
144586396|NCT01139580|521345478|FG001|Overall Study|Misrandomized|0|||
144586397|NCT01139580|521345477|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
144586398|NCT01139580|521345478|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
144586399|NCT01139580|521345477|FG000|Overall Study|Participant Randomization in Error|0|||
144586400|NCT01139580|521345478|FG001|Overall Study|Participant Randomization in Error|1|||
144586401|NCT01142115|521345479|FG000|First Intervention|Lack of Efficacy|1|||
144586402|NCT01142115|521345480|FG001|First Intervention|Lack of Efficacy|1|||
144586403|NCT01142115|521345479|FG000|First Intervention|Adverse Event|1|||
144586404|NCT01142115|521345480|FG001|First Intervention|Adverse Event|0|||
144586405|NCT00633880|521345481|FG000|Open Label Titration|Lack of Efficacy|1|||
144586406|NCT00633880|521345482|FG001|Open Label Titration|Lack of Efficacy|0|||
144586407|NCT00633880|521345483|FG002|Open Label Titration|Lack of Efficacy|0|||
144586408|NCT00633880|521345481|FG000|Open Label Titration|Adverse Event|13|||
144586409|NCT00633880|521345482|FG001|Open Label Titration|Adverse Event|0|||
144586410|NCT00633880|521345483|FG002|Open Label Titration|Adverse Event|0|||
144586411|NCT00633880|521345481|FG000|Open Label Titration|Treatment Failure|55|||
144586412|NCT00633880|521345482|FG001|Open Label Titration|Treatment Failure|0|||
144586413|NCT00633880|521345483|FG002|Open Label Titration|Treatment Failure|0|||
144586414|NCT00633880|521345481|FG000|Open Label Titration|Protocol Violation|6|||
144586415|NCT00633880|521345482|FG001|Open Label Titration|Protocol Violation|0|||
144586416|NCT00633880|521345483|FG002|Open Label Titration|Protocol Violation|0|||
144586417|NCT00633880|521345481|FG000|Open Label Titration|Physician Decision|1|||
144586418|NCT00633880|521345482|FG001|Open Label Titration|Physician Decision|0|||
144586419|NCT00633880|521345483|FG002|Open Label Titration|Physician Decision|0|||
144586420|NCT00633880|521345481|FG000|Open Label Titration|Withdrawal by Subject|4|||
144586421|NCT00633880|521345482|FG001|Open Label Titration|Withdrawal by Subject|0|||
144586422|NCT00633880|521345483|FG002|Open Label Titration|Withdrawal by Subject|0|||
144586423|NCT03208036|521345484|FG000|Baseline Assessment|Withdrawal by Subject|1|||
144586424|NCT03208036|521345485|FG001|Baseline Assessment|Withdrawal by Subject|1|||
144586425|NCT03208036|521345484|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
144586426|NCT03208036|521345485|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
144586427|NCT03208036|521345484|FG000|Intervention|Withdrawal by Subject|3|||
144586428|NCT03208036|521345485|FG001|Intervention|Withdrawal by Subject|2|||
144586429|NCT03208036|521345484|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
144586430|NCT03208036|521345485|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
144586431|NCT03406078|521345486|FG000|Overall Study|Death|1|||
144586432|NCT03406078|521345487|FG001|Overall Study|Death|0|||
144586433|NCT03406078|521345486|FG000|Overall Study|Lost to Follow-up|0|||
144586434|NCT03406078|521345487|FG001|Overall Study|Lost to Follow-up|1|||
144586435|NCT03406078|521345486|FG000|Overall Study|Withdrawal by Subject|5|||
144586436|NCT03406078|521345487|FG001|Overall Study|Withdrawal by Subject|2|||
144586437|NCT00700778|521345488|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
144586438|NCT00350103|521345491|FG000|Overall Study|Adverse Event|12|||
144586439|NCT00350103|521345492|FG001|Overall Study|Adverse Event|29|||
144586440|NCT00350103|521345493|FG002|Overall Study|Adverse Event|17|||
144586441|NCT00350103|521345491|FG000|Overall Study|Lack of Efficacy|5|||
144730619|NCT00358449|521869838|FG001|Overall Study|Lack of Efficacy|1|||
144730620|NCT00358449|521869839|FG002|Overall Study|Lack of Efficacy|0|||
144625833|NCT01235962|521487677|FG000|Overall Study|Withdrawal by Subject|20|||
144625834|NCT01235962|521487678|FG001|Overall Study|Withdrawal by Subject|19|||
144625835|NCT01235962|521487679|FG002|Overall Study|Withdrawal by Subject|62|||
144625836|NCT01235962|521487680|FG003|Overall Study|Withdrawal by Subject|49|||
144625837|NCT01235962|521487677|FG000|Overall Study|Lost to Follow-up|21|||
144625838|NCT01235962|521487678|FG001|Overall Study|Lost to Follow-up|16|||
144625839|NCT01235962|521487679|FG002|Overall Study|Lost to Follow-up|47|||
144625840|NCT01235962|521487680|FG003|Overall Study|Lost to Follow-up|32|||
144625841|NCT01235962|521487677|FG000|Overall Study|Physician Decision|5|||
144625842|NCT01235962|521487678|FG001|Overall Study|Physician Decision|0|||
144625843|NCT01235962|521487679|FG002|Overall Study|Physician Decision|9|||
144625844|NCT01235962|521487680|FG003|Overall Study|Physician Decision|5|||
144625845|NCT01405053|521487681|FG000|Overall Study|Adverse Event|3|||
144625846|NCT01405053|521487682|FG001|Overall Study|Adverse Event|0|||
144625847|NCT01405053|521487681|FG000|Overall Study|Lost to Follow-up|0|||
144625848|NCT01405053|521487682|FG001|Overall Study|Lost to Follow-up|1|||
144625849|NCT01405053|521487681|FG000|Overall Study|Participant choice|2|||
144625850|NCT01405053|521487682|FG001|Overall Study|Participant choice|1|||
144625851|NCT01405053|521487681|FG000|Overall Study|Inadequate therapeutic effect|2|||
144625852|NCT01405053|521487682|FG001|Overall Study|Inadequate therapeutic effect|1|||
144625853|NCT01405053|521487681|FG000|Overall Study|Withdrawal by Subject|3|||
144625854|NCT01405053|521487682|FG001|Overall Study|Withdrawal by Subject|4|||
144625855|NCT01405053|521487681|FG000|Overall Study|Other|0|||
144625856|NCT01405053|521487682|FG001|Overall Study|Other|1|||
144625857|NCT06098729|521487694|FG000|Overall Study|Withdrawal by Subject|1|||
144625858|NCT00993928|521487695|FG000|Overall Study|Withdrawal by Subject|4|||
144625859|NCT00993928|521487696|FG001|Overall Study|Withdrawal by Subject|7|||
144625860|NCT00993928|521487695|FG000|Overall Study|ineligible|1|||
144625861|NCT00993928|521487696|FG001|Overall Study|ineligible|0|||
144625862|NCT02302963|521487697|FG000|Overall Study|Withdrawal by Subject|2|||
144625863|NCT02302963|521487698|FG001|Overall Study|Withdrawal by Subject|1|||
144625864|NCT02302963|521487697|FG000|Overall Study|Steroid injection|0|||
144625865|NCT02302963|521487698|FG001|Overall Study|Steroid injection|1|||
144625866|NCT02302963|521487697|FG000|Overall Study|Physician Decision|1|||
144625867|NCT02302963|521487698|FG001|Overall Study|Physician Decision|0|||
144625868|NCT01920711|521487701|FG000|Overall Study|Death|347|||
144625869|NCT01920711|521487702|FG001|Overall Study|Death|356|||
144625870|NCT01920711|521487701|FG000|Overall Study|Lost to Follow-up|13|||
144625871|NCT01920711|521487702|FG001|Overall Study|Lost to Follow-up|14|||
144625872|NCT01920711|521487701|FG000|Overall Study|Withdrawal by Subject|4|||
144625873|NCT01920711|521487702|FG001|Overall Study|Withdrawal by Subject|3|||
144625874|NCT03891901|521487703|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
144625875|NCT03891901|521487704|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625876|NCT03891901|521487705|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625877|NCT03891901|521487706|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625878|NCT03891901|521487707|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625879|NCT03891901|521487708|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625880|NCT03891901|521487709|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625881|NCT03891901|521487710|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625882|NCT03891901|521487711|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
144625883|NCT03891901|521487703|FG000|Overall Study|Adverse Event|2|||
144625884|NCT03891901|521487704|FG001|Overall Study|Adverse Event|2|||
144625885|NCT03891901|521487705|FG002|Overall Study|Adverse Event|0|||
144625886|NCT03891901|521487706|FG003|Overall Study|Adverse Event|0|||
144625887|NCT03891901|521487707|FG004|Overall Study|Adverse Event|0|||
144625888|NCT03891901|521487708|FG005|Overall Study|Adverse Event|0|||
144625889|NCT03891901|521487709|FG006|Overall Study|Adverse Event|0|||
144625890|NCT03891901|521487710|FG007|Overall Study|Adverse Event|0|||
144625891|NCT03891901|521487711|FG008|Overall Study|Adverse Event|0|||
144625892|NCT03891901|521487703|FG000|Overall Study|Poor venous access|1|||
144625893|NCT03891901|521487704|FG001|Overall Study|Poor venous access|0|||
144730621|NCT00358449|521869837|FG000|Overall Study|Steriod Inhaler was Increased|0|||
144730622|NCT00358449|521869838|FG001|Overall Study|Steriod Inhaler was Increased|0|||
144625894|NCT03891901|521487705|FG002|Overall Study|Poor venous access|0|||
144625895|NCT03891901|521487706|FG003|Overall Study|Poor venous access|0|||
144625896|NCT03891901|521487707|FG004|Overall Study|Poor venous access|0|||
144625897|NCT03891901|521487708|FG005|Overall Study|Poor venous access|0|||
144625898|NCT03891901|521487709|FG006|Overall Study|Poor venous access|0|||
144625899|NCT03891901|521487710|FG007|Overall Study|Poor venous access|0|||
144625900|NCT03891901|521487711|FG008|Overall Study|Poor venous access|0|||
144625901|NCT03891901|521487703|FG000|Overall Study|Withdrawal by Subject|0|||
144625902|NCT03891901|521487704|FG001|Overall Study|Withdrawal by Subject|2|||
144625903|NCT03891901|521487705|FG002|Overall Study|Withdrawal by Subject|0|||
144625904|NCT03891901|521487706|FG003|Overall Study|Withdrawal by Subject|0|||
144625905|NCT03891901|521487707|FG004|Overall Study|Withdrawal by Subject|0|||
144625906|NCT03891901|521487708|FG005|Overall Study|Withdrawal by Subject|0|||
144625907|NCT03891901|521487709|FG006|Overall Study|Withdrawal by Subject|0|||
144625908|NCT03891901|521487710|FG007|Overall Study|Withdrawal by Subject|0|||
144625909|NCT03891901|521487711|FG008|Overall Study|Withdrawal by Subject|0|||
144625910|NCT03355300|521487712|FG000|Overall Study|Physician Decision|0|||
144625911|NCT03355300|521487713|FG001|Overall Study|Physician Decision|1|||
144625912|NCT03355300|521487712|FG000|Overall Study|Lack of Efficacy|2|||
144625913|NCT03355300|521487713|FG001|Overall Study|Lack of Efficacy|1|||
144625914|NCT03355300|521487712|FG000|Overall Study|Other reason|1|||
144625915|NCT03355300|521487713|FG001|Overall Study|Other reason|0|||
144625916|NCT00546052|521487714|FG000|Overall Study|Adverse Event|47|||
144625917|NCT00546052|521487714|FG000|Overall Study|Lost to Follow-up|144|||
144625918|NCT00546052|521487714|FG000|Overall Study|Protocol Violation|9|||
144625919|NCT00546052|521487714|FG000|Overall Study|Withdrawal by Subject|20|||
144625920|NCT00546052|521487714|FG000|Overall Study|Non Compliance|7|||
144625921|NCT01031446|521487725|FG000|Overall Study|Disease Progression|38|||
144625922|NCT01031446|521487725|FG000|Overall Study|Adverse Event|9|||
144625923|NCT01031446|521487725|FG000|Overall Study|Physician Decision|4|||
144625924|NCT01031446|521487725|FG000|Overall Study|Withdrawal by Subject|3|||
144625925|NCT01031446|521487725|FG000|Overall Study|Still on treatment|1|||
144625926|NCT00500682|521487728|FG000|Overall Study|Adverse Event|37|||
144625927|NCT00500682|521487729|FG001|Overall Study|Adverse Event|29|||
144625928|NCT00500682|521487728|FG000|Overall Study|Death|25|||
144625929|NCT00500682|521487729|FG001|Overall Study|Death|16|||
144625930|NCT00500682|521487728|FG000|Overall Study|Lost to Follow-up|11|||
144625931|NCT00500682|521487729|FG001|Overall Study|Lost to Follow-up|11|||
144625932|NCT00500682|521487728|FG000|Overall Study|Physician Decision|6|||
144625933|NCT00500682|521487729|FG001|Overall Study|Physician Decision|10|||
144625934|NCT00500682|521487728|FG000|Overall Study|Pregnancy|2|||
144625935|NCT00500682|521487729|FG001|Overall Study|Pregnancy|0|||
144625936|NCT00500682|521487728|FG000|Overall Study|Protocol Violation|1|||
144625937|NCT00500682|521487729|FG001|Overall Study|Protocol Violation|3|||
144625938|NCT00500682|521487728|FG000|Overall Study|Withdrawal by Subject|80|||
144730623|NCT00358449|521869839|FG002|Overall Study|Steriod Inhaler was Increased|1|||
144586442|NCT00350103|521345492|FG001|Overall Study|Lack of Efficacy|1|||
144586443|NCT00350103|521345493|FG002|Overall Study|Lack of Efficacy|3|||
144586444|NCT00350103|521345491|FG000|Overall Study|Withdrawal by Subject|6|||
144586445|NCT00350103|521345492|FG001|Overall Study|Withdrawal by Subject|6|||
144586446|NCT00350103|521345493|FG002|Overall Study|Withdrawal by Subject|8|||
144586447|NCT00350103|521345491|FG000|Overall Study|Protocol Violation|0|||
144586448|NCT00350103|521345492|FG001|Overall Study|Protocol Violation|0|||
144586449|NCT00350103|521345493|FG002|Overall Study|Protocol Violation|1|||
144586450|NCT00350103|521345491|FG000|Overall Study|Unsatisfactory Compliance|2|||
144586451|NCT00350103|521345492|FG001|Overall Study|Unsatisfactory Compliance|2|||
144586452|NCT00350103|521345493|FG002|Overall Study|Unsatisfactory Compliance|1|||
144586453|NCT00350103|521345491|FG000|Overall Study|Investigator´s decision|1|||
144586454|NCT00350103|521345492|FG001|Overall Study|Investigator´s decision|1|||
144586455|NCT00350103|521345493|FG002|Overall Study|Investigator´s decision|0|||
144586456|NCT00350103|521345491|FG000|Overall Study|Exclusion criteria met|0|||
144586457|NCT00350103|521345492|FG001|Overall Study|Exclusion criteria met|0|||
144586458|NCT00350103|521345493|FG002|Overall Study|Exclusion criteria met|1|||
144586459|NCT00350103|521345491|FG000|Overall Study|Patient relocated|0|||
144586460|NCT00350103|521345492|FG001|Overall Study|Patient relocated|0|||
144586461|NCT00350103|521345493|FG002|Overall Study|Patient relocated|1|||
144586462|NCT00350103|521345491|FG000|Overall Study|Need for prohibited medication|1|||
144586463|NCT00350103|521345492|FG001|Overall Study|Need for prohibited medication|0|||
144586464|NCT00350103|521345493|FG002|Overall Study|Need for prohibited medication|0|||
144586465|NCT00350103|521345491|FG000|Overall Study|Personal reasons|0|||
144586466|NCT00350103|521345492|FG001|Overall Study|Personal reasons|0|||
144586467|NCT00350103|521345493|FG002|Overall Study|Personal reasons|1|||
144586468|NCT00350103|521345491|FG000|Overall Study|Patient stopped feeling pain|1|||
144586469|NCT00350103|521345492|FG001|Overall Study|Patient stopped feeling pain|0|||
144586470|NCT00350103|521345493|FG002|Overall Study|Patient stopped feeling pain|0|||
144586471|NCT00350103|521345491|FG000|Overall Study|PR greater than 250ms|0|||
144586472|NCT00350103|521345492|FG001|Overall Study|PR greater than 250ms|0|||
144586473|NCT00350103|521345493|FG002|Overall Study|PR greater than 250ms|1|||
144586474|NCT00350103|521345491|FG000|Overall Study|Wrong calculation of QT interval|0|||
144586475|NCT00350103|521345492|FG001|Overall Study|Wrong calculation of QT interval|0|||
144586476|NCT00350103|521345493|FG002|Overall Study|Wrong calculation of QT interval|1|||
144586477|NCT00350103|521345491|FG000|Overall Study|Sponsor mistake|1|||
144586478|NCT00350103|521345492|FG001|Overall Study|Sponsor mistake|0|||
144586479|NCT00350103|521345493|FG002|Overall Study|Sponsor mistake|0|||
144586480|NCT00350103|521345491|FG000|Overall Study|Randomization mistake|0|||
144586481|NCT00350103|521345492|FG001|Overall Study|Randomization mistake|1|||
144586482|NCT00350103|521345493|FG002|Overall Study|Randomization mistake|1|||
144586483|NCT00350103|521345491|FG000|Overall Study|Sponsor´s decision|0|||
144586484|NCT00350103|521345492|FG001|Overall Study|Sponsor´s decision|1|||
144586485|NCT00350103|521345493|FG002|Overall Study|Sponsor´s decision|0|||
144586486|NCT00350103|521345491|FG000|Overall Study|Lost, Reason unknown|1|||
144209676|NCT02960490|519961996|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209677|NCT02960490|519961997|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209678|NCT02960490|519961998|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209679|NCT02960490|519961999|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209680|NCT02960490|519962000|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209681|NCT02960490|519962001|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
144209682|NCT02960490|519962002|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
144209683|NCT02960490|519962003|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
144586487|NCT00350103|521345492|FG001|Overall Study|Lost, Reason unknown|1|||
144586488|NCT00350103|521345493|FG002|Overall Study|Lost, Reason unknown|0|||
144586489|NCT02842151|521345494|FG000|Overall Study|Adverse Event|1|||
144586490|NCT02842151|521345494|FG000|Overall Study|Subject moved too far away|1|||
144586491|NCT01879553|521345495|FG000|Overall Study|Withdrawal by Subject|1|||
144586492|NCT01879553|521345496|FG001|Overall Study|Withdrawal by Subject|0|||
144586493|NCT00591851|521345497|FG000|Overall Study|Withdrawal by Subject|3|||
144586494|NCT00591851|521345497|FG000|Overall Study|Adverse Event|2|||
144586495|NCT00591851|521345497|FG000|Overall Study|Progressive Disease|1|||
144586496|NCT00438672|521345498|FG000|Overall Study|Lost to Follow-up|7|||
144586497|NCT00438672|521345499|FG001|Overall Study|Lost to Follow-up|9|||
144586498|NCT02559895|521345500|FG000|Overall Study|Adverse Event|3|||
144586499|NCT02559895|521345501|FG001|Overall Study|Adverse Event|3|||
144586500|NCT02559895|521345502|FG002|Overall Study|Adverse Event|2|||
144586501|NCT02559895|521345503|FG003|Overall Study|Adverse Event|1|||
144586502|NCT02559895|521345500|FG000|Overall Study|Lack of Efficacy|2|||
144586503|NCT02559895|521345501|FG001|Overall Study|Lack of Efficacy|3|||
144586504|NCT02559895|521345502|FG002|Overall Study|Lack of Efficacy|2|||
144586505|NCT02559895|521345503|FG003|Overall Study|Lack of Efficacy|8|||
144586506|NCT02559895|521345500|FG000|Overall Study|Lost to Follow-up|22|||
144586507|NCT02559895|521345501|FG001|Overall Study|Lost to Follow-up|16|||
144586508|NCT02559895|521345502|FG002|Overall Study|Lost to Follow-up|12|||
144586509|NCT02559895|521345503|FG003|Overall Study|Lost to Follow-up|17|||
144586510|NCT02559895|521345500|FG000|Overall Study|Physician Decision|1|||
144586511|NCT02559895|521345501|FG001|Overall Study|Physician Decision|1|||
144586512|NCT02559895|521345502|FG002|Overall Study|Physician Decision|3|||
144586513|NCT02559895|521345503|FG003|Overall Study|Physician Decision|0|||
144586514|NCT02559895|521345500|FG000|Overall Study|Withdrawal by Subject|16|||
144586515|NCT02559895|521345501|FG001|Overall Study|Withdrawal by Subject|9|||
144586516|NCT02559895|521345502|FG002|Overall Study|Withdrawal by Subject|20|||
144586517|NCT02559895|521345503|FG003|Overall Study|Withdrawal by Subject|9|||
144586518|NCT02559895|521345500|FG000|Overall Study|Study Burden|10|||
144586519|NCT02559895|521345501|FG001|Overall Study|Study Burden|16|||
144586520|NCT02559895|521345502|FG002|Overall Study|Study Burden|12|||
144586521|NCT02559895|521345503|FG003|Overall Study|Study Burden|22|||
144586522|NCT02559895|521345500|FG000|Overall Study|Other|1|||
144586523|NCT02559895|521345501|FG001|Overall Study|Other|5|||
144586524|NCT02559895|521345502|FG002|Overall Study|Other|3|||
144586525|NCT02559895|521345503|FG003|Overall Study|Other|3|||
144586526|NCT00320528|521345507|FG000|Study Period II|Adverse Event|3|||
144586527|NCT00320528|521345508|FG001|Study Period II|Adverse Event|4|||
144586528|NCT00320528|521345509|FG002|Study Period II|Adverse Event|8|||
144586529|NCT00320528|521345507|FG000|Study Period II|Parent/Caregiver Decision|8|||
144586530|NCT00320528|521345508|FG001|Study Period II|Parent/Caregiver Decision|3|||
144586531|NCT00320528|521345509|FG002|Study Period II|Parent/Caregiver Decision|11|||
144586532|NCT00320528|521345507|FG000|Study Period II|Withdrawal by Subject|0|||
144586533|NCT00320528|521345508|FG001|Study Period II|Withdrawal by Subject|1|||
144586534|NCT00320528|521345509|FG002|Study Period II|Withdrawal by Subject|1|||
144586535|NCT00320528|521345507|FG000|Study Period II|Entry Criteria Exclusion|0|||
144586536|NCT00320528|521345508|FG001|Study Period II|Entry Criteria Exclusion|2|||
144586537|NCT00320528|521345509|FG002|Study Period II|Entry Criteria Exclusion|2|||
144586538|NCT00320528|521345507|FG000|Study Period III|Adverse Event|1|||
144586539|NCT00320528|521345508|FG001|Study Period III|Adverse Event|0|||
144586540|NCT00320528|521345509|FG002|Study Period III|Adverse Event|0|||
144586541|NCT00320528|521345507|FG000|Study Period III|Lost to Follow-up|1|||
144586542|NCT00320528|521345508|FG001|Study Period III|Lost to Follow-up|0|||
144586543|NCT00320528|521345509|FG002|Study Period III|Lost to Follow-up|0|||
144586544|NCT00320528|521345507|FG000|Study Period III|Withdrawal by Subject|1|||
144586545|NCT00320528|521345508|FG001|Study Period III|Withdrawal by Subject|1|||
144586546|NCT00320528|521345509|FG002|Study Period III|Withdrawal by Subject|2|||
144586547|NCT00320528|521345507|FG000|Study Period III|Lack of Efficacy|2|||
144586548|NCT00320528|521345508|FG001|Study Period III|Lack of Efficacy|0|||
144586549|NCT00320528|521345509|FG002|Study Period III|Lack of Efficacy|0|||
144586550|NCT00320528|521345507|FG000|Study Period III|Parent/Caregiver Decision|14|||
144209684|NCT02368314|519962004|FG000|Overall Study|Withdrawal by Subject|2|||
144586551|NCT00320528|521345508|FG001|Study Period III|Parent/Caregiver Decision|3|||
144586552|NCT00320528|521345509|FG002|Study Period III|Parent/Caregiver Decision|11|||
144586553|NCT00320528|521345507|FG000|Study Period III|Protocol Violation|0|||
144586554|NCT00320528|521345508|FG001|Study Period III|Protocol Violation|1|||
144625939|NCT00500682|521487729|FG001|Overall Study|Withdrawal by Subject|74|||
144625940|NCT00500682|521487728|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
144625941|NCT00500682|521487729|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
144625942|NCT02531646|521487730|FG000|Overall Study|equip. image processing issue|5|||
144625943|NCT02531646|521487731|FG001|Overall Study|equip. image processing issue|1|||
144625944|NCT02531646|521487732|FG002|Overall Study|equip. image processing issue|0|||
144625945|NCT03631706|521487738|FG000|Overall Study|Randomized, not treated|1|||
144625946|NCT03631706|521487739|FG001|Overall Study|Randomized, not treated|0|||
144625947|NCT04484285|521489464|FG000|Overall Study|Unable to operate stimulator|3|||
144625948|NCT04484285|521489465|FG001|Overall Study|Unable to operate stimulator|0|||
144625949|NCT00768898|521489466|FG000|Overall Study|Unrelated injury|1|||
144625950|NCT00768898|521489466|FG000|Overall Study|Headache|1|||
144625951|NCT00930059|521489467|FG000|Overall Study|Death|1|||
144625952|NCT00930059|521489468|FG001|Overall Study|Death|0|||
144625953|NCT00930059|521489467|FG000|Overall Study|Did not meet entrance criteria|1|||
144625954|NCT00930059|521489468|FG001|Overall Study|Did not meet entrance criteria|1|||
144625955|NCT00930059|521489467|FG000|Overall Study|Withdrawal by Subject|3|||
144625956|NCT00930059|521489468|FG001|Overall Study|Withdrawal by Subject|4|||
144625957|NCT00930059|521489467|FG000|Overall Study|Other|1|||
144625958|NCT00930059|521489468|FG001|Overall Study|Other|0|||
144625959|NCT00930059|521489467|FG000|Overall Study|1 site terminated by sponsor|1|||
144625960|NCT00930059|521489468|FG001|Overall Study|1 site terminated by sponsor|1|||
144625961|NCT00930059|521489467|FG000|Overall Study|Adverse Event|1|||
144625962|NCT00930059|521489468|FG001|Overall Study|Adverse Event|6|||
144209685|NCT02368314|519962005|FG001|Overall Study|Withdrawal by Subject|1|||
144209686|NCT02368314|519962004|FG000|Overall Study|Adverse Event|1|||
144209687|NCT02368314|519962005|FG001|Overall Study|Adverse Event|2|||
144625963|NCT04002310|521489469|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
144625964|NCT04002310|521489470|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
144625965|NCT04002310|521489471|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
144625966|NCT04002310|521489472|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
144625967|NCT04002310|521489473|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
144625968|NCT00804687|521489476|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
144625969|NCT00804687|521489477|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
144625970|NCT00804687|521489478|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
144625971|NCT00804687|521489479|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
144625972|NCT00804687|521489480|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
144625973|NCT00804687|521489481|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
144625974|NCT00804687|521489476|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
144625975|NCT00804687|521489477|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
144625976|NCT00804687|521489478|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
144625977|NCT00804687|521489479|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
144625978|NCT00804687|521489480|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
144625979|NCT00804687|521489481|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
144625980|NCT00804687|521489476|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
144625981|NCT00804687|521489477|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
144625982|NCT00804687|521489478|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
144625983|NCT00804687|521489479|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
144625984|NCT00804687|521489480|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
144625985|NCT00804687|521489481|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
144625986|NCT00804687|521489476|FG000|Period 5: Treatment Period|Positive drug test|1|||
144625987|NCT00804687|521489477|FG001|Period 5: Treatment Period|Positive drug test|0|||
144625988|NCT00804687|521489478|FG002|Period 5: Treatment Period|Positive drug test|0|||
144625989|NCT00804687|521489479|FG003|Period 5: Treatment Period|Positive drug test|0|||
144625990|NCT00804687|521489480|FG004|Period 5: Treatment Period|Positive drug test|0|||
144625991|NCT00804687|521489481|FG005|Period 5: Treatment Period|Positive drug test|0|||
144625992|NCT01505894|521489484|FG000|Overall Study|Adverse Event|1|||
144625993|NCT01505894|521489485|FG001|Overall Study|Adverse Event|0|||
144209688|NCT02460679|519962012|FG000|Overall Study|Investigator Decision|1|||
144209689|NCT02460679|519962012|FG000|Overall Study|Withdrawal by Subject|4|||
144625994|NCT01505894|521489486|FG002|Overall Study|Adverse Event|0|||
144625995|NCT01505894|521489487|FG003|Overall Study|Adverse Event|0|||
144625996|NCT01505894|521489488|FG004|Overall Study|Adverse Event|0|||
144625997|NCT01505894|521489489|FG005|Overall Study|Adverse Event|0|||
144625998|NCT01505894|521489490|FG006|Overall Study|Adverse Event|0|||
144625999|NCT01505894|521489491|FG007|Overall Study|Adverse Event|0|||
144626000|NCT01505894|521489492|FG008|Overall Study|Adverse Event|0|||
144626001|NCT01505894|521489484|FG000|Overall Study|Other than specified|0|||
144626002|NCT01505894|521489485|FG001|Overall Study|Other than specified|0|||
144626003|NCT01505894|521489486|FG002|Overall Study|Other than specified|0|||
144626004|NCT01505894|521489487|FG003|Overall Study|Other than specified|0|||
144626005|NCT01505894|521489488|FG004|Overall Study|Other than specified|1|||
144626006|NCT01505894|521489489|FG005|Overall Study|Other than specified|0|||
144626007|NCT01505894|521489490|FG006|Overall Study|Other than specified|0|||
144626008|NCT01505894|521489491|FG007|Overall Study|Other than specified|0|||
144626009|NCT01505894|521489492|FG008|Overall Study|Other than specified|0|||
144626010|NCT02167945|521489497|FG000|Overall Study|Adverse Event|16|||
144626011|NCT02167945|521489497|FG000|Overall Study|Withdrew Consent|42|||
144626012|NCT02167945|521489497|FG000|Overall Study|Lost to Follow-up|122|||
144626013|NCT02167945|521489497|FG000|Overall Study|COVID-19 logistical restrictions|6|||
144626014|NCT02167945|521489497|FG000|Overall Study|Other, not specified|63|||
144626015|NCT00132730|521489498|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
144626016|NCT00132730|521489499|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
144626017|NCT00132730|521489500|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
144626018|NCT00132730|521489501|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
144626019|NCT00132730|521489502|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
144626020|NCT00132730|521489503|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
144626021|NCT00132730|521489498|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
144626022|NCT00132730|521489499|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
144626023|NCT00132730|521489500|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
144626024|NCT00132730|521489501|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
144626025|NCT00132730|521489502|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
144626026|NCT00132730|521489503|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
144626027|NCT00132730|521489498|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
144626028|NCT00132730|521489499|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
144626029|NCT00132730|521489500|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
144626030|NCT00132730|521489501|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
144626031|NCT00132730|521489502|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
144626032|NCT00132730|521489503|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
144626033|NCT00132730|521489498|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
144626034|NCT00132730|521489499|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
144626035|NCT00132730|521489500|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
144626036|NCT00132730|521489501|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
144626037|NCT00132730|521489502|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
144626038|NCT00132730|521489503|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
144626039|NCT00132730|521489498|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
144626040|NCT00132730|521489499|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
144626041|NCT00132730|521489500|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
144626042|NCT00132730|521489501|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
144626043|NCT00132730|521489502|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
144626044|NCT00132730|521489503|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
144626045|NCT00132730|521489498|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
144209690|NCT00339144|519962020|FG000|Overall Study|Disease progression|5|||
144209691|NCT00339144|519962021|FG001|Overall Study|Disease progression|2|||
144209692|NCT00339144|519962022|FG002|Overall Study|Disease progression|2|||
144209693|NCT00339144|519962020|FG000|Overall Study|Study drug toxicity|3|||
144209694|NCT00339144|519962021|FG001|Overall Study|Study drug toxicity|1|||
144209695|NCT00339144|519962022|FG002|Overall Study|Study drug toxicity|1|||
144209696|NCT00339144|519962020|FG000|Overall Study|Participant's request to discontinuation|1|||
144209697|NCT00339144|519962021|FG001|Overall Study|Participant's request to discontinuation|0|||
144209698|NCT00339144|519962022|FG002|Overall Study|Participant's request to discontinuation|1|||
144209699|NCT00478426|519962023|FG000|Overall Study|Withdrawal by Subject|1|||
144262943|NCT03934216|520163795|FG001|Overall Study|Pregnancy|0|||
144626046|NCT00132730|521489499|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
144626047|NCT00132730|521489500|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
144626048|NCT00132730|521489501|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
144626049|NCT00132730|521489502|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
144626050|NCT00132730|521489503|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
144626051|NCT00132730|521489498|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
144626052|NCT00132730|521489499|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
144626053|NCT00132730|521489500|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
144626054|NCT00132730|521489501|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
144626055|NCT00132730|521489502|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
144626056|NCT00132730|521489503|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
144626057|NCT00132730|521489498|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
144626058|NCT00132730|521489499|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
144626059|NCT00132730|521489500|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
144626060|NCT00132730|521489501|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
144626061|NCT00132730|521489502|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
144626062|NCT00132730|521489503|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
144626063|NCT00132730|521489498|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
144626064|NCT00132730|521489499|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
144626065|NCT00132730|521489500|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
144626066|NCT00132730|521489501|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
144626067|NCT00132730|521489502|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
144626068|NCT00132730|521489503|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
144626069|NCT00132730|521489498|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
144626070|NCT00132730|521489499|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
144626071|NCT00132730|521489500|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
144626072|NCT00132730|521489501|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
144626073|NCT00132730|521489502|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
144626074|NCT00132730|521489503|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
144626075|NCT00132730|521489498|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
144626076|NCT00132730|521489499|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
144626077|NCT00132730|521489500|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
144626078|NCT00132730|521489501|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
144626079|NCT00132730|521489502|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
144626080|NCT00132730|521489503|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
144626081|NCT00132730|521489498|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
144626082|NCT00132730|521489499|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
144626083|NCT00132730|521489500|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
144626084|NCT00132730|521489501|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
144626085|NCT00132730|521489502|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
144626086|NCT00132730|521489503|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
144626087|NCT01192347|521489504|FG000|Overall Study|Death|3|||
144626088|NCT01192347|521489504|FG000|Overall Study|Lost to Follow-up|3|||
144626089|NCT01192347|521489504|FG000|Overall Study|Withdrawal by Subject|1|||
144626090|NCT01192347|521489504|FG000|Overall Study|Adverse Event|1|||
144626091|NCT01192347|521489504|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
144626092|NCT01192347|521489504|FG000|Overall Study|Patient seen in different hospital|1|||
144626093|NCT01192347|521489504|FG000|Overall Study|Patient not visiting hospital regularly|1|||
144626094|NCT01192347|521489504|FG000|Overall Study|Patient did not show up for visits|1|||
144626095|NCT02623335|521489505|FG000|Overall Study|Death|8|||
144626096|NCT02623335|521489506|FG001|Overall Study|Death|7|||
144626097|NCT02623335|521489505|FG000|Overall Study|Lost to Follow-up|15|||
144626098|NCT02623335|521489506|FG001|Overall Study|Lost to Follow-up|23|||
144626099|NCT02623335|521489505|FG000|Overall Study|Withdrawal by Subject|2|||
144626100|NCT02623335|521489506|FG001|Overall Study|Withdrawal by Subject|5|||
144626101|NCT02623335|521489505|FG000|Overall Study|Protocol Violation|2|||
144626102|NCT02623335|521489506|FG001|Overall Study|Protocol Violation|1|||
144626103|NCT03739528|521489507|FG000|Overall Study|Not treated|8|||
144626104|NCT03739528|521489508|FG001|Overall Study|Not treated|12|||
144626105|NCT03739528|521489507|FG000|Overall Study|Treatment and study discontinued|6|||
144626106|NCT03739528|521489508|FG001|Overall Study|Treatment and study discontinued|2|||
144626107|NCT03739528|521489507|FG000|Overall Study|Treatment discontinued + study completed|1|||
144626108|NCT03739528|521489508|FG001|Overall Study|Treatment discontinued + study completed|3|||
144626109|NCT00179959|521489509|FG000|Overall Study|Lost to Follow-up|3|||
144626110|NCT00179959|521489510|FG001|Overall Study|Lost to Follow-up|1|||
144626111|NCT00179959|521489509|FG000|Overall Study|Withdrawal by Subject|3|||
144626112|NCT00179959|521489510|FG001|Overall Study|Withdrawal by Subject|2|||
144626113|NCT01262976|521489511|FG000|Up to Month 2|Serious Adverse Event|0|||
144626114|NCT01262976|521489512|FG001|Up to Month 2|Serious Adverse Event|0|||
144626115|NCT01262976|521489513|FG002|Up to Month 2|Serious Adverse Event|1|||
144626116|NCT01262976|521489514|FG003|Up to Month 2|Serious Adverse Event|0|||
144626117|NCT01262976|521489515|FG004|Up to Month 2|Serious Adverse Event|0|||
144626118|NCT01262976|521489516|FG005|Up to Month 2|Serious Adverse Event|0|||
144626119|NCT01262976|521489511|FG000|Up to Month 2|Withdrawal by Subject|1|||
144626120|NCT01262976|521489512|FG001|Up to Month 2|Withdrawal by Subject|0|||
144626121|NCT01262976|521489513|FG002|Up to Month 2|Withdrawal by Subject|0|||
144626122|NCT01262976|521489514|FG003|Up to Month 2|Withdrawal by Subject|0|||
144626123|NCT01262976|521489515|FG004|Up to Month 2|Withdrawal by Subject|0|||
144626124|NCT01262976|521489516|FG005|Up to Month 2|Withdrawal by Subject|0|||
144626125|NCT01262976|521489511|FG000|Up to Month 2|Migrated/moved from study area|0|||
144626126|NCT01262976|521489512|FG001|Up to Month 2|Migrated/moved from study area|1|||
144626127|NCT01262976|521489513|FG002|Up to Month 2|Migrated/moved from study area|0|||
144626128|NCT01262976|521489514|FG003|Up to Month 2|Migrated/moved from study area|0|||
144626129|NCT01262976|521489515|FG004|Up to Month 2|Migrated/moved from study area|1|||
144626130|NCT01262976|521489516|FG005|Up to Month 2|Migrated/moved from study area|1|||
144626131|NCT01262976|521489511|FG000|Up to Month 2|Lost to Follow-up|1|||
144626132|NCT01262976|521489512|FG001|Up to Month 2|Lost to Follow-up|0|||
144626133|NCT01262976|521489513|FG002|Up to Month 2|Lost to Follow-up|0|||
144626134|NCT01262976|521489514|FG003|Up to Month 2|Lost to Follow-up|1|||
144626135|NCT01262976|521489515|FG004|Up to Month 2|Lost to Follow-up|1|||
144626136|NCT01262976|521489516|FG005|Up to Month 2|Lost to Follow-up|1|||
144626137|NCT01262976|521489511|FG000|Up to Month 2|Other|1|||
144626138|NCT01262976|521489512|FG001|Up to Month 2|Other|0|||
144626139|NCT01262976|521489513|FG002|Up to Month 2|Other|0|||
144626140|NCT01262976|521489514|FG003|Up to Month 2|Other|1|||
144626141|NCT01262976|521489515|FG004|Up to Month 2|Other|0|||
144626142|NCT01262976|521489516|FG005|Up to Month 2|Other|2|||
144626143|NCT01262976|521489511|FG000|Up to Month 7|Serious Adverse Event|0|||
144626144|NCT01262976|521489512|FG001|Up to Month 7|Serious Adverse Event|0|||
144626145|NCT01262976|521489513|FG002|Up to Month 7|Serious Adverse Event|2|||
144626146|NCT01262976|521489514|FG003|Up to Month 7|Serious Adverse Event|0|||
144626147|NCT01262976|521489515|FG004|Up to Month 7|Serious Adverse Event|0|||
144626148|NCT01262976|521489516|FG005|Up to Month 7|Serious Adverse Event|0|||
144626149|NCT01262976|521489511|FG000|Up to Month 7|Withdrawal by Subject|1|||
144626150|NCT01262976|521489512|FG001|Up to Month 7|Withdrawal by Subject|0|||
144626151|NCT01262976|521489513|FG002|Up to Month 7|Withdrawal by Subject|0|||
144626152|NCT01262976|521489514|FG003|Up to Month 7|Withdrawal by Subject|0|||
144626153|NCT01262976|521489515|FG004|Up to Month 7|Withdrawal by Subject|0|||
144626154|NCT01262976|521489516|FG005|Up to Month 7|Withdrawal by Subject|0|||
144626155|NCT01262976|521489511|FG000|Up to Month 7|Migrated/moved from study area|0|||
144626156|NCT01262976|521489512|FG001|Up to Month 7|Migrated/moved from study area|0|||
144626157|NCT01262976|521489513|FG002|Up to Month 7|Migrated/moved from study area|1|||
144626158|NCT01262976|521489514|FG003|Up to Month 7|Migrated/moved from study area|3|||
144626159|NCT01262976|521489515|FG004|Up to Month 7|Migrated/moved from study area|1|||
144626160|NCT01262976|521489516|FG005|Up to Month 7|Migrated/moved from study area|1|||
144626161|NCT01262976|521489511|FG000|Up to Month 7|Lost to Follow-up|1|||
144626162|NCT01262976|521489512|FG001|Up to Month 7|Lost to Follow-up|0|||
144626163|NCT01262976|521489513|FG002|Up to Month 7|Lost to Follow-up|1|||
144626164|NCT01262976|521489514|FG003|Up to Month 7|Lost to Follow-up|3|||
144626165|NCT01262976|521489515|FG004|Up to Month 7|Lost to Follow-up|1|||
144626166|NCT01262976|521489516|FG005|Up to Month 7|Lost to Follow-up|3|||
144626167|NCT01262976|521489511|FG000|Up to Month 7|Other|3|||
144626168|NCT01262976|521489512|FG001|Up to Month 7|Other|0|||
144626169|NCT01262976|521489513|FG002|Up to Month 7|Other|2|||
144626170|NCT01262976|521489514|FG003|Up to Month 7|Other|0|||
144626171|NCT01262976|521489515|FG004|Up to Month 7|Other|0|||
144626172|NCT01262976|521489516|FG005|Up to Month 7|Other|0|||
144626173|NCT01262976|521489511|FG000|Up to Year 1|Serious Adverse Event|0|||
144626174|NCT01262976|521489512|FG001|Up to Year 1|Serious Adverse Event|0|||
144626175|NCT01262976|521489513|FG002|Up to Year 1|Serious Adverse Event|2|||
144626176|NCT01262976|521489514|FG003|Up to Year 1|Serious Adverse Event|0|||
144626177|NCT01262976|521489515|FG004|Up to Year 1|Serious Adverse Event|0|||
144626178|NCT01262976|521489516|FG005|Up to Year 1|Serious Adverse Event|0|||
144626179|NCT01262976|521489511|FG000|Up to Year 1|Withdrawal by Subject|1|||
144626180|NCT01262976|521489512|FG001|Up to Year 1|Withdrawal by Subject|0|||
144626181|NCT01262976|521489513|FG002|Up to Year 1|Withdrawal by Subject|0|||
144626182|NCT01262976|521489514|FG003|Up to Year 1|Withdrawal by Subject|0|||
144626183|NCT01262976|521489515|FG004|Up to Year 1|Withdrawal by Subject|0|||
144626184|NCT01262976|521489516|FG005|Up to Year 1|Withdrawal by Subject|0|||
144626185|NCT01262976|521489511|FG000|Up to Year 1|Migrated/moved from study area|1|||
144626186|NCT01262976|521489512|FG001|Up to Year 1|Migrated/moved from study area|0|||
144626187|NCT01262976|521489513|FG002|Up to Year 1|Migrated/moved from study area|0|||
144626188|NCT01262976|521489514|FG003|Up to Year 1|Migrated/moved from study area|3|||
144626189|NCT01262976|521489515|FG004|Up to Year 1|Migrated/moved from study area|3|||
144626190|NCT01262976|521489516|FG005|Up to Year 1|Migrated/moved from study area|2|||
144626191|NCT01262976|521489511|FG000|Up to Year 1|Lost to Follow-up|4|||
144626192|NCT01262976|521489512|FG001|Up to Year 1|Lost to Follow-up|0|||
144626193|NCT01262976|521489513|FG002|Up to Year 1|Lost to Follow-up|0|||
144626194|NCT01262976|521489514|FG003|Up to Year 1|Lost to Follow-up|1|||
144626195|NCT01262976|521489515|FG004|Up to Year 1|Lost to Follow-up|6|||
144626196|NCT01262976|521489516|FG005|Up to Year 1|Lost to Follow-up|5|||
144626197|NCT01262976|521489511|FG000|Up to Year 1|Other|3|||
144626198|NCT01262976|521489512|FG001|Up to Year 1|Other|1|||
144626199|NCT01262976|521489513|FG002|Up to Year 1|Other|0|||
144626200|NCT01262976|521489514|FG003|Up to Year 1|Other|0|||
144626201|NCT01262976|521489515|FG004|Up to Year 1|Other|2|||
144626202|NCT01262976|521489516|FG005|Up to Year 1|Other|1|||
144626203|NCT01262976|521489511|FG000|Up to Year 1|Subjects with unknown completion status|0|||
144626204|NCT01262976|521489512|FG001|Up to Year 1|Subjects with unknown completion status|0|||
144626205|NCT01262976|521489513|FG002|Up to Year 1|Subjects with unknown completion status|1|||
144626206|NCT01262976|521489514|FG003|Up to Year 1|Subjects with unknown completion status|0|||
144626207|NCT01262976|521489515|FG004|Up to Year 1|Subjects with unknown completion status|0|||
144626208|NCT01262976|521489516|FG005|Up to Year 1|Subjects with unknown completion status|1|||
144626209|NCT01262976|521489511|FG000|Up to Year 2|Serious Adverse Event|0|||
144626210|NCT01262976|521489512|FG001|Up to Year 2|Serious Adverse Event|0|||
144626211|NCT01262976|521489513|FG002|Up to Year 2|Serious Adverse Event|2|||
144626212|NCT01262976|521489514|FG003|Up to Year 2|Serious Adverse Event|0|||
144626213|NCT01262976|521489515|FG004|Up to Year 2|Serious Adverse Event|0|||
144626214|NCT01262976|521489516|FG005|Up to Year 2|Serious Adverse Event|0|||
144626215|NCT01262976|521489511|FG000|Up to Year 2|Withdrawal by Subject|1|||
144626216|NCT01262976|521489512|FG001|Up to Year 2|Withdrawal by Subject|0|||
144626217|NCT01262976|521489513|FG002|Up to Year 2|Withdrawal by Subject|0|||
144626218|NCT01262976|521489514|FG003|Up to Year 2|Withdrawal by Subject|0|||
144626219|NCT01262976|521489515|FG004|Up to Year 2|Withdrawal by Subject|0|||
144626220|NCT01262976|521489516|FG005|Up to Year 2|Withdrawal by Subject|0|||
144626221|NCT01262976|521489511|FG000|Up to Year 2|Migrated/moved from study area|0|||
144626222|NCT01262976|521489512|FG001|Up to Year 2|Migrated/moved from study area|0|||
144626223|NCT01262976|521489513|FG002|Up to Year 2|Migrated/moved from study area|0|||
144626224|NCT01262976|521489514|FG003|Up to Year 2|Migrated/moved from study area|2|||
144626225|NCT01262976|521489515|FG004|Up to Year 2|Migrated/moved from study area|1|||
144626226|NCT01262976|521489516|FG005|Up to Year 2|Migrated/moved from study area|2|||
144626227|NCT01262976|521489511|FG000|Up to Year 2|Lost to Follow-up|1|||
144626228|NCT01262976|521489512|FG001|Up to Year 2|Lost to Follow-up|1|||
144626229|NCT01262976|521489513|FG002|Up to Year 2|Lost to Follow-up|2|||
144626230|NCT01262976|521489514|FG003|Up to Year 2|Lost to Follow-up|2|||
144626231|NCT01262976|521489515|FG004|Up to Year 2|Lost to Follow-up|3|||
144626232|NCT01262976|521489516|FG005|Up to Year 2|Lost to Follow-up|3|||
144626233|NCT01262976|521489511|FG000|Up to Year 2|Subjects with unknown completion status|0|||
144626234|NCT01262976|521489512|FG001|Up to Year 2|Subjects with unknown completion status|0|||
144626235|NCT01262976|521489513|FG002|Up to Year 2|Subjects with unknown completion status|1|||
144626236|NCT01262976|521489514|FG003|Up to Year 2|Subjects with unknown completion status|0|||
144626237|NCT01262976|521489515|FG004|Up to Year 2|Subjects with unknown completion status|0|||
144626238|NCT01262976|521489516|FG005|Up to Year 2|Subjects with unknown completion status|0|||
144626239|NCT01262976|521489511|FG000|Up to Year 2|Other|3|||
144626240|NCT01262976|521489512|FG001|Up to Year 2|Other|0|||
144626241|NCT01262976|521489513|FG002|Up to Year 2|Other|0|||
144626242|NCT01262976|521489514|FG003|Up to Year 2|Other|0|||
144626243|NCT01262976|521489515|FG004|Up to Year 2|Other|0|||
144626244|NCT01262976|521489516|FG005|Up to Year 2|Other|0|||
144626245|NCT01262976|521489511|FG000|Up to Year 3|Serious Adverse Event|0|||
144626246|NCT01262976|521489512|FG001|Up to Year 3|Serious Adverse Event|0|||
144626247|NCT01262976|521489513|FG002|Up to Year 3|Serious Adverse Event|2|||
144626248|NCT01262976|521489514|FG003|Up to Year 3|Serious Adverse Event|0|||
144626249|NCT01262976|521489515|FG004|Up to Year 3|Serious Adverse Event|0|||
144626250|NCT01262976|521489516|FG005|Up to Year 3|Serious Adverse Event|0|||
144626251|NCT01262976|521489511|FG000|Up to Year 3|Withdrawal by Subject|1|||
144626252|NCT01262976|521489512|FG001|Up to Year 3|Withdrawal by Subject|0|||
144626253|NCT01262976|521489513|FG002|Up to Year 3|Withdrawal by Subject|0|||
144626254|NCT01262976|521489514|FG003|Up to Year 3|Withdrawal by Subject|0|||
144626255|NCT01262976|521489515|FG004|Up to Year 3|Withdrawal by Subject|0|||
144626256|NCT01262976|521489516|FG005|Up to Year 3|Withdrawal by Subject|0|||
144626257|NCT01262976|521489511|FG000|Up to Year 3|Migrated/moved from study area|0|||
144626258|NCT01262976|521489512|FG001|Up to Year 3|Migrated/moved from study area|0|||
144626259|NCT01262976|521489513|FG002|Up to Year 3|Migrated/moved from study area|0|||
144626260|NCT01262976|521489514|FG003|Up to Year 3|Migrated/moved from study area|2|||
144626261|NCT01262976|521489515|FG004|Up to Year 3|Migrated/moved from study area|1|||
144626262|NCT01262976|521489516|FG005|Up to Year 3|Migrated/moved from study area|1|||
144626263|NCT01262976|521489511|FG000|Up to Year 3|Lost to Follow-up|2|||
144626264|NCT01262976|521489512|FG001|Up to Year 3|Lost to Follow-up|2|||
144626265|NCT01262976|521489513|FG002|Up to Year 3|Lost to Follow-up|4|||
144626266|NCT01262976|521489514|FG003|Up to Year 3|Lost to Follow-up|3|||
144626267|NCT01262976|521489515|FG004|Up to Year 3|Lost to Follow-up|1|||
144626268|NCT01262976|521489516|FG005|Up to Year 3|Lost to Follow-up|3|||
144626269|NCT01262976|521489511|FG000|Up to Year 3|Subjects with unknown completion status|0|||
144626270|NCT01262976|521489512|FG001|Up to Year 3|Subjects with unknown completion status|0|||
144626271|NCT01262976|521489513|FG002|Up to Year 3|Subjects with unknown completion status|1|||
144626272|NCT01262976|521489514|FG003|Up to Year 3|Subjects with unknown completion status|0|||
144626273|NCT01262976|521489515|FG004|Up to Year 3|Subjects with unknown completion status|0|||
144626274|NCT01262976|521489516|FG005|Up to Year 3|Subjects with unknown completion status|0|||
144626275|NCT01262976|521489511|FG000|Up to Year 3|Other|3|||
144626276|NCT01262976|521489512|FG001|Up to Year 3|Other|0|||
144626277|NCT01262976|521489513|FG002|Up to Year 3|Other|0|||
144626278|NCT01262976|521489514|FG003|Up to Year 3|Other|0|||
144626279|NCT01262976|521489515|FG004|Up to Year 3|Other|0|||
144626280|NCT01262976|521489516|FG005|Up to Year 3|Other|0|||
144626281|NCT02400255|521489517|FG000|Overall Study|Relapse|4|||
144626282|NCT02400255|521489518|FG001|Overall Study|Relapse|1|||
144626283|NCT02400255|521489519|FG002|Overall Study|Relapse|1|||
144626284|NCT02400255|521489520|FG003|Overall Study|Relapse|2|||
144209700|NCT00789737|519962024|FG000|Overall Study|Withdrawal by Subject|13|||
144586555|NCT00320528|521345509|FG002|Study Period III|Protocol Violation|0|||
144586556|NCT00320528|521345507|FG000|Study Period III|Physician Decision|0|||
144586557|NCT00320528|521345508|FG001|Study Period III|Physician Decision|1|||
144586558|NCT00320528|521345509|FG002|Study Period III|Physician Decision|2|||
144586559|NCT00320528|521345507|FG000|Study Period III|Sponsor Decision|0|||
144586560|NCT00320528|521345508|FG001|Study Period III|Sponsor Decision|0|||
144586561|NCT00320528|521345509|FG002|Study Period III|Sponsor Decision|1|||
144586562|NCT00320528|521345507|FG000|Study Period III|Atomoxetine Commercially Available|68|||
144586563|NCT00320528|521345508|FG001|Study Period III|Atomoxetine Commercially Available|25|||
144586564|NCT00320528|521345509|FG002|Study Period III|Atomoxetine Commercially Available|90|||
144586565|NCT04540887|521345517|FG000|Overall Study|Withdrawal by Subject|2|||
144586566|NCT00513305|521345518|FG000|Overall Study|Adverse Event|6|||
144586567|NCT00513305|521345519|FG001|Overall Study|Adverse Event|2|||
144586568|NCT00513305|521345518|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
144586569|NCT00513305|521345519|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
144586570|NCT00513305|521345518|FG000|Overall Study|Lack of Efficacy|8|||
144586571|NCT00513305|521345519|FG001|Overall Study|Lack of Efficacy|13|||
144586572|NCT00513305|521345518|FG000|Overall Study|Withdrawal by Subject|1|||
144586573|NCT00513305|521345519|FG001|Overall Study|Withdrawal by Subject|2|||
144586574|NCT00513305|521345518|FG000|Overall Study|Disease progression|8|||
144586575|NCT00513305|521345519|FG001|Overall Study|Disease progression|5|||
144586576|NCT00513305|521345518|FG000|Overall Study|Eligible for stem cell transplant|1|||
144586577|NCT00513305|521345519|FG001|Overall Study|Eligible for stem cell transplant|0|||
144586578|NCT00513305|521345518|FG000|Overall Study|Hematologic counts did not recover|1|||
144586579|NCT00513305|521345519|FG001|Overall Study|Hematologic counts did not recover|0|||
144586580|NCT00513305|521345518|FG000|Overall Study|Physician Decision|1|||
144586581|NCT00513305|521345519|FG001|Overall Study|Physician Decision|0|||
144586582|NCT00513305|521345518|FG000|Overall Study|Persistent hypocellularity|0|||
144586583|NCT00513305|521345519|FG001|Overall Study|Persistent hypocellularity|1|||
144586584|NCT00513305|521345518|FG000|Overall Study|Sponsor Decision|0|||
144586585|NCT00513305|521345519|FG001|Overall Study|Sponsor Decision|2|||
144586586|NCT01262027|521345520|FG000|Overall Study|Adverse Event|1|||
144586587|NCT01262027|521345520|FG000|Overall Study|Withdrawal by Subject|3|||
144586588|NCT01262027|521345520|FG000|Overall Study|Protocol Violation|1|||
144586589|NCT03014479|521345521|FG000|Overall Study|Adverse Event|0|||
144586590|NCT03014479|521345522|FG001|Overall Study|Adverse Event|1|||
144586591|NCT03014479|521345521|FG000|Overall Study|Voluntary Withdrawal|0|||
144586592|NCT03014479|521345522|FG001|Overall Study|Voluntary Withdrawal|2|||
144586593|NCT03014479|521345521|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
144586594|NCT03014479|521345522|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
144586595|NCT02217501|521345528|FG000|Overall Study|Death|3|||
144586596|NCT02217501|521345529|FG001|Overall Study|Death|4|||
144586597|NCT01394978|521345530|FG000|Overall Study|Withdrawal by Subject|2|||
144586598|NCT01394978|521345531|FG001|Overall Study|Withdrawal by Subject|4|||
144586599|NCT01394978|521345530|FG000|Overall Study|Lost to Follow-up|13|||
144586600|NCT01394978|521345531|FG001|Overall Study|Lost to Follow-up|20|||
144586601|NCT01394978|521345530|FG000|Overall Study|Death|6|||
144586602|NCT01394978|521345531|FG001|Overall Study|Death|7|||
144586603|NCT02019667|521345532|FG000|First Intervention (6 Months)|Adverse Event|0|||
144586604|NCT02019667|521345533|FG001|First Intervention (6 Months)|Adverse Event|1|||
144586605|NCT02019667|521345532|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
144586606|NCT02019667|521345533|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
144586607|NCT02019667|521345532|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
144586608|NCT02019667|521345533|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
144586609|NCT01942785|521345534|FG000|Overall Study|Adverse Event|2|||
144586610|NCT01942785|521345534|FG000|Overall Study|Withdrawal by Subject|1|||
144586611|NCT01942785|521345534|FG000|Overall Study|Protocol Violation|1|||
144586612|NCT05038163|521345538|FG000|Stage 1|Did not complete survey|374|||
144586613|NCT05038163|521345539|FG001|Stage 1|Did not complete survey|0|||
144586614|NCT05038163|521345540|FG002|Stage 1|Did not complete survey|0|||
144586615|NCT05038163|521345541|FG003|Stage 1|Did not complete survey|0|||
144586616|NCT05038163|521345542|FG004|Stage 1|Did not complete survey|0|||
144586617|NCT05038163|521345543|FG005|Stage 1|Did not complete survey|0|||
144586618|NCT05038163|521345538|FG000|Stage 2|Did not complete Stage 2 survey|0|||
144586619|NCT05038163|521345539|FG001|Stage 2|Did not complete Stage 2 survey|29|||
144586620|NCT05038163|521345540|FG002|Stage 2|Did not complete Stage 2 survey|30|||
144586621|NCT05038163|521345541|FG003|Stage 2|Did not complete Stage 2 survey|24|||
144586622|NCT05038163|521345542|FG004|Stage 2|Did not complete Stage 2 survey|21|||
144586623|NCT05038163|521345543|FG005|Stage 2|Did not complete Stage 2 survey|100|||
144586624|NCT05453201|521345544|FG000|Overall Study|Withdrawal by Subject|1|||
144586625|NCT03798691|521345547|FG000|Overall Study|Lost to Follow-up|2|||
144209701|NCT00789737|519962025|FG001|Overall Study|Withdrawal by Subject|22|||
144586626|NCT03798691|521345548|FG001|Overall Study|Lost to Follow-up|2|||
144586627|NCT00552929|521345549|FG000|Overall Study|Lost to Follow-up|0|||
144586628|NCT00552929|521345550|FG001|Overall Study|Lost to Follow-up|0|||
144209702|NCT00789737|519962024|FG000|Overall Study|Lost to Follow-up|10|||
144209703|NCT00789737|519962025|FG001|Overall Study|Lost to Follow-up|14|||
144586629|NCT00552929|521345551|FG002|Overall Study|Lost to Follow-up|0|||
144586630|NCT00552929|521345552|FG003|Overall Study|Lost to Follow-up|0|||
144586631|NCT00552929|521345553|FG004|Overall Study|Lost to Follow-up|0|||
144586632|NCT00552929|521345554|FG005|Overall Study|Lost to Follow-up|0|||
144586633|NCT00552929|521345555|FG006|Overall Study|Lost to Follow-up|0|||
144586634|NCT00552929|521345556|FG007|Overall Study|Lost to Follow-up|0|||
144586635|NCT00552929|521345557|FG008|Overall Study|Lost to Follow-up|1|||
144586636|NCT00552929|521345558|FG009|Overall Study|Lost to Follow-up|0|||
144586637|NCT00552929|521345549|FG000|Overall Study|Not Eligible|0|||
144586638|NCT00552929|521345550|FG001|Overall Study|Not Eligible|0|||
144586639|NCT00552929|521345551|FG002|Overall Study|Not Eligible|0|||
144586640|NCT00552929|521345552|FG003|Overall Study|Not Eligible|0|||
144586641|NCT00552929|521345553|FG004|Overall Study|Not Eligible|0|||
144586642|NCT00552929|521345554|FG005|Overall Study|Not Eligible|1|||
144586643|NCT00552929|521345555|FG006|Overall Study|Not Eligible|0|||
144586644|NCT00552929|521345556|FG007|Overall Study|Not Eligible|0|||
144626285|NCT02400255|521489517|FG000|Overall Study|Adverse Event|6|||
144626286|NCT02400255|521489518|FG001|Overall Study|Adverse Event|3|||
144626287|NCT02400255|521489519|FG002|Overall Study|Adverse Event|0|||
144626288|NCT02400255|521489520|FG003|Overall Study|Adverse Event|0|||
144626289|NCT02400255|521489517|FG000|Overall Study|Physician Decision|6|||
144626290|NCT02400255|521489518|FG001|Overall Study|Physician Decision|0|||
144626291|NCT02400255|521489519|FG002|Overall Study|Physician Decision|0|||
144626292|NCT02400255|521489520|FG003|Overall Study|Physician Decision|0|||
144626293|NCT02400255|521489517|FG000|Overall Study|Loss of insurance|1|||
144626294|NCT02400255|521489518|FG001|Overall Study|Loss of insurance|0|||
144626295|NCT02400255|521489519|FG002|Overall Study|Loss of insurance|0|||
144626296|NCT02400255|521489520|FG003|Overall Study|Loss of insurance|0|||
144626297|NCT03261531|521489521|FG000|Overall Study|Withdrawal by Subject|4|||
144626298|NCT02435914|521489524|FG000|Overall Study|Ocular Adverse Event|1|||
144626299|NCT02435914|521489525|FG001|Overall Study|Ocular Adverse Event|0|||
144626300|NCT02435914|521489526|FG002|Overall Study|Ocular Adverse Event|0|||
144626301|NCT02435914|521489527|FG003|Overall Study|Ocular Adverse Event|0|||
144626302|NCT02435914|521489524|FG000|Overall Study|Withdrawal by Subject|0|||
144626303|NCT02435914|521489525|FG001|Overall Study|Withdrawal by Subject|1|||
144626304|NCT02435914|521489526|FG002|Overall Study|Withdrawal by Subject|0|||
144626305|NCT02435914|521489527|FG003|Overall Study|Withdrawal by Subject|0|||
144626306|NCT02435914|521489524|FG000|Overall Study|Other Miscellaneous Reason|0|||
144626307|NCT02435914|521489525|FG001|Overall Study|Other Miscellaneous Reason|0|||
144626308|NCT02435914|521489526|FG002|Overall Study|Other Miscellaneous Reason|1|||
144626309|NCT02435914|521489527|FG003|Overall Study|Other Miscellaneous Reason|0|||
144626310|NCT04871711|521489541|FG000|Overall Study|Withdrawal by Subject|11|||
144626311|NCT04871711|521489542|FG001|Overall Study|Withdrawal by Subject|5|||
144626312|NCT04871711|521489541|FG000|Overall Study|Lack of Efficacy|5|||
144626313|NCT04871711|521489542|FG001|Overall Study|Lack of Efficacy|7|||
144626314|NCT04871711|521489541|FG000|Overall Study|Adverse Event|2|||
144626315|NCT04871711|521489542|FG001|Overall Study|Adverse Event|6|||
144626316|NCT04871711|521489541|FG000|Overall Study|Various reasons|2|||
144626317|NCT04871711|521489542|FG001|Overall Study|Various reasons|1|||
144626318|NCT04871711|521489541|FG000|Overall Study|Lost to Follow-up|0|||
144626319|NCT04871711|521489542|FG001|Overall Study|Lost to Follow-up|2|||
144626320|NCT03979274|521489543|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144626321|NCT03979274|521489544|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144626322|NCT01665144|521489545|FG000|Core Part|Withdrawal by Subject|96|||
144626323|NCT01665144|521489546|FG001|Core Part|Withdrawal by Subject|77|||
144626324|NCT01665144|521489547|FG002|Core Part|Withdrawal by Subject|0|||
144626325|NCT01665144|521489545|FG000|Core Part|Adverse Event|45|||
144626326|NCT01665144|521489546|FG001|Core Part|Adverse Event|18|||
144626327|NCT01665144|521489547|FG002|Core Part|Adverse Event|0|||
144626328|NCT01665144|521489545|FG000|Core Part|Lack of Efficacy|16|||
144626329|NCT01665144|521489546|FG001|Core Part|Lack of Efficacy|11|||
144626330|NCT01665144|521489547|FG002|Core Part|Lack of Efficacy|0|||
144626331|NCT01665144|521489545|FG000|Core Part|Lost to Follow-up|9|||
144626332|NCT01665144|521489546|FG001|Core Part|Lost to Follow-up|8|||
144626333|NCT01665144|521489547|FG002|Core Part|Lost to Follow-up|0|||
144626334|NCT01665144|521489545|FG000|Core Part|Physician Decision|13|||
144626335|NCT01665144|521489546|FG001|Core Part|Physician Decision|1|||
144626336|NCT01665144|521489547|FG002|Core Part|Physician Decision|0|||
144626337|NCT01665144|521489545|FG000|Core Part|Progressive disease|8|||
144626338|NCT01665144|521489546|FG001|Core Part|Progressive disease|4|||
144626339|NCT01665144|521489547|FG002|Core Part|Progressive disease|0|||
144209704|NCT00789737|519962024|FG000|Overall Study|Adverse Event|8|||
144586645|NCT00552929|521345557|FG008|Overall Study|Not Eligible|0|||
144586646|NCT00552929|521345558|FG009|Overall Study|Not Eligible|0|||
144626340|NCT01665144|521489545|FG000|Core Part|Non-compliance with study treatment|5|||
144626341|NCT01665144|521489546|FG001|Core Part|Non-compliance with study treatment|0|||
144626342|NCT01665144|521489547|FG002|Core Part|Non-compliance with study treatment|0|||
144626343|NCT01665144|521489545|FG000|Core Part|Death|3|||
144626344|NCT01665144|521489546|FG001|Core Part|Death|1|||
144626345|NCT01665144|521489547|FG002|Core Part|Death|0|||
144626346|NCT01665144|521489545|FG000|Core Part|Protocol deviation|3|||
144626347|NCT01665144|521489546|FG001|Core Part|Protocol deviation|1|||
144626348|NCT01665144|521489547|FG002|Core Part|Protocol deviation|0|||
144626349|NCT01665144|521489545|FG000|Core Part|New therapy for study indication|2|||
144626350|NCT01665144|521489546|FG001|Core Part|New therapy for study indication|1|||
144626351|NCT01665144|521489547|FG002|Core Part|New therapy for study indication|0|||
144626352|NCT01665144|521489545|FG000|Core Part|Technical problems|2|||
144626353|NCT01665144|521489546|FG001|Core Part|Technical problems|0|||
144626354|NCT01665144|521489547|FG002|Core Part|Technical problems|0|||
144626355|NCT01665144|521489545|FG000|Extension Part|Patient/guardian decision|180|||
144626356|NCT01665144|521489546|FG001|Extension Part|Patient/guardian decision|0|||
144626357|NCT01665144|521489547|FG002|Extension Part|Patient/guardian decision|98|||
144626358|NCT01665144|521489545|FG000|Extension Part|Adverse Event|104|||
144626359|NCT01665144|521489546|FG001|Extension Part|Adverse Event|0|||
144626360|NCT01665144|521489547|FG002|Extension Part|Adverse Event|59|||
144626361|NCT01665144|521489545|FG000|Extension Part|Study closed early|42|||
144626362|NCT01665144|521489546|FG001|Extension Part|Study closed early|0|||
144626363|NCT01665144|521489547|FG002|Extension Part|Study closed early|19|||
144626364|NCT01665144|521489545|FG000|Extension Part|Progressive disease|36|||
144626365|NCT01665144|521489546|FG001|Extension Part|Progressive disease|0|||
144626366|NCT01665144|521489547|FG002|Extension Part|Progressive disease|14|||
144626367|NCT01665144|521489545|FG000|Extension Part|Lack of Efficacy|37|||
144626368|NCT01665144|521489546|FG001|Extension Part|Lack of Efficacy|0|||
144626369|NCT01665144|521489547|FG002|Extension Part|Lack of Efficacy|12|||
144626370|NCT01665144|521489545|FG000|Extension Part|Physician Decision|29|||
144626371|NCT01665144|521489546|FG001|Extension Part|Physician Decision|0|||
144626372|NCT01665144|521489547|FG002|Extension Part|Physician Decision|13|||
144626373|NCT01665144|521489545|FG000|Extension Part|Technical problems|20|||
144626374|NCT01665144|521489546|FG001|Extension Part|Technical problems|0|||
144626375|NCT01665144|521489547|FG002|Extension Part|Technical problems|8|||
144626376|NCT01665144|521489545|FG000|Extension Part|Death|20|||
144626377|NCT01665144|521489546|FG001|Extension Part|Death|0|||
144209705|NCT00789737|519962025|FG001|Overall Study|Adverse Event|8|||
144209706|NCT00789737|519962024|FG000|Overall Study|Protocol Violation|3|||
144626378|NCT01665144|521489547|FG002|Extension Part|Death|4|||
144626379|NCT01665144|521489545|FG000|Extension Part|Missing|12|||
144626380|NCT01665144|521489546|FG001|Extension Part|Missing|0|||
144626381|NCT01665144|521489547|FG002|Extension Part|Missing|6|||
144626382|NCT01665144|521489545|FG000|Extension Part|Lost to Follow-up|9|||
144626383|NCT01665144|521489546|FG001|Extension Part|Lost to Follow-up|0|||
144626384|NCT01665144|521489547|FG002|Extension Part|Lost to Follow-up|5|||
144626385|NCT01665144|521489545|FG000|Extension Part|New therapy for study indication|3|||
144626386|NCT01665144|521489546|FG001|Extension Part|New therapy for study indication|0|||
144626387|NCT01665144|521489547|FG002|Extension Part|New therapy for study indication|2|||
144626388|NCT01665144|521489545|FG000|Extension Part|Protocol deviation|3|||
144626389|NCT01665144|521489546|FG001|Extension Part|Protocol deviation|0|||
144626390|NCT01665144|521489547|FG002|Extension Part|Protocol deviation|0|||
144626391|NCT01913483|521489548|FG000|Overall Study|Withdrawal by Subject|1|||
144626392|NCT01913483|521489549|FG001|Overall Study|Withdrawal by Subject|2|||
144626393|NCT01913483|521489548|FG000|Overall Study|Lost to Follow-up|6|||
144626394|NCT01913483|521489549|FG001|Overall Study|Lost to Follow-up|3|||
144626395|NCT01913483|521489548|FG000|Overall Study|Death|14|||
144626396|NCT01913483|521489549|FG001|Overall Study|Death|17|||
144626397|NCT01816243|521489552|FG000|Overall Study|Adverse Event|6|||
144626398|NCT01816243|521489552|FG000|Overall Study|Lost to Follow-up|1|||
144626399|NCT01816243|521489552|FG000|Overall Study|Lack of Efficacy|1|||
144626400|NCT01816243|521489552|FG000|Overall Study|Not eligible for the study|1|||
144626401|NCT01816243|521489552|FG000|Overall Study|Amputation|3|||
144626402|NCT03434379|521489556|FG000|Global Period|Lost to Follow-up|3|||
144626403|NCT03434379|521489557|FG001|Global Period|Lost to Follow-up|6|||
144626404|NCT03434379|521489558|FG002|Global Period|Lost to Follow-up|0|||
144626405|NCT03434379|521489559|FG003|Global Period|Lost to Follow-up|0|||
144626406|NCT03434379|521489556|FG000|Global Period|Death|115|||
144626407|NCT03434379|521489557|FG001|Global Period|Death|228|||
144626408|NCT03434379|521489558|FG002|Global Period|Death|0|||
144626409|NCT03434379|521489559|FG003|Global Period|Death|0|||
144626410|NCT03434379|521489556|FG000|Global Period|Withdrawal by Subject|20|||
144626411|NCT03434379|521489557|FG001|Global Period|Withdrawal by Subject|21|||
144626412|NCT03434379|521489558|FG002|Global Period|Withdrawal by Subject|0|||
144209707|NCT00789737|519962025|FG001|Overall Study|Protocol Violation|0|||
144626413|NCT03434379|521489559|FG003|Global Period|Withdrawal by Subject|0|||
144626414|NCT03434379|521489556|FG000|Global Period|Reason Unspecified|0|||
144626415|NCT03434379|521489557|FG001|Global Period|Reason Unspecified|1|||
144626416|NCT03434379|521489558|FG002|Global Period|Reason Unspecified|0|||
144626417|NCT03434379|521489559|FG003|Global Period|Reason Unspecified|0|||
144626418|NCT03434379|521489556|FG000|Global Period|Study Ended by Sponsor|26|||
144626419|NCT03434379|521489557|FG001|Global Period|Study Ended by Sponsor|80|||
144626420|NCT03434379|521489558|FG002|Global Period|Study Ended by Sponsor|0|||
144626421|NCT03434379|521489559|FG003|Global Period|Study Ended by Sponsor|0|||
144626422|NCT03434379|521489556|FG000|Global Period|Physician Decision|1|||
144626423|NCT03434379|521489557|FG001|Global Period|Physician Decision|0|||
144626424|NCT03434379|521489558|FG002|Global Period|Physician Decision|0|||
144626425|NCT03434379|521489559|FG003|Global Period|Physician Decision|0|||
144626426|NCT03434379|521489556|FG000|China Extension Period|Lost to Follow-up|0|||
144626427|NCT03434379|521489557|FG001|China Extension Period|Lost to Follow-up|0|||
144626428|NCT03434379|521489558|FG002|China Extension Period|Lost to Follow-up|2|||
144626429|NCT03434379|521489559|FG003|China Extension Period|Lost to Follow-up|3|||
144626430|NCT03434379|521489556|FG000|China Extension Period|Death|0|||
144626431|NCT03434379|521489557|FG001|China Extension Period|Death|0|||
144626432|NCT03434379|521489558|FG002|China Extension Period|Death|46|||
144626433|NCT03434379|521489559|FG003|China Extension Period|Death|88|||
144626434|NCT03434379|521489556|FG000|China Extension Period|Withdrawal by Subject|0|||
144626435|NCT03434379|521489557|FG001|China Extension Period|Withdrawal by Subject|0|||
144626436|NCT03434379|521489558|FG002|China Extension Period|Withdrawal by Subject|8|||
144626437|NCT03434379|521489559|FG003|China Extension Period|Withdrawal by Subject|6|||
144626438|NCT03434379|521489556|FG000|China Extension Period|Study Ended by Sponsor|0|||
144626439|NCT03434379|521489557|FG001|China Extension Period|Study Ended by Sponsor|0|||
144626440|NCT03434379|521489558|FG002|China Extension Period|Study Ended by Sponsor|5|||
144626441|NCT03434379|521489559|FG003|China Extension Period|Study Ended by Sponsor|36|||
144626442|NCT00573794|521489563|FG000|Overall Study|Adverse Event|81|||
144626443|NCT00573794|521489563|FG000|Overall Study|Withdrew Consent|90|||
144626444|NCT00573794|521489563|FG000|Overall Study|Lost to Follow-up|13|||
144626445|NCT00573794|521489563|FG000|Overall Study|Protocol Violation|6|||
144626446|NCT00573794|521489563|FG000|Overall Study|Lack of Efficacy|94|||
144626447|NCT00573794|521489563|FG000|Overall Study|Other|46|||
144626448|NCT02026063|521489564|FG000|Overall Study|Physician Decision|0|||
144626449|NCT02026063|521489565|FG001|Overall Study|Physician Decision|10|||
144626450|NCT02026063|521489564|FG000|Overall Study|Noncompliance with Study Drug|1|||
144626451|NCT02026063|521489565|FG001|Overall Study|Noncompliance with Study Drug|1|||
144626452|NCT02026063|521489564|FG000|Overall Study|Withdrawal of Consent|1|||
144626453|NCT02026063|521489565|FG001|Overall Study|Withdrawal of Consent|6|||
144626454|NCT02026063|521489564|FG000|Overall Study|Adverse Event|5|||
144626455|NCT02026063|521489565|FG001|Overall Study|Adverse Event|20|||
144626456|NCT02026063|521489564|FG000|Overall Study|Lack of Efficacy|0|||
144626457|NCT02026063|521489565|FG001|Overall Study|Lack of Efficacy|4|||
144626458|NCT02026063|521489564|FG000|Overall Study|Lost to Follow-up|0|||
144626459|NCT02026063|521489565|FG001|Overall Study|Lost to Follow-up|1|||
144626460|NCT02026063|521489564|FG000|Overall Study|Reason not Specified|2|||
144626461|NCT02026063|521489565|FG001|Overall Study|Reason not Specified|7|||
144626462|NCT02154087|521489567|FG000|Overall Study|Study Termination|1|||
144626463|NCT00486278|521489572|FG000|Overall Study|Adverse Event|5|||
144626464|NCT00486278|521489572|FG000|Overall Study|Withdrawal by Subject|2|||
144626465|NCT00486278|521489572|FG000|Overall Study|Physician Decision|2|||
144626466|NCT04556617|521489578|FG000|Overall Study|progressive disease|0|||
144626467|NCT04556617|521489579|FG001|Overall Study|progressive disease|2|||
144626468|NCT04556617|521489580|FG002|Overall Study|progressive disease|2|||
144626469|NCT04556617|521489581|FG003|Overall Study|progressive disease|1|||
144626470|NCT04556617|521489582|FG004|Overall Study|progressive disease|1|||
144626471|NCT04556617|521489578|FG000|Overall Study|Physician Decision|0|||
144626472|NCT04556617|521489579|FG001|Overall Study|Physician Decision|0|||
144626473|NCT04556617|521489580|FG002|Overall Study|Physician Decision|2|||
144626474|NCT04556617|521489581|FG003|Overall Study|Physician Decision|0|||
144626475|NCT04556617|521489582|FG004|Overall Study|Physician Decision|0|||
144626476|NCT04556617|521489578|FG000|Overall Study|Adverse Event|0|||
144626477|NCT04556617|521489579|FG001|Overall Study|Adverse Event|0|||
144626478|NCT04556617|521489580|FG002|Overall Study|Adverse Event|2|||
144626479|NCT04556617|521489581|FG003|Overall Study|Adverse Event|3|||
144626480|NCT04556617|521489582|FG004|Overall Study|Adverse Event|0|||
144626481|NCT04556617|521489578|FG000|Overall Study|Withdrawal by Subject|0|||
144626482|NCT04556617|521489579|FG001|Overall Study|Withdrawal by Subject|2|||
144626483|NCT04556617|521489580|FG002|Overall Study|Withdrawal by Subject|1|||
144626484|NCT04556617|521489581|FG003|Overall Study|Withdrawal by Subject|1|||
144626485|NCT04556617|521489582|FG004|Overall Study|Withdrawal by Subject|0|||
144626486|NCT04556617|521489578|FG000|Overall Study|PSA increase|0|||
144209708|NCT00789737|519962024|FG000|Overall Study|Lack of Efficacy|3|||
144626487|NCT04556617|521489579|FG001|Overall Study|PSA increase|1|||
144626488|NCT04556617|521489580|FG002|Overall Study|PSA increase|0|||
144626489|NCT04556617|521489581|FG003|Overall Study|PSA increase|0|||
144626490|NCT04556617|521489582|FG004|Overall Study|PSA increase|0|||
144626491|NCT04556617|521489578|FG000|Overall Study|Sponsor study termination|1|||
144626492|NCT04556617|521489579|FG001|Overall Study|Sponsor study termination|0|||
144626493|NCT04556617|521489580|FG002|Overall Study|Sponsor study termination|0|||
144626494|NCT04556617|521489581|FG003|Overall Study|Sponsor study termination|0|||
144626495|NCT04556617|521489582|FG004|Overall Study|Sponsor study termination|0|||
144626496|NCT05168267|521489583|FG000|Overall Study|Withdrawal by Subject|2|||
144626497|NCT05168267|521489584|FG001|Overall Study|Withdrawal by Subject|1|||
144626498|NCT05168267|521489583|FG000|Overall Study|Withdrawn by Therapist|1|||
144626499|NCT05168267|521489584|FG001|Overall Study|Withdrawn by Therapist|1|||
144626500|NCT05168267|521489583|FG000|Overall Study|Left Facility|1|||
144626501|NCT05168267|521489584|FG001|Overall Study|Left Facility|0|||
144626502|NCT05702736|521489585|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
144626503|NCT05702736|521489586|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
144626504|NCT05702736|521489585|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
144626505|NCT05702736|521489586|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
144626506|NCT00695565|521489589|FG000|Overall Study|Lost to Follow-up|4|||
144626507|NCT00695565|521489590|FG001|Overall Study|Lost to Follow-up|4|||
144626508|NCT00695565|521489589|FG000|Overall Study|Adverse Event|3|||
144626509|NCT00695565|521489590|FG001|Overall Study|Adverse Event|1|||
144626510|NCT00695565|521489589|FG000|Overall Study|Protocol Violation|3|||
144626511|NCT00695565|521489590|FG001|Overall Study|Protocol Violation|1|||
144626512|NCT00695565|521489589|FG000|Overall Study|Withdrawal by Subject|1|||
144626513|NCT00695565|521489590|FG001|Overall Study|Withdrawal by Subject|1|||
144626514|NCT00695565|521489589|FG000|Overall Study|Lack of Efficacy|1|||
144626515|NCT00695565|521489590|FG001|Overall Study|Lack of Efficacy|1|||
144626516|NCT00695565|521489589|FG000|Overall Study|Subject did not follow instructions|1|||
144626517|NCT00695565|521489590|FG001|Overall Study|Subject did not follow instructions|1|||
144626518|NCT02937350|521489591|FG000|Overall Study|Withdrawal by Subject|0|||
144626519|NCT02937350|521489592|FG001|Overall Study|Withdrawal by Subject|1|||
144626520|NCT02937350|521489593|FG002|Overall Study|Withdrawal by Subject|0|||
144626521|NCT01462266|521489594|FG000|Overall Study|Adverse Event|7|||
144626522|NCT01462266|521489595|FG001|Overall Study|Adverse Event|6|||
144626523|NCT01462266|521489594|FG000|Overall Study|Death|2|||
144626524|NCT01462266|521489595|FG001|Overall Study|Death|1|||
144626525|NCT01462266|521489594|FG000|Overall Study|Lack of Efficacy|0|||
144626526|NCT01462266|521489595|FG001|Overall Study|Lack of Efficacy|2|||
144626527|NCT01462266|521489594|FG000|Overall Study|Lost to Follow-up|4|||
144626528|NCT01462266|521489595|FG001|Overall Study|Lost to Follow-up|3|||
144626529|NCT01462266|521489594|FG000|Overall Study|Non-compliance with study drug|3|||
144626530|NCT01462266|521489595|FG001|Overall Study|Non-compliance with study drug|0|||
144626531|NCT01462266|521489594|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
144626532|NCT01462266|521489595|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
144626533|NCT01462266|521489594|FG000|Overall Study|Physician Decision|2|||
144626534|NCT01462266|521489595|FG001|Overall Study|Physician Decision|5|||
144626535|NCT01462266|521489594|FG000|Overall Study|Protocol Violation|1|||
144626536|NCT01462266|521489595|FG001|Overall Study|Protocol Violation|3|||
144626537|NCT01462266|521489594|FG000|Overall Study|Withdrawal by Subject|7|||
144626538|NCT01462266|521489595|FG001|Overall Study|Withdrawal by Subject|2|||
144626539|NCT01462266|521489594|FG000|Overall Study|Screen failure|1|||
144626540|NCT01462266|521489595|FG001|Overall Study|Screen failure|1|||
144626541|NCT01106846|521489596|FG000|Overall Study|Change in surgical procedure|0|||
144626542|NCT01106846|521489597|FG001|Overall Study|Change in surgical procedure|1|||
144626543|NCT00803179|521489601|FG000|Overall Study|Lost to Follow-up|3|||
144626544|NCT02419508|521489604|FG000|Overall Study|Adverse Event|9|||
144626545|NCT02419508|521489605|FG001|Overall Study|Adverse Event|3|||
144626546|NCT02419508|521489604|FG000|Overall Study|Withdrawal by Subject|1|||
144626547|NCT02419508|521489605|FG001|Overall Study|Withdrawal by Subject|0|||
144626548|NCT02419508|521489604|FG000|Overall Study|Other - Reason not specified|0|||
144626549|NCT02419508|521489605|FG001|Overall Study|Other - Reason not specified|1|||
144626550|NCT03110900|521489606|FG000|Overall Study|Sponsor withdrew|1|||
144626551|NCT03110900|521489607|FG001|Overall Study|Sponsor withdrew|1|||
144626552|NCT02320487|521489610|FG000|Overall Study|Reason not Specified|1|||
144626553|NCT02320487|521489610|FG000|Overall Study|Physician Decision|5|||
144626554|NCT02320487|521489610|FG000|Overall Study|Withdrawal by Subject|1|||
144626555|NCT02320487|521489610|FG000|Overall Study|Death|3|||
144626556|NCT02320487|521489610|FG000|Overall Study|Adverse Event|11|||
144626557|NCT03344003|521489611|FG000|Overall Study|Switched to alternative treatment|1|||
144626558|NCT03344003|521489612|FG001|Overall Study|Switched to alternative treatment|0|||
144626559|NCT03344003|521489611|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
144626560|NCT03344003|521489612|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
144626561|NCT06228586|521489613|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
144626562|NCT06228586|521489614|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
144626563|NCT01182428|521489615|FG000|Overall Study|Physician Decision|1|||
144626564|NCT01182428|521489616|FG001|Overall Study|Physician Decision|0|||
144626565|NCT01182428|521489615|FG000|Overall Study|Lost to Follow-up|9|||
144626566|NCT01182428|521489616|FG001|Overall Study|Lost to Follow-up|1|||
144626567|NCT01182428|521489615|FG000|Overall Study|Withdrawal by Subject|1|||
144626568|NCT01182428|521489616|FG001|Overall Study|Withdrawal by Subject|0|||
144626569|NCT00865020|521489619|FG000|Overall Study|Withdrawal by Subject|22|||
144626570|NCT00865020|521489620|FG001|Overall Study|Withdrawal by Subject|16|||
144626571|NCT00865020|521489619|FG000|Overall Study|Adverse Event|9|||
144626572|NCT00865020|521489620|FG001|Overall Study|Adverse Event|14|||
144626573|NCT00865020|521489619|FG000|Overall Study|Abnormal test procedure result(s)|6|||
144626574|NCT00865020|521489620|FG001|Overall Study|Abnormal test procedure result(s)|8|||
144626575|NCT00865020|521489619|FG000|Overall Study|Lost to Follow-up|6|||
144626576|NCT00865020|521489620|FG001|Overall Study|Lost to Follow-up|4|||
144626577|NCT00865020|521489619|FG000|Overall Study|Protocol deviation|4|||
144626578|NCT00865020|521489620|FG001|Overall Study|Protocol deviation|1|||
144626579|NCT00865020|521489619|FG000|Overall Study|Administrative problems|0|||
144626580|NCT00865020|521489620|FG001|Overall Study|Administrative problems|2|||
144626581|NCT00865020|521489619|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144626582|NCT00865020|521489620|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144626583|NCT00865020|521489619|FG000|Overall Study|Death|0|||
144626584|NCT00865020|521489620|FG001|Overall Study|Death|1|||
144626585|NCT00865020|521489619|FG000|Overall Study|Randomized but discontinued|2|||
144626586|NCT00865020|521489620|FG001|Overall Study|Randomized but discontinued|4|||
144626587|NCT00684957|521489621|FG000|Overall Study|Withdrawal by Subject|1|||
144626588|NCT00684957|521489622|FG001|Overall Study|Withdrawal by Subject|1|||
144626589|NCT00684957|521489621|FG000|Overall Study|Lost to Follow-up|1|||
144626590|NCT00684957|521489622|FG001|Overall Study|Lost to Follow-up|0|||
144586647|NCT01147536|521345562|FG000|Overall Study|Administrative study close|2|||
144586648|NCT01147536|521345562|FG000|Overall Study|Death|1|||
144586649|NCT03762200|521345563|FG000|Overall Study|Death|2|||
144586650|NCT05110690|521345568|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
144586651|NCT05110690|521345568|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
144586652|NCT05110690|521345568|FG000|Completion of Intervention|Lost to Follow-up|1|||
144586653|NCT05110690|521345568|FG000|Completion of Intervention|Death|1|||
144586654|NCT05110690|521345568|FG000|Completion of Intervention|Withdrawal by Subject|2|||
144586655|NCT00055601|521346859|FG000|Overall Study|Protocol Violation|1|||
144586656|NCT00055601|521346860|FG001|Overall Study|Protocol Violation|1|||
144586657|NCT00055601|521346859|FG000|Overall Study|No protocol treatment received|1|||
144586658|NCT00055601|521346860|FG001|Overall Study|No protocol treatment received|1|||
144586659|NCT00275262|521346867|FG000|Overall Study|Adverse Event|2|||
144586660|NCT00275262|521346868|FG001|Overall Study|Adverse Event|0|||
144586661|NCT00275262|521346867|FG000|Overall Study|Disease progression|2|||
144586662|NCT00275262|521346868|FG001|Overall Study|Disease progression|5|||
144586663|NCT00275262|521346867|FG000|Overall Study|Lost to Follow-up|0|||
144586664|NCT00275262|521346868|FG001|Overall Study|Lost to Follow-up|2|||
144586665|NCT00275262|521346867|FG000|Overall Study|Protocol Violation|0|||
144586666|NCT00275262|521346868|FG001|Overall Study|Protocol Violation|2|||
144586667|NCT00275262|521346867|FG000|Overall Study|Death|1|||
144586668|NCT00275262|521346868|FG001|Overall Study|Death|0|||
144586669|NCT00275262|521346867|FG000|Overall Study|Started Chemotherapy|1|||
144586670|NCT00275262|521346868|FG001|Overall Study|Started Chemotherapy|0|||
144626591|NCT06272370|521491090|FG000|Overall Study|Lost to Follow-up|0|||
144626592|NCT06272370|521491091|FG001|Overall Study|Lost to Follow-up|3|||
144626593|NCT06272370|521491092|FG002|Overall Study|Lost to Follow-up|1|||
144586671|NCT02217332|521346871|FG000|Overall Study|Adverse Event|3|||
144586672|NCT02217332|521346871|FG000|Overall Study|Dose interruption >1 month|1|||
144586673|NCT02217332|521346871|FG000|Overall Study|Protocol Violation (eligibility)|1|||
144586674|NCT02217332|521346871|FG000|Overall Study|Withdrawal by Subject|1|||
144586675|NCT02217332|521346871|FG000|Overall Study|Lost to Follow-up|1|||
144586676|NCT00759915|521346876|FG000|Overall Study|Withdrawal by Subject|1|||
144626594|NCT06272370|521491093|FG003|Overall Study|Lost to Follow-up|1|||
144626595|NCT02363478|521491094|FG000|Overall Study|Lost to Follow-up|4|||
144626596|NCT02363478|521491094|FG000|Overall Study|Adverse Event|4|||
144626597|NCT02527707|521491095|FG000|Overall Study|Adverse Event|1|||
144626598|NCT02527707|521491095|FG000|Overall Study|Adverse Event|1|||
144626599|NCT00542997|521491096|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
144626600|NCT00542997|521491096|FG000|Wash in / Wash Out Period|Adverse Event|3|||
144626601|NCT00542997|521491096|FG000|Efficacy Period|Adverse Event|3|||
144626602|NCT00352534|521491097|FG000|Initial Staging|Ineligible|8|||
144626603|NCT00352534|521491098|FG001|Initial Staging|Ineligible|9|||
144626604|NCT00352534|521491099|FG002|Initial Staging|Ineligible|0|||
144626605|NCT00352534|521491100|FG003|Initial Staging|Ineligible|0|||
144626606|NCT00352534|521491101|FG004|Initial Staging|Ineligible|0|||
144626607|NCT00352534|521491102|FG005|Initial Staging|Ineligible|0|||
144626608|NCT00352534|521491103|FG006|Initial Staging|Ineligible|0|||
144626609|NCT00352534|521491097|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
144626610|NCT00352534|521491098|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
144626611|NCT00352534|521491099|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
144626612|NCT00352534|521491100|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
144626613|NCT00352534|521491101|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
144626614|NCT00352534|521491102|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
144626615|NCT00352534|521491103|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
144626616|NCT00352534|521491097|FG000|Final Risk Group Assignment|Physician Decision|0|||
144626617|NCT00352534|521491098|FG001|Final Risk Group Assignment|Physician Decision|0|||
144626618|NCT00352534|521491099|FG002|Final Risk Group Assignment|Physician Decision|0|||
144626619|NCT00352534|521491100|FG003|Final Risk Group Assignment|Physician Decision|0|||
144209709|NCT00789737|519962025|FG001|Overall Study|Lack of Efficacy|0|||
144209710|NCT00789737|519962024|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
144209711|NCT00789737|519962025|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
144209712|NCT00789737|519962024|FG000|Overall Study|Other|11|||
144209713|NCT00789737|519962025|FG001|Overall Study|Other|7|||
144626620|NCT00352534|521491101|FG004|Final Risk Group Assignment|Physician Decision|0|||
144626621|NCT00352534|521491102|FG005|Final Risk Group Assignment|Physician Decision|8|||
144626622|NCT00352534|521491103|FG006|Final Risk Group Assignment|Physician Decision|0|||
144626623|NCT00352534|521491097|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
144626624|NCT00352534|521491098|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
144626625|NCT00352534|521491099|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
144626626|NCT00352534|521491100|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
144626627|NCT00352534|521491101|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
144626628|NCT00352534|521491102|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
144626629|NCT00352534|521491103|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
144626630|NCT00352534|521491097|FG000|Final Risk Group Assignment|Ineligible|0|||
144626631|NCT00352534|521491098|FG001|Final Risk Group Assignment|Ineligible|0|||
144626632|NCT00352534|521491099|FG002|Final Risk Group Assignment|Ineligible|3|||
144626633|NCT00352534|521491100|FG003|Final Risk Group Assignment|Ineligible|1|||
144626634|NCT00352534|521491101|FG004|Final Risk Group Assignment|Ineligible|0|||
144626635|NCT00352534|521491102|FG005|Final Risk Group Assignment|Ineligible|13|||
144626636|NCT00352534|521491103|FG006|Final Risk Group Assignment|Ineligible|0|||
144626637|NCT00352534|521491097|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
144626638|NCT00352534|521491098|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
144626639|NCT00352534|521491099|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
144626640|NCT00352534|521491100|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
144626641|NCT00352534|521491101|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
144626642|NCT00352534|521491102|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
144626643|NCT00352534|521491103|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
144626644|NCT00352534|521491097|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
144586677|NCT00759915|521346877|FG001|Overall Study|Withdrawal by Subject|0|||
144586678|NCT00759915|521346876|FG000|Overall Study|Adverse Event|0|||
144586679|NCT00759915|521346877|FG001|Overall Study|Adverse Event|1|||
144586680|NCT03527173|521346878|FG000|Overall Study|Lost to Follow-up|4|||
144586681|NCT03527173|521346879|FG001|Overall Study|Lost to Follow-up|2|||
144586682|NCT03527173|521346878|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
144586683|NCT03527173|521346879|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
144586684|NCT03527173|521346878|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
144586685|NCT03527173|521346879|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
144586686|NCT03527173|521346878|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
144586687|NCT03527173|521346879|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144586688|NCT01664598|521346880|FG000|Overall Study|Sponsor Decision|1|||
144586689|NCT01664598|521346880|FG000|Overall Study|Withdrawal of Informed Consent|4|||
144586690|NCT01664598|521346880|FG000|Overall Study|Adverse Event|1|||
144586691|NCT01658150|521346881|FG000|Overall Study|Withdrawal by Subject|1|||
144586692|NCT03602066|521346882|FG000|Overall Study|Withdrawal by Subject|2|||
144586693|NCT03602066|521346883|FG001|Overall Study|Withdrawal by Subject|0|||
144586694|NCT03602066|521346882|FG000|Overall Study|Physician Decision|1|||
144586695|NCT03602066|521346883|FG001|Overall Study|Physician Decision|0|||
144586696|NCT03245151|521346884|FG000|Overall Study|Withdrawal by Subject|2|||
144586697|NCT03245151|521346885|FG001|Overall Study|Withdrawal by Subject|0|||
144586698|NCT03245151|521346886|FG002|Overall Study|Withdrawal by Subject|0|||
144586699|NCT03245151|521346887|FG003|Overall Study|Withdrawal by Subject|2|||
144586700|NCT03245151|521346888|FG004|Overall Study|Withdrawal by Subject|1|||
144586701|NCT03245151|521346884|FG000|Overall Study|Death|3|||
144586702|NCT03245151|521346885|FG001|Overall Study|Death|14|||
144586703|NCT03245151|521346886|FG002|Overall Study|Death|9|||
144586704|NCT03245151|521346887|FG003|Overall Study|Death|16|||
144586705|NCT03245151|521346888|FG004|Overall Study|Death|7|||
144586706|NCT03245151|521346884|FG000|Overall Study|Sponsor's decision|0|||
144586707|NCT03245151|521346885|FG001|Overall Study|Sponsor's decision|1|||
144586708|NCT03245151|521346886|FG002|Overall Study|Sponsor's decision|0|||
144586709|NCT03245151|521346887|FG003|Overall Study|Sponsor's decision|0|||
144586710|NCT03245151|521346888|FG004|Overall Study|Sponsor's decision|0|||
144586711|NCT04772898|521346895|FG000|Overall Study|Withdrawal by Subject|0|||
144586712|NCT04772898|521346896|FG001|Overall Study|Withdrawal by Subject|1|||
144586713|NCT01004848|521346901|FG000|Overall Study|Lost to Follow-up|55|||
144586714|NCT01004848|521346902|FG001|Overall Study|Lost to Follow-up|45|||
144586715|NCT01631227|521346904|FG000|Overall Study|withdrawn consent|27|||
144586716|NCT01631227|521346905|FG001|Overall Study|withdrawn consent|21|||
144586717|NCT01631227|521346904|FG000|Overall Study|Adverse Event|1|||
144586718|NCT01631227|521346905|FG001|Overall Study|Adverse Event|0|||
144209714|NCT05199090|519962026|FG000|Overall Study|Adverse Event|1|||
144586719|NCT01631227|521346904|FG000|Overall Study|administrative|2|||
144626645|NCT00352534|521491098|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
144626646|NCT00352534|521491099|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
144626647|NCT00352534|521491100|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
144626648|NCT00352534|521491101|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
144626649|NCT00352534|521491102|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
144626650|NCT00352534|521491103|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
144626651|NCT00352534|521491097|FG000|Final Risk Group Assignment|Death|0|||
144626652|NCT00352534|521491098|FG001|Final Risk Group Assignment|Death|0|||
144626653|NCT00352534|521491099|FG002|Final Risk Group Assignment|Death|0|||
144626654|NCT00352534|521491100|FG003|Final Risk Group Assignment|Death|0|||
144626655|NCT00352534|521491101|FG004|Final Risk Group Assignment|Death|0|||
144626656|NCT00352534|521491102|FG005|Final Risk Group Assignment|Death|2|||
144626657|NCT00352534|521491103|FG006|Final Risk Group Assignment|Death|0|||
144626658|NCT02324270|521491104|FG000|Overall Study|Withdrawal by Subject|0|||
144626659|NCT02324270|521491105|FG001|Overall Study|Withdrawal by Subject|1|||
144626660|NCT02324270|521491106|FG002|Overall Study|Withdrawal by Subject|0|||
144626661|NCT02324270|521491104|FG000|Overall Study|Lost to Follow-up|4|||
144626662|NCT02324270|521491105|FG001|Overall Study|Lost to Follow-up|3|||
144626663|NCT02324270|521491106|FG002|Overall Study|Lost to Follow-up|4|||
144626664|NCT02324270|521491104|FG000|Overall Study|Protocol Violation|0|||
144626665|NCT02324270|521491105|FG001|Overall Study|Protocol Violation|1|||
144626666|NCT02324270|521491106|FG002|Overall Study|Protocol Violation|1|||
144626667|NCT02324270|521491104|FG000|Overall Study|Non Compliance with Study Drug|1|||
144626668|NCT02324270|521491105|FG001|Overall Study|Non Compliance with Study Drug|2|||
144626669|NCT02324270|521491106|FG002|Overall Study|Non Compliance with Study Drug|0|||
144626670|NCT00546364|521491107|FG000|Overall Study|Disease progression|5|||
144626671|NCT00546364|521491108|FG001|Overall Study|Disease progression|11|||
144626672|NCT00546364|521491109|FG002|Overall Study|Disease progression|8|||
144626673|NCT00546364|521491107|FG000|Overall Study|Completed and off treatment|1|||
144626674|NCT00546364|521491108|FG001|Overall Study|Completed and off treatment|0|||
144626675|NCT00546364|521491109|FG002|Overall Study|Completed and off treatment|2|||
144626676|NCT00546364|521491107|FG000|Overall Study|Administrative reason by sponsor|1|||
144626677|NCT00546364|521491108|FG001|Overall Study|Administrative reason by sponsor|0|||
144626678|NCT00546364|521491109|FG002|Overall Study|Administrative reason by sponsor|0|||
144626679|NCT00546364|521491107|FG000|Overall Study|Poor compliance/noncompliance|0|||
144626680|NCT00546364|521491108|FG001|Overall Study|Poor compliance/noncompliance|0|||
144626681|NCT00546364|521491109|FG002|Overall Study|Poor compliance/noncompliance|1|||
144626682|NCT00546364|521491107|FG000|Overall Study|No longer meets study criteria|1|||
144626683|NCT00546364|521491108|FG001|Overall Study|No longer meets study criteria|1|||
144626684|NCT00546364|521491109|FG002|Overall Study|No longer meets study criteria|0|||
144626685|NCT00546364|521491107|FG000|Overall Study|Withdrawal by Subject|5|||
144626686|NCT00546364|521491108|FG001|Overall Study|Withdrawal by Subject|6|||
144626687|NCT00546364|521491109|FG002|Overall Study|Withdrawal by Subject|3|||
144626688|NCT00546364|521491107|FG000|Overall Study|Prior taxotere|1|||
144626689|NCT00546364|521491108|FG001|Overall Study|Prior taxotere|0|||
144626690|NCT00546364|521491109|FG002|Overall Study|Prior taxotere|0|||
144626691|NCT00546364|521491107|FG000|Overall Study|Mixed response|1|||
144626692|NCT00546364|521491108|FG001|Overall Study|Mixed response|0|||
144626693|NCT00546364|521491109|FG002|Overall Study|Mixed response|0|||
144626694|NCT00546364|521491107|FG000|Overall Study|Palliative treatment|1|||
144626695|NCT00546364|521491108|FG001|Overall Study|Palliative treatment|0|||
144626696|NCT00546364|521491109|FG002|Overall Study|Palliative treatment|1|||
144626697|NCT00546364|521491107|FG000|Overall Study|Target lesions resected|1|||
144626698|NCT00546364|521491108|FG001|Overall Study|Target lesions resected|0|||
144626699|NCT00546364|521491109|FG002|Overall Study|Target lesions resected|0|||
144626700|NCT00546364|521491107|FG000|Overall Study|Physician Decision|0|||
144626701|NCT00546364|521491108|FG001|Overall Study|Physician Decision|0|||
144626702|NCT00546364|521491109|FG002|Overall Study|Physician Decision|1|||
144626703|NCT00546364|521491107|FG000|Overall Study|Sponsor decision|0|||
144626704|NCT00546364|521491108|FG001|Overall Study|Sponsor decision|0|||
144626705|NCT00546364|521491109|FG002|Overall Study|Sponsor decision|1|||
144626706|NCT03521791|521491110|FG000|Overall Study|Protocol Violation|7|||
144626707|NCT03521791|521491111|FG001|Overall Study|Protocol Violation|17|||
144626708|NCT02090855|521491112|FG000|Overall Study|no evaluable Standard of Truth results|2|||
144626709|NCT00680836|521491113|FG000|Overall Study|Withdrawal by Subject|3|||
144626710|NCT00680836|521491114|FG001|Overall Study|Withdrawal by Subject|0|||
144626711|NCT00680836|521491113|FG000|Overall Study|Lost to Follow-up|3|||
144626712|NCT00680836|521491114|FG001|Overall Study|Lost to Follow-up|1|||
144626713|NCT00680836|521491113|FG000|Overall Study|Physician Decision|2|||
144209715|NCT05199090|519962027|FG001|Overall Study|Adverse Event|4|||
144209716|NCT05199090|519962028|FG002|Overall Study|Adverse Event|0|||
144626714|NCT00680836|521491114|FG001|Overall Study|Physician Decision|1|||
144626715|NCT03786432|521491115|FG000|Overall Study|Screen Failure after consent|1|||
144626716|NCT03786432|521491115|FG000|Overall Study|Lost to Follow-up|4|||
144626717|NCT03786432|521491115|FG000|Overall Study|did not complete 12 month CT scan|1|||
144626718|NCT03038308|521491116|FG000|Overall Study|Surgical resection|1|||
144626719|NCT03038308|521491116|FG000|Overall Study|Withdrawal by Subject|2|||
144626720|NCT03038308|521491116|FG000|Overall Study|Lost to Follow-up|1|||
144626721|NCT00544869|521491118|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
144626722|NCT00544869|521491119|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
144626723|NCT00544869|521491120|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
144626724|NCT00544869|521491118|FG000|Overall Study|Adverse Event|6|||
144626725|NCT00544869|521491119|FG001|Overall Study|Adverse Event|1|||
144626726|NCT00544869|521491120|FG002|Overall Study|Adverse Event|0|||
144626727|NCT00544869|521491118|FG000|Overall Study|Lack of Efficacy|1|||
144626728|NCT00544869|521491119|FG001|Overall Study|Lack of Efficacy|1|||
144626729|NCT00544869|521491120|FG002|Overall Study|Lack of Efficacy|0|||
144626730|NCT00544869|521491118|FG000|Overall Study|Physician Decision|2|||
144626731|NCT00544869|521491119|FG001|Overall Study|Physician Decision|0|||
144626732|NCT00544869|521491120|FG002|Overall Study|Physician Decision|0|||
144626733|NCT01475734|521491121|FG000|Overall Study|Withdrawal by Subject|1|||
144626734|NCT01475734|521491122|FG001|Overall Study|Withdrawal by Subject|0|||
144626735|NCT01475734|521491121|FG000|Overall Study|Protocol Violation|1|||
144626736|NCT01475734|521491122|FG001|Overall Study|Protocol Violation|0|||
144626737|NCT01475734|521491121|FG000|Overall Study|Physician Decision|0|||
144626738|NCT01475734|521491122|FG001|Overall Study|Physician Decision|1|||
144626739|NCT00771472|521491123|FG000|Overall Study|Physician Decision|2|||
144626740|NCT00771472|521491124|FG001|Overall Study|Physician Decision|3|||
144626741|NCT00771472|521491123|FG000|Overall Study|Progressive Disease|3|||
144626742|NCT00771472|521491124|FG001|Overall Study|Progressive Disease|1|||
144626743|NCT00771472|521491123|FG000|Overall Study|Protocol Violation|1|||
144626744|NCT00771472|521491124|FG001|Overall Study|Protocol Violation|0|||
144626745|NCT03968419|521491127|FG000|Treatment Period|Adverse Event|0|||
144626746|NCT03968419|521491128|FG001|Treatment Period|Adverse Event|0|||
144626747|NCT03968419|521491129|FG002|Treatment Period|Adverse Event|1|||
144626748|NCT03968419|521491127|FG000|Safety Follow-up Period|Death|3|||
144626749|NCT03968419|521491128|FG001|Safety Follow-up Period|Death|2|||
144626750|NCT03968419|521491129|FG002|Safety Follow-up Period|Death|1|||
144626751|NCT03968419|521491127|FG000|Safety Follow-up Period|Subject Decision|2|||
144626752|NCT03968419|521491128|FG001|Safety Follow-up Period|Subject Decision|1|||
144626753|NCT03968419|521491129|FG002|Safety Follow-up Period|Subject Decision|0|||
144626754|NCT01390389|521491130|FG000|Overall Study|Withdrawal by Subject|2|||
144626755|NCT01390389|521491131|FG001|Overall Study|Withdrawal by Subject|0|||
144626756|NCT01390389|521491130|FG000|Overall Study|Screen Fail|2|||
144626757|NCT01390389|521491131|FG001|Overall Study|Screen Fail|1|||
144626758|NCT01246206|521491132|FG000|Overall Study|Patient did not receive study regiments.|1|||
144626759|NCT02002975|521491133|FG000|Overall Study|Case Report Forms Uncollected|135|||
144626760|NCT02002975|521491133|FG000|Overall Study|Protocol Deviation|437|||
144626761|NCT00167245|521491134|FG000|Overall Study|Lost to Follow-up|20|||
144626762|NCT00167245|521491135|FG001|Overall Study|Lost to Follow-up|31|||
144626763|NCT00167245|521491134|FG000|Overall Study|Withdrawal by Subject|5|||
144626764|NCT00167245|521491135|FG001|Overall Study|Withdrawal by Subject|8|||
144626765|NCT00167245|521491134|FG000|Overall Study|Incarcerated|3|||
144626766|NCT00167245|521491135|FG001|Overall Study|Incarcerated|2|||
144626767|NCT00167245|521491134|FG000|Overall Study|Drowsy|1|||
144626768|NCT00167245|521491135|FG001|Overall Study|Drowsy|0|||
144626769|NCT01220414|521491138|FG000|Overall Study|Withdrawal by Subject|1|||
144626770|NCT01220414|521491139|FG001|Overall Study|Withdrawal by Subject|0|||
144626771|NCT01220414|521491140|FG002|Overall Study|Withdrawal by Subject|0|||
144626772|NCT01220414|521491141|FG003|Overall Study|Withdrawal by Subject|1|||
144626773|NCT00669617|521491149|FG000|Period 1|Withdrawal by Subject|0|||
144626774|NCT00669617|521491150|FG001|Period 1|Withdrawal by Subject|0|||
144626775|NCT00669617|521491151|FG002|Period 1|Withdrawal by Subject|1|||
144626776|NCT00669617|521491152|FG003|Period 1|Withdrawal by Subject|0|||
144626777|NCT00669617|521491153|FG004|Period 1|Withdrawal by Subject|0|||
144626778|NCT00669617|521491149|FG000|Period 1|Protocol Deviation|0|||
144626779|NCT00669617|521491150|FG001|Period 1|Protocol Deviation|0|||
144626780|NCT00669617|521491151|FG002|Period 1|Protocol Deviation|0|||
144626781|NCT00669617|521491152|FG003|Period 1|Protocol Deviation|0|||
144626782|NCT00669617|521491153|FG004|Period 1|Protocol Deviation|1|||
144626783|NCT00669617|521491149|FG000|Period 3|Lost to Follow-up|1|||
144626784|NCT00669617|521491150|FG001|Period 3|Lost to Follow-up|0|||
144626785|NCT00669617|521491151|FG002|Period 3|Lost to Follow-up|0|||
144626786|NCT00669617|521491152|FG003|Period 3|Lost to Follow-up|0|||
144626787|NCT00669617|521491153|FG004|Period 3|Lost to Follow-up|0|||
144626788|NCT00623831|521491154|FG000|Overall Study|Withdrawal by Subject|1|||
144626789|NCT00623831|521491155|FG001|Overall Study|Withdrawal by Subject|0|||
144626790|NCT00623831|521491154|FG000|Overall Study|Progressive Disease|0|||
144626791|NCT00623831|521491155|FG001|Overall Study|Progressive Disease|1|||
144626792|NCT01276821|521491156|FG000|Overall Study|Protocol Violation|0|||
144626793|NCT01276821|521491157|FG001|Overall Study|Protocol Violation|1|||
144626794|NCT01748071|521491160|FG000|Overall Study|Adverse Event|2|||
144626795|NCT01748071|521491161|FG001|Overall Study|Adverse Event|2|||
144626796|NCT01748071|521491162|FG002|Overall Study|Adverse Event|0|||
144626797|NCT03068325|521491163|FG000|Overall Study|Lost to Follow-up|5|||
144626798|NCT00700180|521491164|FG000|Overall Study|Death|99|||
144626799|NCT00700180|521491165|FG001|Overall Study|Death|114|||
144626800|NCT00700180|521491164|FG000|Overall Study|Alive on treatment|5|||
144626801|NCT00700180|521491165|FG001|Overall Study|Alive on treatment|3|||
144626802|NCT00700180|521491164|FG000|Overall Study|Alive in follow-up|46|||
144626803|NCT00700180|521491165|FG001|Overall Study|Alive in follow-up|27|||
144626804|NCT00700180|521491164|FG000|Overall Study|Lost to Follow-up|4|||
144626805|NCT00700180|521491165|FG001|Overall Study|Lost to Follow-up|5|||
144626806|NCT01613326|521491166|FG000|Overall Study|Adverse Event|7|||
144626807|NCT01613326|521491167|FG001|Overall Study|Adverse Event|5|||
144626808|NCT01613326|521491166|FG000|Overall Study|Withdrawal by Subject|3|||
144626809|NCT01613326|521491167|FG001|Overall Study|Withdrawal by Subject|4|||
144626810|NCT01613326|521491166|FG000|Overall Study|Abnormal test procedure result(s)|2|||
144626811|NCT01613326|521491167|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144626812|NCT01613326|521491166|FG000|Overall Study|inability to use device|1|||
144626813|NCT01613326|521491167|FG001|Overall Study|inability to use device|0|||
144626814|NCT01613326|521491166|FG000|Overall Study|Lack of Efficacy|0|||
144626815|NCT01613326|521491167|FG001|Overall Study|Lack of Efficacy|1|||
144626816|NCT01613326|521491166|FG000|Overall Study|Lost to Follow-up|0|||
144626817|NCT01613326|521491167|FG001|Overall Study|Lost to Follow-up|1|||
144626818|NCT01613326|521491166|FG000|Overall Study|Administrative|0|||
144626819|NCT01613326|521491167|FG001|Overall Study|Administrative|2|||
144626820|NCT01613326|521491166|FG000|Overall Study|Protocol Violation|0|||
144626821|NCT01613326|521491167|FG001|Overall Study|Protocol Violation|1|||
144626822|NCT00168831|521491170|FG000|Overall Study|Adverse Event|36|||
144626823|NCT00168831|521491171|FG001|Overall Study|Adverse Event|47|||
144626824|NCT00168831|521491172|FG002|Overall Study|Adverse Event|74|||
144626825|NCT00168831|521491170|FG000|Overall Study|Lost to Follow-up|5|||
144626826|NCT00168831|521491171|FG001|Overall Study|Lost to Follow-up|6|||
144626827|NCT00168831|521491172|FG002|Overall Study|Lost to Follow-up|4|||
144626828|NCT00168831|521491170|FG000|Overall Study|Withdrawal by Subject|7|||
144626829|NCT00168831|521491171|FG001|Overall Study|Withdrawal by Subject|14|||
144626830|NCT00168831|521491172|FG002|Overall Study|Withdrawal by Subject|19|||
144626831|NCT00168831|521491170|FG000|Overall Study|Protocol Violation|6|||
144626832|NCT00168831|521491171|FG001|Overall Study|Protocol Violation|11|||
144626833|NCT00168831|521491172|FG002|Overall Study|Protocol Violation|11|||
144626834|NCT00168831|521491170|FG000|Overall Study|Other|6|||
144626835|NCT00168831|521491171|FG001|Overall Study|Other|3|||
144626836|NCT00168831|521491172|FG002|Overall Study|Other|6|||
144626837|NCT01622569|521491173|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
144626838|NCT01622569|521491174|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
144626839|NCT01622569|521491175|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
144626840|NCT01622569|521491176|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
144626841|NCT01622569|521491173|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
144626842|NCT01622569|521491174|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
144626843|NCT01622569|521491175|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
144626844|NCT01622569|521491176|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
144626845|NCT01622569|521491173|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
144626846|NCT01622569|521491174|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
144626847|NCT01622569|521491175|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
144626848|NCT01622569|521491176|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
144626849|NCT01622569|521491173|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
144626850|NCT01622569|521491174|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
144626851|NCT01622569|521491175|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
144626852|NCT01622569|521491176|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
144626853|NCT01622569|521491173|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
144626854|NCT01622569|521491174|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
144626855|NCT01622569|521491175|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
144626856|NCT01622569|521491176|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
144626857|NCT01622569|521491173|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
144626858|NCT01622569|521491174|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
144626859|NCT01622569|521491175|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
144626860|NCT01622569|521491176|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
144626861|NCT01622569|521491173|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
144626862|NCT01622569|521491174|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
144626863|NCT01622569|521491175|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
144626864|NCT01622569|521491176|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
144626865|NCT01622569|521491173|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
144626866|NCT01622569|521491174|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
144626867|NCT01622569|521491175|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
144626868|NCT01622569|521491176|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
144209717|NCT05199090|519962029|FG003|Overall Study|Adverse Event|0|||
144586720|NCT01631227|521346905|FG001|Overall Study|administrative|1|||
144586721|NCT00158860|521346908|FG000|Overall Study|Adverse Event|3|||
144586722|NCT00158860|521346909|FG001|Overall Study|Adverse Event|6|||
144586723|NCT00158860|521346908|FG000|Overall Study|Lost to Follow-up|11|||
144586724|NCT00158860|521346909|FG001|Overall Study|Lost to Follow-up|17|||
144586725|NCT00158860|521346908|FG000|Overall Study|Protocol Violation|8|||
144586726|NCT00158860|521346909|FG001|Overall Study|Protocol Violation|23|||
144586727|NCT00158860|521346908|FG000|Overall Study|Withdrawal by Subject|7|||
144586728|NCT00158860|521346909|FG001|Overall Study|Withdrawal by Subject|17|||
144586729|NCT00158860|521346908|FG000|Overall Study|MOVING OUT OF STATE|1|||
144586730|NCT00158860|521346909|FG001|Overall Study|MOVING OUT OF STATE|0|||
144586731|NCT00158860|521346908|FG000|Overall Study|Pregnancy|3|||
144586732|NCT00158860|521346909|FG001|Overall Study|Pregnancy|3|||
144586733|NCT00158860|521346908|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
144586734|NCT00158860|521346909|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
144586735|NCT00158860|521346908|FG000|Overall Study|SPONSOR REQUEST|0|||
144586736|NCT00158860|521346909|FG001|Overall Study|SPONSOR REQUEST|1|||
144586737|NCT00158860|521346908|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
144586738|NCT00158860|521346909|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
144586739|NCT00158860|521346908|FG000|Overall Study|Closed per sponsor|0|||
144586740|NCT00158860|521346909|FG001|Overall Study|Closed per sponsor|1|||
144586741|NCT00964886|521346910|FG000|Overall Study|Lost to Follow-up|2|||
144586742|NCT00964886|521346911|FG001|Overall Study|Lost to Follow-up|2|||
144586743|NCT00964886|521346912|FG002|Overall Study|Lost to Follow-up|6|||
144586744|NCT00964886|521346913|FG003|Overall Study|Lost to Follow-up|4|||
144586745|NCT00964886|521346910|FG000|Overall Study|Withdrawal by Subject|6|||
144586746|NCT00964886|521346911|FG001|Overall Study|Withdrawal by Subject|2|||
144586747|NCT00964886|521346912|FG002|Overall Study|Withdrawal by Subject|5|||
144586748|NCT00964886|521346913|FG003|Overall Study|Withdrawal by Subject|3|||
144586749|NCT00964886|521346910|FG000|Overall Study|Adverse Event|3|||
144586750|NCT00964886|521346911|FG001|Overall Study|Adverse Event|1|||
144586751|NCT00964886|521346912|FG002|Overall Study|Adverse Event|5|||
144586752|NCT00964886|521346913|FG003|Overall Study|Adverse Event|2|||
144586753|NCT00964886|521346910|FG000|Overall Study|Protocol Violation|0|||
144586754|NCT00964886|521346911|FG001|Overall Study|Protocol Violation|2|||
144586755|NCT00964886|521346912|FG002|Overall Study|Protocol Violation|0|||
144586756|NCT00964886|521346913|FG003|Overall Study|Protocol Violation|0|||
144586757|NCT03047395|521346915|FG000|Overall Study|Adverse Event|142|||
144586758|NCT03047395|521346915|FG000|Overall Study|Withdrawal by Subject|155|||
144586759|NCT03047395|521346915|FG000|Overall Study|Lost to Follow-up|144|||
144586760|NCT03047395|521346915|FG000|Overall Study|COVID-19 Infection|2|||
144586761|NCT03047395|521346915|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
144586762|NCT03047395|521346915|FG000|Overall Study|Other, Not Specified|117|||
144586763|NCT00468104|521346921|FG000|First Intervention|Protocol Violation|2|||
144586764|NCT00468104|521346922|FG001|First Intervention|Protocol Violation|1|||
144586765|NCT00468104|521346921|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
144586766|NCT00468104|521346922|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
144586767|NCT00468104|521346921|FG000|First Intervention|died within 3 weeks|1|||
144586768|NCT00468104|521346922|FG001|First Intervention|died within 3 weeks|0|||
144586769|NCT00468104|521346921|FG000|First Intervention|malposition/blocked chest tube tube|2|||
144586770|NCT00468104|521346922|FG001|First Intervention|malposition/blocked chest tube tube|0|||
144586771|NCT00468104|521346921|FG000|First Intervention|large lung mass with minimal effusion|1|||
144586772|NCT00468104|521346922|FG001|First Intervention|large lung mass with minimal effusion|0|||
144586773|NCT00468104|521346921|FG000|First Intervention|associated prolonged pneumothorax|1|||
144586774|NCT00468104|521346922|FG001|First Intervention|associated prolonged pneumothorax|0|||
144586775|NCT00468104|521346921|FG000|First Intervention|trapped lung|1|||
144586776|NCT00468104|521346922|FG001|First Intervention|trapped lung|0|||
144586777|NCT00468104|521346921|FG000|Second Intervention|Withdrawal by Subject|5|||
144586778|NCT00468104|521346922|FG001|Second Intervention|Withdrawal by Subject|2|||
144586779|NCT00468104|521346921|FG000|Second Intervention|discarded for malposition of chest tube|0|||
144586780|NCT00468104|521346922|FG001|Second Intervention|discarded for malposition of chest tube|2|||
144586781|NCT02706899|521346923|FG000|Overall Study|Withdrawal by Subject|1|||
144586782|NCT02706899|521346924|FG001|Overall Study|Withdrawal by Subject|0|||
144586783|NCT02706899|521346923|FG000|Overall Study|Death|8|||
144586784|NCT02706899|521346924|FG001|Overall Study|Death|0|||
144586785|NCT02706899|521346923|FG000|Overall Study|Study Termination by Sponsor|4|||
144586786|NCT02706899|521346924|FG001|Overall Study|Study Termination by Sponsor|6|||
144586787|NCT00324675|521346925|FG000|Overall Study|Adverse Event|1|||
144586788|NCT00324675|521346926|FG001|Overall Study|Adverse Event|0|||
144586789|NCT00381615|521346927|FG000|Overall Study|Withdrawal by Subject|1|||
144586790|NCT00381615|521346928|FG001|Overall Study|Withdrawal by Subject|3|||
144586791|NCT00381615|521346929|FG002|Overall Study|Withdrawal by Subject|0|||
144586792|NCT00381615|521346930|FG003|Overall Study|Withdrawal by Subject|1|||
144586793|NCT00381615|521346927|FG000|Overall Study|Lost to Follow-up|3|||
144586794|NCT00381615|521346928|FG001|Overall Study|Lost to Follow-up|2|||
144626869|NCT02522767|521491178|FG000|Double-blind|Withdrawal by Subject|8|||
144626870|NCT02522767|521491179|FG001|Double-blind|Withdrawal by Subject|11|||
144626871|NCT02522767|521491178|FG000|Double-blind|Lost to Follow-up|1|||
144626872|NCT02522767|521491179|FG001|Double-blind|Lost to Follow-up|0|||
144626873|NCT02522767|521491178|FG000|Double-blind|Adverse Event|1|||
144626874|NCT02522767|521491179|FG001|Double-blind|Adverse Event|10|||
144626875|NCT02522767|521491178|FG000|Double-blind|Protocol Violation|0|||
144626876|NCT02522767|521491179|FG001|Double-blind|Protocol Violation|1|||
144626877|NCT02522767|521491178|FG000|Double-blind|Lack of Efficacy|0|||
144626878|NCT02522767|521491179|FG001|Double-blind|Lack of Efficacy|2|||
144626879|NCT02522767|521491178|FG000|Double-blind|Protocol Deviation|1|||
144626880|NCT02522767|521491179|FG001|Double-blind|Protocol Deviation|0|||
144626881|NCT02522767|521491178|FG000|Open-label|Withdrawal by Subject|2|||
144626882|NCT02522767|521491179|FG001|Open-label|Withdrawal by Subject|3|||
144626883|NCT02522767|521491178|FG000|Open-label|Lost to Follow-up|0|||
144626884|NCT02522767|521491179|FG001|Open-label|Lost to Follow-up|1|||
144626885|NCT02522767|521491178|FG000|Open-label|Adverse Event|2|||
144626886|NCT02522767|521491179|FG001|Open-label|Adverse Event|1|||
144626887|NCT02522767|521491178|FG000|Open-label|Lack of Efficacy|1|||
144626888|NCT02522767|521491179|FG001|Open-label|Lack of Efficacy|1|||
144626889|NCT02522767|521491178|FG000|Open-label|Protocol Violation|0|||
144626890|NCT02522767|521491179|FG001|Open-label|Protocol Violation|1|||
144626891|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
144626892|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
144626893|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
144626894|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
144626895|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
144626896|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
144626897|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
144626898|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
144626899|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
144626900|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
144626901|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
144626902|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
144626903|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
144626904|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
144626905|NCT02288247|521491180|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
144626906|NCT02288247|521491181|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
144626907|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
144626908|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
144626909|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
144626910|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
144626911|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
144626912|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
144626913|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
144626914|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
144626915|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
144626916|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
144626917|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
144626918|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
144626919|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
144626920|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
144626921|NCT02288247|521491180|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
144626922|NCT02288247|521491181|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
144626923|NCT03634800|521491182|FG000|Overall Study|Adverse Event|1|||
144626924|NCT03634800|521491182|FG000|Overall Study|Disease Progression|4|||
144626925|NCT03634800|521491182|FG000|Overall Study|Withdrawal by Subject|1|||
144626926|NCT02624492|521491186|FG000|Overall Study|Adverse Event|2|||
144626927|NCT02624492|521491187|FG001|Overall Study|Adverse Event|2|||
144626928|NCT02624492|521491188|FG002|Overall Study|Adverse Event|2|||
144626929|NCT02624492|521491186|FG000|Overall Study|Progressive disease|0|||
144626930|NCT02624492|521491187|FG001|Overall Study|Progressive disease|2|||
144626931|NCT02624492|521491188|FG002|Overall Study|Progressive disease|3|||
144626932|NCT00191451|521491192|FG000|Overall Study|Withdrawal by Subject|2|||
144626933|NCT00191451|521491193|FG001|Overall Study|Withdrawal by Subject|3|||
144626934|NCT00191451|521491194|FG002|Overall Study|Withdrawal by Subject|5|||
144626935|NCT00191451|521491192|FG000|Overall Study|Physician Decision|2|||
144626936|NCT00191451|521491193|FG001|Overall Study|Physician Decision|9|||
144626937|NCT00191451|521491194|FG002|Overall Study|Physician Decision|6|||
144626938|NCT00191451|521491192|FG000|Overall Study|Sponsor Decision|1|||
144626939|NCT00191451|521491193|FG001|Overall Study|Sponsor Decision|0|||
144626940|NCT00191451|521491194|FG002|Overall Study|Sponsor Decision|0|||
144626941|NCT00191451|521491192|FG000|Overall Study|Ineligible|0|||
144626942|NCT00191451|521491193|FG001|Overall Study|Ineligible|1|||
144626943|NCT00191451|521491194|FG002|Overall Study|Ineligible|0|||
144626944|NCT00191451|521491192|FG000|Overall Study|Reason Not Specified|2|||
144626945|NCT00191451|521491193|FG001|Overall Study|Reason Not Specified|1|||
144626946|NCT00191451|521491194|FG002|Overall Study|Reason Not Specified|3|||
144626947|NCT03555266|521491199|FG000|Overall Study|Protocol Violation|6|||
144626948|NCT03555266|521491200|FG001|Overall Study|Protocol Violation|4|||
144626949|NCT03370770|521491204|FG000|Overall Study|Patient was followed in another hospital center|1|||
144626950|NCT03370770|521491204|FG000|Overall Study|Progressive Disease|98|||
144626951|NCT03370770|521491204|FG000|Overall Study|Adverse Event|2|||
144626952|NCT03370770|521491204|FG000|Overall Study|Death|5|||
144626953|NCT00395967|521491205|FG000|Treatment Period|Failed Mobilization|1|||
144626954|NCT00395967|521491205|FG000|Follow-up Period|Death|1|||
144626955|NCT00395967|521491205|FG000|Follow-up Period|Lost to Follow-up|1|||
144626956|NCT01109940|521491206|FG000|Overall Study|Administrative problems|2|||
144626957|NCT01109940|521491207|FG001|Overall Study|Administrative problems|0|||
144626958|NCT01109940|521491208|FG002|Overall Study|Administrative problems|0|||
144626959|NCT01109940|521491209|FG003|Overall Study|Administrative problems|0|||
144626960|NCT01109940|521491206|FG000|Overall Study|Serious Adverse Event|2|||
144626961|NCT01109940|521491207|FG001|Overall Study|Serious Adverse Event|1|||
144626962|NCT01109940|521491208|FG002|Overall Study|Serious Adverse Event|0|||
144626963|NCT01109940|521491209|FG003|Overall Study|Serious Adverse Event|0|||
144626964|NCT01109940|521491206|FG000|Overall Study|Lost to Follow-up|1|||
144626965|NCT01109940|521491207|FG001|Overall Study|Lost to Follow-up|0|||
144626966|NCT01109940|521491208|FG002|Overall Study|Lost to Follow-up|0|||
144626967|NCT01109940|521491209|FG003|Overall Study|Lost to Follow-up|0|||
144626968|NCT01109940|521491206|FG000|Overall Study|Patient withdrew consent|1|||
144626969|NCT01109940|521491207|FG001|Overall Study|Patient withdrew consent|1|||
144626970|NCT01109940|521491208|FG002|Overall Study|Patient withdrew consent|0|||
144626971|NCT01109940|521491209|FG003|Overall Study|Patient withdrew consent|0|||
144626972|NCT01109940|521491206|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144626973|NCT01109940|521491207|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144626974|NCT01109940|521491208|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
144626975|NCT01109940|521491209|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
144626976|NCT03543410|521491211|FG000|Overall Study|Adverse Event|10|||
144626977|NCT03543410|521491212|FG001|Overall Study|Adverse Event|8|||
144626978|NCT03543410|521491213|FG002|Overall Study|Adverse Event|2|||
144626979|NCT03543410|521491211|FG000|Overall Study|Lack of Efficacy|0|||
144626980|NCT03543410|521491212|FG001|Overall Study|Lack of Efficacy|1|||
144626981|NCT03543410|521491213|FG002|Overall Study|Lack of Efficacy|0|||
144626982|NCT03543410|521491211|FG000|Overall Study|Lost to Follow-up|0|||
144626983|NCT03543410|521491212|FG001|Overall Study|Lost to Follow-up|1|||
144626984|NCT03543410|521491213|FG002|Overall Study|Lost to Follow-up|0|||
144626985|NCT03543410|521491211|FG000|Overall Study|Withdrawal by Subject|5|||
144626986|NCT03543410|521491212|FG001|Overall Study|Withdrawal by Subject|2|||
144626987|NCT03543410|521491213|FG002|Overall Study|Withdrawal by Subject|8|||
144626988|NCT03543410|521491211|FG000|Overall Study|Protocol Violation|0|||
144626989|NCT03543410|521491212|FG001|Overall Study|Protocol Violation|1|||
144626990|NCT03543410|521491213|FG002|Overall Study|Protocol Violation|0|||
144626991|NCT03543410|521491211|FG000|Overall Study|Due to COVID-19|4|||
144626992|NCT03543410|521491212|FG001|Overall Study|Due to COVID-19|0|||
144626993|NCT03543410|521491213|FG002|Overall Study|Due to COVID-19|2|||
144626994|NCT03543410|521491211|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
144626995|NCT03543410|521491212|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
144626996|NCT03543410|521491213|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
144626997|NCT03543410|521491211|FG000|Overall Study|Not Due to COVID-19|2|||
144626998|NCT03543410|521491212|FG001|Overall Study|Not Due to COVID-19|0|||
144626999|NCT03543410|521491213|FG002|Overall Study|Not Due to COVID-19|1|||
144627000|NCT02883244|521491214|FG000|Overall Study|Lost to Follow-up|0|||
144627001|NCT02883244|521491215|FG001|Overall Study|Lost to Follow-up|1|||
144627002|NCT01727258|521491216|FG000|Overall Study|Adverse Event|0|||
144627003|NCT01727258|521491217|FG001|Overall Study|Adverse Event|2|||
144627004|NCT01727258|521491218|FG002|Overall Study|Adverse Event|0|||
144627005|NCT01727258|521491216|FG000|Overall Study|Noncompliance with Study Drug|0|||
144627006|NCT01727258|521491217|FG001|Overall Study|Noncompliance with Study Drug|0|||
144627007|NCT01727258|521491218|FG002|Overall Study|Noncompliance with Study Drug|1|||
144627008|NCT01727258|521491216|FG000|Overall Study|Withdrawal by Subject|1|||
144627009|NCT01727258|521491217|FG001|Overall Study|Withdrawal by Subject|1|||
144627010|NCT01727258|521491218|FG002|Overall Study|Withdrawal by Subject|0|||
144627011|NCT01727258|521491216|FG000|Overall Study|Lost to Follow-up|1|||
144627012|NCT01727258|521491217|FG001|Overall Study|Lost to Follow-up|0|||
144627013|NCT01727258|521491218|FG002|Overall Study|Lost to Follow-up|0|||
144627014|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
144627015|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
144627016|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
144627017|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Death|28|||
144209718|NCT05199090|519962030|FG004|Overall Study|Adverse Event|0|||
144209719|NCT05199090|519962031|FG005|Overall Study|Adverse Event|0|||
144209720|NCT05199090|519962026|FG000|Overall Study|Lost to Follow-up|1|||
144586795|NCT00381615|521346929|FG002|Overall Study|Lost to Follow-up|0|||
144586796|NCT00381615|521346930|FG003|Overall Study|Lost to Follow-up|1|||
144586797|NCT00381615|521346927|FG000|Overall Study|Protocol Violation|0|||
144586798|NCT00381615|521346928|FG001|Overall Study|Protocol Violation|0|||
144586799|NCT00381615|521346929|FG002|Overall Study|Protocol Violation|1|||
144586800|NCT00381615|521346930|FG003|Overall Study|Protocol Violation|0|||
144586801|NCT04860297|521346932|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
144586802|NCT04860297|521346933|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
144586803|NCT04860297|521346934|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
144586804|NCT04860297|521346935|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
144586805|NCT04860297|521346936|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
144586806|NCT04860297|521346937|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
144586807|NCT04860297|521346938|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
144586808|NCT04860297|521346939|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
144586809|NCT04860297|521346932|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
144586810|NCT04860297|521346933|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
144586811|NCT04860297|521346934|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
144586812|NCT04860297|521346935|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
144586813|NCT04860297|521346936|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
144586814|NCT04860297|521346937|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
144586815|NCT04860297|521346938|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
144586816|NCT04860297|521346939|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
144586817|NCT04860297|521346932|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
144586818|NCT04860297|521346933|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
144586819|NCT04860297|521346934|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
144586820|NCT04860297|521346935|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
144586821|NCT04860297|521346936|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
144586822|NCT04860297|521346937|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
144586823|NCT04860297|521346938|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
144586824|NCT04860297|521346939|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
144586825|NCT04860297|521346932|FG000|Part B (Booster Dose)|Other Than Specified|0|||
144586826|NCT04860297|521346933|FG001|Part B (Booster Dose)|Other Than Specified|0|||
144586827|NCT04860297|521346934|FG002|Part B (Booster Dose)|Other Than Specified|0|||
144586828|NCT04860297|521346935|FG003|Part B (Booster Dose)|Other Than Specified|0|||
144586829|NCT04860297|521346936|FG004|Part B (Booster Dose)|Other Than Specified|0|||
144586830|NCT04860297|521346937|FG005|Part B (Booster Dose)|Other Than Specified|1|||
144586831|NCT04860297|521346938|FG006|Part B (Booster Dose)|Other Than Specified|1|||
144586832|NCT04860297|521346939|FG007|Part B (Booster Dose)|Other Than Specified|0|||
144586833|NCT04860297|521346932|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
144586834|NCT04860297|521346933|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
144586835|NCT04860297|521346934|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
144586836|NCT04860297|521346935|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
144586837|NCT04860297|521346936|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
144586838|NCT04860297|521346937|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
144586839|NCT04860297|521346938|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
144586840|NCT04860297|521346939|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
144586841|NCT04860297|521346932|FG000|Part B (Booster Dose)|Death|0|||
144586842|NCT04860297|521346933|FG001|Part B (Booster Dose)|Death|0|||
144586843|NCT04860297|521346934|FG002|Part B (Booster Dose)|Death|0|||
144586844|NCT04860297|521346935|FG003|Part B (Booster Dose)|Death|0|||
144586845|NCT04860297|521346936|FG004|Part B (Booster Dose)|Death|1|||
144586846|NCT04860297|521346937|FG005|Part B (Booster Dose)|Death|2|||
144586847|NCT04860297|521346938|FG006|Part B (Booster Dose)|Death|1|||
144586848|NCT04860297|521346939|FG007|Part B (Booster Dose)|Death|0|||
144586849|NCT04860297|521346932|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
144586850|NCT04860297|521346933|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
144586851|NCT04860297|521346934|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
144586852|NCT04860297|521346935|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
144586853|NCT04860297|521346936|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
144586854|NCT04860297|521346937|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
144586855|NCT04860297|521346938|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
144586856|NCT04860297|521346939|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
144586857|NCT04811131|521346940|FG000|Overall Study|Adverse Event|0|||
144586858|NCT04811131|521346941|FG001|Overall Study|Adverse Event|0|||
144586859|NCT04811131|521346942|FG002|Overall Study|Adverse Event|1|||
144586860|NCT04811131|521346943|FG003|Overall Study|Adverse Event|0|||
144586861|NCT04811131|521346940|FG000|Overall Study|Lack of Efficacy|0|||
144586862|NCT04811131|521346941|FG001|Overall Study|Lack of Efficacy|0|||
144586863|NCT04811131|521346942|FG002|Overall Study|Lack of Efficacy|0|||
144586864|NCT04811131|521346943|FG003|Overall Study|Lack of Efficacy|1|||
144586865|NCT04811131|521346940|FG000|Overall Study|Lost to Follow-up|0|||
144586866|NCT04811131|521346941|FG001|Overall Study|Lost to Follow-up|1|||
144209721|NCT05199090|519962027|FG001|Overall Study|Lost to Follow-up|0|||
144209722|NCT05199090|519962028|FG002|Overall Study|Lost to Follow-up|1|||
144209723|NCT05199090|519962029|FG003|Overall Study|Lost to Follow-up|4|||
144209724|NCT05199090|519962030|FG004|Overall Study|Lost to Follow-up|0|||
144209725|NCT05199090|519962031|FG005|Overall Study|Lost to Follow-up|5|||
144627018|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Death|0|||
144627019|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Death|0|||
144627020|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
144627021|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
144627022|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
144627023|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
144627024|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
144627025|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
144627026|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
144627027|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
144627028|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
144627029|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
144627030|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
144627031|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
144627032|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
144627033|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
144627034|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
144627035|NCT00820755|521491219|FG000|Period 1: Combination Therapy Phase|Other|11|||
144627036|NCT00820755|521491220|FG001|Period 1: Combination Therapy Phase|Other|0|||
144627037|NCT00820755|521491221|FG002|Period 1: Combination Therapy Phase|Other|0|||
144627038|NCT00820755|521491219|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
144627039|NCT00820755|521491220|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
144627040|NCT00820755|521491221|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
144627041|NCT03604445|521491224|FG000|Overall Study|Death|0|||
144627042|NCT03604445|521491225|FG001|Overall Study|Death|0|||
144627043|NCT03604445|521491226|FG002|Overall Study|Death|0|||
144627044|NCT03604445|521491227|FG003|Overall Study|Death|0|||
144627045|NCT03604445|521491228|FG004|Overall Study|Death|0|||
144627046|NCT03604445|521491229|FG005|Overall Study|Death|0|||
144627047|NCT03604445|521491230|FG006|Overall Study|Death|0|||
144627048|NCT03604445|521491231|FG007|Overall Study|Death|0|||
144627049|NCT03604445|521491232|FG008|Overall Study|Death|1|||
144627050|NCT03604445|521491224|FG000|Overall Study|Withdrawal by Subject|0|||
144627051|NCT03604445|521491225|FG001|Overall Study|Withdrawal by Subject|0|||
144627052|NCT03604445|521491226|FG002|Overall Study|Withdrawal by Subject|0|||
144627053|NCT03604445|521491227|FG003|Overall Study|Withdrawal by Subject|0|||
144627054|NCT03604445|521491228|FG004|Overall Study|Withdrawal by Subject|0|||
144627055|NCT03604445|521491229|FG005|Overall Study|Withdrawal by Subject|0|||
144627056|NCT03604445|521491230|FG006|Overall Study|Withdrawal by Subject|1|||
144627057|NCT03604445|521491231|FG007|Overall Study|Withdrawal by Subject|0|||
144627058|NCT03604445|521491232|FG008|Overall Study|Withdrawal by Subject|0|||
144627059|NCT03604445|521491224|FG000|Overall Study|Missing visit|0|||
144627060|NCT03604445|521491225|FG001|Overall Study|Missing visit|0|||
144627061|NCT03604445|521491226|FG002|Overall Study|Missing visit|0|||
144627062|NCT03604445|521491227|FG003|Overall Study|Missing visit|0|||
144627063|NCT03604445|521491228|FG004|Overall Study|Missing visit|0|||
144627064|NCT03604445|521491229|FG005|Overall Study|Missing visit|1|||
144627065|NCT03604445|521491230|FG006|Overall Study|Missing visit|0|||
144627066|NCT03604445|521491231|FG007|Overall Study|Missing visit|1|||
144627067|NCT03604445|521491232|FG008|Overall Study|Missing visit|0|||
144627068|NCT03604445|521491224|FG000|Overall Study|Adverse Event|0|||
144627069|NCT03604445|521491225|FG001|Overall Study|Adverse Event|0|||
144627070|NCT03604445|521491226|FG002|Overall Study|Adverse Event|0|||
144627071|NCT03604445|521491227|FG003|Overall Study|Adverse Event|1|||
144627072|NCT03604445|521491228|FG004|Overall Study|Adverse Event|0|||
144627073|NCT03604445|521491229|FG005|Overall Study|Adverse Event|0|||
144627074|NCT03604445|521491230|FG006|Overall Study|Adverse Event|0|||
144627075|NCT03604445|521491231|FG007|Overall Study|Adverse Event|0|||
144627076|NCT03604445|521491232|FG008|Overall Study|Adverse Event|1|||
144627077|NCT00773279|521491233|FG000|Period 1|Adverse Event|2|||
144627078|NCT00773279|521491234|FG001|Period 1|Adverse Event|1|||
144627079|NCT00773279|521491233|FG000|Period 1|Lack of Efficacy|0|||
144627080|NCT00773279|521491234|FG001|Period 1|Lack of Efficacy|2|||
144627081|NCT00773279|521491233|FG000|Period 1|Unclassified|5|||
144627082|NCT00773279|521491234|FG001|Period 1|Unclassified|1|||
144627083|NCT00773279|521491233|FG000|Period 2|Adverse Event|0|||
144627084|NCT00773279|521491234|FG001|Period 2|Adverse Event|1|||
144209726|NCT05199090|519962026|FG000|Overall Study|Physician Decision|0|||
144209727|NCT05199090|519962027|FG001|Overall Study|Physician Decision|0|||
144209728|NCT05199090|519962028|FG002|Overall Study|Physician Decision|0|||
144627085|NCT00773279|521491233|FG000|Period 2|Lack of Efficacy|1|||
144627086|NCT00773279|521491234|FG001|Period 2|Lack of Efficacy|0|||
144627087|NCT00773279|521491233|FG000|Period 2|Protocol Violation|0|||
144627088|NCT00773279|521491234|FG001|Period 2|Protocol Violation|3|||
144627089|NCT00773279|521491233|FG000|Period 2|Unclassified|2|||
144627090|NCT00773279|521491234|FG001|Period 2|Unclassified|2|||
144627091|NCT01818726|521491236|FG000|Overall Study|Administrative reasons|5|||
144627092|NCT01818726|521491237|FG001|Overall Study|Administrative reasons|1|||
144627093|NCT01818726|521491236|FG000|Overall Study|Withdrawal by Subject|0|||
144627094|NCT01818726|521491237|FG001|Overall Study|Withdrawal by Subject|1|||
144627095|NCT01818726|521491236|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
144627096|NCT01818726|521491237|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
144627097|NCT02551159|521491238|FG000|Overall Study|Death|352|||
144627098|NCT02551159|521491239|FG001|Overall Study|Death|174|||
144627099|NCT02551159|521491240|FG002|Overall Study|Death|161|||
144627100|NCT02551159|521491238|FG000|Overall Study|Withdrawal by Subject|8|||
144627101|NCT02551159|521491239|FG001|Overall Study|Withdrawal by Subject|5|||
144627102|NCT02551159|521491240|FG002|Overall Study|Withdrawal by Subject|16|||
144627103|NCT02551159|521491238|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
144627104|NCT02551159|521491239|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
144627105|NCT02551159|521491240|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
144627106|NCT02175680|521491241|FG000|Overall Study|non-compliance|1|||
144627107|NCT02175680|521491241|FG000|Overall Study|other non-medical reason|1|||
144627108|NCT01469000|521491245|FG000|Overall Study|Withdrawal by Subject|16|||
144627109|NCT01469000|521491246|FG001|Overall Study|Withdrawal by Subject|3|||
144627110|NCT01469000|521491245|FG000|Overall Study|Sponsor Decision|4|||
144627111|NCT01469000|521491246|FG001|Overall Study|Sponsor Decision|1|||
144627112|NCT02183519|521491251|FG000|Overall Study|computer error|3|||
144627113|NCT02183519|521491252|FG001|Overall Study|computer error|0|||
144627114|NCT02183519|521491251|FG000|Overall Study|Did not respond to cough inducter|0|||
144627115|NCT02183519|521491252|FG001|Overall Study|Did not respond to cough inducter|3|||
144627116|NCT01634555|521491255|FG000|Overall Study|Adverse Event|3|||
144627117|NCT01634555|521491255|FG000|Overall Study|Physician Decision|1|||
144627118|NCT01738971|521491256|FG000|Overall Study|Lost to Follow-up|19|||
144627119|NCT01738971|521491257|FG001|Overall Study|Lost to Follow-up|30|||
144627120|NCT01738971|521491258|FG002|Overall Study|Lost to Follow-up|17|||
144627121|NCT04698629|521491263|FG000|Overall Study|Adverse Event|1|||
144627122|NCT02949128|521493290|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
144627123|NCT02949128|521493290|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
144627124|NCT02949128|521493290|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
144627125|NCT02949128|521493290|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
144627126|NCT02949128|521493290|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
144627127|NCT02949128|521493290|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
144627128|NCT02949128|521493290|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
144627129|NCT02949128|521493290|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
144627130|NCT02949128|521493290|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
144627131|NCT02949128|521493290|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
144627132|NCT02152345|521493291|FG000|Overall Study|Case Cancellations|2|||
144627133|NCT02152345|521493292|FG001|Overall Study|Case Cancellations|4|||
144627134|NCT02152345|521493291|FG000|Overall Study|Withdrawal by Subject|2|||
144627135|NCT02152345|521493292|FG001|Overall Study|Withdrawal by Subject|1|||
144627136|NCT00880750|521493298|FG000|First Intervention|Adverse Event|1|||
144627137|NCT00880750|521493299|FG001|First Intervention|Adverse Event|0|||
144627138|NCT00880750|521493298|FG000|First Intervention|Unable to collect urine|4|||
144627139|NCT00880750|521493299|FG001|First Intervention|Unable to collect urine|0|||
144627140|NCT00880750|521493298|FG000|First Intervention|Non-compliance with meals|0|||
144627141|NCT00880750|521493299|FG001|First Intervention|Non-compliance with meals|1|||
144627142|NCT00880750|521493298|FG000|First Intervention|Withdrawal by Subject|2|||
144627143|NCT00880750|521493299|FG001|First Intervention|Withdrawal by Subject|0|||
144627144|NCT00880750|521493298|FG000|First Intervention|Lost to Follow-up|2|||
144627145|NCT00880750|521493299|FG001|First Intervention|Lost to Follow-up|0|||
144627146|NCT00880750|521493298|FG000|Second Intervention|Withdrawal by Subject|2|||
144627147|NCT00880750|521493299|FG001|Second Intervention|Withdrawal by Subject|2|||
144627148|NCT00880750|521493298|FG000|Second Intervention|Protocol Violation|1|||
144627149|NCT00880750|521493299|FG001|Second Intervention|Protocol Violation|0|||
144627150|NCT00880750|521493298|FG000|Second Intervention|Unable to collect urine|1|||
144627151|NCT00880750|521493299|FG001|Second Intervention|Unable to collect urine|0|||
144627152|NCT00667576|521493302|FG000|Overall Study|Withdrawal by Subject|1|||
144627153|NCT00667576|521493303|FG001|Overall Study|Withdrawal by Subject|0|||
144209729|NCT05199090|519962029|FG003|Overall Study|Physician Decision|0|||
144627154|NCT00667576|521493304|FG002|Overall Study|Withdrawal by Subject|1|||
144627155|NCT00667576|521493305|FG003|Overall Study|Withdrawal by Subject|1|||
144627156|NCT00667576|521493306|FG004|Overall Study|Withdrawal by Subject|1|||
144627157|NCT00667576|521493302|FG000|Overall Study|Adverse Event|1|||
144627158|NCT00667576|521493303|FG001|Overall Study|Adverse Event|1|||
144627159|NCT00667576|521493304|FG002|Overall Study|Adverse Event|0|||
144627160|NCT00667576|521493305|FG003|Overall Study|Adverse Event|0|||
144627161|NCT00667576|521493306|FG004|Overall Study|Adverse Event|0|||
144627162|NCT00667576|521493302|FG000|Overall Study|Lost to Follow-up|0|||
144627163|NCT00667576|521493303|FG001|Overall Study|Lost to Follow-up|0|||
144627164|NCT00667576|521493304|FG002|Overall Study|Lost to Follow-up|1|||
144627165|NCT00667576|521493305|FG003|Overall Study|Lost to Follow-up|0|||
144627166|NCT00667576|521493306|FG004|Overall Study|Lost to Follow-up|0|||
144627167|NCT00667576|521493302|FG000|Overall Study|Protocol Violation|0|||
144627168|NCT00667576|521493303|FG001|Overall Study|Protocol Violation|0|||
144627169|NCT00667576|521493304|FG002|Overall Study|Protocol Violation|0|||
144627170|NCT00667576|521493305|FG003|Overall Study|Protocol Violation|1|||
144627171|NCT00667576|521493306|FG004|Overall Study|Protocol Violation|0|||
144627172|NCT00667576|521493302|FG000|Overall Study|Physician Decision|0|||
144627173|NCT00667576|521493303|FG001|Overall Study|Physician Decision|0|||
144627174|NCT00667576|521493304|FG002|Overall Study|Physician Decision|0|||
144627175|NCT00667576|521493305|FG003|Overall Study|Physician Decision|1|||
144627176|NCT00667576|521493306|FG004|Overall Study|Physician Decision|0|||
144627177|NCT00667576|521493302|FG000|Overall Study|Missed Visit|0|||
144627178|NCT00667576|521493303|FG001|Overall Study|Missed Visit|0|||
144627179|NCT00667576|521493304|FG002|Overall Study|Missed Visit|0|||
144627180|NCT00667576|521493305|FG003|Overall Study|Missed Visit|1|||
144627181|NCT00667576|521493306|FG004|Overall Study|Missed Visit|0|||
144627182|NCT03593915|521493307|FG000|Overall Study|Adverse Event|0|||
144627183|NCT03593915|521493308|FG001|Overall Study|Adverse Event|0|||
144627184|NCT03593915|521493309|FG002|Overall Study|Adverse Event|0|||
144627185|NCT03593915|521493310|FG003|Overall Study|Adverse Event|1|||
144627186|NCT03593915|521493311|FG004|Overall Study|Adverse Event|0|||
144627187|NCT03593915|521493312|FG005|Overall Study|Adverse Event|0|||
144627188|NCT03593915|521493307|FG000|Overall Study|Physician Decision|0|||
144627189|NCT03593915|521493308|FG001|Overall Study|Physician Decision|0|||
144627190|NCT03593915|521493309|FG002|Overall Study|Physician Decision|0|||
144627191|NCT03593915|521493310|FG003|Overall Study|Physician Decision|0|||
144627192|NCT03593915|521493311|FG004|Overall Study|Physician Decision|0|||
144627193|NCT03593915|521493312|FG005|Overall Study|Physician Decision|1|||
144627194|NCT01583179|521493313|FG000|Overall Study|Screen failure|1|||
144627195|NCT01583179|521493314|FG001|Overall Study|Screen failure|2|||
144627196|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
144627197|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
144627198|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
144627199|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
144627200|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
144627201|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
144627202|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
144627203|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
144627204|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
144627205|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
144627206|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
144627207|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
144627208|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
144627209|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
144627210|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
144627211|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
144627212|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
144627213|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
144627214|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
144627215|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
144627216|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
144627217|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
144627218|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
144730624|NCT01804270|521869840|FG000|Overall Study|Withdrawal by Subject|1|||
144627219|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
144627220|NCT04660643|521493315|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
144730625|NCT01804270|521869841|FG001|Overall Study|Withdrawal by Subject|1|||
144627221|NCT04660643|521493316|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
144627222|NCT04660643|521493317|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
144730626|NCT04407806|521869846|FG000|Overall Study|Withdrawal by Subject|1|||
144627223|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
144627224|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
144627225|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
144627226|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
144627227|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
144627228|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
144627229|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
144627230|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
144627231|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
144627232|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
144627233|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
144627234|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
144627235|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
144627236|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
144627237|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
144627238|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
144627239|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
144627240|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
144627241|NCT04660643|521493315|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
144627242|NCT04660643|521493316|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
144627243|NCT04660643|521493317|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
144627244|NCT03988907|521493318|FG000|Overall Study|Unable to complete visit|0|||
144627245|NCT03988907|521493319|FG001|Overall Study|Unable to complete visit|1|||
144627246|NCT01430442|521493325|FG000|Overall Study|Subject Withdrew Consent|3|||
144627247|NCT01430442|521493326|FG001|Overall Study|Subject Withdrew Consent|0|||
144627248|NCT01430442|521493327|FG002|Overall Study|Subject Withdrew Consent|1|||
144627249|NCT01430442|521493328|FG003|Overall Study|Subject Withdrew Consent|0|||
144627250|NCT01430442|521493329|FG004|Overall Study|Subject Withdrew Consent|2|||
144627251|NCT01430442|521493330|FG005|Overall Study|Subject Withdrew Consent|1|||
144627252|NCT01430442|521493331|FG006|Overall Study|Subject Withdrew Consent|5|||
144627253|NCT01430442|521493332|FG007|Overall Study|Subject Withdrew Consent|2|||
144627254|NCT01430442|521493325|FG000|Overall Study|Lost to Follow-up|2|||
144627255|NCT01430442|521493326|FG001|Overall Study|Lost to Follow-up|0|||
144627256|NCT01430442|521493327|FG002|Overall Study|Lost to Follow-up|1|||
144627257|NCT01430442|521493328|FG003|Overall Study|Lost to Follow-up|2|||
144627258|NCT01430442|521493329|FG004|Overall Study|Lost to Follow-up|2|||
144627259|NCT01430442|521493330|FG005|Overall Study|Lost to Follow-up|1|||
144627260|NCT01430442|521493331|FG006|Overall Study|Lost to Follow-up|5|||
144627261|NCT01430442|521493332|FG007|Overall Study|Lost to Follow-up|1|||
144627262|NCT01430442|521493325|FG000|Overall Study|Pregnancy|1|||
144627263|NCT01430442|521493326|FG001|Overall Study|Pregnancy|0|||
144627264|NCT01430442|521493327|FG002|Overall Study|Pregnancy|0|||
144627265|NCT01430442|521493328|FG003|Overall Study|Pregnancy|0|||
144627266|NCT01430442|521493329|FG004|Overall Study|Pregnancy|0|||
144627267|NCT01430442|521493330|FG005|Overall Study|Pregnancy|1|||
144627268|NCT01430442|521493331|FG006|Overall Study|Pregnancy|0|||
144627269|NCT01430442|521493332|FG007|Overall Study|Pregnancy|0|||
144627270|NCT01430442|521493325|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
144627271|NCT01430442|521493326|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
144627272|NCT01430442|521493327|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
144627273|NCT01430442|521493328|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
144627274|NCT01430442|521493329|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
144627275|NCT01430442|521493330|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
144627276|NCT01430442|521493331|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
144627277|NCT01430442|521493332|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
144627278|NCT00772629|521493334|FG000|Overall Study|Subject was not vaccinated|1|||
144627279|NCT00772629|521493335|FG001|Overall Study|Subject was not vaccinated|0|||
144627280|NCT00568555|521493341|FG000|Overall Study|Withdrawal by Subject|1|||
144627281|NCT00568555|521493342|FG001|Overall Study|Withdrawal by Subject|1|||
144627282|NCT01871090|521493343|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
144627283|NCT01871090|521493344|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
144627284|NCT01871090|521493343|FG000|Overall Study|Interrogation not completed correctly|1|||
144627285|NCT01871090|521493344|FG001|Overall Study|Interrogation not completed correctly|0|||
144627286|NCT01871090|521493343|FG000|Overall Study|Subject Non-Compliance|0|||
144627287|NCT01871090|521493344|FG001|Overall Study|Subject Non-Compliance|1|||
144627288|NCT01231555|521493345|FG000|Overall Study|Study terminated|8|||
144627289|NCT01231555|521493346|FG001|Overall Study|Study terminated|5|||
144627290|NCT01231555|521493347|FG002|Overall Study|Study terminated|8|||
144627291|NCT01231555|521493345|FG000|Overall Study|Withdrawal by Subject|0|||
144627292|NCT01231555|521493346|FG001|Overall Study|Withdrawal by Subject|2|||
144627293|NCT01231555|521493347|FG002|Overall Study|Withdrawal by Subject|0|||
144627294|NCT01773421|521493348|FG000|Treatment Phase|Other|0|||
144627295|NCT01773421|521493349|FG001|Treatment Phase|Other|0|||
144627296|NCT01773421|521493350|FG002|Treatment Phase|Other|2|||
144627297|NCT01773421|521493351|FG003|Treatment Phase|Other|0|||
144627298|NCT01773421|521493352|FG004|Treatment Phase|Other|0|||
144627299|NCT01773421|521493353|FG005|Treatment Phase|Other|0|||
144627300|NCT01773421|521493354|FG006|Treatment Phase|Other|0|||
144627301|NCT01773421|521493348|FG000|Treatment Phase|Adverse Event|0|||
144627302|NCT01773421|521493349|FG001|Treatment Phase|Adverse Event|0|||
144627303|NCT01773421|521493350|FG002|Treatment Phase|Adverse Event|3|||
144627304|NCT01773421|521493351|FG003|Treatment Phase|Adverse Event|1|||
144627305|NCT01773421|521493352|FG004|Treatment Phase|Adverse Event|0|||
144627306|NCT01773421|521493353|FG005|Treatment Phase|Adverse Event|0|||
144627307|NCT01773421|521493354|FG006|Treatment Phase|Adverse Event|0|||
144627308|NCT01773421|521493348|FG000|Treatment Phase|Withdrawal by Subject|0|||
144627309|NCT01773421|521493349|FG001|Treatment Phase|Withdrawal by Subject|0|||
144627310|NCT01773421|521493350|FG002|Treatment Phase|Withdrawal by Subject|1|||
144627311|NCT01773421|521493351|FG003|Treatment Phase|Withdrawal by Subject|1|||
144627312|NCT01773421|521493352|FG004|Treatment Phase|Withdrawal by Subject|0|||
144627313|NCT01773421|521493353|FG005|Treatment Phase|Withdrawal by Subject|0|||
144627314|NCT01773421|521493354|FG006|Treatment Phase|Withdrawal by Subject|0|||
144627315|NCT01773421|521493348|FG000|Extension Phase|Other|0|||
144627316|NCT01773421|521493349|FG001|Extension Phase|Other|0|||
144627317|NCT01773421|521493350|FG002|Extension Phase|Other|0|||
144627318|NCT01773421|521493351|FG003|Extension Phase|Other|0|||
144627319|NCT01773421|521493352|FG004|Extension Phase|Other|1|||
144627320|NCT01773421|521493353|FG005|Extension Phase|Other|2|||
144627321|NCT01773421|521493354|FG006|Extension Phase|Other|0|||
144627322|NCT01773421|521493348|FG000|Extension Phase|Adverse Event|0|||
144627323|NCT01773421|521493349|FG001|Extension Phase|Adverse Event|0|||
144627324|NCT01773421|521493350|FG002|Extension Phase|Adverse Event|0|||
144627325|NCT01773421|521493351|FG003|Extension Phase|Adverse Event|0|||
144627326|NCT01773421|521493352|FG004|Extension Phase|Adverse Event|2|||
144627327|NCT01773421|521493353|FG005|Extension Phase|Adverse Event|0|||
144627328|NCT01773421|521493354|FG006|Extension Phase|Adverse Event|0|||
144627329|NCT00688909|521493355|FG000|Overall Study|Adverse Event|28|||
144627330|NCT00688909|521493355|FG000|Overall Study|Patient withdrew consent|2|||
144627331|NCT00688909|521493355|FG000|Overall Study|Administrative problems|1|||
144627332|NCT00688909|521493355|FG000|Overall Study|Protocol Violation|2|||
144627333|NCT02472847|521493356|FG000|Overall Study|Withdrawal by Subject|1|||
144627334|NCT02472847|521493357|FG001|Overall Study|Withdrawal by Subject|5|||
144627335|NCT03980938|521493358|FG000|Treatment Period 1|Study Terminated|1|||
144627336|NCT03980938|521493359|FG001|Treatment Period 1|Study Terminated|1|||
144627337|NCT03980938|521493358|FG000|Treatment Period 2|Study Terminated|2|||
144627338|NCT03980938|521493359|FG001|Treatment Period 2|Study Terminated|2|||
144627339|NCT00605267|521493360|FG000|Overall Study|Adverse Event|0|||
144627340|NCT00605267|521493361|FG001|Overall Study|Adverse Event|1|||
144627341|NCT00605267|521493360|FG000|Overall Study|Lack of Efficacy|1|||
144627342|NCT00605267|521493361|FG001|Overall Study|Lack of Efficacy|5|||
144627343|NCT00605267|521493360|FG000|Overall Study|Withdrawal by Subject|2|||
144627344|NCT00605267|521493361|FG001|Overall Study|Withdrawal by Subject|3|||
144627345|NCT00840827|521493362|FG000|Overall Study|Adverse Event|1|||
144627346|NCT00840827|521493362|FG000|Overall Study|Lack of Efficacy|4|||
144627347|NCT00840827|521493362|FG000|Overall Study|Physician Decision|1|||
144627348|NCT01445535|521493363|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
144627349|NCT01445535|521493364|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
144627350|NCT01445535|521493365|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
144627351|NCT01445535|521493366|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
144627352|NCT01445535|521493363|FG000|Overall Study|Disease progression|1|||
144627353|NCT01445535|521493364|FG001|Overall Study|Disease progression|0|||
144627354|NCT01445535|521493365|FG002|Overall Study|Disease progression|1|||
144627355|NCT01445535|521493366|FG003|Overall Study|Disease progression|0|||
144627356|NCT01445535|521493363|FG000|Overall Study|PI discretion|0|||
144627357|NCT01445535|521493364|FG001|Overall Study|PI discretion|0|||
144627358|NCT01445535|521493365|FG002|Overall Study|PI discretion|0|||
144627359|NCT01445535|521493366|FG003|Overall Study|PI discretion|1|||
144627360|NCT03569202|521493372|FG000|Part 3|Physician Decision|1|||
144627361|NCT03569202|521493373|FG001|Part 3|Physician Decision|0|||
144627362|NCT03569202|521493372|FG000|Part 3|Other|1|||
144627363|NCT03569202|521493373|FG001|Part 3|Other|1|||
144627364|NCT00420511|521493374|FG000|Overall Study|Adverse Event|1|||
144627365|NCT00420511|521493375|FG001|Overall Study|Adverse Event|1|||
144627366|NCT00420511|521493374|FG000|Overall Study|Lost to Follow-up|1|||
144627367|NCT00420511|521493375|FG001|Overall Study|Lost to Follow-up|0|||
144627368|NCT02415712|521493376|FG000|Overall Study|Protocol Violation|16|||
144627369|NCT01668654|521493377|FG000|Overall Study|Study Closed/Terminated|3|||
144627370|NCT01668654|521493377|FG000|Overall Study|Withdrawal by Subject|1|||
144627371|NCT04557384|521493378|FG000|Overall Study|Study Terminated by Sponsor|1|||
144627372|NCT04557384|521493378|FG000|Overall Study|Death|1|||
144627373|NCT00454779|521493380|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
144627374|NCT00454779|521493381|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
144627375|NCT00454779|521493380|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
144627376|NCT00454779|521493381|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
144627377|NCT00454779|521493380|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
144627378|NCT00454779|521493381|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
144627379|NCT00454779|521493380|FG000|First-line Treatment Phase|Protocol Violation|0|||
144627380|NCT00454779|521493381|FG001|First-line Treatment Phase|Protocol Violation|1|||
144627381|NCT00454779|521493380|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
144627382|NCT00454779|521493381|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
144209730|NCT05199090|519962030|FG004|Overall Study|Physician Decision|0|||
144209731|NCT05199090|519962031|FG005|Overall Study|Physician Decision|1|||
144627383|NCT00454779|521493380|FG000|First-line Treatment Phase|Ongoing|1|||
144627384|NCT00454779|521493381|FG001|First-line Treatment Phase|Ongoing|0|||
144627385|NCT00454779|521493380|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
144627386|NCT00454779|521493381|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
144627387|NCT00454779|521493380|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
144627388|NCT00454779|521493381|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
144627389|NCT00454779|521493380|FG000|Second-line Treatment Phase|Ongoing|0|||
144627390|NCT00454779|521493381|FG001|Second-line Treatment Phase|Ongoing|1|||
144627391|NCT04173741|521493383|FG000|Overall Study|IVC measurement cannot be done|1|||
144627392|NCT04173741|521493384|FG001|Overall Study|IVC measurement cannot be done|1|||
144627393|NCT00254566|521493386|FG000|Overall Study|Death|1|||
144627394|NCT00254566|521493387|FG001|Overall Study|Death|0|||
144627395|NCT00254566|521493386|FG000|Overall Study|Adverse Event|5|||
144627396|NCT00254566|521493387|FG001|Overall Study|Adverse Event|4|||
144627397|NCT00254566|521493386|FG000|Overall Study|Lack of Efficacy|12|||
144627398|NCT00254566|521493387|FG001|Overall Study|Lack of Efficacy|9|||
144627399|NCT00254566|521493386|FG000|Overall Study|Other|1|||
144627400|NCT00254566|521493387|FG001|Overall Study|Other|5|||
144627401|NCT00254566|521493386|FG000|Overall Study|Withdrawal by Subject|5|||
144627402|NCT00254566|521493387|FG001|Overall Study|Withdrawal by Subject|6|||
144627403|NCT00254566|521493386|FG000|Overall Study|Lost to Follow-up|7|||
144627404|NCT00254566|521493387|FG001|Overall Study|Lost to Follow-up|2|||
144627405|NCT00059202|521493388|FG000|Overall Study|Withdrawal by Subject|5|||
144627406|NCT00059202|521493389|FG001|Overall Study|Withdrawal by Subject|9|||
144627407|NCT00059202|521493388|FG000|Overall Study|Protocol Violation|1|||
144627408|NCT00059202|521493389|FG001|Overall Study|Protocol Violation|3|||
144627409|NCT00059202|521493388|FG000|Overall Study|drug toxicity|0|||
144627410|NCT00059202|521493389|FG001|Overall Study|drug toxicity|3|||
144627411|NCT00548548|521493392|FG000|Overall Study|Death|345|||
144627412|NCT00548548|521493393|FG001|Overall Study|Death|348|||
144627413|NCT00548548|521493392|FG000|Overall Study|Lost to Follow-up|17|||
144627414|NCT00548548|521493393|FG001|Overall Study|Lost to Follow-up|18|||
144627415|NCT01705691|521493395|FG000|Overall Study|Death|1|||
144627416|NCT01705691|521493396|FG001|Overall Study|Death|2|||
144627417|NCT01705691|521493395|FG000|Overall Study|Withdrawal by Subject|1|||
144627418|NCT01705691|521493396|FG001|Overall Study|Withdrawal by Subject|2|||
144627419|NCT01705691|521493395|FG000|Overall Study|Lost to Follow-up|1|||
144627420|NCT01705691|521493396|FG001|Overall Study|Lost to Follow-up|1|||
144627421|NCT01705691|521493395|FG000|Overall Study|Other|0|||
144627422|NCT01705691|521493396|FG001|Overall Study|Other|1|||
144627423|NCT02658448|521493397|FG000|Overall Study|Lost to Follow-up|1|||
144627424|NCT03106779|521493398|FG000|Overall Study|Lack of Efficacy|33|||
144627425|NCT03106779|521493399|FG001|Overall Study|Lack of Efficacy|24|||
144627426|NCT03106779|521493398|FG000|Overall Study|Adverse Event|8|||
144627427|NCT03106779|521493399|FG001|Overall Study|Adverse Event|16|||
144627428|NCT03106779|521493398|FG000|Overall Study|Physician Decision|10|||
144627429|NCT03106779|521493399|FG001|Overall Study|Physician Decision|6|||
144627430|NCT03106779|521493398|FG000|Overall Study|Patient/guardian decision|4|||
144627431|NCT03106779|521493399|FG001|Overall Study|Patient/guardian decision|3|||
144627432|NCT03106779|521493398|FG000|Overall Study|Progressive disease|1|||
144627433|NCT03106779|521493399|FG001|Overall Study|Progressive disease|3|||
144209732|NCT05199090|519962026|FG000|Overall Study|Study terminated by sponsor|0|||
144209733|NCT05199090|519962027|FG001|Overall Study|Study terminated by sponsor|6|||
144209734|NCT05199090|519962028|FG002|Overall Study|Study terminated by sponsor|0|||
144209735|NCT05199090|519962029|FG003|Overall Study|Study terminated by sponsor|0|||
144209736|NCT05199090|519962030|FG004|Overall Study|Study terminated by sponsor|0|||
144627434|NCT03106779|521493398|FG000|Overall Study|Lost to Follow-up|1|||
144627435|NCT03106779|521493399|FG001|Overall Study|Lost to Follow-up|2|||
144627436|NCT03106779|521493398|FG000|Overall Study|Death|1|||
144627437|NCT03106779|521493399|FG001|Overall Study|Death|0|||
144627438|NCT03106779|521493398|FG000|Overall Study|Protocol Violation|1|||
144209737|NCT05199090|519962031|FG005|Overall Study|Study terminated by sponsor|5|||
144627439|NCT03106779|521493399|FG001|Overall Study|Protocol Violation|0|||
144627440|NCT03106779|521493398|FG000|Overall Study|Not treated|1|||
144627441|NCT03106779|521493399|FG001|Overall Study|Not treated|0|||
144627442|NCT04088409|521493400|FG000|Part A|Withdrawal by Subject|2|||
144627443|NCT04088409|521493401|FG001|Part A|Withdrawal by Subject|1|||
144209738|NCT05199090|519962026|FG000|Overall Study|Subject decision|0|||
144209739|NCT05199090|519962027|FG001|Overall Study|Subject decision|4|||
144209740|NCT05199090|519962028|FG002|Overall Study|Subject decision|0|||
144627444|NCT04088409|521493400|FG000|Part A|Did Not Meet Randomization Criteria|2|||
144627445|NCT04088409|521493401|FG001|Part A|Did Not Meet Randomization Criteria|0|||
144627446|NCT04088409|521493400|FG000|Part A|Lack of Efficacy|9|||
144627447|NCT04088409|521493401|FG001|Part A|Lack of Efficacy|0|||
144627448|NCT04088409|521493400|FG000|Part A|Lost to Follow-up|1|||
144627449|NCT04088409|521493401|FG001|Part A|Lost to Follow-up|0|||
144627450|NCT04088409|521493400|FG000|Part A|Adverse Event|1|||
144627451|NCT04088409|521493401|FG001|Part A|Adverse Event|0|||
144627452|NCT04088409|521493400|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
144627453|NCT04088409|521493401|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
144627454|NCT04088409|521493400|FG000|Part B|Ongoing Treatment|10|||
144627455|NCT04088409|521493401|FG001|Part B|Ongoing Treatment|0|||
144627456|NCT04233229|521493402|FG000|Overall Study|Withdrawal by Subject|0|||
144627457|NCT04233229|521493403|FG001|Overall Study|Withdrawal by Subject|1|||
144627458|NCT04233229|521493402|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
144627459|NCT04233229|521493403|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
144627460|NCT04233229|521493402|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
144627461|NCT04233229|521493403|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
144627462|NCT04652804|521493404|FG000|Overall Study|Ineligible post randomization|1|||
144627463|NCT04652804|521493405|FG001|Overall Study|Ineligible post randomization|0|||
144627464|NCT04652804|521493406|FG002|Overall Study|Ineligible post randomization|1|||
144627465|NCT04652804|521493407|FG003|Overall Study|Ineligible post randomization|0|||
144627466|NCT04652804|521493408|FG004|Overall Study|Ineligible post randomization|1|||
144627467|NCT04652804|521493409|FG005|Overall Study|Ineligible post randomization|1|||
144627468|NCT04652804|521493404|FG000|Overall Study|Missing SVR lab results|2|||
144627469|NCT04652804|521493405|FG001|Overall Study|Missing SVR lab results|0|||
144627470|NCT04652804|521493406|FG002|Overall Study|Missing SVR lab results|0|||
144627471|NCT04652804|521493407|FG003|Overall Study|Missing SVR lab results|0|||
144627472|NCT04652804|521493408|FG004|Overall Study|Missing SVR lab results|0|||
144627473|NCT04652804|521493409|FG005|Overall Study|Missing SVR lab results|0|||
144627474|NCT00584194|521493410|FG000|Overall Study|Other|135|||
144627475|NCT04093531|521493411|FG000|Overall Study|failed screening|4|||
144627476|NCT00841763|521493412|FG000|Overall Study|Withdrawal by Subject|60|||
144627477|NCT00841763|521493413|FG001|Overall Study|Withdrawal by Subject|17|||
144209741|NCT05199090|519962029|FG003|Overall Study|Subject decision|2|||
144209742|NCT05199090|519962030|FG004|Overall Study|Subject decision|5|||
144209743|NCT05199090|519962031|FG005|Overall Study|Subject decision|2|||
144627478|NCT00841763|521493414|FG002|Overall Study|Withdrawal by Subject|4|||
144627479|NCT00841763|521493415|FG003|Overall Study|Withdrawal by Subject|1|||
144627480|NCT00841763|521493412|FG000|Overall Study|Adverse Event|9|||
144627481|NCT00841763|521493413|FG001|Overall Study|Adverse Event|10|||
144627482|NCT00841763|521493414|FG002|Overall Study|Adverse Event|3|||
144627483|NCT00841763|521493415|FG003|Overall Study|Adverse Event|2|||
144627484|NCT00841763|521493412|FG000|Overall Study|Lost to Follow-up|63|||
144627485|NCT00841763|521493413|FG001|Overall Study|Lost to Follow-up|25|||
144627486|NCT00841763|521493414|FG002|Overall Study|Lost to Follow-up|0|||
144627487|NCT00841763|521493415|FG003|Overall Study|Lost to Follow-up|0|||
144627488|NCT00841763|521493412|FG000|Overall Study|Protocol Violation|20|||
144627489|NCT00841763|521493413|FG001|Overall Study|Protocol Violation|3|||
144627490|NCT00841763|521493414|FG002|Overall Study|Protocol Violation|1|||
144627491|NCT00841763|521493415|FG003|Overall Study|Protocol Violation|0|||
144627492|NCT00841763|521493412|FG000|Overall Study|Administrative Reasons|3|||
144209744|NCT03485365|519962032|FG000|Overall Study|Protocol Violation|0|||
144209745|NCT03485365|519962033|FG001|Overall Study|Protocol Violation|0|||
144627493|NCT00841763|521493413|FG001|Overall Study|Administrative Reasons|1|||
144627494|NCT00841763|521493414|FG002|Overall Study|Administrative Reasons|0|||
144627495|NCT00841763|521493415|FG003|Overall Study|Administrative Reasons|0|||
144209746|NCT03485365|519962034|FG002|Overall Study|Protocol Violation|0|||
144209747|NCT03485365|519962035|FG003|Overall Study|Protocol Violation|1|||
144209748|NCT03485365|519962036|FG004|Overall Study|Protocol Violation|0|||
144209749|NCT03485365|519962037|FG005|Overall Study|Protocol Violation|0|||
144209750|NCT03485365|519962038|FG006|Overall Study|Protocol Violation|1|||
144209751|NCT03485365|519962039|FG007|Overall Study|Protocol Violation|0|||
144209752|NCT03485365|519962040|FG008|Overall Study|Protocol Violation|0|||
144209753|NCT01210612|519962042|FG000|Overall Study|Withdrawal by Subject|0|||
144209754|NCT01210612|519962043|FG001|Overall Study|Withdrawal by Subject|2|||
144627496|NCT00841763|521493412|FG000|Overall Study|Unable to Classify|7|||
144627497|NCT00841763|521493413|FG001|Overall Study|Unable to Classify|1|||
144627498|NCT00841763|521493414|FG002|Overall Study|Unable to Classify|0|||
144627499|NCT00841763|521493415|FG003|Overall Study|Unable to Classify|0|||
144627500|NCT00927368|521493418|FG000|Overall Study|enrollment in another study|1|||
144627501|NCT00927368|521493419|FG001|Overall Study|enrollment in another study|1|||
144627502|NCT00927368|521493420|FG002|Overall Study|enrollment in another study|2|||
144209755|NCT02290223|519962049|FG000|6 Months|Lost to Follow-up|9|||
144627503|NCT00927368|521493418|FG000|Overall Study|Lost to Follow-up|4|||
144627504|NCT00927368|521493419|FG001|Overall Study|Lost to Follow-up|0|||
144209756|NCT02290223|519962050|FG001|6 Months|Lost to Follow-up|6|||
144209757|NCT02290223|519962049|FG000|6 Months|Withdrawal by Subject|5|||
144209758|NCT02290223|519962050|FG001|6 Months|Withdrawal by Subject|0|||
144209759|NCT02290223|519962049|FG000|6 Months|deceased (not related to study)|2|||
144627505|NCT00927368|521493420|FG002|Overall Study|Lost to Follow-up|0|||
144627506|NCT00927368|521493418|FG000|Overall Study|equipment failure|1|||
144627507|NCT00927368|521493419|FG001|Overall Study|equipment failure|0|||
144627508|NCT00927368|521493420|FG002|Overall Study|equipment failure|0|||
144627509|NCT00927368|521493418|FG000|Overall Study|ineligible post randomization|0|||
144627510|NCT00927368|521493419|FG001|Overall Study|ineligible post randomization|3|||
144627511|NCT00927368|521493420|FG002|Overall Study|ineligible post randomization|1|||
144627512|NCT00927368|521493418|FG000|Overall Study|cancellation of surgery|0|||
144627513|NCT00927368|521493419|FG001|Overall Study|cancellation of surgery|1|||
144627514|NCT00927368|521493420|FG002|Overall Study|cancellation of surgery|2|||
144627515|NCT00364689|521493421|FG000|Overall Study|Lost to Follow-up|1|||
144627516|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
144627517|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
144627518|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
144627519|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
144627520|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
144627521|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
144627522|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
144627523|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
144627524|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
144627525|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
144627526|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
144627527|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
144627528|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
144627529|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
144627530|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
144627531|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
144627532|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
144627533|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
144627534|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
144627535|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
144627536|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
144627537|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
144627538|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
144627539|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
144627540|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Death|2|||
144627541|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Death|1|||
144627542|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Death|2|||
144627543|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Graft loss|0|||
144627544|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Graft loss|2|||
144627545|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Graft loss|0|||
144627546|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
144627547|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
144627548|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
144627549|NCT01114529|521493429|FG000|Completed Study Medication at Month 24|Missing|2|||
144627550|NCT01114529|521493430|FG001|Completed Study Medication at Month 24|Missing|0|||
144627551|NCT01114529|521493431|FG002|Completed Study Medication at Month 24|Missing|0|||
144627552|NCT01114529|521493429|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
144627553|NCT01114529|521493430|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
144627554|NCT01114529|521493431|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
144627555|NCT01114529|521493429|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
144627556|NCT01114529|521493430|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
144627557|NCT01114529|521493431|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
144627558|NCT01114529|521493429|FG000|Completed Study Phase at Month 24|Death|8|||
144627559|NCT01114529|521493430|FG001|Completed Study Phase at Month 24|Death|5|||
144209760|NCT02290223|519962050|FG001|6 Months|deceased (not related to study)|0|||
144209761|NCT02290223|519962049|FG000|12 Months|Lost to Follow-up|16|||
144209762|NCT02290223|519962050|FG001|12 Months|Lost to Follow-up|10|||
144209763|NCT02290223|519962049|FG000|12 Months|Refusal|0|||
144209764|NCT02290223|519962050|FG001|12 Months|Refusal|1|||
144209765|NCT00813800|519962051|FG000|Overall Study|Screen Failure after Consent|2|||
144209766|NCT00813800|519962051|FG000|Overall Study|Adverse Event|1|||
144262944|NCT03934216|520163794|FG000|Overall Study|Withdrawal by Subject|18|||
144262945|NCT03934216|520163795|FG001|Overall Study|Withdrawal by Subject|6|||
144627560|NCT01114529|521493431|FG002|Completed Study Phase at Month 24|Death|4|||
144627561|NCT01114529|521493429|FG000|Completed Study Phase at Month 24|Other|2|||
144209767|NCT00813800|519962051|FG000|Overall Study|Worsening of depression|2|||
144209768|NCT00813800|519962051|FG000|Overall Study|Physician Decision|1|||
144627562|NCT01114529|521493430|FG001|Completed Study Phase at Month 24|Other|0|||
144627563|NCT01114529|521493431|FG002|Completed Study Phase at Month 24|Other|0|||
144627564|NCT01114529|521493429|FG000|Completed Study Phase at Month 24|Missing|2|||
144627565|NCT01114529|521493430|FG001|Completed Study Phase at Month 24|Missing|0|||
144627566|NCT01114529|521493431|FG002|Completed Study Phase at Month 24|Missing|0|||
144627567|NCT01482910|521493433|FG000|Overall Study|Adverse Event|6|||
144627568|NCT01482910|521493434|FG001|Overall Study|Adverse Event|5|||
144627569|NCT01482910|521493433|FG000|Overall Study|Lost to Follow-up|0|||
144627570|NCT01482910|521493434|FG001|Overall Study|Lost to Follow-up|1|||
144627571|NCT01482910|521493433|FG000|Overall Study|Protocol Violation|1|||
144627572|NCT01482910|521493434|FG001|Overall Study|Protocol Violation|1|||
144627573|NCT01482910|521493433|FG000|Overall Study|Withdrawal by Subject|7|||
144627574|NCT01482910|521493434|FG001|Overall Study|Withdrawal by Subject|2|||
144627575|NCT01482910|521493433|FG000|Overall Study|Death|1|||
144627576|NCT01482910|521493434|FG001|Overall Study|Death|0|||
144627577|NCT03222349|521493438|FG000|Overall Study|Treatment B not done|5|||
144627578|NCT03222349|521493439|FG001|Overall Study|Treatment B not done|0|||
144627579|NCT03222349|521493438|FG000|Overall Study|Lost to Follow-up|1|||
144627580|NCT03222349|521493439|FG001|Overall Study|Lost to Follow-up|2|||
144627581|NCT03222349|521493438|FG000|Overall Study|Withdrawal by Subject|1|||
144627582|NCT03222349|521493439|FG001|Overall Study|Withdrawal by Subject|0|||
144627583|NCT03222349|521493438|FG000|Overall Study|Treatment A not done|0|||
144627584|NCT03222349|521493439|FG001|Overall Study|Treatment A not done|5|||
144627585|NCT03222349|521493438|FG000|Overall Study|Study terminated by sponsor|1|||
144627586|NCT03222349|521493439|FG001|Overall Study|Study terminated by sponsor|0|||
144627587|NCT02614079|521493440|FG000|Overall Study|Withdrawal by Subject|1|||
144627588|NCT03072160|521493443|FG000|Overall Study|Adverse Event|3|||
144627589|NCT03072160|521493444|FG001|Overall Study|Adverse Event|1|||
144627590|NCT03072160|521493443|FG000|Overall Study|Refused further treatment|6|||
144627591|NCT03072160|521493444|FG001|Overall Study|Refused further treatment|1|||
144627592|NCT03072160|521493443|FG000|Overall Study|Physician Decision|1|||
144627593|NCT03072160|521493444|FG001|Overall Study|Physician Decision|0|||
144627594|NCT03072160|521493443|FG000|Overall Study|Disease progression on study|1|||
144627595|NCT03072160|521493444|FG001|Overall Study|Disease progression on study|1|||
144627596|NCT03072160|521493443|FG000|Overall Study|No contact|0|||
144627597|NCT03072160|521493444|FG001|Overall Study|No contact|1|||
144627598|NCT00236080|521493445|FG000|Overall Study|Adverse Event|0|||
144627599|NCT00236080|521493446|FG001|Overall Study|Adverse Event|0|||
144627600|NCT00236080|521493447|FG002|Overall Study|Adverse Event|3|||
144627601|NCT00236080|521493448|FG003|Overall Study|Adverse Event|1|||
144627602|NCT00236080|521493449|FG004|Overall Study|Adverse Event|0|||
144627603|NCT00236080|521493445|FG000|Overall Study|Lost to Follow-up|0|||
144627604|NCT00236080|521493446|FG001|Overall Study|Lost to Follow-up|1|||
144627605|NCT00236080|521493447|FG002|Overall Study|Lost to Follow-up|0|||
144627606|NCT00236080|521493448|FG003|Overall Study|Lost to Follow-up|0|||
144627607|NCT00236080|521493449|FG004|Overall Study|Lost to Follow-up|0|||
144627608|NCT00236080|521493445|FG000|Overall Study|Physician Decision|1|||
144627609|NCT00236080|521493446|FG001|Overall Study|Physician Decision|0|||
144627610|NCT00236080|521493447|FG002|Overall Study|Physician Decision|1|||
144627611|NCT00236080|521493448|FG003|Overall Study|Physician Decision|1|||
144627612|NCT00236080|521493449|FG004|Overall Study|Physician Decision|1|||
144627613|NCT00236080|521493445|FG000|Overall Study|Withdrawal by Subject|1|||
144627614|NCT00236080|521493446|FG001|Overall Study|Withdrawal by Subject|0|||
144627615|NCT00236080|521493447|FG002|Overall Study|Withdrawal by Subject|0|||
144627616|NCT00236080|521493448|FG003|Overall Study|Withdrawal by Subject|0|||
144627617|NCT00236080|521493449|FG004|Overall Study|Withdrawal by Subject|0|||
144627618|NCT00236080|521493445|FG000|Overall Study|Miscellaneous|0|||
144627619|NCT00236080|521493446|FG001|Overall Study|Miscellaneous|0|||
144627620|NCT00236080|521493447|FG002|Overall Study|Miscellaneous|1|||
144627621|NCT00236080|521493448|FG003|Overall Study|Miscellaneous|0|||
144627622|NCT00236080|521493449|FG004|Overall Study|Miscellaneous|0|||
144627623|NCT01214044|521493450|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
144627624|NCT01214044|521493450|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
144627625|NCT01214044|521493450|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
144627626|NCT01214044|521493450|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
144627627|NCT01214044|521493450|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
144627628|NCT01214044|521493450|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
144627629|NCT00408694|521493451|FG000|Overall Study|Ineligible|1|||
144627630|NCT00408694|521493451|FG000|Overall Study|No protocol treatment|1|||
144627631|NCT01961544|521493452|FG000|Overall Study|Protocol Violation|1|||
144627632|NCT01961544|521493452|FG000|Overall Study|Withdrawal by Subject|7|||
144627633|NCT01961544|521493452|FG000|Overall Study|Adverse Event|1|||
144627634|NCT01961544|521493452|FG000|Overall Study|Physician Decision|2|||
144627635|NCT01961544|521493452|FG000|Overall Study|Poor Tolerance|1|||
144627636|NCT01961544|521493452|FG000|Overall Study|Aggravation of Steral Pain|1|||
144627637|NCT02251912|521493455|FG000|Overall Study|Withdrawal by Subject|2|||
144627638|NCT02251912|521493456|FG001|Overall Study|Withdrawal by Subject|3|||
144627639|NCT02251912|521493455|FG000|Overall Study|Adverse Event|0|||
144627640|NCT02251912|521493456|FG001|Overall Study|Adverse Event|2|||
144627641|NCT03969888|521493458|FG000|Overall Study|Never Received Study Drug|0|||
144627642|NCT03969888|521493459|FG001|Overall Study|Never Received Study Drug|0|||
144627643|NCT03969888|521493460|FG002|Overall Study|Never Received Study Drug|1|||
144627644|NCT03969888|521493461|FG003|Overall Study|Never Received Study Drug|0|||
144627645|NCT03969888|521493462|FG004|Overall Study|Never Received Study Drug|0|||
144627646|NCT03969888|521493463|FG005|Overall Study|Never Received Study Drug|0|||
144627647|NCT03969888|521493464|FG006|Overall Study|Never Received Study Drug|1|||
144627648|NCT03969888|521493465|FG007|Overall Study|Never Received Study Drug|0|||
144627649|NCT03969888|521493458|FG000|Overall Study|Reason Not Specified|0|||
144627650|NCT03969888|521493459|FG001|Overall Study|Reason Not Specified|0|||
144627651|NCT03969888|521493460|FG002|Overall Study|Reason Not Specified|0|||
144627652|NCT03969888|521493461|FG003|Overall Study|Reason Not Specified|0|||
144627653|NCT03969888|521493462|FG004|Overall Study|Reason Not Specified|0|||
144627654|NCT03969888|521493463|FG005|Overall Study|Reason Not Specified|0|||
144627655|NCT03969888|521493464|FG006|Overall Study|Reason Not Specified|0|||
144627656|NCT03969888|521493465|FG007|Overall Study|Reason Not Specified|1|||
144627657|NCT00091832|521493467|FG000|Overall Study|Physician Decision|1|||
144627658|NCT00091832|521493468|FG001|Overall Study|Physician Decision|0|||
144627659|NCT00091832|521493469|FG002|Overall Study|Physician Decision|0|||
144627660|NCT00091832|521493470|FG003|Overall Study|Physician Decision|0|||
144627661|NCT00091832|521493471|FG004|Overall Study|Physician Decision|0|||
144627662|NCT00091832|521493472|FG005|Overall Study|Physician Decision|0|||
144627663|NCT00091832|521493467|FG000|Overall Study|Adverse Event|0|||
144627664|NCT00091832|521493468|FG001|Overall Study|Adverse Event|0|||
144627665|NCT00091832|521493469|FG002|Overall Study|Adverse Event|0|||
144627666|NCT00091832|521493470|FG003|Overall Study|Adverse Event|1|||
144627667|NCT00091832|521493471|FG004|Overall Study|Adverse Event|3|||
144627668|NCT00091832|521493472|FG005|Overall Study|Adverse Event|0|||
144627669|NCT00091832|521493467|FG000|Overall Study|Withdrawal by Subject|4|||
144627670|NCT00091832|521493468|FG001|Overall Study|Withdrawal by Subject|5|||
144627671|NCT00091832|521493469|FG002|Overall Study|Withdrawal by Subject|0|||
144627672|NCT00091832|521493470|FG003|Overall Study|Withdrawal by Subject|1|||
144627673|NCT00091832|521493471|FG004|Overall Study|Withdrawal by Subject|3|||
144627674|NCT00091832|521493472|FG005|Overall Study|Withdrawal by Subject|1|||
144627675|NCT00091832|521493467|FG000|Overall Study|Death|6|||
144627676|NCT00091832|521493468|FG001|Overall Study|Death|4|||
144627677|NCT00091832|521493469|FG002|Overall Study|Death|5|||
144627678|NCT00091832|521493470|FG003|Overall Study|Death|8|||
144627679|NCT00091832|521493471|FG004|Overall Study|Death|5|||
144627680|NCT00091832|521493472|FG005|Overall Study|Death|6|||
144627681|NCT00091832|521493467|FG000|Overall Study|Disease Progression|2|||
144627682|NCT00091832|521493468|FG001|Overall Study|Disease Progression|0|||
144627683|NCT00091832|521493469|FG002|Overall Study|Disease Progression|0|||
144627684|NCT00091832|521493470|FG003|Overall Study|Disease Progression|1|||
144627685|NCT00091832|521493471|FG004|Overall Study|Disease Progression|1|||
144627686|NCT00091832|521493472|FG005|Overall Study|Disease Progression|2|||
144627687|NCT00091832|521493467|FG000|Overall Study|Ineligibility Determined|0|||
144627688|NCT00091832|521493468|FG001|Overall Study|Ineligibility Determined|0|||
144627689|NCT00091832|521493469|FG002|Overall Study|Ineligibility Determined|1|||
144627690|NCT00091832|521493470|FG003|Overall Study|Ineligibility Determined|0|||
144627691|NCT00091832|521493471|FG004|Overall Study|Ineligibility Determined|1|||
144627692|NCT00091832|521493472|FG005|Overall Study|Ineligibility Determined|0|||
144627693|NCT00091832|521493467|FG000|Overall Study|Lost to Follow-up|1|||
144627694|NCT00091832|521493468|FG001|Overall Study|Lost to Follow-up|0|||
144627695|NCT00091832|521493469|FG002|Overall Study|Lost to Follow-up|3|||
144627696|NCT00091832|521493470|FG003|Overall Study|Lost to Follow-up|3|||
144627697|NCT00091832|521493471|FG004|Overall Study|Lost to Follow-up|2|||
144627698|NCT00091832|521493472|FG005|Overall Study|Lost to Follow-up|1|||
144627699|NCT00091832|521493467|FG000|Overall Study|Noncompliance|0|||
144627700|NCT00091832|521493468|FG001|Overall Study|Noncompliance|1|||
144627701|NCT00091832|521493469|FG002|Overall Study|Noncompliance|0|||
144627702|NCT00091832|521493470|FG003|Overall Study|Noncompliance|0|||
144627703|NCT00091832|521493471|FG004|Overall Study|Noncompliance|0|||
144627704|NCT00091832|521493472|FG005|Overall Study|Noncompliance|0|||
144627705|NCT00091832|521493467|FG000|Overall Study|Other|0|||
144627706|NCT00091832|521493468|FG001|Overall Study|Other|1|||
144627707|NCT00091832|521493469|FG002|Overall Study|Other|2|||
144627708|NCT00091832|521493470|FG003|Overall Study|Other|0|||
144627709|NCT00091832|521493471|FG004|Overall Study|Other|0|||
144627710|NCT00091832|521493472|FG005|Overall Study|Other|0|||
144627711|NCT00091832|521493467|FG000|Overall Study|Protocol Violation|0|||
144627712|NCT00091832|521493468|FG001|Overall Study|Protocol Violation|0|||
144627713|NCT00091832|521493469|FG002|Overall Study|Protocol Violation|1|||
144627714|NCT00091832|521493470|FG003|Overall Study|Protocol Violation|0|||
144627715|NCT00091832|521493471|FG004|Overall Study|Protocol Violation|0|||
144627716|NCT00091832|521493472|FG005|Overall Study|Protocol Violation|1|||
144627717|NCT01557166|521493475|FG000|Overall Study|Adverse Event|20|||
144627718|NCT01557166|521493476|FG001|Overall Study|Adverse Event|6|||
144209769|NCT03456453|519962052|FG000|Overall Study|Withdrawal by Subject|2|||
144209770|NCT03456453|519962053|FG001|Overall Study|Withdrawal by Subject|0|||
144209771|NCT03456453|519962052|FG000|Overall Study|Not released to community|1|||
144209772|NCT03456453|519962053|FG001|Overall Study|Not released to community|5|||
144209773|NCT03456453|519962052|FG000|Overall Study|Lost to Follow-up|0|||
144209774|NCT03456453|519962053|FG001|Overall Study|Lost to Follow-up|2|||
144209775|NCT02785952|519962054|FG000|Overall Study|Adverse Event|31|||
144627719|NCT01557166|521493475|FG000|Overall Study|Lack of Efficacy|2|||
144627720|NCT01557166|521493476|FG001|Overall Study|Lack of Efficacy|1|||
144627721|NCT01557166|521493475|FG000|Overall Study|Protocol Violation|8|||
144627722|NCT01557166|521493476|FG001|Overall Study|Protocol Violation|5|||
144627723|NCT01557166|521493475|FG000|Overall Study|Withdrawn consent|12|||
144627724|NCT01557166|521493476|FG001|Overall Study|Withdrawn consent|20|||
144627725|NCT01557166|521493475|FG000|Overall Study|Target dose not tolerated|1|||
144627726|NCT01557166|521493476|FG001|Overall Study|Target dose not tolerated|0|||
144627727|NCT01557166|521493475|FG000|Overall Study|Psychiatric disorder|1|||
144627728|NCT01557166|521493476|FG001|Overall Study|Psychiatric disorder|0|||
144627729|NCT01557166|521493475|FG000|Overall Study|Unclassified|2|||
144627730|NCT01557166|521493476|FG001|Overall Study|Unclassified|5|||
144627731|NCT04506294|521493477|FG000|Overall Study|Lost to Follow-up|70|||
144627732|NCT04506294|521493478|FG001|Overall Study|Lost to Follow-up|20|||
144627733|NCT04506294|521493477|FG000|Overall Study|Withdrawal by Subject|16|||
144627734|NCT04506294|521493478|FG001|Overall Study|Withdrawal by Subject|2|||
144627735|NCT04949841|521493487|FG000|Overall Study|Adverse Event|7|||
144627736|NCT04949841|521493487|FG000|Overall Study|Death|1|||
144627737|NCT04949841|521493487|FG000|Overall Study|Withdrawal by Subject|52|||
144627738|NCT04949841|521493487|FG000|Overall Study|Pregnancy|4|||
144627739|NCT04949841|521493487|FG000|Overall Study|Lost to Follow-up|9|||
144627740|NCT04949841|521493487|FG000|Overall Study|Lack of Efficacy|55|||
144627741|NCT04949841|521493487|FG000|Overall Study|Various reasons|9|||
144627742|NCT03179436|521493488|FG000|Overall Study|Withdrawal by Subject|1|||
144627743|NCT03179436|521493489|FG001|Overall Study|Withdrawal by Subject|0|||
144627744|NCT03179436|521493490|FG002|Overall Study|Withdrawal by Subject|0|||
144627745|NCT03179436|521493491|FG003|Overall Study|Withdrawal by Subject|4|||
144627746|NCT03179436|521493492|FG004|Overall Study|Withdrawal by Subject|2|||
144627747|NCT03179436|521493493|FG005|Overall Study|Withdrawal by Subject|2|||
144627748|NCT03179436|521493494|FG006|Overall Study|Withdrawal by Subject|5|||
144627749|NCT03179436|521493495|FG007|Overall Study|Withdrawal by Subject|0|||
144627750|NCT03179436|521493496|FG008|Overall Study|Withdrawal by Subject|3|||
144627751|NCT03179436|521493497|FG009|Overall Study|Withdrawal by Subject|0|||
144627752|NCT03179436|521493498|FG010|Overall Study|Withdrawal by Subject|0|||
144627753|NCT03179436|521493499|FG011|Overall Study|Withdrawal by Subject|0|||
144627754|NCT03179436|521493488|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144627755|NCT03179436|521493489|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144627756|NCT03179436|521493490|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144627757|NCT03179436|521493491|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144627758|NCT03179436|521493492|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144627759|NCT03179436|521493493|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144627760|NCT03179436|521493494|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
144627761|NCT03179436|521493495|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
144627762|NCT03179436|521493496|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
144627763|NCT03179436|521493497|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
144627764|NCT03179436|521493498|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
144627765|NCT03179436|521493499|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
144627766|NCT03179436|521493488|FG000|Overall Study|Sponsor Decision|0|||
144627767|NCT03179436|521493489|FG001|Overall Study|Sponsor Decision|0|||
144627768|NCT03179436|521493490|FG002|Overall Study|Sponsor Decision|1|||
144627769|NCT03179436|521493491|FG003|Overall Study|Sponsor Decision|3|||
144627770|NCT03179436|521493492|FG004|Overall Study|Sponsor Decision|9|||
144627771|NCT03179436|521493493|FG005|Overall Study|Sponsor Decision|7|||
144627772|NCT03179436|521493494|FG006|Overall Study|Sponsor Decision|2|||
144627773|NCT03179436|521493495|FG007|Overall Study|Sponsor Decision|4|||
144627774|NCT03179436|521493496|FG008|Overall Study|Sponsor Decision|23|||
144627775|NCT03179436|521493497|FG009|Overall Study|Sponsor Decision|6|||
144627776|NCT03179436|521493498|FG010|Overall Study|Sponsor Decision|7|||
144627777|NCT03179436|521493499|FG011|Overall Study|Sponsor Decision|5|||
144627778|NCT03179436|521493488|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627779|NCT03179436|521493489|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
144627780|NCT03179436|521493490|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627781|NCT03179436|521493491|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627782|NCT03179436|521493492|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627783|NCT03179436|521493493|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
144209776|NCT02785952|519962055|FG001|Overall Study|Adverse Event|19|||
144209777|NCT02785952|519962054|FG000|Overall Study|Refusal unrelated to adverse events|10|||
144209778|NCT02785952|519962055|FG001|Overall Study|Refusal unrelated to adverse events|5|||
144209779|NCT02785952|519962054|FG000|Overall Study|Disease progression/relapse|61|||
144209780|NCT02785952|519962055|FG001|Overall Study|Disease progression/relapse|89|||
144209781|NCT02785952|519962054|FG000|Overall Study|Death|11|||
144209782|NCT02785952|519962055|FG001|Overall Study|Death|7|||
144209783|NCT02785952|519962054|FG000|Overall Study|Other- not protocol specified|6|||
144209784|NCT02785952|519962055|FG001|Overall Study|Other- not protocol specified|4|||
144209785|NCT02785952|519962054|FG000|Overall Study|On protocol treatment|6|||
144209786|NCT02785952|519962055|FG001|Overall Study|On protocol treatment|3|||
144209787|NCT00896480|519962056|FG000|Overall Study|Disease progression/recurrence|21|||
144209788|NCT00205803|519962060|FG000|Infant Series|Lost to Follow-up|10|||
144209789|NCT00205803|519962061|FG001|Infant Series|Lost to Follow-up|4|||
144209790|NCT00205803|519962060|FG000|Infant Series|Withdrawal by Subject|2|||
144586867|NCT04811131|521346942|FG002|Overall Study|Lost to Follow-up|0|||
144586868|NCT04811131|521346943|FG003|Overall Study|Lost to Follow-up|0|||
144586869|NCT04811131|521346940|FG000|Overall Study|Sponsor request|31|||
144627784|NCT03179436|521493494|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627785|NCT03179436|521493495|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627786|NCT03179436|521493496|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627787|NCT03179436|521493497|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627788|NCT03179436|521493498|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627789|NCT03179436|521493499|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
144627790|NCT03179436|521493488|FG000|Overall Study|Lost to Follow-up|1|||
144627791|NCT03179436|521493489|FG001|Overall Study|Lost to Follow-up|0|||
144627792|NCT03179436|521493490|FG002|Overall Study|Lost to Follow-up|0|||
144627793|NCT03179436|521493491|FG003|Overall Study|Lost to Follow-up|1|||
144627794|NCT03179436|521493492|FG004|Overall Study|Lost to Follow-up|0|||
144627795|NCT03179436|521493493|FG005|Overall Study|Lost to Follow-up|1|||
144627796|NCT03179436|521493494|FG006|Overall Study|Lost to Follow-up|0|||
144627797|NCT03179436|521493495|FG007|Overall Study|Lost to Follow-up|0|||
144627798|NCT03179436|521493496|FG008|Overall Study|Lost to Follow-up|1|||
144627799|NCT03179436|521493497|FG009|Overall Study|Lost to Follow-up|1|||
144627800|NCT03179436|521493498|FG010|Overall Study|Lost to Follow-up|0|||
144627801|NCT03179436|521493499|FG011|Overall Study|Lost to Follow-up|0|||
144627802|NCT03179436|521493488|FG000|Overall Study|Death|12|||
144627803|NCT03179436|521493489|FG001|Overall Study|Death|17|||
144627804|NCT03179436|521493490|FG002|Overall Study|Death|7|||
144627805|NCT03179436|521493491|FG003|Overall Study|Death|32|||
144627806|NCT03179436|521493492|FG004|Overall Study|Death|29|||
144627807|NCT03179436|521493493|FG005|Overall Study|Death|30|||
144627808|NCT03179436|521493494|FG006|Overall Study|Death|33|||
144627809|NCT03179436|521493495|FG007|Overall Study|Death|9|||
144627810|NCT03179436|521493496|FG008|Overall Study|Death|84|||
144627811|NCT03179436|521493497|FG009|Overall Study|Death|33|||
144627812|NCT03179436|521493498|FG010|Overall Study|Death|22|||
144627813|NCT03179436|521493499|FG011|Overall Study|Death|15|||
144627814|NCT05888103|521495459|FG000|Overall Study|Participant decision|3|||
144627815|NCT05888103|521495460|FG001|Overall Study|Participant decision|3|||
144627816|NCT01602341|521495461|FG000|Overall Study|Adverse Event|0|||
144209791|NCT00205803|519962061|FG001|Infant Series|Withdrawal by Subject|5|||
144209792|NCT00205803|519962060|FG000|Infant Series|Physician Decision|3|||
144586870|NCT04811131|521346941|FG001|Overall Study|Sponsor request|35|||
144586871|NCT04811131|521346942|FG002|Overall Study|Sponsor request|27|||
144586872|NCT04811131|521346943|FG003|Overall Study|Sponsor request|10|||
144586873|NCT04811131|521346940|FG000|Overall Study|Withdrawal by Subject|3|||
144586874|NCT04811131|521346941|FG001|Overall Study|Withdrawal by Subject|1|||
144586875|NCT04811131|521346942|FG002|Overall Study|Withdrawal by Subject|3|||
144586876|NCT04811131|521346943|FG003|Overall Study|Withdrawal by Subject|1|||
144586877|NCT00620282|521346948|FG000|Overall Study|Adverse Event|0|||
144586878|NCT00620282|521346949|FG001|Overall Study|Adverse Event|1|||
144586879|NCT00620282|521346950|FG002|Overall Study|Adverse Event|0|||
144586880|NCT00620282|521346948|FG000|Overall Study|Arterial line unable to be placed|0|||
144586881|NCT00620282|521346949|FG001|Overall Study|Arterial line unable to be placed|0|||
144586882|NCT00620282|521346950|FG002|Overall Study|Arterial line unable to be placed|1|||
144586883|NCT00620282|521346948|FG000|Overall Study|Withdrawal by Subject|0|||
144586884|NCT00620282|521346949|FG001|Overall Study|Withdrawal by Subject|1|||
144586885|NCT00620282|521346950|FG002|Overall Study|Withdrawal by Subject|0|||
144586886|NCT02703259|521346951|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
144586887|NCT02703259|521346952|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
144586888|NCT02703259|521346951|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
144586889|NCT02703259|521346952|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
144586890|NCT02703259|521346951|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
144586891|NCT02703259|521346952|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
144586892|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|Death|1|||
144586893|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|Death|1|||
144586894|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
144627817|NCT01602341|521495462|FG001|Overall Study|Adverse Event|1|||
144627818|NCT02554929|521495463|FG000|Overall Study|Lost to Follow-up|4|||
144627819|NCT02554929|521495464|FG001|Overall Study|Lost to Follow-up|4|||
144627820|NCT02554929|521495463|FG000|Overall Study|Withdrawal by Subject|2|||
144627821|NCT02554929|521495464|FG001|Overall Study|Withdrawal by Subject|8|||
144627822|NCT01916980|521495465|FG000|Overall Study|Adverse Event|4|||
144627823|NCT01916980|521495466|FG001|Overall Study|Adverse Event|2|||
144627824|NCT01916980|521495465|FG000|Overall Study|Lack of Efficacy|2|||
144627825|NCT01916980|521495466|FG001|Overall Study|Lack of Efficacy|2|||
144627826|NCT01916980|521495465|FG000|Overall Study|Withdrawal by Subject|1|||
144627827|NCT01916980|521495466|FG001|Overall Study|Withdrawal by Subject|0|||
144627828|NCT00483327|521495472|FG000|Overall Study|Adverse Event|1|||
144627829|NCT00483327|521495472|FG000|Overall Study|Withdrawal by Subject|3|||
144627830|NCT00483327|521495472|FG000|Overall Study|Lost to Follow-up|4|||
144627831|NCT00483327|521495472|FG000|Overall Study|Patient Non Compliance|2|||
144627832|NCT00618722|521495473|FG000|Overall Study|Refusal of Treatment|0|||
144627833|NCT00618722|521495474|FG001|Overall Study|Refusal of Treatment|0|||
144627834|NCT00618722|521495475|FG002|Overall Study|Refusal of Treatment|1|||
144627835|NCT00618722|521495476|FG003|Overall Study|Refusal of Treatment|0|||
144627836|NCT00618722|521495473|FG000|Overall Study|Patient Request|1|||
144627837|NCT00618722|521495474|FG001|Overall Study|Patient Request|1|||
144627838|NCT00618722|521495475|FG002|Overall Study|Patient Request|1|||
144627839|NCT00618722|521495476|FG003|Overall Study|Patient Request|1|||
144627840|NCT00618722|521495473|FG000|Overall Study|Inability to Complete Study Procedure|0|||
144627841|NCT00618722|521495474|FG001|Overall Study|Inability to Complete Study Procedure|1|||
144627842|NCT00618722|521495475|FG002|Overall Study|Inability to Complete Study Procedure|0|||
144627843|NCT00618722|521495476|FG003|Overall Study|Inability to Complete Study Procedure|0|||
144627844|NCT00618722|521495473|FG000|Overall Study|Lost to Follow-up|2|||
144627845|NCT00618722|521495474|FG001|Overall Study|Lost to Follow-up|0|||
144627846|NCT00618722|521495475|FG002|Overall Study|Lost to Follow-up|0|||
144627847|NCT00618722|521495476|FG003|Overall Study|Lost to Follow-up|2|||
144627848|NCT00618722|521495473|FG000|Overall Study|Miscellaneous Reasons|0|||
144627849|NCT00618722|521495474|FG001|Overall Study|Miscellaneous Reasons|0|||
144627850|NCT00618722|521495475|FG002|Overall Study|Miscellaneous Reasons|1|||
144627851|NCT00618722|521495476|FG003|Overall Study|Miscellaneous Reasons|1|||
144627852|NCT00200057|521495477|FG000|Overall Study|Lack of Efficacy|3|||
144627853|NCT00200057|521495477|FG000|Overall Study|Exited due to terminal illness of PI|2|||
144627854|NCT00200057|521495477|FG000|Overall Study|Withdrawal by Subject|1|||
144627855|NCT00200057|521495477|FG000|Overall Study|Change in medical condition|1|||
144627856|NCT00200057|521495477|FG000|Overall Study|Infection|1|||
144627857|NCT00200057|521495477|FG000|Overall Study|Death|1|||
144627858|NCT05512949|521495478|FG000|Overall Study|Lost to Follow-up|4|||
144627859|NCT05512949|521495479|FG001|Overall Study|Lost to Follow-up|6|||
144627860|NCT05512949|521495480|FG002|Overall Study|Lost to Follow-up|2|||
144627861|NCT05512949|521495478|FG000|Overall Study|Protocol Violation|0|||
144627862|NCT05512949|521495479|FG001|Overall Study|Protocol Violation|0|||
144627863|NCT05512949|521495480|FG002|Overall Study|Protocol Violation|1|||
144627864|NCT05512949|521495478|FG000|Overall Study|Withdrawal by Subject|1|||
144627865|NCT05512949|521495479|FG001|Overall Study|Withdrawal by Subject|1|||
144627866|NCT05512949|521495480|FG002|Overall Study|Withdrawal by Subject|2|||
144627867|NCT05512949|521495478|FG000|Overall Study|Completion status unknown|1|||
144627868|NCT05512949|521495479|FG001|Overall Study|Completion status unknown|3|||
144627869|NCT05512949|521495480|FG002|Overall Study|Completion status unknown|0|||
144627870|NCT02810964|521495481|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
144627871|NCT02810964|521495482|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
144627872|NCT02810964|521495481|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
144627873|NCT02810964|521495482|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
144627874|NCT02810964|521495481|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
144627875|NCT02810964|521495482|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
144627876|NCT02810964|521495481|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
144627877|NCT02810964|521495482|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
144627878|NCT03523351|521495483|FG000|Overall Study|Death|13|||
144627879|NCT03523351|521495484|FG001|Overall Study|Death|11|||
144627880|NCT03523351|521495483|FG000|Overall Study|Lost to Follow-up|2|||
144627881|NCT03523351|521495484|FG001|Overall Study|Lost to Follow-up|3|||
144627882|NCT03523351|521495483|FG000|Overall Study|Withdrawal by Subject|4|||
144627883|NCT03523351|521495484|FG001|Overall Study|Withdrawal by Subject|0|||
144627884|NCT03523351|521495483|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
144627885|NCT03523351|521495484|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
144627886|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
144627887|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
144627888|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
144627889|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144209793|NCT00205803|519962061|FG001|Infant Series|Physician Decision|1|||
144627890|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144209794|NCT00205803|519962060|FG000|Infant Series|Protocol Violation|1|||
144209795|NCT00205803|519962061|FG001|Infant Series|Protocol Violation|0|||
144209796|NCT00205803|519962060|FG000|Infant Series|Lost Kaiser coverage|0|||
144627891|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144627892|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144627893|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144627894|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
144627895|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
144627896|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
144627897|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144627898|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144627899|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144627900|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144627901|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144627902|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
144627903|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
144627904|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
144627905|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144627906|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144627907|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144627908|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144627909|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144627910|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
144627911|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
144627912|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
144627913|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144627914|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144627915|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144627916|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144627917|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144627918|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
144627919|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
144627920|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
144627921|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144627922|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144627923|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144627924|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144627925|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144627926|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
144627927|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
144627928|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144627929|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144627930|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144627931|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144627932|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144627933|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144627934|NCT01097629|521495488|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
144627935|NCT01097629|521495489|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
144627936|NCT01097629|521495490|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
144627937|NCT01097629|521495491|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144627938|NCT01097629|521495492|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144627939|NCT01097629|521495493|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144627940|NCT01097629|521495494|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144627941|NCT01097629|521495495|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144627942|NCT01097629|521495488|FG000|DB RO Phase|Withdrawal by Subject|0|||
144627943|NCT01097629|521495489|FG001|DB RO Phase|Withdrawal by Subject|0|||
144627944|NCT01097629|521495490|FG002|DB RO Phase|Withdrawal by Subject|0|||
144627945|NCT01097629|521495491|FG003|DB RO Phase|Withdrawal by Subject|0|||
144627946|NCT01097629|521495492|FG004|DB RO Phase|Withdrawal by Subject|0|||
144627947|NCT01097629|521495493|FG005|DB RO Phase|Withdrawal by Subject|0|||
144627948|NCT01097629|521495494|FG006|DB RO Phase|Withdrawal by Subject|0|||
144627949|NCT01097629|521495495|FG007|DB RO Phase|Withdrawal by Subject|1|||
144627950|NCT01097629|521495488|FG000|DB RO Phase|Protocol Violation|0|||
144627951|NCT01097629|521495489|FG001|DB RO Phase|Protocol Violation|0|||
144209797|NCT00205803|519962061|FG001|Infant Series|Lost Kaiser coverage|1|||
144627952|NCT01097629|521495490|FG002|DB RO Phase|Protocol Violation|0|||
144627953|NCT01097629|521495491|FG003|DB RO Phase|Protocol Violation|1|||
144627954|NCT01097629|521495492|FG004|DB RO Phase|Protocol Violation|0|||
144627955|NCT01097629|521495493|FG005|DB RO Phase|Protocol Violation|1|||
144627956|NCT01097629|521495494|FG006|DB RO Phase|Protocol Violation|1|||
144627957|NCT01097629|521495495|FG007|DB RO Phase|Protocol Violation|0|||
144627958|NCT01097629|521495488|FG000|DB RO Phase|Lost to Follow-up|0|||
144627959|NCT01097629|521495489|FG001|DB RO Phase|Lost to Follow-up|0|||
144627960|NCT01097629|521495490|FG002|DB RO Phase|Lost to Follow-up|0|||
144627961|NCT01097629|521495491|FG003|DB RO Phase|Lost to Follow-up|0|||
144627962|NCT01097629|521495492|FG004|DB RO Phase|Lost to Follow-up|0|||
144627963|NCT01097629|521495493|FG005|DB RO Phase|Lost to Follow-up|0|||
144627964|NCT01097629|521495494|FG006|DB RO Phase|Lost to Follow-up|2|||
144627965|NCT01097629|521495495|FG007|DB RO Phase|Lost to Follow-up|0|||
144627966|NCT03609619|521495497|FG000|Overall Study|Adverse Event|1|||
144627967|NCT03609619|521495498|FG001|Overall Study|Adverse Event|0|||
144627968|NCT03609619|521495497|FG000|Overall Study|Lack of Efficacy|1|||
144627969|NCT03609619|521495498|FG001|Overall Study|Lack of Efficacy|2|||
144627970|NCT03609619|521495497|FG000|Overall Study|Protocol Violation|5|||
144627971|NCT03609619|521495498|FG001|Overall Study|Protocol Violation|0|||
144627972|NCT03609619|521495497|FG000|Overall Study|Withdrawal by Subject|2|||
144627973|NCT03609619|521495498|FG001|Overall Study|Withdrawal by Subject|3|||
144627974|NCT03609619|521495497|FG000|Overall Study|Lost to Follow-up|1|||
144627975|NCT03609619|521495498|FG001|Overall Study|Lost to Follow-up|1|||
144627976|NCT05162066|521495499|FG000|Overall Study|Adverse Event|1|||
144627977|NCT05162066|521495500|FG001|Overall Study|Adverse Event|0|||
144627978|NCT05162066|521495501|FG002|Overall Study|Adverse Event|0|||
144627979|NCT05162066|521495499|FG000|Overall Study|Perceived lack of efficacy|1|||
144627980|NCT05162066|521495500|FG001|Overall Study|Perceived lack of efficacy|0|||
144627981|NCT05162066|521495501|FG002|Overall Study|Perceived lack of efficacy|0|||
144627982|NCT01171820|521495502|FG000|Overall Study|Death|3|||
144627983|NCT01171820|521495503|FG001|Overall Study|Death|3|||
144627984|NCT01171820|521495502|FG000|Overall Study|Lost to Follow-up|0|||
144627985|NCT01171820|521495503|FG001|Overall Study|Lost to Follow-up|1|||
144627986|NCT01171820|521495502|FG000|Overall Study|Withdrawal by Subject|2|||
144627987|NCT01171820|521495503|FG001|Overall Study|Withdrawal by Subject|0|||
144627988|NCT01171820|521495502|FG000|Overall Study|Physician Decision|0|||
144627989|NCT01171820|521495503|FG001|Overall Study|Physician Decision|1|||
144627990|NCT01171820|521495502|FG000|Overall Study|1-Year Missed Visit|1|||
144627991|NCT01171820|521495503|FG001|Overall Study|1-Year Missed Visit|1|||
144627992|NCT03969875|521495504|FG000|Overall Study|did not receive allocated intervention|3|||
144627993|NCT03969875|521495505|FG001|Overall Study|did not receive allocated intervention|3|||
144627994|NCT03969875|521495506|FG002|Overall Study|did not receive allocated intervention|4|||
144627995|NCT03969875|521495504|FG000|Overall Study|Protocol Violation|4|||
144627996|NCT03969875|521495505|FG001|Overall Study|Protocol Violation|2|||
144627997|NCT03969875|521495506|FG002|Overall Study|Protocol Violation|2|||
144627998|NCT01307033|521495507|FG000|8-week Double-blind Period|Adverse Event|2|||
144627999|NCT01307033|521495508|FG001|8-week Double-blind Period|Adverse Event|0|||
144628000|NCT01307033|521495509|FG002|8-week Double-blind Period|Adverse Event|0|||
144628001|NCT01307033|521495510|FG003|8-week Double-blind Period|Adverse Event|0|||
144628002|NCT01307033|521495507|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
144628003|NCT01307033|521495508|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
144628004|NCT01307033|521495509|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
144628005|NCT01307033|521495510|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
144628006|NCT01307033|521495507|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
144628007|NCT01307033|521495508|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
144628008|NCT01307033|521495509|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
144628009|NCT01307033|521495510|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
144628010|NCT01307033|521495507|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
144628011|NCT01307033|521495508|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
144628012|NCT01307033|521495509|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
144628013|NCT01307033|521495510|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
144628014|NCT01307033|521495507|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
144628015|NCT01307033|521495508|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
144628016|NCT01307033|521495509|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
144628017|NCT01307033|521495510|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
144628018|NCT01307033|521495507|FG000|44-week Open-label Extension|Adverse Event|0|||
144628019|NCT01307033|521495508|FG001|44-week Open-label Extension|Adverse Event|0|||
144628020|NCT01307033|521495509|FG002|44-week Open-label Extension|Adverse Event|2|||
144628021|NCT01307033|521495510|FG003|44-week Open-label Extension|Adverse Event|1|||
144628022|NCT01307033|521495507|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
144628023|NCT01307033|521495508|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
144628024|NCT01307033|521495509|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
144628025|NCT01307033|521495510|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
144209798|NCT00205803|519962060|FG000|Infant Series|Non-compliant|1|||
144628026|NCT01307033|521495507|FG000|44-week Open-label Extension|Physician Decision|0|||
144628027|NCT01307033|521495508|FG001|44-week Open-label Extension|Physician Decision|0|||
144628028|NCT01307033|521495509|FG002|44-week Open-label Extension|Physician Decision|1|||
144628029|NCT01307033|521495510|FG003|44-week Open-label Extension|Physician Decision|0|||
144628030|NCT01307033|521495507|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
144628031|NCT01307033|521495508|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
144628032|NCT01307033|521495509|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
144628033|NCT01307033|521495510|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
144628034|NCT01307033|521495507|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
144628035|NCT01307033|521495508|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
144628036|NCT01307033|521495509|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
144628037|NCT01307033|521495510|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
144628038|NCT01307033|521495507|FG000|44-week Open-label Extension|Death|0|||
144628039|NCT01307033|521495508|FG001|44-week Open-label Extension|Death|0|||
144628040|NCT01307033|521495509|FG002|44-week Open-label Extension|Death|0|||
144628041|NCT01307033|521495510|FG003|44-week Open-label Extension|Death|1|||
144628042|NCT03502330|521495512|FG000|Overall Study|Adverse Event|2|||
144628043|NCT03502330|521495513|FG001|Overall Study|Adverse Event|1|||
144628044|NCT03502330|521495514|FG002|Overall Study|Adverse Event|0|||
144628045|NCT03502330|521495515|FG003|Overall Study|Adverse Event|0|||
144628046|NCT03502330|521495516|FG004|Overall Study|Adverse Event|1|||
144628047|NCT03502330|521495517|FG005|Overall Study|Adverse Event|0|||
144628048|NCT03502330|521495518|FG006|Overall Study|Adverse Event|1|||
144628049|NCT03502330|521495519|FG007|Overall Study|Adverse Event|1|||
144628050|NCT03502330|521495520|FG008|Overall Study|Adverse Event|0|||
144628051|NCT03502330|521495512|FG000|Overall Study|Lack of Efficacy|1|||
144628052|NCT03502330|521495513|FG001|Overall Study|Lack of Efficacy|5|||
144628053|NCT03502330|521495514|FG002|Overall Study|Lack of Efficacy|3|||
144628054|NCT03502330|521495515|FG003|Overall Study|Lack of Efficacy|5|||
144628055|NCT03502330|521495516|FG004|Overall Study|Lack of Efficacy|1|||
144628056|NCT03502330|521495517|FG005|Overall Study|Lack of Efficacy|5|||
144628057|NCT03502330|521495518|FG006|Overall Study|Lack of Efficacy|5|||
144628058|NCT03502330|521495519|FG007|Overall Study|Lack of Efficacy|6|||
144628059|NCT03502330|521495520|FG008|Overall Study|Lack of Efficacy|0|||
144628060|NCT03502330|521495512|FG000|Overall Study|Physician Decision|0|||
144628061|NCT03502330|521495513|FG001|Overall Study|Physician Decision|0|||
144628062|NCT03502330|521495514|FG002|Overall Study|Physician Decision|0|||
144628063|NCT03502330|521495515|FG003|Overall Study|Physician Decision|0|||
144628064|NCT03502330|521495516|FG004|Overall Study|Physician Decision|1|||
144628065|NCT03502330|521495517|FG005|Overall Study|Physician Decision|0|||
144628066|NCT03502330|521495518|FG006|Overall Study|Physician Decision|0|||
144628067|NCT03502330|521495519|FG007|Overall Study|Physician Decision|0|||
144628068|NCT03502330|521495520|FG008|Overall Study|Physician Decision|0|||
144628069|NCT03502330|521495512|FG000|Overall Study|Withdrawal by Subject|0|||
144628070|NCT03502330|521495513|FG001|Overall Study|Withdrawal by Subject|0|||
144628071|NCT03502330|521495514|FG002|Overall Study|Withdrawal by Subject|0|||
144628072|NCT03502330|521495515|FG003|Overall Study|Withdrawal by Subject|0|||
144628073|NCT03502330|521495516|FG004|Overall Study|Withdrawal by Subject|0|||
144628074|NCT03502330|521495517|FG005|Overall Study|Withdrawal by Subject|1|||
144628075|NCT03502330|521495518|FG006|Overall Study|Withdrawal by Subject|0|||
144628076|NCT03502330|521495519|FG007|Overall Study|Withdrawal by Subject|1|||
144628077|NCT03502330|521495520|FG008|Overall Study|Withdrawal by Subject|0|||
144628078|NCT03502330|521495512|FG000|Overall Study|Death|0|||
144628079|NCT03502330|521495513|FG001|Overall Study|Death|0|||
144628080|NCT03502330|521495514|FG002|Overall Study|Death|0|||
144628081|NCT03502330|521495515|FG003|Overall Study|Death|0|||
144628082|NCT03502330|521495516|FG004|Overall Study|Death|0|||
144628083|NCT03502330|521495517|FG005|Overall Study|Death|0|||
144628084|NCT03502330|521495518|FG006|Overall Study|Death|2|||
144628085|NCT03502330|521495519|FG007|Overall Study|Death|0|||
144628086|NCT03502330|521495520|FG008|Overall Study|Death|0|||
144628087|NCT02804763|521495522|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
144628088|NCT02804763|521495523|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
144628089|NCT02804763|521495524|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
144628090|NCT02804763|521495525|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
144628091|NCT02804763|521495522|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
144628092|NCT02804763|521495523|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
144628093|NCT02804763|521495524|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
144628094|NCT02804763|521495525|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
144628095|NCT02804763|521495522|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
144628096|NCT02804763|521495523|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
144628097|NCT02804763|521495524|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
144209799|NCT00205803|519962061|FG001|Infant Series|Non-compliant|0|||
144209800|NCT00205803|519962060|FG000|Infant Series|Sponsor request|1|||
144209801|NCT00205803|519962061|FG001|Infant Series|Sponsor request|0|||
144209802|NCT00205803|519962060|FG000|After Infant Series|Adverse Event|1|||
144209803|NCT00205803|519962061|FG001|After Infant Series|Adverse Event|1|||
144209804|NCT00205803|519962060|FG000|After Infant Series|Protocol Violation|1|||
144209805|NCT00205803|519962061|FG001|After Infant Series|Protocol Violation|1|||
144209806|NCT00205803|519962060|FG000|After Infant Series|Lost to Follow-up|2|||
144209807|NCT00205803|519962061|FG001|After Infant Series|Lost to Follow-up|1|||
144628098|NCT02804763|521495525|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
144628099|NCT02804763|521495522|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
144628100|NCT02804763|521495523|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
144628101|NCT02804763|521495524|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
144628102|NCT02804763|521495525|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
144628103|NCT02804763|521495522|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
144628104|NCT02804763|521495523|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
144628105|NCT02804763|521495524|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
144628106|NCT02804763|521495525|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
144628107|NCT02804763|521495522|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
144628108|NCT02804763|521495523|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
144628109|NCT02804763|521495524|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
144628110|NCT02804763|521495525|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
144628111|NCT00066690|521495530|FG000|Overall Study|Adverse Event|145|||
144628112|NCT00066690|521495531|FG001|Overall Study|Adverse Event|58|||
144628113|NCT00066690|521495532|FG002|Overall Study|Adverse Event|126|||
144628114|NCT00066690|521495530|FG000|Overall Study|Death|3|||
144628115|NCT00066690|521495531|FG001|Overall Study|Death|0|||
144628116|NCT00066690|521495532|FG002|Overall Study|Death|2|||
144628117|NCT00066690|521495530|FG000|Overall Study|Lack of Efficacy|114|||
144628118|NCT00066690|521495531|FG001|Overall Study|Lack of Efficacy|110|||
144628119|NCT00066690|521495532|FG002|Overall Study|Lack of Efficacy|76|||
144628120|NCT00066690|521495530|FG000|Overall Study|Lost to Follow-up|40|||
144628121|NCT00066690|521495531|FG001|Overall Study|Lost to Follow-up|21|||
144628122|NCT00066690|521495532|FG002|Overall Study|Lost to Follow-up|29|||
144628123|NCT00066690|521495530|FG000|Overall Study|Withdrawal by Subject|50|||
144628124|NCT00066690|521495531|FG001|Overall Study|Withdrawal by Subject|55|||
144628125|NCT00066690|521495532|FG002|Overall Study|Withdrawal by Subject|49|||
144628126|NCT00066690|521495530|FG000|Overall Study|Treatment Ongoing|246|||
144628127|NCT00066690|521495531|FG001|Overall Study|Treatment Ongoing|278|||
144628128|NCT00066690|521495532|FG002|Overall Study|Treatment Ongoing|282|||
144628129|NCT02939131|521495533|FG000|Overall Study|Unable to get to clinic|6|||
144628130|NCT02939131|521495534|FG001|Overall Study|Unable to get to clinic|4|||
144628131|NCT02939131|521495533|FG000|Overall Study|Lost to Follow-up|2|||
144628132|NCT02939131|521495534|FG001|Overall Study|Lost to Follow-up|4|||
144628133|NCT02939131|521495533|FG000|Overall Study|severe debilitation|1|||
144628134|NCT02939131|521495534|FG001|Overall Study|severe debilitation|0|||
144628135|NCT02939131|521495533|FG000|Overall Study|Other|0|||
144628136|NCT02939131|521495534|FG001|Overall Study|Other|1|||
144628137|NCT02939131|521495533|FG000|Overall Study|not willing to adhere to protocol|2|||
144628138|NCT02939131|521495534|FG001|Overall Study|not willing to adhere to protocol|0|||
144628139|NCT00272987|521495535|FG000|Overall Study|Adverse Event|1|||
144628140|NCT00272987|521495536|FG001|Overall Study|Adverse Event|0|||
144628141|NCT00272987|521495537|FG002|Overall Study|Adverse Event|0|||
144628142|NCT00272987|521495535|FG000|Overall Study|Lost to Follow-up|3|||
144628143|NCT00272987|521495536|FG001|Overall Study|Lost to Follow-up|1|||
144628144|NCT00272987|521495537|FG002|Overall Study|Lost to Follow-up|1|||
144628145|NCT00272987|521495535|FG000|Overall Study|Withdrawal by Subject|1|||
144628146|NCT00272987|521495536|FG001|Overall Study|Withdrawal by Subject|0|||
144628147|NCT00272987|521495537|FG002|Overall Study|Withdrawal by Subject|3|||
144209808|NCT00205803|519962060|FG000|After Infant Series|Physician Decision|3|||
144209809|NCT00205803|519962061|FG001|After Infant Series|Physician Decision|2|||
144209810|NCT00205803|519962060|FG000|After Infant Series|Withdrawal by Subject|1|||
144209811|NCT00205803|519962061|FG001|After Infant Series|Withdrawal by Subject|4|||
144628148|NCT00272987|521495535|FG000|Overall Study|Sponsor Terminated study|0|||
144628149|NCT00272987|521495536|FG001|Overall Study|Sponsor Terminated study|1|||
144628150|NCT00272987|521495537|FG002|Overall Study|Sponsor Terminated study|1|||
144628151|NCT00272987|521495535|FG000|Overall Study|Disease progression|1|||
144628152|NCT00272987|521495536|FG001|Overall Study|Disease progression|1|||
144628153|NCT00272987|521495537|FG002|Overall Study|Disease progression|2|||
144628154|NCT00272987|521495535|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
144628155|NCT00272987|521495536|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
144628156|NCT00272987|521495537|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
144628157|NCT00272987|521495535|FG000|Overall Study|Death|1|||
144209812|NCT00205803|519962060|FG000|After Infant Series|Other|10|||
144209813|NCT00205803|519962061|FG001|After Infant Series|Other|4|||
144209814|NCT00205803|519962060|FG000|Toddler Dose|Lost to Follow-up|2|||
144628158|NCT00272987|521495536|FG001|Overall Study|Death|0|||
144628159|NCT00272987|521495537|FG002|Overall Study|Death|0|||
144628160|NCT00331409|521495538|FG000|Overall Study|Lack of Efficacy|4|||
144628161|NCT03653390|521495539|FG000|Overall Study|Lost to Follow-up|12|||
144628162|NCT03653390|521495540|FG001|Overall Study|Lost to Follow-up|8|||
144628163|NCT03653390|521495541|FG002|Overall Study|Lost to Follow-up|7|||
144628164|NCT03653390|521495539|FG000|Overall Study|Withdrawal by Subject|6|||
144628165|NCT03653390|521495540|FG001|Overall Study|Withdrawal by Subject|1|||
144628166|NCT03653390|521495541|FG002|Overall Study|Withdrawal by Subject|1|||
144628167|NCT03653390|521495539|FG000|Overall Study|Death|1|||
144628168|NCT03653390|521495540|FG001|Overall Study|Death|0|||
144628169|NCT03653390|521495541|FG002|Overall Study|Death|0|||
144628170|NCT03653390|521495539|FG000|Overall Study|Paper Survey Lost|1|||
144628171|NCT03653390|521495540|FG001|Overall Study|Paper Survey Lost|0|||
144628172|NCT03653390|521495541|FG002|Overall Study|Paper Survey Lost|0|||
144628173|NCT02769624|521495542|FG000|Overall Study|Lost to Follow-up|0|||
144628174|NCT02769624|521495543|FG001|Overall Study|Lost to Follow-up|1|||
144628175|NCT00448708|521495545|FG000|Overall Study|Death|21|||
144628176|NCT00448708|521495546|FG001|Overall Study|Death|17|||
144628177|NCT00448708|521495545|FG000|Overall Study|Withdrawal by Subject|8|||
144628178|NCT00448708|521495546|FG001|Overall Study|Withdrawal by Subject|4|||
144628179|NCT00448708|521495545|FG000|Overall Study|Lost to Follow-up|6|||
144628180|NCT00448708|521495546|FG001|Overall Study|Lost to Follow-up|8|||
144628181|NCT00448708|521495545|FG000|Overall Study|not listed|0|||
144628182|NCT00448708|521495546|FG001|Overall Study|not listed|2|||
144628183|NCT02908516|521495547|FG000|Overall Study|Study Terminated|3|||
144628184|NCT02908516|521495548|FG001|Overall Study|Study Terminated|3|||
144628185|NCT01225562|521495549|FG000|Overall Study|Withdrawal by Subject|52|||
144628186|NCT01225562|521495550|FG001|Overall Study|Withdrawal by Subject|50|||
144628187|NCT01225562|521495551|FG002|Overall Study|Withdrawal by Subject|52|||
144628188|NCT01225562|521495549|FG000|Overall Study|Lost to Follow-up|3|||
144628189|NCT01225562|521495550|FG001|Overall Study|Lost to Follow-up|6|||
144628190|NCT01225562|521495551|FG002|Overall Study|Lost to Follow-up|1|||
144628191|NCT01481896|521495552|FG000|Overall Study|Lost to Follow-up|12|||
144628192|NCT01162421|521495553|FG000|Overall Study|Did not receive study drug|2|||
144628193|NCT01162421|521495554|FG001|Overall Study|Did not receive study drug|1|||
144628194|NCT01162421|521495553|FG000|Overall Study|Adverse Event|2|||
144628195|NCT01162421|521495554|FG001|Overall Study|Adverse Event|5|||
144628196|NCT01162421|521495553|FG000|Overall Study|Lost to Follow-up|0|||
144628197|NCT01162421|521495554|FG001|Overall Study|Lost to Follow-up|2|||
144628198|NCT01162421|521495553|FG000|Overall Study|Lack of Efficacy|2|||
144628199|NCT01162421|521495554|FG001|Overall Study|Lack of Efficacy|2|||
144628200|NCT01162421|521495553|FG000|Overall Study|Other|2|||
144628201|NCT01162421|521495554|FG001|Overall Study|Other|3|||
144628202|NCT03336502|521495555|FG000|Overall Study|Physician Decision|0|||
144628203|NCT03336502|521495556|FG001|Overall Study|Physician Decision|1|||
144628204|NCT03336502|521495555|FG000|Overall Study|Prohibited Drugs|1|||
144628205|NCT03336502|521495556|FG001|Overall Study|Prohibited Drugs|1|||
144628206|NCT03336502|521495555|FG000|Overall Study|Death|1|||
144628207|NCT03336502|521495556|FG001|Overall Study|Death|2|||
144628208|NCT03336502|521495555|FG000|Overall Study|Adverse Event|2|||
144628209|NCT03336502|521495556|FG001|Overall Study|Adverse Event|5|||
144628210|NCT00480857|521495558|FG000|Overall Study|Lack of Efficacy|2|||
144628211|NCT00611247|521495559|FG000|Overall Study|Death|1|||
144628212|NCT00611247|521495560|FG001|Overall Study|Death|5|||
144628213|NCT00611247|521495559|FG000|Overall Study|Lack of Efficacy|1|||
144628214|NCT00611247|521495560|FG001|Overall Study|Lack of Efficacy|16|||
144628215|NCT01107444|521495561|FG000|Overall Study|Withdrawal by Subject|8|||
144628216|NCT01107444|521495562|FG001|Overall Study|Withdrawal by Subject|12|||
144628217|NCT01107444|521495561|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
144628218|NCT01107444|521495562|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
144628219|NCT01948830|521495565|FG000|Overall Study|Physician Decision|1|||
144628220|NCT01948830|521495566|FG001|Overall Study|Physician Decision|3|||
144628221|NCT01948830|521495565|FG000|Overall Study|Protocol deviation|1|||
144628222|NCT01948830|521495566|FG001|Overall Study|Protocol deviation|2|||
144628223|NCT01948830|521495565|FG000|Overall Study|Lost to Follow-up|5|||
144628224|NCT01948830|521495566|FG001|Overall Study|Lost to Follow-up|4|||
144628225|NCT01948830|521495565|FG000|Overall Study|Withdrawal by Subject|14|||
144628226|NCT01948830|521495566|FG001|Overall Study|Withdrawal by Subject|17|||
144628227|NCT01948830|521495565|FG000|Overall Study|Adverse Event|9|||
144628228|NCT01948830|521495566|FG001|Overall Study|Adverse Event|2|||
144628229|NCT01948830|521495565|FG000|Overall Study|Death|3|||
144628230|NCT01948830|521495566|FG001|Overall Study|Death|4|||
144628231|NCT00243659|521495567|FG000|Overall Study|Withdrawal by Subject|1|||
144262946|NCT03934216|520163794|FG000|Overall Study|Randomized but not treated|1|||
144262947|NCT03934216|520163795|FG001|Overall Study|Randomized but not treated|1|||
144262948|NCT01053741|520163798|FG000|2nd Study Intervention|Physician Decision|0|||
144262949|NCT01053741|520163799|FG001|2nd Study Intervention|Physician Decision|1|||
144628232|NCT00243659|521495568|FG001|Overall Study|Withdrawal by Subject|1|||
144628233|NCT00243659|521495567|FG000|Overall Study|Protocol Violation|1|||
144628234|NCT00243659|521495568|FG001|Overall Study|Protocol Violation|2|||
144628235|NCT01890421|521495569|FG000|Overall Study|Adverse Event|1|||
144628236|NCT01890421|521495569|FG000|Overall Study|Other reason|10|||
144628237|NCT00268242|521495570|FG000|Overall Study|Death|1|||
144628238|NCT00946309|521495573|FG000|Overall Study|Protocol Violation|1|||
144628239|NCT00946309|521495574|FG001|Overall Study|Protocol Violation|0|||
144628240|NCT00946309|521495573|FG000|Overall Study|Lost to Follow-up|0|||
144628241|NCT00946309|521495574|FG001|Overall Study|Lost to Follow-up|1|||
144628242|NCT00946309|521495573|FG000|Overall Study|Procedure cancelled/discontinued|0|||
144628243|NCT00946309|521495574|FG001|Overall Study|Procedure cancelled/discontinued|3|||
144628244|NCT01465659|521495576|FG000|Completed 1 Cycle of Treatment|Death|0|||
144628245|NCT01465659|521495577|FG001|Completed 1 Cycle of Treatment|Death|1|||
144628246|NCT01465659|521495578|FG002|Completed 1 Cycle of Treatment|Death|0|||
144628247|NCT01465659|521495579|FG003|Completed 1 Cycle of Treatment|Death|0|||
144628248|NCT01465659|521495576|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
144628249|NCT01465659|521495577|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
144628250|NCT01465659|521495578|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
144628251|NCT01465659|521495579|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
144628252|NCT01465659|521495576|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
144628253|NCT01465659|521495577|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
144628254|NCT01465659|521495578|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
144628255|NCT01465659|521495579|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
144628256|NCT01465659|521495576|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
144628257|NCT01465659|521495577|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
144628258|NCT01465659|521495578|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
144628259|NCT01465659|521495579|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
144628260|NCT01465659|521495576|FG000|Completed Follow for 1 Year|Death|6|||
144628261|NCT01465659|521495577|FG001|Completed Follow for 1 Year|Death|3|||
144628262|NCT01465659|521495578|FG002|Completed Follow for 1 Year|Death|2|||
144628263|NCT01465659|521495579|FG003|Completed Follow for 1 Year|Death|4|||
144628264|NCT02445586|521495582|FG000|Overall Study|Death|14|||
144628265|NCT02445586|521495582|FG000|Overall Study|Withdrawal by Subject|13|||
144628266|NCT02445586|521495582|FG000|Overall Study|Disease Progression|10|||
144628267|NCT02445586|521495582|FG000|Overall Study|Protocol Violation|1|||
144628268|NCT02445586|521495582|FG000|Overall Study|Medical Condition|1|||
144628269|NCT00428597|521495583|FG000|Overall Study|Randomized but not treated|3|||
144628270|NCT00428597|521495584|FG001|Overall Study|Randomized but not treated|3|||
144628271|NCT00428597|521495583|FG000|Overall Study|Objective Progression or Relapse|19|||
144628272|NCT00428597|521495584|FG001|Overall Study|Objective Progression or Relapse|47|||
144628273|NCT00428597|521495583|FG000|Overall Study|Study Terminated by Sponsor|41|||
144628274|NCT00428597|521495584|FG001|Overall Study|Study Terminated by Sponsor|16|||
144628275|NCT00428597|521495583|FG000|Overall Study|Adverse Event|15|||
144628276|NCT00428597|521495584|FG001|Overall Study|Adverse Event|7|||
144628277|NCT00428597|521495583|FG000|Overall Study|Global Deterioration of Health Status|1|||
144628278|NCT00428597|521495584|FG001|Overall Study|Global Deterioration of Health Status|5|||
144628279|NCT00428597|521495583|FG000|Overall Study|Protocol Violation|2|||
144628280|NCT00428597|521495584|FG001|Overall Study|Protocol Violation|1|||
144628281|NCT00428597|521495583|FG000|Overall Study|Withdrawal by Subject|2|||
144628282|NCT00428597|521495584|FG001|Overall Study|Withdrawal by Subject|1|||
144628283|NCT00428597|521495583|FG000|Overall Study|Other|1|||
144628284|NCT00428597|521495584|FG001|Overall Study|Other|1|||
144628285|NCT00428597|521495583|FG000|Overall Study|Lost to Follow-up|0|||
144628286|NCT00428597|521495584|FG001|Overall Study|Lost to Follow-up|1|||
144628287|NCT00428597|521495583|FG000|Overall Study|Pregnancy|1|||
144209815|NCT00205803|519962061|FG001|Toddler Dose|Lost to Follow-up|3|||
144209816|NCT01104792|519962062|FG000|Overall Study|Adverse Event|77|||
144209817|NCT01104792|519962062|FG000|Overall Study|Insufficient Therapeutic Response|22|||
144209818|NCT01104792|519962062|FG000|Overall Study|Protocol Violation|45|||
144209819|NCT01104792|519962062|FG000|Overall Study|Withdrawal of Consent|179|||
144209820|NCT01104792|519962062|FG000|Overall Study|Lost to Follow-up|43|||
144209821|NCT01104792|519962062|FG000|Overall Study|Reasons Not Specified|27|||
144209822|NCT01104792|519962062|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
144209823|NCT01102374|519962063|FG000|Overall Study|Death|9|||
144209824|NCT01102374|519962064|FG001|Overall Study|Death|13|||
144209825|NCT01102374|519962063|FG000|Overall Study|Lost to Follow-up|7|||
144209826|NCT01102374|519962064|FG001|Overall Study|Lost to Follow-up|6|||
144209827|NCT00658021|519962065|FG000|28-Week Treatment Period|Adverse Event|3|||
144209828|NCT00658021|519962066|FG001|28-Week Treatment Period|Adverse Event|1|||
144209829|NCT00658021|519962067|FG002|28-Week Treatment Period|Adverse Event|0|||
144209830|NCT00658021|519962065|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
144209831|NCT00658021|519962066|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
144209832|NCT00658021|519962067|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
144209833|NCT00658021|519962065|FG000|28-Week Treatment Period|Protocol Violation|0|||
144209834|NCT00658021|519962066|FG001|28-Week Treatment Period|Protocol Violation|2|||
144209835|NCT00658021|519962067|FG002|28-Week Treatment Period|Protocol Violation|1|||
144628288|NCT00428597|521495584|FG001|Overall Study|Pregnancy|0|||
144628289|NCT00428597|521495583|FG000|Overall Study|Death|1|||
144628290|NCT00428597|521495584|FG001|Overall Study|Death|3|||
144628291|NCT00769119|521495588|FG000|Overall Study|Voluntary discontinuation|0|||
144628292|NCT00769119|521495589|FG001|Overall Study|Voluntary discontinuation|2|||
144628293|NCT00769119|521495588|FG000|Overall Study|Adverse Event|1|||
144628294|NCT00769119|521495589|FG001|Overall Study|Adverse Event|1|||
144628295|NCT00769119|521495588|FG000|Overall Study|Disallowed medication|1|||
144628296|NCT00769119|521495589|FG001|Overall Study|Disallowed medication|0|||
144628297|NCT00686647|521495590|FG000|Overall Study|Lost to Follow-up|1|||
144628298|NCT00686647|521495590|FG000|Overall Study|Death|1|||
144628299|NCT01116544|521495592|FG000|Overall Study|Protocol Violation|1|||
144628300|NCT01116544|521495593|FG001|Overall Study|Protocol Violation|0|||
144628301|NCT01116544|521495592|FG000|Overall Study|Withdrawal by Subject|1|||
144628302|NCT01116544|521495593|FG001|Overall Study|Withdrawal by Subject|1|||
144628303|NCT00578643|521495594|FG000|Overall Study|Death|1|||
144628304|NCT00578643|521495594|FG000|Overall Study|Lost to Follow-up|1|||
144628305|NCT01725750|521495595|FG000|Overall Study|Adverse Event|1|||
144628306|NCT01725750|521495596|FG001|Overall Study|Adverse Event|0|||
144628307|NCT01725750|521495595|FG000|Overall Study|Lost to Follow-up|1|||
144628308|NCT01725750|521495596|FG001|Overall Study|Lost to Follow-up|1|||
144628309|NCT01725750|521495595|FG000|Overall Study|Withdrawal by Subject|0|||
144628310|NCT01725750|521495596|FG001|Overall Study|Withdrawal by Subject|9|||
144628311|NCT03828487|521495599|FG000|Overall Study|Physician Decision|1|||
144628312|NCT01990261|521495601|FG000|Overall Study|Death Before Treatment Start|2|||
144628313|NCT01990261|521495601|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
144628314|NCT01990261|521495601|FG000|Overall Study|Death From other Causes|1|||
144628315|NCT01990261|521495601|FG000|Overall Study|Disease Progression (PD)|8|||
144628316|NCT01990261|521495601|FG000|Overall Study|PD Before Treatment Start|1|||
144628317|NCT01990261|521495601|FG000|Overall Study|Dossier not Approved|1|||
144628318|NCT01990261|521495601|FG000|Overall Study|Lost to Follow-up|2|||
144628319|NCT02447848|521495602|FG000|Overall Study|Patient discharged|3|||
144628320|NCT02447848|521495602|FG000|Overall Study|Lack of Efficacy|4|||
144628321|NCT02447848|521495602|FG000|Overall Study|Withdrawal by Subject|4|||
144628322|NCT02307370|521495603|FG000|Overall Study|Death|5|||
144628323|NCT02307370|521495603|FG000|Overall Study|Lost to Follow-up|1|||
144628324|NCT02307370|521495603|FG000|Overall Study|Withdrawal by Subject|1|||
144628325|NCT02307370|521495603|FG000|Overall Study|Declined Addendum ICF|6|||
144628326|NCT02307370|521495603|FG000|Overall Study|No response during telephone contact|5|||
144628327|NCT02307370|521495603|FG000|Overall Study|Protocol Violation|1|||
144628328|NCT05900115|521497805|FG000|Overall Study|Lost to Follow-up|129|||
144628329|NCT05900115|521497806|FG001|Overall Study|Lost to Follow-up|98|||
144628330|NCT00388947|521497807|FG000|Overall Study|Protocol Violation|47|||
144628331|NCT04187092|521497808|FG000|Overall Study|Lost to Follow-up|1|||
144628332|NCT04187092|521497809|FG001|Overall Study|Lost to Follow-up|1|||
144628333|NCT04187092|521497808|FG000|Overall Study|Withdrawal by Subject|1|||
144628334|NCT04187092|521497809|FG001|Overall Study|Withdrawal by Subject|1|||
144628335|NCT04187092|521497808|FG000|Overall Study|Adverse Event|0|||
144628336|NCT04187092|521497809|FG001|Overall Study|Adverse Event|1|||
144628337|NCT00132041|521497816|FG000|Baseline|Ineligible|6|||
144628338|NCT00132041|521497816|FG000|3 Months Post Ablation|Transplant|1|||
144628339|NCT00132041|521497816|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
144628340|NCT00132041|521497816|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
144262950|NCT01396083|520163800|FG000|Overall Study|Adverse Event|2|||
144628341|NCT00132041|521497816|FG000|6 Months Post Ablation|Death|2|||
144628342|NCT00132041|521497816|FG000|6 Months Post Ablation|Transplant|6|||
144628343|NCT00132041|521497816|FG000|9 Months Post Ablation|Death|1|||
144628344|NCT00132041|521497816|FG000|9 Months Post Ablation|Transplant|1|||
144628345|NCT00132041|521497816|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
144628346|NCT00132041|521497816|FG000|12 Months Post Ablation|Death|1|||
144628347|NCT00132041|521497816|FG000|12 Months Post Ablation|Transplant|1|||
144628348|NCT00132041|521497816|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
144628349|NCT00132041|521497816|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
144628350|NCT00132041|521497816|FG000|15 Months Post Ablation|Death|1|||
144628351|NCT00132041|521497816|FG000|15 Months Post Ablation|Transplant|5|||
144628352|NCT00132041|521497816|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
144628353|NCT00132041|521497816|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
144628354|NCT00132041|521497816|FG000|18 Months Post Ablation|Transplant|1|||
144628355|NCT00132041|521497816|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
144628356|NCT00132041|521497816|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
144628357|NCT02327260|521497817|FG000|Overall Study|Lost to Follow-up|2|||
144628358|NCT02327260|521497818|FG001|Overall Study|Lost to Follow-up|3|||
144628359|NCT02327260|521497819|FG002|Overall Study|Lost to Follow-up|2|||
144628360|NCT02327260|521497817|FG000|Overall Study|invalid phone number|1|||
144628361|NCT02327260|521497818|FG001|Overall Study|invalid phone number|1|||
144628362|NCT02327260|521497819|FG002|Overall Study|invalid phone number|0|||
144628363|NCT02327260|521497817|FG000|Overall Study|non-adherence to protocol|2|||
144628364|NCT02327260|521497818|FG001|Overall Study|non-adherence to protocol|0|||
144628365|NCT02327260|521497819|FG002|Overall Study|non-adherence to protocol|0|||
144628366|NCT02327260|521497817|FG000|Overall Study|cognitive concerns|1|||
144628367|NCT02327260|521497818|FG001|Overall Study|cognitive concerns|0|||
144628368|NCT02327260|521497819|FG002|Overall Study|cognitive concerns|0|||
144628369|NCT00860158|521497822|FG000|Overall Study|Study Terminated|1|||
144628370|NCT05499520|521497823|FG000|Overall Study|Lost to Follow-up|0|||
144628371|NCT05499520|521497824|FG001|Overall Study|Lost to Follow-up|0|||
144628372|NCT05499520|521497825|FG002|Overall Study|Lost to Follow-up|38|||
144628373|NCT05499520|521497826|FG003|Overall Study|Lost to Follow-up|41|||
144628374|NCT05499520|521497827|FG004|Overall Study|Lost to Follow-up|46|||
144628375|NCT05499520|521497828|FG005|Overall Study|Lost to Follow-up|0|||
144628376|NCT05499520|521497829|FG006|Overall Study|Lost to Follow-up|31|||
144628377|NCT05499520|521497830|FG007|Overall Study|Lost to Follow-up|45|||
144628378|NCT05499520|521497831|FG008|Overall Study|Lost to Follow-up|42|||
144628379|NCT05499520|521497832|FG009|Overall Study|Lost to Follow-up|0|||
144628380|NCT05499520|521497833|FG010|Overall Study|Lost to Follow-up|0|||
144628381|NCT05499520|521497834|FG011|Overall Study|Lost to Follow-up|37|||
144628382|NCT05499520|521497835|FG012|Overall Study|Lost to Follow-up|53|||
144628383|NCT05499520|521497836|FG013|Overall Study|Lost to Follow-up|49|||
144628384|NCT05499520|521497837|FG014|Overall Study|Lost to Follow-up|0|||
144628385|NCT05499520|521497838|FG015|Overall Study|Lost to Follow-up|36|||
144628386|NCT05499520|521497839|FG016|Overall Study|Lost to Follow-up|58|||
144628387|NCT05499520|521497840|FG017|Overall Study|Lost to Follow-up|53|||
144628388|NCT03588741|521497841|FG000|Overall Study|Withdrawal by Subject|1|||
144628389|NCT00793793|521497843|FG000|Overall Study|Adverse Event|0|||
144628390|NCT00793793|521497844|FG001|Overall Study|Adverse Event|0|||
144628391|NCT00793793|521497845|FG002|Overall Study|Adverse Event|1|||
144628392|NCT00793793|521497846|FG003|Overall Study|Adverse Event|1|||
144628393|NCT00793793|521497847|FG004|Overall Study|Adverse Event|0|||
144628394|NCT00793793|521497848|FG005|Overall Study|Adverse Event|1|||
144628395|NCT00793793|521497849|FG006|Overall Study|Adverse Event|2|||
144628396|NCT00793793|521497850|FG007|Overall Study|Adverse Event|0|||
144628397|NCT00793793|521497851|FG008|Overall Study|Adverse Event|0|||
144628398|NCT00793793|521497852|FG009|Overall Study|Adverse Event|0|||
144628399|NCT00793793|521497853|FG010|Overall Study|Adverse Event|0|||
144628400|NCT00793793|521497854|FG011|Overall Study|Adverse Event|2|||
144628401|NCT00793793|521497843|FG000|Overall Study|Protocol Violation|0|||
144628402|NCT00793793|521497844|FG001|Overall Study|Protocol Violation|0|||
144628403|NCT00793793|521497845|FG002|Overall Study|Protocol Violation|0|||
144628404|NCT00793793|521497846|FG003|Overall Study|Protocol Violation|1|||
144628405|NCT00793793|521497847|FG004|Overall Study|Protocol Violation|0|||
144628406|NCT00793793|521497848|FG005|Overall Study|Protocol Violation|0|||
144628407|NCT00793793|521497849|FG006|Overall Study|Protocol Violation|0|||
144628408|NCT00793793|521497850|FG007|Overall Study|Protocol Violation|0|||
144628409|NCT00793793|521497851|FG008|Overall Study|Protocol Violation|0|||
144628410|NCT00793793|521497852|FG009|Overall Study|Protocol Violation|0|||
144628411|NCT00793793|521497853|FG010|Overall Study|Protocol Violation|0|||
144628412|NCT00793793|521497854|FG011|Overall Study|Protocol Violation|0|||
144628413|NCT00793793|521497843|FG000|Overall Study|Lost to Follow-up|0|||
144628414|NCT00793793|521497844|FG001|Overall Study|Lost to Follow-up|0|||
144628415|NCT00793793|521497845|FG002|Overall Study|Lost to Follow-up|1|||
144628416|NCT00793793|521497846|FG003|Overall Study|Lost to Follow-up|0|||
144628417|NCT00793793|521497847|FG004|Overall Study|Lost to Follow-up|0|||
144628418|NCT00793793|521497848|FG005|Overall Study|Lost to Follow-up|0|||
144628419|NCT00793793|521497849|FG006|Overall Study|Lost to Follow-up|0|||
144628420|NCT00793793|521497850|FG007|Overall Study|Lost to Follow-up|0|||
144628421|NCT00793793|521497851|FG008|Overall Study|Lost to Follow-up|1|||
144628422|NCT00793793|521497852|FG009|Overall Study|Lost to Follow-up|3|||
144628423|NCT00793793|521497853|FG010|Overall Study|Lost to Follow-up|1|||
144628424|NCT00793793|521497854|FG011|Overall Study|Lost to Follow-up|0|||
144628425|NCT00793793|521497843|FG000|Overall Study|Withdrawal by Subject|0|||
144628426|NCT00793793|521497844|FG001|Overall Study|Withdrawal by Subject|0|||
144628427|NCT00793793|521497845|FG002|Overall Study|Withdrawal by Subject|0|||
144628428|NCT00793793|521497846|FG003|Overall Study|Withdrawal by Subject|0|||
144628429|NCT00793793|521497847|FG004|Overall Study|Withdrawal by Subject|1|||
144628430|NCT00793793|521497848|FG005|Overall Study|Withdrawal by Subject|0|||
144628431|NCT00793793|521497849|FG006|Overall Study|Withdrawal by Subject|0|||
144628432|NCT00793793|521497850|FG007|Overall Study|Withdrawal by Subject|0|||
144628433|NCT00793793|521497851|FG008|Overall Study|Withdrawal by Subject|1|||
144628434|NCT00793793|521497852|FG009|Overall Study|Withdrawal by Subject|0|||
144628435|NCT00793793|521497853|FG010|Overall Study|Withdrawal by Subject|0|||
144628436|NCT00793793|521497854|FG011|Overall Study|Withdrawal by Subject|0|||
144628437|NCT00793793|521497843|FG000|Overall Study|reason not specified|0|||
144628438|NCT00793793|521497844|FG001|Overall Study|reason not specified|1|||
144628439|NCT00793793|521497845|FG002|Overall Study|reason not specified|0|||
144628440|NCT00793793|521497846|FG003|Overall Study|reason not specified|1|||
144628441|NCT00793793|521497847|FG004|Overall Study|reason not specified|1|||
144628442|NCT00793793|521497848|FG005|Overall Study|reason not specified|1|||
144628443|NCT00793793|521497849|FG006|Overall Study|reason not specified|2|||
144628444|NCT00793793|521497850|FG007|Overall Study|reason not specified|0|||
144628445|NCT00793793|521497851|FG008|Overall Study|reason not specified|7|||
144628446|NCT00793793|521497852|FG009|Overall Study|reason not specified|6|||
144628447|NCT00793793|521497853|FG010|Overall Study|reason not specified|2|||
144628448|NCT00793793|521497854|FG011|Overall Study|reason not specified|4|||
144628449|NCT01552902|521497856|FG000|Overall Study|Adverse Event|1|||
144628450|NCT01552902|521497857|FG001|Overall Study|Adverse Event|15|||
144628451|NCT01552902|521497858|FG002|Overall Study|Adverse Event|14|||
144628452|NCT01552902|521497856|FG000|Overall Study|Protocol Violation|3|||
144628453|NCT01552902|521497857|FG001|Overall Study|Protocol Violation|3|||
144628454|NCT01552902|521497858|FG002|Overall Study|Protocol Violation|3|||
144628455|NCT01552902|521497856|FG000|Overall Study|Lack of Efficacy|4|||
144628456|NCT01552902|521497857|FG001|Overall Study|Lack of Efficacy|3|||
144628457|NCT01552902|521497858|FG002|Overall Study|Lack of Efficacy|1|||
144628458|NCT01552902|521497856|FG000|Overall Study|Withdrawal by Subject|1|||
144628459|NCT01552902|521497857|FG001|Overall Study|Withdrawal by Subject|9|||
144628460|NCT01552902|521497858|FG002|Overall Study|Withdrawal by Subject|6|||
144628461|NCT01552902|521497856|FG000|Overall Study|Lost to Follow-up|1|||
144628462|NCT01552902|521497857|FG001|Overall Study|Lost to Follow-up|3|||
144628463|NCT01552902|521497858|FG002|Overall Study|Lost to Follow-up|6|||
144628464|NCT01552902|521497856|FG000|Overall Study|Other|3|||
144628465|NCT01552902|521497857|FG001|Overall Study|Other|4|||
144628466|NCT01552902|521497858|FG002|Overall Study|Other|3|||
144628467|NCT02487108|521497861|FG000|Overall Study|Adverse Event|1|||
144628468|NCT02487108|521497862|FG001|Overall Study|Adverse Event|6|||
144628469|NCT02487108|521497863|FG002|Overall Study|Adverse Event|12|||
144628470|NCT02487108|521497864|FG003|Overall Study|Adverse Event|6|||
144628471|NCT02487108|521497861|FG000|Overall Study|Withdrawal by Subject|8|||
144628472|NCT02487108|521497862|FG001|Overall Study|Withdrawal by Subject|5|||
144628473|NCT02487108|521497863|FG002|Overall Study|Withdrawal by Subject|5|||
144628474|NCT02487108|521497864|FG003|Overall Study|Withdrawal by Subject|0|||
144628475|NCT02487108|521497861|FG000|Overall Study|Non-compliance to study medication|3|||
144628476|NCT02487108|521497862|FG001|Overall Study|Non-compliance to study medication|2|||
144628477|NCT02487108|521497863|FG002|Overall Study|Non-compliance to study medication|5|||
144628478|NCT02487108|521497864|FG003|Overall Study|Non-compliance to study medication|4|||
144628479|NCT02487108|521497861|FG000|Overall Study|Protocol Violation|1|||
144628480|NCT02487108|521497862|FG001|Overall Study|Protocol Violation|1|||
144628481|NCT02487108|521497863|FG002|Overall Study|Protocol Violation|2|||
144628482|NCT02487108|521497864|FG003|Overall Study|Protocol Violation|0|||
144628483|NCT02487108|521497861|FG000|Overall Study|Non-compliance to study procedures|0|||
144628484|NCT02487108|521497862|FG001|Overall Study|Non-compliance to study procedures|0|||
144628485|NCT02487108|521497863|FG002|Overall Study|Non-compliance to study procedures|0|||
144628486|NCT02487108|521497864|FG003|Overall Study|Non-compliance to study procedures|1|||
144628487|NCT02487108|521497861|FG000|Overall Study|Other than specified|3|||
144628488|NCT02487108|521497862|FG001|Overall Study|Other than specified|2|||
144628489|NCT02487108|521497863|FG002|Overall Study|Other than specified|2|||
144628490|NCT02487108|521497864|FG003|Overall Study|Other than specified|0|||
144628491|NCT01940484|521497865|FG000|Overall Study|Withdrawal by Subject|3|||
144628492|NCT01940484|521497865|FG000|Overall Study|Underwent transplantation|4|||
144628493|NCT01940484|521497865|FG000|Overall Study|Death|2|||
144628494|NCT01940484|521497865|FG000|Overall Study|Adverse Event|1|||
144628495|NCT03118947|521497874|FG000|Overall Study|Adverse Event|7|||
144628496|NCT03118947|521497874|FG000|Overall Study|Death|3|||
144628497|NCT03118947|521497874|FG000|Overall Study|Lack of Efficacy|4|||
144628498|NCT03118947|521497874|FG000|Overall Study|Non-compliance with study drug|1|||
144628499|NCT03118947|521497874|FG000|Overall Study|Protocol Violation|2|||
144628500|NCT03118947|521497874|FG000|Overall Study|Withdrawal by Subject|3|||
144628501|NCT03118947|521497874|FG000|Overall Study|Withdrawal by caregiver|3|||
144628502|NCT03118947|521497874|FG000|Overall Study|Change in patient's living situation|4|||
144628503|NCT03118947|521497874|FG000|Overall Study|Lost to Follow-up|2|||
144628504|NCT04451330|521497877|FG000|Overall Study|Adverse Event|1|||
144628505|NCT04451330|521497878|FG001|Overall Study|Adverse Event|2|||
144628506|NCT04451330|521497877|FG000|Overall Study|Lost to Follow-up|5|||
144628507|NCT04451330|521497878|FG001|Overall Study|Lost to Follow-up|0|||
144628508|NCT04451330|521497877|FG000|Overall Study|Withdrawal by Subject|3|||
144628509|NCT04451330|521497878|FG001|Overall Study|Withdrawal by Subject|1|||
144628510|NCT04451330|521497877|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144628511|NCT04451330|521497878|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144628512|NCT04451330|521497877|FG000|Overall Study|Other than specified|0|||
144628513|NCT04451330|521497878|FG001|Overall Study|Other than specified|1|||
144628514|NCT05099640|521497879|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
144628515|NCT05099640|521497880|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
144628516|NCT05099640|521497881|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
144628517|NCT05099640|521497879|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
144628518|NCT05099640|521497880|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
144628519|NCT05099640|521497881|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
144628520|NCT05099640|521497879|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
144628521|NCT05099640|521497880|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
144628522|NCT05099640|521497881|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
144628523|NCT05099640|521497879|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
144628524|NCT05099640|521497880|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
144628525|NCT05099640|521497881|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
144628526|NCT05099640|521497879|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
144628527|NCT05099640|521497880|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
144628528|NCT05099640|521497881|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
144628529|NCT05099640|521497879|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
144628530|NCT05099640|521497880|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
144628531|NCT05099640|521497881|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
144628532|NCT02690194|521497882|FG000|Overall Study|Withdrawal by Subject|1|||
144628533|NCT02690194|521497883|FG001|Overall Study|Withdrawal by Subject|4|||
144628534|NCT02690194|521497884|FG002|Overall Study|Withdrawal by Subject|0|||
144628535|NCT01552681|521497885|FG000|Overall Study|Withdrawal by Subject|4|||
144628536|NCT01552681|521497886|FG001|Overall Study|Withdrawal by Subject|0|||
144628537|NCT01552681|521497885|FG000|Overall Study|Physician Decision|1|||
144628538|NCT01552681|521497886|FG001|Overall Study|Physician Decision|0|||
144628539|NCT01552681|521497885|FG000|Overall Study|Subject moved away|0|||
144628540|NCT01552681|521497886|FG001|Overall Study|Subject moved away|1|||
144628541|NCT01987908|521497887|FG000|Placebo Lead-in Period|Adverse Event|2|||
144628542|NCT01987908|521497888|FG001|Placebo Lead-in Period|Adverse Event|0|||
144628543|NCT01987908|521497889|FG002|Placebo Lead-in Period|Adverse Event|0|||
144628544|NCT01987908|521497887|FG000|Placebo Lead-in Period|Physician Decision|2|||
144628545|NCT01987908|521497888|FG001|Placebo Lead-in Period|Physician Decision|0|||
144628546|NCT01987908|521497889|FG002|Placebo Lead-in Period|Physician Decision|0|||
144628547|NCT01987908|521497887|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
144628548|NCT01987908|521497888|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
144628549|NCT01987908|521497889|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
144628550|NCT01987908|521497887|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
144628551|NCT01987908|521497888|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
144628552|NCT01987908|521497889|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
144628553|NCT01987908|521497887|FG000|Treatment Period|Adverse Event|0|||
144628554|NCT01987908|521497888|FG001|Treatment Period|Adverse Event|1|||
144628555|NCT01987908|521497889|FG002|Treatment Period|Adverse Event|1|||
144628556|NCT01987908|521497887|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
144628557|NCT01987908|521497888|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
144628558|NCT01987908|521497889|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
144628559|NCT01987908|521497887|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
144628560|NCT01987908|521497888|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
144628561|NCT01987908|521497889|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
144628562|NCT00189462|521497890|FG000|Overall Study|Lack of Efficacy|5|||
144628563|NCT00189462|521497891|FG001|Overall Study|Lack of Efficacy|1|||
144628564|NCT00189462|521497890|FG000|Overall Study|Lost to Follow-up|18|||
144628565|NCT00189462|521497891|FG001|Overall Study|Lost to Follow-up|20|||
144628566|NCT02772757|521497895|FG000|Overall Study|Withdrawal by Subject|1|||
144628567|NCT02772757|521497896|FG001|Overall Study|Withdrawal by Subject|0|||
144628568|NCT02772757|521497897|FG002|Overall Study|Withdrawal by Subject|1|||
144628569|NCT02772757|521497895|FG000|Overall Study|Protocol Violation|0|||
144628570|NCT02772757|521497896|FG001|Overall Study|Protocol Violation|0|||
144628571|NCT02772757|521497897|FG002|Overall Study|Protocol Violation|1|||
144628572|NCT02772757|521497895|FG000|Overall Study|Physician Decision|0|||
144628573|NCT02772757|521497896|FG001|Overall Study|Physician Decision|3|||
144628574|NCT02772757|521497897|FG002|Overall Study|Physician Decision|3|||
144628575|NCT04698525|521497898|FG000|Overall Study|Lost to Follow-up|1|||
144209836|NCT00658021|519962065|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
144209837|NCT00658021|519962066|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
144209838|NCT00658021|519962067|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
144209839|NCT00658021|519962065|FG000|28-Week Treatment Period|Physician Decision|1|||
144209840|NCT00658021|519962066|FG001|28-Week Treatment Period|Physician Decision|2|||
144628576|NCT04698525|521497899|FG001|Overall Study|Lost to Follow-up|2|||
144628577|NCT04698525|521497898|FG000|Overall Study|Three suffered of Covid-19|2|||
144628578|NCT04698525|521497899|FG001|Overall Study|Three suffered of Covid-19|1|||
144628579|NCT00441792|521497900|FG000|Overall Study|Lost to Follow-up|0|||
144209841|NCT00658021|519962067|FG002|28-Week Treatment Period|Physician Decision|1|||
144628580|NCT00441792|521497901|FG001|Overall Study|Lost to Follow-up|2|||
144628581|NCT03665285|521497904|FG000|Overall Study|Started New Anticancer Treatment|1|||
144628582|NCT03665285|521497905|FG001|Overall Study|Started New Anticancer Treatment|1|||
144628583|NCT03665285|521497906|FG002|Overall Study|Started New Anticancer Treatment|2|||
144628584|NCT03665285|521497907|FG003|Overall Study|Started New Anticancer Treatment|4|||
144209842|NCT00658021|519962065|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
144628585|NCT03665285|521497908|FG004|Overall Study|Started New Anticancer Treatment|1|||
144628586|NCT03665285|521497909|FG005|Overall Study|Started New Anticancer Treatment|1|||
144628587|NCT03665285|521497910|FG006|Overall Study|Started New Anticancer Treatment|2|||
144628588|NCT03665285|521497911|FG007|Overall Study|Started New Anticancer Treatment|15|||
144628589|NCT03665285|521497912|FG008|Overall Study|Started New Anticancer Treatment|1|||
144628590|NCT03665285|521497904|FG000|Overall Study|Disease Progression|0|||
144628591|NCT03665285|521497905|FG001|Overall Study|Disease Progression|0|||
144628592|NCT03665285|521497906|FG002|Overall Study|Disease Progression|3|||
144628593|NCT03665285|521497907|FG003|Overall Study|Disease Progression|1|||
144628594|NCT03665285|521497908|FG004|Overall Study|Disease Progression|0|||
144628595|NCT03665285|521497909|FG005|Overall Study|Disease Progression|0|||
144628596|NCT03665285|521497910|FG006|Overall Study|Disease Progression|0|||
144628597|NCT03665285|521497911|FG007|Overall Study|Disease Progression|7|||
144628598|NCT03665285|521497912|FG008|Overall Study|Disease Progression|1|||
144628599|NCT03665285|521497904|FG000|Overall Study|Hospice|0|||
144628600|NCT03665285|521497905|FG001|Overall Study|Hospice|0|||
144628601|NCT03665285|521497906|FG002|Overall Study|Hospice|0|||
144628602|NCT03665285|521497907|FG003|Overall Study|Hospice|0|||
144628603|NCT03665285|521497908|FG004|Overall Study|Hospice|0|||
144628604|NCT03665285|521497909|FG005|Overall Study|Hospice|0|||
144628605|NCT03665285|521497910|FG006|Overall Study|Hospice|0|||
144628606|NCT03665285|521497911|FG007|Overall Study|Hospice|2|||
144628607|NCT03665285|521497912|FG008|Overall Study|Hospice|0|||
144628608|NCT03665285|521497904|FG000|Overall Study|Withdrawal by Subject|0|||
144628609|NCT03665285|521497905|FG001|Overall Study|Withdrawal by Subject|0|||
144628610|NCT03665285|521497906|FG002|Overall Study|Withdrawal by Subject|0|||
144628611|NCT03665285|521497907|FG003|Overall Study|Withdrawal by Subject|0|||
144628612|NCT03665285|521497908|FG004|Overall Study|Withdrawal by Subject|1|||
144628613|NCT03665285|521497909|FG005|Overall Study|Withdrawal by Subject|0|||
144628614|NCT03665285|521497910|FG006|Overall Study|Withdrawal by Subject|0|||
144628615|NCT03665285|521497911|FG007|Overall Study|Withdrawal by Subject|2|||
144628616|NCT03665285|521497912|FG008|Overall Study|Withdrawal by Subject|0|||
144628617|NCT03665285|521497904|FG000|Overall Study|Physician Decision|0|||
144628618|NCT03665285|521497905|FG001|Overall Study|Physician Decision|0|||
144628619|NCT03665285|521497906|FG002|Overall Study|Physician Decision|0|||
144628620|NCT03665285|521497907|FG003|Overall Study|Physician Decision|0|||
144628621|NCT03665285|521497908|FG004|Overall Study|Physician Decision|0|||
144628622|NCT03665285|521497909|FG005|Overall Study|Physician Decision|0|||
144628623|NCT03665285|521497910|FG006|Overall Study|Physician Decision|0|||
144628624|NCT03665285|521497911|FG007|Overall Study|Physician Decision|2|||
144628625|NCT03665285|521497912|FG008|Overall Study|Physician Decision|0|||
144628626|NCT00888355|521497913|FG000|Overall Study|Adverse Event|10|||
144628627|NCT00888355|521497914|FG001|Overall Study|Adverse Event|0|||
144628628|NCT00888355|521497915|FG002|Overall Study|Adverse Event|3|||
144628629|NCT00888355|521497916|FG003|Overall Study|Adverse Event|3|||
144628630|NCT00888355|521497913|FG000|Overall Study|Lack of Efficacy|9|||
144628631|NCT00888355|521497914|FG001|Overall Study|Lack of Efficacy|2|||
144628632|NCT00888355|521497915|FG002|Overall Study|Lack of Efficacy|5|||
144628633|NCT00888355|521497916|FG003|Overall Study|Lack of Efficacy|2|||
144628634|NCT00888355|521497913|FG000|Overall Study|Lost to Follow-up|0|||
144628635|NCT00888355|521497914|FG001|Overall Study|Lost to Follow-up|2|||
144628636|NCT00888355|521497915|FG002|Overall Study|Lost to Follow-up|2|||
144628637|NCT00888355|521497916|FG003|Overall Study|Lost to Follow-up|0|||
144628638|NCT00888355|521497913|FG000|Overall Study|Protocol Violation|3|||
144628639|NCT00888355|521497914|FG001|Overall Study|Protocol Violation|2|||
144628640|NCT00888355|521497915|FG002|Overall Study|Protocol Violation|1|||
144628641|NCT00888355|521497916|FG003|Overall Study|Protocol Violation|2|||
144628642|NCT00888355|521497913|FG000|Overall Study|Withdrawal by Subject|0|||
144628643|NCT00888355|521497914|FG001|Overall Study|Withdrawal by Subject|3|||
144628644|NCT00888355|521497915|FG002|Overall Study|Withdrawal by Subject|1|||
144628645|NCT00888355|521497916|FG003|Overall Study|Withdrawal by Subject|3|||
144628646|NCT00354601|521497920|FG000|Overall Study|Protocol Violation|1|||
144209843|NCT00658021|519962066|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
144628647|NCT00354601|521497920|FG000|Overall Study|progression|1|||
144628648|NCT03603652|521497921|FG000|Overall Study|Death|2|||
144628649|NCT03213366|521497924|FG000|Overall Study|Lost to Follow-up|9|||
144628650|NCT03213366|521497925|FG001|Overall Study|Lost to Follow-up|4|||
144628651|NCT02532855|521497926|FG000|Overall Study|Lost to Follow-up|4|||
144628652|NCT02532855|521497927|FG001|Overall Study|Lost to Follow-up|3|||
144628653|NCT02532855|521497926|FG000|Overall Study|Withdrawal by Subject|4|||
144628654|NCT02532855|521497927|FG001|Overall Study|Withdrawal by Subject|8|||
144628655|NCT00666926|521497928|FG000|Overall Study|Adverse Event|0|||
144628656|NCT00666926|521497929|FG001|Overall Study|Adverse Event|0|||
144628657|NCT00666926|521497930|FG002|Overall Study|Adverse Event|0|||
144628658|NCT00666926|521497931|FG003|Overall Study|Adverse Event|0|||
144628659|NCT00666926|521497932|FG004|Overall Study|Adverse Event|0|||
144628660|NCT00666926|521497933|FG005|Overall Study|Adverse Event|0|||
144628661|NCT00666926|521497934|FG006|Overall Study|Adverse Event|0|||
144628662|NCT00666926|521497935|FG007|Overall Study|Adverse Event|0|||
144628663|NCT00666926|521497936|FG008|Overall Study|Adverse Event|0|||
144628664|NCT00666926|521497937|FG009|Overall Study|Adverse Event|2|||
144628665|NCT00666926|521497938|FG010|Overall Study|Adverse Event|2|||
144628666|NCT00666926|521497939|FG011|Overall Study|Adverse Event|2|||
144628667|NCT00666926|521497940|FG012|Overall Study|Adverse Event|0|||
144628668|NCT00666926|521497941|FG013|Overall Study|Adverse Event|1|||
144628669|NCT00666926|521497942|FG014|Overall Study|Adverse Event|0|||
144628670|NCT00666926|521497943|FG015|Overall Study|Adverse Event|0|||
144628671|NCT00666926|521497928|FG000|Overall Study|Laboratory abnormality|0|||
144628672|NCT00666926|521497929|FG001|Overall Study|Laboratory abnormality|0|||
144628673|NCT00666926|521497930|FG002|Overall Study|Laboratory abnormality|0|||
144628674|NCT00666926|521497931|FG003|Overall Study|Laboratory abnormality|0|||
144628675|NCT00666926|521497932|FG004|Overall Study|Laboratory abnormality|0|||
144628676|NCT00666926|521497933|FG005|Overall Study|Laboratory abnormality|0|||
144628677|NCT00666926|521497934|FG006|Overall Study|Laboratory abnormality|0|||
144628678|NCT00666926|521497935|FG007|Overall Study|Laboratory abnormality|0|||
144628679|NCT00666926|521497936|FG008|Overall Study|Laboratory abnormality|0|||
144628680|NCT00666926|521497937|FG009|Overall Study|Laboratory abnormality|0|||
144628681|NCT00666926|521497938|FG010|Overall Study|Laboratory abnormality|1|||
144628682|NCT00666926|521497939|FG011|Overall Study|Laboratory abnormality|0|||
144628683|NCT00666926|521497940|FG012|Overall Study|Laboratory abnormality|0|||
144628684|NCT00666926|521497941|FG013|Overall Study|Laboratory abnormality|0|||
144628685|NCT00666926|521497942|FG014|Overall Study|Laboratory abnormality|0|||
144628686|NCT00666926|521497943|FG015|Overall Study|Laboratory abnormality|1|||
144628687|NCT00666926|521497928|FG000|Overall Study|Lack of Efficacy|0|||
144628688|NCT00666926|521497929|FG001|Overall Study|Lack of Efficacy|0|||
144628689|NCT00666926|521497930|FG002|Overall Study|Lack of Efficacy|0|||
144628690|NCT00666926|521497931|FG003|Overall Study|Lack of Efficacy|0|||
144628691|NCT00666926|521497932|FG004|Overall Study|Lack of Efficacy|0|||
144628692|NCT00666926|521497933|FG005|Overall Study|Lack of Efficacy|1|||
144628693|NCT00666926|521497934|FG006|Overall Study|Lack of Efficacy|0|||
144628694|NCT00666926|521497935|FG007|Overall Study|Lack of Efficacy|0|||
144628695|NCT00666926|521497936|FG008|Overall Study|Lack of Efficacy|0|||
144628696|NCT00666926|521497937|FG009|Overall Study|Lack of Efficacy|0|||
144628697|NCT00666926|521497938|FG010|Overall Study|Lack of Efficacy|0|||
144628698|NCT00666926|521497939|FG011|Overall Study|Lack of Efficacy|1|||
144628699|NCT00666926|521497940|FG012|Overall Study|Lack of Efficacy|0|||
144628700|NCT00666926|521497941|FG013|Overall Study|Lack of Efficacy|0|||
144628701|NCT00666926|521497942|FG014|Overall Study|Lack of Efficacy|0|||
144628702|NCT00666926|521497943|FG015|Overall Study|Lack of Efficacy|0|||
144628703|NCT00666926|521497928|FG000|Overall Study|Lost to Follow-up|0|||
144628704|NCT00666926|521497929|FG001|Overall Study|Lost to Follow-up|0|||
144628705|NCT00666926|521497930|FG002|Overall Study|Lost to Follow-up|0|||
144628706|NCT00666926|521497931|FG003|Overall Study|Lost to Follow-up|1|||
144628707|NCT00666926|521497932|FG004|Overall Study|Lost to Follow-up|0|||
144628708|NCT00666926|521497933|FG005|Overall Study|Lost to Follow-up|0|||
144628709|NCT00666926|521497934|FG006|Overall Study|Lost to Follow-up|0|||
144628710|NCT00666926|521497935|FG007|Overall Study|Lost to Follow-up|0|||
144628711|NCT00666926|521497936|FG008|Overall Study|Lost to Follow-up|0|||
144628712|NCT00666926|521497937|FG009|Overall Study|Lost to Follow-up|0|||
144628713|NCT00666926|521497938|FG010|Overall Study|Lost to Follow-up|0|||
144628714|NCT00666926|521497939|FG011|Overall Study|Lost to Follow-up|0|||
144628715|NCT00666926|521497940|FG012|Overall Study|Lost to Follow-up|0|||
144628716|NCT00666926|521497941|FG013|Overall Study|Lost to Follow-up|0|||
144628717|NCT00666926|521497942|FG014|Overall Study|Lost to Follow-up|0|||
144628718|NCT00666926|521497943|FG015|Overall Study|Lost to Follow-up|0|||
144628719|NCT00666926|521497928|FG000|Overall Study|Other|2|||
144628720|NCT00666926|521497929|FG001|Overall Study|Other|4|||
144628721|NCT00666926|521497930|FG002|Overall Study|Other|3|||
144628722|NCT00666926|521497931|FG003|Overall Study|Other|3|||
144628723|NCT00666926|521497932|FG004|Overall Study|Other|3|||
144628724|NCT00666926|521497933|FG005|Overall Study|Other|3|||
144628725|NCT00666926|521497934|FG006|Overall Study|Other|4|||
144628726|NCT00666926|521497935|FG007|Overall Study|Other|0|||
144628727|NCT00666926|521497936|FG008|Overall Study|Other|3|||
144628728|NCT00666926|521497937|FG009|Overall Study|Other|5|||
144628729|NCT00666926|521497938|FG010|Overall Study|Other|3|||
144628730|NCT00666926|521497939|FG011|Overall Study|Other|26|||
144209844|NCT00658021|519962067|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
144209845|NCT00658021|519962065|FG000|28-Week Treatment Period|Loss of glucose control|1|||
144628731|NCT00666926|521497940|FG012|Overall Study|Other|3|||
144628732|NCT00666926|521497941|FG013|Overall Study|Other|2|||
144628733|NCT00666926|521497942|FG014|Overall Study|Other|4|||
144628734|NCT00666926|521497943|FG015|Overall Study|Other|4|||
144628735|NCT00666926|521497928|FG000|Overall Study|Withdrawal by Subject|0|||
144628736|NCT00666926|521497929|FG001|Overall Study|Withdrawal by Subject|0|||
144628737|NCT00666926|521497930|FG002|Overall Study|Withdrawal by Subject|0|||
144209846|NCT00658021|519962066|FG001|28-Week Treatment Period|Loss of glucose control|1|||
144628738|NCT00666926|521497931|FG003|Overall Study|Withdrawal by Subject|0|||
144628739|NCT00666926|521497932|FG004|Overall Study|Withdrawal by Subject|0|||
144628740|NCT00666926|521497933|FG005|Overall Study|Withdrawal by Subject|0|||
144628741|NCT00666926|521497934|FG006|Overall Study|Withdrawal by Subject|0|||
144628742|NCT00666926|521497935|FG007|Overall Study|Withdrawal by Subject|1|||
144628743|NCT00666926|521497936|FG008|Overall Study|Withdrawal by Subject|0|||
144628744|NCT00666926|521497937|FG009|Overall Study|Withdrawal by Subject|3|||
144628745|NCT00666926|521497938|FG010|Overall Study|Withdrawal by Subject|0|||
144628746|NCT00666926|521497939|FG011|Overall Study|Withdrawal by Subject|3|||
144628747|NCT00666926|521497940|FG012|Overall Study|Withdrawal by Subject|0|||
144628748|NCT00666926|521497941|FG013|Overall Study|Withdrawal by Subject|1|||
144628749|NCT00666926|521497942|FG014|Overall Study|Withdrawal by Subject|3|||
144628750|NCT00666926|521497943|FG015|Overall Study|Withdrawal by Subject|3|||
144628751|NCT00666926|521497928|FG000|Overall Study|Death|0|||
144628752|NCT00666926|521497929|FG001|Overall Study|Death|0|||
144628753|NCT00666926|521497930|FG002|Overall Study|Death|0|||
144628754|NCT00666926|521497931|FG003|Overall Study|Death|0|||
144628755|NCT00666926|521497932|FG004|Overall Study|Death|0|||
144628756|NCT00666926|521497933|FG005|Overall Study|Death|0|||
144628757|NCT00666926|521497934|FG006|Overall Study|Death|0|||
144628758|NCT00666926|521497935|FG007|Overall Study|Death|0|||
144628759|NCT00666926|521497936|FG008|Overall Study|Death|0|||
144628760|NCT00666926|521497937|FG009|Overall Study|Death|0|||
144628761|NCT00666926|521497938|FG010|Overall Study|Death|0|||
144628762|NCT00666926|521497939|FG011|Overall Study|Death|1|||
144628763|NCT00666926|521497940|FG012|Overall Study|Death|0|||
144628764|NCT00666926|521497941|FG013|Overall Study|Death|0|||
144628765|NCT00666926|521497942|FG014|Overall Study|Death|0|||
144628766|NCT00666926|521497943|FG015|Overall Study|Death|0|||
144628767|NCT01960855|521497944|FG000|Overall Study|Subject noncompliant|1|||
144628768|NCT01960855|521497945|FG001|Overall Study|Subject noncompliant|0|||
144628769|NCT01960855|521497946|FG002|Overall Study|Subject noncompliant|0|||
144628770|NCT01960855|521497947|FG003|Overall Study|Subject noncompliant|0|||
144628771|NCT01960855|521497948|FG004|Overall Study|Subject noncompliant|0|||
144628772|NCT01960855|521497944|FG000|Overall Study|Adverse Event|2|||
144628773|NCT01960855|521497945|FG001|Overall Study|Adverse Event|0|||
144628774|NCT01960855|521497946|FG002|Overall Study|Adverse Event|6|||
144628775|NCT01960855|521497947|FG003|Overall Study|Adverse Event|2|||
144628776|NCT01960855|521497948|FG004|Overall Study|Adverse Event|2|||
144628777|NCT01960855|521497944|FG000|Overall Study|Lack of Efficacy|1|||
144628778|NCT01960855|521497945|FG001|Overall Study|Lack of Efficacy|1|||
144628779|NCT01960855|521497946|FG002|Overall Study|Lack of Efficacy|0|||
144628780|NCT01960855|521497947|FG003|Overall Study|Lack of Efficacy|0|||
144628781|NCT01960855|521497948|FG004|Overall Study|Lack of Efficacy|0|||
144628782|NCT01960855|521497944|FG000|Overall Study|Other|2|||
144628783|NCT01960855|521497945|FG001|Overall Study|Other|1|||
144628784|NCT01960855|521497946|FG002|Overall Study|Other|1|||
144628785|NCT01960855|521497947|FG003|Overall Study|Other|1|||
144628786|NCT01960855|521497948|FG004|Overall Study|Other|0|||
144628787|NCT01960855|521497944|FG000|Overall Study|Consent withdrawn by subject|3|||
144628788|NCT01960855|521497945|FG001|Overall Study|Consent withdrawn by subject|1|||
144628789|NCT01960855|521497946|FG002|Overall Study|Consent withdrawn by subject|2|||
144628790|NCT01960855|521497947|FG003|Overall Study|Consent withdrawn by subject|1|||
144628791|NCT01960855|521497948|FG004|Overall Study|Consent withdrawn by subject|1|||
144628792|NCT01960855|521497944|FG000|Overall Study|Lost to Follow-up|2|||
144628793|NCT01960855|521497945|FG001|Overall Study|Lost to Follow-up|1|||
144628794|NCT01960855|521497946|FG002|Overall Study|Lost to Follow-up|0|||
144628795|NCT01960855|521497947|FG003|Overall Study|Lost to Follow-up|0|||
144628796|NCT01960855|521497948|FG004|Overall Study|Lost to Follow-up|2|||
144628797|NCT02058147|521497949|FG000|Overall Study|Randomized but not treated|0|||
144628798|NCT02058147|521497950|FG001|Overall Study|Randomized but not treated|0|||
144628799|NCT02058147|521497951|FG002|Overall Study|Randomized but not treated|1|||
144628800|NCT02058147|521497949|FG000|Overall Study|Adverse Event|12|||
144628801|NCT02058147|521497950|FG001|Overall Study|Adverse Event|9|||
144628802|NCT02058147|521497951|FG002|Overall Study|Adverse Event|21|||
144628803|NCT02058147|521497949|FG000|Overall Study|Lack of Efficacy|1|||
144628804|NCT02058147|521497950|FG001|Overall Study|Lack of Efficacy|0|||
144628805|NCT02058147|521497951|FG002|Overall Study|Lack of Efficacy|3|||
144628806|NCT02058147|521497949|FG000|Overall Study|Poor compliance to protocol|8|||
144628807|NCT02058147|521497950|FG001|Overall Study|Poor compliance to protocol|9|||
144628808|NCT02058147|521497951|FG002|Overall Study|Poor compliance to protocol|4|||
144628809|NCT02058147|521497949|FG000|Overall Study|Other than specified|8|||
144209847|NCT00658021|519962067|FG002|28-Week Treatment Period|Loss of glucose control|10|||
144209848|NCT00658021|519962065|FG000|28-Week Treatment Period|Other|2|||
144209849|NCT00658021|519962066|FG001|28-Week Treatment Period|Other|3|||
144628810|NCT02058147|521497950|FG001|Overall Study|Other than specified|9|||
144628811|NCT02058147|521497951|FG002|Overall Study|Other than specified|0|||
144628812|NCT00130286|521497955|FG000|Overall Study|Withdrawal by Subject|0|||
144628813|NCT00130286|521497956|FG001|Overall Study|Withdrawal by Subject|1|||
144209850|NCT00658021|519962067|FG002|28-Week Treatment Period|Other|1|||
144628814|NCT00130286|521497957|FG002|Overall Study|Withdrawal by Subject|2|||
144628815|NCT00130286|521497958|FG003|Overall Study|Withdrawal by Subject|2|||
144628816|NCT00130286|521497955|FG000|Overall Study|Adverse Event|0|||
144628817|NCT00130286|521497956|FG001|Overall Study|Adverse Event|0|||
144628818|NCT00130286|521497957|FG002|Overall Study|Adverse Event|2|||
144628819|NCT00130286|521497958|FG003|Overall Study|Adverse Event|0|||
144628820|NCT00130286|521497955|FG000|Overall Study|Missing lab specimens|0|||
144628821|NCT00130286|521497956|FG001|Overall Study|Missing lab specimens|2|||
144628822|NCT00130286|521497957|FG002|Overall Study|Missing lab specimens|0|||
144628823|NCT00130286|521497958|FG003|Overall Study|Missing lab specimens|0|||
144628824|NCT01014585|521497963|FG000|Overall Study|Adverse Event|0|||
144628825|NCT01014585|521497964|FG001|Overall Study|Adverse Event|2|||
144628826|NCT01014585|521497965|FG002|Overall Study|Adverse Event|0|||
144628827|NCT01014585|521497966|FG003|Overall Study|Adverse Event|3|||
144262951|NCT01396083|520163801|FG001|Overall Study|Adverse Event|28|||
144262952|NCT01396083|520163800|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144262953|NCT01396083|520163801|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
144262954|NCT01396083|520163800|FG000|Overall Study|Consent withdrawn|4|||
144262955|NCT01396083|520163801|FG001|Overall Study|Consent withdrawn|5|||
144262956|NCT01396083|520163800|FG000|Overall Study|Protocol deviation(s)|0|||
144262957|NCT01396083|520163801|FG001|Overall Study|Protocol deviation(s)|1|||
144628828|NCT01014585|521497963|FG000|Overall Study|Withdrawal by Subject|2|||
144628829|NCT01014585|521497964|FG001|Overall Study|Withdrawal by Subject|0|||
144628830|NCT01014585|521497965|FG002|Overall Study|Withdrawal by Subject|1|||
144628831|NCT01014585|521497966|FG003|Overall Study|Withdrawal by Subject|3|||
144628832|NCT01014585|521497963|FG000|Overall Study|Lost to Follow-up|0|||
144628833|NCT01014585|521497964|FG001|Overall Study|Lost to Follow-up|0|||
144628834|NCT01014585|521497965|FG002|Overall Study|Lost to Follow-up|0|||
144628835|NCT01014585|521497966|FG003|Overall Study|Lost to Follow-up|2|||
144628836|NCT01014585|521497963|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
144628837|NCT01014585|521497964|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
144628838|NCT01014585|521497965|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
144628839|NCT01014585|521497966|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
144628840|NCT02154425|521497967|FG000|Screening Period|Adverse Event|1|||
144628841|NCT04178772|521497970|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
144628842|NCT04178772|521497970|FG000|Overall Study|study terminated early due to COVID-19|7|||
144628843|NCT01737931|521497974|FG000|Overall Study|Withdrawal by Subject|0|||
144628844|NCT01737931|521497975|FG001|Overall Study|Withdrawal by Subject|1|||
144628845|NCT01737931|521497976|FG002|Overall Study|Withdrawal by Subject|1|||
144628846|NCT01737931|521497974|FG000|Overall Study|Physician Decision|0|||
144628847|NCT01737931|521497975|FG001|Overall Study|Physician Decision|1|||
144628848|NCT01737931|521497976|FG002|Overall Study|Physician Decision|0|||
144628849|NCT02817087|521497977|FG000|Overall Study|Withdrawal by Subject|2|||
144628850|NCT02817087|521497978|FG001|Overall Study|Withdrawal by Subject|0|||
144628851|NCT00880256|521497979|FG000|Overall Study|Lost to Follow-up|28|||
144628852|NCT00802360|521497980|FG000|Overall Study|Stimulation failure|4|||
144628853|NCT00802360|521497981|FG001|Overall Study|Stimulation failure|0|||
144628854|NCT00802360|521497982|FG002|Overall Study|Stimulation failure|3|||
144628855|NCT00802360|521497983|FG003|Overall Study|Stimulation failure|3|||
144628856|NCT00802360|521497980|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
144628857|NCT00802360|521497981|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
144628858|NCT00802360|521497982|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
144628859|NCT00802360|521497983|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
144628860|NCT00802360|521497980|FG000|Overall Study|Cycle cancelled|0|||
144628861|NCT00802360|521497981|FG001|Overall Study|Cycle cancelled|1|||
144628862|NCT00802360|521497982|FG002|Overall Study|Cycle cancelled|1|||
144628863|NCT00802360|521497983|FG003|Overall Study|Cycle cancelled|1|||
144628864|NCT00802360|521497980|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
144628865|NCT00802360|521497981|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
144628866|NCT00802360|521497982|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
144628867|NCT00802360|521497983|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
144628868|NCT00802360|521497980|FG000|Overall Study|No positive serum pregnancy|17|||
144628869|NCT00802360|521497981|FG001|Overall Study|No positive serum pregnancy|20|||
144628870|NCT00802360|521497982|FG002|Overall Study|No positive serum pregnancy|14|||
144628871|NCT00802360|521497983|FG003|Overall Study|No positive serum pregnancy|10|||
144628872|NCT00802360|521497980|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
144628873|NCT00802360|521497981|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
144628874|NCT00802360|521497982|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
144628875|NCT00802360|521497983|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
144628876|NCT00802360|521497980|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
144628877|NCT00802360|521497981|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
144628878|NCT00802360|521497982|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
144628879|NCT00802360|521497983|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
144628880|NCT00802360|521497980|FG000|Overall Study|Other|2|||
144628881|NCT00802360|521497981|FG001|Overall Study|Other|3|||
144628882|NCT00802360|521497982|FG002|Overall Study|Other|6|||
144628883|NCT00802360|521497983|FG003|Overall Study|Other|3|||
144628884|NCT02041962|521497984|FG000|Overall Study|Lost Aetna Coverage|43|||
144628885|NCT02041962|521497985|FG001|Overall Study|Lost Aetna Coverage|40|||
144628886|NCT02041962|521497984|FG000|Overall Study|Death|1|||
144628887|NCT02041962|521497985|FG001|Overall Study|Death|1|||
144628888|NCT02041962|521497984|FG000|Overall Study|Lost to Follow-up|37|||
144628889|NCT02041962|521497985|FG001|Overall Study|Lost to Follow-up|32|||
144628890|NCT02041962|521497984|FG000|Overall Study|Withdrawal by Subject|0|||
144628891|NCT02041962|521497985|FG001|Overall Study|Withdrawal by Subject|11|||
144628892|NCT02526550|521497996|FG000|Overall Study|Lost to Follow-up|1|||
144628893|NCT00464178|521498002|FG000|Overall Study|Protocol Violation|1|||
144628894|NCT00464178|521498002|FG000|Overall Study|Withdrawal by Subject|1|||
144628895|NCT00670007|521499944|FG000|Overall Study|Drug abuse|1|||
144628896|NCT00670007|521499944|FG000|Overall Study|Lung transplant|1|||
144628897|NCT00670007|521499944|FG000|Overall Study|Travel/Vacation|1|||
144628898|NCT00670007|521499944|FG000|Overall Study|Adverse event, serious fatal|1|||
144628899|NCT00670007|521499944|FG000|Overall Study|Adverse Event|1|||
144628900|NCT00670007|521499944|FG000|Overall Study|Withdrawal by Subject|4|||
144628901|NCT00956943|521499945|FG000|Overall Study|Lost to Follow-up|9|||
144628902|NCT00956943|521499946|FG001|Overall Study|Lost to Follow-up|10|||
144628903|NCT02613208|521499947|FG000|Overall Study|Withdrawal by Subject|1|||
144628904|NCT02613208|521499947|FG000|Overall Study|Change of address|2|||
144628905|NCT02613208|521499947|FG000|Overall Study|Physician Decision|2|||
144628906|NCT02613208|521499947|FG000|Overall Study|Lost to Follow-up|5|||
144628907|NCT02613208|521499947|FG000|Overall Study|Death|37|||
144628908|NCT00270894|521499948|FG000|Overall Study|Adverse Event|1|||
144628909|NCT00270894|521499948|FG000|Overall Study|Withdrawal by Subject|1|||
144628910|NCT01070329|521499949|FG000|Overall Study|Adverse Event|13|||
144628911|NCT01070329|521499950|FG001|Overall Study|Adverse Event|10|||
144628912|NCT01070329|521499949|FG000|Overall Study|Lost to Follow-up|22|||
144628913|NCT01070329|521499950|FG001|Overall Study|Lost to Follow-up|12|||
144628914|NCT01070329|521499949|FG000|Overall Study|Withdrawal by Subject|9|||
144628915|NCT01070329|521499950|FG001|Overall Study|Withdrawal by Subject|11|||
144628916|NCT01070329|521499949|FG000|Overall Study|Protocol Violation|3|||
144628917|NCT01070329|521499950|FG001|Overall Study|Protocol Violation|8|||
144628918|NCT01070329|521499949|FG000|Overall Study|Lack of Efficacy|2|||
144628919|NCT01070329|521499950|FG001|Overall Study|Lack of Efficacy|6|||
144628920|NCT01070329|521499949|FG000|Overall Study|Physician Decision|2|||
144628921|NCT01070329|521499950|FG001|Overall Study|Physician Decision|1|||
144628922|NCT01070329|521499949|FG000|Overall Study|Entry Criteria Not Met|1|||
144628923|NCT01070329|521499950|FG001|Overall Study|Entry Criteria Not Met|0|||
144628924|NCT01070329|521499949|FG000|Overall Study|Sponsor Decision|0|||
144628925|NCT01070329|521499950|FG001|Overall Study|Sponsor Decision|1|||
144628926|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
144628927|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
144628928|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
144628929|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
144628930|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
144628931|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
144628932|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
144628933|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
144628934|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144628935|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
144628936|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144628937|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
144628938|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
144628939|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144628940|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144628941|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
144628942|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
144628943|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
144628944|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
144628945|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
144628946|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
144628947|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
144628948|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
144628949|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
144628950|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
144628951|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
144628952|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
144628953|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
144628954|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
144628955|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
144628956|NCT05195528|521499955|FG000|Placebo-controlled Treatment Period|Other|0|||
144628957|NCT05195528|521499956|FG001|Placebo-controlled Treatment Period|Other|0|||
144628958|NCT05195528|521499957|FG002|Placebo-controlled Treatment Period|Other|1|||
144628959|NCT05195528|521499958|FG003|Placebo-controlled Treatment Period|Other|0|||
144628960|NCT05195528|521499959|FG004|Placebo-controlled Treatment Period|Other|0|||
144628961|NCT05195528|521499955|FG000|Extension Period|PTE or AE or SAE|0|||
144628962|NCT05195528|521499956|FG001|Extension Period|PTE or AE or SAE|4|||
144628963|NCT05195528|521499957|FG002|Extension Period|PTE or AE or SAE|5|||
144628964|NCT05195528|521499958|FG003|Extension Period|PTE or AE or SAE|4|||
144628965|NCT05195528|521499959|FG004|Extension Period|PTE or AE or SAE|4|||
144628966|NCT05195528|521499955|FG000|Extension Period|Protocol Violation|0|||
144628967|NCT05195528|521499956|FG001|Extension Period|Protocol Violation|2|||
144628968|NCT05195528|521499957|FG002|Extension Period|Protocol Violation|1|||
144628969|NCT05195528|521499958|FG003|Extension Period|Protocol Violation|0|||
144628970|NCT05195528|521499959|FG004|Extension Period|Protocol Violation|1|||
144628971|NCT05195528|521499955|FG000|Extension Period|Lost to Follow-up|0|||
144628972|NCT05195528|521499956|FG001|Extension Period|Lost to Follow-up|6|||
144628973|NCT05195528|521499957|FG002|Extension Period|Lost to Follow-up|13|||
144628974|NCT05195528|521499958|FG003|Extension Period|Lost to Follow-up|3|||
144628975|NCT05195528|521499959|FG004|Extension Period|Lost to Follow-up|7|||
144628976|NCT05195528|521499955|FG000|Extension Period|Withdrawal by Subject|0|||
144628977|NCT05195528|521499956|FG001|Extension Period|Withdrawal by Subject|12|||
144628978|NCT05195528|521499957|FG002|Extension Period|Withdrawal by Subject|9|||
144628979|NCT05195528|521499958|FG003|Extension Period|Withdrawal by Subject|6|||
144628980|NCT05195528|521499959|FG004|Extension Period|Withdrawal by Subject|5|||
144628981|NCT05195528|521499955|FG000|Extension Period|Lack of Efficacy|0|||
144628982|NCT05195528|521499956|FG001|Extension Period|Lack of Efficacy|3|||
144628983|NCT05195528|521499957|FG002|Extension Period|Lack of Efficacy|0|||
144628984|NCT05195528|521499958|FG003|Extension Period|Lack of Efficacy|0|||
144628985|NCT05195528|521499959|FG004|Extension Period|Lack of Efficacy|2|||
144628986|NCT05195528|521499955|FG000|Extension Period|Not Treated|0|||
144628987|NCT05195528|521499956|FG001|Extension Period|Not Treated|0|||
144628988|NCT05195528|521499957|FG002|Extension Period|Not Treated|2|||
144628989|NCT05195528|521499958|FG003|Extension Period|Not Treated|3|||
144628990|NCT05195528|521499959|FG004|Extension Period|Not Treated|0|||
144628991|NCT05195528|521499955|FG000|Extension Period|Other|0|||
144628992|NCT05195528|521499956|FG001|Extension Period|Other|1|||
144628993|NCT05195528|521499957|FG002|Extension Period|Other|1|||
144628994|NCT05195528|521499958|FG003|Extension Period|Other|0|||
144628995|NCT05195528|521499959|FG004|Extension Period|Other|0|||
144628996|NCT00950170|521499960|FG000|Overall Study|Parent/Legal Guardian Request|1|||
144628997|NCT00950170|521499960|FG000|Overall Study|Adverse Event|2|||
144628998|NCT00950170|521499960|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
144628999|NCT01254669|521499961|FG000|Overall Study|Withdrawal by Subject|0|||
144629000|NCT01254669|521499962|FG001|Overall Study|Withdrawal by Subject|1|||
144629001|NCT01254669|521499961|FG000|Overall Study|time constraint|2|||
144629002|NCT01254669|521499962|FG001|Overall Study|time constraint|2|||
144629003|NCT01254669|521499961|FG000|Overall Study|called to clinic during intervention|1|||
144629004|NCT01254669|521499962|FG001|Overall Study|called to clinic during intervention|1|||
144629005|NCT02631538|521499963|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
144629006|NCT02631538|521499964|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
144209851|NCT00658021|519962065|FG000|28-Week Treatment Period|Did not receive treatment|2|||
144209852|NCT00658021|519962066|FG001|28-Week Treatment Period|Did not receive treatment|0|||
144209853|NCT00658021|519962067|FG002|28-Week Treatment Period|Did not receive treatment|0|||
144209854|NCT00658021|519962065|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
144209855|NCT00658021|519962066|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
144209856|NCT00658021|519962067|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
144209857|NCT00658021|519962065|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
144209858|NCT00658021|519962066|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
144209859|NCT00658021|519962067|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
144629007|NCT02631538|521499965|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
144629008|NCT02631538|521499966|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
144629009|NCT02631538|521499963|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
144629010|NCT02631538|521499964|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
144629011|NCT02631538|521499965|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
144629012|NCT02631538|521499966|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
144629013|NCT02631538|521499963|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
144629014|NCT02631538|521499964|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
144629015|NCT02631538|521499965|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
144629016|NCT02631538|521499966|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
144629017|NCT02631538|521499963|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
144629018|NCT02631538|521499964|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
144629019|NCT02631538|521499965|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
144629020|NCT02631538|521499966|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
144629021|NCT02631538|521499963|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
144629022|NCT02631538|521499964|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
144629023|NCT02631538|521499965|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
144629024|NCT02631538|521499966|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
144629025|NCT02631538|521499963|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
144629026|NCT02631538|521499964|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
144629027|NCT02631538|521499965|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
144629028|NCT02631538|521499966|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
144629029|NCT00400400|521499967|FG000|Overall Study|Adverse Event|9|||
144629030|NCT00400400|521499968|FG001|Overall Study|Adverse Event|8|||
144629031|NCT00400400|521499967|FG000|Overall Study|Protocol Violation|2|||
144629032|NCT00400400|521499968|FG001|Overall Study|Protocol Violation|0|||
144629033|NCT00400400|521499967|FG000|Overall Study|Withdrawal by Subject|1|||
144629034|NCT00400400|521499968|FG001|Overall Study|Withdrawal by Subject|3|||
144629035|NCT00400400|521499967|FG000|Overall Study|Administrative Problem|1|||
144629036|NCT00400400|521499968|FG001|Overall Study|Administrative Problem|0|||
144629037|NCT00400400|521499967|FG000|Overall Study|Lost to Follow-up|0|||
144629038|NCT00400400|521499968|FG001|Overall Study|Lost to Follow-up|1|||
144629039|NCT00400400|521499967|FG000|Overall Study|Did not receive study drug|1|||
144629040|NCT00400400|521499968|FG001|Overall Study|Did not receive study drug|3|||
144629041|NCT00648167|521499969|FG000|Overall Study|Adverse Event|6|||
144629042|NCT00648167|521499969|FG000|Overall Study|unable to swallow tablets|1|||
144629043|NCT01688050|521499970|FG000|Overall Study|Death|7|||
144629044|NCT01688050|521499970|FG000|Overall Study|Conversion to open repair|1|||
144629045|NCT01688050|521499970|FG000|Overall Study|Lost to Follow-up|13|||
144629046|NCT01688050|521499970|FG000|Overall Study|Withdrawal by Subject|10|||
144629047|NCT01554579|521499971|FG000|Overall Study|Adverse Event|6|||
144629048|NCT01554579|521499972|FG001|Overall Study|Adverse Event|25|||
144629049|NCT01554579|521499971|FG000|Overall Study|Lack of Efficacy|2|||
144629050|NCT01554579|521499972|FG001|Overall Study|Lack of Efficacy|1|||
144629051|NCT01554579|521499971|FG000|Overall Study|Withdrawal by Subject|2|||
144629052|NCT01554579|521499972|FG001|Overall Study|Withdrawal by Subject|1|||
144629053|NCT00234039|521499973|FG000|Overall Study|Adverse Event|2|||
144629054|NCT00234039|521499973|FG000|Overall Study|Progression/relapse|34|||
144629055|NCT00234039|521499973|FG000|Overall Study|Other - Not Protocol Specified|3|||
144629056|NCT00234039|521499973|FG000|Overall Study|Ineligible|9|||
144629057|NCT00234039|521499973|FG000|Overall Study|No Protocol Treatment Received|2|||
144629058|NCT00110019|521499974|FG000|Overall Study|Lack of Efficacy|253|||
144629059|NCT00110019|521499975|FG001|Overall Study|Lack of Efficacy|285|||
144629060|NCT00110019|521499974|FG000|Overall Study|Adverse Event|61|||
144629061|NCT00110019|521499975|FG001|Overall Study|Adverse Event|40|||
144629062|NCT00110019|521499974|FG000|Overall Study|Death|13|||
144629063|NCT00110019|521499975|FG001|Overall Study|Death|15|||
144629064|NCT00110019|521499974|FG000|Overall Study|Withdrawal by Subject|21|||
144629065|NCT00110019|521499975|FG001|Overall Study|Withdrawal by Subject|9|||
144629066|NCT00110019|521499974|FG000|Overall Study|alternative therapy|5|||
144629067|NCT00110019|521499975|FG001|Overall Study|alternative therapy|1|||
144629068|NCT00110019|521499974|FG000|Overall Study|complicating disease|1|||
144629069|NCT00110019|521499975|FG001|Overall Study|complicating disease|1|||
144629070|NCT00110019|521499974|FG000|Overall Study|symptom deterioration|13|||
144629071|NCT00110019|521499975|FG001|Overall Study|symptom deterioration|16|||
144629072|NCT00110019|521499974|FG000|Overall Study|Not start protocol therapy|17|||
144629073|NCT00110019|521499975|FG001|Overall Study|Not start protocol therapy|16|||
144629074|NCT00110019|521499974|FG000|Overall Study|other reasons|22|||
144629075|NCT00110019|521499975|FG001|Overall Study|other reasons|30|||
144629076|NCT01046695|521499978|FG000|Overall Study|Subject had a pacemaker|0|||
144629077|NCT01046695|521499979|FG001|Overall Study|Subject had a pacemaker|1|||
144629078|NCT01046695|521499978|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
144629079|NCT01046695|521499979|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
144629080|NCT02239263|521499980|FG000|Overall Study|Protocol Violation|6|||
144629081|NCT04303000|521499981|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
144629082|NCT04303000|521499982|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
144629083|NCT04303000|521499983|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
144629084|NCT04426695|521499984|FG000|Overall Study|Death|2|||
144629085|NCT04426695|521499985|FG001|Overall Study|Death|0|||
144629086|NCT04426695|521499986|FG002|Overall Study|Death|1|||
144629087|NCT04426695|521499987|FG003|Overall Study|Death|27|||
144629088|NCT04426695|521499988|FG004|Overall Study|Death|25|||
144629089|NCT04426695|521499989|FG005|Overall Study|Death|21|||
144629090|NCT04426695|521499990|FG006|Overall Study|Death|42|||
144629091|NCT04426695|521499991|FG007|Overall Study|Death|23|||
144629092|NCT04426695|521499992|FG008|Overall Study|Death|37|||
144629093|NCT04426695|521499993|FG009|Overall Study|Death|14|||
144629094|NCT04426695|521499994|FG010|Overall Study|Death|8|||
144629095|NCT04426695|521499995|FG011|Overall Study|Death|7|||
144629096|NCT04426695|521499996|FG012|Overall Study|Death|13|||
144629097|NCT04426695|521499997|FG013|Overall Study|Death|25|||
144629098|NCT04426695|521499998|FG014|Overall Study|Death|19|||
144629099|NCT04426695|521499999|FG015|Overall Study|Death|7|||
144629100|NCT04426695|521500000|FG016|Overall Study|Death|8|||
144629101|NCT04426695|521500001|FG017|Overall Study|Death|4|||
144629102|NCT04426695|521499984|FG000|Overall Study|Lost to Follow-up|2|||
144629103|NCT04426695|521499985|FG001|Overall Study|Lost to Follow-up|4|||
144629104|NCT04426695|521499986|FG002|Overall Study|Lost to Follow-up|1|||
144629105|NCT04426695|521499987|FG003|Overall Study|Lost to Follow-up|19|||
144629106|NCT04426695|521499988|FG004|Overall Study|Lost to Follow-up|10|||
144629107|NCT04426695|521499989|FG005|Overall Study|Lost to Follow-up|14|||
144629108|NCT04426695|521499990|FG006|Overall Study|Lost to Follow-up|5|||
144629109|NCT04426695|521499991|FG007|Overall Study|Lost to Follow-up|14|||
144629110|NCT04426695|521499992|FG008|Overall Study|Lost to Follow-up|10|||
144629111|NCT04426695|521499993|FG009|Overall Study|Lost to Follow-up|11|||
144629112|NCT04426695|521499994|FG010|Overall Study|Lost to Follow-up|12|||
144629113|NCT04426695|521499995|FG011|Overall Study|Lost to Follow-up|6|||
144629114|NCT04426695|521499996|FG012|Overall Study|Lost to Follow-up|2|||
144629115|NCT04426695|521499997|FG013|Overall Study|Lost to Follow-up|2|||
144629116|NCT04426695|521499998|FG014|Overall Study|Lost to Follow-up|2|||
144629117|NCT04426695|521499999|FG015|Overall Study|Lost to Follow-up|0|||
144629118|NCT04426695|521500000|FG016|Overall Study|Lost to Follow-up|0|||
144629119|NCT04426695|521500001|FG017|Overall Study|Lost to Follow-up|0|||
144629120|NCT04426695|521499984|FG000|Overall Study|Participant Decision|1|||
144629121|NCT04426695|521499985|FG001|Overall Study|Participant Decision|2|||
144629122|NCT04426695|521499986|FG002|Overall Study|Participant Decision|2|||
144629123|NCT04426695|521499987|FG003|Overall Study|Participant Decision|12|||
144629124|NCT04426695|521499988|FG004|Overall Study|Participant Decision|18|||
144629125|NCT04426695|521499989|FG005|Overall Study|Participant Decision|22|||
144629126|NCT04426695|521499990|FG006|Overall Study|Participant Decision|13|||
144629127|NCT04426695|521499991|FG007|Overall Study|Participant Decision|13|||
144629128|NCT04426695|521499992|FG008|Overall Study|Participant Decision|10|||
144629129|NCT04426695|521499993|FG009|Overall Study|Participant Decision|15|||
144629130|NCT04426695|521499994|FG010|Overall Study|Participant Decision|16|||
144629131|NCT04426695|521499995|FG011|Overall Study|Participant Decision|17|||
144629132|NCT04426695|521499996|FG012|Overall Study|Participant Decision|2|||
144629133|NCT04426695|521499997|FG013|Overall Study|Participant Decision|1|||
144629134|NCT04426695|521499998|FG014|Overall Study|Participant Decision|2|||
144629135|NCT04426695|521499999|FG015|Overall Study|Participant Decision|0|||
144629136|NCT04426695|521500000|FG016|Overall Study|Participant Decision|0|||
144629137|NCT04426695|521500001|FG017|Overall Study|Participant Decision|0|||
144629138|NCT04426695|521499984|FG000|Overall Study|Adverse Event|0|||
144629139|NCT04426695|521499985|FG001|Overall Study|Adverse Event|0|||
144629140|NCT04426695|521499986|FG002|Overall Study|Adverse Event|0|||
144629141|NCT04426695|521499987|FG003|Overall Study|Adverse Event|0|||
144629142|NCT04426695|521499988|FG004|Overall Study|Adverse Event|0|||
144629143|NCT04426695|521499989|FG005|Overall Study|Adverse Event|0|||
144629144|NCT04426695|521499990|FG006|Overall Study|Adverse Event|0|||
144629145|NCT04426695|521499991|FG007|Overall Study|Adverse Event|1|||
144629146|NCT04426695|521499992|FG008|Overall Study|Adverse Event|0|||
144629147|NCT04426695|521499993|FG009|Overall Study|Adverse Event|0|||
144629148|NCT04426695|521499994|FG010|Overall Study|Adverse Event|1|||
144629149|NCT04426695|521499995|FG011|Overall Study|Adverse Event|1|||
144629150|NCT04426695|521499996|FG012|Overall Study|Adverse Event|0|||
144629151|NCT04426695|521499997|FG013|Overall Study|Adverse Event|0|||
144629152|NCT04426695|521499998|FG014|Overall Study|Adverse Event|0|||
144629153|NCT04426695|521499999|FG015|Overall Study|Adverse Event|0|||
144629154|NCT04426695|521500000|FG016|Overall Study|Adverse Event|0|||
144629155|NCT04426695|521500001|FG017|Overall Study|Adverse Event|0|||
144629156|NCT04426695|521499984|FG000|Overall Study|Sponsor Request|0|||
144629157|NCT04426695|521499985|FG001|Overall Study|Sponsor Request|0|||
144629158|NCT04426695|521499986|FG002|Overall Study|Sponsor Request|0|||
144629159|NCT04426695|521499987|FG003|Overall Study|Sponsor Request|0|||
144629160|NCT04426695|521499988|FG004|Overall Study|Sponsor Request|0|||
144629161|NCT04426695|521499989|FG005|Overall Study|Sponsor Request|0|||
144629162|NCT04426695|521499990|FG006|Overall Study|Sponsor Request|1|||
144629163|NCT04426695|521499991|FG007|Overall Study|Sponsor Request|0|||
144629164|NCT04426695|521499992|FG008|Overall Study|Sponsor Request|0|||
144629165|NCT04426695|521499993|FG009|Overall Study|Sponsor Request|0|||
144629166|NCT04426695|521499994|FG010|Overall Study|Sponsor Request|0|||
144629167|NCT04426695|521499995|FG011|Overall Study|Sponsor Request|0|||
144629168|NCT04426695|521499996|FG012|Overall Study|Sponsor Request|0|||
144629169|NCT04426695|521499997|FG013|Overall Study|Sponsor Request|0|||
144629170|NCT04426695|521499998|FG014|Overall Study|Sponsor Request|0|||
144629171|NCT04426695|521499999|FG015|Overall Study|Sponsor Request|0|||
144629172|NCT04426695|521500000|FG016|Overall Study|Sponsor Request|0|||
144629173|NCT04426695|521500001|FG017|Overall Study|Sponsor Request|0|||
144629174|NCT04426695|521499984|FG000|Overall Study|Physician Decision|0|||
144629175|NCT04426695|521499985|FG001|Overall Study|Physician Decision|0|||
144629176|NCT04426695|521499986|FG002|Overall Study|Physician Decision|0|||
144629177|NCT04426695|521499987|FG003|Overall Study|Physician Decision|0|||
144629178|NCT04426695|521499988|FG004|Overall Study|Physician Decision|0|||
144629179|NCT04426695|521499989|FG005|Overall Study|Physician Decision|0|||
144629180|NCT04426695|521499990|FG006|Overall Study|Physician Decision|0|||
144629181|NCT04426695|521499991|FG007|Overall Study|Physician Decision|0|||
144629182|NCT04426695|521499992|FG008|Overall Study|Physician Decision|0|||
144629183|NCT04426695|521499993|FG009|Overall Study|Physician Decision|1|||
144629184|NCT04426695|521499994|FG010|Overall Study|Physician Decision|0|||
144629185|NCT04426695|521499995|FG011|Overall Study|Physician Decision|0|||
144629186|NCT04426695|521499996|FG012|Overall Study|Physician Decision|1|||
144629187|NCT04426695|521499997|FG013|Overall Study|Physician Decision|0|||
144629188|NCT04426695|521499998|FG014|Overall Study|Physician Decision|0|||
144629189|NCT04426695|521499999|FG015|Overall Study|Physician Decision|0|||
144629190|NCT04426695|521500000|FG016|Overall Study|Physician Decision|0|||
144629191|NCT04426695|521500001|FG017|Overall Study|Physician Decision|0|||
144629192|NCT04426695|521499984|FG000|Overall Study|Randomized but Never Treated|3|||
144629193|NCT04426695|521499985|FG001|Overall Study|Randomized but Never Treated|1|||
144629194|NCT04426695|521499986|FG002|Overall Study|Randomized but Never Treated|0|||
144629195|NCT04426695|521499987|FG003|Overall Study|Randomized but Never Treated|4|||
144629196|NCT04426695|521499988|FG004|Overall Study|Randomized but Never Treated|5|||
144629197|NCT04426695|521499989|FG005|Overall Study|Randomized but Never Treated|5|||
144629198|NCT04426695|521499990|FG006|Overall Study|Randomized but Never Treated|4|||
144629199|NCT04426695|521499991|FG007|Overall Study|Randomized but Never Treated|6|||
144629200|NCT04426695|521499992|FG008|Overall Study|Randomized but Never Treated|6|||
144629201|NCT04426695|521499993|FG009|Overall Study|Randomized but Never Treated|3|||
144629202|NCT04426695|521499994|FG010|Overall Study|Randomized but Never Treated|3|||
144629203|NCT04426695|521499995|FG011|Overall Study|Randomized but Never Treated|6|||
144629204|NCT04426695|521499996|FG012|Overall Study|Randomized but Never Treated|1|||
144629205|NCT04426695|521499997|FG013|Overall Study|Randomized but Never Treated|2|||
144629206|NCT04426695|521499998|FG014|Overall Study|Randomized but Never Treated|0|||
144629207|NCT04426695|521499999|FG015|Overall Study|Randomized but Never Treated|0|||
144629208|NCT04426695|521500000|FG016|Overall Study|Randomized but Never Treated|0|||
144629209|NCT04426695|521500001|FG017|Overall Study|Randomized but Never Treated|0|||
144629210|NCT04276207|521500003|FG000|Period 1|Withdrawal by Subject|0|||
144629211|NCT04276207|521500004|FG001|Period 1|Withdrawal by Subject|1|||
144629212|NCT05655377|521500005|FG000|Overall Study|Withdrawal by Subject|2|||
144629213|NCT01256177|521500006|FG000|Overall Study|Withdrawal by Subject|23|||
144629214|NCT01256177|521500007|FG001|Overall Study|Withdrawal by Subject|22|||
144629215|NCT01256177|521500006|FG000|Overall Study|Lost to Follow-up|2|||
144629216|NCT01256177|521500007|FG001|Overall Study|Lost to Follow-up|2|||
144629217|NCT01256177|521500006|FG000|Overall Study|Adverse Event|8|||
144629218|NCT01256177|521500007|FG001|Overall Study|Adverse Event|9|||
144629219|NCT01256177|521500006|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
144629220|NCT01256177|521500007|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
144629221|NCT01256177|521500006|FG000|Overall Study|Condition under Investigation Worsened|1|||
144629222|NCT01256177|521500007|FG001|Overall Study|Condition under Investigation Worsened|0|||
144629223|NCT01256177|521500006|FG000|Overall Study|Lack of Efficacy|11|||
144629224|NCT01256177|521500007|FG001|Overall Study|Lack of Efficacy|2|||
144629225|NCT01256177|521500006|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
144629226|NCT01256177|521500007|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
144629227|NCT00553462|521500009|FG000|Overall Study|Adverse Event|4|||
144629228|NCT00553462|521500009|FG000|Overall Study|Progression|4|||
144629229|NCT00553462|521500009|FG000|Overall Study|Withdrawal by Subject|5|||
144629230|NCT00553462|521500009|FG000|Overall Study|Physician Decision|1|||
144629231|NCT02789657|521500010|FG000|Overall Study|Withdrawal by Subject|2|||
144629232|NCT02789657|521500011|FG001|Overall Study|Withdrawal by Subject|0|||
144629233|NCT02789657|521500012|FG002|Overall Study|Withdrawal by Subject|0|||
144629234|NCT02789657|521500013|FG003|Overall Study|Withdrawal by Subject|0|||
144629235|NCT03882424|521500014|FG000|Overall Study|Lost to Follow-up|3|||
144629236|NCT03882424|521500015|FG001|Overall Study|Lost to Follow-up|0|||
144629237|NCT03882424|521500016|FG002|Overall Study|Lost to Follow-up|0|||
144629238|NCT03882424|521500014|FG000|Overall Study|schedule conflict|1|||
144629239|NCT03882424|521500015|FG001|Overall Study|schedule conflict|0|||
144629240|NCT03882424|521500016|FG002|Overall Study|schedule conflict|0|||
144629241|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Adverse Event|21|||
144629242|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Adverse Event|6|||
144730627|NCT04407806|521869847|FG001|Overall Study|Withdrawal by Subject|2|||
144730628|NCT00496964|521869848|FG000|Overall Study|Withdrawal by Subject|0|||
144629243|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
144629244|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
144629245|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
144629246|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
144730629|NCT00496964|521869849|FG001|Overall Study|Withdrawal by Subject|1|||
144629247|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
144629248|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
144629249|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Physician Decision|0|||
144629250|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Physician Decision|3|||
144629251|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
144629252|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
144629253|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
144629254|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
144629255|NCT00510276|521500025|FG000|Acute Double-Blind Phase|Subject Decision|26|||
144629256|NCT00510276|521500026|FG001|Acute Double-Blind Phase|Subject Decision|28|||
144629257|NCT00510276|521500025|FG000|Extension Open-Label Phase|Adverse Event|9|||
144629258|NCT00510276|521500026|FG001|Extension Open-Label Phase|Adverse Event|18|||
144629259|NCT00510276|521500025|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
144629260|NCT00510276|521500026|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
144629261|NCT00510276|521500025|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
144629262|NCT00510276|521500026|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
144629263|NCT00510276|521500025|FG000|Extension Open-Label Phase|Physician Decision|2|||
144629264|NCT00510276|521500026|FG001|Extension Open-Label Phase|Physician Decision|3|||
144629265|NCT00510276|521500025|FG000|Extension Open-Label Phase|Protocol Violation|0|||
144629266|NCT00510276|521500026|FG001|Extension Open-Label Phase|Protocol Violation|1|||
144629267|NCT00510276|521500025|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
144629268|NCT00510276|521500026|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
144629269|NCT00510276|521500025|FG000|Extension Open-Label Phase|Subject Decision|7|||
144629270|NCT00510276|521500026|FG001|Extension Open-Label Phase|Subject Decision|9|||
144629271|NCT03486392|521500027|FG000|Overall Study|Lost to Follow-up|0|||
144629272|NCT03486392|521500028|FG001|Overall Study|Lost to Follow-up|0|||
144629273|NCT03486392|521500029|FG002|Overall Study|Lost to Follow-up|8|||
144629274|NCT03486392|521500030|FG003|Overall Study|Lost to Follow-up|5|||
144629275|NCT03486392|521500031|FG004|Overall Study|Lost to Follow-up|2|||
144629276|NCT03486392|521500027|FG000|Overall Study|Withdrawal by Subject|3|||
144629277|NCT03486392|521500028|FG001|Overall Study|Withdrawal by Subject|0|||
144629278|NCT03486392|521500029|FG002|Overall Study|Withdrawal by Subject|6|||
144629279|NCT03486392|521500030|FG003|Overall Study|Withdrawal by Subject|4|||
144629280|NCT03486392|521500031|FG004|Overall Study|Withdrawal by Subject|1|||
144629281|NCT03486392|521500027|FG000|Overall Study|Death|0|||
144629282|NCT03486392|521500028|FG001|Overall Study|Death|0|||
144629283|NCT03486392|521500029|FG002|Overall Study|Death|0|||
144629284|NCT03486392|521500030|FG003|Overall Study|Death|0|||
144629285|NCT03486392|521500031|FG004|Overall Study|Death|1|||
144629286|NCT01500057|521500034|FG000|Overall Study|Lost to Follow-up|6|||
144629287|NCT01500057|521500035|FG001|Overall Study|Lost to Follow-up|4|||
144629288|NCT01731678|521500036|FG000|Overall Study|Withdrawal by Subject|3|||
144629289|NCT01731678|521500036|FG000|Overall Study|Did not meet inclusion criteria|1|||
144629290|NCT01731678|521500036|FG000|Overall Study|RMT too high, making TMS difficult|3|||
144629291|NCT00331006|521500037|FG000|Screening Phase|Withdrawal by Subject|1|||
144629292|NCT00331006|521500037|FG000|Screening Phase|enrollment halted|1|||
144629293|NCT00331006|521500037|FG000|Screening Phase|Lost to Follow-up|1|||
144629294|NCT00331006|521500037|FG000|Screening Phase|Ineligible for treatment phase|4|||
144629295|NCT00331006|521500037|FG000|Treatment Phase|Withdrawal by Subject|1|||
144629296|NCT00331006|521500037|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
144629297|NCT00331006|521500037|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
144629298|NCT01318122|521500038|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144629299|NCT01318122|521500039|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144629300|NCT01318122|521500040|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
144629301|NCT01318122|521500041|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
144629302|NCT01318122|521500038|FG000|Enrolled - Long-Term Extension Study|Other|1|||
144629303|NCT01318122|521500039|FG001|Enrolled - Long-Term Extension Study|Other|0|||
144629304|NCT01318122|521500040|FG002|Enrolled - Long-Term Extension Study|Other|0|||
144629305|NCT01318122|521500041|FG003|Enrolled - Long-Term Extension Study|Other|0|||
144629306|NCT01318122|521500038|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
144629307|NCT01318122|521500039|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
144629308|NCT01318122|521500040|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
144629309|NCT01318122|521500041|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
144629310|NCT01318122|521500038|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
144629311|NCT01318122|521500039|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144629312|NCT01318122|521500040|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144629313|NCT01318122|521500041|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
144629314|NCT01318122|521500038|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144629315|NCT01318122|521500039|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
144629316|NCT01318122|521500040|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144629317|NCT01318122|521500041|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144730630|NCT03478397|521869850|FG000|Overall Study|Refused to participate|31|||
144209860|NCT04784533|519962069|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
144629318|NCT01318122|521500038|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
144629319|NCT01318122|521500039|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
144629320|NCT01318122|521500040|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
144629321|NCT01318122|521500041|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
144629322|NCT01486199|521500042|FG000|Two Year Period Between Study Days|Physician Decision|1|||
144629323|NCT01486199|521500043|FG001|Two Year Period Between Study Days|Physician Decision|0|||
144629324|NCT02471716|521500044|FG000|Overall Study|Withdrawal by Subject|0|||
144629325|NCT02471716|521500045|FG001|Overall Study|Withdrawal by Subject|1|||
144629326|NCT02471716|521500046|FG002|Overall Study|Withdrawal by Subject|0|||
144629327|NCT02471716|521500047|FG003|Overall Study|Withdrawal by Subject|2|||
144629328|NCT02471716|521500048|FG004|Overall Study|Withdrawal by Subject|5|||
144629329|NCT02471716|521500044|FG000|Overall Study|Study Terminiated by sponsor|0|||
144629330|NCT02471716|521500045|FG001|Overall Study|Study Terminiated by sponsor|0|||
144629331|NCT02471716|521500046|FG002|Overall Study|Study Terminiated by sponsor|0|||
144629332|NCT02471716|521500047|FG003|Overall Study|Study Terminiated by sponsor|1|||
144629333|NCT02471716|521500048|FG004|Overall Study|Study Terminiated by sponsor|0|||
144629334|NCT02471716|521500044|FG000|Overall Study|Lost to Follow-up|0|||
144629335|NCT02471716|521500045|FG001|Overall Study|Lost to Follow-up|0|||
144629336|NCT02471716|521500046|FG002|Overall Study|Lost to Follow-up|0|||
144629337|NCT02471716|521500047|FG003|Overall Study|Lost to Follow-up|3|||
144629338|NCT02471716|521500048|FG004|Overall Study|Lost to Follow-up|2|||
144629339|NCT02471716|521500044|FG000|Overall Study|Death|0|||
144629340|NCT02471716|521500045|FG001|Overall Study|Death|0|||
144629341|NCT02471716|521500046|FG002|Overall Study|Death|0|||
144629342|NCT02471716|521500047|FG003|Overall Study|Death|1|||
144629343|NCT02471716|521500048|FG004|Overall Study|Death|0|||
144629344|NCT02471716|521500044|FG000|Overall Study|Other|0|||
144629345|NCT02471716|521500045|FG001|Overall Study|Other|0|||
144629346|NCT02471716|521500046|FG002|Overall Study|Other|0|||
144629347|NCT02471716|521500047|FG003|Overall Study|Other|8|||
144629348|NCT02471716|521500048|FG004|Overall Study|Other|9|||
144629349|NCT01360645|521500054|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
144629350|NCT01360645|521500055|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
144629351|NCT01360645|521500056|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
144629352|NCT01360645|521500057|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
144629353|NCT01360645|521500054|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
144629354|NCT01360645|521500055|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
144629355|NCT01360645|521500056|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
144629356|NCT01360645|521500057|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
144629357|NCT01360645|521500054|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
144629358|NCT01360645|521500055|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
144629359|NCT01360645|521500056|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
144629360|NCT01360645|521500057|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
144629361|NCT01360645|521500054|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
144586895|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
144586896|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
144586897|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
144586898|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
144586899|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
144586900|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
144586901|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
144586902|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
144586903|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
144586904|NCT00371683|521346953|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
144586905|NCT00371683|521346954|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
144586906|NCT00371683|521346953|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
144586907|NCT00371683|521346954|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
144586908|NCT00371683|521346953|FG000|Follow-Up Period - Randomized Patients|Death|0|||
144586909|NCT00371683|521346954|FG001|Follow-Up Period - Randomized Patients|Death|2|||
144629362|NCT01360645|521500055|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
144629363|NCT01360645|521500056|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
144629364|NCT01360645|521500057|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
144629365|NCT01360645|521500054|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
144629366|NCT01360645|521500055|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
144629367|NCT01360645|521500056|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
144629368|NCT01360645|521500057|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
144629369|NCT01360645|521500054|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
144629370|NCT01360645|521500055|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
144629371|NCT01360645|521500056|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
144629372|NCT01360645|521500057|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
144629373|NCT01360645|521500054|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
144629374|NCT01360645|521500055|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
144629375|NCT01360645|521500056|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
144629376|NCT01360645|521500057|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
144629377|NCT01360645|521500054|FG000|Phase B (6 Weeks)|Adverse Event|0|||
144629378|NCT01360645|521500055|FG001|Phase B (6 Weeks)|Adverse Event|6|||
144629379|NCT01360645|521500056|FG002|Phase B (6 Weeks)|Adverse Event|0|||
144629380|NCT01360645|521500057|FG003|Phase B (6 Weeks)|Adverse Event|0|||
144629381|NCT01360645|521500054|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
144629382|NCT01360645|521500055|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
144629383|NCT01360645|521500056|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
144629384|NCT01360645|521500057|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
144629385|NCT01360645|521500054|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
144629386|NCT01360645|521500055|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
144629387|NCT01360645|521500056|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
144629388|NCT01360645|521500057|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
144629389|NCT01360645|521500054|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
144629390|NCT01360645|521500055|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
144629391|NCT01360645|521500056|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
144629392|NCT01360645|521500057|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
144629393|NCT01360645|521500054|FG000|Phase A+|Lost to Follow-up|0|||
144629394|NCT01360645|521500055|FG001|Phase A+|Lost to Follow-up|0|||
144629395|NCT01360645|521500056|FG002|Phase A+|Lost to Follow-up|0|||
144629396|NCT01360645|521500057|FG003|Phase A+|Lost to Follow-up|7|||
144629397|NCT01360645|521500054|FG000|Phase A+|Adverse Event|0|||
144629398|NCT01360645|521500055|FG001|Phase A+|Adverse Event|0|||
144629399|NCT01360645|521500056|FG002|Phase A+|Adverse Event|0|||
144629400|NCT01360645|521500057|FG003|Phase A+|Adverse Event|2|||
144629401|NCT01360645|521500054|FG000|Phase A+|Met Withdrawal Criteria|0|||
144629402|NCT01360645|521500055|FG001|Phase A+|Met Withdrawal Criteria|0|||
144629403|NCT01360645|521500056|FG002|Phase A+|Met Withdrawal Criteria|0|||
144629404|NCT01360645|521500057|FG003|Phase A+|Met Withdrawal Criteria|4|||
144629405|NCT01360645|521500054|FG000|Phase A+|Physician Decision|0|||
144629406|NCT01360645|521500055|FG001|Phase A+|Physician Decision|0|||
144629407|NCT01360645|521500056|FG002|Phase A+|Physician Decision|0|||
144629408|NCT01360645|521500057|FG003|Phase A+|Physician Decision|2|||
144629409|NCT01360645|521500054|FG000|Phase A+|Withdrawal by Subject|0|||
144629410|NCT01360645|521500055|FG001|Phase A+|Withdrawal by Subject|0|||
144629411|NCT01360645|521500056|FG002|Phase A+|Withdrawal by Subject|0|||
144629412|NCT01360645|521500057|FG003|Phase A+|Withdrawal by Subject|5|||
144629413|NCT01360645|521500054|FG000|Phase A+|Protocol Deviation|0|||
144629414|NCT01360645|521500055|FG001|Phase A+|Protocol Deviation|0|||
144629415|NCT01360645|521500056|FG002|Phase A+|Protocol Deviation|0|||
144629416|NCT01360645|521500057|FG003|Phase A+|Protocol Deviation|4|||
144629417|NCT02211261|521500064|FG000|Overall Study|Withdrawal by Subject|0|||
144629418|NCT02211261|521500065|FG001|Overall Study|Withdrawal by Subject|0|||
144629419|NCT02211261|521500066|FG002|Overall Study|Withdrawal by Subject|1|||
144629420|NCT02211261|521500067|FG003|Overall Study|Withdrawal by Subject|0|||
144209861|NCT04784533|519962070|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
144209862|NCT04784533|519962071|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209863|NCT04784533|519962072|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209864|NCT04784533|519962073|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209865|NCT04784533|519962074|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209866|NCT04784533|519962075|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209867|NCT04784533|519962076|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209868|NCT04784533|519962077|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209869|NCT04784533|519962078|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
144209870|NCT04784533|519962069|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
144209871|NCT04784533|519962070|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
144209872|NCT04784533|519962071|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144209873|NCT04784533|519962072|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144209874|NCT04784533|519962073|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144209875|NCT04784533|519962074|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144629421|NCT02211261|521500068|FG004|Overall Study|Withdrawal by Subject|2|||
144629422|NCT02211261|521500069|FG005|Overall Study|Withdrawal by Subject|0|||
144629423|NCT02211261|521500070|FG006|Overall Study|Withdrawal by Subject|0|||
144629424|NCT02211261|521500071|FG007|Overall Study|Withdrawal by Subject|0|||
144629425|NCT02211261|521500072|FG008|Overall Study|Withdrawal by Subject|0|||
144629426|NCT02211261|521500073|FG009|Overall Study|Withdrawal by Subject|0|||
144629427|NCT02211261|521500074|FG010|Overall Study|Withdrawal by Subject|0|||
144629428|NCT02211261|521500064|FG000|Overall Study|Other|0|||
144629429|NCT02211261|521500065|FG001|Overall Study|Other|0|||
144629430|NCT02211261|521500066|FG002|Overall Study|Other|0|||
144629431|NCT02211261|521500067|FG003|Overall Study|Other|0|||
144629432|NCT02211261|521500068|FG004|Overall Study|Other|0|||
144629433|NCT02211261|521500069|FG005|Overall Study|Other|1|||
144629434|NCT02211261|521500070|FG006|Overall Study|Other|0|||
144629435|NCT02211261|521500071|FG007|Overall Study|Other|0|||
144629436|NCT02211261|521500072|FG008|Overall Study|Other|0|||
144629437|NCT02211261|521500073|FG009|Overall Study|Other|2|||
144629438|NCT02211261|521500074|FG010|Overall Study|Other|0|||
144629439|NCT02211261|521500064|FG000|Overall Study|Lost to Follow-up|0|||
144629440|NCT02211261|521500065|FG001|Overall Study|Lost to Follow-up|0|||
144629441|NCT02211261|521500066|FG002|Overall Study|Lost to Follow-up|0|||
144629442|NCT02211261|521500067|FG003|Overall Study|Lost to Follow-up|0|||
144629443|NCT02211261|521500068|FG004|Overall Study|Lost to Follow-up|0|||
144629444|NCT02211261|521500069|FG005|Overall Study|Lost to Follow-up|0|||
144629445|NCT02211261|521500070|FG006|Overall Study|Lost to Follow-up|0|||
144629446|NCT02211261|521500071|FG007|Overall Study|Lost to Follow-up|1|||
144629447|NCT02211261|521500072|FG008|Overall Study|Lost to Follow-up|0|||
144629448|NCT02211261|521500073|FG009|Overall Study|Lost to Follow-up|0|||
144629449|NCT02211261|521500074|FG010|Overall Study|Lost to Follow-up|0|||
144629450|NCT00330187|521500075|FG000|Overall Study|Lost to Follow-up|12|||
144629451|NCT00330187|521500076|FG001|Overall Study|Lost to Follow-up|13|||
144629452|NCT00330187|521500077|FG002|Overall Study|Lost to Follow-up|14|||
144629453|NCT00330187|521500078|FG003|Overall Study|Lost to Follow-up|10|||
144629454|NCT00330187|521500075|FG000|Overall Study|Withdrawal by Subject|8|||
144629455|NCT00330187|521500076|FG001|Overall Study|Withdrawal by Subject|5|||
144629456|NCT00330187|521500077|FG002|Overall Study|Withdrawal by Subject|4|||
144629457|NCT00330187|521500078|FG003|Overall Study|Withdrawal by Subject|4|||
144629458|NCT02601573|521500079|FG000|Overall Study|Lost to Follow-up|0|||
144629459|NCT02601573|521500080|FG001|Overall Study|Lost to Follow-up|3|||
144629460|NCT02601573|521500081|FG002|Overall Study|Lost to Follow-up|1|||
144629461|NCT02601573|521500082|FG003|Overall Study|Lost to Follow-up|0|||
144629462|NCT02601573|521500083|FG004|Overall Study|Lost to Follow-up|2|||
144629463|NCT02601573|521500079|FG000|Overall Study|Withdrawal by Subject|0|||
144629464|NCT02601573|521500080|FG001|Overall Study|Withdrawal by Subject|1|||
144629465|NCT02601573|521500081|FG002|Overall Study|Withdrawal by Subject|0|||
144629466|NCT02601573|521500082|FG003|Overall Study|Withdrawal by Subject|1|||
144629467|NCT02601573|521500083|FG004|Overall Study|Withdrawal by Subject|0|||
144629468|NCT03310970|521500084|FG000|Overall Study|Withdrawal by Subject|0|||
144629469|NCT03310970|521500085|FG001|Overall Study|Withdrawal by Subject|1|||
144629470|NCT01133171|521500086|FG000|Overall Study|Withdrawal by Subject|1|||
144629471|NCT01133171|521500087|FG001|Overall Study|Withdrawal by Subject|2|||
144629472|NCT01133171|521500088|FG002|Overall Study|Withdrawal by Subject|0|||
144629473|NCT04062214|521500089|FG000|Week 12|Death|1|||
144629474|NCT04062214|521500090|FG001|Week 12|Death|1|||
144629475|NCT04062214|521500089|FG000|Week 12|Withdrawal by Subject|14|||
144629476|NCT04062214|521500090|FG001|Week 12|Withdrawal by Subject|13|||
144629477|NCT04062214|521500089|FG000|Week 12|Lost to Follow-up|55|||
144629478|NCT04062214|521500090|FG001|Week 12|Lost to Follow-up|68|||
144629479|NCT04062214|521500089|FG000|Week 12|Intermittent missing|31|||
144262958|NCT01396083|520163800|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144262959|NCT01396083|520163801|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144262960|NCT01396083|520163800|FG000|Overall Study|Administrative problems|1|||
144629480|NCT04062214|521500090|FG001|Week 12|Intermittent missing|29|||
144629481|NCT04062214|521500089|FG000|Week 36|Withdrawal by Subject|4|||
144629482|NCT04062214|521500090|FG001|Week 36|Withdrawal by Subject|5|||
144629483|NCT04062214|521500089|FG000|Week 36|Lost to Follow-up|50|||
144629484|NCT04062214|521500090|FG001|Week 36|Lost to Follow-up|46|||
144629485|NCT04062214|521500089|FG000|Week 36|Death|0|||
144629486|NCT04062214|521500090|FG001|Week 36|Death|1|||
144629487|NCT01446419|521500094|FG000|Overall Study|Death|1|||
144629488|NCT01446419|521500095|FG001|Overall Study|Death|0|||
144629489|NCT01446419|521500094|FG000|Overall Study|Withdrawal by Subject|1|||
144629490|NCT01446419|521500095|FG001|Overall Study|Withdrawal by Subject|1|||
144629491|NCT01446419|521500094|FG000|Overall Study|Terminated per protocol|3|||
144629492|NCT01446419|521500095|FG001|Overall Study|Terminated per protocol|0|||
144629493|NCT02542072|521500096|FG000|First Intervention (1 Month)|Adverse Event|1|||
144629494|NCT02542072|521500097|FG001|First Intervention (1 Month)|Adverse Event|1|||
144629495|NCT02542072|521500096|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
144629496|NCT02542072|521500097|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
144629497|NCT02542072|521500096|FG000|First Intervention (1 Month)|Lens discomfort|1|||
144629498|NCT02542072|521500097|FG001|First Intervention (1 Month)|Lens discomfort|2|||
144629499|NCT02542072|521500096|FG000|First Intervention (1 Month)|Protocol Violation|1|||
144629500|NCT02542072|521500097|FG001|First Intervention (1 Month)|Protocol Violation|0|||
144629501|NCT02542072|521500096|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
144629502|NCT02542072|521500097|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
144629503|NCT02542072|521500096|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
144629504|NCT02542072|521500097|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
144629505|NCT00654498|521500098|FG000|Overall Study|Not Treated|1|||
144629506|NCT00654498|521500099|FG001|Overall Study|Not Treated|0|||
144629507|NCT00654498|521500098|FG000|Overall Study|Adverse Event|6|||
144629508|NCT00654498|521500099|FG001|Overall Study|Adverse Event|1|||
144629509|NCT00654498|521500098|FG000|Overall Study|Protocol Violation|1|||
144629510|NCT00654498|521500099|FG001|Overall Study|Protocol Violation|1|||
144629511|NCT00654498|521500098|FG000|Overall Study|Lost to Follow-up|1|||
144629512|NCT00654498|521500099|FG001|Overall Study|Lost to Follow-up|5|||
144629513|NCT00654498|521500098|FG000|Overall Study|Withdrawal by Subject|1|||
144629514|NCT00654498|521500099|FG001|Overall Study|Withdrawal by Subject|0|||
144629515|NCT00654498|521500098|FG000|Overall Study|Other reason not defined above|4|||
144629516|NCT00654498|521500099|FG001|Overall Study|Other reason not defined above|5|||
144629517|NCT01609842|521500100|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
144629518|NCT01609842|521500101|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
144629519|NCT02474329|521500103|FG000|Overall Study|Withdraw or did not contribute data.|13|||
144629520|NCT01356589|521500104|FG000|Overall Study|Enrolled, but not treated|3|||
144629521|NCT01356589|521500104|FG000|Overall Study|Dose data not recorded|2|||
144629522|NCT04343651|521500105|FG000|Overall Study|Physician Decision|2|||
144629523|NCT04343651|521500106|FG001|Overall Study|Physician Decision|1|||
144629524|NCT04343651|521500105|FG000|Overall Study|Lost to Follow-up|2|||
144629525|NCT04343651|521500106|FG001|Overall Study|Lost to Follow-up|1|||
144629526|NCT04343651|521500105|FG000|Overall Study|Protocol Violation|4|||
144629527|NCT04343651|521500106|FG001|Overall Study|Protocol Violation|6|||
144629528|NCT04343651|521500105|FG000|Overall Study|Missing|3|||
144629529|NCT04343651|521500106|FG001|Overall Study|Missing|9|||
144629530|NCT04343651|521500105|FG000|Overall Study|Withdrawal by Subject|0|||
144629531|NCT04343651|521500106|FG001|Overall Study|Withdrawal by Subject|4|||
144629532|NCT04343651|521500105|FG000|Overall Study|Death|0|||
144629533|NCT04343651|521500106|FG001|Overall Study|Death|1|||
144629534|NCT04343651|521500105|FG000|Overall Study|Did not start treatment|1|||
144629535|NCT04343651|521500106|FG001|Overall Study|Did not start treatment|1|||
144629536|NCT04343651|521500105|FG000|Overall Study|Patient did not complete visits 3-6|0|||
144629537|NCT04343651|521500106|FG001|Overall Study|Patient did not complete visits 3-6|1|||
144629538|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
144629539|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
144629540|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
144629541|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144629542|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144629543|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144629544|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144629545|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144629546|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
144629547|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
144629548|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
144629549|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
144629550|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144629551|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144629552|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144629553|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144629554|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144629555|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
144629556|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
144629557|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
144629558|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629559|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629560|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629561|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629562|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629563|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629564|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
144629565|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
144629566|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
144629567|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
144629568|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144629569|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144629570|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144209876|NCT04784533|519962075|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144629571|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144629572|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144209877|NCT04784533|519962076|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144209878|NCT04784533|519962077|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144209879|NCT04784533|519962078|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
144629573|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
144629574|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
144629575|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
144629576|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629577|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629578|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629579|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629580|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629581|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629582|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
144629583|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629584|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629585|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
144629586|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629587|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629588|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629589|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629590|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144629591|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
144730631|NCT03478397|521869851|FG001|Overall Study|Refused to participate|7|||
144730632|NCT02188303|521869852|FG000|Overall Study|Adverse Event|0|||
144730633|NCT02188303|521869853|FG001|Overall Study|Adverse Event|0|||
144730634|NCT02188303|521869854|FG002|Overall Study|Adverse Event|0|||
144629592|NCT01583374|521500110|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629593|NCT01583374|521500111|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
144629594|NCT01583374|521500112|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629595|NCT01583374|521500113|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629596|NCT01583374|521500114|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629597|NCT01583374|521500115|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629598|NCT01583374|521500116|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629599|NCT01583374|521500117|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629600|NCT01583374|521500118|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
144629601|NCT01583374|521500110|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629602|NCT01583374|521500111|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629603|NCT01583374|521500112|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629604|NCT01583374|521500113|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629605|NCT01583374|521500114|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629606|NCT01583374|521500115|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629607|NCT01583374|521500116|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629608|NCT01583374|521500117|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
144629609|NCT01583374|521500118|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
144629610|NCT01583374|521500110|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
144629611|NCT01583374|521500111|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
144629612|NCT01583374|521500112|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
144629613|NCT01583374|521500113|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
144629614|NCT01583374|521500114|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
144629615|NCT01583374|521500115|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
144629616|NCT01583374|521500116|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
144629617|NCT01583374|521500117|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
144629618|NCT01583374|521500118|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
144629619|NCT01583374|521500110|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
144629620|NCT01583374|521500111|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
144629621|NCT01583374|521500112|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
144629622|NCT01583374|521500113|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
144629623|NCT01583374|521500114|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
144629624|NCT01583374|521500115|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
144730635|NCT02188303|521869855|FG003|Overall Study|Adverse Event|0|||
144730636|NCT02188303|521869856|FG004|Overall Study|Adverse Event|0|||
144730637|NCT02188303|521869857|FG005|Overall Study|Adverse Event|2|||
144730638|NCT02188303|521869858|FG006|Overall Study|Adverse Event|0|||
144730639|NCT02188303|521869859|FG007|Overall Study|Adverse Event|2|||
144730640|NCT02188303|521869852|FG000|Overall Study|Dose Termination Criteria Met|0|||
144730641|NCT02188303|521869853|FG001|Overall Study|Dose Termination Criteria Met|0|||
144629625|NCT01583374|521500116|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
144730642|NCT02188303|521869854|FG002|Overall Study|Dose Termination Criteria Met|0|||
144730643|NCT02188303|521869855|FG003|Overall Study|Dose Termination Criteria Met|0|||
144730644|NCT02188303|521869856|FG004|Overall Study|Dose Termination Criteria Met|0|||
144730645|NCT02188303|521869857|FG005|Overall Study|Dose Termination Criteria Met|0|||
144629626|NCT01583374|521500117|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
144629627|NCT01583374|521500118|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
144629628|NCT01583374|521500110|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
144629629|NCT01583374|521500111|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
144629630|NCT01583374|521500112|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
144629631|NCT01583374|521500113|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
144629632|NCT01583374|521500114|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
144629633|NCT01583374|521500115|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
144629634|NCT01583374|521500116|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
144629635|NCT01583374|521500117|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
144629636|NCT01583374|521500118|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
144629637|NCT01583374|521500110|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144629638|NCT01583374|521500111|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144629639|NCT01583374|521500112|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
144629640|NCT01583374|521500113|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144629641|NCT01583374|521500114|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
144629642|NCT01583374|521500115|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
144629643|NCT01583374|521500116|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144629644|NCT01583374|521500117|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144629645|NCT01583374|521500118|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
144629646|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
144629647|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
144629648|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
144629649|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
144629650|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
144629651|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
144629652|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
144629653|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
144629654|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
144629655|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
144629656|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
144629657|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
144629658|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
144629659|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
144629660|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
144629661|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
144629662|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
144629663|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
144629664|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
144629665|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
144629666|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
144629667|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
144629668|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
144629669|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
144629670|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
144629671|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
144629672|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
144629673|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
144629674|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
144629675|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
144629676|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
144629677|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
144629678|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
144629679|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
144629680|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
144629681|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
144629682|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629683|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629684|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629685|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629686|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
144629687|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629688|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
144629689|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629690|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
144629691|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
144629692|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
144629693|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
144629694|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
144629695|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
144629696|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
144629697|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
144629698|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
144629699|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
144629700|NCT01583374|521500110|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
144629701|NCT01583374|521500111|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
144629702|NCT01583374|521500112|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
144629703|NCT01583374|521500113|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
144629704|NCT01583374|521500114|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
144629705|NCT01583374|521500115|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
144629706|NCT01583374|521500116|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
144629707|NCT01583374|521500117|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
144629708|NCT01583374|521500118|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
144629709|NCT01506882|521500121|FG000|Overall Study|Lack of Efficacy|4|||
144629710|NCT01506882|521500122|FG001|Overall Study|Lack of Efficacy|3|||
144629711|NCT01506882|521500121|FG000|Overall Study|Lost to Follow-up|1|||
144629712|NCT01506882|521500122|FG001|Overall Study|Lost to Follow-up|0|||
144629713|NCT01506882|521500121|FG000|Overall Study|Withdrawal by Subject|9|||
144629714|NCT01506882|521500122|FG001|Overall Study|Withdrawal by Subject|3|||
144629715|NCT01506882|521500121|FG000|Overall Study|SAE, non-fatal|2|||
144629716|NCT01506882|521500122|FG001|Overall Study|SAE, non-fatal|0|||
144629717|NCT01506882|521500121|FG000|Overall Study|AE, non-serious non-fatal|3|||
144629718|NCT01506882|521500122|FG001|Overall Study|AE, non-serious non-fatal|1|||
144629719|NCT01506882|521500121|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
144629720|NCT01506882|521500122|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
144629721|NCT01506882|521500121|FG000|Overall Study|Other Reason|2|||
144629722|NCT01506882|521500122|FG001|Overall Study|Other Reason|0|||
144629723|NCT00821678|521500124|FG000|Overall Study|Withdrawal by Subject|8|||
144629724|NCT00821678|521500125|FG001|Overall Study|Withdrawal by Subject|0|||
144629725|NCT00821678|521500124|FG000|Overall Study|Lost to Follow-up|13|||
144629726|NCT00821678|521500125|FG001|Overall Study|Lost to Follow-up|12|||
144629727|NCT00821678|521500124|FG000|Overall Study|Death|0|||
144629728|NCT00821678|521500125|FG001|Overall Study|Death|2|||
144629729|NCT00925600|521502068|FG000|Overall Study|Withdrawal by Subject|16|||
144629730|NCT00925600|521502069|FG001|Overall Study|Withdrawal by Subject|14|||
144629731|NCT00925600|521502068|FG000|Overall Study|Death|4|||
144629732|NCT00925600|521502069|FG001|Overall Study|Death|3|||
144629733|NCT00925600|521502068|FG000|Overall Study|Lost to Follow-up|2|||
144629734|NCT00925600|521502069|FG001|Overall Study|Lost to Follow-up|2|||
144629735|NCT00925600|521502068|FG000|Overall Study|Disease Progression|1|||
144629736|NCT00925600|521502069|FG001|Overall Study|Disease Progression|3|||
144629737|NCT00925600|521502068|FG000|Overall Study|Administrative Decision|1|||
144629738|NCT00925600|521502069|FG001|Overall Study|Administrative Decision|1|||
144629739|NCT00925600|521502068|FG000|Overall Study|Noncompliance|2|||
144629740|NCT00925600|521502069|FG001|Overall Study|Noncompliance|0|||
144629741|NCT00925600|521502068|FG000|Overall Study|Ineligibility Determined|2|||
144629742|NCT00925600|521502069|FG001|Overall Study|Ineligibility Determined|0|||
144629743|NCT00925600|521502068|FG000|Overall Study|Protocol Deviation|0|||
144629744|NCT00925600|521502069|FG001|Overall Study|Protocol Deviation|1|||
144629745|NCT00925600|521502068|FG000|Overall Study|Requirement for Alternative Therapy|0|||
144629746|NCT00925600|521502069|FG001|Overall Study|Requirement for Alternative Therapy|1|||
144629747|NCT00925600|521502068|FG000|Overall Study|Other|3|||
144629748|NCT00925600|521502069|FG001|Overall Study|Other|1|||
144629749|NCT00925600|521502068|FG000|Overall Study|Adverse Event|1|||
144629750|NCT00925600|521502069|FG001|Overall Study|Adverse Event|2|||
144629751|NCT00127127|521502074|FG000|Overall Study|Adverse Event|0|||
144629752|NCT00127127|521502075|FG001|Overall Study|Adverse Event|2|||
144629753|NCT00127127|521502076|FG002|Overall Study|Adverse Event|0|||
144629754|NCT00127127|521502077|FG003|Overall Study|Adverse Event|1|||
144629755|NCT00127127|521502074|FG000|Overall Study|Lack of Efficacy|1|||
144629756|NCT00127127|521502075|FG001|Overall Study|Lack of Efficacy|3|||
144629757|NCT00127127|521502076|FG002|Overall Study|Lack of Efficacy|0|||
144629758|NCT00127127|521502077|FG003|Overall Study|Lack of Efficacy|2|||
144629759|NCT01059448|521502078|FG000|Overall Study|Adverse Event|1|||
144629760|NCT01059448|521502079|FG001|Overall Study|Adverse Event|3|||
144629761|NCT01059448|521502080|FG002|Overall Study|Adverse Event|0|||
144629762|NCT01059448|521502081|FG003|Overall Study|Adverse Event|1|||
144629763|NCT01059448|521502078|FG000|Overall Study|Withdrawal by Subject|2|||
144629764|NCT01059448|521502079|FG001|Overall Study|Withdrawal by Subject|0|||
144629765|NCT01059448|521502080|FG002|Overall Study|Withdrawal by Subject|2|||
144629766|NCT01059448|521502081|FG003|Overall Study|Withdrawal by Subject|4|||
144629767|NCT01059448|521502078|FG000|Overall Study|Disease Progression|2|||
144629768|NCT01059448|521502079|FG001|Overall Study|Disease Progression|1|||
144629769|NCT01059448|521502080|FG002|Overall Study|Disease Progression|4|||
144629770|NCT01059448|521502081|FG003|Overall Study|Disease Progression|2|||
144629771|NCT01059448|521502078|FG000|Overall Study|Administrative Decision|43|||
144629772|NCT01059448|521502079|FG001|Overall Study|Administrative Decision|49|||
144629773|NCT01059448|521502080|FG002|Overall Study|Administrative Decision|45|||
144629774|NCT01059448|521502081|FG003|Overall Study|Administrative Decision|46|||
144629775|NCT01059448|521502078|FG000|Overall Study|Lost to Follow-up|0|||
144629776|NCT01059448|521502079|FG001|Overall Study|Lost to Follow-up|0|||
144629777|NCT01059448|521502080|FG002|Overall Study|Lost to Follow-up|2|||
144629778|NCT01059448|521502081|FG003|Overall Study|Lost to Follow-up|0|||
144629779|NCT01059448|521502078|FG000|Overall Study|Death|0|||
144629780|NCT01059448|521502079|FG001|Overall Study|Death|1|||
144629781|NCT01059448|521502080|FG002|Overall Study|Death|0|||
144629782|NCT01059448|521502081|FG003|Overall Study|Death|0|||
144629783|NCT01059448|521502078|FG000|Overall Study|Other|1|||
144629784|NCT01059448|521502079|FG001|Overall Study|Other|1|||
144629785|NCT01059448|521502080|FG002|Overall Study|Other|0|||
144629786|NCT01059448|521502081|FG003|Overall Study|Other|1|||
144629787|NCT00778830|521502082|FG000|Overall Study|Ongoing at data cut-off|0|||
144629788|NCT00778830|521502083|FG001|Overall Study|Ongoing at data cut-off|1|||
144629789|NCT01891643|521502084|FG000|Overall Study|Adverse event unrelated to study drug|2|||
144629790|NCT01891643|521502085|FG001|Overall Study|Adverse event unrelated to study drug|5|||
144629791|NCT01891643|521502084|FG000|Overall Study|Disease Progression|4|||
144629792|NCT01891643|521502085|FG001|Overall Study|Disease Progression|3|||
144629793|NCT01891643|521502084|FG000|Overall Study|Study Drug Toxicity|3|||
144629794|NCT01891643|521502085|FG001|Overall Study|Study Drug Toxicity|0|||
144629795|NCT01891643|521502084|FG000|Overall Study|Maximum Clinical Benefit|0|||
144629796|NCT01891643|521502085|FG001|Overall Study|Maximum Clinical Benefit|1|||
144629797|NCT01891643|521502084|FG000|Overall Study|Poor/Non-compliance|0|||
144629798|NCT01891643|521502085|FG001|Overall Study|Poor/Non-compliance|1|||
144629799|NCT01891643|521502084|FG000|Overall Study|Participant request to discontinue|1|||
144629800|NCT01891643|521502085|FG001|Overall Study|Participant request to discontinue|0|||
144629801|NCT02591615|521502088|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
144629802|NCT02591615|521502089|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
144629803|NCT02591615|521502090|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
144629804|NCT02591615|521502091|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
144629805|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
144629806|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
144629807|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
144629808|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
144629809|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
144629810|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
144629811|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
144629812|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
144629813|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
144629814|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
144629815|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
144629816|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
144629817|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
144629818|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
144629819|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
144629820|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
144629821|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
144629822|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
144629823|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
144629824|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
144629825|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
144629826|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
144629827|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
144629828|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
144629829|NCT02591615|521502088|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
144629830|NCT02591615|521502089|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
144629831|NCT02591615|521502090|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
144629832|NCT02591615|521502091|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
144629833|NCT02591615|521502088|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
144629834|NCT02591615|521502089|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
144629835|NCT02591615|521502090|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
144629836|NCT02591615|521502091|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
144730646|NCT02188303|521869858|FG006|Overall Study|Dose Termination Criteria Met|2|||
144209880|NCT04784533|519962069|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144629837|NCT02591615|521502088|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
144629838|NCT02591615|521502089|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
144629839|NCT02591615|521502090|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
144629840|NCT02591615|521502091|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
144629841|NCT02591615|521502088|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
144629842|NCT02591615|521502089|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
144629843|NCT02591615|521502090|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
144629844|NCT02591615|521502091|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
144629845|NCT02591615|521502088|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
144629846|NCT02591615|521502089|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
144629847|NCT02591615|521502090|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
144629848|NCT02591615|521502091|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
144629849|NCT02591615|521502088|FG000|Maintenance MK-3475|Adverse Event|0|||
144629850|NCT02591615|521502089|FG001|Maintenance MK-3475|Adverse Event|3|||
144629851|NCT02591615|521502090|FG002|Maintenance MK-3475|Adverse Event|1|||
144629852|NCT02591615|521502091|FG003|Maintenance MK-3475|Adverse Event|2|||
144629853|NCT02591615|521502088|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
144629854|NCT02591615|521502089|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
144629855|NCT02591615|521502090|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
144629856|NCT02591615|521502091|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
144629857|NCT02591615|521502088|FG000|Maintenance MK-3475|Death|0|||
144629858|NCT02591615|521502089|FG001|Maintenance MK-3475|Death|1|||
144629859|NCT02591615|521502090|FG002|Maintenance MK-3475|Death|1|||
144629860|NCT02591615|521502091|FG003|Maintenance MK-3475|Death|0|||
144629861|NCT02591615|521502088|FG000|Maintenance MK-3475|Physician discretion|0|||
144629862|NCT02591615|521502089|FG001|Maintenance MK-3475|Physician discretion|0|||
144209881|NCT04784533|519962070|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
144209882|NCT04784533|519962071|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209883|NCT04784533|519962072|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209884|NCT04784533|519962073|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209885|NCT04784533|519962074|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209886|NCT04784533|519962075|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209887|NCT04784533|519962076|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209888|NCT04784533|519962077|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144209889|NCT04784533|519962078|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
144629863|NCT02591615|521502090|FG002|Maintenance MK-3475|Physician discretion|1|||
144629864|NCT02591615|521502091|FG003|Maintenance MK-3475|Physician discretion|0|||
144629865|NCT02591615|521502088|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
144629866|NCT02591615|521502089|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
144209890|NCT04784533|519962069|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
144209891|NCT04784533|519962070|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209892|NCT04784533|519962071|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209893|NCT04784533|519962072|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209894|NCT04784533|519962073|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209895|NCT04784533|519962074|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209896|NCT04784533|519962075|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144629867|NCT02591615|521502090|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
144629868|NCT02591615|521502091|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
144629869|NCT02591615|521502088|FG000|Maintenance MK-3475|In active treatment|2|||
144629870|NCT02591615|521502089|FG001|Maintenance MK-3475|In active treatment|0|||
144629871|NCT02591615|521502090|FG002|Maintenance MK-3475|In active treatment|0|||
144629872|NCT02591615|521502091|FG003|Maintenance MK-3475|In active treatment|1|||
144629873|NCT04188197|521502092|FG000|Overall Study|Lost to Follow-up|4|||
144629874|NCT04188197|521502093|FG001|Overall Study|Lost to Follow-up|1|||
144629875|NCT04188197|521502092|FG000|Overall Study|Withdrawal by Subject|1|||
144629876|NCT04188197|521502093|FG001|Overall Study|Withdrawal by Subject|1|||
144629877|NCT04188197|521502092|FG000|Overall Study|Pregnancy|0|||
144629878|NCT04188197|521502093|FG001|Overall Study|Pregnancy|1|||
144209897|NCT04784533|519962076|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209898|NCT04784533|519962077|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144629879|NCT02663895|521502103|FG000|Overall Study|Adverse Event|3|||
144629880|NCT02663895|521502103|FG000|Overall Study|Physician Decision|2|||
144629881|NCT02663895|521502103|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
144629882|NCT02663895|521502103|FG000|Overall Study|Withdrawal by Subject|1|||
144629883|NCT02911688|521502107|FG000|Washout|Lost to Follow-up|1|||
144629884|NCT02911688|521502108|FG001|Washout|Lost to Follow-up|1|||
144629885|NCT02911688|521502107|FG000|Washout|Withdrawal by Subject|0|||
144629886|NCT02911688|521502108|FG001|Washout|Withdrawal by Subject|1|||
144629887|NCT00809328|521502111|FG000|Overall Study|Lack of Efficacy|18|||
144629888|NCT00809328|521502111|FG000|Overall Study|Adverse Event|6|||
144730647|NCT02188303|521869859|FG007|Overall Study|Dose Termination Criteria Met|4|||
144730648|NCT04206332|521869860|FG000|Part A|Lost to Follow-up|0|||
144730649|NCT04206332|521869861|FG001|Part A|Lost to Follow-up|1|||
144730650|NCT04206332|521869862|FG002|Part A|Lost to Follow-up|0|||
144730651|NCT04206332|521869863|FG003|Part A|Lost to Follow-up|0|||
144730652|NCT04206332|521869864|FG004|Part A|Lost to Follow-up|0|||
144730653|NCT04206332|521869865|FG005|Part A|Lost to Follow-up|0|||
144730654|NCT04206332|521869866|FG006|Part A|Lost to Follow-up|0|||
144730655|NCT04206332|521869867|FG007|Part A|Lost to Follow-up|0|||
144730656|NCT04206332|521869868|FG008|Part A|Lost to Follow-up|0|||
144730657|NCT04206332|521869869|FG009|Part A|Lost to Follow-up|0|||
144730658|NCT04206332|521869870|FG010|Part A|Lost to Follow-up|0|||
144730659|NCT04206332|521869871|FG011|Part A|Lost to Follow-up|0|||
144730660|NCT04206332|521869872|FG012|Part A|Lost to Follow-up|0|||
144730661|NCT04206332|521869873|FG013|Part A|Lost to Follow-up|0|||
144730662|NCT04206332|521869874|FG014|Part A|Lost to Follow-up|0|||
144730663|NCT04206332|521869875|FG015|Part A|Lost to Follow-up|0|||
144730664|NCT04206332|521869876|FG016|Part A|Lost to Follow-up|0|||
144730665|NCT04206332|521869860|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730666|NCT04206332|521869861|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730667|NCT04206332|521869862|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730668|NCT04206332|521869863|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730669|NCT04206332|521869864|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730670|NCT04206332|521869865|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
144730671|NCT04206332|521869866|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730672|NCT04206332|521869867|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730673|NCT04206332|521869868|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730674|NCT04206332|521869869|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730675|NCT04206332|521869870|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730676|NCT04206332|521869871|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730677|NCT04206332|521869872|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730678|NCT04206332|521869873|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730679|NCT04206332|521869874|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730680|NCT04206332|521869875|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730681|NCT04206332|521869876|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
144730682|NCT04206332|521869860|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730683|NCT04206332|521869861|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730684|NCT04206332|521869862|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730685|NCT04206332|521869863|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730686|NCT04206332|521869864|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730687|NCT04206332|521869865|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730688|NCT04206332|521869866|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730689|NCT04206332|521869867|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
144629889|NCT00809328|521502111|FG000|Overall Study|Protocol Violation|3|||
144629890|NCT00809328|521502111|FG000|Overall Study|Withdrawal by Subject|2|||
144629891|NCT01400932|521502112|FG000|Overall Study|Adverse Event|10|||
144629892|NCT01400932|521502113|FG001|Overall Study|Adverse Event|5|||
144629893|NCT01400932|521502112|FG000|Overall Study|Lack of Efficacy|0|||
144629894|NCT01400932|521502113|FG001|Overall Study|Lack of Efficacy|3|||
144629895|NCT01400932|521502112|FG000|Overall Study|Withdrawal by Subject|2|||
144629896|NCT01400932|521502113|FG001|Overall Study|Withdrawal by Subject|6|||
144629897|NCT01400932|521502112|FG000|Overall Study|Lost to Follow-up|1|||
144629898|NCT01400932|521502113|FG001|Overall Study|Lost to Follow-up|0|||
144629899|NCT01400932|521502112|FG000|Overall Study|Protocol Deviation|0|||
144629900|NCT01400932|521502113|FG001|Overall Study|Protocol Deviation|1|||
144629901|NCT01400932|521502112|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144629902|NCT01400932|521502113|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
144629903|NCT04656990|521502114|FG000|Baseline|pandemic|20|||
144629904|NCT04656990|521502115|FG001|Baseline|pandemic|24|||
144629905|NCT04656990|521502114|FG000|Follow Up Period|Lost to Follow-up|61|||
144629906|NCT04656990|521502115|FG001|Follow Up Period|Lost to Follow-up|73|||
144629907|NCT03244059|521502116|FG000|Specific Aim 1|Physician Decision|1|||
144629908|NCT03244059|521502117|FG001|Specific Aim 1|Physician Decision|0|||
144629909|NCT03244059|521502116|FG000|Specific Aim 2|Physician Decision|1|||
144629910|NCT03244059|521502117|FG001|Specific Aim 2|Physician Decision|0|||
144629911|NCT00282243|521502119|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
144629912|NCT00282243|521502119|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
144629913|NCT00282243|521502119|FG000|Extension Treatment Period|Adverse Event|15|||
144629914|NCT00282243|521502119|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
144629915|NCT00282243|521502119|FG000|Extension Treatment Period|Non-compliance|2|||
144629916|NCT00282243|521502119|FG000|Extension Treatment Period|Physician Decision|1|||
144629917|NCT00851903|521502120|FG000|Overall Study|Withdrawal by Subject|2|||
144629918|NCT02863848|521502121|FG000|Overall Study|Lost to Follow-up|1|||
144629919|NCT02863848|521502122|FG001|Overall Study|Lost to Follow-up|1|||
144629920|NCT02863848|521502121|FG000|Overall Study|Protocol Violation|1|||
144629921|NCT02863848|521502122|FG001|Overall Study|Protocol Violation|2|||
144629922|NCT00686127|521502125|FG000|Overall Study|Withdrawal by Subject|14|||
144730690|NCT04206332|521869868|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730691|NCT04206332|521869869|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730692|NCT04206332|521869870|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
144730693|NCT04206332|521869871|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730694|NCT04206332|521869872|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144629923|NCT00686127|521502126|FG001|Overall Study|Withdrawal by Subject|6|||
144629924|NCT06441877|521502127|FG000|Overall Study|Withdrawal by Subject|0|||
144629925|NCT06441877|521502128|FG001|Overall Study|Withdrawal by Subject|2|||
144629926|NCT06441877|521502129|FG002|Overall Study|Withdrawal by Subject|0|||
144730695|NCT04206332|521869873|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730696|NCT04206332|521869874|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730697|NCT04206332|521869875|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730698|NCT04206332|521869876|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730699|NCT04206332|521869860|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730700|NCT04206332|521869861|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730701|NCT04206332|521869862|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730702|NCT04206332|521869863|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730703|NCT04206332|521869864|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730704|NCT04206332|521869865|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730705|NCT04206332|521869866|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730706|NCT04206332|521869867|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730707|NCT04206332|521869868|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730708|NCT04206332|521869869|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730709|NCT04206332|521869870|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730710|NCT04206332|521869871|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730711|NCT04206332|521869872|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730712|NCT04206332|521869873|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730713|NCT04206332|521869874|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730714|NCT04206332|521869875|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
144730715|NCT04206332|521869876|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
144730716|NCT04206332|521869860|FG000|Part C|Withdrawal by Subject|0|||
144730717|NCT04206332|521869861|FG001|Part C|Withdrawal by Subject|0|||
144730718|NCT04206332|521869862|FG002|Part C|Withdrawal by Subject|0|||
144730719|NCT04206332|521869863|FG003|Part C|Withdrawal by Subject|0|||
144730720|NCT04206332|521869864|FG004|Part C|Withdrawal by Subject|0|||
144730721|NCT04206332|521869865|FG005|Part C|Withdrawal by Subject|0|||
144629927|NCT06441877|521502130|FG003|Overall Study|Withdrawal by Subject|0|||
144629928|NCT03706365|521502133|FG000|Overall Study|Lost to Follow-up|7|||
144629929|NCT03706365|521502134|FG001|Overall Study|Lost to Follow-up|0|||
144629930|NCT03706365|521502133|FG000|Overall Study|Withdrawal by Subject|17|||
144629931|NCT03706365|521502134|FG001|Overall Study|Withdrawal by Subject|15|||
144629932|NCT03706365|521502133|FG000|Overall Study|On Study Treatment|51|||
144629933|NCT03706365|521502134|FG001|Overall Study|On Study Treatment|51|||
144629934|NCT03116113|521502135|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629935|NCT03116113|521502136|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629936|NCT03116113|521502137|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629937|NCT03116113|521502138|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629938|NCT03116113|521502139|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629939|NCT03116113|521502140|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629940|NCT03116113|521502141|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
144629941|NCT03116113|521502142|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
144629942|NCT03116113|521502143|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
144629943|NCT02159807|521502144|FG000|Overall Study|Adverse Event|0|||
144629944|NCT02159807|521502145|FG001|Overall Study|Adverse Event|0|||
144629945|NCT02159807|521502146|FG002|Overall Study|Adverse Event|1|||
144629946|NCT02159807|521502144|FG000|Overall Study|No CSF|1|||
144629947|NCT02159807|521502145|FG001|Overall Study|No CSF|1|||
144629948|NCT02159807|521502146|FG002|Overall Study|No CSF|1|||
144629949|NCT02159807|521502144|FG000|Overall Study|elevated blood pressure|0|||
144629950|NCT02159807|521502145|FG001|Overall Study|elevated blood pressure|0|||
144629951|NCT02159807|521502146|FG002|Overall Study|elevated blood pressure|1|||
144629952|NCT00600171|521502147|FG000|Overall Study|Adverse Event|0|||
144629953|NCT00600171|521502148|FG001|Overall Study|Adverse Event|1|||
144629954|NCT00600171|521502149|FG002|Overall Study|Adverse Event|0|||
144629955|NCT00600171|521502150|FG003|Overall Study|Adverse Event|0|||
144629956|NCT00600171|521502151|FG004|Overall Study|Adverse Event|1|||
144629957|NCT00600171|521502152|FG005|Overall Study|Adverse Event|0|||
144629958|NCT00600171|521502147|FG000|Overall Study|Lack of Efficacy|9|||
144629959|NCT00600171|521502148|FG001|Overall Study|Lack of Efficacy|12|||
144629960|NCT00600171|521502149|FG002|Overall Study|Lack of Efficacy|3|||
144629961|NCT00600171|521502150|FG003|Overall Study|Lack of Efficacy|5|||
144629962|NCT00600171|521502151|FG004|Overall Study|Lack of Efficacy|4|||
144629963|NCT00600171|521502152|FG005|Overall Study|Lack of Efficacy|0|||
144629964|NCT00600171|521502147|FG000|Overall Study|Protocol Violation|1|||
144629965|NCT00600171|521502148|FG001|Overall Study|Protocol Violation|2|||
144629966|NCT00600171|521502149|FG002|Overall Study|Protocol Violation|0|||
144629967|NCT00600171|521502150|FG003|Overall Study|Protocol Violation|1|||
144629968|NCT00600171|521502151|FG004|Overall Study|Protocol Violation|0|||
144629969|NCT00600171|521502152|FG005|Overall Study|Protocol Violation|0|||
144629970|NCT00600171|521502147|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
144629971|NCT00600171|521502148|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144629972|NCT00600171|521502149|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
144629973|NCT00600171|521502150|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
144629974|NCT00600171|521502151|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
144629975|NCT00600171|521502152|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
144629976|NCT00600171|521502147|FG000|Overall Study|Withdrawal by Subject|3|||
144629977|NCT00600171|521502148|FG001|Overall Study|Withdrawal by Subject|0|||
144629978|NCT00600171|521502149|FG002|Overall Study|Withdrawal by Subject|0|||
144629979|NCT00600171|521502150|FG003|Overall Study|Withdrawal by Subject|1|||
144629980|NCT00600171|521502151|FG004|Overall Study|Withdrawal by Subject|1|||
144629981|NCT00600171|521502152|FG005|Overall Study|Withdrawal by Subject|1|||
144629982|NCT00600171|521502147|FG000|Overall Study|Physician Decision|0|||
144629983|NCT00600171|521502148|FG001|Overall Study|Physician Decision|1|||
144629984|NCT00600171|521502149|FG002|Overall Study|Physician Decision|0|||
144629985|NCT00600171|521502150|FG003|Overall Study|Physician Decision|1|||
144629986|NCT00600171|521502151|FG004|Overall Study|Physician Decision|0|||
144629987|NCT00600171|521502152|FG005|Overall Study|Physician Decision|2|||
144629988|NCT00600171|521502147|FG000|Overall Study|Lost to Follow-up|0|||
144629989|NCT00600171|521502148|FG001|Overall Study|Lost to Follow-up|0|||
144629990|NCT00600171|521502149|FG002|Overall Study|Lost to Follow-up|0|||
144629991|NCT00600171|521502150|FG003|Overall Study|Lost to Follow-up|1|||
144629992|NCT00600171|521502151|FG004|Overall Study|Lost to Follow-up|0|||
144629993|NCT00600171|521502152|FG005|Overall Study|Lost to Follow-up|0|||
144629994|NCT02367521|521502153|FG000|Overall Study|severe headache after intervention|2|||
144629995|NCT02367521|521502154|FG001|Overall Study|severe headache after intervention|0|||
144629996|NCT02367521|521502153|FG000|Overall Study|unable to find transportation|2|||
144629997|NCT02367521|521502154|FG001|Overall Study|unable to find transportation|0|||
144629998|NCT00542191|521502158|FG000|Overall Study|Death|3|||
144629999|NCT00469612|521502159|FG000|Overall Study|Study terminated before data collected|2|||
144630000|NCT00469612|521502160|FG001|Overall Study|Study terminated before data collected|0|||
144630001|NCT02720757|521502161|FG000|Overall Study|Other reason|5|||
144630002|NCT02720757|521502161|FG000|Overall Study|Loss of contact|4|||
144630003|NCT02720757|521502161|FG000|Overall Study|Informed consent withdrawal|1|||
144630004|NCT02720757|521502161|FG000|Overall Study|Patients wish to withdraw|2|||
144630005|NCT02720757|521502161|FG000|Overall Study|Missing|3|||
144630006|NCT02720757|521502161|FG000|Overall Study|General exclusion|3|||
144630007|NCT00883493|521502162|FG000|Overall Study|Adverse Event|11|||
144630008|NCT00883493|521502163|FG001|Overall Study|Adverse Event|12|||
144630009|NCT00883493|521502162|FG000|Overall Study|Lack of Efficacy|4|||
144630010|NCT00883493|521502163|FG001|Overall Study|Lack of Efficacy|3|||
144630011|NCT00883493|521502162|FG000|Overall Study|Lost to Follow-up|7|||
144630012|NCT00883493|521502163|FG001|Overall Study|Lost to Follow-up|6|||
144630013|NCT00883493|521502162|FG000|Overall Study|Withdrawal by Subject|11|||
144630014|NCT00883493|521502163|FG001|Overall Study|Withdrawal by Subject|20|||
144630015|NCT00883493|521502162|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
144630016|NCT00883493|521502163|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
144630017|NCT00883493|521502162|FG000|Overall Study|Study specific disc. criteria|2|||
144630018|NCT00883493|521502163|FG001|Overall Study|Study specific disc. criteria|0|||
144630019|NCT00883493|521502162|FG000|Overall Study|Other|5|||
144630020|NCT00883493|521502163|FG001|Overall Study|Other|3|||
144630021|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630022|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
144630023|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630024|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630025|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630026|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
144630027|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
144630028|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
144630029|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
144630030|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
144630031|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
144630032|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
144630033|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630034|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
144630035|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
144630036|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
144630037|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
144630038|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
144630039|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
144630040|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
144630041|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630042|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630043|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630044|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
144630045|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630046|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
144630047|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
144630048|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
144630049|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
144630050|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
144630051|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
144630052|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
144630053|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
144630054|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
144630055|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
144630056|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
144630057|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
144630058|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
144630059|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
144630060|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
144630061|NCT00289913|521502166|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
144630062|NCT00289913|521502167|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630063|NCT00289913|521502168|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
144630064|NCT00289913|521502169|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630065|NCT00289913|521502170|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630066|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630067|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630068|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
144209899|NCT04784533|519962078|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
144209900|NCT04784533|519962069|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
144209901|NCT04784533|519962070|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
144630069|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630070|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630071|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
144630072|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
144630073|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
144630074|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
144630075|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
144630076|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
144630077|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
144630078|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
144630079|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
144630080|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
144630081|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
144630082|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
144630083|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
144630084|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630085|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630086|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
144630087|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630088|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
144209902|NCT04784533|519962071|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209903|NCT04784533|519962072|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209904|NCT04784533|519962073|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209905|NCT04784533|519962074|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209906|NCT04784533|519962075|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209907|NCT04784533|519962076|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209908|NCT04784533|519962077|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209909|NCT04784533|519962078|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
144209910|NCT04784533|519962069|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
144209911|NCT04784533|519962070|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
144209912|NCT04784533|519962071|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209913|NCT04784533|519962072|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209914|NCT04784533|519962073|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209915|NCT04784533|519962074|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209916|NCT04784533|519962075|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209917|NCT04784533|519962076|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144630089|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630090|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630091|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
144630092|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
144630093|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
144630094|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
144630095|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
144630096|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
144630097|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
144630098|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
144630099|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
144630100|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
144630101|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
144630102|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
144630103|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
144630104|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
144630105|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
144630106|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
144630107|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
144630108|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
144630109|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
144630110|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
144630111|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
144630112|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
144730722|NCT04206332|521869866|FG006|Part C|Withdrawal by Subject|0|||
144730723|NCT04206332|521869867|FG007|Part C|Withdrawal by Subject|0|||
144209918|NCT04784533|519962077|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209919|NCT04784533|519962078|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
144209920|NCT04784533|519962069|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209921|NCT04784533|519962070|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209922|NCT04784533|519962071|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
144209923|NCT04784533|519962072|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209924|NCT04784533|519962073|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144630113|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
144630114|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
144630115|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
144630116|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
144630117|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
144630118|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
144630119|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
144630120|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
144630121|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
144630122|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
144630123|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
144630124|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
144630125|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
144630126|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
144630127|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
144630128|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
144630129|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
144630130|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
144630131|NCT00289913|521502166|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
144630132|NCT00289913|521502167|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
144630133|NCT00289913|521502168|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
144630134|NCT00289913|521502169|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
144630135|NCT00289913|521502170|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
144630136|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630137|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
144630138|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630139|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630140|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
144630141|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
144630142|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
144630143|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
144630144|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
144630145|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
144630146|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630147|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630148|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630149|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
144630150|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
144630151|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630152|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630153|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630154|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
144630155|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
144630156|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
144630157|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
144630158|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
144630159|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
144630160|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
144630161|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
144630162|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
144630163|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
144630164|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
144630165|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
144630166|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
144630167|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
144630168|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
144630169|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
144630170|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
144630171|NCT00289913|521502166|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630172|NCT00289913|521502167|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
144630173|NCT00289913|521502168|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630174|NCT00289913|521502169|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630175|NCT00289913|521502170|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
144630176|NCT02357420|521502173|FG000|Overall Study|Adverse Event|3|||
144630177|NCT02357420|521502174|FG001|Overall Study|Adverse Event|3|||
144630178|NCT02357420|521502175|FG002|Overall Study|Adverse Event|8|||
144630179|NCT02357420|521502176|FG003|Overall Study|Adverse Event|9|||
144630180|NCT02357420|521502173|FG000|Overall Study|Investigator Decision|1|||
144630181|NCT02357420|521502174|FG001|Overall Study|Investigator Decision|0|||
144209925|NCT04784533|519962074|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209926|NCT04784533|519962075|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209927|NCT04784533|519962076|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209928|NCT04784533|519962077|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209929|NCT04784533|519962078|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
144209930|NCT04784533|519962069|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144209931|NCT04784533|519962070|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144630182|NCT02357420|521502175|FG002|Overall Study|Investigator Decision|0|||
144630183|NCT02357420|521502176|FG003|Overall Study|Investigator Decision|0|||
144630184|NCT02357420|521502173|FG000|Overall Study|Prohibited Medication|1|||
144209932|NCT04784533|519962071|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144630185|NCT02357420|521502174|FG001|Overall Study|Prohibited Medication|1|||
144630186|NCT02357420|521502175|FG002|Overall Study|Prohibited Medication|0|||
144630187|NCT02357420|521502176|FG003|Overall Study|Prohibited Medication|0|||
144630188|NCT02357420|521502173|FG000|Overall Study|Protocol Non-compliance|0|||
144630189|NCT02357420|521502174|FG001|Overall Study|Protocol Non-compliance|0|||
144630190|NCT02357420|521502175|FG002|Overall Study|Protocol Non-compliance|0|||
144630191|NCT02357420|521502176|FG003|Overall Study|Protocol Non-compliance|1|||
144630192|NCT02357420|521502173|FG000|Overall Study|Withdrawn Consent|4|||
144630193|NCT02357420|521502174|FG001|Overall Study|Withdrawn Consent|8|||
144630194|NCT02357420|521502175|FG002|Overall Study|Withdrawn Consent|6|||
144630195|NCT02357420|521502176|FG003|Overall Study|Withdrawn Consent|6|||
144630196|NCT02357420|521502173|FG000|Overall Study|Lost to Follow-up|3|||
144630197|NCT02357420|521502174|FG001|Overall Study|Lost to Follow-up|0|||
144630198|NCT02357420|521502175|FG002|Overall Study|Lost to Follow-up|2|||
144630199|NCT02357420|521502176|FG003|Overall Study|Lost to Follow-up|3|||
144630200|NCT01061008|521502177|FG000|Overall Study|Badiocephalic fistula failed|3|||
144630201|NCT01061008|521502178|FG001|Overall Study|Badiocephalic fistula failed|2|||
144630202|NCT01061008|521502177|FG000|Overall Study|Death|1|||
144630203|NCT01061008|521502178|FG001|Overall Study|Death|0|||
144630204|NCT01061008|521502177|FG000|Overall Study|Withdrawal by Subject|1|||
144630205|NCT01061008|521502178|FG001|Overall Study|Withdrawal by Subject|3|||
144630206|NCT01061008|521502177|FG000|Overall Study|Unable to exercise following surgery|1|||
144630207|NCT01061008|521502178|FG001|Overall Study|Unable to exercise following surgery|0|||
144630208|NCT01061008|521502177|FG000|Overall Study|Adverse Event|0|||
144262961|NCT01396083|520163801|FG001|Overall Study|Administrative problems|0|||
144262962|NCT01396083|520163800|FG000|Overall Study|Lost to Follow-up|1|||
144262963|NCT01396083|520163801|FG001|Overall Study|Lost to Follow-up|0|||
144262964|NCT00619827|520163802|FG000|Overall Study|Adverse Event|1|||
144262965|NCT00619827|520163803|FG001|Overall Study|Adverse Event|2|||
144262966|NCT00619827|520163802|FG000|Overall Study|Withdrawal by Subject|2|||
144262967|NCT00619827|520163803|FG001|Overall Study|Withdrawal by Subject|2|||
144262968|NCT02806713|520163804|FG000|Overall Study|Urethral injury during procedure|1|||
144630209|NCT01061008|521502178|FG001|Overall Study|Adverse Event|1|||
144630210|NCT02908100|521502180|FG000|Overall Study|Adverse Event|7|||
144630211|NCT02908100|521502181|FG001|Overall Study|Adverse Event|6|||
144630212|NCT02908100|521502182|FG002|Overall Study|Adverse Event|9|||
144630213|NCT02908100|521502180|FG000|Overall Study|Death|2|||
144630214|NCT02908100|521502181|FG001|Overall Study|Death|0|||
144630215|NCT02908100|521502182|FG002|Overall Study|Death|0|||
144630216|NCT02908100|521502180|FG000|Overall Study|Lack of Efficacy|2|||
144630217|NCT02908100|521502181|FG001|Overall Study|Lack of Efficacy|3|||
144209933|NCT04784533|519962072|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144209934|NCT04784533|519962073|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144209935|NCT04784533|519962074|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144209936|NCT04784533|519962075|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144630218|NCT02908100|521502182|FG002|Overall Study|Lack of Efficacy|3|||
144630219|NCT02908100|521502180|FG000|Overall Study|Lost to Follow-up|0|||
144630220|NCT02908100|521502181|FG001|Overall Study|Lost to Follow-up|1|||
144630221|NCT02908100|521502182|FG002|Overall Study|Lost to Follow-up|2|||
144630222|NCT02908100|521502180|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144630223|NCT02908100|521502181|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144630224|NCT02908100|521502182|FG002|Overall Study|Non-Compliance With Study Drug|2|||
144630225|NCT02908100|521502180|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
144630226|NCT02908100|521502181|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
144630227|NCT02908100|521502182|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
144630228|NCT02908100|521502180|FG000|Overall Study|Physician Decision|0|||
144630229|NCT02908100|521502181|FG001|Overall Study|Physician Decision|1|||
144630230|NCT02908100|521502182|FG002|Overall Study|Physician Decision|0|||
144209937|NCT04784533|519962076|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144630231|NCT02908100|521502180|FG000|Overall Study|Pregnancy|1|||
144630232|NCT02908100|521502181|FG001|Overall Study|Pregnancy|2|||
144630233|NCT02908100|521502182|FG002|Overall Study|Pregnancy|0|||
144630234|NCT02908100|521502180|FG000|Overall Study|Withdrawal by Subject|8|||
144630235|NCT02908100|521502181|FG001|Overall Study|Withdrawal by Subject|7|||
144630236|NCT02908100|521502182|FG002|Overall Study|Withdrawal by Subject|5|||
144630237|NCT02908100|521502180|FG000|Overall Study|Randomised in Error|1|||
144630238|NCT02908100|521502181|FG001|Overall Study|Randomised in Error|0|||
144630239|NCT02908100|521502182|FG002|Overall Study|Randomised in Error|0|||
144630240|NCT02024971|521502183|FG000|Overall Study|Data Not Available|30|||
144630241|NCT02024971|521502183|FG000|Overall Study|Lost to Follow-up|6|||
144630242|NCT05254418|521502185|FG000|Overall Study|Adverse Event|2|||
144630243|NCT00440726|521502186|FG000|Phase 1|Dose-Limiting Toxicity|0|||
144630244|NCT00440726|521502187|FG001|Phase 1|Dose-Limiting Toxicity|1|||
144630245|NCT00440726|521502188|FG002|Phase 1|Dose-Limiting Toxicity|0|||
144630246|NCT00440726|521502186|FG000|Phase 1|Physician Decision|1|||
144630247|NCT00440726|521502187|FG001|Phase 1|Physician Decision|0|||
144630248|NCT00440726|521502188|FG002|Phase 1|Physician Decision|0|||
144630249|NCT00440726|521502186|FG000|Phase 2|Death|0|||
144630250|NCT00440726|521502187|FG001|Phase 2|Death|0|||
144630251|NCT00440726|521502188|FG002|Phase 2|Death|1|||
144630252|NCT00440726|521502186|FG000|Phase 2|Adverse Event|0|||
144630253|NCT00440726|521502187|FG001|Phase 2|Adverse Event|0|||
144630254|NCT00440726|521502188|FG002|Phase 2|Adverse Event|1|||
144630255|NCT01808612|521502189|FG000|Treatment Period|Adverse Event|8|||
144630256|NCT01808612|521502190|FG001|Treatment Period|Adverse Event|4|||
144630257|NCT01808612|521502191|FG002|Treatment Period|Adverse Event|3|||
144630258|NCT01808612|521502189|FG000|Treatment Period|Lost to Follow-up|2|||
144630259|NCT01808612|521502190|FG001|Treatment Period|Lost to Follow-up|2|||
144630260|NCT01808612|521502191|FG002|Treatment Period|Lost to Follow-up|1|||
144630261|NCT01808612|521502189|FG000|Treatment Period|Protocol Violation|1|||
144630262|NCT01808612|521502190|FG001|Treatment Period|Protocol Violation|0|||
144630263|NCT01808612|521502191|FG002|Treatment Period|Protocol Violation|0|||
144630264|NCT01808612|521502189|FG000|Treatment Period|Withdrawal by Subject|1|||
144630265|NCT01808612|521502190|FG001|Treatment Period|Withdrawal by Subject|0|||
144630266|NCT01808612|521502191|FG002|Treatment Period|Withdrawal by Subject|4|||
144630267|NCT01808612|521502189|FG000|Treatment Period|Physician Decision|1|||
144630268|NCT01808612|521502190|FG001|Treatment Period|Physician Decision|0|||
144630269|NCT01808612|521502191|FG002|Treatment Period|Physician Decision|4|||
144630270|NCT01808612|521502189|FG000|Treatment Period|Sponsor Decision|1|||
144630271|NCT01808612|521502190|FG001|Treatment Period|Sponsor Decision|0|||
144630272|NCT01808612|521502191|FG002|Treatment Period|Sponsor Decision|0|||
144630273|NCT01808612|521502189|FG000|Treatment Period|Lack of Efficacy|1|||
144630274|NCT01808612|521502190|FG001|Treatment Period|Lack of Efficacy|1|||
144630275|NCT01808612|521502191|FG002|Treatment Period|Lack of Efficacy|2|||
144630276|NCT01808612|521502189|FG000|Discontinuation Period|Adverse Event|1|||
144630277|NCT01808612|521502190|FG001|Discontinuation Period|Adverse Event|0|||
144630278|NCT01808612|521502191|FG002|Discontinuation Period|Adverse Event|0|||
144630279|NCT01808612|521502189|FG000|Discontinuation Period|Physician Decision|1|||
144630280|NCT01808612|521502190|FG001|Discontinuation Period|Physician Decision|0|||
144630281|NCT01808612|521502191|FG002|Discontinuation Period|Physician Decision|0|||
144630282|NCT01808612|521502189|FG000|Discontinuation Period|Lost to Follow-up|0|||
144630283|NCT01808612|521502190|FG001|Discontinuation Period|Lost to Follow-up|1|||
144630284|NCT01808612|521502191|FG002|Discontinuation Period|Lost to Follow-up|0|||
144630285|NCT03683394|521502192|FG000|Overall Study|Withdrawal by Subject|4|||
144630286|NCT03683394|521502193|FG001|Overall Study|Withdrawal by Subject|8|||
144630287|NCT03683394|521502192|FG000|Overall Study|Lost to Follow-up|7|||
144630288|NCT03683394|521502193|FG001|Overall Study|Lost to Follow-up|0|||
144630289|NCT03683394|521502192|FG000|Overall Study|Death|3|||
144630290|NCT03683394|521502193|FG001|Overall Study|Death|1|||
144630291|NCT01058096|521502194|FG000|Double-blind Treatment Phase|Adverse Event|11|||
144630292|NCT01058096|521502195|FG001|Double-blind Treatment Phase|Adverse Event|15|||
144730724|NCT04206332|521869868|FG008|Part C|Withdrawal by Subject|0|||
144209938|NCT04784533|519962077|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
144209939|NCT04784533|519962078|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
144209940|NCT04784533|519962069|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144630293|NCT01058096|521502194|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
144630294|NCT01058096|521502195|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
144630295|NCT01058096|521502194|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
144630296|NCT01058096|521502195|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
144630297|NCT01058096|521502194|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
144630298|NCT01058096|521502195|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
144630299|NCT01058096|521502194|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
144630300|NCT01058096|521502195|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
144209941|NCT04784533|519962070|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144630301|NCT01058096|521502194|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
144730725|NCT04206332|521869869|FG009|Part C|Withdrawal by Subject|0|||
144630302|NCT01058096|521502195|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
144209942|NCT04784533|519962071|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144209943|NCT04784533|519962072|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144209944|NCT04784533|519962073|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144630303|NCT00559273|521502196|FG000|Correction Period (20 Weeks)|Death|3|||
144630304|NCT00559273|521502197|FG001|Correction Period (20 Weeks)|Death|4|||
144630305|NCT00559273|521502196|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
144630306|NCT00559273|521502197|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
144630307|NCT00559273|521502196|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
144630308|NCT00559273|521502197|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
144630309|NCT00559273|521502196|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
144630310|NCT00559273|521502197|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
144630311|NCT00559273|521502196|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
144630312|NCT00559273|521502197|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
144630313|NCT00559273|521502196|FG000|Evaluation Period (8 Weeks)|Death|1|||
144630314|NCT00559273|521502197|FG001|Evaluation Period (8 Weeks)|Death|3|||
144630315|NCT00559273|521502196|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
144630316|NCT00559273|521502197|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
144630317|NCT00559273|521502196|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
144630318|NCT00559273|521502197|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
144630319|NCT00559273|521502196|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
144630320|NCT00559273|521502197|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
144630321|NCT00849667|521502210|FG000|Overall Study|Withdrawal by Subject|16|||
144630322|NCT00849667|521502211|FG001|Overall Study|Withdrawal by Subject|33|||
144630323|NCT00849667|521502212|FG002|Overall Study|Withdrawal by Subject|35|||
144630324|NCT00849667|521502210|FG000|Overall Study|Lost to Follow-up|8|||
144630325|NCT00849667|521502211|FG001|Overall Study|Lost to Follow-up|8|||
144630326|NCT00849667|521502212|FG002|Overall Study|Lost to Follow-up|8|||
144630327|NCT00849667|521502210|FG000|Overall Study|Adverse Event|1|||
144630328|NCT00849667|521502211|FG001|Overall Study|Adverse Event|2|||
144630329|NCT00849667|521502212|FG002|Overall Study|Adverse Event|0|||
144630330|NCT00849667|521502210|FG000|Overall Study|Other|18|||
144630331|NCT00849667|521502211|FG001|Overall Study|Other|19|||
144630332|NCT00849667|521502212|FG002|Overall Study|Other|18|||
144630333|NCT00849667|521502210|FG000|Overall Study|Progressive disease|119|||
144630334|NCT00849667|521502211|FG001|Overall Study|Progressive disease|100|||
144630335|NCT00849667|521502212|FG002|Overall Study|Progressive disease|112|||
144630336|NCT00849667|521502210|FG000|Overall Study|Sponsor decision|208|||
144630337|NCT00849667|521502211|FG001|Overall Study|Sponsor decision|204|||
144630338|NCT00849667|521502212|FG002|Overall Study|Sponsor decision|190|||
144630339|NCT00849667|521502210|FG000|Overall Study|Investigator discretion|0|||
144630340|NCT00849667|521502211|FG001|Overall Study|Investigator discretion|0|||
144630341|NCT00849667|521502212|FG002|Overall Study|Investigator discretion|1|||
144630342|NCT01262625|521502218|FG000|Overall Study|Administrative Error|1|||
144630343|NCT01262625|521502219|FG001|Overall Study|Administrative Error|1|||
144630344|NCT01262625|521502218|FG000|Overall Study|Site Closed|1|||
144630345|NCT01262625|521502219|FG001|Overall Study|Site Closed|0|||
144630346|NCT01869348|521502220|FG000|Overall Study|Withdrawal by Subject|1|||
144630347|NCT01869348|521502221|FG001|Overall Study|Withdrawal by Subject|1|||
144630348|NCT03075163|521502223|FG000|Overall Study|not eligible for treatment limb|138|||
144630349|NCT03075163|521502224|FG001|Overall Study|not eligible for treatment limb|138|||
144630350|NCT04398732|521502225|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
144630351|NCT01299727|521502226|FG000|Overall Study|Withdrawal by Subject|1|||
144630352|NCT01299727|521502227|FG001|Overall Study|Withdrawal by Subject|0|||
144630353|NCT01299727|521502228|FG002|Overall Study|Withdrawal by Subject|0|||
144630354|NCT01299727|521502226|FG000|Overall Study|Adverse Event|0|||
144630355|NCT01299727|521502227|FG001|Overall Study|Adverse Event|0|||
144630356|NCT01299727|521502228|FG002|Overall Study|Adverse Event|1|||
144630357|NCT01299727|521502226|FG000|Overall Study|Completed the Treatment Period|3|||
144630358|NCT01299727|521502227|FG001|Overall Study|Completed the Treatment Period|4|||
144630359|NCT01299727|521502228|FG002|Overall Study|Completed the Treatment Period|3|||
144630360|NCT00944034|521502233|FG000|Overall Study|Inappropriate enrollment|0|||
144209945|NCT04784533|519962074|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144209946|NCT04784533|519962075|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144630361|NCT00944034|521502234|FG001|Overall Study|Inappropriate enrollment|1|||
144630362|NCT00944034|521502235|FG002|Overall Study|Inappropriate enrollment|0|||
144630363|NCT00944034|521502236|FG003|Overall Study|Inappropriate enrollment|1|||
144630364|NCT00944034|521502237|FG004|Overall Study|Inappropriate enrollment|2|||
144630365|NCT00944034|521502238|FG005|Overall Study|Inappropriate enrollment|1|||
144630366|NCT00944034|521502239|FG006|Overall Study|Inappropriate enrollment|0|||
144630367|NCT00944034|521502240|FG007|Overall Study|Inappropriate enrollment|0|||
144630368|NCT00944034|521502241|FG008|Overall Study|Inappropriate enrollment|1|||
144630369|NCT00944034|521502242|FG009|Overall Study|Inappropriate enrollment|1|||
144209947|NCT04784533|519962076|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
144209948|NCT04784533|519962077|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
144630370|NCT00944034|521502243|FG010|Overall Study|Inappropriate enrollment|0|||
144630371|NCT00944034|521502244|FG011|Overall Study|Inappropriate enrollment|0|||
144630372|NCT00944034|521502233|FG000|Overall Study|Withdrawal by Subject|3|||
144630373|NCT00944034|521502234|FG001|Overall Study|Withdrawal by Subject|2|||
144630374|NCT00944034|521502235|FG002|Overall Study|Withdrawal by Subject|6|||
144630375|NCT00944034|521502236|FG003|Overall Study|Withdrawal by Subject|2|||
144630376|NCT00944034|521502237|FG004|Overall Study|Withdrawal by Subject|5|||
144630377|NCT00944034|521502238|FG005|Overall Study|Withdrawal by Subject|8|||
144630378|NCT00944034|521502239|FG006|Overall Study|Withdrawal by Subject|2|||
144630379|NCT00944034|521502240|FG007|Overall Study|Withdrawal by Subject|2|||
144630380|NCT00944034|521502241|FG008|Overall Study|Withdrawal by Subject|3|||
144630381|NCT00944034|521502242|FG009|Overall Study|Withdrawal by Subject|4|||
144630382|NCT00944034|521502243|FG010|Overall Study|Withdrawal by Subject|0|||
144630383|NCT00944034|521502244|FG011|Overall Study|Withdrawal by Subject|4|||
144630384|NCT00944034|521502233|FG000|Overall Study|Lost to Follow-up|0|||
144630385|NCT00944034|521502234|FG001|Overall Study|Lost to Follow-up|4|||
144630386|NCT00944034|521502235|FG002|Overall Study|Lost to Follow-up|2|||
144630387|NCT00944034|521502236|FG003|Overall Study|Lost to Follow-up|0|||
144630388|NCT00944034|521502237|FG004|Overall Study|Lost to Follow-up|5|||
144630389|NCT00944034|521502238|FG005|Overall Study|Lost to Follow-up|7|||
144630390|NCT00944034|521502239|FG006|Overall Study|Lost to Follow-up|0|||
144630391|NCT00944034|521502240|FG007|Overall Study|Lost to Follow-up|1|||
144630392|NCT00944034|521502241|FG008|Overall Study|Lost to Follow-up|5|||
144630393|NCT00944034|521502242|FG009|Overall Study|Lost to Follow-up|1|||
144630394|NCT00944034|521502243|FG010|Overall Study|Lost to Follow-up|1|||
144630395|NCT00944034|521502244|FG011|Overall Study|Lost to Follow-up|0|||
144630396|NCT00944034|521502233|FG000|Overall Study|Death|0|||
144630397|NCT00944034|521502234|FG001|Overall Study|Death|0|||
144630398|NCT00944034|521502235|FG002|Overall Study|Death|1|||
144630399|NCT00944034|521502236|FG003|Overall Study|Death|0|||
144630400|NCT00944034|521502237|FG004|Overall Study|Death|0|||
144630401|NCT00944034|521502238|FG005|Overall Study|Death|0|||
144630402|NCT00944034|521502239|FG006|Overall Study|Death|0|||
144209949|NCT04784533|519962078|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
144630403|NCT00944034|521502240|FG007|Overall Study|Death|0|||
144630404|NCT00944034|521502241|FG008|Overall Study|Death|0|||
144630405|NCT00944034|521502242|FG009|Overall Study|Death|0|||
144630406|NCT00944034|521502243|FG010|Overall Study|Death|0|||
144630407|NCT00944034|521502244|FG011|Overall Study|Death|0|||
144630408|NCT00944034|521502233|FG000|Overall Study|Protocol Violation|2|||
144630409|NCT00944034|521502234|FG001|Overall Study|Protocol Violation|0|||
144630410|NCT00944034|521502235|FG002|Overall Study|Protocol Violation|0|||
144630411|NCT00944034|521502236|FG003|Overall Study|Protocol Violation|1|||
144630412|NCT00944034|521502237|FG004|Overall Study|Protocol Violation|2|||
144630413|NCT00944034|521502238|FG005|Overall Study|Protocol Violation|3|||
144630414|NCT00944034|521502239|FG006|Overall Study|Protocol Violation|0|||
144630415|NCT00944034|521502240|FG007|Overall Study|Protocol Violation|1|||
144630416|NCT00944034|521502241|FG008|Overall Study|Protocol Violation|1|||
144630417|NCT00944034|521502242|FG009|Overall Study|Protocol Violation|4|||
144630418|NCT00944034|521502243|FG010|Overall Study|Protocol Violation|0|||
144630419|NCT00944034|521502244|FG011|Overall Study|Protocol Violation|0|||
144630420|NCT00944034|521502233|FG000|Overall Study|Unable to classify|0|||
144630421|NCT00944034|521502234|FG001|Overall Study|Unable to classify|0|||
144630422|NCT00944034|521502235|FG002|Overall Study|Unable to classify|0|||
144630423|NCT00944034|521502236|FG003|Overall Study|Unable to classify|0|||
144630424|NCT00944034|521502237|FG004|Overall Study|Unable to classify|0|||
144630425|NCT00944034|521502238|FG005|Overall Study|Unable to classify|1|||
144630426|NCT00944034|521502239|FG006|Overall Study|Unable to classify|1|||
144630427|NCT00944034|521502240|FG007|Overall Study|Unable to classify|1|||
144630428|NCT00944034|521502241|FG008|Overall Study|Unable to classify|0|||
144209950|NCT02551666|519962079|FG000|Overall Study|Withdrawal by Subject|1|||
144630429|NCT00944034|521502242|FG009|Overall Study|Unable to classify|0|||
144630430|NCT00944034|521502243|FG010|Overall Study|Unable to classify|0|||
144630431|NCT00944034|521502244|FG011|Overall Study|Unable to classify|0|||
144630432|NCT00944034|521502233|FG000|Overall Study|Administrative reason|0|||
144630433|NCT00944034|521502234|FG001|Overall Study|Administrative reason|0|||
144630434|NCT00944034|521502235|FG002|Overall Study|Administrative reason|0|||
144630435|NCT00944034|521502236|FG003|Overall Study|Administrative reason|0|||
144630436|NCT00944034|521502237|FG004|Overall Study|Administrative reason|0|||
144630437|NCT00944034|521502238|FG005|Overall Study|Administrative reason|0|||
144630438|NCT00944034|521502239|FG006|Overall Study|Administrative reason|1|||
144630439|NCT00944034|521502240|FG007|Overall Study|Administrative reason|0|||
144630440|NCT00944034|521502241|FG008|Overall Study|Administrative reason|0|||
144630441|NCT00944034|521502242|FG009|Overall Study|Administrative reason|0|||
144630442|NCT00944034|521502243|FG010|Overall Study|Administrative reason|0|||
144630443|NCT00944034|521502244|FG011|Overall Study|Administrative reason|0|||
144630444|NCT01596257|521502245|FG000|Overall Study|Inadequate Collection|23|||
144630445|NCT01596257|521502246|FG001|Overall Study|Inadequate Collection|19|||
144630446|NCT00531960|521502248|FG000|Overall Study|Adverse Event|5|||
144630447|NCT00531960|521502249|FG001|Overall Study|Adverse Event|4|||
144630448|NCT00531960|521502248|FG000|Overall Study|Death|3|||
144630449|NCT00531960|521502249|FG001|Overall Study|Death|2|||
144630450|NCT00531960|521502248|FG000|Overall Study|Lack of Efficacy|42|||
144630451|NCT00531960|521502249|FG001|Overall Study|Lack of Efficacy|41|||
144630452|NCT00531960|521502248|FG000|Overall Study|Violation of Selection Criteria|2|||
144630453|NCT00531960|521502249|FG001|Overall Study|Violation of Selection Criteria|0|||
144630454|NCT00531960|521502248|FG000|Overall Study|Refused Treatment|5|||
144630455|NCT00531960|521502249|FG001|Overall Study|Refused Treatment|6|||
144630456|NCT00531960|521502248|FG000|Overall Study|Other|4|||
144630457|NCT00531960|521502249|FG001|Overall Study|Other|10|||
144630458|NCT03157531|521502255|FG000|Overall Study|Death|2|||
144630459|NCT03157531|521502255|FG000|Overall Study|Lost to Follow-up|4|||
144630460|NCT00508391|521502257|FG000|First Treatment|Withdrawal by Subject|6|||
144630461|NCT00508391|521502258|FG001|First Treatment|Withdrawal by Subject|3|||
144630462|NCT00508391|521502257|FG000|Second Treatment|Withdrawal by Subject|2|||
144630463|NCT00508391|521502258|FG001|Second Treatment|Withdrawal by Subject|0|||
144630464|NCT03258814|521502259|FG000|Overall Study|Early Termination|4|||
144630465|NCT03258814|521502260|FG001|Overall Study|Early Termination|3|||
144630466|NCT03258814|521502261|FG002|Overall Study|Early Termination|10|||
144630467|NCT02921425|521502262|FG000|Overall Study|Protocol Violation|9|||
144630468|NCT01445678|521502266|FG000|Overall Study|Adverse Event|12|||
144630469|NCT01445678|521502267|FG001|Overall Study|Adverse Event|8|||
144630470|NCT01445678|521502266|FG000|Overall Study|Lack of Efficacy|0|||
144630471|NCT01445678|521502267|FG001|Overall Study|Lack of Efficacy|2|||
144630472|NCT01445678|521502266|FG000|Overall Study|Lost to Follow-up|8|||
144630473|NCT01445678|521502267|FG001|Overall Study|Lost to Follow-up|5|||
144630474|NCT01445678|521502266|FG000|Overall Study|Protocol Violation|1|||
144630475|NCT01445678|521502267|FG001|Overall Study|Protocol Violation|1|||
144630476|NCT01445678|521502266|FG000|Overall Study|Withdrawal by Subject|9|||
144630477|NCT01445678|521502267|FG001|Overall Study|Withdrawal by Subject|5|||
144630478|NCT01570244|521503866|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
144630479|NCT01879410|521503881|FG000|Overall Study|Adverse Event|9|||
144630480|NCT01879410|521503882|FG001|Overall Study|Adverse Event|14|||
144630481|NCT01879410|521503881|FG000|Overall Study|Lack of Efficacy|4|||
144630482|NCT01879410|521503882|FG001|Overall Study|Lack of Efficacy|6|||
144630483|NCT01879410|521503881|FG000|Overall Study|Protocol Violation|1|||
144630484|NCT01879410|521503882|FG001|Overall Study|Protocol Violation|7|||
144630485|NCT01879410|521503881|FG000|Overall Study|Lost to Follow-up|2|||
144630486|NCT01879410|521503882|FG001|Overall Study|Lost to Follow-up|1|||
144630487|NCT01879410|521503881|FG000|Overall Study|Withdrawal by Subject|7|||
144630488|NCT01879410|521503882|FG001|Overall Study|Withdrawal by Subject|8|||
144630489|NCT01879410|521503881|FG000|Overall Study|Randomised in Error|1|||
144630490|NCT01879410|521503882|FG001|Overall Study|Randomised in Error|2|||
144630491|NCT00713219|521503890|FG000|Overall Study|Death|1|||
144630492|NCT00713219|521503890|FG000|Overall Study|Protocol Violation|1|||
144630493|NCT04897867|521503891|FG000|Overall Study|Withdrawal of Consent|1|||
144630494|NCT04897867|521503891|FG000|Overall Study|Pregnancy|1|||
144630495|NCT04897867|521503891|FG000|Overall Study|Lost to Follow-up|7|||
144630496|NCT04897867|521503891|FG000|Overall Study|Reason not Specified|2|||
144630497|NCT03183128|521503895|FG000|Overall Study|Adverse Event|1|||
144630498|NCT03183128|521503896|FG001|Overall Study|Adverse Event|2|||
144630499|NCT03183128|521503895|FG000|Overall Study|Withdrawal by Subject|1|||
144630500|NCT03183128|521503896|FG001|Overall Study|Withdrawal by Subject|8|||
144630501|NCT03183128|521503895|FG000|Overall Study|Protocol Violation|2|||
144630502|NCT03183128|521503896|FG001|Overall Study|Protocol Violation|0|||
144630503|NCT03183128|521503895|FG000|Overall Study|Lack of Efficacy|4|||
144630504|NCT03183128|521503896|FG001|Overall Study|Lack of Efficacy|27|||
144630505|NCT03183128|521503895|FG000|Overall Study|Lost to Follow-up|1|||
144630506|NCT03183128|521503896|FG001|Overall Study|Lost to Follow-up|0|||
144630507|NCT03183128|521503895|FG000|Overall Study|Death|2|||
144630508|NCT03183128|521503896|FG001|Overall Study|Death|0|||
144630509|NCT03183128|521503895|FG000|Overall Study|Physician Decision|1|||
144630510|NCT03183128|521503896|FG001|Overall Study|Physician Decision|0|||
144630511|NCT01686568|521503899|FG000|Main Study|Withdrawal by Subject|1|||
144630512|NCT01686568|521503900|FG001|Main Study|Withdrawal by Subject|3|||
144630513|NCT01686568|521503899|FG000|Main Study|Noncompliance with protocol|0|||
144630514|NCT01686568|521503900|FG001|Main Study|Noncompliance with protocol|1|||
144630515|NCT01686568|521503899|FG000|Main Study|Liver enzymes above range of exclusion|1|||
144630516|NCT01686568|521503900|FG001|Main Study|Liver enzymes above range of exclusion|0|||
144630517|NCT01686568|521503899|FG000|Sub-Study|Not consented for sub-study|2|||
144630518|NCT01686568|521503900|FG001|Sub-Study|Not consented for sub-study|2|||
144630519|NCT02978222|521503901|FG000|Overall Study|Withdrawal by Subject|2|||
144630520|NCT02978222|521503902|FG001|Overall Study|Withdrawal by Subject|2|||
144630521|NCT02978222|521503901|FG000|Overall Study|Physician Decision|2|||
144630522|NCT02978222|521503902|FG001|Overall Study|Physician Decision|0|||
144630523|NCT02978222|521503901|FG000|Overall Study|Adverse Event|0|||
144630524|NCT02978222|521503902|FG001|Overall Study|Adverse Event|1|||
144630525|NCT02978222|521503901|FG000|Overall Study|Death|1|||
144630526|NCT02978222|521503902|FG001|Overall Study|Death|0|||
144630527|NCT02978222|521503901|FG000|Overall Study|Disease Progression|32|||
144630528|NCT02978222|521503902|FG001|Overall Study|Disease Progression|32|||
144630529|NCT02978222|521503901|FG000|Overall Study|Early Study Termination|24|||
144630530|NCT02978222|521503902|FG001|Overall Study|Early Study Termination|21|||
144630531|NCT01413958|521503903|FG000|Overall Study|Lost to Follow-up|0|||
144630532|NCT01413958|521503904|FG001|Overall Study|Lost to Follow-up|1|||
144630533|NCT01900002|521503905|FG000|Overall Study|Withdrawal by Subject|2|||
144630534|NCT01900002|521503905|FG000|Overall Study|ineligible for Y-90|4|||
144630535|NCT01573910|521503912|FG000|Overall Study|Adverse Event|4|||
144630536|NCT01573910|521503913|FG001|Overall Study|Adverse Event|4|||
144630537|NCT01573910|521503912|FG000|Overall Study|Lost to Follow-up|2|||
144630538|NCT01573910|521503913|FG001|Overall Study|Lost to Follow-up|1|||
144630539|NCT01573910|521503912|FG000|Overall Study|Withdrawal by Subject|0|||
144630540|NCT01573910|521503913|FG001|Overall Study|Withdrawal by Subject|1|||
144630541|NCT01573910|521503912|FG000|Overall Study|Protocol Violation|3|||
144630542|NCT01573910|521503913|FG001|Overall Study|Protocol Violation|0|||
144630543|NCT01573910|521503912|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
144630544|NCT01573910|521503913|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
144630545|NCT00364182|521503914|FG000|First Intervention|Secondary prophylaxis|1|||
144630546|NCT00364182|521503915|FG001|First Intervention|Secondary prophylaxis|0|||
144630547|NCT00364182|521503916|FG002|First Intervention|Secondary prophylaxis|0|||
144630548|NCT00364182|521503914|FG000|First Intervention|Withdrawal by Subject|2|||
144630549|NCT00364182|521503915|FG001|First Intervention|Withdrawal by Subject|0|||
144630550|NCT00364182|521503916|FG002|First Intervention|Withdrawal by Subject|0|||
144630551|NCT00364182|521503914|FG000|Second Intervention|non-compliance|0|||
144630552|NCT00364182|521503915|FG001|Second Intervention|non-compliance|1|||
144630553|NCT00364182|521503916|FG002|Second Intervention|non-compliance|1|||
144630554|NCT00364182|521503914|FG000|Second Intervention|Protocol Violation|0|||
144630555|NCT00364182|521503915|FG001|Second Intervention|Protocol Violation|1|||
144630556|NCT00364182|521503916|FG002|Second Intervention|Protocol Violation|0|||
144630557|NCT00364182|521503914|FG000|Second Intervention|Adverse Event|0|||
144630558|NCT00364182|521503915|FG001|Second Intervention|Adverse Event|0|||
144630559|NCT00364182|521503916|FG002|Second Intervention|Adverse Event|1|||
144630560|NCT00364182|521503914|FG000|Third Intervention|non-compliance|0|||
144630561|NCT00364182|521503915|FG001|Third Intervention|non-compliance|1|||
144630562|NCT00364182|521503916|FG002|Third Intervention|non-compliance|0|||
144630563|NCT00364182|521503914|FG000|Third Intervention|Lost to Follow-up|0|||
144630564|NCT00364182|521503915|FG001|Third Intervention|Lost to Follow-up|0|||
144630565|NCT00364182|521503916|FG002|Third Intervention|Lost to Follow-up|1|||
144630566|NCT02928952|521503920|FG000|Overall Study|Lost to Follow-up|5|||
144630567|NCT02928952|521503921|FG001|Overall Study|Lost to Follow-up|5|||
144630568|NCT02928952|521503920|FG000|Overall Study|Withdrawal by Subject|5|||
144630569|NCT02928952|521503921|FG001|Overall Study|Withdrawal by Subject|1|||
144630570|NCT02928952|521503920|FG000|Overall Study|Physician Decision|0|||
144630571|NCT02928952|521503921|FG001|Overall Study|Physician Decision|1|||
144630572|NCT00974220|521503922|FG000|Treatment Period 1|Adverse Event|2|||
144630573|NCT00974220|521503923|FG001|Treatment Period 1|Adverse Event|1|||
144630574|NCT00974220|521503922|FG000|Treatment Period 1|noncompliant subjects|0|||
144630575|NCT00974220|521503923|FG001|Treatment Period 1|noncompliant subjects|1|||
144630576|NCT01850615|521503924|FG000|Overall Study|Protocol Violation|4|||
144630577|NCT01850615|521503925|FG001|Overall Study|Protocol Violation|1|||
144630578|NCT01850615|521503924|FG000|Overall Study|Adverse Event|2|||
144630579|NCT01850615|521503925|FG001|Overall Study|Adverse Event|1|||
144630580|NCT01850615|521503924|FG000|Overall Study|Withdrawal by Subject|3|||
144630581|NCT01850615|521503925|FG001|Overall Study|Withdrawal by Subject|1|||
144630582|NCT01850615|521503924|FG000|Overall Study|Lost to Follow-up|0|||
144630583|NCT01850615|521503925|FG001|Overall Study|Lost to Follow-up|1|||
144630584|NCT01850615|521503924|FG000|Overall Study|Unclassified|0|||
144630585|NCT01850615|521503925|FG001|Overall Study|Unclassified|1|||
144630586|NCT01227967|521503926|FG000|Overall Study|Protocol Violation|3|||
144630587|NCT01227967|521503927|FG001|Overall Study|Protocol Violation|1|||
144209951|NCT02551666|519962080|FG001|Overall Study|Withdrawal by Subject|3|||
144630588|NCT01227967|521503926|FG000|Overall Study|Death|0|||
144630589|NCT01227967|521503927|FG001|Overall Study|Death|1|||
144630590|NCT01227967|521503926|FG000|Overall Study|Lost to Follow-up|8|||
144630591|NCT01227967|521503927|FG001|Overall Study|Lost to Follow-up|3|||
144630592|NCT01227967|521503926|FG000|Overall Study|Withdrawal by Subject|4|||
144630593|NCT01227967|521503927|FG001|Overall Study|Withdrawal by Subject|3|||
144630594|NCT01227967|521503926|FG000|Overall Study|Physician Decision|0|||
144630595|NCT01227967|521503927|FG001|Overall Study|Physician Decision|1|||
144630596|NCT01227967|521503926|FG000|Overall Study|Never Started Treatment|0|||
144630597|NCT01227967|521503927|FG001|Overall Study|Never Started Treatment|4|||
144630598|NCT01227967|521503926|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
144630599|NCT01227967|521503927|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
144630600|NCT03403400|521503928|FG000|Overall Study|Lost to Follow-up|1|||
144630601|NCT03403400|521503929|FG001|Overall Study|Lost to Follow-up|0|||
144630602|NCT03403400|521503930|FG002|Overall Study|Lost to Follow-up|1|||
144630603|NCT03403400|521503928|FG000|Overall Study|Hospitalization|1|||
144630604|NCT03403400|521503929|FG001|Overall Study|Hospitalization|0|||
144630605|NCT03403400|521503930|FG002|Overall Study|Hospitalization|0|||
144630606|NCT03403400|521503928|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
144630607|NCT03403400|521503929|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
144630608|NCT03403400|521503930|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
144630609|NCT00565617|521503934|FG000|Overall Study|Withdrawal by Subject|1|||
144630610|NCT01273064|521503935|FG000|Overall Study|Adverse Event|5|||
144630611|NCT01273064|521503936|FG001|Overall Study|Adverse Event|1|||
144630612|NCT01273064|521503937|FG002|Overall Study|Adverse Event|3|||
144630613|NCT01273064|521503938|FG003|Overall Study|Adverse Event|2|||
144630614|NCT01273064|521503939|FG004|Overall Study|Adverse Event|1|||
144630615|NCT01273064|521503935|FG000|Overall Study|Withdrawal by Subject|4|||
144630616|NCT01273064|521503936|FG001|Overall Study|Withdrawal by Subject|2|||
144630617|NCT01273064|521503937|FG002|Overall Study|Withdrawal by Subject|2|||
144630618|NCT01273064|521503938|FG003|Overall Study|Withdrawal by Subject|2|||
144630619|NCT01273064|521503939|FG004|Overall Study|Withdrawal by Subject|0|||
144630620|NCT01273064|521503935|FG000|Overall Study|Study Termination|13|||
144630621|NCT01273064|521503936|FG001|Overall Study|Study Termination|27|||
144630622|NCT01273064|521503937|FG002|Overall Study|Study Termination|26|||
144630623|NCT01273064|521503938|FG003|Overall Study|Study Termination|16|||
144630624|NCT01273064|521503939|FG004|Overall Study|Study Termination|8|||
144630625|NCT01273064|521503935|FG000|Overall Study|Lost to Follow-up|1|||
144630626|NCT01273064|521503936|FG001|Overall Study|Lost to Follow-up|0|||
144630627|NCT01273064|521503937|FG002|Overall Study|Lost to Follow-up|0|||
144630628|NCT01273064|521503938|FG003|Overall Study|Lost to Follow-up|0|||
144630629|NCT01273064|521503939|FG004|Overall Study|Lost to Follow-up|0|||
144630630|NCT01273064|521503935|FG000|Overall Study|Physician Decision|0|||
144630631|NCT01273064|521503936|FG001|Overall Study|Physician Decision|0|||
144630632|NCT01273064|521503937|FG002|Overall Study|Physician Decision|0|||
144630633|NCT01273064|521503938|FG003|Overall Study|Physician Decision|0|||
144630634|NCT01273064|521503939|FG004|Overall Study|Physician Decision|1|||
144630635|NCT02867761|521503942|FG000|Overall Study|Participant withdrawn by investigator|0|||
144630636|NCT02867761|521503943|FG001|Overall Study|Participant withdrawn by investigator|1|||
144630637|NCT02867761|521503942|FG000|Overall Study|Lost to Follow-up|25|||
144630638|NCT02867761|521503943|FG001|Overall Study|Lost to Follow-up|18|||
144630639|NCT02867761|521503942|FG000|Overall Study|Unable to complete protocol|3|||
144630640|NCT02867761|521503943|FG001|Overall Study|Unable to complete protocol|7|||
144630641|NCT01512264|521503944|FG000|Overall Study|Lost to Follow-up|0|||
144630642|NCT01512264|521503945|FG001|Overall Study|Lost to Follow-up|0|||
144630643|NCT01512264|521503946|FG002|Overall Study|Lost to Follow-up|0|||
144630644|NCT01512264|521503947|FG003|Overall Study|Lost to Follow-up|1|||
144630645|NCT01931059|521503948|FG000|Day 1|Pregnancy|0|||
144630646|NCT01931059|521503949|FG001|Day 1|Pregnancy|1|||
144630647|NCT01931059|521503948|FG000|Day3|Lost to Follow-up|1|||
144630648|NCT01931059|521503949|FG001|Day3|Lost to Follow-up|0|||
144630649|NCT03158220|521503950|FG000|Overall Study|Screen Failure|0|||
144630650|NCT03158220|521503951|FG001|Overall Study|Screen Failure|1|||
144630651|NCT03158220|521503950|FG000|Overall Study|Withdrawal by Subject|8|||
144630652|NCT03158220|521503951|FG001|Overall Study|Withdrawal by Subject|9|||
144630653|NCT03158220|521503950|FG000|Overall Study|Status unknown|0|||
144630654|NCT03158220|521503951|FG001|Overall Study|Status unknown|1|||
144630655|NCT03158220|521503950|FG000|Overall Study|Lost to Follow-up|8|||
144630656|NCT03158220|521503951|FG001|Overall Study|Lost to Follow-up|5|||
144630657|NCT03158220|521503950|FG000|Overall Study|Physician Decision|1|||
144630658|NCT03158220|521503951|FG001|Overall Study|Physician Decision|0|||
144630659|NCT00848120|521503954|FG000|Overall Study|Adverse Event|1|||
144630660|NCT00560755|521503955|FG000|Overall Study|Protocol Violation|15|||
144630661|NCT00560755|521503955|FG000|Overall Study|Withdrawal by Subject|26|||
144630662|NCT00560755|521503955|FG000|Overall Study|Lost to Follow-up|9|||
144630663|NCT00560755|521503955|FG000|Overall Study|Adverse Event|8|||
144630664|NCT00560755|521503955|FG000|Overall Study|Physician Decision|2|||
144630665|NCT01961115|521503965|FG000|Overall Study|Disease Progression|1|||
144630666|NCT01961115|521503966|FG001|Overall Study|Disease Progression|0|||
144630667|NCT01961115|521503967|FG002|Overall Study|Disease Progression|3|||
144730726|NCT04206332|521869870|FG010|Part C|Withdrawal by Subject|0|||
144730727|NCT04206332|521869871|FG011|Part C|Withdrawal by Subject|0|||
144730728|NCT04206332|521869872|FG012|Part C|Withdrawal by Subject|0|||
144630668|NCT01961115|521503965|FG000|Overall Study|Adverse Event|1|||
144630669|NCT01961115|521503966|FG001|Overall Study|Adverse Event|0|||
144630670|NCT01961115|521503967|FG002|Overall Study|Adverse Event|1|||
144630671|NCT01439945|521503980|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
144630672|NCT01439945|521503981|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
144630673|NCT01439945|521503982|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
144630674|NCT01439945|521503983|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
144630675|NCT01439945|521503980|FG000|Double-Blind Treatment Phase|Ineligible|1|||
144730729|NCT04206332|521869873|FG013|Part C|Withdrawal by Subject|0|||
144630676|NCT01439945|521503981|FG001|Double-Blind Treatment Phase|Ineligible|2|||
144630677|NCT01439945|521503982|FG002|Double-Blind Treatment Phase|Ineligible|0|||
144630678|NCT01439945|521503983|FG003|Double-Blind Treatment Phase|Ineligible|1|||
144630679|NCT04082663|521503984|FG000|Overall Study|Adverse Event|6|||
144630680|NCT04082663|521503984|FG000|Overall Study|Lost to Follow-up|1|||
144630681|NCT00705263|521503987|FG000|Overall Study|Withdrawal by Subject|2|||
144630682|NCT05501119|521503988|FG000|Overall Study|Withdrawal by Subject|2|||
144630683|NCT05501119|521503988|FG000|Overall Study|Lost to Follow-up|5|||
144630684|NCT01752023|521503989|FG000|Overall Study|Physician Decision|2|||
144630685|NCT01752023|521503990|FG001|Overall Study|Physician Decision|1|||
144630686|NCT02959814|521503992|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
144630687|NCT02959814|521503992|FG000|Overall Study|Excluded based on anatomical criteria|2|||
144630688|NCT02959814|521503992|FG000|Overall Study|Protocol Violation|7|||
144630689|NCT02959814|521503992|FG000|Overall Study|FFR not measured|2|||
144630690|NCT02959814|521503992|FG000|Overall Study|In-procedure QFR not computed|6|||
144630691|NCT02959814|521503992|FG000|Overall Study|Excluded by FFR core-lab|24|||
144630692|NCT01078805|521504002|FG000|Overall Study|Clinically significant abnormal lab|5|||
144630693|NCT01078805|521504002|FG000|Overall Study|Death|134|||
144630694|NCT01078805|521504002|FG000|Overall Study|Lost to Follow-up|676|||
144630695|NCT01078805|521504002|FG000|Overall Study|Physician Decision|169|||
144630696|NCT01078805|521504002|FG000|Overall Study|Serious adverse event|26|||
144630697|NCT01078805|521504002|FG000|Overall Study|Sponsor decision|46|||
144630698|NCT01078805|521504002|FG000|Overall Study|Withdrawal by Subject|739|||
144630699|NCT01078805|521504002|FG000|Overall Study|Other|173|||
144630700|NCT01078805|521504002|FG000|Overall Study|Didn't take study drug|82|||
144630701|NCT02246621|521504010|FG000|Overall Study|Withdrawal by Subject|28|||
144630702|NCT02246621|521504011|FG001|Overall Study|Withdrawal by Subject|16|||
144630703|NCT02246621|521504010|FG000|Overall Study|Lost to Follow-up|1|||
144630704|NCT02246621|521504011|FG001|Overall Study|Lost to Follow-up|0|||
144630705|NCT02246621|521504010|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
144630706|NCT02246621|521504011|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
144630707|NCT01292057|521504012|FG000|Overall Study|Protocol Violation|1|||
144630708|NCT01292057|521504013|FG001|Overall Study|Protocol Violation|1|||
144630709|NCT01292057|521504012|FG000|Overall Study|Lost to Follow-up|1|||
144630710|NCT01292057|521504013|FG001|Overall Study|Lost to Follow-up|1|||
144630711|NCT01459614|521504014|FG000|Overall Study|Adverse Event|1|||
144630712|NCT01459614|521504015|FG001|Overall Study|Adverse Event|0|||
144630713|NCT02078219|521504025|FG000|Overall Study|Other|2|||
144630714|NCT02078219|521504026|FG001|Overall Study|Other|2|||
144630715|NCT02078219|521504027|FG002|Overall Study|Other|3|||
144630716|NCT02078219|521504028|FG003|Overall Study|Other|0|||
144630717|NCT02078219|521504029|FG004|Overall Study|Other|1|||
144630718|NCT02078219|521504025|FG000|Overall Study|Withdrawal by Subject|0|||
144630719|NCT02078219|521504026|FG001|Overall Study|Withdrawal by Subject|1|||
144630720|NCT02078219|521504027|FG002|Overall Study|Withdrawal by Subject|0|||
144630721|NCT02078219|521504028|FG003|Overall Study|Withdrawal by Subject|1|||
144630722|NCT02078219|521504029|FG004|Overall Study|Withdrawal by Subject|1|||
144630723|NCT02078219|521504025|FG000|Overall Study|Protocol Violation|0|||
144630724|NCT02078219|521504026|FG001|Overall Study|Protocol Violation|0|||
144630725|NCT02078219|521504027|FG002|Overall Study|Protocol Violation|0|||
144630726|NCT02078219|521504028|FG003|Overall Study|Protocol Violation|1|||
144630727|NCT02078219|521504029|FG004|Overall Study|Protocol Violation|0|||
144630728|NCT02078219|521504025|FG000|Overall Study|Death|0|||
144630729|NCT02078219|521504026|FG001|Overall Study|Death|0|||
144630730|NCT02078219|521504027|FG002|Overall Study|Death|0|||
144630731|NCT02078219|521504028|FG003|Overall Study|Death|1|||
144630732|NCT02078219|521504029|FG004|Overall Study|Death|0|||
144630733|NCT02078219|521504025|FG000|Overall Study|Adverse Event|1|||
144630734|NCT02078219|521504026|FG001|Overall Study|Adverse Event|1|||
144630735|NCT02078219|521504027|FG002|Overall Study|Adverse Event|3|||
144630736|NCT02078219|521504028|FG003|Overall Study|Adverse Event|1|||
144630737|NCT02078219|521504029|FG004|Overall Study|Adverse Event|0|||
144630738|NCT03283085|521504030|FG000|Overall Study|Adverse Event|18|||
144630739|NCT03283085|521504031|FG001|Overall Study|Adverse Event|3|||
144630740|NCT03283085|521504032|FG002|Overall Study|Adverse Event|13|||
144630741|NCT03283085|521504033|FG003|Overall Study|Adverse Event|0|||
144630742|NCT03283085|521504034|FG004|Overall Study|Adverse Event|0|||
144630743|NCT03283085|521504035|FG005|Overall Study|Adverse Event|5|||
144630744|NCT03283085|521504030|FG000|Overall Study|Death|0|||
144630745|NCT03283085|521504031|FG001|Overall Study|Death|0|||
144630746|NCT03283085|521504032|FG002|Overall Study|Death|3|||
144630747|NCT03283085|521504033|FG003|Overall Study|Death|1|||
144630748|NCT03283085|521504034|FG004|Overall Study|Death|0|||
144630749|NCT03283085|521504035|FG005|Overall Study|Death|0|||
144630750|NCT03283085|521504030|FG000|Overall Study|Withdrawal by Subject|42|||
144630751|NCT03283085|521504031|FG001|Overall Study|Withdrawal by Subject|21|||
144630752|NCT03283085|521504032|FG002|Overall Study|Withdrawal by Subject|66|||
144630753|NCT03283085|521504033|FG003|Overall Study|Withdrawal by Subject|3|||
144630754|NCT03283085|521504034|FG004|Overall Study|Withdrawal by Subject|3|||
144630755|NCT03283085|521504035|FG005|Overall Study|Withdrawal by Subject|5|||
144630756|NCT03283085|521504030|FG000|Overall Study|Physician Decision|14|||
144630757|NCT03283085|521504031|FG001|Overall Study|Physician Decision|8|||
144630758|NCT03283085|521504032|FG002|Overall Study|Physician Decision|19|||
144630759|NCT03283085|521504033|FG003|Overall Study|Physician Decision|0|||
144630760|NCT03283085|521504034|FG004|Overall Study|Physician Decision|0|||
144630761|NCT03283085|521504035|FG005|Overall Study|Physician Decision|2|||
144630762|NCT03283085|521504030|FG000|Overall Study|Site Terminated by Sponsor|1|||
144630763|NCT03283085|521504031|FG001|Overall Study|Site Terminated by Sponsor|0|||
144630764|NCT03283085|521504032|FG002|Overall Study|Site Terminated by Sponsor|3|||
144630765|NCT03283085|521504033|FG003|Overall Study|Site Terminated by Sponsor|0|||
144630766|NCT03283085|521504034|FG004|Overall Study|Site Terminated by Sponsor|0|||
144630767|NCT03283085|521504035|FG005|Overall Study|Site Terminated by Sponsor|0|||
144630768|NCT03283085|521504030|FG000|Overall Study|Lost to Follow-up|2|||
144630769|NCT03283085|521504031|FG001|Overall Study|Lost to Follow-up|0|||
144630770|NCT03283085|521504032|FG002|Overall Study|Lost to Follow-up|2|||
144630771|NCT03283085|521504033|FG003|Overall Study|Lost to Follow-up|0|||
144630772|NCT03283085|521504034|FG004|Overall Study|Lost to Follow-up|0|||
144630773|NCT03283085|521504035|FG005|Overall Study|Lost to Follow-up|1|||
144630774|NCT03283085|521504030|FG000|Overall Study|Pregnancy|0|||
144630775|NCT03283085|521504031|FG001|Overall Study|Pregnancy|0|||
144630776|NCT03283085|521504032|FG002|Overall Study|Pregnancy|1|||
144630777|NCT03283085|521504033|FG003|Overall Study|Pregnancy|0|||
144630778|NCT03283085|521504034|FG004|Overall Study|Pregnancy|0|||
144630779|NCT03283085|521504035|FG005|Overall Study|Pregnancy|0|||
144630780|NCT03283085|521504030|FG000|Overall Study|Lack of Efficacy|12|||
144630781|NCT03283085|521504031|FG001|Overall Study|Lack of Efficacy|6|||
144630782|NCT03283085|521504032|FG002|Overall Study|Lack of Efficacy|24|||
144630783|NCT03283085|521504033|FG003|Overall Study|Lack of Efficacy|1|||
144630784|NCT03283085|521504034|FG004|Overall Study|Lack of Efficacy|1|||
144630785|NCT03283085|521504035|FG005|Overall Study|Lack of Efficacy|0|||
144630786|NCT03283085|521504030|FG000|Overall Study|Reason not Specified|0|||
144630787|NCT03283085|521504031|FG001|Overall Study|Reason not Specified|4|||
144630788|NCT03283085|521504032|FG002|Overall Study|Reason not Specified|8|||
144630789|NCT03283085|521504033|FG003|Overall Study|Reason not Specified|0|||
144630790|NCT03283085|521504034|FG004|Overall Study|Reason not Specified|0|||
144630791|NCT03283085|521504035|FG005|Overall Study|Reason not Specified|1|||
144630792|NCT03136107|521504036|FG000|Overall Study|Other (Not specified)|1|||
144630793|NCT04025632|521505852|FG000|Overall Study|Adverse Event|1|||
144630794|NCT04025632|521505853|FG001|Overall Study|Adverse Event|1|||
144630795|NCT04025632|521505852|FG000|Overall Study|Withdrawal by Subject|1|||
144630796|NCT04025632|521505853|FG001|Overall Study|Withdrawal by Subject|1|||
144630797|NCT04025632|521505852|FG000|Overall Study|Study Terminated by Sponsor|10|||
144630798|NCT04025632|521505853|FG001|Overall Study|Study Terminated by Sponsor|9|||
144630799|NCT04025632|521505852|FG000|Overall Study|Physician Decision|3|||
144630800|NCT04025632|521505853|FG001|Overall Study|Physician Decision|1|||
144630801|NCT00376961|521505854|FG000|Initial Registration|Adverse Event|1|||
144630802|NCT00376961|521505855|FG001|Initial Registration|Adverse Event|0|||
144630803|NCT00376961|521505854|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
144630804|NCT00376961|521505855|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
144630805|NCT00376961|521505854|FG000|Initial Registration|Progression/relapse|1|||
144630806|NCT00376961|521505855|FG001|Initial Registration|Progression/relapse|0|||
144630807|NCT00376961|521505854|FG000|Initial Registration|Ineligible|3|||
144630808|NCT00376961|521505855|FG001|Initial Registration|Ineligible|0|||
144630809|NCT00376961|521505854|FG000|Maintenance|Adverse Event|0|||
144630810|NCT00376961|521505855|FG001|Maintenance|Adverse Event|1|||
144630811|NCT00376961|521505854|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
144630812|NCT00376961|521505855|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
144630813|NCT00376961|521505854|FG000|Maintenance|Progression/relapse|0|||
144630814|NCT00376961|521505855|FG001|Maintenance|Progression/relapse|18|||
144630815|NCT00376961|521505854|FG000|Maintenance|Ineligible|0|||
144630816|NCT00376961|521505855|FG001|Maintenance|Ineligible|3|||
144630817|NCT01974817|521505857|FG000|Overall Study|Death|4|||
144630818|NCT01974817|521505857|FG000|Overall Study|Lost to Follow-up|2|||
144630819|NCT01974817|521505857|FG000|Overall Study|Protocol Violation|2|||
144630820|NCT04047797|521505858|FG000|Overall Study|Progressive Disease|1|||
144630821|NCT01793792|521505861|FG000|Overall Study|Death|5|||
144630822|NCT01793792|521505861|FG000|Overall Study|Lost to Follow-up|5|||
144630823|NCT01793792|521505861|FG000|Overall Study|Withdrawal by Subject|1|||
144630824|NCT01793792|521505861|FG000|Overall Study|Device Not Implanted|1|||
144630825|NCT00947531|521505862|FG000|Overall Study|Withdrawal by Subject|10|||
144630826|NCT00947531|521505863|FG001|Overall Study|Withdrawal by Subject|7|||
144630827|NCT00947531|521505862|FG000|Overall Study|Administrative Reason|0|||
144630828|NCT00947531|521505863|FG001|Overall Study|Administrative Reason|1|||
144730730|NCT04206332|521869874|FG014|Part C|Withdrawal by Subject|2|||
144730731|NCT04206332|521869875|FG015|Part C|Withdrawal by Subject|0|||
144630829|NCT00947531|521505862|FG000|Overall Study|Adverse Event|2|||
144630830|NCT00947531|521505863|FG001|Overall Study|Adverse Event|2|||
144630831|NCT00947531|521505862|FG000|Overall Study|Lack of Efficacy|1|||
144630832|NCT00947531|521505863|FG001|Overall Study|Lack of Efficacy|0|||
144630833|NCT00947531|521505862|FG000|Overall Study|Other|1|||
144630834|NCT00947531|521505863|FG001|Overall Study|Other|1|||
144630835|NCT02162862|521505868|FG000|Overall Study|Lost to Follow-up|0|||
144630836|NCT02162862|521505869|FG001|Overall Study|Lost to Follow-up|11|||
144630837|NCT02162862|521505870|FG002|Overall Study|Lost to Follow-up|0|||
144630838|NCT02162862|521505868|FG000|Overall Study|Subject did not feel the med was needed|0|||
144630839|NCT02162862|521505869|FG001|Overall Study|Subject did not feel the med was needed|0|||
144630840|NCT02162862|521505870|FG002|Overall Study|Subject did not feel the med was needed|4|||
144630841|NCT00988247|521505871|FG000|Overall Study|Adverse Event|17|||
144630842|NCT00988247|521505872|FG001|Overall Study|Adverse Event|3|||
144630843|NCT00988247|521505871|FG000|Overall Study|Withdrawal by Subject|44|||
144630844|NCT00988247|521505872|FG001|Overall Study|Withdrawal by Subject|13|||
144630845|NCT00988247|521505871|FG000|Overall Study|Pregnancy|1|||
144630846|NCT00988247|521505872|FG001|Overall Study|Pregnancy|2|||
144630847|NCT00988247|521505871|FG000|Overall Study|Lost to Follow-up|11|||
144630848|NCT00988247|521505872|FG001|Overall Study|Lost to Follow-up|2|||
144630849|NCT00988247|521505871|FG000|Overall Study|Protocol Violation|4|||
144630850|NCT00988247|521505872|FG001|Overall Study|Protocol Violation|5|||
144630851|NCT00988247|521505871|FG000|Overall Study|Sponsor requested withdrawal|3|||
144630852|NCT00988247|521505872|FG001|Overall Study|Sponsor requested withdrawal|1|||
144630853|NCT00988247|521505871|FG000|Overall Study|Other|3|||
144630854|NCT00988247|521505872|FG001|Overall Study|Other|0|||
144630855|NCT03822884|521505873|FG000|Overall Study|Withdrawal by Subject|0|||
144630856|NCT03822884|521505874|FG001|Overall Study|Withdrawal by Subject|0|||
144630857|NCT03822884|521505875|FG002|Overall Study|Withdrawal by Subject|0|||
144630858|NCT03822884|521505876|FG003|Overall Study|Withdrawal by Subject|0|||
144630859|NCT03822884|521505877|FG004|Overall Study|Withdrawal by Subject|1|||
144630860|NCT03822884|521505878|FG005|Overall Study|Withdrawal by Subject|0|||
144630861|NCT03617705|521505883|FG000|Overall Study|Withdrawal by Subject|2|||
144630862|NCT03617705|521505883|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
144630863|NCT03617705|521505883|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
144630864|NCT00214461|521505884|FG000|Overall Study|Adverse Event|0|||
144630865|NCT00214461|521505885|FG001|Overall Study|Adverse Event|0|||
144630866|NCT00214461|521505886|FG002|Overall Study|Adverse Event|1|||
144630867|NCT00214461|521505887|FG003|Overall Study|Adverse Event|1|||
144630868|NCT00214461|521505884|FG000|Overall Study|Withdrawal by Subject|0|||
144630869|NCT00214461|521505885|FG001|Overall Study|Withdrawal by Subject|0|||
144630870|NCT00214461|521505886|FG002|Overall Study|Withdrawal by Subject|1|||
144630871|NCT00214461|521505887|FG003|Overall Study|Withdrawal by Subject|0|||
144630872|NCT02913313|521505888|FG000|Overall Study|DISEASE PROGRESSION|1|||
144630873|NCT02913313|521505889|FG001|Overall Study|DISEASE PROGRESSION|2|||
144630874|NCT02913313|521505890|FG002|Overall Study|DISEASE PROGRESSION|2|||
144630875|NCT02913313|521505891|FG003|Overall Study|DISEASE PROGRESSION|4|||
144630876|NCT02913313|521505892|FG004|Overall Study|DISEASE PROGRESSION|6|||
144630877|NCT02913313|521505893|FG005|Overall Study|DISEASE PROGRESSION|4|||
144630878|NCT02913313|521505894|FG006|Overall Study|DISEASE PROGRESSION|19|||
144630879|NCT02913313|521505895|FG007|Overall Study|DISEASE PROGRESSION|3|||
144630880|NCT02913313|521505896|FG008|Overall Study|DISEASE PROGRESSION|4|||
144630881|NCT02913313|521505897|FG009|Overall Study|DISEASE PROGRESSION|4|||
144630882|NCT02913313|521505898|FG010|Overall Study|DISEASE PROGRESSION|11|||
144630883|NCT02913313|521505899|FG011|Overall Study|DISEASE PROGRESSION|5|||
144630884|NCT02913313|521505900|FG012|Overall Study|DISEASE PROGRESSION|14|||
144630885|NCT02913313|521505901|FG013|Overall Study|DISEASE PROGRESSION|3|||
144630886|NCT02913313|521505888|FG000|Overall Study|Not Reported|0|||
144630887|NCT02913313|521505889|FG001|Overall Study|Not Reported|0|||
144630888|NCT02913313|521505890|FG002|Overall Study|Not Reported|0|||
144630889|NCT02913313|521505891|FG003|Overall Study|Not Reported|0|||
144630890|NCT02913313|521505892|FG004|Overall Study|Not Reported|1|||
144630891|NCT02913313|521505893|FG005|Overall Study|Not Reported|0|||
144630892|NCT02913313|521505894|FG006|Overall Study|Not Reported|0|||
144630893|NCT02913313|521505895|FG007|Overall Study|Not Reported|0|||
144630894|NCT02913313|521505896|FG008|Overall Study|Not Reported|0|||
144630895|NCT02913313|521505897|FG009|Overall Study|Not Reported|0|||
144630896|NCT02913313|521505898|FG010|Overall Study|Not Reported|4|||
144630897|NCT02913313|521505899|FG011|Overall Study|Not Reported|0|||
144630898|NCT02913313|521505900|FG012|Overall Study|Not Reported|0|||
144630899|NCT02913313|521505901|FG013|Overall Study|Not Reported|0|||
144630900|NCT02913313|521505888|FG000|Overall Study|Other reasons|0|||
144630901|NCT02913313|521505889|FG001|Overall Study|Other reasons|0|||
144730732|NCT04206332|521869876|FG016|Part C|Withdrawal by Subject|0|||
144209952|NCT04051619|519962081|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
144209953|NCT04051619|519962082|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
144630902|NCT02913313|521505890|FG002|Overall Study|Other reasons|0|||
144630903|NCT02913313|521505891|FG003|Overall Study|Other reasons|0|||
144630904|NCT02913313|521505892|FG004|Overall Study|Other reasons|1|||
144630905|NCT02913313|521505893|FG005|Overall Study|Other reasons|0|||
144630906|NCT02913313|521505894|FG006|Overall Study|Other reasons|0|||
144630907|NCT02913313|521505895|FG007|Overall Study|Other reasons|0|||
144630908|NCT02913313|521505896|FG008|Overall Study|Other reasons|0|||
144630909|NCT02913313|521505897|FG009|Overall Study|Other reasons|0|||
144630910|NCT02913313|521505898|FG010|Overall Study|Other reasons|1|||
144630911|NCT02913313|521505899|FG011|Overall Study|Other reasons|0|||
144630912|NCT02913313|521505900|FG012|Overall Study|Other reasons|0|||
144630913|NCT02913313|521505901|FG013|Overall Study|Other reasons|0|||
144630914|NCT02913313|521505888|FG000|Overall Study|Withdrawal by Subject|0|||
144630915|NCT02913313|521505889|FG001|Overall Study|Withdrawal by Subject|0|||
144630916|NCT02913313|521505890|FG002|Overall Study|Withdrawal by Subject|1|||
144630917|NCT02913313|521505891|FG003|Overall Study|Withdrawal by Subject|0|||
144630918|NCT02913313|521505892|FG004|Overall Study|Withdrawal by Subject|0|||
144630919|NCT02913313|521505893|FG005|Overall Study|Withdrawal by Subject|0|||
144630920|NCT02913313|521505894|FG006|Overall Study|Withdrawal by Subject|1|||
144630921|NCT02913313|521505895|FG007|Overall Study|Withdrawal by Subject|1|||
144630922|NCT02913313|521505896|FG008|Overall Study|Withdrawal by Subject|0|||
144630923|NCT02913313|521505897|FG009|Overall Study|Withdrawal by Subject|0|||
144630924|NCT02913313|521505898|FG010|Overall Study|Withdrawal by Subject|1|||
144630925|NCT02913313|521505899|FG011|Overall Study|Withdrawal by Subject|0|||
144630926|NCT02913313|521505900|FG012|Overall Study|Withdrawal by Subject|0|||
144630927|NCT02913313|521505901|FG013|Overall Study|Withdrawal by Subject|0|||
144630928|NCT02913313|521505888|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630929|NCT02913313|521505889|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630930|NCT02913313|521505890|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630931|NCT02913313|521505891|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630932|NCT02913313|521505892|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630933|NCT02913313|521505893|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630934|NCT02913313|521505894|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630935|NCT02913313|521505895|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630936|NCT02913313|521505896|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630937|NCT02913313|521505897|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630938|NCT02913313|521505898|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
144630939|NCT02913313|521505899|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
144630940|NCT02913313|521505900|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
144630941|NCT02913313|521505901|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
144630942|NCT02913313|521505888|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
144630943|NCT02913313|521505889|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
144630944|NCT02913313|521505890|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
144630945|NCT02913313|521505891|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
144630946|NCT02913313|521505892|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
144630947|NCT02913313|521505893|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
144630948|NCT02913313|521505894|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
144630949|NCT02913313|521505895|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
144630950|NCT02913313|521505896|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
144630951|NCT02913313|521505897|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
144630952|NCT02913313|521505898|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
144630953|NCT02913313|521505899|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
144630954|NCT02913313|521505900|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
144630955|NCT02913313|521505901|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
144630956|NCT06118385|521505902|FG000|Overall Study|Protocol Violation|0|||
144630957|NCT06118385|521505903|FG001|Overall Study|Protocol Violation|0|||
144630958|NCT06118385|521505904|FG002|Overall Study|Protocol Violation|0|||
144630959|NCT06118385|521505905|FG003|Overall Study|Protocol Violation|0|||
144630960|NCT06118385|521505906|FG004|Overall Study|Protocol Violation|0|||
144630961|NCT06118385|521505907|FG005|Overall Study|Protocol Violation|0|||
144630962|NCT06118385|521505908|FG006|Overall Study|Protocol Violation|0|||
144630963|NCT06118385|521505909|FG007|Overall Study|Protocol Violation|0|||
144630964|NCT06118385|521505910|FG008|Overall Study|Protocol Violation|1|||
144630965|NCT06118385|521505911|FG009|Overall Study|Protocol Violation|0|||
144630966|NCT06118385|521505912|FG010|Overall Study|Protocol Violation|0|||
144630967|NCT06118385|521505913|FG011|Overall Study|Protocol Violation|0|||
144630968|NCT06118385|521505902|FG000|Overall Study|Out-of-range blood tests|0|||
144630969|NCT06118385|521505903|FG001|Overall Study|Out-of-range blood tests|0|||
144630970|NCT06118385|521505904|FG002|Overall Study|Out-of-range blood tests|0|||
144630971|NCT06118385|521505905|FG003|Overall Study|Out-of-range blood tests|0|||
144630972|NCT06118385|521505906|FG004|Overall Study|Out-of-range blood tests|0|||
144630973|NCT06118385|521505907|FG005|Overall Study|Out-of-range blood tests|0|||
144630974|NCT06118385|521505908|FG006|Overall Study|Out-of-range blood tests|0|||
144630975|NCT06118385|521505909|FG007|Overall Study|Out-of-range blood tests|0|||
144630976|NCT06118385|521505910|FG008|Overall Study|Out-of-range blood tests|1|||
144630977|NCT06118385|521505911|FG009|Overall Study|Out-of-range blood tests|0|||
144630978|NCT06118385|521505912|FG010|Overall Study|Out-of-range blood tests|0|||
144630979|NCT06118385|521505913|FG011|Overall Study|Out-of-range blood tests|0|||
144630980|NCT03624946|521505916|FG000|Overall Study|Lost to Follow-up|0|||
144630981|NCT03624946|521505917|FG001|Overall Study|Lost to Follow-up|1|||
144630982|NCT01925209|521505918|FG000|Treatment Epoch|Physician Decision|1|||
144630983|NCT01925209|521505919|FG001|Treatment Epoch|Physician Decision|0|||
144630984|NCT01925209|521505920|FG002|Treatment Epoch|Physician Decision|0|||
144630985|NCT01925209|521505921|FG003|Treatment Epoch|Physician Decision|0|||
144630986|NCT01925209|521505918|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
144630987|NCT01925209|521505919|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
144630988|NCT01925209|521505920|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
144630989|NCT01925209|521505921|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
144630990|NCT01925209|521505918|FG000|Treatment Epoch|Death|1|||
144630991|NCT01925209|521505919|FG001|Treatment Epoch|Death|0|||
144630992|NCT01925209|521505920|FG002|Treatment Epoch|Death|0|||
144630993|NCT01925209|521505921|FG003|Treatment Epoch|Death|0|||
144630994|NCT01925209|521505918|FG000|Treatment Epoch|Protocol deviation|0|||
144630995|NCT01925209|521505919|FG001|Treatment Epoch|Protocol deviation|0|||
144630996|NCT01925209|521505920|FG002|Treatment Epoch|Protocol deviation|1|||
144630997|NCT01925209|521505921|FG003|Treatment Epoch|Protocol deviation|1|||
144630998|NCT01925209|521505918|FG000|Treatment Epoch|Withdrawal by Subject|4|||
144630999|NCT01925209|521505919|FG001|Treatment Epoch|Withdrawal by Subject|3|||
144631000|NCT01925209|521505920|FG002|Treatment Epoch|Withdrawal by Subject|3|||
144631001|NCT01925209|521505921|FG003|Treatment Epoch|Withdrawal by Subject|2|||
144631002|NCT01925209|521505918|FG000|Treatment Epoch|Adverse Event|3|||
144631003|NCT01925209|521505919|FG001|Treatment Epoch|Adverse Event|5|||
144631004|NCT01925209|521505920|FG002|Treatment Epoch|Adverse Event|3|||
144631005|NCT01925209|521505921|FG003|Treatment Epoch|Adverse Event|1|||
144631006|NCT01925209|521505918|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
144631007|NCT01925209|521505919|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
144631008|NCT01925209|521505920|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
144631009|NCT01925209|521505921|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
144631010|NCT01925209|521505918|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
144631011|NCT01925209|521505919|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
144631012|NCT01925209|521505920|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
144631013|NCT01925209|521505921|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
144631014|NCT01925209|521505918|FG000|Follow-up|Adverse Event|1|||
144631015|NCT01925209|521505919|FG001|Follow-up|Adverse Event|4|||
144631016|NCT01925209|521505920|FG002|Follow-up|Adverse Event|0|||
144631017|NCT01925209|521505921|FG003|Follow-up|Adverse Event|1|||
144631018|NCT01925209|521505918|FG000|Follow-up|Physician Decision|0|||
144631019|NCT01925209|521505919|FG001|Follow-up|Physician Decision|0|||
144631020|NCT01925209|521505920|FG002|Follow-up|Physician Decision|1|||
144631021|NCT01925209|521505921|FG003|Follow-up|Physician Decision|0|||
144631022|NCT01925209|521505918|FG000|Follow-up|Non-compliance with study treatment|0|||
144631023|NCT01925209|521505919|FG001|Follow-up|Non-compliance with study treatment|0|||
144631024|NCT01925209|521505920|FG002|Follow-up|Non-compliance with study treatment|0|||
144631025|NCT01925209|521505921|FG003|Follow-up|Non-compliance with study treatment|1|||
144631026|NCT01925209|521505918|FG000|Follow-up|Withdrawal by Subject|0|||
144631027|NCT01925209|521505919|FG001|Follow-up|Withdrawal by Subject|2|||
144631028|NCT01925209|521505920|FG002|Follow-up|Withdrawal by Subject|0|||
144631029|NCT01925209|521505921|FG003|Follow-up|Withdrawal by Subject|2|||
144631030|NCT00675025|521505922|FG000|Overall Study|Study Terminated by Sponsor|38|||
144631031|NCT00675025|521505923|FG001|Overall Study|Study Terminated by Sponsor|42|||
144631032|NCT00675025|521505922|FG000|Overall Study|Adverse Event|6|||
144631033|NCT00675025|521505923|FG001|Overall Study|Adverse Event|11|||
144631034|NCT00675025|521505922|FG000|Overall Study|Lost to Follow-up|6|||
144631035|NCT00675025|521505923|FG001|Overall Study|Lost to Follow-up|4|||
144631036|NCT00675025|521505922|FG000|Overall Study|Withdrawal by Subject|4|||
144631037|NCT00675025|521505923|FG001|Overall Study|Withdrawal by Subject|6|||
144631038|NCT00110994|521505924|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
144631039|NCT00110994|521505925|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
144631040|NCT00110994|521505924|FG000|Double-blind (DB) Treatment|Death|1|||
144631041|NCT00110994|521505925|FG001|Double-blind (DB) Treatment|Death|0|||
144631042|NCT00110994|521505924|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
144631043|NCT00110994|521505925|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
144730733|NCT02334722|521869877|FG000|Overall Study|Lost to Follow-up|4|||
144730734|NCT02334722|521869878|FG001|Overall Study|Lost to Follow-up|0|||
144730735|NCT02334722|521869877|FG000|Overall Study|6 week questionnaire not completed|2|||
144209954|NCT04051619|519962081|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
144631044|NCT00110994|521505924|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
144631045|NCT00110994|521505925|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
144631046|NCT00110994|521505924|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
144631047|NCT00110994|521505925|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
144631048|NCT00110994|521505924|FG000|Double-blind (DB) Treatment|other reasons|2|||
144631049|NCT00110994|521505925|FG001|Double-blind (DB) Treatment|other reasons|3|||
144631050|NCT00110994|521505924|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
144631051|NCT00110994|521505925|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
144631052|NCT00110994|521505924|FG000|Active Follow-up|Other reasons|0|||
144631053|NCT00110994|521505925|FG001|Active Follow-up|Other reasons|2|||
144631054|NCT00110994|521505924|FG000|Long Term Follow-up|Death|19|||
144631055|NCT00110994|521505925|FG001|Long Term Follow-up|Death|17|||
144631056|NCT01551693|521505930|FG000|Overall Study|Disease Progression|1|||
144631057|NCT01551693|521505931|FG001|Overall Study|Disease Progression|0|||
144631058|NCT01551693|521505930|FG000|Overall Study|Adverse Event|0|||
144631059|NCT01551693|521505931|FG001|Overall Study|Adverse Event|1|||
144631060|NCT01551693|521505930|FG000|Overall Study|Withdrawal by Subject|0|||
144631061|NCT01551693|521505931|FG001|Overall Study|Withdrawal by Subject|1|||
144631062|NCT01950819|521505934|FG000|Overall Study|Graft Loss|35|||
144631063|NCT01950819|521505935|FG001|Overall Study|Graft Loss|30|||
144631064|NCT01950819|521505934|FG000|Overall Study|Death|29|||
144631065|NCT01950819|521505935|FG001|Overall Study|Death|34|||
144631066|NCT01950819|521505934|FG000|Overall Study|Subject / Gardian decision|54|||
144631067|NCT01950819|521505935|FG001|Overall Study|Subject / Gardian decision|51|||
144631068|NCT01950819|521505934|FG000|Overall Study|technical problems|2|||
144631069|NCT01950819|521505935|FG001|Overall Study|technical problems|0|||
144631070|NCT01950819|521505934|FG000|Overall Study|Pregnancy|0|||
144631071|NCT01950819|521505935|FG001|Overall Study|Pregnancy|2|||
144631072|NCT01950819|521505934|FG000|Overall Study|Lost to Follow-up|9|||
144631073|NCT01950819|521505935|FG001|Overall Study|Lost to Follow-up|17|||
144631074|NCT04134494|521505936|FG000|Overall Study|Lost to Follow-up|2|||
144631075|NCT00781365|521505937|FG000|Overall Study|Withdrawal by Subject|13|||
144631076|NCT00781365|521505938|FG001|Overall Study|Withdrawal by Subject|8|||
144631077|NCT00781365|521505937|FG000|Overall Study|Did Not Attend Visit|20|||
144631078|NCT00781365|521505938|FG001|Overall Study|Did Not Attend Visit|28|||
144631079|NCT00781365|521505937|FG000|Overall Study|Language barrier|1|||
144631080|NCT00781365|521505938|FG001|Overall Study|Language barrier|0|||
144631081|NCT00238264|521505941|FG000|Overall Study|Death|7|||
144631082|NCT00238264|521505941|FG000|Overall Study|Lost to Follow-up|18|||
144631083|NCT00238264|521505941|FG000|Overall Study|Withdrawal by Subject|4|||
144631084|NCT00238264|521505941|FG000|Overall Study|Ineligible|7|||
144631085|NCT01756456|521505946|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
144631086|NCT01756456|521505947|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
144631087|NCT01756456|521505948|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
144631088|NCT01756456|521505949|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
144631089|NCT01756456|521505950|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
144631090|NCT01756456|521505951|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
144631091|NCT01756456|521505946|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
144631092|NCT01756456|521505947|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
144631093|NCT01756456|521505948|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
144631094|NCT01756456|521505949|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
144631095|NCT01756456|521505950|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
144631096|NCT01756456|521505951|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
144631097|NCT01756456|521505946|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
144631098|NCT01756456|521505947|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
144631099|NCT01756456|521505948|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
144631100|NCT01756456|521505949|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
144631101|NCT01756456|521505950|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
144631102|NCT01756456|521505951|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
144631103|NCT01756456|521505946|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
144631104|NCT01756456|521505947|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
144631105|NCT01756456|521505948|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
144631106|NCT01756456|521505949|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
144631107|NCT01756456|521505950|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
144631108|NCT01756456|521505951|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
144631109|NCT01756456|521505946|FG000|Treatment Period: Phase I/II|Other causes|0|||
144631110|NCT01756456|521505947|FG001|Treatment Period: Phase I/II|Other causes|0|||
144631111|NCT01756456|521505948|FG002|Treatment Period: Phase I/II|Other causes|0|||
144631112|NCT01756456|521505949|FG003|Treatment Period: Phase I/II|Other causes|1|||
144631113|NCT01756456|521505950|FG004|Treatment Period: Phase I/II|Other causes|2|||
144631114|NCT01756456|521505951|FG005|Treatment Period: Phase I/II|Other causes|2|||
144631115|NCT01756456|521505946|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
144631116|NCT01756456|521505947|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
144631117|NCT01756456|521505948|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
144631118|NCT01756456|521505949|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
144631119|NCT01756456|521505950|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
144631120|NCT01756456|521505951|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
144631121|NCT01756456|521505946|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
144631122|NCT01756456|521505947|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
144631123|NCT01756456|521505948|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
144631124|NCT01756456|521505949|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
144631125|NCT01756456|521505950|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
144631126|NCT01756456|521505951|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
144631127|NCT01756456|521505946|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
144631128|NCT01756456|521505947|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
144631129|NCT01756456|521505948|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
144631130|NCT01756456|521505949|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
144631131|NCT01756456|521505950|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
144631132|NCT01756456|521505951|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
144631133|NCT01756456|521505946|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
144631134|NCT01756456|521505947|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
144631135|NCT01756456|521505948|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
144631136|NCT01756456|521505949|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
144631137|NCT01756456|521505950|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
144631138|NCT01756456|521505951|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
144631139|NCT01756456|521505946|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
144631140|NCT01756456|521505947|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
144631141|NCT01756456|521505948|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
144631142|NCT01756456|521505949|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
144631143|NCT01756456|521505950|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
144631144|NCT01756456|521505951|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
144631145|NCT01756456|521505946|FG000|Follow Up Period Phase I/II|Other causes|0|||
144631146|NCT01756456|521505947|FG001|Follow Up Period Phase I/II|Other causes|0|||
144631147|NCT01756456|521505948|FG002|Follow Up Period Phase I/II|Other causes|0|||
144631148|NCT01756456|521505949|FG003|Follow Up Period Phase I/II|Other causes|1|||
144631149|NCT01756456|521505950|FG004|Follow Up Period Phase I/II|Other causes|3|||
144631150|NCT01756456|521505951|FG005|Follow Up Period Phase I/II|Other causes|5|||
144631151|NCT01838044|521505952|FG000|Overall Study|Adverse Event|4|||
144631152|NCT01838044|521505953|FG001|Overall Study|Adverse Event|6|||
144631153|NCT01838044|521505952|FG000|Overall Study|Protocol Violation|3|||
144631154|NCT01838044|521505953|FG001|Overall Study|Protocol Violation|3|||
144631155|NCT01838044|521505952|FG000|Overall Study|Withdrawal by Subject|0|||
144631156|NCT01838044|521505953|FG001|Overall Study|Withdrawal by Subject|2|||
144631157|NCT01838044|521505952|FG000|Overall Study|Insufficient clinical response|1|||
144631158|NCT01838044|521505953|FG001|Overall Study|Insufficient clinical response|2|||
144631159|NCT01838044|521505952|FG000|Overall Study|Medication error without associated AE|0|||
144631160|NCT01838044|521505953|FG001|Overall Study|Medication error without associated AE|1|||
144631161|NCT01838044|521505952|FG000|Overall Study|Lost to Follow-up|0|||
144631162|NCT01838044|521505953|FG001|Overall Study|Lost to Follow-up|2|||
144631163|NCT00706628|521505954|FG000|Overall Study|Other Adverse Event|16|||
144631164|NCT00706628|521505955|FG001|Overall Study|Other Adverse Event|5|||
144631165|NCT00706628|521505956|FG002|Overall Study|Other Adverse Event|5|||
144631166|NCT00706628|521505957|FG003|Overall Study|Other Adverse Event|2|||
144631167|NCT00706628|521505954|FG000|Overall Study|Non compliant with protocol|0|||
144631168|NCT00706628|521505955|FG001|Overall Study|Non compliant with protocol|1|||
144631169|NCT00706628|521505956|FG002|Overall Study|Non compliant with protocol|0|||
144209955|NCT04051619|519962082|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
144631170|NCT00706628|521505957|FG003|Overall Study|Non compliant with protocol|0|||
144631171|NCT00706628|521505954|FG000|Overall Study|Consent withdrawn|6|||
144631172|NCT00706628|521505955|FG001|Overall Study|Consent withdrawn|1|||
144631173|NCT00706628|521505956|FG002|Overall Study|Consent withdrawn|3|||
144631174|NCT00706628|521505957|FG003|Overall Study|Consent withdrawn|0|||
144631175|NCT00706628|521505954|FG000|Overall Study|Progressive disease|20|||
144631176|NCT00706628|521505955|FG001|Overall Study|Progressive disease|13|||
144631177|NCT00706628|521505956|FG002|Overall Study|Progressive disease|8|||
144631178|NCT00706628|521505957|FG003|Overall Study|Progressive disease|1|||
144631179|NCT00706628|521505954|FG000|Overall Study|Other than those stated above|4|||
144631180|NCT00706628|521505955|FG001|Overall Study|Other than those stated above|0|||
144631181|NCT00706628|521505956|FG002|Overall Study|Other than those stated above|0|||
144631182|NCT00706628|521505957|FG003|Overall Study|Other than those stated above|0|||
144631183|NCT00706628|521505954|FG000|Overall Study|Not treated|1|||
144631184|NCT00706628|521505955|FG001|Overall Study|Not treated|1|||
144631185|NCT00706628|521505956|FG002|Overall Study|Not treated|0|||
144631186|NCT00706628|521505957|FG003|Overall Study|Not treated|0|||
144631187|NCT02266433|521505958|FG000|Overall Study|Lost to Follow-up|54|||
144209956|NCT04998851|519963553|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
144209957|NCT04998851|519963554|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
144209958|NCT04998851|519963553|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
144631188|NCT02266433|521505959|FG001|Overall Study|Lost to Follow-up|46|||
144631189|NCT02266433|521505958|FG000|Overall Study|Withdrawal by Subject|5|||
144631190|NCT02266433|521505959|FG001|Overall Study|Withdrawal by Subject|7|||
144631191|NCT01145560|521505960|FG000|Overall Study|Withdrawal by Subject|2|||
144631192|NCT01145560|521505961|FG001|Overall Study|Withdrawal by Subject|1|||
144631193|NCT01145560|521505962|FG002|Overall Study|Withdrawal by Subject|0|||
144631194|NCT01145560|521505960|FG000|Overall Study|Lost to Follow-up|1|||
144631195|NCT01145560|521505961|FG001|Overall Study|Lost to Follow-up|1|||
144631196|NCT01145560|521505962|FG002|Overall Study|Lost to Follow-up|1|||
144631197|NCT01145560|521505960|FG000|Overall Study|No study drug by 24h after organ failure|1|||
144631198|NCT01145560|521505961|FG001|Overall Study|No study drug by 24h after organ failure|0|||
144631199|NCT01145560|521505962|FG002|Overall Study|No study drug by 24h after organ failure|0|||
144631200|NCT01145560|521505960|FG000|Overall Study|Accidental unblinding of study treatment|0|||
144631201|NCT01145560|521505961|FG001|Overall Study|Accidental unblinding of study treatment|1|||
144631202|NCT01145560|521505962|FG002|Overall Study|Accidental unblinding of study treatment|0|||
144631203|NCT01145560|521505960|FG000|Overall Study|False insurance information|0|||
144631204|NCT01145560|521505961|FG001|Overall Study|False insurance information|1|||
144631205|NCT01145560|521505962|FG002|Overall Study|False insurance information|0|||
144631206|NCT01145560|521505960|FG000|Overall Study|Withdrawal of therapy|0|||
144631207|NCT01145560|521505961|FG001|Overall Study|Withdrawal of therapy|0|||
144631208|NCT01145560|521505962|FG002|Overall Study|Withdrawal of therapy|1|||
144631209|NCT00712348|521505963|FG000|Overall Study|Withdrawal by Subject|1|||
144631210|NCT01375764|521505967|FG000|Overall Study|Lost to Follow-up|0|||
144631211|NCT01375764|521505968|FG001|Overall Study|Lost to Follow-up|1|||
144631212|NCT01375764|521505969|FG002|Overall Study|Lost to Follow-up|0|||
144631213|NCT01375764|521505970|FG003|Overall Study|Lost to Follow-up|0|||
144631214|NCT01375764|521505971|FG004|Overall Study|Lost to Follow-up|0|||
144631215|NCT01375764|521505967|FG000|Overall Study|Withdrawal by Subject|2|||
144631216|NCT01375764|521505968|FG001|Overall Study|Withdrawal by Subject|0|||
144631217|NCT01375764|521505969|FG002|Overall Study|Withdrawal by Subject|0|||
144631218|NCT01375764|521505970|FG003|Overall Study|Withdrawal by Subject|0|||
144631219|NCT01375764|521505971|FG004|Overall Study|Withdrawal by Subject|1|||
144631220|NCT01375764|521505967|FG000|Overall Study|Other|0|||
144631221|NCT01375764|521505968|FG001|Overall Study|Other|0|||
144631222|NCT01375764|521505969|FG002|Overall Study|Other|0|||
144631223|NCT01375764|521505970|FG003|Overall Study|Other|1|||
144631224|NCT01375764|521505971|FG004|Overall Study|Other|0|||
144631225|NCT03595280|521505972|FG000|Overall Study|Lost to Follow-up|6|||
144631226|NCT03595280|521505973|FG001|Overall Study|Lost to Follow-up|9|||
144631227|NCT03595280|521505974|FG002|Overall Study|Lost to Follow-up|15|||
144631228|NCT01194440|521505975|FG000|Baseline (First Dose)|Reason not specified|4|||
144631229|NCT01194440|521505975|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
144631230|NCT01194440|521505975|FG000|Baseline (First Dose)|Change in therapy|1|||
144631231|NCT01194440|521505975|FG000|Baseline (First Dose)|Adverse Event|1|||
144631232|NCT01194440|521505975|FG000|6-months (2nd Dose)|Change in therapy|4|||
144631233|NCT00854828|521505976|FG000|Overall Study|Death|1|||
144631234|NCT00854828|521505977|FG001|Overall Study|Death|0|||
144631235|NCT00854828|521505978|FG002|Overall Study|Death|0|||
144631236|NCT00854828|521505979|FG003|Overall Study|Death|0|||
144631237|NCT00854828|521505976|FG000|Overall Study|Withdrawal by Subject|1|||
144631238|NCT00854828|521505977|FG001|Overall Study|Withdrawal by Subject|1|||
144631239|NCT00854828|521505978|FG002|Overall Study|Withdrawal by Subject|0|||
144631240|NCT00854828|521505979|FG003|Overall Study|Withdrawal by Subject|9|||
144631241|NCT00854828|521505976|FG000|Overall Study|Missed 24mo visit|1|||
144631242|NCT00854828|521505977|FG001|Overall Study|Missed 24mo visit|1|||
144631243|NCT00854828|521505978|FG002|Overall Study|Missed 24mo visit|8|||
144631244|NCT00854828|521505979|FG003|Overall Study|Missed 24mo visit|8|||
144631245|NCT02440581|521505984|FG000|Overall Study|Death|0|||
144631246|NCT02440581|521505985|FG001|Overall Study|Death|0|||
144631247|NCT02440581|521505986|FG002|Overall Study|Death|7|||
144631248|NCT02440581|521505987|FG003|Overall Study|Death|5|||
144631249|NCT02440581|521505984|FG000|Overall Study|Transplanted|1|||
144631250|NCT02440581|521505985|FG001|Overall Study|Transplanted|0|||
144631251|NCT02440581|521505986|FG002|Overall Study|Transplanted|3|||
144631252|NCT02440581|521505987|FG003|Overall Study|Transplanted|2|||
144631253|NCT02440581|521505984|FG000|Overall Study|Withdrawal by Subject|4|||
144631254|NCT02440581|521505985|FG001|Overall Study|Withdrawal by Subject|11|||
144631255|NCT02440581|521505986|FG002|Overall Study|Withdrawal by Subject|3|||
144631256|NCT02440581|521505987|FG003|Overall Study|Withdrawal by Subject|7|||
144631257|NCT01468987|521505988|FG000|Overall Study|Adverse Event|12|||
144631258|NCT01468987|521505989|FG001|Overall Study|Adverse Event|9|||
144631259|NCT01468987|521505988|FG000|Overall Study|Death|4|||
144631260|NCT01468987|521505989|FG001|Overall Study|Death|1|||
144631261|NCT01468987|521505988|FG000|Overall Study|Lost to Follow-up|10|||
144631262|NCT01468987|521505989|FG001|Overall Study|Lost to Follow-up|5|||
144631263|NCT01468987|521505988|FG000|Overall Study|Protocol Violation|8|||
144631264|NCT01468987|521505989|FG001|Overall Study|Protocol Violation|2|||
144631265|NCT01468987|521505988|FG000|Overall Study|Withdrawal by Subject|28|||
144631266|NCT01468987|521505989|FG001|Overall Study|Withdrawal by Subject|28|||
144631267|NCT01468987|521505988|FG000|Overall Study|Physician Decision|8|||
144631268|NCT01468987|521505989|FG001|Overall Study|Physician Decision|15|||
144631269|NCT01468987|521505988|FG000|Overall Study|Sponsor Decision|1|||
144631270|NCT01468987|521505989|FG001|Overall Study|Sponsor Decision|0|||
144631271|NCT00787787|521505990|FG000|Overall Study|Lack of Efficacy|4|||
144631272|NCT00787787|521505990|FG000|Overall Study|Adverse Event|3|||
144631273|NCT05032950|521505992|FG000|Overall Study|Adverse Event|0|||
144631274|NCT05032950|521505993|FG001|Overall Study|Adverse Event|0|||
144631275|NCT05032950|521505994|FG002|Overall Study|Adverse Event|1|||
144631276|NCT05032950|521505995|FG003|Overall Study|Adverse Event|1|||
144631277|NCT05032950|521505996|FG004|Overall Study|Adverse Event|0|||
144209959|NCT04998851|519963554|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
144209960|NCT02135614|519963563|FG000|Overall Study|Randomized but Not Treated|2|||
144209961|NCT02135614|519963564|FG001|Overall Study|Randomized but Not Treated|1|||
144209962|NCT02135614|519963563|FG000|Overall Study|Adverse Event|0|||
144209963|NCT02135614|519963564|FG001|Overall Study|Adverse Event|1|||
144631278|NCT05032950|521505997|FG005|Overall Study|Adverse Event|0|||
144631279|NCT03430986|521505998|FG000|24-week Control Period|Adverse Event|1|||
144631280|NCT03430986|521505999|FG001|24-week Control Period|Adverse Event|0|||
144631281|NCT03430986|521505998|FG000|24-week Control Period|Lost to Follow-up|2|||
144631282|NCT03430986|521505999|FG001|24-week Control Period|Lost to Follow-up|2|||
144631283|NCT03430986|521505998|FG000|24-week Control Period|Withdrawal by Participant|5|||
144631284|NCT03430986|521505999|FG001|24-week Control Period|Withdrawal by Participant|0|||
144631285|NCT03430986|521505998|FG000|24-week Control Period|Protocol Deviation|0|||
144631286|NCT03430986|521505999|FG001|24-week Control Period|Protocol Deviation|2|||
144631287|NCT03430986|521505998|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
144631288|NCT03430986|521505999|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
144631289|NCT03430986|521505998|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
144631290|NCT03430986|521505999|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
144631291|NCT04722991|521506003|FG000|Overall Study|Adverse Event|12|||
144631292|NCT04722991|521506004|FG001|Overall Study|Adverse Event|4|||
144631293|NCT04722991|521506003|FG000|Overall Study|Death|2|||
144631294|NCT04722991|521506004|FG001|Overall Study|Death|0|||
144631295|NCT04722991|521506003|FG000|Overall Study|Lost to Follow-up|1|||
144631296|NCT04722991|521506004|FG001|Overall Study|Lost to Follow-up|1|||
144631297|NCT04722991|521506003|FG000|Overall Study|Withdrawal cirterion met|2|||
144631298|NCT04722991|521506004|FG001|Overall Study|Withdrawal cirterion met|2|||
144631299|NCT04722991|521506003|FG000|Overall Study|Other|1|||
144631300|NCT04722991|521506004|FG001|Overall Study|Other|0|||
144631301|NCT04722991|521506003|FG000|Overall Study|Non-compliance|0|||
144631302|NCT04722991|521506004|FG001|Overall Study|Non-compliance|1|||
144631303|NCT04722991|521506003|FG000|Overall Study|Withdrawal by Subject|0|||
144631304|NCT04722991|521506004|FG001|Overall Study|Withdrawal by Subject|1|||
144631305|NCT03186989|521506005|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631306|NCT03186989|521506006|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631307|NCT03186989|521506007|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
144631308|NCT03186989|521506008|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
144631309|NCT03186989|521506009|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
144631310|NCT03186989|521506010|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631311|NCT03186989|521506011|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631312|NCT03186989|521506012|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631313|NCT03186989|521506013|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631314|NCT03186989|521506014|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631315|NCT03186989|521506015|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
144631316|NCT03186989|521506005|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631317|NCT03186989|521506006|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631318|NCT03186989|521506007|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631319|NCT03186989|521506008|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631320|NCT03186989|521506009|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631321|NCT03186989|521506010|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
144631322|NCT03186989|521506011|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631323|NCT03186989|521506012|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631324|NCT03186989|521506013|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631325|NCT03186989|521506014|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144631326|NCT03186989|521506015|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
144209964|NCT02135614|519963563|FG000|Overall Study|Death|1|||
144209965|NCT02135614|519963564|FG001|Overall Study|Death|0|||
144209966|NCT02135614|519963563|FG000|Overall Study|Investigator's Discretion|0|||
144209967|NCT02135614|519963564|FG001|Overall Study|Investigator's Discretion|1|||
144209968|NCT02135614|519963563|FG000|Overall Study|Withdrew Consent|2|||
144209969|NCT02135614|519963564|FG001|Overall Study|Withdrew Consent|2|||
144209970|NCT02135614|519963563|FG000|Overall Study|Lost to Follow-up|3|||
144209971|NCT02135614|519963564|FG001|Overall Study|Lost to Follow-up|0|||
144209972|NCT00253448|519963574|FG000|Overall Study|Withdrawal by Subject|1|||
144209973|NCT02052011|519963575|FG000|Overall Study|Lost to Follow-up|3|||
144631327|NCT03186989|521506005|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631328|NCT03186989|521506006|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631329|NCT03186989|521506007|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631330|NCT03186989|521506008|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631331|NCT03186989|521506009|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631332|NCT03186989|521506010|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631333|NCT03186989|521506011|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
144209974|NCT02052011|519963576|FG001|Overall Study|Lost to Follow-up|0|||
144631334|NCT03186989|521506012|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631335|NCT03186989|521506013|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631336|NCT03186989|521506014|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631337|NCT03186989|521506015|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
144631338|NCT03186989|521506005|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631339|NCT03186989|521506006|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631340|NCT03186989|521506007|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631341|NCT03186989|521506008|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631342|NCT03186989|521506009|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631343|NCT03186989|521506010|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
144631344|NCT03186989|521506011|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
144631345|NCT03186989|521506012|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631346|NCT03186989|521506013|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
144631347|NCT03186989|521506014|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631348|NCT03186989|521506015|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
144631349|NCT01468311|521506027|FG000|Overall Study|mobilization failure|1|||
144631350|NCT01468311|521506027|FG000|Overall Study|Withdrawal by Subject|1|||
144631351|NCT03641560|521506028|FG000|Overall Study|Withdrawal by Subject|6|||
144631352|NCT03641560|521506028|FG000|Overall Study|Progressive disease|40|||
144631353|NCT03641560|521506028|FG000|Overall Study|Death|6|||
144631354|NCT01901224|521507696|FG000|Overall Study|study was not funded and terminated|2|||
144631355|NCT02300129|521507697|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
144631356|NCT02300129|521507698|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
144631357|NCT02300129|521507699|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
144631358|NCT02300129|521507700|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
144631359|NCT02300129|521507697|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
144631360|NCT02300129|521507698|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
144631361|NCT02300129|521507699|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
144631362|NCT02300129|521507700|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
144631363|NCT02300129|521507697|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
144631364|NCT02300129|521507698|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
144631365|NCT02300129|521507699|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
144631366|NCT02300129|521507700|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
144631367|NCT05742984|521507701|FG000|Overall Study|Adverse Event|0|||
144631368|NCT05742984|521507702|FG001|Overall Study|Adverse Event|0|||
144631369|NCT05742984|521507703|FG002|Overall Study|Adverse Event|1|||
144631370|NCT05742984|521507704|FG003|Overall Study|Adverse Event|0|||
144631371|NCT05742984|521507705|FG004|Overall Study|Adverse Event|1|||
144631372|NCT05742984|521507706|FG005|Overall Study|Adverse Event|1|||
144631373|NCT05742984|521507701|FG000|Overall Study|Withdrawal by Subject|0|||
144631374|NCT05742984|521507702|FG001|Overall Study|Withdrawal by Subject|1|||
144631375|NCT05742984|521507703|FG002|Overall Study|Withdrawal by Subject|0|||
144631376|NCT05742984|521507704|FG003|Overall Study|Withdrawal by Subject|0|||
144631377|NCT05742984|521507705|FG004|Overall Study|Withdrawal by Subject|0|||
144631378|NCT05742984|521507706|FG005|Overall Study|Withdrawal by Subject|2|||
144631379|NCT00430755|521507719|FG000|Overall Study|Withdrawal by Subject|53|||
144631380|NCT00103012|521507720|FG000|Overall Study|Withdrawal by Subject|2|||
144631381|NCT00103012|521507721|FG001|Overall Study|Withdrawal by Subject|1|||
144631382|NCT00103012|521507722|FG002|Overall Study|Withdrawal by Subject|2|||
144631383|NCT00103012|521507720|FG000|Overall Study|Pregnancy|1|||
144631384|NCT00103012|521507721|FG001|Overall Study|Pregnancy|0|||
144631385|NCT00103012|521507722|FG002|Overall Study|Pregnancy|0|||
144631386|NCT00103012|521507720|FG000|Overall Study|Adverse Event|0|||
144631387|NCT00103012|521507721|FG001|Overall Study|Adverse Event|0|||
144631388|NCT00103012|521507722|FG002|Overall Study|Adverse Event|1|||
144631389|NCT00103012|521507720|FG000|Overall Study|Subject non-compliant with medications|0|||
144631390|NCT00103012|521507721|FG001|Overall Study|Subject non-compliant with medications|0|||
144631391|NCT00103012|521507722|FG002|Overall Study|Subject non-compliant with medications|1|||
144631392|NCT05211336|521507725|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
144631393|NCT05211336|521507726|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
144631394|NCT05211336|521507725|FG000|Overall Study|Progressive disease|0|||
144631395|NCT05211336|521507726|FG001|Overall Study|Progressive disease|4|||
144631396|NCT05211336|521507725|FG000|Overall Study|Death due to myocardial infarction|0|||
144631397|NCT05211336|521507726|FG001|Overall Study|Death due to myocardial infarction|1|||
144631398|NCT05211336|521507725|FG000|Overall Study|Death due to unknown cause|0|||
144631399|NCT05211336|521507726|FG001|Overall Study|Death due to unknown cause|1|||
144631400|NCT05211336|521507725|FG000|Overall Study|Worsening kidney function and quality of response|0|||
144631401|NCT05211336|521507726|FG001|Overall Study|Worsening kidney function and quality of response|1|||
144631402|NCT01084551|521507727|FG000|Overall Study|Adverse Event|2|||
144631403|NCT01084551|521507728|FG001|Overall Study|Adverse Event|9|||
144631404|NCT01084551|521507729|FG002|Overall Study|Adverse Event|4|||
144631405|NCT01084551|521507727|FG000|Overall Study|Lack of Efficacy|2|||
144631406|NCT01084551|521507728|FG001|Overall Study|Lack of Efficacy|0|||
144631407|NCT01084551|521507729|FG002|Overall Study|Lack of Efficacy|1|||
144631408|NCT01084551|521507727|FG000|Overall Study|Withdrawal by Subject|2|||
144631409|NCT01084551|521507728|FG001|Overall Study|Withdrawal by Subject|1|||
144631410|NCT01084551|521507729|FG002|Overall Study|Withdrawal by Subject|0|||
144631411|NCT01084551|521507727|FG000|Overall Study|Protocol Violation|2|||
144631412|NCT01084551|521507728|FG001|Overall Study|Protocol Violation|4|||
144631413|NCT01084551|521507729|FG002|Overall Study|Protocol Violation|0|||
144631414|NCT01084551|521507727|FG000|Overall Study|Lost to Follow-up|0|||
144631415|NCT01084551|521507728|FG001|Overall Study|Lost to Follow-up|0|||
144631416|NCT01084551|521507729|FG002|Overall Study|Lost to Follow-up|3|||
144631417|NCT01084551|521507727|FG000|Overall Study|Physician Decision|1|||
144631418|NCT01084551|521507728|FG001|Overall Study|Physician Decision|0|||
144631419|NCT01084551|521507729|FG002|Overall Study|Physician Decision|0|||
144631420|NCT00463476|521507730|FG000|Overall Study|Withdrawal by Subject|1|||
144631421|NCT00463476|521507731|FG001|Overall Study|Withdrawal by Subject|2|||
144631422|NCT00463476|521507730|FG000|Overall Study|Lost to Follow-up|1|||
144631423|NCT00463476|521507731|FG001|Overall Study|Lost to Follow-up|1|||
144631424|NCT03502187|521507736|FG000|Overall Study|Withdrawal by Subject|4|||
144631425|NCT03502187|521507737|FG001|Overall Study|Withdrawal by Subject|3|||
144631426|NCT03502187|521507738|FG002|Overall Study|Withdrawal by Subject|3|||
144631427|NCT03502187|521507736|FG000|Overall Study|Lost to Follow-up|5|||
144631428|NCT03502187|521507737|FG001|Overall Study|Lost to Follow-up|4|||
144631429|NCT03502187|521507738|FG002|Overall Study|Lost to Follow-up|5|||
144631430|NCT01848145|521507739|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
144631431|NCT01848145|521507739|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
144631432|NCT01848145|521507739|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
144631433|NCT01848145|521507739|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
144631434|NCT01848145|521507739|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
144631435|NCT01848145|521507739|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
144631436|NCT01848145|521507739|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
144631437|NCT00556426|521507740|FG000|Overall Study|Withdrawal by Subject|3|||
144631438|NCT00556426|521507740|FG000|Overall Study|Death|6|||
144631439|NCT02429856|521507744|FG000|Overall Study|Death|12|||
144631440|NCT02429856|521507745|FG001|Overall Study|Death|13|||
144631441|NCT02429856|521507744|FG000|Overall Study|Lost to Follow-up|6|||
144631442|NCT02429856|521507745|FG001|Overall Study|Lost to Follow-up|5|||
144631443|NCT02429856|521507744|FG000|Overall Study|Withdrawal by Subject|1|||
144631444|NCT02429856|521507745|FG001|Overall Study|Withdrawal by Subject|1|||
144631445|NCT02649634|521507746|FG000|Overall Study|Withdrawal by Subject|3|||
144631446|NCT02649634|521507747|FG001|Overall Study|Withdrawal by Subject|5|||
144631447|NCT02649634|521507746|FG000|Overall Study|Lost to Follow-up|0|||
144631448|NCT02649634|521507747|FG001|Overall Study|Lost to Follow-up|1|||
144631449|NCT00348140|521507748|FG000|Overall Study|Adverse Event|46|||
144631450|NCT00348140|521507749|FG001|Overall Study|Adverse Event|49|||
144631451|NCT00348140|521507750|FG002|Overall Study|Adverse Event|78|||
144631452|NCT00348140|521507748|FG000|Overall Study|Lost to Follow-up|4|||
144631453|NCT00348140|521507749|FG001|Overall Study|Lost to Follow-up|4|||
144631454|NCT00348140|521507750|FG002|Overall Study|Lost to Follow-up|4|||
144631455|NCT00348140|521507748|FG000|Overall Study|Protocol Violation|12|||
144631456|NCT00348140|521507749|FG001|Overall Study|Protocol Violation|13|||
144631457|NCT00348140|521507750|FG002|Overall Study|Protocol Violation|14|||
144631458|NCT00348140|521507748|FG000|Overall Study|Withdrawal by Subject|32|||
144631459|NCT00348140|521507749|FG001|Overall Study|Withdrawal by Subject|40|||
144631460|NCT00348140|521507750|FG002|Overall Study|Withdrawal by Subject|40|||
144631461|NCT00348140|521507748|FG000|Overall Study|Non-compliance|8|||
144631462|NCT00348140|521507749|FG001|Overall Study|Non-compliance|13|||
144631463|NCT00348140|521507750|FG002|Overall Study|Non-compliance|5|||
144631464|NCT00348140|521507748|FG000|Overall Study|Participant at risk due to study drug|2|||
144631465|NCT00348140|521507749|FG001|Overall Study|Participant at risk due to study drug|0|||
144631466|NCT00348140|521507750|FG002|Overall Study|Participant at risk due to study drug|0|||
144631467|NCT00348140|521507748|FG000|Overall Study|Conditional medication increased dose|1|||
144631468|NCT00348140|521507749|FG001|Overall Study|Conditional medication increased dose|0|||
144631469|NCT00348140|521507750|FG002|Overall Study|Conditional medication increased dose|0|||
144631470|NCT00348140|521507748|FG000|Overall Study|Caregiver related|4|||
144631471|NCT00348140|521507749|FG001|Overall Study|Caregiver related|7|||
144631472|NCT00348140|521507750|FG002|Overall Study|Caregiver related|3|||
144631473|NCT00348140|521507748|FG000|Overall Study|Participant hospitalised|3|||
144631474|NCT00348140|521507749|FG001|Overall Study|Participant hospitalised|0|||
144631475|NCT00348140|521507750|FG002|Overall Study|Participant hospitalised|0|||
144631476|NCT00348140|521507748|FG000|Overall Study|Efficacy related|1|||
144631477|NCT00348140|521507749|FG001|Overall Study|Efficacy related|1|||
144631478|NCT00348140|521507750|FG002|Overall Study|Efficacy related|0|||
144631479|NCT00348140|521507748|FG000|Overall Study|Administration related|3|||
144631480|NCT00348140|521507749|FG001|Overall Study|Administration related|1|||
144631481|NCT00348140|521507750|FG002|Overall Study|Administration related|1|||
144631482|NCT00348140|521507748|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
144631483|NCT00348140|521507749|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
144631484|NCT00348140|521507750|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
144631485|NCT00348140|521507748|FG000|Overall Study|Participant unwell|1|||
144631486|NCT00348140|521507749|FG001|Overall Study|Participant unwell|0|||
144631487|NCT00348140|521507750|FG002|Overall Study|Participant unwell|0|||
144631488|NCT00348140|521507748|FG000|Overall Study|Screen failure|1|||
144631489|NCT00348140|521507749|FG001|Overall Study|Screen failure|0|||
144631490|NCT00348140|521507750|FG002|Overall Study|Screen failure|0|||
144631491|NCT00348140|521507748|FG000|Overall Study|Investigator decided to discontinue|4|||
144631492|NCT00348140|521507749|FG001|Overall Study|Investigator decided to discontinue|1|||
144631493|NCT00348140|521507750|FG002|Overall Study|Investigator decided to discontinue|4|||
144631494|NCT00348140|521507748|FG000|Overall Study|Decided to discontinue on their own|1|||
144631495|NCT00348140|521507749|FG001|Overall Study|Decided to discontinue on their own|4|||
144631496|NCT00348140|521507750|FG002|Overall Study|Decided to discontinue on their own|1|||
144631497|NCT00348140|521507748|FG000|Overall Study|Use of prohibited drug|1|||
144631498|NCT00348140|521507749|FG001|Overall Study|Use of prohibited drug|0|||
144631499|NCT00348140|521507750|FG002|Overall Study|Use of prohibited drug|2|||
144631500|NCT00348140|521507748|FG000|Overall Study|Disease progression|1|||
144631501|NCT00348140|521507749|FG001|Overall Study|Disease progression|2|||
144631502|NCT00348140|521507750|FG002|Overall Study|Disease progression|5|||
144631503|NCT00348140|521507748|FG000|Overall Study|Increased risk of cardiac infarction|0|||
144631504|NCT00348140|521507749|FG001|Overall Study|Increased risk of cardiac infarction|1|||
144631505|NCT00348140|521507750|FG002|Overall Study|Increased risk of cardiac infarction|0|||
144631506|NCT00348140|521507748|FG000|Overall Study|Serious adverse event|0|||
144631507|NCT00348140|521507749|FG001|Overall Study|Serious adverse event|1|||
144631508|NCT00348140|521507750|FG002|Overall Study|Serious adverse event|0|||
144631509|NCT00348140|521507748|FG000|Overall Study|Abnormal ECG|0|||
144631510|NCT00348140|521507749|FG001|Overall Study|Abnormal ECG|1|||
144631511|NCT00348140|521507750|FG002|Overall Study|Abnormal ECG|3|||
144631512|NCT00348140|521507748|FG000|Overall Study|Participant died|0|||
144631513|NCT00348140|521507749|FG001|Overall Study|Participant died|1|||
144631514|NCT00348140|521507750|FG002|Overall Study|Participant died|0|||
144631515|NCT00348140|521507748|FG000|Overall Study|Exclusion criteria met|0|||
144631516|NCT00348140|521507749|FG001|Overall Study|Exclusion criteria met|0|||
144631517|NCT00348140|521507750|FG002|Overall Study|Exclusion criteria met|1|||
144631518|NCT00348140|521507748|FG000|Overall Study|Memory declined|0|||
144631519|NCT00348140|521507749|FG001|Overall Study|Memory declined|0|||
144631520|NCT00348140|521507750|FG002|Overall Study|Memory declined|1|||
144631521|NCT04666038|521507763|FG000|Overall Study|Progressive Disease|2|||
144631522|NCT04666038|521507764|FG001|Overall Study|Progressive Disease|0|||
144631523|NCT04666038|521507763|FG000|Overall Study|Death|38|||
144631524|NCT04666038|521507764|FG001|Overall Study|Death|32|||
144631525|NCT04666038|521507763|FG000|Overall Study|Withdrawal by Subject|10|||
144631526|NCT04666038|521507764|FG001|Overall Study|Withdrawal by Subject|19|||
144631527|NCT04666038|521507763|FG000|Overall Study|Lost to Follow-up|0|||
144631528|NCT04666038|521507764|FG001|Overall Study|Lost to Follow-up|2|||
144631529|NCT04666038|521507763|FG000|Overall Study|On Study Treatment|46|||
144631530|NCT04666038|521507764|FG001|Overall Study|On Study Treatment|5|||
144631531|NCT04666038|521507763|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
144631532|NCT04666038|521507764|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
144631533|NCT02658812|521507765|FG000|Overall Study|Disease Progression|7|||
144631534|NCT02658812|521507765|FG000|Overall Study|Unrelated to study treatment|1|||
144631535|NCT02658812|521507765|FG000|Overall Study|Adverse Event|1|||
144631536|NCT02675075|521507769|FG000|Overall Study|Lost to Follow-up|3|||
144631537|NCT02675075|521507770|FG001|Overall Study|Lost to Follow-up|0|||
144631538|NCT02292212|521507779|FG000|ViE Phase|Withdrawal by Subject|1|||
144631539|NCT02292212|521507779|FG000|ViE Phase|Protocol Violation|2|||
144631540|NCT04957290|521507780|FG000|Overall Study|Progressive disease|3|||
144631541|NCT04957290|521507781|FG001|Overall Study|Progressive disease|3|||
144631542|NCT04957290|521507782|FG002|Overall Study|Progressive disease|2|||
144631543|NCT04957290|521507783|FG003|Overall Study|Progressive disease|0|||
144631544|NCT04957290|521507784|FG004|Overall Study|Progressive disease|0|||
144631545|NCT04957290|521507785|FG005|Overall Study|Progressive disease|0|||
144631546|NCT04957290|521507780|FG000|Overall Study|Withdrawal by Subject|1|||
144631547|NCT04957290|521507781|FG001|Overall Study|Withdrawal by Subject|0|||
144631548|NCT04957290|521507782|FG002|Overall Study|Withdrawal by Subject|1|||
144631549|NCT04957290|521507783|FG003|Overall Study|Withdrawal by Subject|0|||
144631550|NCT04957290|521507784|FG004|Overall Study|Withdrawal by Subject|0|||
144631551|NCT04957290|521507785|FG005|Overall Study|Withdrawal by Subject|0|||
144631552|NCT04957290|521507780|FG000|Overall Study|Death|0|||
144631553|NCT04957290|521507781|FG001|Overall Study|Death|2|||
144631554|NCT04957290|521507782|FG002|Overall Study|Death|1|||
144631555|NCT04957290|521507783|FG003|Overall Study|Death|0|||
144631556|NCT04957290|521507784|FG004|Overall Study|Death|0|||
144631557|NCT04957290|521507785|FG005|Overall Study|Death|0|||
144631558|NCT04957290|521507780|FG000|Overall Study|non compliance with study drug|0|||
144631559|NCT04957290|521507781|FG001|Overall Study|non compliance with study drug|1|||
144631560|NCT04957290|521507782|FG002|Overall Study|non compliance with study drug|0|||
144631561|NCT04957290|521507783|FG003|Overall Study|non compliance with study drug|0|||
144631562|NCT04957290|521507784|FG004|Overall Study|non compliance with study drug|0|||
144631563|NCT04957290|521507785|FG005|Overall Study|non compliance with study drug|0|||
144631564|NCT04957290|521507780|FG000|Overall Study|none specified.|0|||
144631565|NCT04957290|521507781|FG001|Overall Study|none specified.|1|||
144631566|NCT04957290|521507782|FG002|Overall Study|none specified.|2|||
144631567|NCT04957290|521507783|FG003|Overall Study|none specified.|0|||
144631568|NCT04957290|521507784|FG004|Overall Study|none specified.|0|||
144631569|NCT04957290|521507785|FG005|Overall Study|none specified.|0|||
144631570|NCT04957290|521507780|FG000|Overall Study|unacceptable toxicity|0|||
144631571|NCT04957290|521507781|FG001|Overall Study|unacceptable toxicity|0|||
144631572|NCT04957290|521507782|FG002|Overall Study|unacceptable toxicity|1|||
144631573|NCT04957290|521507783|FG003|Overall Study|unacceptable toxicity|0|||
144631574|NCT04957290|521507784|FG004|Overall Study|unacceptable toxicity|0|||
144631575|NCT04957290|521507785|FG005|Overall Study|unacceptable toxicity|0|||
144631576|NCT04957290|521507780|FG000|Overall Study|Adverse Event|0|||
144631577|NCT04957290|521507781|FG001|Overall Study|Adverse Event|0|||
144631578|NCT04957290|521507782|FG002|Overall Study|Adverse Event|1|||
144631579|NCT04957290|521507783|FG003|Overall Study|Adverse Event|0|||
144631580|NCT04957290|521507784|FG004|Overall Study|Adverse Event|0|||
144631581|NCT04957290|521507785|FG005|Overall Study|Adverse Event|0|||
144631582|NCT04957290|521507780|FG000|Overall Study|study terminated by sponsor|0|||
144631583|NCT04957290|521507781|FG001|Overall Study|study terminated by sponsor|0|||
144631584|NCT04957290|521507782|FG002|Overall Study|study terminated by sponsor|2|||
144631585|NCT04957290|521507783|FG003|Overall Study|study terminated by sponsor|0|||
144631586|NCT04957290|521507784|FG004|Overall Study|study terminated by sponsor|0|||
144631587|NCT04957290|521507785|FG005|Overall Study|study terminated by sponsor|0|||
144631588|NCT01282229|521507786|FG000|Overall Study|Protocol Violation|2|||
144631589|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631590|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631591|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631592|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
144631593|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631594|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
144631595|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631596|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631597|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631598|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631599|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631600|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631601|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631602|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631603|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631604|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631605|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631606|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631607|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631608|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631609|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631610|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631611|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
144631612|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
144631613|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
144631614|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
144631615|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
144631616|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
144631617|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
144631618|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
144631619|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631620|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631621|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631622|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631623|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631624|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631625|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631626|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631627|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631628|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631629|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631630|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631631|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631632|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631633|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631634|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
144631635|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
144631636|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
144631637|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
144631638|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
144631639|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
144631640|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
144631641|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
144631642|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
144631643|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631644|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631645|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631646|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631647|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631648|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631649|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631650|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631651|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631652|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631653|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631654|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631655|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631656|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631657|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
144631658|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631659|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631660|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
144631661|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631662|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
144631663|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631664|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631665|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631666|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631667|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631668|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631669|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631670|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631671|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631672|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631673|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631674|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631675|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144730736|NCT02334722|521869878|FG001|Overall Study|6 week questionnaire not completed|0|||
144631676|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631677|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631678|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631679|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144730737|NCT02334722|521869877|FG000|Overall Study|Unable to obtain medication|1|||
144631680|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
144631681|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
144631682|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631683|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631684|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
144631685|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631686|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631687|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631688|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631689|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631690|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631691|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631692|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631693|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631694|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631695|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631696|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631697|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631698|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631699|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631700|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631701|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631702|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631703|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
144631704|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631705|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631706|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
144631707|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631708|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631709|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631710|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631711|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631712|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631713|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631714|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631715|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631716|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631717|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631718|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631719|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631720|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631721|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631722|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631723|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631724|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631725|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631726|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
144631727|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631728|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631729|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
144631730|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631731|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631732|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631733|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631734|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631735|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631736|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631737|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631738|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631739|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631740|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631741|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631742|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631743|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631744|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631745|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631746|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631747|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631748|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631749|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
144631750|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631751|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631752|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631753|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
144631754|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631755|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631756|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631757|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631758|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631759|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631760|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631761|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631762|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631763|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631764|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631765|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631766|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631767|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631768|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631769|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631770|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631771|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631772|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
144631773|NCT00896532|521507787|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631774|NCT00896532|521507788|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
144631775|NCT00896532|521507789|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631776|NCT00896532|521507790|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
144631777|NCT00896532|521507791|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
144631778|NCT00896532|521507792|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631779|NCT00896532|521507793|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631780|NCT00896532|521507794|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631781|NCT00896532|521507795|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631782|NCT00896532|521507796|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631783|NCT00896532|521507797|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631784|NCT00896532|521507798|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631785|NCT00896532|521507799|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631786|NCT00896532|521507800|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631787|NCT00896532|521507801|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631788|NCT00896532|521507802|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631789|NCT00896532|521507803|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631790|NCT00896532|521507804|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631791|NCT00896532|521507805|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631792|NCT00896532|521507806|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631793|NCT00896532|521507807|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631794|NCT00896532|521507808|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631795|NCT00896532|521507809|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
144631796|NCT00896532|521507787|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631797|NCT00896532|521507788|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631798|NCT00896532|521507789|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631799|NCT00896532|521507790|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631800|NCT00896532|521507791|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631801|NCT00896532|521507792|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631802|NCT00896532|521507793|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631803|NCT00896532|521507794|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631804|NCT00896532|521507795|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
144631805|NCT00896532|521507796|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631806|NCT00896532|521507797|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631807|NCT00896532|521507798|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631808|NCT00896532|521507799|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631809|NCT00896532|521507800|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631810|NCT00896532|521507801|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631811|NCT00896532|521507802|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631812|NCT00896532|521507803|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631813|NCT00896532|521507804|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631814|NCT00896532|521507805|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144209975|NCT02052011|519963575|FG000|Overall Study|Withdrawal by Subject|1|||
144209976|NCT02052011|519963576|FG001|Overall Study|Withdrawal by Subject|2|||
144209977|NCT00000620|519963577|FG000|Overall Study|Death|86|||
144209978|NCT00000620|519963578|FG001|Overall Study|Death|67|||
144209979|NCT00000620|519963579|FG002|Overall Study|Death|112|||
144209980|NCT00000620|519963580|FG003|Overall Study|Death|126|||
144209981|NCT00000620|519963581|FG004|Overall Study|Death|64|||
144209982|NCT00000620|519963582|FG005|Overall Study|Death|77|||
144209983|NCT00000620|519963583|FG006|Overall Study|Death|91|||
144209984|NCT00000620|519963584|FG007|Overall Study|Death|95|||
144209985|NCT00000620|519963577|FG000|Overall Study|Lost to Follow-up|14|||
144209986|NCT00000620|519963578|FG001|Overall Study|Lost to Follow-up|14|||
144209987|NCT00000620|519963579|FG002|Overall Study|Lost to Follow-up|14|||
144631815|NCT00896532|521507806|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631816|NCT00896532|521507807|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631817|NCT00896532|521507808|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631818|NCT00896532|521507809|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
144631819|NCT00896532|521507787|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631820|NCT00896532|521507788|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631821|NCT00896532|521507789|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631822|NCT00896532|521507790|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631823|NCT00896532|521507791|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631824|NCT00896532|521507792|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631825|NCT00896532|521507793|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631826|NCT00896532|521507794|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631827|NCT00896532|521507795|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631828|NCT00896532|521507796|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631829|NCT00896532|521507797|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631830|NCT00896532|521507798|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631831|NCT00896532|521507799|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
144631832|NCT00896532|521507800|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631833|NCT00896532|521507801|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631834|NCT00896532|521507802|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631835|NCT00896532|521507803|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631836|NCT00896532|521507804|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631837|NCT00896532|521507805|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631838|NCT00896532|521507806|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631839|NCT00896532|521507807|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631840|NCT00896532|521507808|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631841|NCT00896532|521507809|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
144631842|NCT00896532|521507787|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631843|NCT00896532|521507788|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631844|NCT00896532|521507789|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631845|NCT00896532|521507790|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631846|NCT00896532|521507791|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631847|NCT00896532|521507792|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631848|NCT00896532|521507793|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631849|NCT00896532|521507794|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631850|NCT00896532|521507795|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631851|NCT00896532|521507796|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631852|NCT00896532|521507797|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
144631853|NCT00896532|521507798|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631854|NCT00896532|521507799|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
144631855|NCT00896532|521507800|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631856|NCT00896532|521507801|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631857|NCT00896532|521507802|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631858|NCT00896532|521507803|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631859|NCT00896532|521507804|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631860|NCT00896532|521507805|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631861|NCT00896532|521507806|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631862|NCT00896532|521507807|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631863|NCT00896532|521507808|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631864|NCT00896532|521507809|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
144631865|NCT00896532|521507787|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631866|NCT00896532|521507788|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631867|NCT00896532|521507789|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631868|NCT00896532|521507790|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631869|NCT00896532|521507791|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631870|NCT00896532|521507792|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631871|NCT00896532|521507793|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631872|NCT00896532|521507794|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631873|NCT00896532|521507795|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631874|NCT00896532|521507796|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631875|NCT00896532|521507797|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631876|NCT00896532|521507798|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631877|NCT00896532|521507799|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
144631878|NCT00896532|521507800|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
144631879|NCT00896532|521507801|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631880|NCT00896532|521507802|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631881|NCT00896532|521507803|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631882|NCT00896532|521507804|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631883|NCT00896532|521507805|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631884|NCT00896532|521507806|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631885|NCT00896532|521507807|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631886|NCT00896532|521507808|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631887|NCT00896532|521507809|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
144631888|NCT00896532|521507787|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
144631889|NCT00896532|521507788|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
144631890|NCT00896532|521507789|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
144631891|NCT00896532|521507790|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
144631892|NCT00896532|521507791|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
144631893|NCT00896532|521507792|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
144631894|NCT00896532|521507793|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
144631895|NCT00896532|521507794|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
144631896|NCT00896532|521507795|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
144631897|NCT00896532|521507796|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
144631898|NCT00896532|521507797|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
144631899|NCT00896532|521507798|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
144631900|NCT00896532|521507799|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
144631901|NCT00896532|521507800|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
144631902|NCT00896532|521507801|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
144631903|NCT00896532|521507802|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
144631904|NCT00896532|521507803|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
144631905|NCT00896532|521507804|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
144631906|NCT00896532|521507805|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
144631907|NCT00896532|521507806|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
144631908|NCT00896532|521507807|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
144631909|NCT00896532|521507808|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
144631910|NCT00896532|521507809|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
144631911|NCT00896532|521507787|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631912|NCT00896532|521507788|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631913|NCT00896532|521507789|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631914|NCT00896532|521507790|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631915|NCT00896532|521507791|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631916|NCT00896532|521507792|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631917|NCT00896532|521507793|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631918|NCT00896532|521507794|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631919|NCT00896532|521507795|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631920|NCT00896532|521507796|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631921|NCT00896532|521507797|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631922|NCT00896532|521507798|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631923|NCT00896532|521507799|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631924|NCT00896532|521507800|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631925|NCT00896532|521507801|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631926|NCT00896532|521507802|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
144631927|NCT00896532|521507803|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
144631928|NCT00896532|521507804|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631929|NCT00896532|521507805|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631930|NCT00896532|521507806|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631931|NCT00896532|521507807|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631932|NCT00896532|521507808|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631933|NCT00896532|521507809|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
144631934|NCT00896532|521507787|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631935|NCT00896532|521507788|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631936|NCT00896532|521507789|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631937|NCT00896532|521507790|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631938|NCT00896532|521507791|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631939|NCT00896532|521507792|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631940|NCT00896532|521507793|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631941|NCT00896532|521507794|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631942|NCT00896532|521507795|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631943|NCT00896532|521507796|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631944|NCT00896532|521507797|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631945|NCT00896532|521507798|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631946|NCT00896532|521507799|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631947|NCT00896532|521507800|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631948|NCT00896532|521507801|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631949|NCT00896532|521507802|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
144631950|NCT00896532|521507803|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
144631951|NCT00896532|521507804|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
144631952|NCT00896532|521507805|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631953|NCT00896532|521507806|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631954|NCT00896532|521507807|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631955|NCT00896532|521507808|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631956|NCT00896532|521507809|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
144631957|NCT00896532|521507787|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631958|NCT00896532|521507788|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631959|NCT00896532|521507789|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631960|NCT00896532|521507790|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631961|NCT00896532|521507791|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631962|NCT00896532|521507792|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631963|NCT00896532|521507793|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631964|NCT00896532|521507794|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631965|NCT00896532|521507795|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631966|NCT00896532|521507796|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144730738|NCT02334722|521869878|FG001|Overall Study|Unable to obtain medication|1|||
144631967|NCT00896532|521507797|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631968|NCT00896532|521507798|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631969|NCT00896532|521507799|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631970|NCT00896532|521507800|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631971|NCT00896532|521507801|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631972|NCT00896532|521507802|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631973|NCT00896532|521507803|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
144631974|NCT00896532|521507804|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631975|NCT00896532|521507805|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631976|NCT00896532|521507806|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631977|NCT00896532|521507807|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631978|NCT00896532|521507808|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631979|NCT00896532|521507809|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
144631980|NCT00896532|521507787|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
144631981|NCT00896532|521507788|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
144631982|NCT00896532|521507789|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
144631983|NCT00896532|521507790|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
144631984|NCT00896532|521507791|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
144631985|NCT00896532|521507792|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
144631986|NCT00896532|521507793|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
144631987|NCT00896532|521507794|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
144631988|NCT00896532|521507795|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
144730739|NCT02334722|521869877|FG000|Overall Study|Withdrawal by Subject|0|||
144730740|NCT02334722|521869878|FG001|Overall Study|Withdrawal by Subject|3|||
144730741|NCT02334722|521869877|FG000|Overall Study|Adverse Event|0|||
144730742|NCT02334722|521869878|FG001|Overall Study|Adverse Event|2|||
144730743|NCT02334722|521869877|FG000|Overall Study|Physician Decision|0|||
144730744|NCT02334722|521869878|FG001|Overall Study|Physician Decision|1|||
144730745|NCT00239577|521869879|FG000|Primary Phase|Adverse Event|0|||
144730746|NCT00239577|521869880|FG001|Primary Phase|Adverse Event|0|||
144631989|NCT00896532|521507796|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
144631990|NCT00896532|521507797|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
144631991|NCT00896532|521507798|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
144730747|NCT00239577|521869881|FG002|Primary Phase|Adverse Event|1|||
144730748|NCT00239577|521869882|FG003|Primary Phase|Adverse Event|0|||
144631992|NCT00896532|521507799|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
144631993|NCT00896532|521507800|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
144631994|NCT00896532|521507801|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
144631995|NCT00896532|521507802|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
144631996|NCT00896532|521507803|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
144631997|NCT00896532|521507804|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
144631998|NCT00896532|521507805|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
144631999|NCT00896532|521507806|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
144632000|NCT00896532|521507807|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
144632001|NCT00896532|521507808|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
144632002|NCT00896532|521507809|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
144632003|NCT00896532|521507787|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632004|NCT00896532|521507788|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632005|NCT00896532|521507789|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632006|NCT00896532|521507790|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632007|NCT00896532|521507791|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632008|NCT00896532|521507792|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632009|NCT00896532|521507793|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632010|NCT00896532|521507794|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632011|NCT00896532|521507795|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632012|NCT00896532|521507796|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632013|NCT00896532|521507797|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632014|NCT00896532|521507798|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632015|NCT00896532|521507799|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632016|NCT00896532|521507800|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632017|NCT00896532|521507801|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632018|NCT00896532|521507802|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632019|NCT00896532|521507803|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
144632020|NCT00896532|521507804|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632021|NCT00896532|521507805|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632022|NCT00896532|521507806|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632023|NCT00896532|521507807|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632024|NCT00896532|521507808|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632025|NCT00896532|521507809|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
144632026|NCT00896532|521507787|FG000|Months 48-72: Follow-on Phase|Death|0|||
144632027|NCT00896532|521507788|FG001|Months 48-72: Follow-on Phase|Death|0|||
144632028|NCT00896532|521507789|FG002|Months 48-72: Follow-on Phase|Death|0|||
144632029|NCT00896532|521507790|FG003|Months 48-72: Follow-on Phase|Death|0|||
144632030|NCT00896532|521507791|FG004|Months 48-72: Follow-on Phase|Death|0|||
144632031|NCT00896532|521507792|FG005|Months 48-72: Follow-on Phase|Death|0|||
144632032|NCT00896532|521507793|FG006|Months 48-72: Follow-on Phase|Death|0|||
144632033|NCT00896532|521507794|FG007|Months 48-72: Follow-on Phase|Death|0|||
144632034|NCT00896532|521507795|FG008|Months 48-72: Follow-on Phase|Death|0|||
144632035|NCT00896532|521507796|FG009|Months 48-72: Follow-on Phase|Death|0|||
144632036|NCT00896532|521507797|FG010|Months 48-72: Follow-on Phase|Death|0|||
144632037|NCT00896532|521507798|FG011|Months 48-72: Follow-on Phase|Death|0|||
144632038|NCT00896532|521507799|FG012|Months 48-72: Follow-on Phase|Death|0|||
144632039|NCT00896532|521507800|FG013|Months 48-72: Follow-on Phase|Death|0|||
144632040|NCT00896532|521507801|FG014|Months 48-72: Follow-on Phase|Death|0|||
144632041|NCT00896532|521507802|FG015|Months 48-72: Follow-on Phase|Death|0|||
144632042|NCT00896532|521507803|FG016|Months 48-72: Follow-on Phase|Death|0|||
144632043|NCT00896532|521507804|FG017|Months 48-72: Follow-on Phase|Death|0|||
144632044|NCT00896532|521507805|FG018|Months 48-72: Follow-on Phase|Death|1|||
144632045|NCT00896532|521507806|FG019|Months 48-72: Follow-on Phase|Death|0|||
144632046|NCT00896532|521507807|FG020|Months 48-72: Follow-on Phase|Death|0|||
144632047|NCT00896532|521507808|FG021|Months 48-72: Follow-on Phase|Death|0|||
144632048|NCT00896532|521507809|FG022|Months 48-72: Follow-on Phase|Death|0|||
144632049|NCT00896532|521507787|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632050|NCT00896532|521507788|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632051|NCT00896532|521507789|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632052|NCT00896532|521507790|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632053|NCT00896532|521507791|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632054|NCT00896532|521507792|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632055|NCT00896532|521507793|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632056|NCT00896532|521507794|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144209988|NCT00000620|519963580|FG003|Overall Study|Lost to Follow-up|14|||
144632057|NCT00896532|521507795|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632058|NCT00896532|521507796|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632059|NCT00896532|521507797|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632060|NCT00896532|521507798|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144730749|NCT00239577|521869879|FG000|Primary Phase|Other|5|||
144730750|NCT00239577|521869880|FG001|Primary Phase|Other|3|||
144730751|NCT00239577|521869881|FG002|Primary Phase|Other|2|||
144730752|NCT00239577|521869882|FG003|Primary Phase|Other|0|||
144730753|NCT00925769|521869884|FG000|Overall Study|Major toxicity|1|||
144632061|NCT00896532|521507799|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632062|NCT00896532|521507800|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632063|NCT00896532|521507801|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632064|NCT00896532|521507802|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632065|NCT00896532|521507803|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632066|NCT00896532|521507804|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632067|NCT00896532|521507805|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632068|NCT00896532|521507806|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632069|NCT00896532|521507807|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632070|NCT00896532|521507808|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
144632071|NCT00896532|521507809|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
144632072|NCT00896532|521507787|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632073|NCT00896532|521507788|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632074|NCT00896532|521507789|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632075|NCT00896532|521507790|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632076|NCT00896532|521507791|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632077|NCT00896532|521507792|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632078|NCT00896532|521507793|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632079|NCT00896532|521507794|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632080|NCT00896532|521507795|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632081|NCT00896532|521507796|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632082|NCT00896532|521507797|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632083|NCT00896532|521507798|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632084|NCT00896532|521507799|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632085|NCT00896532|521507800|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632086|NCT00896532|521507801|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632087|NCT00896532|521507802|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632088|NCT00896532|521507803|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632089|NCT00896532|521507804|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632090|NCT00896532|521507805|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632091|NCT00896532|521507806|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632092|NCT00896532|521507807|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632093|NCT00896532|521507808|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
144632094|NCT00896532|521507809|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
144632095|NCT02411747|521507810|FG000|Overall Study|Withdrawal by Subject|1|||
144632096|NCT02411747|521507811|FG001|Overall Study|Withdrawal by Subject|0|||
144632097|NCT02411747|521507810|FG000|Overall Study|Protocol Violation|2|||
144632098|NCT02411747|521507811|FG001|Overall Study|Protocol Violation|4|||
144632099|NCT02149810|521507812|FG000|Overall Study|Physician Decision|1|||
144632100|NCT02149810|521507813|FG001|Overall Study|Physician Decision|2|||
144632101|NCT02149810|521507812|FG000|Overall Study|Lost to Follow-up|2|||
144632102|NCT02149810|521507813|FG001|Overall Study|Lost to Follow-up|1|||
144632103|NCT02149810|521507812|FG000|Overall Study|Withdrawal by Subject|5|||
144632104|NCT02149810|521507813|FG001|Overall Study|Withdrawal by Subject|1|||
144632105|NCT00675597|521507814|FG000|Overall Study|Withdrawal by Subject|3|||
144632106|NCT01176916|521507815|FG000|Overall Study|Adverse Event|61|||
144632107|NCT01176916|521507815|FG000|Overall Study|Death|1|||
144632108|NCT01176916|521507815|FG000|Overall Study|Lost to Follow-up|15|||
144632109|NCT01176916|521507815|FG000|Overall Study|Objective progression or relapse|17|||
144632110|NCT01176916|521507815|FG000|Overall Study|Protocol Violation|24|||
144632111|NCT01176916|521507815|FG000|Overall Study|Withdrawal by Subject|37|||
144632112|NCT01176916|521507815|FG000|Overall Study|Other|6|||
144632113|NCT01176916|521507815|FG000|Overall Study|Withdrawal prior to Treatment|6|||
144632114|NCT00996203|521507818|FG000|Overall Study|Adverse Event|3|||
144632115|NCT00996203|521507818|FG000|Overall Study|Lost to Follow-up|1|||
144730754|NCT00925769|521869885|FG001|Overall Study|Major toxicity|0|||
144209989|NCT00000620|519963581|FG004|Overall Study|Lost to Follow-up|15|||
144632116|NCT00996203|521507818|FG000|Overall Study|Lack of Efficacy|1|||
144632117|NCT00996203|521507818|FG000|Overall Study|Protocol Violation|2|||
144632118|NCT01671280|521507819|FG000|Overall Study|Withdrawal by Subject|2|||
144632119|NCT01959165|521507820|FG000|Overall Study|Adverse Event|0|||
144730755|NCT00925769|521869886|FG002|Overall Study|Major toxicity|1|||
144730756|NCT00925769|521869887|FG003|Overall Study|Major toxicity|1|||
144632120|NCT01959165|521507821|FG001|Overall Study|Adverse Event|0|||
144209990|NCT00000620|519963582|FG005|Overall Study|Lost to Follow-up|15|||
144209991|NCT00000620|519963583|FG006|Overall Study|Lost to Follow-up|13|||
144209992|NCT00000620|519963584|FG007|Overall Study|Lost to Follow-up|14|||
144209993|NCT00000620|519963577|FG000|Overall Study|Withdrawal by Subject|40|||
144632121|NCT01959165|521507822|FG002|Overall Study|Adverse Event|0|||
144632122|NCT01959165|521507823|FG003|Overall Study|Adverse Event|1|||
144632123|NCT01959165|521507820|FG000|Overall Study|Lack of Efficacy|1|||
144632124|NCT01959165|521507821|FG001|Overall Study|Lack of Efficacy|0|||
144632125|NCT01959165|521507822|FG002|Overall Study|Lack of Efficacy|0|||
144632126|NCT01959165|521507823|FG003|Overall Study|Lack of Efficacy|0|||
144632127|NCT01959165|521507820|FG000|Overall Study|overdose|0|||
144632128|NCT01959165|521507821|FG001|Overall Study|overdose|0|||
144632129|NCT01959165|521507822|FG002|Overall Study|overdose|0|||
144632130|NCT01959165|521507823|FG003|Overall Study|overdose|1|||
144632131|NCT01959165|521507820|FG000|Overall Study|Welfare recipient|0|||
144632132|NCT01959165|521507821|FG001|Overall Study|Welfare recipient|1|||
144632133|NCT01959165|521507822|FG002|Overall Study|Welfare recipient|0|||
144632134|NCT01959165|521507823|FG003|Overall Study|Welfare recipient|0|||
144632135|NCT03686969|521507824|FG000|Overall Study|Study terminated|1|||
144632136|NCT03686969|521507825|FG001|Overall Study|Study terminated|0|||
144632137|NCT01988090|521507826|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
144632138|NCT01988090|521507827|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
144632139|NCT01988090|521507826|FG000|Start Treament After Randomization|Protocol Violation|0|||
144632140|NCT01988090|521507827|FG001|Start Treament After Randomization|Protocol Violation|1|||
144632141|NCT01988090|521507826|FG000|Complete Study After Start|Withdrawal by Subject|2|||
144632142|NCT01988090|521507827|FG001|Complete Study After Start|Withdrawal by Subject|0|||
144632143|NCT01988090|521507826|FG000|Complete Study After Start|Protocol Violation|1|||
144632144|NCT01988090|521507827|FG001|Complete Study After Start|Protocol Violation|1|||
144632145|NCT03094195|521507828|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
144632146|NCT03094195|521507829|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
144632147|NCT03094195|521507830|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
144632148|NCT03094195|521507831|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144632149|NCT03094195|521507832|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144632150|NCT03094195|521507833|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144632151|NCT03094195|521507834|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144632152|NCT03094195|521507835|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
144632153|NCT03094195|521507828|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
144632154|NCT03094195|521507829|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
144632155|NCT03094195|521507830|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
144632156|NCT03094195|521507831|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144632157|NCT03094195|521507832|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144632158|NCT03094195|521507833|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144632159|NCT03094195|521507834|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144632160|NCT03094195|521507835|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
144632161|NCT03094195|521507828|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632162|NCT03094195|521507829|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632163|NCT03094195|521507830|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
144632164|NCT03094195|521507831|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632165|NCT03094195|521507832|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632166|NCT03094195|521507833|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632167|NCT03094195|521507834|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632168|NCT03094195|521507835|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
144632169|NCT03094195|521507828|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144632170|NCT03094195|521507829|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
144632171|NCT03094195|521507830|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
144632172|NCT03094195|521507831|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144632173|NCT03094195|521507832|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144632174|NCT03094195|521507833|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144632175|NCT03094195|521507834|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144209994|NCT00000620|519963578|FG001|Overall Study|Withdrawal by Subject|27|||
144209995|NCT00000620|519963579|FG002|Overall Study|Withdrawal by Subject|28|||
144209996|NCT00000620|519963580|FG003|Overall Study|Withdrawal by Subject|27|||
144632176|NCT03094195|521507835|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
144632177|NCT03887130|521507843|FG000|Overall Study|Progressive disease|23|||
144632178|NCT03887130|521507844|FG001|Overall Study|Progressive disease|14|||
144632179|NCT03887130|521507845|FG002|Overall Study|Progressive disease|7|||
144632180|NCT03887130|521507843|FG000|Overall Study|Protocol Violation|3|||
144632181|NCT03887130|521507844|FG001|Overall Study|Protocol Violation|1|||
144632182|NCT03887130|521507845|FG002|Overall Study|Protocol Violation|2|||
144632183|NCT03887130|521507843|FG000|Overall Study|Drug related toxicity|7|||
144632184|NCT03887130|521507844|FG001|Overall Study|Drug related toxicity|7|||
144632185|NCT03887130|521507845|FG002|Overall Study|Drug related toxicity|13|||
144632186|NCT03887130|521507843|FG000|Overall Study|Non drug related toxicity|3|||
144632187|NCT03887130|521507844|FG001|Overall Study|Non drug related toxicity|0|||
144632188|NCT03887130|521507845|FG002|Overall Study|Non drug related toxicity|0|||
144632189|NCT03887130|521507843|FG000|Overall Study|Death|2|||
144632190|NCT03887130|521507844|FG001|Overall Study|Death|2|||
144632191|NCT03887130|521507845|FG002|Overall Study|Death|1|||
144632192|NCT03887130|521507843|FG000|Overall Study|Withdrawal by Subject|7|||
144632193|NCT03887130|521507844|FG001|Overall Study|Withdrawal by Subject|6|||
144632194|NCT03887130|521507845|FG002|Overall Study|Withdrawal by Subject|11|||
144632195|NCT03887130|521507843|FG000|Overall Study|other reason|6|||
144632196|NCT03887130|521507844|FG001|Overall Study|other reason|20|||
144632197|NCT03887130|521507845|FG002|Overall Study|other reason|17|||
144632198|NCT00927563|521507846|FG000|Overall Study|Lost to Follow-up|1|||
144632199|NCT00927563|521507846|FG000|Overall Study|Withdrawal by Subject|1|||
144632200|NCT02899156|521507850|FG000|Overall Study|Death|1|||
144632201|NCT02899156|521507851|FG001|Overall Study|Death|0|||
144632202|NCT02899156|521507850|FG000|Overall Study|Physician Decision|0|||
144632203|NCT02899156|521507851|FG001|Overall Study|Physician Decision|1|||
144632204|NCT02116621|521507852|FG000|Baseline|Withdrawal by Subject|0|||
144632205|NCT02116621|521507853|FG001|Baseline|Withdrawal by Subject|4|||
144632206|NCT02116621|521507852|FG000|Three Month Follow-up|Death|1|||
144632207|NCT02116621|521507853|FG001|Three Month Follow-up|Death|1|||
144632208|NCT02116621|521507852|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
144632209|NCT02116621|521507853|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
144632210|NCT02116621|521507852|FG000|Three Month Follow-up|Lost to Follow-up|0|||
144632211|NCT02116621|521507853|FG001|Three Month Follow-up|Lost to Follow-up|1|||
144632212|NCT02116621|521507852|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
144632213|NCT02116621|521507853|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
144632214|NCT02116621|521507852|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
144632215|NCT02116621|521507853|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
144632216|NCT02116621|521507852|FG000|Six Month Follow-up|Lost to Follow-up|2|||
144632217|NCT02116621|521507853|FG001|Six Month Follow-up|Lost to Follow-up|1|||
144632218|NCT02116621|521507852|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
144632219|NCT02116621|521507853|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
144632220|NCT02116621|521507852|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
144632221|NCT02116621|521507853|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
144632222|NCT02116621|521507852|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
144632223|NCT02116621|521507853|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
144632224|NCT02116621|521507852|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
144632225|NCT02116621|521507853|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
144632226|NCT02116621|521507852|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
144632227|NCT02116621|521507853|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
144632228|NCT00961961|521507854|FG000|Phase I|Withdrawal by Subject|7|||
144632229|NCT00961961|521507855|FG001|Phase I|Withdrawal by Subject|0|||
144632230|NCT00961961|521507856|FG002|Phase I|Withdrawal by Subject|0|||
144632231|NCT00961961|521507857|FG003|Phase I|Withdrawal by Subject|0|||
144632232|NCT00961961|521507854|FG000|Phase I|Lost to Follow-up|10|||
144632233|NCT00961961|521507855|FG001|Phase I|Lost to Follow-up|0|||
144632234|NCT00961961|521507856|FG002|Phase I|Lost to Follow-up|0|||
144632235|NCT00961961|521507857|FG003|Phase I|Lost to Follow-up|0|||
144632236|NCT00961961|521507854|FG000|Phase I|Lack of Efficacy|94|||
144632237|NCT00961961|521507855|FG001|Phase I|Lack of Efficacy|0|||
144632238|NCT00961961|521507856|FG002|Phase I|Lack of Efficacy|0|||
144632239|NCT00961961|521507857|FG003|Phase I|Lack of Efficacy|0|||
144632240|NCT00961961|521507854|FG000|Phase I|Adverse Event|7|||
144632241|NCT00961961|521507855|FG001|Phase I|Adverse Event|0|||
144730757|NCT00925769|521869888|FG004|Overall Study|Major toxicity|0|||
144730758|NCT00925769|521869889|FG005|Overall Study|Major toxicity|0|||
144730759|NCT00925769|521869884|FG000|Overall Study|Disease progression|4|||
144730760|NCT00925769|521869885|FG001|Overall Study|Disease progression|5|||
144632242|NCT00961961|521507856|FG002|Phase I|Adverse Event|0|||
144632243|NCT00961961|521507857|FG003|Phase I|Adverse Event|0|||
144632244|NCT00961961|521507854|FG000|Phase I|Physician Decision|8|||
144632245|NCT00961961|521507855|FG001|Phase I|Physician Decision|0|||
144632246|NCT00961961|521507856|FG002|Phase I|Physician Decision|0|||
144632247|NCT00961961|521507857|FG003|Phase I|Physician Decision|0|||
144730761|NCT00925769|521869886|FG002|Overall Study|Disease progression|3|||
144632248|NCT00961961|521507854|FG000|Phase II|Lost to Follow-up|0|||
144632249|NCT00961961|521507855|FG001|Phase II|Lost to Follow-up|0|||
144632250|NCT00961961|521507856|FG002|Phase II|Lost to Follow-up|10|||
144632251|NCT00961961|521507857|FG003|Phase II|Lost to Follow-up|7|||
144632252|NCT00961961|521507854|FG000|Phase II|Adverse Event|0|||
144632253|NCT00961961|521507855|FG001|Phase II|Adverse Event|0|||
144632254|NCT00961961|521507856|FG002|Phase II|Adverse Event|0|||
144632255|NCT00961961|521507857|FG003|Phase II|Adverse Event|1|||
144632256|NCT00961961|521507854|FG000|Phase II|Physician Decision|0|||
144632257|NCT00961961|521507855|FG001|Phase II|Physician Decision|0|||
144730762|NCT00925769|521869887|FG003|Overall Study|Disease progression|4|||
144632258|NCT00961961|521507856|FG002|Phase II|Physician Decision|1|||
144632259|NCT00961961|521507857|FG003|Phase II|Physician Decision|0|||
144632260|NCT00961961|521507854|FG000|Phase II|Withdrawal by Subject|0|||
144632261|NCT00961961|521507855|FG001|Phase II|Withdrawal by Subject|0|||
144632262|NCT00961961|521507856|FG002|Phase II|Withdrawal by Subject|1|||
144632263|NCT00961961|521507857|FG003|Phase II|Withdrawal by Subject|0|||
144632264|NCT01412957|521507858|FG000|Overall Study|Withdrawal by Subject|6|||
144632265|NCT01412957|521507859|FG001|Overall Study|Withdrawal by Subject|22|||
144632266|NCT01412957|521507858|FG000|Overall Study|Lost to Follow-up|7|||
144632267|NCT01412957|521507859|FG001|Overall Study|Lost to Follow-up|2|||
144632268|NCT01412957|521507858|FG000|Overall Study|Death|136|||
144632269|NCT01412957|521507859|FG001|Overall Study|Death|133|||
144632270|NCT00484315|521507860|FG000|12-Month Clinical Follow-up|Death|6|||
144632271|NCT00484315|521507861|FG001|12-Month Clinical Follow-up|Death|2|||
144632272|NCT00484315|521507860|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
144632273|NCT00484315|521507861|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
144632274|NCT00484315|521507860|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
144632275|NCT00484315|521507861|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
144632276|NCT00484315|521507860|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
144632277|NCT00484315|521507861|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
144632278|NCT00484315|521507860|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
144632279|NCT00484315|521507861|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
144632280|NCT00484315|521507860|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
144632281|NCT00484315|521507861|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
144632282|NCT00484315|521507860|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
144632283|NCT00484315|521507861|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
144632284|NCT00943683|521507862|FG000|Overall Study|Adverse Event|3|||
144632285|NCT00943683|521507863|FG001|Overall Study|Adverse Event|3|||
144632286|NCT00943683|521507862|FG000|Overall Study|Lost to Follow-up|1|||
144632287|NCT00943683|521507863|FG001|Overall Study|Lost to Follow-up|1|||
144632288|NCT00943683|521507862|FG000|Overall Study|Protocol Violation|1|||
144632289|NCT00943683|521507863|FG001|Overall Study|Protocol Violation|2|||
144632290|NCT00943683|521507862|FG000|Overall Study|Withdrawal by Subject|1|||
144632291|NCT00943683|521507863|FG001|Overall Study|Withdrawal by Subject|0|||
144632292|NCT00943683|521507862|FG000|Overall Study|Patient Moved|1|||
144632293|NCT00943683|521507863|FG001|Overall Study|Patient Moved|0|||
144632294|NCT01245673|521507864|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
144632295|NCT00413959|521507865|FG000|Overall Study|Pt had only one cycle.|1|||
144632296|NCT00630331|521507866|FG000|Overall Study|Death|2|||
144632297|NCT00630331|521507867|FG001|Overall Study|Death|1|||
144632298|NCT00630331|521507868|FG002|Overall Study|Death|1|||
144632299|NCT00630331|521507866|FG000|Overall Study|Adverse Event|1|||
144632300|NCT00630331|521507867|FG001|Overall Study|Adverse Event|0|||
144632301|NCT00630331|521507868|FG002|Overall Study|Adverse Event|0|||
144632302|NCT00630331|521507866|FG000|Overall Study|Withdrawal by Subject|12|||
144632303|NCT00630331|521507867|FG001|Overall Study|Withdrawal by Subject|7|||
144632304|NCT00630331|521507868|FG002|Overall Study|Withdrawal by Subject|5|||
144632305|NCT00630331|521507866|FG000|Overall Study|Lost to Follow-up|175|||
144632306|NCT00630331|521507867|FG001|Overall Study|Lost to Follow-up|143|||
144632307|NCT00630331|521507868|FG002|Overall Study|Lost to Follow-up|170|||
144632308|NCT00630331|521507866|FG000|Overall Study|Inappropriate enrollment|3|||
144632309|NCT00630331|521507867|FG001|Overall Study|Inappropriate enrollment|6|||
144632310|NCT00630331|521507868|FG002|Overall Study|Inappropriate enrollment|3|||
144632311|NCT00630331|521507866|FG000|Overall Study|Unable to classify|9|||
144632312|NCT00630331|521507867|FG001|Overall Study|Unable to classify|4|||
144632313|NCT00630331|521507868|FG002|Overall Study|Unable to classify|3|||
144632314|NCT00630331|521507866|FG000|Overall Study|Protocol Violation|4|||
144632315|NCT00630331|521507867|FG001|Overall Study|Protocol Violation|5|||
144632316|NCT00630331|521507868|FG002|Overall Study|Protocol Violation|6|||
144632317|NCT02425098|521507869|FG000|Overall Study|Lost to Follow-up|7|||
144632318|NCT02425098|521507870|FG001|Overall Study|Lost to Follow-up|7|||
144632319|NCT02425098|521507869|FG000|Overall Study|Withdrawal by Subject|4|||
144632320|NCT02425098|521507870|FG001|Overall Study|Withdrawal by Subject|8|||
144632321|NCT02425098|521507869|FG000|Overall Study|Pregnancy|2|||
144632322|NCT02425098|521507870|FG001|Overall Study|Pregnancy|0|||
144632323|NCT02425098|521507869|FG000|Overall Study|Reason not Specified|0|||
144632324|NCT02425098|521507870|FG001|Overall Study|Reason not Specified|1|||
144632325|NCT02292771|521507879|FG000|Overall Study|Withdrawal by Subject|2|||
144632326|NCT02292771|521507880|FG001|Overall Study|Withdrawal by Subject|1|||
144632327|NCT02292771|521507879|FG000|Overall Study|Lost to Follow-up|2|||
144632328|NCT02292771|521507880|FG001|Overall Study|Lost to Follow-up|1|||
144632329|NCT03219164|521510025|FG000|Overall Study|Study Terminated by Sponsor|16|||
144632330|NCT03219164|521510026|FG001|Overall Study|Study Terminated by Sponsor|12|||
144632331|NCT03219164|521510025|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
144632332|NCT03219164|521510026|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
144632333|NCT03219164|521510025|FG000|Overall Study|Lost to Follow-up|1|||
144632334|NCT03219164|521510026|FG001|Overall Study|Lost to Follow-up|1|||
144632335|NCT03219164|521510025|FG000|Overall Study|Adverse Event|1|||
144632336|NCT03219164|521510026|FG001|Overall Study|Adverse Event|0|||
144632337|NCT03219164|521510025|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144632338|NCT03219164|521510026|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144632339|NCT03219164|521510025|FG000|Overall Study|Protocol Violation|0|||
144632340|NCT03219164|521510026|FG001|Overall Study|Protocol Violation|1|||
144632341|NCT03219164|521510025|FG000|Overall Study|Withdrew Assent|1|||
144632342|NCT03219164|521510026|FG001|Overall Study|Withdrew Assent|0|||
144632343|NCT02689492|521510027|FG000|Overall Study|Lost to Follow-up|61|||
144632344|NCT02689492|521510027|FG000|Overall Study|Withdrawal by Subject|11|||
144632345|NCT02689492|521510027|FG000|Overall Study|Death|9|||
144632346|NCT02689492|521510027|FG000|Overall Study|Physician Decision|2|||
144632347|NCT02689492|521510027|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
144632348|NCT02689492|521510027|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
144632349|NCT02689492|521510027|FG000|Overall Study|Other than listed|1|||
144632350|NCT02732951|521510028|FG000|Overall Study|Other than listed|1|||
144632351|NCT02732951|521510029|FG001|Overall Study|Other than listed|0|||
144632352|NCT02732951|521510028|FG000|Overall Study|Lost to Follow-up|0|||
144632353|NCT02732951|521510029|FG001|Overall Study|Lost to Follow-up|1|||
144632354|NCT02732951|521510028|FG000|Overall Study|Adverse Event|4|||
144632355|NCT02732951|521510029|FG001|Overall Study|Adverse Event|4|||
144632356|NCT02732951|521510028|FG000|Overall Study|Protocol Violation|0|||
144632357|NCT02732951|521510029|FG001|Overall Study|Protocol Violation|1|||
144632358|NCT00110305|521510031|FG000|Overall Study|Adverse Event|46|||
144632359|NCT00110305|521510032|FG001|Overall Study|Adverse Event|13|||
144632360|NCT00110305|521510031|FG000|Overall Study|Sponsors Decision|1|||
144632361|NCT00110305|521510032|FG001|Overall Study|Sponsors Decision|0|||
144632362|NCT00110305|521510031|FG000|Overall Study|Subject Non-Compliant|9|||
144632363|NCT00110305|521510032|FG001|Overall Study|Subject Non-Compliant|2|||
144632364|NCT00110305|521510031|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
144632365|NCT00110305|521510032|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
144632366|NCT00110305|521510031|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
144632367|NCT00110305|521510032|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
144632368|NCT00110305|521510031|FG000|Overall Study|Protocol Violation|0|||
144632369|NCT00110305|521510032|FG001|Overall Study|Protocol Violation|1|||
144632370|NCT00110305|521510031|FG000|Overall Study|Withdrawal by Subject|7|||
144632371|NCT00110305|521510032|FG001|Overall Study|Withdrawal by Subject|7|||
144632372|NCT00110305|521510031|FG000|Overall Study|Lost to Follow-up|20|||
144632373|NCT00110305|521510032|FG001|Overall Study|Lost to Follow-up|3|||
144632374|NCT00110305|521510031|FG000|Overall Study|Other|8|||
144632375|NCT00110305|521510032|FG001|Overall Study|Other|2|||
144632376|NCT05047523|521510035|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
144632377|NCT05047523|521510036|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
144632378|NCT05047523|521510037|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
144632379|NCT05047523|521510038|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
144632380|NCT05047523|521510039|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
144632381|NCT05047523|521510040|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
144632382|NCT05047523|521510035|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144632383|NCT05047523|521510036|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
144632384|NCT05047523|521510037|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144632385|NCT05047523|521510038|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144632386|NCT05047523|521510039|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144632387|NCT05047523|521510040|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
144632388|NCT05047523|521510035|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
144632389|NCT05047523|521510036|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
144632390|NCT05047523|521510037|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
144632391|NCT05047523|521510038|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
144632392|NCT05047523|521510039|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
144632393|NCT05047523|521510040|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
144632394|NCT05047523|521510035|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
144632395|NCT05047523|521510036|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144730763|NCT00925769|521869888|FG004|Overall Study|Disease progression|2|||
144632396|NCT05047523|521510037|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144632397|NCT05047523|521510038|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144632398|NCT05047523|521510039|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144632399|NCT05047523|521510040|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
144632400|NCT05047523|521510035|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
144632401|NCT05047523|521510036|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
144632402|NCT05047523|521510037|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
144632403|NCT05047523|521510038|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
144730764|NCT00925769|521869889|FG005|Overall Study|Disease progression|3|||
144632404|NCT05047523|521510039|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
144632405|NCT05047523|521510040|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
144632406|NCT05047523|521510035|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
144632407|NCT05047523|521510036|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
144632408|NCT05047523|521510037|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
144632409|NCT05047523|521510038|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
144632410|NCT05047523|521510039|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
144632411|NCT05047523|521510040|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
144632412|NCT00224016|521510045|FG000|Titration Period|Withdrawal by Subject|0|||
144632413|NCT00224016|521510046|FG001|Titration Period|Withdrawal by Subject|1|||
144632414|NCT00224016|521510045|FG000|Titration Period|Lost to Follow-up|1|||
144632415|NCT00224016|521510046|FG001|Titration Period|Lost to Follow-up|0|||
144632416|NCT00224016|521510045|FG000|Maintenance Period|Withdrawal by Subject|2|||
144632417|NCT00224016|521510046|FG001|Maintenance Period|Withdrawal by Subject|0|||
144632418|NCT00224016|521510045|FG000|Maintenance Period|Lost to Follow-up|0|||
144632419|NCT00224016|521510046|FG001|Maintenance Period|Lost to Follow-up|1|||
144632420|NCT01524991|521510049|FG000|Overall Study|Adverse Event|12|||
144632421|NCT01524991|521510049|FG000|Overall Study|Death|1|||
144632422|NCT01524991|521510049|FG000|Overall Study|Disease ProgressionDu|17|||
144632423|NCT01524991|521510049|FG000|Overall Study|Other complicating disease|1|||
144632424|NCT01524991|521510049|FG000|Overall Study|Withdrawal by Subject|2|||
144632425|NCT01524991|521510049|FG000|Overall Study|Symptomatic Deterioration|1|||
144632426|NCT01805180|521510050|FG000|Lead-in Donor Phase|screen failure|1|||
144632427|NCT01805180|521510051|FG001|Lead-in Donor Phase|screen failure|0|||
144632428|NCT01805180|521510052|FG002|Lead-in Donor Phase|screen failure|0|||
144632429|NCT04574999|521510055|FG000|Overall Study|Adverse Event|1|||
144632430|NCT04574999|521510056|FG001|Overall Study|Adverse Event|0|||
144632431|NCT04574999|521510055|FG000|Overall Study|Lack of Efficacy|2|||
144632432|NCT04574999|521510056|FG001|Overall Study|Lack of Efficacy|3|||
144632433|NCT04574999|521510055|FG000|Overall Study|Protocol Violation|1|||
144632434|NCT04574999|521510056|FG001|Overall Study|Protocol Violation|0|||
144632435|NCT04574999|521510055|FG000|Overall Study|Withdrawal by Subject|2|||
144632436|NCT04574999|521510056|FG001|Overall Study|Withdrawal by Subject|2|||
144632437|NCT04574999|521510055|FG000|Overall Study|Lost to Follow-up|1|||
144632438|NCT04574999|521510056|FG001|Overall Study|Lost to Follow-up|0|||
144632439|NCT04574999|521510055|FG000|Overall Study|Personal problems|1|||
144632440|NCT04574999|521510056|FG001|Overall Study|Personal problems|0|||
144632441|NCT04574999|521510055|FG000|Overall Study|Previous planned surgery|1|||
144632442|NCT04574999|521510056|FG001|Overall Study|Previous planned surgery|0|||
144632443|NCT00008385|521510076|FG000|Overall Study|Off treatment reasons not reported|79|||
144632444|NCT00008385|521510077|FG001|Overall Study|Off treatment reasons not reported|70|||
144632445|NCT00008385|521510076|FG000|Overall Study|Progressive disease|52|||
144632446|NCT00008385|521510077|FG001|Overall Study|Progressive disease|117|||
144632447|NCT00008385|521510076|FG000|Overall Study|Adverse Event|8|||
144632448|NCT00008385|521510077|FG001|Overall Study|Adverse Event|20|||
144632449|NCT00008385|521510076|FG000|Overall Study|Death|12|||
144632450|NCT00008385|521510077|FG001|Overall Study|Death|18|||
144632451|NCT00008385|521510076|FG000|Overall Study|Withdrawal by Subject|67|||
144632452|NCT00008385|521510077|FG001|Overall Study|Withdrawal by Subject|157|||
144632453|NCT00008385|521510076|FG000|Overall Study|Start non-protocol therapy|3|||
144632454|NCT00008385|521510077|FG001|Overall Study|Start non-protocol therapy|1|||
144632455|NCT00008385|521510076|FG000|Overall Study|Other complicating disease|17|||
144632456|NCT00008385|521510077|FG001|Overall Study|Other complicating disease|30|||
144632457|NCT00008385|521510076|FG000|Overall Study|Maximum dose reached|0|||
144632458|NCT00008385|521510077|FG001|Overall Study|Maximum dose reached|2|||
144632459|NCT00008385|521510076|FG000|Overall Study|Other|105|||
144632460|NCT00008385|521510077|FG001|Overall Study|Other|212|||
144632461|NCT00008385|521510076|FG000|Overall Study|Not start protocol therapy|44|||
144632462|NCT00008385|521510077|FG001|Overall Study|Not start protocol therapy|175|||
144632463|NCT05148884|521510078|FG000|Overall Study|Withdrawal by Subject|3|||
144632464|NCT05148884|521510079|FG001|Overall Study|Withdrawal by Subject|0|||
144632465|NCT05148884|521510078|FG000|Overall Study|Deep brain stimulation operation|0|||
144632466|NCT05148884|521510079|FG001|Overall Study|Deep brain stimulation operation|1|||
144209997|NCT00000620|519963581|FG004|Overall Study|Withdrawal by Subject|30|||
144209998|NCT00000620|519963582|FG005|Overall Study|Withdrawal by Subject|32|||
144632467|NCT00582556|521510080|FG000|Overall Study|Withdrawal by Subject|0|||
144632468|NCT00582556|521510081|FG001|Overall Study|Withdrawal by Subject|1|||
144632469|NCT00582556|521510082|FG002|Overall Study|Withdrawal by Subject|1|||
144632470|NCT00582556|521510080|FG000|Overall Study|Physician Decision|0|||
144632471|NCT00582556|521510081|FG001|Overall Study|Physician Decision|0|||
144632472|NCT00582556|521510082|FG002|Overall Study|Physician Decision|1|||
144632473|NCT01993888|521510085|FG000|Overall Study|Death|1|||
144632474|NCT01993888|521510086|FG001|Overall Study|Death|1|||
144632475|NCT01993888|521510085|FG000|Overall Study|Lost to Follow-up|1|||
144632476|NCT01993888|521510086|FG001|Overall Study|Lost to Follow-up|1|||
144632477|NCT01993888|521510085|FG000|Overall Study|Withdrawal by Subject|0|||
144632478|NCT01993888|521510086|FG001|Overall Study|Withdrawal by Subject|1|||
144209999|NCT00000620|519963583|FG006|Overall Study|Withdrawal by Subject|32|||
144210000|NCT00000620|519963584|FG007|Overall Study|Withdrawal by Subject|21|||
144210001|NCT00000620|519963577|FG000|Overall Study|missed closeout visit|22|||
144210002|NCT00000620|519963578|FG001|Overall Study|missed closeout visit|28|||
144210003|NCT00000620|519963579|FG002|Overall Study|missed closeout visit|16|||
144210004|NCT00000620|519963580|FG003|Overall Study|missed closeout visit|11|||
144210005|NCT00000620|519963581|FG004|Overall Study|missed closeout visit|26|||
144210006|NCT00000620|519963582|FG005|Overall Study|missed closeout visit|28|||
144210007|NCT00000620|519963583|FG006|Overall Study|missed closeout visit|13|||
144210008|NCT00000620|519963584|FG007|Overall Study|missed closeout visit|16|||
144210009|NCT01851330|519963585|FG000|Overall Study|Lack of Efficacy|10|||
144210010|NCT01851330|519963586|FG001|Overall Study|Lack of Efficacy|9|||
144210011|NCT01851330|519963587|FG002|Overall Study|Lack of Efficacy|2|||
144210012|NCT01851330|519963585|FG000|Overall Study|Lost to Follow-up|1|||
144210013|NCT01851330|519963586|FG001|Overall Study|Lost to Follow-up|6|||
144210014|NCT01851330|519963587|FG002|Overall Study|Lost to Follow-up|9|||
144632479|NCT01341457|521510087|FG000|Overall Study|Adverse Event|2|||
144632480|NCT01341457|521510088|FG001|Overall Study|Adverse Event|0|||
144632481|NCT00365989|521510089|FG000|Overall Study|Withdrawal by Subject|1|||
144632482|NCT00365989|521510089|FG000|Overall Study|Non-compliance|1|||
144632483|NCT00832819|521510094|FG000|Overall Study|Adverse Event|0|||
144632484|NCT00832819|521510095|FG001|Overall Study|Adverse Event|1|||
144632485|NCT00832819|521510096|FG002|Overall Study|Adverse Event|0|||
144632486|NCT00832819|521510094|FG000|Overall Study|Protocol Violation|0|||
144632487|NCT00832819|521510095|FG001|Overall Study|Protocol Violation|0|||
144632488|NCT00832819|521510096|FG002|Overall Study|Protocol Violation|1|||
144632489|NCT00317044|521510097|FG000|Overall Study|Protocol Violation|28|||
144632490|NCT00317044|521510098|FG001|Overall Study|Protocol Violation|22|||
144632491|NCT00317044|521510099|FG002|Overall Study|Protocol Violation|20|||
144632492|NCT00317044|521510097|FG000|Overall Study|Adverse Event|4|||
144632493|NCT00317044|521510098|FG001|Overall Study|Adverse Event|7|||
144632494|NCT00317044|521510099|FG002|Overall Study|Adverse Event|4|||
144632495|NCT00317044|521510097|FG000|Overall Study|Withdrawal by Subject|10|||
144632496|NCT00317044|521510098|FG001|Overall Study|Withdrawal by Subject|7|||
144632497|NCT00317044|521510099|FG002|Overall Study|Withdrawal by Subject|12|||
144632498|NCT00317044|521510097|FG000|Overall Study|Lost to Follow-up|0|||
144632499|NCT00317044|521510098|FG001|Overall Study|Lost to Follow-up|2|||
144632500|NCT00317044|521510099|FG002|Overall Study|Lost to Follow-up|3|||
144632501|NCT00317044|521510097|FG000|Overall Study|Multiple Reasons|6|||
144632502|NCT00317044|521510098|FG001|Overall Study|Multiple Reasons|2|||
144632503|NCT00317044|521510099|FG002|Overall Study|Multiple Reasons|6|||
144632504|NCT02318095|521510102|FG000|Overall Study|Adverse Event|1|||
144632505|NCT01717638|521510103|FG000|Overall Study|Lost to Follow-up|0|||
144632506|NCT01717638|521510104|FG001|Overall Study|Lost to Follow-up|0|||
144632507|NCT01717638|521510105|FG002|Overall Study|Lost to Follow-up|0|||
144632508|NCT01717638|521510106|FG003|Overall Study|Lost to Follow-up|0|||
144632509|NCT01717638|521510107|FG004|Overall Study|Lost to Follow-up|0|||
144632510|NCT01717638|521510108|FG005|Overall Study|Lost to Follow-up|1|||
144632511|NCT01717638|521510109|FG006|Overall Study|Lost to Follow-up|0|||
144632512|NCT01717638|521510110|FG007|Overall Study|Lost to Follow-up|0|||
144632513|NCT01717638|521510111|FG008|Overall Study|Lost to Follow-up|0|||
144632514|NCT01717638|521510112|FG009|Overall Study|Lost to Follow-up|0|||
144632515|NCT01717638|521510113|FG010|Overall Study|Lost to Follow-up|0|||
144632516|NCT01717638|521510114|FG011|Overall Study|Lost to Follow-up|0|||
144632517|NCT01717638|521510115|FG012|Overall Study|Lost to Follow-up|0|||
144632518|NCT01717638|521510103|FG000|Overall Study|Father in hospital|0|||
144632519|NCT01717638|521510104|FG001|Overall Study|Father in hospital|0|||
144632520|NCT01717638|521510105|FG002|Overall Study|Father in hospital|0|||
144632521|NCT01717638|521510106|FG003|Overall Study|Father in hospital|0|||
144632522|NCT01717638|521510107|FG004|Overall Study|Father in hospital|0|||
144632523|NCT01717638|521510108|FG005|Overall Study|Father in hospital|0|||
144632524|NCT01717638|521510109|FG006|Overall Study|Father in hospital|0|||
144632525|NCT01717638|521510110|FG007|Overall Study|Father in hospital|0|||
144632526|NCT01717638|521510111|FG008|Overall Study|Father in hospital|0|||
144632527|NCT01717638|521510112|FG009|Overall Study|Father in hospital|0|||
144210015|NCT01851330|519963585|FG000|Overall Study|Withdrew Consent|2|||
144210016|NCT01851330|519963586|FG001|Overall Study|Withdrew Consent|1|||
144210017|NCT01851330|519963587|FG002|Overall Study|Withdrew Consent|0|||
144210018|NCT01851330|519963585|FG000|Overall Study|Investigator's Discretion|0|||
144210019|NCT01851330|519963586|FG001|Overall Study|Investigator's Discretion|0|||
144632528|NCT01717638|521510113|FG010|Overall Study|Father in hospital|0|||
144632529|NCT01717638|521510114|FG011|Overall Study|Father in hospital|0|||
144632530|NCT01717638|521510115|FG012|Overall Study|Father in hospital|1|||
144632531|NCT01717638|521510103|FG000|Overall Study|Withdrawal by Subject|0|||
144632532|NCT01717638|521510104|FG001|Overall Study|Withdrawal by Subject|1|||
144632533|NCT01717638|521510105|FG002|Overall Study|Withdrawal by Subject|1|||
144632534|NCT01717638|521510106|FG003|Overall Study|Withdrawal by Subject|0|||
144632535|NCT01717638|521510107|FG004|Overall Study|Withdrawal by Subject|1|||
144632536|NCT01717638|521510108|FG005|Overall Study|Withdrawal by Subject|0|||
144632537|NCT01717638|521510109|FG006|Overall Study|Withdrawal by Subject|2|||
144632538|NCT01717638|521510110|FG007|Overall Study|Withdrawal by Subject|1|||
144632539|NCT01717638|521510111|FG008|Overall Study|Withdrawal by Subject|2|||
144632540|NCT01717638|521510112|FG009|Overall Study|Withdrawal by Subject|1|||
144632541|NCT01717638|521510113|FG010|Overall Study|Withdrawal by Subject|0|||
144632542|NCT01717638|521510114|FG011|Overall Study|Withdrawal by Subject|0|||
144632543|NCT01717638|521510115|FG012|Overall Study|Withdrawal by Subject|18|||
144632544|NCT01719757|521510117|FG000|Overall Study|Adverse Event|38|||
144632545|NCT01719757|521510117|FG000|Overall Study|Withdrawal by Subject|15|||
144632546|NCT01719757|521510117|FG000|Overall Study|Lost to Follow-up|20|||
144632547|NCT01719757|521510117|FG000|Overall Study|Protocol Violation|1|||
144632548|NCT01719757|521510117|FG000|Overall Study|well controlled pain|27|||
144632549|NCT02626338|521510118|FG000|Overall Study|Lack of Efficacy|3|||
144632550|NCT02626338|521510119|FG001|Overall Study|Lack of Efficacy|2|||
144632551|NCT02626338|521510120|FG002|Overall Study|Lack of Efficacy|0|||
144632552|NCT00522392|521510121|FG000|Overall Study|Disease progression|0|||
144632553|NCT00522392|521510122|FG001|Overall Study|Disease progression|3|||
144632554|NCT00522392|521510121|FG000|Overall Study|Adverse Event|7|||
144632555|NCT00522392|521510122|FG001|Overall Study|Adverse Event|7|||
144632556|NCT00522392|521510121|FG000|Overall Study|Withdrawal by Subject|1|||
144632557|NCT00522392|521510122|FG001|Overall Study|Withdrawal by Subject|1|||
144632558|NCT00522392|521510121|FG000|Overall Study|Physician Decision|0|||
144632559|NCT00522392|521510122|FG001|Overall Study|Physician Decision|1|||
144632560|NCT00522392|521510121|FG000|Overall Study|Non-compliance|0|||
144632561|NCT00522392|521510122|FG001|Overall Study|Non-compliance|1|||
144632562|NCT00393718|521510132|FG000|Overall Study|Adverse Event|20|||
144632563|NCT00393718|521510133|FG001|Overall Study|Adverse Event|8|||
144632564|NCT00393718|521510132|FG000|Overall Study|Protocol Violation|1|||
144632565|NCT00393718|521510133|FG001|Overall Study|Protocol Violation|2|||
144632566|NCT00393718|521510132|FG000|Overall Study|Lack of Efficacy|10|||
144632567|NCT00393718|521510133|FG001|Overall Study|Lack of Efficacy|9|||
144632568|NCT00393718|521510132|FG000|Overall Study|Hypoglycaemia|3|||
144632569|NCT00393718|521510133|FG001|Overall Study|Hypoglycaemia|2|||
144632570|NCT00393718|521510132|FG000|Overall Study|Subject decision|5|||
144632571|NCT00393718|521510133|FG001|Overall Study|Subject decision|0|||
144632572|NCT00393718|521510132|FG000|Overall Study|Withdrawal of consent|2|||
144632573|NCT00393718|521510133|FG001|Overall Study|Withdrawal of consent|1|||
144632574|NCT00393718|521510132|FG000|Overall Study|Missed measurement|1|||
144632575|NCT00393718|521510133|FG001|Overall Study|Missed measurement|0|||
144632576|NCT00393718|521510132|FG000|Overall Study|Move|1|||
144632577|NCT00393718|521510133|FG001|Overall Study|Move|0|||
144632578|NCT03575104|521510135|FG000|Overall Study|Adverse Event|4|||
144632579|NCT03575104|521510136|FG001|Overall Study|Adverse Event|3|||
144632580|NCT03575104|521510137|FG002|Overall Study|Adverse Event|4|||
144632581|NCT03575104|521510135|FG000|Overall Study|Withdrawal by Subject|13|||
144632582|NCT03575104|521510136|FG001|Overall Study|Withdrawal by Subject|16|||
144632583|NCT03575104|521510137|FG002|Overall Study|Withdrawal by Subject|11|||
144632584|NCT03575104|521510135|FG000|Overall Study|Other reasons|6|||
144632585|NCT03575104|521510136|FG001|Overall Study|Other reasons|8|||
144632586|NCT03575104|521510137|FG002|Overall Study|Other reasons|6|||
144632587|NCT03575104|521510135|FG000|Overall Study|Lost to Follow-up|1|||
144632588|NCT03575104|521510136|FG001|Overall Study|Lost to Follow-up|2|||
144632589|NCT03575104|521510137|FG002|Overall Study|Lost to Follow-up|1|||
144632590|NCT04684420|521510138|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144632591|NCT04684420|521510139|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
144632592|NCT04684420|521510140|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
144632593|NCT04684420|521510141|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
144632594|NCT04684420|521510138|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
144632595|NCT04684420|521510139|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
144632596|NCT04684420|521510140|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
144632597|NCT04684420|521510141|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
144632598|NCT01703000|521510142|FG000|Overall Study|Death|1|||
144632599|NCT02661594|521510143|FG000|Overall Study|Protocol Violation|1|||
144632600|NCT02661594|521510144|FG001|Overall Study|Protocol Violation|0|||
144632601|NCT02661594|521510145|FG002|Overall Study|Protocol Violation|1|||
144632602|NCT02661594|521510146|FG003|Overall Study|Protocol Violation|0|||
144632603|NCT00434967|521510149|FG000|Overall Study|Adverse Event|2|||
144632604|NCT00434967|521510150|FG001|Overall Study|Adverse Event|4|||
144632605|NCT00434967|521510151|FG002|Overall Study|Adverse Event|3|||
144632606|NCT00434967|521510152|FG003|Overall Study|Adverse Event|3|||
144632607|NCT00434967|521510149|FG000|Overall Study|Lost to Follow-up|0|||
144632608|NCT00434967|521510150|FG001|Overall Study|Lost to Follow-up|0|||
144632609|NCT00434967|521510151|FG002|Overall Study|Lost to Follow-up|1|||
144632610|NCT00434967|521510152|FG003|Overall Study|Lost to Follow-up|0|||
144632611|NCT00434967|521510149|FG000|Overall Study|Withdrawal by Subject|2|||
144632612|NCT00434967|521510150|FG001|Overall Study|Withdrawal by Subject|2|||
144632613|NCT00434967|521510151|FG002|Overall Study|Withdrawal by Subject|4|||
144632614|NCT00434967|521510152|FG003|Overall Study|Withdrawal by Subject|6|||
144632615|NCT00434967|521510149|FG000|Overall Study|Randomized in error|0|||
144632616|NCT00434967|521510150|FG001|Overall Study|Randomized in error|0|||
144632617|NCT00434967|521510151|FG002|Overall Study|Randomized in error|0|||
144632618|NCT00434967|521510152|FG003|Overall Study|Randomized in error|1|||
144632619|NCT00434967|521510149|FG000|Overall Study|Protocol Violation|0|||
144632620|NCT00434967|521510150|FG001|Overall Study|Protocol Violation|1|||
144632621|NCT00434967|521510151|FG002|Overall Study|Protocol Violation|0|||
144632622|NCT00434967|521510152|FG003|Overall Study|Protocol Violation|1|||
144632623|NCT00434967|521510149|FG000|Overall Study|Physician Decision|1|||
144632624|NCT00434967|521510150|FG001|Overall Study|Physician Decision|1|||
144632625|NCT00434967|521510151|FG002|Overall Study|Physician Decision|1|||
144632626|NCT00434967|521510152|FG003|Overall Study|Physician Decision|0|||
144632627|NCT00434967|521510149|FG000|Overall Study|Patient Disposition Challenges|2|||
144632628|NCT00434967|521510150|FG001|Overall Study|Patient Disposition Challenges|0|||
144632629|NCT00434967|521510151|FG002|Overall Study|Patient Disposition Challenges|0|||
144632630|NCT00434967|521510152|FG003|Overall Study|Patient Disposition Challenges|3|||
144632631|NCT01169779|521510153|FG000|Overall Study|Adverse Event|3|||
144632632|NCT01169779|521510154|FG001|Overall Study|Adverse Event|11|||
144632633|NCT01169779|521510153|FG000|Overall Study|Lack of Efficacy|1|||
144632634|NCT01169779|521510154|FG001|Overall Study|Lack of Efficacy|0|||
144632635|NCT01169779|521510153|FG000|Overall Study|Protocol Violation|1|||
144632636|NCT01169779|521510154|FG001|Overall Study|Protocol Violation|1|||
144632637|NCT01169779|521510153|FG000|Overall Study|Withdrawal by Subject|3|||
144632638|NCT01169779|521510154|FG001|Overall Study|Withdrawal by Subject|2|||
144632639|NCT01169779|521510153|FG000|Overall Study|Familial and personal reasons|3|||
144632640|NCT01169779|521510154|FG001|Overall Study|Familial and personal reasons|3|||
144632641|NCT01279057|521510155|FG000|Overall Study|Adverse Event|1|||
144632642|NCT01279057|521510156|FG001|Overall Study|Adverse Event|0|||
144632643|NCT01279057|521510157|FG002|Overall Study|Adverse Event|1|||
144632644|NCT01279057|521510155|FG000|Overall Study|Insufficient therapeutic response|0|||
144632645|NCT01279057|521510156|FG001|Overall Study|Insufficient therapeutic response|0|||
144632646|NCT01279057|521510157|FG002|Overall Study|Insufficient therapeutic response|1|||
144632647|NCT01279057|521510155|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
144632648|NCT01279057|521510156|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
144632649|NCT01279057|521510157|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
144632650|NCT01279057|521510155|FG000|Overall Study|Withdrew consent|2|||
144632651|NCT01279057|521510156|FG001|Overall Study|Withdrew consent|0|||
144632652|NCT01279057|521510157|FG002|Overall Study|Withdrew consent|1|||
144632653|NCT01279057|521510155|FG000|Overall Study|Pregnancy|0|||
144632654|NCT01279057|521510156|FG001|Overall Study|Pregnancy|1|||
144632655|NCT01279057|521510157|FG002|Overall Study|Pregnancy|0|||
144632656|NCT01279057|521510155|FG000|Overall Study|Other|3|||
144632657|NCT01279057|521510156|FG001|Overall Study|Other|3|||
144632658|NCT01279057|521510157|FG002|Overall Study|Other|0|||
144632659|NCT00432237|521510158|FG000|Overall Study|Adverse Event|0|||
144632660|NCT00432237|521510159|FG001|Overall Study|Adverse Event|0|||
144632661|NCT00432237|521510160|FG002|Overall Study|Adverse Event|0|||
144632662|NCT00432237|521510161|FG003|Overall Study|Adverse Event|1|||
144632663|NCT00432237|521510158|FG000|Overall Study|Lack of Efficacy|0|||
144632664|NCT00432237|521510159|FG001|Overall Study|Lack of Efficacy|0|||
144632665|NCT00432237|521510160|FG002|Overall Study|Lack of Efficacy|0|||
144632666|NCT00432237|521510161|FG003|Overall Study|Lack of Efficacy|1|||
144632667|NCT00432237|521510158|FG000|Overall Study|Lost to Follow-up|10|||
144632668|NCT00432237|521510159|FG001|Overall Study|Lost to Follow-up|10|||
144730765|NCT00925769|521869884|FG000|Overall Study|Death|0|||
144730766|NCT00925769|521869885|FG001|Overall Study|Death|0|||
144730767|NCT00925769|521869886|FG002|Overall Study|Death|1|||
144730768|NCT00925769|521869887|FG003|Overall Study|Death|0|||
144730769|NCT00925769|521869888|FG004|Overall Study|Death|0|||
144730770|NCT00925769|521869889|FG005|Overall Study|Death|0|||
144730771|NCT00925769|521869884|FG000|Overall Study|Physician Decision|1|||
144730772|NCT00925769|521869885|FG001|Overall Study|Physician Decision|0|||
144730773|NCT00925769|521869886|FG002|Overall Study|Physician Decision|0|||
144730774|NCT00925769|521869887|FG003|Overall Study|Physician Decision|0|||
144632669|NCT00432237|521510160|FG002|Overall Study|Lost to Follow-up|18|||
144632670|NCT00432237|521510161|FG003|Overall Study|Lost to Follow-up|18|||
144632671|NCT00432237|521510158|FG000|Overall Study|Physician Decision|1|||
144632672|NCT00432237|521510159|FG001|Overall Study|Physician Decision|3|||
144632673|NCT00432237|521510160|FG002|Overall Study|Physician Decision|2|||
144632674|NCT00432237|521510161|FG003|Overall Study|Physician Decision|1|||
144632675|NCT00432237|521510158|FG000|Overall Study|Pregnancy|0|||
144632676|NCT00432237|521510159|FG001|Overall Study|Pregnancy|1|||
144632677|NCT00432237|521510160|FG002|Overall Study|Pregnancy|0|||
144632678|NCT00432237|521510161|FG003|Overall Study|Pregnancy|0|||
144632679|NCT00432237|521510158|FG000|Overall Study|Protocol Violation|13|||
144632680|NCT00432237|521510159|FG001|Overall Study|Protocol Violation|10|||
144632681|NCT00432237|521510160|FG002|Overall Study|Protocol Violation|11|||
144632682|NCT00432237|521510161|FG003|Overall Study|Protocol Violation|8|||
144632683|NCT00432237|521510158|FG000|Overall Study|Withdrawal by Subject|5|||
144730775|NCT00925769|521869888|FG004|Overall Study|Physician Decision|0|||
144730776|NCT00925769|521869889|FG005|Overall Study|Physician Decision|0|||
144632684|NCT00432237|521510159|FG001|Overall Study|Withdrawal by Subject|6|||
144632685|NCT00432237|521510160|FG002|Overall Study|Withdrawal by Subject|9|||
144632686|NCT00432237|521510161|FG003|Overall Study|Withdrawal by Subject|11|||
144632687|NCT00432237|521510158|FG000|Overall Study|Lack of Qualifying Event|38|||
144632688|NCT00432237|521510159|FG001|Overall Study|Lack of Qualifying Event|71|||
144632689|NCT00432237|521510160|FG002|Overall Study|Lack of Qualifying Event|69|||
144632690|NCT00432237|521510161|FG003|Overall Study|Lack of Qualifying Event|84|||
144632691|NCT01427309|521510163|FG000|Overall Study|Lost to Follow-up|130|||
144632692|NCT01427309|521510164|FG001|Overall Study|Lost to Follow-up|145|||
144632693|NCT01427309|521510165|FG002|Overall Study|Lost to Follow-up|122|||
144632694|NCT01427309|521510166|FG003|Overall Study|Lost to Follow-up|135|||
144632695|NCT01427309|521510163|FG000|Overall Study|Protocol Violation|42|||
144632696|NCT01427309|521510164|FG001|Overall Study|Protocol Violation|69|||
144632697|NCT01427309|521510165|FG002|Overall Study|Protocol Violation|125|||
144632698|NCT01427309|521510166|FG003|Overall Study|Protocol Violation|124|||
144632699|NCT01427309|521510163|FG000|Overall Study|Adverse Event|0|||
144632700|NCT01427309|521510164|FG001|Overall Study|Adverse Event|0|||
144632701|NCT01427309|521510165|FG002|Overall Study|Adverse Event|3|||
144632702|NCT01427309|521510166|FG003|Overall Study|Adverse Event|1|||
144632703|NCT01427309|521510163|FG000|Overall Study|Serious adverse event|52|||
144632704|NCT01427309|521510164|FG001|Overall Study|Serious adverse event|45|||
144632705|NCT01427309|521510165|FG002|Overall Study|Serious adverse event|50|||
144632706|NCT01427309|521510166|FG003|Overall Study|Serious adverse event|61|||
144632707|NCT01427309|521510163|FG000|Overall Study|Withdrawal by Subject|148|||
144632708|NCT01427309|521510164|FG001|Overall Study|Withdrawal by Subject|148|||
144632709|NCT01427309|521510165|FG002|Overall Study|Withdrawal by Subject|61|||
144632710|NCT01427309|521510166|FG003|Overall Study|Withdrawal by Subject|55|||
144632711|NCT01354132|521510167|FG000|Randomization|Physician Decision|1|||
144632712|NCT01354132|521510168|FG001|Randomization|Physician Decision|0|||
144632713|NCT01354132|521510167|FG000|Randomization|Withdrawal by Subject|0|||
144632714|NCT01354132|521510168|FG001|Randomization|Withdrawal by Subject|1|||
144632715|NCT01354132|521510167|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
144632716|NCT01354132|521510168|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
144632717|NCT01354132|521510167|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
144632718|NCT01354132|521510168|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
144632719|NCT01354132|521510167|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
144632720|NCT01354132|521510168|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
144632721|NCT00928070|521510171|FG000|Overall Study|Lost to Follow-up|1|||
144632722|NCT00928070|521510172|FG001|Overall Study|Lost to Follow-up|2|||
144632723|NCT00928070|521510171|FG000|Overall Study|Withdrawal by Subject|10|||
144632724|NCT00928070|521510172|FG001|Overall Study|Withdrawal by Subject|3|||
144632725|NCT00928070|521510171|FG000|Overall Study|Adverse Event|14|||
144632726|NCT00928070|521510172|FG001|Overall Study|Adverse Event|26|||
144632727|NCT00928070|521510171|FG000|Overall Study|Lack of Efficacy|9|||
144632728|NCT00928070|521510172|FG001|Overall Study|Lack of Efficacy|5|||
144632729|NCT00928070|521510171|FG000|Overall Study|Did not meet entrance criteria|16|||
144632730|NCT00928070|521510172|FG001|Overall Study|Did not meet entrance criteria|9|||
144632731|NCT00928070|521510171|FG000|Overall Study|Protocol Violation|6|||
144632732|NCT00928070|521510172|FG001|Overall Study|Protocol Violation|5|||
144632733|NCT00928070|521510171|FG000|Overall Study|Randomized but not treated|2|||
144632734|NCT00928070|521510172|FG001|Overall Study|Randomized but not treated|2|||
144632735|NCT00928070|521510171|FG000|Overall Study|Other|5|||
144632736|NCT00928070|521510172|FG001|Overall Study|Other|5|||
144632737|NCT00191854|521510173|FG000|Overall Study|Death|26|||
144632738|NCT00191854|521510174|FG001|Overall Study|Death|23|||
144632739|NCT00191854|521510175|FG002|Overall Study|Death|29|||
144632740|NCT00191854|521510173|FG000|Overall Study|Lost to Follow-up|7|||
144632741|NCT00191854|521510174|FG001|Overall Study|Lost to Follow-up|5|||
144632742|NCT00191854|521510175|FG002|Overall Study|Lost to Follow-up|5|||
144632743|NCT00191854|521510173|FG000|Overall Study|Withdrawal by Subject|4|||
144632744|NCT00191854|521510174|FG001|Overall Study|Withdrawal by Subject|2|||
144632745|NCT00191854|521510175|FG002|Overall Study|Withdrawal by Subject|3|||
144632746|NCT00191854|521510173|FG000|Overall Study|Sponsor Decision|0|||
144632747|NCT00191854|521510174|FG001|Overall Study|Sponsor Decision|0|||
144632748|NCT00191854|521510175|FG002|Overall Study|Sponsor Decision|1|||
144632749|NCT00191854|521510173|FG000|Overall Study|Screen Failure|0|||
144632750|NCT00191854|521510174|FG001|Overall Study|Screen Failure|0|||
144632751|NCT00191854|521510175|FG002|Overall Study|Screen Failure|1|||
144632752|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
144632753|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
144632754|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
144632755|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
144632756|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
144632757|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
144632758|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
144632759|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
144632760|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
144632761|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
144632762|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
144632763|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
144632764|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
144632765|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
144632766|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
144632767|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
144632768|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
144632769|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
144632770|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
144632771|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
144632772|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
144632773|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
144632774|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
144632775|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
144632776|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
144632777|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
144632778|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
144632779|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
144632780|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
144632781|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
144632782|NCT00849017|521510176|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
144632783|NCT00849017|521510177|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
144632784|NCT00849017|521510178|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
144632785|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
144632786|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
144632787|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
144632788|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
144632789|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
144632790|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
144632791|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
144632792|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
144632793|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
144632794|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
144632795|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
144632796|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
144632797|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
144632798|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
144632799|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
144632800|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
144632801|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
144632802|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
144632803|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
144632804|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
144632805|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
144632806|NCT00849017|521510176|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
144632807|NCT00849017|521510177|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
144632808|NCT00849017|521510178|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
144632809|NCT01323478|521510183|FG000|Overall Study|Adverse Event|7|||
144632810|NCT01323478|521510183|FG000|Overall Study|Lack of Efficacy|4|||
144632811|NCT01323478|521510183|FG000|Overall Study|Non-compliance With Study Product|3|||
144632812|NCT01323478|521510183|FG000|Overall Study|Protocol Violation|1|||
144632813|NCT01323478|521510183|FG000|Overall Study|Withdrawal of Consent|1|||
144632814|NCT01323478|521510183|FG000|Overall Study|Administrative or Other Reasons|8|||
144632815|NCT02411448|521510184|FG000|Overall Study|Withdrawal by Subject|1|||
144632816|NCT02411448|521510185|FG001|Overall Study|Withdrawal by Subject|14|||
144632817|NCT02411448|521510186|FG002|Overall Study|Withdrawal by Subject|9|||
144632818|NCT02411448|521510184|FG000|Overall Study|Other|0|||
144632819|NCT02411448|521510185|FG001|Overall Study|Other|2|||
144632820|NCT02411448|521510186|FG002|Overall Study|Other|0|||
144632821|NCT02411448|521510184|FG000|Overall Study|Did not receive study treatment|0|||
144262969|NCT02806713|520163805|FG001|Overall Study|Urethral injury during procedure|0|||
144262970|NCT02806713|520163804|FG000|Overall Study|cancelled surgery|1|||
144262971|NCT02806713|520163805|FG001|Overall Study|cancelled surgery|2|||
144262972|NCT00735709|520163806|FG000|Overall Study|Adverse Event|2|||
144262973|NCT00735709|520163807|FG001|Overall Study|Adverse Event|3|||
144262974|NCT00735709|520163808|FG002|Overall Study|Adverse Event|1|||
144632822|NCT02411448|521510185|FG001|Overall Study|Did not receive study treatment|3|||
144632823|NCT02411448|521510186|FG002|Overall Study|Did not receive study treatment|0|||
144632824|NCT02411448|521510184|FG000|Overall Study|Alive on study treatment|3|||
144632825|NCT02411448|521510185|FG001|Overall Study|Alive on study treatment|64|||
144632826|NCT02411448|521510186|FG002|Overall Study|Alive on study treatment|43|||
144632827|NCT02771522|521510189|FG000|Overall Study|Lost to Follow-up|3|||
144632828|NCT02771522|521510189|FG000|Overall Study|Withdrawal by Subject|2|||
144632829|NCT02771522|521510189|FG000|Overall Study|No white spot lesions|3|||
144632830|NCT00862251|521510190|FG000|Overall Study|Adverse Event|8|||
144632831|NCT00862251|521510191|FG001|Overall Study|Adverse Event|3|||
144632832|NCT00862251|521510192|FG002|Overall Study|Adverse Event|1|||
144632833|NCT00862251|521510190|FG000|Overall Study|Lost to Follow-up|0|||
144632834|NCT00862251|521510191|FG001|Overall Study|Lost to Follow-up|0|||
144632835|NCT00862251|521510192|FG002|Overall Study|Lost to Follow-up|1|||
144632836|NCT00862251|521510190|FG000|Overall Study|Protocol Violation|2|||
144632837|NCT00862251|521510191|FG001|Overall Study|Protocol Violation|0|||
144632838|NCT00862251|521510192|FG002|Overall Study|Protocol Violation|1|||
144632839|NCT00862251|521510190|FG000|Overall Study|Withdrawal by Subject|9|||
144632840|NCT00862251|521510191|FG001|Overall Study|Withdrawal by Subject|2|||
144632841|NCT00862251|521510192|FG002|Overall Study|Withdrawal by Subject|6|||
144632842|NCT01728779|521510193|FG000|Overall Study|Withdrawal by Subject|1|||
144632843|NCT00624520|521510194|FG000|Overall Study|Withdrawal by Subject|12|||
144632844|NCT00624520|521510195|FG001|Overall Study|Withdrawal by Subject|7|||
144632845|NCT00624520|521510194|FG000|Overall Study|Death|0|||
144632846|NCT00624520|521510195|FG001|Overall Study|Death|1|||
144632847|NCT02054702|521510205|FG000|Overall Study|Lost to Follow-up|3|||
144632848|NCT02054702|521510206|FG001|Overall Study|Lost to Follow-up|5|||
144632849|NCT02054702|521510205|FG000|Overall Study|Adverse Event|3|||
144632850|NCT02054702|521510206|FG001|Overall Study|Adverse Event|1|||
144632851|NCT02054702|521510205|FG000|Overall Study|Met Withdrawal Criteria|4|||
144632852|NCT02054702|521510206|FG001|Overall Study|Met Withdrawal Criteria|1|||
144632853|NCT02054702|521510205|FG000|Overall Study|Physician Decision|0|||
144632854|NCT02054702|521510206|FG001|Overall Study|Physician Decision|1|||
144632855|NCT02054702|521510205|FG000|Overall Study|Withdrawal by Subject|14|||
144632856|NCT02054702|521510206|FG001|Overall Study|Withdrawal by Subject|4|||
144632857|NCT00934102|521510207|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
144632858|NCT00934102|521510208|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
144632859|NCT00934102|521510209|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
144632860|NCT02318784|521510210|FG000|Overall Study|Adverse Event|13|||
144632861|NCT02318784|521510210|FG000|Overall Study|Death|2|||
144632862|NCT02318784|521510210|FG000|Overall Study|Progressive Disease|37|||
144632863|NCT02318784|521510210|FG000|Overall Study|Withdrawal by Subject|10|||
144632864|NCT02304926|521510211|FG000|Overall Study|Lost to Follow-up|2|||
144632865|NCT02304926|521510212|FG001|Overall Study|Lost to Follow-up|1|||
144632866|NCT04007159|521510218|FG000|Induction Phase|(missed study visits)|16|||
144632867|NCT04007159|521510218|FG000|Induction Phase|Withdrawal by Subject|4|||
144632868|NCT04007159|521510218|FG000|Induction Phase|Adverse Event|2|||
144632869|NCT04007159|521510218|FG000|Challenge Phase|missed study visits|3|||
144632870|NCT04258579|521510219|FG000|Overall Study|Withdrawal by Subject|7|||
144632871|NCT04258579|521510219|FG000|Overall Study|Lost to Follow-up|3|||
144632872|NCT04258579|521510219|FG000|Overall Study|Protocol Violation|2|||
144632873|NCT04258579|521510219|FG000|Overall Study|Adverse Event|1|||
144632874|NCT02388295|521510220|FG000|Dose Escalation Week 1|Adverse Event|1|||
144632875|NCT02388295|521510221|FG001|Dose Escalation Week 1|Adverse Event|2|||
144632876|NCT02388295|521510222|FG002|Dose Escalation Week 1|Adverse Event|1|||
144632877|NCT02388295|521510220|FG000|Dose Escalation Week 1|Determined not eligible|1|||
144210020|NCT01851330|519963587|FG002|Overall Study|Investigator's Discretion|1|||
144210021|NCT01307111|519963590|FG000|IUD Insertion|Lost to Follow-up|2|||
144210022|NCT01307111|519963591|FG001|IUD Insertion|Lost to Follow-up|0|||
144210023|NCT01307111|519963590|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
144210024|NCT01307111|519963591|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
144210025|NCT02289456|519963595|FG000|Induction Period|Death|2|||
144210026|NCT02289456|519963595|FG000|Induction Period|Adverse Event|11|||
144210027|NCT02289456|519963595|FG000|Induction Period|Progressive Disease (PD)|4|||
144210028|NCT02289456|519963595|FG000|Induction Period|Symptomatic Deterioration|4|||
144210029|NCT02289456|519963595|FG000|Induction Period|Withdrawal by Subject|2|||
144210030|NCT02289456|519963595|FG000|Induction Period|Miscellaneous|1|||
144210031|NCT02289456|519963595|FG000|Monotherapy Period|Death|1|||
144210032|NCT02289456|519963595|FG000|Monotherapy Period|Adverse Event|1|||
144632878|NCT02388295|521510221|FG001|Dose Escalation Week 1|Determined not eligible|1|||
144632879|NCT02388295|521510222|FG002|Dose Escalation Week 1|Determined not eligible|1|||
144632880|NCT02388295|521510220|FG000|Dose Escalation Week 2|Protocol Violation|0|||
144632881|NCT02388295|521510221|FG001|Dose Escalation Week 2|Protocol Violation|1|||
144632882|NCT02388295|521510222|FG002|Dose Escalation Week 2|Protocol Violation|0|||
144632883|NCT02388295|521510220|FG000|Dose Escalation Week 2|Determined not eligible|1|||
144632884|NCT02388295|521510221|FG001|Dose Escalation Week 2|Determined not eligible|1|||
144632885|NCT02388295|521510222|FG002|Dose Escalation Week 2|Determined not eligible|1|||
144632886|NCT02388295|521510220|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
144632887|NCT02388295|521510221|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
144632888|NCT02388295|521510222|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
144632889|NCT02076165|521510224|FG000|Overall Study|Lost to Follow-up|7|||
144632890|NCT02076165|521510225|FG001|Overall Study|Lost to Follow-up|5|||
144632891|NCT02076165|521510224|FG000|Overall Study|Refused follow-up assessment|1|||
144632892|NCT02076165|521510225|FG001|Overall Study|Refused follow-up assessment|1|||
144632893|NCT03804684|521510226|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
144632894|NCT03804684|521510227|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
144632895|NCT00486603|521510229|FG000|Overall Study|Withdrawal by Subject|1|||
144632896|NCT00486603|521510230|FG001|Overall Study|Withdrawal by Subject|0|||
144632897|NCT00486603|521510231|FG002|Overall Study|Withdrawal by Subject|0|||
144632898|NCT00486603|521510232|FG003|Overall Study|Withdrawal by Subject|0|||
144632899|NCT00486603|521510233|FG004|Overall Study|Withdrawal by Subject|0|||
144632900|NCT00486603|521510229|FG000|Overall Study|Physician Decision|0|||
144632901|NCT00486603|521510230|FG001|Overall Study|Physician Decision|1|||
144632902|NCT00486603|521510231|FG002|Overall Study|Physician Decision|0|||
144632903|NCT00486603|521510232|FG003|Overall Study|Physician Decision|0|||
144632904|NCT00486603|521510233|FG004|Overall Study|Physician Decision|0|||
144632905|NCT00763009|521510234|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
144632906|NCT01355289|521510235|FG000|Core Study|Adverse Event, Non-Fatal|1|||
144632907|NCT01355289|521510236|FG001|Core Study|Adverse Event, Non-Fatal|0|||
144632908|NCT01355289|521510237|FG002|Core Study|Adverse Event, Non-Fatal|0|||
144632909|NCT01355289|521510238|FG003|Core Study|Adverse Event, Non-Fatal|0|||
144632910|NCT01355289|521510239|FG004|Core Study|Adverse Event, Non-Fatal|0|||
144632911|NCT01355289|521510235|FG000|Core Study|Inadequate Therapeutic Effect|0|||
144632912|NCT01355289|521510236|FG001|Core Study|Inadequate Therapeutic Effect|0|||
144632913|NCT01355289|521510237|FG002|Core Study|Inadequate Therapeutic Effect|0|||
144632914|NCT01355289|521510238|FG003|Core Study|Inadequate Therapeutic Effect|1|||
144632915|NCT01355289|521510239|FG004|Core Study|Inadequate Therapeutic Effect|0|||
144632916|NCT01355289|521510235|FG000|Core Study|Other|0|||
144632917|NCT01355289|521510236|FG001|Core Study|Other|0|||
144632918|NCT01355289|521510237|FG002|Core Study|Other|0|||
144632919|NCT01355289|521510238|FG003|Core Study|Other|1|||
144632920|NCT01355289|521510239|FG004|Core Study|Other|0|||
144632921|NCT01355289|521510235|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
144632922|NCT01355289|521510236|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
144632923|NCT01355289|521510237|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
144632924|NCT01355289|521510238|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
144632925|NCT01355289|521510239|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
144632926|NCT01355289|521510235|FG000|Open Label Extension|Lost to Follow-up|0|||
144632927|NCT01355289|521510236|FG001|Open Label Extension|Lost to Follow-up|0|||
144632928|NCT01355289|521510237|FG002|Open Label Extension|Lost to Follow-up|0|||
144632929|NCT01355289|521510238|FG003|Open Label Extension|Lost to Follow-up|0|||
144632930|NCT01355289|521510239|FG004|Open Label Extension|Lost to Follow-up|1|||
144632931|NCT01355289|521510235|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
144632932|NCT01355289|521510236|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
144632933|NCT01355289|521510237|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
144632934|NCT01355289|521510238|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
144632935|NCT01355289|521510239|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
144632936|NCT01355289|521510235|FG000|Open Label Extension|Other|0|||
144632937|NCT01355289|521510236|FG001|Open Label Extension|Other|0|||
144632938|NCT01355289|521510237|FG002|Open Label Extension|Other|0|||
144632939|NCT01355289|521510238|FG003|Open Label Extension|Other|0|||
144632940|NCT01355289|521510239|FG004|Open Label Extension|Other|3|||
144632941|NCT02706938|521510240|FG000|First Period, 6 Weeks|Adverse Event|8|||
144632942|NCT02706938|521510241|FG001|First Period, 6 Weeks|Adverse Event|0|||
144632943|NCT02706938|521510240|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
144632944|NCT02706938|521510241|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
144632945|NCT02706938|521510240|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
144632946|NCT02706938|521510241|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
144632947|NCT02706938|521510240|FG000|Second Period, 6 Weeks|Adverse Event|0|||
144632948|NCT02706938|521510241|FG001|Second Period, 6 Weeks|Adverse Event|7|||
144632949|NCT02706938|521510240|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
144632950|NCT02706938|521510241|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
144632951|NCT01662648|521510246|FG000|Overall Study|Death|1|||
144632952|NCT01662648|521510247|FG001|Overall Study|Death|3|||
144632953|NCT01662648|521510246|FG000|Overall Study|Adverse Event|40|||
144632954|NCT01662648|521510247|FG001|Overall Study|Adverse Event|37|||
144632955|NCT01662648|521510246|FG000|Overall Study|Lack of Efficacy|17|||
144632956|NCT01662648|521510247|FG001|Overall Study|Lack of Efficacy|16|||
144632957|NCT01662648|521510246|FG000|Overall Study|Participant ineligible to continue trial|1|||
144632958|NCT01662648|521510247|FG001|Overall Study|Participant ineligible to continue trial|1|||
144632959|NCT01662648|521510246|FG000|Overall Study|Lost to Follow-up|24|||
144632960|NCT01662648|521510247|FG001|Overall Study|Lost to Follow-up|36|||
144632961|NCT01662648|521510246|FG000|Overall Study|Withdrawal by Subject|36|||
144632962|NCT01662648|521510247|FG001|Overall Study|Withdrawal by Subject|53|||
144632963|NCT01662648|521510246|FG000|Overall Study|Participant non-compliant|16|||
144632964|NCT01662648|521510247|FG001|Overall Study|Participant non-compliant|20|||
144632965|NCT01662648|521510246|FG000|Overall Study|Other|8|||
144632966|NCT01662648|521510247|FG001|Overall Study|Other|11|||
144632967|NCT01662648|521510246|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
144632968|NCT01662648|521510247|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
144632969|NCT01662648|521510246|FG000|Overall Study|LOE and other reason unspecified|1|||
144632970|NCT01662648|521510247|FG001|Overall Study|LOE and other reason unspecified|0|||
144632971|NCT01662648|521510246|FG000|Overall Study|LOE and Participant non-compliant|0|||
144632972|NCT01662648|521510247|FG001|Overall Study|LOE and Participant non-compliant|1|||
144632973|NCT02868892|521510248|FG000|Overall Study|Investigator left site and no follow-up|6|||
144632974|NCT00868790|521510249|FG000|Period 1|Adverse Event|1|||
144632975|NCT00868790|521510250|FG001|Period 1|Adverse Event|0|||
144632976|NCT00868790|521510251|FG002|Period 1|Adverse Event|0|||
144632977|NCT00868790|521510252|FG003|Period 1|Adverse Event|0|||
144632978|NCT00868790|521510253|FG004|Period 1|Adverse Event|0|||
144632979|NCT00868790|521510254|FG005|Period 1|Adverse Event|0|||
144632980|NCT00868790|521510255|FG006|Period 1|Adverse Event|0|||
144632981|NCT00868790|521510256|FG007|Period 1|Adverse Event|3|||
144632982|NCT00868790|521510257|FG008|Period 1|Adverse Event|1|||
144632983|NCT00868790|521510258|FG009|Period 1|Adverse Event|0|||
144632984|NCT00868790|521510259|FG010|Period 1|Adverse Event|0|||
144632985|NCT00868790|521510260|FG011|Period 1|Adverse Event|0|||
144632986|NCT00868790|521510261|FG012|Period 1|Adverse Event|0|||
144632987|NCT00868790|521510262|FG013|Period 1|Adverse Event|1|||
144632988|NCT00868790|521510249|FG000|Period 1|Protocol Violation|1|||
144632989|NCT00868790|521510250|FG001|Period 1|Protocol Violation|0|||
144632990|NCT00868790|521510251|FG002|Period 1|Protocol Violation|0|||
144632991|NCT00868790|521510252|FG003|Period 1|Protocol Violation|0|||
144632992|NCT00868790|521510253|FG004|Period 1|Protocol Violation|0|||
144632993|NCT00868790|521510254|FG005|Period 1|Protocol Violation|0|||
144632994|NCT00868790|521510255|FG006|Period 1|Protocol Violation|0|||
144632995|NCT00868790|521510256|FG007|Period 1|Protocol Violation|0|||
144632996|NCT00868790|521510257|FG008|Period 1|Protocol Violation|0|||
144632997|NCT00868790|521510258|FG009|Period 1|Protocol Violation|0|||
144632998|NCT00868790|521510259|FG010|Period 1|Protocol Violation|0|||
144632999|NCT00868790|521510260|FG011|Period 1|Protocol Violation|0|||
144633000|NCT00868790|521510261|FG012|Period 1|Protocol Violation|0|||
144633001|NCT00868790|521510262|FG013|Period 1|Protocol Violation|0|||
144633002|NCT00868790|521510249|FG000|Period 1|Withdrawal by Subject|0|||
144633003|NCT00868790|521510250|FG001|Period 1|Withdrawal by Subject|1|||
144633004|NCT00868790|521510251|FG002|Period 1|Withdrawal by Subject|0|||
144633005|NCT00868790|521510252|FG003|Period 1|Withdrawal by Subject|0|||
144633006|NCT00868790|521510253|FG004|Period 1|Withdrawal by Subject|0|||
144633007|NCT00868790|521510254|FG005|Period 1|Withdrawal by Subject|0|||
144633008|NCT00868790|521510255|FG006|Period 1|Withdrawal by Subject|0|||
144633009|NCT00868790|521510256|FG007|Period 1|Withdrawal by Subject|0|||
144633010|NCT00868790|521510257|FG008|Period 1|Withdrawal by Subject|0|||
144633011|NCT00868790|521510258|FG009|Period 1|Withdrawal by Subject|0|||
144633012|NCT00868790|521510259|FG010|Period 1|Withdrawal by Subject|0|||
144633013|NCT00868790|521510260|FG011|Period 1|Withdrawal by Subject|0|||
144633014|NCT00868790|521510261|FG012|Period 1|Withdrawal by Subject|0|||
144633015|NCT00868790|521510262|FG013|Period 1|Withdrawal by Subject|1|||
144633016|NCT00868790|521510249|FG000|Period 1|Abnormal Triglycerides|0|||
144633017|NCT00868790|521510250|FG001|Period 1|Abnormal Triglycerides|0|||
144633018|NCT00868790|521510251|FG002|Period 1|Abnormal Triglycerides|0|||
144633019|NCT00868790|521510252|FG003|Period 1|Abnormal Triglycerides|0|||
144633020|NCT00868790|521510253|FG004|Period 1|Abnormal Triglycerides|1|||
144633021|NCT00868790|521510254|FG005|Period 1|Abnormal Triglycerides|0|||
144633022|NCT00868790|521510255|FG006|Period 1|Abnormal Triglycerides|0|||
144633023|NCT00868790|521510256|FG007|Period 1|Abnormal Triglycerides|0|||
144633024|NCT00868790|521510257|FG008|Period 1|Abnormal Triglycerides|0|||
144633025|NCT00868790|521510258|FG009|Period 1|Abnormal Triglycerides|0|||
144633026|NCT00868790|521510259|FG010|Period 1|Abnormal Triglycerides|0|||
144633027|NCT00868790|521510260|FG011|Period 1|Abnormal Triglycerides|0|||
144633028|NCT00868790|521510261|FG012|Period 1|Abnormal Triglycerides|0|||
144633029|NCT00868790|521510262|FG013|Period 1|Abnormal Triglycerides|0|||
144633030|NCT00868790|521510249|FG000|Period 1|Lost to Follow-up|0|||
144633031|NCT00868790|521510250|FG001|Period 1|Lost to Follow-up|0|||
144633032|NCT00868790|521510251|FG002|Period 1|Lost to Follow-up|0|||
144633033|NCT00868790|521510252|FG003|Period 1|Lost to Follow-up|0|||
144633034|NCT00868790|521510253|FG004|Period 1|Lost to Follow-up|0|||
144633035|NCT00868790|521510254|FG005|Period 1|Lost to Follow-up|1|||
144633036|NCT00868790|521510255|FG006|Period 1|Lost to Follow-up|0|||
144633037|NCT00868790|521510256|FG007|Period 1|Lost to Follow-up|0|||
144633038|NCT00868790|521510257|FG008|Period 1|Lost to Follow-up|0|||
144633039|NCT00868790|521510258|FG009|Period 1|Lost to Follow-up|0|||
144633040|NCT00868790|521510259|FG010|Period 1|Lost to Follow-up|0|||
144633041|NCT00868790|521510260|FG011|Period 1|Lost to Follow-up|0|||
144633042|NCT00868790|521510261|FG012|Period 1|Lost to Follow-up|0|||
144633043|NCT00868790|521510262|FG013|Period 1|Lost to Follow-up|0|||
144633044|NCT00868790|521510249|FG000|Period 2|Adverse Event|0|||
144633045|NCT00868790|521510250|FG001|Period 2|Adverse Event|0|||
144633046|NCT00868790|521510251|FG002|Period 2|Adverse Event|0|||
144633047|NCT00868790|521510252|FG003|Period 2|Adverse Event|0|||
144633048|NCT00868790|521510253|FG004|Period 2|Adverse Event|0|||
144633049|NCT00868790|521510254|FG005|Period 2|Adverse Event|0|||
144633050|NCT00868790|521510255|FG006|Period 2|Adverse Event|0|||
144633051|NCT00868790|521510256|FG007|Period 2|Adverse Event|0|||
144633052|NCT00868790|521510257|FG008|Period 2|Adverse Event|1|||
144633053|NCT00868790|521510258|FG009|Period 2|Adverse Event|0|||
144633054|NCT00868790|521510259|FG010|Period 2|Adverse Event|0|||
144633055|NCT00868790|521510260|FG011|Period 2|Adverse Event|0|||
144633056|NCT00868790|521510261|FG012|Period 2|Adverse Event|0|||
144633057|NCT00868790|521510262|FG013|Period 2|Adverse Event|0|||
144633058|NCT00868790|521510249|FG000|Period 2|Lost to Follow-up|0|||
144633059|NCT00868790|521510250|FG001|Period 2|Lost to Follow-up|1|||
144633060|NCT00868790|521510251|FG002|Period 2|Lost to Follow-up|0|||
144633061|NCT00868790|521510252|FG003|Period 2|Lost to Follow-up|0|||
144633062|NCT00868790|521510253|FG004|Period 2|Lost to Follow-up|0|||
144633063|NCT00868790|521510254|FG005|Period 2|Lost to Follow-up|1|||
144633064|NCT00868790|521510255|FG006|Period 2|Lost to Follow-up|0|||
144633065|NCT00868790|521510256|FG007|Period 2|Lost to Follow-up|0|||
144633066|NCT00868790|521510257|FG008|Period 2|Lost to Follow-up|0|||
144633067|NCT00868790|521510258|FG009|Period 2|Lost to Follow-up|0|||
144633068|NCT00868790|521510259|FG010|Period 2|Lost to Follow-up|0|||
144633069|NCT00868790|521510260|FG011|Period 2|Lost to Follow-up|0|||
144633070|NCT00868790|521510261|FG012|Period 2|Lost to Follow-up|0|||
144633071|NCT00868790|521510262|FG013|Period 2|Lost to Follow-up|0|||
144633072|NCT00868790|521510249|FG000|Period 2|Withdrawal by Subject|0|||
144633073|NCT00868790|521510250|FG001|Period 2|Withdrawal by Subject|0|||
144633074|NCT00868790|521510251|FG002|Period 2|Withdrawal by Subject|0|||
144633075|NCT00868790|521510252|FG003|Period 2|Withdrawal by Subject|0|||
144633076|NCT00868790|521510253|FG004|Period 2|Withdrawal by Subject|0|||
144633077|NCT00868790|521510254|FG005|Period 2|Withdrawal by Subject|0|||
144633078|NCT00868790|521510255|FG006|Period 2|Withdrawal by Subject|0|||
144633079|NCT00868790|521510256|FG007|Period 2|Withdrawal by Subject|0|||
144633080|NCT00868790|521510257|FG008|Period 2|Withdrawal by Subject|1|||
144633081|NCT00868790|521510258|FG009|Period 2|Withdrawal by Subject|0|||
144633082|NCT00868790|521510259|FG010|Period 2|Withdrawal by Subject|0|||
144633083|NCT00868790|521510260|FG011|Period 2|Withdrawal by Subject|0|||
144633084|NCT00868790|521510261|FG012|Period 2|Withdrawal by Subject|0|||
144633085|NCT00868790|521510262|FG013|Period 2|Withdrawal by Subject|1|||
144633086|NCT00868790|521510249|FG000|Period 3|Adverse Event|0|||
144633087|NCT00868790|521510250|FG001|Period 3|Adverse Event|0|||
144633088|NCT00868790|521510251|FG002|Period 3|Adverse Event|0|||
144633089|NCT00868790|521510252|FG003|Period 3|Adverse Event|0|||
144633090|NCT00868790|521510253|FG004|Period 3|Adverse Event|0|||
144633091|NCT00868790|521510254|FG005|Period 3|Adverse Event|0|||
144633092|NCT00868790|521510255|FG006|Period 3|Adverse Event|0|||
144633093|NCT00868790|521510256|FG007|Period 3|Adverse Event|0|||
144633094|NCT00868790|521510257|FG008|Period 3|Adverse Event|0|||
144633095|NCT00868790|521510258|FG009|Period 3|Adverse Event|1|||
144633096|NCT00868790|521510259|FG010|Period 3|Adverse Event|0|||
144633097|NCT00868790|521510260|FG011|Period 3|Adverse Event|0|||
144633098|NCT00868790|521510261|FG012|Period 3|Adverse Event|0|||
144633099|NCT00868790|521510262|FG013|Period 3|Adverse Event|0|||
144633100|NCT00868790|521510249|FG000|Period 3|Protocol Violation|0|||
144633101|NCT00868790|521510250|FG001|Period 3|Protocol Violation|0|||
144633102|NCT00868790|521510251|FG002|Period 3|Protocol Violation|0|||
144633103|NCT00868790|521510252|FG003|Period 3|Protocol Violation|0|||
144633104|NCT00868790|521510253|FG004|Period 3|Protocol Violation|0|||
144633105|NCT00868790|521510254|FG005|Period 3|Protocol Violation|0|||
144633106|NCT00868790|521510255|FG006|Period 3|Protocol Violation|0|||
144633107|NCT00868790|521510256|FG007|Period 3|Protocol Violation|0|||
144633108|NCT00868790|521510257|FG008|Period 3|Protocol Violation|0|||
144633109|NCT00868790|521510258|FG009|Period 3|Protocol Violation|0|||
144633110|NCT00868790|521510259|FG010|Period 3|Protocol Violation|1|||
144633111|NCT00868790|521510260|FG011|Period 3|Protocol Violation|0|||
144633112|NCT00868790|521510261|FG012|Period 3|Protocol Violation|0|||
144633113|NCT00868790|521510262|FG013|Period 3|Protocol Violation|0|||
144633114|NCT00868790|521510249|FG000|Period 3|Study Terminated by Sponsor|0|||
144633115|NCT00868790|521510250|FG001|Period 3|Study Terminated by Sponsor|0|||
144633116|NCT00868790|521510251|FG002|Period 3|Study Terminated by Sponsor|0|||
144633117|NCT00868790|521510252|FG003|Period 3|Study Terminated by Sponsor|1|||
144633118|NCT00868790|521510253|FG004|Period 3|Study Terminated by Sponsor|0|||
144633119|NCT00868790|521510254|FG005|Period 3|Study Terminated by Sponsor|0|||
144633120|NCT00868790|521510255|FG006|Period 3|Study Terminated by Sponsor|0|||
144633121|NCT00868790|521510256|FG007|Period 3|Study Terminated by Sponsor|0|||
144633122|NCT00868790|521510257|FG008|Period 3|Study Terminated by Sponsor|0|||
144633123|NCT00868790|521510258|FG009|Period 3|Study Terminated by Sponsor|0|||
144633124|NCT00868790|521510259|FG010|Period 3|Study Terminated by Sponsor|0|||
144633125|NCT00868790|521510260|FG011|Period 3|Study Terminated by Sponsor|0|||
144633126|NCT00868790|521510261|FG012|Period 3|Study Terminated by Sponsor|0|||
144633127|NCT00868790|521510262|FG013|Period 3|Study Terminated by Sponsor|0|||
144633128|NCT00868790|521510249|FG000|Period 4|Adverse Event|0|||
144633129|NCT00868790|521510250|FG001|Period 4|Adverse Event|0|||
144633130|NCT00868790|521510251|FG002|Period 4|Adverse Event|0|||
144633131|NCT00868790|521510252|FG003|Period 4|Adverse Event|0|||
144633132|NCT00868790|521510253|FG004|Period 4|Adverse Event|0|||
144633133|NCT00868790|521510254|FG005|Period 4|Adverse Event|0|||
144633134|NCT00868790|521510255|FG006|Period 4|Adverse Event|0|||
144633135|NCT00868790|521510256|FG007|Period 4|Adverse Event|1|||
144633136|NCT00868790|521510257|FG008|Period 4|Adverse Event|0|||
144633137|NCT00868790|521510258|FG009|Period 4|Adverse Event|0|||
144633138|NCT00868790|521510259|FG010|Period 4|Adverse Event|1|||
144633139|NCT00868790|521510260|FG011|Period 4|Adverse Event|0|||
144633140|NCT00868790|521510261|FG012|Period 4|Adverse Event|1|||
144633141|NCT00868790|521510262|FG013|Period 4|Adverse Event|0|||
144633142|NCT00868790|521510249|FG000|Period 4|Lost to Follow-up|0|||
144633143|NCT00868790|521510250|FG001|Period 4|Lost to Follow-up|0|||
144633144|NCT00868790|521510251|FG002|Period 4|Lost to Follow-up|0|||
144633145|NCT00868790|521510252|FG003|Period 4|Lost to Follow-up|0|||
144633146|NCT00868790|521510253|FG004|Period 4|Lost to Follow-up|0|||
144633147|NCT00868790|521510254|FG005|Period 4|Lost to Follow-up|0|||
144633148|NCT00868790|521510255|FG006|Period 4|Lost to Follow-up|0|||
144633149|NCT00868790|521510256|FG007|Period 4|Lost to Follow-up|1|||
144633150|NCT00868790|521510257|FG008|Period 4|Lost to Follow-up|0|||
144633151|NCT00868790|521510258|FG009|Period 4|Lost to Follow-up|0|||
144633152|NCT00868790|521510259|FG010|Period 4|Lost to Follow-up|0|||
144633153|NCT00868790|521510260|FG011|Period 4|Lost to Follow-up|0|||
144633154|NCT00868790|521510261|FG012|Period 4|Lost to Follow-up|0|||
144633155|NCT00868790|521510262|FG013|Period 4|Lost to Follow-up|0|||
144633156|NCT00868790|521510249|FG000|Period 4|Study Terminated by Sponsor|2|||
144633157|NCT00868790|521510250|FG001|Period 4|Study Terminated by Sponsor|0|||
144633158|NCT00868790|521510251|FG002|Period 4|Study Terminated by Sponsor|0|||
144633159|NCT00868790|521510252|FG003|Period 4|Study Terminated by Sponsor|0|||
144210033|NCT02289456|519963595|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
144210034|NCT02289456|519963595|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
144210035|NCT02289456|519963595|FG000|Monotherapy Period|Withdrawal by Subject|2|||
144210036|NCT02289456|519963595|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
144210037|NCT02289456|519963595|FG000|Monotherapy Period|Miscellaneous|1|||
144633160|NCT00868790|521510253|FG004|Period 4|Study Terminated by Sponsor|0|||
144633161|NCT00868790|521510254|FG005|Period 4|Study Terminated by Sponsor|0|||
144633162|NCT00868790|521510255|FG006|Period 4|Study Terminated by Sponsor|0|||
144633163|NCT00868790|521510256|FG007|Period 4|Study Terminated by Sponsor|1|||
144633164|NCT00868790|521510257|FG008|Period 4|Study Terminated by Sponsor|2|||
144633165|NCT00868790|521510258|FG009|Period 4|Study Terminated by Sponsor|0|||
144633166|NCT00868790|521510259|FG010|Period 4|Study Terminated by Sponsor|2|||
144633167|NCT00868790|521510260|FG011|Period 4|Study Terminated by Sponsor|1|||
144633168|NCT00868790|521510261|FG012|Period 4|Study Terminated by Sponsor|0|||
144633169|NCT00868790|521510262|FG013|Period 4|Study Terminated by Sponsor|1|||
144633170|NCT00868790|521510249|FG000|Period 4|Abnormal ALT/AST|0|||
144633171|NCT00868790|521510250|FG001|Period 4|Abnormal ALT/AST|0|||
144633172|NCT00868790|521510251|FG002|Period 4|Abnormal ALT/AST|1|||
144633173|NCT00868790|521510252|FG003|Period 4|Abnormal ALT/AST|0|||
144633174|NCT00868790|521510253|FG004|Period 4|Abnormal ALT/AST|0|||
144633175|NCT00868790|521510254|FG005|Period 4|Abnormal ALT/AST|0|||
144633176|NCT00868790|521510255|FG006|Period 4|Abnormal ALT/AST|0|||
144633177|NCT00868790|521510256|FG007|Period 4|Abnormal ALT/AST|0|||
144633178|NCT00868790|521510257|FG008|Period 4|Abnormal ALT/AST|0|||
144633179|NCT00868790|521510258|FG009|Period 4|Abnormal ALT/AST|0|||
144633180|NCT00868790|521510259|FG010|Period 4|Abnormal ALT/AST|0|||
144633181|NCT00868790|521510260|FG011|Period 4|Abnormal ALT/AST|0|||
144633182|NCT00868790|521510261|FG012|Period 4|Abnormal ALT/AST|0|||
144633183|NCT00868790|521510262|FG013|Period 4|Abnormal ALT/AST|0|||
144633184|NCT00868790|521510249|FG000|Post-study|Withdrawal by Subject|0|||
144633185|NCT00868790|521510250|FG001|Post-study|Withdrawal by Subject|0|||
144210038|NCT01371539|519963596|FG000|Period One: One Week|Lost to Follow-up|0|||
144210039|NCT01371539|519963597|FG001|Period One: One Week|Lost to Follow-up|1|||
144633186|NCT00868790|521510251|FG002|Post-study|Withdrawal by Subject|0|||
144633187|NCT00868790|521510252|FG003|Post-study|Withdrawal by Subject|0|||
144633188|NCT00868790|521510253|FG004|Post-study|Withdrawal by Subject|1|||
144633189|NCT00868790|521510254|FG005|Post-study|Withdrawal by Subject|0|||
144633190|NCT00868790|521510255|FG006|Post-study|Withdrawal by Subject|0|||
144633191|NCT00868790|521510256|FG007|Post-study|Withdrawal by Subject|0|||
144210040|NCT01371539|519963596|FG000|Period Two: One Week|Lost to Follow-up|0|||
144210041|NCT01371539|519963597|FG001|Period Two: One Week|Lost to Follow-up|1|||
144210042|NCT01371539|519963596|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
144633192|NCT00868790|521510257|FG008|Post-study|Withdrawal by Subject|0|||
144633193|NCT00868790|521510258|FG009|Post-study|Withdrawal by Subject|0|||
144633194|NCT00868790|521510259|FG010|Post-study|Withdrawal by Subject|0|||
144633195|NCT00868790|521510260|FG011|Post-study|Withdrawal by Subject|0|||
144633196|NCT00868790|521510261|FG012|Post-study|Withdrawal by Subject|0|||
144633197|NCT00868790|521510262|FG013|Post-study|Withdrawal by Subject|0|||
144633198|NCT00868790|521510249|FG000|Post-study|Excluded Medication|0|||
144633199|NCT00868790|521510250|FG001|Post-study|Excluded Medication|0|||
144633200|NCT00868790|521510251|FG002|Post-study|Excluded Medication|0|||
144633201|NCT00868790|521510252|FG003|Post-study|Excluded Medication|0|||
144633202|NCT00868790|521510253|FG004|Post-study|Excluded Medication|0|||
144633203|NCT00868790|521510254|FG005|Post-study|Excluded Medication|0|||
144633204|NCT00868790|521510255|FG006|Post-study|Excluded Medication|0|||
144633205|NCT00868790|521510256|FG007|Post-study|Excluded Medication|2|||
144633206|NCT00868790|521510257|FG008|Post-study|Excluded Medication|0|||
144633207|NCT00868790|521510258|FG009|Post-study|Excluded Medication|1|||
144633208|NCT00868790|521510259|FG010|Post-study|Excluded Medication|0|||
144633209|NCT00868790|521510260|FG011|Post-study|Excluded Medication|0|||
144633210|NCT00868790|521510261|FG012|Post-study|Excluded Medication|0|||
144633211|NCT00868790|521510262|FG013|Post-study|Excluded Medication|0|||
144633212|NCT01750918|521512255|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
144633213|NCT01750918|521512256|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
144633214|NCT01750918|521512257|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
144633215|NCT01750918|521512258|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
144633216|NCT01750918|521512259|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
144633217|NCT01750918|521512260|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
144633218|NCT01750918|521512261|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
144633219|NCT01750918|521512262|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
144633220|NCT01750918|521512255|FG000|Overall Study|Lost to Follow-up|0|||
144633221|NCT01750918|521512256|FG001|Overall Study|Lost to Follow-up|0|||
144633222|NCT01750918|521512257|FG002|Overall Study|Lost to Follow-up|2|||
144633223|NCT01750918|521512258|FG003|Overall Study|Lost to Follow-up|2|||
144633224|NCT01750918|521512259|FG004|Overall Study|Lost to Follow-up|0|||
144633225|NCT01750918|521512260|FG005|Overall Study|Lost to Follow-up|0|||
144633226|NCT01750918|521512261|FG006|Overall Study|Lost to Follow-up|0|||
144633227|NCT01750918|521512262|FG007|Overall Study|Lost to Follow-up|1|||
144633228|NCT01750918|521512255|FG000|Overall Study|Withdrawal by Subject|0|||
144633229|NCT01750918|521512256|FG001|Overall Study|Withdrawal by Subject|0|||
144633230|NCT01750918|521512257|FG002|Overall Study|Withdrawal by Subject|1|||
144633231|NCT01750918|521512258|FG003|Overall Study|Withdrawal by Subject|2|||
144633232|NCT01750918|521512259|FG004|Overall Study|Withdrawal by Subject|1|||
144633233|NCT01750918|521512260|FG005|Overall Study|Withdrawal by Subject|1|||
144633234|NCT01750918|521512261|FG006|Overall Study|Withdrawal by Subject|2|||
144633235|NCT01750918|521512262|FG007|Overall Study|Withdrawal by Subject|2|||
144633236|NCT04840667|521512269|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
144633237|NCT00023322|521512271|FG000|Overall Study|Lost to Follow-up|1|||
144633238|NCT03658889|521512286|FG000|Overall Study|Protocol Violation|2|||
144633239|NCT03658889|521512287|FG001|Overall Study|Protocol Violation|0|||
144633240|NCT00206726|521512289|FG000|Overall Study|Delayed recovery of blood counts|1|||
144633241|NCT00206726|521512289|FG000|Overall Study|Progressive disease or relapsed disease|18|||
144633242|NCT00206726|521512289|FG000|Overall Study|Placed on new protocol|1|||
144633243|NCT00206726|521512289|FG000|Overall Study|Bone marrow transplant|1|||
144633244|NCT00206726|521512289|FG000|Overall Study|Adverse Event|17|||
144633245|NCT00206726|521512289|FG000|Overall Study|Death|4|||
144633246|NCT00206726|521512289|FG000|Overall Study|Protocol Violation|1|||
144633247|NCT00206726|521512289|FG000|Overall Study|Withdrawal by Subject|8|||
144633248|NCT04317690|521512290|FG000|Overall Study|did not have complete information for primary outcome|0|||
144633249|NCT04317690|521512291|FG001|Overall Study|did not have complete information for primary outcome|4|||
144633250|NCT04317690|521512292|FG002|Overall Study|did not have complete information for primary outcome|0|||
144633251|NCT04317690|521512293|FG003|Overall Study|did not have complete information for primary outcome|2|||
144633252|NCT04317690|521512294|FG004|Overall Study|did not have complete information for primary outcome|0|||
144633253|NCT01154101|521512300|FG000|Overall Study|Adverse Event|0|||
144633254|NCT01154101|521512301|FG001|Overall Study|Adverse Event|2|||
144633255|NCT01154101|521512302|FG002|Overall Study|Adverse Event|1|||
144633256|NCT01154101|521512303|FG003|Overall Study|Adverse Event|1|||
144633257|NCT01154101|521512304|FG004|Overall Study|Adverse Event|0|||
144633258|NCT01154101|521512300|FG000|Overall Study|Lost to Follow-up|0|||
144633259|NCT01154101|521512301|FG001|Overall Study|Lost to Follow-up|1|||
144633260|NCT01154101|521512302|FG002|Overall Study|Lost to Follow-up|0|||
144633261|NCT01154101|521512303|FG003|Overall Study|Lost to Follow-up|1|||
144633262|NCT01154101|521512304|FG004|Overall Study|Lost to Follow-up|0|||
144633263|NCT01154101|521512300|FG000|Overall Study|Withdrawal by Subject|0|||
144633264|NCT01154101|521512301|FG001|Overall Study|Withdrawal by Subject|1|||
144633265|NCT01154101|521512302|FG002|Overall Study|Withdrawal by Subject|2|||
144633266|NCT01154101|521512303|FG003|Overall Study|Withdrawal by Subject|0|||
144633267|NCT01154101|521512304|FG004|Overall Study|Withdrawal by Subject|1|||
144633268|NCT05019131|521512305|FG000|Overall Study|Lost to Follow-up|0|||
144633269|NCT05019131|521512306|FG001|Overall Study|Lost to Follow-up|3|||
144633270|NCT03902080|521512307|FG000|Overall Study|Adverse Event|17|||
144633271|NCT03902080|521512308|FG001|Overall Study|Adverse Event|15|||
144633272|NCT03902080|521512307|FG000|Overall Study|Withdrawal by Subject|28|||
144633273|NCT03902080|521512308|FG001|Overall Study|Withdrawal by Subject|35|||
144633274|NCT03902080|521512307|FG000|Overall Study|Lost to Follow-up|6|||
144633275|NCT03902080|521512308|FG001|Overall Study|Lost to Follow-up|7|||
144633276|NCT03902080|521512307|FG000|Overall Study|Other|3|||
144633277|NCT03902080|521512308|FG001|Overall Study|Other|5|||
144633278|NCT03902080|521512307|FG000|Overall Study|Non compliance|4|||
144633279|NCT03902080|521512308|FG001|Overall Study|Non compliance|3|||
144633280|NCT03902080|521512307|FG000|Overall Study|Physician Decision|5|||
144633281|NCT03902080|521512308|FG001|Overall Study|Physician Decision|1|||
144633282|NCT03902080|521512307|FG000|Overall Study|Protocol Violation|3|||
144633283|NCT03902080|521512308|FG001|Overall Study|Protocol Violation|3|||
144633284|NCT03902080|521512307|FG000|Overall Study|Lack of Efficacy|1|||
144633285|NCT03902080|521512308|FG001|Overall Study|Lack of Efficacy|3|||
144633286|NCT03902080|521512307|FG000|Overall Study|Withdrawn prior to dosing|0|||
144633287|NCT03902080|521512308|FG001|Overall Study|Withdrawn prior to dosing|1|||
144633288|NCT01409928|521512309|FG000|Overall Study|Physician Decision|12|||
144633289|NCT02347631|521512310|FG000|First Intervention (2 Months)|Adverse Event|1|||
144633290|NCT02347631|521512311|FG001|First Intervention (2 Months)|Adverse Event|1|||
144633291|NCT02347631|521512310|FG000|First Intervention (2 Months)|Pregnancy|1|||
144633292|NCT02347631|521512311|FG001|First Intervention (2 Months)|Pregnancy|0|||
144633293|NCT02347631|521512310|FG000|First Intervention (2 Months)|Moved out of area|0|||
144633294|NCT02347631|521512311|FG001|First Intervention (2 Months)|Moved out of area|2|||
144633295|NCT02347631|521512310|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
144633296|NCT02347631|521512311|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
144633297|NCT02347631|521512310|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
144633298|NCT02347631|521512311|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
144633299|NCT02347631|521512310|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
144633300|NCT02347631|521512311|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
144633301|NCT02347631|521512310|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
144633302|NCT02347631|521512311|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
144633303|NCT02347631|521512310|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
144633304|NCT02347631|521512311|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
144633305|NCT01111604|521512320|FG000|Overall Study|Lost to Follow-up|0|||
144633306|NCT01111604|521512321|FG001|Overall Study|Lost to Follow-up|0|||
144633307|NCT01111604|521512322|FG002|Overall Study|Lost to Follow-up|1|||
144633308|NCT01111604|521512320|FG000|Overall Study|Withdrew Consent|3|||
144633309|NCT01111604|521512321|FG001|Overall Study|Withdrew Consent|0|||
144633310|NCT01111604|521512322|FG002|Overall Study|Withdrew Consent|2|||
144633311|NCT01111604|521512320|FG000|Overall Study|Withdrawal by Subject|2|||
144633312|NCT01111604|521512321|FG001|Overall Study|Withdrawal by Subject|0|||
144633313|NCT01111604|521512322|FG002|Overall Study|Withdrawal by Subject|0|||
144633314|NCT01111604|521512320|FG000|Overall Study|Death|1|||
144633315|NCT01111604|521512321|FG001|Overall Study|Death|0|||
144633316|NCT01111604|521512322|FG002|Overall Study|Death|0|||
144633317|NCT01111604|521512320|FG000|Overall Study|Met Exclusion Criteria|2|||
144633318|NCT01111604|521512321|FG001|Overall Study|Met Exclusion Criteria|0|||
144633319|NCT01111604|521512322|FG002|Overall Study|Met Exclusion Criteria|0|||
144633320|NCT01295125|521512324|FG000|Overall Study|Study stopped prematurely|9|||
144633321|NCT03838484|521512335|FG000|Overall Study|Lost to Follow-up|0|||
144633322|NCT03838484|521512336|FG001|Overall Study|Lost to Follow-up|1|||
144633323|NCT03838484|521512337|FG002|Overall Study|Lost to Follow-up|0|||
144633324|NCT03838484|521512338|FG003|Overall Study|Lost to Follow-up|0|||
144633325|NCT02507349|521512339|FG000|Overall Study|Death|12|||
144633326|NCT02507349|521512340|FG001|Overall Study|Death|16|||
144633327|NCT02507349|521512339|FG000|Overall Study|Withdrawal by Subject|1|||
144633328|NCT02507349|521512340|FG001|Overall Study|Withdrawal by Subject|1|||
144633329|NCT02507349|521512339|FG000|Overall Study|Lost to Follow-up|174|||
144633330|NCT02507349|521512340|FG001|Overall Study|Lost to Follow-up|144|||
144633331|NCT00813995|521512341|FG000|Overall Study|Clinical adverse event|9|||
144633332|NCT00813995|521512342|FG001|Overall Study|Clinical adverse event|3|||
144633333|NCT00813995|521512341|FG000|Overall Study|Laboratory adverse event|0|||
144633334|NCT00813995|521512342|FG001|Overall Study|Laboratory adverse event|2|||
144633335|NCT00813995|521512341|FG000|Overall Study|Lack of Efficacy|1|||
144633336|NCT00813995|521512342|FG001|Overall Study|Lack of Efficacy|0|||
144633337|NCT00813995|521512341|FG000|Overall Study|Lost to Follow-up|4|||
144633338|NCT00813995|521512342|FG001|Overall Study|Lost to Follow-up|2|||
144633339|NCT00813995|521512341|FG000|Overall Study|Other reason|2|||
144633340|NCT00813995|521512342|FG001|Overall Study|Other reason|2|||
144633341|NCT00813995|521512341|FG000|Overall Study|Protocol Violation|3|||
144633342|NCT00813995|521512342|FG001|Overall Study|Protocol Violation|2|||
144633343|NCT00813995|521512341|FG000|Overall Study|Subject moved|4|||
144633344|NCT00813995|521512342|FG001|Overall Study|Subject moved|0|||
144633345|NCT00813995|521512341|FG000|Overall Study|Withdrawal by Subject|0|||
144633346|NCT00813995|521512342|FG001|Overall Study|Withdrawal by Subject|5|||
144633347|NCT01614964|521512343|FG000|Overall Study|Withdrawal by Subject|2|||
144633348|NCT01614964|521512344|FG001|Overall Study|Withdrawal by Subject|0|||
144633349|NCT01614964|521512343|FG000|Overall Study|Lost to Follow-up|3|||
144633350|NCT01614964|521512344|FG001|Overall Study|Lost to Follow-up|0|||
144633351|NCT00860470|521512355|FG000|Overall Study|Death|6|||
144633352|NCT00860470|521512356|FG001|Overall Study|Death|10|||
144633353|NCT00860470|521512355|FG000|Overall Study|Moved away|8|||
144633354|NCT00860470|521512356|FG001|Overall Study|Moved away|10|||
144633355|NCT00860470|521512355|FG000|Overall Study|Lost to Follow-up|34|||
144633356|NCT00860470|521512356|FG001|Overall Study|Lost to Follow-up|39|||
144633357|NCT00888238|521512358|FG000|Washout Period After Period 2|Adverse Event|0|||
144633358|NCT00888238|521512359|FG001|Washout Period After Period 2|Adverse Event|0|||
144633359|NCT00888238|521512360|FG002|Washout Period After Period 2|Adverse Event|1|||
144633360|NCT02700984|521512361|FG000|Overall Study|Death|2|||
144633361|NCT02700984|521512362|FG001|Overall Study|Death|1|||
144633362|NCT02700984|521512361|FG000|Overall Study|Lost to Follow-up|2|||
144633363|NCT02700984|521512362|FG001|Overall Study|Lost to Follow-up|1|||
144633364|NCT02700984|521512361|FG000|Overall Study|Physician Decision|0|||
144633365|NCT02700984|521512362|FG001|Overall Study|Physician Decision|1|||
144633366|NCT02700984|521512361|FG000|Overall Study|Withdrawal by Subject|8|||
144633367|NCT02700984|521512362|FG001|Overall Study|Withdrawal by Subject|9|||
144633368|NCT02700984|521512361|FG000|Overall Study|Reason not specified|3|||
144633369|NCT02700984|521512362|FG001|Overall Study|Reason not specified|2|||
144633370|NCT01032629|521512364|FG000|Overall Study|Closed Site|21|||
144633371|NCT01032629|521512365|FG001|Overall Study|Closed Site|18|||
144633372|NCT01032629|521512366|FG002|Overall Study|Closed Site|16|||
144633373|NCT01032629|521512364|FG000|Overall Study|Withdrawal by Subject|50|||
144633374|NCT01032629|521512365|FG001|Overall Study|Withdrawal by Subject|36|||
144633375|NCT01032629|521512366|FG002|Overall Study|Withdrawal by Subject|35|||
144633376|NCT01032629|521512364|FG000|Overall Study|Lost to Follow-up|74|||
144633377|NCT01032629|521512365|FG001|Overall Study|Lost to Follow-up|47|||
144633378|NCT01032629|521512366|FG002|Overall Study|Lost to Follow-up|37|||
144633379|NCT03371355|521512367|FG000|Overall Study|Investigator judgment|0|||
144633380|NCT03371355|521512368|FG001|Overall Study|Investigator judgment|0|||
144633381|NCT03371355|521512369|FG002|Overall Study|Investigator judgment|1|||
144633382|NCT03371355|521512370|FG003|Overall Study|Investigator judgment|1|||
144633383|NCT03371355|521512367|FG000|Overall Study|Voluntary withdrawal|1|||
144633384|NCT03371355|521512368|FG001|Overall Study|Voluntary withdrawal|0|||
144633385|NCT03371355|521512369|FG002|Overall Study|Voluntary withdrawal|1|||
144633386|NCT03371355|521512370|FG003|Overall Study|Voluntary withdrawal|2|||
144633387|NCT03371355|521512367|FG000|Overall Study|Adverse Event|0|||
144633388|NCT03371355|521512368|FG001|Overall Study|Adverse Event|1|||
144633389|NCT03371355|521512369|FG002|Overall Study|Adverse Event|2|||
144633390|NCT03371355|521512370|FG003|Overall Study|Adverse Event|3|||
144633391|NCT03371355|521512367|FG000|Overall Study|Reason not Specified|0|||
144633392|NCT03371355|521512368|FG001|Overall Study|Reason not Specified|1|||
144633393|NCT03371355|521512369|FG002|Overall Study|Reason not Specified|0|||
144633394|NCT03371355|521512370|FG003|Overall Study|Reason not Specified|1|||
144633395|NCT00619957|521512371|FG000|Month 24 Double-Blind|Adverse Event|9|||
144633396|NCT00619957|521512372|FG001|Month 24 Double-Blind|Adverse Event|7|||
144633397|NCT00619957|521512371|FG000|Month 24 Double-Blind|Protocol Violation|1|||
144633398|NCT00619957|521512372|FG001|Month 24 Double-Blind|Protocol Violation|0|||
144633399|NCT00619957|521512371|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
144633400|NCT00619957|521512372|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
144633401|NCT00619957|521512371|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
144633402|NCT00619957|521512372|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
144633403|NCT00619957|521512371|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
144633404|NCT00619957|521512372|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
144633405|NCT00619957|521512371|FG000|Month 48 Open-Label|Adverse Event|4|||
144633406|NCT00619957|521512372|FG001|Month 48 Open-Label|Adverse Event|4|||
144633407|NCT00619957|521512371|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
144633408|NCT00619957|521512372|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
144633409|NCT00619957|521512371|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
144633410|NCT00619957|521512372|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
144633411|NCT00723957|521512373|FG000|Overall Study|Adverse event unrelated to study drug|1|||
144633412|NCT00723957|521512374|FG001|Overall Study|Adverse event unrelated to study drug|4|||
144633413|NCT00723957|521512373|FG000|Overall Study|Death|3|||
144633414|NCT00723957|521512374|FG001|Overall Study|Death|4|||
144633415|NCT00723957|521512373|FG000|Overall Study|Disease progression|27|||
144633416|NCT00723957|521512374|FG001|Overall Study|Disease progression|25|||
144633417|NCT00723957|521512373|FG000|Overall Study|Maximum clinical benefit|4|||
144633418|NCT00723957|521512374|FG001|Overall Study|Maximum clinical benefit|5|||
144633419|NCT00723957|521512373|FG000|Overall Study|Investigator decision|1|||
144633420|NCT00723957|521512374|FG001|Overall Study|Investigator decision|1|||
144633421|NCT00723957|521512373|FG000|Overall Study|Study drug toxicity|4|||
144633422|NCT00723957|521512374|FG001|Overall Study|Study drug toxicity|6|||
144633423|NCT00723957|521512373|FG000|Overall Study|Withdrawal by Subject|7|||
144633424|NCT00723957|521512374|FG001|Overall Study|Withdrawal by Subject|5|||
144633425|NCT00723957|521512373|FG000|Overall Study|Reason not analyzed|1|||
144633426|NCT00723957|521512374|FG001|Overall Study|Reason not analyzed|0|||
144262975|NCT00735709|520163809|FG003|Overall Study|Adverse Event|5|||
144633427|NCT00723957|521512373|FG000|Overall Study|Never received treatment|3|||
144633428|NCT00723957|521512374|FG001|Overall Study|Never received treatment|3|||
144633429|NCT01763164|521512380|FG000|Treatment Phase|Participant/Guardian decision|26|||
144633430|NCT01763164|521512381|FG001|Treatment Phase|Participant/Guardian decision|14|||
144633431|NCT01763164|521512380|FG000|Treatment Phase|Protocol Violation|1|||
144633432|NCT01763164|521512381|FG001|Treatment Phase|Protocol Violation|1|||
144633433|NCT01763164|521512380|FG000|Treatment Phase|Progressive Disease|142|||
144633434|NCT01763164|521512381|FG001|Treatment Phase|Progressive Disease|76|||
144633435|NCT01763164|521512380|FG000|Treatment Phase|Physician Decision|24|||
144633436|NCT01763164|521512381|FG001|Treatment Phase|Physician Decision|13|||
144633437|NCT01763164|521512380|FG000|Treatment Phase|Death|10|||
144633438|NCT01763164|521512381|FG001|Treatment Phase|Death|1|||
144633439|NCT01763164|521512380|FG000|Treatment Phase|Adverse Event|66|||
144633440|NCT01763164|521512381|FG001|Treatment Phase|Adverse Event|8|||
144633441|NCT01763164|521512380|FG000|Treatment Phase|Randomized but not Treated|0|||
144633442|NCT01763164|521512381|FG001|Treatment Phase|Randomized but not Treated|19|||
144633443|NCT01763164|521512380|FG000|Treatment Phase|Other|0|||
144633444|NCT01763164|521512381|FG001|Treatment Phase|Other|1|||
144633445|NCT01763164|521512380|FG000|Follow up Phase|New therapy for study indication|12|||
144633446|NCT01763164|521512381|FG001|Follow up Phase|New therapy for study indication|3|||
144633447|NCT01763164|521512380|FG000|Follow up Phase|Death|21|||
144633448|NCT01763164|521512381|FG001|Follow up Phase|Death|4|||
144633449|NCT01763164|521512380|FG000|Follow up Phase|Subject/guardian decision|9|||
144633450|NCT01763164|521512381|FG001|Follow up Phase|Subject/guardian decision|2|||
144633451|NCT01763164|521512380|FG000|Follow up Phase|Progressive disease|127|||
144633452|NCT01763164|521512381|FG001|Follow up Phase|Progressive disease|62|||
144633453|NCT01763164|521512380|FG000|Follow up Phase|Physician Decision|10|||
144633454|NCT01763164|521512381|FG001|Follow up Phase|Physician Decision|3|||
144633455|NCT01763164|521512380|FG000|Follow up Phase|Lost to Follow-up|1|||
144633456|NCT01763164|521512381|FG001|Follow up Phase|Lost to Follow-up|0|||
144633457|NCT01763164|521512380|FG000|Follow up Phase|Adverse Event|17|||
144633458|NCT01763164|521512381|FG001|Follow up Phase|Adverse Event|1|||
144633459|NCT03377634|521512382|FG000|Study Period|Adverse Event|1|||
144633460|NCT03377634|521512383|FG001|Study Period|Adverse Event|0|||
144633461|NCT03377634|521512382|FG000|Study Period|Withdrawal by Subject|1|||
144633462|NCT03377634|521512383|FG001|Study Period|Withdrawal by Subject|0|||
144633463|NCT01264939|521512384|FG000|Overall Study|Adverse Event|1|||
144633464|NCT01264939|521512385|FG001|Overall Study|Adverse Event|3|||
144633465|NCT01264939|521512384|FG000|Overall Study|Lost to Follow-up|0|||
144633466|NCT01264939|521512385|FG001|Overall Study|Lost to Follow-up|3|||
144633467|NCT01264939|521512384|FG000|Overall Study|Physician Decision|1|||
144633468|NCT01264939|521512385|FG001|Overall Study|Physician Decision|1|||
144633469|NCT01264939|521512384|FG000|Overall Study|Patient/Guardian Decision|8|||
144633470|NCT01264939|521512385|FG001|Overall Study|Patient/Guardian Decision|10|||
144633471|NCT01264939|521512384|FG000|Overall Study|Disease Progression|8|||
144633472|NCT01264939|521512385|FG001|Overall Study|Disease Progression|11|||
144633473|NCT01384292|521512389|FG000|Part B|Severe non-compliance to protocol|1|||
144633474|NCT01384292|521512390|FG001|Part B|Severe non-compliance to protocol|0|||
144633475|NCT01384292|521512391|FG002|Part B|Severe non-compliance to protocol|0|||
144633476|NCT01171612|521512393|FG000|Overall Study|Lost to Follow-up|51|||
144633477|NCT00737529|521512394|FG000|Overall Study|Disease Progression|95|||
144633478|NCT00737529|521512394|FG000|Overall Study|Adverse Event|24|||
144633479|NCT00737529|521512394|FG000|Overall Study|Withdrawal by Subject|5|||
144633480|NCT00737529|521512394|FG000|Overall Study|Death|4|||
144633481|NCT00737529|521512394|FG000|Overall Study|Protocol Violation|1|||
144633482|NCT00737529|521512394|FG000|Overall Study|Other|4|||
144633483|NCT04525703|521512395|FG000|Overall Study|Lost to Follow-up|6|||
144210043|NCT01371539|519963597|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
144210044|NCT01371539|519963596|FG000|Period Two: One Week|Time/job conflict|0|||
144210045|NCT01371539|519963597|FG001|Period Two: One Week|Time/job conflict|1|||
144210046|NCT02806024|519963601|FG000|Overall Study|Night Delivery|1|||
144210047|NCT02806024|519963602|FG001|Overall Study|Night Delivery|1|||
144210048|NCT02806024|519963601|FG000|Overall Study|DVT during antepartum admission|0|||
144633484|NCT04525703|521512396|FG001|Overall Study|Lost to Follow-up|15|||
144633485|NCT04525703|521512397|FG002|Overall Study|Lost to Follow-up|8|||
144633486|NCT00291551|521512398|FG000|Overall Study|Death|7|||
144633487|NCT00291551|521512398|FG000|Overall Study|Withdrawal by Subject|6|||
144633488|NCT03682120|521512399|FG000|Overall Study|Lost to Follow-up|11|||
144633489|NCT03682120|521512400|FG001|Overall Study|Lost to Follow-up|4|||
144633490|NCT03682120|521512401|FG002|Overall Study|Lost to Follow-up|5|||
144633491|NCT03682120|521512402|FG003|Overall Study|Lost to Follow-up|2|||
144633492|NCT03682120|521512399|FG000|Overall Study|Physician Decision|1|||
144210049|NCT02806024|519963602|FG001|Overall Study|DVT during antepartum admission|1|||
144633493|NCT03682120|521512400|FG001|Overall Study|Physician Decision|0|||
144633494|NCT03682120|521512401|FG002|Overall Study|Physician Decision|0|||
144633495|NCT03682120|521512402|FG003|Overall Study|Physician Decision|0|||
144633496|NCT03682120|521512399|FG000|Overall Study|Withdrawal by Subject|1|||
144633497|NCT03682120|521512400|FG001|Overall Study|Withdrawal by Subject|2|||
144633498|NCT03682120|521512401|FG002|Overall Study|Withdrawal by Subject|3|||
144633499|NCT03682120|521512402|FG003|Overall Study|Withdrawal by Subject|0|||
144633500|NCT03682120|521512399|FG000|Overall Study|Death|0|||
144633501|NCT03682120|521512400|FG001|Overall Study|Death|1|||
144633502|NCT03682120|521512401|FG002|Overall Study|Death|0|||
144633503|NCT03682120|521512402|FG003|Overall Study|Death|0|||
144633504|NCT03682120|521512399|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
144633505|NCT03682120|521512400|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
144633506|NCT03682120|521512401|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
144633507|NCT03682120|521512402|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
144633508|NCT01015833|521512403|FG000|Overall Study|Death|1|||
144633509|NCT01015833|521512404|FG001|Overall Study|Death|0|||
144633510|NCT01015833|521512403|FG000|Overall Study|Withdrawal by Subject|3|||
144633511|NCT01015833|521512404|FG001|Overall Study|Withdrawal by Subject|2|||
144633512|NCT01015833|521512403|FG000|Overall Study|Adverse Event|0|||
144633513|NCT01015833|521512404|FG001|Overall Study|Adverse Event|1|||
144633514|NCT01015833|521512403|FG000|Overall Study|Physician Decision|2|||
144633515|NCT01015833|521512404|FG001|Overall Study|Physician Decision|0|||
144633516|NCT01015833|521512403|FG000|Overall Study|Symptomatic deterioration|0|||
144633517|NCT01015833|521512404|FG001|Overall Study|Symptomatic deterioration|1|||
144633518|NCT01015833|521512403|FG000|Overall Study|Other|5|||
144633519|NCT01015833|521512404|FG001|Overall Study|Other|1|||
144633520|NCT01015833|521512403|FG000|Overall Study|Motor Vehicle Accidents|1|||
144633521|NCT01015833|521512404|FG001|Overall Study|Motor Vehicle Accidents|0|||
144633522|NCT01015833|521512403|FG000|Overall Study|Did not start treatment|1|||
144633523|NCT01015833|521512404|FG001|Overall Study|Did not start treatment|0|||
144633524|NCT02497001|521512405|FG000|Overall Study|Lost to Follow-up|10|||
144633525|NCT02497001|521512406|FG001|Overall Study|Lost to Follow-up|2|||
144633526|NCT02497001|521512407|FG002|Overall Study|Lost to Follow-up|0|||
144633527|NCT02497001|521512408|FG003|Overall Study|Lost to Follow-up|2|||
144633528|NCT02497001|521512405|FG000|Overall Study|Adverse Event|28|||
144633529|NCT02497001|521512406|FG001|Overall Study|Adverse Event|30|||
144633530|NCT02497001|521512407|FG002|Overall Study|Adverse Event|11|||
144633531|NCT02497001|521512408|FG003|Overall Study|Adverse Event|11|||
144633532|NCT02497001|521512405|FG000|Overall Study|Withdrawal by Subject|14|||
144633533|NCT02497001|521512406|FG001|Overall Study|Withdrawal by Subject|37|||
144633534|NCT02497001|521512407|FG002|Overall Study|Withdrawal by Subject|19|||
144633535|NCT02497001|521512408|FG003|Overall Study|Withdrawal by Subject|15|||
144633536|NCT02497001|521512405|FG000|Overall Study|Physician Decision|5|||
144633537|NCT02497001|521512406|FG001|Overall Study|Physician Decision|11|||
144633538|NCT02497001|521512407|FG002|Overall Study|Physician Decision|5|||
144633539|NCT02497001|521512408|FG003|Overall Study|Physician Decision|1|||
144633540|NCT02497001|521512405|FG000|Overall Study|subjects that were not treated|1|||
144633541|NCT02497001|521512406|FG001|Overall Study|subjects that were not treated|2|||
144633542|NCT02497001|521512407|FG002|Overall Study|subjects that were not treated|2|||
144633543|NCT02497001|521512408|FG003|Overall Study|subjects that were not treated|1|||
144633544|NCT02497001|521512405|FG000|Overall Study|Major Protocol Deviation|3|||
144633545|NCT02497001|521512406|FG001|Overall Study|Major Protocol Deviation|4|||
144633546|NCT02497001|521512407|FG002|Overall Study|Major Protocol Deviation|4|||
144633547|NCT02497001|521512408|FG003|Overall Study|Major Protocol Deviation|4|||
144633548|NCT02497001|521512405|FG000|Overall Study|Lack of Efficacy|10|||
144633549|NCT02497001|521512406|FG001|Overall Study|Lack of Efficacy|16|||
144633550|NCT02497001|521512407|FG002|Overall Study|Lack of Efficacy|6|||
144633551|NCT02497001|521512408|FG003|Overall Study|Lack of Efficacy|6|||
144633552|NCT02497001|521512405|FG000|Overall Study|Protocol Violation|3|||
144633553|NCT02497001|521512406|FG001|Overall Study|Protocol Violation|1|||
144633554|NCT02497001|521512407|FG002|Overall Study|Protocol Violation|3|||
144633555|NCT02497001|521512408|FG003|Overall Study|Protocol Violation|1|||
144633556|NCT03898063|521512411|FG000|Overall Study|Withdrawal by Subject|10|||
144633557|NCT03898063|521512412|FG001|Overall Study|Withdrawal by Subject|8|||
144633558|NCT02949830|521512413|FG000|Overall Study|Adverse Event|1|||
144633559|NCT02949830|521512413|FG000|Overall Study|Withdrawal by Subject|1|||
144633560|NCT01551745|521512414|FG000|Overall Study|Withdrawal by Subject|1|||
144633561|NCT01551745|521512414|FG000|Overall Study|Disease Progression|2|||
144633562|NCT01929135|521512416|FG000|Overall Study|Lost to Follow-up|1|||
144633563|NCT01929135|521512417|FG001|Overall Study|Lost to Follow-up|1|||
144633564|NCT04280081|521512424|FG000|Overall Study|Adverse Event|4|||
144633565|NCT04280081|521512424|FG000|Overall Study|Death|2|||
144633566|NCT04280081|521512424|FG000|Overall Study|Progressive Disease|6|||
144633567|NCT06001307|521514501|FG000|Overall Study|Lost to Follow-up|1|||
144633568|NCT06001307|521514502|FG001|Overall Study|Lost to Follow-up|2|||
144633569|NCT03532100|521514503|FG000|Overall Study|Intervention malfunction|1|||
144633570|NCT04439279|521514504|FG000|Overall Study|Adverse Event|7|||
144633571|NCT04439279|521514504|FG000|Overall Study|Death|4|||
144633572|NCT04439279|521514504|FG000|Overall Study|Disease progression|17|||
144633573|NCT04439279|521514504|FG000|Overall Study|Complicating disease|3|||
144633574|NCT04439279|521514504|FG000|Overall Study|Withdrawal by Subject|2|||
144633575|NCT04439279|521514504|FG000|Overall Study|Ineligible|1|||
144210050|NCT02892149|519963603|FG000|Overall Study|Death|262|||
144210051|NCT02892149|519963604|FG001|Overall Study|Death|278|||
144210052|NCT02892149|519963603|FG000|Overall Study|Withdrawal by Subject|53|||
144210053|NCT02892149|519963604|FG001|Overall Study|Withdrawal by Subject|47|||
144210054|NCT02892149|519963603|FG000|Overall Study|Lost to Follow-up|37|||
144210055|NCT02892149|519963604|FG001|Overall Study|Lost to Follow-up|31|||
144210056|NCT01994850|519963606|FG000|Overall Study|Physician Decision|1|||
144210057|NCT01994850|519963606|FG000|Overall Study|Withdrawal by Subject|1|||
144633576|NCT04439279|521514504|FG000|Overall Study|Treatment still ongoing|1|||
144633577|NCT02031679|521514505|FG000|Overall Study|Protocol Violation|0|||
144633578|NCT02031679|521514506|FG001|Overall Study|Protocol Violation|1|||
144633579|NCT02031679|521514505|FG000|Overall Study|Lack of Efficacy|0|||
144633580|NCT02031679|521514506|FG001|Overall Study|Lack of Efficacy|1|||
144633581|NCT03263806|521514507|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
144633582|NCT03263806|521514508|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
144633583|NCT03263806|521514507|FG000|Overall Study|Withdrawal by Subject|0|||
144633584|NCT03263806|521514508|FG001|Overall Study|Withdrawal by Subject|1|||
144633585|NCT03263806|521514507|FG000|Overall Study|Study Termination|5|||
144633586|NCT03263806|521514508|FG001|Overall Study|Study Termination|6|||
144633587|NCT03312218|521514509|FG000|Overall Study|Never signed in to access the app|54|||
144633588|NCT03312218|521514510|FG001|Overall Study|Never signed in to access the app|58|||
144633589|NCT02360098|521514513|FG000|Overall Study|Physician Decision|7|||
144633590|NCT03293654|521514518|FG000|Overall Study|Lost to Follow-up|0|||
144633591|NCT03293654|521514519|FG001|Overall Study|Lost to Follow-up|1|||
144633592|NCT03293654|521514520|FG002|Overall Study|Lost to Follow-up|0|||
144633593|NCT01919307|521514521|FG000|Overall Study|Withdrawal by Subject|9|||
144633594|NCT06161012|521514523|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
144633595|NCT06161012|521514524|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
144633596|NCT00408005|521514525|FG000|Induction|Adverse Event|19|||
144633597|NCT00408005|521514526|FG001|Induction|Adverse Event|3|||
144633598|NCT00408005|521514527|FG002|Induction|Adverse Event|0|||
144633599|NCT00408005|521514528|FG003|Induction|Adverse Event|0|||
144633600|NCT00408005|521514529|FG004|Induction|Adverse Event|0|||
144633601|NCT00408005|521514530|FG005|Induction|Adverse Event|0|||
144633602|NCT00408005|521514531|FG006|Induction|Adverse Event|0|||
144633603|NCT00408005|521514532|FG007|Induction|Adverse Event|0|||
144633604|NCT00408005|521514525|FG000|Induction|Death|6|||
144633605|NCT00408005|521514526|FG001|Induction|Death|0|||
144633606|NCT00408005|521514527|FG002|Induction|Death|0|||
144633607|NCT00408005|521514528|FG003|Induction|Death|0|||
144633608|NCT00408005|521514529|FG004|Induction|Death|0|||
144633609|NCT00408005|521514530|FG005|Induction|Death|0|||
144633610|NCT00408005|521514531|FG006|Induction|Death|0|||
144633611|NCT00408005|521514532|FG007|Induction|Death|0|||
144633612|NCT00408005|521514525|FG000|Induction|Physician Decision|83|||
144633613|NCT00408005|521514526|FG001|Induction|Physician Decision|9|||
144633614|NCT00408005|521514527|FG002|Induction|Physician Decision|0|||
144633615|NCT00408005|521514528|FG003|Induction|Physician Decision|0|||
144633616|NCT00408005|521514529|FG004|Induction|Physician Decision|0|||
144633617|NCT00408005|521514530|FG005|Induction|Physician Decision|0|||
144633618|NCT00408005|521514531|FG006|Induction|Physician Decision|0|||
144633619|NCT00408005|521514532|FG007|Induction|Physician Decision|0|||
144633620|NCT00408005|521514525|FG000|Induction|Withdrawal by Subject|2|||
144210058|NCT01420965|519963607|FG000|Overall Study|Withdrawal by Subject|1|||
144210059|NCT01420965|519963608|FG001|Overall Study|Withdrawal by Subject|0|||
144210060|NCT01420965|519963609|FG002|Overall Study|Withdrawal by Subject|0|||
144210061|NCT01420965|519963607|FG000|Overall Study|Adverse Event|0|||
144633621|NCT00408005|521514526|FG001|Induction|Withdrawal by Subject|4|||
144633622|NCT00408005|521514527|FG002|Induction|Withdrawal by Subject|0|||
144633623|NCT00408005|521514528|FG003|Induction|Withdrawal by Subject|0|||
144633624|NCT00408005|521514529|FG004|Induction|Withdrawal by Subject|0|||
144633625|NCT00408005|521514530|FG005|Induction|Withdrawal by Subject|0|||
144633626|NCT00408005|521514531|FG006|Induction|Withdrawal by Subject|0|||
144633627|NCT00408005|521514532|FG007|Induction|Withdrawal by Subject|0|||
144633628|NCT00408005|521514525|FG000|Induction|Ineligible|33|||
144633629|NCT00408005|521514526|FG001|Induction|Ineligible|14|||
144633630|NCT00408005|521514527|FG002|Induction|Ineligible|0|||
144633631|NCT00408005|521514528|FG003|Induction|Ineligible|0|||
144633632|NCT00408005|521514529|FG004|Induction|Ineligible|0|||
144633633|NCT00408005|521514530|FG005|Induction|Ineligible|0|||
144633634|NCT00408005|521514531|FG006|Induction|Ineligible|0|||
144633635|NCT00408005|521514532|FG007|Induction|Ineligible|0|||
144633636|NCT00408005|521514525|FG000|Induction|Refusal of Further Protocol Therapy|225|||
144210062|NCT01420965|519963608|FG001|Overall Study|Adverse Event|1|||
144633637|NCT00408005|521514526|FG001|Induction|Refusal of Further Protocol Therapy|44|||
144633638|NCT00408005|521514527|FG002|Induction|Refusal of Further Protocol Therapy|0|||
144633639|NCT00408005|521514528|FG003|Induction|Refusal of Further Protocol Therapy|0|||
144633640|NCT00408005|521514529|FG004|Induction|Refusal of Further Protocol Therapy|0|||
144210063|NCT01420965|519963609|FG002|Overall Study|Adverse Event|0|||
144633641|NCT00408005|521514530|FG005|Induction|Refusal of Further Protocol Therapy|0|||
144633642|NCT00408005|521514531|FG006|Induction|Refusal of Further Protocol Therapy|0|||
144633643|NCT00408005|521514532|FG007|Induction|Refusal of Further Protocol Therapy|0|||
144633644|NCT00408005|521514525|FG000|Induction|Entered another COG therapeutic protocol|4|||
144633645|NCT00408005|521514526|FG001|Induction|Entered another COG therapeutic protocol|0|||
144633646|NCT00408005|521514527|FG002|Induction|Entered another COG therapeutic protocol|0|||
144633647|NCT00408005|521514528|FG003|Induction|Entered another COG therapeutic protocol|0|||
144633648|NCT00408005|521514529|FG004|Induction|Entered another COG therapeutic protocol|0|||
144633649|NCT00408005|521514530|FG005|Induction|Entered another COG therapeutic protocol|0|||
144633650|NCT00408005|521514531|FG006|Induction|Entered another COG therapeutic protocol|0|||
144633651|NCT00408005|521514532|FG007|Induction|Entered another COG therapeutic protocol|0|||
144210064|NCT01890434|519963642|FG000|Overall Study|Adverse Event|8|||
144633652|NCT00408005|521514525|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
144633653|NCT00408005|521514526|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
144633654|NCT00408005|521514527|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
144633655|NCT00408005|521514528|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
144633656|NCT00408005|521514529|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
144633657|NCT00408005|521514530|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
144633658|NCT00408005|521514531|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
144633659|NCT00408005|521514532|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
144633660|NCT00408005|521514525|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
144633661|NCT00408005|521514526|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
144633662|NCT00408005|521514527|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
144633663|NCT00408005|521514528|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
144633664|NCT00408005|521514529|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
144633665|NCT00408005|521514530|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
144633666|NCT00408005|521514531|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
144633667|NCT00408005|521514532|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
144633668|NCT00408005|521514525|FG000|Induction|Progressive Disease|0|||
144633669|NCT00408005|521514526|FG001|Induction|Progressive Disease|1|||
144633670|NCT00408005|521514527|FG002|Induction|Progressive Disease|0|||
144633671|NCT00408005|521514528|FG003|Induction|Progressive Disease|0|||
144633672|NCT00408005|521514529|FG004|Induction|Progressive Disease|0|||
144633673|NCT00408005|521514530|FG005|Induction|Progressive Disease|0|||
144633674|NCT00408005|521514531|FG006|Induction|Progressive Disease|0|||
144633675|NCT00408005|521514532|FG007|Induction|Progressive Disease|0|||
144633676|NCT00408005|521514525|FG000|Induction|Inevaluable|18|||
144633677|NCT00408005|521514526|FG001|Induction|Inevaluable|14|||
144633678|NCT00408005|521514527|FG002|Induction|Inevaluable|0|||
144633679|NCT00408005|521514528|FG003|Induction|Inevaluable|0|||
144633680|NCT00408005|521514529|FG004|Induction|Inevaluable|0|||
144633681|NCT00408005|521514530|FG005|Induction|Inevaluable|0|||
144633682|NCT00408005|521514531|FG006|Induction|Inevaluable|0|||
144633683|NCT00408005|521514532|FG007|Induction|Inevaluable|0|||
144633684|NCT00408005|521514525|FG000|Induction|Failed to Complete Randomization|3|||
144633685|NCT00408005|521514526|FG001|Induction|Failed to Complete Randomization|2|||
144633686|NCT00408005|521514527|FG002|Induction|Failed to Complete Randomization|0|||
144633687|NCT00408005|521514528|FG003|Induction|Failed to Complete Randomization|0|||
144633688|NCT00408005|521514529|FG004|Induction|Failed to Complete Randomization|0|||
144633689|NCT00408005|521514530|FG005|Induction|Failed to Complete Randomization|0|||
144633690|NCT00408005|521514531|FG006|Induction|Failed to Complete Randomization|0|||
144633691|NCT00408005|521514532|FG007|Induction|Failed to Complete Randomization|0|||
144633692|NCT00408005|521514525|FG000|Induction|Protocol Deviation|3|||
144633693|NCT00408005|521514526|FG001|Induction|Protocol Deviation|1|||
144633694|NCT00408005|521514527|FG002|Induction|Protocol Deviation|0|||
144633695|NCT00408005|521514528|FG003|Induction|Protocol Deviation|0|||
144633696|NCT00408005|521514529|FG004|Induction|Protocol Deviation|0|||
144633697|NCT00408005|521514530|FG005|Induction|Protocol Deviation|0|||
144633698|NCT00408005|521514531|FG006|Induction|Protocol Deviation|0|||
144633699|NCT00408005|521514532|FG007|Induction|Protocol Deviation|0|||
144633700|NCT00408005|521514525|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
144633701|NCT00408005|521514526|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
144210065|NCT01890434|519963642|FG000|Overall Study|PCI at external hospital|1|||
144210066|NCT01890434|519963642|FG000|Overall Study|Assessment discrepancy|1|||
144210067|NCT01890434|519963642|FG000|Overall Study|CRC didn't contact participant for FU|1|||
144210068|NCT01890434|519963642|FG000|Overall Study|Could not get whole set of images|1|||
144633702|NCT00408005|521514527|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
144210069|NCT01890434|519963642|FG000|Overall Study|Decline to return for GSPECT|1|||
144210070|NCT01890434|519963642|FG000|Overall Study|GSPECT at rest was not done|1|||
144633703|NCT00408005|521514528|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
144633704|NCT00408005|521514529|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
144633705|NCT00408005|521514530|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
144633706|NCT00408005|521514531|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
144633707|NCT00408005|521514532|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
144262976|NCT00735709|520163806|FG000|Overall Study|Lack of Efficacy|8|||
144633708|NCT00408005|521514525|FG000|Induction|Recurrent leukemia|1|||
144633709|NCT00408005|521514526|FG001|Induction|Recurrent leukemia|0|||
144210071|NCT01890434|519963642|FG000|Overall Study|Participant didn't complete MRI|1|||
144210072|NCT01890434|519963642|FG000|Overall Study|Uncontactable by phone|1|||
144210073|NCT01890434|519963642|FG000|Overall Study|Moved out of position|1|||
144210074|NCT01890434|519963642|FG000|Overall Study|Unable to contact|1|||
144210075|NCT01890434|519963642|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
144210076|NCT01267994|519963645|FG000|Overall Study|Adverse Event|2|||
144210077|NCT02655666|519963646|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
144210078|NCT00895414|519963649|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
144210079|NCT00895414|519963650|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
144210080|NCT00895414|519963649|FG000|First Intervention (14 Days)|Physician Decision|0|||
144633710|NCT00408005|521514527|FG002|Induction|Recurrent leukemia|0|||
144633711|NCT00408005|521514528|FG003|Induction|Recurrent leukemia|0|||
144633712|NCT00408005|521514529|FG004|Induction|Recurrent leukemia|0|||
144633713|NCT00408005|521514530|FG005|Induction|Recurrent leukemia|0|||
144633714|NCT00408005|521514531|FG006|Induction|Recurrent leukemia|0|||
144633715|NCT00408005|521514532|FG007|Induction|Recurrent leukemia|0|||
144633716|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
144633717|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
144633718|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
144633719|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
144633720|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
144633721|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
144633722|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
144633723|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
144633724|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
144633725|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
144633726|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
144633727|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
144633728|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
144633729|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
144633730|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
144633731|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
144633732|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
144633733|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
144633734|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
144633735|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
144633736|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
144633737|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
144633738|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
144633739|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
144633740|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
144633741|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
144633742|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
144633743|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
144633744|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
144633745|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
144633746|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
144633747|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
144633748|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
144633749|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
144633750|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
144633751|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
144633752|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
144633753|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
144633754|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
144633755|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
144633756|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
144633757|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
144633758|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
144633759|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
144633760|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
144633761|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
144633762|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
144633763|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
144633764|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633765|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633766|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633767|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633768|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
144633769|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633770|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633771|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
144633772|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
144633773|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
144633774|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
144633775|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
144633776|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
144633777|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
144633778|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
144633779|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
144633780|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
144633781|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
144633782|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
144633783|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
144633784|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
144633785|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
144633786|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
144633787|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
144633788|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633789|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633790|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633791|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633792|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633793|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
144633794|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633795|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
144633796|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
144633797|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
144633798|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
144633799|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
144633800|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
144633801|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
144633802|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
144633803|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
144633804|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
144633805|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
144633806|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
144633807|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
144633808|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
144633809|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
144633810|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
144633811|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
144633812|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
144633813|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
144633814|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
144633815|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
144633816|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
144633817|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
144633818|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
144700089|NCT00948896|521754509|FG002|Randomization to 24 Months of Age|Death|0|||
144210081|NCT00895414|519963650|FG001|First Intervention (14 Days)|Physician Decision|1|||
144210082|NCT03489109|519963655|FG000|Overall Study|Lost to Follow-up|1|||
144210083|NCT03489109|519963656|FG001|Overall Study|Lost to Follow-up|2|||
144633819|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
144633820|NCT00408005|521514525|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
144633821|NCT00408005|521514526|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
144633822|NCT00408005|521514527|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
144633823|NCT00408005|521514528|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
144633824|NCT00408005|521514529|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
144633825|NCT00408005|521514530|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
144633826|NCT00408005|521514531|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
144633827|NCT00408005|521514532|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
144633828|NCT03155997|521514535|FG000|Overall Study|Withdrawal by Subject|119|||
144633829|NCT03155997|521514536|FG001|Overall Study|Withdrawal by Subject|134|||
144633830|NCT03155997|521514535|FG000|Overall Study|Lost to Follow-up|12|||
144633831|NCT03155997|521514536|FG001|Overall Study|Lost to Follow-up|13|||
144633832|NCT03155997|521514535|FG000|Overall Study|Missing disposition data|0|||
144633833|NCT03155997|521514536|FG001|Overall Study|Missing disposition data|1|||
144633834|NCT03155997|521514535|FG000|Overall Study|On study treatment|2027|||
144633835|NCT03155997|521514536|FG001|Overall Study|On study treatment|2074|||
144633836|NCT04067518|521514537|FG000|Overall Study|Adverse Event|1|||
144633837|NCT04067518|521514538|FG001|Overall Study|Adverse Event|3|||
144730777|NCT00925769|521869884|FG000|Overall Study|Missing documentation|0|||
144730778|NCT00925769|521869885|FG001|Overall Study|Missing documentation|1|||
144730779|NCT00925769|521869886|FG002|Overall Study|Missing documentation|0|||
144730780|NCT00925769|521869887|FG003|Overall Study|Missing documentation|0|||
144730781|NCT00925769|521869888|FG004|Overall Study|Missing documentation|0|||
144730782|NCT00925769|521869889|FG005|Overall Study|Missing documentation|0|||
144730783|NCT00925769|521869884|FG000|Overall Study|End of study visit not done|0|||
144730784|NCT00925769|521869885|FG001|Overall Study|End of study visit not done|0|||
144730785|NCT00925769|521869886|FG002|Overall Study|End of study visit not done|1|||
144730786|NCT00925769|521869887|FG003|Overall Study|End of study visit not done|0|||
144730787|NCT00925769|521869888|FG004|Overall Study|End of study visit not done|0|||
144730788|NCT00925769|521869889|FG005|Overall Study|End of study visit not done|0|||
144730789|NCT00925769|521869884|FG000|Overall Study|Participant is unable to swallow drug|0|||
144730790|NCT00925769|521869885|FG001|Overall Study|Participant is unable to swallow drug|0|||
144730791|NCT00925769|521869886|FG002|Overall Study|Participant is unable to swallow drug|0|||
144730792|NCT00925769|521869887|FG003|Overall Study|Participant is unable to swallow drug|1|||
144730793|NCT00925769|521869888|FG004|Overall Study|Participant is unable to swallow drug|0|||
144730794|NCT00925769|521869889|FG005|Overall Study|Participant is unable to swallow drug|0|||
144730795|NCT00925769|521869884|FG000|Overall Study|Adverse Event|0|||
144730796|NCT00925769|521869885|FG001|Overall Study|Adverse Event|0|||
144730797|NCT00925769|521869886|FG002|Overall Study|Adverse Event|0|||
144730798|NCT00925769|521869887|FG003|Overall Study|Adverse Event|0|||
144730799|NCT00925769|521869888|FG004|Overall Study|Adverse Event|1|||
144730800|NCT00925769|521869889|FG005|Overall Study|Adverse Event|0|||
144730801|NCT01038856|521869892|FG000|Overall Study|Adverse Event|2|||
144730802|NCT02300103|521869893|FG000|Overall Study|Lack of Efficacy|3|||
144730803|NCT02300103|521869893|FG000|Overall Study|Protocol Violation|1|||
144730804|NCT02300103|521869893|FG000|Overall Study|Withdrew Consent|2|||
144730805|NCT04466111|521869894|FG000|Prior to Trial Phase|Physician Decision|1|||
144730806|NCT03553823|521869895|FG000|Overall Study|Physician Decision|0|||
144730807|NCT03553823|521869896|FG001|Overall Study|Physician Decision|1|||
144730808|NCT03603314|521869897|FG000|Overall Study|Lost to Follow-up|0|||
144730809|NCT03603314|521869898|FG001|Overall Study|Lost to Follow-up|3|||
144730810|NCT03603314|521869899|FG002|Overall Study|Lost to Follow-up|0|||
144730811|NCT03603314|521869897|FG000|Overall Study|Protocol Violation|0|||
144730812|NCT03603314|521869898|FG001|Overall Study|Protocol Violation|1|||
144210084|NCT02181790|519963657|FG000|Overall Study|study terminated|2|||
144633838|NCT04067518|521514537|FG000|Overall Study|Screen failures|0|||
144633839|NCT04067518|521514538|FG001|Overall Study|Screen failures|1|||
144633840|NCT04067518|521514537|FG000|Overall Study|Enrolled but not treated|0|||
144633841|NCT04067518|521514538|FG001|Overall Study|Enrolled but not treated|1|||
144633842|NCT02796755|521514541|FG000|Overall Study|Adverse Event|2|||
144633843|NCT02796755|521514542|FG001|Overall Study|Adverse Event|0|||
144633844|NCT00792298|521514546|FG000|Treatment Period 1|Adverse Event|0|||
144633845|NCT00792298|521514547|FG001|Treatment Period 1|Adverse Event|1|||
144633846|NCT00792298|521514548|FG002|Treatment Period 1|Adverse Event|0|||
144633847|NCT00792298|521514549|FG003|Treatment Period 1|Adverse Event|1|||
144633848|NCT00792298|521514550|FG004|Treatment Period 1|Adverse Event|0|||
144633849|NCT00792298|521514551|FG005|Treatment Period 1|Adverse Event|1|||
144633850|NCT00792298|521514552|FG006|Treatment Period 1|Adverse Event|1|||
144633851|NCT00792298|521514553|FG007|Treatment Period 1|Adverse Event|0|||
144730813|NCT03603314|521869899|FG002|Overall Study|Protocol Violation|0|||
144730814|NCT03603314|521869897|FG000|Overall Study|Adverse Event|2|||
144730815|NCT03603314|521869898|FG001|Overall Study|Adverse Event|0|||
144730816|NCT03603314|521869899|FG002|Overall Study|Adverse Event|0|||
144730817|NCT03603314|521869897|FG000|Overall Study|Physician Decision|1|||
144633852|NCT00792298|521514546|FG000|Treatment Period 1|Lack of Efficacy|0|||
144633853|NCT00792298|521514547|FG001|Treatment Period 1|Lack of Efficacy|0|||
144633854|NCT00792298|521514548|FG002|Treatment Period 1|Lack of Efficacy|1|||
144633855|NCT00792298|521514549|FG003|Treatment Period 1|Lack of Efficacy|0|||
144633856|NCT00792298|521514550|FG004|Treatment Period 1|Lack of Efficacy|0|||
144633857|NCT00792298|521514551|FG005|Treatment Period 1|Lack of Efficacy|0|||
144633858|NCT00792298|521514552|FG006|Treatment Period 1|Lack of Efficacy|0|||
144633859|NCT00792298|521514553|FG007|Treatment Period 1|Lack of Efficacy|0|||
144633860|NCT00792298|521514546|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144633861|NCT00792298|521514547|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144633862|NCT00792298|521514548|FG002|Treatment Period 1|Withdrawal by Subject|1|||
144633863|NCT00792298|521514549|FG003|Treatment Period 1|Withdrawal by Subject|2|||
144633864|NCT00792298|521514550|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144633865|NCT00792298|521514551|FG005|Treatment Period 1|Withdrawal by Subject|2|||
144633866|NCT00792298|521514552|FG006|Treatment Period 1|Withdrawal by Subject|1|||
144633867|NCT00792298|521514553|FG007|Treatment Period 1|Withdrawal by Subject|0|||
144633868|NCT00792298|521514546|FG000|Treatment Period 1|Lost to Follow-up|0|||
144633869|NCT00792298|521514547|FG001|Treatment Period 1|Lost to Follow-up|0|||
144633870|NCT00792298|521514548|FG002|Treatment Period 1|Lost to Follow-up|0|||
144633871|NCT00792298|521514549|FG003|Treatment Period 1|Lost to Follow-up|0|||
144633872|NCT00792298|521514550|FG004|Treatment Period 1|Lost to Follow-up|0|||
144633873|NCT00792298|521514551|FG005|Treatment Period 1|Lost to Follow-up|0|||
144633874|NCT00792298|521514552|FG006|Treatment Period 1|Lost to Follow-up|1|||
144633875|NCT00792298|521514553|FG007|Treatment Period 1|Lost to Follow-up|0|||
144633876|NCT00792298|521514546|FG000|Treatment Period 1|Physician Decision|0|||
144633877|NCT00792298|521514547|FG001|Treatment Period 1|Physician Decision|0|||
144633878|NCT00792298|521514548|FG002|Treatment Period 1|Physician Decision|0|||
144633879|NCT00792298|521514549|FG003|Treatment Period 1|Physician Decision|1|||
144633880|NCT00792298|521514550|FG004|Treatment Period 1|Physician Decision|0|||
144633881|NCT00792298|521514551|FG005|Treatment Period 1|Physician Decision|0|||
144633882|NCT00792298|521514552|FG006|Treatment Period 1|Physician Decision|1|||
144633883|NCT00792298|521514553|FG007|Treatment Period 1|Physician Decision|0|||
144633884|NCT00792298|521514546|FG000|Treatment Period 1|Protocol Violation|0|||
144633885|NCT00792298|521514547|FG001|Treatment Period 1|Protocol Violation|0|||
144633886|NCT00792298|521514548|FG002|Treatment Period 1|Protocol Violation|0|||
144633887|NCT00792298|521514549|FG003|Treatment Period 1|Protocol Violation|0|||
144633888|NCT00792298|521514550|FG004|Treatment Period 1|Protocol Violation|0|||
144633889|NCT00792298|521514551|FG005|Treatment Period 1|Protocol Violation|0|||
144633890|NCT00792298|521514552|FG006|Treatment Period 1|Protocol Violation|0|||
144633891|NCT00792298|521514553|FG007|Treatment Period 1|Protocol Violation|1|||
144633892|NCT00792298|521514546|FG000|Washout|Adverse Event|0|||
144633893|NCT00792298|521514547|FG001|Washout|Adverse Event|0|||
144633894|NCT00792298|521514548|FG002|Washout|Adverse Event|0|||
144633895|NCT00792298|521514549|FG003|Washout|Adverse Event|0|||
144633896|NCT00792298|521514550|FG004|Washout|Adverse Event|0|||
144633897|NCT00792298|521514551|FG005|Washout|Adverse Event|1|||
144633898|NCT00792298|521514552|FG006|Washout|Adverse Event|0|||
144633899|NCT00792298|521514553|FG007|Washout|Adverse Event|0|||
144633900|NCT00792298|521514546|FG000|Washout|Withdrawal by Subject|0|||
144633901|NCT00792298|521514547|FG001|Washout|Withdrawal by Subject|0|||
144633902|NCT00792298|521514548|FG002|Washout|Withdrawal by Subject|1|||
144633903|NCT00792298|521514549|FG003|Washout|Withdrawal by Subject|0|||
144633904|NCT00792298|521514550|FG004|Washout|Withdrawal by Subject|0|||
144633905|NCT00792298|521514551|FG005|Washout|Withdrawal by Subject|1|||
144633906|NCT00792298|521514552|FG006|Washout|Withdrawal by Subject|0|||
144633907|NCT00792298|521514553|FG007|Washout|Withdrawal by Subject|0|||
144633908|NCT00792298|521514546|FG000|Treatment Period 2|Lack of Efficacy|0|||
144633909|NCT00792298|521514547|FG001|Treatment Period 2|Lack of Efficacy|0|||
144633910|NCT00792298|521514548|FG002|Treatment Period 2|Lack of Efficacy|0|||
144633911|NCT00792298|521514549|FG003|Treatment Period 2|Lack of Efficacy|0|||
144633912|NCT00792298|521514550|FG004|Treatment Period 2|Lack of Efficacy|1|||
144633913|NCT00792298|521514551|FG005|Treatment Period 2|Lack of Efficacy|0|||
144633914|NCT00792298|521514552|FG006|Treatment Period 2|Lack of Efficacy|0|||
144633915|NCT00792298|521514553|FG007|Treatment Period 2|Lack of Efficacy|0|||
144633916|NCT00792298|521514546|FG000|Treatment Period 2|Physician Decision|0|||
144633917|NCT00792298|521514547|FG001|Treatment Period 2|Physician Decision|0|||
144633918|NCT00792298|521514548|FG002|Treatment Period 2|Physician Decision|0|||
144633919|NCT00792298|521514549|FG003|Treatment Period 2|Physician Decision|0|||
144633920|NCT00792298|521514550|FG004|Treatment Period 2|Physician Decision|0|||
144633921|NCT00792298|521514551|FG005|Treatment Period 2|Physician Decision|0|||
144633922|NCT00792298|521514552|FG006|Treatment Period 2|Physician Decision|1|||
144633923|NCT00792298|521514553|FG007|Treatment Period 2|Physician Decision|0|||
144633924|NCT00792298|521514546|FG000|Treatment Period 2|Pregnancy|0|||
144633925|NCT00792298|521514547|FG001|Treatment Period 2|Pregnancy|0|||
144633926|NCT00792298|521514548|FG002|Treatment Period 2|Pregnancy|1|||
144633927|NCT00792298|521514549|FG003|Treatment Period 2|Pregnancy|0|||
144633928|NCT00792298|521514550|FG004|Treatment Period 2|Pregnancy|0|||
144633929|NCT00792298|521514551|FG005|Treatment Period 2|Pregnancy|0|||
144633930|NCT00792298|521514552|FG006|Treatment Period 2|Pregnancy|0|||
144633931|NCT00792298|521514553|FG007|Treatment Period 2|Pregnancy|0|||
144633932|NCT00792298|521514546|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144633933|NCT00792298|521514547|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144633934|NCT00792298|521514548|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144633935|NCT00792298|521514549|FG003|Treatment Period 2|Withdrawal by Subject|2|||
144633936|NCT00792298|521514550|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144633937|NCT00792298|521514551|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144633938|NCT00792298|521514552|FG006|Treatment Period 2|Withdrawal by Subject|0|||
144633939|NCT00792298|521514553|FG007|Treatment Period 2|Withdrawal by Subject|2|||
144633940|NCT01756274|521514554|FG000|Overall Study|Protocol Violation|2|||
144633941|NCT01756274|521514554|FG000|Overall Study|Laboratory error|1|||
144633942|NCT03304522|521514555|FG000|Overall Study|Adverse Event|0|||
144633943|NCT03304522|521514556|FG001|Overall Study|Adverse Event|4|||
144633944|NCT03304522|521514555|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
144633945|NCT03304522|521514556|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
144633946|NCT03304522|521514555|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
144633947|NCT03304522|521514556|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
144633948|NCT03304522|521514555|FG000|Overall Study|Other|0|||
144633949|NCT03304522|521514556|FG001|Overall Study|Other|1|||
144633950|NCT00755079|521514561|FG000|Overall Study|Lost to Follow-up|1|||
144633951|NCT00755079|521514562|FG001|Overall Study|Lost to Follow-up|3|||
144633952|NCT00755079|521514561|FG000|Overall Study|Adverse Event|0|||
144633953|NCT00755079|521514562|FG001|Overall Study|Adverse Event|1|||
144633954|NCT00755079|521514561|FG000|Overall Study|Withdrawal by Subject|0|||
144633955|NCT00755079|521514562|FG001|Overall Study|Withdrawal by Subject|2|||
144633956|NCT01454076|521514563|FG000|Overall Study|Other|2|||
144633957|NCT01454076|521514564|FG001|Overall Study|Other|0|||
144633958|NCT01454076|521514565|FG002|Overall Study|Other|0|||
144633959|NCT01454076|521514566|FG003|Overall Study|Other|1|||
144633960|NCT01454076|521514567|FG004|Overall Study|Other|2|||
144633961|NCT01454076|521514563|FG000|Overall Study|Withdrawal by Subject|3|||
144633962|NCT01454076|521514564|FG001|Overall Study|Withdrawal by Subject|4|||
144633963|NCT01454076|521514565|FG002|Overall Study|Withdrawal by Subject|2|||
144633964|NCT01454076|521514566|FG003|Overall Study|Withdrawal by Subject|1|||
144633965|NCT01454076|521514567|FG004|Overall Study|Withdrawal by Subject|2|||
144633966|NCT01454076|521514563|FG000|Overall Study|Adverse Event|8|||
144633967|NCT01454076|521514564|FG001|Overall Study|Adverse Event|2|||
144633968|NCT01454076|521514565|FG002|Overall Study|Adverse Event|7|||
144633969|NCT01454076|521514566|FG003|Overall Study|Adverse Event|0|||
144633970|NCT01454076|521514567|FG004|Overall Study|Adverse Event|2|||
144633971|NCT01526148|521514574|FG000|Overall Study|Adverse Event|6|||
144633972|NCT01526148|521514575|FG001|Overall Study|Adverse Event|5|||
144633973|NCT01526148|521514574|FG000|Overall Study|Lost to Follow-up|3|||
144633974|NCT01526148|521514575|FG001|Overall Study|Lost to Follow-up|6|||
144633975|NCT01526148|521514574|FG000|Overall Study|Withdrawal by Subject|2|||
144633976|NCT01526148|521514575|FG001|Overall Study|Withdrawal by Subject|0|||
144633977|NCT01526148|521514574|FG000|Overall Study|Unstable Medical Condition|1|||
144633978|NCT01526148|521514575|FG001|Overall Study|Unstable Medical Condition|0|||
144633979|NCT01526148|521514574|FG000|Overall Study|Unable to discontinue concomitant med|1|||
144633980|NCT01526148|521514575|FG001|Overall Study|Unable to discontinue concomitant med|0|||
144633981|NCT01526148|521514574|FG000|Overall Study|Moved out of state|1|||
144633982|NCT01526148|521514575|FG001|Overall Study|Moved out of state|0|||
144633983|NCT01526148|521514574|FG000|Overall Study|Incarcerated|0|||
144633984|NCT01526148|521514575|FG001|Overall Study|Incarcerated|2|||
144633985|NCT01173653|521514576|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
144633986|NCT01173653|521514577|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
144633987|NCT02452762|521514578|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
144633988|NCT02452762|521514579|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
144633989|NCT02452762|521514578|FG000|Overall Study|Withdrawal by Subject|1|||
144633990|NCT02452762|521514579|FG001|Overall Study|Withdrawal by Subject|0|||
144633991|NCT00584870|521514580|FG000|Overall Study|Adverse Event|4|||
144633992|NCT00584870|521514581|FG001|Overall Study|Adverse Event|3|||
144633993|NCT00584870|521514582|FG002|Overall Study|Adverse Event|2|||
144730818|NCT03603314|521869898|FG001|Overall Study|Physician Decision|1|||
144730819|NCT03603314|521869899|FG002|Overall Study|Physician Decision|0|||
144210085|NCT02181790|519963658|FG001|Overall Study|study terminated|0|||
144633994|NCT00584870|521514580|FG000|Overall Study|Lost to Follow-up|4|||
144633995|NCT00584870|521514581|FG001|Overall Study|Lost to Follow-up|1|||
144633996|NCT00584870|521514582|FG002|Overall Study|Lost to Follow-up|1|||
144633997|NCT00584870|521514580|FG000|Overall Study|Lack of Efficacy|7|||
144633998|NCT00584870|521514581|FG001|Overall Study|Lack of Efficacy|14|||
144633999|NCT00584870|521514582|FG002|Overall Study|Lack of Efficacy|8|||
144634000|NCT00584870|521514580|FG000|Overall Study|Withdrawal by Subject|10|||
144634001|NCT00584870|521514581|FG001|Overall Study|Withdrawal by Subject|5|||
144730820|NCT03603314|521869897|FG000|Overall Study|Withdrawal by Subject|4|||
144210086|NCT03276078|519963659|FG000|Overall Study|Adverse Event|1|||
144210087|NCT02552732|519963660|FG000|Overall Study|Lost to Follow-up|2|||
144210088|NCT02552732|519963660|FG000|Overall Study|Physician Decision|1|||
144210089|NCT02552732|519963660|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
144210090|NCT02552732|519963660|FG000|Overall Study|Withdrawal by Subject|6|||
144210091|NCT01275430|519963662|FG000|Overall Study|Adverse Event|1|||
144634002|NCT00584870|521514582|FG002|Overall Study|Withdrawal by Subject|3|||
144634003|NCT00584870|521514580|FG000|Overall Study|Protocol Violation|1|||
144210092|NCT01275430|519963662|FG000|Overall Study|No Contrast Injection|6|||
144210093|NCT01275430|519963662|FG000|Overall Study|Device Malfunction|1|||
144210094|NCT01275430|519963662|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
144210095|NCT04988087|519963663|FG000|Overall Study|Adverse Event|4|||
144634004|NCT00584870|521514581|FG001|Overall Study|Protocol Violation|1|||
144634005|NCT00584870|521514582|FG002|Overall Study|Protocol Violation|2|||
144634006|NCT00584870|521514580|FG000|Overall Study|Did not met entrance criteria|1|||
144634007|NCT00584870|521514581|FG001|Overall Study|Did not met entrance criteria|0|||
144634008|NCT00584870|521514582|FG002|Overall Study|Did not met entrance criteria|0|||
144634009|NCT00584870|521514580|FG000|Overall Study|Other|2|||
144634010|NCT00584870|521514581|FG001|Overall Study|Other|0|||
144634011|NCT00584870|521514582|FG002|Overall Study|Other|0|||
144634012|NCT00584870|521514580|FG000|Overall Study|Randomized but not treated|0|||
144634013|NCT00584870|521514581|FG001|Overall Study|Randomized but not treated|1|||
144634014|NCT00584870|521514582|FG002|Overall Study|Randomized but not treated|2|||
144634015|NCT03308188|521514583|FG000|Overall Study|Withdrawal by Subject|0|||
144634016|NCT03308188|521514584|FG001|Overall Study|Withdrawal by Subject|3|||
144634017|NCT03308188|521514583|FG000|Overall Study|Death|0|||
144634018|NCT03308188|521514584|FG001|Overall Study|Death|1|||
144634019|NCT01791855|521514585|FG000|Overall Study|Adverse Event|0|||
144634020|NCT01791855|521514586|FG001|Overall Study|Adverse Event|0|||
144634021|NCT01791855|521514587|FG002|Overall Study|Adverse Event|0|||
144634022|NCT01791855|521514588|FG003|Overall Study|Adverse Event|1|||
144634023|NCT01791855|521514585|FG000|Overall Study|Randomized, not treated|0|||
144634024|NCT01791855|521514586|FG001|Overall Study|Randomized, not treated|1|||
144634025|NCT01791855|521514587|FG002|Overall Study|Randomized, not treated|0|||
144634026|NCT01791855|521514588|FG003|Overall Study|Randomized, not treated|0|||
144634027|NCT00772447|521514589|FG000|Overall Study|Withdrawal by Subject|9|||
144634028|NCT00772447|521514590|FG001|Overall Study|Withdrawal by Subject|5|||
144634029|NCT00772447|521514589|FG000|Overall Study|Physician Decision|4|||
144634030|NCT00772447|521514590|FG001|Overall Study|Physician Decision|8|||
144634031|NCT00772447|521514589|FG000|Overall Study|Lost to Follow-up|2|||
144634032|NCT00772447|521514590|FG001|Overall Study|Lost to Follow-up|4|||
144634033|NCT00772447|521514589|FG000|Overall Study|incorrect enrolment|3|||
144634034|NCT00772447|521514590|FG001|Overall Study|incorrect enrolment|4|||
144634035|NCT00772447|521514589|FG000|Overall Study|Protocol Violation|0|||
144634036|NCT00772447|521514590|FG001|Overall Study|Protocol Violation|1|||
144634037|NCT00772447|521514589|FG000|Overall Study|all others|2|||
144634038|NCT00772447|521514590|FG001|Overall Study|all others|2|||
144634039|NCT01957137|521514602|FG000|Randomized Portion|Adverse Event|1|||
144634040|NCT01957137|521514602|FG000|Randomized Portion|Withdrawal by Subject|1|||
144634041|NCT03529409|521514605|FG000|Randomized|Lost to Follow-up|0|||
144634042|NCT03529409|521514606|FG001|Randomized|Lost to Follow-up|0|||
144634043|NCT03529409|521514607|FG002|Randomized|Lost to Follow-up|4|||
144634044|NCT03529409|521514605|FG000|Randomized|Excluded|0|||
144634045|NCT03529409|521514606|FG001|Randomized|Excluded|0|||
144634046|NCT03529409|521514607|FG002|Randomized|Excluded|1|||
144634047|NCT03529409|521514605|FG000|Post-treatment Assessment|Death|1|||
144634048|NCT03529409|521514606|FG001|Post-treatment Assessment|Death|0|||
144634049|NCT03529409|521514607|FG002|Post-treatment Assessment|Death|0|||
144634050|NCT03529409|521514605|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
144634051|NCT03529409|521514606|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
144634052|NCT03529409|521514607|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
144634053|NCT03529409|521514605|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
144634054|NCT03529409|521514606|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
144634055|NCT03529409|521514607|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
144634056|NCT03529409|521514605|FG000|Follow-up Assessment|Death|1|||
144634057|NCT03529409|521514606|FG001|Follow-up Assessment|Death|0|||
144634058|NCT03529409|521514607|FG002|Follow-up Assessment|Death|0|||
144210096|NCT04988087|519963664|FG001|Overall Study|Adverse Event|0|||
144634059|NCT03529409|521514605|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
144634060|NCT03529409|521514606|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
144634061|NCT03529409|521514607|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
144634062|NCT01497262|521514608|FG000|Overall Study|Abnormal Lab Values|4|||
144634063|NCT01497262|521514608|FG000|Overall Study|Abnormal Test Procedure Result|1|||
144634064|NCT01497262|521514608|FG000|Overall Study|Physician Decision|1|||
144634065|NCT01497262|521514608|FG000|Overall Study|Withdrawal by Subject|2|||
144634066|NCT01497262|521514608|FG000|Overall Study|Adverse Event|2|||
144634067|NCT01497262|521514608|FG000|Overall Study|Protocol Violation|1|||
144210097|NCT04988087|519963665|FG002|Overall Study|Adverse Event|0|||
144210098|NCT04988087|519963666|FG003|Overall Study|Adverse Event|0|||
144210099|NCT04988087|519963663|FG000|Overall Study|Withdrawal by Subject|1|||
144210100|NCT04988087|519963664|FG001|Overall Study|Withdrawal by Subject|1|||
144210101|NCT04988087|519963665|FG002|Overall Study|Withdrawal by Subject|0|||
144210102|NCT04988087|519963666|FG003|Overall Study|Withdrawal by Subject|0|||
144210103|NCT04988087|519963663|FG000|Overall Study|Technical problems|7|||
144210104|NCT04988087|519963664|FG001|Overall Study|Technical problems|9|||
144210105|NCT04988087|519963665|FG002|Overall Study|Technical problems|1|||
144210106|NCT04988087|519963666|FG003|Overall Study|Technical problems|2|||
144210107|NCT02752087|519963667|FG000|Washout|Physician Decision|1|||
144210108|NCT02752087|519963668|FG001|Washout|Physician Decision|0|||
144210109|NCT02458287|519963669|FG000|Overall Study|Adverse Event|0|||
144210110|NCT02458287|519963670|FG001|Overall Study|Adverse Event|0|||
144210111|NCT02458287|519963671|FG002|Overall Study|Adverse Event|0|||
144210112|NCT02458287|519963672|FG003|Overall Study|Adverse Event|1|||
144210113|NCT02458287|519963669|FG000|Overall Study|Lost to Follow-up|0|||
144210114|NCT02458287|519963670|FG001|Overall Study|Lost to Follow-up|1|||
144634068|NCT01651780|521514609|FG000|Overall Study|Physician decision: No 30-day visit|2|||
144634069|NCT01651780|521514610|FG001|Overall Study|Physician decision: No 30-day visit|1|||
144634070|NCT01651780|521514609|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
144634071|NCT01651780|521514610|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
144634072|NCT01651780|521514609|FG000|Overall Study|Withdrawal by Subject|2|||
144634073|NCT01651780|521514610|FG001|Overall Study|Withdrawal by Subject|0|||
144634074|NCT01651780|521514609|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
144634075|NCT01651780|521514610|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144634076|NCT01651780|521514609|FG000|Overall Study|Lost to Follow-up|1|||
144634077|NCT01651780|521514610|FG001|Overall Study|Lost to Follow-up|2|||
144634078|NCT01651780|521514609|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
144634079|NCT01651780|521514610|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
144634080|NCT00054132|521514611|FG000|Overall Study|Not Treated|1|||
144634081|NCT01290887|521514612|FG000|Overall Study|Adverse Event|6|||
144634082|NCT01290887|521514613|FG001|Overall Study|Adverse Event|11|||
144634083|NCT01290887|521514612|FG000|Overall Study|Lack of Efficacy|4|||
144634084|NCT01290887|521514613|FG001|Overall Study|Lack of Efficacy|5|||
144634085|NCT01290887|521514612|FG000|Overall Study|Withdrawal by Subject|26|||
144634086|NCT01290887|521514613|FG001|Overall Study|Withdrawal by Subject|32|||
144634087|NCT01290887|521514612|FG000|Overall Study|Protocol Violation|2|||
144634088|NCT01290887|521514613|FG001|Overall Study|Protocol Violation|1|||
144634089|NCT01290887|521514612|FG000|Overall Study|Lost to Follow-up|4|||
144634090|NCT01290887|521514613|FG001|Overall Study|Lost to Follow-up|4|||
144634091|NCT01290887|521514612|FG000|Overall Study|Non-compliance to study procedures|0|||
144634092|NCT01290887|521514613|FG001|Overall Study|Non-compliance to study procedures|1|||
144634093|NCT01290887|521514612|FG000|Overall Study|Non-compliance to study medications|1|||
144634094|NCT01290887|521514613|FG001|Overall Study|Non-compliance to study medications|0|||
144634095|NCT01290887|521514612|FG000|Overall Study|Sponsor closure of study|420|||
144634096|NCT01290887|521514613|FG001|Overall Study|Sponsor closure of study|476|||
144634097|NCT01290887|521514612|FG000|Overall Study|Other|3|||
144634098|NCT01290887|521514613|FG001|Overall Study|Other|6|||
144634099|NCT01628926|521514614|FG000|Overall Study|Adverse Event|13|||
144634100|NCT01628926|521514615|FG001|Overall Study|Adverse Event|11|||
144634101|NCT01628926|521514616|FG002|Overall Study|Adverse Event|9|||
144634102|NCT01628926|521514614|FG000|Overall Study|Lack of Efficacy|2|||
144634103|NCT01628926|521514615|FG001|Overall Study|Lack of Efficacy|1|||
144634104|NCT01628926|521514616|FG002|Overall Study|Lack of Efficacy|5|||
144634105|NCT01628926|521514614|FG000|Overall Study|Withdrawal by Subject|6|||
144634106|NCT01628926|521514615|FG001|Overall Study|Withdrawal by Subject|4|||
144634107|NCT01628926|521514616|FG002|Overall Study|Withdrawal by Subject|2|||
144634108|NCT01628926|521514614|FG000|Overall Study|Protocol Violation|0|||
144634109|NCT01628926|521514615|FG001|Overall Study|Protocol Violation|1|||
144634110|NCT01628926|521514616|FG002|Overall Study|Protocol Violation|0|||
144634111|NCT01628926|521514614|FG000|Overall Study|Discontinuation criteria|3|||
144634112|NCT01628926|521514615|FG001|Overall Study|Discontinuation criteria|4|||
144634113|NCT01628926|521514616|FG002|Overall Study|Discontinuation criteria|0|||
144634114|NCT01628926|521514614|FG000|Overall Study|Physician Decision|2|||
144634115|NCT01628926|521514615|FG001|Overall Study|Physician Decision|2|||
144634116|NCT01628926|521514616|FG002|Overall Study|Physician Decision|1|||
144634117|NCT01889602|521514619|FG000|First Intervention|Adverse Event|1|||
144730821|NCT03603314|521869898|FG001|Overall Study|Withdrawal by Subject|5|||
144210115|NCT02458287|519963671|FG002|Overall Study|Lost to Follow-up|1|||
144634118|NCT01889602|521514620|FG001|First Intervention|Adverse Event|1|||
144634119|NCT01889602|521514621|FG002|First Intervention|Adverse Event|1|||
144210116|NCT02458287|519963672|FG003|Overall Study|Lost to Follow-up|0|||
144210117|NCT02458287|519963669|FG000|Overall Study|Protocol Violation|0|||
144634120|NCT01889602|521514619|FG000|First Intervention|Protocol Violation|0|||
144634121|NCT01889602|521514620|FG001|First Intervention|Protocol Violation|1|||
144634122|NCT01889602|521514621|FG002|First Intervention|Protocol Violation|1|||
144634123|NCT01889602|521514619|FG000|First Intervention|Study ending|0|||
144634124|NCT01889602|521514620|FG001|First Intervention|Study ending|1|||
144634125|NCT01889602|521514621|FG002|First Intervention|Study ending|0|||
144634126|NCT01889602|521514619|FG000|Second Intervention|Adverse Event|0|||
144634127|NCT01889602|521514620|FG001|Second Intervention|Adverse Event|0|||
144634128|NCT01889602|521514621|FG002|Second Intervention|Adverse Event|1|||
144634129|NCT01889602|521514619|FG000|Second Intervention|Study ending|1|||
144210118|NCT02458287|519963670|FG001|Overall Study|Protocol Violation|1|||
144210119|NCT02458287|519963671|FG002|Overall Study|Protocol Violation|0|||
144210120|NCT02458287|519963672|FG003|Overall Study|Protocol Violation|0|||
144210121|NCT02458287|519963669|FG000|Overall Study|Withdrawal by Subject|0|||
144634130|NCT01889602|521514620|FG001|Second Intervention|Study ending|0|||
144634131|NCT01889602|521514621|FG002|Second Intervention|Study ending|0|||
144634132|NCT01889602|521514619|FG000|Second Intervention|Withdrawal by Subject|0|||
144634133|NCT01889602|521514620|FG001|Second Intervention|Withdrawal by Subject|0|||
144634134|NCT01889602|521514621|FG002|Second Intervention|Withdrawal by Subject|1|||
144634135|NCT01889602|521514619|FG000|Third Intervention|Protocol Violation|1|||
144634136|NCT01889602|521514620|FG001|Third Intervention|Protocol Violation|0|||
144634137|NCT01889602|521514621|FG002|Third Intervention|Protocol Violation|0|||
144634138|NCT01889602|521514619|FG000|Third Intervention|Withdrawal by Subject|2|||
144634139|NCT01889602|521514620|FG001|Third Intervention|Withdrawal by Subject|2|||
144634140|NCT01889602|521514621|FG002|Third Intervention|Withdrawal by Subject|0|||
144634141|NCT02764541|521514622|FG000|Overall Study|Withdrawal by Subject|0|||
144634142|NCT02764541|521514623|FG001|Overall Study|Withdrawal by Subject|0|||
144634143|NCT02764541|521514624|FG002|Overall Study|Withdrawal by Subject|0|||
144634144|NCT02764541|521514625|FG003|Overall Study|Withdrawal by Subject|0|||
144634145|NCT02764541|521514626|FG004|Overall Study|Withdrawal by Subject|1|||
144634146|NCT02764541|521514627|FG005|Overall Study|Withdrawal by Subject|1|||
144634147|NCT02764541|521514628|FG006|Overall Study|Withdrawal by Subject|0|||
144634148|NCT02764541|521514629|FG007|Overall Study|Withdrawal by Subject|1|||
144634149|NCT02764541|521514622|FG000|Overall Study|Adverse Event|1|||
144634150|NCT02764541|521514623|FG001|Overall Study|Adverse Event|0|||
144634151|NCT02764541|521514624|FG002|Overall Study|Adverse Event|0|||
144634152|NCT02764541|521514625|FG003|Overall Study|Adverse Event|0|||
144634153|NCT02764541|521514626|FG004|Overall Study|Adverse Event|0|||
144634154|NCT02764541|521514627|FG005|Overall Study|Adverse Event|0|||
144634155|NCT02764541|521514628|FG006|Overall Study|Adverse Event|1|||
144634156|NCT02764541|521514629|FG007|Overall Study|Adverse Event|0|||
144634157|NCT02764541|521514622|FG000|Overall Study|Metastasis|1|||
144634158|NCT02764541|521514623|FG001|Overall Study|Metastasis|0|||
144634159|NCT02764541|521514624|FG002|Overall Study|Metastasis|0|||
144634160|NCT02764541|521514625|FG003|Overall Study|Metastasis|0|||
144634161|NCT02764541|521514626|FG004|Overall Study|Metastasis|0|||
144634162|NCT02764541|521514627|FG005|Overall Study|Metastasis|0|||
144634163|NCT02764541|521514628|FG006|Overall Study|Metastasis|0|||
144634164|NCT02764541|521514629|FG007|Overall Study|Metastasis|0|||
144634165|NCT02764541|521514622|FG000|Overall Study|Disease progression|1|||
144634166|NCT02764541|521514623|FG001|Overall Study|Disease progression|1|||
144634167|NCT02764541|521514624|FG002|Overall Study|Disease progression|0|||
144634168|NCT02764541|521514625|FG003|Overall Study|Disease progression|0|||
144634169|NCT02764541|521514626|FG004|Overall Study|Disease progression|0|||
144634170|NCT02764541|521514627|FG005|Overall Study|Disease progression|0|||
144634171|NCT02764541|521514628|FG006|Overall Study|Disease progression|0|||
144634172|NCT02764541|521514629|FG007|Overall Study|Disease progression|1|||
144634173|NCT02764541|521514622|FG000|Overall Study|Protocol Violation|0|||
144634174|NCT02764541|521514623|FG001|Overall Study|Protocol Violation|0|||
144634175|NCT02764541|521514624|FG002|Overall Study|Protocol Violation|0|||
144634176|NCT02764541|521514625|FG003|Overall Study|Protocol Violation|1|||
144634177|NCT02764541|521514626|FG004|Overall Study|Protocol Violation|0|||
144634178|NCT02764541|521514627|FG005|Overall Study|Protocol Violation|1|||
144634179|NCT02764541|521514628|FG006|Overall Study|Protocol Violation|0|||
144634180|NCT02764541|521514629|FG007|Overall Study|Protocol Violation|0|||
144634181|NCT02764541|521514622|FG000|Overall Study|Physician Decision|0|||
144634182|NCT02764541|521514623|FG001|Overall Study|Physician Decision|0|||
144634183|NCT02764541|521514624|FG002|Overall Study|Physician Decision|0|||
144634184|NCT02764541|521514625|FG003|Overall Study|Physician Decision|1|||
144634185|NCT02764541|521514626|FG004|Overall Study|Physician Decision|0|||
144730822|NCT03603314|521869899|FG002|Overall Study|Withdrawal by Subject|3|||
144210122|NCT02458287|519963670|FG001|Overall Study|Withdrawal by Subject|2|||
144210123|NCT02458287|519963671|FG002|Overall Study|Withdrawal by Subject|2|||
144210124|NCT02458287|519963672|FG003|Overall Study|Withdrawal by Subject|1|||
144634186|NCT02764541|521514627|FG005|Overall Study|Physician Decision|0|||
144634187|NCT02764541|521514628|FG006|Overall Study|Physician Decision|0|||
144634188|NCT02764541|521514629|FG007|Overall Study|Physician Decision|1|||
144634189|NCT02764541|521514622|FG000|Overall Study|Three Cycles completed before surgery|0|||
144634190|NCT02764541|521514623|FG001|Overall Study|Three Cycles completed before surgery|0|||
144634191|NCT02764541|521514624|FG002|Overall Study|Three Cycles completed before surgery|0|||
144634192|NCT02764541|521514625|FG003|Overall Study|Three Cycles completed before surgery|1|||
144634193|NCT02764541|521514626|FG004|Overall Study|Three Cycles completed before surgery|0|||
144634194|NCT02764541|521514627|FG005|Overall Study|Three Cycles completed before surgery|0|||
144634195|NCT02764541|521514628|FG006|Overall Study|Three Cycles completed before surgery|0|||
144634196|NCT02764541|521514629|FG007|Overall Study|Three Cycles completed before surgery|0|||
144634197|NCT02764541|521514622|FG000|Overall Study|Patient Compliance|0|||
144634198|NCT02764541|521514623|FG001|Overall Study|Patient Compliance|0|||
144634199|NCT02764541|521514624|FG002|Overall Study|Patient Compliance|1|||
144634200|NCT02764541|521514625|FG003|Overall Study|Patient Compliance|0|||
144634201|NCT02764541|521514626|FG004|Overall Study|Patient Compliance|0|||
144634202|NCT02764541|521514627|FG005|Overall Study|Patient Compliance|0|||
144634203|NCT02764541|521514628|FG006|Overall Study|Patient Compliance|0|||
144634204|NCT02764541|521514629|FG007|Overall Study|Patient Compliance|0|||
144634205|NCT02764541|521514622|FG000|Overall Study|Death|0|||
144634206|NCT02764541|521514623|FG001|Overall Study|Death|0|||
144634207|NCT02764541|521514624|FG002|Overall Study|Death|0|||
144634208|NCT02764541|521514625|FG003|Overall Study|Death|0|||
144634209|NCT02764541|521514626|FG004|Overall Study|Death|0|||
144634210|NCT02764541|521514627|FG005|Overall Study|Death|0|||
144634211|NCT02764541|521514628|FG006|Overall Study|Death|1|||
144634212|NCT02764541|521514629|FG007|Overall Study|Death|0|||
144634213|NCT02764541|521514622|FG000|Overall Study|Insurance reasons|0|||
144634214|NCT02764541|521514623|FG001|Overall Study|Insurance reasons|0|||
144634215|NCT02764541|521514624|FG002|Overall Study|Insurance reasons|0|||
144634216|NCT02764541|521514625|FG003|Overall Study|Insurance reasons|0|||
144634217|NCT02764541|521514626|FG004|Overall Study|Insurance reasons|0|||
144634218|NCT02764541|521514627|FG005|Overall Study|Insurance reasons|0|||
144634219|NCT02764541|521514628|FG006|Overall Study|Insurance reasons|1|||
144634220|NCT02764541|521514629|FG007|Overall Study|Insurance reasons|0|||
144634221|NCT00749190|521514632|FG000|Overall Study|Adverse Event|0|||
144634222|NCT00749190|521514633|FG001|Overall Study|Adverse Event|2|||
144634223|NCT00749190|521514634|FG002|Overall Study|Adverse Event|0|||
144634224|NCT00749190|521514635|FG003|Overall Study|Adverse Event|4|||
144634225|NCT00749190|521514636|FG004|Overall Study|Adverse Event|0|||
144634226|NCT00749190|521514637|FG005|Overall Study|Adverse Event|3|||
144634227|NCT00749190|521514638|FG006|Overall Study|Adverse Event|0|||
144634228|NCT00749190|521514632|FG000|Overall Study|Lack of Efficacy|3|||
144634229|NCT00749190|521514633|FG001|Overall Study|Lack of Efficacy|1|||
144634230|NCT00749190|521514634|FG002|Overall Study|Lack of Efficacy|1|||
144634231|NCT00749190|521514635|FG003|Overall Study|Lack of Efficacy|0|||
144634232|NCT00749190|521514636|FG004|Overall Study|Lack of Efficacy|0|||
144634233|NCT00749190|521514637|FG005|Overall Study|Lack of Efficacy|1|||
144634234|NCT00749190|521514638|FG006|Overall Study|Lack of Efficacy|0|||
144634235|NCT00749190|521514632|FG000|Overall Study|Withdrawal by Subject|2|||
144634236|NCT00749190|521514633|FG001|Overall Study|Withdrawal by Subject|1|||
144634237|NCT00749190|521514634|FG002|Overall Study|Withdrawal by Subject|0|||
144634238|NCT00749190|521514635|FG003|Overall Study|Withdrawal by Subject|0|||
144634239|NCT00749190|521514636|FG004|Overall Study|Withdrawal by Subject|0|||
144634240|NCT00749190|521514637|FG005|Overall Study|Withdrawal by Subject|1|||
144634241|NCT00749190|521514638|FG006|Overall Study|Withdrawal by Subject|0|||
144634242|NCT00749190|521514632|FG000|Overall Study|Protocol Violation|0|||
144634243|NCT00749190|521514633|FG001|Overall Study|Protocol Violation|1|||
144634244|NCT00749190|521514634|FG002|Overall Study|Protocol Violation|0|||
144634245|NCT00749190|521514635|FG003|Overall Study|Protocol Violation|0|||
144634246|NCT00749190|521514636|FG004|Overall Study|Protocol Violation|0|||
144634247|NCT00749190|521514637|FG005|Overall Study|Protocol Violation|0|||
144730823|NCT03603314|521869897|FG000|Overall Study|Other|0|||
144730824|NCT03603314|521869898|FG001|Overall Study|Other|1|||
144634248|NCT00749190|521514638|FG006|Overall Study|Protocol Violation|1|||
144634249|NCT00749190|521514632|FG000|Overall Study|Other reason not defined above|0|||
144634250|NCT00749190|521514633|FG001|Overall Study|Other reason not defined above|0|||
144634251|NCT00749190|521514634|FG002|Overall Study|Other reason not defined above|0|||
144634252|NCT00749190|521514635|FG003|Overall Study|Other reason not defined above|1|||
144634253|NCT00749190|521514636|FG004|Overall Study|Other reason not defined above|0|||
144634254|NCT00749190|521514637|FG005|Overall Study|Other reason not defined above|0|||
144634255|NCT00749190|521514638|FG006|Overall Study|Other reason not defined above|0|||
144730825|NCT03603314|521869899|FG002|Overall Study|Other|0|||
144730826|NCT03450070|521869900|FG000|Overall Study|Withdrawal by Subject|8|||
144730827|NCT00050778|521869901|FG000|Overall Study|Adverse Event|13|||
144210125|NCT02458287|519963669|FG000|Overall Study|Relocated Out of State|0|||
144210126|NCT02458287|519963670|FG001|Overall Study|Relocated Out of State|0|||
144210127|NCT02458287|519963671|FG002|Overall Study|Relocated Out of State|0|||
144634256|NCT00784758|521514647|FG000|Overall Study|Withdrawal by Subject|3|||
144634257|NCT00784758|521514648|FG001|Overall Study|Withdrawal by Subject|0|||
144634258|NCT00784758|521514647|FG000|Overall Study|Adverse Event|1|||
144634259|NCT00784758|521514648|FG001|Overall Study|Adverse Event|0|||
144634260|NCT02040142|521514649|FG000|Overall Study|Lost to Follow-up|5|||
144634261|NCT02040142|521514649|FG000|Overall Study|Death|17|||
144634262|NCT02040142|521514649|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
144730828|NCT00050778|521869902|FG001|Overall Study|Adverse Event|3|||
144730829|NCT00050778|521869903|FG002|Overall Study|Adverse Event|2|||
144210128|NCT02458287|519963672|FG003|Overall Study|Relocated Out of State|1|||
144210129|NCT02613182|519963673|FG000|Overall Study|Death|6|||
144210130|NCT02613182|519963673|FG000|Overall Study|Physician Decision|1|||
144210131|NCT02613182|519963673|FG000|Overall Study|Study Terminated by Sponsor|21|||
144210132|NCT02613182|519963673|FG000|Overall Study|Withdrawal by Subject|6|||
144210133|NCT00843635|519963674|FG000|Overall Study|Adverse Event|2|||
144210134|NCT00843635|519963675|FG001|Overall Study|Adverse Event|2|||
144210135|NCT00843635|519963676|FG002|Overall Study|Adverse Event|0|||
144210136|NCT01547130|519963677|FG000|Overall Study|Lost to Follow-up|9|||
144210137|NCT01547130|519963678|FG001|Overall Study|Lost to Follow-up|5|||
144210138|NCT03968978|519963679|FG000|Overall Study|Adverse Event|1|||
144210139|NCT03968978|519963680|FG001|Overall Study|Adverse Event|0|||
144210140|NCT02714426|519963684|FG000|Overall Study|Withdrawal by Subject|2|||
144210141|NCT02714426|519963685|FG001|Overall Study|Withdrawal by Subject|2|||
144210142|NCT00025259|519963687|FG000|Overall Study|Death|1|||
144210143|NCT00025259|519963688|FG001|Overall Study|Death|3|||
144210144|NCT00025259|519963689|FG002|Overall Study|Death|0|||
144210145|NCT00025259|519963690|FG003|Overall Study|Death|3|||
144210146|NCT00025259|519963691|FG004|Overall Study|Death|0|||
144210147|NCT00025259|519963692|FG005|Overall Study|Death|1|||
144210148|NCT00025259|519963693|FG006|Overall Study|Death|2|||
144210149|NCT00025259|519963687|FG000|Overall Study|Lack of Efficacy|2|||
144210150|NCT00025259|519963688|FG001|Overall Study|Lack of Efficacy|46|||
144210151|NCT00025259|519963689|FG002|Overall Study|Lack of Efficacy|60|||
144210152|NCT00025259|519963690|FG003|Overall Study|Lack of Efficacy|78|||
144210153|NCT00025259|519963691|FG004|Overall Study|Lack of Efficacy|11|||
144210154|NCT00025259|519963692|FG005|Overall Study|Lack of Efficacy|30|||
144210155|NCT00025259|519963693|FG006|Overall Study|Lack of Efficacy|38|||
144210156|NCT00025259|519963687|FG000|Overall Study|Lost to Follow-up|2|||
144210157|NCT00025259|519963688|FG001|Overall Study|Lost to Follow-up|9|||
144210158|NCT00025259|519963689|FG002|Overall Study|Lost to Follow-up|13|||
144210159|NCT00025259|519963690|FG003|Overall Study|Lost to Follow-up|13|||
144210160|NCT00025259|519963691|FG004|Overall Study|Lost to Follow-up|1|||
144210161|NCT00025259|519963692|FG005|Overall Study|Lost to Follow-up|3|||
144210162|NCT00025259|519963693|FG006|Overall Study|Lost to Follow-up|1|||
144210163|NCT00025259|519963687|FG000|Overall Study|Physician Decision|12|||
144210164|NCT00025259|519963688|FG001|Overall Study|Physician Decision|1|||
144634263|NCT04752384|521514650|FG000|Overall Study|Withdrawal by Subject|1|||
144634264|NCT04752384|521514650|FG000|Overall Study|Death|1|||
144634265|NCT02330419|521514655|FG000|Overall Study|Lost to Follow-up|3|||
144634266|NCT02330419|521514656|FG001|Overall Study|Lost to Follow-up|7|||
144634267|NCT03952559|521514657|FG000|Double Blind Treatment Period|Adverse Event|0|||
144634268|NCT03952559|521514658|FG001|Double Blind Treatment Period|Adverse Event|2|||
144634269|NCT03952559|521514659|FG002|Double Blind Treatment Period|Adverse Event|1|||
144634270|NCT03952559|521514660|FG003|Double Blind Treatment Period|Adverse Event|0|||
144634271|NCT03952559|521514661|FG004|Double Blind Treatment Period|Adverse Event|1|||
144634272|NCT03952559|521514657|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
144634273|NCT03952559|521514658|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
144634274|NCT03952559|521514659|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
144634275|NCT03952559|521514660|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
144634276|NCT03952559|521514661|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
144634277|NCT03952559|521514657|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
144634278|NCT03952559|521514658|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
144634279|NCT03952559|521514659|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
144634280|NCT03952559|521514660|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
144634281|NCT03952559|521514661|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
144634282|NCT03952559|521514657|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
144634283|NCT03952559|521514658|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
144634284|NCT03952559|521514659|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
144634285|NCT03952559|521514660|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
144634286|NCT03952559|521514661|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
144634287|NCT02875223|521514662|FG000|Overall Study|Other reasons|0|||
144634288|NCT02875223|521514663|FG001|Overall Study|Other reasons|0|||
144634289|NCT02875223|521514664|FG002|Overall Study|Other reasons|1|||
144634290|NCT02875223|521514665|FG003|Overall Study|Other reasons|0|||
144634291|NCT02875223|521514666|FG004|Overall Study|Other reasons|1|||
144210165|NCT00025259|519963689|FG002|Overall Study|Physician Decision|0|||
144210166|NCT00025259|519963690|FG003|Overall Study|Physician Decision|5|||
144634292|NCT02875223|521514667|FG005|Overall Study|Other reasons|2|||
144634293|NCT02875223|521514668|FG006|Overall Study|Other reasons|0|||
144634294|NCT02875223|521514669|FG007|Overall Study|Other reasons|2|||
144634295|NCT02875223|521514670|FG008|Overall Study|Other reasons|0|||
144210167|NCT00025259|519963691|FG004|Overall Study|Physician Decision|4|||
144210168|NCT00025259|519963692|FG005|Overall Study|Physician Decision|2|||
144210169|NCT00025259|519963693|FG006|Overall Study|Physician Decision|1|||
144210170|NCT00025259|519963687|FG000|Overall Study|Protocol Violation|3|||
144210171|NCT00025259|519963688|FG001|Overall Study|Protocol Violation|2|||
144634296|NCT02875223|521514671|FG009|Overall Study|Other reasons|0|||
144210172|NCT00025259|519963689|FG002|Overall Study|Protocol Violation|2|||
144210173|NCT00025259|519963690|FG003|Overall Study|Protocol Violation|1|||
144210174|NCT00025259|519963691|FG004|Overall Study|Protocol Violation|2|||
144210175|NCT00025259|519963692|FG005|Overall Study|Protocol Violation|1|||
144210176|NCT00025259|519963693|FG006|Overall Study|Protocol Violation|3|||
144634297|NCT02875223|521514672|FG010|Overall Study|Other reasons|0|||
144634298|NCT02875223|521514673|FG011|Overall Study|Other reasons|0|||
144634299|NCT02875223|521514674|FG012|Overall Study|Other reasons|0|||
144634300|NCT02875223|521514662|FG000|Overall Study|Withdrawal by Subject|0|||
144634301|NCT02875223|521514663|FG001|Overall Study|Withdrawal by Subject|0|||
144634302|NCT02875223|521514664|FG002|Overall Study|Withdrawal by Subject|0|||
144634303|NCT02875223|521514665|FG003|Overall Study|Withdrawal by Subject|0|||
144634304|NCT02875223|521514666|FG004|Overall Study|Withdrawal by Subject|1|||
144634305|NCT02875223|521514667|FG005|Overall Study|Withdrawal by Subject|1|||
144634306|NCT02875223|521514668|FG006|Overall Study|Withdrawal by Subject|0|||
144634307|NCT02875223|521514669|FG007|Overall Study|Withdrawal by Subject|0|||
144634308|NCT02875223|521514670|FG008|Overall Study|Withdrawal by Subject|1|||
144634309|NCT02875223|521514671|FG009|Overall Study|Withdrawal by Subject|0|||
144634310|NCT02875223|521514672|FG010|Overall Study|Withdrawal by Subject|0|||
144634311|NCT02875223|521514673|FG011|Overall Study|Withdrawal by Subject|0|||
144634312|NCT02875223|521514674|FG012|Overall Study|Withdrawal by Subject|0|||
144634313|NCT02875223|521514662|FG000|Overall Study|Progressive disease|0|||
144634314|NCT02875223|521514663|FG001|Overall Study|Progressive disease|0|||
144634315|NCT02875223|521514664|FG002|Overall Study|Progressive disease|1|||
144634316|NCT02875223|521514665|FG003|Overall Study|Progressive disease|0|||
144634317|NCT02875223|521514666|FG004|Overall Study|Progressive disease|0|||
144634318|NCT02875223|521514667|FG005|Overall Study|Progressive disease|0|||
144634319|NCT02875223|521514668|FG006|Overall Study|Progressive disease|0|||
144634320|NCT02875223|521514669|FG007|Overall Study|Progressive disease|0|||
144634321|NCT02875223|521514670|FG008|Overall Study|Progressive disease|0|||
144634322|NCT02875223|521514671|FG009|Overall Study|Progressive disease|12|||
144634323|NCT02875223|521514672|FG010|Overall Study|Progressive disease|2|||
144634324|NCT02875223|521514673|FG011|Overall Study|Progressive disease|3|||
144634325|NCT02875223|521514674|FG012|Overall Study|Progressive disease|6|||
144634326|NCT02875223|521514662|FG000|Overall Study|Death|4|||
144634327|NCT02875223|521514663|FG001|Overall Study|Death|4|||
144634328|NCT02875223|521514664|FG002|Overall Study|Death|3|||
144634329|NCT02875223|521514665|FG003|Overall Study|Death|4|||
144634330|NCT02875223|521514666|FG004|Overall Study|Death|2|||
144634331|NCT02875223|521514667|FG005|Overall Study|Death|3|||
144634332|NCT02875223|521514668|FG006|Overall Study|Death|5|||
144634333|NCT02875223|521514669|FG007|Overall Study|Death|7|||
144634334|NCT02875223|521514670|FG008|Overall Study|Death|3|||
144634335|NCT02875223|521514671|FG009|Overall Study|Death|2|||
144634336|NCT02875223|521514672|FG010|Overall Study|Death|0|||
144634337|NCT02875223|521514673|FG011|Overall Study|Death|0|||
144634338|NCT02875223|521514674|FG012|Overall Study|Death|0|||
144634339|NCT02875223|521514662|FG000|Overall Study|Lost to Follow-up|0|||
144634340|NCT02875223|521514663|FG001|Overall Study|Lost to Follow-up|1|||
144210177|NCT00025259|519963687|FG000|Overall Study|Withdrawal by Subject|9|||
144210178|NCT00025259|519963688|FG001|Overall Study|Withdrawal by Subject|27|||
144210179|NCT00025259|519963689|FG002|Overall Study|Withdrawal by Subject|6|||
144210180|NCT00025259|519963690|FG003|Overall Study|Withdrawal by Subject|14|||
144634341|NCT02875223|521514664|FG002|Overall Study|Lost to Follow-up|1|||
144634342|NCT02875223|521514665|FG003|Overall Study|Lost to Follow-up|0|||
144634343|NCT02875223|521514666|FG004|Overall Study|Lost to Follow-up|1|||
144634344|NCT02875223|521514667|FG005|Overall Study|Lost to Follow-up|0|||
144634345|NCT02875223|521514668|FG006|Overall Study|Lost to Follow-up|1|||
144634346|NCT02875223|521514669|FG007|Overall Study|Lost to Follow-up|1|||
144634347|NCT02875223|521514670|FG008|Overall Study|Lost to Follow-up|0|||
144634348|NCT02875223|521514671|FG009|Overall Study|Lost to Follow-up|0|||
144634349|NCT02875223|521514672|FG010|Overall Study|Lost to Follow-up|0|||
144634350|NCT02875223|521514673|FG011|Overall Study|Lost to Follow-up|0|||
144634351|NCT02875223|521514674|FG012|Overall Study|Lost to Follow-up|0|||
144634352|NCT01870739|521514675|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
144634353|NCT01870739|521514676|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
144634354|NCT01870739|521514675|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
144634355|NCT01870739|521514676|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
144634356|NCT01870739|521514675|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
144634357|NCT01870739|521514676|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
144634358|NCT01870739|521514675|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
144634359|NCT01870739|521514676|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
144210181|NCT00025259|519963691|FG004|Overall Study|Withdrawal by Subject|11|||
144210182|NCT00025259|519963692|FG005|Overall Study|Withdrawal by Subject|8|||
144210183|NCT00025259|519963693|FG006|Overall Study|Withdrawal by Subject|3|||
144634360|NCT01870739|521514675|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
144634361|NCT01870739|521514676|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
144730830|NCT00050778|521869901|FG000|Overall Study|Death|0|||
144634362|NCT01870739|521514675|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
144634363|NCT01870739|521514676|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
144634364|NCT01870739|521514675|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
144634365|NCT01870739|521514676|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
144634366|NCT01986062|521514677|FG000|Overall Study|Lost to Follow-up|1|||
144634367|NCT01986062|521514678|FG001|Overall Study|Lost to Follow-up|0|||
144634368|NCT01986062|521514677|FG000|Overall Study|Withdrawal by Subject|0|||
144634369|NCT01986062|521514678|FG001|Overall Study|Withdrawal by Subject|1|||
144634370|NCT03538743|521514679|FG000|Overall Study|Adverse Event|0|||
144634371|NCT03538743|521514680|FG001|Overall Study|Adverse Event|0|||
144634372|NCT03538743|521514681|FG002|Overall Study|Adverse Event|1|||
144634373|NCT03538743|521514682|FG003|Overall Study|Adverse Event|1|||
144634374|NCT03538743|521514683|FG004|Overall Study|Adverse Event|0|||
144634375|NCT03538743|521514684|FG005|Overall Study|Adverse Event|0|||
144634376|NCT03538743|521514685|FG006|Overall Study|Adverse Event|0|||
144634377|NCT03538743|521514686|FG007|Overall Study|Adverse Event|0|||
144634378|NCT03538743|521514687|FG008|Overall Study|Adverse Event|0|||
144634379|NCT03538743|521514679|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
144634380|NCT03538743|521514680|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
144634381|NCT03538743|521514681|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
144634382|NCT03538743|521514682|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
144634383|NCT03538743|521514683|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
144634384|NCT03538743|521514684|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
144634385|NCT03538743|521514685|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
144634386|NCT03538743|521514686|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
144634387|NCT03538743|521514687|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
144634388|NCT03538743|521514679|FG000|Overall Study|Withdrawal by Subject|0|||
144634389|NCT03538743|521514680|FG001|Overall Study|Withdrawal by Subject|0|||
144634390|NCT03538743|521514681|FG002|Overall Study|Withdrawal by Subject|0|||
144634391|NCT03538743|521514682|FG003|Overall Study|Withdrawal by Subject|1|||
144634392|NCT03538743|521514683|FG004|Overall Study|Withdrawal by Subject|0|||
144634393|NCT03538743|521514684|FG005|Overall Study|Withdrawal by Subject|0|||
144634394|NCT03538743|521514685|FG006|Overall Study|Withdrawal by Subject|0|||
144634395|NCT03538743|521514686|FG007|Overall Study|Withdrawal by Subject|0|||
144634396|NCT03538743|521514687|FG008|Overall Study|Withdrawal by Subject|0|||
144634397|NCT01565980|521514690|FG000|Overall Study|Death|1|||
144634398|NCT01565980|521514691|FG001|Overall Study|Death|0|||
144634399|NCT01565980|521514690|FG000|Overall Study|Lost to Follow-up|1|||
144634400|NCT01565980|521514691|FG001|Overall Study|Lost to Follow-up|0|||
144634401|NCT01565980|521514690|FG000|Overall Study|health complications|1|||
144634402|NCT01565980|521514691|FG001|Overall Study|health complications|1|||
144634403|NCT01565980|521514690|FG000|Overall Study|stopped medical treatment|1|||
144634404|NCT01565980|521514691|FG001|Overall Study|stopped medical treatment|0|||
144634405|NCT01565980|521514690|FG000|Overall Study|Withdrawal by Subject|0|||
144634406|NCT01565980|521514691|FG001|Overall Study|Withdrawal by Subject|3|||
144634407|NCT01926626|521514693|FG000|Overall Study|Withdrawal by Subject|15|||
144634408|NCT01926626|521514693|FG000|Overall Study|Lost to Follow-up|7|||
144634409|NCT01955707|521514694|FG000|Overall Study|Adverse Event|1|||
144634410|NCT01955707|521514695|FG001|Overall Study|Adverse Event|2|||
144634411|NCT01955707|521514694|FG000|Overall Study|Lost to Follow-up|2|||
144634412|NCT01955707|521514695|FG001|Overall Study|Lost to Follow-up|1|||
144634413|NCT01955707|521514694|FG000|Overall Study|Withdrawal by Subject|0|||
144634414|NCT01955707|521514695|FG001|Overall Study|Withdrawal by Subject|3|||
144634415|NCT01955707|521514694|FG000|Overall Study|Death|13|||
144634416|NCT01955707|521514695|FG001|Overall Study|Death|14|||
144634417|NCT01955707|521514694|FG000|Overall Study|Other|4|||
144634418|NCT01955707|521514695|FG001|Overall Study|Other|2|||
144634419|NCT01817790|521514698|FG000|Overall Study|Adverse Event|0|||
144634420|NCT01817790|521514699|FG001|Overall Study|Adverse Event|2|||
144634421|NCT01817790|521514698|FG000|Overall Study|Lost to Follow-up|0|||
144634422|NCT01817790|521514699|FG001|Overall Study|Lost to Follow-up|1|||
144634423|NCT01817790|521514698|FG000|Overall Study|Protocol Violation|2|||
144210184|NCT00025259|519963687|FG000|Overall Study|Ineligible|14|||
144634424|NCT01817790|521514699|FG001|Overall Study|Protocol Violation|1|||
144634425|NCT01817790|521514698|FG000|Overall Study|Withdrawal by Subject|1|||
144634426|NCT01817790|521514699|FG001|Overall Study|Withdrawal by Subject|3|||
144634427|NCT01817790|521514698|FG000|Overall Study|Other: Could not attend appointment|1|||
144634428|NCT01817790|521514699|FG001|Overall Study|Other: Could not attend appointment|1|||
144634429|NCT01671345|521514700|FG000|Overall Study|Lost to Follow-up|10|||
144634430|NCT01671345|521514701|FG001|Overall Study|Lost to Follow-up|6|||
144634431|NCT01671345|521514700|FG000|Overall Study|visit with non-participating physician|3|||
144634432|NCT01671345|521514701|FG001|Overall Study|visit with non-participating physician|3|||
144634433|NCT03636906|521514702|FG000|Overall Study|Adverse Event|0|||
144634434|NCT03636906|521514703|FG001|Overall Study|Adverse Event|0|||
144634435|NCT03636906|521514704|FG002|Overall Study|Adverse Event|1|||
144634436|NCT03636906|521514702|FG000|Overall Study|Lost to Follow-up|1|||
144634437|NCT03636906|521514703|FG001|Overall Study|Lost to Follow-up|0|||
144210185|NCT00025259|519963688|FG001|Overall Study|Ineligible|1|||
144210186|NCT00025259|519963689|FG002|Overall Study|Ineligible|0|||
144210187|NCT00025259|519963690|FG003|Overall Study|Ineligible|0|||
144634438|NCT03636906|521514704|FG002|Overall Study|Lost to Follow-up|0|||
144634439|NCT03636906|521514702|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
144634440|NCT03636906|521514703|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
144634441|NCT03636906|521514704|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
144634442|NCT03636906|521514702|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
144634443|NCT03636906|521514703|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
144634444|NCT03636906|521514704|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
144634445|NCT03636906|521514702|FG000|Overall Study|Other|0|||
144634446|NCT03636906|521514703|FG001|Overall Study|Other|0|||
144634447|NCT03636906|521514704|FG002|Overall Study|Other|1|||
144634448|NCT00891202|521514705|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
144634449|NCT00891202|521514706|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
144634450|NCT00891202|521514707|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
144634451|NCT00891202|521514708|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
144634452|NCT00891202|521514705|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
144634453|NCT00891202|521514706|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
144634454|NCT00891202|521514707|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
144634455|NCT00891202|521514708|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
144634456|NCT00891202|521514705|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
144634457|NCT00891202|521514706|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
144634458|NCT00891202|521514707|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
144634459|NCT00891202|521514708|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
144634460|NCT00891202|521514705|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
144634461|NCT00891202|521514706|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
144634462|NCT00891202|521514707|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
144634463|NCT00891202|521514708|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
144634464|NCT03690869|521514710|FG000|Overall Study|Adverse Event|0|||
144634465|NCT03690869|521514711|FG001|Overall Study|Adverse Event|0|||
144634466|NCT03690869|521514712|FG002|Overall Study|Adverse Event|0|||
144634467|NCT03690869|521514713|FG003|Overall Study|Adverse Event|1|||
144634468|NCT03690869|521514714|FG004|Overall Study|Adverse Event|0|||
144634469|NCT03690869|521514715|FG005|Overall Study|Adverse Event|0|||
144634470|NCT03690869|521514716|FG006|Overall Study|Adverse Event|0|||
144634471|NCT03690869|521514717|FG007|Overall Study|Adverse Event|1|||
144634472|NCT03690869|521514718|FG008|Overall Study|Adverse Event|0|||
144634473|NCT03690869|521514719|FG009|Overall Study|Adverse Event|1|||
144634474|NCT03690869|521514710|FG000|Overall Study|Death|1|||
144634475|NCT03690869|521514711|FG001|Overall Study|Death|1|||
144634476|NCT03690869|521514712|FG002|Overall Study|Death|1|||
144634477|NCT03690869|521514713|FG003|Overall Study|Death|4|||
144634478|NCT03690869|521514714|FG004|Overall Study|Death|2|||
144634479|NCT03690869|521514715|FG005|Overall Study|Death|5|||
144634480|NCT03690869|521514716|FG006|Overall Study|Death|3|||
144634481|NCT03690869|521514717|FG007|Overall Study|Death|2|||
144634482|NCT03690869|521514718|FG008|Overall Study|Death|0|||
144634483|NCT03690869|521514719|FG009|Overall Study|Death|3|||
144634484|NCT03690869|521514710|FG000|Overall Study|Lost to Follow-up|0|||
144634485|NCT03690869|521514711|FG001|Overall Study|Lost to Follow-up|0|||
144634486|NCT03690869|521514712|FG002|Overall Study|Lost to Follow-up|1|||
144634487|NCT03690869|521514713|FG003|Overall Study|Lost to Follow-up|0|||
144634488|NCT03690869|521514714|FG004|Overall Study|Lost to Follow-up|0|||
144634489|NCT03690869|521514715|FG005|Overall Study|Lost to Follow-up|0|||
144634490|NCT03690869|521514716|FG006|Overall Study|Lost to Follow-up|0|||
144634491|NCT03690869|521514717|FG007|Overall Study|Lost to Follow-up|0|||
144634492|NCT03690869|521514718|FG008|Overall Study|Lost to Follow-up|0|||
144634493|NCT03690869|521514719|FG009|Overall Study|Lost to Follow-up|0|||
144634494|NCT03690869|521514710|FG000|Overall Study|Other Treatment|1|||
144634495|NCT03690869|521514711|FG001|Overall Study|Other Treatment|1|||
144634496|NCT03690869|521514712|FG002|Overall Study|Other Treatment|1|||
144634497|NCT03690869|521514713|FG003|Overall Study|Other Treatment|2|||
144634498|NCT03690869|521514714|FG004|Overall Study|Other Treatment|3|||
144634499|NCT03690869|521514715|FG005|Overall Study|Other Treatment|1|||
144634500|NCT03690869|521514716|FG006|Overall Study|Other Treatment|2|||
144634501|NCT03690869|521514717|FG007|Overall Study|Other Treatment|7|||
144210188|NCT00025259|519963691|FG004|Overall Study|Ineligible|6|||
144210189|NCT00025259|519963692|FG005|Overall Study|Ineligible|0|||
144634502|NCT03690869|521514718|FG008|Overall Study|Other Treatment|0|||
144634503|NCT03690869|521514719|FG009|Overall Study|Other Treatment|3|||
144634504|NCT03690869|521514710|FG000|Overall Study|Physician Decision|0|||
144634505|NCT03690869|521514711|FG001|Overall Study|Physician Decision|1|||
144634506|NCT03690869|521514712|FG002|Overall Study|Physician Decision|0|||
144634507|NCT03690869|521514713|FG003|Overall Study|Physician Decision|0|||
144634508|NCT03690869|521514714|FG004|Overall Study|Physician Decision|0|||
144634509|NCT03690869|521514715|FG005|Overall Study|Physician Decision|0|||
144634510|NCT03690869|521514716|FG006|Overall Study|Physician Decision|0|||
144634511|NCT03690869|521514717|FG007|Overall Study|Physician Decision|0|||
144634512|NCT03690869|521514718|FG008|Overall Study|Physician Decision|0|||
144634513|NCT03690869|521514719|FG009|Overall Study|Physician Decision|0|||
144634514|NCT03690869|521514710|FG000|Overall Study|Progressive Disease|1|||
144634515|NCT03690869|521514711|FG001|Overall Study|Progressive Disease|2|||
144634516|NCT03690869|521514712|FG002|Overall Study|Progressive Disease|0|||
144634517|NCT03690869|521514713|FG003|Overall Study|Progressive Disease|1|||
144634518|NCT03690869|521514714|FG004|Overall Study|Progressive Disease|0|||
144634519|NCT03690869|521514715|FG005|Overall Study|Progressive Disease|0|||
144634520|NCT03690869|521514716|FG006|Overall Study|Progressive Disease|0|||
144634521|NCT03690869|521514717|FG007|Overall Study|Progressive Disease|0|||
144634522|NCT03690869|521514718|FG008|Overall Study|Progressive Disease|1|||
144634523|NCT03690869|521514719|FG009|Overall Study|Progressive Disease|1|||
144634524|NCT03690869|521514710|FG000|Overall Study|Subject Decision|0|||
144634525|NCT03690869|521514711|FG001|Overall Study|Subject Decision|0|||
144634526|NCT03690869|521514712|FG002|Overall Study|Subject Decision|0|||
144634527|NCT03690869|521514713|FG003|Overall Study|Subject Decision|1|||
144634528|NCT03690869|521514714|FG004|Overall Study|Subject Decision|0|||
144634529|NCT03690869|521514715|FG005|Overall Study|Subject Decision|0|||
144634530|NCT03690869|521514716|FG006|Overall Study|Subject Decision|0|||
144634531|NCT03690869|521514717|FG007|Overall Study|Subject Decision|1|||
144634532|NCT03690869|521514718|FG008|Overall Study|Subject Decision|0|||
144634533|NCT03690869|521514719|FG009|Overall Study|Subject Decision|0|||
144634534|NCT02338843|521516008|FG000|Overall Study|Adverse Event|2|||
144634535|NCT02338843|521516009|FG001|Overall Study|Adverse Event|1|||
144634536|NCT02338843|521516008|FG000|Overall Study|Death|40|||
144634537|NCT02338843|521516009|FG001|Overall Study|Death|53|||
144634538|NCT02338843|521516008|FG000|Overall Study|Physician Decision|1|||
144634539|NCT02338843|521516009|FG001|Overall Study|Physician Decision|0|||
144634540|NCT02338843|521516008|FG000|Overall Study|Withdrawal by Subject|0|||
144634541|NCT02338843|521516009|FG001|Overall Study|Withdrawal by Subject|2|||
144634542|NCT02338843|521516008|FG000|Overall Study|Subject Recovered|0|||
144634543|NCT02338843|521516009|FG001|Overall Study|Subject Recovered|2|||
144634544|NCT02338843|521516008|FG000|Overall Study|Discontinued prior to randomizat|1|||
144634545|NCT02338843|521516009|FG001|Overall Study|Discontinued prior to randomizat|0|||
144634546|NCT01609933|521516014|FG000|Overall Study|Adverse Event|1|||
144634547|NCT01609933|521516014|FG000|Overall Study|Withdrawal by Subject|3|||
144634548|NCT01252966|521516015|FG000|Overall Study|Lost to Follow-up|16|||
144634549|NCT01252966|521516016|FG001|Overall Study|Lost to Follow-up|10|||
144634550|NCT01252966|521516015|FG000|Overall Study|Withdrawal by Subject|7|||
144634551|NCT01252966|521516016|FG001|Overall Study|Withdrawal by Subject|3|||
144634552|NCT05194345|521516021|FG000|Overall Study|Withdrawal by Subject|6|||
144634553|NCT05194345|521516022|FG001|Overall Study|Withdrawal by Subject|4|||
144634554|NCT05194345|521516023|FG002|Overall Study|Withdrawal by Subject|0|||
144634555|NCT05194345|521516021|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
144634556|NCT05194345|521516022|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
144634557|NCT05194345|521516023|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
144634558|NCT04854499|521516024|FG000|Overall Study|Study Terminated by Sponsor|5|||
144634559|NCT04854499|521516025|FG001|Overall Study|Study Terminated by Sponsor|27|||
144634560|NCT04854499|521516026|FG002|Overall Study|Study Terminated by Sponsor|28|||
144634561|NCT04854499|521516027|FG003|Overall Study|Study Terminated by Sponsor|19|||
144634562|NCT04854499|521516028|FG004|Overall Study|Study Terminated by Sponsor|1|||
144634563|NCT04854499|521516029|FG005|Overall Study|Study Terminated by Sponsor|10|||
144634564|NCT04854499|521516024|FG000|Overall Study|Death|1|||
144634565|NCT04854499|521516025|FG001|Overall Study|Death|23|||
144634566|NCT04854499|521516026|FG002|Overall Study|Death|21|||
144634567|NCT04854499|521516027|FG003|Overall Study|Death|7|||
144634568|NCT04854499|521516028|FG004|Overall Study|Death|6|||
144634569|NCT04854499|521516029|FG005|Overall Study|Death|24|||
144634570|NCT04854499|521516024|FG000|Overall Study|Investigator's Discretion|0|||
144634571|NCT04854499|521516025|FG001|Overall Study|Investigator's Discretion|1|||
144634572|NCT04854499|521516026|FG002|Overall Study|Investigator's Discretion|3|||
144730831|NCT00050778|521869902|FG001|Overall Study|Death|1|||
144730832|NCT00050778|521869903|FG002|Overall Study|Death|1|||
144730833|NCT00050778|521869901|FG000|Overall Study|Lack of Efficacy|16|||
144210190|NCT00025259|519963693|FG006|Overall Study|Ineligible|1|||
144210191|NCT00025259|519963687|FG000|Overall Study|Randomization error|1|||
144210192|NCT00025259|519963688|FG001|Overall Study|Randomization error|0|||
144210193|NCT00025259|519963689|FG002|Overall Study|Randomization error|0|||
144210194|NCT00025259|519963690|FG003|Overall Study|Randomization error|0|||
144210195|NCT00025259|519963691|FG004|Overall Study|Randomization error|1|||
144210196|NCT00025259|519963692|FG005|Overall Study|Randomization error|7|||
144210197|NCT00025259|519963693|FG006|Overall Study|Randomization error|2|||
144210198|NCT00025259|519963687|FG000|Overall Study|Adverse Event|1|||
144210199|NCT00025259|519963688|FG001|Overall Study|Adverse Event|0|||
144210200|NCT00025259|519963689|FG002|Overall Study|Adverse Event|0|||
144210201|NCT00025259|519963690|FG003|Overall Study|Adverse Event|0|||
144634573|NCT04854499|521516027|FG003|Overall Study|Investigator's Discretion|4|||
144634574|NCT04854499|521516028|FG004|Overall Study|Investigator's Discretion|1|||
144634575|NCT04854499|521516029|FG005|Overall Study|Investigator's Discretion|5|||
144634576|NCT04854499|521516024|FG000|Overall Study|Withdrew Consent|0|||
144634577|NCT04854499|521516025|FG001|Overall Study|Withdrew Consent|1|||
144634578|NCT04854499|521516026|FG002|Overall Study|Withdrew Consent|2|||
144634579|NCT04854499|521516027|FG003|Overall Study|Withdrew Consent|2|||
144634580|NCT04854499|521516028|FG004|Overall Study|Withdrew Consent|0|||
144634581|NCT04854499|521516029|FG005|Overall Study|Withdrew Consent|1|||
144634582|NCT04854499|521516024|FG000|Overall Study|Lost to Follow-up|0|||
144634583|NCT04854499|521516025|FG001|Overall Study|Lost to Follow-up|0|||
144634584|NCT04854499|521516026|FG002|Overall Study|Lost to Follow-up|0|||
144634585|NCT04854499|521516027|FG003|Overall Study|Lost to Follow-up|0|||
144634586|NCT04854499|521516028|FG004|Overall Study|Lost to Follow-up|0|||
144634587|NCT04854499|521516029|FG005|Overall Study|Lost to Follow-up|1|||
144634588|NCT05415449|521516030|FG000|Overall Study|Lost to Follow-up|2|||
144634589|NCT05415449|521516030|FG000|Overall Study|Withdrawal by Subject|4|||
144634590|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
144634591|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
144634592|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
144634593|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
144730834|NCT00050778|521869902|FG001|Overall Study|Lack of Efficacy|2|||
144730835|NCT00050778|521869903|FG002|Overall Study|Lack of Efficacy|2|||
144730836|NCT00050778|521869901|FG000|Overall Study|Lost to Follow-up|0|||
144730837|NCT00050778|521869902|FG001|Overall Study|Lost to Follow-up|2|||
144730838|NCT00050778|521869903|FG002|Overall Study|Lost to Follow-up|4|||
144730839|NCT00050778|521869901|FG000|Overall Study|Physician Decision|3|||
144730840|NCT00050778|521869902|FG001|Overall Study|Physician Decision|0|||
144730841|NCT00050778|521869903|FG002|Overall Study|Physician Decision|2|||
144730842|NCT00050778|521869901|FG000|Overall Study|Protocol Violation|2|||
144730843|NCT00050778|521869902|FG001|Overall Study|Protocol Violation|0|||
144730844|NCT00050778|521869903|FG002|Overall Study|Protocol Violation|1|||
144730845|NCT00050778|521869901|FG000|Overall Study|Withdrawal by Subject|6|||
144730846|NCT00050778|521869902|FG001|Overall Study|Withdrawal by Subject|8|||
144730847|NCT00050778|521869903|FG002|Overall Study|Withdrawal by Subject|4|||
144730848|NCT00050778|521869901|FG000|Overall Study|Randomized but not treated|4|||
144730849|NCT00050778|521869902|FG001|Overall Study|Randomized but not treated|5|||
144730850|NCT00050778|521869903|FG002|Overall Study|Randomized but not treated|2|||
144730851|NCT00050778|521869901|FG000|Overall Study|Familial and personal reasons|1|||
144730852|NCT00050778|521869902|FG001|Overall Study|Familial and personal reasons|0|||
144730853|NCT00050778|521869903|FG002|Overall Study|Familial and personal reasons|0|||
144730854|NCT00064753|521869907|FG000|Overall Study|Death|251|||
144730855|NCT00064753|521869908|FG001|Overall Study|Death|242|||
144730856|NCT00064753|521869907|FG000|Overall Study|Withdrawal by Subject|198|||
144730857|NCT00064753|521869908|FG001|Overall Study|Withdrawal by Subject|171|||
144730858|NCT00064753|521869907|FG000|Overall Study|Lost to Follow-up|225|||
144730859|NCT00064753|521869908|FG001|Overall Study|Lost to Follow-up|235|||
144730860|NCT02193880|521869911|FG000|Overall Study|patients did not collect enough HPC|3|||
144730861|NCT01661686|521869917|FG000|Overall Study|Lost to Follow-up|2|||
144730862|NCT01661686|521869918|FG001|Overall Study|Lost to Follow-up|1|||
144730863|NCT01661686|521869917|FG000|Overall Study|did not receive allocated intervention|0|||
144730864|NCT01661686|521869918|FG001|Overall Study|did not receive allocated intervention|1|||
144730865|NCT04869787|521869921|FG000|Screening|Physician Decision|1|||
144730866|NCT04869787|521869921|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
144730867|NCT00813293|521869922|FG000|Overall Study|Intercurrent illness|1|||
144730868|NCT00813293|521869923|FG001|Overall Study|Intercurrent illness|0|||
144730869|NCT00813293|521869922|FG000|Overall Study|Adverse Event|0|||
144730870|NCT00813293|521869923|FG001|Overall Study|Adverse Event|1|||
144730871|NCT02794974|521869924|FG000|Overall Study|Physician Decision|0|||
144730872|NCT02794974|521869925|FG001|Overall Study|Physician Decision|1|||
144730873|NCT00533273|521869926|FG000|Double-blind|Withdrew consent|0|||
144730874|NCT00533273|521869927|FG001|Double-blind|Withdrew consent|2|||
144730875|NCT00533273|521869926|FG000|Open-label|Withdrawal by Subject|6|||
144730876|NCT00533273|521869927|FG001|Open-label|Withdrawal by Subject|0|||
144210202|NCT00025259|519963691|FG004|Overall Study|Adverse Event|0|||
144634594|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
144634595|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
144634596|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
144634597|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
144634598|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
144730877|NCT02202850|521869929|FG000|Overall Study|Other|2|||
144730878|NCT02202850|521869930|FG001|Overall Study|Other|2|||
144730879|NCT02202850|521869929|FG000|Overall Study|Enbrel treatment discontinued|15|||
144730880|NCT02202850|521869930|FG001|Overall Study|Enbrel treatment discontinued|3|||
144730881|NCT02202850|521869929|FG000|Overall Study|Lost to Follow-up|7|||
144730882|NCT02202850|521869930|FG001|Overall Study|Lost to Follow-up|1|||
144634599|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
144634600|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
144634601|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
144634602|NCT02747927|521516034|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
144634603|NCT02747927|521516035|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
144634604|NCT02747927|521516034|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
144634605|NCT02747927|521516035|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
144634606|NCT02747927|521516034|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
144634607|NCT02747927|521516035|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
144634608|NCT02747927|521516034|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
144634609|NCT02747927|521516035|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
144634610|NCT02747927|521516034|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
144634611|NCT02747927|521516035|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
144634612|NCT02747927|521516034|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
144634613|NCT02747927|521516035|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
144634614|NCT02747927|521516034|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
144634615|NCT02747927|521516035|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
144634616|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
144634617|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
144634618|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
144634619|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
144634620|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
144634621|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
144634622|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
144634623|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
144634624|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
144634625|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
144634626|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
144634627|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
144634628|NCT02747927|521516034|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
144634629|NCT02747927|521516035|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
144634630|NCT02747927|521516034|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
144634631|NCT02747927|521516035|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
144634632|NCT02747927|521516034|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
144634633|NCT02747927|521516035|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
144634634|NCT02747927|521516034|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
144634635|NCT02747927|521516035|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
144634636|NCT02747927|521516034|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
144634637|NCT02747927|521516035|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
144634638|NCT02747927|521516034|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
144634639|NCT02747927|521516035|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
144634640|NCT02747927|521516034|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
144634641|NCT02747927|521516035|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
144634642|NCT02747927|521516034|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
144634643|NCT02747927|521516035|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
144634644|NCT02747927|521516034|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
144634645|NCT02747927|521516035|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
144634646|NCT02747927|521516034|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
144634647|NCT02747927|521516035|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
144634648|NCT02747927|521516034|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
144634649|NCT02747927|521516035|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
144634650|NCT02747927|521516034|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
144634651|NCT02747927|521516035|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
144634652|NCT02747927|521516034|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
144634653|NCT02747927|521516035|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
144634654|NCT03932812|521516038|FG000|Overall Study|Lost to Follow-up|12|||
144634655|NCT03932812|521516039|FG001|Overall Study|Lost to Follow-up|14|||
144634656|NCT03932812|521516038|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
144634657|NCT03932812|521516039|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
144634658|NCT00332709|521516040|FG000|Overall Study|Adverse Event|11|||
144634659|NCT00332709|521516041|FG001|Overall Study|Adverse Event|14|||
144262977|NCT00735709|520163807|FG001|Overall Study|Lack of Efficacy|4|||
144634660|NCT00332709|521516040|FG000|Overall Study|Withdrawal by Subject|2|||
144634661|NCT00332709|521516041|FG001|Overall Study|Withdrawal by Subject|3|||
144210203|NCT00025259|519963692|FG005|Overall Study|Adverse Event|0|||
144210204|NCT00025259|519963693|FG006|Overall Study|Adverse Event|0|||
144210205|NCT00863772|519963696|FG000|Overall Study|Adverse Event|1|||
144210206|NCT00863772|519963697|FG001|Overall Study|Adverse Event|4|||
144210207|NCT00863772|519963698|FG002|Overall Study|Adverse Event|0|||
144210208|NCT00863772|519963696|FG000|Overall Study|Lack of Efficacy|4|||
144634662|NCT00332709|521516040|FG000|Overall Study|Lost to Follow-up|2|||
144634663|NCT00332709|521516041|FG001|Overall Study|Lost to Follow-up|0|||
144634664|NCT00332709|521516040|FG000|Overall Study|Administrative Problems|0|||
144634665|NCT00332709|521516041|FG001|Overall Study|Administrative Problems|3|||
144634666|NCT00332709|521516040|FG000|Overall Study|Abnormal test procedure result|1|||
144634667|NCT00332709|521516041|FG001|Overall Study|Abnormal test procedure result|0|||
144634668|NCT03480802|521516042|FG000|Overall Study|Lost to Follow-up|5|||
144634669|NCT03480802|521516043|FG001|Overall Study|Lost to Follow-up|1|||
144634670|NCT03480802|521516042|FG000|Overall Study|Withdrawal by Subject|2|||
144634671|NCT03480802|521516043|FG001|Overall Study|Withdrawal by Subject|1|||
144634672|NCT03480802|521516042|FG000|Overall Study|Relocated|0|||
144634673|NCT03480802|521516043|FG001|Overall Study|Relocated|1|||
144634674|NCT01933932|521516051|FG000|Overall Study|Death|173|||
144634675|NCT01933932|521516052|FG001|Overall Study|Death|163|||
144634676|NCT01933932|521516051|FG000|Overall Study|Withdrawal by Subject|11|||
144634677|NCT01933932|521516052|FG001|Overall Study|Withdrawal by Subject|14|||
144634678|NCT01933932|521516051|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144634679|NCT01933932|521516052|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144634680|NCT02275533|521516053|FG000|Overall Study|Protocol Violation|2|||
144634681|NCT02275533|521516054|FG001|Overall Study|Protocol Violation|0|||
144634682|NCT02275533|521516053|FG000|Overall Study|Never received study treatment|1|||
144634683|NCT02275533|521516054|FG001|Overall Study|Never received study treatment|0|||
144634684|NCT02157883|521516056|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
144634685|NCT02157883|521516056|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
144634686|NCT02157883|521516056|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
144634687|NCT02157883|521516056|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
144730883|NCT01873586|521869931|FG000|Overall Study|Lost to Follow-up|3|||
144730884|NCT00615069|521869932|FG000|Overall Study|Death|10|||
144730885|NCT00615069|521869932|FG000|Overall Study|Physician Decision|2|||
144730886|NCT00615069|521869932|FG000|Overall Study|Withdrawal by Subject|4|||
144730887|NCT00454909|521869933|FG000|Overall Study|Withdrawal by Subject|1|||
144730888|NCT00454909|521869934|FG001|Overall Study|Withdrawal by Subject|0|||
144730889|NCT00454909|521869935|FG002|Overall Study|Withdrawal by Subject|0|||
144730890|NCT00454909|521869933|FG000|Overall Study|Migrated/moved from study area|0|||
144730891|NCT00454909|521869934|FG001|Overall Study|Migrated/moved from study area|0|||
144730892|NCT00454909|521869935|FG002|Overall Study|Migrated/moved from study area|1|||
144730893|NCT00454909|521869933|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
144730894|NCT00454909|521869934|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
144730895|NCT00454909|521869935|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
144730896|NCT00454909|521869933|FG000|Overall Study|Others|1|||
144730897|NCT00454909|521869934|FG001|Overall Study|Others|0|||
144730898|NCT00454909|521869935|FG002|Overall Study|Others|0|||
144730899|NCT02996682|521869936|FG000|Overall Study|Death|0|||
144730900|NCT02996682|521869937|FG001|Overall Study|Death|3|||
144730901|NCT01981720|521869938|FG000|Overall Study|Adverse Event|1|||
144730902|NCT01981720|521869938|FG000|Overall Study|Withdrawal by Subject|3|||
144730903|NCT01981720|521869938|FG000|Overall Study|Pregnancy|1|||
144730904|NCT00282048|521869939|FG000|Overall Study|Lack of Efficacy|30|||
144730905|NCT00282048|521869939|FG000|Overall Study|Adverse Event|22|||
144730906|NCT00282048|521869939|FG000|Overall Study|Withdrawal by Subject|1|||
144730907|NCT00282048|521869939|FG000|Overall Study|Other|8|||
144730908|NCT00282048|521869939|FG000|Overall Study|Ongoing|1|||
144730909|NCT00870870|521869943|FG000|Overall Study|Withdrawal by Subject|0|||
144730910|NCT00870870|521869944|FG001|Overall Study|Withdrawal by Subject|1|||
144730911|NCT00870870|521869945|FG002|Overall Study|Withdrawal by Subject|1|||
144730912|NCT00870870|521869946|FG003|Overall Study|Withdrawal by Subject|3|||
144210209|NCT00863772|519963697|FG001|Overall Study|Lack of Efficacy|2|||
144210210|NCT00863772|519963698|FG002|Overall Study|Lack of Efficacy|4|||
144210211|NCT00863772|519963696|FG000|Overall Study|Lost to Follow-up|5|||
144634688|NCT02157883|521516056|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
144634689|NCT04454489|521516057|FG000|Overall Study|Disease progression|12|||
144634690|NCT04454489|521516057|FG000|Overall Study|Death|4|||
144634691|NCT04454489|521516057|FG000|Overall Study|Adverse Event|1|||
144730913|NCT00870870|521869943|FG000|Overall Study|Adverse Event|0|||
144634692|NCT04454489|521516057|FG000|Overall Study|Physician Decision|1|||
144730914|NCT00870870|521869944|FG001|Overall Study|Adverse Event|0|||
144730915|NCT00870870|521869945|FG002|Overall Study|Adverse Event|2|||
144730916|NCT00870870|521869946|FG003|Overall Study|Adverse Event|2|||
144730917|NCT03639311|521869949|FG000|Maintenance Phase|Lost to Follow-up|1|||
144634693|NCT00501228|521516058|FG000|Overall Study|Withdrawal by Subject|1|||
144634694|NCT01262898|521516059|FG000|Overall Study|Protocol Violation|1|||
144634695|NCT01262898|521516060|FG001|Overall Study|Protocol Violation|1|||
144634696|NCT01262898|521516061|FG002|Overall Study|Protocol Violation|0|||
144634697|NCT01262898|521516062|FG003|Overall Study|Protocol Violation|0|||
144634698|NCT01262898|521516059|FG000|Overall Study|Lost to Follow-up|1|||
144634699|NCT01262898|521516060|FG001|Overall Study|Lost to Follow-up|0|||
144634700|NCT01262898|521516061|FG002|Overall Study|Lost to Follow-up|0|||
144634701|NCT01262898|521516062|FG003|Overall Study|Lost to Follow-up|0|||
144634702|NCT01262898|521516059|FG000|Overall Study|Withdrawal by Subject|1|||
144634703|NCT01262898|521516060|FG001|Overall Study|Withdrawal by Subject|1|||
144634704|NCT01262898|521516061|FG002|Overall Study|Withdrawal by Subject|0|||
144634705|NCT01262898|521516062|FG003|Overall Study|Withdrawal by Subject|0|||
144634706|NCT00885365|521516069|FG000|4 Weeks ON Treatment|Adverse Event|2|||
144634707|NCT00885365|521516070|FG001|4 Weeks ON Treatment|Adverse Event|4|||
144634708|NCT00885365|521516069|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
144634709|NCT00885365|521516070|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
144634710|NCT00885365|521516069|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
144634711|NCT00885365|521516070|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
144634712|NCT01824979|521516071|FG000|Overall Study|Withdrawal by Subject|5|||
144634713|NCT01824979|521516072|FG001|Overall Study|Withdrawal by Subject|0|||
144634714|NCT01824979|521516071|FG000|Overall Study|Physician Decision|2|||
144634715|NCT01824979|521516072|FG001|Overall Study|Physician Decision|0|||
144634716|NCT01824979|521516071|FG000|Overall Study|Protocol Violation|6|||
144634717|NCT01824979|521516072|FG001|Overall Study|Protocol Violation|13|||
144634718|NCT00473876|521516075|FG000|Overall Study|Lost to Follow-up|3|||
144634719|NCT00473876|521516076|FG001|Overall Study|Lost to Follow-up|1|||
144634720|NCT03751111|521516082|FG000|Overall Study|Lack of Efficacy|9|||
144634721|NCT03751111|521516083|FG001|Overall Study|Lack of Efficacy|30|||
144634722|NCT03751111|521516082|FG000|Overall Study|Adverse Event|3|||
144634723|NCT03751111|521516083|FG001|Overall Study|Adverse Event|2|||
144634724|NCT01360996|521516084|FG000|Overall Study|Withdrawal by Subject|4|||
144634725|NCT01360996|521516085|FG001|Overall Study|Withdrawal by Subject|3|||
144634726|NCT01360996|521516086|FG002|Overall Study|Withdrawal by Subject|2|||
144634727|NCT01360996|521516084|FG000|Overall Study|Noncompliant|2|||
144634728|NCT01360996|521516085|FG001|Overall Study|Noncompliant|0|||
144634729|NCT01360996|521516086|FG002|Overall Study|Noncompliant|0|||
144634730|NCT02965378|521516088|FG000|Overall Study|Progression|16|||
144634731|NCT02965378|521516089|FG001|Overall Study|Progression|4|||
144634732|NCT02965378|521516088|FG000|Overall Study|Adverse Event|5|||
144634733|NCT02965378|521516089|FG001|Overall Study|Adverse Event|2|||
144634734|NCT02965378|521516088|FG000|Overall Study|Death|2|||
144634735|NCT02965378|521516089|FG001|Overall Study|Death|0|||
144634736|NCT02965378|521516088|FG000|Overall Study|Refusal|2|||
144634737|NCT02965378|521516089|FG001|Overall Study|Refusal|1|||
144634738|NCT02965378|521516088|FG000|Overall Study|Not protocol specified|0|||
144634739|NCT02965378|521516089|FG001|Overall Study|Not protocol specified|2|||
144634740|NCT04964258|521516090|FG000|Overall Study|Lost to Follow-up|1|||
144634741|NCT04964258|521516091|FG001|Overall Study|Lost to Follow-up|0|||
144634742|NCT04964258|521516092|FG002|Overall Study|Lost to Follow-up|0|||
144634743|NCT04964258|521516093|FG003|Overall Study|Lost to Follow-up|0|||
144634744|NCT04964258|521516094|FG004|Overall Study|Lost to Follow-up|0|||
144634745|NCT04964258|521516095|FG005|Overall Study|Lost to Follow-up|1|||
144634746|NCT04964258|521516096|FG006|Overall Study|Lost to Follow-up|0|||
144634747|NCT04964258|521516097|FG007|Overall Study|Lost to Follow-up|0|||
144634748|NCT04964258|521516098|FG008|Overall Study|Lost to Follow-up|0|||
144634749|NCT04964258|521516099|FG009|Overall Study|Lost to Follow-up|0|||
144634750|NCT04964258|521516100|FG010|Overall Study|Lost to Follow-up|0|||
144634751|NCT01285349|521516102|FG000|Overall Study|Lost to Follow-up|27|||
144634752|NCT01285349|521516103|FG001|Overall Study|Lost to Follow-up|20|||
144634753|NCT01285349|521516104|FG002|Overall Study|Lost to Follow-up|27|||
144634754|NCT02909153|521516105|FG000|Overall Study|Withdrawal by Subject|0|||
144634755|NCT02909153|521516106|FG001|Overall Study|Withdrawal by Subject|1|||
144634756|NCT02909153|521516107|FG002|Overall Study|Withdrawal by Subject|0|||
144634757|NCT02909153|521516108|FG003|Overall Study|Withdrawal by Subject|0|||
144634758|NCT02909153|521516109|FG004|Overall Study|Withdrawal by Subject|0|||
144634759|NCT03040024|521516110|FG000|Overall Study|Adverse Event|0|||
144634760|NCT03040024|521516111|FG001|Overall Study|Adverse Event|1|||
144634761|NCT03040024|521516112|FG002|Overall Study|Adverse Event|0|||
144634762|NCT03040024|521516110|FG000|Overall Study|Death|0|||
144634763|NCT03040024|521516111|FG001|Overall Study|Death|1|||
144634764|NCT03040024|521516112|FG002|Overall Study|Death|0|||
144634765|NCT03040024|521516110|FG000|Overall Study|Physician Decision|0|||
144634766|NCT03040024|521516111|FG001|Overall Study|Physician Decision|0|||
144634767|NCT03040024|521516112|FG002|Overall Study|Physician Decision|1|||
144634768|NCT01818297|521516115|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
144634769|NCT01818297|521516116|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
144634770|NCT01818297|521516115|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
144634771|NCT01818297|521516116|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
144634772|NCT01818297|521516115|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
144634773|NCT01818297|521516116|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
144634774|NCT00631137|521516117|FG000|Overall Study|Withdrawal by Subject|1|||
144634775|NCT00631137|521516118|FG001|Overall Study|Withdrawal by Subject|0|||
144634776|NCT04439344|521516119|FG000|Overall Study|Never started threapy|3|||
144634777|NCT04439344|521516119|FG000|Overall Study|Ineligible|3|||
144634778|NCT04439344|521516119|FG000|Overall Study|Adverse Event|13|||
144634779|NCT04439344|521516119|FG000|Overall Study|Death|2|||
144634780|NCT04439344|521516119|FG000|Overall Study|Disease progression|29|||
144634781|NCT04439344|521516119|FG000|Overall Study|Withdrawal by Subject|2|||
144634782|NCT04439344|521516119|FG000|Overall Study|Alternative therapy|1|||
144634783|NCT01795547|521516120|FG000|Overall Study|Adverse Event|16|||
144634784|NCT01795547|521516121|FG001|Overall Study|Adverse Event|27|||
144634785|NCT01795547|521516120|FG000|Overall Study|Lack of Efficacy|8|||
144634786|NCT01795547|521516121|FG001|Overall Study|Lack of Efficacy|3|||
144634787|NCT01795547|521516120|FG000|Overall Study|Protocol Violation|6|||
144634788|NCT01795547|521516121|FG001|Overall Study|Protocol Violation|4|||
144634789|NCT01795547|521516120|FG000|Overall Study|Lost to Follow-up|2|||
144634790|NCT01795547|521516121|FG001|Overall Study|Lost to Follow-up|5|||
144634791|NCT01795547|521516120|FG000|Overall Study|Withdrawal of consent|7|||
144634792|NCT01795547|521516121|FG001|Overall Study|Withdrawal of consent|12|||
144634793|NCT01795547|521516120|FG000|Overall Study|Not Treated|4|||
144634794|NCT01795547|521516121|FG001|Overall Study|Not Treated|10|||
144634795|NCT01795547|521516120|FG000|Overall Study|Non-compliance with IMP|1|||
144634796|NCT01795547|521516121|FG001|Overall Study|Non-compliance with IMP|1|||
144634797|NCT01795547|521516120|FG000|Overall Study|Others|4|||
144634798|NCT01795547|521516121|FG001|Overall Study|Others|1|||
144634799|NCT01795547|521516120|FG000|Overall Study|Not stated|0|||
144634800|NCT01795547|521516121|FG001|Overall Study|Not stated|1|||
144634801|NCT03437447|521516124|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144634802|NCT03437447|521516125|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144634803|NCT03437447|521516126|FG002|Treatment Period 1|Withdrawal by Subject|1|||
144634804|NCT04167345|521516129|FG000|Overall Study|Other|1|||
144634805|NCT04167345|521516130|FG001|Overall Study|Other|1|||
144210212|NCT00863772|519963697|FG001|Overall Study|Lost to Follow-up|1|||
144210213|NCT00863772|519963698|FG002|Overall Study|Lost to Follow-up|1|||
144634806|NCT04167345|521516131|FG002|Overall Study|Other|0|||
144634807|NCT04167345|521516132|FG003|Overall Study|Other|0|||
144634808|NCT04167345|521516133|FG004|Overall Study|Other|0|||
144634809|NCT04063384|521516792|FG000|Overall Study|placebo manipulation issue|1|||
144634810|NCT04063384|521516793|FG001|Overall Study|placebo manipulation issue|2|||
144634811|NCT04063384|521516794|FG002|Overall Study|placebo manipulation issue|1|||
144634812|NCT04063384|521516795|FG003|Overall Study|placebo manipulation issue|1|||
144634813|NCT04572633|521516799|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
144634814|NCT04439266|521516800|FG000|Overall Study|Ineligible|1|||
144634815|NCT04439266|521516800|FG000|Overall Study|Adverse Event|1|||
144634816|NCT04439266|521516800|FG000|Overall Study|Death|1|||
144634817|NCT04439266|521516800|FG000|Overall Study|Disease progression|1|||
144634818|NCT04439266|521516800|FG000|Overall Study|Still on treatment|1|||
144634819|NCT05052723|521516801|FG000|Overall Study|Death|19|||
144634820|NCT05540652|521516802|FG000|Overall Study|Withdrawal by Subject|1|||
144634821|NCT05424276|521516803|FG000|Overall Study|Adverse Event|1|||
144634822|NCT05424276|521516804|FG001|Overall Study|Adverse Event|0|||
144634823|NCT05424276|521516805|FG002|Overall Study|Adverse Event|0|||
144634824|NCT05424276|521516806|FG003|Overall Study|Adverse Event|2|||
144634825|NCT05424276|521516803|FG000|Overall Study|Withdrawal by Subject|0|||
144634826|NCT05424276|521516804|FG001|Overall Study|Withdrawal by Subject|0|||
144634827|NCT05424276|521516805|FG002|Overall Study|Withdrawal by Subject|2|||
144634828|NCT05424276|521516806|FG003|Overall Study|Withdrawal by Subject|0|||
144634829|NCT05424276|521516803|FG000|Overall Study|Protocol Violation|0|||
144634830|NCT05424276|521516804|FG001|Overall Study|Protocol Violation|1|||
144634831|NCT05424276|521516805|FG002|Overall Study|Protocol Violation|0|||
144634832|NCT05424276|521516806|FG003|Overall Study|Protocol Violation|0|||
144634833|NCT05424276|521516803|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
144634834|NCT05424276|521516804|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
144634835|NCT05424276|521516805|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
144634836|NCT05424276|521516806|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
144634837|NCT04373460|521516808|FG000|Overall Study|Did not receive tranfusion|18|||
144634838|NCT04373460|521516809|FG001|Overall Study|Did not receive tranfusion|26|||
144634839|NCT00151892|521516812|FG000|Overall Study|Lack of Efficacy|50|||
144634840|NCT00151892|521516813|FG001|Overall Study|Lack of Efficacy|57|||
144634841|NCT00151892|521516812|FG000|Overall Study|Patient request|10|||
144634842|NCT00151892|521516813|FG001|Overall Study|Patient request|7|||
144634843|NCT00151892|521516812|FG000|Overall Study|Lost to Follow-up|5|||
144634844|NCT00151892|521516813|FG001|Overall Study|Lost to Follow-up|10|||
144634845|NCT00151892|521516812|FG000|Overall Study|Adverse Event|6|||
144634846|NCT00151892|521516813|FG001|Overall Study|Adverse Event|3|||
144634847|NCT00151892|521516812|FG000|Overall Study|Protocol Violation|3|||
144634848|NCT00151892|521516813|FG001|Overall Study|Protocol Violation|3|||
144634849|NCT00151892|521516812|FG000|Overall Study|Non-compliance|0|||
144634850|NCT00151892|521516813|FG001|Overall Study|Non-compliance|1|||
144634851|NCT00151892|521516812|FG000|Overall Study|Pregnancy|0|||
144634852|NCT00151892|521516813|FG001|Overall Study|Pregnancy|1|||
144634853|NCT00151892|521516812|FG000|Overall Study|Did not return for a visit|1|||
144210214|NCT00863772|519963696|FG000|Overall Study|Protocol Violation|2|||
144210215|NCT00863772|519963697|FG001|Overall Study|Protocol Violation|0|||
144210216|NCT00863772|519963698|FG002|Overall Study|Protocol Violation|2|||
144210217|NCT00863772|519963696|FG000|Overall Study|Withdrawal by Subject|4|||
144210218|NCT00863772|519963697|FG001|Overall Study|Withdrawal by Subject|7|||
144210219|NCT00863772|519963698|FG002|Overall Study|Withdrawal by Subject|5|||
144634854|NCT00151892|521516813|FG001|Overall Study|Did not return for a visit|0|||
144634855|NCT00151892|521516812|FG000|Overall Study|Used prohibited corticosteroids|1|||
144634856|NCT00151892|521516813|FG001|Overall Study|Used prohibited corticosteroids|0|||
144634857|NCT00151892|521516812|FG000|Overall Study|Lack of study medication at center|0|||
144634858|NCT00151892|521516813|FG001|Overall Study|Lack of study medication at center|1|||
144634859|NCT05775289|521516817|FG000|Overall Study|Study Ongoing|20|||
144634860|NCT05775289|521516818|FG001|Overall Study|Study Ongoing|53|||
144634861|NCT05775289|521516819|FG002|Overall Study|Study Ongoing|15|||
144634862|NCT05775289|521516820|FG003|Overall Study|Study Ongoing|55|||
144634863|NCT05775289|521516817|FG000|Overall Study|Death|4|||
144634864|NCT05775289|521516818|FG001|Overall Study|Death|11|||
144634865|NCT05775289|521516819|FG002|Overall Study|Death|8|||
144634866|NCT05775289|521516820|FG003|Overall Study|Death|12|||
144634867|NCT05775289|521516817|FG000|Overall Study|Lost to Follow-up|0|||
144634868|NCT05775289|521516818|FG001|Overall Study|Lost to Follow-up|1|||
144634869|NCT05775289|521516819|FG002|Overall Study|Lost to Follow-up|0|||
144634870|NCT05775289|521516820|FG003|Overall Study|Lost to Follow-up|0|||
144634871|NCT05775289|521516817|FG000|Overall Study|Progressive Disease|0|||
144634872|NCT05775289|521516818|FG001|Overall Study|Progressive Disease|0|||
144634873|NCT05775289|521516819|FG002|Overall Study|Progressive Disease|1|||
144634874|NCT05775289|521516820|FG003|Overall Study|Progressive Disease|0|||
144634875|NCT05775289|521516817|FG000|Overall Study|Withdrawal by Subject|1|||
144634876|NCT05775289|521516818|FG001|Overall Study|Withdrawal by Subject|1|||
144634877|NCT05775289|521516819|FG002|Overall Study|Withdrawal by Subject|0|||
144634878|NCT05775289|521516820|FG003|Overall Study|Withdrawal by Subject|0|||
144634879|NCT04439331|521516821|FG000|Overall Study|Never Start Protocol Therapy|2|||
144634880|NCT04439331|521516821|FG000|Overall Study|Ineligible|2|||
144634881|NCT04439331|521516821|FG000|Overall Study|Mutation Status Not Confirmed|1|||
144634882|NCT04439331|521516821|FG000|Overall Study|Adverse Event|1|||
144634883|NCT04439331|521516821|FG000|Overall Study|Death|1|||
144634884|NCT04439331|521516821|FG000|Overall Study|Disease Progression|20|||
144634885|NCT04439331|521516821|FG000|Overall Study|Withdrawal by Subject|6|||
144634886|NCT04439331|521516821|FG000|Overall Study|Physician Decision|1|||
144634887|NCT04439331|521516821|FG000|Overall Study|Other Complicating Disease|1|||
144634888|NCT03726268|521516822|FG000|Overall Study|Physician Decision|2|||
144730918|NCT03639311|521869950|FG001|Maintenance Phase|Lost to Follow-up|0|||
144730919|NCT03639311|521869951|FG002|Maintenance Phase|Lost to Follow-up|0|||
144730920|NCT03639311|521869949|FG000|Maintenance Phase|Adverse Event|1|||
144730921|NCT03639311|521869950|FG001|Maintenance Phase|Adverse Event|0|||
144730922|NCT03639311|521869951|FG002|Maintenance Phase|Adverse Event|0|||
144730923|NCT03639311|521869949|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
144730924|NCT03639311|521869950|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
144730925|NCT03639311|521869951|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
144730926|NCT03639311|521869949|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
144730927|NCT03639311|521869950|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
144730928|NCT03639311|521869951|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
144730929|NCT03639311|521869949|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
144730930|NCT03639311|521869950|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
144730931|NCT03639311|521869951|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
144730932|NCT03639311|521869949|FG000|Maintenance Phase|Lack of Efficacy|1|||
144210220|NCT00863772|519963696|FG000|Overall Study|Study terminated by sponsor|44|||
144210221|NCT00863772|519963697|FG001|Overall Study|Study terminated by sponsor|45|||
144210222|NCT00863772|519963698|FG002|Overall Study|Study terminated by sponsor|36|||
144210223|NCT00863772|519963696|FG000|Overall Study|Entered extension study|6|||
144210224|NCT00863772|519963697|FG001|Overall Study|Entered extension study|4|||
144634889|NCT03726268|521516823|FG001|Overall Study|Physician Decision|8|||
144634890|NCT03726268|521516824|FG002|Overall Study|Physician Decision|6|||
144634891|NCT03726268|521516825|FG003|Overall Study|Physician Decision|3|||
144730933|NCT03639311|521869950|FG001|Maintenance Phase|Lack of Efficacy|0|||
144634892|NCT03726268|521516822|FG000|Overall Study|Withdrawal by Subject|11|||
144634893|NCT03726268|521516823|FG001|Overall Study|Withdrawal by Subject|5|||
144634894|NCT03726268|521516824|FG002|Overall Study|Withdrawal by Subject|9|||
144634895|NCT03726268|521516825|FG003|Overall Study|Withdrawal by Subject|8|||
144730934|NCT03639311|521869951|FG002|Maintenance Phase|Lack of Efficacy|0|||
144634896|NCT04370509|521516830|FG000|Overall Study|Adverse Event|1|||
144634897|NCT04370509|521516831|FG001|Overall Study|Adverse Event|0|||
144634898|NCT04370509|521516830|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
144634899|NCT04370509|521516831|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
144634900|NCT04743856|521516832|FG000|Overall Study|Lost to Follow-up|6|||
144634901|NCT04743856|521516833|FG001|Overall Study|Lost to Follow-up|7|||
144634902|NCT04743856|521516832|FG000|Overall Study|Withdrawal by Subject|1|||
144634903|NCT04743856|521516833|FG001|Overall Study|Withdrawal by Subject|0|||
144634904|NCT04439188|521516834|FG000|Overall Study|Ineligible|3|||
144634905|NCT04439188|521516834|FG000|Overall Study|Adverse Event|4|||
144634906|NCT04439188|521516834|FG000|Overall Study|Death|1|||
144634907|NCT04439188|521516834|FG000|Overall Study|Disease Progression|25|||
144634908|NCT04439188|521516834|FG000|Overall Study|Withdrawal by Subject|2|||
144634909|NCT01813890|521516835|FG000|Overall Study|Adverse Event|0|||
144634910|NCT01813890|521516836|FG001|Overall Study|Adverse Event|3|||
144634911|NCT01813890|521516837|FG002|Overall Study|Adverse Event|4|||
144634912|NCT01813890|521516835|FG000|Overall Study|Lack of Efficacy|9|||
144634913|NCT01813890|521516836|FG001|Overall Study|Lack of Efficacy|1|||
144634914|NCT01813890|521516837|FG002|Overall Study|Lack of Efficacy|2|||
144634915|NCT04482647|521516838|FG000|Overall Study|Time constraints|2|||
144634916|NCT04482647|521516838|FG000|Overall Study|Health issues|1|||
144634917|NCT04482647|521516838|FG000|Overall Study|Death in the family|1|||
144634918|NCT04482647|521516838|FG000|Overall Study|Disliked the intervention|1|||
144634919|NCT04482647|521516838|FG000|Overall Study|No reasons specified|7|||
144634920|NCT03498521|521516843|FG000|Overall Study|Death|227|||
144634921|NCT03498521|521516844|FG001|Overall Study|Death|79|||
144634922|NCT03498521|521516845|FG002|Overall Study|Death|84|||
144634923|NCT03498521|521516843|FG000|Overall Study|Exclusion criteria|1|||
144634924|NCT03498521|521516844|FG001|Overall Study|Exclusion criteria|0|||
144634925|NCT03498521|521516845|FG002|Overall Study|Exclusion criteria|0|||
144634926|NCT03498521|521516843|FG000|Overall Study|Lost to Follow-up|4|||
144634927|NCT03498521|521516844|FG001|Overall Study|Lost to Follow-up|3|||
144634928|NCT03498521|521516845|FG002|Overall Study|Lost to Follow-up|3|||
144634929|NCT03498521|521516843|FG000|Overall Study|No profile due to technical failure|1|||
144634930|NCT03498521|521516844|FG001|Overall Study|No profile due to technical failure|0|||
144634931|NCT03498521|521516845|FG002|Overall Study|No profile due to technical failure|0|||
144634932|NCT03498521|521516843|FG000|Overall Study|Physician Decision|3|||
144634933|NCT03498521|521516844|FG001|Overall Study|Physician Decision|1|||
144634934|NCT03498521|521516845|FG002|Overall Study|Physician Decision|0|||
144634935|NCT03498521|521516843|FG000|Overall Study|Withdrawal by Subject|11|||
144634936|NCT03498521|521516844|FG001|Overall Study|Withdrawal by Subject|6|||
144634937|NCT03498521|521516845|FG002|Overall Study|Withdrawal by Subject|2|||
144634938|NCT03498521|521516843|FG000|Overall Study|Study terminated by sponsor|79|||
144634939|NCT03498521|521516844|FG001|Overall Study|Study terminated by sponsor|21|||
144634940|NCT03498521|521516845|FG002|Overall Study|Study terminated by sponsor|4|||
144634941|NCT03896581|521517477|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
144634942|NCT03896581|521517478|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
144634943|NCT03896581|521517477|FG000|Overall Study|Withdrawal by Subject|4|||
144634944|NCT03896581|521517478|FG001|Overall Study|Withdrawal by Subject|1|||
144634945|NCT03896581|521517477|FG000|Overall Study|Lost to Follow-up|1|||
144634946|NCT03896581|521517478|FG001|Overall Study|Lost to Follow-up|0|||
144634947|NCT03896581|521517477|FG000|Overall Study|Lack of Efficacy|2|||
144634948|NCT03896581|521517478|FG001|Overall Study|Lack of Efficacy|1|||
144634949|NCT03896581|521517477|FG000|Overall Study|Adverse event, non-fatal|0|||
144634950|NCT03896581|521517478|FG001|Overall Study|Adverse event, non-fatal|2|||
144634951|NCT01445171|521517479|FG000|Overall Study|Lost to Follow-up|11|||
144634952|NCT01445171|521517479|FG000|Overall Study|Withdrawal by Subject|16|||
144634953|NCT01445171|521517479|FG000|Overall Study|Death|51|||
144634954|NCT01445171|521517479|FG000|Overall Study|Subjects declined to return for followup|9|||
144634955|NCT01445171|521517479|FG000|Overall Study|Consented but did not receive device|8|||
144634956|NCT02185521|521517483|FG000|Overall Study|Withdrawal by Subject|1|||
144634957|NCT02185521|521517483|FG000|Overall Study|Protocol Violation|1|||
144634958|NCT00398112|521517484|FG000|Overall Study|Adverse Event|4|||
144634959|NCT00398112|521517484|FG000|Overall Study|Disease progression|9|||
144634960|NCT00398112|521517484|FG000|Overall Study|Alternative treatment|1|||
144634961|NCT00398112|521517484|FG000|Overall Study|Withdrawal by Subject|3|||
144634962|NCT00398112|521517484|FG000|Overall Study|Death|1|||
144634963|NCT01887912|521517486|FG000|Overall Study|Serious adverse event|400|||
144634964|NCT01887912|521517487|FG001|Overall Study|Serious adverse event|198|||
144634965|NCT01887912|521517486|FG000|Overall Study|Other Adverse Event|34|||
144634966|NCT01887912|521517487|FG001|Overall Study|Other Adverse Event|15|||
144634967|NCT01887912|521517486|FG000|Overall Study|Protocol Violation|67|||
144634968|NCT01887912|521517487|FG001|Overall Study|Protocol Violation|37|||
144634969|NCT01887912|521517486|FG000|Overall Study|Lost to Follow-up|163|||
144634970|NCT01887912|521517487|FG001|Overall Study|Lost to Follow-up|74|||
144634971|NCT01887912|521517486|FG000|Overall Study|Withdrawal by Subject|606|||
144634972|NCT01887912|521517487|FG001|Overall Study|Withdrawal by Subject|349|||
144634973|NCT01887912|521517486|FG000|Overall Study|Other|122|||
144634974|NCT01887912|521517487|FG001|Overall Study|Other|58|||
144634975|NCT00450580|521517489|FG000|Overall Study|Adverse Event|5|||
144634976|NCT00450580|521517490|FG001|Overall Study|Adverse Event|7|||
144634977|NCT00450580|521517489|FG000|Overall Study|Lost to Follow-up|4|||
144634978|NCT00450580|521517490|FG001|Overall Study|Lost to Follow-up|5|||
144634979|NCT00450580|521517489|FG000|Overall Study|Withdrawal by Subject|2|||
144634980|NCT00450580|521517490|FG001|Overall Study|Withdrawal by Subject|2|||
144634981|NCT00450580|521517489|FG000|Overall Study|Protocol Violation|1|||
144634982|NCT00450580|521517490|FG001|Overall Study|Protocol Violation|1|||
144634983|NCT00450580|521517489|FG000|Overall Study|Protocol-defined virologic failure|1|||
144634984|NCT00450580|521517490|FG001|Overall Study|Protocol-defined virologic failure|0|||
144634985|NCT00450580|521517489|FG000|Overall Study|Could not comply with scheduled visits|1|||
144634986|NCT00450580|521517490|FG001|Overall Study|Could not comply with scheduled visits|0|||
144634987|NCT00450580|521517489|FG000|Overall Study|Patient went to Brazil|1|||
144634988|NCT00450580|521517490|FG001|Overall Study|Patient went to Brazil|0|||
144634989|NCT00450580|521517489|FG000|Overall Study|Patient could not swallow Norvir|1|||
144634990|NCT00450580|521517490|FG001|Overall Study|Patient could not swallow Norvir|0|||
144634991|NCT00450580|521517489|FG000|Overall Study|Withdrawal due to pregnancy|0|||
144634992|NCT00450580|521517490|FG001|Overall Study|Withdrawal due to pregnancy|1|||
144634993|NCT00603239|521517497|FG000|Overall Study|Adverse Event|4|||
144634994|NCT00603239|521517498|FG001|Overall Study|Adverse Event|1|||
144634995|NCT00603239|521517497|FG000|Overall Study|Entry criteria not met|0|||
144634996|NCT00603239|521517498|FG001|Overall Study|Entry criteria not met|1|||
144634997|NCT00603239|521517497|FG000|Overall Study|Loss of glucose control|3|||
144634998|NCT00603239|521517498|FG001|Overall Study|Loss of glucose control|0|||
144634999|NCT00603239|521517497|FG000|Overall Study|Lost to Follow-up|2|||
144635000|NCT00603239|521517498|FG001|Overall Study|Lost to Follow-up|1|||
144635001|NCT00603239|521517497|FG000|Overall Study|Physician Decision|2|||
144635002|NCT00603239|521517498|FG001|Overall Study|Physician Decision|0|||
144635003|NCT00603239|521517497|FG000|Overall Study|Protocol Violation|2|||
144635004|NCT00603239|521517498|FG001|Overall Study|Protocol Violation|0|||
144635005|NCT00603239|521517497|FG000|Overall Study|Subject decision|2|||
144635006|NCT00603239|521517498|FG001|Overall Study|Subject decision|1|||
144635007|NCT01562028|521517499|FG000|Overall Study|Withdrawal by Subject|1|||
144730935|NCT00822926|521869952|FG000|Second Injection Visit|Lost to Follow-up|1|||
144730936|NCT00822926|521869953|FG001|Second Injection Visit|Lost to Follow-up|0|||
144730937|NCT00822926|521869952|FG000|Second Injection Visit|Withdrawal by Subject|0|||
144730938|NCT00822926|521869953|FG001|Second Injection Visit|Withdrawal by Subject|1|||
144730939|NCT02817841|521871310|FG000|Overall Study|Lost to Follow-up|287|||
144262978|NCT00735709|520163808|FG002|Overall Study|Lack of Efficacy|2|||
144635008|NCT01562028|521517500|FG001|Overall Study|Withdrawal by Subject|1|||
144635009|NCT01562028|521517499|FG000|Overall Study|Lost to Follow-up|2|||
144635010|NCT01562028|521517500|FG001|Overall Study|Lost to Follow-up|1|||
144730940|NCT02817841|521871310|FG000|Overall Study|Withdrawal by Subject|183|||
144730941|NCT02817841|521871310|FG000|Overall Study|Adverse event not related to bleeding|131|||
144730942|NCT02817841|521871310|FG000|Overall Study|Adverse event related to bleeding|51|||
144730943|NCT02817841|521871310|FG000|Overall Study|Pregnancy|32|||
144730944|NCT02817841|521871310|FG000|Overall Study|Pregnancy wish|17|||
144730945|NCT02817841|521871310|FG000|Overall Study|Other reasons|53|||
144730946|NCT02817841|521871310|FG000|Overall Study|Protocol Violation|94|||
144730947|NCT00397488|521871311|FG000|Overall Study|Withdrawal by Subject|3|||
144730948|NCT00397488|521871311|FG000|Overall Study|Adverse Event|3|||
144730949|NCT00397488|521871311|FG000|Overall Study|Death|1|||
144730950|NCT02424097|521871314|FG000|Overall Study|Lost to Follow-up|1|||
144730951|NCT02424097|521871315|FG001|Overall Study|Lost to Follow-up|2|||
144730952|NCT01215981|521871318|FG000|Overall Study|Physician Decision|0|||
144730953|NCT01215981|521871319|FG001|Overall Study|Physician Decision|1|||
144730954|NCT01215981|521871318|FG000|Overall Study|Protocol Violation|1|||
144730955|NCT01215981|521871319|FG001|Overall Study|Protocol Violation|0|||
144730956|NCT01215981|521871318|FG000|Overall Study|Withdrawal by Subject|1|||
144730957|NCT01215981|521871319|FG001|Overall Study|Withdrawal by Subject|0|||
144730958|NCT02943447|521871320|FG000|Blinded Study Phase|Withdrew Consent|1|||
144730959|NCT02943447|521871321|FG001|Blinded Study Phase|Withdrew Consent|2|||
144730960|NCT02943447|521871322|FG002|Blinded Study Phase|Withdrew Consent|1|||
144730961|NCT02943447|521871320|FG000|Blinded Study Phase|Adverse Event|3|||
144730962|NCT02943447|521871321|FG001|Blinded Study Phase|Adverse Event|0|||
144730963|NCT02943447|521871322|FG002|Blinded Study Phase|Adverse Event|0|||
144730964|NCT02943447|521871320|FG000|Blinded Study Phase|Investigator's discretion|1|||
144730965|NCT02943447|521871321|FG001|Blinded Study Phase|Investigator's discretion|0|||
144730966|NCT02943447|521871322|FG002|Blinded Study Phase|Investigator's discretion|0|||
144730967|NCT02943447|521871320|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
144730968|NCT02943447|521871321|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
144730969|NCT02943447|521871322|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
144730970|NCT02943447|521871320|FG000|Open-Label Extension Phase|Adverse Event|4|||
144730971|NCT02943447|521871321|FG001|Open-Label Extension Phase|Adverse Event|7|||
144730972|NCT02943447|521871322|FG002|Open-Label Extension Phase|Adverse Event|3|||
144635011|NCT00391976|521517501|FG000|Overall Study|Adverse Event|0|||
144635012|NCT00391976|521517502|FG001|Overall Study|Adverse Event|0|||
144635013|NCT00391976|521517503|FG002|Overall Study|Adverse Event|1|||
144635014|NCT00391976|521517501|FG000|Overall Study|Withdrawal of consent|0|||
144635015|NCT00391976|521517502|FG001|Overall Study|Withdrawal of consent|1|||
144635016|NCT00391976|521517503|FG002|Overall Study|Withdrawal of consent|1|||
144635017|NCT00391976|521517501|FG000|Overall Study|Lost to Follow-up|1|||
144635018|NCT00391976|521517502|FG001|Overall Study|Lost to Follow-up|2|||
144635019|NCT00391976|521517503|FG002|Overall Study|Lost to Follow-up|0|||
144635020|NCT00391976|521517501|FG000|Overall Study|Inappropriate enrollment|1|||
144635021|NCT00391976|521517502|FG001|Overall Study|Inappropriate enrollment|1|||
144635022|NCT00391976|521517503|FG002|Overall Study|Inappropriate enrollment|0|||
144635023|NCT00391976|521517501|FG000|Overall Study|Protocol deviation/violation|4|||
144635024|NCT00391976|521517502|FG001|Overall Study|Protocol deviation/violation|2|||
144635025|NCT00391976|521517503|FG002|Overall Study|Protocol deviation/violation|1|||
144635026|NCT00391976|521517501|FG000|Overall Study|Recurrence/no eradication of infection|21|||
144635027|NCT00391976|521517502|FG001|Overall Study|Recurrence/no eradication of infection|19|||
144635028|NCT00391976|521517503|FG002|Overall Study|Recurrence/no eradication of infection|0|||
144635029|NCT00391976|521517501|FG000|Overall Study|Unable to classify|0|||
144635030|NCT00391976|521517502|FG001|Overall Study|Unable to classify|0|||
144635031|NCT00391976|521517503|FG002|Overall Study|Unable to classify|1|||
144635032|NCT00391976|521517501|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
144635033|NCT00391976|521517502|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
144635034|NCT00391976|521517503|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
144635035|NCT01701258|521517507|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
144635036|NCT01701258|521517508|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
144635037|NCT01701258|521517509|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
144635038|NCT01701258|521517510|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
144635039|NCT01701258|521517511|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
144635040|NCT01701258|521517512|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
144635041|NCT01701258|521517513|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
144635042|NCT01701258|521517514|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
144635043|NCT01701258|521517515|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
144635044|NCT01701258|521517516|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
144635045|NCT01701258|521517517|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
144635046|NCT01701258|521517518|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
144635047|NCT01701258|521517519|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
144635048|NCT01701258|521517507|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
144635049|NCT01701258|521517508|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
144635050|NCT01701258|521517509|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
144635051|NCT01701258|521517510|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
144635052|NCT01701258|521517511|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
144635053|NCT01701258|521517512|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
144635054|NCT01701258|521517513|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
144635055|NCT01701258|521517514|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
144635056|NCT01701258|521517515|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
144635057|NCT01701258|521517516|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
144635058|NCT01701258|521517517|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
144635059|NCT01701258|521517518|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
144635060|NCT01701258|521517519|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
144635061|NCT01701258|521517507|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
144635062|NCT01701258|521517508|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
144635063|NCT01701258|521517509|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
144635064|NCT01701258|521517510|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
144635065|NCT01701258|521517511|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
144635066|NCT01701258|521517512|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
144635067|NCT01701258|521517513|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
144635068|NCT01701258|521517514|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
144635069|NCT01701258|521517515|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
144635070|NCT01701258|521517516|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
144635071|NCT01701258|521517517|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
144635072|NCT01701258|521517518|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
144635073|NCT01701258|521517519|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
144635074|NCT01701258|521517507|FG000|Assessment and Scheduling|Investigator Terminated|2|||
144635075|NCT01701258|521517508|FG001|Assessment and Scheduling|Investigator Terminated|0|||
144635076|NCT01701258|521517509|FG002|Assessment and Scheduling|Investigator Terminated|0|||
144635077|NCT01701258|521517510|FG003|Assessment and Scheduling|Investigator Terminated|0|||
144635078|NCT01701258|521517511|FG004|Assessment and Scheduling|Investigator Terminated|0|||
144635079|NCT01701258|521517512|FG005|Assessment and Scheduling|Investigator Terminated|0|||
144635080|NCT01701258|521517513|FG006|Assessment and Scheduling|Investigator Terminated|0|||
144635081|NCT01701258|521517514|FG007|Assessment and Scheduling|Investigator Terminated|0|||
144210225|NCT00863772|519963698|FG002|Overall Study|Entered extension study|9|||
144210226|NCT00863772|519963696|FG000|Overall Study|Other|1|||
144210227|NCT00863772|519963697|FG001|Overall Study|Other|2|||
144210228|NCT00863772|519963698|FG002|Overall Study|Other|4|||
144210229|NCT00863772|519963696|FG000|Overall Study|Randomized but not Treated|1|||
144210230|NCT00863772|519963697|FG001|Overall Study|Randomized but not Treated|0|||
144635082|NCT01701258|521517515|FG008|Assessment and Scheduling|Investigator Terminated|0|||
144635083|NCT01701258|521517516|FG009|Assessment and Scheduling|Investigator Terminated|0|||
144635084|NCT01701258|521517517|FG010|Assessment and Scheduling|Investigator Terminated|0|||
144635085|NCT01701258|521517518|FG011|Assessment and Scheduling|Investigator Terminated|0|||
144635086|NCT01701258|521517519|FG012|Assessment and Scheduling|Investigator Terminated|0|||
144635087|NCT01147926|521517520|FG000|Overall Study|Subject Withdrew Consent|9|||
144635088|NCT01147926|521517521|FG001|Overall Study|Subject Withdrew Consent|10|||
144635089|NCT01147926|521517520|FG000|Overall Study|Adverse Event|7|||
144635090|NCT01147926|521517521|FG001|Overall Study|Adverse Event|6|||
144635091|NCT01147926|521517520|FG000|Overall Study|Subject Non-Compliant|5|||
144635092|NCT01147926|521517521|FG001|Overall Study|Subject Non-Compliant|4|||
144635093|NCT01147926|521517520|FG000|Overall Study|Principal investigator left hospital|1|||
144635094|NCT01147926|521517521|FG001|Overall Study|Principal investigator left hospital|3|||
144635095|NCT01147926|521517520|FG000|Overall Study|Selection criteria not met|3|||
144635096|NCT01147926|521517521|FG001|Overall Study|Selection criteria not met|1|||
144635097|NCT01147926|521517520|FG000|Overall Study|Lost to Follow-up|0|||
144635098|NCT01147926|521517521|FG001|Overall Study|Lost to Follow-up|2|||
144635099|NCT01147926|521517520|FG000|Overall Study|Sponsor's Decision|0|||
144635100|NCT01147926|521517521|FG001|Overall Study|Sponsor's Decision|1|||
144635101|NCT01147926|521517520|FG000|Overall Study|Lack of Efficacy|1|||
144635102|NCT01147926|521517521|FG001|Overall Study|Lack of Efficacy|0|||
144635103|NCT01147926|521517520|FG000|Overall Study|Too busy, no time for study|1|||
144635104|NCT01147926|521517521|FG001|Overall Study|Too busy, no time for study|0|||
144635105|NCT01147926|521517520|FG000|Overall Study|Went on holiday|0|||
144635106|NCT01147926|521517521|FG001|Overall Study|Went on holiday|1|||
144635107|NCT01147926|521517520|FG000|Overall Study|Colonoscopy result|0|||
144635108|NCT01147926|521517521|FG001|Overall Study|Colonoscopy result|1|||
144635109|NCT01670994|521517523|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
144635110|NCT01670994|521517524|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
144635111|NCT01670994|521517523|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
144635112|NCT01670994|521517524|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
144635113|NCT01670994|521517523|FG000|Overall Study|Patient experienced DLT|0|||
144635114|NCT01670994|521517524|FG001|Overall Study|Patient experienced DLT|1|||
144635115|NCT02013544|521517526|FG000|Overall Study|Adverse Event|5|||
144635116|NCT02013544|521517527|FG001|Overall Study|Adverse Event|5|||
144635117|NCT02013544|521517526|FG000|Overall Study|Lost to Follow-up|2|||
144635118|NCT02013544|521517527|FG001|Overall Study|Lost to Follow-up|3|||
144635119|NCT02013544|521517526|FG000|Overall Study|Withdrawal by Subject|2|||
144635120|NCT02013544|521517527|FG001|Overall Study|Withdrawal by Subject|8|||
144635121|NCT02013544|521517526|FG000|Overall Study|Physician Decision|0|||
144635122|NCT02013544|521517527|FG001|Overall Study|Physician Decision|1|||
144635123|NCT02013544|521517526|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
144635124|NCT02013544|521517527|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
144635125|NCT03514914|521517528|FG000|Overall Study|Death|3|||
144635126|NCT03514914|521517529|FG001|Overall Study|Death|3|||
144635127|NCT03514914|521517528|FG000|Overall Study|Lost to Follow-up|117|||
144635128|NCT03514914|521517529|FG001|Overall Study|Lost to Follow-up|89|||
144635129|NCT00891735|521517530|FG000|Overall Study|Adverse Event|2|||
144635130|NCT00891735|521517531|FG001|Overall Study|Adverse Event|0|||
144635131|NCT00891735|521517532|FG002|Overall Study|Adverse Event|2|||
144635132|NCT00891735|521517533|FG003|Overall Study|Adverse Event|0|||
144635133|NCT00891735|521517530|FG000|Overall Study|Death|8|||
144635134|NCT00891735|521517531|FG001|Overall Study|Death|5|||
144635135|NCT00891735|521517532|FG002|Overall Study|Death|4|||
144635136|NCT00891735|521517533|FG003|Overall Study|Death|5|||
144635137|NCT00891735|521517530|FG000|Overall Study|Lost to Follow-up|2|||
144635138|NCT00891735|521517531|FG001|Overall Study|Lost to Follow-up|2|||
144635139|NCT00891735|521517532|FG002|Overall Study|Lost to Follow-up|2|||
144635140|NCT00891735|521517533|FG003|Overall Study|Lost to Follow-up|2|||
144635141|NCT00891735|521517530|FG000|Overall Study|Physician's decision to withdraw patient|1|||
144635142|NCT00891735|521517531|FG001|Overall Study|Physician's decision to withdraw patient|0|||
144635143|NCT00891735|521517532|FG002|Overall Study|Physician's decision to withdraw patient|0|||
144635144|NCT00891735|521517533|FG003|Overall Study|Physician's decision to withdraw patient|0|||
144635145|NCT00891735|521517530|FG000|Overall Study|Patient's decision to withdraw|4|||
144210231|NCT00863772|519963698|FG002|Overall Study|Randomized but not Treated|0|||
144635146|NCT00891735|521517531|FG001|Overall Study|Patient's decision to withdraw|9|||
144635147|NCT00891735|521517532|FG002|Overall Study|Patient's decision to withdraw|4|||
144635148|NCT00891735|521517533|FG003|Overall Study|Patient's decision to withdraw|8|||
144635149|NCT01276288|521517535|FG000|Overall Study|Adverse Event|1|||
144635150|NCT01276288|521517536|FG001|Overall Study|Adverse Event|1|||
144635151|NCT01276288|521517537|FG002|Overall Study|Adverse Event|0|||
144635152|NCT01276288|521517538|FG003|Overall Study|Adverse Event|0|||
144635153|NCT01276288|521517535|FG000|Overall Study|not treated|1|||
144635154|NCT01276288|521517536|FG001|Overall Study|not treated|0|||
144635155|NCT01276288|521517537|FG002|Overall Study|not treated|0|||
144635156|NCT01276288|521517538|FG003|Overall Study|not treated|0|||
144635157|NCT05556616|521519573|FG000|Overall Study|Withdrawal by Subject|1|||
144635158|NCT05556616|521519574|FG001|Overall Study|Withdrawal by Subject|0|||
144635159|NCT05556616|521519575|FG002|Overall Study|Withdrawal by Subject|0|||
144635160|NCT05556616|521519576|FG003|Overall Study|Withdrawal by Subject|0|||
144635161|NCT05556616|521519577|FG004|Overall Study|Withdrawal by Subject|0|||
144635162|NCT05556616|521519578|FG005|Overall Study|Withdrawal by Subject|0|||
144635163|NCT05556616|521519579|FG006|Overall Study|Withdrawal by Subject|0|||
144635164|NCT05556616|521519573|FG000|Overall Study|Death|0|||
144635165|NCT05556616|521519574|FG001|Overall Study|Death|0|||
144635166|NCT05556616|521519575|FG002|Overall Study|Death|2|||
144635167|NCT05556616|521519576|FG003|Overall Study|Death|1|||
144635168|NCT05556616|521519577|FG004|Overall Study|Death|0|||
144635169|NCT05556616|521519578|FG005|Overall Study|Death|0|||
144635170|NCT05556616|521519579|FG006|Overall Study|Death|0|||
144635171|NCT05556616|521519573|FG000|Overall Study|Study Terminated by Sponsor|0|||
144635172|NCT05556616|521519574|FG001|Overall Study|Study Terminated by Sponsor|3|||
144635173|NCT05556616|521519575|FG002|Overall Study|Study Terminated by Sponsor|0|||
144635174|NCT05556616|521519576|FG003|Overall Study|Study Terminated by Sponsor|0|||
144635175|NCT05556616|521519577|FG004|Overall Study|Study Terminated by Sponsor|0|||
144635176|NCT05556616|521519578|FG005|Overall Study|Study Terminated by Sponsor|0|||
144635177|NCT05556616|521519579|FG006|Overall Study|Study Terminated by Sponsor|0|||
144635178|NCT00075881|521519581|FG000|Overall Study|Lack of Efficacy|18|||
144635179|NCT00075881|521519581|FG000|Overall Study|Adverse Event|7|||
144635180|NCT00075881|521519581|FG000|Overall Study|Death|1|||
144635181|NCT00075881|521519581|FG000|Overall Study|Withdrawal by Subject|2|||
144635182|NCT00075881|521519581|FG000|Overall Study|Protocol Violation|4|||
144635183|NCT00075881|521519581|FG000|Overall Study|other complicating disease|3|||
144635184|NCT00075881|521519581|FG000|Overall Study|other|4|||
144635185|NCT00075881|521519581|FG000|Overall Study|missing data|2|||
144635186|NCT00075881|521519581|FG000|Overall Study|Ineligible|1|||
144635187|NCT00075881|521519581|FG000|Overall Study|never start protocol therapy|1|||
144635188|NCT03195894|521519582|FG000|Overall Study|"An example is Started other treatment."|4|||
144635189|NCT03195894|521519583|FG001|Overall Study|"An example is Started other treatment."|5|||
144635190|NCT03195894|521519582|FG000|Overall Study|Withdrawal by Subject|15|||
144635191|NCT03195894|521519583|FG001|Overall Study|Withdrawal by Subject|4|||
144635192|NCT03195894|521519582|FG000|Overall Study|Lost to Follow-up|14|||
144635193|NCT03195894|521519583|FG001|Overall Study|Lost to Follow-up|19|||
144635194|NCT00215150|521519588|FG000|Open Label Phase|Lost to Follow-up|7|||
144635195|NCT00215150|521519588|FG000|Open Label Phase|Withdrawal by Subject|1|||
144635196|NCT00215150|521519588|FG000|Open Label Phase|Did not complete a post base visit|13|||
144635197|NCT00215150|521519588|FG000|Open Label Phase|Did not meet randomization criteria|9|||
144635198|NCT00215150|521519588|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
144635199|NCT00215150|521519588|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
144635200|NCT00215150|521519588|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
144635201|NCT02251743|521519589|FG000|Overall Study|Withdrawal by Subject|1|||
144635202|NCT02251743|521519590|FG001|Overall Study|Withdrawal by Subject|1|||
144635203|NCT01028352|521519596|FG000|Overall Study|Ineligible due to baseline average pain|5|||
144635204|NCT01028352|521519596|FG000|Overall Study|Withdrawal by Subject|1|||
144635205|NCT03124459|521519597|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
144635206|NCT03124459|521519598|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
144635207|NCT03124459|521519599|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
144635208|NCT03124459|521519600|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
144635209|NCT03124459|521519601|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
144635210|NCT03124459|521519602|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
144635211|NCT03124459|521519597|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
144635212|NCT03124459|521519598|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
144635213|NCT03124459|521519599|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
144635214|NCT03124459|521519600|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
144635215|NCT03124459|521519601|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
144635216|NCT03124459|521519602|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
144635217|NCT03124459|521519597|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
144635218|NCT03124459|521519598|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
144635219|NCT03124459|521519599|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
144635220|NCT03124459|521519600|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
144635221|NCT03124459|521519601|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
144635222|NCT03124459|521519602|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
144635223|NCT03124459|521519597|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
144635224|NCT03124459|521519598|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
144635225|NCT03124459|521519599|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
144635226|NCT03124459|521519600|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
144635227|NCT03124459|521519601|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
144635228|NCT03124459|521519602|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
144635229|NCT03124459|521519597|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
144635230|NCT03124459|521519598|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
144635231|NCT03124459|521519599|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
144635232|NCT03124459|521519600|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
144635233|NCT03124459|521519601|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
144635234|NCT03124459|521519602|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
144635235|NCT03124459|521519597|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
144635236|NCT03124459|521519598|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
144635237|NCT03124459|521519599|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
144635238|NCT03124459|521519600|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
144635239|NCT03124459|521519601|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
144635240|NCT03124459|521519602|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
144635241|NCT01903876|521519603|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
144635242|NCT01903876|521519604|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
144635243|NCT01903876|521519603|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
144635244|NCT01903876|521519604|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
144635245|NCT00278629|521519605|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
144635246|NCT02612909|521519606|FG000|Phase 2|Withdrawal by Subject|2|||
144635247|NCT02612909|521519607|FG001|Phase 2|Withdrawal by Subject|5|||
144635248|NCT02612909|521519608|FG002|Phase 2|Withdrawal by Subject|0|||
144635249|NCT02612909|521519609|FG003|Phase 2|Withdrawal by Subject|0|||
144635250|NCT02612909|521519610|FG004|Phase 2|Withdrawal by Subject|0|||
144635251|NCT02612909|521519606|FG000|Phase 2|Pregnancy|0|||
144635252|NCT02612909|521519607|FG001|Phase 2|Pregnancy|0|||
144635253|NCT02612909|521519608|FG002|Phase 2|Pregnancy|1|||
144635254|NCT02612909|521519609|FG003|Phase 2|Pregnancy|0|||
144635255|NCT02612909|521519610|FG004|Phase 2|Pregnancy|0|||
144635256|NCT02612909|521519606|FG000|Phase 3|Withdrawal by Subject|0|||
144635257|NCT02612909|521519607|FG001|Phase 3|Withdrawal by Subject|0|||
144635258|NCT02612909|521519608|FG002|Phase 3|Withdrawal by Subject|0|||
144635259|NCT02612909|521519609|FG003|Phase 3|Withdrawal by Subject|1|||
144635260|NCT02612909|521519610|FG004|Phase 3|Withdrawal by Subject|0|||
144635261|NCT00826748|521519613|FG000|Overall Study|Withdrawal by Subject|0|||
144635262|NCT00826748|521519614|FG001|Overall Study|Withdrawal by Subject|0|||
144635263|NCT00826748|521519615|FG002|Overall Study|Withdrawal by Subject|2|||
144635264|NCT00826748|521519613|FG000|Overall Study|Physician Decision|0|||
144635265|NCT00826748|521519614|FG001|Overall Study|Physician Decision|0|||
144635266|NCT00826748|521519615|FG002|Overall Study|Physician Decision|1|||
144635267|NCT00826748|521519613|FG000|Overall Study|Samples Did Not pass QC|0|||
144635268|NCT00826748|521519614|FG001|Overall Study|Samples Did Not pass QC|0|||
144635269|NCT00826748|521519615|FG002|Overall Study|Samples Did Not pass QC|1|||
144635270|NCT05224258|521519618|FG000|Overall Study|Withdrawal by Subject|1|||
144635271|NCT05224258|521519619|FG001|Overall Study|Withdrawal by Subject|1|||
144635272|NCT05224258|521519618|FG000|Overall Study|Physician Decision|1|||
144635273|NCT05224258|521519619|FG001|Overall Study|Physician Decision|1|||
144635274|NCT05224258|521519618|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144635275|NCT05224258|521519619|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144635276|NCT05224258|521519618|FG000|Overall Study|Study Product No Longer in Use|1|||
144635277|NCT05224258|521519619|FG001|Overall Study|Study Product No Longer in Use|0|||
144635278|NCT05224258|521519618|FG000|Overall Study|Adverse Event|0|||
144635279|NCT05224258|521519619|FG001|Overall Study|Adverse Event|1|||
144635280|NCT05224258|521519618|FG000|Overall Study|Protocol Deviation|0|||
144635281|NCT05224258|521519619|FG001|Overall Study|Protocol Deviation|1|||
144635282|NCT05067127|521519620|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
144635283|NCT05067127|521519621|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
144635284|NCT05067127|521519622|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
144210232|NCT00086281|519963699|FG000|Phase 1|Adverse Event|0|||
144210233|NCT00086281|519963700|FG001|Phase 1|Adverse Event|0|||
144635285|NCT05067127|521519623|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
144635286|NCT05067127|521519620|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
144635287|NCT05067127|521519621|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
144635288|NCT05067127|521519622|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
144635289|NCT05067127|521519623|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
144635290|NCT05067127|521519620|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
144210234|NCT00086281|519963701|FG002|Phase 1|Adverse Event|0|||
144210235|NCT00086281|519963702|FG003|Phase 1|Adverse Event|0|||
144210236|NCT00086281|519963703|FG004|Phase 1|Adverse Event|0|||
144210237|NCT00086281|519963704|FG005|Phase 1|Adverse Event|0|||
144635291|NCT05067127|521519621|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
144635292|NCT05067127|521519622|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
144635293|NCT05067127|521519623|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
144635294|NCT05067127|521519620|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
144635295|NCT05067127|521519621|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
144635296|NCT05067127|521519622|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
144635297|NCT05067127|521519623|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
144635298|NCT05067127|521519620|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
144635299|NCT05067127|521519621|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
144635300|NCT05067127|521519622|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
144635301|NCT05067127|521519623|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
144635302|NCT05067127|521519620|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
144635303|NCT05067127|521519621|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
144635304|NCT05067127|521519622|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
144635305|NCT05067127|521519623|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
144635306|NCT05067127|521519620|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
144635307|NCT05067127|521519621|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
144635308|NCT05067127|521519622|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
144635309|NCT05067127|521519623|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
144635310|NCT04462536|521519624|FG000|Overall Study|Withdrawal by Subject|3|||
144635311|NCT04462536|521519625|FG001|Overall Study|Withdrawal by Subject|9|||
144635312|NCT04462536|521519624|FG000|Overall Study|Lost to Follow-up|2|||
144635313|NCT04462536|521519625|FG001|Overall Study|Lost to Follow-up|4|||
144635314|NCT00824564|521519626|FG000|Overall Study|Lost to Follow-up|5|||
144635315|NCT00824564|521519627|FG001|Overall Study|Lost to Follow-up|7|||
144635316|NCT00824564|521519626|FG000|Overall Study|Withdrawal by Subject|1|||
144635317|NCT00824564|521519627|FG001|Overall Study|Withdrawal by Subject|1|||
144635318|NCT00824564|521519626|FG000|Overall Study|Other|1|||
144635319|NCT00824564|521519627|FG001|Overall Study|Other|2|||
144635320|NCT00824564|521519626|FG000|Overall Study|Randomized, but not treated|1|||
144635321|NCT00824564|521519627|FG001|Overall Study|Randomized, but not treated|0|||
144635322|NCT05817045|521519629|FG000|Overall Study|Protocol Violation|0|||
144635323|NCT05817045|521519630|FG001|Overall Study|Protocol Violation|3|||
144730973|NCT02943447|521871320|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
144730974|NCT02943447|521871321|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
144730975|NCT02943447|521871322|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
144730976|NCT02943447|521871320|FG000|Open-Label Extension Phase|Withdrew consent|1|||
144730977|NCT02943447|521871321|FG001|Open-Label Extension Phase|Withdrew consent|1|||
144210238|NCT00086281|519963705|FG006|Phase 1|Adverse Event|0|||
144210239|NCT00086281|519963706|FG007|Phase 1|Adverse Event|0|||
144210240|NCT00086281|519963707|FG008|Phase 1|Adverse Event|0|||
144210241|NCT00086281|519963708|FG009|Phase 1|Adverse Event|1|||
144210242|NCT00086281|519963709|FG010|Phase 1|Adverse Event|2|||
144210243|NCT00086281|519963710|FG011|Phase 1|Adverse Event|1|||
144210244|NCT00086281|519963711|FG012|Phase 1|Adverse Event|1|||
144210245|NCT00086281|519963712|FG013|Phase 1|Adverse Event|1|||
144210246|NCT00086281|519963713|FG014|Phase 1|Adverse Event|2|||
144210247|NCT00086281|519963699|FG000|Phase 1|Protocol Violation|0|||
144210248|NCT00086281|519963700|FG001|Phase 1|Protocol Violation|0|||
144210249|NCT00086281|519963701|FG002|Phase 1|Protocol Violation|0|||
144210250|NCT00086281|519963702|FG003|Phase 1|Protocol Violation|0|||
144210251|NCT00086281|519963703|FG004|Phase 1|Protocol Violation|0|||
144210252|NCT00086281|519963704|FG005|Phase 1|Protocol Violation|0|||
144210253|NCT00086281|519963705|FG006|Phase 1|Protocol Violation|0|||
144210254|NCT00086281|519963706|FG007|Phase 1|Protocol Violation|0|||
144210255|NCT00086281|519963707|FG008|Phase 1|Protocol Violation|0|||
144210256|NCT00086281|519963708|FG009|Phase 1|Protocol Violation|0|||
144210257|NCT00086281|519963709|FG010|Phase 1|Protocol Violation|1|||
144210258|NCT00086281|519963710|FG011|Phase 1|Protocol Violation|0|||
144210259|NCT00086281|519963711|FG012|Phase 1|Protocol Violation|0|||
144210260|NCT00086281|519963712|FG013|Phase 1|Protocol Violation|0|||
144210261|NCT00086281|519963713|FG014|Phase 1|Protocol Violation|0|||
144210262|NCT00086281|519963699|FG000|Phase 1|Serious Adverse Event|0|||
144210263|NCT00086281|519963700|FG001|Phase 1|Serious Adverse Event|0|||
144210264|NCT00086281|519963701|FG002|Phase 1|Serious Adverse Event|0|||
144210265|NCT00086281|519963702|FG003|Phase 1|Serious Adverse Event|0|||
144210266|NCT00086281|519963703|FG004|Phase 1|Serious Adverse Event|0|||
144210267|NCT00086281|519963704|FG005|Phase 1|Serious Adverse Event|0|||
144210268|NCT00086281|519963705|FG006|Phase 1|Serious Adverse Event|0|||
144210269|NCT00086281|519963706|FG007|Phase 1|Serious Adverse Event|0|||
144210270|NCT00086281|519963707|FG008|Phase 1|Serious Adverse Event|0|||
144210271|NCT00086281|519963708|FG009|Phase 1|Serious Adverse Event|0|||
144210272|NCT00086281|519963709|FG010|Phase 1|Serious Adverse Event|0|||
144210273|NCT00086281|519963710|FG011|Phase 1|Serious Adverse Event|0|||
144210274|NCT00086281|519963711|FG012|Phase 1|Serious Adverse Event|0|||
144635324|NCT05817045|521519629|FG000|Overall Study|Withdrawal by Subject|10|||
144635325|NCT05817045|521519630|FG001|Overall Study|Withdrawal by Subject|7|||
144635326|NCT05817045|521519629|FG000|Overall Study|Physician Decision|3|||
144635327|NCT05817045|521519630|FG001|Overall Study|Physician Decision|0|||
144635328|NCT05817045|521519629|FG000|Overall Study|Lost to Follow-up|0|||
144635329|NCT05817045|521519630|FG001|Overall Study|Lost to Follow-up|1|||
144635330|NCT05817045|521519629|FG000|Overall Study|Device Deficiency|1|||
144635331|NCT05817045|521519630|FG001|Overall Study|Device Deficiency|0|||
144635332|NCT05817045|521519629|FG000|Overall Study|System Error|1|||
144635333|NCT05817045|521519630|FG001|Overall Study|System Error|0|||
144635334|NCT05113940|521519631|FG000|Part A (18 Days)|Adverse Event|0|||
144635335|NCT05113940|521519632|FG001|Part A (18 Days)|Adverse Event|0|||
144635336|NCT05113940|521519633|FG002|Part A (18 Days)|Adverse Event|1|||
144635337|NCT05113940|521519634|FG003|Part A (18 Days)|Adverse Event|1|||
144635338|NCT05113940|521519635|FG004|Part A (18 Days)|Adverse Event|1|||
144635339|NCT05113940|521519636|FG005|Part A (18 Days)|Adverse Event|0|||
144635340|NCT05113940|521519637|FG006|Part A (18 Days)|Adverse Event|0|||
144635341|NCT05113940|521519638|FG007|Part A (18 Days)|Adverse Event|0|||
144635342|NCT05113940|521519639|FG008|Part A (18 Days)|Adverse Event|0|||
144635343|NCT05113940|521519640|FG009|Part A (18 Days)|Adverse Event|0|||
144635344|NCT05113940|521519641|FG010|Part A (18 Days)|Adverse Event|0|||
144635345|NCT05113940|521519642|FG011|Part A (18 Days)|Adverse Event|2|||
144635346|NCT05113940|521519643|FG012|Part A (18 Days)|Adverse Event|0|||
144635347|NCT05113940|521519644|FG013|Part A (18 Days)|Adverse Event|0|||
144210275|NCT00086281|519963712|FG013|Phase 1|Serious Adverse Event|0|||
144210276|NCT00086281|519963713|FG014|Phase 1|Serious Adverse Event|1|||
144210277|NCT00086281|519963699|FG000|Phase 2|Adverse Event|0|||
144210278|NCT00086281|519963700|FG001|Phase 2|Adverse Event|0|||
144210279|NCT00086281|519963701|FG002|Phase 2|Adverse Event|0|||
144210280|NCT00086281|519963702|FG003|Phase 2|Adverse Event|0|||
144635348|NCT05113940|521519645|FG014|Part A (18 Days)|Adverse Event|0|||
144635349|NCT05113940|521519631|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635350|NCT05113940|521519632|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635351|NCT05113940|521519633|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635352|NCT05113940|521519634|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635353|NCT05113940|521519635|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635354|NCT05113940|521519636|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635355|NCT05113940|521519637|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635356|NCT05113940|521519638|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635357|NCT05113940|521519639|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635358|NCT05113940|521519640|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635359|NCT05113940|521519641|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635360|NCT05113940|521519642|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635361|NCT05113940|521519643|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635362|NCT05113940|521519644|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
144635363|NCT05113940|521519645|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
144635364|NCT00382967|521519646|FG000|Overall Study|Protocol Violation|1|||
144635365|NCT00382967|521519647|FG001|Overall Study|Protocol Violation|1|||
144635366|NCT02542267|521519649|FG000|Overall Study|Withdrawal by Subject|10|||
144635367|NCT02542267|521519649|FG000|Overall Study|Physician Decision|6|||
144635368|NCT02542267|521519649|FG000|Overall Study|Lost to Follow-up|4|||
144635369|NCT02542267|521519649|FG000|Overall Study|Death|13|||
144635370|NCT02542267|521519649|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
144635371|NCT02542267|521519649|FG000|Overall Study|Other|9|||
144635372|NCT03049449|521519652|FG000|Overall Study|Did not receive treatment.|0|||
144635373|NCT03049449|521519653|FG001|Overall Study|Did not receive treatment.|0|||
144635374|NCT03049449|521519654|FG002|Overall Study|Did not receive treatment.|0|||
144635375|NCT03049449|521519655|FG003|Overall Study|Did not receive treatment.|0|||
144635376|NCT03049449|521519656|FG004|Overall Study|Did not receive treatment.|0|||
144635377|NCT03049449|521519657|FG005|Overall Study|Did not receive treatment.|0|||
144635378|NCT03049449|521519658|FG006|Overall Study|Did not receive treatment.|0|||
144635379|NCT03049449|521519659|FG007|Overall Study|Did not receive treatment.|0|||
144635380|NCT03049449|521519660|FG008|Overall Study|Did not receive treatment.|1|||
144635381|NCT03049449|521519661|FG009|Overall Study|Did not receive treatment.|0|||
144635382|NCT03049449|521519652|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
144635383|NCT03049449|521519653|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
144635384|NCT03049449|521519654|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
144635385|NCT03049449|521519655|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
144635386|NCT03049449|521519656|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
144635387|NCT03049449|521519657|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
144730978|NCT02943447|521871322|FG002|Open-Label Extension Phase|Withdrew consent|1|||
144210281|NCT00086281|519963703|FG004|Phase 2|Adverse Event|0|||
144635388|NCT03049449|521519658|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
144210282|NCT00086281|519963704|FG005|Phase 2|Adverse Event|0|||
144210283|NCT00086281|519963705|FG006|Phase 2|Adverse Event|0|||
144210284|NCT00086281|519963706|FG007|Phase 2|Adverse Event|0|||
144635389|NCT03049449|521519659|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
144635390|NCT03049449|521519660|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
144635391|NCT03049449|521519661|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
144635392|NCT03049449|521519652|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635393|NCT03049449|521519653|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635394|NCT03049449|521519654|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635395|NCT03049449|521519655|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635396|NCT03049449|521519656|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635397|NCT03049449|521519657|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635398|NCT03049449|521519658|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635399|NCT03049449|521519659|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
144210285|NCT00086281|519963707|FG008|Phase 2|Adverse Event|0|||
144635400|NCT03049449|521519660|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
144635401|NCT03049449|521519661|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
144635402|NCT00442598|521519662|FG000|Overall Study|Adverse Event|1|||
144635403|NCT00442598|521519663|FG001|Overall Study|Adverse Event|0|||
144635404|NCT00442598|521519664|FG002|Overall Study|Adverse Event|0|||
144635405|NCT00442598|521519662|FG000|Overall Study|Tumor progression|3|||
144635406|NCT00442598|521519663|FG001|Overall Study|Tumor progression|4|||
144635407|NCT00442598|521519664|FG002|Overall Study|Tumor progression|0|||
144635408|NCT00442598|521519662|FG000|Overall Study|Clinical deterioration|1|||
144635409|NCT00442598|521519663|FG001|Overall Study|Clinical deterioration|2|||
144635410|NCT00442598|521519664|FG002|Overall Study|Clinical deterioration|0|||
144635411|NCT00442598|521519662|FG000|Overall Study|CA125 progression|0|||
144635412|NCT00442598|521519663|FG001|Overall Study|CA125 progression|1|||
144635413|NCT00442598|521519664|FG002|Overall Study|CA125 progression|0|||
144635414|NCT00442598|521519662|FG000|Overall Study|Reduced creatinine clearance|1|||
144635415|NCT00442598|521519663|FG001|Overall Study|Reduced creatinine clearance|0|||
144635416|NCT00442598|521519664|FG002|Overall Study|Reduced creatinine clearance|0|||
144635417|NCT00442598|521519662|FG000|Overall Study|Death|0|||
144635418|NCT00442598|521519663|FG001|Overall Study|Death|1|||
144635419|NCT00442598|521519664|FG002|Overall Study|Death|0|||
144635420|NCT01193686|521519665|FG000|Overall Study|Withdrawal by Subject|4|||
144635421|NCT01193686|521519666|FG001|Overall Study|Withdrawal by Subject|1|||
144635422|NCT01193686|521519665|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
144635423|NCT01193686|521519666|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
144635424|NCT01147809|521519669|FG000|Phase I (168 Days)|Adverse Event|0|||
144635425|NCT01147809|521519670|FG001|Phase I (168 Days)|Adverse Event|0|||
144635426|NCT01147809|521519671|FG002|Phase I (168 Days)|Adverse Event|0|||
144635427|NCT01147809|521519672|FG003|Phase I (168 Days)|Adverse Event|1|||
144635428|NCT01147809|521519673|FG004|Phase I (168 Days)|Adverse Event|0|||
144635429|NCT01147809|521519674|FG005|Phase I (168 Days)|Adverse Event|0|||
144635430|NCT01147809|521519669|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
144635431|NCT01147809|521519670|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
144635432|NCT01147809|521519671|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
144635433|NCT01147809|521519672|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
144635434|NCT01147809|521519673|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
144635435|NCT01147809|521519674|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
144635436|NCT01147809|521519669|FG000|Phase I (168 Days)|Physician Decision|0|||
144635437|NCT01147809|521519670|FG001|Phase I (168 Days)|Physician Decision|1|||
144635438|NCT01147809|521519671|FG002|Phase I (168 Days)|Physician Decision|2|||
144635439|NCT01147809|521519672|FG003|Phase I (168 Days)|Physician Decision|0|||
144635440|NCT01147809|521519673|FG004|Phase I (168 Days)|Physician Decision|0|||
144210286|NCT00086281|519963708|FG009|Phase 2|Adverse Event|0|||
144210287|NCT00086281|519963709|FG010|Phase 2|Adverse Event|0|||
144210288|NCT00086281|519963710|FG011|Phase 2|Adverse Event|0|||
144210289|NCT00086281|519963711|FG012|Phase 2|Adverse Event|1|||
144210290|NCT00086281|519963712|FG013|Phase 2|Adverse Event|1|||
144210291|NCT00086281|519963713|FG014|Phase 2|Adverse Event|0|||
144210292|NCT00908310|519963716|FG000|Overall Study|Death|37|||
144210293|NCT00908310|519963716|FG000|Overall Study|Withdrawal by Subject|7|||
144210294|NCT00908310|519963716|FG000|Overall Study|Lost to Follow-up|7|||
144635441|NCT01147809|521519674|FG005|Phase I (168 Days)|Physician Decision|0|||
144635442|NCT01147809|521519669|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
144635443|NCT01147809|521519670|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
144635444|NCT01147809|521519671|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
144635445|NCT01147809|521519672|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
144210295|NCT00908310|519963716|FG000|Overall Study|Screening failure|5|||
144262979|NCT00735709|520163809|FG003|Overall Study|Lack of Efficacy|3|||
144210296|NCT00908310|519963716|FG000|Overall Study|Other reasons|4|||
144210297|NCT02071849|519963724|FG000|6-month Primary Endpoint|Did not receive device|4|||
144210298|NCT02071849|519963724|FG000|6-month Primary Endpoint|Adverse Event|1|||
144210299|NCT02071849|519963724|FG000|2-year Extended Follow-up|Adverse Event|1|||
144210300|NCT03255655|519963725|FG000|Overall Study|Lost to Follow-up|7|||
144210301|NCT03255655|519963726|FG001|Overall Study|Lost to Follow-up|4|||
144210302|NCT00315731|519963729|FG000|Overall Study|Lost to Follow-up|1|||
144210303|NCT00315731|519963729|FG000|Overall Study|Death|5|||
144210304|NCT04123561|519963734|FG000|Overall Study|Lost to Follow-up|20|||
144210305|NCT04123561|519963735|FG001|Overall Study|Lost to Follow-up|12|||
144210306|NCT04123561|519963736|FG002|Overall Study|Lost to Follow-up|5|||
144210307|NCT04123561|519963734|FG000|Overall Study|Withdrawal by Subject|9|||
144210308|NCT04123561|519963735|FG001|Overall Study|Withdrawal by Subject|7|||
144210309|NCT04123561|519963736|FG002|Overall Study|Withdrawal by Subject|9|||
144210310|NCT04123561|519963734|FG000|Overall Study|Lack of Efficacy|7|||
144210311|NCT04123561|519963735|FG001|Overall Study|Lack of Efficacy|8|||
144210312|NCT04123561|519963736|FG002|Overall Study|Lack of Efficacy|6|||
144210313|NCT04123561|519963734|FG000|Overall Study|Adverse Event|5|||
144210314|NCT04123561|519963735|FG001|Overall Study|Adverse Event|2|||
144210315|NCT04123561|519963736|FG002|Overall Study|Adverse Event|3|||
144635446|NCT01147809|521519673|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
144635447|NCT01147809|521519674|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
144635448|NCT01147809|521519669|FG000|Phase II (168 Days)|Adverse Event|0|||
144635449|NCT01147809|521519670|FG001|Phase II (168 Days)|Adverse Event|0|||
144635450|NCT01147809|521519671|FG002|Phase II (168 Days)|Adverse Event|0|||
144635451|NCT01147809|521519672|FG003|Phase II (168 Days)|Adverse Event|0|||
144635452|NCT01147809|521519673|FG004|Phase II (168 Days)|Adverse Event|3|||
144635453|NCT01147809|521519674|FG005|Phase II (168 Days)|Adverse Event|6|||
144635454|NCT01147809|521519669|FG000|Phase II (168 Days)|Protocol Violation|0|||
144635455|NCT01147809|521519670|FG001|Phase II (168 Days)|Protocol Violation|0|||
144635456|NCT01147809|521519671|FG002|Phase II (168 Days)|Protocol Violation|0|||
144635457|NCT01147809|521519672|FG003|Phase II (168 Days)|Protocol Violation|0|||
144635458|NCT01147809|521519673|FG004|Phase II (168 Days)|Protocol Violation|0|||
144635459|NCT01147809|521519674|FG005|Phase II (168 Days)|Protocol Violation|1|||
144635460|NCT01147809|521519669|FG000|Phase II (168 Days)|Physician Decision|0|||
144635461|NCT01147809|521519670|FG001|Phase II (168 Days)|Physician Decision|0|||
144635462|NCT01147809|521519671|FG002|Phase II (168 Days)|Physician Decision|0|||
144635463|NCT01147809|521519672|FG003|Phase II (168 Days)|Physician Decision|0|||
144635464|NCT01147809|521519673|FG004|Phase II (168 Days)|Physician Decision|5|||
144635465|NCT01147809|521519674|FG005|Phase II (168 Days)|Physician Decision|11|||
144635466|NCT01147809|521519669|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
144635467|NCT01147809|521519670|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
144635468|NCT01147809|521519671|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
144635469|NCT01147809|521519672|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
144635470|NCT01147809|521519673|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
144635471|NCT01147809|521519674|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
144635472|NCT01147809|521519669|FG000|Phase II (168 Days)|Ongoing|0|||
144635473|NCT01147809|521519670|FG001|Phase II (168 Days)|Ongoing|0|||
144635474|NCT01147809|521519671|FG002|Phase II (168 Days)|Ongoing|0|||
144635475|NCT01147809|521519672|FG003|Phase II (168 Days)|Ongoing|0|||
144210316|NCT04123561|519963734|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
144210317|NCT04123561|519963735|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
144210318|NCT04123561|519963736|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
144210319|NCT04123561|519963734|FG000|Overall Study|Death|0|||
144210320|NCT04123561|519963735|FG001|Overall Study|Death|0|||
144210321|NCT04123561|519963736|FG002|Overall Study|Death|1|||
144210322|NCT04123561|519963734|FG000|Overall Study|Protocol Violation|0|||
144210323|NCT04123561|519963735|FG001|Overall Study|Protocol Violation|1|||
144210324|NCT04123561|519963736|FG002|Overall Study|Protocol Violation|0|||
144210325|NCT02542605|519963744|FG000|Part B: Challenge Phase|Sponsor decision|1|||
144210326|NCT02542605|519963745|FG001|Part B: Challenge Phase|Sponsor decision|0|||
144210327|NCT02542605|519963746|FG002|Part B: Challenge Phase|Sponsor decision|0|||
144635476|NCT01147809|521519673|FG004|Phase II (168 Days)|Ongoing|1|||
144635477|NCT01147809|521519674|FG005|Phase II (168 Days)|Ongoing|0|||
144635478|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
144635479|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
144635480|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
144635481|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144635482|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144210328|NCT02542605|519963744|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
144210329|NCT02542605|519963745|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
144210330|NCT02542605|519963746|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
144210331|NCT03132155|519965204|FG000|Overall Study|Lack of Efficacy|6|||
144210332|NCT03132155|519965204|FG000|Overall Study|Lost to Follow-up|1|||
144635483|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144635484|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144635485|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144210333|NCT03132155|519965204|FG000|Overall Study|Withdrawal by Subject|1|||
144210334|NCT03092219|519965205|FG000|Overall Study|Protocol Violation|7|||
144210335|NCT03092219|519965206|FG001|Overall Study|Protocol Violation|4|||
144210336|NCT05013008|519965207|FG000|Overall Study|Exclusion from mBFAS|5|||
144210337|NCT05013008|519965208|FG001|Overall Study|Exclusion from mBFAS|25|||
144210338|NCT01443728|519965209|FG000|Overall Study|Lost to Follow-up|2|||
144210339|NCT01443728|519965210|FG001|Overall Study|Lost to Follow-up|0|||
144210340|NCT01443728|519965209|FG000|Overall Study|Withdrawal by Subject|1|||
144210341|NCT01443728|519965210|FG001|Overall Study|Withdrawal by Subject|1|||
144210342|NCT01443728|519965209|FG000|Overall Study|Adverse Event|0|||
144210343|NCT01443728|519965210|FG001|Overall Study|Adverse Event|2|||
144210344|NCT02242045|519965211|FG000|Overall Study|Investigator's Discretion|1|||
144210345|NCT02242045|519965211|FG000|Overall Study|Progressive Disease|2|||
144210346|NCT02242045|519965211|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
144210347|NCT02242045|519965211|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
144635486|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
144635487|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
144635488|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
144635489|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
144635490|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144635491|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144635492|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144635493|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144635494|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144635495|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
144635496|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
144635497|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
144635498|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
144635499|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144635500|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144635501|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144635502|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144635503|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144635504|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
144635505|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635506|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635507|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
144635508|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635509|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635510|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635511|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635512|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635513|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
144635514|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
144635515|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
144635516|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
144635517|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144635518|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144635519|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144635520|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144635521|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144635522|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144635523|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
144635524|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635525|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635526|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635527|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635528|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635529|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635530|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635531|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
144635532|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
144635533|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
144210348|NCT03760185|519965212|FG000|Overall Study|Lost to Follow-up|1|||
144210349|NCT03760185|519965213|FG001|Overall Study|Lost to Follow-up|1|||
144210350|NCT00976911|519965214|FG000|Overall Study|Withdrawal by Subject|4|||
144262980|NCT00735709|520163806|FG000|Overall Study|Noncompliance|0|||
144635534|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635535|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635536|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635537|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635538|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635539|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635540|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
144635541|NCT01307423|521519675|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635542|NCT01307423|521519676|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
144635543|NCT01307423|521519677|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
144635544|NCT01307423|521519678|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635545|NCT01307423|521519679|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635546|NCT01307423|521519680|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635547|NCT01307423|521519681|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635548|NCT01307423|521519682|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635549|NCT01307423|521519683|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
144635550|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
144635551|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
144635552|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
144635553|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
144635554|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
144635555|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
144635556|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
144635557|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
144635558|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
144635559|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
144635560|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
144635561|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
144635562|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
144635563|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
144635564|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
144635565|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
144635566|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
144635567|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
144635568|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635569|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635570|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635571|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635572|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635573|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
144635574|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635575|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635576|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
144635577|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
144635578|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
144635579|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
144635580|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
144635581|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
144635582|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
144635583|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
144635584|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
144635585|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
144635586|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635587|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635588|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635589|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
144730979|NCT02943447|521871320|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
144730980|NCT02943447|521871321|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
144210351|NCT00976911|519965215|FG001|Overall Study|Withdrawal by Subject|6|||
144635590|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635591|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144730981|NCT02943447|521871322|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
144730982|NCT00840632|521871324|FG000|First Intervention|Withdrawal by Subject|0|||
144730983|NCT00840632|521871325|FG001|First Intervention|Withdrawal by Subject|1|||
144210352|NCT00976911|519965214|FG000|Overall Study|Death|138|||
144210353|NCT00976911|519965215|FG001|Overall Study|Death|126|||
144210354|NCT00976911|519965214|FG000|Overall Study|Adverse Event|0|||
144210355|NCT00976911|519965215|FG001|Overall Study|Adverse Event|1|||
144210356|NCT00976911|519965214|FG000|Overall Study|Protocol Violation|2|||
144210357|NCT00976911|519965215|FG001|Overall Study|Protocol Violation|0|||
144210358|NCT00976911|519965214|FG000|Overall Study|Other|8|||
144210359|NCT00976911|519965215|FG001|Overall Study|Other|9|||
144210360|NCT00976911|519965214|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
144210361|NCT00976911|519965215|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
144210362|NCT01191944|519965216|FG000|Overall Study|Adverse Event|11|||
144210363|NCT01191944|519965217|FG001|Overall Study|Adverse Event|12|||
144210364|NCT01191944|519965216|FG000|Overall Study|Protocol Violation|1|||
144210365|NCT01191944|519965217|FG001|Overall Study|Protocol Violation|2|||
144210366|NCT01191944|519965216|FG000|Overall Study|Withdrawal by Subject|4|||
144210367|NCT01191944|519965217|FG001|Overall Study|Withdrawal by Subject|2|||
144210368|NCT01191944|519965216|FG000|Overall Study|Other|1|||
144210369|NCT01191944|519965217|FG001|Overall Study|Other|3|||
144210370|NCT02954991|519965220|FG000|Overall Study|Death|92|||
144730984|NCT00840632|521871324|FG000|Washout|Withdrawal by Subject|1|||
144730985|NCT00840632|521871325|FG001|Washout|Withdrawal by Subject|1|||
144210371|NCT02954991|519965221|FG001|Overall Study|Death|11|||
144210372|NCT02954991|519965222|FG002|Overall Study|Death|2|||
144210373|NCT02954991|519965220|FG000|Overall Study|Lost to Follow-up|3|||
144635592|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635593|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635594|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
144635595|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
144635596|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
144635597|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
144635598|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
144635599|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
144635600|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
144635601|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
144635602|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
144635603|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
144635604|NCT01307423|521519675|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635605|NCT01307423|521519676|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635606|NCT01307423|521519677|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635607|NCT01307423|521519678|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635608|NCT01307423|521519679|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635609|NCT01307423|521519680|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
144635610|NCT01307423|521519681|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635611|NCT01307423|521519682|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635612|NCT01307423|521519683|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
144635613|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144635614|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
144635615|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
144635616|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144635617|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144635618|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144635619|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
144635620|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
144635621|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
144635622|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144635623|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
144635624|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
144635625|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144635626|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144635627|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144635628|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
144635629|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
144635630|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
144635631|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635632|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635633|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
144635634|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144210374|NCT02954991|519965221|FG001|Overall Study|Lost to Follow-up|2|||
144210375|NCT02954991|519965222|FG002|Overall Study|Lost to Follow-up|0|||
144210376|NCT02954991|519965220|FG000|Overall Study|Withdrawal by Subject|9|||
144210377|NCT02954991|519965221|FG001|Overall Study|Withdrawal by Subject|8|||
144210378|NCT02954991|519965222|FG002|Overall Study|Withdrawal by Subject|1|||
144210379|NCT02954991|519965220|FG000|Overall Study|Study Terminated by Sponsor|18|||
144210380|NCT02954991|519965221|FG001|Overall Study|Study Terminated by Sponsor|10|||
144210381|NCT02954991|519965222|FG002|Overall Study|Study Terminated by Sponsor|1|||
144210382|NCT02954991|519965220|FG000|Overall Study|Miscellaneous|2|||
144210383|NCT02954991|519965221|FG001|Overall Study|Miscellaneous|1|||
144210384|NCT02954991|519965222|FG002|Overall Study|Miscellaneous|1|||
144210385|NCT04602546|519965225|FG000|Overall Study|Training|2|||
144210386|NCT04602546|519965226|FG001|Overall Study|Training|2|||
144210387|NCT04602546|519965227|FG002|Overall Study|Training|1|||
144210388|NCT04602546|519965228|FG003|Overall Study|Training|2|||
144210389|NCT04602546|519965229|FG004|Overall Study|Training|0|||
144210390|NCT04602546|519965225|FG000|Overall Study|Randomized with disqualified data|2|||
144210391|NCT04602546|519965226|FG001|Overall Study|Randomized with disqualified data|0|||
144210392|NCT04602546|519965227|FG002|Overall Study|Randomized with disqualified data|2|||
144210393|NCT04602546|519965228|FG003|Overall Study|Randomized with disqualified data|5|||
144210394|NCT04602546|519965229|FG004|Overall Study|Randomized with disqualified data|3|||
144210395|NCT01275729|519965230|FG000|Overall Study|Death|3|||
144210396|NCT01275729|519965230|FG000|Overall Study|Withdrawal by Subject|1|||
144210397|NCT02252406|519965231|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
144210398|NCT02252406|519965232|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
144210399|NCT02252406|519965231|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
144210400|NCT02252406|519965232|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
144210401|NCT02252406|519965231|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
144210402|NCT02252406|519965232|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
144210403|NCT02252406|519965231|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
144210404|NCT02252406|519965232|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
144210405|NCT02252406|519965231|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
144210406|NCT02252406|519965232|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
144210407|NCT00005957|519965235|FG000|Overall Study|No treated|3|||
144210408|NCT00005957|519965236|FG001|Overall Study|No treated|9|||
144210409|NCT00005957|519965235|FG000|Overall Study|Crossover to the other arm|5|||
144635635|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635636|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635637|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635638|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635639|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
144635640|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144635641|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
144635642|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
144635643|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144635644|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144635645|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144635646|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
144635647|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
144635648|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
144635649|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144635650|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
144635651|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144635652|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144635653|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144635654|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144635655|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
144635656|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
144635657|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
144635658|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144635659|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
144635660|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
144635661|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144635662|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144635663|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144635664|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
144635665|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
144635666|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
144635667|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144635668|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
144635669|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
144635670|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144635671|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144730986|NCT01725529|521871332|FG000|Overall Study|Adverse Event|1|||
144210410|NCT00005957|519965236|FG001|Overall Study|Crossover to the other arm|19|||
144210411|NCT01174043|519965237|FG000|Overall Study|Disease progression|5|||
144210412|NCT01174043|519965237|FG000|Overall Study|Adverse Event|3|||
144210413|NCT01174043|519965237|FG000|Overall Study|Death|1|||
144210414|NCT01174043|519965237|FG000|Overall Study|Withdrawal by Subject|2|||
144210415|NCT02047734|519965238|FG000|Overall Study|Adverse Event|18|||
144210416|NCT02047734|519965239|FG001|Overall Study|Adverse Event|13|||
144210417|NCT02047734|519965240|FG002|Overall Study|Adverse Event|13|||
144210418|NCT02047734|519965238|FG000|Overall Study|Lack of Efficacy|4|||
144210419|NCT02047734|519965239|FG001|Overall Study|Lack of Efficacy|5|||
144635672|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144635673|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
144635674|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
144635675|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
144635676|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635677|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
144635678|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
144635679|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635680|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635681|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635682|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635683|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635684|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
144635685|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144635686|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
144635687|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
144635688|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144635689|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144635690|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144635691|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
144635692|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
144635693|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
144635694|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144635695|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
144635696|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
144635697|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144635698|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144635699|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144635700|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
144635701|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
144262981|NCT00735709|520163807|FG001|Overall Study|Noncompliance|0|||
144262982|NCT00735709|520163808|FG002|Overall Study|Noncompliance|1|||
144262983|NCT00735709|520163809|FG003|Overall Study|Noncompliance|0|||
144262984|NCT00735709|520163806|FG000|Overall Study|Protocol deviations|1|||
144262985|NCT00735709|520163807|FG001|Overall Study|Protocol deviations|2|||
144262986|NCT00735709|520163808|FG002|Overall Study|Protocol deviations|1|||
144210420|NCT02047734|519965240|FG002|Overall Study|Lack of Efficacy|1|||
144210421|NCT02047734|519965238|FG000|Overall Study|Protocol Violation|3|||
144262987|NCT00735709|520163809|FG003|Overall Study|Protocol deviations|1|||
144262988|NCT00735709|520163806|FG000|Overall Study|Voluntary Withdrawal|1|||
144262989|NCT00735709|520163807|FG001|Overall Study|Voluntary Withdrawal|3|||
144262990|NCT00735709|520163808|FG002|Overall Study|Voluntary Withdrawal|5|||
144635702|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
144635703|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635704|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
144635705|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635706|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635707|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635708|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635709|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635710|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
144635711|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
144635712|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635713|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
144635714|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635715|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635716|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635717|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635718|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635719|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635720|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
144635721|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635722|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
144210422|NCT02047734|519965239|FG001|Overall Study|Protocol Violation|1|||
144635723|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635724|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635725|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635726|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635727|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635728|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
144635729|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
144635730|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144635731|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
144635732|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
144635733|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144635734|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144635735|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144635736|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
144635737|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
144635738|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
144635739|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635740|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635741|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
144635742|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635743|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144210423|NCT02047734|519965240|FG002|Overall Study|Protocol Violation|1|||
144635744|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635745|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635746|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635747|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
144635748|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635749|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635750|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635751|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635752|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635753|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635754|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635755|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
144635756|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
144635757|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144635758|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
144635759|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
144635760|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144635761|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144635762|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144635763|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144635764|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
144635765|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
144635766|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635767|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
144635768|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
144635769|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635770|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635771|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635772|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635773|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635774|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
144635775|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144635776|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
144635777|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
144635778|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144635779|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144635780|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144635781|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144635782|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
144635783|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
144635784|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635785|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
144635786|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635787|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635788|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635789|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635790|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635791|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635792|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
144635793|NCT01307423|521519675|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144635794|NCT01307423|521519676|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144635795|NCT01307423|521519677|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
144635796|NCT01307423|521519678|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144635797|NCT01307423|521519679|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144635798|NCT01307423|521519680|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144635799|NCT01307423|521519681|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
144635800|NCT01307423|521519682|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
144635801|NCT01307423|521519683|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
144635802|NCT03406962|521519684|FG000|Overall Study|Death|2|||
144635803|NCT03406962|521519684|FG000|Overall Study|Adverse Event|1|||
144635804|NCT00454207|521519685|FG000|Overall Study|Adverse Event|3|||
144635805|NCT00454207|521519686|FG001|Overall Study|Adverse Event|1|||
144635806|NCT00454207|521519685|FG000|Overall Study|Lack of Efficacy|1|||
144635807|NCT00454207|521519686|FG001|Overall Study|Lack of Efficacy|0|||
144635808|NCT00454207|521519685|FG000|Overall Study|Protocol Violation|0|||
144635809|NCT00454207|521519686|FG001|Overall Study|Protocol Violation|1|||
144635810|NCT01672957|521519687|FG000|Overall Study|Protocol Violation|48|||
144635811|NCT01672957|521519687|FG000|Overall Study|Death|2|||
144635812|NCT01672957|521519687|FG000|Overall Study|ICF Signed After Transplantation|5|||
144635813|NCT00700804|521519688|FG000|Overall Study|Withdrawal by Subject|1|||
144635814|NCT00700804|521519689|FG001|Overall Study|Withdrawal by Subject|2|||
144635815|NCT00700804|521519688|FG000|Overall Study|Protocol Violation|1|||
144635816|NCT00700804|521519689|FG001|Overall Study|Protocol Violation|1|||
144635817|NCT00700804|521519688|FG000|Overall Study|Loose Stools|1|||
144635818|NCT00700804|521519689|FG001|Overall Study|Loose Stools|1|||
144210424|NCT02047734|519965238|FG000|Overall Study|Lost to Follow-up|1|||
144210425|NCT02047734|519965239|FG001|Overall Study|Lost to Follow-up|4|||
144210426|NCT02047734|519965240|FG002|Overall Study|Lost to Follow-up|0|||
144635819|NCT02901431|521519690|FG000|PK Part|Adverse Event|0|||
144635820|NCT02901431|521519691|FG001|PK Part|Adverse Event|1|||
144635821|NCT02901431|521519692|FG002|PK Part|Adverse Event|0|||
144635822|NCT02901431|521519693|FG003|PK Part|Adverse Event|0|||
144635823|NCT02901431|521519694|FG004|PK Part|Adverse Event|0|||
144635824|NCT02901431|521519695|FG005|PK Part|Adverse Event|0|||
144635825|NCT02901431|521519696|FG006|PK Part|Adverse Event|0|||
144635826|NCT02901431|521519697|FG007|PK Part|Adverse Event|0|||
144635827|NCT02901431|521519698|FG008|PK Part|Adverse Event|0|||
144635828|NCT02901431|521519699|FG009|PK Part|Adverse Event|0|||
144635829|NCT02901431|521519700|FG010|PK Part|Adverse Event|0|||
144635830|NCT02901431|521519701|FG011|PK Part|Adverse Event|0|||
144635831|NCT02901431|521519702|FG012|PK Part|Adverse Event|0|||
144635832|NCT02901431|521519690|FG000|PK Part|Lost to Follow-up|0|||
144635833|NCT02901431|521519691|FG001|PK Part|Lost to Follow-up|0|||
144635834|NCT02901431|521519692|FG002|PK Part|Lost to Follow-up|1|||
144635835|NCT02901431|521519693|FG003|PK Part|Lost to Follow-up|0|||
144635836|NCT02901431|521519694|FG004|PK Part|Lost to Follow-up|0|||
144635837|NCT02901431|521519695|FG005|PK Part|Lost to Follow-up|0|||
144635838|NCT02901431|521519696|FG006|PK Part|Lost to Follow-up|0|||
144635839|NCT02901431|521519697|FG007|PK Part|Lost to Follow-up|0|||
144635840|NCT02901431|521519698|FG008|PK Part|Lost to Follow-up|0|||
144635841|NCT02901431|521519699|FG009|PK Part|Lost to Follow-up|0|||
144635842|NCT02901431|521519700|FG010|PK Part|Lost to Follow-up|0|||
144635843|NCT02901431|521519701|FG011|PK Part|Lost to Follow-up|0|||
144635844|NCT02901431|521519702|FG012|PK Part|Lost to Follow-up|0|||
144635845|NCT02901431|521519690|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
144635846|NCT02901431|521519691|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635847|NCT02901431|521519692|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635848|NCT02901431|521519693|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635849|NCT02901431|521519694|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635850|NCT02901431|521519695|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144210427|NCT02047734|519965238|FG000|Overall Study|Death|0|||
144210428|NCT02047734|519965239|FG001|Overall Study|Death|1|||
144210429|NCT02047734|519965240|FG002|Overall Study|Death|0|||
144210430|NCT02047734|519965238|FG000|Overall Study|Withdrawal by Subject|30|||
144635851|NCT02901431|521519696|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635852|NCT02901431|521519697|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635853|NCT02901431|521519698|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635854|NCT02901431|521519699|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635855|NCT02901431|521519700|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635856|NCT02901431|521519701|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635857|NCT02901431|521519702|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
144635858|NCT02901431|521519690|FG000|PK Part|Pending dose confirmation|0|||
144635859|NCT02901431|521519691|FG001|PK Part|Pending dose confirmation|1|||
144635860|NCT02901431|521519692|FG002|PK Part|Pending dose confirmation|0|||
144635861|NCT02901431|521519693|FG003|PK Part|Pending dose confirmation|0|||
144635862|NCT02901431|521519694|FG004|PK Part|Pending dose confirmation|0|||
144635863|NCT02901431|521519695|FG005|PK Part|Pending dose confirmation|0|||
144635864|NCT02901431|521519696|FG006|PK Part|Pending dose confirmation|0|||
144635865|NCT02901431|521519697|FG007|PK Part|Pending dose confirmation|0|||
144635866|NCT02901431|521519698|FG008|PK Part|Pending dose confirmation|0|||
144635867|NCT02901431|521519699|FG009|PK Part|Pending dose confirmation|0|||
144635868|NCT02901431|521519700|FG010|PK Part|Pending dose confirmation|0|||
144635869|NCT02901431|521519701|FG011|PK Part|Pending dose confirmation|0|||
144635870|NCT02901431|521519702|FG012|PK Part|Pending dose confirmation|0|||
144635871|NCT02901431|521519690|FG000|PK Part|8 weeks of treatment ran out|2|||
144635872|NCT02901431|521519691|FG001|PK Part|8 weeks of treatment ran out|0|||
144635873|NCT02901431|521519692|FG002|PK Part|8 weeks of treatment ran out|0|||
144635874|NCT02901431|521519693|FG003|PK Part|8 weeks of treatment ran out|0|||
144635875|NCT02901431|521519694|FG004|PK Part|8 weeks of treatment ran out|0|||
144635876|NCT02901431|521519695|FG005|PK Part|8 weeks of treatment ran out|0|||
144635877|NCT02901431|521519696|FG006|PK Part|8 weeks of treatment ran out|0|||
144635878|NCT02901431|521519697|FG007|PK Part|8 weeks of treatment ran out|0|||
144635879|NCT02901431|521519698|FG008|PK Part|8 weeks of treatment ran out|0|||
144635880|NCT02901431|521519699|FG009|PK Part|8 weeks of treatment ran out|0|||
144635881|NCT02901431|521519700|FG010|PK Part|8 weeks of treatment ran out|0|||
144635882|NCT02901431|521519701|FG011|PK Part|8 weeks of treatment ran out|0|||
144635883|NCT02901431|521519702|FG012|PK Part|8 weeks of treatment ran out|0|||
144635884|NCT02901431|521519690|FG000|PK Part|Stopped treatment after 8 weeks|1|||
144635885|NCT02901431|521519691|FG001|PK Part|Stopped treatment after 8 weeks|0|||
144635886|NCT02901431|521519692|FG002|PK Part|Stopped treatment after 8 weeks|1|||
144635887|NCT02901431|521519693|FG003|PK Part|Stopped treatment after 8 weeks|0|||
144635888|NCT02901431|521519694|FG004|PK Part|Stopped treatment after 8 weeks|0|||
144635889|NCT02901431|521519695|FG005|PK Part|Stopped treatment after 8 weeks|0|||
144635890|NCT02901431|521519696|FG006|PK Part|Stopped treatment after 8 weeks|0|||
144635891|NCT02901431|521519697|FG007|PK Part|Stopped treatment after 8 weeks|0|||
144635892|NCT02901431|521519698|FG008|PK Part|Stopped treatment after 8 weeks|0|||
144635893|NCT02901431|521519699|FG009|PK Part|Stopped treatment after 8 weeks|0|||
144635894|NCT02901431|521519700|FG010|PK Part|Stopped treatment after 8 weeks|0|||
144635895|NCT02901431|521519701|FG011|PK Part|Stopped treatment after 8 weeks|0|||
144635896|NCT02901431|521519702|FG012|PK Part|Stopped treatment after 8 weeks|0|||
144635897|NCT02901431|521519690|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
144635898|NCT02901431|521519691|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635899|NCT02901431|521519692|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
144635900|NCT02901431|521519693|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635901|NCT02901431|521519694|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635902|NCT02901431|521519695|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635903|NCT02901431|521519696|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635904|NCT02901431|521519697|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635905|NCT02901431|521519698|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635906|NCT02901431|521519699|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635907|NCT02901431|521519700|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635908|NCT02901431|521519701|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635909|NCT02901431|521519702|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
144635910|NCT02901431|521519690|FG000|PK Part|Discontinued per Sponsor|0|||
144635911|NCT02901431|521519691|FG001|PK Part|Discontinued per Sponsor|3|||
144635912|NCT02901431|521519692|FG002|PK Part|Discontinued per Sponsor|0|||
144635913|NCT02901431|521519693|FG003|PK Part|Discontinued per Sponsor|0|||
144635914|NCT02901431|521519694|FG004|PK Part|Discontinued per Sponsor|0|||
144635915|NCT02901431|521519695|FG005|PK Part|Discontinued per Sponsor|0|||
144635916|NCT02901431|521519696|FG006|PK Part|Discontinued per Sponsor|0|||
144635917|NCT02901431|521519697|FG007|PK Part|Discontinued per Sponsor|0|||
144635918|NCT02901431|521519698|FG008|PK Part|Discontinued per Sponsor|0|||
144635919|NCT02901431|521519699|FG009|PK Part|Discontinued per Sponsor|0|||
144635920|NCT02901431|521519700|FG010|PK Part|Discontinued per Sponsor|0|||
144635921|NCT02901431|521519701|FG011|PK Part|Discontinued per Sponsor|0|||
144635922|NCT02901431|521519702|FG012|PK Part|Discontinued per Sponsor|0|||
144635923|NCT02901431|521519690|FG000|PK Part|Withdrawal by Subject|1|||
144635924|NCT02901431|521519691|FG001|PK Part|Withdrawal by Subject|1|||
144635925|NCT02901431|521519692|FG002|PK Part|Withdrawal by Subject|3|||
144635926|NCT02901431|521519693|FG003|PK Part|Withdrawal by Subject|0|||
144635927|NCT02901431|521519694|FG004|PK Part|Withdrawal by Subject|0|||
144635928|NCT02901431|521519695|FG005|PK Part|Withdrawal by Subject|0|||
144635929|NCT02901431|521519696|FG006|PK Part|Withdrawal by Subject|0|||
144635930|NCT02901431|521519697|FG007|PK Part|Withdrawal by Subject|0|||
144635931|NCT02901431|521519698|FG008|PK Part|Withdrawal by Subject|0|||
144210431|NCT02047734|519965239|FG001|Overall Study|Withdrawal by Subject|31|||
144635932|NCT02901431|521519699|FG009|PK Part|Withdrawal by Subject|0|||
144635933|NCT02901431|521519700|FG010|PK Part|Withdrawal by Subject|0|||
144635934|NCT02901431|521519701|FG011|PK Part|Withdrawal by Subject|0|||
144635935|NCT02901431|521519702|FG012|PK Part|Withdrawal by Subject|0|||
144635936|NCT02901431|521519690|FG000|Main Treatment Part|Adverse Event|0|||
144635937|NCT02901431|521519691|FG001|Main Treatment Part|Adverse Event|0|||
144210432|NCT02047734|519965240|FG002|Overall Study|Withdrawal by Subject|19|||
144210433|NCT02047734|519965238|FG000|Overall Study|Physician Decision|7|||
144210434|NCT02047734|519965239|FG001|Overall Study|Physician Decision|6|||
144210435|NCT02047734|519965240|FG002|Overall Study|Physician Decision|5|||
144210436|NCT02047734|519965238|FG000|Overall Study|Miscellaneous|2|||
144210437|NCT02047734|519965239|FG001|Overall Study|Miscellaneous|4|||
144210438|NCT02047734|519965240|FG002|Overall Study|Miscellaneous|6|||
144210439|NCT02047734|519965238|FG000|Overall Study|Did Not Receive Study Drug|2|||
144210440|NCT02047734|519965239|FG001|Overall Study|Did Not Receive Study Drug|4|||
144210441|NCT02047734|519965240|FG002|Overall Study|Did Not Receive Study Drug|1|||
144210442|NCT01721317|519965246|FG000|Overall Study|Study Closed / Terminated|2|||
144635938|NCT02901431|521519692|FG002|Main Treatment Part|Adverse Event|0|||
144635939|NCT02901431|521519693|FG003|Main Treatment Part|Adverse Event|3|||
144635940|NCT02901431|521519694|FG004|Main Treatment Part|Adverse Event|3|||
144635941|NCT02901431|521519695|FG005|Main Treatment Part|Adverse Event|4|||
144635942|NCT02901431|521519696|FG006|Main Treatment Part|Adverse Event|1|||
144635943|NCT02901431|521519697|FG007|Main Treatment Part|Adverse Event|0|||
144635944|NCT02901431|521519698|FG008|Main Treatment Part|Adverse Event|0|||
144635945|NCT02901431|521519699|FG009|Main Treatment Part|Adverse Event|0|||
144635946|NCT02901431|521519700|FG010|Main Treatment Part|Adverse Event|0|||
144635947|NCT02901431|521519701|FG011|Main Treatment Part|Adverse Event|0|||
144635948|NCT02901431|521519702|FG012|Main Treatment Part|Adverse Event|0|||
144635949|NCT02901431|521519690|FG000|Main Treatment Part|Lack of Efficacy|0|||
144210443|NCT01721317|519965247|FG001|Overall Study|Study Closed / Terminated|2|||
144210444|NCT01721317|519965246|FG000|Overall Study|Physician Decision|0|||
144635950|NCT02901431|521519691|FG001|Main Treatment Part|Lack of Efficacy|0|||
144635951|NCT02901431|521519692|FG002|Main Treatment Part|Lack of Efficacy|0|||
144635952|NCT02901431|521519693|FG003|Main Treatment Part|Lack of Efficacy|1|||
144635953|NCT02901431|521519694|FG004|Main Treatment Part|Lack of Efficacy|0|||
144635954|NCT02901431|521519695|FG005|Main Treatment Part|Lack of Efficacy|0|||
144635955|NCT02901431|521519696|FG006|Main Treatment Part|Lack of Efficacy|0|||
144635956|NCT02901431|521519697|FG007|Main Treatment Part|Lack of Efficacy|0|||
144635957|NCT02901431|521519698|FG008|Main Treatment Part|Lack of Efficacy|0|||
144635958|NCT02901431|521519699|FG009|Main Treatment Part|Lack of Efficacy|0|||
144635959|NCT02901431|521519700|FG010|Main Treatment Part|Lack of Efficacy|0|||
144635960|NCT02901431|521519701|FG011|Main Treatment Part|Lack of Efficacy|0|||
144635961|NCT02901431|521519702|FG012|Main Treatment Part|Lack of Efficacy|0|||
144635962|NCT02901431|521519690|FG000|Main Treatment Part|Lost to Follow-up|0|||
144635963|NCT02901431|521519691|FG001|Main Treatment Part|Lost to Follow-up|0|||
144635964|NCT02901431|521519692|FG002|Main Treatment Part|Lost to Follow-up|0|||
144635965|NCT02901431|521519693|FG003|Main Treatment Part|Lost to Follow-up|3|||
144635966|NCT02901431|521519694|FG004|Main Treatment Part|Lost to Follow-up|1|||
144635967|NCT02901431|521519695|FG005|Main Treatment Part|Lost to Follow-up|2|||
144635968|NCT02901431|521519696|FG006|Main Treatment Part|Lost to Follow-up|3|||
144635969|NCT02901431|521519697|FG007|Main Treatment Part|Lost to Follow-up|0|||
144635970|NCT02901431|521519698|FG008|Main Treatment Part|Lost to Follow-up|0|||
144635971|NCT02901431|521519699|FG009|Main Treatment Part|Lost to Follow-up|0|||
144635972|NCT02901431|521519700|FG010|Main Treatment Part|Lost to Follow-up|0|||
144635973|NCT02901431|521519701|FG011|Main Treatment Part|Lost to Follow-up|0|||
144635974|NCT02901431|521519702|FG012|Main Treatment Part|Lost to Follow-up|0|||
144635975|NCT02901431|521519690|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
144635976|NCT02901431|521519691|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
144635977|NCT02901431|521519692|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
144635978|NCT02901431|521519693|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
144635979|NCT02901431|521519694|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
144635980|NCT02901431|521519695|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
144635981|NCT02901431|521519696|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
144210445|NCT01721317|519965247|FG001|Overall Study|Physician Decision|1|||
144635982|NCT02901431|521519697|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
144635983|NCT02901431|521519698|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
144635984|NCT02901431|521519699|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
144635985|NCT02901431|521519700|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
144635986|NCT02901431|521519701|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
144635987|NCT02901431|521519702|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
144635988|NCT02901431|521519690|FG000|Main Treatment Part|Physician Decision|0|||
144635989|NCT02901431|521519691|FG001|Main Treatment Part|Physician Decision|0|||
144635990|NCT02901431|521519692|FG002|Main Treatment Part|Physician Decision|0|||
144635991|NCT02901431|521519693|FG003|Main Treatment Part|Physician Decision|1|||
144635992|NCT02901431|521519694|FG004|Main Treatment Part|Physician Decision|0|||
144635993|NCT02901431|521519695|FG005|Main Treatment Part|Physician Decision|0|||
144635994|NCT02901431|521519696|FG006|Main Treatment Part|Physician Decision|1|||
144210446|NCT01721317|519965246|FG000|Overall Study|Withdrawal by Subject|0|||
144210447|NCT01721317|519965247|FG001|Overall Study|Withdrawal by Subject|1|||
144210448|NCT00182325|519965261|FG000|Overall Study|Lost to Follow-up|7|||
144635995|NCT02901431|521519697|FG007|Main Treatment Part|Physician Decision|0|||
144635996|NCT02901431|521519698|FG008|Main Treatment Part|Physician Decision|0|||
144635997|NCT02901431|521519699|FG009|Main Treatment Part|Physician Decision|0|||
144635998|NCT02901431|521519700|FG010|Main Treatment Part|Physician Decision|0|||
144635999|NCT02901431|521519701|FG011|Main Treatment Part|Physician Decision|0|||
144636000|NCT02901431|521519702|FG012|Main Treatment Part|Physician Decision|0|||
144636001|NCT02901431|521519690|FG000|Main Treatment Part|Withdrawal by Subject|0|||
144636002|NCT02901431|521519691|FG001|Main Treatment Part|Withdrawal by Subject|0|||
144636003|NCT02901431|521519692|FG002|Main Treatment Part|Withdrawal by Subject|0|||
144730987|NCT01725529|521871333|FG001|Overall Study|Adverse Event|0|||
144636004|NCT02901431|521519693|FG003|Main Treatment Part|Withdrawal by Subject|18|||
144636005|NCT02901431|521519694|FG004|Main Treatment Part|Withdrawal by Subject|3|||
144636006|NCT02901431|521519695|FG005|Main Treatment Part|Withdrawal by Subject|5|||
144636007|NCT02901431|521519696|FG006|Main Treatment Part|Withdrawal by Subject|6|||
144636008|NCT02901431|521519697|FG007|Main Treatment Part|Withdrawal by Subject|0|||
144636009|NCT02901431|521519698|FG008|Main Treatment Part|Withdrawal by Subject|0|||
144636010|NCT02901431|521519699|FG009|Main Treatment Part|Withdrawal by Subject|0|||
144636011|NCT02901431|521519700|FG010|Main Treatment Part|Withdrawal by Subject|0|||
144636012|NCT02901431|521519701|FG011|Main Treatment Part|Withdrawal by Subject|0|||
144636013|NCT02901431|521519702|FG012|Main Treatment Part|Withdrawal by Subject|0|||
144636014|NCT02901431|521519690|FG000|Open Label Part|Adverse Event|0|||
144636015|NCT02901431|521519691|FG001|Open Label Part|Adverse Event|0|||
144636016|NCT02901431|521519692|FG002|Open Label Part|Adverse Event|0|||
144636017|NCT02901431|521519693|FG003|Open Label Part|Adverse Event|0|||
144636018|NCT02901431|521519694|FG004|Open Label Part|Adverse Event|0|||
144636019|NCT02901431|521519695|FG005|Open Label Part|Adverse Event|0|||
144636020|NCT02901431|521519696|FG006|Open Label Part|Adverse Event|0|||
144636021|NCT02901431|521519697|FG007|Open Label Part|Adverse Event|0|||
144636022|NCT02901431|521519698|FG008|Open Label Part|Adverse Event|4|||
144636023|NCT02901431|521519699|FG009|Open Label Part|Adverse Event|4|||
144636024|NCT02901431|521519700|FG010|Open Label Part|Adverse Event|0|||
144636025|NCT02901431|521519701|FG011|Open Label Part|Adverse Event|4|||
144636026|NCT02901431|521519702|FG012|Open Label Part|Adverse Event|1|||
144636027|NCT02901431|521519690|FG000|Open Label Part|Lost to Follow-up|0|||
144636028|NCT02901431|521519691|FG001|Open Label Part|Lost to Follow-up|0|||
144636029|NCT02901431|521519692|FG002|Open Label Part|Lost to Follow-up|0|||
144636030|NCT02901431|521519693|FG003|Open Label Part|Lost to Follow-up|0|||
144636031|NCT02901431|521519694|FG004|Open Label Part|Lost to Follow-up|0|||
144636032|NCT02901431|521519695|FG005|Open Label Part|Lost to Follow-up|0|||
144636033|NCT02901431|521519696|FG006|Open Label Part|Lost to Follow-up|0|||
144636034|NCT02901431|521519697|FG007|Open Label Part|Lost to Follow-up|0|||
144636035|NCT02901431|521519698|FG008|Open Label Part|Lost to Follow-up|2|||
144636036|NCT02901431|521519699|FG009|Open Label Part|Lost to Follow-up|2|||
144636037|NCT02901431|521519700|FG010|Open Label Part|Lost to Follow-up|1|||
144636038|NCT02901431|521519701|FG011|Open Label Part|Lost to Follow-up|1|||
144636039|NCT02901431|521519702|FG012|Open Label Part|Lost to Follow-up|1|||
144636040|NCT02901431|521519690|FG000|Open Label Part|Physician Decision|0|||
144636041|NCT02901431|521519691|FG001|Open Label Part|Physician Decision|0|||
144636042|NCT02901431|521519692|FG002|Open Label Part|Physician Decision|0|||
144636043|NCT02901431|521519693|FG003|Open Label Part|Physician Decision|0|||
144636044|NCT02901431|521519694|FG004|Open Label Part|Physician Decision|0|||
144636045|NCT02901431|521519695|FG005|Open Label Part|Physician Decision|0|||
144636046|NCT02901431|521519696|FG006|Open Label Part|Physician Decision|0|||
144636047|NCT02901431|521519697|FG007|Open Label Part|Physician Decision|0|||
144636048|NCT02901431|521519698|FG008|Open Label Part|Physician Decision|1|||
144636049|NCT02901431|521519699|FG009|Open Label Part|Physician Decision|1|||
144636050|NCT02901431|521519700|FG010|Open Label Part|Physician Decision|0|||
144636051|NCT02901431|521519701|FG011|Open Label Part|Physician Decision|0|||
144636052|NCT02901431|521519702|FG012|Open Label Part|Physician Decision|0|||
144636053|NCT02901431|521519690|FG000|Open Label Part|Study Terminated By Sponsor|0|||
144636054|NCT02901431|521519691|FG001|Open Label Part|Study Terminated By Sponsor|0|||
144636055|NCT02901431|521519692|FG002|Open Label Part|Study Terminated By Sponsor|0|||
144636056|NCT02901431|521519693|FG003|Open Label Part|Study Terminated By Sponsor|0|||
144636057|NCT02901431|521519694|FG004|Open Label Part|Study Terminated By Sponsor|0|||
144636058|NCT02901431|521519695|FG005|Open Label Part|Study Terminated By Sponsor|0|||
144636059|NCT02901431|521519696|FG006|Open Label Part|Study Terminated By Sponsor|0|||
144636060|NCT02901431|521519697|FG007|Open Label Part|Study Terminated By Sponsor|0|||
144636061|NCT02901431|521519698|FG008|Open Label Part|Study Terminated By Sponsor|35|||
144636062|NCT02901431|521519699|FG009|Open Label Part|Study Terminated By Sponsor|12|||
144636063|NCT02901431|521519700|FG010|Open Label Part|Study Terminated By Sponsor|21|||
144636064|NCT02901431|521519701|FG011|Open Label Part|Study Terminated By Sponsor|31|||
144636065|NCT02901431|521519702|FG012|Open Label Part|Study Terminated By Sponsor|0|||
144636066|NCT02901431|521519690|FG000|Open Label Part|Withdrawal by Subject|0|||
144636067|NCT02901431|521519691|FG001|Open Label Part|Withdrawal by Subject|0|||
144636068|NCT02901431|521519692|FG002|Open Label Part|Withdrawal by Subject|0|||
144636069|NCT02901431|521519693|FG003|Open Label Part|Withdrawal by Subject|0|||
144730988|NCT01725529|521871334|FG002|Overall Study|Adverse Event|0|||
144730989|NCT01725529|521871332|FG000|Overall Study|Lost to Follow-up|2|||
144636070|NCT02901431|521519694|FG004|Open Label Part|Withdrawal by Subject|0|||
144636071|NCT02901431|521519695|FG005|Open Label Part|Withdrawal by Subject|0|||
144636072|NCT02901431|521519696|FG006|Open Label Part|Withdrawal by Subject|0|||
144636073|NCT02901431|521519697|FG007|Open Label Part|Withdrawal by Subject|0|||
144636074|NCT02901431|521519698|FG008|Open Label Part|Withdrawal by Subject|6|||
144636075|NCT02901431|521519699|FG009|Open Label Part|Withdrawal by Subject|5|||
144636076|NCT02901431|521519700|FG010|Open Label Part|Withdrawal by Subject|7|||
144636077|NCT02901431|521519701|FG011|Open Label Part|Withdrawal by Subject|3|||
144636078|NCT02901431|521519702|FG012|Open Label Part|Withdrawal by Subject|1|||
144636079|NCT04223609|521519703|FG000|Overall Study|Adverse Event|0|||
144636080|NCT04223609|521519704|FG001|Overall Study|Adverse Event|1|||
144636081|NCT04223609|521519703|FG000|Overall Study|Missed last visit|0|||
144636082|NCT04223609|521519704|FG001|Overall Study|Missed last visit|1|||
144636083|NCT03440944|521519707|FG000|Overall Study|Physician Decision|1|||
144636084|NCT03440944|521519708|FG001|Overall Study|Physician Decision|0|||
144636085|NCT03440944|521519707|FG000|Overall Study|No Acceptable Vasculature|0|||
144636086|NCT03440944|521519708|FG001|Overall Study|No Acceptable Vasculature|1|||
144636087|NCT00591734|521519709|FG000|Overall Study|Lack of Efficacy|35|||
144636088|NCT00591734|521519709|FG000|Overall Study|Adverse Event|5|||
144636089|NCT00591734|521519709|FG000|Overall Study|Physician Decision|5|||
144636090|NCT00591734|521519709|FG000|Overall Study|Intercurrent Illness|8|||
144636091|NCT02500537|521519710|FG000|Overall Study|Death|2|||
144636092|NCT02500537|521519711|FG001|Overall Study|Death|0|||
144636093|NCT02500537|521519710|FG000|Overall Study|Lost to Follow-up|0|||
144636094|NCT02500537|521519711|FG001|Overall Study|Lost to Follow-up|1|||
144636095|NCT02500537|521519710|FG000|Overall Study|Withdrawal by Subject|1|||
144636096|NCT02500537|521519711|FG001|Overall Study|Withdrawal by Subject|0|||
144636097|NCT04672083|521519712|FG000|Overall Study|Lost to Follow-up|1|||
144636098|NCT04672083|521519713|FG001|Overall Study|Lost to Follow-up|0|||
144636099|NCT04672083|521519714|FG002|Overall Study|Lost to Follow-up|0|||
144636100|NCT04672083|521519715|FG003|Overall Study|Lost to Follow-up|0|||
144636101|NCT04672083|521519716|FG004|Overall Study|Lost to Follow-up|0|||
144636102|NCT01661790|521519717|FG000|Overall Study|Lost to Follow-up|0|||
144636103|NCT01661790|521519718|FG001|Overall Study|Lost to Follow-up|2|||
144636104|NCT00355121|521519723|FG000|Overall Study|Did not receive study vaccine|1|||
144636105|NCT00355121|521519724|FG001|Overall Study|Did not receive study vaccine|0|||
144636106|NCT00355121|521519725|FG002|Overall Study|Did not receive study vaccine|1|||
144636107|NCT00355121|521519723|FG000|Overall Study|Adverse Event|0|||
144636108|NCT00355121|521519724|FG001|Overall Study|Adverse Event|1|||
144636109|NCT00355121|521519725|FG002|Overall Study|Adverse Event|0|||
144636110|NCT00355121|521519723|FG000|Overall Study|Protocol Violation|7|||
144636111|NCT00355121|521519724|FG001|Overall Study|Protocol Violation|9|||
144636112|NCT00355121|521519725|FG002|Overall Study|Protocol Violation|1|||
144636113|NCT00355121|521519723|FG000|Overall Study|Lost to Follow-up|4|||
144636114|NCT00355121|521519724|FG001|Overall Study|Lost to Follow-up|7|||
144636115|NCT00355121|521519725|FG002|Overall Study|Lost to Follow-up|1|||
144636116|NCT00355121|521519723|FG000|Overall Study|Withdrawal by Subject|9|||
144636117|NCT00355121|521519724|FG001|Overall Study|Withdrawal by Subject|10|||
144636118|NCT00355121|521519725|FG002|Overall Study|Withdrawal by Subject|2|||
144636119|NCT00355121|521519723|FG000|Overall Study|Serious adverse events|0|||
144636120|NCT00355121|521519724|FG001|Overall Study|Serious adverse events|2|||
144636121|NCT00355121|521519725|FG002|Overall Study|Serious adverse events|0|||
144636122|NCT04696861|521519727|FG000|Overall Study|Death|1|||
144636123|NCT04696861|521519728|FG001|Overall Study|Death|0|||
144636124|NCT04696861|521519727|FG000|Overall Study|Lost to Follow-up|3|||
144636125|NCT04696861|521519728|FG001|Overall Study|Lost to Follow-up|0|||
144636126|NCT01827384|521519731|FG000|Overall Study|Switched to alternative treatment|0|||
144636127|NCT01827384|521519732|FG001|Overall Study|Switched to alternative treatment|0|||
144636128|NCT01827384|521519733|FG002|Overall Study|Switched to alternative treatment|0|||
144636129|NCT01827384|521519734|FG003|Overall Study|Switched to alternative treatment|0|||
144636130|NCT01827384|521519735|FG004|Overall Study|Switched to alternative treatment|0|||
144636131|NCT01827384|521519736|FG005|Overall Study|Switched to alternative treatment|0|||
144636132|NCT01827384|521519737|FG006|Overall Study|Switched to alternative treatment|0|||
144636133|NCT01827384|521519738|FG007|Overall Study|Switched to alternative treatment|0|||
144210449|NCT00182325|519965262|FG001|Overall Study|Lost to Follow-up|7|||
144636134|NCT01827384|521519739|FG008|Overall Study|Switched to alternative treatment|0|||
144636135|NCT01827384|521519740|FG009|Overall Study|Switched to alternative treatment|0|||
144636136|NCT01827384|521519741|FG010|Overall Study|Switched to alternative treatment|0|||
144636137|NCT01827384|521519742|FG011|Overall Study|Switched to alternative treatment|0|||
144636138|NCT01827384|521519743|FG012|Overall Study|Switched to alternative treatment|0|||
144636139|NCT01827384|521519744|FG013|Overall Study|Switched to alternative treatment|2|||
144636140|NCT01827384|521519731|FG000|Overall Study|Disease progression before treatment|0|||
144636141|NCT01827384|521519732|FG001|Overall Study|Disease progression before treatment|0|||
144636142|NCT01827384|521519733|FG002|Overall Study|Disease progression before treatment|0|||
144636143|NCT01827384|521519734|FG003|Overall Study|Disease progression before treatment|0|||
144636144|NCT01827384|521519735|FG004|Overall Study|Disease progression before treatment|0|||
144636145|NCT01827384|521519736|FG005|Overall Study|Disease progression before treatment|0|||
144636146|NCT01827384|521519737|FG006|Overall Study|Disease progression before treatment|0|||
144636147|NCT01827384|521519738|FG007|Overall Study|Disease progression before treatment|0|||
144636148|NCT01827384|521519739|FG008|Overall Study|Disease progression before treatment|0|||
144636149|NCT01827384|521519740|FG009|Overall Study|Disease progression before treatment|0|||
144636150|NCT01827384|521519741|FG010|Overall Study|Disease progression before treatment|0|||
144636151|NCT01827384|521519742|FG011|Overall Study|Disease progression before treatment|0|||
144210450|NCT00182325|519965261|FG000|Overall Study|Miscarriage|5|||
144210451|NCT00182325|519965262|FG001|Overall Study|Miscarriage|3|||
144210452|NCT00182325|519965261|FG000|Overall Study|Did not complete survey|22|||
144636152|NCT01827384|521519743|FG012|Overall Study|Disease progression before treatment|0|||
144636153|NCT01827384|521519744|FG013|Overall Study|Disease progression before treatment|4|||
144636154|NCT01827384|521519731|FG000|Overall Study|Ineligible|0|||
144636155|NCT01827384|521519732|FG001|Overall Study|Ineligible|0|||
144636156|NCT01827384|521519733|FG002|Overall Study|Ineligible|0|||
144636157|NCT01827384|521519734|FG003|Overall Study|Ineligible|0|||
144636158|NCT01827384|521519735|FG004|Overall Study|Ineligible|0|||
144636159|NCT01827384|521519736|FG005|Overall Study|Ineligible|0|||
144636160|NCT01827384|521519737|FG006|Overall Study|Ineligible|0|||
144636161|NCT01827384|521519738|FG007|Overall Study|Ineligible|0|||
144636162|NCT01827384|521519739|FG008|Overall Study|Ineligible|0|||
144636163|NCT01827384|521519740|FG009|Overall Study|Ineligible|0|||
144636164|NCT01827384|521519741|FG010|Overall Study|Ineligible|0|||
144636165|NCT01827384|521519742|FG011|Overall Study|Ineligible|0|||
144636166|NCT01827384|521519743|FG012|Overall Study|Ineligible|0|||
144636167|NCT01827384|521519744|FG013|Overall Study|Ineligible|19|||
144636168|NCT01827384|521519731|FG000|Overall Study|Participant died before treatment|0|||
144636169|NCT01827384|521519732|FG001|Overall Study|Participant died before treatment|0|||
144636170|NCT01827384|521519733|FG002|Overall Study|Participant died before treatment|0|||
144636171|NCT01827384|521519734|FG003|Overall Study|Participant died before treatment|0|||
144636172|NCT01827384|521519735|FG004|Overall Study|Participant died before treatment|0|||
144636173|NCT01827384|521519736|FG005|Overall Study|Participant died before treatment|0|||
144636174|NCT01827384|521519737|FG006|Overall Study|Participant died before treatment|0|||
144636175|NCT01827384|521519738|FG007|Overall Study|Participant died before treatment|0|||
144636176|NCT01827384|521519739|FG008|Overall Study|Participant died before treatment|0|||
144636177|NCT01827384|521519740|FG009|Overall Study|Participant died before treatment|0|||
144636178|NCT01827384|521519741|FG010|Overall Study|Participant died before treatment|0|||
144636179|NCT01827384|521519742|FG011|Overall Study|Participant died before treatment|0|||
144636180|NCT01827384|521519743|FG012|Overall Study|Participant died before treatment|0|||
144636181|NCT01827384|521519744|FG013|Overall Study|Participant died before treatment|5|||
144636182|NCT01827384|521519731|FG000|Overall Study|Insufficient tumor cells|0|||
144636183|NCT01827384|521519732|FG001|Overall Study|Insufficient tumor cells|0|||
144636184|NCT01827384|521519733|FG002|Overall Study|Insufficient tumor cells|0|||
144636185|NCT01827384|521519734|FG003|Overall Study|Insufficient tumor cells|0|||
144636186|NCT01827384|521519735|FG004|Overall Study|Insufficient tumor cells|0|||
144636187|NCT01827384|521519736|FG005|Overall Study|Insufficient tumor cells|0|||
144636188|NCT01827384|521519737|FG006|Overall Study|Insufficient tumor cells|0|||
144636189|NCT01827384|521519738|FG007|Overall Study|Insufficient tumor cells|0|||
144636190|NCT01827384|521519739|FG008|Overall Study|Insufficient tumor cells|0|||
144636191|NCT01827384|521519740|FG009|Overall Study|Insufficient tumor cells|0|||
144636192|NCT01827384|521519741|FG010|Overall Study|Insufficient tumor cells|0|||
144636193|NCT01827384|521519742|FG011|Overall Study|Insufficient tumor cells|0|||
144636194|NCT01827384|521519743|FG012|Overall Study|Insufficient tumor cells|0|||
144636195|NCT01827384|521519744|FG013|Overall Study|Insufficient tumor cells|13|||
144636196|NCT01827384|521519731|FG000|Overall Study|No actionable mutation|0|||
144636197|NCT01827384|521519732|FG001|Overall Study|No actionable mutation|0|||
144636198|NCT01827384|521519733|FG002|Overall Study|No actionable mutation|0|||
144636199|NCT01827384|521519734|FG003|Overall Study|No actionable mutation|0|||
144636200|NCT01827384|521519735|FG004|Overall Study|No actionable mutation|0|||
144636201|NCT01827384|521519736|FG005|Overall Study|No actionable mutation|0|||
144636202|NCT01827384|521519737|FG006|Overall Study|No actionable mutation|0|||
144636203|NCT01827384|521519738|FG007|Overall Study|No actionable mutation|0|||
144210453|NCT00182325|519965262|FG001|Overall Study|Did not complete survey|43|||
144636204|NCT01827384|521519739|FG008|Overall Study|No actionable mutation|0|||
144636205|NCT01827384|521519740|FG009|Overall Study|No actionable mutation|0|||
144636206|NCT01827384|521519741|FG010|Overall Study|No actionable mutation|0|||
144636207|NCT01827384|521519742|FG011|Overall Study|No actionable mutation|0|||
144636208|NCT01827384|521519743|FG012|Overall Study|No actionable mutation|0|||
144636209|NCT01827384|521519744|FG013|Overall Study|No actionable mutation|73|||
144636210|NCT01827384|521519731|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
144210454|NCT03280381|519965272|FG000|Overall Study|Physician Decision|0|||
144636211|NCT01827384|521519732|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
144636212|NCT01827384|521519733|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
144636213|NCT01827384|521519734|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
144636214|NCT01827384|521519735|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
144636215|NCT01827384|521519736|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
144636216|NCT01827384|521519737|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
144636217|NCT01827384|521519738|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
144636218|NCT01827384|521519739|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
144636219|NCT01827384|521519740|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
144636220|NCT01827384|521519741|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
144636221|NCT01827384|521519742|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
144636222|NCT01827384|521519743|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
144636223|NCT01827384|521519744|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
144636224|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
144636225|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
144636226|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
144636227|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
144636228|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
144636229|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
144636230|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
144636231|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
144636232|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
144636233|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
144636234|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
144636235|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
144636236|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
144636237|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
144636238|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
144636239|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
144636240|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
144636241|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
144636242|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
144636243|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
144636244|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
144636245|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
144636246|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
144636247|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
144636248|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
144636249|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
144636250|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
144636251|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
144636252|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
144636253|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
144636254|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
144636255|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
144636256|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
144636257|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
144636258|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
144636259|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
144636260|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
144636261|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
144636262|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
144636263|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
144636264|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
144636265|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
144636266|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
144636267|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
144636268|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
144636269|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
144636270|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
144636271|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
144636272|NCT01707992|521519750|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
144636273|NCT01707992|521519751|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
144636274|NCT01707992|521519752|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
144636275|NCT01707992|521519753|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
144636276|NCT01707992|521519754|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
144636277|NCT01707992|521519755|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
144636278|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
144636279|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
144636280|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
144636281|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
144636282|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
144636283|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
144636284|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
144636285|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
144636286|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
144636287|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
144636288|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
144636289|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
144636290|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
144636291|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
144636292|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
144636293|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
144636294|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
144636295|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
144636296|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
144636297|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
144636298|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
144636299|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
144636300|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
144636301|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
144636302|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
144636303|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
144636304|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
144636305|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
144636306|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
144636307|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
144636308|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Death|0|||
144636309|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Death|0|||
144636310|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Death|0|||
144636311|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Death|2|||
144636312|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Death|0|||
144636313|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Death|0|||
144636314|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
144636315|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
144636316|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
144636317|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
144636318|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
144636319|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
144636320|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
144636321|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
144636322|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
144636323|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
144636324|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
144636325|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
144636326|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
144636327|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
144636328|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
144636329|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
144636330|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
144636331|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
144636332|NCT01707992|521519750|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
144636333|NCT01707992|521519751|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
144636334|NCT01707992|521519752|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
144730990|NCT01725529|521871333|FG001|Overall Study|Lost to Follow-up|1|||
144730991|NCT01725529|521871334|FG002|Overall Study|Lost to Follow-up|1|||
144730992|NCT01725529|521871332|FG000|Overall Study|Protocol Violation|0|||
144730993|NCT01725529|521871333|FG001|Overall Study|Protocol Violation|1|||
144730994|NCT01725529|521871334|FG002|Overall Study|Protocol Violation|1|||
144730995|NCT01725529|521871332|FG000|Overall Study|Withdrawal by Subject|12|||
144730996|NCT01725529|521871333|FG001|Overall Study|Withdrawal by Subject|14|||
144730997|NCT01725529|521871334|FG002|Overall Study|Withdrawal by Subject|8|||
144730998|NCT05327491|521871342|FG000|Periods 1 & 2|Miscellaneous|0|||
144730999|NCT05327491|521871343|FG001|Periods 1 & 2|Miscellaneous|1|||
144210455|NCT03280381|519965273|FG001|Overall Study|Physician Decision|2|||
144210456|NCT03837743|519965274|FG000|Overall Study|Adverse Event|1|||
144210457|NCT03837743|519965274|FG000|Overall Study|Withdrawal by Subject|2|||
144210458|NCT00252239|519965275|FG000|Overall Study|Withdrawal by Subject|1|||
144210459|NCT00252239|519965276|FG001|Overall Study|Withdrawal by Subject|0|||
144210460|NCT00252239|519965277|FG002|Overall Study|Withdrawal by Subject|0|||
144210461|NCT00252239|519965278|FG003|Overall Study|Withdrawal by Subject|1|||
144210462|NCT00252239|519965275|FG000|Overall Study|Lost to Follow-up|0|||
144210463|NCT00252239|519965276|FG001|Overall Study|Lost to Follow-up|0|||
144210464|NCT00252239|519965277|FG002|Overall Study|Lost to Follow-up|2|||
144210465|NCT00252239|519965278|FG003|Overall Study|Lost to Follow-up|0|||
144210466|NCT01822366|519965286|FG000|Overall Study|Lost to Follow-up|5|||
144210467|NCT01822366|519965287|FG001|Overall Study|Lost to Follow-up|1|||
144210468|NCT01822366|519965288|FG002|Overall Study|Lost to Follow-up|5|||
144210469|NCT01822366|519965289|FG003|Overall Study|Lost to Follow-up|1|||
144210470|NCT01822366|519965286|FG000|Overall Study|Withdrawal by Subject|0|||
144210471|NCT01822366|519965287|FG001|Overall Study|Withdrawal by Subject|6|||
144210472|NCT01822366|519965288|FG002|Overall Study|Withdrawal by Subject|0|||
144210473|NCT01822366|519965289|FG003|Overall Study|Withdrawal by Subject|6|||
144210474|NCT01822366|519965286|FG000|Overall Study|Partial Intervention Completion|0|||
144210475|NCT01822366|519965287|FG001|Overall Study|Partial Intervention Completion|15|||
144210476|NCT01822366|519965288|FG002|Overall Study|Partial Intervention Completion|0|||
144210477|NCT01822366|519965289|FG003|Overall Study|Partial Intervention Completion|15|||
144210478|NCT04868968|519965292|FG000|Overall Study|Lost to Follow-up|1|||
144210479|NCT00384930|519965293|FG000|Overall Study|Adverse Event|5|||
144210480|NCT00384930|519965294|FG001|Overall Study|Adverse Event|4|||
144210481|NCT00384930|519965295|FG002|Overall Study|Adverse Event|12|||
144210482|NCT00384930|519965296|FG003|Overall Study|Adverse Event|11|||
144210483|NCT00384930|519965297|FG004|Overall Study|Adverse Event|14|||
144210484|NCT00384930|519965293|FG000|Overall Study|Entry Criteria Not Met|2|||
144210485|NCT00384930|519965294|FG001|Overall Study|Entry Criteria Not Met|6|||
144210486|NCT00384930|519965295|FG002|Overall Study|Entry Criteria Not Met|7|||
144210487|NCT00384930|519965296|FG003|Overall Study|Entry Criteria Not Met|8|||
144210488|NCT00384930|519965297|FG004|Overall Study|Entry Criteria Not Met|4|||
144210489|NCT00384930|519965293|FG000|Overall Study|Lack of Efficacy|1|||
144210490|NCT00384930|519965294|FG001|Overall Study|Lack of Efficacy|1|||
144636335|NCT01707992|521519753|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
144636336|NCT01707992|521519754|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
144636337|NCT01707992|521519755|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
144636338|NCT00998738|521519757|FG000|Overall Study|Uknown|1|||
144636339|NCT03313050|521519759|FG000|Stage 2: 12 Months|Adverse Event|0|||
144636340|NCT03313050|521519760|FG001|Stage 2: 12 Months|Adverse Event|0|||
144636341|NCT03313050|521519761|FG002|Stage 2: 12 Months|Adverse Event|0|||
144636342|NCT03313050|521519762|FG003|Stage 2: 12 Months|Adverse Event|1|||
144636343|NCT03313050|521519759|FG000|Stage 2: 12 Months|Death|0|||
144636344|NCT03313050|521519760|FG001|Stage 2: 12 Months|Death|0|||
144636345|NCT03313050|521519761|FG002|Stage 2: 12 Months|Death|3|||
144636346|NCT03313050|521519762|FG003|Stage 2: 12 Months|Death|0|||
144636347|NCT03313050|521519759|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
144636348|NCT03313050|521519760|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
144636349|NCT03313050|521519761|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
144636350|NCT03313050|521519762|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
144636351|NCT03313050|521519759|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
144636352|NCT03313050|521519760|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
144636353|NCT03313050|521519761|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
144636354|NCT03313050|521519762|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
144636355|NCT03313050|521519759|FG000|Stage 2: 12 Months|Protocol deviation|0|||
144636356|NCT03313050|521519760|FG001|Stage 2: 12 Months|Protocol deviation|0|||
144636357|NCT03313050|521519761|FG002|Stage 2: 12 Months|Protocol deviation|7|||
144636358|NCT03313050|521519762|FG003|Stage 2: 12 Months|Protocol deviation|7|||
144636359|NCT03313050|521519759|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
144636360|NCT03313050|521519760|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
144636361|NCT03313050|521519761|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
144636362|NCT03313050|521519762|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
144210491|NCT00384930|519965295|FG002|Overall Study|Lack of Efficacy|2|||
144210492|NCT00384930|519965296|FG003|Overall Study|Lack of Efficacy|1|||
144210493|NCT00384930|519965297|FG004|Overall Study|Lack of Efficacy|2|||
144210494|NCT00384930|519965293|FG000|Overall Study|Lost to Follow-up|5|||
144210495|NCT00384930|519965294|FG001|Overall Study|Lost to Follow-up|3|||
144210496|NCT00384930|519965295|FG002|Overall Study|Lost to Follow-up|0|||
144210497|NCT00384930|519965296|FG003|Overall Study|Lost to Follow-up|4|||
144210498|NCT00384930|519965297|FG004|Overall Study|Lost to Follow-up|6|||
144210499|NCT00384930|519965293|FG000|Overall Study|Physician Decision|0|||
144636363|NCT03313050|521519759|FG000|Stage 2: 12 Months|Other|0|||
144636364|NCT03313050|521519760|FG001|Stage 2: 12 Months|Other|0|||
144636365|NCT03313050|521519761|FG002|Stage 2: 12 Months|Other|0|||
144636366|NCT03313050|521519762|FG003|Stage 2: 12 Months|Other|1|||
144636367|NCT04211337|521519763|FG000|Overall Study|On Treatment|175|||
144636368|NCT04211337|521519764|FG001|Overall Study|On Treatment|40|||
144636369|NCT04211337|521519763|FG000|Overall Study|Withdrawal by Subject|0|||
144636370|NCT04211337|521519764|FG001|Overall Study|Withdrawal by Subject|2|||
144636371|NCT02848833|521519773|FG000|Overall Study|subject who are duplicated|1|||
144636372|NCT02848833|521519773|FG000|Overall Study|have not taken the study drug|11|||
144636373|NCT02848833|521519773|FG000|Overall Study|follow-up failure|6|||
144636374|NCT02848833|521519773|FG000|Overall Study|Protocol Violation|119|||
144636375|NCT02847598|521519774|FG000|Overall Study|Adverse Event|0|||
144636376|NCT02847598|521519775|FG001|Overall Study|Adverse Event|0|||
144636377|NCT02847598|521519776|FG002|Overall Study|Adverse Event|0|||
144636378|NCT02847598|521519777|FG003|Overall Study|Adverse Event|0|||
144636379|NCT02847598|521519778|FG004|Overall Study|Adverse Event|0|||
144636380|NCT02847598|521519779|FG005|Overall Study|Adverse Event|0|||
144636381|NCT02847598|521519780|FG006|Overall Study|Adverse Event|0|||
144636382|NCT02847598|521519781|FG007|Overall Study|Adverse Event|1|||
144636383|NCT02847598|521519774|FG000|Overall Study|Consent withdrawn|2|||
144636384|NCT02847598|521519775|FG001|Overall Study|Consent withdrawn|0|||
144636385|NCT02847598|521519776|FG002|Overall Study|Consent withdrawn|0|||
144636386|NCT02847598|521519777|FG003|Overall Study|Consent withdrawn|4|||
144636387|NCT02847598|521519778|FG004|Overall Study|Consent withdrawn|3|||
144636388|NCT02847598|521519779|FG005|Overall Study|Consent withdrawn|2|||
144636389|NCT02847598|521519780|FG006|Overall Study|Consent withdrawn|1|||
144636390|NCT02847598|521519781|FG007|Overall Study|Consent withdrawn|3|||
144636391|NCT02847598|521519774|FG000|Overall Study|Death|3|||
144636392|NCT02847598|521519775|FG001|Overall Study|Death|0|||
144636393|NCT02847598|521519776|FG002|Overall Study|Death|0|||
144636394|NCT02847598|521519777|FG003|Overall Study|Death|0|||
144636395|NCT02847598|521519778|FG004|Overall Study|Death|0|||
144636396|NCT02847598|521519779|FG005|Overall Study|Death|0|||
144636397|NCT02847598|521519780|FG006|Overall Study|Death|0|||
144636398|NCT02847598|521519781|FG007|Overall Study|Death|0|||
144636399|NCT02847598|521519774|FG000|Overall Study|Lost to Follow-up|0|||
144636400|NCT02847598|521519775|FG001|Overall Study|Lost to Follow-up|0|||
144636401|NCT02847598|521519776|FG002|Overall Study|Lost to Follow-up|0|||
144636402|NCT02847598|521519777|FG003|Overall Study|Lost to Follow-up|0|||
144636403|NCT02847598|521519778|FG004|Overall Study|Lost to Follow-up|0|||
144636404|NCT02847598|521519779|FG005|Overall Study|Lost to Follow-up|1|||
144636405|NCT02847598|521519780|FG006|Overall Study|Lost to Follow-up|1|||
144636406|NCT02847598|521519781|FG007|Overall Study|Lost to Follow-up|0|||
144636407|NCT04980391|521519782|FG000|Overall Study|Death|0|||
144636408|NCT04980391|521519783|FG001|Overall Study|Death|0|||
144636409|NCT04980391|521519784|FG002|Overall Study|Death|1|||
144636410|NCT04980391|521519785|FG003|Overall Study|Death|1|||
144636411|NCT04980391|521519782|FG000|Overall Study|Lost to Follow-up|3|||
144636412|NCT04980391|521519783|FG001|Overall Study|Lost to Follow-up|3|||
144636413|NCT04980391|521519784|FG002|Overall Study|Lost to Follow-up|2|||
144636414|NCT04980391|521519785|FG003|Overall Study|Lost to Follow-up|3|||
144636415|NCT04980391|521519782|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
144636416|NCT04980391|521519783|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
144636417|NCT04980391|521519784|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
144636418|NCT04980391|521519785|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
144636419|NCT04980391|521519782|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144636420|NCT04980391|521519783|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144636421|NCT04980391|521519784|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
144636422|NCT04980391|521519785|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144636423|NCT04980391|521519782|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
144636424|NCT04980391|521519783|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
144636425|NCT04980391|521519784|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
144636426|NCT04980391|521519785|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
144636427|NCT02601950|521522060|FG000|Overall Study|Participant enrolled in rollover study|0|||
144636428|NCT02601950|521522061|FG001|Overall Study|Participant enrolled in rollover study|0|||
144636429|NCT02601950|521522062|FG002|Overall Study|Participant enrolled in rollover study|1|||
144210500|NCT00384930|519965294|FG001|Overall Study|Physician Decision|1|||
144636430|NCT02601950|521522063|FG003|Overall Study|Participant enrolled in rollover study|0|||
144636431|NCT02601950|521522064|FG004|Overall Study|Participant enrolled in rollover study|1|||
144636432|NCT02601950|521522065|FG005|Overall Study|Participant enrolled in rollover study|1|||
144636433|NCT02601950|521522066|FG006|Overall Study|Participant enrolled in rollover study|1|||
144636434|NCT02601950|521522067|FG007|Overall Study|Participant enrolled in rollover study|0|||
144636435|NCT02601950|521522060|FG000|Overall Study|Disease progression - radiological|21|||
144636436|NCT02601950|521522061|FG001|Overall Study|Disease progression - radiological|26|||
144636437|NCT02601950|521522062|FG002|Overall Study|Disease progression - radiological|22|||
144636438|NCT02601950|521522063|FG003|Overall Study|Disease progression - radiological|11|||
144636439|NCT02601950|521522064|FG004|Overall Study|Disease progression - radiological|46|||
144636440|NCT02601950|521522065|FG005|Overall Study|Disease progression - radiological|52|||
144636441|NCT02601950|521522066|FG006|Overall Study|Disease progression - radiological|7|||
144636442|NCT02601950|521522067|FG007|Overall Study|Disease progression - radiological|5|||
144636443|NCT02601950|521522060|FG000|Overall Study|Disease progression - clinical|3|||
144636444|NCT02601950|521522061|FG001|Overall Study|Disease progression - clinical|5|||
144636445|NCT02601950|521522062|FG002|Overall Study|Disease progression - clinical|4|||
144636446|NCT02601950|521522063|FG003|Overall Study|Disease progression - clinical|2|||
144636447|NCT02601950|521522064|FG004|Overall Study|Disease progression - clinical|6|||
144636448|NCT02601950|521522065|FG005|Overall Study|Disease progression - clinical|6|||
144636449|NCT02601950|521522066|FG006|Overall Study|Disease progression - clinical|5|||
144636450|NCT02601950|521522067|FG007|Overall Study|Disease progression - clinical|1|||
144636451|NCT02601950|521522060|FG000|Overall Study|Death|6|||
144636452|NCT02601950|521522061|FG001|Overall Study|Death|0|||
144636453|NCT02601950|521522062|FG002|Overall Study|Death|3|||
144636454|NCT02601950|521522063|FG003|Overall Study|Death|1|||
144636455|NCT02601950|521522064|FG004|Overall Study|Death|4|||
144636456|NCT02601950|521522065|FG005|Overall Study|Death|1|||
144636457|NCT02601950|521522066|FG006|Overall Study|Death|0|||
144636458|NCT02601950|521522067|FG007|Overall Study|Death|0|||
144636459|NCT02601950|521522060|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636460|NCT02601950|521522061|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636461|NCT02601950|521522062|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636462|NCT02601950|521522063|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636463|NCT02601950|521522064|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636464|NCT02601950|521522065|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
144636465|NCT02601950|521522066|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636466|NCT02601950|521522067|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
144636467|NCT02601950|521522060|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
144636468|NCT02601950|521522061|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
144636469|NCT02601950|521522062|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
144636470|NCT02601950|521522063|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
144636471|NCT02601950|521522064|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
144636472|NCT02601950|521522065|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
144636473|NCT02601950|521522066|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
144636474|NCT02601950|521522067|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
144636475|NCT02601950|521522060|FG000|Overall Study|Non-compliance|0|||
144636476|NCT02601950|521522061|FG001|Overall Study|Non-compliance|1|||
144636477|NCT02601950|521522062|FG002|Overall Study|Non-compliance|0|||
144636478|NCT02601950|521522063|FG003|Overall Study|Non-compliance|0|||
144636479|NCT02601950|521522064|FG004|Overall Study|Non-compliance|0|||
144636480|NCT02601950|521522065|FG005|Overall Study|Non-compliance|1|||
144636481|NCT02601950|521522066|FG006|Overall Study|Non-compliance|1|||
144636482|NCT02601950|521522067|FG007|Overall Study|Non-compliance|0|||
144636483|NCT02601950|521522060|FG000|Overall Study|Participant refused further study treatment|0|||
144636484|NCT02601950|521522061|FG001|Overall Study|Participant refused further study treatment|1|||
144636485|NCT02601950|521522062|FG002|Overall Study|Participant refused further study treatment|1|||
144636486|NCT02601950|521522063|FG003|Overall Study|Participant refused further study treatment|0|||
144636487|NCT02601950|521522064|FG004|Overall Study|Participant refused further study treatment|2|||
144636488|NCT02601950|521522065|FG005|Overall Study|Participant refused further study treatment|2|||
144636489|NCT02601950|521522066|FG006|Overall Study|Participant refused further study treatment|2|||
144636490|NCT02601950|521522067|FG007|Overall Study|Participant refused further study treatment|1|||
144636491|NCT02601950|521522060|FG000|Overall Study|Investigator discretion|1|||
144636492|NCT02601950|521522061|FG001|Overall Study|Investigator discretion|0|||
144636493|NCT02601950|521522062|FG002|Overall Study|Investigator discretion|1|||
144636494|NCT02601950|521522063|FG003|Overall Study|Investigator discretion|0|||
144636495|NCT02601950|521522064|FG004|Overall Study|Investigator discretion|1|||
144636496|NCT02601950|521522065|FG005|Overall Study|Investigator discretion|1|||
144636497|NCT02601950|521522066|FG006|Overall Study|Investigator discretion|1|||
144210501|NCT00384930|519965295|FG002|Overall Study|Physician Decision|1|||
144636498|NCT02601950|521522067|FG007|Overall Study|Investigator discretion|0|||
144636499|NCT02601950|521522060|FG000|Overall Study|Other|0|||
144636500|NCT02601950|521522061|FG001|Overall Study|Other|0|||
144636501|NCT02601950|521522062|FG002|Overall Study|Other|0|||
144636502|NCT02601950|521522063|FG003|Overall Study|Other|0|||
144636503|NCT02601950|521522064|FG004|Overall Study|Other|2|||
144636504|NCT02601950|521522065|FG005|Overall Study|Other|2|||
144636505|NCT02601950|521522066|FG006|Overall Study|Other|1|||
144636506|NCT02601950|521522067|FG007|Overall Study|Other|0|||
144636507|NCT02731742|521522068|FG000|Overall Study|Death|1|||
144636508|NCT02731742|521522069|FG001|Overall Study|Death|2|||
144636509|NCT02731742|521522070|FG002|Overall Study|Death|5|||
144636510|NCT02731742|521522071|FG003|Overall Study|Death|0|||
144636511|NCT02731742|521522068|FG000|Overall Study|Physician Decision|0|||
144636512|NCT02731742|521522069|FG001|Overall Study|Physician Decision|0|||
144636513|NCT02731742|521522070|FG002|Overall Study|Physician Decision|0|||
144636514|NCT02731742|521522071|FG003|Overall Study|Physician Decision|1|||
144210502|NCT00384930|519965296|FG003|Overall Study|Physician Decision|0|||
144210503|NCT00384930|519965297|FG004|Overall Study|Physician Decision|1|||
144210504|NCT00384930|519965293|FG000|Overall Study|Protocol Violation|1|||
144210505|NCT00384930|519965294|FG001|Overall Study|Protocol Violation|0|||
144210506|NCT00384930|519965295|FG002|Overall Study|Protocol Violation|1|||
144210507|NCT00384930|519965296|FG003|Overall Study|Protocol Violation|6|||
144210508|NCT00384930|519965297|FG004|Overall Study|Protocol Violation|4|||
144210509|NCT00384930|519965293|FG000|Overall Study|Sponsor Decision|3|||
144210510|NCT00384930|519965294|FG001|Overall Study|Sponsor Decision|4|||
144210511|NCT00384930|519965295|FG002|Overall Study|Sponsor Decision|0|||
144210512|NCT00384930|519965296|FG003|Overall Study|Sponsor Decision|5|||
144210513|NCT00384930|519965297|FG004|Overall Study|Sponsor Decision|0|||
144210514|NCT00384930|519965293|FG000|Overall Study|Withdrawal by Subject|9|||
144210515|NCT00384930|519965294|FG001|Overall Study|Withdrawal by Subject|7|||
144636515|NCT02731742|521522068|FG000|Overall Study|Study Terminated by Sponsor|2|||
144636516|NCT02731742|521522069|FG001|Overall Study|Study Terminated by Sponsor|1|||
144636517|NCT02731742|521522070|FG002|Overall Study|Study Terminated by Sponsor|1|||
144636518|NCT02731742|521522071|FG003|Overall Study|Study Terminated by Sponsor|1|||
144636519|NCT00461175|521522072|FG000|Overall Study|Protocol Violation|522|||
144636520|NCT00461175|521522073|FG001|Overall Study|Protocol Violation|365|||
144636521|NCT00331760|521522074|FG000|Overall Study|Ineligible / no protocol treatment|15|||
144636522|NCT00331760|521522075|FG001|Overall Study|Ineligible / no protocol treatment|8|||
144636523|NCT03093155|521522077|FG000|Overall Study|Not Eligible|1|||
144636524|NCT03093155|521522078|FG001|Overall Study|Not Eligible|0|||
144636525|NCT03093155|521522077|FG000|Overall Study|Withdrawal by Subject|0|||
144636526|NCT03093155|521522078|FG001|Overall Study|Withdrawal by Subject|1|||
144636527|NCT03417440|521522079|FG000|Overall Study|Lost to Follow-up|0|||
144636528|NCT03417440|521522080|FG001|Overall Study|Lost to Follow-up|1|||
144636529|NCT03417440|521522081|FG002|Overall Study|Lost to Follow-up|0|||
144636530|NCT03417440|521522082|FG003|Overall Study|Lost to Follow-up|0|||
144636531|NCT03417440|521522083|FG004|Overall Study|Lost to Follow-up|1|||
144636532|NCT03417440|521522084|FG005|Overall Study|Lost to Follow-up|0|||
144636533|NCT03417440|521522085|FG006|Overall Study|Lost to Follow-up|0|||
144636534|NCT03417440|521522086|FG007|Overall Study|Lost to Follow-up|0|||
144636535|NCT03417440|521522079|FG000|Overall Study|Withdrawal by Subject|2|||
144636536|NCT03417440|521522080|FG001|Overall Study|Withdrawal by Subject|0|||
144636537|NCT03417440|521522081|FG002|Overall Study|Withdrawal by Subject|2|||
144636538|NCT03417440|521522082|FG003|Overall Study|Withdrawal by Subject|1|||
144636539|NCT03417440|521522083|FG004|Overall Study|Withdrawal by Subject|1|||
144636540|NCT03417440|521522084|FG005|Overall Study|Withdrawal by Subject|0|||
144636541|NCT03417440|521522085|FG006|Overall Study|Withdrawal by Subject|0|||
144636542|NCT03417440|521522086|FG007|Overall Study|Withdrawal by Subject|1|||
144636543|NCT00607048|521522088|FG000|Overall Study|Adverse Event|0|||
144636544|NCT00607048|521522089|FG001|Overall Study|Adverse Event|1|||
144636545|NCT00607048|521522090|FG002|Overall Study|Adverse Event|0|||
144636546|NCT00607048|521522091|FG003|Overall Study|Adverse Event|0|||
144636547|NCT00607048|521522092|FG004|Overall Study|Adverse Event|4|||
144636548|NCT00607048|521522093|FG005|Overall Study|Adverse Event|0|||
144636549|NCT00607048|521522088|FG000|Overall Study|Global deterioration of health|1|||
144636550|NCT00607048|521522089|FG001|Overall Study|Global deterioration of health|0|||
144636551|NCT00607048|521522090|FG002|Overall Study|Global deterioration of health|0|||
144636552|NCT00607048|521522091|FG003|Overall Study|Global deterioration of health|0|||
144636553|NCT00607048|521522092|FG004|Overall Study|Global deterioration of health|0|||
144636554|NCT00607048|521522093|FG005|Overall Study|Global deterioration of health|0|||
144636555|NCT00607048|521522088|FG000|Overall Study|Objective disease progression - relapse|1|||
144636556|NCT00607048|521522089|FG001|Overall Study|Objective disease progression - relapse|2|||
144636557|NCT00607048|521522090|FG002|Overall Study|Objective disease progression - relapse|4|||
144636558|NCT00607048|521522091|FG003|Overall Study|Objective disease progression - relapse|2|||
144636559|NCT00607048|521522092|FG004|Overall Study|Objective disease progression - relapse|2|||
144636560|NCT00607048|521522093|FG005|Overall Study|Objective disease progression - relapse|2|||
144636561|NCT00607048|521522088|FG000|Overall Study|Withdrawal by Subject|0|||
144636562|NCT00607048|521522089|FG001|Overall Study|Withdrawal by Subject|0|||
144210516|NCT00384930|519965295|FG002|Overall Study|Withdrawal by Subject|7|||
144262991|NCT00735709|520163809|FG003|Overall Study|Voluntary Withdrawal|7|||
144210517|NCT00384930|519965296|FG003|Overall Study|Withdrawal by Subject|6|||
144262992|NCT00735709|520163806|FG000|Overall Study|Lost to Follow-up|0|||
144636563|NCT00607048|521522090|FG002|Overall Study|Withdrawal by Subject|0|||
144636564|NCT00607048|521522091|FG003|Overall Study|Withdrawal by Subject|1|||
144636565|NCT00607048|521522092|FG004|Overall Study|Withdrawal by Subject|0|||
144636566|NCT00607048|521522093|FG005|Overall Study|Withdrawal by Subject|2|||
144636567|NCT00607048|521522088|FG000|Overall Study|Other|1|||
144636568|NCT00607048|521522089|FG001|Overall Study|Other|1|||
144210518|NCT00384930|519965297|FG004|Overall Study|Withdrawal by Subject|16|||
144262993|NCT00735709|520163807|FG001|Overall Study|Lost to Follow-up|1|||
144636569|NCT00607048|521522090|FG002|Overall Study|Other|0|||
144636570|NCT00607048|521522091|FG003|Overall Study|Other|0|||
144636571|NCT00607048|521522092|FG004|Overall Study|Other|0|||
144210519|NCT00384930|519965293|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
144210520|NCT00384930|519965294|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
144210521|NCT00384930|519965295|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
144210522|NCT00384930|519965296|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
144636572|NCT00607048|521522093|FG005|Overall Study|Other|1|||
144636573|NCT00316264|521522094|FG000|Overall Study|Lost to Follow-up|0|||
144636574|NCT00316264|521522095|FG001|Overall Study|Lost to Follow-up|1|||
144636575|NCT00316264|521522096|FG002|Overall Study|Lost to Follow-up|0|||
144636576|NCT00316264|521522094|FG000|Overall Study|Withdrawal of Consent|3|||
144636577|NCT00316264|521522095|FG001|Overall Study|Withdrawal of Consent|5|||
144636578|NCT00316264|521522096|FG002|Overall Study|Withdrawal of Consent|6|||
144636579|NCT00316264|521522094|FG000|Overall Study|Death|2|||
144636580|NCT00316264|521522095|FG001|Overall Study|Death|0|||
144636581|NCT00316264|521522096|FG002|Overall Study|Death|0|||
144636582|NCT00316264|521522094|FG000|Overall Study|Other|1|||
144636583|NCT00316264|521522095|FG001|Overall Study|Other|1|||
144636584|NCT00316264|521522096|FG002|Overall Study|Other|0|||
144636585|NCT04336163|521522097|FG000|Overall Study|Lost to Follow-up|55|||
144636586|NCT04336163|521522098|FG001|Overall Study|Lost to Follow-up|0|||
144636587|NCT00826514|521522099|FG000|Overall Study|Adverse Event|1|||
144636588|NCT00826514|521522100|FG001|Overall Study|Adverse Event|1|||
144636589|NCT00826514|521522099|FG000|Overall Study|Lack of Efficacy|0|||
144636590|NCT00826514|521522100|FG001|Overall Study|Lack of Efficacy|1|||
144636591|NCT00826514|521522099|FG000|Overall Study|Withdrawal by Subject|2|||
144636592|NCT00826514|521522100|FG001|Overall Study|Withdrawal by Subject|3|||
144636593|NCT01773473|521522101|FG000|Overall Study|Adverse Event|3|||
144636594|NCT01773473|521522102|FG001|Overall Study|Adverse Event|2|||
144636595|NCT01773473|521522101|FG000|Overall Study|Protocol Violation|0|||
144636596|NCT01773473|521522102|FG001|Overall Study|Protocol Violation|4|||
144636597|NCT01773473|521522101|FG000|Overall Study|Physician Decision|3|||
144636598|NCT01773473|521522102|FG001|Overall Study|Physician Decision|5|||
144636599|NCT01773473|521522101|FG000|Overall Study|Sponsor Decision|2|||
144636600|NCT01773473|521522102|FG001|Overall Study|Sponsor Decision|0|||
144636601|NCT01773473|521522101|FG000|Overall Study|Lack of Efficacy|0|||
144636602|NCT01773473|521522102|FG001|Overall Study|Lack of Efficacy|1|||
144636603|NCT01773473|521522101|FG000|Overall Study|Non-Compliance with study drug|1|||
144636604|NCT01773473|521522102|FG001|Overall Study|Non-Compliance with study drug|4|||
144636605|NCT01773473|521522101|FG000|Overall Study|Withdrawal by Subject|5|||
144636606|NCT01773473|521522102|FG001|Overall Study|Withdrawal by Subject|3|||
144636607|NCT01773473|521522101|FG000|Overall Study|Lost to Follow-up|2|||
144636608|NCT01773473|521522102|FG001|Overall Study|Lost to Follow-up|0|||
144636609|NCT01085682|521522103|FG000|Overall Study|Withdrawal by Subject|25|||
144636610|NCT01085682|521522104|FG001|Overall Study|Withdrawal by Subject|25|||
144636611|NCT01451645|521522107|FG000|Overall Study|Protocol Violation|1|||
144636612|NCT01451645|521522108|FG001|Overall Study|Protocol Violation|0|||
144636613|NCT01451645|521522107|FG000|Overall Study|Adverse Event|0|||
144636614|NCT01451645|521522108|FG001|Overall Study|Adverse Event|3|||
144636615|NCT01451645|521522107|FG000|Overall Study|Withdrawal by Subject|4|||
144636616|NCT01451645|521522108|FG001|Overall Study|Withdrawal by Subject|2|||
144636617|NCT01451645|521522107|FG000|Overall Study|Lost to Follow-up|4|||
144636618|NCT01451645|521522108|FG001|Overall Study|Lost to Follow-up|3|||
144636619|NCT03926143|521522114|FG000|Overall Study|Physician Decision|3|||
144636620|NCT03926143|521522114|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
144636621|NCT03926143|521522114|FG000|Overall Study|Adverse Event|2|||
144636622|NCT03926143|521522114|FG000|Overall Study|Progressive disease|3|||
144636623|NCT02561156|521522118|FG000|Part 2|Adverse Event|0|||
144636624|NCT02561156|521522119|FG001|Part 2|Adverse Event|0|||
144636625|NCT02561156|521522120|FG002|Part 2|Adverse Event|0|||
144636626|NCT02561156|521522121|FG003|Part 2|Adverse Event|0|||
144636627|NCT02561156|521522122|FG004|Part 2|Adverse Event|0|||
144731000|NCT05327491|521871344|FG002|Periods 1 & 2|Miscellaneous|0|||
144210523|NCT00384930|519965297|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
144210524|NCT00534404|519965298|FG000|Overall Study|Death|0|||
144210525|NCT00534404|519965299|FG001|Overall Study|Death|0|||
144210526|NCT00534404|519965300|FG002|Overall Study|Death|2|||
144210527|NCT00534404|519965298|FG000|Overall Study|Withdrawal by Subject|8|||
144262994|NCT00735709|520163808|FG002|Overall Study|Lost to Follow-up|1|||
144262995|NCT00735709|520163809|FG003|Overall Study|Lost to Follow-up|1|||
144636628|NCT02561156|521522123|FG005|Part 2|Adverse Event|0|||
144636629|NCT02561156|521522124|FG006|Part 2|Adverse Event|0|||
144636630|NCT02561156|521522125|FG007|Part 2|Adverse Event|0|||
144636631|NCT02561156|521522126|FG008|Part 2|Adverse Event|0|||
144636632|NCT02561156|521522127|FG009|Part 2|Adverse Event|0|||
144636633|NCT02561156|521522128|FG010|Part 2|Adverse Event|0|||
144636634|NCT02561156|521522129|FG011|Part 2|Adverse Event|1|||
144636635|NCT02561156|521522130|FG012|Part 2|Adverse Event|0|||
144636636|NCT01071070|521522132|FG000|Overall Study|Adverse Event|0|||
144636637|NCT01071070|521522133|FG001|Overall Study|Adverse Event|3|||
144636638|NCT01071070|521522132|FG000|Overall Study|Withdrawal by Subject|1|||
144636639|NCT01071070|521522133|FG001|Overall Study|Withdrawal by Subject|0|||
144731001|NCT05327491|521871345|FG003|Periods 1 & 2|Miscellaneous|0|||
144636640|NCT01071070|521522132|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
144636641|NCT01071070|521522133|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
144636642|NCT01071070|521522132|FG000|Overall Study|Hypercalcemia|1|||
144636643|NCT01071070|521522133|FG001|Overall Study|Hypercalcemia|0|||
144636644|NCT02207907|521522144|FG000|Overall Study|Lost to Follow-up|3|||
144636645|NCT02207907|521522145|FG001|Overall Study|Lost to Follow-up|1|||
144636646|NCT02207907|521522144|FG000|Overall Study|Withdrawal by Subject|5|||
144636647|NCT02207907|521522145|FG001|Overall Study|Withdrawal by Subject|6|||
144636648|NCT02207907|521522144|FG000|Overall Study|Did not meet study criteria|3|||
144636649|NCT02207907|521522145|FG001|Overall Study|Did not meet study criteria|0|||
144636650|NCT02207907|521522144|FG000|Overall Study|Pregnancy|0|||
144636651|NCT02207907|521522145|FG001|Overall Study|Pregnancy|1|||
144636652|NCT00158184|521522146|FG000|Overall Study|personal issues|3|||
144636653|NCT00158184|521522147|FG001|Overall Study|personal issues|1|||
144636654|NCT00158184|521522146|FG000|Overall Study|failed for follow unit/study rules|2|||
144636655|NCT00158184|521522147|FG001|Overall Study|failed for follow unit/study rules|0|||
144636656|NCT00158184|521522146|FG000|Overall Study|Adverse Event|1|||
144636657|NCT00158184|521522147|FG001|Overall Study|Adverse Event|1|||
144636658|NCT02620020|521522156|FG000|Overall Study|Adverse Event|8|||
144636659|NCT02620020|521522157|FG001|Overall Study|Adverse Event|4|||
144636660|NCT02620020|521522158|FG002|Overall Study|Adverse Event|3|||
144636661|NCT02620020|521522159|FG003|Overall Study|Adverse Event|5|||
144636662|NCT02620020|521522156|FG000|Overall Study|Lost to Follow-up|4|||
144636663|NCT02620020|521522157|FG001|Overall Study|Lost to Follow-up|8|||
144636664|NCT02620020|521522158|FG002|Overall Study|Lost to Follow-up|1|||
144636665|NCT02620020|521522159|FG003|Overall Study|Lost to Follow-up|4|||
144636666|NCT02620020|521522156|FG000|Overall Study|Physician Decision|7|||
144636667|NCT02620020|521522157|FG001|Overall Study|Physician Decision|4|||
144636668|NCT02620020|521522158|FG002|Overall Study|Physician Decision|3|||
144636669|NCT02620020|521522159|FG003|Overall Study|Physician Decision|4|||
144636670|NCT02620020|521522156|FG000|Overall Study|Protocol Violation|5|||
144636671|NCT02620020|521522157|FG001|Overall Study|Protocol Violation|2|||
144636672|NCT02620020|521522158|FG002|Overall Study|Protocol Violation|1|||
144636673|NCT02620020|521522159|FG003|Overall Study|Protocol Violation|1|||
144636674|NCT02620020|521522156|FG000|Overall Study|Withdrawal by Subject|20|||
144636675|NCT02620020|521522157|FG001|Overall Study|Withdrawal by Subject|16|||
144636676|NCT02620020|521522158|FG002|Overall Study|Withdrawal by Subject|17|||
144636677|NCT02620020|521522159|FG003|Overall Study|Withdrawal by Subject|12|||
144636678|NCT02620020|521522156|FG000|Overall Study|Death|0|||
144636679|NCT02620020|521522157|FG001|Overall Study|Death|1|||
144636680|NCT02620020|521522158|FG002|Overall Study|Death|0|||
144636681|NCT02620020|521522159|FG003|Overall Study|Death|0|||
144636682|NCT01025635|521522165|FG000|Overall Study|Withdrawal by Subject|6|||
144636683|NCT01025635|521522166|FG001|Overall Study|Withdrawal by Subject|7|||
144636684|NCT01025635|521522165|FG000|Overall Study|Protocol Violation|4|||
144636685|NCT01025635|521522166|FG001|Overall Study|Protocol Violation|2|||
144636686|NCT01025635|521522165|FG000|Overall Study|Lack of Efficacy|0|||
144636687|NCT01025635|521522166|FG001|Overall Study|Lack of Efficacy|1|||
144636688|NCT01025635|521522165|FG000|Overall Study|Lost to Follow-up|9|||
144636689|NCT01025635|521522166|FG001|Overall Study|Lost to Follow-up|13|||
144636690|NCT01025635|521522165|FG000|Overall Study|Reason not known|4|||
144636691|NCT01025635|521522166|FG001|Overall Study|Reason not known|2|||
144636692|NCT02393209|521522167|FG000|Overall Study|Study Terminated by Sponsor|1|||
144636693|NCT02393209|521522168|FG001|Overall Study|Study Terminated by Sponsor|1|||
144636694|NCT02393209|521522169|FG002|Overall Study|Study Terminated by Sponsor|0|||
144636695|NCT02393209|521522170|FG003|Overall Study|Study Terminated by Sponsor|0|||
144636696|NCT02393209|521522167|FG000|Overall Study|Withdrawal by Patient|1|||
144636697|NCT02393209|521522168|FG001|Overall Study|Withdrawal by Patient|0|||
144636698|NCT02393209|521522169|FG002|Overall Study|Withdrawal by Patient|0|||
144636699|NCT02393209|521522170|FG003|Overall Study|Withdrawal by Patient|0|||
144636700|NCT02393209|521522167|FG000|Overall Study|Death|2|||
144636701|NCT02393209|521522168|FG001|Overall Study|Death|2|||
144731002|NCT05327491|521871342|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
144636702|NCT02393209|521522169|FG002|Overall Study|Death|0|||
144636703|NCT02393209|521522170|FG003|Overall Study|Death|0|||
144636704|NCT02393209|521522167|FG000|Overall Study|Death due to Disease Progression|2|||
144636705|NCT02393209|521522168|FG001|Overall Study|Death due to Disease Progression|2|||
144636706|NCT02393209|521522169|FG002|Overall Study|Death due to Disease Progression|0|||
144636707|NCT02393209|521522170|FG003|Overall Study|Death due to Disease Progression|0|||
144636708|NCT02393209|521522167|FG000|Overall Study|Death from Legionella Infection|0|||
144636709|NCT02393209|521522168|FG001|Overall Study|Death from Legionella Infection|1|||
144636710|NCT02393209|521522169|FG002|Overall Study|Death from Legionella Infection|0|||
144636711|NCT02393209|521522170|FG003|Overall Study|Death from Legionella Infection|0|||
144636712|NCT02393209|521522167|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
144636713|NCT02393209|521522168|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
144636714|NCT02393209|521522169|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
144731003|NCT05327491|521871343|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
144636715|NCT02393209|521522170|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
144636716|NCT02393209|521522167|FG000|Overall Study|Lost to Follow-up|0|||
144636717|NCT02393209|521522168|FG001|Overall Study|Lost to Follow-up|1|||
144636718|NCT02393209|521522169|FG002|Overall Study|Lost to Follow-up|0|||
144636719|NCT02393209|521522170|FG003|Overall Study|Lost to Follow-up|0|||
144636720|NCT03545282|521522171|FG000|Overall Study|Lost to Follow-up|15|||
144636721|NCT03545282|521522172|FG001|Overall Study|Lost to Follow-up|10|||
144636722|NCT03545282|521522171|FG000|Overall Study|Withdrawal by Subject|2|||
144636723|NCT03545282|521522172|FG001|Overall Study|Withdrawal by Subject|2|||
144636724|NCT02582671|521522173|FG000|Overall Study|Failure to return|1|||
144636725|NCT02582671|521522173|FG000|Overall Study|Other, not specified|1|||
144636726|NCT02537678|521522176|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
144636727|NCT02537678|521522177|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
144636728|NCT02537678|521522176|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
144636729|NCT02537678|521522177|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
144636730|NCT02537678|521522176|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
144636731|NCT02537678|521522177|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
144636732|NCT02537678|521522176|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
144636733|NCT02537678|521522177|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
144636734|NCT02537678|521522176|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
144636735|NCT02537678|521522177|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
144636736|NCT02537678|521522176|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
144636737|NCT02537678|521522177|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
144636738|NCT02537678|521522176|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
144636739|NCT02537678|521522177|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
144636740|NCT00629083|521522178|FG000|Overall Study|Adverse Event|0|||
144636741|NCT00629083|521522179|FG001|Overall Study|Adverse Event|2|||
144636742|NCT00629083|521522178|FG000|Overall Study|Lack of Efficacy|3|||
144636743|NCT00629083|521522179|FG001|Overall Study|Lack of Efficacy|1|||
144636744|NCT00629083|521522178|FG000|Overall Study|Withdrawal by Subject|10|||
144636745|NCT00629083|521522179|FG001|Overall Study|Withdrawal by Subject|2|||
144636746|NCT00629083|521522178|FG000|Overall Study|Lost to Follow-up|12|||
144636747|NCT00629083|521522179|FG001|Overall Study|Lost to Follow-up|8|||
144636748|NCT00629083|521522178|FG000|Overall Study|Moved out of country/state|2|||
144636749|NCT00629083|521522179|FG001|Overall Study|Moved out of country/state|1|||
144636750|NCT00629083|521522178|FG000|Overall Study|Refused to return for 12 month visit|1|||
144636751|NCT00629083|521522179|FG001|Overall Study|Refused to return for 12 month visit|0|||
144636752|NCT01478958|521522180|FG000|Overall Study|Withdrawal by Subject|1|||
144636753|NCT01478958|521522181|FG001|Overall Study|Withdrawal by Subject|1|||
144636754|NCT01478958|521522182|FG002|Overall Study|Withdrawal by Subject|1|||
144636755|NCT01478958|521522180|FG000|Overall Study|Weight loss|1|||
144636756|NCT01478958|521522181|FG001|Overall Study|Weight loss|0|||
144636757|NCT01478958|521522182|FG002|Overall Study|Weight loss|0|||
144636758|NCT01478958|521522180|FG000|Overall Study|Re-located|0|||
144636759|NCT01478958|521522181|FG001|Overall Study|Re-located|1|||
144636760|NCT01478958|521522182|FG002|Overall Study|Re-located|0|||
144636761|NCT01478958|521522180|FG000|Overall Study|Unable to comply|0|||
144636762|NCT01478958|521522181|FG001|Overall Study|Unable to comply|0|||
144636763|NCT01478958|521522182|FG002|Overall Study|Unable to comply|2|||
144636764|NCT03401749|521522183|FG000|Overall Study|Lost to Follow-up|20|||
144636765|NCT03401749|521522184|FG001|Overall Study|Lost to Follow-up|16|||
144636766|NCT03401749|521522185|FG002|Overall Study|Lost to Follow-up|26|||
144636767|NCT01499290|521522186|FG000|Overall Study|Withdrawal by Subject|22|||
144636768|NCT01499290|521522187|FG001|Overall Study|Withdrawal by Subject|15|||
144636769|NCT01499290|521522186|FG000|Overall Study|Not specified in study report|11|||
144636770|NCT01499290|521522187|FG001|Overall Study|Not specified in study report|5|||
144636771|NCT01499290|521522186|FG000|Overall Study|Condition improved/subject recovered|1|||
144636772|NCT01499290|521522187|FG001|Overall Study|Condition improved/subject recovered|0|||
144636773|NCT01499290|521522186|FG000|Overall Study|Lack of Efficacy|7|||
144636774|NCT01499290|521522187|FG001|Overall Study|Lack of Efficacy|8|||
144636775|NCT01499290|521522186|FG000|Overall Study|Adverse Event|14|||
144636776|NCT01499290|521522187|FG001|Overall Study|Adverse Event|7|||
144636777|NCT03853694|521522188|FG000|Overall Study|Protocol Violation|3|||
144636778|NCT03853694|521522189|FG001|Overall Study|Protocol Violation|5|||
144636779|NCT03853694|521522190|FG002|Overall Study|Protocol Violation|3|||
144636780|NCT03853694|521522188|FG000|Overall Study|Delivered early|0|||
144731004|NCT05327491|521871344|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
144731005|NCT05327491|521871345|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
144636781|NCT03853694|521522189|FG001|Overall Study|Delivered early|1|||
144636782|NCT03853694|521522190|FG002|Overall Study|Delivered early|0|||
144636783|NCT03853694|521522188|FG000|Overall Study|not suitable to proceed|0|||
144636784|NCT03853694|521522189|FG001|Overall Study|not suitable to proceed|1|||
144636785|NCT03853694|521522190|FG002|Overall Study|not suitable to proceed|0|||
144731006|NCT05612724|521871348|FG000|Overall Study|Lost to Follow-up|4|||
144636786|NCT03853694|521522188|FG000|Overall Study|difficult surgery|0|||
144636787|NCT03853694|521522189|FG001|Overall Study|difficult surgery|0|||
144636788|NCT03853694|521522190|FG002|Overall Study|difficult surgery|1|||
144636789|NCT03853694|521522188|FG000|Overall Study|Lost to Follow-up|0|||
144636790|NCT03853694|521522189|FG001|Overall Study|Lost to Follow-up|1|||
144636791|NCT03853694|521522190|FG002|Overall Study|Lost to Follow-up|0|||
144636792|NCT03853694|521522188|FG000|Overall Study|Withdrawal by Subject|0|||
144636793|NCT03853694|521522189|FG001|Overall Study|Withdrawal by Subject|1|||
144636794|NCT03853694|521522190|FG002|Overall Study|Withdrawal by Subject|0|||
144636795|NCT02209766|521522192|FG000|Overall Study|Withdrawal by Subject|0|||
144636796|NCT02209766|521522193|FG001|Overall Study|Withdrawal by Subject|0|||
144636797|NCT02209766|521522194|FG002|Overall Study|Withdrawal by Subject|0|||
144636798|NCT02209766|521522195|FG003|Overall Study|Withdrawal by Subject|1|||
144636799|NCT02209766|521522196|FG004|Overall Study|Withdrawal by Subject|0|||
144636800|NCT00327444|521522197|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
144636801|NCT00327444|521522198|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
144636802|NCT00327444|521522197|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
144636803|NCT00327444|521522198|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
144636804|NCT00327444|521522197|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
144636805|NCT00327444|521522198|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
144636806|NCT00327444|521522197|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
144636807|NCT00327444|521522198|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
144636808|NCT00327444|521522197|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
144636809|NCT00327444|521522198|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
144636810|NCT00327444|521522197|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
144636811|NCT00327444|521522198|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
144636812|NCT00327444|521522197|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
144636813|NCT00327444|521522198|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
144636814|NCT00327444|521522197|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
144636815|NCT00327444|521522198|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
144636816|NCT00805207|521522199|FG000|Overall Study|Protocol Violation|0|||
144636817|NCT00805207|521522200|FG001|Overall Study|Protocol Violation|0|||
144636818|NCT00805207|521522201|FG002|Overall Study|Protocol Violation|1|||
144636819|NCT00805207|521522202|FG003|Overall Study|Protocol Violation|0|||
144636820|NCT00805207|521522203|FG004|Overall Study|Protocol Violation|0|||
144636821|NCT00805207|521522204|FG005|Overall Study|Protocol Violation|0|||
144636822|NCT00805207|521522205|FG006|Overall Study|Protocol Violation|0|||
144636823|NCT00805207|521522206|FG007|Overall Study|Protocol Violation|0|||
144636824|NCT00805207|521522207|FG008|Overall Study|Protocol Violation|0|||
144636825|NCT00805207|521522199|FG000|Overall Study|Physician Decision|0|||
144636826|NCT00805207|521522200|FG001|Overall Study|Physician Decision|1|||
144636827|NCT00805207|521522201|FG002|Overall Study|Physician Decision|0|||
144636828|NCT00805207|521522202|FG003|Overall Study|Physician Decision|0|||
144636829|NCT00805207|521522203|FG004|Overall Study|Physician Decision|0|||
144636830|NCT00805207|521522204|FG005|Overall Study|Physician Decision|1|||
144636831|NCT00805207|521522205|FG006|Overall Study|Physician Decision|0|||
144636832|NCT00805207|521522206|FG007|Overall Study|Physician Decision|0|||
144636833|NCT00805207|521522207|FG008|Overall Study|Physician Decision|0|||
144636834|NCT00805207|521522199|FG000|Overall Study|Withdrawal by Subject|0|||
144636835|NCT00805207|521522200|FG001|Overall Study|Withdrawal by Subject|1|||
144636836|NCT00805207|521522201|FG002|Overall Study|Withdrawal by Subject|0|||
144636837|NCT00805207|521522202|FG003|Overall Study|Withdrawal by Subject|0|||
144636838|NCT00805207|521522203|FG004|Overall Study|Withdrawal by Subject|1|||
144636839|NCT00805207|521522204|FG005|Overall Study|Withdrawal by Subject|2|||
144636840|NCT00805207|521522205|FG006|Overall Study|Withdrawal by Subject|0|||
144636841|NCT00805207|521522206|FG007|Overall Study|Withdrawal by Subject|0|||
144636842|NCT00805207|521522207|FG008|Overall Study|Withdrawal by Subject|0|||
144636843|NCT00064701|521522208|FG000|One Year Post-transplant|Did not receive study drug|7|||
144636844|NCT00064701|521522209|FG001|One Year Post-transplant|Did not receive study drug|12|||
144636845|NCT00064701|521522210|FG002|One Year Post-transplant|Did not receive study drug|11|||
144636846|NCT00064701|521522208|FG000|One Year Post-transplant|Adverse Event|23|||
144731007|NCT04000815|521871355|FG000|Overall Study|Lost to Follow-up|9|||
144636847|NCT00064701|521522209|FG001|One Year Post-transplant|Adverse Event|19|||
144636848|NCT00064701|521522210|FG002|One Year Post-transplant|Adverse Event|37|||
144636849|NCT00064701|521522208|FG000|One Year Post-transplant|Rejection|0|||
144636850|NCT00064701|521522209|FG001|One Year Post-transplant|Rejection|1|||
144636851|NCT00064701|521522210|FG002|One Year Post-transplant|Rejection|16|||
144636852|NCT00064701|521522208|FG000|One Year Post-transplant|Non-compliance|4|||
144636853|NCT00064701|521522209|FG001|One Year Post-transplant|Non-compliance|2|||
144731008|NCT04000815|521871356|FG001|Overall Study|Lost to Follow-up|2|||
144636854|NCT00064701|521522210|FG002|One Year Post-transplant|Non-compliance|5|||
144636855|NCT00064701|521522208|FG000|One Year Post-transplant|Graft Failure|3|||
144636856|NCT00064701|521522209|FG001|One Year Post-transplant|Graft Failure|2|||
144636857|NCT00064701|521522210|FG002|One Year Post-transplant|Graft Failure|1|||
144636858|NCT00064701|521522208|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
144636859|NCT00064701|521522209|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
144636860|NCT00064701|521522210|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
144636861|NCT00064701|521522208|FG000|One Year Post-transplant|Lost to Follow-up|1|||
144636862|NCT00064701|521522209|FG001|One Year Post-transplant|Lost to Follow-up|0|||
144636863|NCT00064701|521522210|FG002|One Year Post-transplant|Lost to Follow-up|0|||
144636864|NCT00064701|521522208|FG000|One Year Post-transplant|Converted to rapamycin|1|||
144636865|NCT00064701|521522209|FG001|One Year Post-transplant|Converted to rapamycin|0|||
144636866|NCT00064701|521522210|FG002|One Year Post-transplant|Converted to rapamycin|0|||
144636867|NCT00064701|521522208|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
144636868|NCT00064701|521522209|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
144636869|NCT00064701|521522210|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
144636870|NCT00064701|521522208|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
144636871|NCT00064701|521522209|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
144636872|NCT00064701|521522210|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
144636873|NCT00064701|521522208|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
144636874|NCT00064701|521522209|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
144636875|NCT00064701|521522210|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
144636876|NCT00064701|521522208|FG000|One Year Post-transplant|Poor absorption|0|||
144636877|NCT00064701|521522209|FG001|One Year Post-transplant|Poor absorption|1|||
144636878|NCT00064701|521522210|FG002|One Year Post-transplant|Poor absorption|0|||
144636879|NCT00064701|521522208|FG000|One Year Post-transplant|Pancreas transplant|0|||
144636880|NCT00064701|521522209|FG001|One Year Post-transplant|Pancreas transplant|0|||
144636881|NCT00064701|521522210|FG002|One Year Post-transplant|Pancreas transplant|1|||
144636882|NCT00064701|521522208|FG000|Clinical Continuation Phase|Adverse Event|12|||
144636883|NCT00064701|521522209|FG001|Clinical Continuation Phase|Adverse Event|21|||
144636884|NCT00064701|521522210|FG002|Clinical Continuation Phase|Adverse Event|14|||
144636885|NCT00064701|521522208|FG000|Clinical Continuation Phase|Non-compliance|8|||
144636886|NCT00064701|521522209|FG001|Clinical Continuation Phase|Non-compliance|6|||
144636887|NCT00064701|521522210|FG002|Clinical Continuation Phase|Non-compliance|7|||
144636888|NCT00064701|521522208|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
144636889|NCT00064701|521522209|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
144636890|NCT00064701|521522210|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
144636891|NCT00064701|521522208|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
144636892|NCT00064701|521522209|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
144636893|NCT00064701|521522210|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
144636894|NCT00064701|521522208|FG000|Clinical Continuation Phase|Graft Failure|5|||
144636895|NCT00064701|521522209|FG001|Clinical Continuation Phase|Graft Failure|5|||
144636896|NCT00064701|521522210|FG002|Clinical Continuation Phase|Graft Failure|2|||
144636897|NCT00064701|521522208|FG000|Clinical Continuation Phase|Rejection|1|||
144636898|NCT00064701|521522209|FG001|Clinical Continuation Phase|Rejection|2|||
144636899|NCT00064701|521522210|FG002|Clinical Continuation Phase|Rejection|2|||
144636900|NCT00064701|521522208|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
144636901|NCT00064701|521522209|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
144636902|NCT00064701|521522210|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
144636903|NCT00064701|521522208|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
144636904|NCT00064701|521522209|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
144636905|NCT00064701|521522210|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
144636906|NCT00064701|521522208|FG000|Clinical Continuation Phase|Physician Decision|1|||
144636907|NCT00064701|521522209|FG001|Clinical Continuation Phase|Physician Decision|3|||
144636908|NCT00064701|521522210|FG002|Clinical Continuation Phase|Physician Decision|0|||
144636909|NCT00064701|521522208|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
144636910|NCT00064701|521522209|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
144636911|NCT00064701|521522210|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
144636912|NCT00064701|521522208|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
144636913|NCT00064701|521522209|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
144636914|NCT00064701|521522210|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
144210528|NCT00534404|519965299|FG001|Overall Study|Withdrawal by Subject|2|||
144210529|NCT00534404|519965300|FG002|Overall Study|Withdrawal by Subject|38|||
144210530|NCT00534404|519965298|FG000|Overall Study|Removed by study staff|2|||
144210531|NCT00534404|519965299|FG001|Overall Study|Removed by study staff|3|||
144210532|NCT00534404|519965300|FG002|Overall Study|Removed by study staff|1|||
144210533|NCT00534404|519965298|FG000|Overall Study|Lost to Follow-up|170|||
144210534|NCT00534404|519965299|FG001|Overall Study|Lost to Follow-up|138|||
144636915|NCT00064701|521522208|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
144636916|NCT00064701|521522209|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
144636917|NCT00064701|521522210|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
144636918|NCT00064701|521522208|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
144210535|NCT00534404|519965300|FG002|Overall Study|Lost to Follow-up|201|||
144636919|NCT00064701|521522209|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
144636920|NCT00064701|521522210|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
144636921|NCT00064701|521522208|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
144636922|NCT00064701|521522209|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
144636923|NCT00064701|521522210|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
144636924|NCT00064701|521522208|FG000|Clinical Continuation Phase|Patient opted out|0|||
144636925|NCT00064701|521522209|FG001|Clinical Continuation Phase|Patient opted out|0|||
144636926|NCT00064701|521522210|FG002|Clinical Continuation Phase|Patient opted out|1|||
144636927|NCT00481065|521522212|FG000|Overall Study|Adverse event or death|1|||
144636928|NCT00481065|521522213|FG001|Overall Study|Adverse event or death|1|||
144636929|NCT00481065|521522214|FG002|Overall Study|Adverse event or death|3|||
144636930|NCT00481065|521522215|FG003|Overall Study|Adverse event or death|0|||
144636931|NCT00481065|521522216|FG004|Overall Study|Adverse event or death|2|||
144636932|NCT00481065|521522217|FG005|Overall Study|Adverse event or death|0|||
144636933|NCT00481065|521522218|FG006|Overall Study|Adverse event or death|1|||
144636934|NCT00481065|521522219|FG007|Overall Study|Adverse event or death|1|||
144636935|NCT00481065|521522212|FG000|Overall Study|Withdrawal by Subject|11|||
144636936|NCT00481065|521522213|FG001|Overall Study|Withdrawal by Subject|12|||
144636937|NCT00481065|521522214|FG002|Overall Study|Withdrawal by Subject|7|||
144636938|NCT00481065|521522215|FG003|Overall Study|Withdrawal by Subject|11|||
144636939|NCT00481065|521522216|FG004|Overall Study|Withdrawal by Subject|13|||
144636940|NCT00481065|521522217|FG005|Overall Study|Withdrawal by Subject|12|||
144636941|NCT00481065|521522218|FG006|Overall Study|Withdrawal by Subject|9|||
144636942|NCT00481065|521522219|FG007|Overall Study|Withdrawal by Subject|10|||
144636943|NCT00481065|521522212|FG000|Overall Study|Lost to Follow-up|4|||
144636944|NCT00481065|521522213|FG001|Overall Study|Lost to Follow-up|2|||
144636945|NCT00481065|521522214|FG002|Overall Study|Lost to Follow-up|4|||
144636946|NCT00481065|521522215|FG003|Overall Study|Lost to Follow-up|3|||
144636947|NCT00481065|521522216|FG004|Overall Study|Lost to Follow-up|3|||
144636948|NCT00481065|521522217|FG005|Overall Study|Lost to Follow-up|3|||
144636949|NCT00481065|521522218|FG006|Overall Study|Lost to Follow-up|2|||
144636950|NCT00481065|521522219|FG007|Overall Study|Lost to Follow-up|5|||
144636951|NCT00481065|521522212|FG000|Overall Study|Inappropriate enrollment|4|||
144636952|NCT00481065|521522213|FG001|Overall Study|Inappropriate enrollment|0|||
144636953|NCT00481065|521522214|FG002|Overall Study|Inappropriate enrollment|2|||
144636954|NCT00481065|521522215|FG003|Overall Study|Inappropriate enrollment|0|||
144636955|NCT00481065|521522216|FG004|Overall Study|Inappropriate enrollment|2|||
144636956|NCT00481065|521522217|FG005|Overall Study|Inappropriate enrollment|1|||
144636957|NCT00481065|521522218|FG006|Overall Study|Inappropriate enrollment|0|||
144636958|NCT00481065|521522219|FG007|Overall Study|Inappropriate enrollment|1|||
144636959|NCT00481065|521522212|FG000|Overall Study|Administrative reason|0|||
144636960|NCT00481065|521522213|FG001|Overall Study|Administrative reason|0|||
144636961|NCT00481065|521522214|FG002|Overall Study|Administrative reason|0|||
144636962|NCT00481065|521522215|FG003|Overall Study|Administrative reason|0|||
144636963|NCT00481065|521522216|FG004|Overall Study|Administrative reason|0|||
144636964|NCT00481065|521522217|FG005|Overall Study|Administrative reason|2|||
144636965|NCT00481065|521522218|FG006|Overall Study|Administrative reason|1|||
144636966|NCT00481065|521522219|FG007|Overall Study|Administrative reason|0|||
144636967|NCT00481065|521522212|FG000|Overall Study|Protocol Violation|2|||
144636968|NCT00481065|521522213|FG001|Overall Study|Protocol Violation|1|||
144636969|NCT00481065|521522214|FG002|Overall Study|Protocol Violation|1|||
144636970|NCT00481065|521522215|FG003|Overall Study|Protocol Violation|1|||
144636971|NCT00481065|521522216|FG004|Overall Study|Protocol Violation|2|||
144636972|NCT00481065|521522217|FG005|Overall Study|Protocol Violation|6|||
144636973|NCT00481065|521522218|FG006|Overall Study|Protocol Violation|3|||
144636974|NCT00481065|521522219|FG007|Overall Study|Protocol Violation|2|||
144636975|NCT00481065|521522212|FG000|Overall Study|Unable to classify|0|||
144636976|NCT00481065|521522213|FG001|Overall Study|Unable to classify|1|||
144636977|NCT00481065|521522214|FG002|Overall Study|Unable to classify|2|||
144636978|NCT00481065|521522215|FG003|Overall Study|Unable to classify|0|||
144636979|NCT00481065|521522216|FG004|Overall Study|Unable to classify|1|||
144636980|NCT00481065|521522217|FG005|Overall Study|Unable to classify|0|||
144210536|NCT02996487|519965301|FG000|Overall Study|Lost to Follow-up|1|||
144636981|NCT00481065|521522218|FG006|Overall Study|Unable to classify|0|||
144636982|NCT00481065|521522219|FG007|Overall Study|Unable to classify|0|||
144636983|NCT03770403|521522220|FG000|Overall Study|Adverse Event|8|||
144636984|NCT03770403|521522220|FG000|Overall Study|Death|5|||
144636985|NCT03770403|521522220|FG000|Overall Study|Physician Decision|1|||
144636986|NCT03770403|521522220|FG000|Overall Study|Sponsor decision|1|||
144636987|NCT03770403|521522220|FG000|Overall Study|Study terminated by Sponsor|1|||
144636988|NCT03770403|521522220|FG000|Overall Study|Withdrawal by Subject|13|||
144636989|NCT03770403|521522220|FG000|Overall Study|Other|88|||
144636990|NCT03896295|521522221|FG000|Overall Study|Adverse Event|0|||
144636991|NCT03896295|521522222|FG001|Overall Study|Adverse Event|1|||
144636992|NCT03896295|521522221|FG000|Overall Study|COVID-19|7|||
144210537|NCT02996487|519965302|FG001|Overall Study|Lost to Follow-up|1|||
144636993|NCT03896295|521522222|FG001|Overall Study|COVID-19|29|||
144636994|NCT00552110|521522223|FG000|Overall Study|Serious or Life-Threatening AE|0|||
144636995|NCT00552110|521522224|FG001|Overall Study|Serious or Life-Threatening AE|0|||
144636996|NCT00552110|521522225|FG002|Overall Study|Serious or Life-Threatening AE|1|||
144636997|NCT00552110|521522226|FG003|Overall Study|Serious or Life-Threatening AE|0|||
144636998|NCT00552110|521522227|FG004|Overall Study|Serious or Life-Threatening AE|0|||
144636999|NCT00552110|521522223|FG000|Overall Study|Lack of Efficacy|1|||
144637000|NCT00552110|521522224|FG001|Overall Study|Lack of Efficacy|0|||
144637001|NCT00552110|521522225|FG002|Overall Study|Lack of Efficacy|0|||
144637002|NCT00552110|521522226|FG003|Overall Study|Lack of Efficacy|1|||
144637003|NCT00552110|521522227|FG004|Overall Study|Lack of Efficacy|4|||
144637004|NCT00552110|521522223|FG000|Overall Study|Withdrawal by Subject|0|||
144731009|NCT04000815|521871357|FG002|Overall Study|Lost to Follow-up|3|||
144731010|NCT04000815|521871355|FG000|Overall Study|Withdrawal by Subject|4|||
144731011|NCT04000815|521871356|FG001|Overall Study|Withdrawal by Subject|3|||
144731012|NCT04000815|521871357|FG002|Overall Study|Withdrawal by Subject|2|||
144731013|NCT04000815|521871355|FG000|Overall Study|Right ovarian cyst occured|1|||
144731014|NCT04000815|521871356|FG001|Overall Study|Right ovarian cyst occured|0|||
144731015|NCT04000815|521871357|FG002|Overall Study|Right ovarian cyst occured|0|||
144731016|NCT04000815|521871355|FG000|Overall Study|Hypertension occured on follow up|0|||
144731017|NCT04000815|521871356|FG001|Overall Study|Hypertension occured on follow up|0|||
144731018|NCT04000815|521871357|FG002|Overall Study|Hypertension occured on follow up|2|||
144731019|NCT02422264|521871360|FG000|Overall Study|Serious Adverse Event|1|||
144731020|NCT02422264|521871361|FG001|Overall Study|Serious Adverse Event|0|||
144731021|NCT02422264|521871360|FG000|Overall Study|Withdrawal by Subject|1|||
144731022|NCT02422264|521871361|FG001|Overall Study|Withdrawal by Subject|2|||
144731023|NCT02422264|521871360|FG000|Overall Study|Migrated/moved from study area|3|||
144731024|NCT02422264|521871361|FG001|Overall Study|Migrated/moved from study area|1|||
144731025|NCT02422264|521871360|FG000|Overall Study|Subject vaccinated outside of the study|0|||
144731026|NCT02422264|521871361|FG001|Overall Study|Subject vaccinated outside of the study|1|||
144731027|NCT03021018|521871362|FG000|Overall Study|Adverse Event|1|||
144731028|NCT03021018|521871363|FG001|Overall Study|Adverse Event|0|||
144731029|NCT03021018|521871364|FG002|Overall Study|Adverse Event|0|||
144731030|NCT03021018|521871362|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
144731031|NCT03021018|521871363|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
144731032|NCT03021018|521871364|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
144731033|NCT00856388|521871367|FG000|Overall Study|Other|1|||
144731034|NCT01617668|521871368|FG000|Overall Study|Adverse Event|7|||
144731035|NCT01617668|521871369|FG001|Overall Study|Adverse Event|0|||
144731036|NCT01617668|521871370|FG002|Overall Study|Adverse Event|12|||
144731037|NCT01617668|521871371|FG003|Overall Study|Adverse Event|5|||
144731038|NCT01617668|521871368|FG000|Overall Study|Physician Decision|1|||
144731039|NCT01617668|521871369|FG001|Overall Study|Physician Decision|2|||
144731040|NCT01617668|521871370|FG002|Overall Study|Physician Decision|3|||
144731041|NCT01617668|521871371|FG003|Overall Study|Physician Decision|0|||
144731042|NCT01617668|521871368|FG000|Overall Study|Progressive Disease|4|||
144731043|NCT01617668|521871369|FG001|Overall Study|Progressive Disease|4|||
144731044|NCT01617668|521871370|FG002|Overall Study|Progressive Disease|6|||
144731045|NCT01617668|521871371|FG003|Overall Study|Progressive Disease|9|||
144731046|NCT01617668|521871368|FG000|Overall Study|Subject/guardian decision|1|||
144731047|NCT01617668|521871369|FG001|Overall Study|Subject/guardian decision|3|||
144731048|NCT01617668|521871370|FG002|Overall Study|Subject/guardian decision|2|||
144731049|NCT01617668|521871371|FG003|Overall Study|Subject/guardian decision|1|||
144731050|NCT04091971|521871372|FG000|Overall Study|Withdrawal by Subject|1|||
144731051|NCT04091971|521871372|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
144731052|NCT04091971|521871372|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
144731053|NCT01666730|521871374|FG000|Overall Study|Adverse Event|16|||
144731054|NCT01666730|521871374|FG000|Overall Study|Death|2|||
144731055|NCT01666730|521871374|FG000|Overall Study|Physician Decision|5|||
144731056|NCT01666730|521871374|FG000|Overall Study|Withdrawal by Subject|9|||
144731057|NCT01666730|521871374|FG000|Overall Study|Disease progression/relapse|18|||
144731058|NCT01389102|521871375|FG000|Overall Study|Adverse Event|1|||
144731059|NCT01389102|521871376|FG001|Overall Study|Adverse Event|3|||
144731060|NCT01389102|521871377|FG002|Overall Study|Adverse Event|2|||
144731061|NCT01389102|521871378|FG003|Overall Study|Adverse Event|2|||
144637005|NCT00552110|521522224|FG001|Overall Study|Withdrawal by Subject|2|||
144637006|NCT00552110|521522225|FG002|Overall Study|Withdrawal by Subject|0|||
144637007|NCT00552110|521522226|FG003|Overall Study|Withdrawal by Subject|3|||
144637008|NCT00552110|521522227|FG004|Overall Study|Withdrawal by Subject|2|||
144637009|NCT00552110|521522223|FG000|Overall Study|Lost to Follow-up|0|||
144731062|NCT01389102|521871379|FG004|Overall Study|Adverse Event|2|||
144731063|NCT01389102|521871380|FG005|Overall Study|Adverse Event|2|||
144731064|NCT01389102|521871375|FG000|Overall Study|Hurricane Katrina|4|||
144731065|NCT01389102|521871376|FG001|Overall Study|Hurricane Katrina|2|||
144731066|NCT01389102|521871377|FG002|Overall Study|Hurricane Katrina|3|||
144731067|NCT01389102|521871378|FG003|Overall Study|Hurricane Katrina|0|||
144731068|NCT01389102|521871379|FG004|Overall Study|Hurricane Katrina|3|||
144637010|NCT00552110|521522224|FG001|Overall Study|Lost to Follow-up|0|||
144637011|NCT00552110|521522225|FG002|Overall Study|Lost to Follow-up|0|||
144637012|NCT00552110|521522226|FG003|Overall Study|Lost to Follow-up|1|||
144637013|NCT00552110|521522227|FG004|Overall Study|Lost to Follow-up|1|||
144637014|NCT00552110|521522223|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
144637015|NCT00552110|521522224|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
144637016|NCT00552110|521522225|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
144637017|NCT00552110|521522226|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
144637018|NCT00552110|521522227|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
144637019|NCT00552110|521522223|FG000|Overall Study|Withdrawn per Sponsor|0|||
144637020|NCT00552110|521522224|FG001|Overall Study|Withdrawn per Sponsor|1|||
144637021|NCT00552110|521522225|FG002|Overall Study|Withdrawn per Sponsor|0|||
144637022|NCT00552110|521522226|FG003|Overall Study|Withdrawn per Sponsor|0|||
144637023|NCT00552110|521522227|FG004|Overall Study|Withdrawn per Sponsor|1|||
144637024|NCT00552110|521522223|FG000|Overall Study|Use of Prohibited Medication|1|||
144637025|NCT00552110|521522224|FG001|Overall Study|Use of Prohibited Medication|1|||
144637026|NCT00552110|521522225|FG002|Overall Study|Use of Prohibited Medication|0|||
144637027|NCT00552110|521522226|FG003|Overall Study|Use of Prohibited Medication|0|||
144637028|NCT00552110|521522227|FG004|Overall Study|Use of Prohibited Medication|0|||
144637029|NCT00552110|521522223|FG000|Overall Study|Delay of Study due to Relabeling|0|||
144637030|NCT00552110|521522224|FG001|Overall Study|Delay of Study due to Relabeling|0|||
144637031|NCT00552110|521522225|FG002|Overall Study|Delay of Study due to Relabeling|0|||
144637032|NCT00552110|521522226|FG003|Overall Study|Delay of Study due to Relabeling|1|||
144637033|NCT00552110|521522227|FG004|Overall Study|Delay of Study due to Relabeling|0|||
144637034|NCT00552110|521522223|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
144637035|NCT00552110|521522224|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
144637036|NCT00552110|521522225|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
144637037|NCT00552110|521522226|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
144637038|NCT00552110|521522227|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
144637039|NCT00552110|521522223|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
144637040|NCT00552110|521522224|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
144637041|NCT00552110|521522225|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
144637042|NCT00552110|521522226|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
144637043|NCT00552110|521522227|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
144637044|NCT03029832|521522229|FG000|Overall Study|Safety Follow-Up Completed|2|||
144637045|NCT03029832|521522230|FG001|Overall Study|Safety Follow-Up Completed|0|||
144637046|NCT03029832|521522229|FG000|Overall Study|Death due to Disease Progression|1|||
144637047|NCT03029832|521522230|FG001|Overall Study|Death due to Disease Progression|0|||
144637048|NCT03029832|521522229|FG000|Overall Study|Study Terminated By Sponsor|1|||
144637049|NCT03029832|521522230|FG001|Overall Study|Study Terminated By Sponsor|1|||
144637050|NCT01412229|521522231|FG000|Overall Study|Physician Decision|1|||
144637051|NCT02048904|521522236|FG000|Overall Study|Withdrawal by Subject|7|||
144637052|NCT02048904|521522236|FG000|Overall Study|Physician Decision|70|||
144637053|NCT00490542|521522237|FG000|Overall Study|Lost to Follow-up|3|||
144637054|NCT00490542|521522238|FG001|Overall Study|Lost to Follow-up|0|||
144637055|NCT00490542|521522237|FG000|Overall Study|Adverse Event|3|||
144637056|NCT00490542|521522238|FG001|Overall Study|Adverse Event|3|||
144637057|NCT00490542|521522237|FG000|Overall Study|Lack of Efficacy|1|||
144637058|NCT00490542|521522238|FG001|Overall Study|Lack of Efficacy|1|||
144637059|NCT04640766|521522239|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
144637060|NCT00655928|521522240|FG000|Overall Study|Withdrawal by Subject|2|||
144637061|NCT00655928|521522241|FG001|Overall Study|Withdrawal by Subject|1|||
144637062|NCT00655928|521522240|FG000|Overall Study|Physician Decision|1|||
144637063|NCT00655928|521522241|FG001|Overall Study|Physician Decision|1|||
144637064|NCT02654002|521522243|FG000|Overall Study|Adverse Event|0|||
144637065|NCT02654002|521522244|FG001|Overall Study|Adverse Event|0|||
144637066|NCT02654002|521522245|FG002|Overall Study|Adverse Event|0|||
144637067|NCT02654002|521522246|FG003|Overall Study|Adverse Event|0|||
144637068|NCT02654002|521522247|FG004|Overall Study|Adverse Event|0|||
144637069|NCT02654002|521522248|FG005|Overall Study|Adverse Event|0|||
144731069|NCT01389102|521871380|FG005|Overall Study|Hurricane Katrina|1|||
144731070|NCT01389102|521871375|FG000|Overall Study|Lost to Follow-up|4|||
144637070|NCT02654002|521522249|FG006|Overall Study|Adverse Event|1|||
144637071|NCT02654002|521522250|FG007|Overall Study|Adverse Event|0|||
144637072|NCT02654002|521522251|FG008|Overall Study|Adverse Event|0|||
144637073|NCT02654002|521522243|FG000|Overall Study|Withdrew Consent|0|||
144731071|NCT01389102|521871376|FG001|Overall Study|Lost to Follow-up|1|||
144637074|NCT02654002|521522244|FG001|Overall Study|Withdrew Consent|0|||
144637075|NCT02654002|521522245|FG002|Overall Study|Withdrew Consent|0|||
144637076|NCT02654002|521522246|FG003|Overall Study|Withdrew Consent|0|||
144637077|NCT02654002|521522247|FG004|Overall Study|Withdrew Consent|0|||
144637078|NCT02654002|521522248|FG005|Overall Study|Withdrew Consent|1|||
144637079|NCT02654002|521522249|FG006|Overall Study|Withdrew Consent|0|||
144637080|NCT02654002|521522250|FG007|Overall Study|Withdrew Consent|1|||
144637081|NCT02654002|521522251|FG008|Overall Study|Withdrew Consent|0|||
144210538|NCT02996487|519965303|FG002|Overall Study|Lost to Follow-up|0|||
144210539|NCT02996487|519965301|FG000|Overall Study|Death|0|||
144210540|NCT02996487|519965302|FG001|Overall Study|Death|1|||
144637082|NCT01587989|521522252|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
144637083|NCT01587989|521522253|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
144637084|NCT01587989|521522254|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
144637085|NCT01587989|521522252|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
144637086|NCT01587989|521522253|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
144637087|NCT01587989|521522254|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
144637088|NCT01587989|521522252|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
144637089|NCT01587989|521522253|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
144637090|NCT01587989|521522254|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
144637091|NCT01587989|521522252|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
144637092|NCT01587989|521522253|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
144637093|NCT01587989|521522254|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
144637094|NCT01587989|521522252|FG000|Randomized Study Treatment|Screening failure|0|||
144637095|NCT01587989|521522253|FG001|Randomized Study Treatment|Screening failure|1|||
144637096|NCT01587989|521522254|FG002|Randomized Study Treatment|Screening failure|0|||
144637097|NCT01587989|521522252|FG000|Randomized Study Treatment|Physician Decision|0|||
144637098|NCT01587989|521522253|FG001|Randomized Study Treatment|Physician Decision|0|||
144637099|NCT01587989|521522254|FG002|Randomized Study Treatment|Physician Decision|1|||
144637100|NCT06119191|521522255|FG000|Overall Study|Adverse Event|0|||
144637101|NCT06119191|521522256|FG001|Overall Study|Adverse Event|1|||
144637102|NCT06119191|521522255|FG000|Overall Study|Protocol Violation|1|||
144637103|NCT06119191|521522256|FG001|Overall Study|Protocol Violation|0|||
144637104|NCT04375761|521524577|FG000|Overall Study|Death|1|||
144637105|NCT04375761|521524578|FG001|Overall Study|Death|2|||
144637106|NCT04375761|521524577|FG000|Overall Study|Lost to Follow-up|203|||
144637107|NCT04375761|521524578|FG001|Overall Study|Lost to Follow-up|380|||
144637108|NCT04375761|521524577|FG000|Overall Study|Withdrawal by Subject|47|||
144637109|NCT04375761|521524578|FG001|Overall Study|Withdrawal by Subject|98|||
144637110|NCT04375761|521524577|FG000|Overall Study|Noncompliance with study procedure|121|||
144637111|NCT04375761|521524578|FG001|Overall Study|Noncompliance with study procedure|251|||
144637112|NCT04375761|521524577|FG000|Overall Study|Reimbursement not enough|1|||
144637113|NCT04375761|521524578|FG001|Overall Study|Reimbursement not enough|2|||
144637114|NCT04375761|521524577|FG000|Overall Study|Unforeseen family circumstances|1|||
144637115|NCT04375761|521524578|FG001|Overall Study|Unforeseen family circumstances|3|||
144637116|NCT04375761|521524577|FG000|Overall Study|Test too painful|1|||
144637117|NCT04375761|521524578|FG001|Overall Study|Test too painful|1|||
144637118|NCT04375761|521524577|FG000|Overall Study|Moved|0|||
144637119|NCT04375761|521524578|FG001|Overall Study|Moved|2|||
144637120|NCT04375761|521524577|FG000|Overall Study|Nonresponsive|0|||
144637121|NCT04375761|521524578|FG001|Overall Study|Nonresponsive|5|||
144637122|NCT03797001|521524579|FG000|Overall Study|Withdrawn due to COVID19|4|||
144637123|NCT03797001|521524580|FG001|Overall Study|Withdrawn due to COVID19|0|||
144637124|NCT03797001|521524579|FG000|Overall Study|Withdrawal by Subject|7|||
144637125|NCT03797001|521524580|FG001|Overall Study|Withdrawal by Subject|6|||
144637126|NCT03797001|521524579|FG000|Overall Study|Adverse Event|0|||
144637127|NCT03797001|521524580|FG001|Overall Study|Adverse Event|1|||
144637128|NCT05630846|521524583|FG000|Overall Study|Death|1|||
144637129|NCT05630846|521524584|FG001|Overall Study|Death|0|||
144637130|NCT05630846|521524585|FG002|Overall Study|Death|0|||
144637131|NCT05630846|521524586|FG003|Overall Study|Death|0|||
144637132|NCT05630846|521524583|FG000|Overall Study|Withdrawal by Subject|3|||
144637133|NCT05630846|521524584|FG001|Overall Study|Withdrawal by Subject|3|||
144637134|NCT05630846|521524585|FG002|Overall Study|Withdrawal by Subject|4|||
144637135|NCT05630846|521524586|FG003|Overall Study|Withdrawal by Subject|1|||
144637136|NCT05630846|521524583|FG000|Overall Study|Lost to Follow-up|6|||
144637137|NCT05630846|521524584|FG001|Overall Study|Lost to Follow-up|5|||
144637138|NCT05630846|521524585|FG002|Overall Study|Lost to Follow-up|2|||
144637139|NCT05630846|521524586|FG003|Overall Study|Lost to Follow-up|5|||
144637140|NCT05630846|521524583|FG000|Overall Study|Other|1|||
144637141|NCT05630846|521524584|FG001|Overall Study|Other|0|||
144637142|NCT05630846|521524585|FG002|Overall Study|Other|0|||
144637143|NCT05630846|521524586|FG003|Overall Study|Other|0|||
144637144|NCT00960076|521524598|FG000|Overall Study|Adverse Event|1|||
144637145|NCT00960076|521524599|FG001|Overall Study|Adverse Event|7|||
144637146|NCT00960076|521524598|FG000|Overall Study|No longer met study criteria|1|||
144731072|NCT01389102|521871377|FG002|Overall Study|Lost to Follow-up|1|||
144731073|NCT01389102|521871378|FG003|Overall Study|Lost to Follow-up|2|||
144731074|NCT01389102|521871379|FG004|Overall Study|Lost to Follow-up|4|||
144637147|NCT00960076|521524599|FG001|Overall Study|No longer met study criteria|5|||
144637148|NCT00960076|521524598|FG000|Overall Study|Withdrawal by Subject|1|||
144637149|NCT00960076|521524599|FG001|Overall Study|Withdrawal by Subject|2|||
144637150|NCT00960076|521524598|FG000|Overall Study|Lost to Follow-up|3|||
144637151|NCT00960076|521524599|FG001|Overall Study|Lost to Follow-up|3|||
144731075|NCT01389102|521871380|FG005|Overall Study|Lost to Follow-up|1|||
144731076|NCT01389102|521871375|FG000|Overall Study|Protocol Violation|0|||
144731077|NCT01389102|521871376|FG001|Overall Study|Protocol Violation|0|||
144731078|NCT01389102|521871377|FG002|Overall Study|Protocol Violation|3|||
144731079|NCT01389102|521871378|FG003|Overall Study|Protocol Violation|0|||
144210541|NCT02996487|519965303|FG002|Overall Study|Death|0|||
144210542|NCT02996487|519965301|FG000|Overall Study|Withdrawal by Subject|2|||
144637152|NCT00960076|521524598|FG000|Overall Study|Severe non-compliance to protocol|1|||
144637153|NCT00960076|521524599|FG001|Overall Study|Severe non-compliance to protocol|2|||
144637154|NCT00960076|521524598|FG000|Overall Study|Hyperglycemia|1|||
144637155|NCT00960076|521524599|FG001|Overall Study|Hyperglycemia|5|||
144637156|NCT00960076|521524598|FG000|Overall Study|Did not attend the termination visit|0|||
144637157|NCT00960076|521524599|FG001|Overall Study|Did not attend the termination visit|1|||
144637158|NCT00500266|521524600|FG000|Overall Study|Death|3|||
144637159|NCT00500266|521524600|FG000|Overall Study|Lost to Follow-up|3|||
144637160|NCT00500266|521524600|FG000|Overall Study|Withdrawal by Subject|3|||
144637161|NCT00500266|521524600|FG000|Overall Study|Assigned, not treated|4|||
144637162|NCT01431287|521524601|FG000|Overall Study|not treated|0|||
144637163|NCT01431287|521524602|FG001|Overall Study|not treated|0|||
144637164|NCT01431287|521524603|FG002|Overall Study|not treated|1|||
144637165|NCT01431287|521524604|FG003|Overall Study|not treated|0|||
144637166|NCT01431287|521524605|FG004|Overall Study|not treated|0|||
144637167|NCT01431287|521524601|FG000|Overall Study|Adverse Event|59|||
144637168|NCT01431287|521524602|FG001|Overall Study|Adverse Event|57|||
144637169|NCT01431287|521524603|FG002|Overall Study|Adverse Event|53|||
144637170|NCT01431287|521524604|FG003|Overall Study|Adverse Event|33|||
144637171|NCT01431287|521524605|FG004|Overall Study|Adverse Event|41|||
144637172|NCT01431287|521524601|FG000|Overall Study|Non compliant with protocol|6|||
144637173|NCT01431287|521524602|FG001|Overall Study|Non compliant with protocol|6|||
144637174|NCT01431287|521524603|FG002|Overall Study|Non compliant with protocol|5|||
144637175|NCT01431287|521524604|FG003|Overall Study|Non compliant with protocol|6|||
144637176|NCT01431287|521524605|FG004|Overall Study|Non compliant with protocol|5|||
144637177|NCT01431287|521524601|FG000|Overall Study|Lost to Follow-up|0|||
144637178|NCT01431287|521524602|FG001|Overall Study|Lost to Follow-up|3|||
144637179|NCT01431287|521524603|FG002|Overall Study|Lost to Follow-up|2|||
144637180|NCT01431287|521524604|FG003|Overall Study|Lost to Follow-up|3|||
144637181|NCT01431287|521524605|FG004|Overall Study|Lost to Follow-up|1|||
144637182|NCT01431287|521524601|FG000|Overall Study|Consent withdrawn not due to AE|29|||
144637183|NCT01431287|521524602|FG001|Overall Study|Consent withdrawn not due to AE|30|||
144637184|NCT01431287|521524603|FG002|Overall Study|Consent withdrawn not due to AE|34|||
144637185|NCT01431287|521524604|FG003|Overall Study|Consent withdrawn not due to AE|19|||
144637186|NCT01431287|521524605|FG004|Overall Study|Consent withdrawn not due to AE|29|||
144637187|NCT01431287|521524601|FG000|Overall Study|not stated above|4|||
144637188|NCT01431287|521524602|FG001|Overall Study|not stated above|2|||
144637189|NCT01431287|521524603|FG002|Overall Study|not stated above|2|||
144637190|NCT01431287|521524604|FG003|Overall Study|not stated above|2|||
144637191|NCT01431287|521524605|FG004|Overall Study|not stated above|1|||
144637192|NCT02029976|521524606|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
144637193|NCT02029976|521524607|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
144637194|NCT02029976|521524606|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
144637195|NCT02029976|521524607|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
144637196|NCT02029976|521524606|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
144637197|NCT02029976|521524607|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
144637198|NCT02029976|521524606|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
144637199|NCT02029976|521524607|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
144637200|NCT02224664|521524608|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
144637201|NCT02224664|521524609|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
144637202|NCT02224664|521524610|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
144637203|NCT02224664|521524611|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
144637204|NCT02224664|521524612|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
144637205|NCT02224664|521524608|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
144637206|NCT02224664|521524609|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
144637207|NCT02224664|521524610|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
144637208|NCT02224664|521524611|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
144637209|NCT02224664|521524612|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
144637210|NCT02224664|521524608|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
144637211|NCT02224664|521524609|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
144637212|NCT02224664|521524610|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
144637213|NCT02224664|521524611|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
144637214|NCT02224664|521524612|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
144731080|NCT01389102|521871379|FG004|Overall Study|Protocol Violation|1|||
144637215|NCT03019549|521524613|FG000|Washout|DId not meet genotype criteria|11|||
144637216|NCT03019549|521524613|FG000|Period 2|Adverse Event|2|||
144731081|NCT01389102|521871380|FG005|Overall Study|Protocol Violation|1|||
144637217|NCT03019549|521524613|FG000|Period 2|Physician Decision|2|||
144637218|NCT03019549|521524613|FG000|Period 2|Withdrawal by Subject|1|||
144637219|NCT01412879|521524616|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
144637220|NCT01412879|521524617|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
144637221|NCT01412879|521524618|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
144637222|NCT01412879|521524616|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
144637223|NCT01412879|521524617|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
144637224|NCT01412879|521524618|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
144637225|NCT01412879|521524616|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
144637226|NCT01412879|521524617|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
144637227|NCT01412879|521524618|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
144637228|NCT01412879|521524616|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
144637229|NCT01412879|521524617|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
144637230|NCT01412879|521524618|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
144637231|NCT01412879|521524616|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
144637232|NCT01412879|521524617|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
144637233|NCT01412879|521524618|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
144637234|NCT00162773|521524619|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
144637235|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
144637236|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
144637237|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
144637238|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
144637239|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
144637240|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
144637241|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
144637242|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
144637243|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
144637244|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
144637245|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
144637246|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
144637247|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
144637248|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
144637249|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
144637250|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
144637251|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
144637252|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
144637253|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
144637254|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
144637255|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
144637256|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
144637257|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
144637258|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
144637259|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
144637260|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
144637261|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
144637262|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
144637263|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
144637264|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
144637265|NCT02660580|521524621|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
144637266|NCT02660580|521524622|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
144637267|NCT02660580|521524623|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
144637268|NCT02660580|521524624|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
144637269|NCT02660580|521524625|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
144637270|NCT02660580|521524621|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
144637271|NCT02660580|521524622|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
144637272|NCT02660580|521524623|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
144637273|NCT02660580|521524624|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
144637274|NCT02660580|521524625|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
144637275|NCT02660580|521524621|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
144637276|NCT02660580|521524622|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
144637277|NCT02660580|521524623|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
144637278|NCT02660580|521524624|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
144637279|NCT02660580|521524625|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
144637280|NCT02660580|521524621|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
144637281|NCT02660580|521524622|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
144637282|NCT02660580|521524623|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
144637283|NCT02660580|521524624|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
144637284|NCT02660580|521524625|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
144637285|NCT02660580|521524621|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
144637286|NCT02660580|521524622|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
144637287|NCT02660580|521524623|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
144637288|NCT02660580|521524624|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
144637289|NCT02660580|521524625|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
144637290|NCT02660580|521524621|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
144637291|NCT02660580|521524622|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
144637292|NCT02660580|521524623|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
144637293|NCT02660580|521524624|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
144637294|NCT02660580|521524625|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
144637295|NCT02660580|521524621|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
144637296|NCT02660580|521524622|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
144637297|NCT02660580|521524623|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
144637298|NCT02660580|521524624|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
144637299|NCT02660580|521524625|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
144637300|NCT00496366|521524627|FG000|Overall Study|Death|1|||
144637301|NCT00260208|521524630|FG000|Overall Study|Subject withdrew consent|11|||
144637302|NCT00260208|521524631|FG001|Overall Study|Subject withdrew consent|7|||
144637303|NCT00260208|521524630|FG000|Overall Study|Lost to Follow-up|6|||
144637304|NCT00260208|521524631|FG001|Overall Study|Lost to Follow-up|1|||
144637305|NCT00260208|521524630|FG000|Overall Study|Death|12|||
144637306|NCT00260208|521524631|FG001|Overall Study|Death|10|||
144637307|NCT00260208|521524630|FG000|Overall Study|Missing|18|||
144637308|NCT00260208|521524631|FG001|Overall Study|Missing|16|||
144637309|NCT02091440|521524632|FG000|Overall Study|Death|2|||
144637310|NCT00768222|521524633|FG000|Overall Study|Lost to Follow-up|1|||
144637311|NCT00768222|521524634|FG001|Overall Study|Lost to Follow-up|1|||
144637312|NCT00768222|521524633|FG000|Overall Study|Withdrawal by Subject|3|||
144637313|NCT00768222|521524634|FG001|Overall Study|Withdrawal by Subject|1|||
144637314|NCT00768222|521524633|FG000|Overall Study|Protocol Violation|0|||
144637315|NCT00768222|521524634|FG001|Overall Study|Protocol Violation|2|||
144637316|NCT03323749|521524641|FG000|Double-blind Period|Lost to Follow-up|4|||
144637317|NCT03323749|521524642|FG001|Double-blind Period|Lost to Follow-up|5|||
144637318|NCT03323749|521524641|FG000|Double-blind Period|Adverse Event|3|||
144637319|NCT03323749|521524642|FG001|Double-blind Period|Adverse Event|1|||
144637320|NCT03323749|521524641|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
144637321|NCT03323749|521524642|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
144637322|NCT03323749|521524641|FG000|Open-Label Period|Adverse Event|3|||
144637323|NCT03323749|521524642|FG001|Open-Label Period|Adverse Event|10|||
144637324|NCT03323749|521524641|FG000|Open-Label Period|Withdrawal by Subject|7|||
144637325|NCT03323749|521524642|FG001|Open-Label Period|Withdrawal by Subject|5|||
144637326|NCT00506389|521524647|FG000|In-treatment Period|Other|3|||
144637327|NCT00506389|521524648|FG001|In-treatment Period|Other|3|||
144637328|NCT00506389|521524649|FG002|In-treatment Period|Other|4|||
144637329|NCT00506389|521524647|FG000|In-treatment Period|Lost to Follow-up|0|||
144637330|NCT00506389|521524648|FG001|In-treatment Period|Lost to Follow-up|0|||
144637331|NCT00506389|521524649|FG002|In-treatment Period|Lost to Follow-up|1|||
144637332|NCT00506389|521524647|FG000|In-treatment Period|Lack of compliance|1|||
144637333|NCT00506389|521524648|FG001|In-treatment Period|Lack of compliance|0|||
144637334|NCT00506389|521524649|FG002|In-treatment Period|Lack of compliance|0|||
144637335|NCT00506389|521524647|FG000|In-treatment Period|Reasons not related to trial|4|||
144637336|NCT00506389|521524648|FG001|In-treatment Period|Reasons not related to trial|1|||
144637337|NCT00506389|521524649|FG002|In-treatment Period|Reasons not related to trial|0|||
144637338|NCT00506389|521524647|FG000|In-treatment Period|Withdrawal by Subject|3|||
144637339|NCT00506389|521524648|FG001|In-treatment Period|Withdrawal by Subject|3|||
144637340|NCT00506389|521524649|FG002|In-treatment Period|Withdrawal by Subject|4|||
144637341|NCT00506389|521524647|FG000|In-treatment Period|Lack of Efficacy|0|||
144637342|NCT00506389|521524648|FG001|In-treatment Period|Lack of Efficacy|2|||
144637343|NCT00506389|521524649|FG002|In-treatment Period|Lack of Efficacy|0|||
144637344|NCT00506389|521524647|FG000|In-treatment Period|Adverse Event|11|||
144637345|NCT00506389|521524648|FG001|In-treatment Period|Adverse Event|5|||
144637346|NCT00506389|521524649|FG002|In-treatment Period|Adverse Event|2|||
144637347|NCT00506389|521524647|FG000|In-treatment Period|Randomized but not treated|4|||
144637348|NCT00506389|521524648|FG001|In-treatment Period|Randomized but not treated|1|||
144637349|NCT00506389|521524649|FG002|In-treatment Period|Randomized but not treated|1|||
144637350|NCT03095703|521524651|FG000|Overall Study|Withdrawal by Subject|1|||
144637351|NCT03539432|521524652|FG000|Overall Study|Lost to Follow-up|0|||
144637352|NCT03539432|521524653|FG001|Overall Study|Lost to Follow-up|1|||
144637353|NCT03615222|521524671|FG000|Overall Study|Ineligible|26|||
144637354|NCT03615222|521524671|FG000|Overall Study|Withdrawal by Subject|7|||
144637355|NCT03615222|521524671|FG000|Overall Study|Death|1|||
144637356|NCT00476086|521524672|FG000|Overall Study|Alternative therapy|1|||
144637357|NCT00476086|521524672|FG000|Overall Study|Progressive Disease|4|||
144637358|NCT03895203|521524673|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
144210543|NCT02996487|519965302|FG001|Overall Study|Withdrawal by Subject|3|||
144210544|NCT02996487|519965303|FG002|Overall Study|Withdrawal by Subject|0|||
144210545|NCT02027428|519965304|FG000|Induction|Never treated|7|||
144210546|NCT02027428|519965305|FG001|Induction|Never treated|0|||
144210547|NCT02027428|519965306|FG002|Induction|Never treated|0|||
144210548|NCT02027428|519965304|FG000|Induction|Progressive disease|77|||
144210549|NCT02027428|519965305|FG001|Induction|Progressive disease|0|||
144210550|NCT02027428|519965306|FG002|Induction|Progressive disease|0|||
144210551|NCT02027428|519965304|FG000|Induction|Adverse Event|51|||
144210552|NCT02027428|519965305|FG001|Induction|Adverse Event|0|||
144210553|NCT02027428|519965306|FG002|Induction|Adverse Event|0|||
144210554|NCT02027428|519965304|FG000|Induction|Withdrawal by Subject|22|||
144210555|NCT02027428|519965305|FG001|Induction|Withdrawal by Subject|0|||
144210556|NCT02027428|519965306|FG002|Induction|Withdrawal by Subject|0|||
144210557|NCT02027428|519965304|FG000|Induction|Death|21|||
144210558|NCT02027428|519965305|FG001|Induction|Death|0|||
144210559|NCT02027428|519965306|FG002|Induction|Death|0|||
144210560|NCT02027428|519965304|FG000|Induction|Symptomatic deterioration|16|||
144210561|NCT02027428|519965305|FG001|Induction|Symptomatic deterioration|0|||
144210562|NCT02027428|519965306|FG002|Induction|Symptomatic deterioration|0|||
144210563|NCT02027428|519965304|FG000|Induction|Study terminated by sponsor|12|||
144210564|NCT02027428|519965305|FG001|Induction|Study terminated by sponsor|0|||
144210565|NCT02027428|519965306|FG002|Induction|Study terminated by sponsor|0|||
144210566|NCT02027428|519965304|FG000|Induction|Protocol Violation|1|||
144210567|NCT02027428|519965305|FG001|Induction|Protocol Violation|0|||
144210568|NCT02027428|519965306|FG002|Induction|Protocol Violation|0|||
144210569|NCT02027428|519965304|FG000|Induction|Miscellaneous|14|||
144637359|NCT03895203|521524674|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
144637360|NCT03895203|521524675|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
144637361|NCT03895203|521524676|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
144637362|NCT03895203|521524677|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
144637363|NCT03895203|521524678|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
144637364|NCT03895203|521524673|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
144637365|NCT03895203|521524674|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
144637366|NCT03895203|521524675|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
144637367|NCT03895203|521524676|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
144637368|NCT03895203|521524677|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
144637369|NCT03895203|521524678|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
144637370|NCT03895203|521524673|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
144637371|NCT03895203|521524674|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
144637372|NCT03895203|521524675|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
144637373|NCT03895203|521524676|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
144637374|NCT03895203|521524677|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
144637375|NCT03895203|521524678|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
144637376|NCT03895203|521524673|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
144637377|NCT03895203|521524674|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
144637378|NCT03895203|521524675|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
144637379|NCT03895203|521524676|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
144637380|NCT03895203|521524677|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
144637381|NCT03895203|521524678|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
144637382|NCT03895203|521524673|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
144637383|NCT03895203|521524674|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
144637384|NCT03895203|521524675|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
144637385|NCT03895203|521524676|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
144637386|NCT03895203|521524677|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
144210570|NCT02027428|519965305|FG001|Induction|Miscellaneous|0|||
144210571|NCT02027428|519965306|FG002|Induction|Miscellaneous|0|||
144210572|NCT02027428|519965304|FG000|Induction|Induction Treatment Ongoing|4|||
144210573|NCT02027428|519965305|FG001|Induction|Induction Treatment Ongoing|0|||
144210574|NCT02027428|519965306|FG002|Induction|Induction Treatment Ongoing|0|||
144210575|NCT02027428|519965304|FG000|Maintenance|Death|0|||
144210576|NCT02027428|519965305|FG001|Maintenance|Death|3|||
144210577|NCT02027428|519965306|FG002|Maintenance|Death|2|||
144210578|NCT02027428|519965304|FG000|Maintenance|Adverse Event|0|||
144210579|NCT02027428|519965305|FG001|Maintenance|Adverse Event|21|||
144210580|NCT02027428|519965306|FG002|Maintenance|Adverse Event|1|||
144210581|NCT02027428|519965304|FG000|Maintenance|Progressive disease|0|||
144210582|NCT02027428|519965305|FG001|Maintenance|Progressive disease|84|||
144210583|NCT02027428|519965306|FG002|Maintenance|Progressive disease|47|||
144210584|NCT02027428|519965304|FG000|Maintenance|Symptomatic deterioration|0|||
144637387|NCT03895203|521524678|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
144637388|NCT03895203|521524673|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
144637389|NCT03895203|521524674|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
144637390|NCT03895203|521524675|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
144637391|NCT03895203|521524676|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
144637392|NCT03895203|521524677|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
144637393|NCT03895203|521524678|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
144637394|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
144637395|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
144637396|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
144637397|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
144637398|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
144637399|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
144637400|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
144637401|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
144637402|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
144637403|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
144637404|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
144637405|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
144637406|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
144637407|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
144637408|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
144637409|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
144637410|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
144637411|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
144637412|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
144637413|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
144637414|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
144637415|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
144637416|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
144637417|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
144637418|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
144637419|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
144637420|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
144637421|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
144637422|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
144637423|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
144637424|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
144637425|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
144637426|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
144637427|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
144637428|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
144637429|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
144637430|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
144637431|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
144637432|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
144637433|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
144637434|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
144637435|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
144637436|NCT03895203|521524673|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
144637437|NCT03895203|521524674|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
144637438|NCT03895203|521524675|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
144637439|NCT03895203|521524676|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
144637440|NCT03895203|521524677|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
144637441|NCT03895203|521524678|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
144637442|NCT04125680|521524679|FG000|Overall Study|Lost to Follow-up|15|||
144637443|NCT04938648|521524680|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
144637444|NCT04938648|521524681|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
144637445|NCT04938648|521524680|FG000|Overall Study|Patient too ill|0|||
144637446|NCT04938648|521524681|FG001|Overall Study|Patient too ill|1|||
144637447|NCT04938648|521524680|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
144637448|NCT04938648|521524681|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
144731082|NCT01389102|521871375|FG000|Overall Study|Withdrawal by Subject|7|||
144637449|NCT04938648|521524680|FG000|Overall Study|Patient did not have memory problems|1|||
144637450|NCT04938648|521524681|FG001|Overall Study|Patient did not have memory problems|1|||
144637451|NCT04938648|521524680|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
144637452|NCT04938648|521524681|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
144637453|NCT04938648|521524680|FG000|Overall Study|Care partner could not be reached|0|||
144637454|NCT04938648|521524681|FG001|Overall Study|Care partner could not be reached|1|||
144637455|NCT04938648|521524680|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
144637456|NCT04938648|521524681|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
144637457|NCT04938648|521524680|FG000|Overall Study|Withdrawal by Subject|2|||
144637458|NCT04938648|521524681|FG001|Overall Study|Withdrawal by Subject|1|||
144637459|NCT00364793|521524682|FG000|Overall Study|Adverse Event|2|||
144637460|NCT00364793|521524683|FG001|Overall Study|Adverse Event|0|||
144637461|NCT00364793|521524684|FG002|Overall Study|Adverse Event|0|||
144637462|NCT00364793|521524685|FG003|Overall Study|Adverse Event|0|||
144637463|NCT00364793|521524682|FG000|Overall Study|Death|1|||
144637464|NCT00364793|521524683|FG001|Overall Study|Death|0|||
144637465|NCT00364793|521524684|FG002|Overall Study|Death|1|||
144637466|NCT00364793|521524685|FG003|Overall Study|Death|0|||
144637467|NCT00364793|521524682|FG000|Overall Study|Lack of Efficacy|3|||
144637468|NCT00364793|521524683|FG001|Overall Study|Lack of Efficacy|3|||
144637469|NCT00364793|521524684|FG002|Overall Study|Lack of Efficacy|1|||
144637470|NCT00364793|521524685|FG003|Overall Study|Lack of Efficacy|1|||
144637471|NCT00364793|521524682|FG000|Overall Study|Lost to Follow-up|1|||
144637472|NCT00364793|521524683|FG001|Overall Study|Lost to Follow-up|0|||
144637473|NCT00364793|521524684|FG002|Overall Study|Lost to Follow-up|2|||
144637474|NCT00364793|521524685|FG003|Overall Study|Lost to Follow-up|0|||
144637475|NCT00364793|521524682|FG000|Overall Study|Poor or non-compliance|1|||
144637476|NCT00364793|521524683|FG001|Overall Study|Poor or non-compliance|1|||
144637477|NCT00364793|521524684|FG002|Overall Study|Poor or non-compliance|0|||
144637478|NCT00364793|521524685|FG003|Overall Study|Poor or non-compliance|1|||
144637479|NCT00364793|521524682|FG000|Overall Study|No longer meets criteria|0|||
144637480|NCT00364793|521524683|FG001|Overall Study|No longer meets criteria|0|||
144637481|NCT00364793|521524684|FG002|Overall Study|No longer meets criteria|0|||
144637482|NCT00364793|521524685|FG003|Overall Study|No longer meets criteria|1|||
144637483|NCT00364793|521524682|FG000|Overall Study|Withdrawal by Subject|0|||
144637484|NCT00364793|521524683|FG001|Overall Study|Withdrawal by Subject|1|||
144637485|NCT00364793|521524684|FG002|Overall Study|Withdrawal by Subject|0|||
144637486|NCT00364793|521524685|FG003|Overall Study|Withdrawal by Subject|0|||
144637487|NCT00049127|521524686|FG000|Overall Study|Withdrawal by Subject|0|||
144637488|NCT00049127|521524687|FG001|Overall Study|Withdrawal by Subject|0|||
144637489|NCT00049127|521524688|FG002|Overall Study|Withdrawal by Subject|1|||
144637490|NCT00049127|521524689|FG003|Overall Study|Withdrawal by Subject|0|||
144637491|NCT00049127|521524690|FG004|Overall Study|Withdrawal by Subject|0|||
144637492|NCT01287754|521524693|FG000|Overall Study|Death|2|||
144637493|NCT01287754|521524694|FG001|Overall Study|Death|12|||
144637494|NCT01287754|521524693|FG000|Overall Study|Lost to Follow-up|1|||
144637495|NCT01287754|521524694|FG001|Overall Study|Lost to Follow-up|6|||
144637496|NCT01287754|521524693|FG000|Overall Study|Protocol Violation|0|||
144637497|NCT01287754|521524694|FG001|Overall Study|Protocol Violation|3|||
144637498|NCT00001337|521524705|FG000|Overall Study|Switched to alternate treatment|2|||
144637499|NCT00001337|521524706|FG001|Overall Study|Switched to alternate treatment|2|||
144637500|NCT00001337|521524707|FG002|Overall Study|Switched to alternate treatment|0|||
144637501|NCT00001337|521524705|FG000|Overall Study|Refused further treatment|2|||
144637502|NCT00001337|521524706|FG001|Overall Study|Refused further treatment|1|||
144637503|NCT00001337|521524707|FG002|Overall Study|Refused further treatment|0|||
144637504|NCT00001337|521524705|FG000|Overall Study|Began other Tx|1|||
144637505|NCT00001337|521524706|FG001|Overall Study|Began other Tx|0|||
144637506|NCT00001337|521524707|FG002|Overall Study|Began other Tx|0|||
144637507|NCT00001337|521524705|FG000|Overall Study|Physician Decision|3|||
144637508|NCT00001337|521524706|FG001|Overall Study|Physician Decision|1|||
144637509|NCT00001337|521524707|FG002|Overall Study|Physician Decision|0|||
144637510|NCT00001337|521524705|FG000|Overall Study|Doesn't have NHL|0|||
144637511|NCT00001337|521524706|FG001|Overall Study|Doesn't have NHL|1|||
144637512|NCT00001337|521524707|FG002|Overall Study|Doesn't have NHL|0|||
144637513|NCT00001337|521524705|FG000|Overall Study|Non protocol tx needed|3|||
144637514|NCT00001337|521524706|FG001|Overall Study|Non protocol tx needed|1|||
144731083|NCT01389102|521871376|FG001|Overall Study|Withdrawal by Subject|4|||
144637515|NCT00001337|521524707|FG002|Overall Study|Non protocol tx needed|0|||
144637516|NCT00001337|521524705|FG000|Overall Study|Protocol change|1|||
144637517|NCT00001337|521524706|FG001|Overall Study|Protocol change|0|||
144637518|NCT00001337|521524707|FG002|Overall Study|Protocol change|0|||
144731084|NCT01389102|521871377|FG002|Overall Study|Withdrawal by Subject|9|||
144637519|NCT00001337|521524705|FG000|Overall Study|2nd primary disease|0|||
144637520|NCT00001337|521524706|FG001|Overall Study|2nd primary disease|0|||
144637521|NCT00001337|521524707|FG002|Overall Study|2nd primary disease|1|||
144637522|NCT00001337|521524705|FG000|Overall Study|Death during follow up period|9|||
144637523|NCT00001337|521524706|FG001|Overall Study|Death during follow up period|4|||
144637524|NCT00001337|521524707|FG002|Overall Study|Death during follow up period|0|||
144637525|NCT00001337|521524705|FG000|Overall Study|Death on study|19|||
144637526|NCT00001337|521524706|FG001|Overall Study|Death on study|9|||
144637527|NCT00001337|521524707|FG002|Overall Study|Death on study|0|||
144637528|NCT00001337|521524705|FG000|Overall Study|Disease progression during follow-up period|3|||
144637529|NCT00001337|521524706|FG001|Overall Study|Disease progression during follow-up period|1|||
144637530|NCT00001337|521524707|FG002|Overall Study|Disease progression during follow-up period|0|||
144637531|NCT00001337|521524705|FG000|Overall Study|Disease progression on study|33|||
144637532|NCT00001337|521524706|FG001|Overall Study|Disease progression on study|41|||
144637533|NCT00001337|521524707|FG002|Overall Study|Disease progression on study|0|||
144637534|NCT00001337|521524705|FG000|Overall Study|Lost to further follow-up|10|||
144637535|NCT00001337|521524706|FG001|Overall Study|Lost to further follow-up|6|||
144637536|NCT00001337|521524707|FG002|Overall Study|Lost to further follow-up|0|||
144637537|NCT00001337|521524705|FG000|Overall Study|2nd malignancy|1|||
144637538|NCT00001337|521524706|FG001|Overall Study|2nd malignancy|0|||
144637539|NCT00001337|521524707|FG002|Overall Study|2nd malignancy|0|||
144637540|NCT00001337|521524705|FG000|Overall Study|Treatment for second lymphoma|0|||
144637541|NCT00001337|521524706|FG001|Overall Study|Treatment for second lymphoma|1|||
144637542|NCT00001337|521524707|FG002|Overall Study|Treatment for second lymphoma|0|||
144637543|NCT00001337|521524705|FG000|Overall Study|Transfer to transplant|0|||
144637544|NCT00001337|521524706|FG001|Overall Study|Transfer to transplant|1|||
144637545|NCT00001337|521524707|FG002|Overall Study|Transfer to transplant|0|||
144637546|NCT03619213|521524716|FG000|Overall Study|Lost to Follow-up|2|||
144637547|NCT03619213|521524717|FG001|Overall Study|Lost to Follow-up|1|||
144637548|NCT03619213|521524716|FG000|Overall Study|Withdrawal by Subject|8|||
144637549|NCT03619213|521524717|FG001|Overall Study|Withdrawal by Subject|10|||
144637550|NCT03093402|521524718|FG000|Overall Study|Lost to Follow-up|1|||
144637551|NCT03093402|521524719|FG001|Overall Study|Lost to Follow-up|0|||
144637552|NCT03093402|521524720|FG002|Overall Study|Lost to Follow-up|0|||
144637553|NCT03093402|521524721|FG003|Overall Study|Lost to Follow-up|0|||
144637554|NCT03093402|521524718|FG000|Overall Study|Withdrawal by Subject|3|||
144637555|NCT03093402|521524719|FG001|Overall Study|Withdrawal by Subject|3|||
144637556|NCT03093402|521524720|FG002|Overall Study|Withdrawal by Subject|0|||
144637557|NCT03093402|521524721|FG003|Overall Study|Withdrawal by Subject|1|||
144637558|NCT03093402|521524718|FG000|Overall Study|Withdrew prior to dosing|2|||
144637559|NCT03093402|521524719|FG001|Overall Study|Withdrew prior to dosing|1|||
144637560|NCT03093402|521524720|FG002|Overall Study|Withdrew prior to dosing|2|||
144637561|NCT03093402|521524721|FG003|Overall Study|Withdrew prior to dosing|3|||
144637562|NCT03093402|521524718|FG000|Overall Study|Ineligible for study|1|||
144637563|NCT03093402|521524719|FG001|Overall Study|Ineligible for study|0|||
144637564|NCT03093402|521524720|FG002|Overall Study|Ineligible for study|0|||
144637565|NCT03093402|521524721|FG003|Overall Study|Ineligible for study|0|||
144637566|NCT03093402|521524718|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
144637567|NCT03093402|521524719|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
144637568|NCT03093402|521524720|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
144637569|NCT03093402|521524721|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
144637570|NCT02886702|521524722|FG000|Overall Study|Other|4|||
144637571|NCT02886702|521524723|FG001|Overall Study|Other|3|||
144637572|NCT02886702|521524724|FG002|Overall Study|Other|9|||
144637573|NCT02886702|521524722|FG000|Overall Study|Withdrawal by Subject|24|||
144637574|NCT02886702|521524723|FG001|Overall Study|Withdrawal by Subject|18|||
144637575|NCT02886702|521524724|FG002|Overall Study|Withdrawal by Subject|22|||
144637576|NCT02886702|521524722|FG000|Overall Study|Significant Worsening of Condition|0|||
144637577|NCT02886702|521524723|FG001|Overall Study|Significant Worsening of Condition|1|||
144637578|NCT02886702|521524724|FG002|Overall Study|Significant Worsening of Condition|0|||
144637579|NCT02886702|521524722|FG000|Overall Study|Protocol Violation|2|||
144637580|NCT02886702|521524723|FG001|Overall Study|Protocol Violation|2|||
144637581|NCT02886702|521524724|FG002|Overall Study|Protocol Violation|1|||
144637582|NCT02886702|521524722|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144637583|NCT02886702|521524723|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144637584|NCT02886702|521524724|FG002|Overall Study|Non-Compliance With Study Drug|4|||
144637585|NCT02886702|521524722|FG000|Overall Study|Lost to Follow-up|11|||
144637586|NCT02886702|521524723|FG001|Overall Study|Lost to Follow-up|13|||
144637587|NCT02886702|521524724|FG002|Overall Study|Lost to Follow-up|8|||
144637588|NCT02886702|521524722|FG000|Overall Study|Lack of Efficacy|3|||
144637589|NCT02886702|521524723|FG001|Overall Study|Lack of Efficacy|4|||
144637590|NCT02886702|521524724|FG002|Overall Study|Lack of Efficacy|5|||
144637591|NCT02886702|521524722|FG000|Overall Study|Adverse Event|4|||
144637592|NCT02886702|521524723|FG001|Overall Study|Adverse Event|9|||
144637593|NCT02886702|521524724|FG002|Overall Study|Adverse Event|3|||
144637594|NCT02886702|521524722|FG000|Overall Study|Administrative Reasons|0|||
144637595|NCT02886702|521524723|FG001|Overall Study|Administrative Reasons|0|||
144637596|NCT02886702|521524724|FG002|Overall Study|Administrative Reasons|1|||
144637597|NCT01147497|521524727|FG000|Overall Study|failed insertion|2|||
144262996|NCT00735709|520163806|FG000|Overall Study|Excluded medication|1|||
144262997|NCT00735709|520163807|FG001|Overall Study|Excluded medication|0|||
144262998|NCT00735709|520163808|FG002|Overall Study|Excluded medication|0|||
144262999|NCT00735709|520163809|FG003|Overall Study|Excluded medication|1|||
144263000|NCT00521365|520163829|FG000|Overall Study|Adverse Event|3|||
144263001|NCT00521365|520163829|FG000|Overall Study|Lost to Follow-up|6|||
144263002|NCT00521365|520163829|FG000|Overall Study|Protocol deviation|2|||
144263003|NCT00521365|520163829|FG000|Overall Study|Drug compliance|3|||
144263004|NCT00521365|520163829|FG000|Overall Study|Usage of not allowed drugs|6|||
144263005|NCT03150082|520163830|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
144263006|NCT03150082|520163831|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
144263007|NCT01718483|520163832|FG000|Overall Study|Withdrawal by Subject|14|||
144263008|NCT01718483|520163833|FG001|Overall Study|Withdrawal by Subject|12|||
144263009|NCT01718483|520163832|FG000|Overall Study|Adverse Event|5|||
144263010|NCT01718483|520163833|FG001|Overall Study|Adverse Event|12|||
144263011|NCT01718483|520163832|FG000|Overall Study|Lost to Follow-up|8|||
144263012|NCT01718483|520163833|FG001|Overall Study|Lost to Follow-up|3|||
144263013|NCT01718483|520163832|FG000|Overall Study|Protocol Violation|4|||
144263014|NCT01718483|520163833|FG001|Overall Study|Protocol Violation|2|||
144263015|NCT01718483|520163832|FG000|Overall Study|Other|1|||
144263016|NCT01718483|520163833|FG001|Overall Study|Other|4|||
144263017|NCT01718483|520163832|FG000|Overall Study|Pregnancy|1|||
144263018|NCT01718483|520163833|FG001|Overall Study|Pregnancy|1|||
144263019|NCT01718483|520163832|FG000|Overall Study|Lack of Efficacy|1|||
144263020|NCT01718483|520163833|FG001|Overall Study|Lack of Efficacy|0|||
144263021|NCT02119299|520163834|FG000|Overall Study|Withdrawal by Subject|7|||
144263022|NCT02119299|520163834|FG000|Overall Study|Lack of Efficacy|1|||
144263023|NCT02119299|520163834|FG000|Overall Study|Pregnancy|1|||
144263024|NCT04110314|520163835|FG000|Overall Study|Did not meet inclusion criteria|35255|||
144263025|NCT04110314|520163836|FG001|Overall Study|Did not meet inclusion criteria|35104|||
144263026|NCT04110314|520163837|FG002|Overall Study|Did not meet inclusion criteria|35636|||
144263027|NCT04110314|520163838|FG003|Overall Study|Did not meet inclusion criteria|35135|||
144263028|NCT04110314|520163839|FG004|Overall Study|Did not meet inclusion criteria|35247|||
144263029|NCT04110314|520163840|FG005|Overall Study|Did not meet inclusion criteria|35727|||
144263030|NCT00115778|520163842|FG000|Overall Study|Withdrawal by Subject|0|||
144263031|NCT00115778|520163843|FG001|Overall Study|Withdrawal by Subject|1|||
144263032|NCT00249873|520163848|FG000|Overall Study|Not treated|7|||
144263033|NCT00249873|520163849|FG001|Overall Study|Not treated|8|||
144263034|NCT00249873|520163848|FG000|Overall Study|Significant thrombocytopenia|9|||
144263035|NCT00249873|520163849|FG001|Overall Study|Significant thrombocytopenia|8|||
144263036|NCT00249873|520163848|FG000|Overall Study|Severe allergic reaction|8|||
144263037|NCT00249873|520163849|FG001|Overall Study|Severe allergic reaction|1|||
144263038|NCT00249873|520163848|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
144263039|NCT00249873|520163849|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
144263040|NCT00249873|520163848|FG000|Overall Study|Other Serious Adverse Event|86|||
144263041|NCT00249873|520163849|FG001|Overall Study|Other Serious Adverse Event|97|||
144263042|NCT00249873|520163848|FG000|Overall Study|Qualifying condition not present|20|||
144263043|NCT00249873|520163849|FG001|Overall Study|Qualifying condition not present|23|||
144263044|NCT00249873|520163848|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
144637598|NCT01147497|521524728|FG001|Overall Study|failed insertion|0|||
144637599|NCT04026568|521524731|FG000|Overall Study|study terminated|0|||
144637600|NCT04026568|521524732|FG001|Overall Study|study terminated|1|||
144637601|NCT02786901|521524733|FG000|Overall Study|Adverse Event|1|||
144637602|NCT02786901|521524734|FG001|Overall Study|Adverse Event|1|||
144637603|NCT02786901|521524735|FG002|Overall Study|Adverse Event|2|||
144637604|NCT02786901|521524733|FG000|Overall Study|Physician Decision|1|||
144637605|NCT02786901|521524734|FG001|Overall Study|Physician Decision|0|||
144637606|NCT02786901|521524735|FG002|Overall Study|Physician Decision|0|||
144637607|NCT02786901|521524733|FG000|Overall Study|Rescue Therapy Use|71|||
144637608|NCT02786901|521524734|FG001|Overall Study|Rescue Therapy Use|49|||
144637609|NCT02786901|521524735|FG002|Overall Study|Rescue Therapy Use|33|||
144637610|NCT02786901|521524733|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
144637611|NCT02786901|521524734|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
144637612|NCT02786901|521524735|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
144637613|NCT02786901|521524733|FG000|Overall Study|Disallowed medication|1|||
144263045|NCT00249873|520163849|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
144263046|NCT00249873|520163848|FG000|Overall Study|Withdrawal by Subject|504|||
144263047|NCT00249873|520163849|FG001|Overall Study|Withdrawal by Subject|466|||
144263048|NCT00249873|520163848|FG000|Overall Study|Lost to Follow-up|4|||
144263049|NCT00249873|520163849|FG001|Overall Study|Lost to Follow-up|7|||
144637614|NCT02786901|521524734|FG001|Overall Study|Disallowed medication|1|||
144637615|NCT02786901|521524735|FG002|Overall Study|Disallowed medication|0|||
144637616|NCT02786901|521524733|FG000|Overall Study|Randomized in error|2|||
144637617|NCT02786901|521524734|FG001|Overall Study|Randomized in error|0|||
144637618|NCT02786901|521524735|FG002|Overall Study|Randomized in error|1|||
144637619|NCT03367871|521524736|FG000|Overall Study|Lost to Follow-up|1|||
144637620|NCT02209506|521524739|FG000|Overall Study|Withdrawal by Subject|0|||
144637621|NCT02209506|521524740|FG001|Overall Study|Withdrawal by Subject|0|||
144637622|NCT02209506|521524741|FG002|Overall Study|Withdrawal by Subject|0|||
144637623|NCT02209506|521524742|FG003|Overall Study|Withdrawal by Subject|0|||
144637624|NCT02209506|521524743|FG004|Overall Study|Withdrawal by Subject|1|||
144637625|NCT00684814|521524744|FG000|Washout Period of 7 Days|Adverse Event|1|||
144637626|NCT00684814|521524745|FG001|Washout Period of 7 Days|Adverse Event|2|||
144637627|NCT00684814|521524744|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
144637628|NCT00684814|521524745|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
144637629|NCT00684814|521524744|FG000|Second Intervention|Adverse Event|1|||
144637630|NCT00684814|521524745|FG001|Second Intervention|Adverse Event|0|||
144637631|NCT03168867|521524746|FG000|Overall Study|Withdrawal by Subject|1|||
144637632|NCT03168867|521524747|FG001|Overall Study|Withdrawal by Subject|5|||
144637633|NCT04348851|521524748|FG000|Post-Test 1|Withdrawal by Subject|0|||
144637634|NCT04348851|521524749|FG001|Post-Test 1|Withdrawal by Subject|1|||
144637635|NCT04348851|521524750|FG002|Post-Test 1|Withdrawal by Subject|0|||
144637636|NCT04348851|521524751|FG003|Post-Test 1|Withdrawal by Subject|0|||
144637637|NCT04348851|521524748|FG000|Post-Test 1|Lost to Follow-up|0|||
144637638|NCT04348851|521524749|FG001|Post-Test 1|Lost to Follow-up|1|||
144637639|NCT04348851|521524750|FG002|Post-Test 1|Lost to Follow-up|0|||
144637640|NCT04348851|521524751|FG003|Post-Test 1|Lost to Follow-up|0|||
144637641|NCT04348851|521524748|FG000|Post-Test 2|Stroke survivor death|0|||
144637642|NCT04348851|521524749|FG001|Post-Test 2|Stroke survivor death|1|||
144637643|NCT04348851|521524750|FG002|Post-Test 2|Stroke survivor death|0|||
144637644|NCT04348851|521524751|FG003|Post-Test 2|Stroke survivor death|1|||
144637645|NCT04052139|521524752|FG000|Overall Study|Lost to Follow-up|2|||
144637646|NCT04052139|521524753|FG001|Overall Study|Lost to Follow-up|0|||
144637647|NCT04052139|521524754|FG002|Overall Study|Lost to Follow-up|0|||
144637648|NCT04052139|521524752|FG000|Overall Study|Withdrawal by Subject|1|||
144637649|NCT04052139|521524753|FG001|Overall Study|Withdrawal by Subject|0|||
144637650|NCT04052139|521524754|FG002|Overall Study|Withdrawal by Subject|0|||
144637651|NCT00707577|521524755|FG000|Overall Study|Withdrawal by Subject|3|||
144637652|NCT00707577|521524756|FG001|Overall Study|Withdrawal by Subject|2|||
144637653|NCT00707577|521524755|FG000|Overall Study|Lost to Follow-up|34|||
144637654|NCT00707577|521524756|FG001|Overall Study|Lost to Follow-up|25|||
144637655|NCT00707577|521524755|FG000|Overall Study|Left employment|13|||
144637656|NCT00707577|521524756|FG001|Overall Study|Left employment|10|||
144637657|NCT00707577|521524755|FG000|Overall Study|Pregnancy|4|||
144637658|NCT00707577|521524756|FG001|Overall Study|Pregnancy|1|||
144637659|NCT00519077|521524757|FG000|Overall Study|Death|6|||
144637660|NCT00519077|521524757|FG000|Overall Study|Other|2|||
144637661|NCT01967225|521524758|FG000|Overall Study|Adverse Event|3|||
144637662|NCT01967225|521524759|FG001|Overall Study|Adverse Event|1|||
144637663|NCT01967225|521524758|FG000|Overall Study|Withdrawal by Subject|2|||
144637664|NCT01967225|521524759|FG001|Overall Study|Withdrawal by Subject|1|||
144637665|NCT01967225|521524758|FG000|Overall Study|Lack of Efficacy|1|||
144637666|NCT01967225|521524759|FG001|Overall Study|Lack of Efficacy|1|||
144637667|NCT01967225|521524758|FG000|Overall Study|Switching to other therapy|2|||
144637668|NCT01967225|521524759|FG001|Overall Study|Switching to other therapy|0|||
144637669|NCT01967225|521524758|FG000|Overall Study|Protocol driven decision point|1|||
144637670|NCT01967225|521524759|FG001|Overall Study|Protocol driven decision point|0|||
144637671|NCT01967225|521524758|FG000|Overall Study|Logistical difficulties|1|||
144637672|NCT01967225|521524759|FG001|Overall Study|Logistical difficulties|0|||
144637673|NCT01967225|521524758|FG000|Overall Study|Protocol Violation|2|||
144637674|NCT01967225|521524759|FG001|Overall Study|Protocol Violation|0|||
144637675|NCT00642642|521524770|FG000|Treatment & Follow Up|Adverse Event|2|||
144637676|NCT00642642|521524770|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
144637677|NCT00642642|521524770|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
144637678|NCT01275222|521524771|FG000|Phase l by Treatment|Adverse Event|1|||
144637679|NCT01275222|521524772|FG001|Phase l by Treatment|Adverse Event|4|||
144637680|NCT01275222|521524773|FG002|Phase l by Treatment|Adverse Event|2|||
144637681|NCT01275222|521524774|FG003|Phase l by Treatment|Adverse Event|3|||
144637682|NCT01275222|521524775|FG004|Phase l by Treatment|Adverse Event|0|||
144637683|NCT01275222|521524776|FG005|Phase l by Treatment|Adverse Event|0|||
144637684|NCT01275222|521524771|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
144637685|NCT01275222|521524772|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
144637686|NCT01275222|521524773|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
144637687|NCT01275222|521524774|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
144637688|NCT01275222|521524775|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
144637689|NCT01275222|521524776|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
144637690|NCT01275222|521524771|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
144637691|NCT01275222|521524772|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
144637692|NCT01275222|521524773|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
144637693|NCT01275222|521524774|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
144637694|NCT01275222|521524775|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
144637695|NCT01275222|521524776|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
144637696|NCT01275222|521524771|FG000|Phase l by Treatment|Disease progression|12|||
144637697|NCT01275222|521524772|FG001|Phase l by Treatment|Disease progression|8|||
144637698|NCT01275222|521524773|FG002|Phase l by Treatment|Disease progression|2|||
144637699|NCT01275222|521524774|FG003|Phase l by Treatment|Disease progression|5|||
144637700|NCT01275222|521524775|FG004|Phase l by Treatment|Disease progression|0|||
144637701|NCT01275222|521524776|FG005|Phase l by Treatment|Disease progression|0|||
144637702|NCT01275222|521524771|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
144637703|NCT01275222|521524772|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
144637704|NCT01275222|521524773|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
144637705|NCT01275222|521524774|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
144637706|NCT01275222|521524775|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
144637707|NCT01275222|521524776|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
144637708|NCT01275222|521524771|FG000|Phase l by Treatment|Death|0|||
144637709|NCT01275222|521524772|FG001|Phase l by Treatment|Death|1|||
144637710|NCT01275222|521524773|FG002|Phase l by Treatment|Death|0|||
144637711|NCT01275222|521524774|FG003|Phase l by Treatment|Death|1|||
144637712|NCT01275222|521524775|FG004|Phase l by Treatment|Death|0|||
144637713|NCT01275222|521524776|FG005|Phase l by Treatment|Death|0|||
144637714|NCT01275222|521524771|FG000|Phase ll by Stratum|Adverse Event|0|||
144637715|NCT01275222|521524772|FG001|Phase ll by Stratum|Adverse Event|0|||
144637716|NCT01275222|521524773|FG002|Phase ll by Stratum|Adverse Event|0|||
144637717|NCT01275222|521524774|FG003|Phase ll by Stratum|Adverse Event|0|||
144637718|NCT01275222|521524775|FG004|Phase ll by Stratum|Adverse Event|2|||
144637719|NCT01275222|521524776|FG005|Phase ll by Stratum|Adverse Event|10|||
144637720|NCT01275222|521524771|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
144637721|NCT01275222|521524772|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
144637722|NCT01275222|521524773|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
144637723|NCT01275222|521524774|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
144637724|NCT01275222|521524775|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
144637725|NCT01275222|521524776|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
144637726|NCT01275222|521524771|FG000|Phase ll by Stratum|Disease progression|0|||
144637727|NCT01275222|521524772|FG001|Phase ll by Stratum|Disease progression|0|||
144637728|NCT01275222|521524773|FG002|Phase ll by Stratum|Disease progression|0|||
144637729|NCT01275222|521524774|FG003|Phase ll by Stratum|Disease progression|0|||
144637730|NCT01275222|521524775|FG004|Phase ll by Stratum|Disease progression|23|||
144637731|NCT01275222|521524776|FG005|Phase ll by Stratum|Disease progression|31|||
144637732|NCT01275222|521524771|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
144637733|NCT01275222|521524772|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
144637734|NCT01275222|521524773|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
144637735|NCT01275222|521524774|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
144637736|NCT01275222|521524775|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
144637737|NCT01275222|521524776|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
144637738|NCT01275222|521524771|FG000|Phase ll by Stratum|Death|0|||
144637739|NCT01275222|521524772|FG001|Phase ll by Stratum|Death|0|||
144637740|NCT01275222|521524773|FG002|Phase ll by Stratum|Death|0|||
144637741|NCT01275222|521524774|FG003|Phase ll by Stratum|Death|0|||
144637742|NCT01275222|521524775|FG004|Phase ll by Stratum|Death|1|||
144637743|NCT01275222|521524776|FG005|Phase ll by Stratum|Death|1|||
144637744|NCT03832387|521524777|FG000|Overall Study|Protocol Violation|2|||
144637745|NCT03832387|521524778|FG001|Overall Study|Protocol Violation|6|||
144637746|NCT03832387|521524777|FG000|Overall Study|EXCLUSION CRITERIA|3|||
144637747|NCT03832387|521524778|FG001|Overall Study|EXCLUSION CRITERIA|1|||
144637748|NCT01856114|521524779|FG000|Overall Study|Withdrawal by Subject|1|||
144637749|NCT01856114|521524780|FG001|Overall Study|Withdrawal by Subject|0|||
144637750|NCT01856114|521524779|FG000|Overall Study|Adverse Event|1|||
144637751|NCT01856114|521524780|FG001|Overall Study|Adverse Event|0|||
144637752|NCT04906707|521524781|FG000|Overall Study|Withdrawal by Subject|2|||
144637753|NCT04906707|521524782|FG001|Overall Study|Withdrawal by Subject|0|||
144637754|NCT04906707|521524781|FG000|Overall Study|Withdrawal due to PI decision|1|||
144637755|NCT04906707|521524782|FG001|Overall Study|Withdrawal due to PI decision|0|||
144637756|NCT04906707|521524781|FG000|Overall Study|Lost to Follow-up|0|||
144637757|NCT04906707|521524782|FG001|Overall Study|Lost to Follow-up|1|||
144637758|NCT00963807|521524783|FG000|Overall Study|Physician Decision|2|||
144637759|NCT00963807|521524783|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
144263050|NCT00249873|520163848|FG000|Overall Study|Minor bleeding|99|||
144637760|NCT00963807|521524783|FG000|Overall Study|Disease progression|15|||
144637761|NCT01291017|521524784|FG000|Overall Study|Lost to Follow-up|2|||
144637762|NCT01291017|521524784|FG000|Overall Study|Withdrawal by Subject|3|||
144637763|NCT03263091|521527573|FG000|OL Component|Withdrawal by Subject|1|||
144263051|NCT00249873|520163849|FG001|Overall Study|Minor bleeding|37|||
144637764|NCT03263091|521527574|FG001|OL Component|Withdrawal by Subject|1|||
144637765|NCT03263091|521527575|FG002|OL Component|Withdrawal by Subject|0|||
144637766|NCT03263091|521527576|FG003|OL Component|Withdrawal by Subject|0|||
144637767|NCT03263091|521527577|FG004|OL Component|Withdrawal by Subject|0|||
144637768|NCT03263091|521527578|FG005|OL Component|Withdrawal by Subject|0|||
144637769|NCT03263091|521527573|FG000|OL Component|Physician Decision|0|||
144637770|NCT03263091|521527574|FG001|OL Component|Physician Decision|1|||
144637771|NCT03263091|521527575|FG002|OL Component|Physician Decision|2|||
144637772|NCT03263091|521527576|FG003|OL Component|Physician Decision|0|||
144637773|NCT03263091|521527577|FG004|OL Component|Physician Decision|0|||
144637774|NCT03263091|521527578|FG005|OL Component|Physician Decision|0|||
144637775|NCT03263091|521527573|FG000|OL Component|Death|1|||
144637776|NCT03263091|521527574|FG001|OL Component|Death|0|||
144637777|NCT03263091|521527575|FG002|OL Component|Death|0|||
144637778|NCT03263091|521527576|FG003|OL Component|Death|0|||
144637779|NCT03263091|521527577|FG004|OL Component|Death|0|||
144637780|NCT03263091|521527578|FG005|OL Component|Death|0|||
144637781|NCT03263091|521527573|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
144637782|NCT03263091|521527574|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
144637783|NCT03263091|521527575|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
144637784|NCT03263091|521527576|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
144637785|NCT03263091|521527577|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
144637786|NCT03263091|521527578|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
144637787|NCT03263091|521527573|FG000|OL High-EPO Component|Physician Decision|0|||
144637788|NCT03263091|521527574|FG001|OL High-EPO Component|Physician Decision|0|||
144637789|NCT03263091|521527575|FG002|OL High-EPO Component|Physician Decision|0|||
144637790|NCT03263091|521527576|FG003|OL High-EPO Component|Physician Decision|1|||
144637791|NCT03263091|521527577|FG004|OL High-EPO Component|Physician Decision|0|||
144637792|NCT03263091|521527578|FG005|OL High-EPO Component|Physician Decision|0|||
144637793|NCT03263091|521527573|FG000|OL High-EPO Component|Death|0|||
144637794|NCT03263091|521527574|FG001|OL High-EPO Component|Death|0|||
144637795|NCT03263091|521527575|FG002|OL High-EPO Component|Death|0|||
144637796|NCT03263091|521527576|FG003|OL High-EPO Component|Death|3|||
144637797|NCT03263091|521527577|FG004|OL High-EPO Component|Death|0|||
144637798|NCT03263091|521527578|FG005|OL High-EPO Component|Death|0|||
144637799|NCT03263091|521527573|FG000|DB Component|Withdrawal by Subject|0|||
144637800|NCT03263091|521527574|FG001|DB Component|Withdrawal by Subject|0|||
144637801|NCT03263091|521527575|FG002|DB Component|Withdrawal by Subject|0|||
144637802|NCT03263091|521527576|FG003|DB Component|Withdrawal by Subject|0|||
144637803|NCT03263091|521527577|FG004|DB Component|Withdrawal by Subject|22|||
144637804|NCT03263091|521527578|FG005|DB Component|Withdrawal by Subject|8|||
144637805|NCT03263091|521527573|FG000|DB Component|Physician Decision|0|||
144637806|NCT03263091|521527574|FG001|DB Component|Physician Decision|0|||
144637807|NCT03263091|521527575|FG002|DB Component|Physician Decision|0|||
144637808|NCT03263091|521527576|FG003|DB Component|Physician Decision|0|||
144637809|NCT03263091|521527577|FG004|DB Component|Physician Decision|3|||
144637810|NCT03263091|521527578|FG005|DB Component|Physician Decision|1|||
144637811|NCT03263091|521527573|FG000|DB Component|Adverse Event|0|||
144637812|NCT03263091|521527574|FG001|DB Component|Adverse Event|0|||
144637813|NCT03263091|521527575|FG002|DB Component|Adverse Event|0|||
144637814|NCT03263091|521527576|FG003|DB Component|Adverse Event|0|||
144637815|NCT03263091|521527577|FG004|DB Component|Adverse Event|2|||
144637816|NCT03263091|521527578|FG005|DB Component|Adverse Event|1|||
144637817|NCT03263091|521527573|FG000|DB Component|Lost to Follow-up|0|||
144637818|NCT03263091|521527574|FG001|DB Component|Lost to Follow-up|0|||
144637819|NCT03263091|521527575|FG002|DB Component|Lost to Follow-up|0|||
144637820|NCT03263091|521527576|FG003|DB Component|Lost to Follow-up|0|||
144637821|NCT03263091|521527577|FG004|DB Component|Lost to Follow-up|2|||
144637822|NCT03263091|521527578|FG005|DB Component|Lost to Follow-up|1|||
144637823|NCT03263091|521527573|FG000|DB Component|Death|0|||
144637824|NCT03263091|521527574|FG001|DB Component|Death|0|||
144637825|NCT03263091|521527575|FG002|DB Component|Death|0|||
144637826|NCT03263091|521527576|FG003|DB Component|Death|0|||
144637827|NCT03263091|521527577|FG004|DB Component|Death|7|||
144637828|NCT03263091|521527578|FG005|DB Component|Death|4|||
144637829|NCT03263091|521527573|FG000|DB Component|Other than specified|0|||
144637830|NCT03263091|521527574|FG001|DB Component|Other than specified|0|||
144637831|NCT03263091|521527575|FG002|DB Component|Other than specified|0|||
144637832|NCT03263091|521527576|FG003|DB Component|Other than specified|0|||
144637833|NCT03263091|521527577|FG004|DB Component|Other than specified|8|||
144731085|NCT01389102|521871378|FG003|Overall Study|Withdrawal by Subject|2|||
144731086|NCT01389102|521871379|FG004|Overall Study|Withdrawal by Subject|3|||
144731087|NCT01389102|521871380|FG005|Overall Study|Withdrawal by Subject|3|||
144731088|NCT01389102|521871375|FG000|Overall Study|Subject Traveling Out of Country|0|||
144731089|NCT01389102|521871376|FG001|Overall Study|Subject Traveling Out of Country|0|||
144637834|NCT03263091|521527578|FG005|DB Component|Other than specified|6|||
144637835|NCT01381094|521527580|FG000|Overall Study|Adverse Event|1|||
144637836|NCT01381094|521527581|FG001|Overall Study|Adverse Event|2|||
144637837|NCT01381094|521527582|FG002|Overall Study|Adverse Event|0|||
144637838|NCT01381094|521527583|FG003|Overall Study|Adverse Event|1|||
144637839|NCT01381094|521527584|FG004|Overall Study|Adverse Event|0|||
144637840|NCT01381094|521527580|FG000|Overall Study|Lost to Follow-up|0|||
144637841|NCT01381094|521527581|FG001|Overall Study|Lost to Follow-up|0|||
144637842|NCT01381094|521527582|FG002|Overall Study|Lost to Follow-up|0|||
144637843|NCT01381094|521527583|FG003|Overall Study|Lost to Follow-up|0|||
144637844|NCT01381094|521527584|FG004|Overall Study|Lost to Follow-up|1|||
144637845|NCT01381094|521527580|FG000|Overall Study|Withdrawal of informed consent|0|||
144637846|NCT01381094|521527581|FG001|Overall Study|Withdrawal of informed consent|1|||
144637847|NCT01381094|521527582|FG002|Overall Study|Withdrawal of informed consent|0|||
144637848|NCT01381094|521527583|FG003|Overall Study|Withdrawal of informed consent|0|||
144637849|NCT01381094|521527584|FG004|Overall Study|Withdrawal of informed consent|0|||
144637850|NCT01381094|521527580|FG000|Overall Study|Participant given Aranesp injection|1|||
144637851|NCT01381094|521527581|FG001|Overall Study|Participant given Aranesp injection|0|||
144637852|NCT01381094|521527582|FG002|Overall Study|Participant given Aranesp injection|0|||
144637853|NCT01381094|521527583|FG003|Overall Study|Participant given Aranesp injection|0|||
144637854|NCT01381094|521527584|FG004|Overall Study|Participant given Aranesp injection|0|||
144637855|NCT02443402|521527587|FG000|Overall Study|Withdrawal by Subject|3|||
144637856|NCT02443402|521527588|FG001|Overall Study|Withdrawal by Subject|1|||
144637857|NCT02443402|521527587|FG000|Overall Study|Screen Failure|1|||
144637858|NCT02443402|521527588|FG001|Overall Study|Screen Failure|2|||
144637859|NCT01934504|521527591|FG000|Overall Study|Protocol Deviation|0|||
144637860|NCT01934504|521527592|FG001|Overall Study|Protocol Deviation|0|||
144637861|NCT01934504|521527593|FG002|Overall Study|Protocol Deviation|0|||
144637862|NCT01934504|521527594|FG003|Overall Study|Protocol Deviation|2|||
144637863|NCT01934504|521527591|FG000|Overall Study|Study Terminated by Sponsor|1|||
144637864|NCT01934504|521527592|FG001|Overall Study|Study Terminated by Sponsor|0|||
144637865|NCT01934504|521527593|FG002|Overall Study|Study Terminated by Sponsor|5|||
144637866|NCT01934504|521527594|FG003|Overall Study|Study Terminated by Sponsor|5|||
144637867|NCT02665689|521527595|FG000|Overall Study|Adverse Event|1|||
144637868|NCT02665689|521527596|FG001|Overall Study|Adverse Event|0|||
144637869|NCT02665689|521527595|FG000|Overall Study|Trial termination|1|||
144637870|NCT02665689|521527596|FG001|Overall Study|Trial termination|1|||
144637871|NCT02665689|521527595|FG000|Overall Study|Lost to Follow-up|0|||
144637872|NCT02665689|521527596|FG001|Overall Study|Lost to Follow-up|1|||
144637873|NCT00486902|521527597|FG000|Overall Study|Withdrawal by Subject|1|||
144637874|NCT00486902|521527598|FG001|Overall Study|Withdrawal by Subject|2|||
144637875|NCT00486902|521527597|FG000|Overall Study|decision for postpartum tubal ligation|3|||
144637876|NCT00486902|521527598|FG001|Overall Study|decision for postpartum tubal ligation|1|||
144637877|NCT00486902|521527597|FG000|Overall Study|spinal anesthetic protocal violation|1|||
144637878|NCT00486902|521527598|FG001|Overall Study|spinal anesthetic protocal violation|1|||
144637879|NCT00486902|521527597|FG000|Overall Study|Did not meet inclusion criteria|1|||
144637880|NCT00486902|521527598|FG001|Overall Study|Did not meet inclusion criteria|0|||
144637881|NCT00486902|521527597|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
144637882|NCT00486902|521527598|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
144637883|NCT02900092|521527602|FG000|Overall Study|Adverse Event|1|||
144637884|NCT04178590|521527603|FG000|Overall Study|Pregnancy|1|||
144637885|NCT04178590|521527603|FG000|Overall Study|Lost to Follow-up|1|||
144637886|NCT05127486|521527604|FG000|Overall Study|Adverse Event|2|||
144637887|NCT05127486|521527605|FG001|Overall Study|Adverse Event|4|||
144637888|NCT05127486|521527604|FG000|Overall Study|Lack of Efficacy|1|||
144637889|NCT05127486|521527605|FG001|Overall Study|Lack of Efficacy|0|||
144637890|NCT05127486|521527604|FG000|Overall Study|Pregnancy|0|||
144637891|NCT05127486|521527605|FG001|Overall Study|Pregnancy|1|||
144637892|NCT05127486|521527604|FG000|Overall Study|Physician Decision|4|||
144637893|NCT05127486|521527605|FG001|Overall Study|Physician Decision|1|||
144637894|NCT05127486|521527604|FG000|Overall Study|Withdrawal by Subject|14|||
144637895|NCT05127486|521527605|FG001|Overall Study|Withdrawal by Subject|13|||
144637896|NCT05127486|521527604|FG000|Overall Study|Lost to Follow-up|5|||
144637897|NCT05127486|521527605|FG001|Overall Study|Lost to Follow-up|8|||
144637898|NCT02582515|521527606|FG000|Overall Study|Withdrawal by Subject|0|||
144637899|NCT02582515|521527607|FG001|Overall Study|Withdrawal by Subject|1|||
144637900|NCT00775021|521527608|FG000|First Intervention|Lost to Follow-up|1|||
144637901|NCT00775021|521527609|FG001|First Intervention|Lost to Follow-up|0|||
144637902|NCT00775021|521527608|FG000|Second Intervention|Adverse Event|0|||
144637903|NCT00775021|521527609|FG001|Second Intervention|Adverse Event|1|||
144637904|NCT00363415|521527610|FG000|Overall Study|Progressive Disease|196|||
144637905|NCT00363415|521527611|FG001|Overall Study|Progressive Disease|107|||
144637906|NCT00363415|521527610|FG000|Overall Study|Sponsor Decision|67|||
144731090|NCT01389102|521871377|FG002|Overall Study|Subject Traveling Out of Country|0|||
144637907|NCT00363415|521527611|FG001|Overall Study|Sponsor Decision|31|||
144637908|NCT00363415|521527610|FG000|Overall Study|Death|32|||
144637909|NCT00363415|521527611|FG001|Overall Study|Death|29|||
144731091|NCT01389102|521871378|FG003|Overall Study|Subject Traveling Out of Country|1|||
144637910|NCT00363415|521527610|FG000|Overall Study|Adverse Event|24|||
144637911|NCT00363415|521527611|FG001|Overall Study|Adverse Event|15|||
144637912|NCT00363415|521527610|FG000|Overall Study|Physician Decision|18|||
144637913|NCT00363415|521527611|FG001|Overall Study|Physician Decision|35|||
144637914|NCT00363415|521527610|FG000|Overall Study|Entry Criteria Not Met|11|||
144637915|NCT00363415|521527611|FG001|Overall Study|Entry Criteria Not Met|10|||
144637916|NCT00363415|521527610|FG000|Overall Study|Withdrawal by Subject|9|||
144637917|NCT00363415|521527611|FG001|Overall Study|Withdrawal by Subject|15|||
144637918|NCT00363415|521527610|FG000|Overall Study|Lost to Follow-up|3|||
144637919|NCT00363415|521527611|FG001|Overall Study|Lost to Follow-up|3|||
144637920|NCT00363415|521527610|FG000|Overall Study|Protocol Violation|1|||
144637921|NCT00363415|521527611|FG001|Overall Study|Protocol Violation|4|||
144637922|NCT05027802|521527614|FG000|Overall Study|Adverse Event|2|||
144637923|NCT05027802|521527614|FG000|Overall Study|Withdrawal by Subject|18|||
144637924|NCT05027802|521527614|FG000|Overall Study|Death|2|||
144637925|NCT05027802|521527614|FG000|Overall Study|Other|1|||
144637926|NCT04889209|521527621|FG000|All Cohorts Except 15E|Adverse Event|0|||
144637927|NCT04889209|521527622|FG001|All Cohorts Except 15E|Adverse Event|0|||
144637928|NCT04889209|521527623|FG002|All Cohorts Except 15E|Adverse Event|0|||
144637929|NCT04889209|521527624|FG003|All Cohorts Except 15E|Adverse Event|0|||
144637930|NCT04889209|521527625|FG004|All Cohorts Except 15E|Adverse Event|0|||
144637931|NCT04889209|521527626|FG005|All Cohorts Except 15E|Adverse Event|0|||
144637932|NCT04889209|521527627|FG006|All Cohorts Except 15E|Adverse Event|1|||
144637933|NCT04889209|521527628|FG007|All Cohorts Except 15E|Adverse Event|0|||
144637934|NCT04889209|521527629|FG008|All Cohorts Except 15E|Adverse Event|0|||
144637935|NCT04889209|521527630|FG009|All Cohorts Except 15E|Adverse Event|0|||
144637936|NCT04889209|521527631|FG010|All Cohorts Except 15E|Adverse Event|0|||
144637937|NCT04889209|521527632|FG011|All Cohorts Except 15E|Adverse Event|0|||
144637938|NCT04889209|521527633|FG012|All Cohorts Except 15E|Adverse Event|0|||
144637939|NCT04889209|521527634|FG013|All Cohorts Except 15E|Adverse Event|0|||
144637940|NCT04889209|521527635|FG014|All Cohorts Except 15E|Adverse Event|0|||
144637941|NCT04889209|521527636|FG015|All Cohorts Except 15E|Adverse Event|0|||
144637942|NCT04889209|521527637|FG016|All Cohorts Except 15E|Adverse Event|0|||
144637943|NCT04889209|521527638|FG017|All Cohorts Except 15E|Adverse Event|0|||
144637944|NCT04889209|521527621|FG000|All Cohorts Except 15E|Death|0|||
144637945|NCT04889209|521527622|FG001|All Cohorts Except 15E|Death|1|||
144637946|NCT04889209|521527623|FG002|All Cohorts Except 15E|Death|0|||
144637947|NCT04889209|521527624|FG003|All Cohorts Except 15E|Death|0|||
144637948|NCT04889209|521527625|FG004|All Cohorts Except 15E|Death|0|||
144637949|NCT04889209|521527626|FG005|All Cohorts Except 15E|Death|0|||
144637950|NCT04889209|521527627|FG006|All Cohorts Except 15E|Death|0|||
144637951|NCT04889209|521527628|FG007|All Cohorts Except 15E|Death|0|||
144637952|NCT04889209|521527629|FG008|All Cohorts Except 15E|Death|0|||
144637953|NCT04889209|521527630|FG009|All Cohorts Except 15E|Death|0|||
144637954|NCT04889209|521527631|FG010|All Cohorts Except 15E|Death|0|||
144637955|NCT04889209|521527632|FG011|All Cohorts Except 15E|Death|0|||
144637956|NCT04889209|521527633|FG012|All Cohorts Except 15E|Death|0|||
144637957|NCT04889209|521527634|FG013|All Cohorts Except 15E|Death|0|||
144637958|NCT04889209|521527635|FG014|All Cohorts Except 15E|Death|0|||
144637959|NCT04889209|521527636|FG015|All Cohorts Except 15E|Death|0|||
144637960|NCT04889209|521527637|FG016|All Cohorts Except 15E|Death|0|||
144637961|NCT04889209|521527638|FG017|All Cohorts Except 15E|Death|0|||
144637962|NCT04889209|521527621|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
144637963|NCT04889209|521527622|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
144637964|NCT04889209|521527623|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
144637965|NCT04889209|521527624|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
144637966|NCT04889209|521527625|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
144637967|NCT04889209|521527626|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
144637968|NCT04889209|521527627|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
144637969|NCT04889209|521527628|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
144637970|NCT04889209|521527629|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
144637971|NCT04889209|521527630|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
144637972|NCT04889209|521527631|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
144637973|NCT04889209|521527632|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
144637974|NCT04889209|521527633|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
144637975|NCT04889209|521527634|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
144637976|NCT04889209|521527635|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
144637977|NCT04889209|521527636|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
144637978|NCT04889209|521527637|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
144637979|NCT04889209|521527638|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
144637980|NCT04889209|521527621|FG000|All Cohorts Except 15E|Physician Decision|0|||
144637981|NCT04889209|521527622|FG001|All Cohorts Except 15E|Physician Decision|0|||
144637982|NCT04889209|521527623|FG002|All Cohorts Except 15E|Physician Decision|0|||
144637983|NCT04889209|521527624|FG003|All Cohorts Except 15E|Physician Decision|0|||
144637984|NCT04889209|521527625|FG004|All Cohorts Except 15E|Physician Decision|1|||
144637985|NCT04889209|521527626|FG005|All Cohorts Except 15E|Physician Decision|0|||
144637986|NCT04889209|521527627|FG006|All Cohorts Except 15E|Physician Decision|0|||
144637987|NCT04889209|521527628|FG007|All Cohorts Except 15E|Physician Decision|1|||
144637988|NCT04889209|521527629|FG008|All Cohorts Except 15E|Physician Decision|0|||
144637989|NCT04889209|521527630|FG009|All Cohorts Except 15E|Physician Decision|1|||
144637990|NCT04889209|521527631|FG010|All Cohorts Except 15E|Physician Decision|0|||
144637991|NCT04889209|521527632|FG011|All Cohorts Except 15E|Physician Decision|1|||
144637992|NCT04889209|521527633|FG012|All Cohorts Except 15E|Physician Decision|1|||
144637993|NCT04889209|521527634|FG013|All Cohorts Except 15E|Physician Decision|0|||
144637994|NCT04889209|521527635|FG014|All Cohorts Except 15E|Physician Decision|0|||
144637995|NCT04889209|521527636|FG015|All Cohorts Except 15E|Physician Decision|0|||
144637996|NCT04889209|521527637|FG016|All Cohorts Except 15E|Physician Decision|0|||
144263052|NCT00249873|520163848|FG000|Overall Study|Non-compliance|41|||
144263053|NCT00249873|520163849|FG001|Overall Study|Non-compliance|46|||
144263054|NCT00249873|520163848|FG000|Overall Study|Other non serious Adverse Event|112|||
144263055|NCT00249873|520163849|FG001|Overall Study|Other non serious Adverse Event|108|||
144263056|NCT00249873|520163848|FG000|Overall Study|Other contraindicated medication|1|||
144263057|NCT00249873|520163849|FG001|Overall Study|Other contraindicated medication|0|||
144263058|NCT00249873|520163848|FG000|Overall Study|Patient not wish to continue after May08|3|||
144263059|NCT00249873|520163849|FG001|Overall Study|Patient not wish to continue after May08|4|||
144263060|NCT00249873|520163848|FG000|Overall Study|Physician withdrew consent|59|||
144263061|NCT00249873|520163849|FG001|Overall Study|Physician withdrew consent|60|||
144263062|NCT00249873|520163848|FG000|Overall Study|Open label clopidogrel required|31|||
144263063|NCT00249873|520163849|FG001|Overall Study|Open label clopidogrel required|42|||
144263064|NCT00249873|520163848|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
144263065|NCT00249873|520163849|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
144263066|NCT00249873|520163848|FG000|Overall Study|Oral anticoagulant required|159|||
144263067|NCT00249873|520163849|FG001|Overall Study|Oral anticoagulant required|157|||
144263068|NCT00249873|520163848|FG000|Overall Study|Study drug intolerance|5|||
144263069|NCT00249873|520163849|FG001|Overall Study|Study drug intolerance|0|||
144263070|NCT00249873|520163848|FG000|Overall Study|Surgery/ procedure|9|||
144263071|NCT00249873|520163849|FG001|Overall Study|Surgery/ procedure|9|||
144263072|NCT00249873|520163848|FG000|Overall Study|Event related to cardiac condition|12|||
144263073|NCT00249873|520163849|FG001|Overall Study|Event related to cardiac condition|21|||
144263074|NCT00249873|520163848|FG000|Overall Study|Thromboembolic/outcome event|82|||
144263075|NCT00249873|520163849|FG001|Overall Study|Thromboembolic/outcome event|122|||
144263076|NCT00974311|520163850|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
144263077|NCT00974311|520163851|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
144263078|NCT00974311|520163850|FG000|DB Phase (up to 24 Months)|Death|561|||
144263079|NCT00974311|520163851|FG001|DB Phase (up to 24 Months)|Death|298|||
144263080|NCT00974311|520163850|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
144263081|NCT00974311|520163851|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
144263082|NCT00974311|520163850|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
144263083|NCT00974311|520163851|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
144263084|NCT00974311|520163850|FG000|DB Phase (up to 24 Months)|Other|1|||
144263085|NCT00974311|520163851|FG001|DB Phase (up to 24 Months)|Other|0|||
144263086|NCT00974311|520163850|FG000|OLE Phase (up to 77 Months)|Death|14|||
144263087|NCT00974311|520163851|FG001|OLE Phase (up to 77 Months)|Death|21|||
144263088|NCT00974311|520163850|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
144263089|NCT00974311|520163851|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
144263090|NCT00974311|520163850|FG000|OLE Phase (up to 77 Months)|Other|15|||
144263091|NCT00974311|520163851|FG001|OLE Phase (up to 77 Months)|Other|2|||
144263092|NCT00974311|520163850|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
144263093|NCT00974311|520163851|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
144637997|NCT04889209|521527638|FG017|All Cohorts Except 15E|Physician Decision|0|||
144637998|NCT04889209|521527621|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
144637999|NCT04889209|521527622|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
144638000|NCT04889209|521527623|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
144638001|NCT04889209|521527624|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
144638002|NCT04889209|521527625|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
144638003|NCT04889209|521527626|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638004|NCT04889209|521527627|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638005|NCT04889209|521527628|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
144638006|NCT04889209|521527629|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638007|NCT04889209|521527630|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638008|NCT04889209|521527631|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638009|NCT04889209|521527632|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638010|NCT04889209|521527633|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638011|NCT04889209|521527634|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
144638012|NCT04889209|521527635|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
144638013|NCT04889209|521527636|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
144638014|NCT04889209|521527637|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
144638015|NCT04889209|521527638|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
144638016|NCT04889209|521527621|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
144638017|NCT04889209|521527622|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
144638018|NCT04889209|521527623|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638019|NCT04889209|521527624|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638020|NCT04889209|521527625|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638021|NCT04889209|521527626|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
144638022|NCT04889209|521527627|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638023|NCT04889209|521527628|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
144638024|NCT04889209|521527629|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638025|NCT04889209|521527630|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
144638026|NCT04889209|521527631|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638027|NCT04889209|521527632|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638028|NCT04889209|521527633|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638029|NCT04889209|521527634|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638030|NCT04889209|521527635|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638031|NCT04889209|521527636|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638032|NCT04889209|521527637|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
144638033|NCT04889209|521527638|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
144638034|NCT04889209|521527621|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638035|NCT04889209|521527622|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638036|NCT04889209|521527623|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638037|NCT04889209|521527624|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
144638038|NCT04889209|521527625|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638039|NCT04889209|521527626|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638040|NCT04889209|521527627|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638041|NCT04889209|521527628|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638042|NCT04889209|521527629|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638043|NCT04889209|521527630|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638044|NCT04889209|521527631|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638045|NCT04889209|521527632|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638046|NCT04889209|521527633|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144700090|NCT00948896|521754510|FG003|Randomization to 24 Months of Age|Death|0|||
144700091|NCT00948896|521754511|FG004|Randomization to 24 Months of Age|Death|2|||
144700092|NCT00948896|521754512|FG005|Randomization to 24 Months of Age|Death|1|||
144700093|NCT00948896|521754513|FG006|Randomization to 24 Months of Age|Death|2|||
144700094|NCT00948896|521754514|FG007|Randomization to 24 Months of Age|Death|1|||
144700095|NCT00948896|521754507|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
144700096|NCT00948896|521754508|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
144700097|NCT00948896|521754509|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
144700098|NCT00948896|521754510|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
144700099|NCT00948896|521754511|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
144700100|NCT00948896|521754512|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
144700101|NCT00948896|521754513|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
144700102|NCT00948896|521754514|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
144700103|NCT00948896|521754507|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
144700104|NCT00948896|521754508|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
144700105|NCT00948896|521754509|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
144700106|NCT00948896|521754510|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
144700107|NCT00948896|521754511|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
144700108|NCT00948896|521754512|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
144700109|NCT00948896|521754513|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
144700110|NCT00948896|521754514|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
144700111|NCT00948896|521754507|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
144700112|NCT00948896|521754508|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
144700113|NCT00948896|521754509|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
144700114|NCT00948896|521754510|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
144700115|NCT00948896|521754511|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
144700116|NCT00948896|521754512|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
144700117|NCT00948896|521754513|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
144700118|NCT00948896|521754514|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
144700119|NCT00948896|521754507|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
144700120|NCT00948896|521754508|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
144700121|NCT00948896|521754509|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
144700122|NCT00948896|521754510|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
144700123|NCT00948896|521754511|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
144700124|NCT00948896|521754512|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
144700125|NCT00948896|521754513|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
144700126|NCT00948896|521754514|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
144700127|NCT00948896|521754507|FG000|24 Months of Age to 36 Months of Age|Death|0|||
144210585|NCT02027428|519965305|FG001|Maintenance|Symptomatic deterioration|4|||
144210586|NCT02027428|519965306|FG002|Maintenance|Symptomatic deterioration|1|||
144210587|NCT02027428|519965304|FG000|Maintenance|Withdrawal by Subject|0|||
144210588|NCT02027428|519965305|FG001|Maintenance|Withdrawal by Subject|6|||
144210589|NCT02027428|519965306|FG002|Maintenance|Withdrawal by Subject|5|||
144210590|NCT02027428|519965304|FG000|Maintenance|Protocol Violation|0|||
144210591|NCT02027428|519965305|FG001|Maintenance|Protocol Violation|0|||
144210592|NCT02027428|519965306|FG002|Maintenance|Protocol Violation|1|||
144210593|NCT02027428|519965304|FG000|Maintenance|Other|0|||
144210594|NCT02027428|519965305|FG001|Maintenance|Other|6|||
144210595|NCT02027428|519965306|FG002|Maintenance|Other|3|||
144210596|NCT02027428|519965304|FG000|Survival Follow-up|Death|0|||
144210597|NCT02027428|519965305|FG001|Survival Follow-up|Death|78|||
144210598|NCT02027428|519965306|FG002|Survival Follow-up|Death|45|||
144210599|NCT02027428|519965304|FG000|Survival Follow-up|Lost to Follow-up|0|||
144210600|NCT02027428|519965305|FG001|Survival Follow-up|Lost to Follow-up|1|||
144210601|NCT02027428|519965306|FG002|Survival Follow-up|Lost to Follow-up|1|||
144210602|NCT03097991|519965307|FG000|Overall Study|Didn't meet study criteria|8|||
144210603|NCT03097991|519965308|FG001|Overall Study|Didn't meet study criteria|0|||
144210604|NCT03097991|519965307|FG000|Overall Study|Withdrawal by Subject|12|||
144210605|NCT03097991|519965308|FG001|Overall Study|Withdrawal by Subject|6|||
144731092|NCT01389102|521871379|FG004|Overall Study|Subject Traveling Out of Country|0|||
144731093|NCT01389102|521871380|FG005|Overall Study|Subject Traveling Out of Country|0|||
144731094|NCT01389102|521871375|FG000|Overall Study|Subject Moved|2|||
144731095|NCT01389102|521871376|FG001|Overall Study|Subject Moved|0|||
144731096|NCT01389102|521871377|FG002|Overall Study|Subject Moved|1|||
144731097|NCT01389102|521871378|FG003|Overall Study|Subject Moved|0|||
144731098|NCT01389102|521871379|FG004|Overall Study|Subject Moved|0|||
144731099|NCT01389102|521871380|FG005|Overall Study|Subject Moved|0|||
144731100|NCT01389102|521871375|FG000|Overall Study|Unavailable due to husband's illness|0|||
144731101|NCT01389102|521871376|FG001|Overall Study|Unavailable due to husband's illness|1|||
144731102|NCT01389102|521871377|FG002|Overall Study|Unavailable due to husband's illness|0|||
144731103|NCT01389102|521871378|FG003|Overall Study|Unavailable due to husband's illness|0|||
144731104|NCT01389102|521871379|FG004|Overall Study|Unavailable due to husband's illness|0|||
144731105|NCT01389102|521871380|FG005|Overall Study|Unavailable due to husband's illness|0|||
144731106|NCT01389102|521871375|FG000|Overall Study|Investigator Judgement|0|||
144731107|NCT01389102|521871376|FG001|Overall Study|Investigator Judgement|1|||
144731108|NCT01389102|521871377|FG002|Overall Study|Investigator Judgement|0|||
144731109|NCT01389102|521871378|FG003|Overall Study|Investigator Judgement|0|||
144731110|NCT01389102|521871379|FG004|Overall Study|Investigator Judgement|0|||
144731111|NCT01389102|521871380|FG005|Overall Study|Investigator Judgement|0|||
144731112|NCT02910037|521871381|FG000|Overall Study|Withdrawal by Subject|4|||
144731113|NCT02910037|521871381|FG000|Overall Study|Lost to Follow-up|6|||
144731114|NCT00436553|521871382|FG000|Overall Study|Adverse Event|4|||
144731115|NCT00436553|521871383|FG001|Overall Study|Adverse Event|3|||
144731116|NCT00436553|521871384|FG002|Overall Study|Adverse Event|4|||
144731117|NCT00436553|521871382|FG000|Overall Study|Death|3|||
144731118|NCT00436553|521871383|FG001|Overall Study|Death|1|||
144731119|NCT00436553|521871384|FG002|Overall Study|Death|3|||
144731120|NCT00436553|521871382|FG000|Overall Study|Lost to Follow-up|0|||
144731121|NCT00436553|521871383|FG001|Overall Study|Lost to Follow-up|2|||
144731122|NCT00436553|521871384|FG002|Overall Study|Lost to Follow-up|0|||
144731123|NCT00436553|521871382|FG000|Overall Study|Protocol Violation|1|||
144731124|NCT00436553|521871383|FG001|Overall Study|Protocol Violation|0|||
144731125|NCT00436553|521871384|FG002|Overall Study|Protocol Violation|0|||
144731126|NCT00436553|521871382|FG000|Overall Study|Withdrawal by Subject|5|||
144731127|NCT00436553|521871383|FG001|Overall Study|Withdrawal by Subject|6|||
144731128|NCT00436553|521871384|FG002|Overall Study|Withdrawal by Subject|3|||
144731129|NCT01035060|521871385|FG000|Overall Study|Lost to Follow-up|0|||
144731130|NCT01035060|521871386|FG001|Overall Study|Lost to Follow-up|7|||
144731131|NCT01035060|521871385|FG000|Overall Study|Did not quality after 2nd screening|14|||
144731132|NCT01035060|521871386|FG001|Overall Study|Did not quality after 2nd screening|1|||
144731133|NCT01035060|521871385|FG000|Overall Study|Withdrawal by Subject|8|||
144210606|NCT03097991|519965307|FG000|Overall Study|Death of Baby|3|||
144210607|NCT03097991|519965308|FG001|Overall Study|Death of Baby|1|||
144263094|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Death|20|||
144263095|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Death|26|||
144731134|NCT01035060|521871386|FG001|Overall Study|Withdrawal by Subject|6|||
144731135|NCT01035060|521871385|FG000|Overall Study|Physician Decision|2|||
144731136|NCT01035060|521871386|FG001|Overall Study|Physician Decision|0|||
144731137|NCT03522675|521871387|FG000|Overall Study|Screen fail|1|||
144210608|NCT03097991|519965307|FG000|Overall Study|Lost to Follow-up|24|||
144731138|NCT03522675|521871387|FG000|Overall Study|Non-reactive to histamine|1|||
144731139|NCT00707161|521871388|FG000|Overall Study|Physician Decision|6|||
144731140|NCT02674477|521871389|FG000|Overall Study|Protocol Violation|8|||
144731141|NCT02674477|521871390|FG001|Overall Study|Protocol Violation|2|||
144731142|NCT00296647|521871391|FG000|Overall Study|Death|4|||
144731143|NCT00296647|521871392|FG001|Overall Study|Death|1|||
144638047|NCT04889209|521527634|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638048|NCT04889209|521527635|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638049|NCT04889209|521527636|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638050|NCT04889209|521527637|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638051|NCT04889209|521527638|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
144638052|NCT04889209|521527621|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638053|NCT04889209|521527622|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638054|NCT04889209|521527623|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638055|NCT04889209|521527624|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638056|NCT04889209|521527625|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638057|NCT04889209|521527626|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638058|NCT04889209|521527627|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638059|NCT04889209|521527628|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638060|NCT04889209|521527629|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638061|NCT04889209|521527630|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638062|NCT04889209|521527631|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638063|NCT04889209|521527632|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638064|NCT04889209|521527633|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638065|NCT04889209|521527634|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638066|NCT04889209|521527635|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638067|NCT04889209|521527636|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638068|NCT04889209|521527637|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
144638069|NCT04889209|521527638|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
144638070|NCT04889209|521527621|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638071|NCT04889209|521527622|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638072|NCT04889209|521527623|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638073|NCT04889209|521527624|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638074|NCT04889209|521527625|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638075|NCT04889209|521527626|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638076|NCT04889209|521527627|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638077|NCT04889209|521527628|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638078|NCT04889209|521527629|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638079|NCT04889209|521527630|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638080|NCT04889209|521527631|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638081|NCT04889209|521527632|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638082|NCT04889209|521527633|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638083|NCT04889209|521527634|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638084|NCT04889209|521527635|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638085|NCT04889209|521527636|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638086|NCT04889209|521527637|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
144638087|NCT04889209|521527638|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
144638088|NCT04889209|521527621|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638089|NCT04889209|521527622|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638090|NCT04889209|521527623|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638091|NCT04889209|521527624|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638092|NCT04889209|521527625|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638093|NCT04889209|521527626|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638094|NCT04889209|521527627|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638095|NCT04889209|521527628|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638096|NCT04889209|521527629|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638097|NCT04889209|521527630|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638098|NCT04889209|521527631|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638099|NCT04889209|521527632|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638100|NCT04889209|521527633|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638101|NCT04889209|521527634|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638102|NCT04889209|521527635|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638103|NCT04889209|521527636|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638104|NCT04889209|521527637|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
144638105|NCT04889209|521527638|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
144638106|NCT04889209|521527621|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638107|NCT04889209|521527622|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638108|NCT04889209|521527623|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638109|NCT04889209|521527624|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638110|NCT04889209|521527625|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638111|NCT04889209|521527626|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638112|NCT04889209|521527627|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638113|NCT04889209|521527628|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638114|NCT04889209|521527629|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638115|NCT04889209|521527630|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638116|NCT04889209|521527631|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638117|NCT04889209|521527632|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638118|NCT04889209|521527633|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638119|NCT04889209|521527634|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638120|NCT04889209|521527635|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
144638121|NCT04889209|521527636|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638122|NCT04889209|521527637|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638123|NCT04889209|521527638|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
144638124|NCT04607408|521527639|FG000|Overall Study|Lost to Follow-up|0|||
144638125|NCT04607408|521527640|FG001|Overall Study|Lost to Follow-up|0|||
144638126|NCT04607408|521527641|FG002|Overall Study|Lost to Follow-up|0|||
144638127|NCT04607408|521527642|FG003|Overall Study|Lost to Follow-up|1|||
144638128|NCT04607408|521527643|FG004|Overall Study|Lost to Follow-up|0|||
144638129|NCT04607408|521527639|FG000|Overall Study|Withdrawal by Subject|0|||
144638130|NCT04607408|521527640|FG001|Overall Study|Withdrawal by Subject|1|||
144638131|NCT04607408|521527641|FG002|Overall Study|Withdrawal by Subject|0|||
144638132|NCT04607408|521527642|FG003|Overall Study|Withdrawal by Subject|1|||
144638133|NCT04607408|521527643|FG004|Overall Study|Withdrawal by Subject|0|||
144638134|NCT01725165|521527644|FG000|Overall Study|Death|11|||
144638135|NCT01725165|521527645|FG001|Overall Study|Death|18|||
144638136|NCT05590377|521527646|FG000|Overall Study|Death|1|||
144638137|NCT05590377|521527647|FG001|Overall Study|Death|1|||
144638138|NCT05590377|521527648|FG002|Overall Study|Death|2|||
144638139|NCT05590377|521527649|FG003|Overall Study|Death|0|||
144638140|NCT05590377|521527650|FG004|Overall Study|Death|0|||
144638141|NCT05590377|521527646|FG000|Overall Study|Study Terminated by Sponsor|1|||
144638142|NCT05590377|521527647|FG001|Overall Study|Study Terminated by Sponsor|5|||
144638143|NCT05590377|521527648|FG002|Overall Study|Study Terminated by Sponsor|4|||
144638144|NCT05590377|521527649|FG003|Overall Study|Study Terminated by Sponsor|0|||
144638145|NCT05590377|521527650|FG004|Overall Study|Study Terminated by Sponsor|0|||
144638146|NCT05590377|521527646|FG000|Overall Study|Withdrawal by Subject|1|||
144638147|NCT05590377|521527647|FG001|Overall Study|Withdrawal by Subject|0|||
144638148|NCT05590377|521527648|FG002|Overall Study|Withdrawal by Subject|0|||
144638149|NCT05590377|521527649|FG003|Overall Study|Withdrawal by Subject|0|||
144638150|NCT05590377|521527650|FG004|Overall Study|Withdrawal by Subject|0|||
144638151|NCT02688647|521527651|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
144638152|NCT02688647|521527652|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
144638153|NCT02688647|521527651|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
144638154|NCT02688647|521527652|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
144638155|NCT02688647|521527651|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
144638156|NCT02688647|521527652|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
144638157|NCT02688647|521527651|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
144638158|NCT02688647|521527652|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
144638159|NCT02688647|521527651|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
144638160|NCT02688647|521527652|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
144638161|NCT02688647|521527651|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
144638162|NCT02688647|521527652|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
144638163|NCT02688647|521527651|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
144638164|NCT02688647|521527652|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
144638165|NCT02197377|521527660|FG000|Overall Study|Insertion Failure|0|||
144638166|NCT02197377|521527661|FG001|Overall Study|Insertion Failure|3|||
144638167|NCT00502840|521527662|FG000|Overall Study|Adverse Event|5|||
144638168|NCT00502840|521527662|FG000|Overall Study|Additional or changed therapy|48|||
144638169|NCT00502840|521527662|FG000|Overall Study|Lack of Efficacy|11|||
144638170|NCT00502840|521527662|FG000|Overall Study|Protocol Violation|4|||
144638171|NCT00502840|521527662|FG000|Overall Study|Withdrawal by Subject|5|||
144638172|NCT00502840|521527662|FG000|Overall Study|Lost to Follow-up|6|||
144638173|NCT00502840|521527662|FG000|Overall Study|Administrative problems|1|||
144638174|NCT00502840|521527662|FG000|Overall Study|Other|20|||
144638175|NCT01974323|521527663|FG000|Overall Study|Other Reasons|25|||
144638176|NCT01974323|521527664|FG001|Overall Study|Other Reasons|28|||
144638177|NCT01974323|521527663|FG000|Overall Study|Protocol Violation|2|||
144638178|NCT01974323|521527664|FG001|Overall Study|Protocol Violation|2|||
144731144|NCT00296647|521871393|FG002|Overall Study|Death|2|||
144638179|NCT01974323|521527663|FG000|Overall Study|Personal Reasons|15|||
144638180|NCT01974323|521527664|FG001|Overall Study|Personal Reasons|19|||
144638181|NCT01974323|521527663|FG000|Overall Study|Lost to Follow-up|45|||
144638182|NCT01974323|521527664|FG001|Overall Study|Lost to Follow-up|40|||
144638183|NCT01974323|521527663|FG000|Overall Study|Pregnancy|2|||
144638184|NCT01974323|521527664|FG001|Overall Study|Pregnancy|1|||
144638185|NCT01974323|521527663|FG000|Overall Study|Lack of Efficacy|1|||
144638186|NCT01974323|521527664|FG001|Overall Study|Lack of Efficacy|1|||
144638187|NCT01974323|521527663|FG000|Overall Study|Adverse Event|2|||
144638188|NCT01974323|521527664|FG001|Overall Study|Adverse Event|2|||
144638189|NCT00809133|521527665|FG000|Overall Study|Progressive disease|2|||
144638190|NCT00809133|521527666|FG001|Overall Study|Progressive disease|5|||
144638191|NCT00809133|521527667|FG002|Overall Study|Progressive disease|5|||
144638192|NCT00809133|521527668|FG003|Overall Study|Progressive disease|3|||
144638193|NCT00809133|521527669|FG004|Overall Study|Progressive disease|4|||
144638194|NCT00809133|521527670|FG005|Overall Study|Progressive disease|1|||
144638195|NCT00809133|521527671|FG006|Overall Study|Progressive disease|3|||
144638196|NCT00809133|521527672|FG007|Overall Study|Progressive disease|3|||
144638197|NCT00809133|521527673|FG008|Overall Study|Progressive disease|3|||
144638198|NCT00809133|521527674|FG009|Overall Study|Progressive disease|9|||
144638199|NCT00809133|521527675|FG010|Overall Study|Progressive disease|5|||
144638200|NCT00809133|521527676|FG011|Overall Study|Progressive disease|7|||
144638201|NCT00809133|521527677|FG012|Overall Study|Progressive disease|5|||
144638202|NCT00809133|521527678|FG013|Overall Study|Progressive disease|4|||
144638203|NCT00809133|521527665|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638204|NCT00809133|521527666|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638205|NCT00809133|521527667|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638206|NCT00809133|521527668|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638207|NCT00809133|521527669|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638208|NCT00809133|521527670|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144638209|NCT00809133|521527671|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144638210|NCT00809133|521527672|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144638211|NCT00809133|521527673|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638212|NCT00809133|521527674|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638213|NCT00809133|521527675|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638214|NCT00809133|521527676|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638215|NCT00809133|521527677|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144638216|NCT00809133|521527678|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
144638217|NCT00809133|521527665|FG000|Overall Study|Other adverse event|1|||
144638218|NCT00809133|521527666|FG001|Overall Study|Other adverse event|1|||
144638219|NCT00809133|521527667|FG002|Overall Study|Other adverse event|1|||
144638220|NCT00809133|521527668|FG003|Overall Study|Other adverse event|0|||
144638221|NCT00809133|521527669|FG004|Overall Study|Other adverse event|0|||
144638222|NCT00809133|521527670|FG005|Overall Study|Other adverse event|3|||
144638223|NCT00809133|521527671|FG006|Overall Study|Other adverse event|2|||
144638224|NCT00809133|521527672|FG007|Overall Study|Other adverse event|4|||
144638225|NCT00809133|521527673|FG008|Overall Study|Other adverse event|0|||
144638226|NCT00809133|521527674|FG009|Overall Study|Other adverse event|0|||
144638227|NCT00809133|521527675|FG010|Overall Study|Other adverse event|1|||
144638228|NCT00809133|521527676|FG011|Overall Study|Other adverse event|1|||
144638229|NCT00809133|521527677|FG012|Overall Study|Other adverse event|0|||
144638230|NCT00809133|521527678|FG013|Overall Study|Other adverse event|1|||
144638231|NCT00809133|521527665|FG000|Overall Study|Lost to Follow-up|0|||
144638232|NCT00809133|521527666|FG001|Overall Study|Lost to Follow-up|0|||
144638233|NCT00809133|521527667|FG002|Overall Study|Lost to Follow-up|0|||
144638234|NCT00809133|521527668|FG003|Overall Study|Lost to Follow-up|0|||
144638235|NCT00809133|521527669|FG004|Overall Study|Lost to Follow-up|0|||
144638236|NCT00809133|521527670|FG005|Overall Study|Lost to Follow-up|1|||
144638237|NCT00809133|521527671|FG006|Overall Study|Lost to Follow-up|0|||
144638238|NCT00809133|521527672|FG007|Overall Study|Lost to Follow-up|0|||
144638239|NCT00809133|521527673|FG008|Overall Study|Lost to Follow-up|0|||
144638240|NCT00809133|521527674|FG009|Overall Study|Lost to Follow-up|0|||
144638241|NCT00809133|521527675|FG010|Overall Study|Lost to Follow-up|0|||
144638242|NCT00809133|521527676|FG011|Overall Study|Lost to Follow-up|0|||
144638243|NCT00809133|521527677|FG012|Overall Study|Lost to Follow-up|0|||
144731145|NCT00296647|521871394|FG003|Overall Study|Death|1|||
144210609|NCT03097991|519965308|FG001|Overall Study|Lost to Follow-up|38|||
144638244|NCT00809133|521527678|FG013|Overall Study|Lost to Follow-up|0|||
144638245|NCT00809133|521527665|FG000|Overall Study|Consent withdrawn|0|||
144638246|NCT00809133|521527666|FG001|Overall Study|Consent withdrawn|0|||
144638247|NCT00809133|521527667|FG002|Overall Study|Consent withdrawn|0|||
144638248|NCT00809133|521527668|FG003|Overall Study|Consent withdrawn|0|||
144638249|NCT00809133|521527669|FG004|Overall Study|Consent withdrawn|1|||
144638250|NCT00809133|521527670|FG005|Overall Study|Consent withdrawn|0|||
144638251|NCT00809133|521527671|FG006|Overall Study|Consent withdrawn|0|||
144638252|NCT00809133|521527672|FG007|Overall Study|Consent withdrawn|0|||
144638253|NCT00809133|521527673|FG008|Overall Study|Consent withdrawn|0|||
144638254|NCT00809133|521527674|FG009|Overall Study|Consent withdrawn|0|||
144638255|NCT00809133|521527675|FG010|Overall Study|Consent withdrawn|0|||
144638256|NCT00809133|521527676|FG011|Overall Study|Consent withdrawn|0|||
144638257|NCT00809133|521527677|FG012|Overall Study|Consent withdrawn|0|||
144638258|NCT00809133|521527678|FG013|Overall Study|Consent withdrawn|0|||
144638259|NCT00809133|521527665|FG000|Overall Study|Other not mentioned above|0|||
144638260|NCT00809133|521527666|FG001|Overall Study|Other not mentioned above|1|||
144638261|NCT00809133|521527667|FG002|Overall Study|Other not mentioned above|0|||
144638262|NCT00809133|521527668|FG003|Overall Study|Other not mentioned above|0|||
144638263|NCT00809133|521527669|FG004|Overall Study|Other not mentioned above|0|||
144638264|NCT00809133|521527670|FG005|Overall Study|Other not mentioned above|1|||
144638265|NCT00809133|521527671|FG006|Overall Study|Other not mentioned above|0|||
144638266|NCT00809133|521527672|FG007|Overall Study|Other not mentioned above|0|||
144638267|NCT00809133|521527673|FG008|Overall Study|Other not mentioned above|0|||
144638268|NCT00809133|521527674|FG009|Overall Study|Other not mentioned above|0|||
144638269|NCT00809133|521527675|FG010|Overall Study|Other not mentioned above|0|||
144638270|NCT00809133|521527676|FG011|Overall Study|Other not mentioned above|0|||
144638271|NCT00809133|521527677|FG012|Overall Study|Other not mentioned above|0|||
144638272|NCT00809133|521527678|FG013|Overall Study|Other not mentioned above|0|||
144638273|NCT03663166|521527679|FG000|Overall Study|Withdrawal by Subject|1|||
144638274|NCT00727402|521527687|FG000|Overall Study|Physician Decision|116|||
144638275|NCT01287104|521527688|FG000|Overall Study|Patient developed progressive disease|1|||
144638276|NCT01287104|521527689|FG001|Overall Study|Patient developed progressive disease|1|||
144638277|NCT01287104|521527690|FG002|Overall Study|Patient developed progressive disease|3|||
144638278|NCT01287104|521527691|FG003|Overall Study|Patient developed progressive disease|2|||
144638279|NCT01287104|521527688|FG000|Overall Study|Donor anaphylaxis|0|||
144638280|NCT01287104|521527689|FG001|Overall Study|Donor anaphylaxis|1|||
144638281|NCT01287104|521527690|FG002|Overall Study|Donor anaphylaxis|0|||
144638282|NCT01287104|521527691|FG003|Overall Study|Donor anaphylaxis|1|||
144638283|NCT01287104|521527688|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
144638284|NCT01287104|521527689|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
144638285|NCT01287104|521527690|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
144638286|NCT01287104|521527691|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
144638287|NCT01287104|521527688|FG000|Overall Study|Low donor chimerism|0|||
144638288|NCT01287104|521527689|FG001|Overall Study|Low donor chimerism|1|||
144638289|NCT01287104|521527690|FG002|Overall Study|Low donor chimerism|0|||
144638290|NCT01287104|521527691|FG003|Overall Study|Low donor chimerism|0|||
144638291|NCT01287104|521527688|FG000|Overall Study|NK cells did not meet release criteria|0|||
144638292|NCT01287104|521527689|FG001|Overall Study|NK cells did not meet release criteria|1|||
144638293|NCT01287104|521527690|FG002|Overall Study|NK cells did not meet release criteria|0|||
144638294|NCT01287104|521527691|FG003|Overall Study|NK cells did not meet release criteria|0|||
144638295|NCT03068715|521527696|FG000|Overall Study|No longer met inclusion criteria|1|||
144638296|NCT03068715|521527697|FG001|Overall Study|No longer met inclusion criteria|0|||
144638297|NCT00098787|521527698|FG000|Overall Study|Never started treatment|3|||
144638298|NCT00098787|521527699|FG001|Overall Study|Never started treatment|2|||
144638299|NCT00098787|521527700|FG002|Overall Study|Never started treatment|1|||
144638300|NCT00098787|521527698|FG000|Overall Study|Ineligible|9|||
144638301|NCT00098787|521527699|FG001|Overall Study|Ineligible|7|||
144638302|NCT00098787|521527700|FG002|Overall Study|Ineligible|3|||
144638303|NCT00098787|521527698|FG000|Overall Study|Disease progression|28|||
144638304|NCT00098787|521527699|FG001|Overall Study|Disease progression|17|||
144638305|NCT00098787|521527700|FG002|Overall Study|Disease progression|23|||
144638306|NCT00098787|521527698|FG000|Overall Study|Adverse Event|8|||
144638307|NCT00098787|521527699|FG001|Overall Study|Adverse Event|17|||
144638308|NCT00098787|521527700|FG002|Overall Study|Adverse Event|8|||
144638309|NCT00098787|521527698|FG000|Overall Study|Death|6|||
144638310|NCT00098787|521527699|FG001|Overall Study|Death|1|||
144638311|NCT00098787|521527700|FG002|Overall Study|Death|0|||
144638312|NCT00098787|521527698|FG000|Overall Study|Withdrawal by Subject|4|||
144638313|NCT00098787|521527699|FG001|Overall Study|Withdrawal by Subject|12|||
144731146|NCT00296647|521871395|FG004|Overall Study|Death|1|||
144731147|NCT00296647|521871391|FG000|Overall Study|Withdrawal by Subject|28|||
144731148|NCT00296647|521871392|FG001|Overall Study|Withdrawal by Subject|27|||
144210610|NCT03097991|519965307|FG000|Overall Study|Adverse Event|3|||
144638314|NCT00098787|521527700|FG002|Overall Study|Withdrawal by Subject|6|||
144638315|NCT00098787|521527698|FG000|Overall Study|Alternative therapy|8|||
144638316|NCT00098787|521527699|FG001|Overall Study|Alternative therapy|13|||
144638317|NCT00098787|521527700|FG002|Overall Study|Alternative therapy|13|||
144638318|NCT00098787|521527698|FG000|Overall Study|Other|7|||
144638319|NCT00098787|521527699|FG001|Overall Study|Other|6|||
144638320|NCT00098787|521527700|FG002|Overall Study|Other|9|||
144638321|NCT00195650|521527701|FG000|Overall Study|Adverse Event|194|||
144638322|NCT00195650|521527701|FG000|Overall Study|Lack of Efficacy|99|||
144638323|NCT00195650|521527701|FG000|Overall Study|Withdrawal by Subject|67|||
144638324|NCT00195650|521527701|FG000|Overall Study|Lost to Follow-up|44|||
144638325|NCT00195650|521527701|FG000|Overall Study|Death|23|||
144638326|NCT00195650|521527701|FG000|Overall Study|Protocol Violation|15|||
144731149|NCT00296647|521871393|FG002|Overall Study|Withdrawal by Subject|32|||
144210611|NCT03097991|519965308|FG001|Overall Study|Adverse Event|5|||
144263096|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
144263097|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
144263098|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
144263099|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
144263100|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
144263101|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
144263102|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
144263103|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
144263104|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
144263105|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
144263106|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
144263107|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
144263108|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
144263109|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
144263110|NCT00643201|520163854|FG000|Randomized, Completed 6 Months of Study|Other|107|||
144263111|NCT00643201|520163855|FG001|Randomized, Completed 6 Months of Study|Other|107|||
144263112|NCT00643201|520163854|FG000|Completed Study Follow Up|Death|28|||
144263113|NCT00643201|520163855|FG001|Completed Study Follow Up|Death|34|||
144263114|NCT00643201|520163854|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
144263115|NCT00643201|520163855|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
144263116|NCT00643201|520163854|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
144263117|NCT00643201|520163855|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
144263118|NCT00643201|520163854|FG000|Completed Study Follow Up|non-specified|1|||
144263119|NCT00643201|520163855|FG001|Completed Study Follow Up|non-specified|0|||
144263120|NCT00165503|520163856|FG000|Overall Study|Death|1|||
144263121|NCT00165503|520163856|FG000|Overall Study|Lost to Follow-up|12|||
144263122|NCT00165503|520163856|FG000|Overall Study|Unresectable|3|||
144263123|NCT02976519|520163857|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
144263124|NCT02976519|520163858|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
144263125|NCT02976519|520163859|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
144263126|NCT02976519|520163860|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
144263127|NCT02976519|520163861|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
144263128|NCT02976519|520163862|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
144263129|NCT02976519|520163863|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
144263130|NCT02976519|520163857|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
144263131|NCT02976519|520163858|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
144263132|NCT02976519|520163859|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
144263133|NCT02976519|520163860|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
144263134|NCT02976519|520163861|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
144263135|NCT02976519|520163862|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
144263136|NCT02976519|520163863|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
144263137|NCT02976519|520163857|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
144263138|NCT02976519|520163858|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
144263139|NCT02976519|520163859|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
144263140|NCT02976519|520163860|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
144263141|NCT02976519|520163861|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
144263142|NCT02976519|520163862|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
144263143|NCT02976519|520163863|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
144263144|NCT02976519|520163857|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
144263145|NCT02976519|520163858|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
144263146|NCT02976519|520163859|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
144263147|NCT02976519|520163860|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
144263148|NCT02976519|520163861|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
144263149|NCT02976519|520163862|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
144263150|NCT02976519|520163863|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
144263151|NCT02976519|520163857|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
144263152|NCT02976519|520163858|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
144263153|NCT02976519|520163859|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
144638327|NCT00195650|521527701|FG000|Overall Study|Administrative reasons|83|||
144263154|NCT02976519|520163860|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
144263155|NCT02976519|520163861|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
144263156|NCT02976519|520163862|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
144263157|NCT02976519|520163863|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
144263158|NCT02346708|520163864|FG000|Overall Study|Adverse Event|2|||
144263159|NCT02346708|520163865|FG001|Overall Study|Adverse Event|0|||
144263160|NCT02346708|520163864|FG000|Overall Study|Protocol Violation|0|||
144638328|NCT05292755|521527702|FG000|Overall Study|Lost to Follow-up|5|||
144638329|NCT05292755|521527703|FG001|Overall Study|Lost to Follow-up|9|||
144638330|NCT02305563|521527704|FG000|Treatment Period|Disease progression|0|||
144638331|NCT02305563|521527705|FG001|Treatment Period|Disease progression|0|||
144638332|NCT02305563|521527706|FG002|Treatment Period|Disease progression|15|||
144638333|NCT02305563|521527707|FG003|Treatment Period|Disease progression|6|||
144638334|NCT02305563|521527708|FG004|Treatment Period|Disease progression|6|||
144638335|NCT02305563|521527704|FG000|Treatment Period|Study drug toxicity|0|||
144638336|NCT02305563|521527705|FG001|Treatment Period|Study drug toxicity|0|||
144638337|NCT02305563|521527706|FG002|Treatment Period|Study drug toxicity|0|||
144638338|NCT02305563|521527707|FG003|Treatment Period|Study drug toxicity|1|||
144638339|NCT02305563|521527708|FG004|Treatment Period|Study drug toxicity|2|||
144638340|NCT02305563|521527704|FG000|Treatment Period|Death|0|||
144638341|NCT02305563|521527705|FG001|Treatment Period|Death|0|||
144638342|NCT02305563|521527706|FG002|Treatment Period|Death|1|||
144638343|NCT02305563|521527707|FG003|Treatment Period|Death|2|||
144638344|NCT02305563|521527708|FG004|Treatment Period|Death|1|||
144638345|NCT02305563|521527704|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
144638346|NCT02305563|521527705|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
144638347|NCT02305563|521527706|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
144638348|NCT02305563|521527707|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
144638349|NCT02305563|521527708|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
144638350|NCT02305563|521527704|FG000|Treatment Period|Participant request to stop therapy|0|||
144638351|NCT02305563|521527705|FG001|Treatment Period|Participant request to stop therapy|2|||
144638352|NCT02305563|521527706|FG002|Treatment Period|Participant request to stop therapy|0|||
144638353|NCT02305563|521527707|FG003|Treatment Period|Participant request to stop therapy|1|||
144638354|NCT02305563|521527708|FG004|Treatment Period|Participant request to stop therapy|0|||
144638355|NCT02305563|521527704|FG000|Treatment Period|Participant withdrew consent|0|||
144638356|NCT02305563|521527705|FG001|Treatment Period|Participant withdrew consent|0|||
144638357|NCT02305563|521527706|FG002|Treatment Period|Participant withdrew consent|1|||
144638358|NCT02305563|521527707|FG003|Treatment Period|Participant withdrew consent|1|||
144638359|NCT02305563|521527708|FG004|Treatment Period|Participant withdrew consent|1|||
144638360|NCT02305563|521527704|FG000|Treatment Period|Maximum clinical benefit|0|||
144638361|NCT02305563|521527705|FG001|Treatment Period|Maximum clinical benefit|0|||
144638362|NCT02305563|521527706|FG002|Treatment Period|Maximum clinical benefit|0|||
144638363|NCT02305563|521527707|FG003|Treatment Period|Maximum clinical benefit|0|||
144638364|NCT02305563|521527708|FG004|Treatment Period|Maximum clinical benefit|1|||
144638365|NCT02305563|521527704|FG000|Treatment Period|Poor/non-compliance|0|||
144638366|NCT02305563|521527705|FG001|Treatment Period|Poor/non-compliance|0|||
144638367|NCT02305563|521527706|FG002|Treatment Period|Poor/non-compliance|0|||
144638368|NCT02305563|521527707|FG003|Treatment Period|Poor/non-compliance|0|||
144638369|NCT02305563|521527708|FG004|Treatment Period|Poor/non-compliance|1|||
144638370|NCT02305563|521527704|FG000|Treatment Period|Administrative reason by Sponsor|0|||
144638371|NCT02305563|521527705|FG001|Treatment Period|Administrative reason by Sponsor|0|||
144638372|NCT02305563|521527706|FG002|Treatment Period|Administrative reason by Sponsor|0|||
144638373|NCT02305563|521527707|FG003|Treatment Period|Administrative reason by Sponsor|0|||
144638374|NCT02305563|521527708|FG004|Treatment Period|Administrative reason by Sponsor|1|||
144638375|NCT02305563|521527704|FG000|Treatment Period|other reason|2|||
144638376|NCT02305563|521527705|FG001|Treatment Period|other reason|0|||
144638377|NCT02305563|521527706|FG002|Treatment Period|other reason|2|||
144638378|NCT02305563|521527707|FG003|Treatment Period|other reason|2|||
144638379|NCT02305563|521527708|FG004|Treatment Period|other reason|1|||
144638380|NCT02305563|521527704|FG000|Treatment Period|Randomized but not treated|0|||
144638381|NCT02305563|521527705|FG001|Treatment Period|Randomized but not treated|0|||
144638382|NCT02305563|521527706|FG002|Treatment Period|Randomized but not treated|0|||
144638383|NCT02305563|521527707|FG003|Treatment Period|Randomized but not treated|0|||
144638384|NCT02305563|521527708|FG004|Treatment Period|Randomized but not treated|2|||
144638385|NCT02305563|521527704|FG000|Treatment Period|added ULO, then disease progression|0|||
144638386|NCT02305563|521527705|FG001|Treatment Period|added ULO, then disease progression|0|||
144638387|NCT02305563|521527706|FG002|Treatment Period|added ULO, then disease progression|0|||
144638388|NCT02305563|521527707|FG003|Treatment Period|added ULO, then disease progression|0|||
144638389|NCT02305563|521527708|FG004|Treatment Period|added ULO, then disease progression|4|||
144638390|NCT02305563|521527704|FG000|Treatment Period|added ULO; then other reason|0|||
144638391|NCT02305563|521527705|FG001|Treatment Period|added ULO; then other reason|0|||
144638392|NCT02305563|521527706|FG002|Treatment Period|added ULO; then other reason|0|||
144638393|NCT02305563|521527707|FG003|Treatment Period|added ULO; then other reason|0|||
144638394|NCT02305563|521527708|FG004|Treatment Period|added ULO; then other reason|1|||
144638395|NCT02305563|521527704|FG000|Treatment Period|added ULO, then request to stop|0|||
144638396|NCT02305563|521527705|FG001|Treatment Period|added ULO, then request to stop|0|||
144638397|NCT02305563|521527706|FG002|Treatment Period|added ULO, then request to stop|0|||
144638398|NCT02305563|521527707|FG003|Treatment Period|added ULO, then request to stop|0|||
144638399|NCT02305563|521527708|FG004|Treatment Period|added ULO, then request to stop|1|||
144638400|NCT02305563|521527704|FG000|Follow-up Period|Death|0|||
144638401|NCT02305563|521527705|FG001|Follow-up Period|Death|0|||
144638402|NCT02305563|521527706|FG002|Follow-up Period|Death|5|||
144638403|NCT02305563|521527707|FG003|Follow-up Period|Death|4|||
144638404|NCT02305563|521527708|FG004|Follow-up Period|Death|7|||
144638405|NCT02305563|521527704|FG000|Follow-up Period|Participant withdrew consent|0|||
144638406|NCT02305563|521527705|FG001|Follow-up Period|Participant withdrew consent|0|||
144638407|NCT02305563|521527706|FG002|Follow-up Period|Participant withdrew consent|2|||
144638408|NCT02305563|521527707|FG003|Follow-up Period|Participant withdrew consent|1|||
144638409|NCT02305563|521527708|FG004|Follow-up Period|Participant withdrew consent|0|||
144638410|NCT02305563|521527704|FG000|Follow-up Period|other reason|0|||
144638411|NCT02305563|521527705|FG001|Follow-up Period|other reason|0|||
144638412|NCT02305563|521527706|FG002|Follow-up Period|other reason|0|||
144638413|NCT02305563|521527707|FG003|Follow-up Period|other reason|0|||
144638414|NCT02305563|521527708|FG004|Follow-up Period|other reason|1|||
144638415|NCT02305563|521527704|FG000|Follow-up Period|Followup no longer required per protocol|3|||
144638416|NCT02305563|521527705|FG001|Follow-up Period|Followup no longer required per protocol|3|||
144638417|NCT02305563|521527706|FG002|Follow-up Period|Followup no longer required per protocol|4|||
144638418|NCT02305563|521527707|FG003|Follow-up Period|Followup no longer required per protocol|1|||
144638419|NCT02305563|521527708|FG004|Follow-up Period|Followup no longer required per protocol|4|||
144638420|NCT01511445|521527712|FG000|Overall Study|Lost to Follow-up|3|||
144638421|NCT01511445|521527713|FG001|Overall Study|Lost to Follow-up|1|||
144638422|NCT01511445|521527712|FG000|Overall Study|Protocol Violation|1|||
144638423|NCT01511445|521527713|FG001|Overall Study|Protocol Violation|3|||
144638424|NCT01511445|521527712|FG000|Overall Study|Protocol Violation|1|||
144638425|NCT01511445|521527713|FG001|Overall Study|Protocol Violation|0|||
144638426|NCT00144170|521527714|FG000|Overall Study|Adverse Event|84|||
144638427|NCT00144170|521527715|FG001|Overall Study|Adverse Event|41|||
144638428|NCT00144170|521527714|FG000|Overall Study|Protocol Violation|23|||
144638429|NCT00144170|521527715|FG001|Overall Study|Protocol Violation|16|||
144638430|NCT00144170|521527714|FG000|Overall Study|Lost to Follow-up|5|||
144638431|NCT00144170|521527715|FG001|Overall Study|Lost to Follow-up|10|||
144638432|NCT00144170|521527714|FG000|Overall Study|Withdrawal by Subject|29|||
144638433|NCT00144170|521527715|FG001|Overall Study|Withdrawal by Subject|13|||
144638434|NCT00144170|521527714|FG000|Overall Study|Other reason not defined above|211|||
144638435|NCT00144170|521527715|FG001|Overall Study|Other reason not defined above|316|||
144638436|NCT00818259|521527716|FG000|Part I|Withdrawal by Subject|1|||
144638437|NCT00818259|521527717|FG001|Part I|Withdrawal by Subject|0|||
144638438|NCT00818259|521527718|FG002|Part I|Withdrawal by Subject|0|||
144638439|NCT00818259|521527719|FG003|Part I|Withdrawal by Subject|0|||
144638440|NCT00818259|521527720|FG004|Part I|Withdrawal by Subject|0|||
144638441|NCT00818259|521527721|FG005|Part I|Withdrawal by Subject|0|||
144638442|NCT00818259|521527722|FG006|Part I|Withdrawal by Subject|0|||
144638443|NCT00818259|521527723|FG007|Part I|Withdrawal by Subject|0|||
144638444|NCT00818259|521527724|FG008|Part I|Withdrawal by Subject|0|||
144638445|NCT00818259|521527716|FG000|Part II|Physician Decision|0|||
144638446|NCT00818259|521527717|FG001|Part II|Physician Decision|0|||
144638447|NCT00818259|521527718|FG002|Part II|Physician Decision|1|||
144638448|NCT00818259|521527719|FG003|Part II|Physician Decision|0|||
144638449|NCT00818259|521527720|FG004|Part II|Physician Decision|0|||
144638450|NCT00818259|521527721|FG005|Part II|Physician Decision|0|||
144638451|NCT00818259|521527722|FG006|Part II|Physician Decision|0|||
144638452|NCT00818259|521527723|FG007|Part II|Physician Decision|0|||
144638453|NCT00818259|521527724|FG008|Part II|Physician Decision|0|||
144638454|NCT00818259|521527716|FG000|Part II|Lack of Efficacy|0|||
144638455|NCT00818259|521527717|FG001|Part II|Lack of Efficacy|0|||
144638456|NCT00818259|521527718|FG002|Part II|Lack of Efficacy|0|||
144638457|NCT00818259|521527719|FG003|Part II|Lack of Efficacy|1|||
144638458|NCT00818259|521527720|FG004|Part II|Lack of Efficacy|0|||
144210612|NCT00259272|519965309|FG000|Overall Study|Adverse Event|2|||
144210613|NCT00259272|519965310|FG001|Overall Study|Adverse Event|1|||
144210614|NCT00259272|519965311|FG002|Overall Study|Adverse Event|0|||
144638459|NCT00818259|521527721|FG005|Part II|Lack of Efficacy|0|||
144638460|NCT00818259|521527722|FG006|Part II|Lack of Efficacy|0|||
144638461|NCT00818259|521527723|FG007|Part II|Lack of Efficacy|0|||
144638462|NCT00818259|521527724|FG008|Part II|Lack of Efficacy|0|||
144210615|NCT00259272|519965312|FG003|Overall Study|Adverse Event|3|||
144210616|NCT00259272|519965309|FG000|Overall Study|Lack of Efficacy|5|||
144638463|NCT00818259|521527716|FG000|Part II|Not Treated|0|||
144638464|NCT00818259|521527717|FG001|Part II|Not Treated|0|||
144638465|NCT00818259|521527718|FG002|Part II|Not Treated|0|||
144638466|NCT00818259|521527719|FG003|Part II|Not Treated|1|||
144638467|NCT00818259|521527720|FG004|Part II|Not Treated|0|||
144731150|NCT00296647|521871394|FG003|Overall Study|Withdrawal by Subject|16|||
144638468|NCT00818259|521527721|FG005|Part II|Not Treated|0|||
144638469|NCT00818259|521527722|FG006|Part II|Not Treated|0|||
144638470|NCT00818259|521527723|FG007|Part II|Not Treated|0|||
144638471|NCT00818259|521527724|FG008|Part II|Not Treated|0|||
144638472|NCT00818259|521527716|FG000|Part IV|Physician Decision|0|||
144638473|NCT00818259|521527717|FG001|Part IV|Physician Decision|0|||
144638474|NCT00818259|521527718|FG002|Part IV|Physician Decision|0|||
144638475|NCT00818259|521527719|FG003|Part IV|Physician Decision|0|||
144638476|NCT00818259|521527720|FG004|Part IV|Physician Decision|0|||
144638477|NCT00818259|521527721|FG005|Part IV|Physician Decision|1|||
144638478|NCT00818259|521527722|FG006|Part IV|Physician Decision|0|||
144638479|NCT00818259|521527723|FG007|Part IV|Physician Decision|0|||
144638480|NCT00818259|521527724|FG008|Part IV|Physician Decision|0|||
144638481|NCT00818259|521527716|FG000|Part V|Adverse Event|0|||
144638482|NCT00818259|521527717|FG001|Part V|Adverse Event|0|||
144638483|NCT00818259|521527718|FG002|Part V|Adverse Event|0|||
144638484|NCT00818259|521527719|FG003|Part V|Adverse Event|0|||
144638485|NCT00818259|521527720|FG004|Part V|Adverse Event|0|||
144638486|NCT00818259|521527721|FG005|Part V|Adverse Event|0|||
144638487|NCT00818259|521527722|FG006|Part V|Adverse Event|0|||
144638488|NCT00818259|521527723|FG007|Part V|Adverse Event|1|||
144638489|NCT00818259|521527724|FG008|Part V|Adverse Event|0|||
144638490|NCT00666562|521527725|FG000|Overall Study|Withdrawal by Subject|0|||
144638491|NCT00666562|521527726|FG001|Overall Study|Withdrawal by Subject|1|||
144638492|NCT00666562|521527727|FG002|Overall Study|Withdrawal by Subject|0|||
144638493|NCT00666562|521527725|FG000|Overall Study|Concomitant Medication|0|||
144638494|NCT00666562|521527726|FG001|Overall Study|Concomitant Medication|1|||
144638495|NCT00666562|521527727|FG002|Overall Study|Concomitant Medication|0|||
144638496|NCT01976806|521527728|FG000|Overall Study|Lost to Follow-up|1|||
144638497|NCT01976806|521527729|FG001|Overall Study|Lost to Follow-up|4|||
144638498|NCT01976806|521527728|FG000|Overall Study|Adverse Event|1|||
144638499|NCT01976806|521527729|FG001|Overall Study|Adverse Event|1|||
144638500|NCT01976806|521527728|FG000|Overall Study|Withdrawal by Subject|1|||
144638501|NCT01976806|521527729|FG001|Overall Study|Withdrawal by Subject|1|||
144638502|NCT01769105|521527734|FG000|First Intervention|Protocol Violation|2|||
144638503|NCT01769105|521527735|FG001|First Intervention|Protocol Violation|2|||
144638504|NCT01769105|521527734|FG000|Cross-over|Lost to Follow-up|5|||
144638505|NCT01769105|521527735|FG001|Cross-over|Lost to Follow-up|0|||
144638506|NCT00684177|521527736|FG000|Overall Study|Adverse Event|4|||
144638507|NCT00684177|521527737|FG001|Overall Study|Adverse Event|3|||
144638508|NCT00684177|521527736|FG000|Overall Study|Lack of Efficacy|10|||
144638509|NCT00684177|521527737|FG001|Overall Study|Lack of Efficacy|15|||
144638510|NCT00684177|521527736|FG000|Overall Study|Protocol Violation|1|||
144638511|NCT00684177|521527737|FG001|Overall Study|Protocol Violation|0|||
144638512|NCT00684177|521527736|FG000|Overall Study|Lost to Follow-up|2|||
144638513|NCT00684177|521527737|FG001|Overall Study|Lost to Follow-up|1|||
144638514|NCT00684177|521527736|FG000|Overall Study|Physician Decision|2|||
144638515|NCT00684177|521527737|FG001|Overall Study|Physician Decision|0|||
144638516|NCT00684177|521527736|FG000|Overall Study|Withdrawal by Subject|1|||
144638517|NCT00684177|521527737|FG001|Overall Study|Withdrawal by Subject|2|||
144638518|NCT00684177|521527736|FG000|Overall Study|Other|1|||
144638519|NCT00684177|521527737|FG001|Overall Study|Other|2|||
144638520|NCT04030195|521529576|FG000|Overall Study|Withdrawal by Subject|2|||
144638521|NCT04030195|521529577|FG001|Overall Study|Withdrawal by Subject|0|||
144638522|NCT04030195|521529578|FG002|Overall Study|Withdrawal by Subject|0|||
144638523|NCT02109029|521529579|FG000|Part B|Adverse Event|0|||
144638524|NCT02109029|521529580|FG001|Part B|Adverse Event|0|||
144638525|NCT02109029|521529581|FG002|Part B|Adverse Event|0|||
144638526|NCT02109029|521529582|FG003|Part B|Adverse Event|0|||
144638527|NCT02109029|521529583|FG004|Part B|Adverse Event|1|||
144638528|NCT02109029|521529584|FG005|Part B|Adverse Event|1|||
144638529|NCT01056107|521529588|FG000|Overall Study|Withdrawal by Subject|0|||
144638530|NCT01056107|521529589|FG001|Overall Study|Withdrawal by Subject|1|||
144638531|NCT01056107|521529590|FG002|Overall Study|Withdrawal by Subject|3|||
144638532|NCT01056107|521529591|FG003|Overall Study|Withdrawal by Subject|0|||
144638533|NCT01821963|521529605|FG000|Overall Study|Adverse Event|1|||
144638534|NCT00783289|521529606|FG000|Overall Study|Protocol Violation|0|||
144638535|NCT00783289|521529607|FG001|Overall Study|Protocol Violation|1|||
144638536|NCT00783289|521529608|FG002|Overall Study|Protocol Violation|0|||
144638537|NCT00783289|521529609|FG003|Overall Study|Protocol Violation|0|||
144638538|NCT01217606|521529612|FG000|Initial Treatment Phase|Other Reasons|0|||
144638539|NCT01217606|521529613|FG001|Initial Treatment Phase|Other Reasons|2|||
144638540|NCT01217606|521529612|FG000|Initial Treatment Phase|Protocol Violation|3|||
144638541|NCT01217606|521529613|FG001|Initial Treatment Phase|Protocol Violation|2|||
144263161|NCT02346708|520163865|FG001|Overall Study|Protocol Violation|1|||
144638542|NCT01217606|521529612|FG000|Initial Treatment Phase|Personal Reasons|0|||
144638543|NCT01217606|521529613|FG001|Initial Treatment Phase|Personal Reasons|2|||
144638544|NCT01217606|521529612|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
144638545|NCT01217606|521529613|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
144638546|NCT01217606|521529612|FG000|Initial Treatment Phase|Adverse Event|10|||
144638547|NCT01217606|521529613|FG001|Initial Treatment Phase|Adverse Event|6|||
144638548|NCT01217606|521529612|FG000|9-Month Masked Extension|Adverse Event|3|||
144638549|NCT01217606|521529613|FG001|9-Month Masked Extension|Adverse Event|6|||
144638550|NCT01217606|521529612|FG000|9-Month Masked Extension|Other Reasons|4|||
144638551|NCT01217606|521529613|FG001|9-Month Masked Extension|Other Reasons|4|||
144638552|NCT01217606|521529612|FG000|9-Month Masked Extension|Personal Reasons|2|||
144638553|NCT01217606|521529613|FG001|9-Month Masked Extension|Personal Reasons|1|||
144638554|NCT01217606|521529612|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
144263162|NCT00928434|520163868|FG000|Overall Study|Adverse Event|14|||
144263163|NCT00928434|520163869|FG001|Overall Study|Adverse Event|5|||
144638555|NCT01217606|521529613|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
144638556|NCT01217606|521529612|FG000|9-Month Masked Extension|Pregnancy|1|||
144638557|NCT01217606|521529613|FG001|9-Month Masked Extension|Pregnancy|0|||
144638558|NCT01217606|521529612|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
144638559|NCT01217606|521529613|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
144638560|NCT01552057|521529619|FG000|Overall Study|Adverse Event|14|||
144638561|NCT01552057|521529620|FG001|Overall Study|Adverse Event|15|||
144638562|NCT01552057|521529619|FG000|Overall Study|Lack of Efficacy|8|||
144638563|NCT01552057|521529620|FG001|Overall Study|Lack of Efficacy|23|||
144638564|NCT01552057|521529619|FG000|Overall Study|Withdrawal by Subject|5|||
144638565|NCT01552057|521529620|FG001|Overall Study|Withdrawal by Subject|8|||
144638566|NCT01552057|521529619|FG000|Overall Study|Entry Criteria Not Met|2|||
144638567|NCT01552057|521529620|FG001|Overall Study|Entry Criteria Not Met|2|||
144638568|NCT01552057|521529619|FG000|Overall Study|Physician Decision|1|||
144638569|NCT01552057|521529620|FG001|Overall Study|Physician Decision|0|||
144638570|NCT00996840|521529621|FG000|Overall Study|Adverse Event|0|||
144638571|NCT00996840|521529622|FG001|Overall Study|Adverse Event|1|||
144638572|NCT00996840|521529623|FG002|Overall Study|Adverse Event|0|||
144638573|NCT00996840|521529624|FG003|Overall Study|Adverse Event|0|||
144638574|NCT00996840|521529625|FG004|Overall Study|Adverse Event|0|||
144638575|NCT00996840|521529621|FG000|Overall Study|Physician Decision|0|||
144638576|NCT00996840|521529622|FG001|Overall Study|Physician Decision|0|||
144638577|NCT00996840|521529623|FG002|Overall Study|Physician Decision|1|||
144638578|NCT00996840|521529624|FG003|Overall Study|Physician Decision|1|||
144638579|NCT00996840|521529625|FG004|Overall Study|Physician Decision|2|||
144263164|NCT00928434|520163870|FG002|Overall Study|Adverse Event|18|||
144263165|NCT00928434|520163868|FG000|Overall Study|Protocol Violation|5|||
144263166|NCT00928434|520163869|FG001|Overall Study|Protocol Violation|0|||
144263167|NCT00928434|520163870|FG002|Overall Study|Protocol Violation|8|||
144263168|NCT00928434|520163868|FG000|Overall Study|Physician Decision|2|||
144263169|NCT00928434|520163869|FG001|Overall Study|Physician Decision|0|||
144263170|NCT00928434|520163870|FG002|Overall Study|Physician Decision|3|||
144263171|NCT00928434|520163868|FG000|Overall Study|Lost to Follow-up|1|||
144263172|NCT00928434|520163869|FG001|Overall Study|Lost to Follow-up|0|||
144263173|NCT00928434|520163870|FG002|Overall Study|Lost to Follow-up|3|||
144263174|NCT00928434|520163868|FG000|Overall Study|Withdrawal by Subject|5|||
144263175|NCT00928434|520163869|FG001|Overall Study|Withdrawal by Subject|3|||
144263176|NCT00928434|520163870|FG002|Overall Study|Withdrawal by Subject|2|||
144263177|NCT00928434|520163868|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
144263178|NCT00928434|520163869|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
144263179|NCT00928434|520163870|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
144263180|NCT00928434|520163868|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
144263181|NCT00928434|520163869|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
144263182|NCT00928434|520163870|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
144263183|NCT00928434|520163868|FG000|Overall Study|Other (not meeting above criteria)|5|||
144263184|NCT00928434|520163869|FG001|Overall Study|Other (not meeting above criteria)|1|||
144263185|NCT00928434|520163870|FG002|Overall Study|Other (not meeting above criteria)|2|||
144263186|NCT01278342|520163872|FG000|Overall Study|Physician Decision|0|||
144263187|NCT01278342|520163873|FG001|Overall Study|Physician Decision|1|||
144263188|NCT01278342|520163874|FG002|Overall Study|Physician Decision|0|||
144263189|NCT01278342|520163872|FG000|Overall Study|Lost to Follow-up|1|||
144263190|NCT01278342|520163873|FG001|Overall Study|Lost to Follow-up|0|||
144263191|NCT01278342|520163874|FG002|Overall Study|Lost to Follow-up|0|||
144263192|NCT01278342|520163872|FG000|Overall Study|Administrative problems|2|||
144263193|NCT01278342|520163873|FG001|Overall Study|Administrative problems|0|||
144263194|NCT01278342|520163874|FG002|Overall Study|Administrative problems|0|||
144263195|NCT01278342|520163872|FG000|Overall Study|Other|1|||
144263196|NCT01278342|520163873|FG001|Overall Study|Other|0|||
144638580|NCT00996840|521529621|FG000|Overall Study|Withdrawal by Subject|1|||
144263197|NCT01278342|520163874|FG002|Overall Study|Other|0|||
144263198|NCT05417412|520163886|FG000|Overall Study|Lost to Follow-up|2|||
144263199|NCT03126786|520163887|FG000|Overall Study|Adverse Event|3|||
144263200|NCT03126786|520163888|FG001|Overall Study|Adverse Event|0|||
144263201|NCT03126786|520163887|FG000|Overall Study|Lost to Follow-up|0|||
144263202|NCT03126786|520163888|FG001|Overall Study|Lost to Follow-up|1|||
144263203|NCT03126786|520163887|FG000|Overall Study|Withdrawal by Subject|3|||
144263204|NCT03126786|520163888|FG001|Overall Study|Withdrawal by Subject|1|||
144263205|NCT04805671|520163889|FG000|Overall Study|Death|2|||
144638581|NCT00996840|521529622|FG001|Overall Study|Withdrawal by Subject|1|||
144638582|NCT00996840|521529623|FG002|Overall Study|Withdrawal by Subject|0|||
144638583|NCT00996840|521529624|FG003|Overall Study|Withdrawal by Subject|0|||
144638584|NCT00996840|521529625|FG004|Overall Study|Withdrawal by Subject|0|||
144638585|NCT01389245|521529626|FG000|Overall Study|Protocol Violation|10|||
144638586|NCT01389245|521529626|FG000|Overall Study|Lost to Follow-up|3|||
144638587|NCT01389245|521529626|FG000|Overall Study|Withdrawal by Subject|2|||
144263206|NCT04805671|520163890|FG001|Overall Study|Death|7|||
144638588|NCT02292849|521529627|FG000|Overall Study|Lost to Follow-up|0|||
144638589|NCT02292849|521529628|FG001|Overall Study|Lost to Follow-up|2|||
144638590|NCT02292849|521529629|FG002|Overall Study|Lost to Follow-up|2|||
144638591|NCT02292849|521529627|FG000|Overall Study|Physician Decision|4|||
144638592|NCT02292849|521529628|FG001|Overall Study|Physician Decision|0|||
144638593|NCT02292849|521529629|FG002|Overall Study|Physician Decision|0|||
144638594|NCT00097539|521529630|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
144638595|NCT00097539|521529631|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
144638596|NCT00097539|521529632|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
144638597|NCT00097539|521529633|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
144638598|NCT00097539|521529634|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
144638599|NCT00097539|521529635|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
144638600|NCT00097539|521529636|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
144638601|NCT00097539|521529630|FG000|Overall Study|Withdrawal by Subject|925|||
144638602|NCT00097539|521529631|FG001|Overall Study|Withdrawal by Subject|323|||
144638603|NCT00097539|521529632|FG002|Overall Study|Withdrawal by Subject|346|||
144638604|NCT00097539|521529633|FG003|Overall Study|Withdrawal by Subject|217|||
144638605|NCT00097539|521529634|FG004|Overall Study|Withdrawal by Subject|68|||
144638606|NCT00097539|521529635|FG005|Overall Study|Withdrawal by Subject|229|||
144638607|NCT00097539|521529636|FG006|Overall Study|Withdrawal by Subject|3|||
144638608|NCT00097539|521529630|FG000|Overall Study|Participant Non-compliant|2140|||
144638609|NCT00097539|521529631|FG001|Overall Study|Participant Non-compliant|567|||
144638610|NCT00097539|521529632|FG002|Overall Study|Participant Non-compliant|1067|||
144638611|NCT00097539|521529633|FG003|Overall Study|Participant Non-compliant|353|||
144638612|NCT00097539|521529634|FG004|Overall Study|Participant Non-compliant|136|||
144638613|NCT00097539|521529635|FG005|Overall Study|Participant Non-compliant|543|||
144638614|NCT00097539|521529636|FG006|Overall Study|Participant Non-compliant|18|||
144638615|NCT00097539|521529630|FG000|Overall Study|Lack of Efficacy|249|||
144638616|NCT00097539|521529631|FG001|Overall Study|Lack of Efficacy|122|||
144638617|NCT00097539|521529632|FG002|Overall Study|Lack of Efficacy|202|||
144638618|NCT00097539|521529633|FG003|Overall Study|Lack of Efficacy|105|||
144638619|NCT00097539|521529634|FG004|Overall Study|Lack of Efficacy|45|||
144638620|NCT00097539|521529635|FG005|Overall Study|Lack of Efficacy|228|||
144638621|NCT00097539|521529636|FG006|Overall Study|Lack of Efficacy|5|||
144638622|NCT00097539|521529630|FG000|Overall Study|Adverse Event|78|||
144638623|NCT00097539|521529631|FG001|Overall Study|Adverse Event|133|||
144638624|NCT00097539|521529632|FG002|Overall Study|Adverse Event|37|||
144638625|NCT00097539|521529633|FG003|Overall Study|Adverse Event|27|||
144638626|NCT00097539|521529634|FG004|Overall Study|Adverse Event|30|||
144638627|NCT00097539|521529635|FG005|Overall Study|Adverse Event|59|||
144638628|NCT00097539|521529636|FG006|Overall Study|Adverse Event|1|||
144638629|NCT00097539|521529630|FG000|Overall Study|Death|2|||
144638630|NCT00097539|521529631|FG001|Overall Study|Death|7|||
144638631|NCT00097539|521529632|FG002|Overall Study|Death|0|||
144638632|NCT00097539|521529633|FG003|Overall Study|Death|0|||
144638633|NCT00097539|521529634|FG004|Overall Study|Death|1|||
144638634|NCT00097539|521529635|FG005|Overall Study|Death|3|||
144638635|NCT00097539|521529636|FG006|Overall Study|Death|0|||
144638636|NCT00097539|521529630|FG000|Overall Study|Reasons Other Than Above|3602|||
144638637|NCT00097539|521529631|FG001|Overall Study|Reasons Other Than Above|1382|||
144638638|NCT00097539|521529632|FG002|Overall Study|Reasons Other Than Above|1757|||
144638639|NCT00097539|521529633|FG003|Overall Study|Reasons Other Than Above|692|||
144638640|NCT00097539|521529634|FG004|Overall Study|Reasons Other Than Above|361|||
144638641|NCT00097539|521529635|FG005|Overall Study|Reasons Other Than Above|1244|||
144638642|NCT00097539|521529636|FG006|Overall Study|Reasons Other Than Above|34|||
144638643|NCT00097539|521529630|FG000|Overall Study|Reason not Specified|111|||
144638644|NCT00097539|521529631|FG001|Overall Study|Reason not Specified|49|||
144638645|NCT00097539|521529632|FG002|Overall Study|Reason not Specified|53|||
144638646|NCT00097539|521529633|FG003|Overall Study|Reason not Specified|21|||
144638647|NCT00097539|521529634|FG004|Overall Study|Reason not Specified|11|||
144638648|NCT00097539|521529635|FG005|Overall Study|Reason not Specified|40|||
144263207|NCT04805671|520163889|FG000|Overall Study|Lost to Follow-up|1|||
144263208|NCT04805671|520163890|FG001|Overall Study|Lost to Follow-up|0|||
144263209|NCT04805671|520163889|FG000|Overall Study|Withdrawal by Subject|9|||
144263210|NCT04805671|520163890|FG001|Overall Study|Withdrawal by Subject|7|||
144638649|NCT00097539|521529636|FG006|Overall Study|Reason not Specified|2|||
144638650|NCT01506141|521529637|FG000|Overall Study|Adverse Event|0|||
144638651|NCT01506141|521529638|FG001|Overall Study|Adverse Event|2|||
144638652|NCT01506141|521529637|FG000|Overall Study|Participation Terminated by Investigator|1|||
144638653|NCT01506141|521529638|FG001|Overall Study|Participation Terminated by Investigator|1|||
144638654|NCT01506141|521529637|FG000|Overall Study|Site Terminated by Sponsor|2|||
144638655|NCT01506141|521529638|FG001|Overall Study|Site Terminated by Sponsor|0|||
144638656|NCT01506141|521529637|FG000|Overall Study|Reason Not Specified|4|||
144638657|NCT01506141|521529638|FG001|Overall Study|Reason Not Specified|2|||
144638658|NCT02725788|521529649|FG000|Overall Study|Lost to Follow-up|1|||
144638659|NCT02725788|521529650|FG001|Overall Study|Lost to Follow-up|1|||
144638660|NCT02725788|521529649|FG000|Overall Study|Protocol Violation|0|||
144638661|NCT02725788|521529650|FG001|Overall Study|Protocol Violation|1|||
144638662|NCT00828464|521529651|FG000|Overall Study|Withdrawal by Subject|1|||
144638663|NCT00474240|521529652|FG000|Overall Study|Withdrawal by Subject|1|||
144638664|NCT00474240|521529653|FG001|Overall Study|Withdrawal by Subject|1|||
144638665|NCT00474240|521529654|FG002|Overall Study|Withdrawal by Subject|0|||
144638666|NCT00474240|521529655|FG003|Overall Study|Withdrawal by Subject|2|||
144638667|NCT00474240|521529656|FG004|Overall Study|Withdrawal by Subject|3|||
144638668|NCT00474240|521529657|FG005|Overall Study|Withdrawal by Subject|1|||
144638669|NCT00474240|521529652|FG000|Overall Study|Adverse Event|0|||
144638670|NCT00474240|521529653|FG001|Overall Study|Adverse Event|0|||
144638671|NCT00474240|521529654|FG002|Overall Study|Adverse Event|9|||
144638672|NCT00474240|521529655|FG003|Overall Study|Adverse Event|14|||
144638673|NCT00474240|521529656|FG004|Overall Study|Adverse Event|5|||
144638674|NCT00474240|521529657|FG005|Overall Study|Adverse Event|16|||
144638675|NCT00474240|521529652|FG000|Overall Study|Removed due to lab value|0|||
144638676|NCT00474240|521529653|FG001|Overall Study|Removed due to lab value|0|||
144638677|NCT00474240|521529654|FG002|Overall Study|Removed due to lab value|0|||
144638678|NCT00474240|521529655|FG003|Overall Study|Removed due to lab value|0|||
144638679|NCT00474240|521529656|FG004|Overall Study|Removed due to lab value|0|||
144638680|NCT00474240|521529657|FG005|Overall Study|Removed due to lab value|1|||
144638681|NCT00833092|521529658|FG000|Overall Study|Withdrawal by Subject|2|||
144638682|NCT00833092|521529659|FG001|Overall Study|Withdrawal by Subject|3|||
144638683|NCT00833092|521529658|FG000|Overall Study|Protocol Violation|2|||
144638684|NCT00833092|521529659|FG001|Overall Study|Protocol Violation|1|||
144638685|NCT00833092|521529658|FG000|Overall Study|Diarrhea|0|||
144638686|NCT00833092|521529659|FG001|Overall Study|Diarrhea|2|||
144638687|NCT00833092|521529658|FG000|Overall Study|constipation|0|||
144638688|NCT00833092|521529659|FG001|Overall Study|constipation|1|||
144638689|NCT00619229|521529660|FG000|Overall Study|Withdrawal by Subject|1|||
144638690|NCT00619229|521529661|FG001|Overall Study|Withdrawal by Subject|1|||
144638691|NCT00619229|521529660|FG000|Overall Study|Lost to Follow-up|1|||
144638692|NCT00619229|521529661|FG001|Overall Study|Lost to Follow-up|0|||
144638693|NCT00619229|521529660|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
144638694|NCT00619229|521529661|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
144638695|NCT00619229|521529660|FG000|Overall Study|Investigator planned Cataract Operation|1|||
144638696|NCT00619229|521529661|FG001|Overall Study|Investigator planned Cataract Operation|0|||
144638697|NCT01700829|521529662|FG000|Overall Study|Withdrawal by Subject|1|||
144638698|NCT01700829|521529663|FG001|Overall Study|Withdrawal by Subject|1|||
144638699|NCT01075178|521529664|FG000|Subject Matching|eligible but not matched|130|||
144638700|NCT01075178|521529665|FG001|Subject Matching|eligible but not matched|403|||
144638701|NCT01075178|521529664|FG000|Subject Chart Review|died before chart review period|0|||
144638702|NCT01075178|521529665|FG001|Subject Chart Review|died before chart review period|2|||
144638703|NCT01075178|521529664|FG000|Subject Chart Review|no data collected due to site closure|3|||
144638704|NCT01075178|521529665|FG001|Subject Chart Review|no data collected due to site closure|4|||
144638705|NCT01075178|521529664|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
144638706|NCT01075178|521529665|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
144638707|NCT02983604|521529666|FG000|Overall Study|Enrolled but not Treated|0|||
144638708|NCT02983604|521529667|FG001|Overall Study|Enrolled but not Treated|0|||
144638709|NCT02983604|521529668|FG002|Overall Study|Enrolled but not Treated|1|||
144638710|NCT02983604|521529669|FG003|Overall Study|Enrolled but not Treated|0|||
144638711|NCT00355264|521529670|FG000|Extension (Variable Duration)|Adverse Event|1|||
144638712|NCT00355264|521529670|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
144638713|NCT00699192|521529671|FG000|Overall Study|Missing|1|||
144638714|NCT00699192|521529672|FG001|Overall Study|Missing|1|||
144638715|NCT00699192|521529673|FG002|Overall Study|Missing|1|||
144638716|NCT00699192|521529671|FG000|Overall Study|Adverse Event|9|||
144638717|NCT00699192|521529672|FG001|Overall Study|Adverse Event|4|||
144638718|NCT00699192|521529673|FG002|Overall Study|Adverse Event|3|||
144638719|NCT00699192|521529671|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144638720|NCT00699192|521529672|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144638721|NCT00699192|521529673|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144638722|NCT00699192|521529671|FG000|Overall Study|Lack of Efficacy|0|||
144210617|NCT00259272|519965310|FG001|Overall Study|Lack of Efficacy|1|||
144210618|NCT00259272|519965311|FG002|Overall Study|Lack of Efficacy|2|||
144210619|NCT00259272|519965312|FG003|Overall Study|Lack of Efficacy|6|||
144210620|NCT00259272|519965309|FG000|Overall Study|Physician Decision|1|||
144210621|NCT00259272|519965310|FG001|Overall Study|Physician Decision|2|||
144210622|NCT00259272|519965311|FG002|Overall Study|Physician Decision|1|||
144210623|NCT00259272|519965312|FG003|Overall Study|Physician Decision|3|||
144210624|NCT00259272|519965309|FG000|Overall Study|Protocol Violation|2|||
144210625|NCT00259272|519965310|FG001|Overall Study|Protocol Violation|0|||
144210626|NCT00259272|519965311|FG002|Overall Study|Protocol Violation|0|||
144210627|NCT00259272|519965312|FG003|Overall Study|Protocol Violation|1|||
144210628|NCT00259272|519965309|FG000|Overall Study|Sponsor Decision|0|||
144210629|NCT00259272|519965310|FG001|Overall Study|Sponsor Decision|1|||
144638723|NCT00699192|521529672|FG001|Overall Study|Lack of Efficacy|0|||
144638724|NCT00699192|521529673|FG002|Overall Study|Lack of Efficacy|1|||
144638725|NCT00699192|521529671|FG000|Overall Study|Withdrawal by Subject|3|||
144638726|NCT00699192|521529672|FG001|Overall Study|Withdrawal by Subject|2|||
144638727|NCT00699192|521529673|FG002|Overall Study|Withdrawal by Subject|4|||
144638728|NCT00699192|521529671|FG000|Overall Study|Administrative problems|1|||
144638729|NCT00699192|521529672|FG001|Overall Study|Administrative problems|3|||
144638730|NCT00699192|521529673|FG002|Overall Study|Administrative problems|1|||
144638731|NCT00699192|521529671|FG000|Overall Study|Protocol Violation|2|||
144638732|NCT00699192|521529672|FG001|Overall Study|Protocol Violation|2|||
144638733|NCT00699192|521529673|FG002|Overall Study|Protocol Violation|0|||
144638734|NCT04927312|521529676|FG000|Overall Study|Adverse Event|1|||
144638735|NCT04927312|521529676|FG000|Overall Study|Death|1|||
144638736|NCT04927312|521529676|FG000|Overall Study|Withdrawal by Subject|1|||
144638737|NCT04927312|521529676|FG000|Overall Study|Other|1|||
144638738|NCT04919564|521529677|FG000|Overall Study|Lost to Follow-up|1|||
144638739|NCT04919564|521529678|FG001|Overall Study|Lost to Follow-up|0|||
144638740|NCT04919564|521529677|FG000|Overall Study|Physician Decision|1|||
144638741|NCT04919564|521529678|FG001|Overall Study|Physician Decision|1|||
144638742|NCT01241786|521529679|FG000|Overall Study|Lack of Efficacy|5|||
144638743|NCT05340504|521529684|FG000|Overall Study|Withdrawal by Subject|1|||
144638744|NCT05340504|521529685|FG001|Overall Study|Withdrawal by Subject|0|||
144638745|NCT00929240|521529686|FG000|Initial Treatment Phase|Adverse Event|31|||
144638746|NCT00929240|521529687|FG001|Initial Treatment Phase|Adverse Event|0|||
144638747|NCT00929240|521529688|FG002|Initial Treatment Phase|Adverse Event|0|||
144638748|NCT00929240|521529686|FG000|Initial Treatment Phase|Disease progression|41|||
144638749|NCT00929240|521529687|FG001|Initial Treatment Phase|Disease progression|0|||
144638750|NCT00929240|521529688|FG002|Initial Treatment Phase|Disease progression|0|||
144638751|NCT00929240|521529686|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
144638752|NCT00929240|521529687|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
144638753|NCT00929240|521529688|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
144638754|NCT00929240|521529686|FG000|Initial Treatment Phase|Protocol Violation|5|||
144638755|NCT00929240|521529687|FG001|Initial Treatment Phase|Protocol Violation|0|||
144638756|NCT00929240|521529688|FG002|Initial Treatment Phase|Protocol Violation|0|||
144638757|NCT00929240|521529686|FG000|Initial Treatment Phase|Death|2|||
144638758|NCT00929240|521529687|FG001|Initial Treatment Phase|Death|0|||
144638759|NCT00929240|521529688|FG002|Initial Treatment Phase|Death|0|||
144638760|NCT00929240|521529686|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
144638761|NCT00929240|521529687|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
144638762|NCT00929240|521529688|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
144638763|NCT00929240|521529686|FG000|Initial Treatment Phase|Physician Decision|4|||
144638764|NCT00929240|521529687|FG001|Initial Treatment Phase|Physician Decision|0|||
144638765|NCT00929240|521529688|FG002|Initial Treatment Phase|Physician Decision|0|||
144638766|NCT00929240|521529686|FG000|Maintenance Phase|Disease progression|0|||
144638767|NCT00929240|521529687|FG001|Maintenance Phase|Disease progression|73|||
144638768|NCT00929240|521529688|FG002|Maintenance Phase|Disease progression|60|||
144638769|NCT00929240|521529686|FG000|Maintenance Phase|Adverse Event|0|||
144638770|NCT00929240|521529687|FG001|Maintenance Phase|Adverse Event|9|||
144638771|NCT00929240|521529688|FG002|Maintenance Phase|Adverse Event|12|||
144638772|NCT00929240|521529686|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144638773|NCT00929240|521529687|FG001|Maintenance Phase|Withdrawal by Subject|2|||
144638774|NCT00929240|521529688|FG002|Maintenance Phase|Withdrawal by Subject|6|||
144638775|NCT00929240|521529686|FG000|Maintenance Phase|Protocol Violation|0|||
144638776|NCT00929240|521529687|FG001|Maintenance Phase|Protocol Violation|1|||
144638777|NCT00929240|521529688|FG002|Maintenance Phase|Protocol Violation|0|||
144638778|NCT00929240|521529686|FG000|Maintenance Phase|Health authority/Study termination|0|||
144638779|NCT00929240|521529687|FG001|Maintenance Phase|Health authority/Study termination|1|||
144638780|NCT00929240|521529688|FG002|Maintenance Phase|Health authority/Study termination|2|||
144638781|NCT00929240|521529686|FG000|Maintenance Phase|Physician Decision|0|||
144638782|NCT00929240|521529687|FG001|Maintenance Phase|Physician Decision|2|||
144638783|NCT00929240|521529688|FG002|Maintenance Phase|Physician Decision|1|||
144638784|NCT00929240|521529686|FG000|Maintenance Phase|Change of treatment|0|||
144638785|NCT00929240|521529687|FG001|Maintenance Phase|Change of treatment|4|||
144638786|NCT00929240|521529688|FG002|Maintenance Phase|Change of treatment|0|||
144638787|NCT00929240|521529686|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
144638788|NCT00929240|521529687|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
144638789|NCT00929240|521529688|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
144638790|NCT00929240|521529686|FG000|Maintenance Phase|Participant not treated|0|||
144638791|NCT00929240|521529687|FG001|Maintenance Phase|Participant not treated|2|||
144638792|NCT00929240|521529688|FG002|Maintenance Phase|Participant not treated|0|||
144638793|NCT02203149|521529693|FG000|Part 1|Adverse Event|0|||
144638794|NCT02203149|521529694|FG001|Part 1|Adverse Event|1|||
144638795|NCT02203149|521529695|FG002|Part 1|Adverse Event|0|||
144638796|NCT02203149|521529696|FG003|Part 1|Adverse Event|0|||
144638797|NCT02203149|521529697|FG004|Part 1|Adverse Event|0|||
144638798|NCT02203149|521529693|FG000|Part 2|Death|0|||
144638799|NCT02203149|521529694|FG001|Part 2|Death|0|||
144638800|NCT02203149|521529695|FG002|Part 2|Death|1|||
144638801|NCT02203149|521529696|FG003|Part 2|Death|1|||
144638802|NCT02203149|521529697|FG004|Part 2|Death|0|||
144638803|NCT02203149|521529693|FG000|Part 2|Withdrawal by Subject|0|||
144638804|NCT02203149|521529694|FG001|Part 2|Withdrawal by Subject|0|||
144638805|NCT02203149|521529695|FG002|Part 2|Withdrawal by Subject|0|||
144638806|NCT02203149|521529696|FG003|Part 2|Withdrawal by Subject|1|||
144210630|NCT00259272|519965311|FG002|Overall Study|Sponsor Decision|0|||
144210631|NCT00259272|519965312|FG003|Overall Study|Sponsor Decision|0|||
144210632|NCT00259272|519965309|FG000|Overall Study|Withdrawal by Subject|4|||
144210633|NCT00259272|519965310|FG001|Overall Study|Withdrawal by Subject|2|||
144210634|NCT00259272|519965311|FG002|Overall Study|Withdrawal by Subject|2|||
144210635|NCT00259272|519965312|FG003|Overall Study|Withdrawal by Subject|7|||
144210636|NCT00259272|519965309|FG000|Overall Study|Lost to Follow-up|1|||
144210637|NCT00259272|519965310|FG001|Overall Study|Lost to Follow-up|0|||
144210638|NCT00259272|519965311|FG002|Overall Study|Lost to Follow-up|0|||
144210639|NCT00259272|519965312|FG003|Overall Study|Lost to Follow-up|1|||
144638807|NCT02203149|521529697|FG004|Part 2|Withdrawal by Subject|0|||
144638808|NCT02203149|521529693|FG000|Part 2|Adverse Event|0|||
144638809|NCT02203149|521529694|FG001|Part 2|Adverse Event|0|||
144638810|NCT02203149|521529695|FG002|Part 2|Adverse Event|0|||
144638811|NCT02203149|521529696|FG003|Part 2|Adverse Event|1|||
144638812|NCT02203149|521529697|FG004|Part 2|Adverse Event|1|||
144638813|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
144638814|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
144638815|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
144638816|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
144638817|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
144638818|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
144638819|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
144638820|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
144638821|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
144638822|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
144638823|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
144638824|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
144638825|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
144638826|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
144638827|NCT00446030|521529698|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
144638828|NCT00446030|521529699|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
144638829|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
144638830|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
144638831|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
144638832|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
144638833|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
144638834|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
144638835|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
144638836|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
144638837|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
144638838|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
144638839|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
144638840|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
144638841|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
144638842|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
144638843|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
144638844|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
144638845|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
144638846|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
144638847|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
144638848|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
144638849|NCT00446030|521529698|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
144638850|NCT00446030|521529699|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
144638851|NCT00503399|521529702|FG000|Overall Study|Death|2|||
144638852|NCT00503399|521529703|FG001|Overall Study|Death|1|||
144210640|NCT00103610|519965315|FG000|Overall Study|Entered Rescue Procedure|10|||
144210641|NCT00103610|519965316|FG001|Overall Study|Entered Rescue Procedure|52|||
144210642|NCT00103610|519965315|FG000|Overall Study|Death|16|||
144638853|NCT00503399|521529702|FG000|Overall Study|Protocol Violation|1|||
144638854|NCT00503399|521529703|FG001|Overall Study|Protocol Violation|0|||
144638855|NCT00503399|521529702|FG000|Overall Study|Withdrawal by Subject|4|||
144638856|NCT00503399|521529703|FG001|Overall Study|Withdrawal by Subject|2|||
144210643|NCT00103610|519965316|FG001|Overall Study|Death|12|||
144210644|NCT00103610|519965315|FG000|Overall Study|Elective Withdrawal|4|||
144638857|NCT00503399|521529702|FG000|Overall Study|Adverse Event|0|||
144638858|NCT00503399|521529703|FG001|Overall Study|Adverse Event|3|||
144638859|NCT00503399|521529702|FG000|Overall Study|Lost to Follow-up|0|||
144638860|NCT00503399|521529703|FG001|Overall Study|Lost to Follow-up|2|||
144638861|NCT00858832|521529704|FG000|Overall Study|became ineligible: delivered vaginally|1|||
144638862|NCT00858832|521529705|FG001|Overall Study|became ineligible: delivered vaginally|0|||
144638863|NCT00858832|521529704|FG000|Overall Study|Adverse Event|0|||
144638864|NCT00858832|521529705|FG001|Overall Study|Adverse Event|1|||
144638865|NCT00432809|521529706|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
144638866|NCT00432809|521529707|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
144638867|NCT00432809|521529708|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
144638868|NCT00432809|521529706|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
144638869|NCT00432809|521529707|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
144638870|NCT00432809|521529708|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
144638871|NCT03075839|521529709|FG000|Overall Study|Lost to Follow-up|4|||
144638872|NCT04433117|521529710|FG000|Overall Study|Withdrawal by Subject|1|||
144638873|NCT04433117|521529711|FG001|Overall Study|Withdrawal by Subject|0|||
144638874|NCT00190775|521529712|FG000|Overall Study|Adverse Event|57|||
144638875|NCT00190775|521529713|FG001|Overall Study|Adverse Event|22|||
144638876|NCT00190775|521529712|FG000|Overall Study|Satisfactory Response|1|||
144638877|NCT00190775|521529713|FG001|Overall Study|Satisfactory Response|0|||
144638878|NCT00190775|521529712|FG000|Overall Study|Lack of Efficacy|28|||
144638879|NCT00190775|521529713|FG001|Overall Study|Lack of Efficacy|32|||
144638880|NCT00190775|521529712|FG000|Overall Study|Lost to Follow-up|31|||
144638881|NCT00190775|521529713|FG001|Overall Study|Lost to Follow-up|23|||
144638882|NCT00190775|521529712|FG000|Overall Study|Participant Moved|0|||
144638883|NCT00190775|521529713|FG001|Overall Study|Participant Moved|1|||
144638884|NCT00190775|521529712|FG000|Overall Study|Withdrawal by Subject|24|||
144638885|NCT00190775|521529713|FG001|Overall Study|Withdrawal by Subject|13|||
144638886|NCT00190775|521529712|FG000|Overall Study|Sponsor Decision|1|||
144638887|NCT00190775|521529713|FG001|Overall Study|Sponsor Decision|0|||
144638888|NCT00190775|521529712|FG000|Overall Study|Physician Decision|3|||
144638889|NCT00190775|521529713|FG001|Overall Study|Physician Decision|0|||
144638890|NCT00190775|521529712|FG000|Overall Study|Noncompliance|3|||
144638891|NCT00190775|521529713|FG001|Overall Study|Noncompliance|5|||
144638892|NCT00190775|521529712|FG000|Overall Study|Protocol Violation|0|||
144638893|NCT00190775|521529713|FG001|Overall Study|Protocol Violation|1|||
144638894|NCT00190775|521529712|FG000|Overall Study|Exclusion Criteria Met|1|||
144638895|NCT00190775|521529713|FG001|Overall Study|Exclusion Criteria Met|3|||
144638896|NCT01491945|521529714|FG000|Overall Study|Death|30|||
144638897|NCT01491945|521529714|FG000|Overall Study|Withdrwan/LTF|16|||
144638898|NCT01491945|521529714|FG000|Overall Study|Conversion|4|||
144638899|NCT01491945|521529714|FG000|Overall Study|Missed Visit|1|||
144638900|NCT01709331|521529717|FG000|Overall Study|Adverse Event|1|||
144638901|NCT04325503|521529732|FG000|Overall Study|Withdrawal by Subject|1|||
144638902|NCT04325503|521529732|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
144638903|NCT01642212|521529733|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
144638904|NCT01642212|521529734|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
144638905|NCT01642212|521529735|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
144638906|NCT01642212|521529736|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
144638907|NCT01642212|521529737|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
144638908|NCT01642212|521529733|FG000|Double-blind Treatment|Other|0|||
144638909|NCT01642212|521529734|FG001|Double-blind Treatment|Other|2|||
144638910|NCT01642212|521529735|FG002|Double-blind Treatment|Other|1|||
144638911|NCT01642212|521529736|FG003|Double-blind Treatment|Other|0|||
144638912|NCT01642212|521529737|FG004|Double-blind Treatment|Other|0|||
144638913|NCT01642212|521529733|FG000|Double-blind Treatment|Non-compliance|0|||
144638914|NCT01642212|521529734|FG001|Double-blind Treatment|Non-compliance|1|||
144638915|NCT01642212|521529735|FG002|Double-blind Treatment|Non-compliance|0|||
144638916|NCT01642212|521529736|FG003|Double-blind Treatment|Non-compliance|0|||
144731151|NCT00296647|521871395|FG004|Overall Study|Withdrawal by Subject|19|||
144731152|NCT00565448|521871396|FG000|Overall Study|Adverse Event|1|||
144731153|NCT00565448|521871397|FG001|Overall Study|Adverse Event|2|||
144731154|NCT00565448|521871396|FG000|Overall Study|Disease progression|1|||
144731155|NCT00565448|521871397|FG001|Overall Study|Disease progression|0|||
144731156|NCT00565448|521871396|FG000|Overall Study|Withdrawal by Subject|1|||
144731157|NCT00565448|521871397|FG001|Overall Study|Withdrawal by Subject|0|||
144638917|NCT01642212|521529737|FG004|Double-blind Treatment|Non-compliance|0|||
144638918|NCT01642212|521529733|FG000|Double-blind Treatment|Adverse Event|0|||
144638919|NCT01642212|521529734|FG001|Double-blind Treatment|Adverse Event|0|||
144638920|NCT01642212|521529735|FG002|Double-blind Treatment|Adverse Event|1|||
144638921|NCT01642212|521529736|FG003|Double-blind Treatment|Adverse Event|0|||
144638922|NCT01642212|521529737|FG004|Double-blind Treatment|Adverse Event|0|||
144638923|NCT01642212|521529733|FG000|Open-label Extension|Adverse Event|0|||
144731158|NCT01863745|521871398|FG000|Overall Study|Disease Progression|9|||
144731159|NCT01863745|521871398|FG000|Overall Study|Adverse Event|2|||
144731160|NCT01863745|521871398|FG000|Overall Study|Death|1|||
144638924|NCT01642212|521529734|FG001|Open-label Extension|Adverse Event|0|||
144638925|NCT01642212|521529735|FG002|Open-label Extension|Adverse Event|0|||
144638926|NCT01642212|521529736|FG003|Open-label Extension|Adverse Event|3|||
144638927|NCT01642212|521529737|FG004|Open-label Extension|Adverse Event|0|||
144638928|NCT01642212|521529733|FG000|Open-label Extension|Sponsor Decision|0|||
144638929|NCT01642212|521529734|FG001|Open-label Extension|Sponsor Decision|0|||
144638930|NCT01642212|521529735|FG002|Open-label Extension|Sponsor Decision|0|||
144638931|NCT01642212|521529736|FG003|Open-label Extension|Sponsor Decision|7|||
144638932|NCT01642212|521529737|FG004|Open-label Extension|Sponsor Decision|4|||
144638933|NCT01642212|521529733|FG000|Open-label Extension|Consent Withdrawn|0|||
144638934|NCT01642212|521529734|FG001|Open-label Extension|Consent Withdrawn|0|||
144638935|NCT01642212|521529735|FG002|Open-label Extension|Consent Withdrawn|0|||
144638936|NCT01642212|521529736|FG003|Open-label Extension|Consent Withdrawn|0|||
144638937|NCT01642212|521529737|FG004|Open-label Extension|Consent Withdrawn|2|||
144638938|NCT01642212|521529733|FG000|Open-label Extension|Lost to Follow-up|0|||
144638939|NCT01642212|521529734|FG001|Open-label Extension|Lost to Follow-up|0|||
144638940|NCT01642212|521529735|FG002|Open-label Extension|Lost to Follow-up|0|||
144638941|NCT01642212|521529736|FG003|Open-label Extension|Lost to Follow-up|0|||
144638942|NCT01642212|521529737|FG004|Open-label Extension|Lost to Follow-up|1|||
144638943|NCT01642212|521529733|FG000|Open-label Extension|Other|0|||
144638944|NCT01642212|521529734|FG001|Open-label Extension|Other|0|||
144638945|NCT01642212|521529735|FG002|Open-label Extension|Other|0|||
144638946|NCT01642212|521529736|FG003|Open-label Extension|Other|0|||
144638947|NCT01642212|521529737|FG004|Open-label Extension|Other|1|||
144638948|NCT01564784|521529738|FG000|Overall Study|Other|1|||
144638949|NCT01564784|521529739|FG001|Overall Study|Other|0|||
144638950|NCT01564784|521529738|FG000|Overall Study|Subject refused further follow-up|1|||
144638951|NCT01564784|521529739|FG001|Overall Study|Subject refused further follow-up|6|||
144638952|NCT01564784|521529738|FG000|Overall Study|Lost to Follow-up|1|||
144638953|NCT01564784|521529739|FG001|Overall Study|Lost to Follow-up|1|||
144638954|NCT01564784|521529738|FG000|Overall Study|Death|131|||
144638955|NCT01564784|521529739|FG001|Overall Study|Death|126|||
144638956|NCT02272790|521529740|FG000|Overall Study|Physician Decision|0|||
144638957|NCT02272790|521529741|FG001|Overall Study|Physician Decision|1|||
144638958|NCT02272790|521529742|FG002|Overall Study|Physician Decision|0|||
144638959|NCT02272790|521529743|FG003|Overall Study|Physician Decision|0|||
144638960|NCT02272790|521529744|FG004|Overall Study|Physician Decision|0|||
144638961|NCT02272790|521529745|FG005|Overall Study|Physician Decision|0|||
144638962|NCT00332202|521529746|FG000|Overall Study|Adverse Event|72|||
144638963|NCT00332202|521529747|FG001|Overall Study|Adverse Event|28|||
144638964|NCT00332202|521529746|FG000|Overall Study|Lost to Follow-up|2|||
144638965|NCT00332202|521529747|FG001|Overall Study|Lost to Follow-up|1|||
144638966|NCT00332202|521529746|FG000|Overall Study|Physician Decision|6|||
144638967|NCT00332202|521529747|FG001|Overall Study|Physician Decision|8|||
144638968|NCT00332202|521529746|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
144638969|NCT00332202|521529747|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
144638970|NCT00332202|521529746|FG000|Overall Study|Protocol Violation|7|||
144638971|NCT00332202|521529747|FG001|Overall Study|Protocol Violation|2|||
144638972|NCT00332202|521529746|FG000|Overall Study|Sponsor Decision|1|||
144638973|NCT00332202|521529747|FG001|Overall Study|Sponsor Decision|2|||
144638974|NCT00332202|521529746|FG000|Overall Study|Withdrawal by Subject|36|||
144638975|NCT00332202|521529747|FG001|Overall Study|Withdrawal by Subject|17|||
144638976|NCT00332202|521529746|FG000|Overall Study|Progressive Disease|106|||
144638977|NCT00332202|521529747|FG001|Overall Study|Progressive Disease|60|||
144638978|NCT00332202|521529746|FG000|Overall Study|Death|5|||
144638979|NCT00332202|521529747|FG001|Overall Study|Death|2|||
144638980|NCT01444300|521529755|FG000|Overall Study|Adverse Event|4|||
144638981|NCT01444300|521529756|FG001|Overall Study|Adverse Event|0|||
144638982|NCT01697345|521529761|FG000|Overall Study|Withdrawal by Subject|1|||
144638983|NCT00924703|521529762|FG000|Overall Study|Withdrawal by Subject|11|||
144638984|NCT00924703|521529762|FG000|Overall Study|Physician Decision|5|||
144638985|NCT00924703|521529762|FG000|Overall Study|Lost to Follow-up|3|||
144638986|NCT00924703|521529762|FG000|Overall Study|Adverse Event|2|||
144638987|NCT00924703|521529762|FG000|Overall Study|Withdrawal by Sponsor|1|||
144638988|NCT01523873|521529763|FG000|Overall Study|Protocol Violation|422|||
144638989|NCT04429022|521529766|FG000|Overall Study|Protocol Violation|18|||
144638990|NCT04429022|521529767|FG001|Overall Study|Protocol Violation|1|||
144638991|NCT00275561|521529768|FG000|Overall Study|Withdrawal by Subject|0|||
144638992|NCT00275561|521529769|FG001|Overall Study|Withdrawal by Subject|1|||
144638993|NCT00275561|521529768|FG000|Overall Study|Travel|1|||
144638994|NCT00275561|521529769|FG001|Overall Study|Travel|1|||
144638995|NCT00275561|521529768|FG000|Overall Study|Scheduling|1|||
144638996|NCT00275561|521529769|FG001|Overall Study|Scheduling|2|||
144638997|NCT00275561|521529768|FG000|Overall Study|Family Issues|0|||
144638998|NCT00275561|521529769|FG001|Overall Study|Family Issues|2|||
144638999|NCT02582658|521529779|FG000|Overall Study|Failure to Return|10|||
144639000|NCT02582658|521529779|FG000|Overall Study|Insufficient Virological Response|2|||
144639001|NCT02582658|521529779|FG000|Overall Study|Withdrawn Consent|1|||
144639002|NCT02582658|521529779|FG000|Overall Study|Death|1|||
144639003|NCT02582658|521529779|FG000|Overall Study|Not further specified|11|||
144639004|NCT05089708|521531213|FG000|Overall Study|Lost to Follow-up|9|||
144639005|NCT05089708|521531214|FG001|Overall Study|Lost to Follow-up|7|||
144639006|NCT05089708|521531213|FG000|Overall Study|Withdrawal by Subject|3|||
144639007|NCT05089708|521531214|FG001|Overall Study|Withdrawal by Subject|1|||
144639008|NCT05089708|521531213|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
144639009|NCT05089708|521531214|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
144639010|NCT05089708|521531213|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
144639011|NCT05089708|521531214|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
144639012|NCT01440101|521531215|FG000|Overall Study|Adverse Event|2|||
144639013|NCT01440101|521531216|FG001|Overall Study|Adverse Event|0|||
144639014|NCT01440101|521531217|FG002|Overall Study|Adverse Event|0|||
144639015|NCT01440101|521531215|FG000|Overall Study|Withdrawal by Subject|0|||
144639016|NCT01440101|521531216|FG001|Overall Study|Withdrawal by Subject|3|||
144639017|NCT01440101|521531217|FG002|Overall Study|Withdrawal by Subject|1|||
144639018|NCT01440101|521531215|FG000|Overall Study|Other|0|||
144210645|NCT00103610|519965316|FG001|Overall Study|Elective Withdrawal|0|||
144210646|NCT00103610|519965315|FG000|Overall Study|Lost to Follow-up|3|||
144210647|NCT00103610|519965316|FG001|Overall Study|Lost to Follow-up|1|||
144210648|NCT00103610|519965315|FG000|Overall Study|Adverse Event|2|||
144210649|NCT00103610|519965316|FG001|Overall Study|Adverse Event|2|||
144210650|NCT00103610|519965315|FG000|Overall Study|Other|2|||
144210651|NCT00103610|519965316|FG001|Overall Study|Other|7|||
144210652|NCT00103610|519965315|FG000|Overall Study|Failed mobilization|1|||
144210653|NCT00103610|519965316|FG001|Overall Study|Failed mobilization|5|||
144210654|NCT00103610|519965315|FG000|Overall Study|Noncompliance|0|||
144210655|NCT00103610|519965316|FG001|Overall Study|Noncompliance|1|||
144210656|NCT04614246|519965319|FG000|Overall Study|Adverse Event|0|||
144210657|NCT04614246|519965320|FG001|Overall Study|Adverse Event|1|||
144210658|NCT04614246|519965321|FG002|Overall Study|Adverse Event|1|||
144210659|NCT04614246|519965322|FG003|Overall Study|Adverse Event|2|||
144210660|NCT04614246|519965323|FG004|Overall Study|Adverse Event|1|||
144210661|NCT04614246|519965319|FG000|Overall Study|Lost to Follow-up|0|||
144210662|NCT04614246|519965320|FG001|Overall Study|Lost to Follow-up|1|||
144210663|NCT04614246|519965321|FG002|Overall Study|Lost to Follow-up|0|||
144210664|NCT04614246|519965322|FG003|Overall Study|Lost to Follow-up|1|||
144210665|NCT04614246|519965323|FG004|Overall Study|Lost to Follow-up|3|||
144210666|NCT04614246|519965319|FG000|Overall Study|Other reason|0|||
144210667|NCT04614246|519965320|FG001|Overall Study|Other reason|1|||
144639019|NCT01440101|521531216|FG001|Overall Study|Other|1|||
144639020|NCT01440101|521531217|FG002|Overall Study|Other|0|||
144639021|NCT00074958|521531218|FG000|Overall Study|Adverse Event|1|||
144639022|NCT02690701|521531221|FG000|Treatment Period 1|Adverse Event|2|||
144639023|NCT02690701|521531222|FG001|Treatment Period 1|Adverse Event|2|||
144639024|NCT02690701|521531221|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144639025|NCT02690701|521531222|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144639026|NCT02690701|521531221|FG000|Treatment Period 2|Adverse Event|2|||
144639027|NCT02690701|521531222|FG001|Treatment Period 2|Adverse Event|0|||
144639028|NCT02690701|521531221|FG000|Treatment Period 2|Lack of Efficacy|1|||
144639029|NCT02690701|521531222|FG001|Treatment Period 2|Lack of Efficacy|0|||
144639030|NCT02690701|521531221|FG000|Treatment Period 2|Lost to Follow-up|0|||
144639031|NCT02690701|521531222|FG001|Treatment Period 2|Lost to Follow-up|2|||
144639032|NCT02690701|521531221|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144639033|NCT02690701|521531222|FG001|Treatment Period 2|Withdrawal by Subject|2|||
144639034|NCT02690701|521531221|FG000|Treatment Period 2|Protocol Violation|0|||
144639035|NCT02690701|521531222|FG001|Treatment Period 2|Protocol Violation|1|||
144639036|NCT02700451|521531223|FG000|Overall Study|Protocol Violation|2|||
144639037|NCT02700451|521531224|FG001|Overall Study|Protocol Violation|2|||
144639038|NCT02700451|521531225|FG002|Overall Study|Protocol Violation|3|||
144210668|NCT04614246|519965321|FG002|Overall Study|Other reason|2|||
144210669|NCT04614246|519965322|FG003|Overall Study|Other reason|0|||
144210670|NCT04614246|519965323|FG004|Overall Study|Other reason|0|||
144639039|NCT02700451|521531223|FG000|Overall Study|Discontinued intervention|14|||
144639040|NCT02700451|521531224|FG001|Overall Study|Discontinued intervention|15|||
144210671|NCT04614246|519965319|FG000|Overall Study|Withdrawal by Subject|4|||
144210672|NCT04614246|519965320|FG001|Overall Study|Withdrawal by Subject|2|||
144639041|NCT02700451|521531225|FG002|Overall Study|Discontinued intervention|14|||
144210673|NCT04614246|519965321|FG002|Overall Study|Withdrawal by Subject|4|||
144210674|NCT04614246|519965322|FG003|Overall Study|Withdrawal by Subject|3|||
144210675|NCT04614246|519965323|FG004|Overall Study|Withdrawal by Subject|4|||
144639042|NCT02115308|521531227|FG000|Overall Study|Safety Screening|2|||
144639043|NCT02115308|521531228|FG001|Overall Study|Safety Screening|2|||
144210676|NCT04614246|519965319|FG000|Overall Study|Physician Decision|0|||
144210677|NCT04614246|519965320|FG001|Overall Study|Physician Decision|2|||
144210678|NCT04614246|519965321|FG002|Overall Study|Physician Decision|1|||
144210679|NCT04614246|519965322|FG003|Overall Study|Physician Decision|0|||
144639044|NCT00404092|521531230|FG000|Overall Study|Death|1|||
144639045|NCT00404092|521531231|FG001|Overall Study|Death|0|||
144639046|NCT00404092|521531232|FG002|Overall Study|Death|0|||
144639047|NCT00404092|521531233|FG003|Overall Study|Death|0|||
144639048|NCT00404092|521531230|FG000|Overall Study|Adverse Event|0|||
144639049|NCT00404092|521531231|FG001|Overall Study|Adverse Event|0|||
144639050|NCT00404092|521531232|FG002|Overall Study|Adverse Event|1|||
144639051|NCT00404092|521531233|FG003|Overall Study|Adverse Event|0|||
144639052|NCT01658514|521531236|FG000|Overall Study|Protocol Violation|1|||
144639053|NCT01658514|521531237|FG001|Overall Study|Protocol Violation|0|||
144639054|NCT01658514|521531238|FG002|Overall Study|Protocol Violation|2|||
144639055|NCT00749203|521531239|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
144639056|NCT00749203|521531240|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
144639057|NCT00749203|521531239|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
144639058|NCT00749203|521531240|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
144639059|NCT00749203|521531239|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
144639060|NCT00749203|521531240|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
144639061|NCT00749203|521531239|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
144639062|NCT00749203|521531240|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
144639063|NCT00749203|521531239|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
144639064|NCT00749203|521531240|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
144639065|NCT00749203|521531239|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
144639066|NCT00749203|521531240|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
144639067|NCT02337387|521531241|FG000|Overall Study|Adverse Event|0|||
144639068|NCT02337387|521531242|FG001|Overall Study|Adverse Event|1|||
144639069|NCT02337387|521531243|FG002|Overall Study|Adverse Event|0|||
144639070|NCT02337387|521531244|FG003|Overall Study|Adverse Event|0|||
144639071|NCT02337387|521531241|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
144639072|NCT02337387|521531242|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
144639073|NCT02337387|521531243|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
144639074|NCT02337387|521531244|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
144639075|NCT02853760|521531245|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
144639076|NCT02853760|521531246|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
144639077|NCT02853760|521531247|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
144639078|NCT02853760|521531248|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
144639079|NCT02853760|521531249|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
144639080|NCT02853760|521531250|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
144639081|NCT00981526|521531251|FG000|Overall Study|Withdrawal by Subject|0|||
144639082|NCT00981526|521531252|FG001|Overall Study|Withdrawal by Subject|2|||
144639083|NCT00981526|521531251|FG000|Overall Study|Physician Decision|4|||
144639084|NCT00981526|521531252|FG001|Overall Study|Physician Decision|4|||
144639085|NCT01243268|521531253|FG000|Overall Study|Lost to Follow-up|4|||
144639086|NCT01243268|521531253|FG000|Overall Study|Protocol Violation|51|||
144639087|NCT01243268|521531253|FG000|Overall Study|Deviation with contract date|7|||
144639088|NCT01243268|521531253|FG000|Overall Study|Duplicate subject|2|||
144639089|NCT00957853|521531254|FG000|Overall Study|Withdrawal by Subject|1|||
144639090|NCT00957853|521531255|FG001|Overall Study|Withdrawal by Subject|0|||
144639091|NCT00957853|521531256|FG002|Overall Study|Withdrawal by Subject|0|||
144639092|NCT05202808|521531257|FG000|Overall Study|Lost to Follow-up|3|||
144639093|NCT05202808|521531258|FG001|Overall Study|Lost to Follow-up|1|||
144639094|NCT04996797|521531259|FG000|Overall Study|Adverse Event|0|||
144639095|NCT04996797|521531260|FG001|Overall Study|Adverse Event|2|||
144639096|NCT04996797|521531261|FG002|Overall Study|Adverse Event|0|||
144639097|NCT04996797|521531262|FG003|Overall Study|Adverse Event|1|||
144639098|NCT04996797|521531259|FG000|Overall Study|Lack of Efficacy|0|||
144639099|NCT04996797|521531260|FG001|Overall Study|Lack of Efficacy|2|||
144639100|NCT04996797|521531261|FG002|Overall Study|Lack of Efficacy|0|||
144639101|NCT04996797|521531262|FG003|Overall Study|Lack of Efficacy|0|||
144639102|NCT04996797|521531259|FG000|Overall Study|Prohibited Medication|0|||
144639103|NCT04996797|521531260|FG001|Overall Study|Prohibited Medication|1|||
144639104|NCT04996797|521531261|FG002|Overall Study|Prohibited Medication|0|||
144639105|NCT04996797|521531262|FG003|Overall Study|Prohibited Medication|0|||
144639106|NCT04996797|521531259|FG000|Overall Study|Ongoing|68|||
144639107|NCT04996797|521531260|FG001|Overall Study|Ongoing|60|||
144639108|NCT04996797|521531261|FG002|Overall Study|Ongoing|22|||
144263211|NCT04805671|520163889|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
144639109|NCT04996797|521531262|FG003|Overall Study|Ongoing|20|||
144639110|NCT04996797|521531259|FG000|Overall Study|Withdrawal by Subject|0|||
144639111|NCT04996797|521531260|FG001|Overall Study|Withdrawal by Subject|2|||
144639112|NCT04996797|521531261|FG002|Overall Study|Withdrawal by Subject|0|||
144639113|NCT04996797|521531262|FG003|Overall Study|Withdrawal by Subject|0|||
144639114|NCT02793544|521531263|FG000|Overall Study|Death|10|||
144639115|NCT02793544|521531264|FG001|Overall Study|Death|8|||
144639116|NCT02793544|521531263|FG000|Overall Study|Lost to Follow-up|2|||
144639117|NCT02793544|521531264|FG001|Overall Study|Lost to Follow-up|0|||
144639118|NCT02793544|521531263|FG000|Overall Study|Withdrawal by Subject|1|||
144639119|NCT02793544|521531264|FG001|Overall Study|Withdrawal by Subject|0|||
144639120|NCT02495948|521531267|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
144210680|NCT04614246|519965323|FG004|Overall Study|Physician Decision|0|||
144210681|NCT04614246|519965319|FG000|Overall Study|Study terminated by sponsor|10|||
144210682|NCT04614246|519965320|FG001|Overall Study|Study terminated by sponsor|15|||
144210683|NCT04614246|519965321|FG002|Overall Study|Study terminated by sponsor|12|||
144210684|NCT04614246|519965322|FG003|Overall Study|Study terminated by sponsor|13|||
144210685|NCT04614246|519965323|FG004|Overall Study|Study terminated by sponsor|9|||
144210686|NCT04614246|519965319|FG000|Overall Study|Pregnancy|2|||
144210687|NCT04614246|519965320|FG001|Overall Study|Pregnancy|0|||
144210688|NCT04614246|519965321|FG002|Overall Study|Pregnancy|1|||
144210689|NCT04614246|519965322|FG003|Overall Study|Pregnancy|0|||
144210690|NCT04614246|519965323|FG004|Overall Study|Pregnancy|0|||
144210691|NCT01680497|519965324|FG000|Overall Study|Lost to Follow-up|2|||
144210692|NCT00725205|519965325|FG000|Overall Study|Adverse Event|22|||
144210693|NCT00725205|519965325|FG000|Overall Study|Investigator Discontinued|1|||
144210694|NCT00725205|519965325|FG000|Overall Study|Non-compliance With Protocol|14|||
144210695|NCT00725205|519965325|FG000|Overall Study|Other|8|||
144210696|NCT00725205|519965325|FG000|Overall Study|Protocol Defined Clinical Event|1|||
144210697|NCT00725205|519965325|FG000|Overall Study|Treatment Failure|41|||
144210698|NCT05819203|519965327|FG000|Overall Study|Protocol Violation|1|||
144210699|NCT05819203|519965328|FG001|Overall Study|Protocol Violation|2|||
144210700|NCT05819203|519965327|FG000|Overall Study|Withdrawal by Subject|1|||
144210701|NCT05819203|519965328|FG001|Overall Study|Withdrawal by Subject|0|||
144210702|NCT03597464|519965336|FG000|Overall Study|Withdrawal by Subject|4|||
144210703|NCT03597464|519965337|FG001|Overall Study|Withdrawal by Subject|5|||
144639121|NCT02495948|521531268|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
144639122|NCT02495948|521531267|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
144639123|NCT02495948|521531268|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
144639124|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
144639125|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
144639126|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
144639127|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
144639128|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
144639129|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
144639130|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
144639131|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
144639132|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
144639133|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
144639134|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
144639135|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
144639136|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
144639137|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
144639138|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
144639139|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
144639140|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
144639141|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
144639142|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
144210704|NCT03597464|519965336|FG000|Overall Study|Lost to Follow-up|3|||
144210705|NCT03597464|519965337|FG001|Overall Study|Lost to Follow-up|1|||
144210706|NCT03597464|519965336|FG000|Overall Study|Pregnancy|3|||
144210707|NCT03597464|519965337|FG001|Overall Study|Pregnancy|1|||
144210708|NCT03597464|519965336|FG000|Overall Study|Lack of Efficacy|2|||
144263212|NCT04805671|520163890|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
144639143|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
144639144|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
144639145|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
144639146|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
144639147|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
144639148|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
144639149|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
144639150|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
144639151|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
144639152|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
144639153|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
144639154|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
144639155|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
144639156|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
144639157|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
144639158|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
144639159|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
144639160|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
144210709|NCT03597464|519965337|FG001|Overall Study|Lack of Efficacy|0|||
144210710|NCT03597464|519965336|FG000|Overall Study|Physician Decision|2|||
144639161|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
144639162|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
144639163|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
144639164|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
144639165|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
144639166|NCT00100048|521531270|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
144639167|NCT00100048|521531271|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
144639168|NCT00100048|521531272|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
144639169|NCT00100048|521531273|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
144639170|NCT00100048|521531274|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
144639171|NCT00100048|521531275|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
144639172|NCT01822561|521531276|FG000|Overall Study|Withdrawal by Subject|2|||
144639173|NCT02747004|521531277|FG000|Overall Study|Withdrawal by Subject|8|||
144639174|NCT02747004|521531278|FG001|Overall Study|Withdrawal by Subject|5|||
144639175|NCT02747004|521531279|FG002|Overall Study|Withdrawal by Subject|4|||
144639176|NCT02747004|521531277|FG000|Overall Study|Lost to Follow-up|1|||
144639177|NCT02747004|521531278|FG001|Overall Study|Lost to Follow-up|2|||
144639178|NCT02747004|521531279|FG002|Overall Study|Lost to Follow-up|2|||
144639179|NCT02747004|521531277|FG000|Overall Study|on study treatment/follow-up|48|||
144639180|NCT02747004|521531278|FG001|Overall Study|on study treatment/follow-up|42|||
144639181|NCT02747004|521531279|FG002|Overall Study|on study treatment/follow-up|41|||
144639182|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
144639183|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
144639184|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
144639185|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
144639186|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
144639187|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
144639188|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
144639189|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
144639190|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
144639191|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
144639192|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
144639193|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
144639194|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
144639195|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
144639196|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
144639197|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
144639198|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
144639199|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
144639200|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
144639201|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
144639202|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Death|0|||
144639203|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Death|1|||
144639204|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Death|0|||
144639205|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Death|0|||
144639206|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Death|0|||
144639207|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
144639208|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
144639209|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
144639210|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
144639211|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
144639212|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
144639213|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
144639214|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
144639215|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
144639216|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
144639217|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
144639218|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
144639219|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
144639220|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
144639221|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
144639222|NCT05087030|521531280|FG000|Main Period (Week 0 to Week 52)|Other|1|||
144639223|NCT05087030|521531281|FG001|Main Period (Week 0 to Week 52)|Other|2|||
144639224|NCT05087030|521531282|FG002|Main Period (Week 0 to Week 52)|Other|0|||
144639225|NCT05087030|521531283|FG003|Main Period (Week 0 to Week 52)|Other|0|||
144639226|NCT05087030|521531284|FG004|Main Period (Week 0 to Week 52)|Other|0|||
144639227|NCT05087030|521531280|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
144639228|NCT05087030|521531281|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
144639229|NCT05087030|521531282|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
144639230|NCT05087030|521531283|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
144639231|NCT05087030|521531284|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
144639232|NCT04826900|521531285|FG000|Overall Study|Family factor|1|||
144639233|NCT04826900|521531286|FG001|Overall Study|Family factor|1|||
144639234|NCT04885257|521531290|FG000|Overall Study|Withdrawal by Subject|1|||
144639235|NCT04885257|521531291|FG001|Overall Study|Withdrawal by Subject|0|||
144639236|NCT02597062|521531292|FG000|Overall Study|Ineligible|1|||
144639237|NCT03372941|521531293|FG000|Overall Study|Lost to Follow-up|2|||
144639238|NCT03372941|521531294|FG001|Overall Study|Lost to Follow-up|4|||
144639239|NCT00686543|521531295|FG000|Overall Study|Adverse Event|9|||
144639240|NCT00686543|521531296|FG001|Overall Study|Adverse Event|1|||
144639241|NCT00686543|521531297|FG002|Overall Study|Adverse Event|3|||
144639242|NCT00686543|521531298|FG003|Overall Study|Adverse Event|2|||
144639243|NCT00686543|521531295|FG000|Overall Study|Withdrawal by Subject|2|||
144639244|NCT00686543|521531296|FG001|Overall Study|Withdrawal by Subject|0|||
144639245|NCT00686543|521531297|FG002|Overall Study|Withdrawal by Subject|0|||
144639246|NCT00686543|521531298|FG003|Overall Study|Withdrawal by Subject|0|||
144639247|NCT00686543|521531295|FG000|Overall Study|Protocol Violation|3|||
144639248|NCT00686543|521531296|FG001|Overall Study|Protocol Violation|0|||
144639249|NCT00686543|521531297|FG002|Overall Study|Protocol Violation|2|||
144639250|NCT00686543|521531298|FG003|Overall Study|Protocol Violation|1|||
144639251|NCT00609622|521531299|FG000|Overall Study|Adverse Event|14|||
144639252|NCT00609622|521531300|FG001|Overall Study|Adverse Event|10|||
144639253|NCT00609622|521531299|FG000|Overall Study|Withdrawal by Subject|4|||
144639254|NCT00609622|521531300|FG001|Overall Study|Withdrawal by Subject|20|||
144639255|NCT00609622|521531299|FG000|Overall Study|Death|1|||
144639256|NCT00609622|521531300|FG001|Overall Study|Death|4|||
144639257|NCT00609622|521531299|FG000|Overall Study|Protocol Violation|1|||
144639258|NCT00609622|521531300|FG001|Overall Study|Protocol Violation|1|||
144639259|NCT00609622|521531299|FG000|Overall Study|Objective progression or relapse|47|||
144639260|NCT00609622|521531300|FG001|Overall Study|Objective progression or relapse|41|||
144639261|NCT00609622|521531299|FG000|Overall Study|Study terminated by sponsor|16|||
144639262|NCT00609622|521531300|FG001|Overall Study|Study terminated by sponsor|3|||
144639263|NCT00609622|521531299|FG000|Overall Study|Other|7|||
144639264|NCT00609622|521531300|FG001|Overall Study|Other|14|||
144639265|NCT00609622|521531299|FG000|Overall Study|Global deterioration of health status|6|||
144639266|NCT00609622|521531300|FG001|Overall Study|Global deterioration of health status|2|||
144639267|NCT01237951|521531303|FG000|Overall Study|Death|1|||
144639268|NCT01053429|521531304|FG000|Overall Study|Adverse Event|64|||
144639269|NCT01053429|521531304|FG000|Overall Study|Other|309|||
144639270|NCT01708057|521531305|FG000|Overall Study|Withdrawal due to study termination.|1|||
144639271|NCT01708057|521531306|FG001|Overall Study|Withdrawal due to study termination.|1|||
144639272|NCT01708057|521531307|FG002|Overall Study|Withdrawal due to study termination.|1|||
144639273|NCT00752986|521531308|FG000|Overall Study|Withdrawal by Subject|2|||
144639274|NCT00752986|521531309|FG001|Overall Study|Withdrawal by Subject|1|||
144639275|NCT00752986|521531310|FG002|Overall Study|Withdrawal by Subject|2|||
144639276|NCT00752986|521531308|FG000|Overall Study|Protocol Violation|3|||
144639277|NCT00752986|521531309|FG001|Overall Study|Protocol Violation|0|||
144639278|NCT00752986|521531310|FG002|Overall Study|Protocol Violation|0|||
144639279|NCT02970929|521531314|FG000|Overall Study|Adverse Event|18|||
144639280|NCT02970929|521531314|FG000|Overall Study|Lack of Efficacy|8|||
144639281|NCT02970929|521531314|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
144639282|NCT02970929|521531314|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
144639283|NCT02970929|521531314|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
144639284|NCT02970929|521531314|FG000|Overall Study|LOST TO FOLLOWUP|6|||
144639285|NCT02970929|521531314|FG000|Overall Study|MOVED OUT OF STATE|1|||
144639286|NCT02970929|521531314|FG000|Overall Study|Withdrawal by Subject|16|||
144639287|NCT02382133|521531315|FG000|Overall Study|Death|22|||
144639288|NCT02382133|521531315|FG000|Overall Study|transfer out of ICU|4|||
144639289|NCT02382133|521531315|FG000|Overall Study|Physician Decision|2|||
144639290|NCT02382133|521531315|FG000|Overall Study|arterial catheter loss|4|||
144639291|NCT02382133|521531315|FG000|Overall Study|pressure injury both sites|1|||
144639292|NCT02370121|521531322|FG000|Overall Study|Lost to Follow-up|1|||
144639293|NCT02370121|521531323|FG001|Overall Study|Lost to Follow-up|1|||
144639294|NCT00045032|521531325|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
144639295|NCT00045032|521531326|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
144639296|NCT00045032|521531327|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
144639297|NCT00045032|521531325|FG000|Overall Study|Death|22|||
144639298|NCT00045032|521531326|FG001|Overall Study|Death|24|||
144639299|NCT00045032|521531327|FG002|Overall Study|Death|17|||
144731161|NCT01863745|521871398|FG000|Overall Study|Withdrawal by Subject|1|||
144731162|NCT00193609|521871399|FG000|Overall Study|Lack of Efficacy|2|||
144731163|NCT00193609|521871399|FG000|Overall Study|Adverse Event|2|||
144731164|NCT00735904|521871400|FG000|Overall Study|Adverse Event|3|||
144210711|NCT03597464|519965337|FG001|Overall Study|Physician Decision|2|||
144210712|NCT03597464|519965336|FG000|Overall Study|Protocol Violation|1|||
144210713|NCT03597464|519965337|FG001|Overall Study|Protocol Violation|1|||
144639300|NCT00045032|521531325|FG000|Overall Study|Insufficient Therapeutic Response|542|||
144639301|NCT00045032|521531326|FG001|Overall Study|Insufficient Therapeutic Response|437|||
144639302|NCT00045032|521531327|FG002|Overall Study|Insufficient Therapeutic Response|445|||
144639303|NCT00045032|521531325|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
144639304|NCT00045032|521531326|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
144639305|NCT00045032|521531327|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
144639306|NCT00045032|521531325|FG000|Overall Study|Other Protocol Violation|2|||
144639307|NCT00045032|521531326|FG001|Overall Study|Other Protocol Violation|0|||
144639308|NCT00045032|521531327|FG002|Overall Study|Other Protocol Violation|1|||
144639309|NCT00045032|521531325|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
144639310|NCT00045032|521531326|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
144639311|NCT00045032|521531327|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
144639312|NCT00045032|521531325|FG000|Overall Study|Failure to Return|57|||
144639313|NCT00045032|521531326|FG001|Overall Study|Failure to Return|62|||
144639314|NCT00045032|521531327|FG002|Overall Study|Failure to Return|61|||
144639315|NCT00045032|521531325|FG000|Overall Study|Other|93|||
144639316|NCT00045032|521531326|FG001|Overall Study|Other|84|||
144639317|NCT00045032|521531327|FG002|Overall Study|Other|105|||
144639318|NCT02770807|521531328|FG000|Overall Study|Adverse Event|3|||
144639319|NCT02770807|521531329|FG001|Overall Study|Adverse Event|3|||
144639320|NCT02770807|521531330|FG002|Overall Study|Adverse Event|1|||
144639321|NCT02770807|521531328|FG000|Overall Study|Withdrawal by Subject|7|||
144639322|NCT02770807|521531329|FG001|Overall Study|Withdrawal by Subject|3|||
144639323|NCT02770807|521531330|FG002|Overall Study|Withdrawal by Subject|4|||
144639324|NCT02770807|521531328|FG000|Overall Study|Other|0|||
144639325|NCT02770807|521531329|FG001|Overall Study|Other|1|||
144639326|NCT02770807|521531330|FG002|Overall Study|Other|0|||
144639327|NCT02770807|521531328|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
144639328|NCT02770807|521531329|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
144639329|NCT02770807|521531330|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
144639330|NCT02770807|521531328|FG000|Overall Study|Physician Decision|0|||
144639331|NCT02770807|521531329|FG001|Overall Study|Physician Decision|0|||
144639332|NCT02770807|521531330|FG002|Overall Study|Physician Decision|1|||
144639333|NCT00222105|521531333|FG000|Overall Study|Removed due to wrong diagnosis|1|||
144639334|NCT00222105|521531333|FG000|Overall Study|Withdrawal by Subject|1|||
144639335|NCT00222105|521531333|FG000|Overall Study|Adverse Event|8|||
144639336|NCT00222105|521531333|FG000|Overall Study|Treatment delays|2|||
144639337|NCT00222105|521531333|FG000|Overall Study|Death|2|||
144639338|NCT00377962|521532720|FG000|Core Study: 0-12 Months|Adverse Event|18|||
144639339|NCT00377962|521532721|FG001|Core Study: 0-12 Months|Adverse Event|2|||
144639340|NCT00377962|521532720|FG000|Core Study: 0-12 Months|Death|3|||
144639341|NCT00377962|521532721|FG001|Core Study: 0-12 Months|Death|0|||
144639342|NCT00377962|521532720|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
144639343|NCT00377962|521532721|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
144639344|NCT00377962|521532720|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
144639345|NCT00377962|521532721|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
144639346|NCT00377962|521532720|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
144639347|NCT00377962|521532721|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
144639348|NCT00377962|521532720|FG000|Extension Study: 12-24 Months|Death|1|||
144639349|NCT00377962|521532721|FG001|Extension Study: 12-24 Months|Death|1|||
144639350|NCT00377962|521532720|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
144639351|NCT00377962|521532721|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
144210714|NCT03597464|519965336|FG000|Overall Study|Adverse Event|0|||
144210715|NCT03597464|519965337|FG001|Overall Study|Adverse Event|2|||
144210716|NCT03597464|519965336|FG000|Overall Study|Death|0|||
144639352|NCT00377962|521532720|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
144639353|NCT00377962|521532721|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
144639354|NCT00377962|521532720|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
144639355|NCT00377962|521532721|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
144639356|NCT00374556|521532722|FG000|Overall Study|Lost to Follow-up|1|||
144639357|NCT00374556|521532723|FG001|Overall Study|Lost to Follow-up|0|||
144639358|NCT00374556|521532722|FG000|Overall Study|Removed at baseline due to medical cond|0|||
144639359|NCT00374556|521532723|FG001|Overall Study|Removed at baseline due to medical cond|1|||
144639360|NCT00686205|521532729|FG000|Overall Study|Protocol Violation|127|||
144639361|NCT00686205|521532730|FG001|Overall Study|Protocol Violation|0|||
144639362|NCT00686205|521532729|FG000|Overall Study|Withdrawal by Subject|2|||
144639363|NCT00686205|521532730|FG001|Overall Study|Withdrawal by Subject|0|||
144639364|NCT00686205|521532729|FG000|Overall Study|Specimen handling procedure altered|5878|||
144210717|NCT03597464|519965337|FG001|Overall Study|Death|3|||
144639365|NCT00686205|521532730|FG001|Overall Study|Specimen handling procedure altered|0|||
144639366|NCT00686205|521532729|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
144639367|NCT00686205|521532730|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
144639368|NCT00265941|521532731|FG000|Overall Study|Protocol Violation|22|||
144639369|NCT00265941|521532732|FG001|Overall Study|Protocol Violation|25|||
144639370|NCT00265941|521532731|FG000|Overall Study|Lost to Follow-up|1|||
144639371|NCT00265941|521532732|FG001|Overall Study|Lost to Follow-up|1|||
144639372|NCT02886715|521532735|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144639373|NCT02886715|521532736|FG001|Overall Study|Non-Compliance With Study Drug|2|||
144639374|NCT02886715|521532737|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144639375|NCT02886715|521532735|FG000|Overall Study|Adverse Event|4|||
144639376|NCT02886715|521532736|FG001|Overall Study|Adverse Event|2|||
144639377|NCT02886715|521532737|FG002|Overall Study|Adverse Event|0|||
144639378|NCT02886715|521532735|FG000|Overall Study|Lack of Efficacy|0|||
144639379|NCT02886715|521532736|FG001|Overall Study|Lack of Efficacy|2|||
144639380|NCT02886715|521532737|FG002|Overall Study|Lack of Efficacy|1|||
144639381|NCT02886715|521532735|FG000|Overall Study|Lost to Follow-up|29|||
144639382|NCT02886715|521532736|FG001|Overall Study|Lost to Follow-up|26|||
144639383|NCT02886715|521532737|FG002|Overall Study|Lost to Follow-up|10|||
144639384|NCT02886715|521532735|FG000|Overall Study|Pregnancy|1|||
144639385|NCT02886715|521532736|FG001|Overall Study|Pregnancy|1|||
144639386|NCT02886715|521532737|FG002|Overall Study|Pregnancy|1|||
144639387|NCT02886715|521532735|FG000|Overall Study|Protocol Violation|3|||
144639388|NCT02886715|521532736|FG001|Overall Study|Protocol Violation|2|||
144639389|NCT02886715|521532737|FG002|Overall Study|Protocol Violation|1|||
144639390|NCT02886715|521532735|FG000|Overall Study|Withdrawal by Subject|20|||
144639391|NCT02886715|521532736|FG001|Overall Study|Withdrawal by Subject|18|||
144639392|NCT02886715|521532737|FG002|Overall Study|Withdrawal by Subject|5|||
144639393|NCT02886715|521532735|FG000|Overall Study|missing|7|||
144639394|NCT02886715|521532736|FG001|Overall Study|missing|2|||
144639395|NCT02886715|521532737|FG002|Overall Study|missing|2|||
144639396|NCT01676961|521532738|FG000|Overall Study|Death|3|||
144639397|NCT01676961|521532738|FG000|Overall Study|Lost to Follow-up|1|||
144639398|NCT01676961|521532738|FG000|Overall Study|Withdrawal by Subject|1|||
144639399|NCT00768560|521532741|FG000|Intervention Set 1|Adverse Event|0|||
144639400|NCT00768560|521532742|FG001|Intervention Set 1|Adverse Event|1|||
144639401|NCT00768560|521532743|FG002|Intervention Set 1|Adverse Event|0|||
144639402|NCT00768560|521532744|FG003|Intervention Set 1|Adverse Event|0|||
144639403|NCT00768560|521532745|FG004|Intervention Set 1|Adverse Event|0|||
144639404|NCT00768560|521532746|FG005|Intervention Set 1|Adverse Event|0|||
144639405|NCT00117312|521532747|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
144639406|NCT00117312|521532748|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
144639407|NCT00117312|521532749|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
144639408|NCT00117312|521532750|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
144639409|NCT00117312|521532747|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
144639410|NCT00117312|521532748|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
144639411|NCT00117312|521532749|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
144639412|NCT00117312|521532750|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
144639413|NCT00117312|521532747|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
144639414|NCT00117312|521532748|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
144639415|NCT00117312|521532749|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
144639416|NCT00117312|521532750|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
144639417|NCT00117312|521532747|FG000|Overall Study|Other|0|||
144639418|NCT00117312|521532748|FG001|Overall Study|Other|1|||
144639419|NCT00117312|521532749|FG002|Overall Study|Other|3|||
144639420|NCT00117312|521532750|FG003|Overall Study|Other|1|||
144639421|NCT00117312|521532747|FG000|Overall Study|Patient choice|0|||
144639422|NCT00117312|521532748|FG001|Overall Study|Patient choice|0|||
144639423|NCT00117312|521532749|FG002|Overall Study|Patient choice|2|||
144639424|NCT00117312|521532750|FG003|Overall Study|Patient choice|1|||
144639425|NCT00117312|521532747|FG000|Overall Study|Adverse Event|0|||
144639426|NCT00117312|521532748|FG001|Overall Study|Adverse Event|2|||
144639427|NCT00117312|521532749|FG002|Overall Study|Adverse Event|0|||
144639428|NCT00117312|521532750|FG003|Overall Study|Adverse Event|0|||
144210718|NCT02682927|519965343|FG000|Overall Study|Adverse Event|0|||
144639429|NCT00117312|521532747|FG000|Overall Study|Protocol Violation|0|||
144639430|NCT00117312|521532748|FG001|Overall Study|Protocol Violation|1|||
144639431|NCT00117312|521532749|FG002|Overall Study|Protocol Violation|3|||
144210719|NCT02682927|519965344|FG001|Overall Study|Adverse Event|0|||
144639432|NCT00117312|521532750|FG003|Overall Study|Protocol Violation|0|||
144639433|NCT00117312|521532747|FG000|Overall Study|PSA decrease <=50%|0|||
144639434|NCT00117312|521532748|FG001|Overall Study|PSA decrease <=50%|2|||
144210720|NCT02682927|519965345|FG002|Overall Study|Adverse Event|5|||
144210721|NCT02682927|519965346|FG003|Overall Study|Adverse Event|1|||
144731165|NCT00735904|521871400|FG000|Overall Study|Death|20|||
144639435|NCT00117312|521532749|FG002|Overall Study|PSA decrease <=50%|2|||
144639436|NCT00117312|521532750|FG003|Overall Study|PSA decrease <=50%|4|||
144639437|NCT00117312|521532747|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
144639438|NCT00117312|521532748|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
144731166|NCT00735904|521871400|FG000|Overall Study|Protocol Violation|1|||
144210722|NCT02682927|519965347|FG004|Overall Study|Adverse Event|0|||
144639439|NCT00117312|521532749|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
144639440|NCT00117312|521532750|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
144639441|NCT00117312|521532747|FG000|Overall Study|Hepatic abnormality|0|||
144639442|NCT00117312|521532748|FG001|Overall Study|Hepatic abnormality|1|||
144639443|NCT00117312|521532749|FG002|Overall Study|Hepatic abnormality|0|||
144639444|NCT00117312|521532750|FG003|Overall Study|Hepatic abnormality|1|||
144639445|NCT00117312|521532747|FG000|Overall Study|Withdrawal by Subject|0|||
144639446|NCT00117312|521532748|FG001|Overall Study|Withdrawal by Subject|2|||
144639447|NCT00117312|521532749|FG002|Overall Study|Withdrawal by Subject|0|||
144639448|NCT00117312|521532750|FG003|Overall Study|Withdrawal by Subject|0|||
144639449|NCT01128387|521532751|FG000|Overall Study|Physician Decision|0|||
144639450|NCT01128387|521532752|FG001|Overall Study|Physician Decision|1|||
144639451|NCT01535235|521532753|FG000|Overall Study|Adverse Event|1|||
144639452|NCT01535235|521532754|FG001|Overall Study|Adverse Event|0|||
144639453|NCT00389207|521532756|FG000|Overall Study|Adverse Event|26|||
144639454|NCT00389207|521532757|FG001|Overall Study|Adverse Event|32|||
144639455|NCT00389207|521532758|FG002|Overall Study|Adverse Event|10|||
144639456|NCT00389207|521532756|FG000|Overall Study|Protocol Violation|3|||
144639457|NCT00389207|521532757|FG001|Overall Study|Protocol Violation|1|||
144639458|NCT00389207|521532758|FG002|Overall Study|Protocol Violation|4|||
144639459|NCT00389207|521532756|FG000|Overall Study|Lost to Follow-up|12|||
144639460|NCT00389207|521532757|FG001|Overall Study|Lost to Follow-up|9|||
144639461|NCT00389207|521532758|FG002|Overall Study|Lost to Follow-up|7|||
144639462|NCT00389207|521532756|FG000|Overall Study|Withdrawal by Subject|5|||
144639463|NCT00389207|521532757|FG001|Overall Study|Withdrawal by Subject|7|||
144639464|NCT00389207|521532758|FG002|Overall Study|Withdrawal by Subject|11|||
144639465|NCT00389207|521532756|FG000|Overall Study|Other|17|||
144639466|NCT00389207|521532757|FG001|Overall Study|Other|23|||
144639467|NCT00389207|521532758|FG002|Overall Study|Other|9|||
144639468|NCT00509106|521532761|FG000|Overall Study|Adverse Event|3|||
144639469|NCT00509106|521532762|FG001|Overall Study|Adverse Event|2|||
144639470|NCT00509106|521532761|FG000|Overall Study|Noncompliance|0|||
144639471|NCT00509106|521532762|FG001|Overall Study|Noncompliance|1|||
144639472|NCT00509106|521532761|FG000|Overall Study|At the request of sponsor/investigator|1|||
144639473|NCT00509106|521532762|FG001|Overall Study|At the request of sponsor/investigator|2|||
144639474|NCT00509106|521532761|FG000|Overall Study|Withdrew consent|4|||
144639475|NCT00509106|521532762|FG001|Overall Study|Withdrew consent|8|||
144639476|NCT00509106|521532761|FG000|Overall Study|Lost to Follow-up|16|||
144639477|NCT00509106|521532762|FG001|Overall Study|Lost to Follow-up|10|||
144639478|NCT00509106|521532761|FG000|Overall Study|Other|1|||
144639479|NCT00509106|521532762|FG001|Overall Study|Other|0|||
144639480|NCT00509106|521532761|FG000|Overall Study|Death|6|||
144639481|NCT00509106|521532762|FG001|Overall Study|Death|6|||
144639482|NCT01073943|521532775|FG000|Overall Study|Withdrawal by Subject|8|||
144639483|NCT01073943|521532776|FG001|Overall Study|Withdrawal by Subject|2|||
144639484|NCT01073943|521532775|FG000|Overall Study|Protocol Violation|2|||
144639485|NCT01073943|521532776|FG001|Overall Study|Protocol Violation|1|||
144639486|NCT01073943|521532775|FG000|Overall Study|Adverse Event|1|||
144639487|NCT01073943|521532776|FG001|Overall Study|Adverse Event|1|||
144639488|NCT01073943|521532775|FG000|Overall Study|Lost to Follow-up|0|||
144639489|NCT01073943|521532776|FG001|Overall Study|Lost to Follow-up|2|||
144639490|NCT01073943|521532775|FG000|Overall Study|Power outage; colonoscopy not done|1|||
144639491|NCT01073943|521532776|FG001|Overall Study|Power outage; colonoscopy not done|0|||
144639492|NCT01073943|521532775|FG000|Overall Study|Subject forgot|0|||
144639493|NCT01073943|521532776|FG001|Overall Study|Subject forgot|1|||
144639494|NCT01073943|521532775|FG000|Overall Study|Unable to return for follow-up|0|||
144639495|NCT01073943|521532776|FG001|Overall Study|Unable to return for follow-up|1|||
144639496|NCT01073943|521532775|FG000|Overall Study|Could not tolerate prep|1|||
144639497|NCT01073943|521532776|FG001|Overall Study|Could not tolerate prep|0|||
144639498|NCT02371629|521532780|FG000|Overall Study|Patient decision|14|||
144639499|NCT02371629|521532781|FG001|Overall Study|Patient decision|10|||
144639500|NCT02371629|521532780|FG000|Overall Study|Adverse Event|8|||
144639501|NCT02371629|521532781|FG001|Overall Study|Adverse Event|8|||
144639502|NCT02371629|521532780|FG000|Overall Study|Physician Decision|2|||
144639503|NCT02371629|521532781|FG001|Overall Study|Physician Decision|3|||
144639504|NCT02371629|521532780|FG000|Overall Study|Death|1|||
144639505|NCT02371629|521532781|FG001|Overall Study|Death|1|||
144639506|NCT02371629|521532780|FG000|Overall Study|Noncompliance with study treatment|1|||
144639507|NCT02371629|521532781|FG001|Overall Study|Noncompliance with study treatment|0|||
144639508|NCT02371629|521532780|FG000|Overall Study|Lack of Efficacy|0|||
144639509|NCT02371629|521532781|FG001|Overall Study|Lack of Efficacy|2|||
144639510|NCT02371629|521532780|FG000|Overall Study|Protocol deviation|0|||
144639511|NCT02371629|521532781|FG001|Overall Study|Protocol deviation|1|||
144210723|NCT02682927|519965348|FG005|Overall Study|Adverse Event|2|||
144639512|NCT01051739|521532782|FG000|Overall Study|Death|3|||
144639513|NCT01051739|521532783|FG001|Overall Study|Death|3|||
144639514|NCT01051739|521532782|FG000|Overall Study|Withdrawal by Subject|25|||
144210724|NCT02682927|519965343|FG000|Overall Study|Death|0|||
144210725|NCT02682927|519965344|FG001|Overall Study|Death|0|||
144210726|NCT02682927|519965345|FG002|Overall Study|Death|0|||
144210727|NCT02682927|519965346|FG003|Overall Study|Death|1|||
144210728|NCT02682927|519965347|FG004|Overall Study|Death|0|||
144639515|NCT01051739|521532783|FG001|Overall Study|Withdrawal by Subject|10|||
144639516|NCT00824421|521532784|FG000|Overall Study|Adverse Event|6|||
144639517|NCT00824421|521532785|FG001|Overall Study|Adverse Event|6|||
144639518|NCT00824421|521532786|FG002|Overall Study|Adverse Event|6|||
144639519|NCT00824421|521532784|FG000|Overall Study|Death|0|||
144639520|NCT00824421|521532785|FG001|Overall Study|Death|1|||
144639521|NCT00824421|521532786|FG002|Overall Study|Death|0|||
144639522|NCT00824421|521532784|FG000|Overall Study|Lack of Efficacy|5|||
144639523|NCT00824421|521532785|FG001|Overall Study|Lack of Efficacy|7|||
144639524|NCT00824421|521532786|FG002|Overall Study|Lack of Efficacy|4|||
144639525|NCT00824421|521532784|FG000|Overall Study|Lost to Follow-up|2|||
144639526|NCT00824421|521532785|FG001|Overall Study|Lost to Follow-up|3|||
144639527|NCT00824421|521532786|FG002|Overall Study|Lost to Follow-up|0|||
144639528|NCT00824421|521532784|FG000|Overall Study|Pregnancy|1|||
144639529|NCT00824421|521532785|FG001|Overall Study|Pregnancy|0|||
144639530|NCT00824421|521532786|FG002|Overall Study|Pregnancy|1|||
144639531|NCT00824421|521532784|FG000|Overall Study|Withdrawal by Subject|2|||
144639532|NCT00824421|521532785|FG001|Overall Study|Withdrawal by Subject|3|||
144639533|NCT00824421|521532786|FG002|Overall Study|Withdrawal by Subject|3|||
144639534|NCT00824421|521532784|FG000|Overall Study|Randomized but not Treated|1|||
144639535|NCT00824421|521532785|FG001|Overall Study|Randomized but not Treated|1|||
144639536|NCT00824421|521532786|FG002|Overall Study|Randomized but not Treated|0|||
144639537|NCT00824421|521532784|FG000|Overall Study|Other|0|||
144639538|NCT00824421|521532785|FG001|Overall Study|Other|1|||
144639539|NCT00824421|521532786|FG002|Overall Study|Other|0|||
144639540|NCT01794780|521532788|FG000|Overall Study|Adverse Event|0|||
144639541|NCT01794780|521532789|FG001|Overall Study|Adverse Event|1|||
144639542|NCT01794780|521532790|FG002|Overall Study|Adverse Event|2|||
144639543|NCT01794780|521532791|FG003|Overall Study|Adverse Event|0|||
144639544|NCT01794780|521532792|FG004|Overall Study|Adverse Event|0|||
144639545|NCT01794780|521532793|FG005|Overall Study|Adverse Event|0|||
144639546|NCT01794780|521532794|FG006|Overall Study|Adverse Event|0|||
144639547|NCT01794780|521532795|FG007|Overall Study|Adverse Event|0|||
144639548|NCT01794780|521532788|FG000|Overall Study|Death|0|||
144639549|NCT01794780|521532789|FG001|Overall Study|Death|2|||
144639550|NCT01794780|521532790|FG002|Overall Study|Death|14|||
144639551|NCT01794780|521532791|FG003|Overall Study|Death|1|||
144639552|NCT01794780|521532792|FG004|Overall Study|Death|0|||
144639553|NCT01794780|521532793|FG005|Overall Study|Death|9|||
144639554|NCT01794780|521532794|FG006|Overall Study|Death|4|||
144639555|NCT01794780|521532795|FG007|Overall Study|Death|0|||
144639556|NCT01794780|521532788|FG000|Overall Study|Lost to Follow-up|10|||
144639557|NCT01794780|521532789|FG001|Overall Study|Lost to Follow-up|64|||
144639558|NCT01794780|521532790|FG002|Overall Study|Lost to Follow-up|165|||
144639559|NCT01794780|521532791|FG003|Overall Study|Lost to Follow-up|53|||
144639560|NCT01794780|521532792|FG004|Overall Study|Lost to Follow-up|2|||
144639561|NCT01794780|521532793|FG005|Overall Study|Lost to Follow-up|99|||
144639562|NCT01794780|521532794|FG006|Overall Study|Lost to Follow-up|30|||
144639563|NCT01794780|521532795|FG007|Overall Study|Lost to Follow-up|5|||
144639564|NCT01794780|521532788|FG000|Overall Study|Withdrew informed consent|7|||
144639565|NCT01794780|521532789|FG001|Overall Study|Withdrew informed consent|17|||
144639566|NCT01794780|521532790|FG002|Overall Study|Withdrew informed consent|36|||
144639567|NCT01794780|521532791|FG003|Overall Study|Withdrew informed consent|9|||
144639568|NCT01794780|521532792|FG004|Overall Study|Withdrew informed consent|0|||
144639569|NCT01794780|521532793|FG005|Overall Study|Withdrew informed consent|48|||
144639570|NCT01794780|521532794|FG006|Overall Study|Withdrew informed consent|4|||
144210729|NCT02682927|519965348|FG005|Overall Study|Death|0|||
144639571|NCT01794780|521532795|FG007|Overall Study|Withdrew informed consent|3|||
144639572|NCT01794780|521532788|FG000|Overall Study|Other|0|||
144210730|NCT02682927|519965343|FG000|Overall Study|Lack of Efficacy|1|||
144639573|NCT01794780|521532789|FG001|Overall Study|Other|12|||
144639574|NCT01794780|521532790|FG002|Overall Study|Other|25|||
144639575|NCT01794780|521532791|FG003|Overall Study|Other|20|||
144210731|NCT02682927|519965344|FG001|Overall Study|Lack of Efficacy|0|||
144210732|NCT02682927|519965345|FG002|Overall Study|Lack of Efficacy|0|||
144639576|NCT01794780|521532792|FG004|Overall Study|Other|1|||
144639577|NCT01794780|521532793|FG005|Overall Study|Other|24|||
144639578|NCT01794780|521532794|FG006|Overall Study|Other|4|||
144639579|NCT01794780|521532795|FG007|Overall Study|Other|1|||
144639580|NCT02499952|521532796|FG000|Overall Study|Lost to Follow-up|1|||
144639581|NCT02499952|521532796|FG000|Overall Study|Death|9|||
144210733|NCT02682927|519965346|FG003|Overall Study|Lack of Efficacy|1|||
144639582|NCT03527043|521532797|FG000|Overall Study|Withdrawal by Subject|1|||
144639583|NCT03527043|521532798|FG001|Overall Study|Withdrawal by Subject|0|||
144639584|NCT02120417|521532800|FG000|Overall Study|Death|5|||
144639585|NCT02120417|521532801|FG001|Overall Study|Death|1|||
144639586|NCT02120417|521532800|FG000|Overall Study|Adverse Event|3|||
144639587|NCT02120417|521532801|FG001|Overall Study|Adverse Event|9|||
144639588|NCT02120417|521532800|FG000|Overall Study|Participant decision|4|||
144639589|NCT02120417|521532801|FG001|Overall Study|Participant decision|4|||
144639590|NCT02120417|521532800|FG000|Overall Study|Disease progression|41|||
144639591|NCT02120417|521532801|FG001|Overall Study|Disease progression|45|||
144639592|NCT02120417|521532800|FG000|Overall Study|Noncompliance with study treatment|0|||
144639593|NCT02120417|521532801|FG001|Overall Study|Noncompliance with study treatment|2|||
144639594|NCT02120417|521532800|FG000|Overall Study|Physician Decision|2|||
144639595|NCT02120417|521532801|FG001|Overall Study|Physician Decision|3|||
144639596|NCT02120417|521532800|FG000|Overall Study|Other unspecified|5|||
144639597|NCT02120417|521532801|FG001|Overall Study|Other unspecified|4|||
144639598|NCT02286102|521532802|FG000|Overall Study|Screen Failure|1|||
144639599|NCT02286102|521532803|FG001|Overall Study|Screen Failure|1|||
144639600|NCT00927485|521532804|FG000|Overall Study|Adverse Event|4|||
144639601|NCT00927485|521532805|FG001|Overall Study|Adverse Event|2|||
144639602|NCT00927485|521532804|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
144639603|NCT00927485|521532805|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
144639604|NCT00659438|521532806|FG000|Overall Study|Withdrawal by Subject|2|||
144639605|NCT00659438|521532807|FG001|Overall Study|Withdrawal by Subject|2|||
144210734|NCT02682927|519965347|FG004|Overall Study|Lack of Efficacy|0|||
144210735|NCT02682927|519965348|FG005|Overall Study|Lack of Efficacy|0|||
144210736|NCT02682927|519965343|FG000|Overall Study|Other|0|||
144210737|NCT02682927|519965344|FG001|Overall Study|Other|0|||
144210738|NCT02682927|519965345|FG002|Overall Study|Other|0|||
144210739|NCT02682927|519965346|FG003|Overall Study|Other|2|||
144210740|NCT02682927|519965347|FG004|Overall Study|Other|0|||
144210741|NCT02682927|519965348|FG005|Overall Study|Other|0|||
144210742|NCT02682927|519965343|FG000|Overall Study|Withdrawal by Subject|2|||
144210743|NCT02682927|519965344|FG001|Overall Study|Withdrawal by Subject|0|||
144210744|NCT02682927|519965345|FG002|Overall Study|Withdrawal by Subject|1|||
144210745|NCT02682927|519965346|FG003|Overall Study|Withdrawal by Subject|0|||
144210746|NCT02682927|519965347|FG004|Overall Study|Withdrawal by Subject|1|||
144639606|NCT00659438|521532806|FG000|Overall Study|Death|11|||
144639607|NCT00659438|521532807|FG001|Overall Study|Death|6|||
144639608|NCT00659438|521532806|FG000|Overall Study|Lost to Follow-up|1|||
144639609|NCT00659438|521532807|FG001|Overall Study|Lost to Follow-up|0|||
144639610|NCT00201851|521532808|FG000|Overall Study|Lost to Follow-up|2|||
144639611|NCT00201851|521532809|FG001|Overall Study|Lost to Follow-up|1|||
144639612|NCT00201851|521532810|FG002|Overall Study|Lost to Follow-up|0|||
144639613|NCT00201851|521532808|FG000|Overall Study|Ineligible post enrollment|6|||
144639614|NCT00201851|521532809|FG001|Overall Study|Ineligible post enrollment|1|||
144639615|NCT00201851|521532810|FG002|Overall Study|Ineligible post enrollment|1|||
144639616|NCT02469246|521532811|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
144639617|NCT02469246|521532812|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
144639618|NCT02469246|521532811|FG000|Double-Blind Phase|Adverse Event|12|||
144639619|NCT02469246|521532812|FG001|Double-Blind Phase|Adverse Event|9|||
144639620|NCT02469246|521532811|FG000|Double-Blind Phase|Death|2|||
144639621|NCT02469246|521532812|FG001|Double-Blind Phase|Death|0|||
144639622|NCT02469246|521532811|FG000|Double-Blind Phase|Lack of Efficacy|2|||
144639623|NCT02469246|521532812|FG001|Double-Blind Phase|Lack of Efficacy|1|||
144639624|NCT02469246|521532811|FG000|Double-Blind Phase|Investigator's Discretion|8|||
144639625|NCT02469246|521532812|FG001|Double-Blind Phase|Investigator's Discretion|8|||
144639626|NCT02469246|521532811|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
144639627|NCT02469246|521532812|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
144639628|NCT02469246|521532811|FG000|Double-Blind Phase|Protocol Violation|1|||
144639629|NCT02469246|521532812|FG001|Double-Blind Phase|Protocol Violation|1|||
144639630|NCT02469246|521532811|FG000|Double-Blind Phase|Withdrew Consent|25|||
144639631|NCT02469246|521532812|FG001|Double-Blind Phase|Withdrew Consent|25|||
144639632|NCT02469246|521532811|FG000|Double-Blind Phase|Lost to Follow-up|9|||
144639633|NCT02469246|521532812|FG001|Double-Blind Phase|Lost to Follow-up|5|||
144639634|NCT00636818|521532816|FG000|Overall Study|Adverse Event|1|||
144639635|NCT00636818|521532816|FG000|Overall Study|Lost to Follow-up|2|||
144639636|NCT00636818|521532816|FG000|Overall Study|Entry Criteria Exclusion|3|||
144639637|NCT00636818|521532816|FG000|Overall Study|Protocol Violation|1|||
144639638|NCT00636818|521532816|FG000|Overall Study|Withdrawal by Subject|4|||
144639639|NCT00702143|521532822|FG000|Overall Study|Lost to Follow-up|0|||
144639640|NCT00702143|521532823|FG001|Overall Study|Lost to Follow-up|0|||
144210747|NCT02682927|519965348|FG005|Overall Study|Withdrawal by Subject|1|||
144639641|NCT00702143|521532824|FG002|Overall Study|Lost to Follow-up|1|||
144639642|NCT03871491|521532825|FG000|Overall Study|Withdrawal by Subject|14|||
144639643|NCT03871491|521532826|FG001|Overall Study|Withdrawal by Subject|14|||
144639644|NCT03871491|521532827|FG002|Overall Study|Withdrawal by Subject|14|||
144639645|NCT03871491|521532828|FG003|Overall Study|Withdrawal by Subject|14|||
144639646|NCT03871491|521532825|FG000|Overall Study|Physician Decision|0|||
144639647|NCT03871491|521532826|FG001|Overall Study|Physician Decision|0|||
144639648|NCT03871491|521532827|FG002|Overall Study|Physician Decision|1|||
144639649|NCT03871491|521532828|FG003|Overall Study|Physician Decision|1|||
144210748|NCT00340678|519965355|FG000|Overall Study|Lost to Follow-up|1|||
144639650|NCT03871491|521532825|FG000|Overall Study|Lost to Follow-up|50|||
144639651|NCT03871491|521532826|FG001|Overall Study|Lost to Follow-up|15|||
144639652|NCT03871491|521532827|FG002|Overall Study|Lost to Follow-up|36|||
144639653|NCT03871491|521532828|FG003|Overall Study|Lost to Follow-up|11|||
144639654|NCT04091217|521532831|FG000|Overall Study|Lost to Follow-up|2|||
144639655|NCT01624142|521532832|FG000|Overall Study|Withdrawal by Subject|14|||
144639656|NCT01624142|521532833|FG001|Overall Study|Withdrawal by Subject|4|||
144639657|NCT01624142|521532832|FG000|Overall Study|Death|3|||
144639658|NCT01624142|521532833|FG001|Overall Study|Death|6|||
144639659|NCT01624142|521532832|FG000|Overall Study|Study Closure|12|||
144639660|NCT01624142|521532833|FG001|Overall Study|Study Closure|6|||
144639661|NCT01624142|521532832|FG000|Overall Study|Lost to Follow-up|2|||
144639662|NCT01624142|521532833|FG001|Overall Study|Lost to Follow-up|0|||
144639663|NCT01624142|521532832|FG000|Overall Study|Other|1|||
144639664|NCT01624142|521532833|FG001|Overall Study|Other|0|||
144639665|NCT02722044|521532834|FG000|Overall Study|Adverse Event|2|||
144639666|NCT02722044|521532834|FG000|Overall Study|Physician Decision|1|||
144639667|NCT02722044|521532834|FG000|Overall Study|Withdrawal by Subject|1|||
144639668|NCT02722044|521532834|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
144639669|NCT00741819|521532835|FG000|Overall Study|Adverse Event|3|||
144639670|NCT00741819|521532835|FG000|Overall Study|Withdrawal by Subject|3|||
144639671|NCT00741819|521532835|FG000|Overall Study|Death|1|||
144639672|NCT00741819|521532835|FG000|Overall Study|Disease progression|1|||
144639673|NCT01126580|521532836|FG000|Overall Study|Adverse Event|14|||
144639674|NCT01126580|521532837|FG001|Overall Study|Adverse Event|8|||
144639675|NCT01126580|521532838|FG002|Overall Study|Adverse Event|12|||
144639676|NCT01126580|521532836|FG000|Overall Study|Withdrawal by Subject|11|||
144639677|NCT01126580|521532837|FG001|Overall Study|Withdrawal by Subject|19|||
144639678|NCT01126580|521532838|FG002|Overall Study|Withdrawal by Subject|14|||
144639679|NCT01126580|521532836|FG000|Overall Study|Sponsor Decision|5|||
144639680|NCT01126580|521532837|FG001|Overall Study|Sponsor Decision|4|||
144639681|NCT01126580|521532838|FG002|Overall Study|Sponsor Decision|7|||
144639682|NCT01126580|521532836|FG000|Overall Study|Physician Decision|1|||
144639683|NCT01126580|521532837|FG001|Overall Study|Physician Decision|1|||
144639684|NCT01126580|521532838|FG002|Overall Study|Physician Decision|2|||
144639685|NCT01126580|521532836|FG000|Overall Study|Entry Criteria Not Met|1|||
144639686|NCT01126580|521532837|FG001|Overall Study|Entry Criteria Not Met|1|||
144639687|NCT01126580|521532838|FG002|Overall Study|Entry Criteria Not Met|2|||
144639688|NCT01126580|521532836|FG000|Overall Study|Lack of Efficacy|2|||
144639689|NCT01126580|521532837|FG001|Overall Study|Lack of Efficacy|3|||
144639690|NCT01126580|521532838|FG002|Overall Study|Lack of Efficacy|4|||
144639691|NCT01126580|521532836|FG000|Overall Study|Protocol Violation|0|||
144639692|NCT01126580|521532837|FG001|Overall Study|Protocol Violation|1|||
144639693|NCT01126580|521532838|FG002|Overall Study|Protocol Violation|2|||
144639694|NCT01126580|521532836|FG000|Overall Study|Lost to Follow-up|15|||
144639695|NCT01126580|521532837|FG001|Overall Study|Lost to Follow-up|13|||
144639696|NCT01126580|521532838|FG002|Overall Study|Lost to Follow-up|9|||
144639697|NCT01126580|521532836|FG000|Overall Study|Treatment Non-compliance|0|||
144639698|NCT01126580|521532837|FG001|Overall Study|Treatment Non-compliance|2|||
144639699|NCT01126580|521532838|FG002|Overall Study|Treatment Non-compliance|3|||
144639700|NCT01731002|521532839|FG000|Overall Study|Adverse Event|0|||
144639701|NCT01731002|521532840|FG001|Overall Study|Adverse Event|2|||
144639702|NCT01731002|521532841|FG002|Overall Study|Adverse Event|2|||
144639703|NCT01731002|521532839|FG000|Overall Study|Non-Compliant|0|||
144639704|NCT01731002|521532840|FG001|Overall Study|Non-Compliant|1|||
144639705|NCT01731002|521532841|FG002|Overall Study|Non-Compliant|0|||
144639706|NCT01731002|521532839|FG000|Overall Study|Lost to Follow-up|1|||
144639707|NCT01731002|521532840|FG001|Overall Study|Lost to Follow-up|0|||
144639708|NCT01731002|521532841|FG002|Overall Study|Lost to Follow-up|0|||
144639709|NCT01731002|521532839|FG000|Overall Study|Test Agent Discontinuation|0|||
144639710|NCT01731002|521532840|FG001|Overall Study|Test Agent Discontinuation|1|||
144639711|NCT01731002|521532841|FG002|Overall Study|Test Agent Discontinuation|0|||
144639712|NCT01731002|521532839|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
144639713|NCT01731002|521532840|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
144639714|NCT01731002|521532841|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
144639715|NCT01731002|521532839|FG000|Overall Study|Elevated IOP|1|||
144639716|NCT01731002|521532840|FG001|Overall Study|Elevated IOP|0|||
144639717|NCT01731002|521532841|FG002|Overall Study|Elevated IOP|0|||
144639718|NCT01731002|521532839|FG000|Overall Study|Inappropriate use of study medications|0|||
144639719|NCT01731002|521532840|FG001|Overall Study|Inappropriate use of study medications|0|||
144639720|NCT01731002|521532841|FG002|Overall Study|Inappropriate use of study medications|1|||
144639721|NCT00947349|521532842|FG000|Triple Treatment Combination Period|Adverse Event|0|||
144639722|NCT00947349|521532843|FG001|Triple Treatment Combination Period|Adverse Event|1|||
144639723|NCT00947349|521532844|FG002|Triple Treatment Combination Period|Adverse Event|0|||
144639724|NCT00947349|521532845|FG003|Triple Treatment Combination Period|Adverse Event|0|||
144639725|NCT00947349|521532842|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
144639726|NCT00947349|521532843|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
144639727|NCT00947349|521532844|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
144210749|NCT00340678|519965356|FG001|Overall Study|Lost to Follow-up|0|||
144210750|NCT00340678|519965357|FG002|Overall Study|Lost to Follow-up|0|||
144210751|NCT00340678|519965358|FG003|Overall Study|Lost to Follow-up|0|||
144210752|NCT00278889|519965359|FG000|Overall Study|Withdrawal by Subject|0|||
144210753|NCT00278889|519965360|FG001|Overall Study|Withdrawal by Subject|5|||
144210754|NCT00278889|519965361|FG002|Overall Study|Withdrawal by Subject|3|||
144210755|NCT00278889|519965359|FG000|Overall Study|Lost to Follow-up|1|||
144210756|NCT00278889|519965360|FG001|Overall Study|Lost to Follow-up|1|||
144210757|NCT00278889|519965361|FG002|Overall Study|Lost to Follow-up|0|||
144210758|NCT00278889|519965359|FG000|Overall Study|Death|24|||
144210759|NCT00278889|519965360|FG001|Overall Study|Death|21|||
144210760|NCT00278889|519965361|FG002|Overall Study|Death|17|||
144210761|NCT03654599|519965362|FG000|Overall Study|Lost to Follow-up|14|||
144210762|NCT03654599|519965363|FG001|Overall Study|Lost to Follow-up|12|||
144210763|NCT03654599|519965362|FG000|Overall Study|Death|8|||
144210764|NCT03654599|519965363|FG001|Overall Study|Death|6|||
144210765|NCT03654599|519965362|FG000|Overall Study|Withdrawal by Subject|6|||
144210766|NCT03654599|519965363|FG001|Overall Study|Withdrawal by Subject|4|||
144639728|NCT00947349|521532845|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
144639729|NCT00947349|521532842|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
144639730|NCT00947349|521532843|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
144639731|NCT00947349|521532844|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
144639732|NCT00947349|521532845|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
144639733|NCT00947349|521532842|FG000|Overall Study Standard of Care|Other|0|||
144639734|NCT00947349|521532843|FG001|Overall Study Standard of Care|Other|0|||
144639735|NCT00947349|521532844|FG002|Overall Study Standard of Care|Other|0|||
144639736|NCT00947349|521532845|FG003|Overall Study Standard of Care|Other|1|||
144639737|NCT03929250|521532848|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
144639738|NCT03929250|521532849|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
144639739|NCT03277196|521532851|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
144639740|NCT03277196|521532851|FG000|Overall Study|Lost to Follow-up|3|||
144639741|NCT03277196|521532851|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
144639742|NCT03277196|521532851|FG000|Overall Study|Other|2|||
144639743|NCT01024244|521534580|FG000|Overall Study|Adverse Event|1|||
144639744|NCT01024244|521534581|FG001|Overall Study|Adverse Event|2|||
144639745|NCT01024244|521534582|FG002|Overall Study|Adverse Event|0|||
144639746|NCT01024244|521534583|FG003|Overall Study|Adverse Event|1|||
144639747|NCT01024244|521534584|FG004|Overall Study|Adverse Event|2|||
144639748|NCT01024244|521534580|FG000|Overall Study|Entry Criteria Not Met|0|||
144639749|NCT01024244|521534581|FG001|Overall Study|Entry Criteria Not Met|1|||
144639750|NCT01024244|521534582|FG002|Overall Study|Entry Criteria Not Met|0|||
144639751|NCT01024244|521534583|FG003|Overall Study|Entry Criteria Not Met|0|||
144639752|NCT01024244|521534584|FG004|Overall Study|Entry Criteria Not Met|0|||
144639753|NCT01024244|521534580|FG000|Overall Study|Lack of Efficacy|1|||
144639754|NCT01024244|521534581|FG001|Overall Study|Lack of Efficacy|0|||
144639755|NCT01024244|521534582|FG002|Overall Study|Lack of Efficacy|0|||
144639756|NCT01024244|521534583|FG003|Overall Study|Lack of Efficacy|0|||
144639757|NCT01024244|521534584|FG004|Overall Study|Lack of Efficacy|0|||
144639758|NCT01024244|521534580|FG000|Overall Study|Protocol Violation|1|||
144639759|NCT01024244|521534581|FG001|Overall Study|Protocol Violation|0|||
144639760|NCT01024244|521534582|FG002|Overall Study|Protocol Violation|0|||
144639761|NCT01024244|521534583|FG003|Overall Study|Protocol Violation|0|||
144639762|NCT01024244|521534584|FG004|Overall Study|Protocol Violation|2|||
144639763|NCT01024244|521534580|FG000|Overall Study|Sponsor Decision|14|||
144639764|NCT01024244|521534581|FG001|Overall Study|Sponsor Decision|7|||
144639765|NCT01024244|521534582|FG002|Overall Study|Sponsor Decision|14|||
144639766|NCT01024244|521534583|FG003|Overall Study|Sponsor Decision|12|||
144639767|NCT01024244|521534584|FG004|Overall Study|Sponsor Decision|10|||
144639768|NCT01024244|521534580|FG000|Overall Study|Withdrawal by Subject|0|||
144639769|NCT01024244|521534581|FG001|Overall Study|Withdrawal by Subject|1|||
144639770|NCT01024244|521534582|FG002|Overall Study|Withdrawal by Subject|0|||
144639771|NCT01024244|521534583|FG003|Overall Study|Withdrawal by Subject|0|||
144639772|NCT01024244|521534584|FG004|Overall Study|Withdrawal by Subject|0|||
144639773|NCT00473694|521534588|FG000|Overall Study|Adverse Event|0|||
144639774|NCT00473694|521534589|FG001|Overall Study|Adverse Event|1|||
144639775|NCT00473694|521534590|FG002|Overall Study|Adverse Event|0|||
144639776|NCT00473694|521534591|FG003|Overall Study|Adverse Event|0|||
144639777|NCT00473694|521534588|FG000|Overall Study|Participants did not receive treatment|11|||
144639778|NCT00473694|521534589|FG001|Overall Study|Participants did not receive treatment|3|||
144639779|NCT00473694|521534590|FG002|Overall Study|Participants did not receive treatment|5|||
144639780|NCT00473694|521534591|FG003|Overall Study|Participants did not receive treatment|6|||
144639781|NCT00473694|521534588|FG000|Overall Study|Lost to Follow-up|0|||
144639782|NCT00473694|521534589|FG001|Overall Study|Lost to Follow-up|0|||
144639783|NCT00473694|521534590|FG002|Overall Study|Lost to Follow-up|0|||
144639784|NCT00473694|521534591|FG003|Overall Study|Lost to Follow-up|1|||
144210767|NCT01243775|519965364|FG000|Overall Study|Withdrawal by Subject|2|||
144210768|NCT05833139|519967934|FG000|Study Period 2|Adverse Event|1|||
144639785|NCT02468193|521534592|FG000|Overall Study|Adverse Event|4|||
144639786|NCT02468193|521534592|FG000|Overall Study|Subject/ Guardian decision|2|||
144639787|NCT00742781|521534593|FG000|Overall Study|Withdrawal by Subject|3|||
144639788|NCT03874234|521534594|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639789|NCT03874234|521534595|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639790|NCT03874234|521534596|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639791|NCT03874234|521534597|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
144639792|NCT03874234|521534598|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639793|NCT03874234|521534599|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639794|NCT03874234|521534600|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639795|NCT03874234|521534601|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639796|NCT03874234|521534602|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639797|NCT03874234|521534603|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639798|NCT03874234|521534604|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639799|NCT03874234|521534605|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639800|NCT03874234|521534606|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
144639801|NCT03874234|521534594|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
144639802|NCT03874234|521534595|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639803|NCT03874234|521534596|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639804|NCT03874234|521534597|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639805|NCT03874234|521534598|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639806|NCT03874234|521534599|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639807|NCT03874234|521534600|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639808|NCT03874234|521534601|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639809|NCT03874234|521534602|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639810|NCT03874234|521534603|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639811|NCT03874234|521534604|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639812|NCT03874234|521534605|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639813|NCT03874234|521534606|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
144639814|NCT03874234|521534594|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639815|NCT03874234|521534595|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639816|NCT03874234|521534596|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639817|NCT03874234|521534597|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
144639818|NCT03874234|521534598|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639819|NCT03874234|521534599|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639820|NCT03874234|521534600|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639821|NCT03874234|521534601|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639822|NCT03874234|521534602|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639823|NCT03874234|521534603|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639824|NCT03874234|521534604|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639825|NCT03874234|521534605|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639826|NCT03874234|521534606|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
144639827|NCT03874234|521534594|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639828|NCT03874234|521534595|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639829|NCT03874234|521534596|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639830|NCT03874234|521534597|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639831|NCT03874234|521534598|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
144639832|NCT03874234|521534599|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639833|NCT03874234|521534600|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639834|NCT03874234|521534601|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639835|NCT03874234|521534602|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639836|NCT03874234|521534603|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639837|NCT03874234|521534604|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639838|NCT03874234|521534605|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639839|NCT03874234|521534606|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
144639840|NCT03874234|521534594|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639841|NCT03874234|521534595|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639842|NCT03874234|521534596|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639843|NCT03874234|521534597|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639844|NCT03874234|521534598|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639845|NCT03874234|521534599|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639846|NCT03874234|521534600|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639847|NCT03874234|521534601|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
144639848|NCT03874234|521534602|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144263213|NCT01261390|520163891|FG000|Overall Study|Significant Concurrent Illness|1|||
144263214|NCT01261390|520163892|FG001|Overall Study|Significant Concurrent Illness|0|||
144639849|NCT03874234|521534603|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639850|NCT03874234|521534604|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639851|NCT03874234|521534605|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639852|NCT03874234|521534606|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
144639853|NCT03874234|521534594|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639854|NCT03874234|521534595|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639855|NCT03874234|521534596|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639856|NCT03874234|521534597|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639857|NCT03874234|521534598|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
144639858|NCT03874234|521534599|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
144639859|NCT03874234|521534600|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639860|NCT03874234|521534601|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639861|NCT03874234|521534602|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639862|NCT03874234|521534603|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639863|NCT03874234|521534604|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639864|NCT03874234|521534605|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639865|NCT03874234|521534606|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
144639866|NCT03874234|521534594|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639867|NCT03874234|521534595|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639868|NCT03874234|521534596|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639869|NCT03874234|521534597|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639870|NCT03874234|521534598|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639871|NCT03874234|521534599|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639872|NCT03874234|521534600|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
144639873|NCT03874234|521534601|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639874|NCT03874234|521534602|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639875|NCT03874234|521534603|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639876|NCT03874234|521534604|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639877|NCT03874234|521534605|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639878|NCT03874234|521534606|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
144639879|NCT03874234|521534594|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639880|NCT03874234|521534595|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639881|NCT03874234|521534596|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639882|NCT03874234|521534597|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639883|NCT03874234|521534598|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
144639884|NCT03874234|521534599|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639885|NCT03874234|521534600|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639886|NCT03874234|521534601|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639887|NCT03874234|521534602|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639888|NCT03874234|521534603|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639889|NCT03874234|521534604|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639890|NCT03874234|521534605|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639891|NCT03874234|521534606|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
144639892|NCT01896232|521534607|FG000|Overall Study|Death|6|||
144639893|NCT01896232|521534608|FG001|Overall Study|Death|10|||
144639894|NCT01896232|521534607|FG000|Overall Study|Withdrawal by Subject|32|||
144639895|NCT01896232|521534608|FG001|Overall Study|Withdrawal by Subject|31|||
144639896|NCT01896232|521534607|FG000|Overall Study|Sponsor Decision|2|||
144639897|NCT01896232|521534608|FG001|Overall Study|Sponsor Decision|0|||
144639898|NCT01896232|521534607|FG000|Overall Study|Lost to Follow-up|9|||
144639899|NCT01896232|521534608|FG001|Overall Study|Lost to Follow-up|12|||
144639900|NCT03816995|521534617|FG000|Overall Study|Withdrawal by Subject|3|||
144639901|NCT03816995|521534618|FG001|Overall Study|Withdrawal by Subject|1|||
144639902|NCT03816995|521534617|FG000|Overall Study|Cancelled Surgery|8|||
144639903|NCT03816995|521534618|FG001|Overall Study|Cancelled Surgery|12|||
144639904|NCT03816995|521534617|FG000|Overall Study|No wound protector used|11|||
144731167|NCT00735904|521871400|FG000|Overall Study|Withdrawal by Subject|1|||
144731168|NCT00735904|521871400|FG000|Overall Study|Study Terminated by Sponsor|5|||
144731169|NCT00735904|521871400|FG000|Overall Study|Other|8|||
144731170|NCT01171963|521871405|FG000|Overall Study|Adverse Event|10|||
144731171|NCT01171963|521871406|FG001|Overall Study|Adverse Event|15|||
144731172|NCT01171963|521871405|FG000|Overall Study|Lost to Follow-up|23|||
144731173|NCT01171963|521871406|FG001|Overall Study|Lost to Follow-up|24|||
144731174|NCT01171963|521871405|FG000|Overall Study|Other - diarrhoea|1|||
144731175|NCT01171963|521871406|FG001|Overall Study|Other - diarrhoea|0|||
144731176|NCT01171963|521871405|FG000|Overall Study|Withdrawal by Subject|114|||
144263215|NCT01261390|520163893|FG002|Overall Study|Significant Concurrent Illness|1|||
144639905|NCT03816995|521534618|FG001|Overall Study|No wound protector used|17|||
144731177|NCT01171963|521871406|FG001|Overall Study|Withdrawal by Subject|129|||
144731178|NCT05093205|521871407|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
144731179|NCT05093205|521871408|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
144639906|NCT03816995|521534617|FG000|Overall Study|Protocol Violation|2|||
144639907|NCT03816995|521534618|FG001|Overall Study|Protocol Violation|3|||
144639908|NCT02432807|521534622|FG000|Overall Study|Adverse Event|0|||
144639909|NCT02432807|521534623|FG001|Overall Study|Adverse Event|2|||
144639910|NCT02432807|521534622|FG000|Overall Study|Lost to Follow-up|1|||
144639911|NCT02432807|521534623|FG001|Overall Study|Lost to Follow-up|0|||
144639912|NCT02432807|521534622|FG000|Overall Study|Withdrawal by Subject|1|||
144639913|NCT02432807|521534623|FG001|Overall Study|Withdrawal by Subject|1|||
144639914|NCT02432807|521534622|FG000|Overall Study|Other|1|||
144639915|NCT02432807|521534623|FG001|Overall Study|Other|1|||
144639916|NCT03976401|521534624|FG000|Overall Study|Adverse Event|2|||
144639917|NCT03976401|521534625|FG001|Overall Study|Adverse Event|0|||
144639918|NCT03976401|521534626|FG002|Overall Study|Adverse Event|4|||
144639919|NCT03976401|521534627|FG003|Overall Study|Adverse Event|1|||
144639920|NCT03976401|521534628|FG004|Overall Study|Adverse Event|1|||
144639921|NCT03976401|521534629|FG005|Overall Study|Adverse Event|0|||
144639922|NCT03976401|521534624|FG000|Overall Study|Withdrawal by Subject|0|||
144639923|NCT03976401|521534625|FG001|Overall Study|Withdrawal by Subject|1|||
144639924|NCT03976401|521534626|FG002|Overall Study|Withdrawal by Subject|0|||
144639925|NCT03976401|521534627|FG003|Overall Study|Withdrawal by Subject|0|||
144639926|NCT03976401|521534628|FG004|Overall Study|Withdrawal by Subject|0|||
144639927|NCT03976401|521534629|FG005|Overall Study|Withdrawal by Subject|1|||
144639928|NCT03976401|521534624|FG000|Overall Study|Physician Decision|0|||
144639929|NCT03976401|521534625|FG001|Overall Study|Physician Decision|0|||
144639930|NCT03976401|521534626|FG002|Overall Study|Physician Decision|1|||
144639931|NCT03976401|521534627|FG003|Overall Study|Physician Decision|0|||
144639932|NCT03976401|521534628|FG004|Overall Study|Physician Decision|0|||
144639933|NCT03976401|521534629|FG005|Overall Study|Physician Decision|0|||
144639934|NCT03976401|521534624|FG000|Overall Study|Lost to Follow-up|1|||
144639935|NCT03976401|521534625|FG001|Overall Study|Lost to Follow-up|2|||
144639936|NCT03976401|521534626|FG002|Overall Study|Lost to Follow-up|0|||
144639937|NCT03976401|521534627|FG003|Overall Study|Lost to Follow-up|0|||
144639938|NCT03976401|521534628|FG004|Overall Study|Lost to Follow-up|0|||
144639939|NCT03976401|521534629|FG005|Overall Study|Lost to Follow-up|0|||
144639940|NCT03976401|521534624|FG000|Overall Study|Protocol Violation|0|||
144639941|NCT03976401|521534625|FG001|Overall Study|Protocol Violation|1|||
144639942|NCT03976401|521534626|FG002|Overall Study|Protocol Violation|0|||
144639943|NCT03976401|521534627|FG003|Overall Study|Protocol Violation|0|||
144639944|NCT03976401|521534628|FG004|Overall Study|Protocol Violation|0|||
144639945|NCT03976401|521534629|FG005|Overall Study|Protocol Violation|0|||
144639946|NCT03976401|521534624|FG000|Overall Study|Withdrew Consent|0|||
144639947|NCT03976401|521534625|FG001|Overall Study|Withdrew Consent|0|||
144639948|NCT03976401|521534626|FG002|Overall Study|Withdrew Consent|0|||
144639949|NCT03976401|521534627|FG003|Overall Study|Withdrew Consent|1|||
144639950|NCT03976401|521534628|FG004|Overall Study|Withdrew Consent|0|||
144639951|NCT03976401|521534629|FG005|Overall Study|Withdrew Consent|0|||
144639952|NCT04645797|521534636|FG000|Overall Study|Disease Progression|3|||
144639953|NCT04645797|521534637|FG001|Overall Study|Disease Progression|3|||
144639954|NCT04645797|521534638|FG002|Overall Study|Disease Progression|1|||
144639955|NCT04645797|521534639|FG003|Overall Study|Disease Progression|0|||
144639956|NCT04645797|521534640|FG004|Overall Study|Disease Progression|0|||
144639957|NCT04645797|521534641|FG005|Overall Study|Disease Progression|0|||
144639958|NCT04645797|521534642|FG006|Overall Study|Disease Progression|0|||
144639959|NCT04645797|521534636|FG000|Overall Study|Death|3|||
144639960|NCT04645797|521534637|FG001|Overall Study|Death|1|||
144639961|NCT04645797|521534638|FG002|Overall Study|Death|0|||
144639962|NCT04645797|521534639|FG003|Overall Study|Death|0|||
144639963|NCT04645797|521534640|FG004|Overall Study|Death|0|||
144639964|NCT04645797|521534641|FG005|Overall Study|Death|0|||
144639965|NCT04645797|521534642|FG006|Overall Study|Death|0|||
144639966|NCT00942409|521534645|FG000|Overall Study|Lack of Efficacy|1|||
144639967|NCT00942409|521534645|FG000|Overall Study|study drug unavailable|2|||
144639968|NCT02015819|521534648|FG000|Overall Study|Rickham catheter was misaligned|0|||
144639969|NCT02015819|521534649|FG001|Overall Study|Rickham catheter was misaligned|0|||
144639970|NCT02015819|521534650|FG002|Overall Study|Rickham catheter was misaligned|0|||
144639971|NCT02015819|521534651|FG003|Overall Study|Rickham catheter was misaligned|1|||
144639972|NCT01697215|521534654|FG000|Overall Study|Physician Decision|5|||
144639973|NCT01697215|521534654|FG000|Overall Study|Malfunction|9|||
144639974|NCT01697215|521534654|FG000|Overall Study|CXR not available|9|||
144639975|NCT01929083|521534655|FG000|Intervention 1|Lost to Follow-up|2|||
144639976|NCT01929083|521534656|FG001|Intervention 1|Lost to Follow-up|0|||
144639977|NCT01929083|521534655|FG000|Intervention 1|Nonadherent to study medications|1|||
144639978|NCT01929083|521534656|FG001|Intervention 1|Nonadherent to study medications|0|||
144639979|NCT01929083|521534655|FG000|Intervention 2|Adverse Event|0|||
144639980|NCT01929083|521534656|FG001|Intervention 2|Adverse Event|1|||
144639981|NCT02599402|521534657|FG000|Overall Study|Disease progression|153|||
144639982|NCT02599402|521534657|FG000|Overall Study|Study drug toxicity|201|||
144639983|NCT02599402|521534657|FG000|Overall Study|Death|26|||
144639984|NCT02599402|521534657|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
144639985|NCT02599402|521534657|FG000|Overall Study|Participant request to discontinue study treatment|13|||
144639986|NCT02599402|521534657|FG000|Overall Study|Participant withdrew consent|5|||
144639987|NCT02599402|521534657|FG000|Overall Study|Lost to Follow-up|1|||
144639988|NCT02599402|521534657|FG000|Overall Study|Maximum Clinical Benefit|7|||
144639989|NCT02599402|521534657|FG000|Overall Study|Poor/non-compliance|1|||
144639990|NCT02599402|521534657|FG000|Overall Study|Pregnancy|1|||
144639991|NCT02599402|521534657|FG000|Overall Study|Participant no longer met study criteria|7|||
144639992|NCT02599402|521534657|FG000|Overall Study|Other Reasons|95|||
144639993|NCT01122927|521534660|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
144639994|NCT01122927|521534661|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
144639995|NCT01122927|521534660|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
144639996|NCT01122927|521534661|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
144639997|NCT01122927|521534660|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
144639998|NCT01122927|521534661|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
144639999|NCT01122927|521534660|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
144640000|NCT01122927|521534661|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
144640001|NCT01122927|521534660|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
144640002|NCT01122927|521534661|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
144640003|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
144640004|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
144640005|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
144640006|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
144640007|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
144640008|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
144640009|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
144640010|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
144640011|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
144640012|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
144640013|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
144640014|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
144640015|NCT01122927|521534660|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
144640016|NCT01122927|521534661|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
144640017|NCT03182738|521534662|FG000|Overall Study|Lost to Follow-up|9|||
144640018|NCT03182738|521534663|FG001|Overall Study|Lost to Follow-up|3|||
144640019|NCT03182738|521534662|FG000|Overall Study|Pregnancy|0|||
144640020|NCT03182738|521534663|FG001|Overall Study|Pregnancy|1|||
144640021|NCT03182738|521534662|FG000|Overall Study|Withdrawal by Subject|0|||
144640022|NCT03182738|521534663|FG001|Overall Study|Withdrawal by Subject|1|||
144640023|NCT03584009|521534664|FG000|Overall Study|Death|25|||
144640024|NCT03584009|521534665|FG001|Overall Study|Death|18|||
144640025|NCT03584009|521534664|FG000|Overall Study|Lost to Follow-up|0|||
144640026|NCT03584009|521534665|FG001|Overall Study|Lost to Follow-up|1|||
144640027|NCT03584009|521534664|FG000|Overall Study|Physician Decision|1|||
144640028|NCT03584009|521534665|FG001|Overall Study|Physician Decision|1|||
144640029|NCT03584009|521534664|FG000|Overall Study|Study Terminated by Sponsor|22|||
144640030|NCT03584009|521534665|FG001|Overall Study|Study Terminated by Sponsor|30|||
144640031|NCT03584009|521534664|FG000|Overall Study|Withdrawal by Subject|3|||
144640032|NCT03584009|521534665|FG001|Overall Study|Withdrawal by Subject|2|||
144640033|NCT03812510|521534666|FG000|Overall Study|Lost to Follow-up|39|||
144640034|NCT03812510|521534666|FG000|Overall Study|Withdrawal by Subject|42|||
144640035|NCT03812510|521534666|FG000|Overall Study|Physician Decision|2|||
144640036|NCT03812510|521534666|FG000|Overall Study|Study Terminated by Sponsor|9|||
144640037|NCT03812510|521534666|FG000|Overall Study|Did Not Start Study Medication|55|||
144640038|NCT03812510|521534666|FG000|Overall Study|Adverse Event|5|||
144640039|NCT02635204|521534667|FG000|Overall Study|Adverse Event|1|||
144640040|NCT02635204|521534668|FG001|Overall Study|Adverse Event|0|||
144640041|NCT02635204|521534667|FG000|Overall Study|Lost to Follow-up|1|||
144640042|NCT02635204|521534668|FG001|Overall Study|Lost to Follow-up|1|||
144640043|NCT00424398|521534682|FG000|Overall Study|Withdrawal by Subject|2|||
144640044|NCT00424398|521534683|FG001|Overall Study|Withdrawal by Subject|1|||
144640045|NCT00424398|521534684|FG002|Overall Study|Withdrawal by Subject|0|||
144640046|NCT00424398|521534682|FG000|Overall Study|Subject met exclusion criteria|1|||
144640047|NCT00424398|521534683|FG001|Overall Study|Subject met exclusion criteria|0|||
144640048|NCT00424398|521534684|FG002|Overall Study|Subject met exclusion criteria|0|||
144640049|NCT02344576|521534689|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
144640050|NCT02344576|521534690|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
144640051|NCT02344576|521534691|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
144640052|NCT02344576|521534692|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
144640053|NCT02344576|521534689|FG000|1-Month Follow-Up|Death|13|||
144640054|NCT02344576|521534690|FG001|1-Month Follow-Up|Death|8|||
144640055|NCT02344576|521534691|FG002|1-Month Follow-Up|Death|0|||
144640056|NCT02344576|521534692|FG003|1-Month Follow-Up|Death|0|||
144640057|NCT02344576|521534689|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
144640058|NCT02344576|521534690|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
144640059|NCT02344576|521534691|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
144640060|NCT02344576|521534692|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
144640061|NCT02344576|521534689|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
144640062|NCT02344576|521534690|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
144640063|NCT02344576|521534691|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
144640064|NCT02344576|521534692|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
144640065|NCT02344576|521534689|FG000|6-Month Follow-Up|Death|14|||
144640066|NCT02344576|521534690|FG001|6-Month Follow-Up|Death|14|||
144640067|NCT02344576|521534691|FG002|6-Month Follow-Up|Death|0|||
144640068|NCT02344576|521534692|FG003|6-Month Follow-Up|Death|0|||
144640069|NCT02344576|521534689|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
144640070|NCT02344576|521534690|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
144640071|NCT02344576|521534691|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
144640072|NCT02344576|521534692|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
144640073|NCT02344576|521534689|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
144640074|NCT02344576|521534690|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
144640075|NCT02344576|521534691|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
144640076|NCT02344576|521534692|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
144640077|NCT04233424|521534694|FG000|Overall Study|Death|15|||
144640078|NCT04233424|521534695|FG001|Overall Study|Death|16|||
144640079|NCT04233424|521534694|FG000|Overall Study|Withdrawal by Subject|2|||
144640080|NCT04233424|521534695|FG001|Overall Study|Withdrawal by Subject|8|||
144640081|NCT04233424|521534694|FG000|Overall Study|Physician Decision|1|||
144640082|NCT04233424|521534695|FG001|Overall Study|Physician Decision|3|||
144640083|NCT04233424|521534694|FG000|Overall Study|Protocol Violation|3|||
144640084|NCT04233424|521534695|FG001|Overall Study|Protocol Violation|1|||
144640085|NCT04233424|521534694|FG000|Overall Study|Lost to Follow-up|1|||
144210769|NCT02126826|519967935|FG000|Overall Study|Withdrawal by Subject|0|||
144210770|NCT02126826|519967936|FG001|Overall Study|Withdrawal by Subject|0|||
144210771|NCT02126826|519967937|FG002|Overall Study|Withdrawal by Subject|0|||
144210772|NCT02126826|519967938|FG003|Overall Study|Withdrawal by Subject|1|||
144210773|NCT02126826|519967939|FG004|Overall Study|Withdrawal by Subject|0|||
144210774|NCT02126826|519967940|FG005|Overall Study|Withdrawal by Subject|0|||
144210775|NCT02126826|519967941|FG006|Overall Study|Withdrawal by Subject|0|||
144210776|NCT03278626|519967944|FG000|Overall Study|Death|2|||
144210777|NCT03278626|519967944|FG000|Overall Study|Toxicity|1|||
144210778|NCT03278626|519967944|FG000|Overall Study|Disease Progression|2|||
144210779|NCT04971187|519967946|FG000|Overall Study|Screen failures|2|||
144210780|NCT04981717|519967947|FG000|Overall Study|Protocol Violation|0|||
144210781|NCT04981717|519967948|FG001|Overall Study|Protocol Violation|3|||
144210782|NCT04981717|519967947|FG000|Overall Study|Adverse Event|1|||
144210783|NCT04981717|519967948|FG001|Overall Study|Adverse Event|3|||
144210784|NCT04981717|519967947|FG000|Overall Study|Pregnancy|1|||
144210785|NCT04981717|519967948|FG001|Overall Study|Pregnancy|0|||
144210786|NCT04981717|519967947|FG000|Overall Study|Physician Decision|1|||
144210787|NCT04981717|519967948|FG001|Overall Study|Physician Decision|0|||
144210788|NCT04981717|519967947|FG000|Overall Study|Sponsor Request|157|||
144210789|NCT04981717|519967948|FG001|Overall Study|Sponsor Request|172|||
144210790|NCT04981717|519967947|FG000|Overall Study|Lost to Follow-up|4|||
144640086|NCT04233424|521534695|FG001|Overall Study|Lost to Follow-up|3|||
144640087|NCT04233424|521534694|FG000|Overall Study|subject refuse to visit site|2|||
144640088|NCT04233424|521534695|FG001|Overall Study|subject refuse to visit site|0|||
144640089|NCT02698189|521534696|FG000|Overall Study|Physician Decision|3|||
144640090|NCT02698189|521534697|FG001|Overall Study|Physician Decision|0|||
144640091|NCT02698189|521534696|FG000|Overall Study|Progressive disease|0|||
144640092|NCT02698189|521534697|FG001|Overall Study|Progressive disease|5|||
144640093|NCT02698189|521534696|FG000|Overall Study|Study terminated by sponsor|0|||
144640094|NCT02698189|521534697|FG001|Overall Study|Study terminated by sponsor|1|||
144640095|NCT02240706|521534698|FG000|Overall Study|Lack of Efficacy|2|||
144640096|NCT02240706|521534699|FG001|Overall Study|Lack of Efficacy|2|||
144731180|NCT05093205|521871409|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
144731181|NCT05093205|521871410|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
144731182|NCT05093205|521871411|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
144210791|NCT04981717|519967948|FG001|Overall Study|Lost to Follow-up|5|||
144210792|NCT04981717|519967947|FG000|Overall Study|Withdrawal by Subject|50|||
144210793|NCT04981717|519967948|FG001|Overall Study|Withdrawal by Subject|37|||
144640097|NCT02240706|521534700|FG002|Overall Study|Lack of Efficacy|2|||
144640098|NCT02240706|521534701|FG003|Overall Study|Lack of Efficacy|2|||
144640099|NCT02240706|521534702|FG004|Overall Study|Lack of Efficacy|5|||
144640100|NCT02240706|521534703|FG005|Overall Study|Lack of Efficacy|0|||
144210794|NCT00591773|519967949|FG000|Overall Study|Adverse Event|9|||
144210795|NCT00591773|519967950|FG001|Overall Study|Adverse Event|9|||
144210796|NCT00591773|519967951|FG002|Overall Study|Adverse Event|6|||
144210797|NCT00591773|519967949|FG000|Overall Study|Protocol Violation|2|||
144210798|NCT00591773|519967950|FG001|Overall Study|Protocol Violation|3|||
144210799|NCT00591773|519967951|FG002|Overall Study|Protocol Violation|0|||
144640101|NCT02240706|521534704|FG006|Overall Study|Lack of Efficacy|0|||
144640102|NCT02240706|521534698|FG000|Overall Study|Adverse Event|1|||
144640103|NCT02240706|521534699|FG001|Overall Study|Adverse Event|0|||
144640104|NCT02240706|521534700|FG002|Overall Study|Adverse Event|1|||
144640105|NCT02240706|521534701|FG003|Overall Study|Adverse Event|0|||
144640106|NCT02240706|521534702|FG004|Overall Study|Adverse Event|2|||
144640107|NCT02240706|521534703|FG005|Overall Study|Adverse Event|0|||
144640108|NCT02240706|521534704|FG006|Overall Study|Adverse Event|0|||
144640109|NCT02240706|521534698|FG000|Overall Study|Progressive disease|0|||
144640110|NCT02240706|521534699|FG001|Overall Study|Progressive disease|0|||
144640111|NCT02240706|521534700|FG002|Overall Study|Progressive disease|0|||
144640112|NCT02240706|521534701|FG003|Overall Study|Progressive disease|0|||
144640113|NCT02240706|521534702|FG004|Overall Study|Progressive disease|1|||
144640114|NCT02240706|521534703|FG005|Overall Study|Progressive disease|0|||
144640115|NCT02240706|521534704|FG006|Overall Study|Progressive disease|0|||
144640116|NCT02240706|521534698|FG000|Overall Study|Dose limiting toxicity|0|||
144640117|NCT02240706|521534699|FG001|Overall Study|Dose limiting toxicity|0|||
144640118|NCT02240706|521534700|FG002|Overall Study|Dose limiting toxicity|0|||
144640119|NCT02240706|521534701|FG003|Overall Study|Dose limiting toxicity|0|||
144640120|NCT02240706|521534702|FG004|Overall Study|Dose limiting toxicity|1|||
144640121|NCT02240706|521534703|FG005|Overall Study|Dose limiting toxicity|0|||
144640122|NCT02240706|521534704|FG006|Overall Study|Dose limiting toxicity|0|||
144640123|NCT02240706|521534698|FG000|Overall Study|Refused to continue taking medication|0|||
144640124|NCT02240706|521534699|FG001|Overall Study|Refused to continue taking medication|1|||
144640125|NCT02240706|521534700|FG002|Overall Study|Refused to continue taking medication|3|||
144640126|NCT02240706|521534701|FG003|Overall Study|Refused to continue taking medication|1|||
144640127|NCT02240706|521534702|FG004|Overall Study|Refused to continue taking medication|2|||
144640128|NCT02240706|521534703|FG005|Overall Study|Refused to continue taking medication|0|||
144640129|NCT02240706|521534704|FG006|Overall Study|Refused to continue taking medication|0|||
144640130|NCT02240706|521534698|FG000|Overall Study|Insurance billing concerns|0|||
144640131|NCT02240706|521534699|FG001|Overall Study|Insurance billing concerns|0|||
144640132|NCT02240706|521534700|FG002|Overall Study|Insurance billing concerns|0|||
144640133|NCT02240706|521534701|FG003|Overall Study|Insurance billing concerns|1|||
144640134|NCT02240706|521534702|FG004|Overall Study|Insurance billing concerns|0|||
144640135|NCT02240706|521534703|FG005|Overall Study|Insurance billing concerns|0|||
144640136|NCT02240706|521534704|FG006|Overall Study|Insurance billing concerns|0|||
144640137|NCT01076179|521534710|FG000|Overall Study|Withdrawal by Subject|1|||
144640138|NCT00986349|521534711|FG000|Overall Study|Unsuccessful implant procedure|3|||
144640139|NCT00986349|521534711|FG000|Overall Study|Adverse Event|2|||
144640140|NCT00986349|521534711|FG000|Overall Study|Physician Decision|1|||
144640141|NCT00986349|521534711|FG000|Overall Study|device migration|1|||
144640142|NCT02299934|521534712|FG000|Overall Study|Termination of study|13|||
144640143|NCT03248128|521534713|FG000|Overall Study|Lost to Follow-up|1|||
144640144|NCT03248128|521534714|FG001|Overall Study|Lost to Follow-up|0|||
144640145|NCT03248128|521534713|FG000|Overall Study|Withdrawal by Subject|16|||
144640146|NCT03248128|521534714|FG001|Overall Study|Withdrawal by Subject|14|||
144640147|NCT03248128|521534713|FG000|Overall Study|Site Closed|4|||
144640148|NCT03248128|521534714|FG001|Overall Study|Site Closed|3|||
144640149|NCT03248128|521534713|FG000|Overall Study|Randomized, but did not receive treatment|1|||
144640150|NCT03248128|521534714|FG001|Overall Study|Randomized, but did not receive treatment|3|||
144640151|NCT00538681|521534726|FG000|Overall Study|Progressive Disease|7|||
144640152|NCT00538681|521534727|FG001|Overall Study|Progressive Disease|0|||
144640153|NCT00538681|521534728|FG002|Overall Study|Progressive Disease|1|||
144640154|NCT00538681|521534729|FG003|Overall Study|Progressive Disease|0|||
144640155|NCT00538681|521534726|FG000|Overall Study|Sponsor Decision|1|||
144640156|NCT00538681|521534727|FG001|Overall Study|Sponsor Decision|3|||
144640157|NCT00538681|521534728|FG002|Overall Study|Sponsor Decision|8|||
144640158|NCT00538681|521534729|FG003|Overall Study|Sponsor Decision|9|||
144640159|NCT00538681|521534726|FG000|Overall Study|Adverse Event|1|||
144640160|NCT00538681|521534727|FG001|Overall Study|Adverse Event|1|||
144640161|NCT00538681|521534728|FG002|Overall Study|Adverse Event|1|||
144640162|NCT00538681|521534729|FG003|Overall Study|Adverse Event|0|||
144640163|NCT00538681|521534726|FG000|Overall Study|Death|0|||
144640164|NCT00538681|521534727|FG001|Overall Study|Death|0|||
144640165|NCT00538681|521534728|FG002|Overall Study|Death|1|||
144640166|NCT00538681|521534729|FG003|Overall Study|Death|1|||
144640167|NCT00538681|521534726|FG000|Overall Study|Investigator Decision|0|||
144640168|NCT00538681|521534727|FG001|Overall Study|Investigator Decision|0|||
144640169|NCT00538681|521534728|FG002|Overall Study|Investigator Decision|0|||
144640170|NCT00538681|521534729|FG003|Overall Study|Investigator Decision|1|||
144640171|NCT00140855|521534730|FG000|Overall Study|Progressive disease|2|||
144640172|NCT05262764|521534736|FG000|Overall Study|Case report form not collected|9|||
144731183|NCT05093205|521871412|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
144731184|NCT05093205|521871413|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
144640173|NCT05262764|521534736|FG000|Overall Study|No patient visits after entry|23|||
144640174|NCT05262764|521534736|FG000|Overall Study|Registration rule not followed|2|||
144640175|NCT05262764|521534736|FG000|Overall Study|Patient of non-chronic heart failure|1|||
144640176|NCT01392183|521534737|FG000|First Drug Administration|Adverse Event|3|||
144640177|NCT01392183|521534738|FG001|First Drug Administration|Adverse Event|2|||
144640178|NCT01392183|521534737|FG000|First Drug Administration|Death|1|||
144640179|NCT01392183|521534738|FG001|First Drug Administration|Death|0|||
144640180|NCT01392183|521534737|FG000|First Drug Administration|Withdrawal by Subject|10|||
144640181|NCT01392183|521534738|FG001|First Drug Administration|Withdrawal by Subject|17|||
144640182|NCT03972488|521534739|FG000|Overall Study|Progressive disease|42|||
144640183|NCT03972488|521534740|FG001|Overall Study|Progressive disease|44|||
144640184|NCT03972488|521534739|FG000|Overall Study|Physician Decision|13|||
144640185|NCT03972488|521534740|FG001|Overall Study|Physician Decision|7|||
144640186|NCT03972488|521534739|FG000|Overall Study|Adverse Event|8|||
144640187|NCT03972488|521534740|FG001|Overall Study|Adverse Event|1|||
144640188|NCT03972488|521534739|FG000|Overall Study|Death|4|||
144640189|NCT03972488|521534740|FG001|Overall Study|Death|4|||
144640190|NCT03972488|521534739|FG000|Overall Study|Withdrawal by Subject|3|||
144640191|NCT03972488|521534740|FG001|Overall Study|Withdrawal by Subject|4|||
144640192|NCT03972488|521534739|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
144640193|NCT03972488|521534740|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
144640194|NCT04865731|521534746|FG000|Overall Study|Physician Decision|2|||
144640195|NCT04865731|521534747|FG001|Overall Study|Physician Decision|1|||
144640196|NCT04865731|521534746|FG000|Overall Study|Adverse Event|1|||
144640197|NCT04865731|521534747|FG001|Overall Study|Adverse Event|0|||
144640198|NCT04865731|521534746|FG000|Overall Study|Withdrawal by Subject|0|||
144640199|NCT04865731|521534747|FG001|Overall Study|Withdrawal by Subject|1|||
144640200|NCT00541307|521536535|FG000|Overall Study|Death|5|||
144640201|NCT00541307|521536535|FG000|Overall Study|Physician Decision|3|||
144640202|NCT00541307|521536535|FG000|Overall Study|Withdrawal by Subject|6|||
144640203|NCT00541307|521536535|FG000|Overall Study|Lost to Follow-up|4|||
144640204|NCT00541307|521536535|FG000|Overall Study|Subject returned early (outside window)|1|||
144640205|NCT00541307|521536535|FG000|Overall Study|Surgical Bypass|5|||
144640206|NCT04723537|521536536|FG000|Overall Study|Withdrawal by Subject|3|||
144640207|NCT04723537|521536537|FG001|Overall Study|Withdrawal by Subject|0|||
144640208|NCT04723537|521536538|FG002|Overall Study|Withdrawal by Subject|0|||
144640209|NCT04723537|521536536|FG000|Overall Study|Physician Decision|0|||
144640210|NCT04723537|521536537|FG001|Overall Study|Physician Decision|0|||
144640211|NCT04723537|521536538|FG002|Overall Study|Physician Decision|1|||
144640212|NCT04723537|521536536|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
144640213|NCT04723537|521536537|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
144640214|NCT04723537|521536538|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
144640215|NCT01324830|521536539|FG000|Overall Study|Progressive Disease|3|||
144640216|NCT01324830|521536540|FG001|Overall Study|Progressive Disease|2|||
144640217|NCT01324830|521536541|FG002|Overall Study|Progressive Disease|3|||
144640218|NCT01324830|521536542|FG003|Overall Study|Progressive Disease|3|||
144640219|NCT01324830|521536543|FG004|Overall Study|Progressive Disease|6|||
144640220|NCT01324830|521536544|FG005|Overall Study|Progressive Disease|6|||
144640221|NCT01324830|521536545|FG006|Overall Study|Progressive Disease|3|||
144640222|NCT01324830|521536546|FG007|Overall Study|Progressive Disease|3|||
144640223|NCT01324830|521536547|FG008|Overall Study|Progressive Disease|3|||
144640224|NCT01324830|521536548|FG009|Overall Study|Progressive Disease|6|||
144640225|NCT01324830|521536549|FG010|Overall Study|Progressive Disease|2|||
144640226|NCT01324830|521536550|FG011|Overall Study|Progressive Disease|1|||
144640227|NCT01324830|521536551|FG012|Overall Study|Progressive Disease|1|||
144640228|NCT01324830|521536552|FG013|Overall Study|Progressive Disease|1|||
144640229|NCT01324830|521536553|FG014|Overall Study|Progressive Disease|1|||
144640230|NCT01324830|521536554|FG015|Overall Study|Progressive Disease|3|||
144640231|NCT01324830|521536555|FG016|Overall Study|Progressive Disease|2|||
144640232|NCT01324830|521536556|FG017|Overall Study|Progressive Disease|3|||
144640233|NCT01324830|521536557|FG018|Overall Study|Progressive Disease|4|||
144640234|NCT01324830|521536539|FG000|Overall Study|Dose limiting toxicity|0|||
144640235|NCT01324830|521536540|FG001|Overall Study|Dose limiting toxicity|0|||
144640236|NCT01324830|521536541|FG002|Overall Study|Dose limiting toxicity|0|||
144640237|NCT01324830|521536542|FG003|Overall Study|Dose limiting toxicity|0|||
144640238|NCT01324830|521536543|FG004|Overall Study|Dose limiting toxicity|1|||
144640239|NCT01324830|521536544|FG005|Overall Study|Dose limiting toxicity|0|||
144263216|NCT01261390|520163894|FG003|Overall Study|Significant Concurrent Illness|0|||
144640240|NCT01324830|521536545|FG006|Overall Study|Dose limiting toxicity|0|||
144640241|NCT01324830|521536546|FG007|Overall Study|Dose limiting toxicity|0|||
144640242|NCT01324830|521536547|FG008|Overall Study|Dose limiting toxicity|0|||
144640243|NCT01324830|521536548|FG009|Overall Study|Dose limiting toxicity|0|||
144640244|NCT01324830|521536549|FG010|Overall Study|Dose limiting toxicity|0|||
144640245|NCT01324830|521536550|FG011|Overall Study|Dose limiting toxicity|0|||
144640246|NCT01324830|521536551|FG012|Overall Study|Dose limiting toxicity|0|||
144640247|NCT01324830|521536552|FG013|Overall Study|Dose limiting toxicity|0|||
144640248|NCT01324830|521536553|FG014|Overall Study|Dose limiting toxicity|0|||
144640249|NCT01324830|521536554|FG015|Overall Study|Dose limiting toxicity|0|||
144640250|NCT01324830|521536555|FG016|Overall Study|Dose limiting toxicity|1|||
144640251|NCT01324830|521536556|FG017|Overall Study|Dose limiting toxicity|1|||
144640252|NCT01324830|521536557|FG018|Overall Study|Dose limiting toxicity|1|||
144640253|NCT01324830|521536539|FG000|Overall Study|Reason not mentioned above|0|||
144640254|NCT01324830|521536540|FG001|Overall Study|Reason not mentioned above|0|||
144640255|NCT01324830|521536541|FG002|Overall Study|Reason not mentioned above|0|||
144640256|NCT01324830|521536542|FG003|Overall Study|Reason not mentioned above|0|||
144640257|NCT01324830|521536543|FG004|Overall Study|Reason not mentioned above|0|||
144640258|NCT01324830|521536544|FG005|Overall Study|Reason not mentioned above|0|||
144640259|NCT01324830|521536545|FG006|Overall Study|Reason not mentioned above|0|||
144640260|NCT01324830|521536546|FG007|Overall Study|Reason not mentioned above|0|||
144640261|NCT01324830|521536547|FG008|Overall Study|Reason not mentioned above|0|||
144640262|NCT01324830|521536548|FG009|Overall Study|Reason not mentioned above|0|||
144640263|NCT01324830|521536549|FG010|Overall Study|Reason not mentioned above|0|||
144640264|NCT01324830|521536550|FG011|Overall Study|Reason not mentioned above|0|||
144640265|NCT01324830|521536551|FG012|Overall Study|Reason not mentioned above|0|||
144640266|NCT01324830|521536552|FG013|Overall Study|Reason not mentioned above|0|||
144640267|NCT01324830|521536553|FG014|Overall Study|Reason not mentioned above|0|||
144640268|NCT01324830|521536554|FG015|Overall Study|Reason not mentioned above|0|||
144640269|NCT01324830|521536555|FG016|Overall Study|Reason not mentioned above|0|||
144640270|NCT01324830|521536556|FG017|Overall Study|Reason not mentioned above|1|||
144640271|NCT01324830|521536557|FG018|Overall Study|Reason not mentioned above|0|||
144640272|NCT01324830|521536539|FG000|Overall Study|Adverse Event, serious fatal|0|||
144640273|NCT01324830|521536540|FG001|Overall Study|Adverse Event, serious fatal|1|||
144640274|NCT01324830|521536541|FG002|Overall Study|Adverse Event, serious fatal|0|||
144640275|NCT01324830|521536542|FG003|Overall Study|Adverse Event, serious fatal|0|||
144640276|NCT01324830|521536543|FG004|Overall Study|Adverse Event, serious fatal|0|||
144640277|NCT01324830|521536544|FG005|Overall Study|Adverse Event, serious fatal|0|||
144640278|NCT01324830|521536545|FG006|Overall Study|Adverse Event, serious fatal|0|||
144640279|NCT01324830|521536546|FG007|Overall Study|Adverse Event, serious fatal|0|||
144640280|NCT01324830|521536547|FG008|Overall Study|Adverse Event, serious fatal|0|||
144640281|NCT01324830|521536548|FG009|Overall Study|Adverse Event, serious fatal|0|||
144640282|NCT01324830|521536549|FG010|Overall Study|Adverse Event, serious fatal|0|||
144640283|NCT01324830|521536550|FG011|Overall Study|Adverse Event, serious fatal|0|||
144640284|NCT01324830|521536551|FG012|Overall Study|Adverse Event, serious fatal|0|||
144640285|NCT01324830|521536552|FG013|Overall Study|Adverse Event, serious fatal|0|||
144640286|NCT01324830|521536553|FG014|Overall Study|Adverse Event, serious fatal|0|||
144640287|NCT01324830|521536554|FG015|Overall Study|Adverse Event, serious fatal|0|||
144640288|NCT01324830|521536555|FG016|Overall Study|Adverse Event, serious fatal|0|||
144640289|NCT01324830|521536556|FG017|Overall Study|Adverse Event, serious fatal|0|||
144640290|NCT01324830|521536557|FG018|Overall Study|Adverse Event, serious fatal|0|||
144640291|NCT01324830|521536539|FG000|Overall Study|Adverse Event, non-fatal|0|||
144640292|NCT01324830|521536540|FG001|Overall Study|Adverse Event, non-fatal|0|||
144640293|NCT01324830|521536541|FG002|Overall Study|Adverse Event, non-fatal|0|||
144640294|NCT01324830|521536542|FG003|Overall Study|Adverse Event, non-fatal|0|||
144640295|NCT01324830|521536543|FG004|Overall Study|Adverse Event, non-fatal|0|||
144640296|NCT01324830|521536544|FG005|Overall Study|Adverse Event, non-fatal|0|||
144640297|NCT01324830|521536545|FG006|Overall Study|Adverse Event, non-fatal|0|||
144640298|NCT01324830|521536546|FG007|Overall Study|Adverse Event, non-fatal|0|||
144640299|NCT01324830|521536547|FG008|Overall Study|Adverse Event, non-fatal|2|||
144640300|NCT01324830|521536548|FG009|Overall Study|Adverse Event, non-fatal|0|||
144640301|NCT01324830|521536549|FG010|Overall Study|Adverse Event, non-fatal|1|||
144640302|NCT01324830|521536550|FG011|Overall Study|Adverse Event, non-fatal|0|||
144640303|NCT01324830|521536551|FG012|Overall Study|Adverse Event, non-fatal|0|||
144640304|NCT01324830|521536552|FG013|Overall Study|Adverse Event, non-fatal|0|||
144640305|NCT01324830|521536553|FG014|Overall Study|Adverse Event, non-fatal|0|||
144640306|NCT01324830|521536554|FG015|Overall Study|Adverse Event, non-fatal|0|||
144640307|NCT01324830|521536555|FG016|Overall Study|Adverse Event, non-fatal|0|||
144640308|NCT01324830|521536556|FG017|Overall Study|Adverse Event, non-fatal|1|||
144640309|NCT01324830|521536557|FG018|Overall Study|Adverse Event, non-fatal|0|||
144640310|NCT01324830|521536539|FG000|Overall Study|Withdrawal by Subject|0|||
144640311|NCT01324830|521536540|FG001|Overall Study|Withdrawal by Subject|0|||
144640312|NCT01324830|521536541|FG002|Overall Study|Withdrawal by Subject|0|||
144640313|NCT01324830|521536542|FG003|Overall Study|Withdrawal by Subject|0|||
144640314|NCT01324830|521536543|FG004|Overall Study|Withdrawal by Subject|0|||
144640315|NCT01324830|521536544|FG005|Overall Study|Withdrawal by Subject|1|||
144640316|NCT01324830|521536545|FG006|Overall Study|Withdrawal by Subject|0|||
144640317|NCT01324830|521536546|FG007|Overall Study|Withdrawal by Subject|0|||
144640318|NCT01324830|521536547|FG008|Overall Study|Withdrawal by Subject|0|||
144640319|NCT01324830|521536548|FG009|Overall Study|Withdrawal by Subject|0|||
144640320|NCT01324830|521536549|FG010|Overall Study|Withdrawal by Subject|1|||
144640321|NCT01324830|521536550|FG011|Overall Study|Withdrawal by Subject|0|||
144640322|NCT01324830|521536551|FG012|Overall Study|Withdrawal by Subject|0|||
144640323|NCT01324830|521536552|FG013|Overall Study|Withdrawal by Subject|0|||
144640324|NCT01324830|521536553|FG014|Overall Study|Withdrawal by Subject|0|||
144640325|NCT01324830|521536554|FG015|Overall Study|Withdrawal by Subject|0|||
144640326|NCT01324830|521536555|FG016|Overall Study|Withdrawal by Subject|0|||
144640327|NCT01324830|521536556|FG017|Overall Study|Withdrawal by Subject|0|||
144640328|NCT01324830|521536557|FG018|Overall Study|Withdrawal by Subject|1|||
144640329|NCT01485614|521536558|FG000|Randomization|Not Treated|1|||
144640330|NCT01485614|521536559|FG001|Randomization|Not Treated|0|||
144640331|NCT01485614|521536560|FG002|Randomization|Not Treated|0|||
144640332|NCT01485614|521536561|FG003|Randomization|Not Treated|0|||
144640333|NCT01485614|521536558|FG000|Weeks 0-20|Lost to Follow-up|2|||
144640334|NCT01485614|521536559|FG001|Weeks 0-20|Lost to Follow-up|0|||
144640335|NCT01485614|521536560|FG002|Weeks 0-20|Lost to Follow-up|0|||
144640336|NCT01485614|521536561|FG003|Weeks 0-20|Lost to Follow-up|0|||
144640337|NCT01485614|521536558|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
144640338|NCT01485614|521536559|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
144640339|NCT01485614|521536560|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
144640340|NCT01485614|521536561|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
144640341|NCT01485614|521536558|FG000|Weeks 0-20|Withdrawal by Subject|3|||
144640342|NCT01485614|521536559|FG001|Weeks 0-20|Withdrawal by Subject|2|||
144640343|NCT01485614|521536560|FG002|Weeks 0-20|Withdrawal by Subject|1|||
144640344|NCT01485614|521536561|FG003|Weeks 0-20|Withdrawal by Subject|0|||
144640345|NCT01485614|521536558|FG000|Weeks 20-54|Lost to Follow-up|4|||
144640346|NCT01485614|521536559|FG001|Weeks 20-54|Lost to Follow-up|3|||
144640347|NCT01485614|521536560|FG002|Weeks 20-54|Lost to Follow-up|1|||
144640348|NCT01485614|521536561|FG003|Weeks 20-54|Lost to Follow-up|0|||
144640349|NCT01485614|521536558|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
144640350|NCT01485614|521536559|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
144640351|NCT01485614|521536560|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
144640352|NCT01485614|521536561|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
144640353|NCT01485614|521536558|FG000|Weeks 20-54|Withdrawal by Subject|5|||
144640354|NCT01485614|521536559|FG001|Weeks 20-54|Withdrawal by Subject|3|||
144640355|NCT01485614|521536560|FG002|Weeks 20-54|Withdrawal by Subject|0|||
144640356|NCT01485614|521536561|FG003|Weeks 20-54|Withdrawal by Subject|0|||
144640357|NCT00733902|521536562|FG000|Overall Study|Death|0|||
144640358|NCT00733902|521536563|FG001|Overall Study|Death|0|||
144640359|NCT00733902|521536564|FG002|Overall Study|Death|0|||
144640360|NCT00733902|521536565|FG003|Overall Study|Death|1|||
144640361|NCT00733902|521536562|FG000|Overall Study|Adverse Event|3|||
144640362|NCT00733902|521536563|FG001|Overall Study|Adverse Event|4|||
144640363|NCT00733902|521536564|FG002|Overall Study|Adverse Event|7|||
144640364|NCT00733902|521536565|FG003|Overall Study|Adverse Event|11|||
144640365|NCT00733902|521536562|FG000|Overall Study|Lack of Efficacy|56|||
144640366|NCT00733902|521536563|FG001|Overall Study|Lack of Efficacy|21|||
144640367|NCT00733902|521536564|FG002|Overall Study|Lack of Efficacy|34|||
144640368|NCT00733902|521536565|FG003|Overall Study|Lack of Efficacy|23|||
144640369|NCT00733902|521536562|FG000|Overall Study|Protocol Violation|4|||
144640370|NCT00733902|521536563|FG001|Overall Study|Protocol Violation|6|||
144640371|NCT00733902|521536564|FG002|Overall Study|Protocol Violation|3|||
144640372|NCT00733902|521536565|FG003|Overall Study|Protocol Violation|3|||
144640373|NCT00733902|521536562|FG000|Overall Study|Withdrawal by Subject|10|||
144640374|NCT00733902|521536563|FG001|Overall Study|Withdrawal by Subject|5|||
144640375|NCT00733902|521536564|FG002|Overall Study|Withdrawal by Subject|4|||
144640376|NCT00733902|521536565|FG003|Overall Study|Withdrawal by Subject|16|||
144640377|NCT00733902|521536562|FG000|Overall Study|Entered extension study|89|||
144640378|NCT00733902|521536563|FG001|Overall Study|Entered extension study|124|||
144640379|NCT00733902|521536564|FG002|Overall Study|Entered extension study|111|||
144640380|NCT00733902|521536565|FG003|Overall Study|Entered extension study|109|||
144640381|NCT00733902|521536562|FG000|Overall Study|Randomized but not treated|2|||
144640382|NCT00733902|521536563|FG001|Overall Study|Randomized but not treated|2|||
144640383|NCT00733902|521536564|FG002|Overall Study|Randomized but not treated|2|||
144640384|NCT00733902|521536565|FG003|Overall Study|Randomized but not treated|1|||
144640385|NCT02210780|521536566|FG000|Overall Study|Adverse Event|0|||
144640386|NCT02210780|521536567|FG001|Overall Study|Adverse Event|5|||
144640387|NCT02210780|521536566|FG000|Overall Study|Lost to Follow-up|2|||
144640388|NCT02210780|521536567|FG001|Overall Study|Lost to Follow-up|1|||
144640389|NCT02210780|521536566|FG000|Overall Study|Withdrawal by Subject|1|||
144640390|NCT02210780|521536567|FG001|Overall Study|Withdrawal by Subject|1|||
144640391|NCT02210780|521536566|FG000|Overall Study|Physician Decision|1|||
144640392|NCT02210780|521536567|FG001|Overall Study|Physician Decision|0|||
144640393|NCT02210780|521536566|FG000|Overall Study|Protocol Violation|1|||
144640394|NCT02210780|521536567|FG001|Overall Study|Protocol Violation|0|||
144640395|NCT02210780|521536566|FG000|Overall Study|Other than specified above|0|||
144640396|NCT02210780|521536567|FG001|Overall Study|Other than specified above|1|||
144640397|NCT01503021|521536574|FG000|Overall Study|Adverse Event|7|||
144640398|NCT01503021|521536575|FG001|Overall Study|Adverse Event|6|||
144640399|NCT01503021|521536574|FG000|Overall Study|Death|0|||
144640400|NCT01503021|521536575|FG001|Overall Study|Death|2|||
144640401|NCT01503021|521536574|FG000|Overall Study|Lost to Follow-up|2|||
144640402|NCT01503021|521536575|FG001|Overall Study|Lost to Follow-up|0|||
144640403|NCT01503021|521536574|FG000|Overall Study|Physician Decision|3|||
144640404|NCT01503021|521536575|FG001|Overall Study|Physician Decision|0|||
144640405|NCT01503021|521536574|FG000|Overall Study|Protocol Violation|1|||
144640406|NCT01503021|521536575|FG001|Overall Study|Protocol Violation|3|||
144640407|NCT01503021|521536574|FG000|Overall Study|Withdrawal by Subject|9|||
144640408|NCT01503021|521536575|FG001|Overall Study|Withdrawal by Subject|8|||
144640409|NCT01503021|521536574|FG000|Overall Study|Moved, received transplant, etc.|5|||
144640410|NCT01503021|521536575|FG001|Overall Study|Moved, received transplant, etc.|7|||
144640411|NCT00817414|521536576|FG000|Overall Study|Adverse Event|1|||
144640412|NCT00817414|521536577|FG001|Overall Study|Adverse Event|1|||
144640413|NCT00817414|521536578|FG002|Overall Study|Adverse Event|1|||
144640414|NCT00817414|521536579|FG003|Overall Study|Adverse Event|0|||
144640415|NCT00817414|521536580|FG004|Overall Study|Adverse Event|0|||
144640416|NCT00817414|521536576|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
144640417|NCT00817414|521536577|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
144640418|NCT00817414|521536578|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
144640419|NCT00817414|521536579|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
144640420|NCT00817414|521536580|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
144640421|NCT00817414|521536576|FG000|Overall Study|Withdrawal by Subject|1|||
144640422|NCT00817414|521536577|FG001|Overall Study|Withdrawal by Subject|1|||
144640423|NCT00817414|521536578|FG002|Overall Study|Withdrawal by Subject|0|||
144640424|NCT00817414|521536579|FG003|Overall Study|Withdrawal by Subject|0|||
144640425|NCT00817414|521536580|FG004|Overall Study|Withdrawal by Subject|0|||
144640426|NCT00817414|521536576|FG000|Overall Study|Lost to Follow-up|0|||
144640427|NCT00817414|521536577|FG001|Overall Study|Lost to Follow-up|0|||
144640428|NCT00817414|521536578|FG002|Overall Study|Lost to Follow-up|1|||
144640429|NCT00817414|521536579|FG003|Overall Study|Lost to Follow-up|1|||
144640430|NCT00817414|521536580|FG004|Overall Study|Lost to Follow-up|1|||
144640431|NCT00817414|521536576|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
144640432|NCT00817414|521536577|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
144640433|NCT00817414|521536578|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
144640434|NCT00817414|521536579|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
144640435|NCT00817414|521536580|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
144640436|NCT00817414|521536576|FG000|Overall Study|Protocol Violation|0|||
144640437|NCT00817414|521536577|FG001|Overall Study|Protocol Violation|0|||
144640438|NCT00817414|521536578|FG002|Overall Study|Protocol Violation|0|||
144640439|NCT00817414|521536579|FG003|Overall Study|Protocol Violation|0|||
144640440|NCT00817414|521536580|FG004|Overall Study|Protocol Violation|1|||
144640441|NCT00886938|521536581|FG000|Overall Study|Adverse Event|1|||
144640442|NCT00886938|521536581|FG000|Overall Study|Withdrawal by Subject|1|||
144640443|NCT02966314|521536584|FG000|Overall Study|Lost to Follow-up|1|||
144640444|NCT02966314|521536585|FG001|Overall Study|Lost to Follow-up|0|||
144640445|NCT03941548|521536587|FG000|Overall Study|Adverse Event|0|||
144640446|NCT03941548|521536588|FG001|Overall Study|Adverse Event|1|||
144640447|NCT03941548|521536587|FG000|Overall Study|Lost to Follow-up|0|||
144640448|NCT03941548|521536588|FG001|Overall Study|Lost to Follow-up|1|||
144640449|NCT03941548|521536587|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
144640450|NCT03941548|521536588|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
144640451|NCT01242111|521536589|FG000|Overall Study|Adverse Event|1|||
144640452|NCT01242111|521536589|FG000|Overall Study|Withdrawal by Subject|1|||
144640453|NCT01242111|521536589|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
144640454|NCT00870688|521536590|FG000|Overall Study|Lost to Follow-up|2|||
144640455|NCT00870688|521536590|FG000|Overall Study|Death, Unrelated|1|||
144640456|NCT00870688|521536590|FG000|Overall Study|Granules in the Stools|1|||
144640457|NCT03872180|521536591|FG000|Overall Study|Adverse Event|4|||
144640458|NCT03872180|521536591|FG000|Overall Study|Lack of Efficacy|2|||
144640459|NCT02945657|521536594|FG000|Overall Study|Adverse Event|1|||
144640460|NCT02945657|521536594|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
144640461|NCT00087438|521536601|FG000|Overall Study|Ineligible / No protocol treatment|4|||
144640462|NCT00466505|521536602|FG000|Overall Study|disease progression|13|||
144640463|NCT00466505|521536602|FG000|Overall Study|Adverse Event|4|||
144640464|NCT00283387|521536603|FG000|First Intervention|Subject non-compliant|1|||
144640465|NCT00283387|521536604|FG001|First Intervention|Subject non-compliant|1|||
144640466|NCT00283387|521536603|FG000|First Intervention|Withdrawal by Subject|0|||
144640467|NCT00283387|521536604|FG001|First Intervention|Withdrawal by Subject|1|||
144640468|NCT00500071|521536605|FG000|Screening and Washout Phase|Protocol Violation|1|||
144640469|NCT00500071|521536605|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
144640470|NCT00500071|521536605|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
144640471|NCT00500071|521536605|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
144640472|NCT00500071|521536605|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
144640473|NCT00500071|521536605|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
144640474|NCT00500071|521536605|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
144640475|NCT00728416|521536614|FG000|Overall Study|Adverse Event|1|||
144640476|NCT00728416|521536615|FG001|Overall Study|Adverse Event|1|||
144640477|NCT00728416|521536614|FG000|Overall Study|Treatment Failure|0|||
144640478|NCT00728416|521536615|FG001|Overall Study|Treatment Failure|1|||
144640479|NCT00728416|521536614|FG000|Overall Study|Withdrawal by Subject|1|||
144640480|NCT00728416|521536615|FG001|Overall Study|Withdrawal by Subject|0|||
144640481|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
144640482|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
144640483|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
144640484|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
144640485|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
144640486|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
144640487|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Personal issues|2|||
144640488|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Personal issues|0|||
144640489|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Personal issues|0|||
144640490|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Too busy|7|||
144640491|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Too busy|1|||
144640492|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Too busy|0|||
144640493|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Pain|2|||
144640494|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Pain|0|||
144640495|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Pain|0|||
144640496|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Moved|1|||
144640497|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Moved|0|||
144640498|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Moved|0|||
144640499|NCT00594399|521536616|FG000|Initial 3 Month Counseling|Family illness|1|||
144640500|NCT00594399|521536617|FG001|Initial 3 Month Counseling|Family illness|0|||
144640501|NCT00594399|521536618|FG002|Initial 3 Month Counseling|Family illness|0|||
144640502|NCT00594399|521536616|FG000|Rerandomization Arm 1 Only|Death|2|||
144640503|NCT00594399|521536617|FG001|Rerandomization Arm 1 Only|Death|1|||
144640504|NCT00594399|521536618|FG002|Rerandomization Arm 1 Only|Death|0|||
144640505|NCT00594399|521536616|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
144640506|NCT00594399|521536617|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
144640507|NCT00594399|521536618|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
144640508|NCT03830281|521536619|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
144640509|NCT03830281|521536620|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
144640510|NCT03830281|521536619|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
144640511|NCT03830281|521536620|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
144640512|NCT03830281|521536619|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
144640513|NCT03830281|521536620|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
144640514|NCT03830281|521536619|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
144640515|NCT03830281|521536620|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
144640516|NCT03830281|521536619|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
144640517|NCT03830281|521536620|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
144640518|NCT03830281|521536619|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
144640519|NCT03830281|521536620|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
144640520|NCT03830281|521536619|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
144640521|NCT03830281|521536620|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
144640522|NCT03830281|521536619|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
144640523|NCT03830281|521536620|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
144640524|NCT03830281|521536619|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
144640525|NCT03830281|521536620|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
144640526|NCT03293680|521536622|FG000|Overall Study|Death|1|||
144640527|NCT03293680|521536622|FG000|Overall Study|Did not meet inclusion criteria|8|||
144640528|NCT00922935|521536623|FG000|Overall Study|Protocol Violation|0|||
144640529|NCT00922935|521536624|FG001|Overall Study|Protocol Violation|3|||
144640530|NCT00922935|521536625|FG002|Overall Study|Protocol Violation|0|||
144640531|NCT00922935|521536623|FG000|Overall Study|Physician Decision|1|||
144640532|NCT00922935|521536624|FG001|Overall Study|Physician Decision|1|||
144640533|NCT00922935|521536625|FG002|Overall Study|Physician Decision|0|||
144640534|NCT00922935|521536623|FG000|Overall Study|Lost to Follow-up|0|||
144640535|NCT00922935|521536624|FG001|Overall Study|Lost to Follow-up|1|||
144640536|NCT00922935|521536625|FG002|Overall Study|Lost to Follow-up|0|||
144640537|NCT02201940|521536626|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
144640538|NCT02201940|521536627|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
144640539|NCT02201940|521536626|FG000|Overall Study|Lack of Efficacy|2|||
144640540|NCT02201940|521536627|FG001|Overall Study|Lack of Efficacy|113|||
144640541|NCT02201940|521536626|FG000|Overall Study|Lost to Follow-up|5|||
144640542|NCT02201940|521536627|FG001|Overall Study|Lost to Follow-up|0|||
144640543|NCT02201940|521536626|FG000|Overall Study|Withdrew Consent|2|||
144640544|NCT02201940|521536627|FG001|Overall Study|Withdrew Consent|1|||
144640545|NCT02201940|521536626|FG000|Overall Study|Investigator's Discretion|1|||
144640546|NCT02201940|521536627|FG001|Overall Study|Investigator's Discretion|1|||
144640547|NCT02201940|521536626|FG000|Overall Study|Death|1|||
144640548|NCT02201940|521536627|FG001|Overall Study|Death|0|||
144640549|NCT02201940|521536626|FG000|Overall Study|Adverse Event|0|||
144640550|NCT02201940|521536627|FG001|Overall Study|Adverse Event|1|||
144640551|NCT01309737|521536628|FG000|Week 0 to 16|Death|1|||
144640552|NCT01309737|521536629|FG001|Week 0 to 16|Death|0|||
144640553|NCT01309737|521536630|FG002|Week 0 to 16|Death|1|||
144640554|NCT01309737|521536631|FG003|Week 0 to 16|Death|0|||
144640555|NCT01309737|521536632|FG004|Week 0 to 16|Death|0|||
144640556|NCT01309737|521536628|FG000|Week 0 to 16|Adverse Event|11|||
144640557|NCT01309737|521536629|FG001|Week 0 to 16|Adverse Event|10|||
144640558|NCT01309737|521536630|FG002|Week 0 to 16|Adverse Event|5|||
144640559|NCT01309737|521536631|FG003|Week 0 to 16|Adverse Event|0|||
144640560|NCT01309737|521536632|FG004|Week 0 to 16|Adverse Event|0|||
144640561|NCT01309737|521536628|FG000|Week 0 to 16|Lack of Efficacy|15|||
144640562|NCT01309737|521536629|FG001|Week 0 to 16|Lack of Efficacy|2|||
144640563|NCT01309737|521536630|FG002|Week 0 to 16|Lack of Efficacy|24|||
144640564|NCT01309737|521536631|FG003|Week 0 to 16|Lack of Efficacy|0|||
144640565|NCT01309737|521536632|FG004|Week 0 to 16|Lack of Efficacy|0|||
144640566|NCT01309737|521536628|FG000|Week 0 to 16|Lost to Follow-up|7|||
144640567|NCT01309737|521536629|FG001|Week 0 to 16|Lost to Follow-up|8|||
144640568|NCT01309737|521536630|FG002|Week 0 to 16|Lost to Follow-up|3|||
144640569|NCT01309737|521536631|FG003|Week 0 to 16|Lost to Follow-up|0|||
144640570|NCT01309737|521536632|FG004|Week 0 to 16|Lost to Follow-up|0|||
144640571|NCT01309737|521536628|FG000|Week 0 to 16|Withdrawal by Subject|7|||
144640572|NCT01309737|521536629|FG001|Week 0 to 16|Withdrawal by Subject|6|||
144640573|NCT01309737|521536630|FG002|Week 0 to 16|Withdrawal by Subject|7|||
144640574|NCT01309737|521536631|FG003|Week 0 to 16|Withdrawal by Subject|0|||
144640575|NCT01309737|521536632|FG004|Week 0 to 16|Withdrawal by Subject|0|||
144640576|NCT01309737|521536628|FG000|Week 0 to 16|Other|10|||
144640577|NCT01309737|521536629|FG001|Week 0 to 16|Other|14|||
144640578|NCT01309737|521536630|FG002|Week 0 to 16|Other|4|||
144640579|NCT01309737|521536631|FG003|Week 0 to 16|Other|0|||
144640580|NCT01309737|521536632|FG004|Week 0 to 16|Other|0|||
144640581|NCT01309737|521536628|FG000|Week 0 to 16|Randomized, but not treated|1|||
144640582|NCT01309737|521536629|FG001|Week 0 to 16|Randomized, but not treated|0|||
144640583|NCT01309737|521536630|FG002|Week 0 to 16|Randomized, but not treated|0|||
144640584|NCT01309737|521536631|FG003|Week 0 to 16|Randomized, but not treated|0|||
144640585|NCT01309737|521536632|FG004|Week 0 to 16|Randomized, but not treated|0|||
144640586|NCT01309737|521536628|FG000|Week 16 to 52|Death|0|||
144640587|NCT01309737|521536629|FG001|Week 16 to 52|Death|0|||
144640588|NCT01309737|521536630|FG002|Week 16 to 52|Death|0|||
144640589|NCT01309737|521536631|FG003|Week 16 to 52|Death|0|||
144640590|NCT01309737|521536632|FG004|Week 16 to 52|Death|1|||
144640591|NCT01309737|521536628|FG000|Week 16 to 52|Adverse Event|7|||
144640592|NCT01309737|521536629|FG001|Week 16 to 52|Adverse Event|7|||
144640593|NCT01309737|521536630|FG002|Week 16 to 52|Adverse Event|0|||
144640594|NCT01309737|521536631|FG003|Week 16 to 52|Adverse Event|6|||
144640595|NCT01309737|521536632|FG004|Week 16 to 52|Adverse Event|5|||
144640596|NCT01309737|521536628|FG000|Week 16 to 52|Lack of Efficacy|107|||
144640597|NCT01309737|521536629|FG001|Week 16 to 52|Lack of Efficacy|76|||
144640598|NCT01309737|521536630|FG002|Week 16 to 52|Lack of Efficacy|0|||
144640599|NCT01309737|521536631|FG003|Week 16 to 52|Lack of Efficacy|25|||
144640600|NCT01309737|521536632|FG004|Week 16 to 52|Lack of Efficacy|21|||
144640601|NCT01309737|521536628|FG000|Week 16 to 52|Lost to Follow-up|4|||
144640602|NCT01309737|521536629|FG001|Week 16 to 52|Lost to Follow-up|2|||
144640603|NCT01309737|521536630|FG002|Week 16 to 52|Lost to Follow-up|0|||
144640604|NCT01309737|521536631|FG003|Week 16 to 52|Lost to Follow-up|1|||
144640605|NCT01309737|521536632|FG004|Week 16 to 52|Lost to Follow-up|4|||
144640606|NCT01309737|521536628|FG000|Week 16 to 52|Withdrawal by Subject|5|||
144640607|NCT01309737|521536629|FG001|Week 16 to 52|Withdrawal by Subject|6|||
144640608|NCT01309737|521536630|FG002|Week 16 to 52|Withdrawal by Subject|0|||
144640609|NCT01309737|521536631|FG003|Week 16 to 52|Withdrawal by Subject|0|||
144640610|NCT01309737|521536632|FG004|Week 16 to 52|Withdrawal by Subject|2|||
144640611|NCT01309737|521536628|FG000|Week 16 to 52|Other|10|||
144640612|NCT01309737|521536629|FG001|Week 16 to 52|Other|12|||
144640613|NCT01309737|521536630|FG002|Week 16 to 52|Other|0|||
144640614|NCT01309737|521536631|FG003|Week 16 to 52|Other|2|||
144640615|NCT01309737|521536632|FG004|Week 16 to 52|Other|0|||
144640616|NCT03577990|521536639|FG000|Overall Study|Lost to Follow-up|4|||
144640617|NCT03577990|521536640|FG001|Overall Study|Lost to Follow-up|6|||
144640618|NCT03577990|521536639|FG000|Overall Study|Withdrawal by Subject|4|||
144640619|NCT03577990|521536640|FG001|Overall Study|Withdrawal by Subject|7|||
144640620|NCT03934684|521536641|FG000|Overall Study|Participants continuing in study|11|||
144640621|NCT03934684|521536642|FG001|Overall Study|Participants continuing in study|4|||
144640622|NCT03934684|521536641|FG000|Overall Study|Discontinuation of carfilzomib|20|||
144640623|NCT03934684|521536642|FG001|Overall Study|Discontinuation of carfilzomib|30|||
144640624|NCT03934684|521536641|FG000|Overall Study|Death|2|||
144640625|NCT03934684|521536642|FG001|Overall Study|Death|2|||
144640626|NCT03934684|521536641|FG000|Overall Study|Lost to Follow-up|2|||
144640627|NCT03934684|521536642|FG001|Overall Study|Lost to Follow-up|5|||
144640628|NCT03934684|521536641|FG000|Overall Study|Withdrawal by Subject|7|||
144640629|NCT03934684|521536642|FG001|Overall Study|Withdrawal by Subject|8|||
144640630|NCT05662332|521536643|FG000|Overall Study|Death|3|||
144640631|NCT05662332|521536644|FG001|Overall Study|Death|3|||
144640632|NCT05662332|521536643|FG000|Overall Study|Lost to Follow-up|3|||
144640633|NCT05662332|521536644|FG001|Overall Study|Lost to Follow-up|8|||
144640634|NCT05662332|521536643|FG000|Overall Study|Physician Decision|1|||
144640635|NCT05662332|521536644|FG001|Overall Study|Physician Decision|2|||
144640636|NCT05662332|521536643|FG000|Overall Study|Protocol Deviation|2|||
144640637|NCT05662332|521536644|FG001|Overall Study|Protocol Deviation|1|||
144640638|NCT05662332|521536643|FG000|Overall Study|Withdrawal by Subject|14|||
144640639|NCT05662332|521536644|FG001|Overall Study|Withdrawal by Subject|14|||
144640640|NCT05662332|521536643|FG000|Overall Study|Assigned Treatment by Mistake|5|||
144640641|NCT05662332|521536644|FG001|Overall Study|Assigned Treatment by Mistake|7|||
144640642|NCT05662332|521536643|FG000|Overall Study|Non-compliance with study drug|4|||
144640643|NCT05662332|521536644|FG001|Overall Study|Non-compliance with study drug|1|||
144640644|NCT05662332|521536643|FG000|Overall Study|Due to Bariatric surgery|1|||
144640645|NCT05662332|521536644|FG001|Overall Study|Due to Bariatric surgery|0|||
144640646|NCT05662332|521536643|FG000|Overall Study|Subject Moving out of State|0|||
144640647|NCT05662332|521536644|FG001|Overall Study|Subject Moving out of State|1|||
144640648|NCT05662332|521536643|FG000|Overall Study|Subject Missed the Schedule|1|||
144640649|NCT05662332|521536644|FG001|Overall Study|Subject Missed the Schedule|0|||
144640650|NCT05662332|521536643|FG000|Overall Study|The Patient Moved to Another City|1|||
144640651|NCT05662332|521536644|FG001|Overall Study|The Patient Moved to Another City|0|||
144640652|NCT01914679|521536645|FG000|Overall Study|Lack of Efficacy|1|||
144640653|NCT01914679|521536645|FG000|Overall Study|Sponsor terminated study|4|||
144640654|NCT00256295|521536646|FG000|Overall Study|Withdrawal by Subject|3|||
144640655|NCT00256295|521536646|FG000|Overall Study|Death|1|||
144640656|NCT00628355|521536649|FG000|Overall Study|Withdrawal by Subject|1|||
144640657|NCT00628355|521536650|FG001|Overall Study|Withdrawal by Subject|1|||
144640658|NCT01446809|521536654|FG000|Overall Study|Adverse Event|0|||
144640659|NCT01446809|521536655|FG001|Overall Study|Adverse Event|0|||
144640660|NCT01446809|521536656|FG002|Overall Study|Adverse Event|1|||
144640661|NCT01446809|521536654|FG000|Overall Study|Failure to complete study procedures|0|||
144640662|NCT01446809|521536655|FG001|Overall Study|Failure to complete study procedures|0|||
144640663|NCT01446809|521536656|FG002|Overall Study|Failure to complete study procedures|1|||
144640664|NCT01331161|521536657|FG000|Overall Study|Physician Decision|1|||
144640665|NCT01331161|521536658|FG001|Overall Study|Physician Decision|0|||
144640666|NCT01331161|521536657|FG000|Overall Study|Lost to Follow-up|0|||
144640667|NCT01331161|521536658|FG001|Overall Study|Lost to Follow-up|1|||
144640668|NCT01331161|521536657|FG000|Overall Study|Pregnancy|0|||
144640669|NCT01331161|521536658|FG001|Overall Study|Pregnancy|1|||
144640670|NCT01682044|521536659|FG000|Overall Study|Death|1|||
144640671|NCT01682044|521536659|FG000|Overall Study|Progression|3|||
144640672|NCT02581995|521536662|FG000|Overall Study|Unspecified other|3|||
144640673|NCT02581995|521536662|FG000|Overall Study|Adverse Event|6|||
144640674|NCT02581995|521536662|FG000|Overall Study|Lost to Follow-up|5|||
144640675|NCT02581995|521536662|FG000|Overall Study|Withdrawal by participant|12|||
144640676|NCT02581995|521536662|FG000|Overall Study|Physician Decision|1|||
144640677|NCT02581995|521536662|FG000|Overall Study|Death|4|||
144640678|NCT02017444|521538736|FG000|Overall Study|Physician Decision|1|||
144640679|NCT02017444|521538737|FG001|Overall Study|Physician Decision|0|||
144640680|NCT02017444|521538736|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
144640681|NCT02017444|521538737|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
144640682|NCT01614457|521538738|FG000|Overall Study|Non-Compliance|1|||
144640683|NCT01614457|521538739|FG001|Overall Study|Non-Compliance|0|||
144640684|NCT01614457|521538738|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
144640685|NCT01614457|521538739|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
144640686|NCT00886821|521538740|FG000|Stage 2|Adverse Event|0|||
144640687|NCT00886821|521538741|FG001|Stage 2|Adverse Event|0|||
144640688|NCT00886821|521538742|FG002|Stage 2|Adverse Event|0|||
144640689|NCT00886821|521538743|FG003|Stage 2|Adverse Event|0|||
144640690|NCT00886821|521538744|FG004|Stage 2|Adverse Event|0|||
144640691|NCT00886821|521538745|FG005|Stage 2|Adverse Event|0|||
144640692|NCT00886821|521538746|FG006|Stage 2|Adverse Event|0|||
144640693|NCT00886821|521538747|FG007|Stage 2|Adverse Event|0|||
144640694|NCT00886821|521538748|FG008|Stage 2|Adverse Event|0|||
144640695|NCT00886821|521538749|FG009|Stage 2|Adverse Event|0|||
144263217|NCT01261390|520163891|FG000|Overall Study|Dissatisfaction with Treatment|2|||
144263218|NCT01261390|520163892|FG001|Overall Study|Dissatisfaction with Treatment|1|||
144640696|NCT00886821|521538750|FG010|Stage 2|Adverse Event|0|||
144640697|NCT00886821|521538751|FG011|Stage 2|Adverse Event|1|||
144640698|NCT00886821|521538752|FG012|Stage 2|Adverse Event|3|||
144640699|NCT00886821|521538753|FG013|Stage 2|Adverse Event|0|||
144640700|NCT00886821|521538740|FG000|Stage 2|Lost to Follow-up|0|||
144640701|NCT00886821|521538741|FG001|Stage 2|Lost to Follow-up|0|||
144263219|NCT01261390|520163893|FG002|Overall Study|Dissatisfaction with Treatment|1|||
144640702|NCT00886821|521538742|FG002|Stage 2|Lost to Follow-up|0|||
144640703|NCT00886821|521538743|FG003|Stage 2|Lost to Follow-up|0|||
144640704|NCT00886821|521538744|FG004|Stage 2|Lost to Follow-up|0|||
144640705|NCT00886821|521538745|FG005|Stage 2|Lost to Follow-up|0|||
144640706|NCT00886821|521538746|FG006|Stage 2|Lost to Follow-up|0|||
144640707|NCT00886821|521538747|FG007|Stage 2|Lost to Follow-up|0|||
144640708|NCT00886821|521538748|FG008|Stage 2|Lost to Follow-up|0|||
144640709|NCT00886821|521538749|FG009|Stage 2|Lost to Follow-up|0|||
144640710|NCT00886821|521538750|FG010|Stage 2|Lost to Follow-up|0|||
144640711|NCT00886821|521538751|FG011|Stage 2|Lost to Follow-up|0|||
144640712|NCT00886821|521538752|FG012|Stage 2|Lost to Follow-up|2|||
144640713|NCT00886821|521538753|FG013|Stage 2|Lost to Follow-up|1|||
144640714|NCT00942162|521538754|FG000|Overall Study|Death|45|||
144640715|NCT00942162|521538755|FG001|Overall Study|Death|35|||
144640716|NCT00942162|521538756|FG002|Overall Study|Death|0|||
144640717|NCT00942162|521538754|FG000|Overall Study|Withdrawal by Subject|7|||
144640718|NCT00942162|521538755|FG001|Overall Study|Withdrawal by Subject|2|||
144640719|NCT00942162|521538756|FG002|Overall Study|Withdrawal by Subject|0|||
144640720|NCT00942162|521538754|FG000|Overall Study|Lost to Follow-up|4|||
144640721|NCT00942162|521538755|FG001|Overall Study|Lost to Follow-up|0|||
144640722|NCT00942162|521538756|FG002|Overall Study|Lost to Follow-up|0|||
144640723|NCT00942162|521538754|FG000|Overall Study|Other|14|||
144640724|NCT00942162|521538755|FG001|Overall Study|Other|13|||
144640725|NCT00942162|521538756|FG002|Overall Study|Other|2|||
144640726|NCT01416181|521538757|FG000|Part 1|Other|10|||
144640727|NCT01416181|521538758|FG001|Part 1|Other|24|||
144640728|NCT01416181|521538757|FG000|Part 1|Death|0|||
144640729|NCT01416181|521538758|FG001|Part 1|Death|1|||
144640730|NCT01416181|521538757|FG000|Part 1|Investigator Decision|7|||
144640731|NCT01416181|521538758|FG001|Part 1|Investigator Decision|6|||
144640732|NCT01416181|521538757|FG000|Part 1|Withdrawal by Subject|74|||
144640733|NCT01416181|521538758|FG001|Part 1|Withdrawal by Subject|48|||
144640734|NCT01416181|521538757|FG000|Part 1|Lack of Efficacy|16|||
144640735|NCT01416181|521538758|FG001|Part 1|Lack of Efficacy|8|||
144640736|NCT01416181|521538757|FG000|Part 1|Lost to Follow-up|1|||
144640737|NCT01416181|521538758|FG001|Part 1|Lost to Follow-up|1|||
144640738|NCT01416181|521538757|FG000|Part 1|Adverse Event|15|||
144640739|NCT01416181|521538758|FG001|Part 1|Adverse Event|18|||
144640740|NCT01416181|521538757|FG000|Part 1|Ongoing in Follow-Up|14|||
144640741|NCT01416181|521538758|FG001|Part 1|Ongoing in Follow-Up|8|||
144640742|NCT01416181|521538757|FG000|Part 2|Adverse Event|11|||
144640743|NCT01416181|521538758|FG001|Part 2|Adverse Event|4|||
144640744|NCT01416181|521538757|FG000|Part 2|Other|234|||
144640745|NCT01416181|521538758|FG001|Part 2|Other|267|||
144640746|NCT01416181|521538757|FG000|Part 2|Investigator Decision|6|||
144640747|NCT01416181|521538758|FG001|Part 2|Investigator Decision|7|||
144640748|NCT01416181|521538757|FG000|Part 2|Withdrawal by Subject|14|||
144640749|NCT01416181|521538758|FG001|Part 2|Withdrawal by Subject|5|||
144640750|NCT01416181|521538757|FG000|Part 2|Lack of Efficacy|4|||
144640751|NCT01416181|521538758|FG001|Part 2|Lack of Efficacy|1|||
144640752|NCT01416181|521538757|FG000|Part 2|Lost to Follow-up|2|||
144640753|NCT01416181|521538758|FG001|Part 2|Lost to Follow-up|2|||
144640754|NCT00811252|521538759|FG000|Overall Study|Adverse Event|6|||
144640755|NCT00811252|521538760|FG001|Overall Study|Adverse Event|10|||
144640756|NCT00811252|521538761|FG002|Overall Study|Adverse Event|15|||
144640757|NCT00811252|521538759|FG000|Overall Study|Lack of Efficacy|7|||
144640758|NCT00811252|521538760|FG001|Overall Study|Lack of Efficacy|2|||
144640759|NCT00811252|521538761|FG002|Overall Study|Lack of Efficacy|0|||
144640760|NCT00811252|521538759|FG000|Overall Study|Protocol Violation|3|||
144640761|NCT00811252|521538760|FG001|Overall Study|Protocol Violation|3|||
144640762|NCT00811252|521538761|FG002|Overall Study|Protocol Violation|2|||
144640763|NCT00811252|521538759|FG000|Overall Study|Withdrawal of Consent|1|||
144640764|NCT00811252|521538760|FG001|Overall Study|Withdrawal of Consent|2|||
144640765|NCT00811252|521538761|FG002|Overall Study|Withdrawal of Consent|2|||
144640766|NCT00811252|521538759|FG000|Overall Study|Lost to Follow-up|0|||
144640767|NCT00811252|521538760|FG001|Overall Study|Lost to Follow-up|0|||
144640768|NCT00811252|521538761|FG002|Overall Study|Lost to Follow-up|2|||
144640769|NCT00811252|521538759|FG000|Overall Study|Administrative or Other Reasons|0|||
144640770|NCT00811252|521538760|FG001|Overall Study|Administrative or Other Reasons|3|||
144640771|NCT00811252|521538761|FG002|Overall Study|Administrative or Other Reasons|2|||
144640772|NCT01157117|521538762|FG000|Overall Study|Dosing Symptoms|0|||
144640773|NCT01157117|521538763|FG001|Overall Study|Dosing Symptoms|4|||
144640774|NCT01157117|521538764|FG002|Overall Study|Dosing Symptoms|0|||
144640775|NCT01157117|521538762|FG000|Overall Study|Withdrawal by Subject|4|||
144263220|NCT01261390|520163894|FG003|Overall Study|Dissatisfaction with Treatment|2|||
144640776|NCT01157117|521538763|FG001|Overall Study|Withdrawal by Subject|1|||
144640777|NCT01157117|521538764|FG002|Overall Study|Withdrawal by Subject|1|||
144640778|NCT01157117|521538762|FG000|Overall Study|Lack of Efficacy|1|||
144640779|NCT01157117|521538763|FG001|Overall Study|Lack of Efficacy|1|||
144640780|NCT01157117|521538764|FG002|Overall Study|Lack of Efficacy|0|||
144640781|NCT01157117|521538762|FG000|Overall Study|Lost to Follow-up|0|||
144640782|NCT01157117|521538763|FG001|Overall Study|Lost to Follow-up|0|||
144640783|NCT01157117|521538764|FG002|Overall Study|Lost to Follow-up|1|||
144640784|NCT01157117|521538762|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
144640785|NCT01157117|521538763|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
144640786|NCT01157117|521538764|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
144640787|NCT01486264|521538765|FG000|Overall Study|Death|1|||
144640788|NCT01486264|521538766|FG001|Overall Study|Death|1|||
144640789|NCT01486264|521538765|FG000|Overall Study|Adverse Event|3|||
144640790|NCT01486264|521538766|FG001|Overall Study|Adverse Event|3|||
144640791|NCT01486264|521538765|FG000|Overall Study|Lack of Efficacy|6|||
144640792|NCT01486264|521538766|FG001|Overall Study|Lack of Efficacy|10|||
144640793|NCT01486264|521538765|FG000|Overall Study|Withdrawal by Subject|7|||
144640794|NCT01486264|521538766|FG001|Overall Study|Withdrawal by Subject|18|||
144640795|NCT01486264|521538765|FG000|Overall Study|Physician Decision|1|||
144640796|NCT01486264|521538766|FG001|Overall Study|Physician Decision|1|||
144640797|NCT01486264|521538765|FG000|Overall Study|Protocol Violation|3|||
144640798|NCT01486264|521538766|FG001|Overall Study|Protocol Violation|0|||
144640799|NCT01486264|521538765|FG000|Overall Study|Lost to Follow-up|3|||
144640800|NCT01486264|521538766|FG001|Overall Study|Lost to Follow-up|2|||
144640801|NCT01486264|521538765|FG000|Overall Study|Other|5|||
144640802|NCT01486264|521538766|FG001|Overall Study|Other|11|||
144640803|NCT01486264|521538765|FG000|Overall Study|Not treated|0|||
144640804|NCT01486264|521538766|FG001|Overall Study|Not treated|1|||
144640805|NCT01931865|521538767|FG000|Overall Study|Lost to Follow-up|2|||
144640806|NCT01931865|521538767|FG000|Overall Study|Withdrawal by Subject|2|||
144640807|NCT01120626|521538769|FG000|Overall Study|Withdrawal by Subject|1|||
144640808|NCT01120626|521538770|FG001|Overall Study|Withdrawal by Subject|0|||
144640809|NCT01244737|521538771|FG000|Overall Study|Physician Decision|2|||
144640810|NCT01244737|521538772|FG001|Overall Study|Physician Decision|18|||
144640811|NCT01244737|521538773|FG002|Overall Study|Physician Decision|5|||
144640812|NCT01244737|521538771|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
144640813|NCT01244737|521538772|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
144640814|NCT01244737|521538773|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
144640815|NCT01244737|521538771|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
144640816|NCT01244737|521538772|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
144640817|NCT01244737|521538773|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
144640818|NCT01244737|521538771|FG000|Overall Study|MIB immunopathology results not available|3|||
144640819|NCT01244737|521538772|FG001|Overall Study|MIB immunopathology results not available|2|||
144640820|NCT01244737|521538773|FG002|Overall Study|MIB immunopathology results not available|0|||
144640821|NCT01244737|521538771|FG000|Overall Study|PET data failure|0|||
144731185|NCT05093205|521871414|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
144731186|NCT05093205|521871415|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
144731187|NCT05093205|521871416|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
144731188|NCT05093205|521871417|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
144731189|NCT05093205|521871418|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
144731190|NCT05093205|521871419|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
144731191|NCT05093205|521871407|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731192|NCT05093205|521871408|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731193|NCT05093205|521871409|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
144731194|NCT05093205|521871410|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731195|NCT05093205|521871411|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731196|NCT05093205|521871412|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731197|NCT05093205|521871413|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731198|NCT05093205|521871414|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731199|NCT05093205|521871415|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731200|NCT05093205|521871416|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731201|NCT05093205|521871417|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731202|NCT05093205|521871418|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144731203|NCT05093205|521871419|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
144640822|NCT01244737|521538772|FG001|Overall Study|PET data failure|1|||
144640823|NCT01244737|521538773|FG002|Overall Study|PET data failure|0|||
144640824|NCT01244737|521538771|FG000|Overall Study|Withdrawal by Subject|0|||
144640825|NCT01244737|521538772|FG001|Overall Study|Withdrawal by Subject|0|||
144640826|NCT01244737|521538773|FG002|Overall Study|Withdrawal by Subject|1|||
144640827|NCT00356915|521538776|FG000|Overall Study|Non compliance|1|||
144640828|NCT00356915|521538777|FG001|Overall Study|Non compliance|2|||
144640829|NCT00356915|521538778|FG002|Overall Study|Non compliance|1|||
144640830|NCT00356915|521538776|FG000|Overall Study|Protocol Violation|2|||
144640831|NCT00356915|521538777|FG001|Overall Study|Protocol Violation|3|||
144640832|NCT00356915|521538778|FG002|Overall Study|Protocol Violation|2|||
144731204|NCT05093205|521871407|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
144731205|NCT05093205|521871408|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
144640833|NCT00356915|521538776|FG000|Overall Study|Withdrawal by Subject|14|||
144640834|NCT00356915|521538777|FG001|Overall Study|Withdrawal by Subject|14|||
144640835|NCT00356915|521538778|FG002|Overall Study|Withdrawal by Subject|10|||
144640836|NCT00356915|521538776|FG000|Overall Study|Lack of Efficacy|0|||
144731206|NCT05093205|521871409|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
144640837|NCT00356915|521538777|FG001|Overall Study|Lack of Efficacy|0|||
144640838|NCT00356915|521538778|FG002|Overall Study|Lack of Efficacy|3|||
144640839|NCT00356915|521538776|FG000|Overall Study|Lost to Follow-up|27|||
144640840|NCT00356915|521538777|FG001|Overall Study|Lost to Follow-up|34|||
144640841|NCT00356915|521538778|FG002|Overall Study|Lost to Follow-up|14|||
144640842|NCT00356915|521538776|FG000|Overall Study|Administrative Decision|0|||
144640843|NCT00356915|521538777|FG001|Overall Study|Administrative Decision|0|||
144640844|NCT00356915|521538778|FG002|Overall Study|Administrative Decision|1|||
144640845|NCT00356915|521538776|FG000|Overall Study|Physician Decision|0|||
144640846|NCT00356915|521538777|FG001|Overall Study|Physician Decision|2|||
144640847|NCT00356915|521538778|FG002|Overall Study|Physician Decision|0|||
144640848|NCT00356915|521538776|FG000|Overall Study|Adverse Event|21|||
144640849|NCT00356915|521538777|FG001|Overall Study|Adverse Event|31|||
144640850|NCT00356915|521538778|FG002|Overall Study|Adverse Event|8|||
144640851|NCT00356915|521538776|FG000|Overall Study|Miscellaneous reasons|11|||
144640852|NCT00356915|521538777|FG001|Overall Study|Miscellaneous reasons|8|||
144640853|NCT00356915|521538778|FG002|Overall Study|Miscellaneous reasons|3|||
144640854|NCT00488631|521538779|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
144640855|NCT00488631|521538780|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
144640856|NCT00488631|521538781|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
144640857|NCT00488631|521538782|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
144640858|NCT00488631|521538783|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
144640859|NCT00488631|521538784|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
144640860|NCT00488631|521538785|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
144640861|NCT00488631|521538786|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
144640862|NCT00488631|521538787|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
144640863|NCT00488631|521538788|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
144640864|NCT00488631|521538779|FG000|Double Blind Period (Week 0-54)|Death|0|||
144640865|NCT00488631|521538780|FG001|Double Blind Period (Week 0-54)|Death|0|||
144640866|NCT00488631|521538781|FG002|Double Blind Period (Week 0-54)|Death|0|||
144640867|NCT00488631|521538782|FG003|Double Blind Period (Week 0-54)|Death|0|||
144640868|NCT00488631|521538783|FG004|Double Blind Period (Week 0-54)|Death|0|||
144640869|NCT00488631|521538784|FG005|Double Blind Period (Week 0-54)|Death|1|||
144640870|NCT00488631|521538785|FG006|Double Blind Period (Week 0-54)|Death|0|||
144640871|NCT00488631|521538786|FG007|Double Blind Period (Week 0-54)|Death|0|||
144640872|NCT00488631|521538787|FG008|Double Blind Period (Week 0-54)|Death|0|||
144640873|NCT00488631|521538788|FG009|Double Blind Period (Week 0-54)|Death|0|||
144640874|NCT00488631|521538779|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
144640875|NCT00488631|521538780|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
144640876|NCT00488631|521538781|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
144640877|NCT00488631|521538782|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
144640878|NCT00488631|521538783|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
144640879|NCT00488631|521538784|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
144640880|NCT00488631|521538785|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
144640881|NCT00488631|521538786|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
144640882|NCT00488631|521538787|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
144640883|NCT00488631|521538788|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
144640884|NCT00488631|521538779|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
144640885|NCT00488631|521538780|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
144640886|NCT00488631|521538781|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
144640887|NCT00488631|521538782|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
144640888|NCT00488631|521538783|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
144731207|NCT05093205|521871410|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
144731208|NCT05093205|521871411|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
144731209|NCT05093205|521871412|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
144731210|NCT05093205|521871413|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
144731211|NCT05093205|521871414|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
144731212|NCT05093205|521871415|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
144731213|NCT05093205|521871416|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
144731214|NCT05093205|521871417|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
144731215|NCT05093205|521871418|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
144731216|NCT05093205|521871419|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
144731217|NCT05093205|521871407|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
144731218|NCT05093205|521871408|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
144731219|NCT05093205|521871409|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
144731220|NCT05093205|521871410|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
144731221|NCT05093205|521871411|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
144731222|NCT05093205|521871412|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
144731223|NCT05093205|521871413|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
144731224|NCT05093205|521871414|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
144731225|NCT05093205|521871415|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
144640889|NCT00488631|521538784|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
144640890|NCT00488631|521538785|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
144640891|NCT00488631|521538786|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
144640892|NCT00488631|521538787|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
144640893|NCT00488631|521538788|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
144640894|NCT00488631|521538779|FG000|Double Blind Period (Week 0-54)|Other|6|||
144640895|NCT00488631|521538780|FG001|Double Blind Period (Week 0-54)|Other|12|||
144640896|NCT00488631|521538781|FG002|Double Blind Period (Week 0-54)|Other|10|||
144640897|NCT00488631|521538782|FG003|Double Blind Period (Week 0-54)|Other|11|||
144640898|NCT00488631|521538783|FG004|Double Blind Period (Week 0-54)|Other|14|||
144640899|NCT00488631|521538784|FG005|Double Blind Period (Week 0-54)|Other|34|||
144640900|NCT00488631|521538785|FG006|Double Blind Period (Week 0-54)|Other|0|||
144640901|NCT00488631|521538786|FG007|Double Blind Period (Week 0-54)|Other|0|||
144640902|NCT00488631|521538787|FG008|Double Blind Period (Week 0-54)|Other|0|||
144640903|NCT00488631|521538788|FG009|Double Blind Period (Week 0-54)|Other|0|||
144640904|NCT00488631|521538779|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640905|NCT00488631|521538780|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640906|NCT00488631|521538781|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640907|NCT00488631|521538782|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640908|NCT00488631|521538783|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640909|NCT00488631|521538784|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640910|NCT00488631|521538785|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
144640911|NCT00488631|521538786|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
144640912|NCT00488631|521538787|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
144640913|NCT00488631|521538788|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
144640914|NCT00488631|521538779|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
144640915|NCT00488631|521538780|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
144640916|NCT00488631|521538781|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
144640917|NCT00488631|521538782|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
144640918|NCT00488631|521538783|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
144640919|NCT00488631|521538784|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
144640920|NCT00488631|521538785|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
144640921|NCT00488631|521538786|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
144640922|NCT00488631|521538787|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
144640923|NCT00488631|521538788|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
144640924|NCT00488631|521538779|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
144640925|NCT00488631|521538780|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
144640926|NCT00488631|521538781|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
144640927|NCT00488631|521538782|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
144640928|NCT00488631|521538783|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
144640929|NCT00488631|521538784|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
144640930|NCT00488631|521538785|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
144640931|NCT00488631|521538786|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
144640932|NCT00488631|521538787|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
144640933|NCT00488631|521538788|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
144640934|NCT00488631|521538779|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640935|NCT00488631|521538780|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640936|NCT00488631|521538781|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640937|NCT00488631|521538782|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640938|NCT00488631|521538783|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640939|NCT00488631|521538784|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640940|NCT00488631|521538785|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
144640941|NCT00488631|521538786|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640942|NCT00488631|521538787|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
144640943|NCT00488631|521538788|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
144640944|NCT00488631|521538779|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640945|NCT00488631|521538780|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640946|NCT00488631|521538781|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640947|NCT00488631|521538782|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640948|NCT00488631|521538783|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640949|NCT00488631|521538784|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640950|NCT00488631|521538785|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
144263221|NCT01261390|520163891|FG000|Overall Study|Relocation|0|||
144640951|NCT00488631|521538786|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
144640952|NCT00488631|521538787|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
144640953|NCT00488631|521538788|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
144640954|NCT01772134|521538790|FG000|Overall Study|Adverse Event|6|||
144640955|NCT01772134|521538791|FG001|Overall Study|Adverse Event|5|||
144640956|NCT01772134|521538792|FG002|Overall Study|Adverse Event|10|||
144640957|NCT01772134|521538790|FG000|Overall Study|Withdrew Consent|3|||
144640958|NCT01772134|521538791|FG001|Overall Study|Withdrew Consent|1|||
144640959|NCT01772134|521538792|FG002|Overall Study|Withdrew Consent|5|||
144640960|NCT01772134|521538790|FG000|Overall Study|Lost to Follow-up|2|||
144640961|NCT01772134|521538791|FG001|Overall Study|Lost to Follow-up|0|||
144640962|NCT01772134|521538792|FG002|Overall Study|Lost to Follow-up|0|||
144640963|NCT01772134|521538790|FG000|Overall Study|Protocol Deviation|4|||
144640964|NCT01772134|521538791|FG001|Overall Study|Protocol Deviation|3|||
144640965|NCT01772134|521538792|FG002|Overall Study|Protocol Deviation|3|||
144640966|NCT01772134|521538790|FG000|Overall Study|Lack of Efficacy|11|||
144640967|NCT01772134|521538791|FG001|Overall Study|Lack of Efficacy|5|||
144640968|NCT01772134|521538792|FG002|Overall Study|Lack of Efficacy|3|||
144640969|NCT01772134|521538790|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
144640970|NCT01772134|521538791|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
144640971|NCT01772134|521538792|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
144640972|NCT01772134|521538790|FG000|Overall Study|Randomized Study Medication Not Received|2|||
144640973|NCT01772134|521538791|FG001|Overall Study|Randomized Study Medication Not Received|0|||
144640974|NCT01772134|521538792|FG002|Overall Study|Randomized Study Medication Not Received|1|||
144640975|NCT02604264|521538794|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
144640976|NCT02604264|521538795|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
144640977|NCT03192904|521538796|FG000|Overall Study|Physician Decision|3|||
144640978|NCT03192904|521538797|FG001|Overall Study|Physician Decision|1|||
144640979|NCT03192904|521538796|FG000|Overall Study|Lost to Follow-up|0|||
144640980|NCT03192904|521538797|FG001|Overall Study|Lost to Follow-up|1|||
144640981|NCT01023789|521538798|FG000|3 - Year Visit|Death|29|||
144640982|NCT01023789|521538798|FG000|3 - Year Visit|Withdrawal of consent|1|||
144640983|NCT01023789|521538798|FG000|3 - Year Visit|Lost to Follow-up|13|||
144640984|NCT01442181|521538802|FG000|Overall Study|patient refused surgery|1|||
144640985|NCT01442181|521538803|FG001|Overall Study|patient refused surgery|0|||
144640986|NCT01442181|521538802|FG000|Overall Study|no insurance for surgery|1|||
144640987|NCT01442181|521538803|FG001|Overall Study|no insurance for surgery|0|||
144640988|NCT01442181|521538802|FG000|Overall Study|low ejection factor|0|||
144640989|NCT01442181|521538803|FG001|Overall Study|low ejection factor|1|||
144640990|NCT01442181|521538802|FG000|Overall Study|Lost to Follow-up|1|||
144640991|NCT01442181|521538803|FG001|Overall Study|Lost to Follow-up|1|||
144640992|NCT01442181|521538802|FG000|Overall Study|patient in an additional study|1|||
144640993|NCT01442181|521538803|FG001|Overall Study|patient in an additional study|0|||
144640994|NCT01442181|521538802|FG000|Overall Study|atrial fibrillation not noted|0|||
144640995|NCT01442181|521538803|FG001|Overall Study|atrial fibrillation not noted|1|||
144640996|NCT02034123|521538804|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144640997|NCT02034123|521538805|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144640998|NCT02034123|521538806|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144640999|NCT02034123|521538807|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641000|NCT02034123|521538808|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
144641001|NCT02034123|521538809|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641002|NCT02034123|521538810|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641003|NCT02034123|521538811|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
144641004|NCT02034123|521538812|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
144641005|NCT02034123|521538813|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641006|NCT02034123|521538814|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641007|NCT02034123|521538815|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641008|NCT02034123|521538816|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641009|NCT02034123|521538817|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641010|NCT02034123|521538818|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641011|NCT02034123|521538819|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641012|NCT02034123|521538820|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641013|NCT02034123|521538821|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
144641014|NCT02034123|521538804|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641015|NCT02034123|521538805|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144731226|NCT05093205|521871416|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
144731227|NCT05093205|521871417|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
144731228|NCT05093205|521871418|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
144731229|NCT05093205|521871419|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
144731230|NCT05093205|521871407|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
144210800|NCT00591773|519967949|FG000|Overall Study|Lost to Follow-up|1|||
144641016|NCT02034123|521538806|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641017|NCT02034123|521538807|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
144641018|NCT02034123|521538808|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641019|NCT02034123|521538809|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641020|NCT02034123|521538810|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641021|NCT02034123|521538811|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641022|NCT02034123|521538812|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641023|NCT02034123|521538813|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144731231|NCT05093205|521871408|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
144641024|NCT02034123|521538814|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641025|NCT02034123|521538815|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641026|NCT02034123|521538816|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641027|NCT02034123|521538817|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641028|NCT02034123|521538818|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641029|NCT02034123|521538819|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641030|NCT02034123|521538820|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641031|NCT02034123|521538821|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
144641032|NCT02034123|521538804|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641033|NCT02034123|521538805|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641034|NCT02034123|521538806|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641035|NCT02034123|521538807|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641036|NCT02034123|521538808|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641037|NCT02034123|521538809|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641038|NCT02034123|521538810|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641039|NCT02034123|521538811|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641040|NCT02034123|521538812|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
144641041|NCT02034123|521538813|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641042|NCT02034123|521538814|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641043|NCT02034123|521538815|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641044|NCT02034123|521538816|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641045|NCT02034123|521538817|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641046|NCT02034123|521538818|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641047|NCT02034123|521538819|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641048|NCT02034123|521538820|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641049|NCT02034123|521538821|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
144641050|NCT02034123|521538804|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641051|NCT02034123|521538805|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641052|NCT02034123|521538806|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641053|NCT02034123|521538807|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
144641054|NCT02034123|521538808|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
144641055|NCT02034123|521538809|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641056|NCT02034123|521538810|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641057|NCT02034123|521538811|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641058|NCT02034123|521538812|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641059|NCT02034123|521538813|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641060|NCT02034123|521538814|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641061|NCT02034123|521538815|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641062|NCT02034123|521538816|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641063|NCT02034123|521538817|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641064|NCT02034123|521538818|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641065|NCT02034123|521538819|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641066|NCT02034123|521538820|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641067|NCT02034123|521538821|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
144641068|NCT00246259|521538822|FG000|Overall Study|Other|3|||
144641069|NCT00246259|521538823|FG001|Overall Study|Other|3|||
144641070|NCT00246259|521538822|FG000|Overall Study|Not stable by Week 18|2|||
144641071|NCT00246259|521538823|FG001|Overall Study|Not stable by Week 18|1|||
144641072|NCT00246259|521538822|FG000|Overall Study|Participant non-compliant|4|||
144641073|NCT00246259|521538823|FG001|Overall Study|Participant non-compliant|9|||
144641074|NCT00246259|521538822|FG000|Overall Study|Lack of Efficacy|2|||
144641075|NCT00246259|521538823|FG001|Overall Study|Lack of Efficacy|2|||
144641076|NCT00246259|521538822|FG000|Overall Study|Investigator withdrew participant|2|||
144641077|NCT00246259|521538823|FG001|Overall Study|Investigator withdrew participant|0|||
144641078|NCT00246259|521538822|FG000|Overall Study|Adverse Event|5|||
144641079|NCT00246259|521538823|FG001|Overall Study|Adverse Event|0|||
144641080|NCT00246259|521538822|FG000|Overall Study|Lost to Follow-up|3|||
144641081|NCT00246259|521538823|FG001|Overall Study|Lost to Follow-up|4|||
144641082|NCT00246259|521538822|FG000|Overall Study|Withdrawal by Subject|5|||
144641083|NCT00246259|521538823|FG001|Overall Study|Withdrawal by Subject|1|||
144641084|NCT00246259|521538822|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
144641085|NCT00246259|521538823|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
144641086|NCT00709202|521538824|FG000|Overall Study|Withdrawal by Subject|6|||
144210801|NCT00591773|519967950|FG001|Overall Study|Lost to Follow-up|4|||
144210802|NCT00591773|519967951|FG002|Overall Study|Lost to Follow-up|1|||
144210803|NCT00591773|519967949|FG000|Overall Study|Withdrawal by Subject|2|||
144641087|NCT00709202|521538825|FG001|Overall Study|Withdrawal by Subject|6|||
144641088|NCT03301857|521538830|FG000|Overall Study|Death|0|||
144641089|NCT03301857|521538831|FG001|Overall Study|Death|2|||
144641090|NCT03301857|521538830|FG000|Overall Study|Lost to Follow-up|4|||
144641091|NCT03301857|521538831|FG001|Overall Study|Lost to Follow-up|2|||
144641092|NCT03301857|521538830|FG000|Overall Study|Decision by Sponsor|6|||
144641093|NCT03301857|521538831|FG001|Overall Study|Decision by Sponsor|0|||
144641094|NCT03301857|521538830|FG000|Overall Study|Withdrawal by Subject|12|||
144641095|NCT03301857|521538831|FG001|Overall Study|Withdrawal by Subject|4|||
144641096|NCT00855439|521538832|FG000|Overall Study|Withdrawal by Subject|2|||
144641097|NCT00855439|521538833|FG001|Overall Study|Withdrawal by Subject|0|||
144641098|NCT00855439|521538832|FG000|Overall Study|Pregnancy|1|||
144641099|NCT00855439|521538833|FG001|Overall Study|Pregnancy|0|||
144641100|NCT02333227|521538839|FG000|Overall Study|Lost to Follow-up|137|||
144641101|NCT02333227|521538840|FG001|Overall Study|Lost to Follow-up|106|||
144641102|NCT02333227|521538839|FG000|Overall Study|Pregnancy Interrupted|42|||
144641103|NCT02333227|521538840|FG001|Overall Study|Pregnancy Interrupted|89|||
144641104|NCT02333227|521538839|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
144641105|NCT02333227|521538840|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
144641106|NCT03022461|521538841|FG000|Overall Study|Death|3|||
144641107|NCT01982630|521538842|FG000|Overall Study|Adverse Event|2|||
144641108|NCT01982630|521538843|FG001|Overall Study|Adverse Event|0|||
144641109|NCT01982630|521538844|FG002|Overall Study|Adverse Event|1|||
144641110|NCT01982630|521538845|FG003|Overall Study|Adverse Event|0|||
144641111|NCT01982630|521538846|FG004|Overall Study|Adverse Event|1|||
144641112|NCT01982630|521538847|FG005|Overall Study|Adverse Event|2|||
144641113|NCT01982630|521538848|FG006|Overall Study|Adverse Event|1|||
144641114|NCT01982630|521538849|FG007|Overall Study|Adverse Event|0|||
144641115|NCT01982630|521538842|FG000|Overall Study|Physician Decision|1|||
144641116|NCT01982630|521538843|FG001|Overall Study|Physician Decision|0|||
144641117|NCT01982630|521538844|FG002|Overall Study|Physician Decision|2|||
144641118|NCT01982630|521538845|FG003|Overall Study|Physician Decision|1|||
144641119|NCT01982630|521538846|FG004|Overall Study|Physician Decision|2|||
144641120|NCT01982630|521538847|FG005|Overall Study|Physician Decision|0|||
144641121|NCT01982630|521538848|FG006|Overall Study|Physician Decision|0|||
144641122|NCT01982630|521538849|FG007|Overall Study|Physician Decision|0|||
144641123|NCT01982630|521538842|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641124|NCT01982630|521538843|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641125|NCT01982630|521538844|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
144641126|NCT01982630|521538845|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641127|NCT01982630|521538846|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641128|NCT01982630|521538847|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641129|NCT01982630|521538848|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641130|NCT01982630|521538849|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
144641131|NCT01982630|521538842|FG000|Overall Study|Withdrawal by Subject|0|||
144641132|NCT01982630|521538843|FG001|Overall Study|Withdrawal by Subject|0|||
144641133|NCT01982630|521538844|FG002|Overall Study|Withdrawal by Subject|0|||
144641134|NCT01982630|521538845|FG003|Overall Study|Withdrawal by Subject|0|||
144641135|NCT01982630|521538846|FG004|Overall Study|Withdrawal by Subject|0|||
144641136|NCT01982630|521538847|FG005|Overall Study|Withdrawal by Subject|1|||
144641137|NCT01982630|521538848|FG006|Overall Study|Withdrawal by Subject|0|||
144641138|NCT01982630|521538849|FG007|Overall Study|Withdrawal by Subject|0|||
144641139|NCT03459040|521538850|FG000|Overall Study|Death|8|||
144641140|NCT03459040|521538850|FG000|Overall Study|Withdrawal by Subject|1|||
144641141|NCT00561353|521538851|FG000|Overall Study|Subject reached a virologic endpoint|2|||
144641142|NCT00561353|521538852|FG001|Overall Study|Subject reached a virologic endpoint|1|||
144641143|NCT00561353|521538853|FG002|Overall Study|Subject reached a virologic endpoint|1|||
144641144|NCT00561353|521538854|FG003|Overall Study|Subject reached a virologic endpoint|4|||
144641145|NCT00561353|521538855|FG004|Overall Study|Subject reached a virologic endpoint|1|||
144641146|NCT00561353|521538856|FG005|Overall Study|Subject reached a virologic endpoint|3|||
144641147|NCT00561353|521538857|FG006|Overall Study|Subject reached a virologic endpoint|4|||
144641148|NCT00561353|521538858|FG007|Overall Study|Subject reached a virologic endpoint|4|||
144641149|NCT00561353|521538859|FG008|Overall Study|Subject reached a virologic endpoint|5|||
144641150|NCT00561353|521538860|FG009|Overall Study|Subject reached a virologic endpoint|0|||
144641151|NCT00561353|521538851|FG000|Overall Study|Subject ineligible to continue the trial|0|||
144641152|NCT00561353|521538852|FG001|Overall Study|Subject ineligible to continue the trial|0|||
144641153|NCT00561353|521538853|FG002|Overall Study|Subject ineligible to continue the trial|0|||
144641154|NCT00561353|521538854|FG003|Overall Study|Subject ineligible to continue the trial|0|||
144641155|NCT00561353|521538855|FG004|Overall Study|Subject ineligible to continue the trial|0|||
144641156|NCT00561353|521538856|FG005|Overall Study|Subject ineligible to continue the trial|1|||
144641157|NCT00561353|521538857|FG006|Overall Study|Subject ineligible to continue the trial|1|||
144641158|NCT00561353|521538858|FG007|Overall Study|Subject ineligible to continue the trial|0|||
144210804|NCT00591773|519967950|FG001|Overall Study|Withdrawal by Subject|5|||
144210805|NCT00591773|519967951|FG002|Overall Study|Withdrawal by Subject|3|||
144210806|NCT00591773|519967949|FG000|Overall Study|Lack of Efficacy|1|||
144210807|NCT00591773|519967950|FG001|Overall Study|Lack of Efficacy|2|||
144210808|NCT00591773|519967951|FG002|Overall Study|Lack of Efficacy|2|||
144210809|NCT00591773|519967949|FG000|Overall Study|Other|1|||
144641159|NCT00561353|521538859|FG008|Overall Study|Subject ineligible to continue the trial|2|||
144210810|NCT00591773|519967950|FG001|Overall Study|Other|1|||
144210811|NCT00591773|519967951|FG002|Overall Study|Other|4|||
144210812|NCT00287586|519967952|FG000|Overall Study|Withdrew Consent|19|||
144210813|NCT00287586|519967953|FG001|Overall Study|Withdrew Consent|30|||
144210814|NCT00287586|519967952|FG000|Overall Study|Lost to Follow-up|5|||
144210815|NCT00287586|519967953|FG001|Overall Study|Lost to Follow-up|4|||
144210816|NCT00287586|519967952|FG000|Overall Study|Death|2|||
144210817|NCT00287586|519967953|FG001|Overall Study|Death|3|||
144210818|NCT00287586|519967952|FG000|Overall Study|Elevated Hematocrit|3|||
144210819|NCT00287586|519967953|FG001|Overall Study|Elevated Hematocrit|0|||
144210820|NCT00287586|519967952|FG000|Overall Study|Rash|3|||
144210821|NCT00287586|519967953|FG001|Overall Study|Rash|0|||
144210822|NCT00287586|519967952|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
144210823|NCT00287586|519967953|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
144210824|NCT00287586|519967952|FG000|Overall Study|Stroke|2|||
144210825|NCT00287586|519967953|FG001|Overall Study|Stroke|0|||
144210826|NCT00287586|519967952|FG000|Overall Study|Myocardial Infarction|1|||
144210827|NCT00287586|519967953|FG001|Overall Study|Myocardial Infarction|0|||
144210828|NCT00287586|519967952|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
144210829|NCT00287586|519967953|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
144210830|NCT00287586|519967952|FG000|Overall Study|Cognitive Impairment|1|||
144641160|NCT00561353|521538860|FG009|Overall Study|Subject ineligible to continue the trial|1|||
144641161|NCT00561353|521538851|FG000|Overall Study|Other|1|||
144641162|NCT00561353|521538852|FG001|Overall Study|Other|0|||
144641163|NCT00561353|521538853|FG002|Overall Study|Other|1|||
144641164|NCT00561353|521538854|FG003|Overall Study|Other|0|||
144641165|NCT00561353|521538855|FG004|Overall Study|Other|0|||
144641166|NCT00561353|521538856|FG005|Overall Study|Other|2|||
144641167|NCT00561353|521538857|FG006|Overall Study|Other|0|||
144641168|NCT00561353|521538858|FG007|Overall Study|Other|0|||
144641169|NCT00561353|521538859|FG008|Overall Study|Other|0|||
144641170|NCT00561353|521538860|FG009|Overall Study|Other|0|||
144641171|NCT00561353|521538851|FG000|Overall Study|Adverse Event|0|||
144641172|NCT00561353|521538852|FG001|Overall Study|Adverse Event|0|||
144641173|NCT00561353|521538853|FG002|Overall Study|Adverse Event|0|||
144641174|NCT00561353|521538854|FG003|Overall Study|Adverse Event|2|||
144641175|NCT00561353|521538855|FG004|Overall Study|Adverse Event|0|||
144641176|NCT00561353|521538856|FG005|Overall Study|Adverse Event|0|||
144641177|NCT00561353|521538857|FG006|Overall Study|Adverse Event|1|||
144641178|NCT00561353|521538858|FG007|Overall Study|Adverse Event|0|||
144641179|NCT00561353|521538859|FG008|Overall Study|Adverse Event|0|||
144641180|NCT00561353|521538860|FG009|Overall Study|Adverse Event|1|||
144641181|NCT00561353|521538851|FG000|Overall Study|Lost to Follow-up|2|||
144641182|NCT00561353|521538852|FG001|Overall Study|Lost to Follow-up|0|||
144641183|NCT00561353|521538853|FG002|Overall Study|Lost to Follow-up|1|||
144641184|NCT00561353|521538854|FG003|Overall Study|Lost to Follow-up|0|||
144641185|NCT00561353|521538855|FG004|Overall Study|Lost to Follow-up|0|||
144641186|NCT00561353|521538856|FG005|Overall Study|Lost to Follow-up|0|||
144641187|NCT00561353|521538857|FG006|Overall Study|Lost to Follow-up|0|||
144641188|NCT00561353|521538858|FG007|Overall Study|Lost to Follow-up|0|||
144641189|NCT00561353|521538859|FG008|Overall Study|Lost to Follow-up|0|||
144641190|NCT00561353|521538860|FG009|Overall Study|Lost to Follow-up|0|||
144641191|NCT00561353|521538851|FG000|Overall Study|Withdrawal by Subject|0|||
144641192|NCT00561353|521538852|FG001|Overall Study|Withdrawal by Subject|2|||
144641193|NCT00561353|521538853|FG002|Overall Study|Withdrawal by Subject|0|||
144641194|NCT00561353|521538854|FG003|Overall Study|Withdrawal by Subject|0|||
144641195|NCT00561353|521538855|FG004|Overall Study|Withdrawal by Subject|0|||
144731232|NCT05093205|521871409|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
144210831|NCT00287586|519967953|FG001|Overall Study|Cognitive Impairment|0|||
144210832|NCT00287586|519967952|FG000|Overall Study|Pancreatic Cancer|1|||
144210833|NCT00287586|519967953|FG001|Overall Study|Pancreatic Cancer|3|||
144210834|NCT00287586|519967952|FG000|Overall Study|Sleep Apnea|1|||
144210835|NCT00287586|519967953|FG001|Overall Study|Sleep Apnea|0|||
144210836|NCT00287586|519967952|FG000|Overall Study|Shoulder Pain|1|||
144210837|NCT00287586|519967953|FG001|Overall Study|Shoulder Pain|0|||
144210838|NCT00287586|519967952|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
144641196|NCT00561353|521538856|FG005|Overall Study|Withdrawal by Subject|0|||
144641197|NCT00561353|521538857|FG006|Overall Study|Withdrawal by Subject|0|||
144641198|NCT00561353|521538858|FG007|Overall Study|Withdrawal by Subject|0|||
144641199|NCT00561353|521538859|FG008|Overall Study|Withdrawal by Subject|0|||
144641200|NCT00561353|521538860|FG009|Overall Study|Withdrawal by Subject|0|||
144641201|NCT01273818|521538861|FG000|Overall Study|Physician Decision|13|||
144641202|NCT01273818|521538862|FG001|Overall Study|Physician Decision|2|||
144641203|NCT01273818|521538863|FG002|Overall Study|Physician Decision|9|||
144641204|NCT03815175|521538864|FG000|Overall Study|Subject Lost to Follow-up|6|||
144641205|NCT03815175|521538864|FG000|Overall Study|Subject Withdrew Consent|48|||
144641206|NCT03815175|521538864|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
144641207|NCT03815175|521538864|FG000|Overall Study|Death|86|||
144641208|NCT03815175|521538864|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
144641209|NCT03815175|521538864|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
144641210|NCT03815175|521538864|FG000|Overall Study|Other Status Change Reason|1|||
144641211|NCT03815175|521538864|FG000|Overall Study|Missed Visit|12|||
144641212|NCT05300087|521538865|FG000|Overall Study|Withdrawal by Subject|0|||
144641213|NCT05300087|521538866|FG001|Overall Study|Withdrawal by Subject|1|||
144641214|NCT05369806|521538872|FG000|Overall Study|Lost to Follow-up|1|||
144641215|NCT03542682|521538874|FG000|Overall Study|COVID-19 Protocol|0|||
144641216|NCT03542682|521538875|FG001|Overall Study|COVID-19 Protocol|1|||
144641217|NCT04321343|521538877|FG000|Overall Study|Adverse Event|0|||
144641218|NCT04321343|521538878|FG001|Overall Study|Adverse Event|0|||
144641219|NCT04321343|521538879|FG002|Overall Study|Adverse Event|1|||
144641220|NCT04321343|521538880|FG003|Overall Study|Adverse Event|0|||
144641221|NCT04321343|521538877|FG000|Overall Study|Death|0|||
144641222|NCT04321343|521538878|FG001|Overall Study|Death|0|||
144641223|NCT04321343|521538879|FG002|Overall Study|Death|0|||
144641224|NCT04321343|521538880|FG003|Overall Study|Death|1|||
144641225|NCT04321343|521538877|FG000|Overall Study|Pregnancy|1|||
144641226|NCT04321343|521538878|FG001|Overall Study|Pregnancy|0|||
144641227|NCT04321343|521538879|FG002|Overall Study|Pregnancy|0|||
144641228|NCT04321343|521538880|FG003|Overall Study|Pregnancy|0|||
144641229|NCT04321343|521538877|FG000|Overall Study|Protocol Violation|1|||
144641230|NCT04321343|521538878|FG001|Overall Study|Protocol Violation|1|||
144641231|NCT04321343|521538879|FG002|Overall Study|Protocol Violation|1|||
144641232|NCT04321343|521538880|FG003|Overall Study|Protocol Violation|1|||
144641233|NCT04321343|521538877|FG000|Overall Study|Withdrawal by Subject|0|||
144641234|NCT04321343|521538878|FG001|Overall Study|Withdrawal by Subject|6|||
144641235|NCT04321343|521538879|FG002|Overall Study|Withdrawal by Subject|0|||
144641236|NCT04321343|521538880|FG003|Overall Study|Withdrawal by Subject|2|||
144641237|NCT04321343|521538877|FG000|Overall Study|Lost to Follow-up|2|||
144641238|NCT04321343|521538878|FG001|Overall Study|Lost to Follow-up|2|||
144641239|NCT04321343|521538879|FG002|Overall Study|Lost to Follow-up|1|||
144641240|NCT04321343|521538880|FG003|Overall Study|Lost to Follow-up|3|||
144641241|NCT03430310|521538881|FG000|Overall Study|Protocol Violation|2|||
144641242|NCT03430310|521538882|FG001|Overall Study|Protocol Violation|0|||
144641243|NCT03430310|521538881|FG000|Overall Study|Withdrawal by Subject|3|||
144641244|NCT03430310|521538882|FG001|Overall Study|Withdrawal by Subject|2|||
144641245|NCT03430310|521538881|FG000|Overall Study|COVID shutdown March 2020|0|||
144641246|NCT03430310|521538882|FG001|Overall Study|COVID shutdown March 2020|1|||
144641247|NCT03232073|521538889|FG000|Overall Study|Death|1|||
144641248|NCT03232073|521538890|FG001|Overall Study|Death|0|||
144641249|NCT03232073|521538889|FG000|Overall Study|Adverse Event|7|||
144641250|NCT03232073|521538890|FG001|Overall Study|Adverse Event|12|||
144641251|NCT03232073|521538889|FG000|Overall Study|Lost to Follow-up|6|||
144641252|NCT03232073|521538890|FG001|Overall Study|Lost to Follow-up|6|||
144641253|NCT03232073|521538889|FG000|Overall Study|Lack of Efficacy|10|||
144641254|NCT03232073|521538890|FG001|Overall Study|Lack of Efficacy|8|||
144641255|NCT03232073|521538889|FG000|Overall Study|Physician Decision|9|||
144641256|NCT03232073|521538890|FG001|Overall Study|Physician Decision|2|||
144641257|NCT03232073|521538889|FG000|Overall Study|Withdrawal by Subject|54|||
144641258|NCT03232073|521538890|FG001|Overall Study|Withdrawal by Subject|39|||
144641259|NCT03518840|521540282|FG000|Overall Study|Lost to Follow-up|6|||
144641260|NCT00914628|521540283|FG000|Overall Study|Death|35|||
144641261|NCT00914628|521540284|FG001|Overall Study|Death|17|||
144641262|NCT00914628|521540283|FG000|Overall Study|Medical decision|4|||
144641263|NCT00914628|521540284|FG001|Overall Study|Medical decision|0|||
144641264|NCT00914628|521540283|FG000|Overall Study|Protocol Violation|1|||
144641265|NCT00914628|521540284|FG001|Overall Study|Protocol Violation|0|||
144641266|NCT00914628|521540283|FG000|Overall Study|Lack of Efficacy|1|||
144641267|NCT00914628|521540284|FG001|Overall Study|Lack of Efficacy|0|||
144263222|NCT01261390|520163892|FG001|Overall Study|Relocation|1|||
144641268|NCT00914628|521540283|FG000|Overall Study|non-randomized|1|||
144641269|NCT00914628|521540284|FG001|Overall Study|non-randomized|0|||
144641270|NCT00914628|521540283|FG000|Overall Study|Relapse|1|||
144641271|NCT00914628|521540284|FG001|Overall Study|Relapse|2|||
144641272|NCT00914628|521540283|FG000|Overall Study|Study terminated by Sponsor|14|||
144641273|NCT00914628|521540284|FG001|Overall Study|Study terminated by Sponsor|8|||
144641274|NCT00914628|521540283|FG000|Overall Study|Patients who did not receive a single dose|7|||
144641275|NCT00914628|521540284|FG001|Overall Study|Patients who did not receive a single dose|1|||
144641276|NCT03311126|521540285|FG000|Induction|Death|1|||
144641277|NCT03311126|521540285|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
144641278|NCT01756157|521540286|FG000|First Intervention Period|Withdrawal by Subject|1|||
144641279|NCT01756157|521540287|FG001|First Intervention Period|Withdrawal by Subject|0|||
144641280|NCT01756157|521540286|FG000|First Intervention Period|Lost to Follow-up|0|||
144210839|NCT00287586|519967953|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
144210840|NCT00287586|519967952|FG000|Overall Study|Nonadherence|1|||
144210841|NCT00287586|519967953|FG001|Overall Study|Nonadherence|1|||
144210842|NCT00287586|519967952|FG000|Overall Study|Enrolled in Another Study|1|||
144210843|NCT00287586|519967953|FG001|Overall Study|Enrolled in Another Study|0|||
144641281|NCT01756157|521540287|FG001|First Intervention Period|Lost to Follow-up|2|||
144641282|NCT03368859|521540290|FG000|Overall Study|Withdrew Consent|5|||
144641283|NCT03368859|521540291|FG001|Overall Study|Withdrew Consent|4|||
144641284|NCT03368859|521540290|FG000|Overall Study|Death|12|||
144641285|NCT03368859|521540291|FG001|Overall Study|Death|6|||
144641286|NCT03368859|521540290|FG000|Overall Study|Study terminated by Sponsor|18|||
144641287|NCT03368859|521540291|FG001|Overall Study|Study terminated by Sponsor|23|||
144641288|NCT03368859|521540290|FG000|Overall Study|Other|1|||
144641289|NCT03368859|521540291|FG001|Overall Study|Other|1|||
144641290|NCT01713348|521540292|FG000|Overall Study|Withdrawal by Subject|3|||
144641291|NCT01713348|521540293|FG001|Overall Study|Withdrawal by Subject|2|||
144641292|NCT01713348|521540294|FG002|Overall Study|Withdrawal by Subject|2|||
144641293|NCT01713348|521540295|FG003|Overall Study|Withdrawal by Subject|0|||
144641294|NCT01713348|521540292|FG000|Overall Study|Lost to Follow-up|1|||
144641295|NCT01713348|521540293|FG001|Overall Study|Lost to Follow-up|0|||
144641296|NCT01713348|521540294|FG002|Overall Study|Lost to Follow-up|0|||
144641297|NCT01713348|521540295|FG003|Overall Study|Lost to Follow-up|0|||
144641298|NCT00621023|521540296|FG000|Overall Study|Death|5|||
144641299|NCT00621023|521540296|FG000|Overall Study|Follow up discontinued|1|||
144641300|NCT00698516|521540301|FG000|Overall Study|Study Termination|2|||
144641301|NCT00698516|521540301|FG000|Overall Study|Withdrawal by Subject|3|||
144641302|NCT00573131|521540302|FG000|Overall Study|Withdrawal by Subject|10|||
144641303|NCT00573131|521540303|FG001|Overall Study|Withdrawal by Subject|8|||
144641304|NCT03090191|521540304|FG000|Overall Study|Adverse Event|90|||
144641305|NCT03090191|521540305|FG001|Overall Study|Adverse Event|72|||
144641306|NCT03090191|521540304|FG000|Overall Study|Death|365|||
144641307|NCT03090191|521540305|FG001|Overall Study|Death|358|||
144641308|NCT03090191|521540304|FG000|Overall Study|Lost to Follow-up|382|||
144641309|NCT03090191|521540305|FG001|Overall Study|Lost to Follow-up|394|||
144641310|NCT03090191|521540304|FG000|Overall Study|Physician Decision|77|||
144641311|NCT03090191|521540305|FG001|Overall Study|Physician Decision|66|||
144641312|NCT03090191|521540304|FG000|Overall Study|Protocol Violation|43|||
144641313|NCT03090191|521540305|FG001|Overall Study|Protocol Violation|52|||
144641314|NCT03090191|521540304|FG000|Overall Study|Withdrawal by Subject|2160|||
144641315|NCT03090191|521540305|FG001|Overall Study|Withdrawal by Subject|2133|||
144641316|NCT03090191|521540304|FG000|Overall Study|Site terminated|7|||
144641317|NCT03090191|521540305|FG001|Overall Study|Site terminated|8|||
144641318|NCT03090191|521540304|FG000|Overall Study|Other|66|||
144641319|NCT03090191|521540305|FG001|Overall Study|Other|60|||
144641320|NCT03090191|521540304|FG000|Overall Study|Withdrawn before any study vaccination|43|||
144641321|NCT03090191|521540305|FG001|Overall Study|Withdrawn before any study vaccination|52|||
144641322|NCT00893789|521540307|FG000|Overall Study|Withdrawal by Subject|3|||
144641323|NCT00893789|521540308|FG001|Overall Study|Withdrawal by Subject|1|||
144641324|NCT00893789|521540309|FG002|Overall Study|Withdrawal by Subject|3|||
144641325|NCT00893789|521540310|FG003|Overall Study|Withdrawal by Subject|1|||
144641326|NCT00893789|521540307|FG000|Overall Study|Noncompliance With Study Drug|1|||
144641327|NCT00893789|521540308|FG001|Overall Study|Noncompliance With Study Drug|0|||
144641328|NCT00893789|521540309|FG002|Overall Study|Noncompliance With Study Drug|1|||
144641329|NCT00893789|521540310|FG003|Overall Study|Noncompliance With Study Drug|2|||
144641330|NCT00893789|521540307|FG000|Overall Study|Noncompliance With Study Procedures|1|||
144641331|NCT00893789|521540308|FG001|Overall Study|Noncompliance With Study Procedures|0|||
144641332|NCT00893789|521540309|FG002|Overall Study|Noncompliance With Study Procedures|0|||
144641333|NCT00893789|521540310|FG003|Overall Study|Noncompliance With Study Procedures|0|||
144641334|NCT00893789|521540307|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
144641335|NCT00893789|521540308|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
144641336|NCT00893789|521540309|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
144641337|NCT00893789|521540310|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
144641338|NCT00893789|521540307|FG000|Overall Study|Adverse Event|0|||
144641339|NCT00893789|521540308|FG001|Overall Study|Adverse Event|2|||
144641340|NCT00893789|521540309|FG002|Overall Study|Adverse Event|1|||
144641341|NCT00893789|521540310|FG003|Overall Study|Adverse Event|5|||
144641342|NCT00893789|521540307|FG000|Overall Study|Protocol Violation|0|||
144641343|NCT00893789|521540308|FG001|Overall Study|Protocol Violation|1|||
144641344|NCT00893789|521540309|FG002|Overall Study|Protocol Violation|1|||
144641345|NCT00893789|521540310|FG003|Overall Study|Protocol Violation|4|||
144641346|NCT00893789|521540307|FG000|Overall Study|Lost to Follow-up|0|||
144641347|NCT00893789|521540308|FG001|Overall Study|Lost to Follow-up|0|||
144641348|NCT00893789|521540309|FG002|Overall Study|Lost to Follow-up|0|||
144641349|NCT00893789|521540310|FG003|Overall Study|Lost to Follow-up|1|||
144641350|NCT02024464|521540311|FG000|Overall Study|Discontinued|5|||
144210844|NCT00287586|519967952|FG000|Overall Study|Major Depression|0|||
144641351|NCT02024464|521540312|FG001|Overall Study|Discontinued|4|||
144641352|NCT02024464|521540311|FG000|Overall Study|Missed Visits|1|||
144641353|NCT02024464|521540312|FG001|Overall Study|Missed Visits|0|||
144641354|NCT02024464|521540311|FG000|Overall Study|Lost to Follow-up|4|||
144641355|NCT02024464|521540312|FG001|Overall Study|Lost to Follow-up|7|||
144641356|NCT04419506|521540315|FG000|Overall Study|Adverse Event|0|||
144641357|NCT04419506|521540316|FG001|Overall Study|Adverse Event|10|||
144641358|NCT04419506|521540317|FG002|Overall Study|Adverse Event|0|||
144641359|NCT04419506|521540318|FG003|Overall Study|Adverse Event|3|||
144641360|NCT04419506|521540315|FG000|Overall Study|Withdrawal by Subject|0|||
144641361|NCT04419506|521540316|FG001|Overall Study|Withdrawal by Subject|0|||
144641362|NCT04419506|521540317|FG002|Overall Study|Withdrawal by Subject|0|||
144641363|NCT04419506|521540318|FG003|Overall Study|Withdrawal by Subject|1|||
144641364|NCT04419506|521540315|FG000|Overall Study|poor-compliance|0|||
144641365|NCT04419506|521540316|FG001|Overall Study|poor-compliance|0|||
144641366|NCT04419506|521540317|FG002|Overall Study|poor-compliance|0|||
144641367|NCT04419506|521540318|FG003|Overall Study|poor-compliance|1|||
144641368|NCT01845025|521540319|FG000|Overall Study|Adverse Event|6|||
144641369|NCT01845025|521540320|FG001|Overall Study|Adverse Event|3|||
144641370|NCT01845025|521540319|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144641371|NCT01845025|521540320|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144641372|NCT01845025|521540319|FG000|Overall Study|Withdrawal by Subject|48|||
144641373|NCT01845025|521540320|FG001|Overall Study|Withdrawal by Subject|44|||
144641374|NCT01845025|521540319|FG000|Overall Study|Lost to Follow-up|13|||
144641375|NCT01845025|521540320|FG001|Overall Study|Lost to Follow-up|13|||
144641376|NCT01845025|521540319|FG000|Overall Study|Administrative problems|8|||
144641377|NCT01845025|521540320|FG001|Overall Study|Administrative problems|8|||
144641378|NCT01845025|521540319|FG000|Overall Study|Death|2|||
144641379|NCT01845025|521540320|FG001|Overall Study|Death|0|||
144641380|NCT01845025|521540319|FG000|Overall Study|Protocol deviation|3|||
144641381|NCT01845025|521540320|FG001|Overall Study|Protocol deviation|6|||
144641382|NCT01845025|521540319|FG000|Overall Study|Missing|1|||
144641383|NCT01845025|521540320|FG001|Overall Study|Missing|1|||
144641384|NCT02586805|521540329|FG000|Overall Study|Withdrawal by Subject|3|||
144641385|NCT02586805|521540330|FG001|Overall Study|Withdrawal by Subject|1|||
144641386|NCT02586805|521540331|FG002|Overall Study|Withdrawal by Subject|1|||
144641387|NCT02586805|521540332|FG003|Overall Study|Withdrawal by Subject|2|||
144641388|NCT02586805|521540329|FG000|Overall Study|Adverse Event|2|||
144641389|NCT02586805|521540330|FG001|Overall Study|Adverse Event|0|||
144641390|NCT02586805|521540331|FG002|Overall Study|Adverse Event|1|||
144641391|NCT02586805|521540332|FG003|Overall Study|Adverse Event|0|||
144641392|NCT02586805|521540329|FG000|Overall Study|Lost to Follow-up|0|||
144641393|NCT02586805|521540330|FG001|Overall Study|Lost to Follow-up|0|||
144641394|NCT02586805|521540331|FG002|Overall Study|Lost to Follow-up|1|||
144641395|NCT02586805|521540332|FG003|Overall Study|Lost to Follow-up|0|||
144641396|NCT02586805|521540329|FG000|Overall Study|Physician Decision|1|||
144641397|NCT02586805|521540330|FG001|Overall Study|Physician Decision|0|||
144641398|NCT02586805|521540331|FG002|Overall Study|Physician Decision|0|||
144641399|NCT02586805|521540332|FG003|Overall Study|Physician Decision|0|||
144641400|NCT01859403|521540333|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
144641401|NCT01859403|521540334|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
144641402|NCT01859403|521540333|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
144641403|NCT01859403|521540334|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
144641404|NCT01859403|521540333|FG000|Primary Endpoint Measure|Physician Decision|0|||
144641405|NCT01859403|521540334|FG001|Primary Endpoint Measure|Physician Decision|1|||
144641406|NCT01859403|521540333|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
144641407|NCT01859403|521540334|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
144641408|NCT00813748|521540336|FG000|Skin Test Substudy|Physician Decision|0|||
144641409|NCT00813748|521540337|FG001|Skin Test Substudy|Physician Decision|1|||
144641410|NCT03185130|521540340|FG000|Overall Study|Withdrawal by Subject|0|||
144641411|NCT03185130|521540341|FG001|Overall Study|Withdrawal by Subject|2|||
144641412|NCT01531725|521540353|FG000|Overall Study|Protocol Violation|5|||
144641413|NCT03215277|521540354|FG000|Overall Study|Adverse Event|2|||
144641414|NCT03215277|521540355|FG001|Overall Study|Adverse Event|3|||
144641415|NCT03215277|521540354|FG000|Overall Study|Death|1|||
144641416|NCT03215277|521540355|FG001|Overall Study|Death|0|||
144641417|NCT03215277|521540354|FG000|Overall Study|Lost to Follow-up|0|||
144641418|NCT03215277|521540355|FG001|Overall Study|Lost to Follow-up|1|||
144641419|NCT03215277|521540354|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
144641420|NCT03215277|521540355|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
144641421|NCT00472303|521540357|FG000|Titration Phase|Adverse Event|22|||
144641422|NCT00472303|521540358|FG001|Titration Phase|Adverse Event|12|||
144641423|NCT00472303|521540359|FG002|Titration Phase|Adverse Event|0|||
144641424|NCT00472303|521540357|FG000|Titration Phase|Death|4|||
144641425|NCT00472303|521540358|FG001|Titration Phase|Death|2|||
144731233|NCT05093205|521871410|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
144641426|NCT00472303|521540359|FG002|Titration Phase|Death|0|||
144641427|NCT00472303|521540357|FG000|Titration Phase|Lack of Efficacy|10|||
144641428|NCT00472303|521540358|FG001|Titration Phase|Lack of Efficacy|0|||
144641429|NCT00472303|521540359|FG002|Titration Phase|Lack of Efficacy|0|||
144641430|NCT00472303|521540357|FG000|Titration Phase|Withdrawal by Subject|16|||
144641431|NCT00472303|521540358|FG001|Titration Phase|Withdrawal by Subject|13|||
144641432|NCT00472303|521540359|FG002|Titration Phase|Withdrawal by Subject|0|||
144641433|NCT00472303|521540357|FG000|Titration Phase|Trial Medication non-compliant|4|||
144641434|NCT00472303|521540358|FG001|Titration Phase|Trial Medication non-compliant|1|||
144641435|NCT00472303|521540359|FG002|Titration Phase|Trial Medication non-compliant|0|||
144641436|NCT00472303|521540357|FG000|Titration Phase|Other|3|||
144641437|NCT00472303|521540358|FG001|Titration Phase|Other|1|||
144641438|NCT00472303|521540359|FG002|Titration Phase|Other|0|||
144641439|NCT00472303|521540357|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
144641440|NCT00472303|521540358|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
144641441|NCT00472303|521540359|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
144641442|NCT00472303|521540357|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
144641443|NCT00472303|521540358|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
144641444|NCT00472303|521540359|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
144641445|NCT00472303|521540357|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
144641446|NCT00472303|521540358|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
144641447|NCT00472303|521540359|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
144641448|NCT00472303|521540357|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
144641449|NCT00472303|521540358|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
144641450|NCT00472303|521540359|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
144641451|NCT00472303|521540357|FG000|Discontinuations After Titration Phase|Other|5|||
144641452|NCT00472303|521540358|FG001|Discontinuations After Titration Phase|Other|0|||
144641453|NCT00472303|521540359|FG002|Discontinuations After Titration Phase|Other|0|||
144641454|NCT00472303|521540357|FG000|Maintenance Phase|Adverse Event|5|||
144641455|NCT00472303|521540358|FG001|Maintenance Phase|Adverse Event|6|||
144641456|NCT00472303|521540359|FG002|Maintenance Phase|Adverse Event|6|||
144641457|NCT00472303|521540357|FG000|Maintenance Phase|Death|3|||
144641458|NCT00472303|521540358|FG001|Maintenance Phase|Death|0|||
144641459|NCT00472303|521540359|FG002|Maintenance Phase|Death|2|||
144641460|NCT00472303|521540357|FG000|Maintenance Phase|Lack of Efficacy|2|||
144641461|NCT00472303|521540358|FG001|Maintenance Phase|Lack of Efficacy|2|||
144641462|NCT00472303|521540359|FG002|Maintenance Phase|Lack of Efficacy|4|||
144641463|NCT00472303|521540357|FG000|Maintenance Phase|Withdrawal by Subject|6|||
144641464|NCT00472303|521540358|FG001|Maintenance Phase|Withdrawal by Subject|7|||
144641465|NCT00472303|521540359|FG002|Maintenance Phase|Withdrawal by Subject|3|||
144641466|NCT00472303|521540357|FG000|Maintenance Phase|Trial medication non-compliant|0|||
144641467|NCT00472303|521540358|FG001|Maintenance Phase|Trial medication non-compliant|0|||
144641468|NCT00472303|521540359|FG002|Maintenance Phase|Trial medication non-compliant|1|||
144641469|NCT00472303|521540357|FG000|Maintenance Phase|Resolution of pain|0|||
144641470|NCT00472303|521540358|FG001|Maintenance Phase|Resolution of pain|0|||
144641471|NCT00472303|521540359|FG002|Maintenance Phase|Resolution of pain|1|||
144641472|NCT00472303|521540357|FG000|Maintenance Phase|Other|1|||
144641473|NCT00472303|521540358|FG001|Maintenance Phase|Other|1|||
144641474|NCT00472303|521540359|FG002|Maintenance Phase|Other|0|||
144641475|NCT03596164|521540361|FG000|Overall Study|Adverse Event|0|||
144641476|NCT03596164|521540362|FG001|Overall Study|Adverse Event|1|||
144641477|NCT03596164|521540361|FG000|Overall Study|Death|1|||
144641478|NCT03596164|521540362|FG001|Overall Study|Death|0|||
144641479|NCT04112914|521540363|FG000|Overall Study|Lost to Follow-up|13|||
144641480|NCT04112914|521540364|FG001|Overall Study|Lost to Follow-up|9|||
144641481|NCT04112914|521540363|FG000|Overall Study|Withdrawal by Subject|1|||
144641482|NCT04112914|521540364|FG001|Overall Study|Withdrawal by Subject|0|||
144641483|NCT02835495|521540374|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
144641484|NCT02835495|521540375|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
144641485|NCT02835495|521540374|FG000|Overall Study|Declined in-person follow-up visit|4|||
144641486|NCT02835495|521540375|FG001|Overall Study|Declined in-person follow-up visit|2|||
144641487|NCT05421754|521540377|FG000|Overall Study|Technical issue with sensor|1|||
144641488|NCT03486314|521540382|FG000|Part A|Adverse Event|1|||
144641489|NCT03486314|521540383|FG001|Part A|Adverse Event|0|||
144641490|NCT03486314|521540384|FG002|Part A|Adverse Event|0|||
144641491|NCT03486314|521540382|FG000|Part A|Symptomatic Deterioration|2|||
144641492|NCT03486314|521540383|FG001|Part A|Symptomatic Deterioration|0|||
144641493|NCT03486314|521540384|FG002|Part A|Symptomatic Deterioration|0|||
144731234|NCT05093205|521871411|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
144731235|NCT05093205|521871412|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
144641494|NCT04283461|521540385|FG000|Overall Study|Enrolled in separate trial|0|||
144641495|NCT04283461|521540386|FG001|Overall Study|Enrolled in separate trial|0|||
144641496|NCT04283461|521540387|FG002|Overall Study|Enrolled in separate trial|8|||
144641497|NCT04283461|521540388|FG003|Overall Study|Enrolled in separate trial|13|||
144641498|NCT04283461|521540389|FG004|Overall Study|Enrolled in separate trial|12|||
144641499|NCT04283461|521540390|FG005|Overall Study|Enrolled in separate trial|0|||
144641500|NCT04283461|521540391|FG006|Overall Study|Enrolled in separate trial|0|||
144731236|NCT05093205|521871413|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
144210845|NCT00287586|519967953|FG001|Overall Study|Major Depression|2|||
144210846|NCT00287586|519967952|FG000|Overall Study|Lung Cancer|0|||
144210847|NCT00287586|519967953|FG001|Overall Study|Lung Cancer|2|||
144641501|NCT04283461|521540392|FG007|Overall Study|Enrolled in separate trial|8|||
144641502|NCT04283461|521540393|FG008|Overall Study|Enrolled in separate trial|0|||
144641503|NCT04283461|521540394|FG009|Overall Study|Enrolled in separate trial|0|||
144641504|NCT04283461|521540395|FG010|Overall Study|Enrolled in separate trial|0|||
144641505|NCT04283461|521540396|FG011|Overall Study|Enrolled in separate trial|7|||
144641506|NCT04283461|521540397|FG012|Overall Study|Enrolled in separate trial|0|||
144641507|NCT03133767|521540398|FG000|Overall Study|Lost to Follow-up|38|||
144641508|NCT03133767|521540399|FG001|Overall Study|Lost to Follow-up|24|||
144641509|NCT03133767|521540398|FG000|Overall Study|Protocol Violation|0|||
144641510|NCT03133767|521540399|FG001|Overall Study|Protocol Violation|1|||
144641511|NCT00816036|521540402|FG000|Overall Study|Death|47|||
144641512|NCT00816036|521540403|FG001|Overall Study|Death|28|||
144641513|NCT00816036|521540402|FG000|Overall Study|Lost to Follow-up|75|||
144641514|NCT00816036|521540403|FG001|Overall Study|Lost to Follow-up|57|||
144641515|NCT00816036|521540402|FG000|Overall Study|Withdrawal by Subject|54|||
144641516|NCT00816036|521540403|FG001|Overall Study|Withdrawal by Subject|23|||
144641517|NCT01299025|521540404|FG000|Overall Study|Withdrawal by Subject|2|||
144641518|NCT01299025|521540405|FG001|Overall Study|Withdrawal by Subject|1|||
144641519|NCT01299025|521540404|FG000|Overall Study|Lost to Follow-up|1|||
144641520|NCT01299025|521540405|FG001|Overall Study|Lost to Follow-up|0|||
144641521|NCT00004980|521540406|FG000|Overall Study|Withdrawal by Subject|1|||
144641522|NCT00004980|521540407|FG001|Overall Study|Withdrawal by Subject|0|||
144641523|NCT00004980|521540406|FG000|Overall Study|memory difficulties|1|||
144641524|NCT00004980|521540407|FG001|Overall Study|memory difficulties|1|||
144641525|NCT00004980|521540406|FG000|Overall Study|Physician Decision|0|||
144641526|NCT00004980|521540407|FG001|Overall Study|Physician Decision|1|||
144641527|NCT01624194|521540408|FG000|Overall Study|Lost to Follow-up|1|||
144641528|NCT01624194|521540409|FG001|Overall Study|Lost to Follow-up|0|||
144641529|NCT01624194|521540408|FG000|Overall Study|Withdrawal by Subject|1|||
144641530|NCT01624194|521540409|FG001|Overall Study|Withdrawal by Subject|0|||
144641531|NCT03212261|521540410|FG000|Overall Study|Became ineligible d/t tech|2|||
144641532|NCT03212261|521540410|FG000|Overall Study|Tech Trouble- No first study visit|1|||
144641533|NCT03212261|521540410|FG000|Overall Study|Lost to Follow-up|7|||
144641534|NCT03212261|521540410|FG000|Overall Study|Family Emergency|1|||
144641535|NCT03212261|521540410|FG000|Overall Study|Too busy/ No time|5|||
144641536|NCT05480514|521540411|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
144641537|NCT05480514|521540412|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
144641538|NCT05480514|521540411|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
144641539|NCT05480514|521540412|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
144641540|NCT05480514|521540411|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
144641541|NCT05480514|521540412|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
144641542|NCT05480514|521540411|FG000|Period 1|Covid-19 Related|1|||
144641543|NCT05480514|521540412|FG001|Period 1|Covid-19 Related|0|||
144641544|NCT05480514|521540411|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
144641545|NCT05480514|521540412|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
144641546|NCT00820040|521540413|FG000|Overall Study|Death|1|||
144641547|NCT00820040|521540413|FG000|Overall Study|Sponsor terminated study|1|||
144641548|NCT00820040|521540413|FG000|Overall Study|Screen failure|1|||
144641549|NCT00761215|521540416|FG000|Overall Study|Randomized but didn't receive drug|1|||
144641550|NCT00761215|521540417|FG001|Overall Study|Randomized but didn't receive drug|1|||
144641551|NCT00761215|521540418|FG002|Overall Study|Randomized but didn't receive drug|2|||
144641552|NCT00761215|521540416|FG000|Overall Study|Lost to Follow-up|6|||
144641553|NCT00761215|521540417|FG001|Overall Study|Lost to Follow-up|3|||
144641554|NCT00761215|521540418|FG002|Overall Study|Lost to Follow-up|6|||
144641555|NCT00761215|521540416|FG000|Overall Study|Withdrawal by Subject|1|||
144641556|NCT00761215|521540417|FG001|Overall Study|Withdrawal by Subject|0|||
144641557|NCT00761215|521540418|FG002|Overall Study|Withdrawal by Subject|0|||
144641558|NCT00761215|521540416|FG000|Overall Study|Bacteremia|1|||
144210848|NCT00287586|519967952|FG000|Overall Study|Elevated IPSS Score|0|||
144210849|NCT00287586|519967953|FG001|Overall Study|Elevated IPSS Score|1|||
144210850|NCT00287586|519967952|FG000|Overall Study|Retroperitoneal Cancer|0|||
144641559|NCT00761215|521540417|FG001|Overall Study|Bacteremia|0|||
144641560|NCT00761215|521540418|FG002|Overall Study|Bacteremia|0|||
144641561|NCT02932267|521540419|FG000|Overall Study|Withdrawal by Subject|3|||
144641562|NCT02932267|521540419|FG000|Overall Study|Lost to Follow-up|4|||
144641563|NCT02932267|521540419|FG000|Overall Study|Pregnancy|1|||
144641564|NCT03476239|521540420|FG000|Overall Study|Withdrawal by Subject|10|||
144641565|NCT03476239|521540420|FG000|Overall Study|Death|80|||
144641566|NCT03476239|521540420|FG000|Overall Study|Lost to Follow-up|8|||
144641567|NCT01097044|521540424|FG000|Overall Study|Withdrawal by Subject|4|||
144210851|NCT00287586|519967953|FG001|Overall Study|Retroperitoneal Cancer|1|||
144210852|NCT00287586|519967952|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
144641568|NCT01097044|521540425|FG001|Overall Study|Withdrawal by Subject|4|||
144641569|NCT01097044|521540424|FG000|Overall Study|Lost to Follow-up|1|||
144641570|NCT01097044|521540425|FG001|Overall Study|Lost to Follow-up|0|||
144731237|NCT05093205|521871414|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
144731238|NCT05093205|521871415|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
144731239|NCT05093205|521871416|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
144731240|NCT05093205|521871417|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
144731241|NCT05093205|521871418|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
144731242|NCT05093205|521871419|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
144731243|NCT05093205|521871407|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
144731244|NCT05093205|521871408|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
144731245|NCT05093205|521871409|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
144731246|NCT05093205|521871410|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
144731247|NCT05093205|521871411|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
144731248|NCT05093205|521871412|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
144210853|NCT00287586|519967953|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
144210854|NCT00287586|519967952|FG000|Overall Study|Mood Swings and Irritability|0|||
144210855|NCT00287586|519967953|FG001|Overall Study|Mood Swings and Irritability|1|||
144210856|NCT00287586|519967952|FG000|Overall Study|Bradycardia|0|||
144210857|NCT00287586|519967953|FG001|Overall Study|Bradycardia|1|||
144210858|NCT00287586|519967952|FG000|Overall Study|Itchy Swollen Eyes|0|||
144210859|NCT00287586|519967953|FG001|Overall Study|Itchy Swollen Eyes|1|||
144641571|NCT01097044|521540424|FG000|Overall Study|Withdrawal by Sponsor|0|||
144641572|NCT01097044|521540425|FG001|Overall Study|Withdrawal by Sponsor|1|||
144641573|NCT00853632|521542091|FG000|Overall Study|Death|88|||
144641574|NCT00853632|521542091|FG000|Overall Study|Withdrawal by Subject|45|||
144641575|NCT00853632|521542091|FG000|Overall Study|Lost to Follow-up|30|||
144641576|NCT00853632|521542091|FG000|Overall Study|Reoperation/Explant|17|||
144641577|NCT00853632|521542091|FG000|Overall Study|Exit with other reason|22|||
144641578|NCT04493619|521542093|FG000|Overall Study|Death|4|||
144641579|NCT04493619|521542094|FG001|Overall Study|Death|3|||
144641580|NCT04493619|521542095|FG002|Overall Study|Death|3|||
144641581|NCT04493619|521542096|FG003|Overall Study|Death|4|||
144641582|NCT04493619|521542093|FG000|Overall Study|Study discontinued early|10|||
144641583|NCT04493619|521542094|FG001|Overall Study|Study discontinued early|0|||
144641584|NCT04493619|521542095|FG002|Overall Study|Study discontinued early|4|||
144641585|NCT04493619|521542096|FG003|Overall Study|Study discontinued early|8|||
144641586|NCT04493619|521542093|FG000|Overall Study|Lost to Follow-up|0|||
144641587|NCT04493619|521542094|FG001|Overall Study|Lost to Follow-up|0|||
144641588|NCT04493619|521542095|FG002|Overall Study|Lost to Follow-up|0|||
144641589|NCT04493619|521542096|FG003|Overall Study|Lost to Follow-up|1|||
144641590|NCT01672892|521542097|FG000|Overall Study|Protocol Violation|7|||
144641591|NCT01672892|521542098|FG001|Overall Study|Protocol Violation|3|||
144641592|NCT03528681|521542111|FG000|Open-Label Phase|Physician Decision|2|||
144641593|NCT03528681|521542112|FG001|Open-Label Phase|Physician Decision|0|||
144641594|NCT03528681|521542113|FG002|Open-Label Phase|Physician Decision|0|||
144641595|NCT03528681|521542114|FG003|Open-Label Phase|Physician Decision|0|||
144641596|NCT03528681|521542111|FG000|Open-Label Phase|Withdrawal by Subject|8|||
144641597|NCT03528681|521542112|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144641598|NCT03528681|521542113|FG002|Open-Label Phase|Withdrawal by Subject|0|||
144641599|NCT03528681|521542114|FG003|Open-Label Phase|Withdrawal by Subject|0|||
144641600|NCT03528681|521542111|FG000|Open-Label Phase|(Not collected)|4|||
144641601|NCT03528681|521542112|FG001|Open-Label Phase|(Not collected)|0|||
144641602|NCT03528681|521542113|FG002|Open-Label Phase|(Not collected)|0|||
144641603|NCT03528681|521542114|FG003|Open-Label Phase|(Not collected)|0|||
144641604|NCT03528681|521542111|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
144641605|NCT03528681|521542112|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
144641606|NCT03528681|521542113|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
144641607|NCT03528681|521542114|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
144641608|NCT03528681|521542111|FG000|Randomized Treatment Phase|Physician Decision|0|||
144641609|NCT03528681|521542112|FG001|Randomized Treatment Phase|Physician Decision|5|||
144641610|NCT03528681|521542113|FG002|Randomized Treatment Phase|Physician Decision|1|||
144641611|NCT03528681|521542114|FG003|Randomized Treatment Phase|Physician Decision|2|||
144641612|NCT03528681|521542111|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
144641613|NCT03528681|521542112|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
144641614|NCT03528681|521542113|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
144641615|NCT03528681|521542114|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
144641616|NCT03528681|521542111|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
144641617|NCT03528681|521542112|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
144641618|NCT03528681|521542113|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
144641619|NCT03528681|521542114|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
144641620|NCT03528681|521542111|FG000|Randomized Treatment Phase|(Not collected)|0|||
144641621|NCT03528681|521542112|FG001|Randomized Treatment Phase|(Not collected)|4|||
144641622|NCT03528681|521542113|FG002|Randomized Treatment Phase|(Not collected)|6|||
144641623|NCT03528681|521542114|FG003|Randomized Treatment Phase|(Not collected)|5|||
144641624|NCT02342171|521542120|FG000|Overall Study|Death|4|||
144641625|NCT02342171|521542121|FG001|Overall Study|Death|87|||
144731249|NCT05093205|521871413|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
144641626|NCT02342171|521542120|FG000|Overall Study|Received favipiravir|10|||
144641627|NCT02342171|521542121|FG001|Overall Study|Received favipiravir|0|||
144641628|NCT02342171|521542120|FG000|Overall Study|Missing cycle treshold value|1|||
144641629|NCT02342171|521542121|FG001|Overall Study|Missing cycle treshold value|0|||
144641630|NCT02342171|521542120|FG000|Overall Study|Unknown outcome|0|||
144641631|NCT02342171|521542121|FG001|Overall Study|Unknown outcome|1|||
144641632|NCT02342171|521542120|FG000|Overall Study|Missing age data|0|||
144641633|NCT02342171|521542121|FG001|Overall Study|Missing age data|1|||
144641634|NCT00875420|521542124|FG000|Overall Study|Adverse Event|0|||
144641635|NCT00875420|521542125|FG001|Overall Study|Adverse Event|1|||
144641636|NCT00875420|521542126|FG002|Overall Study|Adverse Event|1|||
144641637|NCT00875420|521542127|FG003|Overall Study|Adverse Event|0|||
144641638|NCT00875420|521542128|FG004|Overall Study|Adverse Event|0|||
144731250|NCT05093205|521871414|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
144731251|NCT05093205|521871415|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
144731252|NCT05093205|521871416|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
144731253|NCT05093205|521871417|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
144731254|NCT05093205|521871418|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
144731255|NCT05093205|521871419|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
144731256|NCT05093205|521871407|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
144731257|NCT05093205|521871408|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
144731258|NCT05093205|521871409|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
144731259|NCT05093205|521871410|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
144731260|NCT05093205|521871411|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
144731261|NCT05093205|521871412|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
144731262|NCT05093205|521871413|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
144731263|NCT05093205|521871414|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
144731264|NCT05093205|521871415|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
144731265|NCT05093205|521871416|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
144731266|NCT05093205|521871417|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
144731267|NCT05093205|521871418|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
144731268|NCT05093205|521871419|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
144210860|NCT00287586|519967952|FG000|Overall Study|Recurrent Melanoma|0|||
144210861|NCT00287586|519967953|FG001|Overall Study|Recurrent Melanoma|1|||
144210862|NCT02640482|519967954|FG000|Overall Study|Lost to Follow-up|3|||
144731269|NCT05093205|521871407|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
144731270|NCT05093205|521871408|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
144731271|NCT05093205|521871409|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
144731272|NCT05093205|521871410|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
144731273|NCT05093205|521871411|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
144731274|NCT05093205|521871412|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
144731275|NCT05093205|521871413|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
144731276|NCT05093205|521871414|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
144731277|NCT05093205|521871415|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
144731278|NCT05093205|521871416|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
144731279|NCT05093205|521871417|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
144731280|NCT05093205|521871418|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
144731281|NCT05093205|521871419|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
144731282|NCT05093205|521871407|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731283|NCT05093205|521871408|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731284|NCT05093205|521871409|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731285|NCT05093205|521871410|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731286|NCT05093205|521871411|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731287|NCT05093205|521871412|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731288|NCT05093205|521871413|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731289|NCT05093205|521871414|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731290|NCT05093205|521871415|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731291|NCT05093205|521871416|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
144731292|NCT05093205|521871417|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731293|NCT05093205|521871418|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731294|NCT05093205|521871419|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
144731295|NCT05093205|521871407|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
144731296|NCT05093205|521871408|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
144731297|NCT05093205|521871409|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
144731298|NCT05093205|521871410|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
144731299|NCT05093205|521871411|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
144731300|NCT05093205|521871412|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
144731301|NCT05093205|521871413|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
144210863|NCT02640482|519967955|FG001|Overall Study|Lost to Follow-up|0|||
144641639|NCT00875420|521542124|FG000|Overall Study|Inability to complete study procedures|1|||
144641640|NCT00875420|521542125|FG001|Overall Study|Inability to complete study procedures|0|||
144641641|NCT00875420|521542126|FG002|Overall Study|Inability to complete study procedures|1|||
144210864|NCT01207583|519967956|FG000|Overall Study|Withdrawal by Subject|0|||
144641642|NCT00875420|521542127|FG003|Overall Study|Inability to complete study procedures|1|||
144641643|NCT00875420|521542128|FG004|Overall Study|Inability to complete study procedures|1|||
144641644|NCT00875420|521542124|FG000|Overall Study|Lost to Follow-up|1|||
144641645|NCT00875420|521542125|FG001|Overall Study|Lost to Follow-up|0|||
144641646|NCT00875420|521542126|FG002|Overall Study|Lost to Follow-up|0|||
144641647|NCT00875420|521542127|FG003|Overall Study|Lost to Follow-up|0|||
144641648|NCT00875420|521542128|FG004|Overall Study|Lost to Follow-up|0|||
144641649|NCT00875420|521542124|FG000|Overall Study|Personal reason|0|||
144641650|NCT00875420|521542125|FG001|Overall Study|Personal reason|0|||
144641651|NCT00875420|521542126|FG002|Overall Study|Personal reason|0|||
144641652|NCT00875420|521542127|FG003|Overall Study|Personal reason|0|||
144641653|NCT00875420|521542128|FG004|Overall Study|Personal reason|1|||
144641654|NCT00875420|521542124|FG000|Overall Study|Prohibited medication|0|||
144641655|NCT00875420|521542125|FG001|Overall Study|Prohibited medication|0|||
144641656|NCT00875420|521542126|FG002|Overall Study|Prohibited medication|0|||
144641657|NCT00875420|521542127|FG003|Overall Study|Prohibited medication|1|||
144641658|NCT00875420|521542128|FG004|Overall Study|Prohibited medication|0|||
144641659|NCT00875420|521542124|FG000|Overall Study|Sponsor decision|0|||
144641660|NCT00875420|521542125|FG001|Overall Study|Sponsor decision|1|||
144641661|NCT00875420|521542126|FG002|Overall Study|Sponsor decision|0|||
144641662|NCT00875420|521542127|FG003|Overall Study|Sponsor decision|0|||
144641663|NCT00875420|521542128|FG004|Overall Study|Sponsor decision|0|||
144641664|NCT00875420|521542124|FG000|Overall Study|Withdrawal by Subject|0|||
144641665|NCT00875420|521542125|FG001|Overall Study|Withdrawal by Subject|0|||
144641666|NCT00875420|521542126|FG002|Overall Study|Withdrawal by Subject|1|||
144641667|NCT00875420|521542127|FG003|Overall Study|Withdrawal by Subject|0|||
144641668|NCT00875420|521542128|FG004|Overall Study|Withdrawal by Subject|0|||
144641669|NCT03716726|521542131|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
144641670|NCT03716726|521542132|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
144641671|NCT03716726|521542131|FG000|12 Months Followup|Lost to Follow-up|10|||
144641672|NCT03716726|521542132|FG001|12 Months Followup|Lost to Follow-up|17|||
144641673|NCT02579603|521542133|FG000|Overall Study|Not treated|1|||
144641674|NCT02579603|521542134|FG001|Overall Study|Not treated|0|||
144641675|NCT02579603|521542133|FG000|Overall Study|Adverse Event|2|||
144641676|NCT02579603|521542134|FG001|Overall Study|Adverse Event|2|||
144641677|NCT02579603|521542133|FG000|Overall Study|Other than stated|1|||
144641678|NCT02579603|521542134|FG001|Overall Study|Other than stated|0|||
144641679|NCT00469079|521542135|FG000|Overall Study|Lack of Efficacy|3|||
144641680|NCT00469079|521542136|FG001|Overall Study|Lack of Efficacy|8|||
144641681|NCT00469079|521542137|FG002|Overall Study|Lack of Efficacy|5|||
144641682|NCT00469079|521542135|FG000|Overall Study|Adverse Event|1|||
144641683|NCT00469079|521542136|FG001|Overall Study|Adverse Event|3|||
144641684|NCT00469079|521542137|FG002|Overall Study|Adverse Event|2|||
144641685|NCT00469079|521542135|FG000|Overall Study|Lost to Follow-up|4|||
144641686|NCT00469079|521542136|FG001|Overall Study|Lost to Follow-up|8|||
144641687|NCT00469079|521542137|FG002|Overall Study|Lost to Follow-up|10|||
144641688|NCT00469079|521542135|FG000|Overall Study|Withdrawal by Subject|1|||
144641689|NCT00469079|521542136|FG001|Overall Study|Withdrawal by Subject|2|||
144641690|NCT00469079|521542137|FG002|Overall Study|Withdrawal by Subject|2|||
144641691|NCT00469079|521542135|FG000|Overall Study|Ineligible|0|||
144641692|NCT00469079|521542136|FG001|Overall Study|Ineligible|1|||
144641693|NCT00469079|521542137|FG002|Overall Study|Ineligible|0|||
144641694|NCT01006356|521542141|FG000|Overall Study|Adverse Event|6|||
144641695|NCT01006356|521542141|FG000|Overall Study|Physician Decision|1|||
144641696|NCT01006356|521542141|FG000|Overall Study|Paticipants did not cooperate|6|||
144641697|NCT01006356|521542141|FG000|Overall Study|Withdrawal by Subject|1|||
144641698|NCT01006356|521542141|FG000|Overall Study|Choice by participants|2|||
144641699|NCT01006356|521542141|FG000|Overall Study|Protocol Violation|3|||
144641700|NCT01006356|521542141|FG000|Overall Study|Other|23|||
144641701|NCT02981472|521542143|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
144641702|NCT02981472|521542144|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
144641703|NCT02981472|521542143|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144641704|NCT02981472|521542144|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144641705|NCT02981472|521542143|FG000|Treatment Period|Adverse Event|6|||
144641706|NCT02981472|521542144|FG001|Treatment Period|Adverse Event|1|||
144641707|NCT02981472|521542143|FG000|Treatment Period|Participant withdrew consent|1|||
144641708|NCT02981472|521542144|FG001|Treatment Period|Participant withdrew consent|0|||
144641709|NCT02981472|521542143|FG000|Treatment Period|Lost to Follow-up|0|||
144641710|NCT02981472|521542144|FG001|Treatment Period|Lost to Follow-up|1|||
144641711|NCT02799381|521542147|FG000|Overall Study|Withdrew consent|3|||
144641712|NCT02799381|521542148|FG001|Overall Study|Withdrew consent|2|||
144641713|NCT02799381|521542147|FG000|Overall Study|Adverse Event|0|||
144641714|NCT02799381|521542148|FG001|Overall Study|Adverse Event|1|||
144641715|NCT02799381|521542147|FG000|Overall Study|Participant did not take any study drug|1|||
144731302|NCT05093205|521871414|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
144731303|NCT05093205|521871415|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
144641716|NCT02799381|521542148|FG001|Overall Study|Participant did not take any study drug|0|||
144641717|NCT02698410|521542149|FG000|Overall Study|Adverse Event|2|||
144641718|NCT02698410|521542149|FG000|Overall Study|Withdrawal by Subject|1|||
144641719|NCT02698410|521542149|FG000|Overall Study|Other|1|||
144641720|NCT03952130|521542150|FG000|Overall Study|Adverse Event|0|||
144641721|NCT03952130|521542151|FG001|Overall Study|Adverse Event|1|||
144641722|NCT03952130|521542150|FG000|Overall Study|Lost to Follow-up|1|||
144641723|NCT03952130|521542151|FG001|Overall Study|Lost to Follow-up|0|||
144641724|NCT03952130|521542150|FG000|Overall Study|Withdrawal by Subject|1|||
144641725|NCT03952130|521542151|FG001|Overall Study|Withdrawal by Subject|5|||
144641726|NCT02559505|521542153|FG000|Overall Study|Lost to Follow-up|23|||
144641727|NCT02559505|521542154|FG001|Overall Study|Lost to Follow-up|20|||
144641728|NCT02559505|521542153|FG000|Overall Study|Withdrawal by Subject|4|||
144641729|NCT02559505|521542154|FG001|Overall Study|Withdrawal by Subject|2|||
144641730|NCT05882890|521542155|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
144641731|NCT00613314|521542156|FG000|Overall Study|Adverse Event|5|||
144641732|NCT00613314|521542156|FG000|Overall Study|Protocol Violation|14|||
144641733|NCT00613314|521542156|FG000|Overall Study|Lost to Follow-up|46|||
144641734|NCT00613314|521542156|FG000|Overall Study|Other reason not defined above|90|||
144641735|NCT01584024|521542157|FG000|Overall Study|Lost to Follow-up|10|||
144641736|NCT01584024|521542157|FG000|Overall Study|Withdrawal by Subject|3|||
144641737|NCT04331899|521542161|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
144641738|NCT04331899|521542162|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
144641739|NCT02424539|521542165|FG000|Overall Study|Adverse Event|0|||
144641740|NCT02424539|521542166|FG001|Overall Study|Adverse Event|0|||
144641741|NCT02424539|521542167|FG002|Overall Study|Adverse Event|1|||
144641742|NCT02424539|521542165|FG000|Overall Study|Physician Decision|0|||
144641743|NCT02424539|521542166|FG001|Overall Study|Physician Decision|0|||
144641744|NCT02424539|521542167|FG002|Overall Study|Physician Decision|1|||
144641745|NCT02424539|521542165|FG000|Overall Study|Withdrawal by Subject|3|||
144641746|NCT02424539|521542166|FG001|Overall Study|Withdrawal by Subject|1|||
144641747|NCT02424539|521542167|FG002|Overall Study|Withdrawal by Subject|0|||
144641748|NCT02424539|521542165|FG000|Overall Study|Other: Reached stopping criteria|11|||
144641749|NCT02424539|521542166|FG001|Overall Study|Other: Reached stopping criteria|7|||
144641750|NCT02424539|521542167|FG002|Overall Study|Other: Reached stopping criteria|6|||
144641751|NCT00719810|521542168|FG000|Overall Study|Adverse Event|0|||
144641752|NCT00719810|521542169|FG001|Overall Study|Adverse Event|2|||
144641753|NCT00719810|521542170|FG002|Overall Study|Adverse Event|3|||
144641754|NCT00719810|521542168|FG000|Overall Study|Lost to Follow-up|2|||
144641755|NCT00719810|521542169|FG001|Overall Study|Lost to Follow-up|0|||
144641756|NCT00719810|521542170|FG002|Overall Study|Lost to Follow-up|3|||
144641757|NCT00719810|521542168|FG000|Overall Study|Physician Decision|0|||
144641758|NCT00719810|521542169|FG001|Overall Study|Physician Decision|1|||
144641759|NCT00719810|521542170|FG002|Overall Study|Physician Decision|0|||
144641760|NCT00719810|521542168|FG000|Overall Study|Withdrawal by Subject|1|||
144641761|NCT00719810|521542169|FG001|Overall Study|Withdrawal by Subject|1|||
144641762|NCT00719810|521542170|FG002|Overall Study|Withdrawal by Subject|2|||
144641763|NCT04893265|521542173|FG000|Overall Study|Withdrawal by Subject|2|||
144641764|NCT04893265|521542174|FG001|Overall Study|Withdrawal by Subject|5|||
144641765|NCT04893265|521542173|FG000|Overall Study|Lost to Follow-up|0|||
144641766|NCT04893265|521542174|FG001|Overall Study|Lost to Follow-up|4|||
144641767|NCT01973283|521542176|FG000|Overall Study|Lost to Follow-up|4|||
144641768|NCT04899271|521542184|FG000|Overall Study|Lost to Follow-up|1|||
144641769|NCT04899271|521542185|FG001|Overall Study|Lost to Follow-up|0|||
144641770|NCT04899271|521542184|FG000|Overall Study|Subject request/consent withdrawal|2|||
144641771|NCT04899271|521542185|FG001|Overall Study|Subject request/consent withdrawal|0|||
144641772|NCT00900796|521542186|FG000|Phase 1|Lacked sufficient information|4|||
144641773|NCT00900796|521542186|FG000|Phase 1|Missing information at Week 16|7|||
144641774|NCT00900796|521542186|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
144641775|NCT00900796|521542186|FG000|Phase 2|Lost to Follow-up|5|||
144731304|NCT05093205|521871416|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
144731305|NCT05093205|521871417|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
144210865|NCT01207583|519967957|FG001|Overall Study|Withdrawal by Subject|3|||
144210866|NCT01207583|519967958|FG002|Overall Study|Withdrawal by Subject|1|||
144210867|NCT01207583|519967956|FG000|Overall Study|Participant failed to return|1|||
144210868|NCT01207583|519967957|FG001|Overall Study|Participant failed to return|0|||
144210869|NCT01207583|519967958|FG002|Overall Study|Participant failed to return|0|||
144210870|NCT01207583|519967956|FG000|Overall Study|Lost to Follow-up|0|||
144641776|NCT00730236|521542189|FG000|Overall Study|Adverse Event|4|||
144641777|NCT00730236|521542189|FG000|Overall Study|Withdrawal by Subject|1|||
144641778|NCT00730236|521542189|FG000|Overall Study|Non-compliance|1|||
144641779|NCT02500550|521542191|FG000|Overall Study|Death|7|||
144641780|NCT00465569|521542196|FG000|Overall Study|persistent eczema during dose escalation|1|||
144641781|NCT00465569|521542197|FG001|Overall Study|persistent eczema during dose escalation|0|||
144641782|NCT01985321|521542199|FG000|Overall Study|Protocol Violation|4|||
144641783|NCT01985321|521542200|FG001|Overall Study|Protocol Violation|3|||
144641784|NCT01985321|521542199|FG000|Overall Study|Withdrawal by Subject|1|||
144641785|NCT01985321|521542200|FG001|Overall Study|Withdrawal by Subject|0|||
144641786|NCT01985321|521542199|FG000|Overall Study|Lost to Follow-up|5|||
144641787|NCT01985321|521542200|FG001|Overall Study|Lost to Follow-up|2|||
144641788|NCT01985321|521542199|FG000|Overall Study|Subject treated wrong type of sore|1|||
144641789|NCT01985321|521542200|FG001|Overall Study|Subject treated wrong type of sore|0|||
144641790|NCT00482001|521542201|FG000|Overall Study|Protocol Violation|1|||
144641791|NCT00482001|521542202|FG001|Overall Study|Protocol Violation|1|||
144641792|NCT02388776|521542203|FG000|Overall Study|Death|1|||
144641793|NCT02388776|521542203|FG000|Overall Study|Lost to Follow-up|1|||
144641794|NCT03826914|521542204|FG000|Overall Study|Withdrawal by Subject|1|||
144641795|NCT03826914|521542205|FG001|Overall Study|Withdrawal by Subject|1|||
144641796|NCT00542828|521542208|FG000|Overall Study|Physician Decision|1|||
144641797|NCT00542828|521542208|FG000|Overall Study|Need for Prohibited Treatment|3|||
144641798|NCT00542828|521542208|FG000|Overall Study|Study Prematurely Discontinued|7|||
144641799|NCT00542828|521542208|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
144641800|NCT03953118|521542209|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
144641801|NCT03953118|521542210|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
144641802|NCT05139030|521542216|FG000|Overall Study|Withdrawal by Subject|1|||
144641803|NCT05139030|521542217|FG001|Overall Study|Withdrawal by Subject|3|||
144641804|NCT05139030|521542216|FG000|Overall Study|Adverse Event|0|||
144641805|NCT05139030|521542217|FG001|Overall Study|Adverse Event|1|||
144641806|NCT05139030|521542216|FG000|Overall Study|Failure to meet continuation criteria|0|||
144641807|NCT05139030|521542217|FG001|Overall Study|Failure to meet continuation criteria|1|||
144641808|NCT05502289|521542222|FG000|Period 1|Out Of Window|1|||
144641809|NCT05502289|521542223|FG001|Period 1|Out Of Window|0|||
144641810|NCT00613626|521542224|FG000|Overall Study|Ineligible|0|||
144641811|NCT00613626|521542225|FG001|Overall Study|Ineligible|1|||
144641812|NCT00613626|521542226|FG002|Overall Study|Ineligible|0|||
144641813|NCT04375878|521542229|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
144641814|NCT04375878|521542230|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
144641815|NCT04375878|521542231|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
144641816|NCT04375878|521542232|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
144641817|NCT04375878|521542233|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
144641818|NCT04375878|521542234|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
144641819|NCT04375878|521542229|FG000|Crossover First and Second Interventions|Adverse Event|0|||
144641820|NCT04375878|521542230|FG001|Crossover First and Second Interventions|Adverse Event|0|||
144641821|NCT04375878|521542231|FG002|Crossover First and Second Interventions|Adverse Event|1|||
144641822|NCT04375878|521542232|FG003|Crossover First and Second Interventions|Adverse Event|0|||
144641823|NCT04375878|521542233|FG004|Crossover First and Second Interventions|Adverse Event|0|||
144641824|NCT04375878|521542234|FG005|Crossover First and Second Interventions|Adverse Event|0|||
144731306|NCT05093205|521871418|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
144731307|NCT05093205|521871419|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
144731308|NCT05093205|521871407|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731309|NCT05093205|521871408|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731310|NCT05093205|521871409|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731311|NCT05093205|521871410|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731312|NCT05093205|521871411|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731313|NCT05093205|521871412|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731314|NCT05093205|521871413|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731315|NCT05093205|521871414|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731316|NCT05093205|521871415|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731317|NCT05093205|521871416|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731318|NCT05093205|521871417|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
144731319|NCT05093205|521871418|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731320|NCT05093205|521871419|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
144731321|NCT05093205|521871407|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731322|NCT05093205|521871408|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731323|NCT05093205|521871409|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731324|NCT05093205|521871410|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731325|NCT05093205|521871411|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731326|NCT05093205|521871412|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731327|NCT05093205|521871413|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731328|NCT05093205|521871414|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731329|NCT05093205|521871415|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731330|NCT05093205|521871416|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144731331|NCT05093205|521871417|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144641825|NCT04375878|521542229|FG000|Extension Phase|Withdrawal by Subject|0|||
144641826|NCT04375878|521542230|FG001|Extension Phase|Withdrawal by Subject|0|||
144641827|NCT04375878|521542231|FG002|Extension Phase|Withdrawal by Subject|0|||
144731332|NCT05093205|521871418|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
144731333|NCT05093205|521871419|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
144641828|NCT04375878|521542232|FG003|Extension Phase|Withdrawal by Subject|0|||
144641829|NCT04375878|521542233|FG004|Extension Phase|Withdrawal by Subject|1|||
144641830|NCT04375878|521542234|FG005|Extension Phase|Withdrawal by Subject|0|||
144641831|NCT02296840|521542237|FG000|Overall Study|Adverse Event|1|||
144641832|NCT02296840|521542238|FG001|Overall Study|Adverse Event|1|||
144641833|NCT02296840|521542237|FG000|Overall Study|Protocol Violation|2|||
144641834|NCT02296840|521542238|FG001|Overall Study|Protocol Violation|1|||
144641835|NCT02296840|521542237|FG000|Overall Study|Lost to Follow-up|6|||
144641836|NCT02296840|521542238|FG001|Overall Study|Lost to Follow-up|17|||
144641837|NCT00104871|521542239|FG000|Overall Study|Not evaluable|1|||
144641838|NCT04909463|521543861|FG000|Overall Study|Withdrawal by Subject|0|||
144641839|NCT04909463|521543862|FG001|Overall Study|Withdrawal by Subject|1|||
144641840|NCT04909463|521543863|FG002|Overall Study|Withdrawal by Subject|0|||
144641841|NCT04909463|521543864|FG003|Overall Study|Withdrawal by Subject|0|||
144641842|NCT04909463|521543861|FG000|Overall Study|Lost to Follow-up|2|||
144641843|NCT04909463|521543862|FG001|Overall Study|Lost to Follow-up|1|||
144641844|NCT04909463|521543863|FG002|Overall Study|Lost to Follow-up|1|||
144641845|NCT04909463|521543864|FG003|Overall Study|Lost to Follow-up|0|||
144641846|NCT05408858|521543865|FG000|Overall Study|no longer met eligibility criteria|1|||
144641847|NCT01126619|521543873|FG000|Overall Study|Not eligible for the study|2|||
144641848|NCT01126619|521543873|FG000|Overall Study|Investigator decision|4|||
144641849|NCT01126619|521543873|FG000|Overall Study|Serious adverse event|1|||
144641850|NCT01126619|521543873|FG000|Overall Study|Withdrawal by Subject|9|||
144641851|NCT01126619|521543873|FG000|Overall Study|Non-compliance|1|||
144641852|NCT00947154|521543874|FG000|Overall Study|Lost to Follow-up|1|||
144641853|NCT03293030|521543875|FG000|Overall Study|Withdrawal by Subject|3|||
144641854|NCT01121406|521543878|FG000|Overall Study|Progressive disease RECIST|44|||
144641855|NCT01121406|521543879|FG001|Overall Study|Progressive disease RECIST|28|||
144641856|NCT01121406|521543878|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
144210871|NCT01207583|519967957|FG001|Overall Study|Lost to Follow-up|2|||
144210872|NCT01207583|519967958|FG002|Overall Study|Lost to Follow-up|0|||
144210873|NCT02473523|519967959|FG000|Overall Study|Death|1|||
144210874|NCT02473523|519967959|FG000|Overall Study|Lost to Follow-up|1|||
144210875|NCT00576316|519967965|FG000|Overall Study|Adverse Event|9|||
144210876|NCT00576316|519967965|FG000|Overall Study|Withdrawal by Subject|2|||
144210877|NCT00576316|519967965|FG000|Overall Study|Protocol Violation|9|||
144210878|NCT02552303|519967966|FG000|Allocation|Withdrawal by Subject|2|||
144210879|NCT02552303|519967967|FG001|Allocation|Withdrawal by Subject|1|||
144210880|NCT02552303|519967968|FG002|Allocation|Withdrawal by Subject|1|||
144210881|NCT02552303|519967969|FG003|Allocation|Withdrawal by Subject|1|||
144210882|NCT02552303|519967966|FG000|Allocation|ineligible|1|||
144210883|NCT02552303|519967967|FG001|Allocation|ineligible|1|||
144210884|NCT02552303|519967968|FG002|Allocation|ineligible|0|||
144210885|NCT02552303|519967969|FG003|Allocation|ineligible|0|||
144210886|NCT02552303|519967966|FG000|Follow-Up|Lost to Follow-up|0|||
144210887|NCT02552303|519967967|FG001|Follow-Up|Lost to Follow-up|0|||
144210888|NCT02552303|519967968|FG002|Follow-Up|Lost to Follow-up|1|||
144210889|NCT02552303|519967969|FG003|Follow-Up|Lost to Follow-up|0|||
144210890|NCT02552303|519967966|FG000|Follow-Up|ineligible|0|||
144210891|NCT02552303|519967967|FG001|Follow-Up|ineligible|2|||
144210892|NCT02552303|519967968|FG002|Follow-Up|ineligible|0|||
144641857|NCT01121406|521543879|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
144210893|NCT02552303|519967969|FG003|Follow-Up|ineligible|0|||
144641858|NCT01121406|521543878|FG000|Overall Study|Other AE|3|||
144641859|NCT01121406|521543879|FG001|Overall Study|Other AE|10|||
144641860|NCT01121406|521543878|FG000|Overall Study|Non-compliant with protocol|0|||
144641861|NCT01121406|521543879|FG001|Overall Study|Non-compliant with protocol|2|||
144641862|NCT01121406|521543878|FG000|Overall Study|Lost to Follow-up|0|||
144641863|NCT01121406|521543879|FG001|Overall Study|Lost to Follow-up|1|||
144210894|NCT03106987|519967972|FG000|Overall Study|Death|37|||
144641864|NCT01121406|521543878|FG000|Overall Study|Refused continuation of study med.|1|||
144641865|NCT01121406|521543879|FG001|Overall Study|Refused continuation of study med.|2|||
144210895|NCT03106987|519967973|FG001|Overall Study|Death|22|||
144641866|NCT01121406|521543878|FG000|Overall Study|Reason other than specified above|2|||
144641867|NCT01121406|521543879|FG001|Overall Study|Reason other than specified above|6|||
144641868|NCT01121406|521543878|FG000|Overall Study|Not treated|1|||
144210896|NCT03106987|519967974|FG002|Overall Study|Death|12|||
144210897|NCT03106987|519967975|FG003|Overall Study|Death|8|||
144641869|NCT01121406|521543879|FG001|Overall Study|Not treated|0|||
144641870|NCT01829048|521543880|FG000|Overall Study|Withdrawal by Subject|0|||
144641871|NCT01829048|521543881|FG001|Overall Study|Withdrawal by Subject|0|||
144210898|NCT03106987|519967972|FG000|Overall Study|Lost to Follow-up|2|||
144210899|NCT03106987|519967973|FG001|Overall Study|Lost to Follow-up|0|||
144210900|NCT03106987|519967974|FG002|Overall Study|Lost to Follow-up|2|||
144641872|NCT01829048|521543882|FG002|Overall Study|Withdrawal by Subject|0|||
144641873|NCT01829048|521543883|FG003|Overall Study|Withdrawal by Subject|2|||
144210901|NCT03106987|519967975|FG003|Overall Study|Lost to Follow-up|2|||
144210902|NCT03106987|519967972|FG000|Overall Study|Withdrawal by Subject|5|||
144210903|NCT03106987|519967973|FG001|Overall Study|Withdrawal by Subject|1|||
144210904|NCT03106987|519967974|FG002|Overall Study|Withdrawal by Subject|4|||
144210905|NCT03106987|519967975|FG003|Overall Study|Withdrawal by Subject|1|||
144210906|NCT03336528|519967976|FG000|Overall Study|Protocol Violation|1|||
144210907|NCT03336528|519967977|FG001|Overall Study|Protocol Violation|1|||
144210908|NCT03336528|519967976|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
144210909|NCT03336528|519967977|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
144210910|NCT03336528|519967976|FG000|Overall Study|Did not receive study medication|1|||
144210911|NCT03336528|519967977|FG001|Overall Study|Did not receive study medication|2|||
144210912|NCT00799825|519967980|FG000|Overall Study|Adverse Event|1|||
144210913|NCT00799825|519967980|FG000|Overall Study|Withdrawal by Subject|6|||
144210914|NCT00799825|519967980|FG000|Overall Study|Lost to Follow-up|38|||
144210915|NCT00799825|519967980|FG000|Overall Study|Pregnancy|3|||
144210916|NCT00582010|519967981|FG000|Overall Study|Death|0|||
144210917|NCT00582010|519967982|FG001|Overall Study|Death|1|||
144210918|NCT02463357|519967986|FG000|Overall Study|Withdrawal by Subject|1|||
144210919|NCT02463357|519967987|FG001|Overall Study|Withdrawal by Subject|0|||
144210920|NCT02463357|519967988|FG002|Overall Study|Withdrawal by Subject|0|||
144641874|NCT01829048|521543884|FG004|Overall Study|Withdrawal by Subject|0|||
144641875|NCT00892437|521543885|FG000|Randomized Phase|Randomized but not treated|6|||
144641876|NCT00892437|521543886|FG001|Randomized Phase|Randomized but not treated|0|||
144641877|NCT00892437|521543885|FG000|Randomized Phase|Adverse Event|2|||
144641878|NCT00892437|521543886|FG001|Randomized Phase|Adverse Event|2|||
144641879|NCT00892437|521543885|FG000|Randomized Phase|Lost to Follow-up|1|||
144641880|NCT00892437|521543886|FG001|Randomized Phase|Lost to Follow-up|3|||
144210921|NCT02463357|519967989|FG003|Overall Study|Withdrawal by Subject|0|||
144210922|NCT02463357|519967990|FG004|Overall Study|Withdrawal by Subject|0|||
144210923|NCT02463357|519967986|FG000|Overall Study|Withdrawal by Subject|0|||
144210924|NCT02463357|519967987|FG001|Overall Study|Withdrawal by Subject|0|||
144210925|NCT02463357|519967988|FG002|Overall Study|Withdrawal by Subject|0|||
144210926|NCT02463357|519967989|FG003|Overall Study|Withdrawal by Subject|0|||
144210927|NCT02463357|519967990|FG004|Overall Study|Withdrawal by Subject|1|||
144210928|NCT01399658|519967991|FG000|Overall Study|Ineligible|1|||
144210929|NCT01399658|519967991|FG000|Overall Study|Machine Technical Issue|3|||
144210930|NCT01399658|519967991|FG000|Overall Study|Alternative therapy|1|||
144210931|NCT01399658|519967991|FG000|Overall Study|No reason given|1|||
144641881|NCT00892437|521543885|FG000|Randomized Phase|Investigator's Discretion|1|||
144641882|NCT00892437|521543886|FG001|Randomized Phase|Investigator's Discretion|0|||
144641883|NCT00892437|521543885|FG000|Randomized Phase|Withdrew Consent|1|||
144641884|NCT00892437|521543886|FG001|Randomized Phase|Withdrew Consent|0|||
144210932|NCT02681510|519967992|FG000|Overall Study|Withdrawal by Subject|1|||
144210933|NCT02681510|519967992|FG000|Overall Study|Lost to Follow-up|9|||
144210934|NCT00958893|519967995|FG000|Overall Study|Study prematurely terminated|4|||
144210935|NCT00378573|519967996|FG000|Treatment Period|Adverse Event|9|||
144210936|NCT00378573|519967996|FG000|Treatment Period|Physician Decision|1|||
144210937|NCT00378573|519967996|FG000|Treatment Period|Withdrawal by Subject|2|||
144210938|NCT00378573|519967996|FG000|Treatment Period|Disease Progression|4|||
144210939|NCT00378573|519967996|FG000|Treatment Period|Sponsor decision to close study|1|||
144210940|NCT00378573|519967996|FG000|Follow-up|Death|12|||
144210941|NCT00378573|519967996|FG000|Follow-up|Lost to Follow-up|1|||
144210942|NCT00378573|519967996|FG000|Follow-up|Withdrawal by Subject|1|||
144641885|NCT00892437|521543885|FG000|Open-Label Extension Phase|Adverse Event|4|||
144641886|NCT00892437|521543886|FG001|Open-Label Extension Phase|Adverse Event|2|||
144641887|NCT00892437|521543885|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
144210943|NCT01098474|519968005|FG000|Active Phase|Other|0|||
144210944|NCT01098474|519968006|FG001|Active Phase|Other|0|||
144210945|NCT01098474|519968007|FG002|Active Phase|Other|3|||
144210946|NCT01098474|519968008|FG003|Active Phase|Other|0|||
144210947|NCT01098474|519968009|FG004|Active Phase|Other|0|||
144210948|NCT01098474|519968010|FG005|Active Phase|Other|0|||
144210949|NCT01098474|519968005|FG000|Active Phase|Withdrawal by Subject|1|||
144210950|NCT01098474|519968006|FG001|Active Phase|Withdrawal by Subject|1|||
144210951|NCT01098474|519968007|FG002|Active Phase|Withdrawal by Subject|2|||
144210952|NCT01098474|519968008|FG003|Active Phase|Withdrawal by Subject|0|||
144210953|NCT01098474|519968009|FG004|Active Phase|Withdrawal by Subject|0|||
144210954|NCT01098474|519968010|FG005|Active Phase|Withdrawal by Subject|0|||
144641888|NCT00892437|521543886|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
144210955|NCT01098474|519968005|FG000|Active Phase|Lost to Follow-up|1|||
144210956|NCT01098474|519968006|FG001|Active Phase|Lost to Follow-up|0|||
144641889|NCT00892437|521543885|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
144210957|NCT01098474|519968007|FG002|Active Phase|Lost to Follow-up|0|||
144210958|NCT01098474|519968008|FG003|Active Phase|Lost to Follow-up|0|||
144210959|NCT01098474|519968009|FG004|Active Phase|Lost to Follow-up|0|||
144641890|NCT00892437|521543886|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
144210960|NCT01098474|519968010|FG005|Active Phase|Lost to Follow-up|0|||
144210961|NCT01098474|519968005|FG000|Follow Up Phase|Travelled out of study area|0|||
144210962|NCT01098474|519968006|FG001|Follow Up Phase|Travelled out of study area|0|||
144263223|NCT01261390|520163893|FG002|Overall Study|Relocation|0|||
144210963|NCT01098474|519968007|FG002|Follow Up Phase|Travelled out of study area|0|||
144641891|NCT00892437|521543885|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
144641892|NCT00892437|521543886|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
144641893|NCT00892437|521543885|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
144641894|NCT00892437|521543886|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
144641895|NCT00504257|521543887|FG000|Overall Study|Withdrawal by Subject|2|||
144641896|NCT00504257|521543887|FG000|Overall Study|ineligible histology|2|||
144641897|NCT02750410|521543890|FG000|Double-Blind Treatment Period|Adverse Event|2|||
144641898|NCT02750410|521543891|FG001|Double-Blind Treatment Period|Adverse Event|2|||
144641899|NCT02750410|521543890|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144641900|NCT02750410|521543891|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144641901|NCT02750410|521543890|FG000|Open-Label Extension Period|Adverse Event|5|||
144641902|NCT02750410|521543891|FG001|Open-Label Extension Period|Adverse Event|3|||
144641903|NCT02750410|521543890|FG000|Open-Label Extension Period|Protocol Violation|0|||
144641904|NCT02750410|521543891|FG001|Open-Label Extension Period|Protocol Violation|1|||
144641905|NCT02750410|521543890|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
144641906|NCT02750410|521543891|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
144641907|NCT02504541|521543892|FG000|Overall Study|Adverse Event|4|||
144641908|NCT02504541|521543892|FG000|Overall Study|Withdrawal by Subject|4|||
144641909|NCT02504541|521543892|FG000|Overall Study|Lost to Follow-up|1|||
144641910|NCT02504541|521543892|FG000|Overall Study|Met Stopping Criteria|1|||
144641911|NCT02504541|521543892|FG000|Overall Study|Protocol Violation|2|||
144641912|NCT02504541|521543892|FG000|Overall Study|Termination by Sponsor|1|||
144641913|NCT02504541|521543892|FG000|Overall Study|Other|2|||
144641914|NCT02504541|521543892|FG000|Overall Study|Multiple|5|||
144641915|NCT02318602|521543896|FG000|Overall Study|Adverse Event|0|||
144641916|NCT02318602|521543897|FG001|Overall Study|Adverse Event|1|||
144641917|NCT02318602|521543898|FG002|Overall Study|Adverse Event|1|||
144641918|NCT02318602|521543896|FG000|Overall Study|Withdrawal by Subject|0|||
144641919|NCT02318602|521543897|FG001|Overall Study|Withdrawal by Subject|3|||
144641920|NCT02318602|521543898|FG002|Overall Study|Withdrawal by Subject|0|||
144641921|NCT02318602|521543896|FG000|Overall Study|Death|1|||
144641922|NCT02318602|521543897|FG001|Overall Study|Death|0|||
144641923|NCT02318602|521543898|FG002|Overall Study|Death|0|||
144641924|NCT02318602|521543896|FG000|Overall Study|Guardian decision to withdraw|0|||
144641925|NCT02318602|521543897|FG001|Overall Study|Guardian decision to withdraw|0|||
144641926|NCT02318602|521543898|FG002|Overall Study|Guardian decision to withdraw|1|||
144641927|NCT02580058|521543901|FG000|Overall Study|Adverse Event|16|||
144641928|NCT02580058|521543902|FG001|Overall Study|Adverse Event|30|||
144641929|NCT02580058|521543903|FG002|Overall Study|Adverse Event|20|||
144641930|NCT02580058|521543901|FG000|Overall Study|Death|4|||
144641931|NCT02580058|521543902|FG001|Overall Study|Death|4|||
144641932|NCT02580058|521543903|FG002|Overall Study|Death|5|||
144641933|NCT02580058|521543901|FG000|Overall Study|Physician Decision|1|||
144641934|NCT02580058|521543902|FG001|Overall Study|Physician Decision|3|||
144641935|NCT02580058|521543903|FG002|Overall Study|Physician Decision|11|||
144641936|NCT02580058|521543901|FG000|Overall Study|Other|5|||
144641937|NCT02580058|521543902|FG001|Overall Study|Other|1|||
144641938|NCT02580058|521543903|FG002|Overall Study|Other|3|||
144641939|NCT02580058|521543901|FG000|Overall Study|Withdrawal by Subject|4|||
144641940|NCT02580058|521543902|FG001|Overall Study|Withdrawal by Subject|7|||
144641941|NCT02580058|521543903|FG002|Overall Study|Withdrawal by Subject|31|||
144641942|NCT02580058|521543901|FG000|Overall Study|Global Deterioration of Health Status|19|||
144641943|NCT02580058|521543902|FG001|Overall Study|Global Deterioration of Health Status|18|||
144641944|NCT02580058|521543903|FG002|Overall Study|Global Deterioration of Health Status|24|||
144641945|NCT02580058|521543901|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
144641946|NCT02580058|521543902|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144641947|NCT02580058|521543903|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
144641948|NCT02580058|521543901|FG000|Overall Study|Progressive Disease|137|||
144641949|NCT02580058|521543902|FG001|Overall Study|Progressive Disease|125|||
144210964|NCT01098474|519968008|FG003|Follow Up Phase|Travelled out of study area|0|||
144210965|NCT01098474|519968009|FG004|Follow Up Phase|Travelled out of study area|1|||
144210966|NCT01098474|519968010|FG005|Follow Up Phase|Travelled out of study area|0|||
144210967|NCT01098474|519968005|FG000|Follow Up Phase|Other|0|||
144210968|NCT01098474|519968006|FG001|Follow Up Phase|Other|0|||
144210969|NCT01098474|519968007|FG002|Follow Up Phase|Other|0|||
144641950|NCT02580058|521543903|FG002|Overall Study|Progressive Disease|94|||
144641951|NCT02580058|521543901|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144641952|NCT02580058|521543902|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144641953|NCT02580058|521543903|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144210970|NCT01098474|519968008|FG003|Follow Up Phase|Other|0|||
144641954|NCT01193335|521543904|FG000|After Infant Series|Lost to Follow-up|1|||
144641955|NCT01193335|521543905|FG001|After Infant Series|Lost to Follow-up|2|||
144641956|NCT01193335|521543904|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
144641957|NCT01193335|521543905|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
144641958|NCT01193335|521543904|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
144641959|NCT01193335|521543905|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
144641960|NCT01193335|521543904|FG000|1-Year Follow-up|Lost to Follow-up|4|||
144641961|NCT01193335|521543905|FG001|1-Year Follow-up|Lost to Follow-up|0|||
144641962|NCT01193335|521543904|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
144641963|NCT01193335|521543905|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
144641964|NCT01193335|521543904|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
144641965|NCT01193335|521543905|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
144641966|NCT01733329|521543906|FG000|Overall Study|Protocol Violation|1|||
144641967|NCT01733329|521543907|FG001|Overall Study|Protocol Violation|1|||
144641968|NCT01733329|521543906|FG000|Overall Study|Uterine artery injury|1|||
144641969|NCT01733329|521543907|FG001|Overall Study|Uterine artery injury|0|||
144641970|NCT00095303|521543916|FG000|Main Study|Lost to Follow-up|91|||
144641971|NCT00095303|521543917|FG001|Main Study|Lost to Follow-up|87|||
144641972|NCT00095303|521543916|FG000|Follow Up Study|Lost to Follow-up|59|||
144641973|NCT00095303|521543917|FG001|Follow Up Study|Lost to Follow-up|58|||
144641974|NCT01364467|521543918|FG000|Overall Study|Lost to Follow-up|1|||
144641975|NCT01364467|521543919|FG001|Overall Study|Lost to Follow-up|2|||
144641976|NCT03228186|521543922|FG000|Overall Study|Patient never started treatment|1|||
144641977|NCT01634243|521543923|FG000|Overall Study|Adverse Event|5|||
144641978|NCT01634243|521543924|FG001|Overall Study|Adverse Event|5|||
144641979|NCT01634243|521543923|FG000|Overall Study|Lack of Efficacy|1|||
144641980|NCT01634243|521543924|FG001|Overall Study|Lack of Efficacy|0|||
144641981|NCT04246047|521543927|FG000|Overall Study|Death|50|||
144641982|NCT04246047|521543928|FG001|Overall Study|Death|77|||
144641983|NCT04246047|521543927|FG000|Overall Study|Lost to Follow-up|1|||
144641984|NCT04246047|521543928|FG001|Overall Study|Lost to Follow-up|3|||
144641985|NCT04246047|521543927|FG000|Overall Study|Physician Decision|4|||
144641986|NCT04246047|521543928|FG001|Overall Study|Physician Decision|10|||
144641987|NCT04246047|521543927|FG000|Overall Study|Withdrawal by Subject|19|||
144641988|NCT04246047|521543928|FG001|Overall Study|Withdrawal by Subject|26|||
144641989|NCT04246047|521543927|FG000|Overall Study|Ongoing|169|||
144641990|NCT04246047|521543928|FG001|Overall Study|Ongoing|135|||
144641991|NCT02502864|521543934|FG000|Overall Study|Withdrawal by Subject|1|||
144641992|NCT00519532|521543940|FG000|Overall Study|Adverse Event|11|||
144641993|NCT00519532|521543940|FG000|Overall Study|Withdrawal by Subject|5|||
144641994|NCT00519532|521543940|FG000|Overall Study|Lost to Follow-up|2|||
144641995|NCT00667277|521543941|FG000|Overall Study|Withdrawal by Subject|2|||
144641996|NCT00814710|521543944|FG000|Overall Study|Adverse Event|1|||
144641997|NCT00814710|521543945|FG001|Overall Study|Adverse Event|0|||
144641998|NCT00814710|521543944|FG000|Overall Study|Lost to Follow-up|7|||
144641999|NCT00814710|521543945|FG001|Overall Study|Lost to Follow-up|3|||
144642000|NCT00457639|521543947|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
144642001|NCT00457639|521543948|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
144642002|NCT00457639|521543947|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
144642003|NCT00457639|521543948|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
144642004|NCT00457639|521543947|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
144642005|NCT00457639|521543948|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
144642006|NCT03885284|521543949|FG000|Overall Study|Disease Progression|1|||
144642007|NCT03885284|521543950|FG001|Overall Study|Disease Progression|3|||
144642008|NCT03885284|521543949|FG000|Overall Study|Physician Decision|0|||
144642009|NCT03885284|521543950|FG001|Overall Study|Physician Decision|1|||
144642010|NCT02117687|521543955|FG000|Overall Study|Lost to Follow-up|0|||
144642011|NCT02117687|521543956|FG001|Overall Study|Lost to Follow-up|1|||
144642012|NCT02117687|521543955|FG000|Overall Study|Adverse Event|0|||
144642013|NCT02117687|521543956|FG001|Overall Study|Adverse Event|2|||
144642014|NCT02117687|521543955|FG000|Overall Study|Other Reasons|1|||
144642015|NCT02117687|521543956|FG001|Overall Study|Other Reasons|1|||
144642016|NCT00002850|521543957|FG000|Overall Study|Death|4|||
144642017|NCT00002850|521543958|FG001|Overall Study|Death|1|||
144642018|NCT00002850|521543959|FG002|Overall Study|Death|3|||
144642019|NCT00002850|521543957|FG000|Overall Study|Protocol Violation|1|||
144642020|NCT00002850|521543958|FG001|Overall Study|Protocol Violation|0|||
144642021|NCT00002850|521543959|FG002|Overall Study|Protocol Violation|1|||
144642022|NCT00002850|521543957|FG000|Overall Study|Withdrawal by Subject|0|||
144642023|NCT00002850|521543958|FG001|Overall Study|Withdrawal by Subject|1|||
144642024|NCT00002850|521543959|FG002|Overall Study|Withdrawal by Subject|0|||
144642025|NCT01450540|521543960|FG000|Overall Study|Withdrawal by Subject|19|||
144642026|NCT01450540|521543961|FG001|Overall Study|Withdrawal by Subject|13|||
144642027|NCT01450540|521543960|FG000|Overall Study|protocol deviation|3|||
144642028|NCT01450540|521543961|FG001|Overall Study|protocol deviation|23|||
144642029|NCT01687673|521543973|FG000|Overall Study|Physician Decision|1|||
144642030|NCT02234622|521543974|FG000|Overall Study|Withdrawal by Subject|16|||
144642031|NCT02234622|521543975|FG001|Overall Study|Withdrawal by Subject|22|||
144642032|NCT02234622|521543974|FG000|Overall Study|Lost to Follow-up|27|||
144642033|NCT02234622|521543975|FG001|Overall Study|Lost to Follow-up|14|||
144642034|NCT00618956|521543976|FG000|Overall Study|Adverse Event|10|||
144642035|NCT00618956|521543977|FG001|Overall Study|Adverse Event|34|||
144642036|NCT00618956|521543976|FG000|Overall Study|Lack of Efficacy|2|||
144642037|NCT00618956|521543977|FG001|Overall Study|Lack of Efficacy|1|||
144642038|NCT00618956|521543976|FG000|Overall Study|Withdrawal by Subject|5|||
144642039|NCT00618956|521543977|FG001|Overall Study|Withdrawal by Subject|7|||
144642040|NCT00618956|521543976|FG000|Overall Study|Lost to Follow-up|4|||
144642041|NCT00618956|521543977|FG001|Overall Study|Lost to Follow-up|5|||
144642042|NCT00618956|521543976|FG000|Overall Study|Protocol Violation|2|||
144642043|NCT00618956|521543977|FG001|Overall Study|Protocol Violation|2|||
144642044|NCT00618956|521543976|FG000|Overall Study|did not meet criteria, non-compliance|2|||
144642045|NCT00618956|521543977|FG001|Overall Study|did not meet criteria, non-compliance|1|||
144642046|NCT03598777|521543978|FG000|Overall Study|Study Terminated by Sponsor|3|||
144642047|NCT03598777|521543979|FG001|Overall Study|Study Terminated by Sponsor|0|||
144642048|NCT03598777|521543980|FG002|Overall Study|Study Terminated by Sponsor|0|||
144642049|NCT03598777|521543981|FG003|Overall Study|Study Terminated by Sponsor|0|||
144642050|NCT03598777|521543982|FG004|Overall Study|Study Terminated by Sponsor|15|||
144642051|NCT03598777|521543978|FG000|Overall Study|Withdrawal by Subject|1|||
144642052|NCT03598777|521543979|FG001|Overall Study|Withdrawal by Subject|1|||
144642053|NCT03598777|521543980|FG002|Overall Study|Withdrawal by Subject|0|||
144642054|NCT03598777|521543981|FG003|Overall Study|Withdrawal by Subject|0|||
144642055|NCT03598777|521543982|FG004|Overall Study|Withdrawal by Subject|0|||
144642056|NCT03598777|521543978|FG000|Overall Study|Adverse Event|1|||
144642057|NCT03598777|521543979|FG001|Overall Study|Adverse Event|0|||
144642058|NCT03598777|521543980|FG002|Overall Study|Adverse Event|0|||
144642059|NCT03598777|521543981|FG003|Overall Study|Adverse Event|0|||
144642060|NCT03598777|521543982|FG004|Overall Study|Adverse Event|0|||
144642061|NCT03598777|521543978|FG000|Overall Study|Lost to Follow-up|1|||
144642062|NCT03598777|521543979|FG001|Overall Study|Lost to Follow-up|0|||
144642063|NCT03598777|521543980|FG002|Overall Study|Lost to Follow-up|0|||
144642064|NCT03598777|521543981|FG003|Overall Study|Lost to Follow-up|0|||
144642065|NCT03598777|521543982|FG004|Overall Study|Lost to Follow-up|0|||
144642066|NCT02006576|521543983|FG000|Overall Study|Withdrawal by Subject|4|||
144642067|NCT02006576|521543984|FG001|Overall Study|Withdrawal by Subject|6|||
144642068|NCT02006576|521543985|FG002|Overall Study|Withdrawal by Subject|2|||
144642069|NCT02006576|521543983|FG000|Overall Study|Death|0|||
144642070|NCT02006576|521543984|FG001|Overall Study|Death|0|||
144642071|NCT02006576|521543985|FG002|Overall Study|Death|1|||
144642072|NCT02006576|521543983|FG000|Overall Study|Lost to Follow-up|1|||
144642073|NCT02006576|521543984|FG001|Overall Study|Lost to Follow-up|0|||
144642074|NCT02006576|521543985|FG002|Overall Study|Lost to Follow-up|1|||
144642075|NCT02006576|521543983|FG000|Overall Study|Screen Failure, too sick, other|13|||
144642076|NCT02006576|521543984|FG001|Overall Study|Screen Failure, too sick, other|1|||
144642077|NCT02006576|521543985|FG002|Overall Study|Screen Failure, too sick, other|13|||
144642078|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
144642079|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
144642080|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
144642081|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
144642082|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
144642083|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
144642084|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
144642085|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
144642086|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
144642087|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
144642088|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
144642089|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
144642090|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
144642091|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
144642092|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
144642093|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
144642094|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
144642095|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
144642096|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
144642097|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
144642098|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
144642099|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
144642100|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
144642101|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
144642102|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
144642103|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
144642104|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
144642105|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
144642106|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
144642107|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
144642108|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
144642109|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
144642110|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
144642111|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
144642112|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
144642113|NCT00785577|521543986|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
144642114|NCT00785577|521543987|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
144642115|NCT00785577|521543988|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
144642116|NCT00785577|521543989|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
144642117|NCT00785577|521543990|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
144642118|NCT00785577|521543986|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
144642119|NCT00785577|521543987|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
144210971|NCT01098474|519968009|FG004|Follow Up Phase|Other|0|||
144210972|NCT01098474|519968010|FG005|Follow Up Phase|Other|4|||
144210973|NCT01098474|519968005|FG000|Follow Up Phase|Withdrawal by Subject|0|||
144210974|NCT01098474|519968006|FG001|Follow Up Phase|Withdrawal by Subject|0|||
144210975|NCT01098474|519968007|FG002|Follow Up Phase|Withdrawal by Subject|0|||
144210976|NCT01098474|519968008|FG003|Follow Up Phase|Withdrawal by Subject|2|||
144210977|NCT01098474|519968009|FG004|Follow Up Phase|Withdrawal by Subject|0|||
144210978|NCT01098474|519968010|FG005|Follow Up Phase|Withdrawal by Subject|1|||
144210979|NCT01098474|519968005|FG000|Follow Up Phase|Lost to Follow-up|0|||
144210980|NCT01098474|519968006|FG001|Follow Up Phase|Lost to Follow-up|0|||
144210981|NCT01098474|519968007|FG002|Follow Up Phase|Lost to Follow-up|0|||
144210982|NCT01098474|519968008|FG003|Follow Up Phase|Lost to Follow-up|0|||
144210983|NCT01098474|519968009|FG004|Follow Up Phase|Lost to Follow-up|1|||
144210984|NCT01098474|519968010|FG005|Follow Up Phase|Lost to Follow-up|0|||
144210985|NCT02257385|519968015|FG000|Overall Study|Adverse Event|12|||
144210986|NCT02257385|519968016|FG001|Overall Study|Adverse Event|8|||
144210987|NCT02257385|519968015|FG000|Overall Study|Lack of Efficacy|1|||
144210988|NCT02257385|519968016|FG001|Overall Study|Lack of Efficacy|2|||
144210989|NCT02257385|519968015|FG000|Overall Study|Protocol Violation|5|||
144210990|NCT02257385|519968016|FG001|Overall Study|Protocol Violation|7|||
144210991|NCT02257385|519968015|FG000|Overall Study|Lost to Follow-up|0|||
144210992|NCT02257385|519968016|FG001|Overall Study|Lost to Follow-up|1|||
144210993|NCT02257385|519968015|FG000|Overall Study|Withdrawal by Subject|4|||
144210994|NCT02257385|519968016|FG001|Overall Study|Withdrawal by Subject|4|||
144210995|NCT01449370|519968019|FG000|Overall Study|Disease Progression|5|||
144210996|NCT01449370|519968020|FG001|Overall Study|Disease Progression|4|||
144210997|NCT01449370|519968021|FG002|Overall Study|Disease Progression|8|||
144210998|NCT01449370|519968022|FG003|Overall Study|Disease Progression|3|||
144210999|NCT01449370|519968023|FG004|Overall Study|Disease Progression|3|||
144642120|NCT00785577|521543988|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
144642121|NCT00785577|521543989|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
144642122|NCT00785577|521543990|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
144642123|NCT00785577|521543986|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
144642124|NCT00785577|521543987|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
144642125|NCT00785577|521543988|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
144642126|NCT00785577|521543989|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
144642127|NCT00785577|521543990|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
144642128|NCT02515669|521543999|FG000|228 Week Open-Label Phase|Other|0|||
144642129|NCT02515669|521544000|FG001|228 Week Open-Label Phase|Other|0|||
144642130|NCT02515669|521544001|FG002|228 Week Open-Label Phase|Other|1|||
144642131|NCT02515669|521544002|FG003|228 Week Open-Label Phase|Other|4|||
144642132|NCT02515669|521543999|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
144642133|NCT02515669|521544000|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
144642134|NCT02515669|521544001|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
144642135|NCT02515669|521544002|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
144642136|NCT02515669|521543999|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
144642137|NCT02515669|521544000|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
144642138|NCT02515669|521544001|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
144642139|NCT02515669|521544002|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
144642140|NCT02515669|521543999|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
144642141|NCT02515669|521544000|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
144642142|NCT02515669|521544001|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
144642143|NCT02515669|521544002|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
144642144|NCT02515669|521543999|FG000|228 Week Open-Label Phase|Missing|0|||
144642145|NCT02515669|521544000|FG001|228 Week Open-Label Phase|Missing|2|||
144642146|NCT02515669|521544001|FG002|228 Week Open-Label Phase|Missing|2|||
144642147|NCT02515669|521544002|FG003|228 Week Open-Label Phase|Missing|2|||
144211000|NCT01449370|519968024|FG005|Overall Study|Disease Progression|3|||
144642148|NCT00630032|521544005|FG000|Overall Study|Death|55|||
144642149|NCT00630032|521544006|FG001|Overall Study|Death|49|||
144211001|NCT01449370|519968025|FG006|Overall Study|Disease Progression|3|||
144211002|NCT01449370|519968026|FG007|Overall Study|Disease Progression|2|||
144211003|NCT01449370|519968027|FG008|Overall Study|Disease Progression|9|||
144211004|NCT01449370|519968028|FG009|Overall Study|Disease Progression|1|||
144211005|NCT01449370|519968029|FG010|Overall Study|Disease Progression|3|||
144211006|NCT01449370|519968030|FG011|Overall Study|Disease Progression|3|||
144211007|NCT01449370|519968031|FG012|Overall Study|Disease Progression|2|||
144642150|NCT00630032|521544005|FG000|Overall Study|Withdrawal by Subject|3|||
144642151|NCT00630032|521544006|FG001|Overall Study|Withdrawal by Subject|2|||
144642152|NCT00630032|521544005|FG000|Overall Study|Lost to Follow-up|18|||
144642153|NCT00630032|521544006|FG001|Overall Study|Lost to Follow-up|31|||
144642154|NCT00630032|521544005|FG000|Overall Study|Protocol Violation|1|||
144642155|NCT00630032|521544006|FG001|Overall Study|Protocol Violation|0|||
144642156|NCT00630032|521544005|FG000|Overall Study|Patient has moved|1|||
144642157|NCT00630032|521544006|FG001|Overall Study|Patient has moved|1|||
144642158|NCT00630032|521544005|FG000|Overall Study|Disease progression|1|||
144642159|NCT00630032|521544006|FG001|Overall Study|Disease progression|1|||
144642160|NCT00630032|521544005|FG000|Overall Study|End of monitoring in US centers|11|||
144642161|NCT00630032|521544006|FG001|Overall Study|End of monitoring in US centers|11|||
144642162|NCT02332915|521544007|FG000|Overall Study|Moved out of region|3|||
144642163|NCT02332915|521544008|FG001|Overall Study|Moved out of region|0|||
144642164|NCT02332915|521544007|FG000|Overall Study|Unrelated illness|1|||
144642165|NCT02332915|521544008|FG001|Overall Study|Unrelated illness|1|||
144642166|NCT02332915|521544007|FG000|Overall Study|Travel distance prohibitive|0|||
144642167|NCT02332915|521544008|FG001|Overall Study|Travel distance prohibitive|1|||
144642168|NCT02332915|521544007|FG000|Overall Study|did not meet inclusion criteria|2|||
144642169|NCT02332915|521544008|FG001|Overall Study|did not meet inclusion criteria|4|||
144642170|NCT01901328|521544012|FG000|Overall Study|Lost to Follow-up|1|||
144642171|NCT01901328|521544013|FG001|Overall Study|Lost to Follow-up|0|||
144642172|NCT01901328|521544012|FG000|Overall Study|Physician Decision|0|||
144642173|NCT01901328|521544013|FG001|Overall Study|Physician Decision|1|||
144642174|NCT01901328|521544012|FG000|Overall Study|Protocol Violation|1|||
144642175|NCT01901328|521544013|FG001|Overall Study|Protocol Violation|1|||
144642176|NCT01901328|521544012|FG000|Overall Study|Study Terminated by Sponsor|19|||
144642177|NCT01901328|521544013|FG001|Overall Study|Study Terminated by Sponsor|16|||
144642178|NCT01901328|521544012|FG000|Overall Study|Withdrawal by Subject|1|||
144642179|NCT01901328|521544013|FG001|Overall Study|Withdrawal by Subject|2|||
144642180|NCT01901328|521544012|FG000|Overall Study|Lack of Efficacy|0|||
144642181|NCT01901328|521544013|FG001|Overall Study|Lack of Efficacy|1|||
144642182|NCT05405166|521545761|FG000|Overall Study|Death|49|||
144642183|NCT05405166|521545762|FG001|Overall Study|Death|50|||
144642184|NCT05405166|521545761|FG000|Overall Study|Withdrawal by Subject|10|||
144642185|NCT05405166|521545762|FG001|Overall Study|Withdrawal by Subject|3|||
144642186|NCT05405166|521545761|FG000|Overall Study|Ongoing at the time of PCD|209|||
144642187|NCT05405166|521545762|FG001|Overall Study|Ongoing at the time of PCD|210|||
144642188|NCT01386385|521545763|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
144642189|NCT01386385|521545764|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642190|NCT01386385|521545765|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642191|NCT01386385|521545766|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642192|NCT01386385|521545767|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642193|NCT01386385|521545768|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642194|NCT01386385|521545769|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642195|NCT01386385|521545770|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
144642196|NCT01386385|521545763|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
144642197|NCT01386385|521545764|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642198|NCT01386385|521545765|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642199|NCT01386385|521545766|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642200|NCT01386385|521545767|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642201|NCT01386385|521545768|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642202|NCT01386385|521545769|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642203|NCT01386385|521545770|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
144642204|NCT01386385|521545763|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144642205|NCT01386385|521545764|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144211008|NCT01449370|519968032|FG013|Overall Study|Disease Progression|8|||
144211009|NCT01449370|519968033|FG014|Overall Study|Disease Progression|3|||
144211010|NCT01449370|519968034|FG015|Overall Study|Disease Progression|1|||
144642206|NCT01386385|521545765|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
144642207|NCT01386385|521545766|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144642208|NCT01386385|521545767|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144642209|NCT01386385|521545768|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144731334|NCT05093205|521871407|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
144211011|NCT01449370|519968035|FG016|Overall Study|Disease Progression|4|||
144642210|NCT01386385|521545769|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144642211|NCT01386385|521545770|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
144642212|NCT01386385|521545763|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144642213|NCT01386385|521545764|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144211012|NCT01449370|519968036|FG017|Overall Study|Disease Progression|3|||
144211013|NCT01449370|519968037|FG018|Overall Study|Disease Progression|1|||
144642214|NCT01386385|521545765|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144642215|NCT01386385|521545766|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144642216|NCT01386385|521545767|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
144642217|NCT01386385|521545768|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144642218|NCT01386385|521545769|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144642219|NCT01386385|521545770|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
144642220|NCT01386385|521545763|FG000|Phase II Concurrent CRT|Adverse Event|0|||
144642221|NCT01386385|521545764|FG001|Phase II Concurrent CRT|Adverse Event|0|||
144642222|NCT01386385|521545765|FG002|Phase II Concurrent CRT|Adverse Event|0|||
144642223|NCT01386385|521545766|FG003|Phase II Concurrent CRT|Adverse Event|0|||
144642224|NCT01386385|521545767|FG004|Phase II Concurrent CRT|Adverse Event|0|||
144642225|NCT01386385|521545768|FG005|Phase II Concurrent CRT|Adverse Event|0|||
144642226|NCT01386385|521545769|FG006|Phase II Concurrent CRT|Adverse Event|3|||
144642227|NCT01386385|521545770|FG007|Phase II Concurrent CRT|Adverse Event|3|||
144642228|NCT01386385|521545763|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642229|NCT01386385|521545764|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642230|NCT01386385|521545765|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642231|NCT01386385|521545766|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642232|NCT01386385|521545767|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642233|NCT01386385|521545768|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642234|NCT01386385|521545769|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
144642235|NCT01386385|521545770|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
144642236|NCT01386385|521545763|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
144642237|NCT01386385|521545764|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
144642238|NCT01386385|521545765|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
144642239|NCT01386385|521545766|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
144642240|NCT01386385|521545767|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
144642241|NCT01386385|521545768|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
144642242|NCT01386385|521545769|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
144642243|NCT01386385|521545770|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
144642244|NCT01386385|521545763|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642245|NCT01386385|521545764|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642246|NCT01386385|521545765|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642247|NCT01386385|521545766|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642248|NCT01386385|521545767|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642249|NCT01386385|521545768|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642250|NCT01386385|521545769|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
144642251|NCT01386385|521545770|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
144642252|NCT01386385|521545763|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
144642253|NCT01386385|521545764|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
144642254|NCT01386385|521545765|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
144642255|NCT01386385|521545766|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
144642256|NCT01386385|521545767|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
144642257|NCT01386385|521545768|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
144642258|NCT01386385|521545769|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
144642259|NCT01386385|521545770|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
144642260|NCT01084252|521545772|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642261|NCT01084252|521545773|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642262|NCT01084252|521545774|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642263|NCT01084252|521545775|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642264|NCT01084252|521545776|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642265|NCT01084252|521545777|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642266|NCT01084252|521545778|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642267|NCT01084252|521545779|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642268|NCT01084252|521545780|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642269|NCT01084252|521545781|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642270|NCT01084252|521545782|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642271|NCT01084252|521545783|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642272|NCT01084252|521545784|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
144642273|NCT01084252|521545785|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
144642274|NCT03395210|521545786|FG000|Overall Study|Other|0|||
144642275|NCT03395210|521545787|FG001|Overall Study|Other|0|||
144642276|NCT03395210|521545788|FG002|Overall Study|Other|0|||
144211014|NCT01449370|519968038|FG019|Overall Study|Disease Progression|2|||
144211015|NCT01449370|519968039|FG020|Overall Study|Disease Progression|5|||
144211016|NCT01449370|519968040|FG021|Overall Study|Disease Progression|2|||
144211017|NCT01449370|519968041|FG022|Overall Study|Disease Progression|3|||
144211018|NCT01449370|519968042|FG023|Overall Study|Disease Progression|7|||
144211019|NCT01449370|519968043|FG024|Overall Study|Disease Progression|3|||
144642277|NCT03395210|521545789|FG003|Overall Study|Other|0|||
144642278|NCT03395210|521545790|FG004|Overall Study|Other|1|||
144642279|NCT03395210|521545786|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
144642280|NCT03395210|521545787|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
144642281|NCT03395210|521545788|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
144642282|NCT03395210|521545789|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
144642283|NCT03395210|521545790|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
144642284|NCT03395210|521545786|FG000|Overall Study|Adverse Event|1|||
144642285|NCT03395210|521545787|FG001|Overall Study|Adverse Event|0|||
144642286|NCT03395210|521545788|FG002|Overall Study|Adverse Event|2|||
144642287|NCT03395210|521545789|FG003|Overall Study|Adverse Event|4|||
144642288|NCT03395210|521545790|FG004|Overall Study|Adverse Event|3|||
144642289|NCT03395210|521545786|FG000|Overall Study|Need of Rescue Medication|1|||
144642290|NCT03395210|521545787|FG001|Overall Study|Need of Rescue Medication|0|||
144642291|NCT03395210|521545788|FG002|Overall Study|Need of Rescue Medication|1|||
144642292|NCT03395210|521545789|FG003|Overall Study|Need of Rescue Medication|4|||
144642293|NCT03395210|521545790|FG004|Overall Study|Need of Rescue Medication|0|||
144642294|NCT03395210|521545786|FG000|Overall Study|Lack of Response|0|||
144642295|NCT03395210|521545787|FG001|Overall Study|Lack of Response|0|||
144642296|NCT03395210|521545788|FG002|Overall Study|Lack of Response|0|||
144642297|NCT03395210|521545789|FG003|Overall Study|Lack of Response|5|||
144642298|NCT03395210|521545790|FG004|Overall Study|Lack of Response|5|||
144642299|NCT03395210|521545786|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
144642300|NCT03395210|521545787|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
144642301|NCT03395210|521545788|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
144642302|NCT03395210|521545789|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
144642303|NCT03395210|521545790|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
144642304|NCT03395210|521545786|FG000|Overall Study|Participant Decision|1|||
144642305|NCT03395210|521545787|FG001|Overall Study|Participant Decision|1|||
144642306|NCT03395210|521545788|FG002|Overall Study|Participant Decision|0|||
144642307|NCT03395210|521545789|FG003|Overall Study|Participant Decision|4|||
144642308|NCT03395210|521545790|FG004|Overall Study|Participant Decision|0|||
144642309|NCT03395210|521545786|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
144642310|NCT03395210|521545787|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
144642311|NCT03395210|521545788|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
144642312|NCT03395210|521545789|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
144642313|NCT03395210|521545790|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
144642314|NCT04364854|521545791|FG000|Overall Study|Withdrawal by Subject|1|||
144642315|NCT04364854|521545792|FG001|Overall Study|Withdrawal by Subject|0|||
144642316|NCT04364854|521545793|FG002|Overall Study|Withdrawal by Subject|1|||
144642317|NCT04364854|521545794|FG003|Overall Study|Withdrawal by Subject|3|||
144642318|NCT04364854|521545791|FG000|Overall Study|Death|1|||
144642319|NCT04364854|521545792|FG001|Overall Study|Death|0|||
144642320|NCT04364854|521545793|FG002|Overall Study|Death|0|||
144642321|NCT04364854|521545794|FG003|Overall Study|Death|0|||
144642322|NCT04364854|521545791|FG000|Overall Study|Lost to Follow-up|0|||
144642323|NCT04364854|521545792|FG001|Overall Study|Lost to Follow-up|0|||
144642324|NCT04364854|521545793|FG002|Overall Study|Lost to Follow-up|0|||
144642325|NCT04364854|521545794|FG003|Overall Study|Lost to Follow-up|1|||
144642326|NCT01826214|521545798|FG000|Overall Study|Adverse Event|7|||
144642327|NCT01826214|521545799|FG001|Overall Study|Adverse Event|6|||
144642328|NCT01826214|521545798|FG000|Overall Study|Death|3|||
144642329|NCT01826214|521545799|FG001|Overall Study|Death|1|||
144642330|NCT01826214|521545798|FG000|Overall Study|Lost to Follow-up|1|||
144642331|NCT01826214|521545799|FG001|Overall Study|Lost to Follow-up|0|||
144642332|NCT01826214|521545798|FG000|Overall Study|Physician Decision|0|||
144642333|NCT01826214|521545799|FG001|Overall Study|Physician Decision|2|||
144642334|NCT01826214|521545798|FG000|Overall Study|Progressive disease|22|||
144642335|NCT01826214|521545799|FG001|Overall Study|Progressive disease|21|||
144642336|NCT01826214|521545798|FG000|Overall Study|Study terminated by Sponsor|0|||
144642337|NCT01826214|521545799|FG001|Overall Study|Study terminated by Sponsor|1|||
144642338|NCT01826214|521545798|FG000|Overall Study|Subject/guardian decision|2|||
144642339|NCT01826214|521545799|FG001|Overall Study|Subject/guardian decision|3|||
144642340|NCT00955110|521545800|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
144642341|NCT00955110|521545800|FG000|Treatment Phase|Adverse Event|2|||
144211020|NCT01449370|519968019|FG000|Overall Study|Adverse Event|1|||
144211021|NCT01449370|519968020|FG001|Overall Study|Adverse Event|2|||
144211022|NCT01449370|519968021|FG002|Overall Study|Adverse Event|0|||
144211023|NCT01449370|519968022|FG003|Overall Study|Adverse Event|1|||
144211024|NCT01449370|519968023|FG004|Overall Study|Adverse Event|0|||
144211025|NCT01449370|519968024|FG005|Overall Study|Adverse Event|0|||
144211026|NCT01449370|519968025|FG006|Overall Study|Adverse Event|0|||
144211027|NCT01449370|519968026|FG007|Overall Study|Adverse Event|0|||
144211028|NCT01449370|519968027|FG008|Overall Study|Adverse Event|1|||
144211029|NCT01449370|519968028|FG009|Overall Study|Adverse Event|1|||
144642342|NCT00955110|521545800|FG000|Treatment Phase|Administrative reasons|2|||
144211030|NCT01449370|519968029|FG010|Overall Study|Adverse Event|0|||
144211031|NCT01449370|519968030|FG011|Overall Study|Adverse Event|0|||
144211032|NCT01449370|519968031|FG012|Overall Study|Adverse Event|0|||
144211033|NCT01449370|519968032|FG013|Overall Study|Adverse Event|2|||
144211034|NCT01449370|519968033|FG014|Overall Study|Adverse Event|0|||
144642343|NCT00955110|521545800|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
144642344|NCT00955110|521545800|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
144642345|NCT02128490|521545801|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
144642346|NCT02128490|521545802|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
144642347|NCT02128490|521545803|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
144642348|NCT02128490|521545804|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
144642349|NCT02128490|521545805|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
144642350|NCT02128490|521545801|FG000|Overall Study|Major Protocol Deviation|1|||
144642351|NCT02128490|521545802|FG001|Overall Study|Major Protocol Deviation|2|||
144642352|NCT02128490|521545803|FG002|Overall Study|Major Protocol Deviation|0|||
144642353|NCT02128490|521545804|FG003|Overall Study|Major Protocol Deviation|2|||
144642354|NCT02128490|521545805|FG004|Overall Study|Major Protocol Deviation|2|||
144642355|NCT02128490|521545801|FG000|Overall Study|Lost to Follow-up|0|||
144642356|NCT02128490|521545802|FG001|Overall Study|Lost to Follow-up|0|||
144642357|NCT02128490|521545803|FG002|Overall Study|Lost to Follow-up|1|||
144642358|NCT02128490|521545804|FG003|Overall Study|Lost to Follow-up|1|||
144642359|NCT02128490|521545805|FG004|Overall Study|Lost to Follow-up|1|||
144642360|NCT02128490|521545801|FG000|Overall Study|Voluntary Withdrawal|3|||
144642361|NCT02128490|521545802|FG001|Overall Study|Voluntary Withdrawal|3|||
144642362|NCT02128490|521545803|FG002|Overall Study|Voluntary Withdrawal|1|||
144642363|NCT02128490|521545804|FG003|Overall Study|Voluntary Withdrawal|1|||
144642364|NCT02128490|521545805|FG004|Overall Study|Voluntary Withdrawal|2|||
144642365|NCT02128490|521545801|FG000|Overall Study|Lack of Efficacy|0|||
144642366|NCT02128490|521545802|FG001|Overall Study|Lack of Efficacy|1|||
144642367|NCT02128490|521545803|FG002|Overall Study|Lack of Efficacy|0|||
144642368|NCT02128490|521545804|FG003|Overall Study|Lack of Efficacy|0|||
144642369|NCT02128490|521545805|FG004|Overall Study|Lack of Efficacy|0|||
144642370|NCT02128490|521545801|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
144642371|NCT02128490|521545802|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
144642372|NCT02128490|521545803|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
144642373|NCT02128490|521545804|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
144642374|NCT02128490|521545805|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
144642375|NCT02128490|521545801|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144642376|NCT02128490|521545802|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144642377|NCT02128490|521545803|FG002|Overall Study|Other Miscellaneous Reasons|2|||
144642378|NCT02128490|521545804|FG003|Overall Study|Other Miscellaneous Reasons|1|||
144642379|NCT02128490|521545805|FG004|Overall Study|Other Miscellaneous Reasons|1|||
144642380|NCT02243176|521545806|FG000|Overall Study|Other reason|1|||
144642381|NCT02243176|521545807|FG001|Overall Study|Other reason|2|||
144642382|NCT02243176|521545806|FG000|Overall Study|protocol specified withdrawal critera|1|||
144642383|NCT02243176|521545807|FG001|Overall Study|protocol specified withdrawal critera|3|||
144642384|NCT02243176|521545806|FG000|Overall Study|Protocol Violation|2|||
144731335|NCT05093205|521871408|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
144731336|NCT05093205|521871409|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
144731337|NCT05093205|521871410|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
144731338|NCT05093205|521871411|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
144731339|NCT05093205|521871412|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
144731340|NCT05093205|521871413|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
144731341|NCT05093205|521871414|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
144731342|NCT05093205|521871415|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
144731343|NCT05093205|521871416|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
144731344|NCT05093205|521871417|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
144731345|NCT05093205|521871418|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
144731346|NCT05093205|521871419|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
144731347|NCT05093205|521871407|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731348|NCT05093205|521871408|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731349|NCT05093205|521871409|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144211035|NCT01449370|519968034|FG015|Overall Study|Adverse Event|1|||
144211036|NCT01449370|519968035|FG016|Overall Study|Adverse Event|0|||
144211037|NCT01449370|519968036|FG017|Overall Study|Adverse Event|0|||
144642385|NCT02243176|521545807|FG001|Overall Study|Protocol Violation|1|||
144642386|NCT02243176|521545806|FG000|Overall Study|Withdrawal by Subject|8|||
144642387|NCT02243176|521545807|FG001|Overall Study|Withdrawal by Subject|7|||
144642388|NCT02243176|521545806|FG000|Overall Study|Adverse Event|2|||
144642389|NCT02243176|521545807|FG001|Overall Study|Adverse Event|2|||
144642390|NCT02638012|521545814|FG000|Overall Study|Lost to Follow-up|1|||
144642391|NCT03199911|521545823|FG000|Overall Study|Lost to Follow-up|5|||
144642392|NCT03199911|521545824|FG001|Overall Study|Lost to Follow-up|5|||
144731350|NCT05093205|521871410|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731351|NCT05093205|521871411|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144642393|NCT03199911|521545823|FG000|Overall Study|Did not proceed with surgery|2|||
144642394|NCT03199911|521545824|FG001|Overall Study|Did not proceed with surgery|1|||
144642395|NCT04430348|521545829|FG000|Overall Study|Death|3|||
144642396|NCT04430348|521545830|FG001|Overall Study|Death|2|||
144642397|NCT04430348|521545831|FG002|Overall Study|Death|2|||
144642398|NCT04430348|521545832|FG003|Overall Study|Death|2|||
144642399|NCT04430348|521545833|FG004|Overall Study|Death|2|||
144642400|NCT04430348|521545834|FG005|Overall Study|Death|3|||
144642401|NCT04430348|521545829|FG000|Overall Study|Lost to Follow-up|0|||
144642402|NCT04430348|521545830|FG001|Overall Study|Lost to Follow-up|0|||
144211038|NCT01449370|519968037|FG018|Overall Study|Adverse Event|1|||
144642403|NCT04430348|521545831|FG002|Overall Study|Lost to Follow-up|0|||
144642404|NCT04430348|521545832|FG003|Overall Study|Lost to Follow-up|1|||
144642405|NCT04430348|521545833|FG004|Overall Study|Lost to Follow-up|0|||
144642406|NCT04430348|521545834|FG005|Overall Study|Lost to Follow-up|0|||
144642407|NCT04430348|521545829|FG000|Overall Study|Adverse Event|0|||
144642408|NCT04430348|521545830|FG001|Overall Study|Adverse Event|0|||
144642409|NCT04430348|521545831|FG002|Overall Study|Adverse Event|0|||
144642410|NCT04430348|521545832|FG003|Overall Study|Adverse Event|0|||
144642411|NCT04430348|521545833|FG004|Overall Study|Adverse Event|0|||
144642412|NCT04430348|521545834|FG005|Overall Study|Adverse Event|1|||
144642413|NCT04430348|521545829|FG000|Overall Study|Withdrawal by Subject|0|||
144642414|NCT04430348|521545830|FG001|Overall Study|Withdrawal by Subject|1|||
144642415|NCT04430348|521545831|FG002|Overall Study|Withdrawal by Subject|0|||
144642416|NCT04430348|521545832|FG003|Overall Study|Withdrawal by Subject|0|||
144642417|NCT04430348|521545833|FG004|Overall Study|Withdrawal by Subject|0|||
144642418|NCT04430348|521545834|FG005|Overall Study|Withdrawal by Subject|1|||
144642419|NCT04430348|521545829|FG000|Overall Study|Study Terminated by Sponsor|0|||
144642420|NCT04430348|521545830|FG001|Overall Study|Study Terminated by Sponsor|0|||
144642421|NCT04430348|521545831|FG002|Overall Study|Study Terminated by Sponsor|2|||
144642422|NCT04430348|521545832|FG003|Overall Study|Study Terminated by Sponsor|0|||
144642423|NCT04430348|521545833|FG004|Overall Study|Study Terminated by Sponsor|1|||
144642424|NCT04430348|521545834|FG005|Overall Study|Study Terminated by Sponsor|1|||
144642425|NCT03523585|521545835|FG000|Overall Study|Progressive Disease|174|||
144642426|NCT03523585|521545836|FG001|Overall Study|Progressive Disease|64|||
144642427|NCT03523585|521545837|FG002|Overall Study|Progressive Disease|77|||
144642428|NCT03523585|521545835|FG000|Overall Study|Adverse Event|74|||
144642429|NCT03523585|521545836|FG001|Overall Study|Adverse Event|5|||
144642430|NCT03523585|521545837|FG002|Overall Study|Adverse Event|9|||
144642431|NCT03523585|521545835|FG000|Overall Study|Withdrawal by Subject|30|||
144642432|NCT03523585|521545836|FG001|Overall Study|Withdrawal by Subject|11|||
144642433|NCT03523585|521545837|FG002|Overall Study|Withdrawal by Subject|6|||
144642434|NCT03523585|521545835|FG000|Overall Study|Clinical Progression|23|||
144642435|NCT03523585|521545836|FG001|Overall Study|Clinical Progression|5|||
144642436|NCT03523585|521545837|FG002|Overall Study|Clinical Progression|10|||
144642437|NCT03523585|521545835|FG000|Overall Study|Death|4|||
144642438|NCT03523585|521545836|FG001|Overall Study|Death|0|||
144642439|NCT03523585|521545837|FG002|Overall Study|Death|1|||
144642440|NCT03523585|521545835|FG000|Overall Study|Physician Decision|2|||
144642441|NCT03523585|521545836|FG001|Overall Study|Physician Decision|1|||
144642442|NCT03523585|521545837|FG002|Overall Study|Physician Decision|0|||
144642443|NCT03523585|521545835|FG000|Overall Study|Lost to Follow-up|1|||
144642444|NCT03523585|521545836|FG001|Overall Study|Lost to Follow-up|0|||
144211039|NCT01449370|519968038|FG019|Overall Study|Adverse Event|1|||
144211040|NCT01449370|519968039|FG020|Overall Study|Adverse Event|0|||
144642445|NCT03523585|521545837|FG002|Overall Study|Lost to Follow-up|0|||
144642446|NCT03523585|521545835|FG000|Overall Study|Miscellaneous|1|||
144642447|NCT03523585|521545836|FG001|Overall Study|Miscellaneous|0|||
144642448|NCT03523585|521545837|FG002|Overall Study|Miscellaneous|0|||
144642449|NCT03523585|521545835|FG000|Overall Study|Protocol Deviation|1|||
144211041|NCT01449370|519968040|FG021|Overall Study|Adverse Event|1|||
144211042|NCT01449370|519968041|FG022|Overall Study|Adverse Event|0|||
144211043|NCT01449370|519968042|FG023|Overall Study|Adverse Event|1|||
144642450|NCT03523585|521545836|FG001|Overall Study|Protocol Deviation|0|||
144642451|NCT03523585|521545837|FG002|Overall Study|Protocol Deviation|1|||
144642452|NCT03523585|521545835|FG000|Overall Study|Randomized But Not Treated|2|||
144642453|NCT03523585|521545836|FG001|Overall Study|Randomized But Not Treated|4|||
144211044|NCT01449370|519968043|FG024|Overall Study|Adverse Event|3|||
144211045|NCT01449370|519968019|FG000|Overall Study|Participant Decision|0|||
144263224|NCT01261390|520163894|FG003|Overall Study|Relocation|0|||
144642454|NCT03523585|521545837|FG002|Overall Study|Randomized But Not Treated|3|||
144642455|NCT02874794|521545840|FG000|Overall Study|Physician Decision|3|||
144642456|NCT02874794|521545841|FG001|Overall Study|Physician Decision|2|||
144642457|NCT02874794|521545840|FG000|Overall Study|Withdrawal by Subject|2|||
144642458|NCT02874794|521545841|FG001|Overall Study|Withdrawal by Subject|8|||
144642459|NCT02874794|521545840|FG000|Overall Study|Death|2|||
144642460|NCT02874794|521545841|FG001|Overall Study|Death|1|||
144642461|NCT04328623|521545842|FG000|Overall Study|Protocol Violation|0|||
144642462|NCT04328623|521545843|FG001|Overall Study|Protocol Violation|1|||
144642463|NCT01473004|521545844|FG000|Overall Study|Incomplete Lobar Treatment|1|||
144211046|NCT01449370|519968020|FG001|Overall Study|Participant Decision|0|||
144211047|NCT01449370|519968021|FG002|Overall Study|Participant Decision|0|||
144211048|NCT01449370|519968022|FG003|Overall Study|Participant Decision|0|||
144211049|NCT01449370|519968023|FG004|Overall Study|Participant Decision|0|||
144211050|NCT01449370|519968024|FG005|Overall Study|Participant Decision|0|||
144211051|NCT01449370|519968025|FG006|Overall Study|Participant Decision|0|||
144211052|NCT01449370|519968026|FG007|Overall Study|Participant Decision|1|||
144211053|NCT01449370|519968027|FG008|Overall Study|Participant Decision|1|||
144211054|NCT01449370|519968028|FG009|Overall Study|Participant Decision|0|||
144211055|NCT01449370|519968029|FG010|Overall Study|Participant Decision|0|||
144211056|NCT01449370|519968030|FG011|Overall Study|Participant Decision|0|||
144211057|NCT01449370|519968031|FG012|Overall Study|Participant Decision|1|||
144211058|NCT01449370|519968032|FG013|Overall Study|Participant Decision|1|||
144211059|NCT01449370|519968033|FG014|Overall Study|Participant Decision|0|||
144211060|NCT01449370|519968034|FG015|Overall Study|Participant Decision|1|||
144211061|NCT01449370|519968035|FG016|Overall Study|Participant Decision|3|||
144211062|NCT01449370|519968036|FG017|Overall Study|Participant Decision|0|||
144211063|NCT01449370|519968037|FG018|Overall Study|Participant Decision|1|||
144211064|NCT01449370|519968038|FG019|Overall Study|Participant Decision|0|||
144211065|NCT01449370|519968039|FG020|Overall Study|Participant Decision|0|||
144211066|NCT01449370|519968040|FG021|Overall Study|Participant Decision|1|||
144211067|NCT01449370|519968041|FG022|Overall Study|Participant Decision|0|||
144211068|NCT01449370|519968042|FG023|Overall Study|Participant Decision|0|||
144211069|NCT01449370|519968043|FG024|Overall Study|Participant Decision|1|||
144211070|NCT01449370|519968019|FG000|Overall Study|Lost to Follow-up|0|||
144211071|NCT01449370|519968020|FG001|Overall Study|Lost to Follow-up|0|||
144642464|NCT01473004|521545845|FG001|Overall Study|Incomplete Lobar Treatment|0|||
144642465|NCT03839524|521545847|FG000|Overall Study|Adverse Event|1|||
144642466|NCT05309668|521545851|FG000|Overall Study|Ongoing at data cut-off|14|||
144642467|NCT05309668|521545852|FG001|Overall Study|Ongoing at data cut-off|17|||
144642468|NCT05309668|521545853|FG002|Overall Study|Ongoing at data cut-off|4|||
144642469|NCT03715465|521545854|FG000|Overall Study|Withdrawal by Subject|1|||
144642470|NCT03715465|521545855|FG001|Overall Study|Withdrawal by Subject|2|||
144642471|NCT01451515|521545895|FG000|Overall Study|Death|0|||
144642472|NCT01451515|521545896|FG001|Overall Study|Death|1|||
144642473|NCT01451515|521545897|FG002|Overall Study|Death|0|||
144642474|NCT01451515|521545895|FG000|Overall Study|Withdrawal by Subject|0|||
144642475|NCT01451515|521545896|FG001|Overall Study|Withdrawal by Subject|1|||
144642476|NCT01451515|521545897|FG002|Overall Study|Withdrawal by Subject|0|||
144642477|NCT01451515|521545895|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
144642478|NCT01451515|521545896|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
144642479|NCT01451515|521545897|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
144642480|NCT01451515|521545895|FG000|Overall Study|Relapse (except CNS)|1|||
144642481|NCT01451515|521545896|FG001|Overall Study|Relapse (except CNS)|1|||
144642482|NCT01451515|521545897|FG002|Overall Study|Relapse (except CNS)|0|||
144642483|NCT01021007|521545898|FG000|Overall Study|Lost to Follow-up|1|||
144642484|NCT01021007|521545899|FG001|Overall Study|Lost to Follow-up|1|||
144642485|NCT01021007|521545898|FG000|Overall Study|Adverse Event|1|||
144642486|NCT01021007|521545899|FG001|Overall Study|Adverse Event|3|||
144642487|NCT05490771|521545900|FG000|Overall Study|Disease progression|18|||
144642488|NCT05490771|521545900|FG000|Overall Study|Adverse Event|3|||
144642489|NCT05490771|521545900|FG000|Overall Study|Other complicating disease|1|||
144642490|NCT05490771|521545900|FG000|Overall Study|Withdrawal by Subject|3|||
144642491|NCT05490771|521545900|FG000|Overall Study|Physician Decision|1|||
144642492|NCT05490771|521545900|FG000|Overall Study|Still on treatment|2|||
144642493|NCT05490771|521545900|FG000|Overall Study|Never start protocol therapy|5|||
144642494|NCT05490771|521545900|FG000|Overall Study|Ineligible|2|||
144731352|NCT05093205|521871412|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144211072|NCT01449370|519968021|FG002|Overall Study|Lost to Follow-up|0|||
144642495|NCT01259466|521545903|FG000|Overall Study|Withdrawal by Subject|1|||
144642496|NCT01259466|521545904|FG001|Overall Study|Withdrawal by Subject|9|||
144642497|NCT00184054|521545908|FG000|Overall Study|Adverse Event|1|||
144642498|NCT02485717|521545911|FG000|Overall Study|Lost to Follow-up|6|||
144211073|NCT01449370|519968022|FG003|Overall Study|Lost to Follow-up|0|||
144211074|NCT01449370|519968023|FG004|Overall Study|Lost to Follow-up|0|||
144642499|NCT02485717|521545912|FG001|Overall Study|Lost to Follow-up|0|||
144642500|NCT02485717|521545913|FG002|Overall Study|Lost to Follow-up|0|||
144642501|NCT02485717|521545911|FG000|Overall Study|Withdrawal by Subject|0|||
144642502|NCT02485717|521545912|FG001|Overall Study|Withdrawal by Subject|0|||
144731353|NCT05093205|521871413|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144642503|NCT02485717|521545913|FG002|Overall Study|Withdrawal by Subject|1|||
144211075|NCT01449370|519968024|FG005|Overall Study|Lost to Follow-up|0|||
144211076|NCT01449370|519968025|FG006|Overall Study|Lost to Follow-up|0|||
144211077|NCT01449370|519968026|FG007|Overall Study|Lost to Follow-up|0|||
144211078|NCT01449370|519968027|FG008|Overall Study|Lost to Follow-up|0|||
144642504|NCT02485717|521545911|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
144642505|NCT02485717|521545912|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
144642506|NCT02485717|521545913|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
144642507|NCT02485717|521545911|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
144642508|NCT02485717|521545912|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
144642509|NCT02485717|521545913|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
144642510|NCT00828451|521545914|FG000|Overall Study|Death|2|||
144642511|NCT00828451|521545914|FG000|Overall Study|Lack of intravenous line|7|||
144642512|NCT00828451|521545914|FG000|Overall Study|Withdrawal by Subject|1|||
144642513|NCT00828451|521545914|FG000|Overall Study|Deterioration in clinical status|1|||
144642514|NCT03256539|521545915|FG000|Overall Study|Withdrawal by Subject|0|||
144642515|NCT03256539|521545916|FG001|Overall Study|Withdrawal by Subject|3|||
144642516|NCT03256539|521545915|FG000|Overall Study|Unexpected closure of study components|8|||
144642517|NCT03256539|521545916|FG001|Overall Study|Unexpected closure of study components|4|||
144642518|NCT03914300|521545918|FG000|Overall Study|Adverse Event|1|||
144642519|NCT01650805|521545925|FG000|Overall Study|Withdrawal by Subject|1|||
144642520|NCT01650805|521545926|FG001|Overall Study|Withdrawal by Subject|0|||
144642521|NCT01887210|521545929|FG000|Overall Study|Withdrawal by Subject|1|||
144642522|NCT01887210|521545930|FG001|Overall Study|Withdrawal by Subject|3|||
144642523|NCT01887210|521545929|FG000|Overall Study|Lost to Follow-up|0|||
144642524|NCT01887210|521545930|FG001|Overall Study|Lost to Follow-up|1|||
144642525|NCT02452359|521545931|FG000|Overall Study|Adverse Event|1|||
144642526|NCT02452359|521545931|FG000|Overall Study|Lost to Follow-up|15|||
144642527|NCT02452359|521545931|FG000|Overall Study|Pregnancy|1|||
144642528|NCT02452359|521545931|FG000|Overall Study|Withdrawal by Subject|4|||
144642529|NCT00840463|521545932|FG000|Overall Study|Adverse Event|1|||
144642530|NCT00840463|521545933|FG001|Overall Study|Adverse Event|0|||
144642531|NCT03750838|521545938|FG000|Overall Study|Lost to Follow-up|10|||
144642532|NCT03750838|521545939|FG001|Overall Study|Lost to Follow-up|6|||
144642533|NCT05847881|521545940|FG000|Overall Study|Principal Investigator Decision|8|||
144642534|NCT05847881|521545940|FG000|Overall Study|Withdrawal by Subject|2|||
144642535|NCT05781542|521547302|FG000|Overall Study|Lost to Follow-up|1|||
144642536|NCT05781542|521547303|FG001|Overall Study|Lost to Follow-up|0|||
144642537|NCT05781542|521547304|FG002|Overall Study|Lost to Follow-up|1|||
144642538|NCT03746080|521547307|FG000|Overall Study|In follow up|2|||
144642539|NCT03746080|521547307|FG000|Overall Study|Death|15|||
144642540|NCT05738486|521547308|FG000|Overall Study|Continuing Study|194|||
144642541|NCT05738486|521547309|FG001|Overall Study|Continuing Study|196|||
144642542|NCT05738486|521547310|FG002|Overall Study|Continuing Study|193|||
144642543|NCT05738486|521547311|FG003|Overall Study|Continuing Study|191|||
144642544|NCT05738486|521547308|FG000|Overall Study|Withdrawal by Subject|8|||
144642545|NCT05738486|521547309|FG001|Overall Study|Withdrawal by Subject|5|||
144642546|NCT05738486|521547310|FG002|Overall Study|Withdrawal by Subject|7|||
144642547|NCT05738486|521547311|FG003|Overall Study|Withdrawal by Subject|13|||
144642548|NCT05738486|521547308|FG000|Overall Study|Adverse Event|4|||
144642549|NCT05738486|521547309|FG001|Overall Study|Adverse Event|6|||
144642550|NCT05738486|521547310|FG002|Overall Study|Adverse Event|4|||
144642551|NCT05738486|521547311|FG003|Overall Study|Adverse Event|5|||
144642552|NCT05738486|521547308|FG000|Overall Study|Physician Decision|0|||
144642553|NCT05738486|521547309|FG001|Overall Study|Physician Decision|2|||
144642554|NCT05738486|521547310|FG002|Overall Study|Physician Decision|4|||
144642555|NCT05738486|521547311|FG003|Overall Study|Physician Decision|1|||
144642556|NCT05738486|521547308|FG000|Overall Study|Lost to Follow-up|1|||
144642557|NCT05738486|521547309|FG001|Overall Study|Lost to Follow-up|1|||
144642558|NCT05738486|521547310|FG002|Overall Study|Lost to Follow-up|2|||
144642559|NCT05738486|521547311|FG003|Overall Study|Lost to Follow-up|1|||
144642560|NCT05738486|521547308|FG000|Overall Study|Participant was Non-ambulatory|0|||
144642561|NCT05738486|521547309|FG001|Overall Study|Participant was Non-ambulatory|0|||
144642562|NCT05738486|521547310|FG002|Overall Study|Participant was Non-ambulatory|1|||
144642563|NCT05738486|521547311|FG003|Overall Study|Participant was Non-ambulatory|0|||
144642564|NCT05738486|521547308|FG000|Overall Study|Participant had Poor Venous Access|0|||
144642565|NCT05738486|521547309|FG001|Overall Study|Participant had Poor Venous Access|0|||
144642566|NCT05738486|521547310|FG002|Overall Study|Participant had Poor Venous Access|0|||
144642567|NCT05738486|521547311|FG003|Overall Study|Participant had Poor Venous Access|1|||
144263225|NCT01261390|520163891|FG000|Overall Study|Loss of Interest in the Study|3|||
144263226|NCT01261390|520163892|FG001|Overall Study|Loss of Interest in the Study|1|||
144642568|NCT05738486|521547308|FG000|Overall Study|Assigned Treatment by Mistake|0|||
144263227|NCT01261390|520163893|FG002|Overall Study|Loss of Interest in the Study|0|||
144642569|NCT05738486|521547309|FG001|Overall Study|Assigned Treatment by Mistake|0|||
144642570|NCT05738486|521547310|FG002|Overall Study|Assigned Treatment by Mistake|0|||
144642571|NCT05738486|521547311|FG003|Overall Study|Assigned Treatment by Mistake|1|||
144642572|NCT05738486|521547308|FG000|Overall Study|Death|0|||
144263228|NCT01261390|520163894|FG003|Overall Study|Loss of Interest in the Study|0|||
144642573|NCT05738486|521547309|FG001|Overall Study|Death|0|||
144263229|NCT01261390|520163891|FG000|Overall Study|Lost to Follow-up|1|||
144642574|NCT05738486|521547310|FG002|Overall Study|Death|1|||
144642575|NCT05738486|521547311|FG003|Overall Study|Death|0|||
144642576|NCT05738486|521547308|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
144642577|NCT05738486|521547309|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
144642578|NCT05738486|521547310|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
144642579|NCT05738486|521547311|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
144642580|NCT01843374|521547312|FG000|Overall Study|Death|155|||
144642581|NCT01843374|521547313|FG001|Overall Study|Death|313|||
144642582|NCT01843374|521547312|FG000|Overall Study|Withdrawal by Subject|14|||
144642583|NCT01843374|521547313|FG001|Overall Study|Withdrawal by Subject|20|||
144642584|NCT01843374|521547312|FG000|Overall Study|Withdrawing due to Other reason|20|||
144642585|NCT01843374|521547313|FG001|Overall Study|Withdrawing due to Other reason|46|||
144642586|NCT03113500|521547314|FG000|Overall Study|Withdrawal by Subject|1|||
144642587|NCT02517515|521547317|FG000|Overall Study|Adverse Event|0|||
144642588|NCT02517515|521547318|FG001|Overall Study|Adverse Event|1|||
144642589|NCT02517515|521547317|FG000|Overall Study|Withdrew Consent|0|||
144642590|NCT02517515|521547318|FG001|Overall Study|Withdrew Consent|1|||
144642591|NCT02517515|521547317|FG000|Overall Study|Lost to Follow-up|1|||
144642592|NCT02517515|521547318|FG001|Overall Study|Lost to Follow-up|0|||
144642593|NCT02517515|521547317|FG000|Overall Study|Other|1|||
144642594|NCT02517515|521547318|FG001|Overall Study|Other|0|||
144642595|NCT06400238|521547321|FG000|Overall Study|Started Protocol Therapy|2|||
144642596|NCT06400238|521547321|FG000|Overall Study|Adverse Event|1|||
144642597|NCT06400238|521547321|FG000|Overall Study|Death|1|||
144642598|NCT06400238|521547321|FG000|Overall Study|Disease Progression|27|||
144642599|NCT06400238|521547321|FG000|Overall Study|Withdrawal by Subject|2|||
144642600|NCT06400238|521547321|FG000|Overall Study|Physician Decision|2|||
144642601|NCT01981187|521547326|FG000|Overall Study|Participant/guardian decision|2|||
144642602|NCT01981187|521547326|FG000|Overall Study|Physician Decision|1|||
144642603|NCT01981187|521547326|FG000|Overall Study|Disease progression|2|||
144642604|NCT01981187|521547326|FG000|Overall Study|Adverse Event|7|||
144642605|NCT01362322|521547327|FG000|Overall Study|Withdrawal by Subject|3|||
144642606|NCT01362322|521547328|FG001|Overall Study|Withdrawal by Subject|1|||
144642607|NCT01362322|521547327|FG000|Overall Study|Lost to Follow-up|2|||
144642608|NCT01362322|521547328|FG001|Overall Study|Lost to Follow-up|6|||
144642609|NCT01009463|521547329|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
144642610|NCT01009463|521547330|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144642611|NCT01009463|521547331|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144642612|NCT01009463|521547332|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144642613|NCT01009463|521547333|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
144642614|NCT01009463|521547329|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
144642615|NCT01009463|521547330|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
144642616|NCT01009463|521547331|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
144642617|NCT01009463|521547332|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
144642618|NCT01009463|521547333|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
144642619|NCT01009463|521547329|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
144642620|NCT01009463|521547330|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144642621|NCT01009463|521547331|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144642622|NCT01009463|521547332|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144642623|NCT01009463|521547333|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
144642624|NCT01009463|521547329|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
144642625|NCT01009463|521547330|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
144642626|NCT01009463|521547331|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
144642627|NCT01009463|521547332|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
144642628|NCT01009463|521547333|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
144642629|NCT01009463|521547329|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
144642630|NCT01009463|521547330|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144642631|NCT01009463|521547331|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144642632|NCT01009463|521547332|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144642633|NCT01009463|521547333|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
144642634|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
144642635|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
144642636|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
144642637|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
144642638|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
144642639|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144642640|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
144642641|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
144642642|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
144642643|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
144642644|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
144642645|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
144642646|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
144642647|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
144642648|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
144642649|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
144642650|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
144642651|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
144642652|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
144642653|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
144642654|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
144642655|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
144642656|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
144642657|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
144642658|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
144642659|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
144642660|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
144642661|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
144642662|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
144642663|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
144642664|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144642665|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
144642666|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
144642667|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
144642668|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
144642669|NCT01009463|521547329|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
144642670|NCT01009463|521547330|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
144642671|NCT01009463|521547331|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
144642672|NCT01009463|521547332|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
144642673|NCT01009463|521547333|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
144642674|NCT01062399|521547334|FG000|Overall Study|Protocol Violation|0|||
144642675|NCT01062399|521547335|FG001|Overall Study|Protocol Violation|1|||
144642676|NCT01062399|521547336|FG002|Overall Study|Protocol Violation|0|||
144642677|NCT01062399|521547337|FG003|Overall Study|Protocol Violation|6|||
144642678|NCT01062399|521547338|FG004|Overall Study|Protocol Violation|4|||
144642679|NCT02465034|521547339|FG000|Overall Study|Withdrawal by Subject|1|||
144642680|NCT02465034|521547340|FG001|Overall Study|Withdrawal by Subject|1|||
144642681|NCT02465034|521547339|FG000|Overall Study|Screen fail|2|||
144642682|NCT02465034|521547340|FG001|Overall Study|Screen fail|0|||
144642683|NCT02465034|521547339|FG000|Overall Study|Could not be scheduled for study visit|0|||
144642684|NCT02465034|521547340|FG001|Overall Study|Could not be scheduled for study visit|5|||
144642685|NCT02401256|521547346|FG000|Overall Study|Adverse Event|5|||
144642686|NCT02401256|521547346|FG000|Overall Study|Withdrawal by Subject|12|||
144642687|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
144642688|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
144642689|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
144642690|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
144642691|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
144642692|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
144642693|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
144642694|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
144642695|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
144642696|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
144642697|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
144642698|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
144642699|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
144642700|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
144642701|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
144642702|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
144642703|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
144642704|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
144211079|NCT01449370|519968028|FG009|Overall Study|Lost to Follow-up|0|||
144211080|NCT01449370|519968029|FG010|Overall Study|Lost to Follow-up|0|||
144211081|NCT01449370|519968030|FG011|Overall Study|Lost to Follow-up|0|||
144642705|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Death|0|||
144642706|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Death|1|||
144211082|NCT01449370|519968031|FG012|Overall Study|Lost to Follow-up|0|||
144211083|NCT01449370|519968032|FG013|Overall Study|Lost to Follow-up|0|||
144211084|NCT01449370|519968033|FG014|Overall Study|Lost to Follow-up|0|||
144211085|NCT01449370|519968034|FG015|Overall Study|Lost to Follow-up|0|||
144642707|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Death|0|||
144642708|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
144642709|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
144642710|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
144642711|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
144642712|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
144642713|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
144642714|NCT00430781|521547347|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
144642715|NCT00430781|521547348|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
144642716|NCT00430781|521547349|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
144642717|NCT00430781|521547347|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
144642718|NCT00430781|521547348|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
144642719|NCT00430781|521547349|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
144642720|NCT00430781|521547347|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
144642721|NCT00430781|521547348|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
144642722|NCT00430781|521547349|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
144642723|NCT00430781|521547347|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
144642724|NCT00430781|521547348|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
144642725|NCT00430781|521547349|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
144642726|NCT00430781|521547347|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
144642727|NCT00430781|521547348|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
144642728|NCT00430781|521547349|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
144642729|NCT00430781|521547347|FG000|Final Analysis; 31 July 2008|Other|0|||
144642730|NCT00430781|521547348|FG001|Final Analysis; 31 July 2008|Other|1|||
144642731|NCT00430781|521547349|FG002|Final Analysis; 31 July 2008|Other|0|||
144642732|NCT00430781|521547347|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
144642733|NCT00430781|521547348|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
144642734|NCT00430781|521547349|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
144642735|NCT00430781|521547347|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
144642736|NCT00430781|521547348|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
144642737|NCT00430781|521547349|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
144642738|NCT00430781|521547347|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
144642739|NCT00430781|521547348|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
144642740|NCT00430781|521547349|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
144642741|NCT00430781|521547347|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
144642742|NCT00430781|521547348|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
144642743|NCT00430781|521547349|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
144642744|NCT00430781|521547347|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
144642745|NCT00430781|521547348|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
144642746|NCT00430781|521547349|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
144642747|NCT00430781|521547347|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
144642748|NCT00430781|521547348|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
144642749|NCT00430781|521547349|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
144642750|NCT00430781|521547347|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
144642751|NCT00430781|521547348|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
144642752|NCT00430781|521547349|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
144642753|NCT04329949|521547351|FG000|Overall Study|Death|36|||
144642754|NCT04329949|521547351|FG000|Overall Study|Withdrawal by Subject|4|||
144642755|NCT04329949|521547351|FG000|Overall Study|Termination of study by sponsor|3|||
144642756|NCT00917384|521547354|FG000|Overall Study|Lost to Follow-up|4|||
144642757|NCT00917384|521547355|FG001|Overall Study|Lost to Follow-up|2|||
144642758|NCT00917384|521547354|FG000|Overall Study|Withdrawal by Subject|10|||
144642759|NCT00917384|521547355|FG001|Overall Study|Withdrawal by Subject|2|||
144642760|NCT03717922|521547356|FG000|Overall Study|Lost to Follow-up|2|||
144642761|NCT03717922|521547357|FG001|Overall Study|Lost to Follow-up|2|||
144642762|NCT01458340|521547360|FG000|Overall Study|Adverse Event|5|||
144642763|NCT01458340|521547361|FG001|Overall Study|Adverse Event|4|||
144642764|NCT01458340|521547362|FG002|Overall Study|Adverse Event|2|||
144642765|NCT01458340|521547360|FG000|Overall Study|Lost to Follow-up|3|||
144642766|NCT01458340|521547361|FG001|Overall Study|Lost to Follow-up|3|||
144642767|NCT01458340|521547362|FG002|Overall Study|Lost to Follow-up|10|||
144642768|NCT01458340|521547360|FG000|Overall Study|Miscellaneous|0|||
144642769|NCT01458340|521547361|FG001|Overall Study|Miscellaneous|1|||
144642770|NCT01458340|521547362|FG002|Overall Study|Miscellaneous|0|||
144642771|NCT01458340|521547360|FG000|Overall Study|Physician Decision|1|||
144642772|NCT01458340|521547361|FG001|Overall Study|Physician Decision|1|||
144642773|NCT01458340|521547362|FG002|Overall Study|Physician Decision|2|||
144642774|NCT01458340|521547360|FG000|Overall Study|Protocol Violation|6|||
144642775|NCT01458340|521547361|FG001|Overall Study|Protocol Violation|6|||
144642776|NCT01458340|521547362|FG002|Overall Study|Protocol Violation|5|||
144642777|NCT01458340|521547360|FG000|Overall Study|Withdrawal by Subject|12|||
144642778|NCT01458340|521547361|FG001|Overall Study|Withdrawal by Subject|6|||
144642779|NCT01458340|521547362|FG002|Overall Study|Withdrawal by Subject|4|||
144642780|NCT05218499|521547369|FG000|Overall Study|Not treated|1|||
144642781|NCT05218499|521547370|FG001|Overall Study|Not treated|1|||
144642782|NCT05218499|521547371|FG002|Overall Study|Not treated|8|||
144642783|NCT05218499|521547369|FG000|Overall Study|Death|2|||
144642784|NCT05218499|521547370|FG001|Overall Study|Death|0|||
144642785|NCT05218499|521547371|FG002|Overall Study|Death|0|||
144642786|NCT05218499|521547369|FG000|Overall Study|Other than listed|3|||
144642787|NCT05218499|521547370|FG001|Overall Study|Other than listed|7|||
144642788|NCT05218499|521547371|FG002|Overall Study|Other than listed|10|||
144642789|NCT05218499|521547369|FG000|Overall Study|Protocol deviation|5|||
144642790|NCT05218499|521547370|FG001|Overall Study|Protocol deviation|6|||
144642791|NCT05218499|521547371|FG002|Overall Study|Protocol deviation|4|||
144642792|NCT05218499|521547369|FG000|Overall Study|Technical problems|0|||
144642793|NCT05218499|521547370|FG001|Overall Study|Technical problems|1|||
144642794|NCT05218499|521547371|FG002|Overall Study|Technical problems|0|||
144642795|NCT05218499|521547369|FG000|Overall Study|Burden of trial procedures|0|||
144642796|NCT05218499|521547370|FG001|Overall Study|Burden of trial procedures|1|||
144642797|NCT05218499|521547371|FG002|Overall Study|Burden of trial procedures|2|||
144642798|NCT05218499|521547369|FG000|Overall Study|Clinical disease progression|6|||
144642799|NCT05218499|521547370|FG001|Overall Study|Clinical disease progression|6|||
144642800|NCT05218499|521547371|FG002|Overall Study|Clinical disease progression|11|||
144642801|NCT05218499|521547369|FG000|Overall Study|Objective disease progression|44|||
144642802|NCT05218499|521547370|FG001|Overall Study|Objective disease progression|61|||
144642803|NCT05218499|521547371|FG002|Overall Study|Objective disease progression|42|||
144642804|NCT05218499|521547369|FG000|Overall Study|Adverse Event|11|||
144642805|NCT05218499|521547370|FG001|Overall Study|Adverse Event|36|||
144642806|NCT05218499|521547371|FG002|Overall Study|Adverse Event|9|||
144642807|NCT05218499|521547369|FG000|Overall Study|On treatment at time of snapshot|18|||
144642808|NCT05218499|521547370|FG001|Overall Study|On treatment at time of snapshot|29|||
144642809|NCT05218499|521547371|FG002|Overall Study|On treatment at time of snapshot|0|||
144642810|NCT01575548|521547372|FG000|Overall Study|Adverse Event|15|||
144642811|NCT01575548|521547373|FG001|Overall Study|Adverse Event|2|||
144642812|NCT01575548|521547372|FG000|Overall Study|Disease progression|12|||
144642813|NCT01575548|521547373|FG001|Overall Study|Disease progression|25|||
144642814|NCT01575548|521547372|FG000|Overall Study|Death|1|||
144642815|NCT01575548|521547373|FG001|Overall Study|Death|0|||
144642816|NCT01575548|521547372|FG000|Overall Study|Other complicating disease|1|||
144642817|NCT01575548|521547373|FG001|Overall Study|Other complicating disease|0|||
144642818|NCT01575548|521547372|FG000|Overall Study|Withdrawal by Subject|7|||
144642819|NCT01575548|521547373|FG001|Overall Study|Withdrawal by Subject|3|||
144642820|NCT01575548|521547372|FG000|Overall Study|Noncompliance|1|||
144642821|NCT01575548|521547373|FG001|Overall Study|Noncompliance|0|||
144642822|NCT01575548|521547372|FG000|Overall Study|Anticipated surgery|0|||
144642823|NCT01575548|521547373|FG001|Overall Study|Anticipated surgery|1|||
144642824|NCT01575548|521547372|FG000|Overall Study|Never started protocol therapy|3|||
144642825|NCT01575548|521547373|FG001|Overall Study|Never started protocol therapy|2|||
144642826|NCT01702805|521547380|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
144642827|NCT01702805|521547381|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
144642828|NCT01702805|521547380|FG000|Overall Study|Incomplete Follow-up|18|||
144642829|NCT01702805|521547381|FG001|Overall Study|Incomplete Follow-up|15|||
144642830|NCT01702805|521547380|FG000|Overall Study|Vital Status Assessment Only|40|||
144642831|NCT01702805|521547381|FG001|Overall Study|Vital Status Assessment Only|39|||
144642832|NCT01702805|521547380|FG000|Overall Study|Lost to Follow-up|5|||
144642833|NCT01702805|521547381|FG001|Overall Study|Lost to Follow-up|5|||
144642834|NCT02317510|521547386|FG000|Overall Study|Adverse Event|0|||
144642835|NCT02317510|521547387|FG001|Overall Study|Adverse Event|1|||
144642836|NCT01238120|521547388|FG000|Overall Study|Withdrawal by Subject|4|||
144642837|NCT01238120|521547389|FG001|Overall Study|Withdrawal by Subject|1|||
144642838|NCT01238120|521547390|FG002|Overall Study|Withdrawal by Subject|2|||
144642839|NCT01238120|521547391|FG003|Overall Study|Withdrawal by Subject|5|||
144642840|NCT01238120|521547388|FG000|Overall Study|Lost to Follow-up|2|||
144642841|NCT01238120|521547389|FG001|Overall Study|Lost to Follow-up|0|||
144642842|NCT01238120|521547390|FG002|Overall Study|Lost to Follow-up|1|||
144642843|NCT01238120|521547391|FG003|Overall Study|Lost to Follow-up|1|||
144642844|NCT01238120|521547388|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
144731354|NCT05093205|521871414|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144642845|NCT01238120|521547389|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
144642846|NCT01238120|521547390|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
144642847|NCT01238120|521547391|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
144642848|NCT00881205|521547392|FG000|Overall Study|Adverse Event|8|||
144642849|NCT00881205|521547393|FG001|Overall Study|Adverse Event|3|||
144642850|NCT00881205|521547392|FG000|Overall Study|Withdrawal by Subject|1|||
144211086|NCT01449370|519968035|FG016|Overall Study|Lost to Follow-up|0|||
144642851|NCT00881205|521547393|FG001|Overall Study|Withdrawal by Subject|2|||
144211087|NCT01449370|519968036|FG017|Overall Study|Lost to Follow-up|0|||
144642852|NCT00881205|521547392|FG000|Overall Study|Lost to Follow-up|0|||
144642853|NCT00881205|521547393|FG001|Overall Study|Lost to Follow-up|1|||
144642854|NCT00881205|521547392|FG000|Overall Study|Administrative problems|1|||
144642855|NCT00881205|521547393|FG001|Overall Study|Administrative problems|1|||
144642856|NCT00881205|521547392|FG000|Overall Study|Condition no longer requires drug|1|||
144642857|NCT00881205|521547393|FG001|Overall Study|Condition no longer requires drug|0|||
144642858|NCT03427073|521547395|FG000|Overall Study|Disease Progression|1|||
144642859|NCT03427073|521547396|FG001|Overall Study|Disease Progression|1|||
144642860|NCT03427073|521547397|FG002|Overall Study|Disease Progression|1|||
144642861|NCT03427073|521547398|FG003|Overall Study|Disease Progression|3|||
144642862|NCT03427073|521547399|FG004|Overall Study|Disease Progression|3|||
144642863|NCT03427073|521547400|FG005|Overall Study|Disease Progression|4|||
144642864|NCT03427073|521547401|FG006|Overall Study|Disease Progression|2|||
144642865|NCT03427073|521547402|FG007|Overall Study|Disease Progression|3|||
144642866|NCT03427073|521547395|FG000|Overall Study|Physician Decision|0|||
144642867|NCT03427073|521547396|FG001|Overall Study|Physician Decision|0|||
144642868|NCT03427073|521547397|FG002|Overall Study|Physician Decision|0|||
144642869|NCT03427073|521547398|FG003|Overall Study|Physician Decision|0|||
144642870|NCT03427073|521547399|FG004|Overall Study|Physician Decision|0|||
144642871|NCT03427073|521547400|FG005|Overall Study|Physician Decision|0|||
144642872|NCT03427073|521547401|FG006|Overall Study|Physician Decision|1|||
144642873|NCT03427073|521547402|FG007|Overall Study|Physician Decision|1|||
144642874|NCT00693706|521547405|FG000|Overall Study|Protocol Violation|0|||
144642875|NCT00693706|521547406|FG001|Overall Study|Protocol Violation|1|||
144642876|NCT02498652|521547408|FG000|Overall Study|Protocol Violation|0|||
144642877|NCT02498652|521547409|FG001|Overall Study|Protocol Violation|1|||
144642878|NCT03047213|521547411|FG000|Overall Study|Withdrawal by Subject|2|||
144642879|NCT03047213|521547412|FG001|Overall Study|Withdrawal by Subject|0|||
144642880|NCT03047213|521547411|FG000|Overall Study|Adverse Event|2|||
144642881|NCT03047213|521547412|FG001|Overall Study|Adverse Event|0|||
144642882|NCT04786210|521547413|FG000|Overall Study|Lost to Follow-up|2|||
144642883|NCT04786210|521547413|FG000|Overall Study|Withdrawal by Subject|4|||
144642884|NCT04334148|521547414|FG000|Overall Study|positive nasal swab at baseline|0|||
144642885|NCT04334148|521547415|FG001|Overall Study|positive nasal swab at baseline|1|||
144642886|NCT00498173|521547416|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
144642887|NCT00498173|521547417|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
144642888|NCT00498173|521547418|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
144642889|NCT02827877|521547426|FG000|Overall Study|Withdrawal by Subject|1|||
144642890|NCT05755438|521547427|FG000|12-week DBVC Period|Adverse Event|4|||
144642891|NCT05755438|521547428|FG001|12-week DBVC Period|Adverse Event|1|||
144642892|NCT05755438|521547427|FG000|12-week DBVC Period|Physician Decision|1|||
144642893|NCT05755438|521547428|FG001|12-week DBVC Period|Physician Decision|1|||
144642894|NCT05755438|521547427|FG000|12-week DBVC Period|Protocol Violation|4|||
144642895|NCT05755438|521547428|FG001|12-week DBVC Period|Protocol Violation|2|||
144642896|NCT05755438|521547427|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
144642897|NCT05755438|521547428|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
144642898|NCT05755438|521547427|FG000|12-week DBVC Period|Sponsor Decision|1|||
144642899|NCT05755438|521547428|FG001|12-week DBVC Period|Sponsor Decision|0|||
144642900|NCT05755438|521547427|FG000|40-week OLE Period|Adverse Event|0|||
144642901|NCT05755438|521547428|FG001|40-week OLE Period|Adverse Event|2|||
144642902|NCT05755438|521547427|FG000|40-week OLE Period|Lack of Efficacy|1|||
144642903|NCT05755438|521547428|FG001|40-week OLE Period|Lack of Efficacy|1|||
144642904|NCT05755438|521547427|FG000|40-week OLE Period|Lost to Follow-up|1|||
144642905|NCT05755438|521547428|FG001|40-week OLE Period|Lost to Follow-up|0|||
144642906|NCT05755438|521547427|FG000|40-week OLE Period|Physician Decision|1|||
144642907|NCT05755438|521547428|FG001|40-week OLE Period|Physician Decision|1|||
144642908|NCT05755438|521547427|FG000|40-week OLE Period|Protocol Violation|1|||
144642909|NCT05755438|521547428|FG001|40-week OLE Period|Protocol Violation|1|||
144642910|NCT05755438|521547427|FG000|40-week OLE Period|Withdrawal by Subject|6|||
144642911|NCT05755438|521547428|FG001|40-week OLE Period|Withdrawal by Subject|6|||
144642912|NCT05755438|521547427|FG000|40-week OLE Period|Sponsor Decision|3|||
144642913|NCT05755438|521547428|FG001|40-week OLE Period|Sponsor Decision|0|||
144642914|NCT05755438|521547427|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
144642915|NCT05755438|521547428|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
144642916|NCT05755438|521547427|FG000|40-week OLE Period|Ongoing|46|||
144642917|NCT05755438|521547428|FG001|40-week OLE Period|Ongoing|58|||
144642918|NCT03478683|521547429|FG000|Overall Study|Adverse Event|5|||
144642919|NCT03478683|521547430|FG001|Overall Study|Adverse Event|3|||
144642920|NCT03478683|521547429|FG000|Overall Study|Lost to Follow-up|0|||
144642921|NCT03478683|521547430|FG001|Overall Study|Lost to Follow-up|5|||
144642922|NCT03478683|521547429|FG000|Overall Study|Physician Decision|1|||
144642923|NCT03478683|521547430|FG001|Overall Study|Physician Decision|3|||
144642924|NCT03478683|521547429|FG000|Overall Study|Withdrawal by Subject|7|||
144642925|NCT03478683|521547430|FG001|Overall Study|Withdrawal by Subject|7|||
144642926|NCT03704051|521548554|FG000|Overall Study|Withdrawal by Subject|4|||
144642927|NCT03704051|521548555|FG001|Overall Study|Withdrawal by Subject|0|||
144642928|NCT02495077|521548556|FG000|Overall Study|Adverse Event|0|||
144642929|NCT02495077|521548557|FG001|Overall Study|Adverse Event|1|||
144211088|NCT01449370|519968037|FG018|Overall Study|Lost to Follow-up|0|||
144211089|NCT01449370|519968038|FG019|Overall Study|Lost to Follow-up|0|||
144211090|NCT01449370|519968039|FG020|Overall Study|Lost to Follow-up|1|||
144211091|NCT01449370|519968040|FG021|Overall Study|Lost to Follow-up|0|||
144642930|NCT02495077|521548558|FG002|Overall Study|Adverse Event|1|||
144642931|NCT02495077|521548559|FG003|Overall Study|Adverse Event|0|||
144642932|NCT02495077|521548556|FG000|Overall Study|Death|3|||
144642933|NCT02495077|521548557|FG001|Overall Study|Death|5|||
144642934|NCT02495077|521548558|FG002|Overall Study|Death|0|||
144642935|NCT02495077|521548559|FG003|Overall Study|Death|0|||
144642936|NCT02495077|521548556|FG000|Overall Study|Lost to Follow-up|6|||
144642937|NCT02495077|521548557|FG001|Overall Study|Lost to Follow-up|4|||
144642938|NCT02495077|521548558|FG002|Overall Study|Lost to Follow-up|0|||
144642939|NCT02495077|521548559|FG003|Overall Study|Lost to Follow-up|0|||
144642940|NCT02495077|521548556|FG000|Overall Study|Physician Decision|2|||
144642941|NCT02495077|521548557|FG001|Overall Study|Physician Decision|1|||
144642942|NCT02495077|521548558|FG002|Overall Study|Physician Decision|4|||
144642943|NCT02495077|521548559|FG003|Overall Study|Physician Decision|0|||
144642944|NCT02495077|521548556|FG000|Overall Study|Protocol Violation|0|||
144642945|NCT02495077|521548557|FG001|Overall Study|Protocol Violation|1|||
144642946|NCT02495077|521548558|FG002|Overall Study|Protocol Violation|0|||
144642947|NCT02495077|521548559|FG003|Overall Study|Protocol Violation|0|||
144642948|NCT02495077|521548556|FG000|Overall Study|Screen Failure|0|||
144642949|NCT02495077|521548557|FG001|Overall Study|Screen Failure|0|||
144642950|NCT02495077|521548558|FG002|Overall Study|Screen Failure|0|||
144211092|NCT01449370|519968041|FG022|Overall Study|Lost to Follow-up|0|||
144211093|NCT01449370|519968042|FG023|Overall Study|Lost to Follow-up|0|||
144211094|NCT01449370|519968043|FG024|Overall Study|Lost to Follow-up|0|||
144211095|NCT01449370|519968019|FG000|Overall Study|Other|0|||
144211096|NCT01449370|519968020|FG001|Overall Study|Other|0|||
144211097|NCT01449370|519968021|FG002|Overall Study|Other|0|||
144211098|NCT01449370|519968022|FG003|Overall Study|Other|0|||
144211099|NCT01449370|519968023|FG004|Overall Study|Other|0|||
144211100|NCT01449370|519968024|FG005|Overall Study|Other|0|||
144211101|NCT01449370|519968025|FG006|Overall Study|Other|0|||
144211102|NCT01449370|519968026|FG007|Overall Study|Other|0|||
144211103|NCT01449370|519968027|FG008|Overall Study|Other|1|||
144211104|NCT01449370|519968028|FG009|Overall Study|Other|1|||
144211105|NCT01449370|519968029|FG010|Overall Study|Other|0|||
144211106|NCT01449370|519968030|FG011|Overall Study|Other|0|||
144211107|NCT01449370|519968031|FG012|Overall Study|Other|0|||
144211108|NCT01449370|519968032|FG013|Overall Study|Other|0|||
144211109|NCT01449370|519968033|FG014|Overall Study|Other|0|||
144211110|NCT01449370|519968034|FG015|Overall Study|Other|0|||
144211111|NCT01449370|519968035|FG016|Overall Study|Other|0|||
144211112|NCT01449370|519968036|FG017|Overall Study|Other|0|||
144211113|NCT01449370|519968037|FG018|Overall Study|Other|0|||
144211114|NCT01449370|519968038|FG019|Overall Study|Other|0|||
144211115|NCT01449370|519968039|FG020|Overall Study|Other|0|||
144211116|NCT01449370|519968040|FG021|Overall Study|Other|0|||
144211117|NCT01449370|519968041|FG022|Overall Study|Other|1|||
144211118|NCT01449370|519968042|FG023|Overall Study|Other|1|||
144211119|NCT01449370|519968043|FG024|Overall Study|Other|0|||
144211120|NCT01449370|519968019|FG000|Overall Study|Medication Prohibited by Protocol|0|||
144211121|NCT01449370|519968020|FG001|Overall Study|Medication Prohibited by Protocol|0|||
144211122|NCT01449370|519968021|FG002|Overall Study|Medication Prohibited by Protocol|0|||
144211123|NCT01449370|519968022|FG003|Overall Study|Medication Prohibited by Protocol|0|||
144211124|NCT01449370|519968023|FG004|Overall Study|Medication Prohibited by Protocol|0|||
144211125|NCT01449370|519968024|FG005|Overall Study|Medication Prohibited by Protocol|0|||
144211126|NCT01449370|519968025|FG006|Overall Study|Medication Prohibited by Protocol|0|||
144211127|NCT01449370|519968026|FG007|Overall Study|Medication Prohibited by Protocol|0|||
144263230|NCT01261390|520163892|FG001|Overall Study|Lost to Follow-up|6|||
144642951|NCT02495077|521548559|FG003|Overall Study|Screen Failure|48|||
144642952|NCT02495077|521548556|FG000|Overall Study|Withdrawal by Subject|7|||
144211128|NCT01449370|519968027|FG008|Overall Study|Medication Prohibited by Protocol|0|||
144211129|NCT01449370|519968028|FG009|Overall Study|Medication Prohibited by Protocol|0|||
144211130|NCT01449370|519968029|FG010|Overall Study|Medication Prohibited by Protocol|0|||
144211131|NCT01449370|519968030|FG011|Overall Study|Medication Prohibited by Protocol|0|||
144211132|NCT01449370|519968031|FG012|Overall Study|Medication Prohibited by Protocol|0|||
144211133|NCT01449370|519968032|FG013|Overall Study|Medication Prohibited by Protocol|0|||
144263231|NCT01261390|520163893|FG002|Overall Study|Lost to Follow-up|5|||
144263232|NCT01261390|520163894|FG003|Overall Study|Lost to Follow-up|6|||
144211134|NCT01449370|519968033|FG014|Overall Study|Medication Prohibited by Protocol|0|||
144211135|NCT01449370|519968034|FG015|Overall Study|Medication Prohibited by Protocol|0|||
144211136|NCT01449370|519968035|FG016|Overall Study|Medication Prohibited by Protocol|0|||
144642953|NCT02495077|521548557|FG001|Overall Study|Withdrawal by Subject|7|||
144211137|NCT01449370|519968036|FG017|Overall Study|Medication Prohibited by Protocol|0|||
144211138|NCT01449370|519968037|FG018|Overall Study|Medication Prohibited by Protocol|0|||
144211139|NCT01449370|519968038|FG019|Overall Study|Medication Prohibited by Protocol|0|||
144642954|NCT02495077|521548558|FG002|Overall Study|Withdrawal by Subject|7|||
144211140|NCT01449370|519968039|FG020|Overall Study|Medication Prohibited by Protocol|0|||
144211141|NCT01449370|519968040|FG021|Overall Study|Medication Prohibited by Protocol|0|||
144211142|NCT01449370|519968041|FG022|Overall Study|Medication Prohibited by Protocol|0|||
144642955|NCT02495077|521548559|FG003|Overall Study|Withdrawal by Subject|0|||
144642956|NCT02495077|521548556|FG000|Overall Study|Covid-19 research restrictions|1|||
144642957|NCT02495077|521548557|FG001|Overall Study|Covid-19 research restrictions|0|||
144642958|NCT02495077|521548558|FG002|Overall Study|Covid-19 research restrictions|0|||
144642959|NCT02495077|521548559|FG003|Overall Study|Covid-19 research restrictions|0|||
144642960|NCT02495077|521548556|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
144642961|NCT02495077|521548557|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
144642962|NCT02495077|521548558|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
144642963|NCT02495077|521548559|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
144642964|NCT02495077|521548556|FG000|Overall Study|Incarcerated|0|||
144642965|NCT02495077|521548557|FG001|Overall Study|Incarcerated|1|||
144642966|NCT02495077|521548558|FG002|Overall Study|Incarcerated|0|||
144642967|NCT02495077|521548559|FG003|Overall Study|Incarcerated|0|||
144642968|NCT02495077|521548556|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
144642969|NCT02495077|521548557|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
144642970|NCT02495077|521548558|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
144642971|NCT02495077|521548559|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
144642972|NCT02495077|521548556|FG000|Overall Study|Timing of transplant and randomization|0|||
144642973|NCT02495077|521548557|FG001|Overall Study|Timing of transplant and randomization|0|||
144642974|NCT02495077|521548558|FG002|Overall Study|Timing of transplant and randomization|5|||
144642975|NCT02495077|521548559|FG003|Overall Study|Timing of transplant and randomization|0|||
144642976|NCT02742649|521548560|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
144642977|NCT02742649|521548561|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
144642978|NCT02742649|521548562|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
144642979|NCT02742649|521548563|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
144642980|NCT02742649|521548564|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
144642981|NCT02742649|521548560|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144642982|NCT02742649|521548561|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144642983|NCT02742649|521548562|FG002|Double-Blind Treatment Period|Adverse Event|0|||
144642984|NCT02742649|521548563|FG003|Double-Blind Treatment Period|Adverse Event|0|||
144642985|NCT02742649|521548564|FG004|Double-Blind Treatment Period|Adverse Event|0|||
144642986|NCT02742649|521548560|FG000|Open-Label Period|Lost to Follow-up|0|||
144642987|NCT02742649|521548561|FG001|Open-Label Period|Lost to Follow-up|0|||
144642988|NCT02742649|521548562|FG002|Open-Label Period|Lost to Follow-up|0|||
144642989|NCT02742649|521548563|FG003|Open-Label Period|Lost to Follow-up|0|||
144642990|NCT02742649|521548564|FG004|Open-Label Period|Lost to Follow-up|1|||
144642991|NCT02158533|521548573|FG000|Stage 1|Adverse Event|6|||
144642992|NCT02158533|521548574|FG001|Stage 1|Adverse Event|4|||
144642993|NCT02158533|521548575|FG002|Stage 1|Adverse Event|7|||
144642994|NCT02158533|521548576|FG003|Stage 1|Adverse Event|0|||
144642995|NCT02158533|521548577|FG004|Stage 1|Adverse Event|0|||
144642996|NCT02158533|521548578|FG005|Stage 1|Adverse Event|0|||
144642997|NCT02158533|521548573|FG000|Stage 1|Withdrawal by Subject|3|||
144642998|NCT02158533|521548574|FG001|Stage 1|Withdrawal by Subject|2|||
144642999|NCT02158533|521548575|FG002|Stage 1|Withdrawal by Subject|1|||
144643000|NCT02158533|521548576|FG003|Stage 1|Withdrawal by Subject|0|||
144643001|NCT02158533|521548577|FG004|Stage 1|Withdrawal by Subject|0|||
144643002|NCT02158533|521548578|FG005|Stage 1|Withdrawal by Subject|0|||
144643003|NCT02158533|521548573|FG000|Stage 1|Lack of Efficacy|1|||
144643004|NCT02158533|521548574|FG001|Stage 1|Lack of Efficacy|0|||
144211143|NCT01449370|519968042|FG023|Overall Study|Medication Prohibited by Protocol|1|||
144211144|NCT01449370|519968043|FG024|Overall Study|Medication Prohibited by Protocol|0|||
144643005|NCT02158533|521548575|FG002|Stage 1|Lack of Efficacy|0|||
144643006|NCT02158533|521548576|FG003|Stage 1|Lack of Efficacy|0|||
144643007|NCT02158533|521548577|FG004|Stage 1|Lack of Efficacy|0|||
144643008|NCT02158533|521548578|FG005|Stage 1|Lack of Efficacy|0|||
144643009|NCT02158533|521548573|FG000|Stage 1|Lost to Follow-up|3|||
144643010|NCT02158533|521548574|FG001|Stage 1|Lost to Follow-up|1|||
144643011|NCT02158533|521548575|FG002|Stage 1|Lost to Follow-up|0|||
144643012|NCT02158533|521548576|FG003|Stage 1|Lost to Follow-up|0|||
144643013|NCT02158533|521548577|FG004|Stage 1|Lost to Follow-up|0|||
144643014|NCT02158533|521548578|FG005|Stage 1|Lost to Follow-up|0|||
144211145|NCT01449370|519968019|FG000|Overall Study|Death|0|||
144643015|NCT02158533|521548573|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
144211146|NCT01449370|519968020|FG001|Overall Study|Death|0|||
144211147|NCT01449370|519968021|FG002|Overall Study|Death|0|||
144211148|NCT01449370|519968022|FG003|Overall Study|Death|0|||
144263233|NCT01497067|520163895|FG000|Overall Study|Lost to Follow-up|56|||
144643016|NCT02158533|521548574|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
144643017|NCT02158533|521548575|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
144643018|NCT02158533|521548576|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
144263234|NCT01497067|520163895|FG000|Overall Study|Adverse Event|3|||
144643019|NCT02158533|521548577|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
144643020|NCT02158533|521548578|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
144643021|NCT02158533|521548573|FG000|Stage 1|Non-compliance with study visits|1|||
144643022|NCT02158533|521548574|FG001|Stage 1|Non-compliance with study visits|0|||
144643023|NCT02158533|521548575|FG002|Stage 1|Non-compliance with study visits|0|||
144643024|NCT02158533|521548576|FG003|Stage 1|Non-compliance with study visits|0|||
144643025|NCT02158533|521548577|FG004|Stage 1|Non-compliance with study visits|0|||
144643026|NCT02158533|521548578|FG005|Stage 1|Non-compliance with study visits|0|||
144643027|NCT02158533|521548573|FG000|Stage 2|Adverse Event|0|||
144643028|NCT02158533|521548574|FG001|Stage 2|Adverse Event|0|||
144643029|NCT02158533|521548575|FG002|Stage 2|Adverse Event|0|||
144643030|NCT02158533|521548576|FG003|Stage 2|Adverse Event|0|||
144643031|NCT02158533|521548577|FG004|Stage 2|Adverse Event|0|||
144643032|NCT02158533|521548578|FG005|Stage 2|Adverse Event|1|||
144643033|NCT02158533|521548573|FG000|Stage 2|Lack of Efficacy|0|||
144643034|NCT02158533|521548574|FG001|Stage 2|Lack of Efficacy|0|||
144643035|NCT02158533|521548575|FG002|Stage 2|Lack of Efficacy|0|||
144643036|NCT02158533|521548576|FG003|Stage 2|Lack of Efficacy|0|||
144643037|NCT02158533|521548577|FG004|Stage 2|Lack of Efficacy|1|||
144643038|NCT02158533|521548578|FG005|Stage 2|Lack of Efficacy|0|||
144643039|NCT02158533|521548573|FG000|Stage 2|Lost to Follow-up|0|||
144643040|NCT02158533|521548574|FG001|Stage 2|Lost to Follow-up|0|||
144643041|NCT02158533|521548575|FG002|Stage 2|Lost to Follow-up|0|||
144643042|NCT02158533|521548576|FG003|Stage 2|Lost to Follow-up|1|||
144643043|NCT02158533|521548577|FG004|Stage 2|Lost to Follow-up|1|||
144643044|NCT02158533|521548578|FG005|Stage 2|Lost to Follow-up|2|||
144643045|NCT02158533|521548573|FG000|Stage 2|Withdrawal by Subject|0|||
144643046|NCT02158533|521548574|FG001|Stage 2|Withdrawal by Subject|0|||
144731355|NCT05093205|521871415|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731356|NCT05093205|521871416|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731357|NCT05093205|521871417|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731358|NCT05093205|521871418|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
144731359|NCT05093205|521871419|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
144731360|NCT02979353|521871427|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
144731361|NCT02979353|521871428|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
144731362|NCT02979353|521871427|FG000|Overall Study|Withdrawal by Subject|16|||
144731363|NCT02979353|521871428|FG001|Overall Study|Withdrawal by Subject|12|||
144731364|NCT02979353|521871427|FG000|Overall Study|Death|10|||
144731365|NCT02979353|521871428|FG001|Overall Study|Death|11|||
144731366|NCT02979353|521871427|FG000|Overall Study|Transfer to Hospice Care|19|||
144731367|NCT02979353|521871428|FG001|Overall Study|Transfer to Hospice Care|14|||
144731368|NCT02979353|521871427|FG000|Overall Study|Lost to Follow-up|1|||
144731369|NCT02979353|521871428|FG001|Overall Study|Lost to Follow-up|5|||
144731370|NCT01722877|521871429|FG000|Overall Study|Death|1|||
144731371|NCT01722877|521871429|FG000|Overall Study|Lost to Follow-up|1|||
144731372|NCT03693430|521871432|FG000|Overall Study|Lost to Follow-up|3|||
144731373|NCT03693430|521871433|FG001|Overall Study|Lost to Follow-up|14|||
144731374|NCT03693430|521871432|FG000|Overall Study|Death|1|||
144731375|NCT03693430|521871433|FG001|Overall Study|Death|0|||
144731376|NCT03693430|521871432|FG000|Overall Study|Withdrawal by Subject|0|||
144731377|NCT03693430|521871433|FG001|Overall Study|Withdrawal by Subject|4|||
144731378|NCT02930005|521871434|FG000|Overall Study|Lost to Follow-up|1|||
144731379|NCT02930005|521871435|FG001|Overall Study|Lost to Follow-up|5|||
144731380|NCT00585689|521871436|FG000|Overall Study|Received different ABI-007 schedule|3|||
144731381|NCT00585689|521871436|FG000|Overall Study|Adverse Event|1|||
144731382|NCT00585689|521871436|FG000|Overall Study|Patient Declined Surgery|1|||
144731383|NCT00585689|521871436|FG000|Overall Study|Patient had unresectable disease|1|||
144731384|NCT00585689|521871436|FG000|Overall Study|Death|1|||
144211149|NCT01449370|519968023|FG004|Overall Study|Death|0|||
144211150|NCT01449370|519968024|FG005|Overall Study|Death|0|||
144211151|NCT01449370|519968025|FG006|Overall Study|Death|0|||
144731385|NCT02373098|521871438|FG000|Overall Study|Lost to Follow-up|1|||
144211152|NCT01449370|519968026|FG007|Overall Study|Death|0|||
144211153|NCT01449370|519968027|FG008|Overall Study|Death|0|||
144643047|NCT02158533|521548575|FG002|Stage 2|Withdrawal by Subject|0|||
144643048|NCT02158533|521548576|FG003|Stage 2|Withdrawal by Subject|0|||
144643049|NCT02158533|521548577|FG004|Stage 2|Withdrawal by Subject|1|||
144643050|NCT02158533|521548578|FG005|Stage 2|Withdrawal by Subject|2|||
144643051|NCT02158533|521548573|FG000|Stage 2|Physician Decision|0|||
144643052|NCT02158533|521548574|FG001|Stage 2|Physician Decision|0|||
144643053|NCT02158533|521548575|FG002|Stage 2|Physician Decision|0|||
144643054|NCT02158533|521548576|FG003|Stage 2|Physician Decision|0|||
144643055|NCT02158533|521548577|FG004|Stage 2|Physician Decision|1|||
144643056|NCT02158533|521548578|FG005|Stage 2|Physician Decision|0|||
144731386|NCT02373098|521871439|FG001|Overall Study|Lost to Follow-up|0|||
144731387|NCT02373098|521871438|FG000|Overall Study|Protocol Violation|3|||
144731388|NCT02373098|521871439|FG001|Overall Study|Protocol Violation|0|||
144731389|NCT02373098|521871438|FG000|Overall Study|Withdrawal by Subject|5|||
144731390|NCT02373098|521871439|FG001|Overall Study|Withdrawal by Subject|0|||
144731391|NCT02373098|521871438|FG000|Overall Study|Adverse Event|3|||
144211154|NCT01449370|519968028|FG009|Overall Study|Death|0|||
144211155|NCT01449370|519968029|FG010|Overall Study|Death|0|||
144211156|NCT01449370|519968030|FG011|Overall Study|Death|0|||
144211157|NCT01449370|519968031|FG012|Overall Study|Death|0|||
144211158|NCT01449370|519968032|FG013|Overall Study|Death|0|||
144211159|NCT01449370|519968033|FG014|Overall Study|Death|0|||
144211160|NCT01449370|519968034|FG015|Overall Study|Death|0|||
144643057|NCT02158533|521548573|FG000|Stage 2|Pregnancy|0|||
144211161|NCT01449370|519968035|FG016|Overall Study|Death|0|||
144211162|NCT01449370|519968036|FG017|Overall Study|Death|0|||
144211163|NCT01449370|519968037|FG018|Overall Study|Death|0|||
144211164|NCT01449370|519968038|FG019|Overall Study|Death|0|||
144211165|NCT01449370|519968039|FG020|Overall Study|Death|0|||
144211166|NCT01449370|519968040|FG021|Overall Study|Death|0|||
144211167|NCT01449370|519968041|FG022|Overall Study|Death|0|||
144211168|NCT01449370|519968042|FG023|Overall Study|Death|0|||
144643058|NCT02158533|521548574|FG001|Stage 2|Pregnancy|0|||
144643059|NCT02158533|521548575|FG002|Stage 2|Pregnancy|0|||
144643060|NCT02158533|521548576|FG003|Stage 2|Pregnancy|1|||
144643061|NCT02158533|521548577|FG004|Stage 2|Pregnancy|0|||
144643062|NCT02158533|521548578|FG005|Stage 2|Pregnancy|0|||
144643063|NCT02158533|521548573|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
144643064|NCT02158533|521548574|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
144643065|NCT02158533|521548575|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
144643066|NCT02158533|521548576|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
144643067|NCT02158533|521548577|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
144643068|NCT02158533|521548578|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
144643069|NCT02158533|521548573|FG000|Stage 2|Non-adherence with study visits|0|||
144643070|NCT02158533|521548574|FG001|Stage 2|Non-adherence with study visits|0|||
144643071|NCT02158533|521548575|FG002|Stage 2|Non-adherence with study visits|0|||
144643072|NCT02158533|521548576|FG003|Stage 2|Non-adherence with study visits|0|||
144643073|NCT02158533|521548577|FG004|Stage 2|Non-adherence with study visits|0|||
144643074|NCT02158533|521548578|FG005|Stage 2|Non-adherence with study visits|1|||
144643075|NCT02037919|521548585|FG000|Overall Study|Lost to Follow-up|30|||
144643076|NCT02037919|521548586|FG001|Overall Study|Lost to Follow-up|45|||
144643077|NCT01335971|521548587|FG000|Overall Study|Withdrawal by Subject|1|||
144643078|NCT01335971|521548588|FG001|Overall Study|Withdrawal by Subject|0|||
144643079|NCT01335971|521548589|FG002|Overall Study|Withdrawal by Subject|0|||
144643080|NCT01335971|521548587|FG000|Overall Study|Did not complete bronchoscopy|1|||
144643081|NCT01335971|521548588|FG001|Overall Study|Did not complete bronchoscopy|1|||
144643082|NCT01335971|521548589|FG002|Overall Study|Did not complete bronchoscopy|1|||
144643083|NCT00384956|521548590|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
144643084|NCT03180736|521548591|FG000|Overall Study|Adverse Event|3|||
144643085|NCT03180736|521548592|FG001|Overall Study|Adverse Event|4|||
144643086|NCT03180736|521548591|FG000|Overall Study|Death|10|||
144643087|NCT03180736|521548592|FG001|Overall Study|Death|7|||
144643088|NCT03180736|521548591|FG000|Overall Study|Withdrawal by Subject|5|||
144643089|NCT03180736|521548592|FG001|Overall Study|Withdrawal by Subject|12|||
144643090|NCT03180736|521548591|FG000|Overall Study|Lost to Follow-up|1|||
144643091|NCT03180736|521548592|FG001|Overall Study|Lost to Follow-up|0|||
144643092|NCT03180736|521548591|FG000|Overall Study|Lack of Efficacy|66|||
144643093|NCT03180736|521548592|FG001|Overall Study|Lack of Efficacy|87|||
144643094|NCT03180736|521548591|FG000|Overall Study|Physician Decision|4|||
144643095|NCT03180736|521548592|FG001|Overall Study|Physician Decision|7|||
144643096|NCT03180736|521548591|FG000|Overall Study|randomized but not treated|2|||
144643097|NCT03180736|521548592|FG001|Overall Study|randomized but not treated|3|||
144643098|NCT01389128|521548593|FG000|Overall Study|Fetal distress|1|||
144643099|NCT01389128|521548594|FG001|Overall Study|Fetal distress|0|||
144643100|NCT01389128|521548593|FG000|Overall Study|Cervix dilation stop|1|||
144643101|NCT01389128|521548594|FG001|Overall Study|Cervix dilation stop|2|||
144643102|NCT01389128|521548593|FG000|Overall Study|Rapid labor evolution|3|||
144643103|NCT01389128|521548594|FG001|Overall Study|Rapid labor evolution|2|||
144643104|NCT01389128|521548593|FG000|Overall Study|Intolerance to procedure|0|||
144643105|NCT01389128|521548594|FG001|Overall Study|Intolerance to procedure|2|||
144643106|NCT03230097|521548597|FG000|Overall Study|Adverse Event|2|||
144643107|NCT03230097|521548598|FG001|Overall Study|Adverse Event|1|||
144643108|NCT03230097|521548597|FG000|Overall Study|non-compliance|0|||
144211169|NCT01449370|519968043|FG024|Overall Study|Death|1|||
144211170|NCT01004003|519968052|FG000|Overall Study|Progressive disease|2|||
144211171|NCT01004003|519968053|FG001|Overall Study|Progressive disease|1|||
144643109|NCT03230097|521548598|FG001|Overall Study|non-compliance|1|||
144643110|NCT03230097|521548597|FG000|Overall Study|Lost to Follow-up|2|||
144643111|NCT03230097|521548598|FG001|Overall Study|Lost to Follow-up|4|||
144643112|NCT03230097|521548597|FG000|Overall Study|Withdrawal by Subject|7|||
144643113|NCT03230097|521548598|FG001|Overall Study|Withdrawal by Subject|3|||
144643114|NCT03230097|521548597|FG000|Overall Study|Trial termination|4|||
144211172|NCT01004003|519968054|FG002|Overall Study|Progressive disease|1|||
144211173|NCT01004003|519968055|FG003|Overall Study|Progressive disease|0|||
144211174|NCT01004003|519968056|FG004|Overall Study|Progressive disease|2|||
144211175|NCT01004003|519968057|FG005|Overall Study|Progressive disease|1|||
144211176|NCT01004003|519968058|FG006|Overall Study|Progressive disease|1|||
144211177|NCT01004003|519968059|FG007|Overall Study|Progressive disease|39|||
144211178|NCT01004003|519968060|FG008|Overall Study|Progressive disease|22|||
144211179|NCT01004003|519968052|FG000|Overall Study|Adverse Event|4|||
144211180|NCT01004003|519968053|FG001|Overall Study|Adverse Event|2|||
144211181|NCT01004003|519968054|FG002|Overall Study|Adverse Event|3|||
144211182|NCT01004003|519968055|FG003|Overall Study|Adverse Event|3|||
144643115|NCT03230097|521548598|FG001|Overall Study|Trial termination|5|||
144643116|NCT03230097|521548597|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
144643117|NCT03230097|521548598|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
144643118|NCT03230097|521548597|FG000|Overall Study|outcome event|0|||
144211183|NCT01004003|519968056|FG004|Overall Study|Adverse Event|2|||
144643119|NCT03230097|521548598|FG001|Overall Study|outcome event|1|||
144643120|NCT03056287|521548599|FG000|Overall Study|Withdrawal by Subject|0|||
144643121|NCT03056287|521548600|FG001|Overall Study|Withdrawal by Subject|1|||
144643122|NCT03056287|521548601|FG002|Overall Study|Withdrawal by Subject|0|||
144643123|NCT03056287|521548602|FG003|Overall Study|Withdrawal by Subject|0|||
144643124|NCT03056287|521548599|FG000|Overall Study|move out of area|0|||
144643125|NCT03056287|521548600|FG001|Overall Study|move out of area|0|||
144643126|NCT03056287|521548601|FG002|Overall Study|move out of area|1|||
144643127|NCT03056287|521548602|FG003|Overall Study|move out of area|1|||
144643128|NCT04876391|521548610|FG000|Overall Study|Withdrawal by Subject|1|||
144643129|NCT04876391|521548611|FG001|Overall Study|Withdrawal by Subject|10|||
144643130|NCT04876391|521548610|FG000|Overall Study|Lost to Follow-up|2|||
144643131|NCT04876391|521548611|FG001|Overall Study|Lost to Follow-up|4|||
144643132|NCT04876391|521548610|FG000|Overall Study|Lack of Efficacy|0|||
144643133|NCT04876391|521548611|FG001|Overall Study|Lack of Efficacy|2|||
144643134|NCT04876391|521548610|FG000|Overall Study|Adverse Event|3|||
144643135|NCT04876391|521548611|FG001|Overall Study|Adverse Event|1|||
144643136|NCT04876391|521548610|FG000|Overall Study|Patient non-compliance|0|||
144643137|NCT04876391|521548611|FG001|Overall Study|Patient non-compliance|1|||
144643138|NCT04876391|521548610|FG000|Overall Study|Personal reasons|0|||
144643139|NCT04876391|521548611|FG001|Overall Study|Personal reasons|1|||
144643140|NCT04876391|521548610|FG000|Overall Study|Withdrawn as per protocol|2|||
144643141|NCT04876391|521548611|FG001|Overall Study|Withdrawn as per protocol|2|||
144643142|NCT02286960|521548612|FG000|Overall Study|Lost to Follow-up|3|||
144643143|NCT02286960|521548613|FG001|Overall Study|Lost to Follow-up|3|||
144643144|NCT01486238|521548614|FG000|Overall Study|Death|0|||
144643145|NCT01486238|521548615|FG001|Overall Study|Death|2|||
144643146|NCT01486238|521548614|FG000|Overall Study|Withdrawal by Subject|2|||
144643147|NCT01486238|521548615|FG001|Overall Study|Withdrawal by Subject|1|||
144643148|NCT01486238|521548614|FG000|Overall Study|Lost to Follow-up|0|||
144643149|NCT01486238|521548615|FG001|Overall Study|Lost to Follow-up|3|||
144643150|NCT06129487|521548620|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
144643151|NCT06129487|521548621|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
144643152|NCT00258154|521548622|FG000|Overall Study|Adverse Event|1|||
144643153|NCT00258154|521548623|FG001|Overall Study|Adverse Event|0|||
144643154|NCT00258154|521548622|FG000|Overall Study|Lost to Follow-up|0|||
144643155|NCT00258154|521548623|FG001|Overall Study|Lost to Follow-up|1|||
144643156|NCT00258154|521548622|FG000|Overall Study|Protocol Violation|2|||
144643157|NCT00258154|521548623|FG001|Overall Study|Protocol Violation|1|||
144643158|NCT00258154|521548622|FG000|Overall Study|Withdrawal by Subject|3|||
144643159|NCT00258154|521548623|FG001|Overall Study|Withdrawal by Subject|4|||
144643160|NCT00258154|521548622|FG000|Overall Study|Patient Moved|3|||
144643161|NCT00258154|521548623|FG001|Overall Study|Patient Moved|1|||
144643162|NCT03772327|521548624|FG000|Overall Study|Lost to Follow-up|3|||
144643163|NCT03772327|521548625|FG001|Overall Study|Lost to Follow-up|4|||
144643164|NCT03772327|521548624|FG000|Overall Study|Withdrawal by Subject|2|||
144643165|NCT03772327|521548625|FG001|Overall Study|Withdrawal by Subject|3|||
144643166|NCT04689828|521548626|FG000|Overall Study|Subject decision|5|||
144643167|NCT04689828|521548627|FG001|Overall Study|Subject decision|5|||
144643168|NCT04689828|521548626|FG000|Overall Study|Adverse Event|12|||
144211184|NCT01004003|519968057|FG005|Overall Study|Adverse Event|2|||
144211185|NCT01004003|519968058|FG006|Overall Study|Adverse Event|7|||
144211186|NCT01004003|519968059|FG007|Overall Study|Adverse Event|21|||
144211187|NCT01004003|519968060|FG008|Overall Study|Adverse Event|6|||
144211188|NCT01004003|519968052|FG000|Overall Study|Refused to continue taking trial med.|0|||
144643169|NCT04689828|521548627|FG001|Overall Study|Adverse Event|12|||
144643170|NCT04689828|521548626|FG000|Overall Study|Physician Decision|24|||
144643171|NCT04689828|521548627|FG001|Overall Study|Physician Decision|32|||
144643172|NCT04689828|521548626|FG000|Overall Study|Progressive disease|54|||
144643173|NCT04689828|521548627|FG001|Overall Study|Progressive disease|173|||
144643174|NCT04689828|521548626|FG000|Overall Study|Death|0|||
144211189|NCT01004003|519968053|FG001|Overall Study|Refused to continue taking trial med.|0|||
144643175|NCT04689828|521548627|FG001|Overall Study|Death|1|||
144643176|NCT04689828|521548626|FG000|Overall Study|Lost to Follow-up|1|||
144731392|NCT02373098|521871439|FG001|Overall Study|Adverse Event|0|||
144643177|NCT04689828|521548627|FG001|Overall Study|Lost to Follow-up|0|||
144731393|NCT05067647|521871443|FG000|Overall Study|Lost to Follow-up|1|||
144643178|NCT04689828|521548626|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
144643179|NCT04689828|521548627|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
144643180|NCT04689828|521548626|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
144643181|NCT04689828|521548627|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
144643182|NCT04689828|521548626|FG000|Overall Study|Participants not treated|7|||
144643183|NCT04689828|521548627|FG001|Overall Study|Participants not treated|2|||
144643184|NCT02493751|521548628|FG000|Overall Study|Withdrawal by Subject|2|||
144643185|NCT02493751|521548629|FG001|Overall Study|Withdrawal by Subject|8|||
144643186|NCT02493751|521548628|FG000|Overall Study|Death|6|||
144643187|NCT02493751|521548629|FG001|Overall Study|Death|13|||
144643188|NCT02493751|521548628|FG000|Overall Study|Lost to Follow-up|2|||
144643189|NCT02493751|521548629|FG001|Overall Study|Lost to Follow-up|3|||
144643190|NCT02493751|521548628|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
144643191|NCT02493751|521548629|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
144643192|NCT01824602|521548630|FG000|Overall Study|Withdrawal by Subject|0|||
144643193|NCT01824602|521548631|FG001|Overall Study|Withdrawal by Subject|0|||
144643194|NCT01824602|521548632|FG002|Overall Study|Withdrawal by Subject|1|||
144643195|NCT01824602|521548633|FG003|Overall Study|Withdrawal by Subject|2|||
144643196|NCT01824602|521548630|FG000|Overall Study|Patient non-compliance|0|||
144643197|NCT01824602|521548631|FG001|Overall Study|Patient non-compliance|0|||
144643198|NCT01824602|521548632|FG002|Overall Study|Patient non-compliance|1|||
144643199|NCT01824602|521548633|FG003|Overall Study|Patient non-compliance|0|||
144643200|NCT01824602|521548630|FG000|Overall Study|Adverse Event|1|||
144643201|NCT01824602|521548631|FG001|Overall Study|Adverse Event|0|||
144643202|NCT01824602|521548632|FG002|Overall Study|Adverse Event|2|||
144643203|NCT01824602|521548633|FG003|Overall Study|Adverse Event|2|||
144731394|NCT03897088|521871448|FG000|Overall Study|Withdrawal by Subject|12|||
144731395|NCT03897088|521871449|FG001|Overall Study|Withdrawal by Subject|12|||
144731396|NCT03897088|521871448|FG000|Overall Study|Lost to Follow-up|7|||
144731397|NCT03897088|521871449|FG001|Overall Study|Lost to Follow-up|15|||
144731398|NCT03897088|521871448|FG000|Overall Study|Sponsor Decision|1|||
144731399|NCT03897088|521871449|FG001|Overall Study|Sponsor Decision|2|||
144731400|NCT03897088|521871448|FG000|Overall Study|COVID-19|2|||
144731401|NCT03897088|521871449|FG001|Overall Study|COVID-19|0|||
144731402|NCT03897088|521871448|FG000|Overall Study|Other|3|||
144731403|NCT03897088|521871449|FG001|Overall Study|Other|0|||
144731404|NCT03897088|521871448|FG000|Overall Study|Non-compliance with Study Drug|1|||
144731405|NCT03897088|521871449|FG001|Overall Study|Non-compliance with Study Drug|1|||
144731406|NCT03897088|521871448|FG000|Overall Study|Pregnancy|0|||
144731407|NCT03897088|521871449|FG001|Overall Study|Pregnancy|1|||
144731408|NCT00119379|521871464|FG000|Overall Study|Adverse Event|4|||
144731409|NCT00119379|521871465|FG001|Overall Study|Adverse Event|1|||
144731410|NCT01569152|521871466|FG000|Phase IIa, Period 1|Early Escape|5|||
144731411|NCT01569152|521871467|FG001|Phase IIa, Period 1|Early Escape|22|||
144731412|NCT01569152|521871468|FG002|Phase IIa, Period 1|Early Escape|0|||
144731413|NCT01569152|521871466|FG000|Phase IIa, Period 1|Adverse Event|4|||
144731414|NCT01569152|521871467|FG001|Phase IIa, Period 1|Adverse Event|0|||
144731415|NCT01569152|521871468|FG002|Phase IIa, Period 1|Adverse Event|0|||
144731416|NCT01569152|521871466|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
144731417|NCT01569152|521871467|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
144731418|NCT01569152|521871468|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
144731419|NCT01569152|521871466|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
144731420|NCT01569152|521871467|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
144731421|NCT01569152|521871468|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
144731422|NCT01569152|521871466|FG000|Phase IIa, Period 1|Protocol Violation|0|||
144731423|NCT01569152|521871467|FG001|Phase IIa, Period 1|Protocol Violation|1|||
144731424|NCT01569152|521871468|FG002|Phase IIa, Period 1|Protocol Violation|0|||
144731425|NCT01569152|521871466|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
144731426|NCT01569152|521871467|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
144731427|NCT01569152|521871468|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
144263235|NCT01497067|520163895|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
144263236|NCT01497067|520163895|FG000|Overall Study|Other|13|||
144731428|NCT01569152|521871466|FG000|Safety Extension, Period 3|Adverse Event|0|||
144731429|NCT01569152|521871467|FG001|Safety Extension, Period 3|Adverse Event|0|||
144731430|NCT01569152|521871468|FG002|Safety Extension, Period 3|Adverse Event|4|||
144731431|NCT01569152|521871466|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
144731432|NCT01569152|521871467|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
144731433|NCT01569152|521871468|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
144731434|NCT01569152|521871466|FG000|Safety Extension, Period 3|Physician Decision|0|||
144731435|NCT01569152|521871467|FG001|Safety Extension, Period 3|Physician Decision|0|||
144731436|NCT01569152|521871468|FG002|Safety Extension, Period 3|Physician Decision|2|||
144731437|NCT01569152|521871466|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
144731438|NCT01569152|521871467|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
144731439|NCT01569152|521871468|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
144643204|NCT01824602|521548630|FG000|Overall Study|Treatment failure|0|||
144643205|NCT01824602|521548631|FG001|Overall Study|Treatment failure|0|||
144643206|NCT01824602|521548632|FG002|Overall Study|Treatment failure|0|||
144643207|NCT01824602|521548633|FG003|Overall Study|Treatment failure|1|||
144643208|NCT02192359|521548634|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
144643209|NCT02192359|521548635|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
144643210|NCT02192359|521548636|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
144643211|NCT02192359|521548637|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
144643212|NCT02192359|521548634|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
144643213|NCT02192359|521548635|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
144643214|NCT02192359|521548636|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
144643215|NCT02192359|521548637|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
144643216|NCT02192359|521548634|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
144643217|NCT02192359|521548635|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
144643218|NCT02192359|521548636|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
144643219|NCT02192359|521548637|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
144643220|NCT01548638|521548640|FG000|Overall Study|Protocol Violation|3|||
144643221|NCT01548638|521548640|FG000|Overall Study|Withdrawal by Subject|1|||
144643222|NCT05445843|521548641|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
144643223|NCT05445843|521548642|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
144643224|NCT05445843|521548641|FG000|Overall Study|Progressive disease|17|||
144643225|NCT05445843|521548642|FG001|Overall Study|Progressive disease|9|||
144643226|NCT05445843|521548641|FG000|Overall Study|Physician Decision|16|||
144643227|NCT05445843|521548642|FG001|Overall Study|Physician Decision|4|||
144643228|NCT05445843|521548641|FG000|Overall Study|Death|6|||
144643229|NCT05445843|521548642|FG001|Overall Study|Death|3|||
144643230|NCT05445843|521548641|FG000|Overall Study|Subject decision|6|||
144643231|NCT05445843|521548642|FG001|Overall Study|Subject decision|2|||
144643232|NCT05445843|521548641|FG000|Overall Study|Adverse Event|2|||
144643233|NCT05445843|521548642|FG001|Overall Study|Adverse Event|0|||
144643234|NCT04090164|521548647|FG000|Overall Study|incomplete data on file|245|||
144643235|NCT04090164|521548648|FG001|Overall Study|incomplete data on file|0|||
144643236|NCT03414359|521548652|FG000|Overall Study|Lack of Efficacy|1|||
144643237|NCT03414359|521548653|FG001|Overall Study|Lack of Efficacy|1|||
144643238|NCT03414359|521548652|FG000|Overall Study|Protocol Violation|0|||
144643239|NCT03414359|521548653|FG001|Overall Study|Protocol Violation|1|||
144643240|NCT01877655|521548654|FG000|Overall Study|Death|57|||
144643241|NCT01877655|521548655|FG001|Overall Study|Death|52|||
144643242|NCT01877655|521548654|FG000|Overall Study|Withdrawal by Subject|18|||
144643243|NCT01877655|521548655|FG001|Overall Study|Withdrawal by Subject|26|||
144211190|NCT01004003|519968054|FG002|Overall Study|Refused to continue taking trial med.|0|||
144211191|NCT01004003|519968055|FG003|Overall Study|Refused to continue taking trial med.|0|||
144211192|NCT01004003|519968056|FG004|Overall Study|Refused to continue taking trial med.|0|||
144211193|NCT01004003|519968057|FG005|Overall Study|Refused to continue taking trial med.|0|||
144643244|NCT01877655|521548654|FG000|Overall Study|Physician Decision|11|||
144643245|NCT01877655|521548655|FG001|Overall Study|Physician Decision|10|||
144643246|NCT01877655|521548654|FG000|Overall Study|Miscellaneous|4|||
144643247|NCT01877655|521548655|FG001|Overall Study|Miscellaneous|4|||
144643248|NCT01877655|521548654|FG000|Overall Study|Randomized but Never Received Drug|8|||
144643249|NCT01877655|521548655|FG001|Overall Study|Randomized but Never Received Drug|5|||
144643250|NCT00095121|521548658|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
144643251|NCT00095121|521548659|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
144643252|NCT00095121|521548658|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
144643253|NCT00095121|521548659|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
144643254|NCT04070378|521548662|FG000|Overall Study|Withdrawal by Subject|2|||
144643255|NCT04070378|521548662|FG000|Overall Study|Screen Failure|6|||
144643256|NCT04070378|521548662|FG000|Overall Study|Physician Decision|1|||
144643257|NCT04070378|521548662|FG000|Overall Study|Adverse Event|1|||
144643258|NCT02462889|521548664|FG000|Overall Study|Withdrawal by Subject|2|||
144643259|NCT02462889|521548665|FG001|Overall Study|Withdrawal by Subject|6|||
144643260|NCT02462889|521548664|FG000|Overall Study|Death|1|||
144643261|NCT02462889|521548665|FG001|Overall Study|Death|5|||
144643262|NCT04636177|521548666|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
144643263|NCT04636177|521548667|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
144643264|NCT04636177|521548666|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
144643265|NCT04636177|521548667|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
144211194|NCT01004003|519968058|FG006|Overall Study|Refused to continue taking trial med.|0|||
144211195|NCT01004003|519968059|FG007|Overall Study|Refused to continue taking trial med.|0|||
144643266|NCT04636177|521548666|FG000|Single-arm portion|Withdrawal by Subject|1|||
144643267|NCT04636177|521548667|FG001|Single-arm portion|Withdrawal by Subject|0|||
144643268|NCT04636177|521548666|FG000|Single-arm portion|Adverse Event|1|||
144643269|NCT04636177|521548667|FG001|Single-arm portion|Adverse Event|0|||
144643270|NCT02277444|521548668|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
144643271|NCT02277444|521548668|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
144643272|NCT02277444|521548668|FG000|Treatment Period (Week 0-52)|Other|1|||
144643273|NCT02277444|521548668|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
144643274|NCT02277444|521548668|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
144643275|NCT02277444|521548668|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
144643276|NCT02277444|521548668|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
144643277|NCT02277444|521548668|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
144643278|NCT02277444|521548668|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
144643279|NCT05278104|521548669|FG000|Overall Study|Not treated|1|||
144643280|NCT05278104|521548670|FG001|Overall Study|Not treated|0|||
144643281|NCT05278104|521548669|FG000|Overall Study|Adverse Event|2|||
144643282|NCT05278104|521548670|FG001|Overall Study|Adverse Event|1|||
144643283|NCT05278104|521548669|FG000|Overall Study|Exclusion criteria not met|1|||
144643284|NCT05278104|521548670|FG001|Overall Study|Exclusion criteria not met|0|||
144643285|NCT03439345|521551096|FG000|Overall Study|Lost to Follow-up|0|||
144643286|NCT03439345|521551097|FG001|Overall Study|Lost to Follow-up|1|||
144643287|NCT03439345|521551096|FG000|Overall Study|Consent withdrawn|0|||
144643288|NCT03439345|521551097|FG001|Overall Study|Consent withdrawn|1|||
144643289|NCT01943539|521551100|FG000|Overall Study|Non-compliance with at-home intervention|4|||
144643290|NCT01943539|521551101|FG001|Overall Study|Non-compliance with at-home intervention|0|||
144643291|NCT01254344|521551116|FG000|Overall Study|Adverse Event|2|||
144643292|NCT01254344|521551117|FG001|Overall Study|Adverse Event|5|||
144643293|NCT01254344|521551116|FG000|Overall Study|Physician Decision|7|||
144643294|NCT01254344|521551117|FG001|Overall Study|Physician Decision|4|||
144643295|NCT01254344|521551116|FG000|Overall Study|Protocol Violation|1|||
144643296|NCT01254344|521551117|FG001|Overall Study|Protocol Violation|4|||
144643297|NCT01254344|521551116|FG000|Overall Study|Withdrawal by Subject|3|||
144643298|NCT01254344|521551117|FG001|Overall Study|Withdrawal by Subject|6|||
144643299|NCT00847613|521551118|FG000|Overall Study|Ongoing at cut-off date|250|||
144643300|NCT00847613|521551119|FG001|Overall Study|Ongoing at cut-off date|265|||
144643301|NCT00847613|521551120|FG002|Overall Study|Ongoing at cut-off date|64|||
144643302|NCT00847613|521551121|FG003|Overall Study|Ongoing at cut-off date|64|||
144643303|NCT00847613|521551118|FG000|Overall Study|Death|1|||
144643304|NCT00847613|521551119|FG001|Overall Study|Death|1|||
144643305|NCT00847613|521551120|FG002|Overall Study|Death|0|||
144643306|NCT00847613|521551121|FG003|Overall Study|Death|0|||
144643307|NCT00847613|521551118|FG000|Overall Study|Adverse Event|36|||
144643308|NCT00847613|521551119|FG001|Overall Study|Adverse Event|26|||
144643309|NCT00847613|521551120|FG002|Overall Study|Adverse Event|5|||
144643310|NCT00847613|521551121|FG003|Overall Study|Adverse Event|6|||
144643311|NCT00847613|521551118|FG000|Overall Study|Lack of Efficacy|7|||
144643312|NCT00847613|521551119|FG001|Overall Study|Lack of Efficacy|3|||
144643313|NCT00847613|521551120|FG002|Overall Study|Lack of Efficacy|3|||
144643314|NCT00847613|521551121|FG003|Overall Study|Lack of Efficacy|1|||
144643315|NCT00847613|521551118|FG000|Overall Study|Study terminated by Sponsor|1|||
144643316|NCT00847613|521551119|FG001|Overall Study|Study terminated by Sponsor|0|||
144643317|NCT00847613|521551120|FG002|Overall Study|Study terminated by Sponsor|2|||
144643318|NCT00847613|521551121|FG003|Overall Study|Study terminated by Sponsor|1|||
144643319|NCT00847613|521551118|FG000|Overall Study|Lost to Follow-up|5|||
144643320|NCT00847613|521551119|FG001|Overall Study|Lost to Follow-up|0|||
144643321|NCT00847613|521551120|FG002|Overall Study|Lost to Follow-up|0|||
144643322|NCT00847613|521551121|FG003|Overall Study|Lost to Follow-up|3|||
144643323|NCT00847613|521551118|FG000|Overall Study|Protocol Violation|6|||
144643324|NCT00847613|521551119|FG001|Overall Study|Protocol Violation|6|||
144643325|NCT00847613|521551120|FG002|Overall Study|Protocol Violation|3|||
144643326|NCT00847613|521551121|FG003|Overall Study|Protocol Violation|1|||
144643327|NCT00847613|521551118|FG000|Overall Study|Pregnancy|1|||
144643328|NCT00847613|521551119|FG001|Overall Study|Pregnancy|1|||
144643329|NCT00847613|521551120|FG002|Overall Study|Pregnancy|0|||
144643330|NCT00847613|521551121|FG003|Overall Study|Pregnancy|0|||
144643331|NCT00847613|521551118|FG000|Overall Study|Site closure|1|||
144643332|NCT00847613|521551119|FG001|Overall Study|Site closure|0|||
144643333|NCT00847613|521551120|FG002|Overall Study|Site closure|0|||
144643334|NCT00847613|521551121|FG003|Overall Study|Site closure|1|||
144643335|NCT00847613|521551118|FG000|Overall Study|Withdrawal by Subject|8|||
144643336|NCT00847613|521551119|FG001|Overall Study|Withdrawal by Subject|11|||
144643337|NCT00847613|521551120|FG002|Overall Study|Withdrawal by Subject|2|||
144643338|NCT00847613|521551121|FG003|Overall Study|Withdrawal by Subject|2|||
144643339|NCT00847613|521551118|FG000|Overall Study|Participant moved|4|||
144643340|NCT00847613|521551119|FG001|Overall Study|Participant moved|1|||
144643341|NCT00847613|521551120|FG002|Overall Study|Participant moved|0|||
144643342|NCT00847613|521551121|FG003|Overall Study|Participant moved|0|||
144643343|NCT00847613|521551118|FG000|Overall Study|Sponsor request|0|||
144643344|NCT00847613|521551119|FG001|Overall Study|Sponsor request|1|||
144643345|NCT00847613|521551120|FG002|Overall Study|Sponsor request|0|||
144643346|NCT00847613|521551121|FG003|Overall Study|Sponsor request|0|||
144643347|NCT00847613|521551118|FG000|Overall Study|Randomized, but not treated|0|||
144643348|NCT00847613|521551119|FG001|Overall Study|Randomized, but not treated|3|||
144643349|NCT00847613|521551120|FG002|Overall Study|Randomized, but not treated|0|||
144643350|NCT00847613|521551121|FG003|Overall Study|Randomized, but not treated|0|||
144643351|NCT00847613|521551118|FG000|Overall Study|Other|1|||
144643352|NCT00847613|521551119|FG001|Overall Study|Other|1|||
144643353|NCT00847613|521551120|FG002|Overall Study|Other|2|||
144643354|NCT00847613|521551121|FG003|Overall Study|Other|0|||
144643355|NCT00754390|521551122|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
144643356|NCT00754390|521551122|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
144643357|NCT00754390|521551122|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
144643358|NCT00754390|521551122|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
144643359|NCT00845429|521551126|FG000|Overall Study|Protocol Violation|5|||
144643360|NCT00845429|521551127|FG001|Overall Study|Protocol Violation|4|||
144643361|NCT00845429|521551128|FG002|Overall Study|Protocol Violation|7|||
144643362|NCT00845429|521551126|FG000|Overall Study|Lost to Follow-up|7|||
144643363|NCT00845429|521551127|FG001|Overall Study|Lost to Follow-up|9|||
144643364|NCT00845429|521551128|FG002|Overall Study|Lost to Follow-up|10|||
144643365|NCT00845429|521551126|FG000|Overall Study|Withdrawal by Subject|2|||
144643366|NCT00845429|521551127|FG001|Overall Study|Withdrawal by Subject|2|||
144643367|NCT00845429|521551128|FG002|Overall Study|Withdrawal by Subject|2|||
144643368|NCT00845429|521551126|FG000|Overall Study|Serious adverse event|0|||
144643369|NCT00845429|521551127|FG001|Overall Study|Serious adverse event|0|||
144643370|NCT00845429|521551128|FG002|Overall Study|Serious adverse event|1|||
144643371|NCT00587223|521551134|FG000|Overall Study|Adverse Event|1|||
144643372|NCT00195351|521551135|FG000|Overall Study|Lost to Follow-up|9|||
144643373|NCT00195351|521551136|FG001|Overall Study|Lost to Follow-up|9|||
144643374|NCT00195351|521551135|FG000|Overall Study|Withdrawal by Subject|6|||
144643375|NCT00195351|521551136|FG001|Overall Study|Withdrawal by Subject|3|||
144643376|NCT00195351|521551135|FG000|Overall Study|Protocol Deviation|3|||
144643377|NCT00195351|521551136|FG001|Overall Study|Protocol Deviation|2|||
144643378|NCT00195351|521551135|FG000|Overall Study|Death|3|||
144643379|NCT00195351|521551136|FG001|Overall Study|Death|1|||
144643380|NCT00195351|521551135|FG000|Overall Study|Lack of Efficacy|0|||
144643381|NCT00195351|521551136|FG001|Overall Study|Lack of Efficacy|1|||
144643382|NCT02111369|521551137|FG000|Overall Study|Lost to Follow-up|2|||
144643383|NCT02111369|521551137|FG000|Overall Study|Withdrawal by Subject|1|||
144643384|NCT04332419|521551143|FG000|Overall Study|Withdrawal by Subject|1|||
144643385|NCT01480180|521551144|FG000|Main Phase|Withdrawal criteria|12|||
144643386|NCT01480180|521551145|FG001|Main Phase|Withdrawal criteria|1|||
144643387|NCT01480180|521551146|FG002|Main Phase|Withdrawal criteria|0|||
144643388|NCT01480180|521551147|FG003|Main Phase|Withdrawal criteria|0|||
144643389|NCT01480180|521551148|FG004|Main Phase|Withdrawal criteria|0|||
144643390|NCT01480180|521551149|FG005|Main Phase|Withdrawal criteria|0|||
144643391|NCT01480180|521551144|FG000|Main Phase|Lack of Efficacy|1|||
144643392|NCT01480180|521551145|FG001|Main Phase|Lack of Efficacy|0|||
144643393|NCT01480180|521551146|FG002|Main Phase|Lack of Efficacy|0|||
144643394|NCT01480180|521551147|FG003|Main Phase|Lack of Efficacy|0|||
144643395|NCT01480180|521551148|FG004|Main Phase|Lack of Efficacy|0|||
144643396|NCT01480180|521551149|FG005|Main Phase|Lack of Efficacy|0|||
144643397|NCT01480180|521551144|FG000|Main Phase|Non-compliance|3|||
144643398|NCT01480180|521551145|FG001|Main Phase|Non-compliance|0|||
144643399|NCT01480180|521551146|FG002|Main Phase|Non-compliance|0|||
144643400|NCT01480180|521551147|FG003|Main Phase|Non-compliance|0|||
144643401|NCT01480180|521551148|FG004|Main Phase|Non-compliance|0|||
144643402|NCT01480180|521551149|FG005|Main Phase|Non-compliance|0|||
144643403|NCT01480180|521551144|FG000|Main Phase|Unclassified|3|||
144643404|NCT01480180|521551145|FG001|Main Phase|Unclassified|0|||
144643405|NCT01480180|521551146|FG002|Main Phase|Unclassified|0|||
144643406|NCT01480180|521551147|FG003|Main Phase|Unclassified|0|||
144643407|NCT01480180|521551148|FG004|Main Phase|Unclassified|0|||
144643408|NCT01480180|521551149|FG005|Main Phase|Unclassified|0|||
144643409|NCT01480180|521551144|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
144643410|NCT01480180|521551145|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
144643411|NCT01480180|521551146|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
144643412|NCT01480180|521551147|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
144643413|NCT01480180|521551148|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
144643414|NCT01480180|521551149|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
144643415|NCT01480180|521551144|FG000|Extension Phase, Part 1|Unclassified|0|||
144643416|NCT01480180|521551145|FG001|Extension Phase, Part 1|Unclassified|0|||
144643417|NCT01480180|521551146|FG002|Extension Phase, Part 1|Unclassified|1|||
144643418|NCT01480180|521551147|FG003|Extension Phase, Part 1|Unclassified|0|||
144643419|NCT01480180|521551148|FG004|Extension Phase, Part 1|Unclassified|0|||
144643420|NCT01480180|521551149|FG005|Extension Phase, Part 1|Unclassified|0|||
144643421|NCT01480180|521551144|FG000|Extension Phase, Part 1|Adverse Event|0|||
144643422|NCT01480180|521551145|FG001|Extension Phase, Part 1|Adverse Event|0|||
144643423|NCT01480180|521551146|FG002|Extension Phase, Part 1|Adverse Event|4|||
144643424|NCT01480180|521551147|FG003|Extension Phase, Part 1|Adverse Event|1|||
144643425|NCT01480180|521551148|FG004|Extension Phase, Part 1|Adverse Event|0|||
144643426|NCT01480180|521551149|FG005|Extension Phase, Part 1|Adverse Event|0|||
144643427|NCT01480180|521551144|FG000|Extension Phase, Part 1|Change of treatment|0|||
144643428|NCT01480180|521551145|FG001|Extension Phase, Part 1|Change of treatment|0|||
144643429|NCT01480180|521551146|FG002|Extension Phase, Part 1|Change of treatment|0|||
144643430|NCT01480180|521551147|FG003|Extension Phase, Part 1|Change of treatment|9|||
144643431|NCT01480180|521551148|FG004|Extension Phase, Part 1|Change of treatment|0|||
144643432|NCT01480180|521551149|FG005|Extension Phase, Part 1|Change of treatment|0|||
144643433|NCT01480180|521551144|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
144643434|NCT01480180|521551145|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
144643435|NCT01480180|521551146|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
144643436|NCT01480180|521551147|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
144643437|NCT01480180|521551148|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
144643438|NCT01480180|521551149|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
144643439|NCT01480180|521551144|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
144643440|NCT01480180|521551145|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
144643441|NCT01480180|521551146|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
144643442|NCT01480180|521551147|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
144643443|NCT01480180|521551148|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
144643444|NCT01480180|521551149|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
144643445|NCT01480180|521551144|FG000|Extension Phase, Part 2|Unclassified|0|||
144643446|NCT01480180|521551145|FG001|Extension Phase, Part 2|Unclassified|0|||
144643447|NCT01480180|521551146|FG002|Extension Phase, Part 2|Unclassified|3|||
144643448|NCT01480180|521551147|FG003|Extension Phase, Part 2|Unclassified|1|||
144643449|NCT01480180|521551148|FG004|Extension Phase, Part 2|Unclassified|1|||
144643450|NCT01480180|521551149|FG005|Extension Phase, Part 2|Unclassified|0|||
144643451|NCT00971321|521551150|FG000|Up to Month 7|Withdrawal by Subject|1|||
144643452|NCT00971321|521551151|FG001|Up to Month 7|Withdrawal by Subject|0|||
144643453|NCT00971321|521551150|FG000|Up to Month 7|Migrated/moved from study area|3|||
144643454|NCT00971321|521551151|FG001|Up to Month 7|Migrated/moved from study area|2|||
144643455|NCT00971321|521551150|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
144643456|NCT00971321|521551151|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
144643457|NCT00971321|521551150|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
144643458|NCT00971321|521551151|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
144643459|NCT00971321|521551150|FG000|Up to Month 11-12|Lost to Follow-up|1|||
144643460|NCT00971321|521551151|FG001|Up to Month 11-12|Lost to Follow-up|0|||
144643461|NCT00519623|521551152|FG000|Overall Study|Adverse Event|1|||
144643462|NCT04222725|521551153|FG000|Overall Study|Adverse Event|0|||
144643463|NCT04222725|521551154|FG001|Overall Study|Adverse Event|1|||
144643464|NCT04222725|521551155|FG002|Overall Study|Adverse Event|0|||
144643465|NCT04222725|521551156|FG003|Overall Study|Adverse Event|0|||
144643466|NCT03819140|521551157|FG000|Overall Study|Lost to Follow-up|1|||
144643467|NCT03819140|521551158|FG001|Overall Study|Lost to Follow-up|2|||
144643468|NCT03819140|521551157|FG000|Overall Study|Withdrawal by Subject|3|||
144643469|NCT03819140|521551158|FG001|Overall Study|Withdrawal by Subject|2|||
144643470|NCT03819140|521551157|FG000|Overall Study|Adverse Event|0|||
144643471|NCT03819140|521551158|FG001|Overall Study|Adverse Event|1|||
144643472|NCT03819140|521551157|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
144643473|NCT03819140|521551158|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
144643474|NCT03819140|521551157|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
144643475|NCT03819140|521551158|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
144643476|NCT00658333|521551159|FG000|Overall Study|Adverse Event|2|||
144643477|NCT00658333|521551160|FG001|Overall Study|Adverse Event|1|||
144643478|NCT03519178|521551161|FG000|PF-06873600 Treatment|Adverse Event|0|||
144643479|NCT03519178|521551162|FG001|PF-06873600 Treatment|Adverse Event|0|||
144643480|NCT03519178|521551163|FG002|PF-06873600 Treatment|Adverse Event|0|||
144643481|NCT03519178|521551164|FG003|PF-06873600 Treatment|Adverse Event|0|||
144643482|NCT03519178|521551165|FG004|PF-06873600 Treatment|Adverse Event|0|||
144643483|NCT03519178|521551166|FG005|PF-06873600 Treatment|Adverse Event|0|||
144643484|NCT03519178|521551167|FG006|PF-06873600 Treatment|Adverse Event|0|||
144643485|NCT03519178|521551168|FG007|PF-06873600 Treatment|Adverse Event|2|||
144643486|NCT03519178|521551169|FG008|PF-06873600 Treatment|Adverse Event|1|||
144643487|NCT03519178|521551170|FG009|PF-06873600 Treatment|Adverse Event|0|||
144643488|NCT03519178|521551171|FG010|PF-06873600 Treatment|Adverse Event|0|||
144643489|NCT03519178|521551172|FG011|PF-06873600 Treatment|Adverse Event|0|||
144643490|NCT03519178|521551173|FG012|PF-06873600 Treatment|Adverse Event|1|||
144643491|NCT03519178|521551174|FG013|PF-06873600 Treatment|Adverse Event|3|||
144643492|NCT03519178|521551175|FG014|PF-06873600 Treatment|Adverse Event|2|||
144643493|NCT03519178|521551161|FG000|PF-06873600 Treatment|Death|0|||
144643494|NCT03519178|521551162|FG001|PF-06873600 Treatment|Death|0|||
144643495|NCT03519178|521551163|FG002|PF-06873600 Treatment|Death|0|||
144643496|NCT03519178|521551164|FG003|PF-06873600 Treatment|Death|0|||
144643497|NCT03519178|521551165|FG004|PF-06873600 Treatment|Death|0|||
144643498|NCT03519178|521551166|FG005|PF-06873600 Treatment|Death|0|||
144643499|NCT03519178|521551167|FG006|PF-06873600 Treatment|Death|0|||
144643500|NCT03519178|521551168|FG007|PF-06873600 Treatment|Death|0|||
144643501|NCT03519178|521551169|FG008|PF-06873600 Treatment|Death|1|||
144643502|NCT03519178|521551170|FG009|PF-06873600 Treatment|Death|1|||
144643503|NCT03519178|521551171|FG010|PF-06873600 Treatment|Death|0|||
144643504|NCT03519178|521551172|FG011|PF-06873600 Treatment|Death|0|||
144643505|NCT03519178|521551173|FG012|PF-06873600 Treatment|Death|0|||
144643506|NCT03519178|521551174|FG013|PF-06873600 Treatment|Death|0|||
144643507|NCT03519178|521551175|FG014|PF-06873600 Treatment|Death|1|||
144643508|NCT03519178|521551161|FG000|PF-06873600 Treatment|Physician Decision|0|||
144643509|NCT03519178|521551162|FG001|PF-06873600 Treatment|Physician Decision|0|||
144643510|NCT03519178|521551163|FG002|PF-06873600 Treatment|Physician Decision|0|||
144643511|NCT03519178|521551164|FG003|PF-06873600 Treatment|Physician Decision|0|||
144643512|NCT03519178|521551165|FG004|PF-06873600 Treatment|Physician Decision|0|||
144643513|NCT03519178|521551166|FG005|PF-06873600 Treatment|Physician Decision|0|||
144643514|NCT03519178|521551167|FG006|PF-06873600 Treatment|Physician Decision|0|||
144643515|NCT03519178|521551168|FG007|PF-06873600 Treatment|Physician Decision|1|||
144643516|NCT03519178|521551169|FG008|PF-06873600 Treatment|Physician Decision|0|||
144643517|NCT03519178|521551170|FG009|PF-06873600 Treatment|Physician Decision|0|||
144643518|NCT03519178|521551171|FG010|PF-06873600 Treatment|Physician Decision|1|||
144643519|NCT03519178|521551172|FG011|PF-06873600 Treatment|Physician Decision|0|||
144643520|NCT03519178|521551173|FG012|PF-06873600 Treatment|Physician Decision|0|||
144643521|NCT03519178|521551174|FG013|PF-06873600 Treatment|Physician Decision|4|||
144643522|NCT03519178|521551175|FG014|PF-06873600 Treatment|Physician Decision|1|||
144643523|NCT03519178|521551161|FG000|PF-06873600 Treatment|Progressive disease|1|||
144643524|NCT03519178|521551162|FG001|PF-06873600 Treatment|Progressive disease|1|||
144643525|NCT03519178|521551163|FG002|PF-06873600 Treatment|Progressive disease|1|||
144643526|NCT03519178|521551164|FG003|PF-06873600 Treatment|Progressive disease|1|||
144643527|NCT03519178|521551165|FG004|PF-06873600 Treatment|Progressive disease|6|||
144643528|NCT03519178|521551166|FG005|PF-06873600 Treatment|Progressive disease|7|||
144643529|NCT03519178|521551167|FG006|PF-06873600 Treatment|Progressive disease|3|||
144643530|NCT03519178|521551168|FG007|PF-06873600 Treatment|Progressive disease|7|||
144643531|NCT03519178|521551169|FG008|PF-06873600 Treatment|Progressive disease|3|||
144643532|NCT03519178|521551170|FG009|PF-06873600 Treatment|Progressive disease|5|||
144643533|NCT03519178|521551171|FG010|PF-06873600 Treatment|Progressive disease|4|||
144643534|NCT03519178|521551172|FG011|PF-06873600 Treatment|Progressive disease|3|||
144643535|NCT03519178|521551173|FG012|PF-06873600 Treatment|Progressive disease|4|||
144643536|NCT03519178|521551174|FG013|PF-06873600 Treatment|Progressive disease|28|||
144643537|NCT03519178|521551175|FG014|PF-06873600 Treatment|Progressive disease|8|||
144643538|NCT03519178|521551161|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
144643539|NCT03519178|521551162|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
144643540|NCT03519178|521551163|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
144643541|NCT03519178|521551164|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
144643542|NCT03519178|521551165|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
144643543|NCT03519178|521551166|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
144643544|NCT03519178|521551167|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
144643545|NCT03519178|521551168|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
144643546|NCT03519178|521551169|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
144643547|NCT03519178|521551170|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
144643548|NCT03519178|521551171|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
144643549|NCT03519178|521551172|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
144643550|NCT03519178|521551173|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
144643551|NCT03519178|521551174|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
144643552|NCT03519178|521551175|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
144643553|NCT03519178|521551161|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
144643554|NCT03519178|521551162|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
144643555|NCT03519178|521551163|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
144643556|NCT03519178|521551164|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
144643557|NCT03519178|521551165|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
144643558|NCT03519178|521551166|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
144643559|NCT03519178|521551167|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
144643560|NCT03519178|521551168|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
144643561|NCT03519178|521551169|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
144643562|NCT03519178|521551170|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
144643563|NCT03519178|521551171|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
144643564|NCT03519178|521551172|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
144643565|NCT03519178|521551173|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
144643566|NCT03519178|521551174|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
144643567|NCT03519178|521551175|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
144643568|NCT03519178|521551161|FG000|PF-06873600 Treatment|Refused further treatment|0|||
144643569|NCT03519178|521551162|FG001|PF-06873600 Treatment|Refused further treatment|1|||
144211196|NCT01004003|519968060|FG008|Overall Study|Refused to continue taking trial med.|2|||
144643570|NCT03519178|521551163|FG002|PF-06873600 Treatment|Refused further treatment|0|||
144643571|NCT03519178|521551164|FG003|PF-06873600 Treatment|Refused further treatment|0|||
144643572|NCT03519178|521551165|FG004|PF-06873600 Treatment|Refused further treatment|1|||
144643573|NCT03519178|521551166|FG005|PF-06873600 Treatment|Refused further treatment|0|||
144643574|NCT03519178|521551167|FG006|PF-06873600 Treatment|Refused further treatment|0|||
144643575|NCT03519178|521551168|FG007|PF-06873600 Treatment|Refused further treatment|0|||
144643576|NCT03519178|521551169|FG008|PF-06873600 Treatment|Refused further treatment|0|||
144643577|NCT03519178|521551170|FG009|PF-06873600 Treatment|Refused further treatment|0|||
144643578|NCT03519178|521551171|FG010|PF-06873600 Treatment|Refused further treatment|0|||
144643579|NCT03519178|521551172|FG011|PF-06873600 Treatment|Refused further treatment|0|||
144643580|NCT03519178|521551173|FG012|PF-06873600 Treatment|Refused further treatment|0|||
144643581|NCT03519178|521551174|FG013|PF-06873600 Treatment|Refused further treatment|0|||
144643582|NCT03519178|521551175|FG014|PF-06873600 Treatment|Refused further treatment|1|||
144643583|NCT03519178|521551161|FG000|PF-06873600 Treatment|Other|0|||
144643584|NCT03519178|521551162|FG001|PF-06873600 Treatment|Other|0|||
144643585|NCT03519178|521551163|FG002|PF-06873600 Treatment|Other|0|||
144643586|NCT03519178|521551164|FG003|PF-06873600 Treatment|Other|0|||
144643587|NCT03519178|521551165|FG004|PF-06873600 Treatment|Other|0|||
144643588|NCT03519178|521551166|FG005|PF-06873600 Treatment|Other|0|||
144643589|NCT03519178|521551167|FG006|PF-06873600 Treatment|Other|0|||
144643590|NCT03519178|521551168|FG007|PF-06873600 Treatment|Other|0|||
144643591|NCT03519178|521551169|FG008|PF-06873600 Treatment|Other|1|||
144643592|NCT03519178|521551170|FG009|PF-06873600 Treatment|Other|0|||
144643593|NCT03519178|521551171|FG010|PF-06873600 Treatment|Other|0|||
144731440|NCT01706536|521871469|FG000|Overall Study|Withdrawal by Subject|1|||
144731441|NCT01706536|521871470|FG001|Overall Study|Withdrawal by Subject|0|||
144731442|NCT01706536|521871471|FG002|Overall Study|Withdrawal by Subject|1|||
144731443|NCT01706536|521871472|FG003|Overall Study|Withdrawal by Subject|0|||
144731444|NCT01706536|521871473|FG004|Overall Study|Withdrawal by Subject|0|||
144731445|NCT01706536|521871469|FG000|Overall Study|Adverse Event|2|||
144731446|NCT01706536|521871470|FG001|Overall Study|Adverse Event|3|||
144731447|NCT01706536|521871471|FG002|Overall Study|Adverse Event|4|||
144731448|NCT01706536|521871472|FG003|Overall Study|Adverse Event|3|||
144731449|NCT01706536|521871473|FG004|Overall Study|Adverse Event|2|||
144731450|NCT01706536|521871469|FG000|Overall Study|Lack of Efficacy|1|||
144731451|NCT01706536|521871470|FG001|Overall Study|Lack of Efficacy|0|||
144731452|NCT01706536|521871471|FG002|Overall Study|Lack of Efficacy|0|||
144731453|NCT01706536|521871472|FG003|Overall Study|Lack of Efficacy|1|||
144731454|NCT01706536|521871473|FG004|Overall Study|Lack of Efficacy|0|||
144731455|NCT01706536|521871469|FG000|Overall Study|non compliance|0|||
144731456|NCT01706536|521871470|FG001|Overall Study|non compliance|1|||
144731457|NCT01706536|521871471|FG002|Overall Study|non compliance|0|||
144731458|NCT01706536|521871472|FG003|Overall Study|non compliance|0|||
144731459|NCT01706536|521871473|FG004|Overall Study|non compliance|0|||
144643594|NCT03519178|521551172|FG011|PF-06873600 Treatment|Other|0|||
144643595|NCT03519178|521551173|FG012|PF-06873600 Treatment|Other|0|||
144643596|NCT03519178|521551174|FG013|PF-06873600 Treatment|Other|1|||
144643597|NCT03519178|521551175|FG014|PF-06873600 Treatment|Other|3|||
144643598|NCT03519178|521551161|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
144643599|NCT03519178|521551162|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
144643600|NCT03519178|521551163|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
144643601|NCT03519178|521551164|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
144643602|NCT03519178|521551165|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
144643603|NCT03519178|521551166|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
144643604|NCT03519178|521551167|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
144643605|NCT03519178|521551168|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
144643606|NCT03519178|521551169|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
144643607|NCT03519178|521551170|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
144211197|NCT01004003|519968052|FG000|Overall Study|Other|0|||
144211198|NCT01004003|519968053|FG001|Overall Study|Other|0|||
144211199|NCT01004003|519968054|FG002|Overall Study|Other|0|||
144211200|NCT01004003|519968055|FG003|Overall Study|Other|0|||
144211201|NCT01004003|519968056|FG004|Overall Study|Other|0|||
144643608|NCT03519178|521551171|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
144643609|NCT03519178|521551172|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
144643610|NCT03519178|521551173|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
144643611|NCT03519178|521551174|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
144643612|NCT03519178|521551175|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
144211202|NCT01004003|519968057|FG005|Overall Study|Other|1|||
144211203|NCT01004003|519968058|FG006|Overall Study|Other|0|||
144643613|NCT03519178|521551161|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643614|NCT03519178|521551162|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643615|NCT03519178|521551163|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643616|NCT03519178|521551164|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643617|NCT03519178|521551165|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
144731460|NCT01469546|521871476|FG000|Received 5 mg Dose|Adverse Event|13|||
144643618|NCT03519178|521551166|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643619|NCT03519178|521551167|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643620|NCT03519178|521551168|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643621|NCT03519178|521551169|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643622|NCT03519178|521551170|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643623|NCT03519178|521551171|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643624|NCT03519178|521551172|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643625|NCT03519178|521551173|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
144643626|NCT03519178|521551174|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
144643627|NCT03519178|521551175|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
144643628|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Adverse Event|0|||
144643629|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Adverse Event|0|||
144643630|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Adverse Event|0|||
144643631|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Adverse Event|0|||
144643632|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Adverse Event|0|||
144643633|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Adverse Event|0|||
144643634|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Adverse Event|0|||
144731461|NCT01469546|521871476|FG000|Received 5 mg Dose|Death|2|||
144731462|NCT01469546|521871476|FG000|Received 5 mg Dose|Protocol Violation|2|||
144731463|NCT01469546|521871476|FG000|Received 5 mg Dose|Progressive Disease|3|||
144731464|NCT01469546|521871476|FG000|Received 5 mg Dose|Physician Decision|3|||
144731465|NCT00385684|521871477|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
144731466|NCT00385684|521871478|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
144731467|NCT00385684|521871477|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
144731468|NCT00385684|521871478|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
144731469|NCT00385684|521871477|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
144731470|NCT00385684|521871478|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
144731471|NCT01811953|521873171|FG000|Overall Study|Adverse Event|0|||
144731472|NCT01811953|521873172|FG001|Overall Study|Adverse Event|0|||
144731473|NCT01811953|521873173|FG002|Overall Study|Adverse Event|0|||
144731474|NCT01811953|521873174|FG003|Overall Study|Adverse Event|1|||
144731475|NCT01811953|521873175|FG004|Overall Study|Adverse Event|0|||
144731476|NCT01811953|521873176|FG005|Overall Study|Adverse Event|1|||
144731477|NCT01811953|521873171|FG000|Overall Study|Protocol Violation|0|||
144731478|NCT01811953|521873172|FG001|Overall Study|Protocol Violation|0|||
144731479|NCT01811953|521873173|FG002|Overall Study|Protocol Violation|0|||
144731480|NCT01811953|521873174|FG003|Overall Study|Protocol Violation|0|||
144731481|NCT01811953|521873175|FG004|Overall Study|Protocol Violation|1|||
144731482|NCT01811953|521873176|FG005|Overall Study|Protocol Violation|0|||
144731483|NCT02028715|521873181|FG000|Overall Study|Adverse Event|2|||
144731484|NCT02028715|521873182|FG001|Overall Study|Adverse Event|2|||
144731485|NCT02028715|521873181|FG000|Overall Study|Physician Decision|1|||
144731486|NCT02028715|521873182|FG001|Overall Study|Physician Decision|0|||
144731487|NCT02028715|521873181|FG000|Overall Study|Did not complete satisfaction surveys|2|||
144731488|NCT02028715|521873182|FG001|Overall Study|Did not complete satisfaction surveys|2|||
144731489|NCT02533258|521873183|FG000|Overall Study|Adverse Event|1|||
144731490|NCT02533258|521873183|FG000|Overall Study|Death|2|||
144731491|NCT02533258|521873183|FG000|Overall Study|Other|1|||
144731492|NCT02533258|521873183|FG000|Overall Study|Economic factor|1|||
144731493|NCT02533258|521873183|FG000|Overall Study|Progression of pleural effusion|1|||
144731494|NCT02533258|521873183|FG000|Overall Study|Lack of Efficacy|2|||
144731495|NCT03655106|521873184|FG000|Overall Study|Withdrawal by Subject|3|||
144731496|NCT03655106|521873185|FG001|Overall Study|Withdrawal by Subject|2|||
144731497|NCT03655106|521873184|FG000|Overall Study|Lost to Follow-up|2|||
144731498|NCT03655106|521873185|FG001|Overall Study|Lost to Follow-up|1|||
144731499|NCT03655106|521873184|FG000|Overall Study|Duplicate Enrollment|1|||
144731500|NCT03655106|521873185|FG001|Overall Study|Duplicate Enrollment|1|||
144731501|NCT03655106|521873184|FG000|Overall Study|Protocol Violation|3|||
144731502|NCT03655106|521873185|FG001|Overall Study|Protocol Violation|0|||
144731503|NCT01710657|521873189|FG000|Overall Study|Lost to Follow-up|2|||
144643635|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Adverse Event|0|||
144643636|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Adverse Event|0|||
144643637|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Adverse Event|0|||
144643638|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Adverse Event|0|||
144731504|NCT01710657|521873190|FG001|Overall Study|Lost to Follow-up|0|||
144731505|NCT01710657|521873191|FG002|Overall Study|Lost to Follow-up|1|||
144731506|NCT01710657|521873189|FG000|Overall Study|Protocol Violation|2|||
144731507|NCT01710657|521873190|FG001|Overall Study|Protocol Violation|2|||
144643639|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Adverse Event|0|||
144643640|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Adverse Event|0|||
144731508|NCT01710657|521873191|FG002|Overall Study|Protocol Violation|0|||
144731509|NCT01710657|521873189|FG000|Overall Study|Adverse Event|14|||
144731510|NCT01710657|521873190|FG001|Overall Study|Adverse Event|8|||
144731511|NCT01710657|521873191|FG002|Overall Study|Adverse Event|28|||
144731512|NCT01710657|521873189|FG000|Overall Study|Withdrawal by Subject|0|||
144731513|NCT01710657|521873190|FG001|Overall Study|Withdrawal by Subject|1|||
144731514|NCT01710657|521873191|FG002|Overall Study|Withdrawal by Subject|2|||
144731515|NCT01710657|521873189|FG000|Overall Study|Lack of Efficacy|0|||
144731516|NCT01710657|521873190|FG001|Overall Study|Lack of Efficacy|1|||
144731517|NCT01710657|521873191|FG002|Overall Study|Lack of Efficacy|1|||
144731518|NCT01049334|521873195|FG000|Overall Study|Withdrawal by Subject|5|||
144731519|NCT01049334|521873196|FG001|Overall Study|Withdrawal by Subject|3|||
144731520|NCT01049334|521873195|FG000|Overall Study|Adverse Event|2|||
144731521|NCT01049334|521873196|FG001|Overall Study|Adverse Event|3|||
144731522|NCT01049334|521873195|FG000|Overall Study|Physician Decision|2|||
144731523|NCT01049334|521873196|FG001|Overall Study|Physician Decision|0|||
144731524|NCT01049334|521873195|FG000|Overall Study|Protocol Violation|0|||
144731525|NCT01049334|521873196|FG001|Overall Study|Protocol Violation|1|||
144731526|NCT01367457|521873199|FG000|Overall Study|Death|2|||
144731527|NCT01367457|521873200|FG001|Overall Study|Death|0|||
144731528|NCT01367457|521873201|FG002|Overall Study|Death|0|||
144731529|NCT01367457|521873199|FG000|Overall Study|Investigator's decision|2|||
144731530|NCT01367457|521873200|FG001|Overall Study|Investigator's decision|0|||
144731531|NCT01367457|521873201|FG002|Overall Study|Investigator's decision|0|||
144731532|NCT01367457|521873199|FG000|Overall Study|Clinical decline (CD)|2|||
144731533|NCT01367457|521873200|FG001|Overall Study|Clinical decline (CD)|0|||
144731534|NCT01367457|521873201|FG002|Overall Study|Clinical decline (CD)|0|||
144731535|NCT01367457|521873199|FG000|Overall Study|Progression and death|8|||
144731536|NCT01367457|521873200|FG001|Overall Study|Progression and death|0|||
144731537|NCT01367457|521873201|FG002|Overall Study|Progression and death|0|||
144731538|NCT01367457|521873199|FG000|Overall Study|Toxicity|16|||
144731539|NCT01367457|521873200|FG001|Overall Study|Toxicity|0|||
144731540|NCT01367457|521873201|FG002|Overall Study|Toxicity|0|||
144731541|NCT01367457|521873199|FG000|Overall Study|Progression|137|||
144731542|NCT01367457|521873200|FG001|Overall Study|Progression|0|||
144731543|NCT01367457|521873201|FG002|Overall Study|Progression|0|||
144731544|NCT01367457|521873199|FG000|Overall Study|Patient asks for rest + slow progression|1|||
144731545|NCT01367457|521873200|FG001|Overall Study|Patient asks for rest + slow progression|0|||
144731546|NCT01367457|521873201|FG002|Overall Study|Patient asks for rest + slow progression|0|||
144731547|NCT01367457|521873199|FG000|Overall Study|Investigator's opinion, stable disease|1|||
144731548|NCT01367457|521873200|FG001|Overall Study|Investigator's opinion, stable disease|0|||
144731549|NCT01367457|521873201|FG002|Overall Study|Investigator's opinion, stable disease|0|||
144731550|NCT01367457|521873199|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
144731551|NCT01367457|521873200|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
144731552|NCT01367457|521873201|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
144731553|NCT01367457|521873199|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
144731554|NCT01367457|521873200|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
144643641|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Adverse Event|1|||
144643642|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Adverse Event|0|||
144643643|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Death|0|||
144643644|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Death|0|||
144643645|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Death|0|||
144643646|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Death|0|||
144643647|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Death|0|||
144643648|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Death|0|||
144643649|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Death|0|||
144643650|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Death|0|||
144643651|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Death|0|||
144643652|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Death|1|||
144643653|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Death|0|||
144643654|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Death|0|||
144643655|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Death|0|||
144643656|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Death|0|||
144643657|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Death|1|||
144643658|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643659|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643660|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643661|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643662|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643663|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643664|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643665|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643666|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643667|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643668|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643669|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643670|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643671|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
144643672|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
144643673|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Physician Decision|0|||
144731555|NCT01367457|521873201|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
144731556|NCT01367457|521873199|FG000|Overall Study|low grade toxicities + stable disease|1|||
144731557|NCT01367457|521873200|FG001|Overall Study|low grade toxicities + stable disease|0|||
144643674|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Physician Decision|0|||
144643675|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Physician Decision|0|||
144643676|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Physician Decision|0|||
144643677|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Physician Decision|0|||
144643678|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Physician Decision|0|||
144643679|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Physician Decision|0|||
144643680|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Physician Decision|0|||
144643681|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Physician Decision|0|||
144643682|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Physician Decision|0|||
144643683|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Physician Decision|0|||
144643684|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Physician Decision|0|||
144643685|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Physician Decision|0|||
144643686|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Physician Decision|4|||
144643687|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Physician Decision|2|||
144643688|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Progressive disease|0|||
144643689|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Progressive disease|0|||
144643690|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Progressive disease|0|||
144643691|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Progressive disease|0|||
144643692|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Progressive disease|0|||
144643693|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Progressive disease|0|||
144643694|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Progressive disease|0|||
144643695|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Progressive disease|0|||
144643696|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Progressive disease|0|||
144643697|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Progressive disease|5|||
144643698|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Progressive disease|0|||
144643699|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Progressive disease|0|||
144643700|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Progressive disease|0|||
144643701|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Progressive disease|30|||
144643702|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Progressive disease|8|||
144643703|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643704|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643705|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643706|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643707|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643708|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643709|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643710|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144731558|NCT01367457|521873201|FG002|Overall Study|low grade toxicities + stable disease|0|||
144731559|NCT01367457|521873199|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
144731560|NCT01367457|521873200|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
144731561|NCT01367457|521873201|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
144731562|NCT01367457|521873199|FG000|Overall Study|Withdrawal by Subject|1|||
144731563|NCT01367457|521873200|FG001|Overall Study|Withdrawal by Subject|0|||
144731564|NCT01367457|521873201|FG002|Overall Study|Withdrawal by Subject|0|||
144731565|NCT01367457|521873199|FG000|Overall Study|CD, associated leukaemia|1|||
144731566|NCT01367457|521873200|FG001|Overall Study|CD, associated leukaemia|0|||
144731567|NCT01367457|521873201|FG002|Overall Study|CD, associated leukaemia|0|||
144731568|NCT01367457|521873199|FG000|Overall Study|Uncontrolled pain|1|||
144731569|NCT01367457|521873200|FG001|Overall Study|Uncontrolled pain|0|||
144731570|NCT01367457|521873201|FG002|Overall Study|Uncontrolled pain|0|||
144731571|NCT01367457|521873199|FG000|Overall Study|Overall status worsens to grade 4|1|||
144731572|NCT01367457|521873200|FG001|Overall Study|Overall status worsens to grade 4|0|||
144731573|NCT01367457|521873201|FG002|Overall Study|Overall status worsens to grade 4|0|||
144731574|NCT01367457|521873199|FG000|Overall Study|Stabilisation + frequent infections|1|||
144643711|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643712|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643713|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643714|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643715|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
144643716|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
144731575|NCT01367457|521873200|FG001|Overall Study|Stabilisation + frequent infections|0|||
144731576|NCT01367457|521873201|FG002|Overall Study|Stabilisation + frequent infections|0|||
144731577|NCT01367457|521873199|FG000|Overall Study|No clinical benefit|1|||
144731578|NCT01367457|521873200|FG001|Overall Study|No clinical benefit|0|||
144731579|NCT01367457|521873201|FG002|Overall Study|No clinical benefit|0|||
144731580|NCT01367457|521873199|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
144731581|NCT01367457|521873200|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
144731582|NCT01367457|521873201|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
144643717|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
144643718|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144731583|NCT01367457|521873199|FG000|Overall Study|Overall decline|1|||
144731584|NCT01367457|521873200|FG001|Overall Study|Overall decline|0|||
144731585|NCT01367457|521873201|FG002|Overall Study|Overall decline|0|||
144731586|NCT01367457|521873199|FG000|Overall Study|Rejection of treatment|1|||
144731587|NCT01367457|521873200|FG001|Overall Study|Rejection of treatment|0|||
144731588|NCT01367457|521873201|FG002|Overall Study|Rejection of treatment|0|||
144731589|NCT01367457|521873199|FG000|Overall Study|Lost to Follow-up|1|||
144731590|NCT01367457|521873200|FG001|Overall Study|Lost to Follow-up|0|||
144731591|NCT01367457|521873201|FG002|Overall Study|Lost to Follow-up|0|||
144731592|NCT01367457|521873199|FG000|Overall Study|Death from septic shock|1|||
144731593|NCT01367457|521873200|FG001|Overall Study|Death from septic shock|0|||
144731594|NCT01367457|521873201|FG002|Overall Study|Death from septic shock|0|||
144731595|NCT01367457|521873199|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
144731596|NCT01367457|521873200|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
144731597|NCT01367457|521873201|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
144731598|NCT01367457|521873199|FG000|Overall Study|Patient's Wish|1|||
144731599|NCT01367457|521873200|FG001|Overall Study|Patient's Wish|0|||
144731600|NCT01367457|521873201|FG002|Overall Study|Patient's Wish|0|||
144731601|NCT01367457|521873199|FG000|Overall Study|Palliative. Overall decline|1|||
144731602|NCT01367457|521873200|FG001|Overall Study|Palliative. Overall decline|0|||
144731603|NCT01367457|521873201|FG002|Overall Study|Palliative. Overall decline|0|||
144731604|NCT01367457|521873199|FG000|Overall Study|Suspected DP/suspected active infection|1|||
144731605|NCT01367457|521873200|FG001|Overall Study|Suspected DP/suspected active infection|0|||
144731606|NCT01367457|521873201|FG002|Overall Study|Suspected DP/suspected active infection|0|||
144731607|NCT03447262|521873202|FG000|Overall Study|Adverse Event|7|||
144731608|NCT03447262|521873202|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
144731609|NCT03447262|521873202|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
144731610|NCT03447262|521873202|FG000|Overall Study|Death|2|||
144731611|NCT03447262|521873202|FG000|Overall Study|Study Termination by Sponsor|455|||
144731612|NCT03447262|521873202|FG000|Overall Study|Other|4|||
144731613|NCT02058498|521873203|FG000|Overall Study|Withdrawal by Subject|4|||
144731614|NCT03988803|521873204|FG000|Period 2|Prematurely discontinued from medication|2|||
144731615|NCT03988803|521873204|FG000|Period 2|Adverse Event|1|||
144731616|NCT02736721|521873205|FG000|Overall Study|Adverse Event|8|||
144731617|NCT02736721|521873205|FG000|Overall Study|Lost to Follow-up|3|||
144731618|NCT02736721|521873205|FG000|Overall Study|Other|5|||
144731619|NCT01171989|521873215|FG000|Overall Study|Lost to Follow-up|0|||
144731620|NCT01171989|521873216|FG001|Overall Study|Lost to Follow-up|0|||
144731621|NCT01171989|521873217|FG002|Overall Study|Lost to Follow-up|1|||
144643719|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643720|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643721|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643722|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643723|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643724|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643725|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643726|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643727|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
144643728|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643729|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643730|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
144643731|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
144643732|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
144643733|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643734|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643735|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643736|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643737|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643738|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643739|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643740|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
144643741|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
144731622|NCT01772537|521873218|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
144643742|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
144643743|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
144731623|NCT01772537|521873219|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
144731624|NCT01772537|521873220|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
144731625|NCT02511782|521873221|FG000|Overall Study|Withdrawal by Subject|1|||
144731626|NCT02511782|521873222|FG001|Overall Study|Withdrawal by Subject|0|||
144731627|NCT02511782|521873223|FG002|Overall Study|Withdrawal by Subject|0|||
144731628|NCT03627091|521873224|FG000|Overall Study|Adverse Event|0|||
144731629|NCT03627091|521873225|FG001|Overall Study|Adverse Event|0|||
144643744|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
144211204|NCT01004003|519968059|FG007|Overall Study|Other|0|||
144211205|NCT01004003|519968060|FG008|Overall Study|Other|0|||
144211206|NCT01098487|519968061|FG000|Overall Study|Adverse Event|22|||
144211207|NCT01098487|519968061|FG000|Overall Study|Lack of Efficacy|11|||
144211208|NCT01098487|519968061|FG000|Overall Study|Withdrawal by Subject|7|||
144211209|NCT01098487|519968061|FG000|Overall Study|Lost to Follow-up|3|||
144211210|NCT01098487|519968061|FG000|Overall Study|Physician Decision|1|||
144211211|NCT03301623|519968062|FG000|Overall Study|Death|3|||
144211212|NCT03301623|519968063|FG001|Overall Study|Death|1|||
144211213|NCT03301623|519968062|FG000|Overall Study|Withdrawal by Subject|11|||
144643745|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
144211214|NCT03301623|519968063|FG001|Overall Study|Withdrawal by Subject|13|||
144211215|NCT03301623|519968062|FG000|Overall Study|Lost to Follow-up|3|||
144211216|NCT03301623|519968063|FG001|Overall Study|Lost to Follow-up|1|||
144211217|NCT01374269|519968065|FG000|Overall Study|Withdrawal by Subject|4|||
144211218|NCT01374269|519968066|FG001|Overall Study|Withdrawal by Subject|0|||
144211219|NCT01374269|519968065|FG000|Overall Study|Lost to Follow-up|1|||
144211220|NCT01374269|519968066|FG001|Overall Study|Lost to Follow-up|3|||
144211221|NCT01374269|519968065|FG000|Overall Study|closed research|1|||
144211222|NCT01374269|519968066|FG001|Overall Study|closed research|2|||
144211223|NCT03316547|519968069|FG000|Overall Study|Death|3|||
144211224|NCT03316547|519968070|FG001|Overall Study|Death|1|||
144211225|NCT03316547|519968069|FG000|Overall Study|Lost to Follow-up|6|||
144211226|NCT03316547|519968070|FG001|Overall Study|Lost to Follow-up|6|||
144211227|NCT03316547|519968069|FG000|Overall Study|Withdrawal by Subject|3|||
144211228|NCT03316547|519968070|FG001|Overall Study|Withdrawal by Subject|2|||
144211229|NCT03316547|519968069|FG000|Overall Study|Transfer to another hospital|6|||
144211230|NCT03316547|519968070|FG001|Overall Study|Transfer to another hospital|4|||
144211231|NCT00996892|519968071|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
144211232|NCT00996892|519968072|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
144211233|NCT00996892|519968073|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
144211234|NCT00996892|519968074|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
144211235|NCT00996892|519968075|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
144211236|NCT00996892|519968076|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
144211237|NCT00996892|519968077|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
144211238|NCT00996892|519968078|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
144211239|NCT00996892|519968079|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
144211240|NCT00996892|519968080|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
144211241|NCT00996892|519968081|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
144211242|NCT00996892|519968082|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
144211243|NCT00996892|519968083|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
144211244|NCT00996892|519968084|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
144211245|NCT00996892|519968085|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
144211246|NCT00996892|519968086|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
144211247|NCT00996892|519968087|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
144211248|NCT00996892|519968088|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
144211249|NCT00996892|519968089|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
144211250|NCT00996892|519968090|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
144211251|NCT00996892|519968071|FG000|Dose-Escalation Stage 1|Death|1|||
144211252|NCT00996892|519968072|FG001|Dose-Escalation Stage 1|Death|0|||
144211253|NCT00996892|519968073|FG002|Dose-Escalation Stage 1|Death|0|||
144211254|NCT00996892|519968074|FG003|Dose-Escalation Stage 1|Death|0|||
144211255|NCT00996892|519968075|FG004|Dose-Escalation Stage 1|Death|0|||
144211256|NCT00996892|519968076|FG005|Dose-Escalation Stage 1|Death|1|||
144211257|NCT00996892|519968077|FG006|Dose-Escalation Stage 1|Death|0|||
144211258|NCT00996892|519968078|FG007|Dose-Escalation Stage 1|Death|0|||
144211259|NCT00996892|519968079|FG008|Dose-Escalation Stage 1|Death|0|||
144211260|NCT00996892|519968080|FG009|Dose-Escalation Stage 1|Death|0|||
144211261|NCT00996892|519968081|FG010|Dose-Escalation Stage 1|Death|0|||
144643746|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
144643747|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
144211262|NCT00996892|519968082|FG011|Dose-Escalation Stage 1|Death|0|||
144211263|NCT00996892|519968083|FG012|Dose-Escalation Stage 1|Death|0|||
144211264|NCT00996892|519968084|FG013|Dose-Escalation Stage 1|Death|0|||
144211265|NCT00996892|519968085|FG014|Dose-Escalation Stage 1|Death|0|||
144211266|NCT00996892|519968086|FG015|Dose-Escalation Stage 1|Death|0|||
144211267|NCT00996892|519968087|FG016|Dose-Escalation Stage 1|Death|0|||
144211268|NCT00996892|519968088|FG017|Dose-Escalation Stage 1|Death|0|||
144211269|NCT00996892|519968089|FG018|Dose-Escalation Stage 1|Death|0|||
144211270|NCT00996892|519968090|FG019|Dose-Escalation Stage 1|Death|0|||
144211271|NCT00996892|519968071|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
144211272|NCT00996892|519968072|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
144211273|NCT00996892|519968073|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
144211274|NCT00996892|519968074|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
144263237|NCT03066830|520163896|FG000|Overall Study|At the Participant's own Request|16|||
144643748|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
144211275|NCT00996892|519968075|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
144643749|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
144643750|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
144643751|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
144643752|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
144643753|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
144643754|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
144643755|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
144643756|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
144643757|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
144643758|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
144643759|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
144643760|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
144643761|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
144643762|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
144643763|NCT03519178|521551161|FG000|Fulvestrant. Treatment|Other|0|||
144643764|NCT03519178|521551162|FG001|Fulvestrant. Treatment|Other|0|||
144643765|NCT03519178|521551163|FG002|Fulvestrant. Treatment|Other|0|||
144643766|NCT03519178|521551164|FG003|Fulvestrant. Treatment|Other|0|||
144643767|NCT03519178|521551165|FG004|Fulvestrant. Treatment|Other|0|||
144643768|NCT03519178|521551166|FG005|Fulvestrant. Treatment|Other|0|||
144643769|NCT03519178|521551167|FG006|Fulvestrant. Treatment|Other|0|||
144643770|NCT03519178|521551168|FG007|Fulvestrant. Treatment|Other|0|||
144643771|NCT03519178|521551169|FG008|Fulvestrant. Treatment|Other|0|||
144643772|NCT03519178|521551170|FG009|Fulvestrant. Treatment|Other|0|||
144643773|NCT03519178|521551171|FG010|Fulvestrant. Treatment|Other|0|||
144643774|NCT03519178|521551172|FG011|Fulvestrant. Treatment|Other|0|||
144643775|NCT03519178|521551173|FG012|Fulvestrant. Treatment|Other|0|||
144643776|NCT03519178|521551174|FG013|Fulvestrant. Treatment|Other|1|||
144643777|NCT03519178|521551175|FG014|Fulvestrant. Treatment|Other|3|||
144643778|NCT03519178|521551161|FG000|Letrozole Treatment|Physician Decision|0|||
144643779|NCT03519178|521551162|FG001|Letrozole Treatment|Physician Decision|0|||
144643780|NCT03519178|521551163|FG002|Letrozole Treatment|Physician Decision|0|||
144643781|NCT03519178|521551164|FG003|Letrozole Treatment|Physician Decision|0|||
144643782|NCT03519178|521551165|FG004|Letrozole Treatment|Physician Decision|0|||
144643783|NCT03519178|521551166|FG005|Letrozole Treatment|Physician Decision|0|||
144643784|NCT03519178|521551167|FG006|Letrozole Treatment|Physician Decision|0|||
144643785|NCT03519178|521551168|FG007|Letrozole Treatment|Physician Decision|0|||
144643786|NCT03519178|521551169|FG008|Letrozole Treatment|Physician Decision|0|||
144643787|NCT03519178|521551170|FG009|Letrozole Treatment|Physician Decision|0|||
144643788|NCT03519178|521551171|FG010|Letrozole Treatment|Physician Decision|1|||
144643789|NCT03519178|521551172|FG011|Letrozole Treatment|Physician Decision|0|||
144643790|NCT03519178|521551173|FG012|Letrozole Treatment|Physician Decision|0|||
144643791|NCT03519178|521551174|FG013|Letrozole Treatment|Physician Decision|0|||
144643792|NCT03519178|521551175|FG014|Letrozole Treatment|Physician Decision|0|||
144643793|NCT03519178|521551161|FG000|Letrozole Treatment|Progressive disease|0|||
144643794|NCT03519178|521551162|FG001|Letrozole Treatment|Progressive disease|0|||
144643795|NCT03519178|521551163|FG002|Letrozole Treatment|Progressive disease|0|||
144643796|NCT03519178|521551164|FG003|Letrozole Treatment|Progressive disease|0|||
144643797|NCT03519178|521551165|FG004|Letrozole Treatment|Progressive disease|0|||
144643798|NCT03519178|521551166|FG005|Letrozole Treatment|Progressive disease|0|||
144643799|NCT03519178|521551167|FG006|Letrozole Treatment|Progressive disease|0|||
144643800|NCT03519178|521551168|FG007|Letrozole Treatment|Progressive disease|0|||
144643801|NCT03519178|521551169|FG008|Letrozole Treatment|Progressive disease|0|||
144643802|NCT03519178|521551170|FG009|Letrozole Treatment|Progressive disease|0|||
144643803|NCT03519178|521551171|FG010|Letrozole Treatment|Progressive disease|4|||
144643804|NCT03519178|521551172|FG011|Letrozole Treatment|Progressive disease|0|||
144643805|NCT03519178|521551173|FG012|Letrozole Treatment|Progressive disease|0|||
144643806|NCT03519178|521551174|FG013|Letrozole Treatment|Progressive disease|0|||
144643807|NCT03519178|521551175|FG014|Letrozole Treatment|Progressive disease|0|||
144643808|NCT03519178|521551161|FG000|Letrozole Treatment|Global deterioration of health status|0|||
144643809|NCT03519178|521551162|FG001|Letrozole Treatment|Global deterioration of health status|0|||
144643810|NCT03519178|521551163|FG002|Letrozole Treatment|Global deterioration of health status|0|||
144643811|NCT03519178|521551164|FG003|Letrozole Treatment|Global deterioration of health status|0|||
144643812|NCT03519178|521551165|FG004|Letrozole Treatment|Global deterioration of health status|0|||
144643813|NCT03519178|521551166|FG005|Letrozole Treatment|Global deterioration of health status|0|||
144643814|NCT03519178|521551167|FG006|Letrozole Treatment|Global deterioration of health status|0|||
144643815|NCT03519178|521551168|FG007|Letrozole Treatment|Global deterioration of health status|0|||
144643816|NCT03519178|521551169|FG008|Letrozole Treatment|Global deterioration of health status|0|||
144643817|NCT03519178|521551170|FG009|Letrozole Treatment|Global deterioration of health status|0|||
144643818|NCT03519178|521551171|FG010|Letrozole Treatment|Global deterioration of health status|2|||
144643819|NCT03519178|521551172|FG011|Letrozole Treatment|Global deterioration of health status|0|||
144643820|NCT03519178|521551173|FG012|Letrozole Treatment|Global deterioration of health status|0|||
144643821|NCT03519178|521551174|FG013|Letrozole Treatment|Global deterioration of health status|0|||
144643822|NCT03519178|521551175|FG014|Letrozole Treatment|Global deterioration of health status|0|||
144643823|NCT03519178|521551161|FG000|Follow-Up|Death|0|||
144643824|NCT03519178|521551162|FG001|Follow-Up|Death|0|||
144643825|NCT03519178|521551163|FG002|Follow-Up|Death|0|||
144643826|NCT03519178|521551164|FG003|Follow-Up|Death|0|||
144643827|NCT03519178|521551165|FG004|Follow-Up|Death|0|||
144643828|NCT03519178|521551166|FG005|Follow-Up|Death|0|||
144643829|NCT03519178|521551167|FG006|Follow-Up|Death|0|||
144643830|NCT03519178|521551168|FG007|Follow-Up|Death|0|||
144643831|NCT03519178|521551169|FG008|Follow-Up|Death|3|||
144643832|NCT03519178|521551170|FG009|Follow-Up|Death|1|||
144643833|NCT03519178|521551171|FG010|Follow-Up|Death|0|||
144643834|NCT03519178|521551172|FG011|Follow-Up|Death|0|||
144643835|NCT03519178|521551173|FG012|Follow-Up|Death|2|||
144643836|NCT03519178|521551174|FG013|Follow-Up|Death|0|||
144643837|NCT03519178|521551175|FG014|Follow-Up|Death|0|||
144643838|NCT03519178|521551161|FG000|Follow-Up|Lost to Follow-up|0|||
144643839|NCT03519178|521551162|FG001|Follow-Up|Lost to Follow-up|0|||
144643840|NCT03519178|521551163|FG002|Follow-Up|Lost to Follow-up|0|||
144643841|NCT03519178|521551164|FG003|Follow-Up|Lost to Follow-up|0|||
144643842|NCT03519178|521551165|FG004|Follow-Up|Lost to Follow-up|0|||
144643843|NCT03519178|521551166|FG005|Follow-Up|Lost to Follow-up|3|||
144643844|NCT03519178|521551167|FG006|Follow-Up|Lost to Follow-up|1|||
144643845|NCT03519178|521551168|FG007|Follow-Up|Lost to Follow-up|4|||
144643846|NCT03519178|521551169|FG008|Follow-Up|Lost to Follow-up|1|||
144643847|NCT03519178|521551170|FG009|Follow-Up|Lost to Follow-up|0|||
144643848|NCT03519178|521551171|FG010|Follow-Up|Lost to Follow-up|0|||
144643849|NCT03519178|521551172|FG011|Follow-Up|Lost to Follow-up|0|||
144643850|NCT03519178|521551173|FG012|Follow-Up|Lost to Follow-up|0|||
144643851|NCT03519178|521551174|FG013|Follow-Up|Lost to Follow-up|0|||
144643852|NCT03519178|521551175|FG014|Follow-Up|Lost to Follow-up|0|||
144643853|NCT03519178|521551161|FG000|Follow-Up|Withdrawal by Subject|1|||
144643854|NCT03519178|521551162|FG001|Follow-Up|Withdrawal by Subject|2|||
144643855|NCT03519178|521551163|FG002|Follow-Up|Withdrawal by Subject|2|||
144643856|NCT03519178|521551164|FG003|Follow-Up|Withdrawal by Subject|3|||
144643857|NCT03519178|521551165|FG004|Follow-Up|Withdrawal by Subject|5|||
144643858|NCT03519178|521551166|FG005|Follow-Up|Withdrawal by Subject|1|||
144643859|NCT03519178|521551167|FG006|Follow-Up|Withdrawal by Subject|2|||
144643860|NCT03519178|521551168|FG007|Follow-Up|Withdrawal by Subject|6|||
144643861|NCT03519178|521551169|FG008|Follow-Up|Withdrawal by Subject|5|||
144643862|NCT03519178|521551170|FG009|Follow-Up|Withdrawal by Subject|2|||
144643863|NCT03519178|521551171|FG010|Follow-Up|Withdrawal by Subject|3|||
144643864|NCT03519178|521551172|FG011|Follow-Up|Withdrawal by Subject|5|||
144643865|NCT03519178|521551173|FG012|Follow-Up|Withdrawal by Subject|2|||
144643866|NCT03519178|521551174|FG013|Follow-Up|Withdrawal by Subject|0|||
144643867|NCT03519178|521551175|FG014|Follow-Up|Withdrawal by Subject|0|||
144643868|NCT03519178|521551161|FG000|Follow-Up|Other|0|||
144643869|NCT03519178|521551162|FG001|Follow-Up|Other|0|||
144643870|NCT03519178|521551163|FG002|Follow-Up|Other|0|||
144643871|NCT03519178|521551164|FG003|Follow-Up|Other|0|||
144643872|NCT03519178|521551165|FG004|Follow-Up|Other|0|||
144643873|NCT03519178|521551166|FG005|Follow-Up|Other|0|||
144643874|NCT03519178|521551167|FG006|Follow-Up|Other|0|||
144643875|NCT03519178|521551168|FG007|Follow-Up|Other|1|||
144643876|NCT03519178|521551169|FG008|Follow-Up|Other|0|||
144643877|NCT03519178|521551170|FG009|Follow-Up|Other|0|||
144643878|NCT03519178|521551171|FG010|Follow-Up|Other|0|||
144643879|NCT03519178|521551172|FG011|Follow-Up|Other|0|||
144643880|NCT03519178|521551173|FG012|Follow-Up|Other|0|||
144643881|NCT03519178|521551174|FG013|Follow-Up|Other|0|||
144643882|NCT03519178|521551175|FG014|Follow-Up|Other|0|||
144643883|NCT03519178|521551161|FG000|Long-term Follow-up|Death|0|||
144643884|NCT03519178|521551162|FG001|Long-term Follow-up|Death|0|||
144643885|NCT03519178|521551163|FG002|Long-term Follow-up|Death|0|||
144643886|NCT03519178|521551164|FG003|Long-term Follow-up|Death|0|||
144643887|NCT03519178|521551165|FG004|Long-term Follow-up|Death|0|||
144643888|NCT03519178|521551166|FG005|Long-term Follow-up|Death|0|||
144643889|NCT03519178|521551167|FG006|Long-term Follow-up|Death|0|||
144643890|NCT03519178|521551168|FG007|Long-term Follow-up|Death|0|||
144643891|NCT03519178|521551169|FG008|Long-term Follow-up|Death|0|||
144643892|NCT03519178|521551170|FG009|Long-term Follow-up|Death|0|||
144643893|NCT03519178|521551171|FG010|Long-term Follow-up|Death|0|||
144643894|NCT03519178|521551172|FG011|Long-term Follow-up|Death|0|||
144643895|NCT03519178|521551173|FG012|Long-term Follow-up|Death|0|||
144643896|NCT03519178|521551174|FG013|Long-term Follow-up|Death|4|||
144643897|NCT03519178|521551175|FG014|Long-term Follow-up|Death|4|||
144643898|NCT03519178|521551161|FG000|Long-term Follow-up|Lost to Follow-up|0|||
144643899|NCT03519178|521551162|FG001|Long-term Follow-up|Lost to Follow-up|0|||
144643900|NCT03519178|521551163|FG002|Long-term Follow-up|Lost to Follow-up|0|||
144643901|NCT03519178|521551164|FG003|Long-term Follow-up|Lost to Follow-up|0|||
144643902|NCT03519178|521551165|FG004|Long-term Follow-up|Lost to Follow-up|0|||
144643903|NCT03519178|521551166|FG005|Long-term Follow-up|Lost to Follow-up|0|||
144643904|NCT03519178|521551167|FG006|Long-term Follow-up|Lost to Follow-up|0|||
144643905|NCT03519178|521551168|FG007|Long-term Follow-up|Lost to Follow-up|0|||
144643906|NCT03519178|521551169|FG008|Long-term Follow-up|Lost to Follow-up|0|||
144643907|NCT03519178|521551170|FG009|Long-term Follow-up|Lost to Follow-up|0|||
144211276|NCT00996892|519968076|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
144643908|NCT03519178|521551171|FG010|Long-term Follow-up|Lost to Follow-up|0|||
144643909|NCT03519178|521551172|FG011|Long-term Follow-up|Lost to Follow-up|0|||
144643910|NCT03519178|521551173|FG012|Long-term Follow-up|Lost to Follow-up|0|||
144643911|NCT03519178|521551174|FG013|Long-term Follow-up|Lost to Follow-up|1|||
144643912|NCT03519178|521551175|FG014|Long-term Follow-up|Lost to Follow-up|1|||
144643913|NCT03519178|521551161|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
144643914|NCT03519178|521551162|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
144643915|NCT03519178|521551163|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
144643916|NCT03519178|521551164|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
144643917|NCT03519178|521551165|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
144643918|NCT03519178|521551166|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
144643919|NCT03519178|521551167|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
144643920|NCT03519178|521551168|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
144643921|NCT03519178|521551169|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
144643922|NCT03519178|521551170|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
144643923|NCT03519178|521551171|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
144643924|NCT03519178|521551172|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
144643925|NCT03519178|521551173|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
144643926|NCT03519178|521551174|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
144643927|NCT03519178|521551175|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
144643928|NCT03519178|521551161|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
144643929|NCT03519178|521551162|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
144643930|NCT03519178|521551163|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
144643931|NCT03519178|521551164|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
144643932|NCT03519178|521551165|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
144643933|NCT03519178|521551166|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
144643934|NCT03519178|521551167|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
144643935|NCT03519178|521551168|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
144643936|NCT03519178|521551169|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
144643937|NCT03519178|521551170|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
144643938|NCT03519178|521551171|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
144643939|NCT03519178|521551172|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
144643940|NCT03519178|521551173|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
144643941|NCT03519178|521551174|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
144643942|NCT03519178|521551175|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
144643943|NCT03519178|521551161|FG000|Long-term Follow-up|Other|0|||
144643944|NCT03519178|521551162|FG001|Long-term Follow-up|Other|0|||
144643945|NCT03519178|521551163|FG002|Long-term Follow-up|Other|0|||
144643946|NCT03519178|521551164|FG003|Long-term Follow-up|Other|0|||
144643947|NCT03519178|521551165|FG004|Long-term Follow-up|Other|0|||
144643948|NCT03519178|521551166|FG005|Long-term Follow-up|Other|0|||
144643949|NCT03519178|521551167|FG006|Long-term Follow-up|Other|0|||
144643950|NCT03519178|521551168|FG007|Long-term Follow-up|Other|0|||
144643951|NCT03519178|521551169|FG008|Long-term Follow-up|Other|0|||
144643952|NCT03519178|521551170|FG009|Long-term Follow-up|Other|0|||
144643953|NCT03519178|521551171|FG010|Long-term Follow-up|Other|0|||
144643954|NCT03519178|521551172|FG011|Long-term Follow-up|Other|0|||
144643955|NCT03519178|521551173|FG012|Long-term Follow-up|Other|0|||
144643956|NCT03519178|521551174|FG013|Long-term Follow-up|Other|0|||
144643957|NCT03519178|521551175|FG014|Long-term Follow-up|Other|1|||
144643958|NCT03519178|521551161|FG000|Long-term Follow-up|Global deterioration of health status|0|||
144643959|NCT03519178|521551162|FG001|Long-term Follow-up|Global deterioration of health status|0|||
144643960|NCT03519178|521551163|FG002|Long-term Follow-up|Global deterioration of health status|0|||
144643961|NCT03519178|521551164|FG003|Long-term Follow-up|Global deterioration of health status|0|||
144643962|NCT03519178|521551165|FG004|Long-term Follow-up|Global deterioration of health status|0|||
144643963|NCT03519178|521551166|FG005|Long-term Follow-up|Global deterioration of health status|0|||
144643964|NCT03519178|521551167|FG006|Long-term Follow-up|Global deterioration of health status|0|||
144643965|NCT03519178|521551168|FG007|Long-term Follow-up|Global deterioration of health status|0|||
144643966|NCT03519178|521551169|FG008|Long-term Follow-up|Global deterioration of health status|0|||
144643967|NCT03519178|521551170|FG009|Long-term Follow-up|Global deterioration of health status|0|||
144643968|NCT03519178|521551171|FG010|Long-term Follow-up|Global deterioration of health status|0|||
144211277|NCT00996892|519968077|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
144211278|NCT00996892|519968078|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
144211279|NCT00996892|519968079|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
144643969|NCT03519178|521551172|FG011|Long-term Follow-up|Global deterioration of health status|0|||
144211280|NCT00996892|519968080|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
144211281|NCT00996892|519968081|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
144211282|NCT00996892|519968082|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
144643970|NCT03519178|521551173|FG012|Long-term Follow-up|Global deterioration of health status|0|||
144643971|NCT03519178|521551174|FG013|Long-term Follow-up|Global deterioration of health status|1|||
144643972|NCT03519178|521551175|FG014|Long-term Follow-up|Global deterioration of health status|0|||
144643973|NCT03249350|521551176|FG000|Overall Study|Participant did not initiate treatment|5|||
144643974|NCT03249350|521551177|FG001|Overall Study|Participant did not initiate treatment|8|||
144643975|NCT01591330|521551180|FG000|Period 1|Adverse Event|1|||
144643976|NCT01591330|521551181|FG001|Period 1|Adverse Event|0|||
144643977|NCT01591330|521551182|FG002|Period 1|Adverse Event|0|||
144643978|NCT01591330|521551183|FG003|Period 1|Adverse Event|0|||
144643979|NCT01591330|521551180|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
144643980|NCT01591330|521551181|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
144643981|NCT01591330|521551182|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
144643982|NCT01591330|521551183|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
144643983|NCT01591330|521551180|FG000|Period 2|Adverse Event|1|||
144643984|NCT01591330|521551181|FG001|Period 2|Adverse Event|0|||
144643985|NCT01591330|521551182|FG002|Period 2|Adverse Event|0|||
144643986|NCT01591330|521551183|FG003|Period 2|Adverse Event|0|||
144643987|NCT01450137|521551184|FG000|Up to Week 12|Adverse Event|2|||
144643988|NCT01450137|521551185|FG001|Up to Week 12|Adverse Event|1|||
144643989|NCT01450137|521551184|FG000|Up to Week 12|Withdrawal by Subject|0|||
144643990|NCT01450137|521551185|FG001|Up to Week 12|Withdrawal by Subject|2|||
144643991|NCT01450137|521551184|FG000|Week 12 to Study End|Death|0|||
144643992|NCT01450137|521551185|FG001|Week 12 to Study End|Death|1|||
144643993|NCT01450137|521551184|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
144643994|NCT01450137|521551185|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
144643995|NCT02986373|521551186|FG000|Overall Study|Adverse Event|4|||
144643996|NCT02986373|521551186|FG000|Overall Study|Lost to Follow-up|1|||
144643997|NCT02986373|521551186|FG000|Overall Study|Withdrawal by Subject|10|||
144643998|NCT02986373|521551186|FG000|Overall Study|Other|24|||
144643999|NCT01919411|521551194|FG000|Overall Study|Lost to Follow-up|2|||
144644000|NCT01919411|521551195|FG001|Overall Study|Lost to Follow-up|4|||
144644001|NCT01919411|521551194|FG000|Overall Study|Physician Decision|1|||
144644002|NCT01919411|521551195|FG001|Overall Study|Physician Decision|0|||
144644003|NCT01919411|521551194|FG000|Overall Study|Protocol Violation|2|||
144644004|NCT01919411|521551195|FG001|Overall Study|Protocol Violation|1|||
144644005|NCT00144300|521551196|FG000|Overall Study|Adverse Event|18|||
144644006|NCT00144300|521551197|FG001|Overall Study|Adverse Event|16|||
144644007|NCT00144300|521551196|FG000|Overall Study|Protocol Violation|1|||
144644008|NCT00144300|521551197|FG001|Overall Study|Protocol Violation|3|||
144644009|NCT00144300|521551196|FG000|Overall Study|Lost to Follow-up|3|||
144644010|NCT00144300|521551197|FG001|Overall Study|Lost to Follow-up|0|||
144644011|NCT00144300|521551196|FG000|Overall Study|Withdrawal by Subject|6|||
144644012|NCT00144300|521551197|FG001|Overall Study|Withdrawal by Subject|6|||
144644013|NCT00144300|521551196|FG000|Overall Study|Other reason (not specified)|1|||
144644014|NCT00144300|521551197|FG001|Overall Study|Other reason (not specified)|3|||
144644015|NCT02426086|521551200|FG000|Overall Study|Death|33|||
144644016|NCT02426086|521551201|FG001|Overall Study|Death|36|||
144644017|NCT02426086|521551200|FG000|Overall Study|Lost to Follow-up|2|||
144644018|NCT02426086|521551201|FG001|Overall Study|Lost to Follow-up|0|||
144644019|NCT02426086|521551200|FG000|Overall Study|Study Terminated by Sponsor|5|||
144644020|NCT02426086|521551201|FG001|Overall Study|Study Terminated by Sponsor|14|||
144644021|NCT02426086|521551200|FG000|Overall Study|Withdrawal by Subject|8|||
144644022|NCT02426086|521551201|FG001|Overall Study|Withdrawal by Subject|9|||
144644023|NCT00524303|521551202|FG000|Overall Study|Lost to Follow-up|6|||
144644024|NCT00524303|521551203|FG001|Overall Study|Lost to Follow-up|0|||
144644025|NCT00524303|521551204|FG002|Overall Study|Lost to Follow-up|3|||
144644026|NCT00524303|521551202|FG000|Overall Study|Protocol Violation|0|||
144644027|NCT00524303|521551203|FG001|Overall Study|Protocol Violation|1|||
144644028|NCT00524303|521551204|FG002|Overall Study|Protocol Violation|1|||
144644029|NCT00524303|521551202|FG000|Overall Study|Withdrawal by Subject|3|||
144644030|NCT00524303|521551203|FG001|Overall Study|Withdrawal by Subject|0|||
144644031|NCT00524303|521551204|FG002|Overall Study|Withdrawal by Subject|4|||
144644032|NCT00524303|521551202|FG000|Overall Study|Death|0|||
144644033|NCT00524303|521551203|FG001|Overall Study|Death|2|||
144644034|NCT00524303|521551204|FG002|Overall Study|Death|3|||
144644035|NCT00524303|521551202|FG000|Overall Study|Adverse Event|1|||
144644036|NCT00524303|521551203|FG001|Overall Study|Adverse Event|2|||
144644037|NCT00524303|521551204|FG002|Overall Study|Adverse Event|3|||
144644038|NCT00524303|521551202|FG000|Overall Study|Did not Complete Study Dosing|1|||
144644039|NCT00524303|521551203|FG001|Overall Study|Did not Complete Study Dosing|0|||
144644040|NCT00524303|521551204|FG002|Overall Study|Did not Complete Study Dosing|0|||
144644041|NCT00524303|521551202|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
144644042|NCT00524303|521551203|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
144644043|NCT00524303|521551204|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
144644044|NCT00524303|521551202|FG000|Overall Study|Disease Progression|0|||
144644045|NCT00524303|521551203|FG001|Overall Study|Disease Progression|4|||
144644046|NCT00524303|521551204|FG002|Overall Study|Disease Progression|1|||
144644047|NCT00524303|521551202|FG000|Overall Study|Disease Recurrence|0|||
144644048|NCT00524303|521551203|FG001|Overall Study|Disease Recurrence|1|||
144644049|NCT00524303|521551204|FG002|Overall Study|Disease Recurrence|0|||
144644050|NCT00524303|521551202|FG000|Overall Study|Sponsor Request|0|||
144644051|NCT00524303|521551203|FG001|Overall Study|Sponsor Request|0|||
144644052|NCT00524303|521551204|FG002|Overall Study|Sponsor Request|1|||
144644053|NCT00524303|521551202|FG000|Overall Study|Physician Decision|0|||
144644054|NCT00524303|521551203|FG001|Overall Study|Physician Decision|0|||
144644055|NCT00524303|521551204|FG002|Overall Study|Physician Decision|1|||
144644056|NCT00524303|521551202|FG000|Overall Study|Completed 5 years|0|||
144644057|NCT00524303|521551203|FG001|Overall Study|Completed 5 years|0|||
144644058|NCT00524303|521551204|FG002|Overall Study|Completed 5 years|1|||
144644059|NCT01607892|521551211|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
144644060|NCT01607892|521551212|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
144644061|NCT01607892|521551213|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
144644062|NCT01607892|521551214|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
144644063|NCT01607892|521551215|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
144644064|NCT01607892|521551211|FG000|Overall Study|Death|4|||
144644065|NCT01607892|521551212|FG001|Overall Study|Death|2|||
144644066|NCT01607892|521551213|FG002|Overall Study|Death|8|||
144644067|NCT01607892|521551214|FG003|Overall Study|Death|10|||
144644068|NCT01607892|521551215|FG004|Overall Study|Death|3|||
144644069|NCT01607892|521551211|FG000|Overall Study|Investigator discretion|2|||
144644070|NCT01607892|521551212|FG001|Overall Study|Investigator discretion|4|||
144644071|NCT01607892|521551213|FG002|Overall Study|Investigator discretion|4|||
144644072|NCT01607892|521551214|FG003|Overall Study|Investigator discretion|8|||
144644073|NCT01607892|521551215|FG004|Overall Study|Investigator discretion|0|||
144644074|NCT01607892|521551211|FG000|Overall Study|Other treatments became available|1|||
144644075|NCT01607892|521551212|FG001|Overall Study|Other treatments became available|1|||
144644076|NCT01607892|521551213|FG002|Overall Study|Other treatments became available|0|||
144644077|NCT01607892|521551214|FG003|Overall Study|Other treatments became available|0|||
144644078|NCT01607892|521551215|FG004|Overall Study|Other treatments became available|2|||
144644079|NCT01607892|521551211|FG000|Overall Study|Intercurrent illness|1|||
144644080|NCT01607892|521551212|FG001|Overall Study|Intercurrent illness|0|||
144644081|NCT01607892|521551213|FG002|Overall Study|Intercurrent illness|0|||
144644082|NCT01607892|521551214|FG003|Overall Study|Intercurrent illness|3|||
144644083|NCT01607892|521551215|FG004|Overall Study|Intercurrent illness|0|||
144644084|NCT01607892|521551211|FG000|Overall Study|Non-Compliance with study procedures|0|||
144644085|NCT01607892|521551212|FG001|Overall Study|Non-Compliance with study procedures|0|||
144644086|NCT01607892|521551213|FG002|Overall Study|Non-Compliance with study procedures|1|||
144644087|NCT01607892|521551214|FG003|Overall Study|Non-Compliance with study procedures|0|||
144644088|NCT01607892|521551215|FG004|Overall Study|Non-Compliance with study procedures|0|||
144644089|NCT01607892|521551211|FG000|Overall Study|Consent withdrawn by participant|9|||
144644090|NCT01607892|521551212|FG001|Overall Study|Consent withdrawn by participant|4|||
144644091|NCT01607892|521551213|FG002|Overall Study|Consent withdrawn by participant|24|||
144644092|NCT01607892|521551214|FG003|Overall Study|Consent withdrawn by participant|14|||
144644093|NCT01607892|521551215|FG004|Overall Study|Consent withdrawn by participant|4|||
144644094|NCT01607892|521551211|FG000|Overall Study|Disease progression|38|||
144644095|NCT01607892|521551212|FG001|Overall Study|Disease progression|13|||
144644096|NCT01607892|521551213|FG002|Overall Study|Disease progression|37|||
144644097|NCT01607892|521551214|FG003|Overall Study|Disease progression|57|||
144644098|NCT01607892|521551215|FG004|Overall Study|Disease progression|9|||
144644099|NCT01607892|521551211|FG000|Overall Study|Incidence or severity of Adverse events|3|||
144644100|NCT01607892|521551212|FG001|Overall Study|Incidence or severity of Adverse events|3|||
144644101|NCT01607892|521551213|FG002|Overall Study|Incidence or severity of Adverse events|7|||
144644102|NCT01607892|521551214|FG003|Overall Study|Incidence or severity of Adverse events|2|||
144644103|NCT01607892|521551215|FG004|Overall Study|Incidence or severity of Adverse events|6|||
144644104|NCT02273973|521551218|FG000|Overall Study|Adverse Event|4|||
144644105|NCT02273973|521551219|FG001|Overall Study|Adverse Event|0|||
144644106|NCT02273973|521551218|FG000|Overall Study|Withdrawal by Subject|2|||
144644107|NCT02273973|521551219|FG001|Overall Study|Withdrawal by Subject|3|||
144644108|NCT02273973|521551218|FG000|Overall Study|Death|1|||
144644109|NCT02273973|521551219|FG001|Overall Study|Death|0|||
144644110|NCT02273973|521551218|FG000|Overall Study|Non-compliance|1|||
144644111|NCT02273973|521551219|FG001|Overall Study|Non-compliance|0|||
144644112|NCT02273973|521551218|FG000|Overall Study|Protocol Violation|1|||
144644113|NCT02273973|521551219|FG001|Overall Study|Protocol Violation|0|||
144644114|NCT02273973|521551218|FG000|Overall Study|Progression of disease|0|||
144644115|NCT02273973|521551219|FG001|Overall Study|Progression of disease|2|||
144644116|NCT02273973|521551218|FG000|Overall Study|Lost to Follow-up|0|||
144644117|NCT02273973|521551219|FG001|Overall Study|Lost to Follow-up|1|||
144644118|NCT02273973|521551218|FG000|Overall Study|Physician Decision|0|||
144644119|NCT02273973|521551219|FG001|Overall Study|Physician Decision|1|||
144644120|NCT02273973|521551218|FG000|Overall Study|Reason not specified|0|||
144644121|NCT02273973|521551219|FG001|Overall Study|Reason not specified|1|||
144644122|NCT03022422|521551221|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
144644123|NCT03022422|521551222|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
144644124|NCT03022422|521551223|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
144644125|NCT03022422|521551224|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
144644126|NCT03022422|521551225|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
144644127|NCT03022422|521551226|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
144644128|NCT01769404|521551227|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
144644129|NCT01769404|521551228|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
144644130|NCT01769404|521551227|FG000|Treatment Period 1|Withdrawal by Subject|3|||
144644131|NCT01769404|521551228|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144644132|NCT01769404|521551227|FG000|Treatment Period 1|Sponsor decision|1|||
144644133|NCT01769404|521551228|FG001|Treatment Period 1|Sponsor decision|0|||
144644134|NCT01769404|521551227|FG000|Treatment Period 2|Sponsor decision|7|||
144644135|NCT01769404|521551228|FG001|Treatment Period 2|Sponsor decision|0|||
144644136|NCT00538733|521551229|FG000|Overall Study|Adverse Event|8|||
144644137|NCT00538733|521551229|FG000|Overall Study|Death|1|||
144644138|NCT00538733|521551229|FG000|Overall Study|declined to participate|2|||
144644139|NCT00538733|521551229|FG000|Overall Study|still on therapy|1|||
144644140|NCT02032524|521551234|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
144644141|NCT02032524|521551235|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
144644142|NCT02032524|521551236|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
144644143|NCT02032524|521551237|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
144644144|NCT02032524|521551238|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
144644145|NCT02032524|521551239|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
144644146|NCT02032524|521551234|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
144644147|NCT02032524|521551235|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
144644148|NCT02032524|521551236|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
144644149|NCT02032524|521551237|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
144644150|NCT02032524|521551238|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
144644151|NCT02032524|521551239|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
144644152|NCT02032524|521551234|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
144644153|NCT02032524|521551235|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
144644154|NCT02032524|521551236|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
144644155|NCT02032524|521551237|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
144644156|NCT02032524|521551238|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
144644157|NCT02032524|521551239|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
144644158|NCT02032524|521551234|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
144644159|NCT02032524|521551235|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
144644160|NCT02032524|521551236|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
144644161|NCT02032524|521551237|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
144644162|NCT02032524|521551238|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
144644163|NCT02032524|521551239|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
144644164|NCT02032524|521551234|FG000|Period 2: LTS13769 Study|Other|0|||
144644165|NCT02032524|521551235|FG001|Period 2: LTS13769 Study|Other|0|||
144644166|NCT02032524|521551236|FG002|Period 2: LTS13769 Study|Other|0|||
144644167|NCT02032524|521551237|FG003|Period 2: LTS13769 Study|Other|0|||
144644168|NCT02032524|521551238|FG004|Period 2: LTS13769 Study|Other|0|||
144644169|NCT02032524|521551239|FG005|Period 2: LTS13769 Study|Other|1|||
144644170|NCT03497689|521551245|FG000|Overall Study|Adverse Event|2|||
144644171|NCT03497689|521551245|FG000|Overall Study|Death|1|||
144644172|NCT03497689|521551245|FG000|Overall Study|Physician Decision|1|||
144644173|NCT03497689|521551245|FG000|Overall Study|Withdrawal by Subject|1|||
144644174|NCT03497689|521551245|FG000|Overall Study|Protocol Violation|2|||
144644175|NCT03567187|521551246|FG000|Overall Study|Lost to Follow-up|18|||
144644176|NCT03596645|521551249|FG000|Overall Study|Adverse Event|17|||
144644177|NCT03596645|521551250|FG001|Overall Study|Adverse Event|0|||
144644178|NCT03596645|521551249|FG000|Overall Study|Lack of Efficacy|8|||
144644179|NCT03596645|521551250|FG001|Overall Study|Lack of Efficacy|0|||
144644180|NCT03596645|521551249|FG000|Overall Study|Lost to Follow-up|1|||
144644181|NCT03596645|521551250|FG001|Overall Study|Lost to Follow-up|1|||
144644182|NCT03596645|521551249|FG000|Overall Study|Physician Decision|1|||
144644183|NCT03596645|521551250|FG001|Overall Study|Physician Decision|1|||
144644184|NCT03596645|521551249|FG000|Overall Study|Protocol Violation|1|||
144644185|NCT03596645|521551250|FG001|Overall Study|Protocol Violation|0|||
144644186|NCT03596645|521551249|FG000|Overall Study|Initiated Prohibited Medication|1|||
144644187|NCT03596645|521551250|FG001|Overall Study|Initiated Prohibited Medication|0|||
144644188|NCT03596645|521551249|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144644189|NCT03596645|521551250|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144644190|NCT03596645|521551249|FG000|Overall Study|No mucosal healing achieved|1|||
144644191|NCT03596645|521551250|FG001|Overall Study|No mucosal healing achieved|0|||
144644192|NCT03596645|521551249|FG000|Overall Study|Disease progression|1|||
144644193|NCT03596645|521551250|FG001|Overall Study|Disease progression|0|||
144644194|NCT03596645|521551249|FG000|Overall Study|Ongoing|37|||
144644195|NCT03596645|521551250|FG001|Overall Study|Ongoing|12|||
144644196|NCT03596645|521551249|FG000|Overall Study|Randomized but not treated|0|||
144644197|NCT03596645|521551250|FG001|Overall Study|Randomized but not treated|1|||
144644198|NCT02032875|521551251|FG000|Treatment Period|Adverse Event|1|||
144644199|NCT02032875|521551252|FG001|Treatment Period|Adverse Event|0|||
144644200|NCT02032875|521551251|FG000|Treatment Period|Liver transplant, No extension needed|0|||
144644201|NCT02032875|521551252|FG001|Treatment Period|Liver transplant, No extension needed|1|||
144644202|NCT02032875|521551251|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
144644203|NCT02032875|521551252|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
144644204|NCT02032875|521551251|FG000|Follow-up Period|Death|0|||
144644205|NCT02032875|521551252|FG001|Follow-up Period|Death|1|||
144644206|NCT02032875|521551251|FG000|Follow-up Period|Virologic Relapse|3|||
144211283|NCT00996892|519968083|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
144211284|NCT00996892|519968084|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
144644207|NCT02032875|521551252|FG001|Follow-up Period|Virologic Relapse|10|||
144644208|NCT04358458|521551253|FG000|Overall Study|Death|1|||
144644209|NCT04358458|521551254|FG001|Overall Study|Death|1|||
144644210|NCT04358458|521551255|FG002|Overall Study|Death|3|||
144644211|NCT04358458|521551256|FG003|Overall Study|Death|8|||
144644212|NCT04358458|521551257|FG004|Overall Study|Death|1|||
144644213|NCT04358458|521551258|FG005|Overall Study|Death|6|||
144644214|NCT04358458|521551259|FG006|Overall Study|Death|2|||
144644215|NCT04358458|521551260|FG007|Overall Study|Death|3|||
144644216|NCT04358458|521551253|FG000|Overall Study|Lost to Follow-up|0|||
144644217|NCT04358458|521551254|FG001|Overall Study|Lost to Follow-up|0|||
144644218|NCT04358458|521551255|FG002|Overall Study|Lost to Follow-up|0|||
144644219|NCT04358458|521551256|FG003|Overall Study|Lost to Follow-up|0|||
144644220|NCT04358458|521551257|FG004|Overall Study|Lost to Follow-up|0|||
144644221|NCT04358458|521551258|FG005|Overall Study|Lost to Follow-up|0|||
144644222|NCT04358458|521551259|FG006|Overall Study|Lost to Follow-up|0|||
144644223|NCT04358458|521551260|FG007|Overall Study|Lost to Follow-up|1|||
144644224|NCT04358458|521551253|FG000|Overall Study|Site is closing study participation|0|||
144644225|NCT04358458|521551254|FG001|Overall Study|Site is closing study participation|0|||
144644226|NCT04358458|521551255|FG002|Overall Study|Site is closing study participation|0|||
144644227|NCT04358458|521551256|FG003|Overall Study|Site is closing study participation|1|||
144644228|NCT04358458|521551257|FG004|Overall Study|Site is closing study participation|0|||
144644229|NCT04358458|521551258|FG005|Overall Study|Site is closing study participation|0|||
144644230|NCT04358458|521551259|FG006|Overall Study|Site is closing study participation|0|||
144644231|NCT04358458|521551260|FG007|Overall Study|Site is closing study participation|0|||
144644232|NCT04358458|521551253|FG000|Overall Study|Sponsor request|2|||
144644233|NCT04358458|521551254|FG001|Overall Study|Sponsor request|3|||
144644234|NCT04358458|521551255|FG002|Overall Study|Sponsor request|3|||
144644235|NCT04358458|521551256|FG003|Overall Study|Sponsor request|0|||
144644236|NCT04358458|521551257|FG004|Overall Study|Sponsor request|2|||
144644237|NCT04358458|521551258|FG005|Overall Study|Sponsor request|3|||
144644238|NCT04358458|521551259|FG006|Overall Study|Sponsor request|1|||
144644239|NCT04358458|521551260|FG007|Overall Study|Sponsor request|1|||
144644240|NCT04358458|521551253|FG000|Overall Study|Withdrawal by Subject|0|||
144644241|NCT04358458|521551254|FG001|Overall Study|Withdrawal by Subject|0|||
144644242|NCT04358458|521551255|FG002|Overall Study|Withdrawal by Subject|1|||
144644243|NCT04358458|521551256|FG003|Overall Study|Withdrawal by Subject|1|||
144644244|NCT04358458|521551257|FG004|Overall Study|Withdrawal by Subject|0|||
144644245|NCT04358458|521551258|FG005|Overall Study|Withdrawal by Subject|1|||
144644246|NCT04358458|521551259|FG006|Overall Study|Withdrawal by Subject|0|||
144644247|NCT04358458|521551260|FG007|Overall Study|Withdrawal by Subject|1|||
144644248|NCT03191786|521551261|FG000|Overall Study|Death|236|||
144644249|NCT03191786|521551262|FG001|Overall Study|Death|127|||
144644250|NCT03191786|521551261|FG000|Overall Study|Lost to Follow-up|9|||
144644251|NCT03191786|521551262|FG001|Overall Study|Lost to Follow-up|3|||
144644252|NCT03191786|521551261|FG000|Overall Study|Physician Decision|1|||
144644253|NCT03191786|521551262|FG001|Overall Study|Physician Decision|0|||
144211285|NCT00996892|519968085|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
144211286|NCT00996892|519968086|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
144211287|NCT00996892|519968087|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
144211288|NCT00996892|519968088|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
144211289|NCT00996892|519968089|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
144211290|NCT00996892|519968090|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
144211291|NCT00996892|519968071|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211292|NCT00996892|519968072|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
144211293|NCT00996892|519968073|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144644254|NCT03191786|521551261|FG000|Overall Study|Moved to Post Trial Access Program|30|||
144644255|NCT03191786|521551262|FG001|Overall Study|Moved to Post Trial Access Program|5|||
144211294|NCT00996892|519968074|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
144644256|NCT03191786|521551261|FG000|Overall Study|Withdrawal by Subject|26|||
144644257|NCT03191786|521551262|FG001|Overall Study|Withdrawal by Subject|16|||
144644258|NCT04513158|521551265|FG000|Overall Study|Screen Failure|1|||
144700128|NCT00948896|521754508|FG001|24 Months of Age to 36 Months of Age|Death|2|||
144700129|NCT00948896|521754509|FG002|24 Months of Age to 36 Months of Age|Death|2|||
144700130|NCT00948896|521754510|FG003|24 Months of Age to 36 Months of Age|Death|0|||
144700131|NCT00948896|521754511|FG004|24 Months of Age to 36 Months of Age|Death|0|||
144700132|NCT00948896|521754512|FG005|24 Months of Age to 36 Months of Age|Death|1|||
144700133|NCT00948896|521754513|FG006|24 Months of Age to 36 Months of Age|Death|0|||
144700134|NCT00948896|521754514|FG007|24 Months of Age to 36 Months of Age|Death|0|||
144700135|NCT00948896|521754507|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
144644259|NCT03167619|521552803|FG000|Overall Study|Death|11|||
144644260|NCT03167619|521552804|FG001|Overall Study|Death|8|||
144644261|NCT03167619|521552803|FG000|Overall Study|Withdrawal by Subject|1|||
144644262|NCT03167619|521552804|FG001|Overall Study|Withdrawal by Subject|2|||
144644263|NCT03167619|521552803|FG000|Overall Study|Physician Decision|0|||
144644264|NCT03167619|521552804|FG001|Overall Study|Physician Decision|1|||
144644265|NCT01348919|521552805|FG000|Overall Study|Adverse Event|3|||
144644266|NCT01348919|521552806|FG001|Overall Study|Adverse Event|1|||
144644267|NCT01348919|521552807|FG002|Overall Study|Adverse Event|0|||
144644268|NCT01348919|521552805|FG000|Overall Study|Withdrawal by Subject|0|||
144644269|NCT01348919|521552806|FG001|Overall Study|Withdrawal by Subject|1|||
144644270|NCT01348919|521552807|FG002|Overall Study|Withdrawal by Subject|0|||
144644271|NCT01348919|521552805|FG000|Overall Study|Disease progression|0|||
144644272|NCT01348919|521552806|FG001|Overall Study|Disease progression|1|||
144644273|NCT01348919|521552807|FG002|Overall Study|Disease progression|1|||
144644274|NCT00443560|521552808|FG000|Overall Study|No intrathecal dose|58|||
144644275|NCT00443560|521552809|FG001|Overall Study|No intrathecal dose|26|||
144644276|NCT00443560|521552808|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
144644277|NCT00443560|521552809|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
144644278|NCT02082184|521552810|FG000|Overall Study|Adverse Event|1|||
144644279|NCT02082184|521552811|FG001|Overall Study|Adverse Event|0|||
144644280|NCT02082184|521552810|FG000|Overall Study|Medical diagnosis|1|||
144644281|NCT02082184|521552811|FG001|Overall Study|Medical diagnosis|2|||
144644282|NCT02082184|521552810|FG000|Overall Study|Device associated symptoms|5|||
144644283|NCT02082184|521552811|FG001|Overall Study|Device associated symptoms|0|||
144644284|NCT02082184|521552810|FG000|Overall Study|Withdrawal by Subject|3|||
144644285|NCT02082184|521552811|FG001|Overall Study|Withdrawal by Subject|2|||
144644286|NCT02082184|521552810|FG000|Overall Study|Protocol Violation|0|||
144644287|NCT02082184|521552811|FG001|Overall Study|Protocol Violation|6|||
144644288|NCT02082184|521552810|FG000|Overall Study|Lost to Follow-up|0|||
144644289|NCT02082184|521552811|FG001|Overall Study|Lost to Follow-up|2|||
144644290|NCT02082184|521552810|FG000|Overall Study|Subject non-compliance|0|||
144644291|NCT02082184|521552811|FG001|Overall Study|Subject non-compliance|1|||
144644292|NCT01978912|521552813|FG000|Overall Study|Adverse Event|0|||
144644293|NCT01978912|521552814|FG001|Overall Study|Adverse Event|1|||
144644294|NCT01978912|521552815|FG002|Overall Study|Adverse Event|0|||
144644295|NCT01978912|521552816|FG003|Overall Study|Adverse Event|0|||
144644296|NCT01978912|521552813|FG000|Overall Study|Lost to Follow-up|1|||
144644297|NCT01978912|521552814|FG001|Overall Study|Lost to Follow-up|1|||
144644298|NCT01978912|521552815|FG002|Overall Study|Lost to Follow-up|0|||
144644299|NCT01978912|521552816|FG003|Overall Study|Lost to Follow-up|1|||
144644300|NCT01978912|521552813|FG000|Overall Study|Withdrawal by Subject|1|||
144644301|NCT01978912|521552814|FG001|Overall Study|Withdrawal by Subject|0|||
144644302|NCT01978912|521552815|FG002|Overall Study|Withdrawal by Subject|2|||
144644303|NCT01978912|521552816|FG003|Overall Study|Withdrawal by Subject|2|||
144644304|NCT01978912|521552813|FG000|Overall Study|Lumbar Surgery|1|||
144644305|NCT01978912|521552814|FG001|Overall Study|Lumbar Surgery|0|||
144644306|NCT01978912|521552815|FG002|Overall Study|Lumbar Surgery|1|||
144644307|NCT01978912|521552816|FG003|Overall Study|Lumbar Surgery|0|||
144644308|NCT01978912|521552813|FG000|Overall Study|Intradiscal Steroid Injection|0|||
144263238|NCT03066830|520163897|FG001|Overall Study|At the Participant's own Request|17|||
144263239|NCT03066830|520163896|FG000|Overall Study|Other|3|||
144263240|NCT03066830|520163897|FG001|Overall Study|Other|0|||
144263241|NCT03066830|520163896|FG000|Overall Study|Poor Compliance to Protocol|1|||
144263242|NCT03066830|520163897|FG001|Overall Study|Poor Compliance to Protocol|0|||
144263243|NCT03066830|520163896|FG000|Overall Study|Adverse Event|2|||
144263244|NCT03066830|520163897|FG001|Overall Study|Adverse Event|2|||
144263245|NCT03066830|520163896|FG000|Overall Study|Lost to Follow-up|11|||
144644309|NCT01978912|521552814|FG001|Overall Study|Intradiscal Steroid Injection|1|||
144644310|NCT01978912|521552815|FG002|Overall Study|Intradiscal Steroid Injection|0|||
144644311|NCT01978912|521552816|FG003|Overall Study|Intradiscal Steroid Injection|0|||
144644312|NCT00685178|521552819|FG000|Overall Study|Adverse Event|1|||
144644313|NCT00685178|521552820|FG001|Overall Study|Adverse Event|5|||
144644314|NCT00685178|521552821|FG002|Overall Study|Adverse Event|2|||
144644315|NCT00685178|521552822|FG003|Overall Study|Adverse Event|4|||
144644316|NCT00685178|521552819|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
144644317|NCT00685178|521552820|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
144644318|NCT00685178|521552821|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
144644319|NCT00685178|521552822|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
144644320|NCT00685178|521552819|FG000|Overall Study|voluntary study discharge|4|||
144644321|NCT00685178|521552820|FG001|Overall Study|voluntary study discharge|5|||
144644322|NCT00685178|521552821|FG002|Overall Study|voluntary study discharge|1|||
144644323|NCT00685178|521552822|FG003|Overall Study|voluntary study discharge|1|||
144644324|NCT00685178|521552819|FG000|Overall Study|incarcerated|1|||
144644325|NCT00685178|521552820|FG001|Overall Study|incarcerated|3|||
144731630|NCT03627091|521873226|FG002|Overall Study|Adverse Event|2|||
144644326|NCT00685178|521552821|FG002|Overall Study|incarcerated|7|||
144731631|NCT03627091|521873224|FG000|Overall Study|Withdrawal by Subject|2|||
144211295|NCT00996892|519968075|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
144211296|NCT00996892|519968076|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
144644327|NCT00685178|521552822|FG003|Overall Study|incarcerated|0|||
144644328|NCT00685178|521552819|FG000|Overall Study|administrative (disciplinary) discharge|0|||
144644329|NCT00685178|521552820|FG001|Overall Study|administrative (disciplinary) discharge|1|||
144644330|NCT00685178|521552821|FG002|Overall Study|administrative (disciplinary) discharge|0|||
144644331|NCT00685178|521552822|FG003|Overall Study|administrative (disciplinary) discharge|2|||
144644332|NCT00685178|521552819|FG000|Overall Study|Pregnancy|0|||
144644333|NCT00685178|521552820|FG001|Overall Study|Pregnancy|0|||
144644334|NCT00685178|521552821|FG002|Overall Study|Pregnancy|0|||
144644335|NCT00685178|521552822|FG003|Overall Study|Pregnancy|1|||
144644336|NCT00077623|521552830|FG000|Overall Study|Adverse Event|1|||
144644337|NCT00077623|521552831|FG001|Overall Study|Adverse Event|0|||
144644338|NCT00077623|521552832|FG002|Overall Study|Adverse Event|1|||
144644339|NCT00077623|521552830|FG000|Overall Study|Withdrawal by Subject|2|||
144644340|NCT00077623|521552831|FG001|Overall Study|Withdrawal by Subject|10|||
144644341|NCT00077623|521552832|FG002|Overall Study|Withdrawal by Subject|1|||
144644342|NCT00077623|521552830|FG000|Overall Study|Other-Non safety reason|18|||
144644343|NCT00077623|521552831|FG001|Overall Study|Other-Non safety reason|15|||
144644344|NCT00077623|521552832|FG002|Overall Study|Other-Non safety reason|19|||
144644345|NCT00077623|521552830|FG000|Overall Study|Insufficient therapeutic response|2|||
144644346|NCT00077623|521552831|FG001|Overall Study|Insufficient therapeutic response|0|||
144644347|NCT00077623|521552832|FG002|Overall Study|Insufficient therapeutic response|0|||
144644348|NCT00077623|521552830|FG000|Overall Study|Death|12|||
144644349|NCT00077623|521552831|FG001|Overall Study|Death|18|||
144644350|NCT00077623|521552832|FG002|Overall Study|Death|11|||
144644351|NCT00077623|521552830|FG000|Overall Study|Failure to return|1|||
144644352|NCT00077623|521552831|FG001|Overall Study|Failure to return|0|||
144644353|NCT00077623|521552832|FG002|Overall Study|Failure to return|0|||
144644354|NCT01334125|521552833|FG000|Overall Study|Lost to Follow-up|3|||
144644355|NCT01334125|521552834|FG001|Overall Study|Lost to Follow-up|3|||
144644356|NCT02138110|521552838|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
144644357|NCT02138110|521552838|FG000|Overall Scaffold Implantation|Death|3|||
144644358|NCT00882713|521552840|FG000|Overall Study|Adverse Event|2|||
144644359|NCT00882713|521552840|FG000|Overall Study|Death|3|||
144644360|NCT00882713|521552840|FG000|Overall Study|Administrative reasons|4|||
144644361|NCT00882713|521552840|FG000|Overall Study|refused treatment/withdrew consent|4|||
144644362|NCT00882713|521552840|FG000|Overall Study|Blood transfusion|2|||
144644363|NCT00882713|521552840|FG000|Overall Study|Insufficient therapeutic response|3|||
144644364|NCT00882713|521552840|FG000|Overall Study|Failure to return|2|||
144644365|NCT00882713|521552840|FG000|Overall Study|Other - Reasons|2|||
144644366|NCT00401973|521552843|FG000|Overall Study|Adverse Event|2|||
144644367|NCT00401973|521552844|FG001|Overall Study|Adverse Event|8|||
144644368|NCT00401973|521552845|FG002|Overall Study|Adverse Event|4|||
144644369|NCT00401973|521552843|FG000|Overall Study|Clinical Relapse|0|||
144644370|NCT00401973|521552844|FG001|Overall Study|Clinical Relapse|1|||
144644371|NCT00401973|521552845|FG002|Overall Study|Clinical Relapse|1|||
144644372|NCT00401973|521552843|FG000|Overall Study|Lack of Efficacy|0|||
144644373|NCT00401973|521552844|FG001|Overall Study|Lack of Efficacy|0|||
144644374|NCT00401973|521552845|FG002|Overall Study|Lack of Efficacy|3|||
144644375|NCT00401973|521552843|FG000|Overall Study|Lost to Follow-up|2|||
144644376|NCT00401973|521552844|FG001|Overall Study|Lost to Follow-up|2|||
144644377|NCT00401973|521552845|FG002|Overall Study|Lost to Follow-up|2|||
144644378|NCT00401973|521552843|FG000|Overall Study|Physician Decision|2|||
144644379|NCT00401973|521552844|FG001|Overall Study|Physician Decision|0|||
144644380|NCT00401973|521552845|FG002|Overall Study|Physician Decision|1|||
144644381|NCT00401973|521552843|FG000|Overall Study|Protocol Violation|1|||
144211297|NCT00996892|519968077|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
144644382|NCT00401973|521552844|FG001|Overall Study|Protocol Violation|2|||
144644383|NCT00401973|521552845|FG002|Overall Study|Protocol Violation|3|||
144644384|NCT00401973|521552843|FG000|Overall Study|Sponsor Decision|0|||
144644385|NCT00401973|521552844|FG001|Overall Study|Sponsor Decision|1|||
144644386|NCT00401973|521552845|FG002|Overall Study|Sponsor Decision|0|||
144644387|NCT00401973|521552843|FG000|Overall Study|Withdrawal by Subject|4|||
144644388|NCT00401973|521552844|FG001|Overall Study|Withdrawal by Subject|12|||
144644389|NCT00401973|521552845|FG002|Overall Study|Withdrawal by Subject|9|||
144644390|NCT01408537|521552846|FG000|Overall Study|Withdrawal by Subject|2|||
144644391|NCT01408537|521552846|FG000|Overall Study|Protocol Violation|3|||
144644392|NCT01408537|521552846|FG000|Overall Study|Lost to Follow-up|3|||
144644393|NCT05523362|521552847|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
144644394|NCT05523362|521552847|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
144211298|NCT00996892|519968078|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144644395|NCT05523362|521552847|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
144644396|NCT05523362|521552847|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
144644397|NCT01059812|521552850|FG000|Overall Study|Adverse Event|9|||
144644398|NCT01059812|521552851|FG001|Overall Study|Adverse Event|5|||
144644399|NCT01059812|521552850|FG000|Overall Study|Lack of Efficacy|2|||
144211299|NCT00996892|519968079|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211300|NCT00996892|519968080|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211301|NCT00996892|519968081|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211302|NCT00996892|519968082|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211303|NCT00996892|519968083|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211304|NCT00996892|519968084|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211305|NCT00996892|519968085|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211306|NCT00996892|519968086|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211307|NCT00996892|519968087|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211308|NCT00996892|519968088|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211309|NCT00996892|519968089|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211310|NCT00996892|519968090|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
144211311|NCT00996892|519968071|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
144211312|NCT00996892|519968072|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
144211313|NCT00996892|519968073|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
144211314|NCT00996892|519968074|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
144211315|NCT00996892|519968075|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
144263246|NCT03066830|520163897|FG001|Overall Study|Lost to Follow-up|3|||
144644400|NCT01059812|521552851|FG001|Overall Study|Lack of Efficacy|2|||
144644401|NCT01059812|521552850|FG000|Overall Study|Protocol Violation|3|||
144644402|NCT01059812|521552851|FG001|Overall Study|Protocol Violation|1|||
144644403|NCT01059812|521552850|FG000|Overall Study|Withdrawal Criteria|9|||
144644404|NCT01059812|521552851|FG001|Overall Study|Withdrawal Criteria|4|||
144644405|NCT01059812|521552850|FG000|Overall Study|Unclassified|14|||
144644406|NCT01059812|521552851|FG001|Overall Study|Unclassified|4|||
144644407|NCT00149214|521552856|FG000|Overall Study|Adverse Event|12|||
144644408|NCT00149214|521552857|FG001|Overall Study|Adverse Event|9|||
144644409|NCT00149214|521552856|FG000|Overall Study|Withdrawal by Subject|4|||
144644410|NCT00149214|521552857|FG001|Overall Study|Withdrawal by Subject|1|||
144644411|NCT00149214|521552856|FG000|Overall Study|Physician Decision|3|||
144644412|NCT00149214|521552857|FG001|Overall Study|Physician Decision|3|||
144644413|NCT00149214|521552856|FG000|Overall Study|Sponsor Decision|0|||
144644414|NCT00149214|521552857|FG001|Overall Study|Sponsor Decision|1|||
144644415|NCT00149214|521552856|FG000|Overall Study|Progressive Disease|7|||
144644416|NCT00149214|521552857|FG001|Overall Study|Progressive Disease|3|||
144644417|NCT00756002|521552858|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
144644418|NCT00756002|521552859|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
144644419|NCT00756002|521552858|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144644420|NCT00756002|521552859|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
144644421|NCT00756002|521552858|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
144644422|NCT00756002|521552859|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
144644423|NCT00756002|521552858|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
144644424|NCT00756002|521552859|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
144644425|NCT00756002|521552858|FG000|Double-Blind Treatment Period|Other|2|||
144644426|NCT00756002|521552859|FG001|Double-Blind Treatment Period|Other|2|||
144644427|NCT00174941|521552863|FG000|Overall Study|Adverse Event|1|||
144644428|NCT00174941|521552864|FG001|Overall Study|Adverse Event|10|||
144644429|NCT00174941|521552865|FG002|Overall Study|Adverse Event|2|||
144644430|NCT00174941|521552866|FG003|Overall Study|Adverse Event|13|||
144644431|NCT00174941|521552863|FG000|Overall Study|Protocol Violation|0|||
144644432|NCT00174941|521552864|FG001|Overall Study|Protocol Violation|1|||
144644433|NCT00174941|521552865|FG002|Overall Study|Protocol Violation|0|||
144644434|NCT00174941|521552866|FG003|Overall Study|Protocol Violation|1|||
144644435|NCT00174941|521552863|FG000|Overall Study|Lost to Follow-up|0|||
144644436|NCT00174941|521552864|FG001|Overall Study|Lost to Follow-up|3|||
144644437|NCT00174941|521552865|FG002|Overall Study|Lost to Follow-up|2|||
144644438|NCT00174941|521552866|FG003|Overall Study|Lost to Follow-up|5|||
144644439|NCT00174941|521552863|FG000|Overall Study|Personal Reason(s)|0|||
144644440|NCT00174941|521552864|FG001|Overall Study|Personal Reason(s)|14|||
144644441|NCT00174941|521552865|FG002|Overall Study|Personal Reason(s)|8|||
144644442|NCT00174941|521552866|FG003|Overall Study|Personal Reason(s)|22|||
144644443|NCT00174941|521552863|FG000|Overall Study|Gout Flare|0|||
144644444|NCT00174941|521552864|FG001|Overall Study|Gout Flare|4|||
144644445|NCT00174941|521552865|FG002|Overall Study|Gout Flare|4|||
144644446|NCT00174941|521552866|FG003|Overall Study|Gout Flare|8|||
144644447|NCT00174941|521552863|FG000|Overall Study|Reason Not Specified|1|||
144644448|NCT00174941|521552864|FG001|Overall Study|Reason Not Specified|6|||
144644449|NCT00174941|521552865|FG002|Overall Study|Reason Not Specified|2|||
144644450|NCT00174941|521552866|FG003|Overall Study|Reason Not Specified|9|||
144644451|NCT04329923|521552867|FG000|Overall Study|Withdrawal by Subject|1|||
144644452|NCT04329923|521552868|FG001|Overall Study|Withdrawal by Subject|4|||
144644453|NCT04329923|521552869|FG002|Overall Study|Withdrawal by Subject|1|||
144644454|NCT04329923|521552870|FG003|Overall Study|Withdrawal by Subject|1|||
144644455|NCT04329923|521552871|FG004|Overall Study|Withdrawal by Subject|1|||
144644456|NCT04329923|521552872|FG005|Overall Study|Withdrawal by Subject|1|||
144644457|NCT04329923|521552867|FG000|Overall Study|early termination of study|0|||
144211316|NCT00996892|519968076|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
144644458|NCT04329923|521552868|FG001|Overall Study|early termination of study|0|||
144644459|NCT04329923|521552869|FG002|Overall Study|early termination of study|0|||
144644460|NCT04329923|521552870|FG003|Overall Study|early termination of study|0|||
144644461|NCT04329923|521552871|FG004|Overall Study|early termination of study|1|||
144644462|NCT04329923|521552872|FG005|Overall Study|early termination of study|2|||
144644463|NCT04329923|521552867|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
144644464|NCT04329923|521552868|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
144644465|NCT04329923|521552869|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
144644466|NCT04329923|521552870|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
144644467|NCT04329923|521552871|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
144644468|NCT04329923|521552872|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
144644469|NCT03126227|521552873|FG000|Overall Study|Adverse Event|43|||
144644470|NCT03126227|521552874|FG001|Overall Study|Adverse Event|4|||
144644471|NCT03126227|521552873|FG000|Overall Study|Death|0|||
144644472|NCT03126227|521552874|FG001|Overall Study|Death|1|||
144644473|NCT03126227|521552873|FG000|Overall Study|Lost to Follow-up|0|||
144644474|NCT03126227|521552874|FG001|Overall Study|Lost to Follow-up|1|||
144644475|NCT03126227|521552873|FG000|Overall Study|Physician Decision|2|||
144644476|NCT03126227|521552874|FG001|Overall Study|Physician Decision|0|||
144644477|NCT03126227|521552873|FG000|Overall Study|Protocol Violation|1|||
144644478|NCT03126227|521552874|FG001|Overall Study|Protocol Violation|0|||
144644479|NCT03126227|521552873|FG000|Overall Study|Withdrawal by Subject|19|||
144644480|NCT03126227|521552874|FG001|Overall Study|Withdrawal by Subject|3|||
144644481|NCT03126227|521552873|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
144644482|NCT03126227|521552874|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
144644483|NCT03126227|521552873|FG000|Overall Study|Lack of dosing compliance|2|||
144644484|NCT03126227|521552874|FG001|Overall Study|Lack of dosing compliance|0|||
144211317|NCT00996892|519968077|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
144211318|NCT00996892|519968078|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
144211319|NCT00996892|519968079|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
144211320|NCT00996892|519968080|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
144211321|NCT00996892|519968081|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
144211322|NCT00996892|519968082|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
144211323|NCT00996892|519968083|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
144211324|NCT00996892|519968084|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
144211325|NCT00996892|519968085|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
144211326|NCT00996892|519968086|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
144211327|NCT00996892|519968087|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
144211328|NCT00996892|519968088|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
144211329|NCT00996892|519968089|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
144211330|NCT00996892|519968090|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
144211331|NCT00996892|519968071|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
144211332|NCT00996892|519968072|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
144211333|NCT00996892|519968073|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
144211334|NCT00996892|519968074|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
144211335|NCT00996892|519968075|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
144211336|NCT00996892|519968076|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
144211337|NCT00996892|519968077|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
144211338|NCT00996892|519968078|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
144211339|NCT00996892|519968079|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
144211340|NCT00996892|519968080|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
144211341|NCT00996892|519968081|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
144211342|NCT00996892|519968082|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
144211343|NCT00996892|519968083|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
144644485|NCT03126227|521552873|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
144644486|NCT03126227|521552874|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
144644487|NCT03126227|521552873|FG000|Overall Study|Scheduling conflict|1|||
144644488|NCT03126227|521552874|FG001|Overall Study|Scheduling conflict|0|||
144644489|NCT01260181|521552880|FG000|Overall Study|Decision of Investigator|1|||
144211344|NCT00996892|519968084|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
144211345|NCT00996892|519968085|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
144211346|NCT00996892|519968086|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
144211347|NCT00996892|519968087|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
144211348|NCT00996892|519968088|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
144211349|NCT00996892|519968089|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
144644490|NCT01588197|521552883|FG000|Overall Study|Lack of Efficacy|0|||
144644491|NCT01588197|521552884|FG001|Overall Study|Lack of Efficacy|1|||
144644492|NCT01588197|521552883|FG000|Overall Study|No MRI|1|||
144644493|NCT01588197|521552884|FG001|Overall Study|No MRI|0|||
144644494|NCT03351244|521552885|FG000|Overall Study|Adverse Event|7|||
144644495|NCT03351244|521552886|FG001|Overall Study|Adverse Event|11|||
144644496|NCT03351244|521552887|FG002|Overall Study|Adverse Event|12|||
144644497|NCT03351244|521552885|FG000|Overall Study|Investigator's decision|0|||
144644498|NCT03351244|521552886|FG001|Overall Study|Investigator's decision|0|||
144644499|NCT03351244|521552887|FG002|Overall Study|Investigator's decision|2|||
144644500|NCT03351244|521552885|FG000|Overall Study|System error|0|||
144644501|NCT03351244|521552886|FG001|Overall Study|System error|0|||
144644502|NCT03351244|521552887|FG002|Overall Study|System error|2|||
144644503|NCT03351244|521552885|FG000|Overall Study|COVID-19 restrictions|3|||
144644504|NCT03351244|521552886|FG001|Overall Study|COVID-19 restrictions|0|||
144644505|NCT03351244|521552887|FG002|Overall Study|COVID-19 restrictions|1|||
144211350|NCT00996892|519968090|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
144211351|NCT00996892|519968071|FG000|Dose-Escalation Stage 1A|Death|0|||
144211352|NCT00996892|519968072|FG001|Dose-Escalation Stage 1A|Death|0|||
144211353|NCT00996892|519968073|FG002|Dose-Escalation Stage 1A|Death|0|||
144211354|NCT00996892|519968074|FG003|Dose-Escalation Stage 1A|Death|0|||
144211355|NCT00996892|519968075|FG004|Dose-Escalation Stage 1A|Death|0|||
144211356|NCT00996892|519968076|FG005|Dose-Escalation Stage 1A|Death|0|||
144211357|NCT00996892|519968077|FG006|Dose-Escalation Stage 1A|Death|0|||
144211358|NCT00996892|519968078|FG007|Dose-Escalation Stage 1A|Death|0|||
144211359|NCT00996892|519968079|FG008|Dose-Escalation Stage 1A|Death|0|||
144211360|NCT00996892|519968080|FG009|Dose-Escalation Stage 1A|Death|2|||
144211361|NCT00996892|519968081|FG010|Dose-Escalation Stage 1A|Death|0|||
144211362|NCT00996892|519968082|FG011|Dose-Escalation Stage 1A|Death|1|||
144211363|NCT00996892|519968083|FG012|Dose-Escalation Stage 1A|Death|1|||
144211364|NCT00996892|519968084|FG013|Dose-Escalation Stage 1A|Death|0|||
144644506|NCT03351244|521552885|FG000|Overall Study|Non-compliance|2|||
144644507|NCT03351244|521552886|FG001|Overall Study|Non-compliance|5|||
144644508|NCT03351244|521552887|FG002|Overall Study|Non-compliance|0|||
144644509|NCT03351244|521552885|FG000|Overall Study|Withdrawal by Subject|11|||
144644510|NCT03351244|521552886|FG001|Overall Study|Withdrawal by Subject|16|||
144644511|NCT03351244|521552887|FG002|Overall Study|Withdrawal by Subject|13|||
144644512|NCT03351244|521552885|FG000|Overall Study|Lost to Follow-up|2|||
144644513|NCT03351244|521552886|FG001|Overall Study|Lost to Follow-up|6|||
144644514|NCT03351244|521552887|FG002|Overall Study|Lost to Follow-up|4|||
144644515|NCT03351244|521552885|FG000|Overall Study|Protocol Violation|2|||
144644516|NCT03351244|521552886|FG001|Overall Study|Protocol Violation|2|||
144644517|NCT03351244|521552887|FG002|Overall Study|Protocol Violation|0|||
144644518|NCT01844076|521552894|FG000|Overall Study|Adverse Event|1|||
144644519|NCT01844076|521552895|FG001|Overall Study|Adverse Event|0|||
144644520|NCT01844076|521552896|FG002|Overall Study|Adverse Event|0|||
144644521|NCT01844076|521552897|FG003|Overall Study|Adverse Event|0|||
144644522|NCT01844076|521552894|FG000|Overall Study|Withdrawal by Subject|1|||
144644523|NCT01844076|521552895|FG001|Overall Study|Withdrawal by Subject|0|||
144644524|NCT01844076|521552896|FG002|Overall Study|Withdrawal by Subject|0|||
144644525|NCT01844076|521552897|FG003|Overall Study|Withdrawal by Subject|0|||
144644526|NCT00635102|521552906|FG000|Overall Study|Withdrawal by Subject|7|||
144644527|NCT00635102|521552907|FG001|Overall Study|Withdrawal by Subject|8|||
144644528|NCT00440401|521552912|FG000|Overall Study|Adverse Event|2|||
144644529|NCT00440401|521552913|FG001|Overall Study|Adverse Event|1|||
144644530|NCT00440401|521552912|FG000|Overall Study|Other|2|||
144644531|NCT00440401|521552913|FG001|Overall Study|Other|5|||
144644532|NCT01925703|521552914|FG000|Overall Study|Physician Decision|1|||
144644533|NCT01925703|521552914|FG000|Overall Study|Lost to Follow-up|2|||
144644534|NCT01925703|521552914|FG000|Overall Study|Discharge prior to full iron repletion|1|||
144644535|NCT01938625|521552915|FG000|Overall Study|Withdrawal by Subject|0|||
144644536|NCT01938625|521552916|FG001|Overall Study|Withdrawal by Subject|1|||
144644537|NCT01938625|521552915|FG000|Overall Study|Adverse Event|0|||
144644538|NCT01938625|521552916|FG001|Overall Study|Adverse Event|1|||
144644539|NCT01937312|521552917|FG000|Overall Study|Adverse Event|10|||
144644540|NCT01937312|521552918|FG001|Overall Study|Adverse Event|1|||
144644541|NCT01937312|521552917|FG000|Overall Study|Lack of Efficacy|0|||
144644542|NCT01937312|521552918|FG001|Overall Study|Lack of Efficacy|1|||
144211365|NCT00996892|519968085|FG014|Dose-Escalation Stage 1A|Death|0|||
144211366|NCT00996892|519968086|FG015|Dose-Escalation Stage 1A|Death|0|||
144211367|NCT00996892|519968087|FG016|Dose-Escalation Stage 1A|Death|0|||
144211368|NCT00996892|519968088|FG017|Dose-Escalation Stage 1A|Death|0|||
144211369|NCT00996892|519968089|FG018|Dose-Escalation Stage 1A|Death|0|||
144644543|NCT01937312|521552917|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
144644544|NCT01937312|521552918|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
144211370|NCT00996892|519968090|FG019|Dose-Escalation Stage 1A|Death|0|||
144644545|NCT00091793|521552919|FG000|Overall Study|Adverse Event|1|||
144644546|NCT00091793|521552920|FG001|Overall Study|Adverse Event|2|||
144644547|NCT00091793|521552919|FG000|Overall Study|Withdrawal by Subject|10|||
144644548|NCT00091793|521552920|FG001|Overall Study|Withdrawal by Subject|15|||
144644549|NCT00091793|521552919|FG000|Overall Study|Ineligibility determined|2|||
144644550|NCT00091793|521552920|FG001|Overall Study|Ineligibility determined|0|||
144644551|NCT00091793|521552919|FG000|Overall Study|Lost to Follow-up|7|||
144644552|NCT00091793|521552920|FG001|Overall Study|Lost to Follow-up|5|||
144644553|NCT00091793|521552919|FG000|Overall Study|Noncompliance|2|||
144644554|NCT00091793|521552920|FG001|Overall Study|Noncompliance|0|||
144211371|NCT00996892|519968071|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
144211372|NCT00996892|519968072|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
144211373|NCT00996892|519968073|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
144644555|NCT00091793|521552919|FG000|Overall Study|Other|2|||
144644556|NCT00091793|521552920|FG001|Overall Study|Other|0|||
144644557|NCT03794986|521552922|FG000|Overall Study|0 Sessions Attended|34|||
144644558|NCT03794986|521552923|FG001|Overall Study|0 Sessions Attended|37|||
144644559|NCT03794986|521552922|FG000|Overall Study|Withdrawal by Subject|4|||
144644560|NCT03794986|521552923|FG001|Overall Study|Withdrawal by Subject|6|||
144644561|NCT03794986|521552922|FG000|Overall Study|Protocol Violation|1|||
144644562|NCT03794986|521552923|FG001|Overall Study|Protocol Violation|0|||
144211374|NCT00996892|519968074|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
144211375|NCT00996892|519968075|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
144211376|NCT00996892|519968076|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
144211377|NCT00996892|519968077|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
144211378|NCT00996892|519968078|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
144211379|NCT00996892|519968079|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
144211380|NCT00996892|519968080|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
144211381|NCT00996892|519968081|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
144211382|NCT00996892|519968082|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
144211383|NCT00996892|519968083|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
144211384|NCT00996892|519968084|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
144644563|NCT05309083|521552924|FG000|Overall Study|Withdrawal by Subject|2|||
144644564|NCT00474253|521552925|FG000|Overall Study|Withdrew consent|2|||
144644565|NCT00474253|521552926|FG001|Overall Study|Withdrew consent|0|||
144644566|NCT00474253|521552925|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
144644567|NCT00474253|521552926|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
144644568|NCT00474253|521552925|FG000|Overall Study|Lost to Follow-up|1|||
144644569|NCT00474253|521552926|FG001|Overall Study|Lost to Follow-up|0|||
144644570|NCT00474253|521552925|FG000|Overall Study|Discharged prior to study completion|0|||
144211385|NCT00996892|519968085|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
144211386|NCT00996892|519968086|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
144211387|NCT00996892|519968087|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
144211388|NCT00996892|519968088|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
144211389|NCT00996892|519968089|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
144211390|NCT00996892|519968090|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
144211391|NCT00996892|519968071|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211392|NCT00996892|519968072|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211393|NCT00996892|519968073|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211394|NCT00996892|519968074|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211395|NCT00996892|519968075|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211396|NCT00996892|519968076|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211397|NCT00996892|519968077|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211398|NCT00996892|519968078|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211399|NCT00996892|519968079|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211400|NCT00996892|519968080|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
144211401|NCT00996892|519968081|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
144211402|NCT00996892|519968082|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
144211403|NCT00996892|519968083|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
144211404|NCT00996892|519968084|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211405|NCT00996892|519968085|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211406|NCT00996892|519968086|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211407|NCT00996892|519968087|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211408|NCT00996892|519968088|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211409|NCT00996892|519968089|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144211410|NCT00996892|519968090|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
144644571|NCT00474253|521552926|FG001|Overall Study|Discharged prior to study completion|1|||
144644572|NCT01165229|521552927|FG000|Overall Study|Serious Adverse Event|456|||
144644573|NCT01165229|521552928|FG001|Overall Study|Serious Adverse Event|487|||
144211411|NCT00996892|519968071|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
144211412|NCT00996892|519968072|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
144211413|NCT00996892|519968073|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
144211414|NCT00996892|519968074|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
144211415|NCT00996892|519968075|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
144211416|NCT00996892|519968076|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
144211417|NCT00996892|519968077|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
144211418|NCT00996892|519968078|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
144263247|NCT01827592|520163899|FG000|Overall Study|Adverse Event|11|||
144644574|NCT01165229|521552927|FG000|Overall Study|Non-Serious Adverse Event|47|||
144644575|NCT01165229|521552928|FG001|Overall Study|Non-Serious Adverse Event|15|||
144644576|NCT01165229|521552927|FG000|Overall Study|Protocol Violation|6|||
144644577|NCT01165229|521552928|FG001|Overall Study|Protocol Violation|8|||
144644578|NCT01165229|521552927|FG000|Overall Study|Withdrawal by Subject|387|||
144644579|NCT01165229|521552928|FG001|Overall Study|Withdrawal by Subject|396|||
144644580|NCT01165229|521552927|FG000|Overall Study|Migrated/moved from study area|51|||
144644581|NCT01165229|521552928|FG001|Overall Study|Migrated/moved from study area|46|||
144644582|NCT01165229|521552927|FG000|Overall Study|Lost to Follow-up|123|||
144644583|NCT01165229|521552928|FG001|Overall Study|Lost to Follow-up|133|||
144644584|NCT01165229|521552927|FG000|Overall Study|Suspected HZ Episode|2|||
144644585|NCT01165229|521552928|FG001|Overall Study|Suspected HZ Episode|2|||
144644586|NCT01165229|521552927|FG000|Overall Study|No reason from the subject|108|||
144644587|NCT01165229|521552928|FG001|Overall Study|No reason from the subject|102|||
144644588|NCT01165229|521552927|FG000|Overall Study|Unknown completion status|0|||
144644589|NCT01165229|521552928|FG001|Overall Study|Unknown completion status|1|||
144644590|NCT00550238|521552932|FG000|Overall Study|Adverse Event|88|||
144644591|NCT00550238|521552932|FG000|Overall Study|Death|34|||
144644592|NCT00550238|521552932|FG000|Overall Study|Disease progression|46|||
144644593|NCT00550238|521552932|FG000|Overall Study|Withdrawal by Subject|167|||
144644594|NCT00550238|521552932|FG000|Overall Study|Physician Decision|31|||
144644595|NCT00550238|521552932|FG000|Overall Study|Patient noncompliance|25|||
144644596|NCT00550238|521552932|FG000|Overall Study|Lost to Follow-up|13|||
144644597|NCT00550238|521552932|FG000|Overall Study|Sponsor decision|55|||
144644598|NCT03133481|521552933|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
144644599|NCT03133481|521552934|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
144644600|NCT01184989|521552939|FG000|Overall Study|Adverse Event|11|||
144644601|NCT01184989|521552939|FG000|Overall Study|Withdrawal by Subject|1|||
144644602|NCT01570491|521552940|FG000|Overall Study|Lost to Follow-up|3|||
144644603|NCT01570491|521552941|FG001|Overall Study|Lost to Follow-up|1|||
144644604|NCT01570491|521552940|FG000|Overall Study|treatment: not given or discontinued|2|||
144644605|NCT01570491|521552941|FG001|Overall Study|treatment: not given or discontinued|0|||
144644606|NCT05370157|521552944|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
144644607|NCT05370157|521552945|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
144644608|NCT05370157|521552944|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
144644609|NCT05370157|521552945|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
144644610|NCT01508676|521552946|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
144644611|NCT01508676|521552947|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
144644612|NCT01508676|521552946|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
144644613|NCT01508676|521552947|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
144644614|NCT01508676|521552946|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
144644615|NCT01508676|521552947|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
144644616|NCT01508676|521552946|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
144644617|NCT01508676|521552947|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
144644618|NCT01508676|521552946|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
144644619|NCT01508676|521552947|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
144644620|NCT03700892|521552948|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
144644621|NCT03700892|521552949|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
144644622|NCT03700892|521552950|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
144644623|NCT00849212|521552952|FG000|Overall Study|Lack of Efficacy|1|||
144644624|NCT00849212|521552952|FG000|Overall Study|Withdrawal by Subject|3|||
144644625|NCT00849212|521552952|FG000|Overall Study|Adverse Event|2|||
144644626|NCT00849212|521552952|FG000|Overall Study|Miscellaneous|1|||
144644627|NCT04407507|521552953|FG000|Overall Study|Withdrawal by Subject|0|||
144644628|NCT04407507|521552954|FG001|Overall Study|Withdrawal by Subject|1|||
144644629|NCT01499576|521552955|FG000|Overall Study|Physician Decision|12|||
144644630|NCT01499576|521552955|FG000|Overall Study|Withdrawal by Subject|9|||
144644631|NCT02413255|521555057|FG000|Overall Study|Voluntary Withdrawal|0|||
144644632|NCT02413255|521555058|FG001|Overall Study|Voluntary Withdrawal|0|||
144644633|NCT02413255|521555059|FG002|Overall Study|Voluntary Withdrawal|0|||
144644634|NCT02413255|521555060|FG003|Overall Study|Voluntary Withdrawal|0|||
144644635|NCT02413255|521555061|FG004|Overall Study|Voluntary Withdrawal|0|||
144644636|NCT02413255|521555062|FG005|Overall Study|Voluntary Withdrawal|0|||
144644637|NCT02413255|521555063|FG006|Overall Study|Voluntary Withdrawal|0|||
144644638|NCT02413255|521555064|FG007|Overall Study|Voluntary Withdrawal|0|||
144644639|NCT02413255|521555065|FG008|Overall Study|Voluntary Withdrawal|0|||
144644640|NCT02413255|521555066|FG009|Overall Study|Voluntary Withdrawal|0|||
144644641|NCT02413255|521555067|FG010|Overall Study|Voluntary Withdrawal|0|||
144644642|NCT02413255|521555068|FG011|Overall Study|Voluntary Withdrawal|0|||
144644643|NCT02413255|521555069|FG012|Overall Study|Voluntary Withdrawal|0|||
144644644|NCT02413255|521555070|FG013|Overall Study|Voluntary Withdrawal|0|||
144644645|NCT02413255|521555071|FG014|Overall Study|Voluntary Withdrawal|1|||
144644646|NCT02413255|521555072|FG015|Overall Study|Voluntary Withdrawal|0|||
144644647|NCT02413255|521555073|FG016|Overall Study|Voluntary Withdrawal|0|||
144644648|NCT02333331|521555074|FG000|Overall Study|Adverse Event|1|||
144644649|NCT02333331|521555075|FG001|Overall Study|Adverse Event|0|||
144644650|NCT02333331|521555076|FG002|Overall Study|Adverse Event|4|||
144644651|NCT02333331|521555077|FG003|Overall Study|Adverse Event|1|||
144644652|NCT02333331|521555074|FG000|Overall Study|Death|0|||
144644653|NCT02333331|521555075|FG001|Overall Study|Death|0|||
144644654|NCT02333331|521555076|FG002|Overall Study|Death|2|||
144644655|NCT02333331|521555077|FG003|Overall Study|Death|0|||
144644656|NCT02333331|521555074|FG000|Overall Study|Lost to Follow-up|0|||
144644657|NCT02333331|521555075|FG001|Overall Study|Lost to Follow-up|0|||
144644658|NCT02333331|521555076|FG002|Overall Study|Lost to Follow-up|1|||
144644659|NCT02333331|521555077|FG003|Overall Study|Lost to Follow-up|0|||
144644660|NCT02333331|521555074|FG000|Overall Study|Physician Decision|0|||
144644661|NCT02333331|521555075|FG001|Overall Study|Physician Decision|1|||
144644662|NCT02333331|521555076|FG002|Overall Study|Physician Decision|0|||
144644663|NCT02333331|521555077|FG003|Overall Study|Physician Decision|0|||
144644664|NCT02333331|521555074|FG000|Overall Study|Protocol Deviation|0|||
144644665|NCT02333331|521555075|FG001|Overall Study|Protocol Deviation|3|||
144644666|NCT02333331|521555076|FG002|Overall Study|Protocol Deviation|2|||
144644667|NCT02333331|521555077|FG003|Overall Study|Protocol Deviation|1|||
144644668|NCT02333331|521555074|FG000|Overall Study|Patient/Guardian Decision|1|||
144644669|NCT02333331|521555075|FG001|Overall Study|Patient/Guardian Decision|2|||
144644670|NCT02333331|521555076|FG002|Overall Study|Patient/Guardian Decision|9|||
144644671|NCT02333331|521555077|FG003|Overall Study|Patient/Guardian Decision|1|||
144644672|NCT02413398|521555078|FG000|Overall Study|Lost to Follow-up|2|||
144644673|NCT02413398|521555079|FG001|Overall Study|Lost to Follow-up|4|||
144644674|NCT02413398|521555078|FG000|Overall Study|Withdrawal by Subject|1|||
144644675|NCT02413398|521555079|FG001|Overall Study|Withdrawal by Subject|1|||
144644676|NCT02413398|521555078|FG000|Overall Study|Other Eligibility criteria|1|||
144644677|NCT02413398|521555079|FG001|Overall Study|Other Eligibility criteria|2|||
144644678|NCT01494038|521555082|FG000|Overall Study|Protocol Violation|1|||
144644679|NCT01494038|521555083|FG001|Overall Study|Protocol Violation|1|||
144644680|NCT01494038|521555082|FG000|Overall Study|Lost to Follow-up|18|||
144644681|NCT01494038|521555083|FG001|Overall Study|Lost to Follow-up|20|||
144644682|NCT01494038|521555082|FG000|Overall Study|Withdrawal by Subject|44|||
144644683|NCT01494038|521555083|FG001|Overall Study|Withdrawal by Subject|34|||
144644684|NCT01494038|521555082|FG000|Overall Study|Not able to get to clinic|21|||
144644685|NCT01494038|521555083|FG001|Overall Study|Not able to get to clinic|15|||
144644686|NCT01494038|521555082|FG000|Overall Study|Not willing to adhere to reqs|2|||
144644687|NCT01494038|521555083|FG001|Overall Study|Not willing to adhere to reqs|9|||
144644688|NCT01494038|521555082|FG000|Overall Study|Death|2|||
144644689|NCT01494038|521555083|FG001|Overall Study|Death|4|||
144644690|NCT00537940|521555086|FG000|Overall Study|Adverse Event|20|||
144644691|NCT00537940|521555087|FG001|Overall Study|Adverse Event|19|||
144644692|NCT00537940|521555086|FG000|Overall Study|Lack of Efficacy|8|||
144644693|NCT00537940|521555087|FG001|Overall Study|Lack of Efficacy|16|||
144644694|NCT00537940|521555086|FG000|Overall Study|Lost to Follow-up|23|||
144644695|NCT00537940|521555087|FG001|Overall Study|Lost to Follow-up|29|||
144644696|NCT00537940|521555086|FG000|Overall Study|Withdrawal by Subject|113|||
144644697|NCT00537940|521555087|FG001|Overall Study|Withdrawal by Subject|95|||
144644698|NCT00537940|521555086|FG000|Overall Study|Protocol Violation|6|||
144644699|NCT00537940|521555087|FG001|Overall Study|Protocol Violation|4|||
144644700|NCT00537940|521555086|FG000|Overall Study|Pregnancy|1|||
144644701|NCT00537940|521555087|FG001|Overall Study|Pregnancy|1|||
144644702|NCT00537940|521555086|FG000|Overall Study|Study terminated by sponsor|2|||
144644703|NCT00537940|521555087|FG001|Overall Study|Study terminated by sponsor|3|||
144644704|NCT00537940|521555086|FG000|Overall Study|Other|10|||
144644705|NCT00537940|521555087|FG001|Overall Study|Other|12|||
144644706|NCT04075604|521555094|FG000|Overall Study|Adverse Event|0|||
144644707|NCT04075604|521555095|FG001|Overall Study|Adverse Event|0|||
144644708|NCT04075604|521555096|FG002|Overall Study|Adverse Event|3|||
144644709|NCT04075604|521555094|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144644710|NCT04075604|521555095|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144644711|NCT04075604|521555096|FG002|Overall Study|Participant request to discontinue study treatment|1|||
144644712|NCT04075604|521555094|FG000|Overall Study|Participant withdrew consent|0|||
144644713|NCT04075604|521555095|FG001|Overall Study|Participant withdrew consent|0|||
144644714|NCT04075604|521555096|FG002|Overall Study|Participant withdrew consent|1|||
144644715|NCT04075604|521555094|FG000|Overall Study|Other reasons|1|||
144644716|NCT04075604|521555095|FG001|Overall Study|Other reasons|0|||
144644717|NCT04075604|521555096|FG002|Overall Study|Other reasons|0|||
144644718|NCT04075604|521555094|FG000|Overall Study|Disease progression|0|||
144644719|NCT04075604|521555095|FG001|Overall Study|Disease progression|1|||
144644720|NCT04075604|521555096|FG002|Overall Study|Disease progression|0|||
144644721|NCT04075604|521555094|FG000|Overall Study|Study drug toxicity|0|||
144644722|NCT04075604|521555095|FG001|Overall Study|Study drug toxicity|5|||
144644723|NCT04075604|521555096|FG002|Overall Study|Study drug toxicity|1|||
144644724|NCT02760602|521555097|FG000|Overall Study|Withdrawal by Subject|1|||
144644725|NCT02760602|521555098|FG001|Overall Study|Withdrawal by Subject|0|||
144644726|NCT02760602|521555097|FG000|Overall Study|Terminated by sponsor|12|||
144644727|NCT02760602|521555098|FG001|Overall Study|Terminated by sponsor|13|||
144644728|NCT00345605|521555103|FG000|Arm 1|Adverse Event|0|||
144644729|NCT00345605|521555104|FG001|Arm 1|Adverse Event|1|||
144644730|NCT00345605|521555103|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
144644731|NCT00345605|521555104|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
144644732|NCT05299892|521555105|FG000|Overall Study|Withdrawal by Subject|2|||
144644733|NCT03334214|521555107|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
144644734|NCT03334214|521555108|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
144644735|NCT03334214|521555107|FG000|Overall Study|Withdrawal by Subject|0|||
144644736|NCT03334214|521555108|FG001|Overall Study|Withdrawal by Subject|1|||
144644737|NCT03334214|521555107|FG000|Overall Study|Other|1|||
144644738|NCT03334214|521555108|FG001|Overall Study|Other|0|||
144644739|NCT02088034|521555110|FG000|Overall Study|Lost to Follow-up|1|||
144644740|NCT02088034|521555111|FG001|Overall Study|Lost to Follow-up|1|||
144644741|NCT02088034|521555112|FG002|Overall Study|Lost to Follow-up|0|||
144644742|NCT02088034|521555110|FG000|Overall Study|Pregnancy|2|||
144644743|NCT02088034|521555111|FG001|Overall Study|Pregnancy|1|||
144644744|NCT02088034|521555112|FG002|Overall Study|Pregnancy|2|||
144644745|NCT00308620|521555115|FG000|Overall Study|Death|1|||
144644746|NCT00308620|521555116|FG001|Overall Study|Death|1|||
144644747|NCT00308620|521555117|FG002|Overall Study|Death|0|||
144644748|NCT00308620|521555115|FG000|Overall Study|Lost to Follow-up|0|||
144644749|NCT00308620|521555116|FG001|Overall Study|Lost to Follow-up|0|||
144644750|NCT00308620|521555117|FG002|Overall Study|Lost to Follow-up|1|||
144644751|NCT01025336|521555118|FG000|Overall Study|Protocol Violation|0|||
144644752|NCT01025336|521555119|FG001|Overall Study|Protocol Violation|0|||
144644753|NCT01025336|521555120|FG002|Overall Study|Protocol Violation|0|||
144644754|NCT01025336|521555121|FG003|Overall Study|Protocol Violation|2|||
144644755|NCT01025336|521555122|FG004|Overall Study|Protocol Violation|0|||
144644756|NCT00637728|521555126|FG000|Double-blind Phase|Adverse Event|1|||
144644757|NCT00637728|521555127|FG001|Double-blind Phase|Adverse Event|0|||
144644758|NCT00637728|521555128|FG002|Double-blind Phase|Adverse Event|0|||
144644759|NCT00637728|521555126|FG000|Double-blind Phase|Non-compliance|2|||
144644760|NCT00637728|521555127|FG001|Double-blind Phase|Non-compliance|0|||
144644761|NCT00637728|521555128|FG002|Double-blind Phase|Non-compliance|0|||
144644762|NCT00637728|521555126|FG000|Double-blind Phase|Study Discontinued|1|||
144644763|NCT00637728|521555127|FG001|Double-blind Phase|Study Discontinued|1|||
144644764|NCT00637728|521555128|FG002|Double-blind Phase|Study Discontinued|0|||
144644765|NCT01050062|521555131|FG000|Overall Study|Adverse Event|75|||
144644766|NCT01050062|521555132|FG001|Overall Study|Adverse Event|22|||
144644767|NCT01050062|521555131|FG000|Overall Study|Lost to Follow-up|83|||
144644768|NCT01050062|521555132|FG001|Overall Study|Lost to Follow-up|35|||
144644769|NCT01050062|521555131|FG000|Overall Study|Lack of Efficacy|22|||
144644770|NCT01050062|521555132|FG001|Overall Study|Lack of Efficacy|35|||
144644771|NCT01050062|521555131|FG000|Overall Study|Physician Decision|74|||
144644772|NCT01050062|521555132|FG001|Overall Study|Physician Decision|9|||
144644773|NCT01050062|521555131|FG000|Overall Study|Others|17|||
144644774|NCT01050062|521555132|FG001|Overall Study|Others|11|||
144644775|NCT01873950|521555133|FG000|Period 5|Withdrawal by Subject|0|||
144644776|NCT01873950|521555134|FG001|Period 5|Withdrawal by Subject|0|||
144644777|NCT01873950|521555135|FG002|Period 5|Withdrawal by Subject|0|||
144644778|NCT01873950|521555136|FG003|Period 5|Withdrawal by Subject|1|||
144644779|NCT01873950|521555137|FG004|Period 5|Withdrawal by Subject|0|||
144644780|NCT03894540|521555138|FG000|Overall Study|Adverse Event|0|||
144644781|NCT03894540|521555139|FG001|Overall Study|Adverse Event|0|||
144644782|NCT03894540|521555140|FG002|Overall Study|Adverse Event|0|||
144644783|NCT03894540|521555141|FG003|Overall Study|Adverse Event|0|||
144644784|NCT03894540|521555142|FG004|Overall Study|Adverse Event|1|||
144644785|NCT03894540|521555143|FG005|Overall Study|Adverse Event|0|||
144644786|NCT03894540|521555138|FG000|Overall Study|Withdrawal by Subject|0|||
144644787|NCT03894540|521555139|FG001|Overall Study|Withdrawal by Subject|0|||
144644788|NCT03894540|521555140|FG002|Overall Study|Withdrawal by Subject|0|||
144211419|NCT00996892|519968079|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
144644789|NCT03894540|521555141|FG003|Overall Study|Withdrawal by Subject|0|||
144644790|NCT03894540|521555142|FG004|Overall Study|Withdrawal by Subject|1|||
144644791|NCT03894540|521555143|FG005|Overall Study|Withdrawal by Subject|0|||
144644792|NCT03894540|521555138|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
144644793|NCT03894540|521555139|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
144644794|NCT03894540|521555140|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
144644795|NCT03894540|521555141|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
144644796|NCT03894540|521555142|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
144644797|NCT03894540|521555143|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
144644798|NCT03894540|521555138|FG000|Overall Study|Progressive Disease Clinical|1|||
144644799|NCT03894540|521555139|FG001|Overall Study|Progressive Disease Clinical|1|||
144644800|NCT03894540|521555140|FG002|Overall Study|Progressive Disease Clinical|0|||
144644801|NCT03894540|521555141|FG003|Overall Study|Progressive Disease Clinical|1|||
144644802|NCT03894540|521555142|FG004|Overall Study|Progressive Disease Clinical|5|||
144644803|NCT03894540|521555143|FG005|Overall Study|Progressive Disease Clinical|1|||
144644804|NCT03894540|521555138|FG000|Overall Study|Study termination by sponsor|0|||
144644805|NCT03894540|521555139|FG001|Overall Study|Study termination by sponsor|0|||
144644806|NCT03894540|521555140|FG002|Overall Study|Study termination by sponsor|0|||
144644807|NCT03894540|521555141|FG003|Overall Study|Study termination by sponsor|0|||
144644808|NCT03894540|521555142|FG004|Overall Study|Study termination by sponsor|2|||
144644809|NCT03894540|521555143|FG005|Overall Study|Study termination by sponsor|0|||
144644810|NCT00593112|521555144|FG000|Overall Study|Scan Anxiety|3|||
144644811|NCT00593112|521555145|FG001|Overall Study|Scan Anxiety|0|||
144644812|NCT00593112|521555144|FG000|Overall Study|Abnormal Scan|1|||
144644813|NCT00593112|521555145|FG001|Overall Study|Abnormal Scan|0|||
144644814|NCT00593112|521555144|FG000|Overall Study|Unreadable Scan|1|||
144644815|NCT00593112|521555145|FG001|Overall Study|Unreadable Scan|0|||
144644816|NCT00593112|521555144|FG000|Overall Study|Withdrawal by Subject|5|||
144644817|NCT00593112|521555145|FG001|Overall Study|Withdrawal by Subject|0|||
144644818|NCT03043365|521555146|FG000|Weeks 0 to Week 8|Adverse Event|1|||
144644819|NCT03043365|521555147|FG001|Weeks 0 to Week 8|Adverse Event|3|||
144644820|NCT03043365|521555146|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
144644821|NCT03043365|521555147|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
144644822|NCT03043365|521555146|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
144644823|NCT03043365|521555147|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
144644824|NCT02723630|521555148|FG000|Intervention Period 1|Adverse Event|1|||
144644825|NCT02723630|521555149|FG001|Intervention Period 1|Adverse Event|0|||
144644826|NCT02723630|521555150|FG002|Intervention Period 1|Adverse Event|0|||
144644827|NCT02723630|521555151|FG003|Intervention Period 1|Adverse Event|0|||
144644828|NCT02723630|521555152|FG004|Intervention Period 1|Adverse Event|0|||
144644829|NCT02723630|521555153|FG005|Intervention Period 1|Adverse Event|0|||
144644830|NCT02723630|521555148|FG000|Intervention Period 3|consumption of restricted item|0|||
144644831|NCT02723630|521555149|FG001|Intervention Period 3|consumption of restricted item|1|||
144644832|NCT02723630|521555150|FG002|Intervention Period 3|consumption of restricted item|0|||
144644833|NCT02723630|521555151|FG003|Intervention Period 3|consumption of restricted item|0|||
144644834|NCT02723630|521555152|FG004|Intervention Period 3|consumption of restricted item|0|||
144644835|NCT02723630|521555153|FG005|Intervention Period 3|consumption of restricted item|0|||
144644836|NCT03455543|521555154|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
144644837|NCT03455543|521555155|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
144644838|NCT03455543|521555156|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
144644839|NCT03455543|521555154|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
144644840|NCT03455543|521555155|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
144644841|NCT03455543|521555156|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
144644842|NCT03455543|521555154|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
144644843|NCT03455543|521555155|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
144644844|NCT03455543|521555156|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
144644845|NCT03455543|521555154|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
144644846|NCT03455543|521555155|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
144644847|NCT03455543|521555156|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
144644848|NCT03455543|521555154|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
144644849|NCT03455543|521555155|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
144644850|NCT03455543|521555156|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
144644851|NCT03455543|521555154|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
144644852|NCT03455543|521555155|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
144644853|NCT03455543|521555156|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
144644854|NCT03455543|521555154|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
144644855|NCT03455543|521555155|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
144644856|NCT03455543|521555156|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
144644857|NCT03455543|521555154|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
144644858|NCT03455543|521555155|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
144644859|NCT03455543|521555156|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
144644860|NCT03455543|521555154|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
144644861|NCT03455543|521555155|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
144644862|NCT03455543|521555156|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
144644863|NCT00852930|521555157|FG000|Overall Study|Withdrawal by Subject|1|||
144644864|NCT00852930|521555158|FG001|Overall Study|Withdrawal by Subject|1|||
144644865|NCT00852930|521555159|FG002|Overall Study|Withdrawal by Subject|1|||
144644866|NCT00852930|521555157|FG000|Overall Study|Physician Decision|0|||
144644867|NCT00852930|521555158|FG001|Overall Study|Physician Decision|0|||
144644868|NCT00852930|521555159|FG002|Overall Study|Physician Decision|1|||
144644869|NCT00779038|521555160|FG000|Overall Study|Study Prematurely Terminated|13|||
144644870|NCT05372315|521555163|FG000|Overall Study|Withdrawal by Subject|1|||
144644871|NCT05372315|521555164|FG001|Overall Study|Withdrawal by Subject|0|||
144263248|NCT01827592|520163900|FG001|Overall Study|Adverse Event|9|||
144644872|NCT00537745|521555165|FG000|Overall Study|Did not meet eligibility criteria|2|||
144644873|NCT00537745|521555165|FG000|Overall Study|Withdrawal by Subject|2|||
144644874|NCT00537745|521555165|FG000|Overall Study|Subject unable to provide Interlock info|1|||
144644875|NCT01512368|521555166|FG000|Overall Study|Protocol Violation|3|||
144644876|NCT02532543|521555168|FG000|Overall Study|Lost to Follow-up|0|||
144644877|NCT02532543|521555169|FG001|Overall Study|Lost to Follow-up|0|||
144644878|NCT02532543|521555170|FG002|Overall Study|Lost to Follow-up|1|||
144644879|NCT02532543|521555171|FG003|Overall Study|Lost to Follow-up|0|||
144644880|NCT00650585|521555172|FG000|Overall Study|Lost to Follow-up|505|||
144644881|NCT00650585|521555173|FG001|Overall Study|Lost to Follow-up|482|||
144644882|NCT00650585|521555172|FG000|Overall Study|No parental consent|935|||
144644883|NCT00650585|521555173|FG001|Overall Study|No parental consent|866|||
144644884|NCT00650585|521555172|FG000|Overall Study|Excluded/ruled ineligible|357|||
144644885|NCT00650585|521555173|FG001|Overall Study|Excluded/ruled ineligible|129|||
144644886|NCT00923091|521555184|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
144644887|NCT00923091|521555185|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
144644888|NCT00923091|521555186|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
144644889|NCT00923091|521555187|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
144644890|NCT00923091|521555188|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
144644891|NCT00923091|521555189|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
144644892|NCT00923091|521555190|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
144644893|NCT00923091|521555191|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
144644894|NCT00923091|521555192|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
144644895|NCT00923091|521555193|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
144644896|NCT00923091|521555194|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
144644897|NCT00923091|521555195|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
144644898|NCT00923091|521555196|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
144644899|NCT00923091|521555184|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
144644900|NCT00923091|521555185|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
144644901|NCT00923091|521555186|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
144644902|NCT00923091|521555187|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
144644903|NCT00923091|521555188|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
144644904|NCT00923091|521555189|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
144644905|NCT00923091|521555190|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
144644906|NCT00923091|521555191|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
144644907|NCT00923091|521555192|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
144644908|NCT00923091|521555193|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
144644909|NCT00923091|521555194|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
144644910|NCT00923091|521555195|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
144644911|NCT00923091|521555196|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
144644912|NCT00923091|521555184|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
144644913|NCT00923091|521555185|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
144644914|NCT00923091|521555186|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
144644915|NCT00923091|521555187|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
144644916|NCT00923091|521555188|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
144644917|NCT00923091|521555189|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
144644918|NCT00923091|521555190|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
144644919|NCT00923091|521555191|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
144644920|NCT00923091|521555192|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
144644921|NCT00923091|521555193|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
144644922|NCT00923091|521555194|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
144644923|NCT00923091|521555195|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
144644924|NCT00923091|521555196|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
144644925|NCT00923091|521555184|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644926|NCT00923091|521555185|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644927|NCT00923091|521555186|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644928|NCT00923091|521555187|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644929|NCT00923091|521555188|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644930|NCT00923091|521555189|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
144644931|NCT00923091|521555190|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644932|NCT00923091|521555191|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644933|NCT00923091|521555192|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144211420|NCT00996892|519968080|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
144644934|NCT00923091|521555193|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144211421|NCT00996892|519968081|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
144211422|NCT00996892|519968082|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
144644935|NCT00923091|521555194|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144211423|NCT00996892|519968083|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
144644936|NCT00923091|521555195|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644937|NCT00923091|521555196|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
144644938|NCT00923091|521555184|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644939|NCT00923091|521555185|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
144644940|NCT00923091|521555186|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644941|NCT00923091|521555187|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
144644942|NCT00923091|521555188|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644943|NCT00923091|521555189|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
144644944|NCT00923091|521555190|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644945|NCT00923091|521555191|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644946|NCT00923091|521555192|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644947|NCT00923091|521555193|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644948|NCT00923091|521555194|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644949|NCT00923091|521555195|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644950|NCT00923091|521555196|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
144644951|NCT00923091|521555184|FG000|Period III (Single-Blind)|Adverse Event|5|||
144644952|NCT00923091|521555185|FG001|Period III (Single-Blind)|Adverse Event|0|||
144644953|NCT00923091|521555186|FG002|Period III (Single-Blind)|Adverse Event|0|||
144644954|NCT00923091|521555187|FG003|Period III (Single-Blind)|Adverse Event|0|||
144644955|NCT00923091|521555188|FG004|Period III (Single-Blind)|Adverse Event|0|||
144644956|NCT00923091|521555189|FG005|Period III (Single-Blind)|Adverse Event|0|||
144644957|NCT00923091|521555190|FG006|Period III (Single-Blind)|Adverse Event|0|||
144644958|NCT00923091|521555191|FG007|Period III (Single-Blind)|Adverse Event|0|||
144644959|NCT00923091|521555192|FG008|Period III (Single-Blind)|Adverse Event|0|||
144644960|NCT00923091|521555193|FG009|Period III (Single-Blind)|Adverse Event|0|||
144644961|NCT00923091|521555194|FG010|Period III (Single-Blind)|Adverse Event|0|||
144644962|NCT00923091|521555195|FG011|Period III (Single-Blind)|Adverse Event|0|||
144644963|NCT00923091|521555196|FG012|Period III (Single-Blind)|Adverse Event|0|||
144644964|NCT00923091|521555184|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
144644965|NCT00923091|521555185|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644966|NCT00923091|521555186|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644967|NCT00923091|521555187|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644968|NCT00923091|521555188|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644969|NCT00923091|521555189|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644970|NCT00923091|521555190|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644971|NCT00923091|521555191|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644972|NCT00923091|521555192|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644973|NCT00923091|521555193|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644974|NCT00923091|521555194|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644975|NCT00923091|521555195|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644976|NCT00923091|521555196|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
144644977|NCT00923091|521555184|FG000|Period III (Single-Blind)|Protocol Violation|3|||
144644978|NCT00923091|521555185|FG001|Period III (Single-Blind)|Protocol Violation|0|||
144644979|NCT00923091|521555186|FG002|Period III (Single-Blind)|Protocol Violation|0|||
144644980|NCT00923091|521555187|FG003|Period III (Single-Blind)|Protocol Violation|0|||
144644981|NCT00923091|521555188|FG004|Period III (Single-Blind)|Protocol Violation|0|||
144644982|NCT00923091|521555189|FG005|Period III (Single-Blind)|Protocol Violation|0|||
144644983|NCT00923091|521555190|FG006|Period III (Single-Blind)|Protocol Violation|0|||
144644984|NCT00923091|521555191|FG007|Period III (Single-Blind)|Protocol Violation|0|||
144644985|NCT00923091|521555192|FG008|Period III (Single-Blind)|Protocol Violation|0|||
144644986|NCT00923091|521555193|FG009|Period III (Single-Blind)|Protocol Violation|0|||
144644987|NCT00923091|521555194|FG010|Period III (Single-Blind)|Protocol Violation|0|||
144644988|NCT00923091|521555195|FG011|Period III (Single-Blind)|Protocol Violation|0|||
144644989|NCT00923091|521555196|FG012|Period III (Single-Blind)|Protocol Violation|0|||
144644990|NCT00923091|521555184|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
144644991|NCT00923091|521555185|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
144644992|NCT00923091|521555186|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
144644993|NCT00923091|521555187|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
144644994|NCT00923091|521555188|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
144644995|NCT00923091|521555189|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
144644996|NCT00923091|521555190|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
144644997|NCT00923091|521555191|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
144644998|NCT00923091|521555192|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
144644999|NCT00923091|521555193|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
144645000|NCT00923091|521555194|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
144645001|NCT00923091|521555195|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
144645002|NCT00923091|521555196|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
144645003|NCT00923091|521555184|FG000|Period IV (Double-Blind)|Adverse Event|2|||
144645004|NCT00923091|521555185|FG001|Period IV (Double-Blind)|Adverse Event|0|||
144645005|NCT00923091|521555186|FG002|Period IV (Double-Blind)|Adverse Event|0|||
144645006|NCT00923091|521555187|FG003|Period IV (Double-Blind)|Adverse Event|0|||
144645007|NCT00923091|521555188|FG004|Period IV (Double-Blind)|Adverse Event|0|||
144645008|NCT00923091|521555189|FG005|Period IV (Double-Blind)|Adverse Event|0|||
144645009|NCT00923091|521555190|FG006|Period IV (Double-Blind)|Adverse Event|0|||
144645010|NCT00923091|521555191|FG007|Period IV (Double-Blind)|Adverse Event|0|||
144645011|NCT00923091|521555192|FG008|Period IV (Double-Blind)|Adverse Event|0|||
144645012|NCT00923091|521555193|FG009|Period IV (Double-Blind)|Adverse Event|0|||
144645013|NCT00923091|521555194|FG010|Period IV (Double-Blind)|Adverse Event|0|||
144645014|NCT00923091|521555195|FG011|Period IV (Double-Blind)|Adverse Event|0|||
144645015|NCT00923091|521555196|FG012|Period IV (Double-Blind)|Adverse Event|0|||
144645016|NCT00923091|521555184|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645017|NCT00923091|521555185|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
144645018|NCT00923091|521555186|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645019|NCT00923091|521555187|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645020|NCT00923091|521555188|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645021|NCT00923091|521555189|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645022|NCT00923091|521555190|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645023|NCT00923091|521555191|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645024|NCT00923091|521555192|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645025|NCT00923091|521555193|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645026|NCT00923091|521555194|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645027|NCT00923091|521555195|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645028|NCT00923091|521555196|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
144645029|NCT00923091|521555184|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
144645030|NCT00923091|521555185|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
144645031|NCT00923091|521555186|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
144645032|NCT00923091|521555187|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
144645033|NCT00923091|521555188|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
144645034|NCT00923091|521555189|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
144645035|NCT00923091|521555190|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
144645036|NCT00923091|521555191|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
144645037|NCT00923091|521555192|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
144645038|NCT00923091|521555193|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
144645039|NCT00923091|521555194|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
144645040|NCT00923091|521555195|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
144645041|NCT00923091|521555196|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
144645042|NCT00923091|521555184|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645043|NCT00923091|521555185|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645044|NCT00923091|521555186|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645045|NCT00923091|521555187|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645046|NCT00923091|521555188|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645047|NCT00923091|521555189|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645048|NCT00923091|521555190|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645049|NCT00923091|521555191|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645050|NCT00923091|521555192|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
144645051|NCT00923091|521555193|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645052|NCT00923091|521555194|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645053|NCT00923091|521555195|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
144645054|NCT00923091|521555196|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
144645055|NCT00923091|521555184|FG000|Period V (Double -Blind)|Protocol Violation|0|||
144645056|NCT00923091|521555185|FG001|Period V (Double -Blind)|Protocol Violation|0|||
144645057|NCT00923091|521555186|FG002|Period V (Double -Blind)|Protocol Violation|0|||
144645058|NCT00923091|521555187|FG003|Period V (Double -Blind)|Protocol Violation|0|||
144645059|NCT00923091|521555188|FG004|Period V (Double -Blind)|Protocol Violation|0|||
144645060|NCT00923091|521555189|FG005|Period V (Double -Blind)|Protocol Violation|0|||
144645061|NCT00923091|521555190|FG006|Period V (Double -Blind)|Protocol Violation|0|||
144645062|NCT00923091|521555191|FG007|Period V (Double -Blind)|Protocol Violation|0|||
144645063|NCT00923091|521555192|FG008|Period V (Double -Blind)|Protocol Violation|0|||
144645064|NCT00923091|521555193|FG009|Period V (Double -Blind)|Protocol Violation|0|||
144645065|NCT00923091|521555194|FG010|Period V (Double -Blind)|Protocol Violation|0|||
144645066|NCT00923091|521555195|FG011|Period V (Double -Blind)|Protocol Violation|0|||
144645067|NCT00923091|521555196|FG012|Period V (Double -Blind)|Protocol Violation|1|||
144645068|NCT00923091|521555184|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
144645069|NCT00923091|521555185|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
144645070|NCT00923091|521555186|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
144645071|NCT00923091|521555187|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
144645072|NCT00923091|521555188|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
144645073|NCT00923091|521555189|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
144645074|NCT00923091|521555190|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
144645075|NCT00923091|521555191|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
144645076|NCT00923091|521555192|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
144645077|NCT00923091|521555193|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
144645078|NCT00923091|521555194|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
144645079|NCT00923091|521555195|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
144645080|NCT00923091|521555196|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
144645081|NCT00923091|521555184|FG000|Period VI (Open-Label)|Adverse Event|17|||
144645082|NCT00923091|521555185|FG001|Period VI (Open-Label)|Adverse Event|0|||
144645083|NCT00923091|521555186|FG002|Period VI (Open-Label)|Adverse Event|4|||
144645084|NCT00923091|521555187|FG003|Period VI (Open-Label)|Adverse Event|1|||
144645085|NCT00923091|521555188|FG004|Period VI (Open-Label)|Adverse Event|1|||
144645086|NCT00923091|521555189|FG005|Period VI (Open-Label)|Adverse Event|0|||
144645087|NCT00923091|521555190|FG006|Period VI (Open-Label)|Adverse Event|0|||
144645088|NCT00923091|521555191|FG007|Period VI (Open-Label)|Adverse Event|0|||
144645089|NCT00923091|521555192|FG008|Period VI (Open-Label)|Adverse Event|0|||
144645090|NCT00923091|521555193|FG009|Period VI (Open-Label)|Adverse Event|0|||
144645091|NCT00923091|521555194|FG010|Period VI (Open-Label)|Adverse Event|0|||
144645092|NCT00923091|521555195|FG011|Period VI (Open-Label)|Adverse Event|0|||
144645093|NCT00923091|521555196|FG012|Period VI (Open-Label)|Adverse Event|0|||
144645094|NCT00923091|521555184|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
144645095|NCT00923091|521555185|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
144645096|NCT00923091|521555186|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
144645097|NCT00923091|521555187|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645098|NCT00923091|521555188|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
144645099|NCT00923091|521555189|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645100|NCT00923091|521555190|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645101|NCT00923091|521555191|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645102|NCT00923091|521555192|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645103|NCT00923091|521555193|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645104|NCT00923091|521555194|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645105|NCT00923091|521555195|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645106|NCT00923091|521555196|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
144645107|NCT00923091|521555184|FG000|Period VI (Open-Label)|Protocol Violation|6|||
144645108|NCT00923091|521555185|FG001|Period VI (Open-Label)|Protocol Violation|1|||
144645109|NCT00923091|521555186|FG002|Period VI (Open-Label)|Protocol Violation|3|||
144645110|NCT00923091|521555187|FG003|Period VI (Open-Label)|Protocol Violation|1|||
144645111|NCT00923091|521555188|FG004|Period VI (Open-Label)|Protocol Violation|4|||
144645112|NCT00923091|521555189|FG005|Period VI (Open-Label)|Protocol Violation|0|||
144645113|NCT00923091|521555190|FG006|Period VI (Open-Label)|Protocol Violation|0|||
144645114|NCT00923091|521555191|FG007|Period VI (Open-Label)|Protocol Violation|0|||
144645115|NCT00923091|521555192|FG008|Period VI (Open-Label)|Protocol Violation|0|||
144645116|NCT00923091|521555193|FG009|Period VI (Open-Label)|Protocol Violation|0|||
144645117|NCT00923091|521555194|FG010|Period VI (Open-Label)|Protocol Violation|0|||
144645118|NCT00923091|521555195|FG011|Period VI (Open-Label)|Protocol Violation|0|||
144645119|NCT00923091|521555196|FG012|Period VI (Open-Label)|Protocol Violation|0|||
144211424|NCT00996892|519968084|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
144211425|NCT00996892|519968085|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
144211426|NCT00996892|519968086|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
144211427|NCT00996892|519968087|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
144211428|NCT00996892|519968088|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
144211429|NCT00996892|519968089|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
144645120|NCT00923091|521555184|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
144645121|NCT00923091|521555185|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
144211430|NCT00996892|519968090|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
144211431|NCT00996892|519968071|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
144211432|NCT00996892|519968072|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
144263249|NCT01827592|520163901|FG002|Overall Study|Adverse Event|2|||
144645122|NCT00923091|521555186|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
144645123|NCT00923091|521555187|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
144645124|NCT00923091|521555188|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
144645125|NCT00923091|521555189|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
144645126|NCT00923091|521555190|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
144645127|NCT00923091|521555191|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
144645128|NCT00923091|521555192|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
144645129|NCT00923091|521555193|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
144645130|NCT00923091|521555194|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
144263250|NCT01827592|520163899|FG000|Overall Study|Physician Decision|0|||
144263251|NCT01827592|520163900|FG001|Overall Study|Physician Decision|2|||
144645131|NCT00923091|521555195|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
144645132|NCT00923091|521555196|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
144645133|NCT00923091|521555184|FG000|Period VI (Open-Label)|Other Reason|0|||
144645134|NCT00923091|521555185|FG001|Period VI (Open-Label)|Other Reason|0|||
144645135|NCT00923091|521555186|FG002|Period VI (Open-Label)|Other Reason|0|||
144645136|NCT00923091|521555187|FG003|Period VI (Open-Label)|Other Reason|1|||
144645137|NCT00923091|521555188|FG004|Period VI (Open-Label)|Other Reason|1|||
144645138|NCT00923091|521555189|FG005|Period VI (Open-Label)|Other Reason|0|||
144645139|NCT00923091|521555190|FG006|Period VI (Open-Label)|Other Reason|0|||
144645140|NCT00923091|521555191|FG007|Period VI (Open-Label)|Other Reason|0|||
144645141|NCT00923091|521555192|FG008|Period VI (Open-Label)|Other Reason|0|||
144645142|NCT00923091|521555193|FG009|Period VI (Open-Label)|Other Reason|0|||
144645143|NCT00923091|521555194|FG010|Period VI (Open-Label)|Other Reason|0|||
144645144|NCT00923091|521555195|FG011|Period VI (Open-Label)|Other Reason|0|||
144645145|NCT00923091|521555196|FG012|Period VI (Open-Label)|Other Reason|0|||
144645146|NCT03443024|521555198|FG000|Overall Study|Adverse Event|2|||
144645147|NCT03443024|521555199|FG001|Overall Study|Adverse Event|4|||
144645148|NCT03443024|521555200|FG002|Overall Study|Adverse Event|3|||
144645149|NCT03443024|521555201|FG003|Overall Study|Adverse Event|1|||
144645150|NCT03443024|521555198|FG000|Overall Study|Lost to Follow-up|9|||
144645151|NCT03443024|521555199|FG001|Overall Study|Lost to Follow-up|9|||
144645152|NCT03443024|521555200|FG002|Overall Study|Lost to Follow-up|7|||
144645153|NCT03443024|521555201|FG003|Overall Study|Lost to Follow-up|5|||
144645154|NCT03443024|521555198|FG000|Overall Study|Withdrawal by Subject|8|||
144645155|NCT03443024|521555199|FG001|Overall Study|Withdrawal by Subject|15|||
144645156|NCT03443024|521555200|FG002|Overall Study|Withdrawal by Subject|9|||
144645157|NCT03443024|521555201|FG003|Overall Study|Withdrawal by Subject|23|||
144645158|NCT03443024|521555198|FG000|Overall Study|Physician Decision|1|||
144645159|NCT03443024|521555199|FG001|Overall Study|Physician Decision|2|||
144645160|NCT03443024|521555200|FG002|Overall Study|Physician Decision|0|||
144645161|NCT03443024|521555201|FG003|Overall Study|Physician Decision|1|||
144645162|NCT03443024|521555198|FG000|Overall Study|Sponsor Decision|1|||
144645163|NCT03443024|521555199|FG001|Overall Study|Sponsor Decision|1|||
144645164|NCT03443024|521555200|FG002|Overall Study|Sponsor Decision|0|||
144645165|NCT03443024|521555201|FG003|Overall Study|Sponsor Decision|0|||
144645166|NCT03443024|521555198|FG000|Overall Study|Protocol Deviation|0|||
144645167|NCT03443024|521555199|FG001|Overall Study|Protocol Deviation|0|||
144645168|NCT03443024|521555200|FG002|Overall Study|Protocol Deviation|0|||
144645169|NCT03443024|521555201|FG003|Overall Study|Protocol Deviation|2|||
144645170|NCT00624338|521555203|FG000|Overall Study|Adverse Event|14|||
144645171|NCT00624338|521555204|FG001|Overall Study|Adverse Event|14|||
144645172|NCT00624338|521555205|FG002|Overall Study|Adverse Event|18|||
144645173|NCT00624338|521555203|FG000|Overall Study|Lost to Follow-up|1|||
144645174|NCT00624338|521555204|FG001|Overall Study|Lost to Follow-up|0|||
144645175|NCT00624338|521555205|FG002|Overall Study|Lost to Follow-up|0|||
144645176|NCT00624338|521555203|FG000|Overall Study|Lack of Efficacy|11|||
144645177|NCT00624338|521555204|FG001|Overall Study|Lack of Efficacy|3|||
144645178|NCT00624338|521555205|FG002|Overall Study|Lack of Efficacy|14|||
144645179|NCT00624338|521555203|FG000|Overall Study|Protocol Violation|3|||
144645180|NCT00624338|521555204|FG001|Overall Study|Protocol Violation|3|||
144645181|NCT00624338|521555205|FG002|Overall Study|Protocol Violation|2|||
144645182|NCT00624338|521555203|FG000|Overall Study|Death|0|||
144645183|NCT00624338|521555204|FG001|Overall Study|Death|2|||
144645184|NCT00624338|521555205|FG002|Overall Study|Death|0|||
144645185|NCT00624338|521555203|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
144645186|NCT00624338|521555204|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
144645187|NCT00624338|521555205|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
144645188|NCT00624338|521555203|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
144645189|NCT00624338|521555204|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
144645190|NCT00624338|521555205|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
144645191|NCT00624338|521555203|FG000|Overall Study|Other|15|||
144645192|NCT00624338|521555204|FG001|Overall Study|Other|5|||
144645193|NCT00624338|521555205|FG002|Overall Study|Other|9|||
144645194|NCT00624338|521555203|FG000|Overall Study|Randomized but not treated|2|||
144645195|NCT00624338|521555204|FG001|Overall Study|Randomized but not treated|1|||
144645196|NCT00624338|521555205|FG002|Overall Study|Randomized but not treated|3|||
144645197|NCT05593432|521555206|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
144645198|NCT05593432|521555207|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
144645199|NCT05593432|521555208|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
144263252|NCT01827592|520163901|FG002|Overall Study|Physician Decision|1|||
144263253|NCT01827592|520163899|FG000|Overall Study|Protocol Violation|2|||
144263254|NCT01827592|520163900|FG001|Overall Study|Protocol Violation|1|||
144645200|NCT05593432|521555209|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
144645201|NCT05593432|521555206|FG000|16-Week OLE Period|Lack of Efficacy|0|||
144645202|NCT05593432|521555207|FG001|16-Week OLE Period|Lack of Efficacy|0|||
144645203|NCT05593432|521555208|FG002|16-Week OLE Period|Lack of Efficacy|0|||
144645204|NCT05593432|521555209|FG003|16-Week OLE Period|Lack of Efficacy|1|||
144645205|NCT05593432|521555206|FG000|16-Week OLE Period|Lost to Follow-up|0|||
144645206|NCT05593432|521555207|FG001|16-Week OLE Period|Lost to Follow-up|0|||
144645207|NCT05593432|521555208|FG002|16-Week OLE Period|Lost to Follow-up|1|||
144645208|NCT05593432|521555209|FG003|16-Week OLE Period|Lost to Follow-up|2|||
144645209|NCT05593432|521555206|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
144645210|NCT05593432|521555207|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
144645211|NCT05593432|521555208|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
144645212|NCT05593432|521555209|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
144645213|NCT05897853|521555210|FG000|Overall Study|Lost to Follow-up|2|||
144645214|NCT05897853|521555211|FG001|Overall Study|Lost to Follow-up|0|||
144645215|NCT05897853|521555210|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
144645216|NCT05897853|521555211|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
144645217|NCT01476787|521555215|FG000|Treatment|Progression|64|||
144645218|NCT01476787|521555216|FG001|Treatment|Progression|71|||
144645219|NCT01476787|521555215|FG000|Treatment|Toxicity|44|||
144645220|NCT01476787|521555216|FG001|Treatment|Toxicity|16|||
144645221|NCT01476787|521555215|FG000|Treatment|Death|0|||
144645222|NCT01476787|521555216|FG001|Treatment|Death|1|||
144645223|NCT01476787|521555215|FG000|Treatment|Withdrawal by Subject|3|||
144645224|NCT01476787|521555216|FG001|Treatment|Withdrawal by Subject|14|||
144645225|NCT01476787|521555215|FG000|Treatment|Major protocol violation|1|||
144645226|NCT01476787|521555216|FG001|Treatment|Major protocol violation|6|||
144645227|NCT01476787|521555215|FG000|Treatment|Other reasons|10|||
144645228|NCT01476787|521555216|FG001|Treatment|Other reasons|22|||
144645229|NCT01476787|521555215|FG000|Treatment|Concurrent illness|12|||
144645230|NCT01476787|521555216|FG001|Treatment|Concurrent illness|9|||
144645231|NCT01476787|521555215|FG000|Treatment|Insufficient response|15|||
144645232|NCT01476787|521555216|FG001|Treatment|Insufficient response|3|||
144645233|NCT01476787|521555215|FG000|Treatment|Voluntary treatment discontinuation|8|||
144645234|NCT01476787|521555216|FG001|Treatment|Voluntary treatment discontinuation|4|||
144645235|NCT02782715|521555220|FG000|Overall Study|Withdrawal by Subject|1|||
144645236|NCT04458857|521555221|FG000|Overall Study|Adverse Event|0|||
144645237|NCT04458857|521555222|FG001|Overall Study|Adverse Event|1|||
144645238|NCT04458857|521555223|FG002|Overall Study|Adverse Event|0|||
144645239|NCT04458857|521555221|FG000|Overall Study|Withdrawal by Subject|2|||
144645240|NCT04458857|521555222|FG001|Overall Study|Withdrawal by Subject|0|||
144645241|NCT04458857|521555223|FG002|Overall Study|Withdrawal by Subject|0|||
144645242|NCT04458857|521555221|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144645243|NCT04458857|521555222|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144645244|NCT04458857|521555223|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144645245|NCT04458857|521555221|FG000|Overall Study|Non-compliance with study drug|0|||
144645246|NCT04458857|521555222|FG001|Overall Study|Non-compliance with study drug|1|||
144645247|NCT04458857|521555223|FG002|Overall Study|Non-compliance with study drug|0|||
144645248|NCT04458857|521555221|FG000|Overall Study|Lost to Follow-up|4|||
144645249|NCT04458857|521555222|FG001|Overall Study|Lost to Follow-up|1|||
144645250|NCT04458857|521555223|FG002|Overall Study|Lost to Follow-up|0|||
144645251|NCT04800315|521555232|FG000|Randomization|Did not receive study treatment|1|||
144645252|NCT04800315|521555233|FG001|Randomization|Did not receive study treatment|0|||
144645253|NCT04800315|521555234|FG002|Randomization|Did not receive study treatment|0|||
144645254|NCT04800315|521555235|FG003|Randomization|Did not receive study treatment|0|||
144645255|NCT04800315|521555232|FG000|Treatment Period|Adverse Event|4|||
144645256|NCT04800315|521555233|FG001|Treatment Period|Adverse Event|2|||
144645257|NCT04800315|521555234|FG002|Treatment Period|Adverse Event|1|||
144645258|NCT04800315|521555235|FG003|Treatment Period|Adverse Event|2|||
144645259|NCT04800315|521555232|FG000|Treatment Period|Lack of Efficacy|1|||
144645260|NCT04800315|521555233|FG001|Treatment Period|Lack of Efficacy|0|||
144645261|NCT04800315|521555234|FG002|Treatment Period|Lack of Efficacy|0|||
144645262|NCT04800315|521555235|FG003|Treatment Period|Lack of Efficacy|3|||
144645263|NCT04800315|521555232|FG000|Treatment Period|Lost to Follow-up|0|||
144645264|NCT04800315|521555233|FG001|Treatment Period|Lost to Follow-up|1|||
144645265|NCT04800315|521555234|FG002|Treatment Period|Lost to Follow-up|2|||
144645266|NCT04800315|521555235|FG003|Treatment Period|Lost to Follow-up|2|||
144645267|NCT04800315|521555232|FG000|Treatment Period|Withdrawal by participant|0|||
144645268|NCT04800315|521555233|FG001|Treatment Period|Withdrawal by participant|0|||
144645269|NCT04800315|521555234|FG002|Treatment Period|Withdrawal by participant|0|||
144645270|NCT04800315|521555235|FG003|Treatment Period|Withdrawal by participant|4|||
144645271|NCT04800315|521555232|FG000|Treatment Period|Other Reasons|0|||
144645272|NCT04800315|521555233|FG001|Treatment Period|Other Reasons|2|||
144645273|NCT04800315|521555234|FG002|Treatment Period|Other Reasons|0|||
144645274|NCT04800315|521555235|FG003|Treatment Period|Other Reasons|1|||
144645275|NCT00753922|521555236|FG000|Overall Study|Lost to Follow-up|155|||
144645276|NCT00753922|521555237|FG001|Overall Study|Lost to Follow-up|24|||
144645277|NCT00753922|521555238|FG002|Overall Study|Lost to Follow-up|28|||
144645278|NCT00753922|521555239|FG003|Overall Study|Lost to Follow-up|5|||
144645279|NCT00753922|521555236|FG000|Overall Study|Withdrawal by Subject|9|||
144645280|NCT00753922|521555237|FG001|Overall Study|Withdrawal by Subject|11|||
144645281|NCT00753922|521555238|FG002|Overall Study|Withdrawal by Subject|4|||
144645282|NCT00753922|521555239|FG003|Overall Study|Withdrawal by Subject|2|||
144645283|NCT00753922|521555236|FG000|Overall Study|Patient Non-compliance|55|||
144645284|NCT00753922|521555237|FG001|Overall Study|Patient Non-compliance|22|||
144645285|NCT00753922|521555238|FG002|Overall Study|Patient Non-compliance|14|||
144645286|NCT00753922|521555239|FG003|Overall Study|Patient Non-compliance|11|||
144645287|NCT00753922|521555236|FG000|Overall Study|Patients Not Completing Visit|11|||
144645288|NCT00753922|521555237|FG001|Overall Study|Patients Not Completing Visit|0|||
144645289|NCT00753922|521555238|FG002|Overall Study|Patients Not Completing Visit|1|||
144645290|NCT00753922|521555239|FG003|Overall Study|Patients Not Completing Visit|0|||
144645291|NCT00753922|521555236|FG000|Overall Study|Death|2|||
144645292|NCT00753922|521555237|FG001|Overall Study|Death|23|||
144645293|NCT00753922|521555238|FG002|Overall Study|Death|2|||
144645294|NCT00753922|521555239|FG003|Overall Study|Death|1|||
144645295|NCT00753922|521555236|FG000|Overall Study|Discontinuation Due to Explantation|14|||
144645296|NCT00753922|521555237|FG001|Overall Study|Discontinuation Due to Explantation|14|||
144645297|NCT00753922|521555238|FG002|Overall Study|Discontinuation Due to Explantation|14|||
144645298|NCT00753922|521555239|FG003|Overall Study|Discontinuation Due to Explantation|4|||
144645299|NCT01662999|521555240|FG000|Period 3|Withdrawal by Subject|0|||
144645300|NCT01662999|521555241|FG001|Period 3|Withdrawal by Subject|1|||
144645301|NCT01662999|521555242|FG002|Period 3|Withdrawal by Subject|0|||
144645302|NCT01662999|521555243|FG003|Period 3|Withdrawal by Subject|0|||
144645303|NCT01662999|521555244|FG004|Period 3|Withdrawal by Subject|0|||
144645304|NCT01662999|521555245|FG005|Period 3|Withdrawal by Subject|0|||
144645305|NCT01933672|521555250|FG000|Metformin Run-in Period|Adverse Event|1|||
144645306|NCT01933672|521555251|FG001|Metformin Run-in Period|Adverse Event|0|||
144645307|NCT01933672|521555252|FG002|Metformin Run-in Period|Adverse Event|0|||
144645308|NCT01933672|521555253|FG003|Metformin Run-in Period|Adverse Event|0|||
144645309|NCT01933672|521555254|FG004|Metformin Run-in Period|Adverse Event|0|||
144645310|NCT01933672|521555255|FG005|Metformin Run-in Period|Adverse Event|0|||
144645311|NCT01933672|521555256|FG006|Metformin Run-in Period|Adverse Event|0|||
144645312|NCT01933672|521555250|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
144645313|NCT01933672|521555251|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
144645314|NCT01933672|521555252|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
144645315|NCT01933672|521555253|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
144645316|NCT01933672|521555254|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
144645317|NCT01933672|521555255|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
144645318|NCT01933672|521555256|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
144645319|NCT01933672|521555250|FG000|Metformin Run-in Period|Other|5|||
144645320|NCT01933672|521555251|FG001|Metformin Run-in Period|Other|0|||
144645321|NCT01933672|521555252|FG002|Metformin Run-in Period|Other|0|||
144645322|NCT01933672|521555253|FG003|Metformin Run-in Period|Other|0|||
144645323|NCT01933672|521555254|FG004|Metformin Run-in Period|Other|0|||
144645324|NCT01933672|521555255|FG005|Metformin Run-in Period|Other|0|||
144645325|NCT01933672|521555256|FG006|Metformin Run-in Period|Other|0|||
144645326|NCT01933672|521555250|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645327|NCT01933672|521555251|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645328|NCT01933672|521555252|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645329|NCT01933672|521555253|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645330|NCT01933672|521555254|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
144645331|NCT01933672|521555255|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645332|NCT01933672|521555256|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645333|NCT01933672|521555250|FG000|First Intervention Period (12-16 Days)|Other|0|||
144645334|NCT01933672|521555251|FG001|First Intervention Period (12-16 Days)|Other|0|||
144645335|NCT01933672|521555252|FG002|First Intervention Period (12-16 Days)|Other|1|||
144645336|NCT01933672|521555253|FG003|First Intervention Period (12-16 Days)|Other|0|||
144645337|NCT01933672|521555254|FG004|First Intervention Period (12-16 Days)|Other|0|||
144645338|NCT01933672|521555255|FG005|First Intervention Period (12-16 Days)|Other|1|||
144645339|NCT01933672|521555256|FG006|First Intervention Period (12-16 Days)|Other|0|||
144645340|NCT01933672|521555250|FG000|Second Intervention Period (12-16 Days)|Other|0|||
144645341|NCT01933672|521555251|FG001|Second Intervention Period (12-16 Days)|Other|1|||
144645342|NCT01933672|521555252|FG002|Second Intervention Period (12-16 Days)|Other|1|||
144645343|NCT01933672|521555253|FG003|Second Intervention Period (12-16 Days)|Other|0|||
144645344|NCT01933672|521555254|FG004|Second Intervention Period (12-16 Days)|Other|0|||
144645345|NCT01933672|521555255|FG005|Second Intervention Period (12-16 Days)|Other|0|||
144645346|NCT01933672|521555256|FG006|Second Intervention Period (12-16 Days)|Other|0|||
144645347|NCT01933672|521555250|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645348|NCT01933672|521555251|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645349|NCT01933672|521555252|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645350|NCT01933672|521555253|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
144645351|NCT01933672|521555254|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645352|NCT01933672|521555255|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645353|NCT01933672|521555256|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
144645354|NCT01933672|521555250|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
144645355|NCT01933672|521555251|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
144645356|NCT01933672|521555252|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
144645357|NCT01933672|521555253|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
144731632|NCT03627091|521873225|FG001|Overall Study|Withdrawal by Subject|0|||
144731633|NCT03627091|521873226|FG002|Overall Study|Withdrawal by Subject|2|||
144211433|NCT00996892|519968073|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
144645358|NCT01933672|521555254|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
144645359|NCT01933672|521555255|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
144645360|NCT01933672|521555256|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
144645361|NCT02403206|521555258|FG000|Overall Study|Lost to Follow-up|4|||
144645362|NCT02403206|521555259|FG001|Overall Study|Lost to Follow-up|3|||
144645363|NCT02403206|521555258|FG000|Overall Study|Physician Decision|2|||
144645364|NCT02403206|521555259|FG001|Overall Study|Physician Decision|0|||
144645365|NCT02403206|521555258|FG000|Overall Study|Withdrawal by Subject|3|||
144645366|NCT02403206|521555259|FG001|Overall Study|Withdrawal by Subject|3|||
144645367|NCT02403206|521555258|FG000|Overall Study|Reason not given|2|||
144645368|NCT02403206|521555259|FG001|Overall Study|Reason not given|4|||
144645369|NCT01282814|521555260|FG000|First Intervention|Emesis During Dosing Interval|0|||
144645370|NCT01282814|521555261|FG001|First Intervention|Emesis During Dosing Interval|3|||
144645371|NCT01282814|521555260|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
144645372|NCT01282814|521555261|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144645373|NCT00957372|521555262|FG000|PART I|Lost to Follow-up|0|||
144645374|NCT00957372|521555263|FG001|PART I|Lost to Follow-up|0|||
144645375|NCT00957372|521555264|FG002|PART I|Lost to Follow-up|1|||
144645376|NCT00957372|521555265|FG003|PART I|Lost to Follow-up|0|||
144645377|NCT00957372|521555262|FG000|PART II|Withdrawal by Subject|0|||
144645378|NCT00957372|521555263|FG001|PART II|Withdrawal by Subject|0|||
144645379|NCT00957372|521555264|FG002|PART II|Withdrawal by Subject|0|||
144645380|NCT00957372|521555265|FG003|PART II|Withdrawal by Subject|8|||
144645381|NCT00957372|521555262|FG000|PART II|Physician Decision|0|||
144645382|NCT00957372|521555263|FG001|PART II|Physician Decision|0|||
144645383|NCT00957372|521555264|FG002|PART II|Physician Decision|0|||
144645384|NCT00957372|521555265|FG003|PART II|Physician Decision|1|||
144645385|NCT00957372|521555262|FG000|PART II|Pregnancy|0|||
144645386|NCT00957372|521555263|FG001|PART II|Pregnancy|0|||
144645387|NCT00957372|521555264|FG002|PART II|Pregnancy|0|||
144645388|NCT00957372|521555265|FG003|PART II|Pregnancy|1|||
144645389|NCT00957372|521555262|FG000|PART II|Not Know|0|||
144645390|NCT00957372|521555263|FG001|PART II|Not Know|0|||
144645391|NCT00957372|521555264|FG002|PART II|Not Know|0|||
144645392|NCT00957372|521555265|FG003|PART II|Not Know|20|||
144645393|NCT00957372|521555262|FG000|PART II|Adverse Event|0|||
144645394|NCT00957372|521555263|FG001|PART II|Adverse Event|0|||
144645395|NCT00957372|521555264|FG002|PART II|Adverse Event|0|||
144645396|NCT00957372|521555265|FG003|PART II|Adverse Event|10|||
144645397|NCT00957372|521555262|FG000|PART II|Patient non-compliance|0|||
144645398|NCT00957372|521555263|FG001|PART II|Patient non-compliance|0|||
144645399|NCT00957372|521555264|FG002|PART II|Patient non-compliance|0|||
144645400|NCT00957372|521555265|FG003|PART II|Patient non-compliance|4|||
144645401|NCT01444391|521555268|FG000|Overall Study|Death|1|||
144645402|NCT01287117|521555269|FG000|Overall Study|Adverse Event|2|||
144645403|NCT01287117|521555270|FG001|Overall Study|Adverse Event|1|||
144645404|NCT01287117|521555271|FG002|Overall Study|Adverse Event|1|||
144645405|NCT01287117|521555272|FG003|Overall Study|Adverse Event|1|||
144645406|NCT01287117|521555269|FG000|Overall Study|Lost to Follow-up|1|||
144645407|NCT01287117|521555270|FG001|Overall Study|Lost to Follow-up|1|||
144645408|NCT01287117|521555271|FG002|Overall Study|Lost to Follow-up|0|||
144645409|NCT01287117|521555272|FG003|Overall Study|Lost to Follow-up|0|||
144645410|NCT01287117|521555269|FG000|Overall Study|Physician Decision|0|||
144645411|NCT01287117|521555270|FG001|Overall Study|Physician Decision|1|||
144645412|NCT01287117|521555271|FG002|Overall Study|Physician Decision|1|||
144645413|NCT01287117|521555272|FG003|Overall Study|Physician Decision|1|||
144645414|NCT01287117|521555269|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
144645415|NCT01287117|521555270|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
144645416|NCT01287117|521555271|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
144645417|NCT01287117|521555272|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
144645418|NCT01287117|521555269|FG000|Overall Study|Disease Progression|10|||
144645419|NCT01287117|521555270|FG001|Overall Study|Disease Progression|5|||
144645420|NCT01287117|521555271|FG002|Overall Study|Disease Progression|6|||
144645421|NCT01287117|521555272|FG003|Overall Study|Disease Progression|5|||
144645422|NCT01676116|521555273|FG000|Overall Study|Withdrawal criteria|2|||
144645423|NCT01676116|521555274|FG001|Overall Study|Withdrawal criteria|14|||
144645424|NCT01676116|521555273|FG000|Overall Study|Adverse Event|1|||
144645425|NCT01676116|521555274|FG001|Overall Study|Adverse Event|2|||
144645426|NCT01676116|521555273|FG000|Overall Study|Unclassified|4|||
144645427|NCT01676116|521555274|FG001|Overall Study|Unclassified|10|||
144645428|NCT01676116|521555273|FG000|Overall Study|Protocol Violation|9|||
144645429|NCT01676116|521555274|FG001|Overall Study|Protocol Violation|3|||
144645430|NCT05635838|521556939|FG000|16-Week DBVC Period|Adverse Event|2|||
144645431|NCT05635838|521556940|FG001|16-Week DBVC Period|Adverse Event|0|||
144645432|NCT05635838|521556941|FG002|16-Week DBVC Period|Adverse Event|0|||
144645433|NCT05635838|521556942|FG003|16-Week DBVC Period|Adverse Event|0|||
144645434|NCT05635838|521556939|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
144645435|NCT05635838|521556940|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
144645436|NCT05635838|521556941|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
144731634|NCT03627091|521873224|FG000|Overall Study|Physician Decision|2|||
144645437|NCT05635838|521556942|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
144645438|NCT05635838|521556939|FG000|16-Week DBVC Period|Physician Decision|0|||
144645439|NCT05635838|521556940|FG001|16-Week DBVC Period|Physician Decision|1|||
144645440|NCT05635838|521556941|FG002|16-Week DBVC Period|Physician Decision|0|||
144645441|NCT05635838|521556942|FG003|16-Week DBVC Period|Physician Decision|0|||
144645442|NCT05635838|521556939|FG000|16-Week DBVC Period|Protocol Violation|1|||
144645443|NCT05635838|521556940|FG001|16-Week DBVC Period|Protocol Violation|0|||
144645444|NCT05635838|521556941|FG002|16-Week DBVC Period|Protocol Violation|0|||
144645445|NCT05635838|521556942|FG003|16-Week DBVC Period|Protocol Violation|0|||
144645446|NCT05635838|521556939|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
144645447|NCT05635838|521556940|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
144645448|NCT05635838|521556941|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
144645449|NCT05635838|521556942|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
144645450|NCT05635838|521556939|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
144645451|NCT05635838|521556940|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
144645452|NCT05635838|521556941|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
144645453|NCT05635838|521556942|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
144645454|NCT05635838|521556939|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
144645455|NCT05635838|521556940|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
144645456|NCT05635838|521556941|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
144645457|NCT05635838|521556942|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
144645458|NCT05635838|521556939|FG000|16-Week OLE Period|Adverse Event|0|||
144645459|NCT05635838|521556940|FG001|16-Week OLE Period|Adverse Event|0|||
144645460|NCT05635838|521556941|FG002|16-Week OLE Period|Adverse Event|0|||
144645461|NCT05635838|521556942|FG003|16-Week OLE Period|Adverse Event|2|||
144645462|NCT05635838|521556939|FG000|16-Week OLE Period|Lost to Follow-up|0|||
144645463|NCT05635838|521556940|FG001|16-Week OLE Period|Lost to Follow-up|0|||
144645464|NCT05635838|521556941|FG002|16-Week OLE Period|Lost to Follow-up|1|||
144645465|NCT05635838|521556942|FG003|16-Week OLE Period|Lost to Follow-up|3|||
144645466|NCT05635838|521556939|FG000|16-Week OLE Period|Physician Decision|0|||
144645467|NCT05635838|521556940|FG001|16-Week OLE Period|Physician Decision|0|||
144645468|NCT05635838|521556941|FG002|16-Week OLE Period|Physician Decision|0|||
144645469|NCT05635838|521556942|FG003|16-Week OLE Period|Physician Decision|1|||
144645470|NCT05635838|521556939|FG000|16-Week OLE Period|Protocol Violation|0|||
144645471|NCT05635838|521556940|FG001|16-Week OLE Period|Protocol Violation|0|||
144645472|NCT05635838|521556941|FG002|16-Week OLE Period|Protocol Violation|1|||
144645473|NCT05635838|521556942|FG003|16-Week OLE Period|Protocol Violation|1|||
144645474|NCT05635838|521556939|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
144645475|NCT05635838|521556940|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
144645476|NCT05635838|521556941|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
144645477|NCT05635838|521556942|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
144645478|NCT05635838|521556939|FG000|16-Week OLE Period|Pregnancy|0|||
144645479|NCT05635838|521556940|FG001|16-Week OLE Period|Pregnancy|0|||
144645480|NCT05635838|521556941|FG002|16-Week OLE Period|Pregnancy|1|||
144645481|NCT05635838|521556942|FG003|16-Week OLE Period|Pregnancy|0|||
144645482|NCT02031146|521556945|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
144645483|NCT02031146|521556946|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
144645484|NCT02031146|521556947|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
144645485|NCT02031146|521556948|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
144645486|NCT02031146|521556949|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
144645487|NCT02031146|521556950|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
144645488|NCT02031146|521556951|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
144645489|NCT05165394|521556952|FG000|Overall Study|Withdrawal by Subject|5|||
144645490|NCT05165394|521556953|FG001|Overall Study|Withdrawal by Subject|1|||
144645491|NCT05165394|521556952|FG000|Overall Study|Lost to Follow-up|1|||
144645492|NCT05165394|521556953|FG001|Overall Study|Lost to Follow-up|2|||
144645493|NCT05165394|521556952|FG000|Overall Study|Other Than Specified|0|||
144645494|NCT05165394|521556953|FG001|Overall Study|Other Than Specified|1|||
144645495|NCT00001259|521556956|FG000|Study 2|Adverse Event|0|||
144645496|NCT00001259|521556957|FG001|Study 2|Adverse Event|0|||
144645497|NCT00001259|521556958|FG002|Study 2|Adverse Event|0|||
144645498|NCT00001259|521556959|FG003|Study 2|Adverse Event|0|||
144645499|NCT00001259|521556960|FG004|Study 2|Adverse Event|2|||
144645500|NCT00001259|521556961|FG005|Study 2|Adverse Event|0|||
144645501|NCT00001259|521556962|FG006|Study 2|Adverse Event|0|||
144645502|NCT03705494|521556963|FG000|Overall Study|Lost to Follow-up|2|||
144645503|NCT03705494|521556964|FG001|Overall Study|Lost to Follow-up|1|||
144645504|NCT03705494|521556963|FG000|Overall Study|Withdrawal by Subject|5|||
144645505|NCT03705494|521556964|FG001|Overall Study|Withdrawal by Subject|2|||
144645506|NCT01582282|521556965|FG000|Overall Study|Adverse Event|1|||
144645507|NCT01582282|521556966|FG001|Overall Study|Adverse Event|1|||
144645508|NCT01582282|521556967|FG002|Overall Study|Adverse Event|0|||
144645509|NCT01582282|521556965|FG000|Overall Study|Lost to Follow-up|1|||
144645510|NCT01582282|521556966|FG001|Overall Study|Lost to Follow-up|0|||
144645511|NCT01582282|521556967|FG002|Overall Study|Lost to Follow-up|0|||
144211434|NCT00996892|519968074|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
144211435|NCT00996892|519968075|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
144211436|NCT00996892|519968076|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
144211437|NCT00996892|519968077|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
144211438|NCT00996892|519968078|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
144211439|NCT00996892|519968079|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
144211440|NCT00996892|519968080|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
144211441|NCT00996892|519968081|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
144211442|NCT00996892|519968082|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
144645512|NCT01582282|521556965|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
144645513|NCT01582282|521556966|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
144645514|NCT01582282|521556967|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
144645515|NCT02629393|521556969|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
144645516|NCT02629393|521556969|FG000|Overall Study|Physician Decision|1|||
144645517|NCT03937986|521556970|FG000|Overall Study|COVID-19 Pandemic|1|||
144645518|NCT01853228|521556971|FG000|Phase 1|Lack of Efficacy|8|||
144645519|NCT01853228|521556972|FG001|Phase 1|Lack of Efficacy|0|||
144645520|NCT01853228|521556971|FG000|Phase 1|Other|1|||
144645521|NCT01853228|521556972|FG001|Phase 1|Other|0|||
144645522|NCT01853228|521556971|FG000|Phase 2|Physician Decision|0|||
144645523|NCT01853228|521556972|FG001|Phase 2|Physician Decision|1|||
144645524|NCT01853228|521556971|FG000|Phase 2|Proceed To Transplant|0|||
144645525|NCT01853228|521556972|FG001|Phase 2|Proceed To Transplant|3|||
144645526|NCT01853228|521556971|FG000|Phase 2|Lack of Efficacy|0|||
144645527|NCT01853228|521556972|FG001|Phase 2|Lack of Efficacy|4|||
144645528|NCT02839746|521556974|FG000|Overall Study|Not met selection criteria|12|||
144645529|NCT02089737|521556975|FG000|Overall Study|Survey form not completed|5|||
144645530|NCT02089737|521556975|FG000|Overall Study|Not treated|1|||
144645531|NCT01300286|521556976|FG000|Overall Study|did not get dosed|1|||
144645532|NCT02767570|521556977|FG000|Overall Study|Lost to Follow-up|3|||
144645533|NCT02767570|521556978|FG001|Overall Study|Lost to Follow-up|0|||
144645534|NCT02767570|521556977|FG000|Overall Study|COVID shutdown|2|||
144645535|NCT02767570|521556978|FG001|Overall Study|COVID shutdown|5|||
144645536|NCT02767570|521556977|FG000|Overall Study|Increased pain|2|||
144645537|NCT02767570|521556978|FG001|Overall Study|Increased pain|0|||
144645538|NCT02767570|521556977|FG000|Overall Study|Withdrawal by Subject|1|||
144645539|NCT02767570|521556978|FG001|Overall Study|Withdrawal by Subject|3|||
144645540|NCT02767570|521556977|FG000|Overall Study|Unrelated medical issue|1|||
144645541|NCT02767570|521556978|FG001|Overall Study|Unrelated medical issue|1|||
144645542|NCT02767570|521556977|FG000|Overall Study|Received intra-articular injection|0|||
144645543|NCT02767570|521556978|FG001|Overall Study|Received intra-articular injection|1|||
144645544|NCT04426630|521556979|FG000|Overall Study|Death|4|||
144645545|NCT04426630|521556979|FG000|Overall Study|Lost to Follow-up|2|||
144645546|NCT01123889|521556980|FG000|Overall Study|Lost to Follow-up|3|||
144645547|NCT01123889|521556981|FG001|Overall Study|Lost to Follow-up|1|||
144645548|NCT02786537|521556982|FG000|As Randomized|Adverse Event|0|||
144645549|NCT02786537|521556983|FG001|As Randomized|Adverse Event|11|||
144645550|NCT02786537|521556984|FG002|As Randomized|Adverse Event|0|||
144645551|NCT02786537|521556985|FG003|As Randomized|Adverse Event|4|||
144645552|NCT02786537|521556986|FG004|As Randomized|Adverse Event|6|||
144645553|NCT02786537|521556987|FG005|As Randomized|Adverse Event|2|||
144645554|NCT02786537|521556982|FG000|As Randomized|Lack of Efficacy|0|||
144645555|NCT02786537|521556983|FG001|As Randomized|Lack of Efficacy|0|||
144645556|NCT02786537|521556984|FG002|As Randomized|Lack of Efficacy|0|||
144645557|NCT02786537|521556985|FG003|As Randomized|Lack of Efficacy|1|||
144645558|NCT02786537|521556986|FG004|As Randomized|Lack of Efficacy|0|||
144645559|NCT02786537|521556987|FG005|As Randomized|Lack of Efficacy|0|||
144645560|NCT02786537|521556982|FG000|As Randomized|Withdrawal by Subject|1|||
144645561|NCT02786537|521556983|FG001|As Randomized|Withdrawal by Subject|2|||
144645562|NCT02786537|521556984|FG002|As Randomized|Withdrawal by Subject|0|||
144645563|NCT02786537|521556985|FG003|As Randomized|Withdrawal by Subject|1|||
144645564|NCT02786537|521556986|FG004|As Randomized|Withdrawal by Subject|1|||
144645565|NCT02786537|521556987|FG005|As Randomized|Withdrawal by Subject|0|||
144731635|NCT03627091|521873225|FG001|Overall Study|Physician Decision|0|||
144731636|NCT03627091|521873226|FG002|Overall Study|Physician Decision|0|||
144211443|NCT00996892|519968083|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
144211444|NCT00996892|519968084|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
144645566|NCT02786537|521556982|FG000|As Randomized|Death|0|||
144645567|NCT02786537|521556983|FG001|As Randomized|Death|2|||
144645568|NCT02786537|521556984|FG002|As Randomized|Death|0|||
144645569|NCT02786537|521556985|FG003|As Randomized|Death|3|||
144645570|NCT02786537|521556986|FG004|As Randomized|Death|1|||
144645571|NCT02786537|521556987|FG005|As Randomized|Death|0|||
144645572|NCT02786537|521556982|FG000|As Randomized|Non-compliance with study drug|1|||
144645573|NCT02786537|521556983|FG001|As Randomized|Non-compliance with study drug|11|||
144645574|NCT02786537|521556984|FG002|As Randomized|Non-compliance with study drug|0|||
144645575|NCT02786537|521556985|FG003|As Randomized|Non-compliance with study drug|1|||
144731637|NCT03627091|521873224|FG000|Overall Study|Site terminated by sponsor|0|||
144645576|NCT02786537|521556986|FG004|As Randomized|Non-compliance with study drug|0|||
144645577|NCT02786537|521556987|FG005|As Randomized|Non-compliance with study drug|1|||
144645578|NCT02786537|521556982|FG000|As Randomized|Lost to treatment follow-up|4|||
144645579|NCT02786537|521556983|FG001|As Randomized|Lost to treatment follow-up|32|||
144645580|NCT02786537|521556984|FG002|As Randomized|Lost to treatment follow-up|0|||
144645581|NCT02786537|521556985|FG003|As Randomized|Lost to treatment follow-up|24|||
144645582|NCT02786537|521556986|FG004|As Randomized|Lost to treatment follow-up|4|||
144645583|NCT02786537|521556987|FG005|As Randomized|Lost to treatment follow-up|4|||
144645584|NCT02786537|521556982|FG000|As Randomized|Incarceration|0|||
144645585|NCT02786537|521556983|FG001|As Randomized|Incarceration|1|||
144645586|NCT02786537|521556984|FG002|As Randomized|Incarceration|0|||
144645587|NCT02786537|521556985|FG003|As Randomized|Incarceration|0|||
144645588|NCT02786537|521556986|FG004|As Randomized|Incarceration|0|||
144645589|NCT02786537|521556987|FG005|As Randomized|Incarceration|0|||
144645590|NCT02786537|521556982|FG000|As Randomized|Opiate Dependency Relapse|0|||
144645591|NCT02786537|521556983|FG001|As Randomized|Opiate Dependency Relapse|1|||
144645592|NCT02786537|521556984|FG002|As Randomized|Opiate Dependency Relapse|0|||
144645593|NCT02786537|521556985|FG003|As Randomized|Opiate Dependency Relapse|0|||
144645594|NCT02786537|521556986|FG004|As Randomized|Opiate Dependency Relapse|0|||
144645595|NCT02786537|521556987|FG005|As Randomized|Opiate Dependency Relapse|0|||
144645596|NCT02786537|521556982|FG000|As Randomized|HCV drugs stolen from pt|0|||
144645597|NCT02786537|521556983|FG001|As Randomized|HCV drugs stolen from pt|1|||
144645598|NCT02786537|521556984|FG002|As Randomized|HCV drugs stolen from pt|0|||
144645599|NCT02786537|521556985|FG003|As Randomized|HCV drugs stolen from pt|0|||
144645600|NCT02786537|521556986|FG004|As Randomized|HCV drugs stolen from pt|0|||
144645601|NCT02786537|521556987|FG005|As Randomized|HCV drugs stolen from pt|0|||
144645602|NCT02786537|521556982|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
144645603|NCT02786537|521556983|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
144645604|NCT02786537|521556984|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
144645605|NCT02786537|521556985|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
144645606|NCT02786537|521556986|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
144645607|NCT02786537|521556987|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
144645608|NCT02786537|521556982|FG000|As Randomized|Subject lost insurance|0|||
144645609|NCT02786537|521556983|FG001|As Randomized|Subject lost insurance|0|||
144645610|NCT02786537|521556984|FG002|As Randomized|Subject lost insurance|0|||
144645611|NCT02786537|521556985|FG003|As Randomized|Subject lost insurance|1|||
144645612|NCT02786537|521556986|FG004|As Randomized|Subject lost insurance|0|||
144645613|NCT02786537|521556987|FG005|As Randomized|Subject lost insurance|0|||
144645614|NCT02786537|521556982|FG000|As Treated|Adverse Event|0|||
144645615|NCT02786537|521556983|FG001|As Treated|Adverse Event|11|||
144645616|NCT02786537|521556984|FG002|As Treated|Adverse Event|0|||
144645617|NCT02786537|521556985|FG003|As Treated|Adverse Event|4|||
144645618|NCT02786537|521556986|FG004|As Treated|Adverse Event|6|||
144645619|NCT02786537|521556987|FG005|As Treated|Adverse Event|2|||
144645620|NCT02786537|521556982|FG000|As Treated|Death|0|||
144645621|NCT02786537|521556983|FG001|As Treated|Death|2|||
144645622|NCT02786537|521556984|FG002|As Treated|Death|0|||
144645623|NCT02786537|521556985|FG003|As Treated|Death|3|||
144645624|NCT02786537|521556986|FG004|As Treated|Death|1|||
144645625|NCT02786537|521556987|FG005|As Treated|Death|0|||
144645626|NCT02786537|521556982|FG000|As Treated|Lack of Efficacy|0|||
144645627|NCT02786537|521556983|FG001|As Treated|Lack of Efficacy|0|||
144645628|NCT02786537|521556984|FG002|As Treated|Lack of Efficacy|0|||
144645629|NCT02786537|521556985|FG003|As Treated|Lack of Efficacy|1|||
144645630|NCT02786537|521556986|FG004|As Treated|Lack of Efficacy|0|||
144645631|NCT02786537|521556987|FG005|As Treated|Lack of Efficacy|0|||
144645632|NCT02786537|521556982|FG000|As Treated|Lost to Follow-up|4|||
144645633|NCT02786537|521556983|FG001|As Treated|Lost to Follow-up|32|||
144645634|NCT02786537|521556984|FG002|As Treated|Lost to Follow-up|0|||
144645635|NCT02786537|521556985|FG003|As Treated|Lost to Follow-up|25|||
144645636|NCT02786537|521556986|FG004|As Treated|Lost to Follow-up|4|||
144645637|NCT02786537|521556987|FG005|As Treated|Lost to Follow-up|4|||
144645638|NCT02786537|521556982|FG000|As Treated|Non-compliance with study drug|1|||
144645639|NCT02786537|521556983|FG001|As Treated|Non-compliance with study drug|11|||
144645640|NCT02786537|521556984|FG002|As Treated|Non-compliance with study drug|0|||
144645641|NCT02786537|521556985|FG003|As Treated|Non-compliance with study drug|1|||
144645642|NCT02786537|521556986|FG004|As Treated|Non-compliance with study drug|0|||
144645643|NCT02786537|521556987|FG005|As Treated|Non-compliance with study drug|1|||
144645644|NCT02786537|521556982|FG000|As Treated|Lost insurance|0|||
144645645|NCT02786537|521556983|FG001|As Treated|Lost insurance|0|||
144645646|NCT02786537|521556984|FG002|As Treated|Lost insurance|0|||
144645647|NCT02786537|521556985|FG003|As Treated|Lost insurance|1|||
144645648|NCT02786537|521556986|FG004|As Treated|Lost insurance|0|||
144645649|NCT02786537|521556987|FG005|As Treated|Lost insurance|0|||
144645650|NCT02786537|521556982|FG000|As Treated|Withdrawal by Subject|1|||
144645651|NCT02786537|521556983|FG001|As Treated|Withdrawal by Subject|2|||
144645652|NCT02786537|521556984|FG002|As Treated|Withdrawal by Subject|0|||
144645653|NCT02786537|521556985|FG003|As Treated|Withdrawal by Subject|0|||
144645654|NCT02786537|521556986|FG004|As Treated|Withdrawal by Subject|1|||
144211445|NCT00996892|519968085|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
144211446|NCT00996892|519968086|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
144211447|NCT00996892|519968087|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
144211448|NCT00996892|519968088|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
144645655|NCT02786537|521556987|FG005|As Treated|Withdrawal by Subject|0|||
144645656|NCT02786537|521556982|FG000|As Treated|Incarceration|0|||
144645657|NCT02786537|521556983|FG001|As Treated|Incarceration|1|||
144645658|NCT02786537|521556984|FG002|As Treated|Incarceration|0|||
144645659|NCT02786537|521556985|FG003|As Treated|Incarceration|0|||
144645660|NCT02786537|521556986|FG004|As Treated|Incarceration|0|||
144645661|NCT02786537|521556987|FG005|As Treated|Incarceration|0|||
144645662|NCT02786537|521556982|FG000|As Treated|Opiate dependency relapse|0|||
144645663|NCT02786537|521556983|FG001|As Treated|Opiate dependency relapse|1|||
144645664|NCT02786537|521556984|FG002|As Treated|Opiate dependency relapse|0|||
144645665|NCT02786537|521556985|FG003|As Treated|Opiate dependency relapse|0|||
144645666|NCT02786537|521556986|FG004|As Treated|Opiate dependency relapse|0|||
144645667|NCT02786537|521556987|FG005|As Treated|Opiate dependency relapse|0|||
144645668|NCT02786537|521556982|FG000|As Treated|Drugs stolen from patient|0|||
144645669|NCT02786537|521556983|FG001|As Treated|Drugs stolen from patient|1|||
144645670|NCT02786537|521556984|FG002|As Treated|Drugs stolen from patient|0|||
144645671|NCT02786537|521556985|FG003|As Treated|Drugs stolen from patient|0|||
144645672|NCT02786537|521556986|FG004|As Treated|Drugs stolen from patient|0|||
144645673|NCT02786537|521556987|FG005|As Treated|Drugs stolen from patient|0|||
144645674|NCT02786537|521556982|FG000|As Treated|Advised to stop tx after loss of meds|0|||
144645675|NCT02786537|521556983|FG001|As Treated|Advised to stop tx after loss of meds|1|||
144645676|NCT02786537|521556984|FG002|As Treated|Advised to stop tx after loss of meds|0|||
144645677|NCT02786537|521556985|FG003|As Treated|Advised to stop tx after loss of meds|0|||
144645678|NCT02786537|521556986|FG004|As Treated|Advised to stop tx after loss of meds|0|||
144645679|NCT02786537|521556987|FG005|As Treated|Advised to stop tx after loss of meds|0|||
144645680|NCT01330381|521556988|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
144645681|NCT01330381|521556989|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
144645682|NCT01330381|521556990|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
144645683|NCT01330381|521556988|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
144645684|NCT01330381|521556989|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
144645685|NCT01330381|521556990|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
144645686|NCT01330381|521556988|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
144645687|NCT01330381|521556989|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
144645688|NCT01330381|521556990|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
144645689|NCT01330381|521556988|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
144645690|NCT01330381|521556989|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
144645691|NCT01330381|521556990|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
144645692|NCT01330381|521556988|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
144645693|NCT01330381|521556989|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
144645694|NCT01330381|521556990|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
144645695|NCT01330381|521556988|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
144645696|NCT01330381|521556989|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
144645697|NCT01330381|521556990|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
144645698|NCT01330381|521556988|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
144645699|NCT01330381|521556989|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
144645700|NCT01330381|521556990|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
144645701|NCT01330381|521556988|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
144645702|NCT01330381|521556989|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
144645703|NCT01330381|521556990|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
144645704|NCT01330381|521556988|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
144645705|NCT01330381|521556989|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
144645706|NCT01330381|521556990|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
144645707|NCT01330381|521556988|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
144645708|NCT01330381|521556989|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
144645709|NCT01330381|521556990|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
144645710|NCT01272180|521556991|FG000|Overall Study|Adverse Event|0|||
144645711|NCT01272180|521556992|FG001|Overall Study|Adverse Event|0|||
144645712|NCT01272180|521556993|FG002|Overall Study|Adverse Event|1|||
144645713|NCT01272180|521556994|FG003|Overall Study|Adverse Event|0|||
144645714|NCT01272180|521556991|FG000|Overall Study|Withdrawal by Subject|2|||
144645715|NCT01272180|521556992|FG001|Overall Study|Withdrawal by Subject|6|||
144645716|NCT01272180|521556993|FG002|Overall Study|Withdrawal by Subject|3|||
144731638|NCT03627091|521873225|FG001|Overall Study|Site terminated by sponsor|1|||
144731639|NCT03627091|521873226|FG002|Overall Study|Site terminated by sponsor|0|||
144731640|NCT03627091|521873224|FG000|Overall Study|Disease relapse|7|||
144211449|NCT00996892|519968089|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
144645717|NCT01272180|521556994|FG003|Overall Study|Withdrawal by Subject|2|||
144645718|NCT01272180|521556991|FG000|Overall Study|Lost to Follow-up|15|||
144645719|NCT01272180|521556992|FG001|Overall Study|Lost to Follow-up|14|||
144645720|NCT01272180|521556993|FG002|Overall Study|Lost to Follow-up|8|||
144645721|NCT01272180|521556994|FG003|Overall Study|Lost to Follow-up|10|||
144645722|NCT01272180|521556991|FG000|Overall Study|Inappropriate enrollment|0|||
144645723|NCT01272180|521556992|FG001|Overall Study|Inappropriate enrollment|0|||
144645724|NCT01272180|521556993|FG002|Overall Study|Inappropriate enrollment|1|||
144645725|NCT01272180|521556994|FG003|Overall Study|Inappropriate enrollment|1|||
144645726|NCT01272180|521556991|FG000|Overall Study|Protocol Violation|0|||
144645727|NCT01272180|521556992|FG001|Overall Study|Protocol Violation|1|||
144645728|NCT01272180|521556993|FG002|Overall Study|Protocol Violation|0|||
144645729|NCT01272180|521556994|FG003|Overall Study|Protocol Violation|1|||
144645730|NCT03000452|521556995|FG000|Treatment Period|Death|1|||
144645731|NCT03000452|521556995|FG000|Treatment Period|Progressive Disease (PD)|14|||
144645732|NCT03000452|521556995|FG000|Treatment Period|Physician Decision|1|||
144645733|NCT03000452|521556995|FG000|Treatment Period|Miscellaneous|2|||
144645734|NCT03000452|521556995|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
144645735|NCT03000452|521556995|FG000|Follow-Up Period|Death|3|||
144645736|NCT03000452|521556995|FG000|Follow-Up Period|Withdrawal by Subject|3|||
144645737|NCT02640612|521556997|FG000|Overall Study|Adverse Event|6|||
144645738|NCT02640612|521556998|FG001|Overall Study|Adverse Event|7|||
144645739|NCT02640612|521556999|FG002|Overall Study|Adverse Event|2|||
144645740|NCT02640612|521556997|FG000|Overall Study|Death|1|||
144645741|NCT02640612|521556998|FG001|Overall Study|Death|0|||
144645742|NCT02640612|521556999|FG002|Overall Study|Death|0|||
144645743|NCT02640612|521556997|FG000|Overall Study|Withdrawal by Subject|10|||
144645744|NCT02640612|521556998|FG001|Overall Study|Withdrawal by Subject|3|||
144645745|NCT02640612|521556999|FG002|Overall Study|Withdrawal by Subject|3|||
144645746|NCT02640612|521556997|FG000|Overall Study|Lost to Follow-up|4|||
144645747|NCT02640612|521556998|FG001|Overall Study|Lost to Follow-up|1|||
144645748|NCT02640612|521556999|FG002|Overall Study|Lost to Follow-up|1|||
144645749|NCT02640612|521556997|FG000|Overall Study|Protocol Violation|0|||
144645750|NCT02640612|521556998|FG001|Overall Study|Protocol Violation|2|||
144645751|NCT02640612|521556999|FG002|Overall Study|Protocol Violation|0|||
144645752|NCT02640612|521556997|FG000|Overall Study|Lack of Efficacy|1|||
144645753|NCT02640612|521556998|FG001|Overall Study|Lack of Efficacy|1|||
144645754|NCT02640612|521556999|FG002|Overall Study|Lack of Efficacy|0|||
144645755|NCT03472534|521557001|FG000|Overall Study|Withdrawal by Subject|9|||
144645756|NCT03472534|521557001|FG000|Overall Study|Adverse Event|2|||
144645757|NCT01221233|521557004|FG000|Overall Study|Withdrawal by Subject|3|||
144645758|NCT01221233|521557005|FG001|Overall Study|Withdrawal by Subject|1|||
144263255|NCT01827592|520163901|FG002|Overall Study|Protocol Violation|0|||
144645759|NCT03865407|521557008|FG000|Overall Study|Adverse Event|1|||
144645760|NCT03865407|521557009|FG001|Overall Study|Adverse Event|0|||
144645761|NCT03865407|521557008|FG000|Overall Study|Withdrawal by Subject|1|||
144645762|NCT03865407|521557009|FG001|Overall Study|Withdrawal by Subject|0|||
144645763|NCT03865407|521557008|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
144645764|NCT03865407|521557009|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
144645765|NCT01645280|521557010|FG000|Overall Study|Death|0|||
144645766|NCT01645280|521557011|FG001|Overall Study|Death|1|||
144645767|NCT01645280|521557012|FG002|Overall Study|Death|0|||
144645768|NCT01645280|521557013|FG003|Overall Study|Death|0|||
144645769|NCT01645280|521557014|FG004|Overall Study|Death|0|||
144645770|NCT01645280|521557010|FG000|Overall Study|Withdrawal by Subject|4|||
144645771|NCT01645280|521557011|FG001|Overall Study|Withdrawal by Subject|0|||
144645772|NCT01645280|521557012|FG002|Overall Study|Withdrawal by Subject|2|||
144645773|NCT01645280|521557013|FG003|Overall Study|Withdrawal by Subject|4|||
144263256|NCT01827592|520163899|FG000|Overall Study|Lost to Follow-up|1|||
144645774|NCT01645280|521557014|FG004|Overall Study|Withdrawal by Subject|5|||
144645775|NCT01645280|521557010|FG000|Overall Study|Lost to Follow-up|0|||
144645776|NCT01645280|521557011|FG001|Overall Study|Lost to Follow-up|0|||
144645777|NCT01645280|521557012|FG002|Overall Study|Lost to Follow-up|0|||
144645778|NCT01645280|521557013|FG003|Overall Study|Lost to Follow-up|2|||
144645779|NCT01645280|521557014|FG004|Overall Study|Lost to Follow-up|1|||
144645780|NCT01645280|521557010|FG000|Overall Study|Other|1|||
144645781|NCT01645280|521557011|FG001|Overall Study|Other|1|||
144645782|NCT01645280|521557012|FG002|Overall Study|Other|2|||
144645783|NCT01645280|521557013|FG003|Overall Study|Other|0|||
144645784|NCT01645280|521557014|FG004|Overall Study|Other|0|||
144645785|NCT01645280|521557010|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
144645786|NCT01645280|521557011|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
144645787|NCT01645280|521557012|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
144645788|NCT01645280|521557013|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
144263257|NCT01827592|520163900|FG001|Overall Study|Lost to Follow-up|2|||
144263258|NCT01827592|520163901|FG002|Overall Study|Lost to Follow-up|2|||
144645789|NCT01645280|521557014|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
144645790|NCT00467649|521557015|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
144645791|NCT00467649|521557016|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
144645792|NCT00467649|521557017|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
144645793|NCT00467649|521557018|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
144645794|NCT00467649|521557019|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
144645795|NCT00467649|521557020|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
144645796|NCT00467649|521557015|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
144645797|NCT00467649|521557016|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
144645798|NCT00467649|521557017|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
144645799|NCT00467649|521557018|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
144645800|NCT00467649|521557019|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
144645801|NCT00467649|521557020|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
144645802|NCT00467649|521557015|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
144645803|NCT00467649|521557016|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
144645804|NCT00467649|521557017|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
144645805|NCT00467649|521557018|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
144645806|NCT00467649|521557019|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
144645807|NCT00467649|521557020|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
144645808|NCT00467649|521557015|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
144645809|NCT00467649|521557016|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
144645810|NCT00467649|521557017|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
144645811|NCT00467649|521557018|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
144645812|NCT00467649|521557019|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
144645813|NCT00467649|521557020|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
144645814|NCT00467649|521557015|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
144645815|NCT00467649|521557016|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
144645816|NCT00467649|521557017|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
144645817|NCT00467649|521557018|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
144645818|NCT00467649|521557019|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
144645819|NCT00467649|521557020|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
144645820|NCT00467649|521557015|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
144645821|NCT00467649|521557016|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
144645822|NCT00467649|521557017|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
144645823|NCT00467649|521557018|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
144645824|NCT00467649|521557019|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
144645825|NCT00467649|521557020|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
144645826|NCT00467649|521557015|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
144645827|NCT00467649|521557016|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
144645828|NCT00467649|521557017|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
144645829|NCT00467649|521557018|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
144645830|NCT00467649|521557019|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
144645831|NCT00467649|521557020|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
144645832|NCT01009294|521557021|FG000|Overall Study|Study discontinued by Sponsor|6|||
144645833|NCT03240081|521557022|FG000|Overall Study|Withdrawal by Subject|0|||
144645834|NCT03240081|521557023|FG001|Overall Study|Withdrawal by Subject|2|||
144645835|NCT03240081|521557022|FG000|Overall Study|Lost to Follow-up|0|||
144645836|NCT03240081|521557023|FG001|Overall Study|Lost to Follow-up|1|||
144645837|NCT00883753|521557024|FG000|Overall Study|Adverse Event|37|||
144645838|NCT00883753|521557024|FG000|Overall Study|Death|2|||
144645839|NCT00883753|521557024|FG000|Overall Study|Insufficient therapeutic response|16|||
144645840|NCT00883753|521557024|FG000|Overall Study|Lost to Follow-up|4|||
144645841|NCT00883753|521557024|FG000|Overall Study|Violation of selection criteria at entry|7|||
144645842|NCT00883753|521557024|FG000|Overall Study|Protocol Violation|2|||
144645843|NCT00883753|521557024|FG000|Overall Study|Refused treatment|4|||
144645844|NCT00883753|521557024|FG000|Overall Study|Withdrew consent|10|||
144645845|NCT00883753|521557024|FG000|Overall Study|Investigator's decision|17|||
144645846|NCT00883753|521557024|FG000|Overall Study|Administrative/Other|8|||
144645847|NCT03114969|521557025|FG000|Overall Study|Lost to Follow-up|0|||
144645848|NCT03114969|521557026|FG001|Overall Study|Lost to Follow-up|0|||
144645849|NCT03114969|521557027|FG002|Overall Study|Lost to Follow-up|3|||
144645850|NCT03114969|521557028|FG003|Overall Study|Lost to Follow-up|2|||
144645851|NCT03114969|521557029|FG004|Overall Study|Lost to Follow-up|0|||
144645852|NCT03114969|521557030|FG005|Overall Study|Lost to Follow-up|0|||
144645853|NCT03114969|521557031|FG006|Overall Study|Lost to Follow-up|0|||
144645854|NCT03114969|521557032|FG007|Overall Study|Lost to Follow-up|0|||
144645855|NCT03114969|521557033|FG008|Overall Study|Lost to Follow-up|0|||
144645856|NCT03114969|521557025|FG000|Overall Study|Adverse Event|0|||
144645857|NCT03114969|521557026|FG001|Overall Study|Adverse Event|0|||
144645858|NCT03114969|521557027|FG002|Overall Study|Adverse Event|1|||
144645859|NCT03114969|521557028|FG003|Overall Study|Adverse Event|0|||
144645860|NCT03114969|521557029|FG004|Overall Study|Adverse Event|0|||
144645861|NCT03114969|521557030|FG005|Overall Study|Adverse Event|1|||
144645862|NCT03114969|521557031|FG006|Overall Study|Adverse Event|1|||
144645863|NCT03114969|521557032|FG007|Overall Study|Adverse Event|0|||
144645864|NCT03114969|521557033|FG008|Overall Study|Adverse Event|2|||
144645865|NCT04925570|521557038|FG000|Overall Study|Protocol Violation|24|||
144645866|NCT04925570|521557039|FG001|Overall Study|Protocol Violation|30|||
144645867|NCT04925570|521557038|FG000|Overall Study|Withdrawal by Subject|0|||
144645868|NCT04925570|521557039|FG001|Overall Study|Withdrawal by Subject|2|||
144645869|NCT05121103|521557042|FG000|Overall Study|Progressive disease|2|||
144645870|NCT05121103|521557043|FG001|Overall Study|Progressive disease|1|||
144645871|NCT05121103|521557044|FG002|Overall Study|Progressive disease|6|||
144645872|NCT05121103|521557042|FG000|Overall Study|Physician Decision|2|||
144645873|NCT05121103|521557043|FG001|Overall Study|Physician Decision|1|||
144645874|NCT05121103|521557044|FG002|Overall Study|Physician Decision|0|||
144645875|NCT05121103|521557042|FG000|Overall Study|Withdrawal by Subject|0|||
144645876|NCT05121103|521557043|FG001|Overall Study|Withdrawal by Subject|1|||
144645877|NCT05121103|521557044|FG002|Overall Study|Withdrawal by Subject|0|||
144645878|NCT01926886|521557047|FG000|Overall Study|Administrative/other|1|||
144645879|NCT01926886|521557048|FG001|Overall Study|Administrative/other|0|||
144645880|NCT01926886|521557047|FG000|Overall Study|Adverse event/intercurrent illness|4|||
144645881|NCT01926886|521557048|FG001|Overall Study|Adverse event/intercurrent illness|0|||
144645882|NCT01926886|521557047|FG000|Overall Study|Disease progression/recurrence|4|||
144645883|NCT01926886|521557048|FG001|Overall Study|Disease progression/recurrence|0|||
144645884|NCT01926886|521557047|FG000|Overall Study|Withdrawal by Subject|15|||
144645885|NCT01926886|521557048|FG001|Overall Study|Withdrawal by Subject|0|||
144645886|NCT01926886|521557047|FG000|Overall Study|Failure to return|3|||
144645887|NCT01926886|521557048|FG001|Overall Study|Failure to return|0|||
144645888|NCT01926886|521557047|FG000|Overall Study|Recurrence of disease|1|||
144645889|NCT01926886|521557048|FG001|Overall Study|Recurrence of disease|0|||
144645890|NCT01926886|521557047|FG000|Overall Study|Progression of disease|2|||
144645891|NCT01926886|521557048|FG001|Overall Study|Progression of disease|0|||
144645892|NCT01926886|521557047|FG000|Overall Study|Death|1|||
144645893|NCT01926886|521557048|FG001|Overall Study|Death|0|||
144645894|NCT01926886|521557047|FG000|Overall Study|Did not cooperate|1|||
144645895|NCT01926886|521557048|FG001|Overall Study|Did not cooperate|0|||
144645896|NCT02609399|521557049|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
144645897|NCT02609399|521557050|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
144645898|NCT02609399|521557049|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
144645899|NCT02609399|521557050|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
144645900|NCT02609399|521557049|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
144645901|NCT02609399|521557050|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
144645902|NCT03368404|521557054|FG000|Overall Study|Adverse Event|2|||
144645903|NCT03368404|521557055|FG001|Overall Study|Adverse Event|1|||
144645904|NCT03368404|521557054|FG000|Overall Study|Withdrawal by Subject|1|||
144645905|NCT03368404|521557055|FG001|Overall Study|Withdrawal by Subject|1|||
144645906|NCT00995371|521557056|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
144645907|NCT00995371|521557057|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
144645908|NCT02983292|521557058|FG000|Overall Study|Participant unwell & cannot travel|2|||
144645909|NCT02983292|521557058|FG000|Overall Study|Lost to Follow-up|3|||
144645910|NCT02983292|521557058|FG000|Overall Study|Participant withdrew consent|2|||
144645911|NCT02983292|521557058|FG000|Overall Study|Revision|7|||
144645912|NCT02983292|521557058|FG000|Overall Study|Death|1|||
144645913|NCT02983292|521557058|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
144645914|NCT02983292|521557058|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
144645915|NCT02983292|521557058|FG000|Overall Study|Participant relocation|1|||
144645916|NCT01751646|521557059|FG000|Overall Study|Lost to Follow-up|5|||
144645917|NCT01751646|521557060|FG001|Overall Study|Lost to Follow-up|1|||
144645918|NCT01751646|521557059|FG000|Overall Study|Withdrawal by Subject|0|||
144645919|NCT01751646|521557060|FG001|Overall Study|Withdrawal by Subject|4|||
144645920|NCT01751646|521557059|FG000|Overall Study|Starting hormone therapy|1|||
144645921|NCT01751646|521557060|FG001|Overall Study|Starting hormone therapy|0|||
144645922|NCT01751646|521557059|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
144645923|NCT01751646|521557060|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
144645924|NCT01751646|521557059|FG000|Overall Study|Inadvertent enrollment|1|||
144645925|NCT01751646|521557060|FG001|Overall Study|Inadvertent enrollment|1|||
144645926|NCT01751646|521557059|FG000|Overall Study|Moved out of the area|1|||
144645927|NCT01751646|521557060|FG001|Overall Study|Moved out of the area|5|||
144645928|NCT01751646|521557059|FG000|Overall Study|Inability to attend required visits|0|||
144645929|NCT01751646|521557060|FG001|Overall Study|Inability to attend required visits|1|||
144645930|NCT01751646|521557059|FG000|Overall Study|Off study due to multiple obligations|0|||
144645931|NCT01751646|521557060|FG001|Overall Study|Off study due to multiple obligations|1|||
144645932|NCT01751646|521557059|FG000|Overall Study|Fails to comply with study requirements|0|||
144263259|NCT01827592|520163899|FG000|Overall Study|Withdrawal by Subject|12|||
144645933|NCT01751646|521557060|FG001|Overall Study|Fails to comply with study requirements|1|||
144645934|NCT01751646|521557059|FG000|Overall Study|Childcare issues|1|||
144645935|NCT01751646|521557060|FG001|Overall Study|Childcare issues|1|||
144645936|NCT02190591|521557061|FG000|Overall Study|Withdrawal by Subject|1|||
144645937|NCT02190591|521557062|FG001|Overall Study|Withdrawal by Subject|8|||
144645938|NCT02190591|521557061|FG000|Overall Study|Protocol Violation|1|||
144645939|NCT02190591|521557062|FG001|Overall Study|Protocol Violation|0|||
144645940|NCT02190591|521557061|FG000|Overall Study|did not use peanut ball as instructed|0|||
144645941|NCT02190591|521557062|FG001|Overall Study|did not use peanut ball as instructed|2|||
144645942|NCT02190591|521557061|FG000|Overall Study|face presentation so she was ineligible|0|||
144645943|NCT02190591|521557062|FG001|Overall Study|face presentation so she was ineligible|1|||
144645944|NCT00857246|521557063|FG000|Induction Regimen|Adverse Event|1|||
144645945|NCT00857246|521557063|FG000|Induction Regimen|disease-related complications|1|||
144645946|NCT00857246|521557063|FG000|Induction Regimen|Withdrawal by Subject|1|||
144645947|NCT00857246|521557063|FG000|Surgery (Curative)|disease progression|6|||
144645948|NCT00857246|521557063|FG000|ChemoRT|Withdrawal by Subject|1|||
144645949|NCT00857246|521557063|FG000|ChemoRT|Adverse Event|2|||
144645950|NCT01151137|521557066|FG000|Overall Study|Death|15|||
144645951|NCT01151137|521557067|FG001|Overall Study|Death|27|||
144645952|NCT01151137|521557066|FG000|Overall Study|Lost to Follow-up|1|||
144645953|NCT01151137|521557067|FG001|Overall Study|Lost to Follow-up|1|||
144645954|NCT00072189|521557068|FG000|Overall Study|Withdrawal by Subject|1|||
144645955|NCT02973815|521557069|FG000|Post Intervention|Death|1|||
144645956|NCT02973815|521557070|FG001|Post Intervention|Death|0|||
144645957|NCT02973815|521557069|FG000|Post Intervention|Lost to Follow-up|7|||
144645958|NCT02973815|521557070|FG001|Post Intervention|Lost to Follow-up|24|||
144645959|NCT02973815|521557069|FG000|Follow-up|Lost to Follow-up|2|||
144645960|NCT02973815|521557070|FG001|Follow-up|Lost to Follow-up|0|||
144645961|NCT04542291|521557071|FG000|Overall Study|Adverse Event|1|||
144645962|NCT04542291|521557071|FG000|Overall Study|Physician Decision|2|||
144645963|NCT01739595|521557075|FG000|Overall Study|Adverse Event|3|||
144645964|NCT01739595|521557076|FG001|Overall Study|Adverse Event|0|||
144645965|NCT01739595|521557077|FG002|Overall Study|Adverse Event|0|||
144645966|NCT01739595|521557075|FG000|Overall Study|Lost to Follow-up|2|||
144645967|NCT01739595|521557076|FG001|Overall Study|Lost to Follow-up|0|||
144645968|NCT01739595|521557077|FG002|Overall Study|Lost to Follow-up|0|||
144645969|NCT01739595|521557075|FG000|Overall Study|Withdrawal by Subject|2|||
144645970|NCT01739595|521557076|FG001|Overall Study|Withdrawal by Subject|1|||
144645971|NCT01739595|521557077|FG002|Overall Study|Withdrawal by Subject|2|||
144645972|NCT01739595|521557075|FG000|Overall Study|Eligibility issue|3|||
144645973|NCT01739595|521557076|FG001|Overall Study|Eligibility issue|0|||
144645974|NCT01739595|521557077|FG002|Overall Study|Eligibility issue|0|||
144645975|NCT01739595|521557075|FG000|Overall Study|Protocol Violation|1|||
144645976|NCT01739595|521557076|FG001|Overall Study|Protocol Violation|0|||
144645977|NCT01739595|521557077|FG002|Overall Study|Protocol Violation|0|||
144645978|NCT01739595|521557075|FG000|Overall Study|Lab assessment|1|||
144645979|NCT01739595|521557076|FG001|Overall Study|Lab assessment|0|||
144645980|NCT01739595|521557077|FG002|Overall Study|Lab assessment|0|||
144645981|NCT01739595|521557075|FG000|Overall Study|Drug discrepancy|1|||
144645982|NCT01739595|521557076|FG001|Overall Study|Drug discrepancy|0|||
144645983|NCT01739595|521557077|FG002|Overall Study|Drug discrepancy|0|||
144645984|NCT02704429|521557078|FG000|Part A: 24 Weeks|Adverse Event|3|||
144645985|NCT02704429|521557079|FG001|Part A: 24 Weeks|Adverse Event|0|||
144645986|NCT02704429|521557078|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
144645987|NCT02704429|521557079|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
144645988|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Adverse Event|37|||
144645989|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Adverse Event|0|||
144645990|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Adverse Event|0|||
144645991|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Adverse Event|0|||
144645992|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Death|2|||
144645993|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Death|0|||
144645994|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Death|0|||
144645995|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Death|0|||
144645996|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
144645997|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
144645998|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
144645999|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
144646000|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
144646001|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
144646002|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
144646003|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
144646004|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
144646005|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
144646006|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
144646007|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
144646008|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
144646009|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
144646010|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
144646011|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
144211450|NCT00996892|519968090|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
144211451|NCT00996892|519968071|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
144211452|NCT00996892|519968072|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
144211453|NCT00996892|519968073|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
144211454|NCT00996892|519968074|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
144211455|NCT00996892|519968075|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
144211456|NCT00996892|519968076|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
144211457|NCT00996892|519968077|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
144211458|NCT00996892|519968078|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
144211459|NCT00996892|519968079|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
144211460|NCT00996892|519968080|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
144211461|NCT00996892|519968081|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
144211462|NCT00996892|519968082|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
144211463|NCT00996892|519968083|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
144211464|NCT00996892|519968084|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
144211465|NCT00996892|519968085|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
144211466|NCT00996892|519968086|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
144211467|NCT00996892|519968087|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
144211468|NCT00996892|519968088|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
144211469|NCT00996892|519968089|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
144211470|NCT00996892|519968090|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
144211471|NCT00996892|519968071|FG000|Expansion Stage 2|Adverse Event|0|||
144211472|NCT00996892|519968072|FG001|Expansion Stage 2|Adverse Event|0|||
144211473|NCT00996892|519968073|FG002|Expansion Stage 2|Adverse Event|0|||
144211474|NCT00996892|519968074|FG003|Expansion Stage 2|Adverse Event|0|||
144211475|NCT00996892|519968075|FG004|Expansion Stage 2|Adverse Event|0|||
144211476|NCT00996892|519968076|FG005|Expansion Stage 2|Adverse Event|0|||
144211477|NCT00996892|519968077|FG006|Expansion Stage 2|Adverse Event|0|||
144211478|NCT00996892|519968078|FG007|Expansion Stage 2|Adverse Event|0|||
144211479|NCT00996892|519968079|FG008|Expansion Stage 2|Adverse Event|0|||
144211480|NCT00996892|519968080|FG009|Expansion Stage 2|Adverse Event|0|||
144211481|NCT00996892|519968081|FG010|Expansion Stage 2|Adverse Event|0|||
144211482|NCT00996892|519968082|FG011|Expansion Stage 2|Adverse Event|0|||
144211483|NCT00996892|519968083|FG012|Expansion Stage 2|Adverse Event|0|||
144211484|NCT00996892|519968084|FG013|Expansion Stage 2|Adverse Event|0|||
144211485|NCT00996892|519968085|FG014|Expansion Stage 2|Adverse Event|0|||
144211486|NCT00996892|519968086|FG015|Expansion Stage 2|Adverse Event|0|||
144211487|NCT00996892|519968087|FG016|Expansion Stage 2|Adverse Event|0|||
144211488|NCT00996892|519968088|FG017|Expansion Stage 2|Adverse Event|0|||
144211489|NCT00996892|519968089|FG018|Expansion Stage 2|Adverse Event|3|||
144211490|NCT00996892|519968090|FG019|Expansion Stage 2|Adverse Event|0|||
144646012|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Physician Decision|4|||
144646013|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Physician Decision|0|||
144646014|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Physician Decision|0|||
144646015|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Physician Decision|0|||
144646016|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Pregnancy|1|||
144646017|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Pregnancy|0|||
144646018|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Pregnancy|0|||
144646019|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Pregnancy|0|||
144646020|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
144646021|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
144646022|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
144646023|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
144646024|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
144646025|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
144646026|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
144646027|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
144646028|NCT01855789|521557093|FG000|1) Baseline up to Week 24|Other|4|||
144646029|NCT01855789|521557094|FG001|1) Baseline up to Week 24|Other|0|||
144646030|NCT01855789|521557095|FG002|1) Baseline up to Week 24|Other|0|||
144646031|NCT01855789|521557096|FG003|1) Baseline up to Week 24|Other|0|||
144646032|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
144211491|NCT00996892|519968071|FG000|Expansion Stage 2|Death|0|||
144211492|NCT00996892|519968072|FG001|Expansion Stage 2|Death|0|||
144211493|NCT00996892|519968073|FG002|Expansion Stage 2|Death|0|||
144646033|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
144646034|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
144646035|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
144211494|NCT00996892|519968074|FG003|Expansion Stage 2|Death|0|||
144211495|NCT00996892|519968075|FG004|Expansion Stage 2|Death|0|||
144211496|NCT00996892|519968076|FG005|Expansion Stage 2|Death|0|||
144211497|NCT00996892|519968077|FG006|Expansion Stage 2|Death|0|||
144211498|NCT00996892|519968078|FG007|Expansion Stage 2|Death|0|||
144211499|NCT00996892|519968079|FG008|Expansion Stage 2|Death|0|||
144211500|NCT00996892|519968080|FG009|Expansion Stage 2|Death|0|||
144211501|NCT00996892|519968081|FG010|Expansion Stage 2|Death|0|||
144211502|NCT00996892|519968082|FG011|Expansion Stage 2|Death|0|||
144211503|NCT00996892|519968083|FG012|Expansion Stage 2|Death|0|||
144211504|NCT00996892|519968084|FG013|Expansion Stage 2|Death|0|||
144211505|NCT00996892|519968085|FG014|Expansion Stage 2|Death|0|||
144211506|NCT00996892|519968086|FG015|Expansion Stage 2|Death|0|||
144211507|NCT00996892|519968087|FG016|Expansion Stage 2|Death|0|||
144211508|NCT00996892|519968088|FG017|Expansion Stage 2|Death|0|||
144211509|NCT00996892|519968089|FG018|Expansion Stage 2|Death|2|||
144211510|NCT00996892|519968090|FG019|Expansion Stage 2|Death|0|||
144211511|NCT00996892|519968071|FG000|Expansion Stage 2|Physician Decision|0|||
144211512|NCT00996892|519968072|FG001|Expansion Stage 2|Physician Decision|0|||
144211513|NCT00996892|519968073|FG002|Expansion Stage 2|Physician Decision|0|||
144211514|NCT00996892|519968074|FG003|Expansion Stage 2|Physician Decision|0|||
144211515|NCT00996892|519968075|FG004|Expansion Stage 2|Physician Decision|0|||
144211516|NCT00996892|519968076|FG005|Expansion Stage 2|Physician Decision|0|||
144211517|NCT00996892|519968077|FG006|Expansion Stage 2|Physician Decision|0|||
144211518|NCT00996892|519968078|FG007|Expansion Stage 2|Physician Decision|0|||
144211519|NCT00996892|519968079|FG008|Expansion Stage 2|Physician Decision|0|||
144211520|NCT00996892|519968080|FG009|Expansion Stage 2|Physician Decision|0|||
144211521|NCT00996892|519968081|FG010|Expansion Stage 2|Physician Decision|0|||
144211522|NCT00996892|519968082|FG011|Expansion Stage 2|Physician Decision|0|||
144211523|NCT00996892|519968083|FG012|Expansion Stage 2|Physician Decision|0|||
144211524|NCT00996892|519968084|FG013|Expansion Stage 2|Physician Decision|0|||
144211525|NCT00996892|519968085|FG014|Expansion Stage 2|Physician Decision|0|||
144211526|NCT00996892|519968086|FG015|Expansion Stage 2|Physician Decision|0|||
144211527|NCT00996892|519968087|FG016|Expansion Stage 2|Physician Decision|0|||
144211528|NCT00996892|519968088|FG017|Expansion Stage 2|Physician Decision|0|||
144211529|NCT00996892|519968089|FG018|Expansion Stage 2|Physician Decision|1|||
144211530|NCT00996892|519968090|FG019|Expansion Stage 2|Physician Decision|0|||
144211531|NCT00996892|519968071|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
144211532|NCT00996892|519968072|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
144211533|NCT00996892|519968073|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
144211534|NCT00996892|519968074|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
144211535|NCT00996892|519968075|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
144646036|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
144646037|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
144646038|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
144646039|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
144646040|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
144646041|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
144646042|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
144646043|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
144646044|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
144646045|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
144646046|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
144646047|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
144646048|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
144646049|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
144646050|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
144646051|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
144646052|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
144646053|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
144646054|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
144646055|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
144646056|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
144646057|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
144646058|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
144646059|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
144646060|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
144646061|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
144646062|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
144646063|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
144646064|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
144211536|NCT00996892|519968076|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
144211537|NCT00996892|519968077|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
144211538|NCT00996892|519968078|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
144211539|NCT00996892|519968079|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
144211540|NCT00996892|519968080|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
144211541|NCT00996892|519968081|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
144211542|NCT00996892|519968082|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
144211543|NCT00996892|519968083|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
144211544|NCT00996892|519968084|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
144646065|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
144646066|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
144646067|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
144646068|NCT01855789|521557093|FG000|2) Week 24 up to End of Study|Other|0|||
144646069|NCT01855789|521557094|FG001|2) Week 24 up to End of Study|Other|0|||
144646070|NCT01855789|521557095|FG002|2) Week 24 up to End of Study|Other|0|||
144646071|NCT01855789|521557096|FG003|2) Week 24 up to End of Study|Other|1|||
144646072|NCT04952389|521557097|FG000|Overall Study|Withdrawal by Subject|8|||
144646073|NCT04952389|521557098|FG001|Overall Study|Withdrawal by Subject|4|||
144646074|NCT00778999|521557099|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
144646075|NCT00778999|521557100|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
144646076|NCT00778999|521557099|FG000|Overall Study|Did not receive recFSH|14|||
144646077|NCT00778999|521557100|FG001|Overall Study|Did not receive recFSH|20|||
144646078|NCT00744055|521558217|FG000|Overall Study|Withdrawal by Subject|6|||
144646079|NCT00744055|521558218|FG001|Overall Study|Withdrawal by Subject|9|||
144646080|NCT00744055|521558217|FG000|Overall Study|Lack of Efficacy|0|||
144646081|NCT00744055|521558218|FG001|Overall Study|Lack of Efficacy|1|||
144646082|NCT00744055|521558217|FG000|Overall Study|Physician Decision|0|||
144646083|NCT00744055|521558218|FG001|Overall Study|Physician Decision|2|||
144646084|NCT00744055|521558217|FG000|Overall Study|Protocol Violation|1|||
144646085|NCT00744055|521558218|FG001|Overall Study|Protocol Violation|1|||
144646086|NCT00744055|521558217|FG000|Overall Study|Lost to Follow-up|0|||
144646087|NCT00744055|521558218|FG001|Overall Study|Lost to Follow-up|1|||
144646088|NCT03635190|521558219|FG000|Overall Study|Lost to Follow-up|4|||
144646089|NCT03635190|521558219|FG000|Overall Study|Death|3|||
144646090|NCT03635190|521558219|FG000|Overall Study|Withdrawal by Subject|1|||
144646091|NCT03635190|521558219|FG000|Overall Study|Patient moved and did not return for follow up|1|||
144646092|NCT03842709|521558220|FG000|Overall Study|Withdrawal by Subject|3|||
144646093|NCT03842709|521558221|FG001|Overall Study|Withdrawal by Subject|3|||
144646094|NCT03842709|521558220|FG000|Overall Study|Lost to Follow-up|1|||
144646095|NCT03842709|521558221|FG001|Overall Study|Lost to Follow-up|0|||
144646096|NCT02424149|521558222|FG000|Overall Study|surgery cancelled|2|||
144646097|NCT02424149|521558223|FG001|Overall Study|surgery cancelled|0|||
144646098|NCT02424149|521558222|FG000|Overall Study|Withdrawal by Subject|0|||
144646099|NCT02424149|521558223|FG001|Overall Study|Withdrawal by Subject|1|||
144646100|NCT01357239|521558228|FG000|Stratum: All Patients|Adverse Event|0|||
144646101|NCT01357239|521558229|FG001|Stratum: All Patients|Adverse Event|0|||
144646102|NCT01357239|521558230|FG002|Stratum: All Patients|Adverse Event|1|||
144646103|NCT01357239|521558231|FG003|Stratum: All Patients|Adverse Event|1|||
144646104|NCT01357239|521558228|FG000|Stratum: All Patients|Subject withdrew consent|0|||
144646105|NCT01357239|521558229|FG001|Stratum: All Patients|Subject withdrew consent|0|||
144646106|NCT01357239|521558230|FG002|Stratum: All Patients|Subject withdrew consent|1|||
144646107|NCT01357239|521558231|FG003|Stratum: All Patients|Subject withdrew consent|1|||
144646108|NCT01357239|521558228|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
144646109|NCT01357239|521558229|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
144646110|NCT01357239|521558230|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
144646111|NCT01357239|521558231|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
144646112|NCT01357239|521558228|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
144211545|NCT00996892|519968085|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
144646113|NCT01357239|521558229|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
144646114|NCT01357239|521558230|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
144646115|NCT01357239|521558231|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
144646116|NCT01357239|521558228|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
144646117|NCT01357239|521558229|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
144646118|NCT01357239|521558230|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
144646119|NCT01357239|521558231|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
144646120|NCT02614794|521558236|FG000|Overall Study|Death|258|||
144646121|NCT02614794|521558237|FG001|Overall Study|Death|151|||
144646122|NCT02614794|521558236|FG000|Overall Study|Study closure by Sponsor|119|||
144646123|NCT02614794|521558237|FG001|Overall Study|Study closure by Sponsor|45|||
144646124|NCT02614794|521558236|FG000|Overall Study|Withdrawal by Subject|24|||
144646125|NCT02614794|521558237|FG001|Overall Study|Withdrawal by Subject|5|||
144646126|NCT02614794|521558236|FG000|Overall Study|Lost to Follow-up|7|||
144646127|NCT02614794|521558237|FG001|Overall Study|Lost to Follow-up|0|||
144646128|NCT02614794|521558236|FG000|Overall Study|Physician Decision|1|||
144646129|NCT02614794|521558237|FG001|Overall Study|Physician Decision|1|||
144646130|NCT02614794|521558236|FG000|Overall Study|Hospital closure|1|||
144646131|NCT02614794|521558237|FG001|Overall Study|Hospital closure|0|||
144211546|NCT00996892|519968086|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
144646132|NCT03396471|521558238|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
144646133|NCT03396471|521558238|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
144646134|NCT03396471|521558238|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
144646135|NCT03396471|521558238|FG000|Study Treatment - Up to 22 Months|Death|2|||
144646136|NCT03396471|521558238|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
144211547|NCT00996892|519968087|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
144211548|NCT00996892|519968088|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
144211549|NCT00996892|519968089|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
144211550|NCT00996892|519968090|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
144211551|NCT00996892|519968071|FG000|Expansion Stage 2|Disease Progression|0|||
144211552|NCT00996892|519968072|FG001|Expansion Stage 2|Disease Progression|0|||
144211553|NCT00996892|519968073|FG002|Expansion Stage 2|Disease Progression|0|||
144211554|NCT00996892|519968074|FG003|Expansion Stage 2|Disease Progression|0|||
144211555|NCT00996892|519968075|FG004|Expansion Stage 2|Disease Progression|0|||
144211556|NCT00996892|519968076|FG005|Expansion Stage 2|Disease Progression|0|||
144211557|NCT00996892|519968077|FG006|Expansion Stage 2|Disease Progression|0|||
144211558|NCT00996892|519968078|FG007|Expansion Stage 2|Disease Progression|0|||
144211559|NCT00996892|519968079|FG008|Expansion Stage 2|Disease Progression|0|||
144211560|NCT00996892|519968080|FG009|Expansion Stage 2|Disease Progression|0|||
144211561|NCT00996892|519968081|FG010|Expansion Stage 2|Disease Progression|0|||
144211562|NCT00996892|519968082|FG011|Expansion Stage 2|Disease Progression|0|||
144211563|NCT00996892|519968083|FG012|Expansion Stage 2|Disease Progression|0|||
144646137|NCT03396471|521558238|FG000|Follow up - Up to 2 Years|Death|9|||
144646138|NCT03396471|521558238|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
144646139|NCT03396471|521558238|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
144646140|NCT03396471|521558238|FG000|Follow up - Up to 2 Years|study terminated|1|||
144646141|NCT03396471|521558238|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
144646142|NCT03396471|521558238|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
144646143|NCT03237845|521558242|FG000|Overall Study|Adverse Event|0|||
144646144|NCT03237845|521558243|FG001|Overall Study|Adverse Event|1|||
144646145|NCT03237845|521558242|FG000|Overall Study|Lost to Follow-up|13|||
144646146|NCT03237845|521558243|FG001|Overall Study|Lost to Follow-up|10|||
144646147|NCT03237845|521558242|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
144646148|NCT03237845|521558243|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
144646149|NCT03237845|521558242|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
144646150|NCT03237845|521558243|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
144646151|NCT03237845|521558242|FG000|Overall Study|Physician Decision|1|||
144646152|NCT03237845|521558243|FG001|Overall Study|Physician Decision|2|||
144646153|NCT03237845|521558242|FG000|Overall Study|Pregnancy|1|||
144646154|NCT03237845|521558243|FG001|Overall Study|Pregnancy|0|||
144646155|NCT03237845|521558242|FG000|Overall Study|Protocol Deviation|0|||
144646156|NCT03237845|521558243|FG001|Overall Study|Protocol Deviation|1|||
144646157|NCT03237845|521558242|FG000|Overall Study|Technical Problems|8|||
144646158|NCT03237845|521558243|FG001|Overall Study|Technical Problems|1|||
144646159|NCT03237845|521558242|FG000|Overall Study|Withdrawal by Subject|3|||
144646160|NCT03237845|521558243|FG001|Overall Study|Withdrawal by Subject|3|||
144646161|NCT03237845|521558242|FG000|Overall Study|Other Reasons|4|||
144646162|NCT03237845|521558243|FG001|Overall Study|Other Reasons|0|||
144646163|NCT00234104|521558250|FG000|Overall Study|Adverse Event|4|||
144646164|NCT00234104|521558251|FG001|Overall Study|Adverse Event|0|||
144646165|NCT00234104|521558252|FG002|Overall Study|Adverse Event|3|||
144646166|NCT00234104|521558253|FG003|Overall Study|Adverse Event|5|||
144646167|NCT00234104|521558250|FG000|Overall Study|Protocol Violation|0|||
144646168|NCT00234104|521558251|FG001|Overall Study|Protocol Violation|0|||
144646169|NCT00234104|521558252|FG002|Overall Study|Protocol Violation|0|||
144646170|NCT00234104|521558253|FG003|Overall Study|Protocol Violation|1|||
144646171|NCT00234104|521558250|FG000|Overall Study|Physician Decision|0|||
144646172|NCT00234104|521558251|FG001|Overall Study|Physician Decision|1|||
144646173|NCT00234104|521558252|FG002|Overall Study|Physician Decision|2|||
144646174|NCT00234104|521558253|FG003|Overall Study|Physician Decision|2|||
144646175|NCT00546819|521558256|FG000|Overall Study|Adverse Event|2|||
144646176|NCT00546819|521558257|FG001|Overall Study|Adverse Event|3|||
144646177|NCT00546819|521558256|FG000|Overall Study|Lost to Follow-up|2|||
144646178|NCT00546819|521558257|FG001|Overall Study|Lost to Follow-up|1|||
144646179|NCT00546819|521558256|FG000|Overall Study|Withdrawal by Subject|4|||
144646180|NCT00546819|521558257|FG001|Overall Study|Withdrawal by Subject|2|||
144646181|NCT02460822|521558258|FG000|Overall Study|Withdrawal by Subject|1|||
144646182|NCT01743027|521558265|FG000|Overall Study|Adverse Event|2|||
144646183|NCT01743027|521558266|FG001|Overall Study|Adverse Event|0|||
144646184|NCT01743027|521558267|FG002|Overall Study|Adverse Event|0|||
144646185|NCT01743027|521558268|FG003|Overall Study|Adverse Event|0|||
144646186|NCT01743027|521558265|FG000|Overall Study|Lost to Follow-up|0|||
144211564|NCT00996892|519968084|FG013|Expansion Stage 2|Disease Progression|0|||
144646187|NCT01743027|521558266|FG001|Overall Study|Lost to Follow-up|0|||
144646188|NCT01743027|521558267|FG002|Overall Study|Lost to Follow-up|2|||
144646189|NCT01743027|521558268|FG003|Overall Study|Lost to Follow-up|0|||
144646190|NCT01743027|521558265|FG000|Overall Study|Progressive Disease|1|||
144646191|NCT01743027|521558266|FG001|Overall Study|Progressive Disease|4|||
144646192|NCT01743027|521558267|FG002|Overall Study|Progressive Disease|3|||
144646193|NCT01743027|521558268|FG003|Overall Study|Progressive Disease|0|||
144646194|NCT01743027|521558265|FG000|Overall Study|Protocol Violation|1|||
144646195|NCT01743027|521558266|FG001|Overall Study|Protocol Violation|1|||
144646196|NCT01743027|521558267|FG002|Overall Study|Protocol Violation|1|||
144646197|NCT01743027|521558268|FG003|Overall Study|Protocol Violation|0|||
144646198|NCT01743027|521558265|FG000|Overall Study|Withdrawal by Subject|1|||
144646199|NCT01743027|521558266|FG001|Overall Study|Withdrawal by Subject|0|||
144646200|NCT01743027|521558267|FG002|Overall Study|Withdrawal by Subject|3|||
144646201|NCT01743027|521558268|FG003|Overall Study|Withdrawal by Subject|1|||
144646202|NCT02111811|521558269|FG000|Treatment Phase|Lost to Follow-up|22|||
144646203|NCT02111811|521558270|FG001|Treatment Phase|Lost to Follow-up|18|||
144646204|NCT02111811|521558269|FG000|Treatment Phase|Death|2|||
144646205|NCT02111811|521558270|FG001|Treatment Phase|Death|0|||
144646206|NCT02111811|521558269|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
144646207|NCT02111811|521558270|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
144646208|NCT02111811|521558269|FG000|Follow up Period (Aim 2)|Death|2|||
144646209|NCT02111811|521558270|FG001|Follow up Period (Aim 2)|Death|0|||
144646210|NCT01359982|521558272|FG000|Overall Study|Adverse Event|2|||
144646211|NCT01359982|521558273|FG001|Overall Study|Adverse Event|0|||
144646212|NCT01359982|521558274|FG002|Overall Study|Adverse Event|0|||
144646213|NCT01359982|521558275|FG003|Overall Study|Adverse Event|1|||
144646214|NCT01359982|521558276|FG004|Overall Study|Adverse Event|0|||
144646215|NCT01359982|521558277|FG005|Overall Study|Adverse Event|0|||
144646216|NCT01359982|521558272|FG000|Overall Study|Death|1|||
144646217|NCT01359982|521558273|FG001|Overall Study|Death|0|||
144646218|NCT01359982|521558274|FG002|Overall Study|Death|0|||
144646219|NCT01359982|521558275|FG003|Overall Study|Death|0|||
144646220|NCT01359982|521558276|FG004|Overall Study|Death|0|||
144646221|NCT01359982|521558277|FG005|Overall Study|Death|0|||
144646222|NCT00196937|521558284|FG000|Overall Study|Serious Adverse Event|1|||
144646223|NCT00196937|521558285|FG001|Overall Study|Serious Adverse Event|0|||
144646224|NCT00196937|521558286|FG002|Overall Study|Serious Adverse Event|0|||
144646225|NCT00196937|521558284|FG000|Overall Study|Non-serious adverse event|1|||
144646226|NCT00196937|521558285|FG001|Overall Study|Non-serious adverse event|1|||
144646227|NCT00196937|521558286|FG002|Overall Study|Non-serious adverse event|1|||
144646228|NCT00196937|521558284|FG000|Overall Study|Withdrawal by Subject|0|||
144646229|NCT00196937|521558285|FG001|Overall Study|Withdrawal by Subject|0|||
144646230|NCT00196937|521558286|FG002|Overall Study|Withdrawal by Subject|2|||
144646231|NCT00196937|521558284|FG000|Overall Study|Lost to Follow-up|4|||
144646232|NCT00196937|521558285|FG001|Overall Study|Lost to Follow-up|3|||
144646233|NCT00196937|521558286|FG002|Overall Study|Lost to Follow-up|3|||
144646234|NCT00196937|521558284|FG000|Overall Study|Other|3|||
144646235|NCT00196937|521558285|FG001|Overall Study|Other|1|||
144646236|NCT00196937|521558286|FG002|Overall Study|Other|1|||
144646237|NCT04725682|521558289|FG000|Overall Study|Withdrawal by Subject|7|||
144646238|NCT04725682|521558290|FG001|Overall Study|Withdrawal by Subject|5|||
144646239|NCT04725682|521558289|FG000|Overall Study|Failed to comply with the requirements|2|||
144646240|NCT04725682|521558290|FG001|Overall Study|Failed to comply with the requirements|1|||
144646241|NCT04725682|521558289|FG000|Overall Study|Adverse Event|1|||
144646242|NCT04725682|521558290|FG001|Overall Study|Adverse Event|1|||
144646243|NCT04725682|521558289|FG000|Overall Study|Death|0|||
144263260|NCT01827592|520163900|FG001|Overall Study|Withdrawal by Subject|11|||
144263261|NCT01827592|520163901|FG002|Overall Study|Withdrawal by Subject|11|||
144263262|NCT01827592|520163899|FG000|Overall Study|Patient's substantial non-compliance|1|||
144263263|NCT01827592|520163900|FG001|Overall Study|Patient's substantial non-compliance|1|||
144263264|NCT01827592|520163901|FG002|Overall Study|Patient's substantial non-compliance|6|||
144263265|NCT01827592|520163899|FG000|Overall Study|Trial terminated by Sponsor|47|||
144263266|NCT01827592|520163900|FG001|Overall Study|Trial terminated by Sponsor|53|||
144263267|NCT01827592|520163901|FG002|Overall Study|Trial terminated by Sponsor|51|||
144263268|NCT01827592|520163899|FG000|Overall Study|Others|0|||
144646244|NCT04725682|521558290|FG001|Overall Study|Death|1|||
144646245|NCT00964795|521558291|FG000|Overall Study|Withdrawal by Subject|79|||
144646246|NCT00964795|521558291|FG000|Overall Study|Adverse Event|12|||
144646247|NCT00964795|521558291|FG000|Overall Study|Death|14|||
144646248|NCT00964795|521558291|FG000|Overall Study|Lost to Follow-up|7|||
144646249|NCT00964795|521558291|FG000|Overall Study|Termination of Study by Sponsor|169|||
144646250|NCT00964795|521558291|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
144263269|NCT01827592|520163900|FG001|Overall Study|Others|1|||
144263270|NCT01827592|520163901|FG002|Overall Study|Others|3|||
144646251|NCT00964795|521558291|FG000|Overall Study|Other|23|||
144646252|NCT02453841|521558299|FG000|Overall Study|Protocol Violation|1|||
144646253|NCT02453841|521558299|FG000|Overall Study|Unable to obtain blood samples|2|||
144646254|NCT00586690|521558300|FG000|Overall Study|Death|2|||
144646255|NCT00586690|521558301|FG001|Overall Study|Death|0|||
144646256|NCT00586690|521558300|FG000|Overall Study|Disease Progression|10|||
144646257|NCT00586690|521558301|FG001|Overall Study|Disease Progression|0|||
144646258|NCT00586690|521558300|FG000|Overall Study|Adverse Event|1|||
144646259|NCT00586690|521558301|FG001|Overall Study|Adverse Event|0|||
144646260|NCT00586690|521558300|FG000|Overall Study|Lack of Efficacy|2|||
144646261|NCT00586690|521558301|FG001|Overall Study|Lack of Efficacy|0|||
144646262|NCT00586690|521558300|FG000|Overall Study|Lab can't accommodate|1|||
144646263|NCT00586690|521558301|FG001|Overall Study|Lab can't accommodate|0|||
144646264|NCT03851510|521558302|FG000|Overall Study|Screen Fail|1|||
144646265|NCT03851510|521558302|FG000|Overall Study|Adverse Event|1|||
144646266|NCT03851510|521558302|FG000|Overall Study|Withdrawal by Subject|1|||
144646267|NCT04579393|521558305|FG000|Overall Study|Withdrawal by Subject|2|||
144646268|NCT04579393|521558306|FG001|Overall Study|Withdrawal by Subject|2|||
144646269|NCT04579393|521558305|FG000|Overall Study|Death|1|||
144646270|NCT04579393|521558306|FG001|Overall Study|Death|3|||
144646271|NCT02104180|521558308|FG000|Overall Study|Protocol Violation|1|||
144646272|NCT02104180|521558309|FG001|Overall Study|Protocol Violation|0|||
144646273|NCT01524289|521558310|FG000|Overall Study|Lost to Follow-up|0|||
144646274|NCT01524289|521558311|FG001|Overall Study|Lost to Follow-up|1|||
144646275|NCT01524289|521558310|FG000|Overall Study|Physician Decision|1|||
144646276|NCT01524289|521558311|FG001|Overall Study|Physician Decision|0|||
144646277|NCT01524289|521558310|FG000|Overall Study|Protocol Violation|5|||
144646278|NCT01524289|521558311|FG001|Overall Study|Protocol Violation|1|||
144646279|NCT01524289|521558310|FG000|Overall Study|Withdrawal by Subject|11|||
144646280|NCT01524289|521558311|FG001|Overall Study|Withdrawal by Subject|7|||
144646281|NCT01524289|521558310|FG000|Overall Study|Adverse Event|12|||
144646282|NCT01524289|521558311|FG001|Overall Study|Adverse Event|5|||
144646283|NCT01524289|521558310|FG000|Overall Study|Did not take study medication|1|||
144646284|NCT01524289|521558311|FG001|Overall Study|Did not take study medication|0|||
144646285|NCT00104104|521558314|FG000|Overall Study|Adverse Event|8|||
144646286|NCT00104104|521558315|FG001|Overall Study|Adverse Event|8|||
144646287|NCT00104104|521558314|FG000|Overall Study|Abnormal laboratory value(s)|20|||
144646288|NCT00104104|521558315|FG001|Overall Study|Abnormal laboratory value(s)|14|||
144646289|NCT00104104|521558314|FG000|Overall Study|Lack of Efficacy|0|||
144646290|NCT00104104|521558315|FG001|Overall Study|Lack of Efficacy|3|||
144646291|NCT00104104|521558314|FG000|Overall Study|Condition no longer requires study drug|7|||
144646292|NCT00104104|521558315|FG001|Overall Study|Condition no longer requires study drug|4|||
144646293|NCT00104104|521558314|FG000|Overall Study|Protocol Violation|5|||
144646294|NCT00104104|521558315|FG001|Overall Study|Protocol Violation|2|||
144646295|NCT00104104|521558314|FG000|Overall Study|Withdrawal by Subject|11|||
144646296|NCT00104104|521558315|FG001|Overall Study|Withdrawal by Subject|15|||
144646297|NCT00104104|521558314|FG000|Overall Study|Lost to Follow-up|3|||
144646298|NCT00104104|521558315|FG001|Overall Study|Lost to Follow-up|7|||
144646299|NCT00104104|521558314|FG000|Overall Study|Administrative problems|12|||
144646300|NCT00104104|521558315|FG001|Overall Study|Administrative problems|13|||
144646301|NCT00104104|521558314|FG000|Overall Study|Death|9|||
144646302|NCT00104104|521558315|FG001|Overall Study|Death|6|||
144646303|NCT01056523|521558320|FG000|Overall Study|Death|1|||
144646304|NCT01056523|521558321|FG001|Overall Study|Death|0|||
144646305|NCT01056523|521558322|FG002|Overall Study|Death|2|||
144646306|NCT01056523|521558323|FG003|Overall Study|Death|3|||
144646307|NCT01056523|521558324|FG004|Overall Study|Death|0|||
144646308|NCT01056523|521558325|FG005|Overall Study|Death|0|||
144646309|NCT01056523|521558326|FG006|Overall Study|Death|1|||
144646310|NCT01821677|521558327|FG000|Overall Study|Adverse Event|4|||
144646311|NCT01821677|521558328|FG001|Overall Study|Adverse Event|6|||
144646312|NCT01821677|521558329|FG002|Overall Study|Adverse Event|5|||
144646313|NCT01821677|521558327|FG000|Overall Study|Physician Decision|1|||
144646314|NCT01821677|521558328|FG001|Overall Study|Physician Decision|4|||
144646315|NCT01821677|521558329|FG002|Overall Study|Physician Decision|1|||
144646316|NCT01821677|521558327|FG000|Overall Study|Non-compliance|0|||
144646317|NCT01821677|521558328|FG001|Overall Study|Non-compliance|1|||
144646318|NCT01821677|521558329|FG002|Overall Study|Non-compliance|2|||
144646319|NCT01821677|521558327|FG000|Overall Study|Lost to Follow-up|2|||
144646320|NCT01821677|521558328|FG001|Overall Study|Lost to Follow-up|1|||
144646321|NCT01821677|521558329|FG002|Overall Study|Lost to Follow-up|3|||
144646322|NCT01821677|521558327|FG000|Overall Study|Protocol Violation|0|||
144646323|NCT01821677|521558328|FG001|Overall Study|Protocol Violation|0|||
144646324|NCT01821677|521558329|FG002|Overall Study|Protocol Violation|2|||
144646325|NCT01821677|521558327|FG000|Overall Study|Withdrawal by Subject|7|||
144646326|NCT01821677|521558328|FG001|Overall Study|Withdrawal by Subject|3|||
144646327|NCT01821677|521558329|FG002|Overall Study|Withdrawal by Subject|2|||
144646328|NCT01821677|521558327|FG000|Overall Study|Other|9|||
144646329|NCT01821677|521558328|FG001|Overall Study|Other|0|||
144646330|NCT01821677|521558329|FG002|Overall Study|Other|0|||
144646331|NCT02209597|521558334|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
144646332|NCT02209597|521558334|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
144646333|NCT02209597|521558334|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
144646334|NCT02209597|521558334|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
144646335|NCT01863758|521558336|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
144646336|NCT01863758|521558336|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
144646337|NCT02606877|521558339|FG000|Overall Study|Adverse Event|3|||
144646338|NCT02606877|521558340|FG001|Overall Study|Adverse Event|0|||
144646339|NCT02606877|521558339|FG000|Overall Study|Non-compliance with protocol|0|||
144646340|NCT02606877|521558340|FG001|Overall Study|Non-compliance with protocol|1|||
144646341|NCT02606877|521558339|FG000|Overall Study|Other than listed above|1|||
144646342|NCT02606877|521558340|FG001|Overall Study|Other than listed above|0|||
144646343|NCT03067311|521558346|FG000|Overall Study|Lost to Follow-up|1|||
144646344|NCT03067311|521558347|FG001|Overall Study|Lost to Follow-up|1|||
144646345|NCT03067311|521558346|FG000|Overall Study|Moved away|1|||
144646346|NCT03067311|521558347|FG001|Overall Study|Moved away|1|||
144646347|NCT02903511|521558348|FG000|Overall Study|Withdrawal by Subject|1|||
144646348|NCT02903511|521558349|FG001|Overall Study|Withdrawal by Subject|0|||
144646349|NCT02903511|521558348|FG000|Overall Study|Lost to Follow-up|3|||
144646350|NCT02903511|521558349|FG001|Overall Study|Lost to Follow-up|2|||
144646351|NCT00907738|521558350|FG000|Overall Study|Adverse Event|2|||
144646352|NCT00907738|521558351|FG001|Overall Study|Adverse Event|0|||
144646353|NCT00907738|521558352|FG002|Overall Study|Adverse Event|1|||
144646354|NCT00907738|521558353|FG003|Overall Study|Adverse Event|0|||
144646355|NCT00907738|521558354|FG004|Overall Study|Adverse Event|0|||
144646356|NCT00907738|521558350|FG000|Overall Study|not specified or withdrew consent|3|||
144646357|NCT00907738|521558351|FG001|Overall Study|not specified or withdrew consent|0|||
144646358|NCT00907738|521558352|FG002|Overall Study|not specified or withdrew consent|0|||
144646359|NCT00907738|521558353|FG003|Overall Study|not specified or withdrew consent|0|||
144646360|NCT00907738|521558354|FG004|Overall Study|not specified or withdrew consent|0|||
144646361|NCT00907738|521558350|FG000|Overall Study|Disease progression|8|||
144646362|NCT00907738|521558351|FG001|Overall Study|Disease progression|1|||
144646363|NCT00907738|521558352|FG002|Overall Study|Disease progression|6|||
144646364|NCT00907738|521558353|FG003|Overall Study|Disease progression|4|||
144646365|NCT00907738|521558354|FG004|Overall Study|Disease progression|2|||
144646366|NCT01518699|521559730|FG000|Period 2|Protocol Violation|1|||
144646367|NCT01518699|521559731|FG001|Period 2|Protocol Violation|1|||
144646368|NCT01518699|521559732|FG002|Period 2|Protocol Violation|0|||
144646369|NCT01518699|521559733|FG003|Period 2|Protocol Violation|0|||
144646370|NCT01518699|521559734|FG004|Period 2|Protocol Violation|0|||
144646371|NCT01518699|521559735|FG005|Period 2|Protocol Violation|0|||
144646372|NCT01518699|521559730|FG000|Period 2|Lost to Follow-up|0|||
144646373|NCT01518699|521559731|FG001|Period 2|Lost to Follow-up|1|||
144646374|NCT01518699|521559732|FG002|Period 2|Lost to Follow-up|0|||
144646375|NCT01518699|521559733|FG003|Period 2|Lost to Follow-up|0|||
144646376|NCT01518699|521559734|FG004|Period 2|Lost to Follow-up|0|||
144646377|NCT01518699|521559735|FG005|Period 2|Lost to Follow-up|0|||
144646378|NCT01518699|521559730|FG000|Period 2|Adverse Event|1|||
144646379|NCT01518699|521559731|FG001|Period 2|Adverse Event|0|||
144646380|NCT01518699|521559732|FG002|Period 2|Adverse Event|0|||
144646381|NCT01518699|521559733|FG003|Period 2|Adverse Event|0|||
144646382|NCT01518699|521559734|FG004|Period 2|Adverse Event|0|||
144646383|NCT01518699|521559735|FG005|Period 2|Adverse Event|0|||
144646384|NCT03692910|521559738|FG000|Overall Study|Lost to Follow-up|4|||
144646385|NCT03692910|521559739|FG001|Overall Study|Lost to Follow-up|0|||
144646386|NCT03692910|521559740|FG002|Overall Study|Lost to Follow-up|0|||
144646387|NCT03692910|521559738|FG000|Overall Study|Withdrawal by Subject|2|||
144646388|NCT03692910|521559739|FG001|Overall Study|Withdrawal by Subject|0|||
144646389|NCT03692910|521559740|FG002|Overall Study|Withdrawal by Subject|0|||
144646390|NCT00417612|521559741|FG000|Overall Study|Errant diagnosis|0|||
144646391|NCT00417612|521559742|FG001|Overall Study|Errant diagnosis|1|||
144646392|NCT00417612|521559741|FG000|Overall Study|Adverse Event|2|||
144646393|NCT00417612|521559742|FG001|Overall Study|Adverse Event|0|||
144646394|NCT00417612|521559741|FG000|Overall Study|Protocol Violation|0|||
144646395|NCT00417612|521559742|FG001|Overall Study|Protocol Violation|2|||
144646396|NCT00417612|521559741|FG000|Overall Study|Lost to Follow-up|1|||
144646397|NCT00417612|521559742|FG001|Overall Study|Lost to Follow-up|0|||
144646398|NCT00486226|521559745|FG000|Overall Study|Death|3|||
144646399|NCT00486226|521559745|FG000|Overall Study|Adverse Event|1|||
144646400|NCT00486226|521559745|FG000|Overall Study|Withdrawal by Subject|1|||
144646401|NCT00486226|521559745|FG000|Overall Study|Lost to Follow-up|8|||
144646402|NCT03846947|521559750|FG000|Overall Study|technical issues with imaging sequence|2|||
144646403|NCT02940886|521559751|FG000|Overall Study|Adverse Event|7|||
144646404|NCT02940886|521559752|FG001|Overall Study|Adverse Event|3|||
144646405|NCT02940886|521559751|FG000|Overall Study|Protocol Violation|0|||
144646406|NCT02940886|521559752|FG001|Overall Study|Protocol Violation|2|||
144646407|NCT02940886|521559751|FG000|Overall Study|Withdrawal by Subject|28|||
144646408|NCT02940886|521559752|FG001|Overall Study|Withdrawal by Subject|20|||
144646409|NCT02940886|521559751|FG000|Overall Study|Death|1|||
144646410|NCT02940886|521559752|FG001|Overall Study|Death|0|||
144646411|NCT02940886|521559751|FG000|Overall Study|Lack of Efficacy|1|||
144646412|NCT02940886|521559752|FG001|Overall Study|Lack of Efficacy|0|||
144646413|NCT02940886|521559751|FG000|Overall Study|Lost to Follow-up|49|||
144646414|NCT02940886|521559752|FG001|Overall Study|Lost to Follow-up|21|||
144646415|NCT02940886|521559751|FG000|Overall Study|Physician Decision|9|||
144646416|NCT02940886|521559752|FG001|Overall Study|Physician Decision|4|||
144646417|NCT02940886|521559751|FG000|Overall Study|Sponsor decision|0|||
144646418|NCT02940886|521559752|FG001|Overall Study|Sponsor decision|1|||
144646419|NCT02940886|521559751|FG000|Overall Study|No treatment|7|||
144646420|NCT02940886|521559752|FG001|Overall Study|No treatment|2|||
144646421|NCT02940886|521559751|FG000|Overall Study|Enrolment error|0|||
144646422|NCT02940886|521559752|FG001|Overall Study|Enrolment error|1|||
144646423|NCT03216265|521559753|FG000|Overall Study|Adverse Event|2|||
144646424|NCT03216265|521559754|FG001|Overall Study|Adverse Event|0|||
144646425|NCT03216265|521559755|FG002|Overall Study|Adverse Event|2|||
144646426|NCT03216265|521559753|FG000|Overall Study|Lost to Follow-up|0|||
144646427|NCT03216265|521559754|FG001|Overall Study|Lost to Follow-up|1|||
144646428|NCT03216265|521559755|FG002|Overall Study|Lost to Follow-up|0|||
144646429|NCT03216265|521559753|FG000|Overall Study|Withdrawal by Subject|0|||
144646430|NCT03216265|521559754|FG001|Overall Study|Withdrawal by Subject|0|||
144646431|NCT03216265|521559755|FG002|Overall Study|Withdrawal by Subject|1|||
144646432|NCT01306058|521559757|FG000|Overall Study|Death|1|||
144646433|NCT01306058|521559757|FG000|Overall Study|Enrolled but did not get treatment|1|||
144646434|NCT01539837|521559758|FG000|Overall Study|reduce neutrophil level|0|||
144646435|NCT01539837|521559759|FG001|Overall Study|reduce neutrophil level|1|||
144646436|NCT01539837|521559760|FG002|Overall Study|reduce neutrophil level|1|||
144646437|NCT01539837|521559758|FG000|Overall Study|bad compliance|0|||
144646438|NCT01539837|521559759|FG001|Overall Study|bad compliance|0|||
144646439|NCT01539837|521559760|FG002|Overall Study|bad compliance|1|||
144646440|NCT00849693|521559761|FG000|Acute Treatment Phase|Adverse Event|12|||
144646441|NCT00849693|521559762|FG001|Acute Treatment Phase|Adverse Event|7|||
144646442|NCT00849693|521559763|FG002|Acute Treatment Phase|Adverse Event|6|||
144646443|NCT00849693|521559764|FG003|Acute Treatment Phase|Adverse Event|4|||
144646444|NCT00849693|521559761|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
144646445|NCT00849693|521559762|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
144646446|NCT00849693|521559763|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
144646447|NCT00849693|521559764|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
144646448|NCT00849693|521559761|FG000|Acute Treatment Phase|Protocol Violation|1|||
144646449|NCT00849693|521559762|FG001|Acute Treatment Phase|Protocol Violation|5|||
144646450|NCT00849693|521559763|FG002|Acute Treatment Phase|Protocol Violation|2|||
144646451|NCT00849693|521559764|FG003|Acute Treatment Phase|Protocol Violation|6|||
144646452|NCT00849693|521559761|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
144646453|NCT00849693|521559762|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
144646454|NCT00849693|521559763|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
144646455|NCT00849693|521559764|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
144646456|NCT00849693|521559761|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
144646457|NCT00849693|521559762|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
144646458|NCT00849693|521559763|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
144731641|NCT03627091|521873225|FG001|Overall Study|Disease relapse|5|||
144211565|NCT00996892|519968085|FG014|Expansion Stage 2|Disease Progression|0|||
144211566|NCT00996892|519968086|FG015|Expansion Stage 2|Disease Progression|0|||
144211567|NCT00996892|519968087|FG016|Expansion Stage 2|Disease Progression|0|||
144211568|NCT00996892|519968088|FG017|Expansion Stage 2|Disease Progression|0|||
144211569|NCT00996892|519968089|FG018|Expansion Stage 2|Disease Progression|28|||
144211570|NCT00996892|519968090|FG019|Expansion Stage 2|Disease Progression|0|||
144211571|NCT00996892|519968071|FG000|Expansion Stage 2A|Adverse Event|0|||
144211572|NCT00996892|519968072|FG001|Expansion Stage 2A|Adverse Event|0|||
144211573|NCT00996892|519968073|FG002|Expansion Stage 2A|Adverse Event|0|||
144211574|NCT00996892|519968074|FG003|Expansion Stage 2A|Adverse Event|0|||
144211575|NCT00996892|519968075|FG004|Expansion Stage 2A|Adverse Event|0|||
144211576|NCT00996892|519968076|FG005|Expansion Stage 2A|Adverse Event|0|||
144211577|NCT00996892|519968077|FG006|Expansion Stage 2A|Adverse Event|0|||
144211578|NCT00996892|519968078|FG007|Expansion Stage 2A|Adverse Event|0|||
144211579|NCT00996892|519968079|FG008|Expansion Stage 2A|Adverse Event|0|||
144211580|NCT00996892|519968080|FG009|Expansion Stage 2A|Adverse Event|0|||
144211581|NCT00996892|519968081|FG010|Expansion Stage 2A|Adverse Event|0|||
144211582|NCT00996892|519968082|FG011|Expansion Stage 2A|Adverse Event|0|||
144211583|NCT00996892|519968083|FG012|Expansion Stage 2A|Adverse Event|0|||
144211584|NCT00996892|519968084|FG013|Expansion Stage 2A|Adverse Event|0|||
144211585|NCT00996892|519968085|FG014|Expansion Stage 2A|Adverse Event|0|||
144211586|NCT00996892|519968086|FG015|Expansion Stage 2A|Adverse Event|0|||
144211587|NCT00996892|519968087|FG016|Expansion Stage 2A|Adverse Event|0|||
144211588|NCT00996892|519968088|FG017|Expansion Stage 2A|Adverse Event|0|||
144211589|NCT00996892|519968089|FG018|Expansion Stage 2A|Adverse Event|0|||
144211590|NCT00996892|519968090|FG019|Expansion Stage 2A|Adverse Event|8|||
144211591|NCT00996892|519968071|FG000|Expansion Stage 2A|Physician Decision|0|||
144211592|NCT00996892|519968072|FG001|Expansion Stage 2A|Physician Decision|0|||
144211593|NCT00996892|519968073|FG002|Expansion Stage 2A|Physician Decision|0|||
144211594|NCT00996892|519968074|FG003|Expansion Stage 2A|Physician Decision|0|||
144211595|NCT00996892|519968075|FG004|Expansion Stage 2A|Physician Decision|0|||
144646459|NCT00849693|521559764|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
144211596|NCT00996892|519968076|FG005|Expansion Stage 2A|Physician Decision|0|||
144211597|NCT00996892|519968077|FG006|Expansion Stage 2A|Physician Decision|0|||
144211598|NCT00996892|519968078|FG007|Expansion Stage 2A|Physician Decision|0|||
144646460|NCT00849693|521559761|FG000|Acute Treatment Phase|Physician Decision|2|||
144646461|NCT00849693|521559762|FG001|Acute Treatment Phase|Physician Decision|1|||
144731642|NCT03627091|521873226|FG002|Overall Study|Disease relapse|1|||
144211599|NCT00996892|519968079|FG008|Expansion Stage 2A|Physician Decision|0|||
144263271|NCT04980014|520165381|FG000|Overall Study|Participants who are Duplicated|1|||
144263272|NCT04980014|520165381|FG000|Overall Study|Follow-up Failure|13|||
144646462|NCT00849693|521559763|FG002|Acute Treatment Phase|Physician Decision|2|||
144646463|NCT00849693|521559764|FG003|Acute Treatment Phase|Physician Decision|1|||
144646464|NCT00849693|521559761|FG000|Acute Treatment Phase|Sponsor decision|0|||
144646465|NCT00849693|521559762|FG001|Acute Treatment Phase|Sponsor decision|0|||
144646466|NCT00849693|521559763|FG002|Acute Treatment Phase|Sponsor decision|1|||
144646467|NCT00849693|521559764|FG003|Acute Treatment Phase|Sponsor decision|0|||
144646468|NCT00849693|521559761|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
144646469|NCT00849693|521559762|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
144646470|NCT00849693|521559763|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
144646471|NCT00849693|521559764|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
144646472|NCT00849693|521559761|FG000|Extension Phase|Adverse Event|4|||
144646473|NCT00849693|521559762|FG001|Extension Phase|Adverse Event|6|||
144646474|NCT00849693|521559763|FG002|Extension Phase|Adverse Event|3|||
144646475|NCT00849693|521559764|FG003|Extension Phase|Adverse Event|7|||
144646476|NCT00849693|521559761|FG000|Extension Phase|Lost to Follow-up|7|||
144646477|NCT00849693|521559762|FG001|Extension Phase|Lost to Follow-up|5|||
144646478|NCT00849693|521559763|FG002|Extension Phase|Lost to Follow-up|6|||
144646479|NCT00849693|521559764|FG003|Extension Phase|Lost to Follow-up|6|||
144646480|NCT00849693|521559761|FG000|Extension Phase|Protocol Violation|0|||
144646481|NCT00849693|521559762|FG001|Extension Phase|Protocol Violation|3|||
144646482|NCT00849693|521559763|FG002|Extension Phase|Protocol Violation|2|||
144646483|NCT00849693|521559764|FG003|Extension Phase|Protocol Violation|3|||
144646484|NCT00849693|521559761|FG000|Extension Phase|Withdrawal by Subject|6|||
144646485|NCT00849693|521559762|FG001|Extension Phase|Withdrawal by Subject|9|||
144646486|NCT00849693|521559763|FG002|Extension Phase|Withdrawal by Subject|10|||
144646487|NCT00849693|521559764|FG003|Extension Phase|Withdrawal by Subject|15|||
144646488|NCT00849693|521559761|FG000|Extension Phase|Parent or caregiver decision|9|||
144646489|NCT00849693|521559762|FG001|Extension Phase|Parent or caregiver decision|4|||
144646490|NCT00849693|521559763|FG002|Extension Phase|Parent or caregiver decision|10|||
144646491|NCT00849693|521559764|FG003|Extension Phase|Parent or caregiver decision|5|||
144646492|NCT00849693|521559761|FG000|Extension Phase|Physician Decision|1|||
144646493|NCT00849693|521559762|FG001|Extension Phase|Physician Decision|1|||
144646494|NCT00849693|521559763|FG002|Extension Phase|Physician Decision|2|||
144646495|NCT00849693|521559764|FG003|Extension Phase|Physician Decision|0|||
144646496|NCT00849693|521559761|FG000|Extension Phase|Sponsor decision|1|||
144646497|NCT00849693|521559762|FG001|Extension Phase|Sponsor decision|0|||
144646498|NCT00849693|521559763|FG002|Extension Phase|Sponsor decision|0|||
144646499|NCT00849693|521559764|FG003|Extension Phase|Sponsor decision|1|||
144646500|NCT00849693|521559761|FG000|Extension Phase|Lack of Efficacy|2|||
144646501|NCT00849693|521559762|FG001|Extension Phase|Lack of Efficacy|2|||
144646502|NCT00849693|521559763|FG002|Extension Phase|Lack of Efficacy|2|||
144646503|NCT00849693|521559764|FG003|Extension Phase|Lack of Efficacy|1|||
144646504|NCT00224107|521559765|FG000|Overall Study|Adverse Event|20|||
144646505|NCT00224107|521559766|FG001|Overall Study|Adverse Event|6|||
144646506|NCT00224107|521559765|FG000|Overall Study|Protocol Violation|2|||
144646507|NCT00224107|521559766|FG001|Overall Study|Protocol Violation|3|||
144646508|NCT00224107|521559765|FG000|Overall Study|Withdrawal by Subject|1|||
144646509|NCT00224107|521559766|FG001|Overall Study|Withdrawal by Subject|4|||
144646510|NCT00224107|521559765|FG000|Overall Study|Lack of Efficacy|2|||
144646511|NCT00224107|521559766|FG001|Overall Study|Lack of Efficacy|0|||
144646512|NCT00224107|521559765|FG000|Overall Study|Lost to Follow-up|4|||
144646513|NCT00224107|521559766|FG001|Overall Study|Lost to Follow-up|0|||
144646514|NCT00224107|521559765|FG000|Overall Study|Physician Decision|1|||
144646515|NCT00224107|521559766|FG001|Overall Study|Physician Decision|0|||
144646516|NCT00224107|521559765|FG000|Overall Study|Other|1|||
144646517|NCT00224107|521559766|FG001|Overall Study|Other|1|||
144646518|NCT02046564|521559768|FG000|Overall Study|Adverse Event|6|||
144646519|NCT02046564|521559769|FG001|Overall Study|Adverse Event|3|||
144646520|NCT02046564|521559768|FG000|Overall Study|Physician Decision|0|||
144646521|NCT02046564|521559769|FG001|Overall Study|Physician Decision|1|||
144646522|NCT02046564|521559768|FG000|Overall Study|Protocol Violation|3|||
144263273|NCT04980014|520165381|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
144646523|NCT02046564|521559769|FG001|Overall Study|Protocol Violation|1|||
144646524|NCT02046564|521559768|FG000|Overall Study|Withdrawal by Subject|4|||
144646525|NCT02046564|521559769|FG001|Overall Study|Withdrawal by Subject|10|||
144646526|NCT02046564|521559768|FG000|Overall Study|Subject met withdrawal criteria|2|||
144646527|NCT02046564|521559769|FG001|Overall Study|Subject met withdrawal criteria|5|||
144263274|NCT04980014|520165381|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
144646528|NCT00984659|521559770|FG000|2-week Run-in Period|Adverse Event|8|||
144646529|NCT00984659|521559771|FG001|2-week Run-in Period|Adverse Event|0|||
144263275|NCT04980014|520165381|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
144263276|NCT02317991|520165382|FG000|Overall Study|Adverse Event|12|||
144646530|NCT00984659|521559772|FG002|2-week Run-in Period|Adverse Event|0|||
144646531|NCT00984659|521559773|FG003|2-week Run-in Period|Adverse Event|0|||
144646532|NCT00984659|521559770|FG000|2-week Run-in Period|Protocol Violation|5|||
144646533|NCT00984659|521559771|FG001|2-week Run-in Period|Protocol Violation|0|||
144646534|NCT00984659|521559772|FG002|2-week Run-in Period|Protocol Violation|0|||
144646535|NCT00984659|521559773|FG003|2-week Run-in Period|Protocol Violation|0|||
144646536|NCT00984659|521559770|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
144646537|NCT00984659|521559771|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
144646538|NCT00984659|521559772|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
144646539|NCT00984659|521559773|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
144646540|NCT00984659|521559770|FG000|2-week Run-in Period|Lost to Follow-up|3|||
144646541|NCT00984659|521559771|FG001|2-week Run-in Period|Lost to Follow-up|0|||
144646542|NCT00984659|521559772|FG002|2-week Run-in Period|Lost to Follow-up|0|||
144646543|NCT00984659|521559773|FG003|2-week Run-in Period|Lost to Follow-up|0|||
144646544|NCT00984659|521559770|FG000|2-week Run-in Period|Physician Decision|10|||
144646545|NCT00984659|521559771|FG001|2-week Run-in Period|Physician Decision|0|||
144646546|NCT00984659|521559772|FG002|2-week Run-in Period|Physician Decision|0|||
144646547|NCT00984659|521559773|FG003|2-week Run-in Period|Physician Decision|0|||
144646548|NCT00984659|521559770|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
144646549|NCT00984659|521559771|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144646550|NCT00984659|521559772|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144646551|NCT00984659|521559773|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
144646552|NCT00984659|521559770|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
144646553|NCT00984659|521559771|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
144646554|NCT00984659|521559772|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
144646555|NCT00984659|521559773|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
144646556|NCT00984659|521559770|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
144646557|NCT00984659|521559771|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
144646558|NCT00984659|521559772|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
144646559|NCT00984659|521559773|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
144646560|NCT00984659|521559770|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
144646561|NCT00984659|521559771|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
144646562|NCT00984659|521559772|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
144646563|NCT00984659|521559773|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
144646564|NCT00984659|521559770|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
144646565|NCT00984659|521559771|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
144646566|NCT00984659|521559772|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
144646567|NCT00984659|521559773|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
144646568|NCT00984659|521559770|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
144646569|NCT00984659|521559771|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
144646570|NCT00984659|521559772|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
144646571|NCT00984659|521559773|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
144646572|NCT00984659|521559770|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144646573|NCT00984659|521559771|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
144646574|NCT00984659|521559772|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
144646575|NCT00984659|521559773|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
144646576|NCT00537823|521559781|FG000|Overall Study|Adverse Event|2|||
144646577|NCT00537823|521559782|FG001|Overall Study|Adverse Event|0|||
144646578|NCT03065530|521559783|FG000|Overall Study|Lack of Efficacy|1|||
144646579|NCT03065530|521559784|FG001|Overall Study|Lack of Efficacy|1|||
144646580|NCT03065530|521559785|FG002|Overall Study|Lack of Efficacy|0|||
144646581|NCT03065530|521559786|FG003|Overall Study|Lack of Efficacy|1|||
144646582|NCT03065530|521559783|FG000|Overall Study|Protocol Violation|1|||
144646583|NCT03065530|521559784|FG001|Overall Study|Protocol Violation|0|||
144646584|NCT03065530|521559785|FG002|Overall Study|Protocol Violation|1|||
144646585|NCT03065530|521559786|FG003|Overall Study|Protocol Violation|1|||
144646586|NCT02873221|521559787|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
144646587|NCT02873221|521559788|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
144646588|NCT02873221|521559789|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
144646589|NCT02873221|521559787|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
144646590|NCT02873221|521559788|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
144646591|NCT02873221|521559789|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
144731643|NCT03627091|521873224|FG000|Overall Study|Other|1|||
144211600|NCT00996892|519968080|FG009|Expansion Stage 2A|Physician Decision|0|||
144211601|NCT00996892|519968081|FG010|Expansion Stage 2A|Physician Decision|0|||
144211602|NCT00996892|519968082|FG011|Expansion Stage 2A|Physician Decision|0|||
144646592|NCT02873221|521559787|FG000|Treatment Period|Protocol Violation|2|||
144646593|NCT02873221|521559788|FG001|Treatment Period|Protocol Violation|5|||
144646594|NCT02873221|521559789|FG002|Treatment Period|Protocol Violation|8|||
144646595|NCT02873221|521559787|FG000|Treatment Period|Pregnancy|4|||
144646596|NCT02873221|521559788|FG001|Treatment Period|Pregnancy|6|||
144646597|NCT02873221|521559789|FG002|Treatment Period|Pregnancy|3|||
144646598|NCT02873221|521559787|FG000|Treatment Period|Lack of Qualifying Event|0|||
144731644|NCT03627091|521873225|FG001|Overall Study|Other|0|||
144263277|NCT02317991|520165382|FG000|Overall Study|Death|4|||
144646599|NCT02873221|521559788|FG001|Treatment Period|Lack of Qualifying Event|3|||
144646600|NCT02873221|521559789|FG002|Treatment Period|Lack of Qualifying Event|1|||
144646601|NCT02873221|521559787|FG000|Treatment Period|Withdrawal of Consent|52|||
144646602|NCT02873221|521559788|FG001|Treatment Period|Withdrawal of Consent|51|||
144646603|NCT02873221|521559789|FG002|Treatment Period|Withdrawal of Consent|41|||
144646604|NCT02873221|521559787|FG000|Treatment Period|Lack of Efficacy|0|||
144646605|NCT02873221|521559788|FG001|Treatment Period|Lack of Efficacy|17|||
144646606|NCT02873221|521559789|FG002|Treatment Period|Lack of Efficacy|12|||
144646607|NCT02873221|521559787|FG000|Treatment Period|Adverse Event|4|||
144646608|NCT02873221|521559788|FG001|Treatment Period|Adverse Event|9|||
144646609|NCT02873221|521559789|FG002|Treatment Period|Adverse Event|11|||
144646610|NCT02873221|521559787|FG000|Treatment Period|Lost to Follow-up|26|||
144646611|NCT02873221|521559788|FG001|Treatment Period|Lost to Follow-up|30|||
144646612|NCT02873221|521559789|FG002|Treatment Period|Lost to Follow-up|26|||
144646613|NCT02873221|521559787|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
144646614|NCT02873221|521559788|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
144646615|NCT02873221|521559789|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
144646616|NCT02873221|521559787|FG000|Safety Follow-up Period|Protocol Violation|0|||
144646617|NCT02873221|521559788|FG001|Safety Follow-up Period|Protocol Violation|0|||
144646618|NCT02873221|521559789|FG002|Safety Follow-up Period|Protocol Violation|1|||
144646619|NCT02873221|521559787|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
144646620|NCT02873221|521559788|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
144646621|NCT02873221|521559789|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
144646622|NCT02873221|521559787|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
144646623|NCT02873221|521559788|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
144646624|NCT02873221|521559789|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
144646625|NCT02717546|521559793|FG000|Overall Study|Lost to Follow-up|12|||
144646626|NCT01319929|521559800|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
144646627|NCT01319929|521559801|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
144646628|NCT01319929|521559800|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
144646629|NCT01319929|521559801|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
144646630|NCT01319929|521559800|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
144646631|NCT01319929|521559801|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
144646632|NCT01319929|521559800|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
144646633|NCT01319929|521559801|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
144646634|NCT01319929|521559800|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
144646635|NCT01319929|521559801|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
144646636|NCT03849560|521559802|FG000|Overall Study|Withdrawal by Subject|1|||
144646637|NCT03849560|521559803|FG001|Overall Study|Withdrawal by Subject|0|||
144646638|NCT03849560|521559804|FG002|Overall Study|Withdrawal by Subject|0|||
144646639|NCT04045613|521559805|FG000|Overall Study|Adverse Event|2|||
144646640|NCT04045613|521559806|FG001|Overall Study|Adverse Event|2|||
144646641|NCT04045613|521559807|FG002|Overall Study|Adverse Event|1|||
144646642|NCT04045613|521559808|FG003|Overall Study|Adverse Event|1|||
144646643|NCT04045613|521559809|FG004|Overall Study|Adverse Event|0|||
144646644|NCT04045613|521559810|FG005|Overall Study|Adverse Event|0|||
144646645|NCT04045613|521559811|FG006|Overall Study|Adverse Event|1|||
144646646|NCT04045613|521559805|FG000|Overall Study|Withdrawal by Subject|0|||
144646647|NCT04045613|521559806|FG001|Overall Study|Withdrawal by Subject|5|||
144646648|NCT04045613|521559807|FG002|Overall Study|Withdrawal by Subject|0|||
144646649|NCT04045613|521559808|FG003|Overall Study|Withdrawal by Subject|0|||
144646650|NCT04045613|521559809|FG004|Overall Study|Withdrawal by Subject|0|||
144646651|NCT04045613|521559810|FG005|Overall Study|Withdrawal by Subject|1|||
144646652|NCT04045613|521559811|FG006|Overall Study|Withdrawal by Subject|0|||
144646653|NCT04045613|521559805|FG000|Overall Study|Physician Decision|2|||
144646654|NCT04045613|521559806|FG001|Overall Study|Physician Decision|0|||
144646655|NCT04045613|521559807|FG002|Overall Study|Physician Decision|0|||
144646656|NCT04045613|521559808|FG003|Overall Study|Physician Decision|0|||
144646657|NCT04045613|521559809|FG004|Overall Study|Physician Decision|1|||
144646658|NCT04045613|521559810|FG005|Overall Study|Physician Decision|0|||
144646659|NCT04045613|521559811|FG006|Overall Study|Physician Decision|0|||
144646660|NCT04045613|521559805|FG000|Overall Study|Death|3|||
144646661|NCT04045613|521559806|FG001|Overall Study|Death|0|||
144646662|NCT04045613|521559807|FG002|Overall Study|Death|0|||
144646663|NCT04045613|521559808|FG003|Overall Study|Death|0|||
144646664|NCT04045613|521559809|FG004|Overall Study|Death|0|||
144646665|NCT04045613|521559810|FG005|Overall Study|Death|0|||
144646666|NCT04045613|521559811|FG006|Overall Study|Death|1|||
144646667|NCT04045613|521559805|FG000|Overall Study|Other reasons|0|||
144646668|NCT04045613|521559806|FG001|Overall Study|Other reasons|1|||
144646669|NCT04045613|521559807|FG002|Overall Study|Other reasons|0|||
144646670|NCT04045613|521559808|FG003|Overall Study|Other reasons|0|||
144646671|NCT04045613|521559809|FG004|Overall Study|Other reasons|0|||
144646672|NCT04045613|521559810|FG005|Overall Study|Other reasons|0|||
144731645|NCT03627091|521873226|FG002|Overall Study|Other|0|||
144211603|NCT00996892|519968083|FG012|Expansion Stage 2A|Physician Decision|0|||
144646673|NCT04045613|521559811|FG006|Overall Study|Other reasons|1|||
144646674|NCT04045613|521559805|FG000|Overall Study|Progressive disease: Clinical progression|1|||
144646675|NCT04045613|521559806|FG001|Overall Study|Progressive disease: Clinical progression|0|||
144646676|NCT04045613|521559807|FG002|Overall Study|Progressive disease: Clinical progression|3|||
144646677|NCT04045613|521559808|FG003|Overall Study|Progressive disease: Clinical progression|1|||
144646678|NCT04045613|521559809|FG004|Overall Study|Progressive disease: Clinical progression|1|||
144646679|NCT04045613|521559810|FG005|Overall Study|Progressive disease: Clinical progression|3|||
144646680|NCT04045613|521559811|FG006|Overall Study|Progressive disease: Clinical progression|3|||
144646681|NCT04045613|521559805|FG000|Overall Study|Progressive disease: Radiological progression|24|||
144646682|NCT04045613|521559806|FG001|Overall Study|Progressive disease: Radiological progression|6|||
144646683|NCT04045613|521559807|FG002|Overall Study|Progressive disease: Radiological progression|8|||
144646684|NCT04045613|521559808|FG003|Overall Study|Progressive disease: Radiological progression|0|||
144646685|NCT04045613|521559809|FG004|Overall Study|Progressive disease: Radiological progression|6|||
144646686|NCT04045613|521559810|FG005|Overall Study|Progressive disease: Radiological progression|6|||
144646687|NCT04045613|521559811|FG006|Overall Study|Progressive disease: Radiological progression|11|||
144646688|NCT01633060|521559818|FG000|Randomization Phase|Protocol deviation|1|||
144646689|NCT01633060|521559819|FG001|Randomization Phase|Protocol deviation|2|||
144646690|NCT01633060|521559818|FG000|Randomization Phase|Technical problem|0|||
144646691|NCT01633060|521559819|FG001|Randomization Phase|Technical problem|1|||
144646692|NCT01633060|521559818|FG000|Treatment Phase|Adverse Event|24|||
144646693|NCT01633060|521559819|FG001|Treatment Phase|Adverse Event|3|||
144646694|NCT01633060|521559818|FG000|Treatment Phase|Lost to Follow-up|1|||
144646695|NCT01633060|521559819|FG001|Treatment Phase|Lost to Follow-up|0|||
144646696|NCT01633060|521559818|FG000|Treatment Phase|Physician Decision|16|||
144646697|NCT01633060|521559819|FG001|Treatment Phase|Physician Decision|7|||
144646698|NCT01633060|521559818|FG000|Treatment Phase|Progressive Disease|210|||
144646699|NCT01633060|521559819|FG001|Treatment Phase|Progressive Disease|120|||
144646700|NCT01633060|521559818|FG000|Treatment Phase|Protocol Deviation|1|||
144646701|NCT01633060|521559819|FG001|Treatment Phase|Protocol Deviation|0|||
144646702|NCT01633060|521559818|FG000|Treatment Phase|Study Terminated by sponsor|7|||
144646703|NCT01633060|521559819|FG001|Treatment Phase|Study Terminated by sponsor|3|||
144646704|NCT01633060|521559818|FG000|Treatment Phase|Subject/guardian decision|25|||
144646705|NCT01633060|521559819|FG001|Treatment Phase|Subject/guardian decision|4|||
144646706|NCT01633060|521559818|FG000|Treatment Phase|Death|4|||
144646707|NCT01633060|521559819|FG001|Treatment Phase|Death|3|||
144646708|NCT01633060|521559818|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
144646709|NCT01633060|521559819|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144646710|NCT01633060|521559818|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
144646711|NCT01633060|521559819|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
144646712|NCT01633060|521559818|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
144646713|NCT01633060|521559819|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
144646714|NCT01633060|521559818|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
144646715|NCT01633060|521559819|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
144646716|NCT01633060|521559818|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
144646717|NCT01633060|521559819|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
144646718|NCT01633060|521559818|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
144646719|NCT01633060|521559819|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
144646720|NCT03633331|521559827|FG000|Overall Study|Withdrawal by Subject|1|||
144646721|NCT03233048|521559828|FG000|Overall Study|Withdrawal by Subject|1|||
144646722|NCT01856673|521559829|FG000|Overall Study|Withdrawal by Subject|44|||
144646723|NCT01856673|521559830|FG001|Overall Study|Withdrawal by Subject|50|||
144646724|NCT01856673|521559831|FG002|Overall Study|Withdrawal by Subject|33|||
144646725|NCT01856673|521559829|FG000|Overall Study|Lost to Follow-up|31|||
144646726|NCT01856673|521559830|FG001|Overall Study|Lost to Follow-up|34|||
144646727|NCT01856673|521559831|FG002|Overall Study|Lost to Follow-up|0|||
144646728|NCT01856673|521559829|FG000|Overall Study|Unknown reasons|9|||
144646729|NCT01856673|521559830|FG001|Overall Study|Unknown reasons|0|||
144646730|NCT01856673|521559831|FG002|Overall Study|Unknown reasons|0|||
144646731|NCT01856673|521559829|FG000|Overall Study|Psychologist decision|1|||
144646732|NCT01856673|521559830|FG001|Overall Study|Psychologist decision|0|||
144646733|NCT01856673|521559831|FG002|Overall Study|Psychologist decision|0|||
144646734|NCT01856673|521559829|FG000|Overall Study|Paperwork errors|8|||
144646735|NCT01856673|521559830|FG001|Overall Study|Paperwork errors|0|||
144211604|NCT00996892|519968084|FG013|Expansion Stage 2A|Physician Decision|0|||
144211605|NCT00996892|519968085|FG014|Expansion Stage 2A|Physician Decision|0|||
144211606|NCT00996892|519968086|FG015|Expansion Stage 2A|Physician Decision|0|||
144646736|NCT01856673|521559831|FG002|Overall Study|Paperwork errors|0|||
144646737|NCT01856673|521559829|FG000|Overall Study|Death|1|||
144646738|NCT01856673|521559830|FG001|Overall Study|Death|1|||
144646739|NCT01856673|521559831|FG002|Overall Study|Death|0|||
144646740|NCT01856673|521559829|FG000|Overall Study|Protocol Violation|1|||
144646741|NCT01856673|521559830|FG001|Overall Study|Protocol Violation|0|||
144646742|NCT01856673|521559831|FG002|Overall Study|Protocol Violation|1|||
144646743|NCT02859415|521559832|FG000|Overall Study|Physician Decision|1|||
144646744|NCT02859415|521559833|FG001|Overall Study|Physician Decision|0|||
144646745|NCT02859415|521559832|FG000|Overall Study|Off treatment due to cardiac event|0|||
144646746|NCT02859415|521559833|FG001|Overall Study|Off treatment due to cardiac event|1|||
144646747|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Adverse Event|12|||
144646748|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Adverse Event|3|||
144646749|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Adverse Event|4|||
144646750|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Adverse Event|2|||
144646751|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
144646752|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
144646753|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
144646754|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
144646755|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
144646756|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
144646757|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
144646758|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
144646759|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
144646760|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
144646761|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
144646762|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
144646763|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
144646764|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
144646765|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
144646766|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
144646767|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
144646768|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
144646769|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
144646770|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
144646771|NCT02436239|521559834|FG000|Open-Lable Treatment Period|Other Reason|1|||
144646772|NCT02436239|521559835|FG001|Open-Lable Treatment Period|Other Reason|1|||
144646773|NCT02436239|521559836|FG002|Open-Lable Treatment Period|Other Reason|0|||
144646774|NCT02436239|521559837|FG003|Open-Lable Treatment Period|Other Reason|0|||
144646775|NCT02436239|521559834|FG000|Down-Taper Period|Withdrawal by Subject|4|||
144646776|NCT02436239|521559835|FG001|Down-Taper Period|Withdrawal by Subject|4|||
144646777|NCT02436239|521559836|FG002|Down-Taper Period|Withdrawal by Subject|1|||
144646778|NCT02436239|521559837|FG003|Down-Taper Period|Withdrawal by Subject|2|||
144646779|NCT02168946|521559838|FG000|Overall Study|Adverse Event|8|||
144646780|NCT02168946|521559839|FG001|Overall Study|Adverse Event|5|||
144646781|NCT02168946|521559838|FG000|Overall Study|Lost to Follow-up|3|||
144646782|NCT02168946|521559839|FG001|Overall Study|Lost to Follow-up|0|||
144646783|NCT02168946|521559838|FG000|Overall Study|Subject unable to come back for visits|1|||
144646784|NCT02168946|521559839|FG001|Overall Study|Subject unable to come back for visits|0|||
144646785|NCT00450866|521559844|FG000|Overall Study|Adverse Event|0|||
144646786|NCT00450866|521559845|FG001|Overall Study|Adverse Event|1|||
144646787|NCT00450866|521559844|FG000|Overall Study|Withdrawal by Subject|5|||
144646788|NCT00450866|521559845|FG001|Overall Study|Withdrawal by Subject|2|||
144646789|NCT00450866|521559844|FG000|Overall Study|Death|1|||
144646790|NCT00450866|521559845|FG001|Overall Study|Death|0|||
144646791|NCT00450866|521559844|FG000|Overall Study|Physician Decision|1|||
144646792|NCT00450866|521559845|FG001|Overall Study|Physician Decision|0|||
144646793|NCT02498821|521559846|FG000|Overall Study|Screen failure|3|||
144646794|NCT02498821|521559847|FG001|Overall Study|Screen failure|5|||
144731646|NCT00450190|521873227|FG000|Overall Study|Withdrawal by Subject|2|||
144731647|NCT00834756|521873228|FG000|First Intervention|Adverse Event|1|||
144731648|NCT00834756|521873229|FG001|First Intervention|Adverse Event|0|||
144731649|NCT00834756|521873228|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
144731650|NCT00834756|521873229|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
144731651|NCT01498120|521873235|FG000|Overall Study|Lost to Follow-up|1|||
144731652|NCT01498120|521873235|FG000|Overall Study|Withdrawal by Subject|5|||
144731653|NCT01498120|521873235|FG000|Overall Study|AE, non-serious non-fatal|3|||
144646795|NCT00231478|521559854|FG000|Overall Study|Protocol Violation|3|||
144646796|NCT00231478|521559855|FG001|Overall Study|Protocol Violation|2|||
144646797|NCT00231478|521559854|FG000|Overall Study|Refused Treatment|1|||
144646798|NCT00231478|521559855|FG001|Overall Study|Refused Treatment|1|||
144646799|NCT00231478|521559854|FG000|Overall Study|Withdrawal by Subject|1|||
144646800|NCT00231478|521559855|FG001|Overall Study|Withdrawal by Subject|0|||
144646801|NCT00231478|521559854|FG000|Overall Study|Adverse Event|0|||
144731654|NCT01498120|521873235|FG000|Overall Study|Other|4|||
144646802|NCT00231478|521559855|FG001|Overall Study|Adverse Event|1|||
144731655|NCT00112463|521873238|FG000|Overall Study|Physician Decision|1|||
144646803|NCT00231478|521559854|FG000|Overall Study|Administrative|3|||
144646804|NCT00231478|521559855|FG001|Overall Study|Administrative|2|||
144646805|NCT04538950|521559856|FG000|Overall Study|Pulmonary Issues|2|||
144646806|NCT04538950|521559856|FG000|Overall Study|illness|2|||
144646807|NCT00970294|521559861|FG000|Overall Study|Physician Decision|4|||
144646808|NCT00970294|521559861|FG000|Overall Study|Withdrawal by Subject|1|||
144646809|NCT01333189|521559864|FG000|Overall Study|Time constraints|1|||
144646810|NCT01333189|521559865|FG001|Overall Study|Time constraints|0|||
144646811|NCT01333189|521559864|FG000|Overall Study|Adverse Event|1|||
144646812|NCT01333189|521559865|FG001|Overall Study|Adverse Event|0|||
144646813|NCT01333189|521559864|FG000|Overall Study|Transportation difficulties|0|||
144646814|NCT01333189|521559865|FG001|Overall Study|Transportation difficulties|1|||
144646815|NCT01333189|521559864|FG000|Overall Study|Moved from region|0|||
144646816|NCT01333189|521559865|FG001|Overall Study|Moved from region|1|||
144646817|NCT00393458|521559866|FG000|Overall Study|Adverse Event|35|||
144646818|NCT00393458|521559867|FG001|Overall Study|Adverse Event|24|||
144646819|NCT00393458|521559868|FG002|Overall Study|Adverse Event|40|||
144646820|NCT00393458|521559869|FG003|Overall Study|Adverse Event|35|||
144646821|NCT00393458|521559866|FG000|Overall Study|Subject withdrew consent|27|||
144646822|NCT00393458|521559867|FG001|Overall Study|Subject withdrew consent|40|||
144646823|NCT00393458|521559868|FG002|Overall Study|Subject withdrew consent|33|||
144646824|NCT00393458|521559869|FG003|Overall Study|Subject withdrew consent|50|||
144646825|NCT00393458|521559866|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
144646826|NCT00393458|521559867|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
144646827|NCT00393458|521559868|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
144646828|NCT00393458|521559869|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
144646829|NCT00393458|521559866|FG000|Overall Study|Protocol deviation|11|||
144646830|NCT00393458|521559867|FG001|Overall Study|Protocol deviation|11|||
144646831|NCT00393458|521559868|FG002|Overall Study|Protocol deviation|11|||
144646832|NCT00393458|521559869|FG003|Overall Study|Protocol deviation|10|||
144646833|NCT00393458|521559866|FG000|Overall Study|Administrative problems|7|||
144646834|NCT00393458|521559867|FG001|Overall Study|Administrative problems|8|||
144646835|NCT00393458|521559868|FG002|Overall Study|Administrative problems|5|||
144646836|NCT00393458|521559869|FG003|Overall Study|Administrative problems|2|||
144646837|NCT00393458|521559866|FG000|Overall Study|Lost to Follow-up|5|||
144646838|NCT00393458|521559867|FG001|Overall Study|Lost to Follow-up|6|||
144646839|NCT00393458|521559868|FG002|Overall Study|Lost to Follow-up|5|||
144646840|NCT00393458|521559869|FG003|Overall Study|Lost to Follow-up|3|||
144646841|NCT00393458|521559866|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144646842|NCT00393458|521559867|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144646843|NCT00393458|521559868|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144646844|NCT00393458|521559869|FG003|Overall Study|Abnormal laboratory value(s)|0|||
144646845|NCT00393458|521559866|FG000|Overall Study|Death|1|||
144646846|NCT00393458|521559867|FG001|Overall Study|Death|1|||
144646847|NCT00393458|521559868|FG002|Overall Study|Death|5|||
144646848|NCT00393458|521559869|FG003|Overall Study|Death|5|||
144646849|NCT00393458|521559866|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144646850|NCT00393458|521559867|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144646851|NCT00393458|521559868|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144646852|NCT00393458|521559869|FG003|Overall Study|Abnormal test procedure result(s)|2|||
144646853|NCT00393458|521559866|FG000|Overall Study|Subject no longer requires study drug|0|||
144646854|NCT00393458|521559867|FG001|Overall Study|Subject no longer requires study drug|1|||
144646855|NCT00393458|521559868|FG002|Overall Study|Subject no longer requires study drug|0|||
144646856|NCT00393458|521559869|FG003|Overall Study|Subject no longer requires study drug|0|||
144646857|NCT01707147|521559876|FG000|Overall Study|Administered Trajenta prior to contract|5|||
144646858|NCT01707147|521559876|FG000|Overall Study|Patients who have not taken Trajenta|1|||
144646859|NCT01707147|521559876|FG000|Overall Study|Follow-up failure|17|||
144646860|NCT01707147|521559876|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
144646861|NCT01326962|521559880|FG000|Overall Study|Adverse Event|1|||
144646862|NCT01326962|521559880|FG000|Overall Study|Withdrawal by Subject|1|||
144646863|NCT01326962|521559880|FG000|Overall Study|Lost to Follow-up|3|||
144646864|NCT01326962|521559880|FG000|Overall Study|Other|2|||
144646865|NCT02053246|521559881|FG000|Overall Study|Withdrawal by Subject|3|||
144646866|NCT02053246|521559881|FG000|Overall Study|Physician Decision|1|||
144646867|NCT00793585|521559882|FG000|Overall Study|Adverse Event|1|||
144646868|NCT00793585|521559883|FG001|Overall Study|Adverse Event|1|||
144646869|NCT00793585|521559882|FG000|Overall Study|Protocol Violation|1|||
144646870|NCT00793585|521559883|FG001|Overall Study|Protocol Violation|2|||
144646871|NCT03429556|521559884|FG000|Overall Study|Lost to Follow-up|0|||
144646872|NCT03429556|521559885|FG001|Overall Study|Lost to Follow-up|1|||
144646873|NCT03429556|521559886|FG002|Overall Study|Lost to Follow-up|0|||
144646874|NCT03429556|521559887|FG003|Overall Study|Lost to Follow-up|0|||
144646875|NCT00035815|521559888|FG000|Overall Study|Withdrawal by Subject|17|||
144646876|NCT00035815|521559889|FG001|Overall Study|Withdrawal by Subject|11|||
144646877|NCT01266148|521561972|FG000|Overall Study|Adverse Event|2|||
144646878|NCT01266148|521561973|FG001|Overall Study|Adverse Event|0|||
144646879|NCT01266148|521561972|FG000|Overall Study|Ongoing rejection|1|||
144646880|NCT01266148|521561973|FG001|Overall Study|Ongoing rejection|0|||
144646881|NCT01266148|521561972|FG000|Overall Study|2 2R rejections|1|||
144646882|NCT01266148|521561973|FG001|Overall Study|2 2R rejections|0|||
144646883|NCT01266148|521561972|FG000|Overall Study|Death|2|||
144646884|NCT01266148|521561973|FG001|Overall Study|Death|3|||
144646885|NCT01266148|521561972|FG000|Overall Study|missing mGFR value + AE|1|||
144646886|NCT01266148|521561973|FG001|Overall Study|missing mGFR value + AE|0|||
144646887|NCT00521339|521561980|FG000|Treatment Phase|Adverse Event|2|||
144646888|NCT00521339|521561981|FG001|Treatment Phase|Adverse Event|0|||
144646889|NCT00521339|521561982|FG002|Treatment Phase|Adverse Event|0|||
144646890|NCT00521339|521561980|FG000|Treatment Phase|Intolerability to study drug|2|||
144646891|NCT00521339|521561981|FG001|Treatment Phase|Intolerability to study drug|0|||
144646892|NCT00521339|521561982|FG002|Treatment Phase|Intolerability to study drug|0|||
144646893|NCT00521339|521561980|FG000|Treatment Phase|Lack of Efficacy|3|||
144646894|NCT00521339|521561981|FG001|Treatment Phase|Lack of Efficacy|0|||
144646895|NCT00521339|521561982|FG002|Treatment Phase|Lack of Efficacy|0|||
144646896|NCT00521339|521561980|FG000|Treatment Phase|Withdrawal by Subject|3|||
144646897|NCT00521339|521561981|FG001|Treatment Phase|Withdrawal by Subject|0|||
144646898|NCT00521339|521561982|FG002|Treatment Phase|Withdrawal by Subject|0|||
144646899|NCT00521339|521561980|FG000|Treatment Phase|Lost to Follow-up|1|||
144646900|NCT00521339|521561981|FG001|Treatment Phase|Lost to Follow-up|0|||
144646901|NCT00521339|521561982|FG002|Treatment Phase|Lost to Follow-up|0|||
144646902|NCT00521339|521561980|FG000|Treatment Phase|Protocol Violation|1|||
144646903|NCT00521339|521561981|FG001|Treatment Phase|Protocol Violation|0|||
144646904|NCT00521339|521561982|FG002|Treatment Phase|Protocol Violation|0|||
144646905|NCT00521339|521561980|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
144646906|NCT00521339|521561981|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
144646907|NCT00521339|521561982|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
144646908|NCT00521339|521561980|FG000|Treatment Extension Phase|Death|0|||
144646909|NCT00521339|521561981|FG001|Treatment Extension Phase|Death|0|||
144646910|NCT00521339|521561982|FG002|Treatment Extension Phase|Death|1|||
144646911|NCT01650779|521561991|FG000|Overall Study|Withdrawal by Subject|1|||
144646912|NCT01736683|521561992|FG000|Overall Study|Disease Relapse|0|||
144646913|NCT01736683|521561993|FG001|Overall Study|Disease Relapse|0|||
144646914|NCT01736683|521561994|FG002|Overall Study|Disease Relapse|2|||
144646915|NCT01736683|521561995|FG003|Overall Study|Disease Relapse|1|||
144646916|NCT01736683|521561996|FG004|Overall Study|Disease Relapse|0|||
144646917|NCT01736683|521561992|FG000|Overall Study|Adverse Event|0|||
144646918|NCT01736683|521561993|FG001|Overall Study|Adverse Event|2|||
144646919|NCT01736683|521561994|FG002|Overall Study|Adverse Event|2|||
144646920|NCT01736683|521561995|FG003|Overall Study|Adverse Event|3|||
144646921|NCT01736683|521561996|FG004|Overall Study|Adverse Event|2|||
144646922|NCT01736683|521561992|FG000|Overall Study|Withdrawal by Subject|0|||
144646923|NCT01736683|521561993|FG001|Overall Study|Withdrawal by Subject|0|||
144646924|NCT01736683|521561994|FG002|Overall Study|Withdrawal by Subject|3|||
144646925|NCT01736683|521561995|FG003|Overall Study|Withdrawal by Subject|1|||
144646926|NCT01736683|521561996|FG004|Overall Study|Withdrawal by Subject|1|||
144646927|NCT01736683|521561992|FG000|Overall Study|Lack of Therapeutic Effect|7|||
144646928|NCT01736683|521561993|FG001|Overall Study|Lack of Therapeutic Effect|4|||
144646929|NCT01736683|521561994|FG002|Overall Study|Lack of Therapeutic Effect|13|||
144646930|NCT01736683|521561995|FG003|Overall Study|Lack of Therapeutic Effect|20|||
144646931|NCT01736683|521561996|FG004|Overall Study|Lack of Therapeutic Effect|1|||
144646932|NCT01736683|521561992|FG000|Overall Study|Progressive Disease|0|||
144646933|NCT01736683|521561993|FG001|Overall Study|Progressive Disease|0|||
144646934|NCT01736683|521561994|FG002|Overall Study|Progressive Disease|0|||
144646935|NCT01736683|521561995|FG003|Overall Study|Progressive Disease|1|||
144646936|NCT01736683|521561996|FG004|Overall Study|Progressive Disease|0|||
144646937|NCT01736683|521561992|FG000|Overall Study|Other|0|||
144646938|NCT01736683|521561993|FG001|Overall Study|Other|0|||
144211607|NCT00996892|519968087|FG016|Expansion Stage 2A|Physician Decision|0|||
144211608|NCT00996892|519968088|FG017|Expansion Stage 2A|Physician Decision|0|||
144211609|NCT00996892|519968089|FG018|Expansion Stage 2A|Physician Decision|0|||
144211610|NCT00996892|519968090|FG019|Expansion Stage 2A|Physician Decision|2|||
144211611|NCT00996892|519968071|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
144646939|NCT01736683|521561994|FG002|Overall Study|Other|1|||
144211612|NCT00996892|519968072|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
144211613|NCT00996892|519968073|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
144211614|NCT00996892|519968074|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
144646940|NCT01736683|521561995|FG003|Overall Study|Other|9|||
144646941|NCT01736683|521561996|FG004|Overall Study|Other|1|||
144731656|NCT00112463|521873238|FG000|Overall Study|Progression|30|||
144646942|NCT00098345|521561998|FG000|Overall Study|Adverse Event|7|||
144646943|NCT00098345|521561998|FG000|Overall Study|Withdrawal by Subject|2|||
144646944|NCT00098345|521561998|FG000|Overall Study|progression|4|||
144646945|NCT01183858|521561999|FG000|Overall Study|Death not related to Progressive Disease|5|||
144646946|NCT01183858|521562000|FG001|Overall Study|Death not related to Progressive Disease|6|||
144646947|NCT01183858|521561999|FG000|Overall Study|Adverse Event|14|||
144646948|NCT01183858|521562000|FG001|Overall Study|Adverse Event|11|||
144646949|NCT01183858|521561999|FG000|Overall Study|Investigator's Decision|0|||
144646950|NCT01183858|521562000|FG001|Overall Study|Investigator's Decision|3|||
144646951|NCT01183858|521561999|FG000|Overall Study|Insufficient Therapeutic Response|2|||
144646952|NCT01183858|521562000|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144646953|NCT01183858|521561999|FG000|Overall Study|Refused Treatment|1|||
144646954|NCT01183858|521562000|FG001|Overall Study|Refused Treatment|4|||
144646955|NCT01183858|521561999|FG000|Overall Study|Withdrew Consent|4|||
144646956|NCT01183858|521562000|FG001|Overall Study|Withdrew Consent|4|||
144646957|NCT01183858|521561999|FG000|Overall Study|Discontinued Smoking|3|||
144646958|NCT01183858|521562000|FG001|Overall Study|Discontinued Smoking|1|||
144646959|NCT01183858|521561999|FG000|Overall Study|Protocol Violation|1|||
144211615|NCT00996892|519968075|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
144211616|NCT00996892|519968076|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
144211617|NCT00996892|519968077|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
144211618|NCT00996892|519968078|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
144646960|NCT01183858|521562000|FG001|Overall Study|Protocol Violation|0|||
144646961|NCT01183858|521561999|FG000|Overall Study|Administrative/Other|6|||
144646962|NCT01183858|521562000|FG001|Overall Study|Administrative/Other|6|||
144646963|NCT01183858|521561999|FG000|Overall Study|Progressive Disease|112|||
144646964|NCT01183858|521562000|FG001|Overall Study|Progressive Disease|115|||
144646965|NCT01183858|521561999|FG000|Overall Study|Death related to Progressive Disease|4|||
144646966|NCT01183858|521562000|FG001|Overall Study|Death related to Progressive Disease|5|||
144646967|NCT01183858|521561999|FG000|Overall Study|Lost to Follow-up|1|||
144646968|NCT01183858|521562000|FG001|Overall Study|Lost to Follow-up|1|||
144646969|NCT01295905|521562005|FG000|Overall Study|Did not meet inclusion criteria|1|||
144646970|NCT01295905|521562006|FG001|Overall Study|Did not meet inclusion criteria|0|||
144646971|NCT01295905|521562005|FG000|Overall Study|Met exclusion criteria|1|||
144646972|NCT01295905|521562006|FG001|Overall Study|Met exclusion criteria|0|||
144646973|NCT03707977|521562007|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
144646974|NCT03707977|521562008|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
144646975|NCT03707977|521562009|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
144646976|NCT03707977|521562007|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
144646977|NCT03707977|521562008|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
144646978|NCT03707977|521562009|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
144646979|NCT00641147|521562010|FG000|Completed 4 Months.|Physician Decision|1|||
144646980|NCT00641147|521562011|FG001|Completed 4 Months.|Physician Decision|0|||
144646981|NCT00641147|521562010|FG000|Completed 4 Months.|Adverse Event|1|||
144646982|NCT00641147|521562011|FG001|Completed 4 Months.|Adverse Event|0|||
144646983|NCT00641147|521562010|FG000|Completed 8 Months.|Physician Decision|2|||
144646984|NCT00641147|521562011|FG001|Completed 8 Months.|Physician Decision|1|||
144646985|NCT00641147|521562010|FG000|Completed 8 Months.|non compliance|1|||
144646986|NCT00641147|521562011|FG001|Completed 8 Months.|non compliance|0|||
144646987|NCT00641147|521562010|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
144646988|NCT00641147|521562011|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
144646989|NCT00641147|521562010|FG000|Completed 12 Months.|Physician Decision|1|||
144646990|NCT00641147|521562011|FG001|Completed 12 Months.|Physician Decision|1|||
144646991|NCT00641147|521562010|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
144646992|NCT00641147|521562011|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
144646993|NCT00641147|521562010|FG000|Completed 16 Months.|Physician Decision|1|||
144646994|NCT00641147|521562011|FG001|Completed 16 Months.|Physician Decision|0|||
144646995|NCT00641147|521562010|FG000|Completed 16 Months.|Lost to Follow-up|1|||
144646996|NCT00641147|521562011|FG001|Completed 16 Months.|Lost to Follow-up|0|||
144646997|NCT00791128|521562012|FG000|Overall Study|Adverse Event|4|||
144646998|NCT00791128|521562012|FG000|Overall Study|Device migration|2|||
144646999|NCT00791128|521562012|FG000|Overall Study|non-compliance by subject|2|||
144647000|NCT00791128|521562012|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
144647001|NCT01629667|521562013|FG000|Overall Study|Lost to Follow-up|0|||
144647002|NCT01629667|521562014|FG001|Overall Study|Lost to Follow-up|1|||
144647003|NCT01629667|521562015|FG002|Overall Study|Lost to Follow-up|1|||
144647004|NCT01629667|521562013|FG000|Overall Study|Withdrawal by Subject|31|||
144647005|NCT01629667|521562014|FG001|Overall Study|Withdrawal by Subject|20|||
144647006|NCT01629667|521562015|FG002|Overall Study|Withdrawal by Subject|28|||
144647007|NCT01629667|521562013|FG000|Overall Study|Death|1|||
144647008|NCT01629667|521562014|FG001|Overall Study|Death|5|||
144647009|NCT01629667|521562015|FG002|Overall Study|Death|3|||
144647010|NCT01629667|521562013|FG000|Overall Study|Randomized, not treated|2|||
144647011|NCT01629667|521562014|FG001|Overall Study|Randomized, not treated|1|||
144647012|NCT01629667|521562015|FG002|Overall Study|Randomized, not treated|0|||
144647013|NCT01629667|521562013|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
144731657|NCT00112463|521873238|FG000|Overall Study|Second Primary|1|||
144647014|NCT01629667|521562014|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
144647015|NCT01629667|521562015|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
144647016|NCT01629667|521562013|FG000|Overall Study|Requiring lung transplant|2|||
144647017|NCT01629667|521562014|FG001|Overall Study|Requiring lung transplant|1|||
144647018|NCT01629667|521562015|FG002|Overall Study|Requiring lung transplant|3|||
144647019|NCT01629667|521562013|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
144647020|NCT01629667|521562014|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
144647021|NCT01629667|521562015|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
144647022|NCT01629667|521562013|FG000|Overall Study|Started other medicine|1|||
144647023|NCT01629667|521562014|FG001|Overall Study|Started other medicine|0|||
144647024|NCT01629667|521562015|FG002|Overall Study|Started other medicine|1|||
144647025|NCT01629667|521562013|FG000|Overall Study|Site error in safety follow-up|0|||
144647026|NCT01629667|521562014|FG001|Overall Study|Site error in safety follow-up|0|||
144647027|NCT01629667|521562015|FG002|Overall Study|Site error in safety follow-up|1|||
144647028|NCT01629667|521562013|FG000|Overall Study|Enrolled in another clinical study|0|||
144647029|NCT01629667|521562014|FG001|Overall Study|Enrolled in another clinical study|1|||
144647030|NCT01629667|521562015|FG002|Overall Study|Enrolled in another clinical study|0|||
144647031|NCT01629667|521562013|FG000|Overall Study|Code break|1|||
144647032|NCT01629667|521562014|FG001|Overall Study|Code break|0|||
144647033|NCT01629667|521562015|FG002|Overall Study|Code break|0|||
144647034|NCT00670111|521562017|FG000|Enrollment to One Month|Testing Failure|0|||
144647035|NCT00670111|521562018|FG001|Enrollment to One Month|Testing Failure|0|||
144647036|NCT00670111|521562019|FG002|Enrollment to One Month|Testing Failure|13|||
144647037|NCT00670111|521562017|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
144647038|NCT00670111|521562018|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
144647039|NCT00670111|521562019|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
144647040|NCT00670111|521562017|FG000|Enrollment to One Month|Physician Decision|1|||
144647041|NCT00670111|521562018|FG001|Enrollment to One Month|Physician Decision|0|||
144647042|NCT00670111|521562019|FG002|Enrollment to One Month|Physician Decision|0|||
144647043|NCT02623361|521562020|FG000|Overall Study|Protocol Violation|0|||
144647044|NCT02623361|521562021|FG001|Overall Study|Protocol Violation|1|||
144647045|NCT02623361|521562020|FG000|Overall Study|Withdrawal by Subject|0|||
144647046|NCT02623361|521562021|FG001|Overall Study|Withdrawal by Subject|1|||
144647047|NCT02441803|521562023|FG000|Overall Study|Physician Decision|0|||
144647048|NCT02441803|521562024|FG001|Overall Study|Physician Decision|2|||
144647049|NCT02441803|521562025|FG002|Overall Study|Physician Decision|2|||
144647050|NCT00328198|521562031|FG000|Treatment|Adverse Event|21|||
144647051|NCT00328198|521562031|FG000|Treatment|Death|1|||
144647052|NCT00328198|521562031|FG000|Treatment|Physician Decision|5|||
144647053|NCT00328198|521562031|FG000|Treatment|Withdrawal by Subject|5|||
144647054|NCT00328198|521562031|FG000|Treatment|Evidence of disease progression|2|||
144647055|NCT00328198|521562031|FG000|Treatment|Non-compliance|1|||
144647056|NCT00328198|521562031|FG000|Treatment|Confirmed complete response, MRD -|3|||
144647057|NCT00328198|521562031|FG000|Follow-up|Lost to Follow-up|4|||
144647058|NCT00328198|521562031|FG000|Follow-up|Death|31|||
144647059|NCT01720667|521562032|FG000|Overall Study|Adverse Event|1|||
144647060|NCT01720667|521562033|FG001|Overall Study|Adverse Event|1|||
144647061|NCT01720667|521562032|FG000|Overall Study|Withdrawal by Subject|3|||
144647062|NCT01720667|521562033|FG001|Overall Study|Withdrawal by Subject|0|||
144647063|NCT02117050|521562036|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
144647064|NCT02052960|521562038|FG000|Overall Study|Adverse Event|19|||
144647065|NCT02052960|521562039|FG001|Overall Study|Adverse Event|17|||
144647066|NCT02052960|521562038|FG000|Overall Study|Protocol Violation|4|||
144647067|NCT02052960|521562039|FG001|Overall Study|Protocol Violation|3|||
144647068|NCT02052960|521562038|FG000|Overall Study|Withdrawal by Subject|6|||
144647069|NCT02052960|521562039|FG001|Overall Study|Withdrawal by Subject|11|||
144647070|NCT02052960|521562038|FG000|Overall Study|Other|25|||
144647071|NCT02052960|521562039|FG001|Overall Study|Other|15|||
144647072|NCT00491530|521562042|FG000|Overall Study|Adverse Event|6|||
144647073|NCT00491530|521562043|FG001|Overall Study|Adverse Event|1|||
144647074|NCT00491530|521562044|FG002|Overall Study|Adverse Event|2|||
144647075|NCT00491530|521562042|FG000|Overall Study|Withdrawal by Subject|3|||
144263278|NCT02317991|520165382|FG000|Overall Study|Withdrawal by Subject|8|||
144263279|NCT02317991|520165382|FG000|Overall Study|Progressive Disease|41|||
144263280|NCT01051921|520165384|FG000|Overall Study|Physician Decision|9|||
144263281|NCT01051921|520165384|FG000|Overall Study|Adverse Event|8|||
144647076|NCT00491530|521562043|FG001|Overall Study|Withdrawal by Subject|0|||
144647077|NCT00491530|521562044|FG002|Overall Study|Withdrawal by Subject|0|||
144647078|NCT00491530|521562042|FG000|Overall Study|Lost to Follow-up|3|||
144647079|NCT00491530|521562043|FG001|Overall Study|Lost to Follow-up|2|||
144647080|NCT00491530|521562044|FG002|Overall Study|Lost to Follow-up|2|||
144731658|NCT00112463|521873238|FG000|Overall Study|Toxicity|3|||
144263282|NCT01051921|520165384|FG000|Overall Study|Withdrawal by Subject|7|||
144263283|NCT01051921|520165384|FG000|Overall Study|Lost to Follow-up|4|||
144647081|NCT00491530|521562042|FG000|Overall Study|Lack of Efficacy|0|||
144647082|NCT00491530|521562043|FG001|Overall Study|Lack of Efficacy|1|||
144647083|NCT00491530|521562044|FG002|Overall Study|Lack of Efficacy|0|||
144647084|NCT00491530|521562042|FG000|Overall Study|Investigator Discretion|0|||
144647085|NCT00491530|521562043|FG001|Overall Study|Investigator Discretion|1|||
144647086|NCT00491530|521562044|FG002|Overall Study|Investigator Discretion|0|||
144647087|NCT00491530|521562042|FG000|Overall Study|Patient Request|0|||
144263284|NCT01051921|520165384|FG000|Overall Study|virological failure|1|||
144647088|NCT00491530|521562043|FG001|Overall Study|Patient Request|1|||
144647089|NCT00491530|521562044|FG002|Overall Study|Patient Request|0|||
144647090|NCT00491530|521562042|FG000|Overall Study|Use of Prohibited Medication|0|||
144647091|NCT00491530|521562043|FG001|Overall Study|Use of Prohibited Medication|0|||
144647092|NCT00491530|521562044|FG002|Overall Study|Use of Prohibited Medication|1|||
144647093|NCT01396525|521562045|FG000|Overall Study|Withdrawal by Subject|8|||
144647094|NCT01396525|521562045|FG000|Overall Study|Death|14|||
144647095|NCT01396525|521562045|FG000|Overall Study|Lost to Follow-up|4|||
144647096|NCT00949650|521562046|FG000|Overall Study|Progressive disease|188|||
144647097|NCT00949650|521562047|FG001|Overall Study|Progressive disease|19|||
144647098|NCT00949650|521562046|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
144647099|NCT00949650|521562047|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
144647100|NCT00949650|521562046|FG000|Overall Study|Other Adverse Event (AE)|28|||
144647101|NCT00949650|521562047|FG001|Overall Study|Other Adverse Event (AE)|17|||
144647102|NCT00949650|521562046|FG000|Overall Study|Protocol Violation|1|||
144647103|NCT00949650|521562047|FG001|Overall Study|Protocol Violation|4|||
144647104|NCT00949650|521562046|FG000|Overall Study|Refusal to continue medication|7|||
144647105|NCT00949650|521562047|FG001|Overall Study|Refusal to continue medication|11|||
144647106|NCT00949650|521562046|FG000|Overall Study|Not treated|1|||
144647107|NCT00949650|521562047|FG001|Overall Study|Not treated|4|||
144647108|NCT00949650|521562046|FG000|Overall Study|Other not specified above|5|||
144647109|NCT00949650|521562047|FG001|Overall Study|Other not specified above|0|||
144647110|NCT01971476|521562050|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
144647111|NCT01971476|521562051|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
144647112|NCT01971476|521562052|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
144647113|NCT01971476|521562050|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
144647114|NCT01971476|521562051|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
144647115|NCT01971476|521562052|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
144647116|NCT01971476|521562050|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
144647117|NCT01971476|521562051|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
144647118|NCT01971476|521562052|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
144647119|NCT00138151|521562053|FG000|Overall Study|Withdrawal by Subject|3|||
144647120|NCT00138151|521562053|FG000|Overall Study|Physician Decision|1|||
144647121|NCT02675517|521562056|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
144647122|NCT02675517|521562056|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
144647123|NCT02619253|521562059|FG000|Overall Study|Adverse Event|0|||
144647124|NCT02619253|521562060|FG001|Overall Study|Adverse Event|0|||
144647125|NCT02619253|521562061|FG002|Overall Study|Adverse Event|1|||
144647126|NCT02619253|521562062|FG003|Overall Study|Adverse Event|1|||
144647127|NCT02619253|521562063|FG004|Overall Study|Adverse Event|3|||
144647128|NCT02619253|521562059|FG000|Overall Study|Alternative Therapy|0|||
144647129|NCT02619253|521562060|FG001|Overall Study|Alternative Therapy|0|||
144647130|NCT02619253|521562061|FG002|Overall Study|Alternative Therapy|1|||
144647131|NCT02619253|521562062|FG003|Overall Study|Alternative Therapy|0|||
144647132|NCT02619253|521562063|FG004|Overall Study|Alternative Therapy|0|||
144647133|NCT02619253|521562059|FG000|Overall Study|Death|0|||
144647134|NCT02619253|521562060|FG001|Overall Study|Death|0|||
144647135|NCT02619253|521562061|FG002|Overall Study|Death|0|||
144647136|NCT02619253|521562062|FG003|Overall Study|Death|1|||
144647137|NCT02619253|521562063|FG004|Overall Study|Death|0|||
144647138|NCT02619253|521562059|FG000|Overall Study|Disease Progression|4|||
144647139|NCT02619253|521562060|FG001|Overall Study|Disease Progression|2|||
144647140|NCT02619253|521562061|FG002|Overall Study|Disease Progression|8|||
144647141|NCT02619253|521562062|FG003|Overall Study|Disease Progression|9|||
144647142|NCT02619253|521562063|FG004|Overall Study|Disease Progression|10|||
144647143|NCT02619253|521562059|FG000|Overall Study|Needed a disqualifying therapy|0|||
144647144|NCT02619253|521562060|FG001|Overall Study|Needed a disqualifying therapy|0|||
144647145|NCT02619253|521562061|FG002|Overall Study|Needed a disqualifying therapy|1|||
144647146|NCT02619253|521562062|FG003|Overall Study|Needed a disqualifying therapy|0|||
144647147|NCT02619253|521562063|FG004|Overall Study|Needed a disqualifying therapy|0|||
144647148|NCT02619253|521562059|FG000|Overall Study|Transferred to hospice|0|||
144647149|NCT02619253|521562060|FG001|Overall Study|Transferred to hospice|0|||
144647150|NCT02619253|521562061|FG002|Overall Study|Transferred to hospice|1|||
144647151|NCT02619253|521562062|FG003|Overall Study|Transferred to hospice|0|||
144211619|NCT00996892|519968079|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
144647152|NCT02619253|521562063|FG004|Overall Study|Transferred to hospice|0|||
144647153|NCT02619253|521562059|FG000|Overall Study|Physician Decision|0|||
144647154|NCT02619253|521562060|FG001|Overall Study|Physician Decision|1|||
144211620|NCT00996892|519968080|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
144647155|NCT02619253|521562061|FG002|Overall Study|Physician Decision|2|||
144647156|NCT02619253|521562062|FG003|Overall Study|Physician Decision|3|||
144647157|NCT02619253|521562063|FG004|Overall Study|Physician Decision|0|||
144647158|NCT02619253|521562059|FG000|Overall Study|Withdrawal by Subject|0|||
144211621|NCT00996892|519968081|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
144647159|NCT02619253|521562060|FG001|Overall Study|Withdrawal by Subject|1|||
144647160|NCT02619253|521562061|FG002|Overall Study|Withdrawal by Subject|0|||
144647161|NCT02619253|521562062|FG003|Overall Study|Withdrawal by Subject|0|||
144647162|NCT02619253|521562063|FG004|Overall Study|Withdrawal by Subject|2|||
144211622|NCT00996892|519968082|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
144211623|NCT00996892|519968083|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
144647163|NCT00301067|521562068|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
144647164|NCT00301067|521562069|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
144647165|NCT00301067|521562070|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
144647166|NCT00301067|521562071|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
144647167|NCT00301067|521562068|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
144647168|NCT00301067|521562069|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
144647169|NCT00301067|521562070|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
144647170|NCT00301067|521562071|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
144647171|NCT00301067|521562068|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
144647172|NCT00301067|521562069|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
144647173|NCT00301067|521562070|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
144647174|NCT00301067|521562071|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
144647175|NCT00301067|521562068|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
144647176|NCT00301067|521562069|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
144647177|NCT00301067|521562070|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
144647178|NCT00301067|521562071|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
144647179|NCT00301067|521562068|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
144647180|NCT00301067|521562069|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
144647181|NCT00301067|521562070|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
144647182|NCT00301067|521562071|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
144647183|NCT00301067|521562068|FG000|Follow up Until Death|Alive at last data cut point|1|||
144647184|NCT00301067|521562069|FG001|Follow up Until Death|Alive at last data cut point|0|||
144647185|NCT00301067|521562070|FG002|Follow up Until Death|Alive at last data cut point|0|||
144647186|NCT00301067|521562071|FG003|Follow up Until Death|Alive at last data cut point|1|||
144647187|NCT00149825|521562072|FG000|Overall Study|Intolerance to medication side effects|1|||
144647188|NCT00149825|521562073|FG001|Overall Study|Intolerance to medication side effects|2|||
144647189|NCT00149825|521562072|FG000|Overall Study|Time commitments|2|||
144647190|NCT00149825|521562073|FG001|Overall Study|Time commitments|1|||
144647191|NCT00149825|521562072|FG000|Overall Study|Not liking insomnia therapy|1|||
144647192|NCT00149825|521562073|FG001|Overall Study|Not liking insomnia therapy|0|||
144647193|NCT00149825|521562072|FG000|Overall Study|Other|1|||
144647194|NCT00149825|521562073|FG001|Overall Study|Other|0|||
144647195|NCT00069121|521562074|FG000|Overall Study|Death|286|||
144647196|NCT00069121|521562075|FG001|Overall Study|Death|242|||
144647197|NCT00069121|521562074|FG000|Overall Study|Withdrawal by Subject|18|||
144647198|NCT00069121|521562075|FG001|Overall Study|Withdrawal by Subject|20|||
144647199|NCT00069121|521562074|FG000|Overall Study|Lost to Follow-up|63|||
144647200|NCT00069121|521562075|FG001|Overall Study|Lost to Follow-up|63|||
144647201|NCT00942708|521562076|FG000|Overall Study|Withdrawal by Subject|1|||
144647202|NCT01457339|521562081|FG000|Period 3 (100 mg)|Adverse Event|0|||
144647203|NCT01457339|521562082|FG001|Period 3 (100 mg)|Adverse Event|1|||
144647204|NCT01457339|521562081|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
144647205|NCT01457339|521562082|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
144647206|NCT01457339|521562081|FG000|Period 6 (250 mg)|Family Emergency|1|||
144647207|NCT01457339|521562082|FG001|Period 6 (250 mg)|Family Emergency|0|||
144647208|NCT01457339|521562081|FG000|Period 6 (250 mg)|Personal appointment|0|||
144647209|NCT01457339|521562082|FG001|Period 6 (250 mg)|Personal appointment|1|||
144647210|NCT00306891|521562085|FG000|Part A|Withdrawal by Subject|1|||
144647211|NCT00306891|521562086|FG001|Part A|Withdrawal by Subject|1|||
144647212|NCT00306891|521562087|FG002|Part A|Withdrawal by Subject|0|||
144647213|NCT00306891|521562088|FG003|Part A|Withdrawal by Subject|0|||
144647214|NCT00306891|521562085|FG000|Part A|Condition under investigation worsened|2|||
144647215|NCT00306891|521562086|FG001|Part A|Condition under investigation worsened|2|||
144647216|NCT00306891|521562087|FG002|Part A|Condition under investigation worsened|0|||
144647217|NCT00306891|521562088|FG003|Part A|Condition under investigation worsened|0|||
144647218|NCT00306891|521562085|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
144647219|NCT00306891|521562086|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
144647220|NCT00306891|521562087|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
144211624|NCT00996892|519968084|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
144211625|NCT00996892|519968085|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
144211626|NCT00996892|519968086|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
144647221|NCT00306891|521562088|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
144647222|NCT00306891|521562085|FG000|Part A|Partial bowel obstruction|1|||
144647223|NCT00306891|521562086|FG001|Part A|Partial bowel obstruction|0|||
144647224|NCT00306891|521562087|FG002|Part A|Partial bowel obstruction|0|||
144647225|NCT00306891|521562088|FG003|Part A|Partial bowel obstruction|0|||
144647226|NCT00306891|521562085|FG000|Part A|Reaccumul. of ascites following drainage|0|||
144647227|NCT00306891|521562086|FG001|Part A|Reaccumul. of ascites following drainage|1|||
144211627|NCT00996892|519968087|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
144647228|NCT00306891|521562087|FG002|Part A|Reaccumul. of ascites following drainage|0|||
144647229|NCT00306891|521562088|FG003|Part A|Reaccumul. of ascites following drainage|0|||
144647230|NCT00306891|521562085|FG000|Part A|Suspicion of second malignancy|0|||
144647231|NCT00306891|521562086|FG001|Part A|Suspicion of second malignancy|1|||
144647232|NCT00306891|521562087|FG002|Part A|Suspicion of second malignancy|0|||
144647233|NCT00306891|521562088|FG003|Part A|Suspicion of second malignancy|0|||
144647234|NCT00306891|521562085|FG000|Part A|QTC interval outwith elig. criteria|1|||
144647235|NCT00306891|521562086|FG001|Part A|QTC interval outwith elig. criteria|0|||
144647236|NCT00306891|521562087|FG002|Part A|QTC interval outwith elig. criteria|0|||
144647237|NCT00306891|521562088|FG003|Part A|QTC interval outwith elig. criteria|0|||
144647238|NCT00306891|521562085|FG000|Part B|Death|0|||
144647239|NCT00306891|521562086|FG001|Part B|Death|0|||
144647240|NCT00306891|521562087|FG002|Part B|Death|1|||
144647241|NCT00306891|521562088|FG003|Part B|Death|2|||
144647242|NCT00306891|521562085|FG000|Part B|Adverse Event|0|||
144647243|NCT00306891|521562086|FG001|Part B|Adverse Event|0|||
144647244|NCT00306891|521562087|FG002|Part B|Adverse Event|5|||
144647245|NCT00306891|521562088|FG003|Part B|Adverse Event|5|||
144647246|NCT00306891|521562085|FG000|Part B|Withdrawal by Subject|0|||
144647247|NCT00306891|521562086|FG001|Part B|Withdrawal by Subject|0|||
144647248|NCT00306891|521562087|FG002|Part B|Withdrawal by Subject|3|||
144647249|NCT00306891|521562088|FG003|Part B|Withdrawal by Subject|1|||
144647250|NCT00306891|521562085|FG000|Part B|Condition under investigation worsened|0|||
144647251|NCT00306891|521562086|FG001|Part B|Condition under investigation worsened|0|||
144647252|NCT00306891|521562087|FG002|Part B|Condition under investigation worsened|2|||
144647253|NCT00306891|521562088|FG003|Part B|Condition under investigation worsened|8|||
144647254|NCT00306891|521562085|FG000|Part B|Development of study specific disc crit.|0|||
144647255|NCT00306891|521562086|FG001|Part B|Development of study specific disc crit.|0|||
144647256|NCT00306891|521562087|FG002|Part B|Development of study specific disc crit.|0|||
144647257|NCT00306891|521562088|FG003|Part B|Development of study specific disc crit.|1|||
144647258|NCT02613572|521562089|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
144647259|NCT02613572|521562090|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
144647260|NCT02613572|521562091|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
144647261|NCT02613572|521562089|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
144647262|NCT02613572|521562090|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
144647263|NCT02613572|521562091|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
144647264|NCT00847561|521562097|FG000|Overall Study|Withdrawal by Subject|4|||
144647265|NCT00847561|521562098|FG001|Overall Study|Withdrawal by Subject|3|||
144647266|NCT00847561|521562097|FG000|Overall Study|Unable to schedule|9|||
144647267|NCT00847561|521562098|FG001|Overall Study|Unable to schedule|1|||
144647268|NCT02489630|521562099|FG000|Overall Study|Oversedation|1|||
144647269|NCT02489630|521562100|FG001|Overall Study|Oversedation|1|||
144647270|NCT02489630|521562099|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
144647271|NCT02489630|521562100|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
144647272|NCT00377299|521562101|FG000|Overall Study|Lost to Follow-up|14|||
144647273|NCT00377299|521562102|FG001|Overall Study|Lost to Follow-up|19|||
144647274|NCT00377299|521562101|FG000|Overall Study|Adverse Event|0|||
144647275|NCT00377299|521562102|FG001|Overall Study|Adverse Event|1|||
144647276|NCT00377299|521562101|FG000|Overall Study|Withdrawal by Subject|5|||
144647277|NCT00377299|521562102|FG001|Overall Study|Withdrawal by Subject|4|||
144647278|NCT02369510|521562105|FG000|Overall Study|Spilled Medication|1|||
144647279|NCT02369510|521562106|FG001|Overall Study|Spilled Medication|2|||
144647280|NCT02369510|521562107|FG002|Overall Study|Spilled Medication|1|||
144647281|NCT02369510|521562105|FG000|Overall Study|Epidural Activation|1|||
144647282|NCT02369510|521562106|FG001|Overall Study|Epidural Activation|1|||
144647283|NCT02369510|521562107|FG002|Overall Study|Epidural Activation|5|||
144647284|NCT02050048|521562108|FG000|Overall Study|Lost to Follow-up|0|||
144647285|NCT02050048|521562109|FG001|Overall Study|Lost to Follow-up|1|||
144647286|NCT02050048|521562108|FG000|Overall Study|Death|1|||
144647287|NCT02050048|521562109|FG001|Overall Study|Death|0|||
144647288|NCT02050048|521562108|FG000|Overall Study|Ineligible after ERCP|4|||
144647289|NCT02050048|521562109|FG001|Overall Study|Ineligible after ERCP|1|||
144647290|NCT04285723|521562114|FG000|Overall Study|Subject decision|1|||
144647291|NCT04285723|521562115|FG001|Overall Study|Subject decision|2|||
144647292|NCT04285723|521562114|FG000|Overall Study|Physician Decision|1|||
144647293|NCT04285723|521562115|FG001|Overall Study|Physician Decision|0|||
144647294|NCT04285723|521562114|FG000|Overall Study|No efficiency|1|||
144647295|NCT04285723|521562115|FG001|Overall Study|No efficiency|0|||
144647296|NCT01507246|521562116|FG000|Overall Study|Required different surgical procedures|2|||
144647297|NCT01507246|521562117|FG001|Overall Study|Required different surgical procedures|1|||
144647298|NCT02975349|521562118|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144647299|NCT02975349|521562119|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144647300|NCT02975349|521562120|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144647301|NCT02975349|521562121|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
144647302|NCT02975349|521562122|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
144647303|NCT02975349|521562123|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144647304|NCT02975349|521562124|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144647305|NCT02975349|521562118|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144647306|NCT02975349|521562119|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144647307|NCT02975349|521562120|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144647308|NCT02975349|521562121|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144647309|NCT02975349|521562122|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144647310|NCT02975349|521562123|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144647311|NCT02975349|521562124|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144647312|NCT02975349|521562118|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
144647313|NCT02975349|521562119|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
144647314|NCT02975349|521562120|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
144647315|NCT02975349|521562121|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
144647316|NCT02975349|521562122|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
144647317|NCT02975349|521562123|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
144647318|NCT02975349|521562124|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
144647319|NCT02975349|521562118|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
144647320|NCT02975349|521562119|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
144647321|NCT02975349|521562120|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
144647322|NCT02975349|521562121|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
144647323|NCT02975349|521562122|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
144647324|NCT02975349|521562123|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
144647325|NCT02975349|521562124|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
144647326|NCT02975349|521562118|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
144647327|NCT02975349|521562119|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
144647328|NCT02975349|521562120|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
144647329|NCT02975349|521562121|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
144647330|NCT02975349|521562122|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
144647331|NCT02975349|521562123|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
144647332|NCT02975349|521562124|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
144647333|NCT02975349|521562118|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
144647334|NCT02975349|521562119|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
144647335|NCT02975349|521562120|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
144647336|NCT02975349|521562121|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
144647337|NCT02975349|521562122|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
144647338|NCT02975349|521562123|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
144647339|NCT02975349|521562124|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
144647340|NCT02975349|521562118|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
144647341|NCT02975349|521562119|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
144647342|NCT02975349|521562120|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
144647343|NCT02975349|521562121|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
144647344|NCT02975349|521562122|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
144647345|NCT02975349|521562123|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
144647346|NCT02975349|521562124|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
144647347|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
144647348|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
144647349|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
144647350|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
144647351|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
144647352|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
144647353|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
144647354|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
144647355|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
144647356|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
144647357|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
144647358|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
144647359|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
144647360|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
144647361|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
144731659|NCT00112463|521873238|FG000|Overall Study|Withdrawal by Subject|2|||
144731660|NCT00112463|521873238|FG000|Overall Study|Never started treatment|2|||
144647362|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
144647363|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
144647364|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
144647365|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
144211628|NCT00996892|519968088|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
144211629|NCT00996892|519968089|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
144731661|NCT01118312|521873239|FG000|Overall Study|Lost to Follow-up|33|||
144731662|NCT01118312|521873240|FG001|Overall Study|Lost to Follow-up|32|||
144263285|NCT01051921|520165384|FG000|Overall Study|patient moved|1|||
144263286|NCT01165307|520165386|FG000|Overall Study|Lost to Follow-up|11|||
144647366|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
144647367|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
144647368|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
144647369|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
144647370|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
144647371|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
144647372|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
144647373|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
144647374|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
144647375|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
144647376|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
144647377|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
144647378|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
144647379|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
144647380|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
144647381|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
144647382|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
144647383|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
144647384|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
144647385|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
144647386|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
144647387|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
144647388|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
144647389|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
144647390|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
144647391|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
144647392|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
144647393|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
144647394|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
144647395|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
144647396|NCT02975349|521562118|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
144647397|NCT02975349|521562119|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
144647398|NCT02975349|521562120|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
144647399|NCT02975349|521562121|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
144647400|NCT02975349|521562122|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
144647401|NCT02975349|521562123|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
144647402|NCT02975349|521562124|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
144647403|NCT05363293|521562125|FG000|Overall Study|Withdrawal by Subject|1|||
144647404|NCT05363293|521562126|FG001|Overall Study|Withdrawal by Subject|0|||
144647405|NCT05363293|521562127|FG002|Overall Study|Withdrawal by Subject|0|||
144647406|NCT05363293|521562128|FG003|Overall Study|Withdrawal by Subject|0|||
144647407|NCT05363293|521562129|FG004|Overall Study|Withdrawal by Subject|0|||
144647408|NCT05363293|521562130|FG005|Overall Study|Withdrawal by Subject|0|||
144647409|NCT05363293|521562131|FG006|Overall Study|Withdrawal by Subject|0|||
144647410|NCT05363293|521562132|FG007|Overall Study|Withdrawal by Subject|0|||
144647411|NCT05363293|521562133|FG008|Overall Study|Withdrawal by Subject|0|||
144647412|NCT05363293|521562134|FG009|Overall Study|Withdrawal by Subject|0|||
144647413|NCT01089725|521562138|FG000|Overall Study|Adverse Event|1|||
144647414|NCT01089725|521562139|FG001|Overall Study|Adverse Event|1|||
144647415|NCT01089725|521562140|FG002|Overall Study|Adverse Event|0|||
144647416|NCT01089725|521562141|FG003|Overall Study|Adverse Event|0|||
144647417|NCT01089725|521562142|FG004|Overall Study|Adverse Event|2|||
144647418|NCT01089725|521562138|FG000|Overall Study|Lack of Efficacy|4|||
144647419|NCT01089725|521562139|FG001|Overall Study|Lack of Efficacy|3|||
144647420|NCT01089725|521562140|FG002|Overall Study|Lack of Efficacy|1|||
144647421|NCT01089725|521562141|FG003|Overall Study|Lack of Efficacy|0|||
144647422|NCT01089725|521562142|FG004|Overall Study|Lack of Efficacy|4|||
144647423|NCT01089725|521562138|FG000|Overall Study|Lost to Follow-up|2|||
144647424|NCT01089725|521562139|FG001|Overall Study|Lost to Follow-up|2|||
144647425|NCT01089725|521562140|FG002|Overall Study|Lost to Follow-up|0|||
144647426|NCT01089725|521562141|FG003|Overall Study|Lost to Follow-up|3|||
144731663|NCT01118312|521873239|FG000|Overall Study|Withdrawal by Subject|1|||
144647427|NCT01089725|521562142|FG004|Overall Study|Lost to Follow-up|0|||
144647428|NCT01089725|521562138|FG000|Overall Study|Protocol Violation|0|||
144731664|NCT01118312|521873240|FG001|Overall Study|Withdrawal by Subject|3|||
144647429|NCT01089725|521562139|FG001|Overall Study|Protocol Violation|0|||
144731665|NCT00678639|521873241|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
144731666|NCT00678639|521873242|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
144263287|NCT01165307|520165387|FG001|Overall Study|Lost to Follow-up|3|||
144263288|NCT01165307|520165386|FG000|Overall Study|Withdrawal by Subject|2|||
144263289|NCT01165307|520165387|FG001|Overall Study|Withdrawal by Subject|0|||
144263290|NCT01165307|520165386|FG000|Overall Study|Subject not available for contact|1|||
144263291|NCT01165307|520165387|FG001|Overall Study|Subject not available for contact|0|||
144647430|NCT01089725|521562140|FG002|Overall Study|Protocol Violation|1|||
144647431|NCT01089725|521562141|FG003|Overall Study|Protocol Violation|1|||
144647432|NCT01089725|521562142|FG004|Overall Study|Protocol Violation|0|||
144647433|NCT01089725|521562138|FG000|Overall Study|Withdrawal by Subject|5|||
144647434|NCT01089725|521562139|FG001|Overall Study|Withdrawal by Subject|5|||
144647435|NCT01089725|521562140|FG002|Overall Study|Withdrawal by Subject|4|||
144647436|NCT01089725|521562141|FG003|Overall Study|Withdrawal by Subject|5|||
144647437|NCT01089725|521562142|FG004|Overall Study|Withdrawal by Subject|4|||
144647438|NCT01089725|521562138|FG000|Overall Study|Study Terminated by Sponsor|51|||
144647439|NCT01089725|521562139|FG001|Overall Study|Study Terminated by Sponsor|56|||
144647440|NCT01089725|521562140|FG002|Overall Study|Study Terminated by Sponsor|53|||
144647441|NCT01089725|521562141|FG003|Overall Study|Study Terminated by Sponsor|68|||
144647442|NCT01089725|521562142|FG004|Overall Study|Study Terminated by Sponsor|68|||
144647443|NCT01089725|521562138|FG000|Overall Study|Randomized, but not treated|0|||
144647444|NCT01089725|521562139|FG001|Overall Study|Randomized, but not treated|1|||
144647445|NCT01089725|521562140|FG002|Overall Study|Randomized, but not treated|2|||
144647446|NCT01089725|521562141|FG003|Overall Study|Randomized, but not treated|1|||
144647447|NCT01089725|521562142|FG004|Overall Study|Randomized, but not treated|2|||
144647448|NCT01089725|521562138|FG000|Overall Study|Other|3|||
144647449|NCT01089725|521562139|FG001|Overall Study|Other|0|||
144647450|NCT01089725|521562140|FG002|Overall Study|Other|0|||
144647451|NCT01089725|521562141|FG003|Overall Study|Other|1|||
144647452|NCT01089725|521562142|FG004|Overall Study|Other|0|||
144647453|NCT05243550|521563760|FG000|Overall Study|Ongoing in the Study|171|||
144647454|NCT05243550|521563760|FG000|Overall Study|Withdrawal by Subject|10|||
144647455|NCT05243550|521563760|FG000|Overall Study|Lost to Follow-up|7|||
144647456|NCT05243550|521563760|FG000|Overall Study|Adverse Event|3|||
144647457|NCT05243550|521563760|FG000|Overall Study|Noncompliance|1|||
144647458|NCT05243550|521563760|FG000|Overall Study|Physician Decision|1|||
144647459|NCT05243550|521563760|FG000|Overall Study|Other Reason|4|||
144647460|NCT01894516|521563761|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
144647461|NCT01894516|521563762|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
144647462|NCT01894516|521563763|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
144647463|NCT01894516|521563764|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
144647464|NCT01894516|521563761|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
144647465|NCT01894516|521563762|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144647466|NCT01894516|521563763|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144647467|NCT01894516|521563764|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
144647468|NCT01894516|521563761|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
144647469|NCT01894516|521563762|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
144647470|NCT01894516|521563763|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
144647471|NCT01894516|521563764|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
144647472|NCT01894516|521563761|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
144647473|NCT01894516|521563762|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
144647474|NCT01894516|521563763|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
144647475|NCT01894516|521563764|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
144647476|NCT01894516|521563761|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
144647477|NCT01894516|521563762|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
144647478|NCT01894516|521563763|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
144647479|NCT01894516|521563764|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
144647480|NCT01894516|521563761|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
144263292|NCT03627832|520165391|FG000|Overall Study|Withdrawal by Subject|10|||
144263293|NCT03627832|520165392|FG001|Overall Study|Withdrawal by Subject|1|||
144263294|NCT00048035|520165395|FG000|Core Period|Early Withdrawals|4|||
144263295|NCT00048035|520165396|FG001|Core Period|Early Withdrawals|2|||
144647481|NCT01894516|521563762|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
144647482|NCT01894516|521563763|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
144647483|NCT01894516|521563764|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
144647484|NCT01894516|521563761|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
144647485|NCT01894516|521563762|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
144647486|NCT01894516|521563763|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
144647487|NCT01894516|521563764|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
144647488|NCT01894516|521563761|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
144647489|NCT01894516|521563762|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
144647490|NCT01894516|521563763|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
144647491|NCT01894516|521563764|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
144647492|NCT01486316|521563767|FG000|Overall Study|Device explanted with/without re-implant|3|||
144647493|NCT01486316|521563768|FG001|Overall Study|Device explanted with/without re-implant|2|||
144647494|NCT01486316|521563769|FG002|Overall Study|Device explanted with/without re-implant|0|||
144647495|NCT01486316|521563770|FG003|Overall Study|Device explanted with/without re-implant|2|||
144647496|NCT01486316|521563767|FG000|Overall Study|Not meeting eligibility criteria|0|||
144647497|NCT01486316|521563768|FG001|Overall Study|Not meeting eligibility criteria|0|||
144647498|NCT01486316|521563769|FG002|Overall Study|Not meeting eligibility criteria|1|||
144647499|NCT01486316|521563770|FG003|Overall Study|Not meeting eligibility criteria|0|||
144647500|NCT01486316|521563767|FG000|Overall Study|Withdrawal by Subject|1|||
144647501|NCT01486316|521563768|FG001|Overall Study|Withdrawal by Subject|0|||
144647502|NCT01486316|521563769|FG002|Overall Study|Withdrawal by Subject|3|||
144647503|NCT01486316|521563770|FG003|Overall Study|Withdrawal by Subject|0|||
144647504|NCT01486316|521563767|FG000|Overall Study|Physician Decision|0|||
144647505|NCT01486316|521563768|FG001|Overall Study|Physician Decision|0|||
144647506|NCT01486316|521563769|FG002|Overall Study|Physician Decision|1|||
144647507|NCT01486316|521563770|FG003|Overall Study|Physician Decision|0|||
144647508|NCT01486316|521563767|FG000|Overall Study|Death|0|||
144647509|NCT01486316|521563768|FG001|Overall Study|Death|1|||
144647510|NCT01486316|521563769|FG002|Overall Study|Death|0|||
144647511|NCT01486316|521563770|FG003|Overall Study|Death|0|||
144647512|NCT00375934|521563780|FG000|Overall Study|Adverse Event|1|||
144647513|NCT00375934|521563781|FG001|Overall Study|Adverse Event|1|||
144647514|NCT00375934|521563780|FG000|Overall Study|Withdrawal by Subject|2|||
144647515|NCT00375934|521563781|FG001|Overall Study|Withdrawal by Subject|2|||
144647516|NCT00375934|521563780|FG000|Overall Study|Lack of Efficacy|0|||
144647517|NCT00375934|521563781|FG001|Overall Study|Lack of Efficacy|2|||
144647518|NCT00375934|521563780|FG000|Overall Study|Physician Decision|0|||
144647519|NCT00375934|521563781|FG001|Overall Study|Physician Decision|1|||
144647520|NCT03191396|521563782|FG000|Overall Study|Lost to Follow-up|0|||
144647521|NCT03191396|521563783|FG001|Overall Study|Lost to Follow-up|3|||
144647522|NCT03191396|521563782|FG000|Overall Study|Withdrawal by Subject|3|||
144647523|NCT03191396|521563783|FG001|Overall Study|Withdrawal by Subject|2|||
144647524|NCT02452970|521563786|FG000|Overall Study|Adverse Event|1|||
144647525|NCT00893113|521563787|FG000|Overall Study|Lost to Follow-up|4|||
144647526|NCT00893113|521563788|FG001|Overall Study|Lost to Follow-up|8|||
144647527|NCT00893113|521563787|FG000|Overall Study|Early Termination|1|||
144647528|NCT00893113|521563788|FG001|Overall Study|Early Termination|1|||
144647529|NCT00893113|521563787|FG000|Overall Study|Withdrew Consent|8|||
144647530|NCT00893113|521563788|FG001|Overall Study|Withdrew Consent|7|||
144647531|NCT03270085|521563791|FG000|Overall Study|Withdrawal by Subject|1|||
144647532|NCT03270085|521563792|FG001|Overall Study|Withdrawal by Subject|0|||
144647533|NCT01269125|521563793|FG000|Overall Study|Adverse Event|3|||
144647534|NCT01269125|521563794|FG001|Overall Study|Adverse Event|5|||
144647535|NCT01269125|521563795|FG002|Overall Study|Adverse Event|0|||
144647536|NCT01269125|521563793|FG000|Overall Study|Lost to Follow-up|4|||
144647537|NCT01269125|521563794|FG001|Overall Study|Lost to Follow-up|0|||
144647538|NCT01269125|521563795|FG002|Overall Study|Lost to Follow-up|0|||
144647539|NCT02114203|521563797|FG000|Overall Study|Adverse Event|0|||
144647540|NCT02114203|521563798|FG001|Overall Study|Adverse Event|1|||
144647541|NCT02114203|521563799|FG002|Overall Study|Adverse Event|0|||
144647542|NCT02114203|521563797|FG000|Overall Study|Withdrawal by Subject|0|||
144647543|NCT02114203|521563798|FG001|Overall Study|Withdrawal by Subject|1|||
144647544|NCT02114203|521563799|FG002|Overall Study|Withdrawal by Subject|0|||
144647545|NCT01040832|521563800|FG000|Overall Study|Adverse Event|4|||
144647546|NCT01040832|521563801|FG001|Overall Study|Adverse Event|5|||
144647547|NCT01040832|521563800|FG000|Overall Study|Death|4|||
144647548|NCT01040832|521563801|FG001|Overall Study|Death|6|||
144647549|NCT01040832|521563800|FG000|Overall Study|Withdrawal by Subject|2|||
144647550|NCT01040832|521563801|FG001|Overall Study|Withdrawal by Subject|3|||
144647551|NCT01040832|521563800|FG000|Overall Study|Progressive disease|32|||
144647552|NCT01040832|521563801|FG001|Overall Study|Progressive disease|17|||
144647553|NCT01040832|521563800|FG000|Overall Study|Symptomatic deterioration|2|||
144647554|NCT01040832|521563801|FG001|Overall Study|Symptomatic deterioration|5|||
144647555|NCT01040832|521563800|FG000|Overall Study|Other|2|||
144731667|NCT00986245|521873243|FG000|First Intervention|Poor compliance|8|||
144731668|NCT00986245|521873244|FG001|First Intervention|Poor compliance|4|||
144263296|NCT00048035|520165397|FG002|Core Period|Early Withdrawals|1|||
144647556|NCT01040832|521563801|FG001|Overall Study|Other|1|||
144647557|NCT00151411|521563806|FG000|Overall Study|Lost to Follow-up|15|||
144647558|NCT00151411|521563807|FG001|Overall Study|Lost to Follow-up|19|||
144647559|NCT00151411|521563806|FG000|Overall Study|Withdrawal by Subject|12|||
144647560|NCT00151411|521563807|FG001|Overall Study|Withdrawal by Subject|20|||
144647561|NCT00151411|521563806|FG000|Overall Study|Adverse Event|6|||
144647562|NCT00151411|521563807|FG001|Overall Study|Adverse Event|0|||
144647563|NCT00151411|521563806|FG000|Overall Study|Pregnancy|0|||
144647564|NCT00151411|521563807|FG001|Overall Study|Pregnancy|4|||
144647565|NCT01283581|521563808|FG000|Overall Study|Lost to Follow-up|8|||
144647566|NCT01283581|521563809|FG001|Overall Study|Lost to Follow-up|6|||
144647567|NCT01283581|521563810|FG002|Overall Study|Lost to Follow-up|8|||
144647568|NCT01283581|521563808|FG000|Overall Study|Withdrawal by Subject|2|||
144647569|NCT01283581|521563809|FG001|Overall Study|Withdrawal by Subject|5|||
144647570|NCT01283581|521563810|FG002|Overall Study|Withdrawal by Subject|2|||
144647571|NCT01283581|521563808|FG000|Overall Study|Adverse Event|1|||
144647572|NCT01283581|521563809|FG001|Overall Study|Adverse Event|1|||
144647573|NCT01283581|521563810|FG002|Overall Study|Adverse Event|4|||
144647574|NCT01283581|521563808|FG000|Overall Study|Physician Decision|0|||
144647575|NCT01283581|521563809|FG001|Overall Study|Physician Decision|1|||
144647576|NCT01283581|521563810|FG002|Overall Study|Physician Decision|2|||
144647577|NCT01283581|521563808|FG000|Overall Study|Protocol Violation|0|||
144647578|NCT01283581|521563809|FG001|Overall Study|Protocol Violation|1|||
144647579|NCT01283581|521563810|FG002|Overall Study|Protocol Violation|2|||
144647580|NCT01283581|521563808|FG000|Overall Study|Noncompliance|1|||
144647581|NCT01283581|521563809|FG001|Overall Study|Noncompliance|0|||
144647582|NCT01283581|521563810|FG002|Overall Study|Noncompliance|0|||
144647583|NCT01283581|521563808|FG000|Overall Study|Investigator unblinded|0|||
144647584|NCT01283581|521563809|FG001|Overall Study|Investigator unblinded|0|||
144647585|NCT01283581|521563810|FG002|Overall Study|Investigator unblinded|1|||
144647586|NCT01283581|521563808|FG000|Overall Study|"Early termination"|0|||
144647587|NCT01283581|521563809|FG001|Overall Study|"Early termination"|0|||
144647588|NCT01283581|521563810|FG002|Overall Study|"Early termination"|1|||
144647589|NCT01712438|521563811|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
144647590|NCT01712438|521563811|FG000|Overall Study|Ongoing ITI treatment|6|||
144647591|NCT01712438|521563811|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
144647592|NCT01712438|521563811|FG000|Overall Study|Prematurely Discontinued|25|||
144647593|NCT01259492|521563812|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
144647594|NCT01259492|521563813|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
144647595|NCT01259492|521563814|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
144647596|NCT01259492|521563815|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
144647597|NCT01259492|521563812|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
144647598|NCT01259492|521563813|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
144647599|NCT01259492|521563814|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
144647600|NCT01259492|521563815|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
144647601|NCT01259492|521563812|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
144647602|NCT01259492|521563813|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
144647603|NCT01259492|521563814|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
144647604|NCT01259492|521563815|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
144647605|NCT01259492|521563812|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
144647606|NCT01259492|521563813|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
144647607|NCT01259492|521563814|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
144647608|NCT01259492|521563815|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
144647609|NCT01259492|521563812|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
144647610|NCT01259492|521563813|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
144647611|NCT01259492|521563814|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
144647612|NCT01259492|521563815|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
144647613|NCT01259492|521563812|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
144647614|NCT01259492|521563813|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
144647615|NCT01259492|521563814|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
144647616|NCT01259492|521563815|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
144647617|NCT01259492|521563812|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
144647618|NCT01259492|521563813|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
144647619|NCT01259492|521563814|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
144647620|NCT01259492|521563815|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
144647621|NCT01259492|521563812|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
144647622|NCT01259492|521563813|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
144647623|NCT01259492|521563814|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
144647624|NCT01259492|521563815|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
144647625|NCT01259492|521563812|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
144647626|NCT01259492|521563813|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
144647627|NCT01259492|521563814|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
144647628|NCT01259492|521563815|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
144647629|NCT01259492|521563812|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
144647630|NCT01259492|521563813|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
144647631|NCT01259492|521563814|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
144647632|NCT01259492|521563815|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
144647633|NCT01259492|521563812|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
144647634|NCT01259492|521563813|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
144647635|NCT01259492|521563814|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
144647636|NCT01259492|521563815|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
144647637|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
144647638|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
144647639|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
144211630|NCT00996892|519968090|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
144211631|NCT00996892|519968071|FG000|Expansion Stage 2A|Disease Progression|0|||
144647640|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
144647641|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
144647642|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
144647643|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
144647644|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
144647645|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
144647646|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
144647647|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
144647648|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
144647649|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
144647650|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
144647651|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
144647652|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
144647653|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
144647654|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
144647655|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
144647656|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
144647657|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
144647658|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
144647659|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
144647660|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
144647661|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
144647662|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
144647663|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
144647664|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
144647665|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
144647666|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
144647667|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
144647668|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
144647669|NCT01259492|521563812|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
144647670|NCT01259492|521563813|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
144647671|NCT01259492|521563814|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
144647672|NCT01259492|521563815|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
144647673|NCT01981122|521563816|FG000|Overall Study|Withdrawal by Subject|0|||
144647674|NCT01981122|521563817|FG001|Overall Study|Withdrawal by Subject|2|||
144647675|NCT01981122|521563816|FG000|Overall Study|Protocol Violation|0|||
144647676|NCT01981122|521563817|FG001|Overall Study|Protocol Violation|1|||
144647677|NCT01981122|521563816|FG000|Overall Study|Lost to Follow-up|0|||
144647678|NCT01981122|521563817|FG001|Overall Study|Lost to Follow-up|1|||
144647679|NCT01981122|521563816|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
144647680|NCT01981122|521563817|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
144647681|NCT01981122|521563816|FG000|Overall Study|Death|14|||
144647682|NCT01981122|521563817|FG001|Overall Study|Death|15|||
144647683|NCT00634543|521563826|FG000|Overall Study|Other|1|||
144647684|NCT00634543|521563827|FG001|Overall Study|Other|2|||
144647685|NCT00634543|521563826|FG000|Overall Study|Protocol Violation|3|||
144647686|NCT00634543|521563827|FG001|Overall Study|Protocol Violation|3|||
144647687|NCT00634543|521563826|FG000|Overall Study|Adverse Event|11|||
144647688|NCT00634543|521563827|FG001|Overall Study|Adverse Event|11|||
144647689|NCT00634543|521563826|FG000|Overall Study|Withdrawal by Subject|4|||
144647690|NCT00634543|521563827|FG001|Overall Study|Withdrawal by Subject|4|||
144647691|NCT00634543|521563826|FG000|Overall Study|Lost to Follow-up|0|||
144647692|NCT00634543|521563827|FG001|Overall Study|Lost to Follow-up|1|||
144647693|NCT03515538|521563828|FG000|Overall Study|Lack of Efficacy|2|||
144647694|NCT03515538|521563829|FG001|Overall Study|Lack of Efficacy|0|||
144647695|NCT03515538|521563830|FG002|Overall Study|Lack of Efficacy|2|||
144647696|NCT03515538|521563831|FG003|Overall Study|Lack of Efficacy|0|||
144647697|NCT03515538|521563828|FG000|Overall Study|Death|0|||
144647698|NCT03515538|521563829|FG001|Overall Study|Death|0|||
144647699|NCT03515538|521563830|FG002|Overall Study|Death|1|||
144647700|NCT03515538|521563831|FG003|Overall Study|Death|0|||
144647701|NCT03515538|521563828|FG000|Overall Study|Protocol Violation|0|||
144647702|NCT03515538|521563829|FG001|Overall Study|Protocol Violation|0|||
144647703|NCT03515538|521563830|FG002|Overall Study|Protocol Violation|0|||
144211632|NCT00996892|519968072|FG001|Expansion Stage 2A|Disease Progression|0|||
144647704|NCT03515538|521563831|FG003|Overall Study|Protocol Violation|1|||
144647705|NCT03515538|521563828|FG000|Overall Study|Screen failure (baseline dropout)|0|||
144647706|NCT03515538|521563829|FG001|Overall Study|Screen failure (baseline dropout)|1|||
144647707|NCT03515538|521563830|FG002|Overall Study|Screen failure (baseline dropout)|0|||
144647708|NCT03515538|521563831|FG003|Overall Study|Screen failure (baseline dropout)|0|||
144647709|NCT03515538|521563828|FG000|Overall Study|Withdrawal by Subject|2|||
144647710|NCT03515538|521563829|FG001|Overall Study|Withdrawal by Subject|2|||
144647711|NCT03515538|521563830|FG002|Overall Study|Withdrawal by Subject|1|||
144647712|NCT03515538|521563831|FG003|Overall Study|Withdrawal by Subject|3|||
144647713|NCT03515538|521563828|FG000|Overall Study|Physician Decision|1|||
144647714|NCT03515538|521563829|FG001|Overall Study|Physician Decision|0|||
144647715|NCT03515538|521563830|FG002|Overall Study|Physician Decision|0|||
144647716|NCT03515538|521563831|FG003|Overall Study|Physician Decision|1|||
144647717|NCT02397655|521563839|FG000|Overall Study|data not completed|1301|||
144647718|NCT03069690|521563840|FG000|Pregnancy Intervention|Pregnancy loss|9|||
144647719|NCT03069690|521563841|FG001|Pregnancy Intervention|Pregnancy loss|4|||
144647720|NCT03069690|521563842|FG002|Pregnancy Intervention|Pregnancy loss|0|||
144647721|NCT03069690|521563843|FG003|Pregnancy Intervention|Pregnancy loss|0|||
144647722|NCT03069690|521563844|FG004|Pregnancy Intervention|Pregnancy loss|0|||
144647723|NCT03069690|521563845|FG005|Pregnancy Intervention|Pregnancy loss|0|||
144647724|NCT03069690|521563840|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
144647725|NCT03069690|521563841|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
144647726|NCT03069690|521563842|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
144647727|NCT03069690|521563843|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
144647728|NCT03069690|521563844|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
144647729|NCT03069690|521563845|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
144647730|NCT03069690|521563840|FG000|Postpartum Intervention|Lost to Follow-up|0|||
144647731|NCT03069690|521563841|FG001|Postpartum Intervention|Lost to Follow-up|0|||
144647732|NCT03069690|521563842|FG002|Postpartum Intervention|Lost to Follow-up|5|||
144647733|NCT03069690|521563843|FG003|Postpartum Intervention|Lost to Follow-up|5|||
144647734|NCT03069690|521563844|FG004|Postpartum Intervention|Lost to Follow-up|2|||
144647735|NCT03069690|521563845|FG005|Postpartum Intervention|Lost to Follow-up|4|||
144647736|NCT02564120|521563846|FG000|Overall Study|Did not return release forms|160|||
144647737|NCT02564120|521563846|FG000|Overall Study|Death|58|||
144647738|NCT02564120|521563846|FG000|Overall Study|Withdrawal by Subject|204|||
144647739|NCT02564120|521563846|FG000|Overall Study|Other medical condition|24|||
144647740|NCT01966731|521563847|FG000|Overall Study|Death|2|||
144647741|NCT01966731|521563847|FG000|Overall Study|Lost to Follow-up|1|||
144647742|NCT01966731|521563847|FG000|Overall Study|Physician Decision|2|||
144647743|NCT01966731|521563847|FG000|Overall Study|Follow up is not complete|600|||
144647744|NCT01966731|521563847|FG000|Overall Study|Screening Failure|29|||
144647745|NCT01966731|521563847|FG000|Overall Study|Found to be ineligible|1|||
144647746|NCT01380093|521563848|FG000|Naloxone Challenge Phase|Screen failures|21|||
144647747|NCT01380093|521563849|FG001|Naloxone Challenge Phase|Screen failures|0|||
144647748|NCT01380093|521563850|FG002|Naloxone Challenge Phase|Screen failures|0|||
144647749|NCT01380093|521563851|FG003|Naloxone Challenge Phase|Screen failures|0|||
144647750|NCT01380093|521563852|FG004|Naloxone Challenge Phase|Screen failures|0|||
144647751|NCT01380093|521563853|FG005|Naloxone Challenge Phase|Screen failures|0|||
144647752|NCT01380093|521563854|FG006|Naloxone Challenge Phase|Screen failures|0|||
144647753|NCT01380093|521563855|FG007|Naloxone Challenge Phase|Screen failures|0|||
144647754|NCT01380093|521563856|FG008|Naloxone Challenge Phase|Screen failures|0|||
144647755|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647756|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
144647757|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647758|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647759|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647760|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647761|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647762|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647763|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
144647764|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144647765|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
144647766|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
144647767|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144647768|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144263297|NCT00048035|520165398|FG003|Core Period|Early Withdrawals|1|||
144647769|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144647770|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144647771|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144647772|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
144647773|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144647774|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
144647775|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144647776|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144263298|NCT00048035|520165399|FG004|Core Period|Early Withdrawals|1|||
144647777|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144263299|NCT00048035|520165400|FG005|Core Period|Early Withdrawals|1|||
144647778|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144647779|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144647780|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144647781|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
144647782|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647783|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
144647784|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
144647785|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647786|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647787|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647788|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647789|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647790|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
144647791|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647792|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
144647793|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
144647794|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647795|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647796|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647797|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647798|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647799|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
144647800|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647801|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647802|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
144647803|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647804|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647805|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647806|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647807|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647808|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
144647809|NCT01380093|521563848|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647810|NCT01380093|521563849|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647811|NCT01380093|521563850|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
144647812|NCT01380093|521563851|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647813|NCT01380093|521563852|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647814|NCT01380093|521563853|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647815|NCT01380093|521563854|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647816|NCT01380093|521563855|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647817|NCT01380093|521563856|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
144647818|NCT01380093|521563848|FG000|Treatment Phase: Second Intervention|Other|0|||
144647819|NCT01380093|521563849|FG001|Treatment Phase: Second Intervention|Other|0|||
144647820|NCT01380093|521563850|FG002|Treatment Phase: Second Intervention|Other|0|||
144647821|NCT01380093|521563851|FG003|Treatment Phase: Second Intervention|Other|1|||
144647822|NCT01380093|521563852|FG004|Treatment Phase: Second Intervention|Other|0|||
144647823|NCT01380093|521563853|FG005|Treatment Phase: Second Intervention|Other|0|||
144647824|NCT01380093|521563854|FG006|Treatment Phase: Second Intervention|Other|0|||
144647825|NCT01380093|521563855|FG007|Treatment Phase: Second Intervention|Other|0|||
144647826|NCT01380093|521563856|FG008|Treatment Phase: Second Intervention|Other|0|||
144647827|NCT01380093|521563848|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
144647828|NCT01380093|521563849|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
144647829|NCT01380093|521563850|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
144647830|NCT01380093|521563851|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
144647831|NCT01380093|521563852|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
144647832|NCT01380093|521563853|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
144647833|NCT01380093|521563854|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
144647834|NCT01380093|521563855|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
144647835|NCT01380093|521563856|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
144647836|NCT01380093|521563848|FG000|Treatment Phase: Third Intervention|Other|0|||
144647837|NCT01380093|521563849|FG001|Treatment Phase: Third Intervention|Other|0|||
144647838|NCT01380093|521563850|FG002|Treatment Phase: Third Intervention|Other|0|||
144647839|NCT01380093|521563851|FG003|Treatment Phase: Third Intervention|Other|0|||
144647840|NCT01380093|521563852|FG004|Treatment Phase: Third Intervention|Other|0|||
144647841|NCT01380093|521563853|FG005|Treatment Phase: Third Intervention|Other|0|||
144647842|NCT01380093|521563854|FG006|Treatment Phase: Third Intervention|Other|0|||
144647843|NCT01380093|521563855|FG007|Treatment Phase: Third Intervention|Other|0|||
144647844|NCT01380093|521563856|FG008|Treatment Phase: Third Intervention|Other|1|||
144211633|NCT00996892|519968073|FG002|Expansion Stage 2A|Disease Progression|0|||
144647845|NCT03952650|521563857|FG000|Overall Study|TRAVEL|0|||
144647846|NCT03952650|521563858|FG001|Overall Study|TRAVEL|4|||
144647847|NCT03952650|521563859|FG002|Overall Study|TRAVEL|0|||
144647848|NCT03952650|521563860|FG003|Overall Study|TRAVEL|4|||
144647849|NCT03952650|521563861|FG004|Overall Study|TRAVEL|0|||
144647850|NCT03952650|521563862|FG005|Overall Study|TRAVEL|3|||
144647851|NCT03952650|521563863|FG006|Overall Study|TRAVEL|2|||
144647852|NCT03952650|521563857|FG000|Overall Study|Withdrawal by Subject|0|||
144647853|NCT03952650|521563858|FG001|Overall Study|Withdrawal by Subject|2|||
144647854|NCT03952650|521563859|FG002|Overall Study|Withdrawal by Subject|0|||
144647855|NCT03952650|521563860|FG003|Overall Study|Withdrawal by Subject|3|||
144647856|NCT03952650|521563861|FG004|Overall Study|Withdrawal by Subject|0|||
144647857|NCT03952650|521563862|FG005|Overall Study|Withdrawal by Subject|1|||
144647858|NCT03952650|521563863|FG006|Overall Study|Withdrawal by Subject|1|||
144647859|NCT03952650|521563857|FG000|Overall Study|Lost to Follow-up|0|||
144647860|NCT03952650|521563858|FG001|Overall Study|Lost to Follow-up|1|||
144647861|NCT03952650|521563859|FG002|Overall Study|Lost to Follow-up|0|||
144647862|NCT03952650|521563860|FG003|Overall Study|Lost to Follow-up|0|||
144647863|NCT03952650|521563861|FG004|Overall Study|Lost to Follow-up|0|||
144647864|NCT03952650|521563862|FG005|Overall Study|Lost to Follow-up|1|||
144647865|NCT03952650|521563863|FG006|Overall Study|Lost to Follow-up|1|||
144647866|NCT03952650|521563857|FG000|Overall Study|Received wrong vaccine and travelled|0|||
144647867|NCT03952650|521563858|FG001|Overall Study|Received wrong vaccine and travelled|0|||
144647868|NCT03952650|521563859|FG002|Overall Study|Received wrong vaccine and travelled|0|||
144647869|NCT03952650|521563860|FG003|Overall Study|Received wrong vaccine and travelled|0|||
144647870|NCT03952650|521563861|FG004|Overall Study|Received wrong vaccine and travelled|0|||
144647871|NCT03952650|521563862|FG005|Overall Study|Received wrong vaccine and travelled|1|||
144647872|NCT03952650|521563863|FG006|Overall Study|Received wrong vaccine and travelled|0|||
144647873|NCT03952650|521563857|FG000|Overall Study|Unable to make study visit|0|||
144647874|NCT03952650|521563858|FG001|Overall Study|Unable to make study visit|0|||
144647875|NCT03952650|521563859|FG002|Overall Study|Unable to make study visit|0|||
144647876|NCT03952650|521563860|FG003|Overall Study|Unable to make study visit|0|||
144647877|NCT03952650|521563861|FG004|Overall Study|Unable to make study visit|0|||
144647878|NCT03952650|521563862|FG005|Overall Study|Unable to make study visit|1|||
144647879|NCT03952650|521563863|FG006|Overall Study|Unable to make study visit|0|||
144647880|NCT00592683|521563864|FG000|Overall Study|Found ineligible|0|||
144647881|NCT00592683|521563865|FG001|Overall Study|Found ineligible|1|||
144647882|NCT00592683|521563864|FG000|Overall Study|Withdrawal by Subject|1|||
144647883|NCT00592683|521563865|FG001|Overall Study|Withdrawal by Subject|0|||
144647884|NCT00592683|521563864|FG000|Overall Study|Adverse Event|0|||
144647885|NCT00592683|521563865|FG001|Overall Study|Adverse Event|2|||
144647886|NCT00592683|521563864|FG000|Overall Study|Protocol Violation|1|||
144647887|NCT00592683|521563865|FG001|Overall Study|Protocol Violation|0|||
144647888|NCT00592683|521563864|FG000|Overall Study|Study drug expired|1|||
144647889|NCT00592683|521563865|FG001|Overall Study|Study drug expired|0|||
144647890|NCT00592683|521563864|FG000|Overall Study|Other|1|||
144647891|NCT00592683|521563865|FG001|Overall Study|Other|0|||
144647892|NCT00592683|521563864|FG000|Overall Study|Lost to Follow-up|0|||
144647893|NCT00592683|521563865|FG001|Overall Study|Lost to Follow-up|1|||
144647894|NCT00545818|521563866|FG000|Overall Study|Protocol Violation|1|||
144647895|NCT00545818|521563867|FG001|Overall Study|Protocol Violation|0|||
144647896|NCT00545818|521563866|FG000|Overall Study|Adverse Event|1|||
144647897|NCT00545818|521563867|FG001|Overall Study|Adverse Event|1|||
144647898|NCT00545818|521563866|FG000|Overall Study|Lost to Follow-up|1|||
144647899|NCT00545818|521563867|FG001|Overall Study|Lost to Follow-up|6|||
144647900|NCT00609609|521563868|FG000|Overall Study|Withdrawal by Subject|2|||
144647901|NCT00609609|521563869|FG001|Overall Study|Withdrawal by Subject|0|||
144647902|NCT00609609|521563868|FG000|Overall Study|Progression|4|||
144647903|NCT00609609|521563869|FG001|Overall Study|Progression|2|||
144647904|NCT03988751|521563870|FG000|Overall Study|Withdrawal by Subject|1|||
144647905|NCT03988751|521563871|FG001|Overall Study|Withdrawal by Subject|0|||
144647906|NCT03988751|521563870|FG000|Overall Study|Protocol Violation|0|||
144647907|NCT03988751|521563871|FG001|Overall Study|Protocol Violation|1|||
144647908|NCT00844883|521563872|FG000|Overall Study|Bridged to liver transplant|3|||
144647909|NCT00844883|521563872|FG000|Overall Study|Bridged to resection|1|||
144647910|NCT01325493|521563875|FG000|Overall Study|Protocol Violation|0|||
144647911|NCT01325493|521563876|FG001|Overall Study|Protocol Violation|1|||
144647912|NCT01325493|521563875|FG000|Overall Study|loss of neuromonitoring signals|0|||
144647913|NCT01325493|521563876|FG001|Overall Study|loss of neuromonitoring signals|2|||
144647914|NCT01325493|521563875|FG000|Overall Study|Allergy|1|||
144731669|NCT00986245|521873243|FG000|First Intervention|Lack of Efficacy|1|||
144647915|NCT01325493|521563876|FG001|Overall Study|Allergy|0|||
144647916|NCT03671369|521563880|FG000|Overall Study|Other|1|||
144647917|NCT03671369|521563880|FG000|Overall Study|Withdrawal by Subject|289|||
144647918|NCT03671369|521563880|FG000|Overall Study|Not willing to be vaccinated|1|||
144647919|NCT02612077|521563882|FG000|Overall Study|Adverse Event|3|||
144731670|NCT00986245|521873244|FG001|First Intervention|Lack of Efficacy|2|||
144647920|NCT02612077|521563882|FG000|Overall Study|Withdrawal by Subject|9|||
144647921|NCT02612077|521563882|FG000|Overall Study|Protocol Violation|28|||
144647922|NCT02612077|521563882|FG000|Overall Study|Lost to Follow-up|20|||
144647923|NCT02612077|521563882|FG000|Overall Study|Death|377|||
144647924|NCT02612077|521563882|FG000|Overall Study|Moved or Changed Medical Team|23|||
144647925|NCT02612077|521563882|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
144647926|NCT02612077|521563882|FG000|Overall Study|Disease Progression|3|||
144647927|NCT02612077|521563882|FG000|Overall Study|Unknown reason|2|||
144647928|NCT01716169|521563883|FG000|Overall Study|Adverse Event|1|||
144647929|NCT01716169|521563883|FG000|Overall Study|Lost to Follow-up|1|||
144647930|NCT01716169|521563883|FG000|Overall Study|Withdrawal by Subject|1|||
144647931|NCT01716169|521563883|FG000|Overall Study|inconsistent dressing application|1|||
144211634|NCT00996892|519968074|FG003|Expansion Stage 2A|Disease Progression|0|||
144647932|NCT00553787|521563884|FG000|Overall Study|Adverse Event|34|||
144647933|NCT00553787|521563885|FG001|Overall Study|Adverse Event|21|||
144647934|NCT00553787|521563886|FG002|Overall Study|Adverse Event|67|||
144647935|NCT00553787|521563884|FG000|Overall Study|Lost to Follow-up|132|||
144647936|NCT00553787|521563885|FG001|Overall Study|Lost to Follow-up|44|||
144647937|NCT00553787|521563886|FG002|Overall Study|Lost to Follow-up|78|||
144647938|NCT00553787|521563884|FG000|Overall Study|Withdrawal by Subject|151|||
144647939|NCT00553787|521563885|FG001|Overall Study|Withdrawal by Subject|40|||
144647940|NCT00553787|521563886|FG002|Overall Study|Withdrawal by Subject|83|||
144647941|NCT00553787|521563884|FG000|Overall Study|Lack of Efficacy|31|||
144647942|NCT00553787|521563885|FG001|Overall Study|Lack of Efficacy|1|||
144647943|NCT00553787|521563886|FG002|Overall Study|Lack of Efficacy|3|||
144647944|NCT00553787|521563884|FG000|Overall Study|Pregnancy|0|||
144647945|NCT00553787|521563885|FG001|Overall Study|Pregnancy|1|||
144647946|NCT00553787|521563886|FG002|Overall Study|Pregnancy|2|||
144647947|NCT00553787|521563884|FG000|Overall Study|non compliance|4|||
144647948|NCT00553787|521563885|FG001|Overall Study|non compliance|0|||
144647949|NCT00553787|521563886|FG002|Overall Study|non compliance|11|||
144647950|NCT00553787|521563884|FG000|Overall Study|Requirement for restricted medication|8|||
144647951|NCT00553787|521563885|FG001|Overall Study|Requirement for restricted medication|7|||
144647952|NCT00553787|521563886|FG002|Overall Study|Requirement for restricted medication|5|||
144647953|NCT00553787|521563884|FG000|Overall Study|Other|18|||
144647954|NCT00553787|521563885|FG001|Overall Study|Other|10|||
144647955|NCT00553787|521563886|FG002|Overall Study|Other|13|||
144647956|NCT00793104|521563887|FG000|Overall Study|Lost to Follow-up|1|||
144647957|NCT03494725|521563890|FG000|Overall Study|Withdrawal by Subject|0|||
144647958|NCT03494725|521563891|FG001|Overall Study|Withdrawal by Subject|2|||
144647959|NCT03494725|521563890|FG000|Overall Study|Antibiotic use|1|||
144647960|NCT03494725|521563891|FG001|Overall Study|Antibiotic use|0|||
144647961|NCT00514449|521563892|FG000|Overall Study|Withdrawal by Subject|1|||
144211635|NCT00996892|519968075|FG004|Expansion Stage 2A|Disease Progression|0|||
144211636|NCT00996892|519968076|FG005|Expansion Stage 2A|Disease Progression|0|||
144211637|NCT00996892|519968077|FG006|Expansion Stage 2A|Disease Progression|0|||
144211638|NCT00996892|519968078|FG007|Expansion Stage 2A|Disease Progression|0|||
144211639|NCT00996892|519968079|FG008|Expansion Stage 2A|Disease Progression|0|||
144211640|NCT00996892|519968080|FG009|Expansion Stage 2A|Disease Progression|0|||
144211641|NCT00996892|519968081|FG010|Expansion Stage 2A|Disease Progression|0|||
144211642|NCT00996892|519968082|FG011|Expansion Stage 2A|Disease Progression|0|||
144211643|NCT00996892|519968083|FG012|Expansion Stage 2A|Disease Progression|0|||
144211644|NCT00996892|519968084|FG013|Expansion Stage 2A|Disease Progression|0|||
144211645|NCT00996892|519968085|FG014|Expansion Stage 2A|Disease Progression|0|||
144211646|NCT00996892|519968086|FG015|Expansion Stage 2A|Disease Progression|0|||
144211647|NCT00996892|519968087|FG016|Expansion Stage 2A|Disease Progression|0|||
144211648|NCT00996892|519968088|FG017|Expansion Stage 2A|Disease Progression|0|||
144211649|NCT00996892|519968089|FG018|Expansion Stage 2A|Disease Progression|0|||
144211650|NCT00996892|519968090|FG019|Expansion Stage 2A|Disease Progression|31|||
144211651|NCT01653912|519968091|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
144211652|NCT01653912|519968092|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
144211653|NCT01653912|519968093|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
144211654|NCT01653912|519968094|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
144211655|NCT01653912|519968095|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
144211656|NCT01653912|519968096|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
144211657|NCT01653912|519968091|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
144211658|NCT01653912|519968092|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
144211659|NCT01653912|519968093|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
144647962|NCT00514449|521563893|FG001|Overall Study|Withdrawal by Subject|2|||
144647963|NCT00514449|521563892|FG000|Overall Study|Protocol Violation|1|||
144647964|NCT00514449|521563893|FG001|Overall Study|Protocol Violation|2|||
144647965|NCT00514449|521563892|FG000|Overall Study|Lost to Follow-up|1|||
144647966|NCT00514449|521563893|FG001|Overall Study|Lost to Follow-up|0|||
144647967|NCT01164501|521563898|FG000|Overall Study|Not treated|2|||
144647968|NCT01164501|521563899|FG001|Overall Study|Not treated|0|||
144647969|NCT01164501|521563900|FG002|Overall Study|Not treated|1|||
144647970|NCT01164501|521563898|FG000|Overall Study|Adverse Event|18|||
144647971|NCT01164501|521563899|FG001|Overall Study|Adverse Event|4|||
144647972|NCT01164501|521563900|FG002|Overall Study|Adverse Event|21|||
144647973|NCT01164501|521563898|FG000|Overall Study|Lack of Efficacy|0|||
144647974|NCT01164501|521563899|FG001|Overall Study|Lack of Efficacy|0|||
144647975|NCT01164501|521563900|FG002|Overall Study|Lack of Efficacy|1|||
144647976|NCT01164501|521563898|FG000|Overall Study|Non compliant with protocol|1|||
144647977|NCT01164501|521563899|FG001|Overall Study|Non compliant with protocol|1|||
144647978|NCT01164501|521563900|FG002|Overall Study|Non compliant with protocol|4|||
144647979|NCT01164501|521563898|FG000|Overall Study|Lost to Follow-up|3|||
144647980|NCT01164501|521563899|FG001|Overall Study|Lost to Follow-up|0|||
144647981|NCT01164501|521563900|FG002|Overall Study|Lost to Follow-up|3|||
144647982|NCT01164501|521563898|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
144647983|NCT01164501|521563899|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
144647984|NCT01164501|521563900|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
144647985|NCT01164501|521563898|FG000|Overall Study|Other reason not defined above|9|||
144647986|NCT01164501|521563899|FG001|Overall Study|Other reason not defined above|1|||
144647987|NCT01164501|521563900|FG002|Overall Study|Other reason not defined above|4|||
144647988|NCT01096667|521563902|FG000|Overall Study|Lost to Follow-up|1|||
144647989|NCT01096667|521563903|FG001|Overall Study|Lost to Follow-up|1|||
144647990|NCT01096667|521563904|FG002|Overall Study|Lost to Follow-up|1|||
144647991|NCT01096667|521563905|FG003|Overall Study|Lost to Follow-up|0|||
144647992|NCT01096667|521563906|FG004|Overall Study|Lost to Follow-up|0|||
144647993|NCT01096667|521563902|FG000|Overall Study|Withdrawal by Subject|1|||
144647994|NCT01096667|521563903|FG001|Overall Study|Withdrawal by Subject|0|||
144647995|NCT01096667|521563904|FG002|Overall Study|Withdrawal by Subject|0|||
144647996|NCT01096667|521563905|FG003|Overall Study|Withdrawal by Subject|1|||
144647997|NCT01096667|521563906|FG004|Overall Study|Withdrawal by Subject|0|||
144647998|NCT01096667|521563902|FG000|Overall Study|Reason not available|0|||
144647999|NCT01096667|521563903|FG001|Overall Study|Reason not available|1|||
144648000|NCT01096667|521563904|FG002|Overall Study|Reason not available|1|||
144648001|NCT01096667|521563905|FG003|Overall Study|Reason not available|1|||
144648002|NCT01096667|521563906|FG004|Overall Study|Reason not available|0|||
144648003|NCT01096667|521563902|FG000|Overall Study|Protocol Violation|0|||
144648004|NCT01096667|521563903|FG001|Overall Study|Protocol Violation|0|||
144648005|NCT01096667|521563904|FG002|Overall Study|Protocol Violation|0|||
144648006|NCT01096667|521563905|FG003|Overall Study|Protocol Violation|1|||
144648007|NCT01096667|521563906|FG004|Overall Study|Protocol Violation|0|||
144648008|NCT01096667|521563902|FG000|Overall Study|Not treated|1|||
144648009|NCT01096667|521563903|FG001|Overall Study|Not treated|0|||
144648010|NCT01096667|521563904|FG002|Overall Study|Not treated|0|||
144648011|NCT01096667|521563905|FG003|Overall Study|Not treated|0|||
144648012|NCT01096667|521563906|FG004|Overall Study|Not treated|0|||
144648013|NCT00673673|521563907|FG000|Overall Study|Progressive disease|27|||
144648014|NCT00673673|521563907|FG000|Overall Study|Adverse Event|4|||
144648015|NCT00673673|521563907|FG000|Overall Study|Withdrawal by Subject|3|||
144648016|NCT00673673|521563907|FG000|Overall Study|Investigators' discretion|2|||
144648017|NCT02531035|521565482|FG000|Overall Study|Death|0|||
144648018|NCT02531035|521565483|FG001|Overall Study|Death|1|||
144648019|NCT02531035|521565482|FG000|Overall Study|Protocol Violation|1|||
144648020|NCT02531035|521565483|FG001|Overall Study|Protocol Violation|1|||
144648021|NCT02531035|521565482|FG000|Overall Study|Noncompliance with study drug|8|||
144648022|NCT02531035|521565483|FG001|Overall Study|Noncompliance with study drug|3|||
144648023|NCT02531035|521565482|FG000|Overall Study|Physician Decision|1|||
144648024|NCT02531035|521565483|FG001|Overall Study|Physician Decision|0|||
144648025|NCT02531035|521565482|FG000|Overall Study|Adverse Event|16|||
144648026|NCT02531035|521565483|FG001|Overall Study|Adverse Event|45|||
144648027|NCT02531035|521565482|FG000|Overall Study|Other|3|||
144648028|NCT02531035|521565483|FG001|Overall Study|Other|2|||
144648029|NCT02531035|521565482|FG000|Overall Study|Withdrawal by Subject|42|||
144648030|NCT02531035|521565483|FG001|Overall Study|Withdrawal by Subject|32|||
144211660|NCT01653912|519968094|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
144211661|NCT01653912|519968095|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
144211662|NCT01653912|519968096|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
144211663|NCT01653912|519968091|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
144211664|NCT01653912|519968092|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
144211665|NCT01653912|519968093|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
144648031|NCT02531035|521565482|FG000|Overall Study|Lost to Follow-up|8|||
144648032|NCT02531035|521565483|FG001|Overall Study|Lost to Follow-up|10|||
144648033|NCT02531035|521565482|FG000|Overall Study|Randomized, not treated|2|||
144648034|NCT02531035|521565483|FG001|Overall Study|Randomized, not treated|1|||
144648035|NCT02400346|521565484|FG000|Overall Study|Adverse Event|24|||
144648036|NCT02400346|521565484|FG000|Overall Study|Lack of Efficacy|9|||
144648037|NCT02400346|521565484|FG000|Overall Study|Non-compliance with IMP|1|||
144648038|NCT02400346|521565484|FG000|Overall Study|Withdrawal by Subject|7|||
144648039|NCT02400346|521565484|FG000|Overall Study|Administrative or other reason(s)|2|||
144648040|NCT02400346|521565484|FG000|Overall Study|Lost to Follow-up|1|||
144648041|NCT00500149|521565485|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
144648042|NCT00500149|521565486|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
144648043|NCT00500149|521565485|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
144648044|NCT00500149|521565486|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
144648045|NCT00500149|521565485|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
144648046|NCT00500149|521565486|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
144648047|NCT00500149|521565485|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
144648048|NCT00500149|521565486|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
144648049|NCT00500149|521565485|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
144648050|NCT00500149|521565486|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
144648051|NCT00500149|521565485|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
144648052|NCT00500149|521565486|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
144648053|NCT00500149|521565485|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
144648054|NCT00500149|521565486|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
144648055|NCT01058369|521565487|FG000|Overall Study|Adverse Event|1|||
144648056|NCT01058369|521565487|FG000|Overall Study|Early termination study|1|||
144648057|NCT00089843|521565488|FG000|Overall Study|Withdrawal by Subject|1|||
144648058|NCT00089843|521565489|FG001|Overall Study|Withdrawal by Subject|4|||
144648059|NCT00089843|521565490|FG002|Overall Study|Withdrawal by Subject|5|||
144648060|NCT00089843|521565491|FG003|Overall Study|Withdrawal by Subject|6|||
144648061|NCT00089843|521565488|FG000|Overall Study|Physician Decision|1|||
144648062|NCT00089843|521565489|FG001|Overall Study|Physician Decision|0|||
144648063|NCT00089843|521565490|FG002|Overall Study|Physician Decision|0|||
144648064|NCT00089843|521565491|FG003|Overall Study|Physician Decision|1|||
144648065|NCT01157169|521565492|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
144648066|NCT01157169|521565493|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
144648067|NCT01157169|521565492|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
144648068|NCT01157169|521565493|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
144648069|NCT00663858|521565494|FG000|Overall Study|Adverse Event|9|||
144648070|NCT00663858|521565495|FG001|Overall Study|Adverse Event|1|||
144648071|NCT00663858|521565496|FG002|Overall Study|Adverse Event|6|||
144648072|NCT00663858|521565494|FG000|Overall Study|Lack of Efficacy|5|||
144648073|NCT00663858|521565495|FG001|Overall Study|Lack of Efficacy|1|||
144648074|NCT00663858|521565496|FG002|Overall Study|Lack of Efficacy|3|||
144648075|NCT00663858|521565494|FG000|Overall Study|Withdrawal by Subject|7|||
144648076|NCT00663858|521565495|FG001|Overall Study|Withdrawal by Subject|3|||
144648077|NCT00663858|521565496|FG002|Overall Study|Withdrawal by Subject|3|||
144648078|NCT00663858|521565494|FG000|Overall Study|Protocol Violation|5|||
144648079|NCT00663858|521565495|FG001|Overall Study|Protocol Violation|3|||
144648080|NCT00663858|521565496|FG002|Overall Study|Protocol Violation|4|||
144648081|NCT00663858|521565494|FG000|Overall Study|Other|8|||
144648082|NCT00663858|521565495|FG001|Overall Study|Other|2|||
144648083|NCT00663858|521565496|FG002|Overall Study|Other|4|||
144648084|NCT03060577|521565497|FG000|Overall Study|Withdrawal by Subject|25|||
144648085|NCT03060577|521565498|FG001|Overall Study|Withdrawal by Subject|5|||
144648086|NCT03060577|521565497|FG000|Overall Study|Physician Decision|4|||
144648087|NCT03060577|521565498|FG001|Overall Study|Physician Decision|3|||
144648088|NCT03060577|521565497|FG000|Overall Study|Lost to Follow-up|3|||
144648089|NCT03060577|521565498|FG001|Overall Study|Lost to Follow-up|0|||
144648090|NCT03060577|521565497|FG000|Overall Study|Death|7|||
144648091|NCT03060577|521565498|FG001|Overall Study|Death|1|||
144648092|NCT03060577|521565497|FG000|Overall Study|Adverse Event|9|||
144648093|NCT03060577|521565498|FG001|Overall Study|Adverse Event|1|||
144648094|NCT03060577|521565497|FG000|Overall Study|Inclusion/Exclusion|1|||
144648095|NCT03060577|521565498|FG001|Overall Study|Inclusion/Exclusion|0|||
144648096|NCT03060577|521565497|FG000|Overall Study|Other|8|||
144648097|NCT03060577|521565498|FG001|Overall Study|Other|2|||
144648098|NCT01277289|521565502|FG000|Overall Study|fragile vein|1|||
144648099|NCT01277289|521565503|FG001|Overall Study|fragile vein|0|||
144648100|NCT01277289|521565502|FG000|Overall Study|Physician Decision|1|||
144648101|NCT01277289|521565503|FG001|Overall Study|Physician Decision|0|||
144648102|NCT01277289|521565502|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
144648103|NCT01277289|521565503|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
144648104|NCT01277289|521565502|FG000|Overall Study|Protocol Violation|1|||
144648105|NCT01277289|521565503|FG001|Overall Study|Protocol Violation|1|||
144648106|NCT01277289|521565502|FG000|Overall Study|Adverse Event|2|||
144648107|NCT01277289|521565503|FG001|Overall Study|Adverse Event|1|||
144648108|NCT01277289|521565502|FG000|Overall Study|consent withdrawn|1|||
144211666|NCT01653912|519968094|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
144211667|NCT01653912|519968095|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
144648109|NCT01277289|521565503|FG001|Overall Study|consent withdrawn|1|||
144648110|NCT01277289|521565502|FG000|Overall Study|premature closure of the study|4|||
144648111|NCT01277289|521565503|FG001|Overall Study|premature closure of the study|2|||
144648112|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
144648113|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
144648114|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
144648115|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
144648116|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
144648117|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
144648118|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
144648119|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
144263300|NCT00048035|520165401|FG006|Core Period|Early Withdrawals|0|||
144263301|NCT00048035|520165402|FG007|Core Period|Early Withdrawals|0|||
144263302|NCT00048035|520165395|FG000|Extension Year 1|Early Withdrawals|0|||
144263303|NCT00048035|520165396|FG001|Extension Year 1|Early Withdrawals|0|||
144263304|NCT00048035|520165397|FG002|Extension Year 1|Early Withdrawals|0|||
144648120|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
144648121|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
144648122|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
144648123|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
144648124|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
144648125|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
144648126|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
144648127|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
144648128|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
144648129|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
144648130|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
144648131|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
144648132|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
144648133|NCT00092547|521565504|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
144648134|NCT00092547|521565505|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
144648135|NCT00092547|521565506|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
144648136|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
144648137|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
144648138|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
144648139|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
144648140|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
144648141|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
144648142|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
144648143|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
144648144|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
144648145|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
144648146|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
144648147|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
144648148|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
144648149|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
144648150|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
144648151|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
144648152|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
144648153|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
144648154|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
144648155|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
144648156|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
144648157|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
144648158|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
144648159|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
144648160|NCT00092547|521565504|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
144648161|NCT00092547|521565505|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
144648162|NCT00092547|521565506|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
144648163|NCT00092547|521565504|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
144648164|NCT00092547|521565505|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
144648165|NCT00092547|521565506|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
144648166|NCT00092547|521565504|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
144648167|NCT00092547|521565505|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
144648168|NCT00092547|521565506|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
144648169|NCT00092547|521565504|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
144648170|NCT00092547|521565505|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
144648171|NCT00092547|521565506|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
144648172|NCT00092547|521565504|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
144263305|NCT00048035|520165398|FG003|Extension Year 1|Early Withdrawals|0|||
144648173|NCT00092547|521565505|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
144263306|NCT00048035|520165399|FG004|Extension Year 1|Early Withdrawals|0|||
144648174|NCT00092547|521565506|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
144648175|NCT00641043|521565512|FG000|Overall Study|Adverse Event|6|||
144648176|NCT00641043|521565513|FG001|Overall Study|Adverse Event|4|||
144648177|NCT00641043|521565512|FG000|Overall Study|Protocol Violation|2|||
144648178|NCT00641043|521565513|FG001|Overall Study|Protocol Violation|3|||
144648179|NCT00641043|521565512|FG000|Overall Study|Lost to Follow-up|3|||
144648180|NCT00641043|521565513|FG001|Overall Study|Lost to Follow-up|2|||
144648181|NCT00641043|521565512|FG000|Overall Study|Withdrawal by Subject|4|||
144648182|NCT00641043|521565513|FG001|Overall Study|Withdrawal by Subject|4|||
144648183|NCT00641043|521565512|FG000|Overall Study|Other incl. lack of efficacy|4|||
144648184|NCT00641043|521565513|FG001|Overall Study|Other incl. lack of efficacy|2|||
144648185|NCT02584634|521565514|FG000|Overall Study|Adverse Event|3|||
144648186|NCT02584634|521565515|FG001|Overall Study|Adverse Event|5|||
144648187|NCT02584634|521565514|FG000|Overall Study|Death|0|||
144648188|NCT02584634|521565515|FG001|Overall Study|Death|1|||
144648189|NCT02584634|521565514|FG000|Overall Study|Lost to Follow-up|0|||
144648190|NCT02584634|521565515|FG001|Overall Study|Lost to Follow-up|1|||
144648191|NCT02584634|521565514|FG000|Overall Study|Physician Decision|1|||
144648192|NCT02584634|521565515|FG001|Overall Study|Physician Decision|2|||
144648193|NCT02584634|521565514|FG000|Overall Study|Progressive disease|7|||
144648194|NCT02584634|521565515|FG001|Overall Study|Progressive disease|15|||
144648195|NCT02584634|521565514|FG000|Overall Study|Withdrawal by Subject|1|||
144648196|NCT02584634|521565515|FG001|Overall Study|Withdrawal by Subject|1|||
144648197|NCT02584634|521565514|FG000|Overall Study|Other|0|||
144648198|NCT02584634|521565515|FG001|Overall Study|Other|6|||
144648199|NCT00474630|521565516|FG000|Overall Study|Adverse Event|98|||
144648200|NCT00474630|521565517|FG001|Overall Study|Adverse Event|26|||
144648201|NCT00474630|521565516|FG000|Overall Study|Lost to Follow-up|22|||
144648202|NCT00474630|521565517|FG001|Overall Study|Lost to Follow-up|15|||
144648203|NCT00474630|521565516|FG000|Overall Study|Withdrawal by Subject|21|||
144648204|NCT00474630|521565517|FG001|Overall Study|Withdrawal by Subject|15|||
144648205|NCT00474630|521565516|FG000|Overall Study|Protocol Violation|3|||
144648206|NCT00474630|521565517|FG001|Overall Study|Protocol Violation|4|||
144648207|NCT00474630|521565516|FG000|Overall Study|Lack of Efficacy|5|||
144648208|NCT00474630|521565517|FG001|Overall Study|Lack of Efficacy|6|||
144648209|NCT00474630|521565516|FG000|Overall Study|Drug noncompliance, other|11|||
144648210|NCT00474630|521565517|FG001|Overall Study|Drug noncompliance, other|4|||
144648211|NCT03088605|521565518|FG000|Overall Study|Withdrawal by Subject|1|||
144648212|NCT03088605|521565519|FG001|Overall Study|Withdrawal by Subject|0|||
144648213|NCT00553059|521565524|FG000|Overall Study|Deemed ineligible|1|||
144648214|NCT00553059|521565525|FG001|Overall Study|Deemed ineligible|1|||
144648215|NCT00553059|521565524|FG000|Overall Study|Drug supply not available|0|||
144648216|NCT00553059|521565525|FG001|Overall Study|Drug supply not available|1|||
144648217|NCT04601272|521565533|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
144648218|NCT04601272|521565534|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
144648219|NCT04601272|521565535|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
144648220|NCT00414440|521565536|FG000|Core Period|Withdrawal by Subject|70|||
144648221|NCT00414440|521565537|FG001|Core Period|Withdrawal by Subject|32|||
144648222|NCT00414440|521565536|FG000|Extension Period|Lost to Follow-up|44|||
144648223|NCT00414440|521565537|FG001|Extension Period|Lost to Follow-up|52|||
144648224|NCT00414440|521565536|FG000|Extension Period|Did not consent to continue follow up|61|||
144648225|NCT00414440|521565537|FG001|Extension Period|Did not consent to continue follow up|54|||
144648226|NCT00414440|521565536|FG000|Extension Period|Other|1|||
144648227|NCT00414440|521565537|FG001|Extension Period|Other|1|||
144648228|NCT00414440|521565536|FG000|Extension Period|Administrative|16|||
144648229|NCT00414440|521565537|FG001|Extension Period|Administrative|16|||
144648230|NCT00414440|521565536|FG000|Extension Period|Death|1|||
144648231|NCT00414440|521565537|FG001|Extension Period|Death|2|||
144648232|NCT00414440|521565536|FG000|Extension Period|Withdrawal by Subject|9|||
144648233|NCT00414440|521565537|FG001|Extension Period|Withdrawal by Subject|7|||
144648234|NCT00414440|521565536|FG000|Extension Period|Not included in follow up period|18|||
144648235|NCT00414440|521565537|FG001|Extension Period|Not included in follow up period|8|||
144648236|NCT04382651|521565538|FG000|Overall Study|Death|26|||
144648237|NCT04382651|521565539|FG001|Overall Study|Death|23|||
144648238|NCT04382651|521565538|FG000|Overall Study|Lost to Follow-up|3|||
144731671|NCT00986245|521873243|FG000|First Intervention|Withdrawal by Subject|0|||
144648239|NCT04382651|521565539|FG001|Overall Study|Lost to Follow-up|4|||
144648240|NCT04382651|521565538|FG000|Overall Study|Withdrawal by Subject|2|||
144648241|NCT04382651|521565539|FG001|Overall Study|Withdrawal by Subject|0|||
144648242|NCT04382651|521565538|FG000|Overall Study|Physician Decision|0|||
144648243|NCT04382651|521565539|FG001|Overall Study|Physician Decision|1|||
144731672|NCT00986245|521873244|FG001|First Intervention|Withdrawal by Subject|1|||
144648244|NCT02732912|521565540|FG000|Overall Study|Discharged before night|2|||
144648245|NCT02732912|521565541|FG001|Overall Study|Discharged before night|6|||
144648246|NCT02732912|521565540|FG000|Overall Study|Incomplete completion of questionnaire|2|||
144648247|NCT02732912|521565541|FG001|Overall Study|Incomplete completion of questionnaire|3|||
144648248|NCT02732912|521565540|FG000|Overall Study|No outcome; discharged or refused|6|||
144648249|NCT02732912|521565541|FG001|Overall Study|No outcome; discharged or refused|9|||
144648250|NCT01507545|521565542|FG000|Overall Study|Withdrawal by Subject|6|||
144648251|NCT01507545|521565543|FG001|Overall Study|Withdrawal by Subject|2|||
144648252|NCT01507545|521565542|FG000|Overall Study|Lost to Follow-up|1|||
144648253|NCT01507545|521565543|FG001|Overall Study|Lost to Follow-up|0|||
144648254|NCT01507545|521565542|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
144648255|NCT01507545|521565543|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
144648256|NCT01507545|521565542|FG000|Overall Study|Progressive disease|60|||
144648257|NCT01507545|521565543|FG001|Overall Study|Progressive disease|27|||
144648258|NCT01507545|521565542|FG000|Overall Study|Other|6|||
144648259|NCT01507545|521565543|FG001|Overall Study|Other|4|||
144648260|NCT01873742|521565544|FG000|Overall Study|Lost to Follow-up|68|||
144648261|NCT01873742|521565545|FG001|Overall Study|Lost to Follow-up|76|||
144648262|NCT00790296|521565547|FG000|Overall Study|Did not meet study eligibility criteria|1|||
144648263|NCT00790296|521565548|FG001|Overall Study|Did not meet study eligibility criteria|1|||
144648264|NCT00790296|521565547|FG000|Overall Study|Adverse Event|0|||
144648265|NCT00790296|521565548|FG001|Overall Study|Adverse Event|1|||
144648266|NCT01671488|521565549|FG000|Overall Study|Withdrawal by Subject|1|||
144648267|NCT01753518|521565550|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
144648268|NCT01753518|521565551|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
144648269|NCT01753518|521565550|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
144648270|NCT01753518|521565551|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
144648271|NCT01753518|521565550|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
144648272|NCT01753518|521565551|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
144648273|NCT01753518|521565550|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
144648274|NCT01753518|521565551|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
144648275|NCT00940342|521565552|FG000|Overall Study|Adverse Event|0|||
144648276|NCT00940342|521565553|FG001|Overall Study|Adverse Event|2|||
144648277|NCT00940342|521565554|FG002|Overall Study|Adverse Event|1|||
144648278|NCT03503773|521565555|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
144648279|NCT03503773|521565556|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
144648280|NCT03503773|521565555|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
144648281|NCT03503773|521565556|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
144648282|NCT03503773|521565555|FG000|Overall Study|Not completing the primary ABPM|3|||
144648283|NCT03503773|521565556|FG001|Overall Study|Not completing the primary ABPM|1|||
144648284|NCT03503773|521565555|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
144648285|NCT03503773|521565556|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
144648286|NCT01088412|521565562|FG000|Overall Study|Adverse Event|38|||
144648287|NCT01088412|521565563|FG001|Overall Study|Adverse Event|0|||
144648288|NCT01088412|521565564|FG002|Overall Study|Adverse Event|0|||
144648289|NCT01088412|521565562|FG000|Overall Study|Death|42|||
144648290|NCT01088412|521565563|FG001|Overall Study|Death|6|||
144648291|NCT01088412|521565564|FG002|Overall Study|Death|0|||
144648292|NCT01088412|521565562|FG000|Overall Study|Other Reason per Case Report Form|2089|||
144648293|NCT01088412|521565563|FG001|Overall Study|Other Reason per Case Report Form|103|||
144648294|NCT01088412|521565564|FG002|Overall Study|Other Reason per Case Report Form|9|||
144648295|NCT01088412|521565562|FG000|Overall Study|Withdrawal by Subject|1761|||
144648296|NCT01088412|521565563|FG001|Overall Study|Withdrawal by Subject|25|||
144648297|NCT01088412|521565564|FG002|Overall Study|Withdrawal by Subject|1|||
144648298|NCT01088412|521565562|FG000|Overall Study|Received Another GH Product|79|||
144648299|NCT01088412|521565563|FG001|Overall Study|Received Another GH Product|0|||
144648300|NCT01088412|521565564|FG002|Overall Study|Received Another GH Product|0|||
144648301|NCT01088412|521565562|FG000|Overall Study|Participant Moved|601|||
144648302|NCT01088412|521565563|FG001|Overall Study|Participant Moved|21|||
144648303|NCT01088412|521565564|FG002|Overall Study|Participant Moved|2|||
144648304|NCT01088412|521565562|FG000|Overall Study|Physician Decision|1041|||
144648305|NCT01088412|521565563|FG001|Overall Study|Physician Decision|8|||
144648306|NCT01088412|521565564|FG002|Overall Study|Physician Decision|4|||
144648307|NCT01088412|521565562|FG000|Overall Study|Sponsor Decision|4467|||
144648308|NCT01088412|521565563|FG001|Overall Study|Sponsor Decision|79|||
144648309|NCT01088412|521565564|FG002|Overall Study|Sponsor Decision|23|||
144648310|NCT01088412|521565562|FG000|Overall Study|Third Party Required to Change Brand|487|||
144648311|NCT01088412|521565563|FG001|Overall Study|Third Party Required to Change Brand|0|||
144648312|NCT01088412|521565564|FG002|Overall Study|Third Party Required to Change Brand|0|||
144648313|NCT01088412|521565562|FG000|Overall Study|Lost to Follow-up|3052|||
144211668|NCT01653912|519968096|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
144648314|NCT01088412|521565563|FG001|Overall Study|Lost to Follow-up|130|||
144648315|NCT01088412|521565564|FG002|Overall Study|Lost to Follow-up|11|||
144648316|NCT01088412|521565562|FG000|Overall Study|Study Summary Not Completed|4360|||
144648317|NCT01088412|521565563|FG001|Overall Study|Study Summary Not Completed|64|||
144648318|NCT01088412|521565564|FG002|Overall Study|Study Summary Not Completed|22|||
144648319|NCT02285010|521565565|FG000|Overall Study|not abdominal hysterectomy|2|||
144648320|NCT02285010|521565566|FG001|Overall Study|not abdominal hysterectomy|0|||
144648321|NCT02285010|521565565|FG000|Overall Study|Not spinal anesthesia|3|||
144648322|NCT02285010|521565566|FG001|Overall Study|Not spinal anesthesia|1|||
144648323|NCT00532259|521565567|FG000|Overall Study|Withdrawal by Subject|2|||
144648324|NCT00532259|521565567|FG000|Overall Study|Adverse Event|1|||
144648325|NCT00532259|521565567|FG000|Overall Study|Death|1|||
144648326|NCT00532259|521565567|FG000|Overall Study|Lack of Efficacy|21|||
144648327|NCT00532259|521565567|FG000|Overall Study|Lost to Follow-up|3|||
144648328|NCT00532259|521565567|FG000|Overall Study|Physician Decision|3|||
144648329|NCT00532259|521565567|FG000|Overall Study|Protocol Violation|1|||
144648330|NCT00206518|521565569|FG000|Overall Study|Lack of Efficacy|6|||
144648331|NCT00206518|521565570|FG001|Overall Study|Lack of Efficacy|4|||
144648332|NCT00206518|521565569|FG000|Overall Study|Adverse Event|2|||
144648333|NCT00206518|521565570|FG001|Overall Study|Adverse Event|1|||
144648334|NCT00206518|521565569|FG000|Overall Study|Physician Decision|1|||
144648335|NCT00206518|521565570|FG001|Overall Study|Physician Decision|0|||
144648336|NCT00206518|521565569|FG000|Overall Study|Protocol Violation|1|||
144648337|NCT00206518|521565570|FG001|Overall Study|Protocol Violation|1|||
144648338|NCT02335450|521565571|FG000|Overall Study|Pregnancy|1|||
144648339|NCT00853905|521565574|FG000|Overall Study|Lost to Follow-up|1|||
144648340|NCT00853905|521565575|FG001|Overall Study|Lost to Follow-up|3|||
144648341|NCT00853905|521565574|FG000|Overall Study|Withdrawal by Subject|0|||
144648342|NCT00853905|521565575|FG001|Overall Study|Withdrawal by Subject|1|||
144648343|NCT00853905|521565574|FG000|Overall Study|never had surgery|1|||
144648344|NCT00853905|521565575|FG001|Overall Study|never had surgery|0|||
144648345|NCT05258058|521565583|FG000|Overall Study|Withdrawal by Subject|2|||
144648346|NCT00408681|521565590|FG000|Overall Study|Lack of Efficacy|2|||
144648347|NCT00408681|521565590|FG000|Overall Study|Adverse Event|7|||
144648348|NCT00447421|521565597|FG000|Overall Study|Lack of Efficacy|1|||
144648349|NCT00447421|521565597|FG000|Overall Study|Adverse Event|3|||
144648350|NCT00447421|521565597|FG000|Overall Study|Sponsor Decision|2|||
144648351|NCT00465738|521565598|FG000|Overall Study|Lost to Follow-up|2|||
144648352|NCT00465738|521565599|FG001|Overall Study|Lost to Follow-up|0|||
144648353|NCT00465738|521565598|FG000|Overall Study|Adverse Event|0|||
144648354|NCT00465738|521565599|FG001|Overall Study|Adverse Event|1|||
144648355|NCT00465738|521565598|FG000|Overall Study|Withdrawal by Subject|2|||
144648356|NCT00465738|521565599|FG001|Overall Study|Withdrawal by Subject|0|||
144648357|NCT00465738|521565598|FG000|Overall Study|Other|2|||
144648358|NCT00465738|521565599|FG001|Overall Study|Other|5|||
144648359|NCT01787591|521565600|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
144648360|NCT01787591|521565601|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
144648361|NCT01787591|521565602|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
144648362|NCT01787591|521565603|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
144648363|NCT02725177|521565606|FG000|Overall Study|Physician Decision|4|||
144648364|NCT02725177|521565606|FG000|Overall Study|Adverse Event|1|||
144648365|NCT02707757|521565607|FG000|Overall Study|Protocol Violation|3|||
144648366|NCT02707757|521565608|FG001|Overall Study|Protocol Violation|2|||
144648367|NCT02707757|521565607|FG000|Overall Study|Withdrawal by Subject|2|||
144648368|NCT02707757|521565608|FG001|Overall Study|Withdrawal by Subject|0|||
144648369|NCT02707757|521565607|FG000|Overall Study|Death|0|||
144648370|NCT02707757|521565608|FG001|Overall Study|Death|1|||
144648371|NCT02707757|521565607|FG000|Overall Study|Adverse Event|6|||
144648372|NCT02707757|521565608|FG001|Overall Study|Adverse Event|4|||
144648373|NCT02707757|521565607|FG000|Overall Study|Renal transplant/elective operation|1|||
144648374|NCT02707757|521565608|FG001|Overall Study|Renal transplant/elective operation|5|||
144648375|NCT00638846|521565609|FG000|Overall Study|Adverse Event|0|||
144648376|NCT00638846|521565610|FG001|Overall Study|Adverse Event|1|||
144648377|NCT00638846|521565609|FG000|Overall Study|Lost to Follow-up|3|||
144648378|NCT00638846|521565610|FG001|Overall Study|Lost to Follow-up|2|||
144648379|NCT00638846|521565609|FG000|Overall Study|lens issue|1|||
144648380|NCT00638846|521565610|FG001|Overall Study|lens issue|3|||
144648381|NCT00734929|521565615|FG000|Overall Study|Lost to Follow-up|1|||
144648382|NCT00734929|521565616|FG001|Overall Study|Lost to Follow-up|2|||
144648383|NCT00734929|521565615|FG000|Overall Study|No intervention/ screen fail|5|||
144648384|NCT00734929|521565616|FG001|Overall Study|No intervention/ screen fail|3|||
144648385|NCT04799782|521565617|FG000|Washout|Physician Decision|2|||
144648386|NCT04799782|521565618|FG001|Washout|Physician Decision|0|||
144648387|NCT04799782|521565617|FG000|Washout|Withdrawal by Subject|0|||
144648388|NCT04799782|521565618|FG001|Washout|Withdrawal by Subject|2|||
144648389|NCT04799782|521565617|FG000|Washout|Lost to Follow-up|0|||
144648390|NCT04799782|521565618|FG001|Washout|Lost to Follow-up|1|||
144648391|NCT01589094|521565625|FG000|Overall Study|Did not receive treatment|2|||
144648392|NCT00969618|521565634|FG000|Overall Study|Adverse Event|29|||
144648393|NCT00969618|521565634|FG000|Overall Study|Entry Criteria Not Met|3|||
144648394|NCT00969618|521565634|FG000|Overall Study|Lack of Efficacy|2|||
144648395|NCT00969618|521565634|FG000|Overall Study|Lost to Follow-up|7|||
144648396|NCT00969618|521565634|FG000|Overall Study|Physician Decision|1|||
144648397|NCT00969618|521565634|FG000|Overall Study|Protocol Violation|9|||
144648398|NCT00969618|521565634|FG000|Overall Study|Withdrawal by Subject|27|||
144648399|NCT01318902|521565639|FG000|Overall Study|Symptomatic Deterioration|0|||
144648400|NCT01318902|521565640|FG001|Overall Study|Symptomatic Deterioration|1|||
144648401|NCT01318902|521565641|FG002|Overall Study|Symptomatic Deterioration|1|||
144648402|NCT01318902|521565642|FG003|Overall Study|Symptomatic Deterioration|2|||
144648403|NCT01318902|521565639|FG000|Overall Study|Withdrawal by Patient|0|||
144648404|NCT01318902|521565640|FG001|Overall Study|Withdrawal by Patient|1|||
144648405|NCT01318902|521565641|FG002|Overall Study|Withdrawal by Patient|0|||
144648406|NCT01318902|521565642|FG003|Overall Study|Withdrawal by Patient|3|||
144648407|NCT01318902|521565639|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
144648408|NCT01318902|521565640|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
144648409|NCT01318902|521565641|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
144648410|NCT01318902|521565642|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
144648411|NCT01318902|521565639|FG000|Overall Study|Adverse Event|0|||
144648412|NCT01318902|521565640|FG001|Overall Study|Adverse Event|1|||
144648413|NCT01318902|521565641|FG002|Overall Study|Adverse Event|0|||
144648414|NCT01318902|521565642|FG003|Overall Study|Adverse Event|0|||
144648415|NCT01318902|521565639|FG000|Overall Study|Terminated by Sponsor|0|||
144648416|NCT01318902|521565640|FG001|Overall Study|Terminated by Sponsor|0|||
144648417|NCT01318902|521565641|FG002|Overall Study|Terminated by Sponsor|1|||
144648418|NCT01318902|521565642|FG003|Overall Study|Terminated by Sponsor|0|||
144648419|NCT04168645|521567192|FG000|Overall Study|Lost to Follow-up|23|||
144648420|NCT04168645|521567193|FG001|Overall Study|Lost to Follow-up|28|||
144648421|NCT04168645|521567194|FG002|Overall Study|Lost to Follow-up|15|||
144648422|NCT04168645|521567195|FG003|Overall Study|Lost to Follow-up|12|||
144648423|NCT04168645|521567192|FG000|Overall Study|Death|1|||
144648424|NCT04168645|521567193|FG001|Overall Study|Death|1|||
144648425|NCT04168645|521567194|FG002|Overall Study|Death|0|||
144648426|NCT04168645|521567195|FG003|Overall Study|Death|0|||
144648427|NCT04168645|521567192|FG000|Overall Study|Withdrawal by Subject|5|||
144648428|NCT04168645|521567193|FG001|Overall Study|Withdrawal by Subject|2|||
144648429|NCT04168645|521567194|FG002|Overall Study|Withdrawal by Subject|2|||
144648430|NCT04168645|521567195|FG003|Overall Study|Withdrawal by Subject|2|||
144648431|NCT04168645|521567192|FG000|Overall Study|Administrative Withdrawal|3|||
144648432|NCT04168645|521567193|FG001|Overall Study|Administrative Withdrawal|1|||
144648433|NCT04168645|521567194|FG002|Overall Study|Administrative Withdrawal|1|||
144648434|NCT04168645|521567195|FG003|Overall Study|Administrative Withdrawal|3|||
144648435|NCT01158534|521567196|FG000|Overall Study|Withdrawal by Subject|1|||
144648436|NCT01158534|521567196|FG000|Overall Study|Death|1|||
144648437|NCT01158534|521567196|FG000|Overall Study|Other|1|||
144648438|NCT03042611|521567197|FG000|Core Phase|Withdrawal by Subject|13|||
144648439|NCT03042611|521567198|FG001|Core Phase|Withdrawal by Subject|4|||
144648440|NCT03042611|521567199|FG002|Core Phase|Withdrawal by Subject|0|||
144648441|NCT03042611|521567200|FG003|Core Phase|Withdrawal by Subject|0|||
144648442|NCT03042611|521567197|FG000|Core Phase|Death|232|||
144648443|NCT03042611|521567198|FG001|Core Phase|Death|110|||
144648444|NCT03042611|521567199|FG002|Core Phase|Death|0|||
144648445|NCT03042611|521567200|FG003|Core Phase|Death|0|||
144648446|NCT03042611|521567197|FG000|Core Phase|Lost to Follow-up|4|||
144648447|NCT03042611|521567198|FG001|Core Phase|Lost to Follow-up|7|||
144648448|NCT03042611|521567199|FG002|Core Phase|Lost to Follow-up|0|||
144648449|NCT03042611|521567200|FG003|Core Phase|Lost to Follow-up|0|||
144648450|NCT03042611|521567197|FG000|Core Phase|Physician Decision|7|||
144648451|NCT03042611|521567198|FG001|Core Phase|Physician Decision|2|||
144648452|NCT03042611|521567199|FG002|Core Phase|Physician Decision|0|||
144648453|NCT03042611|521567200|FG003|Core Phase|Physician Decision|0|||
144648454|NCT03042611|521567197|FG000|Core Phase|Study Closed|0|||
144648455|NCT03042611|521567198|FG001|Core Phase|Study Closed|1|||
144648456|NCT03042611|521567199|FG002|Core Phase|Study Closed|0|||
144648457|NCT03042611|521567200|FG003|Core Phase|Study Closed|0|||
144648458|NCT03042611|521567197|FG000|Extension Phase|Death|0|||
144648459|NCT03042611|521567198|FG001|Extension Phase|Death|0|||
144648460|NCT03042611|521567199|FG002|Extension Phase|Death|34|||
144648461|NCT03042611|521567200|FG003|Extension Phase|Death|16|||
144648462|NCT03042611|521567197|FG000|Extension Phase|Lost to Follow-up|0|||
144648463|NCT03042611|521567198|FG001|Extension Phase|Lost to Follow-up|0|||
144648464|NCT03042611|521567199|FG002|Extension Phase|Lost to Follow-up|1|||
144648465|NCT03042611|521567200|FG003|Extension Phase|Lost to Follow-up|1|||
144648466|NCT03042611|521567197|FG000|Extension Phase|Study Closed|0|||
144648467|NCT03042611|521567198|FG001|Extension Phase|Study Closed|0|||
144648468|NCT03042611|521567199|FG002|Extension Phase|Study Closed|17|||
144648469|NCT03042611|521567200|FG003|Extension Phase|Study Closed|11|||
144648470|NCT01666444|521567203|FG000|Overall Study|Did not initiate treatment|2|||
144648471|NCT01666444|521567204|FG001|Overall Study|Did not initiate treatment|1|||
144648472|NCT01371838|521567214|FG000|Overall Study|Withdrawal by Subject|27|||
144648473|NCT01371838|521567215|FG001|Overall Study|Withdrawal by Subject|33|||
144648474|NCT01371838|521567214|FG000|Overall Study|Lost to Follow-up|10|||
144648475|NCT01371838|521567215|FG001|Overall Study|Lost to Follow-up|20|||
144648476|NCT01371838|521567214|FG000|Overall Study|Death|3|||
144648477|NCT01371838|521567215|FG001|Overall Study|Death|4|||
144648478|NCT01371838|521567214|FG000|Overall Study|Protocol Violation|3|||
144648479|NCT01371838|521567215|FG001|Overall Study|Protocol Violation|0|||
144648480|NCT01371838|521567214|FG000|Overall Study|Investigator Decision|3|||
144648481|NCT01371838|521567215|FG001|Overall Study|Investigator Decision|8|||
144648482|NCT01371838|521567214|FG000|Overall Study|Last follow-up visit not conducted|2|||
144648483|NCT01371838|521567215|FG001|Overall Study|Last follow-up visit not conducted|0|||
144211669|NCT01653912|519968091|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211670|NCT01653912|519968092|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211671|NCT01653912|519968093|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211672|NCT01653912|519968094|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
144211673|NCT01653912|519968095|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211674|NCT01653912|519968096|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211675|NCT01653912|519968091|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
144211676|NCT01653912|519968092|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
144211677|NCT01653912|519968093|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
144211678|NCT01653912|519968094|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
144211679|NCT01653912|519968095|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
144211680|NCT01653912|519968096|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
144211681|NCT01653912|519968091|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
144211682|NCT01653912|519968092|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
144211683|NCT01653912|519968093|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
144211684|NCT01653912|519968094|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
144211685|NCT01653912|519968095|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
144211686|NCT01653912|519968096|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
144211687|NCT01653912|519968091|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211688|NCT01653912|519968092|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211689|NCT01653912|519968093|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211690|NCT01653912|519968094|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211691|NCT01653912|519968095|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
144211692|NCT01653912|519968096|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
144211693|NCT00708227|519968097|FG000|Overall Study|Physician Decision|0|||
144211694|NCT00708227|519968098|FG001|Overall Study|Physician Decision|3|||
144211695|NCT00708227|519968099|FG002|Overall Study|Physician Decision|1|||
144211696|NCT00708227|519968100|FG003|Overall Study|Physician Decision|2|||
144211697|NCT00708227|519968097|FG000|Overall Study|Withdrawal by Subject|1|||
144211698|NCT00708227|519968098|FG001|Overall Study|Withdrawal by Subject|2|||
144211699|NCT00708227|519968099|FG002|Overall Study|Withdrawal by Subject|0|||
144211700|NCT00708227|519968100|FG003|Overall Study|Withdrawal by Subject|1|||
144648484|NCT01371838|521567214|FG000|Overall Study|Lack of therapeutic response|0|||
144648485|NCT01371838|521567215|FG001|Overall Study|Lack of therapeutic response|1|||
144648486|NCT01371838|521567214|FG000|Overall Study|Surgery|1|||
144648487|NCT01371838|521567215|FG001|Overall Study|Surgery|0|||
144648488|NCT02225223|521567219|FG000|Overall Study|Death|10|||
144648489|NCT02225223|521567220|FG001|Overall Study|Death|1|||
144648490|NCT02225223|521567219|FG000|Overall Study|Lost to Follow-up|5|||
144648491|NCT02225223|521567220|FG001|Overall Study|Lost to Follow-up|0|||
144648492|NCT02225223|521567219|FG000|Overall Study|Other|1|||
144648493|NCT02225223|521567220|FG001|Overall Study|Other|2|||
144648494|NCT02225223|521567219|FG000|Overall Study|Physician Decision|1|||
144648495|NCT02225223|521567220|FG001|Overall Study|Physician Decision|0|||
144648496|NCT02225223|521567219|FG000|Overall Study|Withdrawal by Subject|2|||
144648497|NCT02225223|521567220|FG001|Overall Study|Withdrawal by Subject|2|||
144648498|NCT03567291|521567221|FG000|Period I|Adverse Event|14|||
144648499|NCT03567291|521567222|FG001|Period I|Adverse Event|0|||
144648500|NCT03567291|521567223|FG002|Period I|Adverse Event|0|||
144648501|NCT03567291|521567224|FG003|Period I|Adverse Event|0|||
144648502|NCT03567291|521567221|FG000|Period I|Protocol Violation|1|||
144648503|NCT03567291|521567222|FG001|Period I|Protocol Violation|0|||
144648504|NCT03567291|521567223|FG002|Period I|Protocol Violation|0|||
144648505|NCT03567291|521567224|FG003|Period I|Protocol Violation|0|||
144211701|NCT04007991|519968101|FG000|Overall Study|Withdrawal by Subject|1|||
144211702|NCT04007991|519968102|FG001|Overall Study|Withdrawal by Subject|1|||
144648506|NCT03567291|521567221|FG000|Period I|Withdrawal by Subject|23|||
144648507|NCT03567291|521567222|FG001|Period I|Withdrawal by Subject|0|||
144648508|NCT03567291|521567223|FG002|Period I|Withdrawal by Subject|0|||
144648509|NCT03567291|521567224|FG003|Period I|Withdrawal by Subject|0|||
144648510|NCT03567291|521567221|FG000|Period I|Lost to Follow-up|2|||
144211703|NCT04007991|519968101|FG000|Overall Study|Physician Decision|1|||
144211704|NCT04007991|519968102|FG001|Overall Study|Physician Decision|1|||
144211705|NCT04007991|519968101|FG000|Overall Study|Non-compliance with Study Drug|0|||
144211706|NCT04007991|519968102|FG001|Overall Study|Non-compliance with Study Drug|1|||
144648511|NCT03567291|521567222|FG001|Period I|Lost to Follow-up|0|||
144648512|NCT03567291|521567223|FG002|Period I|Lost to Follow-up|0|||
144648513|NCT03567291|521567224|FG003|Period I|Lost to Follow-up|0|||
144648514|NCT03567291|521567221|FG000|Period I|Terminated by sponsor|44|||
144648515|NCT03567291|521567222|FG001|Period I|Terminated by sponsor|0|||
144648516|NCT03567291|521567223|FG002|Period I|Terminated by sponsor|0|||
144648517|NCT03567291|521567224|FG003|Period I|Terminated by sponsor|0|||
144648518|NCT03567291|521567221|FG000|Period I|Missing or unknown|7|||
144648519|NCT03567291|521567222|FG001|Period I|Missing or unknown|0|||
144648520|NCT03567291|521567223|FG002|Period I|Missing or unknown|0|||
144648521|NCT03567291|521567224|FG003|Period I|Missing or unknown|0|||
144648522|NCT03567291|521567221|FG000|Period II|Adverse Event|0|||
144648523|NCT03567291|521567222|FG001|Period II|Adverse Event|1|||
144648524|NCT03567291|521567223|FG002|Period II|Adverse Event|0|||
144648525|NCT03567291|521567224|FG003|Period II|Adverse Event|0|||
144648526|NCT03567291|521567221|FG000|Period II|Missing or unknown|0|||
144648527|NCT03567291|521567222|FG001|Period II|Missing or unknown|2|||
144648528|NCT03567291|521567223|FG002|Period II|Missing or unknown|1|||
144648529|NCT03567291|521567224|FG003|Period II|Missing or unknown|0|||
144648530|NCT03567291|521567221|FG000|Period III|Adverse Event|0|||
144648531|NCT03567291|521567222|FG001|Period III|Adverse Event|0|||
144648532|NCT03567291|521567223|FG002|Period III|Adverse Event|0|||
144648533|NCT03567291|521567224|FG003|Period III|Adverse Event|4|||
144648534|NCT03567291|521567221|FG000|Period III|Withdrawal by Subject|0|||
144648535|NCT03567291|521567222|FG001|Period III|Withdrawal by Subject|0|||
144648536|NCT03567291|521567223|FG002|Period III|Withdrawal by Subject|0|||
144648537|NCT03567291|521567224|FG003|Period III|Withdrawal by Subject|4|||
144648538|NCT03567291|521567221|FG000|Period III|Lost to Follow-up|0|||
144648539|NCT03567291|521567222|FG001|Period III|Lost to Follow-up|0|||
144648540|NCT03567291|521567223|FG002|Period III|Lost to Follow-up|0|||
144648541|NCT03567291|521567224|FG003|Period III|Lost to Follow-up|1|||
144648542|NCT03567291|521567221|FG000|Period III|Terminated by sponsor|0|||
144648543|NCT03567291|521567222|FG001|Period III|Terminated by sponsor|0|||
144648544|NCT03567291|521567223|FG002|Period III|Terminated by sponsor|0|||
144648545|NCT03567291|521567224|FG003|Period III|Terminated by sponsor|68|||
144648546|NCT03567291|521567221|FG000|Period III|Missing or unknown|0|||
144648547|NCT03567291|521567222|FG001|Period III|Missing or unknown|0|||
144648548|NCT03567291|521567223|FG002|Period III|Missing or unknown|0|||
144648549|NCT03567291|521567224|FG003|Period III|Missing or unknown|8|||
144648550|NCT03666143|521567225|FG000|Overall Study|Death|158|||
144648551|NCT03666143|521567225|FG000|Overall Study|Sponsor Decision|31|||
144648552|NCT03666143|521567225|FG000|Overall Study|Withdrawal by Subject|11|||
144648553|NCT03666143|521567225|FG000|Overall Study|Lost to Follow-up|5|||
144648554|NCT03666143|521567225|FG000|Overall Study|Physician Decision|1|||
144648555|NCT03666143|521567225|FG000|Overall Study|Rolled into extension study|9|||
144648556|NCT03666143|521567225|FG000|Overall Study|Progressive Disease|1|||
144648557|NCT01103349|521567226|FG000|Overall Study|Adverse Event|8|||
144648558|NCT01103349|521567227|FG001|Overall Study|Adverse Event|5|||
144648559|NCT01103349|521567228|FG002|Overall Study|Adverse Event|3|||
144648560|NCT01103349|521567226|FG000|Overall Study|Consent withdrawn|1|||
144648561|NCT01103349|521567227|FG001|Overall Study|Consent withdrawn|0|||
144648562|NCT01103349|521567228|FG002|Overall Study|Consent withdrawn|0|||
144648563|NCT01103349|521567226|FG000|Overall Study|Incorrectly included in the trial|1|||
144648564|NCT01103349|521567227|FG001|Overall Study|Incorrectly included in the trial|0|||
144648565|NCT01103349|521567228|FG002|Overall Study|Incorrectly included in the trial|0|||
144648566|NCT01103349|521567226|FG000|Overall Study|Withdrawal by Subject|1|||
144648567|NCT01103349|521567227|FG001|Overall Study|Withdrawal by Subject|1|||
144648568|NCT01103349|521567228|FG002|Overall Study|Withdrawal by Subject|0|||
144648569|NCT01103349|521567226|FG000|Overall Study|did not want to take trial medication|0|||
144648570|NCT01103349|521567227|FG001|Overall Study|did not want to take trial medication|1|||
144648571|NCT01103349|521567228|FG002|Overall Study|did not want to take trial medication|0|||
144648572|NCT01103349|521567226|FG000|Overall Study|forgot to take medication|0|||
144648573|NCT01103349|521567227|FG001|Overall Study|forgot to take medication|0|||
144648574|NCT01103349|521567228|FG002|Overall Study|forgot to take medication|1|||
144648575|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
144648576|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
144648577|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
144648578|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
144648579|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
144648580|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
144648581|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
144648582|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
144648583|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
144648584|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
144648585|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
144648586|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
144648587|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
144648588|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
144648589|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
144648590|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
144648591|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
144648592|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
144648593|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
144648594|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
144648595|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
144648596|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
144648597|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
144648598|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
144648599|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
144648600|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
144648601|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
144648602|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
144648603|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
144648604|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
144648605|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
144648606|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
144648607|NCT00958568|521567230|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
144648608|NCT00958568|521567231|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
144648609|NCT00958568|521567232|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
144648610|NCT00958568|521567233|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
144648611|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
144648612|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
144648613|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
144648614|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
144648615|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
144648616|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
144648617|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
144648618|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
144648619|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
144648620|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
144648621|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
144648622|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
144648623|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
144648624|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
144648625|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
144648626|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
144648627|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
144648628|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
144648629|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
144648630|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
144648631|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
144648632|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
144648633|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
144648634|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
144648635|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
144648636|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
144648637|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
144648638|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
144648639|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
144648640|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
144648641|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
144648642|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
144648643|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
144648644|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
144648645|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
144648646|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
144648647|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
144648648|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
144648649|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
144648650|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
144648651|NCT00958568|521567230|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
144731673|NCT00986245|521873243|FG000|First Intervention|Protocol Violation|0|||
144731674|NCT00986245|521873244|FG001|First Intervention|Protocol Violation|1|||
144731675|NCT00986245|521873243|FG000|First Intervention|Out of indication|1|||
144731676|NCT00986245|521873244|FG001|First Intervention|Out of indication|0|||
144731677|NCT00986245|521873243|FG000|Second Intervention|Poor compliance|1|||
144211707|NCT04007991|519968101|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
144648652|NCT00958568|521567231|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
144648653|NCT00958568|521567232|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
144648654|NCT00958568|521567233|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
144648655|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
144648656|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
144648657|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
144648658|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
144648659|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
144648660|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
144648661|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
144648662|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
144648663|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
144648664|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
144211708|NCT04007991|519968102|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
144211709|NCT04007991|519968101|FG000|Overall Study|Adverse event, non-fatal|5|||
144211710|NCT04007991|519968102|FG001|Overall Study|Adverse event, non-fatal|0|||
144211711|NCT04007991|519968101|FG000|Overall Study|Lost to Follow-up|2|||
144211712|NCT04007991|519968102|FG001|Overall Study|Lost to Follow-up|1|||
144211713|NCT01987479|519968103|FG000|Overall Study|Protocol Violation|1|||
144211714|NCT01987479|519968103|FG000|Overall Study|Physician Decision|2|||
144211715|NCT01987479|519968103|FG000|Overall Study|Participant/legal guardian decision|1|||
144211716|NCT01987479|519968103|FG000|Overall Study|Other|5|||
144211717|NCT01987479|519968103|FG000|Overall Study|Lost to Follow-up|1|||
144211718|NCT01987479|519968103|FG000|Overall Study|Adverse Event|7|||
144211719|NCT05314816|519968104|FG000|Overall Study|Lost to Follow-up|5|||
144211720|NCT05314816|519968105|FG001|Overall Study|Lost to Follow-up|0|||
144211721|NCT05314816|519968106|FG002|Overall Study|Lost to Follow-up|1|||
144211722|NCT05314816|519968104|FG000|Overall Study|Protocol Violation|13|||
144211723|NCT05314816|519968105|FG001|Overall Study|Protocol Violation|8|||
144211724|NCT05314816|519968106|FG002|Overall Study|Protocol Violation|0|||
144211725|NCT04042376|519968107|FG000|Overall Study|Withdrawal by Subject|1|||
144211726|NCT04042376|519968107|FG000|Overall Study|Death|3|||
144211727|NCT00974922|519970346|FG000|Overall Study|study terminated|24|||
144211728|NCT00459355|519970347|FG000|Overall Study|Subject no longer met inc criteria|20|||
144211729|NCT00459355|519970348|FG001|Overall Study|Subject no longer met inc criteria|18|||
144211730|NCT01762800|519970349|FG000|Overall Study|Adverse Event|8|||
144211731|NCT01762800|519970350|FG001|Overall Study|Adverse Event|13|||
144211732|NCT01762800|519970349|FG000|Overall Study|Lack of Efficacy|3|||
144211733|NCT01762800|519970350|FG001|Overall Study|Lack of Efficacy|2|||
144211734|NCT01762800|519970349|FG000|Overall Study|Study Closed/Terminated|0|||
144211735|NCT01762800|519970350|FG001|Overall Study|Study Closed/Terminated|1|||
144211736|NCT01762800|519970349|FG000|Overall Study|Physician Decision|1|||
144211737|NCT01762800|519970350|FG001|Overall Study|Physician Decision|1|||
144211738|NCT01762800|519970349|FG000|Overall Study|Withdrawal by Subject|7|||
144211739|NCT01762800|519970350|FG001|Overall Study|Withdrawal by Subject|4|||
144211740|NCT01173120|519970351|FG000|Overall Study|Lack of Efficacy|2|||
144211741|NCT01173120|519970351|FG000|Overall Study|Lost to Follow-up|1|||
144211742|NCT01173120|519970351|FG000|Overall Study|Participant Decision|2|||
144211743|NCT01173120|519970351|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
144648665|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
144648666|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
144648667|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
144648668|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
144648669|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
144648670|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
144648671|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
144648672|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
144211744|NCT01173120|519970351|FG000|Overall Study|Switch-Participant Decision|12|||
144211745|NCT01173120|519970351|FG000|Overall Study|Switch-Difficulty With Device|12|||
144211746|NCT00517881|519970352|FG000|Overall Study|Protocol Violation|2|||
144211747|NCT00517881|519970352|FG000|Overall Study|Adverse Event|1|||
144211748|NCT00517881|519970352|FG000|Overall Study|Renal transplantation|2|||
144211749|NCT02906358|519970353|FG000|Overall Study|Withdrawal by Subject|10|||
144211750|NCT02906358|519970354|FG001|Overall Study|Withdrawal by Subject|7|||
144211751|NCT02906358|519970353|FG000|Overall Study|Lost to Follow-up|12|||
144211752|NCT02906358|519970354|FG001|Overall Study|Lost to Follow-up|15|||
144211753|NCT02699684|519970355|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
144211754|NCT02699684|519970356|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
144211755|NCT01145508|519970357|FG000|Overall Study|Adverse Event|1|||
144648673|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
144211756|NCT01145508|519970358|FG001|Overall Study|Adverse Event|0|||
144211757|NCT01145508|519970357|FG000|Overall Study|Death|1|||
144648674|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
144648675|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
144648676|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
144648677|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
144648678|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
144648679|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
144648680|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
144648681|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
144648682|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
144648683|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
144648684|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
144648685|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
144648686|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
144648687|NCT00958568|521567230|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
144648688|NCT00958568|521567231|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
144648689|NCT00958568|521567232|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
144648690|NCT00958568|521567233|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
144648691|NCT00915005|521567234|FG000|Overall Study|Withdrawal by Subject|4|||
144648692|NCT00915005|521567235|FG001|Overall Study|Withdrawal by Subject|4|||
144648693|NCT00915005|521567234|FG000|Overall Study|Patient preferred protons therapy|6|||
144648694|NCT00915005|521567235|FG001|Overall Study|Patient preferred protons therapy|0|||
144648695|NCT00915005|521567234|FG000|Overall Study|Insurance denial|3|||
144648696|NCT00915005|521567235|FG001|Overall Study|Insurance denial|15|||
144648697|NCT00283712|521567240|FG000|Overall Study|Death|0|||
144648698|NCT00283712|521567241|FG001|Overall Study|Death|1|||
144648699|NCT02747043|521567249|FG000|Overall Study|Other|1|||
144648700|NCT02747043|521567250|FG001|Overall Study|Other|1|||
144648701|NCT02747043|521567249|FG000|Overall Study|Adverse Event|3|||
144648702|NCT02747043|521567250|FG001|Overall Study|Adverse Event|1|||
144648703|NCT02747043|521567249|FG000|Overall Study|Withdrawal by Subject|1|||
144648704|NCT02747043|521567250|FG001|Overall Study|Withdrawal by Subject|1|||
144648705|NCT02747043|521567249|FG000|Overall Study|Physician Decision|1|||
144648706|NCT02747043|521567250|FG001|Overall Study|Physician Decision|1|||
144648707|NCT02747043|521567249|FG000|Overall Study|Protocol Violation|0|||
144648708|NCT02747043|521567250|FG001|Overall Study|Protocol Violation|1|||
144648709|NCT02747043|521567249|FG000|Overall Study|Disease progression|4|||
144648710|NCT02747043|521567250|FG001|Overall Study|Disease progression|0|||
144648711|NCT00907478|521567251|FG000|Overall Study|Ineligibility determined|0|||
144648712|NCT00907478|521567252|FG001|Overall Study|Ineligibility determined|0|||
144648713|NCT00907478|521567253|FG002|Overall Study|Ineligibility determined|1|||
144648714|NCT00907478|521567251|FG000|Overall Study|Noncompliance|0|||
144648715|NCT00907478|521567252|FG001|Overall Study|Noncompliance|0|||
144648716|NCT00907478|521567253|FG002|Overall Study|Noncompliance|1|||
144648717|NCT00907478|521567251|FG000|Overall Study|Adverse Event|3|||
144648718|NCT00907478|521567252|FG001|Overall Study|Adverse Event|1|||
144648719|NCT00907478|521567253|FG002|Overall Study|Adverse Event|2|||
144648720|NCT00907478|521567251|FG000|Overall Study|Withdrawal by Subject|8|||
144648721|NCT00907478|521567252|FG001|Overall Study|Withdrawal by Subject|9|||
144648722|NCT00907478|521567253|FG002|Overall Study|Withdrawal by Subject|6|||
144648723|NCT00907478|521567251|FG000|Overall Study|Requirement for alternative therapy|1|||
144648724|NCT00907478|521567252|FG001|Overall Study|Requirement for alternative therapy|2|||
144648725|NCT00907478|521567253|FG002|Overall Study|Requirement for alternative therapy|3|||
144648726|NCT00907478|521567251|FG000|Overall Study|Physician Decision|2|||
144648727|NCT00907478|521567252|FG001|Overall Study|Physician Decision|0|||
144648728|NCT00907478|521567253|FG002|Overall Study|Physician Decision|3|||
144648729|NCT00907478|521567251|FG000|Overall Study|Death|4|||
144648730|NCT00907478|521567252|FG001|Overall Study|Death|2|||
144648731|NCT00907478|521567253|FG002|Overall Study|Death|1|||
144648732|NCT00907478|521567251|FG000|Overall Study|Protocol-specified criteria|5|||
144648733|NCT00907478|521567252|FG001|Overall Study|Protocol-specified criteria|2|||
144648734|NCT00907478|521567253|FG002|Overall Study|Protocol-specified criteria|3|||
144648735|NCT00907478|521567251|FG000|Overall Study|Pregnancy|0|||
144648736|NCT00907478|521567252|FG001|Overall Study|Pregnancy|1|||
144648737|NCT00907478|521567253|FG002|Overall Study|Pregnancy|1|||
144648738|NCT00907478|521567251|FG000|Overall Study|Lost to Follow-up|1|||
144648739|NCT00907478|521567252|FG001|Overall Study|Lost to Follow-up|0|||
144648740|NCT00907478|521567253|FG002|Overall Study|Lost to Follow-up|0|||
144648741|NCT00907478|521567251|FG000|Overall Study|Other|3|||
144648742|NCT00907478|521567252|FG001|Overall Study|Other|0|||
144648743|NCT00907478|521567253|FG002|Overall Study|Other|1|||
144648744|NCT01936649|521567260|FG000|Overall Study|Withdrawal by Subject|4|||
144648745|NCT01936649|521567260|FG000|Overall Study|Physician Decision|2|||
144648746|NCT01936649|521567260|FG000|Overall Study|Protocol Violation|2|||
144648747|NCT01936649|521567260|FG000|Overall Study|Other than specified above|5|||
144648748|NCT02546856|521567261|FG000|4 Months Evaluation|Death|2|||
144648749|NCT02546856|521567262|FG001|4 Months Evaluation|Death|3|||
144648750|NCT02546856|521567261|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
144648751|NCT02546856|521567262|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
144648752|NCT02546856|521567261|FG000|4 Months Evaluation|Lost to Follow-up|3|||
144648753|NCT02546856|521567262|FG001|4 Months Evaluation|Lost to Follow-up|3|||
144648754|NCT02546856|521567261|FG000|4 Months Evaluation|Physician Decision|3|||
144648755|NCT02546856|521567262|FG001|4 Months Evaluation|Physician Decision|0|||
144648756|NCT02546856|521567261|FG000|4 Months Evaluation|Working or living abroad|5|||
144648757|NCT02546856|521567262|FG001|4 Months Evaluation|Working or living abroad|1|||
144648758|NCT02546856|521567261|FG000|4 Months Evaluation|reasons not due to titration|4|||
144648759|NCT02546856|521567262|FG001|4 Months Evaluation|reasons not due to titration|1|||
144648760|NCT02546856|521567261|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
144648761|NCT02546856|521567262|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
144648762|NCT02546856|521567261|FG000|6 Months Evaluation|Death|1|||
144648763|NCT02546856|521567262|FG001|6 Months Evaluation|Death|1|||
144648764|NCT02546856|521567261|FG000|6 Months Evaluation|Lost to Follow-up|1|||
144648765|NCT02546856|521567262|FG001|6 Months Evaluation|Lost to Follow-up|1|||
144648766|NCT02546856|521567261|FG000|6 Months Evaluation|Working or living abroad|6|||
144648767|NCT02546856|521567262|FG001|6 Months Evaluation|Working or living abroad|4|||
144648768|NCT02546856|521567261|FG000|6 Months Evaluation|reasons not due to titration|0|||
144648769|NCT02546856|521567262|FG001|6 Months Evaluation|reasons not due to titration|1|||
144648770|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
144648771|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
144648772|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
144648773|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144648774|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144648775|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144648776|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144648777|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
144648778|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
144648779|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
144648780|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
144648781|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144648782|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144648783|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144648784|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144648785|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
144648786|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
144648787|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
144648788|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
144648789|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144648790|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144648791|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144648792|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144648793|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
144648794|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
144648795|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
144648796|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144648797|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144648798|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144648799|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144648800|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144648801|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
144648802|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
144648803|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
144648804|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
144648805|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144648806|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144648807|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144211758|NCT01145508|519970358|FG001|Overall Study|Death|0|||
144211759|NCT01145508|519970357|FG000|Overall Study|Physician Decision|2|||
144211760|NCT01145508|519970358|FG001|Overall Study|Physician Decision|1|||
144211761|NCT01145508|519970357|FG000|Overall Study|Never started treatment|1|||
144648808|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144648809|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
144648810|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
144731678|NCT00986245|521873244|FG001|Second Intervention|Poor compliance|0|||
144731679|NCT00986245|521873243|FG000|Second Intervention|Lost to Follow-up|1|||
144731680|NCT00986245|521873244|FG001|Second Intervention|Lost to Follow-up|0|||
144648811|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
144648812|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
144648813|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
144648814|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
144648815|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
144648816|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
144648817|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
144648818|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
144648819|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
144648820|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144648821|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144648822|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144648823|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144648824|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144648825|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
144648826|NCT01097616|521567263|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648827|NCT01097616|521567264|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648828|NCT01097616|521567265|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
144648829|NCT01097616|521567266|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648830|NCT01097616|521567267|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648831|NCT01097616|521567268|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648832|NCT01097616|521567269|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648833|NCT01097616|521567270|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
144648834|NCT01097616|521567263|FG000|Optional DB EXT Phase|Adverse Event|0|||
144648835|NCT01097616|521567264|FG001|Optional DB EXT Phase|Adverse Event|7|||
144648836|NCT01097616|521567265|FG002|Optional DB EXT Phase|Adverse Event|2|||
144648837|NCT01097616|521567266|FG003|Optional DB EXT Phase|Adverse Event|0|||
144648838|NCT01097616|521567267|FG004|Optional DB EXT Phase|Adverse Event|0|||
144648839|NCT01097616|521567268|FG005|Optional DB EXT Phase|Adverse Event|0|||
144648840|NCT01097616|521567269|FG006|Optional DB EXT Phase|Adverse Event|0|||
144731681|NCT00986245|521873243|FG000|Second Intervention|Protocol Violation|0|||
144731682|NCT00986245|521873244|FG001|Second Intervention|Protocol Violation|1|||
144648841|NCT01097616|521567270|FG007|Optional DB EXT Phase|Adverse Event|0|||
144648842|NCT01097616|521567263|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
144648843|NCT01097616|521567264|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
144648844|NCT01097616|521567265|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
144648845|NCT01097616|521567266|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
144648846|NCT01097616|521567267|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
144648847|NCT01097616|521567268|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
144648848|NCT01097616|521567269|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
144648849|NCT01097616|521567270|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
144648850|NCT01097616|521567263|FG000|Optional DB EXT Phase|Protocol Violation|0|||
144648851|NCT01097616|521567264|FG001|Optional DB EXT Phase|Protocol Violation|2|||
144648852|NCT01097616|521567265|FG002|Optional DB EXT Phase|Protocol Violation|3|||
144648853|NCT01097616|521567266|FG003|Optional DB EXT Phase|Protocol Violation|0|||
144648854|NCT01097616|521567267|FG004|Optional DB EXT Phase|Protocol Violation|0|||
144648855|NCT01097616|521567268|FG005|Optional DB EXT Phase|Protocol Violation|0|||
144648856|NCT01097616|521567269|FG006|Optional DB EXT Phase|Protocol Violation|0|||
144211762|NCT01145508|519970358|FG001|Overall Study|Never started treatment|1|||
144211763|NCT02129608|519970361|FG000|Overall Study|Lost to Follow-up|0|||
144211764|NCT02129608|519970362|FG001|Overall Study|Lost to Follow-up|1|||
144211765|NCT02129608|519970363|FG002|Overall Study|Lost to Follow-up|1|||
144211766|NCT02129608|519970361|FG000|Overall Study|Withdrawal by Subject|0|||
144211767|NCT02129608|519970362|FG001|Overall Study|Withdrawal by Subject|0|||
144648857|NCT01097616|521567270|FG007|Optional DB EXT Phase|Protocol Violation|0|||
144731683|NCT01214850|521873245|FG000|Overall Study|Withdrawal by Subject|38|||
144731684|NCT01214850|521873246|FG001|Overall Study|Withdrawal by Subject|31|||
144731685|NCT01214850|521873247|FG002|Overall Study|Withdrawal by Subject|28|||
144211768|NCT02129608|519970363|FG002|Overall Study|Withdrawal by Subject|2|||
144211769|NCT00451204|519970372|FG000|Overall Study|Adverse Event|4|||
144211770|NCT00451204|519970373|FG001|Overall Study|Adverse Event|6|||
144211771|NCT00451204|519970372|FG000|Overall Study|Lack of Efficacy|4|||
144211772|NCT00451204|519970373|FG001|Overall Study|Lack of Efficacy|4|||
144648858|NCT01097616|521567263|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
144648859|NCT01097616|521567264|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
144648860|NCT01097616|521567265|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
144648861|NCT01097616|521567266|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
144731686|NCT01214850|521873245|FG000|Overall Study|Lost to Follow-up|124|||
144211773|NCT00451204|519970372|FG000|Overall Study|Lost to Follow-up|4|||
144648862|NCT01097616|521567267|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
144648863|NCT01097616|521567268|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
144731687|NCT01214850|521873246|FG001|Overall Study|Lost to Follow-up|98|||
144648864|NCT01097616|521567269|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
144648865|NCT01097616|521567270|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
144648866|NCT01097616|521567263|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
144648867|NCT01097616|521567264|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
144648868|NCT01097616|521567265|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
144648869|NCT01097616|521567266|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
144648870|NCT01097616|521567267|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
144648871|NCT01097616|521567268|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
144648872|NCT01097616|521567269|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
144648873|NCT01097616|521567270|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
144648874|NCT01097616|521567263|FG000|Optional DB EXT Phase|Physician Decision|1|||
144648875|NCT01097616|521567264|FG001|Optional DB EXT Phase|Physician Decision|0|||
144648876|NCT01097616|521567265|FG002|Optional DB EXT Phase|Physician Decision|0|||
144648877|NCT01097616|521567266|FG003|Optional DB EXT Phase|Physician Decision|0|||
144648878|NCT01097616|521567267|FG004|Optional DB EXT Phase|Physician Decision|0|||
144648879|NCT01097616|521567268|FG005|Optional DB EXT Phase|Physician Decision|0|||
144648880|NCT01097616|521567269|FG006|Optional DB EXT Phase|Physician Decision|0|||
144648881|NCT01097616|521567270|FG007|Optional DB EXT Phase|Physician Decision|0|||
144648882|NCT01097616|521567263|FG000|DB RO Phase|Adverse Event|0|||
144648883|NCT01097616|521567264|FG001|DB RO Phase|Adverse Event|0|||
144648884|NCT01097616|521567265|FG002|DB RO Phase|Adverse Event|0|||
144648885|NCT01097616|521567266|FG003|DB RO Phase|Adverse Event|0|||
144648886|NCT01097616|521567267|FG004|DB RO Phase|Adverse Event|0|||
144648887|NCT01097616|521567268|FG005|DB RO Phase|Adverse Event|0|||
144648888|NCT01097616|521567269|FG006|DB RO Phase|Adverse Event|1|||
144648889|NCT01097616|521567270|FG007|DB RO Phase|Adverse Event|0|||
144648890|NCT01097616|521567263|FG000|DB RO Phase|Withdrawal by Subject|0|||
144648891|NCT01097616|521567264|FG001|DB RO Phase|Withdrawal by Subject|0|||
144648892|NCT01097616|521567265|FG002|DB RO Phase|Withdrawal by Subject|0|||
144648893|NCT01097616|521567266|FG003|DB RO Phase|Withdrawal by Subject|0|||
144648894|NCT01097616|521567267|FG004|DB RO Phase|Withdrawal by Subject|0|||
144648895|NCT01097616|521567268|FG005|DB RO Phase|Withdrawal by Subject|1|||
144648896|NCT01097616|521567269|FG006|DB RO Phase|Withdrawal by Subject|0|||
144648897|NCT01097616|521567270|FG007|DB RO Phase|Withdrawal by Subject|0|||
144648898|NCT01097616|521567263|FG000|DB RO Phase|Lost to Follow-up|0|||
144648899|NCT01097616|521567264|FG001|DB RO Phase|Lost to Follow-up|0|||
144648900|NCT01097616|521567265|FG002|DB RO Phase|Lost to Follow-up|0|||
144648901|NCT01097616|521567266|FG003|DB RO Phase|Lost to Follow-up|1|||
144648902|NCT01097616|521567267|FG004|DB RO Phase|Lost to Follow-up|1|||
144648903|NCT01097616|521567268|FG005|DB RO Phase|Lost to Follow-up|0|||
144648904|NCT01097616|521567269|FG006|DB RO Phase|Lost to Follow-up|0|||
144648905|NCT01097616|521567270|FG007|DB RO Phase|Lost to Follow-up|1|||
144648906|NCT01097616|521567263|FG000|DB RO Phase|Not Treated in RO|0|||
144648907|NCT01097616|521567264|FG001|DB RO Phase|Not Treated in RO|0|||
144648908|NCT01097616|521567265|FG002|DB RO Phase|Not Treated in RO|0|||
144648909|NCT01097616|521567266|FG003|DB RO Phase|Not Treated in RO|0|||
144648910|NCT01097616|521567267|FG004|DB RO Phase|Not Treated in RO|0|||
144648911|NCT01097616|521567268|FG005|DB RO Phase|Not Treated in RO|1|||
144648912|NCT01097616|521567269|FG006|DB RO Phase|Not Treated in RO|0|||
144648913|NCT01097616|521567270|FG007|DB RO Phase|Not Treated in RO|0|||
144648914|NCT04655586|521567275|FG000|Overall Study|Physician Decision|1|||
144648915|NCT04655586|521567276|FG001|Overall Study|Physician Decision|3|||
144648916|NCT04655586|521567277|FG002|Overall Study|Physician Decision|4|||
144648917|NCT04655586|521567275|FG000|Overall Study|Withdrawal by Subject|1|||
144648918|NCT04655586|521567276|FG001|Overall Study|Withdrawal by Subject|3|||
144648919|NCT04655586|521567277|FG002|Overall Study|Withdrawal by Subject|1|||
144648920|NCT03268746|521567285|FG000|Overall Study|Withdrawal by Subject|1|||
144648921|NCT00117338|521567286|FG000|Overall Study|Adverse Event|0|||
144648922|NCT00117338|521567287|FG001|Overall Study|Adverse Event|1|||
144648923|NCT00117338|521567286|FG000|Overall Study|Protocol Violation|3|||
144648924|NCT00117338|521567287|FG001|Overall Study|Protocol Violation|2|||
144648925|NCT00117338|521567286|FG000|Overall Study|Withdrawal by Subject|1|||
144648926|NCT00117338|521567287|FG001|Overall Study|Withdrawal by Subject|0|||
144648927|NCT00117338|521567286|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
144648928|NCT00117338|521567287|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
144648929|NCT00117338|521567286|FG000|Overall Study|Lack of Efficacy|0|||
144648930|NCT00117338|521567287|FG001|Overall Study|Lack of Efficacy|1|||
144648931|NCT00546351|521567288|FG000|Overall Study|Adverse Event|76|||
144648932|NCT00546351|521567288|FG000|Overall Study|Lack of Efficacy|15|||
144648933|NCT00546351|521567288|FG000|Overall Study|Withdrawal by Subject|109|||
144648934|NCT00546351|521567288|FG000|Overall Study|Lost to Follow-up|9|||
144648935|NCT00546351|521567288|FG000|Overall Study|Protocol Deviation|1|||
144648936|NCT00546351|521567288|FG000|Overall Study|Unsatisfactory compliance|9|||
144648937|NCT00546351|521567288|FG000|Overall Study|Other reasons for premature termination|17|||
144648938|NCT04734873|521567289|FG000|Overall Study|Lost to Follow-up|1|||
144648939|NCT04734873|521567290|FG001|Overall Study|Lost to Follow-up|3|||
144648940|NCT04734873|521567291|FG002|Overall Study|Lost to Follow-up|2|||
144648941|NCT04734873|521567289|FG000|Overall Study|Randomized but not dosed|1|||
144648942|NCT04734873|521567290|FG001|Overall Study|Randomized but not dosed|0|||
144648943|NCT04734873|521567291|FG002|Overall Study|Randomized but not dosed|1|||
144648944|NCT00201201|521567292|FG000|Overall Study|Death|0|||
144648945|NCT00201201|521567293|FG001|Overall Study|Death|2|||
144648946|NCT00201201|521567292|FG000|Overall Study|Withdrawal by Subject|5|||
144648947|NCT00201201|521567293|FG001|Overall Study|Withdrawal by Subject|5|||
144648948|NCT01342640|521567297|FG000|Overall Study|Adverse Event|3|||
144648949|NCT01342640|521567297|FG000|Overall Study|Protocol Violation|16|||
144648950|NCT01342640|521567297|FG000|Overall Study|Lost to Follow-up|21|||
144648951|NCT01342640|521567297|FG000|Overall Study|Other|1|||
144648952|NCT00891657|521567298|FG000|Overall Study|Withdrawal by Subject|1|||
144648953|NCT00891657|521567299|FG001|Overall Study|Withdrawal by Subject|1|||
144648954|NCT00479466|521567302|FG000|Overall Study|Adverse Event|5|||
144648955|NCT00479466|521567303|FG001|Overall Study|Adverse Event|1|||
144648956|NCT00479466|521567304|FG002|Overall Study|Adverse Event|0|||
144648957|NCT00479466|521567305|FG003|Overall Study|Adverse Event|1|||
144648958|NCT00479466|521567306|FG004|Overall Study|Adverse Event|2|||
144648959|NCT00479466|521567307|FG005|Overall Study|Adverse Event|0|||
144648960|NCT00479466|521567302|FG000|Overall Study|Hyperglycemia|0|||
144648961|NCT00479466|521567303|FG001|Overall Study|Hyperglycemia|0|||
144648962|NCT00479466|521567304|FG002|Overall Study|Hyperglycemia|0|||
144648963|NCT00479466|521567305|FG003|Overall Study|Hyperglycemia|0|||
144648964|NCT00479466|521567306|FG004|Overall Study|Hyperglycemia|0|||
144648965|NCT00479466|521567307|FG005|Overall Study|Hyperglycemia|1|||
144648966|NCT00479466|521567302|FG000|Overall Study|Lack of Efficacy|2|||
144648967|NCT00479466|521567303|FG001|Overall Study|Lack of Efficacy|0|||
144648968|NCT00479466|521567304|FG002|Overall Study|Lack of Efficacy|1|||
144648969|NCT00479466|521567305|FG003|Overall Study|Lack of Efficacy|0|||
144648970|NCT00479466|521567306|FG004|Overall Study|Lack of Efficacy|0|||
144648971|NCT00479466|521567307|FG005|Overall Study|Lack of Efficacy|0|||
144648972|NCT00479466|521567302|FG000|Overall Study|Lost to Follow-up|0|||
144648973|NCT00479466|521567303|FG001|Overall Study|Lost to Follow-up|1|||
144648974|NCT00479466|521567304|FG002|Overall Study|Lost to Follow-up|1|||
144648975|NCT00479466|521567305|FG003|Overall Study|Lost to Follow-up|0|||
144648976|NCT00479466|521567306|FG004|Overall Study|Lost to Follow-up|2|||
144648977|NCT00479466|521567307|FG005|Overall Study|Lost to Follow-up|2|||
144648978|NCT00479466|521567302|FG000|Overall Study|Physician Decision|2|||
144648979|NCT00479466|521567303|FG001|Overall Study|Physician Decision|1|||
144648980|NCT00479466|521567304|FG002|Overall Study|Physician Decision|1|||
144648981|NCT00479466|521567305|FG003|Overall Study|Physician Decision|0|||
144648982|NCT00479466|521567306|FG004|Overall Study|Physician Decision|0|||
144648983|NCT00479466|521567307|FG005|Overall Study|Physician Decision|0|||
144648984|NCT00479466|521567302|FG000|Overall Study|Pregnancy|0|||
144648985|NCT00479466|521567303|FG001|Overall Study|Pregnancy|0|||
144648986|NCT00479466|521567304|FG002|Overall Study|Pregnancy|0|||
144648987|NCT00479466|521567305|FG003|Overall Study|Pregnancy|0|||
144648988|NCT00479466|521567306|FG004|Overall Study|Pregnancy|1|||
144648989|NCT00479466|521567307|FG005|Overall Study|Pregnancy|0|||
144648990|NCT00479466|521567302|FG000|Overall Study|Protocol Violation|1|||
144648991|NCT00479466|521567303|FG001|Overall Study|Protocol Violation|0|||
144648992|NCT00479466|521567304|FG002|Overall Study|Protocol Violation|0|||
144648993|NCT00479466|521567305|FG003|Overall Study|Protocol Violation|0|||
144648994|NCT00479466|521567306|FG004|Overall Study|Protocol Violation|0|||
144648995|NCT00479466|521567307|FG005|Overall Study|Protocol Violation|0|||
144648996|NCT00479466|521567302|FG000|Overall Study|Withdrawal by Subject|3|||
144648997|NCT00479466|521567303|FG001|Overall Study|Withdrawal by Subject|5|||
144648998|NCT00479466|521567304|FG002|Overall Study|Withdrawal by Subject|0|||
144648999|NCT00479466|521567305|FG003|Overall Study|Withdrawal by Subject|2|||
144649000|NCT00479466|521567306|FG004|Overall Study|Withdrawal by Subject|3|||
144649001|NCT00479466|521567307|FG005|Overall Study|Withdrawal by Subject|1|||
144649002|NCT02927171|521567310|FG000|Overall Study|Lost to Follow-up|0|||
144649003|NCT02927171|521567311|FG001|Overall Study|Lost to Follow-up|1|||
144649004|NCT02240628|521567314|FG000|Overall Study|Physician Decision|6|||
144649005|NCT02240628|521567315|FG001|Overall Study|Physician Decision|5|||
144649006|NCT04530825|521567318|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
144649007|NCT04530825|521567319|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
144649008|NCT04530825|521567320|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
144649009|NCT04530825|521567321|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
144649010|NCT04530825|521567318|FG000|Overall Study|Did not complete follow-up|3|||
144649011|NCT04530825|521567319|FG001|Overall Study|Did not complete follow-up|0|||
144649012|NCT04530825|521567320|FG002|Overall Study|Did not complete follow-up|0|||
144649013|NCT04530825|521567321|FG003|Overall Study|Did not complete follow-up|0|||
144649014|NCT04101422|521567322|FG000|Overall Study|Ineligible|1|||
144649015|NCT04101422|521567323|FG001|Overall Study|Ineligible|0|||
144649016|NCT04101422|521567324|FG002|Overall Study|Ineligible|9|||
144649017|NCT04101422|521567325|FG003|Overall Study|Ineligible|0|||
144649018|NCT04101422|521567322|FG000|Overall Study|Withdrawal by Subject|0|||
144649019|NCT04101422|521567323|FG001|Overall Study|Withdrawal by Subject|0|||
144649020|NCT04101422|521567324|FG002|Overall Study|Withdrawal by Subject|1|||
144649021|NCT04101422|521567325|FG003|Overall Study|Withdrawal by Subject|0|||
144211774|NCT00451204|519970373|FG001|Overall Study|Lost to Follow-up|4|||
144211775|NCT00451204|519970372|FG000|Overall Study|Protocol Violation|1|||
144211776|NCT00451204|519970373|FG001|Overall Study|Protocol Violation|0|||
144211777|NCT00451204|519970372|FG000|Overall Study|Patient refusal|8|||
144211778|NCT00451204|519970373|FG001|Overall Study|Patient refusal|4|||
144211779|NCT00451204|519970372|FG000|Overall Study|Other|1|||
144211780|NCT00451204|519970373|FG001|Overall Study|Other|2|||
144211781|NCT01266031|519970374|FG000|Overall Study|Not treated|0|||
144211782|NCT01266031|519970375|FG001|Overall Study|Not treated|3|||
144211783|NCT01266031|519970376|FG002|Overall Study|Not treated|2|||
144211784|NCT02114385|519970379|FG000|Overall Study|Withdrawal by Subject|3|||
144211785|NCT02114385|519970380|FG001|Overall Study|Withdrawal by Subject|2|||
144211786|NCT02114385|519970379|FG000|Overall Study|Lost to Follow-up|0|||
144211787|NCT02114385|519970380|FG001|Overall Study|Lost to Follow-up|6|||
144211788|NCT00230178|519970386|FG000|Overall Study|Adverse Event|1|||
144211789|NCT00230178|519970387|FG001|Overall Study|Adverse Event|5|||
144211790|NCT00230178|519970388|FG002|Overall Study|Adverse Event|2|||
144211791|NCT00230178|519970386|FG000|Overall Study|Withdrawal by Subject|0|||
144211792|NCT00230178|519970387|FG001|Overall Study|Withdrawal by Subject|0|||
144211793|NCT00230178|519970388|FG002|Overall Study|Withdrawal by Subject|1|||
144211794|NCT00230178|519970386|FG000|Overall Study|Various other reasons|3|||
144211795|NCT00230178|519970387|FG001|Overall Study|Various other reasons|2|||
144211796|NCT00230178|519970388|FG002|Overall Study|Various other reasons|4|||
144211797|NCT01753297|519970389|FG000|Overall Study|Lost to Follow-up|7|||
144211798|NCT01753297|519970390|FG001|Overall Study|Lost to Follow-up|2|||
144211799|NCT01753297|519970389|FG000|Overall Study|Withdrawal by Subject|26|||
144211800|NCT01753297|519970390|FG001|Overall Study|Withdrawal by Subject|23|||
144211801|NCT01753297|519970389|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
144211802|NCT01753297|519970390|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
144211803|NCT01753297|519970389|FG000|Overall Study|Death|0|||
144211804|NCT01753297|519970390|FG001|Overall Study|Death|2|||
144211805|NCT01753297|519970389|FG000|Overall Study|Did not attend end of study visit|7|||
144211806|NCT01753297|519970390|FG001|Overall Study|Did not attend end of study visit|8|||
144211807|NCT02533180|519970391|FG000|Overall Study|Death|0|||
144211808|NCT02533180|519970392|FG001|Overall Study|Death|2|||
144211809|NCT02533180|519970391|FG000|Overall Study|Lost to Follow-up|0|||
144211810|NCT02533180|519970392|FG001|Overall Study|Lost to Follow-up|1|||
144211811|NCT02533180|519970391|FG000|Overall Study|Physician Decision|0|||
144211812|NCT02533180|519970392|FG001|Overall Study|Physician Decision|1|||
144649022|NCT04101422|521567322|FG000|Overall Study|Not attending to the stimuli|0|||
144649023|NCT04101422|521567323|FG001|Overall Study|Not attending to the stimuli|0|||
144649024|NCT04101422|521567324|FG002|Overall Study|Not attending to the stimuli|4|||
144649025|NCT04101422|521567325|FG003|Overall Study|Not attending to the stimuli|0|||
144649026|NCT04101422|521567322|FG000|Overall Study|Did not download app|0|||
144649027|NCT04101422|521567323|FG001|Overall Study|Did not download app|0|||
144649028|NCT04101422|521567324|FG002|Overall Study|Did not download app|0|||
144649029|NCT04101422|521567325|FG003|Overall Study|Did not download app|17|||
144649030|NCT04101422|521567322|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
144649031|NCT04101422|521567323|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
144649032|NCT04101422|521567324|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
144649033|NCT04101422|521567325|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
144649034|NCT00850499|521567326|FG000|Overall Study|Adverse Event|3|||
144649035|NCT00850499|521567327|FG001|Overall Study|Adverse Event|1|||
144649036|NCT00850499|521567326|FG000|Overall Study|Lack of Efficacy|0|||
144649037|NCT00850499|521567327|FG001|Overall Study|Lack of Efficacy|1|||
144649038|NCT04498910|521567328|FG000|Overall Study|Lost to Follow-up|0|||
144649039|NCT04498910|521567329|FG001|Overall Study|Lost to Follow-up|1|||
144649040|NCT04498910|521567328|FG000|Overall Study|Withdrawal by Subject|2|||
144649041|NCT04498910|521567329|FG001|Overall Study|Withdrawal by Subject|1|||
144649042|NCT04498910|521567328|FG000|Overall Study|Adverse Event|1|||
144649043|NCT04498910|521567329|FG001|Overall Study|Adverse Event|0|||
144649044|NCT00909090|521567333|FG000|Overall Study|Lost to Follow-up|17|||
144649045|NCT00909090|521567334|FG001|Overall Study|Lost to Follow-up|17|||
144649046|NCT00718861|521567336|FG000|Overall Study|Withdrawal by Subject|15|||
144649047|NCT00718861|521567337|FG001|Overall Study|Withdrawal by Subject|10|||
144263307|NCT00048035|520165400|FG005|Extension Year 1|Early Withdrawals|0|||
144649048|NCT00718861|521567336|FG000|Overall Study|Adverse Event|2|||
144649049|NCT00718861|521567337|FG001|Overall Study|Adverse Event|1|||
144649050|NCT00718861|521567336|FG000|Overall Study|Lost to Follow-up|2|||
144649051|NCT00718861|521567337|FG001|Overall Study|Lost to Follow-up|1|||
144731688|NCT01214850|521873247|FG002|Overall Study|Lost to Follow-up|123|||
144211813|NCT02533180|519970391|FG000|Overall Study|Withdrawal by Subject|2|||
144211814|NCT02533180|519970392|FG001|Overall Study|Withdrawal by Subject|5|||
144211815|NCT02533180|519970391|FG000|Overall Study|Screen Failure|37|||
144211816|NCT02533180|519970392|FG001|Overall Study|Screen Failure|0|||
144211817|NCT02533180|519970391|FG000|Overall Study|Protocol Deviation|0|||
144211818|NCT02533180|519970392|FG001|Overall Study|Protocol Deviation|1|||
144211819|NCT02533180|519970391|FG000|Overall Study|Non-compliance|0|||
144211820|NCT02533180|519970392|FG001|Overall Study|Non-compliance|1|||
144211821|NCT00447876|519970393|FG000|Overall Study|Withdrawal by Subject|1|||
144211822|NCT00447876|519970394|FG001|Overall Study|Withdrawal by Subject|4|||
144211823|NCT00447876|519970393|FG000|Overall Study|Lost to Follow-up|1|||
144211824|NCT00447876|519970394|FG001|Overall Study|Lost to Follow-up|0|||
144211825|NCT00447876|519970393|FG000|Overall Study|Deterioration of symptomology|1|||
144211826|NCT00447876|519970394|FG001|Overall Study|Deterioration of symptomology|0|||
144211827|NCT02439970|519970399|FG000|Overall Study|Study Terminated|2|||
144211828|NCT02439970|519970400|FG001|Overall Study|Study Terminated|3|||
144211829|NCT02952586|519970405|FG000|Lead-In Phase (7 Days)|Death|0|||
144211830|NCT02952586|519970406|FG001|Lead-In Phase (7 Days)|Death|1|||
144211831|NCT02952586|519970405|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
144211832|NCT02952586|519970406|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
144211833|NCT02952586|519970405|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
144211834|NCT02952586|519970406|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
144211835|NCT02952586|519970405|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
144211836|NCT02952586|519970406|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
144211837|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
144211838|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
144211839|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
144211840|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
144211841|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
144649052|NCT00718861|521567336|FG000|Overall Study|Administrative Problems|1|||
144649053|NCT00718861|521567337|FG001|Overall Study|Administrative Problems|1|||
144649054|NCT00718861|521567336|FG000|Overall Study|Death|1|||
144649055|NCT00718861|521567337|FG001|Overall Study|Death|5|||
144649056|NCT01749735|521567339|FG000|Overall Study|Withdrawal by Subject|1|||
144649057|NCT01749735|521567340|FG001|Overall Study|Withdrawal by Subject|0|||
144649058|NCT02926573|521567341|FG000|Overall Study|Nausea|1|||
144649059|NCT02926573|521567342|FG001|Overall Study|Nausea|0|||
144649060|NCT02926573|521567341|FG000|Overall Study|Remain intubated|2|||
144649061|NCT02926573|521567342|FG001|Overall Study|Remain intubated|2|||
144649062|NCT02926573|521567341|FG000|Overall Study|Change in surgery plan|3|||
144649063|NCT02926573|521567342|FG001|Overall Study|Change in surgery plan|1|||
144649064|NCT02926573|521567341|FG000|Overall Study|Change to outpatient status|5|||
144649065|NCT02926573|521567342|FG001|Overall Study|Change to outpatient status|1|||
144649066|NCT02926573|521567341|FG000|Overall Study|Withdrawal by Subject|0|||
144649067|NCT02926573|521567342|FG001|Overall Study|Withdrawal by Subject|2|||
144649068|NCT02926573|521567341|FG000|Overall Study|Return to operating room|0|||
144649069|NCT02926573|521567342|FG001|Overall Study|Return to operating room|2|||
144649070|NCT02926573|521567341|FG000|Overall Study|Delirium|0|||
144649071|NCT02926573|521567342|FG001|Overall Study|Delirium|1|||
144649072|NCT00611455|521567345|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
144649073|NCT00611455|521567346|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
144649074|NCT00611455|521567347|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
144649075|NCT00611455|521567345|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
144649076|NCT00611455|521567346|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144649077|NCT00611455|521567347|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
144649078|NCT00611455|521567345|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
144649079|NCT00611455|521567346|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
144649080|NCT00611455|521567347|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
144649081|NCT00611455|521567345|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
144649082|NCT00611455|521567346|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
144649083|NCT00611455|521567347|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144649084|NCT00611455|521567345|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
144649085|NCT00611455|521567346|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
144649086|NCT00611455|521567347|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
144649087|NCT00611455|521567345|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
144211842|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
144211843|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
144211844|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
144211845|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
144649088|NCT00611455|521567346|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
144649089|NCT00611455|521567347|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
144211846|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
144649090|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
144649091|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
144649092|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
144649093|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
144211847|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
144211848|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
144263308|NCT00048035|520165401|FG006|Extension Year 1|Early Withdrawals|11|||
144263309|NCT00048035|520165402|FG007|Extension Year 1|Early Withdrawals|11|||
144263310|NCT00048035|520165395|FG000|Extension Year 2|Early Withdrawals|0|||
144263311|NCT00048035|520165396|FG001|Extension Year 2|Early Withdrawals|0|||
144263312|NCT00048035|520165397|FG002|Extension Year 2|Early Withdrawals|0|||
144263313|NCT00048035|520165398|FG003|Extension Year 2|Early Withdrawals|0|||
144263314|NCT00048035|520165399|FG004|Extension Year 2|Early Withdrawals|0|||
144263315|NCT00048035|520165400|FG005|Extension Year 2|Early Withdrawals|0|||
144263316|NCT00048035|520165401|FG006|Extension Year 2|Early Withdrawals|3|||
144263317|NCT00048035|520165402|FG007|Extension Year 2|Early Withdrawals|3|||
144263318|NCT05137717|520165407|FG000|Overall Study|Death|2|||
144263319|NCT05137717|520165407|FG000|Overall Study|Withdrawal by Subject|6|||
144649094|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
144649095|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
144649096|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
144649097|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
144263320|NCT02619617|520165409|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
144649098|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
144649099|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
144649100|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
144649101|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
144649102|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
144649103|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
144649104|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
144649105|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
144649106|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
144649107|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
144649108|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
144649109|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
144649110|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
144649111|NCT00611455|521567345|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
144649112|NCT00611455|521567346|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
144649113|NCT00611455|521567347|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
144649114|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
144649115|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
144649116|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
144649117|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
144649118|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
144649119|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
144649120|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
144649121|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
144649122|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
144649123|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
144649124|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
144649125|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
144649126|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
144649127|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
144649128|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
144649129|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
144649130|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
144649131|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
144649132|NCT00611455|521567345|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
144649133|NCT00611455|521567346|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
144649134|NCT00611455|521567347|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
144649135|NCT00858702|521567350|FG000|Overall Study|Lack of Efficacy|1|||
144649136|NCT00858702|521567351|FG001|Overall Study|Lack of Efficacy|0|||
144649137|NCT00858702|521567350|FG000|Overall Study|Protocol Violation|1|||
144649138|NCT00858702|521567351|FG001|Overall Study|Protocol Violation|1|||
144649139|NCT00858702|521567350|FG000|Overall Study|Other|2|||
144649140|NCT00858702|521567351|FG001|Overall Study|Other|1|||
144649141|NCT00858702|521567350|FG000|Overall Study|Withdrawal by Subject|1|||
144649142|NCT00858702|521567351|FG001|Overall Study|Withdrawal by Subject|0|||
144649143|NCT04983901|521567352|FG000|Overall Study|Death|1|||
144649144|NCT04983901|521567353|FG001|Overall Study|Death|4|||
144649145|NCT04983901|521567352|FG000|Overall Study|Lost to Follow-up|3|||
144263321|NCT02619617|520165410|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
144649146|NCT04983901|521567353|FG001|Overall Study|Lost to Follow-up|0|||
144263322|NCT02619617|520165409|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
144649147|NCT04983901|521567352|FG000|Overall Study|Protocol Violation|1|||
144649148|NCT04983901|521567353|FG001|Overall Study|Protocol Violation|0|||
144649149|NCT04983901|521567352|FG000|Overall Study|Withdrawal by Subject|1|||
144649150|NCT04983901|521567353|FG001|Overall Study|Withdrawal by Subject|2|||
144649151|NCT01174784|521567354|FG000|Overall Study|Screen fails|4|||
144649152|NCT01214434|521567357|FG000|Overall Study|Withdrawal by Subject|1|||
144649153|NCT01214434|521567358|FG001|Overall Study|Withdrawal by Subject|0|||
144649154|NCT01214434|521567357|FG000|Overall Study|Lost to Follow-up|2|||
144649155|NCT01214434|521567358|FG001|Overall Study|Lost to Follow-up|2|||
144649156|NCT01214434|521567357|FG000|Overall Study|Site error|1|||
144649157|NCT01214434|521567358|FG001|Overall Study|Site error|0|||
144649158|NCT00425438|521567359|FG000|Overall Study|Termination by Sponsor|25|||
144649159|NCT00425438|521567360|FG001|Overall Study|Termination by Sponsor|27|||
144649160|NCT02902809|521567361|FG000|Overall Study|Discontinuation of asthma program|28|||
144649161|NCT05094154|521568957|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
144649162|NCT05094154|521568958|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
144649163|NCT05094154|521568957|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
144649164|NCT05094154|521568958|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
144649165|NCT02100657|521568959|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
144649166|NCT02100657|521568960|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
144649167|NCT02100657|521568961|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
144649168|NCT02100657|521568959|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
144649169|NCT02100657|521568960|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
144649170|NCT02100657|521568961|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
144731689|NCT01214850|521873245|FG000|Overall Study|Protocol Violation|5|||
144731690|NCT01214850|521873246|FG001|Overall Study|Protocol Violation|5|||
144731691|NCT01214850|521873247|FG002|Overall Study|Protocol Violation|6|||
144211849|NCT02952586|519970405|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
144649171|NCT02100657|521568959|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
144649172|NCT02100657|521568960|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
144649173|NCT02100657|521568961|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
144649174|NCT02100657|521568959|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
144649175|NCT02100657|521568960|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
144649176|NCT02100657|521568961|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
144649177|NCT02100657|521568959|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
144649178|NCT02100657|521568960|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
144649179|NCT02100657|521568961|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
144649180|NCT02100657|521568959|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
144649181|NCT02100657|521568960|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
144649182|NCT02100657|521568961|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
144649183|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
144649184|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
144649185|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
144649186|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Death|0|||
144649187|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Death|0|||
144649188|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Death|1|||
144649189|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
144649190|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
144649191|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
144649192|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
144649193|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
144649194|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
144649195|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
144649196|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
144649197|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
144649198|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
144649199|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
144649200|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
144649201|NCT02100657|521568959|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
144649202|NCT02100657|521568960|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
144211850|NCT02952586|519970406|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
144211851|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Death|3|||
144211852|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Death|8|||
144211853|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
144211854|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
144211855|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
144211856|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
144731692|NCT01214850|521873245|FG000|Overall Study|Adverse event or death|11|||
144649203|NCT02100657|521568961|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
144649204|NCT01543490|521568965|FG000|Overall Study|Adverse Event|4|||
144211857|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
144649205|NCT01543490|521568966|FG001|Overall Study|Adverse Event|0|||
144649206|NCT01543490|521568965|FG000|Overall Study|Physician Decision|1|||
144649207|NCT01543490|521568966|FG001|Overall Study|Physician Decision|0|||
144649208|NCT01543490|521568965|FG000|Overall Study|Lack of Efficacy|3|||
144649209|NCT01543490|521568966|FG001|Overall Study|Lack of Efficacy|3|||
144649210|NCT01543490|521568965|FG000|Overall Study|Lost to Follow-up|5|||
144649211|NCT01543490|521568966|FG001|Overall Study|Lost to Follow-up|0|||
144649212|NCT01543490|521568965|FG000|Overall Study|Withdrawal by Subject|2|||
144649213|NCT01543490|521568966|FG001|Overall Study|Withdrawal by Subject|0|||
144649214|NCT01543490|521568965|FG000|Overall Study|Other-Various Administrative Reasons|1|||
144649215|NCT01543490|521568966|FG001|Overall Study|Other-Various Administrative Reasons|2|||
144649216|NCT03825042|521568968|FG000|Overall Study|Adverse Event|1|||
144649217|NCT03825042|521568969|FG001|Overall Study|Adverse Event|0|||
144649218|NCT03825042|521568968|FG000|Overall Study|Withdrawal by Subject|1|||
144649219|NCT03825042|521568969|FG001|Overall Study|Withdrawal by Subject|0|||
144649220|NCT04003155|521568970|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
144649221|NCT04003155|521568971|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
144649222|NCT04003155|521568972|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
144649223|NCT04003155|521568973|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
144649224|NCT04003155|521568974|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
144649225|NCT04003155|521568970|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
144649226|NCT04003155|521568971|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
144649227|NCT04003155|521568972|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
144649228|NCT04003155|521568973|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
144649229|NCT04003155|521568974|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
144649230|NCT04003155|521568970|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
144649231|NCT04003155|521568971|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
144649232|NCT04003155|521568972|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
144649233|NCT04003155|521568973|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
144649234|NCT04003155|521568974|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
144649235|NCT04003155|521568970|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
144649236|NCT04003155|521568971|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
144649237|NCT04003155|521568972|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
144649238|NCT04003155|521568973|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
144649239|NCT04003155|521568974|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
144649240|NCT04003155|521568970|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
144649241|NCT04003155|521568971|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
144649242|NCT04003155|521568972|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
144649243|NCT04003155|521568973|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
144649244|NCT04003155|521568974|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
144649245|NCT04003155|521568970|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
144649246|NCT04003155|521568971|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
144649247|NCT04003155|521568972|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
144649248|NCT04003155|521568973|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
144649249|NCT04003155|521568974|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
144649250|NCT04003155|521568970|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
144649251|NCT04003155|521568971|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
144649252|NCT04003155|521568972|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
144649253|NCT04003155|521568973|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
144649254|NCT04003155|521568974|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
144649255|NCT04003155|521568970|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
144649256|NCT04003155|521568971|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
144649257|NCT04003155|521568972|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
144649258|NCT04003155|521568973|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
144649259|NCT04003155|521568974|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
144211858|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
144649260|NCT04003155|521568970|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
144649261|NCT04003155|521568971|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
144649262|NCT04003155|521568972|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
144649263|NCT04003155|521568973|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
144649264|NCT04003155|521568974|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
144649265|NCT00950690|521568976|FG000|Overall Study|Death|4|||
144649266|NCT00950690|521568976|FG000|Overall Study|Adverse Event|15|||
144649267|NCT00950690|521568976|FG000|Overall Study|Lack of Efficacy|22|||
144649268|NCT00950690|521568976|FG000|Overall Study|Lost to Follow-up|40|||
144649269|NCT00950690|521568976|FG000|Overall Study|Other|163|||
144649270|NCT00084682|521568977|FG000|Overall Study|Withdrawal by Subject|1|||
144649271|NCT03554005|521568978|FG000|Overall Study|Not in participant's best interest|0|||
144649272|NCT03554005|521568979|FG001|Overall Study|Not in participant's best interest|0|||
144731693|NCT01214850|521873246|FG001|Overall Study|Adverse event or death|8|||
144649273|NCT03554005|521568980|FG002|Overall Study|Not in participant's best interest|0|||
144649274|NCT03554005|521568981|FG003|Overall Study|Not in participant's best interest|0|||
144649275|NCT03554005|521568982|FG004|Overall Study|Not in participant's best interest|0|||
144649276|NCT03554005|521568983|FG005|Overall Study|Not in participant's best interest|1|||
144649277|NCT03554005|521568978|FG000|Overall Study|Disease Progression|1|||
144649278|NCT03554005|521568979|FG001|Overall Study|Disease Progression|1|||
144649279|NCT03554005|521568980|FG002|Overall Study|Disease Progression|1|||
144649280|NCT03554005|521568981|FG003|Overall Study|Disease Progression|1|||
144649281|NCT03554005|521568982|FG004|Overall Study|Disease Progression|5|||
144649282|NCT03554005|521568983|FG005|Overall Study|Disease Progression|6|||
144649283|NCT03554005|521568978|FG000|Overall Study|Adverse Event|0|||
144649284|NCT03554005|521568979|FG001|Overall Study|Adverse Event|0|||
144649285|NCT03554005|521568980|FG002|Overall Study|Adverse Event|0|||
144649286|NCT03554005|521568981|FG003|Overall Study|Adverse Event|0|||
144649287|NCT03554005|521568982|FG004|Overall Study|Adverse Event|0|||
144649288|NCT03554005|521568983|FG005|Overall Study|Adverse Event|3|||
144649289|NCT03554005|521568978|FG000|Overall Study|Physician Decision|0|||
144649290|NCT03554005|521568979|FG001|Overall Study|Physician Decision|0|||
144649291|NCT03554005|521568980|FG002|Overall Study|Physician Decision|0|||
144649292|NCT03554005|521568981|FG003|Overall Study|Physician Decision|0|||
144649293|NCT03554005|521568982|FG004|Overall Study|Physician Decision|1|||
144649294|NCT03554005|521568983|FG005|Overall Study|Physician Decision|0|||
144649295|NCT03554005|521568978|FG000|Overall Study|Other|0|||
144649296|NCT03554005|521568979|FG001|Overall Study|Other|0|||
144649297|NCT03554005|521568980|FG002|Overall Study|Other|0|||
144649298|NCT03554005|521568981|FG003|Overall Study|Other|0|||
144649299|NCT03554005|521568982|FG004|Overall Study|Other|0|||
144649300|NCT03554005|521568983|FG005|Overall Study|Other|1|||
144649301|NCT03648476|521568984|FG000|Overall Study|Withdrawal by Subject|2|||
144649302|NCT03648476|521568985|FG001|Overall Study|Withdrawal by Subject|1|||
144649303|NCT02639182|521568986|FG000|Overall Study|Disease Progression|50|||
144649304|NCT02639182|521568987|FG001|Overall Study|Disease Progression|49|||
144649305|NCT02639182|521568986|FG000|Overall Study|Adverse Event|7|||
144649306|NCT02639182|521568987|FG001|Overall Study|Adverse Event|5|||
144649307|NCT02639182|521568986|FG000|Overall Study|Physician Decision|3|||
144649308|NCT02639182|521568987|FG001|Overall Study|Physician Decision|3|||
144649309|NCT02639182|521568986|FG000|Overall Study|Withdrew Consent|5|||
144649310|NCT02639182|521568987|FG001|Overall Study|Withdrew Consent|4|||
144649311|NCT02639182|521568986|FG000|Overall Study|Lost to Follow-up|0|||
144649312|NCT02639182|521568987|FG001|Overall Study|Lost to Follow-up|1|||
144649313|NCT02639182|521568986|FG000|Overall Study|Study Closure|1|||
144649314|NCT02639182|521568987|FG001|Overall Study|Study Closure|2|||
144649315|NCT02639182|521568986|FG000|Overall Study|Sponsor Ended Study|0|||
144649316|NCT02639182|521568987|FG001|Overall Study|Sponsor Ended Study|1|||
144649317|NCT02639182|521568986|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
144649318|NCT02639182|521568987|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
144649319|NCT00589472|521568988|FG000|Overall Study|Adverse Event|1|||
144649320|NCT01651052|521568989|FG000|Overall Study|Death|21|||
144649321|NCT01651052|521568989|FG000|Overall Study|Explant|1|||
144649322|NCT01651052|521568989|FG000|Overall Study|Withdrawal by Subject|1|||
144649323|NCT01651052|521568989|FG000|Overall Study|Lost to Follow-up|3|||
144649324|NCT04983940|521568990|FG000|Overall Study|Lost to Follow-up|14|||
144649325|NCT04983940|521568990|FG000|Overall Study|Lack of Efficacy|2|||
144649326|NCT04156646|521568994|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
144649327|NCT04156646|521568995|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
144649328|NCT01208181|521568998|FG000|Part 1|Withdrawal by Subject|11|||
144649329|NCT01208181|521568999|FG001|Part 1|Withdrawal by Subject|10|||
144649330|NCT01208181|521569000|FG002|Part 1|Withdrawal by Subject|0|||
144649331|NCT01208181|521569001|FG003|Part 1|Withdrawal by Subject|0|||
144649332|NCT01208181|521569002|FG004|Part 1|Withdrawal by Subject|0|||
144649333|NCT01208181|521568998|FG000|Part 1|Technical problem|5|||
144649334|NCT01208181|521568999|FG001|Part 1|Technical problem|0|||
144649335|NCT01208181|521569000|FG002|Part 1|Technical problem|0|||
144649336|NCT01208181|521569001|FG003|Part 1|Technical problem|0|||
144649337|NCT01208181|521569002|FG004|Part 1|Technical problem|0|||
144649338|NCT01208181|521568998|FG000|Part 1|Protocol Violation|10|||
144731694|NCT01214850|521873247|FG002|Overall Study|Adverse event or death|3|||
144649339|NCT01208181|521568999|FG001|Part 1|Protocol Violation|5|||
144649340|NCT01208181|521569000|FG002|Part 1|Protocol Violation|0|||
144649341|NCT01208181|521569001|FG003|Part 1|Protocol Violation|0|||
144649342|NCT01208181|521569002|FG004|Part 1|Protocol Violation|0|||
144649343|NCT01208181|521568998|FG000|Part 1|Physician Decision|4|||
144649344|NCT01208181|521568999|FG001|Part 1|Physician Decision|0|||
144649345|NCT01208181|521569000|FG002|Part 1|Physician Decision|0|||
144649346|NCT01208181|521569001|FG003|Part 1|Physician Decision|0|||
144649347|NCT01208181|521569002|FG004|Part 1|Physician Decision|0|||
144649348|NCT01208181|521568998|FG000|Part 1|Non-compliance with study drug|1|||
144649349|NCT01208181|521568999|FG001|Part 1|Non-compliance with study drug|1|||
144649350|NCT01208181|521569000|FG002|Part 1|Non-compliance with study drug|0|||
144649351|NCT01208181|521569001|FG003|Part 1|Non-compliance with study drug|0|||
144649352|NCT01208181|521569002|FG004|Part 1|Non-compliance with study drug|0|||
144649353|NCT01208181|521568998|FG000|Part 1|Lost to Follow-up|5|||
144649354|NCT01208181|521568999|FG001|Part 1|Lost to Follow-up|3|||
144649355|NCT01208181|521569000|FG002|Part 1|Lost to Follow-up|0|||
144649356|NCT01208181|521569001|FG003|Part 1|Lost to Follow-up|0|||
144649357|NCT01208181|521569002|FG004|Part 1|Lost to Follow-up|1|||
144649358|NCT01208181|521568998|FG000|Part 1|Lack of Efficacy|37|||
144649359|NCT01208181|521568999|FG001|Part 1|Lack of Efficacy|12|||
144649360|NCT01208181|521569000|FG002|Part 1|Lack of Efficacy|0|||
144649361|NCT01208181|521569001|FG003|Part 1|Lack of Efficacy|0|||
144649362|NCT01208181|521569002|FG004|Part 1|Lack of Efficacy|17|||
144649363|NCT01208181|521568998|FG000|Part 1|Adverse Event|26|||
144649364|NCT01208181|521568999|FG001|Part 1|Adverse Event|24|||
144649365|NCT01208181|521569000|FG002|Part 1|Adverse Event|0|||
144649366|NCT01208181|521569001|FG003|Part 1|Adverse Event|0|||
144649367|NCT01208181|521569002|FG004|Part 1|Adverse Event|4|||
144649368|NCT01208181|521568998|FG000|Part 2|Adverse Event|0|||
144649369|NCT01208181|521568999|FG001|Part 2|Adverse Event|0|||
144649370|NCT01208181|521569000|FG002|Part 2|Adverse Event|6|||
144649371|NCT01208181|521569001|FG003|Part 2|Adverse Event|7|||
144649372|NCT01208181|521569002|FG004|Part 2|Adverse Event|0|||
144649373|NCT01208181|521568998|FG000|Part 2|Withdrawal by Subject|0|||
144211859|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
144649374|NCT01208181|521568999|FG001|Part 2|Withdrawal by Subject|0|||
144211860|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
144211861|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
144211862|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
144211863|NCT02952586|519970405|FG000|CRT for Cisplatin (63 Days)|Other|1|||
144211864|NCT02952586|519970406|FG001|CRT for Cisplatin (63 Days)|Other|1|||
144211865|NCT02952586|519970405|FG000|CRT for IMRT (63 Days)|Death|5|||
144211866|NCT02952586|519970406|FG001|CRT for IMRT (63 Days)|Death|8|||
144211867|NCT02952586|519970405|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
144211868|NCT02952586|519970406|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
144211869|NCT02952586|519970405|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
144211870|NCT02952586|519970406|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
144211871|NCT02952586|519970405|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
144211872|NCT02952586|519970406|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
144649375|NCT01208181|521569000|FG002|Part 2|Withdrawal by Subject|1|||
144649376|NCT01208181|521569001|FG003|Part 2|Withdrawal by Subject|1|||
144649377|NCT01208181|521569002|FG004|Part 2|Withdrawal by Subject|0|||
144649378|NCT01208181|521568998|FG000|Part 2|Protocol Violation|0|||
144211873|NCT02952586|519970405|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
144211874|NCT02952586|519970406|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
144211875|NCT02952586|519970405|FG000|CRT for IMRT (63 Days)|Other|1|||
144649379|NCT01208181|521568999|FG001|Part 2|Protocol Violation|0|||
144649380|NCT01208181|521569000|FG002|Part 2|Protocol Violation|1|||
144649381|NCT01208181|521569001|FG003|Part 2|Protocol Violation|0|||
144649382|NCT01208181|521569002|FG004|Part 2|Protocol Violation|0|||
144649383|NCT01208181|521568998|FG000|Part 2|Physician Decision|0|||
144649384|NCT01208181|521568999|FG001|Part 2|Physician Decision|0|||
144649385|NCT01208181|521569000|FG002|Part 2|Physician Decision|1|||
144649386|NCT01208181|521569001|FG003|Part 2|Physician Decision|2|||
144649387|NCT01208181|521569002|FG004|Part 2|Physician Decision|0|||
144649388|NCT01208181|521568998|FG000|Part 2|Non-compliance with study drug|0|||
144649389|NCT01208181|521568999|FG001|Part 2|Non-compliance with study drug|0|||
144649390|NCT01208181|521569000|FG002|Part 2|Non-compliance with study drug|1|||
144649391|NCT01208181|521569001|FG003|Part 2|Non-compliance with study drug|1|||
144649392|NCT01208181|521569002|FG004|Part 2|Non-compliance with study drug|0|||
144211876|NCT02952586|519970406|FG001|CRT for IMRT (63 Days)|Other|0|||
144649393|NCT01208181|521568998|FG000|Part 2|Lost to Follow-up|0|||
144649394|NCT01208181|521568999|FG001|Part 2|Lost to Follow-up|0|||
144649395|NCT01208181|521569000|FG002|Part 2|Lost to Follow-up|1|||
144649396|NCT01208181|521569001|FG003|Part 2|Lost to Follow-up|2|||
144211877|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Death|17|||
144211878|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Death|11|||
144649397|NCT01208181|521569002|FG004|Part 2|Lost to Follow-up|0|||
144211879|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
144211880|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
144211881|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
144211882|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
144649398|NCT01208181|521568998|FG000|Part 2|Lack of Efficacy|0|||
144649399|NCT01208181|521568999|FG001|Part 2|Lack of Efficacy|0|||
144649400|NCT01208181|521569000|FG002|Part 2|Lack of Efficacy|5|||
144649401|NCT01208181|521569001|FG003|Part 2|Lack of Efficacy|7|||
144649402|NCT01208181|521569002|FG004|Part 2|Lack of Efficacy|0|||
144649403|NCT01478347|521569004|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
144649404|NCT01478347|521569004|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
144649405|NCT01478347|521569004|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
144649406|NCT01645930|521569005|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
144649407|NCT01645930|521569005|FG000|Overall Study|Progressive Disease|12|||
144649408|NCT01645930|521569005|FG000|Overall Study|Adverse Event|4|||
144211883|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
144211884|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
144211885|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
144211886|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
144211887|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
144211888|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
144211889|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
144649409|NCT01645930|521569005|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
144649410|NCT01645930|521569005|FG000|Overall Study|Withdrawal by Participant|2|||
144649411|NCT01645930|521569005|FG000|Overall Study|Reason not Defined|1|||
144649412|NCT01748760|521569006|FG000|Overall Study|Withdrawal by Subject|1|||
144649413|NCT01748760|521569007|FG001|Overall Study|Withdrawal by Subject|1|||
144649414|NCT01748760|521569006|FG000|Overall Study|Lost to Follow-up|5|||
144649415|NCT01748760|521569007|FG001|Overall Study|Lost to Follow-up|1|||
144649416|NCT03245814|521569008|FG000|Overall Study|Lost to Follow-up|5|||
144649417|NCT03245814|521569009|FG001|Overall Study|Lost to Follow-up|8|||
144649418|NCT03245814|521569008|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
144649419|NCT03245814|521569009|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
144649420|NCT02263365|521569013|FG000|Overall Study|Physician Decision|22|||
144649421|NCT02263365|521569014|FG001|Overall Study|Physician Decision|18|||
144649422|NCT00510692|521569015|FG000|Overall Study|Adverse Event|1|||
144649423|NCT00510692|521569016|FG001|Overall Study|Adverse Event|3|||
144649424|NCT00510692|521569015|FG000|Overall Study|Withdrawal by Subject|1|||
144649425|NCT00510692|521569016|FG001|Overall Study|Withdrawal by Subject|0|||
144649426|NCT00945191|521569017|FG000|Overall Study|Did not achieve a complete response|18|||
144649427|NCT00945191|521569017|FG000|Overall Study|Participant relocated to another state|1|||
144649428|NCT00945191|521569017|FG000|Overall Study|Disease progression|3|||
144649429|NCT00945191|521569017|FG000|Overall Study|Serious adverse event or adverse event|1|||
144649430|NCT00945191|521569017|FG000|Overall Study|Investigator's discretion|1|||
144649431|NCT01845077|521569020|FG000|Washout Period|Lost to Follow-up|0|||
144649432|NCT01845077|521569021|FG001|Washout Period|Lost to Follow-up|1|||
144649433|NCT01845077|521569022|FG002|Washout Period|Lost to Follow-up|0|||
144649434|NCT01845077|521569023|FG003|Washout Period|Lost to Follow-up|1|||
144649435|NCT01845077|521569024|FG004|Washout Period|Lost to Follow-up|0|||
144649436|NCT01845077|521569025|FG005|Washout Period|Lost to Follow-up|1|||
144649437|NCT01845077|521569020|FG000|Washout Period|Adverse Event|1|||
144649438|NCT01845077|521569021|FG001|Washout Period|Adverse Event|0|||
144649439|NCT01845077|521569022|FG002|Washout Period|Adverse Event|0|||
144649440|NCT01845077|521569023|FG003|Washout Period|Adverse Event|0|||
144649441|NCT01845077|521569024|FG004|Washout Period|Adverse Event|0|||
144649442|NCT01845077|521569025|FG005|Washout Period|Adverse Event|0|||
144649443|NCT01845077|521569020|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
144649444|NCT01845077|521569021|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
144649445|NCT01845077|521569022|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
144649446|NCT01845077|521569023|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
144649447|NCT01845077|521569024|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
144649448|NCT01845077|521569025|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
144649449|NCT01845077|521569020|FG000|Washout Period|Protocol Violation|0|||
144649450|NCT01845077|521569021|FG001|Washout Period|Protocol Violation|0|||
144649451|NCT01845077|521569022|FG002|Washout Period|Protocol Violation|0|||
144649452|NCT01845077|521569023|FG003|Washout Period|Protocol Violation|1|||
144649453|NCT01845077|521569024|FG004|Washout Period|Protocol Violation|1|||
144649454|NCT01845077|521569025|FG005|Washout Period|Protocol Violation|0|||
144649455|NCT00394914|521569028|FG000|Treatment Period|Adverse Event|0|||
144649456|NCT00394914|521569029|FG001|Treatment Period|Adverse Event|3|||
144649457|NCT00394914|521569030|FG002|Treatment Period|Adverse Event|1|||
144649458|NCT00394914|521569028|FG000|Treatment Period|Lost to Follow-up|0|||
144649459|NCT00394914|521569029|FG001|Treatment Period|Lost to Follow-up|1|||
144649460|NCT00394914|521569030|FG002|Treatment Period|Lost to Follow-up|0|||
144649461|NCT00394914|521569028|FG000|Treatment Period|Withdrawal by Subject|0|||
144649462|NCT00394914|521569029|FG001|Treatment Period|Withdrawal by Subject|2|||
144649463|NCT00394914|521569030|FG002|Treatment Period|Withdrawal by Subject|2|||
144649464|NCT00394914|521569028|FG000|Treatment Period|Noncompliance with protocol|0|||
144649465|NCT00394914|521569029|FG001|Treatment Period|Noncompliance with protocol|3|||
144649466|NCT00394914|521569030|FG002|Treatment Period|Noncompliance with protocol|2|||
144649467|NCT00394914|521569028|FG000|Treatment Period|Did not meet protocol eligibility|0|||
144649468|NCT00394914|521569029|FG001|Treatment Period|Did not meet protocol eligibility|1|||
144649469|NCT00394914|521569030|FG002|Treatment Period|Did not meet protocol eligibility|1|||
144649470|NCT00312377|521569034|FG000|Overall Study|Death|403|||
144649471|NCT00312377|521569035|FG001|Overall Study|Death|418|||
144649472|NCT00312377|521569034|FG000|Overall Study|Withdrawal by Subject|23|||
144649473|NCT00312377|521569035|FG001|Overall Study|Withdrawal by Subject|30|||
144649474|NCT00312377|521569034|FG000|Overall Study|Lost to Follow-up|9|||
144731695|NCT01214850|521873245|FG000|Overall Study|Inappropriate enrollment|2|||
144649475|NCT00312377|521569035|FG001|Overall Study|Lost to Follow-up|12|||
144649476|NCT00312377|521569034|FG000|Overall Study|Non-compliance|0|||
144649477|NCT00312377|521569035|FG001|Overall Study|Non-compliance|2|||
144649478|NCT00312377|521569034|FG000|Overall Study|Randomised but never received treatment|6|||
144649479|NCT00312377|521569035|FG001|Overall Study|Randomised but never received treatment|6|||
144649480|NCT00312377|521569034|FG000|Overall Study|Discontinue treatment survival follow up|202|||
144649481|NCT00312377|521569035|FG001|Overall Study|Discontinue treatment survival follow up|200|||
144649482|NCT00312377|521569034|FG000|Overall Study|Site ended participation in study|1|||
144649483|NCT00312377|521569035|FG001|Overall Study|Site ended participation in study|0|||
144649484|NCT00872898|521569036|FG000|Part Two - Double Blind|Adverse Event|4|||
144649485|NCT00872898|521569037|FG001|Part Two - Double Blind|Adverse Event|3|||
144649486|NCT00872898|521569036|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
144649487|NCT00872898|521569037|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
144649488|NCT00872898|521569036|FG000|Part Two - Double Blind|Protocol Violation|1|||
144649489|NCT00872898|521569037|FG001|Part Two - Double Blind|Protocol Violation|0|||
144649490|NCT00872898|521569036|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
144649491|NCT00872898|521569037|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
144649492|NCT00872898|521569036|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
144649493|NCT00872898|521569037|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
144649494|NCT00872898|521569036|FG000|Part Two - Double Blind|Other reasons|2|||
144649495|NCT00872898|521569037|FG001|Part Two - Double Blind|Other reasons|0|||
144649496|NCT03290300|521569043|FG000|Overall Study|Lost to Follow-up|3|||
144649497|NCT01001494|521569044|FG000|Overall Study|Adverse Event|8|||
144649498|NCT01001494|521569045|FG001|Overall Study|Adverse Event|4|||
144649499|NCT01001494|521569046|FG002|Overall Study|Adverse Event|6|||
144649500|NCT01001494|521569044|FG000|Overall Study|Protocol Violation|0|||
144649501|NCT01001494|521569045|FG001|Overall Study|Protocol Violation|1|||
144649502|NCT01001494|521569046|FG002|Overall Study|Protocol Violation|1|||
144649503|NCT01001494|521569044|FG000|Overall Study|Lost to Follow-up|2|||
144649504|NCT01001494|521569045|FG001|Overall Study|Lost to Follow-up|0|||
144649505|NCT01001494|521569046|FG002|Overall Study|Lost to Follow-up|1|||
144649506|NCT01001494|521569044|FG000|Overall Study|Withdrawal by Subject|9|||
144649507|NCT01001494|521569045|FG001|Overall Study|Withdrawal by Subject|7|||
144649508|NCT01001494|521569046|FG002|Overall Study|Withdrawal by Subject|17|||
144649509|NCT01001494|521569044|FG000|Overall Study|COPD exacerbation|3|||
144649510|NCT01001494|521569045|FG001|Overall Study|COPD exacerbation|4|||
144649511|NCT01001494|521569046|FG002|Overall Study|COPD exacerbation|5|||
144649512|NCT01001494|521569044|FG000|Overall Study|Lack of Efficacy|2|||
144649513|NCT01001494|521569045|FG001|Overall Study|Lack of Efficacy|0|||
144649514|NCT01001494|521569046|FG002|Overall Study|Lack of Efficacy|8|||
144649515|NCT01001494|521569044|FG000|Overall Study|Other|0|||
144649516|NCT01001494|521569045|FG001|Overall Study|Other|1|||
144649517|NCT01001494|521569046|FG002|Overall Study|Other|3|||
144649518|NCT02179398|521569047|FG000|Overall Study|Lack of obligatory data|3|||
144649519|NCT02179398|521569048|FG001|Overall Study|Lack of obligatory data|3|||
144649520|NCT02179398|521569047|FG000|Overall Study|Lost to Follow-up|0|||
144649521|NCT02179398|521569048|FG001|Overall Study|Lost to Follow-up|1|||
144649522|NCT02519231|521569052|FG000|Overall Study|Lost to Follow-up|2|||
144649523|NCT02519231|521569053|FG001|Overall Study|Lost to Follow-up|5|||
144649524|NCT02519231|521569052|FG000|Overall Study|Withdrawal by Subject|0|||
144649525|NCT02519231|521569053|FG001|Overall Study|Withdrawal by Subject|1|||
144649526|NCT00815308|521569054|FG000|Overall Study|Adverse Event|4|||
144649527|NCT00815308|521569054|FG000|Overall Study|Withdrawal by Subject|0|||
144649528|NCT00815308|521569054|FG000|Overall Study|Protocol Violation|6|||
144649529|NCT03176966|521569059|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
144649530|NCT03176966|521569060|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
144649531|NCT03176966|521569059|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
144649532|NCT03176966|521569060|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
144649533|NCT03176966|521569059|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
144649534|NCT03176966|521569060|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
144649535|NCT03176966|521569059|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
144649536|NCT03176966|521569060|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
144649537|NCT03176966|521569059|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
144649538|NCT03176966|521569060|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
144649539|NCT03176966|521569059|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
144649540|NCT03176966|521569060|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
144649541|NCT03176966|521569059|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
144649542|NCT03176966|521569060|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
144649543|NCT01520922|521569064|FG000|Treatment Phase|Physician Decision|2|||
144649544|NCT01520922|521569065|FG001|Treatment Phase|Physician Decision|1|||
144649545|NCT01520922|521569064|FG000|Treatment Phase|Progression|0|||
144649546|NCT01520922|521569065|FG001|Treatment Phase|Progression|2|||
144649547|NCT01520922|521569064|FG000|Treatment Phase|Adverse Event|3|||
144649548|NCT01520922|521569065|FG001|Treatment Phase|Adverse Event|5|||
144649549|NCT01520922|521569064|FG000|Follow up|Lost to Follow-up|0|||
144211890|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
144211891|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
144211892|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
144649550|NCT01520922|521569065|FG001|Follow up|Lost to Follow-up|1|||
144649551|NCT01520922|521569064|FG000|Survival Follow-up|Withdrawal by Subject|1|||
144649552|NCT01520922|521569065|FG001|Survival Follow-up|Withdrawal by Subject|0|||
144649553|NCT01696877|521569068|FG000|Overall Study|Adverse Event|0|||
144649554|NCT01696877|521569069|FG001|Overall Study|Adverse Event|1|||
144649555|NCT00515463|521569070|FG000|Overall Study|Physician Decision|4|||
144649556|NCT00515463|521569071|FG001|Overall Study|Physician Decision|2|||
144649557|NCT00515463|521569070|FG000|Overall Study|Adverse Event|1|||
144649558|NCT00515463|521569071|FG001|Overall Study|Adverse Event|2|||
144649559|NCT00515463|521569070|FG000|Overall Study|Withdrawal by Subject|3|||
144649560|NCT00515463|521569071|FG001|Overall Study|Withdrawal by Subject|4|||
144649561|NCT00515463|521569070|FG000|Overall Study|Lost to Follow-up|6|||
144649562|NCT00515463|521569071|FG001|Overall Study|Lost to Follow-up|5|||
144649563|NCT00515463|521569070|FG000|Overall Study|Other|0|||
144649564|NCT00515463|521569071|FG001|Overall Study|Other|1|||
144649565|NCT00916721|521569072|FG000|Overall Study|Lost to Follow-up|0|||
144649566|NCT00916721|521569073|FG001|Overall Study|Lost to Follow-up|1|||
144649567|NCT00916721|521569072|FG000|Overall Study|Adverse Event|6|||
144649568|NCT00916721|521569073|FG001|Overall Study|Adverse Event|3|||
144649569|NCT00916721|521569072|FG000|Overall Study|Withdrawal by Subject|2|||
144649570|NCT00916721|521569073|FG001|Overall Study|Withdrawal by Subject|2|||
144649571|NCT00916721|521569072|FG000|Overall Study|Protocol Violation|2|||
144649572|NCT00916721|521569073|FG001|Overall Study|Protocol Violation|4|||
144649573|NCT01903434|521569077|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
144649574|NCT01903434|521569078|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
144649575|NCT01903434|521569077|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
144649576|NCT01903434|521569078|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
144649577|NCT01469052|521569081|FG000|Overall Study|Adverse Event|2|||
144649578|NCT01469052|521569082|FG001|Overall Study|Adverse Event|3|||
144649579|NCT01469052|521569083|FG002|Overall Study|Adverse Event|0|||
144649580|NCT01469052|521569084|FG003|Overall Study|Adverse Event|2|||
144649581|NCT01469052|521569085|FG004|Overall Study|Adverse Event|0|||
144649582|NCT01469052|521569086|FG005|Overall Study|Adverse Event|1|||
144649583|NCT01469052|521569081|FG000|Overall Study|Progressive disease|3|||
144649584|NCT01469052|521569082|FG001|Overall Study|Progressive disease|0|||
144649585|NCT01469052|521569083|FG002|Overall Study|Progressive disease|5|||
144649586|NCT01469052|521569084|FG003|Overall Study|Progressive disease|3|||
144649587|NCT01469052|521569085|FG004|Overall Study|Progressive disease|7|||
144649588|NCT01469052|521569086|FG005|Overall Study|Progressive disease|2|||
144649589|NCT01469052|521569081|FG000|Overall Study|Lack of Efficacy|0|||
144649590|NCT01469052|521569082|FG001|Overall Study|Lack of Efficacy|0|||
144649591|NCT01469052|521569083|FG002|Overall Study|Lack of Efficacy|0|||
144649592|NCT01469052|521569084|FG003|Overall Study|Lack of Efficacy|0|||
144649593|NCT01469052|521569085|FG004|Overall Study|Lack of Efficacy|0|||
144649594|NCT01469052|521569086|FG005|Overall Study|Lack of Efficacy|2|||
144649595|NCT01469052|521569081|FG000|Overall Study|Moved to rollover protocol|1|||
144649596|NCT01469052|521569082|FG001|Overall Study|Moved to rollover protocol|0|||
144649597|NCT01469052|521569083|FG002|Overall Study|Moved to rollover protocol|1|||
144649598|NCT01469052|521569084|FG003|Overall Study|Moved to rollover protocol|0|||
144649599|NCT01469052|521569085|FG004|Overall Study|Moved to rollover protocol|0|||
144649600|NCT01469052|521569086|FG005|Overall Study|Moved to rollover protocol|1|||
144649601|NCT01469052|521569081|FG000|Overall Study|Other|0|||
144649602|NCT01469052|521569082|FG001|Overall Study|Other|1|||
144649603|NCT01469052|521569083|FG002|Overall Study|Other|0|||
144649604|NCT01469052|521569084|FG003|Overall Study|Other|0|||
144649605|NCT01469052|521569085|FG004|Overall Study|Other|1|||
144649606|NCT01469052|521569086|FG005|Overall Study|Other|0|||
144649607|NCT02749370|521569087|FG000|Overall Study|Withdrawal by Subject|11|||
144649608|NCT02749370|521569087|FG000|Overall Study|Lost to Follow-up|3|||
144211893|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Other|2|||
144649609|NCT01519427|521569091|FG000|Overall Study|disease progression|2|||
144649610|NCT03894904|521569092|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
144649611|NCT03894904|521569093|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
144649612|NCT03894904|521569092|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
144649613|NCT03894904|521569093|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
144649614|NCT02190435|521569094|FG000|Overall Study|First 12 patients were lead-ins|12|||
144649615|NCT02190435|521569095|FG001|Overall Study|First 12 patients were lead-ins|0|||
144649616|NCT02190435|521569094|FG000|Overall Study|3 consented screen fails|3|||
144649617|NCT02190435|521569095|FG001|Overall Study|3 consented screen fails|0|||
144649618|NCT00336492|521569096|FG000|Overall Study|Adverse Event|4|||
144731696|NCT01214850|521873246|FG001|Overall Study|Inappropriate enrollment|1|||
144649619|NCT00336492|521569097|FG001|Overall Study|Adverse Event|3|||
144649620|NCT00336492|521569098|FG002|Overall Study|Adverse Event|6|||
144649621|NCT00336492|521569096|FG000|Overall Study|Lack of Efficacy|6|||
144649622|NCT00336492|521569097|FG001|Overall Study|Lack of Efficacy|1|||
144649623|NCT00336492|521569098|FG002|Overall Study|Lack of Efficacy|4|||
144649624|NCT00336492|521569096|FG000|Overall Study|Other|5|||
144649625|NCT00336492|521569097|FG001|Overall Study|Other|0|||
144649626|NCT00336492|521569098|FG002|Overall Study|Other|1|||
144649627|NCT01781026|521569099|FG000|Overall Study|Lack of Efficacy|2|||
144649628|NCT02269319|521569100|FG000|Overall Study|Lost to Follow-up|4|||
144649629|NCT02269319|521569101|FG001|Overall Study|Lost to Follow-up|3|||
144649630|NCT02269319|521569100|FG000|Overall Study|Adverse Event|0|||
144649631|NCT02269319|521569101|FG001|Overall Study|Adverse Event|1|||
144649632|NCT02269319|521569100|FG000|Overall Study|Instructions not followed|1|||
144649633|NCT02269319|521569101|FG001|Overall Study|Instructions not followed|0|||
144649634|NCT00404768|521569104|FG000|Part A and B|Withdrawn due to labor progression|1|||
144649635|NCT00404768|521569105|FG001|Part A and B|Withdrawn due to labor progression|0|||
144649636|NCT00404768|521569106|FG002|Part A and B|Withdrawn due to labor progression|0|||
144649637|NCT00404768|521569107|FG003|Part A and B|Withdrawn due to labor progression|0|||
144649638|NCT00404768|521569104|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
144649639|NCT00404768|521569105|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
144649640|NCT00404768|521569106|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
144649641|NCT00404768|521569107|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
144649642|NCT00404768|521569104|FG000|Part C|Adverse Event|0|||
144649643|NCT00404768|521569105|FG001|Part C|Adverse Event|0|||
144649644|NCT00404768|521569106|FG002|Part C|Adverse Event|0|||
144649645|NCT00404768|521569107|FG003|Part C|Adverse Event|3|||
144649646|NCT00404768|521569104|FG000|Part C|Lost to Follow-up|0|||
144649647|NCT00404768|521569105|FG001|Part C|Lost to Follow-up|0|||
144649648|NCT00404768|521569106|FG002|Part C|Lost to Follow-up|3|||
144649649|NCT00404768|521569107|FG003|Part C|Lost to Follow-up|1|||
144649650|NCT00404768|521569104|FG000|Part C|Withdrawal by Subject|0|||
144649651|NCT00404768|521569105|FG001|Part C|Withdrawal by Subject|0|||
144649652|NCT00404768|521569106|FG002|Part C|Withdrawal by Subject|2|||
144649653|NCT00404768|521569107|FG003|Part C|Withdrawal by Subject|1|||
144649654|NCT00404768|521569104|FG000|Part C|Early withdrawal from study medication|0|||
144649655|NCT00404768|521569105|FG001|Part C|Early withdrawal from study medication|0|||
144649656|NCT00404768|521569106|FG002|Part C|Early withdrawal from study medication|1|||
144649657|NCT00404768|521569107|FG003|Part C|Early withdrawal from study medication|0|||
144649658|NCT00404768|521569104|FG000|Part C|Participant did not respond to therapy|0|||
144649659|NCT00404768|521569105|FG001|Part C|Participant did not respond to therapy|0|||
144649660|NCT00404768|521569106|FG002|Part C|Participant did not respond to therapy|1|||
144649661|NCT00404768|521569107|FG003|Part C|Participant did not respond to therapy|1|||
144649662|NCT00404768|521569104|FG000|Part C|Physician withdrew the study medication|0|||
144649663|NCT00404768|521569105|FG001|Part C|Physician withdrew the study medication|0|||
144649664|NCT00404768|521569106|FG002|Part C|Physician withdrew the study medication|1|||
144649665|NCT00404768|521569107|FG003|Part C|Physician withdrew the study medication|0|||
144649666|NCT00404768|521569104|FG000|Part C|Participant delivered baby|0|||
144649667|NCT00404768|521569105|FG001|Part C|Participant delivered baby|0|||
144649668|NCT00404768|521569106|FG002|Part C|Participant delivered baby|0|||
144649669|NCT00404768|521569107|FG003|Part C|Participant delivered baby|1|||
144649670|NCT00404768|521569104|FG000|Part C|Unsatisfactory uterine response to IP|0|||
144649671|NCT00404768|521569105|FG001|Part C|Unsatisfactory uterine response to IP|0|||
144649672|NCT00404768|521569106|FG002|Part C|Unsatisfactory uterine response to IP|0|||
144649673|NCT00404768|521569107|FG003|Part C|Unsatisfactory uterine response to IP|1|||
144649674|NCT00404768|521569104|FG000|Part C|Active labor|0|||
144649675|NCT00404768|521569105|FG001|Part C|Active labor|0|||
144649676|NCT00404768|521569106|FG002|Part C|Active labor|0|||
144649677|NCT00404768|521569107|FG003|Part C|Active labor|1|||
144649678|NCT00404768|521569104|FG000|Part C|Lack of Efficacy|0|||
144649679|NCT00404768|521569105|FG001|Part C|Lack of Efficacy|0|||
144649680|NCT00404768|521569106|FG002|Part C|Lack of Efficacy|0|||
144649681|NCT00404768|521569107|FG003|Part C|Lack of Efficacy|2|||
144649682|NCT00404768|521569104|FG000|Part C|Treatment failure|0|||
144649683|NCT00404768|521569105|FG001|Part C|Treatment failure|0|||
144649684|NCT00404768|521569106|FG002|Part C|Treatment failure|0|||
144649685|NCT00404768|521569107|FG003|Part C|Treatment failure|1|||
144649686|NCT00404768|521569104|FG000|Part C|Investigator discretion|0|||
144649687|NCT00404768|521569105|FG001|Part C|Investigator discretion|0|||
144649688|NCT00404768|521569106|FG002|Part C|Investigator discretion|0|||
144649689|NCT00404768|521569107|FG003|Part C|Investigator discretion|1|||
144649690|NCT00404768|521569104|FG000|Part C|Researcher suspended study medication|0|||
144649691|NCT00404768|521569105|FG001|Part C|Researcher suspended study medication|0|||
144649692|NCT00404768|521569106|FG002|Part C|Researcher suspended study medication|0|||
144649693|NCT00404768|521569107|FG003|Part C|Researcher suspended study medication|1|||
144649694|NCT04773041|521569110|FG000|Overall Study|Unable to data match|1|||
144649695|NCT04773041|521569111|FG001|Overall Study|Unable to data match|0|||
144649696|NCT04773041|521569112|FG002|Overall Study|Unable to data match|0|||
144649697|NCT02699515|521570623|FG000|Overall Study|Death|3|||
144649698|NCT02699515|521570624|FG001|Overall Study|Death|3|||
144649699|NCT02699515|521570625|FG002|Overall Study|Death|3|||
144649700|NCT02699515|521570626|FG003|Overall Study|Death|23|||
144649701|NCT02699515|521570627|FG004|Overall Study|Death|22|||
144649702|NCT02699515|521570628|FG005|Overall Study|Death|23|||
144649703|NCT02699515|521570629|FG006|Overall Study|Death|3|||
144649704|NCT02699515|521570630|FG007|Overall Study|Death|5|||
144649705|NCT02699515|521570623|FG000|Overall Study|Withdrawal by Subject|0|||
144649706|NCT02699515|521570624|FG001|Overall Study|Withdrawal by Subject|0|||
144649707|NCT02699515|521570625|FG002|Overall Study|Withdrawal by Subject|3|||
144649708|NCT02699515|521570626|FG003|Overall Study|Withdrawal by Subject|1|||
144649709|NCT02699515|521570627|FG004|Overall Study|Withdrawal by Subject|5|||
144649710|NCT02699515|521570628|FG005|Overall Study|Withdrawal by Subject|3|||
144649711|NCT02699515|521570629|FG006|Overall Study|Withdrawal by Subject|0|||
144649712|NCT02699515|521570630|FG007|Overall Study|Withdrawal by Subject|1|||
144649713|NCT02699515|521570623|FG000|Overall Study|Other|1|||
144649714|NCT02699515|521570624|FG001|Overall Study|Other|0|||
144649715|NCT02699515|521570625|FG002|Overall Study|Other|1|||
144649716|NCT02699515|521570626|FG003|Overall Study|Other|6|||
144649717|NCT02699515|521570627|FG004|Overall Study|Other|4|||
144649718|NCT02699515|521570628|FG005|Overall Study|Other|3|||
144649719|NCT02699515|521570629|FG006|Overall Study|Other|0|||
144649720|NCT02699515|521570630|FG007|Overall Study|Other|0|||
144649721|NCT01240811|521570641|FG000|Overall Study|Physician Decision|0|||
144649722|NCT01240811|521570642|FG001|Overall Study|Physician Decision|1|||
144649723|NCT01240811|521570643|FG002|Overall Study|Physician Decision|0|||
144649724|NCT01240811|521570641|FG000|Overall Study|Withdrawal by Subject|0|||
144649725|NCT01240811|521570642|FG001|Overall Study|Withdrawal by Subject|0|||
144649726|NCT01240811|521570643|FG002|Overall Study|Withdrawal by Subject|1|||
144649727|NCT00128206|521570644|FG000|Overall Study|Lost to Follow-up|137|||
144649728|NCT00128206|521570645|FG001|Overall Study|Lost to Follow-up|118|||
144649729|NCT00128206|521570644|FG000|Overall Study|Adverse Event|0|||
144649730|NCT00128206|521570645|FG001|Overall Study|Adverse Event|2|||
144649731|NCT03032068|521570648|FG000|Overall Study|Adverse Event|1|||
144649732|NCT01597622|521570649|FG000|Overall Study|Adverse Event|7|||
144649733|NCT01597622|521570649|FG000|Overall Study|Lack of Efficacy|3|||
144649734|NCT01597622|521570649|FG000|Overall Study|Protocol Violation|1|||
144649735|NCT01597622|521570649|FG000|Overall Study|Lost to Follow-up|1|||
144649736|NCT01597622|521570649|FG000|Overall Study|Investigator Discretion|5|||
144649737|NCT01597622|521570649|FG000|Overall Study|Withdrawal by Subject|20|||
144649738|NCT01597622|521570649|FG000|Overall Study|Death|1|||
144649739|NCT01988012|521570657|FG000|Overall Study|Adverse Event|5|||
144649740|NCT01988012|521570657|FG000|Overall Study|Insufficient Therapeutic Response|3|||
144649741|NCT01988012|521570657|FG000|Overall Study|Patient Withdrawal of Consent|4|||
144649742|NCT01988012|521570657|FG000|Overall Study|Lost to Follow-up|1|||
144649743|NCT01988012|521570657|FG000|Overall Study|Physician Decision|1|||
144649744|NCT01988012|521570657|FG000|Overall Study|Protocol Violation|1|||
144649745|NCT01228071|521570660|FG000|Overall Study|Protocol Violation|1|||
144649746|NCT01228071|521570660|FG000|Overall Study|Withdrawal by Subject|1|||
144649747|NCT03314519|521570661|FG000|Overall Study|Protocol Violation|3|||
144649748|NCT03314519|521570662|FG001|Overall Study|Protocol Violation|2|||
144649749|NCT01713036|521570665|FG000|Overall Study|Death|1|||
144649750|NCT00592358|521570666|FG000|Overall Study|Withdrawal by Subject|2|||
144649751|NCT00592358|521570666|FG000|Overall Study|Adverse Event|1|||
144649752|NCT00592358|521570666|FG000|Overall Study|Lack of Efficacy|2|||
144649753|NCT00592358|521570666|FG000|Overall Study|Inability to swallow pills|1|||
144649754|NCT01166659|521570667|FG000|Overall Study|Subject Decision|8|||
144649755|NCT01166659|521570667|FG000|Overall Study|Investigator Decision|2|||
144649756|NCT01166659|521570667|FG000|Overall Study|Death|1|||
144649757|NCT01166659|521570667|FG000|Overall Study|Lost to Follow-up|1|||
144649758|NCT01166659|521570667|FG000|Overall Study|Study Closed at Site|1|||
144649759|NCT03238248|521570672|FG000|Overall Study|Death|5|||
144263323|NCT02619617|520165410|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
144649760|NCT03238248|521570672|FG000|Overall Study|Withdrawal by Subject|7|||
144649761|NCT03238248|521570672|FG000|Overall Study|Participant proceeding to transplant|10|||
144649762|NCT03238248|521570672|FG000|Overall Study|Lack of Efficacy|4|||
144649763|NCT03238248|521570672|FG000|Overall Study|Physician Decision|3|||
144649764|NCT03238248|521570672|FG000|Overall Study|Transitioning to another study|1|||
144649765|NCT03238248|521570672|FG000|Overall Study|No longer benefiting|1|||
144649766|NCT03238248|521570672|FG000|Overall Study|Other complicating disease|1|||
144649767|NCT03238248|521570672|FG000|Overall Study|Adverse Event|5|||
144649768|NCT03238248|521570672|FG000|Overall Study|Disease progression|26|||
144649769|NCT03238248|521570672|FG000|Overall Study|N/A participant is still on treatment|1|||
144649770|NCT03238248|521570672|FG000|Overall Study|Decline in condition|1|||
144263324|NCT02735980|520165411|FG000|Overall Study|Adverse Event|0|||
144263325|NCT02735980|520165412|FG001|Overall Study|Adverse Event|4|||
144649771|NCT03238248|521570672|FG000|Overall Study|Alternative therapy|2|||
144649772|NCT01013883|521570679|FG000|Overall Study|Lost to Follow-up|2|||
144649773|NCT01013883|521570680|FG001|Overall Study|Lost to Follow-up|2|||
144263326|NCT02735980|520165413|FG002|Overall Study|Adverse Event|1|||
144649774|NCT02241512|521570681|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
144649775|NCT02241512|521570682|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
144649776|NCT04275310|521570685|FG000|Overall Study|Non-randomized due to running out of funding|4|||
144649777|NCT04275310|521570686|FG001|Overall Study|Non-randomized due to running out of funding|0|||
144649778|NCT00631488|521570689|FG000|Overall Study|Adverse Event|1|||
144649779|NCT00631488|521570690|FG001|Overall Study|Adverse Event|0|||
144649780|NCT00631488|521570691|FG002|Overall Study|Adverse Event|0|||
144649781|NCT00631488|521570689|FG000|Overall Study|Lost to Follow-up|2|||
144649782|NCT00631488|521570690|FG001|Overall Study|Lost to Follow-up|2|||
144649783|NCT00631488|521570691|FG002|Overall Study|Lost to Follow-up|0|||
144649784|NCT00631488|521570689|FG000|Overall Study|Physician Decision|1|||
144649785|NCT00631488|521570690|FG001|Overall Study|Physician Decision|0|||
144649786|NCT00631488|521570691|FG002|Overall Study|Physician Decision|1|||
144649787|NCT00631488|521570689|FG000|Overall Study|Protocol Violation|0|||
144649788|NCT00631488|521570690|FG001|Overall Study|Protocol Violation|0|||
144649789|NCT00631488|521570691|FG002|Overall Study|Protocol Violation|1|||
144263327|NCT02735980|520165411|FG000|Overall Study|Death|5|||
144263328|NCT02735980|520165412|FG001|Overall Study|Death|4|||
144649790|NCT00130208|521570694|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
144649791|NCT00130208|521570695|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
144649792|NCT00130208|521570694|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
144649793|NCT00130208|521570695|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
144649794|NCT00130208|521570694|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
144649795|NCT00130208|521570695|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
144649796|NCT00130208|521570694|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
144649797|NCT00130208|521570695|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
144649798|NCT00130208|521570694|FG000|Maintenance Period (26 Weeks)|Other|1|||
144649799|NCT00130208|521570695|FG001|Maintenance Period (26 Weeks)|Other|1|||
144649800|NCT00130208|521570694|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
144649801|NCT00130208|521570695|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
144649802|NCT00130208|521570694|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
144649803|NCT00130208|521570695|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
144649804|NCT00130208|521570694|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
144649805|NCT00130208|521570695|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
144649806|NCT00130208|521570694|FG000|Washout Period (8 Weeks)|Other|1|||
144649807|NCT00130208|521570695|FG001|Washout Period (8 Weeks)|Other|1|||
144649808|NCT02385123|521570700|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
144649809|NCT00552305|521570704|FG000|Overall Study|Adverse Event|43|||
144649810|NCT00552305|521570704|FG000|Overall Study|Lack of Efficacy|120|||
144649811|NCT00552305|521570704|FG000|Overall Study|Lost to Follow-up|4|||
144649812|NCT00552305|521570704|FG000|Overall Study|Protocol Violation|3|||
144649813|NCT00552305|521570704|FG000|Overall Study|Withdrawal by Subject|44|||
144649814|NCT00552305|521570704|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
144649815|NCT00552305|521570704|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
144649816|NCT00552305|521570704|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
144731697|NCT01214850|521873247|FG002|Overall Study|Inappropriate enrollment|0|||
144263329|NCT02735980|520165413|FG002|Overall Study|Death|0|||
144263330|NCT02735980|520165411|FG000|Overall Study|Physician Decision|3|||
144263331|NCT02735980|520165412|FG001|Overall Study|Physician Decision|1|||
144263332|NCT02735980|520165413|FG002|Overall Study|Physician Decision|0|||
144263333|NCT02735980|520165411|FG000|Overall Study|Screen failure|1|||
144263334|NCT02735980|520165412|FG001|Overall Study|Screen failure|0|||
144263335|NCT02735980|520165413|FG002|Overall Study|Screen failure|0|||
144263336|NCT02735980|520165411|FG000|Overall Study|Withdrawal by Subject|1|||
144263337|NCT02735980|520165412|FG001|Overall Study|Withdrawal by Subject|2|||
144263338|NCT02735980|520165413|FG002|Overall Study|Withdrawal by Subject|0|||
144263339|NCT00509899|520165414|FG000|Overall Study|Progressive disease|1|||
144263340|NCT00509899|520165415|FG001|Overall Study|Progressive disease|3|||
144263341|NCT00509899|520165416|FG002|Overall Study|Progressive disease|5|||
144263342|NCT00509899|520165417|FG003|Overall Study|Progressive disease|1|||
144263343|NCT00509899|520165418|FG004|Overall Study|Progressive disease|0|||
144263344|NCT00509899|520165419|FG005|Overall Study|Progressive disease|1|||
144263345|NCT00509899|520165420|FG006|Overall Study|Progressive disease|0|||
144649817|NCT00552305|521570704|FG000|Overall Study|Unsatisfactory compliance|11|||
144649818|NCT00552305|521570704|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
144649819|NCT00552305|521570704|FG000|Overall Study|AE/Other: prohibited drug required|1|||
144649820|NCT00552305|521570704|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
144649821|NCT00552305|521570704|FG000|Overall Study|Other: Site closed|4|||
144649822|NCT00552305|521570704|FG000|Overall Study|Other: Personal problems|1|||
144649823|NCT00552305|521570704|FG000|Overall Study|Other: Unable to attend visits|1|||
144263346|NCT00509899|520165421|FG007|Overall Study|Progressive disease|0|||
144263347|NCT00509899|520165414|FG000|Overall Study|Unacceptable Toxicity|1|||
144263348|NCT00509899|520165415|FG001|Overall Study|Unacceptable Toxicity|0|||
144263349|NCT00509899|520165416|FG002|Overall Study|Unacceptable Toxicity|0|||
144263350|NCT00509899|520165417|FG003|Overall Study|Unacceptable Toxicity|2|||
144211894|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Other|1|||
144211895|NCT02952586|519970405|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
144211896|NCT02952586|519970406|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
144649824|NCT00552305|521570704|FG000|Overall Study|Other: Subject underwent surgery|4|||
144649825|NCT00552305|521570704|FG000|Overall Study|Other: Subject became pregnant|1|||
144649826|NCT00552305|521570704|FG000|Overall Study|Other: Health problems, not drug related|1|||
144649827|NCT00552305|521570704|FG000|Overall Study|Other: Subject moved from area|2|||
144649828|NCT00552305|521570704|FG000|Overall Study|Other: Subject incarcerated|1|||
144649829|NCT00552305|521570704|FG000|Overall Study|Other: Subject went to rehab|1|||
144649830|NCT02345434|521570705|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
144649831|NCT02345434|521570706|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
144649832|NCT01703819|521570707|FG000|Overall Study|Adverse Event|0|||
144649833|NCT01703819|521570708|FG001|Overall Study|Adverse Event|1|||
144649834|NCT01703819|521570707|FG000|Overall Study|Withdrawal by Subject|0|||
144649835|NCT01703819|521570708|FG001|Overall Study|Withdrawal by Subject|1|||
144649836|NCT04230486|521570715|FG000|Overall Study|Screen Failure|1|||
144649837|NCT01302041|521570716|FG000|Overall Study|Death|5|||
144649838|NCT01302041|521570716|FG000|Overall Study|Withdrawal by Subject|4|||
144649839|NCT01302041|521570716|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
144649840|NCT01302041|521570716|FG000|Overall Study|Other-Miscellaneous Reason|2|||
144649841|NCT02234583|521570721|FG000|Overall Study|Adverse Event|172|||
144649842|NCT02234583|521570722|FG001|Overall Study|Adverse Event|156|||
144649843|NCT02234583|521570721|FG000|Overall Study|Withdrawal by Subject|109|||
144649844|NCT02234583|521570722|FG001|Overall Study|Withdrawal by Subject|157|||
144649845|NCT02234583|521570721|FG000|Overall Study|Lost to Follow-up|0|||
144649846|NCT02234583|521570722|FG001|Overall Study|Lost to Follow-up|1|||
144649847|NCT02234583|521570721|FG000|Overall Study|Lack of Efficacy|58|||
144649848|NCT02234583|521570722|FG001|Overall Study|Lack of Efficacy|103|||
144649849|NCT02234583|521570721|FG000|Overall Study|Protocol Violation|35|||
144649850|NCT02234583|521570722|FG001|Overall Study|Protocol Violation|42|||
144649851|NCT02234583|521570721|FG000|Overall Study|Other|39|||
144649852|NCT02234583|521570722|FG001|Overall Study|Other|97|||
144649853|NCT00367640|521570725|FG000|Overall Study|Adverse Event|3|||
144649854|NCT00367640|521570726|FG001|Overall Study|Adverse Event|6|||
144649855|NCT00367640|521570727|FG002|Overall Study|Adverse Event|8|||
144649856|NCT00367640|521570728|FG003|Overall Study|Adverse Event|0|||
144649857|NCT00367640|521570725|FG000|Overall Study|Withdrawal by Subject|8|||
144649858|NCT00367640|521570726|FG001|Overall Study|Withdrawal by Subject|11|||
144649859|NCT00367640|521570727|FG002|Overall Study|Withdrawal by Subject|8|||
144649860|NCT00367640|521570728|FG003|Overall Study|Withdrawal by Subject|6|||
144649861|NCT00367640|521570725|FG000|Overall Study|Any other reason not above-mentioned|7|||
144649862|NCT00367640|521570726|FG001|Overall Study|Any other reason not above-mentioned|5|||
144649863|NCT00367640|521570727|FG002|Overall Study|Any other reason not above-mentioned|3|||
144649864|NCT00367640|521570728|FG003|Overall Study|Any other reason not above-mentioned|4|||
144649865|NCT00771030|521570731|FG000|Overall Study|Adverse Event|0|||
144649866|NCT00771030|521570732|FG001|Overall Study|Adverse Event|1|||
144649867|NCT00771030|521570733|FG002|Overall Study|Adverse Event|0|||
144649868|NCT00771030|521570734|FG003|Overall Study|Adverse Event|0|||
144649869|NCT00771030|521570735|FG004|Overall Study|Adverse Event|0|||
144649870|NCT00771030|521570736|FG005|Overall Study|Adverse Event|0|||
144649871|NCT00771030|521570737|FG006|Overall Study|Adverse Event|0|||
144649872|NCT01839188|521570738|FG000|Overall Study|Withdrawal by Subject|1|||
144649873|NCT02805907|521570739|FG000|Overall Study|Lost to Follow-up|3|||
144649874|NCT02805907|521570740|FG001|Overall Study|Lost to Follow-up|3|||
144649875|NCT01264965|521570757|FG000|Overall Study|Withdrawal by Subject|10|||
144649876|NCT01022853|521570759|FG000|Overall Study|Progressive disease|2|||
144649877|NCT01022853|521570760|FG001|Overall Study|Progressive disease|3|||
144649878|NCT01022853|521570761|FG002|Overall Study|Progressive disease|11|||
144649879|NCT01022853|521570762|FG003|Overall Study|Progressive disease|7|||
144649880|NCT01022853|521570763|FG004|Overall Study|Progressive disease|1|||
144649881|NCT01022853|521570759|FG000|Overall Study|Dose-limiting toxicity|0|||
144211897|NCT02952586|519970405|FG000|Follow-Up Phase (90 Days)|Death|12|||
144211898|NCT02952586|519970406|FG001|Follow-Up Phase (90 Days)|Death|10|||
144649882|NCT01022853|521570760|FG001|Overall Study|Dose-limiting toxicity|0|||
144649883|NCT01022853|521570761|FG002|Overall Study|Dose-limiting toxicity|0|||
144649884|NCT01022853|521570762|FG003|Overall Study|Dose-limiting toxicity|0|||
144649885|NCT01022853|521570763|FG004|Overall Study|Dose-limiting toxicity|1|||
144649886|NCT01022853|521570759|FG000|Overall Study|Withdrawal by Subject|0|||
144649887|NCT01022853|521570760|FG001|Overall Study|Withdrawal by Subject|1|||
144649888|NCT01022853|521570761|FG002|Overall Study|Withdrawal by Subject|1|||
144649889|NCT01022853|521570762|FG003|Overall Study|Withdrawal by Subject|1|||
144649890|NCT01022853|521570763|FG004|Overall Study|Withdrawal by Subject|0|||
144649891|NCT01022853|521570759|FG000|Overall Study|Other not stated above|1|||
144649892|NCT01022853|521570760|FG001|Overall Study|Other not stated above|0|||
144649893|NCT01022853|521570761|FG002|Overall Study|Other not stated above|1|||
144211899|NCT02952586|519970405|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
144649894|NCT01022853|521570762|FG003|Overall Study|Other not stated above|0|||
144649895|NCT01022853|521570763|FG004|Overall Study|Other not stated above|0|||
144211900|NCT02952586|519970406|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
144211901|NCT02952586|519970405|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
144211902|NCT02952586|519970406|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
144649896|NCT02416908|521570764|FG000|Dose Escalation Phase|Adverse Event|0|||
144649897|NCT02416908|521570765|FG001|Dose Escalation Phase|Adverse Event|0|||
144649898|NCT02416908|521570766|FG002|Dose Escalation Phase|Adverse Event|3|||
144649899|NCT02416908|521570767|FG003|Dose Escalation Phase|Adverse Event|0|||
144649900|NCT02416908|521570764|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
144649901|NCT02416908|521570765|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
144649902|NCT02416908|521570766|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
144649903|NCT02416908|521570767|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144649904|NCT02075255|521570769|FG000|Overall Study|Study specific withdrawal criteria|0|||
144649905|NCT02075255|521570770|FG001|Overall Study|Study specific withdrawal criteria|1|||
144649906|NCT02075255|521570771|FG002|Overall Study|Study specific withdrawal criteria|1|||
144649907|NCT02075255|521570769|FG000|Overall Study|Withdrawal by Subject|4|||
144649908|NCT02075255|521570770|FG001|Overall Study|Withdrawal by Subject|1|||
144649909|NCT02075255|521570771|FG002|Overall Study|Withdrawal by Subject|0|||
144649910|NCT02075255|521570769|FG000|Overall Study|Lost to Follow-up|0|||
144649911|NCT02075255|521570770|FG001|Overall Study|Lost to Follow-up|0|||
144649912|NCT02075255|521570771|FG002|Overall Study|Lost to Follow-up|1|||
144649913|NCT02075255|521570769|FG000|Overall Study|Adverse Event|0|||
144649914|NCT02075255|521570770|FG001|Overall Study|Adverse Event|0|||
144649915|NCT02075255|521570771|FG002|Overall Study|Adverse Event|1|||
144649916|NCT02075255|521570769|FG000|Overall Study|Death|0|||
144649917|NCT02075255|521570770|FG001|Overall Study|Death|2|||
144649918|NCT02075255|521570771|FG002|Overall Study|Death|0|||
144649919|NCT03792750|521570772|FG000|Overall Study|Death|3|||
144649920|NCT01327339|521570773|FG000|Overall Study|Protocol Violation|8|||
144649921|NCT00700752|521570774|FG000|First Intervention|Withdrawal by Subject|0|||
144649922|NCT00700752|521570775|FG001|First Intervention|Withdrawal by Subject|2|||
144649923|NCT01004146|521570776|FG000|Overall Study|Withdrawal by Subject|4|||
144649924|NCT01004146|521570777|FG001|Overall Study|Withdrawal by Subject|5|||
144649925|NCT02792777|521570780|FG000|Overall Study|Withdrawal by Subject|2|||
144649926|NCT02792777|521570781|FG001|Overall Study|Withdrawal by Subject|0|||
144649927|NCT02792777|521570780|FG000|Overall Study|Recording malfunction|2|||
144649928|NCT02792777|521570781|FG001|Overall Study|Recording malfunction|0|||
144649929|NCT02792777|521570780|FG000|Overall Study|Later determined to be ineligible|2|||
144649930|NCT02792777|521570781|FG001|Overall Study|Later determined to be ineligible|0|||
144649931|NCT02792777|521570780|FG000|Overall Study|Participant interviewed twice|1|||
144649932|NCT02792777|521570781|FG001|Overall Study|Participant interviewed twice|0|||
144649933|NCT03575468|521570782|FG000|Overall Study|Withdrawal by Subject|3|||
144649934|NCT03575468|521570783|FG001|Overall Study|Withdrawal by Subject|0|||
144649935|NCT03575468|521570782|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
144649936|NCT03575468|521570783|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
144649937|NCT03575468|521570782|FG000|Overall Study|Lost to Follow-up|13|||
144649938|NCT03575468|521570783|FG001|Overall Study|Lost to Follow-up|17|||
144649939|NCT05270694|521572483|FG000|Overall Study|Death|1|||
144649940|NCT05270694|521572483|FG000|Overall Study|Medical issues impacted ability to participate|2|||
144649941|NCT05270694|521572483|FG000|Overall Study|Lost to Follow-up|3|||
144649942|NCT05270694|521572483|FG000|Overall Study|Withdrawal by Subject|3|||
144649943|NCT02855411|521572497|FG000|Overall Study|Study terminated by sponsor|21|||
144649944|NCT02855411|521572497|FG000|Overall Study|Does not meet entrance criteria|14|||
144649945|NCT01372878|521572500|FG000|Overall Study|Withdrawal by Subject|63|||
144649946|NCT01372878|521572500|FG000|Overall Study|Protocol Violation|17|||
144649947|NCT01372878|521572500|FG000|Overall Study|incomplete study procedure|104|||
144649948|NCT02616029|521572501|FG000|Overall Study|Adverse Event|1|||
144649949|NCT02616029|521572502|FG001|Overall Study|Adverse Event|0|||
144649950|NCT02616029|521572501|FG000|Overall Study|Death|0|||
144649951|NCT02616029|521572502|FG001|Overall Study|Death|1|||
144649952|NCT02616029|521572501|FG000|Overall Study|Protocol Violation|1|||
144649953|NCT02616029|521572502|FG001|Overall Study|Protocol Violation|0|||
144649954|NCT02616029|521572501|FG000|Overall Study|Withdrew Consent|1|||
144649955|NCT02616029|521572502|FG001|Overall Study|Withdrew Consent|0|||
144211903|NCT02952586|519970405|FG000|Follow-Up Phase (90 Days)|Other|7|||
144649956|NCT02616029|521572501|FG000|Overall Study|Enrolled and Never Treated|1|||
144649957|NCT02616029|521572502|FG001|Overall Study|Enrolled and Never Treated|1|||
144649958|NCT03215264|521572503|FG000|Dose Level 2|Adverse Event|0|||
144649959|NCT03215264|521572504|FG001|Dose Level 2|Adverse Event|1|||
144649960|NCT03215264|521572505|FG002|Dose Level 2|Adverse Event|0|||
144649961|NCT03215264|521572503|FG000|Dose Level 3|Withdrawal by Subject|0|||
144649962|NCT03215264|521572504|FG001|Dose Level 3|Withdrawal by Subject|0|||
144649963|NCT03215264|521572505|FG002|Dose Level 3|Withdrawal by Subject|1|||
144211904|NCT02952586|519970406|FG001|Follow-Up Phase (90 Days)|Other|5|||
144211905|NCT02952586|519970405|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
144211906|NCT02952586|519970406|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
144211907|NCT02952586|519970405|FG000|LT Follow-up (up to 45 Months)|Death|51|||
144211908|NCT02952586|519970406|FG001|LT Follow-up (up to 45 Months)|Death|31|||
144211909|NCT02952586|519970405|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
144211910|NCT02952586|519970406|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
144211911|NCT02952586|519970405|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
144211912|NCT02952586|519970406|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
144211913|NCT02952586|519970405|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
144649964|NCT02145156|521572507|FG000|Overall Study|No match to vaccination records|60|||
144649965|NCT02145156|521572508|FG001|Overall Study|No match to vaccination records|52|||
144649966|NCT02145156|521572509|FG002|Overall Study|No match to vaccination records|41|||
144649967|NCT02064439|521572510|FG000|Overall Study|Adverse Event|51|||
144649968|NCT02064439|521572511|FG001|Overall Study|Adverse Event|47|||
144649969|NCT02064439|521572512|FG002|Overall Study|Adverse Event|46|||
144649970|NCT02064439|521572510|FG000|Overall Study|Death|0|||
144649971|NCT02064439|521572511|FG001|Overall Study|Death|2|||
144649972|NCT02064439|521572512|FG002|Overall Study|Death|3|||
144649973|NCT02064439|521572510|FG000|Overall Study|Withdrawal by Subject|29|||
144649974|NCT02064439|521572511|FG001|Overall Study|Withdrawal by Subject|18|||
144649975|NCT02064439|521572512|FG002|Overall Study|Withdrawal by Subject|26|||
144649976|NCT02064439|521572510|FG000|Overall Study|Protocol Violation|3|||
144649977|NCT02064439|521572511|FG001|Overall Study|Protocol Violation|5|||
144649978|NCT02064439|521572512|FG002|Overall Study|Protocol Violation|3|||
144649979|NCT02064439|521572510|FG000|Overall Study|Lost to Follow-up|1|||
144649980|NCT02064439|521572511|FG001|Overall Study|Lost to Follow-up|3|||
144649981|NCT02064439|521572512|FG002|Overall Study|Lost to Follow-up|4|||
144649982|NCT02064439|521572510|FG000|Overall Study|Non-compliance with study medication|21|||
144649983|NCT02064439|521572511|FG001|Overall Study|Non-compliance with study medication|19|||
144649984|NCT02064439|521572512|FG002|Overall Study|Non-compliance with study medication|23|||
144649985|NCT02064439|521572510|FG000|Overall Study|Physician Decision|0|||
144649986|NCT02064439|521572511|FG001|Overall Study|Physician Decision|1|||
144649987|NCT02064439|521572512|FG002|Overall Study|Physician Decision|1|||
144649988|NCT02064439|521572510|FG000|Overall Study|Logistical difficulties|6|||
144649989|NCT02064439|521572511|FG001|Overall Study|Logistical difficulties|5|||
144649990|NCT02064439|521572512|FG002|Overall Study|Logistical difficulties|2|||
144649991|NCT02064439|521572510|FG000|Overall Study|Efficacy outcome reached|18|||
144649992|NCT02064439|521572511|FG001|Overall Study|Efficacy outcome reached|16|||
144211914|NCT02952586|519970406|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
144211915|NCT00492778|519970407|FG000|Overall Study|Ineligible by Pathology Review|8|||
144211916|NCT00492778|519970408|FG001|Overall Study|Ineligible by Pathology Review|1|||
144211917|NCT03717012|519970409|FG000|Overall Study|Due to trial termination|1|||
144211918|NCT03717012|519970410|FG001|Overall Study|Due to trial termination|2|||
144211919|NCT03717012|519970409|FG000|Overall Study|Protocol Violation|0|||
144211920|NCT03717012|519970410|FG001|Overall Study|Protocol Violation|2|||
144211921|NCT03717012|519970409|FG000|Overall Study|Adverse Event|0|||
144211922|NCT03717012|519970410|FG001|Overall Study|Adverse Event|1|||
144211923|NCT03717012|519970409|FG000|Overall Study|Lung transplant|0|||
144211924|NCT03717012|519970410|FG001|Overall Study|Lung transplant|1|||
144211925|NCT00789035|519970411|FG000|Overall Study|Adverse Event|0|||
144211926|NCT00789035|519970412|FG001|Overall Study|Adverse Event|2|||
144211927|NCT00789035|519970413|FG002|Overall Study|Adverse Event|0|||
144211928|NCT00789035|519970414|FG003|Overall Study|Adverse Event|1|||
144211929|NCT00789035|519970415|FG004|Overall Study|Adverse Event|3|||
144211930|NCT00789035|519970411|FG000|Overall Study|Lack of Efficacy|3|||
144211931|NCT00789035|519970412|FG001|Overall Study|Lack of Efficacy|0|||
144211932|NCT00789035|519970413|FG002|Overall Study|Lack of Efficacy|0|||
144649993|NCT02064439|521572512|FG002|Overall Study|Efficacy outcome reached|57|||
144649994|NCT02064439|521572510|FG000|Overall Study|Safety outcome reached|12|||
144211933|NCT00789035|519970414|FG003|Overall Study|Lack of Efficacy|0|||
144649995|NCT02064439|521572511|FG001|Overall Study|Safety outcome reached|20|||
144211934|NCT00789035|519970415|FG004|Overall Study|Lack of Efficacy|2|||
144211935|NCT00789035|519970411|FG000|Overall Study|Protocol Violation|1|||
144211936|NCT00789035|519970412|FG001|Overall Study|Protocol Violation|0|||
144211937|NCT00789035|519970413|FG002|Overall Study|Protocol Violation|0|||
144211938|NCT00789035|519970414|FG003|Overall Study|Protocol Violation|0|||
144211939|NCT00789035|519970415|FG004|Overall Study|Protocol Violation|0|||
144211940|NCT00789035|519970411|FG000|Overall Study|Withdrawal by Subject|0|||
144211941|NCT00789035|519970412|FG001|Overall Study|Withdrawal by Subject|2|||
144211942|NCT00789035|519970413|FG002|Overall Study|Withdrawal by Subject|0|||
144649996|NCT02064439|521572512|FG002|Overall Study|Safety outcome reached|10|||
144211943|NCT00789035|519970414|FG003|Overall Study|Withdrawal by Subject|0|||
144211944|NCT00789035|519970415|FG004|Overall Study|Withdrawal by Subject|0|||
144211945|NCT00789035|519970411|FG000|Overall Study|Other reason not defined above|2|||
144649997|NCT02064439|521572510|FG000|Overall Study|Other|2|||
144649998|NCT02064439|521572511|FG001|Overall Study|Other|2|||
144649999|NCT02064439|521572512|FG002|Overall Study|Other|7|||
144650000|NCT02433288|521572513|FG000|Overall Study|Severe non-compliance to protocol|13|||
144650001|NCT02433288|521572514|FG001|Overall Study|Severe non-compliance to protocol|7|||
144650002|NCT02433288|521572513|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
144650003|NCT02433288|521572514|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
144650004|NCT02433288|521572513|FG000|Overall Study|Withdrawal by Subject|101|||
144650005|NCT02433288|521572514|FG001|Overall Study|Withdrawal by Subject|99|||
144650006|NCT02433288|521572513|FG000|Overall Study|Lost to Follow-up|2|||
144650007|NCT02433288|521572514|FG001|Overall Study|Lost to Follow-up|14|||
144650008|NCT02433288|521572513|FG000|Overall Study|Death|0|||
144650009|NCT02433288|521572514|FG001|Overall Study|Death|3|||
144650010|NCT03350750|521572515|FG000|Overall Study|Death|1|||
144650011|NCT03350750|521572516|FG001|Overall Study|Death|1|||
144650012|NCT01849250|521572517|FG000|Overall Study|Withdrawal by Subject|1|||
144650013|NCT01849250|521572518|FG001|Overall Study|Withdrawal by Subject|0|||
144650014|NCT01849250|521572517|FG000|Overall Study|Not Evaluable|5|||
144650015|NCT01849250|521572518|FG001|Overall Study|Not Evaluable|3|||
144650016|NCT01849250|521572517|FG000|Overall Study|Screen Failure|1|||
144650017|NCT01849250|521572518|FG001|Overall Study|Screen Failure|0|||
144650018|NCT04504032|521572520|FG000|Overall Study|Adverse Event|1|||
144650019|NCT04504032|521572521|FG001|Overall Study|Adverse Event|2|||
144650020|NCT04504032|521572520|FG000|Overall Study|Lost to Follow-up|6|||
144650021|NCT04504032|521572521|FG001|Overall Study|Lost to Follow-up|9|||
144650022|NCT04504032|521572520|FG000|Overall Study|Protocol Violation|2|||
144650023|NCT04504032|521572521|FG001|Overall Study|Protocol Violation|0|||
144650024|NCT04504032|521572520|FG000|Overall Study|Study terminated by sponsor|1|||
144650025|NCT04504032|521572521|FG001|Overall Study|Study terminated by sponsor|2|||
144650026|NCT04504032|521572520|FG000|Overall Study|Withdrawal by Subject|9|||
144650027|NCT04504032|521572521|FG001|Overall Study|Withdrawal by Subject|11|||
144650028|NCT04504032|521572520|FG000|Overall Study|Disease progression prior to dosing|15|||
144650029|NCT04504032|521572521|FG001|Overall Study|Disease progression prior to dosing|3|||
144650030|NCT04504032|521572520|FG000|Overall Study|Drug supply issues|1|||
144650031|NCT04504032|521572521|FG001|Overall Study|Drug supply issues|1|||
144650032|NCT04504032|521572520|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
144650033|NCT04504032|521572521|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
144650034|NCT02795767|521572524|FG000|Overall Study|Received Commercial Emicizumab|1|||
144650035|NCT02795767|521572525|FG001|Overall Study|Received Commercial Emicizumab|0|||
144650036|NCT02795767|521572526|FG002|Overall Study|Received Commercial Emicizumab|0|||
144650037|NCT03964415|521572531|FG000|Overall Study|Sponsor's decision|1563|||
144650038|NCT03964415|521572532|FG001|Overall Study|Sponsor's decision|1528|||
144650039|NCT03964415|521572531|FG000|Overall Study|Lost to Follow-up|139|||
144650040|NCT03964415|521572532|FG001|Overall Study|Lost to Follow-up|146|||
144650041|NCT03964415|521572531|FG000|Overall Study|Withdrawal by Subject|68|||
144650042|NCT03964415|521572532|FG001|Overall Study|Withdrawal by Subject|72|||
144650043|NCT03964415|521572531|FG000|Overall Study|Physician Decision|34|||
144650044|NCT03964415|521572532|FG001|Overall Study|Physician Decision|48|||
144650045|NCT03964415|521572531|FG000|Overall Study|Adverse Event|3|||
144650046|NCT03964415|521572532|FG001|Overall Study|Adverse Event|0|||
144650047|NCT03964415|521572531|FG000|Overall Study|Death|4|||
144650048|NCT03964415|521572532|FG001|Overall Study|Death|6|||
144650049|NCT03964415|521572531|FG000|Overall Study|Protocol Violation|1|||
144650050|NCT03964415|521572532|FG001|Overall Study|Protocol Violation|4|||
144650051|NCT03964415|521572531|FG000|Overall Study|Other|35|||
144650052|NCT03964415|521572532|FG001|Overall Study|Other|38|||
144650053|NCT03964415|521572531|FG000|Overall Study|Randomized but not treated|6|||
144650054|NCT03964415|521572532|FG001|Overall Study|Randomized but not treated|7|||
144650055|NCT01302769|521572533|FG000|Overall Study|Lost to Follow-up|1|||
144650056|NCT01302769|521572534|FG001|Overall Study|Lost to Follow-up|1|||
144650057|NCT01426386|521572543|FG000|Overall Study|Adverse Event|0|||
144650058|NCT01426386|521572544|FG001|Overall Study|Adverse Event|1|||
144650059|NCT01426386|521572545|FG002|Overall Study|Adverse Event|0|||
144650060|NCT01426386|521572546|FG003|Overall Study|Adverse Event|0|||
144650061|NCT01426386|521572547|FG004|Overall Study|Adverse Event|0|||
144650062|NCT01426386|521572548|FG005|Overall Study|Adverse Event|0|||
144650063|NCT01426386|521572543|FG000|Overall Study|Did not attend scheduled visit|1|||
144650064|NCT01426386|521572544|FG001|Overall Study|Did not attend scheduled visit|4|||
144650065|NCT01426386|521572545|FG002|Overall Study|Did not attend scheduled visit|0|||
144650066|NCT01426386|521572546|FG003|Overall Study|Did not attend scheduled visit|0|||
144650067|NCT01426386|521572547|FG004|Overall Study|Did not attend scheduled visit|2|||
144650068|NCT01426386|521572548|FG005|Overall Study|Did not attend scheduled visit|1|||
144650069|NCT01426386|521572543|FG000|Overall Study|Poor response|2|||
144650070|NCT01426386|521572544|FG001|Overall Study|Poor response|1|||
144650071|NCT01426386|521572545|FG002|Overall Study|Poor response|2|||
144650072|NCT01426386|521572546|FG003|Overall Study|Poor response|0|||
144650073|NCT01426386|521572547|FG004|Overall Study|Poor response|1|||
144650074|NCT01426386|521572548|FG005|Overall Study|Poor response|0|||
144650075|NCT01426386|521572543|FG000|Overall Study|Personal reasons|0|||
144650076|NCT01426386|521572544|FG001|Overall Study|Personal reasons|0|||
144650077|NCT01426386|521572545|FG002|Overall Study|Personal reasons|0|||
144650078|NCT01426386|521572546|FG003|Overall Study|Personal reasons|0|||
144650079|NCT01426386|521572547|FG004|Overall Study|Personal reasons|1|||
144650080|NCT01426386|521572548|FG005|Overall Study|Personal reasons|0|||
144650081|NCT03694522|521572550|FG000|Overall Study|Withdrawal by Subject|8|||
144650082|NCT03694522|521572551|FG001|Overall Study|Withdrawal by Subject|10|||
144650083|NCT03694522|521572550|FG000|Overall Study|Physician Decision|53|||
144650084|NCT03694522|521572551|FG001|Overall Study|Physician Decision|54|||
144650085|NCT03694522|521572550|FG000|Overall Study|Other|1|||
144650086|NCT03694522|521572551|FG001|Overall Study|Other|1|||
144650087|NCT03694522|521572550|FG000|Overall Study|Lost to Follow-up|0|||
144650088|NCT03694522|521572551|FG001|Overall Study|Lost to Follow-up|1|||
144650089|NCT02760407|521572552|FG000|Overall Study|Death|2|||
144650090|NCT02760407|521572553|FG001|Overall Study|Death|3|||
144650091|NCT02760407|521572554|FG002|Overall Study|Death|1|||
144650092|NCT02760407|521572555|FG003|Overall Study|Death|1|||
144650093|NCT02760407|521572552|FG000|Overall Study|Lost to Follow-up|1|||
144650094|NCT02760407|521572553|FG001|Overall Study|Lost to Follow-up|7|||
144650095|NCT02760407|521572554|FG002|Overall Study|Lost to Follow-up|4|||
144650096|NCT02760407|521572555|FG003|Overall Study|Lost to Follow-up|6|||
144650097|NCT02760407|521572552|FG000|Overall Study|Withdrawal by Subject|25|||
144650098|NCT02760407|521572553|FG001|Overall Study|Withdrawal by Subject|31|||
144650099|NCT02760407|521572554|FG002|Overall Study|Withdrawal by Subject|37|||
144650100|NCT02760407|521572555|FG003|Overall Study|Withdrawal by Subject|25|||
144650101|NCT02760407|521572552|FG000|Overall Study|Violation of Eligibility criteria|0|||
144650102|NCT02760407|521572553|FG001|Overall Study|Violation of Eligibility criteria|0|||
144650103|NCT02760407|521572554|FG002|Overall Study|Violation of Eligibility criteria|1|||
144650104|NCT02760407|521572555|FG003|Overall Study|Violation of Eligibility criteria|1|||
144650105|NCT02760407|521572552|FG000|Overall Study|Personal reasons|0|||
144650106|NCT02760407|521572553|FG001|Overall Study|Personal reasons|0|||
144650107|NCT02760407|521572554|FG002|Overall Study|Personal reasons|0|||
144650108|NCT02760407|521572555|FG003|Overall Study|Personal reasons|1|||
144650109|NCT02760407|521572552|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
144650110|NCT02760407|521572553|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
144650111|NCT02760407|521572554|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
144650112|NCT02760407|521572555|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
144650113|NCT02760407|521572552|FG000|Overall Study|Use of prohibited Medication|0|||
144650114|NCT02760407|521572553|FG001|Overall Study|Use of prohibited Medication|0|||
144650115|NCT02760407|521572554|FG002|Overall Study|Use of prohibited Medication|1|||
144650116|NCT02760407|521572555|FG003|Overall Study|Use of prohibited Medication|0|||
144650117|NCT02760407|521572552|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
144650118|NCT02760407|521572553|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
144650119|NCT02760407|521572554|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
144650120|NCT02760407|521572555|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
144650121|NCT02760407|521572552|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
144650122|NCT02760407|521572553|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
144650123|NCT02760407|521572554|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
144650124|NCT02760407|521572555|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
144650125|NCT02760407|521572552|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
144650126|NCT02760407|521572553|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
144650127|NCT02760407|521572554|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
144650128|NCT02760407|521572555|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
144650129|NCT02760407|521572552|FG000|Overall Study|Inadequately Enrolled|0|||
144650130|NCT02760407|521572553|FG001|Overall Study|Inadequately Enrolled|0|||
144650131|NCT02760407|521572554|FG002|Overall Study|Inadequately Enrolled|0|||
144650132|NCT02760407|521572555|FG003|Overall Study|Inadequately Enrolled|1|||
144650133|NCT02760407|521572552|FG000|Overall Study|Withdrawal By PI's Decision|0|||
144650134|NCT02760407|521572553|FG001|Overall Study|Withdrawal By PI's Decision|1|||
144650135|NCT02760407|521572554|FG002|Overall Study|Withdrawal By PI's Decision|0|||
144650136|NCT02760407|521572555|FG003|Overall Study|Withdrawal By PI's Decision|0|||
144650137|NCT02760407|521572552|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
144650138|NCT02760407|521572553|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
144650139|NCT02760407|521572554|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
144211946|NCT00789035|519970412|FG001|Overall Study|Other reason not defined above|3|||
144211947|NCT00789035|519970413|FG002|Overall Study|Other reason not defined above|1|||
144211948|NCT00789035|519970414|FG003|Overall Study|Other reason not defined above|0|||
144650140|NCT02760407|521572555|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
144700136|NCT00948896|521754508|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
144263351|NCT00509899|520165418|FG004|Overall Study|Unacceptable Toxicity|0|||
144263352|NCT00509899|520165419|FG005|Overall Study|Unacceptable Toxicity|0|||
144650141|NCT02760407|521572552|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
144650142|NCT02760407|521572553|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
144650143|NCT02760407|521572554|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
144650144|NCT02760407|521572555|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
144650145|NCT02760407|521572552|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
144650146|NCT02760407|521572553|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
144650147|NCT02760407|521572554|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
144650148|NCT02760407|521572555|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
144650149|NCT02760407|521572552|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
144650150|NCT02760407|521572553|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
144650151|NCT02760407|521572554|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
144650152|NCT02760407|521572555|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
144650153|NCT02760407|521572552|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
144650154|NCT02760407|521572553|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
144650155|NCT02760407|521572554|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
144650156|NCT02760407|521572555|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
144650157|NCT02760407|521572552|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
144650158|NCT02760407|521572553|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
144650159|NCT02760407|521572554|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
144650160|NCT02760407|521572555|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
144650161|NCT02760407|521572552|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
144650162|NCT02760407|521572553|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
144650163|NCT02760407|521572554|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
144650164|NCT02760407|521572555|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
144650165|NCT02760407|521572552|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
144650166|NCT02760407|521572553|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
144650167|NCT02760407|521572554|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
144650168|NCT02760407|521572555|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
144650169|NCT02760407|521572552|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
144650170|NCT02760407|521572553|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
144650171|NCT02760407|521572554|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
144650172|NCT02760407|521572555|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
144650173|NCT02522377|521572556|FG000|Overall Study|Withdrawal by Subject|1|||
144650174|NCT02522377|521572557|FG001|Overall Study|Withdrawal by Subject|0|||
144650175|NCT02522377|521572556|FG000|Overall Study|Remission Achieved|3|||
144650176|NCT02522377|521572557|FG001|Overall Study|Remission Achieved|0|||
144650177|NCT01158950|521572558|FG000|1st Intervention (1 Day)|Physician Decision|1|||
144650178|NCT01158950|521572559|FG001|1st Intervention (1 Day)|Physician Decision|2|||
144650179|NCT02116972|521572562|FG000|Overall Study|Adverse Event|4|||
144650180|NCT02116972|521572563|FG001|Overall Study|Adverse Event|4|||
144650181|NCT02116972|521572564|FG002|Overall Study|Adverse Event|1|||
144650182|NCT02116972|521572562|FG000|Overall Study|Withdrawal by Subject|1|||
144650183|NCT02116972|521572563|FG001|Overall Study|Withdrawal by Subject|1|||
144650184|NCT02116972|521572564|FG002|Overall Study|Withdrawal by Subject|5|||
144650185|NCT02116972|521572562|FG000|Overall Study|Protocol Violation|1|||
144650186|NCT02116972|521572563|FG001|Overall Study|Protocol Violation|0|||
144650187|NCT02116972|521572564|FG002|Overall Study|Protocol Violation|1|||
144650188|NCT02116972|521572562|FG000|Overall Study|Lost to Follow-up|4|||
144650189|NCT02116972|521572563|FG001|Overall Study|Lost to Follow-up|3|||
144650190|NCT02116972|521572564|FG002|Overall Study|Lost to Follow-up|1|||
144650191|NCT02116972|521572562|FG000|Overall Study|Lack of Efficacy|6|||
144650192|NCT02116972|521572563|FG001|Overall Study|Lack of Efficacy|6|||
144650193|NCT02116972|521572564|FG002|Overall Study|Lack of Efficacy|5|||
144650194|NCT02116972|521572562|FG000|Overall Study|scheduling conflicts and relocation|3|||
144650195|NCT02116972|521572563|FG001|Overall Study|scheduling conflicts and relocation|3|||
144650196|NCT02116972|521572564|FG002|Overall Study|scheduling conflicts and relocation|6|||
144650197|NCT00784784|521572565|FG000|Overall Study|Withdrawal by Subject|2|||
144650198|NCT00784784|521572566|FG001|Overall Study|Withdrawal by Subject|2|||
144650199|NCT01797432|521572568|FG000|Overall Study|Lost to Follow-up|1|||
144650200|NCT01797432|521572568|FG000|Overall Study|Adverse Event|1|||
144650201|NCT01797432|521572568|FG000|Overall Study|Withdrawal by Subject|1|||
144650202|NCT01797432|521572568|FG000|Overall Study|lived too far from study site|1|||
144263353|NCT00509899|520165420|FG006|Overall Study|Unacceptable Toxicity|0|||
144211949|NCT00789035|519970415|FG004|Overall Study|Other reason not defined above|1|||
144211950|NCT00658879|519970416|FG000|Overall Study|Protocol Violation|1|||
144211951|NCT02640690|519970419|FG000|Overall Study|Lost to Follow-up|7|||
144211952|NCT02640690|519970420|FG001|Overall Study|Lost to Follow-up|7|||
144211953|NCT02640690|519970419|FG000|Overall Study|Withdrawal by Subject|16|||
144650203|NCT02795156|521572569|FG000|Overall Study|Progressive Disease|22|||
144650204|NCT02795156|521572570|FG001|Overall Study|Progressive Disease|7|||
144650205|NCT02795156|521572571|FG002|Overall Study|Progressive Disease|34|||
144650206|NCT02795156|521572572|FG003|Overall Study|Progressive Disease|7|||
144650207|NCT02795156|521572569|FG000|Overall Study|Adverse Event|13|||
144650208|NCT02795156|521572570|FG001|Overall Study|Adverse Event|2|||
144650209|NCT02795156|521572571|FG002|Overall Study|Adverse Event|3|||
144650210|NCT02795156|521572572|FG003|Overall Study|Adverse Event|2|||
144650211|NCT02795156|521572569|FG000|Overall Study|Death|1|||
144650212|NCT02795156|521572570|FG001|Overall Study|Death|1|||
144650213|NCT02795156|521572571|FG002|Overall Study|Death|1|||
144650214|NCT02795156|521572572|FG003|Overall Study|Death|0|||
144650215|NCT02795156|521572569|FG000|Overall Study|Physician Decision|1|||
144650216|NCT02795156|521572570|FG001|Overall Study|Physician Decision|0|||
144650217|NCT02795156|521572571|FG002|Overall Study|Physician Decision|1|||
144650218|NCT02795156|521572572|FG003|Overall Study|Physician Decision|0|||
144650219|NCT02795156|521572569|FG000|Overall Study|Withdrawal by Subject|2|||
144650220|NCT02795156|521572570|FG001|Overall Study|Withdrawal by Subject|0|||
144650221|NCT02795156|521572571|FG002|Overall Study|Withdrawal by Subject|3|||
144650222|NCT02795156|521572572|FG003|Overall Study|Withdrawal by Subject|0|||
144650223|NCT00492921|521572573|FG000|Overall Study|Death|1|||
144650224|NCT00492921|521572574|FG001|Overall Study|Death|0|||
144650225|NCT00492921|521572575|FG002|Overall Study|Death|1|||
144650226|NCT00652093|521572576|FG000|Overall Study|Withdrawal by Subject|0|||
144650227|NCT00652093|521572577|FG001|Overall Study|Withdrawal by Subject|0|||
144650228|NCT00652093|521572578|FG002|Overall Study|Withdrawal by Subject|1|||
144650229|NCT00652093|521572579|FG003|Overall Study|Withdrawal by Subject|0|||
144650230|NCT00652093|521572580|FG004|Overall Study|Withdrawal by Subject|1|||
144650231|NCT00652093|521572581|FG005|Overall Study|Withdrawal by Subject|0|||
144650232|NCT00652093|521572576|FG000|Overall Study|Physician Decision|0|||
144650233|NCT00652093|521572577|FG001|Overall Study|Physician Decision|0|||
144650234|NCT00652093|521572578|FG002|Overall Study|Physician Decision|0|||
144650235|NCT00652093|521572579|FG003|Overall Study|Physician Decision|0|||
144650236|NCT00652093|521572580|FG004|Overall Study|Physician Decision|1|||
144650237|NCT00652093|521572581|FG005|Overall Study|Physician Decision|0|||
144650238|NCT01422304|521572582|FG000|Overall Study|Adverse Event|0|||
144650239|NCT01422304|521572583|FG001|Overall Study|Adverse Event|1|||
144650240|NCT01422304|521572582|FG000|Overall Study|Lost to Follow-up|14|||
144650241|NCT01422304|521572583|FG001|Overall Study|Lost to Follow-up|20|||
144650242|NCT01422304|521572582|FG000|Overall Study|Never Entered Follow-up|2|||
144650243|NCT01422304|521572583|FG001|Overall Study|Never Entered Follow-up|1|||
144650244|NCT01422304|521572582|FG000|Overall Study|Protocol Violation|1|||
144650245|NCT01422304|521572583|FG001|Overall Study|Protocol Violation|0|||
144650246|NCT01422304|521572582|FG000|Overall Study|Withdrawal by Subject|4|||
144650247|NCT01422304|521572583|FG001|Overall Study|Withdrawal by Subject|2|||
144650248|NCT01422304|521572582|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
144650249|NCT01422304|521572583|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
144650250|NCT01422304|521572582|FG000|Overall Study|Not Treated|3|||
144650251|NCT01422304|521572583|FG001|Overall Study|Not Treated|11|||
144650252|NCT02961764|521572586|FG000|Overall Study|Protocol Violation|0|||
144650253|NCT02961764|521572587|FG001|Overall Study|Protocol Violation|1|||
144650254|NCT02961764|521572586|FG000|Overall Study|Death|2|||
144650255|NCT02961764|521572587|FG001|Overall Study|Death|0|||
144650256|NCT02961764|521572586|FG000|Overall Study|Lost to Follow-up|35|||
144650257|NCT02961764|521572587|FG001|Overall Study|Lost to Follow-up|24|||
144650258|NCT02961764|521572586|FG000|Overall Study|Withdrawal by Subject|2|||
144211954|NCT02640690|519970420|FG001|Overall Study|Withdrawal by Subject|20|||
144650259|NCT02961764|521572587|FG001|Overall Study|Withdrawal by Subject|0|||
144650260|NCT00469014|521572588|FG000|Initial Phase Randomization|Disease Progression|0|||
144650261|NCT00469014|521572589|FG001|Initial Phase Randomization|Disease Progression|1|||
144650262|NCT00469014|521572590|FG002|Initial Phase Randomization|Disease Progression|1|||
144650263|NCT00469014|521572591|FG003|Initial Phase Randomization|Disease Progression|0|||
144650264|NCT00469014|521572588|FG000|Initial Phase Randomization|No Response|1|||
144650265|NCT00469014|521572589|FG001|Initial Phase Randomization|No Response|0|||
144731698|NCT01214850|521873245|FG000|Overall Study|Administrative reason|1|||
144650266|NCT00469014|521572590|FG002|Initial Phase Randomization|No Response|0|||
144650267|NCT00469014|521572591|FG003|Initial Phase Randomization|No Response|1|||
144650268|NCT00469014|521572588|FG000|Adaptive Randomization|Not Evaluable|1|||
144650269|NCT00469014|521572589|FG001|Adaptive Randomization|Not Evaluable|0|||
144650270|NCT00469014|521572590|FG002|Adaptive Randomization|Not Evaluable|0|||
144650271|NCT00469014|521572591|FG003|Adaptive Randomization|Not Evaluable|1|||
144650272|NCT00469014|521572588|FG000|Adaptive Randomization|No Response|0|||
144211955|NCT02640690|519970419|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
144650273|NCT00469014|521572589|FG001|Adaptive Randomization|No Response|1|||
144650274|NCT00469014|521572590|FG002|Adaptive Randomization|No Response|0|||
144650275|NCT00469014|521572591|FG003|Adaptive Randomization|No Response|0|||
144650276|NCT00469014|521572588|FG000|Adaptive Randomization|Death|0|||
144650277|NCT00469014|521572589|FG001|Adaptive Randomization|Death|0|||
144650278|NCT00469014|521572590|FG002|Adaptive Randomization|Death|1|||
144650279|NCT00469014|521572591|FG003|Adaptive Randomization|Death|0|||
144650280|NCT03461289|521572597|FG000|Overall Study|Death|1|||
144650281|NCT00866294|521572598|FG000|Overall Study|Adverse Event|12|||
144650282|NCT00866294|521572599|FG001|Overall Study|Adverse Event|13|||
144650283|NCT00866294|521572600|FG002|Overall Study|Adverse Event|9|||
144650284|NCT00866294|521572598|FG000|Overall Study|Lack of Efficacy|7|||
144650285|NCT00866294|521572599|FG001|Overall Study|Lack of Efficacy|1|||
144650286|NCT00866294|521572600|FG002|Overall Study|Lack of Efficacy|0|||
144650287|NCT00866294|521572598|FG000|Overall Study|Protocol Violation|2|||
144650288|NCT00866294|521572599|FG001|Overall Study|Protocol Violation|0|||
144650289|NCT00866294|521572600|FG002|Overall Study|Protocol Violation|0|||
144650290|NCT00866294|521572598|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
144650291|NCT00866294|521572599|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144650292|NCT00866294|521572600|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
144650293|NCT00866294|521572598|FG000|Overall Study|Lost to Follow-up|1|||
144650294|NCT00866294|521572599|FG001|Overall Study|Lost to Follow-up|3|||
144650295|NCT00866294|521572600|FG002|Overall Study|Lost to Follow-up|0|||
144650296|NCT00866294|521572598|FG000|Overall Study|Physician Decision|6|||
144650297|NCT00866294|521572599|FG001|Overall Study|Physician Decision|2|||
144650298|NCT00866294|521572600|FG002|Overall Study|Physician Decision|1|||
144650299|NCT02119104|521572601|FG000|Overall Study|Protocol Violation|16|||
144650300|NCT01632878|521572603|FG000|Screening|Physician Decision|268|||
144650301|NCT01632878|521572603|FG000|Treatment|Lost to Follow-up|41|||
144650302|NCT01632878|521572603|FG000|Treatment|Withdrawal by Subject|36|||
144650303|NCT01632878|521572603|FG000|Treatment|Physician Decision|34|||
144650304|NCT01632878|521572603|FG000|Treatment|missing information|4|||
144650305|NCT01632878|521572603|FG000|Treatment|no information on study completion|43|||
144650306|NCT02698423|521572604|FG000|Overall Study|Lost to Follow-up|19|||
144650307|NCT02698423|521572605|FG001|Overall Study|Lost to Follow-up|24|||
144650308|NCT00081289|521572608|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
144650309|NCT00081289|521572609|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
144650310|NCT00081289|521572608|FG000|Overall Study|Ineligible / no protocol treatment|3|||
144650311|NCT00081289|521572609|FG001|Overall Study|Ineligible / no protocol treatment|4|||
144650312|NCT02508701|521572612|FG000|Overall Study|Lost to Follow-up|9|||
144650313|NCT02508701|521572613|FG001|Overall Study|Lost to Follow-up|5|||
144650314|NCT02508701|521572614|FG002|Overall Study|Lost to Follow-up|5|||
144650315|NCT02508701|521572615|FG003|Overall Study|Lost to Follow-up|3|||
144650316|NCT00530712|521572617|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
144650317|NCT00530712|521572617|FG000|30 Day Follow-up Visit|Missed Visit|5|||
144650318|NCT00530712|521572617|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
144650319|NCT00530712|521572617|FG000|6 Month Follow-up Visit|Missed Visit|3|||
144650320|NCT00530712|521572617|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
144650321|NCT00530712|521572617|FG000|6 Month Follow-up Visit|Death|2|||
144650322|NCT00530712|521572617|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
144650323|NCT00530712|521572617|FG000|12 Month Follow-up Visit|Missed Visit|3|||
144650324|NCT00530712|521572617|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
144650325|NCT00530712|521572617|FG000|12 Month Follow-up Visit|Death|9|||
144650326|NCT02260193|521572627|FG000|Overall Study|Lack of Efficacy|0|||
144211956|NCT02640690|519970420|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
144211957|NCT01520870|519970421|FG000|Overall Study|Withdrawal by Subject|2|||
144211958|NCT01118975|519970422|FG000|Overall Study|Adverse Event|0|||
144211959|NCT01118975|519970423|FG001|Overall Study|Adverse Event|1|||
144211960|NCT01645787|519970424|FG000|Washout (2 Weeks)|Adverse Event|1|||
144211961|NCT01645787|519970425|FG001|Washout (2 Weeks)|Adverse Event|0|||
144211962|NCT02620579|519970426|FG000|Overall Study|Physician Decision|0|||
144211963|NCT02620579|519970427|FG001|Overall Study|Physician Decision|0|||
144211964|NCT02620579|519970428|FG002|Overall Study|Physician Decision|0|||
144211965|NCT02620579|519970429|FG003|Overall Study|Physician Decision|1|||
144650327|NCT02260193|521572628|FG001|Overall Study|Lack of Efficacy|1|||
144650328|NCT02260193|521572629|FG002|Overall Study|Lack of Efficacy|6|||
144650329|NCT02260193|521572627|FG000|Overall Study|Adverse Event|3|||
144650330|NCT02260193|521572628|FG001|Overall Study|Adverse Event|4|||
144650331|NCT02260193|521572629|FG002|Overall Study|Adverse Event|1|||
144650332|NCT02260193|521572627|FG000|Overall Study|Protocol Violation|0|||
144650333|NCT02260193|521572628|FG001|Overall Study|Protocol Violation|4|||
144650334|NCT02260193|521572629|FG002|Overall Study|Protocol Violation|0|||
144650335|NCT02260193|521572627|FG000|Overall Study|Withdrawal by Subject|3|||
144650336|NCT02260193|521572628|FG001|Overall Study|Withdrawal by Subject|0|||
144211966|NCT02620579|519970426|FG000|Overall Study|Withdrawal by Subject|0|||
144211967|NCT02620579|519970427|FG001|Overall Study|Withdrawal by Subject|1|||
144211968|NCT02620579|519970428|FG002|Overall Study|Withdrawal by Subject|1|||
144650337|NCT02260193|521572629|FG002|Overall Study|Withdrawal by Subject|2|||
144650338|NCT02260193|521572627|FG000|Overall Study|Kidney Transplantation|0|||
144650339|NCT02260193|521572628|FG001|Overall Study|Kidney Transplantation|0|||
144650340|NCT02260193|521572629|FG002|Overall Study|Kidney Transplantation|1|||
144650341|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
144650342|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
144650343|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
144650344|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
144211969|NCT02620579|519970429|FG003|Overall Study|Withdrawal by Subject|0|||
144211970|NCT00796107|519970435|FG000|Overall Study|Lack of Efficacy|1|||
144211971|NCT00796107|519970435|FG000|Overall Study|Progressive Disease|5|||
144650345|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Death|8|||
144650346|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Death|3|||
144650347|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
144650348|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
144650349|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
144650350|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
144650351|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
144650352|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
144650353|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
144650354|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
144650355|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
144650356|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
144650357|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
144650358|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
144650359|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
144650360|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
144650361|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
144650362|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
144650363|NCT00494871|521573941|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
144650364|NCT00494871|521573942|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
144650365|NCT00494871|521573941|FG000|Follow-up (FU) Period|Adverse Event|1|||
144650366|NCT00494871|521573942|FG001|Follow-up (FU) Period|Adverse Event|1|||
144650367|NCT00494871|521573941|FG000|Follow-up (FU) Period|Death|13|||
144650368|NCT00494871|521573942|FG001|Follow-up (FU) Period|Death|12|||
144650369|NCT00494871|521573941|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
144650370|NCT00494871|521573942|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
144650371|NCT00494871|521573941|FG000|Follow-up (FU) Period|Physician Decision|0|||
144650372|NCT00494871|521573942|FG001|Follow-up (FU) Period|Physician Decision|1|||
144650373|NCT00494871|521573941|FG000|Follow-up (FU) Period|Protocol Violation|1|||
144650374|NCT00494871|521573942|FG001|Follow-up (FU) Period|Protocol Violation|0|||
144650375|NCT00494871|521573941|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
144650376|NCT00494871|521573942|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
144650377|NCT00494871|521573941|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
144650378|NCT00494871|521573942|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
144650379|NCT04543955|521573943|FG000|Overall Study|Company cancelled study|1|||
144650380|NCT04543955|521573944|FG001|Overall Study|Company cancelled study|0|||
144650381|NCT03918642|521573945|FG000|Overall Study|Lost to Follow-up|12|||
144650382|NCT03918642|521573946|FG001|Overall Study|Lost to Follow-up|10|||
144650383|NCT01912872|521573947|FG000|Overall Study|Lost to Follow-up|2|||
144650384|NCT01912872|521573948|FG001|Overall Study|Lost to Follow-up|3|||
144650385|NCT01912872|521573949|FG002|Overall Study|Lost to Follow-up|5|||
144650386|NCT01912872|521573950|FG003|Overall Study|Lost to Follow-up|5|||
144650387|NCT01912872|521573947|FG000|Overall Study|Other unspecified|3|||
144650388|NCT01912872|521573948|FG001|Overall Study|Other unspecified|1|||
144650389|NCT01912872|521573949|FG002|Overall Study|Other unspecified|3|||
144650390|NCT01912872|521573950|FG003|Overall Study|Other unspecified|0|||
144650391|NCT01912872|521573947|FG000|Overall Study|Informed consent withdrawn|0|||
144650392|NCT01912872|521573948|FG001|Overall Study|Informed consent withdrawn|0|||
144650393|NCT01912872|521573949|FG002|Overall Study|Informed consent withdrawn|1|||
144650394|NCT01912872|521573950|FG003|Overall Study|Informed consent withdrawn|1|||
144650395|NCT01912872|521573947|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
144211972|NCT04315506|519970444|FG000|Overall Study|Lost to Follow-up|74|||
144650396|NCT01912872|521573948|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
144650397|NCT01912872|521573949|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
144650398|NCT01912872|521573950|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
144650399|NCT01912872|521573947|FG000|Overall Study|Protocol Violation|0|||
144650400|NCT01912872|521573948|FG001|Overall Study|Protocol Violation|0|||
144650401|NCT01912872|521573949|FG002|Overall Study|Protocol Violation|1|||
144650402|NCT01912872|521573950|FG003|Overall Study|Protocol Violation|0|||
144211973|NCT04315506|519970445|FG001|Overall Study|Lost to Follow-up|82|||
144211974|NCT04315506|519970444|FG000|Overall Study|Withdrawal by Subject|8|||
144211975|NCT04315506|519970445|FG001|Overall Study|Withdrawal by Subject|8|||
144211976|NCT04315506|519970444|FG000|Overall Study|Physician Decision|0|||
144211977|NCT04315506|519970445|FG001|Overall Study|Physician Decision|1|||
144211978|NCT00626561|519970448|FG000|Overall Study|Withdrawal by Subject|2|||
144211979|NCT00626561|519970448|FG000|Overall Study|Disease Progression|2|||
144211980|NCT03993379|519970449|FG000|Overall Study|The study was terminated early due to business decision.|0|||
144211981|NCT03993379|519970450|FG001|Overall Study|The study was terminated early due to business decision.|2|||
144211982|NCT03993379|519970451|FG002|Overall Study|The study was terminated early due to business decision.|0|||
144211983|NCT03993379|519970452|FG003|Overall Study|The study was terminated early due to business decision.|0|||
144211984|NCT03993379|519970449|FG000|Overall Study|Withdrawal by Subject|0|||
144263354|NCT00509899|520165421|FG007|Overall Study|Unacceptable Toxicity|0|||
144263355|NCT00509899|520165414|FG000|Overall Study|Withdrawal by Subject|6|||
144263356|NCT00509899|520165415|FG001|Overall Study|Withdrawal by Subject|2|||
144263357|NCT00509899|520165416|FG002|Overall Study|Withdrawal by Subject|3|||
144263358|NCT00509899|520165417|FG003|Overall Study|Withdrawal by Subject|0|||
144263359|NCT00509899|520165418|FG004|Overall Study|Withdrawal by Subject|3|||
144263360|NCT00509899|520165419|FG005|Overall Study|Withdrawal by Subject|2|||
144263361|NCT00509899|520165420|FG006|Overall Study|Withdrawal by Subject|0|||
144263362|NCT00509899|520165421|FG007|Overall Study|Withdrawal by Subject|0|||
144263363|NCT00509899|520165414|FG000|Overall Study|Physician Decision|4|||
144263364|NCT00509899|520165415|FG001|Overall Study|Physician Decision|2|||
144263365|NCT00509899|520165416|FG002|Overall Study|Physician Decision|7|||
144263366|NCT00509899|520165417|FG003|Overall Study|Physician Decision|0|||
144263367|NCT00509899|520165418|FG004|Overall Study|Physician Decision|1|||
144263368|NCT00509899|520165419|FG005|Overall Study|Physician Decision|4|||
144263369|NCT00509899|520165420|FG006|Overall Study|Physician Decision|0|||
144263370|NCT00509899|520165421|FG007|Overall Study|Physician Decision|0|||
144263371|NCT00509899|520165414|FG000|Overall Study|Intercurrent Illness|1|||
144263372|NCT00509899|520165415|FG001|Overall Study|Intercurrent Illness|0|||
144263373|NCT00509899|520165416|FG002|Overall Study|Intercurrent Illness|0|||
144263374|NCT00509899|520165417|FG003|Overall Study|Intercurrent Illness|1|||
144263375|NCT00509899|520165418|FG004|Overall Study|Intercurrent Illness|0|||
144263376|NCT00509899|520165419|FG005|Overall Study|Intercurrent Illness|1|||
144263377|NCT00509899|520165420|FG006|Overall Study|Intercurrent Illness|0|||
144263378|NCT00509899|520165421|FG007|Overall Study|Intercurrent Illness|0|||
144650403|NCT01912872|521573947|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144650404|NCT01912872|521573948|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144650405|NCT01912872|521573949|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144650406|NCT01912872|521573950|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
144650407|NCT01912872|521573947|FG000|Overall Study|Withdrawal of study medication|0|||
144650408|NCT01912872|521573948|FG001|Overall Study|Withdrawal of study medication|0|||
144650409|NCT01912872|521573949|FG002|Overall Study|Withdrawal of study medication|0|||
144263379|NCT00509899|520165414|FG000|Overall Study|Death|2|||
144650410|NCT01912872|521573950|FG003|Overall Study|Withdrawal of study medication|2|||
144650411|NCT01912872|521573947|FG000|Overall Study|Missing|0|||
144650412|NCT01912872|521573948|FG001|Overall Study|Missing|0|||
144650413|NCT01912872|521573949|FG002|Overall Study|Missing|0|||
144650414|NCT01912872|521573950|FG003|Overall Study|Missing|1|||
144650415|NCT04760314|521573951|FG000|Induction Period|Withdrawal by Subject|0|||
144650416|NCT04760314|521573952|FG001|Induction Period|Withdrawal by Subject|1|||
144650417|NCT04760314|521573953|FG002|Induction Period|Withdrawal by Subject|1|||
144650418|NCT04760314|521573954|FG003|Induction Period|Withdrawal by Subject|0|||
144650419|NCT04760314|521573955|FG004|Induction Period|Withdrawal by Subject|0|||
144650420|NCT04760314|521573956|FG005|Induction Period|Withdrawal by Subject|0|||
144650421|NCT04760314|521573957|FG006|Induction Period|Withdrawal by Subject|0|||
144650422|NCT04760314|521573958|FG007|Induction Period|Withdrawal by Subject|0|||
144650423|NCT04760314|521573959|FG008|Induction Period|Withdrawal by Subject|0|||
144650424|NCT04760314|521573960|FG009|Induction Period|Withdrawal by Subject|0|||
144263380|NCT00509899|520165415|FG001|Overall Study|Death|2|||
144263381|NCT00509899|520165416|FG002|Overall Study|Death|3|||
144650425|NCT04760314|521573961|FG010|Induction Period|Withdrawal by Subject|0|||
144211985|NCT03993379|519970450|FG001|Overall Study|Withdrawal by Subject|1|||
144211986|NCT03993379|519970451|FG002|Overall Study|Withdrawal by Subject|0|||
144263382|NCT00509899|520165417|FG003|Overall Study|Death|0|||
144263383|NCT00509899|520165418|FG004|Overall Study|Death|1|||
144211987|NCT03993379|519970452|FG003|Overall Study|Withdrawal by Subject|0|||
144263384|NCT00509899|520165419|FG005|Overall Study|Death|1|||
144263385|NCT00509899|520165420|FG006|Overall Study|Death|1|||
144263386|NCT00509899|520165421|FG007|Overall Study|Death|1|||
144263387|NCT00509899|520165414|FG000|Overall Study|Lack of Efficacy|1|||
144263388|NCT00509899|520165415|FG001|Overall Study|Lack of Efficacy|0|||
144650426|NCT04760314|521573951|FG000|Induction Period|Adverse Event|0|||
144650427|NCT04760314|521573952|FG001|Induction Period|Adverse Event|0|||
144650428|NCT04760314|521573953|FG002|Induction Period|Adverse Event|2|||
144650429|NCT04760314|521573954|FG003|Induction Period|Adverse Event|0|||
144650430|NCT04760314|521573955|FG004|Induction Period|Adverse Event|0|||
144650431|NCT04760314|521573956|FG005|Induction Period|Adverse Event|0|||
144650432|NCT04760314|521573957|FG006|Induction Period|Adverse Event|0|||
144650433|NCT04760314|521573958|FG007|Induction Period|Adverse Event|0|||
144650434|NCT04760314|521573959|FG008|Induction Period|Adverse Event|0|||
144650435|NCT04760314|521573960|FG009|Induction Period|Adverse Event|0|||
144650436|NCT04760314|521573961|FG010|Induction Period|Adverse Event|0|||
144650437|NCT04760314|521573951|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650438|NCT04760314|521573952|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650439|NCT04760314|521573953|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650440|NCT04760314|521573954|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
144650441|NCT04760314|521573955|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
144650442|NCT04760314|521573956|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
144650443|NCT04760314|521573957|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
144650444|NCT04760314|521573958|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650445|NCT04760314|521573959|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650446|NCT04760314|521573960|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650447|NCT04760314|521573961|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
144650448|NCT04760314|521573951|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650449|NCT04760314|521573952|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650450|NCT04760314|521573953|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650451|NCT04760314|521573954|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
144650452|NCT04760314|521573955|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144211988|NCT02604407|519970453|FG000|Overall Study|Adverse Event|0|||
144211989|NCT02604407|519970454|FG001|Overall Study|Adverse Event|7|||
144211990|NCT02604407|519970455|FG002|Overall Study|Adverse Event|5|||
144211991|NCT02604407|519970453|FG000|Overall Study|Protocol Violation|2|||
144211992|NCT02604407|519970454|FG001|Overall Study|Protocol Violation|0|||
144211993|NCT02604407|519970455|FG002|Overall Study|Protocol Violation|0|||
144211994|NCT02604407|519970453|FG000|Overall Study|Withdrawal by Subject|3|||
144211995|NCT02604407|519970454|FG001|Overall Study|Withdrawal by Subject|3|||
144211996|NCT02604407|519970455|FG002|Overall Study|Withdrawal by Subject|5|||
144211997|NCT02604407|519970453|FG000|Overall Study|Lost to Follow-up|2|||
144211998|NCT02604407|519970454|FG001|Overall Study|Lost to Follow-up|1|||
144211999|NCT02604407|519970455|FG002|Overall Study|Lost to Follow-up|2|||
144212000|NCT02604407|519970453|FG000|Overall Study|Lack of Efficacy|1|||
144212001|NCT02604407|519970454|FG001|Overall Study|Lack of Efficacy|0|||
144212002|NCT02604407|519970455|FG002|Overall Study|Lack of Efficacy|0|||
144212003|NCT02604407|519970453|FG000|Overall Study|Other|3|||
144212004|NCT02604407|519970454|FG001|Overall Study|Other|1|||
144212005|NCT02604407|519970455|FG002|Overall Study|Other|4|||
144212006|NCT00606632|519970458|FG000|Overall Study|Withdrawal by Subject|13|||
144212007|NCT00606632|519970458|FG000|Overall Study|Miscellaneous reasons|9|||
144212008|NCT00711880|519970461|FG000|Overall Study|Adverse Event|11|||
144212009|NCT00711880|519970462|FG001|Overall Study|Adverse Event|2|||
144212010|NCT00711880|519970461|FG000|Overall Study|Patient non-compliance|1|||
144212011|NCT00711880|519970462|FG001|Overall Study|Patient non-compliance|0|||
144212012|NCT00711880|519970461|FG000|Overall Study|Lack of Efficacy|1|||
144212013|NCT00711880|519970462|FG001|Overall Study|Lack of Efficacy|5|||
144212014|NCT00704132|519970463|FG000|Overall Study|Clinical Adverse Experience|1|||
144212015|NCT00704132|519970464|FG001|Overall Study|Clinical Adverse Experience|0|||
144212016|NCT00704132|519970463|FG000|Overall Study|Lack of Efficacy|0|||
144212017|NCT00704132|519970464|FG001|Overall Study|Lack of Efficacy|1|||
144212018|NCT00704132|519970463|FG000|Overall Study|Withdrawal by Subject|0|||
144212019|NCT00704132|519970464|FG001|Overall Study|Withdrawal by Subject|1|||
144212020|NCT03348163|519970465|FG000|Overall Study|Withdrawal by Subject|2|||
144212021|NCT03348163|519970466|FG001|Overall Study|Withdrawal by Subject|0|||
144212022|NCT02756208|519970467|FG000|Overall Study|Withdrawal by Subject|1|||
144212023|NCT02756208|519970468|FG001|Overall Study|Withdrawal by Subject|0|||
144212024|NCT02756208|519970469|FG002|Overall Study|Withdrawal by Subject|1|||
144212025|NCT02756208|519970470|FG003|Overall Study|Withdrawal by Subject|3|||
144212026|NCT02756208|519970467|FG000|Overall Study|Lost to Follow-up|3|||
144650453|NCT04760314|521573956|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
144212027|NCT02756208|519970468|FG001|Overall Study|Lost to Follow-up|1|||
144212028|NCT02756208|519970469|FG002|Overall Study|Lost to Follow-up|1|||
144212029|NCT02756208|519970470|FG003|Overall Study|Lost to Follow-up|1|||
144212030|NCT02756208|519970467|FG000|Overall Study|Physician Decision|1|||
144212031|NCT02756208|519970468|FG001|Overall Study|Physician Decision|0|||
144212032|NCT02756208|519970469|FG002|Overall Study|Physician Decision|0|||
144212033|NCT02756208|519970470|FG003|Overall Study|Physician Decision|0|||
144212034|NCT02756208|519970467|FG000|Overall Study|Protocol Violation|0|||
144212035|NCT02756208|519970468|FG001|Overall Study|Protocol Violation|1|||
144212036|NCT02756208|519970469|FG002|Overall Study|Protocol Violation|0|||
144212037|NCT02756208|519970470|FG003|Overall Study|Protocol Violation|0|||
144212038|NCT02585778|519970471|FG000|Overall Study|Adverse Event|17|||
144212039|NCT02585778|519970472|FG001|Overall Study|Adverse Event|4|||
144650454|NCT04760314|521573957|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
144650455|NCT04760314|521573958|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650456|NCT04760314|521573959|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650457|NCT04760314|521573960|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650458|NCT04760314|521573961|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
144650459|NCT04760314|521573951|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650460|NCT04760314|521573952|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650461|NCT04760314|521573953|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650462|NCT04760314|521573954|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650463|NCT04760314|521573955|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
144650464|NCT04760314|521573956|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650465|NCT04760314|521573957|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650466|NCT04760314|521573958|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650467|NCT04760314|521573959|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650468|NCT04760314|521573960|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650469|NCT04760314|521573961|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
144650470|NCT04760314|521573951|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
144650471|NCT04760314|521573952|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
144650472|NCT04760314|521573953|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
144650473|NCT04760314|521573954|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
144650474|NCT04760314|521573955|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
144650475|NCT04760314|521573956|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
144650476|NCT04760314|521573957|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
144650477|NCT04760314|521573958|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
144650478|NCT04760314|521573959|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
144650479|NCT04760314|521573960|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
144650480|NCT04760314|521573961|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
144650481|NCT04760314|521573951|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650482|NCT04760314|521573952|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650483|NCT04760314|521573953|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650484|NCT04760314|521573954|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650485|NCT04760314|521573955|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650486|NCT04760314|521573956|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650487|NCT04760314|521573957|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650488|NCT04760314|521573958|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
144650489|NCT04760314|521573959|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
144650490|NCT04760314|521573960|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
144650491|NCT04760314|521573961|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
144650492|NCT04760314|521573951|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650493|NCT04760314|521573952|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650494|NCT04760314|521573953|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650495|NCT04760314|521573954|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650496|NCT04760314|521573955|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650497|NCT04760314|521573956|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650498|NCT04760314|521573957|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650499|NCT04760314|521573958|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
144650500|NCT04760314|521573959|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
144650501|NCT04760314|521573960|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
144650502|NCT04760314|521573961|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
144650503|NCT04760314|521573951|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650504|NCT04760314|521573952|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650505|NCT04760314|521573953|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650506|NCT04760314|521573954|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650507|NCT04760314|521573955|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650508|NCT04760314|521573956|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650509|NCT04760314|521573957|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650510|NCT04760314|521573958|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
144650511|NCT04760314|521573959|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650512|NCT04760314|521573960|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650513|NCT04760314|521573961|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
144650514|NCT04760314|521573951|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650515|NCT04760314|521573952|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650516|NCT04760314|521573953|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650517|NCT04760314|521573954|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650518|NCT04760314|521573955|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650519|NCT04760314|521573956|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650520|NCT04760314|521573957|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650521|NCT04760314|521573958|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650522|NCT04760314|521573959|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
144650523|NCT04760314|521573960|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
144650524|NCT04760314|521573961|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
144650525|NCT02345161|521573967|FG000|Overall Study|Withdrawal by Subject|25|||
144650526|NCT02345161|521573968|FG001|Overall Study|Withdrawal by Subject|33|||
144650527|NCT02345161|521573967|FG000|Overall Study|Adverse Event|16|||
144650528|NCT02345161|521573968|FG001|Overall Study|Adverse Event|19|||
144650529|NCT02345161|521573967|FG000|Overall Study|Physician Decision|4|||
144650530|NCT02345161|521573968|FG001|Overall Study|Physician Decision|4|||
144650531|NCT02345161|521573967|FG000|Overall Study|Lost to Follow-up|0|||
144650532|NCT02345161|521573968|FG001|Overall Study|Lost to Follow-up|1|||
144650533|NCT00972244|521573971|FG000|Overall Study|Incorrect Enrolment|1|||
144650534|NCT00972244|521573972|FG001|Overall Study|Incorrect Enrolment|0|||
144650535|NCT00972244|521573973|FG002|Overall Study|Incorrect Enrolment|0|||
144650536|NCT00972244|521573974|FG003|Overall Study|Incorrect Enrolment|0|||
144650537|NCT00972244|521573975|FG004|Overall Study|Incorrect Enrolment|0|||
144650538|NCT00972244|521573971|FG000|Overall Study|Adverse Event|0|||
144650539|NCT00972244|521573972|FG001|Overall Study|Adverse Event|1|||
144650540|NCT00972244|521573973|FG002|Overall Study|Adverse Event|1|||
144650541|NCT00972244|521573974|FG003|Overall Study|Adverse Event|0|||
144650542|NCT00972244|521573975|FG004|Overall Study|Adverse Event|0|||
144650543|NCT00972244|521573971|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
144650544|NCT00972244|521573972|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
144650545|NCT00972244|521573973|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
144650546|NCT00972244|521573974|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
144650547|NCT00972244|521573975|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
144650548|NCT00972244|521573971|FG000|Overall Study|Withdrawal by Subject|1|||
144650549|NCT00972244|521573972|FG001|Overall Study|Withdrawal by Subject|2|||
144650550|NCT00972244|521573973|FG002|Overall Study|Withdrawal by Subject|1|||
144650551|NCT00972244|521573974|FG003|Overall Study|Withdrawal by Subject|0|||
144650552|NCT00972244|521573975|FG004|Overall Study|Withdrawal by Subject|1|||
144650553|NCT00972244|521573971|FG000|Overall Study|Safety|0|||
144650554|NCT00972244|521573972|FG001|Overall Study|Safety|0|||
144650555|NCT00972244|521573973|FG002|Overall Study|Safety|0|||
144650556|NCT00972244|521573974|FG003|Overall Study|Safety|0|||
144650557|NCT00972244|521573975|FG004|Overall Study|Safety|1|||
144650558|NCT00972244|521573971|FG000|Overall Study|Death|1|||
144650559|NCT00972244|521573972|FG001|Overall Study|Death|0|||
144650560|NCT00972244|521573973|FG002|Overall Study|Death|0|||
144650561|NCT00972244|521573974|FG003|Overall Study|Death|0|||
144650562|NCT00972244|521573975|FG004|Overall Study|Death|0|||
144650563|NCT00972244|521573971|FG000|Overall Study|Various|0|||
144650564|NCT00972244|521573972|FG001|Overall Study|Various|0|||
144650565|NCT00972244|521573973|FG002|Overall Study|Various|0|||
144650566|NCT00972244|521573974|FG003|Overall Study|Various|0|||
144650567|NCT00972244|521573975|FG004|Overall Study|Various|2|||
144650568|NCT00090285|521573976|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
144650569|NCT00090285|521573977|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
144650570|NCT00090285|521573978|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
144650571|NCT00090285|521573979|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
144650572|NCT00090285|521573980|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
144650573|NCT00090285|521573981|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
144650574|NCT00090285|521573976|FG000|Base Study Vaccination Period|Adverse Event|2|||
144650575|NCT00090285|521573977|FG001|Base Study Vaccination Period|Adverse Event|4|||
144650576|NCT00090285|521573978|FG002|Base Study Vaccination Period|Adverse Event|0|||
144650577|NCT00090285|521573979|FG003|Base Study Vaccination Period|Adverse Event|0|||
144650578|NCT00090285|521573980|FG004|Base Study Vaccination Period|Adverse Event|0|||
144650579|NCT00090285|521573981|FG005|Base Study Vaccination Period|Adverse Event|0|||
144650580|NCT00090285|521573976|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
144650581|NCT00090285|521573977|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
144650582|NCT00090285|521573978|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
144650583|NCT00090285|521573979|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
144650584|NCT00090285|521573980|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
144650585|NCT00090285|521573981|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
144212040|NCT02585778|519970471|FG000|Overall Study|Participant did not wish to continue|9|||
144212041|NCT02585778|519970472|FG001|Overall Study|Participant did not wish to continue|4|||
144650586|NCT00090285|521573976|FG000|Base Study Vaccination Period|Protocol Violation|2|||
144650587|NCT00090285|521573977|FG001|Base Study Vaccination Period|Protocol Violation|3|||
144650588|NCT00090285|521573978|FG002|Base Study Vaccination Period|Protocol Violation|0|||
144650589|NCT00090285|521573979|FG003|Base Study Vaccination Period|Protocol Violation|0|||
144650590|NCT00090285|521573980|FG004|Base Study Vaccination Period|Protocol Violation|0|||
144650591|NCT00090285|521573981|FG005|Base Study Vaccination Period|Protocol Violation|0|||
144650592|NCT00090285|521573976|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
144650593|NCT00090285|521573977|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
144650594|NCT00090285|521573978|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
144650595|NCT00090285|521573979|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
144650596|NCT00090285|521573980|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
144650597|NCT00090285|521573981|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
144650598|NCT00090285|521573976|FG000|Base Study Vaccination Period|Uncooperative|2|||
144650599|NCT00090285|521573977|FG001|Base Study Vaccination Period|Uncooperative|2|||
144650600|NCT00090285|521573978|FG002|Base Study Vaccination Period|Uncooperative|0|||
144650601|NCT00090285|521573979|FG003|Base Study Vaccination Period|Uncooperative|0|||
144650602|NCT00090285|521573980|FG004|Base Study Vaccination Period|Uncooperative|0|||
144650603|NCT00090285|521573981|FG005|Base Study Vaccination Period|Uncooperative|0|||
144650604|NCT00090285|521573976|FG000|Base Study Vaccination Period|Moved|20|||
144650605|NCT00090285|521573977|FG001|Base Study Vaccination Period|Moved|21|||
144650606|NCT00090285|521573978|FG002|Base Study Vaccination Period|Moved|0|||
144650607|NCT00090285|521573979|FG003|Base Study Vaccination Period|Moved|0|||
144650608|NCT00090285|521573980|FG004|Base Study Vaccination Period|Moved|0|||
144650609|NCT00090285|521573981|FG005|Base Study Vaccination Period|Moved|0|||
144650610|NCT00090285|521573976|FG000|Base Study Vaccination Period|Site Terminated|1|||
144650611|NCT00090285|521573977|FG001|Base Study Vaccination Period|Site Terminated|0|||
144650612|NCT00090285|521573978|FG002|Base Study Vaccination Period|Site Terminated|0|||
144650613|NCT00090285|521573979|FG003|Base Study Vaccination Period|Site Terminated|0|||
144650614|NCT00090285|521573980|FG004|Base Study Vaccination Period|Site Terminated|0|||
144650615|NCT00090285|521573981|FG005|Base Study Vaccination Period|Site Terminated|0|||
144650616|NCT00090285|521573976|FG000|Base Study Vaccination Period|Other|2|||
144650617|NCT00090285|521573977|FG001|Base Study Vaccination Period|Other|2|||
144650618|NCT00090285|521573978|FG002|Base Study Vaccination Period|Other|0|||
144650619|NCT00090285|521573979|FG003|Base Study Vaccination Period|Other|0|||
144650620|NCT00090285|521573980|FG004|Base Study Vaccination Period|Other|0|||
144650621|NCT00090285|521573981|FG005|Base Study Vaccination Period|Other|0|||
144650622|NCT00090285|521573976|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
144650623|NCT00090285|521573977|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
144650624|NCT00090285|521573978|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
144650625|NCT00090285|521573979|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
144650626|NCT00090285|521573980|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
144650627|NCT00090285|521573981|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
144650628|NCT00090285|521573976|FG000|Base Study Vaccination Period|HIV positive|1|||
144650629|NCT00090285|521573977|FG001|Base Study Vaccination Period|HIV positive|1|||
144650630|NCT00090285|521573978|FG002|Base Study Vaccination Period|HIV positive|0|||
144650631|NCT00090285|521573979|FG003|Base Study Vaccination Period|HIV positive|0|||
144650632|NCT00090285|521573980|FG004|Base Study Vaccination Period|HIV positive|0|||
144650633|NCT00090285|521573981|FG005|Base Study Vaccination Period|HIV positive|0|||
144650634|NCT00090285|521573976|FG000|Base Study Follow-up Period|Adverse Event|3|||
144650635|NCT00090285|521573977|FG001|Base Study Follow-up Period|Adverse Event|10|||
144650636|NCT00090285|521573978|FG002|Base Study Follow-up Period|Adverse Event|0|||
144650637|NCT00090285|521573979|FG003|Base Study Follow-up Period|Adverse Event|0|||
144650638|NCT00090285|521573980|FG004|Base Study Follow-up Period|Adverse Event|0|||
144650639|NCT00090285|521573981|FG005|Base Study Follow-up Period|Adverse Event|0|||
144650640|NCT00090285|521573976|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
144650641|NCT00090285|521573977|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
144650642|NCT00090285|521573978|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
144650643|NCT00090285|521573979|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
144650644|NCT00090285|521573980|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
144650645|NCT00090285|521573981|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
144650646|NCT00090285|521573976|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
144650647|NCT00090285|521573977|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
144650648|NCT00090285|521573978|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
144650649|NCT00090285|521573979|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
144650650|NCT00090285|521573980|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
144731699|NCT01214850|521873246|FG001|Overall Study|Administrative reason|0|||
144731700|NCT01214850|521873247|FG002|Overall Study|Administrative reason|0|||
144212042|NCT02585778|519970471|FG000|Overall Study|Poor compliance to study protocol|0|||
144212043|NCT02585778|519970472|FG001|Overall Study|Poor compliance to study protocol|2|||
144212044|NCT02585778|519970471|FG000|Overall Study|Death|0|||
144212045|NCT02585778|519970472|FG001|Overall Study|Death|1|||
144731701|NCT01214850|521873245|FG000|Overall Study|Unable to classify|2|||
144731702|NCT01214850|521873246|FG001|Overall Study|Unable to classify|1|||
144731703|NCT01214850|521873247|FG002|Overall Study|Unable to classify|1|||
144650651|NCT00090285|521573981|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
144650652|NCT00090285|521573976|FG000|Base Study Follow-up Period|Moved|41|||
144650653|NCT00090285|521573977|FG001|Base Study Follow-up Period|Moved|36|||
144650654|NCT00090285|521573978|FG002|Base Study Follow-up Period|Moved|0|||
144650655|NCT00090285|521573979|FG003|Base Study Follow-up Period|Moved|0|||
144650656|NCT00090285|521573980|FG004|Base Study Follow-up Period|Moved|0|||
144650657|NCT00090285|521573981|FG005|Base Study Follow-up Period|Moved|0|||
144650658|NCT00090285|521573976|FG000|Base Study Follow-up Period|Other|2|||
144731704|NCT00610363|521873248|FG000|Overall Study|Non-compliance with protocol|0|||
144650659|NCT00090285|521573977|FG001|Base Study Follow-up Period|Other|0|||
144650660|NCT00090285|521573978|FG002|Base Study Follow-up Period|Other|0|||
144650661|NCT00090285|521573979|FG003|Base Study Follow-up Period|Other|0|||
144650662|NCT00090285|521573980|FG004|Base Study Follow-up Period|Other|0|||
144650663|NCT00090285|521573981|FG005|Base Study Follow-up Period|Other|0|||
144650664|NCT00090285|521573976|FG000|Base Study Follow-up Period|Protocol Violation|1|||
144650665|NCT00090285|521573977|FG001|Base Study Follow-up Period|Protocol Violation|0|||
144650666|NCT00090285|521573978|FG002|Base Study Follow-up Period|Protocol Violation|0|||
144650667|NCT00090285|521573979|FG003|Base Study Follow-up Period|Protocol Violation|0|||
144650668|NCT00090285|521573980|FG004|Base Study Follow-up Period|Protocol Violation|0|||
144650669|NCT00090285|521573981|FG005|Base Study Follow-up Period|Protocol Violation|0|||
144650670|NCT00090285|521573976|FG000|Base Study Follow-up Period|Uncooperative|3|||
144650671|NCT00090285|521573977|FG001|Base Study Follow-up Period|Uncooperative|4|||
144650672|NCT00090285|521573978|FG002|Base Study Follow-up Period|Uncooperative|0|||
144650673|NCT00090285|521573979|FG003|Base Study Follow-up Period|Uncooperative|0|||
144650674|NCT00090285|521573980|FG004|Base Study Follow-up Period|Uncooperative|0|||
144650675|NCT00090285|521573981|FG005|Base Study Follow-up Period|Uncooperative|0|||
144650676|NCT00090285|521573976|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
144650677|NCT00090285|521573977|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
144650678|NCT00090285|521573978|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
144650679|NCT00090285|521573979|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
144650680|NCT00090285|521573980|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
144650681|NCT00090285|521573981|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
144650682|NCT00090285|521573976|FG000|Extension 1|Adverse Event|0|||
144650683|NCT00090285|521573977|FG001|Extension 1|Adverse Event|0|||
144650684|NCT00090285|521573978|FG002|Extension 1|Adverse Event|2|||
144650685|NCT00090285|521573979|FG003|Extension 1|Adverse Event|0|||
144650686|NCT00090285|521573980|FG004|Extension 1|Adverse Event|0|||
144650687|NCT00090285|521573981|FG005|Extension 1|Adverse Event|0|||
144650688|NCT00090285|521573976|FG000|Extension 1|Lost to Follow-up|0|||
144731705|NCT00610363|521873249|FG001|Overall Study|Non-compliance with protocol|1|||
144212046|NCT02585778|519970471|FG000|Overall Study|Randomized but not treated|1|||
144212047|NCT02585778|519970472|FG001|Overall Study|Randomized but not treated|2|||
144212048|NCT02585778|519970471|FG000|Overall Study|Other than specified above|6|||
144212049|NCT02585778|519970472|FG001|Overall Study|Other than specified above|2|||
144212050|NCT04841577|519970473|FG000|Overall Study|Adverse Event|5|||
144212051|NCT04841577|519970474|FG001|Overall Study|Adverse Event|10|||
144212052|NCT04841577|519970473|FG000|Overall Study|Lost to Follow-up|8|||
144212053|NCT04841577|519970474|FG001|Overall Study|Lost to Follow-up|7|||
144212054|NCT04841577|519970473|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
144212055|NCT04841577|519970474|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
144212056|NCT04841577|519970473|FG000|Overall Study|Other|0|||
144212057|NCT04841577|519970474|FG001|Overall Study|Other|1|||
144212058|NCT00356525|519970482|FG000|Overall Study|Progressive Disease|8|||
144212059|NCT00356525|519970483|FG001|Overall Study|Progressive Disease|5|||
144212060|NCT00356525|519970484|FG002|Overall Study|Progressive Disease|4|||
144212061|NCT00356525|519970485|FG003|Overall Study|Progressive Disease|2|||
144212062|NCT00356525|519970482|FG000|Overall Study|Adverse Event|1|||
144212063|NCT00356525|519970483|FG001|Overall Study|Adverse Event|3|||
144212064|NCT00356525|519970484|FG002|Overall Study|Adverse Event|1|||
144212065|NCT00356525|519970485|FG003|Overall Study|Adverse Event|1|||
144212066|NCT00356525|519970482|FG000|Overall Study|Lost to Follow-up|1|||
144212067|NCT00356525|519970483|FG001|Overall Study|Lost to Follow-up|0|||
144212068|NCT00356525|519970484|FG002|Overall Study|Lost to Follow-up|0|||
144212069|NCT00356525|519970485|FG003|Overall Study|Lost to Follow-up|0|||
144212070|NCT00356525|519970482|FG000|Overall Study|Physician Decision|2|||
144212071|NCT00356525|519970483|FG001|Overall Study|Physician Decision|2|||
144212072|NCT00356525|519970484|FG002|Overall Study|Physician Decision|2|||
144212073|NCT00356525|519970485|FG003|Overall Study|Physician Decision|1|||
144212074|NCT00356525|519970482|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
144212075|NCT00356525|519970483|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
144212076|NCT00356525|519970484|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
144212077|NCT00356525|519970485|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
144212078|NCT00356525|519970482|FG000|Overall Study|Withdrawal by Subject|1|||
144212079|NCT00356525|519970483|FG001|Overall Study|Withdrawal by Subject|1|||
144212080|NCT00356525|519970484|FG002|Overall Study|Withdrawal by Subject|0|||
144212081|NCT00356525|519970485|FG003|Overall Study|Withdrawal by Subject|3|||
144212082|NCT00356525|519970482|FG000|Overall Study|Death|0|||
144212083|NCT00356525|519970483|FG001|Overall Study|Death|0|||
144212084|NCT00356525|519970484|FG002|Overall Study|Death|0|||
144212085|NCT00356525|519970485|FG003|Overall Study|Death|1|||
144212086|NCT00356525|519970482|FG000|Overall Study|Sponsor Decision|0|||
144212087|NCT00356525|519970483|FG001|Overall Study|Sponsor Decision|0|||
144212088|NCT00356525|519970484|FG002|Overall Study|Sponsor Decision|0|||
144212089|NCT00356525|519970485|FG003|Overall Study|Sponsor Decision|1|||
144212090|NCT00652340|519970486|FG000|Overall Study|Had not progressed.|4|||
144212091|NCT00652340|519970487|FG001|Overall Study|Had not progressed.|3|||
144263389|NCT00509899|520165416|FG002|Overall Study|Lack of Efficacy|2|||
144650689|NCT00090285|521573977|FG001|Extension 1|Lost to Follow-up|0|||
144650690|NCT00090285|521573978|FG002|Extension 1|Lost to Follow-up|35|||
144650691|NCT00090285|521573979|FG003|Extension 1|Lost to Follow-up|0|||
144650692|NCT00090285|521573980|FG004|Extension 1|Lost to Follow-up|0|||
144650693|NCT00090285|521573981|FG005|Extension 1|Lost to Follow-up|0|||
144650694|NCT00090285|521573976|FG000|Extension 1|Withdrawal by Subject|0|||
144650695|NCT00090285|521573977|FG001|Extension 1|Withdrawal by Subject|0|||
144650696|NCT00090285|521573978|FG002|Extension 1|Withdrawal by Subject|13|||
144650697|NCT00090285|521573979|FG003|Extension 1|Withdrawal by Subject|1|||
144650698|NCT00090285|521573980|FG004|Extension 1|Withdrawal by Subject|0|||
144650699|NCT00090285|521573981|FG005|Extension 1|Withdrawal by Subject|0|||
144650700|NCT00090285|521573976|FG000|Extension 1|Other|0|||
144650701|NCT00090285|521573977|FG001|Extension 1|Other|0|||
144650702|NCT00090285|521573978|FG002|Extension 1|Other|4|||
144650703|NCT00090285|521573979|FG003|Extension 1|Other|0|||
144650704|NCT00090285|521573980|FG004|Extension 1|Other|0|||
144650705|NCT00090285|521573981|FG005|Extension 1|Other|0|||
144650706|NCT00090285|521573976|FG000|Extension 1|Moved|0|||
144650707|NCT00090285|521573977|FG001|Extension 1|Moved|0|||
144650708|NCT00090285|521573978|FG002|Extension 1|Moved|3|||
144650709|NCT00090285|521573979|FG003|Extension 1|Moved|0|||
144650710|NCT00090285|521573980|FG004|Extension 1|Moved|0|||
144650711|NCT00090285|521573981|FG005|Extension 1|Moved|0|||
144650712|NCT00090285|521573976|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
144650713|NCT00090285|521573977|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
144650714|NCT00090285|521573978|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
144650715|NCT00090285|521573979|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
144650716|NCT00090285|521573980|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
144650717|NCT00090285|521573981|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
144650718|NCT00090285|521573976|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144650719|NCT00090285|521573977|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144650720|NCT00090285|521573978|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144650721|NCT00090285|521573979|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144650722|NCT00090285|521573980|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
144650723|NCT00090285|521573981|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
144650724|NCT00090285|521573976|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144650725|NCT00090285|521573977|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144650726|NCT00090285|521573978|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144650727|NCT00090285|521573979|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144212092|NCT03682107|519970488|FG000|Overall Study|Withdrawal by Subject|0|||
144650728|NCT00090285|521573980|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
144650729|NCT00090285|521573981|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
144650730|NCT00090285|521573976|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
144650731|NCT00090285|521573977|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
144650732|NCT00090285|521573978|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
144650733|NCT00090285|521573979|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
144650734|NCT00090285|521573980|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
144650735|NCT00090285|521573981|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
144650736|NCT00907881|521573984|FG000|Overall Study|Lost to Follow-up|59|||
144650737|NCT00907881|521573984|FG000|Overall Study|Noncompliance|5|||
144650738|NCT00907881|521573984|FG000|Overall Study|Withdrawal by Subject|5|||
144650739|NCT00907881|521573984|FG000|Overall Study|Protocol Violation|1|||
144650740|NCT00907881|521573984|FG000|Overall Study|Missing discontinuation information|15|||
144650741|NCT01849848|521573992|FG000|Overall Study|Physician Decision|1|||
144650742|NCT01849848|521573992|FG000|Overall Study|Progression of the primary disease|3|||
144650743|NCT01070303|521573993|FG000|Overall Study|Adverse Event|39|||
144650744|NCT01070303|521573993|FG000|Overall Study|Withdrawal by Subject|20|||
144650745|NCT01070303|521573993|FG000|Overall Study|Lost to Follow-up|9|||
144212093|NCT03682107|519970489|FG001|Overall Study|Withdrawal by Subject|1|||
144212094|NCT03682107|519970490|FG002|Overall Study|Withdrawal by Subject|0|||
144650746|NCT01070303|521573993|FG000|Overall Study|Protocol Violation|0|||
144650747|NCT01070303|521573993|FG000|Overall Study|Lack of Efficacy|2|||
144212095|NCT03682107|519970491|FG003|Overall Study|Withdrawal by Subject|0|||
144650748|NCT01070303|521573993|FG000|Overall Study|Administrative Reason|1|||
144650749|NCT01070303|521573993|FG000|Overall Study|Other|18|||
144650750|NCT00859898|521573995|FG000|Overall Study|Lack of Efficacy|0|||
144650751|NCT00859898|521573996|FG001|Overall Study|Lack of Efficacy|1|||
144650752|NCT00859898|521573997|FG002|Overall Study|Lack of Efficacy|1|||
144212096|NCT03682107|519970492|FG004|Overall Study|Withdrawal by Subject|0|||
144650753|NCT00859898|521573995|FG000|Overall Study|Adverse Event|4|||
144650754|NCT00859898|521573996|FG001|Overall Study|Adverse Event|9|||
144650755|NCT00859898|521573997|FG002|Overall Study|Adverse Event|8|||
144650756|NCT00859898|521573995|FG000|Overall Study|Withdrawal by Subject|11|||
144650757|NCT00859898|521573996|FG001|Overall Study|Withdrawal by Subject|8|||
144650758|NCT00859898|521573997|FG002|Overall Study|Withdrawal by Subject|11|||
144650759|NCT00859898|521573995|FG000|Overall Study|Death|0|||
144650760|NCT00859898|521573996|FG001|Overall Study|Death|0|||
144650761|NCT00859898|521573997|FG002|Overall Study|Death|1|||
144650762|NCT00859898|521573995|FG000|Overall Study|Lost to Follow-up|10|||
144650763|NCT00859898|521573996|FG001|Overall Study|Lost to Follow-up|11|||
144650764|NCT00859898|521573997|FG002|Overall Study|Lost to Follow-up|5|||
144650765|NCT00859898|521573995|FG000|Overall Study|poor/non-compliance|2|||
144650766|NCT00859898|521573996|FG001|Overall Study|poor/non-compliance|0|||
144650767|NCT00859898|521573997|FG002|Overall Study|poor/non-compliance|0|||
144650768|NCT00859898|521573995|FG000|Overall Study|No longer meets criteria|0|||
144650769|NCT00859898|521573996|FG001|Overall Study|No longer meets criteria|1|||
144650770|NCT00859898|521573997|FG002|Overall Study|No longer meets criteria|0|||
144650771|NCT00859898|521573995|FG000|Overall Study|non-specified|1|||
144650772|NCT00859898|521573996|FG001|Overall Study|non-specified|1|||
144650773|NCT00859898|521573997|FG002|Overall Study|non-specified|1|||
144650774|NCT02417233|521574000|FG000|Overall Study|Death|4|||
144650775|NCT02417233|521574001|FG001|Overall Study|Death|10|||
144650776|NCT02417233|521574002|FG002|Overall Study|Death|14|||
144650777|NCT02417233|521574000|FG000|Overall Study|Lost to Follow-up|27|||
144650778|NCT02417233|521574001|FG001|Overall Study|Lost to Follow-up|39|||
144650779|NCT02417233|521574002|FG002|Overall Study|Lost to Follow-up|34|||
144650780|NCT02417233|521574000|FG000|Overall Study|Protocol Violation|2|||
144650781|NCT02417233|521574001|FG001|Overall Study|Protocol Violation|0|||
144650782|NCT02417233|521574002|FG002|Overall Study|Protocol Violation|2|||
144650783|NCT02417233|521574000|FG000|Overall Study|Withdrawal by Subject|2|||
144650784|NCT02417233|521574001|FG001|Overall Study|Withdrawal by Subject|1|||
144650785|NCT02417233|521574002|FG002|Overall Study|Withdrawal by Subject|8|||
144650786|NCT02417233|521574000|FG000|Overall Study|Relocation out of study area|1|||
144650787|NCT02417233|521574001|FG001|Overall Study|Relocation out of study area|0|||
144650788|NCT02417233|521574002|FG002|Overall Study|Relocation out of study area|1|||
144650789|NCT02417233|521574000|FG000|Overall Study|Mentally unstable|0|||
144650790|NCT02417233|521574001|FG001|Overall Study|Mentally unstable|1|||
144650791|NCT02417233|521574002|FG002|Overall Study|Mentally unstable|0|||
144650792|NCT00532883|521574003|FG000|Overall Study|Adverse Event|1|||
144650793|NCT00532883|521574004|FG001|Overall Study|Adverse Event|0|||
144650794|NCT00532883|521574005|FG002|Overall Study|Adverse Event|0|||
144650795|NCT00532883|521574006|FG003|Overall Study|Adverse Event|1|||
144650796|NCT00532883|521574003|FG000|Overall Study|Lost to Follow-up|1|||
144650797|NCT00532883|521574004|FG001|Overall Study|Lost to Follow-up|1|||
144650798|NCT00532883|521574005|FG002|Overall Study|Lost to Follow-up|1|||
144650799|NCT00532883|521574006|FG003|Overall Study|Lost to Follow-up|0|||
144650800|NCT00532883|521574003|FG000|Overall Study|Withdrawal by Subject|0|||
144650801|NCT00532883|521574004|FG001|Overall Study|Withdrawal by Subject|1|||
144650802|NCT00532883|521574005|FG002|Overall Study|Withdrawal by Subject|1|||
144650803|NCT00532883|521574006|FG003|Overall Study|Withdrawal by Subject|0|||
144650804|NCT00532883|521574003|FG000|Overall Study|Subject was Nonadherent|0|||
144650805|NCT00532883|521574004|FG001|Overall Study|Subject was Nonadherent|1|||
144650806|NCT00532883|521574005|FG002|Overall Study|Subject was Nonadherent|1|||
144650807|NCT00532883|521574006|FG003|Overall Study|Subject was Nonadherent|0|||
144650808|NCT00532883|521574003|FG000|Overall Study|Early Study Termination|4|||
144650809|NCT00532883|521574004|FG001|Overall Study|Early Study Termination|4|||
144212097|NCT00214383|519970495|FG000|Overall Study|Lost to Follow-up|16|||
144212098|NCT00214383|519970496|FG001|Overall Study|Lost to Follow-up|26|||
144212099|NCT00879411|519970497|FG000|Overall Study|lost to follow-up (non-AE)|162|||
144212100|NCT01038297|519970498|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
144212101|NCT01038297|519970499|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
144212102|NCT01038297|519970500|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
144212103|NCT00345631|519970507|FG000|Overall Study|Withdrawal by Subject|1|||
144650810|NCT00532883|521574005|FG002|Overall Study|Early Study Termination|1|||
144650811|NCT00532883|521574006|FG003|Overall Study|Early Study Termination|4|||
144650812|NCT03799718|521574007|FG000|Overall Study|Adverse Event|2|||
144650813|NCT05232097|521574008|FG000|Overall Study|Physician Decision|1|||
144650814|NCT00871858|521574009|FG000|Overall Study|Protocol Violation|3|||
144650815|NCT00871858|521574010|FG001|Overall Study|Protocol Violation|4|||
144650816|NCT00871858|521574009|FG000|Overall Study|Adverse Event|1|||
144650817|NCT00871858|521574010|FG001|Overall Study|Adverse Event|1|||
144650818|NCT00871858|521574009|FG000|Overall Study|Withdrawal by Subject|1|||
144650819|NCT00871858|521574010|FG001|Overall Study|Withdrawal by Subject|1|||
144650820|NCT00871858|521574009|FG000|Overall Study|Lost to Follow-up|0|||
144212104|NCT00345631|519970508|FG001|Overall Study|Withdrawal by Subject|0|||
144212105|NCT00345631|519970509|FG002|Overall Study|Withdrawal by Subject|1|||
144650821|NCT00871858|521574010|FG001|Overall Study|Lost to Follow-up|1|||
144650822|NCT01097330|521574014|FG000|Overall Study|Study terminated early|7|||
144650823|NCT01097330|521574015|FG001|Overall Study|Study terminated early|5|||
144650824|NCT03078608|521574020|FG000|Overall Study|Death|1|||
144650825|NCT03078608|521574021|FG001|Overall Study|Death|2|||
144650826|NCT03078608|521574022|FG002|Overall Study|Death|0|||
144650827|NCT03078608|521574023|FG003|Overall Study|Death|0|||
144650828|NCT03078608|521574020|FG000|Overall Study|Withdrawal by Subject|8|||
144650829|NCT03078608|521574021|FG001|Overall Study|Withdrawal by Subject|1|||
144650830|NCT03078608|521574022|FG002|Overall Study|Withdrawal by Subject|0|||
144650831|NCT03078608|521574023|FG003|Overall Study|Withdrawal by Subject|0|||
144212106|NCT00345631|519970507|FG000|Overall Study|Adverse Event|0|||
144212107|NCT00345631|519970508|FG001|Overall Study|Adverse Event|1|||
144212108|NCT00345631|519970509|FG002|Overall Study|Adverse Event|0|||
144212109|NCT00345631|519970507|FG000|Overall Study|Lost to Follow-up|3|||
144212110|NCT00345631|519970508|FG001|Overall Study|Lost to Follow-up|7|||
144212111|NCT00345631|519970509|FG002|Overall Study|Lost to Follow-up|4|||
144212112|NCT00345631|519970507|FG000|Overall Study|Other reasons|0|||
144212113|NCT00345631|519970508|FG001|Overall Study|Other reasons|0|||
144212114|NCT00345631|519970509|FG002|Overall Study|Other reasons|1|||
144212115|NCT01130597|519970517|FG000|Overall Study|Protocol-specified (High K+)|1|||
144212116|NCT01130597|519970517|FG000|Overall Study|Adverse Event|4|||
144212117|NCT01130597|519970517|FG000|Overall Study|Death|1|||
144212118|NCT01130597|519970517|FG000|Overall Study|Protocol Violation|1|||
144650832|NCT03078608|521574020|FG000|Overall Study|Lost to Follow-up|5|||
144650833|NCT03078608|521574021|FG001|Overall Study|Lost to Follow-up|8|||
144650834|NCT03078608|521574022|FG002|Overall Study|Lost to Follow-up|4|||
144731706|NCT00610363|521873248|FG000|Overall Study|Adverse Event|3|||
144731707|NCT00610363|521873249|FG001|Overall Study|Adverse Event|1|||
144731708|NCT00610363|521873248|FG000|Overall Study|Lack of Efficacy|2|||
144731709|NCT00610363|521873249|FG001|Overall Study|Lack of Efficacy|0|||
144731710|NCT00610363|521873248|FG000|Overall Study|Lost to Follow-up|4|||
144731711|NCT00610363|521873249|FG001|Overall Study|Lost to Follow-up|0|||
144731712|NCT00610363|521873248|FG000|Overall Study|Withdrawal by Subject|1|||
144731713|NCT00610363|521873249|FG001|Overall Study|Withdrawal by Subject|0|||
144731714|NCT00610363|521873248|FG000|Overall Study|Other than specified above|1|||
144731715|NCT00610363|521873249|FG001|Overall Study|Other than specified above|1|||
144731716|NCT03204539|521873250|FG000|Overall Study|Loss of funding|0|||
144731717|NCT03204539|521873251|FG001|Overall Study|Loss of funding|1|||
144731718|NCT03361228|521873263|FG000|Overall Study|Other|1|||
144731719|NCT03361228|521873264|FG001|Overall Study|Other|1|||
144731720|NCT03361228|521873263|FG000|Overall Study|Death|3|||
144731721|NCT03361228|521873264|FG001|Overall Study|Death|0|||
144731722|NCT00302952|521873265|FG000|Overall Study|Physician Decision|1|||
144731723|NCT00302952|521873266|FG001|Overall Study|Physician Decision|1|||
144731724|NCT00302952|521873265|FG000|Overall Study|Withdrawal by Subject|2|||
144731725|NCT00302952|521873266|FG001|Overall Study|Withdrawal by Subject|3|||
144731726|NCT00302952|521873265|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
144731727|NCT00302952|521873266|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
144731728|NCT00336479|521873267|FG000|Overall Study|Adverse Event|8|||
144731729|NCT00336479|521873268|FG001|Overall Study|Adverse Event|11|||
144731730|NCT00336479|521873269|FG002|Overall Study|Adverse Event|18|||
144731731|NCT00336479|521873270|FG003|Overall Study|Adverse Event|4|||
144731732|NCT00336479|521873267|FG000|Overall Study|Noncompliant|1|||
144731733|NCT00336479|521873268|FG001|Overall Study|Noncompliant|7|||
144212119|NCT03371459|519970518|FG000|Washout|Lost to Follow-up|0|||
144650835|NCT03078608|521574023|FG003|Overall Study|Lost to Follow-up|1|||
144650836|NCT00863928|521574029|FG000|Overall Study|Protocol Violation|26|||
144650837|NCT00863928|521574030|FG001|Overall Study|Protocol Violation|0|||
144650838|NCT00863928|521574029|FG000|Overall Study|Withdrawal by Subject|3|||
144650839|NCT00863928|521574030|FG001|Overall Study|Withdrawal by Subject|0|||
144650840|NCT00863928|521574029|FG000|Overall Study|surgery cancellation|4|||
144650841|NCT00863928|521574030|FG001|Overall Study|surgery cancellation|0|||
144650842|NCT00863928|521574029|FG000|Overall Study|medication allergy|3|||
144650843|NCT00863928|521574030|FG001|Overall Study|medication allergy|0|||
144650844|NCT02124798|521574031|FG000|Overall Study|Adverse Event|3|||
144650845|NCT02124798|521574031|FG000|Overall Study|Lost to Follow-up|1|||
144650846|NCT01137435|521574036|FG000|Overall Study|Lost to Follow-up|24|||
144650847|NCT01137435|521574036|FG000|Overall Study|Off label usage|4|||
144650848|NCT00487279|521574045|FG000|Overall Study|Death|1|||
144731734|NCT00336479|521873269|FG002|Overall Study|Noncompliant|3|||
144212120|NCT03371459|519970519|FG001|Washout|Lost to Follow-up|1|||
144212121|NCT01589497|519970520|FG000|Overall Study|Withdrawal by Subject|0|||
144650849|NCT00487279|521574046|FG001|Overall Study|Death|0|||
144650850|NCT00487279|521574045|FG000|Overall Study|Withdrawal by Subject|0|||
144731735|NCT00336479|521873270|FG003|Overall Study|Noncompliant|0|||
144731736|NCT00336479|521873267|FG000|Overall Study|Physician Decision|2|||
144731737|NCT00336479|521873268|FG001|Overall Study|Physician Decision|3|||
144212122|NCT01589497|519970521|FG001|Overall Study|Withdrawal by Subject|1|||
144212123|NCT01589497|519970522|FG002|Overall Study|Withdrawal by Subject|0|||
144212124|NCT01589497|519970523|FG003|Overall Study|Withdrawal by Subject|1|||
144212125|NCT01589497|519970520|FG000|Overall Study|Death|1|||
144650851|NCT00487279|521574046|FG001|Overall Study|Withdrawal by Subject|2|||
144650852|NCT02746679|521574047|FG000|Overall Study|Lost to Follow-up|4|||
144650853|NCT02746679|521574048|FG001|Overall Study|Lost to Follow-up|6|||
144650854|NCT00501852|521574049|FG000|Overall Study|Adverse Event|3|||
144650855|NCT00501852|521574049|FG000|Overall Study|Withdrawal by Subject|2|||
144731738|NCT00336479|521873269|FG002|Overall Study|Physician Decision|1|||
144731739|NCT00336479|521873270|FG003|Overall Study|Physician Decision|0|||
144731740|NCT00336479|521873267|FG000|Overall Study|Lost to Follow-up|3|||
144731741|NCT00336479|521873268|FG001|Overall Study|Lost to Follow-up|2|||
144650856|NCT01171521|521574052|FG000|Overall Study|Lost to Follow-up|5|||
144650857|NCT01171521|521574052|FG000|Overall Study|screen failure|1|||
144650858|NCT01416610|521574053|FG000|Overall Study|Adverse Event|4|||
144650859|NCT01416610|521574053|FG000|Overall Study|Adverse Event -Patient decision|3|||
144650860|NCT01416610|521574053|FG000|Overall Study|Lack of Efficacy|4|||
144650861|NCT01416610|521574053|FG000|Overall Study|No reason given|5|||
144650862|NCT01416610|521574053|FG000|Overall Study|Withdrawal by Subject|13|||
144650863|NCT01416610|521574053|FG000|Overall Study|Lost to Follow-up|7|||
144650864|NCT01416610|521574053|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
144650865|NCT01927562|521574054|FG000|Overall Study|Lost to Follow-up|30|||
144650866|NCT01927562|521574054|FG000|Overall Study|Withdrawal by Subject|3|||
144650867|NCT01927562|521574054|FG000|Overall Study|Physician Decision|5|||
144650868|NCT00651118|521574057|FG000|Overall Study|Adverse Event|4|||
144650869|NCT00651118|521574058|FG001|Overall Study|Adverse Event|0|||
144650870|NCT00651118|521574059|FG002|Overall Study|Adverse Event|1|||
144650871|NCT00651118|521574060|FG003|Overall Study|Adverse Event|1|||
144650872|NCT00651118|521574057|FG000|Overall Study|Protocol Violation|2|||
144650873|NCT00651118|521574058|FG001|Overall Study|Protocol Violation|2|||
144650874|NCT00651118|521574059|FG002|Overall Study|Protocol Violation|6|||
144650875|NCT00651118|521574060|FG003|Overall Study|Protocol Violation|2|||
144650876|NCT00651118|521574057|FG000|Overall Study|Lost to Follow-up|2|||
144650877|NCT00651118|521574058|FG001|Overall Study|Lost to Follow-up|0|||
144650878|NCT00651118|521574059|FG002|Overall Study|Lost to Follow-up|1|||
144650879|NCT00651118|521574060|FG003|Overall Study|Lost to Follow-up|2|||
144650880|NCT00651118|521574057|FG000|Overall Study|administrative|1|||
144650881|NCT00651118|521574058|FG001|Overall Study|administrative|4|||
144650882|NCT00651118|521574059|FG002|Overall Study|administrative|2|||
144650883|NCT00651118|521574060|FG003|Overall Study|administrative|1|||
144650884|NCT00651118|521574057|FG000|Overall Study|Withdrawal by Subject|0|||
144650885|NCT00651118|521574058|FG001|Overall Study|Withdrawal by Subject|1|||
144650886|NCT00651118|521574059|FG002|Overall Study|Withdrawal by Subject|1|||
144650887|NCT00651118|521574060|FG003|Overall Study|Withdrawal by Subject|1|||
144650888|NCT03117049|521574061|FG000|Overall Study|Continued the follow-up period|109|||
144650889|NCT03117049|521574062|FG001|Overall Study|Continued the follow-up period|129|||
144650890|NCT03117049|521574061|FG000|Overall Study|Died|82|||
144650891|NCT03117049|521574062|FG001|Overall Study|Died|93|||
144650892|NCT03117049|521574061|FG000|Overall Study|Consent withdrawal|7|||
144650893|NCT03117049|521574062|FG001|Overall Study|Consent withdrawal|6|||
144650894|NCT03117049|521574061|FG000|Overall Study|Missing contact|3|||
144650895|NCT03117049|521574062|FG001|Overall Study|Missing contact|3|||
144650896|NCT00839098|521574063|FG000|Overall Study|Withdrawal by Subject|2|||
144650897|NCT00839098|521574064|FG001|Overall Study|Withdrawal by Subject|1|||
144650898|NCT00839098|521574065|FG002|Overall Study|Withdrawal by Subject|7|||
144650899|NCT02399475|521574068|FG000|Overall Study|Physician Decision|1|||
144650900|NCT02399475|521574069|FG001|Overall Study|Physician Decision|0|||
144650901|NCT00935220|521574070|FG000|Overall Study|Adverse Event|1|||
144650902|NCT00935220|521574070|FG000|Overall Study|Other reason (not specified)|1|||
144650903|NCT01415440|521574073|FG000|Overall Study|Lost to Follow-up|0|||
144650904|NCT01415440|521574074|FG001|Overall Study|Lost to Follow-up|1|||
144650905|NCT01415440|521574075|FG002|Overall Study|Lost to Follow-up|2|||
144650906|NCT01415440|521574073|FG000|Overall Study|Physician Decision|3|||
144650907|NCT01415440|521574074|FG001|Overall Study|Physician Decision|0|||
144650908|NCT01415440|521574075|FG002|Overall Study|Physician Decision|0|||
144650909|NCT01415440|521574073|FG000|Overall Study|Withdrawal by Subject|1|||
144650910|NCT01415440|521574074|FG001|Overall Study|Withdrawal by Subject|0|||
144650911|NCT01415440|521574075|FG002|Overall Study|Withdrawal by Subject|0|||
144212126|NCT01589497|519970521|FG001|Overall Study|Death|0|||
144212127|NCT01589497|519970522|FG002|Overall Study|Death|0|||
144212128|NCT01589497|519970523|FG003|Overall Study|Death|0|||
144212129|NCT01589497|519970520|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
144212130|NCT01589497|519970521|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
144650912|NCT00633139|521574076|FG000|Overall Study|Non compliance|0|||
144650913|NCT00633139|521574077|FG001|Overall Study|Non compliance|0|||
144650914|NCT00633139|521574078|FG002|Overall Study|Non compliance|1|||
144650915|NCT00633139|521574076|FG000|Overall Study|Withdrawal by Subject|0|||
144650916|NCT00633139|521574077|FG001|Overall Study|Withdrawal by Subject|1|||
144650917|NCT00633139|521574078|FG002|Overall Study|Withdrawal by Subject|0|||
144650918|NCT02160977|521574081|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
144650919|NCT02160977|521574082|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
144650920|NCT02160977|521574081|FG000|Three Months After Surgery|Lost to Follow-up|0|||
144650921|NCT02160977|521574082|FG001|Three Months After Surgery|Lost to Follow-up|2|||
144650922|NCT02160977|521574081|FG000|Six Months After Surgery|Lost to Follow-up|2|||
144650923|NCT02160977|521574082|FG001|Six Months After Surgery|Lost to Follow-up|1|||
144650924|NCT01522651|521574084|FG000|Overall Study|Adverse Event|3|||
144650925|NCT01522651|521574085|FG001|Overall Study|Adverse Event|4|||
144650926|NCT01522651|521574086|FG002|Overall Study|Adverse Event|4|||
144263390|NCT00509899|520165417|FG003|Overall Study|Lack of Efficacy|0|||
144650927|NCT01522651|521574087|FG003|Overall Study|Adverse Event|5|||
144650928|NCT01522651|521574088|FG004|Overall Study|Adverse Event|4|||
144650929|NCT01522651|521574084|FG000|Overall Study|Cardioversion|1|||
144650930|NCT01522651|521574085|FG001|Overall Study|Cardioversion|0|||
144650931|NCT01522651|521574086|FG002|Overall Study|Cardioversion|0|||
144650932|NCT01522651|521574087|FG003|Overall Study|Cardioversion|0|||
144650933|NCT01522651|521574088|FG004|Overall Study|Cardioversion|0|||
144650934|NCT01522651|521574084|FG000|Overall Study|Device Malfunction|0|||
144650935|NCT01522651|521574085|FG001|Overall Study|Device Malfunction|1|||
144650936|NCT01522651|521574086|FG002|Overall Study|Device Malfunction|0|||
144650937|NCT01522651|521574087|FG003|Overall Study|Device Malfunction|0|||
144650938|NCT01522651|521574088|FG004|Overall Study|Device Malfunction|0|||
144650939|NCT01522651|521574084|FG000|Overall Study|Investigator's Discretion|0|||
144650940|NCT01522651|521574085|FG001|Overall Study|Investigator's Discretion|1|||
144650941|NCT01522651|521574086|FG002|Overall Study|Investigator's Discretion|0|||
144650942|NCT01522651|521574087|FG003|Overall Study|Investigator's Discretion|0|||
144650943|NCT01522651|521574088|FG004|Overall Study|Investigator's Discretion|0|||
144650944|NCT01522651|521574084|FG000|Overall Study|Protocol Violation|3|||
144650945|NCT01522651|521574085|FG001|Overall Study|Protocol Violation|0|||
144650946|NCT01522651|521574086|FG002|Overall Study|Protocol Violation|0|||
144650947|NCT01522651|521574087|FG003|Overall Study|Protocol Violation|0|||
144650948|NCT01522651|521574088|FG004|Overall Study|Protocol Violation|0|||
144650949|NCT01522651|521574084|FG000|Overall Study|Reason Not Specified|0|||
144650950|NCT01522651|521574085|FG001|Overall Study|Reason Not Specified|0|||
144650951|NCT01522651|521574086|FG002|Overall Study|Reason Not Specified|0|||
144650952|NCT01522651|521574087|FG003|Overall Study|Reason Not Specified|1|||
144650953|NCT01522651|521574088|FG004|Overall Study|Reason Not Specified|0|||
144650954|NCT01522651|521574084|FG000|Overall Study|Participant Non-Compliance|1|||
144650955|NCT01522651|521574085|FG001|Overall Study|Participant Non-Compliance|0|||
144650956|NCT01522651|521574086|FG002|Overall Study|Participant Non-Compliance|0|||
144650957|NCT01522651|521574087|FG003|Overall Study|Participant Non-Compliance|0|||
144650958|NCT01522651|521574088|FG004|Overall Study|Participant Non-Compliance|0|||
144650959|NCT01522651|521574084|FG000|Overall Study|Withdrew Consent|1|||
144650960|NCT01522651|521574085|FG001|Overall Study|Withdrew Consent|1|||
144650961|NCT01522651|521574086|FG002|Overall Study|Withdrew Consent|0|||
144650962|NCT01522651|521574087|FG003|Overall Study|Withdrew Consent|1|||
144650963|NCT01522651|521574088|FG004|Overall Study|Withdrew Consent|1|||
144650964|NCT01522651|521574084|FG000|Overall Study|Randomized but Never Treated|0|||
144650965|NCT01522651|521574085|FG001|Overall Study|Randomized but Never Treated|1|||
144650966|NCT01522651|521574086|FG002|Overall Study|Randomized but Never Treated|0|||
144650967|NCT01522651|521574087|FG003|Overall Study|Randomized but Never Treated|1|||
144650968|NCT01522651|521574088|FG004|Overall Study|Randomized but Never Treated|1|||
144650969|NCT02658656|521574089|FG000|Screening|Failed eligibility criteria|0|||
144650970|NCT02658656|521574090|FG001|Screening|Failed eligibility criteria|0|||
144650971|NCT02658656|521574091|FG002|Screening|Failed eligibility criteria|263|||
144650972|NCT02658656|521574089|FG000|Randomization|Withdrawal by Subject|8|||
144650973|NCT02658656|521574090|FG001|Randomization|Withdrawal by Subject|7|||
144650974|NCT02658656|521574091|FG002|Randomization|Withdrawal by Subject|0|||
144650975|NCT02658656|521574089|FG000|Randomization|Lost to Follow-up|1|||
144650976|NCT02658656|521574090|FG001|Randomization|Lost to Follow-up|3|||
144650977|NCT02658656|521574091|FG002|Randomization|Lost to Follow-up|0|||
144650978|NCT02658656|521574089|FG000|Randomization|Adverse Event|4|||
144650979|NCT02658656|521574090|FG001|Randomization|Adverse Event|0|||
144650980|NCT02658656|521574091|FG002|Randomization|Adverse Event|0|||
144650981|NCT02658656|521574089|FG000|Randomization|Administrative Termination|3|||
144650982|NCT02658656|521574090|FG001|Randomization|Administrative Termination|1|||
144650983|NCT02658656|521574091|FG002|Randomization|Administrative Termination|0|||
144650984|NCT02658656|521574089|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
144650985|NCT02658656|521574090|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
144650986|NCT02658656|521574091|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
144650987|NCT02658656|521574089|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
144650988|NCT02658656|521574090|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
144650989|NCT02658656|521574091|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
144650990|NCT02658656|521574089|FG000|Randomization|Not eligible for Randomization|1|||
144650991|NCT02658656|521574090|FG001|Randomization|Not eligible for Randomization|0|||
144650992|NCT02658656|521574091|FG002|Randomization|Not eligible for Randomization|0|||
144650993|NCT02658656|521574089|FG000|Randomization|Protocol Violation|1|||
144650994|NCT02658656|521574090|FG001|Randomization|Protocol Violation|0|||
144650995|NCT02658656|521574091|FG002|Randomization|Protocol Violation|0|||
144650996|NCT01118143|521574092|FG000|Overall Study|Withdrawal by Subject|2|||
144650997|NCT01118143|521574093|FG001|Overall Study|Withdrawal by Subject|5|||
144650998|NCT02112448|521574094|FG000|Overall Study|lab values precluding use of ketorolac|2|||
144650999|NCT02112448|521574095|FG001|Overall Study|lab values precluding use of ketorolac|2|||
144651000|NCT02112448|521574094|FG000|Overall Study|Protocol Violation|1|||
144651001|NCT02112448|521574095|FG001|Overall Study|Protocol Violation|2|||
144651002|NCT02112448|521574094|FG000|Overall Study|Physician Decision|4|||
144651003|NCT02112448|521574095|FG001|Overall Study|Physician Decision|6|||
144651004|NCT02112448|521574094|FG000|Overall Study|required heparin so could not use ketoro|1|||
144651005|NCT02112448|521574095|FG001|Overall Study|required heparin so could not use ketoro|0|||
144651006|NCT03132805|521575756|FG000|Overall Study|Lost to Follow-up|142|||
144651007|NCT03132805|521575757|FG001|Overall Study|Lost to Follow-up|141|||
144651008|NCT03132805|521575758|FG002|Overall Study|Lost to Follow-up|113|||
144651009|NCT03009539|521575759|FG000|Overall Study|Lost to Follow-up|132|||
144651010|NCT03009539|521575760|FG001|Overall Study|Lost to Follow-up|113|||
144651011|NCT03009539|521575761|FG002|Overall Study|Lost to Follow-up|132|||
144651012|NCT03009539|521575762|FG003|Overall Study|Lost to Follow-up|113|||
144651013|NCT03151148|521575763|FG000|Overall Study|Lost to Follow-up|1|||
144651014|NCT03151148|521575764|FG001|Overall Study|Lost to Follow-up|0|||
144651015|NCT03151148|521575763|FG000|Overall Study|Withdrawal by Subject|1|||
144651016|NCT03151148|521575764|FG001|Overall Study|Withdrawal by Subject|0|||
144651017|NCT00710034|521575765|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
144651018|NCT00710034|521575766|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
144651019|NCT00710034|521575765|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
144651020|NCT00710034|521575766|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
144651021|NCT00710034|521575765|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
144651022|NCT00710034|521575766|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
144651023|NCT00710034|521575765|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
144651024|NCT00710034|521575766|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
144651025|NCT00710034|521575765|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
144651026|NCT00710034|521575766|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
144651027|NCT00710034|521575765|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
144651028|NCT00710034|521575766|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
144651029|NCT00710034|521575765|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
144651030|NCT00710034|521575766|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
144651031|NCT00710034|521575765|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
144651032|NCT00710034|521575766|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
144651033|NCT00710034|521575765|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
144651034|NCT00710034|521575766|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
144651035|NCT00710034|521575765|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
144651036|NCT00710034|521575766|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
144651037|NCT00710034|521575765|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
144651038|NCT00710034|521575766|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
144651039|NCT01614769|521575769|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
144651040|NCT01614769|521575770|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
144651041|NCT01614769|521575771|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
144651042|NCT01614769|521575772|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
144651043|NCT01614769|521575773|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
144651044|NCT01614769|521575774|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
144651045|NCT01614769|521575769|FG000|Period 1|Protocol Violation|0|||
144651046|NCT01614769|521575770|FG001|Period 1|Protocol Violation|0|||
144651047|NCT01614769|521575771|FG002|Period 1|Protocol Violation|0|||
144651048|NCT01614769|521575772|FG003|Period 1|Protocol Violation|1|||
144651049|NCT01614769|521575773|FG004|Period 1|Protocol Violation|0|||
144651050|NCT01614769|521575774|FG005|Period 1|Protocol Violation|0|||
144651051|NCT01614769|521575769|FG000|Period 1|Withdrawal by Subject|1|||
144651052|NCT01614769|521575770|FG001|Period 1|Withdrawal by Subject|0|||
144651053|NCT01614769|521575771|FG002|Period 1|Withdrawal by Subject|0|||
144651054|NCT01614769|521575772|FG003|Period 1|Withdrawal by Subject|0|||
144651055|NCT01614769|521575773|FG004|Period 1|Withdrawal by Subject|0|||
144651056|NCT01614769|521575774|FG005|Period 1|Withdrawal by Subject|0|||
144651057|NCT01614769|521575769|FG000|Period 3|Withdrawal by Subject|0|||
144651058|NCT01614769|521575770|FG001|Period 3|Withdrawal by Subject|0|||
144651059|NCT01614769|521575771|FG002|Period 3|Withdrawal by Subject|1|||
144651060|NCT01614769|521575772|FG003|Period 3|Withdrawal by Subject|0|||
144651061|NCT01614769|521575773|FG004|Period 3|Withdrawal by Subject|0|||
144651062|NCT01614769|521575774|FG005|Period 3|Withdrawal by Subject|0|||
144651063|NCT04439838|521575777|FG000|Overall Study|Withdrawal by Subject|0|||
144651064|NCT04439838|521575778|FG001|Overall Study|Withdrawal by Subject|0|||
144651065|NCT04439838|521575779|FG002|Overall Study|Withdrawal by Subject|0|||
144651066|NCT04439838|521575780|FG003|Overall Study|Withdrawal by Subject|0|||
144651067|NCT04439838|521575781|FG004|Overall Study|Withdrawal by Subject|0|||
144651068|NCT04439838|521575782|FG005|Overall Study|Withdrawal by Subject|0|||
144651069|NCT04439838|521575783|FG006|Overall Study|Withdrawal by Subject|0|||
144651070|NCT04439838|521575784|FG007|Overall Study|Withdrawal by Subject|0|||
144651071|NCT04439838|521575785|FG008|Overall Study|Withdrawal by Subject|1|||
144651072|NCT01958671|521575788|FG000|Overall Study|Adverse Event|1|||
144651073|NCT01958671|521575789|FG001|Overall Study|Adverse Event|1|||
144651074|NCT01958671|521575790|FG002|Overall Study|Adverse Event|5|||
144651075|NCT01958671|521575788|FG000|Overall Study|Death|1|||
144651076|NCT01958671|521575789|FG001|Overall Study|Death|0|||
144651077|NCT01958671|521575790|FG002|Overall Study|Death|0|||
144731742|NCT00336479|521873269|FG002|Overall Study|Lost to Follow-up|0|||
144731743|NCT00336479|521873270|FG003|Overall Study|Lost to Follow-up|0|||
144731744|NCT00336479|521873267|FG000|Overall Study|Withdrawal by Subject|3|||
144731745|NCT00336479|521873268|FG001|Overall Study|Withdrawal by Subject|2|||
144731746|NCT00336479|521873269|FG002|Overall Study|Withdrawal by Subject|3|||
144731747|NCT00336479|521873270|FG003|Overall Study|Withdrawal by Subject|0|||
144731748|NCT00336479|521873267|FG000|Overall Study|Other|0|||
144731749|NCT00336479|521873268|FG001|Overall Study|Other|0|||
144731750|NCT00336479|521873269|FG002|Overall Study|Other|1|||
144651078|NCT01958671|521575788|FG000|Overall Study|Excluded medication|0|||
144651079|NCT01958671|521575789|FG001|Overall Study|Excluded medication|0|||
144651080|NCT01958671|521575790|FG002|Overall Study|Excluded medication|1|||
144651081|NCT01958671|521575788|FG000|Overall Study|Hyperglycemia|0|||
144651082|NCT01958671|521575789|FG001|Overall Study|Hyperglycemia|0|||
144651083|NCT01958671|521575790|FG002|Overall Study|Hyperglycemia|2|||
144651084|NCT01958671|521575788|FG000|Overall Study|Lost to Follow-up|7|||
144651085|NCT01958671|521575789|FG001|Overall Study|Lost to Follow-up|11|||
144651086|NCT01958671|521575790|FG002|Overall Study|Lost to Follow-up|7|||
144651087|NCT01958671|521575788|FG000|Overall Study|Non-compliance with study drug|1|||
144651088|NCT01958671|521575789|FG001|Overall Study|Non-compliance with study drug|1|||
144651089|NCT01958671|521575790|FG002|Overall Study|Non-compliance with study drug|1|||
144651090|NCT01958671|521575788|FG000|Overall Study|Pregnancy|0|||
144651091|NCT01958671|521575789|FG001|Overall Study|Pregnancy|0|||
144651092|NCT01958671|521575790|FG002|Overall Study|Pregnancy|1|||
144651093|NCT01958671|521575788|FG000|Overall Study|Protocol Violation|0|||
144651094|NCT01958671|521575789|FG001|Overall Study|Protocol Violation|1|||
144651095|NCT01958671|521575790|FG002|Overall Study|Protocol Violation|0|||
144651096|NCT01958671|521575788|FG000|Overall Study|Study site terminated by sponsor|1|||
144651097|NCT01958671|521575789|FG001|Overall Study|Study site terminated by sponsor|0|||
144651098|NCT01958671|521575790|FG002|Overall Study|Study site terminated by sponsor|1|||
144651099|NCT01958671|521575788|FG000|Overall Study|Participant moved|0|||
144651100|NCT01958671|521575789|FG001|Overall Study|Participant moved|0|||
144651101|NCT01958671|521575790|FG002|Overall Study|Participant moved|1|||
144651102|NCT01958671|521575788|FG000|Overall Study|Withdrawal by Subject|8|||
144651103|NCT01958671|521575789|FG001|Overall Study|Withdrawal by Subject|10|||
144651104|NCT01958671|521575790|FG002|Overall Study|Withdrawal by Subject|13|||
144651105|NCT02778867|521575791|FG000|Phase 1|Withdrawal by Subject|2|||
144651106|NCT02778867|521575792|FG001|Phase 1|Withdrawal by Subject|3|||
144651107|NCT02778867|521575793|FG002|Phase 1|Withdrawal by Subject|0|||
144651108|NCT02778867|521575794|FG003|Phase 1|Withdrawal by Subject|0|||
144651109|NCT02778867|521575791|FG000|Phase 2|Withdrawal by Subject|0|||
144651110|NCT02778867|521575792|FG001|Phase 2|Withdrawal by Subject|0|||
144651111|NCT02778867|521575793|FG002|Phase 2|Withdrawal by Subject|1|||
144651112|NCT02778867|521575794|FG003|Phase 2|Withdrawal by Subject|0|||
144651113|NCT02778867|521575791|FG000|Phase 2|Physician Decision|0|||
144651114|NCT02778867|521575792|FG001|Phase 2|Physician Decision|0|||
144651115|NCT02778867|521575793|FG002|Phase 2|Physician Decision|0|||
144651116|NCT02778867|521575794|FG003|Phase 2|Physician Decision|1|||
144651117|NCT02778867|521575791|FG000|Phase 2|Adverse Event|0|||
144651118|NCT02778867|521575792|FG001|Phase 2|Adverse Event|0|||
144651119|NCT02778867|521575793|FG002|Phase 2|Adverse Event|0|||
144651120|NCT02778867|521575794|FG003|Phase 2|Adverse Event|1|||
144651121|NCT00960440|521575796|FG000|Overall Study|Death|0|||
144651122|NCT00960440|521575797|FG001|Overall Study|Death|0|||
144651123|NCT00960440|521575798|FG002|Overall Study|Death|0|||
144651124|NCT00960440|521575799|FG003|Overall Study|Death|1|||
144651125|NCT00960440|521575796|FG000|Overall Study|Adverse Event|12|||
144651126|NCT00960440|521575797|FG001|Overall Study|Adverse Event|12|||
144651127|NCT00960440|521575798|FG002|Overall Study|Adverse Event|4|||
144651128|NCT00960440|521575799|FG003|Overall Study|Adverse Event|4|||
144651129|NCT00960440|521575796|FG000|Overall Study|Lack of Efficacy|2|||
144651130|NCT00960440|521575797|FG001|Overall Study|Lack of Efficacy|5|||
144731751|NCT00336479|521873270|FG003|Overall Study|Other|0|||
144731752|NCT00336479|521873267|FG000|Overall Study|Virologic Stopping Rule|20|||
144731753|NCT00336479|521873268|FG001|Overall Study|Virologic Stopping Rule|0|||
144731754|NCT00336479|521873269|FG002|Overall Study|Virologic Stopping Rule|0|||
144731755|NCT00336479|521873270|FG003|Overall Study|Virologic Stopping Rule|0|||
144651131|NCT00960440|521575798|FG002|Overall Study|Lack of Efficacy|3|||
144651132|NCT00960440|521575799|FG003|Overall Study|Lack of Efficacy|8|||
144651133|NCT00960440|521575796|FG000|Overall Study|Protocol Violation|2|||
144651134|NCT00960440|521575797|FG001|Overall Study|Protocol Violation|8|||
144651135|NCT00960440|521575798|FG002|Overall Study|Protocol Violation|3|||
144651136|NCT00960440|521575799|FG003|Overall Study|Protocol Violation|4|||
144651137|NCT00960440|521575796|FG000|Overall Study|Withdrawal by Subject|9|||
144651138|NCT00960440|521575797|FG001|Overall Study|Withdrawal by Subject|5|||
144651139|NCT00960440|521575798|FG002|Overall Study|Withdrawal by Subject|2|||
144651140|NCT00960440|521575799|FG003|Overall Study|Withdrawal by Subject|1|||
144651141|NCT00960440|521575796|FG000|Overall Study|Other|1|||
144651142|NCT00960440|521575797|FG001|Overall Study|Other|1|||
144731756|NCT00855738|521873279|FG000|Overall Study|Lost to Follow-up|2|||
144651143|NCT00960440|521575798|FG002|Overall Study|Other|1|||
144651144|NCT00960440|521575799|FG003|Overall Study|Other|0|||
144651145|NCT01312428|521575802|FG000|Overall Study|Study Termination|3|||
144651146|NCT01312428|521575803|FG001|Overall Study|Study Termination|4|||
144651147|NCT02202031|521575804|FG000|Overall Study|Lost to Follow-up|1|||
144651148|NCT02202031|521575805|FG001|Overall Study|Lost to Follow-up|0|||
144651149|NCT02202031|521575804|FG000|Overall Study|Too Busy|1|||
144651150|NCT02202031|521575805|FG001|Overall Study|Too Busy|3|||
144651151|NCT02202031|521575804|FG000|Overall Study|Illness/Medical Reason|0|||
144651152|NCT02202031|521575805|FG001|Overall Study|Illness/Medical Reason|2|||
144651153|NCT02202031|521575804|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
144651154|NCT02202031|521575805|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
144651155|NCT02184143|521575806|FG000|Overall Study|Withdrawal by Subject|4|||
144651156|NCT02184143|521575807|FG001|Overall Study|Withdrawal by Subject|4|||
144651157|NCT02184143|521575806|FG000|Overall Study|Lost to Follow-up|5|||
144651158|NCT02184143|521575807|FG001|Overall Study|Lost to Follow-up|3|||
144651159|NCT02184143|521575806|FG000|Overall Study|Death|1|||
144651160|NCT02184143|521575807|FG001|Overall Study|Death|0|||
144651161|NCT00321984|521575810|FG000|Overall Study|Adverse Event|9|||
144651162|NCT00321984|521575811|FG001|Overall Study|Adverse Event|6|||
144651163|NCT00321984|521575812|FG002|Overall Study|Adverse Event|8|||
144651164|NCT00321984|521575810|FG000|Overall Study|Protocol Violation|0|||
144651165|NCT00321984|521575811|FG001|Overall Study|Protocol Violation|1|||
144651166|NCT00321984|521575812|FG002|Overall Study|Protocol Violation|1|||
144651167|NCT00321984|521575810|FG000|Overall Study|Lost to Follow-up|2|||
144651168|NCT00321984|521575811|FG001|Overall Study|Lost to Follow-up|4|||
144651169|NCT00321984|521575812|FG002|Overall Study|Lost to Follow-up|2|||
144651170|NCT00321984|521575810|FG000|Overall Study|Withdrawal by Subject|8|||
144651171|NCT00321984|521575811|FG001|Overall Study|Withdrawal by Subject|6|||
144651172|NCT00321984|521575812|FG002|Overall Study|Withdrawal by Subject|5|||
144651173|NCT00321984|521575810|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
144651174|NCT00321984|521575811|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
144651175|NCT00321984|521575812|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
144651176|NCT00321984|521575810|FG000|Overall Study|Lack of Efficacy|3|||
144651177|NCT00321984|521575811|FG001|Overall Study|Lack of Efficacy|1|||
144651178|NCT00321984|521575812|FG002|Overall Study|Lack of Efficacy|3|||
144651179|NCT00321984|521575810|FG000|Overall Study|Noncompliant|0|||
144651180|NCT00321984|521575811|FG001|Overall Study|Noncompliant|0|||
144651181|NCT00321984|521575812|FG002|Overall Study|Noncompliant|2|||
144651182|NCT00321984|521575810|FG000|Overall Study|Pregnancy|0|||
144651183|NCT00321984|521575811|FG001|Overall Study|Pregnancy|1|||
144651184|NCT00321984|521575812|FG002|Overall Study|Pregnancy|0|||
144651185|NCT00321984|521575810|FG000|Overall Study|Per Subject Request|1|||
144651186|NCT00321984|521575811|FG001|Overall Study|Per Subject Request|0|||
144651187|NCT00321984|521575812|FG002|Overall Study|Per Subject Request|0|||
144651188|NCT00321984|521575810|FG000|Overall Study|Per Investigator Request|1|||
144651189|NCT00321984|521575811|FG001|Overall Study|Per Investigator Request|0|||
144651190|NCT00321984|521575812|FG002|Overall Study|Per Investigator Request|0|||
144651191|NCT00321984|521575810|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
144651192|NCT00321984|521575811|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
144651193|NCT00321984|521575812|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
144651194|NCT01024465|521575813|FG000|Overall Study|Adverse Event|2|||
144651195|NCT01024465|521575813|FG000|Overall Study|Physician Decision|1|||
144651196|NCT01734993|521575814|FG000|Overall Study|Adverse Event|1|||
144651197|NCT01734993|521575814|FG000|Overall Study|Lack of Efficacy|1|||
144651198|NCT03303339|521575817|FG000|Overall Study|Death|2|||
144651199|NCT03303339|521575818|FG001|Overall Study|Death|2|||
144651200|NCT03303339|521575819|FG002|Overall Study|Death|2|||
144651201|NCT03303339|521575820|FG003|Overall Study|Death|1|||
144212131|NCT01589497|519970522|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
144212132|NCT01589497|519970523|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
144651202|NCT03303339|521575821|FG004|Overall Study|Death|4|||
144651203|NCT03303339|521575822|FG005|Overall Study|Death|2|||
144651204|NCT03303339|521575823|FG006|Overall Study|Death|2|||
144651205|NCT03303339|521575824|FG007|Overall Study|Death|2|||
144651206|NCT03303339|521575825|FG008|Overall Study|Death|3|||
144651207|NCT03303339|521575826|FG009|Overall Study|Death|3|||
144651208|NCT03303339|521575827|FG010|Overall Study|Death|4|||
144651209|NCT03303339|521575828|FG011|Overall Study|Death|24|||
144651210|NCT03303339|521575817|FG000|Overall Study|Study Terminated by Sponsor|0|||
144651211|NCT03303339|521575818|FG001|Overall Study|Study Terminated by Sponsor|0|||
144651212|NCT03303339|521575819|FG002|Overall Study|Study Terminated by Sponsor|0|||
144651213|NCT03303339|521575820|FG003|Overall Study|Study Terminated by Sponsor|0|||
144651214|NCT03303339|521575821|FG004|Overall Study|Study Terminated by Sponsor|0|||
144651215|NCT03303339|521575822|FG005|Overall Study|Study Terminated by Sponsor|0|||
144651216|NCT03303339|521575823|FG006|Overall Study|Study Terminated by Sponsor|0|||
144651217|NCT03303339|521575824|FG007|Overall Study|Study Terminated by Sponsor|0|||
144651218|NCT03303339|521575825|FG008|Overall Study|Study Terminated by Sponsor|1|||
144651219|NCT03303339|521575826|FG009|Overall Study|Study Terminated by Sponsor|0|||
144651220|NCT03303339|521575827|FG010|Overall Study|Study Terminated by Sponsor|1|||
144651221|NCT03303339|521575828|FG011|Overall Study|Study Terminated by Sponsor|1|||
144651222|NCT03303339|521575817|FG000|Overall Study|Withdrawal by Subject|1|||
144651223|NCT03303339|521575818|FG001|Overall Study|Withdrawal by Subject|0|||
144651224|NCT03303339|521575819|FG002|Overall Study|Withdrawal by Subject|0|||
144651225|NCT03303339|521575820|FG003|Overall Study|Withdrawal by Subject|0|||
144651226|NCT03303339|521575821|FG004|Overall Study|Withdrawal by Subject|0|||
144651227|NCT03303339|521575822|FG005|Overall Study|Withdrawal by Subject|1|||
144651228|NCT03303339|521575823|FG006|Overall Study|Withdrawal by Subject|1|||
144651229|NCT03303339|521575824|FG007|Overall Study|Withdrawal by Subject|0|||
144651230|NCT03303339|521575825|FG008|Overall Study|Withdrawal by Subject|0|||
144651231|NCT03303339|521575826|FG009|Overall Study|Withdrawal by Subject|0|||
144651232|NCT03303339|521575827|FG010|Overall Study|Withdrawal by Subject|0|||
144651233|NCT03303339|521575828|FG011|Overall Study|Withdrawal by Subject|2|||
144651234|NCT03303339|521575817|FG000|Overall Study|Physician Decision|0|||
144651235|NCT03303339|521575818|FG001|Overall Study|Physician Decision|0|||
144651236|NCT03303339|521575819|FG002|Overall Study|Physician Decision|0|||
144212133|NCT02516553|519970528|FG000|Overall Study|Progressive disease|2|||
144212134|NCT02516553|519970529|FG001|Overall Study|Progressive disease|2|||
144212135|NCT02516553|519970530|FG002|Overall Study|Progressive disease|3|||
144212136|NCT02516553|519970531|FG003|Overall Study|Progressive disease|5|||
144212137|NCT02516553|519970532|FG004|Overall Study|Progressive disease|3|||
144212138|NCT02516553|519970533|FG005|Overall Study|Progressive disease|0|||
144212139|NCT02516553|519970534|FG006|Overall Study|Progressive disease|5|||
144212140|NCT02516553|519970535|FG007|Overall Study|Progressive disease|5|||
144212141|NCT02516553|519970536|FG008|Overall Study|Progressive disease|11|||
144212142|NCT02516553|519970537|FG009|Overall Study|Progressive disease|3|||
144212143|NCT02516553|519970538|FG010|Overall Study|Progressive disease|10|||
144212144|NCT02516553|519970539|FG011|Overall Study|Progressive disease|8|||
144212145|NCT02516553|519970540|FG012|Overall Study|Progressive disease|8|||
144212146|NCT02516553|519970541|FG013|Overall Study|Progressive disease|2|||
144212147|NCT02516553|519970542|FG014|Overall Study|Progressive disease|2|||
144212148|NCT02516553|519970543|FG015|Overall Study|Progressive disease|2|||
144212149|NCT02516553|519970544|FG016|Overall Study|Progressive disease|1|||
144212150|NCT02516553|519970545|FG017|Overall Study|Progressive disease|9|||
144212151|NCT02516553|519970546|FG018|Overall Study|Progressive disease|12|||
144212152|NCT02516553|519970547|FG019|Overall Study|Progressive disease|7|||
144212153|NCT02516553|519970548|FG020|Overall Study|Progressive disease|16|||
144212154|NCT02516553|519970549|FG021|Overall Study|Progressive disease|18|||
144212155|NCT02516553|519970528|FG000|Overall Study|Dose limiting toxicity|0|||
144212156|NCT02516553|519970529|FG001|Overall Study|Dose limiting toxicity|0|||
144212157|NCT02516553|519970530|FG002|Overall Study|Dose limiting toxicity|0|||
144212158|NCT02516553|519970531|FG003|Overall Study|Dose limiting toxicity|0|||
144212159|NCT02516553|519970532|FG004|Overall Study|Dose limiting toxicity|3|||
144212160|NCT02516553|519970533|FG005|Overall Study|Dose limiting toxicity|1|||
144212161|NCT02516553|519970534|FG006|Overall Study|Dose limiting toxicity|1|||
144212162|NCT02516553|519970535|FG007|Overall Study|Dose limiting toxicity|0|||
144212163|NCT02516553|519970536|FG008|Overall Study|Dose limiting toxicity|1|||
144212164|NCT02516553|519970537|FG009|Overall Study|Dose limiting toxicity|0|||
144212165|NCT02516553|519970538|FG010|Overall Study|Dose limiting toxicity|0|||
144212166|NCT02516553|519970539|FG011|Overall Study|Dose limiting toxicity|1|||
144212167|NCT02516553|519970540|FG012|Overall Study|Dose limiting toxicity|0|||
144212168|NCT02516553|519970541|FG013|Overall Study|Dose limiting toxicity|1|||
144212169|NCT02516553|519970542|FG014|Overall Study|Dose limiting toxicity|0|||
144212170|NCT02516553|519970543|FG015|Overall Study|Dose limiting toxicity|0|||
144212171|NCT02516553|519970544|FG016|Overall Study|Dose limiting toxicity|1|||
144212172|NCT02516553|519970545|FG017|Overall Study|Dose limiting toxicity|1|||
144212173|NCT02516553|519970546|FG018|Overall Study|Dose limiting toxicity|0|||
144212174|NCT02516553|519970547|FG019|Overall Study|Dose limiting toxicity|2|||
144212175|NCT02516553|519970548|FG020|Overall Study|Dose limiting toxicity|0|||
144212176|NCT02516553|519970549|FG021|Overall Study|Dose limiting toxicity|0|||
144212177|NCT02516553|519970528|FG000|Overall Study|Other Adverse Events|0|||
144212178|NCT02516553|519970529|FG001|Overall Study|Other Adverse Events|0|||
144212179|NCT02516553|519970530|FG002|Overall Study|Other Adverse Events|0|||
144651237|NCT03303339|521575820|FG003|Overall Study|Physician Decision|0|||
144212180|NCT02516553|519970531|FG003|Overall Study|Other Adverse Events|1|||
144212181|NCT02516553|519970532|FG004|Overall Study|Other Adverse Events|0|||
144212182|NCT02516553|519970533|FG005|Overall Study|Other Adverse Events|1|||
144212183|NCT02516553|519970534|FG006|Overall Study|Other Adverse Events|0|||
144212184|NCT02516553|519970535|FG007|Overall Study|Other Adverse Events|0|||
144212185|NCT02516553|519970536|FG008|Overall Study|Other Adverse Events|0|||
144212186|NCT02516553|519970537|FG009|Overall Study|Other Adverse Events|1|||
144212187|NCT02516553|519970538|FG010|Overall Study|Other Adverse Events|3|||
144651238|NCT03303339|521575821|FG004|Overall Study|Physician Decision|1|||
144212188|NCT02516553|519970539|FG011|Overall Study|Other Adverse Events|2|||
144212189|NCT02516553|519970540|FG012|Overall Study|Other Adverse Events|0|||
144263391|NCT00509899|520165418|FG004|Overall Study|Lack of Efficacy|0|||
144651239|NCT03303339|521575822|FG005|Overall Study|Physician Decision|0|||
144651240|NCT03303339|521575823|FG006|Overall Study|Physician Decision|0|||
144651241|NCT03303339|521575824|FG007|Overall Study|Physician Decision|0|||
144651242|NCT03303339|521575825|FG008|Overall Study|Physician Decision|0|||
144651243|NCT03303339|521575826|FG009|Overall Study|Physician Decision|0|||
144651244|NCT03303339|521575827|FG010|Overall Study|Physician Decision|0|||
144651245|NCT03303339|521575828|FG011|Overall Study|Physician Decision|0|||
144651246|NCT03303339|521575817|FG000|Overall Study|Safety/Non-compliance|0|||
144651247|NCT03303339|521575818|FG001|Overall Study|Safety/Non-compliance|0|||
144651248|NCT03303339|521575819|FG002|Overall Study|Safety/Non-compliance|0|||
144651249|NCT03303339|521575820|FG003|Overall Study|Safety/Non-compliance|0|||
144651250|NCT03303339|521575821|FG004|Overall Study|Safety/Non-compliance|0|||
144651251|NCT03303339|521575822|FG005|Overall Study|Safety/Non-compliance|0|||
144651252|NCT03303339|521575823|FG006|Overall Study|Safety/Non-compliance|0|||
144651253|NCT03303339|521575824|FG007|Overall Study|Safety/Non-compliance|0|||
144651254|NCT03303339|521575825|FG008|Overall Study|Safety/Non-compliance|0|||
144651255|NCT03303339|521575826|FG009|Overall Study|Safety/Non-compliance|0|||
144651256|NCT03303339|521575827|FG010|Overall Study|Safety/Non-compliance|0|||
144651257|NCT03303339|521575828|FG011|Overall Study|Safety/Non-compliance|1|||
144651258|NCT01400971|521575829|FG000|Overall Study|Death|82|||
144651259|NCT01400971|521575829|FG000|Overall Study|Lost to Follow-up|196|||
144651260|NCT01400971|521575829|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
144651261|NCT01400971|521575829|FG000|Overall Study|Physician Decision|57|||
144651262|NCT01400971|521575829|FG000|Overall Study|Withdrawal by Subject|158|||
144651263|NCT01400971|521575829|FG000|Overall Study|Other|422|||
144651264|NCT00642616|521575835|FG000|Overall Study|Adverse Event|2|||
144651265|NCT00642616|521575836|FG001|Overall Study|Adverse Event|0|||
144651266|NCT00642616|521575837|FG002|Overall Study|Adverse Event|1|||
144731757|NCT00855738|521873279|FG000|Overall Study|Adverse Event|1|||
144731758|NCT00855738|521873279|FG000|Overall Study|Subject Defaulted|1|||
144731759|NCT00855738|521873279|FG000|Overall Study|Death|1|||
144731760|NCT04320849|521873280|FG000|Overall Study|Withdrawal by Subject|4|||
144731761|NCT04320849|521873280|FG000|Overall Study|Imaging data unavailable|2|||
144731762|NCT04320849|521873280|FG000|Overall Study|Incomplete imaging|2|||
144731763|NCT03929393|521873283|FG000|Overall Study|Death|1|||
144731764|NCT03929393|521873284|FG001|Overall Study|Death|0|||
144731765|NCT03929393|521873283|FG000|Overall Study|Time Commitment|2|||
144651267|NCT00642616|521575838|FG003|Overall Study|Adverse Event|0|||
144651268|NCT00642616|521575835|FG000|Overall Study|Study Terminated by Sponsor|7|||
144651269|NCT00642616|521575836|FG001|Overall Study|Study Terminated by Sponsor|6|||
144651270|NCT00642616|521575837|FG002|Overall Study|Study Terminated by Sponsor|4|||
144651271|NCT00642616|521575838|FG003|Overall Study|Study Terminated by Sponsor|5|||
144651272|NCT00642616|521575835|FG000|Overall Study|Withdrawal by Subject|0|||
144651273|NCT00642616|521575836|FG001|Overall Study|Withdrawal by Subject|1|||
144651274|NCT00642616|521575837|FG002|Overall Study|Withdrawal by Subject|1|||
144651275|NCT00642616|521575838|FG003|Overall Study|Withdrawal by Subject|1|||
144651276|NCT00642616|521575835|FG000|Overall Study|Protocol Violation|0|||
144651277|NCT00642616|521575836|FG001|Overall Study|Protocol Violation|0|||
144651278|NCT00642616|521575837|FG002|Overall Study|Protocol Violation|2|||
144651279|NCT00642616|521575838|FG003|Overall Study|Protocol Violation|0|||
144651280|NCT00642616|521575835|FG000|Overall Study|Physician Decision|0|||
144651281|NCT00642616|521575836|FG001|Overall Study|Physician Decision|0|||
144651282|NCT00642616|521575837|FG002|Overall Study|Physician Decision|1|||
144651283|NCT00642616|521575838|FG003|Overall Study|Physician Decision|1|||
144651284|NCT00399802|521575839|FG000|Overall Study|Adverse Event|0|||
144651285|NCT00399802|521575840|FG001|Overall Study|Adverse Event|2|||
144651286|NCT00399802|521575839|FG000|Overall Study|Participant discontinued by mistake|0|||
144651287|NCT00399802|521575840|FG001|Overall Study|Participant discontinued by mistake|1|||
144651288|NCT00542815|521575845|FG000|Overall Study|Adverse Event|19|||
144651289|NCT00542815|521575846|FG001|Overall Study|Adverse Event|6|||
144651290|NCT00542815|521575847|FG002|Overall Study|Adverse Event|9|||
144651291|NCT00542815|521575845|FG000|Overall Study|Death|10|||
144651292|NCT00542815|521575846|FG001|Overall Study|Death|7|||
144651293|NCT00542815|521575847|FG002|Overall Study|Death|3|||
144651294|NCT00542815|521575845|FG000|Overall Study|Lack of Efficacy|9|||
144651295|NCT00542815|521575846|FG001|Overall Study|Lack of Efficacy|2|||
144651296|NCT00542815|521575847|FG002|Overall Study|Lack of Efficacy|0|||
144651297|NCT00542815|521575845|FG000|Overall Study|Physician Decision|2|||
144731766|NCT03929393|521873284|FG001|Overall Study|Time Commitment|5|||
144651298|NCT00542815|521575846|FG001|Overall Study|Physician Decision|1|||
144651299|NCT00542815|521575847|FG002|Overall Study|Physician Decision|0|||
144651300|NCT00542815|521575845|FG000|Overall Study|Protocol Violation|1|||
144651301|NCT00542815|521575846|FG001|Overall Study|Protocol Violation|1|||
144651302|NCT00542815|521575847|FG002|Overall Study|Protocol Violation|2|||
144731767|NCT03929393|521873283|FG000|Overall Study|Motor Vehicle Accident|0|||
144731768|NCT03929393|521873284|FG001|Overall Study|Motor Vehicle Accident|1|||
144651303|NCT00542815|521575845|FG000|Overall Study|Withdrawal by Subject|41|||
144651304|NCT00542815|521575846|FG001|Overall Study|Withdrawal by Subject|5|||
144731769|NCT03929393|521873283|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
144263392|NCT00509899|520165419|FG005|Overall Study|Lack of Efficacy|1|||
144263393|NCT00509899|520165420|FG006|Overall Study|Lack of Efficacy|0|||
144263394|NCT00509899|520165421|FG007|Overall Study|Lack of Efficacy|0|||
144263395|NCT01711983|520165426|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
144263396|NCT01711983|520165426|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
144263397|NCT01711983|520165426|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
144263398|NCT01711983|520165426|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
144263399|NCT00737100|520165427|FG000|Overall Study|Adverse Event|6|||
144263400|NCT00737100|520165428|FG001|Overall Study|Adverse Event|5|||
144263401|NCT00737100|520165429|FG002|Overall Study|Adverse Event|3|||
144263402|NCT00737100|520165427|FG000|Overall Study|Lost to Follow-up|0|||
144263403|NCT00737100|520165428|FG001|Overall Study|Lost to Follow-up|1|||
144263404|NCT00737100|520165429|FG002|Overall Study|Lost to Follow-up|0|||
144263405|NCT00737100|520165427|FG000|Overall Study|Withdrawal by Subject|0|||
144263406|NCT00737100|520165428|FG001|Overall Study|Withdrawal by Subject|0|||
144263407|NCT00737100|520165429|FG002|Overall Study|Withdrawal by Subject|3|||
144263408|NCT00737100|520165427|FG000|Overall Study|Reason discontinued not explained above|1|||
144263409|NCT00737100|520165428|FG001|Overall Study|Reason discontinued not explained above|1|||
144263410|NCT00737100|520165429|FG002|Overall Study|Reason discontinued not explained above|1|||
144263411|NCT03713684|520165432|FG000|Overall Study|Adverse Event|1|||
144263412|NCT03713684|520165433|FG001|Overall Study|Adverse Event|3|||
144263413|NCT03713684|520165434|FG002|Overall Study|Adverse Event|1|||
144263414|NCT03713684|520165435|FG003|Overall Study|Adverse Event|0|||
144263415|NCT03713684|520165432|FG000|Overall Study|Poor compliance to protocol|2|||
144263416|NCT03713684|520165433|FG001|Overall Study|Poor compliance to protocol|1|||
144263417|NCT03713684|520165434|FG002|Overall Study|Poor compliance to protocol|0|||
144263418|NCT03713684|520165435|FG003|Overall Study|Poor compliance to protocol|1|||
144263419|NCT03713684|520165432|FG000|Overall Study|Withdrawal by Subject|14|||
144263420|NCT03713684|520165433|FG001|Overall Study|Withdrawal by Subject|6|||
144263421|NCT03713684|520165434|FG002|Overall Study|Withdrawal by Subject|14|||
144263422|NCT03713684|520165435|FG003|Overall Study|Withdrawal by Subject|16|||
144263423|NCT03713684|520165432|FG000|Overall Study|Other than specified|69|||
144263424|NCT03713684|520165433|FG001|Overall Study|Other than specified|77|||
144263425|NCT03713684|520165434|FG002|Overall Study|Other than specified|73|||
144263426|NCT03713684|520165435|FG003|Overall Study|Other than specified|70|||
144263427|NCT00528424|520165436|FG000|Overall Study|Lost to Follow-up|13|||
144263428|NCT00528424|520165436|FG000|Overall Study|Withdrew consent|2|||
144651305|NCT00542815|521575847|FG002|Overall Study|Withdrawal by Subject|8|||
144651306|NCT00542815|521575845|FG000|Overall Study|Other reasons|24|||
144651307|NCT00542815|521575846|FG001|Overall Study|Other reasons|10|||
144651308|NCT00542815|521575847|FG002|Overall Study|Other reasons|10|||
144651309|NCT01041573|521575850|FG000|Overall Study|Withdrawal by Subject|2|||
144651310|NCT01041573|521575851|FG001|Overall Study|Withdrawal by Subject|5|||
144651311|NCT01041573|521575852|FG002|Overall Study|Withdrawal by Subject|2|||
144651312|NCT01041573|521575853|FG003|Overall Study|Withdrawal by Subject|0|||
144651313|NCT01041573|521575850|FG000|Overall Study|Death|1|||
144651314|NCT01041573|521575851|FG001|Overall Study|Death|0|||
144651315|NCT01041573|521575852|FG002|Overall Study|Death|0|||
144651316|NCT01041573|521575853|FG003|Overall Study|Death|0|||
144651317|NCT01041573|521575850|FG000|Overall Study|Lost to Follow-up|0|||
144651318|NCT01041573|521575851|FG001|Overall Study|Lost to Follow-up|1|||
144651319|NCT01041573|521575852|FG002|Overall Study|Lost to Follow-up|2|||
144651320|NCT01041573|521575853|FG003|Overall Study|Lost to Follow-up|1|||
144651321|NCT01041573|521575850|FG000|Overall Study|Adverse Event|0|||
144651322|NCT01041573|521575851|FG001|Overall Study|Adverse Event|2|||
144651323|NCT01041573|521575852|FG002|Overall Study|Adverse Event|0|||
144651324|NCT01041573|521575853|FG003|Overall Study|Adverse Event|0|||
144651325|NCT01041573|521575850|FG000|Overall Study|relocation|1|||
144651326|NCT01041573|521575851|FG001|Overall Study|relocation|4|||
144651327|NCT01041573|521575852|FG002|Overall Study|relocation|3|||
144651328|NCT01041573|521575853|FG003|Overall Study|relocation|1|||
144651329|NCT01041573|521575850|FG000|Overall Study|further blood extraction|0|||
144651330|NCT01041573|521575851|FG001|Overall Study|further blood extraction|1|||
144651331|NCT01041573|521575852|FG002|Overall Study|further blood extraction|0|||
144651332|NCT01041573|521575853|FG003|Overall Study|further blood extraction|0|||
144651333|NCT01041573|521575850|FG000|Overall Study|positive to anti-HCV|1|||
144651334|NCT01041573|521575851|FG001|Overall Study|positive to anti-HCV|0|||
144263429|NCT00528424|520165436|FG000|Overall Study|Administrative reason|2|||
144651335|NCT01041573|521575852|FG002|Overall Study|positive to anti-HCV|0|||
144263430|NCT00528424|520165436|FG000|Overall Study|Other|12|||
144263431|NCT02595502|520165437|FG000|Period 1|Adverse Event|0|||
144263432|NCT02595502|520165438|FG001|Period 1|Adverse Event|1|||
144651336|NCT01041573|521575853|FG003|Overall Study|positive to anti-HCV|0|||
144651337|NCT02955186|521575854|FG000|Overall Study|Withdrawal by Subject|6|||
144651338|NCT02955186|521575855|FG001|Overall Study|Withdrawal by Subject|2|||
144651339|NCT02955186|521575854|FG000|Overall Study|Protocol Violation|1|||
144651340|NCT02955186|521575855|FG001|Overall Study|Protocol Violation|0|||
144651341|NCT01618656|521575858|FG000|Overall Study|Withdrawal by Subject|7|||
144651342|NCT01618656|521575859|FG001|Overall Study|Withdrawal by Subject|3|||
144651343|NCT01618656|521575858|FG000|Overall Study|Physician Decision|1|||
144651344|NCT01618656|521575859|FG001|Overall Study|Physician Decision|1|||
144651345|NCT01899144|521575860|FG000|Treatment Period 2|Other|1|||
144651346|NCT01899144|521575860|FG000|Treatment Period 3|Other|2|||
144651347|NCT01899144|521575860|FG000|Treatment Period 5|Other|1|||
144651348|NCT00751881|521575863|FG000|Core Treatment Period|Not treated|1|||
144651349|NCT00751881|521575864|FG001|Core Treatment Period|Not treated|1|||
144651350|NCT00751881|521575865|FG002|Core Treatment Period|Not treated|2|||
144651351|NCT00751881|521575863|FG000|Core Treatment Period|Adverse Event|26|||
144651352|NCT00751881|521575864|FG001|Core Treatment Period|Adverse Event|54|||
144651353|NCT00751881|521575865|FG002|Core Treatment Period|Adverse Event|58|||
144651354|NCT00751881|521575863|FG000|Core Treatment Period|Lack of Efficacy|37|||
144651355|NCT00751881|521575864|FG001|Core Treatment Period|Lack of Efficacy|30|||
144651356|NCT00751881|521575865|FG002|Core Treatment Period|Lack of Efficacy|20|||
144651357|NCT00751881|521575863|FG000|Core Treatment Period|Poor compliance to protocol|15|||
144651358|NCT00751881|521575864|FG001|Core Treatment Period|Poor compliance to protocol|3|||
144651359|NCT00751881|521575865|FG002|Core Treatment Period|Poor compliance to protocol|4|||
144651360|NCT00751881|521575863|FG000|Core Treatment Period|Lost to Follow-up|6|||
144651361|NCT00751881|521575864|FG001|Core Treatment Period|Lost to Follow-up|4|||
144651362|NCT00751881|521575865|FG002|Core Treatment Period|Lost to Follow-up|3|||
144651363|NCT00751881|521575863|FG000|Core Treatment Period|Other: protocol deviation|3|||
144651364|NCT00751881|521575864|FG001|Core Treatment Period|Other: protocol deviation|3|||
144651365|NCT00751881|521575865|FG002|Core Treatment Period|Other: protocol deviation|7|||
144651366|NCT00751881|521575863|FG000|Core Treatment Period|Other: wish to parent|5|||
144651367|NCT00751881|521575864|FG001|Core Treatment Period|Other: wish to parent|7|||
144651368|NCT00751881|521575865|FG002|Core Treatment Period|Other: wish to parent|4|||
144651369|NCT00751881|521575863|FG000|Core Treatment Period|Other: personal/family constraints|6|||
144651370|NCT00751881|521575864|FG001|Core Treatment Period|Other: personal/family constraints|7|||
144651371|NCT00751881|521575865|FG002|Core Treatment Period|Other: personal/family constraints|10|||
144651372|NCT00751881|521575863|FG000|Core Treatment Period|Other: MS treatment change|6|||
144651373|NCT00751881|521575864|FG001|Core Treatment Period|Other: MS treatment change|4|||
144651374|NCT00751881|521575865|FG002|Core Treatment Period|Other: MS treatment change|4|||
144651375|NCT00751881|521575863|FG000|Core Treatment Period|Other: tolerability complaints|2|||
144651376|NCT00751881|521575864|FG001|Core Treatment Period|Other: tolerability complaints|0|||
144651377|NCT00751881|521575865|FG002|Core Treatment Period|Other: tolerability complaints|0|||
144651378|NCT00751881|521575863|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
144651379|NCT00751881|521575864|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
144651380|NCT00751881|521575865|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
144651381|NCT00751881|521575863|FG000|Extension Study Period|Adverse Event|18|||
144651382|NCT00751881|521575864|FG001|Extension Study Period|Adverse Event|20|||
144651383|NCT00751881|521575865|FG002|Extension Study Period|Adverse Event|21|||
144651384|NCT00751881|521575863|FG000|Extension Study Period|Lack of Efficacy|14|||
144651385|NCT00751881|521575864|FG001|Extension Study Period|Lack of Efficacy|10|||
144651386|NCT00751881|521575865|FG002|Extension Study Period|Lack of Efficacy|20|||
144651387|NCT00751881|521575863|FG000|Extension Study Period|Lost to Follow-up|4|||
144651388|NCT00751881|521575864|FG001|Extension Study Period|Lost to Follow-up|9|||
144651389|NCT00751881|521575865|FG002|Extension Study Period|Lost to Follow-up|6|||
144651390|NCT00751881|521575863|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
144651391|NCT00751881|521575864|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
144651392|NCT00751881|521575865|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
144651393|NCT00751881|521575863|FG000|Extension Study Period|Other than specified above|26|||
144651394|NCT00751881|521575864|FG001|Extension Study Period|Other than specified above|30|||
144651395|NCT00751881|521575865|FG002|Extension Study Period|Other than specified above|18|||
144651396|NCT04770155|521575866|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651397|NCT04770155|521575867|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651398|NCT04770155|521575868|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651399|NCT04770155|521575869|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651400|NCT04770155|521575870|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651401|NCT04770155|521575871|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651402|NCT04770155|521575872|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651403|NCT04770155|521575873|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
144651404|NCT00864227|521575874|FG000|Overall Study|Withdrawal by Subject|1|||
144651405|NCT00864227|521575874|FG000|Overall Study|Disease Relapse/Progression|3|||
144651406|NCT03241173|521575875|FG000|Overall Study|Death|3|||
144651407|NCT03241173|521575876|FG001|Overall Study|Death|2|||
144651408|NCT03241173|521575877|FG002|Overall Study|Death|4|||
144651409|NCT03241173|521575878|FG003|Overall Study|Death|4|||
144651410|NCT03241173|521575879|FG004|Overall Study|Death|2|||
144651411|NCT03241173|521575880|FG005|Overall Study|Death|2|||
144651412|NCT03241173|521575881|FG006|Overall Study|Death|3|||
144651413|NCT03241173|521575882|FG007|Overall Study|Death|1|||
144651414|NCT03241173|521575883|FG008|Overall Study|Death|0|||
144651415|NCT03241173|521575884|FG009|Overall Study|Death|5|||
144651416|NCT03241173|521575885|FG010|Overall Study|Death|4|||
144651417|NCT03241173|521575886|FG011|Overall Study|Death|3|||
144651418|NCT03241173|521575887|FG012|Overall Study|Death|0|||
144651419|NCT03241173|521575888|FG013|Overall Study|Death|0|||
144651420|NCT03241173|521575889|FG014|Overall Study|Death|0|||
144651421|NCT03241173|521575875|FG000|Overall Study|Withdrawal by Subject|0|||
144651422|NCT03241173|521575876|FG001|Overall Study|Withdrawal by Subject|0|||
144651423|NCT03241173|521575877|FG002|Overall Study|Withdrawal by Subject|1|||
144651424|NCT03241173|521575878|FG003|Overall Study|Withdrawal by Subject|0|||
144651425|NCT03241173|521575879|FG004|Overall Study|Withdrawal by Subject|0|||
144651426|NCT03241173|521575880|FG005|Overall Study|Withdrawal by Subject|1|||
144651427|NCT03241173|521575881|FG006|Overall Study|Withdrawal by Subject|0|||
144651428|NCT03241173|521575882|FG007|Overall Study|Withdrawal by Subject|0|||
144651429|NCT03241173|521575883|FG008|Overall Study|Withdrawal by Subject|0|||
144651430|NCT03241173|521575884|FG009|Overall Study|Withdrawal by Subject|0|||
144651431|NCT03241173|521575885|FG010|Overall Study|Withdrawal by Subject|0|||
144651432|NCT03241173|521575886|FG011|Overall Study|Withdrawal by Subject|0|||
144651433|NCT03241173|521575887|FG012|Overall Study|Withdrawal by Subject|0|||
144651434|NCT03241173|521575888|FG013|Overall Study|Withdrawal by Subject|0|||
144651435|NCT03241173|521575889|FG014|Overall Study|Withdrawal by Subject|0|||
144651436|NCT03241173|521575875|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
144651437|NCT03241173|521575876|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
144651438|NCT03241173|521575877|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
144651439|NCT03241173|521575878|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
144651440|NCT03241173|521575879|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
144651441|NCT03241173|521575880|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
144651442|NCT03241173|521575881|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
144651443|NCT03241173|521575882|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
144651444|NCT03241173|521575883|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
144651445|NCT03241173|521575884|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
144651446|NCT03241173|521575885|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
144651447|NCT03241173|521575886|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
144651448|NCT03241173|521575887|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
144651449|NCT03241173|521575888|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
144651450|NCT03241173|521575889|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
144651451|NCT03241173|521575875|FG000|Overall Study|Lost to Follow-up|0|||
144651452|NCT03241173|521575876|FG001|Overall Study|Lost to Follow-up|0|||
144651453|NCT03241173|521575877|FG002|Overall Study|Lost to Follow-up|0|||
144731770|NCT03929393|521873284|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
144731771|NCT03929393|521873283|FG000|Overall Study|Other|1|||
144731772|NCT03929393|521873284|FG001|Overall Study|Other|3|||
144731773|NCT00319735|521873285|FG000|Overall Study|Death|2|||
144731774|NCT03262012|521873295|FG000|Overall Study|Withdrawal by Subject|15|||
144731775|NCT03262012|521873296|FG001|Overall Study|Withdrawal by Subject|13|||
144731776|NCT03262012|521873297|FG002|Overall Study|Withdrawal by Subject|8|||
144731777|NCT03262012|521873298|FG003|Overall Study|Withdrawal by Subject|7|||
144731778|NCT03262012|521873295|FG000|Overall Study|Adverse Event|10|||
144731779|NCT03262012|521873296|FG001|Overall Study|Adverse Event|12|||
144731780|NCT03262012|521873297|FG002|Overall Study|Adverse Event|4|||
144731781|NCT03262012|521873298|FG003|Overall Study|Adverse Event|6|||
144212190|NCT02516553|519970541|FG013|Overall Study|Other Adverse Events|1|||
144212191|NCT02516553|519970542|FG014|Overall Study|Other Adverse Events|0|||
144212192|NCT02516553|519970543|FG015|Overall Study|Other Adverse Events|0|||
144212193|NCT02516553|519970544|FG016|Overall Study|Other Adverse Events|0|||
144212194|NCT02516553|519970545|FG017|Overall Study|Other Adverse Events|2|||
144212195|NCT02516553|519970546|FG018|Overall Study|Other Adverse Events|1|||
144212196|NCT02516553|519970547|FG019|Overall Study|Other Adverse Events|2|||
144212197|NCT02516553|519970548|FG020|Overall Study|Other Adverse Events|2|||
144731782|NCT03262012|521873295|FG000|Overall Study|Physician Decision|2|||
144212198|NCT02516553|519970549|FG021|Overall Study|Other Adverse Events|1|||
144212199|NCT02516553|519970528|FG000|Overall Study|Refused to continue trial medication|0|||
144212200|NCT02516553|519970529|FG001|Overall Study|Refused to continue trial medication|0|||
144263433|NCT02595502|520165437|FG000|Period 1|Withdrawal by Subject|1|||
144731783|NCT03262012|521873296|FG001|Overall Study|Physician Decision|5|||
144731784|NCT03262012|521873297|FG002|Overall Study|Physician Decision|1|||
144651454|NCT03241173|521575878|FG003|Overall Study|Lost to Follow-up|0|||
144651455|NCT03241173|521575879|FG004|Overall Study|Lost to Follow-up|1|||
144651456|NCT03241173|521575880|FG005|Overall Study|Lost to Follow-up|0|||
144651457|NCT03241173|521575881|FG006|Overall Study|Lost to Follow-up|0|||
144651458|NCT03241173|521575882|FG007|Overall Study|Lost to Follow-up|0|||
144651459|NCT03241173|521575883|FG008|Overall Study|Lost to Follow-up|0|||
144651460|NCT03241173|521575884|FG009|Overall Study|Lost to Follow-up|1|||
144651461|NCT03241173|521575885|FG010|Overall Study|Lost to Follow-up|0|||
144651462|NCT03241173|521575886|FG011|Overall Study|Lost to Follow-up|0|||
144651463|NCT03241173|521575887|FG012|Overall Study|Lost to Follow-up|0|||
144651464|NCT03241173|521575888|FG013|Overall Study|Lost to Follow-up|0|||
144651465|NCT03241173|521575889|FG014|Overall Study|Lost to Follow-up|0|||
144651466|NCT01765764|521575890|FG000|Treatment Period|Adverse Event|1|||
144651467|NCT01765764|521575891|FG001|Treatment Period|Adverse Event|2|||
144651468|NCT01765764|521575892|FG002|Treatment Period|Adverse Event|1|||
144651469|NCT01765764|521575890|FG000|Treatment Period|Lost to Follow-up|0|||
144651470|NCT01765764|521575891|FG001|Treatment Period|Lost to Follow-up|3|||
144651471|NCT01765764|521575892|FG002|Treatment Period|Lost to Follow-up|2|||
144651472|NCT01765764|521575890|FG000|Treatment Period|Personal Reasons|1|||
144651473|NCT01765764|521575891|FG001|Treatment Period|Personal Reasons|2|||
144651474|NCT01765764|521575892|FG002|Treatment Period|Personal Reasons|1|||
144651475|NCT01765764|521575890|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
144651476|NCT01765764|521575891|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
144651477|NCT01765764|521575892|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
144651478|NCT02144220|521575893|FG000|Overall Study|technology incompatibility|9|||
144651479|NCT02144220|521575893|FG000|Overall Study|Lack of Efficacy|4|||
144651480|NCT02144220|521575893|FG000|Overall Study|Physician Decision|3|||
144651481|NCT02144220|521575893|FG000|Overall Study|Withdrawal by Subject|2|||
144651482|NCT02144220|521575893|FG000|Overall Study|Protocol Violation|1|||
144651483|NCT03242759|521575898|FG000|Overall Study|Adverse Event|5|||
144651484|NCT03242759|521575899|FG001|Overall Study|Adverse Event|1|||
144651485|NCT03242759|521575898|FG000|Overall Study|Withdrawal by Subject|4|||
144651486|NCT03242759|521575899|FG001|Overall Study|Withdrawal by Subject|3|||
144651487|NCT03242759|521575898|FG000|Overall Study|Lost to Follow-up|3|||
144651488|NCT03242759|521575899|FG001|Overall Study|Lost to Follow-up|1|||
144651489|NCT03242759|521575898|FG000|Overall Study|Administrative problems|1|||
144651490|NCT03242759|521575899|FG001|Overall Study|Administrative problems|1|||
144651491|NCT03242759|521575898|FG000|Overall Study|Death|22|||
144651492|NCT03242759|521575899|FG001|Overall Study|Death|0|||
144651493|NCT03242759|521575898|FG000|Overall Study|Change visit schedule|0|||
144651494|NCT03242759|521575899|FG001|Overall Study|Change visit schedule|1|||
144651495|NCT00798967|521575906|FG000|Overall Study|Adverse Event|2|||
144651496|NCT00798967|521575907|FG001|Overall Study|Adverse Event|3|||
144651497|NCT00798967|521575906|FG000|Overall Study|Withdrawal by Subject|0|||
144651498|NCT00798967|521575907|FG001|Overall Study|Withdrawal by Subject|1|||
144651499|NCT00798967|521575906|FG000|Overall Study|Physician Decision|1|||
144651500|NCT00798967|521575907|FG001|Overall Study|Physician Decision|0|||
144651501|NCT00798967|521575906|FG000|Overall Study|Randomized in error by site|1|||
144651502|NCT00798967|521575907|FG001|Overall Study|Randomized in error by site|0|||
144651503|NCT00227877|521575910|FG000|Pre-visit Assessment|Technical difficulties|7|||
144651504|NCT00227877|521575911|FG001|Pre-visit Assessment|Technical difficulties|3|||
144651505|NCT00227877|521575912|FG002|Pre-visit Assessment|Technical difficulties|0|||
144651506|NCT00227877|521575913|FG003|Pre-visit Assessment|Technical difficulties|0|||
144651507|NCT00227877|521575910|FG000|Post-visit Checklist|Lost to Follow-up|24|||
144651508|NCT00227877|521575911|FG001|Post-visit Checklist|Lost to Follow-up|13|||
144651509|NCT00227877|521575912|FG002|Post-visit Checklist|Lost to Follow-up|1|||
144651510|NCT00227877|521575913|FG003|Post-visit Checklist|Lost to Follow-up|0|||
144651511|NCT00227877|521575910|FG000|3-months Follow-up|Completed late|135|||
144651512|NCT00227877|521575911|FG001|3-months Follow-up|Completed late|128|||
144651513|NCT00227877|521575912|FG002|3-months Follow-up|Completed late|34|||
144651514|NCT00227877|521575913|FG003|3-months Follow-up|Completed late|8|||
144651515|NCT00227877|521575910|FG000|3-months Follow-up|Lost to Follow-up|178|||
144651516|NCT00227877|521575911|FG001|3-months Follow-up|Lost to Follow-up|139|||
144651517|NCT00227877|521575912|FG002|3-months Follow-up|Lost to Follow-up|18|||
144651518|NCT00227877|521575913|FG003|3-months Follow-up|Lost to Follow-up|13|||
144651519|NCT00227877|521575910|FG000|12-months Follow-up|Completed late|78|||
144651520|NCT00227877|521575911|FG001|12-months Follow-up|Completed late|74|||
144263434|NCT02595502|520165438|FG001|Period 1|Withdrawal by Subject|0|||
144651521|NCT00227877|521575912|FG002|12-months Follow-up|Completed late|1|||
144651522|NCT00227877|521575913|FG003|12-months Follow-up|Completed late|0|||
144651523|NCT00227877|521575910|FG000|12-months Follow-up|Lost to Follow-up|232|||
144651524|NCT00227877|521575911|FG001|12-months Follow-up|Lost to Follow-up|189|||
144651525|NCT00227877|521575912|FG002|12-months Follow-up|Lost to Follow-up|30|||
144651526|NCT00227877|521575913|FG003|12-months Follow-up|Lost to Follow-up|26|||
144651527|NCT03103750|521575916|FG000|Overall Study|Adverse Event|1|||
144651528|NCT03103750|521575917|FG001|Overall Study|Adverse Event|0|||
144651529|NCT03103750|521575916|FG000|Overall Study|Lost to Follow-up|1|||
144651530|NCT03103750|521575917|FG001|Overall Study|Lost to Follow-up|0|||
144651531|NCT03103750|521575916|FG000|Overall Study|PET Equipment Related|2|||
144651532|NCT03103750|521575917|FG001|Overall Study|PET Equipment Related|2|||
144651533|NCT01663740|521575918|FG000|Overall Study|Lost to Follow-up|1|||
144651534|NCT01663740|521575919|FG001|Overall Study|Lost to Follow-up|4|||
144651535|NCT01663740|521575918|FG000|Overall Study|Other|9|||
144651536|NCT01663740|521575919|FG001|Overall Study|Other|2|||
144651537|NCT01663740|521575918|FG000|Overall Study|Inclusion/Exclusion not met|1|||
144651538|NCT01663740|521575919|FG001|Overall Study|Inclusion/Exclusion not met|0|||
144651539|NCT01663740|521575918|FG000|Overall Study|Death|0|||
144651540|NCT01663740|521575919|FG001|Overall Study|Death|1|||
144651541|NCT01663740|521575918|FG000|Overall Study|Withdrawal by Subject|2|||
144651542|NCT01663740|521575919|FG001|Overall Study|Withdrawal by Subject|1|||
144651543|NCT01663740|521575918|FG000|Overall Study|No end of study status|3|||
144651544|NCT01663740|521575919|FG001|Overall Study|No end of study status|0|||
144651545|NCT02522481|521575920|FG000|Overall Study|discontinued|1|||
144651546|NCT02522481|521575920|FG000|Overall Study|Not dosed|2|||
144651547|NCT03123939|521575923|FG000|Overall Study|Lack of Efficacy|6|||
144651548|NCT03123939|521575923|FG000|Overall Study|Death|5|||
144651549|NCT03123939|521575923|FG000|Overall Study|Physician Decision|2|||
144651550|NCT03123939|521575923|FG000|Overall Study|Subject/guardian decision|2|||
144651551|NCT03123939|521575923|FG000|Overall Study|Lost to Follow-up|1|||
144651552|NCT03123939|521575923|FG000|Overall Study|New therapy for study indication|1|||
144651553|NCT03123939|521575923|FG000|Overall Study|Protocol deviation|1|||
144651554|NCT03123939|521575923|FG000|Overall Study|Progressive disease|18|||
144651555|NCT03123939|521575923|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
144651556|NCT03123939|521575923|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
144651557|NCT04267562|521577576|FG000|Assessed for Eligibility|Screen Failure|64|||
144651558|NCT04267562|521577576|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
144651559|NCT04267562|521577576|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
144651560|NCT04267562|521577576|FG000|Assessed for Eligibility|Site closure|6|||
144651561|NCT04267562|521577576|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
144651562|NCT04267562|521577576|FG000|Assessed for Eligibility|Physician Decision|1|||
144651563|NCT04267562|521577576|FG000|Month 24|Elective hysterectomy|1|||
144651564|NCT04267562|521577576|FG000|Month 24|Lost to Follow-up|1|||
144651565|NCT04267562|521577576|FG000|Month 36|Elective hysterectomy|2|||
144651566|NCT04267562|521577576|FG000|Month 36|Lost to Follow-up|3|||
144651567|NCT01937130|521577578|FG000|Overall Study|Withdrawal by Subject|0|||
144651568|NCT01937130|521577579|FG001|Overall Study|Withdrawal by Subject|0|||
144651569|NCT01937130|521577580|FG002|Overall Study|Withdrawal by Subject|0|||
144651570|NCT01937130|521577581|FG003|Overall Study|Withdrawal by Subject|1|||
144651571|NCT01937130|521577578|FG000|Overall Study|Adverse Event|0|||
144651572|NCT01937130|521577579|FG001|Overall Study|Adverse Event|1|||
144651573|NCT01937130|521577580|FG002|Overall Study|Adverse Event|0|||
144651574|NCT01937130|521577581|FG003|Overall Study|Adverse Event|1|||
144651575|NCT01937130|521577578|FG000|Overall Study|Death|1|||
144651576|NCT01937130|521577579|FG001|Overall Study|Death|1|||
144651577|NCT01937130|521577580|FG002|Overall Study|Death|1|||
144651578|NCT01937130|521577581|FG003|Overall Study|Death|0|||
144651579|NCT01937130|521577578|FG000|Overall Study|Lost to Follow-up|2|||
144651580|NCT01937130|521577579|FG001|Overall Study|Lost to Follow-up|0|||
144651581|NCT01937130|521577580|FG002|Overall Study|Lost to Follow-up|2|||
144651582|NCT01937130|521577581|FG003|Overall Study|Lost to Follow-up|0|||
144651583|NCT01937130|521577578|FG000|Overall Study|Physician Decision|0|||
144651584|NCT01937130|521577579|FG001|Overall Study|Physician Decision|1|||
144651585|NCT01937130|521577580|FG002|Overall Study|Physician Decision|0|||
144651586|NCT01937130|521577581|FG003|Overall Study|Physician Decision|0|||
144651587|NCT01937130|521577578|FG000|Overall Study|Patients unable to swallow|0|||
144651588|NCT01937130|521577579|FG001|Overall Study|Patients unable to swallow|1|||
144651589|NCT01937130|521577580|FG002|Overall Study|Patients unable to swallow|0|||
144651590|NCT01937130|521577581|FG003|Overall Study|Patients unable to swallow|0|||
144651591|NCT01937130|521577578|FG000|Overall Study|Patient lost to FU due to death|2|||
144651592|NCT01937130|521577579|FG001|Overall Study|Patient lost to FU due to death|0|||
144651593|NCT01937130|521577580|FG002|Overall Study|Patient lost to FU due to death|0|||
144651594|NCT01937130|521577581|FG003|Overall Study|Patient lost to FU due to death|0|||
144651595|NCT01850563|521577582|FG000|Overall Study|Not eligible|3|||
144651596|NCT01850563|521577583|FG001|Overall Study|Not eligible|0|||
144651597|NCT01431144|521577584|FG000|Overall Study|Implant mobility and removal|2|||
144651598|NCT01431144|521577585|FG001|Overall Study|Implant mobility and removal|0|||
144651599|NCT00408421|521577586|FG000|Treatment Initial Randomization|Adverse Event|5|||
144651600|NCT00408421|521577587|FG001|Treatment Initial Randomization|Adverse Event|9|||
144651601|NCT00408421|521577588|FG002|Treatment Initial Randomization|Adverse Event|0|||
144651602|NCT00408421|521577586|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
144651603|NCT00408421|521577587|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
144651604|NCT00408421|521577588|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
144651605|NCT00408421|521577586|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
144651606|NCT00408421|521577587|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
144731785|NCT03262012|521873298|FG003|Overall Study|Physician Decision|0|||
144651607|NCT00408421|521577588|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
144651608|NCT00408421|521577586|FG000|Treatment Initial Randomization|Physician Decision|1|||
144651609|NCT00408421|521577587|FG001|Treatment Initial Randomization|Physician Decision|0|||
144651610|NCT00408421|521577588|FG002|Treatment Initial Randomization|Physician Decision|0|||
144651611|NCT00408421|521577586|FG000|Treatment Initial Randomization|Protocol Violation|0|||
144651612|NCT00408421|521577587|FG001|Treatment Initial Randomization|Protocol Violation|1|||
144651613|NCT00408421|521577588|FG002|Treatment Initial Randomization|Protocol Violation|0|||
144651614|NCT00408421|521577586|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
144651615|NCT00408421|521577587|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
144651616|NCT00408421|521577588|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
144651617|NCT00408421|521577586|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
144651618|NCT00408421|521577587|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
144651619|NCT00408421|521577588|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
144651620|NCT00408421|521577586|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
144651621|NCT00408421|521577587|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
144651622|NCT00408421|521577588|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
144651623|NCT00408421|521577586|FG000|Treatment Re-Randomization|Adverse Event|2|||
144651624|NCT00408421|521577587|FG001|Treatment Re-Randomization|Adverse Event|2|||
144651625|NCT00408421|521577588|FG002|Treatment Re-Randomization|Adverse Event|4|||
144651626|NCT00408421|521577586|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
144651627|NCT00408421|521577587|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
144651628|NCT00408421|521577588|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
144651629|NCT00408421|521577586|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
144651630|NCT00408421|521577587|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
144651631|NCT00408421|521577588|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
144651632|NCT00408421|521577586|FG000|Treatment Re-Randomization|Physician Decision|1|||
144651633|NCT00408421|521577587|FG001|Treatment Re-Randomization|Physician Decision|3|||
144651634|NCT00408421|521577588|FG002|Treatment Re-Randomization|Physician Decision|0|||
144651635|NCT00408421|521577586|FG000|Treatment Re-Randomization|Protocol Violation|1|||
144651636|NCT00408421|521577587|FG001|Treatment Re-Randomization|Protocol Violation|1|||
144651637|NCT00408421|521577588|FG002|Treatment Re-Randomization|Protocol Violation|0|||
144651638|NCT00408421|521577586|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
144651639|NCT00408421|521577587|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
144651640|NCT00408421|521577588|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
144651641|NCT02322892|521577589|FG000|Overall Study|Surgery cancelled|1|||
144651642|NCT02322892|521577590|FG001|Overall Study|Surgery cancelled|2|||
144651643|NCT02322892|521577589|FG000|Overall Study|Met exclusion criteria|0|||
144651644|NCT02322892|521577590|FG001|Overall Study|Met exclusion criteria|1|||
144651645|NCT02322892|521577589|FG000|Overall Study|Protocol Violation|1|||
144651646|NCT02322892|521577590|FG001|Overall Study|Protocol Violation|0|||
144651647|NCT02125331|521577593|FG000|Overall Study|Protocol Violation|1|||
144651648|NCT02125331|521577594|FG001|Overall Study|Protocol Violation|0|||
144651649|NCT02125331|521577593|FG000|Overall Study|technical problem|2|||
144651650|NCT02125331|521577594|FG001|Overall Study|technical problem|0|||
144651651|NCT02125331|521577593|FG000|Overall Study|screen failure|2|||
144651652|NCT02125331|521577594|FG001|Overall Study|screen failure|0|||
144651653|NCT01115569|521577603|FG000|Conversion/Titration Phase|Adverse Event|59|||
144651654|NCT01115569|521577604|FG001|Conversion/Titration Phase|Adverse Event|0|||
144651655|NCT01115569|521577603|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
144651656|NCT01115569|521577604|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
144651657|NCT01115569|521577603|FG000|Conversion/Titration Phase|Physician Decision|5|||
144651658|NCT01115569|521577604|FG001|Conversion/Titration Phase|Physician Decision|0|||
144651659|NCT01115569|521577603|FG000|Conversion/Titration Phase|Protocol Violation|68|||
144651660|NCT01115569|521577604|FG001|Conversion/Titration Phase|Protocol Violation|0|||
144651661|NCT01115569|521577603|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
144651662|NCT01115569|521577604|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
144212201|NCT02516553|519970530|FG002|Overall Study|Refused to continue trial medication|0|||
144212202|NCT02516553|519970531|FG003|Overall Study|Refused to continue trial medication|0|||
144212203|NCT02516553|519970532|FG004|Overall Study|Refused to continue trial medication|0|||
144212204|NCT02516553|519970533|FG005|Overall Study|Refused to continue trial medication|0|||
144212205|NCT02516553|519970534|FG006|Overall Study|Refused to continue trial medication|0|||
144212206|NCT02516553|519970535|FG007|Overall Study|Refused to continue trial medication|0|||
144212207|NCT02516553|519970536|FG008|Overall Study|Refused to continue trial medication|0|||
144212208|NCT02516553|519970537|FG009|Overall Study|Refused to continue trial medication|0|||
144212209|NCT02516553|519970538|FG010|Overall Study|Refused to continue trial medication|1|||
144263435|NCT02595502|520165437|FG000|Period 1|Lost to Follow-up|0|||
144651663|NCT01115569|521577603|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
144651664|NCT01115569|521577604|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
144651665|NCT01115569|521577603|FG000|Maintenance Phase|Adverse Event|0|||
144651666|NCT01115569|521577604|FG001|Maintenance Phase|Adverse Event|43|||
144651667|NCT01115569|521577603|FG000|Maintenance Phase|Lost to Follow-up|0|||
144731786|NCT03262012|521873295|FG000|Overall Study|Lack of Efficacy|0|||
144212210|NCT02516553|519970539|FG011|Overall Study|Refused to continue trial medication|0|||
144651668|NCT01115569|521577604|FG001|Maintenance Phase|Lost to Follow-up|8|||
144651669|NCT01115569|521577603|FG000|Maintenance Phase|Physician Decision|0|||
144651670|NCT01115569|521577604|FG001|Maintenance Phase|Physician Decision|3|||
144651671|NCT01115569|521577603|FG000|Maintenance Phase|Protocol Violation|0|||
144651672|NCT01115569|521577604|FG001|Maintenance Phase|Protocol Violation|9|||
144651673|NCT01115569|521577603|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144651674|NCT01115569|521577604|FG001|Maintenance Phase|Withdrawal by Subject|27|||
144651675|NCT01115569|521577603|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
144651676|NCT01115569|521577604|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
144651677|NCT01115569|521577603|FG000|Maintenance Phase|Administrative|0|||
144651678|NCT01115569|521577604|FG001|Maintenance Phase|Administrative|1|||
144651679|NCT02115815|521577605|FG000|Overall Study|Withdrawal by Subject|2|||
144651680|NCT02115815|521577606|FG001|Overall Study|Withdrawal by Subject|0|||
144651681|NCT02115815|521577607|FG002|Overall Study|Withdrawal by Subject|0|||
144651682|NCT02115815|521577608|FG003|Overall Study|Withdrawal by Subject|0|||
144651683|NCT02115815|521577609|FG004|Overall Study|Withdrawal by Subject|0|||
144651684|NCT02115815|521577610|FG005|Overall Study|Withdrawal by Subject|0|||
144651685|NCT02115815|521577611|FG006|Overall Study|Withdrawal by Subject|0|||
144651686|NCT02115815|521577605|FG000|Overall Study|Not enough drug to dose participant|0|||
144651687|NCT02115815|521577606|FG001|Overall Study|Not enough drug to dose participant|0|||
144651688|NCT02115815|521577607|FG002|Overall Study|Not enough drug to dose participant|0|||
144651689|NCT02115815|521577608|FG003|Overall Study|Not enough drug to dose participant|0|||
144651690|NCT02115815|521577609|FG004|Overall Study|Not enough drug to dose participant|0|||
144651691|NCT02115815|521577610|FG005|Overall Study|Not enough drug to dose participant|1|||
144651692|NCT02115815|521577611|FG006|Overall Study|Not enough drug to dose participant|0|||
144651693|NCT02115815|521577605|FG000|Overall Study|Missed appointment, randomized in error|0|||
144651694|NCT02115815|521577606|FG001|Overall Study|Missed appointment, randomized in error|0|||
144651695|NCT02115815|521577607|FG002|Overall Study|Missed appointment, randomized in error|0|||
144651696|NCT02115815|521577608|FG003|Overall Study|Missed appointment, randomized in error|0|||
144651697|NCT02115815|521577609|FG004|Overall Study|Missed appointment, randomized in error|0|||
144651698|NCT02115815|521577610|FG005|Overall Study|Missed appointment, randomized in error|1|||
144651699|NCT02115815|521577611|FG006|Overall Study|Missed appointment, randomized in error|0|||
144651700|NCT03504774|521577612|FG000|Overall Study|Adverse Event|2|||
144651701|NCT03504774|521577613|FG001|Overall Study|Adverse Event|0|||
144651702|NCT03504774|521577612|FG000|Overall Study|Lost to Follow-up|0|||
144651703|NCT03504774|521577613|FG001|Overall Study|Lost to Follow-up|1|||
144651704|NCT03504774|521577612|FG000|Overall Study|Protocol Violation|11|||
144651705|NCT03504774|521577613|FG001|Overall Study|Protocol Violation|3|||
144651706|NCT03504774|521577612|FG000|Overall Study|failed wk 52 DBPCFC|1|||
144651707|NCT03504774|521577613|FG001|Overall Study|failed wk 52 DBPCFC|0|||
144651708|NCT01781429|521577614|FG000|Overall Study|Death|0|||
144651709|NCT01781429|521577615|FG001|Overall Study|Death|0|||
144651710|NCT01781429|521577616|FG002|Overall Study|Death|0|||
144651711|NCT01781429|521577617|FG003|Overall Study|Death|0|||
144651712|NCT01781429|521577618|FG004|Overall Study|Death|0|||
144651713|NCT01781429|521577619|FG005|Overall Study|Death|0|||
144651714|NCT01781429|521577620|FG006|Overall Study|Death|0|||
144651715|NCT01781429|521577621|FG007|Overall Study|Death|0|||
144651716|NCT01781429|521577622|FG008|Overall Study|Death|0|||
144651717|NCT01781429|521577623|FG009|Overall Study|Death|1|||
144651718|NCT01781429|521577624|FG010|Overall Study|Death|0|||
144651719|NCT01781429|521577625|FG011|Overall Study|Death|0|||
144731787|NCT03262012|521873296|FG001|Overall Study|Lack of Efficacy|5|||
144731788|NCT03262012|521873297|FG002|Overall Study|Lack of Efficacy|1|||
144212211|NCT02516553|519970540|FG012|Overall Study|Refused to continue trial medication|0|||
144212212|NCT02516553|519970541|FG013|Overall Study|Refused to continue trial medication|0|||
144212213|NCT02516553|519970542|FG014|Overall Study|Refused to continue trial medication|0|||
144212214|NCT02516553|519970543|FG015|Overall Study|Refused to continue trial medication|0|||
144212215|NCT02516553|519970544|FG016|Overall Study|Refused to continue trial medication|0|||
144212216|NCT02516553|519970545|FG017|Overall Study|Refused to continue trial medication|0|||
144212217|NCT02516553|519970546|FG018|Overall Study|Refused to continue trial medication|1|||
144212218|NCT02516553|519970547|FG019|Overall Study|Refused to continue trial medication|0|||
144651720|NCT01781429|521577626|FG012|Overall Study|Death|1|||
144263436|NCT02595502|520165438|FG001|Period 1|Lost to Follow-up|1|||
144651721|NCT01781429|521577627|FG013|Overall Study|Death|0|||
144651722|NCT01781429|521577628|FG014|Overall Study|Death|1|||
144651723|NCT01781429|521577629|FG015|Overall Study|Death|0|||
144651724|NCT01781429|521577614|FG000|Overall Study|Withdrawal by Subject|0|||
144651725|NCT01781429|521577615|FG001|Overall Study|Withdrawal by Subject|0|||
144651726|NCT01781429|521577616|FG002|Overall Study|Withdrawal by Subject|0|||
144651727|NCT01781429|521577617|FG003|Overall Study|Withdrawal by Subject|0|||
144651728|NCT01781429|521577618|FG004|Overall Study|Withdrawal by Subject|0|||
144651729|NCT01781429|521577619|FG005|Overall Study|Withdrawal by Subject|0|||
144731789|NCT03262012|521873298|FG003|Overall Study|Lack of Efficacy|2|||
144651730|NCT01781429|521577620|FG006|Overall Study|Withdrawal by Subject|0|||
144651731|NCT01781429|521577621|FG007|Overall Study|Withdrawal by Subject|0|||
144651732|NCT01781429|521577622|FG008|Overall Study|Withdrawal by Subject|1|||
144651733|NCT01781429|521577623|FG009|Overall Study|Withdrawal by Subject|3|||
144651734|NCT01781429|521577624|FG010|Overall Study|Withdrawal by Subject|1|||
144651735|NCT01781429|521577625|FG011|Overall Study|Withdrawal by Subject|1|||
144651736|NCT01781429|521577626|FG012|Overall Study|Withdrawal by Subject|5|||
144651737|NCT01781429|521577627|FG013|Overall Study|Withdrawal by Subject|2|||
144651738|NCT01781429|521577628|FG014|Overall Study|Withdrawal by Subject|3|||
144651739|NCT01781429|521577629|FG015|Overall Study|Withdrawal by Subject|0|||
144651740|NCT01781429|521577614|FG000|Overall Study|Disease Progression|1|||
144651741|NCT01781429|521577615|FG001|Overall Study|Disease Progression|0|||
144651742|NCT01781429|521577616|FG002|Overall Study|Disease Progression|1|||
144651743|NCT01781429|521577617|FG003|Overall Study|Disease Progression|1|||
144651744|NCT01781429|521577618|FG004|Overall Study|Disease Progression|1|||
144651745|NCT01781429|521577619|FG005|Overall Study|Disease Progression|4|||
144651746|NCT01781429|521577620|FG006|Overall Study|Disease Progression|7|||
144651747|NCT01781429|521577621|FG007|Overall Study|Disease Progression|4|||
144651748|NCT01781429|521577622|FG008|Overall Study|Disease Progression|6|||
144651749|NCT01781429|521577623|FG009|Overall Study|Disease Progression|15|||
144651750|NCT01781429|521577624|FG010|Overall Study|Disease Progression|15|||
144651751|NCT01781429|521577625|FG011|Overall Study|Disease Progression|15|||
144651752|NCT01781429|521577626|FG012|Overall Study|Disease Progression|15|||
144651753|NCT01781429|521577627|FG013|Overall Study|Disease Progression|4|||
144651754|NCT01781429|521577628|FG014|Overall Study|Disease Progression|11|||
144651755|NCT01781429|521577629|FG015|Overall Study|Disease Progression|0|||
144651756|NCT01781429|521577614|FG000|Overall Study|Unacceptable Toxicity|0|||
144651757|NCT01781429|521577615|FG001|Overall Study|Unacceptable Toxicity|0|||
144651758|NCT01781429|521577616|FG002|Overall Study|Unacceptable Toxicity|0|||
144651759|NCT01781429|521577617|FG003|Overall Study|Unacceptable Toxicity|0|||
144651760|NCT01781429|521577618|FG004|Overall Study|Unacceptable Toxicity|0|||
144651761|NCT01781429|521577619|FG005|Overall Study|Unacceptable Toxicity|0|||
144651762|NCT01781429|521577620|FG006|Overall Study|Unacceptable Toxicity|0|||
144651763|NCT01781429|521577621|FG007|Overall Study|Unacceptable Toxicity|0|||
144651764|NCT01781429|521577622|FG008|Overall Study|Unacceptable Toxicity|0|||
144651765|NCT01781429|521577623|FG009|Overall Study|Unacceptable Toxicity|0|||
144651766|NCT01781429|521577624|FG010|Overall Study|Unacceptable Toxicity|0|||
144651767|NCT01781429|521577625|FG011|Overall Study|Unacceptable Toxicity|2|||
144651768|NCT01781429|521577626|FG012|Overall Study|Unacceptable Toxicity|0|||
144651769|NCT01781429|521577627|FG013|Overall Study|Unacceptable Toxicity|0|||
144651770|NCT01781429|521577628|FG014|Overall Study|Unacceptable Toxicity|0|||
144651771|NCT01781429|521577629|FG015|Overall Study|Unacceptable Toxicity|0|||
144651772|NCT01781429|521577614|FG000|Overall Study|Patient Condition Changed|0|||
144651773|NCT01781429|521577615|FG001|Overall Study|Patient Condition Changed|0|||
144651774|NCT01781429|521577616|FG002|Overall Study|Patient Condition Changed|0|||
144731790|NCT03262012|521873295|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
144731791|NCT03262012|521873296|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
144731792|NCT03262012|521873297|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
144731793|NCT03262012|521873298|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
144731794|NCT02801877|521873301|FG000|Overall Study|Lost to Follow-up|1|||
144731795|NCT02801877|521873302|FG001|Overall Study|Lost to Follow-up|1|||
144731796|NCT02801877|521873303|FG002|Overall Study|Lost to Follow-up|2|||
144731797|NCT02801877|521873304|FG003|Overall Study|Lost to Follow-up|0|||
144731798|NCT02801877|521873301|FG000|Overall Study|Never Started Treatment|2|||
144731799|NCT02801877|521873302|FG001|Overall Study|Never Started Treatment|0|||
144731800|NCT02801877|521873303|FG002|Overall Study|Never Started Treatment|4|||
144731801|NCT02801877|521873304|FG003|Overall Study|Never Started Treatment|0|||
144731802|NCT00154102|521873305|FG000|Overall Study|investigational study phase ongoing|7|||
144651775|NCT01781429|521577617|FG003|Overall Study|Patient Condition Changed|0|||
144731803|NCT00154102|521873306|FG001|Overall Study|investigational study phase ongoing|2|||
144731804|NCT01223365|521873308|FG000|Open-label Titration Period|Enrolled but not treated|1|||
144731805|NCT01223365|521873308|FG000|Open-label Titration Period|Adverse Event|23|||
144212219|NCT02516553|519970548|FG020|Overall Study|Refused to continue trial medication|0|||
144212220|NCT02516553|519970549|FG021|Overall Study|Refused to continue trial medication|1|||
144731806|NCT01223365|521873308|FG000|Open-label Titration Period|Lack of Efficacy|3|||
144731807|NCT01223365|521873308|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
144212221|NCT02516553|519970528|FG000|Overall Study|other reasons than listed|0|||
144651776|NCT01781429|521577618|FG004|Overall Study|Patient Condition Changed|0|||
144651777|NCT01781429|521577619|FG005|Overall Study|Patient Condition Changed|0|||
144651778|NCT01781429|521577620|FG006|Overall Study|Patient Condition Changed|0|||
144651779|NCT01781429|521577621|FG007|Overall Study|Patient Condition Changed|0|||
144651780|NCT01781429|521577622|FG008|Overall Study|Patient Condition Changed|0|||
144651781|NCT01781429|521577623|FG009|Overall Study|Patient Condition Changed|4|||
144651782|NCT01781429|521577624|FG010|Overall Study|Patient Condition Changed|0|||
144651783|NCT01781429|521577625|FG011|Overall Study|Patient Condition Changed|1|||
144651784|NCT01781429|521577626|FG012|Overall Study|Patient Condition Changed|0|||
144651785|NCT01781429|521577627|FG013|Overall Study|Patient Condition Changed|1|||
144651786|NCT01781429|521577628|FG014|Overall Study|Patient Condition Changed|0|||
144651787|NCT01781429|521577629|FG015|Overall Study|Patient Condition Changed|0|||
144651788|NCT01781429|521577614|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
144651789|NCT01781429|521577615|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
144651790|NCT01781429|521577616|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
144651791|NCT01781429|521577617|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
144651792|NCT01781429|521577618|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
144651793|NCT01781429|521577619|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
144651794|NCT01781429|521577620|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
144651795|NCT01781429|521577621|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
144651796|NCT01781429|521577622|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
144651797|NCT01781429|521577623|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
144651798|NCT01781429|521577624|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
144651799|NCT01781429|521577625|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
144651800|NCT01781429|521577626|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
144651801|NCT01781429|521577627|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
144651802|NCT01781429|521577628|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
144651803|NCT01781429|521577629|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
144651804|NCT01781429|521577614|FG000|Overall Study|Enrolled, but not treated|0|||
144651805|NCT01781429|521577615|FG001|Overall Study|Enrolled, but not treated|0|||
144651806|NCT01781429|521577616|FG002|Overall Study|Enrolled, but not treated|0|||
144651807|NCT01781429|521577617|FG003|Overall Study|Enrolled, but not treated|0|||
144731808|NCT01223365|521873308|FG000|Open-label Titration Period|Protocol Violation|1|||
144731809|NCT01223365|521873308|FG000|Open-label Titration Period|Lost to Follow-up|2|||
144212222|NCT02516553|519970529|FG001|Overall Study|other reasons than listed|0|||
144212223|NCT02516553|519970530|FG002|Overall Study|other reasons than listed|0|||
144212224|NCT02516553|519970531|FG003|Overall Study|other reasons than listed|0|||
144212225|NCT02516553|519970532|FG004|Overall Study|other reasons than listed|0|||
144212226|NCT02516553|519970533|FG005|Overall Study|other reasons than listed|0|||
144212227|NCT02516553|519970534|FG006|Overall Study|other reasons than listed|0|||
144212228|NCT02516553|519970535|FG007|Overall Study|other reasons than listed|1|||
144212229|NCT02516553|519970536|FG008|Overall Study|other reasons than listed|1|||
144212230|NCT02516553|519970537|FG009|Overall Study|other reasons than listed|0|||
144212231|NCT02516553|519970538|FG010|Overall Study|other reasons than listed|1|||
144212232|NCT02516553|519970539|FG011|Overall Study|other reasons than listed|1|||
144212233|NCT02516553|519970540|FG012|Overall Study|other reasons than listed|0|||
144212234|NCT02516553|519970541|FG013|Overall Study|other reasons than listed|0|||
144212235|NCT02516553|519970542|FG014|Overall Study|other reasons than listed|0|||
144212236|NCT02516553|519970543|FG015|Overall Study|other reasons than listed|0|||
144212237|NCT02516553|519970544|FG016|Overall Study|other reasons than listed|0|||
144212238|NCT02516553|519970545|FG017|Overall Study|other reasons than listed|0|||
144212239|NCT02516553|519970546|FG018|Overall Study|other reasons than listed|0|||
144212240|NCT02516553|519970547|FG019|Overall Study|other reasons than listed|0|||
144212241|NCT02516553|519970548|FG020|Overall Study|other reasons than listed|2|||
144212242|NCT02516553|519970549|FG021|Overall Study|other reasons than listed|2|||
144212243|NCT03052127|519970551|FG000|Overall Study|Withdrawal by Subject|0|||
144212244|NCT03052127|519970552|FG001|Overall Study|Withdrawal by Subject|0|||
144212245|NCT03052127|519970553|FG002|Overall Study|Withdrawal by Subject|0|||
144212246|NCT03052127|519970554|FG003|Overall Study|Withdrawal by Subject|0|||
144212247|NCT03052127|519970555|FG004|Overall Study|Withdrawal by Subject|0|||
144212248|NCT03052127|519970556|FG005|Overall Study|Withdrawal by Subject|0|||
144212249|NCT03052127|519970557|FG006|Overall Study|Withdrawal by Subject|0|||
144212250|NCT03052127|519970558|FG007|Overall Study|Withdrawal by Subject|1|||
144212251|NCT03052127|519970559|FG008|Overall Study|Withdrawal by Subject|1|||
144212252|NCT03052127|519970560|FG009|Overall Study|Withdrawal by Subject|1|||
144212253|NCT03052127|519970561|FG010|Overall Study|Withdrawal by Subject|0|||
144212254|NCT03052127|519970562|FG011|Overall Study|Withdrawal by Subject|0|||
144212255|NCT03052127|519970551|FG000|Overall Study|Discontinuation by Sponsor|0|||
144212256|NCT03052127|519970552|FG001|Overall Study|Discontinuation by Sponsor|0|||
144212257|NCT03052127|519970553|FG002|Overall Study|Discontinuation by Sponsor|0|||
144212258|NCT03052127|519970554|FG003|Overall Study|Discontinuation by Sponsor|0|||
144651808|NCT01781429|521577618|FG004|Overall Study|Enrolled, but not treated|0|||
144651809|NCT01781429|521577619|FG005|Overall Study|Enrolled, but not treated|0|||
144651810|NCT01781429|521577620|FG006|Overall Study|Enrolled, but not treated|0|||
144651811|NCT01781429|521577621|FG007|Overall Study|Enrolled, but not treated|0|||
144651812|NCT01781429|521577622|FG008|Overall Study|Enrolled, but not treated|0|||
144651813|NCT01781429|521577623|FG009|Overall Study|Enrolled, but not treated|0|||
144731810|NCT01223365|521873308|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
144212259|NCT03052127|519970555|FG004|Overall Study|Discontinuation by Sponsor|0|||
144651814|NCT01781429|521577624|FG010|Overall Study|Enrolled, but not treated|1|||
144651815|NCT01781429|521577625|FG011|Overall Study|Enrolled, but not treated|0|||
144651816|NCT01781429|521577626|FG012|Overall Study|Enrolled, but not treated|0|||
144731811|NCT01223365|521873308|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
144731812|NCT01223365|521873308|FG000|Open-label Titration Period|Starting physical therapy|1|||
144731813|NCT01223365|521873308|FG000|Open-label Treatment Period|Adverse Event|39|||
144731814|NCT01223365|521873308|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
144731815|NCT01223365|521873308|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
144731816|NCT01223365|521873308|FG000|Open-label Treatment Period|Protocol Violation|15|||
144731817|NCT01223365|521873308|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
144651817|NCT01781429|521577627|FG013|Overall Study|Enrolled, but not treated|0|||
144651818|NCT01781429|521577628|FG014|Overall Study|Enrolled, but not treated|0|||
144651819|NCT01781429|521577629|FG015|Overall Study|Enrolled, but not treated|0|||
144651820|NCT01703286|521577636|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
144651821|NCT01703286|521577637|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
144651822|NCT01703286|521577638|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
144651823|NCT01703286|521577639|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
144651824|NCT01703286|521577640|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
144651825|NCT01703286|521577641|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
144651826|NCT01703286|521577636|FG000|Period 2 Including Washout|Adverse Event|0|||
144651827|NCT01703286|521577637|FG001|Period 2 Including Washout|Adverse Event|0|||
144651828|NCT01703286|521577638|FG002|Period 2 Including Washout|Adverse Event|0|||
144651829|NCT01703286|521577639|FG003|Period 2 Including Washout|Adverse Event|1|||
144651830|NCT01703286|521577640|FG004|Period 2 Including Washout|Adverse Event|0|||
144651831|NCT01703286|521577641|FG005|Period 2 Including Washout|Adverse Event|0|||
144651832|NCT02421120|521577642|FG000|Overall Study|Adverse Event|1|||
144651833|NCT00931892|521577643|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
144651834|NCT00931892|521577644|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
144651835|NCT02207530|521577645|FG000|Overall Study|Worsening condition under investigation|78|||
144651836|NCT02207530|521577645|FG000|Overall Study|Patient decision to stop study treatment|5|||
144651837|NCT02207530|521577645|FG000|Overall Study|Adverse Event|8|||
144651838|NCT06094296|521577646|FG000|Overall Study|Progressive Disease|1|||
144651839|NCT06094296|521577647|FG001|Overall Study|Progressive Disease|0|||
144651840|NCT06094296|521577648|FG002|Overall Study|Progressive Disease|0|||
144651841|NCT06094296|521577649|FG003|Overall Study|Progressive Disease|0|||
144651842|NCT00986258|521577650|FG000|Observation Period|Not eligible to be dosed|11|||
144651843|NCT00986258|521577650|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
144651844|NCT00986258|521577650|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
144651845|NCT00986258|521577650|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
144651846|NCT00986258|521577650|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
144651847|NCT00986258|521577650|FG000|Titration and Optimal Dose Period|Other|1|||
144651848|NCT00986258|521577650|FG000|Maintenance Period|Adverse Event|5|||
144651849|NCT00986258|521577650|FG000|Maintenance Period|Lack of Efficacy|2|||
144651850|NCT00986258|521577650|FG000|Maintenance Period|Withdrawal by Subject|2|||
144651851|NCT04964063|521577651|FG000|Overall Study|Adverse Event|4|||
144651852|NCT04964063|521577651|FG000|Overall Study|Lost to Follow-up|47|||
144651853|NCT04964063|521577651|FG000|Overall Study|Withdrawal by Subject|5|||
144651854|NCT04964063|521577651|FG000|Overall Study|Baseline Tasks Expired|41|||
144651855|NCT04964063|521577651|FG000|Overall Study|Participant withdrawn in error|1|||
144651856|NCT01809262|521577654|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651857|NCT01809262|521577655|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651858|NCT01809262|521577656|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651859|NCT01809262|521577657|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651860|NCT01809262|521577658|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
144651861|NCT01809262|521577659|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651862|NCT01809262|521577660|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651863|NCT01809262|521577661|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651864|NCT01809262|521577662|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
144651865|NCT01809262|521577663|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
144731818|NCT01223365|521873308|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
144731819|NCT01223365|521873308|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
144731820|NCT01223365|521873308|FG000|Open-label Treatment Period|Moved out of area|2|||
144731821|NCT01223365|521873308|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
144731822|NCT01223365|521873308|FG000|Open-label Treatment Period|"Out of window"|1|||
144731823|NCT01223365|521873308|FG000|Open-label Treatment Period|Starting physical therapy|1|||
144731824|NCT01223365|521873308|FG000|Open-label Treatment Period|Physician Decision|2|||
144212260|NCT03052127|519970556|FG005|Overall Study|Discontinuation by Sponsor|0|||
144651866|NCT01809262|521577654|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651867|NCT01809262|521577655|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
144651868|NCT01809262|521577656|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651869|NCT01809262|521577657|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651870|NCT01809262|521577658|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651871|NCT01809262|521577659|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651872|NCT01809262|521577660|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144263437|NCT02595502|520165437|FG000|Period 2|Adverse Event|1|||
144263438|NCT02595502|520165438|FG001|Period 2|Adverse Event|1|||
144263439|NCT02595502|520165437|FG000|Period 2|Received incorrect lens at Period 1|0|||
144263440|NCT02595502|520165438|FG001|Period 2|Received incorrect lens at Period 1|1|||
144263441|NCT02595502|520165437|FG000|Period 3|Protocol Violation|0|||
144263442|NCT02595502|520165438|FG001|Period 3|Protocol Violation|1|||
144263443|NCT02595502|520165437|FG000|Period 3|Lost to Follow-up|1|||
144263444|NCT02595502|520165438|FG001|Period 3|Lost to Follow-up|0|||
144263445|NCT02595502|520165437|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
144263446|NCT02595502|520165438|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
144263447|NCT03286218|520165439|FG000|Qualification Phase Period 1|Adverse Event|1|||
144263448|NCT03286218|520165440|FG001|Qualification Phase Period 1|Adverse Event|0|||
144263449|NCT03286218|520165441|FG002|Qualification Phase Period 1|Adverse Event|0|||
144263450|NCT03286218|520165442|FG003|Qualification Phase Period 1|Adverse Event|0|||
144263451|NCT03286218|520165443|FG004|Qualification Phase Period 1|Adverse Event|0|||
144263452|NCT03286218|520165444|FG005|Qualification Phase Period 1|Adverse Event|0|||
144263453|NCT03286218|520165445|FG006|Qualification Phase Period 1|Adverse Event|0|||
144263454|NCT03286218|520165446|FG007|Qualification Phase Period 1|Adverse Event|0|||
144651873|NCT01809262|521577661|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651874|NCT01809262|521577662|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651875|NCT01809262|521577663|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
144651876|NCT01505491|521577664|FG000|Overall Study|Other reason not listed|1|||
144651877|NCT01505491|521577665|FG001|Overall Study|Other reason not listed|0|||
144651878|NCT01505491|521577666|FG002|Overall Study|Other reason not listed|0|||
144651879|NCT01505491|521577664|FG000|Overall Study|Withdrawal by Subject|1|||
144651880|NCT01505491|521577665|FG001|Overall Study|Withdrawal by Subject|1|||
144651881|NCT01505491|521577666|FG002|Overall Study|Withdrawal by Subject|4|||
144651882|NCT01505491|521577664|FG000|Overall Study|Lost to Follow-up|0|||
144651883|NCT01505491|521577665|FG001|Overall Study|Lost to Follow-up|0|||
144651884|NCT01505491|521577666|FG002|Overall Study|Lost to Follow-up|1|||
144651885|NCT01740440|521577668|FG000|Overall Study|Lost to Follow-up|3|||
144651886|NCT01063751|521577670|FG000|Overall Study|Censored from analyses|42|||
144651887|NCT01063751|521577670|FG000|Overall Study|Withdrawal by Subject|34|||
144651888|NCT01063751|521577670|FG000|Overall Study|Lost to Follow-up|30|||
144651889|NCT01063751|521577670|FG000|Overall Study|Death|13|||
144651890|NCT01063751|521577670|FG000|Overall Study|Sponsored Terminated Study|60|||
144651891|NCT01063751|521577670|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
144651892|NCT01063751|521577670|FG000|Overall Study|Investigator site closed|10|||
144212261|NCT03052127|519970557|FG006|Overall Study|Discontinuation by Sponsor|0|||
144212262|NCT03052127|519970558|FG007|Overall Study|Discontinuation by Sponsor|0|||
144212263|NCT03052127|519970559|FG008|Overall Study|Discontinuation by Sponsor|4|||
144212264|NCT03052127|519970560|FG009|Overall Study|Discontinuation by Sponsor|2|||
144212265|NCT03052127|519970561|FG010|Overall Study|Discontinuation by Sponsor|5|||
144212266|NCT03052127|519970562|FG011|Overall Study|Discontinuation by Sponsor|13|||
144212267|NCT03052127|519970551|FG000|Overall Study|Inability to comply with trial requirements|0|||
144212268|NCT03052127|519970552|FG001|Overall Study|Inability to comply with trial requirements|0|||
144212269|NCT03052127|519970553|FG002|Overall Study|Inability to comply with trial requirements|1|||
144212270|NCT03052127|519970554|FG003|Overall Study|Inability to comply with trial requirements|0|||
144212271|NCT03052127|519970555|FG004|Overall Study|Inability to comply with trial requirements|0|||
144212272|NCT03052127|519970556|FG005|Overall Study|Inability to comply with trial requirements|0|||
144212273|NCT03052127|519970557|FG006|Overall Study|Inability to comply with trial requirements|0|||
144212274|NCT03052127|519970558|FG007|Overall Study|Inability to comply with trial requirements|0|||
144212275|NCT03052127|519970559|FG008|Overall Study|Inability to comply with trial requirements|0|||
144212276|NCT03052127|519970560|FG009|Overall Study|Inability to comply with trial requirements|0|||
144212277|NCT03052127|519970561|FG010|Overall Study|Inability to comply with trial requirements|0|||
144212278|NCT03052127|519970562|FG011|Overall Study|Inability to comply with trial requirements|0|||
144212279|NCT03052127|519970551|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
144212280|NCT03052127|519970552|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212281|NCT03052127|519970553|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212282|NCT03052127|519970554|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212283|NCT03052127|519970555|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
144212284|NCT03052127|519970556|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
144212285|NCT03052127|519970557|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
144212286|NCT03052127|519970558|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212287|NCT03052127|519970559|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144263455|NCT03286218|520165447|FG008|Qualification Phase Period 1|Adverse Event|0|||
144651893|NCT01063751|521577670|FG000|Overall Study|Revision|6|||
144651894|NCT01063751|521577670|FG000|Overall Study|Physician Decision|4|||
144651895|NCT03408873|521577676|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
144651896|NCT03408873|521577676|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
144651897|NCT03408873|521577676|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
144651898|NCT03408873|521577676|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
144651899|NCT03408873|521577676|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
144651900|NCT03408873|521577676|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
144651901|NCT00406315|521577682|FG000|Overall Study|Death|1|||
144651902|NCT00406315|521577682|FG000|Overall Study|Adverse Event|39|||
144651903|NCT00406315|521577682|FG000|Overall Study|Laboratory Abnormality|4|||
144651904|NCT00406315|521577682|FG000|Overall Study|Lack of Efficacy|13|||
144651905|NCT00406315|521577682|FG000|Overall Study|Other|33|||
144651906|NCT00406315|521577682|FG000|Overall Study|Lost to Follow-up|21|||
144651907|NCT00406315|521577682|FG000|Overall Study|Withdrawal by Subject|30|||
144651908|NCT01797783|521577686|FG000|Overall Study|Adverse Event|1|||
144651909|NCT01797783|521577687|FG001|Overall Study|Adverse Event|1|||
144651910|NCT01797783|521577686|FG000|Overall Study|Withdrawal by Subject|1|||
144651911|NCT01797783|521577687|FG001|Overall Study|Withdrawal by Subject|0|||
144651912|NCT02214186|521577692|FG000|Overall Study|Lost to Follow-up|1|||
144651913|NCT02214186|521577693|FG001|Overall Study|Lost to Follow-up|1|||
144651914|NCT02214186|521577692|FG000|Overall Study|Protocol Violation|1|||
144651915|NCT02214186|521577693|FG001|Overall Study|Protocol Violation|1|||
144651916|NCT01525849|521577694|FG000|Overall Study|Lost to Follow-up|3|||
144651917|NCT01525849|521577695|FG001|Overall Study|Lost to Follow-up|2|||
144651918|NCT01525849|521577694|FG000|Overall Study|Withdrawal by Subject|1|||
144651919|NCT01525849|521577695|FG001|Overall Study|Withdrawal by Subject|9|||
144651920|NCT01525849|521577694|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
144651921|NCT01525849|521577695|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
144651922|NCT01525849|521577694|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
144651923|NCT01525849|521577695|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
144651924|NCT01469013|521577696|FG000|Part A (Treatment Period)|Adverse Event|1|||
144651925|NCT01469013|521577697|FG001|Part A (Treatment Period)|Adverse Event|0|||
144651926|NCT01469013|521577698|FG002|Part A (Treatment Period)|Adverse Event|0|||
144651927|NCT01469013|521577699|FG003|Part A (Treatment Period)|Adverse Event|0|||
144651928|NCT01469013|521577700|FG004|Part A (Treatment Period)|Adverse Event|1|||
144651929|NCT01469013|521577701|FG005|Part A (Treatment Period)|Adverse Event|0|||
144651930|NCT01469013|521577702|FG006|Part A (Treatment Period)|Adverse Event|0|||
144651931|NCT01469013|521577703|FG007|Part A (Treatment Period)|Adverse Event|0|||
144651932|NCT01469013|521577704|FG008|Part A (Treatment Period)|Adverse Event|0|||
144651933|NCT01469013|521577705|FG009|Part A (Treatment Period)|Adverse Event|0|||
144651934|NCT01469013|521577706|FG010|Part A (Treatment Period)|Adverse Event|0|||
144651935|NCT01469013|521577707|FG011|Part A (Treatment Period)|Adverse Event|0|||
144651936|NCT01469013|521577708|FG012|Part A (Treatment Period)|Adverse Event|0|||
144651937|NCT01469013|521577696|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651938|NCT01469013|521577697|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651939|NCT01469013|521577698|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
144651940|NCT01469013|521577699|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651941|NCT01469013|521577700|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651942|NCT01469013|521577701|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651943|NCT01469013|521577702|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651944|NCT01469013|521577703|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651945|NCT01469013|521577704|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651946|NCT01469013|521577705|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651947|NCT01469013|521577706|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651948|NCT01469013|521577707|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651949|NCT01469013|521577708|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
144651950|NCT01469013|521577696|FG000|Part B (Extension Period)|Adverse Event|0|||
144651951|NCT01469013|521577697|FG001|Part B (Extension Period)|Adverse Event|0|||
144651952|NCT01469013|521577698|FG002|Part B (Extension Period)|Adverse Event|0|||
144651953|NCT01469013|521577699|FG003|Part B (Extension Period)|Adverse Event|0|||
144651954|NCT01469013|521577700|FG004|Part B (Extension Period)|Adverse Event|0|||
144651955|NCT01469013|521577701|FG005|Part B (Extension Period)|Adverse Event|2|||
144651956|NCT01469013|521577702|FG006|Part B (Extension Period)|Adverse Event|5|||
144651957|NCT01469013|521577703|FG007|Part B (Extension Period)|Adverse Event|5|||
144651958|NCT01469013|521577704|FG008|Part B (Extension Period)|Adverse Event|3|||
144651959|NCT01469013|521577705|FG009|Part B (Extension Period)|Adverse Event|3|||
144651960|NCT01469013|521577706|FG010|Part B (Extension Period)|Adverse Event|1|||
144651961|NCT01469013|521577707|FG011|Part B (Extension Period)|Adverse Event|6|||
144651962|NCT01469013|521577708|FG012|Part B (Extension Period)|Adverse Event|3|||
144651963|NCT01469013|521577696|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
144651964|NCT01469013|521577697|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
144651965|NCT01469013|521577698|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
144651966|NCT01469013|521577699|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
144651967|NCT01469013|521577700|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
144651968|NCT01469013|521577701|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
144651969|NCT01469013|521577702|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
144651970|NCT01469013|521577703|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
144651971|NCT01469013|521577704|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
144263456|NCT03286218|520165448|FG009|Qualification Phase Period 1|Adverse Event|0|||
144263457|NCT03286218|520165449|FG010|Qualification Phase Period 1|Adverse Event|0|||
144263458|NCT03286218|520165450|FG011|Qualification Phase Period 1|Adverse Event|0|||
144263459|NCT03286218|520165439|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263460|NCT03286218|520165440|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
144263461|NCT03286218|520165441|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263462|NCT03286218|520165442|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263463|NCT03286218|520165443|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263464|NCT03286218|520165444|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263465|NCT03286218|520165445|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263466|NCT03286218|520165446|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263467|NCT03286218|520165447|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263468|NCT03286218|520165448|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263469|NCT03286218|520165449|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263470|NCT03286218|520165450|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
144263471|NCT03286218|520165439|FG000|Qualification Phase Period 2|Adverse Event|0|||
144263472|NCT03286218|520165440|FG001|Qualification Phase Period 2|Adverse Event|1|||
144263473|NCT03286218|520165441|FG002|Qualification Phase Period 2|Adverse Event|0|||
144263474|NCT03286218|520165442|FG003|Qualification Phase Period 2|Adverse Event|0|||
144263475|NCT03286218|520165443|FG004|Qualification Phase Period 2|Adverse Event|0|||
144263476|NCT03286218|520165444|FG005|Qualification Phase Period 2|Adverse Event|0|||
144263477|NCT03286218|520165445|FG006|Qualification Phase Period 2|Adverse Event|0|||
144263478|NCT03286218|520165446|FG007|Qualification Phase Period 2|Adverse Event|0|||
144263479|NCT03286218|520165447|FG008|Qualification Phase Period 2|Adverse Event|0|||
144263480|NCT03286218|520165448|FG009|Qualification Phase Period 2|Adverse Event|0|||
144263481|NCT03286218|520165449|FG010|Qualification Phase Period 2|Adverse Event|0|||
144263482|NCT03286218|520165450|FG011|Qualification Phase Period 2|Adverse Event|0|||
144263483|NCT03286218|520165439|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
144263484|NCT03286218|520165440|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
144263485|NCT03286218|520165441|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263486|NCT03286218|520165442|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263487|NCT03286218|520165443|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263488|NCT03286218|520165444|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263489|NCT03286218|520165445|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263490|NCT03286218|520165446|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263491|NCT03286218|520165447|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263492|NCT03286218|520165448|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263493|NCT03286218|520165449|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263494|NCT03286218|520165450|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
144263495|NCT03286218|520165439|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
144263496|NCT03286218|520165440|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
144263497|NCT03286218|520165441|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
144263498|NCT03286218|520165442|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
144263499|NCT03286218|520165443|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
144263500|NCT03286218|520165444|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
144263501|NCT03286218|520165445|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
144263502|NCT03286218|520165446|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
144651972|NCT01469013|521577705|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
144651973|NCT01469013|521577706|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
144651974|NCT01469013|521577707|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
144651975|NCT01469013|521577708|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
144651976|NCT00339183|521577709|FG000|Overall Study|Adverse Event|5|||
144651977|NCT00339183|521577710|FG001|Overall Study|Adverse Event|3|||
144651978|NCT00339183|521577709|FG000|Overall Study|Withdrawal by Subject|16|||
144651979|NCT00339183|521577710|FG001|Overall Study|Withdrawal by Subject|19|||
144651980|NCT00339183|521577709|FG000|Overall Study|Physician Decision|2|||
144651981|NCT00339183|521577710|FG001|Overall Study|Physician Decision|4|||
144651982|NCT00339183|521577709|FG000|Overall Study|Lost to Follow-up|17|||
144263503|NCT03286218|520165447|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
144263504|NCT03286218|520165448|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
144263505|NCT03286218|520165449|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
144263506|NCT03286218|520165450|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
144651983|NCT00339183|521577710|FG001|Overall Study|Lost to Follow-up|17|||
144651984|NCT00339183|521577709|FG000|Overall Study|Protocol-specified criteria|12|||
144651985|NCT00339183|521577710|FG001|Overall Study|Protocol-specified criteria|8|||
144651986|NCT00339183|521577709|FG000|Overall Study|Missing reason|3|||
144651987|NCT00339183|521577710|FG001|Overall Study|Missing reason|1|||
144651988|NCT00339183|521577709|FG000|Overall Study|Other|46|||
144651989|NCT00339183|521577710|FG001|Overall Study|Other|40|||
144651990|NCT00339183|521577709|FG000|Overall Study|Ongoing|20|||
144651991|NCT00339183|521577710|FG001|Overall Study|Ongoing|13|||
144651992|NCT00793819|521577711|FG000|Overall Study|Adverse Event|8|||
144651993|NCT00793819|521577712|FG001|Overall Study|Adverse Event|4|||
144651994|NCT00793819|521577711|FG000|Overall Study|Lack of Efficacy|1|||
144651995|NCT00793819|521577712|FG001|Overall Study|Lack of Efficacy|1|||
144651996|NCT00793819|521577711|FG000|Overall Study|Withdrawal by Subject|4|||
144651997|NCT00793819|521577712|FG001|Overall Study|Withdrawal by Subject|3|||
144651998|NCT00793819|521577711|FG000|Overall Study|Lost to Follow-up|1|||
144651999|NCT00793819|521577712|FG001|Overall Study|Lost to Follow-up|1|||
144652000|NCT00446446|521577715|FG000|Overall Study|Death|10|||
144652001|NCT00446446|521577715|FG000|Overall Study|Withdrawal by Subject|6|||
144652002|NCT00446446|521577715|FG000|Overall Study|Other|4|||
144652003|NCT00446446|521577715|FG000|Overall Study|Disease Progession|2|||
144652004|NCT00446446|521577715|FG000|Overall Study|Adverse Event|1|||
144652005|NCT00446446|521577715|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
144652006|NCT01172288|521577720|FG000|Overall Study|Adverse Event|1|||
144652007|NCT01172288|521577721|FG001|Overall Study|Adverse Event|0|||
144652008|NCT01172288|521577720|FG000|Overall Study|Protocol Violation|0|||
144652009|NCT01172288|521577721|FG001|Overall Study|Protocol Violation|1|||
144652010|NCT01188798|521577726|FG000|Overall Study|Death|0|||
144652011|NCT01188798|521577727|FG001|Overall Study|Death|1|||
144652012|NCT01188798|521577726|FG000|Overall Study|Required additional transplant|1|||
144652013|NCT01188798|521577727|FG001|Overall Study|Required additional transplant|1|||
144652014|NCT01188798|521577726|FG000|Overall Study|Protocol closure|1|||
144652015|NCT01188798|521577727|FG001|Overall Study|Protocol closure|1|||
144652016|NCT00611130|521577728|FG000|Overall Study|Lost to Follow-up|25|||
144652017|NCT00611130|521577729|FG001|Overall Study|Lost to Follow-up|29|||
144652018|NCT00611130|521577728|FG000|Overall Study|Protocol noncompliance|7|||
144652019|NCT00611130|521577729|FG001|Overall Study|Protocol noncompliance|6|||
144652020|NCT00611130|521577728|FG000|Overall Study|Withdrawal by Subject|6|||
144652021|NCT00611130|521577729|FG001|Overall Study|Withdrawal by Subject|5|||
144652022|NCT00611130|521577728|FG000|Overall Study|Other|5|||
144652023|NCT00611130|521577729|FG001|Overall Study|Other|4|||
144652024|NCT00611130|521577728|FG000|Overall Study|Incarceration|3|||
144652025|NCT00611130|521577729|FG001|Overall Study|Incarceration|2|||
144652026|NCT00611130|521577728|FG000|Overall Study|Administrative|1|||
144652027|NCT00611130|521577729|FG001|Overall Study|Administrative|1|||
144652028|NCT00611130|521577728|FG000|Overall Study|Adverse Event|1|||
144652029|NCT00611130|521577729|FG001|Overall Study|Adverse Event|0|||
144652030|NCT00611130|521577728|FG000|Overall Study|Death|1|||
144652031|NCT00611130|521577729|FG001|Overall Study|Death|0|||
144652032|NCT03662334|521577731|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
144652033|NCT03662334|521577732|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
144652034|NCT00723840|521577735|FG000|Overall Study|Lost to Follow-up|2|||
144652035|NCT00723840|521577735|FG000|Overall Study|Failure to return|18|||
144652036|NCT00723840|521577735|FG000|Overall Study|Withdrawal by Subject|55|||
144652037|NCT00723840|521577735|FG000|Overall Study|Serious Adverse Events|3|||
144652038|NCT00723840|521577735|FG000|Overall Study|Other Medical Event|2|||
144652039|NCT00723840|521577735|FG000|Overall Study|Unspecified reason|2|||
144652040|NCT01879618|521577738|FG000|Overall Study|Does not meet entrance criteria|1|||
144652041|NCT01879618|521577738|FG000|Overall Study|Withdrawal by Subject|1|||
144652042|NCT01879618|521577738|FG000|Overall Study|Surgery;changed schedule; not available|8|||
144652043|NCT01879618|521577738|FG000|Overall Study|Protocol Violation|6|||
144652044|NCT01879618|521577738|FG000|Overall Study|Adverse Event|5|||
144652045|NCT01161524|521577742|FG000|Core Study (23 Weeks)|Adverse Event|3|||
144652046|NCT01161524|521577743|FG001|Core Study (23 Weeks)|Adverse Event|0|||
144652047|NCT01161524|521577744|FG002|Core Study (23 Weeks)|Adverse Event|0|||
144652048|NCT01161524|521577742|FG000|Core Study (23 Weeks)|Other|1|||
144652049|NCT01161524|521577743|FG001|Core Study (23 Weeks)|Other|0|||
144652050|NCT01161524|521577744|FG002|Core Study (23 Weeks)|Other|0|||
144652051|NCT01161524|521577742|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
144652052|NCT01161524|521577743|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
144652053|NCT01161524|521577744|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
144652054|NCT01161524|521577742|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
144652055|NCT01161524|521577743|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
144652056|NCT01161524|521577744|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
144652057|NCT01161524|521577742|FG000|Core Study (23 Weeks)|Subject Choice|3|||
144652058|NCT01161524|521577743|FG001|Core Study (23 Weeks)|Subject Choice|2|||
144652059|NCT01161524|521577744|FG002|Core Study (23 Weeks)|Subject Choice|0|||
144652060|NCT01161524|521577742|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
144652061|NCT01161524|521577743|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
144652062|NCT01161524|521577744|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
144652063|NCT01161524|521577742|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
144652064|NCT01161524|521577743|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
144652065|NCT01161524|521577744|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
144731825|NCT02682602|521873309|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
144731826|NCT02682602|521873310|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
144731827|NCT02682602|521873309|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
144731828|NCT02682602|521873310|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
144731829|NCT03567174|521873311|FG000|Overall Study|Death|24|||
144731830|NCT03567174|521873312|FG001|Overall Study|Death|31|||
144731831|NCT03567174|521873311|FG000|Overall Study|Lost to Follow-up|165|||
144731832|NCT03567174|521873312|FG001|Overall Study|Lost to Follow-up|174|||
144731833|NCT02140060|521873313|FG000|Overall Study|Adverse Event|0|||
144731834|NCT02140060|521873314|FG001|Overall Study|Adverse Event|0|||
144731835|NCT02140060|521873315|FG002|Overall Study|Adverse Event|0|||
144731836|NCT02140060|521873316|FG003|Overall Study|Adverse Event|1|||
144731837|NCT02140060|521873317|FG004|Overall Study|Adverse Event|1|||
144731838|NCT02140060|521873318|FG005|Overall Study|Adverse Event|1|||
144731839|NCT02140060|521873313|FG000|Overall Study|Lack of Efficacy|0|||
144731840|NCT02140060|521873314|FG001|Overall Study|Lack of Efficacy|0|||
144731841|NCT02140060|521873315|FG002|Overall Study|Lack of Efficacy|0|||
144731842|NCT02140060|521873316|FG003|Overall Study|Lack of Efficacy|1|||
144731843|NCT02140060|521873317|FG004|Overall Study|Lack of Efficacy|0|||
144731844|NCT02140060|521873318|FG005|Overall Study|Lack of Efficacy|0|||
144731845|NCT06358820|521875651|FG000|Overall Study|Adverse Event|11|||
144731846|NCT06358820|521875651|FG000|Overall Study|kidney transplantation|3|||
144731847|NCT06358820|521875651|FG000|Overall Study|patient voluntary withdrawal|6|||
144731848|NCT06358820|521875651|FG000|Overall Study|Physician Decision|1|||
144731849|NCT01124175|521875656|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
144731850|NCT01124175|521875657|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
144731851|NCT00942968|521875658|FG000|Overall Study|Adverse Event|60|||
144731852|NCT00942968|521875658|FG000|Overall Study|Death|76|||
144731853|NCT00942968|521875658|FG000|Overall Study|Protocol Violation|9|||
144731854|NCT00942968|521875658|FG000|Overall Study|Lost to Follow-up|4|||
144731855|NCT00942968|521875658|FG000|Overall Study|Withdrawal by Subject|44|||
144731856|NCT00942968|521875658|FG000|Overall Study|Sponsor request|5|||
144731857|NCT00942968|521875658|FG000|Overall Study|Physician Decision|11|||
144731858|NCT00942968|521875658|FG000|Overall Study|Progression of disease|12|||
144212288|NCT03052127|519970560|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212289|NCT03052127|519970561|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212290|NCT03052127|519970562|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
144212291|NCT04324073|519972197|FG000|Overall Study|withdrew consent|0|||
144212292|NCT04324073|519972198|FG001|Overall Study|withdrew consent|4|||
144652066|NCT01161524|521577742|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
144652067|NCT01161524|521577743|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
144652068|NCT01161524|521577744|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
144652069|NCT01161524|521577742|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
144652070|NCT01161524|521577743|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
144652071|NCT01161524|521577744|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
144652072|NCT01161524|521577742|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
144652073|NCT01161524|521577743|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
144652074|NCT01161524|521577744|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
144652075|NCT03634072|521577745|FG000|Overall Study|Early termination of overall study|1|||
144652076|NCT03634072|521577746|FG001|Overall Study|Early termination of overall study|0|||
144652077|NCT01558089|521577749|FG000|Overall Study|Adverse Event|1|||
144652078|NCT01558089|521577749|FG000|Overall Study|Lack of Efficacy|1|||
144652079|NCT01558089|521577749|FG000|Overall Study|Lost to Follow-up|5|||
144652080|NCT01558089|521577749|FG000|Overall Study|Withdrawal by Subject|6|||
144212293|NCT04324073|519972199|FG002|Overall Study|withdrew consent|2|||
144212294|NCT04324073|519972200|FG003|Overall Study|withdrew consent|8|||
144212295|NCT02260570|519972205|FG000|Overall Study|Withdrawal by Subject|2|||
144212296|NCT02260570|519972206|FG001|Overall Study|Withdrawal by Subject|1|||
144652081|NCT01952015|521577750|FG000|Induction|Protocol Violation|1|||
144212297|NCT02260570|519972205|FG000|Overall Study|Physician Decision|1|||
144212298|NCT02260570|519972206|FG001|Overall Study|Physician Decision|1|||
144212299|NCT03996447|519972207|FG000|First MRI Examination|Adverse Event|2|||
144212300|NCT03996447|519972208|FG001|First MRI Examination|Adverse Event|0|||
144652082|NCT01952015|521577750|FG000|Maintenance|Adverse Event|2|||
144212301|NCT03996447|519972207|FG000|First MRI Examination|Withdrawal by Subject|1|||
144212302|NCT03996447|519972208|FG001|First MRI Examination|Withdrawal by Subject|2|||
144652083|NCT01952015|521577750|FG000|Treatment Period 3|Physician Decision|9|||
144731859|NCT00942968|521875658|FG000|Overall Study|Inferior vena cava filter placement|4|||
144731860|NCT00942968|521875658|FG000|Overall Study|Pulmonary embolism (PE)|1|||
144731861|NCT00942968|521875658|FG000|Overall Study|Participant required pancreatic biopsy|1|||
144731862|NCT00942968|521875658|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
144731863|NCT01045096|521875659|FG000|Overall Study|Withdrawal by Subject|2|||
144731864|NCT01045096|521875660|FG001|Overall Study|Withdrawal by Subject|0|||
144212303|NCT03996447|519972207|FG000|First MRI Examination|Protocol Violation|0|||
144212304|NCT03996447|519972208|FG001|First MRI Examination|Protocol Violation|1|||
144212305|NCT03996447|519972207|FG000|Washout|Adverse Event|2|||
144212306|NCT03996447|519972208|FG001|Washout|Adverse Event|0|||
144212307|NCT03996447|519972207|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
144212308|NCT03996447|519972208|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
144212309|NCT03996447|519972207|FG000|Washout|Withdrawal by Subject|0|||
144212310|NCT03996447|519972208|FG001|Washout|Withdrawal by Subject|1|||
144212311|NCT03996447|519972207|FG000|Washout|Other reason|1|||
144212312|NCT03996447|519972208|FG001|Washout|Other reason|1|||
144212313|NCT00369486|519972211|FG000|4-Week Visit|Missed visit|2|||
144212314|NCT00369486|519972212|FG001|4-Week Visit|Missed visit|2|||
144212315|NCT00369486|519972213|FG002|4-Week Visit|Missed visit|0|||
144212316|NCT00369486|519972214|FG003|4-Week Visit|Missed visit|2|||
144212317|NCT00369486|519972215|FG004|4-Week Visit|Missed visit|1|||
144212318|NCT00369486|519972211|FG000|4-Week Visit|Dropped|0|||
144212319|NCT00369486|519972212|FG001|4-Week Visit|Dropped|0|||
144212320|NCT00369486|519972213|FG002|4-Week Visit|Dropped|1|||
144212321|NCT00369486|519972214|FG003|4-Week Visit|Dropped|0|||
144212322|NCT00369486|519972215|FG004|4-Week Visit|Dropped|0|||
144212323|NCT00369486|519972211|FG000|8-Week Visit|Missed visit|0|||
144212324|NCT00369486|519972212|FG001|8-Week Visit|Missed visit|1|||
144212325|NCT00369486|519972213|FG002|8-Week Visit|Missed visit|0|||
144212326|NCT00369486|519972214|FG003|8-Week Visit|Missed visit|0|||
144212327|NCT00369486|519972215|FG004|8-Week Visit|Missed visit|1|||
144212328|NCT00369486|519972211|FG000|8-Week Visit|Dropped|0|||
144212329|NCT00369486|519972212|FG001|8-Week Visit|Dropped|0|||
144212330|NCT00369486|519972213|FG002|8-Week Visit|Dropped|0|||
144212331|NCT00369486|519972214|FG003|8-Week Visit|Dropped|1|||
144212332|NCT00369486|519972215|FG004|8-Week Visit|Dropped|0|||
144212333|NCT00369486|519972211|FG000|17-Week Visit|Missed visit|0|||
144212334|NCT00369486|519972212|FG001|17-Week Visit|Missed visit|0|||
144212335|NCT00369486|519972213|FG002|17-Week Visit|Missed visit|1|||
144212336|NCT00369486|519972214|FG003|17-Week Visit|Missed visit|1|||
144212337|NCT00369486|519972215|FG004|17-Week Visit|Missed visit|1|||
144212338|NCT00369486|519972211|FG000|34-Week Visit|Dropped|0|||
144212339|NCT00369486|519972212|FG001|34-Week Visit|Dropped|1|||
144212340|NCT00369486|519972213|FG002|34-Week Visit|Dropped|1|||
144212341|NCT00369486|519972214|FG003|34-Week Visit|Dropped|3|||
144212342|NCT00369486|519972215|FG004|34-Week Visit|Dropped|3|||
144212343|NCT01810302|519972222|FG000|Overall Study|Death|1|||
144212344|NCT01810302|519972223|FG001|Overall Study|Death|0|||
144212345|NCT01810302|519972222|FG000|Overall Study|Physician Decision|0|||
144212346|NCT01810302|519972223|FG001|Overall Study|Physician Decision|1|||
144212347|NCT01659125|519972227|FG000|Overall Study|Withdrawal by Subject|2|||
144212348|NCT01659125|519972227|FG000|Overall Study|Lost to Follow-up|7|||
144212349|NCT01659125|519972227|FG000|Overall Study|Technical Problem|1|||
144212350|NCT01659125|519972227|FG000|Overall Study|Time Constraints|2|||
144212351|NCT01659125|519972227|FG000|Overall Study|Failed to Start Treatment|2|||
144212352|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #1|24|||
144212353|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #1|0|||
144212354|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
144212355|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
144212356|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212357|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144652084|NCT03090737|521577751|FG000|Overall Study|Other reasons|1|||
144652085|NCT03090737|521577751|FG000|Overall Study|Completed treatment as per protocol|17|||
144652086|NCT03090737|521577751|FG000|Overall Study|Maximum clinical benefit|2|||
144652087|NCT03090737|521577751|FG000|Overall Study|Adverse event unrelated to study drug|7|||
144212358|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
144212359|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
144212360|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
144212361|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
144212362|NCT03888066|519972228|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212363|NCT03888066|519972229|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212364|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212365|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212366|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
144212367|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
144212368|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212369|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212370|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
144212371|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212372|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #2|5|||
144212373|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #2|0|||
144652088|NCT03090737|521577751|FG000|Overall Study|Study drug toxicity|4|||
144652089|NCT03090737|521577751|FG000|Overall Study|Disease progression|98|||
144652090|NCT03141307|521577752|FG000|In-Hospital|Withdrawal by Subject|0|||
144263507|NCT03286218|520165439|FG000|Qualification Phase Period 2|Protocol Violation|2|||
144263508|NCT03286218|520165440|FG001|Qualification Phase Period 2|Protocol Violation|0|||
144263509|NCT03286218|520165441|FG002|Qualification Phase Period 2|Protocol Violation|0|||
144263510|NCT03286218|520165442|FG003|Qualification Phase Period 2|Protocol Violation|0|||
144263511|NCT03286218|520165443|FG004|Qualification Phase Period 2|Protocol Violation|0|||
144263512|NCT03286218|520165444|FG005|Qualification Phase Period 2|Protocol Violation|0|||
144263513|NCT03286218|520165445|FG006|Qualification Phase Period 2|Protocol Violation|0|||
144263514|NCT03286218|520165446|FG007|Qualification Phase Period 2|Protocol Violation|0|||
144263515|NCT03286218|520165447|FG008|Qualification Phase Period 2|Protocol Violation|0|||
144263516|NCT03286218|520165448|FG009|Qualification Phase Period 2|Protocol Violation|0|||
144263517|NCT03286218|520165449|FG010|Qualification Phase Period 2|Protocol Violation|0|||
144263518|NCT03286218|520165450|FG011|Qualification Phase Period 2|Protocol Violation|0|||
144263519|NCT03286218|520165439|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
144263520|NCT03286218|520165440|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
144263521|NCT03286218|520165441|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263522|NCT03286218|520165442|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263523|NCT03286218|520165443|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263524|NCT03286218|520165444|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263525|NCT03286218|520165445|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263526|NCT03286218|520165446|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
144652091|NCT03141307|521577753|FG001|In-Hospital|Withdrawal by Subject|2|||
144652092|NCT03141307|521577752|FG000|In-Hospital|Protocol Violation|4|||
144652093|NCT03141307|521577753|FG001|In-Hospital|Protocol Violation|0|||
144652094|NCT03141307|521577752|FG000|Follow-Up|Lost to Follow-up|97|||
144652095|NCT03141307|521577753|FG001|Follow-Up|Lost to Follow-up|54|||
144652096|NCT02078713|521579668|FG000|Overall Study|Lost to Follow-up|49|||
144652097|NCT02078713|521579669|FG001|Overall Study|Lost to Follow-up|55|||
144652098|NCT02078713|521579670|FG002|Overall Study|Lost to Follow-up|0|||
144212374|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
144212375|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
144212376|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
144212377|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
144212378|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
144212379|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
144212380|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #3|11|||
144212381|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #3|0|||
144212382|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
144212383|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
144212384|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
144212385|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
144212386|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212387|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212388|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #4|3|||
144212389|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #4|0|||
144212390|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
144212391|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
144212392|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
144212393|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
144212394|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
144212395|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
144212396|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
144212397|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
144212398|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
144212399|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212400|NCT03888066|519972228|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
144212401|NCT03888066|519972229|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
144212402|NCT03888066|519972228|FG000|Run-in Phase|AE (Adverse Event)|17|||
144212403|NCT03888066|519972229|FG001|Run-in Phase|AE (Adverse Event)|0|||
144263527|NCT03286218|520165447|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263528|NCT03286218|520165448|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
144652099|NCT02078713|521579671|FG003|Overall Study|Lost to Follow-up|0|||
144652100|NCT02078713|521579668|FG000|Overall Study|Pregnant at baseline|3|||
144652101|NCT02078713|521579669|FG001|Overall Study|Pregnant at baseline|5|||
144652102|NCT02078713|521579670|FG002|Overall Study|Pregnant at baseline|0|||
144263529|NCT03286218|520165449|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263530|NCT03286218|520165450|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
144263531|NCT03286218|520165439|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263532|NCT03286218|520165440|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263533|NCT03286218|520165441|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
144263534|NCT03286218|520165442|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
144263535|NCT03286218|520165443|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263536|NCT03286218|520165444|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
144263537|NCT03286218|520165445|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263538|NCT03286218|520165446|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263539|NCT03286218|520165447|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263540|NCT03286218|520165448|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
144263541|NCT03286218|520165449|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
144652103|NCT02078713|521579671|FG003|Overall Study|Pregnant at baseline|0|||
144263542|NCT03286218|520165450|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
144263543|NCT03286218|520165439|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263544|NCT03286218|520165440|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263545|NCT03286218|520165441|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263546|NCT03286218|520165442|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263547|NCT03286218|520165443|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263548|NCT03286218|520165444|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263549|NCT03286218|520165445|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263550|NCT03286218|520165446|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263551|NCT03286218|520165447|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263552|NCT03286218|520165448|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263553|NCT03286218|520165449|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
144263554|NCT03286218|520165450|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
144263555|NCT01576575|520165452|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
144263556|NCT01576575|520165452|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
144263557|NCT01576575|520165452|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
144263558|NCT02157519|520165456|FG000|Overall Study|Death|3|||
144263559|NCT02157519|520165457|FG001|Overall Study|Death|1|||
144263560|NCT02157519|520165456|FG000|Overall Study|Withdrawal by Subject|7|||
144263561|NCT02157519|520165457|FG001|Overall Study|Withdrawal by Subject|0|||
144263562|NCT02157519|520165456|FG000|Overall Study|Lost to Follow-up|1|||
144263563|NCT02157519|520165457|FG001|Overall Study|Lost to Follow-up|0|||
144263564|NCT01656395|520165458|FG000|Overall Study|Adverse Event|1|||
144263565|NCT01656395|520165459|FG001|Overall Study|Adverse Event|14|||
144263566|NCT01656395|520165460|FG002|Overall Study|Adverse Event|5|||
144263567|NCT01656395|520165461|FG003|Overall Study|Adverse Event|4|||
144263568|NCT01656395|520165462|FG004|Overall Study|Adverse Event|5|||
144263569|NCT01656395|520165463|FG005|Overall Study|Adverse Event|7|||
144263570|NCT01656395|520165464|FG006|Overall Study|Adverse Event|0|||
144263571|NCT01656395|520165465|FG007|Overall Study|Adverse Event|0|||
144263572|NCT01656395|520165458|FG000|Overall Study|Lack of Efficacy|1|||
144263573|NCT01656395|520165459|FG001|Overall Study|Lack of Efficacy|8|||
144263574|NCT01656395|520165460|FG002|Overall Study|Lack of Efficacy|6|||
144263575|NCT01656395|520165461|FG003|Overall Study|Lack of Efficacy|1|||
144263576|NCT01656395|520165462|FG004|Overall Study|Lack of Efficacy|1|||
144263577|NCT01656395|520165463|FG005|Overall Study|Lack of Efficacy|6|||
144263578|NCT01656395|520165464|FG006|Overall Study|Lack of Efficacy|0|||
144263579|NCT01656395|520165465|FG007|Overall Study|Lack of Efficacy|0|||
144263580|NCT01656395|520165458|FG000|Overall Study|Lost to Follow-up|1|||
144263581|NCT01656395|520165459|FG001|Overall Study|Lost to Follow-up|0|||
144263582|NCT01656395|520165460|FG002|Overall Study|Lost to Follow-up|0|||
144263583|NCT01656395|520165461|FG003|Overall Study|Lost to Follow-up|0|||
144263584|NCT01656395|520165462|FG004|Overall Study|Lost to Follow-up|0|||
144263585|NCT01656395|520165463|FG005|Overall Study|Lost to Follow-up|0|||
144263586|NCT01656395|520165464|FG006|Overall Study|Lost to Follow-up|0|||
144263587|NCT01656395|520165465|FG007|Overall Study|Lost to Follow-up|0|||
144652104|NCT02078713|521579668|FG000|Overall Study|Enrolled twice|0|||
144652105|NCT02078713|521579669|FG001|Overall Study|Enrolled twice|1|||
144652106|NCT02078713|521579670|FG002|Overall Study|Enrolled twice|0|||
144652107|NCT02078713|521579671|FG003|Overall Study|Enrolled twice|0|||
144652108|NCT00696657|521579672|FG000|Overall Study|Protocol Violation|0|||
144652109|NCT00696657|521579673|FG001|Overall Study|Protocol Violation|0|||
144652110|NCT00696657|521579674|FG002|Overall Study|Protocol Violation|0|||
144263588|NCT01656395|520165458|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144263589|NCT01656395|520165459|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144263590|NCT01656395|520165460|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144263591|NCT01656395|520165461|FG003|Overall Study|Non-Compliance with Study Drug|0|||
144263592|NCT01656395|520165462|FG004|Overall Study|Non-Compliance with Study Drug|1|||
144263593|NCT01656395|520165463|FG005|Overall Study|Non-Compliance with Study Drug|1|||
144263594|NCT01656395|520165464|FG006|Overall Study|Non-Compliance with Study Drug|0|||
144263595|NCT01656395|520165465|FG007|Overall Study|Non-Compliance with Study Drug|0|||
144731865|NCT01045096|521875661|FG002|Overall Study|Withdrawal by Subject|0|||
144731866|NCT01045096|521875659|FG000|Overall Study|Other|1|||
144731867|NCT01045096|521875660|FG001|Overall Study|Other|0|||
144731868|NCT01045096|521875661|FG002|Overall Study|Other|0|||
144731869|NCT03497897|521875662|FG000|Overall Study|Adverse Event|1|||
144731870|NCT03497897|521875663|FG001|Overall Study|Adverse Event|1|||
144731871|NCT03497897|521875664|FG002|Overall Study|Adverse Event|1|||
144731872|NCT03497897|521875662|FG000|Overall Study|Lost to Follow-up|2|||
144731873|NCT03497897|521875663|FG001|Overall Study|Lost to Follow-up|0|||
144731874|NCT03497897|521875664|FG002|Overall Study|Lost to Follow-up|2|||
144731875|NCT03497897|521875662|FG000|Overall Study|Physician Decision|1|||
144731876|NCT03497897|521875663|FG001|Overall Study|Physician Decision|0|||
144731877|NCT03497897|521875664|FG002|Overall Study|Physician Decision|0|||
144731878|NCT03497897|521875662|FG000|Overall Study|Subject/Guardian Decision|2|||
144731879|NCT03497897|521875663|FG001|Overall Study|Subject/Guardian Decision|1|||
144731880|NCT03497897|521875664|FG002|Overall Study|Subject/Guardian Decision|3|||
144731881|NCT01993030|521875669|FG000|Overall Study|Adverse Event|0|||
144731882|NCT01993030|521875670|FG001|Overall Study|Adverse Event|4|||
144731883|NCT05038293|521875671|FG000|Overall Study|device was not operating properly for one subject.|1|||
144731884|NCT05038293|521875672|FG001|Overall Study|device was not operating properly for one subject.|0|||
144731885|NCT05038293|521875671|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
144731886|NCT05038293|521875672|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
144731887|NCT00893464|521875673|FG000|Overall Study|Did not complete therapy/experience PD|0|||
144731888|NCT00893464|521875674|FG001|Overall Study|Did not complete therapy/experience PD|0|||
144731889|NCT00893464|521875675|FG002|Overall Study|Did not complete therapy/experience PD|0|||
144731890|NCT00893464|521875676|FG003|Overall Study|Did not complete therapy/experience PD|0|||
144731891|NCT00893464|521875677|FG004|Overall Study|Did not complete therapy/experience PD|0|||
144731892|NCT00893464|521875678|FG005|Overall Study|Did not complete therapy/experience PD|0|||
144731893|NCT00893464|521875679|FG006|Overall Study|Did not complete therapy/experience PD|2|||
144731894|NCT00893464|521875680|FG007|Overall Study|Did not complete therapy/experience PD|2|||
144731895|NCT03136380|521875689|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144731896|NCT03136380|521875690|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
144731897|NCT03136380|521875691|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144731898|NCT03136380|521875692|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144731899|NCT03136380|521875693|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144731900|NCT02419937|521875697|FG000|Overall Study|Lost to Follow-up|1|||
144731901|NCT02419937|521875698|FG001|Overall Study|Lost to Follow-up|0|||
144731902|NCT01544127|521875699|FG000|Overall Study|Lost to Follow-up|4|||
144731903|NCT01544127|521875700|FG001|Overall Study|Lost to Follow-up|2|||
144731904|NCT01544127|521875701|FG002|Overall Study|Lost to Follow-up|9|||
144731905|NCT01544127|521875699|FG000|Overall Study|Withdrawal by Subject|2|||
144731906|NCT01544127|521875700|FG001|Overall Study|Withdrawal by Subject|2|||
144731907|NCT01544127|521875701|FG002|Overall Study|Withdrawal by Subject|1|||
144731908|NCT01544127|521875699|FG000|Overall Study|Discharged out of catchment area|1|||
144731909|NCT01544127|521875700|FG001|Overall Study|Discharged out of catchment area|1|||
144731910|NCT01544127|521875701|FG002|Overall Study|Discharged out of catchment area|1|||
144731911|NCT01544127|521875699|FG000|Overall Study|Death|1|||
144731912|NCT01544127|521875700|FG001|Overall Study|Death|0|||
144652111|NCT00696657|521579675|FG003|Overall Study|Protocol Violation|0|||
144652112|NCT00696657|521579676|FG004|Overall Study|Protocol Violation|0|||
144652113|NCT00696657|521579677|FG005|Overall Study|Protocol Violation|1|||
144652114|NCT00696657|521579678|FG006|Overall Study|Protocol Violation|0|||
144652115|NCT00696657|521579679|FG007|Overall Study|Protocol Violation|0|||
144652116|NCT00696657|521579680|FG008|Overall Study|Protocol Violation|1|||
144652117|NCT00696657|521579672|FG000|Overall Study|Lack of Efficacy|0|||
144652118|NCT00696657|521579673|FG001|Overall Study|Lack of Efficacy|1|||
144652119|NCT00696657|521579674|FG002|Overall Study|Lack of Efficacy|0|||
144652120|NCT00696657|521579675|FG003|Overall Study|Lack of Efficacy|0|||
144652121|NCT00696657|521579676|FG004|Overall Study|Lack of Efficacy|0|||
144652122|NCT00696657|521579677|FG005|Overall Study|Lack of Efficacy|0|||
144652123|NCT00696657|521579678|FG006|Overall Study|Lack of Efficacy|0|||
144652124|NCT00696657|521579679|FG007|Overall Study|Lack of Efficacy|0|||
144652125|NCT00696657|521579680|FG008|Overall Study|Lack of Efficacy|0|||
144652126|NCT00696657|521579672|FG000|Overall Study|Withdrawal criteria|1|||
144652127|NCT00696657|521579673|FG001|Overall Study|Withdrawal criteria|3|||
144652128|NCT00696657|521579674|FG002|Overall Study|Withdrawal criteria|2|||
144652129|NCT00696657|521579675|FG003|Overall Study|Withdrawal criteria|2|||
144652130|NCT00696657|521579676|FG004|Overall Study|Withdrawal criteria|0|||
144731913|NCT01544127|521875701|FG002|Overall Study|Death|0|||
144731914|NCT01544127|521875699|FG000|Overall Study|Jail or Prison|1|||
144652131|NCT00696657|521579677|FG005|Overall Study|Withdrawal criteria|0|||
144652132|NCT00696657|521579678|FG006|Overall Study|Withdrawal criteria|1|||
144731915|NCT01544127|521875700|FG001|Overall Study|Jail or Prison|1|||
144731916|NCT01544127|521875701|FG002|Overall Study|Jail or Prison|2|||
144731917|NCT01544127|521875699|FG000|Overall Study|Became Psychotic|1|||
144652133|NCT00696657|521579679|FG007|Overall Study|Withdrawal criteria|1|||
144652134|NCT00696657|521579680|FG008|Overall Study|Withdrawal criteria|2|||
144652135|NCT00696657|521579672|FG000|Overall Study|Unclassified|0|||
144652136|NCT00696657|521579673|FG001|Overall Study|Unclassified|1|||
144652137|NCT00696657|521579674|FG002|Overall Study|Unclassified|3|||
144652138|NCT00696657|521579675|FG003|Overall Study|Unclassified|2|||
144652139|NCT00696657|521579676|FG004|Overall Study|Unclassified|4|||
144652140|NCT00696657|521579677|FG005|Overall Study|Unclassified|2|||
144652141|NCT00696657|521579678|FG006|Overall Study|Unclassified|0|||
144652142|NCT00696657|521579679|FG007|Overall Study|Unclassified|0|||
144652143|NCT00696657|521579680|FG008|Overall Study|Unclassified|1|||
144652144|NCT00696657|521579672|FG000|Overall Study|Adverse Event|0|||
144652145|NCT00696657|521579673|FG001|Overall Study|Adverse Event|0|||
144652146|NCT00696657|521579674|FG002|Overall Study|Adverse Event|3|||
144652147|NCT00696657|521579675|FG003|Overall Study|Adverse Event|7|||
144652148|NCT00696657|521579676|FG004|Overall Study|Adverse Event|6|||
144652149|NCT00696657|521579677|FG005|Overall Study|Adverse Event|9|||
144652150|NCT00696657|521579678|FG006|Overall Study|Adverse Event|14|||
144652151|NCT00696657|521579679|FG007|Overall Study|Adverse Event|2|||
144652152|NCT00696657|521579680|FG008|Overall Study|Adverse Event|5|||
144652153|NCT02601001|521579681|FG000|Dosing Period 2|Adverse Event|0|||
144652154|NCT02601001|521579682|FG001|Dosing Period 2|Adverse Event|0|||
144652155|NCT02601001|521579683|FG002|Dosing Period 2|Adverse Event|0|||
144652156|NCT02601001|521579684|FG003|Dosing Period 2|Adverse Event|0|||
144652157|NCT02601001|521579685|FG004|Dosing Period 2|Adverse Event|0|||
144652158|NCT02601001|521579686|FG005|Dosing Period 2|Adverse Event|0|||
144652159|NCT02601001|521579687|FG006|Dosing Period 2|Adverse Event|1|||
144652160|NCT01989546|521579688|FG000|Overall Study|Clinical Progression|1|||
144652161|NCT01989546|521579688|FG000|Overall Study|Disease progression on study|8|||
144652162|NCT03123354|521579689|FG000|Overall Study|Physician Decision|6|||
144652163|NCT01876732|521579692|FG000|Overall Study|MMA was not over 800mg/dL|75|||
144263596|NCT01656395|520165458|FG000|Overall Study|Other|0|||
144263597|NCT01656395|520165459|FG001|Overall Study|Other|0|||
144263598|NCT01656395|520165460|FG002|Overall Study|Other|1|||
144263599|NCT01656395|520165461|FG003|Overall Study|Other|0|||
144263600|NCT01656395|520165462|FG004|Overall Study|Other|0|||
144263601|NCT01656395|520165463|FG005|Overall Study|Other|1|||
144263602|NCT01656395|520165464|FG006|Overall Study|Other|0|||
144263603|NCT01656395|520165465|FG007|Overall Study|Other|0|||
144263604|NCT01656395|520165458|FG000|Overall Study|Physician Decision|2|||
144263605|NCT01656395|520165459|FG001|Overall Study|Physician Decision|3|||
144263606|NCT01656395|520165460|FG002|Overall Study|Physician Decision|3|||
144263607|NCT01656395|520165461|FG003|Overall Study|Physician Decision|2|||
144263608|NCT01656395|520165462|FG004|Overall Study|Physician Decision|3|||
144263609|NCT01656395|520165463|FG005|Overall Study|Physician Decision|3|||
144263610|NCT01656395|520165464|FG006|Overall Study|Physician Decision|0|||
144263611|NCT01656395|520165465|FG007|Overall Study|Physician Decision|0|||
144263612|NCT01656395|520165458|FG000|Overall Study|Pregnancy|0|||
144263613|NCT01656395|520165459|FG001|Overall Study|Pregnancy|0|||
144263614|NCT01656395|520165460|FG002|Overall Study|Pregnancy|1|||
144263615|NCT01656395|520165461|FG003|Overall Study|Pregnancy|0|||
144263616|NCT01656395|520165462|FG004|Overall Study|Pregnancy|0|||
144263617|NCT01656395|520165463|FG005|Overall Study|Pregnancy|0|||
144263618|NCT01656395|520165464|FG006|Overall Study|Pregnancy|0|||
144263619|NCT01656395|520165465|FG007|Overall Study|Pregnancy|0|||
144263620|NCT01656395|520165458|FG000|Overall Study|Progressive Disease|0|||
144263621|NCT01656395|520165459|FG001|Overall Study|Progressive Disease|0|||
144263622|NCT01656395|520165460|FG002|Overall Study|Progressive Disease|0|||
144263623|NCT01656395|520165461|FG003|Overall Study|Progressive Disease|0|||
144263624|NCT01656395|520165462|FG004|Overall Study|Progressive Disease|0|||
144263625|NCT01656395|520165463|FG005|Overall Study|Progressive Disease|1|||
144263626|NCT01656395|520165464|FG006|Overall Study|Progressive Disease|0|||
144263627|NCT01656395|520165465|FG007|Overall Study|Progressive Disease|0|||
144263628|NCT01656395|520165458|FG000|Overall Study|Protocol Violation|6|||
144263629|NCT01656395|520165459|FG001|Overall Study|Protocol Violation|6|||
144263630|NCT01656395|520165460|FG002|Overall Study|Protocol Violation|9|||
144263631|NCT01656395|520165461|FG003|Overall Study|Protocol Violation|2|||
144263632|NCT01656395|520165462|FG004|Overall Study|Protocol Violation|4|||
144263633|NCT01656395|520165463|FG005|Overall Study|Protocol Violation|10|||
144731918|NCT01544127|521875700|FG001|Overall Study|Became Psychotic|0|||
144263634|NCT01656395|520165464|FG006|Overall Study|Protocol Violation|0|||
144263635|NCT01656395|520165465|FG007|Overall Study|Protocol Violation|0|||
144263636|NCT01656395|520165458|FG000|Overall Study|Screen Failure|2|||
144263637|NCT01656395|520165459|FG001|Overall Study|Screen Failure|1|||
144263638|NCT01656395|520165460|FG002|Overall Study|Screen Failure|7|||
144263639|NCT01656395|520165461|FG003|Overall Study|Screen Failure|1|||
144263640|NCT01656395|520165462|FG004|Overall Study|Screen Failure|0|||
144263641|NCT01656395|520165463|FG005|Overall Study|Screen Failure|8|||
144263642|NCT01656395|520165464|FG006|Overall Study|Screen Failure|0|||
144263643|NCT01656395|520165465|FG007|Overall Study|Screen Failure|0|||
144263644|NCT01656395|520165458|FG000|Overall Study|Withdrawal by Subject|3|||
144263645|NCT01656395|520165459|FG001|Overall Study|Withdrawal by Subject|1|||
144652164|NCT00305006|521579693|FG000|Overall Study|Withdrawal by Subject|1|||
144263646|NCT01656395|520165460|FG002|Overall Study|Withdrawal by Subject|4|||
144263647|NCT01656395|520165461|FG003|Overall Study|Withdrawal by Subject|2|||
144263648|NCT01656395|520165462|FG004|Overall Study|Withdrawal by Subject|0|||
144263649|NCT01656395|520165463|FG005|Overall Study|Withdrawal by Subject|3|||
144263650|NCT01656395|520165464|FG006|Overall Study|Withdrawal by Subject|0|||
144263651|NCT01656395|520165465|FG007|Overall Study|Withdrawal by Subject|0|||
144263652|NCT02048722|520165474|FG000|2 Cycles of Treatment|Adverse Event|2|||
144652165|NCT00305006|521579694|FG001|Overall Study|Withdrawal by Subject|0|||
144652166|NCT00305006|521579693|FG000|Overall Study|Failure to complete pretest|0|||
144652167|NCT00305006|521579694|FG001|Overall Study|Failure to complete pretest|1|||
144212404|NCT03888066|519972228|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
144212405|NCT03888066|519972229|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
144212406|NCT03888066|519972228|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212407|NCT03888066|519972229|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212408|NCT03888066|519972228|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
144212409|NCT03888066|519972229|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212410|NCT03888066|519972228|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
144212411|NCT03888066|519972229|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
144212412|NCT03888066|519972228|FG000|Run-in Phase|Withdrawal by Subject|43|||
144212413|NCT03888066|519972229|FG001|Run-in Phase|Withdrawal by Subject|0|||
144212414|NCT03888066|519972228|FG000|Run-in Phase|AE; Physician Decision|1|||
144212415|NCT03888066|519972229|FG001|Run-in Phase|AE; Physician Decision|0|||
144212416|NCT03888066|519972228|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
144212417|NCT03888066|519972229|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
144212418|NCT03888066|519972228|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
144212419|NCT03888066|519972229|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
144212420|NCT03888066|519972228|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
144212421|NCT03888066|519972229|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
144212422|NCT03888066|519972228|FG000|Run-in Phase|Death|1|||
144212423|NCT03888066|519972229|FG001|Run-in Phase|Death|0|||
144212424|NCT03888066|519972228|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
144212425|NCT03888066|519972229|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
144212426|NCT03888066|519972228|FG000|Run-in Phase|Physician Decision|1|||
144212427|NCT03888066|519972229|FG001|Run-in Phase|Physician Decision|0|||
144212428|NCT03888066|519972228|FG000|Run-in Phase|Protocol Violation|13|||
144212429|NCT03888066|519972229|FG001|Run-in Phase|Protocol Violation|0|||
144212430|NCT03888066|519972228|FG000|Run-in Phase|Sponsor Request|34|||
144212431|NCT03888066|519972229|FG001|Run-in Phase|Sponsor Request|0|||
144212432|NCT03888066|519972228|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
144212433|NCT03888066|519972229|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
144212434|NCT03888066|519972228|FG000|Run-in Phase|Withdrawal Of Consent|1|||
144212435|NCT03888066|519972229|FG001|Run-in Phase|Withdrawal Of Consent|0|||
144212436|NCT03888066|519972228|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
144212437|NCT03888066|519972229|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
144212438|NCT03888066|519972228|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
144212439|NCT03888066|519972229|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
144212440|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
144212441|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
144212442|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
144212443|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
144212444|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
144212445|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
144212446|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
144212447|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
144212448|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
144212449|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
144212450|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
144212451|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
144212452|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
144212453|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
144212454|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
144212455|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
144212456|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
144212457|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
144212458|NCT03888066|519972228|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
144212459|NCT03888066|519972229|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
144212460|NCT02207634|519972230|FG000|Overall Study|Withdrawal by Subject|21|||
144263653|NCT02048722|520165474|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
144212461|NCT02207634|519972231|FG001|Overall Study|Withdrawal by Subject|31|||
144212462|NCT02207634|519972230|FG000|Overall Study|Lost to Follow-up|1|||
144212463|NCT02207634|519972231|FG001|Overall Study|Lost to Follow-up|0|||
144652168|NCT02606045|521579695|FG000|Overall Study|Study closed before treament could begin|1|||
144652169|NCT02606045|521579696|FG001|Overall Study|Study closed before treament could begin|2|||
144652170|NCT01996319|521579697|FG000|Overall Study|Protocol Violation|1|||
144652171|NCT01996319|521579698|FG001|Overall Study|Protocol Violation|0|||
144652172|NCT01996319|521579697|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
144652173|NCT01996319|521579698|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
144652174|NCT01996319|521579697|FG000|Overall Study|Adverse Event|2|||
144652175|NCT01996319|521579698|FG001|Overall Study|Adverse Event|2|||
144652176|NCT01671085|521579699|FG000|Overall Study|Withdrawal by Subject|1|||
144652177|NCT01671085|521579700|FG001|Overall Study|Withdrawal by Subject|0|||
144652178|NCT00637273|521579701|FG000|Overall Study|Adverse Event|11|||
144652179|NCT00637273|521579702|FG001|Overall Study|Adverse Event|5|||
144652180|NCT00637273|521579703|FG002|Overall Study|Adverse Event|7|||
144652181|NCT00637273|521579701|FG000|Overall Study|Lost to Follow-up|8|||
144652182|NCT00637273|521579702|FG001|Overall Study|Lost to Follow-up|9|||
144652183|NCT00637273|521579703|FG002|Overall Study|Lost to Follow-up|13|||
144652184|NCT00637273|521579701|FG000|Overall Study|Protocol Violation|2|||
144652185|NCT00637273|521579702|FG001|Overall Study|Protocol Violation|4|||
144652186|NCT00637273|521579703|FG002|Overall Study|Protocol Violation|1|||
144652187|NCT00637273|521579701|FG000|Overall Study|Withdrawal of Consent|18|||
144652188|NCT00637273|521579702|FG001|Overall Study|Withdrawal of Consent|6|||
144652189|NCT00637273|521579703|FG002|Overall Study|Withdrawal of Consent|18|||
144652190|NCT00637273|521579701|FG000|Overall Study|Investigator Decision|1|||
144652191|NCT00637273|521579702|FG001|Overall Study|Investigator Decision|3|||
144652192|NCT00637273|521579703|FG002|Overall Study|Investigator Decision|1|||
144652193|NCT00637273|521579701|FG000|Overall Study|Administrative|2|||
144652194|NCT00637273|521579702|FG001|Overall Study|Administrative|0|||
144652195|NCT00637273|521579703|FG002|Overall Study|Administrative|0|||
144652196|NCT00637273|521579701|FG000|Overall Study|Loss of Glucose Control|1|||
144652197|NCT00637273|521579702|FG001|Overall Study|Loss of Glucose Control|1|||
144652198|NCT00637273|521579703|FG002|Overall Study|Loss of Glucose Control|1|||
144652199|NCT03332667|521579705|FG000|Overall Study|Adverse Event|0|||
144652200|NCT03332667|521579706|FG001|Overall Study|Adverse Event|0|||
144652201|NCT03332667|521579707|FG002|Overall Study|Adverse Event|2|||
144652202|NCT03332667|521579708|FG003|Overall Study|Adverse Event|1|||
144652203|NCT03332667|521579705|FG000|Overall Study|Withdrawal by Subject|2|||
144652204|NCT03332667|521579706|FG001|Overall Study|Withdrawal by Subject|1|||
144652205|NCT03332667|521579707|FG002|Overall Study|Withdrawal by Subject|5|||
144652206|NCT03332667|521579708|FG003|Overall Study|Withdrawal by Subject|1|||
144652207|NCT03332667|521579705|FG000|Overall Study|Disease Progression or Relapse|2|||
144652208|NCT03332667|521579706|FG001|Overall Study|Disease Progression or Relapse|1|||
144652209|NCT03332667|521579707|FG002|Overall Study|Disease Progression or Relapse|3|||
144652210|NCT03332667|521579708|FG003|Overall Study|Disease Progression or Relapse|0|||
144652211|NCT03332667|521579705|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
144652212|NCT03332667|521579706|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
144652213|NCT03332667|521579707|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
144652214|NCT03332667|521579708|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
144652215|NCT03332667|521579705|FG000|Overall Study|No Treatment Received|0|||
144652216|NCT03332667|521579706|FG001|Overall Study|No Treatment Received|0|||
144652217|NCT03332667|521579707|FG002|Overall Study|No Treatment Received|1|||
144652218|NCT03332667|521579708|FG003|Overall Study|No Treatment Received|0|||
144652219|NCT01035606|521579709|FG000|Overall Study|change in health, job demands,family|3|||
144652220|NCT01035606|521579710|FG001|Overall Study|change in health, job demands,family|3|||
144652221|NCT01035606|521579711|FG002|Overall Study|change in health, job demands,family|4|||
144652222|NCT01120093|521579713|FG000|Treatment Period 1|Adverse Event|0|||
144652223|NCT01120093|521579714|FG001|Treatment Period 1|Adverse Event|0|||
144652224|NCT01120093|521579715|FG002|Treatment Period 1|Adverse Event|1|||
144212464|NCT02077140|519972232|FG000|Overall Study|Lost to Follow-up|4|||
144652225|NCT01120093|521579716|FG003|Treatment Period 1|Adverse Event|0|||
144652226|NCT01120093|521579717|FG004|Treatment Period 1|Adverse Event|1|||
144652227|NCT01120093|521579713|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144652228|NCT01120093|521579714|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144652229|NCT01120093|521579715|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144652230|NCT01120093|521579716|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144652231|NCT01120093|521579717|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144652232|NCT01120093|521579713|FG000|Treatment Period 2|Adverse Event|0|||
144652233|NCT01120093|521579714|FG001|Treatment Period 2|Adverse Event|0|||
144652234|NCT01120093|521579715|FG002|Treatment Period 2|Adverse Event|0|||
144652235|NCT01120093|521579716|FG003|Treatment Period 2|Adverse Event|1|||
144212465|NCT02077140|519972233|FG001|Overall Study|Lost to Follow-up|1|||
144652236|NCT01120093|521579717|FG004|Treatment Period 2|Adverse Event|0|||
144652237|NCT01120093|521579713|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144652238|NCT01120093|521579714|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144652239|NCT01120093|521579715|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144652240|NCT01120093|521579716|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144652241|NCT01120093|521579717|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144652242|NCT01120093|521579713|FG000|Treatment Period 3|Lack of Efficacy|0|||
144652243|NCT01120093|521579714|FG001|Treatment Period 3|Lack of Efficacy|0|||
144652244|NCT01120093|521579715|FG002|Treatment Period 3|Lack of Efficacy|0|||
144652245|NCT01120093|521579716|FG003|Treatment Period 3|Lack of Efficacy|1|||
144652246|NCT01120093|521579717|FG004|Treatment Period 3|Lack of Efficacy|0|||
144652247|NCT01120093|521579713|FG000|Treatment Period 3|Adverse Event|0|||
144652248|NCT01120093|521579714|FG001|Treatment Period 3|Adverse Event|0|||
144652249|NCT01120093|521579715|FG002|Treatment Period 3|Adverse Event|0|||
144652250|NCT01120093|521579716|FG003|Treatment Period 3|Adverse Event|0|||
144652251|NCT01120093|521579717|FG004|Treatment Period 3|Adverse Event|1|||
144652252|NCT01120093|521579713|FG000|Treatment Period 3|Withdrawal by Subject|0|||
144652253|NCT01120093|521579714|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144652254|NCT01120093|521579715|FG002|Treatment Period 3|Withdrawal by Subject|1|||
144652255|NCT01120093|521579716|FG003|Treatment Period 3|Withdrawal by Subject|0|||
144652256|NCT01120093|521579717|FG004|Treatment Period 3|Withdrawal by Subject|0|||
144652257|NCT01120093|521579713|FG000|Treatment Period 4|Adverse Event|1|||
144652258|NCT01120093|521579714|FG001|Treatment Period 4|Adverse Event|0|||
144652259|NCT01120093|521579715|FG002|Treatment Period 4|Adverse Event|0|||
144652260|NCT01120093|521579716|FG003|Treatment Period 4|Adverse Event|0|||
144652261|NCT01120093|521579717|FG004|Treatment Period 4|Adverse Event|0|||
144652262|NCT01120093|521579713|FG000|Treatment Period 5|Adverse Event|0|||
144652263|NCT01120093|521579714|FG001|Treatment Period 5|Adverse Event|1|||
144652264|NCT01120093|521579715|FG002|Treatment Period 5|Adverse Event|0|||
144652265|NCT01120093|521579716|FG003|Treatment Period 5|Adverse Event|1|||
144652266|NCT01120093|521579717|FG004|Treatment Period 5|Adverse Event|0|||
144652267|NCT03649321|521579718|FG000|Overall Study|Withdrawal by Subject|1|||
144652268|NCT03649321|521579719|FG001|Overall Study|Withdrawal by Subject|0|||
144652269|NCT03649321|521579718|FG000|Overall Study|Death|1|||
144652270|NCT03649321|521579719|FG001|Overall Study|Death|0|||
144652271|NCT00431847|521579723|FG000|Overall Study|completion of less than two study visits|6|||
144652272|NCT00431847|521579724|FG001|Overall Study|completion of less than two study visits|3|||
144652273|NCT00431847|521579725|FG002|Overall Study|completion of less than two study visits|4|||
144652274|NCT00431847|521579726|FG003|Overall Study|completion of less than two study visits|14|||
144652275|NCT00431847|521579727|FG004|Overall Study|completion of less than two study visits|0|||
144652276|NCT00431847|521579723|FG000|Overall Study|Protocol Violation|0|||
144652277|NCT00431847|521579724|FG001|Overall Study|Protocol Violation|0|||
144652278|NCT00431847|521579725|FG002|Overall Study|Protocol Violation|0|||
144652279|NCT00431847|521579726|FG003|Overall Study|Protocol Violation|0|||
144652280|NCT00431847|521579727|FG004|Overall Study|Protocol Violation|1|||
144652281|NCT02142894|521579730|FG000|Overall Study|Protocol Violation|8|||
144652282|NCT02853331|521579732|FG000|Overall Study|Death|59|||
144652283|NCT02853331|521579733|FG001|Overall Study|Death|95|||
144652284|NCT02853331|521579732|FG000|Overall Study|Withdrawal by Subject|5|||
144652285|NCT02853331|521579733|FG001|Overall Study|Withdrawal by Subject|9|||
144652286|NCT02853331|521579732|FG000|Overall Study|Ongoing in study|368|||
144652287|NCT02853331|521579733|FG001|Overall Study|Ongoing in study|325|||
144652288|NCT01455428|521579734|FG000|Overall Study|Protocol Violation|2|||
144652289|NCT01455428|521579735|FG001|Overall Study|Protocol Violation|1|||
144652290|NCT01455428|521579734|FG000|Overall Study|Adverse Event|6|||
144652291|NCT01455428|521579735|FG001|Overall Study|Adverse Event|2|||
144652292|NCT01455428|521579734|FG000|Overall Study|Lost to Follow-up|1|||
144652293|NCT01455428|521579735|FG001|Overall Study|Lost to Follow-up|1|||
144652294|NCT01455428|521579734|FG000|Overall Study|Withdrawal by Subject|2|||
144652295|NCT01455428|521579735|FG001|Overall Study|Withdrawal by Subject|5|||
144652296|NCT01455428|521579734|FG000|Overall Study|Did not meet entrance criteria|0|||
144652297|NCT01455428|521579735|FG001|Overall Study|Did not meet entrance criteria|2|||
144652298|NCT01455428|521579734|FG000|Overall Study|Insufficient clinical response|0|||
144652299|NCT01455428|521579735|FG001|Overall Study|Insufficient clinical response|2|||
144652300|NCT01455428|521579734|FG000|Overall Study|Did not receive treatment|1|||
144652301|NCT01455428|521579735|FG001|Overall Study|Did not receive treatment|1|||
144652302|NCT01455428|521579734|FG000|Overall Study|Other|2|||
144652303|NCT01455428|521579735|FG001|Overall Study|Other|4|||
144652304|NCT02062151|521579739|FG000|Overall Study|screen failure|1|||
144652305|NCT00257192|521579742|FG000|Overall Study|Adverse Event|21|||
144652306|NCT00257192|521579743|FG001|Overall Study|Adverse Event|10|||
144652307|NCT00257192|521579742|FG000|Overall Study|Laboratory abnormality|1|||
144731919|NCT01544127|521875701|FG002|Overall Study|Became Psychotic|0|||
144731920|NCT01544127|521875699|FG000|Overall Study|Researcher withdrew|1|||
144731921|NCT01544127|521875700|FG001|Overall Study|Researcher withdrew|0|||
144731922|NCT01544127|521875701|FG002|Overall Study|Researcher withdrew|0|||
144652308|NCT00257192|521579743|FG001|Overall Study|Laboratory abnormality|1|||
144652309|NCT00257192|521579742|FG000|Overall Study|Lost to Follow-up|3|||
144652310|NCT00257192|521579743|FG001|Overall Study|Lost to Follow-up|3|||
144652311|NCT00257192|521579742|FG000|Overall Study|Insufficient clinical response|18|||
144731923|NCT01544127|521875699|FG000|Overall Study|Went active duty|0|||
144652312|NCT00257192|521579743|FG001|Overall Study|Insufficient clinical response|18|||
144652313|NCT00257192|521579742|FG000|Overall Study|Withdrawal by Subject|14|||
144652314|NCT00257192|521579743|FG001|Overall Study|Withdrawal by Subject|2|||
144652315|NCT00257192|521579742|FG000|Overall Study|Randomized but not treated|0|||
144652316|NCT00257192|521579743|FG001|Overall Study|Randomized but not treated|1|||
144652317|NCT00257192|521579742|FG000|Overall Study|Study terminated by sponsor|1|||
144652318|NCT00257192|521579743|FG001|Overall Study|Study terminated by sponsor|0|||
144652319|NCT00257192|521579742|FG000|Overall Study|Miscellaneous|0|||
144652320|NCT00257192|521579743|FG001|Overall Study|Miscellaneous|4|||
144652321|NCT00570739|521579744|FG000|Overall Study|Adverse Event|8|||
144652322|NCT00570739|521579745|FG001|Overall Study|Adverse Event|6|||
144652323|NCT00570739|521579746|FG002|Overall Study|Adverse Event|2|||
144652324|NCT00570739|521579747|FG003|Overall Study|Adverse Event|2|||
144652325|NCT00570739|521579744|FG000|Overall Study|Lost to Follow-up|4|||
144652326|NCT00570739|521579745|FG001|Overall Study|Lost to Follow-up|5|||
144652327|NCT00570739|521579746|FG002|Overall Study|Lost to Follow-up|4|||
144652328|NCT00570739|521579747|FG003|Overall Study|Lost to Follow-up|1|||
144652329|NCT00570739|521579744|FG000|Overall Study|Physician Decision|1|||
144652330|NCT00570739|521579745|FG001|Overall Study|Physician Decision|1|||
144652331|NCT00570739|521579746|FG002|Overall Study|Physician Decision|0|||
144652332|NCT00570739|521579747|FG003|Overall Study|Physician Decision|0|||
144652333|NCT00570739|521579744|FG000|Overall Study|Withdrawal by Subject|7|||
144652334|NCT00570739|521579745|FG001|Overall Study|Withdrawal by Subject|7|||
144652335|NCT00570739|521579746|FG002|Overall Study|Withdrawal by Subject|3|||
144652336|NCT00570739|521579747|FG003|Overall Study|Withdrawal by Subject|5|||
144652337|NCT00570739|521579744|FG000|Overall Study|Required restricted medication|0|||
144652338|NCT00570739|521579745|FG001|Overall Study|Required restricted medication|0|||
144652339|NCT00570739|521579746|FG002|Overall Study|Required restricted medication|1|||
144652340|NCT00570739|521579747|FG003|Overall Study|Required restricted medication|0|||
144652341|NCT00570739|521579744|FG000|Overall Study|Met discontinuation criteria|1|||
144652342|NCT00570739|521579745|FG001|Overall Study|Met discontinuation criteria|0|||
144652343|NCT00570739|521579746|FG002|Overall Study|Met discontinuation criteria|1|||
144652344|NCT00570739|521579747|FG003|Overall Study|Met discontinuation criteria|1|||
144652345|NCT00570739|521579744|FG000|Overall Study|Other|0|||
144652346|NCT00570739|521579745|FG001|Overall Study|Other|2|||
144652347|NCT00570739|521579746|FG002|Overall Study|Other|5|||
144652348|NCT00570739|521579747|FG003|Overall Study|Other|3|||
144652349|NCT00751101|521579749|FG000|Overall Study|Withdrawal by Subject|1|||
144652350|NCT00751101|521579750|FG001|Overall Study|Withdrawal by Subject|0|||
144652351|NCT00751101|521579749|FG000|Overall Study|No HFS / Never Started Patch/|0|||
144652352|NCT00751101|521579750|FG001|Overall Study|No HFS / Never Started Patch/|4|||
144652353|NCT00751101|521579749|FG000|Overall Study|Never began capecitabine|1|||
144652354|NCT00751101|521579750|FG001|Overall Study|Never began capecitabine|0|||
144652355|NCT00751101|521579749|FG000|Overall Study|Physician Decision|0|||
144652356|NCT00751101|521579750|FG001|Overall Study|Physician Decision|1|||
144652357|NCT02086565|521579751|FG000|Overall Study|Lost to Follow-up|9|||
144652358|NCT02086565|521579752|FG001|Overall Study|Lost to Follow-up|7|||
144652359|NCT02086565|521579751|FG000|Overall Study|Withdrawal by Subject|2|||
144652360|NCT02086565|521579752|FG001|Overall Study|Withdrawal by Subject|1|||
144652361|NCT02086565|521579751|FG000|Overall Study|Death|3|||
144652362|NCT02086565|521579752|FG001|Overall Study|Death|2|||
144652363|NCT02086565|521579751|FG000|Overall Study|withdrawn by research team|2|||
144652364|NCT02086565|521579752|FG001|Overall Study|withdrawn by research team|2|||
144652365|NCT00739297|521579753|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
144652366|NCT00739297|521579754|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
144652367|NCT00739297|521579755|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
144652368|NCT00739297|521579756|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
144731924|NCT01544127|521875700|FG001|Overall Study|Went active duty|0|||
144731925|NCT01544127|521875701|FG002|Overall Study|Went active duty|1|||
144731926|NCT01256684|521875702|FG000|Overall Study|Adverse Event|1|||
144731927|NCT01256684|521875703|FG001|Overall Study|Adverse Event|4|||
144731928|NCT01256684|521875704|FG002|Overall Study|Adverse Event|2|||
144731929|NCT01256684|521875702|FG000|Overall Study|Withdrawal by Subject|4|||
144731930|NCT01256684|521875703|FG001|Overall Study|Withdrawal by Subject|0|||
144731931|NCT01256684|521875704|FG002|Overall Study|Withdrawal by Subject|2|||
144652369|NCT00739297|521579757|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
144652370|NCT00739297|521579758|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
144652371|NCT00739297|521579759|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
144652372|NCT00739297|521579753|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
144652373|NCT00739297|521579754|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
144652374|NCT00739297|521579755|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
144652375|NCT00739297|521579756|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
144652376|NCT00739297|521579757|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
144652377|NCT00739297|521579758|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
144652378|NCT00739297|521579759|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
144652379|NCT01921270|521579762|FG000|Overall Study|Withdrawal by Subject|1|||
144652380|NCT00844428|521579763|FG000|Screening Period|Screen Failure|3|||
144652381|NCT00844428|521579763|FG000|Extension Treatment Period|Death|1|||
144652382|NCT00844428|521579763|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
144652383|NCT00789477|521579764|FG000|Overall Study|Withdrawal by Subject|2|||
144212466|NCT02077140|519972234|FG002|Overall Study|Lost to Follow-up|2|||
144212467|NCT02077140|519972235|FG003|Overall Study|Lost to Follow-up|2|||
144212468|NCT02077140|519972236|FG004|Overall Study|Lost to Follow-up|3|||
144212469|NCT02077140|519972232|FG000|Overall Study|Withdrawal by Subject|0|||
144652384|NCT00789477|521579765|FG001|Overall Study|Withdrawal by Subject|1|||
144652385|NCT00789477|521579766|FG002|Overall Study|Withdrawal by Subject|3|||
144652386|NCT00789477|521579767|FG003|Overall Study|Withdrawal by Subject|2|||
144652387|NCT00789477|521579768|FG004|Overall Study|Withdrawal by Subject|3|||
144212470|NCT02077140|519972233|FG001|Overall Study|Withdrawal by Subject|1|||
144212471|NCT02077140|519972234|FG002|Overall Study|Withdrawal by Subject|0|||
144212472|NCT02077140|519972235|FG003|Overall Study|Withdrawal by Subject|2|||
144212473|NCT02077140|519972236|FG004|Overall Study|Withdrawal by Subject|2|||
144212474|NCT00113763|519972240|FG000|Overall Study|Adverse Event|5|||
144212475|NCT00113763|519972241|FG001|Overall Study|Adverse Event|2|||
144212476|NCT00113763|519972240|FG000|Overall Study|Disease Progression|28|||
144212477|NCT00113763|519972241|FG001|Overall Study|Disease Progression|14|||
144212478|NCT00113763|519972240|FG000|Overall Study|Lost to Follow-up|10|||
144212479|NCT00113763|519972241|FG001|Overall Study|Lost to Follow-up|0|||
144212480|NCT00113763|519972240|FG000|Overall Study|Withdrawal by Subject|1|||
144212481|NCT00113763|519972241|FG001|Overall Study|Withdrawal by Subject|4|||
144212482|NCT00113763|519972240|FG000|Overall Study|Other|27|||
144212483|NCT00113763|519972241|FG001|Overall Study|Other|6|||
144212484|NCT00113763|519972240|FG000|Overall Study|Non-compliance|1|||
144212485|NCT00113763|519972241|FG001|Overall Study|Non-compliance|0|||
144212486|NCT00113763|519972240|FG000|Overall Study|Ongoing|1|||
144212487|NCT00113763|519972241|FG001|Overall Study|Ongoing|0|||
144212488|NCT02847260|519972242|FG000|Overall Study|Adverse Event|3|||
144212489|NCT02847260|519972242|FG000|Overall Study|Withdrawal by Subject|2|||
144212490|NCT02847260|519972242|FG000|Overall Study|Clinical Deterioration|1|||
144212491|NCT02847260|519972242|FG000|Overall Study|Physician Decision|1|||
144212492|NCT03055624|519972245|FG000|Overall Study|Study closed|9|||
144212493|NCT02111603|519972249|FG000|Overall Study|Withdrawal by Subject|1|||
144212494|NCT01582152|519972250|FG000|Overall Study|Disease Progression|4|||
144212495|NCT01582152|519972251|FG001|Overall Study|Disease Progression|5|||
144212496|NCT01582152|519972250|FG000|Overall Study|Adverse Event|2|||
144652388|NCT00789477|521579764|FG000|Overall Study|Protocol Violation|1|||
144652389|NCT00789477|521579765|FG001|Overall Study|Protocol Violation|0|||
144652390|NCT00789477|521579766|FG002|Overall Study|Protocol Violation|0|||
144652391|NCT00789477|521579767|FG003|Overall Study|Protocol Violation|1|||
144652392|NCT00789477|521579768|FG004|Overall Study|Protocol Violation|0|||
144652393|NCT00789477|521579764|FG000|Overall Study|Adverse Event|3|||
144652394|NCT00789477|521579765|FG001|Overall Study|Adverse Event|3|||
144652395|NCT00789477|521579766|FG002|Overall Study|Adverse Event|1|||
144652396|NCT00789477|521579767|FG003|Overall Study|Adverse Event|0|||
144652397|NCT00789477|521579768|FG004|Overall Study|Adverse Event|0|||
144652398|NCT00789477|521579764|FG000|Overall Study|Death|1|||
144652399|NCT00789477|521579765|FG001|Overall Study|Death|1|||
144652400|NCT00789477|521579766|FG002|Overall Study|Death|2|||
144652401|NCT00789477|521579767|FG003|Overall Study|Death|2|||
144652402|NCT00789477|521579768|FG004|Overall Study|Death|0|||
144652403|NCT00789477|521579764|FG000|Overall Study|Lost to Follow-up|0|||
144652404|NCT00789477|521579765|FG001|Overall Study|Lost to Follow-up|1|||
144652405|NCT00789477|521579766|FG002|Overall Study|Lost to Follow-up|4|||
144652406|NCT00789477|521579767|FG003|Overall Study|Lost to Follow-up|2|||
144652407|NCT00789477|521579768|FG004|Overall Study|Lost to Follow-up|4|||
144212497|NCT01582152|519972251|FG001|Overall Study|Adverse Event|1|||
144212498|NCT01434810|519972252|FG000|Overall Study|Did not receive treatment|11|||
144212499|NCT01434810|519972253|FG001|Overall Study|Did not receive treatment|3|||
144652408|NCT00789477|521579764|FG000|Overall Study|Lack of Efficacy|2|||
144212500|NCT01434810|519972252|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
144212501|NCT01434810|519972253|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
144652409|NCT00789477|521579765|FG001|Overall Study|Lack of Efficacy|0|||
144212502|NCT01609023|519972260|FG000|Overall Study|Lack of Efficacy|3|||
144212503|NCT01609023|519972260|FG000|Overall Study|Withdrawal by Subject|4|||
144731932|NCT01256684|521875702|FG000|Overall Study|Physician Decision|0|||
144212504|NCT01609023|519972260|FG000|Overall Study|Lost to Follow-up|8|||
144212505|NCT01609023|519972260|FG000|Overall Study|Toxicity|3|||
144652410|NCT00789477|521579766|FG002|Overall Study|Lack of Efficacy|0|||
144652411|NCT00789477|521579767|FG003|Overall Study|Lack of Efficacy|0|||
144652412|NCT00789477|521579768|FG004|Overall Study|Lack of Efficacy|0|||
144652413|NCT00789477|521579764|FG000|Overall Study|Other|2|||
144652414|NCT00789477|521579765|FG001|Overall Study|Other|0|||
144652415|NCT00789477|521579766|FG002|Overall Study|Other|1|||
144652416|NCT00789477|521579767|FG003|Overall Study|Other|3|||
144652417|NCT00789477|521579768|FG004|Overall Study|Other|0|||
144652418|NCT00455858|521579769|FG000|Overall Study|Lost to Follow-up|2|||
144652419|NCT00455858|521579769|FG000|Overall Study|Protocol Violation|1|||
144652420|NCT00455858|521579769|FG000|Overall Study|Lack of Efficacy|1|||
144652421|NCT00455858|521579769|FG000|Overall Study|Well controlled FPG without insulin|1|||
144652422|NCT00455858|521579769|FG000|Overall Study|Withdrawal|1|||
144652423|NCT02137772|521579770|FG000|Overall Study|Adverse Event|6|||
144652424|NCT02137772|521579771|FG001|Overall Study|Adverse Event|3|||
144652425|NCT02137772|521579770|FG000|Overall Study|Death|71|||
144652426|NCT02137772|521579771|FG001|Overall Study|Death|44|||
144652427|NCT02137772|521579770|FG000|Overall Study|Lost to Follow-up|8|||
144652428|NCT02137772|521579771|FG001|Overall Study|Lost to Follow-up|4|||
144652429|NCT02137772|521579770|FG000|Overall Study|Physician Decision|15|||
144652430|NCT02137772|521579771|FG001|Overall Study|Physician Decision|5|||
144652431|NCT02137772|521579770|FG000|Overall Study|Withdrawal by Subject|28|||
144652432|NCT02137772|521579771|FG001|Overall Study|Withdrawal by Subject|17|||
144652433|NCT02137772|521579770|FG000|Overall Study|Non-compliance with study drug|1|||
144652434|NCT02137772|521579771|FG001|Overall Study|Non-compliance with study drug|0|||
144652435|NCT02137772|521579770|FG000|Overall Study|Not treated|3|||
144652436|NCT02137772|521579771|FG001|Overall Study|Not treated|2|||
144652437|NCT02092389|521579772|FG000|Overall Study|Adverse Event|1|||
144652438|NCT02092389|521579772|FG000|Overall Study|Other|5|||
144652439|NCT01844700|521579773|FG000|Overall Study|Lack of Efficacy|1|||
144652440|NCT01844700|521579774|FG001|Overall Study|Lack of Efficacy|0|||
144652441|NCT01844700|521579773|FG000|Overall Study|refused medication switch|1|||
144652442|NCT01844700|521579774|FG001|Overall Study|refused medication switch|0|||
144652443|NCT01844700|521579773|FG000|Overall Study|Withdrawal by Subject|1|||
144652444|NCT01844700|521579774|FG001|Overall Study|Withdrawal by Subject|0|||
144652445|NCT01844700|521579773|FG000|Overall Study|stopped taking meds|0|||
144652446|NCT01844700|521579774|FG001|Overall Study|stopped taking meds|1|||
144652447|NCT01242020|521579775|FG000|Overall Study|Withdrawal by Subject|2|||
144652448|NCT01242020|521579776|FG001|Overall Study|Withdrawal by Subject|0|||
144652449|NCT01242020|521579775|FG000|Overall Study|Failed screening|1|||
144652450|NCT01242020|521579776|FG001|Overall Study|Failed screening|0|||
144652451|NCT02680847|521579777|FG000|Overall Study|Other|2|||
144652452|NCT02680847|521579778|FG001|Overall Study|Other|0|||
144652453|NCT02680847|521579779|FG002|Overall Study|Other|0|||
144652454|NCT02680847|521579777|FG000|Overall Study|No longer met eligibility criteria|2|||
144652455|NCT02680847|521579778|FG001|Overall Study|No longer met eligibility criteria|2|||
144652456|NCT02680847|521579779|FG002|Overall Study|No longer met eligibility criteria|0|||
144652457|NCT02680847|521579777|FG000|Overall Study|Unwilling to participate in study|1|||
144652458|NCT02680847|521579778|FG001|Overall Study|Unwilling to participate in study|1|||
144652459|NCT02680847|521579779|FG002|Overall Study|Unwilling to participate in study|0|||
144652460|NCT02680847|521579777|FG000|Overall Study|Lack of Efficacy|0|||
144652461|NCT02680847|521579778|FG001|Overall Study|Lack of Efficacy|0|||
144652462|NCT02680847|521579779|FG002|Overall Study|Lack of Efficacy|2|||
144652463|NCT02680847|521579777|FG000|Overall Study|Adverse Event|0|||
144652464|NCT02680847|521579778|FG001|Overall Study|Adverse Event|0|||
144652465|NCT02680847|521579779|FG002|Overall Study|Adverse Event|1|||
144652466|NCT02375698|521579780|FG000|Overall Study|Withdrawal by Subject|0|||
144652467|NCT02375698|521579781|FG001|Overall Study|Withdrawal by Subject|2|||
144652468|NCT02375698|521579780|FG000|Overall Study|Physician Decision|2|||
144652469|NCT02375698|521579781|FG001|Overall Study|Physician Decision|0|||
144652470|NCT00772967|521579782|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
144652471|NCT00772967|521579783|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
144652472|NCT00772967|521579784|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
144652473|NCT00772967|521579785|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
144652474|NCT00772967|521579786|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
144652475|NCT00772967|521579787|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
144652476|NCT00772967|521579782|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
144652477|NCT00772967|521579783|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
144652478|NCT00772967|521579784|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
144652479|NCT00772967|521579785|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
144652480|NCT00772967|521579786|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
144652481|NCT00772967|521579787|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
144652482|NCT00772967|521579782|FG000|Crossover Treatment 3|Adverse Event|0|||
144652483|NCT00772967|521579783|FG001|Crossover Treatment 3|Adverse Event|0|||
144652484|NCT00772967|521579784|FG002|Crossover Treatment 3|Adverse Event|0|||
144652485|NCT00772967|521579785|FG003|Crossover Treatment 3|Adverse Event|0|||
144652486|NCT00772967|521579786|FG004|Crossover Treatment 3|Adverse Event|1|||
144652487|NCT00772967|521579787|FG005|Crossover Treatment 3|Adverse Event|0|||
144652488|NCT01595646|521579788|FG000|Overall Study|Withdrawal by Subject|1|||
144652489|NCT01595646|521579789|FG001|Overall Study|Withdrawal by Subject|0|||
144652490|NCT01595646|521579790|FG002|Overall Study|Withdrawal by Subject|0|||
144652491|NCT04172831|521579792|FG000|Overall Study|Adverse Event|21|||
144652492|NCT04172831|521579793|FG001|Overall Study|Adverse Event|9|||
144652493|NCT04172831|521579792|FG000|Overall Study|Lack of Efficacy|2|||
144652494|NCT04172831|521579793|FG001|Overall Study|Lack of Efficacy|8|||
144263654|NCT02048722|520165474|FG000|2 Cycles of Treatment|Progressive Disease|2|||
144263655|NCT02048722|520165474|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
144263656|NCT02048722|520165474|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
144263657|NCT02048722|520165474|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
144263658|NCT00274742|520165479|FG000|Overall Study|Adverse Event|0|||
144263659|NCT00274742|520165480|FG001|Overall Study|Adverse Event|4|||
144263660|NCT00274742|520165481|FG002|Overall Study|Adverse Event|1|||
144263661|NCT00274742|520165482|FG003|Overall Study|Adverse Event|4|||
144263662|NCT00274742|520165483|FG004|Overall Study|Adverse Event|12|||
144263663|NCT00274742|520165484|FG005|Overall Study|Adverse Event|3|||
144652495|NCT04172831|521579792|FG000|Overall Study|Physician Decision|0|||
144652496|NCT04172831|521579793|FG001|Overall Study|Physician Decision|1|||
144652497|NCT04172831|521579792|FG000|Overall Study|Withdrawal by Subject|12|||
144652498|NCT04172831|521579793|FG001|Overall Study|Withdrawal by Subject|11|||
144652499|NCT04172831|521579792|FG000|Overall Study|Lost to Follow-up|4|||
144652500|NCT04172831|521579793|FG001|Overall Study|Lost to Follow-up|9|||
144652501|NCT04172831|521579792|FG000|Overall Study|COVID-19 related crisis|3|||
144652502|NCT04172831|521579793|FG001|Overall Study|COVID-19 related crisis|3|||
144212506|NCT01609023|519972260|FG000|Overall Study|Disease progression|10|||
144212507|NCT01609023|519972260|FG000|Overall Study|Physician Decision|2|||
144212508|NCT01609023|519972260|FG000|Overall Study|Death|2|||
144212509|NCT01609023|519972260|FG000|Overall Study|Personal reasons|1|||
144212510|NCT00794339|519972265|FG000|Overall Study|Withdrawal by Subject|3|||
144212511|NCT00794339|519972265|FG000|Overall Study|Ineligible|4|||
144212512|NCT00794339|519972265|FG000|Overall Study|Tx prior to ATSM|3|||
144212513|NCT00794339|519972265|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
144212514|NCT00794339|519972265|FG000|Overall Study|Tx not per protocol|1|||
144212515|NCT01611857|519972266|FG000|Overall Study|Withdrawal by Subject|0|||
144212516|NCT01611857|519972267|FG001|Overall Study|Withdrawal by Subject|2|||
144212517|NCT04974749|519972286|FG000|Overall Study|Withdrawal by Subject|2|||
144212518|NCT04974749|519972286|FG000|Overall Study|Gestation|1|||
144212519|NCT00362336|519972287|FG000|Overall Study|Serious Adverse Event|1|||
144212520|NCT00362336|519972288|FG001|Overall Study|Serious Adverse Event|0|||
144212521|NCT00362336|519972289|FG002|Overall Study|Serious Adverse Event|1|||
144212522|NCT00362336|519972287|FG000|Overall Study|Protocol Violation|0|||
144212523|NCT00362336|519972288|FG001|Overall Study|Protocol Violation|0|||
144212524|NCT00362336|519972289|FG002|Overall Study|Protocol Violation|1|||
144212525|NCT00362336|519972287|FG000|Overall Study|Lost to Follow-up|6|||
144212526|NCT00362336|519972288|FG001|Overall Study|Lost to Follow-up|4|||
144212527|NCT00362336|519972289|FG002|Overall Study|Lost to Follow-up|0|||
144212528|NCT00362336|519972287|FG000|Overall Study|Withdrawal by Subject|3|||
144212529|NCT00362336|519972288|FG001|Overall Study|Withdrawal by Subject|3|||
144212530|NCT00362336|519972289|FG002|Overall Study|Withdrawal by Subject|1|||
144212531|NCT01524978|519972299|FG000|Overall Study|Other|16|||
144212532|NCT01524978|519972300|FG001|Overall Study|Other|2|||
144212533|NCT01524978|519972301|FG002|Overall Study|Other|1|||
144212534|NCT01524978|519972302|FG003|Overall Study|Other|2|||
144212535|NCT01524978|519972303|FG004|Overall Study|Other|1|||
144212536|NCT01524978|519972304|FG005|Overall Study|Other|3|||
144212537|NCT01524978|519972305|FG006|Overall Study|Other|17|||
144212538|NCT01524978|519972306|FG007|Overall Study|Other|1|||
144212539|NCT01524978|519972307|FG008|Overall Study|Other|2|||
144212540|NCT01524978|519972308|FG009|Overall Study|Other|2|||
144212541|NCT01524978|519972309|FG010|Overall Study|Other|5|||
144212542|NCT01524978|519972299|FG000|Overall Study|Withdrawal by Subject|12|||
144212543|NCT01524978|519972300|FG001|Overall Study|Withdrawal by Subject|0|||
144212544|NCT01524978|519972301|FG002|Overall Study|Withdrawal by Subject|1|||
144212545|NCT01524978|519972302|FG003|Overall Study|Withdrawal by Subject|1|||
144212546|NCT01524978|519972303|FG004|Overall Study|Withdrawal by Subject|3|||
144212547|NCT01524978|519972304|FG005|Overall Study|Withdrawal by Subject|1|||
144212548|NCT01524978|519972305|FG006|Overall Study|Withdrawal by Subject|6|||
144212549|NCT01524978|519972306|FG007|Overall Study|Withdrawal by Subject|2|||
144212550|NCT01524978|519972307|FG008|Overall Study|Withdrawal by Subject|4|||
144212551|NCT01524978|519972308|FG009|Overall Study|Withdrawal by Subject|0|||
144212552|NCT01524978|519972309|FG010|Overall Study|Withdrawal by Subject|5|||
144212553|NCT01524978|519972299|FG000|Overall Study|Lost to Follow-up|0|||
144212554|NCT01524978|519972300|FG001|Overall Study|Lost to Follow-up|0|||
144212555|NCT01524978|519972301|FG002|Overall Study|Lost to Follow-up|3|||
144212556|NCT01524978|519972302|FG003|Overall Study|Lost to Follow-up|0|||
144212557|NCT01524978|519972303|FG004|Overall Study|Lost to Follow-up|1|||
144212558|NCT01524978|519972304|FG005|Overall Study|Lost to Follow-up|1|||
144212559|NCT01524978|519972305|FG006|Overall Study|Lost to Follow-up|2|||
144212560|NCT01524978|519972306|FG007|Overall Study|Lost to Follow-up|0|||
144212561|NCT01524978|519972307|FG008|Overall Study|Lost to Follow-up|1|||
144212562|NCT01524978|519972308|FG009|Overall Study|Lost to Follow-up|1|||
144212563|NCT01524978|519972309|FG010|Overall Study|Lost to Follow-up|1|||
144263664|NCT00274742|520165479|FG000|Overall Study|Lost to Follow-up|0|||
144652503|NCT04172831|521579792|FG000|Overall Study|Subject non-compliance|1|||
144652504|NCT04172831|521579793|FG001|Overall Study|Subject non-compliance|1|||
144263665|NCT00274742|520165480|FG001|Overall Study|Lost to Follow-up|0|||
144263666|NCT00274742|520165481|FG002|Overall Study|Lost to Follow-up|0|||
144263667|NCT00274742|520165482|FG003|Overall Study|Lost to Follow-up|0|||
144263668|NCT00274742|520165483|FG004|Overall Study|Lost to Follow-up|1|||
144263669|NCT00274742|520165484|FG005|Overall Study|Lost to Follow-up|0|||
144263670|NCT00274742|520165479|FG000|Overall Study|End of Study|0|||
144263671|NCT00274742|520165480|FG001|Overall Study|End of Study|0|||
144263672|NCT00274742|520165481|FG002|Overall Study|End of Study|0|||
144263673|NCT00274742|520165482|FG003|Overall Study|End of Study|1|||
144263674|NCT00274742|520165483|FG004|Overall Study|End of Study|0|||
144263675|NCT00274742|520165484|FG005|Overall Study|End of Study|0|||
144263676|NCT00274742|520165479|FG000|Overall Study|Disease Progression|0|||
144263677|NCT00274742|520165480|FG001|Overall Study|Disease Progression|1|||
144263678|NCT00274742|520165481|FG002|Overall Study|Disease Progression|1|||
144263679|NCT00274742|520165482|FG003|Overall Study|Disease Progression|0|||
144263680|NCT00274742|520165483|FG004|Overall Study|Disease Progression|1|||
144263681|NCT00274742|520165484|FG005|Overall Study|Disease Progression|0|||
144263682|NCT00274742|520165479|FG000|Overall Study|Other|0|||
144263683|NCT00274742|520165480|FG001|Overall Study|Other|3|||
144263684|NCT00274742|520165481|FG002|Overall Study|Other|0|||
144263685|NCT00274742|520165482|FG003|Overall Study|Other|0|||
144263686|NCT00274742|520165483|FG004|Overall Study|Other|2|||
144263687|NCT00274742|520165484|FG005|Overall Study|Other|0|||
144263688|NCT04742673|520165488|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
144263689|NCT04742673|520165489|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
144263690|NCT04073303|520165492|FG000|Overall Study|Adverse Event|0|||
144263691|NCT04073303|520165493|FG001|Overall Study|Adverse Event|2|||
144263692|NCT04073303|520165492|FG000|Overall Study|Withdrawal by Subject|16|||
144263693|NCT04073303|520165493|FG001|Overall Study|Withdrawal by Subject|36|||
144263694|NCT04073303|520165492|FG000|Overall Study|Lost to Follow-up|6|||
144263695|NCT04073303|520165493|FG001|Overall Study|Lost to Follow-up|1|||
144263696|NCT04073303|520165492|FG000|Overall Study|Protocol Deviation|0|||
144652505|NCT04172831|521579792|FG000|Overall Study|Family emergency|1|||
144212564|NCT01524978|519972299|FG000|Overall Study|Death|34|||
144212565|NCT01524978|519972300|FG001|Overall Study|Death|2|||
144212566|NCT01524978|519972301|FG002|Overall Study|Death|5|||
144212567|NCT01524978|519972302|FG003|Overall Study|Death|24|||
144212568|NCT01524978|519972303|FG004|Overall Study|Death|4|||
144212569|NCT01524978|519972304|FG005|Overall Study|Death|4|||
144212570|NCT01524978|519972305|FG006|Overall Study|Death|1|||
144212571|NCT01524978|519972306|FG007|Overall Study|Death|9|||
144212572|NCT01524978|519972307|FG008|Overall Study|Death|5|||
144212573|NCT01524978|519972308|FG009|Overall Study|Death|6|||
144212574|NCT01524978|519972309|FG010|Overall Study|Death|17|||
144212575|NCT03066258|519972312|FG000|Overall Study|Death|1|||
144212576|NCT03066258|519972313|FG001|Overall Study|Death|0|||
144212577|NCT03066258|519972314|FG002|Overall Study|Death|0|||
144212578|NCT03066258|519972315|FG003|Overall Study|Death|0|||
144212579|NCT03066258|519972316|FG004|Overall Study|Death|1|||
144212580|NCT02165735|519972317|FG000|Overall Study|Lost to Follow-up|12|||
144212581|NCT02165735|519972318|FG001|Overall Study|Lost to Follow-up|10|||
144212582|NCT02165735|519972317|FG000|Overall Study|Withdrawal by Subject|3|||
144212583|NCT02165735|519972318|FG001|Overall Study|Withdrawal by Subject|0|||
144212584|NCT02165735|519972317|FG000|Overall Study|Participant indicated lack of time|1|||
144212585|NCT02165735|519972318|FG001|Overall Study|Participant indicated lack of time|3|||
144212586|NCT02165735|519972317|FG000|Overall Study|Protocol Violation|0|||
144212587|NCT02165735|519972318|FG001|Overall Study|Protocol Violation|1|||
144212588|NCT02784795|519972319|FG000|Overall Study|Progressive Disease|2|||
144212589|NCT02784795|519972320|FG001|Overall Study|Progressive Disease|1|||
144212590|NCT02784795|519972321|FG002|Overall Study|Progressive Disease|1|||
144212591|NCT02784795|519972322|FG003|Overall Study|Progressive Disease|0|||
144212592|NCT02784795|519972323|FG004|Overall Study|Progressive Disease|2|||
144212593|NCT02784795|519972324|FG005|Overall Study|Progressive Disease|0|||
144212594|NCT02784795|519972325|FG006|Overall Study|Progressive Disease|2|||
144212595|NCT02784795|519972326|FG007|Overall Study|Progressive Disease|0|||
144212596|NCT02784795|519972327|FG008|Overall Study|Progressive Disease|0|||
144212597|NCT02784795|519972328|FG009|Overall Study|Progressive Disease|0|||
144212598|NCT02784795|519972329|FG010|Overall Study|Progressive Disease|1|||
144212599|NCT02784795|519972330|FG011|Overall Study|Progressive Disease|0|||
144212600|NCT02784795|519972319|FG000|Overall Study|Adverse Event|1|||
144212601|NCT02784795|519972320|FG001|Overall Study|Adverse Event|0|||
144263697|NCT04073303|520165493|FG001|Overall Study|Protocol Deviation|4|||
144263698|NCT04073303|520165492|FG000|Overall Study|Other|1|||
144263699|NCT04073303|520165493|FG001|Overall Study|Other|1|||
144263700|NCT00227539|520165503|FG000|Overall Study|Protocol Violation|1|||
144212602|NCT02784795|519972321|FG002|Overall Study|Adverse Event|0|||
144263701|NCT01166750|520165504|FG000|Overall Study|Lost to Follow-up|1|||
144263702|NCT01166750|520165505|FG001|Overall Study|Lost to Follow-up|0|||
144263703|NCT03113968|520165506|FG000|Overall Study|Withdrawal by Subject|31|||
144263704|NCT03113968|520165507|FG001|Overall Study|Withdrawal by Subject|4|||
144652506|NCT04172831|521579793|FG001|Overall Study|Family emergency|0|||
144652507|NCT01276847|521579796|FG000|Overall Study|Withdrawal by Subject|1|||
144652508|NCT01276847|521579797|FG001|Overall Study|Withdrawal by Subject|0|||
144652509|NCT01276847|521579798|FG002|Overall Study|Withdrawal by Subject|0|||
144652510|NCT02021812|521579799|FG000|Overall Study|Death|8|||
144652511|NCT02021812|521579799|FG000|Overall Study|Withdrawal by Subject|3|||
144652512|NCT02021812|521579799|FG000|Overall Study|Lost to Follow-up|2|||
144652513|NCT02021812|521579799|FG000|Overall Study|Refuse to return, COVD 19|2|||
144652514|NCT00564629|521579800|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
144652515|NCT00564629|521579801|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
144652516|NCT01597193|521579806|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
144652517|NCT01597193|521579807|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
144652518|NCT01597193|521579808|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
144652519|NCT01597193|521579809|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
144652520|NCT01597193|521579810|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
144652521|NCT01597193|521579811|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
144652522|NCT01597193|521579812|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
144652523|NCT01597193|521579806|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
144652524|NCT01597193|521579807|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
144652525|NCT01597193|521579808|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
144652526|NCT01597193|521579809|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
144652527|NCT01597193|521579810|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
144652528|NCT01597193|521579811|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
144652529|NCT01597193|521579812|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
144652530|NCT01597193|521579806|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
144652531|NCT01597193|521579807|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
144652532|NCT01597193|521579808|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
144652533|NCT01597193|521579809|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
144652534|NCT01597193|521579810|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
144652535|NCT01597193|521579811|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
144652536|NCT01597193|521579812|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
144652537|NCT01597193|521579806|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
144652538|NCT01597193|521579807|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
144652539|NCT01597193|521579808|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
144652540|NCT01597193|521579809|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
144652541|NCT01597193|521579810|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
144652542|NCT01597193|521579811|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
144731933|NCT01256684|521875703|FG001|Overall Study|Physician Decision|1|||
144731934|NCT01256684|521875704|FG002|Overall Study|Physician Decision|0|||
144731935|NCT01256684|521875702|FG000|Overall Study|Lack of Efficacy|0|||
144731936|NCT01256684|521875703|FG001|Overall Study|Lack of Efficacy|1|||
144731937|NCT01256684|521875704|FG002|Overall Study|Lack of Efficacy|1|||
144731938|NCT01256684|521875702|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
144731939|NCT01256684|521875703|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
144731940|NCT01256684|521875704|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
144731941|NCT02914600|521875705|FG000|Overall Study|Adverse Event|298|||
144731942|NCT02914600|521875706|FG001|Overall Study|Adverse Event|35|||
144731943|NCT02914600|521875707|FG002|Overall Study|Adverse Event|25|||
144731944|NCT02914600|521875705|FG000|Overall Study|Sponsors decision|287|||
144731945|NCT02914600|521875706|FG001|Overall Study|Sponsors decision|41|||
144731946|NCT02914600|521875707|FG002|Overall Study|Sponsors decision|12|||
144731947|NCT02914600|521875705|FG000|Overall Study|Withdrawal by Subject|158|||
144731948|NCT02914600|521875706|FG001|Overall Study|Withdrawal by Subject|20|||
144731949|NCT02914600|521875707|FG002|Overall Study|Withdrawal by Subject|18|||
144731950|NCT02914600|521875705|FG000|Overall Study|Investigators discretion|169|||
144731951|NCT02914600|521875706|FG001|Overall Study|Investigators discretion|14|||
144731952|NCT02914600|521875707|FG002|Overall Study|Investigators discretion|13|||
144731953|NCT02914600|521875705|FG000|Overall Study|Lost to Follow-up|10|||
144731954|NCT02914600|521875706|FG001|Overall Study|Lost to Follow-up|4|||
144731955|NCT02914600|521875707|FG002|Overall Study|Lost to Follow-up|0|||
144731956|NCT02914600|521875705|FG000|Overall Study|Pregnancy|8|||
144731957|NCT02914600|521875706|FG001|Overall Study|Pregnancy|0|||
144731958|NCT02914600|521875707|FG002|Overall Study|Pregnancy|0|||
144731959|NCT02914600|521875705|FG000|Overall Study|Protocol Violation|5|||
144731960|NCT02914600|521875706|FG001|Overall Study|Protocol Violation|3|||
144731961|NCT02914600|521875707|FG002|Overall Study|Protocol Violation|0|||
144731962|NCT02914600|521875705|FG000|Overall Study|Non-compliance with study drug|6|||
144731963|NCT02914600|521875706|FG001|Overall Study|Non-compliance with study drug|1|||
144731964|NCT02914600|521875707|FG002|Overall Study|Non-compliance with study drug|0|||
144731965|NCT02914600|521875705|FG000|Overall Study|Death|3|||
144731966|NCT02914600|521875706|FG001|Overall Study|Death|1|||
144731967|NCT02914600|521875707|FG002|Overall Study|Death|1|||
144731968|NCT02914600|521875705|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
144731969|NCT02914600|521875706|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
144652543|NCT01597193|521579812|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
144652544|NCT01597193|521579806|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
144652545|NCT01597193|521579807|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
144652546|NCT01597193|521579808|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
144652547|NCT01597193|521579809|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
144212603|NCT02784795|519972322|FG003|Overall Study|Adverse Event|1|||
144212604|NCT02784795|519972323|FG004|Overall Study|Adverse Event|0|||
144212605|NCT02784795|519972324|FG005|Overall Study|Adverse Event|0|||
144212606|NCT02784795|519972325|FG006|Overall Study|Adverse Event|1|||
144212607|NCT02784795|519972326|FG007|Overall Study|Adverse Event|0|||
144212608|NCT02784795|519972327|FG008|Overall Study|Adverse Event|0|||
144212609|NCT02784795|519972328|FG009|Overall Study|Adverse Event|0|||
144212610|NCT02784795|519972329|FG010|Overall Study|Adverse Event|0|||
144212611|NCT02784795|519972330|FG011|Overall Study|Adverse Event|2|||
144212612|NCT02784795|519972319|FG000|Overall Study|Withdrawal by Subject|1|||
144212613|NCT02784795|519972320|FG001|Overall Study|Withdrawal by Subject|0|||
144212614|NCT02784795|519972321|FG002|Overall Study|Withdrawal by Subject|2|||
144212615|NCT02784795|519972322|FG003|Overall Study|Withdrawal by Subject|1|||
144212616|NCT02784795|519972323|FG004|Overall Study|Withdrawal by Subject|3|||
144212617|NCT02784795|519972324|FG005|Overall Study|Withdrawal by Subject|0|||
144212618|NCT02784795|519972325|FG006|Overall Study|Withdrawal by Subject|0|||
144212619|NCT02784795|519972326|FG007|Overall Study|Withdrawal by Subject|1|||
144212620|NCT02784795|519972327|FG008|Overall Study|Withdrawal by Subject|0|||
144212621|NCT02784795|519972328|FG009|Overall Study|Withdrawal by Subject|0|||
144212622|NCT02784795|519972329|FG010|Overall Study|Withdrawal by Subject|0|||
144212623|NCT02784795|519972330|FG011|Overall Study|Withdrawal by Subject|2|||
144212624|NCT02784795|519972319|FG000|Overall Study|Death|0|||
144212625|NCT02784795|519972320|FG001|Overall Study|Death|0|||
144212626|NCT02784795|519972321|FG002|Overall Study|Death|0|||
144212627|NCT02784795|519972322|FG003|Overall Study|Death|0|||
144212628|NCT02784795|519972323|FG004|Overall Study|Death|1|||
144212629|NCT02784795|519972324|FG005|Overall Study|Death|0|||
144212630|NCT02784795|519972325|FG006|Overall Study|Death|0|||
144212631|NCT02784795|519972326|FG007|Overall Study|Death|0|||
144212632|NCT02784795|519972327|FG008|Overall Study|Death|0|||
144212633|NCT02784795|519972328|FG009|Overall Study|Death|0|||
144212634|NCT02784795|519972329|FG010|Overall Study|Death|0|||
144212635|NCT02784795|519972330|FG011|Overall Study|Death|0|||
144212636|NCT02784795|519972319|FG000|Overall Study|Physician Decision|0|||
144212637|NCT02784795|519972320|FG001|Overall Study|Physician Decision|0|||
144212638|NCT02784795|519972321|FG002|Overall Study|Physician Decision|0|||
144212639|NCT02784795|519972322|FG003|Overall Study|Physician Decision|0|||
144212640|NCT02784795|519972323|FG004|Overall Study|Physician Decision|0|||
144212641|NCT02784795|519972324|FG005|Overall Study|Physician Decision|0|||
144212642|NCT02784795|519972325|FG006|Overall Study|Physician Decision|1|||
144212643|NCT02784795|519972326|FG007|Overall Study|Physician Decision|0|||
144212644|NCT02784795|519972327|FG008|Overall Study|Physician Decision|0|||
144212645|NCT02784795|519972328|FG009|Overall Study|Physician Decision|0|||
144212646|NCT02784795|519972329|FG010|Overall Study|Physician Decision|0|||
144212647|NCT02784795|519972330|FG011|Overall Study|Physician Decision|0|||
144212648|NCT00101283|519972333|FG000|Overall Study|Withdrawal by Subject|0|||
144212649|NCT00101283|519972334|FG001|Overall Study|Withdrawal by Subject|1|||
144212650|NCT00101283|519972333|FG000|Overall Study|Insurance Refusal|0|||
144212651|NCT00101283|519972334|FG001|Overall Study|Insurance Refusal|1|||
144212652|NCT00101283|519972333|FG000|Overall Study|Prostate Cancer Recurrence|0|||
144212653|NCT00101283|519972334|FG001|Overall Study|Prostate Cancer Recurrence|1|||
144212654|NCT00595309|519972335|FG000|Overall Study|Lost to Follow-up|1|||
144212655|NCT00595309|519972335|FG000|Overall Study|planned vaccination against yellow fever|1|||
144212656|NCT00595309|519972335|FG000|Overall Study|acute infection after V0|1|||
144212657|NCT00595309|519972335|FG000|Overall Study|personal reason|1|||
144212658|NCT01372748|519972338|FG000|Overall Study|Lost to Follow-up|16|||
144212659|NCT01372748|519972339|FG001|Overall Study|Lost to Follow-up|34|||
144652548|NCT01597193|521579810|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
144652549|NCT01597193|521579811|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
144212660|NCT01372748|519972338|FG000|Overall Study|Withdrawal by Subject|7|||
144212661|NCT01372748|519972339|FG001|Overall Study|Withdrawal by Subject|5|||
144212662|NCT00191191|519972340|FG000|Overall Study|Entry Criteria Exclusion|2|||
144212663|NCT00191191|519972341|FG001|Overall Study|Entry Criteria Exclusion|0|||
144652550|NCT01597193|521579812|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
144652551|NCT03184701|521579813|FG000|Overall Study|Death|3|||
144212664|NCT00191191|519972340|FG000|Overall Study|Treated with Another Systemic Agent|1|||
144212665|NCT00191191|519972341|FG001|Overall Study|Treated with Another Systemic Agent|1|||
144212666|NCT00191191|519972340|FG000|Overall Study|Adverse Event|11|||
144212667|NCT00191191|519972341|FG001|Overall Study|Adverse Event|21|||
144212668|NCT00191191|519972340|FG000|Overall Study|Progressive Disease|84|||
144212669|NCT00191191|519972341|FG001|Overall Study|Progressive Disease|72|||
144212670|NCT00191191|519972340|FG000|Overall Study|Toxicity After Dose Reduction|7|||
144212671|NCT00191191|519972341|FG001|Overall Study|Toxicity After Dose Reduction|8|||
144652552|NCT03184701|521579813|FG000|Overall Study|Physician Decision|3|||
144652553|NCT03184701|521579813|FG000|Overall Study|Withdrawal by Subject|6|||
144652554|NCT03184701|521579813|FG000|Overall Study|Lost to Follow-up|5|||
144652555|NCT00064662|521579818|FG000|Overall Study|Death|1|||
144652556|NCT00064662|521579819|FG001|Overall Study|Death|1|||
144652557|NCT00064662|521579818|FG000|Overall Study|Lost to Follow-up|57|||
144652558|NCT00064662|521579819|FG001|Overall Study|Lost to Follow-up|44|||
144652559|NCT00064662|521579818|FG000|Overall Study|Withdrawal by Subject|14|||
144652560|NCT00064662|521579819|FG001|Overall Study|Withdrawal by Subject|14|||
144652561|NCT00064662|521579818|FG000|Overall Study|Administratively withdrawn|2|||
144652562|NCT00064662|521579819|FG001|Overall Study|Administratively withdrawn|2|||
144652563|NCT00365976|521579826|FG000|Overall Study|Withdrawal by Subject|1|||
144652564|NCT00365976|521579827|FG001|Overall Study|Withdrawal by Subject|5|||
144652565|NCT01963117|521579828|FG000|Overall Study|Death|1|||
144652566|NCT01000064|521579829|FG000|Overall Study|Withdrawal by Subject|1|||
144652567|NCT01000064|521579830|FG001|Overall Study|Withdrawal by Subject|1|||
144652568|NCT02518620|521579831|FG000|Overall Study|Adverse Event|23|||
144652569|NCT02518620|521579832|FG001|Overall Study|Adverse Event|11|||
144652570|NCT02518620|521579831|FG000|Overall Study|Lack of Efficacy|2|||
144652571|NCT02518620|521579832|FG001|Overall Study|Lack of Efficacy|0|||
144652572|NCT02518620|521579831|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144652573|NCT02518620|521579832|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144652574|NCT02518620|521579831|FG000|Overall Study|Physician Decision|1|||
144652575|NCT02518620|521579832|FG001|Overall Study|Physician Decision|1|||
144652576|NCT02518620|521579831|FG000|Overall Study|Sponsor's Decision|0|||
144652577|NCT02518620|521579832|FG001|Overall Study|Sponsor's Decision|3|||
144652578|NCT02518620|521579831|FG000|Overall Study|Lost to Follow-up|1|||
144652579|NCT02518620|521579832|FG001|Overall Study|Lost to Follow-up|1|||
144652580|NCT02518620|521579831|FG000|Overall Study|Withdrawal by Subject|17|||
144652581|NCT02518620|521579832|FG001|Overall Study|Withdrawal by Subject|9|||
144652582|NCT02518620|521579831|FG000|Overall Study|Death|1|||
144652583|NCT02518620|521579832|FG001|Overall Study|Death|0|||
144652584|NCT02518620|521579831|FG000|Overall Study|Pregnancy Wish|3|||
144652585|NCT02518620|521579832|FG001|Overall Study|Pregnancy Wish|0|||
144652586|NCT02518620|521579831|FG000|Overall Study|Pregnancy|1|||
144652587|NCT02518620|521579832|FG001|Overall Study|Pregnancy|0|||
144652588|NCT02518620|521579831|FG000|Overall Study|Relocation|2|||
144652589|NCT02518620|521579832|FG001|Overall Study|Relocation|1|||
144652590|NCT01605396|521579835|FG000|Overall Study|Adverse Event|5|||
144652591|NCT01605396|521579836|FG001|Overall Study|Adverse Event|3|||
144652592|NCT01605396|521579835|FG000|Overall Study|Lost to Follow-up|1|||
144652593|NCT01605396|521579836|FG001|Overall Study|Lost to Follow-up|0|||
144652594|NCT01605396|521579835|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144652595|NCT01605396|521579836|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144652596|NCT01605396|521579835|FG000|Overall Study|Physician Decision|2|||
144652597|NCT01605396|521579836|FG001|Overall Study|Physician Decision|2|||
144652598|NCT01605396|521579835|FG000|Overall Study|Progressive Disease|23|||
144652599|NCT01605396|521579836|FG001|Overall Study|Progressive Disease|27|||
144652600|NCT01605396|521579835|FG000|Overall Study|Withdrawal by Subject|4|||
144652601|NCT01605396|521579836|FG001|Overall Study|Withdrawal by Subject|2|||
144652602|NCT01605396|521579835|FG000|Overall Study|Transfer Off Study|4|||
144652603|NCT01605396|521579836|FG001|Overall Study|Transfer Off Study|5|||
144652604|NCT04400318|521581668|FG000|Overall Study|Adverse Event|1|||
144652605|NCT04400318|521581669|FG001|Overall Study|Adverse Event|0|||
144652606|NCT04400318|521581668|FG000|Overall Study|Withdrawal by Subject|1|||
144652607|NCT04400318|521581669|FG001|Overall Study|Withdrawal by Subject|1|||
144652608|NCT04400318|521581668|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
144652609|NCT04400318|521581669|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
144652610|NCT04359823|521581670|FG000|Overall Study|Lost to Follow-up|0|||
144652611|NCT04359823|521581671|FG001|Overall Study|Lost to Follow-up|1|||
144652612|NCT04359823|521581670|FG000|Overall Study|Withdrawal by Subject|0|||
144652613|NCT04359823|521581671|FG001|Overall Study|Withdrawal by Subject|1|||
144652614|NCT04191967|521581672|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
144652615|NCT04191967|521581672|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
144652616|NCT01790438|521581676|FG000|Overall Study|Adverse Event|3|||
144652617|NCT01790438|521581677|FG001|Overall Study|Adverse Event|2|||
144652618|NCT01790438|521581676|FG000|Overall Study|Death|4|||
144652619|NCT01790438|521581677|FG001|Overall Study|Death|0|||
144652620|NCT01790438|521581676|FG000|Overall Study|Lost to Follow-up|5|||
144652621|NCT01790438|521581677|FG001|Overall Study|Lost to Follow-up|2|||
144652622|NCT01790438|521581676|FG000|Overall Study|Withdrawal by Subject|13|||
144652623|NCT01790438|521581677|FG001|Overall Study|Withdrawal by Subject|2|||
144652624|NCT01790438|521581676|FG000|Overall Study|Physician Decision|3|||
144652625|NCT01790438|521581677|FG001|Overall Study|Physician Decision|1|||
144652626|NCT01790438|521581676|FG000|Overall Study|Sponsor Decision|0|||
144652627|NCT01790438|521581677|FG001|Overall Study|Sponsor Decision|3|||
144652628|NCT01790438|521581676|FG000|Overall Study|Protocol Required Discontinuation|7|||
144652629|NCT01790438|521581677|FG001|Overall Study|Protocol Required Discontinuation|1|||
144731970|NCT02914600|521875707|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
144731971|NCT02914600|521875705|FG000|Overall Study|Enrolled but not treated|1|||
144731972|NCT02914600|521875706|FG001|Overall Study|Enrolled but not treated|0|||
144731973|NCT02914600|521875707|FG002|Overall Study|Enrolled but not treated|0|||
144731974|NCT02457520|521875708|FG000|Active Treatment Phase|Adverse Event|10|||
144731975|NCT02457520|521875708|FG000|Active Treatment Phase|Lost to Follow-up|8|||
144731976|NCT02457520|521875708|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
144731977|NCT02457520|521875708|FG000|Active Treatment Phase|other|4|||
144263705|NCT02111174|520165508|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
144263706|NCT02111174|520165509|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
144263707|NCT02111174|520165508|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
144263708|NCT02111174|520165509|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
144263709|NCT02111174|520165508|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
144263710|NCT02111174|520165509|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
144263711|NCT02111174|520165508|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
144263712|NCT02111174|520165509|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
144263713|NCT00901342|520165510|FG000|Overall Study|Adverse Event|1|||
144263714|NCT00901342|520165510|FG000|Overall Study|Death|4|||
144263715|NCT00901342|520165510|FG000|Overall Study|Disease progression|1|||
144263716|NCT00901342|520165510|FG000|Overall Study|Withdrawal by Subject|9|||
144263717|NCT02716779|520165511|FG000|Monotherapy|Adverse Event|0|||
144263718|NCT02716779|520165512|FG001|Monotherapy|Adverse Event|1|||
144263719|NCT02716779|520165513|FG002|Monotherapy|Adverse Event|1|||
144263720|NCT02716779|520165511|FG000|Combination Therapy|Adverse Event|0|||
144263721|NCT02716779|520165512|FG001|Combination Therapy|Adverse Event|2|||
144263722|NCT02716779|520165513|FG002|Combination Therapy|Adverse Event|1|||
144263723|NCT03421379|520165519|FG000|Period 1|Withdrawal by Subject|0|||
144263724|NCT03421379|520165520|FG001|Period 1|Withdrawal by Subject|1|||
144652630|NCT02433210|521581681|FG000|Overall Study|Physician Decision|1|||
144652631|NCT02433210|521581682|FG001|Overall Study|Physician Decision|0|||
144652632|NCT02433210|521581683|FG002|Overall Study|Physician Decision|0|||
144652633|NCT02090114|521581684|FG000|Overall Study|Withdrawal by Subject|3|||
144652634|NCT02090114|521581685|FG001|Overall Study|Withdrawal by Subject|6|||
144652635|NCT02090114|521581686|FG002|Overall Study|Withdrawal by Subject|2|||
144652636|NCT02090114|521581687|FG003|Overall Study|Withdrawal by Subject|1|||
144652637|NCT02090114|521581684|FG000|Overall Study|Physician Decision|5|||
144652638|NCT02090114|521581685|FG001|Overall Study|Physician Decision|0|||
144652639|NCT02090114|521581686|FG002|Overall Study|Physician Decision|1|||
144652640|NCT02090114|521581687|FG003|Overall Study|Physician Decision|1|||
144731978|NCT02457520|521875708|FG000|Active Treatment Phase|Physician Decision|1|||
144731979|NCT02457520|521875708|FG000|Active Treatment Phase|Protocol Violation|1|||
144731980|NCT02457520|521875708|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
144731981|NCT02457520|521875708|FG000|Post-treatment Period|Other: Retreatment Required|7|||
144731982|NCT02457520|521875708|FG000|Post-treatment Period|Lost to Follow-up|23|||
144731983|NCT02457520|521875708|FG000|Post-treatment Period|Other|3|||
144731984|NCT02457520|521875708|FG000|Post-treatment Period|Physician Decision|1|||
144731985|NCT02457520|521875708|FG000|Post-treatment Period|Withdrawal by Subject|14|||
144731986|NCT00184600|521875709|FG000|Overall Study|Adverse Event|9|||
144731987|NCT00184600|521875710|FG001|Overall Study|Adverse Event|0|||
144731988|NCT00184600|521875711|FG002|Overall Study|Adverse Event|5|||
144731989|NCT00184600|521875709|FG000|Overall Study|Death|3|||
144731990|NCT00184600|521875710|FG001|Overall Study|Death|9|||
144731991|NCT00184600|521875711|FG002|Overall Study|Death|7|||
144731992|NCT00184600|521875709|FG000|Overall Study|Lack of Efficacy|3|||
144731993|NCT00184600|521875710|FG001|Overall Study|Lack of Efficacy|1|||
144731994|NCT00184600|521875711|FG002|Overall Study|Lack of Efficacy|3|||
144731995|NCT00184600|521875709|FG000|Overall Study|Lost to Follow-up|4|||
144731996|NCT00184600|521875710|FG001|Overall Study|Lost to Follow-up|6|||
144731997|NCT00184600|521875711|FG002|Overall Study|Lost to Follow-up|1|||
144731998|NCT00184600|521875709|FG000|Overall Study|Protocol Violation|2|||
144731999|NCT00184600|521875710|FG001|Overall Study|Protocol Violation|2|||
144732000|NCT00184600|521875711|FG002|Overall Study|Protocol Violation|3|||
144732001|NCT00184600|521875709|FG000|Overall Study|Withdrawal by Subject|20|||
144263725|NCT03421379|520165519|FG000|Period 1|Physician Decision|1|||
144263726|NCT03421379|520165520|FG001|Period 1|Physician Decision|1|||
144263727|NCT03421379|520165519|FG000|Period 1|Did not receive treatment|1|||
144732002|NCT00184600|521875710|FG001|Overall Study|Withdrawal by Subject|28|||
144732003|NCT00184600|521875711|FG002|Overall Study|Withdrawal by Subject|12|||
144732004|NCT00184600|521875709|FG000|Overall Study|Unclassified|4|||
144732005|NCT00184600|521875710|FG001|Overall Study|Unclassified|5|||
144732006|NCT00184600|521875711|FG002|Overall Study|Unclassified|3|||
144732007|NCT00696020|521875714|FG000|Overall Study|Adverse Event|3|||
144732008|NCT00696020|521875715|FG001|Overall Study|Adverse Event|1|||
144732009|NCT00696020|521875716|FG002|Overall Study|Adverse Event|2|||
144732010|NCT00696020|521875717|FG003|Overall Study|Adverse Event|1|||
144732011|NCT00696020|521875714|FG000|Overall Study|Lack of Efficacy|1|||
144732012|NCT00696020|521875715|FG001|Overall Study|Lack of Efficacy|0|||
144652641|NCT02090114|521581684|FG000|Overall Study|Adverse Event|1|||
144652642|NCT02090114|521581685|FG001|Overall Study|Adverse Event|2|||
144652643|NCT02090114|521581686|FG002|Overall Study|Adverse Event|2|||
144652644|NCT02090114|521581687|FG003|Overall Study|Adverse Event|0|||
144652645|NCT02090114|521581684|FG000|Overall Study|Progressive Disease|20|||
144652646|NCT02090114|521581685|FG001|Overall Study|Progressive Disease|21|||
144652647|NCT02090114|521581686|FG002|Overall Study|Progressive Disease|23|||
144652648|NCT02090114|521581687|FG003|Overall Study|Progressive Disease|6|||
144652649|NCT02090114|521581684|FG000|Overall Study|Death|1|||
144652650|NCT02090114|521581685|FG001|Overall Study|Death|0|||
144652651|NCT02090114|521581686|FG002|Overall Study|Death|1|||
144212672|NCT00191191|519972340|FG000|Overall Study|Family/Caregiver Decision|5|||
144212673|NCT00191191|519972341|FG001|Overall Study|Family/Caregiver Decision|7|||
144212674|NCT00191191|519972340|FG000|Overall Study|Lost to Follow-up|1|||
144212675|NCT00191191|519972341|FG001|Overall Study|Lost to Follow-up|0|||
144212676|NCT00191191|519972340|FG000|Overall Study|Physician Decision|3|||
144212677|NCT00191191|519972341|FG001|Overall Study|Physician Decision|2|||
144212678|NCT00191191|519972340|FG000|Overall Study|Good Clinical Practice Violation|0|||
144212679|NCT00191191|519972341|FG001|Overall Study|Good Clinical Practice Violation|1|||
144212680|NCT00442962|519972342|FG000|Overall Study|Pregnancy|1|||
144212681|NCT00442962|519972342|FG000|Overall Study|Lost to Follow-up|7|||
144212682|NCT04238650|519972343|FG000|Overall Study|Withdrawal by Subject|0|||
144212683|NCT04238650|519972344|FG001|Overall Study|Withdrawal by Subject|1|||
144212684|NCT03633825|519972345|FG000|Enrollment|Did not post on network|5066|||
144212685|NCT03633825|519972346|FG001|Enrollment|Did not post on network|5080|||
144212686|NCT03633825|519972345|FG000|Enrollment|Post not classified as crisis|13967|||
144212687|NCT03633825|519972346|FG001|Enrollment|Post not classified as crisis|13757|||
144212688|NCT03633825|519972345|FG000|Follow up|Lost to Follow-up|478|||
144212689|NCT03633825|519972346|FG001|Follow up|Lost to Follow-up|450|||
144212690|NCT01685840|519972351|FG000|Overall Study|Death|77|||
144212691|NCT01685840|519972352|FG001|Overall Study|Death|66|||
144212692|NCT01685840|519972351|FG000|Overall Study|Lost to Follow-up|27|||
144212693|NCT01685840|519972352|FG001|Overall Study|Lost to Follow-up|25|||
144212694|NCT01685840|519972351|FG000|Overall Study|Physician Decision|3|||
144212695|NCT01685840|519972352|FG001|Overall Study|Physician Decision|7|||
144212696|NCT01685840|519972351|FG000|Overall Study|Withdrawal by Subject|14|||
144212697|NCT01685840|519972352|FG001|Overall Study|Withdrawal by Subject|17|||
144212698|NCT01685840|519972351|FG000|Overall Study|Futility|197|||
144212699|NCT01685840|519972352|FG001|Overall Study|Futility|200|||
144212700|NCT01685840|519972351|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
144212701|NCT01685840|519972352|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
144212702|NCT00710866|519972353|FG000|Overall Study|Protocol Violation|5|||
144212703|NCT00710866|519972354|FG001|Overall Study|Protocol Violation|4|||
144212704|NCT00710866|519972353|FG000|Overall Study|Withdrawal by Subject|2|||
144212705|NCT00710866|519972354|FG001|Overall Study|Withdrawal by Subject|1|||
144212706|NCT00710866|519972353|FG000|Overall Study|Lost to Follow-up|1|||
144212707|NCT00710866|519972354|FG001|Overall Study|Lost to Follow-up|0|||
144212708|NCT00710866|519972353|FG000|Overall Study|Failed to meet eligibility|1|||
144212709|NCT00710866|519972354|FG001|Overall Study|Failed to meet eligibility|1|||
144212710|NCT04759768|519972361|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
144212711|NCT04759768|519972362|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
144212712|NCT04759768|519972361|FG000|Washout (7 Days)|Physician Decision|0|||
144652652|NCT02090114|521581687|FG003|Overall Study|Death|0|||
144652653|NCT01931462|521581688|FG000|Overall Study|Withdrawal by Subject|1|||
144652654|NCT01793051|521581693|FG000|Overall Study|Withdrawal by Subject|6|||
144652655|NCT01793051|521581694|FG001|Overall Study|Withdrawal by Subject|4|||
144652656|NCT01793051|521581693|FG000|Overall Study|Adverse Event|0|||
144652657|NCT01793051|521581694|FG001|Overall Study|Adverse Event|2|||
144652658|NCT01793051|521581693|FG000|Overall Study|Too ill to continue|1|||
144652659|NCT01793051|521581694|FG001|Overall Study|Too ill to continue|0|||
144212713|NCT04759768|519972362|FG001|Washout (7 Days)|Physician Decision|1|||
144212714|NCT01128543|519972363|FG000|Overall Study|Withdrawal by Subject|3|||
144212715|NCT01128543|519972363|FG000|Overall Study|Protocol Violation|1|||
144212716|NCT04324021|519972364|FG000|Overall Study|Adverse Event|1|||
144652660|NCT01793051|521581693|FG000|Overall Study|Switched chemo|1|||
144652661|NCT01793051|521581694|FG001|Overall Study|Switched chemo|1|||
144652662|NCT01793051|521581693|FG000|Overall Study|Lack of compliance|1|||
144212717|NCT04324021|519972365|FG001|Overall Study|Adverse Event|0|||
144212718|NCT04324021|519972366|FG002|Overall Study|Adverse Event|0|||
144212719|NCT04324021|519972364|FG000|Overall Study|Lack of Efficacy|0|||
144212720|NCT04324021|519972365|FG001|Overall Study|Lack of Efficacy|0|||
144212721|NCT04324021|519972366|FG002|Overall Study|Lack of Efficacy|1|||
144212722|NCT04324021|519972364|FG000|Overall Study|Death|1|||
144212723|NCT04324021|519972365|FG001|Overall Study|Death|1|||
144212724|NCT04324021|519972366|FG002|Overall Study|Death|0|||
144212725|NCT04877457|519972367|FG000|Overall Study|Early termination of study due to low enrollment|2|||
144652663|NCT01793051|521581694|FG001|Overall Study|Lack of compliance|0|||
144652664|NCT01793051|521581693|FG000|Overall Study|Requested to be removed from the study|1|||
144652665|NCT01793051|521581694|FG001|Overall Study|Requested to be removed from the study|1|||
144263728|NCT03421379|520165520|FG001|Period 1|Did not receive treatment|2|||
144263729|NCT03771963|520165521|FG000|Overall Study|Lost to Follow-up|22|||
144263730|NCT03771963|520165521|FG000|Overall Study|Withdrawal of Consent|10|||
144263731|NCT00101868|520165522|FG000|Overall Study|Death|10|||
144263732|NCT00101868|520165523|FG001|Overall Study|Death|10|||
144263733|NCT00101868|520165522|FG000|Overall Study|Withdrawal by Subject|8|||
144263734|NCT00101868|520165523|FG001|Overall Study|Withdrawal by Subject|9|||
144652666|NCT00059215|521581695|FG000|Overall Study|Adverse Event|5|||
144652667|NCT00059215|521581696|FG001|Overall Study|Adverse Event|5|||
144652668|NCT00059215|521581697|FG002|Overall Study|Adverse Event|9|||
144652669|NCT00059215|521581698|FG003|Overall Study|Adverse Event|9|||
144652670|NCT00059215|521581695|FG000|Overall Study|Death|0|||
144652671|NCT00059215|521581696|FG001|Overall Study|Death|0|||
144652672|NCT00059215|521581697|FG002|Overall Study|Death|3|||
144652673|NCT00059215|521581698|FG003|Overall Study|Death|0|||
144652674|NCT00059215|521581695|FG000|Overall Study|Lost to Follow-up|1|||
144652675|NCT00059215|521581696|FG001|Overall Study|Lost to Follow-up|2|||
144652676|NCT00059215|521581697|FG002|Overall Study|Lost to Follow-up|0|||
144212726|NCT04877457|519972368|FG001|Overall Study|Early termination of study due to low enrollment|1|||
144212727|NCT03516513|519972369|FG000|Overall Study|Withdrawal by Subject|2|||
144212728|NCT03516513|519972370|FG001|Overall Study|Withdrawal by Subject|2|||
144212729|NCT03516513|519972371|FG002|Overall Study|Withdrawal by Subject|0|||
144212730|NCT03516513|519972372|FG003|Overall Study|Withdrawal by Subject|0|||
144212731|NCT04158245|519974492|FG000|Overall Study|Lost to Follow-up|1|||
144212732|NCT04458922|519974493|FG000|Overall Study|Withdrawal by Subject|1|||
144212733|NCT04458922|519974494|FG001|Overall Study|Withdrawal by Subject|0|||
144212734|NCT04458922|519974495|FG002|Overall Study|Withdrawal by Subject|2|||
144212735|NCT04458922|519974493|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
144212736|NCT04458922|519974494|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
144212737|NCT04458922|519974495|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
144212738|NCT04458922|519974493|FG000|Overall Study|Adverse Event|1|||
144212739|NCT04458922|519974494|FG001|Overall Study|Adverse Event|0|||
144212740|NCT04458922|519974495|FG002|Overall Study|Adverse Event|0|||
144212741|NCT04458922|519974493|FG000|Overall Study|Started new study|0|||
144652677|NCT00059215|521581698|FG003|Overall Study|Lost to Follow-up|0|||
144652678|NCT00059215|521581695|FG000|Overall Study|Withdrawal by Subject|4|||
144652679|NCT00059215|521581696|FG001|Overall Study|Withdrawal by Subject|4|||
144652680|NCT00059215|521581697|FG002|Overall Study|Withdrawal by Subject|1|||
144652681|NCT00059215|521581698|FG003|Overall Study|Withdrawal by Subject|3|||
144652682|NCT00059215|521581695|FG000|Overall Study|Protocol Violation|1|||
144652683|NCT00059215|521581696|FG001|Overall Study|Protocol Violation|0|||
144652684|NCT00059215|521581697|FG002|Overall Study|Protocol Violation|1|||
144652685|NCT00059215|521581698|FG003|Overall Study|Protocol Violation|0|||
144652686|NCT00059215|521581695|FG000|Overall Study|Protocol entry criteria not met|1|||
144652687|NCT00059215|521581696|FG001|Overall Study|Protocol entry criteria not met|1|||
144652688|NCT00059215|521581697|FG002|Overall Study|Protocol entry criteria not met|0|||
144652689|NCT00059215|521581698|FG003|Overall Study|Protocol entry criteria not met|2|||
144652690|NCT00059215|521581695|FG000|Overall Study|Physician Decision|1|||
144652691|NCT00059215|521581696|FG001|Overall Study|Physician Decision|2|||
144652692|NCT00059215|521581697|FG002|Overall Study|Physician Decision|1|||
144652693|NCT00059215|521581698|FG003|Overall Study|Physician Decision|1|||
144652694|NCT04494633|521581702|FG000|Overall Study|Lost to Follow-up|5|||
144652695|NCT04494633|521581703|FG001|Overall Study|Lost to Follow-up|3|||
144652696|NCT04494633|521581702|FG000|Overall Study|Protocol Violation|1|||
144652697|NCT04494633|521581703|FG001|Overall Study|Protocol Violation|1|||
144652698|NCT04907539|521581704|FG000|Overall Study|Consent withdrawn|1|||
144652699|NCT04907539|521581705|FG001|Overall Study|Consent withdrawn|0|||
144652700|NCT04907539|521581704|FG000|Overall Study|Death|14|||
144652701|NCT04907539|521581705|FG001|Overall Study|Death|3|||
144652702|NCT01881620|521581708|FG000|Overall Study|Protocol Violation|4|||
144652703|NCT01808118|521581711|FG000|Period 1|Adverse Event|15|||
144652704|NCT01808118|521581712|FG001|Period 1|Adverse Event|0|||
144652705|NCT01808118|521581713|FG002|Period 1|Adverse Event|0|||
144652706|NCT01808118|521581711|FG000|Period 1|Withdrew consent|24|||
144652707|NCT01808118|521581712|FG001|Period 1|Withdrew consent|0|||
144652708|NCT01808118|521581713|FG002|Period 1|Withdrew consent|0|||
144652709|NCT01808118|521581711|FG000|Period 1|Lost to Follow-up|9|||
144652710|NCT01808118|521581712|FG001|Period 1|Lost to Follow-up|0|||
144212742|NCT04458922|519974494|FG001|Overall Study|Started new study|0|||
144652711|NCT01808118|521581713|FG002|Period 1|Lost to Follow-up|0|||
144732013|NCT00696020|521875716|FG002|Overall Study|Lack of Efficacy|0|||
144212743|NCT04458922|519974495|FG002|Overall Study|Started new study|1|||
144212744|NCT04458922|519974493|FG000|Overall Study|Progressive disease|6|||
144263735|NCT00101868|520165522|FG000|Overall Study|Protocol Violation|3|||
144212745|NCT04458922|519974494|FG001|Overall Study|Progressive disease|8|||
144263736|NCT00101868|520165523|FG001|Overall Study|Protocol Violation|0|||
144263737|NCT00101868|520165522|FG000|Overall Study|Lost to Follow-up|8|||
144652712|NCT01808118|521581711|FG000|Period 1|Did not meet criteria for remission|303|||
144652713|NCT01808118|521581712|FG001|Period 1|Did not meet criteria for remission|0|||
144652714|NCT01808118|521581713|FG002|Period 1|Did not meet criteria for remission|0|||
144652715|NCT01808118|521581711|FG000|Period 1|Enrolled in error|7|||
144652716|NCT01808118|521581712|FG001|Period 1|Enrolled in error|0|||
144652717|NCT01808118|521581713|FG002|Period 1|Enrolled in error|0|||
144652718|NCT01808118|521581711|FG000|Period 1|Did not meet inclusion criteria|3|||
144652719|NCT01808118|521581712|FG001|Period 1|Did not meet inclusion criteria|0|||
144652720|NCT01808118|521581713|FG002|Period 1|Did not meet inclusion criteria|0|||
144652721|NCT01808118|521581711|FG000|Period 1|Non-conformance with inclusion criteria|3|||
144652722|NCT01808118|521581712|FG001|Period 1|Non-conformance with inclusion criteria|0|||
144652723|NCT01808118|521581713|FG002|Period 1|Non-conformance with inclusion criteria|0|||
144652724|NCT01808118|521581711|FG000|Period 1|Investigator decision: site closure|2|||
144652725|NCT01808118|521581712|FG001|Period 1|Investigator decision: site closure|0|||
144652726|NCT01808118|521581713|FG002|Period 1|Investigator decision: site closure|0|||
144652727|NCT01808118|521581711|FG000|Period 1|Non-compliance per sponsor|1|||
144652728|NCT01808118|521581712|FG001|Period 1|Non-compliance per sponsor|0|||
144652729|NCT01808118|521581713|FG002|Period 1|Non-compliance per sponsor|0|||
144652730|NCT01808118|521581711|FG000|Period 1|Lack of Efficacy|1|||
144652731|NCT01808118|521581712|FG001|Period 1|Lack of Efficacy|0|||
144652732|NCT01808118|521581713|FG002|Period 1|Lack of Efficacy|0|||
144652733|NCT01808118|521581711|FG000|Period 2|Adverse Event|0|||
144652734|NCT01808118|521581712|FG001|Period 2|Adverse Event|4|||
144652735|NCT01808118|521581713|FG002|Period 2|Adverse Event|0|||
144652736|NCT01808118|521581711|FG000|Period 2|Withdrew consent|0|||
144652737|NCT01808118|521581712|FG001|Period 2|Withdrew consent|7|||
144652738|NCT01808118|521581713|FG002|Period 2|Withdrew consent|6|||
144212746|NCT04458922|519974495|FG002|Overall Study|Progressive disease|2|||
144212747|NCT04458922|519974493|FG000|Overall Study|Death|1|||
144212748|NCT04458922|519974494|FG001|Overall Study|Death|0|||
144212749|NCT04458922|519974495|FG002|Overall Study|Death|2|||
144212750|NCT04458922|519974493|FG000|Overall Study|Participant started chemotherapy|0|||
144212751|NCT04458922|519974494|FG001|Overall Study|Participant started chemotherapy|1|||
144212752|NCT04458922|519974495|FG002|Overall Study|Participant started chemotherapy|0|||
144212753|NCT04856930|519974496|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
144212754|NCT04856930|519974497|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
144212755|NCT04856930|519974498|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
144212756|NCT04856930|519974496|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
144212757|NCT04856930|519974497|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
144212758|NCT04856930|519974498|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
144212759|NCT04856930|519974496|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
144212760|NCT04856930|519974497|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
144212761|NCT04856930|519974498|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
144212762|NCT04856930|519974496|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
144212763|NCT04856930|519974497|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
144212764|NCT04856930|519974498|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
144212765|NCT04856930|519974496|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
144212766|NCT04856930|519974497|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
144212767|NCT04856930|519974498|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
144212768|NCT04856930|519974496|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
144212769|NCT04856930|519974497|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
144212770|NCT04856930|519974498|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
144212771|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
144212772|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
144212773|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
144212774|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
144212775|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
144212776|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
144212777|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
144212778|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
144212779|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
144212780|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
144212781|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
144212782|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
144212783|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
144212784|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
144212785|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
144212786|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
144212787|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
144212788|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
144212789|NCT04856930|519974496|FG000|Extension Period (16 Weeks)|Other than specified|0|||
144652739|NCT01808118|521581711|FG000|Period 2|Lost to Follow-up|0|||
144652740|NCT01808118|521581712|FG001|Period 2|Lost to Follow-up|0|||
144212790|NCT04856930|519974497|FG001|Extension Period (16 Weeks)|Other than specified|0|||
144212791|NCT04856930|519974498|FG002|Extension Period (16 Weeks)|Other than specified|1|||
144212792|NCT04856930|519974496|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
144212793|NCT04856930|519974497|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
144212794|NCT04856930|519974498|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
144212795|NCT04856930|519974496|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
144212796|NCT04856930|519974497|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
144212797|NCT04856930|519974498|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
144212798|NCT04856930|519974496|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
144212799|NCT04856930|519974497|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
144212800|NCT04856930|519974498|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
144212801|NCT04856930|519974496|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
144212802|NCT04856930|519974497|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
144212803|NCT04856930|519974498|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
144212804|NCT02465398|519974504|FG000|Overall Study|Death|7|||
144212805|NCT02465398|519974504|FG000|Overall Study|Revision|7|||
144212806|NCT02465398|519974504|FG000|Overall Study|did not receive study device|1|||
144212807|NCT02465398|519974504|FG000|Overall Study|Withdrawal by Subject|1|||
144212808|NCT02465398|519974504|FG000|Overall Study|Lost to Follow-up|14|||
144212809|NCT00678210|519974505|FG000|Overall Study|Adverse Event|1|||
144212810|NCT00678210|519974506|FG001|Overall Study|Adverse Event|2|||
144212811|NCT00678210|519974507|FG002|Overall Study|Adverse Event|3|||
144212812|NCT00678210|519974508|FG003|Overall Study|Adverse Event|3|||
144212813|NCT00678210|519974505|FG000|Overall Study|Lack of Efficacy|2|||
144212814|NCT00678210|519974506|FG001|Overall Study|Lack of Efficacy|3|||
144212815|NCT00678210|519974507|FG002|Overall Study|Lack of Efficacy|1|||
144212816|NCT00678210|519974508|FG003|Overall Study|Lack of Efficacy|9|||
144212817|NCT00678210|519974505|FG000|Overall Study|Lost to Follow-up|4|||
144212818|NCT00678210|519974506|FG001|Overall Study|Lost to Follow-up|2|||
144212819|NCT00678210|519974507|FG002|Overall Study|Lost to Follow-up|0|||
144212820|NCT00678210|519974508|FG003|Overall Study|Lost to Follow-up|1|||
144212821|NCT00678210|519974505|FG000|Overall Study|Withdrawal by Subject|3|||
144212822|NCT00678210|519974506|FG001|Overall Study|Withdrawal by Subject|4|||
144212823|NCT00678210|519974507|FG002|Overall Study|Withdrawal by Subject|1|||
144212824|NCT00678210|519974508|FG003|Overall Study|Withdrawal by Subject|7|||
144212825|NCT00678210|519974505|FG000|Overall Study|Other|1|||
144212826|NCT00678210|519974506|FG001|Overall Study|Other|0|||
144212827|NCT00678210|519974507|FG002|Overall Study|Other|1|||
144212828|NCT00678210|519974508|FG003|Overall Study|Other|0|||
144212829|NCT04825912|519974509|FG000|Overall Study|Death|3|||
144212830|NCT04825912|519974509|FG000|Overall Study|Withdrawal by Subject|1|||
144212831|NCT01009814|519974512|FG000|Overall Study|No longer met study criteria|1|||
144212832|NCT01009814|519974513|FG001|Overall Study|No longer met study criteria|1|||
144212833|NCT01009814|519974514|FG002|Overall Study|No longer met study criteria|0|||
144212834|NCT01009814|519974515|FG003|Overall Study|No longer met study criteria|0|||
144212835|NCT01009814|519974516|FG004|Overall Study|No longer met study criteria|0|||
144212836|NCT00618371|519974517|FG000|Overall Study|Withdrawal by Subject|2|||
144212837|NCT01383707|519974522|FG000|Overall Study|Consent withdrawal|6|||
144212838|NCT01383707|519974522|FG000|Overall Study|Death|19|||
144212839|NCT01383707|519974522|FG000|Overall Study|Other|8|||
144212840|NCT01383707|519974522|FG000|Overall Study|Sponsor's decision|2|||
144212841|NCT01383707|519974522|FG000|Overall Study|Adverse Event|14|||
144263738|NCT00101868|520165523|FG001|Overall Study|Lost to Follow-up|13|||
144263739|NCT03718429|520165524|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
144212842|NCT01383707|519974522|FG000|Overall Study|Progressive disease|23|||
144212843|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
144212844|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
144212845|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
144212846|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
144212847|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
144212848|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
144212849|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
144212850|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
144212851|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
144212852|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
144212853|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
144212854|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
144212855|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
144212856|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
144212857|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
144212858|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
144212859|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
144212860|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
144212861|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
144212862|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
144652741|NCT01808118|521581713|FG002|Period 2|Lost to Follow-up|2|||
144652742|NCT01808118|521581711|FG000|Period 2|Investigator no longer conducting trials|0|||
144652743|NCT01808118|521581712|FG001|Period 2|Investigator no longer conducting trials|1|||
144652744|NCT01808118|521581713|FG002|Period 2|Investigator no longer conducting trials|0|||
144652745|NCT01808118|521581711|FG000|Period 2|Switched to other therapy|0|||
144652746|NCT01808118|521581712|FG001|Period 2|Switched to other therapy|1|||
144652747|NCT01808118|521581713|FG002|Period 2|Switched to other therapy|0|||
144652748|NCT00414310|521581714|FG000|Overall Study|Not treated|1|||
144652749|NCT00414310|521581715|FG001|Overall Study|Not treated|0|||
144652750|NCT01254604|521581721|FG000|Overall Study|Lost to Follow-up|1|||
144652751|NCT01254604|521581722|FG001|Overall Study|Lost to Follow-up|1|||
144652752|NCT01254604|521581721|FG000|Overall Study|Protocol Violation|2|||
144652753|NCT01254604|521581722|FG001|Overall Study|Protocol Violation|2|||
144652754|NCT01254604|521581721|FG000|Overall Study|Withdrawal by Subject|2|||
144652755|NCT01254604|521581722|FG001|Overall Study|Withdrawal by Subject|4|||
144652756|NCT01254604|521581721|FG000|Overall Study|Adverse Event|3|||
144652757|NCT01254604|521581722|FG001|Overall Study|Adverse Event|2|||
144652758|NCT03074162|521581723|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
144652759|NCT03074162|521581724|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
144652760|NCT03074162|521581725|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
144652761|NCT03074162|521581726|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
144652762|NCT03074162|521581727|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
144652763|NCT03074162|521581728|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
144652764|NCT03074162|521581723|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
144652765|NCT03074162|521581724|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
144652766|NCT03074162|521581725|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
144652767|NCT03074162|521581726|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
144652768|NCT03074162|521581727|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
144652769|NCT03074162|521581728|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
144652770|NCT03074162|521581723|FG000|Period 3|Withdrawal by Subject|1|||
144652771|NCT03074162|521581724|FG001|Period 3|Withdrawal by Subject|0|||
144652772|NCT03074162|521581725|FG002|Period 3|Withdrawal by Subject|0|||
144652773|NCT03074162|521581726|FG003|Period 3|Withdrawal by Subject|0|||
144652774|NCT03074162|521581727|FG004|Period 3|Withdrawal by Subject|1|||
144652775|NCT03074162|521581728|FG005|Period 3|Withdrawal by Subject|0|||
144652776|NCT02948777|521581734|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
144263740|NCT03718429|520165525|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
144263741|NCT03718429|520165526|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
144263742|NCT03718429|520165527|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
144263743|NCT01945944|520165530|FG000|Overall Study|Adverse Event|0|||
144263744|NCT01945944|520165531|FG001|Overall Study|Adverse Event|2|||
144263745|NCT01945944|520165530|FG000|Overall Study|Physician Decision|1|||
144652777|NCT05070429|521581735|FG000|Overall Study|Death|0|||
144652778|NCT05070429|521581736|FG001|Overall Study|Death|4|||
144652779|NCT05070429|521581735|FG000|Overall Study|Withdrawal by Subject|2|||
144652780|NCT05070429|521581736|FG001|Overall Study|Withdrawal by Subject|1|||
144652781|NCT05070429|521581735|FG000|Overall Study|Other|15|||
144652782|NCT05070429|521581736|FG001|Overall Study|Other|5|||
144652783|NCT03242928|521581737|FG000|Overall Study|Adverse Event|2|||
144652784|NCT03242928|521581738|FG001|Overall Study|Adverse Event|1|||
144652785|NCT03242928|521581737|FG000|Overall Study|Lost to Follow-up|2|||
144652786|NCT03242928|521581738|FG001|Overall Study|Lost to Follow-up|0|||
144652787|NCT03242928|521581737|FG000|Overall Study|Physician Decision|0|||
144652788|NCT03242928|521581738|FG001|Overall Study|Physician Decision|1|||
144652789|NCT03242928|521581737|FG000|Overall Study|Withdrawal by Subject|5|||
144652790|NCT03242928|521581738|FG001|Overall Study|Withdrawal by Subject|3|||
144652791|NCT02436577|521581739|FG000|Overall Study|Protocol Deviation|0|||
144652792|NCT02436577|521581740|FG001|Overall Study|Protocol Deviation|1|||
144652793|NCT02436577|521581741|FG002|Overall Study|Protocol Deviation|0|||
144652794|NCT02436577|521581742|FG003|Overall Study|Protocol Deviation|0|||
144652795|NCT02436577|521581743|FG004|Overall Study|Protocol Deviation|0|||
144652796|NCT02436577|521581744|FG005|Overall Study|Protocol Deviation|0|||
144652797|NCT00625365|521581748|FG000|Overall Study|Withdrawal by Subject|1|||
144652798|NCT00625365|521581748|FG000|Overall Study|No IV access|5|||
144652799|NCT00625365|521581748|FG000|Overall Study|VSD|1|||
144652800|NCT03650452|521581749|FG000|Overall Study|Physician Decision|1|||
144652801|NCT03650452|521581750|FG001|Overall Study|Physician Decision|0|||
144652802|NCT03650452|521581749|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
144263746|NCT01945944|520165531|FG001|Overall Study|Physician Decision|0|||
144652803|NCT03650452|521581750|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144652804|NCT03650452|521581749|FG000|Overall Study|Adverse Event|3|||
144652805|NCT03650452|521581750|FG001|Overall Study|Adverse Event|4|||
144652806|NCT03650452|521581749|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
144652807|NCT03650452|521581750|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
144652808|NCT02531373|521581761|FG000|Overall Study|Lack of Efficacy|0|||
144652809|NCT02531373|521581762|FG001|Overall Study|Lack of Efficacy|0|||
144263747|NCT01945944|520165530|FG000|Overall Study|Withdrawal by Subject|0|||
144263748|NCT01945944|520165531|FG001|Overall Study|Withdrawal by Subject|1|||
144263749|NCT01395810|520165534|FG000|Overall Study|Adverse Event|0|||
144263750|NCT01395810|520165535|FG001|Overall Study|Adverse Event|1|||
144263751|NCT01395810|520165536|FG002|Overall Study|Adverse Event|0|||
144263752|NCT01395810|520165537|FG003|Overall Study|Adverse Event|0|||
144263753|NCT01395810|520165534|FG000|Overall Study|Lack of Efficacy|0|||
144263754|NCT01395810|520165535|FG001|Overall Study|Lack of Efficacy|1|||
144263755|NCT01395810|520165536|FG002|Overall Study|Lack of Efficacy|0|||
144263756|NCT01395810|520165537|FG003|Overall Study|Lack of Efficacy|0|||
144263757|NCT01395810|520165534|FG000|Overall Study|Withdrawal criteria|0|||
144263758|NCT01395810|520165535|FG001|Overall Study|Withdrawal criteria|2|||
144263759|NCT01395810|520165536|FG002|Overall Study|Withdrawal criteria|0|||
144263760|NCT01395810|520165537|FG003|Overall Study|Withdrawal criteria|0|||
144263761|NCT01395810|520165534|FG000|Overall Study|Unclassified|2|||
144263762|NCT01395810|520165535|FG001|Overall Study|Unclassified|0|||
144263763|NCT01395810|520165536|FG002|Overall Study|Unclassified|0|||
144263764|NCT01395810|520165537|FG003|Overall Study|Unclassified|0|||
144263765|NCT05027815|520165538|FG000|Overall Study|Death|2|||
144263766|NCT05027815|520165539|FG001|Overall Study|Death|1|||
144263767|NCT03877224|520165545|FG000|Overall Study|Death|3|||
144263768|NCT03877224|520165546|FG001|Overall Study|Death|2|||
144263769|NCT03877224|520165545|FG000|Overall Study|Withdrawal by Subject|1|||
144263770|NCT03877224|520165546|FG001|Overall Study|Withdrawal by Subject|6|||
144263771|NCT03877224|520165545|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
144263772|NCT03877224|520165546|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
144263773|NCT01001429|520167502|FG000|Overall Study|surgery cancelled|0|||
144263774|NCT01001429|520167503|FG001|Overall Study|surgery cancelled|1|||
144263775|NCT01063855|520167506|FG000|Overall Study|Adverse Event|4|||
144263776|NCT01063855|520167507|FG001|Overall Study|Adverse Event|4|||
144263777|NCT01063855|520167506|FG000|Overall Study|Death|0|||
144652810|NCT02531373|521581763|FG002|Overall Study|Lack of Efficacy|0|||
144652811|NCT02531373|521581764|FG003|Overall Study|Lack of Efficacy|0|||
144652812|NCT02531373|521581765|FG004|Overall Study|Lack of Efficacy|3|||
144652813|NCT02531373|521581766|FG005|Overall Study|Lack of Efficacy|2|||
144652814|NCT02531373|521581767|FG006|Overall Study|Lack of Efficacy|4|||
144652815|NCT02531373|521581768|FG007|Overall Study|Lack of Efficacy|8|||
144652816|NCT02531373|521581769|FG008|Overall Study|Lack of Efficacy|5|||
144652817|NCT02531373|521581761|FG000|Overall Study|Lost to Follow-up|0|||
144652818|NCT02531373|521581762|FG001|Overall Study|Lost to Follow-up|0|||
144652819|NCT02531373|521581763|FG002|Overall Study|Lost to Follow-up|0|||
144652820|NCT02531373|521581764|FG003|Overall Study|Lost to Follow-up|0|||
144652821|NCT02531373|521581765|FG004|Overall Study|Lost to Follow-up|0|||
144652822|NCT02531373|521581766|FG005|Overall Study|Lost to Follow-up|2|||
144652823|NCT02531373|521581767|FG006|Overall Study|Lost to Follow-up|2|||
144652824|NCT02531373|521581768|FG007|Overall Study|Lost to Follow-up|0|||
144652825|NCT02531373|521581769|FG008|Overall Study|Lost to Follow-up|0|||
144652826|NCT02531373|521581761|FG000|Overall Study|Physician Decision|0|||
144652827|NCT02531373|521581762|FG001|Overall Study|Physician Decision|0|||
144652828|NCT02531373|521581763|FG002|Overall Study|Physician Decision|0|||
144652829|NCT02531373|521581764|FG003|Overall Study|Physician Decision|0|||
144652830|NCT02531373|521581765|FG004|Overall Study|Physician Decision|2|||
144652831|NCT02531373|521581766|FG005|Overall Study|Physician Decision|1|||
144652832|NCT02531373|521581767|FG006|Overall Study|Physician Decision|0|||
144652833|NCT02531373|521581768|FG007|Overall Study|Physician Decision|0|||
144652834|NCT02531373|521581769|FG008|Overall Study|Physician Decision|0|||
144652835|NCT02531373|521581761|FG000|Overall Study|Protocol Violation|0|||
144652836|NCT02531373|521581762|FG001|Overall Study|Protocol Violation|0|||
144652837|NCT02531373|521581763|FG002|Overall Study|Protocol Violation|0|||
144652838|NCT02531373|521581764|FG003|Overall Study|Protocol Violation|0|||
144652839|NCT02531373|521581765|FG004|Overall Study|Protocol Violation|0|||
144652840|NCT02531373|521581766|FG005|Overall Study|Protocol Violation|1|||
144652841|NCT02531373|521581767|FG006|Overall Study|Protocol Violation|1|||
144652842|NCT02531373|521581768|FG007|Overall Study|Protocol Violation|0|||
144652843|NCT02531373|521581769|FG008|Overall Study|Protocol Violation|1|||
144652844|NCT02531373|521581761|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144652845|NCT02531373|521581762|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144652846|NCT02531373|521581763|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144263778|NCT01063855|520167507|FG001|Overall Study|Death|1|||
144263779|NCT01063855|520167506|FG000|Overall Study|Lost to Follow-up|8|||
144263780|NCT01063855|520167507|FG001|Overall Study|Lost to Follow-up|4|||
144263781|NCT01063855|520167506|FG000|Overall Study|Pregnancy|1|||
144652847|NCT02531373|521581764|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144652848|NCT02531373|521581765|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144652849|NCT02531373|521581766|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
144263782|NCT01063855|520167507|FG001|Overall Study|Pregnancy|0|||
144652850|NCT02531373|521581767|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
144652851|NCT02531373|521581768|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
144652852|NCT02531373|521581769|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
144652853|NCT02531373|521581761|FG000|Overall Study|Withdrawal by Subject|0|||
144212863|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
144212864|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
144212865|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
144212866|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
144212867|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
144212868|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
144212869|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
144212870|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
144212871|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
144212872|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
144212873|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
144212874|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
144212875|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
144652854|NCT02531373|521581762|FG001|Overall Study|Withdrawal by Subject|0|||
144652855|NCT02531373|521581763|FG002|Overall Study|Withdrawal by Subject|0|||
144652856|NCT02531373|521581764|FG003|Overall Study|Withdrawal by Subject|0|||
144652857|NCT02531373|521581765|FG004|Overall Study|Withdrawal by Subject|3|||
144652858|NCT02531373|521581766|FG005|Overall Study|Withdrawal by Subject|0|||
144652859|NCT02531373|521581767|FG006|Overall Study|Withdrawal by Subject|0|||
144652860|NCT02531373|521581768|FG007|Overall Study|Withdrawal by Subject|0|||
144652861|NCT02531373|521581769|FG008|Overall Study|Withdrawal by Subject|0|||
144652862|NCT00623467|521581770|FG000|Overall Study|Lost to Follow-up|1|||
144652863|NCT00623467|521581770|FG000|Overall Study|Protocol Violation|4|||
144652864|NCT00623467|521581770|FG000|Overall Study|Withdrawal by Subject|2|||
144652865|NCT02795988|521581779|FG000|Phase 1b|Withdrawal by Subject|0|||
144652866|NCT02795988|521581780|FG001|Phase 1b|Withdrawal by Subject|1|||
144652867|NCT02795988|521581781|FG002|Phase 1b|Withdrawal by Subject|0|||
144652868|NCT02795988|521581782|FG003|Phase 1b|Withdrawal by Subject|0|||
144652869|NCT02795988|521581783|FG004|Phase 1b|Withdrawal by Subject|0|||
144652870|NCT02795988|521581784|FG005|Phase 1b|Withdrawal by Subject|0|||
144652871|NCT02795988|521581785|FG006|Phase 1b|Withdrawal by Subject|0|||
144652872|NCT02795988|521581779|FG000|Phase 1b|Death|1|||
144652873|NCT02795988|521581780|FG001|Phase 1b|Death|2|||
144652874|NCT02795988|521581781|FG002|Phase 1b|Death|1|||
144652875|NCT02795988|521581782|FG003|Phase 1b|Death|0|||
144652876|NCT02795988|521581783|FG004|Phase 1b|Death|0|||
144652877|NCT02795988|521581784|FG005|Phase 1b|Death|0|||
144652878|NCT02795988|521581785|FG006|Phase 1b|Death|0|||
144652879|NCT02795988|521581779|FG000|Phase 1b|Physician Decision|0|||
144652880|NCT02795988|521581780|FG001|Phase 1b|Physician Decision|0|||
144652881|NCT02795988|521581781|FG002|Phase 1b|Physician Decision|1|||
144652882|NCT02795988|521581782|FG003|Phase 1b|Physician Decision|0|||
144652883|NCT02795988|521581783|FG004|Phase 1b|Physician Decision|0|||
144652884|NCT02795988|521581784|FG005|Phase 1b|Physician Decision|0|||
144652885|NCT02795988|521581785|FG006|Phase 1b|Physician Decision|0|||
144652886|NCT02795988|521581779|FG000|Phase 1b|Progressive Disease|2|||
144652887|NCT02795988|521581780|FG001|Phase 1b|Progressive Disease|2|||
144652888|NCT02795988|521581781|FG002|Phase 1b|Progressive Disease|0|||
144652889|NCT02795988|521581782|FG003|Phase 1b|Progressive Disease|0|||
144652890|NCT02795988|521581783|FG004|Phase 1b|Progressive Disease|0|||
144652891|NCT02795988|521581784|FG005|Phase 1b|Progressive Disease|0|||
144652892|NCT02795988|521581785|FG006|Phase 1b|Progressive Disease|0|||
144652893|NCT02795988|521581779|FG000|Phase 2|Withdrawal by Subject|0|||
144652894|NCT02795988|521581780|FG001|Phase 2|Withdrawal by Subject|0|||
144652895|NCT02795988|521581781|FG002|Phase 2|Withdrawal by Subject|0|||
144652896|NCT02795988|521581782|FG003|Phase 2|Withdrawal by Subject|1|||
144652897|NCT02795988|521581783|FG004|Phase 2|Withdrawal by Subject|0|||
144732014|NCT00696020|521875717|FG003|Overall Study|Lack of Efficacy|0|||
144732015|NCT00696020|521875714|FG000|Overall Study|Protocol Violation|0|||
144732016|NCT00696020|521875715|FG001|Overall Study|Protocol Violation|0|||
144732017|NCT00696020|521875716|FG002|Overall Study|Protocol Violation|0|||
144212876|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
144212877|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
144212878|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
144212879|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
144652898|NCT02795988|521581784|FG005|Phase 2|Withdrawal by Subject|0|||
144652899|NCT02795988|521581785|FG006|Phase 2|Withdrawal by Subject|0|||
144652900|NCT02795988|521581779|FG000|Phase 2|Death|0|||
144732018|NCT00696020|521875717|FG003|Overall Study|Protocol Violation|1|||
144212880|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
144652901|NCT02795988|521581780|FG001|Phase 2|Death|0|||
144652902|NCT02795988|521581781|FG002|Phase 2|Death|0|||
144652903|NCT02795988|521581782|FG003|Phase 2|Death|17|||
144652904|NCT02795988|521581783|FG004|Phase 2|Death|17|||
144652905|NCT02795988|521581784|FG005|Phase 2|Death|0|||
144652906|NCT02795988|521581785|FG006|Phase 2|Death|0|||
144652907|NCT02795988|521581779|FG000|Phase 2|Other|0|||
144652908|NCT02795988|521581780|FG001|Phase 2|Other|0|||
144652909|NCT02795988|521581781|FG002|Phase 2|Other|0|||
144652910|NCT02795988|521581782|FG003|Phase 2|Other|1|||
144652911|NCT02795988|521581783|FG004|Phase 2|Other|0|||
144652912|NCT02795988|521581784|FG005|Phase 2|Other|0|||
144652913|NCT02795988|521581785|FG006|Phase 2|Other|0|||
144652914|NCT02795988|521581779|FG000|Phase 2 Extension|Death|0|||
144652915|NCT02795988|521581780|FG001|Phase 2 Extension|Death|0|||
144652916|NCT02795988|521581781|FG002|Phase 2 Extension|Death|0|||
144652917|NCT02795988|521581782|FG003|Phase 2 Extension|Death|0|||
144652918|NCT02795988|521581783|FG004|Phase 2 Extension|Death|0|||
144652919|NCT02795988|521581784|FG005|Phase 2 Extension|Death|5|||
144652920|NCT02795988|521581785|FG006|Phase 2 Extension|Death|6|||
144652921|NCT02795988|521581779|FG000|Phase 2 Extension|Other reasons|0|||
144212881|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
144212882|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
144212883|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212884|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212885|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212886|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
144212887|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212888|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212889|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212890|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212891|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212892|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
144212893|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
144212894|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
144212895|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
144212896|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
144212897|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
144212898|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
144212899|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
144212900|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
144212901|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
144212902|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
144212903|NCT03104400|519974523|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212904|NCT03104400|519974524|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212905|NCT03104400|519974525|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212906|NCT03104400|519974526|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
144212907|NCT03104400|519974527|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212908|NCT03104400|519974528|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212909|NCT03104400|519974529|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212910|NCT03104400|519974530|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212911|NCT03104400|519974531|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212912|NCT03104400|519974532|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
144212913|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
144212914|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
144212915|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
144212916|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
144212917|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
144212918|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
144212919|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
144212920|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
144212921|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
144212922|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
144212923|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
144212924|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
144212925|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
144212926|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
144212927|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
144212928|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
144212929|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
144212930|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
144212931|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
144212932|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
144212933|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
144212934|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
144212935|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
144212936|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
144212937|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
144212938|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
144652922|NCT02795988|521581780|FG001|Phase 2 Extension|Other reasons|0|||
144652923|NCT02795988|521581781|FG002|Phase 2 Extension|Other reasons|0|||
144652924|NCT02795988|521581782|FG003|Phase 2 Extension|Other reasons|0|||
144652925|NCT02795988|521581783|FG004|Phase 2 Extension|Other reasons|0|||
144652926|NCT02795988|521581784|FG005|Phase 2 Extension|Other reasons|2|||
144263783|NCT01063855|520167506|FG000|Overall Study|Lack of Efficacy|0|||
144263784|NCT01063855|520167507|FG001|Overall Study|Lack of Efficacy|1|||
144263785|NCT01063855|520167506|FG000|Overall Study|Withdrawal by Subject|11|||
144652927|NCT02795988|521581785|FG006|Phase 2 Extension|Other reasons|1|||
144652928|NCT02834403|521581786|FG000|Overall Study|Physician Decision|2|||
144263786|NCT01063855|520167507|FG001|Overall Study|Withdrawal by Subject|8|||
144263787|NCT01063855|520167506|FG000|Overall Study|Reason not specified|13|||
144263788|NCT01063855|520167507|FG001|Overall Study|Reason not specified|11|||
144263789|NCT03234036|520167510|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
144263790|NCT03234036|520167511|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
144263791|NCT03234036|520167512|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
144263792|NCT03234036|520167513|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
144263793|NCT02163395|520167514|FG000|Overall Study|Withdrawal by Subject|1|||
144263794|NCT02163395|520167514|FG000|Overall Study|Lost to Follow-up|3|||
144263795|NCT02163395|520167514|FG000|Overall Study|Adverse Event|1|||
144263796|NCT01145482|520167518|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
144263797|NCT01145482|520167519|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
144263798|NCT02515630|520167520|FG000|Overall Study|Withdrawal by Subject|5|||
144263799|NCT02515630|520167520|FG000|Overall Study|Adverse Event|4|||
144263800|NCT02515630|520167520|FG000|Overall Study|Physician Decision|4|||
144263801|NCT02515630|520167520|FG000|Overall Study|Death|2|||
144263802|NCT02515630|520167520|FG000|Overall Study|Disease Progression|1|||
144263803|NCT00458003|520167521|FG000|Overall Study|Non protocol spinal anesthesia|1|||
144263804|NCT00458003|520167522|FG001|Overall Study|Non protocol spinal anesthesia|1|||
144263805|NCT02154139|520167527|FG000|Overall Study|Injection not administered|2|||
144263806|NCT02154139|520167527|FG000|Overall Study|Other|2|||
144263807|NCT02154139|520167527|FG000|Overall Study|Investigator transferred|3|||
144263808|NCT00473655|520167528|FG000|Overall Study|Lost to Follow-up|9|||
144263809|NCT00473655|520167529|FG001|Overall Study|Lost to Follow-up|5|||
144263810|NCT00473655|520167530|FG002|Overall Study|Lost to Follow-up|8|||
144263811|NCT02087774|520167532|FG000|Overall Study|Were absent day of data collection|8|||
144263812|NCT02087774|520167533|FG001|Overall Study|Were absent day of data collection|20|||
144263813|NCT00243919|520167541|FG000|Overall Study|Death|3|||
144263814|NCT00243919|520167542|FG001|Overall Study|Death|4|||
144263815|NCT00243919|520167543|FG002|Overall Study|Death|6|||
144263816|NCT00243919|520167541|FG000|Overall Study|Withdrawal by Subject|6|||
144263817|NCT00243919|520167542|FG001|Overall Study|Withdrawal by Subject|6|||
144263818|NCT00243919|520167543|FG002|Overall Study|Withdrawal by Subject|2|||
144263819|NCT00243919|520167541|FG000|Overall Study|Lost to Follow-up|6|||
144263820|NCT00243919|520167542|FG001|Overall Study|Lost to Follow-up|7|||
144263821|NCT00243919|520167543|FG002|Overall Study|Lost to Follow-up|3|||
144263822|NCT00243919|520167541|FG000|Overall Study|Administrative Error|1|||
144263823|NCT00243919|520167542|FG001|Overall Study|Administrative Error|0|||
144263824|NCT00243919|520167543|FG002|Overall Study|Administrative Error|0|||
144263825|NCT00243919|520167541|FG000|Overall Study|Physician Decision|1|||
144263826|NCT00243919|520167542|FG001|Overall Study|Physician Decision|1|||
144263827|NCT00243919|520167543|FG002|Overall Study|Physician Decision|0|||
144263828|NCT04919317|520167544|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
144263829|NCT04919317|520167545|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
144263830|NCT04919317|520167544|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
144263831|NCT04919317|520167545|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
144263832|NCT03225170|520167546|FG000|Overall Study|Lost to Follow-up|4|||
144652929|NCT02834403|521581787|FG001|Overall Study|Physician Decision|1|||
144652930|NCT02834403|521581788|FG002|Overall Study|Physician Decision|2|||
144652931|NCT02834403|521581789|FG003|Overall Study|Physician Decision|1|||
144652932|NCT02834403|521581790|FG004|Overall Study|Physician Decision|1|||
144652933|NCT02834403|521581791|FG005|Overall Study|Physician Decision|2|||
144652934|NCT02834403|521581792|FG006|Overall Study|Physician Decision|12|||
144263833|NCT03225170|520167547|FG001|Overall Study|Lost to Follow-up|4|||
144263834|NCT03225170|520167548|FG002|Overall Study|Lost to Follow-up|0|||
144263835|NCT03225170|520167546|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
144263836|NCT03225170|520167547|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
144263837|NCT03225170|520167548|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
144263838|NCT01529606|520167549|FG000|Overall Study|Lost to Follow-up|21|||
144263839|NCT01529606|520167550|FG001|Overall Study|Lost to Follow-up|18|||
144263840|NCT05209880|520167555|FG000|1-Month Follow-up|Spoke with Doctor|5|||
144263841|NCT05209880|520167556|FG001|1-Month Follow-up|Spoke with Doctor|5|||
144263842|NCT05209880|520167555|FG000|1-Month Follow-up|Lost to Follow-up|7|||
144263843|NCT05209880|520167556|FG001|1-Month Follow-up|Lost to Follow-up|9|||
144263844|NCT05209880|520167555|FG000|1-Month Follow-up|Discontinued|0|||
144652935|NCT02834403|521581786|FG000|Overall Study|Adverse Event|0|||
144652936|NCT02834403|521581787|FG001|Overall Study|Adverse Event|0|||
144652937|NCT02834403|521581788|FG002|Overall Study|Adverse Event|0|||
144652938|NCT02834403|521581789|FG003|Overall Study|Adverse Event|0|||
144652939|NCT02834403|521581790|FG004|Overall Study|Adverse Event|1|||
144652940|NCT02834403|521581791|FG005|Overall Study|Adverse Event|1|||
144652941|NCT02834403|521581792|FG006|Overall Study|Adverse Event|3|||
144652942|NCT02834403|521581786|FG000|Overall Study|Withdrawal by Subject|0|||
144652943|NCT02834403|521581787|FG001|Overall Study|Withdrawal by Subject|1|||
144652944|NCT02834403|521581788|FG002|Overall Study|Withdrawal by Subject|0|||
144652945|NCT02834403|521581789|FG003|Overall Study|Withdrawal by Subject|0|||
144652946|NCT02834403|521581790|FG004|Overall Study|Withdrawal by Subject|1|||
144652947|NCT02834403|521581791|FG005|Overall Study|Withdrawal by Subject|0|||
144652948|NCT02834403|521581792|FG006|Overall Study|Withdrawal by Subject|0|||
144652949|NCT02834403|521581786|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
144652950|NCT02834403|521581787|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
144652951|NCT02834403|521581788|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
144652952|NCT02834403|521581789|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
144652953|NCT02834403|521581790|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
144652954|NCT02834403|521581791|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
144652955|NCT02834403|521581792|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
144652956|NCT02341014|521581793|FG000|Overall Study|Adverse Event|0|||
144652957|NCT02341014|521581794|FG001|Overall Study|Adverse Event|1|||
144652958|NCT02341014|521581795|FG002|Overall Study|Adverse Event|0|||
144652959|NCT02341014|521581796|FG003|Overall Study|Adverse Event|0|||
144652960|NCT02341014|521581797|FG004|Overall Study|Adverse Event|2|||
144652961|NCT00390780|521581798|FG000|Overall Study|Not completed|10|||
144652962|NCT00390780|521581799|FG001|Overall Study|Not completed|4|||
144652963|NCT00390780|521581798|FG000|Overall Study|Protocol Violation|6|||
144652964|NCT00390780|521581799|FG001|Overall Study|Protocol Violation|4|||
144652965|NCT00390780|521581798|FG000|Overall Study|Lost to Follow-up|3|||
144652966|NCT00390780|521581799|FG001|Overall Study|Lost to Follow-up|6|||
144652967|NCT00390780|521581798|FG000|Overall Study|Adverse Event|2|||
144652968|NCT00390780|521581799|FG001|Overall Study|Adverse Event|3|||
144652969|NCT00390780|521581798|FG000|Overall Study|Death|1|||
144652970|NCT00390780|521581799|FG001|Overall Study|Death|3|||
144652971|NCT00390780|521581798|FG000|Overall Study|Withdrawal by Subject|1|||
144652972|NCT00390780|521581799|FG001|Overall Study|Withdrawal by Subject|2|||
144652973|NCT00390780|521581798|FG000|Overall Study|Inclusion criteria not satisfied|0|||
144652974|NCT00390780|521581799|FG001|Overall Study|Inclusion criteria not satisfied|2|||
144652975|NCT00390780|521581798|FG000|Overall Study|Lost to follow up and other reasons|0|||
144652976|NCT00390780|521581799|FG001|Overall Study|Lost to follow up and other reasons|1|||
144652977|NCT00390780|521581798|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
144652978|NCT00390780|521581799|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
144652979|NCT00390780|521581798|FG000|Overall Study|SAE, death|0|||
144212939|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
144212940|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
144212941|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
144212942|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
144212943|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
144212944|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
144212945|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
144212946|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
144212947|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
144212948|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
144212949|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
144212950|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
144212951|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
144212952|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
144212953|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144212954|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144212955|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144212956|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144212957|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144652980|NCT00390780|521581799|FG001|Overall Study|SAE, death|1|||
144652981|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
144212958|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144212959|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
144212960|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
144212961|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
144652982|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
144652983|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
144652984|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
144652985|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
144652986|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
144652987|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
144652988|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
144652989|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
144212962|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
144212963|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212964|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212965|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212966|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212967|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212968|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212969|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212970|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
144212971|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
144212972|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
144212973|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
144212974|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
144212975|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
144212976|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
144212977|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
144212978|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
144212979|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
144212980|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
144212981|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
144212982|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
144212983|NCT03104400|519974523|FG000|Period 2 Week 56 - 260)|Other|0|||
144212984|NCT03104400|519974524|FG001|Period 2 Week 56 - 260)|Other|0|||
144212985|NCT03104400|519974525|FG002|Period 2 Week 56 - 260)|Other|0|||
144212986|NCT03104400|519974526|FG003|Period 2 Week 56 - 260)|Other|0|||
144212987|NCT03104400|519974527|FG004|Period 2 Week 56 - 260)|Other|0|||
144212988|NCT03104400|519974528|FG005|Period 2 Week 56 - 260)|Other|0|||
144212989|NCT03104400|519974529|FG006|Period 2 Week 56 - 260)|Other|0|||
144212990|NCT03104400|519974530|FG007|Period 2 Week 56 - 260)|Other|0|||
144212991|NCT03104400|519974531|FG008|Period 2 Week 56 - 260)|Other|1|||
144212992|NCT03104400|519974532|FG009|Period 2 Week 56 - 260)|Other|1|||
144212993|NCT02013817|519974533|FG000|Overall Study|Adverse Event|12|||
144212994|NCT02013817|519974533|FG000|Overall Study|Withdrawal by Subject|4|||
144212995|NCT02013817|519974533|FG000|Overall Study|Death|2|||
144212996|NCT02013817|519974533|FG000|Overall Study|Other|9|||
144212997|NCT00855894|519974534|FG000|Overall Study|Death|31|||
144212998|NCT00855894|519974534|FG000|Overall Study|Patient's decision|1|||
144212999|NCT00855894|519974534|FG000|Overall Study|Disease progression|1|||
144213000|NCT04172597|519974535|FG000|Overall Study|Disease Progression|0|||
144213001|NCT04172597|519974536|FG001|Overall Study|Disease Progression|0|||
144213002|NCT04172597|519974537|FG002|Overall Study|Disease Progression|0|||
144213003|NCT04172597|519974538|FG003|Overall Study|Disease Progression|0|||
144213004|NCT04172597|519974539|FG004|Overall Study|Disease Progression|1|||
144213005|NCT04414618|519974540|FG000|Overall Study|Death|3|||
144213006|NCT04414618|519974541|FG001|Overall Study|Death|3|||
144213007|NCT04414618|519974540|FG000|Overall Study|Withdrawal by Subject|2|||
144213008|NCT04414618|519974541|FG001|Overall Study|Withdrawal by Subject|1|||
144213009|NCT04414618|519974540|FG000|Overall Study|Lost to Follow-up|2|||
144213010|NCT04414618|519974541|FG001|Overall Study|Lost to Follow-up|3|||
144263845|NCT05209880|520167556|FG001|1-Month Follow-up|Discontinued|1|||
144263846|NCT05209880|520167555|FG000|3-Month Follow-up|Spoke with Doctor|17|||
144263847|NCT05209880|520167556|FG001|3-Month Follow-up|Spoke with Doctor|7|||
144263848|NCT05209880|520167555|FG000|3-Month Follow-up|Lost to Follow-up|8|||
144263849|NCT05209880|520167556|FG001|3-Month Follow-up|Lost to Follow-up|10|||
144263850|NCT05209880|520167555|FG000|3-Month Follow-up|Discontinued|1|||
144263851|NCT05209880|520167556|FG001|3-Month Follow-up|Discontinued|3|||
144263852|NCT05209880|520167555|FG000|6-Month Follow-up|Spoke with Doctor|25|||
144263853|NCT05209880|520167556|FG001|6-Month Follow-up|Spoke with Doctor|14|||
144263854|NCT05209880|520167555|FG000|6-Month Follow-up|Lost to Follow-up|9|||
144263855|NCT05209880|520167556|FG001|6-Month Follow-up|Lost to Follow-up|14|||
144263856|NCT05209880|520167555|FG000|6-Month Follow-up|Discontinued|1|||
144263857|NCT05209880|520167556|FG001|6-Month Follow-up|Discontinued|3|||
144263858|NCT04144322|520167559|FG000|Overall Study|Lack of Efficacy|2|||
144213011|NCT04414618|519974540|FG000|Overall Study|Physician Decision|1|||
144213012|NCT04414618|519974541|FG001|Overall Study|Physician Decision|0|||
144213013|NCT02661217|519974542|FG000|Overall Study|Physician Decision|12|||
144213014|NCT02661217|519974543|FG001|Overall Study|Physician Decision|15|||
144213015|NCT02661217|519974542|FG000|Overall Study|Lost to Follow-up|1|||
144213016|NCT02661217|519974543|FG001|Overall Study|Lost to Follow-up|4|||
144213017|NCT02661217|519974542|FG000|Overall Study|Protocol Deviation|0|||
144213018|NCT02661217|519974543|FG001|Overall Study|Protocol Deviation|4|||
144652990|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
144652991|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
144652992|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
144652993|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
144263859|NCT04144322|520167560|FG001|Overall Study|Lack of Efficacy|2|||
144263860|NCT04817332|520167561|FG000|Overall Study|Lost to Follow-up|3|||
144263861|NCT04817332|520167562|FG001|Overall Study|Lost to Follow-up|3|||
144263862|NCT04817332|520167561|FG000|Overall Study|Protocol Violation|2|||
144263863|NCT04817332|520167562|FG001|Overall Study|Protocol Violation|0|||
144263864|NCT05635045|520167563|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
144263865|NCT05635045|520167564|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
144263866|NCT05635045|520167565|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
144263867|NCT05635045|520167566|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
144263868|NCT03143101|520167567|FG000|Overall Study|Withdrawal by Subject|0|||
144263869|NCT03143101|520167568|FG001|Overall Study|Withdrawal by Subject|1|||
144263870|NCT03143101|520167569|FG002|Overall Study|Withdrawal by Subject|0|||
144263871|NCT03143101|520167567|FG000|Overall Study|Lost to Follow-up|2|||
144263872|NCT03143101|520167568|FG001|Overall Study|Lost to Follow-up|2|||
144263873|NCT03143101|520167569|FG002|Overall Study|Lost to Follow-up|0|||
144263874|NCT05227118|520167572|FG000|Overall Study|Adverse Event|0|||
144263875|NCT05227118|520167573|FG001|Overall Study|Adverse Event|0|||
144263876|NCT05227118|520167574|FG002|Overall Study|Adverse Event|1|||
144263877|NCT05227118|520167575|FG003|Overall Study|Adverse Event|0|||
144263878|NCT05227118|520167572|FG000|Overall Study|Withdrawal by Subject|0|||
144263879|NCT05227118|520167573|FG001|Overall Study|Withdrawal by Subject|0|||
144263880|NCT05227118|520167574|FG002|Overall Study|Withdrawal by Subject|2|||
144263881|NCT05227118|520167575|FG003|Overall Study|Withdrawal by Subject|0|||
144263882|NCT01435759|520167576|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
144263883|NCT01435759|520167577|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
144263884|NCT01435759|520167578|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
144263885|NCT01435759|520167579|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
144263886|NCT01435759|520167580|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
144263887|NCT01435759|520167581|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
144263888|NCT01435759|520167576|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
144263889|NCT01435759|520167577|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
144263890|NCT01435759|520167578|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
144263891|NCT01435759|520167579|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
144263892|NCT01435759|520167580|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
144263893|NCT01435759|520167581|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
144263894|NCT01435759|520167576|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
144263895|NCT01435759|520167577|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144263896|NCT01435759|520167578|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144263897|NCT01435759|520167579|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144263898|NCT01435759|520167580|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144263899|NCT01435759|520167581|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
144263900|NCT01435759|520167576|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
144263901|NCT01435759|520167577|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144263902|NCT01435759|520167578|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144263903|NCT01435759|520167579|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144263904|NCT01435759|520167580|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144263905|NCT01435759|520167581|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
144263906|NCT01435759|520167576|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
144263907|NCT01435759|520167577|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263908|NCT01435759|520167578|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263909|NCT01435759|520167579|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263910|NCT01435759|520167580|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263911|NCT01435759|520167581|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263912|NCT01435759|520167576|FG000|Antidepressant Lead-in Phase|Other|119|||
144263913|NCT01435759|520167577|FG001|Antidepressant Lead-in Phase|Other|0|||
144263914|NCT01435759|520167578|FG002|Antidepressant Lead-in Phase|Other|0|||
144263915|NCT01435759|520167579|FG003|Antidepressant Lead-in Phase|Other|0|||
144263916|NCT01435759|520167580|FG004|Antidepressant Lead-in Phase|Other|0|||
144263917|NCT01435759|520167581|FG005|Antidepressant Lead-in Phase|Other|0|||
144263918|NCT01435759|520167576|FG000|Double-blind Phase|Adverse Event|7|||
144263919|NCT01435759|520167577|FG001|Double-blind Phase|Adverse Event|0|||
144263920|NCT01435759|520167578|FG002|Double-blind Phase|Adverse Event|1|||
144263921|NCT01435759|520167579|FG003|Double-blind Phase|Adverse Event|1|||
144263922|NCT01435759|520167580|FG004|Double-blind Phase|Adverse Event|1|||
144263923|NCT01435759|520167581|FG005|Double-blind Phase|Adverse Event|3|||
144263924|NCT01435759|520167576|FG000|Double-blind Phase|Protocol Violation|2|||
144263925|NCT01435759|520167577|FG001|Double-blind Phase|Protocol Violation|0|||
144732019|NCT00696020|521875714|FG000|Overall Study|Withdrawal by Subject|0|||
144732020|NCT00696020|521875715|FG001|Overall Study|Withdrawal by Subject|1|||
144732021|NCT00696020|521875716|FG002|Overall Study|Withdrawal by Subject|0|||
144732022|NCT00696020|521875717|FG003|Overall Study|Withdrawal by Subject|1|||
144263926|NCT01435759|520167578|FG002|Double-blind Phase|Protocol Violation|1|||
144732023|NCT00696020|521875714|FG000|Overall Study|Other not stated above|0|||
144732024|NCT00696020|521875715|FG001|Overall Study|Other not stated above|0|||
144732025|NCT00696020|521875716|FG002|Overall Study|Other not stated above|1|||
144732026|NCT00696020|521875717|FG003|Overall Study|Other not stated above|1|||
144732027|NCT00624065|521875718|FG000|Overall Study|Adverse Event|5|||
144732028|NCT00624065|521875719|FG001|Overall Study|Adverse Event|6|||
144732029|NCT00624065|521875718|FG000|Overall Study|Lost to Follow-up|4|||
144732030|NCT00624065|521875719|FG001|Overall Study|Lost to Follow-up|1|||
144732031|NCT00624065|521875718|FG000|Overall Study|Consent withdrawn|6|||
144732032|NCT00624065|521875719|FG001|Overall Study|Consent withdrawn|5|||
144732033|NCT00624065|521875718|FG000|Overall Study|Lack of Efficacy|0|||
144732034|NCT00624065|521875719|FG001|Overall Study|Lack of Efficacy|3|||
144732035|NCT00624065|521875718|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
144732036|NCT00624065|521875719|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
144732037|NCT01387022|521875720|FG000|Overall Study|Death|1|||
144732038|NCT01387022|521875721|FG001|Overall Study|Death|1|||
144732039|NCT01387022|521875720|FG000|Overall Study|Lost to Follow-up|0|||
144732040|NCT01387022|521875721|FG001|Overall Study|Lost to Follow-up|3|||
144732041|NCT02076022|521875725|FG000|Overall Study|Withdrawal by Subject|2|||
144732042|NCT02076022|521875726|FG001|Overall Study|Withdrawal by Subject|0|||
144732043|NCT00312663|521875727|FG000|Immunization Phase|Adverse Event|0|||
144732044|NCT00312663|521875728|FG001|Immunization Phase|Adverse Event|1|||
144732045|NCT00312663|521875729|FG002|Immunization Phase|Adverse Event|0|||
144732046|NCT00286754|521875733|FG000|Overall Study|Adverse Event|2|||
144732047|NCT00286754|521875734|FG001|Overall Study|Adverse Event|2|||
144732048|NCT00286754|521875735|FG002|Overall Study|Adverse Event|3|||
144732049|NCT00286754|521875733|FG000|Overall Study|Withdrawal by Subject|6|||
144732050|NCT00286754|521875734|FG001|Overall Study|Withdrawal by Subject|2|||
144732051|NCT00286754|521875735|FG002|Overall Study|Withdrawal by Subject|0|||
144732052|NCT00286754|521875733|FG000|Overall Study|Lost to Follow-up|12|||
144732053|NCT00286754|521875734|FG001|Overall Study|Lost to Follow-up|14|||
144732054|NCT00286754|521875735|FG002|Overall Study|Lost to Follow-up|6|||
144732055|NCT00286754|521875733|FG000|Overall Study|Moved out of state|0|||
144732056|NCT00286754|521875734|FG001|Overall Study|Moved out of state|0|||
144732057|NCT00286754|521875735|FG002|Overall Study|Moved out of state|1|||
144732058|NCT02661295|521875736|FG000|Overall Study|Death|1|||
144732059|NCT02661295|521875736|FG000|Overall Study|Transferred Out|1|||
144732060|NCT02661295|521875736|FG000|Overall Study|Kidney Transplant|1|||
144732061|NCT02661295|521875736|FG000|Overall Study|Withdrawn due to side effects|8|||
144732062|NCT02661295|521875736|FG000|Overall Study|Withdrawn due to access type|1|||
144732063|NCT02661295|521875736|FG000|Overall Study|Withdrawn due to allergies|1|||
144732064|NCT02661295|521875736|FG000|Overall Study|Withdrawn due to non-compliance|1|||
144732065|NCT02661295|521875736|FG000|Overall Study|Withdrawal by Subject|3|||
144732066|NCT02661295|521875736|FG000|Overall Study|Failed screening|2|||
144732067|NCT02336165|521875737|FG000|Overall Study|Death|3|||
144732068|NCT02336165|521875738|FG001|Overall Study|Death|0|||
144732069|NCT02336165|521875739|FG002|Overall Study|Death|0|||
144732070|NCT02336165|521875740|FG003|Overall Study|Death|0|||
144732071|NCT02336165|521875741|FG004|Overall Study|Death|1|||
144732072|NCT02336165|521875737|FG000|Overall Study|Physician Decision|2|||
144732073|NCT02336165|521875738|FG001|Overall Study|Physician Decision|2|||
144732074|NCT02336165|521875739|FG002|Overall Study|Physician Decision|1|||
144732075|NCT02336165|521875740|FG003|Overall Study|Physician Decision|1|||
144213019|NCT02661217|519974542|FG000|Overall Study|Non-compliance with study treatment|5|||
144732076|NCT02336165|521875741|FG004|Overall Study|Physician Decision|0|||
144732077|NCT02336165|521875737|FG000|Overall Study|Withdrawal by Subject|0|||
144732078|NCT02336165|521875738|FG001|Overall Study|Withdrawal by Subject|0|||
144732079|NCT02336165|521875739|FG002|Overall Study|Withdrawal by Subject|1|||
144732080|NCT02336165|521875740|FG003|Overall Study|Withdrawal by Subject|0|||
144732081|NCT02336165|521875741|FG004|Overall Study|Withdrawal by Subject|1|||
144732082|NCT02336165|521875737|FG000|Overall Study|Adverse Event|4|||
144732083|NCT02336165|521875738|FG001|Overall Study|Adverse Event|1|||
144732084|NCT02336165|521875739|FG002|Overall Study|Adverse Event|2|||
144732085|NCT02336165|521875740|FG003|Overall Study|Adverse Event|4|||
144732086|NCT02336165|521875741|FG004|Overall Study|Adverse Event|1|||
144732087|NCT02336165|521875737|FG000|Overall Study|Progressive disease|23|||
144732088|NCT02336165|521875738|FG001|Overall Study|Progressive disease|22|||
144732089|NCT02336165|521875739|FG002|Overall Study|Progressive disease|27|||
144732090|NCT02336165|521875740|FG003|Overall Study|Progressive disease|24|||
144732091|NCT02336165|521875741|FG004|Overall Study|Progressive disease|19|||
144732092|NCT02336165|521875737|FG000|Overall Study|Non-compliance|1|||
144732093|NCT02336165|521875738|FG001|Overall Study|Non-compliance|0|||
144732094|NCT02336165|521875739|FG002|Overall Study|Non-compliance|0|||
144732095|NCT02336165|521875740|FG003|Overall Study|Non-compliance|1|||
144732096|NCT02336165|521875741|FG004|Overall Study|Non-compliance|0|||
144732097|NCT02336165|521875737|FG000|Overall Study|Other|1|||
144732098|NCT02336165|521875738|FG001|Overall Study|Other|0|||
144732099|NCT02336165|521875739|FG002|Overall Study|Other|0|||
144732100|NCT02336165|521875740|FG003|Overall Study|Other|1|||
144732101|NCT02336165|521875741|FG004|Overall Study|Other|0|||
144213020|NCT02661217|519974543|FG001|Overall Study|Non-compliance with study treatment|5|||
144213021|NCT02661217|519974542|FG000|Overall Study|Death|21|||
144213022|NCT02661217|519974543|FG001|Overall Study|Death|15|||
144213023|NCT02661217|519974542|FG000|Overall Study|Adverse Event|10|||
144213024|NCT02661217|519974543|FG001|Overall Study|Adverse Event|8|||
144213025|NCT02661217|519974542|FG000|Overall Study|Withdrawal by Subject|15|||
144213026|NCT02661217|519974543|FG001|Overall Study|Withdrawal by Subject|19|||
144213027|NCT02661217|519974542|FG000|Overall Study|Did not enter follow-up epoch|7|||
144652994|NCT02232516|521581804|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
144652995|NCT02232516|521581804|FG000|Survival Follow-up|Death|15|||
144652996|NCT02232516|521581804|FG000|Survival Follow-up|Withdrawal by Subject|3|||
144652997|NCT02232516|521581804|FG000|Survival Follow-up|Lost to Follow-up|1|||
144652998|NCT02232516|521581804|FG000|Survival Follow-up|Still in follow-up|5|||
144652999|NCT05058664|521581805|FG000|Overall Study|No follow-up data provided|4|||
144653000|NCT05058664|521581806|FG001|Overall Study|No follow-up data provided|0|||
144653001|NCT05058664|521581807|FG002|Overall Study|No follow-up data provided|2|||
144653002|NCT05058664|521581805|FG000|Overall Study|Withdrawal by Subject|0|||
144653003|NCT05058664|521581806|FG001|Overall Study|Withdrawal by Subject|0|||
144653004|NCT05058664|521581807|FG002|Overall Study|Withdrawal by Subject|1|||
144653005|NCT01585961|521581808|FG000|Overall Study|Death|6|||
144653006|NCT01585961|521581808|FG000|Overall Study|Physician Decision|1|||
144653007|NCT01585961|521581808|FG000|Overall Study|Decision to use non-study catheter|1|||
144653008|NCT01585961|521581808|FG000|Overall Study|Withdrawal by Subject|1|||
144653009|NCT01585961|521581808|FG000|Overall Study|Lost to Follow-up|23|||
144653010|NCT01585961|521581808|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
144653011|NCT01258348|521581809|FG000|Overall Study|Adverse Event|1|||
144653012|NCT01258348|521581810|FG001|Overall Study|Adverse Event|1|||
144653013|NCT01258348|521581811|FG002|Overall Study|Adverse Event|3|||
144653014|NCT01258348|521581812|FG003|Overall Study|Adverse Event|2|||
144653015|NCT01258348|521581813|FG004|Overall Study|Adverse Event|4|||
144653016|NCT01258348|521581809|FG000|Overall Study|Progressive Disease|0|||
144653017|NCT01258348|521581810|FG001|Overall Study|Progressive Disease|3|||
144653018|NCT01258348|521581811|FG002|Overall Study|Progressive Disease|0|||
144653019|NCT01258348|521581812|FG003|Overall Study|Progressive Disease|2|||
144653020|NCT01258348|521581813|FG004|Overall Study|Progressive Disease|2|||
144653021|NCT01258348|521581809|FG000|Overall Study|Physician Decision|0|||
144653022|NCT01258348|521581810|FG001|Overall Study|Physician Decision|0|||
144653023|NCT01258348|521581811|FG002|Overall Study|Physician Decision|0|||
144653024|NCT01258348|521581812|FG003|Overall Study|Physician Decision|2|||
144653025|NCT01258348|521581813|FG004|Overall Study|Physician Decision|0|||
144653026|NCT01258348|521581809|FG000|Overall Study|Withdrawal by Subject|0|||
144653027|NCT01258348|521581810|FG001|Overall Study|Withdrawal by Subject|1|||
144653028|NCT01258348|521581811|FG002|Overall Study|Withdrawal by Subject|0|||
144653029|NCT01258348|521581812|FG003|Overall Study|Withdrawal by Subject|0|||
144653030|NCT01258348|521581813|FG004|Overall Study|Withdrawal by Subject|0|||
144653031|NCT00231062|521581825|FG000|Overall Study|Physician Decision|6|||
144653032|NCT01651260|521581829|FG000|Overall Study|unable to apply product|3|||
144653033|NCT02239094|521581830|FG000|Overall Study|Withdrawal by Subject|1|||
144653034|NCT02239094|521581830|FG000|Overall Study|Remitted before started|1|||
144653035|NCT03648996|521581833|FG000|Overall Study|Withdrawal by Subject|0|||
144653036|NCT03648996|521581834|FG001|Overall Study|Withdrawal by Subject|2|||
144653037|NCT03648996|521581835|FG002|Overall Study|Withdrawal by Subject|2|||
144653038|NCT03648996|521581833|FG000|Overall Study|Physician Decision|2|||
144653039|NCT03648996|521581834|FG001|Overall Study|Physician Decision|0|||
144653040|NCT03648996|521581835|FG002|Overall Study|Physician Decision|0|||
144653041|NCT00590681|521581836|FG000|Overall Study|Withdrawal by Subject|7|||
144653042|NCT00590681|521581836|FG000|Overall Study|Adverse Event|8|||
144653043|NCT00590681|521581836|FG000|Overall Study|Death|3|||
144653044|NCT00590681|521581836|FG000|Overall Study|Lost to Follow-up|1|||
144653045|NCT00590681|521581836|FG000|Overall Study|disease progression|1|||
144653046|NCT01259297|521581837|FG000|Double Blind Randomized Period|Death|1|||
144653047|NCT01259297|521581838|FG001|Double Blind Randomized Period|Death|1|||
144653048|NCT01259297|521581839|FG002|Double Blind Randomized Period|Death|1|||
144653049|NCT01259297|521581840|FG003|Double Blind Randomized Period|Death|2|||
144653050|NCT01259297|521581841|FG004|Double Blind Randomized Period|Death|1|||
144653051|NCT01259297|521581842|FG005|Double Blind Randomized Period|Death|5|||
144653052|NCT01259297|521581843|FG006|Double Blind Randomized Period|Death|2|||
144653053|NCT01259297|521581844|FG007|Double Blind Randomized Period|Death|1|||
144653054|NCT01259297|521581837|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
144653055|NCT01259297|521581838|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
144653056|NCT01259297|521581839|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
144653057|NCT01259297|521581840|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
144653058|NCT01259297|521581841|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
144732102|NCT00910663|521875746|FG000|Period 1|Withdrawal by Subject|0|||
144213028|NCT02661217|519974543|FG001|Overall Study|Did not enter follow-up epoch|10|||
144213029|NCT02661217|519974542|FG000|Overall Study|Death - no study drug received|1|||
144653059|NCT01259297|521581842|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
144653060|NCT01259297|521581843|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
144213030|NCT02661217|519974543|FG001|Overall Study|Death - no study drug received|2|||
144213031|NCT02661217|519974542|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
144213032|NCT02661217|519974543|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
144213033|NCT02075515|519974544|FG000|Overall Study|Serious Adverse Event|1|||
144213034|NCT02075515|519974545|FG001|Overall Study|Serious Adverse Event|1|||
144213035|NCT02075515|519974546|FG002|Overall Study|Serious Adverse Event|1|||
144213036|NCT02075515|519974544|FG000|Overall Study|Non-Serious Adverse Event|0|||
144213037|NCT02075515|519974545|FG001|Overall Study|Non-Serious Adverse Event|1|||
144213038|NCT02075515|519974546|FG002|Overall Study|Non-Serious Adverse Event|0|||
144213039|NCT02075515|519974544|FG000|Overall Study|Withdrawal by Subject|2|||
144213040|NCT02075515|519974545|FG001|Overall Study|Withdrawal by Subject|0|||
144213041|NCT02075515|519974546|FG002|Overall Study|Withdrawal by Subject|1|||
144213042|NCT02075515|519974544|FG000|Overall Study|Lost to Follow-up|1|||
144213043|NCT02075515|519974545|FG001|Overall Study|Lost to Follow-up|3|||
144213044|NCT02075515|519974546|FG002|Overall Study|Lost to Follow-up|6|||
144213045|NCT00741338|519974549|FG000|Overall Study|Adverse Event|0|||
144213046|NCT00741338|519974550|FG001|Overall Study|Adverse Event|1|||
144213047|NCT03593395|519974551|FG000|Overall Study|Lost to Follow-up|48|||
144213048|NCT03593395|519974552|FG001|Overall Study|Lost to Follow-up|3|||
144213049|NCT03593395|519974551|FG000|Overall Study|Withdrawal by Subject|5|||
144213050|NCT03593395|519974552|FG001|Overall Study|Withdrawal by Subject|24|||
144213051|NCT03593395|519974551|FG000|Overall Study|Death|2|||
144213052|NCT03593395|519974552|FG001|Overall Study|Death|3|||
144213053|NCT03593395|519974551|FG000|Overall Study|Physician Decision|0|||
144213054|NCT03593395|519974552|FG001|Overall Study|Physician Decision|6|||
144213055|NCT03593395|519974551|FG000|Overall Study|Participant Relocated|19|||
144213056|NCT03593395|519974552|FG001|Overall Study|Participant Relocated|3|||
144213057|NCT03593395|519974551|FG000|Overall Study|No Information|1|||
144213058|NCT03593395|519974552|FG001|Overall Study|No Information|7|||
144213059|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
144213060|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
144213061|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
144213062|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
144213063|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
144213064|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
144213065|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
144213066|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
144213067|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
144213068|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
144213069|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
144213070|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
144213071|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
144213072|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
144213073|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
144213074|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
144213075|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
144213076|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
144213077|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
144213078|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
144213079|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
144213080|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144653061|NCT01259297|521581844|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
144213081|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
144213082|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144213083|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
144213084|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
144213085|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
144213086|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
144213087|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
144213088|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
144213089|NCT03713632|519974553|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
144213090|NCT03713632|519974554|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
144213091|NCT03713632|519974555|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
144213092|NCT03713632|519974556|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
144213093|NCT03713632|519974557|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
144213094|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
144213095|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
144213096|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
144653062|NCT01259297|521581837|FG000|Double Blind Randomized Period|Other reasons|0|||
144653063|NCT01259297|521581838|FG001|Double Blind Randomized Period|Other reasons|1|||
144653064|NCT01259297|521581839|FG002|Double Blind Randomized Period|Other reasons|0|||
144653065|NCT01259297|521581840|FG003|Double Blind Randomized Period|Other reasons|0|||
144653066|NCT01259297|521581841|FG004|Double Blind Randomized Period|Other reasons|1|||
144653067|NCT01259297|521581842|FG005|Double Blind Randomized Period|Other reasons|2|||
144653068|NCT01259297|521581843|FG006|Double Blind Randomized Period|Other reasons|3|||
144653069|NCT01259297|521581844|FG007|Double Blind Randomized Period|Other reasons|1|||
144213097|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
144213098|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
144213099|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
144213100|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
144213101|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
144213102|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
144213103|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
144213104|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
144213105|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
144213106|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
144213107|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
144213108|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
144213109|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
144213110|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
144213111|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
144213112|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
144213113|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
144213114|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
144213115|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
144213116|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
144213117|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
144213118|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
144213119|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
144213120|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
144213121|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
144213122|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
144213123|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
144213124|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Death|0|||
144213125|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Death|1|||
144213126|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Death|0|||
144653070|NCT01345786|521581849|FG000|Overall Study|Adverse Event|0|||
144653071|NCT01345786|521581850|FG001|Overall Study|Adverse Event|1|||
144653072|NCT01345786|521581851|FG002|Overall Study|Adverse Event|3|||
144653073|NCT01345786|521581852|FG003|Overall Study|Adverse Event|1|||
144653074|NCT01345786|521581849|FG000|Overall Study|Subject withdrew consent|2|||
144653075|NCT01345786|521581850|FG001|Overall Study|Subject withdrew consent|2|||
144653076|NCT01345786|521581851|FG002|Overall Study|Subject withdrew consent|1|||
144653077|NCT01345786|521581852|FG003|Overall Study|Subject withdrew consent|0|||
144653078|NCT01345786|521581849|FG000|Overall Study|Noncompliance with protocol|1|||
144653079|NCT01345786|521581850|FG001|Overall Study|Noncompliance with protocol|0|||
144653080|NCT01345786|521581851|FG002|Overall Study|Noncompliance with protocol|1|||
144653081|NCT01345786|521581852|FG003|Overall Study|Noncompliance with protocol|0|||
144653082|NCT01345786|521581849|FG000|Overall Study|Administrative|3|||
144653083|NCT01345786|521581850|FG001|Overall Study|Administrative|5|||
144653084|NCT01345786|521581851|FG002|Overall Study|Administrative|0|||
144653085|NCT01345786|521581852|FG003|Overall Study|Administrative|0|||
144653086|NCT01345786|521581849|FG000|Overall Study|Lost to Follow-up|0|||
144653087|NCT01345786|521581850|FG001|Overall Study|Lost to Follow-up|0|||
144653088|NCT01345786|521581851|FG002|Overall Study|Lost to Follow-up|0|||
144653089|NCT01345786|521581852|FG003|Overall Study|Lost to Follow-up|2|||
144653090|NCT01780389|521581855|FG000|Overall Study|Adverse Event|1|||
144213127|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Death|0|||
144213128|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Death|0|||
144653091|NCT01095250|521581856|FG000|Overall Study|administrative reasons|8|||
144213129|NCT03713632|519974553|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144213130|NCT03713632|519974554|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
144213131|NCT03713632|519974555|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144213132|NCT03713632|519974556|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144213133|NCT03713632|519974557|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
144213134|NCT02797171|519974563|FG000|Overall Study|Lost to Follow-up|2|||
144213135|NCT02797171|519974564|FG001|Overall Study|Lost to Follow-up|0|||
144653092|NCT01095250|521581857|FG001|Overall Study|administrative reasons|10|||
144653093|NCT01095250|521581858|FG002|Overall Study|administrative reasons|7|||
144653094|NCT01095250|521581859|FG003|Overall Study|administrative reasons|5|||
144213136|NCT02797171|519974565|FG002|Overall Study|Lost to Follow-up|2|||
144213137|NCT02797171|519974566|FG003|Overall Study|Lost to Follow-up|1|||
144213138|NCT02797171|519974567|FG004|Overall Study|Lost to Follow-up|2|||
144213139|NCT02797171|519974568|FG005|Overall Study|Lost to Follow-up|0|||
144213140|NCT02797171|519974563|FG000|Overall Study|Withdrawal by Subject|1|||
144213141|NCT02797171|519974564|FG001|Overall Study|Withdrawal by Subject|1|||
144213142|NCT02797171|519974565|FG002|Overall Study|Withdrawal by Subject|0|||
144213143|NCT02797171|519974566|FG003|Overall Study|Withdrawal by Subject|0|||
144213144|NCT02797171|519974567|FG004|Overall Study|Withdrawal by Subject|0|||
144213145|NCT02797171|519974568|FG005|Overall Study|Withdrawal by Subject|0|||
144213146|NCT02797171|519974563|FG000|Overall Study|Protocol Violation|1|||
144213147|NCT02797171|519974564|FG001|Overall Study|Protocol Violation|0|||
144213148|NCT02797171|519974565|FG002|Overall Study|Protocol Violation|0|||
144213149|NCT02797171|519974566|FG003|Overall Study|Protocol Violation|0|||
144213150|NCT02797171|519974567|FG004|Overall Study|Protocol Violation|0|||
144213151|NCT02797171|519974568|FG005|Overall Study|Protocol Violation|0|||
144213152|NCT02797171|519974563|FG000|Overall Study|Participant unable to adhere|0|||
144213153|NCT02797171|519974564|FG001|Overall Study|Participant unable to adhere|1|||
144213154|NCT02797171|519974565|FG002|Overall Study|Participant unable to adhere|0|||
144213155|NCT02797171|519974566|FG003|Overall Study|Participant unable to adhere|0|||
144213156|NCT02797171|519974567|FG004|Overall Study|Participant unable to adhere|0|||
144213157|NCT02797171|519974568|FG005|Overall Study|Participant unable to adhere|0|||
144213158|NCT02797171|519974563|FG000|Overall Study|Not Randomized|0|||
144213159|NCT02797171|519974564|FG001|Overall Study|Not Randomized|0|||
144213160|NCT02797171|519974565|FG002|Overall Study|Not Randomized|0|||
144213161|NCT02797171|519974566|FG003|Overall Study|Not Randomized|0|||
144213162|NCT02797171|519974567|FG004|Overall Study|Not Randomized|0|||
144213163|NCT02797171|519974568|FG005|Overall Study|Not Randomized|1|||
144213164|NCT02540083|519974569|FG000|Overall Study|Withdrawal by Subject|16|||
144213165|NCT00134901|519974570|FG000|Overall Study|Lost to Follow-up|5|||
144213166|NCT00134901|519974571|FG001|Overall Study|Lost to Follow-up|5|||
144213167|NCT00134901|519974570|FG000|Overall Study|discontinued intervention|12|||
144213168|NCT00134901|519974571|FG001|Overall Study|discontinued intervention|10|||
144213169|NCT02301390|519974574|FG000|Overall Study|Withdrawal by Subject|3|||
144213170|NCT02301390|519974575|FG001|Overall Study|Withdrawal by Subject|5|||
144213171|NCT02301390|519974574|FG000|Overall Study|Protocol Violation|1|||
144213172|NCT02301390|519974575|FG001|Overall Study|Protocol Violation|0|||
144213173|NCT02301390|519974574|FG000|Overall Study|Physician Decision|1|||
144653095|NCT01095250|521581856|FG000|Overall Study|Withdrawal by Subject|0|||
144653096|NCT01095250|521581857|FG001|Overall Study|Withdrawal by Subject|0|||
144653097|NCT01095250|521581858|FG002|Overall Study|Withdrawal by Subject|1|||
144653098|NCT01095250|521581859|FG003|Overall Study|Withdrawal by Subject|0|||
144213174|NCT02301390|519974575|FG001|Overall Study|Physician Decision|0|||
144653099|NCT01323673|521581862|FG000|Overall Study|Adverse Event|0|||
144653100|NCT01323673|521581863|FG001|Overall Study|Adverse Event|1|||
144653101|NCT01323673|521581862|FG000|Overall Study|Lost to Follow-up|0|||
144213175|NCT02301390|519974574|FG000|Overall Study|Lost to Follow-up|0|||
144213176|NCT02301390|519974575|FG001|Overall Study|Lost to Follow-up|1|||
144213177|NCT02301390|519974574|FG000|Overall Study|Death|2|||
144213178|NCT02301390|519974575|FG001|Overall Study|Death|2|||
144213179|NCT02301390|519974574|FG000|Overall Study|Procedure not completed|0|||
144213180|NCT02301390|519974575|FG001|Overall Study|Procedure not completed|4|||
144213181|NCT02301390|519974574|FG000|Overall Study|Missed multiple visits|1|||
144213182|NCT02301390|519974575|FG001|Overall Study|Missed multiple visits|1|||
144653102|NCT01323673|521581863|FG001|Overall Study|Lost to Follow-up|1|||
144653103|NCT01323673|521581862|FG000|Overall Study|Protocol Violation|1|||
144653104|NCT01323673|521581863|FG001|Overall Study|Protocol Violation|0|||
144653105|NCT01323673|521581862|FG000|Overall Study|Withdrawal by Subject|2|||
144653106|NCT01323673|521581863|FG001|Overall Study|Withdrawal by Subject|3|||
144653107|NCT04598165|521581864|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
144653108|NCT04598165|521581865|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
144653109|NCT04598165|521581864|FG000|Completed 6-week Follow-up|Death|2|||
144653110|NCT04598165|521581865|FG001|Completed 6-week Follow-up|Death|1|||
144653111|NCT04598165|521581864|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
144653112|NCT04598165|521581865|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
144653113|NCT04598165|521581864|FG000|Completed 6-week Follow-up|Ineligible|4|||
144653114|NCT04598165|521581865|FG001|Completed 6-week Follow-up|Ineligible|3|||
144653115|NCT04598165|521581864|FG000|Completed 6-week Follow-up|Partner refusal|0|||
144653116|NCT04598165|521581865|FG001|Completed 6-week Follow-up|Partner refusal|1|||
144653117|NCT04598165|521581864|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
144653118|NCT04598165|521581865|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
144653119|NCT03625986|521583582|FG000|Randomization Period|Lost to Follow-up|7|||
144213183|NCT02301390|519974574|FG000|Overall Study|study terminated|2|||
144213184|NCT02301390|519974575|FG001|Overall Study|study terminated|0|||
144213185|NCT00185588|519974576|FG000|Overall Study|Adverse Event|3|||
144213186|NCT00185588|519974577|FG001|Overall Study|Adverse Event|1|||
144213187|NCT00185588|519974578|FG002|Overall Study|Adverse Event|4|||
144213188|NCT00185588|519974579|FG003|Overall Study|Adverse Event|2|||
144213189|NCT00185588|519974576|FG000|Overall Study|Lost to Follow-up|0|||
144213190|NCT00185588|519974577|FG001|Overall Study|Lost to Follow-up|0|||
144213191|NCT00185588|519974578|FG002|Overall Study|Lost to Follow-up|1|||
144213192|NCT00185588|519974579|FG003|Overall Study|Lost to Follow-up|2|||
144213193|NCT00185588|519974576|FG000|Overall Study|Withdrawal by Subject|0|||
144213194|NCT00185588|519974577|FG001|Overall Study|Withdrawal by Subject|1|||
144213195|NCT00185588|519974578|FG002|Overall Study|Withdrawal by Subject|0|||
144213196|NCT00185588|519974579|FG003|Overall Study|Withdrawal by Subject|0|||
144213197|NCT00185588|519974576|FG000|Overall Study|Physician Decision|0|||
144213198|NCT00185588|519974577|FG001|Overall Study|Physician Decision|0|||
144213199|NCT00185588|519974578|FG002|Overall Study|Physician Decision|1|||
144213200|NCT00185588|519974579|FG003|Overall Study|Physician Decision|0|||
144213201|NCT00398866|519974580|FG000|Overall Study|Adverse Event|1|||
144213202|NCT00398866|519974581|FG001|Overall Study|Adverse Event|0|||
144213203|NCT00398866|519974582|FG002|Overall Study|Adverse Event|0|||
144213204|NCT00398866|519974580|FG000|Overall Study|Lack of Efficacy|0|||
144213205|NCT00398866|519974581|FG001|Overall Study|Lack of Efficacy|0|||
144213206|NCT00398866|519974582|FG002|Overall Study|Lack of Efficacy|1|||
144213207|NCT00398866|519974580|FG000|Overall Study|Lost to Follow-up|7|||
144213208|NCT00398866|519974581|FG001|Overall Study|Lost to Follow-up|6|||
144213209|NCT00398866|519974582|FG002|Overall Study|Lost to Follow-up|4|||
144213210|NCT00398866|519974580|FG000|Overall Study|Withdrawal by Subject|5|||
144213211|NCT00398866|519974581|FG001|Overall Study|Withdrawal by Subject|1|||
144213212|NCT00398866|519974582|FG002|Overall Study|Withdrawal by Subject|2|||
144213213|NCT00398866|519974580|FG000|Overall Study|Unable to complete requirements of study|1|||
144213214|NCT00398866|519974581|FG001|Overall Study|Unable to complete requirements of study|1|||
144213215|NCT00398866|519974582|FG002|Overall Study|Unable to complete requirements of study|1|||
144213216|NCT02481869|519974583|FG000|Overall Study|Lost to Follow-up|3|||
144213217|NCT02481869|519974584|FG001|Overall Study|Lost to Follow-up|4|||
144213218|NCT02481869|519974583|FG000|Overall Study|Withdrawal by Subject|2|||
144213219|NCT02481869|519974584|FG001|Overall Study|Withdrawal by Subject|0|||
144213220|NCT03908437|519974587|FG000|Overall Study|Death|0|||
144213221|NCT03908437|519974588|FG001|Overall Study|Death|1|||
144213222|NCT03908437|519974587|FG000|Overall Study|Lost to Follow-up|31|||
144213223|NCT03908437|519974588|FG001|Overall Study|Lost to Follow-up|24|||
144213224|NCT05445492|519974589|FG000|Overall Study|Physician Decision|1|||
144213225|NCT04289363|519974592|FG000|Overall Study|Lost to Follow-up|14|||
144213226|NCT04289363|519974593|FG001|Overall Study|Lost to Follow-up|0|||
144213227|NCT03126435|519974594|FG000|Overall Study|Death|90|||
144213228|NCT03126435|519974595|FG001|Overall Study|Death|84|||
144213229|NCT03126435|519974594|FG000|Overall Study|Lost to Follow-up|4|||
144213230|NCT03126435|519974595|FG001|Overall Study|Lost to Follow-up|3|||
144213231|NCT03126435|519974594|FG000|Overall Study|Physician Decision|0|||
144213232|NCT03126435|519974595|FG001|Overall Study|Physician Decision|1|||
144213233|NCT03126435|519974594|FG000|Overall Study|Withdrawal by Subject|6|||
144213234|NCT03126435|519974595|FG001|Overall Study|Withdrawal by Subject|12|||
144213235|NCT03126435|519974594|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
144213236|NCT03126435|519974595|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
144213237|NCT03971474|519974596|FG000|Overall Study|Adverse Event|11|||
144213238|NCT03971474|519974597|FG001|Overall Study|Adverse Event|7|||
144213239|NCT03971474|519974596|FG000|Overall Study|Refusal unrelated to adverse event|5|||
144213240|NCT03971474|519974597|FG001|Overall Study|Refusal unrelated to adverse event|1|||
144213241|NCT03971474|519974596|FG000|Overall Study|Progression/relapse|40|||
144213242|NCT03971474|519974597|FG001|Overall Study|Progression/relapse|47|||
144213243|NCT03971474|519974596|FG000|Overall Study|Death|6|||
144213244|NCT03971474|519974597|FG001|Overall Study|Death|3|||
144213245|NCT03971474|519974596|FG000|Overall Study|Other - not protocol specified|5|||
144213246|NCT03971474|519974597|FG001|Overall Study|Other - not protocol specified|4|||
144213247|NCT03971474|519974596|FG000|Overall Study|On treatment|0|||
144263927|NCT01435759|520167579|FG003|Double-blind Phase|Protocol Violation|2|||
144263928|NCT01435759|520167580|FG004|Double-blind Phase|Protocol Violation|0|||
144213248|NCT03971474|519974597|FG001|Overall Study|On treatment|7|||
144263929|NCT01435759|520167581|FG005|Double-blind Phase|Protocol Violation|1|||
144213249|NCT01807065|519974598|FG000|Overall Study|Receive no sip-T due to IV access|1|||
144213250|NCT01807065|519974599|FG001|Overall Study|Receive no sip-T due to IV access|1|||
144213251|NCT01699815|519974601|FG000|Overall Study|Protocol Violation|4|||
144213252|NCT01699815|519974602|FG001|Overall Study|Protocol Violation|7|||
144213253|NCT01699815|519974601|FG000|Overall Study|record could not be located|1|||
144213254|NCT01699815|519974602|FG001|Overall Study|record could not be located|0|||
144213255|NCT01699815|519974601|FG000|Overall Study|Adverse Event|0|||
144213256|NCT01699815|519974602|FG001|Overall Study|Adverse Event|1|||
144213257|NCT01295320|519974603|FG000|Overall Study|Adverse Event|2|||
144213258|NCT01295320|519974603|FG000|Overall Study|Lost to Follow-up|4|||
144213259|NCT01295320|519974603|FG000|Overall Study|Withdrawal by Subject|2|||
144213260|NCT01295320|519974603|FG000|Overall Study|Subject was bedridden|1|||
144653120|NCT03625986|521583583|FG001|Randomization Period|Lost to Follow-up|12|||
144213261|NCT01295320|519974603|FG000|Overall Study|Unable to travel|1|||
144213262|NCT05124691|519974604|FG000|Phase II|Eligibility criteria|0|||
144213263|NCT05124691|519974605|FG001|Phase II|Eligibility criteria|1|||
144213264|NCT05124691|519974606|FG002|Phase II|Eligibility criteria|0|||
144213265|NCT05124691|519974604|FG000|Phase II|Withdrawal by Subject|6|||
144213266|NCT05124691|519974605|FG001|Phase II|Withdrawal by Subject|2|||
144213267|NCT05124691|519974606|FG002|Phase II|Withdrawal by Subject|3|||
144213268|NCT05124691|519974604|FG000|Phase III|Withdrawal by Subject|6|||
144213269|NCT05124691|519974605|FG001|Phase III|Withdrawal by Subject|4|||
144213270|NCT05124691|519974606|FG002|Phase III|Withdrawal by Subject|4|||
144213271|NCT05124691|519974604|FG000|Phase III|Lost to Follow-up|1|||
144213272|NCT05124691|519974605|FG001|Phase III|Lost to Follow-up|0|||
144213273|NCT05124691|519974606|FG002|Phase III|Lost to Follow-up|0|||
144213274|NCT03509467|519974607|FG000|Overall Study|Withdrawal by Subject|5|||
144213275|NCT03509467|519974608|FG001|Overall Study|Withdrawal by Subject|1|||
144213276|NCT03509467|519974609|FG002|Overall Study|Withdrawal by Subject|6|||
144213277|NCT03509467|519974610|FG003|Overall Study|Withdrawal by Subject|7|||
144213278|NCT03509467|519974611|FG004|Overall Study|Withdrawal by Subject|10|||
144213279|NCT03509467|519974612|FG005|Overall Study|Withdrawal by Subject|10|||
144213280|NCT03509467|519974613|FG006|Overall Study|Withdrawal by Subject|10|||
144213281|NCT03509467|519974614|FG007|Overall Study|Withdrawal by Subject|10|||
144213282|NCT03509467|519974607|FG000|Overall Study|Death|0|||
144213283|NCT03509467|519974608|FG001|Overall Study|Death|0|||
144213284|NCT03509467|519974609|FG002|Overall Study|Death|2|||
144213285|NCT03509467|519974610|FG003|Overall Study|Death|2|||
144213286|NCT03509467|519974611|FG004|Overall Study|Death|1|||
144213287|NCT03509467|519974612|FG005|Overall Study|Death|0|||
144213288|NCT03509467|519974613|FG006|Overall Study|Death|1|||
144213289|NCT03509467|519974614|FG007|Overall Study|Death|0|||
144213290|NCT03509467|519974607|FG000|Overall Study|Proxy Withdrawal|0|||
144213291|NCT03509467|519974608|FG001|Overall Study|Proxy Withdrawal|0|||
144213292|NCT03509467|519974609|FG002|Overall Study|Proxy Withdrawal|0|||
144213293|NCT03509467|519974610|FG003|Overall Study|Proxy Withdrawal|0|||
144263930|NCT01435759|520167576|FG000|Double-blind Phase|Withdrawal by Subject|17|||
144263931|NCT01435759|520167577|FG001|Double-blind Phase|Withdrawal by Subject|4|||
144263932|NCT01435759|520167578|FG002|Double-blind Phase|Withdrawal by Subject|3|||
144263933|NCT01435759|520167579|FG003|Double-blind Phase|Withdrawal by Subject|4|||
144653121|NCT03625986|521583582|FG000|Randomization Period|Withdrawal by Subject|10|||
144653122|NCT03625986|521583583|FG001|Randomization Period|Withdrawal by Subject|6|||
144653123|NCT02410902|521583589|FG000|Overall Study|Adverse Event|2|||
144653124|NCT02410902|521583590|FG001|Overall Study|Adverse Event|3|||
144653125|NCT02410902|521583589|FG000|Overall Study|Lost to Follow-up|4|||
144653126|NCT02410902|521583590|FG001|Overall Study|Lost to Follow-up|1|||
144653127|NCT02410902|521583589|FG000|Overall Study|Protocol Violation|1|||
144653128|NCT02410902|521583590|FG001|Overall Study|Protocol Violation|4|||
144653129|NCT02410902|521583589|FG000|Overall Study|Withdrawal by Subject|6|||
144653130|NCT02410902|521583590|FG001|Overall Study|Withdrawal by Subject|8|||
144653131|NCT02410902|521583589|FG000|Overall Study|Non-Compliance|8|||
144653132|NCT02410902|521583590|FG001|Overall Study|Non-Compliance|2|||
144653133|NCT00953043|521583591|FG000|Overall Study|Withdrawal by Subject|4|||
144653134|NCT00953043|521583592|FG001|Overall Study|Withdrawal by Subject|0|||
144653135|NCT00953043|521583591|FG000|Overall Study|Physician Decision|0|||
144653136|NCT00953043|521583592|FG001|Overall Study|Physician Decision|2|||
144653137|NCT00747617|521583594|FG000|Overall Study|Lost to Follow-up|3|||
144653138|NCT00747617|521583595|FG001|Overall Study|Lost to Follow-up|1|||
144653139|NCT02279524|521583596|FG000|Overall Study|Withdrawal by Subject|3|||
144653140|NCT02279524|521583597|FG001|Overall Study|Withdrawal by Subject|6|||
144653141|NCT02279524|521583598|FG002|Overall Study|Withdrawal by Subject|3|||
144653142|NCT02279524|521583596|FG000|Overall Study|Adverse Event|4|||
144653143|NCT02279524|521583597|FG001|Overall Study|Adverse Event|3|||
144653144|NCT02279524|521583598|FG002|Overall Study|Adverse Event|2|||
144653145|NCT02279524|521583596|FG000|Overall Study|Lost to Follow-up|1|||
144653146|NCT02279524|521583597|FG001|Overall Study|Lost to Follow-up|1|||
144653147|NCT02279524|521583598|FG002|Overall Study|Lost to Follow-up|0|||
144653148|NCT02279524|521583596|FG000|Overall Study|Disallowed medication|1|||
144653149|NCT02279524|521583597|FG001|Overall Study|Disallowed medication|1|||
144653150|NCT02279524|521583598|FG002|Overall Study|Disallowed medication|2|||
144213294|NCT03509467|519974611|FG004|Overall Study|Proxy Withdrawal|0|||
144213295|NCT03509467|519974612|FG005|Overall Study|Proxy Withdrawal|0|||
144213296|NCT03509467|519974613|FG006|Overall Study|Proxy Withdrawal|0|||
144213297|NCT03509467|519974614|FG007|Overall Study|Proxy Withdrawal|1|||
144263934|NCT01435759|520167580|FG004|Double-blind Phase|Withdrawal by Subject|2|||
144653151|NCT02279524|521583596|FG000|Overall Study|Bariatric surgery|1|||
144653152|NCT02279524|521583597|FG001|Overall Study|Bariatric surgery|0|||
144653153|NCT02279524|521583598|FG002|Overall Study|Bariatric surgery|0|||
144732103|NCT00910663|521875747|FG001|Period 1|Withdrawal by Subject|1|||
144213298|NCT00428116|519974615|FG000|Overall Study|Death|1|||
144213299|NCT00428116|519974616|FG001|Overall Study|Death|0|||
144213300|NCT00428116|519974615|FG000|Overall Study|Withdrawal by Subject|1|||
144263935|NCT01435759|520167581|FG005|Double-blind Phase|Withdrawal by Subject|2|||
144653154|NCT01746732|521583599|FG000|Lead-In Period|Withdrawal by Subject|1|||
144653155|NCT01746732|521583600|FG001|Lead-In Period|Withdrawal by Subject|0|||
144653156|NCT01746732|521583601|FG002|Lead-In Period|Withdrawal by Subject|0|||
144653157|NCT01746732|521583599|FG000|Period 1|Physician Decision|0|||
144653158|NCT01746732|521583600|FG001|Period 1|Physician Decision|1|||
144653159|NCT01746732|521583601|FG002|Period 1|Physician Decision|0|||
144213301|NCT00428116|519974616|FG001|Overall Study|Withdrawal by Subject|0|||
144213302|NCT00428116|519974615|FG000|Overall Study|Lost to Follow-up|1|||
144213303|NCT00428116|519974616|FG001|Overall Study|Lost to Follow-up|0|||
144213304|NCT02125877|519974617|FG000|Overall Study|Physician Decision|1|||
144213305|NCT02125877|519974618|FG001|Overall Study|Physician Decision|0|||
144213306|NCT02125877|519974617|FG000|Overall Study|Death|0|||
144213307|NCT02125877|519974618|FG001|Overall Study|Death|1|||
144653160|NCT01746732|521583599|FG000|Period 2|Withdrawal by Subject|0|||
144213308|NCT02125877|519974617|FG000|Overall Study|Administrative problems|0|||
144213309|NCT02125877|519974618|FG001|Overall Study|Administrative problems|1|||
144213310|NCT02125877|519974617|FG000|Overall Study|Participant/guardian decision|0|||
144213311|NCT02125877|519974618|FG001|Overall Study|Participant/guardian decision|2|||
144213312|NCT02125877|519974617|FG000|Overall Study|Withdrawal by Subject|2|||
144213313|NCT02125877|519974618|FG001|Overall Study|Withdrawal by Subject|1|||
144213314|NCT02125877|519974617|FG000|Overall Study|Protocol deviation|4|||
144213315|NCT02125877|519974618|FG001|Overall Study|Protocol deviation|1|||
144213316|NCT02125877|519974617|FG000|Overall Study|Adverse Event|6|||
144213317|NCT02125877|519974618|FG001|Overall Study|Adverse Event|4|||
144213318|NCT01141205|519974619|FG000|Overall Study|Physician Decision|1|||
144213319|NCT01141205|519974620|FG001|Overall Study|Physician Decision|1|||
144213320|NCT01141205|519974619|FG000|Overall Study|Lost to Follow-up|1|||
144213321|NCT01141205|519974620|FG001|Overall Study|Lost to Follow-up|0|||
144213322|NCT01141205|519974619|FG000|Overall Study|Withdrawal by Subject|1|||
144213323|NCT01141205|519974620|FG001|Overall Study|Withdrawal by Subject|1|||
144213324|NCT02800642|519974621|FG000|Overall Study|Death|3|||
144213325|NCT02800642|519974621|FG000|Overall Study|Other|10|||
144213326|NCT02800642|519974621|FG000|Overall Study|Physician Decision|2|||
144213327|NCT02800642|519974621|FG000|Overall Study|Adverse Event|6|||
144213328|NCT02800642|519974621|FG000|Overall Study|Withdrawal by Subject|3|||
144213329|NCT02800642|519974621|FG000|Overall Study|Lost to Follow-up|1|||
144213330|NCT02374346|519974622|FG000|Overall Study|operated or discharged during weekend|48|||
144213331|NCT01941498|519974625|FG000|Overall Study|Relocated out of state|1|||
144213332|NCT00396565|519974630|FG000|Overall Study|Physician Decision|3|||
144213333|NCT00396565|519974631|FG001|Overall Study|Physician Decision|1|||
144213334|NCT00396565|519974632|FG002|Overall Study|Physician Decision|2|||
144213335|NCT00396565|519974630|FG000|Overall Study|Adverse Event|5|||
144213336|NCT00396565|519974631|FG001|Overall Study|Adverse Event|13|||
144213337|NCT00396565|519974632|FG002|Overall Study|Adverse Event|3|||
144213338|NCT00396565|519974630|FG000|Overall Study|Withdrawal by Subject|8|||
144213339|NCT00396565|519974631|FG001|Overall Study|Withdrawal by Subject|13|||
144213340|NCT00396565|519974632|FG002|Overall Study|Withdrawal by Subject|1|||
144213341|NCT00396565|519974630|FG000|Overall Study|Lack of Efficacy|32|||
144213342|NCT00396565|519974631|FG001|Overall Study|Lack of Efficacy|64|||
144213343|NCT00396565|519974632|FG002|Overall Study|Lack of Efficacy|11|||
144213344|NCT04487067|519974635|FG000|Overall Study|Adverse Event|3|||
144213345|NCT04487067|519974635|FG000|Overall Study|Death Other Than Progressive Disease|60|||
144213346|NCT04487067|519974635|FG000|Overall Study|Death Due To Progressive Disease|40|||
144213347|NCT04487067|519974635|FG000|Overall Study|Lost to Follow-up|3|||
144213348|NCT04487067|519974635|FG000|Overall Study|Progressive Disease|1|||
144213349|NCT04487067|519974635|FG000|Overall Study|Protocol Violation|3|||
144213350|NCT04487067|519974635|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
144213351|NCT04487067|519974635|FG000|Overall Study|Withdrawal by Subject|15|||
144213352|NCT05299528|519974636|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
144653161|NCT01746732|521583600|FG001|Period 2|Withdrawal by Subject|0|||
144653162|NCT01746732|521583601|FG002|Period 2|Withdrawal by Subject|2|||
144653163|NCT01746732|521583599|FG000|Period 2|Adverse Event|0|||
144213353|NCT05299528|519974637|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
144213354|NCT05299528|519974638|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
144213355|NCT05299528|519974639|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
144213356|NCT05299528|519974640|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
144213357|NCT05299528|519974641|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
144213358|NCT05299528|519974642|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
144213359|NCT05299528|519974636|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
144213360|NCT05299528|519974637|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
144263936|NCT01435759|520167576|FG000|Double-blind Phase|Lost to Follow-up|31|||
144653164|NCT01746732|521583600|FG001|Period 2|Adverse Event|0|||
144653165|NCT01746732|521583601|FG002|Period 2|Adverse Event|1|||
144653166|NCT01746732|521583599|FG000|Period 2|Lost to Follow-up|0|||
144213361|NCT05299528|519974638|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
144213362|NCT05299528|519974639|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
144213363|NCT05299528|519974640|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
144213364|NCT05299528|519974641|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
144213365|NCT05299528|519974642|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
144213366|NCT05299528|519974636|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
144213367|NCT05299528|519974637|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
144213368|NCT05299528|519974638|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
144213369|NCT05299528|519974639|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
144213370|NCT05299528|519974640|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
144213371|NCT05299528|519974641|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
144213372|NCT05299528|519974642|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
144213373|NCT01885195|519974643|FG000|Overall Study|Adverse Event|29|||
144213374|NCT01885195|519974643|FG000|Overall Study|Death|1|||
144213375|NCT01885195|519974643|FG000|Overall Study|Disease Progression|67|||
144213376|NCT01885195|519974643|FG000|Overall Study|Protocol Deviation|2|||
144213377|NCT01885195|519974643|FG000|Overall Study|Physician Decision|3|||
144213378|NCT01885195|519974643|FG000|Overall Study|Patient/guardian decision|8|||
144213379|NCT03390426|519974644|FG000|Overall Study|Protocol Violation|0|||
144213380|NCT03390426|519974645|FG001|Overall Study|Protocol Violation|1|||
144213381|NCT02521376|519974655|FG000|Overall Study|Enrolled, But Not Treated|1|||
144213382|NCT02521376|519974656|FG001|Overall Study|Enrolled, But Not Treated|0|||
144213383|NCT02521376|519974657|FG002|Overall Study|Enrolled, But Not Treated|0|||
144213384|NCT02521376|519974658|FG003|Overall Study|Enrolled, But Not Treated|0|||
144213385|NCT00143247|519974659|FG000|Overall Study|Death|8|||
144213386|NCT00143247|519974659|FG000|Overall Study|Adverse Event|19|||
144213387|NCT00143247|519974659|FG000|Overall Study|Lack of Efficacy|3|||
144213388|NCT00143247|519974659|FG000|Overall Study|Withdrawal by Subject|55|||
144213389|NCT00143247|519974659|FG000|Overall Study|Study terminated by sponsor|31|||
144213390|NCT00143247|519974659|FG000|Overall Study|Protocol Violation|15|||
144213391|NCT00143247|519974659|FG000|Overall Study|Lost to Follow-up|12|||
144213392|NCT00143247|519974659|FG000|Overall Study|following inaccurate lab adverse event|1|||
144213393|NCT00143247|519974659|FG000|Overall Study|Other|12|||
144213394|NCT02933255|519974662|FG000|Overall Study|Discontinued due to study closure.|1|||
144213395|NCT02933255|519974663|FG001|Overall Study|Discontinued due to study closure.|0|||
144213396|NCT02766283|519974664|FG000|Overall Study|Lost to Follow-up|27|||
144213397|NCT03207867|519974671|FG000|Overall Study|Adverse Event|1|||
144213398|NCT03207867|519974672|FG001|Overall Study|Adverse Event|0|||
144213399|NCT03207867|519974673|FG002|Overall Study|Adverse Event|1|||
144213400|NCT03207867|519974674|FG003|Overall Study|Adverse Event|0|||
144213401|NCT03207867|519974675|FG004|Overall Study|Adverse Event|0|||
144213402|NCT03207867|519974676|FG005|Overall Study|Adverse Event|2|||
144213403|NCT03207867|519974677|FG006|Overall Study|Adverse Event|1|||
144213404|NCT03207867|519974678|FG007|Overall Study|Adverse Event|1|||
144213405|NCT03207867|519974679|FG008|Overall Study|Adverse Event|2|||
144213406|NCT03207867|519974680|FG009|Overall Study|Adverse Event|2|||
144213407|NCT03207867|519974681|FG010|Overall Study|Adverse Event|0|||
144213408|NCT03207867|519974682|FG011|Overall Study|Adverse Event|0|||
144213409|NCT03207867|519974683|FG012|Overall Study|Adverse Event|0|||
144213410|NCT03207867|519974684|FG013|Overall Study|Adverse Event|0|||
144213411|NCT03207867|519974685|FG014|Overall Study|Adverse Event|0|||
144213412|NCT03207867|519974686|FG015|Overall Study|Adverse Event|0|||
144653167|NCT01746732|521583600|FG001|Period 2|Lost to Follow-up|0|||
144653168|NCT01746732|521583601|FG002|Period 2|Lost to Follow-up|1|||
144653169|NCT03509207|521583602|FG000|Overall Study|Death|2|||
144653170|NCT02817555|521583603|FG000|Overall Study|Death|1|||
144653171|NCT02817555|521583604|FG001|Overall Study|Death|3|||
144653172|NCT02817555|521583603|FG000|Overall Study|moved away|1|||
144653173|NCT02817555|521583604|FG001|Overall Study|moved away|0|||
144653174|NCT02817555|521583603|FG000|Overall Study|transplant|1|||
144653175|NCT02817555|521583604|FG001|Overall Study|transplant|1|||
144213413|NCT03207867|519974687|FG016|Overall Study|Adverse Event|3|||
144213414|NCT03207867|519974688|FG017|Overall Study|Adverse Event|1|||
144213415|NCT03207867|519974689|FG018|Overall Study|Adverse Event|2|||
144213416|NCT03207867|519974690|FG019|Overall Study|Adverse Event|1|||
144213417|NCT03207867|519974691|FG020|Overall Study|Adverse Event|0|||
144213418|NCT03207867|519974692|FG021|Overall Study|Adverse Event|0|||
144213419|NCT03207867|519974693|FG022|Overall Study|Adverse Event|0|||
144653176|NCT02817555|521583603|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
144213420|NCT03207867|519974694|FG023|Overall Study|Adverse Event|0|||
144213421|NCT03207867|519974671|FG000|Overall Study|Death|0|||
144213422|NCT03207867|519974672|FG001|Overall Study|Death|0|||
144213423|NCT03207867|519974673|FG002|Overall Study|Death|0|||
144213424|NCT03207867|519974674|FG003|Overall Study|Death|0|||
144213425|NCT03207867|519974675|FG004|Overall Study|Death|0|||
144213426|NCT03207867|519974676|FG005|Overall Study|Death|1|||
144653177|NCT02817555|521583604|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
144213427|NCT03207867|519974677|FG006|Overall Study|Death|0|||
144653178|NCT01043185|521583605|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
144653179|NCT01043185|521583606|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
144653180|NCT01043185|521583607|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
144653181|NCT01043185|521583608|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
144653182|NCT01043185|521583609|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
144213428|NCT03207867|519974678|FG007|Overall Study|Death|3|||
144213429|NCT03207867|519974679|FG008|Overall Study|Death|1|||
144213430|NCT03207867|519974680|FG009|Overall Study|Death|2|||
144213431|NCT03207867|519974681|FG010|Overall Study|Death|0|||
144213432|NCT03207867|519974682|FG011|Overall Study|Death|1|||
144213433|NCT03207867|519974683|FG012|Overall Study|Death|0|||
144213434|NCT03207867|519974684|FG013|Overall Study|Death|1|||
144213435|NCT03207867|519974685|FG014|Overall Study|Death|0|||
144213436|NCT03207867|519974686|FG015|Overall Study|Death|0|||
144213437|NCT03207867|519974687|FG016|Overall Study|Death|0|||
144213438|NCT03207867|519974688|FG017|Overall Study|Death|2|||
144213439|NCT03207867|519974689|FG018|Overall Study|Death|0|||
144213440|NCT03207867|519974690|FG019|Overall Study|Death|1|||
144213441|NCT03207867|519974691|FG020|Overall Study|Death|0|||
144213442|NCT03207867|519974692|FG021|Overall Study|Death|0|||
144213443|NCT03207867|519974693|FG022|Overall Study|Death|0|||
144213444|NCT03207867|519974694|FG023|Overall Study|Death|0|||
144213445|NCT03207867|519974671|FG000|Overall Study|Physician Decision|3|||
144213446|NCT03207867|519974672|FG001|Overall Study|Physician Decision|5|||
144213447|NCT03207867|519974673|FG002|Overall Study|Physician Decision|0|||
144213448|NCT03207867|519974674|FG003|Overall Study|Physician Decision|3|||
144213449|NCT03207867|519974675|FG004|Overall Study|Physician Decision|2|||
144213450|NCT03207867|519974676|FG005|Overall Study|Physician Decision|0|||
144213451|NCT03207867|519974677|FG006|Overall Study|Physician Decision|0|||
144213452|NCT03207867|519974678|FG007|Overall Study|Physician Decision|0|||
144213453|NCT03207867|519974679|FG008|Overall Study|Physician Decision|4|||
144213454|NCT03207867|519974680|FG009|Overall Study|Physician Decision|2|||
144213455|NCT03207867|519974681|FG010|Overall Study|Physician Decision|0|||
144213456|NCT03207867|519974682|FG011|Overall Study|Physician Decision|4|||
144213457|NCT03207867|519974683|FG012|Overall Study|Physician Decision|0|||
144213458|NCT03207867|519974684|FG013|Overall Study|Physician Decision|0|||
144213459|NCT03207867|519974685|FG014|Overall Study|Physician Decision|2|||
144213460|NCT03207867|519974686|FG015|Overall Study|Physician Decision|1|||
144213461|NCT03207867|519974687|FG016|Overall Study|Physician Decision|1|||
144213462|NCT03207867|519974688|FG017|Overall Study|Physician Decision|2|||
144213463|NCT03207867|519974689|FG018|Overall Study|Physician Decision|1|||
144653183|NCT01043185|521583610|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
144653184|NCT01043185|521583611|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
144653185|NCT01043185|521583612|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
144653186|NCT01043185|521583613|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
144653187|NCT01043185|521583614|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
144653188|NCT00137436|521583615|FG000|Overall Study|Adverse Event|13|||
144653189|NCT00137436|521583615|FG000|Overall Study|Death|2|||
144653190|NCT00137436|521583615|FG000|Overall Study|Lack of Efficacy|17|||
144653191|NCT00137436|521583615|FG000|Overall Study|Withdrawal by Subject|6|||
144653192|NCT00137436|521583615|FG000|Overall Study|Other|5|||
144653193|NCT00165646|521583616|FG000|Overall Study|Adverse Event|1|||
144653194|NCT00165646|521583617|FG001|Overall Study|Adverse Event|1|||
144653195|NCT00165646|521583618|FG002|Overall Study|Adverse Event|1|||
144653196|NCT00165646|521583616|FG000|Overall Study|Lack of Efficacy|1|||
144653197|NCT00165646|521583617|FG001|Overall Study|Lack of Efficacy|2|||
144653198|NCT00165646|521583618|FG002|Overall Study|Lack of Efficacy|0|||
144653199|NCT00165646|521583616|FG000|Overall Study|Withdrawal by Subject|0|||
144653200|NCT00165646|521583617|FG001|Overall Study|Withdrawal by Subject|2|||
144653201|NCT00165646|521583618|FG002|Overall Study|Withdrawal by Subject|1|||
144653202|NCT00165646|521583616|FG000|Overall Study|Physician Decision|2|||
144653203|NCT00165646|521583617|FG001|Overall Study|Physician Decision|0|||
144653204|NCT00165646|521583618|FG002|Overall Study|Physician Decision|2|||
144653205|NCT00165646|521583616|FG000|Overall Study|Protocol Violation|1|||
144653206|NCT00165646|521583617|FG001|Overall Study|Protocol Violation|0|||
144653207|NCT00165646|521583618|FG002|Overall Study|Protocol Violation|0|||
144653208|NCT04657016|521583619|FG000|Overall Study|Adverse Event|2|||
144653209|NCT04657016|521583620|FG001|Overall Study|Adverse Event|4|||
144213464|NCT03207867|519974690|FG019|Overall Study|Physician Decision|3|||
144213465|NCT03207867|519974691|FG020|Overall Study|Physician Decision|0|||
144213466|NCT03207867|519974692|FG021|Overall Study|Physician Decision|0|||
144213467|NCT03207867|519974693|FG022|Overall Study|Physician Decision|0|||
144213468|NCT03207867|519974694|FG023|Overall Study|Physician Decision|0|||
144213469|NCT03207867|519974671|FG000|Overall Study|Progressive Disease|7|||
144213470|NCT03207867|519974672|FG001|Overall Study|Progressive Disease|7|||
144213471|NCT03207867|519974673|FG002|Overall Study|Progressive Disease|9|||
144213472|NCT03207867|519974674|FG003|Overall Study|Progressive Disease|10|||
144213473|NCT03207867|519974675|FG004|Overall Study|Progressive Disease|11|||
144213474|NCT03207867|519974676|FG005|Overall Study|Progressive Disease|10|||
144213475|NCT03207867|519974677|FG006|Overall Study|Progressive Disease|9|||
144213476|NCT03207867|519974678|FG007|Overall Study|Progressive Disease|8|||
144213477|NCT03207867|519974679|FG008|Overall Study|Progressive Disease|19|||
144213478|NCT03207867|519974680|FG009|Overall Study|Progressive Disease|23|||
144213479|NCT03207867|519974681|FG010|Overall Study|Progressive Disease|2|||
144213480|NCT03207867|519974682|FG011|Overall Study|Progressive Disease|24|||
144213481|NCT03207867|519974683|FG012|Overall Study|Progressive Disease|3|||
144213482|NCT03207867|519974684|FG013|Overall Study|Progressive Disease|11|||
144213483|NCT03207867|519974685|FG014|Overall Study|Progressive Disease|9|||
144213484|NCT03207867|519974686|FG015|Overall Study|Progressive Disease|5|||
144213485|NCT03207867|519974687|FG016|Overall Study|Progressive Disease|10|||
144213486|NCT03207867|519974688|FG017|Overall Study|Progressive Disease|14|||
144213487|NCT03207867|519974689|FG018|Overall Study|Progressive Disease|13|||
144213488|NCT03207867|519974690|FG019|Overall Study|Progressive Disease|14|||
144213489|NCT03207867|519974691|FG020|Overall Study|Progressive Disease|6|||
144213490|NCT03207867|519974692|FG021|Overall Study|Progressive Disease|3|||
144213491|NCT03207867|519974693|FG022|Overall Study|Progressive Disease|3|||
144213492|NCT03207867|519974694|FG023|Overall Study|Progressive Disease|3|||
144213493|NCT03207867|519974671|FG000|Overall Study|Patient/guardian Decision|0|||
144213494|NCT03207867|519974672|FG001|Overall Study|Patient/guardian Decision|0|||
144213495|NCT03207867|519974673|FG002|Overall Study|Patient/guardian Decision|1|||
144213496|NCT03207867|519974674|FG003|Overall Study|Patient/guardian Decision|1|||
144213497|NCT03207867|519974675|FG004|Overall Study|Patient/guardian Decision|1|||
144213498|NCT03207867|519974676|FG005|Overall Study|Patient/guardian Decision|2|||
144213499|NCT03207867|519974677|FG006|Overall Study|Patient/guardian Decision|1|||
144213500|NCT03207867|519974678|FG007|Overall Study|Patient/guardian Decision|0|||
144213501|NCT03207867|519974679|FG008|Overall Study|Patient/guardian Decision|1|||
144213502|NCT03207867|519974680|FG009|Overall Study|Patient/guardian Decision|0|||
144213503|NCT03207867|519974681|FG010|Overall Study|Patient/guardian Decision|0|||
144213504|NCT03207867|519974682|FG011|Overall Study|Patient/guardian Decision|1|||
144263937|NCT01435759|520167577|FG001|Double-blind Phase|Lost to Follow-up|1|||
144263938|NCT01435759|520167578|FG002|Double-blind Phase|Lost to Follow-up|2|||
144263939|NCT01435759|520167579|FG003|Double-blind Phase|Lost to Follow-up|0|||
144213505|NCT03207867|519974683|FG012|Overall Study|Patient/guardian Decision|0|||
144263940|NCT01435759|520167580|FG004|Double-blind Phase|Lost to Follow-up|3|||
144653210|NCT04657016|521583619|FG000|Overall Study|Death|1|||
144653211|NCT04657016|521583620|FG001|Overall Study|Death|1|||
144653212|NCT04657016|521583619|FG000|Overall Study|Lost to Follow-up|24|||
144653213|NCT04657016|521583620|FG001|Overall Study|Lost to Follow-up|12|||
144653214|NCT04657016|521583619|FG000|Overall Study|Physician Decision|1|||
144653215|NCT04657016|521583620|FG001|Overall Study|Physician Decision|2|||
144653216|NCT04657016|521583619|FG000|Overall Study|Pregnancy|2|||
144653217|NCT04657016|521583620|FG001|Overall Study|Pregnancy|2|||
144653218|NCT04657016|521583619|FG000|Overall Study|Protocol Deviation|1|||
144653219|NCT04657016|521583620|FG001|Overall Study|Protocol Deviation|0|||
144653220|NCT04657016|521583619|FG000|Overall Study|Withdrawal by Subject|28|||
144653221|NCT04657016|521583620|FG001|Overall Study|Withdrawal by Subject|14|||
144653222|NCT04657016|521583619|FG000|Overall Study|Other - as reported by the investigator|6|||
144653223|NCT04657016|521583620|FG001|Overall Study|Other - as reported by the investigator|0|||
144653224|NCT00701727|521583621|FG000|First Treatment Period|Adverse Event|0|||
144653225|NCT00701727|521583622|FG001|First Treatment Period|Adverse Event|0|||
144653226|NCT00701727|521583621|FG000|First Treatment Period|Withdrawal by Subject|1|||
144653227|NCT00701727|521583622|FG001|First Treatment Period|Withdrawal by Subject|0|||
144653228|NCT00701727|521583621|FG000|First Treatment Period|sponsor decision|0|||
144653229|NCT00701727|521583622|FG001|First Treatment Period|sponsor decision|1|||
144653230|NCT00701727|521583621|FG000|First Treatment Period|Lost to Follow-up|0|||
144653231|NCT00701727|521583622|FG001|First Treatment Period|Lost to Follow-up|1|||
144653232|NCT00701727|521583621|FG000|Second Treatment Period|Withdrawal by Subject|2|||
144653233|NCT00701727|521583622|FG001|Second Treatment Period|Withdrawal by Subject|0|||
144653234|NCT00523341|521583625|FG000|Overall Study|Withdrawal by Subject|399|||
144653235|NCT00523341|521583626|FG001|Overall Study|Withdrawal by Subject|427|||
144653236|NCT00523341|521583625|FG000|Overall Study|Other|181|||
144653237|NCT00523341|521583626|FG001|Overall Study|Other|198|||
144653238|NCT00523341|521583625|FG000|Overall Study|Adverse Event|122|||
144653239|NCT00523341|521583626|FG001|Overall Study|Adverse Event|155|||
144653240|NCT00523341|521583625|FG000|Overall Study|Death|101|||
144653241|NCT00523341|521583626|FG001|Overall Study|Death|110|||
144213506|NCT03207867|519974684|FG013|Overall Study|Patient/guardian Decision|1|||
144213507|NCT03207867|519974685|FG014|Overall Study|Patient/guardian Decision|2|||
144653242|NCT00523341|521583625|FG000|Overall Study|Lost to Follow-up|73|||
144213508|NCT03207867|519974686|FG015|Overall Study|Patient/guardian Decision|0|||
144213509|NCT03207867|519974687|FG016|Overall Study|Patient/guardian Decision|1|||
144213510|NCT03207867|519974688|FG017|Overall Study|Patient/guardian Decision|3|||
144653243|NCT00523341|521583626|FG001|Overall Study|Lost to Follow-up|61|||
144653244|NCT00523341|521583625|FG000|Overall Study|Non-compliance|20|||
144213511|NCT03207867|519974689|FG018|Overall Study|Patient/guardian Decision|4|||
144213512|NCT03207867|519974690|FG019|Overall Study|Patient/guardian Decision|1|||
144263941|NCT01435759|520167581|FG005|Double-blind Phase|Lost to Follow-up|3|||
144653245|NCT00523341|521583626|FG001|Overall Study|Non-compliance|13|||
144732104|NCT02726581|521875748|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
144732105|NCT02726581|521875749|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
144732106|NCT02726581|521875750|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
144732107|NCT02726581|521875748|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
144732108|NCT02726581|521875749|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
144732109|NCT02726581|521875750|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
144732110|NCT02726581|521875748|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144732111|NCT02726581|521875749|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144732112|NCT02726581|521875750|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144732113|NCT02726581|521875748|FG000|Treatment Period|Disease progression|47|||
144732114|NCT02726581|521875749|FG001|Treatment Period|Disease progression|50|||
144732115|NCT02726581|521875750|FG002|Treatment Period|Disease progression|16|||
144732116|NCT02726581|521875748|FG000|Treatment Period|Other reasons|9|||
144732117|NCT02726581|521875749|FG001|Treatment Period|Other reasons|8|||
144732118|NCT02726581|521875750|FG002|Treatment Period|Other reasons|2|||
144732119|NCT02726581|521875748|FG000|Treatment Period|Study drug toxicity|6|||
144732120|NCT02726581|521875749|FG001|Treatment Period|Study drug toxicity|3|||
144732121|NCT02726581|521875750|FG002|Treatment Period|Study drug toxicity|2|||
144732122|NCT02726581|521875748|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
144732123|NCT02726581|521875749|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
144732124|NCT02726581|521875750|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
144732125|NCT02726581|521875748|FG000|Treatment Period|Participant withdrew consent|3|||
144732126|NCT02726581|521875749|FG001|Treatment Period|Participant withdrew consent|1|||
144732127|NCT02726581|521875750|FG002|Treatment Period|Participant withdrew consent|1|||
144732128|NCT02726581|521875748|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
144732129|NCT02726581|521875749|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
144732130|NCT02726581|521875750|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
144732131|NCT02726581|521875748|FG000|Treatment Period|Maximum clinical benefit|0|||
144732132|NCT02726581|521875749|FG001|Treatment Period|Maximum clinical benefit|2|||
144732133|NCT02726581|521875750|FG002|Treatment Period|Maximum clinical benefit|0|||
144732134|NCT02726581|521875748|FG000|Treatment Period|Death|1|||
144732135|NCT02726581|521875749|FG001|Treatment Period|Death|0|||
144732136|NCT02726581|521875750|FG002|Treatment Period|Death|0|||
144732137|NCT02726581|521875748|FG000|Treatment Period|Poor/non-compliance|1|||
144732138|NCT02726581|521875749|FG001|Treatment Period|Poor/non-compliance|0|||
144732139|NCT02726581|521875750|FG002|Treatment Period|Poor/non-compliance|0|||
144732140|NCT02726581|521875748|FG000|Treatment Period|Participant no longer meets study criteria|0|||
144732141|NCT02726581|521875749|FG001|Treatment Period|Participant no longer meets study criteria|1|||
144732142|NCT02726581|521875750|FG002|Treatment Period|Participant no longer meets study criteria|0|||
144732143|NCT02865850|521875751|FG000|Overall Study|Death|15|||
144732144|NCT02865850|521875752|FG001|Overall Study|Death|19|||
144732145|NCT02865850|521875751|FG000|Overall Study|Withdrawal by Subject|3|||
144732146|NCT02865850|521875752|FG001|Overall Study|Withdrawal by Subject|2|||
144732147|NCT02865850|521875751|FG000|Overall Study|Lost to Follow-up|3|||
144732148|NCT02865850|521875752|FG001|Overall Study|Lost to Follow-up|2|||
144732149|NCT01844375|521875756|FG000|Overall Study|Protocol Violation|1|||
144732150|NCT01844375|521875757|FG001|Overall Study|Protocol Violation|1|||
144732151|NCT01536574|521875759|FG000|Overall Study|Adverse Event|4|||
144732152|NCT01536574|521875760|FG001|Overall Study|Adverse Event|5|||
144732153|NCT01536574|521875759|FG000|Overall Study|Withdrawal by Subject|1|||
144732154|NCT01536574|521875760|FG001|Overall Study|Withdrawal by Subject|2|||
144213513|NCT03207867|519974691|FG020|Overall Study|Patient/guardian Decision|0|||
144213514|NCT03207867|519974692|FG021|Overall Study|Patient/guardian Decision|0|||
144213515|NCT03207867|519974693|FG022|Overall Study|Patient/guardian Decision|0|||
144213516|NCT03207867|519974694|FG023|Overall Study|Patient/guardian Decision|0|||
144213517|NCT03922529|519976832|FG000|Overall Study|Withdrawal by Subject|13|||
144213518|NCT03922529|519976833|FG001|Overall Study|Withdrawal by Subject|12|||
144213519|NCT03922529|519976832|FG000|Overall Study|Death|7|||
144213520|NCT03922529|519976833|FG001|Overall Study|Death|12|||
144213521|NCT03922529|519976832|FG000|Overall Study|Lost to Follow-up|12|||
144213522|NCT03922529|519976833|FG001|Overall Study|Lost to Follow-up|19|||
144263942|NCT01435759|520167576|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
144732155|NCT01536574|521875759|FG000|Overall Study|Lack of Efficacy|1|||
144732156|NCT01536574|521875760|FG001|Overall Study|Lack of Efficacy|0|||
144732157|NCT01376167|521875761|FG000|Overall Study|Lost to Follow-up|2|||
144732158|NCT01376167|521875762|FG001|Overall Study|Lost to Follow-up|4|||
144732159|NCT01376167|521875763|FG002|Overall Study|Lost to Follow-up|2|||
144213523|NCT03922529|519976832|FG000|Overall Study|Adverse Event|1|||
144213524|NCT03922529|519976833|FG001|Overall Study|Adverse Event|0|||
144213525|NCT03922529|519976832|FG000|Overall Study|Death after withdrawal|1|||
144732160|NCT01376167|521875761|FG000|Overall Study|Physician Decision|1|||
144732161|NCT01376167|521875762|FG001|Overall Study|Physician Decision|1|||
144732162|NCT01376167|521875763|FG002|Overall Study|Physician Decision|0|||
144263943|NCT01435759|520167577|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263944|NCT01435759|520167578|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263945|NCT01435759|520167579|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
144263946|NCT01435759|520167580|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
144263947|NCT01435759|520167581|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
144653246|NCT00523341|521583625|FG000|Overall Study|Physician Decision|14|||
144653247|NCT00523341|521583626|FG001|Overall Study|Physician Decision|13|||
144653248|NCT00523341|521583625|FG000|Overall Study|Requirement for Alternative Therapy|4|||
144653249|NCT00523341|521583626|FG001|Overall Study|Requirement for Alternative Therapy|14|||
144653250|NCT00523341|521583625|FG000|Overall Study|Protocol Deviation|6|||
144653251|NCT00523341|521583626|FG001|Overall Study|Protocol Deviation|5|||
144653252|NCT00523341|521583625|FG000|Overall Study|Ineligibility Determined|3|||
144653253|NCT00523341|521583626|FG001|Overall Study|Ineligibility Determined|4|||
144653254|NCT00523341|521583625|FG000|Overall Study|Disease Progression|1|||
144653255|NCT00523341|521583626|FG001|Overall Study|Disease Progression|0|||
144653256|NCT00912015|521583627|FG000|Overall Study|Lack of Efficacy|1|||
144653257|NCT00912015|521583628|FG001|Overall Study|Lack of Efficacy|0|||
144653258|NCT00912015|521583629|FG002|Overall Study|Lack of Efficacy|0|||
144653259|NCT00912015|521583630|FG003|Overall Study|Lack of Efficacy|0|||
144653260|NCT00912015|521583627|FG000|Overall Study|Withdrawal by Subject|8|||
144653261|NCT00912015|521583628|FG001|Overall Study|Withdrawal by Subject|8|||
144653262|NCT00912015|521583629|FG002|Overall Study|Withdrawal by Subject|3|||
144653263|NCT00912015|521583630|FG003|Overall Study|Withdrawal by Subject|0|||
144653264|NCT00912015|521583627|FG000|Overall Study|Protocol Violation|1|||
144653265|NCT00912015|521583628|FG001|Overall Study|Protocol Violation|0|||
144653266|NCT00912015|521583629|FG002|Overall Study|Protocol Violation|0|||
144653267|NCT00912015|521583630|FG003|Overall Study|Protocol Violation|1|||
144653268|NCT00912015|521583627|FG000|Overall Study|Adverse Event|6|||
144653269|NCT00912015|521583628|FG001|Overall Study|Adverse Event|0|||
144653270|NCT00912015|521583629|FG002|Overall Study|Adverse Event|0|||
144653271|NCT00912015|521583630|FG003|Overall Study|Adverse Event|1|||
144653272|NCT05137041|521583631|FG000|Overall Study|Lost to Follow-up|1|||
144653273|NCT05137041|521583632|FG001|Overall Study|Lost to Follow-up|1|||
144653274|NCT05137041|521583631|FG000|Overall Study|Withdrawal by Subject|0|||
144653275|NCT05137041|521583632|FG001|Overall Study|Withdrawal by Subject|2|||
144653276|NCT05137041|521583631|FG000|Overall Study|Reason not Specified|0|||
144653277|NCT05137041|521583632|FG001|Overall Study|Reason not Specified|1|||
144653278|NCT01356602|521583633|FG000|Overall Study|Protocol Deviation|0|||
144653279|NCT01356602|521583634|FG001|Overall Study|Protocol Deviation|1|||
144653280|NCT01356602|521583635|FG002|Overall Study|Protocol Deviation|1|||
144653281|NCT01356602|521583633|FG000|Overall Study|Administrative Problems|1|||
144653282|NCT01356602|521583634|FG001|Overall Study|Administrative Problems|4|||
144653283|NCT01356602|521583635|FG002|Overall Study|Administrative Problems|5|||
144653284|NCT01356602|521583633|FG000|Overall Study|Lost to Follow-up|4|||
144653285|NCT01356602|521583634|FG001|Overall Study|Lost to Follow-up|5|||
144653286|NCT01356602|521583635|FG002|Overall Study|Lost to Follow-up|6|||
144653287|NCT01356602|521583633|FG000|Overall Study|Withdrawal by Subject|4|||
144653288|NCT01356602|521583634|FG001|Overall Study|Withdrawal by Subject|3|||
144653289|NCT01356602|521583635|FG002|Overall Study|Withdrawal by Subject|7|||
144653290|NCT01356602|521583633|FG000|Overall Study|Lack of Efficacy|0|||
144653291|NCT01356602|521583634|FG001|Overall Study|Lack of Efficacy|1|||
144653292|NCT01356602|521583635|FG002|Overall Study|Lack of Efficacy|4|||
144653293|NCT01356602|521583633|FG000|Overall Study|Adverse Event|0|||
144653294|NCT01356602|521583634|FG001|Overall Study|Adverse Event|1|||
144653295|NCT01356602|521583635|FG002|Overall Study|Adverse Event|1|||
144653296|NCT01605071|521583636|FG000|Overall Study|Withdrawal by Subject|3|||
144653297|NCT01605071|521583637|FG001|Overall Study|Withdrawal by Subject|2|||
144653298|NCT00392171|521583638|FG000|Overall Study|Did not meet inclusion criteria|4|||
144653299|NCT00392171|521583638|FG000|Overall Study|Disease progression|101|||
144653300|NCT03470922|521583640|FG000|Overall Study|Death|107|||
144653301|NCT03470922|521583641|FG001|Overall Study|Death|118|||
144653302|NCT03470922|521583640|FG000|Overall Study|Lost to Follow-up|5|||
144732163|NCT01376167|521875761|FG000|Overall Study|Withdrawal by Subject|1|||
144732164|NCT01376167|521875762|FG001|Overall Study|Withdrawal by Subject|5|||
144263948|NCT01435759|520167576|FG000|Double-blind Phase|Other|8|||
144653303|NCT03470922|521583641|FG001|Overall Study|Lost to Follow-up|5|||
144653304|NCT03470922|521583640|FG000|Overall Study|Participant Withdrew Consent|4|||
144653305|NCT03470922|521583641|FG001|Overall Study|Participant Withdrew Consent|9|||
144653306|NCT03470922|521583640|FG000|Overall Study|Other reasons|1|||
144653307|NCT03470922|521583641|FG001|Overall Study|Other reasons|0|||
144653308|NCT03470922|521583640|FG000|Overall Study|Not reported|1|||
144653309|NCT03470922|521583641|FG001|Overall Study|Not reported|0|||
144653310|NCT02819310|521583642|FG000|Overall Study|Withdrawal by Subject|37|||
144653311|NCT02819310|521583642|FG000|Overall Study|Lost to Follow-up|16|||
144653312|NCT02819310|521583642|FG000|Overall Study|Adverse Event|13|||
144653313|NCT02819310|521583642|FG000|Overall Study|Lack of Efficacy|5|||
144653314|NCT02819310|521583642|FG000|Overall Study|Physician Decision|8|||
144653315|NCT02819310|521583642|FG000|Overall Study|Protocol Violation|30|||
144653316|NCT01993329|521583645|FG000|Period 2|Adverse Event|0|||
144653317|NCT01993329|521583646|FG001|Period 2|Adverse Event|0|||
144213526|NCT03922529|519976833|FG001|Overall Study|Death after withdrawal|0|||
144213527|NCT03922529|519976832|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
144213528|NCT03922529|519976833|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
144213529|NCT03922529|519976832|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
144213530|NCT03922529|519976833|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
144213531|NCT02017015|519976834|FG000|Overall Study|Adverse Event|9|||
144213532|NCT02017015|519976834|FG000|Overall Study|Withdrawal by Subject|21|||
144213533|NCT02017015|519976834|FG000|Overall Study|Death|4|||
144213534|NCT02017015|519976834|FG000|Overall Study|Progressive Disease|31|||
144213535|NCT02017015|519976834|FG000|Overall Study|Non-compliance with study drug|2|||
144213536|NCT02017015|519976834|FG000|Overall Study|Physician Decision|2|||
144213537|NCT04034927|519976837|FG000|Overall Study|Adverse Event|4|||
144213538|NCT04034927|519976838|FG001|Overall Study|Adverse Event|9|||
144213539|NCT04034927|519976837|FG000|Overall Study|Death|0|||
144213540|NCT04034927|519976838|FG001|Overall Study|Death|1|||
144213541|NCT04034927|519976837|FG000|Overall Study|Withdrawal by Subject|0|||
144213542|NCT04034927|519976838|FG001|Overall Study|Withdrawal by Subject|3|||
144213543|NCT04034927|519976837|FG000|Overall Study|Still on Treatment|2|||
144213544|NCT04034927|519976838|FG001|Overall Study|Still on Treatment|1|||
144213545|NCT04034927|519976837|FG000|Overall Study|Other|1|||
144213546|NCT04034927|519976838|FG001|Overall Study|Other|1|||
144213547|NCT02291510|519976839|FG000|Overall Study|Adverse Event|0|||
144213548|NCT02291510|519976840|FG001|Overall Study|Adverse Event|0|||
144213549|NCT02291510|519976841|FG002|Overall Study|Adverse Event|0|||
144213550|NCT02291510|519976842|FG003|Overall Study|Adverse Event|1|||
144213551|NCT03965689|519976845|FG000|Overall Study|Too sick to get study intervention|2|||
144213552|NCT01427608|519976848|FG000|Overall Study|Death|1|||
144213553|NCT01427608|519976849|FG001|Overall Study|Death|0|||
144213554|NCT01427608|519976848|FG000|Overall Study|Withdrawal by Subject|7|||
144213555|NCT01427608|519976849|FG001|Overall Study|Withdrawal by Subject|3|||
144213556|NCT01427608|519976848|FG000|Overall Study|Relapsed-all cause|13|||
144213557|NCT01427608|519976849|FG001|Overall Study|Relapsed-all cause|34|||
144213558|NCT01427608|519976848|FG000|Overall Study|Events not attributed to study meds|0|||
144213559|NCT01427608|519976849|FG001|Overall Study|Events not attributed to study meds|1|||
144213560|NCT04071405|519976850|FG000|Overall Study|Protocol Violation|3|||
144213561|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
144213562|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
144213563|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
144213564|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
144213565|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
144213566|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
144213567|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
144213568|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
144213569|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
144213570|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
144213571|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
144213572|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
144213573|NCT02422797|519976851|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
144213574|NCT02422797|519976852|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
144213575|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
144213576|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
144213577|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
144213578|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
144213579|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
144213580|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
144213581|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
144213582|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
144213583|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
144213584|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
144213585|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
144213586|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
144213587|NCT02422797|519976851|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
144213588|NCT02422797|519976852|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
144213589|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
144213590|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
144213591|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
144213592|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
144653318|NCT01993329|521583647|FG002|Period 2|Adverse Event|0|||
144213593|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
144213594|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
144213595|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
144653319|NCT01993329|521583648|FG003|Period 2|Adverse Event|0|||
144653320|NCT01993329|521583649|FG004|Period 2|Adverse Event|0|||
144653321|NCT01993329|521583650|FG005|Period 2|Adverse Event|1|||
144653322|NCT01993329|521583645|FG000|Wash-out|Personal reasons|0|||
144653323|NCT01993329|521583646|FG001|Wash-out|Personal reasons|1|||
144653324|NCT01993329|521583647|FG002|Wash-out|Personal reasons|0|||
144653325|NCT01993329|521583648|FG003|Wash-out|Personal reasons|0|||
144653326|NCT01993329|521583649|FG004|Wash-out|Personal reasons|0|||
144653327|NCT01993329|521583650|FG005|Wash-out|Personal reasons|0|||
144653328|NCT02311478|521583651|FG000|Overall Study|Withdrawal by Subject|1|||
144653329|NCT02311478|521583651|FG000|Overall Study|Lost to Follow-up|5|||
144653330|NCT02311478|521583651|FG000|Overall Study|Failed IUD Insertion|1|||
144653331|NCT03276936|521583652|FG000|Overall Study|Adverse Event|4|||
144653332|NCT03276936|521583653|FG001|Overall Study|Adverse Event|2|||
144653333|NCT03276936|521583652|FG000|Overall Study|Lost to Follow-up|16|||
144653334|NCT03276936|521583653|FG001|Overall Study|Lost to Follow-up|13|||
144653335|NCT03276936|521583652|FG000|Overall Study|Withdrawal by Subject|30|||
144653336|NCT03276936|521583653|FG001|Overall Study|Withdrawal by Subject|20|||
144653337|NCT03276936|521583652|FG000|Overall Study|Not mentioned|6|||
144653338|NCT03276936|521583653|FG001|Overall Study|Not mentioned|3|||
144653339|NCT03041116|521583654|FG000|Double-blind|Death|0|||
144653340|NCT03041116|521583655|FG001|Double-blind|Death|2|||
144653341|NCT03041116|521583654|FG000|Double-blind|Withdrawal by Subject|0|||
144653342|NCT03041116|521583655|FG001|Double-blind|Withdrawal by Subject|4|||
144653343|NCT03041116|521583654|FG000|Open-label|Death|1|||
144653344|NCT03041116|521583655|FG001|Open-label|Death|0|||
144653345|NCT03041116|521583654|FG000|Open-label|Termination of the study by Sponsor|39|||
144653346|NCT03041116|521583655|FG001|Open-label|Termination of the study by Sponsor|37|||
144653347|NCT03041116|521583654|FG000|Open-label|Withdrawal by Subject|1|||
144653348|NCT03041116|521583655|FG001|Open-label|Withdrawal by Subject|0|||
144653349|NCT00943319|521583656|FG000|Overall Study|Death|1|||
144653350|NCT02043301|521583657|FG000|Overall Study|Discontinued|0|||
144653351|NCT02043301|521583658|FG001|Overall Study|Discontinued|1|||
144653352|NCT02043301|521583659|FG002|Overall Study|Discontinued|0|||
144653353|NCT03097328|521583660|FG000|Overall Study|Still on Therapy|2|||
144653354|NCT03097328|521583660|FG000|Overall Study|Progressive Disease|29|||
144653355|NCT03097328|521583660|FG000|Overall Study|Adverse Event|4|||
144653356|NCT03097328|521583660|FG000|Overall Study|Withdrawal by Subject|1|||
144653357|NCT03097328|521583660|FG000|Overall Study|Physician Decision|1|||
144213596|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
144213597|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
144213598|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
144213599|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
144213600|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
144213601|NCT02422797|519976851|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
144213602|NCT02422797|519976852|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
144213603|NCT05246670|519976855|FG000|Overall Study|Withdrawal by Subject|2|||
144213604|NCT05246670|519976856|FG001|Overall Study|Withdrawal by Subject|3|||
144213605|NCT05246670|519976857|FG002|Overall Study|Withdrawal by Subject|0|||
144653358|NCT03097328|521583660|FG000|Overall Study|Patient Decision|1|||
144653359|NCT03097328|521583660|FG000|Overall Study|Ineligible for Study Drug|1|||
144653360|NCT01798134|521583661|FG000|Overall Study|Lost to Follow-up|1|||
144653361|NCT01798134|521583661|FG000|Overall Study|Withdrawal by Subject|3|||
144653362|NCT01798134|521583661|FG000|Overall Study|Death|2|||
144653363|NCT01798134|521583661|FG000|Overall Study|Adverse Event|3|||
144653364|NCT01798134|521583661|FG000|Overall Study|Physician Decision|3|||
144653365|NCT01798134|521583661|FG000|Overall Study|Liver transplant/surgery|4|||
144653366|NCT02653976|521583662|FG000|Overall Study|Withdrawal by Subject|5|||
144653367|NCT02653976|521583662|FG000|Overall Study|Death|4|||
144653368|NCT02023164|521583663|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
144213606|NCT05246670|519976858|FG003|Overall Study|Withdrawal by Subject|1|||
144213607|NCT05246670|519976855|FG000|Overall Study|Adverse Event|0|||
144213608|NCT05246670|519976856|FG001|Overall Study|Adverse Event|0|||
144213609|NCT05246670|519976857|FG002|Overall Study|Adverse Event|1|||
144653369|NCT02023164|521583664|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
144653370|NCT03703375|521583665|FG000|Randomization Period|Withdrawal by Subject|0|||
144653371|NCT03703375|521583666|FG001|Randomization Period|Withdrawal by Subject|0|||
144653372|NCT03703375|521583667|FG002|Randomization Period|Withdrawal by Subject|0|||
144653373|NCT03703375|521583668|FG003|Randomization Period|Withdrawal by Subject|1|||
144653374|NCT03703375|521583665|FG000|Randomization Period|Completed safety run-in treatment|7|||
144653375|NCT03703375|521583666|FG001|Randomization Period|Completed safety run-in treatment|0|||
144653376|NCT03703375|521583667|FG002|Randomization Period|Completed safety run-in treatment|0|||
144653377|NCT03703375|521583668|FG003|Randomization Period|Completed safety run-in treatment|0|||
144213610|NCT05246670|519976858|FG003|Overall Study|Adverse Event|0|||
144213611|NCT05246670|519976855|FG000|Overall Study|Physician Decision|1|||
144213612|NCT05246670|519976856|FG001|Overall Study|Physician Decision|0|||
144213613|NCT05246670|519976857|FG002|Overall Study|Physician Decision|0|||
144213614|NCT05246670|519976858|FG003|Overall Study|Physician Decision|0|||
144213615|NCT05246670|519976855|FG000|Overall Study|Protocol Violation|1|||
144213616|NCT05246670|519976856|FG001|Overall Study|Protocol Violation|0|||
144213617|NCT05246670|519976857|FG002|Overall Study|Protocol Violation|0|||
144213618|NCT05246670|519976858|FG003|Overall Study|Protocol Violation|0|||
144213619|NCT04152291|519976859|FG000|Overall Study|Covid-19 restrictions|27|||
144213620|NCT04152291|519976859|FG000|Overall Study|Withdrawal by Subject|3|||
144213621|NCT03597295|519976860|FG000|Overall Study|Death|70|||
144213622|NCT03597295|519976860|FG000|Overall Study|Lost to Follow-up|7|||
144213623|NCT05211726|519976861|FG000|Overall Study|Withdrawal by Subject|2|||
144213624|NCT05211726|519976862|FG001|Overall Study|Withdrawal by Subject|3|||
144213625|NCT05211726|519976861|FG000|Overall Study|Protocol Violation|0|||
144213626|NCT05211726|519976862|FG001|Overall Study|Protocol Violation|1|||
144213627|NCT01973595|519976863|FG000|Washout|Withdrawal by Subject|1|||
144213628|NCT01973595|519976864|FG001|Washout|Withdrawal by Subject|0|||
144213629|NCT01973595|519976865|FG002|Washout|Withdrawal by Subject|1|||
144213630|NCT01973595|519976866|FG003|Washout|Withdrawal by Subject|0|||
144213631|NCT02508935|519976867|FG000|Overall Study|Withdrawal by Subject|1|||
144213632|NCT02508935|519976867|FG000|Overall Study|Withdrawal by Caregiver|8|||
144213633|NCT02508935|519976867|FG000|Overall Study|Pain Score <4|1|||
144213634|NCT02508935|519976867|FG000|Overall Study|Emesis|3|||
144213635|NCT02508935|519976867|FG000|Overall Study|Adverse Event|3|||
144213636|NCT02508935|519976867|FG000|Overall Study|Protocol Violation|1|||
144213637|NCT02508935|519976867|FG000|Overall Study|Physician Decision|1|||
144213638|NCT02508935|519976867|FG000|Overall Study|Trial terminated by sponsor|5|||
144213639|NCT04868500|519976876|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
144213640|NCT04868500|519976877|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
144213641|NCT04868500|519976876|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
144213642|NCT04868500|519976877|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
144213643|NCT02676765|519976878|FG000|Overall Study|Lost to Follow-up|0|||
144213644|NCT02676765|519976879|FG001|Overall Study|Lost to Follow-up|1|||
144213645|NCT03340974|519976880|FG000|Completion of Study -Long Term Follow up|Death|8|||
144213646|NCT03340974|519976881|FG001|Completion of Study -Long Term Follow up|Death|5|||
144213647|NCT03340974|519976882|FG002|Completion of Study -Long Term Follow up|Death|5|||
144213648|NCT03340974|519976883|FG003|Completion of Study -Long Term Follow up|Death|7|||
144213649|NCT03340974|519976880|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
144213650|NCT03340974|519976881|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
144213651|NCT03340974|519976882|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
144213652|NCT03340974|519976883|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
144213653|NCT03340974|519976880|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
144213654|NCT03340974|519976881|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
144213655|NCT03340974|519976882|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
144213656|NCT03340974|519976883|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
144213657|NCT03340974|519976880|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
144213658|NCT03340974|519976881|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
144213659|NCT03340974|519976882|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
144213660|NCT03340974|519976883|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
144213661|NCT00246324|519976890|FG000|Overall Study|Withdrawal by Subject|1|||
144213662|NCT02006732|519976891|FG000|Overall Study|Adverse Event|10|||
144213663|NCT02006732|519976892|FG001|Overall Study|Adverse Event|7|||
144213664|NCT02006732|519976893|FG002|Overall Study|Adverse Event|4|||
144213665|NCT02006732|519976894|FG003|Overall Study|Adverse Event|2|||
144213666|NCT02006732|519976891|FG000|Overall Study|Lack of Efficacy|6|||
144213667|NCT02006732|519976892|FG001|Overall Study|Lack of Efficacy|3|||
144213668|NCT02006732|519976893|FG002|Overall Study|Lack of Efficacy|1|||
144213669|NCT02006732|519976894|FG003|Overall Study|Lack of Efficacy|1|||
144213670|NCT02006732|519976891|FG000|Overall Study|Protocol Violation|1|||
144213671|NCT02006732|519976892|FG001|Overall Study|Protocol Violation|1|||
144213672|NCT02006732|519976893|FG002|Overall Study|Protocol Violation|0|||
144263949|NCT01435759|520167577|FG001|Double-blind Phase|Other|2|||
144263950|NCT01435759|520167578|FG002|Double-blind Phase|Other|0|||
144653378|NCT03703375|521583665|FG000|Treatment Period|Other Reasons|0|||
144213673|NCT02006732|519976894|FG003|Overall Study|Protocol Violation|0|||
144213674|NCT02006732|519976891|FG000|Overall Study|Lost to Follow-up|0|||
144213675|NCT02006732|519976892|FG001|Overall Study|Lost to Follow-up|1|||
144213676|NCT02006732|519976893|FG002|Overall Study|Lost to Follow-up|0|||
144213677|NCT02006732|519976894|FG003|Overall Study|Lost to Follow-up|0|||
144213678|NCT02006732|519976891|FG000|Overall Study|Withdrawal by Subject|3|||
144213679|NCT02006732|519976892|FG001|Overall Study|Withdrawal by Subject|0|||
144263951|NCT01435759|520167579|FG003|Double-blind Phase|Other|2|||
144263952|NCT01435759|520167580|FG004|Double-blind Phase|Other|0|||
144213680|NCT02006732|519976893|FG002|Overall Study|Withdrawal by Subject|4|||
144213681|NCT02006732|519976894|FG003|Overall Study|Withdrawal by Subject|1|||
144213682|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
144213683|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
144213684|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
144213685|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Death|1|||
144213686|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Death|3|||
144213687|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Death|1|||
144213688|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
144213689|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
144213690|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
144213691|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
144213692|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
144213693|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
144213694|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
144213695|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
144213696|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
144213697|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
144213698|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
144213699|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
144213700|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
144213701|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
144213702|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
144213703|NCT00299130|519976895|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
144213704|NCT00299130|519976896|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
144213705|NCT00299130|519976897|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
144213706|NCT00299130|519976895|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
144213707|NCT00299130|519976896|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
144213708|NCT00299130|519976897|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
144213709|NCT00299130|519976895|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
144213710|NCT00299130|519976896|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
144213711|NCT00299130|519976897|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
144213712|NCT00299130|519976895|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
144213713|NCT00299130|519976896|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
144213714|NCT00299130|519976897|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
144213715|NCT00299130|519976895|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
144213716|NCT00299130|519976896|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
144213717|NCT00299130|519976897|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
144213718|NCT00299130|519976895|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
144213719|NCT00299130|519976896|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
144213720|NCT00299130|519976897|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
144213721|NCT00299130|519976895|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
144213722|NCT00299130|519976896|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
144213723|NCT00299130|519976897|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
144213724|NCT00299130|519976895|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
144213725|NCT00299130|519976896|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
144213726|NCT00299130|519976897|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
144213727|NCT00299130|519976895|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
144213728|NCT00299130|519976896|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
144213729|NCT00299130|519976897|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
144213730|NCT00299130|519976895|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
144213731|NCT00299130|519976896|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
144213732|NCT00299130|519976897|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
144213733|NCT02211417|519976898|FG000|Overall Study|Withdrawal by Subject|11|||
144213734|NCT02211417|519976899|FG001|Overall Study|Withdrawal by Subject|8|||
144213735|NCT02211417|519976898|FG000|Overall Study|Protocol Violation|1|||
144213736|NCT02211417|519976899|FG001|Overall Study|Protocol Violation|0|||
144213737|NCT02211417|519976898|FG000|Overall Study|Pregnancy|0|||
144213738|NCT02211417|519976899|FG001|Overall Study|Pregnancy|1|||
144213739|NCT02211417|519976898|FG000|Overall Study|Lost to Follow-up|2|||
144213740|NCT02211417|519976899|FG001|Overall Study|Lost to Follow-up|3|||
144213741|NCT02211417|519976898|FG000|Overall Study|Adverse Event|1|||
144263953|NCT01435759|520167581|FG005|Double-blind Phase|Other|0|||
144263954|NCT03727841|520167584|FG000|Overall Study|Physician Decision|3|||
144263955|NCT03727841|520167585|FG001|Overall Study|Physician Decision|1|||
144263956|NCT01601496|520167586|FG000|Overall Study|Physician Decision|1|||
144263957|NCT01601496|520167586|FG000|Overall Study|Withdrawal by Subject|1|||
144263958|NCT01601496|520167586|FG000|Overall Study|Lost to Follow-up|6|||
144263959|NCT01601496|520167586|FG000|Overall Study|Death|4|||
144213742|NCT02211417|519976899|FG001|Overall Study|Adverse Event|4|||
144213743|NCT01198132|519976900|FG000|Overall Study|Withdrawal by Subject|4|||
144213744|NCT01198132|519976901|FG001|Overall Study|Withdrawal by Subject|5|||
144213745|NCT01198132|519976900|FG000|Overall Study|Physician Decision|5|||
144213746|NCT01198132|519976901|FG001|Overall Study|Physician Decision|4|||
144213747|NCT01198132|519976900|FG000|Overall Study|Other Unspecified|3|||
144213748|NCT01198132|519976901|FG001|Overall Study|Other Unspecified|6|||
144213749|NCT01198132|519976900|FG000|Overall Study|Lack of Efficacy|2|||
144213750|NCT01198132|519976901|FG001|Overall Study|Lack of Efficacy|3|||
144213751|NCT01198132|519976900|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
144213752|NCT01198132|519976901|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
144213753|NCT01198132|519976900|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
144213754|NCT01198132|519976901|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
144213755|NCT01198132|519976900|FG000|Overall Study|Adverse Event|0|||
144213756|NCT01198132|519976901|FG001|Overall Study|Adverse Event|1|||
144213757|NCT01198132|519976900|FG000|Overall Study|Protocol Violation|1|||
144213758|NCT01198132|519976901|FG001|Overall Study|Protocol Violation|0|||
144213759|NCT01755091|519976902|FG000|Overall Study|Withdrawal by Subject|6|||
144213760|NCT01755091|519976903|FG001|Overall Study|Withdrawal by Subject|1|||
144213761|NCT01755091|519976904|FG002|Overall Study|Withdrawal by Subject|3|||
144213762|NCT01755091|519976902|FG000|Overall Study|Adverse Event|1|||
144213763|NCT01755091|519976903|FG001|Overall Study|Adverse Event|1|||
144213764|NCT01755091|519976904|FG002|Overall Study|Adverse Event|1|||
144213765|NCT01755091|519976902|FG000|Overall Study|Lost to Follow-up|1|||
144213766|NCT01755091|519976903|FG001|Overall Study|Lost to Follow-up|0|||
144213767|NCT01755091|519976904|FG002|Overall Study|Lost to Follow-up|1|||
144213768|NCT01755091|519976902|FG000|Overall Study|Physician Decision|1|||
144213769|NCT01755091|519976903|FG001|Overall Study|Physician Decision|1|||
144213770|NCT01755091|519976904|FG002|Overall Study|Physician Decision|2|||
144213771|NCT00490841|519976905|FG000|Overall Study|Death|5|||
144213772|NCT00490841|519976905|FG000|Overall Study|Withdrawal by Subject|4|||
144213773|NCT00490841|519976905|FG000|Overall Study|Lost to Follow-up|1|||
144213774|NCT00490841|519976905|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
144213775|NCT04697069|519976908|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
144213776|NCT04697069|519976909|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
144213777|NCT04697069|519976908|FG000|Overall Study|Study termination|2|||
144213778|NCT04697069|519976909|FG001|Overall Study|Study termination|1|||
144213779|NCT02779855|519976910|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
144213780|NCT02779855|519976911|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
144213781|NCT02779855|519976912|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
144213782|NCT01301729|519976913|FG000|Overall Study|Withdrawal by Subject|2|||
144213783|NCT01301729|519976913|FG000|Overall Study|Participant did not Return for Treatment|1|||
144213784|NCT01301729|519976913|FG000|Overall Study|Violated Selection Criteria|1|||
144213785|NCT03071276|519976914|FG000|Overall Study|Adverse Event|1|||
144213786|NCT03071276|519976914|FG000|Overall Study|Lack of Efficacy|14|||
144213787|NCT05794503|519976915|FG000|Overall Study|Operation Cancelled|2|||
144213788|NCT05794503|519976916|FG001|Overall Study|Operation Cancelled|0|||
144213789|NCT05794503|519976915|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
144213790|NCT05794503|519976916|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
144213791|NCT05794503|519976915|FG000|Overall Study|Protocol Violation|1|||
144213792|NCT05794503|519976916|FG001|Overall Study|Protocol Violation|0|||
144213793|NCT00447993|519976919|FG000|Overall Study|Lost to Follow-up|0|||
144213794|NCT00447993|519976920|FG001|Overall Study|Lost to Follow-up|0|||
144213795|NCT00447993|519976921|FG002|Overall Study|Lost to Follow-up|2|||
144213796|NCT00447993|519976922|FG003|Overall Study|Lost to Follow-up|2|||
144213797|NCT00447993|519976919|FG000|Overall Study|Withdrawal by Subject|0|||
144213798|NCT00447993|519976920|FG001|Overall Study|Withdrawal by Subject|0|||
144213799|NCT00447993|519976921|FG002|Overall Study|Withdrawal by Subject|2|||
144213800|NCT00447993|519976922|FG003|Overall Study|Withdrawal by Subject|2|||
144213801|NCT02503787|519976927|FG000|Enrollment|Withdrawal by Subject|6|||
144213802|NCT02503787|519976927|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
144213803|NCT02503787|519976927|FG000|Enrollment|Physician Decision|2|||
144213804|NCT02503787|519976927|FG000|Enrollment|Insurance issue|2|||
144213805|NCT02503787|519976927|FG000|Enrollment|Lost to Follow-up|1|||
144213806|NCT02503787|519976927|FG000|Enrollment|Study closure|1|||
144213807|NCT02503787|519976927|FG000|Enrollment|Adverse Event|1|||
144213808|NCT02503787|519976927|FG000|Enrollment|Protocol Violation|1|||
144213809|NCT02503787|519976927|FG000|Enrollment|Inability to implant system|1|||
144213810|NCT02503787|519976927|FG000|Enrollment|Unable to be programmed|1|||
144213811|NCT02503787|519976927|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
144213812|NCT02503787|519976927|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
144213813|NCT02503787|519976927|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
144213814|NCT02503787|519976927|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
144213815|NCT02503787|519976927|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
144213816|NCT02503787|519976927|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
144263960|NCT01601496|520167586|FG000|Overall Study|Other: patient refusal to continue|3|||
144263961|NCT02689804|520167587|FG000|Overall Study|Withdrawal by Subject|2|||
144263962|NCT02689804|520167588|FG001|Overall Study|Withdrawal by Subject|0|||
144263963|NCT00426764|520167590|FG000|Overall Study|Protocol Violation|1|||
144263964|NCT00426764|520167590|FG000|Overall Study|Withdrawal by Subject|4|||
144263965|NCT00426764|520167590|FG000|Overall Study|Physician Decision|6|||
144263966|NCT00426764|520167590|FG000|Overall Study|Compassionate Use|1|||
144263967|NCT00426764|520167590|FG000|Overall Study|Progressive Disease|83|||
144263968|NCT00426764|520167590|FG000|Overall Study|Adverse Event|24|||
144263969|NCT00426764|520167590|FG000|Overall Study|Other|1|||
144263970|NCT00426764|520167590|FG000|Overall Study|Death|1|||
144263971|NCT00426764|520167590|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
144263972|NCT04396626|520167597|FG000|Overall Study|Premature termination of study|975|||
144263973|NCT02849587|520167598|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
144263974|NCT02849587|520167599|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
144263975|NCT02849587|520167600|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
144263976|NCT02849587|520167598|FG000|Overall Study|Withdrawal by Subject|0|||
144263977|NCT02849587|520167599|FG001|Overall Study|Withdrawal by Subject|1|||
144263978|NCT02849587|520167600|FG002|Overall Study|Withdrawal by Subject|0|||
144263979|NCT00871234|520167601|FG000|Overall Study|Adverse Event|2|||
144263980|NCT00871234|520167601|FG000|Overall Study|Lost to Follow-up|3|||
144263981|NCT00128661|520167602|FG000|Overall Study|Adverse Event|14|||
144263982|NCT00128661|520167603|FG001|Overall Study|Adverse Event|11|||
144263983|NCT00128661|520167602|FG000|Overall Study|Lost to Follow-up|10|||
144263984|NCT00128661|520167603|FG001|Overall Study|Lost to Follow-up|7|||
144263985|NCT00128661|520167602|FG000|Overall Study|Withdrawal by Subject|243|||
144263986|NCT00128661|520167603|FG001|Overall Study|Withdrawal by Subject|232|||
144263987|NCT00128661|520167602|FG000|Overall Study|Other|7|||
144653379|NCT03703375|521583666|FG001|Treatment Period|Other Reasons|1|||
144653380|NCT03703375|521583667|FG002|Treatment Period|Other Reasons|0|||
144653381|NCT03703375|521583668|FG003|Treatment Period|Other Reasons|3|||
144653382|NCT03703375|521583665|FG000|Treatment Period|Consent Withdrawal|0|||
144653383|NCT03703375|521583666|FG001|Treatment Period|Consent Withdrawal|0|||
144653384|NCT03703375|521583667|FG002|Treatment Period|Consent Withdrawal|0|||
144653385|NCT03703375|521583668|FG003|Treatment Period|Consent Withdrawal|1|||
144653386|NCT03703375|521583665|FG000|Treatment Period|Death|1|||
144653387|NCT03703375|521583666|FG001|Treatment Period|Death|0|||
144653388|NCT03703375|521583667|FG002|Treatment Period|Death|1|||
144653389|NCT03703375|521583668|FG003|Treatment Period|Death|2|||
144653390|NCT03703375|521583665|FG000|Treatment Period|Toxicity of Study Treatment|2|||
144653391|NCT03703375|521583666|FG001|Treatment Period|Toxicity of Study Treatment|0|||
144653392|NCT03703375|521583667|FG002|Treatment Period|Toxicity of Study Treatment|4|||
144653393|NCT03703375|521583668|FG003|Treatment Period|Toxicity of Study Treatment|1|||
144653394|NCT03703375|521583665|FG000|Treatment Period|Progression|32|||
144653395|NCT03703375|521583666|FG001|Treatment Period|Progression|1|||
144653396|NCT03703375|521583667|FG002|Treatment Period|Progression|7|||
144653397|NCT03703375|521583668|FG003|Treatment Period|Progression|11|||
144653398|NCT03703375|521583665|FG000|Treatment Period|Completed treatment|7|||
144653399|NCT03703375|521583666|FG001|Treatment Period|Completed treatment|2|||
144653400|NCT03703375|521583667|FG002|Treatment Period|Completed treatment|0|||
144653401|NCT03703375|521583668|FG003|Treatment Period|Completed treatment|0|||
144653402|NCT00615290|521583669|FG000|Overall Study|Adverse Event|2|||
144653403|NCT00615290|521583669|FG000|Overall Study|Lost to Follow-up|3|||
144653404|NCT00615290|521583669|FG000|Overall Study|Withdrawal by Subject|1|||
144653405|NCT00615290|521583669|FG000|Overall Study|Other|2|||
144263988|NCT00128661|520167603|FG001|Overall Study|Other|8|||
144653406|NCT00372190|521583675|FG000|Overall Study|Lost to Follow-up|3|||
144653407|NCT00372190|521583676|FG001|Overall Study|Lost to Follow-up|1|||
144653408|NCT04705597|521583677|FG000|Overall Study|Death|16|||
144653409|NCT04705597|521583678|FG001|Overall Study|Death|9|||
144653410|NCT04705597|521583677|FG000|Overall Study|Lost to Follow-up|1|||
144653411|NCT04705597|521583678|FG001|Overall Study|Lost to Follow-up|0|||
144263989|NCT04863872|520167606|FG000|Overall Study|Withdrawal by Subject|4|||
144653412|NCT04705597|521583677|FG000|Overall Study|Withdrawal by Subject|1|||
144653413|NCT04705597|521583678|FG001|Overall Study|Withdrawal by Subject|2|||
144653414|NCT00273858|521583688|FG000|Overall Study|Not completed 24 month observation time|334|||
144653415|NCT00273858|521583688|FG000|Overall Study|Lost to Follow-up|101|||
144653416|NCT00273858|521583688|FG000|Overall Study|Withdrawal by Subject|21|||
144263990|NCT04863872|520167607|FG001|Overall Study|Withdrawal by Subject|15|||
144263991|NCT04863872|520167606|FG000|Overall Study|Death|5|||
144263992|NCT04863872|520167607|FG001|Overall Study|Death|2|||
144263993|NCT04863872|520167606|FG000|Overall Study|Lost to Follow-up|2|||
144263994|NCT04863872|520167607|FG001|Overall Study|Lost to Follow-up|1|||
144263995|NCT01275144|520167608|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
144653417|NCT00273858|521583688|FG000|Overall Study|Adverse Event|81|||
144653418|NCT00109733|521583691|FG000|Overall Study|Protocol Violation|0|||
144653419|NCT00109733|521583692|FG001|Overall Study|Protocol Violation|1|||
144263996|NCT01275144|520167609|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
144263997|NCT05607576|520167611|FG000|Overall Study|immediate sensor error|2|||
144263998|NCT05607576|520167611|FG000|Overall Study|Physician Decision|2|||
144263999|NCT02998151|520167621|FG000|Overall Study|Withdrawal by Subject|3|||
144264000|NCT02998151|520167621|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
144732165|NCT01376167|521875763|FG002|Overall Study|Withdrawal by Subject|4|||
144732166|NCT02193165|521875764|FG000|4 Week Product Use|Lost to Follow-up|1|||
144732167|NCT02193165|521875765|FG001|4 Week Product Use|Lost to Follow-up|1|||
144732168|NCT02193165|521875766|FG002|4 Week Product Use|Lost to Follow-up|1|||
144732169|NCT02193165|521875764|FG000|6 Week Product Use|Lost to Follow-up|0|||
144732170|NCT02193165|521875765|FG001|6 Week Product Use|Lost to Follow-up|1|||
144732171|NCT02193165|521875766|FG002|6 Week Product Use|Lost to Follow-up|0|||
144732172|NCT04239872|521875767|FG000|Overall Study|Lost to Follow-up|0|||
144732173|NCT04239872|521875768|FG001|Overall Study|Lost to Follow-up|1|||
144732174|NCT01173692|521875769|FG000|Overall Study|Adverse Event|1|||
144732175|NCT01173692|521875770|FG001|Overall Study|Adverse Event|2|||
144732176|NCT01173692|521875769|FG000|Overall Study|Withdrawal by Subject|1|||
144732177|NCT01173692|521875770|FG001|Overall Study|Withdrawal by Subject|3|||
144732178|NCT01472341|521875771|FG000|Overall Study|Started insulin therapy|55|||
144732179|NCT01472341|521875771|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
144732180|NCT01472341|521875771|FG000|Overall Study|Withdrawal by Subject|39|||
144732181|NCT01472341|521875771|FG000|Overall Study|Lost to Follow-up|52|||
144732182|NCT01472341|521875771|FG000|Overall Study|Laboratory parameters unavailable|25|||
144732183|NCT01472341|521875771|FG000|Overall Study|Death|9|||
144732184|NCT00579670|521875772|FG000|Overall Study|Death|1|||
144732185|NCT00579670|521875773|FG001|Overall Study|Death|0|||
144732186|NCT00579670|521875774|FG002|Overall Study|Death|0|||
144732187|NCT00579670|521875775|FG003|Overall Study|Death|0|||
144732188|NCT00579670|521875776|FG004|Overall Study|Death|0|||
144732189|NCT00579670|521875772|FG000|Overall Study|Adverse Event|1|||
144732190|NCT00579670|521875773|FG001|Overall Study|Adverse Event|0|||
144732191|NCT00579670|521875774|FG002|Overall Study|Adverse Event|1|||
144732192|NCT00579670|521875775|FG003|Overall Study|Adverse Event|2|||
144732193|NCT00579670|521875776|FG004|Overall Study|Adverse Event|0|||
144732194|NCT00579670|521875772|FG000|Overall Study|Lack of Efficacy|0|||
144732195|NCT00579670|521875773|FG001|Overall Study|Lack of Efficacy|0|||
144732196|NCT00579670|521875774|FG002|Overall Study|Lack of Efficacy|1|||
144732197|NCT00579670|521875775|FG003|Overall Study|Lack of Efficacy|14|||
144732198|NCT00579670|521875776|FG004|Overall Study|Lack of Efficacy|0|||
144732199|NCT00579670|521875772|FG000|Overall Study|Lost to Follow-up|0|||
144732200|NCT00579670|521875773|FG001|Overall Study|Lost to Follow-up|1|||
144732201|NCT00579670|521875774|FG002|Overall Study|Lost to Follow-up|0|||
144732202|NCT00579670|521875775|FG003|Overall Study|Lost to Follow-up|4|||
144732203|NCT00579670|521875776|FG004|Overall Study|Lost to Follow-up|0|||
144732204|NCT00579670|521875772|FG000|Overall Study|Other|0|||
144732205|NCT00579670|521875773|FG001|Overall Study|Other|0|||
144732206|NCT00579670|521875774|FG002|Overall Study|Other|1|||
144732207|NCT00579670|521875775|FG003|Overall Study|Other|2|||
144732208|NCT00579670|521875776|FG004|Overall Study|Other|0|||
144732209|NCT00579670|521875772|FG000|Overall Study|Withdrawal by Subject|0|||
144732210|NCT00579670|521875773|FG001|Overall Study|Withdrawal by Subject|0|||
144732211|NCT00579670|521875774|FG002|Overall Study|Withdrawal by Subject|1|||
144732212|NCT00579670|521875775|FG003|Overall Study|Withdrawal by Subject|0|||
144732213|NCT00579670|521875776|FG004|Overall Study|Withdrawal by Subject|0|||
144732214|NCT01546545|521875782|FG000|Overall Study|Withdrawal by Subject|1|||
144732215|NCT04060147|521875783|FG000|Overall Study|Withdrew consent|1|||
144732216|NCT00550537|521875786|FG000|Overall Study|Death|18|||
144264001|NCT02998151|520167621|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
144264002|NCT02573259|520167627|FG000|Overall Study|Death|1|||
144264003|NCT02573259|520167628|FG001|Overall Study|Death|6|||
144264004|NCT02573259|520167629|FG002|Overall Study|Death|5|||
144264005|NCT02573259|520167630|FG003|Overall Study|Death|6|||
144732217|NCT00550537|521875786|FG000|Overall Study|Adverse Event|20|||
144732218|NCT00550537|521875786|FG000|Overall Study|Disease progression before|46|||
144732219|NCT00550537|521875786|FG000|Overall Study|Withdrawal by Subject|7|||
144732220|NCT00550537|521875786|FG000|Overall Study|Change in treatment plan|4|||
144732221|NCT00550537|521875786|FG000|Overall Study|Other complicating ilness|3|||
144732222|NCT00550537|521875786|FG000|Overall Study|Declining performance status|2|||
144732223|NCT00550537|521875786|FG000|Overall Study|Treated closer to home|4|||
144732224|NCT02008565|521875787|FG000|Overall Study|Protocol Violation|1|||
144732225|NCT02008565|521875788|FG001|Overall Study|Protocol Violation|1|||
144732226|NCT02008565|521875789|FG002|Overall Study|Protocol Violation|2|||
144732227|NCT02008565|521875790|FG003|Overall Study|Protocol Violation|0|||
144732228|NCT00268905|521875791|FG000|Overall Study|Adverse Event|3|||
144732229|NCT00268905|521875792|FG001|Overall Study|Adverse Event|0|||
144732230|NCT00268905|521875793|FG002|Overall Study|Adverse Event|4|||
144732231|NCT00268905|521875791|FG000|Overall Study|Lost to Follow-up|0|||
144732232|NCT00268905|521875792|FG001|Overall Study|Lost to Follow-up|1|||
144732233|NCT00268905|521875793|FG002|Overall Study|Lost to Follow-up|0|||
144213817|NCT04700137|519976928|FG000|Overall Study|Lost to Follow-up|1|||
144213818|NCT04700137|519976929|FG001|Overall Study|Lost to Follow-up|6|||
144213819|NCT04700137|519976930|FG002|Overall Study|Lost to Follow-up|1|||
144213820|NCT04700137|519976931|FG003|Overall Study|Lost to Follow-up|1|||
144213821|NCT04700137|519976928|FG000|Overall Study|Withdrawal by Subject|0|||
144213822|NCT04700137|519976929|FG001|Overall Study|Withdrawal by Subject|0|||
144213823|NCT04700137|519976930|FG002|Overall Study|Withdrawal by Subject|1|||
144653420|NCT00109733|521583691|FG000|Overall Study|Stopped taking study drug|1|||
144653421|NCT00109733|521583692|FG001|Overall Study|Stopped taking study drug|1|||
144653422|NCT00109733|521583691|FG000|Overall Study|Non-compliant|0|||
144653423|NCT00109733|521583692|FG001|Overall Study|Non-compliant|1|||
144653424|NCT00109733|521583691|FG000|Overall Study|Could not commit time for study|1|||
144653425|NCT00109733|521583692|FG001|Overall Study|Could not commit time for study|1|||
144653426|NCT01702363|521583693|FG000|Overall Study|Adverse Event|14|||
144653427|NCT01702363|521583693|FG000|Overall Study|Lack of Efficacy|4|||
144653428|NCT01702363|521583693|FG000|Overall Study|Withdrawal by Subject|2|||
144653429|NCT02985450|521583696|FG000|Overall Study|Lost to Follow-up|7|||
144653430|NCT01905397|521583699|FG000|Overall Study|Death|0|||
144653431|NCT01905397|521583700|FG001|Overall Study|Death|1|||
144653432|NCT01905397|521583699|FG000|Overall Study|Withdrawal by Subject|2|||
144653433|NCT01905397|521583700|FG001|Overall Study|Withdrawal by Subject|0|||
144653434|NCT01905397|521583699|FG000|Overall Study|Surgery canceled/aborted|9|||
144653435|NCT01905397|521583700|FG001|Overall Study|Surgery canceled/aborted|5|||
144653436|NCT01905397|521583699|FG000|Overall Study|Incision < 7 cm|2|||
144653437|NCT01905397|521583700|FG001|Overall Study|Incision < 7 cm|0|||
144653438|NCT01905397|521583699|FG000|Overall Study|Wrong treatment|1|||
144653439|NCT01905397|521583700|FG001|Overall Study|Wrong treatment|1|||
144653440|NCT01905397|521583699|FG000|Overall Study|Device not applied|3|||
144653441|NCT01905397|521583700|FG001|Overall Study|Device not applied|0|||
144653442|NCT01905397|521583699|FG000|Overall Study|Dressing not applied in operating room|1|||
144653443|NCT01905397|521583700|FG001|Overall Study|Dressing not applied in operating room|0|||
144653444|NCT01905397|521583699|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
144653445|NCT01905397|521583700|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
144653446|NCT00443430|521583706|FG000|Overall Study|Lack of Efficacy|3|||
144653447|NCT00443430|521583707|FG001|Overall Study|Lack of Efficacy|3|||
144653448|NCT00443430|521583706|FG000|Overall Study|Adverse Event|1|||
144653449|NCT00443430|521583707|FG001|Overall Study|Adverse Event|1|||
144653450|NCT00592501|521583708|FG000|Overall Study|Withdrawal by Subject|1|||
144653451|NCT00592501|521583708|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
144653452|NCT00053846|521583709|FG000|Overall Study|Changed mind|8|||
144653453|NCT00053846|521583710|FG001|Overall Study|Changed mind|13|||
144653454|NCT00053846|521583709|FG000|Overall Study|Became too ill|8|||
144653455|NCT00053846|521583710|FG001|Overall Study|Became too ill|7|||
144653456|NCT00053846|521583709|FG000|Overall Study|Expired|5|||
144653457|NCT00053846|521583710|FG001|Overall Study|Expired|0|||
144653458|NCT00053846|521583709|FG000|Overall Study|Became ineligible|3|||
144653459|NCT00053846|521583710|FG001|Overall Study|Became ineligible|1|||
144653460|NCT00053846|521583709|FG000|Overall Study|Did not return data|1|||
144653461|NCT00053846|521583710|FG001|Overall Study|Did not return data|2|||
144653462|NCT00053846|521583709|FG000|Overall Study|Quit due to side effects|1|||
144653463|NCT00053846|521583710|FG001|Overall Study|Quit due to side effects|3|||
144653464|NCT00053846|521583709|FG000|Overall Study|Pills too large|0|||
144653465|NCT00053846|521583710|FG001|Overall Study|Pills too large|1|||
144653466|NCT03880227|521583712|FG000|First Visit|Withdrawal by Subject|1|||
144653467|NCT03880227|521583713|FG001|First Visit|Withdrawal by Subject|0|||
144653468|NCT03880227|521583714|FG002|First Visit|Withdrawal by Subject|0|||
144653469|NCT03880227|521583715|FG003|First Visit|Withdrawal by Subject|0|||
144653470|NCT03880227|521583712|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
144653471|NCT03880227|521583713|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
144653472|NCT03880227|521583714|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
144653473|NCT03880227|521583715|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
144653474|NCT03880227|521583712|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
144653475|NCT03880227|521583713|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
144653476|NCT03880227|521583714|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
144653477|NCT03880227|521583715|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
144653478|NCT03880227|521583712|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
144653479|NCT03880227|521583713|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
144213824|NCT04700137|519976931|FG003|Overall Study|Withdrawal by Subject|0|||
144213825|NCT04700137|519976928|FG000|Overall Study|Death|0|||
144213826|NCT04700137|519976929|FG001|Overall Study|Death|0|||
144213827|NCT04700137|519976930|FG002|Overall Study|Death|1|||
144653480|NCT03880227|521583714|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
144653481|NCT03880227|521583715|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
144653482|NCT00504166|521583716|FG000|Overall Study|Adverse Event|1|||
144653483|NCT00504166|521583717|FG001|Overall Study|Adverse Event|4|||
144213828|NCT04700137|519976931|FG003|Overall Study|Death|0|||
144213829|NCT04787627|519976932|FG000|Overall Study|Withdrawal by Subject|3|||
144213830|NCT04787627|519976933|FG001|Overall Study|Withdrawal by Subject|0|||
144213831|NCT04787627|519976932|FG000|Overall Study|Physician Decision|2|||
144213832|NCT04787627|519976933|FG001|Overall Study|Physician Decision|0|||
144213833|NCT04787627|519976932|FG000|Overall Study|Excluded|0|||
144213834|NCT04787627|519976933|FG001|Overall Study|Excluded|1|||
144213835|NCT00548093|519976934|FG000|Overall Study|Death|33|||
144213836|NCT00548093|519976935|FG001|Overall Study|Death|13|||
144213837|NCT00548093|519976934|FG000|Overall Study|Lost to Follow-up|3|||
144653484|NCT00504166|521583716|FG000|Overall Study|Withdrawal by Subject|3|||
144653485|NCT00504166|521583717|FG001|Overall Study|Withdrawal by Subject|6|||
144653486|NCT00504166|521583716|FG000|Overall Study|Physician Decision|1|||
144653487|NCT00504166|521583717|FG001|Overall Study|Physician Decision|1|||
144653488|NCT00504166|521583716|FG000|Overall Study|Lost to Follow-up|1|||
144653489|NCT00504166|521583717|FG001|Overall Study|Lost to Follow-up|3|||
144653490|NCT02229864|521583718|FG000|Overall Study|Death|2|||
144653491|NCT02229864|521583718|FG000|Overall Study|Lost to Follow-up|1|||
144653492|NCT00783705|521583721|FG000|Overall Study|Adverse Event|2|||
144653493|NCT00783705|521583722|FG001|Overall Study|Adverse Event|0|||
144653494|NCT00783705|521583721|FG000|Overall Study|Withdrawal by Subject|3|||
144653495|NCT00783705|521583722|FG001|Overall Study|Withdrawal by Subject|2|||
144653496|NCT00783705|521583721|FG000|Overall Study|Lost to Follow-up|1|||
144653497|NCT00783705|521583722|FG001|Overall Study|Lost to Follow-up|3|||
144653498|NCT03844633|521583723|FG000|1 Week FU|Lost to Follow-up|0|||
144653499|NCT03844633|521583724|FG001|1 Week FU|Lost to Follow-up|1|||
144653500|NCT03844633|521583725|FG002|1 Week FU|Lost to Follow-up|4|||
144653501|NCT03844633|521583723|FG000|12-month Follow-up|Lost to Follow-up|7|||
144653502|NCT03844633|521583724|FG001|12-month Follow-up|Lost to Follow-up|5|||
144653503|NCT03844633|521583725|FG002|12-month Follow-up|Lost to Follow-up|8|||
144653504|NCT02588248|521583728|FG000|Overall Study|Physician Decision|4|||
144653505|NCT02588248|521583729|FG001|Overall Study|Physician Decision|3|||
144653506|NCT04229446|521583732|FG000|Overall Study|Death|12|||
144653507|NCT04229446|521583733|FG001|Overall Study|Death|10|||
144653508|NCT04229446|521583732|FG000|Overall Study|Lost to Follow-up|5|||
144653509|NCT04229446|521583733|FG001|Overall Study|Lost to Follow-up|8|||
144653510|NCT00705224|521583734|FG000|Overall Study|Adverse Event|1|||
144653511|NCT00705224|521583734|FG000|Overall Study|Lack of Efficacy|2|||
144653512|NCT00705224|521583734|FG000|Overall Study|Withdrawal by Subject|3|||
144653513|NCT00705224|521583734|FG000|Overall Study|Lost to Follow-up|5|||
144653514|NCT03596177|521583736|FG000|Single Blind Period|Withdrawal by Subject|1|||
144653515|NCT03596177|521583737|FG001|Single Blind Period|Withdrawal by Subject|1|||
144653516|NCT03596177|521583736|FG000|Single Blind Period|Other|1|||
144653517|NCT03596177|521583737|FG001|Single Blind Period|Other|0|||
144653518|NCT03596177|521583736|FG000|Double Blind Period|Withdrawal by Subject|0|||
144653519|NCT03596177|521583737|FG001|Double Blind Period|Withdrawal by Subject|1|||
144653520|NCT03596177|521583736|FG000|Double Blind Period|Other|0|||
144653521|NCT03596177|521583737|FG001|Double Blind Period|Other|4|||
144653522|NCT03596177|521583736|FG000|Double Blind Period|Death during safety follow-up|0|||
144653523|NCT03596177|521583737|FG001|Double Blind Period|Death during safety follow-up|1|||
144653524|NCT02566525|521583738|FG000|Overall Study|Protocol Violation|3|||
144653525|NCT02566525|521583739|FG001|Overall Study|Protocol Violation|5|||
144653526|NCT00337467|521583742|FG000|Overall Study|Adverse Event|3|||
144653527|NCT00337467|521583742|FG000|Overall Study|Subject Withdrew Consent|2|||
144653528|NCT00337467|521583742|FG000|Overall Study|Pregnancy|1|||
144653529|NCT00337467|521583742|FG000|Overall Study|Lost to Follow-up|2|||
144653530|NCT00337467|521583742|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
144653531|NCT03141086|521583743|FG000|Overall Study|Study Terminated By Sponsor|1|||
144653532|NCT03141086|521583744|FG001|Overall Study|Study Terminated By Sponsor|1|||
144653533|NCT03141086|521583743|FG000|Overall Study|Withdrawal by Subject|0|||
144653534|NCT03141086|521583744|FG001|Overall Study|Withdrawal by Subject|1|||
144653535|NCT03141086|521583743|FG000|Overall Study|Protocol Violation|0|||
144653536|NCT03141086|521583744|FG001|Overall Study|Protocol Violation|1|||
144653537|NCT03141086|521583743|FG000|Overall Study|Adverse Event|0|||
144653538|NCT03141086|521583744|FG001|Overall Study|Adverse Event|2|||
144653539|NCT04083222|521583746|FG000|Overall Study|Voluntary Withdrawal|0|||
144653540|NCT04083222|521583747|FG001|Overall Study|Voluntary Withdrawal|1|||
144653541|NCT04083222|521583746|FG000|Overall Study|Reason not Specified|0|||
144653542|NCT04083222|521583747|FG001|Overall Study|Reason not Specified|1|||
144653543|NCT04430582|521583748|FG000|Overall Study|Found to meet exclusionary criteria|1|||
144653544|NCT04430582|521583749|FG001|Overall Study|Found to meet exclusionary criteria|0|||
144732234|NCT00268905|521875791|FG000|Overall Study|Withdrawal by Subject|0|||
144732235|NCT00268905|521875792|FG001|Overall Study|Withdrawal by Subject|0|||
144213838|NCT00548093|519976935|FG001|Overall Study|Lost to Follow-up|1|||
144213839|NCT00548093|519976934|FG000|Overall Study|Objective progression or relapse|1|||
144213840|NCT00548093|519976935|FG001|Overall Study|Objective progression or relapse|1|||
144653545|NCT04430582|521583748|FG000|Overall Study|Withdrawal by Subject|0|||
144653546|NCT04430582|521583749|FG001|Overall Study|Withdrawal by Subject|1|||
144653547|NCT03607682|521583750|FG000|Overall Study|Withdrawal by Subject|1|||
144732236|NCT00268905|521875793|FG002|Overall Study|Withdrawal by Subject|3|||
144732237|NCT00268905|521875791|FG000|Overall Study|Progressive Disease|28|||
144732238|NCT00268905|521875792|FG001|Overall Study|Progressive Disease|4|||
144732239|NCT00268905|521875793|FG002|Overall Study|Progressive Disease|3|||
144732240|NCT00268905|521875791|FG000|Overall Study|Physician Decision|3|||
144732241|NCT00268905|521875792|FG001|Overall Study|Physician Decision|0|||
144732242|NCT00268905|521875793|FG002|Overall Study|Physician Decision|1|||
144732243|NCT00268905|521875791|FG000|Overall Study|Clinical Progression|9|||
144732244|NCT00268905|521875792|FG001|Overall Study|Clinical Progression|4|||
144732245|NCT00268905|521875793|FG002|Overall Study|Clinical Progression|1|||
144732246|NCT00617305|521875794|FG000|Overall Study|Adverse Event|4|||
144732247|NCT00617305|521875795|FG001|Overall Study|Adverse Event|0|||
144732248|NCT00617305|521875796|FG002|Overall Study|Adverse Event|0|||
144732249|NCT00617305|521875794|FG000|Overall Study|Death|1|||
144732250|NCT00617305|521875795|FG001|Overall Study|Death|0|||
144732251|NCT00617305|521875796|FG002|Overall Study|Death|0|||
144732252|NCT00617305|521875794|FG000|Overall Study|Physician Decision|1|||
144732253|NCT00617305|521875795|FG001|Overall Study|Physician Decision|0|||
144732254|NCT00617305|521875796|FG002|Overall Study|Physician Decision|0|||
144732255|NCT00617305|521875794|FG000|Overall Study|Protocol Violation|1|||
144732256|NCT00617305|521875795|FG001|Overall Study|Protocol Violation|0|||
144732257|NCT00617305|521875796|FG002|Overall Study|Protocol Violation|1|||
144732258|NCT00617305|521875794|FG000|Overall Study|Withdrawal by Subject|1|||
144732259|NCT00617305|521875795|FG001|Overall Study|Withdrawal by Subject|0|||
144732260|NCT00617305|521875796|FG002|Overall Study|Withdrawal by Subject|0|||
144732261|NCT04185909|521875797|FG000|Overall Study|Lost to Follow-up|1|||
144732262|NCT00857623|521875798|FG000|Overall Study|Adverse Event|5|||
144732263|NCT00857623|521875799|FG001|Overall Study|Adverse Event|2|||
144732264|NCT00857623|521875798|FG000|Overall Study|Study-specific discontinuation criteria|5|||
144732265|NCT00857623|521875799|FG001|Overall Study|Study-specific discontinuation criteria|3|||
144732266|NCT00857623|521875798|FG000|Overall Study|Withdrawal by Subject|2|||
144732267|NCT00857623|521875799|FG001|Overall Study|Withdrawal by Subject|1|||
144732268|NCT00857623|521875798|FG000|Overall Study|Lack of Efficacy|1|||
144732269|NCT00857623|521875799|FG001|Overall Study|Lack of Efficacy|1|||
144732270|NCT00857623|521875798|FG000|Overall Study|Severe non-compliance to protocol|1|||
144732271|NCT00857623|521875799|FG001|Overall Study|Severe non-compliance to protocol|1|||
144732272|NCT00857623|521875798|FG000|Overall Study|Intake of prohibited medication|0|||
144732273|NCT00857623|521875799|FG001|Overall Study|Intake of prohibited medication|1|||
144732274|NCT00857623|521875798|FG000|Overall Study|Positive for HEP C|0|||
144732275|NCT00857623|521875799|FG001|Overall Study|Positive for HEP C|1|||
144732276|NCT02193178|521875800|FG000|Overall Study|Lost to Follow-up|1|||
144732277|NCT02193178|521875800|FG000|Overall Study|Dry eyes|1|||
144213841|NCT00548093|519976934|FG000|Overall Study|Other|11|||
144213842|NCT00548093|519976935|FG001|Overall Study|Other|1|||
144213843|NCT00548093|519976934|FG000|Overall Study|Withdrawal by Subject|1|||
144213844|NCT00548093|519976935|FG001|Overall Study|Withdrawal by Subject|0|||
144213845|NCT00548093|519976934|FG000|Overall Study|Completed post-treatment follow-up|1|||
144213846|NCT00548093|519976935|FG001|Overall Study|Completed post-treatment follow-up|0|||
144213847|NCT02924727|519976940|FG000|Overall Study|Withdrawal by Subject|2|||
144213848|NCT02924727|519976941|FG001|Overall Study|Withdrawal by Subject|4|||
144213849|NCT02924727|519976940|FG000|Overall Study|Lost to Follow-up|2|||
144213850|NCT02924727|519976941|FG001|Overall Study|Lost to Follow-up|5|||
144213851|NCT02924727|519976940|FG000|Overall Study|Death|221|||
144213852|NCT02924727|519976941|FG001|Overall Study|Death|247|||
144213853|NCT02924727|519976940|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
144213854|NCT02924727|519976941|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
144213855|NCT03694327|519976942|FG000|Overall Study|Lost to Follow-up|13|||
144213856|NCT03694327|519976943|FG001|Overall Study|Lost to Follow-up|23|||
144213857|NCT01464931|519976946|FG000|Overall Study|Withdrawal by Subject|1|||
144213858|NCT01464931|519976947|FG001|Overall Study|Withdrawal by Subject|0|||
144213859|NCT01982812|519976948|FG000|Overall Study|Death|1|||
144213860|NCT01982812|519976949|FG001|Overall Study|Death|5|||
144213861|NCT01982812|519976948|FG000|Overall Study|Adverse Event|0|||
144732278|NCT03435081|521875801|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
144732279|NCT03435081|521875802|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
144732280|NCT03435081|521875803|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
144732281|NCT03435081|521875801|FG000|Week 0 to Week 16|Adverse Event|2|||
144732282|NCT03435081|521875802|FG001|Week 0 to Week 16|Adverse Event|2|||
144732283|NCT03435081|521875803|FG002|Week 0 to Week 16|Adverse Event|2|||
144732284|NCT03435081|521875801|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
144732285|NCT03435081|521875802|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
144732286|NCT03435081|521875803|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
144732287|NCT03435081|521875801|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
144732288|NCT03435081|521875802|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
144732289|NCT03435081|521875803|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
144213862|NCT01982812|519976949|FG001|Overall Study|Adverse Event|5|||
144213863|NCT00174954|519976950|FG000|Overall Study|Adverse Event|2|||
144732290|NCT03435081|521875801|FG000|Week 0 to Week 16|Pregnancy|1|||
144264006|NCT02573259|520167631|FG004|Overall Study|Death|9|||
144264007|NCT02573259|520167632|FG005|Overall Study|Death|32|||
144264008|NCT02573259|520167633|FG006|Overall Study|Death|21|||
144264009|NCT02573259|520167627|FG000|Overall Study|Lost to Follow-up|0|||
144264010|NCT02573259|520167628|FG001|Overall Study|Lost to Follow-up|0|||
144264011|NCT02573259|520167629|FG002|Overall Study|Lost to Follow-up|0|||
144264012|NCT02573259|520167630|FG003|Overall Study|Lost to Follow-up|0|||
144264013|NCT02573259|520167631|FG004|Overall Study|Lost to Follow-up|0|||
144264014|NCT02573259|520167632|FG005|Overall Study|Lost to Follow-up|2|||
144264015|NCT02573259|520167633|FG006|Overall Study|Lost to Follow-up|1|||
144264016|NCT02573259|520167627|FG000|Overall Study|Participant refused further follow-up|0|||
144264017|NCT02573259|520167628|FG001|Overall Study|Participant refused further follow-up|2|||
144264018|NCT02573259|520167629|FG002|Overall Study|Participant refused further follow-up|1|||
144264019|NCT02573259|520167630|FG003|Overall Study|Participant refused further follow-up|0|||
144264020|NCT02573259|520167631|FG004|Overall Study|Participant refused further follow-up|3|||
144264021|NCT02573259|520167632|FG005|Overall Study|Participant refused further follow-up|20|||
144264022|NCT02573259|520167633|FG006|Overall Study|Participant refused further follow-up|7|||
144264023|NCT02573259|520167627|FG000|Overall Study|Other|0|||
144264024|NCT02573259|520167628|FG001|Overall Study|Other|0|||
144264025|NCT02573259|520167629|FG002|Overall Study|Other|0|||
144264026|NCT02573259|520167630|FG003|Overall Study|Other|0|||
144264027|NCT02573259|520167631|FG004|Overall Study|Other|1|||
144264028|NCT02573259|520167632|FG005|Overall Study|Other|4|||
144264029|NCT02573259|520167633|FG006|Overall Study|Other|5|||
144264030|NCT00751140|520167634|FG000|Overall Study|benign angioma excluded from analysis|1|||
144264031|NCT00003471|520167637|FG000|Overall Study|Not evaluable|4|||
144264032|NCT00808067|520167638|FG000|Overall Study|Major/minor bleed|30|||
144264033|NCT00808067|520167639|FG001|Overall Study|Major/minor bleed|44|||
144264034|NCT00808067|520167638|FG000|Overall Study|Outcome event - other|33|||
144264035|NCT00808067|520167639|FG001|Overall Study|Outcome event - other|25|||
144264036|NCT00808067|520167638|FG000|Overall Study|Adverse Event|111|||
144264037|NCT00808067|520167639|FG001|Overall Study|Adverse Event|121|||
144264038|NCT00808067|520167638|FG000|Overall Study|Hospitalization (not including surgery)|18|||
144264039|NCT00808067|520167639|FG001|Overall Study|Hospitalization (not including surgery)|17|||
144264040|NCT00808067|520167638|FG000|Overall Study|Hospitalization due to surgery|37|||
144264041|NCT00808067|520167639|FG001|Overall Study|Hospitalization due to surgery|40|||
144264042|NCT00808067|520167638|FG000|Overall Study|Reduced creatinine clearance|53|||
144264043|NCT00808067|520167639|FG001|Overall Study|Reduced creatinine clearance|55|||
144264044|NCT00808067|520167638|FG000|Overall Study|Elevated LFT results|7|||
144264045|NCT00808067|520167639|FG001|Overall Study|Elevated LFT results|3|||
144264046|NCT00808067|520167638|FG000|Overall Study|Patient refused to take study medication|65|||
144264047|NCT00808067|520167639|FG001|Overall Study|Patient refused to take study medication|76|||
144264048|NCT00808067|520167638|FG000|Overall Study|Missing|1|||
144264049|NCT00808067|520167639|FG001|Overall Study|Missing|0|||
144264050|NCT00808067|520167638|FG000|Overall Study|Death|1|||
144264051|NCT00808067|520167639|FG001|Overall Study|Death|1|||
144264052|NCT00808067|520167638|FG000|Overall Study|Procedure|6|||
144264053|NCT00808067|520167639|FG001|Overall Study|Procedure|7|||
144264054|NCT00808067|520167638|FG000|Overall Study|Withdrawal by Subject|21|||
144264055|NCT00808067|520167639|FG001|Overall Study|Withdrawal by Subject|25|||
144264056|NCT00808067|520167638|FG000|Overall Study|Site closed|4|||
144264057|NCT00808067|520167639|FG001|Overall Study|Site closed|3|||
144264058|NCT00808067|520167638|FG000|Overall Study|Physician Decision|47|||
144264059|NCT00808067|520167639|FG001|Overall Study|Physician Decision|38|||
144264060|NCT00808067|520167638|FG000|Overall Study|Protocol Violation|3|||
144264061|NCT00808067|520167639|FG001|Overall Study|Protocol Violation|11|||
144264062|NCT00808067|520167638|FG000|Overall Study|Patient elected|7|||
144264063|NCT00808067|520167639|FG001|Overall Study|Patient elected|9|||
144653548|NCT03607682|521583750|FG000|Overall Study|Disease progression|1|||
144653549|NCT00376688|521583751|FG000|Overall Study|Adverse Event|3|||
144653550|NCT00376688|521583751|FG000|Overall Study|Death|1|||
144653551|NCT01770353|521583752|FG000|Overall Study|Progressive disease|2|||
144653552|NCT01770353|521583753|FG001|Overall Study|Progressive disease|1|||
144653553|NCT01770353|521583752|FG000|Overall Study|Adverse Event|0|||
144264064|NCT00808067|520167638|FG000|Overall Study|Site closed for cause|19|||
144264065|NCT00808067|520167639|FG001|Overall Study|Site closed for cause|19|||
144264066|NCT00808067|520167638|FG000|Overall Study|Other reason not defined above|5|||
144264067|NCT00808067|520167639|FG001|Overall Study|Other reason not defined above|5|||
144264068|NCT00808067|520167638|FG000|Overall Study|Excluded from analysis|13|||
144264069|NCT00808067|520167639|FG001|Overall Study|Excluded from analysis|19|||
144264070|NCT00689338|520167640|FG000|Overall Study|Death|65|||
144264071|NCT00689338|520167640|FG000|Overall Study|Adverse Event|13|||
144264072|NCT00689338|520167640|FG000|Overall Study|Insufficient Clinical Response|1|||
144264073|NCT00689338|520167640|FG000|Overall Study|Lack of Efficacy|6|||
144264074|NCT00689338|520167640|FG000|Overall Study|Other|8|||
144264075|NCT00689338|520167640|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
144264076|NCT00689338|520167640|FG000|Overall Study|Lost to Follow-up|5|||
144653554|NCT01770353|521583753|FG001|Overall Study|Adverse Event|1|||
144653555|NCT01770353|521583752|FG000|Overall Study|Protocol Violation|1|||
144653556|NCT01770353|521583753|FG001|Overall Study|Protocol Violation|0|||
144653557|NCT01770353|521583752|FG000|Overall Study|Physician Decision|0|||
144653558|NCT01770353|521583753|FG001|Overall Study|Physician Decision|3|||
144653559|NCT01770353|521583752|FG000|Overall Study|Clinical deterioration|3|||
144653560|NCT01770353|521583753|FG001|Overall Study|Clinical deterioration|6|||
144653561|NCT01770353|521583752|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
144653562|NCT01770353|521583753|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
144653563|NCT02574312|521583754|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
144653564|NCT02574312|521583755|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
144653565|NCT05128162|521583756|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
144653566|NCT05128162|521583756|FG000|Overall Study|Physician Decision|1|||
144653567|NCT01432262|521585538|FG000|Overall Study|Withdrawal by Subject|2|||
144653568|NCT01432262|521585539|FG001|Overall Study|Withdrawal by Subject|1|||
144653569|NCT01104558|521585542|FG000|Overall Study|Protocol Violation|6|||
144653570|NCT01104558|521585542|FG000|Overall Study|Missing of primary efficacy assessment|10|||
144653571|NCT01104558|521585542|FG000|Overall Study|Missing of genetic analysis results|1|||
144653572|NCT01755195|521585544|FG000|Overall Study|Participant noncompliance|2|||
144653573|NCT01755195|521585544|FG000|Overall Study|Switched to alternative treatment|4|||
144653574|NCT01755195|521585544|FG000|Overall Study|Withdrawal by Subject|1|||
144653575|NCT01755195|521585544|FG000|Overall Study|Participant refused to start treatment|1|||
144653576|NCT01755195|521585544|FG000|Overall Study|Participant has been consented for another trial|1|||
144653577|NCT01755195|521585544|FG000|Overall Study|Refused further treatment|3|||
144653578|NCT01755195|521585544|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
144653579|NCT01675011|521585547|FG000|Overall Study|Trial terminated by Sponsor|3|||
144653580|NCT01675011|521585548|FG001|Overall Study|Trial terminated by Sponsor|1|||
144653581|NCT00366548|521585549|FG000|Infant Series|Adverse Event|1|||
144653582|NCT00366548|521585550|FG001|Infant Series|Adverse Event|3|||
144653583|NCT00366548|521585549|FG000|Infant Series|Protocol Violation|0|||
144653584|NCT00366548|521585550|FG001|Infant Series|Protocol Violation|1|||
144653585|NCT00366548|521585549|FG000|Infant Series|Withdrawal by Subject|3|||
144653586|NCT00366548|521585550|FG001|Infant Series|Withdrawal by Subject|1|||
144653587|NCT00366548|521585549|FG000|After Infant Series|Withdrawal by Subject|3|||
144653588|NCT00366548|521585550|FG001|After Infant Series|Withdrawal by Subject|1|||
144653589|NCT00366548|521585549|FG000|After Infant Series|Adverse Event|2|||
144653590|NCT00366548|521585550|FG001|After Infant Series|Adverse Event|0|||
144653591|NCT00366548|521585549|FG000|After Infant Series|Lost to Follow-up|1|||
144653592|NCT00366548|521585550|FG001|After Infant Series|Lost to Follow-up|0|||
144653593|NCT02849990|521585551|FG000|Overall Study|Adverse Event|1|||
144653594|NCT02849990|521585551|FG000|Overall Study|Withdrawal by Subject|1|||
144653595|NCT02678741|521585552|FG000|Overall Study|Death|4|||
144653596|NCT02678741|521585552|FG000|Overall Study|Withdrawal by Subject|1|||
144653597|NCT02678741|521585552|FG000|Overall Study|ineligible|3|||
144653598|NCT02678741|521585552|FG000|Overall Study|Not RECIST Measurable|2|||
144653599|NCT02678741|521585552|FG000|Overall Study|Lack of Efficacy|10|||
144653600|NCT01795898|521585553|FG000|Overall Study|Adverse Event|27|||
144653601|NCT01795898|521585553|FG000|Overall Study|Lost to Follow-up|20|||
144653602|NCT01795898|521585553|FG000|Overall Study|Withdrawal of consent|6|||
144653603|NCT01795898|521585553|FG000|Overall Study|Diagnosed with metastasis|1|||
144653604|NCT01795898|521585553|FG000|Overall Study|No pain|1|||
144653605|NCT01795898|521585553|FG000|Overall Study|Death|1|||
144653606|NCT01795898|521585553|FG000|Overall Study|Withdrew consent & had adverse events|3|||
144653607|NCT01795898|521585553|FG000|Overall Study|Physician Decision|1|||
144653608|NCT03539458|521585554|FG000|Overall Study|Death|1|||
144653609|NCT01984346|521585555|FG000|Overall Study|Physician Decision|4|||
144653610|NCT01984346|521585556|FG001|Overall Study|Physician Decision|2|||
144653611|NCT01984346|521585555|FG000|Overall Study|Withdrawal by Subject|2|||
144653612|NCT01984346|521585556|FG001|Overall Study|Withdrawal by Subject|2|||
144653613|NCT01984346|521585555|FG000|Overall Study|Enrollment Closed|8|||
144653614|NCT01984346|521585556|FG001|Overall Study|Enrollment Closed|1|||
144653615|NCT01984346|521585555|FG000|Overall Study|Insurance Coverage|1|||
144653616|NCT01984346|521585556|FG001|Overall Study|Insurance Coverage|0|||
144732291|NCT03435081|521875802|FG001|Week 0 to Week 16|Pregnancy|0|||
144653617|NCT01984346|521585555|FG000|Overall Study|Intra-operative Exclusion|2|||
144653618|NCT01984346|521585556|FG001|Overall Study|Intra-operative Exclusion|0|||
144653619|NCT00536731|521585557|FG000|Overall Study|Adverse Event|3|||
144653620|NCT00536731|521585558|FG001|Overall Study|Adverse Event|2|||
144653621|NCT00536731|521585559|FG002|Overall Study|Adverse Event|3|||
144653622|NCT00536731|521585557|FG000|Overall Study|Withdrawal by Subject|0|||
144653623|NCT00536731|521585558|FG001|Overall Study|Withdrawal by Subject|2|||
144653624|NCT00536731|521585559|FG002|Overall Study|Withdrawal by Subject|0|||
144653625|NCT00536731|521585557|FG000|Overall Study|Intake of prohibited conc. medication|0|||
144653626|NCT00536731|521585558|FG001|Overall Study|Intake of prohibited conc. medication|0|||
144653627|NCT00536731|521585559|FG002|Overall Study|Intake of prohibited conc. medication|1|||
144653628|NCT00536731|521585557|FG000|Overall Study|Safety reasons|0|||
144653629|NCT00536731|521585558|FG001|Overall Study|Safety reasons|0|||
144653630|NCT00536731|521585559|FG002|Overall Study|Safety reasons|1|||
144653631|NCT00536731|521585557|FG000|Overall Study|Other|1|||
144653632|NCT00536731|521585558|FG001|Overall Study|Other|1|||
144653633|NCT00536731|521585559|FG002|Overall Study|Other|0|||
144653634|NCT00718419|521585560|FG000|Overall Study|Adverse Event|2|||
144653635|NCT00718419|521585561|FG001|Overall Study|Adverse Event|1|||
144653636|NCT00718419|521585560|FG000|Overall Study|Physician Decision|1|||
144653637|NCT00718419|521585561|FG001|Overall Study|Physician Decision|6|||
144653638|NCT00718419|521585560|FG000|Overall Study|Sponsor decision|0|||
144653639|NCT00718419|521585561|FG001|Overall Study|Sponsor decision|1|||
144653640|NCT00718419|521585560|FG000|Overall Study|Withdrawal by Subject|0|||
144653641|NCT00718419|521585561|FG001|Overall Study|Withdrawal by Subject|5|||
144653642|NCT00718419|521585560|FG000|Overall Study|Progressive Disease|7|||
144653643|NCT00718419|521585561|FG001|Overall Study|Progressive Disease|25|||
144653644|NCT00718419|521585560|FG000|Overall Study|Death Due to Progressive Disease|2|||
144653645|NCT00718419|521585561|FG001|Overall Study|Death Due to Progressive Disease|0|||
144653646|NCT00718419|521585560|FG000|Overall Study|Death Due to Study Drug Related|0|||
144653647|NCT00718419|521585561|FG001|Overall Study|Death Due to Study Drug Related|1|||
144653648|NCT00718419|521585560|FG000|Overall Study|Death Due to Adverse Events|1|||
144653649|NCT00718419|521585561|FG001|Overall Study|Death Due to Adverse Events|0|||
144653650|NCT01623531|521585564|FG000|Overall Study|Death|1|||
144653651|NCT01623531|521585565|FG001|Overall Study|Death|0|||
144653652|NCT01623531|521585564|FG000|Overall Study|Protocol Violation|2|||
144653653|NCT01623531|521585565|FG001|Overall Study|Protocol Violation|1|||
144653654|NCT01623531|521585564|FG000|Overall Study|Missing data at primary outcome time poi|1|||
144653655|NCT01623531|521585565|FG001|Overall Study|Missing data at primary outcome time poi|1|||
144653656|NCT04184622|521585567|FG000|Primary Treatment Period|Adverse Event|6|||
144653657|NCT04184622|521585568|FG001|Primary Treatment Period|Adverse Event|4|||
144653658|NCT04184622|521585569|FG002|Primary Treatment Period|Adverse Event|8|||
144653659|NCT04184622|521585570|FG003|Primary Treatment Period|Adverse Event|6|||
144653660|NCT04184622|521585567|FG000|Primary Treatment Period|Death|4|||
144653661|NCT04184622|521585568|FG001|Primary Treatment Period|Death|4|||
144653662|NCT04184622|521585569|FG002|Primary Treatment Period|Death|2|||
144653663|NCT04184622|521585570|FG003|Primary Treatment Period|Death|1|||
144653664|NCT04184622|521585567|FG000|Primary Treatment Period|Lost to Follow-up|41|||
144653665|NCT04184622|521585568|FG001|Primary Treatment Period|Lost to Follow-up|17|||
144653666|NCT04184622|521585569|FG002|Primary Treatment Period|Lost to Follow-up|15|||
144653667|NCT04184622|521585570|FG003|Primary Treatment Period|Lost to Follow-up|13|||
144653668|NCT04184622|521585567|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
144653669|NCT04184622|521585568|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
144653670|NCT04184622|521585569|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
144653671|NCT04184622|521585570|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
144653672|NCT04184622|521585567|FG000|Primary Treatment Period|Physician Decision|0|||
144653673|NCT04184622|521585568|FG001|Primary Treatment Period|Physician Decision|0|||
144653674|NCT04184622|521585569|FG002|Primary Treatment Period|Physician Decision|3|||
144653675|NCT04184622|521585570|FG003|Primary Treatment Period|Physician Decision|1|||
144653676|NCT04184622|521585567|FG000|Primary Treatment Period|Pregnancy|4|||
144653677|NCT04184622|521585568|FG001|Primary Treatment Period|Pregnancy|3|||
144653678|NCT04184622|521585569|FG002|Primary Treatment Period|Pregnancy|4|||
144653679|NCT04184622|521585570|FG003|Primary Treatment Period|Pregnancy|1|||
144653680|NCT04184622|521585567|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
144653681|NCT04184622|521585568|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
144653682|NCT04184622|521585569|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
144653683|NCT04184622|521585570|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
144653684|NCT04184622|521585567|FG000|Additional Treatment Period|Adverse Event|1|||
144653685|NCT04184622|521585568|FG001|Additional Treatment Period|Adverse Event|2|||
144653686|NCT04184622|521585569|FG002|Additional Treatment Period|Adverse Event|1|||
144653687|NCT04184622|521585570|FG003|Additional Treatment Period|Adverse Event|0|||
144653688|NCT04184622|521585567|FG000|Additional Treatment Period|Death|0|||
144653689|NCT04184622|521585568|FG001|Additional Treatment Period|Death|0|||
144653690|NCT04184622|521585569|FG002|Additional Treatment Period|Death|1|||
144653691|NCT04184622|521585570|FG003|Additional Treatment Period|Death|1|||
144653692|NCT04184622|521585567|FG000|Additional Treatment Period|Lost to Follow-up|6|||
144653693|NCT04184622|521585568|FG001|Additional Treatment Period|Lost to Follow-up|4|||
144653694|NCT04184622|521585569|FG002|Additional Treatment Period|Lost to Follow-up|8|||
144653695|NCT04184622|521585570|FG003|Additional Treatment Period|Lost to Follow-up|6|||
144653696|NCT04184622|521585567|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
144653697|NCT04184622|521585568|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
144653698|NCT04184622|521585569|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
144653699|NCT04184622|521585570|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
144653700|NCT04184622|521585567|FG000|Additional Treatment Period|Physician Decision|0|||
144653701|NCT04184622|521585568|FG001|Additional Treatment Period|Physician Decision|0|||
144653702|NCT04184622|521585569|FG002|Additional Treatment Period|Physician Decision|1|||
144264077|NCT00689338|520167640|FG000|Overall Study|Withdrawal by Subject|3|||
144264078|NCT00689338|520167640|FG000|Overall Study|Protocol Violation|15|||
144264079|NCT00715403|520167641|FG000|Overall Study|Progressive disease|0|||
144264080|NCT00715403|520167642|FG001|Overall Study|Progressive disease|1|||
144264081|NCT00715403|520167643|FG002|Overall Study|Progressive disease|3|||
144264082|NCT00715403|520167644|FG003|Overall Study|Progressive disease|9|||
144264083|NCT00715403|520167645|FG004|Overall Study|Progressive disease|5|||
144264084|NCT00715403|520167646|FG005|Overall Study|Progressive disease|14|||
144264085|NCT00715403|520167647|FG006|Overall Study|Progressive disease|1|||
144264086|NCT00715403|520167641|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
144264087|NCT00715403|520167642|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
144264088|NCT00715403|520167643|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
144264089|NCT00715403|520167644|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
144264090|NCT00715403|520167645|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
144264091|NCT00715403|520167646|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
144264092|NCT00715403|520167647|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
144264093|NCT00715403|520167641|FG000|Overall Study|Other Adverse Event than DLT|1|||
144264094|NCT00715403|520167642|FG001|Overall Study|Other Adverse Event than DLT|0|||
144264095|NCT00715403|520167643|FG002|Overall Study|Other Adverse Event than DLT|0|||
144264096|NCT00715403|520167644|FG003|Overall Study|Other Adverse Event than DLT|0|||
144264097|NCT00715403|520167645|FG004|Overall Study|Other Adverse Event than DLT|0|||
144264098|NCT00715403|520167646|FG005|Overall Study|Other Adverse Event than DLT|2|||
144264099|NCT00715403|520167647|FG006|Overall Study|Other Adverse Event than DLT|0|||
144264100|NCT00715403|520167641|FG000|Overall Study|Protocol Violation|0|||
144264101|NCT00715403|520167642|FG001|Overall Study|Protocol Violation|0|||
144264102|NCT00715403|520167643|FG002|Overall Study|Protocol Violation|0|||
144264103|NCT00715403|520167644|FG003|Overall Study|Protocol Violation|0|||
144264104|NCT00715403|520167645|FG004|Overall Study|Protocol Violation|0|||
144264105|NCT00715403|520167646|FG005|Overall Study|Protocol Violation|1|||
144264106|NCT00715403|520167647|FG006|Overall Study|Protocol Violation|0|||
144264107|NCT00715403|520167641|FG000|Overall Study|Other reason not defined above|0|||
144264108|NCT00715403|520167642|FG001|Overall Study|Other reason not defined above|0|||
144264109|NCT00715403|520167643|FG002|Overall Study|Other reason not defined above|1|||
144264110|NCT00715403|520167644|FG003|Overall Study|Other reason not defined above|0|||
144264111|NCT00715403|520167645|FG004|Overall Study|Other reason not defined above|1|||
144264112|NCT00715403|520167646|FG005|Overall Study|Other reason not defined above|1|||
144264113|NCT00715403|520167647|FG006|Overall Study|Other reason not defined above|0|||
144264114|NCT02104895|520167648|FG000|Overall Study|Withdrawal by Subject|0|||
144264115|NCT02104895|520167649|FG001|Overall Study|Withdrawal by Subject|14|||
144264116|NCT03839394|520167650|FG000|Overall Study|Lost to Follow-up|6|||
144264117|NCT03839394|520167651|FG001|Overall Study|Lost to Follow-up|8|||
144264118|NCT03839394|520167650|FG000|Overall Study|Withdrawal by Subject|0|||
144264119|NCT03839394|520167651|FG001|Overall Study|Withdrawal by Subject|2|||
144264120|NCT02532283|520167656|FG000|Overall Study|Adverse Event|0|||
144264121|NCT02532283|520167657|FG001|Overall Study|Adverse Event|1|||
144264122|NCT02532283|520167656|FG000|Overall Study|Death|1|||
144264123|NCT02532283|520167657|FG001|Overall Study|Death|0|||
144264124|NCT02532283|520167656|FG000|Overall Study|Lost to Follow-up|0|||
144264125|NCT02532283|520167657|FG001|Overall Study|Lost to Follow-up|1|||
144264126|NCT02532283|520167656|FG000|Overall Study|Withdrawal by Subject|8|||
144264127|NCT02532283|520167657|FG001|Overall Study|Withdrawal by Subject|3|||
144264128|NCT01817075|520167658|FG000|Overall Study|Adverse Event|7|||
144264129|NCT01817075|520167659|FG001|Overall Study|Adverse Event|5|||
144264130|NCT01817075|520167658|FG000|Overall Study|Physician Decision|9|||
144264131|NCT01817075|520167659|FG001|Overall Study|Physician Decision|12|||
144264132|NCT01817075|520167658|FG000|Overall Study|Withdrawal by Subject|31|||
144264133|NCT01817075|520167659|FG001|Overall Study|Withdrawal by Subject|15|||
144264134|NCT01817075|520167658|FG000|Overall Study|Received Sorafenib after enrollment|0|||
144653703|NCT04184622|521585570|FG003|Additional Treatment Period|Physician Decision|0|||
144653704|NCT04184622|521585567|FG000|Additional Treatment Period|Pregnancy|0|||
144653705|NCT04184622|521585568|FG001|Additional Treatment Period|Pregnancy|0|||
144653706|NCT04184622|521585569|FG002|Additional Treatment Period|Pregnancy|0|||
144653707|NCT04184622|521585570|FG003|Additional Treatment Period|Pregnancy|1|||
144264135|NCT01817075|520167659|FG001|Overall Study|Received Sorafenib after enrollment|1|||
144653708|NCT04184622|521585567|FG000|Additional Treatment Period|Protocol deviation|0|||
144653709|NCT04184622|521585568|FG001|Additional Treatment Period|Protocol deviation|0|||
144653710|NCT04184622|521585569|FG002|Additional Treatment Period|Protocol deviation|1|||
144264136|NCT01817075|520167658|FG000|Overall Study|Ineligible|0|||
144264137|NCT01817075|520167659|FG001|Overall Study|Ineligible|2|||
144264138|NCT04376515|520167662|FG000|Overall Study|Found to have been vaccinated before study start|6|||
144264139|NCT04376515|520167663|FG001|Overall Study|Found to have been vaccinated before study start|6|||
144264140|NCT03811821|520167664|FG000|Overall Study|Adverse Event|1|||
144264141|NCT03811821|520167665|FG001|Overall Study|Adverse Event|1|||
144264142|NCT03811821|520167664|FG000|Overall Study|Withdrawal by Subject|5|||
144264143|NCT03811821|520167665|FG001|Overall Study|Withdrawal by Subject|4|||
144653711|NCT04184622|521585570|FG003|Additional Treatment Period|Protocol deviation|0|||
144653712|NCT04184622|521585567|FG000|Additional Treatment Period|Site closed|1|||
144653713|NCT04184622|521585568|FG001|Additional Treatment Period|Site closed|0|||
144653714|NCT04184622|521585569|FG002|Additional Treatment Period|Site closed|1|||
144653715|NCT04184622|521585570|FG003|Additional Treatment Period|Site closed|0|||
144653716|NCT04184622|521585567|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
144653717|NCT04184622|521585568|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
144653718|NCT04184622|521585569|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
144653719|NCT04184622|521585570|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
144653720|NCT04184622|521585567|FG000|Safety Follow-up Period|Adverse Event|6|||
144653721|NCT04184622|521585568|FG001|Safety Follow-up Period|Adverse Event|8|||
144653722|NCT04184622|521585569|FG002|Safety Follow-up Period|Adverse Event|9|||
144653723|NCT04184622|521585570|FG003|Safety Follow-up Period|Adverse Event|16|||
144653724|NCT04184622|521585567|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
144653725|NCT04184622|521585568|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
144653726|NCT04184622|521585569|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
144653727|NCT04184622|521585570|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
144653728|NCT04184622|521585567|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
144653729|NCT04184622|521585568|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
144653730|NCT04184622|521585569|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
144653731|NCT04184622|521585570|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
144653732|NCT04184622|521585567|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
144653733|NCT04184622|521585568|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
144653734|NCT04184622|521585569|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
144653735|NCT04184622|521585570|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
144653736|NCT04184622|521585567|FG000|Safety Follow-up Period|Physician Decision|1|||
144653737|NCT04184622|521585568|FG001|Safety Follow-up Period|Physician Decision|0|||
144653738|NCT04184622|521585569|FG002|Safety Follow-up Period|Physician Decision|0|||
144653739|NCT04184622|521585570|FG003|Safety Follow-up Period|Physician Decision|1|||
144653740|NCT04184622|521585567|FG000|Safety Follow-up Period|Pregnancy|1|||
144653741|NCT04184622|521585568|FG001|Safety Follow-up Period|Pregnancy|3|||
144653742|NCT04184622|521585569|FG002|Safety Follow-up Period|Pregnancy|0|||
144653743|NCT04184622|521585570|FG003|Safety Follow-up Period|Pregnancy|6|||
144653744|NCT04184622|521585567|FG000|Safety Follow-up Period|Protocol deviation|1|||
144653745|NCT04184622|521585568|FG001|Safety Follow-up Period|Protocol deviation|0|||
144653746|NCT04184622|521585569|FG002|Safety Follow-up Period|Protocol deviation|0|||
144653747|NCT04184622|521585570|FG003|Safety Follow-up Period|Protocol deviation|0|||
144653748|NCT04184622|521585567|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
144653749|NCT04184622|521585568|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
144653750|NCT04184622|521585569|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
144653751|NCT04184622|521585570|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
144653752|NCT01070550|521585571|FG000|Overall Study|Adverse Event|43|||
144653753|NCT01070550|521585572|FG001|Overall Study|Adverse Event|1|||
144653754|NCT01070550|521585573|FG002|Overall Study|Adverse Event|3|||
144653755|NCT01070550|521585574|FG003|Overall Study|Adverse Event|0|||
144653756|NCT01070550|521585575|FG004|Overall Study|Adverse Event|0|||
144653757|NCT01070550|521585576|FG005|Overall Study|Adverse Event|0|||
144653758|NCT01070550|521585571|FG000|Overall Study|Death|20|||
144653759|NCT01070550|521585572|FG001|Overall Study|Death|4|||
144653760|NCT01070550|521585573|FG002|Overall Study|Death|3|||
144653761|NCT01070550|521585574|FG003|Overall Study|Death|0|||
144653762|NCT01070550|521585575|FG004|Overall Study|Death|0|||
144653763|NCT01070550|521585576|FG005|Overall Study|Death|0|||
144653764|NCT01070550|521585571|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
144653765|NCT01070550|521585572|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
144653766|NCT01070550|521585573|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
144653767|NCT01070550|521585574|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
144653768|NCT01070550|521585575|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
144653769|NCT01070550|521585576|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
144653770|NCT01070550|521585571|FG000|Overall Study|Early termination|3|||
144653771|NCT01070550|521585572|FG001|Overall Study|Early termination|0|||
144653772|NCT01070550|521585573|FG002|Overall Study|Early termination|0|||
144653773|NCT01070550|521585574|FG003|Overall Study|Early termination|0|||
144653774|NCT01070550|521585575|FG004|Overall Study|Early termination|0|||
144653775|NCT01070550|521585576|FG005|Overall Study|Early termination|0|||
144653776|NCT01070550|521585571|FG000|Overall Study|Failed to return|450|||
144653777|NCT01070550|521585572|FG001|Overall Study|Failed to return|33|||
144653778|NCT01070550|521585573|FG002|Overall Study|Failed to return|144|||
144653779|NCT01070550|521585574|FG003|Overall Study|Failed to return|40|||
144653780|NCT01070550|521585575|FG004|Overall Study|Failed to return|1|||
144653781|NCT01070550|521585576|FG005|Overall Study|Failed to return|2|||
144653782|NCT01070550|521585571|FG000|Overall Study|Incomplete treatment|2|||
144653783|NCT01070550|521585572|FG001|Overall Study|Incomplete treatment|0|||
144653784|NCT01070550|521585573|FG002|Overall Study|Incomplete treatment|0|||
144653785|NCT01070550|521585574|FG003|Overall Study|Incomplete treatment|0|||
144653786|NCT01070550|521585575|FG004|Overall Study|Incomplete treatment|0|||
144653787|NCT01070550|521585576|FG005|Overall Study|Incomplete treatment|0|||
144653788|NCT01070550|521585571|FG000|Overall Study|Lab test not done|22|||
144653789|NCT01070550|521585572|FG001|Overall Study|Lab test not done|3|||
144653790|NCT01070550|521585573|FG002|Overall Study|Lab test not done|4|||
144653791|NCT01070550|521585574|FG003|Overall Study|Lab test not done|1|||
144653792|NCT01070550|521585575|FG004|Overall Study|Lab test not done|0|||
144653793|NCT01070550|521585576|FG005|Overall Study|Lab test not done|1|||
144653794|NCT01070550|521585571|FG000|Overall Study|Lack of Efficacy|65|||
144653795|NCT01070550|521585572|FG001|Overall Study|Lack of Efficacy|1|||
144653796|NCT01070550|521585573|FG002|Overall Study|Lack of Efficacy|5|||
144653797|NCT01070550|521585574|FG003|Overall Study|Lack of Efficacy|5|||
144653798|NCT01070550|521585575|FG004|Overall Study|Lack of Efficacy|0|||
144653799|NCT01070550|521585576|FG005|Overall Study|Lack of Efficacy|1|||
144653800|NCT01070550|521585571|FG000|Overall Study|Miscellaneous|12|||
144653801|NCT01070550|521585572|FG001|Overall Study|Miscellaneous|2|||
144653802|NCT01070550|521585573|FG002|Overall Study|Miscellaneous|3|||
144653803|NCT01070550|521585574|FG003|Overall Study|Miscellaneous|1|||
144653804|NCT01070550|521585575|FG004|Overall Study|Miscellaneous|0|||
144653805|NCT01070550|521585576|FG005|Overall Study|Miscellaneous|0|||
144653806|NCT01070550|521585571|FG000|Overall Study|New treatment started|3|||
144653807|NCT01070550|521585572|FG001|Overall Study|New treatment started|1|||
144653808|NCT01070550|521585573|FG002|Overall Study|New treatment started|0|||
144653809|NCT01070550|521585574|FG003|Overall Study|New treatment started|2|||
144653810|NCT01070550|521585575|FG004|Overall Study|New treatment started|0|||
144653811|NCT01070550|521585576|FG005|Overall Study|New treatment started|0|||
144653812|NCT01070550|521585571|FG000|Overall Study|Non-responders|493|||
144653813|NCT01070550|521585572|FG001|Overall Study|Non-responders|4|||
144653814|NCT01070550|521585573|FG002|Overall Study|Non-responders|21|||
144653815|NCT01070550|521585574|FG003|Overall Study|Non-responders|20|||
144653816|NCT01070550|521585575|FG004|Overall Study|Non-responders|0|||
144653817|NCT01070550|521585576|FG005|Overall Study|Non-responders|2|||
144653818|NCT01070550|521585571|FG000|Overall Study|Not categorized|33|||
144653819|NCT01070550|521585572|FG001|Overall Study|Not categorized|2|||
144653820|NCT01070550|521585573|FG002|Overall Study|Not categorized|6|||
144653821|NCT01070550|521585574|FG003|Overall Study|Not categorized|1|||
144653822|NCT01070550|521585575|FG004|Overall Study|Not categorized|0|||
144653823|NCT01070550|521585576|FG005|Overall Study|Not categorized|1|||
144653824|NCT01070550|521585571|FG000|Overall Study|Protocol Violation|15|||
144653825|NCT01070550|521585572|FG001|Overall Study|Protocol Violation|1|||
144653826|NCT01070550|521585573|FG002|Overall Study|Protocol Violation|1|||
144653827|NCT01070550|521585574|FG003|Overall Study|Protocol Violation|1|||
144653828|NCT01070550|521585575|FG004|Overall Study|Protocol Violation|0|||
144653829|NCT01070550|521585576|FG005|Overall Study|Protocol Violation|0|||
144653830|NCT01070550|521585571|FG000|Overall Study|Relapse|44|||
144653831|NCT01070550|521585572|FG001|Overall Study|Relapse|5|||
144653832|NCT01070550|521585573|FG002|Overall Study|Relapse|14|||
144653833|NCT01070550|521585574|FG003|Overall Study|Relapse|4|||
144653834|NCT01070550|521585575|FG004|Overall Study|Relapse|0|||
144653835|NCT01070550|521585576|FG005|Overall Study|Relapse|0|||
144653836|NCT01070550|521585571|FG000|Overall Study|Result not available|3|||
144653837|NCT01070550|521585572|FG001|Overall Study|Result not available|1|||
144653838|NCT01070550|521585573|FG002|Overall Study|Result not available|3|||
144653839|NCT01070550|521585574|FG003|Overall Study|Result not available|0|||
144213864|NCT00174954|519976950|FG000|Overall Study|No tophi found in MRI|1|||
144213865|NCT00174954|519976950|FG000|Overall Study|Physician Decision|1|||
144213866|NCT02185053|519976951|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
144213867|NCT02185053|519976952|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
144213868|NCT02185053|519976953|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
144213869|NCT02185053|519976951|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
144213870|NCT02185053|519976952|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
144213871|NCT02185053|519976953|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
144213872|NCT02185053|519976951|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
144213873|NCT02185053|519976952|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
144213874|NCT02185053|519976953|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
144213875|NCT02185053|519976951|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
144213876|NCT02185053|519976952|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
144653840|NCT01070550|521585575|FG004|Overall Study|Result not available|0|||
144653841|NCT01070550|521585576|FG005|Overall Study|Result not available|0|||
144653842|NCT01070550|521585571|FG000|Overall Study|Screen failure|1|||
144653843|NCT01070550|521585572|FG001|Overall Study|Screen failure|0|||
144653844|NCT01070550|521585573|FG002|Overall Study|Screen failure|0|||
144653845|NCT01070550|521585574|FG003|Overall Study|Screen failure|0|||
144653846|NCT01070550|521585575|FG004|Overall Study|Screen failure|0|||
144653847|NCT01070550|521585576|FG005|Overall Study|Screen failure|0|||
144653848|NCT01070550|521585571|FG000|Overall Study|Sponsor decision|1|||
144653849|NCT01070550|521585572|FG001|Overall Study|Sponsor decision|0|||
144653850|NCT01070550|521585573|FG002|Overall Study|Sponsor decision|0|||
144653851|NCT01070550|521585574|FG003|Overall Study|Sponsor decision|0|||
144653852|NCT01070550|521585575|FG004|Overall Study|Sponsor decision|0|||
144653853|NCT01070550|521585576|FG005|Overall Study|Sponsor decision|0|||
144653854|NCT01070550|521585571|FG000|Overall Study|Treatment duration shortened|1|||
144653855|NCT01070550|521585572|FG001|Overall Study|Treatment duration shortened|0|||
144653856|NCT01070550|521585573|FG002|Overall Study|Treatment duration shortened|0|||
144653857|NCT01070550|521585574|FG003|Overall Study|Treatment duration shortened|0|||
144653858|NCT01070550|521585575|FG004|Overall Study|Treatment duration shortened|0|||
144653859|NCT01070550|521585576|FG005|Overall Study|Treatment duration shortened|0|||
144653860|NCT01070550|521585571|FG000|Overall Study|Treatment interrupted|7|||
144653861|NCT01070550|521585572|FG001|Overall Study|Treatment interrupted|0|||
144653862|NCT01070550|521585573|FG002|Overall Study|Treatment interrupted|1|||
144653863|NCT01070550|521585574|FG003|Overall Study|Treatment interrupted|1|||
144653864|NCT01070550|521585575|FG004|Overall Study|Treatment interrupted|0|||
144653865|NCT01070550|521585576|FG005|Overall Study|Treatment interrupted|0|||
144653866|NCT01070550|521585571|FG000|Overall Study|Treatment not started|14|||
144653867|NCT01070550|521585572|FG001|Overall Study|Treatment not started|2|||
144653868|NCT01070550|521585573|FG002|Overall Study|Treatment not started|4|||
144653869|NCT01070550|521585574|FG003|Overall Study|Treatment not started|0|||
144653870|NCT01070550|521585575|FG004|Overall Study|Treatment not started|0|||
144653871|NCT01070550|521585576|FG005|Overall Study|Treatment not started|0|||
144653872|NCT01070550|521585571|FG000|Overall Study|Treatment restarted|0|||
144653873|NCT01070550|521585572|FG001|Overall Study|Treatment restarted|1|||
144653874|NCT01070550|521585573|FG002|Overall Study|Treatment restarted|0|||
144653875|NCT01070550|521585574|FG003|Overall Study|Treatment restarted|0|||
144653876|NCT01070550|521585575|FG004|Overall Study|Treatment restarted|0|||
144653877|NCT01070550|521585576|FG005|Overall Study|Treatment restarted|0|||
144653878|NCT01070550|521585571|FG000|Overall Study|Treatment stopped|3|||
144653879|NCT01070550|521585572|FG001|Overall Study|Treatment stopped|0|||
144653880|NCT01070550|521585573|FG002|Overall Study|Treatment stopped|0|||
144653881|NCT01070550|521585574|FG003|Overall Study|Treatment stopped|0|||
144653882|NCT01070550|521585575|FG004|Overall Study|Treatment stopped|0|||
144653883|NCT01070550|521585576|FG005|Overall Study|Treatment stopped|0|||
144653884|NCT01070550|521585571|FG000|Overall Study|Treatment unavailable|1|||
144653885|NCT01070550|521585572|FG001|Overall Study|Treatment unavailable|0|||
144653886|NCT01070550|521585573|FG002|Overall Study|Treatment unavailable|0|||
144653887|NCT01070550|521585574|FG003|Overall Study|Treatment unavailable|0|||
144653888|NCT01070550|521585575|FG004|Overall Study|Treatment unavailable|0|||
144653889|NCT01070550|521585576|FG005|Overall Study|Treatment unavailable|0|||
144653890|NCT01070550|521585571|FG000|Overall Study|Treatment was stopped early|7|||
144653891|NCT01070550|521585572|FG001|Overall Study|Treatment was stopped early|0|||
144653892|NCT01070550|521585573|FG002|Overall Study|Treatment was stopped early|0|||
144653893|NCT01070550|521585574|FG003|Overall Study|Treatment was stopped early|0|||
144653894|NCT01070550|521585575|FG004|Overall Study|Treatment was stopped early|0|||
144653895|NCT01070550|521585576|FG005|Overall Study|Treatment was stopped early|0|||
144653896|NCT01070550|521585571|FG000|Overall Study|Other|5|||
144653897|NCT01070550|521585572|FG001|Overall Study|Other|0|||
144653898|NCT01070550|521585573|FG002|Overall Study|Other|0|||
144653899|NCT01070550|521585574|FG003|Overall Study|Other|1|||
144653900|NCT01070550|521585575|FG004|Overall Study|Other|0|||
144653901|NCT01070550|521585576|FG005|Overall Study|Other|0|||
144653902|NCT01070550|521585571|FG000|Overall Study|Withdrawal by Subject|35|||
144653903|NCT01070550|521585572|FG001|Overall Study|Withdrawal by Subject|0|||
144653904|NCT01070550|521585573|FG002|Overall Study|Withdrawal by Subject|3|||
144653905|NCT01070550|521585574|FG003|Overall Study|Withdrawal by Subject|0|||
144653906|NCT01070550|521585575|FG004|Overall Study|Withdrawal by Subject|0|||
144653907|NCT01070550|521585576|FG005|Overall Study|Withdrawal by Subject|0|||
144653908|NCT01234402|521585581|FG000|Overall Study|Lost to Follow-up|0|||
144653909|NCT01234402|521585582|FG001|Overall Study|Lost to Follow-up|1|||
144653910|NCT01234402|521585583|FG002|Overall Study|Lost to Follow-up|3|||
144653911|NCT01234402|521585581|FG000|Overall Study|Withdrawal by Subject|1|||
144653912|NCT01234402|521585582|FG001|Overall Study|Withdrawal by Subject|3|||
144653913|NCT01234402|521585583|FG002|Overall Study|Withdrawal by Subject|4|||
144653914|NCT01234402|521585581|FG000|Overall Study|Never treated: Death|0|||
144653915|NCT01234402|521585582|FG001|Overall Study|Never treated: Death|0|||
144653916|NCT01234402|521585583|FG002|Overall Study|Never treated: Death|1|||
144653917|NCT01234402|521585581|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
144653918|NCT01234402|521585582|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
144653919|NCT01234402|521585583|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
144653920|NCT01234402|521585581|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
144653921|NCT01234402|521585582|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
144653922|NCT01234402|521585583|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
144653923|NCT01106534|521585585|FG000|Overall Study|Withdrawal by Subject|18|||
144653924|NCT01106534|521585585|FG000|Overall Study|Lost to Follow-up|2|||
144653925|NCT01106534|521585585|FG000|Overall Study|Death|16|||
144653926|NCT01106534|521585585|FG000|Overall Study|Physician Decision|1|||
144653927|NCT00069576|521585591|FG000|Original Trial|Lost to Follow-up|25|||
144653928|NCT00069576|521585592|FG001|Original Trial|Lost to Follow-up|33|||
144653929|NCT00069576|521585591|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
144653930|NCT00069576|521585592|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
144653931|NCT00002663|521585593|FG000|Overall Study|Death|4|||
144653932|NCT00002663|521585594|FG001|Overall Study|Death|1|||
144653933|NCT00002663|521585595|FG002|Overall Study|Death|1|||
144653934|NCT00002663|521585596|FG003|Overall Study|Death|0|||
144653935|NCT00002663|521585597|FG004|Overall Study|Death|0|||
144653936|NCT00002663|521585598|FG005|Overall Study|Death|13|||
144653937|NCT00002663|521585599|FG006|Overall Study|Death|0|||
144653938|NCT00002663|521585600|FG007|Overall Study|Death|1|||
144653939|NCT00002663|521585601|FG008|Overall Study|Death|1|||
144653940|NCT00002663|521585602|FG009|Overall Study|Death|1|||
144653941|NCT00002663|521585593|FG000|Overall Study|Lost to Follow-up|3|||
144653942|NCT00002663|521585594|FG001|Overall Study|Lost to Follow-up|0|||
144653943|NCT00002663|521585595|FG002|Overall Study|Lost to Follow-up|0|||
144653944|NCT00002663|521585596|FG003|Overall Study|Lost to Follow-up|1|||
144653945|NCT00002663|521585597|FG004|Overall Study|Lost to Follow-up|0|||
144653946|NCT00002663|521585598|FG005|Overall Study|Lost to Follow-up|1|||
144653947|NCT00002663|521585599|FG006|Overall Study|Lost to Follow-up|0|||
144653948|NCT00002663|521585600|FG007|Overall Study|Lost to Follow-up|0|||
144653949|NCT00002663|521585601|FG008|Overall Study|Lost to Follow-up|0|||
144653950|NCT00002663|521585602|FG009|Overall Study|Lost to Follow-up|0|||
144653951|NCT00002663|521585593|FG000|Overall Study|Other|0|||
144653952|NCT00002663|521585594|FG001|Overall Study|Other|1|||
144653953|NCT00002663|521585595|FG002|Overall Study|Other|0|||
144653954|NCT00002663|521585596|FG003|Overall Study|Other|0|||
144653955|NCT00002663|521585597|FG004|Overall Study|Other|0|||
144653956|NCT00002663|521585598|FG005|Overall Study|Other|1|||
144653957|NCT00002663|521585599|FG006|Overall Study|Other|1|||
144653958|NCT00002663|521585600|FG007|Overall Study|Other|0|||
144653959|NCT00002663|521585601|FG008|Overall Study|Other|0|||
144653960|NCT00002663|521585602|FG009|Overall Study|Other|0|||
144653961|NCT00002663|521585593|FG000|Overall Study|Physician Decision|0|||
144653962|NCT00002663|521585594|FG001|Overall Study|Physician Decision|0|||
144653963|NCT00002663|521585595|FG002|Overall Study|Physician Decision|0|||
144653964|NCT00002663|521585596|FG003|Overall Study|Physician Decision|0|||
144653965|NCT00002663|521585597|FG004|Overall Study|Physician Decision|1|||
144653966|NCT00002663|521585598|FG005|Overall Study|Physician Decision|0|||
144653967|NCT00002663|521585599|FG006|Overall Study|Physician Decision|0|||
144653968|NCT00002663|521585600|FG007|Overall Study|Physician Decision|0|||
144653969|NCT00002663|521585601|FG008|Overall Study|Physician Decision|1|||
144653970|NCT00002663|521585602|FG009|Overall Study|Physician Decision|1|||
144653971|NCT00002663|521585593|FG000|Overall Study|Adverse Event|0|||
144653972|NCT00002663|521585594|FG001|Overall Study|Adverse Event|0|||
144653973|NCT00002663|521585595|FG002|Overall Study|Adverse Event|0|||
144653974|NCT00002663|521585596|FG003|Overall Study|Adverse Event|1|||
144653975|NCT00002663|521585597|FG004|Overall Study|Adverse Event|0|||
144213877|NCT02185053|519976953|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
144213878|NCT02185053|519976951|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
144213879|NCT02185053|519976952|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
144213880|NCT02185053|519976953|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
144213881|NCT02185053|519976951|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
144213882|NCT02185053|519976952|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
144213883|NCT02185053|519976953|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
144213884|NCT02185053|519976951|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
144264144|NCT03811821|520167664|FG000|Overall Study|Lost to Follow-up|2|||
144264145|NCT03811821|520167665|FG001|Overall Study|Lost to Follow-up|2|||
144653976|NCT00002663|521585598|FG005|Overall Study|Adverse Event|0|||
144653977|NCT00002663|521585599|FG006|Overall Study|Adverse Event|0|||
144653978|NCT00002663|521585600|FG007|Overall Study|Adverse Event|1|||
144653979|NCT00002663|521585601|FG008|Overall Study|Adverse Event|0|||
144653980|NCT00002663|521585602|FG009|Overall Study|Adverse Event|0|||
144653981|NCT00905307|521585604|FG000|Overall Study|Switched to Open Label Rescue|7|||
144653982|NCT00905307|521585605|FG001|Overall Study|Switched to Open Label Rescue|17|||
144653983|NCT00905307|521585606|FG002|Overall Study|Switched to Open Label Rescue|11|||
144213885|NCT02185053|519976952|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
144264146|NCT03811821|520167664|FG000|Overall Study|Contraindication for treatment|0|||
144264147|NCT03811821|520167665|FG001|Overall Study|Contraindication for treatment|1|||
144653984|NCT00905307|521585607|FG003|Overall Study|Switched to Open Label Rescue|11|||
144653985|NCT00905307|521585608|FG004|Overall Study|Switched to Open Label Rescue|4|||
144653986|NCT00905307|521585609|FG005|Overall Study|Switched to Open Label Rescue|15|||
144653987|NCT00905307|521585604|FG000|Overall Study|Lost to Follow-up|0|||
144653988|NCT00905307|521585605|FG001|Overall Study|Lost to Follow-up|0|||
144653989|NCT00905307|521585606|FG002|Overall Study|Lost to Follow-up|0|||
144653990|NCT00905307|521585607|FG003|Overall Study|Lost to Follow-up|0|||
144653991|NCT00905307|521585608|FG004|Overall Study|Lost to Follow-up|1|||
144653992|NCT00905307|521585609|FG005|Overall Study|Lost to Follow-up|1|||
144653993|NCT00905307|521585604|FG000|Overall Study|Adverse Event|3|||
144653994|NCT00905307|521585605|FG001|Overall Study|Adverse Event|4|||
144653995|NCT00905307|521585606|FG002|Overall Study|Adverse Event|5|||
144653996|NCT00905307|521585607|FG003|Overall Study|Adverse Event|11|||
144653997|NCT00905307|521585608|FG004|Overall Study|Adverse Event|3|||
144653998|NCT00905307|521585609|FG005|Overall Study|Adverse Event|5|||
144653999|NCT00905307|521585604|FG000|Overall Study|Withdrawal by Subject|5|||
144654000|NCT00905307|521585605|FG001|Overall Study|Withdrawal by Subject|13|||
144732292|NCT03435081|521875803|FG002|Week 0 to Week 16|Pregnancy|0|||
144654001|NCT00905307|521585606|FG002|Overall Study|Withdrawal by Subject|15|||
144654002|NCT00905307|521585607|FG003|Overall Study|Withdrawal by Subject|11|||
144732293|NCT03435081|521875801|FG000|Week 0 to Week 16|Non-compliance|1|||
144732294|NCT03435081|521875802|FG001|Week 0 to Week 16|Non-compliance|0|||
144732295|NCT03435081|521875803|FG002|Week 0 to Week 16|Non-compliance|2|||
144732296|NCT03435081|521875801|FG000|Week 0 to Week 16|Inadequate Response|0|||
144732297|NCT03435081|521875802|FG001|Week 0 to Week 16|Inadequate Response|1|||
144732298|NCT03435081|521875803|FG002|Week 0 to Week 16|Inadequate Response|0|||
144732299|NCT03435081|521875801|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
144732300|NCT03435081|521875802|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
144732301|NCT03435081|521875803|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
144732302|NCT03435081|521875801|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
144732303|NCT03435081|521875802|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
144732304|NCT03435081|521875803|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
144732305|NCT03435081|521875801|FG000|Week 16 to Week 104|Adverse Event|1|||
144732306|NCT03435081|521875802|FG001|Week 16 to Week 104|Adverse Event|0|||
144732307|NCT03435081|521875803|FG002|Week 16 to Week 104|Adverse Event|2|||
144732308|NCT03435081|521875801|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
144732309|NCT03435081|521875802|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
144732310|NCT03435081|521875803|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
144732311|NCT03435081|521875801|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
144732312|NCT03435081|521875802|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
144732313|NCT03435081|521875803|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
144732314|NCT03435081|521875801|FG000|Week 16 to Week 104|Non--Compliance|0|||
144732315|NCT03435081|521875802|FG001|Week 16 to Week 104|Non--Compliance|0|||
144732316|NCT03435081|521875803|FG002|Week 16 to Week 104|Non--Compliance|1|||
144732317|NCT00420238|521875806|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
144732318|NCT00420238|521875807|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
144732319|NCT00420238|521875806|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
144732320|NCT00420238|521875807|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
144732321|NCT00420238|521875806|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
144732322|NCT00420238|521875807|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
144732323|NCT00420238|521875806|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
144732324|NCT00420238|521875807|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
144732325|NCT00420238|521875806|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
144732326|NCT00420238|521875807|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
144732327|NCT00420238|521875806|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
144732328|NCT00420238|521875807|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
144732329|NCT04510285|521875808|FG000|Overall Study|Death|1|||
144732330|NCT00626548|521875809|FG000|Overall Study|Adverse Event|164|||
144732331|NCT00626548|521875810|FG001|Overall Study|Adverse Event|44|||
144732332|NCT00626548|521875809|FG000|Overall Study|Withdrawal by Subject|42|||
144732333|NCT00626548|521875810|FG001|Overall Study|Withdrawal by Subject|46|||
144732334|NCT00626548|521875809|FG000|Overall Study|Protocol Violation|4|||
144732335|NCT00626548|521875810|FG001|Overall Study|Protocol Violation|11|||
144732336|NCT00626548|521875809|FG000|Overall Study|Lost to Follow-up|2|||
144732337|NCT00626548|521875810|FG001|Overall Study|Lost to Follow-up|2|||
144732338|NCT00626548|521875809|FG000|Overall Study|Other termination reason|493|||
144732339|NCT00626548|521875810|FG001|Overall Study|Other termination reason|613|||
144732340|NCT00048581|521875811|FG000|Double-Blind Period|Adverse Event|9|||
144732341|NCT00048581|521875812|FG001|Double-Blind Period|Adverse Event|5|||
144732342|NCT00048581|521875813|FG002|Double-Blind Period|Adverse Event|0|||
144213886|NCT02185053|519976953|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
144654003|NCT00905307|521585608|FG004|Overall Study|Withdrawal by Subject|4|||
144654004|NCT00905307|521585609|FG005|Overall Study|Withdrawal by Subject|13|||
144654005|NCT00905307|521585604|FG000|Overall Study|Protocol Violation|1|||
144732343|NCT00048581|521875811|FG000|Double-Blind Period|Lack of Efficacy|14|||
144732344|NCT00048581|521875812|FG001|Double-Blind Period|Lack of Efficacy|27|||
144732345|NCT00048581|521875813|FG002|Double-Blind Period|Lack of Efficacy|0|||
144732346|NCT00048581|521875811|FG000|Double-Blind Period|Lost to Follow-up|5|||
144732347|NCT00048581|521875812|FG001|Double-Blind Period|Lost to Follow-up|0|||
144654006|NCT00905307|521585605|FG001|Overall Study|Protocol Violation|0|||
144654007|NCT00905307|521585606|FG002|Overall Study|Protocol Violation|1|||
144654008|NCT00905307|521585607|FG003|Overall Study|Protocol Violation|0|||
144654009|NCT00905307|521585608|FG004|Overall Study|Protocol Violation|0|||
144654010|NCT00905307|521585609|FG005|Overall Study|Protocol Violation|0|||
144654011|NCT00905307|521585604|FG000|Overall Study|Lack of Efficacy|6|||
144654012|NCT00905307|521585605|FG001|Overall Study|Lack of Efficacy|3|||
144654013|NCT00905307|521585606|FG002|Overall Study|Lack of Efficacy|5|||
144654014|NCT00905307|521585607|FG003|Overall Study|Lack of Efficacy|4|||
144654015|NCT00905307|521585608|FG004|Overall Study|Lack of Efficacy|4|||
144654016|NCT00905307|521585609|FG005|Overall Study|Lack of Efficacy|8|||
144654017|NCT03838367|521585610|FG000|Overall Study|Early termination of study|3|||
144654018|NCT03838367|521585611|FG001|Overall Study|Early termination of study|4|||
144654019|NCT03838367|521585612|FG002|Overall Study|Early termination of study|3|||
144654020|NCT03838367|521585613|FG003|Overall Study|Early termination of study|0|||
144654021|NCT03406104|521585614|FG000|Overall Study|Lost to Follow-up|2|||
144654022|NCT03406104|521585614|FG000|Overall Study|Withdrawal by Subject|2|||
144654023|NCT03406104|521585614|FG000|Overall Study|due to Covid patient did not want to travel|1|||
144654024|NCT03406104|521585614|FG000|Overall Study|Death|2|||
144654025|NCT00525148|521585615|FG000|Overall Study|Other Adverse Event|3|||
144654026|NCT00525148|521585616|FG001|Overall Study|Other Adverse Event|5|||
144654027|NCT00525148|521585617|FG002|Overall Study|Other Adverse Event|1|||
144654028|NCT00525148|521585618|FG003|Overall Study|Other Adverse Event|8|||
144654029|NCT00525148|521585615|FG000|Overall Study|Progressive disease|18|||
144654030|NCT00525148|521585616|FG001|Overall Study|Progressive disease|30|||
144654031|NCT00525148|521585617|FG002|Overall Study|Progressive disease|6|||
144654032|NCT00525148|521585618|FG003|Overall Study|Progressive disease|49|||
144654033|NCT00525148|521585615|FG000|Overall Study|Refused continuation of study medication|0|||
144654034|NCT00525148|521585616|FG001|Overall Study|Refused continuation of study medication|2|||
144654035|NCT00525148|521585617|FG002|Overall Study|Refused continuation of study medication|0|||
144654036|NCT00525148|521585618|FG003|Overall Study|Refused continuation of study medication|1|||
144654037|NCT00525148|521585615|FG000|Overall Study|Other than stated|2|||
144654038|NCT00525148|521585616|FG001|Overall Study|Other than stated|1|||
144654039|NCT00525148|521585617|FG002|Overall Study|Other than stated|0|||
144654040|NCT00525148|521585618|FG003|Overall Study|Other than stated|3|||
144654041|NCT03015610|521585619|FG000|Overall Study|Lost to Follow-up|1|||
144654042|NCT03015610|521585620|FG001|Overall Study|Lost to Follow-up|5|||
144654043|NCT01603641|521585621|FG000|Overall Study|Did not Receive Treatment|3|||
144654044|NCT01603641|521585621|FG000|Overall Study|Adverse Event|1|||
144654045|NCT01603641|521585621|FG000|Overall Study|Lack of Efficacy|1|||
144654046|NCT01603641|521585621|FG000|Overall Study|Lost to Follow-up|6|||
144654047|NCT01603641|521585621|FG000|Overall Study|Personal Reasons|18|||
144654048|NCT01603641|521585621|FG000|Overall Study|Other Miscellaneous Reasons|6|||
144654049|NCT05100199|521585628|FG000|Overall Study|Lost to Follow-up|5|||
144654050|NCT05100199|521585629|FG001|Overall Study|Lost to Follow-up|8|||
144654051|NCT05100199|521585630|FG002|Overall Study|Lost to Follow-up|3|||
144213887|NCT02185053|519976951|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
144213888|NCT02185053|519976952|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
144213889|NCT02185053|519976953|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
144213890|NCT00307437|519976954|FG000|Controlled Period|Adverse Event|7|||
144213891|NCT00307437|519976955|FG001|Controlled Period|Adverse Event|2|||
144213892|NCT00307437|519976956|FG002|Controlled Period|Adverse Event|5|||
144213893|NCT00307437|519976957|FG003|Controlled Period|Adverse Event|0|||
144213894|NCT00307437|519976958|FG004|Controlled Period|Adverse Event|0|||
144213895|NCT00307437|519976959|FG005|Controlled Period|Adverse Event|0|||
144213896|NCT00307437|519976960|FG006|Controlled Period|Adverse Event|0|||
144213897|NCT00307437|519976954|FG000|Controlled Period|Death|0|||
144213898|NCT00307437|519976955|FG001|Controlled Period|Death|0|||
144213899|NCT00307437|519976956|FG002|Controlled Period|Death|1|||
144213900|NCT00307437|519976957|FG003|Controlled Period|Death|0|||
144213901|NCT00307437|519976958|FG004|Controlled Period|Death|0|||
144213902|NCT00307437|519976959|FG005|Controlled Period|Death|0|||
144213903|NCT00307437|519976960|FG006|Controlled Period|Death|0|||
144264148|NCT03811821|520167664|FG000|Overall Study|Tolerability|0|||
144264149|NCT03811821|520167665|FG001|Overall Study|Tolerability|3|||
144654052|NCT05100199|521585631|FG003|Overall Study|Lost to Follow-up|6|||
144654053|NCT05100199|521585628|FG000|Overall Study|Withdrawal by Subject|3|||
144654054|NCT05100199|521585629|FG001|Overall Study|Withdrawal by Subject|3|||
144654055|NCT05100199|521585630|FG002|Overall Study|Withdrawal by Subject|9|||
144654056|NCT05100199|521585631|FG003|Overall Study|Withdrawal by Subject|7|||
144654057|NCT05100199|521585628|FG000|Overall Study|Other|0|||
144654058|NCT05100199|521585629|FG001|Overall Study|Other|0|||
144654059|NCT05100199|521585630|FG002|Overall Study|Other|1|||
144654060|NCT05100199|521585631|FG003|Overall Study|Other|1|||
144654061|NCT00114972|521585632|FG000|Overall Study|Withdrawal by Subject|40|||
144213904|NCT00307437|519976954|FG000|Controlled Period|Lack of Efficacy|2|||
144213905|NCT00307437|519976955|FG001|Controlled Period|Lack of Efficacy|0|||
144213906|NCT00307437|519976956|FG002|Controlled Period|Lack of Efficacy|0|||
144213907|NCT00307437|519976957|FG003|Controlled Period|Lack of Efficacy|0|||
144213908|NCT00307437|519976958|FG004|Controlled Period|Lack of Efficacy|0|||
144654062|NCT00114972|521585633|FG001|Overall Study|Withdrawal by Subject|7|||
144654063|NCT00114972|521585632|FG000|Overall Study|Lost to Follow-up|8|||
144654064|NCT00114972|521585633|FG001|Overall Study|Lost to Follow-up|5|||
144654065|NCT02890329|521585634|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
144654066|NCT02890329|521585635|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
144654067|NCT02890329|521585636|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
144654068|NCT02890329|521585637|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
144654069|NCT02890329|521585638|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
144654070|NCT02890329|521585639|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
144654071|NCT02890329|521585634|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
144654072|NCT02890329|521585635|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
144654073|NCT02890329|521585636|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
144654074|NCT02890329|521585637|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
144654075|NCT02890329|521585638|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
144654076|NCT02890329|521585639|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
144654077|NCT02890329|521585634|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
144654078|NCT02890329|521585635|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
144654079|NCT02890329|521585636|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
144654080|NCT02890329|521585637|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
144654081|NCT02890329|521585638|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
144654082|NCT02890329|521585639|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
144654083|NCT02890329|521585634|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
144654084|NCT02890329|521585635|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
144654085|NCT02890329|521585636|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
144654086|NCT02890329|521585637|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
144654087|NCT02890329|521585638|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
144654088|NCT02890329|521585639|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
144654089|NCT02691247|521585643|FG000|Overall Study|Withdrawal by Subject|1|||
144654090|NCT02691247|521585644|FG001|Overall Study|Withdrawal by Subject|2|||
144654091|NCT02691247|521585645|FG002|Overall Study|Withdrawal by Subject|2|||
144654092|NCT02691247|521585643|FG000|Overall Study|Lost to Follow-up|2|||
144654093|NCT02691247|521585644|FG001|Overall Study|Lost to Follow-up|0|||
144654094|NCT02691247|521585645|FG002|Overall Study|Lost to Follow-up|1|||
144654095|NCT02552355|521585646|FG000|Overall Study|Adverse Event|0|||
144654096|NCT02552355|521585647|FG001|Overall Study|Adverse Event|2|||
144654097|NCT02552355|521585648|FG002|Overall Study|Adverse Event|2|||
144654098|NCT02552355|521585649|FG003|Overall Study|Adverse Event|0|||
144654099|NCT02552355|521585646|FG000|Overall Study|Withdrawal by Subject|0|||
144654100|NCT02552355|521585647|FG001|Overall Study|Withdrawal by Subject|0|||
144654101|NCT02552355|521585648|FG002|Overall Study|Withdrawal by Subject|0|||
144654102|NCT02552355|521585649|FG003|Overall Study|Withdrawal by Subject|1|||
144654103|NCT01519245|521585650|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
144654104|NCT01519245|521585651|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
144654105|NCT00803244|521585654|FG000|Overall Study|Adverse Event|1|||
144654106|NCT00803244|521585655|FG001|Overall Study|Adverse Event|2|||
144654107|NCT00803244|521585654|FG000|Overall Study|Withdrawal by Subject|2|||
144654108|NCT00803244|521585655|FG001|Overall Study|Withdrawal by Subject|3|||
144654109|NCT00803244|521585654|FG000|Overall Study|Any other reason not above-mentioned|4|||
144654110|NCT00803244|521585655|FG001|Overall Study|Any other reason not above-mentioned|10|||
144654111|NCT03321929|521585657|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
144654112|NCT00616239|521585658|FG000|Overall Study|Withdrawal by Subject|2|||
144654113|NCT01052012|521585659|FG000|Overall Study|Not treated|2|||
144654114|NCT01052012|521585660|FG001|Overall Study|Not treated|5|||
144654115|NCT01052012|521585661|FG002|Overall Study|Not treated|0|||
144654116|NCT01052012|521585662|FG003|Overall Study|Not treated|0|||
144654117|NCT01052012|521585663|FG004|Overall Study|Not treated|11|||
144654118|NCT01052012|521585664|FG005|Overall Study|Not treated|8|||
144654119|NCT01052012|521585659|FG000|Overall Study|Adverse Event|1|||
144654120|NCT01052012|521585660|FG001|Overall Study|Adverse Event|0|||
144654121|NCT01052012|521585661|FG002|Overall Study|Adverse Event|0|||
144654122|NCT01052012|521585662|FG003|Overall Study|Adverse Event|1|||
144654123|NCT01052012|521585663|FG004|Overall Study|Adverse Event|0|||
144654124|NCT01052012|521585664|FG005|Overall Study|Adverse Event|0|||
144654125|NCT01052012|521585659|FG000|Overall Study|Lost to Follow-up|0|||
144654126|NCT01052012|521585660|FG001|Overall Study|Lost to Follow-up|0|||
144654127|NCT01052012|521585661|FG002|Overall Study|Lost to Follow-up|0|||
144654128|NCT01052012|521585662|FG003|Overall Study|Lost to Follow-up|0|||
144654129|NCT01052012|521585663|FG004|Overall Study|Lost to Follow-up|1|||
144654130|NCT01052012|521585664|FG005|Overall Study|Lost to Follow-up|0|||
144213909|NCT00307437|519976959|FG005|Controlled Period|Lack of Efficacy|0|||
144213910|NCT00307437|519976960|FG006|Controlled Period|Lack of Efficacy|0|||
144264150|NCT03811821|520167664|FG000|Overall Study|Comorbidities|0|||
144654131|NCT01052012|521585659|FG000|Overall Study|Withdrawal by Subject|1|||
144654132|NCT01052012|521585660|FG001|Overall Study|Withdrawal by Subject|1|||
144654133|NCT01052012|521585661|FG002|Overall Study|Withdrawal by Subject|0|||
144654134|NCT01052012|521585662|FG003|Overall Study|Withdrawal by Subject|0|||
144654135|NCT01052012|521585663|FG004|Overall Study|Withdrawal by Subject|3|||
144654136|NCT01052012|521585664|FG005|Overall Study|Withdrawal by Subject|1|||
144654137|NCT01052012|521585659|FG000|Overall Study|Physician Decision|0|||
144654138|NCT01052012|521585660|FG001|Overall Study|Physician Decision|0|||
144654139|NCT01052012|521585661|FG002|Overall Study|Physician Decision|0|||
144654140|NCT01052012|521585662|FG003|Overall Study|Physician Decision|0|||
144654141|NCT01052012|521585663|FG004|Overall Study|Physician Decision|0|||
144654142|NCT01052012|521585664|FG005|Overall Study|Physician Decision|1|||
144654143|NCT01052012|521585659|FG000|Overall Study|Other|0|||
144654144|NCT01052012|521585660|FG001|Overall Study|Other|0|||
144654145|NCT01052012|521585661|FG002|Overall Study|Other|0|||
144654146|NCT01052012|521585662|FG003|Overall Study|Other|0|||
144654147|NCT01052012|521585663|FG004|Overall Study|Other|1|||
144654148|NCT01052012|521585664|FG005|Overall Study|Other|0|||
144654149|NCT02873715|521585665|FG000|Overall Study|Lost to Follow-up|84|||
144654150|NCT02873715|521585666|FG001|Overall Study|Lost to Follow-up|94|||
144654151|NCT02873715|521585665|FG000|Overall Study|Withdrawal by Subject|7|||
144654152|NCT02873715|521585666|FG001|Overall Study|Withdrawal by Subject|26|||
144654153|NCT00933335|521585667|FG000|Overall Study|Lost to Follow-up|1|||
144654154|NCT00933335|521585668|FG001|Overall Study|Lost to Follow-up|3|||
144654155|NCT00933335|521585667|FG000|Overall Study|Withdrawal by Subject|0|||
144654156|NCT00933335|521585668|FG001|Overall Study|Withdrawal by Subject|1|||
144654157|NCT00933335|521585667|FG000|Overall Study|Progressive Disease|0|||
144654158|NCT00933335|521585668|FG001|Overall Study|Progressive Disease|11|||
144654159|NCT00933335|521585667|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
144654160|NCT00933335|521585668|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
144654161|NCT00933335|521585667|FG000|Overall Study|Co-morbid Illness|1|||
144654162|NCT00933335|521585668|FG001|Overall Study|Co-morbid Illness|0|||
144654163|NCT01096550|521585669|FG000|Overall Study|discontinued site|10|||
144654164|NCT01096550|521585670|FG001|Overall Study|discontinued site|11|||
144654165|NCT01096550|521585669|FG000|Overall Study|non-regular treatment track at clinic|1|||
144654166|NCT01096550|521585670|FG001|Overall Study|non-regular treatment track at clinic|1|||
144654167|NCT01096550|521585669|FG000|Overall Study|clinic readmission|1|||
144654168|NCT01096550|521585670|FG001|Overall Study|clinic readmission|1|||
144654169|NCT01096550|521585669|FG000|Overall Study|Withdrawal by Subject|0|||
144654170|NCT01096550|521585670|FG001|Overall Study|Withdrawal by Subject|1|||
144654171|NCT01096550|521585669|FG000|Overall Study|non-African American participant|13|||
144654172|NCT01096550|521585670|FG001|Overall Study|non-African American participant|6|||
144654173|NCT01096550|521585669|FG000|Overall Study|Lost to Follow-up|12|||
144654174|NCT01096550|521585670|FG001|Overall Study|Lost to Follow-up|9|||
144654175|NCT02650284|521585673|FG000|Overall Study|Lost to Follow-up|3|||
144654176|NCT02650284|521585674|FG001|Overall Study|Lost to Follow-up|3|||
144654177|NCT02650284|521585673|FG000|Overall Study|Consent incorrectly taken|0|||
144654178|NCT02650284|521585674|FG001|Overall Study|Consent incorrectly taken|1|||
144654179|NCT04590937|521585675|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
144654180|NCT02084134|521585683|FG000|Overall Study|Protocol Violation|4|||
144654181|NCT02084134|521585684|FG001|Overall Study|Protocol Violation|2|||
144654182|NCT02084134|521585683|FG000|Overall Study|Death|0|||
144213911|NCT00307437|519976954|FG000|Controlled Period|Lost to Follow-up|2|||
144213912|NCT00307437|519976955|FG001|Controlled Period|Lost to Follow-up|3|||
144213913|NCT00307437|519976956|FG002|Controlled Period|Lost to Follow-up|0|||
144213914|NCT00307437|519976957|FG003|Controlled Period|Lost to Follow-up|0|||
144213915|NCT00307437|519976958|FG004|Controlled Period|Lost to Follow-up|0|||
144213916|NCT00307437|519976959|FG005|Controlled Period|Lost to Follow-up|0|||
144213917|NCT00307437|519976960|FG006|Controlled Period|Lost to Follow-up|0|||
144213918|NCT00307437|519976954|FG000|Controlled Period|Other|5|||
144213919|NCT00307437|519976955|FG001|Controlled Period|Other|1|||
144213920|NCT00307437|519976956|FG002|Controlled Period|Other|3|||
144213921|NCT00307437|519976957|FG003|Controlled Period|Other|0|||
144213922|NCT00307437|519976958|FG004|Controlled Period|Other|0|||
144654183|NCT02084134|521585684|FG001|Overall Study|Death|1|||
144654184|NCT02807454|521585685|FG000|Overall Study|Adverse Event|1|||
144654185|NCT02807454|521585686|FG001|Overall Study|Adverse Event|0|||
144654186|NCT02807454|521585685|FG000|Overall Study|Withdrawal by Subject|0|||
144654187|NCT02807454|521585686|FG001|Overall Study|Withdrawal by Subject|1|||
144213923|NCT00307437|519976959|FG005|Controlled Period|Other|0|||
144213924|NCT00307437|519976960|FG006|Controlled Period|Other|0|||
144264151|NCT03811821|520167665|FG001|Overall Study|Comorbidities|2|||
144654188|NCT02807454|521585685|FG000|Overall Study|Progressive Disease|30|||
144654189|NCT02807454|521585686|FG001|Overall Study|Progressive Disease|3|||
144654190|NCT02807454|521585685|FG000|Overall Study|Other Reasons|1|||
144654191|NCT02807454|521585686|FG001|Overall Study|Other Reasons|1|||
144213925|NCT00307437|519976954|FG000|After Controlled Period|Adverse Event|0|||
144213926|NCT00307437|519976955|FG001|After Controlled Period|Adverse Event|0|||
144213927|NCT00307437|519976956|FG002|After Controlled Period|Adverse Event|0|||
144732348|NCT00048581|521875813|FG002|Double-Blind Period|Lost to Follow-up|0|||
144732349|NCT00048581|521875811|FG000|Double-Blind Period|Withdrawal by Subject|5|||
144732350|NCT00048581|521875812|FG001|Double-Blind Period|Withdrawal by Subject|2|||
144732351|NCT00048581|521875813|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144732352|NCT00048581|521875811|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
144732353|NCT00048581|521875812|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
144732354|NCT00048581|521875813|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
144732355|NCT00048581|521875811|FG000|Double-Blind Period|Investigator Decision|1|||
144732356|NCT00048581|521875812|FG001|Double-Blind Period|Investigator Decision|0|||
144732357|NCT00048581|521875813|FG002|Double-Blind Period|Investigator Decision|0|||
144732358|NCT00048581|521875811|FG000|Open-Label Period|Death|0|||
144732359|NCT00048581|521875812|FG001|Open-Label Period|Death|0|||
144732360|NCT00048581|521875813|FG002|Open-Label Period|Death|4|||
144732361|NCT00048581|521875811|FG000|Open-Label Period|Adverse Event|0|||
144732362|NCT00048581|521875812|FG001|Open-Label Period|Adverse Event|0|||
144732363|NCT00048581|521875813|FG002|Open-Label Period|Adverse Event|37|||
144732364|NCT00048581|521875811|FG000|Open-Label Period|Lack of Efficacy|0|||
144732365|NCT00048581|521875812|FG001|Open-Label Period|Lack of Efficacy|0|||
144732366|NCT00048581|521875813|FG002|Open-Label Period|Lack of Efficacy|69|||
144732367|NCT00048581|521875811|FG000|Open-Label Period|Lost to Follow-up|0|||
144732368|NCT00048581|521875812|FG001|Open-Label Period|Lost to Follow-up|0|||
144732369|NCT00048581|521875813|FG002|Open-Label Period|Lost to Follow-up|14|||
144732370|NCT00048581|521875811|FG000|Open-Label Period|Withdrawal by Subject|0|||
144213928|NCT00307437|519976957|FG003|After Controlled Period|Adverse Event|18|||
144213929|NCT00307437|519976958|FG004|After Controlled Period|Adverse Event|16|||
144213930|NCT00307437|519976959|FG005|After Controlled Period|Adverse Event|31|||
144654192|NCT05468086|521585687|FG000|Overall Study|Withdrawal by Subject|3|||
144654193|NCT05468086|521585687|FG000|Overall Study|Subject was found ineligible after consent|1|||
144654194|NCT01070784|521585691|FG000|Overall Study|Withdrawal by Subject|6|||
144654195|NCT01070784|521585692|FG001|Overall Study|Withdrawal by Subject|9|||
144654196|NCT01070784|521585691|FG000|Overall Study|Adverse Event|14|||
144654197|NCT01070784|521585692|FG001|Overall Study|Adverse Event|9|||
144654198|NCT02815397|521585694|FG000|Overall Study|Physician Decision|2|||
144654199|NCT01518192|521585695|FG000|Overall Study|Lost to Follow-up|29|||
144654200|NCT01518192|521585696|FG001|Overall Study|Lost to Follow-up|26|||
144654201|NCT01518192|521585697|FG002|Overall Study|Lost to Follow-up|35|||
144654202|NCT00085540|521585698|FG000|Overall Study|Withdrawal by Subject|0|||
144654203|NCT00085540|521585699|FG001|Overall Study|Withdrawal by Subject|1|||
144654204|NCT00085540|521585698|FG000|Overall Study|Protocol Violation|0|||
144654205|NCT00085540|521585699|FG001|Overall Study|Protocol Violation|1|||
144654206|NCT01200511|521585700|FG000|Overall Study|Lost to Follow-up|3|||
144654207|NCT01200511|521585700|FG000|Overall Study|Withdrawal by Subject|1|||
144654208|NCT01200511|521585700|FG000|Overall Study|Adverse Event|1|||
144654209|NCT00237796|521585701|FG000|Overall Study|Baseline and one other ILSS required|10|||
144654210|NCT00237796|521585702|FG001|Overall Study|Baseline and one other ILSS required|5|||
144654211|NCT04920084|521586747|FG000|Overall Study|Adverse Event|1|||
144654212|NCT04920084|521586747|FG000|Overall Study|Lost to Follow-up|2|||
144654213|NCT04920084|521586747|FG000|Overall Study|Withdrawal by Subject|2|||
144654214|NCT00620321|521586748|FG000|Overall Study|Adverse Event|1|||
144654215|NCT00620321|521586749|FG001|Overall Study|Adverse Event|1|||
144654216|NCT00620321|521586748|FG000|Overall Study|Death|1|||
144654217|NCT00620321|521586749|FG001|Overall Study|Death|1|||
144654218|NCT00620321|521586748|FG000|Overall Study|Physician Decision|0|||
144654219|NCT00620321|521586749|FG001|Overall Study|Physician Decision|7|||
144654220|NCT00620321|521586748|FG000|Overall Study|Progressive Disease|5|||
144654221|NCT00620321|521586749|FG001|Overall Study|Progressive Disease|5|||
144654222|NCT00620321|521586748|FG000|Overall Study|Sponsor Decision|0|||
144654223|NCT00620321|521586749|FG001|Overall Study|Sponsor Decision|1|||
144654224|NCT00620321|521586748|FG000|Overall Study|Withdrawal by Subject|1|||
144654225|NCT00620321|521586749|FG001|Overall Study|Withdrawal by Subject|1|||
144213931|NCT00307437|519976960|FG006|After Controlled Period|Adverse Event|40|||
144213932|NCT00307437|519976954|FG000|After Controlled Period|Death|0|||
144654226|NCT01701583|521586750|FG000|Overall Study|Withdrawal by Subject|2|||
144654227|NCT01701583|521586751|FG001|Overall Study|Withdrawal by Subject|0|||
144654228|NCT01441440|521586752|FG000|Overall Study|Death|1|||
144654229|NCT01441440|521586753|FG001|Overall Study|Death|0|||
144654230|NCT01441440|521586754|FG002|Overall Study|Death|1|||
144654231|NCT01441440|521586752|FG000|Overall Study|Adverse Event|2|||
144732371|NCT00048581|521875812|FG001|Open-Label Period|Withdrawal by Subject|0|||
144732372|NCT00048581|521875813|FG002|Open-Label Period|Withdrawal by Subject|20|||
144732373|NCT00048581|521875811|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
144732374|NCT00048581|521875812|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
144732375|NCT00048581|521875813|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
144654232|NCT01441440|521586753|FG001|Overall Study|Adverse Event|9|||
144213933|NCT00307437|519976955|FG001|After Controlled Period|Death|0|||
144213934|NCT00307437|519976956|FG002|After Controlled Period|Death|0|||
144654233|NCT01441440|521586754|FG002|Overall Study|Adverse Event|9|||
144654234|NCT01441440|521586752|FG000|Overall Study|Lost to Follow-up|0|||
144654235|NCT01441440|521586753|FG001|Overall Study|Lost to Follow-up|2|||
144654236|NCT01441440|521586754|FG002|Overall Study|Lost to Follow-up|1|||
144654237|NCT01441440|521586752|FG000|Overall Study|Withdrawal by Subject|11|||
144654238|NCT01441440|521586753|FG001|Overall Study|Withdrawal by Subject|9|||
144654239|NCT01441440|521586754|FG002|Overall Study|Withdrawal by Subject|9|||
144654240|NCT01441440|521586752|FG000|Overall Study|Pregnancy|1|||
144654241|NCT01441440|521586753|FG001|Overall Study|Pregnancy|0|||
144654242|NCT01441440|521586754|FG002|Overall Study|Pregnancy|0|||
144654243|NCT01441440|521586752|FG000|Overall Study|Lack of Efficacy|1|||
144654244|NCT01441440|521586753|FG001|Overall Study|Lack of Efficacy|0|||
144654245|NCT01441440|521586754|FG002|Overall Study|Lack of Efficacy|1|||
144654246|NCT01441440|521586752|FG000|Overall Study|Moving|0|||
144654247|NCT01441440|521586753|FG001|Overall Study|Moving|1|||
144654248|NCT01441440|521586754|FG002|Overall Study|Moving|1|||
144654249|NCT01441440|521586752|FG000|Overall Study|Work-related matter|0|||
144654250|NCT01441440|521586753|FG001|Overall Study|Work-related matter|1|||
144654251|NCT01441440|521586754|FG002|Overall Study|Work-related matter|0|||
144654252|NCT01441440|521586752|FG000|Overall Study|Difficllty in keeping the schedule|1|||
144654253|NCT01441440|521586753|FG001|Overall Study|Difficllty in keeping the schedule|1|||
144654254|NCT01441440|521586754|FG002|Overall Study|Difficllty in keeping the schedule|0|||
144654255|NCT01345123|521586755|FG000|Overall Study|participants no longer with health plan|79|||
144654256|NCT01345123|521586756|FG001|Overall Study|participants no longer with health plan|85|||
144654257|NCT01345123|521586757|FG002|Overall Study|participants no longer with health plan|88|||
144654258|NCT00883558|521586758|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
144654259|NCT00883558|521586759|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
144654260|NCT00883558|521586760|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
144654261|NCT00883558|521586758|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
144654262|NCT00883558|521586759|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
144654263|NCT00883558|521586760|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
144213935|NCT00307437|519976957|FG003|After Controlled Period|Death|3|||
144654264|NCT00883558|521586758|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
144654265|NCT00883558|521586759|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
144654266|NCT00883558|521586760|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
144654267|NCT00883558|521586758|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
144654268|NCT00883558|521586759|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
144654269|NCT00883558|521586760|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
144654270|NCT00883558|521586758|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
144654271|NCT00883558|521586759|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
144654272|NCT00883558|521586760|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
144654273|NCT01252134|521586762|FG000|Period 1, 8 Hours|Personal Reasons|0|||
144654274|NCT01252134|521586763|FG001|Period 1, 8 Hours|Personal Reasons|1|||
144654275|NCT01252134|521586764|FG002|Period 1, 8 Hours|Personal Reasons|1|||
144654276|NCT01252134|521586765|FG003|Period 1, 8 Hours|Personal Reasons|0|||
144654277|NCT01252134|521586766|FG004|Period 1, 8 Hours|Personal Reasons|0|||
144654278|NCT01252134|521586767|FG005|Period 1, 8 Hours|Personal Reasons|0|||
144654279|NCT02273050|521586769|FG000|Overall Study|Adverse Event|4|||
144654280|NCT02273050|521586770|FG001|Overall Study|Adverse Event|3|||
144654281|NCT02273050|521586771|FG002|Overall Study|Adverse Event|3|||
144654282|NCT02273050|521586769|FG000|Overall Study|Death|0|||
144654283|NCT02273050|521586770|FG001|Overall Study|Death|0|||
144654284|NCT02273050|521586771|FG002|Overall Study|Death|1|||
144654285|NCT02273050|521586769|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
144654286|NCT02273050|521586770|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
144654287|NCT02273050|521586771|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
144654288|NCT02273050|521586769|FG000|Overall Study|Lack of Efficacy|0|||
144654289|NCT02273050|521586770|FG001|Overall Study|Lack of Efficacy|1|||
144654290|NCT02273050|521586771|FG002|Overall Study|Lack of Efficacy|1|||
144654291|NCT02273050|521586769|FG000|Overall Study|Withdrawal by Subject|17|||
144654292|NCT02273050|521586770|FG001|Overall Study|Withdrawal by Subject|14|||
144213936|NCT00307437|519976958|FG004|After Controlled Period|Death|1|||
144213937|NCT00307437|519976959|FG005|After Controlled Period|Death|1|||
144654293|NCT02273050|521586771|FG002|Overall Study|Withdrawal by Subject|16|||
144654294|NCT02273050|521586769|FG000|Overall Study|Lost to Follow-up|0|||
144654295|NCT02273050|521586770|FG001|Overall Study|Lost to Follow-up|2|||
144732376|NCT00048581|521875811|FG000|Open-Label Period|Poor/Non-compliance|0|||
144213938|NCT00307437|519976960|FG006|After Controlled Period|Death|3|||
144654296|NCT02273050|521586771|FG002|Overall Study|Lost to Follow-up|3|||
144654297|NCT02273050|521586769|FG000|Overall Study|Protocol Violation|3|||
144654298|NCT02273050|521586770|FG001|Overall Study|Protocol Violation|1|||
144654299|NCT02273050|521586771|FG002|Overall Study|Protocol Violation|4|||
144732377|NCT00048581|521875812|FG001|Open-Label Period|Poor/Non-compliance|0|||
144213939|NCT00307437|519976954|FG000|After Controlled Period|Lack of Efficacy|0|||
144213940|NCT00307437|519976955|FG001|After Controlled Period|Lack of Efficacy|0|||
144654300|NCT00903032|521586772|FG000|Overall Study|Withdrawal by Subject|5|||
144213941|NCT00307437|519976956|FG002|After Controlled Period|Lack of Efficacy|0|||
144213942|NCT00307437|519976957|FG003|After Controlled Period|Lack of Efficacy|15|||
144654301|NCT00903032|521586773|FG001|Overall Study|Withdrawal by Subject|3|||
144654302|NCT00903032|521586772|FG000|Overall Study|Lost to Follow-up|2|||
144654303|NCT00903032|521586773|FG001|Overall Study|Lost to Follow-up|2|||
144654304|NCT01675531|521586775|FG000|Overall Study|Adverse Event|9|||
144654305|NCT01675531|521586775|FG000|Overall Study|Withdrawal by Subject|7|||
144654306|NCT01675531|521586775|FG000|Overall Study|Lack of Efficacy|1|||
144654307|NCT01675531|521586775|FG000|Overall Study|Protocol Violation|8|||
144654308|NCT00972478|521586783|FG000|Overall Study|Adverse Event|3|||
144654309|NCT00972478|521586784|FG001|Overall Study|Adverse Event|16|||
144654310|NCT00972478|521586783|FG000|Overall Study|Withdrawal by Subject|1|||
144654311|NCT00972478|521586784|FG001|Overall Study|Withdrawal by Subject|8|||
144654312|NCT00972478|521586783|FG000|Overall Study|Progression/Relapse|0|||
144654313|NCT00972478|521586784|FG001|Overall Study|Progression/Relapse|2|||
144654314|NCT00972478|521586783|FG000|Overall Study|Death|0|||
144654315|NCT00972478|521586784|FG001|Overall Study|Death|2|||
144654316|NCT00972478|521586783|FG000|Overall Study|Not protocol specified|1|||
144654317|NCT00972478|521586784|FG001|Overall Study|Not protocol specified|1|||
144654318|NCT00972478|521586783|FG000|Overall Study|Ineligible|1|||
144654319|NCT00972478|521586784|FG001|Overall Study|Ineligible|7|||
144654320|NCT00972478|521586783|FG000|Overall Study|Not start protocol treatment|1|||
144654321|NCT00972478|521586784|FG001|Overall Study|Not start protocol treatment|2|||
144654322|NCT02561000|521586785|FG000|Overall Study|Withdrawal by Subject|2|||
144654323|NCT02561000|521586786|FG001|Overall Study|Withdrawal by Subject|3|||
144654324|NCT02561000|521586787|FG002|Overall Study|Withdrawal by Subject|0|||
144654325|NCT02561000|521586785|FG000|Overall Study|Adverse Event|0|||
144654326|NCT02561000|521586786|FG001|Overall Study|Adverse Event|1|||
144654327|NCT02561000|521586787|FG002|Overall Study|Adverse Event|0|||
144654328|NCT03952468|521586788|FG000|Overall Study|Death|0|||
144654329|NCT03952468|521586789|FG001|Overall Study|Death|1|||
144654330|NCT03952468|521586788|FG000|Overall Study|Adverse Event|0|||
144654331|NCT03952468|521586789|FG001|Overall Study|Adverse Event|1|||
144654332|NCT03952468|521586788|FG000|Overall Study|Physician Decision|1|||
144654333|NCT03952468|521586789|FG001|Overall Study|Physician Decision|0|||
144654334|NCT03952468|521586788|FG000|Overall Study|Lost to Follow-up|3|||
144654335|NCT03952468|521586789|FG001|Overall Study|Lost to Follow-up|4|||
144654336|NCT03952468|521586788|FG000|Overall Study|Withdrawal by Subject|2|||
144654337|NCT03952468|521586789|FG001|Overall Study|Withdrawal by Subject|1|||
144654338|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
144654339|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
144654340|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
144654341|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
144654342|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
144654343|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
144654344|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
144654345|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
144654346|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
144654347|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
144654348|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
144654349|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
144654350|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
144654351|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
144654352|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
144654353|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
144654354|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
144654355|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
144654356|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
144654357|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
144654358|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
144654359|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Other|0|||
144654360|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Other|1|||
144654361|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Other|0|||
144654362|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Other|0|||
144654363|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Other|0|||
144213943|NCT00307437|519976958|FG004|After Controlled Period|Lack of Efficacy|17|||
144213944|NCT00307437|519976959|FG005|After Controlled Period|Lack of Efficacy|37|||
144654364|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Other|0|||
144213945|NCT00307437|519976960|FG006|After Controlled Period|Lack of Efficacy|24|||
144654365|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Other|0|||
144732378|NCT00048581|521875813|FG002|Open-Label Period|Poor/Non-compliance|5|||
144213946|NCT00307437|519976954|FG000|After Controlled Period|Lost to Follow-up|0|||
144654366|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
144654367|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
144654368|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
144654369|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
144654370|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
144654371|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
144654372|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
144654373|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
144654374|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
144654375|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
144654376|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
144654377|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
144654378|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
144654379|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
144654380|NCT00365716|521586790|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
144654381|NCT00365716|521586791|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
144654382|NCT00365716|521586792|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
144654383|NCT00365716|521586793|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
144654384|NCT00365716|521586794|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
144654385|NCT00365716|521586795|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
144654386|NCT00365716|521586796|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
144654387|NCT00365716|521586790|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
144654388|NCT00365716|521586791|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
144654389|NCT00365716|521586792|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
144654390|NCT00365716|521586793|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
144654391|NCT00365716|521586794|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
144654392|NCT00365716|521586795|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
144654393|NCT00365716|521586796|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
144654394|NCT00365716|521586790|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
144654395|NCT00365716|521586791|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
144654396|NCT00365716|521586792|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
144654397|NCT00365716|521586793|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
144654398|NCT00365716|521586794|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
144654399|NCT00365716|521586795|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
144654400|NCT00365716|521586796|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
144654401|NCT00365716|521586790|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
144654402|NCT00365716|521586791|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
144654403|NCT00365716|521586792|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
144654404|NCT00365716|521586793|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
144654405|NCT00365716|521586794|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
144654406|NCT00365716|521586795|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
144654407|NCT00365716|521586796|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
144654408|NCT00365716|521586790|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
144654409|NCT00365716|521586791|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
144654410|NCT00365716|521586792|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
144654411|NCT00365716|521586793|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
144654412|NCT00365716|521586794|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
144654413|NCT00365716|521586795|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
144654414|NCT00365716|521586796|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
144654415|NCT00365716|521586790|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
144654416|NCT00365716|521586791|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
144654417|NCT00365716|521586792|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
144654418|NCT00365716|521586793|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
144654419|NCT00365716|521586794|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
144654420|NCT00365716|521586795|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
144654421|NCT00365716|521586796|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
144654422|NCT00365716|521586790|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
144654423|NCT00365716|521586791|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
144654424|NCT00365716|521586792|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
144654425|NCT00365716|521586793|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
144654426|NCT00365716|521586794|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
144654427|NCT00365716|521586795|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
144213947|NCT00307437|519976955|FG001|After Controlled Period|Lost to Follow-up|0|||
144213948|NCT00307437|519976956|FG002|After Controlled Period|Lost to Follow-up|0|||
144654428|NCT00365716|521586796|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
144654429|NCT00365716|521586790|FG000|Extension 1|Lost to Follow-up|0|||
144654430|NCT00365716|521586791|FG001|Extension 1|Lost to Follow-up|0|||
144732379|NCT00048581|521875811|FG000|Open-Label Period|Pregnancy|0|||
144732380|NCT00048581|521875812|FG001|Open-Label Period|Pregnancy|0|||
144732381|NCT00048581|521875813|FG002|Open-Label Period|Pregnancy|7|||
144213949|NCT00307437|519976957|FG003|After Controlled Period|Lost to Follow-up|7|||
144213950|NCT00307437|519976958|FG004|After Controlled Period|Lost to Follow-up|12|||
144213951|NCT00307437|519976959|FG005|After Controlled Period|Lost to Follow-up|13|||
144213952|NCT00307437|519976960|FG006|After Controlled Period|Lost to Follow-up|18|||
144213953|NCT00307437|519976954|FG000|After Controlled Period|Other|0|||
144213954|NCT00307437|519976955|FG001|After Controlled Period|Other|0|||
144213955|NCT00307437|519976956|FG002|After Controlled Period|Other|0|||
144213956|NCT00307437|519976957|FG003|After Controlled Period|Other|15|||
144213957|NCT00307437|519976958|FG004|After Controlled Period|Other|9|||
144213958|NCT00307437|519976959|FG005|After Controlled Period|Other|40|||
144213959|NCT00307437|519976960|FG006|After Controlled Period|Other|28|||
144213960|NCT00509795|519976961|FG000|Overall Study|Adverse Event|4|||
144213961|NCT00509795|519976962|FG001|Overall Study|Adverse Event|3|||
144213962|NCT00509795|519976963|FG002|Overall Study|Adverse Event|5|||
144213963|NCT00509795|519976964|FG003|Overall Study|Adverse Event|4|||
144213964|NCT00509795|519976961|FG000|Overall Study|Death|3|||
144213965|NCT00509795|519976962|FG001|Overall Study|Death|1|||
144213966|NCT00509795|519976963|FG002|Overall Study|Death|2|||
144213967|NCT00509795|519976964|FG003|Overall Study|Death|7|||
144213968|NCT00509795|519976961|FG000|Overall Study|Lack of Efficacy|0|||
144213969|NCT00509795|519976962|FG001|Overall Study|Lack of Efficacy|0|||
144213970|NCT00509795|519976963|FG002|Overall Study|Lack of Efficacy|2|||
144213971|NCT00509795|519976964|FG003|Overall Study|Lack of Efficacy|2|||
144213972|NCT00509795|519976961|FG000|Overall Study|Lost to Follow-up|1|||
144213973|NCT00509795|519976962|FG001|Overall Study|Lost to Follow-up|2|||
144213974|NCT00509795|519976963|FG002|Overall Study|Lost to Follow-up|4|||
144654431|NCT00365716|521586792|FG002|Extension 1|Lost to Follow-up|0|||
144654432|NCT00365716|521586793|FG003|Extension 1|Lost to Follow-up|0|||
144654433|NCT00365716|521586794|FG004|Extension 1|Lost to Follow-up|0|||
144654434|NCT00365716|521586795|FG005|Extension 1|Lost to Follow-up|1|||
144654435|NCT00365716|521586796|FG006|Extension 1|Lost to Follow-up|0|||
144654436|NCT00365716|521586790|FG000|Extension 1|Other|0|||
144654437|NCT00365716|521586791|FG001|Extension 1|Other|0|||
144654438|NCT00365716|521586792|FG002|Extension 1|Other|0|||
144654439|NCT00365716|521586793|FG003|Extension 1|Other|0|||
144654440|NCT00365716|521586794|FG004|Extension 1|Other|0|||
144654441|NCT00365716|521586795|FG005|Extension 1|Other|9|||
144654442|NCT00365716|521586796|FG006|Extension 1|Other|0|||
144654443|NCT00365716|521586790|FG000|Extension 1|Moved|0|||
144654444|NCT00365716|521586791|FG001|Extension 1|Moved|0|||
144654445|NCT00365716|521586792|FG002|Extension 1|Moved|0|||
144654446|NCT00365716|521586793|FG003|Extension 1|Moved|0|||
144654447|NCT00365716|521586794|FG004|Extension 1|Moved|0|||
144654448|NCT00365716|521586795|FG005|Extension 1|Moved|4|||
144654449|NCT00365716|521586796|FG006|Extension 1|Moved|0|||
144654450|NCT00365716|521586790|FG000|Extension 1|Withdrawal by Subject|0|||
144654451|NCT00365716|521586791|FG001|Extension 1|Withdrawal by Subject|0|||
144654452|NCT00365716|521586792|FG002|Extension 1|Withdrawal by Subject|0|||
144654453|NCT00365716|521586793|FG003|Extension 1|Withdrawal by Subject|0|||
144654454|NCT00365716|521586794|FG004|Extension 1|Withdrawal by Subject|0|||
144654455|NCT00365716|521586795|FG005|Extension 1|Withdrawal by Subject|3|||
144654456|NCT00365716|521586796|FG006|Extension 1|Withdrawal by Subject|0|||
144654457|NCT00365716|521586790|FG000|Extension 1|Pregnancy|0|||
144654458|NCT00365716|521586791|FG001|Extension 1|Pregnancy|0|||
144654459|NCT00365716|521586792|FG002|Extension 1|Pregnancy|0|||
144654460|NCT00365716|521586793|FG003|Extension 1|Pregnancy|0|||
144654461|NCT00365716|521586794|FG004|Extension 1|Pregnancy|0|||
144654462|NCT00365716|521586795|FG005|Extension 1|Pregnancy|4|||
144654463|NCT00365716|521586796|FG006|Extension 1|Pregnancy|0|||
144654464|NCT00365716|521586790|FG000|Extension 1|Protocol Violation|0|||
144654465|NCT00365716|521586791|FG001|Extension 1|Protocol Violation|0|||
144654466|NCT00365716|521586792|FG002|Extension 1|Protocol Violation|0|||
144654467|NCT00365716|521586793|FG003|Extension 1|Protocol Violation|0|||
144654468|NCT00365716|521586794|FG004|Extension 1|Protocol Violation|0|||
144654469|NCT00365716|521586795|FG005|Extension 1|Protocol Violation|1|||
144654470|NCT00365716|521586796|FG006|Extension 1|Protocol Violation|0|||
144654471|NCT00365716|521586790|FG000|Extension 2|Lost to Follow-up|0|||
144654472|NCT00365716|521586791|FG001|Extension 2|Lost to Follow-up|0|||
144654473|NCT00365716|521586792|FG002|Extension 2|Lost to Follow-up|0|||
144654474|NCT00365716|521586793|FG003|Extension 2|Lost to Follow-up|0|||
144213975|NCT00509795|519976964|FG003|Overall Study|Lost to Follow-up|4|||
144213976|NCT00509795|519976961|FG000|Overall Study|OTHER|1|||
144213977|NCT00509795|519976962|FG001|Overall Study|OTHER|0|||
144213978|NCT00509795|519976963|FG002|Overall Study|OTHER|4|||
144213979|NCT00509795|519976964|FG003|Overall Study|OTHER|1|||
144213980|NCT00509795|519976961|FG000|Overall Study|Protocol Violation|3|||
144654475|NCT00365716|521586794|FG004|Extension 2|Lost to Follow-up|0|||
144654476|NCT00365716|521586795|FG005|Extension 2|Lost to Follow-up|0|||
144654477|NCT00365716|521586796|FG006|Extension 2|Lost to Follow-up|2|||
144654478|NCT00365716|521586790|FG000|Extension 2|Other|0|||
144654479|NCT00365716|521586791|FG001|Extension 2|Other|0|||
144654480|NCT00365716|521586792|FG002|Extension 2|Other|0|||
144654481|NCT00365716|521586793|FG003|Extension 2|Other|0|||
144654482|NCT00365716|521586794|FG004|Extension 2|Other|0|||
144654483|NCT00365716|521586795|FG005|Extension 2|Other|0|||
144654484|NCT00365716|521586796|FG006|Extension 2|Other|3|||
144654485|NCT00365716|521586790|FG000|Extension 2|Withdrawal by Subject|0|||
144654486|NCT00365716|521586791|FG001|Extension 2|Withdrawal by Subject|0|||
144654487|NCT00365716|521586792|FG002|Extension 2|Withdrawal by Subject|0|||
144654488|NCT00365716|521586793|FG003|Extension 2|Withdrawal by Subject|0|||
144654489|NCT00365716|521586794|FG004|Extension 2|Withdrawal by Subject|0|||
144654490|NCT00365716|521586795|FG005|Extension 2|Withdrawal by Subject|0|||
144654491|NCT00365716|521586796|FG006|Extension 2|Withdrawal by Subject|5|||
144654492|NCT02280291|521586797|FG000|Overall Study|Lost to Follow-up|2|||
144654493|NCT02280291|521586798|FG001|Overall Study|Lost to Follow-up|1|||
144654494|NCT02280291|521586799|FG002|Overall Study|Lost to Follow-up|3|||
144654495|NCT02280291|521586800|FG003|Overall Study|Lost to Follow-up|8|||
144654496|NCT02280291|521586797|FG000|Overall Study|Protocol Violation|1|||
144654497|NCT02280291|521586798|FG001|Overall Study|Protocol Violation|0|||
144654498|NCT02280291|521586799|FG002|Overall Study|Protocol Violation|0|||
144654499|NCT02280291|521586800|FG003|Overall Study|Protocol Violation|0|||
144654500|NCT02280291|521586797|FG000|Overall Study|Other|1|||
144654501|NCT02280291|521586798|FG001|Overall Study|Other|1|||
144654502|NCT02280291|521586799|FG002|Overall Study|Other|0|||
144654503|NCT02280291|521586800|FG003|Overall Study|Other|0|||
144654504|NCT00506077|521586801|FG000|Treatment Period 1|Adverse Event|2|||
144654505|NCT00506077|521586802|FG001|Treatment Period 1|Adverse Event|1|||
144654506|NCT00506077|521586801|FG000|Treatment Period 1|Lost to Follow-up|0|||
144654507|NCT00506077|521586802|FG001|Treatment Period 1|Lost to Follow-up|2|||
144654508|NCT00506077|521586801|FG000|Treatment Period 1|Withdrawal by Subject|2|||
144654509|NCT00506077|521586802|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144654510|NCT00506077|521586801|FG000|Treatment Period 2|Adverse Event|0|||
144654511|NCT00506077|521586802|FG001|Treatment Period 2|Adverse Event|1|||
144654512|NCT00506077|521586801|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144654513|NCT00506077|521586802|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144654514|NCT00316303|521586804|FG000|Overall Study|Lost to Follow-up|11|||
144654515|NCT00316303|521586805|FG001|Overall Study|Lost to Follow-up|16|||
144654516|NCT01293032|521586808|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
144654517|NCT01293032|521586809|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
144654518|NCT01293032|521586810|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
144654519|NCT01293032|521586811|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
144654520|NCT01293032|521586808|FG000|Treatment|Adverse Event|0|||
144654521|NCT01293032|521586809|FG001|Treatment|Adverse Event|0|||
144654522|NCT01293032|521586810|FG002|Treatment|Adverse Event|1|||
144654523|NCT01293032|521586811|FG003|Treatment|Adverse Event|1|||
144654524|NCT01293032|521586808|FG000|Treatment|Withdrawal by Subject|2|||
144654525|NCT01293032|521586809|FG001|Treatment|Withdrawal by Subject|4|||
144654526|NCT01293032|521586810|FG002|Treatment|Withdrawal by Subject|0|||
144654527|NCT01293032|521586811|FG003|Treatment|Withdrawal by Subject|0|||
144654528|NCT01293032|521586808|FG000|Treatment|Disease Progression, relapse|0|||
144654529|NCT01293032|521586809|FG001|Treatment|Disease Progression, relapse|1|||
144654530|NCT01293032|521586810|FG002|Treatment|Disease Progression, relapse|0|||
144654531|NCT01293032|521586811|FG003|Treatment|Disease Progression, relapse|0|||
144654532|NCT05590793|521586816|FG000|Overall Study|Withdrawal by Subject|6|||
144654533|NCT05590793|521586816|FG000|Overall Study|Physician Decision|1|||
144213981|NCT00509795|519976962|FG001|Overall Study|Protocol Violation|0|||
144654534|NCT04060667|521586817|FG000|Overall Study|Lost to Follow-up|75|||
144654535|NCT04060667|521586818|FG001|Overall Study|Lost to Follow-up|10|||
144654536|NCT04488822|521586819|FG000|Overall Study|Adverse Event|8|||
144654537|NCT04488822|521586819|FG000|Overall Study|Withdrawal by Subject|1|||
144654538|NCT01929044|521586829|FG000|Overall Study|Adverse Event|1|||
144654539|NCT01929044|521586830|FG001|Overall Study|Adverse Event|0|||
144654540|NCT01929044|521586829|FG000|Overall Study|Protocol Violation|9|||
144654541|NCT01929044|521586830|FG001|Overall Study|Protocol Violation|14|||
144654542|NCT01929044|521586829|FG000|Overall Study|Not Treated|1|||
144654543|NCT01929044|521586830|FG001|Overall Study|Not Treated|3|||
144654544|NCT01165203|521586833|FG000|Active Phase|Serious Adverse Event|1|||
144654545|NCT01165203|521586834|FG001|Active Phase|Serious Adverse Event|0|||
144654546|NCT01165203|521586833|FG000|Active Phase|Withdrawal by Subject|2|||
144654547|NCT01165203|521586834|FG001|Active Phase|Withdrawal by Subject|1|||
144654548|NCT01165203|521586833|FG000|Active Phase|Migrated/moved from study area|0|||
144654549|NCT01165203|521586834|FG001|Active Phase|Migrated/moved from study area|1|||
144654550|NCT01165203|521586833|FG000|Active Phase|Lost to Follow-up|2|||
144654551|NCT01165203|521586834|FG001|Active Phase|Lost to Follow-up|0|||
144654552|NCT01165203|521586833|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
144654553|NCT01165203|521586834|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
144654554|NCT01165203|521586833|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
144654555|NCT01165203|521586834|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
144654556|NCT01165203|521586833|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
144654557|NCT01165203|521586834|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
144654558|NCT01165203|521586833|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
144213982|NCT00509795|519976963|FG002|Overall Study|Protocol Violation|3|||
144732382|NCT00048581|521875811|FG000|Open-Label Period|Study Site Closure|0|||
144654559|NCT01165203|521586834|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
144654560|NCT01165203|521586833|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
144654561|NCT01165203|521586834|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
144654562|NCT00374907|521586835|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
144654563|NCT00374907|521586836|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
144654564|NCT00374907|521586835|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
144654565|NCT00374907|521586836|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
144654566|NCT00374907|521586835|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
144654567|NCT00374907|521586836|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
144654568|NCT00374907|521586835|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
144654569|NCT00374907|521586836|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
144654570|NCT00374907|521586835|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
144654571|NCT00374907|521586836|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
144654572|NCT02582749|521586837|FG000|Overall Study|Study terminated by funder|5|||
144654573|NCT02582749|521586838|FG001|Overall Study|Study terminated by funder|10|||
144654574|NCT02582749|521586837|FG000|Overall Study|Withdrawal by Subject|0|||
144654575|NCT02582749|521586838|FG001|Overall Study|Withdrawal by Subject|1|||
144654576|NCT00426751|521586839|FG000|Overall Study|Adverse Event|8|||
144654577|NCT00426751|521586840|FG001|Overall Study|Adverse Event|1|||
144654578|NCT00426751|521586839|FG000|Overall Study|Lost to Follow-up|7|||
144654579|NCT00426751|521586840|FG001|Overall Study|Lost to Follow-up|6|||
144654580|NCT00426751|521586839|FG000|Overall Study|Consent Withdrawn|0|||
144654581|NCT00426751|521586840|FG001|Overall Study|Consent Withdrawn|1|||
144654582|NCT00426751|521586839|FG000|Overall Study|Other Reasons|7|||
144654583|NCT00426751|521586840|FG001|Overall Study|Other Reasons|12|||
144654584|NCT03288779|521586845|FG000|Overall Study|Withdrawal by Subject|3|||
144654585|NCT01355068|521586849|FG000|First Intervention Period|Adverse Event|0|||
144654586|NCT01355068|521586850|FG001|First Intervention Period|Adverse Event|1|||
144654587|NCT01355068|521586849|FG000|First Intervention Period|Withdrawal by Subject|0|||
144654588|NCT01355068|521586850|FG001|First Intervention Period|Withdrawal by Subject|1|||
144654589|NCT02504892|521586851|FG000|Overall Study|Adverse event-pneumonitis|2|||
144654590|NCT00524745|521586852|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
144654591|NCT00524745|521586853|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
144654592|NCT00524745|521586854|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
144654593|NCT00524745|521586855|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
144654594|NCT00540449|521586856|FG000|Overall Study|Adverse Event|12|||
144654595|NCT00540449|521586857|FG001|Overall Study|Adverse Event|32|||
144654596|NCT00540449|521586856|FG000|Overall Study|Sponsor's Decision|1|||
144654597|NCT00540449|521586857|FG001|Overall Study|Sponsor's Decision|1|||
144654598|NCT00540449|521586856|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
144654599|NCT00540449|521586857|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
144654600|NCT00540449|521586856|FG000|Overall Study|Lost to Follow-up|19|||
144654601|NCT00540449|521586857|FG001|Overall Study|Lost to Follow-up|17|||
144654602|NCT00540449|521586856|FG000|Overall Study|Subject Non-Compliant|7|||
144654603|NCT00540449|521586857|FG001|Overall Study|Subject Non-Compliant|5|||
144654604|NCT00540449|521586856|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
144654605|NCT00540449|521586857|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
144654606|NCT00540449|521586856|FG000|Overall Study|Withdrawal by Subject|10|||
144654607|NCT00540449|521586857|FG001|Overall Study|Withdrawal by Subject|10|||
144654608|NCT00540449|521586856|FG000|Overall Study|Other|1|||
144654609|NCT00540449|521586857|FG001|Overall Study|Other|4|||
144654610|NCT00601523|521586858|FG000|Overall Study|Adverse Event|42|||
144654611|NCT00601523|521586859|FG001|Overall Study|Adverse Event|14|||
144654612|NCT00601523|521586858|FG000|Overall Study|Lack of Efficacy|3|||
144654613|NCT00601523|521586859|FG001|Overall Study|Lack of Efficacy|0|||
144654614|NCT00601523|521586858|FG000|Overall Study|Protocol Violation|5|||
144654615|NCT00601523|521586859|FG001|Overall Study|Protocol Violation|1|||
144654616|NCT00601523|521586858|FG000|Overall Study|Lost to Follow-up|0|||
144654617|NCT00601523|521586859|FG001|Overall Study|Lost to Follow-up|1|||
144654618|NCT00601523|521586858|FG000|Overall Study|Withdrawal by Subject|18|||
144654619|NCT00601523|521586859|FG001|Overall Study|Withdrawal by Subject|9|||
144654620|NCT00601523|521586858|FG000|Overall Study|Other|9|||
144654621|NCT00601523|521586859|FG001|Overall Study|Other|1|||
144654622|NCT03643432|521586860|FG000|Overall Study|Lost to Follow-up|1|||
144654623|NCT03643432|521586861|FG001|Overall Study|Lost to Follow-up|0|||
144654624|NCT00804193|521586862|FG000|Overall Study|Lack of baseline fungus|32|||
144654625|NCT00804193|521586863|FG001|Overall Study|Lack of baseline fungus|31|||
144654626|NCT00804193|521586864|FG002|Overall Study|Lack of baseline fungus|19|||
144654627|NCT00804193|521586862|FG000|Overall Study|Adverse Event|0|||
144654628|NCT00804193|521586863|FG001|Overall Study|Adverse Event|0|||
144654629|NCT00804193|521586864|FG002|Overall Study|Adverse Event|2|||
144654630|NCT00804193|521586862|FG000|Overall Study|Lack of Efficacy|1|||
144654631|NCT00804193|521586863|FG001|Overall Study|Lack of Efficacy|1|||
144654632|NCT00804193|521586864|FG002|Overall Study|Lack of Efficacy|3|||
144654633|NCT00804193|521586862|FG000|Overall Study|Protocol Violation|0|||
144654634|NCT00804193|521586863|FG001|Overall Study|Protocol Violation|8|||
144654635|NCT00804193|521586864|FG002|Overall Study|Protocol Violation|2|||
144654636|NCT00804193|521586862|FG000|Overall Study|Lost to Follow-up|3|||
144654637|NCT00804193|521586863|FG001|Overall Study|Lost to Follow-up|3|||
144654638|NCT00804193|521586864|FG002|Overall Study|Lost to Follow-up|4|||
144654639|NCT00804193|521586862|FG000|Overall Study|Withdrawal by Subject|3|||
144654640|NCT00804193|521586863|FG001|Overall Study|Withdrawal by Subject|1|||
144654641|NCT00804193|521586864|FG002|Overall Study|Withdrawal by Subject|2|||
144654642|NCT04072146|521586867|FG000|Overall Study|Adverse Event|0|||
144654643|NCT04072146|521586868|FG001|Overall Study|Adverse Event|1|||
144654644|NCT01617434|521586869|FG000|Overall Study|Adverse Event|12|||
144654645|NCT01617434|521586870|FG001|Overall Study|Adverse Event|3|||
144654646|NCT01617434|521586869|FG000|Overall Study|Protocol Violation|8|||
144654647|NCT01617434|521586870|FG001|Overall Study|Protocol Violation|7|||
144654648|NCT01617434|521586869|FG000|Overall Study|Withdrawal Criteria|12|||
144654649|NCT01617434|521586870|FG001|Overall Study|Withdrawal Criteria|37|||
144654650|NCT01617434|521586869|FG000|Overall Study|Unclassified|3|||
144654651|NCT01617434|521586870|FG001|Overall Study|Unclassified|4|||
144654652|NCT03283163|521586871|FG000|Overall Study|Lost to Follow-up|1|||
144654653|NCT03283163|521586871|FG000|Overall Study|other life commitments|6|||
144654654|NCT03283163|521586871|FG000|Overall Study|COVID-19 institution wide halting|1|||
144654655|NCT03283163|521586871|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
144654656|NCT03283163|521586871|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
144654657|NCT00968253|521586872|FG000|Overall Study|Death|0|||
144654658|NCT00968253|521586873|FG001|Overall Study|Death|0|||
144654659|NCT00968253|521586874|FG002|Overall Study|Death|2|||
144654660|NCT00968253|521586872|FG000|Overall Study|Withdrawal by Subject|0|||
144654661|NCT00968253|521586873|FG001|Overall Study|Withdrawal by Subject|0|||
144654662|NCT00968253|521586874|FG002|Overall Study|Withdrawal by Subject|1|||
144654663|NCT00968253|521586872|FG000|Overall Study|Disease Progression|0|||
144654664|NCT00968253|521586873|FG001|Overall Study|Disease Progression|3|||
144654665|NCT00968253|521586874|FG002|Overall Study|Disease Progression|3|||
144654666|NCT00968253|521586872|FG000|Overall Study|Adverse Event|0|||
144654667|NCT00968253|521586873|FG001|Overall Study|Adverse Event|0|||
144654668|NCT00968253|521586874|FG002|Overall Study|Adverse Event|1|||
144654669|NCT00370149|521586876|FG000|Overall Study|Physician Decision|16|||
144654670|NCT00370149|521586877|FG001|Overall Study|Physician Decision|16|||
144654671|NCT00370149|521586876|FG000|Overall Study|Protocol Violation|1|||
144654672|NCT00370149|521586877|FG001|Overall Study|Protocol Violation|0|||
144654673|NCT00370149|521586876|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
144654674|NCT00370149|521586877|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
144654675|NCT00370149|521586876|FG000|Overall Study|Pre-existing infection|0|||
144654676|NCT00370149|521586877|FG001|Overall Study|Pre-existing infection|1|||
144654677|NCT00370149|521586876|FG000|Overall Study|Antibiotic coated dressing placed|0|||
144654678|NCT00370149|521586877|FG001|Overall Study|Antibiotic coated dressing placed|1|||
144654679|NCT02340819|521588006|FG000|Overall Study|Adverse Event|1|||
144654680|NCT02340819|521588006|FG000|Overall Study|Withdrawal by Subject|2|||
144654681|NCT02340819|521588006|FG000|Overall Study|Discontinued with other reason|1|||
144654682|NCT02361762|521588007|FG000|Overall Study|Withdrawal by Subject|0|||
144654683|NCT02361762|521588008|FG001|Overall Study|Withdrawal by Subject|1|||
144654684|NCT02361762|521588007|FG000|Overall Study|Lost to Follow-up|0|||
144654685|NCT02361762|521588008|FG001|Overall Study|Lost to Follow-up|1|||
144654686|NCT00028002|521588009|FG000|Overall Study|Withdrawal by Subject|3|||
144654687|NCT00028002|521588009|FG000|Overall Study|Ineligible|8|||
144654688|NCT00051558|521588011|FG000|Overall Study|Adverse Event|30|||
144654689|NCT00051558|521588012|FG001|Overall Study|Adverse Event|18|||
144654690|NCT00051558|521588011|FG000|Overall Study|Withdrawal by Subject|29|||
144654691|NCT00051558|521588012|FG001|Overall Study|Withdrawal by Subject|42|||
144654692|NCT00051558|521588011|FG000|Overall Study|Death|9|||
144654693|NCT00051558|521588012|FG001|Overall Study|Death|15|||
144654694|NCT00051558|521588011|FG000|Overall Study|Lost to Follow-up|4|||
144654695|NCT00051558|521588012|FG001|Overall Study|Lost to Follow-up|13|||
144213983|NCT00509795|519976964|FG003|Overall Study|Protocol Violation|1|||
144654696|NCT00051558|521588011|FG000|Overall Study|Protocol Violation|3|||
144654697|NCT00051558|521588012|FG001|Overall Study|Protocol Violation|4|||
144654698|NCT00051558|521588011|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
144654699|NCT00051558|521588012|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
144654700|NCT00051558|521588011|FG000|Overall Study|Sponsor Decision|6|||
144654701|NCT00051558|521588012|FG001|Overall Study|Sponsor Decision|1|||
144654702|NCT00051558|521588011|FG000|Overall Study|Other|2|||
144213984|NCT00509795|519976961|FG000|Overall Study|Withdrawal by Subject|10|||
144654703|NCT00051558|521588012|FG001|Overall Study|Other|1|||
144654704|NCT00051558|521588011|FG000|Overall Study|Significant Lab Value|2|||
144654705|NCT00051558|521588012|FG001|Overall Study|Significant Lab Value|0|||
144654706|NCT00051558|521588011|FG000|Overall Study|Physician Decision|5|||
144654707|NCT00051558|521588012|FG001|Overall Study|Physician Decision|0|||
144654708|NCT03508622|521588019|FG000|Overall Study|Protocol Violation|1|||
144654709|NCT03508622|521588020|FG001|Overall Study|Protocol Violation|0|||
144654710|NCT03508622|521588019|FG000|Overall Study|Withdrawal by Subject|1|||
144654711|NCT03508622|521588020|FG001|Overall Study|Withdrawal by Subject|0|||
144654712|NCT03508622|521588019|FG000|Overall Study|Lost to Follow-up|16|||
144654713|NCT03508622|521588020|FG001|Overall Study|Lost to Follow-up|0|||
144654714|NCT03508622|521588019|FG000|Overall Study|Incomplete data|0|||
144654715|NCT03508622|521588020|FG001|Overall Study|Incomplete data|24|||
144654716|NCT02499146|521588021|FG000|Overall Study|Lost to Follow-up|1|||
144654717|NCT02499146|521588021|FG000|Overall Study|Withdrawal by Subject|1|||
144654718|NCT02499146|521588021|FG000|Overall Study|Other|2|||
144654719|NCT02499146|521588021|FG000|Overall Study|Ongoing at date of cut-off|9|||
144654720|NCT02499146|521588021|FG000|Overall Study|Began other treatment/therapy|13|||
144654721|NCT03161678|521588022|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
144654722|NCT03161678|521588023|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
144654723|NCT03161678|521588024|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
144654724|NCT03161678|521588025|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
144654725|NCT03161678|521588026|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
144654726|NCT03161678|521588027|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
144654727|NCT03161678|521588022|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
144654728|NCT03161678|521588023|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
144654729|NCT03161678|521588024|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
144654730|NCT03161678|521588025|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
144654731|NCT03161678|521588026|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
144654732|NCT03161678|521588027|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
144654733|NCT03161678|521588022|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
144654734|NCT03161678|521588023|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
144654735|NCT03161678|521588024|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
144654736|NCT03161678|521588025|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
144654737|NCT03161678|521588026|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
144654738|NCT03161678|521588027|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
144654739|NCT03161678|521588022|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
144654740|NCT03161678|521588023|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
144654741|NCT03161678|521588024|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
144654742|NCT03161678|521588025|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
144654743|NCT03161678|521588026|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
144654744|NCT03161678|521588027|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
144654745|NCT00752609|521588028|FG000|Overall Study|Adverse Event|2|||
144654746|NCT00752609|521588029|FG001|Overall Study|Adverse Event|2|||
144654747|NCT00752609|521588028|FG000|Overall Study|Withdrawal by Subject|3|||
144654748|NCT00752609|521588029|FG001|Overall Study|Withdrawal by Subject|0|||
144654749|NCT00752609|521588028|FG000|Overall Study|Physician Decision|1|||
144654750|NCT00752609|521588029|FG001|Overall Study|Physician Decision|0|||
144654751|NCT00752609|521588028|FG000|Overall Study|Death|1|||
144654752|NCT00752609|521588029|FG001|Overall Study|Death|0|||
144654753|NCT00752609|521588028|FG000|Overall Study|Met exclusion criteria|1|||
144654754|NCT00752609|521588029|FG001|Overall Study|Met exclusion criteria|0|||
144654755|NCT00752609|521588028|FG000|Overall Study|Received Aranesp in error|1|||
144654756|NCT00752609|521588029|FG001|Overall Study|Received Aranesp in error|0|||
144654757|NCT01757704|521588035|FG000|Overall Study|Protocol Violation|1|||
144654758|NCT01757704|521588036|FG001|Overall Study|Protocol Violation|3|||
144654759|NCT02749721|521588039|FG000|Screening|Withdrawal by Subject|1|||
144654760|NCT02749721|521588039|FG000|Screening|Lost to Follow-up|2|||
144654761|NCT02749721|521588039|FG000|Screening|Protocol Violation|3|||
144654762|NCT02749721|521588039|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
144654763|NCT02749721|521588039|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
144654764|NCT01555463|521588044|FG000|Treatment|Adverse Event|6|||
144654765|NCT01555463|521588045|FG001|Treatment|Adverse Event|12|||
144654766|NCT01555463|521588044|FG000|Treatment|Withdrawal by Subject|24|||
144654767|NCT01555463|521588045|FG001|Treatment|Withdrawal by Subject|36|||
144654768|NCT01555463|521588044|FG000|Treatment|Lost to Follow-up|28|||
144654769|NCT01555463|521588045|FG001|Treatment|Lost to Follow-up|23|||
144654770|NCT01555463|521588044|FG000|Treatment|Protocol Violation|4|||
144654771|NCT01555463|521588045|FG001|Treatment|Protocol Violation|5|||
144654772|NCT01555463|521588044|FG000|Treatment|Other reason|2|||
144654773|NCT01555463|521588045|FG001|Treatment|Other reason|3|||
144654774|NCT01555463|521588044|FG000|Follow up|Adverse Event|2|||
144654775|NCT01555463|521588045|FG001|Follow up|Adverse Event|5|||
144654776|NCT01555463|521588044|FG000|Follow up|Death|0|||
144654777|NCT01555463|521588045|FG001|Follow up|Death|1|||
144654778|NCT01555463|521588044|FG000|Follow up|Withdrawal by Subject|22|||
144654779|NCT01555463|521588045|FG001|Follow up|Withdrawal by Subject|22|||
144654780|NCT01555463|521588044|FG000|Follow up|Lost to Follow-up|9|||
144654781|NCT01555463|521588045|FG001|Follow up|Lost to Follow-up|10|||
144654782|NCT01555463|521588044|FG000|Follow up|Protocol Violation|2|||
144654783|NCT01555463|521588045|FG001|Follow up|Protocol Violation|4|||
144654784|NCT01555463|521588044|FG000|Follow up|Other reason|3|||
144654785|NCT01555463|521588045|FG001|Follow up|Other reason|3|||
144264152|NCT01683604|520167666|FG000|Overall Study|Adverse Event|2|||
144264153|NCT01683604|520167666|FG000|Overall Study|Lack of Efficacy|1|||
144264154|NCT01683604|520167666|FG000|Overall Study|Other|2|||
144264155|NCT04006145|520169367|FG000|Overall Study|Lost to Follow-up|0|||
144264156|NCT04006145|520169368|FG001|Overall Study|Lost to Follow-up|1|||
144264157|NCT04006145|520169367|FG000|Overall Study|Other|1|||
144264158|NCT04006145|520169368|FG001|Overall Study|Other|2|||
144264159|NCT00010257|520169371|FG000|Overall Study|Withdrawal by Subject|1|||
144264160|NCT00010257|520169372|FG001|Overall Study|Withdrawal by Subject|0|||
144264161|NCT02063672|520169373|FG000|Overall Study|Ongoing Follow-up|27|||
144264162|NCT02063672|520169374|FG001|Overall Study|Ongoing Follow-up|14|||
144264163|NCT02063672|520169373|FG000|Overall Study|Death|5|||
144264164|NCT02063672|520169374|FG001|Overall Study|Death|3|||
144264165|NCT02063672|520169373|FG000|Overall Study|Lost to Follow-up|1|||
144264166|NCT02063672|520169374|FG001|Overall Study|Lost to Follow-up|3|||
144264167|NCT02063672|520169373|FG000|Overall Study|Withdrawal by Subject|2|||
144264168|NCT02063672|520169374|FG001|Overall Study|Withdrawal by Subject|2|||
144654786|NCT04333433|521588046|FG000|Overall Study|Withdrawal by Subject|6|||
144654787|NCT04333433|521588047|FG001|Overall Study|Withdrawal by Subject|3|||
144654788|NCT04333433|521588046|FG000|Overall Study|Death|3|||
144654789|NCT04333433|521588047|FG001|Overall Study|Death|0|||
144654790|NCT04333433|521588046|FG000|Overall Study|Lost to Follow-up|6|||
144654791|NCT04333433|521588047|FG001|Overall Study|Lost to Follow-up|1|||
144654792|NCT04333433|521588046|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
144654793|NCT04333433|521588047|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
144654794|NCT02026271|521588048|FG000|Overall Study|Adverse Event|2|||
144654795|NCT02026271|521588049|FG001|Overall Study|Adverse Event|3|||
144654796|NCT02026271|521588050|FG002|Overall Study|Adverse Event|2|||
144654797|NCT02026271|521588051|FG003|Overall Study|Adverse Event|3|||
144654798|NCT02026271|521588052|FG004|Overall Study|Adverse Event|0|||
144654799|NCT02026271|521588048|FG000|Overall Study|Withdrawal by Subject|0|||
144654800|NCT02026271|521588049|FG001|Overall Study|Withdrawal by Subject|0|||
144654801|NCT02026271|521588050|FG002|Overall Study|Withdrawal by Subject|0|||
144654802|NCT02026271|521588051|FG003|Overall Study|Withdrawal by Subject|0|||
144654803|NCT02026271|521588052|FG004|Overall Study|Withdrawal by Subject|1|||
144654804|NCT02275026|521588055|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
144654805|NCT02275026|521588055|FG000|Overall Study|Withdrawal by Subject|4|||
144654806|NCT02275026|521588055|FG000|Overall Study|Ineligible due to medical history|13|||
144654807|NCT02275026|521588055|FG000|Overall Study|MRI malfunction precluded testing|1|||
144654808|NCT02275026|521588055|FG000|Overall Study|Ineligible after MRI findings|1|||
144654809|NCT02275026|521588055|FG000|Overall Study|Lost to Follow-up|2|||
144654810|NCT02275026|521588055|FG000|Overall Study|Scanner failure|1|||
144654811|NCT01108809|521588056|FG000|Overall Study|Adverse Event|3|||
144654812|NCT01108809|521588056|FG000|Overall Study|Lost to Follow-up|1|||
144654813|NCT02213198|521588060|FG000|Baseline|No show for intake|7|||
144654814|NCT02213198|521588061|FG001|Baseline|No show for intake|9|||
144654815|NCT02213198|521588060|FG000|Baseline|Withdrawal by Subject|34|||
144654816|NCT02213198|521588061|FG001|Baseline|Withdrawal by Subject|11|||
144654817|NCT02213198|521588060|FG000|Baseline|transferred out of clinic|7|||
144654818|NCT02213198|521588061|FG001|Baseline|transferred out of clinic|9|||
144654819|NCT02213198|521588060|FG000|Baseline|Lost to Follow-up|40|||
144654820|NCT02213198|521588061|FG001|Baseline|Lost to Follow-up|21|||
144654821|NCT02213198|521588060|FG000|Baseline|incarcerated,violent|0|||
144654822|NCT02213198|521588061|FG001|Baseline|incarcerated,violent|1|||
144654823|NCT02213198|521588060|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
144654824|NCT02213198|521588061|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
144654825|NCT02213198|521588060|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
144654826|NCT02213198|521588061|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
144654827|NCT02213198|521588060|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
144654828|NCT02213198|521588061|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
144654829|NCT02213198|521588060|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
144654830|NCT02213198|521588061|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
144264169|NCT02498678|520169376|FG000|Overall Study|interference from the surgical team|0|||
144264170|NCT02498678|520169377|FG001|Overall Study|interference from the surgical team|2|||
144264171|NCT01405560|520169378|FG000|Overall Study|Physician Decision|1|||
144264172|NCT01484951|520169381|FG000|Overall Study|Adverse Event|3|||
144264173|NCT01484951|520169381|FG000|Overall Study|Personal Reasons|1|||
144264174|NCT01484951|520169381|FG000|Overall Study|Non-Compliance|1|||
144264175|NCT02169505|520169383|FG000|Overall Study|Withdrawal by Subject|1|||
144264176|NCT02035553|520169384|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
144264177|NCT02035553|520169385|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
144654831|NCT02213198|521588060|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
144654832|NCT02213198|521588061|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
144654833|NCT02213198|521588060|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
144654834|NCT02213198|521588061|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
144654835|NCT00001262|521588062|FG000|Overall Study|Death|10|||
144654836|NCT00001262|521588063|FG001|Overall Study|Death|11|||
144654837|NCT00001262|521588064|FG002|Overall Study|Death|0|||
144654838|NCT00001262|521588062|FG000|Overall Study|Withdrawal by Subject|0|||
144654839|NCT00001262|521588063|FG001|Overall Study|Withdrawal by Subject|3|||
144654840|NCT00001262|521588064|FG002|Overall Study|Withdrawal by Subject|0|||
144654841|NCT02379923|521588068|FG000|Overall Study|Death|5|||
144654842|NCT00576693|521588069|FG000|Overall Study|Lost to Follow-up|7|||
144654843|NCT00576693|521588070|FG001|Overall Study|Lost to Follow-up|11|||
144654844|NCT00576693|521588069|FG000|Overall Study|Withdrawal by Subject|3|||
144654845|NCT00576693|521588070|FG001|Overall Study|Withdrawal by Subject|13|||
144654846|NCT01413178|521588071|FG000|Overall Study|Toxicity|1|||
144654847|NCT01413178|521588072|FG001|Overall Study|Toxicity|0|||
144654848|NCT01413178|521588071|FG000|Overall Study|Ineligible|0|||
144654849|NCT01413178|521588072|FG001|Overall Study|Ineligible|2|||
144654850|NCT04238663|521588073|FG000|Overall Study|Lost to Follow-up|0|||
144654851|NCT04238663|521588074|FG001|Overall Study|Lost to Follow-up|1|||
144654852|NCT04238663|521588075|FG002|Overall Study|Lost to Follow-up|0|||
144654853|NCT01193348|521588076|FG000|Screening Period|Screen Failure|5|||
144654854|NCT01193348|521588076|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
144654855|NCT01193348|521588076|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
144654856|NCT01193348|521588076|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
144654857|NCT01193348|521588076|FG000|Extension Treatment Period|Physician Decision|1|||
144654858|NCT01193348|521588076|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
144654859|NCT01721408|521588077|FG000|Overall Study|Adverse Event|6|||
144654860|NCT01721408|521588078|FG001|Overall Study|Adverse Event|1|||
144654861|NCT01721408|521588077|FG000|Overall Study|Death|1|||
144654862|NCT01721408|521588078|FG001|Overall Study|Death|0|||
144654863|NCT01721408|521588077|FG000|Overall Study|Insufficient clinical response|15|||
144654864|NCT01721408|521588078|FG001|Overall Study|Insufficient clinical response|6|||
144654865|NCT01721408|521588077|FG000|Overall Study|No longer willing to participate study|9|||
144654866|NCT01721408|521588078|FG001|Overall Study|No longer willing to participate study|10|||
144654867|NCT01721408|521588077|FG000|Overall Study|Protocol Violation|0|||
144654868|NCT01721408|521588078|FG001|Overall Study|Protocol Violation|2|||
144654869|NCT01721408|521588077|FG000|Overall Study|Other|3|||
144654870|NCT01721408|521588078|FG001|Overall Study|Other|3|||
144654871|NCT01721408|521588077|FG000|Overall Study|Lost to Follow-up|1|||
144654872|NCT01721408|521588078|FG001|Overall Study|Lost to Follow-up|2|||
144654873|NCT01721408|521588077|FG000|Overall Study|Does not meet entrance criteria|1|||
144654874|NCT01721408|521588078|FG001|Overall Study|Does not meet entrance criteria|0|||
144654875|NCT02928406|521588081|FG000|Overall Study|Death|780|||
144654876|NCT02928406|521588081|FG000|Overall Study|Progressive disease|3|||
144654877|NCT02928406|521588081|FG000|Overall Study|Lost to Follow-up|49|||
144654878|NCT02928406|521588081|FG000|Overall Study|Non-compliance|2|||
144654879|NCT02928406|521588081|FG000|Overall Study|Withdrawal by Subject|40|||
144654880|NCT02928406|521588081|FG000|Overall Study|Study terminated by sponsor|57|||
144654881|NCT02928406|521588081|FG000|Overall Study|Physician Decision|1|||
144654882|NCT02928406|521588081|FG000|Overall Study|Various reasons|72|||
144654883|NCT03987620|521588082|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
144654884|NCT03987620|521588083|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
144654885|NCT03987620|521588082|FG000|Overall Study|Adverse Event|3|||
144654886|NCT03987620|521588083|FG001|Overall Study|Adverse Event|0|||
144654887|NCT03987620|521588082|FG000|Overall Study|Lost to Follow-up|1|||
144654888|NCT03987620|521588083|FG001|Overall Study|Lost to Follow-up|2|||
144654889|NCT03987620|521588082|FG000|Overall Study|Physician Decision|0|||
144654890|NCT03987620|521588083|FG001|Overall Study|Physician Decision|1|||
144654891|NCT03987620|521588082|FG000|Overall Study|Pregnancy|1|||
144654892|NCT03987620|521588083|FG001|Overall Study|Pregnancy|0|||
144654893|NCT03987620|521588082|FG000|Overall Study|Withdrawal by Subject|7|||
144732383|NCT00048581|521875812|FG001|Open-Label Period|Study Site Closure|0|||
144654894|NCT03987620|521588083|FG001|Overall Study|Withdrawal by Subject|1|||
144654895|NCT03987620|521588082|FG000|Overall Study|Other|2|||
144654896|NCT03987620|521588083|FG001|Overall Study|Other|5|||
144732384|NCT00048581|521875813|FG002|Open-Label Period|Study Site Closure|2|||
144732385|NCT00048581|521875811|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
144732386|NCT00048581|521875812|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
144732387|NCT00048581|521875813|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
144654897|NCT02149836|521588085|FG000|Overall Study|Withdrawal by Subject|1|||
144654898|NCT01745393|521588086|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
144654899|NCT01745393|521588087|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
144654900|NCT01745393|521588086|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
144654901|NCT01745393|521588087|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
144654902|NCT01745393|521588086|FG000|12-month Follow-up|Lost to Follow-up|6|||
144654903|NCT01745393|521588087|FG001|12-month Follow-up|Lost to Follow-up|5|||
144654904|NCT00786838|521588088|FG000|Overall Study|Physician Decision|4|||
144654905|NCT00786838|521588088|FG000|Overall Study|Death|4|||
144654906|NCT00786838|521588088|FG000|Overall Study|Adverse Event|6|||
144654907|NCT00786838|521588088|FG000|Overall Study|Progressive disease|31|||
144654908|NCT00786838|521588088|FG000|Overall Study|Withdrawal by Subject|4|||
144654909|NCT02488759|521588089|FG000|Overall Study|Disease progression|73|||
144654910|NCT02488759|521588090|FG001|Overall Study|Disease progression|111|||
144654911|NCT02488759|521588091|FG002|Overall Study|Disease progression|62|||
144654912|NCT02488759|521588092|FG003|Overall Study|Disease progression|7|||
144654913|NCT02488759|521588093|FG004|Overall Study|Disease progression|4|||
144654914|NCT02488759|521588094|FG005|Overall Study|Disease progression|2|||
144654915|NCT02488759|521588089|FG000|Overall Study|Study drug toxicity|11|||
144654916|NCT02488759|521588090|FG001|Overall Study|Study drug toxicity|33|||
144654917|NCT02488759|521588091|FG002|Overall Study|Study drug toxicity|31|||
144654918|NCT02488759|521588092|FG003|Overall Study|Study drug toxicity|0|||
144654919|NCT02488759|521588093|FG004|Overall Study|Study drug toxicity|0|||
144654920|NCT02488759|521588094|FG005|Overall Study|Study drug toxicity|2|||
144654921|NCT02488759|521588089|FG000|Overall Study|Adverse event unrelated to study drug|9|||
144654922|NCT02488759|521588090|FG001|Overall Study|Adverse event unrelated to study drug|11|||
144654923|NCT02488759|521588091|FG002|Overall Study|Adverse event unrelated to study drug|7|||
144654924|NCT02488759|521588092|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144654925|NCT02488759|521588093|FG004|Overall Study|Adverse event unrelated to study drug|1|||
144654926|NCT02488759|521588094|FG005|Overall Study|Adverse event unrelated to study drug|0|||
144654927|NCT02488759|521588089|FG000|Overall Study|Participant request to discontinue study treatment|6|||
144654928|NCT02488759|521588090|FG001|Overall Study|Participant request to discontinue study treatment|8|||
144654929|NCT02488759|521588091|FG002|Overall Study|Participant request to discontinue study treatment|4|||
144654930|NCT02488759|521588092|FG003|Overall Study|Participant request to discontinue study treatment|0|||
144654931|NCT02488759|521588093|FG004|Overall Study|Participant request to discontinue study treatment|0|||
144654932|NCT02488759|521588094|FG005|Overall Study|Participant request to discontinue study treatment|0|||
144654933|NCT02488759|521588089|FG000|Overall Study|Withdrawal by Subject|4|||
144654934|NCT02488759|521588090|FG001|Overall Study|Withdrawal by Subject|0|||
144654935|NCT02488759|521588091|FG002|Overall Study|Withdrawal by Subject|3|||
144654936|NCT02488759|521588092|FG003|Overall Study|Withdrawal by Subject|0|||
144654937|NCT02488759|521588093|FG004|Overall Study|Withdrawal by Subject|0|||
144654938|NCT02488759|521588094|FG005|Overall Study|Withdrawal by Subject|2|||
144654939|NCT02488759|521588089|FG000|Overall Study|Lost to Follow-up|0|||
144654940|NCT02488759|521588090|FG001|Overall Study|Lost to Follow-up|0|||
144654941|NCT02488759|521588091|FG002|Overall Study|Lost to Follow-up|2|||
144654942|NCT02488759|521588092|FG003|Overall Study|Lost to Follow-up|0|||
144654943|NCT02488759|521588093|FG004|Overall Study|Lost to Follow-up|0|||
144654944|NCT02488759|521588094|FG005|Overall Study|Lost to Follow-up|0|||
144654945|NCT02488759|521588089|FG000|Overall Study|Maximum clinical benefit|3|||
144654946|NCT02488759|521588090|FG001|Overall Study|Maximum clinical benefit|0|||
144654947|NCT02488759|521588091|FG002|Overall Study|Maximum clinical benefit|1|||
144654948|NCT02488759|521588092|FG003|Overall Study|Maximum clinical benefit|0|||
144654949|NCT02488759|521588093|FG004|Overall Study|Maximum clinical benefit|0|||
144654950|NCT02488759|521588094|FG005|Overall Study|Maximum clinical benefit|0|||
144654951|NCT02488759|521588089|FG000|Overall Study|Other reasons|7|||
144654952|NCT02488759|521588090|FG001|Overall Study|Other reasons|32|||
144654953|NCT02488759|521588091|FG002|Overall Study|Other reasons|23|||
144654954|NCT02488759|521588092|FG003|Overall Study|Other reasons|1|||
144654955|NCT02488759|521588093|FG004|Overall Study|Other reasons|1|||
144654956|NCT02488759|521588094|FG005|Overall Study|Other reasons|1|||
144654957|NCT03860844|521588095|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
144654958|NCT03860844|521588096|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
144654959|NCT03860844|521588097|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
144654960|NCT03860844|521588095|FG000|Overall Study|Progressive disease|5|||
144654961|NCT03860844|521588096|FG001|Overall Study|Progressive disease|3|||
144654962|NCT03860844|521588097|FG002|Overall Study|Progressive disease|4|||
144654963|NCT03860844|521588095|FG000|Overall Study|Other, Not related to COVID-19|0|||
144654964|NCT03860844|521588096|FG001|Overall Study|Other, Not related to COVID-19|1|||
144654965|NCT03860844|521588097|FG002|Overall Study|Other, Not related to COVID-19|0|||
144654966|NCT01678807|521588105|FG000|Overall Study|Adverse Event|4|||
144732388|NCT00048581|521875811|FG000|Open-Label Period|Problem With Transportation To Site|0|||
144654967|NCT01678807|521588106|FG001|Overall Study|Adverse Event|4|||
144654968|NCT01678807|521588107|FG002|Overall Study|Adverse Event|0|||
144654969|NCT01678807|521588105|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
144654970|NCT01678807|521588106|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
144732389|NCT00048581|521875812|FG001|Open-Label Period|Problem With Transportation To Site|0|||
144732390|NCT00048581|521875813|FG002|Open-Label Period|Problem With Transportation To Site|1|||
144732391|NCT00048581|521875811|FG000|Open-Label Period|Primary Investigator Retired|0|||
144732392|NCT00048581|521875812|FG001|Open-Label Period|Primary Investigator Retired|0|||
144732393|NCT00048581|521875813|FG002|Open-Label Period|Primary Investigator Retired|2|||
144732394|NCT00048581|521875811|FG000|Open-Label Period|Study Ended By Sponsor|0|||
144654971|NCT01678807|521588107|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
144654972|NCT00719732|521588108|FG000|Overall Study|Lost to Follow-up|20|||
144654973|NCT00719732|521588108|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
144654974|NCT00719732|521588108|FG000|Overall Study|Illness not associated with device|1|||
144654975|NCT05306873|521589524|FG000|Stage 2|Study stopped|1|||
144654976|NCT05306873|521589525|FG001|Stage 2|Study stopped|1|||
144654977|NCT05306873|521589526|FG002|Stage 2|Study stopped|0|||
144654978|NCT05306873|521589527|FG003|Stage 2|Study stopped|0|||
144654979|NCT05306873|521589524|FG000|Stage 2|Stage 2 Treatment Failure|2|||
144654980|NCT05306873|521589525|FG001|Stage 2|Stage 2 Treatment Failure|3|||
144654981|NCT05306873|521589526|FG002|Stage 2|Stage 2 Treatment Failure|0|||
144654982|NCT05306873|521589527|FG003|Stage 2|Stage 2 Treatment Failure|0|||
144654983|NCT05306873|521589524|FG000|Stage 2|Logistical issues due to participant moving|1|||
144654984|NCT05306873|521589525|FG001|Stage 2|Logistical issues due to participant moving|0|||
144654985|NCT05306873|521589526|FG002|Stage 2|Logistical issues due to participant moving|0|||
144654986|NCT05306873|521589527|FG003|Stage 2|Logistical issues due to participant moving|0|||
144654987|NCT05306873|521589524|FG000|Stage 3|Stage 3 Treatment Failure|0|||
144654988|NCT05306873|521589525|FG001|Stage 3|Stage 3 Treatment Failure|0|||
144654989|NCT05306873|521589526|FG002|Stage 3|Stage 3 Treatment Failure|0|||
144654990|NCT05306873|521589527|FG003|Stage 3|Stage 3 Treatment Failure|1|||
144654991|NCT05306873|521589524|FG000|Stage 3|Study Stopped|0|||
144654992|NCT05306873|521589525|FG001|Stage 3|Study Stopped|0|||
144654993|NCT05306873|521589526|FG002|Stage 3|Study Stopped|1|||
144654994|NCT05306873|521589527|FG003|Stage 3|Study Stopped|0|||
144654995|NCT04467164|521589530|FG000|Washout (1 Week)|Lost to Follow-up|2|||
144654996|NCT04467164|521589531|FG001|Washout (1 Week)|Lost to Follow-up|0|||
144654997|NCT02750813|521589532|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
144654998|NCT02750813|521589533|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
144654999|NCT02750813|521589532|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
144655000|NCT02750813|521589533|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
144655001|NCT03100942|521589536|FG000|Randomized Treatment Period|Withdrew Consent|4|||
144655002|NCT03100942|521589537|FG001|Randomized Treatment Period|Withdrew Consent|5|||
144655003|NCT03100942|521589538|FG002|Randomized Treatment Period|Withdrew Consent|3|||
144655004|NCT03100942|521589539|FG003|Randomized Treatment Period|Withdrew Consent|3|||
144655005|NCT03100942|521589540|FG004|Randomized Treatment Period|Withdrew Consent|0|||
144655006|NCT03100942|521589541|FG005|Randomized Treatment Period|Withdrew Consent|0|||
144655007|NCT03100942|521589542|FG006|Randomized Treatment Period|Withdrew Consent|0|||
144655008|NCT03100942|521589536|FG000|Randomized Treatment Period|Adverse Event|5|||
144655009|NCT03100942|521589537|FG001|Randomized Treatment Period|Adverse Event|2|||
144655010|NCT03100942|521589538|FG002|Randomized Treatment Period|Adverse Event|1|||
144655011|NCT03100942|521589539|FG003|Randomized Treatment Period|Adverse Event|0|||
144655012|NCT03100942|521589540|FG004|Randomized Treatment Period|Adverse Event|0|||
144655013|NCT03100942|521589541|FG005|Randomized Treatment Period|Adverse Event|0|||
144655014|NCT03100942|521589542|FG006|Randomized Treatment Period|Adverse Event|0|||
144655015|NCT03100942|521589536|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
144655016|NCT03100942|521589537|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
144655017|NCT03100942|521589538|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
144655018|NCT03100942|521589539|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
144655019|NCT03100942|521589540|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
144655020|NCT03100942|521589541|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
144655021|NCT03100942|521589542|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
144655022|NCT03100942|521589536|FG000|Randomized Treatment Period|Protocol Violation|0|||
144655023|NCT03100942|521589537|FG001|Randomized Treatment Period|Protocol Violation|1|||
144655024|NCT03100942|521589538|FG002|Randomized Treatment Period|Protocol Violation|1|||
144655025|NCT03100942|521589539|FG003|Randomized Treatment Period|Protocol Violation|1|||
144655026|NCT03100942|521589540|FG004|Randomized Treatment Period|Protocol Violation|0|||
144655027|NCT03100942|521589541|FG005|Randomized Treatment Period|Protocol Violation|0|||
144655028|NCT03100942|521589542|FG006|Randomized Treatment Period|Protocol Violation|0|||
144655029|NCT03100942|521589536|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
144213985|NCT00509795|519976962|FG001|Overall Study|Withdrawal by Subject|5|||
144213986|NCT00509795|519976963|FG002|Overall Study|Withdrawal by Subject|7|||
144213987|NCT00509795|519976964|FG003|Overall Study|Withdrawal by Subject|8|||
144213988|NCT00338728|519976966|FG000|Overall Study|Screen Failure|14|||
144213989|NCT04380961|519976972|FG000|Overall Study|Lost to Follow-up|17|||
144213990|NCT04380961|519976973|FG001|Overall Study|Lost to Follow-up|11|||
144213991|NCT04380961|519976972|FG000|Overall Study|Withdrawal by Subject|3|||
144213992|NCT04380961|519976973|FG001|Overall Study|Withdrawal by Subject|0|||
144213993|NCT04380961|519976972|FG000|Overall Study|Death|22|||
144213994|NCT04380961|519976973|FG001|Overall Study|Death|16|||
144213995|NCT04380961|519976972|FG000|Overall Study|Other|1|||
144213996|NCT04380961|519976973|FG001|Overall Study|Other|0|||
144213997|NCT04380961|519976972|FG000|Overall Study|Randomized but Not Treated|1|||
144213998|NCT04380961|519976973|FG001|Overall Study|Randomized but Not Treated|2|||
144213999|NCT00805961|519976974|FG000|Modality Therapy|Withdrawal by Subject|1|||
144732395|NCT00048581|521875812|FG001|Open-Label Period|Study Ended By Sponsor|0|||
144655030|NCT03100942|521589537|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
144655031|NCT03100942|521589538|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
144655032|NCT03100942|521589539|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
144655033|NCT03100942|521589540|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
144655034|NCT03100942|521589541|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
144655035|NCT03100942|521589542|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
144655036|NCT03100942|521589536|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
144655037|NCT03100942|521589537|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
144655038|NCT03100942|521589538|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
144655039|NCT03100942|521589539|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
144655040|NCT03100942|521589540|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
144655041|NCT03100942|521589541|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
144655042|NCT03100942|521589542|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
144655043|NCT03100942|521589536|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
144655044|NCT03100942|521589537|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
144655045|NCT03100942|521589538|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
144655046|NCT03100942|521589539|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
144655047|NCT03100942|521589540|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
144655048|NCT03100942|521589541|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
144655049|NCT03100942|521589542|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
144732396|NCT00048581|521875813|FG002|Open-Label Period|Study Ended By Sponsor|1|||
144732397|NCT01406795|521875814|FG000|Overall Study|Withdrawal by Subject|1|||
144732398|NCT03966365|521875815|FG000|Overall Study|Protocol Violation|1|||
144732399|NCT03966365|521875816|FG001|Overall Study|Protocol Violation|0|||
144732400|NCT00463606|521875817|FG000|Overall Study|Adverse Event|21|||
144732401|NCT00463606|521875818|FG001|Overall Study|Adverse Event|18|||
144732402|NCT00463606|521875819|FG002|Overall Study|Adverse Event|11|||
144732403|NCT00463606|521875817|FG000|Overall Study|Withdrawal by Subject|11|||
144732404|NCT00463606|521875818|FG001|Overall Study|Withdrawal by Subject|11|||
144732405|NCT00463606|521875819|FG002|Overall Study|Withdrawal by Subject|5|||
144732406|NCT00463606|521875817|FG000|Overall Study|Lost to Follow-up|2|||
144732407|NCT00463606|521875818|FG001|Overall Study|Lost to Follow-up|2|||
144732408|NCT00463606|521875819|FG002|Overall Study|Lost to Follow-up|3|||
144732409|NCT00463606|521875817|FG000|Overall Study|Subject noncompliance|1|||
144732410|NCT00463606|521875818|FG001|Overall Study|Subject noncompliance|1|||
144732411|NCT00463606|521875819|FG002|Overall Study|Subject noncompliance|0|||
144732412|NCT00463606|521875817|FG000|Overall Study|Subject moved out of town|1|||
144732413|NCT00463606|521875818|FG001|Overall Study|Subject moved out of town|0|||
144732414|NCT00463606|521875819|FG002|Overall Study|Subject moved out of town|0|||
144732415|NCT00463606|521875817|FG000|Overall Study|Physician Decision|0|||
144732416|NCT00463606|521875818|FG001|Overall Study|Physician Decision|1|||
144732417|NCT00463606|521875819|FG002|Overall Study|Physician Decision|0|||
144732418|NCT00463606|521875817|FG000|Overall Study|Sponsor request|0|||
144732419|NCT00463606|521875818|FG001|Overall Study|Sponsor request|1|||
144732420|NCT00463606|521875819|FG002|Overall Study|Sponsor request|0|||
144732421|NCT00463606|521875817|FG000|Overall Study|Exclusion criteria violation|2|||
144732422|NCT00463606|521875818|FG001|Overall Study|Exclusion criteria violation|0|||
144732423|NCT00463606|521875819|FG002|Overall Study|Exclusion criteria violation|0|||
144732424|NCT00463606|521875817|FG000|Overall Study|Coordinator error|1|||
144732425|NCT00463606|521875818|FG001|Overall Study|Coordinator error|0|||
144732426|NCT00463606|521875819|FG002|Overall Study|Coordinator error|0|||
144732427|NCT00463606|521875817|FG000|Overall Study|Patient randomized in error|1|||
144732428|NCT00463606|521875818|FG001|Overall Study|Patient randomized in error|0|||
144732429|NCT00463606|521875819|FG002|Overall Study|Patient randomized in error|0|||
144732430|NCT00463606|521875817|FG000|Overall Study|Participation in another ABT-335 trial|1|||
144732431|NCT00463606|521875818|FG001|Overall Study|Participation in another ABT-335 trial|0|||
144732432|NCT00463606|521875819|FG002|Overall Study|Participation in another ABT-335 trial|0|||
144732433|NCT00463606|521875817|FG000|Overall Study|Protocol Violation|0|||
144732434|NCT00463606|521875818|FG001|Overall Study|Protocol Violation|0|||
144732435|NCT00463606|521875819|FG002|Overall Study|Protocol Violation|1|||
144732436|NCT05376319|521877067|FG000|Overall Study|Funding termination|2|||
144655050|NCT01429792|521589543|FG000|Overall Study|Other Reasons|67|||
144655051|NCT01429792|521589543|FG000|Overall Study|Unknown Disposition|94|||
144732437|NCT05376319|521877068|FG001|Overall Study|Funding termination|4|||
144732438|NCT00520130|521877071|FG000|Overall Study|Disease progression on study|4|||
144732439|NCT00520130|521877072|FG001|Overall Study|Disease progression on study|0|||
144732440|NCT00520130|521877071|FG000|Overall Study|Physician Decision|1|||
144732441|NCT00520130|521877072|FG001|Overall Study|Physician Decision|1|||
144732442|NCT01511939|521877074|FG000|Overall Study|Withdrawal by Subject|2|||
144732443|NCT01511939|521877075|FG001|Overall Study|Withdrawal by Subject|1|||
144732444|NCT01511939|521877076|FG002|Overall Study|Withdrawal by Subject|0|||
144732445|NCT00723528|521877079|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
144264178|NCT02035553|520169384|FG000|Overall Study|Adverse Event|10|||
144264179|NCT02035553|520169385|FG001|Overall Study|Adverse Event|6|||
144264180|NCT02035553|520169384|FG000|Overall Study|Physician Decision|3|||
144264181|NCT02035553|520169385|FG001|Overall Study|Physician Decision|2|||
144264182|NCT02035553|520169384|FG000|Overall Study|Lack of Efficacy|1|||
144264183|NCT02035553|520169385|FG001|Overall Study|Lack of Efficacy|1|||
144264184|NCT02035553|520169384|FG000|Overall Study|Withdrawal by Subject|4|||
144264185|NCT02035553|520169385|FG001|Overall Study|Withdrawal by Subject|7|||
144264186|NCT02035553|520169384|FG000|Overall Study|Non-compliance with Study Drug|0|||
144264187|NCT02035553|520169385|FG001|Overall Study|Non-compliance with Study Drug|1|||
144264188|NCT02035553|520169384|FG000|Overall Study|Lost to Follow-up|0|||
144264189|NCT02035553|520169385|FG001|Overall Study|Lost to Follow-up|1|||
144264190|NCT02035553|520169384|FG000|Overall Study|Other Reason|0|||
144264191|NCT02035553|520169385|FG001|Overall Study|Other Reason|4|||
144264192|NCT01854697|520169386|FG000|Overall Study|Adverse Event|1|||
144264193|NCT01854697|520169387|FG001|Overall Study|Adverse Event|0|||
144264194|NCT01854697|520169388|FG002|Overall Study|Adverse Event|0|||
144264195|NCT01854697|520169389|FG003|Overall Study|Adverse Event|0|||
144264196|NCT01854697|520169390|FG004|Overall Study|Adverse Event|1|||
144264197|NCT01854697|520169386|FG000|Overall Study|Lost to Follow-up|4|||
144264198|NCT01854697|520169387|FG001|Overall Study|Lost to Follow-up|1|||
144264199|NCT01854697|520169388|FG002|Overall Study|Lost to Follow-up|1|||
144264200|NCT01854697|520169389|FG003|Overall Study|Lost to Follow-up|2|||
144264201|NCT01854697|520169390|FG004|Overall Study|Lost to Follow-up|0|||
144264202|NCT01854697|520169386|FG000|Overall Study|To enter another AbbVie study|1|||
144655052|NCT01429792|521589543|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
144655053|NCT01429792|521589543|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
144655054|NCT01429792|521589543|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
144655055|NCT01429792|521589543|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
144655056|NCT01429792|521589543|FG000|Overall Study|Withdrawal by Subject|70|||
144655057|NCT01429792|521589543|FG000|Overall Study|Lost to Follow-up|88|||
144655058|NCT01617681|521589544|FG000|Period 1 Double Blind|Adverse Event|2|||
144655059|NCT01617681|521589545|FG001|Period 1 Double Blind|Adverse Event|0|||
144655060|NCT01617681|521589546|FG002|Period 1 Double Blind|Adverse Event|0|||
144655061|NCT01617681|521589547|FG003|Period 1 Double Blind|Adverse Event|2|||
144655062|NCT01617681|521589548|FG004|Period 1 Double Blind|Adverse Event|0|||
144655063|NCT01617681|521589544|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
144655064|NCT01617681|521589545|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
144655065|NCT01617681|521589546|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
144655066|NCT01617681|521589547|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
144655067|NCT01617681|521589548|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
144655068|NCT01617681|521589544|FG000|Period 2 Open Label|Adverse Event|0|||
144655069|NCT01617681|521589545|FG001|Period 2 Open Label|Adverse Event|0|||
144655070|NCT01617681|521589546|FG002|Period 2 Open Label|Adverse Event|0|||
144655071|NCT01617681|521589547|FG003|Period 2 Open Label|Adverse Event|0|||
144655072|NCT01617681|521589548|FG004|Period 2 Open Label|Adverse Event|3|||
144655073|NCT01617681|521589544|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
144655074|NCT01617681|521589545|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
144655075|NCT01617681|521589546|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
144655076|NCT01617681|521589547|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
144655077|NCT01617681|521589548|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
144655078|NCT01597557|521589552|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
144655079|NCT01597557|521589553|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
144655080|NCT01263691|521589554|FG000|Overall Study|Lost to Follow-up|1|||
144655081|NCT01263691|521589555|FG001|Overall Study|Lost to Follow-up|0|||
144655082|NCT01263691|521589556|FG002|Overall Study|Lost to Follow-up|1|||
144655083|NCT01263691|521589557|FG003|Overall Study|Lost to Follow-up|1|||
144655084|NCT01263691|521589558|FG004|Overall Study|Lost to Follow-up|0|||
144655085|NCT01263691|521589559|FG005|Overall Study|Lost to Follow-up|0|||
144655086|NCT01263691|521589554|FG000|Overall Study|Withdrawal by Subject|1|||
144655087|NCT01263691|521589555|FG001|Overall Study|Withdrawal by Subject|0|||
144655088|NCT01263691|521589556|FG002|Overall Study|Withdrawal by Subject|0|||
144655089|NCT01263691|521589557|FG003|Overall Study|Withdrawal by Subject|0|||
144655090|NCT01263691|521589558|FG004|Overall Study|Withdrawal by Subject|0|||
144655091|NCT01263691|521589559|FG005|Overall Study|Withdrawal by Subject|0|||
144655092|NCT01263691|521589554|FG000|Overall Study|Adverse Event|1|||
144264203|NCT01854697|520169387|FG001|Overall Study|To enter another AbbVie study|0|||
144264204|NCT01854697|520169388|FG002|Overall Study|To enter another AbbVie study|0|||
144655093|NCT01263691|521589555|FG001|Overall Study|Adverse Event|0|||
144655094|NCT01263691|521589556|FG002|Overall Study|Adverse Event|0|||
144655095|NCT01263691|521589557|FG003|Overall Study|Adverse Event|0|||
144655096|NCT01263691|521589558|FG004|Overall Study|Adverse Event|0|||
144655097|NCT01263691|521589559|FG005|Overall Study|Adverse Event|0|||
144655098|NCT05761444|521589562|FG000|Overall Study|Protocol Violation|2|||
144655099|NCT05761444|521589563|FG001|Overall Study|Protocol Violation|1|||
144655100|NCT05761444|521589562|FG000|Overall Study|Adverse Event|2|||
144264205|NCT01854697|520169389|FG003|Overall Study|To enter another AbbVie study|0|||
144264206|NCT01854697|520169390|FG004|Overall Study|To enter another AbbVie study|1|||
144264207|NCT01854697|520169386|FG000|Overall Study|Withdrew Consent|0|||
144264208|NCT01854697|520169387|FG001|Overall Study|Withdrew Consent|1|||
144264209|NCT01854697|520169388|FG002|Overall Study|Withdrew Consent|0|||
144264210|NCT01854697|520169389|FG003|Overall Study|Withdrew Consent|1|||
144264211|NCT01854697|520169390|FG004|Overall Study|Withdrew Consent|0|||
144264212|NCT01854697|520169386|FG000|Overall Study|Other|0|||
144264213|NCT01854697|520169387|FG001|Overall Study|Other|1|||
144264214|NCT01854697|520169388|FG002|Overall Study|Other|1|||
144264215|NCT01854697|520169389|FG003|Overall Study|Other|0|||
144264216|NCT01854697|520169390|FG004|Overall Study|Other|0|||
144264217|NCT01607593|520169396|FG000|Overall Study|Adverse Event|15|||
144264218|NCT01607593|520169396|FG000|Overall Study|Lack of Efficacy|16|||
144264219|NCT01607593|520169396|FG000|Overall Study|Lost to Follow-up|25|||
144264220|NCT01607593|520169396|FG000|Overall Study|Continuation|33|||
144264221|NCT01607593|520169396|FG000|Overall Study|Other|4|||
144264222|NCT00483652|520169399|FG000|Double-blind Treatment Period|Protocol Violation|2|||
144264223|NCT00483652|520169400|FG001|Double-blind Treatment Period|Protocol Violation|1|||
144264224|NCT00483652|520169399|FG000|Double-blind Treatment Period|Adverse Event|3|||
144264225|NCT00483652|520169400|FG001|Double-blind Treatment Period|Adverse Event|4|||
144655101|NCT05761444|521589563|FG001|Overall Study|Adverse Event|2|||
144655102|NCT05761444|521589562|FG000|Overall Study|Withdrawal by Subject|3|||
144732446|NCT00723528|521877080|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
144655103|NCT05761444|521589563|FG001|Overall Study|Withdrawal by Subject|2|||
144655104|NCT05761444|521589562|FG000|Overall Study|Other|1|||
144655105|NCT05761444|521589563|FG001|Overall Study|Other|0|||
144655106|NCT00850759|521589565|FG000|Overall Study|Lost to Follow-up|7|||
144655107|NCT00850759|521589566|FG001|Overall Study|Lost to Follow-up|5|||
144655108|NCT00850759|521589567|FG002|Overall Study|Lost to Follow-up|5|||
144655109|NCT00850759|521589568|FG003|Overall Study|Lost to Follow-up|3|||
144655110|NCT03196505|521589569|FG000|Overall Study|Physician Decision|26|||
144655111|NCT03196505|521589570|FG001|Overall Study|Physician Decision|26|||
144655112|NCT01005719|521589571|FG000|Period 1|Adverse Event|0|||
144655113|NCT01005719|521589572|FG001|Period 1|Adverse Event|0|||
144655114|NCT01005719|521589573|FG002|Period 1|Adverse Event|0|||
144655115|NCT01005719|521589574|FG003|Period 1|Adverse Event|1|||
144655116|NCT01005719|521589575|FG004|Period 1|Adverse Event|0|||
144655117|NCT01005719|521589576|FG005|Period 1|Adverse Event|0|||
144655118|NCT01005719|521589571|FG000|Period 1|Delay in completing study procedures|0|||
144655119|NCT01005719|521589572|FG001|Period 1|Delay in completing study procedures|0|||
144655120|NCT01005719|521589573|FG002|Period 1|Delay in completing study procedures|0|||
144655121|NCT01005719|521589574|FG003|Period 1|Delay in completing study procedures|0|||
144655122|NCT01005719|521589575|FG004|Period 1|Delay in completing study procedures|0|||
144655123|NCT01005719|521589576|FG005|Period 1|Delay in completing study procedures|1|||
144655124|NCT01005719|521589571|FG000|Period 2|Adverse Event|0|||
144655125|NCT01005719|521589572|FG001|Period 2|Adverse Event|0|||
144655126|NCT01005719|521589573|FG002|Period 2|Adverse Event|0|||
144655127|NCT01005719|521589574|FG003|Period 2|Adverse Event|0|||
144655128|NCT01005719|521589575|FG004|Period 2|Adverse Event|1|||
144655129|NCT01005719|521589576|FG005|Period 2|Adverse Event|1|||
144655130|NCT02389816|521589577|FG000|Overall Study|Randomized but Not Treated|1|||
144655131|NCT02389816|521589578|FG001|Overall Study|Randomized but Not Treated|0|||
144655132|NCT02389816|521589579|FG002|Overall Study|Randomized but Not Treated|0|||
144655133|NCT02389816|521589577|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
144655134|NCT02389816|521589578|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
144655135|NCT02389816|521589579|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
144655136|NCT02389816|521589577|FG000|Overall Study|Major Protocol Deviation|1|||
144655137|NCT02389816|521589578|FG001|Overall Study|Major Protocol Deviation|0|||
144655138|NCT02389816|521589579|FG002|Overall Study|Major Protocol Deviation|0|||
144732447|NCT00723528|521877081|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
144655139|NCT02389816|521589577|FG000|Overall Study|Lost to Follow-up|1|||
144655140|NCT02389816|521589578|FG001|Overall Study|Lost to Follow-up|0|||
144655141|NCT02389816|521589579|FG002|Overall Study|Lost to Follow-up|0|||
144214000|NCT00805961|519976974|FG000|Modality Therapy|Adverse Event|1|||
144214001|NCT00805961|519976974|FG000|Modality Therapy|Disease Progression|2|||
144214002|NCT00805961|519976974|FG000|Treatment-Free Interval|Adverse Event|3|||
144214003|NCT00805961|519976974|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
144214004|NCT00805961|519976974|FG000|Treatment-Free Interval|Physician Decision|1|||
144214005|NCT00805961|519976974|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
144214006|NCT00805961|519976974|FG000|Maintenance Treatment|Lack of Efficacy|13|||
144214007|NCT00805961|519976974|FG000|Maintenance Treatment|Intercurrent Illness|7|||
144214008|NCT00805961|519976974|FG000|Maintenance Treatment|Adverse Event|6|||
144214009|NCT00805961|519976974|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
144214010|NCT00805961|519976974|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
144264226|NCT00483652|520169399|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
144655142|NCT02389816|521589577|FG000|Overall Study|Withdrawal of Consent|6|||
144655143|NCT02389816|521589578|FG001|Overall Study|Withdrawal of Consent|4|||
144732448|NCT00723528|521877082|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
144732449|NCT00723528|521877083|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
144732450|NCT00723528|521877084|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
144732451|NCT00723528|521877085|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
144732452|NCT00723528|521877079|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
144732453|NCT00723528|521877080|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
144732454|NCT00723528|521877081|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
144732455|NCT00723528|521877082|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
144732456|NCT00723528|521877083|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
144732457|NCT00723528|521877084|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
144732458|NCT00723528|521877085|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
144732459|NCT00723528|521877079|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
144732460|NCT00723528|521877080|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
144732461|NCT00723528|521877081|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
144732462|NCT00723528|521877082|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
144732463|NCT00723528|521877083|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
144732464|NCT00723528|521877084|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
144732465|NCT00723528|521877085|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
144732466|NCT00723528|521877079|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
144732467|NCT00723528|521877080|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
144732468|NCT00723528|521877081|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
144732469|NCT00723528|521877082|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
144732470|NCT00723528|521877083|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
144732471|NCT00723528|521877084|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
144732472|NCT00723528|521877085|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
144732473|NCT00723528|521877079|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
144732474|NCT00723528|521877080|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
144732475|NCT00723528|521877081|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
144732476|NCT00723528|521877082|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
144732477|NCT00723528|521877083|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
144732478|NCT00723528|521877084|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
144732479|NCT00723528|521877085|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
144732480|NCT00723528|521877079|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
144732481|NCT00723528|521877080|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
144732482|NCT00723528|521877081|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
144732483|NCT00723528|521877082|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
144732484|NCT00723528|521877083|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
144732485|NCT00723528|521877084|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
144732486|NCT00723528|521877085|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
144732487|NCT00723528|521877079|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
144655144|NCT02389816|521589579|FG002|Overall Study|Withdrawal of Consent|4|||
144655145|NCT02389816|521589577|FG000|Overall Study|Lack of Efficacy|1|||
144655146|NCT02389816|521589578|FG001|Overall Study|Lack of Efficacy|0|||
144655147|NCT02389816|521589579|FG002|Overall Study|Lack of Efficacy|0|||
144655148|NCT02389816|521589577|FG000|Overall Study|Non Compliance with Study Drug|1|||
144655149|NCT02389816|521589578|FG001|Overall Study|Non Compliance with Study Drug|1|||
144655150|NCT02389816|521589579|FG002|Overall Study|Non Compliance with Study Drug|1|||
144655151|NCT02389816|521589577|FG000|Overall Study|Reason not Specified|0|||
144655152|NCT02389816|521589578|FG001|Overall Study|Reason not Specified|2|||
144655153|NCT02389816|521589579|FG002|Overall Study|Reason not Specified|0|||
144655154|NCT02918266|521589580|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
144655155|NCT02918266|521589581|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655156|NCT02918266|521589582|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655157|NCT02918266|521589583|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655158|NCT02918266|521589584|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655159|NCT02918266|521589585|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144732488|NCT00723528|521877080|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
144732489|NCT00723528|521877081|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
144264227|NCT00483652|520169400|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
144264228|NCT00483652|520169399|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
144655160|NCT02918266|521589586|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
144655161|NCT02918266|521589587|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655162|NCT02918266|521589588|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
144655163|NCT02918266|521589589|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655164|NCT02918266|521589590|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
144655165|NCT01259856|521589597|FG000|Overall Study|Adverse Event|12|||
144655166|NCT01259856|521589598|FG001|Overall Study|Adverse Event|9|||
144655167|NCT01259856|521589597|FG000|Overall Study|Death|0|||
144655168|NCT01259856|521589598|FG001|Overall Study|Death|1|||
144655169|NCT01259856|521589597|FG000|Overall Study|Lack of Efficacy|3|||
144655170|NCT01259856|521589598|FG001|Overall Study|Lack of Efficacy|1|||
144655171|NCT01259856|521589597|FG000|Overall Study|Lost to Follow-up|1|||
144655172|NCT01259856|521589598|FG001|Overall Study|Lost to Follow-up|1|||
144655173|NCT01259856|521589597|FG000|Overall Study|Physician Decision|2|||
144655174|NCT01259856|521589598|FG001|Overall Study|Physician Decision|1|||
144655175|NCT01259856|521589597|FG000|Overall Study|Withdrawal by Subject|9|||
144655176|NCT01259856|521589598|FG001|Overall Study|Withdrawal by Subject|10|||
144655177|NCT01259856|521589597|FG000|Overall Study|Treatment never started|0|||
144655178|NCT01259856|521589598|FG001|Overall Study|Treatment never started|6|||
144655179|NCT01259856|521589597|FG000|Overall Study|Study closure by sponsor|40|||
144655180|NCT01259856|521589598|FG001|Overall Study|Study closure by sponsor|41|||
144655181|NCT01259856|521589597|FG000|Overall Study|Patient developed other disease|0|||
144655182|NCT01259856|521589598|FG001|Overall Study|Patient developed other disease|1|||
144655183|NCT01259856|521589597|FG000|Overall Study|Transfer to another study|0|||
144655184|NCT01259856|521589598|FG001|Overall Study|Transfer to another study|1|||
144655185|NCT01259856|521589597|FG000|Overall Study|Unknown/missing|2|||
144655186|NCT01259856|521589598|FG001|Overall Study|Unknown/missing|2|||
144655187|NCT05114590|521589599|FG000|Overall Study|Adverse Event|1|||
144655188|NCT05114590|521589599|FG000|Overall Study|Investigator decision|1|||
144655189|NCT05114590|521589599|FG000|Overall Study|Lost to Follow-up|5|||
144655190|NCT05114590|521589599|FG000|Overall Study|Withdrawal by Subject|5|||
144655191|NCT05114590|521589599|FG000|Overall Study|Other|2|||
144655192|NCT00358917|521589600|FG000|Overall Study|Adverse Event|14|||
144655193|NCT00358917|521589601|FG001|Overall Study|Adverse Event|21|||
144655194|NCT00358917|521589600|FG000|Overall Study|Withdrawal by Subject|5|||
144655195|NCT00358917|521589601|FG001|Overall Study|Withdrawal by Subject|7|||
144655196|NCT00358917|521589600|FG000|Overall Study|Lost to Follow-up|20|||
144655197|NCT00358917|521589601|FG001|Overall Study|Lost to Follow-up|17|||
144655198|NCT00358917|521589600|FG000|Overall Study|Noncompliance|12|||
144655199|NCT00358917|521589601|FG001|Overall Study|Noncompliance|11|||
144655200|NCT00358917|521589600|FG000|Overall Study|Death|2|||
144655201|NCT00358917|521589601|FG001|Overall Study|Death|3|||
144655202|NCT00358917|521589600|FG000|Overall Study|Virologic failure|11|||
144655203|NCT00358917|521589601|FG001|Overall Study|Virologic failure|8|||
144655204|NCT00358917|521589600|FG000|Overall Study|Unable to Continue Participation|2|||
144655205|NCT00358917|521589601|FG001|Overall Study|Unable to Continue Participation|2|||
144655206|NCT00938327|521589603|FG000|Overall Study|Adverse Event|2|||
144655207|NCT00938327|521589603|FG000|Overall Study|Protocol Violation|1|||
144655208|NCT00938327|521589603|FG000|Overall Study|Withdrawal by Subject|4|||
144655209|NCT00938327|521589603|FG000|Overall Study|Lost to Follow-up|37|||
144655210|NCT00938327|521589603|FG000|Overall Study|2nd dose received outside of the study|7|||
144655211|NCT00938327|521589603|FG000|Overall Study|Vaccine not received as out of stock|9|||
144655212|NCT01425190|521589604|FG000|Overall Study|Full dose not consumed.|1|||
144655213|NCT01425190|521589605|FG001|Overall Study|Full dose not consumed.|0|||
144655214|NCT01425190|521589606|FG002|Overall Study|Full dose not consumed.|0|||
144655215|NCT01035255|521589608|FG000|Overall Study|Death|724|||
144655216|NCT01035255|521589609|FG001|Overall Study|Death|844|||
144655217|NCT01035255|521589608|FG000|Overall Study|Lost to Follow-up|2|||
144655218|NCT01035255|521589609|FG001|Overall Study|Lost to Follow-up|5|||
144655219|NCT01035255|521589608|FG000|Overall Study|patient's request|15|||
144655220|NCT01035255|521589609|FG001|Overall Study|patient's request|13|||
144655221|NCT00195260|521589612|FG000|Part 1: Dose Escalation|Adverse Event|0|||
144655222|NCT00195260|521589613|FG001|Part 1: Dose Escalation|Adverse Event|1|||
144655223|NCT00195260|521589614|FG002|Part 1: Dose Escalation|Adverse Event|0|||
144655224|NCT00195260|521589615|FG003|Part 1: Dose Escalation|Adverse Event|1|||
144655225|NCT00195260|521589616|FG004|Part 1: Dose Escalation|Adverse Event|1|||
144214011|NCT00805961|519976974|FG000|Maintenance Treatment|Withdrawn Consent|1|||
144655226|NCT00195260|521589617|FG005|Part 1: Dose Escalation|Adverse Event|0|||
144655227|NCT00195260|521589618|FG006|Part 1: Dose Escalation|Adverse Event|3|||
144655228|NCT00195260|521589619|FG007|Part 1: Dose Escalation|Adverse Event|0|||
144655229|NCT00195260|521589620|FG008|Part 1: Dose Escalation|Adverse Event|0|||
144655230|NCT00195260|521589621|FG009|Part 1: Dose Escalation|Adverse Event|0|||
144655231|NCT00195260|521589622|FG010|Part 1: Dose Escalation|Adverse Event|0|||
144655232|NCT00195260|521589612|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655233|NCT00195260|521589613|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655234|NCT00195260|521589614|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655235|NCT00195260|521589615|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655236|NCT00195260|521589616|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
144214012|NCT04803305|519976975|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
144655237|NCT00195260|521589617|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655238|NCT00195260|521589618|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655239|NCT00195260|521589619|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
144655240|NCT00195260|521589620|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655241|NCT00195260|521589621|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655242|NCT00195260|521589622|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144655243|NCT00195260|521589612|FG000|Part 1: Dose Escalation|Death|0|||
144655244|NCT00195260|521589613|FG001|Part 1: Dose Escalation|Death|0|||
144655245|NCT00195260|521589614|FG002|Part 1: Dose Escalation|Death|0|||
144655246|NCT00195260|521589615|FG003|Part 1: Dose Escalation|Death|0|||
144655247|NCT00195260|521589616|FG004|Part 1: Dose Escalation|Death|0|||
144655248|NCT00195260|521589617|FG005|Part 1: Dose Escalation|Death|0|||
144655249|NCT00195260|521589618|FG006|Part 1: Dose Escalation|Death|0|||
144655250|NCT00195260|521589619|FG007|Part 1: Dose Escalation|Death|1|||
144655251|NCT00195260|521589620|FG008|Part 1: Dose Escalation|Death|0|||
144655252|NCT00195260|521589621|FG009|Part 1: Dose Escalation|Death|0|||
144655253|NCT00195260|521589622|FG010|Part 1: Dose Escalation|Death|0|||
144655254|NCT00195260|521589612|FG000|Part 1: Dose Escalation|Disease Progression|3|||
144655255|NCT00195260|521589613|FG001|Part 1: Dose Escalation|Disease Progression|2|||
144655256|NCT00195260|521589614|FG002|Part 1: Dose Escalation|Disease Progression|5|||
144655257|NCT00195260|521589615|FG003|Part 1: Dose Escalation|Disease Progression|6|||
144655258|NCT00195260|521589616|FG004|Part 1: Dose Escalation|Disease Progression|4|||
144655259|NCT00195260|521589617|FG005|Part 1: Dose Escalation|Disease Progression|6|||
144655260|NCT00195260|521589618|FG006|Part 1: Dose Escalation|Disease Progression|7|||
144655261|NCT00195260|521589619|FG007|Part 1: Dose Escalation|Disease Progression|4|||
144655262|NCT00195260|521589620|FG008|Part 1: Dose Escalation|Disease Progression|0|||
144655263|NCT00195260|521589621|FG009|Part 1: Dose Escalation|Disease Progression|0|||
144655264|NCT00195260|521589622|FG010|Part 1: Dose Escalation|Disease Progression|0|||
144655265|NCT00195260|521589612|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
144655266|NCT00195260|521589613|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
144655267|NCT00195260|521589614|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
144655268|NCT00195260|521589615|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655269|NCT00195260|521589616|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655270|NCT00195260|521589617|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
144655271|NCT00195260|521589618|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655272|NCT00195260|521589619|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655273|NCT00195260|521589620|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655274|NCT00195260|521589621|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655275|NCT00195260|521589622|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
144655276|NCT00195260|521589612|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655277|NCT00195260|521589613|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655278|NCT00195260|521589614|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655279|NCT00195260|521589615|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655280|NCT00195260|521589616|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655281|NCT00195260|521589617|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655282|NCT00195260|521589618|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655283|NCT00195260|521589619|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
144655284|NCT00195260|521589620|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
144655285|NCT00195260|521589621|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
144655286|NCT00195260|521589622|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
144655287|NCT00195260|521589612|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655288|NCT00195260|521589613|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655289|NCT00195260|521589614|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655290|NCT00195260|521589615|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655291|NCT00195260|521589616|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655292|NCT00195260|521589617|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655293|NCT00195260|521589618|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655294|NCT00195260|521589619|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
144655295|NCT00195260|521589620|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
144655296|NCT00195260|521589621|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
144655297|NCT00195260|521589622|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
144655298|NCT00195260|521589612|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655299|NCT00195260|521589613|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655300|NCT00195260|521589614|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655301|NCT00195260|521589615|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655302|NCT00195260|521589616|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655303|NCT00195260|521589617|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655304|NCT00195260|521589618|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655305|NCT00195260|521589619|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
144655306|NCT00195260|521589620|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
144655307|NCT00195260|521589621|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
144655308|NCT00195260|521589622|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
144655309|NCT00195260|521589612|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655310|NCT00195260|521589613|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655311|NCT00195260|521589614|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655312|NCT00195260|521589615|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655313|NCT00195260|521589616|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655314|NCT00195260|521589617|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655315|NCT00195260|521589618|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655316|NCT00195260|521589619|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
144655317|NCT00195260|521589620|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
144655318|NCT00195260|521589621|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
144655319|NCT00195260|521589622|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
144655320|NCT03007953|521589625|FG000|Overall Study|Withdrawal by Subject|5|||
144655321|NCT03007953|521589626|FG001|Overall Study|Withdrawal by Subject|2|||
144655322|NCT03007953|521589625|FG000|Overall Study|Death|5|||
144655323|NCT03007953|521589626|FG001|Overall Study|Death|7|||
144655324|NCT03007953|521589625|FG000|Overall Study|Lost to Follow-up|3|||
144655325|NCT03007953|521589626|FG001|Overall Study|Lost to Follow-up|2|||
144655326|NCT03007953|521589625|FG000|Overall Study|Enrolled in Hospice|3|||
144655327|NCT03007953|521589626|FG001|Overall Study|Enrolled in Hospice|2|||
144655328|NCT02538666|521589629|FG000|Pre-Treatment|Disease progression|1|||
144655329|NCT02538666|521589630|FG001|Pre-Treatment|Disease progression|0|||
144655330|NCT02538666|521589631|FG002|Pre-Treatment|Disease progression|0|||
144655331|NCT02538666|521589629|FG000|Pre-Treatment|no longer meets study criteria|1|||
144655332|NCT02538666|521589630|FG001|Pre-Treatment|no longer meets study criteria|0|||
144655333|NCT02538666|521589631|FG002|Pre-Treatment|no longer meets study criteria|0|||
144655334|NCT02538666|521589629|FG000|Pre-Treatment|Withdrew Consent|0|||
144655335|NCT02538666|521589630|FG001|Pre-Treatment|Withdrew Consent|1|||
144655336|NCT02538666|521589631|FG002|Pre-Treatment|Withdrew Consent|1|||
144655337|NCT02538666|521589629|FG000|Treatment|Disease progression|270|||
144655338|NCT02538666|521589630|FG001|Treatment|Disease progression|227|||
144655339|NCT02538666|521589631|FG002|Treatment|Disease progression|165|||
144655340|NCT02538666|521589629|FG000|Treatment|Study drug toxicity|1|||
144655341|NCT02538666|521589630|FG001|Treatment|Study drug toxicity|29|||
144655342|NCT02538666|521589631|FG002|Treatment|Study drug toxicity|92|||
144655343|NCT02538666|521589629|FG000|Treatment|Death|0|||
144655344|NCT02538666|521589630|FG001|Treatment|Death|2|||
144655345|NCT02538666|521589631|FG002|Treatment|Death|3|||
144655346|NCT02538666|521589629|FG000|Treatment|Adverse event unrelated to study drug|8|||
144655347|NCT02538666|521589630|FG001|Treatment|Adverse event unrelated to study drug|10|||
144655348|NCT02538666|521589631|FG002|Treatment|Adverse event unrelated to study drug|15|||
144655349|NCT02538666|521589629|FG000|Treatment|Participant request to discontinue study treatment|3|||
144655350|NCT02538666|521589630|FG001|Treatment|Participant request to discontinue study treatment|6|||
144655351|NCT02538666|521589631|FG002|Treatment|Participant request to discontinue study treatment|11|||
144655352|NCT02538666|521589629|FG000|Treatment|Participant withdrew consent|2|||
144655353|NCT02538666|521589630|FG001|Treatment|Participant withdrew consent|5|||
144655354|NCT02538666|521589631|FG002|Treatment|Participant withdrew consent|3|||
144655355|NCT02538666|521589629|FG000|Treatment|Lost to Follow-up|0|||
144655356|NCT02538666|521589630|FG001|Treatment|Lost to Follow-up|1|||
144655357|NCT02538666|521589631|FG002|Treatment|Lost to Follow-up|1|||
144655358|NCT02538666|521589629|FG000|Treatment|Maximum clinical benefit|4|||
144655359|NCT02538666|521589630|FG001|Treatment|Maximum clinical benefit|3|||
144655360|NCT02538666|521589631|FG002|Treatment|Maximum clinical benefit|4|||
144655361|NCT02538666|521589629|FG000|Treatment|Poor/non-compliance|0|||
144655362|NCT02538666|521589630|FG001|Treatment|Poor/non-compliance|1|||
144655363|NCT02538666|521589631|FG002|Treatment|Poor/non-compliance|0|||
144655364|NCT02538666|521589629|FG000|Treatment|Participant no longer meets study criteria|0|||
144655365|NCT02538666|521589630|FG001|Treatment|Participant no longer meets study criteria|2|||
144655366|NCT02538666|521589631|FG002|Treatment|Participant no longer meets study criteria|0|||
144655367|NCT02538666|521589629|FG000|Treatment|Administrative reason by sponsor|0|||
144655368|NCT02538666|521589630|FG001|Treatment|Administrative reason by sponsor|0|||
144655369|NCT02538666|521589631|FG002|Treatment|Administrative reason by sponsor|1|||
144655370|NCT02538666|521589629|FG000|Treatment|Other reasons|8|||
144655371|NCT02538666|521589630|FG001|Treatment|Other reasons|15|||
144655372|NCT02538666|521589631|FG002|Treatment|Other reasons|5|||
144655373|NCT02538666|521589629|FG000|Treatment|Not reported|2|||
144655374|NCT02538666|521589630|FG001|Treatment|Not reported|2|||
144655375|NCT02538666|521589631|FG002|Treatment|Not reported|2|||
144655376|NCT00829166|521589632|FG000|Overall Study|Death|305|||
144655377|NCT00829166|521589633|FG001|Overall Study|Death|333|||
144655378|NCT00829166|521589632|FG000|Overall Study|Lost to Follow-up|5|||
144214013|NCT04803305|519976976|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
144655379|NCT00829166|521589633|FG001|Overall Study|Lost to Follow-up|4|||
144655380|NCT00829166|521589632|FG000|Overall Study|Physician's Decision|4|||
144655381|NCT00829166|521589633|FG001|Overall Study|Physician's Decision|3|||
144655382|NCT00829166|521589632|FG000|Overall Study|Subject's Decision|41|||
144655383|NCT00829166|521589633|FG001|Overall Study|Subject's Decision|55|||
144655384|NCT00829166|521589632|FG000|Overall Study|Sponsor's Decision|137|||
144655385|NCT00829166|521589633|FG001|Overall Study|Sponsor's Decision|98|||
144655386|NCT00829166|521589632|FG000|Overall Study|Reason Not Specified|3|||
144655387|NCT00829166|521589633|FG001|Overall Study|Reason Not Specified|3|||
144655388|NCT01635933|521589634|FG000|Overall Study|Adverse Event|1|||
144655389|NCT01635933|521589635|FG001|Overall Study|Adverse Event|0|||
144655390|NCT01635933|521589634|FG000|Overall Study|Lost to Follow-up|0|||
144655391|NCT01635933|521589635|FG001|Overall Study|Lost to Follow-up|5|||
144655392|NCT01635933|521589634|FG000|Overall Study|Subject decision|1|||
144655393|NCT01635933|521589635|FG001|Overall Study|Subject decision|1|||
144655394|NCT01635933|521589634|FG000|Overall Study|Noncompliance|0|||
144655395|NCT01635933|521589635|FG001|Overall Study|Noncompliance|1|||
144655396|NCT01635933|521589634|FG000|Overall Study|No longer had transportation|0|||
144655397|NCT01635933|521589635|FG001|Overall Study|No longer had transportation|1|||
144655398|NCT01544595|521589638|FG000|Status at Week 68|Adverse Event|3|||
144655399|NCT01544595|521589639|FG001|Status at Week 68|Adverse Event|2|||
144655400|NCT01544595|521589640|FG002|Status at Week 68|Adverse Event|1|||
144655401|NCT01544595|521589641|FG003|Status at Week 68|Adverse Event|0|||
144655402|NCT01544595|521589642|FG004|Status at Week 68|Adverse Event|0|||
144655403|NCT01544595|521589643|FG005|Status at Week 68|Adverse Event|0|||
144655404|NCT01544595|521589638|FG000|Status at Week 68|Lack of Efficacy|1|||
144655405|NCT01544595|521589639|FG001|Status at Week 68|Lack of Efficacy|0|||
144655406|NCT01544595|521589640|FG002|Status at Week 68|Lack of Efficacy|0|||
144655407|NCT01544595|521589641|FG003|Status at Week 68|Lack of Efficacy|0|||
144655408|NCT01544595|521589642|FG004|Status at Week 68|Lack of Efficacy|0|||
144655409|NCT01544595|521589643|FG005|Status at Week 68|Lack of Efficacy|0|||
144655410|NCT01544595|521589638|FG000|Status at Week 68|Lost to Follow-up|1|||
144655411|NCT01544595|521589639|FG001|Status at Week 68|Lost to Follow-up|1|||
144655412|NCT01544595|521589640|FG002|Status at Week 68|Lost to Follow-up|0|||
144655413|NCT01544595|521589641|FG003|Status at Week 68|Lost to Follow-up|0|||
144655414|NCT01544595|521589642|FG004|Status at Week 68|Lost to Follow-up|0|||
144655415|NCT01544595|521589643|FG005|Status at Week 68|Lost to Follow-up|0|||
144655416|NCT01544595|521589638|FG000|Status at Week 68|Non-compliance with study treatment|1|||
144655417|NCT01544595|521589639|FG001|Status at Week 68|Non-compliance with study treatment|0|||
144655418|NCT01544595|521589640|FG002|Status at Week 68|Non-compliance with study treatment|0|||
144655419|NCT01544595|521589641|FG003|Status at Week 68|Non-compliance with study treatment|1|||
144655420|NCT01544595|521589642|FG004|Status at Week 68|Non-compliance with study treatment|0|||
144655421|NCT01544595|521589643|FG005|Status at Week 68|Non-compliance with study treatment|0|||
144655422|NCT01544595|521589638|FG000|Status at Week 68|Protocol Violation|2|||
144655423|NCT01544595|521589639|FG001|Status at Week 68|Protocol Violation|0|||
144655424|NCT01544595|521589640|FG002|Status at Week 68|Protocol Violation|1|||
144655425|NCT01544595|521589641|FG003|Status at Week 68|Protocol Violation|1|||
144655426|NCT01544595|521589642|FG004|Status at Week 68|Protocol Violation|0|||
144655427|NCT01544595|521589643|FG005|Status at Week 68|Protocol Violation|0|||
144655428|NCT01544595|521589638|FG000|Status at Week 68|Technical problems|1|||
144655429|NCT01544595|521589639|FG001|Status at Week 68|Technical problems|0|||
144655430|NCT01544595|521589640|FG002|Status at Week 68|Technical problems|0|||
144655431|NCT01544595|521589641|FG003|Status at Week 68|Technical problems|1|||
144655432|NCT01544595|521589642|FG004|Status at Week 68|Technical problems|0|||
144655433|NCT01544595|521589643|FG005|Status at Week 68|Technical problems|0|||
144655434|NCT01544595|521589638|FG000|Status at Week 68|Withdrawal by Subject|0|||
144655435|NCT01544595|521589639|FG001|Status at Week 68|Withdrawal by Subject|1|||
144655436|NCT01544595|521589640|FG002|Status at Week 68|Withdrawal by Subject|1|||
144655437|NCT01544595|521589641|FG003|Status at Week 68|Withdrawal by Subject|2|||
144655438|NCT01544595|521589642|FG004|Status at Week 68|Withdrawal by Subject|0|||
144655439|NCT01544595|521589643|FG005|Status at Week 68|Withdrawal by Subject|0|||
144655440|NCT01544595|521589638|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
144655441|NCT01544595|521589639|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
144655442|NCT01544595|521589640|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
144655443|NCT01544595|521589641|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
144655444|NCT01544595|521589642|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
144655445|NCT01544595|521589643|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
144655446|NCT01544595|521589638|FG000|Status at Week 156|Withdrawal by Subject|9|||
144655447|NCT01544595|521589639|FG001|Status at Week 156|Withdrawal by Subject|10|||
144655448|NCT01544595|521589640|FG002|Status at Week 156|Withdrawal by Subject|4|||
144214014|NCT04803305|519976975|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
144214015|NCT04803305|519976976|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
144214016|NCT04803305|519976975|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
144214017|NCT04803305|519976976|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
144214018|NCT04803305|519976975|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
144214019|NCT04803305|519976976|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
144214020|NCT04803305|519976975|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
144264229|NCT00483652|520169400|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
144655449|NCT01544595|521589641|FG003|Status at Week 156|Withdrawal by Subject|9|||
144655450|NCT01544595|521589642|FG004|Status at Week 156|Withdrawal by Subject|20|||
144655451|NCT01544595|521589643|FG005|Status at Week 156|Withdrawal by Subject|6|||
144655452|NCT01544595|521589638|FG000|Status at Week 156|Adverse Event|9|||
144655453|NCT01544595|521589639|FG001|Status at Week 156|Adverse Event|11|||
144655454|NCT01544595|521589640|FG002|Status at Week 156|Adverse Event|1|||
144655455|NCT01544595|521589641|FG003|Status at Week 156|Adverse Event|3|||
144655456|NCT01544595|521589642|FG004|Status at Week 156|Adverse Event|4|||
144655457|NCT01544595|521589643|FG005|Status at Week 156|Adverse Event|2|||
144655458|NCT01544595|521589638|FG000|Status at Week 156|Lost to Follow-up|4|||
144655459|NCT01544595|521589639|FG001|Status at Week 156|Lost to Follow-up|4|||
144655460|NCT01544595|521589640|FG002|Status at Week 156|Lost to Follow-up|0|||
144655461|NCT01544595|521589641|FG003|Status at Week 156|Lost to Follow-up|1|||
144655462|NCT01544595|521589642|FG004|Status at Week 156|Lost to Follow-up|4|||
144655463|NCT01544595|521589643|FG005|Status at Week 156|Lost to Follow-up|1|||
144655464|NCT01544595|521589638|FG000|Status at Week 156|Non-compliance with study treatement|0|||
144655465|NCT01544595|521589639|FG001|Status at Week 156|Non-compliance with study treatement|1|||
144655466|NCT01544595|521589640|FG002|Status at Week 156|Non-compliance with study treatement|0|||
144655467|NCT01544595|521589641|FG003|Status at Week 156|Non-compliance with study treatement|1|||
144655468|NCT01544595|521589642|FG004|Status at Week 156|Non-compliance with study treatement|0|||
144655469|NCT01544595|521589643|FG005|Status at Week 156|Non-compliance with study treatement|1|||
144655470|NCT01544595|521589638|FG000|Status at Week 156|Physician Decision|0|||
144655471|NCT01544595|521589639|FG001|Status at Week 156|Physician Decision|3|||
144655472|NCT01544595|521589640|FG002|Status at Week 156|Physician Decision|1|||
144655473|NCT01544595|521589641|FG003|Status at Week 156|Physician Decision|0|||
144655474|NCT01544595|521589642|FG004|Status at Week 156|Physician Decision|0|||
144655475|NCT01544595|521589643|FG005|Status at Week 156|Physician Decision|0|||
144655476|NCT01544595|521589638|FG000|Status at Week 156|Pregnancy|2|||
144655477|NCT01544595|521589639|FG001|Status at Week 156|Pregnancy|3|||
144655478|NCT01544595|521589640|FG002|Status at Week 156|Pregnancy|0|||
144655479|NCT01544595|521589641|FG003|Status at Week 156|Pregnancy|0|||
144655480|NCT01544595|521589642|FG004|Status at Week 156|Pregnancy|0|||
144655481|NCT01544595|521589643|FG005|Status at Week 156|Pregnancy|0|||
144655482|NCT01544595|521589638|FG000|Status at Week 156|Protocol Violation|3|||
144655483|NCT01544595|521589639|FG001|Status at Week 156|Protocol Violation|1|||
144655484|NCT01544595|521589640|FG002|Status at Week 156|Protocol Violation|2|||
144655485|NCT01544595|521589641|FG003|Status at Week 156|Protocol Violation|2|||
144655486|NCT01544595|521589642|FG004|Status at Week 156|Protocol Violation|0|||
144655487|NCT01544595|521589643|FG005|Status at Week 156|Protocol Violation|0|||
144655488|NCT01544595|521589638|FG000|Status at Week 156|Technical problems|3|||
144655489|NCT01544595|521589639|FG001|Status at Week 156|Technical problems|1|||
144655490|NCT01544595|521589640|FG002|Status at Week 156|Technical problems|0|||
144655491|NCT01544595|521589641|FG003|Status at Week 156|Technical problems|1|||
144655492|NCT01544595|521589642|FG004|Status at Week 156|Technical problems|0|||
144655493|NCT01544595|521589643|FG005|Status at Week 156|Technical problems|0|||
144655494|NCT01544595|521589638|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
144655495|NCT01544595|521589639|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
144655496|NCT01544595|521589640|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
144655497|NCT01544595|521589641|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
144655498|NCT01544595|521589642|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
144655499|NCT01544595|521589643|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
144655500|NCT01544595|521589638|FG000|Status at Week 156|Lack of Efficacy|1|||
144655501|NCT01544595|521589639|FG001|Status at Week 156|Lack of Efficacy|0|||
144655502|NCT01544595|521589640|FG002|Status at Week 156|Lack of Efficacy|1|||
144655503|NCT01544595|521589641|FG003|Status at Week 156|Lack of Efficacy|4|||
144655504|NCT01544595|521589642|FG004|Status at Week 156|Lack of Efficacy|10|||
144655505|NCT01544595|521589643|FG005|Status at Week 156|Lack of Efficacy|5|||
144655506|NCT00878072|521589644|FG000|Overall Study|Withdrew consent|2|||
144655507|NCT03382899|521589650|FG000|Overall Study|Ineligibility Determined|0|||
144655508|NCT03382899|521589651|FG001|Overall Study|Ineligibility Determined|1|||
144655509|NCT03382899|521589650|FG000|Overall Study|Lost to Follow-up|0|||
144655510|NCT03382899|521589651|FG001|Overall Study|Lost to Follow-up|1|||
144655511|NCT03382899|521589650|FG000|Overall Study|Sponsor's decision|31|||
144655512|NCT03382899|521589651|FG001|Overall Study|Sponsor's decision|28|||
144655513|NCT03382899|521589650|FG000|Overall Study|Withdrawal by Subject|0|||
144655514|NCT03382899|521589651|FG001|Overall Study|Withdrawal by Subject|5|||
144655515|NCT00872170|521589652|FG000|Overall Study|Adverse Event|1|||
144655516|NCT00872170|521589653|FG001|Overall Study|Adverse Event|0|||
144655517|NCT01987986|521589654|FG000|Overall Study|Lost to Follow-up|1|||
144655518|NCT01987986|521589655|FG001|Overall Study|Lost to Follow-up|0|||
144655519|NCT01987986|521589656|FG002|Overall Study|Lost to Follow-up|0|||
144655520|NCT01987986|521589657|FG003|Overall Study|Lost to Follow-up|0|||
144655521|NCT01987986|521589654|FG000|Overall Study|Adverse Event|1|||
144732490|NCT00723528|521877082|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
144655522|NCT01987986|521589655|FG001|Overall Study|Adverse Event|0|||
144655523|NCT01987986|521589656|FG002|Overall Study|Adverse Event|2|||
144264230|NCT00468585|520169402|FG000|Overall Study|Patient not treated|1|||
144264231|NCT00468585|520169403|FG001|Overall Study|Patient not treated|0|||
144264232|NCT00468585|520169404|FG002|Overall Study|Patient not treated|1|||
144264233|NCT00468585|520169405|FG003|Overall Study|Patient not treated|0|||
144264234|NCT00468585|520169402|FG000|Overall Study|Patient found to be ineligible|0|||
144264235|NCT00468585|520169403|FG001|Overall Study|Patient found to be ineligible|0|||
144264236|NCT00468585|520169404|FG002|Overall Study|Patient found to be ineligible|1|||
144264237|NCT00468585|520169405|FG003|Overall Study|Patient found to be ineligible|0|||
144264238|NCT00468585|520169402|FG000|Overall Study|Adverse Event|0|||
144264239|NCT00468585|520169403|FG001|Overall Study|Adverse Event|0|||
144264240|NCT00468585|520169404|FG002|Overall Study|Adverse Event|1|||
144264241|NCT00468585|520169405|FG003|Overall Study|Adverse Event|0|||
144264242|NCT00468585|520169402|FG000|Overall Study|Withdrawal by Subject|0|||
144264243|NCT00468585|520169403|FG001|Overall Study|Withdrawal by Subject|0|||
144264244|NCT00468585|520169404|FG002|Overall Study|Withdrawal by Subject|2|||
144264245|NCT00468585|520169405|FG003|Overall Study|Withdrawal by Subject|1|||
144264246|NCT01290718|520169408|FG000|Overall Study|Early termination of the study|4|||
144264247|NCT04176939|520169413|FG000|Overall Study|Withdrawal by Subject|5|||
144264248|NCT04176939|520169413|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
144264249|NCT04176939|520169413|FG000|Overall Study|Lost to Follow-up|2|||
144264250|NCT04176939|520169413|FG000|Overall Study|Unspecified reason|4|||
144264251|NCT04176939|520169413|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
144264252|NCT00230048|520169414|FG000|Overall Study|Lost to Follow-up|13|||
144264253|NCT00230048|520169415|FG001|Overall Study|Lost to Follow-up|18|||
144264254|NCT02869789|520169416|FG000|Overall Study|Disease progression|184|||
144264255|NCT02869789|520169417|FG001|Overall Study|Disease progression|109|||
144264256|NCT02869789|520169418|FG002|Overall Study|Disease progression|260|||
144264257|NCT02869789|520169419|FG003|Overall Study|Disease progression|19|||
144264258|NCT02869789|520169416|FG000|Overall Study|Study drug toxicity|90|||
144264259|NCT02869789|520169417|FG001|Overall Study|Study drug toxicity|32|||
144264260|NCT02869789|520169418|FG002|Overall Study|Study drug toxicity|55|||
144264261|NCT02869789|520169419|FG003|Overall Study|Study drug toxicity|14|||
144264262|NCT02869789|520169416|FG000|Overall Study|Death|7|||
144264263|NCT02869789|520169417|FG001|Overall Study|Death|3|||
144264264|NCT02869789|520169418|FG002|Overall Study|Death|5|||
144264265|NCT02869789|520169419|FG003|Overall Study|Death|1|||
144264266|NCT02869789|520169416|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
144264267|NCT02869789|520169417|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
144264268|NCT02869789|520169418|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
144264269|NCT02869789|520169419|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
144264270|NCT02869789|520169416|FG000|Overall Study|Participant request to discontinue study treatment|10|||
144264271|NCT02869789|520169417|FG001|Overall Study|Participant request to discontinue study treatment|5|||
144264272|NCT02869789|520169418|FG002|Overall Study|Participant request to discontinue study treatment|5|||
144264273|NCT02869789|520169419|FG003|Overall Study|Participant request to discontinue study treatment|3|||
144264274|NCT02869789|520169416|FG000|Overall Study|Withdrawal by Subject|5|||
144264275|NCT02869789|520169417|FG001|Overall Study|Withdrawal by Subject|2|||
144264276|NCT02869789|520169418|FG002|Overall Study|Withdrawal by Subject|7|||
144264277|NCT02869789|520169419|FG003|Overall Study|Withdrawal by Subject|2|||
144264278|NCT02869789|520169416|FG000|Overall Study|Lost to Follow-up|0|||
144264279|NCT02869789|520169417|FG001|Overall Study|Lost to Follow-up|0|||
144264280|NCT02869789|520169418|FG002|Overall Study|Lost to Follow-up|2|||
144264281|NCT02869789|520169419|FG003|Overall Study|Lost to Follow-up|0|||
144264282|NCT02869789|520169416|FG000|Overall Study|Maximum clinical benefit|5|||
144264283|NCT02869789|520169417|FG001|Overall Study|Maximum clinical benefit|2|||
144264284|NCT02869789|520169418|FG002|Overall Study|Maximum clinical benefit|1|||
144264285|NCT02869789|520169419|FG003|Overall Study|Maximum clinical benefit|0|||
144264286|NCT02869789|520169416|FG000|Overall Study|Poor/Non-compliance|0|||
144264287|NCT02869789|520169417|FG001|Overall Study|Poor/Non-compliance|2|||
144655524|NCT01987986|521589657|FG003|Overall Study|Adverse Event|0|||
144655525|NCT03259334|521589658|FG000|Overall Study|Adverse Event|3|||
144655526|NCT03259334|521589659|FG001|Overall Study|Adverse Event|8|||
144655527|NCT03259334|521589660|FG002|Overall Study|Adverse Event|5|||
144264288|NCT02869789|520169418|FG002|Overall Study|Poor/Non-compliance|1|||
144264289|NCT02869789|520169419|FG003|Overall Study|Poor/Non-compliance|0|||
144264290|NCT02869789|520169416|FG000|Overall Study|Participant no longer meets study criteria|0|||
144264291|NCT02869789|520169417|FG001|Overall Study|Participant no longer meets study criteria|1|||
144264292|NCT02869789|520169418|FG002|Overall Study|Participant no longer meets study criteria|1|||
144264293|NCT02869789|520169419|FG003|Overall Study|Participant no longer meets study criteria|0|||
144264294|NCT02869789|520169416|FG000|Overall Study|Administrative reason by sponsor|0|||
144264295|NCT02869789|520169417|FG001|Overall Study|Administrative reason by sponsor|0|||
144264296|NCT02869789|520169418|FG002|Overall Study|Administrative reason by sponsor|1|||
144264297|NCT02869789|520169419|FG003|Overall Study|Administrative reason by sponsor|0|||
144264298|NCT02869789|520169416|FG000|Overall Study|Other reasons|4|||
144264299|NCT02869789|520169417|FG001|Overall Study|Other reasons|8|||
144655528|NCT03259334|521589658|FG000|Overall Study|Withdrawal by Subject|4|||
144655529|NCT03259334|521589659|FG001|Overall Study|Withdrawal by Subject|2|||
144655530|NCT03259334|521589660|FG002|Overall Study|Withdrawal by Subject|4|||
144655531|NCT03259334|521589658|FG000|Overall Study|Physician Decision|1|||
144655532|NCT03259334|521589659|FG001|Overall Study|Physician Decision|0|||
144655533|NCT03259334|521589660|FG002|Overall Study|Physician Decision|0|||
144655534|NCT03259334|521589658|FG000|Overall Study|Lost to Follow-up|0|||
144655535|NCT03259334|521589659|FG001|Overall Study|Lost to Follow-up|2|||
144655536|NCT03259334|521589660|FG002|Overall Study|Lost to Follow-up|1|||
144655537|NCT03259334|521589658|FG000|Overall Study|Protocol Deviation|0|||
144655538|NCT03259334|521589659|FG001|Overall Study|Protocol Deviation|3|||
144655539|NCT03259334|521589660|FG002|Overall Study|Protocol Deviation|2|||
144655540|NCT03259334|521589658|FG000|Overall Study|Lack of Efficacy|2|||
144655541|NCT03259334|521589659|FG001|Overall Study|Lack of Efficacy|0|||
144655542|NCT03259334|521589660|FG002|Overall Study|Lack of Efficacy|1|||
144655543|NCT03259334|521589658|FG000|Overall Study|Randomized but never treated|0|||
144655544|NCT03259334|521589659|FG001|Overall Study|Randomized but never treated|2|||
144655545|NCT03259334|521589660|FG002|Overall Study|Randomized but never treated|0|||
144655546|NCT04160468|521589663|FG000|Overall Study|Lost to Follow-up|19|||
144655547|NCT04160468|521589664|FG001|Overall Study|Lost to Follow-up|4|||
144655548|NCT04160468|521589663|FG000|Overall Study|Randomized but not dosed|6|||
144655549|NCT04160468|521589664|FG001|Overall Study|Randomized but not dosed|0|||
144655550|NCT04160468|521589663|FG000|Overall Study|Withdrawal by Subject|4|||
144655551|NCT04160468|521589664|FG001|Overall Study|Withdrawal by Subject|1|||
144655552|NCT04160468|521589663|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
144655553|NCT04160468|521589664|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
144655554|NCT04160468|521589663|FG000|Overall Study|Participant incarcerated|1|||
144655555|NCT04160468|521589664|FG001|Overall Study|Participant incarcerated|0|||
144655556|NCT01187901|521589665|FG000|Overall Study|Protocol Violation|1|||
144655557|NCT01187901|521589666|FG001|Overall Study|Protocol Violation|0|||
144655558|NCT01187901|521589665|FG000|Overall Study|Lost to Follow-up|1|||
144655559|NCT01187901|521589666|FG001|Overall Study|Lost to Follow-up|2|||
144655560|NCT01187901|521589665|FG000|Overall Study|Unrelated Health Reasons|1|||
144655561|NCT01187901|521589666|FG001|Overall Study|Unrelated Health Reasons|2|||
144655562|NCT01187901|521589665|FG000|Overall Study|Suspected Allergic Reaction|1|||
144655563|NCT01187901|521589666|FG001|Overall Study|Suspected Allergic Reaction|1|||
144655564|NCT01187901|521589665|FG000|Overall Study|Adverse Event|3|||
144655565|NCT01187901|521589666|FG001|Overall Study|Adverse Event|0|||
144655566|NCT01187901|521589665|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
144655567|NCT01187901|521589666|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
144655568|NCT01187901|521589665|FG000|Overall Study|Pregnancy|0|||
144655569|NCT01187901|521589666|FG001|Overall Study|Pregnancy|2|||
144655570|NCT01402284|521589667|FG000|Overall Study|Withdrawal consent|2|||
144655571|NCT01402284|521589667|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
144655572|NCT01402284|521589667|FG000|Overall Study|Physician Decision|1|||
144655573|NCT01402284|521589667|FG000|Overall Study|Disease progression on study|10|||
144655574|NCT00540436|521589668|FG000|First 12-Week Treatment Period|Adverse Event|1|||
144655575|NCT00540436|521589668|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
144655576|NCT00540436|521589668|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
144655577|NCT00540436|521589668|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
144655578|NCT00905021|521589673|FG000|Overall Study|Adverse Event|2|||
144655579|NCT05281523|521589674|FG000|Overall Study|Adverse Event|1|||
144655580|NCT05281523|521589675|FG001|Overall Study|Adverse Event|1|||
144655581|NCT05281523|521589674|FG000|Overall Study|Physician Decision|1|||
144655582|NCT05281523|521589675|FG001|Overall Study|Physician Decision|1|||
144655583|NCT05281523|521589674|FG000|Overall Study|Withdrawal by Subject|5|||
144655584|NCT05281523|521589675|FG001|Overall Study|Withdrawal by Subject|15|||
144655585|NCT05281523|521589674|FG000|Overall Study|GCP violations|3|||
144655586|NCT05281523|521589675|FG001|Overall Study|GCP violations|4|||
144655587|NCT02429427|521589676|FG000|Overall Study|Adverse Event|220|||
144655588|NCT02429427|521589677|FG001|Overall Study|Adverse Event|92|||
144655589|NCT02429427|521589676|FG000|Overall Study|Protocol Violation|10|||
144655590|NCT02429427|521589677|FG001|Overall Study|Protocol Violation|6|||
144655591|NCT02429427|521589676|FG000|Overall Study|Lost to Follow-up|15|||
144655592|NCT02429427|521589677|FG001|Overall Study|Lost to Follow-up|6|||
144655593|NCT02429427|521589676|FG000|Overall Study|Withdrawal by Subject|64|||
144655594|NCT02429427|521589677|FG001|Overall Study|Withdrawal by Subject|34|||
144655595|NCT02429427|521589676|FG000|Overall Study|Other|62|||
144655596|NCT02429427|521589677|FG001|Overall Study|Other|41|||
144655597|NCT04038255|521591029|FG000|Overall Study|Lost to Follow-up|0|||
144655598|NCT04038255|521591030|FG001|Overall Study|Lost to Follow-up|9|||
144655599|NCT04038255|521591031|FG002|Overall Study|Lost to Follow-up|5|||
144655600|NCT04038255|521591029|FG000|Overall Study|Withdrawal by Subject|0|||
144655601|NCT04038255|521591030|FG001|Overall Study|Withdrawal by Subject|0|||
144655602|NCT04038255|521591031|FG002|Overall Study|Withdrawal by Subject|1|||
144655603|NCT04491877|521591032|FG000|Overall Study|Protocol Deviation|1|||
144655604|NCT04491877|521591033|FG001|Overall Study|Protocol Deviation|0|||
144655605|NCT04491877|521591034|FG002|Overall Study|Protocol Deviation|2|||
144655606|NCT04491877|521591035|FG003|Overall Study|Protocol Deviation|0|||
144655607|NCT04491877|521591036|FG004|Overall Study|Protocol Deviation|0|||
144655608|NCT04491877|521591037|FG005|Overall Study|Protocol Deviation|0|||
144655609|NCT04491877|521591038|FG006|Overall Study|Protocol Deviation|1|||
144655610|NCT04491877|521591039|FG007|Overall Study|Protocol Deviation|1|||
144655611|NCT04491877|521591040|FG008|Overall Study|Protocol Deviation|0|||
144655612|NCT04491877|521591032|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144655613|NCT04491877|521591033|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144655614|NCT04491877|521591034|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144655615|NCT04491877|521591035|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
144655616|NCT04491877|521591036|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144655617|NCT04491877|521591037|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
144655618|NCT04491877|521591038|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
144655619|NCT04491877|521591039|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
144655620|NCT04491877|521591040|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
144655621|NCT04491877|521591032|FG000|Overall Study|Lost to Follow-up|0|||
144655622|NCT04491877|521591033|FG001|Overall Study|Lost to Follow-up|2|||
144655623|NCT04491877|521591034|FG002|Overall Study|Lost to Follow-up|0|||
144655624|NCT04491877|521591035|FG003|Overall Study|Lost to Follow-up|0|||
144655625|NCT04491877|521591036|FG004|Overall Study|Lost to Follow-up|0|||
144655626|NCT04491877|521591037|FG005|Overall Study|Lost to Follow-up|0|||
144655627|NCT04491877|521591038|FG006|Overall Study|Lost to Follow-up|2|||
144655628|NCT04491877|521591039|FG007|Overall Study|Lost to Follow-up|1|||
144655629|NCT04491877|521591040|FG008|Overall Study|Lost to Follow-up|1|||
144655630|NCT01096446|521591044|FG000|Overall Study|Death|1|||
144655631|NCT01096446|521591045|FG001|Overall Study|Death|0|||
144655632|NCT01096446|521591044|FG000|Overall Study|Protocol Violation|2|||
144655633|NCT01096446|521591045|FG001|Overall Study|Protocol Violation|0|||
144655634|NCT00074412|521591047|FG000|Overall Study|Death|30|||
144655635|NCT00074412|521591048|FG001|Overall Study|Death|26|||
144655636|NCT00074412|521591047|FG000|Overall Study|Lost to Follow-up|52|||
144655637|NCT00074412|521591048|FG001|Overall Study|Lost to Follow-up|58|||
144655638|NCT02626819|521591051|FG000|Overall Study|Lost to Follow-up|3|||
144655639|NCT02626819|521591052|FG001|Overall Study|Lost to Follow-up|2|||
144655640|NCT02626819|521591051|FG000|Overall Study|Withdrawal by Subject|1|||
144655641|NCT02626819|521591052|FG001|Overall Study|Withdrawal by Subject|0|||
144655642|NCT02626819|521591051|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
144655643|NCT02626819|521591052|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
144655644|NCT02163993|521591055|FG000|Treatment Period|Adverse Event|0|||
144655645|NCT02163993|521591056|FG001|Treatment Period|Adverse Event|1|||
144655646|NCT02163993|521591057|FG002|Treatment Period|Adverse Event|0|||
144655647|NCT02163993|521591058|FG003|Treatment Period|Adverse Event|0|||
144655648|NCT02163993|521591059|FG004|Treatment Period|Adverse Event|1|||
144655649|NCT02163993|521591055|FG000|Treatment Period|Lost to Follow-up|2|||
144655650|NCT02163993|521591056|FG001|Treatment Period|Lost to Follow-up|3|||
144655651|NCT02163993|521591057|FG002|Treatment Period|Lost to Follow-up|1|||
144655652|NCT02163993|521591058|FG003|Treatment Period|Lost to Follow-up|3|||
144655653|NCT02163993|521591059|FG004|Treatment Period|Lost to Follow-up|1|||
144655654|NCT02163993|521591055|FG000|Treatment Period|Physician Decision|1|||
144655655|NCT02163993|521591056|FG001|Treatment Period|Physician Decision|0|||
144655656|NCT02163993|521591057|FG002|Treatment Period|Physician Decision|0|||
144655657|NCT02163993|521591058|FG003|Treatment Period|Physician Decision|0|||
144655658|NCT02163993|521591059|FG004|Treatment Period|Physician Decision|0|||
144655659|NCT02163993|521591055|FG000|Treatment Period|Protocol Violation|2|||
144655660|NCT02163993|521591056|FG001|Treatment Period|Protocol Violation|1|||
144655661|NCT02163993|521591057|FG002|Treatment Period|Protocol Violation|0|||
144655662|NCT02163993|521591058|FG003|Treatment Period|Protocol Violation|1|||
144655663|NCT02163993|521591059|FG004|Treatment Period|Protocol Violation|2|||
144655664|NCT02163993|521591055|FG000|Treatment Period|Withdrawal by Subject|6|||
144655665|NCT02163993|521591056|FG001|Treatment Period|Withdrawal by Subject|4|||
144655666|NCT02163993|521591057|FG002|Treatment Period|Withdrawal by Subject|1|||
144655667|NCT02163993|521591058|FG003|Treatment Period|Withdrawal by Subject|4|||
144655668|NCT02163993|521591059|FG004|Treatment Period|Withdrawal by Subject|1|||
144655669|NCT02163993|521591055|FG000|Treatment Period|Not treated|1|||
144655670|NCT02163993|521591056|FG001|Treatment Period|Not treated|0|||
144655671|NCT02163993|521591057|FG002|Treatment Period|Not treated|0|||
144655672|NCT02163993|521591058|FG003|Treatment Period|Not treated|1|||
144655673|NCT02163993|521591059|FG004|Treatment Period|Not treated|2|||
144655674|NCT02163993|521591055|FG000|Post-treatment Period|Adverse Event|0|||
144655675|NCT02163993|521591056|FG001|Post-treatment Period|Adverse Event|0|||
144655676|NCT02163993|521591057|FG002|Post-treatment Period|Adverse Event|1|||
144655677|NCT02163993|521591058|FG003|Post-treatment Period|Adverse Event|0|||
144655678|NCT02163993|521591059|FG004|Post-treatment Period|Adverse Event|0|||
144655679|NCT02163993|521591055|FG000|Post-treatment Period|Lost to Follow-up|2|||
144655680|NCT02163993|521591056|FG001|Post-treatment Period|Lost to Follow-up|2|||
144655681|NCT02163993|521591057|FG002|Post-treatment Period|Lost to Follow-up|3|||
144655682|NCT02163993|521591058|FG003|Post-treatment Period|Lost to Follow-up|1|||
144655683|NCT02163993|521591059|FG004|Post-treatment Period|Lost to Follow-up|0|||
144655684|NCT02163993|521591055|FG000|Post-treatment Period|Protocol Violation|0|||
144655685|NCT02163993|521591056|FG001|Post-treatment Period|Protocol Violation|0|||
144655686|NCT02163993|521591057|FG002|Post-treatment Period|Protocol Violation|0|||
144655687|NCT02163993|521591058|FG003|Post-treatment Period|Protocol Violation|0|||
144655688|NCT02163993|521591059|FG004|Post-treatment Period|Protocol Violation|1|||
144264300|NCT02869789|520169418|FG002|Overall Study|Other reasons|6|||
144264301|NCT02869789|520169419|FG003|Overall Study|Other reasons|0|||
144264302|NCT00676403|520169422|FG000|Overall Study|Adverse Event|1|||
144264303|NCT00676403|520169423|FG001|Overall Study|Adverse Event|2|||
144264304|NCT00676403|520169424|FG002|Overall Study|Adverse Event|0|||
144655689|NCT02163993|521591055|FG000|Post-treatment Period|Withdrawal by Subject|2|||
144655690|NCT02163993|521591056|FG001|Post-treatment Period|Withdrawal by Subject|4|||
144655691|NCT02163993|521591057|FG002|Post-treatment Period|Withdrawal by Subject|0|||
144655692|NCT02163993|521591058|FG003|Post-treatment Period|Withdrawal by Subject|1|||
144655693|NCT02163993|521591059|FG004|Post-treatment Period|Withdrawal by Subject|2|||
144655694|NCT02273752|521591060|FG000|Overall Study|Trial was terminated early|2|||
144655695|NCT02042404|521591061|FG000|Overall Study|Death|1|||
144655696|NCT02042404|521591062|FG001|Overall Study|Death|0|||
144655697|NCT02042404|521591061|FG000|Overall Study|Unrelated Adverse Event|3|||
144655698|NCT02042404|521591062|FG001|Overall Study|Unrelated Adverse Event|0|||
144655699|NCT02042404|521591061|FG000|Overall Study|Inability to meet time requirements|1|||
144655700|NCT02042404|521591062|FG001|Overall Study|Inability to meet time requirements|0|||
144655701|NCT00726323|521591063|FG000|Overall Study|Withdrawal by Subject|3|||
144655702|NCT00726323|521591064|FG001|Overall Study|Withdrawal by Subject|1|||
144655703|NCT00726323|521591063|FG000|Overall Study|Physician Decision|1|||
144655704|NCT00726323|521591064|FG001|Overall Study|Physician Decision|0|||
144655705|NCT00726323|521591063|FG000|Overall Study|Progressive disease|23|||
144655706|NCT00726323|521591064|FG001|Overall Study|Progressive disease|16|||
144655707|NCT00726323|521591063|FG000|Overall Study|Clinical progression|0|||
144655708|NCT00726323|521591064|FG001|Overall Study|Clinical progression|3|||
144655709|NCT00726323|521591063|FG000|Overall Study|Adverse Event|9|||
144655710|NCT00726323|521591064|FG001|Overall Study|Adverse Event|9|||
144655711|NCT00726323|521591063|FG000|Overall Study|Death|1|||
144655712|NCT00726323|521591064|FG001|Overall Study|Death|0|||
144655713|NCT00726323|521591063|FG000|Overall Study|Participant wished to discontinue|0|||
144655714|NCT00726323|521591064|FG001|Overall Study|Participant wished to discontinue|1|||
144655715|NCT00726323|521591063|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
144655716|NCT00726323|521591064|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
144655717|NCT00879814|521591066|FG000|Overall Study|Adverse Event|0|||
144655718|NCT00879814|521591067|FG001|Overall Study|Adverse Event|1|||
144655719|NCT00879814|521591068|FG002|Overall Study|Adverse Event|0|||
144655720|NCT00879814|521591069|FG003|Overall Study|Adverse Event|0|||
144655721|NCT00879814|521591066|FG000|Overall Study|Lost to Follow-up|1|||
144655722|NCT00879814|521591067|FG001|Overall Study|Lost to Follow-up|0|||
144655723|NCT00879814|521591068|FG002|Overall Study|Lost to Follow-up|0|||
144655724|NCT00879814|521591069|FG003|Overall Study|Lost to Follow-up|2|||
144655725|NCT00879814|521591066|FG000|Overall Study|Participant Failed to Return|0|||
144655726|NCT00879814|521591067|FG001|Overall Study|Participant Failed to Return|0|||
144655727|NCT00879814|521591068|FG002|Overall Study|Participant Failed to Return|0|||
144655728|NCT00879814|521591069|FG003|Overall Study|Participant Failed to Return|1|||
144655729|NCT00879814|521591066|FG000|Overall Study|Withdrawal by Subject|3|||
144655730|NCT00879814|521591067|FG001|Overall Study|Withdrawal by Subject|1|||
144655731|NCT00879814|521591068|FG002|Overall Study|Withdrawal by Subject|1|||
144655732|NCT00879814|521591069|FG003|Overall Study|Withdrawal by Subject|2|||
144655733|NCT00879814|521591066|FG000|Overall Study|Physician Decision|0|||
144655734|NCT00879814|521591067|FG001|Overall Study|Physician Decision|0|||
144655735|NCT00879814|521591068|FG002|Overall Study|Physician Decision|1|||
144655736|NCT00879814|521591069|FG003|Overall Study|Physician Decision|0|||
144655737|NCT00879814|521591066|FG000|Overall Study|Other|0|||
144655738|NCT00879814|521591067|FG001|Overall Study|Other|0|||
144655739|NCT00879814|521591068|FG002|Overall Study|Other|1|||
144655740|NCT00879814|521591069|FG003|Overall Study|Other|0|||
144655741|NCT00630812|521591080|FG000|Randomisation to First Dose|Adverse Event|1|||
144655742|NCT00630812|521591081|FG001|Randomisation to First Dose|Adverse Event|1|||
144655743|NCT00630812|521591080|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
144655744|NCT00630812|521591081|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
144655745|NCT00630812|521591080|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
144655746|NCT00630812|521591081|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
144655747|NCT00630812|521591080|FG000|Randomisation to First Dose|Protocol Violation|4|||
144655748|NCT00630812|521591081|FG001|Randomisation to First Dose|Protocol Violation|1|||
144655749|NCT00630812|521591080|FG000|Double Blind Treatment Period|Adverse Event|13|||
144264305|NCT00676403|520169425|FG003|Overall Study|Adverse Event|5|||
144655750|NCT00630812|521591081|FG001|Double Blind Treatment Period|Adverse Event|5|||
144655751|NCT00630812|521591080|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
144655752|NCT00630812|521591081|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
144655753|NCT00630812|521591080|FG000|Double Blind Treatment Period|Physician Decision|2|||
144655754|NCT00630812|521591081|FG001|Double Blind Treatment Period|Physician Decision|1|||
144655755|NCT00630812|521591080|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144655756|NCT00630812|521591081|FG001|Double Blind Treatment Period|Protocol Violation|0|||
144655757|NCT00630812|521591080|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
144655758|NCT00630812|521591081|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
144655759|NCT00630812|521591080|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
144655760|NCT00630812|521591081|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
144655761|NCT00630812|521591080|FG000|Double Blind Treatment Period|Non-compliance|0|||
144655762|NCT00630812|521591081|FG001|Double Blind Treatment Period|Non-compliance|1|||
144655763|NCT03430245|521591084|FG000|Overall Study|Withdrawal by Subject|6|||
144655764|NCT03430245|521591084|FG000|Overall Study|Lost to Follow-up|1|||
144655765|NCT05628181|521591085|FG000|Overall Study|Death|2|||
144655766|NCT05628181|521591086|FG001|Overall Study|Death|4|||
144655767|NCT05628181|521591087|FG002|Overall Study|Death|0|||
144655768|NCT04102098|521591088|FG000|Main Study Period|Ongoing in study|302|||
144655769|NCT04102098|521591089|FG001|Main Study Period|Ongoing in study|291|||
144655770|NCT04102098|521591088|FG000|Main Study Period|Death|20|||
144655771|NCT04102098|521591089|FG001|Main Study Period|Death|27|||
144655772|NCT04102098|521591088|FG000|Main Study Period|Lost to Follow-up|1|||
144655773|NCT04102098|521591089|FG001|Main Study Period|Lost to Follow-up|1|||
144655774|NCT04102098|521591088|FG000|Main Study Period|Physician Decision|0|||
144655775|NCT04102098|521591089|FG001|Main Study Period|Physician Decision|1|||
144655776|NCT04102098|521591088|FG000|Main Study Period|Withdrawal by Subject|11|||
144655777|NCT04102098|521591089|FG001|Main Study Period|Withdrawal by Subject|14|||
144655778|NCT04102098|521591088|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
144655779|NCT04102098|521591089|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
144655780|NCT04102098|521591088|FG000|Crossover: AS Who Crossed Over|Death|11|||
144655781|NCT04102098|521591089|FG001|Crossover: AS Who Crossed Over|Death|0|||
144655782|NCT04102098|521591088|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
144655783|NCT04102098|521591089|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
144655784|NCT04742907|521591096|FG000|Overall Study|Adverse Event|1|||
144655785|NCT04742907|521591097|FG001|Overall Study|Adverse Event|0|||
144655786|NCT04742907|521591098|FG002|Overall Study|Adverse Event|1|||
144655787|NCT04742907|521591096|FG000|Overall Study|Lost to Follow-up|3|||
144655788|NCT04742907|521591097|FG001|Overall Study|Lost to Follow-up|3|||
144655789|NCT04742907|521591098|FG002|Overall Study|Lost to Follow-up|2|||
144655790|NCT04742907|521591096|FG000|Overall Study|Physician Decision|0|||
144655791|NCT04742907|521591097|FG001|Overall Study|Physician Decision|1|||
144655792|NCT04742907|521591098|FG002|Overall Study|Physician Decision|0|||
144655793|NCT04742907|521591096|FG000|Overall Study|Protocol Violation|1|||
144655794|NCT04742907|521591097|FG001|Overall Study|Protocol Violation|1|||
144655795|NCT04742907|521591098|FG002|Overall Study|Protocol Violation|1|||
144655796|NCT04742907|521591096|FG000|Overall Study|Withdrawal by Subject|5|||
144655797|NCT04742907|521591097|FG001|Overall Study|Withdrawal by Subject|6|||
144655798|NCT04742907|521591098|FG002|Overall Study|Withdrawal by Subject|4|||
144655799|NCT04742907|521591096|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
144655800|NCT04742907|521591097|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
144655801|NCT04742907|521591098|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
144655802|NCT04742907|521591096|FG000|Overall Study|Did Not Receive the Study Drug|2|||
144655803|NCT04742907|521591097|FG001|Overall Study|Did Not Receive the Study Drug|4|||
144655804|NCT04742907|521591098|FG002|Overall Study|Did Not Receive the Study Drug|4|||
144655805|NCT01428063|521591099|FG000|Overall Study|Lack of Efficacy|8|||
144655806|NCT01428063|521591100|FG001|Overall Study|Lack of Efficacy|4|||
144655807|NCT01428063|521591101|FG002|Overall Study|Lack of Efficacy|1|||
144655808|NCT01428063|521591099|FG000|Overall Study|Adverse Event|2|||
144655809|NCT01428063|521591100|FG001|Overall Study|Adverse Event|3|||
144655810|NCT01428063|521591101|FG002|Overall Study|Adverse Event|0|||
144655811|NCT01428063|521591099|FG000|Overall Study|Lost to Follow-up|0|||
144655812|NCT01428063|521591100|FG001|Overall Study|Lost to Follow-up|2|||
144655813|NCT01428063|521591101|FG002|Overall Study|Lost to Follow-up|0|||
144655814|NCT01428063|521591099|FG000|Overall Study|No longer meets study criteria|0|||
144655815|NCT01428063|521591100|FG001|Overall Study|No longer meets study criteria|1|||
144655816|NCT01428063|521591101|FG002|Overall Study|No longer meets study criteria|0|||
144655817|NCT06150573|521591102|FG000|Overall Study|Did not meet study criteria|1|||
144655818|NCT06150573|521591103|FG001|Overall Study|Did not meet study criteria|0|||
144655819|NCT06150573|521591102|FG000|Overall Study|Adverse Event|1|||
144655820|NCT06150573|521591103|FG001|Overall Study|Adverse Event|0|||
144655821|NCT06150573|521591102|FG000|Overall Study|Lost to Follow-up|0|||
144655822|NCT06150573|521591103|FG001|Overall Study|Lost to Follow-up|1|||
144655823|NCT06150573|521591102|FG000|Overall Study|Protocol Violation|0|||
144655824|NCT06150573|521591103|FG001|Overall Study|Protocol Violation|1|||
144655825|NCT06150573|521591102|FG000|Overall Study|Withdrawal by Subject|2|||
144655826|NCT06150573|521591103|FG001|Overall Study|Withdrawal by Subject|0|||
144655827|NCT02284906|521591104|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144655828|NCT02284906|521591105|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
144655829|NCT02284906|521591106|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144655830|NCT02284906|521591104|FG000|Overall Study|Major Protocol Deviation|0|||
144655831|NCT02284906|521591105|FG001|Overall Study|Major Protocol Deviation|1|||
144655832|NCT02284906|521591106|FG002|Overall Study|Major Protocol Deviation|0|||
144655833|NCT02284906|521591104|FG000|Overall Study|Voluntary Withdrawal|2|||
144655834|NCT02284906|521591105|FG001|Overall Study|Voluntary Withdrawal|4|||
144655835|NCT02284906|521591106|FG002|Overall Study|Voluntary Withdrawal|5|||
144655836|NCT02284906|521591104|FG000|Overall Study|Study Termination|0|||
144655837|NCT02284906|521591105|FG001|Overall Study|Study Termination|11|||
144655838|NCT02284906|521591106|FG002|Overall Study|Study Termination|14|||
144655839|NCT02284906|521591104|FG000|Overall Study|Reason not Specified|1|||
144655840|NCT02284906|521591105|FG001|Overall Study|Reason not Specified|1|||
144655841|NCT02284906|521591106|FG002|Overall Study|Reason not Specified|0|||
144655842|NCT01753076|521591107|FG000|Overall Study|Adverse Event|17|||
144655843|NCT01753076|521591108|FG001|Overall Study|Adverse Event|18|||
144655844|NCT01753076|521591107|FG000|Overall Study|Lack of Efficacy|3|||
144655845|NCT01753076|521591108|FG001|Overall Study|Lack of Efficacy|1|||
144655846|NCT01753076|521591107|FG000|Overall Study|Lost to Follow-up|2|||
144655847|NCT01753076|521591108|FG001|Overall Study|Lost to Follow-up|1|||
144655848|NCT01753076|521591107|FG000|Overall Study|Physician Decision|4|||
144655849|NCT01753076|521591108|FG001|Overall Study|Physician Decision|2|||
144655850|NCT01753076|521591107|FG000|Overall Study|Withdrawal by Subject|14|||
144655851|NCT01753076|521591108|FG001|Overall Study|Withdrawal by Subject|24|||
144655852|NCT01753076|521591107|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
144655853|NCT01753076|521591108|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
144655854|NCT02575079|521591109|FG000|Overall Study|Death|3|||
144655855|NCT02575079|521591110|FG001|Overall Study|Death|0|||
144655856|NCT02575079|521591109|FG000|Overall Study|Withdrawal by Subject|3|||
144655857|NCT02575079|521591110|FG001|Overall Study|Withdrawal by Subject|0|||
144655858|NCT00788775|521591111|FG000|Overall Study|Progressive Disease|8|||
144655859|NCT00788775|521591112|FG001|Overall Study|Progressive Disease|6|||
144655860|NCT00788775|521591111|FG000|Overall Study|Withdrawal by Subject|0|||
144655861|NCT00788775|521591112|FG001|Overall Study|Withdrawal by Subject|2|||
144655862|NCT00788775|521591111|FG000|Overall Study|Patient Non-Compliance|1|||
144655863|NCT00788775|521591112|FG001|Overall Study|Patient Non-Compliance|0|||
144655864|NCT00788775|521591111|FG000|Overall Study|Patient's measurable disease resected.|1|||
144655865|NCT00788775|521591112|FG001|Overall Study|Patient's measurable disease resected.|0|||
144655866|NCT00578864|521591113|FG000|Overall Study|Death|1|||
144655867|NCT00578864|521591114|FG001|Overall Study|Death|0|||
144655868|NCT01217190|521591118|FG000|Second Dosing|Withdrawal by Subject|0|||
144655869|NCT01217190|521591119|FG001|Second Dosing|Withdrawal by Subject|2|||
144655870|NCT01594476|521591120|FG000|Overall Study|Protocol Violation|1|||
144655871|NCT01594476|521591121|FG001|Overall Study|Protocol Violation|3|||
144655872|NCT03116399|521591122|FG000|Overall Study|Death|8|||
144655873|NCT03116399|521591123|FG001|Overall Study|Death|3|||
144655874|NCT03116399|521591122|FG000|Overall Study|Lost to Follow-up|7|||
144655875|NCT03116399|521591123|FG001|Overall Study|Lost to Follow-up|11|||
144655876|NCT03116399|521591122|FG000|Overall Study|Investigator Decision|1|||
144655877|NCT03116399|521591123|FG001|Overall Study|Investigator Decision|1|||
144655878|NCT03116399|521591122|FG000|Overall Study|Withdrawal by Subject|24|||
144655879|NCT03116399|521591123|FG001|Overall Study|Withdrawal by Subject|9|||
144655880|NCT05692154|521591125|FG000|Overall Study|Adverse Event|0|||
144655881|NCT05692154|521591126|FG001|Overall Study|Adverse Event|1|||
144655882|NCT01379534|521591127|FG000|Treatment Phase|Withdrawal by Subject|2|||
144655883|NCT01379534|521591128|FG001|Treatment Phase|Withdrawal by Subject|2|||
144655884|NCT01379534|521591127|FG000|Treatment Phase|Progressive disease|13|||
144655885|NCT01379534|521591128|FG001|Treatment Phase|Progressive disease|22|||
144655886|NCT01379534|521591127|FG000|Treatment Phase|Adverse Event|7|||
144655887|NCT01379534|521591128|FG001|Treatment Phase|Adverse Event|7|||
144732491|NCT00723528|521877083|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
144732492|NCT00723528|521877084|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
144655888|NCT01379534|521591127|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
144655889|NCT01379534|521591128|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
144655890|NCT01379534|521591127|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
144655891|NCT01379534|521591128|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
144655892|NCT01379534|521591127|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
144655893|NCT01379534|521591128|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
144655894|NCT01379534|521591127|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
144655895|NCT01379534|521591128|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
144655896|NCT04743635|521591131|FG000|Overall Study|Lost to Follow-up|2|||
144655897|NCT04743635|521591132|FG001|Overall Study|Lost to Follow-up|0|||
144655898|NCT01954121|521591133|FG000|Overall Study|Lack of Efficacy|94|||
144655899|NCT01954121|521591134|FG001|Overall Study|Lack of Efficacy|41|||
144655900|NCT01954121|521591133|FG000|Overall Study|Protocol Violation|0|||
144655901|NCT01954121|521591134|FG001|Overall Study|Protocol Violation|2|||
144655902|NCT01954121|521591133|FG000|Overall Study|Lost to Follow-up|5|||
144655903|NCT01954121|521591134|FG001|Overall Study|Lost to Follow-up|6|||
144655904|NCT01954121|521591133|FG000|Overall Study|Withdrawal by Subject|18|||
144655905|NCT01954121|521591134|FG001|Overall Study|Withdrawal by Subject|12|||
144655906|NCT01954121|521591133|FG000|Overall Study|Pregnancy|1|||
144655907|NCT01954121|521591134|FG001|Overall Study|Pregnancy|1|||
144655908|NCT01954121|521591133|FG000|Overall Study|AE, serious fatal|1|||
144655909|NCT01954121|521591134|FG001|Overall Study|AE, serious fatal|0|||
144655910|NCT01954121|521591133|FG000|Overall Study|AE, non-serious non-fatal|5|||
144655911|NCT01954121|521591134|FG001|Overall Study|AE, non-serious non-fatal|22|||
144655912|NCT01954121|521591133|FG000|Overall Study|SAE, non-fatal|1|||
144655913|NCT01954121|521591134|FG001|Overall Study|SAE, non-fatal|4|||
144655914|NCT01954121|521591133|FG000|Overall Study|Non-compliant with study procedures|1|||
144655915|NCT01954121|521591134|FG001|Overall Study|Non-compliant with study procedures|0|||
144655916|NCT01954121|521591133|FG000|Overall Study|Non-compliant patient|1|||
144655917|NCT01954121|521591134|FG001|Overall Study|Non-compliant patient|1|||
144655918|NCT01954121|521591133|FG000|Overall Study|Subject did not follow instructions|0|||
144655919|NCT01954121|521591134|FG001|Overall Study|Subject did not follow instructions|2|||
144655920|NCT01064648|521591139|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
144655921|NCT01064648|521591140|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
144655922|NCT01064648|521591141|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
144655923|NCT01064648|521591142|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
144655924|NCT01064648|521591139|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
144655925|NCT01064648|521591140|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
144655926|NCT01064648|521591141|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
144655927|NCT01064648|521591142|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
144655928|NCT01064648|521591139|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
144655929|NCT01064648|521591140|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
144655930|NCT01064648|521591141|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
144655931|NCT01064648|521591142|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
144655932|NCT01064648|521591139|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
144655933|NCT01064648|521591140|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
144655934|NCT01064648|521591141|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
144655935|NCT01064648|521591142|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
144655936|NCT01064648|521591139|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
144655937|NCT01064648|521591140|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
144655938|NCT01064648|521591141|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
144655939|NCT01064648|521591142|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
144655940|NCT01064648|521591139|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
144655941|NCT01064648|521591140|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
144655942|NCT01064648|521591141|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
144655943|NCT01064648|521591142|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
144655944|NCT01064648|521591139|FG000|Phase II|Adverse Event|0|||
144655945|NCT01064648|521591140|FG001|Phase II|Adverse Event|0|||
144655946|NCT01064648|521591141|FG002|Phase II|Adverse Event|15|||
144655947|NCT01064648|521591142|FG003|Phase II|Adverse Event|8|||
144655948|NCT01064648|521591139|FG000|Phase II|Death|0|||
144655949|NCT01064648|521591140|FG001|Phase II|Death|0|||
144655950|NCT01064648|521591141|FG002|Phase II|Death|4|||
144655951|NCT01064648|521591142|FG003|Phase II|Death|5|||
144655952|NCT01064648|521591139|FG000|Phase II|Withdrawal by Subject|0|||
144655953|NCT01064648|521591140|FG001|Phase II|Withdrawal by Subject|0|||
144655954|NCT01064648|521591141|FG002|Phase II|Withdrawal by Subject|2|||
144655955|NCT01064648|521591142|FG003|Phase II|Withdrawal by Subject|5|||
144655956|NCT01064648|521591139|FG000|Phase II|Progression|0|||
144655957|NCT01064648|521591140|FG001|Phase II|Progression|0|||
144655958|NCT01064648|521591141|FG002|Phase II|Progression|21|||
144655959|NCT01064648|521591142|FG003|Phase II|Progression|27|||
144655960|NCT01064648|521591139|FG000|Phase II|Non-protocol specified|0|||
144655961|NCT01064648|521591140|FG001|Phase II|Non-protocol specified|0|||
144655962|NCT01064648|521591141|FG002|Phase II|Non-protocol specified|5|||
144655963|NCT01064648|521591142|FG003|Phase II|Non-protocol specified|3|||
144655964|NCT01064648|521591139|FG000|Phase II|Under Review|0|||
144655965|NCT01064648|521591140|FG001|Phase II|Under Review|0|||
144655966|NCT01064648|521591141|FG002|Phase II|Under Review|2|||
144655967|NCT01064648|521591142|FG003|Phase II|Under Review|0|||
144655968|NCT05513391|521591143|FG000|Overall Study|Adverse Event|1|||
144655969|NCT05513391|521591144|FG001|Overall Study|Adverse Event|0|||
144655970|NCT05513391|521591143|FG000|Overall Study|Protocol Deviation|0|||
144655971|NCT05513391|521591144|FG001|Overall Study|Protocol Deviation|1|||
144655972|NCT05513391|521591143|FG000|Overall Study|Withdrawal by Subject|3|||
144655973|NCT05513391|521591144|FG001|Overall Study|Withdrawal by Subject|1|||
144655974|NCT05513391|521591143|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144655975|NCT05513391|521591144|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
144655976|NCT05513391|521591143|FG000|Overall Study|Lost to Follow-up|0|||
144264306|NCT00676403|520169426|FG004|Overall Study|Adverse Event|1|||
144264307|NCT00676403|520169427|FG005|Overall Study|Adverse Event|2|||
144264308|NCT00676403|520169422|FG000|Overall Study|Lost to Follow-up|0|||
144264309|NCT00676403|520169423|FG001|Overall Study|Lost to Follow-up|0|||
144264310|NCT00676403|520169424|FG002|Overall Study|Lost to Follow-up|0|||
144264311|NCT00676403|520169425|FG003|Overall Study|Lost to Follow-up|0|||
144264312|NCT00676403|520169426|FG004|Overall Study|Lost to Follow-up|0|||
144264313|NCT00676403|520169427|FG005|Overall Study|Lost to Follow-up|1|||
144264314|NCT00676403|520169422|FG000|Overall Study|Reason Unspecified|1|||
144264315|NCT00676403|520169423|FG001|Overall Study|Reason Unspecified|0|||
144264316|NCT00676403|520169424|FG002|Overall Study|Reason Unspecified|1|||
144264317|NCT00676403|520169425|FG003|Overall Study|Reason Unspecified|0|||
144264318|NCT00676403|520169426|FG004|Overall Study|Reason Unspecified|0|||
144264319|NCT00676403|520169427|FG005|Overall Study|Reason Unspecified|1|||
144264320|NCT00676403|520169422|FG000|Overall Study|Withdrawal by Subject|0|||
144264321|NCT00676403|520169423|FG001|Overall Study|Withdrawal by Subject|0|||
144264322|NCT00676403|520169424|FG002|Overall Study|Withdrawal by Subject|0|||
144264323|NCT00676403|520169425|FG003|Overall Study|Withdrawal by Subject|0|||
144264324|NCT00676403|520169426|FG004|Overall Study|Withdrawal by Subject|0|||
144264325|NCT00676403|520169427|FG005|Overall Study|Withdrawal by Subject|1|||
144264326|NCT01746862|520169428|FG000|Overall Study|Withdrawal by Subject|1|||
144264327|NCT01746862|520169429|FG001|Overall Study|Withdrawal by Subject|1|||
144264328|NCT01746862|520169428|FG000|Overall Study|Protocol Violation|1|||
144264329|NCT01746862|520169429|FG001|Overall Study|Protocol Violation|0|||
144264330|NCT01746862|520169428|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
144264331|NCT01746862|520169429|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
144264332|NCT01746862|520169428|FG000|Overall Study|Entered puberty during the study|1|||
144264333|NCT01746862|520169429|FG001|Overall Study|Entered puberty during the study|0|||
144264334|NCT00731822|520169432|FG000|Overall Study|Adverse Event|2|||
144264335|NCT00731822|520169433|FG001|Overall Study|Adverse Event|1|||
144264336|NCT00731822|520169432|FG000|Overall Study|Protocol Violation|1|||
144264337|NCT00731822|520169433|FG001|Overall Study|Protocol Violation|0|||
144264338|NCT00731822|520169432|FG000|Overall Study|Lost to Follow-up|1|||
144264339|NCT00731822|520169433|FG001|Overall Study|Lost to Follow-up|0|||
144264340|NCT02131064|520169443|FG000|Overall Study|Death|5|||
144264341|NCT02131064|520169444|FG001|Overall Study|Death|6|||
144264342|NCT02131064|520169443|FG000|Overall Study|Lost to Follow-up|4|||
144264343|NCT02131064|520169444|FG001|Overall Study|Lost to Follow-up|8|||
144264344|NCT02131064|520169443|FG000|Overall Study|Withdrawal by Subject|14|||
144264345|NCT02131064|520169444|FG001|Overall Study|Withdrawal by Subject|18|||
144264346|NCT02131064|520169443|FG000|Overall Study|Other|2|||
144264347|NCT02131064|520169444|FG001|Overall Study|Other|2|||
144655977|NCT05513391|521591144|FG001|Overall Study|Lost to Follow-up|2|||
144655978|NCT05183867|521593929|FG000|Overall Study|Withdrawal by Subject|3|||
144655979|NCT05183867|521593930|FG001|Overall Study|Withdrawal by Subject|2|||
144655980|NCT05183867|521593931|FG002|Overall Study|Withdrawal by Subject|0|||
144655981|NCT00418834|521593934|FG000|Overall Study|Adverse Event|16|||
144655982|NCT00418834|521593935|FG001|Overall Study|Adverse Event|9|||
144655983|NCT00418834|521593934|FG000|Overall Study|Lost to Follow-up|0|||
144655984|NCT00418834|521593935|FG001|Overall Study|Lost to Follow-up|1|||
144655985|NCT00418834|521593934|FG000|Overall Study|Protocol Violation|4|||
144655986|NCT00418834|521593935|FG001|Overall Study|Protocol Violation|3|||
144655987|NCT00418834|521593934|FG000|Overall Study|Withdrawal by Subject|3|||
144655988|NCT00418834|521593935|FG001|Overall Study|Withdrawal by Subject|7|||
144655989|NCT01953328|521593936|FG000|Overall Study|Withdrawal by Subject|0|||
144655990|NCT01953328|521593937|FG001|Overall Study|Withdrawal by Subject|0|||
144655991|NCT01953328|521593938|FG002|Overall Study|Withdrawal by Subject|0|||
144655992|NCT01953328|521593939|FG003|Overall Study|Withdrawal by Subject|0|||
144655993|NCT01953328|521593940|FG004|Overall Study|Withdrawal by Subject|1|||
144655994|NCT01953328|521593941|FG005|Overall Study|Withdrawal by Subject|0|||
144655995|NCT01953328|521593942|FG006|Overall Study|Withdrawal by Subject|0|||
144264348|NCT03243305|520169448|FG000|Overall Study|Lost to Follow-up|250|||
144264349|NCT03243305|520169448|FG000|Overall Study|Withdrawal by Subject|170|||
144264350|NCT03243305|520169448|FG000|Overall Study|Pregnancy|104|||
144264351|NCT03243305|520169448|FG000|Overall Study|Non-Compliance with Study Drug|38|||
144264352|NCT03243305|520169448|FG000|Overall Study|Adverse Event|23|||
144264353|NCT03243305|520169448|FG000|Overall Study|No sexually active|26|||
144264354|NCT03243305|520169448|FG000|Overall Study|Physician Decision|22|||
144264355|NCT03243305|520169448|FG000|Overall Study|Protocol Violation|22|||
144264356|NCT03243305|520169448|FG000|Overall Study|Study method no longer primary method|12|||
144264357|NCT03243305|520169448|FG000|Overall Study|Study Terminated by Sponsor|1|||
144655996|NCT01953328|521593943|FG007|Overall Study|Withdrawal by Subject|0|||
144655997|NCT01953328|521593936|FG000|Overall Study|Lost to Follow-up|0|||
144655998|NCT01953328|521593937|FG001|Overall Study|Lost to Follow-up|0|||
144655999|NCT01953328|521593938|FG002|Overall Study|Lost to Follow-up|0|||
144656000|NCT01953328|521593939|FG003|Overall Study|Lost to Follow-up|0|||
144264358|NCT03243305|520169448|FG000|Overall Study|Early terminations|267|||
144264359|NCT00673257|520169449|FG000|Overall Study|Withdrawal by Subject|4|||
144656001|NCT01953328|521593940|FG004|Overall Study|Lost to Follow-up|1|||
144656002|NCT01953328|521593941|FG005|Overall Study|Lost to Follow-up|0|||
144656003|NCT01953328|521593942|FG006|Overall Study|Lost to Follow-up|0|||
144656004|NCT01953328|521593943|FG007|Overall Study|Lost to Follow-up|0|||
144656005|NCT05113953|521593949|FG000|Overall Study|Adverse Event|5|||
144656006|NCT05113953|521593950|FG001|Overall Study|Adverse Event|0|||
144656007|NCT05113953|521593951|FG002|Overall Study|Adverse Event|3|||
144656008|NCT05113953|521593949|FG000|Overall Study|Lost to Follow-up|3|||
144656009|NCT05113953|521593950|FG001|Overall Study|Lost to Follow-up|4|||
144656010|NCT05113953|521593951|FG002|Overall Study|Lost to Follow-up|2|||
144656011|NCT05113953|521593949|FG000|Overall Study|Non-compliance with Study Drug|1|||
144656012|NCT05113953|521593950|FG001|Overall Study|Non-compliance with Study Drug|0|||
144656013|NCT05113953|521593951|FG002|Overall Study|Non-compliance with Study Drug|0|||
144656014|NCT05113953|521593949|FG000|Overall Study|Withdrawal by Subject|2|||
144656015|NCT05113953|521593950|FG001|Overall Study|Withdrawal by Subject|6|||
144656016|NCT05113953|521593951|FG002|Overall Study|Withdrawal by Subject|4|||
144656017|NCT05113953|521593949|FG000|Overall Study|Reason not Specified|2|||
144732493|NCT00723528|521877085|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
144732494|NCT00723528|521877079|FG000|Period 2: After Controlled Period|Other|0|||
144732495|NCT00723528|521877080|FG001|Period 2: After Controlled Period|Other|0|||
144732496|NCT00723528|521877081|FG002|Period 2: After Controlled Period|Other|0|||
144732497|NCT00723528|521877082|FG003|Period 2: After Controlled Period|Other|0|||
144732498|NCT00723528|521877083|FG004|Period 2: After Controlled Period|Other|1|||
144732499|NCT00723528|521877084|FG005|Period 2: After Controlled Period|Other|4|||
144732500|NCT00723528|521877085|FG006|Period 2: After Controlled Period|Other|0|||
144732501|NCT00723528|521877079|FG000|Period 2: After Controlled Period|Adverse Event|0|||
144732502|NCT00723528|521877080|FG001|Period 2: After Controlled Period|Adverse Event|0|||
144656018|NCT05113953|521593950|FG001|Overall Study|Reason not Specified|0|||
144656019|NCT05113953|521593951|FG002|Overall Study|Reason not Specified|0|||
144656020|NCT00492856|521593952|FG000|Induction|Adverse Event|2|||
144656021|NCT00492856|521593953|FG001|Induction|Adverse Event|0|||
144732503|NCT00723528|521877081|FG002|Period 2: After Controlled Period|Adverse Event|0|||
144732504|NCT00723528|521877082|FG003|Period 2: After Controlled Period|Adverse Event|0|||
144656022|NCT00492856|521593954|FG002|Induction|Adverse Event|0|||
144656023|NCT00492856|521593955|FG003|Induction|Adverse Event|0|||
144656024|NCT00492856|521593952|FG000|Induction|Withdrawal by Subject|1|||
144656025|NCT00492856|521593953|FG001|Induction|Withdrawal by Subject|0|||
144656026|NCT00492856|521593954|FG002|Induction|Withdrawal by Subject|0|||
144656027|NCT00492856|521593955|FG003|Induction|Withdrawal by Subject|0|||
144656028|NCT00492856|521593952|FG000|Induction|Death|3|||
144656029|NCT00492856|521593953|FG001|Induction|Death|0|||
144656030|NCT00492856|521593954|FG002|Induction|Death|0|||
144656031|NCT00492856|521593955|FG003|Induction|Death|0|||
144656032|NCT00492856|521593952|FG000|Consolidation|Adverse Event|6|||
144656033|NCT00492856|521593953|FG001|Consolidation|Adverse Event|0|||
144656034|NCT00492856|521593954|FG002|Consolidation|Adverse Event|0|||
144656035|NCT00492856|521593955|FG003|Consolidation|Adverse Event|0|||
144656036|NCT00492856|521593952|FG000|Consolidation|Not protocol specified|2|||
144656037|NCT00492856|521593953|FG001|Consolidation|Not protocol specified|0|||
144656038|NCT00492856|521593954|FG002|Consolidation|Not protocol specified|0|||
144656039|NCT00492856|521593955|FG003|Consolidation|Not protocol specified|0|||
144656040|NCT00492856|521593952|FG000|Consolidation|Lost to Follow-up|1|||
144656041|NCT00492856|521593953|FG001|Consolidation|Lost to Follow-up|0|||
144732505|NCT00723528|521877083|FG004|Period 2: After Controlled Period|Adverse Event|1|||
144732506|NCT00723528|521877084|FG005|Period 2: After Controlled Period|Adverse Event|0|||
144732507|NCT00723528|521877085|FG006|Period 2: After Controlled Period|Adverse Event|1|||
144732508|NCT00723528|521877079|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
144732509|NCT00723528|521877080|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
144732510|NCT00723528|521877081|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
144732511|NCT00723528|521877082|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
144732512|NCT00723528|521877083|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
144732513|NCT00723528|521877084|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
144732514|NCT00723528|521877085|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
144656042|NCT00492856|521593954|FG002|Consolidation|Lost to Follow-up|0|||
144656043|NCT00492856|521593955|FG003|Consolidation|Lost to Follow-up|0|||
144656044|NCT00492856|521593952|FG000|Post-consolidation|Adverse Event|0|||
144656045|NCT00492856|521593953|FG001|Post-consolidation|Adverse Event|4|||
144656046|NCT00492856|521593954|FG002|Post-consolidation|Adverse Event|0|||
144656047|NCT00492856|521593955|FG003|Post-consolidation|Adverse Event|1|||
144656048|NCT00492856|521593952|FG000|Post-consolidation|Withdrawal by Subject|0|||
144656049|NCT00492856|521593953|FG001|Post-consolidation|Withdrawal by Subject|4|||
144656050|NCT00492856|521593954|FG002|Post-consolidation|Withdrawal by Subject|0|||
144656051|NCT00492856|521593955|FG003|Post-consolidation|Withdrawal by Subject|0|||
144656052|NCT00492856|521593952|FG000|Post-consolidation|Death|0|||
144656053|NCT00492856|521593953|FG001|Post-consolidation|Death|1|||
144732515|NCT00723528|521877079|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
144264360|NCT00673257|520169449|FG000|Overall Study|Unable to obtain specimen|1|||
144264361|NCT02417753|520169452|FG000|Overall Study|Death|1|||
144656054|NCT00492856|521593954|FG002|Post-consolidation|Death|0|||
144656055|NCT00492856|521593955|FG003|Post-consolidation|Death|0|||
144656056|NCT00492856|521593952|FG000|Post-consolidation|Not protocol specified|0|||
144656057|NCT00492856|521593953|FG001|Post-consolidation|Not protocol specified|1|||
144656058|NCT00492856|521593954|FG002|Post-consolidation|Not protocol specified|0|||
144656059|NCT00492856|521593955|FG003|Post-consolidation|Not protocol specified|0|||
144656060|NCT00492856|521593952|FG000|Post-consolidation|Lost to Follow-up|0|||
144656061|NCT00492856|521593953|FG001|Post-consolidation|Lost to Follow-up|2|||
144656062|NCT00492856|521593954|FG002|Post-consolidation|Lost to Follow-up|0|||
144732516|NCT00723528|521877080|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
144732517|NCT00723528|521877081|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
144214021|NCT04803305|519976976|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
144214022|NCT04803305|519976975|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
144214023|NCT04803305|519976976|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
144214024|NCT04803305|519976975|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
144214025|NCT04803305|519976976|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
144214026|NCT04803305|519976975|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
144214027|NCT04803305|519976976|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
144214028|NCT01862484|519976977|FG000|Overall Study|Lack of Efficacy|1|||
144214029|NCT01862484|519976978|FG001|Overall Study|Lack of Efficacy|1|||
144214030|NCT01862484|519976977|FG000|Overall Study|Lost to Follow-up|1|||
144214031|NCT01862484|519976978|FG001|Overall Study|Lost to Follow-up|2|||
144214032|NCT01862484|519976977|FG000|Overall Study|Protocol Violation|0|||
144214033|NCT01862484|519976978|FG001|Overall Study|Protocol Violation|2|||
144214034|NCT01862484|519976977|FG000|Overall Study|Withdrawal by Subject|0|||
144214035|NCT01862484|519976978|FG001|Overall Study|Withdrawal by Subject|3|||
144214036|NCT00721227|519976979|FG000|Overall Study|Lost to Follow-up|3|||
144214037|NCT00721227|519976980|FG001|Overall Study|Lost to Follow-up|0|||
144214038|NCT00721227|519976979|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
144214039|NCT00721227|519976980|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
144214040|NCT00993421|519976981|FG000|Overall Study|Adverse Event|2|||
144214041|NCT00993421|519976982|FG001|Overall Study|Adverse Event|7|||
144214042|NCT00993421|519976983|FG002|Overall Study|Adverse Event|6|||
144214043|NCT00993421|519976984|FG003|Overall Study|Adverse Event|9|||
144214044|NCT00993421|519976985|FG004|Overall Study|Adverse Event|5|||
144214045|NCT00993421|519976986|FG005|Overall Study|Adverse Event|7|||
144214046|NCT00993421|519976987|FG006|Overall Study|Adverse Event|1|||
144214047|NCT00993421|519976981|FG000|Overall Study|Sponsor Decision|36|||
144214048|NCT00993421|519976982|FG001|Overall Study|Sponsor Decision|31|||
144214049|NCT00993421|519976983|FG002|Overall Study|Sponsor Decision|28|||
144214050|NCT00993421|519976984|FG003|Overall Study|Sponsor Decision|30|||
144214051|NCT00993421|519976985|FG004|Overall Study|Sponsor Decision|38|||
144214052|NCT00993421|519976986|FG005|Overall Study|Sponsor Decision|30|||
144214053|NCT00993421|519976987|FG006|Overall Study|Sponsor Decision|29|||
144214054|NCT00993421|519976981|FG000|Overall Study|Lost to Follow-up|3|||
144214055|NCT00993421|519976982|FG001|Overall Study|Lost to Follow-up|5|||
144214056|NCT00993421|519976983|FG002|Overall Study|Lost to Follow-up|5|||
144214057|NCT00993421|519976984|FG003|Overall Study|Lost to Follow-up|0|||
144214058|NCT00993421|519976985|FG004|Overall Study|Lost to Follow-up|0|||
144214059|NCT00993421|519976986|FG005|Overall Study|Lost to Follow-up|0|||
144214060|NCT00993421|519976987|FG006|Overall Study|Lost to Follow-up|6|||
144214061|NCT00993421|519976981|FG000|Overall Study|Withdrawal by Subject|3|||
144214062|NCT00993421|519976982|FG001|Overall Study|Withdrawal by Subject|2|||
144214063|NCT00993421|519976983|FG002|Overall Study|Withdrawal by Subject|3|||
144214064|NCT00993421|519976984|FG003|Overall Study|Withdrawal by Subject|3|||
144214065|NCT00993421|519976985|FG004|Overall Study|Withdrawal by Subject|3|||
144214066|NCT00993421|519976986|FG005|Overall Study|Withdrawal by Subject|5|||
144214067|NCT00993421|519976987|FG006|Overall Study|Withdrawal by Subject|3|||
144214068|NCT00993421|519976981|FG000|Overall Study|Death|0|||
144214069|NCT00993421|519976982|FG001|Overall Study|Death|0|||
144214070|NCT00993421|519976983|FG002|Overall Study|Death|0|||
144214071|NCT00993421|519976984|FG003|Overall Study|Death|0|||
144214072|NCT00993421|519976985|FG004|Overall Study|Death|0|||
144214073|NCT00993421|519976986|FG005|Overall Study|Death|0|||
144214074|NCT00993421|519976987|FG006|Overall Study|Death|1|||
144214075|NCT00993421|519976981|FG000|Overall Study|Entry Criteria Exclusion|0|||
144264362|NCT03380377|520169457|FG000|Overall Study|Physician Decision|1|||
144214076|NCT00993421|519976982|FG001|Overall Study|Entry Criteria Exclusion|0|||
144656063|NCT00492856|521593955|FG003|Post-consolidation|Lost to Follow-up|0|||
144214077|NCT00993421|519976983|FG002|Overall Study|Entry Criteria Exclusion|1|||
144214078|NCT00993421|519976984|FG003|Overall Study|Entry Criteria Exclusion|3|||
144214079|NCT00993421|519976985|FG004|Overall Study|Entry Criteria Exclusion|0|||
144214080|NCT00993421|519976986|FG005|Overall Study|Entry Criteria Exclusion|1|||
144264363|NCT03380377|520169457|FG000|Overall Study|Withdrawal by Subject|1|||
144656064|NCT00492856|521593952|FG000|Post-consolidation|Observation Arm|0|||
144656065|NCT00492856|521593953|FG001|Post-consolidation|Observation Arm|0|||
144656066|NCT00492856|521593954|FG002|Post-consolidation|Observation Arm|27|||
144656067|NCT00492856|521593955|FG003|Post-consolidation|Observation Arm|0|||
144656068|NCT01520324|521593958|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
144656069|NCT03488472|521593959|FG000|Overall Study|disease progression additional mets|1|||
144656070|NCT00502307|521593960|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
144656071|NCT00502307|521593961|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
144656072|NCT00502307|521593962|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
144656073|NCT00502307|521593960|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
144656074|NCT00502307|521593961|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
144656075|NCT00502307|521593962|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
144656076|NCT00502307|521593960|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
144656077|NCT00502307|521593961|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
144656078|NCT00502307|521593962|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
144656079|NCT00502307|521593960|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
144656080|NCT00502307|521593961|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
144656081|NCT00502307|521593962|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
144656082|NCT00502307|521593960|FG000|Maintenance Period|Progressive disease|80|||
144656083|NCT00502307|521593961|FG001|Maintenance Period|Progressive disease|0|||
144656084|NCT00502307|521593962|FG002|Maintenance Period|Progressive disease|0|||
144656085|NCT00502307|521593960|FG000|Maintenance Period|Discontinued due to other reasons|68|||
144656086|NCT00502307|521593961|FG001|Maintenance Period|Discontinued due to other reasons|0|||
144656087|NCT00502307|521593962|FG002|Maintenance Period|Discontinued due to other reasons|0|||
144656088|NCT00748553|521593963|FG000|Overall Study|Adverse Event|0|||
144656089|NCT00748553|521593964|FG001|Overall Study|Adverse Event|1|||
144656090|NCT00748553|521593963|FG000|Overall Study|disease progression|2|||
144656091|NCT00748553|521593964|FG001|Overall Study|disease progression|0|||
144656092|NCT00748553|521593963|FG000|Overall Study|noncompliance|1|||
144656093|NCT00748553|521593964|FG001|Overall Study|noncompliance|0|||
144656094|NCT00948818|521593965|FG000|Overall Study|Adverse Event|10|||
144656095|NCT00948818|521593966|FG001|Overall Study|Adverse Event|32|||
144656096|NCT00948818|521593965|FG000|Overall Study|Protocol Violation|9|||
144656097|NCT00948818|521593966|FG001|Overall Study|Protocol Violation|10|||
144656098|NCT00948818|521593965|FG000|Overall Study|Withdrawal by Subject|25|||
144656099|NCT00948818|521593966|FG001|Overall Study|Withdrawal by Subject|25|||
144656100|NCT00948818|521593965|FG000|Overall Study|Lost to Follow-up|10|||
144656101|NCT00948818|521593966|FG001|Overall Study|Lost to Follow-up|17|||
144656102|NCT00948818|521593965|FG000|Overall Study|Lack of Efficacy|4|||
144656103|NCT00948818|521593966|FG001|Overall Study|Lack of Efficacy|5|||
144656104|NCT00948818|521593965|FG000|Overall Study|Other Reason|4|||
144656105|NCT00948818|521593966|FG001|Overall Study|Other Reason|5|||
144656106|NCT00745368|521593967|FG000|Overall Study|Unable to provide sample|3|||
144656107|NCT02364947|521593968|FG000|Overall Study|Withdrawal by Subject|10|||
144656108|NCT02364947|521593969|FG001|Overall Study|Withdrawal by Subject|8|||
144656109|NCT02364947|521593970|FG002|Overall Study|Withdrawal by Subject|9|||
144214081|NCT00993421|519976987|FG006|Overall Study|Entry Criteria Exclusion|0|||
144214082|NCT00993421|519976981|FG000|Overall Study|Physician Decision|0|||
144214083|NCT00993421|519976982|FG001|Overall Study|Physician Decision|0|||
144214084|NCT00993421|519976983|FG002|Overall Study|Physician Decision|0|||
144214085|NCT00993421|519976984|FG003|Overall Study|Physician Decision|0|||
144214086|NCT00993421|519976985|FG004|Overall Study|Physician Decision|0|||
144214087|NCT00993421|519976986|FG005|Overall Study|Physician Decision|1|||
144214088|NCT00993421|519976987|FG006|Overall Study|Physician Decision|1|||
144214089|NCT00993421|519976981|FG000|Overall Study|Protocol Violation|0|||
144214090|NCT00993421|519976982|FG001|Overall Study|Protocol Violation|0|||
144214091|NCT00993421|519976983|FG002|Overall Study|Protocol Violation|0|||
144214092|NCT00993421|519976984|FG003|Overall Study|Protocol Violation|0|||
144214093|NCT00993421|519976985|FG004|Overall Study|Protocol Violation|0|||
144214094|NCT00993421|519976986|FG005|Overall Study|Protocol Violation|2|||
144214095|NCT00993421|519976987|FG006|Overall Study|Protocol Violation|1|||
144214096|NCT02759692|519976988|FG000|Period 1|Test article no longer available|1|||
144214097|NCT02759692|519976989|FG001|Period 1|Test article no longer available|1|||
144214098|NCT02759692|519976988|FG000|Period 1|No longer meets eligibility criteria.|1|||
144214099|NCT02759692|519976989|FG001|Period 1|No longer meets eligibility criteria.|0|||
144214100|NCT02759692|519976988|FG000|Period 1|Miss-Randomized|1|||
144214101|NCT02759692|519976989|FG001|Period 1|Miss-Randomized|1|||
144214102|NCT02759692|519976988|FG000|Period 2|Lost to Follow-up|1|||
144214103|NCT02759692|519976989|FG001|Period 2|Lost to Follow-up|0|||
144214104|NCT02759692|519976988|FG000|Period 2|Test article no longer available|0|||
144214105|NCT02759692|519976989|FG001|Period 2|Test article no longer available|1|||
144214106|NCT00912912|519976990|FG000|Overall Study|Withdrawal by Subject|1|||
144214107|NCT00912912|519976990|FG000|Overall Study|Disease Progression|3|||
144214108|NCT02447744|519976991|FG000|Overall Study|Withdrawal by Subject|3|||
144656110|NCT02364947|521593968|FG000|Overall Study|Adverse Event|45|||
144656111|NCT02364947|521593969|FG001|Overall Study|Adverse Event|33|||
144656112|NCT02364947|521593970|FG002|Overall Study|Adverse Event|11|||
144656113|NCT02364947|521593968|FG000|Overall Study|Protocol Violation|1|||
144656114|NCT02364947|521593969|FG001|Overall Study|Protocol Violation|1|||
144656115|NCT02364947|521593970|FG002|Overall Study|Protocol Violation|1|||
144656116|NCT02364947|521593968|FG000|Overall Study|Physician Decision|3|||
144656117|NCT02364947|521593969|FG001|Overall Study|Physician Decision|2|||
144656118|NCT02364947|521593970|FG002|Overall Study|Physician Decision|5|||
144656119|NCT02364947|521593968|FG000|Overall Study|Death|0|||
144656120|NCT02364947|521593969|FG001|Overall Study|Death|1|||
144656121|NCT02364947|521593970|FG002|Overall Study|Death|0|||
144656122|NCT00423085|521593971|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
144656123|NCT00423085|521593972|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
144656124|NCT00423085|521593973|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
144656125|NCT00423085|521593974|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
144656126|NCT00423085|521593971|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
144656127|NCT00423085|521593972|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
144656128|NCT00423085|521593973|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
144656129|NCT00423085|521593974|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144656130|NCT00423085|521593971|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
144656131|NCT00423085|521593972|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
144656132|NCT00423085|521593973|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
144656133|NCT00423085|521593974|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
144656134|NCT00423085|521593971|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
144656135|NCT00423085|521593972|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
144656136|NCT00423085|521593973|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
144656137|NCT00423085|521593974|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
144656138|NCT00423085|521593971|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
144656139|NCT00423085|521593972|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
144656140|NCT00423085|521593973|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
144656141|NCT00423085|521593974|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
144656142|NCT00423085|521593971|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
144656143|NCT00423085|521593972|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
144656144|NCT00423085|521593973|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
144656145|NCT00423085|521593974|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
144656146|NCT00423085|521593971|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
144656147|NCT00423085|521593972|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
144656148|NCT00423085|521593973|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
144656149|NCT00423085|521593974|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
144656150|NCT00423085|521593971|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
144656151|NCT00423085|521593972|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
144656152|NCT00423085|521593973|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
144656153|NCT00423085|521593974|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
144656154|NCT00423085|521593971|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
144656155|NCT00423085|521593972|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
144656156|NCT00423085|521593973|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
144656157|NCT00423085|521593974|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
144656158|NCT00423085|521593971|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
144656159|NCT00423085|521593972|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
144656160|NCT00423085|521593973|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
144656161|NCT00423085|521593974|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
144656162|NCT00423085|521593971|FG000|52-Week Open-Label Extension Phase|Death|0|||
144656163|NCT00423085|521593972|FG001|52-Week Open-Label Extension Phase|Death|0|||
144656164|NCT00423085|521593973|FG002|52-Week Open-Label Extension Phase|Death|0|||
144656165|NCT00423085|521593974|FG003|52-Week Open-Label Extension Phase|Death|2|||
144656166|NCT00853489|521593975|FG000|Overall Study|Lost to Follow-up|5|||
144656167|NCT00853489|521593976|FG001|Overall Study|Lost to Follow-up|2|||
144656168|NCT02326467|521593977|FG000|Overall Study|Withdrawal by Subject|1|||
144656169|NCT05525975|521593978|FG000|Overall Study|Surgery cancellation|4|||
144656170|NCT05525975|521593979|FG001|Overall Study|Surgery cancellation|5|||
144656171|NCT05525975|521593978|FG000|Overall Study|didn't fill prescription|1|||
144656172|NCT05525975|521593979|FG001|Overall Study|didn't fill prescription|0|||
144656173|NCT05525975|521593978|FG000|Overall Study|Withdrawal by Subject|0|||
144656174|NCT05525975|521593979|FG001|Overall Study|Withdrawal by Subject|3|||
144214109|NCT02447744|519976992|FG001|Overall Study|Withdrawal by Subject|1|||
144656175|NCT01998581|521593983|FG000|Overall Study|Refused repeat treatment|20|||
144656176|NCT01998581|521593984|FG001|Overall Study|Refused repeat treatment|4|||
144656177|NCT01998581|521593983|FG000|Overall Study|Protocol Violation|1|||
144656178|NCT01998581|521593984|FG001|Overall Study|Protocol Violation|0|||
144264364|NCT02600923|520169458|FG000|Overall Study|Death|10|||
144264365|NCT02600923|520169458|FG000|Overall Study|Adverse Event|3|||
144264366|NCT02600923|520169458|FG000|Overall Study|Global deterioration of health status|2|||
144264367|NCT02600923|520169458|FG000|Overall Study|Insufficient clinical response|6|||
144264368|NCT02600923|520169458|FG000|Overall Study|Lost to Follow-up|1|||
144264369|NCT02600923|520169458|FG000|Overall Study|Withdrawal by Subject|5|||
144264370|NCT02600923|520169458|FG000|Overall Study|Objective progression or relapse|50|||
144264371|NCT02600923|520169458|FG000|Overall Study|Study terminated by Sponsor|53|||
144264372|NCT02600923|520169458|FG000|Overall Study|Not treated|1|||
144264373|NCT00792909|520169459|FG000|Overall Study|Withdrawal by Subject|0|||
144264374|NCT00792909|520169460|FG001|Overall Study|Withdrawal by Subject|1|||
144264375|NCT00792909|520169461|FG002|Overall Study|Withdrawal by Subject|0|||
144264376|NCT00385918|520169465|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
144264377|NCT00385918|520169466|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
144264378|NCT00385918|520169467|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
144264379|NCT00385918|520169465|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
144264380|NCT00385918|520169466|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
144264381|NCT00385918|520169467|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
144264382|NCT00385918|520169465|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
144264383|NCT00385918|520169466|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
144264384|NCT00385918|520169467|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
144264385|NCT00385918|520169465|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
144264386|NCT00385918|520169466|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
144264387|NCT00385918|520169467|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
144264388|NCT00385918|520169465|FG000|Intervention Phase After Randomization|Physician Decision|1|||
144264389|NCT00385918|520169466|FG001|Intervention Phase After Randomization|Physician Decision|0|||
144264390|NCT00385918|520169467|FG002|Intervention Phase After Randomization|Physician Decision|0|||
144264391|NCT00385918|520169465|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
144264392|NCT00385918|520169466|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
144264393|NCT00385918|520169467|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
144264394|NCT02782741|520169468|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
144264395|NCT02782741|520169469|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
144264396|NCT02782741|520169470|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
144264397|NCT02782741|520169468|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
144656179|NCT01998581|521593983|FG000|Overall Study|Withdrawal by Subject|8|||
144656180|NCT01998581|521593984|FG001|Overall Study|Withdrawal by Subject|1|||
144656181|NCT01998581|521593983|FG000|Overall Study|Lost to Follow-up|12|||
144656182|NCT01998581|521593984|FG001|Overall Study|Lost to Follow-up|4|||
144656183|NCT01998581|521593983|FG000|Overall Study|Adverse Event|1|||
144656184|NCT01998581|521593984|FG001|Overall Study|Adverse Event|1|||
144656185|NCT01998581|521593983|FG000|Overall Study|Other reasons|3|||
144656186|NCT01998581|521593984|FG001|Overall Study|Other reasons|2|||
144656187|NCT01998581|521593983|FG000|Overall Study|Randomized but withdrew before treatment|1|||
144656188|NCT01998581|521593984|FG001|Overall Study|Randomized but withdrew before treatment|0|||
144656189|NCT01251276|521593985|FG000|Overall Study|Protocol Violation|1|||
144656190|NCT01251276|521593986|FG001|Overall Study|Protocol Violation|0|||
144656191|NCT01251276|521593985|FG000|Overall Study|Lost to Follow-up|0|||
144656192|NCT01251276|521593986|FG001|Overall Study|Lost to Follow-up|1|||
144656193|NCT02245568|521593990|FG000|Overall Study|Study terminated by Sponsor|346|||
144656194|NCT02245568|521593990|FG000|Overall Study|Adverse Event|144|||
144656195|NCT02245568|521593990|FG000|Overall Study|Lack of Efficacy|98|||
144656196|NCT02245568|521593990|FG000|Overall Study|Withdrawal by Caregiver|85|||
144656197|NCT02245568|521593990|FG000|Overall Study|Withdrawal by Subject|77|||
144656198|NCT02245568|521593990|FG000|Overall Study|Withdrawal by Legal Representative|31|||
144656199|NCT02245568|521593990|FG000|Overall Study|Missing (Site closure)|16|||
144656200|NCT02245568|521593990|FG000|Overall Study|Physician Decision|14|||
144656201|NCT02245568|521593990|FG000|Overall Study|Non-compliance with study drug|11|||
144656202|NCT02245568|521593990|FG000|Overall Study|Death|9|||
144656203|NCT02245568|521593990|FG000|Overall Study|Blue staining|6|||
144264398|NCT02782741|520169469|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
144264399|NCT02782741|520169470|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
144264400|NCT02782741|520169468|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
144656204|NCT02245568|521593990|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
144656205|NCT02245568|521593990|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
144656206|NCT02245568|521593990|FG000|Overall Study|Lost to Follow-up|5|||
144656207|NCT00441441|521593991|FG000|Overall Study|Adverse Event|2|||
144656208|NCT00441441|521593992|FG001|Overall Study|Adverse Event|1|||
144656209|NCT00441441|521593991|FG000|Overall Study|Protocol Violation|4|||
144656210|NCT00441441|521593992|FG001|Overall Study|Protocol Violation|6|||
144656211|NCT00441441|521593991|FG000|Overall Study|Exacerbation of asthma|1|||
144656212|NCT00441441|521593992|FG001|Overall Study|Exacerbation of asthma|2|||
144656213|NCT00441441|521593991|FG000|Overall Study|Withdrawal by Subject|1|||
144656214|NCT00441441|521593992|FG001|Overall Study|Withdrawal by Subject|2|||
144656215|NCT00441441|521593991|FG000|Overall Study|Other|3|||
144656216|NCT00441441|521593992|FG001|Overall Study|Other|3|||
144656217|NCT01051986|521593993|FG000|Overall Study|Death|1|||
144656218|NCT01051986|521593994|FG001|Overall Study|Death|0|||
144656219|NCT01051986|521593993|FG000|Overall Study|Withdrawal by Subject|2|||
144656220|NCT01051986|521593994|FG001|Overall Study|Withdrawal by Subject|1|||
144656221|NCT01051986|521593993|FG000|Overall Study|Protocol Violation|2|||
144656222|NCT01051986|521593994|FG001|Overall Study|Protocol Violation|3|||
144656223|NCT01725152|521593996|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
144656224|NCT01725152|521593997|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
144656225|NCT01725152|521593996|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
144656226|NCT01725152|521593997|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
144656227|NCT01725152|521593996|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
144656228|NCT01725152|521593997|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
144656229|NCT01725152|521593996|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
144656230|NCT01725152|521593997|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
144656231|NCT02044159|521593998|FG000|Overall Study|Consent declined (deferred consent)|2|||
144656232|NCT02044159|521593999|FG001|Overall Study|Consent declined (deferred consent)|4|||
144656233|NCT02044159|521593998|FG000|Overall Study|No longer eligible, drug not given|1|||
144656234|NCT02044159|521593999|FG001|Overall Study|No longer eligible, drug not given|0|||
144656235|NCT02044159|521593998|FG000|Overall Study|Nurse declined to give study drug|1|||
144656236|NCT02044159|521593999|FG001|Overall Study|Nurse declined to give study drug|0|||
144656237|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
144656238|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144656239|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144656240|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144656241|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144656242|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
144656243|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144656244|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144656245|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144656246|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144656247|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
144656248|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144656249|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144656250|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144656251|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144656252|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
144656253|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
144656254|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
144656255|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
144656256|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
144656257|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
144656258|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
144656259|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
144656260|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
144656261|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
144656262|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
144656263|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144656264|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144656265|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144656266|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144656267|NCT01111539|521594000|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
144656268|NCT01111539|521594001|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
144656269|NCT01111539|521594002|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
144656270|NCT01111539|521594003|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
144656271|NCT01111539|521594004|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
144656272|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144656273|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144656274|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
144214110|NCT02447744|519976991|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
144214111|NCT02447744|519976992|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
144214112|NCT00306995|519976993|FG000|Study Part I|Withdrawal by Subject|0|||
144214113|NCT00306995|519976994|FG001|Study Part I|Withdrawal by Subject|0|||
144656275|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
144214114|NCT00306995|519976995|FG002|Study Part I|Withdrawal by Subject|0|||
144656276|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
144656277|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144656278|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144656279|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
144656280|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144656281|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
144656282|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
144656283|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
144656284|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
144656285|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
144656286|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
144656287|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
144656288|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
144656289|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
144656290|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
144656291|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
144656292|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
144656293|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
144656294|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
144656295|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
144656296|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
144656297|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
144656298|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
144656299|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
144656300|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
144656301|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
144656302|NCT01111539|521594000|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144656303|NCT01111539|521594001|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144656304|NCT01111539|521594002|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144656305|NCT01111539|521594003|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144656306|NCT01111539|521594004|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
144656307|NCT03580382|521594005|FG000|Overall Study|Early Termination of Study|0|||
144656308|NCT03580382|521594006|FG001|Overall Study|Early Termination of Study|3|||
144656309|NCT02808312|521594007|FG000|Overall Study|Enrolled but Never Treated|0|||
144656310|NCT02808312|521594008|FG001|Overall Study|Enrolled but Never Treated|0|||
144656311|NCT02808312|521594009|FG002|Overall Study|Enrolled but Never Treated|1|||
144656312|NCT02808312|521594010|FG003|Overall Study|Enrolled but Never Treated|0|||
144656313|NCT02808312|521594011|FG004|Overall Study|Enrolled but Never Treated|0|||
144656314|NCT03628417|521594012|FG000|Overall Study|Death|1|||
144732518|NCT00723528|521877082|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
144732519|NCT00723528|521877083|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
144732520|NCT00723528|521877084|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
144732521|NCT00723528|521877085|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
144732522|NCT03785548|521877088|FG000|Overall Study|age > 80|1|||
144732523|NCT03785548|521877089|FG001|Overall Study|age > 80|0|||
144732524|NCT03785548|521877088|FG000|Overall Study|no Postop queries|1|||
144732525|NCT03785548|521877089|FG001|Overall Study|no Postop queries|0|||
144732526|NCT00667862|521877091|FG000|Overall Study|Adverse Event|9|||
144732527|NCT00667862|521877091|FG000|Overall Study|Death|1|||
144732528|NCT00667862|521877091|FG000|Overall Study|Disease Progression|22|||
144732529|NCT00667862|521877091|FG000|Overall Study|Withdrawal by Subject|3|||
144732530|NCT02495857|521877097|FG000|Overall Study|Adverse Event|5|||
144656315|NCT03628417|521594013|FG001|Overall Study|Death|1|||
144656316|NCT05619172|521594017|FG000|Safety Cohort 1|Death|7|||
144656317|NCT05619172|521594018|FG001|Safety Cohort 1|Death|0|||
144656318|NCT05619172|521594017|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
144656319|NCT05619172|521594018|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
144656320|NCT05619172|521594017|FG000|Safety Cohort 2|Death|0|||
144656321|NCT05619172|521594018|FG001|Safety Cohort 2|Death|1|||
144656322|NCT05619172|521594017|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
144656323|NCT05619172|521594018|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
144656324|NCT04263142|521594019|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
144732531|NCT02495857|521877098|FG001|Overall Study|Adverse Event|0|||
144656325|NCT04263142|521594020|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
144656326|NCT04263142|521594021|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
144732532|NCT02495857|521877099|FG002|Overall Study|Adverse Event|1|||
144732533|NCT02495857|521877097|FG000|Overall Study|Withdrawal by Subject|9|||
144732534|NCT02495857|521877098|FG001|Overall Study|Withdrawal by Subject|6|||
144656327|NCT04263142|521594022|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
144656328|NCT04263142|521594023|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
144656329|NCT04263142|521594019|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
144656330|NCT04263142|521594020|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
144656331|NCT04263142|521594021|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
144656332|NCT04263142|521594022|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
144656333|NCT04263142|521594023|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
144656334|NCT00450372|521594025|FG000|Overall Study|Physician Decision|1|||
144656335|NCT00769704|521594026|FG000|Overall Study|Lost to Follow-up|3|||
144656336|NCT00769704|521594027|FG001|Overall Study|Lost to Follow-up|2|||
144656337|NCT00769704|521594026|FG000|Overall Study|Death|95|||
144656338|NCT00769704|521594027|FG001|Overall Study|Death|190|||
144656339|NCT00769704|521594026|FG000|Overall Study|Withdrawal by Subject|12|||
144656340|NCT00769704|521594027|FG001|Overall Study|Withdrawal by Subject|5|||
144656341|NCT00769704|521594026|FG000|Overall Study|Other|1|||
144656342|NCT00769704|521594027|FG001|Overall Study|Other|2|||
144656343|NCT00520676|521594031|FG000|Overall Study|Death|84|||
144656344|NCT00520676|521594032|FG001|Overall Study|Death|81|||
144656345|NCT00520676|521594031|FG000|Overall Study|Lost to Follow-up|6|||
144656346|NCT00520676|521594032|FG001|Overall Study|Lost to Follow-up|10|||
144656347|NCT00520676|521594031|FG000|Overall Study|Physician Decision|4|||
144656348|NCT00520676|521594032|FG001|Overall Study|Physician Decision|1|||
144656349|NCT00520676|521594031|FG000|Overall Study|Withdrawal by Subject|7|||
144656350|NCT00520676|521594032|FG001|Overall Study|Withdrawal by Subject|11|||
144656351|NCT05131451|521594035|FG000|Overall Study|Protocol Violation|1|||
144656352|NCT05131451|521594036|FG001|Overall Study|Protocol Violation|0|||
144656353|NCT01856595|521594041|FG000|Overall Study|Withdrawal by Subject|0|||
144656354|NCT01856595|521594042|FG001|Overall Study|Withdrawal by Subject|1|||
144656355|NCT01856595|521594043|FG002|Overall Study|Withdrawal by Subject|0|||
144656356|NCT01856595|521594044|FG003|Overall Study|Withdrawal by Subject|0|||
144656357|NCT01856595|521594045|FG004|Overall Study|Withdrawal by Subject|0|||
144656358|NCT01856595|521594046|FG005|Overall Study|Withdrawal by Subject|0|||
144656359|NCT01856595|521594047|FG006|Overall Study|Withdrawal by Subject|1|||
144656360|NCT01856595|521594048|FG007|Overall Study|Withdrawal by Subject|0|||
144656361|NCT01856595|521594049|FG008|Overall Study|Withdrawal by Subject|0|||
144656362|NCT04426825|521594052|FG000|Overall Study|Death|17|||
144656363|NCT04426825|521594052|FG000|Overall Study|Lost to Follow-up|1|||
144656364|NCT04426825|521594052|FG000|Overall Study|Study terminated by sponsor|5|||
144656365|NCT01763905|521594059|FG000|Overall Study|Withdrawal by Subject|1|||
144656366|NCT01763905|521594060|FG001|Overall Study|Withdrawal by Subject|1|||
144656367|NCT01763905|521594061|FG002|Overall Study|Withdrawal by Subject|0|||
144656368|NCT01763905|521594062|FG003|Overall Study|Withdrawal by Subject|1|||
144656369|NCT01763905|521594059|FG000|Overall Study|Decision by sponsor|5|||
144656370|NCT01763905|521594060|FG001|Overall Study|Decision by sponsor|0|||
144656371|NCT01763905|521594061|FG002|Overall Study|Decision by sponsor|8|||
144656372|NCT01763905|521594062|FG003|Overall Study|Decision by sponsor|0|||
144656373|NCT01763905|521594059|FG000|Overall Study|Lost to Follow-up|0|||
144656374|NCT01763905|521594060|FG001|Overall Study|Lost to Follow-up|0|||
144656375|NCT01763905|521594061|FG002|Overall Study|Lost to Follow-up|1|||
144656376|NCT01763905|521594062|FG003|Overall Study|Lost to Follow-up|0|||
144656377|NCT04346628|521594063|FG000|Overall Study|Lost to Follow-up|4|||
144656378|NCT04346628|521594064|FG001|Overall Study|Lost to Follow-up|4|||
144656379|NCT04346628|521594063|FG000|Overall Study|Withdrew (had personal reasons)|2|||
144656380|NCT04346628|521594064|FG001|Overall Study|Withdrew (had personal reasons)|5|||
144656381|NCT04346628|521594063|FG000|Overall Study|Withdrew (medication intolerant)|0|||
144656382|NCT04346628|521594064|FG001|Overall Study|Withdrew (medication intolerant)|3|||
144656383|NCT04346628|521594063|FG000|Overall Study|Withdrew (declined intervention)|0|||
144656384|NCT04346628|521594064|FG001|Overall Study|Withdrew (declined intervention)|1|||
144656385|NCT03165721|521594073|FG000|Overall Study|Refused further treatment|3|||
144656386|NCT03165721|521594074|FG001|Overall Study|Refused further treatment|0|||
144656387|NCT03165721|521594075|FG002|Overall Study|Refused further treatment|0|||
144656388|NCT03165721|521594073|FG000|Overall Study|Physician Decision|1|||
144656389|NCT03165721|521594074|FG001|Overall Study|Physician Decision|0|||
144656390|NCT03165721|521594075|FG002|Overall Study|Physician Decision|0|||
144214115|NCT00306995|519976996|FG003|Study Part I|Withdrawal by Subject|0|||
144656391|NCT01863849|521594077|FG000|Overall Study|Lost to Follow-up|1|||
144656392|NCT01863849|521594078|FG001|Overall Study|Lost to Follow-up|0|||
144656393|NCT01457118|521594079|FG000|Overall Study|Adverse Event|1|||
144656394|NCT01457118|521594080|FG001|Overall Study|Adverse Event|0|||
144656395|NCT01457118|521594081|FG002|Overall Study|Adverse Event|0|||
144656396|NCT01457118|521594082|FG003|Overall Study|Adverse Event|1|||
144656397|NCT01457118|521594079|FG000|Overall Study|Clinical Progression|0|||
144656398|NCT01457118|521594080|FG001|Overall Study|Clinical Progression|1|||
144656399|NCT01457118|521594081|FG002|Overall Study|Clinical Progression|0|||
144656400|NCT01457118|521594082|FG003|Overall Study|Clinical Progression|1|||
144656401|NCT01457118|521594079|FG000|Overall Study|Physician Decision|2|||
144656402|NCT01457118|521594080|FG001|Overall Study|Physician Decision|0|||
144656403|NCT01457118|521594081|FG002|Overall Study|Physician Decision|0|||
144656404|NCT01457118|521594082|FG003|Overall Study|Physician Decision|0|||
144656405|NCT01457118|521594079|FG000|Overall Study|Progressive Disease by RECIST|12|||
144656406|NCT01457118|521594080|FG001|Overall Study|Progressive Disease by RECIST|3|||
144656407|NCT01457118|521594081|FG002|Overall Study|Progressive Disease by RECIST|1|||
144656408|NCT01457118|521594082|FG003|Overall Study|Progressive Disease by RECIST|0|||
144656409|NCT01457118|521594079|FG000|Overall Study|Withdrawal by Subject|5|||
144656410|NCT01457118|521594080|FG001|Overall Study|Withdrawal by Subject|0|||
144656411|NCT01457118|521594081|FG002|Overall Study|Withdrawal by Subject|0|||
144656412|NCT01457118|521594082|FG003|Overall Study|Withdrawal by Subject|0|||
144656413|NCT02324842|521594083|FG000|Overall Study|Lost to Follow-up|1|||
144656414|NCT02324842|521594084|FG001|Overall Study|Lost to Follow-up|1|||
144656415|NCT02324842|521594085|FG002|Overall Study|Lost to Follow-up|2|||
144656416|NCT02750800|521594089|FG000|Overall Study|Adverse Event|18|||
144656417|NCT02750800|521594089|FG000|Overall Study|Lost to Follow-up|12|||
144656418|NCT02750800|521594089|FG000|Overall Study|Investigator decision|53|||
144656419|NCT02750800|521594089|FG000|Overall Study|Patient request|12|||
144656420|NCT02750800|521594089|FG000|Overall Study|Other, not specified|3|||
144656421|NCT03456713|521594092|FG000|Overall Study|Lost to Follow-up|1|||
144656422|NCT03456713|521594093|FG001|Overall Study|Lost to Follow-up|0|||
144656423|NCT03456713|521594094|FG002|Overall Study|Lost to Follow-up|0|||
144656424|NCT03456713|521594095|FG003|Overall Study|Lost to Follow-up|0|||
144656425|NCT01202227|521594101|FG000|Overall Study|Adverse Event|16|||
144656426|NCT01202227|521594101|FG000|Overall Study|Withdrawal by Subject|2|||
144656427|NCT01202227|521594101|FG000|Overall Study|Lack of Efficacy|1|||
144656428|NCT00643487|521594102|FG000|Overall Study|Technical difficulty|3|||
144656429|NCT04402008|521594105|FG000|Overall Study|Adverse Event|0|||
144656430|NCT04402008|521594106|FG001|Overall Study|Adverse Event|0|||
144656431|NCT04402008|521594107|FG002|Overall Study|Adverse Event|0|||
144656432|NCT04402008|521594108|FG003|Overall Study|Adverse Event|1|||
144656433|NCT04402008|521594109|FG004|Overall Study|Adverse Event|0|||
144656434|NCT04402008|521594110|FG005|Overall Study|Adverse Event|0|||
144656435|NCT04402008|521594111|FG006|Overall Study|Adverse Event|0|||
144656436|NCT04402008|521594105|FG000|Overall Study|Disease Progression|3|||
144656437|NCT04402008|521594106|FG001|Overall Study|Disease Progression|2|||
144656438|NCT04402008|521594107|FG002|Overall Study|Disease Progression|3|||
144656439|NCT04402008|521594108|FG003|Overall Study|Disease Progression|3|||
144656440|NCT04402008|521594109|FG004|Overall Study|Disease Progression|4|||
144656441|NCT04402008|521594110|FG005|Overall Study|Disease Progression|3|||
144656442|NCT04402008|521594111|FG006|Overall Study|Disease Progression|10|||
144656443|NCT04402008|521594105|FG000|Overall Study|Withdrawal by Subject|0|||
144656444|NCT04402008|521594106|FG001|Overall Study|Withdrawal by Subject|1|||
144656445|NCT04402008|521594107|FG002|Overall Study|Withdrawal by Subject|0|||
144656446|NCT04402008|521594108|FG003|Overall Study|Withdrawal by Subject|0|||
144656447|NCT04402008|521594109|FG004|Overall Study|Withdrawal by Subject|1|||
144656448|NCT04402008|521594110|FG005|Overall Study|Withdrawal by Subject|0|||
144656449|NCT04402008|521594111|FG006|Overall Study|Withdrawal by Subject|0|||
144656450|NCT04402008|521594105|FG000|Overall Study|Sponsor Decision|0|||
144656451|NCT04402008|521594106|FG001|Overall Study|Sponsor Decision|0|||
144656452|NCT04402008|521594107|FG002|Overall Study|Sponsor Decision|0|||
144656453|NCT04402008|521594108|FG003|Overall Study|Sponsor Decision|0|||
144656454|NCT04402008|521594109|FG004|Overall Study|Sponsor Decision|0|||
144656455|NCT04402008|521594110|FG005|Overall Study|Sponsor Decision|0|||
144656456|NCT04402008|521594111|FG006|Overall Study|Sponsor Decision|3|||
144656457|NCT04402008|521594105|FG000|Overall Study|Death|0|||
144656458|NCT04402008|521594106|FG001|Overall Study|Death|0|||
144656459|NCT04402008|521594107|FG002|Overall Study|Death|0|||
144656460|NCT04402008|521594108|FG003|Overall Study|Death|0|||
144656461|NCT04402008|521594109|FG004|Overall Study|Death|1|||
144656462|NCT04402008|521594110|FG005|Overall Study|Death|0|||
144656463|NCT04402008|521594111|FG006|Overall Study|Death|2|||
144732535|NCT02495857|521877099|FG002|Overall Study|Withdrawal by Subject|10|||
144732536|NCT02495857|521877097|FG000|Overall Study|Physician Decision|0|||
144732537|NCT02495857|521877098|FG001|Overall Study|Physician Decision|1|||
144656464|NCT04402008|521594105|FG000|Overall Study|Other|0|||
144656465|NCT04402008|521594106|FG001|Overall Study|Other|0|||
144656466|NCT04402008|521594107|FG002|Overall Study|Other|0|||
144656467|NCT04402008|521594108|FG003|Overall Study|Other|0|||
144656468|NCT04402008|521594109|FG004|Overall Study|Other|0|||
144656469|NCT04402008|521594110|FG005|Overall Study|Other|0|||
144656470|NCT04402008|521594111|FG006|Overall Study|Other|5|||
144656471|NCT00069095|521594112|FG000|Primary Treatment Phase|Ongoing|0|||
144656472|NCT00069095|521594113|FG001|Primary Treatment Phase|Ongoing|0|||
144656473|NCT00069095|521594114|FG002|Primary Treatment Phase|Ongoing|5|||
144656474|NCT00069095|521594115|FG003|Primary Treatment Phase|Ongoing|7|||
144656475|NCT00069095|521594116|FG004|Primary Treatment Phase|Ongoing|7|||
144656476|NCT00069095|521594117|FG005|Primary Treatment Phase|Ongoing|4|||
144656477|NCT00069095|521594112|FG000|Primary Treatment Phase|Admin/Other|29|||
144656478|NCT00069095|521594113|FG001|Primary Treatment Phase|Admin/Other|38|||
144656479|NCT00069095|521594114|FG002|Primary Treatment Phase|Admin/Other|31|||
144656480|NCT00069095|521594115|FG003|Primary Treatment Phase|Admin/Other|45|||
144656481|NCT00069095|521594116|FG004|Primary Treatment Phase|Admin/Other|48|||
144656482|NCT00069095|521594117|FG005|Primary Treatment Phase|Admin/Other|42|||
144264401|NCT02782741|520169469|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
144264402|NCT02782741|520169470|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
144264403|NCT02782741|520169468|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
144264404|NCT02782741|520169469|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
144264405|NCT02782741|520169470|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
144264406|NCT02782741|520169468|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
144264407|NCT02782741|520169469|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
144264408|NCT02782741|520169470|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
144264409|NCT04157088|520169471|FG000|Overall Study|Study terminated by sponsor|23|||
144264410|NCT04157088|520169471|FG000|Overall Study|Withdrawal by Subject|4|||
144264411|NCT04157088|520169471|FG000|Overall Study|Lost to Follow-up|2|||
144264412|NCT04157088|520169471|FG000|Overall Study|Death|1|||
144264413|NCT02421419|520169472|FG000|Overall Study|Physician Decision|0|||
144264414|NCT02421419|520169473|FG001|Overall Study|Physician Decision|0|||
144264415|NCT02421419|520169474|FG002|Overall Study|Physician Decision|1|||
144264416|NCT01676701|520169476|FG000|Overall Study|Protocol Violation|1|||
144264417|NCT01676701|520169477|FG001|Overall Study|Protocol Violation|0|||
144264418|NCT01676701|520169476|FG000|Overall Study|Sponsor Decision|3|||
144656483|NCT00069095|521594112|FG000|Primary Treatment Phase|Adverse Event|99|||
144656484|NCT00069095|521594113|FG001|Primary Treatment Phase|Adverse Event|92|||
144656485|NCT00069095|521594114|FG002|Primary Treatment Phase|Adverse Event|71|||
144656486|NCT00069095|521594115|FG003|Primary Treatment Phase|Adverse Event|72|||
144656487|NCT00069095|521594116|FG004|Primary Treatment Phase|Adverse Event|109|||
144656488|NCT00069095|521594117|FG005|Primary Treatment Phase|Adverse Event|101|||
144656489|NCT00069095|521594112|FG000|Primary Treatment Phase|Death|14|||
144656490|NCT00069095|521594113|FG001|Primary Treatment Phase|Death|8|||
144656491|NCT00069095|521594114|FG002|Primary Treatment Phase|Death|2|||
144656492|NCT00069095|521594115|FG003|Primary Treatment Phase|Death|5|||
144656493|NCT00069095|521594116|FG004|Primary Treatment Phase|Death|8|||
144656494|NCT00069095|521594117|FG005|Primary Treatment Phase|Death|8|||
144656495|NCT00069095|521594112|FG000|Primary Treatment Phase|Failure to return|5|||
144656496|NCT00069095|521594113|FG001|Primary Treatment Phase|Failure to return|5|||
144656497|NCT00069095|521594114|FG002|Primary Treatment Phase|Failure to return|0|||
144656498|NCT00069095|521594115|FG003|Primary Treatment Phase|Failure to return|0|||
144656499|NCT00069095|521594116|FG004|Primary Treatment Phase|Failure to return|0|||
144656500|NCT00069095|521594117|FG005|Primary Treatment Phase|Failure to return|2|||
144656501|NCT00069095|521594112|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
144656502|NCT00069095|521594113|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
144656503|NCT00069095|521594114|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
144656504|NCT00069095|521594115|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
144656505|NCT00069095|521594116|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
144656506|NCT00069095|521594117|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
144656507|NCT00069095|521594112|FG000|Primary Treatment Phase|Refused treatment|15|||
144656508|NCT00069095|521594113|FG001|Primary Treatment Phase|Refused treatment|26|||
144656509|NCT00069095|521594114|FG002|Primary Treatment Phase|Refused treatment|17|||
144656510|NCT00069095|521594115|FG003|Primary Treatment Phase|Refused treatment|31|||
144656511|NCT00069095|521594116|FG004|Primary Treatment Phase|Refused treatment|24|||
144656512|NCT00069095|521594117|FG005|Primary Treatment Phase|Refused treatment|27|||
144656513|NCT00069095|521594112|FG000|Primary Treatment Phase|Withdrew|2|||
144656514|NCT00069095|521594113|FG001|Primary Treatment Phase|Withdrew|3|||
144656515|NCT00069095|521594114|FG002|Primary Treatment Phase|Withdrew|8|||
144656516|NCT00069095|521594115|FG003|Primary Treatment Phase|Withdrew|2|||
144656517|NCT00069095|521594116|FG004|Primary Treatment Phase|Withdrew|4|||
144656518|NCT00069095|521594117|FG005|Primary Treatment Phase|Withdrew|9|||
144656519|NCT00069095|521594112|FG000|Primary Treatment Phase|Other Violation|0|||
144656520|NCT00069095|521594113|FG001|Primary Treatment Phase|Other Violation|1|||
144656521|NCT00069095|521594114|FG002|Primary Treatment Phase|Other Violation|1|||
144264419|NCT01676701|520169477|FG001|Overall Study|Sponsor Decision|4|||
144264420|NCT02115607|520169478|FG000|Overall Study|Withdrawal by Subject|1|||
144264421|NCT00196105|520169482|FG000|Overall Study|Lost to Follow-up|4|||
144264422|NCT00196105|520169483|FG001|Overall Study|Lost to Follow-up|5|||
144264423|NCT00196105|520169484|FG002|Overall Study|Lost to Follow-up|7|||
144264424|NCT00549549|520169485|FG000|Overall Study|Adverse Event|5|||
144264425|NCT00549549|520169486|FG001|Overall Study|Adverse Event|3|||
144264426|NCT00549549|520169487|FG002|Overall Study|Adverse Event|1|||
144264427|NCT00549549|520169488|FG003|Overall Study|Adverse Event|9|||
144264428|NCT00549549|520169485|FG000|Overall Study|Lack of Efficacy|9|||
144264429|NCT00549549|520169486|FG001|Overall Study|Lack of Efficacy|6|||
144656522|NCT00069095|521594115|FG003|Primary Treatment Phase|Other Violation|1|||
144656523|NCT00069095|521594116|FG004|Primary Treatment Phase|Other Violation|0|||
144656524|NCT00069095|521594117|FG005|Primary Treatment Phase|Other Violation|1|||
144656525|NCT00069095|521594112|FG000|Primary Treatment Phase|Violation criteria|0|||
144656526|NCT00069095|521594113|FG001|Primary Treatment Phase|Violation criteria|2|||
144656527|NCT00069095|521594114|FG002|Primary Treatment Phase|Violation criteria|4|||
144264430|NCT00549549|520169487|FG002|Overall Study|Lack of Efficacy|4|||
144656528|NCT00069095|521594115|FG003|Primary Treatment Phase|Violation criteria|3|||
144656529|NCT00069095|521594116|FG004|Primary Treatment Phase|Violation criteria|1|||
144656530|NCT00069095|521594117|FG005|Primary Treatment Phase|Violation criteria|5|||
144656531|NCT00069095|521594112|FG000|Post-study Treatment Phase|Missing reason|1|||
144656532|NCT00069095|521594113|FG001|Post-study Treatment Phase|Missing reason|3|||
144656533|NCT00069095|521594114|FG002|Post-study Treatment Phase|Missing reason|12|||
144656534|NCT00069095|521594115|FG003|Post-study Treatment Phase|Missing reason|8|||
144656535|NCT00069095|521594116|FG004|Post-study Treatment Phase|Missing reason|18|||
144656536|NCT00069095|521594117|FG005|Post-study Treatment Phase|Missing reason|17|||
144656537|NCT00069095|521594112|FG000|Post-study Treatment Phase|Adverse Event|2|||
144656538|NCT00069095|521594113|FG001|Post-study Treatment Phase|Adverse Event|3|||
144656539|NCT00069095|521594114|FG002|Post-study Treatment Phase|Adverse Event|1|||
144656540|NCT00069095|521594115|FG003|Post-study Treatment Phase|Adverse Event|0|||
144656541|NCT00069095|521594116|FG004|Post-study Treatment Phase|Adverse Event|5|||
144656542|NCT00069095|521594117|FG005|Post-study Treatment Phase|Adverse Event|1|||
144656543|NCT00069095|521594112|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
144656544|NCT00069095|521594113|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
144656545|NCT00069095|521594114|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
144656546|NCT00069095|521594115|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
144656547|NCT00069095|521594116|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
144656548|NCT00069095|521594117|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
144656549|NCT00069095|521594112|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
144656550|NCT00069095|521594113|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
144656551|NCT00069095|521594114|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
144656552|NCT00069095|521594115|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
144656553|NCT00069095|521594116|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
144656554|NCT00069095|521594117|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
144656555|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
144656556|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
144656557|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
144656558|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
144656559|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
144656560|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
144656561|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant had complete response|1|||
144656562|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant had complete response|1|||
144656563|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant had complete response|0|||
144656564|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant had complete response|0|||
144656565|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant had complete response|0|||
144656566|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant had complete response|0|||
144656567|NCT00069095|521594112|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
144656568|NCT00069095|521594113|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
144656569|NCT00069095|521594114|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
144656570|NCT00069095|521594115|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
144656571|NCT00069095|521594116|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
144656572|NCT00069095|521594117|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
144656573|NCT00069095|521594112|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
144656574|NCT00069095|521594113|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
144656575|NCT00069095|521594114|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
144656576|NCT00069095|521594115|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
144656577|NCT00069095|521594116|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
144656578|NCT00069095|521594117|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
144656579|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
144656580|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
144656581|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
144656582|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
144656583|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
144656584|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
144656585|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
144656586|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
144656587|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
144656588|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
144656589|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
144656590|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
144656591|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
144656592|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
144656593|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
144656594|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
144656595|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
144656596|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
144656597|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
144656598|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
144656599|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
144656600|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
144656601|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
144656602|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
144656603|NCT00069095|521594112|FG000|Post-study Treatment Phase|Surgery|0|||
144656604|NCT00069095|521594113|FG001|Post-study Treatment Phase|Surgery|0|||
144656605|NCT00069095|521594114|FG002|Post-study Treatment Phase|Surgery|0|||
144656606|NCT00069095|521594115|FG003|Post-study Treatment Phase|Surgery|1|||
144656607|NCT00069095|521594116|FG004|Post-study Treatment Phase|Surgery|1|||
144656608|NCT00069095|521594117|FG005|Post-study Treatment Phase|Surgery|0|||
144656609|NCT00069095|521594112|FG000|Post-study Treatment Phase|Death|0|||
144656610|NCT00069095|521594113|FG001|Post-study Treatment Phase|Death|0|||
144656611|NCT00069095|521594114|FG002|Post-study Treatment Phase|Death|0|||
144656612|NCT00069095|521594115|FG003|Post-study Treatment Phase|Death|0|||
144656613|NCT00069095|521594116|FG004|Post-study Treatment Phase|Death|1|||
144656614|NCT00069095|521594117|FG005|Post-study Treatment Phase|Death|0|||
144656615|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
144656616|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
144656617|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
144656618|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
144656619|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
144656620|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
144656621|NCT00069095|521594112|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
144656622|NCT00069095|521594113|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
144656623|NCT00069095|521594114|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
144656624|NCT00069095|521594115|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
144656625|NCT00069095|521594116|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
144656626|NCT00069095|521594117|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
144656627|NCT00069095|521594112|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
144656628|NCT00069095|521594113|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
144656629|NCT00069095|521594114|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
144656630|NCT00069095|521594115|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
144656631|NCT00069095|521594116|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
144656632|NCT00069095|521594117|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
144656633|NCT00069095|521594112|FG000|Post-study Treatment Phase|Investigator decision|0|||
144656634|NCT00069095|521594113|FG001|Post-study Treatment Phase|Investigator decision|0|||
144656635|NCT00069095|521594114|FG002|Post-study Treatment Phase|Investigator decision|0|||
144656636|NCT00069095|521594115|FG003|Post-study Treatment Phase|Investigator decision|0|||
144656637|NCT00069095|521594116|FG004|Post-study Treatment Phase|Investigator decision|0|||
144656638|NCT00069095|521594117|FG005|Post-study Treatment Phase|Investigator decision|1|||
144656639|NCT00069095|521594112|FG000|Follow-up Phase|Death|174|||
144656640|NCT00069095|521594113|FG001|Follow-up Phase|Death|206|||
144656641|NCT00069095|521594114|FG002|Follow-up Phase|Death|120|||
144656642|NCT00069095|521594115|FG003|Follow-up Phase|Death|112|||
144656643|NCT00069095|521594116|FG004|Follow-up Phase|Death|92|||
144656644|NCT00069095|521594117|FG005|Follow-up Phase|Death|101|||
144656645|NCT04716933|521594121|FG000|Overall Study|Sponsor Decision|36|||
144656646|NCT04716933|521594122|FG001|Overall Study|Sponsor Decision|33|||
144656647|NCT04716933|521594121|FG000|Overall Study|Death|65|||
144214116|NCT00306995|519976997|FG004|Study Part I|Withdrawal by Subject|0|||
144214117|NCT00306995|519976998|FG005|Study Part I|Withdrawal by Subject|0|||
144214118|NCT00306995|519976999|FG006|Study Part I|Withdrawal by Subject|1|||
144214119|NCT00306995|519976993|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
144214120|NCT00306995|519976994|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
144214121|NCT00306995|519976995|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
144656648|NCT04716933|521594122|FG001|Overall Study|Death|67|||
144656649|NCT03249792|521594127|FG000|Arms 1, 2, and 4|Death|1|||
144656650|NCT03249792|521594128|FG001|Arms 1, 2, and 4|Death|1|||
144656651|NCT03249792|521594129|FG002|Arms 1, 2, and 4|Death|0|||
144656652|NCT03249792|521594130|FG003|Arms 1, 2, and 4|Death|2|||
144656653|NCT03249792|521594131|FG004|Arms 1, 2, and 4|Death|3|||
144656654|NCT03249792|521594132|FG005|Arms 1, 2, and 4|Death|2|||
144656655|NCT03249792|521594133|FG006|Arms 1, 2, and 4|Death|2|||
144656656|NCT03249792|521594134|FG007|Arms 1, 2, and 4|Death|4|||
144656657|NCT03249792|521594135|FG008|Arms 1, 2, and 4|Death|2|||
144656658|NCT03249792|521594136|FG009|Arms 1, 2, and 4|Death|1|||
144656659|NCT03249792|521594137|FG010|Arms 1, 2, and 4|Death|7|||
144656660|NCT03249792|521594138|FG011|Arms 1, 2, and 4|Death|7|||
144656661|NCT03249792|521594139|FG012|Arms 1, 2, and 4|Death|12|||
144656662|NCT03249792|521594140|FG013|Arms 1, 2, and 4|Death|7|||
144656663|NCT03249792|521594141|FG014|Arms 1, 2, and 4|Death|0|||
144656664|NCT03249792|521594142|FG015|Arms 1, 2, and 4|Death|4|||
144656665|NCT03249792|521594143|FG016|Arms 1, 2, and 4|Death|4|||
144656666|NCT03249792|521594144|FG017|Arms 1, 2, and 4|Death|12|||
144656667|NCT03249792|521594145|FG018|Arms 1, 2, and 4|Death|6|||
144656668|NCT03249792|521594146|FG019|Arms 1, 2, and 4|Death|4|||
144656669|NCT03249792|521594147|FG020|Arms 1, 2, and 4|Death|2|||
144656670|NCT03249792|521594148|FG021|Arms 1, 2, and 4|Death|3|||
144656671|NCT03249792|521594149|FG022|Arms 1, 2, and 4|Death|1|||
144656672|NCT03249792|521594150|FG023|Arms 1, 2, and 4|Death|1|||
144656673|NCT03249792|521594151|FG024|Arms 1, 2, and 4|Death|4|||
144656674|NCT03249792|521594152|FG025|Arms 1, 2, and 4|Death|0|||
144656675|NCT03249792|521594153|FG026|Arms 1, 2, and 4|Death|0|||
144656676|NCT03249792|521594154|FG027|Arms 1, 2, and 4|Death|0|||
144656677|NCT03249792|521594155|FG028|Arms 1, 2, and 4|Death|0|||
144656678|NCT03249792|521594156|FG029|Arms 1, 2, and 4|Death|0|||
144656679|NCT03249792|521594157|FG030|Arms 1, 2, and 4|Death|0|||
144656680|NCT03249792|521594158|FG031|Arms 1, 2, and 4|Death|0|||
144656681|NCT03249792|521594159|FG032|Arms 1, 2, and 4|Death|0|||
144656682|NCT03249792|521594127|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656683|NCT03249792|521594128|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656684|NCT03249792|521594129|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
144656685|NCT03249792|521594130|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656686|NCT03249792|521594131|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656687|NCT03249792|521594132|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
144656688|NCT03249792|521594133|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
144656689|NCT03249792|521594134|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656690|NCT03249792|521594135|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
144656691|NCT03249792|521594136|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
144656692|NCT03249792|521594137|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
144656693|NCT03249792|521594138|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
144656694|NCT03249792|521594139|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
144656695|NCT03249792|521594140|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
144656696|NCT03249792|521594141|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656697|NCT03249792|521594142|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656698|NCT03249792|521594143|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
144656699|NCT03249792|521594144|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656700|NCT03249792|521594145|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
144656701|NCT03249792|521594146|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656702|NCT03249792|521594147|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656703|NCT03249792|521594148|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656704|NCT03249792|521594149|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
144656705|NCT03249792|521594150|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
144656706|NCT03249792|521594151|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656707|NCT03249792|521594152|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656708|NCT03249792|521594153|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656709|NCT03249792|521594154|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656710|NCT03249792|521594155|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656711|NCT03249792|521594156|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656712|NCT03249792|521594157|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656713|NCT03249792|521594158|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656714|NCT03249792|521594159|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
144656715|NCT03249792|521594127|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
144656716|NCT03249792|521594128|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
144656717|NCT03249792|521594129|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
144656718|NCT03249792|521594130|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
144656719|NCT03249792|521594131|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
144656720|NCT03249792|521594132|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
144656721|NCT03249792|521594133|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
144656722|NCT03249792|521594134|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
144656723|NCT03249792|521594135|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
144656724|NCT03249792|521594136|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
144656725|NCT03249792|521594137|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
144656726|NCT03249792|521594138|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
144656727|NCT03249792|521594139|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
144656728|NCT03249792|521594140|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
144656729|NCT03249792|521594141|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
144656730|NCT03249792|521594142|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
144656731|NCT03249792|521594143|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
144656732|NCT03249792|521594144|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
144656733|NCT03249792|521594145|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
144656734|NCT03249792|521594146|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
144656735|NCT03249792|521594147|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
144656736|NCT03249792|521594148|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
144656737|NCT03249792|521594149|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
144732538|NCT02495857|521877099|FG002|Overall Study|Physician Decision|0|||
144656738|NCT03249792|521594150|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
144656739|NCT03249792|521594151|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
144656740|NCT03249792|521594152|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
144656741|NCT03249792|521594153|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
144656742|NCT03249792|521594154|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
144656743|NCT03249792|521594155|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
144656744|NCT03249792|521594156|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
144656745|NCT03249792|521594157|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
144656746|NCT03249792|521594158|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
144656747|NCT03249792|521594159|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
144656748|NCT03249792|521594127|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656749|NCT03249792|521594128|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656750|NCT03249792|521594129|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656751|NCT03249792|521594130|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656752|NCT03249792|521594131|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656753|NCT03249792|521594132|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656754|NCT03249792|521594133|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656755|NCT03249792|521594134|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656756|NCT03249792|521594135|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
144656757|NCT03249792|521594136|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656758|NCT03249792|521594137|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656759|NCT03249792|521594138|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656760|NCT03249792|521594139|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656761|NCT03249792|521594140|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656762|NCT03249792|521594141|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656763|NCT03249792|521594142|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656764|NCT03249792|521594143|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
144656765|NCT03249792|521594144|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
144656766|NCT03249792|521594145|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656767|NCT03249792|521594146|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
144656768|NCT03249792|521594147|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656769|NCT03249792|521594148|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656770|NCT03249792|521594149|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656771|NCT03249792|521594150|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656772|NCT03249792|521594151|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656773|NCT03249792|521594152|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656774|NCT03249792|521594153|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656775|NCT03249792|521594154|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
144586910|NCT00371683|521346953|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
144586911|NCT00371683|521346954|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
144586912|NCT00371683|521346953|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
144586913|NCT00371683|521346954|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
144586914|NCT03181789|521346955|FG000|Overall Study|Withdrawal by Subject|0|||
144586915|NCT03181789|521346956|FG001|Overall Study|Withdrawal by Subject|1|||
144586916|NCT03181789|521346957|FG002|Overall Study|Withdrawal by Subject|1|||
144586917|NCT03181789|521346958|FG003|Overall Study|Withdrawal by Subject|0|||
144656776|NCT03249792|521594155|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656777|NCT03249792|521594156|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656778|NCT03249792|521594157|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656779|NCT03249792|521594158|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656780|NCT03249792|521594159|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
144656781|NCT03249792|521594127|FG000|Switch Over Period|Withdrawal by Subject|0|||
144656782|NCT03249792|521594128|FG001|Switch Over Period|Withdrawal by Subject|0|||
144656783|NCT03249792|521594129|FG002|Switch Over Period|Withdrawal by Subject|0|||
144656784|NCT03249792|521594130|FG003|Switch Over Period|Withdrawal by Subject|0|||
144656785|NCT03249792|521594131|FG004|Switch Over Period|Withdrawal by Subject|0|||
144656786|NCT03249792|521594132|FG005|Switch Over Period|Withdrawal by Subject|0|||
144656787|NCT03249792|521594133|FG006|Switch Over Period|Withdrawal by Subject|0|||
144656788|NCT03249792|521594134|FG007|Switch Over Period|Withdrawal by Subject|0|||
144656789|NCT03249792|521594135|FG008|Switch Over Period|Withdrawal by Subject|0|||
144656790|NCT03249792|521594136|FG009|Switch Over Period|Withdrawal by Subject|0|||
144656791|NCT03249792|521594137|FG010|Switch Over Period|Withdrawal by Subject|0|||
144656792|NCT03249792|521594138|FG011|Switch Over Period|Withdrawal by Subject|0|||
144732539|NCT02495857|521877097|FG000|Overall Study|Protocol Violation|1|||
144656793|NCT03249792|521594139|FG012|Switch Over Period|Withdrawal by Subject|0|||
144656794|NCT03249792|521594140|FG013|Switch Over Period|Withdrawal by Subject|0|||
144656795|NCT03249792|521594141|FG014|Switch Over Period|Withdrawal by Subject|0|||
144656796|NCT03249792|521594142|FG015|Switch Over Period|Withdrawal by Subject|0|||
144656797|NCT03249792|521594143|FG016|Switch Over Period|Withdrawal by Subject|0|||
144656798|NCT03249792|521594144|FG017|Switch Over Period|Withdrawal by Subject|0|||
144656799|NCT03249792|521594145|FG018|Switch Over Period|Withdrawal by Subject|0|||
144656800|NCT03249792|521594146|FG019|Switch Over Period|Withdrawal by Subject|0|||
144732540|NCT02495857|521877098|FG001|Overall Study|Protocol Violation|1|||
144732541|NCT02495857|521877099|FG002|Overall Study|Protocol Violation|2|||
144732542|NCT02495857|521877097|FG000|Overall Study|Lost to Follow-up|4|||
144656801|NCT03249792|521594147|FG020|Switch Over Period|Withdrawal by Subject|0|||
144656802|NCT03249792|521594148|FG021|Switch Over Period|Withdrawal by Subject|0|||
144656803|NCT03249792|521594149|FG022|Switch Over Period|Withdrawal by Subject|0|||
144656804|NCT03249792|521594150|FG023|Switch Over Period|Withdrawal by Subject|0|||
144656805|NCT03249792|521594151|FG024|Switch Over Period|Withdrawal by Subject|0|||
144656806|NCT03249792|521594152|FG025|Switch Over Period|Withdrawal by Subject|0|||
144656807|NCT03249792|521594153|FG026|Switch Over Period|Withdrawal by Subject|0|||
144656808|NCT03249792|521594154|FG027|Switch Over Period|Withdrawal by Subject|0|||
144656809|NCT03249792|521594155|FG028|Switch Over Period|Withdrawal by Subject|0|||
144656810|NCT03249792|521594156|FG029|Switch Over Period|Withdrawal by Subject|0|||
144656811|NCT03249792|521594157|FG030|Switch Over Period|Withdrawal by Subject|0|||
144656812|NCT03249792|521594158|FG031|Switch Over Period|Withdrawal by Subject|1|||
144656813|NCT03249792|521594159|FG032|Switch Over Period|Withdrawal by Subject|0|||
144656814|NCT03249792|521594127|FG000|Switch Over Period|Progressive Disease|0|||
144656815|NCT03249792|521594128|FG001|Switch Over Period|Progressive Disease|0|||
144656816|NCT03249792|521594129|FG002|Switch Over Period|Progressive Disease|0|||
144656817|NCT03249792|521594130|FG003|Switch Over Period|Progressive Disease|0|||
144656818|NCT03249792|521594131|FG004|Switch Over Period|Progressive Disease|0|||
144656819|NCT03249792|521594132|FG005|Switch Over Period|Progressive Disease|0|||
144656820|NCT03249792|521594133|FG006|Switch Over Period|Progressive Disease|0|||
144656821|NCT03249792|521594134|FG007|Switch Over Period|Progressive Disease|0|||
144656822|NCT03249792|521594135|FG008|Switch Over Period|Progressive Disease|0|||
144656823|NCT03249792|521594136|FG009|Switch Over Period|Progressive Disease|0|||
144656824|NCT03249792|521594137|FG010|Switch Over Period|Progressive Disease|0|||
144656825|NCT03249792|521594138|FG011|Switch Over Period|Progressive Disease|0|||
144656826|NCT03249792|521594139|FG012|Switch Over Period|Progressive Disease|0|||
144656827|NCT03249792|521594140|FG013|Switch Over Period|Progressive Disease|0|||
144656828|NCT03249792|521594141|FG014|Switch Over Period|Progressive Disease|0|||
144656829|NCT03249792|521594142|FG015|Switch Over Period|Progressive Disease|0|||
144656830|NCT03249792|521594143|FG016|Switch Over Period|Progressive Disease|0|||
144656831|NCT03249792|521594144|FG017|Switch Over Period|Progressive Disease|0|||
144656832|NCT03249792|521594145|FG018|Switch Over Period|Progressive Disease|0|||
144656833|NCT03249792|521594146|FG019|Switch Over Period|Progressive Disease|0|||
144656834|NCT03249792|521594147|FG020|Switch Over Period|Progressive Disease|0|||
144656835|NCT03249792|521594148|FG021|Switch Over Period|Progressive Disease|0|||
144656836|NCT03249792|521594149|FG022|Switch Over Period|Progressive Disease|0|||
144656837|NCT03249792|521594150|FG023|Switch Over Period|Progressive Disease|0|||
144656838|NCT03249792|521594151|FG024|Switch Over Period|Progressive Disease|0|||
144656839|NCT03249792|521594152|FG025|Switch Over Period|Progressive Disease|0|||
144656840|NCT03249792|521594153|FG026|Switch Over Period|Progressive Disease|1|||
144656841|NCT03249792|521594154|FG027|Switch Over Period|Progressive Disease|0|||
144656842|NCT03249792|521594155|FG028|Switch Over Period|Progressive Disease|1|||
144656843|NCT03249792|521594156|FG029|Switch Over Period|Progressive Disease|2|||
144656844|NCT03249792|521594157|FG030|Switch Over Period|Progressive Disease|1|||
144656845|NCT03249792|521594158|FG031|Switch Over Period|Progressive Disease|0|||
144656846|NCT03249792|521594159|FG032|Switch Over Period|Progressive Disease|1|||
144656847|NCT03249792|521594127|FG000|Switch Over Period|Adverse Event|0|||
144656848|NCT03249792|521594128|FG001|Switch Over Period|Adverse Event|0|||
144656849|NCT03249792|521594129|FG002|Switch Over Period|Adverse Event|0|||
144656850|NCT03249792|521594130|FG003|Switch Over Period|Adverse Event|0|||
144656851|NCT03249792|521594131|FG004|Switch Over Period|Adverse Event|0|||
144732543|NCT02495857|521877098|FG001|Overall Study|Lost to Follow-up|5|||
144732544|NCT02495857|521877099|FG002|Overall Study|Lost to Follow-up|3|||
144732545|NCT02495857|521877097|FG000|Overall Study|Other|3|||
144732546|NCT02495857|521877098|FG001|Overall Study|Other|3|||
144732547|NCT02495857|521877099|FG002|Overall Study|Other|2|||
144732548|NCT02883452|521877101|FG000|Overall Study|Withdrawal by Subject|1|||
144732549|NCT02883452|521877102|FG001|Overall Study|Withdrawal by Subject|1|||
144656852|NCT03249792|521594132|FG005|Switch Over Period|Adverse Event|0|||
144656853|NCT03249792|521594133|FG006|Switch Over Period|Adverse Event|0|||
144656854|NCT03249792|521594134|FG007|Switch Over Period|Adverse Event|0|||
144656855|NCT03249792|521594135|FG008|Switch Over Period|Adverse Event|0|||
144656856|NCT03249792|521594136|FG009|Switch Over Period|Adverse Event|0|||
144656857|NCT03249792|521594137|FG010|Switch Over Period|Adverse Event|0|||
144656858|NCT03249792|521594138|FG011|Switch Over Period|Adverse Event|0|||
144656859|NCT03249792|521594139|FG012|Switch Over Period|Adverse Event|0|||
144656860|NCT03249792|521594140|FG013|Switch Over Period|Adverse Event|0|||
144656861|NCT03249792|521594141|FG014|Switch Over Period|Adverse Event|0|||
144656862|NCT03249792|521594142|FG015|Switch Over Period|Adverse Event|0|||
144656863|NCT03249792|521594143|FG016|Switch Over Period|Adverse Event|0|||
144656864|NCT03249792|521594144|FG017|Switch Over Period|Adverse Event|0|||
144732550|NCT02883452|521877103|FG002|Overall Study|Withdrawal by Subject|3|||
144656865|NCT03249792|521594145|FG018|Switch Over Period|Adverse Event|0|||
144656866|NCT03249792|521594146|FG019|Switch Over Period|Adverse Event|0|||
144732551|NCT02883452|521877104|FG003|Overall Study|Withdrawal by Subject|0|||
144732552|NCT02883452|521877105|FG004|Overall Study|Withdrawal by Subject|2|||
144656867|NCT03249792|521594147|FG020|Switch Over Period|Adverse Event|0|||
144656868|NCT03249792|521594148|FG021|Switch Over Period|Adverse Event|0|||
144656869|NCT03249792|521594149|FG022|Switch Over Period|Adverse Event|0|||
144656870|NCT03249792|521594150|FG023|Switch Over Period|Adverse Event|0|||
144656871|NCT03249792|521594151|FG024|Switch Over Period|Adverse Event|0|||
144656872|NCT03249792|521594152|FG025|Switch Over Period|Adverse Event|1|||
144656873|NCT03249792|521594153|FG026|Switch Over Period|Adverse Event|0|||
144656874|NCT03249792|521594154|FG027|Switch Over Period|Adverse Event|1|||
144656875|NCT03249792|521594155|FG028|Switch Over Period|Adverse Event|0|||
144656876|NCT03249792|521594156|FG029|Switch Over Period|Adverse Event|0|||
144656877|NCT03249792|521594157|FG030|Switch Over Period|Adverse Event|0|||
144656878|NCT03249792|521594158|FG031|Switch Over Period|Adverse Event|0|||
144656879|NCT03249792|521594159|FG032|Switch Over Period|Adverse Event|0|||
144656880|NCT01087528|521594164|FG000|Overall Study|Withdrawal by Subject|1|||
144656881|NCT01087528|521594164|FG000|Overall Study|Incomplete CE procedure|6|||
144656882|NCT04937816|521594168|FG000|Overall Study|Study drug stopped, reason missing|5|||
144656883|NCT04937816|521594169|FG001|Overall Study|Study drug stopped, reason missing|3|||
144656884|NCT04937816|521594170|FG002|Overall Study|Study drug stopped, reason missing|4|||
144656885|NCT04937816|521594171|FG003|Overall Study|Study drug stopped, reason missing|6|||
144656886|NCT04937816|521594172|FG004|Overall Study|Study drug stopped, reason missing|1|||
144656887|NCT04937816|521594173|FG005|Overall Study|Study drug stopped, reason missing|0|||
144656888|NCT04937816|521594174|FG006|Overall Study|Study drug stopped, reason missing|0|||
144656889|NCT04937816|521594168|FG000|Overall Study|Other than stated below|173|||
144656890|NCT04937816|521594169|FG001|Overall Study|Other than stated below|143|||
144656891|NCT04937816|521594170|FG002|Overall Study|Other than stated below|125|||
144656892|NCT04937816|521594171|FG003|Overall Study|Other than stated below|44|||
144656893|NCT04937816|521594172|FG004|Overall Study|Other than stated below|45|||
144656894|NCT04937816|521594173|FG005|Overall Study|Other than stated below|28|||
144656895|NCT04937816|521594174|FG006|Overall Study|Other than stated below|31|||
144656896|NCT04937816|521594168|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
144656897|NCT04937816|521594169|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
144656898|NCT04937816|521594170|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
144656899|NCT04937816|521594171|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
144656900|NCT04937816|521594172|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
144656901|NCT04937816|521594173|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
144656902|NCT04937816|521594174|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
144656903|NCT04937816|521594168|FG000|Overall Study|Lost to Follow-up|15|||
144656904|NCT04937816|521594169|FG001|Overall Study|Lost to Follow-up|9|||
144656905|NCT04937816|521594170|FG002|Overall Study|Lost to Follow-up|6|||
144656906|NCT04937816|521594171|FG003|Overall Study|Lost to Follow-up|6|||
144656907|NCT04937816|521594172|FG004|Overall Study|Lost to Follow-up|16|||
144656908|NCT04937816|521594173|FG005|Overall Study|Lost to Follow-up|11|||
144656909|NCT04937816|521594174|FG006|Overall Study|Lost to Follow-up|17|||
144656910|NCT04937816|521594168|FG000|Overall Study|Protocol Violation|15|||
144656911|NCT04937816|521594169|FG001|Overall Study|Protocol Violation|15|||
144656912|NCT04937816|521594170|FG002|Overall Study|Protocol Violation|12|||
144656913|NCT04937816|521594171|FG003|Overall Study|Protocol Violation|30|||
144656914|NCT04937816|521594172|FG004|Overall Study|Protocol Violation|24|||
144656915|NCT04937816|521594173|FG005|Overall Study|Protocol Violation|5|||
144656916|NCT04937816|521594174|FG006|Overall Study|Protocol Violation|5|||
144656917|NCT04937816|521594168|FG000|Overall Study|Adverse Event|303|||
144656918|NCT04937816|521594169|FG001|Overall Study|Adverse Event|267|||
144656919|NCT04937816|521594170|FG002|Overall Study|Adverse Event|273|||
144656920|NCT04937816|521594171|FG003|Overall Study|Adverse Event|553|||
144656921|NCT04937816|521594172|FG004|Overall Study|Adverse Event|575|||
144656922|NCT04937816|521594173|FG005|Overall Study|Adverse Event|343|||
144656923|NCT04937816|521594174|FG006|Overall Study|Adverse Event|337|||
144656924|NCT04937816|521594168|FG000|Overall Study|Not treated|4|||
144656925|NCT04937816|521594169|FG001|Overall Study|Not treated|2|||
144656926|NCT04937816|521594170|FG002|Overall Study|Not treated|2|||
144656927|NCT04937816|521594171|FG003|Overall Study|Not treated|2|||
144656928|NCT04937816|521594172|FG004|Overall Study|Not treated|1|||
144214122|NCT00306995|519976996|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
144214123|NCT00306995|519976997|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
144656929|NCT04937816|521594173|FG005|Overall Study|Not treated|4|||
144656930|NCT04937816|521594174|FG006|Overall Study|Not treated|0|||
144656931|NCT05513053|521594175|FG000|Overall Study|Lost to Follow-up|9|||
144656932|NCT05513053|521594176|FG001|Overall Study|Lost to Follow-up|11|||
144656933|NCT05513053|521594175|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144656934|NCT05513053|521594176|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144656935|NCT05513053|521594175|FG000|Overall Study|Withdrawal by Subject|2|||
144656936|NCT05513053|521594176|FG001|Overall Study|Withdrawal by Subject|9|||
144656937|NCT05513053|521594175|FG000|Overall Study|Protocol Violation|6|||
144656938|NCT05513053|521594176|FG001|Overall Study|Protocol Violation|3|||
144656939|NCT05513053|521594175|FG000|Overall Study|Adverse Event|0|||
144656940|NCT05513053|521594176|FG001|Overall Study|Adverse Event|2|||
144656941|NCT01328249|521595436|FG000|Overall Study|Adverse Event|3|||
144656942|NCT01328249|521595437|FG001|Overall Study|Adverse Event|0|||
144214124|NCT00306995|519976998|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
144214125|NCT00306995|519976999|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
144656943|NCT01328249|521595436|FG000|Overall Study|Disease progression|1|||
144656944|NCT01328249|521595437|FG001|Overall Study|Disease progression|0|||
144656945|NCT01328249|521595436|FG000|Overall Study|Withdrawal by Subject|1|||
144656946|NCT01328249|521595437|FG001|Overall Study|Withdrawal by Subject|1|||
144656947|NCT01328249|521595436|FG000|Overall Study|Moved before end of treatment visit|1|||
144656948|NCT01328249|521595437|FG001|Overall Study|Moved before end of treatment visit|0|||
144656949|NCT01328249|521595436|FG000|Overall Study|Subject choice|1|||
144656950|NCT01328249|521595437|FG001|Overall Study|Subject choice|1|||
144656951|NCT01328249|521595436|FG000|Overall Study|Protocol Violation|0|||
144656952|NCT01328249|521595437|FG001|Overall Study|Protocol Violation|1|||
144656953|NCT02330549|521595438|FG000|Overall Study|Adverse Event|1|||
144656954|NCT02330549|521595439|FG001|Overall Study|Adverse Event|0|||
144656955|NCT02330549|521595438|FG000|Overall Study|Subject withdrew consent|2|||
144656956|NCT02330549|521595439|FG001|Overall Study|Subject withdrew consent|1|||
144656957|NCT02330549|521595438|FG000|Overall Study|Failure to meet randomization criteria|1|||
144656958|NCT02330549|521595439|FG001|Overall Study|Failure to meet randomization criteria|0|||
144656959|NCT03439748|521595442|FG000|Overall Study|Withdrawal by Subject|11|||
144656960|NCT03439748|521595443|FG001|Overall Study|Withdrawal by Subject|17|||
144656961|NCT03298412|521595444|FG000|Run-in Period|Other, Not Specified|1|||
144656962|NCT03298412|521595444|FG000|Run-in Period|Disease Progression|1|||
144656963|NCT03298412|521595444|FG000|Run-in Period|Ineligibility Determined|1|||
144656964|NCT03298412|521595444|FG000|Run-in Period|Decision by Sponsor|6|||
144656965|NCT01894477|521595447|FG000|Overall Study|Protocol Violation|0|||
144656966|NCT01894477|521595448|FG001|Overall Study|Protocol Violation|1|||
144656967|NCT01894477|521595447|FG000|Overall Study|protocol changed due SC changed to cord|0|||
144656968|NCT01894477|521595448|FG001|Overall Study|protocol changed due SC changed to cord|1|||
144656969|NCT01028651|521595450|FG000|Overall Study|Death|2|||
144656970|NCT01028651|521595450|FG000|Overall Study|Adverse Event|1|||
144656971|NCT01533935|521595451|FG000|Overall Study|Adverse Event|5|||
144656972|NCT01533935|521595452|FG001|Overall Study|Adverse Event|7|||
144656973|NCT01533935|521595453|FG002|Overall Study|Adverse Event|1|||
144656974|NCT01533935|521595454|FG003|Overall Study|Adverse Event|5|||
144656975|NCT01533935|521595455|FG004|Overall Study|Adverse Event|3|||
144656976|NCT01533935|521595451|FG000|Overall Study|Protocol Violation|0|||
144656977|NCT01533935|521595452|FG001|Overall Study|Protocol Violation|2|||
144656978|NCT01533935|521595453|FG002|Overall Study|Protocol Violation|0|||
144656979|NCT01533935|521595454|FG003|Overall Study|Protocol Violation|0|||
144656980|NCT01533935|521595455|FG004|Overall Study|Protocol Violation|0|||
144656981|NCT01533935|521595451|FG000|Overall Study|Lost to Follow-up|0|||
144656982|NCT01533935|521595452|FG001|Overall Study|Lost to Follow-up|0|||
144656983|NCT01533935|521595453|FG002|Overall Study|Lost to Follow-up|1|||
144656984|NCT01533935|521595454|FG003|Overall Study|Lost to Follow-up|0|||
144656985|NCT01533935|521595455|FG004|Overall Study|Lost to Follow-up|0|||
144656986|NCT01533935|521595451|FG000|Overall Study|Withdrawal by Subject|0|||
144656987|NCT01533935|521595452|FG001|Overall Study|Withdrawal by Subject|4|||
144656988|NCT01533935|521595453|FG002|Overall Study|Withdrawal by Subject|5|||
144656989|NCT01533935|521595454|FG003|Overall Study|Withdrawal by Subject|2|||
144656990|NCT01533935|521595455|FG004|Overall Study|Withdrawal by Subject|4|||
144656991|NCT01533935|521595451|FG000|Overall Study|Other reason not defined above|1|||
144656992|NCT01533935|521595452|FG001|Overall Study|Other reason not defined above|0|||
144656993|NCT01533935|521595453|FG002|Overall Study|Other reason not defined above|1|||
144656994|NCT01533935|521595454|FG003|Overall Study|Other reason not defined above|0|||
144656995|NCT01533935|521595455|FG004|Overall Study|Other reason not defined above|1|||
144656996|NCT05631548|521595456|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
144656997|NCT05631548|521595457|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
144656998|NCT04075266|521595460|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
144656999|NCT04075266|521595461|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
144657000|NCT04075266|521595460|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
144657001|NCT04075266|521595461|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
144657002|NCT05132569|521595462|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
144657003|NCT05132569|521595463|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
144657004|NCT05132569|521595462|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
144657005|NCT05132569|521595463|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
144657006|NCT05132569|521595462|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
144657007|NCT05132569|521595463|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
144657008|NCT01554956|521595464|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
144657009|NCT01554956|521595465|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
144657010|NCT01554956|521595466|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
144657011|NCT01554956|521595464|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
144657012|NCT01554956|521595465|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
144657013|NCT01554956|521595466|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
144264431|NCT00549549|520169488|FG003|Overall Study|Lack of Efficacy|2|||
144264432|NCT00549549|520169485|FG000|Overall Study|Lost to Follow-up|1|||
144264433|NCT00549549|520169486|FG001|Overall Study|Lost to Follow-up|0|||
144264434|NCT00549549|520169487|FG002|Overall Study|Lost to Follow-up|1|||
144264435|NCT00549549|520169488|FG003|Overall Study|Lost to Follow-up|2|||
144264436|NCT00549549|520169485|FG000|Overall Study|Withdrawal by Subject|0|||
144264437|NCT00549549|520169486|FG001|Overall Study|Withdrawal by Subject|4|||
144264438|NCT00549549|520169487|FG002|Overall Study|Withdrawal by Subject|1|||
144264439|NCT00549549|520169488|FG003|Overall Study|Withdrawal by Subject|0|||
144264440|NCT00549549|520169485|FG000|Overall Study|Other|9|||
144264441|NCT00549549|520169486|FG001|Overall Study|Other|9|||
144264442|NCT00549549|520169487|FG002|Overall Study|Other|9|||
144264443|NCT00549549|520169488|FG003|Overall Study|Other|11|||
144264444|NCT00549549|520169485|FG000|Overall Study|Randomized but not treated|0|||
144264445|NCT00549549|520169486|FG001|Overall Study|Randomized but not treated|0|||
144264446|NCT00549549|520169487|FG002|Overall Study|Randomized but not treated|1|||
144264447|NCT00549549|520169488|FG003|Overall Study|Randomized but not treated|1|||
144264448|NCT04058028|520169492|FG000|Overall Study|Withdrawal of Consent from Study|12|||
144264449|NCT04058028|520169493|FG001|Overall Study|Withdrawal of Consent from Study|8|||
144264450|NCT04058028|520169494|FG002|Overall Study|Withdrawal of Consent from Study|6|||
144264451|NCT04058028|520169495|FG003|Overall Study|Withdrawal of Consent from Study|7|||
144264452|NCT04058028|520169492|FG000|Overall Study|Decision by Sponsor|13|||
144264453|NCT04058028|520169493|FG001|Overall Study|Decision by Sponsor|4|||
144264454|NCT04058028|520169494|FG002|Overall Study|Decision by Sponsor|1|||
144264455|NCT04058028|520169495|FG003|Overall Study|Decision by Sponsor|35|||
144264456|NCT04058028|520169492|FG000|Overall Study|Lost to Follow-up|1|||
144264457|NCT04058028|520169493|FG001|Overall Study|Lost to Follow-up|1|||
144264458|NCT04058028|520169494|FG002|Overall Study|Lost to Follow-up|1|||
144264459|NCT04058028|520169495|FG003|Overall Study|Lost to Follow-up|0|||
144264460|NCT04058028|520169492|FG000|Overall Study|Death|0|||
144264461|NCT04058028|520169493|FG001|Overall Study|Death|1|||
144264462|NCT04058028|520169494|FG002|Overall Study|Death|0|||
144264463|NCT04058028|520169495|FG003|Overall Study|Death|0|||
144264464|NCT02227784|520169496|FG000|Double-Blind Phase|Adverse Event|3|||
144264465|NCT02227784|520169497|FG001|Double-Blind Phase|Adverse Event|2|||
144264466|NCT02227784|520169498|FG002|Double-Blind Phase|Adverse Event|1|||
144264467|NCT02227784|520169499|FG003|Double-Blind Phase|Adverse Event|3|||
144264468|NCT02227784|520169500|FG004|Double-Blind Phase|Adverse Event|0|||
144264469|NCT02227784|520169496|FG000|Double-Blind Phase|Physician Decision|1|||
144264470|NCT02227784|520169497|FG001|Double-Blind Phase|Physician Decision|0|||
144657014|NCT01554956|521595464|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
144657015|NCT01554956|521595465|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
144657016|NCT01554956|521595466|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
144657017|NCT03656926|521595467|FG000|Overall Study|Adverse Event|5|||
144657018|NCT03656926|521595468|FG001|Overall Study|Adverse Event|4|||
144657019|NCT03656926|521595467|FG000|Overall Study|Withdrawal by Subject|7|||
144657020|NCT03656926|521595468|FG001|Overall Study|Withdrawal by Subject|2|||
144657021|NCT03656926|521595467|FG000|Overall Study|Screen fail after randomization|1|||
144657022|NCT03656926|521595468|FG001|Overall Study|Screen fail after randomization|0|||
144657023|NCT03656926|521595467|FG000|Overall Study|PI decision due to patient condition|1|||
144657024|NCT03656926|521595468|FG001|Overall Study|PI decision due to patient condition|0|||
144657025|NCT03656926|521595467|FG000|Overall Study|Patient unresponsiveness|1|||
144657026|NCT03656926|521595468|FG001|Overall Study|Patient unresponsiveness|0|||
144657027|NCT00913978|521595469|FG000|Overall Study|Surgeon choice|1|||
144657028|NCT00913978|521595470|FG001|Overall Study|Surgeon choice|3|||
144657029|NCT05610176|521595471|FG000|Overall Study|Death|6|||
144657030|NCT00210158|521595472|FG000|Overall Study|Protocol Violation|0|||
144657031|NCT00210158|521595473|FG001|Overall Study|Protocol Violation|2|||
144264471|NCT02227784|520169498|FG002|Double-Blind Phase|Physician Decision|0|||
144264472|NCT02227784|520169499|FG003|Double-Blind Phase|Physician Decision|1|||
144264473|NCT02227784|520169500|FG004|Double-Blind Phase|Physician Decision|0|||
144264474|NCT02227784|520169496|FG000|Double-Blind Phase|Protocol Violation|0|||
144264475|NCT02227784|520169497|FG001|Double-Blind Phase|Protocol Violation|0|||
144264476|NCT02227784|520169498|FG002|Double-Blind Phase|Protocol Violation|1|||
144264477|NCT02227784|520169499|FG003|Double-Blind Phase|Protocol Violation|1|||
144264478|NCT02227784|520169500|FG004|Double-Blind Phase|Protocol Violation|0|||
144657032|NCT01327651|521595474|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
144264479|NCT02227784|520169496|FG000|Double-Blind Phase|Sponsor Decision|34|||
144264480|NCT02227784|520169497|FG001|Double-Blind Phase|Sponsor Decision|15|||
144264481|NCT02227784|520169498|FG002|Double-Blind Phase|Sponsor Decision|14|||
144264482|NCT02227784|520169499|FG003|Double-Blind Phase|Sponsor Decision|32|||
144264483|NCT02227784|520169500|FG004|Double-Blind Phase|Sponsor Decision|0|||
144264484|NCT02227784|520169496|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
144264485|NCT02227784|520169497|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
144264486|NCT02227784|520169498|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
144657033|NCT01327651|521595475|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
144657034|NCT01327651|521595476|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
144657035|NCT01327651|521595477|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
144657036|NCT01327651|521595478|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
144657037|NCT01327651|521595479|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
144657038|NCT01327651|521595480|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
144657039|NCT01327651|521595481|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
144657040|NCT01327651|521595482|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
144732553|NCT02883452|521877106|FG005|Overall Study|Withdrawal by Subject|5|||
144732554|NCT02883452|521877101|FG000|Overall Study|Disease progression|1|||
144732555|NCT02883452|521877102|FG001|Overall Study|Disease progression|0|||
144732556|NCT02883452|521877103|FG002|Overall Study|Disease progression|0|||
144732557|NCT02883452|521877104|FG003|Overall Study|Disease progression|1|||
144732558|NCT02883452|521877105|FG004|Overall Study|Disease progression|4|||
144732559|NCT02883452|521877106|FG005|Overall Study|Disease progression|5|||
144732560|NCT02883452|521877101|FG000|Overall Study|Adverse Event|2|||
144732561|NCT02883452|521877102|FG001|Overall Study|Adverse Event|1|||
144732562|NCT02883452|521877103|FG002|Overall Study|Adverse Event|1|||
144732563|NCT02883452|521877104|FG003|Overall Study|Adverse Event|1|||
144732564|NCT02883452|521877105|FG004|Overall Study|Adverse Event|1|||
144732565|NCT02883452|521877106|FG005|Overall Study|Adverse Event|3|||
144732566|NCT02883452|521877101|FG000|Overall Study|Physician Decision|0|||
144732567|NCT02883452|521877102|FG001|Overall Study|Physician Decision|0|||
144732568|NCT02883452|521877103|FG002|Overall Study|Physician Decision|0|||
144732569|NCT02883452|521877104|FG003|Overall Study|Physician Decision|0|||
144732570|NCT02883452|521877105|FG004|Overall Study|Physician Decision|4|||
144732571|NCT02883452|521877106|FG005|Overall Study|Physician Decision|1|||
144732572|NCT02883452|521877101|FG000|Overall Study|Death|1|||
144732573|NCT02883452|521877102|FG001|Overall Study|Death|0|||
144732574|NCT02883452|521877103|FG002|Overall Study|Death|1|||
144732575|NCT02883452|521877104|FG003|Overall Study|Death|0|||
144732576|NCT02883452|521877105|FG004|Overall Study|Death|0|||
144732577|NCT02883452|521877106|FG005|Overall Study|Death|0|||
144732578|NCT02883452|521877101|FG000|Overall Study|Other|0|||
144732579|NCT02883452|521877102|FG001|Overall Study|Other|0|||
144732580|NCT02883452|521877103|FG002|Overall Study|Other|0|||
144732581|NCT02883452|521877104|FG003|Overall Study|Other|0|||
144732582|NCT02883452|521877105|FG004|Overall Study|Other|0|||
144732583|NCT02883452|521877106|FG005|Overall Study|Other|1|||
144732584|NCT00667095|521877116|FG000|Overall Study|Withdrawal by Subject|0|||
144732585|NCT00667095|521877117|FG001|Overall Study|Withdrawal by Subject|1|||
144732586|NCT01520909|521877118|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
144732587|NCT01520909|521877119|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
144732588|NCT01520909|521877120|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
144732589|NCT01520909|521877118|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
144732590|NCT01520909|521877119|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
144732591|NCT01520909|521877120|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
144732592|NCT01520909|521877118|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
144732593|NCT01520909|521877119|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
144732594|NCT01520909|521877120|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
144732595|NCT01520909|521877118|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
144732596|NCT01520909|521877119|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
144732597|NCT01520909|521877120|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
144732598|NCT00830206|521877123|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
144732599|NCT00830206|521877124|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
144732600|NCT00905346|521877131|FG000|Period 1|Withdrawal by Subject|1|||
144732601|NCT00905346|521877132|FG001|Period 1|Withdrawal by Subject|0|||
144732602|NCT01435265|521877133|FG000|Overall Study|Lost to Follow-up|0|||
144732603|NCT01435265|521877134|FG001|Overall Study|Lost to Follow-up|1|||
144732604|NCT03351335|521877135|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
144732605|NCT03351335|521877136|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
144732606|NCT03351335|521877137|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
144732607|NCT04605094|521877138|FG000|Overall Study|Adverse Event|2|||
144657041|NCT01327651|521595474|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
144657042|NCT01327651|521595475|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144732608|NCT04605094|521877139|FG001|Overall Study|Adverse Event|2|||
144657043|NCT01327651|521595476|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144732609|NCT04605094|521877138|FG000|Overall Study|Lost to Follow-up|1|||
144732610|NCT04605094|521877139|FG001|Overall Study|Lost to Follow-up|4|||
144732611|NCT04605094|521877138|FG000|Overall Study|Physician Decision|2|||
144732612|NCT04605094|521877139|FG001|Overall Study|Physician Decision|2|||
144732613|NCT04605094|521877138|FG000|Overall Study|Study terminated by Sponsor|31|||
144732614|NCT04605094|521877139|FG001|Overall Study|Study terminated by Sponsor|33|||
144732615|NCT04605094|521877138|FG000|Overall Study|Withdrawal by Subject|22|||
144732616|NCT04605094|521877139|FG001|Overall Study|Withdrawal by Subject|19|||
144732617|NCT04605094|521877138|FG000|Overall Study|Other|1|||
144657044|NCT01327651|521595477|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144732618|NCT04605094|521877139|FG001|Overall Study|Other|1|||
144732619|NCT01900691|521877140|FG000|Overall Study|Death|7|||
144732620|NCT01900691|521877140|FG000|Overall Study|Lost to Follow-up|4|||
144732621|NCT01900691|521877140|FG000|Overall Study|Study Device Not Placed|3|||
144732622|NCT01900691|521877140|FG000|Overall Study|Non study stent placed|2|||
144732623|NCT01900691|521877140|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
144732624|NCT01900691|521877140|FG000|Overall Study|Complete stent migration through digestive tract|1|||
144732625|NCT00469417|521877143|FG000|Overall Study|Treatment failure all lesions|18|||
144657045|NCT01327651|521595478|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144657046|NCT01327651|521595479|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144657047|NCT01327651|521595480|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144657048|NCT01327651|521595481|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144657049|NCT01327651|521595482|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
144657050|NCT01327651|521595474|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
144657051|NCT01327651|521595475|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
144657052|NCT01327651|521595476|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
144657053|NCT01327651|521595477|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
144657054|NCT01327651|521595478|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
144657055|NCT01327651|521595479|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
144657056|NCT01327651|521595480|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
144657057|NCT01327651|521595481|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
144657058|NCT01327651|521595482|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
144657059|NCT01327651|521595474|FG000|Post Study Follow-up|Lost to Follow-up|0|||
144732626|NCT00469417|521877144|FG001|Overall Study|Treatment failure all lesions|11|||
144732627|NCT00469417|521877143|FG000|Overall Study|Consent withdrawn|1|||
144732628|NCT00469417|521877144|FG001|Overall Study|Consent withdrawn|1|||
144732629|NCT00469417|521877143|FG000|Overall Study|Adverse Event|8|||
144732630|NCT00469417|521877144|FG001|Overall Study|Adverse Event|2|||
144732631|NCT00469417|521877143|FG000|Overall Study|Lost to Follow-up|1|||
144732632|NCT00469417|521877144|FG001|Overall Study|Lost to Follow-up|2|||
144732633|NCT00469417|521877143|FG000|Overall Study|Intercurrent disease|0|||
144214126|NCT01277601|519978616|FG000|Overall Study|Adverse Event|5|||
144214127|NCT01277601|519978617|FG001|Overall Study|Adverse Event|3|||
144214128|NCT01277601|519978618|FG002|Overall Study|Adverse Event|0|||
144214129|NCT01277601|519978619|FG003|Overall Study|Adverse Event|7|||
144214130|NCT01277601|519978616|FG000|Overall Study|Withdrawal by Subject|18|||
144214131|NCT01277601|519978617|FG001|Overall Study|Withdrawal by Subject|21|||
144214132|NCT01277601|519978618|FG002|Overall Study|Withdrawal by Subject|8|||
144214133|NCT01277601|519978619|FG003|Overall Study|Withdrawal by Subject|17|||
144214134|NCT01277601|519978616|FG000|Overall Study|Lost to Follow-up|7|||
144214135|NCT01277601|519978617|FG001|Overall Study|Lost to Follow-up|9|||
144214136|NCT01277601|519978618|FG002|Overall Study|Lost to Follow-up|4|||
144214137|NCT01277601|519978619|FG003|Overall Study|Lost to Follow-up|2|||
144214138|NCT01277601|519978616|FG000|Overall Study|Physician Decision|3|||
144214139|NCT01277601|519978617|FG001|Overall Study|Physician Decision|5|||
144214140|NCT01277601|519978618|FG002|Overall Study|Physician Decision|1|||
144214141|NCT01277601|519978619|FG003|Overall Study|Physician Decision|6|||
144214142|NCT01277601|519978616|FG000|Overall Study|Pregnancy|2|||
144214143|NCT01277601|519978617|FG001|Overall Study|Pregnancy|2|||
144214144|NCT01277601|519978618|FG002|Overall Study|Pregnancy|4|||
144214145|NCT01277601|519978619|FG003|Overall Study|Pregnancy|1|||
144214146|NCT01277601|519978616|FG000|Overall Study|Noncompliance with Study Drug|1|||
144214147|NCT01277601|519978617|FG001|Overall Study|Noncompliance with Study Drug|3|||
144214148|NCT01277601|519978618|FG002|Overall Study|Noncompliance with Study Drug|2|||
144214149|NCT01277601|519978619|FG003|Overall Study|Noncompliance with Study Drug|0|||
144214150|NCT01277601|519978616|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
144214151|NCT01277601|519978617|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
144214152|NCT01277601|519978618|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
144214153|NCT01277601|519978619|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
144214154|NCT01277601|519978616|FG000|Overall Study|Protocol Violation|0|||
144214155|NCT01277601|519978617|FG001|Overall Study|Protocol Violation|2|||
144214156|NCT01277601|519978618|FG002|Overall Study|Protocol Violation|5|||
144214157|NCT01277601|519978619|FG003|Overall Study|Protocol Violation|0|||
144214158|NCT01277601|519978616|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
144214159|NCT01277601|519978617|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
144214160|NCT01277601|519978618|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
144214161|NCT01277601|519978619|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
144214162|NCT03765788|519978621|FG000|Overall Study|Subject decision|2|||
144214163|NCT03765788|519978622|FG001|Overall Study|Subject decision|3|||
144214164|NCT03765788|519978621|FG000|Overall Study|Physician Decision|2|||
144214165|NCT03765788|519978622|FG001|Overall Study|Physician Decision|4|||
144214166|NCT03765788|519978621|FG000|Overall Study|Death|0|||
144214167|NCT03765788|519978622|FG001|Overall Study|Death|1|||
144214168|NCT03765788|519978621|FG000|Overall Study|Lost to Follow-up|1|||
144214169|NCT03765788|519978622|FG001|Overall Study|Lost to Follow-up|0|||
144214170|NCT01433055|519978623|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
144214171|NCT01433055|519978624|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
144214172|NCT01433055|519978623|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
144214173|NCT01433055|519978624|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
144214174|NCT01769456|519978625|FG000|Overall Study|Lost to Follow-up|19|||
144214175|NCT01769456|519978625|FG000|Overall Study|Withdrawal by Subject|3|||
144214176|NCT01769456|519978625|FG000|Overall Study|Did not receive PCC intervention|6|||
144214177|NCT01769456|519978625|FG000|Overall Study|Moved out of the area|3|||
144214178|NCT01769456|519978625|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
144214179|NCT01769456|519978625|FG000|Overall Study|Parental request to youth to withdraw|1|||
144214180|NCT05244122|519978634|FG000|Overall Study|Withdrawal by Subject|318|||
144214181|NCT01214655|519978635|FG000|Part A|Progressive Disease|7|||
144214182|NCT01214655|519978636|FG001|Part A|Progressive Disease|0|||
144214183|NCT01214655|519978637|FG002|Part A|Progressive Disease|0|||
144214184|NCT01214655|519978635|FG000|Part A|Physician Decision|1|||
144214185|NCT01214655|519978636|FG001|Part A|Physician Decision|0|||
144214186|NCT01214655|519978637|FG002|Part A|Physician Decision|0|||
144214187|NCT01214655|519978635|FG000|Part B|Progressive disease|0|||
144214188|NCT01214655|519978636|FG001|Part B|Progressive disease|10|||
144214189|NCT01214655|519978637|FG002|Part B|Progressive disease|0|||
144214190|NCT01214655|519978635|FG000|Part B|Death|0|||
144214191|NCT01214655|519978636|FG001|Part B|Death|1|||
144214192|NCT01214655|519978637|FG002|Part B|Death|0|||
144214193|NCT01214655|519978635|FG000|Part B|Withdrawal by Subject|0|||
144214194|NCT01214655|519978636|FG001|Part B|Withdrawal by Subject|2|||
144214195|NCT01214655|519978637|FG002|Part B|Withdrawal by Subject|0|||
144214196|NCT01214655|519978635|FG000|Part C|Progressive Disease|0|||
144214197|NCT01214655|519978636|FG001|Part C|Progressive Disease|0|||
144214198|NCT01214655|519978637|FG002|Part C|Progressive Disease|5|||
144214199|NCT01214655|519978635|FG000|Part C|Death|0|||
144214200|NCT01214655|519978636|FG001|Part C|Death|0|||
144214201|NCT01214655|519978637|FG002|Part C|Death|1|||
144214202|NCT01214655|519978635|FG000|Part C|Physician Decision|0|||
144214203|NCT01214655|519978636|FG001|Part C|Physician Decision|0|||
144214204|NCT01214655|519978637|FG002|Part C|Physician Decision|1|||
144214205|NCT01977417|519978645|FG000|Overall Study|Adverse Event|1|||
144214206|NCT01977417|519978646|FG001|Overall Study|Adverse Event|0|||
144214207|NCT01977417|519978645|FG000|Overall Study|Withdrawal by Subject|2|||
144214208|NCT01977417|519978646|FG001|Overall Study|Withdrawal by Subject|4|||
144214209|NCT01977417|519978645|FG000|Overall Study|Female enrollment goal met|0|||
144214210|NCT01977417|519978646|FG001|Overall Study|Female enrollment goal met|2|||
144214211|NCT01692626|519978647|FG000|Overall Study|Death|0|||
144214212|NCT01692626|519978648|FG001|Overall Study|Death|1|||
144214213|NCT01692626|519978647|FG000|Overall Study|Adverse Event|2|||
144214214|NCT01692626|519978648|FG001|Overall Study|Adverse Event|3|||
144214215|NCT01692626|519978647|FG000|Overall Study|Protocol Violation|1|||
144214216|NCT01692626|519978648|FG001|Overall Study|Protocol Violation|2|||
144214217|NCT01692626|519978647|FG000|Overall Study|Withdrawal by Subject|1|||
144214218|NCT01692626|519978648|FG001|Overall Study|Withdrawal by Subject|0|||
144214219|NCT02794870|519978656|FG000|Overall Study|Withdrawal by Subject|2|||
144214220|NCT02794870|519978657|FG001|Overall Study|Withdrawal by Subject|0|||
144214221|NCT02437903|519978658|FG000|Overall Study|Adverse Event|1|||
144214222|NCT02437903|519978658|FG000|Overall Study|Withdrawal by Subject|1|||
144586918|NCT03181789|521346955|FG000|Overall Study|Lost to Follow-up|7|||
144214223|NCT02437903|519978658|FG000|Overall Study|Lost to Follow-up|3|||
144214224|NCT01121562|519978659|FG000|Overall Study|Objective progression or relapse|8|||
144214225|NCT01121562|519978659|FG000|Overall Study|Withdrawal by Subject|1|||
144214226|NCT01121562|519978659|FG000|Overall Study|Adverse Event|1|||
144214227|NCT01121562|519978659|FG000|Overall Study|Sponsor Decision|1|||
144214228|NCT01121562|519978659|FG000|Overall Study|Met study discontinuation criteria|1|||
144214229|NCT01495702|519978660|FG000|Randomized Phase|Randomized But Not Treated|1|||
144214230|NCT01495702|519978661|FG001|Randomized Phase|Randomized But Not Treated|4|||
144214231|NCT01495702|519978660|FG000|Randomized Phase|Adverse Event|2|||
144586919|NCT03181789|521346956|FG001|Overall Study|Lost to Follow-up|1|||
144586920|NCT03181789|521346957|FG002|Overall Study|Lost to Follow-up|0|||
144586921|NCT03181789|521346958|FG003|Overall Study|Lost to Follow-up|0|||
144586922|NCT03181789|521346955|FG000|Overall Study|Participant unable to adhere to visit|0|||
144586923|NCT03181789|521346956|FG001|Overall Study|Participant unable to adhere to visit|1|||
144586924|NCT03181789|521346957|FG002|Overall Study|Participant unable to adhere to visit|0|||
144586925|NCT03181789|521346958|FG003|Overall Study|Participant unable to adhere to visit|0|||
144586926|NCT01131182|521346959|FG000|Overall Study|Withdrawal by Subject|1|||
144586927|NCT01131182|521346960|FG001|Overall Study|Withdrawal by Subject|1|||
144586928|NCT01131182|521346959|FG000|Overall Study|Lost to Follow-up|14|||
144586929|NCT01131182|521346960|FG001|Overall Study|Lost to Follow-up|15|||
144586930|NCT01131182|521346959|FG000|Overall Study|Other Reason|1|||
144586931|NCT01131182|521346960|FG001|Overall Study|Other Reason|0|||
144264487|NCT02227784|520169499|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
144264488|NCT02227784|520169500|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
144264489|NCT02227784|520169496|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
144264490|NCT02227784|520169497|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
144264491|NCT02227784|520169498|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
144264492|NCT02227784|520169499|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
144264493|NCT02227784|520169500|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
144264494|NCT02227784|520169496|FG000|Open-Label Extension Phase (OLE)|Death|0|||
144264495|NCT02227784|520169497|FG001|Open-Label Extension Phase (OLE)|Death|0|||
144264496|NCT02227784|520169498|FG002|Open-Label Extension Phase (OLE)|Death|0|||
144264497|NCT02227784|520169499|FG003|Open-Label Extension Phase (OLE)|Death|0|||
144264498|NCT02227784|520169500|FG004|Open-Label Extension Phase (OLE)|Death|1|||
144264499|NCT02227784|520169496|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
144264500|NCT02227784|520169497|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
144264501|NCT02227784|520169498|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
144264502|NCT02227784|520169499|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
144264503|NCT02227784|520169500|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
144264504|NCT02227784|520169496|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
144264505|NCT02227784|520169497|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
144264506|NCT02227784|520169498|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
144264507|NCT02227784|520169499|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
144264508|NCT02227784|520169500|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
144264509|NCT02155699|520169501|FG000|Overall Study|Withdrawal by Subject|0|||
144264510|NCT02155699|520169502|FG001|Overall Study|Withdrawal by Subject|3|||
144264511|NCT02155699|520169503|FG002|Overall Study|Withdrawal by Subject|6|||
144264512|NCT02155699|520169504|FG003|Overall Study|Withdrawal by Subject|1|||
144264513|NCT02155699|520169501|FG000|Overall Study|Lost to Follow-up|0|||
144264514|NCT02155699|520169502|FG001|Overall Study|Lost to Follow-up|0|||
144264515|NCT02155699|520169503|FG002|Overall Study|Lost to Follow-up|0|||
144264516|NCT02155699|520169504|FG003|Overall Study|Lost to Follow-up|3|||
144264517|NCT02155699|520169501|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
144264518|NCT02155699|520169502|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
144264519|NCT02155699|520169503|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
144264520|NCT02155699|520169504|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
144264521|NCT00485069|520169505|FG000|Overall Study|Adverse Event|10|||
144264522|NCT00485069|520169506|FG001|Overall Study|Adverse Event|4|||
144264523|NCT00485069|520169505|FG000|Overall Study|Lack of Efficacy|2|||
144264524|NCT00485069|520169506|FG001|Overall Study|Lack of Efficacy|1|||
144264525|NCT00485069|520169505|FG000|Overall Study|Protocol Violation|0|||
144264526|NCT00485069|520169506|FG001|Overall Study|Protocol Violation|1|||
144264527|NCT00485069|520169505|FG000|Overall Study|Withdrawal by Subject|6|||
144264528|NCT00485069|520169506|FG001|Overall Study|Withdrawal by Subject|6|||
144264529|NCT00828113|520169509|FG000|Overall Study|Withdrawal by Subject|27|||
144264530|NCT00828113|520169510|FG001|Overall Study|Withdrawal by Subject|26|||
144264531|NCT00828113|520169509|FG000|Overall Study|Lost to Follow-up|3|||
144264532|NCT00828113|520169510|FG001|Overall Study|Lost to Follow-up|5|||
144264533|NCT01365130|520169511|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
144264534|NCT05616013|520169512|FG000|Overall Study|Adverse Event|6|||
144264535|NCT05616013|520169513|FG001|Overall Study|Adverse Event|12|||
144264536|NCT05616013|520169514|FG002|Overall Study|Adverse Event|8|||
144264537|NCT05616013|520169515|FG003|Overall Study|Adverse Event|4|||
144264538|NCT05616013|520169516|FG004|Overall Study|Adverse Event|6|||
144264539|NCT05616013|520169517|FG005|Overall Study|Adverse Event|8|||
144657060|NCT01327651|521595475|FG001|Post Study Follow-up|Lost to Follow-up|1|||
144657061|NCT01327651|521595476|FG002|Post Study Follow-up|Lost to Follow-up|1|||
144657062|NCT01327651|521595477|FG003|Post Study Follow-up|Lost to Follow-up|0|||
144657063|NCT01327651|521595478|FG004|Post Study Follow-up|Lost to Follow-up|0|||
144657064|NCT01327651|521595479|FG005|Post Study Follow-up|Lost to Follow-up|0|||
144657065|NCT01327651|521595480|FG006|Post Study Follow-up|Lost to Follow-up|4|||
144657066|NCT01327651|521595481|FG007|Post Study Follow-up|Lost to Follow-up|1|||
144657067|NCT01327651|521595482|FG008|Post Study Follow-up|Lost to Follow-up|2|||
144657068|NCT02868216|521595485|FG000|Overall Study|Death|0|||
144657069|NCT02868216|521595486|FG001|Overall Study|Death|1|||
144657070|NCT02868216|521595485|FG000|Overall Study|coronary artery bypass|1|||
144657071|NCT02868216|521595486|FG001|Overall Study|coronary artery bypass|0|||
144264540|NCT05616013|520169518|FG006|Overall Study|Adverse Event|3|||
144264541|NCT05616013|520169519|FG007|Overall Study|Adverse Event|6|||
144264542|NCT05616013|520169520|FG008|Overall Study|Adverse Event|1|||
144264543|NCT05616013|520169512|FG000|Overall Study|Lost to Follow-up|5|||
144657072|NCT02868216|521595485|FG000|Overall Study|Withdrawal by Subject|7|||
144657073|NCT02868216|521595486|FG001|Overall Study|Withdrawal by Subject|5|||
144264544|NCT05616013|520169513|FG001|Overall Study|Lost to Follow-up|4|||
144264545|NCT05616013|520169514|FG002|Overall Study|Lost to Follow-up|3|||
144264546|NCT05616013|520169515|FG003|Overall Study|Lost to Follow-up|2|||
144264547|NCT05616013|520169516|FG004|Overall Study|Lost to Follow-up|0|||
144264548|NCT05616013|520169517|FG005|Overall Study|Lost to Follow-up|5|||
144264549|NCT05616013|520169518|FG006|Overall Study|Lost to Follow-up|2|||
144264550|NCT05616013|520169519|FG007|Overall Study|Lost to Follow-up|1|||
144264551|NCT05616013|520169520|FG008|Overall Study|Lost to Follow-up|2|||
144264552|NCT05616013|520169512|FG000|Overall Study|Non-compliance with study requirements|2|||
144264553|NCT05616013|520169513|FG001|Overall Study|Non-compliance with study requirements|2|||
144264554|NCT05616013|520169514|FG002|Overall Study|Non-compliance with study requirements|2|||
144264555|NCT05616013|520169515|FG003|Overall Study|Non-compliance with study requirements|3|||
144264556|NCT05616013|520169516|FG004|Overall Study|Non-compliance with study requirements|0|||
144264557|NCT05616013|520169517|FG005|Overall Study|Non-compliance with study requirements|2|||
144264558|NCT05616013|520169518|FG006|Overall Study|Non-compliance with study requirements|1|||
144264559|NCT05616013|520169519|FG007|Overall Study|Non-compliance with study requirements|1|||
144264560|NCT05616013|520169520|FG008|Overall Study|Non-compliance with study requirements|4|||
144264561|NCT05616013|520169512|FG000|Overall Study|Withdrawal by Subject|11|||
144264562|NCT05616013|520169513|FG001|Overall Study|Withdrawal by Subject|9|||
144264563|NCT05616013|520169514|FG002|Overall Study|Withdrawal by Subject|8|||
144264564|NCT05616013|520169515|FG003|Overall Study|Withdrawal by Subject|6|||
144264565|NCT05616013|520169516|FG004|Overall Study|Withdrawal by Subject|3|||
144264566|NCT05616013|520169517|FG005|Overall Study|Withdrawal by Subject|4|||
144264567|NCT05616013|520169518|FG006|Overall Study|Withdrawal by Subject|6|||
144264568|NCT05616013|520169519|FG007|Overall Study|Withdrawal by Subject|5|||
144264569|NCT05616013|520169520|FG008|Overall Study|Withdrawal by Subject|4|||
144657074|NCT01201798|521595489|FG000|Overall Study|Adverse Event|2|||
144657075|NCT01201798|521595490|FG001|Overall Study|Adverse Event|0|||
144657076|NCT01201798|521595489|FG000|Overall Study|Lost to Follow-up|3|||
144657077|NCT01201798|521595490|FG001|Overall Study|Lost to Follow-up|5|||
144657078|NCT01201798|521595489|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
144657079|NCT01201798|521595490|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
144657080|NCT01201798|521595489|FG000|Overall Study|Noncompliance|1|||
144657081|NCT01201798|521595490|FG001|Overall Study|Noncompliance|0|||
144657082|NCT01201798|521595489|FG000|Overall Study|Protocol Violation|1|||
144657083|NCT01201798|521595490|FG001|Overall Study|Protocol Violation|1|||
144657084|NCT01201798|521595489|FG000|Overall Study|Treatment Failure|1|||
144657085|NCT01201798|521595490|FG001|Overall Study|Treatment Failure|8|||
144657086|NCT03609359|521595503|FG000|Overall Study|Progression of primary disease (PD)|25|||
144657087|NCT03609359|521595503|FG000|Overall Study|Patient's refusal|1|||
144657088|NCT03609359|521595503|FG000|Overall Study|Physician Decision|1|||
144657089|NCT03609359|521595503|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
144657090|NCT01912729|521595505|FG000|Overall Study|Withdrawal by Subject|0|||
144657091|NCT01912729|521595506|FG001|Overall Study|Withdrawal by Subject|1|||
144657092|NCT04285346|521595514|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
144657093|NCT04285346|521595515|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
144657094|NCT04285346|521595514|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
144657095|NCT04285346|521595515|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144657096|NCT04285346|521595514|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
144657097|NCT04285346|521595515|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
144657098|NCT01975272|521595516|FG000|Overall Study|Excluded after protocol amendment|1|||
144657099|NCT01975272|521595517|FG001|Overall Study|Excluded after protocol amendment|1|||
144657100|NCT01975272|521595518|FG002|Overall Study|Excluded after protocol amendment|2|||
144657101|NCT00850460|521595520|FG000|Overall Study|Lost to Follow-up|4|||
144657102|NCT00850460|521595521|FG001|Overall Study|Lost to Follow-up|4|||
144657103|NCT05372575|521595524|FG000|Overall Study|Protocol Violation|7|||
144657104|NCT05372575|521595525|FG001|Overall Study|Protocol Violation|16|||
144657105|NCT03196297|521595526|FG000|Main Period|Withdrawal by Subject|4|||
144657106|NCT03196297|521595526|FG000|Extension Period|Withdrawal by Subject|1|||
144657107|NCT03196297|521595526|FG000|Extension Period|Lack of Efficacy|2|||
144657108|NCT03510663|521595527|FG000|Overall Study|Withdrawal by Subject|0|||
144657109|NCT03510663|521595528|FG001|Overall Study|Withdrawal by Subject|1|||
144657110|NCT03510663|521595529|FG002|Overall Study|Withdrawal by Subject|0|||
144657111|NCT03510663|521595530|FG003|Overall Study|Withdrawal by Subject|0|||
144657112|NCT03510663|521595531|FG004|Overall Study|Withdrawal by Subject|0|||
144657113|NCT03510663|521595532|FG005|Overall Study|Withdrawal by Subject|0|||
144264570|NCT05616013|520169512|FG000|Overall Study|Physician Decision|0|||
144264571|NCT05616013|520169513|FG001|Overall Study|Physician Decision|0|||
144264572|NCT05616013|520169514|FG002|Overall Study|Physician Decision|1|||
144657114|NCT03510663|521595533|FG006|Overall Study|Withdrawal by Subject|0|||
144657115|NCT03510663|521595534|FG007|Overall Study|Withdrawal by Subject|0|||
144657116|NCT04370028|521595541|FG000|Overall Study|Withdrawal by Subject|695|||
144657117|NCT04370028|521595541|FG000|Overall Study|Protocol Violation|9|||
144264573|NCT05616013|520169515|FG003|Overall Study|Physician Decision|0|||
144264574|NCT05616013|520169516|FG004|Overall Study|Physician Decision|0|||
144264575|NCT05616013|520169517|FG005|Overall Study|Physician Decision|1|||
144264576|NCT05616013|520169518|FG006|Overall Study|Physician Decision|3|||
144657118|NCT04370028|521595541|FG000|Overall Study|Adverse Event|3|||
144657119|NCT01465178|521595543|FG000|Overall Study|Withdrawal by Subject|1|||
144657120|NCT01465178|521595544|FG001|Overall Study|Withdrawal by Subject|0|||
144657121|NCT00436215|521595548|FG000|Overall Study|Refused further treatment|3|||
144657122|NCT00436215|521595548|FG000|Overall Study|Small bowel obstruction|1|||
144657123|NCT00309777|521595549|FG000|Overall Study|Adverse Event|13|||
144657124|NCT00309777|521595550|FG001|Overall Study|Adverse Event|2|||
144657125|NCT00309777|521595551|FG002|Overall Study|Adverse Event|8|||
144657126|NCT00309777|521595552|FG003|Overall Study|Adverse Event|1|||
144657127|NCT00309777|521595549|FG000|Overall Study|Protocol Violation|4|||
144657128|NCT00309777|521595550|FG001|Overall Study|Protocol Violation|1|||
144657129|NCT00309777|521595551|FG002|Overall Study|Protocol Violation|3|||
144657130|NCT00309777|521595552|FG003|Overall Study|Protocol Violation|1|||
144657131|NCT00309777|521595549|FG000|Overall Study|Withdrawal by Subject|6|||
144657132|NCT00309777|521595550|FG001|Overall Study|Withdrawal by Subject|5|||
144657133|NCT00309777|521595551|FG002|Overall Study|Withdrawal by Subject|7|||
144657134|NCT00309777|521595552|FG003|Overall Study|Withdrawal by Subject|2|||
144657135|NCT00309777|521595549|FG000|Overall Study|Lost to Follow-up|0|||
144657136|NCT00309777|521595550|FG001|Overall Study|Lost to Follow-up|0|||
144657137|NCT00309777|521595551|FG002|Overall Study|Lost to Follow-up|1|||
144657138|NCT00309777|521595552|FG003|Overall Study|Lost to Follow-up|0|||
144657139|NCT00309777|521595549|FG000|Overall Study|Death|0|||
144657140|NCT00309777|521595550|FG001|Overall Study|Death|1|||
144657141|NCT00309777|521595551|FG002|Overall Study|Death|0|||
144657142|NCT00309777|521595552|FG003|Overall Study|Death|0|||
144657143|NCT03050359|521596923|FG000|Overall Study|Randomized But Not Treated|2|||
144657144|NCT03050359|521596924|FG001|Overall Study|Randomized But Not Treated|0|||
144657145|NCT03050359|521596923|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
144657146|NCT03050359|521596924|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
144657147|NCT03050359|521596923|FG000|Overall Study|Significant Protocol Deviation|2|||
144657148|NCT03050359|521596924|FG001|Overall Study|Significant Protocol Deviation|3|||
144657149|NCT03050359|521596923|FG000|Overall Study|Lost to Follow-up|2|||
144657150|NCT03050359|521596924|FG001|Overall Study|Lost to Follow-up|1|||
144657151|NCT03050359|521596923|FG000|Overall Study|Voluntary Withdrawal|4|||
144657152|NCT03050359|521596924|FG001|Overall Study|Voluntary Withdrawal|6|||
144657153|NCT03050359|521596923|FG000|Overall Study|Pregnancy|1|||
144657154|NCT03050359|521596924|FG001|Overall Study|Pregnancy|0|||
144657155|NCT03050359|521596923|FG000|Overall Study|Reason Not Specified|1|||
144657156|NCT03050359|521596924|FG001|Overall Study|Reason Not Specified|0|||
144657157|NCT02614287|521596927|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
144657158|NCT02614287|521596928|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
144657159|NCT02614287|521596927|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
144657160|NCT02614287|521596928|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
144657161|NCT02614287|521596927|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
144657162|NCT02614287|521596928|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
144657163|NCT02614287|521596927|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
144657164|NCT02614287|521596928|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
144657165|NCT02614287|521596927|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
144657166|NCT02614287|521596928|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
144657167|NCT02614287|521596927|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
144657168|NCT02614287|521596928|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
144657169|NCT02614287|521596927|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
144657170|NCT02614287|521596928|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
144657171|NCT02614287|521596927|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
144657172|NCT02614287|521596928|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
144657173|NCT01727713|521596936|FG000|Overall Study|Lost to Follow-up|5|||
144657174|NCT01727713|521596936|FG000|Overall Study|Adverse Event|10|||
144657175|NCT01727713|521596936|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
144657176|NCT01727713|521596936|FG000|Overall Study|Withdrawal by Subject|13|||
144657177|NCT01727713|521596936|FG000|Overall Study|Protocol Deviation|2|||
144657178|NCT00532948|521596937|FG000|Overall Study|Protocol Violation|1|||
144657179|NCT00532948|521596938|FG001|Overall Study|Protocol Violation|0|||
144657180|NCT00532948|521596939|FG002|Overall Study|Protocol Violation|0|||
144657181|NCT00532948|521596937|FG000|Overall Study|Death|3|||
144657182|NCT00532948|521596938|FG001|Overall Study|Death|3|||
144657183|NCT00532948|521596939|FG002|Overall Study|Death|4|||
144657184|NCT00532948|521596937|FG000|Overall Study|Violation of selection criteria at entry|0|||
144657185|NCT00532948|521596938|FG001|Overall Study|Violation of selection criteria at entry|1|||
144657186|NCT00532948|521596939|FG002|Overall Study|Violation of selection criteria at entry|0|||
144657187|NCT00532948|521596937|FG000|Overall Study|Failure to return|0|||
144657188|NCT00532948|521596938|FG001|Overall Study|Failure to return|1|||
144657189|NCT00532948|521596939|FG002|Overall Study|Failure to return|0|||
144657190|NCT00995345|521596941|FG000|Overall Study|Withdrawal by Subject|4|||
144657191|NCT00995345|521596942|FG001|Overall Study|Withdrawal by Subject|2|||
144657192|NCT00995345|521596943|FG002|Overall Study|Withdrawal by Subject|1|||
144657193|NCT00995345|521596944|FG003|Overall Study|Withdrawal by Subject|3|||
144657194|NCT00995345|521596945|FG004|Overall Study|Withdrawal by Subject|1|||
144657195|NCT00995345|521596941|FG000|Overall Study|Adverse Event|3|||
144657196|NCT00995345|521596942|FG001|Overall Study|Adverse Event|1|||
144657197|NCT00995345|521596943|FG002|Overall Study|Adverse Event|2|||
144657198|NCT00995345|521596944|FG003|Overall Study|Adverse Event|0|||
144657199|NCT00995345|521596945|FG004|Overall Study|Adverse Event|1|||
144657200|NCT00995345|521596941|FG000|Overall Study|Lost to Follow-up|2|||
144657201|NCT00995345|521596942|FG001|Overall Study|Lost to Follow-up|2|||
144657202|NCT00995345|521596943|FG002|Overall Study|Lost to Follow-up|2|||
144657203|NCT00995345|521596944|FG003|Overall Study|Lost to Follow-up|1|||
144657204|NCT00995345|521596945|FG004|Overall Study|Lost to Follow-up|0|||
144657205|NCT00995345|521596941|FG000|Overall Study|all other reasons combined|2|||
144657206|NCT00995345|521596942|FG001|Overall Study|all other reasons combined|2|||
144657207|NCT00995345|521596943|FG002|Overall Study|all other reasons combined|2|||
144657208|NCT00995345|521596944|FG003|Overall Study|all other reasons combined|1|||
144657209|NCT00995345|521596945|FG004|Overall Study|all other reasons combined|3|||
144657210|NCT02651194|521596946|FG000|Overall Study|Lost to Follow-up|3|||
144657211|NCT02651194|521596946|FG000|Overall Study|Other|2|||
144657212|NCT01842308|521596949|FG000|Overall Study|Withdrawal by Subject|0|||
144657213|NCT01842308|521596950|FG001|Overall Study|Withdrawal by Subject|0|||
144657214|NCT01842308|521596951|FG002|Overall Study|Withdrawal by Subject|0|||
144657215|NCT01842308|521596952|FG003|Overall Study|Withdrawal by Subject|0|||
144657216|NCT01842308|521596953|FG004|Overall Study|Withdrawal by Subject|1|||
144657217|NCT01253044|521596955|FG000|Overall Study|Lost to Follow-up|38|||
144657218|NCT01253044|521596956|FG001|Overall Study|Lost to Follow-up|29|||
144657219|NCT03885726|521596957|FG000|Overall Study|Staffing issues/lost interest|1|||
144657220|NCT03885726|521596957|FG000|Overall Study|Early discharge from hospital|3|||
144657221|NCT00987623|521596958|FG000|Overall Study|Lost to Follow-up|2|||
144657222|NCT00987623|521596959|FG001|Overall Study|Lost to Follow-up|1|||
144657223|NCT00987623|521596958|FG000|Overall Study|Time/job conflict|2|||
144657224|NCT00987623|521596959|FG001|Overall Study|Time/job conflict|0|||
144657225|NCT00987623|521596958|FG000|Overall Study|Discomfort|1|||
144657226|NCT00987623|521596959|FG001|Overall Study|Discomfort|0|||
144657227|NCT00987623|521596958|FG000|Overall Study|Biomicroscopy|0|||
144657228|NCT00987623|521596959|FG001|Overall Study|Biomicroscopy|1|||
144657229|NCT00987623|521596958|FG000|Overall Study|Influenza|0|||
144657230|NCT00987623|521596959|FG001|Overall Study|Influenza|1|||
144657231|NCT02702193|521596960|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
144657232|NCT02702193|521596961|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
144657233|NCT02702193|521596960|FG000|4 Month Follow up|Withdrawal by Subject|1|||
144657234|NCT02702193|521596961|FG001|4 Month Follow up|Withdrawal by Subject|0|||
144657235|NCT02702193|521596960|FG000|4 Month Follow up|Lost to Follow-up|17|||
144657236|NCT02702193|521596961|FG001|4 Month Follow up|Lost to Follow-up|18|||
144657237|NCT02702193|521596960|FG000|8 Month Follow up|Withdrawal by Subject|1|||
144657238|NCT02702193|521596961|FG001|8 Month Follow up|Withdrawal by Subject|0|||
144657239|NCT02702193|521596960|FG000|8 Month Follow up|Lost to Follow-up|14|||
144657240|NCT02702193|521596961|FG001|8 Month Follow up|Lost to Follow-up|18|||
144657241|NCT02702193|521596960|FG000|12 Month Follow up|Withdrawal by Subject|1|||
144657242|NCT02702193|521596961|FG001|12 Month Follow up|Withdrawal by Subject|0|||
144657243|NCT02702193|521596960|FG000|12 Month Follow up|Lost to Follow-up|16|||
144657244|NCT02702193|521596961|FG001|12 Month Follow up|Lost to Follow-up|18|||
144657245|NCT02399813|521596965|FG000|Overall Study|Progressive Disease-Radiographic|2|||
144657246|NCT02399813|521596965|FG000|Overall Study|Death|20|||
144657247|NCT02399813|521596965|FG000|Overall Study|Withdrawal by Subject|3|||
144657248|NCT02399813|521596965|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
144657249|NCT02399813|521596965|FG000|Overall Study|Lost to Follow-up|2|||
144657250|NCT02399813|521596965|FG000|Overall Study|Other than specified|5|||
144657251|NCT00988559|521596966|FG000|Overall Study|Withdrawal by Subject|1|||
144657252|NCT00988559|521596967|FG001|Overall Study|Withdrawal by Subject|1|||
144657253|NCT00988559|521596968|FG002|Overall Study|Withdrawal by Subject|0|||
144657254|NCT00988559|521596969|FG003|Overall Study|Withdrawal by Subject|1|||
144657255|NCT00988559|521596966|FG000|Overall Study|Pregnancy|0|||
144657256|NCT00988559|521596967|FG001|Overall Study|Pregnancy|1|||
144657257|NCT00988559|521596968|FG002|Overall Study|Pregnancy|1|||
144657258|NCT00988559|521596969|FG003|Overall Study|Pregnancy|0|||
144657259|NCT00988559|521596966|FG000|Overall Study|Lost to Follow-up|0|||
144657260|NCT00988559|521596967|FG001|Overall Study|Lost to Follow-up|0|||
144214232|NCT01495702|519978661|FG001|Randomized Phase|Adverse Event|2|||
144214233|NCT01495702|519978660|FG000|Randomized Phase|Death|1|||
144657261|NCT00988559|521596968|FG002|Overall Study|Lost to Follow-up|1|||
144657262|NCT00988559|521596969|FG003|Overall Study|Lost to Follow-up|0|||
144657263|NCT02224846|521596970|FG000|Period 1 (Month 3)|Adverse Event|2|||
144657264|NCT02224846|521596971|FG001|Period 1 (Month 3)|Adverse Event|1|||
144657265|NCT02224846|521596970|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
144657266|NCT02224846|521596971|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
144657267|NCT02224846|521596970|FG000|Period 1 (Month 3)|Protocol Violation|4|||
144657268|NCT02224846|521596971|FG001|Period 1 (Month 3)|Protocol Violation|8|||
144214234|NCT01495702|519978661|FG001|Randomized Phase|Death|0|||
144264577|NCT05616013|520169519|FG007|Overall Study|Physician Decision|0|||
144264578|NCT05616013|520169520|FG008|Overall Study|Physician Decision|0|||
144264579|NCT05616013|520169512|FG000|Overall Study|Protocol Violation|0|||
144264580|NCT05616013|520169513|FG001|Overall Study|Protocol Violation|0|||
144264581|NCT05616013|520169514|FG002|Overall Study|Protocol Violation|0|||
144264582|NCT05616013|520169515|FG003|Overall Study|Protocol Violation|0|||
144264583|NCT05616013|520169516|FG004|Overall Study|Protocol Violation|0|||
144264584|NCT05616013|520169517|FG005|Overall Study|Protocol Violation|0|||
144264585|NCT05616013|520169518|FG006|Overall Study|Protocol Violation|1|||
144264586|NCT05616013|520169519|FG007|Overall Study|Protocol Violation|0|||
144264587|NCT05616013|520169520|FG008|Overall Study|Protocol Violation|2|||
144264588|NCT05616013|520169512|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
144264589|NCT05616013|520169513|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264590|NCT05616013|520169514|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264591|NCT05616013|520169515|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264592|NCT05616013|520169516|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264593|NCT05616013|520169517|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264594|NCT05616013|520169518|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264595|NCT05616013|520169519|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264596|NCT05616013|520169520|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
144264597|NCT05616013|520169512|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
144264598|NCT05616013|520169513|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264599|NCT05616013|520169514|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264600|NCT05616013|520169515|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264601|NCT05616013|520169516|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264602|NCT05616013|520169517|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264603|NCT05616013|520169518|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264604|NCT05616013|520169519|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264605|NCT05616013|520169520|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
144264606|NCT05616013|520169512|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
144264607|NCT05616013|520169513|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264608|NCT05616013|520169514|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264609|NCT05616013|520169515|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264610|NCT05616013|520169516|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264611|NCT05616013|520169517|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264612|NCT05616013|520169518|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264613|NCT05616013|520169519|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264614|NCT05616013|520169520|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
144264615|NCT05616013|520169512|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144657269|NCT02224846|521596970|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
144657270|NCT02224846|521596971|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
144657271|NCT02224846|521596970|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
144657272|NCT02224846|521596971|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
144657273|NCT02224846|521596970|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
144657274|NCT02224846|521596971|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
144657275|NCT02224846|521596970|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
144657276|NCT02224846|521596971|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
144657277|NCT02224846|521596970|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
144657278|NCT02224846|521596971|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
144657279|NCT02224846|521596970|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
144657280|NCT02224846|521596971|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
144657281|NCT02224846|521596970|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
144657282|NCT02224846|521596971|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
144657283|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
144657284|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
144657285|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
144657286|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
144657287|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
144657288|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
144657289|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
144657290|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
144657291|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
144657292|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
144657293|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
144657294|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
144732634|NCT00469417|521877144|FG001|Overall Study|Intercurrent disease|1|||
144732635|NCT00469417|521877143|FG000|Overall Study|Randomized but not treated|2|||
144657295|NCT02224846|521596970|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
144657296|NCT02224846|521596971|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
144657297|NCT03280550|521596972|FG000|Overall Study|Withdrawal by Subject|2|||
144657298|NCT03280550|521596973|FG001|Overall Study|Withdrawal by Subject|2|||
144657299|NCT03280550|521596972|FG000|Overall Study|Physician Decision|0|||
144657300|NCT03280550|521596973|FG001|Overall Study|Physician Decision|1|||
144657301|NCT03345836|521596978|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
144657302|NCT03345836|521596979|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
144657303|NCT03345836|521596980|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
144657304|NCT03345836|521596981|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
144657305|NCT03345836|521596982|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
144657306|NCT03345836|521596983|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
144657307|NCT03345836|521596978|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
144657308|NCT03345836|521596979|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
144657309|NCT03345836|521596980|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
144657310|NCT03345836|521596981|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
144657311|NCT03345836|521596982|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
144657312|NCT03345836|521596983|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
144657313|NCT03345836|521596978|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
144657314|NCT03345836|521596979|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
144657315|NCT03345836|521596980|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
144657316|NCT03345836|521596981|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
144657317|NCT03345836|521596982|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
144657318|NCT03345836|521596983|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
144657319|NCT03345836|521596978|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
144657320|NCT03345836|521596979|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
144657321|NCT03345836|521596980|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
144657322|NCT03345836|521596981|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
144657323|NCT03345836|521596982|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
144657324|NCT03345836|521596983|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
144657325|NCT03345836|521596978|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
144657326|NCT03345836|521596979|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
144657327|NCT03345836|521596980|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
144657328|NCT03345836|521596981|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
144657329|NCT03345836|521596982|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
144657330|NCT03345836|521596983|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
144657331|NCT03345836|521596978|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
144657332|NCT03345836|521596979|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
144657333|NCT03345836|521596980|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
144657334|NCT03345836|521596981|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
144657335|NCT03345836|521596982|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
144657336|NCT03345836|521596983|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
144657337|NCT03345836|521596978|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
144657338|NCT03345836|521596979|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
144657339|NCT03345836|521596980|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
144657340|NCT03345836|521596981|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
144657341|NCT03345836|521596982|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
144657342|NCT03345836|521596983|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
144657343|NCT03345836|521596978|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
144657344|NCT03345836|521596979|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
144657345|NCT03345836|521596980|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
144657346|NCT03345836|521596981|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
144657347|NCT03345836|521596982|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
144657348|NCT03345836|521596983|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
144657349|NCT03345836|521596978|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
144657350|NCT03345836|521596979|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
144657351|NCT03345836|521596980|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
144657352|NCT03345836|521596981|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
144657353|NCT03345836|521596982|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
144657354|NCT03345836|521596983|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
144264616|NCT05616013|520169513|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
144657355|NCT03345836|521596978|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
144264617|NCT05616013|520169514|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144264618|NCT05616013|520169515|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144657356|NCT03345836|521596979|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
144657357|NCT03345836|521596980|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
144657358|NCT03345836|521596981|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
144657359|NCT03345836|521596982|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
144657360|NCT03345836|521596983|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
144657361|NCT03345836|521596978|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
144657362|NCT03345836|521596979|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
144657363|NCT03345836|521596980|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
144657364|NCT03345836|521596981|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
144657365|NCT03345836|521596982|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
144657366|NCT03345836|521596983|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
144657367|NCT00320385|521596986|FG000|Overall Study|Lost to Follow-up|7|||
144657368|NCT00320385|521596987|FG001|Overall Study|Lost to Follow-up|10|||
144657369|NCT00320385|521596986|FG000|Overall Study|Withdrawal by Subject|6|||
144657370|NCT00320385|521596987|FG001|Overall Study|Withdrawal by Subject|7|||
144657371|NCT00320385|521596986|FG000|Overall Study|Sponsor Terminated Study|2|||
144657372|NCT00320385|521596987|FG001|Overall Study|Sponsor Terminated Study|1|||
144657373|NCT00320385|521596986|FG000|Overall Study|Investigator Decision|0|||
144657374|NCT00320385|521596987|FG001|Overall Study|Investigator Decision|1|||
144657375|NCT00320385|521596986|FG000|Overall Study|Death|1|||
144657376|NCT00320385|521596987|FG001|Overall Study|Death|2|||
144657377|NCT00320385|521596986|FG000|Overall Study|Serious Adverse Event|1|||
144657378|NCT00320385|521596987|FG001|Overall Study|Serious Adverse Event|0|||
144657379|NCT00320385|521596986|FG000|Overall Study|Withdrew Consent|1|||
144657380|NCT00320385|521596987|FG001|Overall Study|Withdrew Consent|0|||
144657381|NCT00320385|521596986|FG000|Overall Study|Adverse Event|0|||
144657382|NCT00320385|521596987|FG001|Overall Study|Adverse Event|1|||
144657383|NCT00222729|521596988|FG000|Overall Study|Adverse Event|3|||
144657384|NCT01915849|521596996|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
144657385|NCT01915849|521596997|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
144657386|NCT01915849|521596998|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
144657387|NCT01915849|521596999|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
144657388|NCT01915849|521596996|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
144657389|NCT01915849|521596997|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144657390|NCT01915849|521596998|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144657391|NCT01915849|521596999|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
144657392|NCT01798706|521597000|FG000|Overall Study|Adverse Event|15|||
144657393|NCT01798706|521597001|FG001|Overall Study|Adverse Event|10|||
144657394|NCT01798706|521597000|FG000|Overall Study|Lack of Efficacy|0|||
144657395|NCT01798706|521597001|FG001|Overall Study|Lack of Efficacy|2|||
144657396|NCT01798706|521597000|FG000|Overall Study|Poor compliance to protocol|1|||
144657397|NCT01798706|521597001|FG001|Overall Study|Poor compliance to protocol|0|||
144657398|NCT01798706|521597000|FG000|Overall Study|Other than specified above|5|||
144657399|NCT01798706|521597001|FG001|Overall Study|Other than specified above|9|||
144657400|NCT00496873|521597002|FG000|Overall Study|Ineligible|2|||
144657401|NCT00496873|521597002|FG000|Overall Study|Death|2|||
144657402|NCT00496873|521597002|FG000|Overall Study|Withdrawal by Subject|3|||
144657403|NCT00748540|521597003|FG000|Overall Study|Physician Decision|1|||
144657404|NCT02775864|521597004|FG000|Overall Study|Data ended end of 2010|1764|||
144657405|NCT02775864|521597005|FG001|Overall Study|Data ended end of 2010|2880|||
144657406|NCT02775864|521597006|FG002|Overall Study|Data ended end of 2010|1140|||
144657407|NCT02775864|521597007|FG003|Overall Study|Data ended end of 2010|1194|||
144657408|NCT02775864|521597004|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
144657409|NCT02775864|521597005|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
144657410|NCT02775864|521597006|FG002|Overall Study|Medicaid eligibility discontinued|720|||
144657411|NCT02775864|521597007|FG003|Overall Study|Medicaid eligibility discontinued|890|||
144657412|NCT02028338|521597008|FG000|Overall Study|Withdrawal by Subject|3|||
144657413|NCT02028338|521597009|FG001|Overall Study|Withdrawal by Subject|1|||
144657414|NCT02028338|521597008|FG000|Overall Study|Unable to contact participant|1|||
144657415|NCT02028338|521597009|FG001|Overall Study|Unable to contact participant|0|||
144657416|NCT03552549|521597010|FG000|Overall Study|Disease progression|25|||
144657417|NCT03552549|521597011|FG001|Overall Study|Disease progression|17|||
144657418|NCT03552549|521597010|FG000|Overall Study|Adverse event in first 12 months|12|||
144657419|NCT03552549|521597011|FG001|Overall Study|Adverse event in first 12 months|8|||
144657420|NCT03552549|521597010|FG000|Overall Study|Withdrawal by Subject|7|||
144657421|NCT03552549|521597011|FG001|Overall Study|Withdrawal by Subject|7|||
144657422|NCT03552549|521597010|FG000|Overall Study|Unknown (no reason provided)|4|||
144657423|NCT03552549|521597011|FG001|Overall Study|Unknown (no reason provided)|2|||
144657424|NCT03552549|521597010|FG000|Overall Study|Not in participant's best interest|2|||
144657425|NCT03552549|521597011|FG001|Overall Study|Not in participant's best interest|1|||
144657426|NCT03552549|521597010|FG000|Overall Study|Did not complete study treatment|2|||
144657427|NCT03552549|521597011|FG001|Overall Study|Did not complete study treatment|3|||
144657428|NCT03552549|521597010|FG000|Overall Study|Did not meet eligibility criteria|1|||
144657429|NCT03552549|521597011|FG001|Overall Study|Did not meet eligibility criteria|0|||
144657430|NCT03552549|521597010|FG000|Overall Study|Administrative|0|||
144657431|NCT03552549|521597011|FG001|Overall Study|Administrative|14|||
144657432|NCT02761993|521597020|FG000|Overall Study|Adverse Event|0|||
144657433|NCT02761993|521597021|FG001|Overall Study|Adverse Event|2|||
144657434|NCT02761993|521597022|FG002|Overall Study|Adverse Event|0|||
144657435|NCT02761993|521597020|FG000|Overall Study|Lost to Follow-up|1|||
144657436|NCT02761993|521597021|FG001|Overall Study|Lost to Follow-up|3|||
144657437|NCT02761993|521597022|FG002|Overall Study|Lost to Follow-up|2|||
144657438|NCT02761993|521597020|FG000|Overall Study|Withdrawal by Subject|1|||
144657439|NCT02761993|521597021|FG001|Overall Study|Withdrawal by Subject|1|||
144657440|NCT02761993|521597022|FG002|Overall Study|Withdrawal by Subject|2|||
144657441|NCT00256867|521597023|FG000|Overall Study|Adverse Event|0|||
144657442|NCT00256867|521597024|FG001|Overall Study|Adverse Event|1|||
144657443|NCT00256867|521597025|FG002|Overall Study|Adverse Event|1|||
144657444|NCT00256867|521597026|FG003|Overall Study|Adverse Event|1|||
144657445|NCT00256867|521597027|FG004|Overall Study|Adverse Event|2|||
144657446|NCT00256867|521597028|FG005|Overall Study|Adverse Event|2|||
144657447|NCT00256867|521597029|FG006|Overall Study|Adverse Event|1|||
144657448|NCT00256867|521597030|FG007|Overall Study|Adverse Event|4|||
144657449|NCT00256867|521597023|FG000|Overall Study|Lost to Follow-up|2|||
144657450|NCT00256867|521597024|FG001|Overall Study|Lost to Follow-up|2|||
144657451|NCT00256867|521597025|FG002|Overall Study|Lost to Follow-up|2|||
144657452|NCT00256867|521597026|FG003|Overall Study|Lost to Follow-up|3|||
144657453|NCT00256867|521597027|FG004|Overall Study|Lost to Follow-up|2|||
144657454|NCT00256867|521597028|FG005|Overall Study|Lost to Follow-up|0|||
144657455|NCT00256867|521597029|FG006|Overall Study|Lost to Follow-up|1|||
144657456|NCT00256867|521597030|FG007|Overall Study|Lost to Follow-up|2|||
144657457|NCT00256867|521597023|FG000|Overall Study|Protocol Violation|0|||
144657458|NCT00256867|521597024|FG001|Overall Study|Protocol Violation|0|||
144657459|NCT00256867|521597025|FG002|Overall Study|Protocol Violation|0|||
144657460|NCT00256867|521597026|FG003|Overall Study|Protocol Violation|1|||
144657461|NCT00256867|521597027|FG004|Overall Study|Protocol Violation|0|||
144657462|NCT00256867|521597028|FG005|Overall Study|Protocol Violation|1|||
144657463|NCT00256867|521597029|FG006|Overall Study|Protocol Violation|0|||
144657464|NCT00256867|521597030|FG007|Overall Study|Protocol Violation|1|||
144657465|NCT00256867|521597023|FG000|Overall Study|Withdrawal by Subject|0|||
144657466|NCT00256867|521597024|FG001|Overall Study|Withdrawal by Subject|0|||
144657467|NCT00256867|521597025|FG002|Overall Study|Withdrawal by Subject|1|||
144657468|NCT00256867|521597026|FG003|Overall Study|Withdrawal by Subject|1|||
144657469|NCT00256867|521597027|FG004|Overall Study|Withdrawal by Subject|2|||
144657470|NCT00256867|521597028|FG005|Overall Study|Withdrawal by Subject|2|||
144657471|NCT00256867|521597029|FG006|Overall Study|Withdrawal by Subject|3|||
144657472|NCT00256867|521597030|FG007|Overall Study|Withdrawal by Subject|2|||
144657473|NCT00256867|521597023|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657474|NCT00256867|521597024|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
144657475|NCT00256867|521597025|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657476|NCT00256867|521597026|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657477|NCT00256867|521597027|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657478|NCT00256867|521597028|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657479|NCT00256867|521597029|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657480|NCT00256867|521597030|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
144657481|NCT00256867|521597023|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657482|NCT00256867|521597024|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657483|NCT00256867|521597025|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657484|NCT00256867|521597026|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657485|NCT00256867|521597027|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657486|NCT00256867|521597028|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657487|NCT00256867|521597029|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
144657488|NCT00256867|521597030|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
144657489|NCT00256867|521597023|FG000|Overall Study|Investigator's Decision|0|||
144657490|NCT00256867|521597024|FG001|Overall Study|Investigator's Decision|0|||
144657491|NCT00256867|521597025|FG002|Overall Study|Investigator's Decision|0|||
144657492|NCT00256867|521597026|FG003|Overall Study|Investigator's Decision|0|||
144657493|NCT00256867|521597027|FG004|Overall Study|Investigator's Decision|1|||
144657494|NCT00256867|521597028|FG005|Overall Study|Investigator's Decision|0|||
144657495|NCT00256867|521597029|FG006|Overall Study|Investigator's Decision|0|||
144657496|NCT00256867|521597030|FG007|Overall Study|Investigator's Decision|0|||
144657497|NCT00256867|521597023|FG000|Overall Study|Non-compliance with study medication|0|||
144657498|NCT00256867|521597024|FG001|Overall Study|Non-compliance with study medication|0|||
144657499|NCT00256867|521597025|FG002|Overall Study|Non-compliance with study medication|0|||
144657500|NCT00256867|521597026|FG003|Overall Study|Non-compliance with study medication|0|||
144657501|NCT00256867|521597027|FG004|Overall Study|Non-compliance with study medication|0|||
144657502|NCT00256867|521597028|FG005|Overall Study|Non-compliance with study medication|0|||
144657503|NCT00256867|521597029|FG006|Overall Study|Non-compliance with study medication|0|||
144657504|NCT00256867|521597030|FG007|Overall Study|Non-compliance with study medication|1|||
144657505|NCT00256867|521597023|FG000|Overall Study|Participant travelled Overseas|0|||
144657506|NCT00256867|521597024|FG001|Overall Study|Participant travelled Overseas|1|||
144657507|NCT00256867|521597025|FG002|Overall Study|Participant travelled Overseas|0|||
144657508|NCT00256867|521597026|FG003|Overall Study|Participant travelled Overseas|0|||
144657509|NCT00256867|521597027|FG004|Overall Study|Participant travelled Overseas|0|||
144657510|NCT00256867|521597028|FG005|Overall Study|Participant travelled Overseas|0|||
144657511|NCT00256867|521597029|FG006|Overall Study|Participant travelled Overseas|0|||
144657512|NCT00256867|521597030|FG007|Overall Study|Participant travelled Overseas|0|||
144657513|NCT00256867|521597023|FG000|Overall Study|Participant out of assessment window|0|||
144657514|NCT00256867|521597024|FG001|Overall Study|Participant out of assessment window|0|||
144657515|NCT00256867|521597025|FG002|Overall Study|Participant out of assessment window|1|||
144657516|NCT00256867|521597026|FG003|Overall Study|Participant out of assessment window|0|||
144657517|NCT00256867|521597027|FG004|Overall Study|Participant out of assessment window|0|||
144657518|NCT00256867|521597028|FG005|Overall Study|Participant out of assessment window|0|||
144657519|NCT00256867|521597029|FG006|Overall Study|Participant out of assessment window|0|||
144657520|NCT00256867|521597030|FG007|Overall Study|Participant out of assessment window|0|||
144657521|NCT00256867|521597023|FG000|Overall Study|Withdrawal by participant|0|||
144657522|NCT00256867|521597024|FG001|Overall Study|Withdrawal by participant|0|||
144657523|NCT00256867|521597025|FG002|Overall Study|Withdrawal by participant|0|||
144657524|NCT00256867|521597026|FG003|Overall Study|Withdrawal by participant|0|||
144657525|NCT00256867|521597027|FG004|Overall Study|Withdrawal by participant|0|||
144657526|NCT00256867|521597028|FG005|Overall Study|Withdrawal by participant|1|||
144657527|NCT00256867|521597029|FG006|Overall Study|Withdrawal by participant|0|||
144657528|NCT00256867|521597030|FG007|Overall Study|Withdrawal by participant|0|||
144657529|NCT01930799|521597037|FG000|Overall Study|Withdrawal by Subject|3|||
144657530|NCT01930799|521597037|FG000|Overall Study|Lost to Follow-up|5|||
144657531|NCT00875017|521597038|FG000|First Intervention|Withdrawal by Subject|1|||
144657532|NCT00875017|521597039|FG001|First Intervention|Withdrawal by Subject|0|||
144657533|NCT00875017|521597040|FG002|First Intervention|Withdrawal by Subject|1|||
144657534|NCT00875017|521597041|FG003|First Intervention|Withdrawal by Subject|0|||
144657535|NCT00875017|521597042|FG004|First Intervention|Withdrawal by Subject|0|||
144657536|NCT00875017|521597043|FG005|First Intervention|Withdrawal by Subject|0|||
144657537|NCT00875017|521597038|FG000|First Intervention|Adverse Event|0|||
144657538|NCT00875017|521597039|FG001|First Intervention|Adverse Event|0|||
144657539|NCT00875017|521597040|FG002|First Intervention|Adverse Event|0|||
144657540|NCT00875017|521597041|FG003|First Intervention|Adverse Event|1|||
144657541|NCT00875017|521597042|FG004|First Intervention|Adverse Event|0|||
144657542|NCT00875017|521597043|FG005|First Intervention|Adverse Event|0|||
144657543|NCT00875017|521597038|FG000|First Intervention|Problems collecting rectal effluent|1|||
144657544|NCT00875017|521597039|FG001|First Intervention|Problems collecting rectal effluent|0|||
144657545|NCT00875017|521597040|FG002|First Intervention|Problems collecting rectal effluent|0|||
144657546|NCT00875017|521597041|FG003|First Intervention|Problems collecting rectal effluent|0|||
144657547|NCT00875017|521597042|FG004|First Intervention|Problems collecting rectal effluent|0|||
144657548|NCT00875017|521597043|FG005|First Intervention|Problems collecting rectal effluent|0|||
144657549|NCT00875017|521597038|FG000|First Intervention|Intolerance to nasogastric tube|0|||
144657550|NCT00875017|521597039|FG001|First Intervention|Intolerance to nasogastric tube|0|||
144657551|NCT00875017|521597040|FG002|First Intervention|Intolerance to nasogastric tube|0|||
144657552|NCT00875017|521597041|FG003|First Intervention|Intolerance to nasogastric tube|0|||
144657553|NCT00875017|521597042|FG004|First Intervention|Intolerance to nasogastric tube|1|||
144657554|NCT00875017|521597043|FG005|First Intervention|Intolerance to nasogastric tube|0|||
144657555|NCT00875017|521597038|FG000|Washout|Problem collecting rectal effluent|0|||
144657556|NCT00875017|521597039|FG001|Washout|Problem collecting rectal effluent|0|||
144657557|NCT00875017|521597040|FG002|Washout|Problem collecting rectal effluent|1|||
144657558|NCT00875017|521597041|FG003|Washout|Problem collecting rectal effluent|0|||
144657559|NCT00875017|521597042|FG004|Washout|Problem collecting rectal effluent|0|||
144657560|NCT00875017|521597043|FG005|Washout|Problem collecting rectal effluent|0|||
144657561|NCT00875017|521597038|FG000|Second Intervention|Adverse Event|0|||
144657562|NCT00875017|521597039|FG001|Second Intervention|Adverse Event|0|||
144657563|NCT00875017|521597040|FG002|Second Intervention|Adverse Event|0|||
144657564|NCT00875017|521597041|FG003|Second Intervention|Adverse Event|1|||
144657565|NCT00875017|521597042|FG004|Second Intervention|Adverse Event|0|||
144657566|NCT00875017|521597043|FG005|Second Intervention|Adverse Event|0|||
144732636|NCT00469417|521877144|FG001|Overall Study|Randomized but not treated|0|||
144657567|NCT00875017|521597038|FG000|Washout|Problems collecting rectal effluent|0|||
144657568|NCT00875017|521597039|FG001|Washout|Problems collecting rectal effluent|1|||
144657569|NCT00875017|521597040|FG002|Washout|Problems collecting rectal effluent|0|||
144657570|NCT00875017|521597041|FG003|Washout|Problems collecting rectal effluent|0|||
144657571|NCT00875017|521597042|FG004|Washout|Problems collecting rectal effluent|0|||
144732637|NCT00909610|521877147|FG000|Period: First Intervention|Adverse Event|0|||
144732638|NCT00909610|521877148|FG001|Period: First Intervention|Adverse Event|1|||
144732639|NCT00909610|521877147|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
144732640|NCT00909610|521877148|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
144732641|NCT00909610|521877147|FG000|Period: Second Intervention|Adverse Event|1|||
144732642|NCT00909610|521877148|FG001|Period: Second Intervention|Adverse Event|0|||
144732643|NCT04123548|521877156|FG000|Overall Study|Withdrawal by Subject|1|||
144732644|NCT04123548|521877156|FG000|Overall Study|Lost to Follow-up|8|||
144732645|NCT04123548|521877156|FG000|Overall Study|Death|4|||
144732646|NCT04123548|521877156|FG000|Overall Study|Reason Not Specified|1|||
144732647|NCT00418184|521877159|FG000|Double-blind Phase|Withdrawal by Subject|22|||
144732648|NCT00418184|521877160|FG001|Double-blind Phase|Withdrawal by Subject|9|||
144732649|NCT00418184|521877159|FG000|Double-blind Phase|Adverse Event|2|||
144732650|NCT00418184|521877160|FG001|Double-blind Phase|Adverse Event|1|||
144732651|NCT00418184|521877159|FG000|Double-blind Phase|Poor compliance|3|||
144297087|NCT01182350|520292440|FG001|Overall Study|Unevaluable for Biopsy|0|||
144657572|NCT00875017|521597043|FG005|Washout|Problems collecting rectal effluent|0|||
144657573|NCT00875017|521597038|FG000|Third Intervention|Adverse Event|0|||
144657574|NCT00875017|521597039|FG001|Third Intervention|Adverse Event|1|||
144657575|NCT00875017|521597040|FG002|Third Intervention|Adverse Event|1|||
144657576|NCT00875017|521597041|FG003|Third Intervention|Adverse Event|0|||
144657577|NCT00875017|521597042|FG004|Third Intervention|Adverse Event|0|||
144657578|NCT00875017|521597043|FG005|Third Intervention|Adverse Event|0|||
144657579|NCT00875017|521597038|FG000|Washout|Withdrawal by Subject|0|||
144657580|NCT00875017|521597039|FG001|Washout|Withdrawal by Subject|0|||
144657581|NCT00875017|521597040|FG002|Washout|Withdrawal by Subject|0|||
144657582|NCT00875017|521597041|FG003|Washout|Withdrawal by Subject|0|||
144657583|NCT00875017|521597042|FG004|Washout|Withdrawal by Subject|1|||
144657584|NCT00875017|521597043|FG005|Washout|Withdrawal by Subject|0|||
144657585|NCT00875017|521597038|FG000|Fourth Intervention|Inability to comply with fasting|0|||
144657586|NCT00875017|521597039|FG001|Fourth Intervention|Inability to comply with fasting|0|||
144657587|NCT00875017|521597040|FG002|Fourth Intervention|Inability to comply with fasting|0|||
144657588|NCT00875017|521597041|FG003|Fourth Intervention|Inability to comply with fasting|0|||
144657589|NCT00875017|521597042|FG004|Fourth Intervention|Inability to comply with fasting|0|||
144657590|NCT00875017|521597043|FG005|Fourth Intervention|Inability to comply with fasting|1|||
144657591|NCT02689219|521597044|FG000|Overall Study|Death|1|||
144657592|NCT02689219|521597045|FG001|Overall Study|Death|1|||
144657593|NCT02689219|521597044|FG000|Overall Study|Disease Progression|10|||
144657594|NCT02689219|521597045|FG001|Overall Study|Disease Progression|6|||
144657595|NCT03342469|521597046|FG000|Overall Study|Withdrawal by Subject|0|||
144657596|NCT03342469|521597047|FG001|Overall Study|Withdrawal by Subject|1|||
144657597|NCT03342469|521597048|FG002|Overall Study|Withdrawal by Subject|0|||
144657598|NCT03342469|521597049|FG003|Overall Study|Withdrawal by Subject|0|||
144657599|NCT05515601|521597055|FG000|Overall Study|Withdrawal by Subject|1|||
144657600|NCT05515601|521597056|FG001|Overall Study|Withdrawal by Subject|3|||
144657601|NCT05515601|521597057|FG002|Overall Study|Withdrawal by Subject|2|||
144657602|NCT05515601|521597058|FG003|Overall Study|Withdrawal by Subject|1|||
144657603|NCT05515601|521597059|FG004|Overall Study|Withdrawal by Subject|1|||
144657604|NCT05515601|521597060|FG005|Overall Study|Withdrawal by Subject|1|||
144657605|NCT05515601|521597055|FG000|Overall Study|Lost to Follow-up|0|||
144657606|NCT05515601|521597056|FG001|Overall Study|Lost to Follow-up|0|||
144657607|NCT05515601|521597057|FG002|Overall Study|Lost to Follow-up|0|||
144657608|NCT05515601|521597058|FG003|Overall Study|Lost to Follow-up|0|||
144657609|NCT05515601|521597059|FG004|Overall Study|Lost to Follow-up|1|||
144657610|NCT05515601|521597060|FG005|Overall Study|Lost to Follow-up|0|||
144657611|NCT00777491|521597061|FG000|Overall Study|Protocol Violation|0|||
144657612|NCT00777491|521597062|FG001|Overall Study|Protocol Violation|2|||
144657613|NCT00777491|521597061|FG000|Overall Study|Did not receive any protocol treatment|2|||
144657614|NCT00777491|521597062|FG001|Overall Study|Did not receive any protocol treatment|0|||
144657615|NCT01689207|521597063|FG000|Overall Study|Adverse Event|0|||
144657616|NCT01689207|521597064|FG001|Overall Study|Adverse Event|1|||
144657617|NCT01689207|521597065|FG002|Overall Study|Adverse Event|0|||
144657618|NCT01689207|521597066|FG003|Overall Study|Adverse Event|0|||
144657619|NCT01689207|521597067|FG004|Overall Study|Adverse Event|2|||
144657620|NCT01689207|521597068|FG005|Overall Study|Adverse Event|1|||
144657621|NCT01689207|521597069|FG006|Overall Study|Adverse Event|0|||
144657622|NCT01689207|521597070|FG007|Overall Study|Adverse Event|0|||
144657623|NCT01689207|521597071|FG008|Overall Study|Adverse Event|1|||
144657624|NCT01689207|521597072|FG009|Overall Study|Adverse Event|0|||
144657625|NCT01689207|521597073|FG010|Overall Study|Adverse Event|0|||
144732652|NCT00418184|521877160|FG001|Double-blind Phase|Poor compliance|1|||
144732653|NCT01247701|521877163|FG000|Overall Study|Death|2|||
144732654|NCT01247701|521877163|FG000|Overall Study|Relapsed|8|||
144732655|NCT04166630|521877164|FG000|Overall Study|Withdrawal by Subject|0|||
144732656|NCT04166630|521877165|FG001|Overall Study|Withdrawal by Subject|1|||
144732657|NCT01838941|521877166|FG000|Overall Study|Adverse Event|1|||
144657626|NCT01912768|521597074|FG000|Overall Study|Adverse Event|2|||
144732658|NCT01838941|521877166|FG000|Overall Study|Withdrawal by Subject|1|||
144214235|NCT01495702|519978660|FG000|Randomized Phase|Lack of Efficacy|2|||
144657627|NCT01912768|521597075|FG001|Overall Study|Adverse Event|0|||
144657628|NCT01912768|521597074|FG000|Overall Study|Lost to Follow-up|2|||
144657629|NCT01912768|521597075|FG001|Overall Study|Lost to Follow-up|1|||
144657630|NCT01912768|521597074|FG000|Overall Study|Withdrawal by Subject|5|||
144657631|NCT01912768|521597075|FG001|Overall Study|Withdrawal by Subject|3|||
144657632|NCT01912768|521597074|FG000|Overall Study|Randomized in error|1|||
144657633|NCT01912768|521597075|FG001|Overall Study|Randomized in error|0|||
144657634|NCT02426658|521597078|FG000|Overall Study|Withdrawal by Subject|1|||
144657635|NCT02426658|521597078|FG000|Overall Study|Patient expired before treatment|2|||
144657636|NCT00524316|521597079|FG000|Overall Study|Withdrawal by Subject|2|||
144657637|NCT00524316|521597079|FG000|Overall Study|Adverse Event|7|||
144657638|NCT00524316|521597079|FG000|Overall Study|Disease Progression|7|||
144657639|NCT00488033|521597080|FG000|Overall Study|Withdrawal by Subject|1|||
144657640|NCT00488033|521597081|FG001|Overall Study|Withdrawal by Subject|0|||
144657641|NCT01204658|521597084|FG000|Primary Phase|Adverse Event|0|||
144657642|NCT01204658|521597085|FG001|Primary Phase|Adverse Event|0|||
144657643|NCT01204658|521597086|FG002|Primary Phase|Adverse Event|1|||
144657644|NCT01204658|521597087|FG003|Primary Phase|Adverse Event|0|||
144657645|NCT03364335|521598402|FG000|Overall Study|Adverse Event|3|||
144657646|NCT03364335|521598403|FG001|Overall Study|Adverse Event|4|||
144657647|NCT03364335|521598404|FG002|Overall Study|Adverse Event|1|||
144657648|NCT03364335|521598405|FG003|Overall Study|Adverse Event|2|||
144657649|NCT03364335|521598406|FG004|Overall Study|Adverse Event|0|||
144657650|NCT03364335|521598402|FG000|Overall Study|Lost to Follow-up|7|||
144657651|NCT03364335|521598403|FG001|Overall Study|Lost to Follow-up|7|||
144657652|NCT03364335|521598404|FG002|Overall Study|Lost to Follow-up|10|||
144657653|NCT03364335|521598405|FG003|Overall Study|Lost to Follow-up|11|||
144657654|NCT03364335|521598406|FG004|Overall Study|Lost to Follow-up|11|||
144657655|NCT01575197|521598407|FG000|Overall Study|Migration out of study area|1|||
144657656|NCT01575197|521598408|FG001|Overall Study|Migration out of study area|5|||
144657657|NCT01575197|521598409|FG002|Overall Study|Migration out of study area|4|||
144657658|NCT01575197|521598407|FG000|Overall Study|SAE|0|||
144657659|NCT01575197|521598408|FG001|Overall Study|SAE|1|||
144657660|NCT01575197|521598409|FG002|Overall Study|SAE|0|||
144657661|NCT01575197|521598407|FG000|Overall Study|Lost to Follow-up|0|||
144657662|NCT01575197|521598408|FG001|Overall Study|Lost to Follow-up|1|||
144657663|NCT01575197|521598409|FG002|Overall Study|Lost to Follow-up|0|||
144657664|NCT01575197|521598407|FG000|Overall Study|Withdrawal by Subject|0|||
144657665|NCT01575197|521598408|FG001|Overall Study|Withdrawal by Subject|1|||
144657666|NCT01575197|521598409|FG002|Overall Study|Withdrawal by Subject|1|||
144657667|NCT01575197|521598407|FG000|Overall Study|Protocol Violation|2|||
144657668|NCT01575197|521598408|FG001|Overall Study|Protocol Violation|1|||
144657669|NCT01575197|521598409|FG002|Overall Study|Protocol Violation|1|||
144657670|NCT00833248|521598413|FG000|Overall Study|Adverse Event|3|||
144657671|NCT00833248|521598414|FG001|Overall Study|Adverse Event|0|||
144657672|NCT00833248|521598413|FG000|Overall Study|Protocol Violation|1|||
144214236|NCT01495702|519978661|FG001|Randomized Phase|Lack of Efficacy|0|||
144214237|NCT01495702|519978660|FG000|Randomized Phase|Investigators Discretion|2|||
144214238|NCT01495702|519978661|FG001|Randomized Phase|Investigators Discretion|0|||
144214239|NCT01495702|519978660|FG000|Randomized Phase|Withdrew Consent|10|||
144214240|NCT01495702|519978661|FG001|Randomized Phase|Withdrew Consent|18|||
144214241|NCT01495702|519978660|FG000|Randomized Phase|Lost to Follow-up|4|||
144214242|NCT01495702|519978661|FG001|Randomized Phase|Lost to Follow-up|3|||
144214243|NCT01495702|519978660|FG000|Randomized Phase|Participant Noncompliance|1|||
144214244|NCT01495702|519978661|FG001|Randomized Phase|Participant Noncompliance|0|||
144214245|NCT01495702|519978660|FG000|Randomized Phase|Protocol Violation|3|||
144214246|NCT01495702|519978661|FG001|Randomized Phase|Protocol Violation|1|||
144214247|NCT00616421|519978662|FG000|Overall Study|Withdrawal by Subject|9|||
144214248|NCT00616421|519978663|FG001|Overall Study|Withdrawal by Subject|11|||
144214249|NCT00616421|519978664|FG002|Overall Study|Withdrawal by Subject|8|||
144214250|NCT00616421|519978662|FG000|Overall Study|Lost to Follow-up|12|||
144214251|NCT00616421|519978663|FG001|Overall Study|Lost to Follow-up|26|||
144214252|NCT00616421|519978664|FG002|Overall Study|Lost to Follow-up|30|||
144214253|NCT00616421|519978662|FG000|Overall Study|Inappropriate enrollment|3|||
144214254|NCT00616421|519978663|FG001|Overall Study|Inappropriate enrollment|0|||
144214255|NCT00616421|519978664|FG002|Overall Study|Inappropriate enrollment|1|||
144214256|NCT00616421|519978662|FG000|Overall Study|Administrative reason|1|||
144657673|NCT00833248|521598414|FG001|Overall Study|Protocol Violation|2|||
144657674|NCT00833248|521598413|FG000|Overall Study|Withdrawal by Subject|0|||
144657675|NCT00833248|521598414|FG001|Overall Study|Withdrawal by Subject|1|||
144657676|NCT00262080|521598418|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
144657677|NCT00262080|521598419|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
144657678|NCT00262080|521598420|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
144657679|NCT00262080|521598418|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
144657680|NCT00262080|521598419|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
144657681|NCT00262080|521598420|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
144657682|NCT00262080|521598418|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
144264619|NCT05616013|520169516|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144264620|NCT05616013|520169517|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144264621|NCT05616013|520169518|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144264622|NCT05616013|520169519|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144264623|NCT05616013|520169520|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
144264624|NCT05616013|520169512|FG000|Overall Study|Participant Decision, Time Constraints|0|||
144264625|NCT05616013|520169513|FG001|Overall Study|Participant Decision, Time Constraints|1|||
144264626|NCT05616013|520169514|FG002|Overall Study|Participant Decision, Time Constraints|0|||
144264627|NCT05616013|520169515|FG003|Overall Study|Participant Decision, Time Constraints|0|||
144264628|NCT05616013|520169516|FG004|Overall Study|Participant Decision, Time Constraints|0|||
144264629|NCT05616013|520169517|FG005|Overall Study|Participant Decision, Time Constraints|0|||
144264630|NCT05616013|520169518|FG006|Overall Study|Participant Decision, Time Constraints|0|||
144264631|NCT05616013|520169519|FG007|Overall Study|Participant Decision, Time Constraints|0|||
144264632|NCT05616013|520169520|FG008|Overall Study|Participant Decision, Time Constraints|0|||
144264633|NCT05616013|520169512|FG000|Overall Study|Prohibited Concomitant Medication|0|||
144264634|NCT05616013|520169513|FG001|Overall Study|Prohibited Concomitant Medication|0|||
144264635|NCT05616013|520169514|FG002|Overall Study|Prohibited Concomitant Medication|1|||
144264636|NCT05616013|520169515|FG003|Overall Study|Prohibited Concomitant Medication|0|||
144264637|NCT05616013|520169516|FG004|Overall Study|Prohibited Concomitant Medication|0|||
144264638|NCT05616013|520169517|FG005|Overall Study|Prohibited Concomitant Medication|0|||
144264639|NCT05616013|520169518|FG006|Overall Study|Prohibited Concomitant Medication|0|||
144264640|NCT05616013|520169519|FG007|Overall Study|Prohibited Concomitant Medication|0|||
144264641|NCT05616013|520169520|FG008|Overall Study|Prohibited Concomitant Medication|0|||
144264642|NCT05616013|520169512|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264643|NCT05616013|520169513|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264644|NCT05616013|520169514|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
144264645|NCT05616013|520169515|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264646|NCT05616013|520169516|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264647|NCT05616013|520169517|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264648|NCT05616013|520169518|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264649|NCT05616013|520169519|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
144264650|NCT05616013|520169520|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
144657683|NCT00262080|521598419|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
144657684|NCT00262080|521598420|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
144657685|NCT00262080|521598418|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
144657686|NCT00262080|521598419|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
144657687|NCT00262080|521598420|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
144264651|NCT05616013|520169512|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264652|NCT05616013|520169513|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264653|NCT05616013|520169514|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264654|NCT05616013|520169515|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
144264655|NCT05616013|520169516|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144657688|NCT00262080|521598418|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
144657689|NCT00262080|521598419|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
144657690|NCT00262080|521598420|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
144657691|NCT00262080|521598418|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
144657692|NCT00262080|521598419|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
144657693|NCT00262080|521598420|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
144657694|NCT01030458|521598427|FG000|Overall Study|Lost to Follow-up|9|||
144657695|NCT01030458|521598428|FG001|Overall Study|Lost to Follow-up|10|||
144657696|NCT01030458|521598427|FG000|Overall Study|Withdrawal by Subject|2|||
144657697|NCT01030458|521598428|FG001|Overall Study|Withdrawal by Subject|3|||
144657698|NCT01030458|521598427|FG000|Overall Study|Logistical reasons|9|||
144657699|NCT01030458|521598428|FG001|Overall Study|Logistical reasons|5|||
144657700|NCT01030458|521598427|FG000|Overall Study|Moved or changed job|6|||
144657701|NCT01030458|521598428|FG001|Overall Study|Moved or changed job|13|||
144657702|NCT01030458|521598427|FG000|Overall Study|Side effect of medication|1|||
144657703|NCT01030458|521598428|FG001|Overall Study|Side effect of medication|1|||
144657704|NCT02420223|521598429|FG000|Overall Study|Adverse Event|1|||
144657705|NCT02420223|521598430|FG001|Overall Study|Adverse Event|0|||
144657706|NCT02420223|521598429|FG000|Overall Study|Physician Decision|0|||
144657707|NCT02420223|521598430|FG001|Overall Study|Physician Decision|2|||
144657708|NCT01361009|521598431|FG000|Overall Study|Protocol Violation|116|||
144657709|NCT01826422|521598432|FG000|Overall Study|Withdrawal by Subject|1|||
144657710|NCT01826422|521598433|FG001|Overall Study|Withdrawal by Subject|3|||
144657711|NCT04009096|521598437|FG000|Overall Study|Withdrawal by Subject|0|||
144264656|NCT05616013|520169517|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264657|NCT05616013|520169518|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264658|NCT05616013|520169519|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264659|NCT05616013|520169520|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
144264660|NCT05616013|520169512|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264661|NCT05616013|520169513|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264662|NCT05616013|520169514|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264663|NCT05616013|520169515|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264664|NCT05616013|520169516|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264665|NCT05616013|520169517|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264666|NCT05616013|520169518|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
144264667|NCT05616013|520169519|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264668|NCT05616013|520169520|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
144264669|NCT05616013|520169512|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264670|NCT05616013|520169513|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264671|NCT05616013|520169514|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264672|NCT05616013|520169515|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264673|NCT05616013|520169516|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264674|NCT05616013|520169517|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264675|NCT05616013|520169518|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264676|NCT05616013|520169519|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
144264677|NCT05616013|520169520|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
144657712|NCT04009096|521598438|FG001|Overall Study|Withdrawal by Subject|7|||
144657713|NCT04009096|521598439|FG002|Overall Study|Withdrawal by Subject|0|||
144657714|NCT04009096|521598437|FG000|Overall Study|Physician Decision|0|||
144657715|NCT04009096|521598438|FG001|Overall Study|Physician Decision|1|||
144657716|NCT04009096|521598439|FG002|Overall Study|Physician Decision|0|||
144657717|NCT05151471|521598440|FG000|Overall Study|Adverse Event|21|||
144657718|NCT05151471|521598441|FG001|Overall Study|Adverse Event|16|||
144657719|NCT05151471|521598440|FG000|Overall Study|Death|1|||
144657720|NCT05151471|521598441|FG001|Overall Study|Death|0|||
144657721|NCT05151471|521598440|FG000|Overall Study|Lost to Follow-up|0|||
144657722|NCT05151471|521598441|FG001|Overall Study|Lost to Follow-up|1|||
144657723|NCT05151471|521598440|FG000|Overall Study|Withdrawal by Subject|7|||
144657724|NCT05151471|521598441|FG001|Overall Study|Withdrawal by Subject|9|||
144657725|NCT05151471|521598440|FG000|Overall Study|Study terminated by sponsor|49|||
144657726|NCT05151471|521598441|FG001|Overall Study|Study terminated by sponsor|47|||
144657727|NCT05151471|521598440|FG000|Overall Study|Other|2|||
144657728|NCT05151471|521598441|FG001|Overall Study|Other|1|||
144657729|NCT03010423|521598442|FG000|Overall Study|Study termination|8|||
144657730|NCT03484923|521598445|FG000|Overall Study|Adverse Event|3|||
144657731|NCT03484923|521598446|FG001|Overall Study|Adverse Event|3|||
144657732|NCT03484923|521598447|FG002|Overall Study|Adverse Event|5|||
144657733|NCT03484923|521598448|FG003|Overall Study|Adverse Event|11|||
144657734|NCT03484923|521598449|FG004|Overall Study|Adverse Event|1|||
144657735|NCT03484923|521598445|FG000|Overall Study|Death|2|||
144657736|NCT03484923|521598446|FG001|Overall Study|Death|2|||
144657737|NCT03484923|521598447|FG002|Overall Study|Death|3|||
144657738|NCT03484923|521598448|FG003|Overall Study|Death|0|||
144657739|NCT03484923|521598449|FG004|Overall Study|Death|1|||
144657740|NCT03484923|521598445|FG000|Overall Study|Physician Decision|6|||
144657741|NCT03484923|521598446|FG001|Overall Study|Physician Decision|7|||
144657742|NCT03484923|521598447|FG002|Overall Study|Physician Decision|6|||
144657743|NCT03484923|521598448|FG003|Overall Study|Physician Decision|3|||
144732659|NCT01034358|521877167|FG000|Overall Study|Withdrawal by Subject|1|||
144732660|NCT01034358|521877167|FG000|Overall Study|Protocol Violation|1|||
144732661|NCT02822235|521877168|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
144732662|NCT02822235|521877169|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
144732663|NCT02822235|521877168|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
144657744|NCT03484923|521598449|FG004|Overall Study|Physician Decision|2|||
144657745|NCT03484923|521598445|FG000|Overall Study|Progressive disease|33|||
144657746|NCT03484923|521598446|FG001|Overall Study|Progressive disease|28|||
144657747|NCT03484923|521598447|FG002|Overall Study|Progressive disease|26|||
144657748|NCT03484923|521598448|FG003|Overall Study|Progressive disease|30|||
144657749|NCT03484923|521598449|FG004|Overall Study|Progressive disease|16|||
144657750|NCT03484923|521598445|FG000|Overall Study|Subject Decision|1|||
144657751|NCT03484923|521598446|FG001|Overall Study|Subject Decision|3|||
144732664|NCT02822235|521877169|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
144732665|NCT02822235|521877168|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
144732666|NCT02822235|521877169|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
144657752|NCT03484923|521598447|FG002|Overall Study|Subject Decision|3|||
144657753|NCT03484923|521598448|FG003|Overall Study|Subject Decision|0|||
144657754|NCT03484923|521598449|FG004|Overall Study|Subject Decision|1|||
144657755|NCT00115349|521598452|FG000|Overall Study|Study closed due to low enrollment.|11|||
144657756|NCT00115349|521598453|FG001|Overall Study|Study closed due to low enrollment.|9|||
144657757|NCT02935634|521598454|FG000|Randomization|Participant withdrew consent|0|||
144657758|NCT02935634|521598455|FG001|Randomization|Participant withdrew consent|1|||
144657759|NCT02935634|521598456|FG002|Randomization|Participant withdrew consent|0|||
144657760|NCT02935634|521598457|FG003|Randomization|Participant withdrew consent|0|||
144657761|NCT02935634|521598458|FG004|Randomization|Participant withdrew consent|0|||
144657762|NCT02935634|521598459|FG005|Randomization|Participant withdrew consent|0|||
144732667|NCT02822235|521877168|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
144732668|NCT02822235|521877169|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
144732669|NCT02822235|521877168|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
144657763|NCT02935634|521598454|FG000|Randomization|Death|2|||
144657764|NCT02935634|521598455|FG001|Randomization|Death|1|||
144657765|NCT02935634|521598456|FG002|Randomization|Death|1|||
144657766|NCT02935634|521598457|FG003|Randomization|Death|0|||
144657767|NCT02935634|521598458|FG004|Randomization|Death|0|||
144657768|NCT02935634|521598459|FG005|Randomization|Death|0|||
144657769|NCT02935634|521598454|FG000|Randomization|Other reasons|0|||
144657770|NCT02935634|521598455|FG001|Randomization|Other reasons|2|||
144657771|NCT02935634|521598456|FG002|Randomization|Other reasons|2|||
144657772|NCT02935634|521598457|FG003|Randomization|Other reasons|0|||
144657773|NCT02935634|521598458|FG004|Randomization|Other reasons|0|||
144657774|NCT02935634|521598459|FG005|Randomization|Other reasons|0|||
144657775|NCT02935634|521598454|FG000|Treatment: Track 1|Disease progression|15|||
144657776|NCT02935634|521598455|FG001|Treatment: Track 1|Disease progression|17|||
144657777|NCT02935634|521598456|FG002|Treatment: Track 1|Disease progression|28|||
144657778|NCT02935634|521598457|FG003|Treatment: Track 1|Disease progression|4|||
144657779|NCT02935634|521598458|FG004|Treatment: Track 1|Disease progression|6|||
144657780|NCT02935634|521598459|FG005|Treatment: Track 1|Disease progression|2|||
144657781|NCT02935634|521598454|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
144657782|NCT02935634|521598455|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
144657783|NCT02935634|521598456|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
144657784|NCT02935634|521598457|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
144657785|NCT02935634|521598458|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
144657786|NCT02935634|521598459|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
144657787|NCT02935634|521598454|FG000|Treatment: Track 1|Lost to Follow-up|1|||
144657788|NCT02935634|521598455|FG001|Treatment: Track 1|Lost to Follow-up|0|||
144657789|NCT02935634|521598456|FG002|Treatment: Track 1|Lost to Follow-up|0|||
144657790|NCT02935634|521598457|FG003|Treatment: Track 1|Lost to Follow-up|0|||
144657791|NCT02935634|521598458|FG004|Treatment: Track 1|Lost to Follow-up|0|||
144657792|NCT02935634|521598459|FG005|Treatment: Track 1|Lost to Follow-up|0|||
144657793|NCT02935634|521598454|FG000|Treatment: Track 1|Study drug toxicity|2|||
144657794|NCT02935634|521598455|FG001|Treatment: Track 1|Study drug toxicity|1|||
144657795|NCT02935634|521598456|FG002|Treatment: Track 1|Study drug toxicity|3|||
144657796|NCT02935634|521598457|FG003|Treatment: Track 1|Study drug toxicity|0|||
144657797|NCT02935634|521598458|FG004|Treatment: Track 1|Study drug toxicity|0|||
144657798|NCT02935634|521598459|FG005|Treatment: Track 1|Study drug toxicity|1|||
144657799|NCT02935634|521598454|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
144657800|NCT02935634|521598455|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
144657801|NCT02935634|521598456|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
144657802|NCT02935634|521598457|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
144657803|NCT02935634|521598458|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
144657804|NCT02935634|521598459|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
144657805|NCT02935634|521598454|FG000|Treatment: Track 1|Participant withdrew consent|2|||
144657806|NCT02935634|521598455|FG001|Treatment: Track 1|Participant withdrew consent|0|||
144214257|NCT00616421|519978663|FG001|Overall Study|Administrative reason|0|||
144214258|NCT00616421|519978664|FG002|Overall Study|Administrative reason|0|||
144657807|NCT02935634|521598456|FG002|Treatment: Track 1|Participant withdrew consent|1|||
144657808|NCT02935634|521598457|FG003|Treatment: Track 1|Participant withdrew consent|0|||
144657809|NCT02935634|521598458|FG004|Treatment: Track 1|Participant withdrew consent|1|||
144657810|NCT02935634|521598459|FG005|Treatment: Track 1|Participant withdrew consent|0|||
144657811|NCT02935634|521598454|FG000|Treatment: Track 1|Other reasons|0|||
144657812|NCT02935634|521598455|FG001|Treatment: Track 1|Other reasons|0|||
144657813|NCT02935634|521598456|FG002|Treatment: Track 1|Other reasons|2|||
144657814|NCT02935634|521598457|FG003|Treatment: Track 1|Other reasons|0|||
144657815|NCT02935634|521598458|FG004|Treatment: Track 1|Other reasons|0|||
144657816|NCT02935634|521598459|FG005|Treatment: Track 1|Other reasons|0|||
144657817|NCT02935634|521598454|FG000|Treatment: Track 2|Disease progression|13|||
144657818|NCT02935634|521598455|FG001|Treatment: Track 2|Disease progression|26|||
144657819|NCT02935634|521598456|FG002|Treatment: Track 2|Disease progression|20|||
144657820|NCT02935634|521598457|FG003|Treatment: Track 2|Disease progression|5|||
144657821|NCT02935634|521598458|FG004|Treatment: Track 2|Disease progression|1|||
144657822|NCT02935634|521598459|FG005|Treatment: Track 2|Disease progression|4|||
144657823|NCT02935634|521598454|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
144657824|NCT02935634|521598455|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
144657825|NCT02935634|521598456|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
144657826|NCT02935634|521598457|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
144657827|NCT02935634|521598458|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
144657828|NCT02935634|521598459|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
144657829|NCT02935634|521598454|FG000|Treatment: Track 2|Study drug toxicity|7|||
144657830|NCT02935634|521598455|FG001|Treatment: Track 2|Study drug toxicity|3|||
144657831|NCT02935634|521598456|FG002|Treatment: Track 2|Study drug toxicity|0|||
144657832|NCT02935634|521598457|FG003|Treatment: Track 2|Study drug toxicity|0|||
144657833|NCT02935634|521598458|FG004|Treatment: Track 2|Study drug toxicity|0|||
144657834|NCT02935634|521598459|FG005|Treatment: Track 2|Study drug toxicity|0|||
144657835|NCT02935634|521598454|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
144657836|NCT02935634|521598455|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
144657837|NCT02935634|521598456|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
144657838|NCT02935634|521598457|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
144657839|NCT02935634|521598458|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
144657840|NCT02935634|521598459|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
144657841|NCT02935634|521598454|FG000|Treatment: Track 2|Participant withdrew consent|0|||
144657842|NCT02935634|521598455|FG001|Treatment: Track 2|Participant withdrew consent|1|||
144657843|NCT02935634|521598456|FG002|Treatment: Track 2|Participant withdrew consent|1|||
144657844|NCT02935634|521598457|FG003|Treatment: Track 2|Participant withdrew consent|0|||
144657845|NCT02935634|521598458|FG004|Treatment: Track 2|Participant withdrew consent|1|||
144657846|NCT02935634|521598459|FG005|Treatment: Track 2|Participant withdrew consent|0|||
144657847|NCT05122650|521598463|FG000|Overall Study|Adverse Event|4|||
144657848|NCT05122650|521598464|FG001|Overall Study|Adverse Event|16|||
144657849|NCT05122650|521598465|FG002|Overall Study|Adverse Event|11|||
144657850|NCT05122650|521598466|FG003|Overall Study|Adverse Event|12|||
144657851|NCT05122650|521598463|FG000|Overall Study|Lack of Efficacy|0|||
144657852|NCT05122650|521598464|FG001|Overall Study|Lack of Efficacy|1|||
144657853|NCT05122650|521598465|FG002|Overall Study|Lack of Efficacy|1|||
144657854|NCT05122650|521598466|FG003|Overall Study|Lack of Efficacy|2|||
144657855|NCT05122650|521598463|FG000|Overall Study|Lost to Follow-up|1|||
144657856|NCT05122650|521598464|FG001|Overall Study|Lost to Follow-up|1|||
144657857|NCT05122650|521598465|FG002|Overall Study|Lost to Follow-up|3|||
144657858|NCT05122650|521598466|FG003|Overall Study|Lost to Follow-up|0|||
144657859|NCT05122650|521598463|FG000|Overall Study|Non-compliance with study intervention|0|||
144657860|NCT05122650|521598464|FG001|Overall Study|Non-compliance with study intervention|0|||
144657861|NCT05122650|521598465|FG002|Overall Study|Non-compliance with study intervention|0|||
144657862|NCT05122650|521598466|FG003|Overall Study|Non-compliance with study intervention|2|||
144657863|NCT05122650|521598463|FG000|Overall Study|Protocol Violation|0|||
144657864|NCT05122650|521598464|FG001|Overall Study|Protocol Violation|1|||
144657865|NCT05122650|521598465|FG002|Overall Study|Protocol Violation|0|||
144657866|NCT05122650|521598466|FG003|Overall Study|Protocol Violation|1|||
144657867|NCT05122650|521598463|FG000|Overall Study|Randomized by mistake|0|||
144657868|NCT05122650|521598464|FG001|Overall Study|Randomized by mistake|0|||
144657869|NCT05122650|521598465|FG002|Overall Study|Randomized by mistake|3|||
144657870|NCT05122650|521598466|FG003|Overall Study|Randomized by mistake|2|||
144657871|NCT05122650|521598463|FG000|Overall Study|Sponsor request|0|||
144657872|NCT05122650|521598464|FG001|Overall Study|Sponsor request|1|||
144657873|NCT05122650|521598465|FG002|Overall Study|Sponsor request|1|||
144657874|NCT05122650|521598466|FG003|Overall Study|Sponsor request|2|||
144657875|NCT05122650|521598463|FG000|Overall Study|Withdrawal by Subject|3|||
144657876|NCT05122650|521598464|FG001|Overall Study|Withdrawal by Subject|7|||
144657877|NCT05122650|521598465|FG002|Overall Study|Withdrawal by Subject|4|||
144657878|NCT05122650|521598466|FG003|Overall Study|Withdrawal by Subject|8|||
144657879|NCT05122650|521598463|FG000|Overall Study|Other|5|||
144214259|NCT00616421|519978662|FG000|Overall Study|Protocol Violation|0|||
144214260|NCT00616421|519978663|FG001|Overall Study|Protocol Violation|1|||
144214261|NCT00616421|519978664|FG002|Overall Study|Protocol Violation|2|||
144657880|NCT05122650|521598464|FG001|Overall Study|Other|0|||
144657881|NCT05122650|521598465|FG002|Overall Study|Other|0|||
144657882|NCT05122650|521598466|FG003|Overall Study|Other|0|||
144657883|NCT00610935|521598469|FG000|Overall Study|Lost to Follow-up|0|||
144657884|NCT00610935|521598470|FG001|Overall Study|Lost to Follow-up|1|||
144657885|NCT00610935|521598469|FG000|Overall Study|Withdrawal by Subject|0|||
144657886|NCT00610935|521598470|FG001|Overall Study|Withdrawal by Subject|2|||
144657887|NCT00610935|521598469|FG000|Overall Study|Sponsor Discontinuation|1|||
144657888|NCT00610935|521598470|FG001|Overall Study|Sponsor Discontinuation|0|||
144657889|NCT01842620|521598475|FG000|Period 1|Withdrawal by Subject|1|||
144214262|NCT00616421|519978662|FG000|Overall Study|Unable to classify|1|||
144264678|NCT05616013|520169512|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264679|NCT05616013|520169513|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264680|NCT05616013|520169514|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264681|NCT05616013|520169515|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264682|NCT05616013|520169516|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264683|NCT05616013|520169517|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264684|NCT05616013|520169518|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
144657890|NCT01842620|521598476|FG001|Period 1|Withdrawal by Subject|0|||
144657891|NCT01477892|521598479|FG000|Overall Study|Withdrawal by Subject|0|||
144657892|NCT01477892|521598480|FG001|Overall Study|Withdrawal by Subject|2|||
144657893|NCT01921257|521598481|FG000|Overall Study|Adverse Event|1|||
144657894|NCT01921257|521598481|FG000|Overall Study|Protocol Violation|1|||
144657895|NCT01921257|521598481|FG000|Overall Study|Withdrawal by Subject|1|||
144657896|NCT00364845|521598482|FG000|Overall Study|Adverse Event|1|||
144657897|NCT00364845|521598483|FG001|Overall Study|Adverse Event|0|||
144657898|NCT00364845|521598482|FG000|Overall Study|Withdrawal by Subject|2|||
144657899|NCT00364845|521598483|FG001|Overall Study|Withdrawal by Subject|1|||
144657900|NCT00364845|521598482|FG000|Overall Study|Physician Decision|8|||
144657901|NCT00364845|521598483|FG001|Overall Study|Physician Decision|8|||
144657902|NCT00364845|521598482|FG000|Overall Study|Lost to Follow-up|0|||
144657903|NCT00364845|521598483|FG001|Overall Study|Lost to Follow-up|1|||
144657904|NCT00364845|521598482|FG000|Overall Study|Death|0|||
144657905|NCT00364845|521598483|FG001|Overall Study|Death|1|||
144657906|NCT01199263|521598484|FG000|Overall Study|Ineligible|0|||
144657907|NCT01199263|521598485|FG001|Overall Study|Ineligible|2|||
144657908|NCT01199263|521598484|FG000|Overall Study|Never Treated|6|||
144657909|NCT01199263|521598485|FG001|Overall Study|Never Treated|0|||
144657910|NCT03255291|521598486|FG000|Overall Study|Determined to be ineligible|10|||
144657911|NCT03255291|521598487|FG001|Overall Study|Determined to be ineligible|12|||
144657912|NCT03255291|521598488|FG002|Overall Study|Determined to be ineligible|6|||
144657913|NCT03255291|521598489|FG003|Overall Study|Determined to be ineligible|6|||
144657914|NCT03255291|521598490|FG004|Overall Study|Determined to be ineligible|5|||
144657915|NCT03255291|521598491|FG005|Overall Study|Determined to be ineligible|10|||
144657916|NCT03255291|521598486|FG000|Overall Study|Baseline data collection issues|3|||
144657917|NCT03255291|521598487|FG001|Overall Study|Baseline data collection issues|0|||
144657918|NCT03255291|521598488|FG002|Overall Study|Baseline data collection issues|0|||
144657919|NCT03255291|521598489|FG003|Overall Study|Baseline data collection issues|0|||
144657920|NCT03255291|521598490|FG004|Overall Study|Baseline data collection issues|2|||
144657921|NCT03255291|521598491|FG005|Overall Study|Baseline data collection issues|0|||
144657922|NCT01515306|521598492|FG000|Overall Study|Adverse Event|3|||
144657923|NCT01515306|521598493|FG001|Overall Study|Adverse Event|2|||
144657924|NCT01515306|521598492|FG000|Overall Study|Progressive Disease|19|||
144657925|NCT01515306|521598493|FG001|Overall Study|Progressive Disease|9|||
144657926|NCT01515306|521598492|FG000|Overall Study|Withdrawal by Subject|1|||
144657927|NCT01515306|521598493|FG001|Overall Study|Withdrawal by Subject|2|||
144657928|NCT01515306|521598492|FG000|Overall Study|Physician Decision|1|||
144657929|NCT01515306|521598493|FG001|Overall Study|Physician Decision|1|||
144657930|NCT03591146|521598504|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
144657931|NCT03591146|521598505|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
144657932|NCT03591146|521598506|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
144657933|NCT03591146|521598507|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
144657934|NCT03591146|521598508|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
144657935|NCT03591146|521598504|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
144657936|NCT03591146|521598505|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
144657937|NCT03591146|521598506|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
144657938|NCT03591146|521598507|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
144657939|NCT03591146|521598508|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
144657940|NCT03591146|521598504|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
144657941|NCT03591146|521598505|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
144657942|NCT03591146|521598506|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
144657943|NCT03591146|521598507|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
144657944|NCT03591146|521598508|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
144657945|NCT03591146|521598504|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
144657946|NCT03591146|521598505|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
144657947|NCT03591146|521598506|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
144657948|NCT03591146|521598507|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
144657949|NCT03591146|521598508|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
144657950|NCT04369430|521598509|FG000|Overall Study|Adverse Event|2|||
144657951|NCT04369430|521598510|FG001|Overall Study|Adverse Event|3|||
144657952|NCT04369430|521598509|FG000|Overall Study|Death|1|||
144657953|NCT04369430|521598510|FG001|Overall Study|Death|0|||
144657954|NCT04369430|521598509|FG000|Overall Study|Withdrawal by Subject|4|||
144657955|NCT04369430|521598510|FG001|Overall Study|Withdrawal by Subject|3|||
144264685|NCT05616013|520169519|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
144264686|NCT05616013|520169520|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
144264687|NCT00447902|520169521|FG000|Overall Study|Adverse Event|0|||
144264688|NCT00447902|520169522|FG001|Overall Study|Adverse Event|3|||
144264689|NCT00447902|520169521|FG000|Overall Study|Protocol Violation|1|||
144264690|NCT00447902|520169522|FG001|Overall Study|Protocol Violation|0|||
144264691|NCT00447902|520169521|FG000|Overall Study|Withdrawal by Subject|0|||
144264692|NCT00447902|520169522|FG001|Overall Study|Withdrawal by Subject|1|||
144264693|NCT00447902|520169521|FG000|Overall Study|included patients who discontinued|1|||
144264694|NCT00447902|520169522|FG001|Overall Study|included patients who discontinued|1|||
144264695|NCT00447902|520169521|FG000|Overall Study|Lack of Efficacy|2|||
144264696|NCT00447902|520169522|FG001|Overall Study|Lack of Efficacy|1|||
144264697|NCT01386606|520171568|FG000|Overall Study|Adverse Event|0|||
144264698|NCT01386606|520171569|FG001|Overall Study|Adverse Event|1|||
144264699|NCT01386606|520171570|FG002|Overall Study|Adverse Event|0|||
144264700|NCT01386606|520171571|FG003|Overall Study|Adverse Event|0|||
144264701|NCT01386606|520171568|FG000|Overall Study|Withdrawal by Subject|0|||
144264702|NCT01386606|520171569|FG001|Overall Study|Withdrawal by Subject|1|||
144264703|NCT01386606|520171570|FG002|Overall Study|Withdrawal by Subject|1|||
144264704|NCT01386606|520171571|FG003|Overall Study|Withdrawal by Subject|0|||
144264705|NCT01386606|520171568|FG000|Overall Study|Protocol Violation|1|||
144264706|NCT01386606|520171569|FG001|Overall Study|Protocol Violation|0|||
144264707|NCT01386606|520171570|FG002|Overall Study|Protocol Violation|1|||
144264708|NCT01386606|520171571|FG003|Overall Study|Protocol Violation|1|||
144264709|NCT01386606|520171568|FG000|Overall Study|Lost to Follow-up|2|||
144264710|NCT01386606|520171569|FG001|Overall Study|Lost to Follow-up|0|||
144264711|NCT01386606|520171570|FG002|Overall Study|Lost to Follow-up|0|||
144264712|NCT01386606|520171571|FG003|Overall Study|Lost to Follow-up|0|||
144264713|NCT01386606|520171568|FG000|Overall Study|Subject incarcerated|0|||
144264714|NCT01386606|520171569|FG001|Overall Study|Subject incarcerated|1|||
144657956|NCT04369430|521598509|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
144657957|NCT04369430|521598510|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
144657958|NCT04369430|521598509|FG000|Overall Study|Lost to Follow-up|0|||
144657959|NCT04369430|521598510|FG001|Overall Study|Lost to Follow-up|1|||
144657960|NCT04737031|521598511|FG000|Overall Study|Patients who did not have a treatment visit|0|||
144657961|NCT04737031|521598512|FG001|Overall Study|Patients who did not have a treatment visit|31|||
144657962|NCT04737031|521598513|FG002|Overall Study|Patients who did not have a treatment visit|93|||
144657963|NCT04737031|521598514|FG003|Overall Study|Patients who did not have a treatment visit|227|||
144657964|NCT00444626|521598519|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
144657965|NCT00444626|521598519|FG000|Initial Treatment Period|Adverse Event|1|||
144657966|NCT00444626|521598519|FG000|Initial Treatment Period|Lost to Follow-up|9|||
144657967|NCT00008138|521598520|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
144657968|NCT00008138|521598520|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
144657969|NCT00008138|521598520|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
144657970|NCT00008138|521598520|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
144657971|NCT00008138|521598520|FG000|Interval Debulking|Withdrawal by Subject|2|||
144657972|NCT00008138|521598520|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
144657973|NCT00008138|521598520|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
144657974|NCT00008138|521598520|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
144657975|NCT03453151|521598521|FG000|Overall Study|Withdrawal by Subject|1|||
144657976|NCT03453151|521598521|FG000|Overall Study|Physician Decision|3|||
144657977|NCT04594239|521598527|FG000|Overall Study|Withdrawal by Subject|3|||
144657978|NCT04594239|521598528|FG001|Overall Study|Withdrawal by Subject|4|||
144657979|NCT04594239|521598529|FG002|Overall Study|Withdrawal by Subject|2|||
144657980|NCT04594239|521598530|FG003|Overall Study|Withdrawal by Subject|4|||
144657981|NCT04594239|521598527|FG000|Overall Study|Lost to Follow-up|8|||
144657982|NCT04594239|521598528|FG001|Overall Study|Lost to Follow-up|5|||
144657983|NCT04594239|521598529|FG002|Overall Study|Lost to Follow-up|4|||
144657984|NCT04594239|521598530|FG003|Overall Study|Lost to Follow-up|6|||
144657985|NCT04594239|521598527|FG000|Overall Study|Subject relocated|0|||
144657986|NCT04594239|521598528|FG001|Overall Study|Subject relocated|0|||
144264715|NCT01386606|520171570|FG002|Overall Study|Subject incarcerated|0|||
144264716|NCT01386606|520171571|FG003|Overall Study|Subject incarcerated|0|||
144264717|NCT01386606|520171568|FG000|Overall Study|Unable to draw PK|1|||
144657987|NCT04594239|521598529|FG002|Overall Study|Subject relocated|0|||
144657988|NCT04594239|521598530|FG003|Overall Study|Subject relocated|1|||
144657989|NCT00091390|521598531|FG000|Overall Study|Protocol Violation|1|||
144657990|NCT00091390|521598531|FG000|Overall Study|No protocol treatment|3|||
144657991|NCT03229759|521598539|FG000|Overall Study|Screen Failure|30|||
144657992|NCT03725202|521600148|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
144657993|NCT03725202|521600149|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
144657994|NCT03725202|521600150|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
144657995|NCT03725202|521600151|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
144657996|NCT03725202|521600152|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
144657997|NCT03725202|521600153|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
144732670|NCT02822235|521877169|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
144732671|NCT02822235|521877168|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
144732672|NCT02822235|521877169|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
144732673|NCT00627016|521877172|FG000|Overall Study|Adverse Event|1|||
144732674|NCT00627016|521877173|FG001|Overall Study|Adverse Event|1|||
144732675|NCT00627016|521877172|FG000|Overall Study|Protocol Violation|0|||
144732676|NCT00627016|521877173|FG001|Overall Study|Protocol Violation|2|||
144732677|NCT00627016|521877172|FG000|Overall Study|Lost to Follow-up|0|||
144732678|NCT00627016|521877173|FG001|Overall Study|Lost to Follow-up|1|||
144732679|NCT00627016|521877172|FG000|Overall Study|Withdrawal by Subject|2|||
144732680|NCT00627016|521877173|FG001|Overall Study|Withdrawal by Subject|1|||
144732681|NCT00627016|521877172|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
144732682|NCT00627016|521877173|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
144732683|NCT00627016|521877172|FG000|Overall Study|Lack of Efficacy|1|||
144732684|NCT00627016|521877173|FG001|Overall Study|Lack of Efficacy|0|||
144732685|NCT00627016|521877172|FG000|Overall Study|Placed on Excluded Drugs|1|||
144732686|NCT00627016|521877173|FG001|Overall Study|Placed on Excluded Drugs|0|||
144732687|NCT00627016|521877172|FG000|Overall Study|Pregnancy|1|||
144732688|NCT00627016|521877173|FG001|Overall Study|Pregnancy|0|||
144732689|NCT01534663|521877174|FG000|Overall Study|Lost to Follow-up|0|||
144214263|NCT00616421|519978663|FG001|Overall Study|Unable to classify|0|||
144214264|NCT00616421|519978664|FG002|Overall Study|Unable to classify|0|||
144214265|NCT04152863|519978665|FG000|Overall Study|Death|13|||
144657998|NCT03725202|521600154|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
144657999|NCT03725202|521600155|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
144658000|NCT03725202|521600148|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
144658001|NCT03725202|521600149|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
144658002|NCT03725202|521600150|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
144658003|NCT03725202|521600151|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
144658004|NCT03725202|521600152|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
144658005|NCT03725202|521600153|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
144658006|NCT03725202|521600154|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
144658007|NCT03725202|521600155|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
144658008|NCT03725202|521600148|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
144658009|NCT03725202|521600149|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658010|NCT03725202|521600150|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658011|NCT03725202|521600151|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658012|NCT03725202|521600152|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658013|NCT03725202|521600153|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658014|NCT03725202|521600154|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658015|NCT03725202|521600155|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
144658016|NCT03725202|521600148|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
144658017|NCT03725202|521600149|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144658018|NCT03725202|521600150|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144732690|NCT01534663|521877175|FG001|Overall Study|Lost to Follow-up|2|||
144732691|NCT01534663|521877174|FG000|Overall Study|Adverse Event|2|||
144732692|NCT01534663|521877175|FG001|Overall Study|Adverse Event|1|||
144732693|NCT04088760|521877178|FG000|Overall Study|Physician Decision|1|||
144214266|NCT04152863|519978666|FG001|Overall Study|Death|12|||
144214267|NCT04152863|519978667|FG002|Overall Study|Death|7|||
144214268|NCT04152863|519978665|FG000|Overall Study|Physician Decision|1|||
144214269|NCT04152863|519978666|FG001|Overall Study|Physician Decision|1|||
144214270|NCT04152863|519978667|FG002|Overall Study|Physician Decision|1|||
144214271|NCT04152863|519978665|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
144214272|NCT04152863|519978666|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
144214273|NCT04152863|519978667|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
144214274|NCT04152863|519978665|FG000|Overall Study|Withdrawal by Subject|2|||
144214275|NCT04152863|519978666|FG001|Overall Study|Withdrawal by Subject|1|||
144214276|NCT04152863|519978667|FG002|Overall Study|Withdrawal by Subject|3|||
144214277|NCT03790657|519978672|FG000|Overall Study|Adverse Event|1|||
144214278|NCT03790657|519978673|FG001|Overall Study|Adverse Event|1|||
144214279|NCT03790657|519978672|FG000|Overall Study|Withdrawal by Subject|1|||
144214280|NCT03790657|519978673|FG001|Overall Study|Withdrawal by Subject|1|||
144732694|NCT00377260|521877179|FG000|Overall Study|Lost to Follow-up|0|||
144732695|NCT00377260|521877180|FG001|Overall Study|Lost to Follow-up|1|||
144732696|NCT00377260|521877179|FG000|Overall Study|Withdrawal by Subject|2|||
144732697|NCT00377260|521877180|FG001|Overall Study|Withdrawal by Subject|4|||
144732698|NCT00829530|521877181|FG000|First Intervention|Adverse Event|0|||
144732699|NCT00829530|521877182|FG001|First Intervention|Adverse Event|1|||
144732700|NCT00829530|521877181|FG000|First Intervention|Intolerance to Venopuncture|0|||
144214281|NCT02276807|519978674|FG000|Overall Study|Withdrawal by Subject|8|||
144214282|NCT02276807|519978675|FG001|Overall Study|Withdrawal by Subject|7|||
144214283|NCT02276807|519978674|FG000|Overall Study|Lost to Follow-up|10|||
144658019|NCT03725202|521600151|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144658020|NCT03725202|521600152|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144658021|NCT03725202|521600153|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144658022|NCT03725202|521600154|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144658023|NCT03725202|521600155|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
144658024|NCT03725202|521600148|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
144658025|NCT03725202|521600149|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
144658026|NCT03725202|521600150|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
144658027|NCT03725202|521600151|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
144658028|NCT03725202|521600152|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
144658029|NCT03725202|521600153|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
144658030|NCT03725202|521600154|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
144658031|NCT03725202|521600155|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
144658032|NCT03725202|521600148|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658033|NCT03725202|521600149|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658034|NCT03725202|521600150|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
144658035|NCT03725202|521600151|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658036|NCT03725202|521600152|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658037|NCT03725202|521600153|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658038|NCT03725202|521600154|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658039|NCT03725202|521600155|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
144658040|NCT03725202|521600148|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
144658041|NCT03725202|521600149|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
144658042|NCT03725202|521600150|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
144658043|NCT03725202|521600151|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
144658044|NCT03725202|521600152|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
144658045|NCT03725202|521600153|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
144658046|NCT03725202|521600154|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
144658047|NCT03725202|521600155|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
144658048|NCT03725202|521600148|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
144658049|NCT03725202|521600149|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
144658050|NCT03725202|521600150|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
144658051|NCT03725202|521600151|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
144658052|NCT03725202|521600152|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
144658053|NCT03725202|521600153|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
144658054|NCT03725202|521600154|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
144658055|NCT03725202|521600155|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
144658056|NCT03725202|521600148|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
144658057|NCT03725202|521600149|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
144658058|NCT03725202|521600150|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
144658059|NCT03725202|521600151|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
144658060|NCT03725202|521600152|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
144658061|NCT03725202|521600153|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
144658062|NCT03725202|521600154|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
144658063|NCT03725202|521600155|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
144658064|NCT03725202|521600148|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658065|NCT03725202|521600149|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658066|NCT03725202|521600150|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658067|NCT03725202|521600151|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658068|NCT03725202|521600152|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658069|NCT03725202|521600153|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658070|NCT03725202|521600154|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
144658071|NCT03725202|521600155|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
144658072|NCT03725202|521600148|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144658073|NCT03725202|521600149|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144658074|NCT03725202|521600150|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144658075|NCT03725202|521600151|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144658076|NCT03725202|521600152|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144658077|NCT03725202|521600153|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
144658078|NCT03725202|521600154|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144658079|NCT03725202|521600155|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
144214284|NCT02276807|519978675|FG001|Overall Study|Lost to Follow-up|10|||
144214285|NCT02370238|519978683|FG000|Overall Study|Death|42|||
144658080|NCT03725202|521600148|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
144658081|NCT03725202|521600149|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
144658082|NCT03725202|521600150|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
144658083|NCT03725202|521600151|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
144658084|NCT03725202|521600152|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
144658085|NCT03725202|521600153|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
144658086|NCT03725202|521600154|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
144658087|NCT03725202|521600155|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
144658088|NCT00434512|521600162|FG000|Overall Study|Migrated/moved from study area|0|||
144658089|NCT00434512|521600163|FG001|Overall Study|Migrated/moved from study area|0|||
144732701|NCT00829530|521877182|FG001|First Intervention|Intolerance to Venopuncture|1|||
144732702|NCT00829530|521877181|FG000|Second Intervention|Intolerance to Venopuncture|1|||
144732703|NCT00829530|521877182|FG001|Second Intervention|Intolerance to Venopuncture|0|||
144732704|NCT01391793|521877183|FG000|Overall Study|Ineligible|3|||
144732705|NCT01391793|521877184|FG001|Overall Study|Ineligible|0|||
144732706|NCT01391793|521877183|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
144732707|NCT01391793|521877184|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
144732708|NCT01391793|521877183|FG000|Overall Study|No DMSA|73|||
144732709|NCT01391793|521877184|FG001|Overall Study|No DMSA|57|||
144732710|NCT01015625|521877185|FG000|Overall Study|Lost to Follow-up|3|||
144732711|NCT01015625|521877186|FG001|Overall Study|Lost to Follow-up|1|||
144658090|NCT00434512|521600164|FG002|Overall Study|Migrated/moved from study area|0|||
144658091|NCT00434512|521600165|FG003|Overall Study|Migrated/moved from study area|1|||
144658092|NCT00434512|521600166|FG004|Overall Study|Migrated/moved from study area|1|||
144658093|NCT00434512|521600167|FG005|Overall Study|Migrated/moved from study area|1|||
144658094|NCT00434512|521600162|FG000|Overall Study|Other|0|||
144658095|NCT00434512|521600163|FG001|Overall Study|Other|1|||
144658096|NCT00434512|521600164|FG002|Overall Study|Other|0|||
144658097|NCT00434512|521600165|FG003|Overall Study|Other|0|||
144658098|NCT00434512|521600166|FG004|Overall Study|Other|0|||
144658099|NCT00434512|521600167|FG005|Overall Study|Other|0|||
144658100|NCT03303092|521600168|FG000|Overall Study|Adverse Event|1|||
144658101|NCT03303092|521600169|FG001|Overall Study|Adverse Event|0|||
144658102|NCT03303092|521600170|FG002|Overall Study|Adverse Event|1|||
144658103|NCT03303092|521600168|FG000|Overall Study|Protocol Violation|1|||
144658104|NCT03303092|521600169|FG001|Overall Study|Protocol Violation|5|||
144658105|NCT03303092|521600170|FG002|Overall Study|Protocol Violation|1|||
144658106|NCT03303092|521600168|FG000|Overall Study|Withdrawal by Subject|1|||
144658107|NCT03303092|521600169|FG001|Overall Study|Withdrawal by Subject|1|||
144658108|NCT03303092|521600170|FG002|Overall Study|Withdrawal by Subject|3|||
144658109|NCT05906732|521600176|FG000|Overall Study|Withdrawal by Subject|1|||
144658110|NCT05906732|521600177|FG001|Overall Study|Withdrawal by Subject|0|||
144658111|NCT05906732|521600178|FG002|Overall Study|Withdrawal by Subject|0|||
144658112|NCT05906732|521600179|FG003|Overall Study|Withdrawal by Subject|0|||
144658113|NCT05906732|521600176|FG000|Overall Study|Physician Decision|2|||
144658114|NCT05906732|521600177|FG001|Overall Study|Physician Decision|4|||
144658115|NCT05906732|521600178|FG002|Overall Study|Physician Decision|0|||
144658116|NCT05906732|521600179|FG003|Overall Study|Physician Decision|0|||
144658117|NCT02052778|521600180|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
144658118|NCT02052778|521600181|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
144658119|NCT02052778|521600182|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
144658120|NCT02052778|521600183|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
144658121|NCT02052778|521600184|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
144658122|NCT02052778|521600185|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
144658123|NCT02052778|521600186|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658124|NCT02052778|521600187|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
144658125|NCT02052778|521600188|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
144658126|NCT02052778|521600189|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
144658127|NCT02052778|521600190|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
144658128|NCT02052778|521600191|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
144658129|NCT02052778|521600192|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
144658130|NCT02052778|521600193|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
144658131|NCT02052778|521600194|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658132|NCT02052778|521600195|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658133|NCT02052778|521600196|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658134|NCT02052778|521600197|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658135|NCT02052778|521600198|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658136|NCT02052778|521600199|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658137|NCT02052778|521600200|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144732712|NCT01015625|521877185|FG000|Overall Study|Withdrawal by Subject|2|||
144732713|NCT01015625|521877186|FG001|Overall Study|Withdrawal by Subject|3|||
144214286|NCT02370238|519978684|FG001|Overall Study|Death|35|||
144214287|NCT02370238|519978683|FG000|Overall Study|Lost to Follow-up|1|||
144658138|NCT02052778|521600201|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658139|NCT02052778|521600202|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
144658140|NCT02052778|521600180|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
144658141|NCT02052778|521600181|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
144658142|NCT02052778|521600182|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
144658143|NCT02052778|521600183|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
144658144|NCT02052778|521600184|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
144658145|NCT02052778|521600185|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
144658146|NCT02052778|521600186|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
144658147|NCT02052778|521600187|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
144658148|NCT02052778|521600188|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
144658149|NCT02052778|521600189|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658150|NCT02052778|521600190|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658151|NCT02052778|521600191|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
144658152|NCT02052778|521600192|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
144658153|NCT02052778|521600193|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
144658154|NCT02052778|521600194|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658155|NCT02052778|521600195|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658156|NCT02052778|521600196|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658157|NCT02052778|521600197|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658158|NCT02052778|521600198|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658159|NCT02052778|521600199|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658160|NCT02052778|521600200|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658161|NCT02052778|521600201|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658162|NCT02052778|521600202|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
144658163|NCT02052778|521600180|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658164|NCT02052778|521600181|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658165|NCT02052778|521600182|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658166|NCT02052778|521600183|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658167|NCT02052778|521600184|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658168|NCT02052778|521600185|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658169|NCT02052778|521600186|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658170|NCT02052778|521600187|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658171|NCT02052778|521600188|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658172|NCT02052778|521600189|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658173|NCT02052778|521600190|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658174|NCT02052778|521600191|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658175|NCT02052778|521600192|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658176|NCT02052778|521600193|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
144732714|NCT01015625|521877185|FG000|Overall Study|Physician Decision|2|||
144214288|NCT02370238|519978684|FG001|Overall Study|Lost to Follow-up|3|||
144214289|NCT02370238|519978683|FG000|Overall Study|Withdrawal by Subject|2|||
144214290|NCT02370238|519978684|FG001|Overall Study|Withdrawal by Subject|6|||
144214291|NCT02370238|519978683|FG000|Overall Study|Other|2|||
144214292|NCT02370238|519978684|FG001|Overall Study|Other|1|||
144214293|NCT01153425|519978685|FG000|Overall Study|Withdrawal by Subject|3|||
144214294|NCT01153425|519978686|FG001|Overall Study|Withdrawal by Subject|3|||
144214295|NCT01482312|519978687|FG000|Period 1, 90 Minutes of Wear|Other|1|||
144214296|NCT01482312|519978688|FG001|Period 1, 90 Minutes of Wear|Other|0|||
144214297|NCT01482312|519978689|FG002|Period 1, 90 Minutes of Wear|Other|0|||
144214298|NCT01482312|519978687|FG000|Period 2, 90 Minutes of Wear|Other|1|||
144214299|NCT01482312|519978688|FG001|Period 2, 90 Minutes of Wear|Other|0|||
144214300|NCT01482312|519978689|FG002|Period 2, 90 Minutes of Wear|Other|0|||
144214301|NCT03154125|519978694|FG000|Overall Study|Lost to Follow-up|11|||
144214302|NCT03154125|519978695|FG001|Overall Study|Lost to Follow-up|11|||
144214303|NCT03154125|519978696|FG002|Overall Study|Lost to Follow-up|0|||
144214304|NCT03154125|519978694|FG000|Overall Study|Withdrawal by Subject|49|||
144214305|NCT03154125|519978695|FG001|Overall Study|Withdrawal by Subject|55|||
144214306|NCT03154125|519978696|FG002|Overall Study|Withdrawal by Subject|8|||
144214307|NCT03154125|519978694|FG000|Overall Study|Physician Decision|13|||
144214308|NCT03154125|519978695|FG001|Overall Study|Physician Decision|6|||
144214309|NCT03154125|519978696|FG002|Overall Study|Physician Decision|0|||
144214310|NCT03154125|519978694|FG000|Overall Study|Protocol Violation|3|||
144214311|NCT03154125|519978695|FG001|Overall Study|Protocol Violation|5|||
144214312|NCT03154125|519978696|FG002|Overall Study|Protocol Violation|0|||
144214313|NCT00799058|519978697|FG000|Overall Study|Withdrawal by Subject|2|||
144214314|NCT00799058|519978698|FG001|Overall Study|Withdrawal by Subject|2|||
144658177|NCT02052778|521600194|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658178|NCT02052778|521600195|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658179|NCT02052778|521600196|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144732715|NCT01015625|521877186|FG001|Overall Study|Physician Decision|0|||
144732716|NCT01015625|521877185|FG000|Overall Study|Death|30|||
144732717|NCT01015625|521877186|FG001|Overall Study|Death|22|||
144658180|NCT02052778|521600197|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658181|NCT02052778|521600198|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658182|NCT02052778|521600199|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658183|NCT02052778|521600200|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658184|NCT02052778|521600201|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658185|NCT02052778|521600202|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
144658186|NCT02052778|521600180|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
144658187|NCT02052778|521600181|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
144658188|NCT02052778|521600182|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
144658189|NCT02052778|521600183|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
144658190|NCT02052778|521600184|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
144658191|NCT02052778|521600185|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
144732718|NCT03107091|521877188|FG000|Overall Study|Physician Decision|1|||
144732719|NCT00105196|521877193|FG000|Overall Study|Lack of Efficacy|2|||
144732720|NCT00105196|521877194|FG001|Overall Study|Lack of Efficacy|3|||
144732721|NCT00105196|521877193|FG000|Overall Study|Adverse Event|11|||
144732722|NCT00105196|521877194|FG001|Overall Study|Adverse Event|3|||
144732723|NCT00105196|521877193|FG000|Overall Study|Withdrawal by Subject|6|||
144732724|NCT00105196|521877194|FG001|Overall Study|Withdrawal by Subject|6|||
144732725|NCT00105196|521877193|FG000|Overall Study|Lost to Follow-up|3|||
144732726|NCT00105196|521877194|FG001|Overall Study|Lost to Follow-up|2|||
144732727|NCT00105196|521877193|FG000|Overall Study|Poor/noncompliance|3|||
144658192|NCT02052778|521600186|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
144658193|NCT02052778|521600187|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
144658194|NCT02052778|521600188|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
144658195|NCT02052778|521600189|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
144658196|NCT02052778|521600190|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
144658197|NCT02052778|521600191|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
144658198|NCT02052778|521600192|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
144658199|NCT02052778|521600193|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
144658200|NCT02052778|521600194|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
144658201|NCT02052778|521600195|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
144658202|NCT02052778|521600196|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
144658203|NCT02052778|521600197|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
144658204|NCT02052778|521600198|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
144658205|NCT02052778|521600199|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
144658206|NCT02052778|521600200|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
144658207|NCT02052778|521600201|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
144658208|NCT02052778|521600202|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
144658209|NCT02052778|521600180|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658210|NCT02052778|521600181|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658211|NCT02052778|521600182|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658212|NCT02052778|521600183|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658213|NCT02052778|521600184|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658214|NCT02052778|521600185|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658215|NCT02052778|521600186|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658216|NCT02052778|521600187|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658217|NCT02052778|521600188|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
144658218|NCT02052778|521600189|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658219|NCT02052778|521600190|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658220|NCT02052778|521600191|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658221|NCT02052778|521600192|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658222|NCT02052778|521600193|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
144658223|NCT02052778|521600194|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658224|NCT02052778|521600195|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144732728|NCT00105196|521877194|FG001|Overall Study|Poor/noncompliance|4|||
144732729|NCT00105196|521877193|FG000|Overall Study|Protocol Violation|5|||
144732730|NCT00105196|521877194|FG001|Overall Study|Protocol Violation|2|||
144732731|NCT00105196|521877193|FG000|Overall Study|pending surgery|0|||
144732732|NCT00105196|521877194|FG001|Overall Study|pending surgery|1|||
144732733|NCT00105196|521877193|FG000|Overall Study|marijuana use|0|||
144732734|NCT00105196|521877194|FG001|Overall Study|marijuana use|1|||
144264718|NCT01386606|520171569|FG001|Overall Study|Unable to draw PK|0|||
144658225|NCT02052778|521600196|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658226|NCT02052778|521600197|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658227|NCT02052778|521600198|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658228|NCT02052778|521600199|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658229|NCT02052778|521600200|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658230|NCT02052778|521600201|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658231|NCT02052778|521600202|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
144658232|NCT02052778|521600180|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144214315|NCT00799058|519978699|FG002|Overall Study|Withdrawal by Subject|2|||
144658233|NCT02052778|521600181|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658234|NCT02052778|521600182|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658235|NCT02052778|521600183|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658236|NCT02052778|521600184|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658237|NCT02052778|521600185|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
144658238|NCT02052778|521600186|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658239|NCT02052778|521600187|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658240|NCT02052778|521600188|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658241|NCT02052778|521600189|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658242|NCT02052778|521600190|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658243|NCT02052778|521600191|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658244|NCT02052778|521600192|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
144658245|NCT02052778|521600193|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658246|NCT02052778|521600194|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144732735|NCT00105196|521877193|FG000|Overall Study|Subject became unblinded|0|||
144214316|NCT00799058|519978697|FG000|Overall Study|Lost to Follow-up|1|||
144214317|NCT00799058|519978698|FG001|Overall Study|Lost to Follow-up|2|||
144214318|NCT00799058|519978699|FG002|Overall Study|Lost to Follow-up|1|||
144214319|NCT00799058|519978697|FG000|Overall Study|Adverse Event|0|||
144214320|NCT00799058|519978698|FG001|Overall Study|Adverse Event|2|||
144214321|NCT00799058|519978699|FG002|Overall Study|Adverse Event|0|||
144214322|NCT00799058|519978697|FG000|Overall Study|Pregnancy|1|||
144214323|NCT00799058|519978698|FG001|Overall Study|Pregnancy|0|||
144214324|NCT00799058|519978699|FG002|Overall Study|Pregnancy|0|||
144214325|NCT00799058|519978697|FG000|Overall Study|Not adherent|3|||
144214326|NCT00799058|519978698|FG001|Overall Study|Not adherent|2|||
144214327|NCT00799058|519978699|FG002|Overall Study|Not adherent|1|||
144214328|NCT00799058|519978697|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
144214329|NCT00799058|519978698|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
144214330|NCT00799058|519978699|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
144214331|NCT00799058|519978697|FG000|Overall Study|IP dispensing error|1|||
144214332|NCT00799058|519978698|FG001|Overall Study|IP dispensing error|0|||
144214333|NCT00799058|519978699|FG002|Overall Study|IP dispensing error|0|||
144214334|NCT00799058|519978697|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
144214335|NCT00799058|519978698|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
144214336|NCT00799058|519978699|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
144214337|NCT00799058|519978697|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
144214338|NCT00799058|519978698|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
144214339|NCT00799058|519978699|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
144214340|NCT00799058|519978697|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
144214341|NCT00799058|519978698|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
144214342|NCT00799058|519978699|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
144214343|NCT00799058|519978697|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
144214344|NCT00799058|519978698|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
144214345|NCT00799058|519978699|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
144214346|NCT00810511|519978702|FG000|Overall Study|Protocol Violation|0|||
144214347|NCT00810511|519978703|FG001|Overall Study|Protocol Violation|1|||
144214348|NCT00810511|519978702|FG000|Overall Study|Lack of Efficacy|9|||
144214349|NCT00810511|519978703|FG001|Overall Study|Lack of Efficacy|1|||
144214350|NCT00810511|519978702|FG000|Overall Study|death in the family|0|||
144214351|NCT00810511|519978703|FG001|Overall Study|death in the family|1|||
144214352|NCT00810511|519978702|FG000|Overall Study|Lost to Follow-up|1|||
144214353|NCT00810511|519978703|FG001|Overall Study|Lost to Follow-up|0|||
144214354|NCT00810511|519978702|FG000|Overall Study|deposits on contact lens|0|||
144214355|NCT00810511|519978703|FG001|Overall Study|deposits on contact lens|1|||
144214356|NCT02088697|519978704|FG000|Period I|Physician Decision|1|||
144214357|NCT02088697|519978705|FG001|Period I|Physician Decision|4|||
144214358|NCT02088697|519978704|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
144658247|NCT02052778|521600195|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658248|NCT02052778|521600196|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658249|NCT02052778|521600197|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658250|NCT02052778|521600198|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658251|NCT02052778|521600199|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658252|NCT02052778|521600200|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658253|NCT02052778|521600201|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658254|NCT02052778|521600202|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
144658255|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658256|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658257|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658258|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658259|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658260|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658261|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658262|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658263|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658264|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658265|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658266|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658267|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658268|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658269|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
144658270|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
144658271|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
144658272|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
144658273|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
144658274|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
144658275|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
144658276|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
144658277|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
144658278|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658279|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658280|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658281|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658282|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658283|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658284|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658285|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658286|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658287|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658288|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658289|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658290|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658291|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658292|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
144658293|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
144658294|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658295|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
144658296|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
144658297|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
144658298|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
144658299|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
144658300|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
144658301|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658302|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658303|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658304|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658305|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144264719|NCT01386606|520171570|FG002|Overall Study|Unable to draw PK|0|||
144264720|NCT01386606|520171571|FG003|Overall Study|Unable to draw PK|0|||
144264721|NCT01386606|520171568|FG000|Overall Study|T levels too high|0|||
144264722|NCT01386606|520171569|FG001|Overall Study|T levels too high|1|||
144264723|NCT01386606|520171570|FG002|Overall Study|T levels too high|1|||
144264724|NCT01386606|520171571|FG003|Overall Study|T levels too high|0|||
144264725|NCT01095835|520171574|FG000|Overall Study|Adverse Event|8|||
144264726|NCT01095835|520171575|FG001|Overall Study|Adverse Event|6|||
144264727|NCT01095835|520171576|FG002|Overall Study|Adverse Event|6|||
144264728|NCT01095835|520171574|FG000|Overall Study|Lack of Efficacy|0|||
144264729|NCT01095835|520171575|FG001|Overall Study|Lack of Efficacy|1|||
144264730|NCT01095835|520171576|FG002|Overall Study|Lack of Efficacy|0|||
144264731|NCT01095835|520171574|FG000|Overall Study|Physician Decision|0|||
144264732|NCT01095835|520171575|FG001|Overall Study|Physician Decision|0|||
144264733|NCT01095835|520171576|FG002|Overall Study|Physician Decision|1|||
144264734|NCT01095835|520171574|FG000|Overall Study|Withdrawal by Subject|1|||
144264735|NCT01095835|520171575|FG001|Overall Study|Withdrawal by Subject|3|||
144264736|NCT01095835|520171576|FG002|Overall Study|Withdrawal by Subject|0|||
144264737|NCT01095835|520171574|FG000|Overall Study|Non study compliance|0|||
144264738|NCT01095835|520171575|FG001|Overall Study|Non study compliance|0|||
144264739|NCT01095835|520171576|FG002|Overall Study|Non study compliance|1|||
144264740|NCT01095835|520171574|FG000|Overall Study|Protocol Violation|1|||
144264741|NCT01095835|520171575|FG001|Overall Study|Protocol Violation|2|||
144264742|NCT01095835|520171576|FG002|Overall Study|Protocol Violation|0|||
144264743|NCT03110354|520171580|FG000|Overall Study|Death|1|||
144264744|NCT03110354|520171581|FG001|Overall Study|Death|0|||
144264745|NCT03110354|520171582|FG002|Overall Study|Death|0|||
144264746|NCT03110354|520171583|FG003|Overall Study|Death|1|||
144264747|NCT03110354|520171584|FG004|Overall Study|Death|0|||
144264748|NCT03110354|520171580|FG000|Overall Study|Start of new therapy|0|||
144264749|NCT03110354|520171581|FG001|Overall Study|Start of new therapy|0|||
144264750|NCT03110354|520171582|FG002|Overall Study|Start of new therapy|0|||
144264751|NCT03110354|520171583|FG003|Overall Study|Start of new therapy|0|||
144264752|NCT03110354|520171584|FG004|Overall Study|Start of new therapy|1|||
144264753|NCT03110354|520171580|FG000|Overall Study|Failure to achieve response|2|||
144264754|NCT03110354|520171581|FG001|Overall Study|Failure to achieve response|3|||
144264755|NCT03110354|520171582|FG002|Overall Study|Failure to achieve response|0|||
144264756|NCT03110354|520171583|FG003|Overall Study|Failure to achieve response|2|||
144264757|NCT03110354|520171584|FG004|Overall Study|Failure to achieve response|1|||
144264758|NCT03110354|520171580|FG000|Overall Study|Progressive disease|1|||
144264759|NCT03110354|520171581|FG001|Overall Study|Progressive disease|1|||
144264760|NCT03110354|520171582|FG002|Overall Study|Progressive disease|3|||
144264761|NCT03110354|520171583|FG003|Overall Study|Progressive disease|4|||
144264762|NCT03110354|520171584|FG004|Overall Study|Progressive disease|2|||
144264763|NCT03110354|520171580|FG000|Overall Study|Adverse Event|0|||
144264764|NCT03110354|520171581|FG001|Overall Study|Adverse Event|0|||
144264765|NCT03110354|520171582|FG002|Overall Study|Adverse Event|0|||
144264766|NCT03110354|520171583|FG003|Overall Study|Adverse Event|2|||
144264767|NCT03110354|520171584|FG004|Overall Study|Adverse Event|2|||
144264768|NCT03110354|520171580|FG000|Overall Study|Other|0|||
144264769|NCT03110354|520171581|FG001|Overall Study|Other|0|||
144264770|NCT03110354|520171582|FG002|Overall Study|Other|0|||
144264771|NCT03110354|520171583|FG003|Overall Study|Other|1|||
144264772|NCT03110354|520171584|FG004|Overall Study|Other|1|||
144264773|NCT00116688|520171589|FG000|Overall Study|Protocol deviation|1|||
144264774|NCT00116688|520171590|FG001|Overall Study|Protocol deviation|0|||
144264775|NCT00116688|520171589|FG000|Overall Study|Noncompliance|3|||
144732736|NCT00105196|521877194|FG001|Overall Study|Subject became unblinded|1|||
144732737|NCT03025880|521877195|FG000|Overall Study|Adverse Event|1|||
144732738|NCT03025880|521877196|FG001|Overall Study|Adverse Event|0|||
144264776|NCT00116688|520171590|FG001|Overall Study|Noncompliance|1|||
144264777|NCT00116688|520171589|FG000|Overall Study|Adverse Event|11|||
144264778|NCT00116688|520171590|FG001|Overall Study|Adverse Event|0|||
144264779|NCT00116688|520171589|FG000|Overall Study|Withdrawal by Subject|26|||
144264780|NCT00116688|520171590|FG001|Overall Study|Withdrawal by Subject|2|||
144264781|NCT00116688|520171589|FG000|Overall Study|Requirement for alternative therapy|11|||
144264782|NCT00116688|520171590|FG001|Overall Study|Requirement for alternative therapy|1|||
144264783|NCT00116688|520171589|FG000|Overall Study|Physician Decision|7|||
144264784|NCT00116688|520171590|FG001|Overall Study|Physician Decision|0|||
144264785|NCT00116688|520171589|FG000|Overall Study|Lost to Follow-up|3|||
144264786|NCT00116688|520171590|FG001|Overall Study|Lost to Follow-up|0|||
144732739|NCT03025880|521877195|FG000|Overall Study|Death|1|||
144732740|NCT03025880|521877196|FG001|Overall Study|Death|1|||
144264787|NCT00116688|520171589|FG000|Overall Study|Death|15|||
144264788|NCT00116688|520171590|FG001|Overall Study|Death|0|||
144732741|NCT03025880|521877195|FG000|Overall Study|Withdrawal by Subject|0|||
144264789|NCT00116688|520171589|FG000|Overall Study|Protocol-specified criteria|3|||
144264790|NCT00116688|520171590|FG001|Overall Study|Protocol-specified criteria|0|||
144264791|NCT00116688|520171589|FG000|Overall Study|Pregnancy|1|||
144264792|NCT00116688|520171590|FG001|Overall Study|Pregnancy|0|||
144264793|NCT00116688|520171589|FG000|Overall Study|Other|11|||
144732742|NCT03025880|521877196|FG001|Overall Study|Withdrawal by Subject|1|||
144732743|NCT03025880|521877195|FG000|Overall Study|Physician Decision|0|||
144732744|NCT03025880|521877196|FG001|Overall Study|Physician Decision|1|||
144732745|NCT03025880|521877195|FG000|Overall Study|Progressive Disease|12|||
144732746|NCT03025880|521877196|FG001|Overall Study|Progressive Disease|19|||
144732747|NCT02728102|521877197|FG000|Overall Study|Death|3|||
144732748|NCT02728102|521877198|FG001|Overall Study|Death|0|||
144732749|NCT02728102|521877199|FG002|Overall Study|Death|1|||
144732750|NCT02728102|521877197|FG000|Overall Study|Withdrawal by Subject|0|||
144732751|NCT02728102|521877198|FG001|Overall Study|Withdrawal by Subject|2|||
144732752|NCT02728102|521877199|FG002|Overall Study|Withdrawal by Subject|3|||
144732753|NCT02728102|521877197|FG000|Overall Study|Physician Decision|1|||
144732754|NCT02728102|521877198|FG001|Overall Study|Physician Decision|1|||
144732755|NCT02728102|521877199|FG002|Overall Study|Physician Decision|0|||
144732756|NCT02728102|521877197|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
144732757|NCT02728102|521877198|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
144732758|NCT02728102|521877199|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
144732759|NCT02728102|521877197|FG000|Overall Study|Covid|0|||
144732760|NCT02728102|521877198|FG001|Overall Study|Covid|0|||
144732761|NCT02728102|521877199|FG002|Overall Study|Covid|1|||
144732762|NCT00553280|521877201|FG000|Overall Study|Adverse Event|19|||
144732763|NCT00553280|521877201|FG000|Overall Study|Lack of Efficacy|3|||
144732764|NCT00553280|521877201|FG000|Overall Study|Withdrawal by Subject|3|||
144732765|NCT00553280|521877201|FG000|Overall Study|Physician Decision|1|||
144732766|NCT01536405|521877202|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
144732767|NCT01536405|521877203|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
144732768|NCT01536405|521877202|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
144732769|NCT01536405|521877203|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
144732770|NCT01536405|521877202|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
144732771|NCT01536405|521877203|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
144732772|NCT01536405|521877202|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
144732773|NCT01536405|521877203|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
144732774|NCT01536405|521877202|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
144732775|NCT01536405|521877203|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
144732776|NCT01536405|521877202|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
144732777|NCT01536405|521877203|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
144732778|NCT01536405|521877202|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
144732779|NCT01536405|521877203|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
144732780|NCT01536405|521877202|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
144732781|NCT01536405|521877203|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
144732782|NCT01536405|521877202|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
144732783|NCT01536405|521877203|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
144732784|NCT01536405|521877202|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
144732785|NCT01536405|521877203|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
144732786|NCT01536405|521877202|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
144732787|NCT01536405|521877203|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
144732788|NCT01536405|521877202|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
144732789|NCT01536405|521877203|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
144732790|NCT01536405|521877202|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
144732791|NCT01536405|521877203|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
144732792|NCT02514122|521877206|FG000|Overall Study|Withdrawal by Subject|2|||
144732793|NCT02514122|521877207|FG001|Overall Study|Withdrawal by Subject|0|||
144732794|NCT01417078|521877208|FG000|Overall Study|Withdrawal by Subject|1|||
144732795|NCT02421952|521877209|FG000|Overall Study|Diary Not Returned|93|||
144732796|NCT02421952|521877209|FG000|Overall Study|Failed seriation task|13|||
144732797|NCT02421952|521877209|FG000|Overall Study|Subject uncooperative for baseline test|2|||
144732798|NCT02421952|521877209|FG000|Overall Study|Surgery cancelled|1|||
144732799|NCT01294787|521879198|FG000|Period 1|Adverse Event|0|||
144732800|NCT01294787|521879199|FG001|Period 1|Adverse Event|0|||
144732801|NCT01294787|521879200|FG002|Period 1|Adverse Event|0|||
144732802|NCT01294787|521879201|FG003|Period 1|Adverse Event|0|||
144732803|NCT01294787|521879202|FG004|Period 1|Adverse Event|1|||
144732804|NCT01294787|521879203|FG005|Period 1|Adverse Event|0|||
144732805|NCT01294787|521879198|FG000|Period 1|Withdrawal by Subject|0|||
144732806|NCT01294787|521879199|FG001|Period 1|Withdrawal by Subject|0|||
144732807|NCT01294787|521879200|FG002|Period 1|Withdrawal by Subject|0|||
144732808|NCT01294787|521879201|FG003|Period 1|Withdrawal by Subject|1|||
144732809|NCT01294787|521879202|FG004|Period 1|Withdrawal by Subject|1|||
144732810|NCT01294787|521879203|FG005|Period 1|Withdrawal by Subject|1|||
144732811|NCT01294787|521879198|FG000|Period 1|Administrative problem|0|||
144732812|NCT01294787|521879199|FG001|Period 1|Administrative problem|0|||
144732813|NCT01294787|521879200|FG002|Period 1|Administrative problem|1|||
144732814|NCT01294787|521879201|FG003|Period 1|Administrative problem|0|||
144732815|NCT01294787|521879202|FG004|Period 1|Administrative problem|0|||
144732816|NCT01294787|521879203|FG005|Period 1|Administrative problem|1|||
144732817|NCT01294787|521879198|FG000|Period 2|Adverse Event|0|||
144732818|NCT01294787|521879199|FG001|Period 2|Adverse Event|3|||
144732819|NCT01294787|521879200|FG002|Period 2|Adverse Event|0|||
144732820|NCT01294787|521879201|FG003|Period 2|Adverse Event|1|||
144732821|NCT01294787|521879202|FG004|Period 2|Adverse Event|0|||
144732822|NCT01294787|521879203|FG005|Period 2|Adverse Event|0|||
144732823|NCT01294787|521879198|FG000|Period 2|No longer needs study drug|0|||
144732824|NCT01294787|521879199|FG001|Period 2|No longer needs study drug|0|||
144732825|NCT01294787|521879200|FG002|Period 2|No longer needs study drug|0|||
144732826|NCT01294787|521879201|FG003|Period 2|No longer needs study drug|1|||
144732827|NCT01294787|521879202|FG004|Period 2|No longer needs study drug|0|||
144732828|NCT01294787|521879203|FG005|Period 2|No longer needs study drug|0|||
144732829|NCT01294787|521879198|FG000|Period 3|Adverse Event|0|||
144732830|NCT01294787|521879199|FG001|Period 3|Adverse Event|0|||
144732831|NCT01294787|521879200|FG002|Period 3|Adverse Event|0|||
144732832|NCT01294787|521879201|FG003|Period 3|Adverse Event|0|||
144732833|NCT01294787|521879202|FG004|Period 3|Adverse Event|1|||
144732834|NCT01294787|521879203|FG005|Period 3|Adverse Event|0|||
144732835|NCT01948258|521879206|FG000|Overall Study|Pregnancy|41|||
144732836|NCT01948258|521879206|FG000|Overall Study|Did not complete by cut-off date|35|||
144732837|NCT01948258|521879206|FG000|Overall Study|Lost to Follow-up|27|||
144732838|NCT01948258|521879206|FG000|Overall Study|Withdrawal by SPD|8|||
144732839|NCT01948258|521879206|FG000|Overall Study|Withdrawal by Subject|6|||
144732840|NCT01948258|521879206|FG000|Overall Study|Health Care Professional|43|||
144732841|NCT01948258|521879206|FG000|Overall Study|Removed from statistical analysis|2|||
144732842|NCT01466166|521879210|FG000|Overall Study|Death|1|||
144264794|NCT00116688|520171590|FG001|Overall Study|Other|0|||
144658306|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658307|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658308|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658309|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658310|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658311|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658312|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658313|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658314|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658315|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
144658316|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
144658317|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
144658318|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658319|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
144658320|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
144658321|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658322|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658323|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
144658324|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658325|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658326|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658327|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658328|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658329|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658330|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658331|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658332|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658333|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658334|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658335|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658336|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658337|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658338|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
144658339|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
144658340|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658341|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658342|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144732843|NCT01466166|521879210|FG000|Overall Study|Lost to Follow-up|7|||
144732844|NCT01466166|521879210|FG000|Overall Study|Infusion Reaction (IR)|27|||
144732845|NCT01466166|521879210|FG000|Overall Study|Adverse Event (Other than IR)|11|||
144732846|NCT01466166|521879210|FG000|Overall Study|Elevated Serum Uric Acid|78|||
144732847|NCT01466166|521879210|FG000|Overall Study|Withdrawal by Subject|13|||
144732848|NCT01466166|521879210|FG000|Overall Study|Sponsor Decision|4|||
144658343|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658344|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658345|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658346|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
144658347|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658348|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658349|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658350|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658351|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658352|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658353|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658354|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658355|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658356|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658357|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658358|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658359|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658360|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658361|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
144658362|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
144658363|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658364|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658365|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658366|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
144658367|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658368|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658369|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
144658370|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
144658371|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
144658372|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
144658373|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
144658374|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
144214359|NCT02088697|519978705|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
144214360|NCT00462904|519978706|FG000|Overall Study|Lost to Follow-up|1|||
144214361|NCT02652949|519978707|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
144214362|NCT02652949|519978707|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
144214363|NCT02652949|519978707|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
144214364|NCT02652949|519978707|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
144214365|NCT02652949|519978707|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
144214366|NCT02652949|519978707|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
144214367|NCT02652949|519978707|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
144214368|NCT02652949|519978707|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
144214369|NCT02652949|519978707|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
144214370|NCT02652949|519978707|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
144214371|NCT02652949|519978707|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
144214372|NCT02652949|519978707|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
144214373|NCT02652949|519978707|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
144214374|NCT02652949|519978707|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
144214375|NCT02652949|519978707|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
144214376|NCT02652949|519978707|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
144214377|NCT02652949|519978707|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
144214378|NCT04342819|519978708|FG000|Overall Study|Declined|4|||
144214379|NCT04342819|519978708|FG000|Overall Study|Not meeeting selection criteria|1|||
144214380|NCT02287922|519978709|FG000|Overall Study|Adverse Event|1|||
144214381|NCT02287922|519978710|FG001|Overall Study|Adverse Event|1|||
144214382|NCT02287922|519978711|FG002|Overall Study|Adverse Event|3|||
144214383|NCT02287922|519978712|FG003|Overall Study|Adverse Event|4|||
144214384|NCT02287922|519978709|FG000|Overall Study|Withdrawal by Subject|1|||
144214385|NCT02287922|519978710|FG001|Overall Study|Withdrawal by Subject|1|||
144214386|NCT02287922|519978711|FG002|Overall Study|Withdrawal by Subject|1|||
144214387|NCT02287922|519978712|FG003|Overall Study|Withdrawal by Subject|2|||
144214388|NCT02287922|519978709|FG000|Overall Study|Lost to Follow-up|0|||
144214389|NCT02287922|519978710|FG001|Overall Study|Lost to Follow-up|0|||
144214390|NCT02287922|519978711|FG002|Overall Study|Lost to Follow-up|1|||
144214391|NCT02287922|519978712|FG003|Overall Study|Lost to Follow-up|0|||
144214392|NCT02287922|519978709|FG000|Overall Study|Sponsor's decision|0|||
144658375|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
144658376|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
144658377|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
144658378|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
144658379|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
144658380|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
144658381|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
144658382|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
144658383|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
144658384|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
144658385|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
144658386|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
144658387|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
144658388|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
144658389|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
144658390|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
144658391|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
144658392|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
144658393|NCT02052778|521600180|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658394|NCT02052778|521600181|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658395|NCT02052778|521600182|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658396|NCT02052778|521600183|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658397|NCT02052778|521600184|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658398|NCT02052778|521600185|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658399|NCT02052778|521600186|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658400|NCT02052778|521600187|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658401|NCT02052778|521600188|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658402|NCT02052778|521600189|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658403|NCT02052778|521600190|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658404|NCT02052778|521600191|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658405|NCT02052778|521600192|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658406|NCT02052778|521600193|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658407|NCT02052778|521600194|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
144658408|NCT02052778|521600195|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
144658409|NCT02052778|521600196|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
144658410|NCT02052778|521600197|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658411|NCT02052778|521600198|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
144658412|NCT02052778|521600199|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658413|NCT02052778|521600200|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658414|NCT02052778|521600201|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658415|NCT02052778|521600202|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
144658416|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658417|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658418|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658419|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658420|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658421|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658422|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658423|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658424|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658425|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658426|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658427|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658428|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658429|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658430|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658431|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658432|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658433|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658434|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658435|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658436|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144732849|NCT01466166|521879210|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
144732850|NCT01466166|521879210|FG000|Overall Study|Other|20|||
144658437|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
144658438|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
144658439|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144732851|NCT01340495|521879215|FG000|Overall Study|Withdrawal by Subject|1|||
144732852|NCT00070291|521879216|FG000|Step 1|Withdrawal by Subject|1|||
144658440|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658441|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658442|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658443|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658444|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658445|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658446|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658447|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658448|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658449|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658450|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658451|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658452|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658453|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658454|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658455|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658456|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658457|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658458|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658459|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658460|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
144658461|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
144658462|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658463|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658464|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658465|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658466|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658467|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658468|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658469|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658470|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658471|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658472|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658473|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658474|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658475|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658476|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658477|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658478|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658479|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658480|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658481|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658482|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658483|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
144658484|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
144658485|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658486|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658487|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658488|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658489|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658490|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658491|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658492|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658493|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658494|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658495|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658496|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658497|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658498|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658499|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658500|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658501|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658502|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144264795|NCT01775670|520171594|FG000|Overall Study|Lost to Follow-up|1|||
144264796|NCT01775670|520171595|FG001|Overall Study|Lost to Follow-up|1|||
144264797|NCT01298700|520171596|FG000|Overall Study|Adverse Event|50|||
144264798|NCT01298700|520171597|FG001|Overall Study|Adverse Event|51|||
144264799|NCT01298700|520171596|FG000|Overall Study|Lack of Efficacy|9|||
144264800|NCT01298700|520171597|FG001|Overall Study|Lack of Efficacy|14|||
144264801|NCT01298700|520171596|FG000|Overall Study|Lost to Follow-up|5|||
144264802|NCT01298700|520171597|FG001|Overall Study|Lost to Follow-up|2|||
144264803|NCT01298700|520171596|FG000|Overall Study|Withdrawal by Subject|12|||
144264804|NCT01298700|520171597|FG001|Overall Study|Withdrawal by Subject|9|||
144264805|NCT01298700|520171596|FG000|Overall Study|Protocol Violation|6|||
144264806|NCT01298700|520171597|FG001|Overall Study|Protocol Violation|4|||
144264807|NCT01298700|520171596|FG000|Overall Study|Other Miscellaneous Reasons|16|||
144264808|NCT01298700|520171597|FG001|Overall Study|Other Miscellaneous Reasons|15|||
144264809|NCT01298700|520171596|FG000|Overall Study|Did not Receive Study Drug|3|||
144264810|NCT01298700|520171597|FG001|Overall Study|Did not Receive Study Drug|5|||
144264811|NCT01307787|520171598|FG000|Overall Study|Withdrawal by Subject|2|||
144658503|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658504|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658505|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658506|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
144658507|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
144658508|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658509|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658510|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658511|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658512|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658513|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658514|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658515|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658516|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658517|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658518|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658519|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658520|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658521|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658522|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658523|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658524|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658525|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658526|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658527|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658528|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658529|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
144658530|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
144658531|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
144658532|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
144658533|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
144658534|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
144658535|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
144658536|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
144658537|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
144658538|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
144658539|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
144658540|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
144658541|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
144658542|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
144658543|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
144658544|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
144264812|NCT01307787|520171599|FG001|Overall Study|Withdrawal by Subject|0|||
144264813|NCT01965327|520171600|FG000|Overall Study|Physician Decision|2|||
144264814|NCT00104052|520171601|FG000|Overall Study|Adverse Event|1|||
144658545|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
144658546|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
144658547|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
144658548|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
144658549|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
144658550|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
144264815|NCT00104052|520171601|FG000|Overall Study|Lack of Efficacy|26|||
144264816|NCT00104052|520171601|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
144264817|NCT01294423|520171606|FG000|Overall Study|Adverse Event|1|||
144658551|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
144214393|NCT02287922|519978710|FG001|Overall Study|Sponsor's decision|0|||
144214394|NCT02287922|519978711|FG002|Overall Study|Sponsor's decision|0|||
144214395|NCT02287922|519978712|FG003|Overall Study|Sponsor's decision|1|||
144214396|NCT02287922|519978709|FG000|Overall Study|Other|1|||
144214397|NCT02287922|519978710|FG001|Overall Study|Other|0|||
144214398|NCT02287922|519978711|FG002|Overall Study|Other|2|||
144214399|NCT02287922|519978712|FG003|Overall Study|Other|0|||
144214400|NCT00699816|519978713|FG000|Overall Study|Protocol Violation|1|||
144214401|NCT00699816|519978714|FG001|Overall Study|Protocol Violation|3|||
144214402|NCT01569295|519978715|FG000|Overall Study|Progressive Disease|75|||
144214403|NCT01569295|519978716|FG001|Overall Study|Progressive Disease|139|||
144214404|NCT01569295|519978715|FG000|Overall Study|Adverse Event|39|||
144214405|NCT01569295|519978716|FG001|Overall Study|Adverse Event|14|||
144214406|NCT01569295|519978715|FG000|Overall Study|Withdrawal by Subject|25|||
144658552|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
144658553|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
144658554|NCT02052778|521600180|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658555|NCT02052778|521600181|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658556|NCT02052778|521600182|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658557|NCT02052778|521600183|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658558|NCT02052778|521600184|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658559|NCT02052778|521600185|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658560|NCT02052778|521600186|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658561|NCT02052778|521600187|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658562|NCT02052778|521600188|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658563|NCT02052778|521600189|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658564|NCT02052778|521600190|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658565|NCT02052778|521600191|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658566|NCT02052778|521600192|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658567|NCT02052778|521600193|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658568|NCT02052778|521600194|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658569|NCT02052778|521600195|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658570|NCT02052778|521600196|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658571|NCT02052778|521600197|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658572|NCT02052778|521600198|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658573|NCT02052778|521600199|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658574|NCT02052778|521600200|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658575|NCT02052778|521600201|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
144658576|NCT02052778|521600202|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
144658577|NCT01358877|521600207|FG000|Overall Study|Death|80|||
144658578|NCT01358877|521600208|FG001|Overall Study|Death|89|||
144658579|NCT01358877|521600207|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
144658580|NCT01358877|521600208|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
144658581|NCT01358877|521600207|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
144658582|NCT01358877|521600208|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
144658583|NCT01358877|521600207|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
144658584|NCT01358877|521600208|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
144658585|NCT01358877|521600207|FG000|Overall Study|Other|142|||
144658586|NCT01358877|521600208|FG001|Overall Study|Other|129|||
144658587|NCT01994226|521600213|FG000|Overall Study|Protocol Violation|13|||
144658588|NCT01994226|521600214|FG001|Overall Study|Protocol Violation|10|||
144658589|NCT01994226|521600213|FG000|Overall Study|Early Cessation of treatment|6|||
144658590|NCT01994226|521600214|FG001|Overall Study|Early Cessation of treatment|11|||
144658591|NCT01409031|521600215|FG000|Overall Study|transferred to other hosp|1|||
144658592|NCT01409031|521600216|FG001|Overall Study|transferred to other hosp|0|||
144658593|NCT02345252|521600217|FG000|Double-Blind Phase|Adverse Event|2|||
144658594|NCT02345252|521600218|FG001|Double-Blind Phase|Adverse Event|3|||
144658595|NCT02345252|521600217|FG000|Double-Blind Phase|Death|1|||
144658596|NCT02345252|521600218|FG001|Double-Blind Phase|Death|2|||
144658597|NCT02345252|521600217|FG000|Double-Blind Phase|Lack of Efficacy|1|||
144658598|NCT02345252|521600218|FG001|Double-Blind Phase|Lack of Efficacy|0|||
144214407|NCT01569295|519978716|FG001|Overall Study|Withdrawal by Subject|12|||
144214408|NCT01569295|519978715|FG000|Overall Study|Death|19|||
144214409|NCT01569295|519978716|FG001|Overall Study|Death|15|||
144214410|NCT01569295|519978715|FG000|Overall Study|Physician Decision|13|||
144214411|NCT01569295|519978716|FG001|Overall Study|Physician Decision|18|||
144214412|NCT01569295|519978715|FG000|Overall Study|Study Terminated by Sponsor|24|||
144264818|NCT01294423|520171607|FG001|Overall Study|Adverse Event|2|||
144658599|NCT02345252|521600217|FG000|Double-Blind Phase|Investigator's Discretion|4|||
144658600|NCT02345252|521600218|FG001|Double-Blind Phase|Investigator's Discretion|6|||
144658601|NCT02345252|521600217|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
144658602|NCT02345252|521600218|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
144658603|NCT02345252|521600217|FG000|Double-Blind Phase|Protocol Violation|2|||
144658604|NCT02345252|521600218|FG001|Double-Blind Phase|Protocol Violation|1|||
144214413|NCT01569295|519978716|FG001|Overall Study|Study Terminated by Sponsor|2|||
144264819|NCT01294423|520171608|FG002|Overall Study|Adverse Event|3|||
144264820|NCT01294423|520171606|FG000|Overall Study|Withdrawal by Subject|1|||
144264821|NCT01294423|520171607|FG001|Overall Study|Withdrawal by Subject|2|||
144264822|NCT01294423|520171608|FG002|Overall Study|Withdrawal by Subject|2|||
144264823|NCT01294423|520171606|FG000|Overall Study|subject no longer meets study criteria|2|||
144264824|NCT01294423|520171607|FG001|Overall Study|subject no longer meets study criteria|5|||
144264825|NCT01294423|520171608|FG002|Overall Study|subject no longer meets study criteria|2|||
144264826|NCT01294423|520171606|FG000|Overall Study|poor/non-compliance|1|||
144264827|NCT01294423|520171607|FG001|Overall Study|poor/non-compliance|0|||
144264828|NCT01294423|520171608|FG002|Overall Study|poor/non-compliance|1|||
144264829|NCT01831427|520171611|FG000|Overall Study|Adverse Event|0|||
144264830|NCT01831427|520171612|FG001|Overall Study|Adverse Event|1|||
144264831|NCT01831427|520171613|FG002|Overall Study|Adverse Event|0|||
144264832|NCT01831427|520171614|FG003|Overall Study|Adverse Event|0|||
144264833|NCT01831427|520171615|FG004|Overall Study|Adverse Event|0|||
144264834|NCT01831427|520171616|FG005|Overall Study|Adverse Event|1|||
144264835|NCT01831427|520171617|FG006|Overall Study|Adverse Event|0|||
144264836|NCT01831427|520171618|FG007|Overall Study|Adverse Event|1|||
144264837|NCT01831427|520171619|FG008|Overall Study|Adverse Event|0|||
144264838|NCT01831427|520171620|FG009|Overall Study|Adverse Event|0|||
144264839|NCT01831427|520171621|FG010|Overall Study|Adverse Event|2|||
144264840|NCT01831427|520171611|FG000|Overall Study|Investigator's Discretion|0|||
144264841|NCT01831427|520171612|FG001|Overall Study|Investigator's Discretion|0|||
144264842|NCT01831427|520171613|FG002|Overall Study|Investigator's Discretion|0|||
144264843|NCT01831427|520171614|FG003|Overall Study|Investigator's Discretion|1|||
144264844|NCT01831427|520171615|FG004|Overall Study|Investigator's Discretion|0|||
144264845|NCT01831427|520171616|FG005|Overall Study|Investigator's Discretion|0|||
144264846|NCT01831427|520171617|FG006|Overall Study|Investigator's Discretion|0|||
144264847|NCT01831427|520171618|FG007|Overall Study|Investigator's Discretion|0|||
144264848|NCT01831427|520171619|FG008|Overall Study|Investigator's Discretion|0|||
144264849|NCT01831427|520171620|FG009|Overall Study|Investigator's Discretion|0|||
144264850|NCT01831427|520171621|FG010|Overall Study|Investigator's Discretion|0|||
144264851|NCT01831427|520171611|FG000|Overall Study|Withdrew Consent|0|||
144264852|NCT01831427|520171612|FG001|Overall Study|Withdrew Consent|0|||
144264853|NCT01831427|520171613|FG002|Overall Study|Withdrew Consent|0|||
144264854|NCT01831427|520171614|FG003|Overall Study|Withdrew Consent|0|||
144264855|NCT01831427|520171615|FG004|Overall Study|Withdrew Consent|0|||
144264856|NCT01831427|520171616|FG005|Overall Study|Withdrew Consent|0|||
144264857|NCT01831427|520171617|FG006|Overall Study|Withdrew Consent|2|||
144264858|NCT01831427|520171618|FG007|Overall Study|Withdrew Consent|0|||
144264859|NCT01831427|520171619|FG008|Overall Study|Withdrew Consent|0|||
144264860|NCT01831427|520171620|FG009|Overall Study|Withdrew Consent|1|||
144264861|NCT01831427|520171621|FG010|Overall Study|Withdrew Consent|1|||
144264862|NCT00728494|520171622|FG000|Overall Study|Adverse Event|7|||
144264863|NCT00728494|520171623|FG001|Overall Study|Adverse Event|0|||
144264864|NCT00728494|520171622|FG000|Overall Study|Withdrawal by Subject|0|||
144264865|NCT00728494|520171623|FG001|Overall Study|Withdrawal by Subject|2|||
144264866|NCT00728494|520171622|FG000|Overall Study|Lack of Efficacy|2|||
144264867|NCT00728494|520171623|FG001|Overall Study|Lack of Efficacy|4|||
144264868|NCT00728494|520171622|FG000|Overall Study|No data available|0|||
144264869|NCT00728494|520171623|FG001|Overall Study|No data available|1|||
144264870|NCT00126594|520171624|FG000|Overall Study|Ineligible|2|||
144264871|NCT00126594|520171625|FG001|Overall Study|Ineligible|0|||
144264872|NCT00126594|520171624|FG000|Overall Study|Withdrawal by Subject|0|||
144264873|NCT00126594|520171625|FG001|Overall Study|Withdrawal by Subject|4|||
144264874|NCT00126594|520171624|FG000|Overall Study|Physician Decision|1|||
144264875|NCT00126594|520171625|FG001|Overall Study|Physician Decision|3|||
144264876|NCT00126594|520171624|FG000|Overall Study|Adverse Event|7|||
144264877|NCT00126594|520171625|FG001|Overall Study|Adverse Event|5|||
144264878|NCT00126594|520171624|FG000|Overall Study|Non-compliance|0|||
144264879|NCT00126594|520171625|FG001|Overall Study|Non-compliance|1|||
144264880|NCT00126594|520171624|FG000|Overall Study|Disease Progression|29|||
144264881|NCT00126594|520171625|FG001|Overall Study|Disease Progression|24|||
144264882|NCT00891813|520171626|FG000|Overall Study|Adverse Event|3|||
144264883|NCT00891813|520171626|FG000|Overall Study|Withdrawal by Subject|1|||
144264884|NCT00891813|520171626|FG000|Overall Study|Patient Noncompliance|6|||
144264885|NCT00891813|520171626|FG000|Overall Study|Protocol Violation|2|||
144264886|NCT02059239|520171627|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
144658605|NCT02345252|521600217|FG000|Double-Blind Phase|Withdrew Consent|21|||
144658606|NCT02345252|521600218|FG001|Double-Blind Phase|Withdrew Consent|23|||
144658607|NCT02345252|521600217|FG000|Double-Blind Phase|Lost to Follow-up|8|||
144264887|NCT02059239|520171628|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
144264888|NCT02059239|520171627|FG000|Overall Study|Physician Decision|1|||
144264889|NCT02059239|520171628|FG001|Overall Study|Physician Decision|0|||
144264890|NCT01268267|520171630|FG000|Overall Study|Protocol Violation|1|||
144264891|NCT01545388|520171636|FG000|Overall Study|Adverse Event|2|||
144264892|NCT01545388|520171637|FG001|Overall Study|Adverse Event|4|||
144264893|NCT01545388|520171638|FG002|Overall Study|Adverse Event|1|||
144658608|NCT02345252|521600218|FG001|Double-Blind Phase|Lost to Follow-up|10|||
144658609|NCT02345252|521600217|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
144658610|NCT02345252|521600218|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
144658611|NCT01980706|521600223|FG000|Overall Study|Withdrawal by Subject|9|||
144658612|NCT01980706|521600224|FG001|Overall Study|Withdrawal by Subject|6|||
144658613|NCT01980706|521600225|FG002|Overall Study|Withdrawal by Subject|2|||
144658614|NCT01980706|521600223|FG000|Overall Study|Adverse Event|1|||
144658615|NCT01980706|521600224|FG001|Overall Study|Adverse Event|2|||
144658616|NCT01980706|521600225|FG002|Overall Study|Adverse Event|5|||
144658617|NCT01980706|521600223|FG000|Overall Study|Lost to Follow-up|3|||
144658618|NCT01980706|521600224|FG001|Overall Study|Lost to Follow-up|4|||
144658619|NCT01980706|521600225|FG002|Overall Study|Lost to Follow-up|3|||
144658620|NCT01980706|521600223|FG000|Overall Study|miscellaneous|4|||
144658621|NCT01980706|521600224|FG001|Overall Study|miscellaneous|5|||
144658622|NCT01980706|521600225|FG002|Overall Study|miscellaneous|3|||
144658623|NCT04171037|521600230|FG000|Overall Study|Lost to Follow-up|1|||
144658624|NCT04171037|521600231|FG001|Overall Study|Lost to Follow-up|0|||
144658625|NCT04171037|521600230|FG000|Overall Study|Physician Decision|3|||
144658626|NCT04171037|521600231|FG001|Overall Study|Physician Decision|3|||
144658627|NCT02232087|521600232|FG000|Overall Study|Withdrawal by Subject|2|||
144658628|NCT02232087|521600233|FG001|Overall Study|Withdrawal by Subject|0|||
144658629|NCT02232087|521600234|FG002|Overall Study|Withdrawal by Subject|0|||
144658630|NCT02232087|521600235|FG003|Overall Study|Withdrawal by Subject|0|||
144658631|NCT02232087|521600236|FG004|Overall Study|Withdrawal by Subject|0|||
144658632|NCT02232087|521600237|FG005|Overall Study|Withdrawal by Subject|1|||
144658633|NCT02232087|521600232|FG000|Overall Study|poor inhalation technique|0|||
144658634|NCT02232087|521600233|FG001|Overall Study|poor inhalation technique|1|||
144658635|NCT02232087|521600234|FG002|Overall Study|poor inhalation technique|0|||
144658636|NCT02232087|521600235|FG003|Overall Study|poor inhalation technique|0|||
144658637|NCT02232087|521600236|FG004|Overall Study|poor inhalation technique|0|||
144658638|NCT02232087|521600237|FG005|Overall Study|poor inhalation technique|2|||
144658639|NCT02232087|521600232|FG000|Overall Study|protocol stop criteria|0|||
144658640|NCT02232087|521600233|FG001|Overall Study|protocol stop criteria|1|||
144658641|NCT02232087|521600234|FG002|Overall Study|protocol stop criteria|0|||
144658642|NCT02232087|521600235|FG003|Overall Study|protocol stop criteria|1|||
144658643|NCT02232087|521600236|FG004|Overall Study|protocol stop criteria|0|||
144658644|NCT02232087|521600237|FG005|Overall Study|protocol stop criteria|0|||
144658645|NCT02232087|521600232|FG000|Overall Study|Adverse Event|0|||
144658646|NCT02232087|521600233|FG001|Overall Study|Adverse Event|0|||
144658647|NCT02232087|521600234|FG002|Overall Study|Adverse Event|0|||
144658648|NCT02232087|521600235|FG003|Overall Study|Adverse Event|0|||
144658649|NCT02232087|521600236|FG004|Overall Study|Adverse Event|1|||
144658650|NCT02232087|521600237|FG005|Overall Study|Adverse Event|0|||
144658651|NCT01864018|521600245|FG000|Overall Study|Ineligible|3|||
144658652|NCT01864018|521600246|FG001|Overall Study|Ineligible|1|||
144658653|NCT04056455|521600247|FG000|Overall Study|Adverse Event|1|||
144658654|NCT04056455|521600248|FG001|Overall Study|Adverse Event|0|||
144658655|NCT03521687|521600250|FG000|Overall Study|Adverse Event|4|||
144658656|NCT03521687|521600250|FG000|Overall Study|Physician Decision|1|||
144658657|NCT04891770|521600254|FG000|Overall Study|Withdrew consent|1|||
144658658|NCT04891770|521600255|FG001|Overall Study|Withdrew consent|3|||
144658659|NCT04891770|521600256|FG002|Overall Study|Withdrew consent|0|||
144658660|NCT04891770|521600254|FG000|Overall Study|Enrolled but never treated|0|||
144658661|NCT04891770|521600255|FG001|Overall Study|Enrolled but never treated|0|||
144658662|NCT04891770|521600256|FG002|Overall Study|Enrolled but never treated|1|||
144658663|NCT04891770|521600254|FG000|Overall Study|Investigator's discretion|0|||
144658664|NCT04891770|521600255|FG001|Overall Study|Investigator's discretion|1|||
144658665|NCT04891770|521600256|FG002|Overall Study|Investigator's discretion|0|||
144658666|NCT00830037|521600257|FG000|Overall Study|Withdrawal by Subject|2|||
144264894|NCT01545388|520171636|FG000|Overall Study|Lack of Efficacy|3|||
144658667|NCT00830037|521600258|FG001|Overall Study|Withdrawal by Subject|3|||
144658668|NCT00830037|521600257|FG000|Overall Study|Lost to Follow-up|1|||
144658669|NCT00830037|521600258|FG001|Overall Study|Lost to Follow-up|2|||
144658670|NCT00830037|521600257|FG000|Overall Study|Active when terminated by DSMB|15|||
144658671|NCT00830037|521600258|FG001|Overall Study|Active when terminated by DSMB|14|||
144658672|NCT01952834|521600259|FG000|Overall Study|Adverse Event|1|||
144658673|NCT00740779|521600260|FG000|Overall Study|Adverse Event|4|||
144658674|NCT00740779|521600261|FG001|Overall Study|Adverse Event|6|||
144658675|NCT00740779|521600262|FG002|Overall Study|Adverse Event|3|||
144264895|NCT01545388|520171637|FG001|Overall Study|Lack of Efficacy|2|||
144658676|NCT00740779|521600260|FG000|Overall Study|Protocol Violation|1|||
144658677|NCT00740779|521600261|FG001|Overall Study|Protocol Violation|1|||
144658678|NCT00740779|521600262|FG002|Overall Study|Protocol Violation|1|||
144658679|NCT00740779|521600260|FG000|Overall Study|Lack of Efficacy|0|||
144658680|NCT00740779|521600261|FG001|Overall Study|Lack of Efficacy|0|||
144658681|NCT00740779|521600262|FG002|Overall Study|Lack of Efficacy|2|||
144658682|NCT00740779|521600260|FG000|Overall Study|Withdrawal by Subject|2|||
144658683|NCT00740779|521600261|FG001|Overall Study|Withdrawal by Subject|4|||
144658684|NCT00740779|521600262|FG002|Overall Study|Withdrawal by Subject|2|||
144658685|NCT00740779|521600260|FG000|Overall Study|Lost to Follow-up|2|||
144658686|NCT00740779|521600261|FG001|Overall Study|Lost to Follow-up|3|||
144658687|NCT00740779|521600262|FG002|Overall Study|Lost to Follow-up|5|||
144658688|NCT05091060|521600263|FG000|Overall Study|Lost to Follow-up|1|||
144658689|NCT02739594|521600264|FG000|Overall Study|Undesired Event|3|||
144658690|NCT02739594|521600265|FG001|Overall Study|Undesired Event|4|||
144658691|NCT02739594|521600264|FG000|Overall Study|Violation of Eligibility Criteria|1|||
144658692|NCT02739594|521600265|FG001|Overall Study|Violation of Eligibility Criteria|2|||
144658693|NCT02739594|521600264|FG000|Overall Study|Protocol Violation|5|||
144658694|NCT02739594|521600265|FG001|Overall Study|Protocol Violation|6|||
144658695|NCT02739594|521600264|FG000|Overall Study|Death|4|||
144658696|NCT02739594|521600265|FG001|Overall Study|Death|2|||
144658697|NCT02739594|521600264|FG000|Overall Study|Renal Insufficiency|4|||
144658698|NCT02739594|521600265|FG001|Overall Study|Renal Insufficiency|6|||
144658699|NCT02739594|521600264|FG000|Overall Study|Administrative Reasons|1|||
144658700|NCT02739594|521600265|FG001|Overall Study|Administrative Reasons|3|||
144658701|NCT02739594|521600264|FG000|Overall Study|Withdrawal by Subject|1|||
144658702|NCT02739594|521600265|FG001|Overall Study|Withdrawal by Subject|1|||
144658703|NCT02739594|521600264|FG000|Overall Study|Lost to Follow-up|0|||
144658704|NCT02739594|521600265|FG001|Overall Study|Lost to Follow-up|1|||
144658705|NCT02739594|521600264|FG000|Overall Study|Elevated Serum Creatinine|0|||
144658706|NCT02739594|521600265|FG001|Overall Study|Elevated Serum Creatinine|1|||
144658707|NCT02739594|521600264|FG000|Overall Study|Other|6|||
144658708|NCT02739594|521600265|FG001|Overall Study|Other|2|||
144658709|NCT00527111|521600266|FG000|Overall Study|Adverse Event|14|||
144658710|NCT00527111|521600267|FG001|Overall Study|Adverse Event|13|||
144658711|NCT00527111|521600266|FG000|Overall Study|Death|0|||
144658712|NCT00527111|521600267|FG001|Overall Study|Death|1|||
144658713|NCT00527111|521600266|FG000|Overall Study|Investigator Request|2|||
144658714|NCT00527111|521600267|FG001|Overall Study|Investigator Request|1|||
144658715|NCT00527111|521600266|FG000|Overall Study|Patient Request|2|||
144658716|NCT00527111|521600267|FG001|Overall Study|Patient Request|5|||
144658717|NCT00527111|521600266|FG000|Overall Study|Other|2|||
144658718|NCT00527111|521600267|FG001|Overall Study|Other|2|||
144658719|NCT00634244|521600270|FG000|Overall Study|Never started treatment|0|||
144658720|NCT00634244|521600271|FG001|Overall Study|Never started treatment|1|||
144658721|NCT00634244|521600272|FG002|Overall Study|Never started treatment|0|||
144658722|NCT00634244|521600270|FG000|Overall Study|Death|1|||
144658723|NCT00634244|521600271|FG001|Overall Study|Death|6|||
144658724|NCT00634244|521600272|FG002|Overall Study|Death|0|||
144658725|NCT00634244|521600270|FG000|Overall Study|Adverse Event|0|||
144658726|NCT00634244|521600271|FG001|Overall Study|Adverse Event|2|||
144658727|NCT00634244|521600272|FG002|Overall Study|Adverse Event|0|||
144658728|NCT00634244|521600270|FG000|Overall Study|Withdrawal by Subject|0|||
144658729|NCT00634244|521600271|FG001|Overall Study|Withdrawal by Subject|1|||
144658730|NCT00634244|521600272|FG002|Overall Study|Withdrawal by Subject|0|||
144658731|NCT00634244|521600270|FG000|Overall Study|Physician Decision|0|||
144658732|NCT00634244|521600271|FG001|Overall Study|Physician Decision|1|||
144658733|NCT00634244|521600272|FG002|Overall Study|Physician Decision|0|||
144658734|NCT00634244|521600270|FG000|Overall Study|Disease progression/relapse|0|||
144658735|NCT00634244|521600271|FG001|Overall Study|Disease progression/relapse|1|||
144658736|NCT00634244|521600272|FG002|Overall Study|Disease progression/relapse|0|||
144658737|NCT00634244|521600270|FG000|Overall Study|Other complicating disease|0|||
144658738|NCT00634244|521600271|FG001|Overall Study|Other complicating disease|1|||
144658739|NCT00634244|521600272|FG002|Overall Study|Other complicating disease|0|||
144658740|NCT00142519|521600273|FG000|Overall Study|Not Treated|7|||
144658741|NCT00142519|521600274|FG001|Overall Study|Not Treated|9|||
144658742|NCT00142519|521600273|FG000|Overall Study|Protocol Violation|1|||
144732853|NCT00070291|521879216|FG000|Step 1|Adverse Event|1|||
144732854|NCT00070291|521879216|FG000|Step 2|Adverse Event|1|||
144732855|NCT02262377|521879217|FG000|Overall Study|Lost to Follow-up|5|||
144658743|NCT00142519|521600274|FG001|Overall Study|Protocol Violation|0|||
144658744|NCT00142519|521600273|FG000|Overall Study|Withdrawal by Subject|10|||
144732856|NCT02262377|521879218|FG001|Overall Study|Lost to Follow-up|6|||
144658745|NCT00142519|521600274|FG001|Overall Study|Withdrawal by Subject|7|||
144658746|NCT01468909|521600279|FG000|Overall Study|Never Treated|2|||
144658747|NCT01468909|521600280|FG001|Overall Study|Never Treated|2|||
144658748|NCT02635737|521600281|FG000|Overall Study|Protocol Violation|1|||
144658749|NCT01511419|521600282|FG000|Dose 2|Physician Decision|1|||
144658750|NCT01511419|521600283|FG001|Dose 2|Physician Decision|0|||
144658751|NCT00937768|521600284|FG000|Overall Study|Refused Further Treatment|3|||
144658752|NCT00937768|521600285|FG001|Overall Study|Refused Further Treatment|2|||
144658753|NCT00937768|521600284|FG000|Overall Study|Disease Progression|1|||
144658754|NCT00937768|521600285|FG001|Overall Study|Disease Progression|1|||
144658755|NCT00937768|521600284|FG000|Overall Study|Alternate Treatment|0|||
144658756|NCT00937768|521600285|FG001|Overall Study|Alternate Treatment|1|||
144658757|NCT00937768|521600284|FG000|Overall Study|No Further Funding|4|||
144658758|NCT00937768|521600285|FG001|Overall Study|No Further Funding|4|||
144732857|NCT02262377|521879217|FG000|Overall Study|Found ineligible after enrollment|3|||
144658759|NCT02065622|521600286|FG000|Induction Study|Adverse Event|13|||
144658760|NCT02065622|521600287|FG001|Induction Study|Adverse Event|19|||
144658761|NCT02065622|521600288|FG002|Induction Study|Adverse Event|0|||
144658762|NCT02065622|521600289|FG003|Induction Study|Adverse Event|0|||
144658763|NCT02065622|521600290|FG004|Induction Study|Adverse Event|0|||
144658764|NCT02065622|521600286|FG000|Induction Study|Withdrawal by Subject|3|||
144658765|NCT02065622|521600287|FG001|Induction Study|Withdrawal by Subject|5|||
144658766|NCT02065622|521600288|FG002|Induction Study|Withdrawal by Subject|0|||
144658767|NCT02065622|521600289|FG003|Induction Study|Withdrawal by Subject|0|||
144658768|NCT02065622|521600290|FG004|Induction Study|Withdrawal by Subject|0|||
144658769|NCT02065622|521600286|FG000|Induction Study|Lost to Follow-up|1|||
144658770|NCT02065622|521600287|FG001|Induction Study|Lost to Follow-up|0|||
144658771|NCT02065622|521600288|FG002|Induction Study|Lost to Follow-up|0|||
144658772|NCT02065622|521600289|FG003|Induction Study|Lost to Follow-up|0|||
144658773|NCT02065622|521600290|FG004|Induction Study|Lost to Follow-up|0|||
144658774|NCT02065622|521600286|FG000|Induction Study|Lack of Efficacy|22|||
144658775|NCT02065622|521600287|FG001|Induction Study|Lack of Efficacy|27|||
144658776|NCT02065622|521600288|FG002|Induction Study|Lack of Efficacy|0|||
144658777|NCT02065622|521600289|FG003|Induction Study|Lack of Efficacy|0|||
144658778|NCT02065622|521600290|FG004|Induction Study|Lack of Efficacy|0|||
144658779|NCT02065622|521600286|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
144658780|NCT02065622|521600287|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
144658781|NCT02065622|521600288|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
144658782|NCT02065622|521600289|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
144658783|NCT02065622|521600290|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
144658784|NCT02065622|521600286|FG000|Induction Study|Subject Noncompliance|1|||
144658785|NCT02065622|521600287|FG001|Induction Study|Subject Noncompliance|1|||
144658786|NCT02065622|521600288|FG002|Induction Study|Subject Noncompliance|0|||
144658787|NCT02065622|521600289|FG003|Induction Study|Subject Noncompliance|0|||
144658788|NCT02065622|521600290|FG004|Induction Study|Subject Noncompliance|0|||
144658789|NCT02065622|521600286|FG000|Induction Study|Other, Not Specified|3|||
144658790|NCT02065622|521600287|FG001|Induction Study|Other, Not Specified|2|||
144658791|NCT02065622|521600288|FG002|Induction Study|Other, Not Specified|0|||
144658792|NCT02065622|521600289|FG003|Induction Study|Other, Not Specified|0|||
144658793|NCT02065622|521600290|FG004|Induction Study|Other, Not Specified|0|||
144658794|NCT02065622|521600286|FG000|Maintenance Study|Adverse Event|0|||
144658795|NCT02065622|521600287|FG001|Maintenance Study|Adverse Event|0|||
144658796|NCT02065622|521600288|FG002|Maintenance Study|Adverse Event|25|||
144658797|NCT02065622|521600289|FG003|Maintenance Study|Adverse Event|22|||
144658798|NCT02065622|521600290|FG004|Maintenance Study|Adverse Event|11|||
144658799|NCT02065622|521600286|FG000|Maintenance Study|Withdrawal by Subject|0|||
144658800|NCT02065622|521600287|FG001|Maintenance Study|Withdrawal by Subject|0|||
144658801|NCT02065622|521600288|FG002|Maintenance Study|Withdrawal by Subject|11|||
144658802|NCT02065622|521600289|FG003|Maintenance Study|Withdrawal by Subject|5|||
144658803|NCT02065622|521600290|FG004|Maintenance Study|Withdrawal by Subject|7|||
144658804|NCT02065622|521600286|FG000|Maintenance Study|Lost to Follow-up|0|||
144658805|NCT02065622|521600287|FG001|Maintenance Study|Lost to Follow-up|0|||
144658806|NCT02065622|521600288|FG002|Maintenance Study|Lost to Follow-up|4|||
144658807|NCT02065622|521600289|FG003|Maintenance Study|Lost to Follow-up|1|||
144658808|NCT02065622|521600290|FG004|Maintenance Study|Lost to Follow-up|1|||
144658809|NCT02065622|521600286|FG000|Maintenance Study|Lack of Efficacy|0|||
144658810|NCT02065622|521600287|FG001|Maintenance Study|Lack of Efficacy|0|||
144658811|NCT02065622|521600288|FG002|Maintenance Study|Lack of Efficacy|70|||
144658812|NCT02065622|521600289|FG003|Maintenance Study|Lack of Efficacy|55|||
144658813|NCT02065622|521600290|FG004|Maintenance Study|Lack of Efficacy|19|||
144658814|NCT02065622|521600286|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
144658815|NCT02065622|521600287|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
144658816|NCT02065622|521600288|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
144658817|NCT02065622|521600289|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
144658818|NCT02065622|521600290|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
144658819|NCT02065622|521600286|FG000|Maintenance Study|Subject Non-Compliance|0|||
144658820|NCT02065622|521600287|FG001|Maintenance Study|Subject Non-Compliance|0|||
144658821|NCT02065622|521600288|FG002|Maintenance Study|Subject Non-Compliance|1|||
144658822|NCT02065622|521600289|FG003|Maintenance Study|Subject Non-Compliance|3|||
144658823|NCT02065622|521600290|FG004|Maintenance Study|Subject Non-Compliance|2|||
144658824|NCT02065622|521600286|FG000|Maintenance Study|Other, Not Specified|0|||
144214414|NCT01569295|519978715|FG000|Overall Study|Other Reason not Specified|3|||
144214415|NCT01569295|519978716|FG001|Overall Study|Other Reason not Specified|5|||
144214416|NCT01569295|519978715|FG000|Overall Study|Non-Compliance with Study Drug|6|||
144214417|NCT01569295|519978716|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144214418|NCT01569295|519978715|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
144214419|NCT01569295|519978716|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
144214420|NCT01569295|519978715|FG000|Overall Study|Lost to Follow-up|1|||
144658825|NCT02065622|521600287|FG001|Maintenance Study|Other, Not Specified|0|||
144658826|NCT02065622|521600288|FG002|Maintenance Study|Other, Not Specified|6|||
144658827|NCT02065622|521600289|FG003|Maintenance Study|Other, Not Specified|14|||
144658828|NCT02065622|521600290|FG004|Maintenance Study|Other, Not Specified|2|||
144658829|NCT02065622|521600286|FG000|Maintenance Study|Unknown Reason|0|||
144658830|NCT02065622|521600287|FG001|Maintenance Study|Unknown Reason|0|||
144658831|NCT02065622|521600288|FG002|Maintenance Study|Unknown Reason|0|||
144658832|NCT02065622|521600289|FG003|Maintenance Study|Unknown Reason|1|||
144658833|NCT02065622|521600290|FG004|Maintenance Study|Unknown Reason|0|||
144658834|NCT04973228|521600293|FG000|Overall Study|Adverse Event|2|||
144658835|NCT04973228|521600294|FG001|Overall Study|Adverse Event|3|||
144658836|NCT04973228|521600293|FG000|Overall Study|Lack of Efficacy|1|||
144658837|NCT04973228|521600294|FG001|Overall Study|Lack of Efficacy|3|||
144658838|NCT04973228|521600293|FG000|Overall Study|Lost to Follow-up|12|||
144658839|NCT04973228|521600294|FG001|Overall Study|Lost to Follow-up|4|||
144658840|NCT04973228|521600293|FG000|Overall Study|Withdrawal by Subject|11|||
144658841|NCT04973228|521600294|FG001|Overall Study|Withdrawal by Subject|4|||
144658842|NCT04973228|521600293|FG000|Overall Study|Did not tolerate application|1|||
144658843|NCT04973228|521600294|FG001|Overall Study|Did not tolerate application|0|||
144658844|NCT04973228|521600293|FG000|Overall Study|Wanted to early terminate and use own product|0|||
144658845|NCT04973228|521600294|FG001|Overall Study|Wanted to early terminate and use own product|1|||
144658846|NCT04973228|521600293|FG000|Overall Study|Missed visits due to new work schedule|1|||
144658847|NCT04973228|521600294|FG001|Overall Study|Missed visits due to new work schedule|0|||
144658848|NCT02678780|521600295|FG000|Overall Study|Adverse Event|11|||
144658849|NCT02678780|521600296|FG001|Overall Study|Adverse Event|14|||
144658850|NCT02678780|521600295|FG000|Overall Study|Withdrawal by Subject|2|||
144658851|NCT02678780|521600296|FG001|Overall Study|Withdrawal by Subject|1|||
144658852|NCT02678780|521600295|FG000|Overall Study|Sponsor discontinuation|7|||
144658853|NCT02678780|521600296|FG001|Overall Study|Sponsor discontinuation|4|||
144658854|NCT02678780|521600295|FG000|Overall Study|Death|1|||
144658855|NCT02678780|521600296|FG001|Overall Study|Death|1|||
144658856|NCT02678780|521600295|FG000|Overall Study|Other|6|||
144658857|NCT02678780|521600296|FG001|Overall Study|Other|8|||
144658858|NCT00406640|521600314|FG000|Acute Phase|Adverse Event|18|||
144658859|NCT00406640|521600315|FG001|Acute Phase|Adverse Event|13|||
144658860|NCT00406640|521600314|FG000|Acute Phase|Failed to Return|5|||
144658861|NCT00406640|521600315|FG001|Acute Phase|Failed to Return|1|||
144658862|NCT00406640|521600314|FG000|Acute Phase|Physician Decision|0|||
144658863|NCT00406640|521600315|FG001|Acute Phase|Physician Decision|1|||
144658864|NCT00406640|521600314|FG000|Acute Phase|Lost to Follow-up|7|||
144658865|NCT00406640|521600315|FG001|Acute Phase|Lost to Follow-up|4|||
144658866|NCT00406640|521600314|FG000|Acute Phase|Protocol deviation|4|||
144658867|NCT00406640|521600315|FG001|Acute Phase|Protocol deviation|10|||
144658868|NCT00406640|521600314|FG000|Acute Phase|Protocol Violation|3|||
144658869|NCT00406640|521600315|FG001|Acute Phase|Protocol Violation|2|||
144658870|NCT00406640|521600314|FG000|Acute Phase|Withdrawal by Subject|11|||
144658871|NCT00406640|521600315|FG001|Acute Phase|Withdrawal by Subject|9|||
144658872|NCT00406640|521600314|FG000|Acute Phase|Lack of Efficacy|3|||
144658873|NCT00406640|521600315|FG001|Acute Phase|Lack of Efficacy|3|||
144658874|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
144658875|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
144658876|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Death|1|||
144658877|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Death|0|||
144658878|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
144658879|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
144658880|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
144658881|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
144658882|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
144658883|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
144658884|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|non-compliance|7|||
144658885|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|non-compliance|5|||
144658886|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
144658887|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
144658888|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
144658889|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
144658890|NCT00406640|521600314|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
144658891|NCT00406640|521600315|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
144658892|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
144658893|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
144658894|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
144658895|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
144658896|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
144658897|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
144658898|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
144658899|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
144732858|NCT02262377|521879218|FG001|Overall Study|Found ineligible after enrollment|0|||
144732859|NCT02262377|521879217|FG000|Overall Study|Withdrawal by Subject|4|||
144732860|NCT02262377|521879218|FG001|Overall Study|Withdrawal by Subject|0|||
144732861|NCT04915755|521879219|FG000|Overall Study|Physician Decision|3|||
144732862|NCT04915755|521879220|FG001|Overall Study|Physician Decision|2|||
144732863|NCT04915755|521879219|FG000|Overall Study|Withdrawal by Subject|1|||
144732864|NCT04915755|521879220|FG001|Overall Study|Withdrawal by Subject|1|||
144732865|NCT04915755|521879219|FG000|Overall Study|Ongoing for PACT|3|||
144732866|NCT04915755|521879220|FG001|Overall Study|Ongoing for PACT|2|||
144732867|NCT04915755|521879219|FG000|Overall Study|Other|7|||
144214421|NCT01569295|519978716|FG001|Overall Study|Lost to Follow-up|1|||
144214422|NCT03607487|519978723|FG000|Overall Study|Withdrawal by Subject|2|||
144214423|NCT03607487|519978724|FG001|Overall Study|Withdrawal by Subject|0|||
144214424|NCT03607487|519978725|FG002|Overall Study|Withdrawal by Subject|0|||
144732868|NCT04915755|521879220|FG001|Overall Study|Other|11|||
144732869|NCT01591785|521879221|FG000|Overall Study|worsening condition|1|||
144214425|NCT03607487|519978726|FG003|Overall Study|Withdrawal by Subject|1|||
144214426|NCT01884337|519978727|FG000|Treatment|Adverse Event|2|||
144214427|NCT01884337|519978728|FG001|Treatment|Adverse Event|2|||
144214428|NCT01884337|519978727|FG000|Treatment|Subj. request to discont. treatment|2|||
144214429|NCT01884337|519978728|FG001|Treatment|Subj. request to discont. treatment|0|||
144214430|NCT01884337|519978727|FG000|Follow-up Period|Lost to Follow-up|1|||
144214431|NCT01884337|519978728|FG001|Follow-up Period|Lost to Follow-up|1|||
144214432|NCT02455518|519978729|FG000|Overall Study|Protocol Violation|0|||
144214433|NCT02455518|519978730|FG001|Overall Study|Protocol Violation|1|||
144214434|NCT02455518|519978731|FG002|Overall Study|Protocol Violation|1|||
144214435|NCT02455518|519978732|FG003|Overall Study|Protocol Violation|3|||
144214436|NCT04223752|519978738|FG000|Overall Study|Participant enrolled in error|0|||
144214437|NCT04223752|519978739|FG001|Overall Study|Participant enrolled in error|0|||
144214438|NCT04223752|519978740|FG002|Overall Study|Participant enrolled in error|0|||
144214439|NCT04223752|519978741|FG003|Overall Study|Participant enrolled in error|0|||
144214440|NCT04223752|519978742|FG004|Overall Study|Participant enrolled in error|1|||
144214441|NCT04223752|519978738|FG000|Overall Study|Death|0|||
144214442|NCT04223752|519978739|FG001|Overall Study|Death|0|||
144214443|NCT04223752|519978740|FG002|Overall Study|Death|0|||
144214444|NCT04223752|519978741|FG003|Overall Study|Death|2|||
144214445|NCT04223752|519978742|FG004|Overall Study|Death|1|||
144214446|NCT04759703|519978743|FG000|Overall Study|Withdrawal by Subject|4|||
144214447|NCT04759703|519978744|FG001|Overall Study|Withdrawal by Subject|9|||
144214448|NCT04759703|519978743|FG000|Overall Study|Adverse Event|1|||
144214449|NCT04759703|519978744|FG001|Overall Study|Adverse Event|0|||
144214450|NCT04759703|519978743|FG000|Overall Study|Lost to Follow-up|2|||
144214451|NCT04759703|519978744|FG001|Overall Study|Lost to Follow-up|0|||
144214452|NCT04186845|519978756|FG000|Overall Study|Death|2|||
144214453|NCT04186845|519978756|FG000|Overall Study|Lost to Follow-up|1|||
144214454|NCT04186845|519978756|FG000|Overall Study|Physician Decision|1|||
144214455|NCT04186845|519978756|FG000|Overall Study|Protocol Violation|1|||
144214456|NCT04186845|519978756|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
144214457|NCT04186845|519978756|FG000|Overall Study|Biopsy ordered but not done|1|||
144214458|NCT04186845|519978756|FG000|Overall Study|It was previously confirmed|1|||
144214459|NCT04186845|519978756|FG000|Overall Study|Patient cancelled scheduled scans|2|||
144214460|NCT04186845|519978756|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
144264896|NCT01545388|520171638|FG002|Overall Study|Lack of Efficacy|5|||
144264897|NCT01545388|520171636|FG000|Overall Study|Participant moved or relocated|1|||
144264898|NCT01545388|520171637|FG001|Overall Study|Participant moved or relocated|0|||
144264899|NCT01545388|520171638|FG002|Overall Study|Participant moved or relocated|0|||
144732870|NCT01591785|521879222|FG001|Overall Study|worsening condition|2|||
144732871|NCT01591785|521879221|FG000|Overall Study|Protocol Violation|2|||
144732872|NCT01591785|521879222|FG001|Overall Study|Protocol Violation|0|||
144732873|NCT01591785|521879221|FG000|Overall Study|Lost to Follow-up|1|||
144732874|NCT01591785|521879222|FG001|Overall Study|Lost to Follow-up|0|||
144732875|NCT00396279|521879224|FG000|Overall Study|Ongoing in study|26|||
144214461|NCT04186845|519978756|FG000|Overall Study|Subject refused confirmatory imaging|1|||
144214462|NCT04186845|519978756|FG000|Overall Study|Too small to biopsy|1|||
144214463|NCT05061420|519978757|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
144214464|NCT05061420|519978758|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
144214465|NCT05061420|519978759|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
144214466|NCT05061420|519978757|FG000|Overall Study|Progressive disease|11|||
144214467|NCT05061420|519978758|FG001|Overall Study|Progressive disease|15|||
144214468|NCT05061420|519978759|FG002|Overall Study|Progressive disease|14|||
144214469|NCT05061420|519978757|FG000|Overall Study|Withdrawal by Subject|2|||
144214470|NCT05061420|519978758|FG001|Overall Study|Withdrawal by Subject|0|||
144214471|NCT05061420|519978759|FG002|Overall Study|Withdrawal by Subject|1|||
144214472|NCT05061420|519978757|FG000|Overall Study|Not related to COVID-19|2|||
144214473|NCT05061420|519978758|FG001|Overall Study|Not related to COVID-19|0|||
144732876|NCT00396279|521879224|FG000|Overall Study|Disease progression|2|||
144658900|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
144658901|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
144658902|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
144658903|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
144658904|NCT00406640|521600314|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
144658905|NCT00406640|521600315|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
144658906|NCT02669862|521602095|FG000|Overall Study|Lost to Follow-up|0|||
144658907|NCT02669862|521602096|FG001|Overall Study|Lost to Follow-up|2|||
144658908|NCT02669862|521602097|FG002|Overall Study|Lost to Follow-up|1|||
144658909|NCT02669862|521602095|FG000|Overall Study|Withdrawal by Subject|2|||
144658910|NCT02669862|521602096|FG001|Overall Study|Withdrawal by Subject|2|||
144658911|NCT02669862|521602097|FG002|Overall Study|Withdrawal by Subject|3|||
144658912|NCT02669862|521602095|FG000|Overall Study|moved|0|||
144658913|NCT02669862|521602096|FG001|Overall Study|moved|1|||
144658914|NCT02669862|521602097|FG002|Overall Study|moved|0|||
144658915|NCT02669862|521602095|FG000|Overall Study|Protocol Violation|0|||
144658916|NCT02669862|521602096|FG001|Overall Study|Protocol Violation|0|||
144658917|NCT02669862|521602097|FG002|Overall Study|Protocol Violation|1|||
144658918|NCT03987919|521602099|FG000|Overall Study|Adverse Event|1|||
144658919|NCT03987919|521602100|FG001|Overall Study|Adverse Event|4|||
144658920|NCT03987919|521602101|FG002|Overall Study|Adverse Event|1|||
144658921|NCT03987919|521602102|FG003|Overall Study|Adverse Event|3|||
144658922|NCT03987919|521602099|FG000|Overall Study|Death|4|||
144658923|NCT03987919|521602100|FG001|Overall Study|Death|4|||
144658924|NCT03987919|521602101|FG002|Overall Study|Death|4|||
144658925|NCT03987919|521602102|FG003|Overall Study|Death|1|||
144658926|NCT03987919|521602099|FG000|Overall Study|Lost to Follow-up|5|||
144658927|NCT03987919|521602100|FG001|Overall Study|Lost to Follow-up|6|||
144658928|NCT03987919|521602101|FG002|Overall Study|Lost to Follow-up|8|||
144658929|NCT03987919|521602102|FG003|Overall Study|Lost to Follow-up|12|||
144658930|NCT03987919|521602099|FG000|Overall Study|Physician Decision|0|||
144658931|NCT03987919|521602100|FG001|Overall Study|Physician Decision|2|||
144658932|NCT03987919|521602101|FG002|Overall Study|Physician Decision|0|||
144658933|NCT03987919|521602102|FG003|Overall Study|Physician Decision|4|||
144658934|NCT03987919|521602099|FG000|Overall Study|Pregnancy|1|||
144658935|NCT03987919|521602100|FG001|Overall Study|Pregnancy|0|||
144658936|NCT03987919|521602101|FG002|Overall Study|Pregnancy|1|||
144658937|NCT03987919|521602102|FG003|Overall Study|Pregnancy|1|||
144658938|NCT03987919|521602099|FG000|Overall Study|Protocol Violation|0|||
144658939|NCT03987919|521602100|FG001|Overall Study|Protocol Violation|1|||
144658940|NCT03987919|521602101|FG002|Overall Study|Protocol Violation|0|||
144658941|NCT03987919|521602102|FG003|Overall Study|Protocol Violation|0|||
144658942|NCT03987919|521602099|FG000|Overall Study|Site terminated by Sponsor|0|||
144658943|NCT03987919|521602100|FG001|Overall Study|Site terminated by Sponsor|0|||
144658944|NCT03987919|521602101|FG002|Overall Study|Site terminated by Sponsor|0|||
144658945|NCT03987919|521602102|FG003|Overall Study|Site terminated by Sponsor|1|||
144658946|NCT03987919|521602099|FG000|Overall Study|Withdrawal by Subject|7|||
144658947|NCT03987919|521602100|FG001|Overall Study|Withdrawal by Subject|7|||
144658948|NCT03987919|521602101|FG002|Overall Study|Withdrawal by Subject|8|||
144658949|NCT03987919|521602102|FG003|Overall Study|Withdrawal by Subject|4|||
144658950|NCT03987919|521602099|FG000|Overall Study|Other - as reported by the investigator|1|||
144658951|NCT03987919|521602100|FG001|Overall Study|Other - as reported by the investigator|3|||
144658952|NCT03987919|521602101|FG002|Overall Study|Other - as reported by the investigator|2|||
144658953|NCT03987919|521602102|FG003|Overall Study|Other - as reported by the investigator|0|||
144658954|NCT01194804|521602103|FG000|Overall Study|Withdrawal by Subject|1|||
144658955|NCT02670915|521602104|FG000|Overall Study|Withdrawal by Subject|0|||
144658956|NCT02670915|521602105|FG001|Overall Study|Withdrawal by Subject|1|||
144658957|NCT02670915|521602106|FG002|Overall Study|Withdrawal by Subject|4|||
144658958|NCT02670915|521602104|FG000|Overall Study|Withdrawal by parent/guardian|4|||
144658959|NCT02670915|521602105|FG001|Overall Study|Withdrawal by parent/guardian|4|||
144214474|NCT05061420|519978759|FG002|Overall Study|Not related to COVID-19|0|||
144214475|NCT01814553|519978763|FG000|Overall Study|PD per clinical progression|6|||
144214476|NCT01814553|519978764|FG001|Overall Study|PD per clinical progression|8|||
144658960|NCT02670915|521602106|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144658961|NCT02670915|521602104|FG000|Overall Study|Unclassified|0|||
144658962|NCT02670915|521602105|FG001|Overall Study|Unclassified|3|||
144658963|NCT02670915|521602106|FG002|Overall Study|Unclassified|0|||
144658964|NCT01670656|521602107|FG000|Overall Study|Non-compliance with study drug|0|||
144658965|NCT01670656|521602108|FG001|Overall Study|Non-compliance with study drug|0|||
144658966|NCT01670656|521602109|FG002|Overall Study|Non-compliance with study drug|3|||
144658967|NCT01670656|521602110|FG003|Overall Study|Non-compliance with study drug|0|||
144658968|NCT01670656|521602111|FG004|Overall Study|Non-compliance with study drug|1|||
144658969|NCT01670656|521602107|FG000|Overall Study|Pregnancy|0|||
144658970|NCT01670656|521602108|FG001|Overall Study|Pregnancy|0|||
144658971|NCT01670656|521602109|FG002|Overall Study|Pregnancy|0|||
144214477|NCT01814553|519978763|FG000|Overall Study|Other Adverse Event|4|||
144214478|NCT01814553|519978764|FG001|Overall Study|Other Adverse Event|5|||
144658972|NCT01670656|521602110|FG003|Overall Study|Pregnancy|0|||
144658973|NCT01670656|521602111|FG004|Overall Study|Pregnancy|1|||
144658974|NCT01670656|521602107|FG000|Overall Study|Withdrawal by Subject|1|||
144658975|NCT01670656|521602108|FG001|Overall Study|Withdrawal by Subject|1|||
144658976|NCT01670656|521602109|FG002|Overall Study|Withdrawal by Subject|0|||
144658977|NCT01670656|521602110|FG003|Overall Study|Withdrawal by Subject|0|||
144658978|NCT01670656|521602111|FG004|Overall Study|Withdrawal by Subject|0|||
144658979|NCT01670656|521602107|FG000|Overall Study|Non-compliance with protocol|0|||
144658980|NCT01670656|521602108|FG001|Overall Study|Non-compliance with protocol|3|||
144658981|NCT01670656|521602109|FG002|Overall Study|Non-compliance with protocol|1|||
144658982|NCT01670656|521602110|FG003|Overall Study|Non-compliance with protocol|1|||
144658983|NCT01670656|521602111|FG004|Overall Study|Non-compliance with protocol|2|||
144658984|NCT01670656|521602107|FG000|Overall Study|Adverse Event|2|||
144658985|NCT01670656|521602108|FG001|Overall Study|Adverse Event|2|||
144658986|NCT01670656|521602109|FG002|Overall Study|Adverse Event|2|||
144658987|NCT01670656|521602110|FG003|Overall Study|Adverse Event|3|||
144658988|NCT01670656|521602111|FG004|Overall Study|Adverse Event|3|||
144658989|NCT01670656|521602107|FG000|Overall Study|Subject withdrew consent|0|||
144658990|NCT01670656|521602108|FG001|Overall Study|Subject withdrew consent|1|||
144658991|NCT01670656|521602109|FG002|Overall Study|Subject withdrew consent|2|||
144658992|NCT01670656|521602110|FG003|Overall Study|Subject withdrew consent|1|||
144658993|NCT01670656|521602111|FG004|Overall Study|Subject withdrew consent|1|||
144658994|NCT01670656|521602107|FG000|Overall Study|Lost to Follow-up|0|||
144658995|NCT01670656|521602108|FG001|Overall Study|Lost to Follow-up|0|||
144658996|NCT01670656|521602109|FG002|Overall Study|Lost to Follow-up|0|||
144658997|NCT01670656|521602110|FG003|Overall Study|Lost to Follow-up|0|||
144658998|NCT01670656|521602111|FG004|Overall Study|Lost to Follow-up|3|||
144658999|NCT01670656|521602107|FG000|Overall Study|Subject moved|0|||
144659000|NCT01670656|521602108|FG001|Overall Study|Subject moved|0|||
144659001|NCT01670656|521602109|FG002|Overall Study|Subject moved|0|||
144659002|NCT01670656|521602110|FG003|Overall Study|Subject moved|1|||
144659003|NCT01670656|521602111|FG004|Overall Study|Subject moved|0|||
144659004|NCT03331666|521602112|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
144659005|NCT03331666|521602113|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
144659006|NCT00111475|521602114|FG000|Overall Study|Lost to Follow-up|0|||
144659007|NCT00111475|521602115|FG001|Overall Study|Lost to Follow-up|0|||
144659008|NCT00111475|521602116|FG002|Overall Study|Lost to Follow-up|0|||
144659009|NCT00111475|521602117|FG003|Overall Study|Lost to Follow-up|0|||
144659010|NCT00111475|521602118|FG004|Overall Study|Lost to Follow-up|0|||
144659011|NCT00111475|521602119|FG005|Overall Study|Lost to Follow-up|1|||
144659012|NCT00111475|521602120|FG006|Overall Study|Lost to Follow-up|0|||
144659013|NCT00111475|521602121|FG007|Overall Study|Lost to Follow-up|0|||
144659014|NCT00111475|521602122|FG008|Overall Study|Lost to Follow-up|0|||
144659015|NCT00111475|521602123|FG009|Overall Study|Lost to Follow-up|0|||
144659016|NCT01995136|521602126|FG000|Overall Study|Change in residence|1|||
144659017|NCT03544268|521602127|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
144659018|NCT03544268|521602128|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
144659019|NCT01830543|521602132|FG000|Overall Study|Subject Decision|19|||
144659020|NCT01830543|521602133|FG001|Overall Study|Subject Decision|21|||
144659021|NCT01830543|521602134|FG002|Overall Study|Subject Decision|57|||
144659022|NCT01830543|521602132|FG000|Overall Study|Adverse Event|91|||
144659023|NCT01830543|521602133|FG001|Overall Study|Adverse Event|77|||
144659024|NCT01830543|521602134|FG002|Overall Study|Adverse Event|76|||
144659025|NCT01830543|521602132|FG000|Overall Study|Death|20|||
144659026|NCT01830543|521602133|FG001|Overall Study|Death|22|||
144659027|NCT01830543|521602134|FG002|Overall Study|Death|22|||
144659028|NCT01830543|521602132|FG000|Overall Study|Protocol Violation|3|||
144659029|NCT01830543|521602133|FG001|Overall Study|Protocol Violation|7|||
144659030|NCT01830543|521602134|FG002|Overall Study|Protocol Violation|7|||
144659031|NCT01830543|521602132|FG000|Overall Study|Physician Decision|11|||
144659032|NCT01830543|521602133|FG001|Overall Study|Physician Decision|5|||
144659033|NCT01830543|521602134|FG002|Overall Study|Physician Decision|12|||
144659034|NCT01830543|521602132|FG000|Overall Study|Withdrawal by consent|3|||
144214479|NCT01814553|519978763|FG000|Overall Study|Withdrawal by Subject|1|||
144214480|NCT01814553|519978764|FG001|Overall Study|Withdrawal by Subject|1|||
144214481|NCT01814553|519978763|FG000|Overall Study|Other than stated|7|||
144659035|NCT01830543|521602133|FG001|Overall Study|Withdrawal by consent|3|||
144659036|NCT01830543|521602134|FG002|Overall Study|Withdrawal by consent|3|||
144659037|NCT01830543|521602132|FG000|Overall Study|Other|12|||
144659038|NCT01830543|521602133|FG001|Overall Study|Other|17|||
144659039|NCT01830543|521602134|FG002|Overall Study|Other|37|||
144659040|NCT04281030|521602142|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
144659041|NCT04281030|521602143|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
144659042|NCT04281030|521602142|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
144659043|NCT04281030|521602143|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
144214482|NCT01814553|519978764|FG001|Overall Study|Other than stated|8|||
144214483|NCT04138823|519978765|FG000|Overall Study|Clinical disease progression|0|||
144214484|NCT04138823|519978766|FG001|Overall Study|Clinical disease progression|0|||
144659044|NCT01395368|521602144|FG000|Overall Study|Physician Decision|14|||
144659045|NCT01395368|521602144|FG000|Overall Study|Withdrawal by Subject|2|||
144659046|NCT00288860|521602149|FG000|Overall Study|Did not complete intake|4|||
144659047|NCT00288860|521602150|FG001|Overall Study|Did not complete intake|8|||
144659048|NCT00288860|521602149|FG000|Overall Study|Death|4|||
144659049|NCT00288860|521602150|FG001|Overall Study|Death|3|||
144659050|NCT00288860|521602149|FG000|Overall Study|Withdrawal by Subject|20|||
144659051|NCT00288860|521602150|FG001|Overall Study|Withdrawal by Subject|15|||
144659052|NCT00288860|521602149|FG000|Overall Study|Lost to Follow-up|74|||
144659053|NCT00288860|521602150|FG001|Overall Study|Lost to Follow-up|71|||
144659054|NCT02179515|521602153|FG000|Overall Study|switched to alternative treatment|0|||
144659055|NCT02179515|521602154|FG001|Overall Study|switched to alternative treatment|1|||
144659056|NCT02179515|521602155|FG002|Overall Study|switched to alternative treatment|1|||
144659057|NCT02179515|521602153|FG000|Overall Study|Death|0|||
144659058|NCT02179515|521602154|FG001|Overall Study|Death|1|||
144659059|NCT02179515|521602155|FG002|Overall Study|Death|1|||
144659060|NCT02179515|521602153|FG000|Overall Study|refused further treatment|0|||
144659061|NCT02179515|521602154|FG001|Overall Study|refused further treatment|3|||
144659062|NCT02179515|521602155|FG002|Overall Study|refused further treatment|4|||
144659063|NCT02179515|521602153|FG000|Overall Study|Disease progression on study|2|||
144659064|NCT02179515|521602154|FG001|Overall Study|Disease progression on study|11|||
144659065|NCT02179515|521602155|FG002|Overall Study|Disease progression on study|8|||
144659066|NCT00782418|521602156|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
144659067|NCT00782418|521602157|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
144659068|NCT00782418|521602158|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
144659069|NCT00782418|521602159|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
144659070|NCT00782418|521602160|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
144659071|NCT00782418|521602161|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
144659072|NCT00782418|521602162|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
144659073|NCT00782418|521602156|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
144659074|NCT00782418|521602157|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
144659075|NCT00782418|521602158|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
144659076|NCT00782418|521602159|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
144659077|NCT00782418|521602160|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
144659078|NCT00782418|521602161|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
144659079|NCT00782418|521602162|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
144659080|NCT05142332|521602163|FG000|Overall Study|Withdrawal by Subject|0|||
144659081|NCT05142332|521602164|FG001|Overall Study|Withdrawal by Subject|1|||
144659082|NCT05142332|521602165|FG002|Overall Study|Withdrawal by Subject|2|||
144659083|NCT05142332|521602166|FG003|Overall Study|Withdrawal by Subject|0|||
144659084|NCT05142332|521602167|FG004|Overall Study|Withdrawal by Subject|0|||
144659085|NCT05142332|521602168|FG005|Overall Study|Withdrawal by Subject|2|||
144659086|NCT05142332|521602169|FG006|Overall Study|Withdrawal by Subject|6|||
144659087|NCT05142332|521602163|FG000|Overall Study|Left ED|3|||
144659088|NCT05142332|521602164|FG001|Overall Study|Left ED|0|||
144659089|NCT05142332|521602165|FG002|Overall Study|Left ED|4|||
144659090|NCT05142332|521602166|FG003|Overall Study|Left ED|6|||
144659091|NCT05142332|521602167|FG004|Overall Study|Left ED|1|||
144659092|NCT05142332|521602168|FG005|Overall Study|Left ED|2|||
144659093|NCT05142332|521602169|FG006|Overall Study|Left ED|6|||
144659094|NCT05142332|521602163|FG000|Overall Study|Physician Decision|0|||
144659095|NCT05142332|521602164|FG001|Overall Study|Physician Decision|0|||
144659096|NCT05142332|521602165|FG002|Overall Study|Physician Decision|2|||
144659097|NCT05142332|521602166|FG003|Overall Study|Physician Decision|1|||
144659098|NCT05142332|521602167|FG004|Overall Study|Physician Decision|0|||
144659099|NCT05142332|521602168|FG005|Overall Study|Physician Decision|0|||
144659100|NCT05142332|521602169|FG006|Overall Study|Physician Decision|3|||
144659101|NCT05142332|521602163|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
144659102|NCT05142332|521602164|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
144659103|NCT05142332|521602165|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
144659104|NCT05142332|521602166|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
144659105|NCT05142332|521602167|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
144214485|NCT04138823|519978767|FG002|Overall Study|Clinical disease progression|1|||
144214486|NCT04138823|519978765|FG000|Overall Study|Objective disease progression|3|||
144659106|NCT05142332|521602168|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
144659107|NCT05142332|521602169|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
144659108|NCT02116660|521602170|FG000|Overall Study|Deteriorating renal function|0|||
144659109|NCT02116660|521602171|FG001|Overall Study|Deteriorating renal function|1|||
144659110|NCT02116660|521602170|FG000|Overall Study|Adverse Event|1|||
144659111|NCT02116660|521602171|FG001|Overall Study|Adverse Event|1|||
144659112|NCT02116660|521602170|FG000|Overall Study|Withdrawal by Subject|0|||
144659113|NCT02116660|521602171|FG001|Overall Study|Withdrawal by Subject|2|||
144659114|NCT02116660|521602170|FG000|Overall Study|Organization reason|1|||
144659115|NCT02116660|521602171|FG001|Overall Study|Organization reason|0|||
144659116|NCT01718509|521602172|FG000|Overall Study|Lost to Follow-up|18|||
144659117|NCT01718509|521602173|FG001|Overall Study|Lost to Follow-up|15|||
144659118|NCT01718509|521602172|FG000|Overall Study|Withdrawal by Subject|7|||
144659119|NCT01718509|521602173|FG001|Overall Study|Withdrawal by Subject|13|||
144659120|NCT01718509|521602172|FG000|Overall Study|Adverse Event|5|||
144659121|NCT01718509|521602173|FG001|Overall Study|Adverse Event|7|||
144659122|NCT01718509|521602172|FG000|Overall Study|Other|13|||
144659123|NCT01718509|521602173|FG001|Overall Study|Other|11|||
144659124|NCT01718509|521602172|FG000|Overall Study|Protocol Violation|4|||
144659125|NCT01718509|521602173|FG001|Overall Study|Protocol Violation|2|||
144659126|NCT01718509|521602172|FG000|Overall Study|Lack of Efficacy|1|||
144659127|NCT01718509|521602173|FG001|Overall Study|Lack of Efficacy|0|||
144659128|NCT00411788|521602178|FG000|Overall Study|Protocol Violation|1|||
144659129|NCT00411788|521602178|FG000|Overall Study|Adverse Event|1|||
144659130|NCT00390416|521602180|FG000|Overall Study|Withdrawal by Subject|1|||
144659131|NCT00390416|521602180|FG000|Overall Study|Not treated|3|||
144659132|NCT01592409|521602181|FG000|Overall Study|Withdrawal by Subject|0|||
144659133|NCT01592409|521602182|FG001|Overall Study|Withdrawal by Subject|1|||
144659134|NCT01219959|521602183|FG000|Overall Study|Adverse Event|6|||
144659135|NCT01219959|521602184|FG001|Overall Study|Adverse Event|14|||
144659136|NCT01219959|521602183|FG000|Overall Study|Physician Decision|0|||
144659137|NCT01219959|521602184|FG001|Overall Study|Physician Decision|4|||
144659138|NCT01219959|521602183|FG000|Overall Study|Withdrawal by Subject|0|||
144659139|NCT01219959|521602184|FG001|Overall Study|Withdrawal by Subject|2|||
144659140|NCT01219959|521602183|FG000|Overall Study|Renal Transplantation|0|||
144659141|NCT01219959|521602184|FG001|Overall Study|Renal Transplantation|3|||
144659142|NCT01219959|521602183|FG000|Overall Study|Other|1|||
144659143|NCT01219959|521602184|FG001|Overall Study|Other|0|||
144659144|NCT01728584|521602185|FG000|Overall Study|Adverse Event|1|||
144659145|NCT01728584|521602186|FG001|Overall Study|Adverse Event|0|||
144659146|NCT01728584|521602187|FG002|Overall Study|Adverse Event|0|||
144659147|NCT01728584|521602188|FG003|Overall Study|Adverse Event|0|||
144659148|NCT01728584|521602185|FG000|Overall Study|Physician Decision|4|||
144659149|NCT01728584|521602186|FG001|Overall Study|Physician Decision|0|||
144659150|NCT01728584|521602187|FG002|Overall Study|Physician Decision|1|||
144659151|NCT01728584|521602188|FG003|Overall Study|Physician Decision|0|||
144659152|NCT01728584|521602185|FG000|Overall Study|Withdrawal by Subject|1|||
144659153|NCT01728584|521602186|FG001|Overall Study|Withdrawal by Subject|0|||
144659154|NCT01728584|521602187|FG002|Overall Study|Withdrawal by Subject|0|||
144659155|NCT01728584|521602188|FG003|Overall Study|Withdrawal by Subject|0|||
144659156|NCT01728584|521602185|FG000|Overall Study|Screen failure|1|||
144659157|NCT01728584|521602186|FG001|Overall Study|Screen failure|0|||
144659158|NCT01728584|521602187|FG002|Overall Study|Screen failure|0|||
144659159|NCT01728584|521602188|FG003|Overall Study|Screen failure|0|||
144659160|NCT01728584|521602185|FG000|Overall Study|Other reason (not specified)|1|||
144659161|NCT01728584|521602186|FG001|Overall Study|Other reason (not specified)|0|||
144659162|NCT01728584|521602187|FG002|Overall Study|Other reason (not specified)|0|||
144659163|NCT01728584|521602188|FG003|Overall Study|Other reason (not specified)|1|||
144659164|NCT00471536|521602190|FG000|Overall Study|Withdrawal by Subject|1|||
144659165|NCT02546674|521602193|FG000|Overall Study|Adverse Event|19|||
144659166|NCT02546674|521602193|FG000|Overall Study|Death|1|||
144659167|NCT02546674|521602193|FG000|Overall Study|Lost to Follow-up|1|||
144659168|NCT02546674|521602193|FG000|Overall Study|Physician Decision|13|||
144659169|NCT02546674|521602193|FG000|Overall Study|Pregnancy|1|||
144659170|NCT02546674|521602193|FG000|Overall Study|Progressive Disease|2|||
144659171|NCT02546674|521602193|FG000|Overall Study|Protocol Deviation|2|||
144659172|NCT02546674|521602193|FG000|Overall Study|Subject/Guardian Decision|6|||
144659173|NCT02546674|521602193|FG000|Overall Study|Withdrawal of Informed Consent|3|||
144659174|NCT01401010|521602194|FG000|Overall Study|Could not interpret assay results|1|||
144659175|NCT01401010|521602195|FG001|Overall Study|Could not interpret assay results|0|||
144659176|NCT04360187|521602203|FG000|Double-Blind Treatment|Adverse Event|9|||
144659177|NCT04360187|521602204|FG001|Double-Blind Treatment|Adverse Event|11|||
144659178|NCT04360187|521602203|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
144659179|NCT04360187|521602204|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
144659180|NCT04360187|521602203|FG000|Double-Blind Treatment|Physician Decision|1|||
144659181|NCT04360187|521602204|FG001|Double-Blind Treatment|Physician Decision|0|||
144659182|NCT04360187|521602203|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
144659183|NCT04360187|521602204|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
144659184|NCT04360187|521602203|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
144659185|NCT04360187|521602204|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
144659186|NCT04360187|521602203|FG000|Follow-Up|Lost to Follow-up|1|||
144659187|NCT04360187|521602204|FG001|Follow-Up|Lost to Follow-up|0|||
144659188|NCT02203838|521602205|FG000|Overall Study|Lack of Efficacy|7|||
144659189|NCT02203838|521602206|FG001|Overall Study|Lack of Efficacy|0|||
144659190|NCT02203838|521602207|FG002|Overall Study|Lack of Efficacy|1|||
144659191|NCT02203838|521602208|FG003|Overall Study|Lack of Efficacy|1|||
144659192|NCT02203838|521602205|FG000|Overall Study|Adverse Event|46|||
144659193|NCT02203838|521602206|FG001|Overall Study|Adverse Event|6|||
144659194|NCT02203838|521602207|FG002|Overall Study|Adverse Event|3|||
144659195|NCT02203838|521602208|FG003|Overall Study|Adverse Event|2|||
144659196|NCT02203838|521602205|FG000|Overall Study|Lost to Follow-up|39|||
144659197|NCT02203838|521602206|FG001|Overall Study|Lost to Follow-up|3|||
144659198|NCT02203838|521602207|FG002|Overall Study|Lost to Follow-up|2|||
144659199|NCT02203838|521602208|FG003|Overall Study|Lost to Follow-up|1|||
144659200|NCT02203838|521602205|FG000|Overall Study|Protocol Violation|7|||
144659201|NCT02203838|521602206|FG001|Overall Study|Protocol Violation|3|||
144659202|NCT02203838|521602207|FG002|Overall Study|Protocol Violation|0|||
144659203|NCT02203838|521602208|FG003|Overall Study|Protocol Violation|0|||
144659204|NCT02203838|521602205|FG000|Overall Study|Withdrawal by Subject|83|||
144659205|NCT02203838|521602206|FG001|Overall Study|Withdrawal by Subject|10|||
144659206|NCT02203838|521602207|FG002|Overall Study|Withdrawal by Subject|8|||
144659207|NCT02203838|521602208|FG003|Overall Study|Withdrawal by Subject|11|||
144659208|NCT02203838|521602205|FG000|Overall Study|Physician Decision|27|||
144659209|NCT02203838|521602206|FG001|Overall Study|Physician Decision|0|||
144659210|NCT02203838|521602207|FG002|Overall Study|Physician Decision|2|||
144659211|NCT02203838|521602208|FG003|Overall Study|Physician Decision|3|||
144659212|NCT02203838|521602205|FG000|Overall Study|Other|1|||
144659213|NCT02203838|521602206|FG001|Overall Study|Other|0|||
144659214|NCT02203838|521602207|FG002|Overall Study|Other|0|||
144659215|NCT02203838|521602208|FG003|Overall Study|Other|0|||
144659216|NCT05896761|521602209|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
144659217|NCT05896761|521602210|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
144659218|NCT05896761|521602209|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
144659219|NCT05896761|521602210|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
144659220|NCT01318083|521602211|FG000|Overall Study|Adverse Event|4|||
144659221|NCT01318083|521602212|FG001|Overall Study|Adverse Event|1|||
144659222|NCT01318083|521602213|FG002|Overall Study|Adverse Event|2|||
144659223|NCT01318083|521602211|FG000|Overall Study|Withdrawal by Subject|1|||
144659224|NCT01318083|521602212|FG001|Overall Study|Withdrawal by Subject|0|||
144659225|NCT01318083|521602213|FG002|Overall Study|Withdrawal by Subject|2|||
144659226|NCT01318083|521602211|FG000|Overall Study|Lack of Efficacy|0|||
144659227|NCT01318083|521602212|FG001|Overall Study|Lack of Efficacy|0|||
144659228|NCT01318083|521602213|FG002|Overall Study|Lack of Efficacy|1|||
144659229|NCT01318083|521602211|FG000|Overall Study|Treatment Complications|1|||
144659230|NCT01318083|521602212|FG001|Overall Study|Treatment Complications|0|||
144659231|NCT01318083|521602213|FG002|Overall Study|Treatment Complications|0|||
144659232|NCT01318083|521602211|FG000|Overall Study|Lack of Study Medication Compliance|0|||
144659233|NCT01318083|521602212|FG001|Overall Study|Lack of Study Medication Compliance|1|||
144659234|NCT01318083|521602213|FG002|Overall Study|Lack of Study Medication Compliance|0|||
144659235|NCT02065869|521602215|FG000|Overall Study|Death|7|||
144659236|NCT02065869|521602215|FG000|Overall Study|Disease relapse|16|||
144659237|NCT02065869|521602215|FG000|Overall Study|Lost to Follow-up|4|||
144659238|NCT02065869|521602215|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
144659239|NCT02065869|521602215|FG000|Overall Study|Withdrawal by Subject|1|||
144659240|NCT00952289|521602218|FG000|All Participants|Death|9|||
144659241|NCT00952289|521602219|FG001|All Participants|Death|9|||
144659242|NCT00952289|521602218|FG000|All Participants|Adverse Event|8|||
144659243|NCT00952289|521602219|FG001|All Participants|Adverse Event|8|||
144659244|NCT00952289|521602218|FG000|All Participants|Disease progression|3|||
144659245|NCT00952289|521602219|FG001|All Participants|Disease progression|12|||
144659246|NCT00952289|521602218|FG000|All Participants|Withdrawal by Subject|1|||
144659247|NCT00952289|521602219|FG001|All Participants|Withdrawal by Subject|10|||
144659248|NCT00952289|521602218|FG000|All Participants|Data lost during site relocation|0|||
144659249|NCT00952289|521602219|FG001|All Participants|Data lost during site relocation|1|||
144659250|NCT00952289|521602218|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
144659251|NCT00952289|521602219|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
144659252|NCT00952289|521602218|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
144659253|NCT00952289|521602219|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
144659254|NCT00952289|521602218|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
144659255|NCT00952289|521602219|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
144659256|NCT00952289|521602218|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
144659257|NCT00952289|521602219|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
144659258|NCT00952289|521602218|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
144659259|NCT00952289|521602219|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
144659260|NCT03827473|521602220|FG000|Overall Study|Withdrawal by Subject|1|||
144659261|NCT03827473|521602221|FG001|Overall Study|Withdrawal by Subject|0|||
144659262|NCT01423617|521602228|FG000|Overall Study|Lost to Follow-up|0|||
144659263|NCT01423617|521602229|FG001|Overall Study|Lost to Follow-up|1|||
144264900|NCT01545388|520171636|FG000|Overall Study|Withdrawal by Subject|1|||
144264901|NCT01545388|520171637|FG001|Overall Study|Withdrawal by Subject|4|||
144659264|NCT03855137|521602232|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
144659265|NCT03855137|521602233|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
144659266|NCT03855137|521602234|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
144659267|NCT03855137|521602232|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
144659268|NCT03855137|521602233|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
144659269|NCT03855137|521602234|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
144659270|NCT03855137|521602232|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
144659271|NCT03855137|521602233|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
144659272|NCT03855137|521602234|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
144659273|NCT03855137|521602232|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
144659274|NCT03855137|521602233|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
144659275|NCT03855137|521602234|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
144659276|NCT03855137|521602232|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
144659277|NCT03855137|521602233|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
144659278|NCT03855137|521602234|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
144659279|NCT03855137|521602232|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
144659280|NCT03855137|521602233|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
144659281|NCT03855137|521602234|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
144659282|NCT03855137|521602232|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
144659283|NCT03855137|521602233|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
144659284|NCT03855137|521602234|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
144659285|NCT03855137|521602232|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
144659286|NCT03855137|521602233|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
144659287|NCT03855137|521602234|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
144659288|NCT03855137|521602232|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
144659289|NCT03855137|521602233|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
144659290|NCT03855137|521602234|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
144659291|NCT03855137|521602232|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
144659292|NCT03855137|521602233|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
144659293|NCT03855137|521602234|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
144659294|NCT02435277|521602235|FG000|Overall Study|Adverse Event|1|||
144659295|NCT02435277|521602236|FG001|Overall Study|Adverse Event|1|||
144659296|NCT02435277|521602237|FG002|Overall Study|Adverse Event|0|||
144659297|NCT02435277|521602238|FG003|Overall Study|Adverse Event|0|||
144659298|NCT02435277|521602235|FG000|Overall Study|Withdrawal by Subject|1|||
144659299|NCT02435277|521602236|FG001|Overall Study|Withdrawal by Subject|0|||
144659300|NCT02435277|521602237|FG002|Overall Study|Withdrawal by Subject|0|||
144214487|NCT04138823|519978766|FG001|Overall Study|Objective disease progression|2|||
144214488|NCT04138823|519978767|FG002|Overall Study|Objective disease progression|5|||
144214489|NCT03138655|519978768|FG000|Overall Study|Adverse Event|2|||
144214490|NCT03138655|519978769|FG001|Overall Study|Adverse Event|1|||
144214491|NCT03138655|519978770|FG002|Overall Study|Adverse Event|2|||
144214492|NCT03138655|519978771|FG003|Overall Study|Adverse Event|1|||
144214493|NCT03138655|519978772|FG004|Overall Study|Adverse Event|1|||
144214494|NCT03138655|519978773|FG005|Overall Study|Adverse Event|4|||
144214495|NCT03138655|519978774|FG006|Overall Study|Adverse Event|2|||
144214496|NCT03138655|519978775|FG007|Overall Study|Adverse Event|2|||
144214497|NCT03138655|519978768|FG000|Overall Study|Withdrawal by Subject|0|||
144214498|NCT03138655|519978769|FG001|Overall Study|Withdrawal by Subject|1|||
144214499|NCT03138655|519978770|FG002|Overall Study|Withdrawal by Subject|0|||
144214500|NCT03138655|519978771|FG003|Overall Study|Withdrawal by Subject|0|||
144214501|NCT03138655|519978772|FG004|Overall Study|Withdrawal by Subject|0|||
144214502|NCT03138655|519978773|FG005|Overall Study|Withdrawal by Subject|0|||
144214503|NCT03138655|519978774|FG006|Overall Study|Withdrawal by Subject|1|||
144214504|NCT03138655|519978775|FG007|Overall Study|Withdrawal by Subject|0|||
144214505|NCT03138655|519978768|FG000|Overall Study|Reason not Specified|1|||
144214506|NCT03138655|519978769|FG001|Overall Study|Reason not Specified|0|||
144214507|NCT03138655|519978770|FG002|Overall Study|Reason not Specified|0|||
144214508|NCT03138655|519978771|FG003|Overall Study|Reason not Specified|2|||
144214509|NCT03138655|519978772|FG004|Overall Study|Reason not Specified|1|||
144214510|NCT03138655|519978773|FG005|Overall Study|Reason not Specified|1|||
144214511|NCT03138655|519978774|FG006|Overall Study|Reason not Specified|0|||
144214512|NCT03138655|519978775|FG007|Overall Study|Reason not Specified|0|||
144659301|NCT02435277|521602238|FG003|Overall Study|Withdrawal by Subject|0|||
144214513|NCT02859142|519978776|FG000|Overall Study|Adverse Event|1|||
144214514|NCT02859142|519978777|FG001|Overall Study|Adverse Event|2|||
144214515|NCT02859142|519978776|FG000|Overall Study|Lost to Follow-up|1|||
144214516|NCT02859142|519978777|FG001|Overall Study|Lost to Follow-up|4|||
144214517|NCT02859142|519978776|FG000|Overall Study|Withdrawal by Subject|2|||
144659302|NCT01067508|521602239|FG000|Overall Study|Physician Decision|0|||
144214518|NCT02859142|519978777|FG001|Overall Study|Withdrawal by Subject|0|||
144214519|NCT02859142|519978776|FG000|Overall Study|Scheduling difficulties|0|||
144214520|NCT02859142|519978777|FG001|Overall Study|Scheduling difficulties|3|||
144214521|NCT03290079|519978778|FG000|Overall Study|Death|2|||
144214522|NCT02466685|519978779|FG000|Overall Study|Adverse Event|5|||
144214523|NCT02466685|519978780|FG001|Overall Study|Adverse Event|2|||
144214524|NCT02466685|519978779|FG000|Overall Study|Lost to Follow-up|1|||
144214525|NCT02466685|519978780|FG001|Overall Study|Lost to Follow-up|1|||
144214526|NCT02466685|519978779|FG000|Overall Study|Withdrawal by Subject|1|||
144214527|NCT02466685|519978780|FG001|Overall Study|Withdrawal by Subject|0|||
144214528|NCT02466685|519978779|FG000|Overall Study|Physician Decision|1|||
144214529|NCT02466685|519978780|FG001|Overall Study|Physician Decision|1|||
144214530|NCT01277211|519978783|FG000|Overall Study|Adverse Event|60|||
144732877|NCT00396279|521879224|FG000|Overall Study|Withdrawal by Subject|1|||
144732878|NCT00396279|521879224|FG000|Overall Study|Physician Decision|1|||
144732879|NCT01882257|521879225|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
144732880|NCT01882257|521879226|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
144732881|NCT01882257|521879227|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
144732882|NCT01882257|521879225|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
144732883|NCT01882257|521879226|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
144732884|NCT01882257|521879227|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
144732885|NCT02724462|521879228|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
144732886|NCT02724462|521879229|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
144732887|NCT02724462|521879228|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
144732888|NCT02724462|521879229|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
144732889|NCT02724462|521879228|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
144732890|NCT02724462|521879229|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
144732891|NCT02724462|521879228|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
144732892|NCT02724462|521879229|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
144732893|NCT02724462|521879228|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
144732894|NCT02724462|521879229|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
144732895|NCT02724462|521879228|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
144732896|NCT02724462|521879229|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
144732897|NCT01954394|521879230|FG000|Overall Study|Enrolled but not treated|1|||
144732898|NCT01954394|521879231|FG001|Overall Study|Enrolled but not treated|0|||
144732899|NCT01954394|521879230|FG000|Overall Study|Adverse Event|10|||
144732900|NCT01954394|521879231|FG001|Overall Study|Adverse Event|23|||
144732901|NCT01954394|521879230|FG000|Overall Study|Poor compliance to protocol|7|||
144732902|NCT01954394|521879231|FG001|Overall Study|Poor compliance to protocol|7|||
144732903|NCT01954394|521879230|FG000|Overall Study|Participant Moved|0|||
144732904|NCT01954394|521879231|FG001|Overall Study|Participant Moved|4|||
144732905|NCT01954394|521879230|FG000|Overall Study|Related to Study Drug administration|2|||
144732906|NCT01954394|521879231|FG001|Overall Study|Related to Study Drug administration|2|||
144732907|NCT01954394|521879230|FG000|Overall Study|Other than specified above|10|||
144732908|NCT01954394|521879231|FG001|Overall Study|Other than specified above|21|||
144732909|NCT04089735|521879232|FG000|Overall Study|Adverse Event|1|||
144732910|NCT04089735|521879233|FG001|Overall Study|Adverse Event|0|||
144732911|NCT04089735|521879234|FG002|Overall Study|Adverse Event|1|||
144732912|NCT04089735|521879235|FG003|Overall Study|Adverse Event|1|||
144732913|NCT04089735|521879236|FG004|Overall Study|Adverse Event|0|||
144732914|NCT04089735|521879237|FG005|Overall Study|Adverse Event|0|||
144732915|NCT04089735|521879232|FG000|Overall Study|Physician Decision|0|||
144732916|NCT04089735|521879233|FG001|Overall Study|Physician Decision|3|||
144732917|NCT04089735|521879234|FG002|Overall Study|Physician Decision|0|||
144732918|NCT04089735|521879235|FG003|Overall Study|Physician Decision|0|||
144732919|NCT04089735|521879236|FG004|Overall Study|Physician Decision|0|||
144732920|NCT04089735|521879237|FG005|Overall Study|Physician Decision|0|||
144732921|NCT04089735|521879232|FG000|Overall Study|Withdrawal by Subject|0|||
144732922|NCT04089735|521879233|FG001|Overall Study|Withdrawal by Subject|0|||
144732923|NCT04089735|521879234|FG002|Overall Study|Withdrawal by Subject|1|||
144732924|NCT04089735|521879235|FG003|Overall Study|Withdrawal by Subject|0|||
144732925|NCT04089735|521879236|FG004|Overall Study|Withdrawal by Subject|0|||
144732926|NCT04089735|521879237|FG005|Overall Study|Withdrawal by Subject|0|||
144732927|NCT04089735|521879232|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
144732928|NCT04089735|521879233|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
144732929|NCT04089735|521879234|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
144732930|NCT04089735|521879235|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
144732931|NCT04089735|521879236|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
144264902|NCT01545388|520171638|FG002|Overall Study|Withdrawal by Subject|2|||
144659303|NCT01067508|521602240|FG001|Overall Study|Physician Decision|1|||
144659304|NCT01067508|521602239|FG000|Overall Study|Withdrawal by Subject|0|||
144659305|NCT01067508|521602240|FG001|Overall Study|Withdrawal by Subject|1|||
144659306|NCT04715230|521602241|FG000|Overall Study|Withdrawal by Subject|1|||
144659307|NCT04715230|521602242|FG001|Overall Study|Withdrawal by Subject|0|||
144659308|NCT04715230|521602243|FG002|Overall Study|Withdrawal by Subject|0|||
144659309|NCT04715230|521602241|FG000|Overall Study|Lost to Follow-up|0|||
144659310|NCT04715230|521602242|FG001|Overall Study|Lost to Follow-up|5|||
144659311|NCT04715230|521602243|FG002|Overall Study|Lost to Follow-up|1|||
144659312|NCT01687413|521602257|FG000|Overall Study|Withdrawal by Subject|0|||
144659313|NCT01687413|521602258|FG001|Overall Study|Withdrawal by Subject|2|||
144659314|NCT01687413|521602257|FG000|Overall Study|Not eligible|0|||
144659315|NCT01687413|521602258|FG001|Overall Study|Not eligible|2|||
144659316|NCT01687413|521602257|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
144659317|NCT01687413|521602258|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
144659318|NCT00488618|521602266|FG000|Overall Study|Adverse Event|13|||
144659319|NCT00488618|521602267|FG001|Overall Study|Adverse Event|17|||
144659320|NCT00488618|521602266|FG000|Overall Study|Insufficient Therapeutic Response|18|||
144659321|NCT00488618|521602267|FG001|Overall Study|Insufficient Therapeutic Response|11|||
144659322|NCT00488618|521602266|FG000|Overall Study|Protocol Violation|0|||
144659323|NCT00488618|521602267|FG001|Overall Study|Protocol Violation|2|||
144659324|NCT00488618|521602266|FG000|Overall Study|Withdrawal of Consent|15|||
144659325|NCT00488618|521602267|FG001|Overall Study|Withdrawal of Consent|13|||
144659326|NCT00488618|521602266|FG000|Overall Study|Lost to Follow-up|1|||
144659327|NCT00488618|521602267|FG001|Overall Study|Lost to Follow-up|0|||
144659328|NCT00992446|521602268|FG000|Overall Study|Disease Progression|1|||
144659329|NCT00992446|521602268|FG000|Overall Study|Withdrawal by Subject|2|||
144659330|NCT00992446|521602268|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
144659331|NCT02020031|521604454|FG000|Overall Study|Physician Decision|1|||
144659332|NCT02020031|521604455|FG001|Overall Study|Physician Decision|1|||
144659333|NCT00755846|521604456|FG000|Overall Study|Adverse Event|0|||
144659334|NCT00755846|521604457|FG001|Overall Study|Adverse Event|0|||
144659335|NCT00755846|521604458|FG002|Overall Study|Adverse Event|0|||
144659336|NCT00755846|521604459|FG003|Overall Study|Adverse Event|1|||
144659337|NCT00755846|521604460|FG004|Overall Study|Adverse Event|3|||
144659338|NCT00755846|521604461|FG005|Overall Study|Adverse Event|2|||
144659339|NCT00755846|521604456|FG000|Overall Study|Protocol Violation|1|||
144659340|NCT00755846|521604457|FG001|Overall Study|Protocol Violation|1|||
144659341|NCT00755846|521604458|FG002|Overall Study|Protocol Violation|1|||
144659342|NCT00755846|521604459|FG003|Overall Study|Protocol Violation|1|||
144659343|NCT00755846|521604460|FG004|Overall Study|Protocol Violation|1|||
144659344|NCT00755846|521604461|FG005|Overall Study|Protocol Violation|1|||
144659345|NCT00755846|521604456|FG000|Overall Study|Lost to Follow-up|0|||
144659346|NCT00755846|521604457|FG001|Overall Study|Lost to Follow-up|2|||
144659347|NCT00755846|521604458|FG002|Overall Study|Lost to Follow-up|1|||
144659348|NCT00755846|521604459|FG003|Overall Study|Lost to Follow-up|0|||
144659349|NCT00755846|521604460|FG004|Overall Study|Lost to Follow-up|4|||
144659350|NCT00755846|521604461|FG005|Overall Study|Lost to Follow-up|2|||
144659351|NCT00755846|521604456|FG000|Overall Study|Withdrawal by Subject|2|||
144659352|NCT00755846|521604457|FG001|Overall Study|Withdrawal by Subject|3|||
144659353|NCT00755846|521604458|FG002|Overall Study|Withdrawal by Subject|5|||
144659354|NCT00755846|521604459|FG003|Overall Study|Withdrawal by Subject|2|||
144659355|NCT00755846|521604460|FG004|Overall Study|Withdrawal by Subject|0|||
144659356|NCT00755846|521604461|FG005|Overall Study|Withdrawal by Subject|1|||
144659357|NCT00755846|521604456|FG000|Overall Study|Hyperglycemic Rescue|21|||
144659358|NCT00755846|521604457|FG001|Overall Study|Hyperglycemic Rescue|7|||
144659359|NCT00755846|521604458|FG002|Overall Study|Hyperglycemic Rescue|5|||
144659360|NCT00755846|521604459|FG003|Overall Study|Hyperglycemic Rescue|8|||
144659361|NCT00755846|521604460|FG004|Overall Study|Hyperglycemic Rescue|8|||
144659362|NCT00755846|521604461|FG005|Overall Study|Hyperglycemic Rescue|7|||
144659363|NCT00755846|521604456|FG000|Overall Study|Physician Decision|1|||
144659364|NCT00755846|521604457|FG001|Overall Study|Physician Decision|3|||
144659365|NCT00755846|521604458|FG002|Overall Study|Physician Decision|0|||
144659366|NCT00755846|521604459|FG003|Overall Study|Physician Decision|1|||
144659367|NCT00755846|521604460|FG004|Overall Study|Physician Decision|0|||
144732932|NCT04089735|521879237|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
144732933|NCT02128997|521879239|FG000|Overall Study|Lost to Follow-up|6|||
144732934|NCT02128997|521879240|FG001|Overall Study|Lost to Follow-up|11|||
144659368|NCT00755846|521604461|FG005|Overall Study|Physician Decision|1|||
144214531|NCT01277211|519978784|FG001|Overall Study|Adverse Event|22|||
144659369|NCT00755846|521604456|FG000|Overall Study|Administrative Error|0|||
144659370|NCT00755846|521604457|FG001|Overall Study|Administrative Error|1|||
144659371|NCT00755846|521604458|FG002|Overall Study|Administrative Error|0|||
144659372|NCT00755846|521604459|FG003|Overall Study|Administrative Error|0|||
144659373|NCT00755846|521604460|FG004|Overall Study|Administrative Error|0|||
144659374|NCT00755846|521604461|FG005|Overall Study|Administrative Error|0|||
144732935|NCT00096447|521879245|FG000|Overall Study|Never treated|1|||
144659375|NCT00755846|521604456|FG000|Overall Study|Participant Non-compliance|0|||
144659376|NCT00755846|521604457|FG001|Overall Study|Participant Non-compliance|0|||
144659377|NCT00755846|521604458|FG002|Overall Study|Participant Non-compliance|0|||
144659378|NCT00755846|521604459|FG003|Overall Study|Participant Non-compliance|0|||
144659379|NCT00755846|521604460|FG004|Overall Study|Participant Non-compliance|1|||
144659380|NCT00755846|521604461|FG005|Overall Study|Participant Non-compliance|0|||
144659381|NCT00786032|521604471|FG000|Overall Study|Death|4|||
144659382|NCT00786032|521604471|FG000|Overall Study|Withdrawal by Subject|14|||
144659383|NCT00786032|521604471|FG000|Overall Study|Did not complete in the timeframe|6|||
144659384|NCT00683475|521604472|FG000|Overall Study|Withdrawal by Subject|1|||
144659385|NCT00683475|521604473|FG001|Overall Study|Withdrawal by Subject|0|||
144659386|NCT00683475|521604472|FG000|Overall Study|Never Treated: Adverse Event|2|||
144659387|NCT00683475|521604473|FG001|Overall Study|Never Treated: Adverse Event|3|||
144659388|NCT00683475|521604472|FG000|Overall Study|Never Treated: Progressive Disease|1|||
144659389|NCT00683475|521604473|FG001|Overall Study|Never Treated: Progressive Disease|0|||
144659390|NCT02922634|521604474|FG000|Overall Study|Withdrawal by Subject|5|||
144659391|NCT02922634|521604474|FG000|Overall Study|Did not have their surgery|5|||
144659392|NCT02294318|521604475|FG000|Overall Study|Worsening of drinking|3|||
144659393|NCT02294318|521604476|FG001|Overall Study|Worsening of drinking|0|||
144659394|NCT02294318|521604475|FG000|Overall Study|Not exposed to intervention|0|||
144659395|NCT02294318|521604476|FG001|Overall Study|Not exposed to intervention|2|||
144659396|NCT02429258|521604477|FG000|Overall Study|Withdrawal by Subject|2|||
144659397|NCT02429258|521604478|FG001|Overall Study|Withdrawal by Subject|0|||
144659398|NCT02429258|521604477|FG000|Overall Study|Protocol Violation|0|||
144659399|NCT02429258|521604478|FG001|Overall Study|Protocol Violation|1|||
144659400|NCT01694420|521604481|FG000|Overall Study|Lost to Follow-up|3|||
144659401|NCT00762372|521604482|FG000|Overall Study|Adverse Event|1|||
144659402|NCT00762372|521604483|FG001|Overall Study|Adverse Event|0|||
144659403|NCT00762372|521604484|FG002|Overall Study|Adverse Event|0|||
144659404|NCT00818207|521604485|FG000|Overall Study|Adverse Event|6|||
144659405|NCT00818207|521604486|FG001|Overall Study|Adverse Event|0|||
144659406|NCT00818207|521604485|FG000|Overall Study|Lost to Follow-up|160|||
144659407|NCT00818207|521604486|FG001|Overall Study|Lost to Follow-up|146|||
144659408|NCT00818207|521604485|FG000|Overall Study|Multiple reasons|11|||
144659409|NCT00818207|521604486|FG001|Overall Study|Multiple reasons|12|||
144659410|NCT00818207|521604485|FG000|Overall Study|Withdrawal by Subject|42|||
144659411|NCT00818207|521604486|FG001|Overall Study|Withdrawal by Subject|104|||
144659412|NCT00818207|521604485|FG000|Overall Study|Death|3|||
144659413|NCT00818207|521604486|FG001|Overall Study|Death|5|||
144659414|NCT02616185|521604487|FG000|Overall Study|Death|0|||
144659415|NCT02616185|521604488|FG001|Overall Study|Death|0|||
144659416|NCT02616185|521604489|FG002|Overall Study|Death|0|||
144659417|NCT02616185|521604490|FG003|Overall Study|Death|1|||
144659418|NCT02616185|521604491|FG004|Overall Study|Death|2|||
144659419|NCT02616185|521604492|FG005|Overall Study|Death|0|||
144659420|NCT02616185|521604493|FG006|Overall Study|Death|0|||
144659421|NCT02616185|521604494|FG007|Overall Study|Death|2|||
144659422|NCT02616185|521604495|FG008|Overall Study|Death|1|||
144659423|NCT02616185|521604487|FG000|Overall Study|Study terminated by sponsor|0|||
144659424|NCT02616185|521604488|FG001|Overall Study|Study terminated by sponsor|0|||
144659425|NCT02616185|521604489|FG002|Overall Study|Study terminated by sponsor|1|||
144659426|NCT02616185|521604490|FG003|Overall Study|Study terminated by sponsor|0|||
144659427|NCT02616185|521604491|FG004|Overall Study|Study terminated by sponsor|0|||
144659428|NCT02616185|521604492|FG005|Overall Study|Study terminated by sponsor|0|||
144659429|NCT02616185|521604493|FG006|Overall Study|Study terminated by sponsor|5|||
144659430|NCT02616185|521604494|FG007|Overall Study|Study terminated by sponsor|2|||
144659431|NCT02616185|521604495|FG008|Overall Study|Study terminated by sponsor|0|||
144659432|NCT02616185|521604487|FG000|Overall Study|Participant refused further follow-up|1|||
144659433|NCT02616185|521604488|FG001|Overall Study|Participant refused further follow-up|1|||
144659434|NCT02616185|521604489|FG002|Overall Study|Participant refused further follow-up|2|||
144659435|NCT02616185|521604490|FG003|Overall Study|Participant refused further follow-up|3|||
144659436|NCT02616185|521604491|FG004|Overall Study|Participant refused further follow-up|4|||
144659437|NCT02616185|521604492|FG005|Overall Study|Participant refused further follow-up|0|||
144659438|NCT02616185|521604493|FG006|Overall Study|Participant refused further follow-up|3|||
144659439|NCT02616185|521604494|FG007|Overall Study|Participant refused further follow-up|4|||
144732936|NCT00834743|521879246|FG000|Second Intervention|Withdrawal by Subject|1|||
144214532|NCT01277211|519978783|FG000|Overall Study|Pregnancy|9|||
144659440|NCT02616185|521604495|FG008|Overall Study|Participant refused further follow-up|3|||
144659441|NCT02616185|521604487|FG000|Overall Study|Not reported|0|||
144659442|NCT02616185|521604488|FG001|Overall Study|Not reported|0|||
144659443|NCT02616185|521604489|FG002|Overall Study|Not reported|0|||
144659444|NCT02616185|521604490|FG003|Overall Study|Not reported|1|||
144659445|NCT02616185|521604491|FG004|Overall Study|Not reported|3|||
144659446|NCT02616185|521604492|FG005|Overall Study|Not reported|1|||
144659447|NCT02616185|521604493|FG006|Overall Study|Not reported|0|||
144659448|NCT02616185|521604494|FG007|Overall Study|Not reported|5|||
144659449|NCT02616185|521604495|FG008|Overall Study|Not reported|2|||
144214533|NCT01277211|519978784|FG001|Overall Study|Pregnancy|4|||
144214534|NCT01277211|519978783|FG000|Overall Study|Lost to Follow-up|14|||
144214535|NCT01277211|519978784|FG001|Overall Study|Lost to Follow-up|9|||
144214536|NCT01277211|519978783|FG000|Overall Study|Did not wish to continue|17|||
144214537|NCT01277211|519978784|FG001|Overall Study|Did not wish to continue|0|||
144214538|NCT01277211|519978783|FG000|Overall Study|Withdrew Consent|9|||
144214539|NCT01277211|519978784|FG001|Overall Study|Withdrew Consent|9|||
144214540|NCT01277211|519978783|FG000|Overall Study|Non-compliance with protocol|13|||
144214541|NCT01277211|519978784|FG001|Overall Study|Non-compliance with protocol|4|||
144214542|NCT01277211|519978783|FG000|Overall Study|Did not meet protocol eligibility|1|||
144214543|NCT01277211|519978784|FG001|Overall Study|Did not meet protocol eligibility|0|||
144214544|NCT01277211|519978783|FG000|Overall Study|Administrative|3|||
144214545|NCT01277211|519978784|FG001|Overall Study|Administrative|0|||
144214546|NCT01277211|519978783|FG000|Overall Study|Pregnancy wish|0|||
144214547|NCT01277211|519978784|FG001|Overall Study|Pregnancy wish|2|||
144214548|NCT01277211|519978783|FG000|Overall Study|Discontinued prior to treatment|24|||
144214549|NCT01277211|519978784|FG001|Overall Study|Discontinued prior to treatment|13|||
144214550|NCT03452943|519978785|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
144214551|NCT03452943|519978786|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
144214552|NCT03452943|519978785|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
144214553|NCT03452943|519978786|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
144214554|NCT03452943|519978785|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
144214555|NCT03452943|519978786|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
144214556|NCT03452943|519978785|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
144214557|NCT03452943|519978786|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
144214558|NCT03452943|519978785|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
144214559|NCT03452943|519978786|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
144214560|NCT03452943|519978785|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
144214561|NCT03452943|519978786|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
144214562|NCT03514017|519978791|FG000|Overall Study|Death|1|||
144214563|NCT03514017|519978791|FG000|Overall Study|Adverse Event|1|||
144214564|NCT05422625|519978794|FG000|Overall Study|Withdrawal by Subject|1|||
144214565|NCT05422625|519978795|FG001|Overall Study|Withdrawal by Subject|0|||
144214566|NCT01496976|519979884|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
144214567|NCT05938621|519979885|FG000|Overall Study|Lost to Follow-up|1|||
144214568|NCT05938621|519979886|FG001|Overall Study|Lost to Follow-up|5|||
144214569|NCT05938621|519979887|FG002|Overall Study|Lost to Follow-up|2|||
144214570|NCT05938621|519979888|FG003|Overall Study|Lost to Follow-up|2|||
144214571|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
144214572|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
144214573|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
144214574|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
144214575|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
144214576|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
144214577|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
144214578|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
144214579|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
144214580|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
144214581|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
144214582|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
144214583|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
144214584|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
144214585|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
144214586|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
144214587|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
144214588|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
144214589|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
144214590|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
144214591|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
144214592|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
144214593|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
144214594|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
144214595|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
144214596|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
144214597|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
144214598|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
144214599|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
144214600|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
144214601|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
144214602|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
144214603|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
144264903|NCT01545388|520171636|FG000|Overall Study|Other|1|||
144264904|NCT01545388|520171637|FG001|Overall Study|Other|1|||
144264905|NCT01545388|520171638|FG002|Overall Study|Other|0|||
144264906|NCT01825200|520171640|FG000|Overall Study|Lost to Follow-up|5|||
144264907|NCT01825200|520171641|FG001|Overall Study|Lost to Follow-up|6|||
144264908|NCT01825200|520171640|FG000|Overall Study|Withdrawal by Subject|0|||
144264909|NCT01825200|520171641|FG001|Overall Study|Withdrawal by Subject|1|||
144264910|NCT02127658|520171646|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
144264911|NCT02127658|520171647|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
144264912|NCT02127658|520171646|FG000|Overall Study|Withdrawal by Subject|0|||
144264913|NCT02127658|520171647|FG001|Overall Study|Withdrawal by Subject|2|||
144264914|NCT02127658|520171646|FG000|Overall Study|Physician Decision|0|||
144264915|NCT02127658|520171647|FG001|Overall Study|Physician Decision|1|||
144264916|NCT03834493|520171648|FG000|Overall Study|Participants Ongoing|311|||
144264917|NCT03834493|520171649|FG001|Overall Study|Participants Ongoing|324|||
144264918|NCT03834493|520171648|FG000|Overall Study|Withdrawal by Subject|20|||
144264919|NCT03834493|520171649|FG001|Overall Study|Withdrawal by Subject|17|||
144264920|NCT03834493|520171648|FG000|Overall Study|Physician Decision|1|||
144264921|NCT03834493|520171649|FG001|Overall Study|Physician Decision|0|||
144264922|NCT03834493|520171648|FG000|Overall Study|Death|289|||
144264923|NCT03834493|520171649|FG001|Overall Study|Death|282|||
144264924|NCT02277028|520171652|FG000|Overall Study|Lost to Follow-up|1|||
144264925|NCT02277028|520171653|FG001|Overall Study|Lost to Follow-up|0|||
144264926|NCT02277028|520171652|FG000|Overall Study|Withdrawal by Subject|0|||
144264927|NCT02277028|520171653|FG001|Overall Study|Withdrawal by Subject|1|||
144264928|NCT02718911|520171654|FG000|Overall Study|Adverse Event|0|||
144264929|NCT02718911|520171655|FG001|Overall Study|Adverse Event|0|||
144264930|NCT02718911|520171656|FG002|Overall Study|Adverse Event|0|||
144264931|NCT02718911|520171657|FG003|Overall Study|Adverse Event|0|||
144264932|NCT02718911|520171658|FG004|Overall Study|Adverse Event|0|||
144264933|NCT02718911|520171659|FG005|Overall Study|Adverse Event|0|||
144264934|NCT02718911|520171660|FG006|Overall Study|Adverse Event|0|||
144264935|NCT02718911|520171661|FG007|Overall Study|Adverse Event|0|||
144659450|NCT02494778|521604496|FG000|Overall Study|Death|3|||
144659451|NCT02494778|521604496|FG000|Overall Study|Other|173|||
144659452|NCT02494778|521604496|FG000|Overall Study|Lack of Efficacy|4|||
144659453|NCT02494778|521604496|FG000|Overall Study|Adverse Event|18|||
144659454|NCT02494778|521604496|FG000|Overall Study|Withdrawal by Subject|20|||
144659455|NCT02494778|521604496|FG000|Overall Study|Lost to Follow-up|2|||
144659456|NCT02494778|521604496|FG000|Overall Study|Noncompliant with study drug admin.|1|||
144659457|NCT01303380|521604497|FG000|Overall Study|Lack of compliance to study procedures|1|||
144659458|NCT03621943|521604498|FG000|First Randomized Intervention|Lost to Follow-up|51|||
144659459|NCT03621943|521604499|FG001|First Randomized Intervention|Lost to Follow-up|54|||
144659460|NCT03621943|521604498|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
144659461|NCT03621943|521604499|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
144659462|NCT03621943|521604498|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
144659463|NCT03621943|521604499|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
144659464|NCT03621943|521604498|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
144659465|NCT03621943|521604499|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
144659466|NCT02174861|521604500|FG000|Overall Study|Decision by sponsor|8|||
144659467|NCT02174861|521604500|FG000|Overall Study|Withdrawal by Subject|124|||
144659468|NCT02174861|521604500|FG000|Overall Study|Lost to Follow-up|26|||
144659469|NCT01215734|521604501|FG000|Overall Study|Death|0|||
144659470|NCT01215734|521604502|FG001|Overall Study|Death|1|||
144659471|NCT00315705|521604503|FG000|Phase 1|Refused further treatment|1|||
144659472|NCT00315705|521604503|FG000|Phase 1|Failure to achieve response|8|||
144659473|NCT00315705|521604503|FG000|Phase 1|Disease relapse|4|||
144659474|NCT00315705|521604503|FG000|Phase 1|Scheduled for transplant|9|||
144659475|NCT00315705|521604503|FG000|Phase 1|Death|3|||
144659476|NCT00315705|521604503|FG000|Phase 2|Physician Decision|4|||
144659477|NCT00315705|521604503|FG000|Phase 2|Adverse Event|1|||
144659478|NCT00315705|521604503|FG000|Phase 2|Failure to achieve response|3|||
144659479|NCT00315705|521604503|FG000|Phase 2|Disease relapse|1|||
144659480|NCT00315705|521604503|FG000|Phase 2|Scheduled for transplant|8|||
144264936|NCT02718911|520171662|FG008|Overall Study|Adverse Event|0|||
144264937|NCT02718911|520171663|FG009|Overall Study|Adverse Event|2|||
144264938|NCT02718911|520171654|FG000|Overall Study|Death|2|||
144264939|NCT02718911|520171655|FG001|Overall Study|Death|3|||
144659481|NCT00315705|521604503|FG000|Phase 2|Other|1|||
144264940|NCT02718911|520171656|FG002|Overall Study|Death|1|||
144659482|NCT00315705|521604503|FG000|Phase 2|Death|7|||
144659483|NCT01346371|521604504|FG000|Overall Study|Lost to Follow-up|2|||
144659484|NCT01346371|521604505|FG001|Overall Study|Lost to Follow-up|0|||
144659485|NCT01716533|521604506|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
144264941|NCT02718911|520171657|FG003|Overall Study|Death|0|||
144264942|NCT02718911|520171658|FG004|Overall Study|Death|1|||
144264943|NCT02718911|520171659|FG005|Overall Study|Death|3|||
144659486|NCT01716533|521604507|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
144264944|NCT02718911|520171660|FG006|Overall Study|Death|1|||
144264945|NCT02718911|520171661|FG007|Overall Study|Death|1|||
144264946|NCT02718911|520171662|FG008|Overall Study|Death|4|||
144264947|NCT02718911|520171663|FG009|Overall Study|Death|3|||
144264948|NCT02718911|520171654|FG000|Overall Study|Lost to Follow-up|0|||
144264949|NCT02718911|520171655|FG001|Overall Study|Lost to Follow-up|0|||
144264950|NCT02718911|520171656|FG002|Overall Study|Lost to Follow-up|0|||
144264951|NCT02718911|520171657|FG003|Overall Study|Lost to Follow-up|0|||
144264952|NCT02718911|520171658|FG004|Overall Study|Lost to Follow-up|0|||
144264953|NCT02718911|520171659|FG005|Overall Study|Lost to Follow-up|0|||
144264954|NCT02718911|520171660|FG006|Overall Study|Lost to Follow-up|0|||
144264955|NCT02718911|520171661|FG007|Overall Study|Lost to Follow-up|0|||
144264956|NCT02718911|520171662|FG008|Overall Study|Lost to Follow-up|1|||
144264957|NCT02718911|520171663|FG009|Overall Study|Lost to Follow-up|0|||
144264958|NCT02718911|520171654|FG000|Overall Study|Physician Decision|2|||
144264959|NCT02718911|520171655|FG001|Overall Study|Physician Decision|0|||
144264960|NCT02718911|520171656|FG002|Overall Study|Physician Decision|1|||
144264961|NCT02718911|520171657|FG003|Overall Study|Physician Decision|1|||
144264962|NCT02718911|520171658|FG004|Overall Study|Physician Decision|0|||
144264963|NCT02718911|520171659|FG005|Overall Study|Physician Decision|0|||
144264964|NCT02718911|520171660|FG006|Overall Study|Physician Decision|0|||
144264965|NCT02718911|520171661|FG007|Overall Study|Physician Decision|1|||
144264966|NCT02718911|520171662|FG008|Overall Study|Physician Decision|2|||
144264967|NCT02718911|520171663|FG009|Overall Study|Physician Decision|1|||
144264968|NCT02718911|520171654|FG000|Overall Study|Withdrawal by Subject|0|||
144264969|NCT02718911|520171655|FG001|Overall Study|Withdrawal by Subject|0|||
144264970|NCT02718911|520171656|FG002|Overall Study|Withdrawal by Subject|0|||
144264971|NCT02718911|520171657|FG003|Overall Study|Withdrawal by Subject|0|||
144264972|NCT02718911|520171658|FG004|Overall Study|Withdrawal by Subject|1|||
144264973|NCT02718911|520171659|FG005|Overall Study|Withdrawal by Subject|0|||
144264974|NCT02718911|520171660|FG006|Overall Study|Withdrawal by Subject|0|||
144264975|NCT02718911|520171661|FG007|Overall Study|Withdrawal by Subject|0|||
144264976|NCT02718911|520171662|FG008|Overall Study|Withdrawal by Subject|1|||
144264977|NCT02718911|520171663|FG009|Overall Study|Withdrawal by Subject|4|||
144264978|NCT02718911|520171654|FG000|Overall Study|Reason Not Collected|0|||
144264979|NCT02718911|520171655|FG001|Overall Study|Reason Not Collected|0|||
144264980|NCT02718911|520171656|FG002|Overall Study|Reason Not Collected|1|||
144264981|NCT02718911|520171657|FG003|Overall Study|Reason Not Collected|0|||
144264982|NCT02718911|520171658|FG004|Overall Study|Reason Not Collected|0|||
144264983|NCT02718911|520171659|FG005|Overall Study|Reason Not Collected|0|||
144264984|NCT02718911|520171660|FG006|Overall Study|Reason Not Collected|2|||
144264985|NCT02718911|520171661|FG007|Overall Study|Reason Not Collected|1|||
144264986|NCT02718911|520171662|FG008|Overall Study|Reason Not Collected|4|||
144264987|NCT02718911|520171663|FG009|Overall Study|Reason Not Collected|9|||
144264988|NCT01867008|520171664|FG000|Overall Study|Withdrawal by Subject|1|||
144264989|NCT00983372|520171665|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
144264990|NCT00983372|520171665|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
144264991|NCT00983372|520171665|FG000|Diltiazem ER Alone|Adverse Event|1|||
144264992|NCT03589807|520171672|FG000|Overall Study|Lost to Follow-up|0|||
144264993|NCT03589807|520171673|FG001|Overall Study|Lost to Follow-up|2|||
144264994|NCT03589807|520171674|FG002|Overall Study|Lost to Follow-up|2|||
144264995|NCT03589807|520171675|FG003|Overall Study|Lost to Follow-up|3|||
144264996|NCT03589807|520171676|FG004|Overall Study|Lost to Follow-up|1|||
144264997|NCT03589807|520171677|FG005|Overall Study|Lost to Follow-up|1|||
144264998|NCT03589807|520171672|FG000|Overall Study|Withdrawal by Subject|0|||
144264999|NCT03589807|520171673|FG001|Overall Study|Withdrawal by Subject|5|||
144265000|NCT03589807|520171674|FG002|Overall Study|Withdrawal by Subject|0|||
144265001|NCT03589807|520171675|FG003|Overall Study|Withdrawal by Subject|0|||
144265002|NCT03589807|520171676|FG004|Overall Study|Withdrawal by Subject|0|||
144265003|NCT03589807|520171677|FG005|Overall Study|Withdrawal by Subject|0|||
144265004|NCT03589807|520171672|FG000|Overall Study|Protocol Violation|0|||
144659487|NCT01716533|521604508|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
144659488|NCT01716533|521604509|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
144659489|NCT01716533|521604506|FG000|Overall Study|Withdrawal by Subject|0|||
144659490|NCT01716533|521604507|FG001|Overall Study|Withdrawal by Subject|0|||
144659491|NCT01716533|521604508|FG002|Overall Study|Withdrawal by Subject|0|||
144659492|NCT01716533|521604509|FG003|Overall Study|Withdrawal by Subject|5|||
144265005|NCT03589807|520171673|FG001|Overall Study|Protocol Violation|0|||
144265006|NCT03589807|520171674|FG002|Overall Study|Protocol Violation|0|||
144265007|NCT03589807|520171675|FG003|Overall Study|Protocol Violation|1|||
144265008|NCT03589807|520171676|FG004|Overall Study|Protocol Violation|0|||
144265009|NCT03589807|520171677|FG005|Overall Study|Protocol Violation|0|||
144265010|NCT03589807|520171672|FG000|Overall Study|Enrolled but treatment not administered|0|||
144265011|NCT03589807|520171673|FG001|Overall Study|Enrolled but treatment not administered|0|||
144265012|NCT03589807|520171674|FG002|Overall Study|Enrolled but treatment not administered|0|||
144265013|NCT03589807|520171675|FG003|Overall Study|Enrolled but treatment not administered|0|||
144265014|NCT03589807|520171676|FG004|Overall Study|Enrolled but treatment not administered|1|||
144265015|NCT03589807|520171677|FG005|Overall Study|Enrolled but treatment not administered|0|||
144659493|NCT01716533|521604506|FG000|Overall Study|Death|0|||
144659494|NCT01716533|521604507|FG001|Overall Study|Death|0|||
144659495|NCT01716533|521604508|FG002|Overall Study|Death|0|||
144659496|NCT01716533|521604509|FG003|Overall Study|Death|2|||
144214604|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
144214605|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
144214606|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
144214607|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
144214608|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
144214609|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
144214610|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
144214611|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
144214612|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
144214613|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
144214614|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
144214615|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
144214616|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
144214617|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214618|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214619|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214620|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214621|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214622|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214623|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214624|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
144214625|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214626|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
144214627|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214628|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214629|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214630|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214631|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214632|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214633|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214634|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214635|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214636|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
144214637|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214638|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214639|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214640|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214641|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214642|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
144214643|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
144214644|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214645|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214646|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214647|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214648|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214649|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214650|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214651|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
144214652|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
144214653|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214654|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214655|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214656|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214657|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214658|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214659|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144214660|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
144659497|NCT01716533|521604506|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
144659498|NCT01716533|521604507|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
144659499|NCT01716533|521604508|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
144659500|NCT01716533|521604509|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
144659501|NCT00495495|521604519|FG000|Overall Study|Protocol Violation|99|||
144659502|NCT02702518|521604522|FG000|Overall Study|Lost to Follow-up|3|||
144659503|NCT02702518|521604523|FG001|Overall Study|Lost to Follow-up|4|||
144659504|NCT00789958|521604524|FG000|Overall Study|Adverse Event|3|||
144659505|NCT00789958|521604524|FG000|Overall Study|Withdrawal by Subject|4|||
144659506|NCT00789958|521604524|FG000|Overall Study|Progression|3|||
144659507|NCT00789958|521604524|FG000|Overall Study|not protocol specified|1|||
144659508|NCT00789958|521604524|FG000|Overall Study|Not eligible/not analyzable|26|||
144659509|NCT00254293|521604527|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
144659510|NCT00254293|521604528|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
144659511|NCT00254293|521604529|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
144659512|NCT00254293|521604530|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
144659513|NCT00254293|521604531|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
144659514|NCT00254293|521604532|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
144659515|NCT00254293|521604533|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
144659516|NCT00254293|521604527|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
144659517|NCT00254293|521604528|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
144659518|NCT00254293|521604529|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
144659519|NCT00254293|521604530|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
144659520|NCT00254293|521604531|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
144659521|NCT00254293|521604532|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
144659522|NCT00254293|521604533|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
144659523|NCT00254293|521604527|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
144659524|NCT00254293|521604528|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
144659525|NCT00254293|521604529|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
144659526|NCT00254293|521604530|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
144659527|NCT00254293|521604531|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
144659528|NCT00254293|521604532|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
144659529|NCT00254293|521604533|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
144659530|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Death|0|||
144659531|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Death|0|||
144659532|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Death|1|||
144659533|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Death|0|||
144659534|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Death|0|||
144659535|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Death|0|||
144659536|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Death|0|||
144659537|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
144659538|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
144659539|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
144659540|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
144659541|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
144659542|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
144659543|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
144659544|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
144659545|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
144659546|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
144659547|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
144659548|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
144659549|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
144659550|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
144659551|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
144659552|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
144659553|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
144659554|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
144659555|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
144659556|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
144659557|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
144659558|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
144659559|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
144659560|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
144659561|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
144659562|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
144659563|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
144732937|NCT00834743|521879247|FG001|Second Intervention|Withdrawal by Subject|0|||
144659564|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
144659565|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
144732938|NCT02924883|521879248|FG000|Overall Study|Death|39|||
144659566|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
144659567|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
144659568|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
144659569|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
144659570|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
144659571|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
144659572|NCT00254293|521604527|FG000|LTE Open Label Variable SC Dosing|Other|0|||
144659573|NCT00254293|521604528|FG001|LTE Open Label Variable SC Dosing|Other|0|||
144659574|NCT00254293|521604529|FG002|LTE Open Label Variable SC Dosing|Other|2|||
144659575|NCT00254293|521604530|FG003|LTE Open Label Variable SC Dosing|Other|0|||
144659576|NCT00254293|521604531|FG004|LTE Open Label Variable SC Dosing|Other|0|||
144659577|NCT00254293|521604532|FG005|LTE Open Label Variable SC Dosing|Other|0|||
144659578|NCT00254293|521604533|FG006|LTE Open Label Variable SC Dosing|Other|0|||
144659579|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Death|0|||
144659580|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Death|0|||
144659581|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Death|0|||
144659582|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Death|0|||
144659583|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Death|0|||
144659584|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Death|0|||
144659585|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Death|3|||
144659586|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
144659587|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
144659588|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
144659589|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
144659590|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
144659591|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
144659592|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
144659593|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
144659594|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
144659595|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
144659596|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
144659597|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
144659598|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
144659599|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
144659600|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
144659601|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
144659602|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
144659603|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
144659604|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
144659605|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
144659606|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
144659607|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
144659608|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
144659609|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
144659610|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
144659611|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
144659612|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
144214661|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
144214662|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214663|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214664|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214665|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214666|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214667|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214668|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214669|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
144214670|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214671|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
144214672|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
144214673|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214674|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214675|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214676|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214677|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144214678|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
144659613|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
144659614|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
144659615|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
144659616|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
144659617|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
144659618|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
144659619|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
144659620|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
144659621|NCT00254293|521604527|FG000|LTE Open Label Fixed Dosing|Other|0|||
144659622|NCT00254293|521604528|FG001|LTE Open Label Fixed Dosing|Other|0|||
144659623|NCT00254293|521604529|FG002|LTE Open Label Fixed Dosing|Other|0|||
144659624|NCT00254293|521604530|FG003|LTE Open Label Fixed Dosing|Other|0|||
144659625|NCT00254293|521604531|FG004|LTE Open Label Fixed Dosing|Other|0|||
144214679|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
144214680|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
144214681|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144214682|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144659626|NCT00254293|521604532|FG005|LTE Open Label Fixed Dosing|Other|0|||
144659627|NCT00254293|521604533|FG006|LTE Open Label Fixed Dosing|Other|1|||
144659628|NCT01000727|521604537|FG000|Overall Study|Lost to Follow-up|41|||
144659629|NCT01000727|521604538|FG001|Overall Study|Lost to Follow-up|43|||
144659630|NCT01000727|521604537|FG000|Overall Study|Withdrawal by Subject|111|||
144659631|NCT01000727|521604538|FG001|Overall Study|Withdrawal by Subject|109|||
144659632|NCT01000727|521604537|FG000|Overall Study|Study closed/terminated|23|||
144659633|NCT01000727|521604538|FG001|Overall Study|Study closed/terminated|24|||
144659634|NCT03196193|521604541|FG000|Overall Study|Adverse Event|1|||
144659635|NCT03196193|521604542|FG001|Overall Study|Adverse Event|0|||
144659636|NCT03196193|521604541|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
144659637|NCT03196193|521604542|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
144659638|NCT02709083|521604543|FG000|Overall Study|Original PI left institution|7|||
144659639|NCT01026389|521604550|FG000|Overall Study|Withdrawal by Subject|1|||
144659640|NCT01026389|521604551|FG001|Overall Study|Withdrawal by Subject|3|||
144659641|NCT01026389|521604550|FG000|Overall Study|change of treatment, patient moved|4|||
144659642|NCT01026389|521604551|FG001|Overall Study|change of treatment, patient moved|2|||
144659643|NCT04410198|521604552|FG000|Overall Study|Death|10|||
144659644|NCT04410198|521604552|FG000|Overall Study|Withdrawal by Subject|7|||
144659645|NCT04410198|521604552|FG000|Overall Study|Transferred/Relocation|4|||
144659646|NCT04410198|521604552|FG000|Overall Study|Kidney Transplant|9|||
144659647|NCT04410198|521604552|FG000|Overall Study|Adverse Event|4|||
144659648|NCT04410198|521604552|FG000|Overall Study|Physician Decision|2|||
144659649|NCT04410198|521604552|FG000|Overall Study|Other than specified|1|||
144659650|NCT02006667|521604553|FG000|Overall Study|Adverse Event|3|||
144659651|NCT02006667|521604553|FG000|Overall Study|Death|2|||
144659652|NCT02006667|521604553|FG000|Overall Study|Withdrawal by Subject|1|||
144659653|NCT02939937|521604556|FG000|Overall Study|Adverse Event|5|||
144659654|NCT02939937|521604557|FG001|Overall Study|Adverse Event|0|||
144659655|NCT02939937|521604556|FG000|Overall Study|Lost to Follow-up|1|||
144659656|NCT02939937|521604557|FG001|Overall Study|Lost to Follow-up|3|||
144659657|NCT02681055|521604562|FG000|Weeks 5-12|Adverse Event|1|||
144659658|NCT02695524|521604563|FG000|Overall Study|Lost to Follow-up|3|||
144659659|NCT02695524|521604564|FG001|Overall Study|Lost to Follow-up|2|||
144659660|NCT02695524|521604563|FG000|Overall Study|Death|0|||
144659661|NCT02695524|521604564|FG001|Overall Study|Death|1|||
144659662|NCT01860534|521604567|FG000|ROP #1|Needed treatment for ROP|0|||
144659663|NCT01860534|521604568|FG001|ROP #1|Needed treatment for ROP|1|||
144659664|NCT01860534|521604567|FG000|ROP #2|discharged prior to ROP #2|1|||
144659665|NCT01860534|521604568|FG001|ROP #2|discharged prior to ROP #2|0|||
144659666|NCT01094730|521604569|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
144659667|NCT01094730|521604570|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
144659668|NCT01094730|521604569|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
144214683|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144214684|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144214685|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144214686|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144214687|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
144214688|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214689|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
144214690|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214691|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214692|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214693|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144659669|NCT01094730|521604570|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
144732939|NCT02924883|521879249|FG001|Overall Study|Death|20|||
144659670|NCT01094730|521604569|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
144659671|NCT01094730|521604570|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
144659672|NCT01094730|521604569|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
144732940|NCT02924883|521879248|FG000|Overall Study|Lost to Follow-up|1|||
144659673|NCT01094730|521604570|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
144659674|NCT01094730|521604569|FG000|Period 2 (14 Days)|Protocol Violation|2|||
144659675|NCT01094730|521604570|FG001|Period 2 (14 Days)|Protocol Violation|0|||
144659676|NCT01094730|521604569|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
144214694|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214695|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214696|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
144214697|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214698|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
144214699|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214700|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214701|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214702|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214703|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214704|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214705|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
144214706|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214707|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214708|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
144214709|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214710|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214711|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214712|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214713|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214714|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
144214715|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214716|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214717|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
144214718|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214719|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214720|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214721|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214722|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214723|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
144214724|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214725|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214726|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
144214727|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214728|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214729|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214730|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214731|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214732|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
144214733|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214734|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214735|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214736|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214737|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214738|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214739|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
144214740|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214741|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
144214742|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
144214743|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
144214744|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144659677|NCT01094730|521604570|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
144659678|NCT01094730|521604569|FG000|Period 2 (14 Days)|Adverse Event|0|||
144659679|NCT01094730|521604570|FG001|Period 2 (14 Days)|Adverse Event|1|||
144659680|NCT01094730|521604569|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
144659681|NCT01094730|521604570|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
144659682|NCT01958125|521604571|FG000|Overall Study|Missing diary data|2|||
144659683|NCT01958125|521604572|FG001|Overall Study|Missing diary data|6|||
144659684|NCT01958125|521604571|FG000|Overall Study|No headache attacks|0|||
144659685|NCT01958125|521604572|FG001|Overall Study|No headache attacks|2|||
144659686|NCT04096326|521604573|FG000|Overall Study|Withdrawal by Subject|0|||
144659687|NCT04096326|521604574|FG001|Overall Study|Withdrawal by Subject|0|||
144659688|NCT04096326|521604575|FG002|Overall Study|Withdrawal by Subject|0|||
144659689|NCT04096326|521604576|FG003|Overall Study|Withdrawal by Subject|0|||
144659690|NCT04096326|521604577|FG004|Overall Study|Withdrawal by Subject|0|||
144659691|NCT04096326|521604578|FG005|Overall Study|Withdrawal by Subject|0|||
144659692|NCT04096326|521604579|FG006|Overall Study|Withdrawal by Subject|1|||
144659693|NCT04096326|521604580|FG007|Overall Study|Withdrawal by Subject|0|||
144659694|NCT04096326|521604581|FG008|Overall Study|Withdrawal by Subject|0|||
144659695|NCT04096326|521604582|FG009|Overall Study|Withdrawal by Subject|0|||
144659696|NCT04096326|521604573|FG000|Overall Study|Lost to Follow-up|0|||
144659697|NCT04096326|521604574|FG001|Overall Study|Lost to Follow-up|1|||
144659698|NCT04096326|521604575|FG002|Overall Study|Lost to Follow-up|0|||
144659699|NCT04096326|521604576|FG003|Overall Study|Lost to Follow-up|0|||
144659700|NCT04096326|521604577|FG004|Overall Study|Lost to Follow-up|0|||
144659701|NCT04096326|521604578|FG005|Overall Study|Lost to Follow-up|0|||
144659702|NCT04096326|521604579|FG006|Overall Study|Lost to Follow-up|0|||
144659703|NCT04096326|521604580|FG007|Overall Study|Lost to Follow-up|0|||
144659704|NCT04096326|521604581|FG008|Overall Study|Lost to Follow-up|0|||
144659705|NCT04096326|521604582|FG009|Overall Study|Lost to Follow-up|0|||
144659706|NCT04096326|521604573|FG000|Overall Study|COVID-19-related reasons|0|||
144659707|NCT04096326|521604574|FG001|Overall Study|COVID-19-related reasons|0|||
144659708|NCT04096326|521604575|FG002|Overall Study|COVID-19-related reasons|0|||
144659709|NCT04096326|521604576|FG003|Overall Study|COVID-19-related reasons|0|||
144659710|NCT04096326|521604577|FG004|Overall Study|COVID-19-related reasons|1|||
144659711|NCT04096326|521604578|FG005|Overall Study|COVID-19-related reasons|5|||
144659712|NCT04096326|521604579|FG006|Overall Study|COVID-19-related reasons|0|||
144659713|NCT04096326|521604580|FG007|Overall Study|COVID-19-related reasons|0|||
144659714|NCT04096326|521604581|FG008|Overall Study|COVID-19-related reasons|0|||
144659715|NCT04096326|521604582|FG009|Overall Study|COVID-19-related reasons|0|||
144659716|NCT04804033|521604584|FG000|Period 1: DBT Phase|Adverse Event|1|||
144659717|NCT04804033|521604585|FG001|Period 1: DBT Phase|Adverse Event|5|||
144659718|NCT04804033|521604586|FG002|Period 1: DBT Phase|Adverse Event|3|||
144659719|NCT04804033|521604587|FG003|Period 1: DBT Phase|Adverse Event|4|||
144659720|NCT04804033|521604584|FG000|Period 1: DBT Phase|Death|1|||
144659721|NCT04804033|521604585|FG001|Period 1: DBT Phase|Death|0|||
144659722|NCT04804033|521604586|FG002|Period 1: DBT Phase|Death|0|||
144659723|NCT04804033|521604587|FG003|Period 1: DBT Phase|Death|0|||
144659724|NCT04804033|521604584|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
144659725|NCT04804033|521604585|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
144659726|NCT04804033|521604586|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
144659727|NCT04804033|521604587|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
144659728|NCT04804033|521604584|FG000|Period 1: DBT Phase|Non-compliance|1|||
144659729|NCT04804033|521604585|FG001|Period 1: DBT Phase|Non-compliance|0|||
144659730|NCT04804033|521604586|FG002|Period 1: DBT Phase|Non-compliance|1|||
144659731|NCT04804033|521604587|FG003|Period 1: DBT Phase|Non-compliance|2|||
144659732|NCT04804033|521604584|FG000|Period 1: DBT Phase|Other|0|||
144659733|NCT04804033|521604585|FG001|Period 1: DBT Phase|Other|1|||
144659734|NCT04804033|521604586|FG002|Period 1: DBT Phase|Other|0|||
144659735|NCT04804033|521604587|FG003|Period 1: DBT Phase|Other|0|||
144659736|NCT04804033|521604584|FG000|Period 1: DBT Phase|Pregnancy|2|||
144659737|NCT04804033|521604585|FG001|Period 1: DBT Phase|Pregnancy|0|||
144659738|NCT04804033|521604586|FG002|Period 1: DBT Phase|Pregnancy|0|||
144659739|NCT04804033|521604587|FG003|Period 1: DBT Phase|Pregnancy|0|||
144659740|NCT04804033|521604584|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
144659741|NCT04804033|521604585|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
144659742|NCT04804033|521604586|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
144659743|NCT04804033|521604587|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
144659744|NCT04804033|521604584|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
144659745|NCT04804033|521604585|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
144659746|NCT04804033|521604586|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
144659747|NCT04804033|521604587|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
144659748|NCT04804033|521604584|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
144659749|NCT04804033|521604585|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
144659750|NCT04804033|521604586|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
144659751|NCT04804033|521604587|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
144265016|NCT01534273|520171678|FG000|Period 1|Physician Decision|0|||
144659752|NCT04804033|521604584|FG000|Period 2: OLE Phase|Adverse Event|3|||
144659753|NCT04804033|521604585|FG001|Period 2: OLE Phase|Adverse Event|4|||
144659754|NCT04804033|521604586|FG002|Period 2: OLE Phase|Adverse Event|2|||
144659755|NCT04804033|521604587|FG003|Period 2: OLE Phase|Adverse Event|0|||
144659756|NCT04804033|521604584|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
144659757|NCT04804033|521604585|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
144214745|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144214746|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144214747|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144214748|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144214749|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144214750|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
144214751|NCT03598790|519979889|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214752|NCT03598790|519979890|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214753|NCT03598790|519979891|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
144214754|NCT03598790|519979892|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214755|NCT03598790|519979893|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214756|NCT03598790|519979894|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214757|NCT03598790|519979895|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214758|NCT03598790|519979896|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214759|NCT03598790|519979897|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
144214760|NCT03598790|519979889|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144214761|NCT03598790|519979890|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144214762|NCT03598790|519979891|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144214763|NCT03598790|519979892|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
144659758|NCT04804033|521604586|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
144659759|NCT04804033|521604587|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
144659760|NCT04804033|521604584|FG000|Period 2: OLE Phase|Non-compliance|2|||
144659761|NCT04804033|521604585|FG001|Period 2: OLE Phase|Non-compliance|2|||
144659762|NCT04804033|521604586|FG002|Period 2: OLE Phase|Non-compliance|0|||
144659763|NCT04804033|521604587|FG003|Period 2: OLE Phase|Non-compliance|1|||
144659764|NCT04804033|521604584|FG000|Period 2: OLE Phase|Other|0|||
144659765|NCT04804033|521604585|FG001|Period 2: OLE Phase|Other|2|||
144659766|NCT04804033|521604586|FG002|Period 2: OLE Phase|Other|0|||
144659767|NCT04804033|521604587|FG003|Period 2: OLE Phase|Other|0|||
144659768|NCT04804033|521604584|FG000|Period 2: OLE Phase|Physician Decision|1|||
144659769|NCT04804033|521604585|FG001|Period 2: OLE Phase|Physician Decision|1|||
144659770|NCT04804033|521604586|FG002|Period 2: OLE Phase|Physician Decision|0|||
144659771|NCT04804033|521604587|FG003|Period 2: OLE Phase|Physician Decision|0|||
144659772|NCT04804033|521604584|FG000|Period 2: OLE Phase|Pregnancy|0|||
144659773|NCT04804033|521604585|FG001|Period 2: OLE Phase|Pregnancy|0|||
144659774|NCT04804033|521604586|FG002|Period 2: OLE Phase|Pregnancy|2|||
144659775|NCT04804033|521604587|FG003|Period 2: OLE Phase|Pregnancy|0|||
144659776|NCT04804033|521604584|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
144659777|NCT04804033|521604585|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
144659778|NCT04804033|521604586|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
144659779|NCT04804033|521604587|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
144659780|NCT04804033|521604584|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
144659781|NCT04804033|521604585|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
144659782|NCT04804033|521604586|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
144659783|NCT04804033|521604587|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
144659784|NCT04804033|521604584|FG000|Period 2: OLE Phase|Not reported|0|||
144659785|NCT04804033|521604585|FG001|Period 2: OLE Phase|Not reported|2|||
144659786|NCT04804033|521604586|FG002|Period 2: OLE Phase|Not reported|0|||
144659787|NCT04804033|521604587|FG003|Period 2: OLE Phase|Not reported|0|||
144659788|NCT04804033|521604584|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
144659789|NCT04804033|521604585|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
144659790|NCT04804033|521604586|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
144659791|NCT04804033|521604587|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
144659792|NCT04804033|521604584|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
144659793|NCT04804033|521604585|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
144659794|NCT04804033|521604586|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
144659795|NCT04804033|521604587|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
144659796|NCT04804033|521604584|FG000|Period 3: Follow-up Phase|Other|0|||
144659797|NCT04804033|521604585|FG001|Period 3: Follow-up Phase|Other|1|||
144659798|NCT04804033|521604586|FG002|Period 3: Follow-up Phase|Other|2|||
144659799|NCT04804033|521604587|FG003|Period 3: Follow-up Phase|Other|1|||
144659800|NCT04804033|521604584|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
144732941|NCT02924883|521879249|FG001|Overall Study|Lost to Follow-up|0|||
144659801|NCT04804033|521604585|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
144659802|NCT04804033|521604586|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
144659803|NCT04804033|521604587|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
144659804|NCT04804033|521604584|FG000|Period 3: Follow-up Phase|Not reported|18|||
144659805|NCT04804033|521604585|FG001|Period 3: Follow-up Phase|Not reported|15|||
144659806|NCT04804033|521604586|FG002|Period 3: Follow-up Phase|Not reported|1|||
144214764|NCT03598790|519979893|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
144214765|NCT03598790|519979894|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
144659807|NCT04804033|521604587|FG003|Period 3: Follow-up Phase|Not reported|4|||
144659808|NCT00668200|521604598|FG000|Overall Study|Withdrawal by Subject|2|||
144659809|NCT00668200|521604598|FG000|Overall Study|Lost to Follow-up|1|||
144659810|NCT01496430|521604599|FG000|Overall Study|Adverse Event|0|||
144659811|NCT01496430|521604600|FG001|Overall Study|Adverse Event|0|||
144659812|NCT01496430|521604601|FG002|Overall Study|Adverse Event|1|||
144659813|NCT01496430|521604599|FG000|Overall Study|Major Protocol Deviation|0|||
144659814|NCT01496430|521604600|FG001|Overall Study|Major Protocol Deviation|0|||
144659815|NCT01496430|521604601|FG002|Overall Study|Major Protocol Deviation|1|||
144659816|NCT01496430|521604599|FG000|Overall Study|Lost to Follow-up|2|||
144659817|NCT01496430|521604600|FG001|Overall Study|Lost to Follow-up|3|||
144659818|NCT01496430|521604601|FG002|Overall Study|Lost to Follow-up|1|||
144659819|NCT01496430|521604599|FG000|Overall Study|Voluntary Withdrawal|2|||
144659820|NCT01496430|521604600|FG001|Overall Study|Voluntary Withdrawal|1|||
144659821|NCT01496430|521604601|FG002|Overall Study|Voluntary Withdrawal|6|||
144659822|NCT01496430|521604599|FG000|Overall Study|Principal Investigator Discretion|0|||
144659823|NCT01496430|521604600|FG001|Overall Study|Principal Investigator Discretion|1|||
144659824|NCT01496430|521604601|FG002|Overall Study|Principal Investigator Discretion|1|||
144659825|NCT01496430|521604599|FG000|Overall Study|Other|2|||
144659826|NCT01496430|521604600|FG001|Overall Study|Other|0|||
144659827|NCT01496430|521604601|FG002|Overall Study|Other|0|||
144659828|NCT01100307|521604602|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
144659829|NCT01100307|521604603|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
144659830|NCT01100307|521604602|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
144659831|NCT01100307|521604603|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
144659832|NCT01100307|521604602|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
144659833|NCT01100307|521604603|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
144659834|NCT01100307|521604602|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
144659835|NCT01100307|521604603|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
144659836|NCT01100307|521604602|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
144659837|NCT01100307|521604603|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
144659838|NCT01100307|521604602|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
144659839|NCT01100307|521604603|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
144659840|NCT00997321|521604604|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
144659841|NCT00997321|521604605|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
144659842|NCT02509598|521604606|FG000|Overall Study|Withdrawal by Subject|1|||
144659843|NCT02512068|521604607|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
144659844|NCT02512068|521604608|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
144659845|NCT02512068|521604607|FG000|Overall Study|Major Protocol Deviation|1|||
144659846|NCT02512068|521604608|FG001|Overall Study|Major Protocol Deviation|0|||
144659847|NCT02512068|521604607|FG000|Overall Study|Voluntary Withdrawal|0|||
144659848|NCT02512068|521604608|FG001|Overall Study|Voluntary Withdrawal|1|||
144659849|NCT02512068|521604607|FG000|Overall Study|Lack of Efficacy|0|||
144659850|NCT02512068|521604608|FG001|Overall Study|Lack of Efficacy|1|||
144659851|NCT02512068|521604607|FG000|Overall Study|Reason Not Specified|3|||
144659852|NCT02512068|521604608|FG001|Overall Study|Reason Not Specified|5|||
144659853|NCT01153763|521604617|FG000|Overall Study|Study Closed|16|||
144659854|NCT01153763|521604617|FG000|Overall Study|Lost to Follow-up|1|||
144659855|NCT01153763|521604617|FG000|Overall Study|Physician Decision|2|||
144659856|NCT01153763|521604617|FG000|Overall Study|Withdrawal by Subject|2|||
144659857|NCT02993224|521604618|FG000|Core Phase - Period 1|Adverse Event|4|||
144659858|NCT02993224|521604618|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
144659859|NCT02993224|521604618|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
144659860|NCT02993224|521604618|FG000|Core Phase- Period 2|Adverse Event|1|||
144659861|NCT02993224|521604618|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
144659862|NCT02993224|521604618|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
144659863|NCT02993224|521604618|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
144659864|NCT02993224|521604618|FG000|Extension Phase|Adverse Event|3|||
144659865|NCT02993224|521604618|FG000|Extension Phase|Withdrawal by Subject|3|||
144659866|NCT02993224|521604618|FG000|Extension Phase|Lost to Follow-up|2|||
144214766|NCT03598790|519979895|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144659867|NCT02993224|521604618|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
144659868|NCT02427477|521604628|FG000|Period 1|Adverse Event|1|||
144659869|NCT02427477|521604629|FG001|Period 1|Adverse Event|0|||
144659870|NCT00471445|521604630|FG000|Overall Study|Withdrawal by Subject|1|||
144659871|NCT00471445|521604631|FG001|Overall Study|Withdrawal by Subject|1|||
144659872|NCT00471445|521604630|FG000|Overall Study|Ineligible|1|||
144659873|NCT00471445|521604631|FG001|Overall Study|Ineligible|0|||
144659874|NCT00471445|521604630|FG000|Overall Study|Protocol Violation|0|||
144659875|NCT00471445|521604631|FG001|Overall Study|Protocol Violation|1|||
144659876|NCT01552928|521604632|FG000|Period 3|Adverse Event|0|||
144659877|NCT01552928|521604633|FG001|Period 3|Adverse Event|0|||
144659878|NCT01552928|521604634|FG002|Period 3|Adverse Event|1|||
144659879|NCT01552928|521604635|FG003|Period 3|Adverse Event|0|||
144659880|NCT01767194|521604636|FG000|Overall Study|Adverse Event|1|||
144659881|NCT01767194|521604637|FG001|Overall Study|Adverse Event|1|||
144659882|NCT01767194|521604636|FG000|Overall Study|Death|0|||
144659883|NCT01767194|521604637|FG001|Overall Study|Death|1|||
144659884|NCT01767194|521604636|FG000|Overall Study|Lack of Efficacy|12|||
144659885|NCT01767194|521604637|FG001|Overall Study|Lack of Efficacy|11|||
144659886|NCT01767194|521604636|FG000|Overall Study|Physician Decision|2|||
144659887|NCT01767194|521604637|FG001|Overall Study|Physician Decision|23|||
144659888|NCT01767194|521604636|FG000|Overall Study|Withdrawal by Subject|0|||
144659889|NCT01767194|521604637|FG001|Overall Study|Withdrawal by Subject|1|||
144659890|NCT01767194|521604636|FG000|Overall Study|Ineligible|1|||
144659891|NCT01767194|521604637|FG001|Overall Study|Ineligible|1|||
144659892|NCT01767194|521604636|FG000|Overall Study|Refusal by patient/parent|2|||
144659893|NCT01767194|521604637|FG001|Overall Study|Refusal by patient/parent|4|||
144659894|NCT01767194|521604636|FG000|Overall Study|Criteria not met on time for next cycle|0|||
144659895|NCT01767194|521604637|FG001|Overall Study|Criteria not met on time for next cycle|1|||
144659896|NCT02723604|521606251|FG000|Overall Study|ineligible|1|||
144659897|NCT02723604|521606251|FG000|Overall Study|never received treatment|1|||
144659898|NCT00506948|521606257|FG000|Overall Study|Death|4|||
144659899|NCT00506948|521606257|FG000|Overall Study|Adverse Event|5|||
144659900|NCT00506948|521606257|FG000|Overall Study|Physician Decision|1|||
144659901|NCT02395653|521606258|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
144659902|NCT02395653|521606258|FG000|Overall Study|Consent Withdrawn at Screening|1|||
144659903|NCT02395653|521606258|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
144659904|NCT02395653|521606258|FG000|Overall Study|Investigator Decision at Screening|1|||
144659905|NCT02395653|521606258|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
144659906|NCT02395653|521606258|FG000|Overall Study|Withdrawal by Subject|1|||
144659907|NCT02395653|521606258|FG000|Overall Study|Lost to Follow-up|1|||
144659908|NCT00165841|521606259|FG000|Overall Study|Adverse Event|2|||
144659909|NCT00165841|521606260|FG001|Overall Study|Adverse Event|3|||
144659910|NCT00165841|521606259|FG000|Overall Study|Lack of Efficacy|6|||
144659911|NCT00165841|521606260|FG001|Overall Study|Lack of Efficacy|33|||
144659912|NCT00165841|521606259|FG000|Overall Study|Lost to Follow-up|4|||
144659913|NCT00165841|521606260|FG001|Overall Study|Lost to Follow-up|4|||
144659914|NCT00165841|521606259|FG000|Overall Study|Withdrawal by Subject|7|||
144659915|NCT00165841|521606260|FG001|Overall Study|Withdrawal by Subject|8|||
144659916|NCT00165841|521606259|FG000|Overall Study|Physician Decision|1|||
144659917|NCT00165841|521606260|FG001|Overall Study|Physician Decision|0|||
144659918|NCT00165841|521606259|FG000|Overall Study|Protocol Violation|6|||
144659919|NCT00165841|521606260|FG001|Overall Study|Protocol Violation|8|||
144659920|NCT00165841|521606259|FG000|Overall Study|Other|3|||
144659921|NCT00165841|521606260|FG001|Overall Study|Other|5|||
144659922|NCT00165841|521606259|FG000|Overall Study|Medication Noncompliance|1|||
144659923|NCT00165841|521606260|FG001|Overall Study|Medication Noncompliance|1|||
144659924|NCT00296725|521606261|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
144659925|NCT00296725|521606261|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
144659926|NCT00296725|521606261|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
144659927|NCT03137121|521606266|FG000|Overall Study|Withdrawal by Subject|0|||
144659928|NCT03137121|521606267|FG001|Overall Study|Withdrawal by Subject|1|||
144659929|NCT01626352|521606268|FG000|Overall Study|Disease Progression|3|||
144659930|NCT01626352|521606268|FG000|Overall Study|Intercurrent Illness|2|||
144659931|NCT01626352|521606268|FG000|Overall Study|Death|2|||
144659932|NCT01626352|521606268|FG000|Overall Study|Withdrawal by Subject|1|||
144659933|NCT01626352|521606268|FG000|Overall Study|Non-Compliance|1|||
144659934|NCT01626352|521606268|FG000|Overall Study|Never Treated|1|||
144659935|NCT00798655|521606274|FG000|Overall Study|Did not receive at least one dose of pan|2|||
144659936|NCT03446651|521606275|FG000|Overall Study|Lost to Follow-up|4|||
144659937|NCT03446651|521606276|FG001|Overall Study|Lost to Follow-up|0|||
144659938|NCT03446651|521606275|FG000|Overall Study|Open Label Participants|5|||
144659939|NCT03446651|521606276|FG001|Overall Study|Open Label Participants|0|||
144659940|NCT00343291|521606277|FG000|Overall Study|Adverse Event|13|||
144659941|NCT00343291|521606278|FG001|Overall Study|Adverse Event|13|||
144659942|NCT00343291|521606277|FG000|Overall Study|Death|3|||
144659943|NCT00343291|521606278|FG001|Overall Study|Death|2|||
144659944|NCT00343291|521606277|FG000|Overall Study|Progressive disease|33|||
144659945|NCT00343291|521606278|FG001|Overall Study|Progressive disease|34|||
144659946|NCT00343291|521606277|FG000|Overall Study|Withdrawal by Subject|0|||
144659947|NCT00343291|521606278|FG001|Overall Study|Withdrawal by Subject|2|||
144659948|NCT00343291|521606277|FG000|Overall Study|Other|8|||
144659949|NCT00343291|521606278|FG001|Overall Study|Other|5|||
144214767|NCT03598790|519979896|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144214768|NCT03598790|519979897|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
144214769|NCT03598790|519979889|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214770|NCT03598790|519979890|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144659950|NCT03712345|521606279|FG000|Overall Study|Failure to meet randomization criteria|0|||
144659951|NCT03712345|521606280|FG001|Overall Study|Failure to meet randomization criteria|0|||
144659952|NCT03712345|521606281|FG002|Overall Study|Failure to meet randomization criteria|1|||
144659953|NCT00960934|521606284|FG000|Overall Study|Adverse Event|2|||
144659954|NCT00960934|521606285|FG001|Overall Study|Adverse Event|3|||
144659955|NCT00960934|521606286|FG002|Overall Study|Adverse Event|3|||
144659956|NCT00960934|521606287|FG003|Overall Study|Adverse Event|2|||
144659957|NCT00960934|521606288|FG004|Overall Study|Adverse Event|4|||
144659958|NCT00960934|521606289|FG005|Overall Study|Adverse Event|3|||
144659959|NCT00960934|521606284|FG000|Overall Study|Lack of Efficacy|1|||
144659960|NCT00960934|521606285|FG001|Overall Study|Lack of Efficacy|0|||
144659961|NCT00960934|521606286|FG002|Overall Study|Lack of Efficacy|0|||
144659962|NCT00960934|521606287|FG003|Overall Study|Lack of Efficacy|0|||
144659963|NCT00960934|521606288|FG004|Overall Study|Lack of Efficacy|0|||
144659964|NCT00960934|521606289|FG005|Overall Study|Lack of Efficacy|0|||
144659965|NCT00960934|521606284|FG000|Overall Study|Lost to Follow-up|0|||
144659966|NCT00960934|521606285|FG001|Overall Study|Lost to Follow-up|1|||
144659967|NCT00960934|521606286|FG002|Overall Study|Lost to Follow-up|0|||
144659968|NCT00960934|521606287|FG003|Overall Study|Lost to Follow-up|0|||
144659969|NCT00960934|521606288|FG004|Overall Study|Lost to Follow-up|0|||
144659970|NCT00960934|521606289|FG005|Overall Study|Lost to Follow-up|0|||
144659971|NCT00960934|521606284|FG000|Overall Study|Other|2|||
144659972|NCT00960934|521606285|FG001|Overall Study|Other|1|||
144659973|NCT00960934|521606286|FG002|Overall Study|Other|5|||
144659974|NCT00960934|521606287|FG003|Overall Study|Other|4|||
144659975|NCT00960934|521606288|FG004|Overall Study|Other|2|||
144659976|NCT00960934|521606289|FG005|Overall Study|Other|2|||
144659977|NCT00960934|521606284|FG000|Overall Study|Physician Decision|0|||
144659978|NCT00960934|521606285|FG001|Overall Study|Physician Decision|1|||
144659979|NCT00960934|521606286|FG002|Overall Study|Physician Decision|0|||
144659980|NCT00960934|521606287|FG003|Overall Study|Physician Decision|0|||
144659981|NCT00960934|521606288|FG004|Overall Study|Physician Decision|0|||
144659982|NCT00960934|521606289|FG005|Overall Study|Physician Decision|0|||
144659983|NCT00960934|521606284|FG000|Overall Study|Progressive Disease|1|||
144659984|NCT00960934|521606285|FG001|Overall Study|Progressive Disease|1|||
144659985|NCT00960934|521606286|FG002|Overall Study|Progressive Disease|0|||
144659986|NCT00960934|521606287|FG003|Overall Study|Progressive Disease|0|||
144659987|NCT00960934|521606288|FG004|Overall Study|Progressive Disease|1|||
144659988|NCT00960934|521606289|FG005|Overall Study|Progressive Disease|1|||
144659989|NCT00960934|521606284|FG000|Overall Study|Protocol Violation|3|||
144659990|NCT00960934|521606285|FG001|Overall Study|Protocol Violation|4|||
144659991|NCT00960934|521606286|FG002|Overall Study|Protocol Violation|0|||
144659992|NCT00960934|521606287|FG003|Overall Study|Protocol Violation|3|||
144659993|NCT00960934|521606288|FG004|Overall Study|Protocol Violation|3|||
144659994|NCT00960934|521606289|FG005|Overall Study|Protocol Violation|2|||
144659995|NCT00960934|521606284|FG000|Overall Study|Withdrawal by Subject|5|||
144659996|NCT00960934|521606285|FG001|Overall Study|Withdrawal by Subject|6|||
144659997|NCT00960934|521606286|FG002|Overall Study|Withdrawal by Subject|4|||
144659998|NCT00960934|521606287|FG003|Overall Study|Withdrawal by Subject|5|||
144659999|NCT00960934|521606288|FG004|Overall Study|Withdrawal by Subject|5|||
144660000|NCT00960934|521606289|FG005|Overall Study|Withdrawal by Subject|7|||
144660001|NCT00960934|521606284|FG000|Overall Study|Study Terminated by Sponsor|50|||
144660002|NCT00960934|521606285|FG001|Overall Study|Study Terminated by Sponsor|46|||
144660003|NCT00960934|521606286|FG002|Overall Study|Study Terminated by Sponsor|52|||
144660004|NCT00960934|521606287|FG003|Overall Study|Study Terminated by Sponsor|50|||
144660005|NCT00960934|521606288|FG004|Overall Study|Study Terminated by Sponsor|49|||
144660006|NCT00960934|521606289|FG005|Overall Study|Study Terminated by Sponsor|49|||
144660007|NCT00839423|521606296|FG000|Overall Study|Adverse Event|4|||
144660008|NCT00839423|521606297|FG001|Overall Study|Adverse Event|3|||
144660009|NCT00839423|521606298|FG002|Overall Study|Adverse Event|7|||
144660010|NCT00839423|521606299|FG003|Overall Study|Adverse Event|16|||
144660011|NCT00839423|521606296|FG000|Overall Study|Lack of Efficacy|6|||
144660012|NCT00839423|521606297|FG001|Overall Study|Lack of Efficacy|6|||
144660013|NCT00839423|521606298|FG002|Overall Study|Lack of Efficacy|3|||
144660014|NCT00839423|521606299|FG003|Overall Study|Lack of Efficacy|2|||
144660015|NCT00839423|521606296|FG000|Overall Study|Non-compliance|0|||
144660016|NCT00839423|521606297|FG001|Overall Study|Non-compliance|0|||
144660017|NCT00839423|521606298|FG002|Overall Study|Non-compliance|0|||
144660018|NCT00839423|521606299|FG003|Overall Study|Non-compliance|1|||
144265017|NCT01534273|520171679|FG001|Period 1|Physician Decision|0|||
144265018|NCT01534273|520171680|FG002|Period 1|Physician Decision|0|||
144660019|NCT00839423|521606296|FG000|Overall Study|Protocol Violation|0|||
144660020|NCT00839423|521606297|FG001|Overall Study|Protocol Violation|1|||
144660021|NCT00839423|521606298|FG002|Overall Study|Protocol Violation|2|||
144660022|NCT00839423|521606299|FG003|Overall Study|Protocol Violation|0|||
144660023|NCT00839423|521606296|FG000|Overall Study|Withdrawal of consent|4|||
144660024|NCT00839423|521606297|FG001|Overall Study|Withdrawal of consent|0|||
144660025|NCT00839423|521606298|FG002|Overall Study|Withdrawal of consent|4|||
144660026|NCT00839423|521606299|FG003|Overall Study|Withdrawal of consent|1|||
144660027|NCT00839423|521606296|FG000|Overall Study|Lost to Follow-up|1|||
144660028|NCT00839423|521606297|FG001|Overall Study|Lost to Follow-up|0|||
144660029|NCT00839423|521606298|FG002|Overall Study|Lost to Follow-up|1|||
144660030|NCT00839423|521606299|FG003|Overall Study|Lost to Follow-up|0|||
144660031|NCT00839423|521606296|FG000|Overall Study|Administrative or other reasons|3|||
144660032|NCT00839423|521606297|FG001|Overall Study|Administrative or other reasons|0|||
144660033|NCT00839423|521606298|FG002|Overall Study|Administrative or other reasons|1|||
144660034|NCT00839423|521606299|FG003|Overall Study|Administrative or other reasons|0|||
144660035|NCT01071096|521606300|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
144660036|NCT01071096|521606301|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
144660037|NCT02585999|521606302|FG000|Overall Study|Lost to Follow-up|1|||
144660038|NCT02585999|521606302|FG000|Overall Study|Protocol Violation|1|||
144660039|NCT01332019|521606303|FG000|Overall Study|Was Not Dosed|1|||
144660040|NCT01332019|521606304|FG001|Overall Study|Was Not Dosed|0|||
144660041|NCT01332019|521606303|FG000|Overall Study|Other|16|||
144660042|NCT01332019|521606304|FG001|Overall Study|Other|18|||
144660043|NCT01332019|521606303|FG000|Overall Study|Death|2|||
144660044|NCT01332019|521606304|FG001|Overall Study|Death|1|||
144660045|NCT01332019|521606303|FG000|Overall Study|Physician Decision|4|||
144660046|NCT01332019|521606304|FG001|Overall Study|Physician Decision|3|||
144660047|NCT01332019|521606303|FG000|Overall Study|Withdrawal by Subject|73|||
144660048|NCT01332019|521606304|FG001|Overall Study|Withdrawal by Subject|71|||
144660049|NCT01332019|521606303|FG000|Overall Study|Lost to Follow-up|4|||
144660050|NCT01332019|521606304|FG001|Overall Study|Lost to Follow-up|7|||
144660051|NCT01332019|521606303|FG000|Overall Study|Adverse Event|13|||
144660052|NCT01332019|521606304|FG001|Overall Study|Adverse Event|22|||
144660053|NCT01369849|521606305|FG000|Overall Study|Ineligible prior to treatment|0|||
144660054|NCT01369849|521606306|FG001|Overall Study|Ineligible prior to treatment|0|||
144660055|NCT01369849|521606307|FG002|Overall Study|Ineligible prior to treatment|1|||
144660056|NCT01369849|521606305|FG000|Overall Study|Ineligible after receiving treatment|0|||
144660057|NCT01369849|521606306|FG001|Overall Study|Ineligible after receiving treatment|1|||
144660058|NCT01369849|521606307|FG002|Overall Study|Ineligible after receiving treatment|0|||
144660059|NCT00871377|521606308|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
144660060|NCT00871377|521606309|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
144660061|NCT00871377|521606310|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
144660062|NCT00871377|521606311|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
144660063|NCT00871377|521606312|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
144660064|NCT00871377|521606313|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
144660065|NCT00871377|521606308|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
144660066|NCT00871377|521606309|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
144660067|NCT00871377|521606310|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
144660068|NCT00871377|521606311|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
144660069|NCT00871377|521606312|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
144660070|NCT00871377|521606313|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
144660071|NCT00871377|521606308|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
144660072|NCT00871377|521606309|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660073|NCT00871377|521606310|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660074|NCT00871377|521606311|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660075|NCT00871377|521606312|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660076|NCT00871377|521606313|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660077|NCT00871377|521606308|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660078|NCT00871377|521606309|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660079|NCT00871377|521606310|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660080|NCT00871377|521606311|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660081|NCT00871377|521606312|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
144660082|NCT00871377|521606313|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
144660083|NCT00871377|521606308|FG000|Third Intervention (10 Weeks)|Death|0|||
144660084|NCT00871377|521606309|FG001|Third Intervention (10 Weeks)|Death|0|||
144660085|NCT00871377|521606310|FG002|Third Intervention (10 Weeks)|Death|0|||
144660086|NCT00871377|521606311|FG003|Third Intervention (10 Weeks)|Death|1|||
144660087|NCT00871377|521606312|FG004|Third Intervention (10 Weeks)|Death|0|||
144660088|NCT00871377|521606313|FG005|Third Intervention (10 Weeks)|Death|0|||
144660089|NCT00120289|521606314|FG000|Overall Study|Death|96|||
144660090|NCT00120289|521606315|FG001|Overall Study|Death|82|||
144660091|NCT00120289|521606314|FG000|Overall Study|Lost to Follow-up|11|||
144660092|NCT00120289|521606315|FG001|Overall Study|Lost to Follow-up|14|||
144660093|NCT00120289|521606314|FG000|Overall Study|Withdrawal by Subject|14|||
144660094|NCT00120289|521606315|FG001|Overall Study|Withdrawal by Subject|13|||
144660095|NCT00882999|521606317|FG000|Overall Study|Adverse Event|0|||
144660096|NCT00882999|521606318|FG001|Overall Study|Adverse Event|0|||
144660097|NCT00882999|521606319|FG002|Overall Study|Adverse Event|0|||
144660098|NCT00882999|521606320|FG003|Overall Study|Adverse Event|0|||
144660099|NCT00882999|521606321|FG004|Overall Study|Adverse Event|1|||
144660100|NCT00882999|521606322|FG005|Overall Study|Adverse Event|0|||
144660101|NCT00882999|521606323|FG006|Overall Study|Adverse Event|0|||
144660102|NCT00882999|521606317|FG000|Overall Study|Death|0|||
144660103|NCT00882999|521606318|FG001|Overall Study|Death|1|||
144660104|NCT00882999|521606319|FG002|Overall Study|Death|0|||
144265019|NCT01534273|520171681|FG003|Period 1|Physician Decision|1|||
144265020|NCT01534273|520171682|FG004|Period 1|Physician Decision|0|||
144265021|NCT01534273|520171683|FG005|Period 1|Physician Decision|0|||
144265022|NCT01534273|520171684|FG006|Period 1|Physician Decision|0|||
144265023|NCT01619865|520171685|FG000|Overall Study|Adverse Event|1|||
144265024|NCT01619865|520171685|FG000|Overall Study|Death|2|||
144265025|NCT01619865|520171685|FG000|Overall Study|subject not able to comply|1|||
144265026|NCT03586050|520171686|FG000|Overall Study|Death|3|||
144265027|NCT03586050|520171686|FG000|Overall Study|Withdrawal by Subject|2|||
144265028|NCT01494818|520171687|FG000|Overall Study|Relocation|1|||
144265029|NCT01494818|520171688|FG001|Overall Study|Relocation|2|||
144265030|NCT01494818|520171687|FG000|Overall Study|Lost to Follow-up|1|||
144265031|NCT01494818|520171688|FG001|Overall Study|Lost to Follow-up|0|||
144265032|NCT00593918|520171689|FG000|Overall Study|Withdrawal by Subject|5|||
144265033|NCT00593918|520171690|FG001|Overall Study|Withdrawal by Subject|24|||
144265034|NCT00791999|520171695|FG000|Overall Study|Protocol planed withdrawal|14|||
144265035|NCT00791999|520171696|FG001|Overall Study|Protocol planed withdrawal|11|||
144265036|NCT00791999|520171697|FG002|Overall Study|Protocol planed withdrawal|11|||
144265037|NCT00791999|520171698|FG003|Overall Study|Protocol planed withdrawal|45|||
144265038|NCT00791999|520171695|FG000|Overall Study|Withdrawal by Subject|0|||
144265039|NCT00791999|520171696|FG001|Overall Study|Withdrawal by Subject|1|||
144265040|NCT00791999|520171697|FG002|Overall Study|Withdrawal by Subject|0|||
144265041|NCT00791999|520171698|FG003|Overall Study|Withdrawal by Subject|2|||
144265042|NCT00791999|520171695|FG000|Overall Study|Protocol Violation|3|||
144265043|NCT00791999|520171696|FG001|Overall Study|Protocol Violation|0|||
144265044|NCT00791999|520171697|FG002|Overall Study|Protocol Violation|1|||
144265045|NCT00791999|520171698|FG003|Overall Study|Protocol Violation|0|||
144265046|NCT00791999|520171695|FG000|Overall Study|Adverse Event|3|||
144265047|NCT00791999|520171696|FG001|Overall Study|Adverse Event|3|||
144265048|NCT00791999|520171697|FG002|Overall Study|Adverse Event|7|||
144265049|NCT00791999|520171698|FG003|Overall Study|Adverse Event|3|||
144265050|NCT00791999|520171695|FG000|Overall Study|Lack of Efficacy|0|||
144265051|NCT00791999|520171696|FG001|Overall Study|Lack of Efficacy|1|||
144265052|NCT00791999|520171697|FG002|Overall Study|Lack of Efficacy|0|||
144265053|NCT00791999|520171698|FG003|Overall Study|Lack of Efficacy|2|||
144265054|NCT00791999|520171695|FG000|Overall Study|Reason other than those above|1|||
144265055|NCT00791999|520171696|FG001|Overall Study|Reason other than those above|0|||
144265056|NCT00791999|520171697|FG002|Overall Study|Reason other than those above|1|||
144265057|NCT00791999|520171698|FG003|Overall Study|Reason other than those above|0|||
144265058|NCT00570401|520171703|FG000|Overall Study|Adverse Event|2|||
144265059|NCT01710020|520171704|FG000|Period 1|Protocol Violation|1|||
144265060|NCT01764841|520171705|FG000|Overall Study|Logistical Difficulties|0|||
144265061|NCT01764841|520171706|FG001|Overall Study|Logistical Difficulties|1|||
144265062|NCT01764841|520171707|FG002|Overall Study|Logistical Difficulties|0|||
144265063|NCT01764841|520171708|FG003|Overall Study|Logistical Difficulties|0|||
144265064|NCT01764841|520171705|FG000|Overall Study|Death|3|||
144265065|NCT01764841|520171706|FG001|Overall Study|Death|0|||
144265066|NCT01764841|520171707|FG002|Overall Study|Death|1|||
144214771|NCT03598790|519979891|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214772|NCT03598790|519979892|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
144214773|NCT03598790|519979893|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214774|NCT03598790|519979894|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214775|NCT03598790|519979895|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214776|NCT03598790|519979896|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214777|NCT03598790|519979897|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
144214778|NCT03598790|519979889|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214779|NCT03598790|519979890|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214780|NCT03598790|519979891|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214781|NCT03598790|519979892|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
144214782|NCT03598790|519979893|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144265067|NCT01764841|520171708|FG003|Overall Study|Death|4|||
144265068|NCT01764841|520171705|FG000|Overall Study|No Follow Up|1|||
144265069|NCT01764841|520171706|FG001|Overall Study|No Follow Up|0|||
144265070|NCT01764841|520171707|FG002|Overall Study|No Follow Up|1|||
144265071|NCT01764841|520171708|FG003|Overall Study|No Follow Up|0|||
144265072|NCT01764841|520171705|FG000|Overall Study|Protocol Violation|0|||
144265073|NCT01764841|520171706|FG001|Overall Study|Protocol Violation|1|||
144265074|NCT01764841|520171707|FG002|Overall Study|Protocol Violation|0|||
144265075|NCT01764841|520171708|FG003|Overall Study|Protocol Violation|0|||
144265076|NCT01764841|520171705|FG000|Overall Study|Withdrawal by Subject|16|||
144265077|NCT01764841|520171706|FG001|Overall Study|Withdrawal by Subject|24|||
144265078|NCT01764841|520171707|FG002|Overall Study|Withdrawal by Subject|11|||
144265079|NCT01764841|520171708|FG003|Overall Study|Withdrawal by Subject|15|||
144265080|NCT01764841|520171705|FG000|Overall Study|Lost to Follow-up|3|||
144265081|NCT01764841|520171706|FG001|Overall Study|Lost to Follow-up|0|||
144265082|NCT01764841|520171707|FG002|Overall Study|Lost to Follow-up|1|||
144265083|NCT01764841|520171708|FG003|Overall Study|Lost to Follow-up|0|||
144660105|NCT00882999|521606320|FG003|Overall Study|Death|0|||
144660106|NCT00882999|521606321|FG004|Overall Study|Death|0|||
144660107|NCT00882999|521606322|FG005|Overall Study|Death|0|||
144660108|NCT00882999|521606323|FG006|Overall Study|Death|0|||
144660109|NCT00882999|521606317|FG000|Overall Study|Withdrawal by Subject|7|||
144660110|NCT00882999|521606318|FG001|Overall Study|Withdrawal by Subject|6|||
144660111|NCT00882999|521606319|FG002|Overall Study|Withdrawal by Subject|3|||
144660112|NCT00882999|521606320|FG003|Overall Study|Withdrawal by Subject|3|||
144660113|NCT00882999|521606321|FG004|Overall Study|Withdrawal by Subject|6|||
144660114|NCT00882999|521606322|FG005|Overall Study|Withdrawal by Subject|5|||
144660115|NCT00882999|521606323|FG006|Overall Study|Withdrawal by Subject|5|||
144660116|NCT00882999|521606317|FG000|Overall Study|Lost to Follow-up|0|||
144660117|NCT00882999|521606318|FG001|Overall Study|Lost to Follow-up|1|||
144660118|NCT00882999|521606319|FG002|Overall Study|Lost to Follow-up|1|||
144660119|NCT00882999|521606320|FG003|Overall Study|Lost to Follow-up|2|||
144660120|NCT00882999|521606321|FG004|Overall Study|Lost to Follow-up|1|||
144660121|NCT00882999|521606322|FG005|Overall Study|Lost to Follow-up|1|||
144660122|NCT00882999|521606323|FG006|Overall Study|Lost to Follow-up|2|||
144660123|NCT00882999|521606317|FG000|Overall Study|Physician Decision|1|||
144660124|NCT00882999|521606318|FG001|Overall Study|Physician Decision|0|||
144660125|NCT00882999|521606319|FG002|Overall Study|Physician Decision|0|||
144660126|NCT00882999|521606320|FG003|Overall Study|Physician Decision|0|||
144660127|NCT00882999|521606321|FG004|Overall Study|Physician Decision|0|||
144660128|NCT00882999|521606322|FG005|Overall Study|Physician Decision|1|||
144660129|NCT00882999|521606323|FG006|Overall Study|Physician Decision|1|||
144660130|NCT01757405|521606324|FG000|Overall Study|Lost to Follow-up|1|||
144660131|NCT01757405|521606325|FG001|Overall Study|Lost to Follow-up|1|||
144660132|NCT01757405|521606324|FG000|Overall Study|Withdrawal by Subject|0|||
144660133|NCT01757405|521606325|FG001|Overall Study|Withdrawal by Subject|1|||
144660134|NCT00238303|521606326|FG000|Overall Study|Withdrawal by Subject|11|||
144660135|NCT00238303|521606327|FG001|Overall Study|Withdrawal by Subject|1|||
144660136|NCT00238303|521606328|FG002|Overall Study|Withdrawal by Subject|2|||
144660137|NCT00238303|521606326|FG000|Overall Study|Death|1|||
144660138|NCT00238303|521606327|FG001|Overall Study|Death|0|||
144660139|NCT00238303|521606328|FG002|Overall Study|Death|1|||
144660140|NCT00238303|521606326|FG000|Overall Study|Other Medical Problems|2|||
144660141|NCT00238303|521606327|FG001|Overall Study|Other Medical Problems|0|||
144660142|NCT00238303|521606328|FG002|Overall Study|Other Medical Problems|2|||
144660143|NCT00238303|521606326|FG000|Overall Study|Poor tolerance of study treatment|1|||
144660144|NCT00238303|521606327|FG001|Overall Study|Poor tolerance of study treatment|0|||
144660145|NCT00238303|521606328|FG002|Overall Study|Poor tolerance of study treatment|1|||
144660146|NCT00238303|521606326|FG000|Overall Study|Adverse Event|0|||
144660147|NCT00238303|521606327|FG001|Overall Study|Adverse Event|1|||
144660148|NCT00238303|521606328|FG002|Overall Study|Adverse Event|3|||
144660149|NCT00937560|521606329|FG000|Initial Treatment|Death|6|||
144660150|NCT00937560|521606329|FG000|Initial Treatment|Withdraw consent|3|||
144660151|NCT00937560|521606329|FG000|Initial Treatment|Adverse Event|1|||
144660152|NCT00937560|521606329|FG000|Initial Treatment|Lost to Follow-up|1|||
144660153|NCT00937560|521606329|FG000|Initial Treatment|No end of study page|10|||
144660154|NCT00937560|521606329|FG000|Maintenance Treatment|Death|12|||
144660155|NCT00937560|521606329|FG000|Maintenance Treatment|Withdraw consent|5|||
144660156|NCT00937560|521606329|FG000|Maintenance Treatment|According to protocol|1|||
144660157|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
144660158|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
144660159|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
144660160|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
144660161|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
144660162|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
144660163|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
144660164|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
144660165|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
144660166|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
144660167|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
144660168|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
144660169|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
144660170|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
144660171|NCT00848549|521606330|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
144660172|NCT00848549|521606331|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
144660173|NCT00848549|521606330|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
144660174|NCT00848549|521606331|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
144660175|NCT00848549|521606330|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
144660176|NCT00848549|521606331|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
144660177|NCT00848549|521606330|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
144660178|NCT00848549|521606331|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
144214783|NCT03598790|519979894|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214784|NCT03598790|519979895|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214785|NCT03598790|519979896|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214786|NCT03598790|519979897|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
144214787|NCT03598790|519979889|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214788|NCT03598790|519979890|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214789|NCT03598790|519979891|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214790|NCT03598790|519979892|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
144214791|NCT03598790|519979893|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
144214792|NCT03598790|519979894|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214793|NCT03598790|519979895|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214794|NCT03598790|519979896|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214795|NCT03598790|519979897|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
144214796|NCT03598790|519979889|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214797|NCT03598790|519979890|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214798|NCT03598790|519979891|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214799|NCT03598790|519979892|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
144214800|NCT03598790|519979893|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214801|NCT03598790|519979894|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214802|NCT03598790|519979895|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214803|NCT03598790|519979896|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214804|NCT03598790|519979897|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
144214805|NCT05292183|519979899|FG000|Overall Study|Adverse Event|1|||
144214806|NCT01059786|519979900|FG000|Overall Study|Did not receive 6 cycles.|0|||
144214807|NCT01059786|519979901|FG001|Overall Study|Did not receive 6 cycles.|0|||
144214808|NCT01059786|519979902|FG002|Overall Study|Did not receive 6 cycles.|4|||
144214809|NCT01059786|519979903|FG003|Overall Study|Did not receive 6 cycles.|1|||
144214810|NCT01059786|519979904|FG004|Overall Study|Did not receive 6 cycles.|0|||
144214811|NCT04559347|519979905|FG000|Overall Study|Death|1|||
144214812|NCT04559347|519979906|FG001|Overall Study|Death|0|||
144214813|NCT04559347|519979905|FG000|Overall Study|Thoracotomy conversion|1|||
144214814|NCT04559347|519979906|FG001|Overall Study|Thoracotomy conversion|1|||
144214815|NCT04559347|519979905|FG000|Overall Study|Provider unavailable|2|||
144214816|NCT04559347|519979906|FG001|Overall Study|Provider unavailable|1|||
144214817|NCT04559347|519979905|FG000|Overall Study|Other|2|||
144214818|NCT04559347|519979906|FG001|Overall Study|Other|1|||
144214819|NCT00371033|519979907|FG000|Overall Study|Lost to Follow-up|3|||
144214820|NCT00371033|519979908|FG001|Overall Study|Lost to Follow-up|2|||
144214821|NCT00371033|519979907|FG000|Overall Study|No longer interested|2|||
144214822|NCT00371033|519979908|FG001|Overall Study|No longer interested|0|||
144214823|NCT00371033|519979907|FG000|Overall Study|Uknown|3|||
144214824|NCT00371033|519979908|FG001|Overall Study|Uknown|1|||
144214825|NCT03816878|519979914|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
144214826|NCT03816878|519979915|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
144214827|NCT03816878|519979914|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
144214828|NCT03816878|519979915|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
144214829|NCT03355469|519979916|FG000|Overall Study|COVID-19|3|||
144214830|NCT03355469|519979917|FG001|Overall Study|COVID-19|2|||
144214831|NCT03355469|519979918|FG002|Overall Study|COVID-19|3|||
144214832|NCT03355469|519979919|FG003|Overall Study|COVID-19|3|||
144214833|NCT03355469|519979916|FG000|Overall Study|Lost to Follow-up|1|||
144214834|NCT03355469|519979917|FG001|Overall Study|Lost to Follow-up|0|||
144214835|NCT03355469|519979918|FG002|Overall Study|Lost to Follow-up|1|||
144214836|NCT03355469|519979919|FG003|Overall Study|Lost to Follow-up|0|||
144214837|NCT03355469|519979916|FG000|Overall Study|Withdrawal by Subject|2|||
144214838|NCT03355469|519979917|FG001|Overall Study|Withdrawal by Subject|1|||
144214839|NCT03355469|519979918|FG002|Overall Study|Withdrawal by Subject|0|||
144214840|NCT03355469|519979919|FG003|Overall Study|Withdrawal by Subject|3|||
144214841|NCT05626231|519979920|FG000|Provider Enrollment|Worked part-time|4|||
144214842|NCT05626231|519979920|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
144214843|NCT05626231|519979920|FG000|Provider Enrollment|Non-clinical employee|1|||
144660179|NCT00848549|521606330|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
144660180|NCT00848549|521606331|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
144660181|NCT00848549|521606330|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
144660182|NCT00848549|521606331|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
144214844|NCT05626231|519979920|FG000|Provider Enrollment|Provider does not see clients|3|||
144214845|NCT05626231|519979920|FG000|Provider Enrollment|Other|5|||
144214846|NCT03203850|519979923|FG000|Overall Study|Subject/guardian decision|4|||
144214847|NCT03203850|519979924|FG001|Overall Study|Subject/guardian decision|3|||
144214848|NCT03203850|519979923|FG000|Overall Study|Adverse Event|3|||
144214849|NCT03203850|519979924|FG001|Overall Study|Adverse Event|0|||
144214850|NCT03203850|519979923|FG000|Overall Study|Death|1|||
144214851|NCT03203850|519979924|FG001|Overall Study|Death|0|||
144214852|NCT02969382|519979929|FG000|Overall Study|Adverse Event|8|||
144214853|NCT02969382|519979930|FG001|Overall Study|Adverse Event|10|||
144214854|NCT02969382|519979929|FG000|Overall Study|Lack of Efficacy|4|||
144214855|NCT02969382|519979930|FG001|Overall Study|Lack of Efficacy|5|||
144214856|NCT02969382|519979929|FG000|Overall Study|Death|0|||
144214857|NCT02969382|519979930|FG001|Overall Study|Death|1|||
144214858|NCT02969382|519979929|FG000|Overall Study|PROTOCOL DEVIATION|0|||
144214859|NCT02969382|519979930|FG001|Overall Study|PROTOCOL DEVIATION|1|||
144214860|NCT02969382|519979929|FG000|Overall Study|Withdrawal by Subject|14|||
144214861|NCT02969382|519979930|FG001|Overall Study|Withdrawal by Subject|9|||
144214862|NCT05223920|519979931|FG000|Overall Study|Adverse Event|6|||
144214863|NCT05223920|519979932|FG001|Overall Study|Adverse Event|3|||
144214864|NCT05223920|519979931|FG000|Overall Study|Death|2|||
144214865|NCT05223920|519979932|FG001|Overall Study|Death|0|||
144214866|NCT05223920|519979931|FG000|Overall Study|Disease Progression|1|||
144214867|NCT05223920|519979932|FG001|Overall Study|Disease Progression|2|||
144214868|NCT05223920|519979931|FG000|Overall Study|Physician Decision|1|||
144214869|NCT05223920|519979932|FG001|Overall Study|Physician Decision|2|||
144214870|NCT05223920|519979931|FG000|Overall Study|Sponsor decision|11|||
144214871|NCT05223920|519979932|FG001|Overall Study|Sponsor decision|9|||
144214872|NCT05223920|519979931|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
144214873|NCT05223920|519979932|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
144214874|NCT05223920|519979931|FG000|Overall Study|Subject decision|1|||
144214875|NCT05223920|519979932|FG001|Overall Study|Subject decision|0|||
144214876|NCT05223920|519979931|FG000|Overall Study|Withdrawal by Subject|1|||
144214877|NCT05223920|519979932|FG001|Overall Study|Withdrawal by Subject|6|||
144214878|NCT00261950|519979933|FG000|Overall Study|Lost to Follow-up|2|||
144214879|NCT00261950|519979933|FG000|Overall Study|Death|6|||
144214880|NCT00261950|519979933|FG000|Overall Study|Withdrawal by Subject|5|||
144214881|NCT00261950|519979933|FG000|Overall Study|Other|1|||
144214882|NCT00261950|519979933|FG000|Overall Study|Physician Decision|1|||
144214883|NCT00261950|519979933|FG000|Overall Study|Protocol specified Criteria|11|||
144214884|NCT01023035|519979934|FG000|Treatment Period|Adverse Event|27|||
144214885|NCT01023035|519979935|FG001|Treatment Period|Adverse Event|32|||
144214886|NCT01023035|519979936|FG002|Treatment Period|Adverse Event|50|||
144214887|NCT01023035|519979934|FG000|Treatment Period|Non-Medical Reasons|19|||
144214888|NCT01023035|519979935|FG001|Treatment Period|Non-Medical Reasons|22|||
144214889|NCT01023035|519979936|FG002|Treatment Period|Non-Medical Reasons|44|||
144214890|NCT01023035|519979934|FG000|Treatment Period|Treatment Failure|26|||
144214891|NCT01023035|519979935|FG001|Treatment Period|Treatment Failure|31|||
144214892|NCT01023035|519979936|FG002|Treatment Period|Treatment Failure|24|||
144214893|NCT01023035|519979934|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
144214894|NCT01023035|519979935|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
144214895|NCT01023035|519979936|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
144214896|NCT01023035|519979934|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
144214897|NCT01023035|519979935|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
144660183|NCT00848549|521606330|FG000|E2090-E044-314 (Extension Study)|Other|5|||
144660184|NCT00848549|521606331|FG001|E2090-E044-314 (Extension Study)|Other|6|||
144660185|NCT02561299|521606332|FG000|Overall Study|Death|2|||
144660186|NCT02561299|521606333|FG001|Overall Study|Death|4|||
144660187|NCT02561299|521606332|FG000|Overall Study|Lost to Follow-up|1|||
144660188|NCT02561299|521606333|FG001|Overall Study|Lost to Follow-up|0|||
144660189|NCT02561299|521606332|FG000|Overall Study|Withdrawal by Subject|2|||
144660190|NCT02561299|521606333|FG001|Overall Study|Withdrawal by Subject|2|||
144660191|NCT01248130|521606334|FG000|Overall Study|Protocol Violation|1|||
144660192|NCT01248130|521606335|FG001|Overall Study|Protocol Violation|0|||
144660193|NCT01248130|521606334|FG000|Overall Study|Ineligible|1|||
144660194|NCT01248130|521606335|FG001|Overall Study|Ineligible|0|||
144660195|NCT01911845|521606340|FG000|Overall Study|Adverse Event|2|||
144660196|NCT01911845|521606340|FG000|Overall Study|Lost to Follow-up|1|||
144660197|NCT01911845|521606340|FG000|Overall Study|Other (not specified)|3|||
144660198|NCT00501046|521606341|FG000|Overall Study|Adverse Event|21|||
144660199|NCT00501046|521606342|FG001|Overall Study|Adverse Event|25|||
144214898|NCT01023035|519979936|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
144214899|NCT01937871|519979939|FG000|Overall Study|Adverse Event|6|||
144214900|NCT01937871|519979940|FG001|Overall Study|Adverse Event|6|||
144214901|NCT01937871|519979941|FG002|Overall Study|Adverse Event|2|||
144214902|NCT01937871|519979939|FG000|Overall Study|Lost to Follow-up|8|||
144214903|NCT01937871|519979940|FG001|Overall Study|Lost to Follow-up|2|||
144214904|NCT01937871|519979941|FG002|Overall Study|Lost to Follow-up|4|||
144214905|NCT01937871|519979939|FG000|Overall Study|Withdrawal by Subject|9|||
144214906|NCT01937871|519979940|FG001|Overall Study|Withdrawal by Subject|6|||
144660200|NCT00501046|521606341|FG000|Overall Study|Death|23|||
144660201|NCT00501046|521606342|FG001|Overall Study|Death|30|||
144214907|NCT01937871|519979941|FG002|Overall Study|Withdrawal by Subject|4|||
144660202|NCT00501046|521606341|FG000|Overall Study|Lost to Follow-up|14|||
144214908|NCT01937871|519979939|FG000|Overall Study|Physician Decision|0|||
144214909|NCT01937871|519979940|FG001|Overall Study|Physician Decision|1|||
144214910|NCT01937871|519979941|FG002|Overall Study|Physician Decision|0|||
144214911|NCT01937871|519979939|FG000|Overall Study|Entry Criteria Not Met|1|||
144214912|NCT01937871|519979940|FG001|Overall Study|Entry Criteria Not Met|2|||
144214913|NCT01937871|519979941|FG002|Overall Study|Entry Criteria Not Met|1|||
144214914|NCT00247676|519979945|FG000|Overall Study|Death|5|||
144214915|NCT00247676|519979945|FG000|Overall Study|Adverse Event|11|||
144214916|NCT00247676|519979945|FG000|Overall Study|Lack of Efficacy|15|||
144214917|NCT00247676|519979945|FG000|Overall Study|Other|3|||
144214918|NCT00247676|519979945|FG000|Overall Study|Withdrawal by Subject|2|||
144214919|NCT05219448|519979946|FG000|Overall Study|Lost to Follow-up|9|||
144214920|NCT05219448|519979947|FG001|Overall Study|Lost to Follow-up|0|||
144214921|NCT00911300|519979948|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
144214922|NCT00911300|519979949|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
144214923|NCT00911300|519979948|FG000|Overall Study|Death|1|||
144214924|NCT00911300|519979949|FG001|Overall Study|Death|0|||
144214925|NCT00911300|519979948|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
144214926|NCT00911300|519979949|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
144214927|NCT00911300|519979948|FG000|Overall Study|Adverse Event|14|||
144214928|NCT00911300|519979949|FG001|Overall Study|Adverse Event|6|||
144214929|NCT00911300|519979948|FG000|Overall Study|Protocol Violation|3|||
144214930|NCT00911300|519979949|FG001|Overall Study|Protocol Violation|2|||
144214931|NCT00911300|519979948|FG000|Overall Study|Consent Withdrawn|4|||
144214932|NCT00911300|519979949|FG001|Overall Study|Consent Withdrawn|12|||
144214933|NCT00911300|519979948|FG000|Overall Study|Coronary Angiography Performed|1|||
144214934|NCT00911300|519979949|FG001|Overall Study|Coronary Angiography Performed|0|||
144214935|NCT00911300|519979948|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
144214936|NCT00911300|519979949|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
144214937|NCT00911300|519979948|FG000|Overall Study|Received Commercial Treatment|1|||
144214938|NCT00911300|519979949|FG001|Overall Study|Received Commercial Treatment|0|||
144214939|NCT00911300|519979948|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
144214940|NCT00911300|519979949|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
144214941|NCT00911300|519979948|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
144214942|NCT00911300|519979949|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
144214943|NCT00911300|519979948|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
144214944|NCT00911300|519979949|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
144214945|NCT00911300|519979948|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
144214946|NCT00911300|519979949|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
144214947|NCT00911300|519979948|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
144214948|NCT00911300|519979949|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
144214949|NCT00911300|519979948|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
144214950|NCT00911300|519979949|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
144214951|NCT00911300|519979948|FG000|Overall Study|International Normalized Ratio Too High|0|||
144214952|NCT00911300|519979949|FG001|Overall Study|International Normalized Ratio Too High|1|||
144214953|NCT00911300|519979948|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
144214954|NCT00911300|519979949|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
144214955|NCT00911300|519979948|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
144214956|NCT00911300|519979949|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
144214957|NCT00911300|519979948|FG000|Overall Study|Physician Decision|0|||
144214958|NCT00911300|519979949|FG001|Overall Study|Physician Decision|1|||
144214959|NCT00911300|519979948|FG000|Overall Study|Treatment Stopped by Mistake|0|||
144214960|NCT00911300|519979949|FG001|Overall Study|Treatment Stopped by Mistake|1|||
144214961|NCT00911300|519979948|FG000|Overall Study|Randomized; No Study Medication Received|0|||
144214962|NCT00911300|519979949|FG001|Overall Study|Randomized; No Study Medication Received|2|||
144214963|NCT00668317|519979950|FG000|Overall Study|Adverse Event|2|||
144214964|NCT00560391|519979956|FG000|Overall Study|Still on treatment|0|||
144214965|NCT00560391|519979957|FG001|Overall Study|Still on treatment|0|||
144265084|NCT04010461|520171709|FG000|Overall Study|COVID based withdrawal|5|||
144660203|NCT00501046|521606342|FG001|Overall Study|Lost to Follow-up|13|||
144660204|NCT00501046|521606341|FG000|Overall Study|Physician Decision|7|||
144660205|NCT00501046|521606342|FG001|Overall Study|Physician Decision|2|||
144660206|NCT00501046|521606341|FG000|Overall Study|Pregnancy|0|||
144660207|NCT00501046|521606342|FG001|Overall Study|Pregnancy|3|||
144660208|NCT00501046|521606341|FG000|Overall Study|Protocol Violation|2|||
144660209|NCT00501046|521606342|FG001|Overall Study|Protocol Violation|1|||
144660210|NCT00501046|521606341|FG000|Overall Study|Withdrawal by Subject|84|||
144214966|NCT00560391|519979958|FG002|Overall Study|Still on treatment|0|||
144214967|NCT00560391|519979959|FG003|Overall Study|Still on treatment|1|||
144214968|NCT00560391|519979960|FG004|Overall Study|Still on treatment|2|||
144214969|NCT03668808|519979961|FG000|First Intervention|Withdrawal by Subject|2|||
144214970|NCT03668808|519979962|FG001|First Intervention|Withdrawal by Subject|2|||
144214971|NCT00280735|519979963|FG000|Overall Study|Adverse Event|5|||
144214972|NCT00280735|519979963|FG000|Overall Study|Lack of Efficacy|3|||
144214973|NCT00280735|519979963|FG000|Overall Study|Withdrawal by Subject|8|||
144660211|NCT00501046|521606342|FG001|Overall Study|Withdrawal by Subject|83|||
144660212|NCT00501046|521606341|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
144660213|NCT00501046|521606342|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
144660214|NCT02488551|521606348|FG000|Overall Study|Lost to Follow-up|4|||
144660215|NCT02488551|521606349|FG001|Overall Study|Lost to Follow-up|7|||
144660216|NCT02488551|521606350|FG002|Overall Study|Lost to Follow-up|0|||
144660217|NCT02488551|521606351|FG003|Overall Study|Lost to Follow-up|0|||
144660218|NCT02488551|521606348|FG000|Overall Study|Military Deployment|1|||
144660219|NCT02488551|521606349|FG001|Overall Study|Military Deployment|1|||
144660220|NCT02488551|521606350|FG002|Overall Study|Military Deployment|0|||
144660221|NCT02488551|521606351|FG003|Overall Study|Military Deployment|0|||
144660222|NCT01188564|521606359|FG000|Double-blind Phase|randomized not treated|1|||
144660223|NCT01188564|521606360|FG001|Double-blind Phase|randomized not treated|0|||
144660224|NCT01934894|521606361|FG000|Overall Study|Adverse Event|1|||
144660225|NCT01934894|521606362|FG001|Overall Study|Adverse Event|2|||
144660226|NCT01934894|521606361|FG000|Overall Study|Death|2|||
144660227|NCT01934894|521606362|FG001|Overall Study|Death|0|||
144660228|NCT01934894|521606361|FG000|Overall Study|Withdrawal by Subject|0|||
144660229|NCT01934894|521606362|FG001|Overall Study|Withdrawal by Subject|1|||
144660230|NCT01934894|521606361|FG000|Overall Study|Progressive Disease|3|||
144660231|NCT01934894|521606362|FG001|Overall Study|Progressive Disease|2|||
144660232|NCT02864940|521606368|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
144660233|NCT02864940|521606369|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
144660234|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
144660235|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660236|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660237|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660238|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660239|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660240|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660241|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660242|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144660243|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
144660244|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660245|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660246|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660247|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660248|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660249|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660250|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660251|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144660252|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
144660253|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660254|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660255|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660256|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660257|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660258|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660259|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660260|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144660261|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
144660262|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660263|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660264|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660265|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660266|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660267|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660268|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660269|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
144660270|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
144660271|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660272|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660273|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660274|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660275|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660276|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660277|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144660278|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144265085|NCT04010461|520171709|FG000|Overall Study|Withdrawal by Subject|5|||
144265086|NCT04010461|520171709|FG000|Overall Study|Adverse Event|1|||
144265087|NCT04010461|520171709|FG000|Overall Study|No Motor Threshold obtainable|1|||
144265088|NCT04010461|520171709|FG000|Overall Study|Physician Decision|1|||
144265089|NCT00102596|520171710|FG000|Part A|Screen failures|6|||
144265090|NCT00102596|520171711|FG001|Part A|Screen failures|0|||
144265091|NCT00102596|520171710|FG000|Part A|Adverse Event|1|||
144265092|NCT00102596|520171711|FG001|Part A|Adverse Event|0|||
144265093|NCT02688933|520171712|FG000|Overall Study|Adverse Event|3|||
144265094|NCT02688933|520171713|FG001|Overall Study|Adverse Event|1|||
144265095|NCT02688933|520171712|FG000|Overall Study|Lack of Efficacy|2|||
144265096|NCT02688933|520171713|FG001|Overall Study|Lack of Efficacy|2|||
144265097|NCT02688933|520171712|FG000|Overall Study|Poor compliance to protocol|7|||
144265098|NCT02688933|520171713|FG001|Overall Study|Poor compliance to protocol|4|||
144265099|NCT02688933|520171712|FG000|Overall Study|Hypoglycemia|2|||
144265100|NCT02688933|520171713|FG001|Overall Study|Hypoglycemia|0|||
144265101|NCT02688933|520171712|FG000|Overall Study|Other than Specified|14|||
144265102|NCT02688933|520171713|FG001|Overall Study|Other than Specified|25|||
144265103|NCT02688933|520171712|FG000|Overall Study|Lost to Follow-up|1|||
144265104|NCT02688933|520171713|FG001|Overall Study|Lost to Follow-up|5|||
144265105|NCT00248651|520171714|FG000|Overall Study|Withdrawal by Subject|28|||
144265106|NCT00248651|520171715|FG001|Overall Study|Withdrawal by Subject|40|||
144265107|NCT00248651|520171716|FG002|Overall Study|Withdrawal by Subject|32|||
144265108|NCT05547386|520171717|FG000|Overall Study|Withdrawal by Subject|7|||
144265109|NCT04622969|520171718|FG000|Overall Study|Withdrawal by Subject|2|||
144265110|NCT04622969|520171719|FG001|Overall Study|Withdrawal by Subject|3|||
144265111|NCT05116202|520171720|FG000|Overall Study|Study Terminated by Sponsor|21|||
144265112|NCT05116202|520171721|FG001|Overall Study|Study Terminated by Sponsor|38|||
144265113|NCT05116202|520171722|FG002|Overall Study|Study Terminated by Sponsor|17|||
144265114|NCT05116202|520171723|FG003|Overall Study|Study Terminated by Sponsor|18|||
144265115|NCT05116202|520171724|FG004|Overall Study|Study Terminated by Sponsor|0|||
144265116|NCT05116202|520171720|FG000|Overall Study|Withdrawal by Subject|0|||
144265117|NCT05116202|520171721|FG001|Overall Study|Withdrawal by Subject|1|||
144265118|NCT05116202|520171722|FG002|Overall Study|Withdrawal by Subject|1|||
144265119|NCT05116202|520171723|FG003|Overall Study|Withdrawal by Subject|1|||
144265120|NCT05116202|520171724|FG004|Overall Study|Withdrawal by Subject|1|||
144265121|NCT05116202|520171720|FG000|Overall Study|Lost to Follow-up|0|||
144265122|NCT05116202|520171721|FG001|Overall Study|Lost to Follow-up|0|||
144265123|NCT05116202|520171722|FG002|Overall Study|Lost to Follow-up|0|||
144265124|NCT05116202|520171723|FG003|Overall Study|Lost to Follow-up|0|||
144265125|NCT05116202|520171724|FG004|Overall Study|Lost to Follow-up|2|||
144265126|NCT05116202|520171720|FG000|Overall Study|Death|1|||
144265127|NCT05116202|520171721|FG001|Overall Study|Death|1|||
144265128|NCT05116202|520171722|FG002|Overall Study|Death|2|||
144265129|NCT05116202|520171723|FG003|Overall Study|Death|1|||
144265130|NCT05116202|520171724|FG004|Overall Study|Death|5|||
144265131|NCT05067972|520171725|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
144265132|NCT05067972|520171726|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
144265133|NCT05067972|520171727|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
144265134|NCT05067972|520171728|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
144265135|NCT05067972|520171729|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
144265136|NCT05067972|520171730|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
144265137|NCT05067972|520171731|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
144265138|NCT05067972|520171725|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
144265139|NCT05067972|520171726|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
144265140|NCT05067972|520171727|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
144265141|NCT05067972|520171728|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
144265142|NCT05067972|520171729|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
144265143|NCT05067972|520171730|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
144265144|NCT05067972|520171731|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
144265145|NCT05067972|520171725|FG000|Part 1: Treatment|Progressive Disease|3|||
144265146|NCT05067972|520171726|FG001|Part 1: Treatment|Progressive Disease|3|||
144660279|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
144660280|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144660281|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144660282|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144265147|NCT05067972|520171727|FG002|Part 1: Treatment|Progressive Disease|4|||
144265148|NCT05067972|520171728|FG003|Part 1: Treatment|Progressive Disease|2|||
144265149|NCT05067972|520171729|FG004|Part 1: Treatment|Progressive Disease|3|||
144265150|NCT05067972|520171730|FG005|Part 1: Treatment|Progressive Disease|0|||
144660283|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144265151|NCT05067972|520171731|FG006|Part 1: Treatment|Progressive Disease|2|||
144265152|NCT05067972|520171725|FG000|Part 1: Treatment|Physician Decision|0|||
144265153|NCT05067972|520171726|FG001|Part 1: Treatment|Physician Decision|0|||
144265154|NCT05067972|520171727|FG002|Part 1: Treatment|Physician Decision|0|||
144265155|NCT05067972|520171728|FG003|Part 1: Treatment|Physician Decision|1|||
144214974|NCT00280735|519979963|FG000|Overall Study|Intercurrent Illness|2|||
144214975|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
144214976|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Death|1|||
144214977|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
144214978|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
144214979|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
144214980|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
144214981|NCT02001987|519979965|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
144214982|NCT02001987|519979965|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
144214983|NCT02001987|519979965|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
144214984|NCT02001987|519979965|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
144214985|NCT02001987|519979965|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
144214986|NCT02001987|519979965|FG000|LTE Period (52 Weeks)|Other|3|||
144214987|NCT02288325|519979969|FG000|Run-in Period|Adverse Event|48|||
144214988|NCT02288325|519979970|FG001|Run-in Period|Adverse Event|0|||
144214989|NCT02288325|519979971|FG002|Run-in Period|Adverse Event|0|||
144214990|NCT02288325|519979969|FG000|Run-in Period|Lack of Efficacy|16|||
144214991|NCT02288325|519979970|FG001|Run-in Period|Lack of Efficacy|0|||
144214992|NCT02288325|519979971|FG002|Run-in Period|Lack of Efficacy|0|||
144214993|NCT02288325|519979969|FG000|Run-in Period|Withdrawal of Consent|28|||
144214994|NCT02288325|519979970|FG001|Run-in Period|Withdrawal of Consent|0|||
144660284|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144660285|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144660286|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144660287|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144660288|NCT02175771|521606370|FG000|Run-In Period (Pre-assignment)|Other|8|||
144660289|NCT02175771|521606371|FG001|Run-In Period (Pre-assignment)|Other|0|||
144660290|NCT02175771|521606372|FG002|Run-In Period (Pre-assignment)|Other|0|||
144660291|NCT02175771|521606373|FG003|Run-In Period (Pre-assignment)|Other|0|||
144660292|NCT02175771|521606374|FG004|Run-In Period (Pre-assignment)|Other|0|||
144660293|NCT02175771|521606375|FG005|Run-In Period (Pre-assignment)|Other|0|||
144660294|NCT02175771|521606376|FG006|Run-In Period (Pre-assignment)|Other|0|||
144660295|NCT02175771|521606377|FG007|Run-In Period (Pre-assignment)|Other|0|||
144660296|NCT02175771|521606378|FG008|Run-In Period (Pre-assignment)|Other|0|||
144660297|NCT02175771|521606370|FG000|Treatment Period|Adverse Event|0|||
144660298|NCT02175771|521606371|FG001|Treatment Period|Adverse Event|2|||
144660299|NCT02175771|521606372|FG002|Treatment Period|Adverse Event|1|||
144660300|NCT02175771|521606373|FG003|Treatment Period|Adverse Event|1|||
144660301|NCT02175771|521606374|FG004|Treatment Period|Adverse Event|1|||
144660302|NCT02175771|521606375|FG005|Treatment Period|Adverse Event|3|||
144660303|NCT02175771|521606376|FG006|Treatment Period|Adverse Event|2|||
144660304|NCT02175771|521606377|FG007|Treatment Period|Adverse Event|0|||
144660305|NCT02175771|521606378|FG008|Treatment Period|Adverse Event|1|||
144660306|NCT02175771|521606370|FG000|Treatment Period|Withdrawal by Subject|0|||
144660307|NCT02175771|521606371|FG001|Treatment Period|Withdrawal by Subject|9|||
144660308|NCT02175771|521606372|FG002|Treatment Period|Withdrawal by Subject|3|||
144660309|NCT02175771|521606373|FG003|Treatment Period|Withdrawal by Subject|6|||
144660310|NCT02175771|521606374|FG004|Treatment Period|Withdrawal by Subject|2|||
144660311|NCT02175771|521606375|FG005|Treatment Period|Withdrawal by Subject|4|||
144660312|NCT02175771|521606376|FG006|Treatment Period|Withdrawal by Subject|2|||
144660313|NCT02175771|521606377|FG007|Treatment Period|Withdrawal by Subject|9|||
144660314|NCT02175771|521606378|FG008|Treatment Period|Withdrawal by Subject|2|||
144660315|NCT02175771|521606370|FG000|Treatment Period|Noncompliance|0|||
144660316|NCT02175771|521606371|FG001|Treatment Period|Noncompliance|1|||
144660317|NCT02175771|521606372|FG002|Treatment Period|Noncompliance|2|||
144660318|NCT02175771|521606373|FG003|Treatment Period|Noncompliance|0|||
144660319|NCT02175771|521606374|FG004|Treatment Period|Noncompliance|0|||
144660320|NCT02175771|521606375|FG005|Treatment Period|Noncompliance|0|||
144660321|NCT02175771|521606376|FG006|Treatment Period|Noncompliance|0|||
144660322|NCT02175771|521606377|FG007|Treatment Period|Noncompliance|0|||
144660323|NCT02175771|521606378|FG008|Treatment Period|Noncompliance|1|||
144660324|NCT02175771|521606370|FG000|Treatment Period|Protocol Violation|0|||
144660325|NCT02175771|521606371|FG001|Treatment Period|Protocol Violation|0|||
144660326|NCT02175771|521606372|FG002|Treatment Period|Protocol Violation|0|||
144660327|NCT02175771|521606373|FG003|Treatment Period|Protocol Violation|0|||
144660328|NCT02175771|521606374|FG004|Treatment Period|Protocol Violation|0|||
144214995|NCT02288325|519979971|FG002|Run-in Period|Withdrawal of Consent|0|||
144214996|NCT02288325|519979969|FG000|Run-in Period|Lost to Follow-up|25|||
144214997|NCT02288325|519979970|FG001|Run-in Period|Lost to Follow-up|0|||
144214998|NCT02288325|519979971|FG002|Run-in Period|Lost to Follow-up|0|||
144214999|NCT02288325|519979969|FG000|Run-in Period|Protocol Violation|17|||
144215000|NCT02288325|519979970|FG001|Run-in Period|Protocol Violation|0|||
144660329|NCT02175771|521606375|FG005|Treatment Period|Protocol Violation|0|||
144660330|NCT02175771|521606376|FG006|Treatment Period|Protocol Violation|0|||
144660331|NCT02175771|521606377|FG007|Treatment Period|Protocol Violation|1|||
144660332|NCT02175771|521606378|FG008|Treatment Period|Protocol Violation|0|||
144660333|NCT02175771|521606370|FG000|Treatment Period|Disease progression|0|||
144660334|NCT02175771|521606371|FG001|Treatment Period|Disease progression|0|||
144660335|NCT02175771|521606372|FG002|Treatment Period|Disease progression|0|||
144660336|NCT02175771|521606373|FG003|Treatment Period|Disease progression|0|||
144660337|NCT02175771|521606374|FG004|Treatment Period|Disease progression|0|||
144660338|NCT02175771|521606375|FG005|Treatment Period|Disease progression|0|||
144660339|NCT02175771|521606376|FG006|Treatment Period|Disease progression|0|||
144660340|NCT02175771|521606377|FG007|Treatment Period|Disease progression|2|||
144660341|NCT02175771|521606378|FG008|Treatment Period|Disease progression|0|||
144660342|NCT02175771|521606370|FG000|Treatment Period|Lost to Follow-up|0|||
144660343|NCT02175771|521606371|FG001|Treatment Period|Lost to Follow-up|3|||
144660344|NCT02175771|521606372|FG002|Treatment Period|Lost to Follow-up|1|||
144660345|NCT02175771|521606373|FG003|Treatment Period|Lost to Follow-up|3|||
144660346|NCT02175771|521606374|FG004|Treatment Period|Lost to Follow-up|1|||
144660347|NCT02175771|521606375|FG005|Treatment Period|Lost to Follow-up|2|||
144660348|NCT02175771|521606376|FG006|Treatment Period|Lost to Follow-up|1|||
144660349|NCT02175771|521606377|FG007|Treatment Period|Lost to Follow-up|2|||
144660350|NCT02175771|521606378|FG008|Treatment Period|Lost to Follow-up|2|||
144660351|NCT02175771|521606370|FG000|Treatment Period|Lack of Efficacy|0|||
144660352|NCT02175771|521606371|FG001|Treatment Period|Lack of Efficacy|0|||
144660353|NCT02175771|521606372|FG002|Treatment Period|Lack of Efficacy|0|||
144660354|NCT02175771|521606373|FG003|Treatment Period|Lack of Efficacy|0|||
144660355|NCT02175771|521606374|FG004|Treatment Period|Lack of Efficacy|0|||
144660356|NCT02175771|521606375|FG005|Treatment Period|Lack of Efficacy|1|||
144660357|NCT02175771|521606376|FG006|Treatment Period|Lack of Efficacy|0|||
144660358|NCT02175771|521606377|FG007|Treatment Period|Lack of Efficacy|1|||
144660359|NCT02175771|521606378|FG008|Treatment Period|Lack of Efficacy|0|||
144660360|NCT02175771|521606370|FG000|Treatment Period|Other|0|||
144660361|NCT02175771|521606371|FG001|Treatment Period|Other|1|||
144660362|NCT02175771|521606372|FG002|Treatment Period|Other|0|||
144660363|NCT02175771|521606373|FG003|Treatment Period|Other|3|||
144660364|NCT02175771|521606374|FG004|Treatment Period|Other|1|||
144660365|NCT02175771|521606375|FG005|Treatment Period|Other|0|||
144660366|NCT02175771|521606376|FG006|Treatment Period|Other|0|||
144660367|NCT02175771|521606377|FG007|Treatment Period|Other|2|||
144660368|NCT02175771|521606378|FG008|Treatment Period|Other|0|||
144660369|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
144660370|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
144660371|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
144660372|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
144660373|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
144660374|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
144660375|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
144660376|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
144660377|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
144660378|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
144660379|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
144660380|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
144660381|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
144660382|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
144660383|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
144660384|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
144660385|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
144660386|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
144660387|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
144660388|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
144660389|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
144660390|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
144660391|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
144660392|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144660393|NCT01106625|521606382|FG000|Core Period: Baseline to Week 26|Other|8|||
144660394|NCT01106625|521606383|FG001|Core Period: Baseline to Week 26|Other|7|||
144215001|NCT02288325|519979971|FG002|Run-in Period|Protocol Violation|0|||
144215002|NCT02288325|519979969|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
144215003|NCT02288325|519979970|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
144660395|NCT01106625|521606384|FG002|Core Period: Baseline to Week 26|Other|4|||
144660396|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
144215004|NCT02288325|519979971|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
144660397|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
144660398|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
144215005|NCT02288325|519979969|FG000|Run-in Period|Reason not Specified|8|||
144660399|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
144660400|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
144660401|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
144660402|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
144660403|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
144660404|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
144660405|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144660406|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
144660407|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144660408|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
144660409|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144660410|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144660411|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
144660412|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
144660413|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
144660414|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
144660415|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
144660416|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
144660417|NCT01106625|521606382|FG000|Extension Period: Week 26 to Week 52|Other|5|||
144660418|NCT01106625|521606383|FG001|Extension Period: Week 26 to Week 52|Other|5|||
144660419|NCT01106625|521606384|FG002|Extension Period: Week 26 to Week 52|Other|4|||
144660420|NCT02496585|521606385|FG000|Overall Study|Death|3|||
144660421|NCT02496585|521606386|FG001|Overall Study|Death|0|||
144660422|NCT02496585|521606385|FG000|Overall Study|Lost to Follow-up|2|||
144660423|NCT02496585|521606386|FG001|Overall Study|Lost to Follow-up|0|||
144660424|NCT02496585|521606385|FG000|Overall Study|Withdrawal by Subject|1|||
144660425|NCT02496585|521606386|FG001|Overall Study|Withdrawal by Subject|2|||
144660426|NCT02496585|521606385|FG000|Overall Study|Progression of Malignancy|4|||
144660427|NCT02496585|521606386|FG001|Overall Study|Progression of Malignancy|1|||
144660428|NCT01151579|521606389|FG000|Overall Study|Physician Decision|3|||
144660429|NCT01151579|521606390|FG001|Overall Study|Physician Decision|1|||
144660430|NCT01151579|521606389|FG000|Overall Study|Withdrawal by Subject|3|||
144660431|NCT01151579|521606390|FG001|Overall Study|Withdrawal by Subject|2|||
144660432|NCT01151579|521606389|FG000|Overall Study|Not meet inclusion criteria|6|||
144660433|NCT01151579|521606390|FG001|Overall Study|Not meet inclusion criteria|4|||
144660434|NCT01276457|521606391|FG000|Core Study|Adverse Event|6|||
144660435|NCT01276457|521606392|FG001|Core Study|Adverse Event|3|||
144660436|NCT01276457|521606391|FG000|Core Study|Lost to Follow-up|1|||
144660437|NCT01276457|521606392|FG001|Core Study|Lost to Follow-up|2|||
144660438|NCT01276457|521606391|FG000|Core Study|Administrative problems|1|||
144660439|NCT01276457|521606392|FG001|Core Study|Administrative problems|1|||
144660440|NCT01276457|521606391|FG000|Core Study|Death|2|||
144660441|NCT01276457|521606392|FG001|Core Study|Death|2|||
144660442|NCT01276457|521606391|FG000|Core Study|Lack of Efficacy|3|||
144660443|NCT01276457|521606392|FG001|Core Study|Lack of Efficacy|12|||
144660444|NCT01276457|521606391|FG000|Extension Study|Lost to Follow-up|3|||
144660445|NCT01276457|521606392|FG001|Extension Study|Lost to Follow-up|0|||
144660446|NCT01276457|521606391|FG000|Extension Study|Death|0|||
144660447|NCT01276457|521606392|FG001|Extension Study|Death|1|||
144660448|NCT01276457|521606391|FG000|Extension Study|Lack of Efficacy|3|||
144660449|NCT01276457|521606392|FG001|Extension Study|Lack of Efficacy|1|||
144660450|NCT04544709|521606398|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
144660451|NCT03238235|521606399|FG000|Overall Study|Adverse Event|2|||
144660452|NCT03238235|521606400|FG001|Overall Study|Adverse Event|0|||
144660453|NCT03238235|521606399|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
144660454|NCT03238235|521606400|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
144660455|NCT04436822|521606401|FG000|Overall Study|Physician Decision|2|||
144660456|NCT04436822|521606402|FG001|Overall Study|Physician Decision|0|||
144660457|NCT04436822|521606401|FG000|Overall Study|Sponsor request|1|||
144660458|NCT04436822|521606402|FG001|Overall Study|Sponsor request|0|||
144660459|NCT04436822|521606401|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144660460|NCT04436822|521606402|FG001|Overall Study|Withdrawal by parent/guardian|3|||
144660461|NCT04436822|521606401|FG000|Overall Study|Unsuccessful procedure|0|||
144660462|NCT04436822|521606402|FG001|Overall Study|Unsuccessful procedure|1|||
144660463|NCT04436822|521606401|FG000|Overall Study|Withdrawal due to Covid-19|8|||
144660464|NCT04436822|521606402|FG001|Overall Study|Withdrawal due to Covid-19|1|||
144660465|NCT04436822|521606401|FG000|Overall Study|Withdrawal by Subject|1|||
144660466|NCT04436822|521606402|FG001|Overall Study|Withdrawal by Subject|0|||
144660467|NCT04436822|521606401|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
144660468|NCT04436822|521606402|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
144660469|NCT03807739|521606403|FG000|Overall Study|Adverse Event|1|||
144660470|NCT03807739|521606404|FG001|Overall Study|Adverse Event|0|||
144660471|NCT03807739|521606405|FG002|Overall Study|Adverse Event|0|||
144215006|NCT02288325|519979970|FG001|Run-in Period|Reason not Specified|0|||
144215007|NCT02288325|519979971|FG002|Run-in Period|Reason not Specified|0|||
144215008|NCT02288325|519979969|FG000|Stabilization Period|Adverse Event|13|||
144215009|NCT02288325|519979970|FG001|Stabilization Period|Adverse Event|0|||
144215010|NCT02288325|519979971|FG002|Stabilization Period|Adverse Event|0|||
144215011|NCT02288325|519979969|FG000|Stabilization Period|Lack of Efficacy|22|||
144215012|NCT02288325|519979970|FG001|Stabilization Period|Lack of Efficacy|0|||
144215013|NCT02288325|519979971|FG002|Stabilization Period|Lack of Efficacy|0|||
144215014|NCT02288325|519979969|FG000|Stabilization Period|Withdrawal of Consent|23|||
144215015|NCT02288325|519979970|FG001|Stabilization Period|Withdrawal of Consent|0|||
144215016|NCT02288325|519979971|FG002|Stabilization Period|Withdrawal of Consent|0|||
144215017|NCT02288325|519979969|FG000|Stabilization Period|Lost to Follow-up|12|||
144215018|NCT02288325|519979970|FG001|Stabilization Period|Lost to Follow-up|0|||
144215019|NCT02288325|519979971|FG002|Stabilization Period|Lost to Follow-up|0|||
144215020|NCT02288325|519979969|FG000|Stabilization Period|Protocol Violation|8|||
144215021|NCT02288325|519979970|FG001|Stabilization Period|Protocol Violation|0|||
144215022|NCT02288325|519979971|FG002|Stabilization Period|Protocol Violation|0|||
144215023|NCT02288325|519979969|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
144215024|NCT02288325|519979970|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
144215025|NCT02288325|519979971|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
144215026|NCT02288325|519979969|FG000|Stabilization Period|Reason not Specified|15|||
144215027|NCT02288325|519979970|FG001|Stabilization Period|Reason not Specified|0|||
144215028|NCT02288325|519979971|FG002|Stabilization Period|Reason not Specified|0|||
144215029|NCT02288325|519979969|FG000|Double-blind Treatment Period|Adverse Event|0|||
144215030|NCT02288325|519979970|FG001|Double-blind Treatment Period|Adverse Event|2|||
144215031|NCT02288325|519979971|FG002|Double-blind Treatment Period|Adverse Event|5|||
144215032|NCT02288325|519979969|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
144215033|NCT02288325|519979970|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
144215034|NCT02288325|519979971|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
144215035|NCT02288325|519979969|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144215036|NCT02288325|519979970|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
144215037|NCT02288325|519979971|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
144215038|NCT02288325|519979969|FG000|Double-blind Treatment Period|Protocol Violation|0|||
144215039|NCT02288325|519979970|FG001|Double-blind Treatment Period|Protocol Violation|1|||
144215040|NCT02288325|519979971|FG002|Double-blind Treatment Period|Protocol Violation|2|||
144215041|NCT02288325|519979969|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
144215042|NCT02288325|519979970|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
144215043|NCT02288325|519979971|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
144215044|NCT02288325|519979969|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
144215045|NCT02288325|519979970|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
144215046|NCT02288325|519979971|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
144215047|NCT05180227|519979974|FG000|Overall Study|Hypertension at screening|1|||
144215048|NCT05180227|519979974|FG000|Overall Study|Lost to Follow-up|1|||
144215049|NCT01632280|519979975|FG000|Overall Study|Withdrawal by Subject|1|||
144215050|NCT01632280|519979976|FG001|Overall Study|Withdrawal by Subject|0|||
144660472|NCT03807739|521606406|FG003|Overall Study|Adverse Event|0|||
144660473|NCT03807739|521606403|FG000|Overall Study|Withdrawal by Subject|1|||
144660474|NCT03807739|521606404|FG001|Overall Study|Withdrawal by Subject|0|||
144660475|NCT03807739|521606405|FG002|Overall Study|Withdrawal by Subject|0|||
144660476|NCT03807739|521606406|FG003|Overall Study|Withdrawal by Subject|0|||
144660477|NCT05118386|521606407|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
144660478|NCT05118386|521606408|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
144660479|NCT05118386|521606409|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
144660480|NCT05118386|521606410|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
144660481|NCT05118386|521606411|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
144660482|NCT05118386|521606412|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
144660483|NCT05118386|521606407|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
144660484|NCT05118386|521606408|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
144660485|NCT05118386|521606409|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
144660486|NCT05118386|521606410|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
144660487|NCT05118386|521606411|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
144660488|NCT05118386|521606412|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
144660489|NCT00369668|521606416|FG000|Overall Study|Lack of Efficacy|4|||
144660490|NCT00369668|521606417|FG001|Overall Study|Lack of Efficacy|5|||
144660491|NCT00369668|521606418|FG002|Overall Study|Lack of Efficacy|7|||
144660492|NCT00303108|521606421|FG000|Overall Study|Adverse Event|5|||
144660493|NCT00303108|521606422|FG001|Overall Study|Adverse Event|6|||
144660494|NCT00303108|521606423|FG002|Overall Study|Adverse Event|7|||
144660495|NCT00303108|521606421|FG000|Overall Study|Patient Request|4|||
144660496|NCT00303108|521606422|FG001|Overall Study|Patient Request|2|||
144660497|NCT00303108|521606423|FG002|Overall Study|Patient Request|8|||
144660498|NCT00303108|521606421|FG000|Overall Study|Failed Entry|1|||
144660499|NCT00303108|521606422|FG001|Overall Study|Failed Entry|0|||
144660500|NCT00303108|521606423|FG002|Overall Study|Failed Entry|1|||
144660501|NCT00303108|521606421|FG000|Overall Study|ineligible|2|||
144660502|NCT00303108|521606422|FG001|Overall Study|ineligible|1|||
144660503|NCT00303108|521606423|FG002|Overall Study|ineligible|0|||
144660504|NCT00894413|521606424|FG000|Overall Study|Physician Decision|0|||
144660505|NCT00894413|521606425|FG001|Overall Study|Physician Decision|2|||
144660506|NCT00894413|521606424|FG000|Overall Study|Adverse Event|0|||
144660507|NCT00894413|521606425|FG001|Overall Study|Adverse Event|2|||
144660508|NCT00894413|521606424|FG000|Overall Study|Withdrawal by Subject|0|||
144660509|NCT00894413|521606425|FG001|Overall Study|Withdrawal by Subject|4|||
144660510|NCT01697267|521608694|FG000|Overall Study|Death|3|||
144660511|NCT01697267|521608695|FG001|Overall Study|Death|1|||
144660512|NCT01697267|521608694|FG000|Overall Study|Withdrawal by Subject|5|||
144660513|NCT01697267|521608695|FG001|Overall Study|Withdrawal by Subject|5|||
144660514|NCT01697267|521608694|FG000|Overall Study|Adverse Event|2|||
144660515|NCT01697267|521608695|FG001|Overall Study|Adverse Event|1|||
144660516|NCT01697267|521608694|FG000|Overall Study|Lost to Follow-up|2|||
144660517|NCT01697267|521608695|FG001|Overall Study|Lost to Follow-up|4|||
144660518|NCT01697267|521608694|FG000|Overall Study|Physician Decision|2|||
144660519|NCT01697267|521608695|FG001|Overall Study|Physician Decision|4|||
144660520|NCT05254613|521608702|FG000|Overall Study|Lost to Follow-up|0|||
144660521|NCT05254613|521608703|FG001|Overall Study|Lost to Follow-up|0|||
144660522|NCT05254613|521608704|FG002|Overall Study|Lost to Follow-up|1|||
144660523|NCT02338492|521608705|FG000|Overall Study|Death|32|||
144660524|NCT02338492|521608705|FG000|Overall Study|Adverse Event|3|||
144660525|NCT02338492|521608705|FG000|Overall Study|Lost to Follow-up|4|||
144660526|NCT02338492|521608705|FG000|Overall Study|Reason not captured above|6|||
144660527|NCT00174785|521608706|FG000|Overall Study|Adverse Event|293|||
144660528|NCT00174785|521608707|FG001|Overall Study|Adverse Event|191|||
144660529|NCT00174785|521608706|FG000|Overall Study|Protocol Violation|14|||
144660530|NCT00174785|521608707|FG001|Overall Study|Protocol Violation|14|||
144660531|NCT00174785|521608706|FG000|Overall Study|Withdrawal by Subject|173|||
144660532|NCT00174785|521608707|FG001|Overall Study|Withdrawal by Subject|175|||
144660533|NCT00174785|521608706|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
144660534|NCT00174785|521608707|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
144660535|NCT00174785|521608706|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
144660536|NCT00174785|521608707|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
144660537|NCT00174785|521608706|FG000|Overall Study|Other prohibited medication|5|||
144660538|NCT00174785|521608707|FG001|Overall Study|Other prohibited medication|3|||
144660539|NCT00174785|521608706|FG000|Overall Study|Family request|6|||
144660540|NCT00174785|521608707|FG001|Overall Study|Family request|8|||
144660541|NCT00174785|521608706|FG000|Overall Study|Not pre-specified/Not coded|56|||
144660542|NCT00174785|521608707|FG001|Overall Study|Not pre-specified/Not coded|70|||
144660543|NCT00310388|521608708|FG000|Primary Reporting Phase|Adverse Event|101|||
144660544|NCT00310388|521608709|FG001|Primary Reporting Phase|Adverse Event|0|||
144660545|NCT00310388|521608708|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
144660546|NCT00310388|521608709|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
144660547|NCT00310388|521608708|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
144660548|NCT00310388|521608709|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
144660549|NCT00310388|521608708|FG000|Primary Reporting Phase|Protocol Violation|10|||
144660550|NCT00310388|521608709|FG001|Primary Reporting Phase|Protocol Violation|0|||
144660551|NCT00310388|521608708|FG000|Primary Reporting Phase|Pregnancy|3|||
144660552|NCT00310388|521608709|FG001|Primary Reporting Phase|Pregnancy|0|||
144660553|NCT00310388|521608708|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
144660554|NCT00310388|521608709|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
144660555|NCT00310388|521608708|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
144660556|NCT00310388|521608709|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
144215051|NCT02215967|519979982|FG000|Overall Study|Patient became ineligible for treatment|0|||
144660557|NCT00310388|521608708|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
144660558|NCT00310388|521608709|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
144660559|NCT00310388|521608708|FG000|Primary Reporting Phase|Physician Decision|2|||
144660560|NCT00310388|521608709|FG001|Primary Reporting Phase|Physician Decision|0|||
144660561|NCT00310388|521608708|FG000|Primary Reporting Phase|Request of the sponsor|19|||
144215052|NCT02215967|519979983|FG001|Overall Study|Patient became ineligible for treatment|0|||
144660562|NCT00310388|521608709|FG001|Primary Reporting Phase|Request of the sponsor|0|||
144660563|NCT00310388|521608708|FG000|Primary Reporting Phase|Failed to return|8|||
144660564|NCT00310388|521608709|FG001|Primary Reporting Phase|Failed to return|0|||
144660565|NCT00310388|521608708|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
144660566|NCT00310388|521608709|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
144660567|NCT00310388|521608708|FG000|Primary Reporting Phase|Participant request|2|||
144660568|NCT00310388|521608709|FG001|Primary Reporting Phase|Participant request|0|||
144265156|NCT05067972|520171729|FG004|Part 1: Treatment|Physician Decision|0|||
144265157|NCT05067972|520171730|FG005|Part 1: Treatment|Physician Decision|0|||
144265158|NCT05067972|520171731|FG006|Part 1: Treatment|Physician Decision|0|||
144265159|NCT05067972|520171725|FG000|Part 1: Treatment|Death|0|||
144265160|NCT05067972|520171726|FG001|Part 1: Treatment|Death|0|||
144265161|NCT05067972|520171727|FG002|Part 1: Treatment|Death|0|||
144265162|NCT05067972|520171728|FG003|Part 1: Treatment|Death|2|||
144265163|NCT05067972|520171729|FG004|Part 1: Treatment|Death|0|||
144265164|NCT05067972|520171730|FG005|Part 1: Treatment|Death|0|||
144265165|NCT05067972|520171731|FG006|Part 1: Treatment|Death|0|||
144265166|NCT05067972|520171725|FG000|Part 1: Treatment|Adverse Event|0|||
144265167|NCT05067972|520171726|FG001|Part 1: Treatment|Adverse Event|0|||
144265168|NCT05067972|520171727|FG002|Part 1: Treatment|Adverse Event|0|||
144265169|NCT05067972|520171728|FG003|Part 1: Treatment|Adverse Event|0|||
144265170|NCT05067972|520171729|FG004|Part 1: Treatment|Adverse Event|0|||
144265171|NCT05067972|520171730|FG005|Part 1: Treatment|Adverse Event|2|||
144265172|NCT05067972|520171731|FG006|Part 1: Treatment|Adverse Event|1|||
144265173|NCT05067972|520171725|FG000|Part 1: Follow-up|Adverse Event|0|||
144265174|NCT05067972|520171726|FG001|Part 1: Follow-up|Adverse Event|0|||
144265175|NCT05067972|520171727|FG002|Part 1: Follow-up|Adverse Event|0|||
144265176|NCT05067972|520171728|FG003|Part 1: Follow-up|Adverse Event|0|||
144265177|NCT05067972|520171729|FG004|Part 1: Follow-up|Adverse Event|0|||
144265178|NCT05067972|520171730|FG005|Part 1: Follow-up|Adverse Event|1|||
144265179|NCT05067972|520171731|FG006|Part 1: Follow-up|Adverse Event|0|||
144265180|NCT05067972|520171725|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
144265181|NCT05067972|520171726|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
144265182|NCT05067972|520171727|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
144265183|NCT05067972|520171728|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
144265184|NCT05067972|520171729|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
144265185|NCT05067972|520171730|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
144265186|NCT05067972|520171731|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
144265187|NCT05067972|520171725|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
144265188|NCT05067972|520171726|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
144265189|NCT05067972|520171727|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
144265190|NCT05067972|520171728|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
144265191|NCT05067972|520171729|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
144265192|NCT05067972|520171730|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
144265193|NCT05067972|520171731|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
144265194|NCT05067972|520171725|FG000|Part 1: Follow-up|Physician Decision|0|||
144265195|NCT05067972|520171726|FG001|Part 1: Follow-up|Physician Decision|0|||
144265196|NCT05067972|520171727|FG002|Part 1: Follow-up|Physician Decision|0|||
144265197|NCT05067972|520171728|FG003|Part 1: Follow-up|Physician Decision|1|||
144265198|NCT05067972|520171729|FG004|Part 1: Follow-up|Physician Decision|0|||
144265199|NCT05067972|520171730|FG005|Part 1: Follow-up|Physician Decision|0|||
144265200|NCT05067972|520171731|FG006|Part 1: Follow-up|Physician Decision|0|||
144265201|NCT05067972|520171725|FG000|Part 1: Follow-up|Death|1|||
144265202|NCT05067972|520171726|FG001|Part 1: Follow-up|Death|2|||
144265203|NCT05067972|520171727|FG002|Part 1: Follow-up|Death|1|||
144265204|NCT05067972|520171728|FG003|Part 1: Follow-up|Death|0|||
144265205|NCT05067972|520171729|FG004|Part 1: Follow-up|Death|1|||
144265206|NCT05067972|520171730|FG005|Part 1: Follow-up|Death|0|||
144265207|NCT05067972|520171731|FG006|Part 1: Follow-up|Death|1|||
144265208|NCT04391842|520171732|FG000|Overall Study|Withdrawal by Subject|2|||
144265209|NCT00810199|520171733|FG000|Overall Study|Adverse Event|24|||
144265210|NCT00810199|520171734|FG001|Overall Study|Adverse Event|26|||
144265211|NCT00810199|520171733|FG000|Overall Study|Death|4|||
144265212|NCT00810199|520171734|FG001|Overall Study|Death|6|||
144265213|NCT00810199|520171733|FG000|Overall Study|Withdrew consent|9|||
144265214|NCT00810199|520171734|FG001|Overall Study|Withdrew consent|12|||
144265215|NCT00810199|520171733|FG000|Overall Study|Insufficient therapeutic response|5|||
144265216|NCT00810199|520171734|FG001|Overall Study|Insufficient therapeutic response|14|||
144265217|NCT00810199|520171733|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
144265218|NCT00810199|520171734|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
144265219|NCT00810199|520171733|FG000|Overall Study|Administrative/Other|5|||
144265220|NCT00810199|520171734|FG001|Overall Study|Administrative/Other|6|||
144265221|NCT00810199|520171733|FG000|Overall Study|Protocol Violation|2|||
144265222|NCT00810199|520171734|FG001|Overall Study|Protocol Violation|6|||
144265223|NCT00810199|520171733|FG000|Overall Study|Failure to return|1|||
144265224|NCT00810199|520171734|FG001|Overall Study|Failure to return|4|||
144265225|NCT00810199|520171733|FG000|Overall Study|Did not receive study drug|2|||
144265226|NCT00810199|520171734|FG001|Overall Study|Did not receive study drug|1|||
144265227|NCT00992017|520171736|FG000|Overall Study|Lost to Follow-up|2|||
144265228|NCT00992017|520171736|FG000|Overall Study|Withdrawal by Subject|2|||
144265229|NCT00992017|520171736|FG000|Overall Study|Unable to get to clinic|5|||
144265230|NCT00992017|520171736|FG000|Overall Study|Not adhere to study requirements|1|||
144265231|NCT02864407|520171737|FG000|Overall Study|Protocol Violation|3|||
144265232|NCT02864407|520171737|FG000|Overall Study|Lost to Follow-up|115|||
144265233|NCT02864407|520171737|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
144660569|NCT00310388|521608708|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
144660570|NCT00310388|521608709|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
144660571|NCT00310388|521608708|FG000|Primary Reporting Phase|Discontinuation of study|1|||
144660572|NCT00310388|521608709|FG001|Primary Reporting Phase|Discontinuation of study|0|||
144660573|NCT00310388|521608708|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
144660574|NCT00310388|521608709|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
144660575|NCT00310388|521608708|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
144660576|NCT00310388|521608709|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
144660577|NCT00310388|521608708|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
144660578|NCT00310388|521608709|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
144660579|NCT00310388|521608708|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
144660580|NCT00310388|521608709|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
144660581|NCT00310388|521608708|FG000|Primary Reporting Phase|Participant passed away|1|||
144660582|NCT00310388|521608709|FG001|Primary Reporting Phase|Participant passed away|0|||
144660583|NCT00310388|521608708|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
144660584|NCT00310388|521608709|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
144660585|NCT00310388|521608708|FG000|Primary Reporting Phase|Missing|1|||
144660586|NCT00310388|521608709|FG001|Primary Reporting Phase|Missing|0|||
144660587|NCT00310388|521608708|FG000|Primary Reporting Phase|Other|1|||
144660588|NCT00310388|521608709|FG001|Primary Reporting Phase|Other|0|||
144660589|NCT00310388|521608708|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
144660590|NCT00310388|521608709|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
144660591|NCT00310388|521608708|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
144660592|NCT00310388|521608709|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
144660593|NCT00310388|521608708|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
144660594|NCT00310388|521608709|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
144660595|NCT00310388|521608708|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
144660596|NCT00310388|521608709|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
144660597|NCT01576016|521608716|FG000|Lead Safety|Death|132|||
144660598|NCT01576016|521608717|FG001|Lead Safety|Death|0|||
144660599|NCT01576016|521608716|FG000|Lead Safety|Withdrawal by Subject|81|||
144660600|NCT01576016|521608717|FG001|Lead Safety|Withdrawal by Subject|0|||
144660601|NCT01576016|521608716|FG000|Lead Safety|System Explanted without Replacement|24|||
144660602|NCT01576016|521608717|FG001|Lead Safety|System Explanted without Replacement|0|||
144660603|NCT01576016|521608716|FG000|Lead Safety|Physician Decision|14|||
144660604|NCT01576016|521608717|FG001|Lead Safety|Physician Decision|0|||
144660605|NCT01576016|521608716|FG000|Lead Safety|Lost to Follow-up|13|||
144660606|NCT01576016|521608717|FG001|Lead Safety|Lost to Follow-up|0|||
144660607|NCT01576016|521608716|FG000|Lead Safety|Unsuccessful implant|2|||
144660608|NCT01576016|521608717|FG001|Lead Safety|Unsuccessful implant|0|||
144660609|NCT01576016|521608716|FG000|Lead Safety|Sponsor request|1|||
144660610|NCT01576016|521608717|FG001|Lead Safety|Sponsor request|0|||
144660611|NCT01576016|521608716|FG000|Lead Safety|Device replaced with CRT-D|1|||
144660612|NCT01576016|521608717|FG001|Lead Safety|Device replaced with CRT-D|0|||
144660613|NCT01576016|521608716|FG000|Lead Safety|Patient on Palliative Care|1|||
144660614|NCT01576016|521608717|FG001|Lead Safety|Patient on Palliative Care|0|||
144660615|NCT01576016|521608716|FG000|Lead Safety|Patient noncompliance|1|||
144660616|NCT01576016|521608717|FG001|Lead Safety|Patient noncompliance|0|||
144660617|NCT01576016|521608716|FG000|Lead Safety|Too far from study site|1|||
144660618|NCT01576016|521608717|FG001|Lead Safety|Too far from study site|0|||
144660619|NCT01576016|521608716|FG000|Lead Safety|System deactivated|1|||
144660620|NCT01576016|521608717|FG001|Lead Safety|System deactivated|0|||
144660621|NCT01576016|521608716|FG000|Lead Safety|Patient no longer followed by study PI|1|||
144660622|NCT01576016|521608717|FG001|Lead Safety|Patient no longer followed by study PI|0|||
144660623|NCT01576016|521608716|FG000|MRI Safety|Withdrawal by Subject|0|||
144660624|NCT01576016|521608717|FG001|MRI Safety|Withdrawal by Subject|10|||
144660625|NCT01576016|521608716|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
144660626|NCT01576016|521608717|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
144660627|NCT01576016|521608716|FG000|MRI Safety|Has not yet completed MRI scan|0|||
144660628|NCT01576016|521608717|FG001|MRI Safety|Has not yet completed MRI scan|56|||
144660629|NCT01576016|521608716|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
144660630|NCT01576016|521608717|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
144660631|NCT04507867|521608720|FG000|Overall Study|Death|7|||
144660632|NCT04507867|521608721|FG001|Overall Study|Death|1|||
144660633|NCT03364673|521608722|FG000|Overall Study|Withdrawal by Subject|2|||
144660634|NCT03364673|521608722|FG000|Overall Study|Injury unrelated to study|3|||
144660635|NCT02208024|521608723|FG000|Overall Study|Withdrawal by Subject|1|||
144660636|NCT00779324|521608724|FG000|Overall Study|Lost to Follow-up|2|||
144660637|NCT00779324|521608725|FG001|Overall Study|Lost to Follow-up|1|||
144660638|NCT00779324|521608724|FG000|Overall Study|Withdrawal by Subject|4|||
144660639|NCT00779324|521608725|FG001|Overall Study|Withdrawal by Subject|2|||
144660640|NCT00779324|521608724|FG000|Overall Study|Missed visit|1|||
144660641|NCT00779324|521608725|FG001|Overall Study|Missed visit|1|||
144660642|NCT02207556|521608726|FG000|Overall Study|Physician Decision|1|||
144660643|NCT02207556|521608727|FG001|Overall Study|Physician Decision|0|||
144660644|NCT02207556|521608726|FG000|Overall Study|Withdrawal by Subject|1|||
144660645|NCT02207556|521608727|FG001|Overall Study|Withdrawal by Subject|0|||
144660646|NCT02207556|521608726|FG000|Overall Study|Death|0|||
144660647|NCT02207556|521608727|FG001|Overall Study|Death|5|||
144660648|NCT03558555|521608728|FG000|Overall Study|Lost to Follow-up|2|||
144660649|NCT03558555|521608729|FG001|Overall Study|Lost to Follow-up|1|||
144660650|NCT00194025|521608730|FG000|Overall Study|Adverse Event|1|||
144660651|NCT00194025|521608730|FG000|Overall Study|non-adherence with study medication|4|||
144660652|NCT00543569|521608731|FG000|Overall Study|Death|2|||
144660653|NCT00543569|521608732|FG001|Overall Study|Death|2|||
144660654|NCT00543569|521608733|FG002|Overall Study|Death|3|||
144660655|NCT00543569|521608734|FG003|Overall Study|Death|1|||
144660656|NCT00543569|521608731|FG000|Overall Study|Lost to Follow-up|0|||
144660657|NCT00543569|521608732|FG001|Overall Study|Lost to Follow-up|0|||
144660658|NCT00543569|521608733|FG002|Overall Study|Lost to Follow-up|1|||
144660659|NCT00543569|521608734|FG003|Overall Study|Lost to Follow-up|1|||
144660660|NCT00543569|521608731|FG000|Overall Study|Miscellaneous Reasons|7|||
144660661|NCT00543569|521608732|FG001|Overall Study|Miscellaneous Reasons|3|||
144660662|NCT00543569|521608733|FG002|Overall Study|Miscellaneous Reasons|11|||
144660663|NCT00543569|521608734|FG003|Overall Study|Miscellaneous Reasons|4|||
144660664|NCT00543569|521608731|FG000|Overall Study|Randomized but never received study drug|3|||
144660665|NCT00543569|521608732|FG001|Overall Study|Randomized but never received study drug|3|||
144660666|NCT00543569|521608733|FG002|Overall Study|Randomized but never received study drug|5|||
144660667|NCT00543569|521608734|FG003|Overall Study|Randomized but never received study drug|3|||
144660668|NCT00862849|521608735|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
144660669|NCT00862849|521608736|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
144660670|NCT00862849|521608737|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
144660671|NCT00862849|521608738|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
144660672|NCT00862849|521608739|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
144660673|NCT00862849|521608740|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
144660674|NCT00862849|521608735|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
144660675|NCT00862849|521608736|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
144660676|NCT00862849|521608737|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
144660677|NCT00862849|521608738|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
144660678|NCT00862849|521608739|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
144660679|NCT00862849|521608740|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
144660680|NCT00617409|521608741|FG000|Overall Study|Withdrawal by Subject|4|||
144660681|NCT00617409|521608742|FG001|Overall Study|Withdrawal by Subject|1|||
144660682|NCT00617409|521608743|FG002|Overall Study|Withdrawal by Subject|2|||
144660683|NCT00617409|521608741|FG000|Overall Study|Adverse Event|0|||
144660684|NCT00617409|521608742|FG001|Overall Study|Adverse Event|2|||
144660685|NCT00617409|521608743|FG002|Overall Study|Adverse Event|3|||
144660686|NCT00617409|521608741|FG000|Overall Study|Disease Progression|8|||
144660687|NCT00617409|521608742|FG001|Overall Study|Disease Progression|8|||
144660688|NCT00617409|521608743|FG002|Overall Study|Disease Progression|18|||
144660689|NCT00617409|521608741|FG000|Overall Study|Death|3|||
144660690|NCT00617409|521608742|FG001|Overall Study|Death|5|||
144660691|NCT00617409|521608743|FG002|Overall Study|Death|4|||
144660692|NCT00617409|521608741|FG000|Overall Study|Alternative Therapy|1|||
144660693|NCT00617409|521608742|FG001|Overall Study|Alternative Therapy|2|||
144660694|NCT00617409|521608743|FG002|Overall Study|Alternative Therapy|0|||
144660695|NCT02108951|521608746|FG000|Overall Study|Lost to Follow-up|1|||
144660696|NCT02108951|521608746|FG000|Overall Study|Patient's/guardian's decision|1|||
144660697|NCT02108951|521608746|FG000|Overall Study|Study Terminated by Sponsor|14|||
144660698|NCT00718666|521608747|FG000|Booster Phase Year 5|No active participation request|0|||
144660699|NCT00718666|521608748|FG001|Booster Phase Year 5|No active participation request|0|||
144660700|NCT00718666|521608749|FG002|Booster Phase Year 5|No active participation request|1|||
144660701|NCT00718666|521608747|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
144660702|NCT00718666|521608748|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
144660703|NCT00718666|521608749|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
144660704|NCT00718666|521608747|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
144660705|NCT00718666|521608748|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
144660706|NCT00718666|521608749|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
144660707|NCT00718666|521608747|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
144660708|NCT00718666|521608748|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
144660709|NCT00718666|521608749|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
144660710|NCT02196038|521608752|FG000|Overall Study|Death|16|||
144732942|NCT02924883|521879248|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
144660711|NCT02196038|521608753|FG001|Overall Study|Death|21|||
144660712|NCT02196038|521608752|FG000|Overall Study|Withdrawal by Subject|0|||
144660713|NCT02196038|521608753|FG001|Overall Study|Withdrawal by Subject|1|||
144660714|NCT02196038|521608752|FG000|Overall Study|Lost to Follow-up|1|||
144660715|NCT02196038|521608753|FG001|Overall Study|Lost to Follow-up|0|||
144732943|NCT02924883|521879249|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
144732944|NCT02924883|521879248|FG000|Overall Study|Protocol Violation|1|||
144732945|NCT02924883|521879249|FG001|Overall Study|Protocol Violation|0|||
144732946|NCT02924883|521879248|FG000|Overall Study|Withdrawal by Subject|22|||
144732947|NCT02924883|521879249|FG001|Overall Study|Withdrawal by Subject|16|||
144732948|NCT02924883|521879248|FG000|Overall Study|Progressive Disease|1|||
144732949|NCT02924883|521879249|FG001|Overall Study|Progressive Disease|0|||
144732950|NCT02924883|521879248|FG000|Overall Study|Study Terminated by Sponsor|69|||
144732951|NCT02924883|521879249|FG001|Overall Study|Study Terminated by Sponsor|32|||
144732952|NCT01422538|521879251|FG000|Overall Study|Lost to Follow-up|0|||
144732953|NCT01422538|521879252|FG001|Overall Study|Lost to Follow-up|1|||
144732954|NCT01422538|521879253|FG002|Overall Study|Lost to Follow-up|1|||
144732955|NCT01422538|521879251|FG000|Overall Study|Missed visit|0|||
144732956|NCT01422538|521879252|FG001|Overall Study|Missed visit|1|||
144732957|NCT01422538|521879253|FG002|Overall Study|Missed visit|1|||
144732958|NCT00004562|521879254|FG000|Overall Study|Lost to Follow-up|102|||
144732959|NCT00004562|521879255|FG001|Overall Study|Lost to Follow-up|91|||
144732960|NCT02770820|521879256|FG000|Overall Study|Death|1|||
144732961|NCT02770820|521879256|FG000|Overall Study|Physician Decision|2|||
144732962|NCT00301366|521879257|FG000|Overall Study|Adverse Event|1|||
144732963|NCT00552669|521879260|FG000|Overall Study|Death|3|||
144732964|NCT00552669|521879261|FG001|Overall Study|Death|7|||
144215053|NCT02215967|519979984|FG002|Overall Study|Patient became ineligible for treatment|0|||
144215054|NCT02215967|519979985|FG003|Overall Study|Patient became ineligible for treatment|3|||
144215055|NCT02215967|519979982|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
144215056|NCT02215967|519979983|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
144215057|NCT02215967|519979984|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
144215058|NCT02215967|519979985|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
144215059|NCT01954745|519979986|FG000|Overall Study|Radiological Progression|11|||
144215060|NCT01954745|519979986|FG000|Overall Study|Clinical Progression|5|||
144215061|NCT01954745|519979986|FG000|Overall Study|Adverse Event|2|||
144215062|NCT01954745|519979986|FG000|Overall Study|Death|1|||
144215063|NCT00352417|519979990|FG000|Overall Study|Adverse Event|1|||
144215064|NCT00352417|519979991|FG001|Overall Study|Adverse Event|0|||
144215065|NCT00352417|519979990|FG000|Overall Study|Protocol Violation|0|||
144215066|NCT00352417|519979991|FG001|Overall Study|Protocol Violation|2|||
144215067|NCT00352417|519979990|FG000|Overall Study|Withdrawal by Subject|1|||
144215068|NCT00352417|519979991|FG001|Overall Study|Withdrawal by Subject|2|||
144215069|NCT00352417|519979990|FG000|Overall Study|Lost to Follow-up|1|||
144215070|NCT00352417|519979991|FG001|Overall Study|Lost to Follow-up|0|||
144732965|NCT03195491|521879262|FG000|Overall Study|Study drug toxicity|25|||
144732966|NCT03195491|521879263|FG001|Overall Study|Study drug toxicity|3|||
144732967|NCT03195491|521879262|FG000|Overall Study|Maximum clinical benefit|5|||
144732968|NCT03195491|521879263|FG001|Overall Study|Maximum clinical benefit|0|||
144732969|NCT03195491|521879262|FG000|Overall Study|Lost to Follow-up|1|||
144732970|NCT03195491|521879263|FG001|Overall Study|Lost to Follow-up|0|||
144732971|NCT03195491|521879262|FG000|Overall Study|Death|3|||
144732972|NCT03195491|521879263|FG001|Overall Study|Death|0|||
144732973|NCT03195491|521879262|FG000|Overall Study|Adverse event unrelated to study drug|19|||
144732974|NCT03195491|521879263|FG001|Overall Study|Adverse event unrelated to study drug|2|||
144215071|NCT00352417|519979990|FG000|Overall Study|Schedule Change|2|||
144215072|NCT00352417|519979991|FG001|Overall Study|Schedule Change|1|||
144215073|NCT04460885|519981601|FG000|Overall Study|Withdrawal by Subject|6|||
144215074|NCT04460885|519981602|FG001|Overall Study|Withdrawal by Subject|8|||
144215075|NCT04460885|519981601|FG000|Overall Study|Site closure|1|||
144215076|NCT04460885|519981602|FG001|Overall Study|Site closure|0|||
144215077|NCT04460885|519981601|FG000|Overall Study|Death|5|||
144215078|NCT04460885|519981602|FG001|Overall Study|Death|4|||
144215079|NCT04460885|519981601|FG000|Overall Study|Physician Decision|2|||
144215080|NCT04460885|519981602|FG001|Overall Study|Physician Decision|1|||
144732975|NCT03195491|521879262|FG000|Overall Study|Disease progression|266|||
144732976|NCT03195491|521879263|FG001|Overall Study|Disease progression|8|||
144732977|NCT03195491|521879262|FG000|Overall Study|Other reasons|10|||
144732978|NCT03195491|521879263|FG001|Overall Study|Other reasons|0|||
144732979|NCT03195491|521879262|FG000|Overall Study|Participant withdrew consent|8|||
144732980|NCT03195491|521879263|FG001|Overall Study|Participant withdrew consent|1|||
144732981|NCT03195491|521879262|FG000|Overall Study|Participant no longer meets study criteria|0|||
144215081|NCT04460885|519981601|FG000|Overall Study|Lost to Follow-up|4|||
144215082|NCT04460885|519981602|FG001|Overall Study|Lost to Follow-up|4|||
144215083|NCT04205812|519981603|FG000|Randomized Treatment Period|Ongoing|28|||
144215084|NCT04205812|519981604|FG001|Randomized Treatment Period|Ongoing|138|||
144215085|NCT04205812|519981603|FG000|Randomized Treatment Period|Death|94|||
144215086|NCT04205812|519981604|FG001|Randomized Treatment Period|Death|226|||
144215087|NCT04205812|519981603|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
144215088|NCT04205812|519981604|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
144215089|NCT04205812|519981603|FG000|Randomized Treatment Period|Physician Decision|1|||
144215090|NCT04205812|519981604|FG001|Randomized Treatment Period|Physician Decision|4|||
144660716|NCT01098461|521608758|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
144660717|NCT01098461|521608759|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
144660718|NCT01098461|521608760|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
144660719|NCT01098461|521608761|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
144660720|NCT01098461|521608758|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
144660721|NCT01098461|521608759|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
144660722|NCT01098461|521608760|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
144660723|NCT01098461|521608761|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
144660724|NCT01098461|521608758|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
144660725|NCT01098461|521608759|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
144660726|NCT01098461|521608760|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
144660727|NCT01098461|521608761|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
144660728|NCT01098461|521608758|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
144660729|NCT01098461|521608759|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
144660730|NCT01098461|521608760|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
144660731|NCT01098461|521608761|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
144660732|NCT01098461|521608758|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
144660733|NCT01098461|521608759|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
144660734|NCT01098461|521608760|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
144660735|NCT01098461|521608761|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
144660736|NCT01098461|521608758|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
144660737|NCT01098461|521608759|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
144660738|NCT01098461|521608760|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
144660739|NCT01098461|521608761|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
144660740|NCT01098461|521608758|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
144660741|NCT01098461|521608759|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
144660742|NCT01098461|521608760|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
144660743|NCT01098461|521608761|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
144660744|NCT01474746|521608764|FG000|Overall Study|Lost to Follow-up|1|||
144660745|NCT01474746|521608765|FG001|Overall Study|Lost to Follow-up|1|||
144660746|NCT01474746|521608764|FG000|Overall Study|Withdrawal by Subject|2|||
144660747|NCT01474746|521608765|FG001|Overall Study|Withdrawal by Subject|1|||
144660748|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
144660749|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
144660750|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Death|2|||
144660751|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Death|1|||
144660752|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
144660753|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
144660754|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
144660755|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
144660756|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
144660757|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
144660758|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
144660759|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
144660760|NCT03633227|521608766|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
144660761|NCT03633227|521608767|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
144660762|NCT03633227|521608766|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
144660763|NCT03633227|521608767|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
144660764|NCT03633227|521608766|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
144660765|NCT03633227|521608767|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
144660766|NCT03633227|521608766|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
144660767|NCT03633227|521608767|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
144660768|NCT03633227|521608766|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
144660769|NCT03633227|521608767|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
144660770|NCT03633227|521608766|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
144660771|NCT03633227|521608767|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
144660772|NCT01766336|521608776|FG000|Overall Study|Adverse Event|11|||
144660773|NCT01766336|521608777|FG001|Overall Study|Adverse Event|8|||
144660774|NCT01766336|521608776|FG000|Overall Study|Death|4|||
144660775|NCT01766336|521608777|FG001|Overall Study|Death|3|||
144660776|NCT01766336|521608776|FG000|Overall Study|Lost to Follow-up|1|||
144660777|NCT01766336|521608777|FG001|Overall Study|Lost to Follow-up|3|||
144660778|NCT01766336|521608776|FG000|Overall Study|Physician Decision|4|||
144660779|NCT01766336|521608777|FG001|Overall Study|Physician Decision|2|||
144660780|NCT01766336|521608776|FG000|Overall Study|Protocol Violation|0|||
144660781|NCT01766336|521608777|FG001|Overall Study|Protocol Violation|1|||
144660782|NCT01766336|521608776|FG000|Overall Study|Sponsor Decision|52|||
144265234|NCT02864407|520171737|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
144215091|NCT04205812|519981603|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
144265235|NCT02864407|520171737|FG000|Overall Study|Consent prior to the contract date|1|||
144265236|NCT02287038|520171747|FG000|Overall Study|Stopped attending appointments|3|||
144265237|NCT02287038|520171748|FG001|Overall Study|Stopped attending appointments|2|||
144265238|NCT02287038|520171747|FG000|Overall Study|Anxiety after starting medication|0|||
144265239|NCT02287038|520171748|FG001|Overall Study|Anxiety after starting medication|1|||
144265240|NCT02287038|520171747|FG000|Overall Study|Nausea after starting medication|1|||
144265241|NCT02287038|520171748|FG001|Overall Study|Nausea after starting medication|0|||
144265242|NCT02287038|520171747|FG000|Overall Study|Abnormal ECG after starting medication|1|||
144265243|NCT02287038|520171748|FG001|Overall Study|Abnormal ECG after starting medication|0|||
144265244|NCT05502302|520171756|FG000|Overall Study|Lost to Follow-up|6|||
144265245|NCT05502302|520171756|FG000|Overall Study|Death|2|||
144660783|NCT01766336|521608777|FG001|Overall Study|Sponsor Decision|43|||
144660784|NCT01766336|521608776|FG000|Overall Study|Withdrawal by Subject|18|||
144660785|NCT01766336|521608777|FG001|Overall Study|Withdrawal by Subject|15|||
144660786|NCT02605447|521608779|FG000|Overall Study|Death|66|||
144660787|NCT02605447|521608779|FG000|Overall Study|Physician Decision|1|||
144660788|NCT02605447|521608779|FG000|Overall Study|Lost to Follow-up|24|||
144660789|NCT02605447|521608779|FG000|Overall Study|Withdrawal by Subject|10|||
144660790|NCT02605447|521608779|FG000|Overall Study|Not disclosed|1|||
144660791|NCT01479374|521608780|FG000|Overall Study|Adverse Event|2|||
144660792|NCT01479374|521608781|FG001|Overall Study|Adverse Event|1|||
144660793|NCT01479374|521608782|FG002|Overall Study|Adverse Event|0|||
144660794|NCT01479374|521608780|FG000|Overall Study|Lost to Follow-up|1|||
144660795|NCT01479374|521608781|FG001|Overall Study|Lost to Follow-up|2|||
144660796|NCT01479374|521608782|FG002|Overall Study|Lost to Follow-up|0|||
144660797|NCT01479374|521608780|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
144660798|NCT01479374|521608781|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
144660799|NCT01479374|521608782|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
144660800|NCT01479374|521608780|FG000|Overall Study|Other|0|||
144660801|NCT01479374|521608781|FG001|Overall Study|Other|4|||
144660802|NCT01479374|521608782|FG002|Overall Study|Other|5|||
144660803|NCT01606761|521608783|FG000|Prior to Week 24|Lost to Follow-up|0|||
144660804|NCT01606761|521608784|FG001|Prior to Week 24|Lost to Follow-up|3|||
144660805|NCT01606761|521608785|FG002|Prior to Week 24|Lost to Follow-up|2|||
144660806|NCT01606761|521608786|FG003|Prior to Week 24|Lost to Follow-up|0|||
144660807|NCT01606761|521608787|FG004|Prior to Week 24|Lost to Follow-up|0|||
144660808|NCT01606761|521608783|FG000|Prior to Week 24|Withdrawal by Subject|12|||
144660809|NCT01606761|521608784|FG001|Prior to Week 24|Withdrawal by Subject|10|||
144660810|NCT01606761|521608785|FG002|Prior to Week 24|Withdrawal by Subject|9|||
144660811|NCT01606761|521608786|FG003|Prior to Week 24|Withdrawal by Subject|0|||
144660812|NCT01606761|521608787|FG004|Prior to Week 24|Withdrawal by Subject|0|||
144660813|NCT01606761|521608783|FG000|Prior to Week 24|Adverse Event|11|||
144660814|NCT01606761|521608784|FG001|Prior to Week 24|Adverse Event|18|||
144660815|NCT01606761|521608785|FG002|Prior to Week 24|Adverse Event|22|||
144660816|NCT01606761|521608786|FG003|Prior to Week 24|Adverse Event|0|||
144660817|NCT01606761|521608787|FG004|Prior to Week 24|Adverse Event|0|||
144660818|NCT01606761|521608783|FG000|Prior to Week 24|Lack of Efficacy|15|||
144660819|NCT01606761|521608784|FG001|Prior to Week 24|Lack of Efficacy|14|||
144660820|NCT01606761|521608785|FG002|Prior to Week 24|Lack of Efficacy|8|||
144660821|NCT01606761|521608786|FG003|Prior to Week 24|Lack of Efficacy|0|||
144660822|NCT01606761|521608787|FG004|Prior to Week 24|Lack of Efficacy|0|||
144660823|NCT01606761|521608783|FG000|Prior to Week 24|Physician Decision|0|||
144660824|NCT01606761|521608784|FG001|Prior to Week 24|Physician Decision|3|||
144660825|NCT01606761|521608785|FG002|Prior to Week 24|Physician Decision|1|||
144660826|NCT01606761|521608786|FG003|Prior to Week 24|Physician Decision|0|||
144660827|NCT01606761|521608787|FG004|Prior to Week 24|Physician Decision|0|||
144660828|NCT01606761|521608783|FG000|Prior to Week 24|Other|4|||
144215092|NCT04205812|519981604|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
144215093|NCT04205812|519981603|FG000|Randomized Treatment Period|Progressive Disease|0|||
144215094|NCT04205812|519981604|FG001|Randomized Treatment Period|Progressive Disease|1|||
144215095|NCT04205812|519981603|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
144215096|NCT04205812|519981604|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
144215097|NCT04205812|519981603|FG000|Monotherapy Treatment Period|Ongoing|17|||
144215098|NCT04205812|519981604|FG001|Monotherapy Treatment Period|Ongoing|0|||
144265246|NCT02155985|520171765|FG000|Overall Study|Withdrawal by Subject|0|||
144660829|NCT01606761|521608784|FG001|Prior to Week 24|Other|7|||
144660830|NCT01606761|521608785|FG002|Prior to Week 24|Other|5|||
144660831|NCT01606761|521608786|FG003|Prior to Week 24|Other|0|||
144660832|NCT01606761|521608787|FG004|Prior to Week 24|Other|0|||
144660833|NCT01606761|521608783|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
144660834|NCT01606761|521608784|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
144660835|NCT01606761|521608785|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
144660836|NCT01606761|521608786|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
144660837|NCT01606761|521608787|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
144215099|NCT04205812|519981603|FG000|Monotherapy Treatment Period|Death|39|||
144215100|NCT04205812|519981604|FG001|Monotherapy Treatment Period|Death|0|||
144215101|NCT04205812|519981603|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
144215102|NCT04205812|519981604|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
144215103|NCT04205812|519981603|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
144215104|NCT04205812|519981604|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
144215105|NCT05929651|519981609|FG000|Overall Study|Protocol Deviation|1|||
144215106|NCT05929651|519981609|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
144215107|NCT05026177|519981610|FG000|Overall Study|Adverse Event|33|||
144215108|NCT05026177|519981611|FG001|Overall Study|Adverse Event|33|||
144215109|NCT05026177|519981612|FG002|Overall Study|Adverse Event|17|||
144215110|NCT05026177|519981610|FG000|Overall Study|Lost to Follow-up|7|||
144215111|NCT05026177|519981611|FG001|Overall Study|Lost to Follow-up|6|||
144215112|NCT05026177|519981612|FG002|Overall Study|Lost to Follow-up|8|||
144215113|NCT05026177|519981610|FG000|Overall Study|Noncompliance with study drug|6|||
144215114|NCT05026177|519981611|FG001|Overall Study|Noncompliance with study drug|2|||
144215115|NCT05026177|519981612|FG002|Overall Study|Noncompliance with study drug|1|||
144215116|NCT05026177|519981610|FG000|Overall Study|Physician Decision|4|||
144215117|NCT05026177|519981611|FG001|Overall Study|Physician Decision|1|||
144215118|NCT05026177|519981612|FG002|Overall Study|Physician Decision|0|||
144215119|NCT05026177|519981610|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
144215120|NCT05026177|519981611|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
144215121|NCT05026177|519981612|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
144215122|NCT05026177|519981610|FG000|Overall Study|Withdrawal by Subject|53|||
144215123|NCT05026177|519981611|FG001|Overall Study|Withdrawal by Subject|51|||
144215124|NCT05026177|519981612|FG002|Overall Study|Withdrawal by Subject|55|||
144215125|NCT05026177|519981610|FG000|Overall Study|Protocol Violation|0|||
144215126|NCT05026177|519981611|FG001|Overall Study|Protocol Violation|1|||
144215127|NCT05026177|519981612|FG002|Overall Study|Protocol Violation|0|||
144215128|NCT05026177|519981610|FG000|Overall Study|Study terminated by sponsor|70|||
144215129|NCT05026177|519981611|FG001|Overall Study|Study terminated by sponsor|74|||
144215130|NCT05026177|519981612|FG002|Overall Study|Study terminated by sponsor|67|||
144215131|NCT05026177|519981610|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
144215132|NCT05026177|519981611|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
144215133|NCT05026177|519981612|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
144215134|NCT05026177|519981610|FG000|Overall Study|Starting alternative treatment|0|||
144215135|NCT05026177|519981611|FG001|Overall Study|Starting alternative treatment|1|||
144215136|NCT05026177|519981612|FG002|Overall Study|Starting alternative treatment|1|||
144215137|NCT05026177|519981610|FG000|Overall Study|Noncompliance with study procedures|0|||
144215138|NCT05026177|519981611|FG001|Overall Study|Noncompliance with study procedures|1|||
144215139|NCT05026177|519981612|FG002|Overall Study|Noncompliance with study procedures|1|||
144215140|NCT05026177|519981610|FG000|Overall Study|Met stopping criteria|0|||
144215141|NCT05026177|519981611|FG001|Overall Study|Met stopping criteria|0|||
144215142|NCT05026177|519981612|FG002|Overall Study|Met stopping criteria|1|||
144215143|NCT05026177|519981610|FG000|Overall Study|Health issues preventing continuation|0|||
144215144|NCT05026177|519981611|FG001|Overall Study|Health issues preventing continuation|0|||
144215145|NCT05026177|519981612|FG002|Overall Study|Health issues preventing continuation|1|||
144215146|NCT05026177|519981610|FG000|Overall Study|Randomized in error, not treated|0|||
144215147|NCT05026177|519981611|FG001|Overall Study|Randomized in error, not treated|0|||
144215148|NCT05026177|519981612|FG002|Overall Study|Randomized in error, not treated|2|||
144586932|NCT00998790|521346963|FG000|Overall Study|Withdrawal by Subject|21|||
144586933|NCT01080716|521346964|FG000|Part 1|Physician Decision|1|||
144586934|NCT01080716|521346965|FG001|Part 1|Physician Decision|0|||
144586935|NCT01080716|521346966|FG002|Part 1|Physician Decision|0|||
144586936|NCT01080716|521346967|FG003|Part 1|Physician Decision|0|||
144586937|NCT01993927|521346968|FG000|Overall Study|Case Report Forms Uncollected|18|||
144586938|NCT01993927|521346968|FG000|Overall Study|Protocol Violation|11|||
144586939|NCT00895154|521346969|FG000|Overall Study|Lost to Follow-up|1|||
144586940|NCT00895154|521346970|FG001|Overall Study|Lost to Follow-up|1|||
144586941|NCT00895154|521346969|FG000|Overall Study|Withdrawal by Subject|0|||
144586942|NCT00895154|521346970|FG001|Overall Study|Withdrawal by Subject|1|||
144586943|NCT00287690|521346971|FG000|Overall Study|Protocol Violation|20|||
144586944|NCT00287690|521346972|FG001|Overall Study|Protocol Violation|26|||
144586945|NCT01146782|521346973|FG000|Screening Cohort|Screen Failure|187|||
144586946|NCT01146782|521346973|FG000|Screening Cohort|Lost to Follow-up|4|||
144586947|NCT01146782|521346973|FG000|Screening Cohort|Physician Decision|1|||
144586948|NCT01146782|521346973|FG000|Screening Cohort|Withdrawal by Subject|29|||
144586949|NCT01146782|521346973|FG000|Safety Cohort|Screen Failure|61|||
144586950|NCT01146782|521346973|FG000|Safety Cohort|Withdrawal by Subject|4|||
144586951|NCT01146782|521346973|FG000|Safety Cohort|Control AHI <5|4|||
144586952|NCT01146782|521346973|FG000|Safety Cohort|TST <4 hrs|14|||
144586953|NCT01146782|521346973|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
144586954|NCT01146782|521346973|FG000|Primary Endpoint Cohort|Physician Decision|1|||
144660838|NCT01606761|521608783|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
144660839|NCT01606761|521608784|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
144660840|NCT01606761|521608785|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
144660841|NCT01606761|521608786|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
144660842|NCT01606761|521608787|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
144660843|NCT01606761|521608783|FG000|Week 24 to Week 52|Adverse Event|0|||
144660844|NCT01606761|521608784|FG001|Week 24 to Week 52|Adverse Event|11|||
144660845|NCT01606761|521608785|FG002|Week 24 to Week 52|Adverse Event|14|||
144660846|NCT01606761|521608786|FG003|Week 24 to Week 52|Adverse Event|3|||
144660847|NCT01606761|521608787|FG004|Week 24 to Week 52|Adverse Event|15|||
144660848|NCT01606761|521608783|FG000|Week 24 to Week 52|Death|0|||
144660849|NCT01606761|521608784|FG001|Week 24 to Week 52|Death|0|||
144660850|NCT01606761|521608785|FG002|Week 24 to Week 52|Death|2|||
144660851|NCT01606761|521608786|FG003|Week 24 to Week 52|Death|1|||
144660852|NCT01606761|521608787|FG004|Week 24 to Week 52|Death|0|||
144660853|NCT01606761|521608783|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
144660854|NCT01606761|521608784|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
144660855|NCT01606761|521608785|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
144660856|NCT01606761|521608786|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
144660857|NCT01606761|521608787|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
144660858|NCT01606761|521608783|FG000|Week 24 to Week 52|Physician Decision|0|||
144660859|NCT01606761|521608784|FG001|Week 24 to Week 52|Physician Decision|1|||
144660860|NCT01606761|521608785|FG002|Week 24 to Week 52|Physician Decision|1|||
144660861|NCT01606761|521608786|FG003|Week 24 to Week 52|Physician Decision|0|||
144660862|NCT01606761|521608787|FG004|Week 24 to Week 52|Physician Decision|0|||
144660863|NCT01606761|521608783|FG000|Week 24 to Week 52|Other|0|||
144660864|NCT01606761|521608784|FG001|Week 24 to Week 52|Other|1|||
144660865|NCT01606761|521608785|FG002|Week 24 to Week 52|Other|5|||
144660866|NCT01606761|521608786|FG003|Week 24 to Week 52|Other|2|||
144660867|NCT01606761|521608787|FG004|Week 24 to Week 52|Other|2|||
144660868|NCT01606761|521608783|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
144660869|NCT01606761|521608784|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
144660870|NCT01606761|521608785|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
144660871|NCT01606761|521608786|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
144660872|NCT01606761|521608787|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
144660873|NCT01606761|521608783|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
144660874|NCT01606761|521608784|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
144660875|NCT01606761|521608785|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
144660876|NCT01606761|521608786|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
144660877|NCT01606761|521608787|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
144660878|NCT01606761|521608783|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
144660879|NCT01606761|521608784|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
144586955|NCT00470366|521346974|FG000|Overall Study|Adverse Event|3|||
144586956|NCT00470366|521346974|FG000|Overall Study|Poor compliance|1|||
144660880|NCT01606761|521608785|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
144660881|NCT01606761|521608786|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
144660882|NCT01606761|521608787|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
144660883|NCT01606761|521608783|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
144660884|NCT01606761|521608784|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
144660885|NCT01606761|521608785|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
144660886|NCT01606761|521608786|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
144660887|NCT01606761|521608787|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
144660888|NCT05086289|521608788|FG000|Overall Study|Adverse Event|4|||
144660889|NCT05086289|521608789|FG001|Overall Study|Adverse Event|2|||
144586957|NCT03562975|521346984|FG000|Overall Study|Death|1|||
144586958|NCT03562975|521346984|FG000|Overall Study|Lost to Follow-up|1|||
144586959|NCT03562975|521346984|FG000|Overall Study|Withdrawal by Subject|1|||
144586960|NCT01758900|521346989|FG000|Overall Study|difficulty for further intubation|7|||
144586961|NCT01758900|521346990|FG001|Overall Study|difficulty for further intubation|8|||
144586962|NCT00935818|521346992|FG000|Overall Study|Withdrawal by Subject|45|||
144586963|NCT00935818|521346993|FG001|Overall Study|Withdrawal by Subject|50|||
144586964|NCT00935818|521346992|FG000|Overall Study|Lost to Follow-up|40|||
144586965|NCT00935818|521346993|FG001|Overall Study|Lost to Follow-up|42|||
144586966|NCT00935818|521346992|FG000|Overall Study|Adverse Event|6|||
144586967|NCT00935818|521346993|FG001|Overall Study|Adverse Event|7|||
144586968|NCT00935818|521346992|FG000|Overall Study|Physician Decision|0|||
144586969|NCT00935818|521346993|FG001|Overall Study|Physician Decision|1|||
144586970|NCT05559476|521346996|FG000|Overall Study|Adverse Event|2|||
144586971|NCT05559476|521346997|FG001|Overall Study|Adverse Event|0|||
144586972|NCT05559476|521346996|FG000|Overall Study|Lost to Follow-up|13|||
144586973|NCT05559476|521346997|FG001|Overall Study|Lost to Follow-up|12|||
144586974|NCT05559476|521346996|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
144586975|NCT05559476|521346997|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
144586976|NCT05559476|521346996|FG000|Overall Study|Other|0|||
144586977|NCT05559476|521346997|FG001|Overall Study|Other|2|||
144660890|NCT05086289|521608788|FG000|Overall Study|Lost to Follow-up|2|||
144660891|NCT05086289|521608789|FG001|Overall Study|Lost to Follow-up|0|||
144660892|NCT05086289|521608788|FG000|Overall Study|Non-compliance with study drug|2|||
144660893|NCT05086289|521608789|FG001|Overall Study|Non-compliance with study drug|1|||
144660894|NCT05086289|521608788|FG000|Overall Study|Physician Decision|2|||
144660895|NCT05086289|521608789|FG001|Overall Study|Physician Decision|0|||
144660896|NCT05086289|521608788|FG000|Overall Study|Withdrawal by Subject|5|||
144660897|NCT05086289|521608789|FG001|Overall Study|Withdrawal by Subject|2|||
144660898|NCT02045212|521608791|FG000|Overall Study|Adverse Event|0|||
144660899|NCT02045212|521608792|FG001|Overall Study|Adverse Event|1|||
144660900|NCT02045212|521608791|FG000|Overall Study|Withdrawal by Subject|1|||
144660901|NCT02045212|521608792|FG001|Overall Study|Withdrawal by Subject|0|||
144660902|NCT02045212|521608791|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
144660903|NCT02045212|521608792|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
144660904|NCT00515008|521608798|FG000|Overall Study|Lost to Follow-up|1|||
144660905|NCT00515008|521608799|FG001|Overall Study|Lost to Follow-up|0|||
144660906|NCT00515008|521608798|FG000|Overall Study|Declined|0|||
144660907|NCT00515008|521608799|FG001|Overall Study|Declined|3|||
144660908|NCT00515008|521608798|FG000|Overall Study|Left the Boston Area|1|||
144660909|NCT00515008|521608799|FG001|Overall Study|Left the Boston Area|1|||
144660910|NCT00515008|521608798|FG000|Overall Study|Scheduling conflict|1|||
144660911|NCT00515008|521608799|FG001|Overall Study|Scheduling conflict|0|||
144660912|NCT03135028|521608800|FG000|Overall Study|Death|6|||
144660913|NCT03135028|521608800|FG000|Overall Study|Study Terminated by Sponsor|2|||
144660914|NCT03135028|521608800|FG000|Overall Study|Withdrew Consent|1|||
144660915|NCT01814800|521608803|FG000|Overall Study|Adverse Event|2|||
144660916|NCT01814800|521608803|FG000|Overall Study|Pregnancy|1|||
144660917|NCT01814800|521608803|FG000|Overall Study|Sponsor decision|1|||
144660918|NCT01814800|521608803|FG000|Overall Study|Subject relocation|1|||
144660919|NCT02371759|521608804|FG000|Overall Study|Protocol Violation|3|||
144660920|NCT02371759|521608805|FG001|Overall Study|Protocol Violation|1|||
144660921|NCT02371759|521608806|FG002|Overall Study|Protocol Violation|1|||
144660922|NCT02371759|521608807|FG003|Overall Study|Protocol Violation|0|||
144660923|NCT02371759|521608808|FG004|Overall Study|Protocol Violation|3|||
144215181|NCT02731638|519981619|FG000|Overall Study|Lost to Follow-up|6|||
144215182|NCT02731638|519981620|FG001|Overall Study|Lost to Follow-up|9|||
144215183|NCT02454608|519981621|FG000|Double-Blind Period|Lack of Efficacy|0|||
144660924|NCT02371759|521608809|FG005|Overall Study|Protocol Violation|1|||
144660925|NCT02371759|521608810|FG006|Overall Study|Protocol Violation|0|||
144215184|NCT02454608|519981622|FG001|Double-Blind Period|Lack of Efficacy|2|||
144215185|NCT02454608|519981623|FG002|Double-Blind Period|Lack of Efficacy|0|||
144660926|NCT02371759|521608811|FG007|Overall Study|Protocol Violation|3|||
144660927|NCT02371759|521608804|FG000|Overall Study|Withdrawal by Subject|0|||
144660928|NCT02371759|521608805|FG001|Overall Study|Withdrawal by Subject|0|||
144660929|NCT02371759|521608806|FG002|Overall Study|Withdrawal by Subject|0|||
144660930|NCT02371759|521608807|FG003|Overall Study|Withdrawal by Subject|0|||
144660931|NCT02371759|521608808|FG004|Overall Study|Withdrawal by Subject|0|||
144660932|NCT02371759|521608809|FG005|Overall Study|Withdrawal by Subject|0|||
144660933|NCT02371759|521608810|FG006|Overall Study|Withdrawal by Subject|0|||
144660934|NCT02371759|521608811|FG007|Overall Study|Withdrawal by Subject|1|||
144660935|NCT03375112|521608817|FG000|Overall Study|Withdrawal by Subject|3|||
144660936|NCT03375112|521608818|FG001|Overall Study|Withdrawal by Subject|0|||
144660937|NCT00243230|521608819|FG000|Double-Blind Period|Adverse Event|0|||
144660938|NCT00243230|521608820|FG001|Double-Blind Period|Adverse Event|2|||
144660939|NCT00243230|521608821|FG002|Double-Blind Period|Adverse Event|2|||
144660940|NCT00243230|521608822|FG003|Double-Blind Period|Adverse Event|0|||
144660941|NCT00243230|521608819|FG000|Double-Blind Period|Withdrawal by Subject|1|||
144660942|NCT00243230|521608820|FG001|Double-Blind Period|Withdrawal by Subject|0|||
144660943|NCT00243230|521608821|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144660944|NCT00243230|521608822|FG003|Double-Blind Period|Withdrawal by Subject|0|||
144215186|NCT02454608|519981621|FG000|Open Label Period|Lost to Follow-up|0|||
144215187|NCT02454608|519981622|FG001|Open Label Period|Lost to Follow-up|0|||
144215188|NCT02454608|519981623|FG002|Open Label Period|Lost to Follow-up|11|||
144215189|NCT02454608|519981621|FG000|Open Label Period|Withdrawal by Subject|0|||
144215190|NCT02454608|519981622|FG001|Open Label Period|Withdrawal by Subject|0|||
144215191|NCT02454608|519981623|FG002|Open Label Period|Withdrawal by Subject|8|||
144215192|NCT02717455|519981624|FG000|Overall Study|Adverse Event|1|||
144215193|NCT02717455|519981625|FG001|Overall Study|Adverse Event|0|||
144215194|NCT02717455|519981626|FG002|Overall Study|Adverse Event|0|||
144215195|NCT02717455|519981627|FG003|Overall Study|Adverse Event|2|||
144215196|NCT02717455|519981628|FG004|Overall Study|Adverse Event|2|||
144660945|NCT00243230|521608819|FG000|Double-Blind Period|Protocol Violation|0|||
144215197|NCT02717455|519981629|FG005|Overall Study|Adverse Event|2|||
144215198|NCT02717455|519981624|FG000|Overall Study|Withdrawal by Subject|1|||
144215199|NCT02717455|519981625|FG001|Overall Study|Withdrawal by Subject|1|||
144660946|NCT00243230|521608820|FG001|Double-Blind Period|Protocol Violation|0|||
144660947|NCT00243230|521608821|FG002|Double-Blind Period|Protocol Violation|1|||
144660948|NCT00243230|521608822|FG003|Double-Blind Period|Protocol Violation|0|||
144660949|NCT00243230|521608819|FG000|Double-Blind Period|Randomized but Not Treated|0|||
144660950|NCT00243230|521608820|FG001|Double-Blind Period|Randomized but Not Treated|0|||
144660951|NCT00243230|521608821|FG002|Double-Blind Period|Randomized but Not Treated|2|||
144660952|NCT00243230|521608822|FG003|Double-Blind Period|Randomized but Not Treated|0|||
144660953|NCT00243230|521608819|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
144660954|NCT00243230|521608820|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
144660955|NCT00243230|521608821|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
144660956|NCT00243230|521608822|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
144660957|NCT00243230|521608819|FG000|Open Label Period|Adverse Event|0|||
144660958|NCT00243230|521608820|FG001|Open Label Period|Adverse Event|0|||
144660959|NCT00243230|521608821|FG002|Open Label Period|Adverse Event|0|||
144660960|NCT00243230|521608822|FG003|Open Label Period|Adverse Event|2|||
144660961|NCT00243230|521608819|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
144660962|NCT00243230|521608820|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
144660963|NCT00243230|521608821|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
144660964|NCT00243230|521608822|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
144660965|NCT00243230|521608819|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
144660966|NCT00243230|521608820|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
144660967|NCT00243230|521608821|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
144660968|NCT00243230|521608822|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
144660969|NCT00243230|521608819|FG000|Open Label Period|Lost to Follow-up|0|||
144660970|NCT00243230|521608820|FG001|Open Label Period|Lost to Follow-up|0|||
144660971|NCT00243230|521608821|FG002|Open Label Period|Lost to Follow-up|0|||
144660972|NCT00243230|521608822|FG003|Open Label Period|Lost to Follow-up|2|||
144660973|NCT00243230|521608819|FG000|Open Label Period|Withdrawal by Subject|0|||
144660974|NCT00243230|521608820|FG001|Open Label Period|Withdrawal by Subject|0|||
144660975|NCT00243230|521608821|FG002|Open Label Period|Withdrawal by Subject|0|||
144660976|NCT00243230|521608822|FG003|Open Label Period|Withdrawal by Subject|2|||
144660977|NCT00243230|521608819|FG000|Open Label Period|Protocol Violation|0|||
144660978|NCT00243230|521608820|FG001|Open Label Period|Protocol Violation|0|||
144660979|NCT00243230|521608821|FG002|Open Label Period|Protocol Violation|0|||
144660980|NCT00243230|521608822|FG003|Open Label Period|Protocol Violation|2|||
144660981|NCT00243230|521608819|FG000|Open Label Period|Administrative Reason|0|||
144660982|NCT00243230|521608820|FG001|Open Label Period|Administrative Reason|0|||
144660983|NCT00243230|521608821|FG002|Open Label Period|Administrative Reason|0|||
144660984|NCT00243230|521608822|FG003|Open Label Period|Administrative Reason|63|||
144660985|NCT03136185|521608825|FG000|Overall Study|Adverse Event|0|||
144660986|NCT03136185|521608826|FG001|Overall Study|Adverse Event|1|||
144660987|NCT03136185|521608827|FG002|Overall Study|Adverse Event|3|||
144660988|NCT03136185|521608828|FG003|Overall Study|Adverse Event|1|||
144660989|NCT03136185|521608829|FG004|Overall Study|Adverse Event|2|||
144660990|NCT03136185|521608830|FG005|Overall Study|Adverse Event|2|||
144660991|NCT03136185|521608831|FG006|Overall Study|Adverse Event|5|||
144660992|NCT03136185|521608832|FG007|Overall Study|Adverse Event|1|||
144660993|NCT03136185|521608833|FG008|Overall Study|Adverse Event|1|||
144660994|NCT03136185|521608825|FG000|Overall Study|Death|0|||
144660995|NCT03136185|521608826|FG001|Overall Study|Death|0|||
144660996|NCT03136185|521608827|FG002|Overall Study|Death|0|||
144660997|NCT03136185|521608828|FG003|Overall Study|Death|1|||
144660998|NCT03136185|521608829|FG004|Overall Study|Death|1|||
144660999|NCT03136185|521608830|FG005|Overall Study|Death|0|||
144661000|NCT03136185|521608831|FG006|Overall Study|Death|1|||
144661001|NCT03136185|521608832|FG007|Overall Study|Death|0|||
144661002|NCT03136185|521608833|FG008|Overall Study|Death|0|||
144661003|NCT03136185|521608825|FG000|Overall Study|Physician Decision|3|||
144661004|NCT03136185|521608826|FG001|Overall Study|Physician Decision|1|||
144661005|NCT03136185|521608827|FG002|Overall Study|Physician Decision|1|||
144661006|NCT03136185|521608828|FG003|Overall Study|Physician Decision|2|||
144661007|NCT03136185|521608829|FG004|Overall Study|Physician Decision|1|||
144661008|NCT03136185|521608830|FG005|Overall Study|Physician Decision|2|||
144661009|NCT03136185|521608831|FG006|Overall Study|Physician Decision|1|||
144661010|NCT03136185|521608832|FG007|Overall Study|Physician Decision|0|||
144732982|NCT03195491|521879263|FG001|Overall Study|Participant no longer meets study criteria|1|||
144732983|NCT03195491|521879262|FG000|Overall Study|Participant request to discontinue study treatment|10|||
144661011|NCT03136185|521608833|FG008|Overall Study|Physician Decision|1|||
144661012|NCT03136185|521608825|FG000|Overall Study|Protocol Defined Disease Progression|0|||
144661013|NCT03136185|521608826|FG001|Overall Study|Protocol Defined Disease Progression|0|||
144661014|NCT03136185|521608827|FG002|Overall Study|Protocol Defined Disease Progression|1|||
144661015|NCT03136185|521608828|FG003|Overall Study|Protocol Defined Disease Progression|0|||
144661016|NCT03136185|521608829|FG004|Overall Study|Protocol Defined Disease Progression|0|||
144732984|NCT03195491|521879263|FG001|Overall Study|Participant request to discontinue study treatment|0|||
144732985|NCT01263704|521879264|FG000|Overall Study|Progressive disease|18|||
144661017|NCT03136185|521608830|FG005|Overall Study|Protocol Defined Disease Progression|1|||
144661018|NCT03136185|521608831|FG006|Overall Study|Protocol Defined Disease Progression|0|||
144732986|NCT01263704|521879264|FG000|Overall Study|Adverse Event|3|||
144732987|NCT01263704|521879264|FG000|Overall Study|Death|2|||
144732988|NCT01263704|521879264|FG000|Overall Study|Patient withdrew consent|2|||
144732989|NCT01263704|521879264|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
144732990|NCT01263704|521879264|FG000|Overall Study|Lost to Follow-up|1|||
144732991|NCT01263704|521879264|FG000|Overall Study|Colon metastases|1|||
144732992|NCT01263704|521879264|FG000|Overall Study|Principal Investigator (PI) decision|1|||
144732993|NCT01061866|521879265|FG000|Overall Study|Adverse Event|2|||
144732994|NCT01270503|521879266|FG000|Overall Study|Lost to Follow-up|1|||
144732995|NCT00252720|521879268|FG000|Overall Study|Withdrawal by Subject|95|||
144732996|NCT00252720|521879269|FG001|Overall Study|Withdrawal by Subject|97|||
144732997|NCT00252720|521879268|FG000|Overall Study|Death|7|||
144732998|NCT00252720|521879269|FG001|Overall Study|Death|8|||
144732999|NCT00252720|521879268|FG000|Overall Study|Moving|23|||
144733000|NCT00252720|521879269|FG001|Overall Study|Moving|42|||
144733001|NCT00252720|521879268|FG000|Overall Study|Mainly patients lost to follow-up|7|||
144733002|NCT00252720|521879269|FG001|Overall Study|Mainly patients lost to follow-up|18|||
144215200|NCT02717455|519981626|FG002|Overall Study|Withdrawal by Subject|0|||
144661019|NCT03136185|521608832|FG007|Overall Study|Protocol Defined Disease Progression|1|||
144661020|NCT03136185|521608833|FG008|Overall Study|Protocol Defined Disease Progression|1|||
144661021|NCT03136185|521608825|FG000|Overall Study|Withdrawal by Subject|1|||
144661022|NCT03136185|521608826|FG001|Overall Study|Withdrawal by Subject|0|||
144661023|NCT03136185|521608827|FG002|Overall Study|Withdrawal by Subject|1|||
144661024|NCT03136185|521608828|FG003|Overall Study|Withdrawal by Subject|1|||
144661025|NCT03136185|521608829|FG004|Overall Study|Withdrawal by Subject|1|||
144661026|NCT03136185|521608830|FG005|Overall Study|Withdrawal by Subject|1|||
144661027|NCT03136185|521608831|FG006|Overall Study|Withdrawal by Subject|2|||
144661028|NCT03136185|521608832|FG007|Overall Study|Withdrawal by Subject|3|||
144661029|NCT03136185|521608833|FG008|Overall Study|Withdrawal by Subject|3|||
144661030|NCT03136185|521608825|FG000|Overall Study|Not Reported|4|||
144661031|NCT03136185|521608826|FG001|Overall Study|Not Reported|1|||
144661032|NCT03136185|521608827|FG002|Overall Study|Not Reported|0|||
144661033|NCT03136185|521608828|FG003|Overall Study|Not Reported|1|||
144661034|NCT03136185|521608829|FG004|Overall Study|Not Reported|0|||
144661035|NCT03136185|521608830|FG005|Overall Study|Not Reported|2|||
144661036|NCT03136185|521608831|FG006|Overall Study|Not Reported|1|||
144661037|NCT03136185|521608832|FG007|Overall Study|Not Reported|1|||
144661038|NCT03136185|521608833|FG008|Overall Study|Not Reported|0|||
144661039|NCT03201198|521608836|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
144661040|NCT03201198|521608837|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
144661041|NCT03201198|521608836|FG000|Overall Study|Withdrawal by Subject|2|||
144661042|NCT03201198|521608837|FG001|Overall Study|Withdrawal by Subject|3|||
144661043|NCT03213626|521608838|FG000|Overall Study|Adverse Event|1|||
144661044|NCT03213626|521608838|FG000|Overall Study|Progressive Disease|6|||
144661045|NCT02998554|521608840|FG000|Overall Study|Adverse Event|8|||
144661046|NCT02998554|521608841|FG001|Overall Study|Adverse Event|3|||
144661047|NCT02998554|521608840|FG000|Overall Study|Protocol deviation|1|||
144661048|NCT02998554|521608841|FG001|Overall Study|Protocol deviation|0|||
144661049|NCT02998554|521608840|FG000|Overall Study|Withdrawal by Subject|2|||
144661050|NCT02998554|521608841|FG001|Overall Study|Withdrawal by Subject|6|||
144661051|NCT02998554|521608840|FG000|Overall Study|Lost to Follow-up|0|||
144661052|NCT02998554|521608841|FG001|Overall Study|Lost to Follow-up|1|||
144661053|NCT02998554|521608840|FG000|Overall Study|Lack of Efficacy|0|||
144661054|NCT02998554|521608841|FG001|Overall Study|Lack of Efficacy|1|||
144661055|NCT01454401|521608846|FG000|Overall Study|Death|1|||
144661056|NCT01454401|521608846|FG000|Overall Study|hospitalised|1|||
144215201|NCT02717455|519981627|FG003|Overall Study|Withdrawal by Subject|2|||
144215202|NCT02717455|519981628|FG004|Overall Study|Withdrawal by Subject|2|||
144215203|NCT02717455|519981629|FG005|Overall Study|Withdrawal by Subject|1|||
144215204|NCT02717455|519981624|FG000|Overall Study|Death|1|||
144215205|NCT02717455|519981625|FG001|Overall Study|Death|0|||
144215206|NCT02717455|519981626|FG002|Overall Study|Death|0|||
144215207|NCT02717455|519981627|FG003|Overall Study|Death|0|||
144215208|NCT02717455|519981628|FG004|Overall Study|Death|1|||
144215209|NCT02717455|519981629|FG005|Overall Study|Death|0|||
144215210|NCT02717455|519981624|FG000|Overall Study|Did not receive study drug|0|||
144215211|NCT02717455|519981625|FG001|Overall Study|Did not receive study drug|0|||
144215212|NCT02717455|519981626|FG002|Overall Study|Did not receive study drug|0|||
144215213|NCT02717455|519981627|FG003|Overall Study|Did not receive study drug|1|||
144215214|NCT02717455|519981628|FG004|Overall Study|Did not receive study drug|0|||
144215215|NCT02717455|519981629|FG005|Overall Study|Did not receive study drug|1|||
144215216|NCT02717455|519981624|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
144215217|NCT02717455|519981625|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
144733003|NCT00102440|521879270|FG000|Overall Study|Lost to Follow-up|25|||
144733004|NCT00102440|521879271|FG001|Overall Study|Lost to Follow-up|18|||
144733005|NCT00102440|521879272|FG002|Overall Study|Lost to Follow-up|21|||
144733006|NCT00102440|521879270|FG000|Overall Study|Adverse Event|16|||
144733007|NCT00102440|521879271|FG001|Overall Study|Adverse Event|23|||
144733008|NCT00102440|521879272|FG002|Overall Study|Adverse Event|8|||
144733009|NCT00102440|521879270|FG000|Overall Study|Gout Flare|10|||
144733010|NCT00102440|521879271|FG001|Overall Study|Gout Flare|28|||
144733011|NCT00102440|521879272|FG002|Overall Study|Gout Flare|9|||
144733012|NCT00102440|521879270|FG000|Overall Study|Personal Reason(s)|19|||
144733013|NCT00102440|521879271|FG001|Overall Study|Personal Reason(s)|13|||
144733014|NCT00102440|521879272|FG002|Overall Study|Personal Reason(s)|13|||
144733015|NCT00102440|521879270|FG000|Overall Study|Other|11|||
144733016|NCT00102440|521879271|FG001|Overall Study|Other|14|||
144733017|NCT00102440|521879272|FG002|Overall Study|Other|14|||
144733018|NCT00102440|521879270|FG000|Overall Study|Protocol Violation|7|||
144733019|NCT00102440|521879271|FG001|Overall Study|Protocol Violation|2|||
144733020|NCT00102440|521879272|FG002|Overall Study|Protocol Violation|1|||
144733021|NCT00772941|521879273|FG000|Overall Study|CRFs not available|195|||
144733022|NCT00772941|521879273|FG000|Overall Study|Study not completed|16|||
144733023|NCT00772941|521879273|FG000|Overall Study|Missed Visits|374|||
144733024|NCT00772941|521879273|FG000|Overall Study|Poor Compliance|7|||
144733025|NCT00772941|521879273|FG000|Overall Study|GPSP Violation|90|||
144733026|NCT04786184|521879275|FG000|Overall Study|Adverse Event|4|||
144733027|NCT04786184|521879276|FG001|Overall Study|Adverse Event|0|||
144733028|NCT04786184|521879275|FG000|Overall Study|Withdrawal by Subject|3|||
144733029|NCT04786184|521879276|FG001|Overall Study|Withdrawal by Subject|1|||
144733030|NCT04786184|521879275|FG000|Overall Study|Lost to Follow-up|4|||
144733031|NCT04786184|521879276|FG001|Overall Study|Lost to Follow-up|2|||
144733032|NCT02255097|521879277|FG000|Overall Study|Death|151|||
144733033|NCT02255097|521879277|FG000|Overall Study|Lost to Follow-up|5|||
144733034|NCT02255097|521879277|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
144733035|NCT02255097|521879277|FG000|Overall Study|Withdrawal by Subject|7|||
144733036|NCT02255097|521879277|FG000|Overall Study|Allocated but not treated|1|||
144733037|NCT01010542|521879278|FG000|Overall Study|Adverse Event|0|||
144733038|NCT01010542|521879279|FG001|Overall Study|Adverse Event|1|||
144733039|NCT01010542|521879280|FG002|Overall Study|Adverse Event|0|||
144733040|NCT01010542|521879278|FG000|Overall Study|Lost to Follow-up|0|||
144733041|NCT01010542|521879279|FG001|Overall Study|Lost to Follow-up|1|||
144733042|NCT01010542|521879280|FG002|Overall Study|Lost to Follow-up|0|||
144733043|NCT01010542|521879278|FG000|Overall Study|Withdrawal by Subject|0|||
144733044|NCT01010542|521879279|FG001|Overall Study|Withdrawal by Subject|3|||
144733045|NCT01010542|521879280|FG002|Overall Study|Withdrawal by Subject|2|||
144733046|NCT01745120|521879281|FG000|Overall Study|Investigator decision|1|||
144733047|NCT01745120|521879282|FG001|Overall Study|Investigator decision|0|||
144661057|NCT01454401|521608846|FG000|Overall Study|osteomyelitis|2|||
144661058|NCT01454401|521608846|FG000|Overall Study|non-adherence|1|||
144661059|NCT03675737|521608847|FG000|Overall Study|Death|593|||
144661060|NCT03675737|521608848|FG001|Overall Study|Death|660|||
144661061|NCT03675737|521608847|FG000|Overall Study|Lost to Follow-up|1|||
144661062|NCT03675737|521608848|FG001|Overall Study|Lost to Follow-up|5|||
144661063|NCT03675737|521608847|FG000|Overall Study|Physician Decision|1|||
144661064|NCT03675737|521608848|FG001|Overall Study|Physician Decision|0|||
144661065|NCT03675737|521608847|FG000|Overall Study|Withdrawal by Subject|14|||
144661066|NCT03675737|521608848|FG001|Overall Study|Withdrawal by Subject|12|||
144661067|NCT03675737|521608847|FG000|Overall Study|Ongoing in Study|181|||
144661068|NCT03675737|521608848|FG001|Overall Study|Ongoing in Study|112|||
144661069|NCT00352755|521610092|FG000|Overall Study|Physician Decision|1|||
144661070|NCT00352755|521610092|FG000|Overall Study|Adverse Event|1|||
144661071|NCT00311181|521610093|FG000|Overall Study|Final DFTs were not obtained|96|||
144661072|NCT02397694|521610096|FG000|Double-Blinded Phase|Adverse Event|1|||
144661073|NCT02397694|521610097|FG001|Double-Blinded Phase|Adverse Event|0|||
144661074|NCT02397694|521610096|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
144661075|NCT02397694|521610097|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
144661076|NCT02397694|521610096|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
144661077|NCT02397694|521610097|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
144661078|NCT02397694|521610096|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
144661079|NCT02397694|521610097|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
144661080|NCT02397694|521610096|FG000|Open Label Extension Phase|Protocol Violation|1|||
144661081|NCT02397694|521610097|FG001|Open Label Extension Phase|Protocol Violation|0|||
144733048|NCT01675765|521879283|FG000|Overall Study|Progressive disease|4|||
144661082|NCT02397694|521610096|FG000|Open Label Extension Phase|Withdrew Consent|3|||
144661083|NCT02397694|521610097|FG001|Open Label Extension Phase|Withdrew Consent|1|||
144661084|NCT02397694|521610096|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
144733049|NCT01675765|521879284|FG001|Overall Study|Progressive disease|4|||
144733050|NCT01675765|521879283|FG000|Overall Study|Adverse Event|1|||
144733051|NCT01675765|521879284|FG001|Overall Study|Adverse Event|2|||
144733052|NCT01675765|521879283|FG000|Overall Study|Withdrawal by Subject|2|||
144733053|NCT01675765|521879284|FG001|Overall Study|Withdrawal by Subject|0|||
144733054|NCT01675765|521879283|FG000|Overall Study|Death|1|||
144733055|NCT01675765|521879284|FG001|Overall Study|Death|0|||
144733056|NCT01675765|521879283|FG000|Overall Study|Clinical progression|3|||
144661085|NCT02397694|521610097|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
144661086|NCT02622724|521610099|FG000|Overall Study|Death|51|||
144661087|NCT02622724|521610100|FG001|Overall Study|Death|53|||
144661088|NCT02622724|521610099|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
144661089|NCT02622724|521610100|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
144265247|NCT02155985|520171766|FG001|Overall Study|Withdrawal by Subject|0|||
144265248|NCT02155985|520171767|FG002|Overall Study|Withdrawal by Subject|1|||
144265249|NCT02155985|520171765|FG000|Overall Study|Lost to Follow-up|1|||
144265250|NCT02155985|520171766|FG001|Overall Study|Lost to Follow-up|0|||
144265251|NCT02155985|520171767|FG002|Overall Study|Lost to Follow-up|0|||
144265252|NCT02667301|520171768|FG000|Overall Study|Adverse Event|1|||
144265253|NCT02667301|520171768|FG000|Overall Study|Lack of Efficacy|1|||
144265254|NCT00735007|520171769|FG000|Overall Study|Adverse Event|4|||
144265255|NCT00735007|520171769|FG000|Overall Study|Protocol Violation|1|||
144661090|NCT02622724|521610099|FG000|Overall Study|Early termination of study|38|||
144661091|NCT02622724|521610100|FG001|Overall Study|Early termination of study|43|||
144661092|NCT00487084|521610101|FG000|Overall Study|Did not receive intervention|4|||
144661093|NCT00487084|521610102|FG001|Overall Study|Did not receive intervention|3|||
144661094|NCT00487084|521610103|FG002|Overall Study|Did not receive intervention|5|||
144661095|NCT00836277|521610104|FG000|Overall Study|Not evaluable for response|6|||
144661096|NCT00377611|521610108|FG000|Overall Study|Adverse Event|2|||
144661097|NCT00377611|521610109|FG001|Overall Study|Adverse Event|9|||
144661098|NCT00377611|521610108|FG000|Overall Study|Protocol Violation|2|||
144661099|NCT00377611|521610109|FG001|Overall Study|Protocol Violation|0|||
144661100|NCT00377611|521610108|FG000|Overall Study|Withdrawal by Subject|0|||
144661101|NCT00377611|521610109|FG001|Overall Study|Withdrawal by Subject|5|||
144661102|NCT00377611|521610108|FG000|Overall Study|Lost to Follow-up|18|||
144661103|NCT00377611|521610109|FG001|Overall Study|Lost to Follow-up|16|||
144661104|NCT00377611|521610108|FG000|Overall Study|Other|0|||
144661105|NCT00377611|521610109|FG001|Overall Study|Other|3|||
144661106|NCT00111917|521610110|FG000|Overall Study|Withdrawal by Subject|1|||
144661107|NCT00111917|521610111|FG001|Overall Study|Withdrawal by Subject|1|||
144661108|NCT01640925|521610112|FG000|Overall Study|Withdrawal by Subject|1|||
144661109|NCT01640925|521610113|FG001|Overall Study|Withdrawal by Subject|0|||
144661110|NCT01640925|521610112|FG000|Overall Study|Previously enrolled in this trial|13|||
144661111|NCT01640925|521610113|FG001|Overall Study|Previously enrolled in this trial|11|||
144661112|NCT02156492|521610114|FG000|Period 1|No Reason Given|0|||
144661113|NCT02156492|521610115|FG001|Period 1|No Reason Given|1|||
144661114|NCT02156492|521610116|FG002|Period 1|No Reason Given|0|||
144661115|NCT02156492|521610114|FG000|Period 3|Adverse Event|0|||
144661116|NCT02156492|521610115|FG001|Period 3|Adverse Event|1|||
144661117|NCT02156492|521610116|FG002|Period 3|Adverse Event|0|||
144661118|NCT02387372|521610136|FG000|Overall Study|Not Treated|1|||
144661119|NCT02387372|521610137|FG001|Overall Study|Not Treated|0|||
144661120|NCT00082758|521610139|FG000|Overall Study|Adverse Event|0|||
144661121|NCT00082758|521610140|FG001|Overall Study|Adverse Event|2|||
144661122|NCT00082758|521610141|FG002|Overall Study|Adverse Event|0|||
144661123|NCT00082758|521610139|FG000|Overall Study|Lack of Efficacy|12|||
144661124|NCT00082758|521610140|FG001|Overall Study|Lack of Efficacy|13|||
144661125|NCT00082758|521610141|FG002|Overall Study|Lack of Efficacy|0|||
144661126|NCT00082758|521610139|FG000|Overall Study|Physician Decision|0|||
144661127|NCT00082758|521610140|FG001|Overall Study|Physician Decision|1|||
144661128|NCT00082758|521610141|FG002|Overall Study|Physician Decision|0|||
144661129|NCT00082758|521610139|FG000|Overall Study|Withdrawal by Subject|3|||
144661130|NCT00082758|521610140|FG001|Overall Study|Withdrawal by Subject|0|||
144661131|NCT00082758|521610141|FG002|Overall Study|Withdrawal by Subject|0|||
144661132|NCT00082758|521610139|FG000|Overall Study|Protocol Violation|0|||
144661133|NCT00082758|521610140|FG001|Overall Study|Protocol Violation|1|||
144661134|NCT00082758|521610141|FG002|Overall Study|Protocol Violation|0|||
144661135|NCT02106455|521610148|FG000|Overall Study|Case Report Form Uncollected|6|||
144661136|NCT02106455|521610148|FG000|Overall Study|Protocol Deviation|2|||
144661137|NCT01260467|521610149|FG000|Overall Study|Withdrawal by Subject|2|||
144661138|NCT00436566|521610156|FG000|Overall Study|Withdrawal by Subject|2|||
144661139|NCT00436566|521610156|FG000|Overall Study|Protocol Violation|1|||
144661140|NCT01954251|521610157|FG000|Overall Study|Adverse Event|5|||
144661141|NCT01954251|521610158|FG001|Overall Study|Adverse Event|7|||
144661142|NCT01954251|521610157|FG000|Overall Study|Lost to Follow-up|6|||
144661143|NCT01954251|521610158|FG001|Overall Study|Lost to Follow-up|6|||
144661144|NCT01954251|521610157|FG000|Overall Study|Withdrawal by Subject|2|||
144661145|NCT01954251|521610158|FG001|Overall Study|Withdrawal by Subject|6|||
144661146|NCT02504268|521610161|FG000|Overall Study|Adverse Event|18|||
144661147|NCT02504268|521610162|FG001|Overall Study|Adverse Event|8|||
144661148|NCT02504268|521610163|FG002|Overall Study|Adverse Event|14|||
144661149|NCT02504268|521610164|FG003|Overall Study|Adverse Event|0|||
144265256|NCT01883895|520171773|FG000|Overall Study|Lost to Follow-up|2|||
144265257|NCT02895295|520171774|FG000|Overall Study|Survey Non-response|71|||
144661150|NCT02504268|521610165|FG004|Overall Study|Adverse Event|0|||
144661151|NCT02504268|521610166|FG005|Overall Study|Adverse Event|0|||
144661152|NCT02504268|521610167|FG006|Overall Study|Adverse Event|0|||
144661153|NCT02504268|521610168|FG007|Overall Study|Adverse Event|0|||
144661154|NCT02504268|521610169|FG008|Overall Study|Adverse Event|0|||
144661155|NCT02504268|521610161|FG000|Overall Study|Withdrawal of Consent|11|||
144661156|NCT02504268|521610162|FG001|Overall Study|Withdrawal of Consent|10|||
144661157|NCT02504268|521610163|FG002|Overall Study|Withdrawal of Consent|3|||
144661158|NCT02504268|521610164|FG003|Overall Study|Withdrawal of Consent|0|||
144661159|NCT02504268|521610165|FG004|Overall Study|Withdrawal of Consent|0|||
144661160|NCT02504268|521610166|FG005|Overall Study|Withdrawal of Consent|0|||
144661161|NCT02504268|521610167|FG006|Overall Study|Withdrawal of Consent|0|||
144661162|NCT02504268|521610168|FG007|Overall Study|Withdrawal of Consent|0|||
144661163|NCT02504268|521610169|FG008|Overall Study|Withdrawal of Consent|0|||
144661164|NCT02504268|521610161|FG000|Overall Study|Pregnancy|2|||
144661165|NCT02504268|521610162|FG001|Overall Study|Pregnancy|0|||
144661166|NCT02504268|521610163|FG002|Overall Study|Pregnancy|0|||
144661167|NCT02504268|521610164|FG003|Overall Study|Pregnancy|0|||
144661168|NCT02504268|521610165|FG004|Overall Study|Pregnancy|0|||
144661169|NCT02504268|521610166|FG005|Overall Study|Pregnancy|0|||
144661170|NCT02504268|521610167|FG006|Overall Study|Pregnancy|0|||
144661171|NCT02504268|521610168|FG007|Overall Study|Pregnancy|0|||
144661172|NCT02504268|521610169|FG008|Overall Study|Pregnancy|0|||
144661173|NCT02504268|521610161|FG000|Overall Study|Lost to Follow-up|3|||
144661174|NCT02504268|521610162|FG001|Overall Study|Lost to Follow-up|6|||
144661175|NCT02504268|521610163|FG002|Overall Study|Lost to Follow-up|4|||
144661176|NCT02504268|521610164|FG003|Overall Study|Lost to Follow-up|0|||
144661177|NCT02504268|521610165|FG004|Overall Study|Lost to Follow-up|0|||
144661178|NCT02504268|521610166|FG005|Overall Study|Lost to Follow-up|0|||
144661179|NCT02504268|521610167|FG006|Overall Study|Lost to Follow-up|0|||
144661180|NCT02504268|521610168|FG007|Overall Study|Lost to Follow-up|0|||
144661181|NCT02504268|521610169|FG008|Overall Study|Lost to Follow-up|0|||
144661182|NCT02504268|521610161|FG000|Overall Study|Death|1|||
144661183|NCT02504268|521610162|FG001|Overall Study|Death|1|||
144661184|NCT02504268|521610163|FG002|Overall Study|Death|0|||
144661185|NCT02504268|521610164|FG003|Overall Study|Death|0|||
144661186|NCT02504268|521610165|FG004|Overall Study|Death|0|||
144661187|NCT02504268|521610166|FG005|Overall Study|Death|0|||
144661188|NCT02504268|521610167|FG006|Overall Study|Death|0|||
144661189|NCT02504268|521610168|FG007|Overall Study|Death|0|||
144661190|NCT02504268|521610169|FG008|Overall Study|Death|0|||
144661191|NCT02504268|521610161|FG000|Overall Study|Subject Request to Discontinue|11|||
144661192|NCT02504268|521610162|FG001|Overall Study|Subject Request to Discontinue|3|||
144661193|NCT02504268|521610163|FG002|Overall Study|Subject Request to Discontinue|6|||
144661194|NCT02504268|521610164|FG003|Overall Study|Subject Request to Discontinue|0|||
144661195|NCT02504268|521610165|FG004|Overall Study|Subject Request to Discontinue|0|||
144661196|NCT02504268|521610166|FG005|Overall Study|Subject Request to Discontinue|0|||
144661197|NCT02504268|521610167|FG006|Overall Study|Subject Request to Discontinue|0|||
144661198|NCT02504268|521610168|FG007|Overall Study|Subject Request to Discontinue|0|||
144661199|NCT02504268|521610169|FG008|Overall Study|Subject Request to Discontinue|0|||
144661200|NCT02504268|521610161|FG000|Overall Study|No Longer Meets Study Criteria|2|||
144661201|NCT02504268|521610162|FG001|Overall Study|No Longer Meets Study Criteria|3|||
144661202|NCT02504268|521610163|FG002|Overall Study|No Longer Meets Study Criteria|0|||
144661203|NCT02504268|521610164|FG003|Overall Study|No Longer Meets Study Criteria|0|||
144661204|NCT02504268|521610165|FG004|Overall Study|No Longer Meets Study Criteria|0|||
144661205|NCT02504268|521610166|FG005|Overall Study|No Longer Meets Study Criteria|0|||
144661206|NCT02504268|521610167|FG006|Overall Study|No Longer Meets Study Criteria|0|||
144661207|NCT02504268|521610168|FG007|Overall Study|No Longer Meets Study Criteria|0|||
144661208|NCT02504268|521610169|FG008|Overall Study|No Longer Meets Study Criteria|0|||
144661209|NCT02504268|521610161|FG000|Overall Study|Lack of Efficacy|11|||
144661210|NCT02504268|521610162|FG001|Overall Study|Lack of Efficacy|35|||
144661211|NCT02504268|521610163|FG002|Overall Study|Lack of Efficacy|9|||
144661212|NCT02504268|521610164|FG003|Overall Study|Lack of Efficacy|0|||
144661213|NCT02504268|521610165|FG004|Overall Study|Lack of Efficacy|0|||
144661214|NCT02504268|521610166|FG005|Overall Study|Lack of Efficacy|0|||
144661215|NCT02504268|521610167|FG006|Overall Study|Lack of Efficacy|0|||
144661216|NCT02504268|521610168|FG007|Overall Study|Lack of Efficacy|0|||
144661217|NCT02504268|521610169|FG008|Overall Study|Lack of Efficacy|0|||
144661218|NCT02504268|521610161|FG000|Overall Study|Poor/Non-Compliance|3|||
144661219|NCT02504268|521610162|FG001|Overall Study|Poor/Non-Compliance|2|||
144733057|NCT01675765|521879284|FG001|Overall Study|Clinical progression|2|||
144733058|NCT03965091|521879285|FG000|Overall Study|Adverse Event|0|||
144733059|NCT03965091|521879286|FG001|Overall Study|Adverse Event|2|||
144661220|NCT02504268|521610163|FG002|Overall Study|Poor/Non-Compliance|3|||
144661221|NCT02504268|521610164|FG003|Overall Study|Poor/Non-Compliance|0|||
144661222|NCT02504268|521610165|FG004|Overall Study|Poor/Non-Compliance|0|||
144661223|NCT02504268|521610166|FG005|Overall Study|Poor/Non-Compliance|0|||
144661224|NCT02504268|521610167|FG006|Overall Study|Poor/Non-Compliance|0|||
144661225|NCT02504268|521610168|FG007|Overall Study|Poor/Non-Compliance|0|||
144661226|NCT02504268|521610169|FG008|Overall Study|Poor/Non-Compliance|0|||
144733060|NCT03965091|521879287|FG002|Overall Study|Adverse Event|3|||
144661227|NCT02504268|521610161|FG000|Overall Study|Not Disclosed|1|||
144661228|NCT02504268|521610162|FG001|Overall Study|Not Disclosed|0|||
144661229|NCT02504268|521610163|FG002|Overall Study|Not Disclosed|2|||
144661230|NCT02504268|521610164|FG003|Overall Study|Not Disclosed|0|||
144661231|NCT02504268|521610165|FG004|Overall Study|Not Disclosed|0|||
144661232|NCT02504268|521610166|FG005|Overall Study|Not Disclosed|0|||
144661233|NCT02504268|521610167|FG006|Overall Study|Not Disclosed|0|||
144661234|NCT02504268|521610168|FG007|Overall Study|Not Disclosed|0|||
144661235|NCT02504268|521610169|FG008|Overall Study|Not Disclosed|0|||
144661236|NCT03025217|521610170|FG000|Overall Study|Pregnancy|1|||
144265258|NCT02895295|520171775|FG001|Overall Study|Survey Non-response|94|||
144265259|NCT02895295|520171776|FG002|Overall Study|Survey Non-response|92|||
144265260|NCT04414787|520171781|FG000|Overall Study|Patient Death|18|||
144661237|NCT03025217|521610170|FG000|Overall Study|Lost to Follow-up|1|||
144661238|NCT03025217|521610170|FG000|Overall Study|Not eligible, poor English|2|||
144661239|NCT02124707|521610177|FG000|Overall Study|Adverse Event|5|||
144661240|NCT02124707|521610177|FG000|Overall Study|Physician Decision|1|||
144661241|NCT02124707|521610177|FG000|Overall Study|Death|1|||
144661242|NCT00781599|521610178|FG000|Overall Study|Lost to Follow-up|7|||
144661243|NCT00781599|521610179|FG001|Overall Study|Lost to Follow-up|4|||
144661244|NCT03198754|521610180|FG000|Overall Study|Withdrawal by Subject|5|||
144661245|NCT03198754|521610181|FG001|Overall Study|Withdrawal by Subject|4|||
144661246|NCT03198754|521610180|FG000|Overall Study|Lost to Follow-up|4|||
144661247|NCT03198754|521610181|FG001|Overall Study|Lost to Follow-up|3|||
144661248|NCT03198754|521610180|FG000|Overall Study|Ineligible|2|||
144661249|NCT03198754|521610181|FG001|Overall Study|Ineligible|1|||
144661250|NCT00421343|521610190|FG000|Overall Study|Death|1|||
144661251|NCT00421343|521610190|FG000|Overall Study|Withdrawal by Subject|2|||
144661252|NCT00421343|521610190|FG000|Overall Study|Lost to Follow-up|3|||
144661253|NCT03471767|521610198|FG000|Overall Study|Withdrawal by Subject|3|||
144661254|NCT03471767|521610199|FG001|Overall Study|Withdrawal by Subject|1|||
144661255|NCT03471767|521610198|FG000|Overall Study|Adverse Event|1|||
144661256|NCT03471767|521610199|FG001|Overall Study|Adverse Event|0|||
144661257|NCT03471767|521610198|FG000|Overall Study|Lost to Follow-up|1|||
144661258|NCT03471767|521610199|FG001|Overall Study|Lost to Follow-up|0|||
144661259|NCT03471767|521610198|FG000|Overall Study|PI Withdrawal|1|||
144661260|NCT03471767|521610199|FG001|Overall Study|PI Withdrawal|3|||
144661261|NCT01952730|521610202|FG000|Overall Study|FDA shut down core lab used by study|1|||
144661262|NCT00608530|521610203|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
144661263|NCT00608530|521610204|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
144661264|NCT00608530|521610205|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
144661265|NCT00608530|521610206|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
144661266|NCT00608530|521610203|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
144661267|NCT00608530|521610204|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
144661268|NCT00608530|521610205|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
144661269|NCT00608530|521610206|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
144661270|NCT00608530|521610203|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
144661271|NCT00608530|521610204|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
144661272|NCT00608530|521610205|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
144661273|NCT00608530|521610206|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
144661274|NCT00608530|521610203|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
144661275|NCT00608530|521610204|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
144661276|NCT00608530|521610205|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
144661277|NCT00608530|521610206|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
144661278|NCT00608530|521610203|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
144661279|NCT00608530|521610204|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
144661280|NCT00608530|521610205|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
144661281|NCT00608530|521610206|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
144661282|NCT00608530|521610203|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
144661283|NCT00608530|521610204|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
144661284|NCT00608530|521610205|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
144661285|NCT00608530|521610206|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
144661286|NCT01514188|521610207|FG000|Overall Study|Adverse Event|3|||
144661287|NCT01514188|521610208|FG001|Overall Study|Adverse Event|5|||
144661288|NCT01514188|521610207|FG000|Overall Study|Withdrawal by Subject|2|||
144661289|NCT01514188|521610208|FG001|Overall Study|Withdrawal by Subject|4|||
144661290|NCT01514188|521610207|FG000|Overall Study|Protocol Violation|2|||
144661291|NCT01514188|521610208|FG001|Overall Study|Protocol Violation|4|||
144661292|NCT01514188|521610207|FG000|Overall Study|Physician Decision|0|||
144661293|NCT01514188|521610208|FG001|Overall Study|Physician Decision|2|||
144661294|NCT01514188|521610207|FG000|Overall Study|Disease Progression|13|||
144661295|NCT01514188|521610208|FG001|Overall Study|Disease Progression|14|||
144661296|NCT01514188|521610207|FG000|Overall Study|Death|1|||
144661297|NCT01514188|521610208|FG001|Overall Study|Death|3|||
144661298|NCT01514188|521610207|FG000|Overall Study|Other|2|||
144661299|NCT01514188|521610208|FG001|Overall Study|Other|1|||
144733061|NCT03965091|521879285|FG000|Overall Study|Withdrawal by Subject|11|||
144733062|NCT03965091|521879286|FG001|Overall Study|Withdrawal by Subject|3|||
144733063|NCT03965091|521879287|FG002|Overall Study|Withdrawal by Subject|5|||
144733064|NCT03965091|521879285|FG000|Overall Study|Non-compliance with study drug|0|||
144733065|NCT03965091|521879286|FG001|Overall Study|Non-compliance with study drug|0|||
144733066|NCT03965091|521879287|FG002|Overall Study|Non-compliance with study drug|1|||
144733067|NCT03965091|521879285|FG000|Overall Study|Lost to Follow-up|1|||
144733068|NCT03965091|521879286|FG001|Overall Study|Lost to Follow-up|1|||
144733069|NCT03965091|521879287|FG002|Overall Study|Lost to Follow-up|1|||
144733070|NCT03965091|521879285|FG000|Overall Study|Lack of Efficacy|2|||
144733071|NCT03965091|521879286|FG001|Overall Study|Lack of Efficacy|0|||
144733072|NCT03965091|521879287|FG002|Overall Study|Lack of Efficacy|0|||
144733073|NCT03965091|521879285|FG000|Overall Study|Other than specified|9|||
144733074|NCT03965091|521879286|FG001|Overall Study|Other than specified|11|||
144733075|NCT03965091|521879287|FG002|Overall Study|Other than specified|8|||
144733076|NCT01185821|521879291|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144733077|NCT01185821|521879292|FG001|Overall Study|Abnormal laboratory value(s)|2|||
144733078|NCT01185821|521879293|FG002|Overall Study|Abnormal laboratory value(s)|1|||
144733079|NCT01185821|521879294|FG003|Overall Study|Abnormal laboratory value(s)|0|||
144733080|NCT01185821|521879295|FG004|Overall Study|Abnormal laboratory value(s)|0|||
144733081|NCT01185821|521879291|FG000|Overall Study|Protocol Violation|0|||
144733082|NCT01185821|521879292|FG001|Overall Study|Protocol Violation|0|||
144733083|NCT01185821|521879293|FG002|Overall Study|Protocol Violation|0|||
144733084|NCT01185821|521879294|FG003|Overall Study|Protocol Violation|1|||
144733085|NCT01185821|521879295|FG004|Overall Study|Protocol Violation|1|||
144733086|NCT01185821|521879291|FG000|Overall Study|Abnormal test procedure result|0|||
144733087|NCT01185821|521879292|FG001|Overall Study|Abnormal test procedure result|0|||
144733088|NCT01185821|521879293|FG002|Overall Study|Abnormal test procedure result|0|||
144733089|NCT01185821|521879294|FG003|Overall Study|Abnormal test procedure result|0|||
144733090|NCT01185821|521879295|FG004|Overall Study|Abnormal test procedure result|1|||
144733091|NCT01185821|521879291|FG000|Overall Study|Death|0|||
144733092|NCT01185821|521879292|FG001|Overall Study|Death|1|||
144733093|NCT01185821|521879293|FG002|Overall Study|Death|0|||
144733094|NCT01185821|521879294|FG003|Overall Study|Death|0|||
144733095|NCT01185821|521879295|FG004|Overall Study|Death|0|||
144733096|NCT01185821|521879291|FG000|Overall Study|Condition no longer required study drug|0|||
144733097|NCT01185821|521879292|FG001|Overall Study|Condition no longer required study drug|0|||
144733098|NCT01185821|521879293|FG002|Overall Study|Condition no longer required study drug|0|||
144733099|NCT01185821|521879294|FG003|Overall Study|Condition no longer required study drug|0|||
144733100|NCT01185821|521879295|FG004|Overall Study|Condition no longer required study drug|1|||
144733101|NCT01185821|521879291|FG000|Overall Study|Adverse Event|2|||
144733102|NCT01185821|521879292|FG001|Overall Study|Adverse Event|3|||
144733103|NCT01185821|521879293|FG002|Overall Study|Adverse Event|1|||
144733104|NCT01185821|521879294|FG003|Overall Study|Adverse Event|2|||
144733105|NCT01185821|521879295|FG004|Overall Study|Adverse Event|5|||
144733106|NCT01185821|521879291|FG000|Overall Study|Lack of Efficacy|0|||
144733107|NCT01185821|521879292|FG001|Overall Study|Lack of Efficacy|0|||
144733108|NCT01185821|521879293|FG002|Overall Study|Lack of Efficacy|3|||
144733109|NCT01185821|521879294|FG003|Overall Study|Lack of Efficacy|0|||
144733110|NCT01185821|521879295|FG004|Overall Study|Lack of Efficacy|9|||
144733111|NCT01185821|521879291|FG000|Overall Study|Withdrawal by Subject|3|||
144733112|NCT01185821|521879292|FG001|Overall Study|Withdrawal by Subject|2|||
144733113|NCT01185821|521879293|FG002|Overall Study|Withdrawal by Subject|2|||
144733114|NCT01185821|521879294|FG003|Overall Study|Withdrawal by Subject|1|||
144733115|NCT01185821|521879295|FG004|Overall Study|Withdrawal by Subject|3|||
144733116|NCT01185821|521879291|FG000|Overall Study|Lost to Follow-up|1|||
144733117|NCT01185821|521879292|FG001|Overall Study|Lost to Follow-up|1|||
144661300|NCT03599141|521610214|FG000|Overall Study|Lost to Follow-up|3|||
144661301|NCT03599141|521610215|FG001|Overall Study|Lost to Follow-up|1|||
144661302|NCT03126539|521610223|FG000|Overall Study|Lost to Follow-up|1|||
144661303|NCT03126539|521610224|FG001|Overall Study|Lost to Follow-up|1|||
144661304|NCT03126539|521610225|FG002|Overall Study|Lost to Follow-up|1|||
144661305|NCT03126539|521610226|FG003|Overall Study|Lost to Follow-up|0|||
144661306|NCT03126539|521610227|FG004|Overall Study|Lost to Follow-up|0|||
144661307|NCT01005732|521610230|FG000|Overall Study|Lost to Follow-up|10|||
144661308|NCT01005732|521610230|FG000|Overall Study|Death|1|||
144661309|NCT02596711|521610231|FG000|Overall Study|Lost to Follow-up|1|||
144733118|NCT01185821|521879293|FG002|Overall Study|Lost to Follow-up|2|||
144733119|NCT01185821|521879294|FG003|Overall Study|Lost to Follow-up|1|||
144733120|NCT01185821|521879295|FG004|Overall Study|Lost to Follow-up|2|||
144733121|NCT01185821|521879291|FG000|Overall Study|Administrative problems|0|||
144733122|NCT01185821|521879292|FG001|Overall Study|Administrative problems|0|||
144661310|NCT02596711|521610232|FG001|Overall Study|Lost to Follow-up|2|||
144733123|NCT01185821|521879293|FG002|Overall Study|Administrative problems|1|||
144733124|NCT01185821|521879294|FG003|Overall Study|Administrative problems|1|||
144733125|NCT01185821|521879295|FG004|Overall Study|Administrative problems|2|||
144661311|NCT02596711|521610233|FG002|Overall Study|Lost to Follow-up|3|||
144661312|NCT00632463|521610234|FG000|Overall Study|Adverse Event|0|||
144661313|NCT00632463|521610235|FG001|Overall Study|Adverse Event|1|||
144661314|NCT00632463|521610236|FG002|Overall Study|Adverse Event|0|||
144661315|NCT02112994|521610240|FG000|Overall Study|Progressive Disease|0|||
144661316|NCT02112994|521610241|FG001|Overall Study|Progressive Disease|0|||
144661317|NCT02112994|521610242|FG002|Overall Study|Progressive Disease|1|||
144661318|NCT02112994|521610240|FG000|Overall Study|Pregnancy|0|||
144661319|NCT02112994|521610241|FG001|Overall Study|Pregnancy|1|||
144661320|NCT02112994|521610242|FG002|Overall Study|Pregnancy|1|||
144661321|NCT02112994|521610240|FG000|Overall Study|Liver Transplant|0|||
144661322|NCT02112994|521610241|FG001|Overall Study|Liver Transplant|1|||
144661323|NCT02112994|521610242|FG002|Overall Study|Liver Transplant|0|||
144661324|NCT02112994|521610240|FG000|Overall Study|Withdrawal by Subject|0|||
144661325|NCT02112994|521610241|FG001|Overall Study|Withdrawal by Subject|0|||
144661326|NCT02112994|521610242|FG002|Overall Study|Withdrawal by Subject|1|||
144661327|NCT01683071|521610246|FG000|Part 1|Lack of Efficacy|1|||
144661328|NCT01683071|521610247|FG001|Part 1|Lack of Efficacy|0|||
144661329|NCT01683071|521610248|FG002|Part 1|Lack of Efficacy|0|||
144661330|NCT01683071|521610249|FG003|Part 1|Lack of Efficacy|3|||
144661331|NCT01683071|521610250|FG004|Part 1|Lack of Efficacy|0|||
144661332|NCT01683071|521610251|FG005|Part 1|Lack of Efficacy|0|||
144661333|NCT01683071|521610246|FG000|Part 1|Withdrawal by Subject|1|||
144661334|NCT01683071|521610247|FG001|Part 1|Withdrawal by Subject|2|||
144661335|NCT01683071|521610248|FG002|Part 1|Withdrawal by Subject|2|||
144661336|NCT01683071|521610249|FG003|Part 1|Withdrawal by Subject|1|||
144661337|NCT01683071|521610250|FG004|Part 1|Withdrawal by Subject|0|||
144661338|NCT01683071|521610251|FG005|Part 1|Withdrawal by Subject|0|||
144661339|NCT01683071|521610246|FG000|Part 1|Surgery Cancelled|1|||
144661340|NCT01683071|521610247|FG001|Part 1|Surgery Cancelled|0|||
144661341|NCT01683071|521610248|FG002|Part 1|Surgery Cancelled|0|||
144661342|NCT01683071|521610249|FG003|Part 1|Surgery Cancelled|0|||
144661343|NCT01683071|521610250|FG004|Part 1|Surgery Cancelled|0|||
144661344|NCT01683071|521610251|FG005|Part 1|Surgery Cancelled|0|||
144661345|NCT01683071|521610246|FG000|Part 1|Did not receive study drug|1|||
144661346|NCT01683071|521610247|FG001|Part 1|Did not receive study drug|0|||
144661347|NCT01683071|521610248|FG002|Part 1|Did not receive study drug|0|||
144661348|NCT01683071|521610249|FG003|Part 1|Did not receive study drug|1|||
144661349|NCT01683071|521610250|FG004|Part 1|Did not receive study drug|0|||
144661350|NCT01683071|521610251|FG005|Part 1|Did not receive study drug|0|||
144661351|NCT01683071|521610246|FG000|Part 1|Early termination; met exclusion criteria|0|||
144661352|NCT01683071|521610247|FG001|Part 1|Early termination; met exclusion criteria|2|||
144661353|NCT01683071|521610248|FG002|Part 1|Early termination; met exclusion criteria|1|||
144661354|NCT01683071|521610249|FG003|Part 1|Early termination; met exclusion criteria|0|||
144661355|NCT01683071|521610250|FG004|Part 1|Early termination; met exclusion criteria|0|||
144661356|NCT01683071|521610251|FG005|Part 1|Early termination; met exclusion criteria|0|||
144661357|NCT01683071|521610246|FG000|Part 2|Lack of Efficacy|0|||
144661358|NCT01683071|521610247|FG001|Part 2|Lack of Efficacy|0|||
144661359|NCT01683071|521610248|FG002|Part 2|Lack of Efficacy|0|||
144661360|NCT01683071|521610249|FG003|Part 2|Lack of Efficacy|0|||
144661361|NCT01683071|521610250|FG004|Part 2|Lack of Efficacy|3|||
144661362|NCT01683071|521610251|FG005|Part 2|Lack of Efficacy|4|||
144661363|NCT01683071|521610246|FG000|Part 2|Lost to Follow-up|0|||
144661364|NCT01683071|521610247|FG001|Part 2|Lost to Follow-up|0|||
144661365|NCT01683071|521610248|FG002|Part 2|Lost to Follow-up|0|||
144661366|NCT01683071|521610249|FG003|Part 2|Lost to Follow-up|0|||
144661367|NCT01683071|521610250|FG004|Part 2|Lost to Follow-up|2|||
144661368|NCT01683071|521610251|FG005|Part 2|Lost to Follow-up|0|||
144661369|NCT01683071|521610246|FG000|Part 2|Withdrawal by Subject|0|||
144661370|NCT01683071|521610247|FG001|Part 2|Withdrawal by Subject|0|||
144661371|NCT01683071|521610248|FG002|Part 2|Withdrawal by Subject|0|||
144661372|NCT01683071|521610249|FG003|Part 2|Withdrawal by Subject|0|||
144661373|NCT01683071|521610250|FG004|Part 2|Withdrawal by Subject|3|||
144661374|NCT01683071|521610251|FG005|Part 2|Withdrawal by Subject|3|||
144661375|NCT01683071|521610246|FG000|Part 2|Surgery cancelled|0|||
144661376|NCT01683071|521610247|FG001|Part 2|Surgery cancelled|0|||
144733126|NCT01534520|521879296|FG000|Overall Study|Adverse Event|0|||
144733127|NCT01534520|521879297|FG001|Overall Study|Adverse Event|1|||
144733128|NCT01059903|521879306|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
144733129|NCT01059903|521879307|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
144661377|NCT01683071|521610248|FG002|Part 2|Surgery cancelled|0|||
144733130|NCT00385593|521879308|FG000|Overall Study|Adverse Event|3|||
144733131|NCT00385593|521879309|FG001|Overall Study|Adverse Event|2|||
144661378|NCT01683071|521610249|FG003|Part 2|Surgery cancelled|0|||
144661379|NCT01683071|521610250|FG004|Part 2|Surgery cancelled|4|||
144661380|NCT01683071|521610251|FG005|Part 2|Surgery cancelled|2|||
144661381|NCT01683071|521610246|FG000|Part 2|Did not receive study drug|0|||
144661382|NCT01683071|521610247|FG001|Part 2|Did not receive study drug|0|||
144661383|NCT01683071|521610248|FG002|Part 2|Did not receive study drug|0|||
144661384|NCT01683071|521610249|FG003|Part 2|Did not receive study drug|0|||
144661385|NCT01683071|521610250|FG004|Part 2|Did not receive study drug|2|||
144661386|NCT01683071|521610251|FG005|Part 2|Did not receive study drug|1|||
144661387|NCT01683071|521610246|FG000|Part 2|Met exclusion criterion|0|||
144733132|NCT00385593|521879308|FG000|Overall Study|Withdrawal by Subject|17|||
144733133|NCT00385593|521879309|FG001|Overall Study|Withdrawal by Subject|7|||
144733134|NCT00385593|521879308|FG000|Overall Study|Lost to Follow-up|12|||
144733135|NCT00385593|521879309|FG001|Overall Study|Lost to Follow-up|8|||
144733136|NCT00385593|521879308|FG000|Overall Study|Protocol Violation|7|||
144733137|NCT00385593|521879309|FG001|Overall Study|Protocol Violation|4|||
144733138|NCT00385593|521879308|FG000|Overall Study|Several reasons|17|||
144733139|NCT00385593|521879309|FG001|Overall Study|Several reasons|15|||
144733140|NCT00385593|521879308|FG000|Overall Study|Incorrect inclusion|2|||
144733141|NCT00385593|521879309|FG001|Overall Study|Incorrect inclusion|0|||
144733142|NCT00385593|521879308|FG000|Overall Study|Incorrect randomization|0|||
144733143|NCT00385593|521879309|FG001|Overall Study|Incorrect randomization|1|||
144733144|NCT03725605|521879310|FG000|Overall Study|Unsuccessful TIL expansion|2|||
144733145|NCT03555305|521879311|FG000|Period 1|Physician Decision|0|||
144733146|NCT03555305|521879312|FG001|Period 1|Physician Decision|1|||
144733147|NCT03555305|521879311|FG000|Period 1|Adverse Event|0|||
144733148|NCT03555305|521879312|FG001|Period 1|Adverse Event|1|||
144733149|NCT03586726|521879320|FG000|Overall Study|Withdrawal by Subject|1|||
144733150|NCT03135834|521879321|FG000|Stage 1|Adverse Event|1|||
144733151|NCT03135834|521879322|FG001|Stage 1|Adverse Event|2|||
144733152|NCT03135834|521879323|FG002|Stage 1|Adverse Event|2|||
144733153|NCT03135834|521879324|FG003|Stage 1|Adverse Event|1|||
144733154|NCT03135834|521879321|FG000|Stage 1|Death|1|||
144733155|NCT03135834|521879322|FG001|Stage 1|Death|0|||
144733156|NCT03135834|521879323|FG002|Stage 1|Death|0|||
144733157|NCT03135834|521879324|FG003|Stage 1|Death|0|||
144733158|NCT03135834|521879321|FG000|Stage 1|Lost to Follow-up|17|||
144733159|NCT03135834|521879322|FG001|Stage 1|Lost to Follow-up|24|||
144733160|NCT03135834|521879323|FG002|Stage 1|Lost to Follow-up|21|||
144733161|NCT03135834|521879324|FG003|Stage 1|Lost to Follow-up|38|||
144733162|NCT03135834|521879321|FG000|Stage 1|No longer met eligibility criteria|1|||
144733163|NCT03135834|521879322|FG001|Stage 1|No longer met eligibility criteria|6|||
144733164|NCT03135834|521879323|FG002|Stage 1|No longer met eligibility criteria|2|||
144733165|NCT03135834|521879324|FG003|Stage 1|No longer met eligibility criteria|5|||
144733166|NCT03135834|521879321|FG000|Stage 1|Other|0|||
144733167|NCT03135834|521879322|FG001|Stage 1|Other|2|||
144733168|NCT03135834|521879323|FG002|Stage 1|Other|1|||
144733169|NCT03135834|521879324|FG003|Stage 1|Other|0|||
144733170|NCT03135834|521879321|FG000|Stage 1|Physician Decision|0|||
144733171|NCT03135834|521879322|FG001|Stage 1|Physician Decision|1|||
144661388|NCT01683071|521610247|FG001|Part 2|Met exclusion criterion|0|||
144661389|NCT01683071|521610248|FG002|Part 2|Met exclusion criterion|0|||
144661390|NCT01683071|521610249|FG003|Part 2|Met exclusion criterion|0|||
144661391|NCT01683071|521610250|FG004|Part 2|Met exclusion criterion|1|||
144661392|NCT01683071|521610251|FG005|Part 2|Met exclusion criterion|1|||
144661393|NCT01683071|521610246|FG000|Part 2|Protocol deviation|0|||
144661394|NCT01683071|521610247|FG001|Part 2|Protocol deviation|0|||
144661395|NCT01683071|521610248|FG002|Part 2|Protocol deviation|0|||
144661396|NCT01683071|521610249|FG003|Part 2|Protocol deviation|0|||
144661397|NCT01683071|521610250|FG004|Part 2|Protocol deviation|1|||
144661398|NCT01683071|521610251|FG005|Part 2|Protocol deviation|2|||
144661399|NCT01683071|521610246|FG000|Part 2|Withdrawal by investigator decision|0|||
144661400|NCT01683071|521610247|FG001|Part 2|Withdrawal by investigator decision|0|||
144661401|NCT01683071|521610248|FG002|Part 2|Withdrawal by investigator decision|0|||
144661402|NCT01683071|521610249|FG003|Part 2|Withdrawal by investigator decision|0|||
144661403|NCT01683071|521610250|FG004|Part 2|Withdrawal by investigator decision|1|||
144661404|NCT01683071|521610251|FG005|Part 2|Withdrawal by investigator decision|2|||
144661405|NCT02349789|521611585|FG000|Overall Study|Withdrawal by Subject|2|||
144661406|NCT02625324|521611588|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
144661407|NCT02625324|521611588|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
144661408|NCT02625324|521611588|FG000|6-Month Follow-up Subject Accountability|Death|5|||
144661409|NCT02625324|521611588|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
144733172|NCT03135834|521879323|FG002|Stage 1|Physician Decision|0|||
144733173|NCT03135834|521879324|FG003|Stage 1|Physician Decision|0|||
144661410|NCT02625324|521611588|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
144661411|NCT02625324|521611588|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
144661412|NCT02625324|521611588|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
144733174|NCT03135834|521879321|FG000|Stage 1|Pregnancy|0|||
144661413|NCT02625324|521611588|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
144733175|NCT03135834|521879322|FG001|Stage 1|Pregnancy|4|||
144733176|NCT03135834|521879323|FG002|Stage 1|Pregnancy|2|||
144733177|NCT03135834|521879324|FG003|Stage 1|Pregnancy|4|||
144733178|NCT03135834|521879321|FG000|Stage 1|Protocol Violation|1|||
144733179|NCT03135834|521879322|FG001|Stage 1|Protocol Violation|1|||
144733180|NCT03135834|521879323|FG002|Stage 1|Protocol Violation|2|||
144733181|NCT03135834|521879324|FG003|Stage 1|Protocol Violation|1|||
144733182|NCT03135834|521879321|FG000|Stage 1|Withdrawal by parent/guardian|2|||
144733183|NCT03135834|521879322|FG001|Stage 1|Withdrawal by parent/guardian|10|||
144733184|NCT03135834|521879323|FG002|Stage 1|Withdrawal by parent/guardian|2|||
144733185|NCT03135834|521879324|FG003|Stage 1|Withdrawal by parent/guardian|1|||
144661414|NCT02625324|521611588|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
144661415|NCT02625324|521611588|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
144661416|NCT02625324|521611588|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
144661417|NCT02625324|521611588|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
144661418|NCT02625324|521611588|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
144661419|NCT02625324|521611588|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
144661420|NCT02625324|521611588|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
144661421|NCT02625324|521611588|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
144661422|NCT02625324|521611588|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
144661423|NCT02457182|521611589|FG000|Overall Study|Lost to Follow-up|1|||
144661424|NCT02457182|521611590|FG001|Overall Study|Lost to Follow-up|0|||
144661425|NCT01116687|521611591|FG000|Overall Study|Withdrawal by Subject|4|||
144661426|NCT00424528|521611592|FG000|Overall Study|Adverse Event|2|||
144661427|NCT00424528|521611593|FG001|Overall Study|Adverse Event|1|||
144661428|NCT00424528|521611594|FG002|Overall Study|Adverse Event|2|||
144661429|NCT00424528|521611592|FG000|Overall Study|Protocol Violation|1|||
144661430|NCT00424528|521611593|FG001|Overall Study|Protocol Violation|1|||
144661431|NCT00424528|521611594|FG002|Overall Study|Protocol Violation|0|||
144661432|NCT00424528|521611592|FG000|Overall Study|Lost to Follow-up|0|||
144661433|NCT00424528|521611593|FG001|Overall Study|Lost to Follow-up|1|||
144661434|NCT00424528|521611594|FG002|Overall Study|Lost to Follow-up|0|||
144661435|NCT00424528|521611592|FG000|Overall Study|noncompliance with study requirements|2|||
144661436|NCT00424528|521611593|FG001|Overall Study|noncompliance with study requirements|1|||
144661437|NCT00424528|521611594|FG002|Overall Study|noncompliance with study requirements|2|||
144661438|NCT02115113|521611595|FG000|Participants in Run-in Period|Death|0|||
144661439|NCT02115113|521611596|FG001|Participants in Run-in Period|Death|0|||
144661440|NCT02115113|521611597|FG002|Participants in Run-in Period|Death|1|||
144661441|NCT02115113|521611595|FG000|Participants in Run-in Period|Administrative problems|0|||
144661442|NCT02115113|521611596|FG001|Participants in Run-in Period|Administrative problems|0|||
144661443|NCT02115113|521611597|FG002|Participants in Run-in Period|Administrative problems|1|||
144661444|NCT02115113|521611595|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
144661445|NCT02115113|521611596|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
144661446|NCT02115113|521611597|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
144661447|NCT02115113|521611595|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
144661448|NCT02115113|521611596|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
144661449|NCT02115113|521611597|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
144661450|NCT02115113|521611595|FG000|Participants Randomized|Lost to Follow-up|1|||
144661451|NCT02115113|521611596|FG001|Participants Randomized|Lost to Follow-up|0|||
144661452|NCT02115113|521611597|FG002|Participants Randomized|Lost to Follow-up|0|||
144661453|NCT02115113|521611595|FG000|Participants Randomized|Death|1|||
144661454|NCT02115113|521611596|FG001|Participants Randomized|Death|0|||
144661455|NCT02115113|521611597|FG002|Participants Randomized|Death|0|||
144661456|NCT00789191|521611599|FG000|Overall Study|Adverse Event|2|||
144661457|NCT00789191|521611600|FG001|Overall Study|Adverse Event|4|||
144661458|NCT00789191|521611599|FG000|Overall Study|Lack of Efficacy|0|||
144661459|NCT00789191|521611600|FG001|Overall Study|Lack of Efficacy|5|||
144661460|NCT00789191|521611599|FG000|Overall Study|Protocol Violation|5|||
144661461|NCT00789191|521611600|FG001|Overall Study|Protocol Violation|3|||
144661462|NCT00789191|521611599|FG000|Overall Study|Withdrawal Criteria|2|||
144661463|NCT00789191|521611600|FG001|Overall Study|Withdrawal Criteria|4|||
144661464|NCT00789191|521611599|FG000|Overall Study|Unclassified|5|||
144661465|NCT00789191|521611600|FG001|Overall Study|Unclassified|3|||
144661466|NCT01009983|521611601|FG000|Overall Study|necessary scans not completed|1|||
144661467|NCT03497429|521611602|FG000|Overall Study|Progressive disease|3|||
144661468|NCT03497429|521611603|FG001|Overall Study|Progressive disease|4|||
144661469|NCT03497429|521611602|FG000|Overall Study|Adverse Event|0|||
144661470|NCT03497429|521611603|FG001|Overall Study|Adverse Event|2|||
144661471|NCT00967226|521611607|FG000|Overall Study|Adverse Event|0|||
144661472|NCT00967226|521611608|FG001|Overall Study|Adverse Event|5|||
144661473|NCT00967226|521611607|FG000|Overall Study|Protocol Violation|2|||
144661474|NCT00967226|521611608|FG001|Overall Study|Protocol Violation|0|||
144661475|NCT00967226|521611607|FG000|Overall Study|Physician Decision|0|||
144661476|NCT00967226|521611608|FG001|Overall Study|Physician Decision|1|||
144661477|NCT00605722|521611609|FG000|Overall Study|Adverse Event|6|||
144661478|NCT00605722|521611609|FG000|Overall Study|Insufficient therapeutic response|44|||
144661479|NCT00605722|521611609|FG000|Overall Study|Failure to return|1|||
144661480|NCT00356863|521611615|FG000|Overall Study|Death|16|||
144661481|NCT00356863|521611616|FG001|Overall Study|Death|32|||
144661482|NCT00356863|521611615|FG000|Overall Study|Lost to Follow-up|76|||
144661483|NCT00356863|521611616|FG001|Overall Study|Lost to Follow-up|43|||
144661484|NCT00333619|521611619|FG000|Overall Study|Death|12|||
144661485|NCT00333619|521611620|FG001|Overall Study|Death|6|||
144661486|NCT00333619|521611619|FG000|Overall Study|Withdrawal by Subject|6|||
144661487|NCT00333619|521611620|FG001|Overall Study|Withdrawal by Subject|1|||
144661488|NCT00333619|521611619|FG000|Overall Study|Lost to Follow-up|3|||
144661489|NCT00333619|521611620|FG001|Overall Study|Lost to Follow-up|3|||
144661490|NCT00280150|521611621|FG000|Overall Study|Adverse Event|0|||
144661491|NCT00280150|521611622|FG001|Overall Study|Adverse Event|1|||
144661492|NCT00280150|521611623|FG002|Overall Study|Adverse Event|2|||
144661493|NCT00280150|521611624|FG003|Overall Study|Adverse Event|3|||
144661494|NCT00280150|521611621|FG000|Overall Study|Lack of Efficacy|0|||
144661495|NCT00280150|521611622|FG001|Overall Study|Lack of Efficacy|0|||
144661496|NCT00280150|521611623|FG002|Overall Study|Lack of Efficacy|0|||
144661497|NCT00280150|521611624|FG003|Overall Study|Lack of Efficacy|3|||
144661498|NCT00280150|521611621|FG000|Overall Study|Physician Decision|0|||
144661499|NCT00280150|521611622|FG001|Overall Study|Physician Decision|0|||
144661500|NCT00280150|521611623|FG002|Overall Study|Physician Decision|0|||
144661501|NCT00280150|521611624|FG003|Overall Study|Physician Decision|1|||
144661502|NCT00280150|521611621|FG000|Overall Study|Protocol Violation|0|||
144661503|NCT00280150|521611622|FG001|Overall Study|Protocol Violation|0|||
144661504|NCT00280150|521611623|FG002|Overall Study|Protocol Violation|0|||
144661505|NCT00280150|521611624|FG003|Overall Study|Protocol Violation|1|||
144661506|NCT00280150|521611621|FG000|Overall Study|Withdrawal by Subject|0|||
144661507|NCT00280150|521611622|FG001|Overall Study|Withdrawal by Subject|0|||
144661508|NCT00280150|521611623|FG002|Overall Study|Withdrawal by Subject|0|||
144661509|NCT00280150|521611624|FG003|Overall Study|Withdrawal by Subject|1|||
144661510|NCT00280150|521611621|FG000|Overall Study|Did not get consolidation therapy|3|||
144661511|NCT00280150|521611622|FG001|Overall Study|Did not get consolidation therapy|0|||
144661512|NCT00280150|521611623|FG002|Overall Study|Did not get consolidation therapy|3|||
144661513|NCT00280150|521611624|FG003|Overall Study|Did not get consolidation therapy|0|||
144661514|NCT00280150|521611621|FG000|Overall Study|Declining Performance Status|0|||
144661515|NCT00280150|521611622|FG001|Overall Study|Declining Performance Status|0|||
144661516|NCT00280150|521611623|FG002|Overall Study|Declining Performance Status|0|||
144661517|NCT00280150|521611624|FG003|Overall Study|Declining Performance Status|1|||
144661518|NCT02871401|521611631|FG000|Overall Study|Adverse Event|1|||
144661519|NCT02871401|521611632|FG001|Overall Study|Adverse Event|0|||
144661520|NCT04031404|521611633|FG000|Baseline|Lost to Follow-up|0|||
144661521|NCT04031404|521611634|FG001|Baseline|Lost to Follow-up|1|||
144661522|NCT04031404|521611633|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
144661523|NCT04031404|521611634|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
144661524|NCT04031404|521611633|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
144661525|NCT04031404|521611634|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
144661526|NCT04031404|521611633|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
144661527|NCT04031404|521611634|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
144661528|NCT04031404|521611633|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
144661529|NCT04031404|521611634|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
144661530|NCT00568958|521611637|FG000|Allocation|Withdrawal by Subject|7|||
144661531|NCT00568958|521611638|FG001|Allocation|Withdrawal by Subject|3|||
144661532|NCT00568958|521611637|FG000|Allocation|Physician Decision|2|||
144661533|NCT00568958|521611638|FG001|Allocation|Physician Decision|0|||
144661534|NCT00568958|521611637|FG000|Follow-Up|Withdrawal by Subject|6|||
144661535|NCT00568958|521611638|FG001|Follow-Up|Withdrawal by Subject|6|||
144661536|NCT00568958|521611637|FG000|Follow-Up|Physician Decision|1|||
144661537|NCT00568958|521611638|FG001|Follow-Up|Physician Decision|1|||
144661538|NCT00568958|521611637|FG000|Follow-Up|Family Emergency|1|||
144661539|NCT00568958|521611638|FG001|Follow-Up|Family Emergency|0|||
144661540|NCT00568958|521611637|FG000|Follow-Up|Adverse Event|1|||
144661541|NCT00568958|521611638|FG001|Follow-Up|Adverse Event|0|||
144661542|NCT03583372|521611639|FG000|Overall Study|Withdrawal by Subject|6|||
144661543|NCT03583372|521611640|FG001|Overall Study|Withdrawal by Subject|11|||
144661544|NCT03583372|521611641|FG002|Overall Study|Withdrawal by Subject|7|||
144661545|NCT03583372|521611642|FG003|Overall Study|Withdrawal by Subject|8|||
144661546|NCT03583372|521611639|FG000|Overall Study|Lost to Follow-up|4|||
144661547|NCT03583372|521611640|FG001|Overall Study|Lost to Follow-up|6|||
144661548|NCT03583372|521611641|FG002|Overall Study|Lost to Follow-up|3|||
144661549|NCT03583372|521611642|FG003|Overall Study|Lost to Follow-up|2|||
144661550|NCT03583372|521611639|FG000|Overall Study|Adverse Event|1|||
144661551|NCT03583372|521611640|FG001|Overall Study|Adverse Event|3|||
144661552|NCT03583372|521611641|FG002|Overall Study|Adverse Event|4|||
144661553|NCT03583372|521611642|FG003|Overall Study|Adverse Event|4|||
144661554|NCT03583372|521611639|FG000|Overall Study|Physician Decision|0|||
144661555|NCT03583372|521611640|FG001|Overall Study|Physician Decision|1|||
144265261|NCT04414787|520171782|FG001|Overall Study|Patient Death|18|||
144661556|NCT03583372|521611641|FG002|Overall Study|Physician Decision|1|||
144661557|NCT03583372|521611642|FG003|Overall Study|Physician Decision|1|||
144661558|NCT03583372|521611639|FG000|Overall Study|Lack of Efficacy|0|||
144661559|NCT03583372|521611640|FG001|Overall Study|Lack of Efficacy|1|||
144661560|NCT03583372|521611641|FG002|Overall Study|Lack of Efficacy|0|||
144661561|NCT03583372|521611642|FG003|Overall Study|Lack of Efficacy|1|||
144661562|NCT03583372|521611639|FG000|Overall Study|Death|1|||
144661563|NCT03583372|521611640|FG001|Overall Study|Death|0|||
144661564|NCT03583372|521611641|FG002|Overall Study|Death|0|||
144661565|NCT03583372|521611642|FG003|Overall Study|Death|0|||
144661566|NCT03583372|521611639|FG000|Overall Study|Protocol Violation|0|||
144661567|NCT03583372|521611640|FG001|Overall Study|Protocol Violation|1|||
144661568|NCT03583372|521611641|FG002|Overall Study|Protocol Violation|0|||
144661569|NCT03583372|521611642|FG003|Overall Study|Protocol Violation|0|||
144661570|NCT03583372|521611639|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
144661571|NCT03583372|521611640|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
144661572|NCT03583372|521611641|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
144661573|NCT03583372|521611642|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
144661574|NCT03583372|521611639|FG000|Overall Study|Did Not Receive Study Drug|0|||
144661575|NCT03583372|521611640|FG001|Overall Study|Did Not Receive Study Drug|1|||
144661576|NCT03583372|521611641|FG002|Overall Study|Did Not Receive Study Drug|0|||
144661577|NCT03583372|521611642|FG003|Overall Study|Did Not Receive Study Drug|0|||
144661578|NCT03583372|521611639|FG000|Overall Study|Captured as Other in the Database|1|||
144661579|NCT03583372|521611640|FG001|Overall Study|Captured as Other in the Database|2|||
144661580|NCT03583372|521611641|FG002|Overall Study|Captured as Other in the Database|4|||
144661581|NCT03583372|521611642|FG003|Overall Study|Captured as Other in the Database|1|||
144661582|NCT02796391|521611643|FG000|Overall Study|Lost to Follow-up|2|||
144661583|NCT02796391|521611644|FG001|Overall Study|Lost to Follow-up|2|||
144661584|NCT02796391|521611645|FG002|Overall Study|Lost to Follow-up|13|||
144661585|NCT02796391|521611646|FG003|Overall Study|Lost to Follow-up|8|||
144661586|NCT02796391|521611647|FG004|Overall Study|Lost to Follow-up|14|||
144661587|NCT02796391|521611648|FG005|Overall Study|Lost to Follow-up|13|||
144661588|NCT02796391|521611643|FG000|Overall Study|COVID|0|||
144661589|NCT02796391|521611644|FG001|Overall Study|COVID|0|||
144661590|NCT02796391|521611645|FG002|Overall Study|COVID|5|||
144661591|NCT02796391|521611646|FG003|Overall Study|COVID|5|||
144661592|NCT02796391|521611647|FG004|Overall Study|COVID|2|||
144661593|NCT02796391|521611648|FG005|Overall Study|COVID|4|||
144661594|NCT02796391|521611643|FG000|Overall Study|Participant did not like study cigarettes|0|||
144661595|NCT02796391|521611644|FG001|Overall Study|Participant did not like study cigarettes|0|||
144661596|NCT02796391|521611645|FG002|Overall Study|Participant did not like study cigarettes|3|||
144661597|NCT02796391|521611646|FG003|Overall Study|Participant did not like study cigarettes|0|||
144661598|NCT02796391|521611647|FG004|Overall Study|Participant did not like study cigarettes|0|||
144661599|NCT02796391|521611648|FG005|Overall Study|Participant did not like study cigarettes|0|||
144661600|NCT02796391|521611643|FG000|Overall Study|Withdrawal by Subject|1|||
144661601|NCT02796391|521611644|FG001|Overall Study|Withdrawal by Subject|1|||
144661602|NCT02796391|521611645|FG002|Overall Study|Withdrawal by Subject|4|||
144661603|NCT02796391|521611646|FG003|Overall Study|Withdrawal by Subject|3|||
144661604|NCT02796391|521611647|FG004|Overall Study|Withdrawal by Subject|4|||
144661605|NCT02796391|521611648|FG005|Overall Study|Withdrawal by Subject|3|||
144661606|NCT02796391|521611643|FG000|Overall Study|Adverse Event|0|||
144661607|NCT02796391|521611644|FG001|Overall Study|Adverse Event|0|||
144661608|NCT02796391|521611645|FG002|Overall Study|Adverse Event|0|||
144661609|NCT02796391|521611646|FG003|Overall Study|Adverse Event|1|||
144661610|NCT02796391|521611647|FG004|Overall Study|Adverse Event|0|||
144661611|NCT02796391|521611648|FG005|Overall Study|Adverse Event|0|||
144661612|NCT02796391|521611643|FG000|Overall Study|Protocol Violation|0|||
144661613|NCT02796391|521611644|FG001|Overall Study|Protocol Violation|0|||
144661614|NCT02796391|521611645|FG002|Overall Study|Protocol Violation|0|||
144661615|NCT02796391|521611646|FG003|Overall Study|Protocol Violation|1|||
144661616|NCT02796391|521611647|FG004|Overall Study|Protocol Violation|0|||
144661617|NCT02796391|521611648|FG005|Overall Study|Protocol Violation|0|||
144661618|NCT00831441|521611649|FG000|Randomized|Death|82|||
144661619|NCT00831441|521611650|FG001|Randomized|Death|81|||
144661620|NCT00831441|521611649|FG000|Randomized|Adverse Event|248|||
144661621|NCT00831441|521611650|FG001|Randomized|Adverse Event|321|||
144661622|NCT00831441|521611649|FG000|Randomized|Emergency procedure|2|||
144661623|NCT00831441|521611650|FG001|Randomized|Emergency procedure|2|||
144661624|NCT00831441|521611649|FG000|Randomized|Elective procedure|26|||
144661625|NCT00831441|521611650|FG001|Randomized|Elective procedure|25|||
144661626|NCT00831441|521611649|FG000|Randomized|Physician Decision|26|||
144661627|NCT00831441|521611650|FG001|Randomized|Physician Decision|35|||
144661628|NCT00831441|521611649|FG000|Randomized|No longer met criteria|13|||
144661629|NCT00831441|521611650|FG001|Randomized|No longer met criteria|19|||
144661630|NCT00831441|521611649|FG000|Randomized|Withdrawal by Subject|178|||
144661631|NCT00831441|521611650|FG001|Randomized|Withdrawal by Subject|212|||
144661632|NCT00831441|521611649|FG000|Randomized|Lost to Follow-up|26|||
144661633|NCT00831441|521611650|FG001|Randomized|Lost to Follow-up|35|||
144661634|NCT00831441|521611649|FG000|Randomized|Administrative reason by sponsor|2780|||
144265262|NCT04414787|520171783|FG002|Overall Study|Patient Death|15|||
144661635|NCT00831441|521611650|FG001|Randomized|Administrative reason by sponsor|2671|||
144661636|NCT00831441|521611649|FG000|Randomized|poor/non-compliance|30|||
144661637|NCT00831441|521611650|FG001|Randomized|poor/non-compliance|38|||
144661638|NCT00831441|521611649|FG000|Randomized|non-specified|276|||
144661639|NCT00831441|521611650|FG001|Randomized|non-specified|266|||
144661640|NCT00831441|521611649|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
144661641|NCT00831441|521611650|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
144661642|NCT00831441|521611649|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
144265263|NCT04414787|520171784|FG003|Overall Study|Patient Death|15|||
144265264|NCT04414787|520171781|FG000|Overall Study|Patient Hospitalization|1|||
144265265|NCT04414787|520171782|FG001|Overall Study|Patient Hospitalization|1|||
144265266|NCT04414787|520171783|FG002|Overall Study|Patient Hospitalization|2|||
144265267|NCT04414787|520171784|FG003|Overall Study|Patient Hospitalization|2|||
144265268|NCT04414787|520171781|FG000|Overall Study|Lost to Follow-up|7|||
144265269|NCT04414787|520171782|FG001|Overall Study|Lost to Follow-up|7|||
144265270|NCT04414787|520171783|FG002|Overall Study|Lost to Follow-up|5|||
144265271|NCT04414787|520171784|FG003|Overall Study|Lost to Follow-up|5|||
144265272|NCT04414787|520171781|FG000|Overall Study|Residence in post-acute care facility|3|||
144265273|NCT04414787|520171782|FG001|Overall Study|Residence in post-acute care facility|3|||
144265274|NCT04414787|520171783|FG002|Overall Study|Residence in post-acute care facility|5|||
144265275|NCT04414787|520171784|FG003|Overall Study|Residence in post-acute care facility|5|||
144265276|NCT00490919|520171785|FG000|Open-label Run-in Period|Adverse Event|239|||
144265277|NCT00490919|520171786|FG001|Open-label Run-in Period|Adverse Event|0|||
144265278|NCT00490919|520171787|FG002|Open-label Run-in Period|Adverse Event|0|||
144265279|NCT00490919|520171785|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
144265280|NCT00490919|520171786|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
144265281|NCT00490919|520171787|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
144265282|NCT00490919|520171785|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
144265283|NCT00490919|520171786|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
144265284|NCT00490919|520171787|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
144265285|NCT00490919|520171785|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
144265286|NCT00490919|520171786|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
144265287|NCT00490919|520171787|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
144265288|NCT00490919|520171785|FG000|Open-label Run-in Period|Administrative|40|||
144265289|NCT00490919|520171786|FG001|Open-label Run-in Period|Administrative|0|||
144265290|NCT00490919|520171787|FG002|Open-label Run-in Period|Administrative|0|||
144265291|NCT00490919|520171785|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
144265292|NCT00490919|520171786|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
144265293|NCT00490919|520171787|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
144265294|NCT00490919|520171785|FG000|Double-blind Phase|Adverse Event|0|||
144265295|NCT00490919|520171786|FG001|Double-blind Phase|Adverse Event|40|||
144265296|NCT00490919|520171787|FG002|Double-blind Phase|Adverse Event|20|||
144265297|NCT00490919|520171785|FG000|Double-blind Phase|Withdrawal by Subject|0|||
144265298|NCT00490919|520171786|FG001|Double-blind Phase|Withdrawal by Subject|10|||
144265299|NCT00490919|520171787|FG002|Double-blind Phase|Withdrawal by Subject|11|||
144265300|NCT00490919|520171785|FG000|Double-blind Phase|Lost to Follow-up|0|||
144265301|NCT00490919|520171786|FG001|Double-blind Phase|Lost to Follow-up|8|||
144265302|NCT00490919|520171787|FG002|Double-blind Phase|Lost to Follow-up|11|||
144265303|NCT00490919|520171785|FG000|Double-blind Phase|Lack of Efficacy|0|||
144265304|NCT00490919|520171786|FG001|Double-blind Phase|Lack of Efficacy|22|||
144265305|NCT00490919|520171787|FG002|Double-blind Phase|Lack of Efficacy|36|||
144265306|NCT00490919|520171785|FG000|Double-blind Phase|Administrative|0|||
144265307|NCT00490919|520171786|FG001|Double-blind Phase|Administrative|6|||
144265308|NCT00490919|520171787|FG002|Double-blind Phase|Administrative|6|||
144661643|NCT00831441|521611650|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
144661644|NCT00831441|521611649|FG000|Follow Up (30 Days)|Death|63|||
144661645|NCT00831441|521611650|FG001|Follow Up (30 Days)|Death|86|||
144661646|NCT00831441|521611649|FG000|Follow Up (30 Days)|non-specified|16|||
144661647|NCT00831441|521611650|FG001|Follow Up (30 Days)|non-specified|26|||
144661648|NCT00831441|521611649|FG000|Follow Up (30 Days)|missing end of study status|0|||
144661649|NCT00831441|521611650|FG001|Follow Up (30 Days)|missing end of study status|1|||
144661650|NCT05674344|521611651|FG000|Overall Study|Screen Fail|21|||
144661651|NCT05674344|521611651|FG000|Overall Study|Incomplete study procedures|3|||
144661652|NCT04831515|521611652|FG000|First Intervention|Adverse Event|0|||
144661653|NCT04831515|521611653|FG001|First Intervention|Adverse Event|1|||
144661654|NCT00756886|521611657|FG000|Overall Study|Lost to Follow-up|1|||
144661655|NCT00756886|521611658|FG001|Overall Study|Lost to Follow-up|0|||
144661656|NCT00756886|521611657|FG000|Overall Study|Adverse Event|0|||
144661657|NCT00756886|521611658|FG001|Overall Study|Adverse Event|3|||
144661658|NCT00756886|521611657|FG000|Overall Study|Lack of Efficacy|1|||
144661659|NCT00756886|521611658|FG001|Overall Study|Lack of Efficacy|0|||
144661660|NCT00756886|521611657|FG000|Overall Study|Ineligible|9|||
144661661|NCT00756886|521611658|FG001|Overall Study|Ineligible|4|||
144661662|NCT04348656|521611660|FG000|Overall Study|Withdrawal by Subject|2|||
144661663|NCT04348656|521611661|FG001|Overall Study|Withdrawal by Subject|0|||
144661664|NCT04348656|521611660|FG000|Overall Study|Lost to Follow-up|11|||
144661665|NCT04348656|521611661|FG001|Overall Study|Lost to Follow-up|6|||
144265309|NCT02481050|520173871|FG000|Overall Study|Adverse Event|1|||
144265310|NCT02481050|520173871|FG000|Overall Study|Disease Progression|47|||
144265311|NCT02481050|520173871|FG000|Overall Study|Withdrawal by Subject|7|||
144265312|NCT02481050|520173871|FG000|Overall Study|Other|3|||
144265313|NCT02357459|520173872|FG000|Overall Study|Adverse Event|0|||
144265314|NCT02357459|520173873|FG001|Overall Study|Adverse Event|1|||
144265315|NCT02357459|520173874|FG002|Overall Study|Adverse Event|1|||
144661666|NCT03072719|521611662|FG000|Overall Study|Adverse Event|1|||
144661667|NCT03072719|521611663|FG001|Overall Study|Adverse Event|1|||
144661668|NCT01088438|521611664|FG000|Overall Study|Withdrawal by Subject|11|||
144661669|NCT01088438|521611665|FG001|Overall Study|Withdrawal by Subject|6|||
144661670|NCT01088438|521611664|FG000|Overall Study|Lost to Follow-up|18|||
144661671|NCT01088438|521611665|FG001|Overall Study|Lost to Follow-up|30|||
144661672|NCT01363713|521611666|FG000|Overall Study|Adverse Event|1|||
144661673|NCT01363713|521611666|FG000|Overall Study|Protocol Violation|3|||
144661674|NCT01363713|521611666|FG000|Overall Study|Withdrawal by Subject|2|||
144661675|NCT01199055|521611669|FG000|Overall Study|Death|0|||
144661676|NCT01199055|521611670|FG001|Overall Study|Death|1|||
144661677|NCT01199055|521611671|FG002|Overall Study|Death|0|||
144661678|NCT01199055|521611669|FG000|Overall Study|Physician Decision|0|||
144661679|NCT01199055|521611670|FG001|Overall Study|Physician Decision|1|||
144661680|NCT01199055|521611671|FG002|Overall Study|Physician Decision|1|||
144661681|NCT01199055|521611669|FG000|Overall Study|Progressive disease|2|||
144661682|NCT01199055|521611670|FG001|Overall Study|Progressive disease|1|||
144661683|NCT01199055|521611671|FG002|Overall Study|Progressive disease|2|||
144661684|NCT01199055|521611669|FG000|Overall Study|Withdrawal by Subject|0|||
144661685|NCT01199055|521611670|FG001|Overall Study|Withdrawal by Subject|0|||
144661686|NCT01199055|521611671|FG002|Overall Study|Withdrawal by Subject|1|||
144661687|NCT00511342|521611672|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
144661688|NCT00511342|521611673|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
144733186|NCT03135834|521879321|FG000|Stage 1|Withdrawal by Subject|16|||
144733187|NCT03135834|521879322|FG001|Stage 1|Withdrawal by Subject|22|||
144733188|NCT03135834|521879323|FG002|Stage 1|Withdrawal by Subject|7|||
144733189|NCT03135834|521879324|FG003|Stage 1|Withdrawal by Subject|10|||
144733190|NCT03135834|521879321|FG000|Stage 1|Randomized but not Vaccinated|0|||
144733191|NCT03135834|521879322|FG001|Stage 1|Randomized but not Vaccinated|3|||
144733192|NCT03135834|521879323|FG002|Stage 1|Randomized but not Vaccinated|1|||
144733193|NCT03135834|521879324|FG003|Stage 1|Randomized but not Vaccinated|6|||
144733194|NCT03135834|521879321|FG000|Stage 2|Lost to Follow-up|0|||
144733195|NCT03135834|521879322|FG001|Stage 2|Lost to Follow-up|1|||
144733196|NCT03135834|521879323|FG002|Stage 2|Lost to Follow-up|0|||
144733197|NCT03135834|521879324|FG003|Stage 2|Lost to Follow-up|0|||
144733198|NCT03135834|521879321|FG000|Stage 2|Withdrawal by Subject|0|||
144733199|NCT03135834|521879322|FG001|Stage 2|Withdrawal by Subject|1|||
144733200|NCT03135834|521879323|FG002|Stage 2|Withdrawal by Subject|0|||
144733201|NCT03135834|521879324|FG003|Stage 2|Withdrawal by Subject|0|||
144733202|NCT03135834|521879321|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
144733203|NCT03135834|521879322|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
144733204|NCT03135834|521879323|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
144733205|NCT03135834|521879324|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
144733206|NCT03135834|521879321|FG000|Stage 2|Did not receive Booster Vaccination|1|||
144733207|NCT03135834|521879322|FG001|Stage 2|Did not receive Booster Vaccination|1|||
144733208|NCT03135834|521879323|FG002|Stage 2|Did not receive Booster Vaccination|0|||
144733209|NCT03135834|521879324|FG003|Stage 2|Did not receive Booster Vaccination|0|||
144733210|NCT00965185|521879325|FG000|Overall Study|Lost to Follow-up|2|||
144733211|NCT00965185|521879326|FG001|Overall Study|Lost to Follow-up|0|||
144733212|NCT00965185|521879325|FG000|Overall Study|Withdrawal by Subject|0|||
144733213|NCT00965185|521879326|FG001|Overall Study|Withdrawal by Subject|1|||
144733214|NCT02100228|521879327|FG000|Overall Study|Other|19|||
144733215|NCT02100228|521879328|FG001|Overall Study|Other|19|||
144733216|NCT02100228|521879327|FG000|Overall Study|Administrative reason|0|||
144733217|NCT02100228|521879328|FG001|Overall Study|Administrative reason|1|||
144733218|NCT02100228|521879327|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
144733219|NCT02100228|521879328|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
144733220|NCT02100228|521879327|FG000|Overall Study|Non-compliance|0|||
144733221|NCT02100228|521879328|FG001|Overall Study|Non-compliance|3|||
144733222|NCT02100228|521879327|FG000|Overall Study|Lost to Follow-up|0|||
144733223|NCT02100228|521879328|FG001|Overall Study|Lost to Follow-up|1|||
144733224|NCT02100228|521879327|FG000|Overall Study|Withdrawal by Subject|27|||
144733225|NCT02100228|521879328|FG001|Overall Study|Withdrawal by Subject|37|||
144733226|NCT02100228|521879327|FG000|Overall Study|Adverse Event|16|||
144733227|NCT02100228|521879328|FG001|Overall Study|Adverse Event|12|||
144733228|NCT02100228|521879327|FG000|Overall Study|Death|1|||
144733229|NCT02100228|521879328|FG001|Overall Study|Death|1|||
144733230|NCT00214422|521879329|FG000|Overall Study|Physician Decision|2|||
144733231|NCT00214422|521879330|FG001|Overall Study|Physician Decision|0|||
144733232|NCT00214422|521879331|FG002|Overall Study|Physician Decision|0|||
144661689|NCT00511342|521611672|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
144661690|NCT00511342|521611673|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
144661691|NCT00511342|521611672|FG000|Overall Study|Pregnancy|0|||
144661692|NCT00511342|521611673|FG001|Overall Study|Pregnancy|1|||
144733233|NCT00214422|521879329|FG000|Overall Study|Developed esophageal ca|1|||
144733234|NCT00214422|521879330|FG001|Overall Study|Developed esophageal ca|0|||
144733235|NCT00214422|521879331|FG002|Overall Study|Developed esophageal ca|0|||
144733236|NCT00214422|521879329|FG000|Overall Study|Pt taken off study|1|||
144733237|NCT00214422|521879330|FG001|Overall Study|Pt taken off study|1|||
144661693|NCT00511342|521611672|FG000|Overall Study|Pregnancy wish|0|||
144661694|NCT00511342|521611673|FG001|Overall Study|Pregnancy wish|1|||
144661695|NCT00511342|521611672|FG000|Overall Study|Lost to Follow-up|1|||
144661696|NCT00511342|521611673|FG001|Overall Study|Lost to Follow-up|5|||
144661697|NCT00511342|521611672|FG000|Overall Study|Other Reason|2|||
144661698|NCT00511342|521611673|FG001|Overall Study|Other Reason|2|||
144661699|NCT02432040|521611674|FG000|Overall Study|Lack of Efficacy|3|||
144661700|NCT02432040|521611675|FG001|Overall Study|Lack of Efficacy|0|||
144661701|NCT02432040|521611674|FG000|Overall Study|Lost to Follow-up|4|||
144661702|NCT02432040|521611675|FG001|Overall Study|Lost to Follow-up|5|||
144661703|NCT02432040|521611674|FG000|Overall Study|Physician Decision|1|||
144661704|NCT02432040|521611675|FG001|Overall Study|Physician Decision|1|||
144661705|NCT00305253|521611679|FG000|Overall Study|Withdrawal by Subject|0|||
144661706|NCT00305253|521611680|FG001|Overall Study|Withdrawal by Subject|1|||
144661707|NCT01357915|521611681|FG000|Overall Study|Lost to Follow-up|3|||
144661708|NCT01357915|521611682|FG001|Overall Study|Lost to Follow-up|0|||
144661709|NCT01019486|521611684|FG000|Overall Study|Withdrawal by Subject|1|||
144661710|NCT01019486|521611685|FG001|Overall Study|Withdrawal by Subject|1|||
144661711|NCT01019486|521611686|FG002|Overall Study|Withdrawal by Subject|1|||
144661712|NCT05373706|521611688|FG000|Overall Study|Lost to Follow-up|2|||
144661713|NCT05373706|521611689|FG001|Overall Study|Lost to Follow-up|2|||
144661714|NCT02402218|521611692|FG000|Overall Study|Did not pickup study medication|12|||
144661715|NCT02402218|521611693|FG001|Overall Study|Did not pickup study medication|9|||
144661716|NCT02402218|521611694|FG002|Overall Study|Did not pickup study medication|13|||
144661717|NCT02402218|521611692|FG000|Overall Study|Lack of Efficacy|0|||
144661718|NCT02402218|521611693|FG001|Overall Study|Lack of Efficacy|1|||
144661719|NCT02402218|521611694|FG002|Overall Study|Lack of Efficacy|1|||
144661720|NCT02402218|521611692|FG000|Overall Study|Death|1|||
144661721|NCT02402218|521611693|FG001|Overall Study|Death|0|||
144661722|NCT02402218|521611694|FG002|Overall Study|Death|0|||
144661723|NCT02402218|521611692|FG000|Overall Study|Reinfection|0|||
144661724|NCT02402218|521611693|FG001|Overall Study|Reinfection|0|||
144661725|NCT02402218|521611694|FG002|Overall Study|Reinfection|1|||
144661726|NCT02402218|521611692|FG000|Overall Study|Adverse Event|0|||
144661727|NCT02402218|521611693|FG001|Overall Study|Adverse Event|2|||
144661728|NCT02402218|521611694|FG002|Overall Study|Adverse Event|1|||
144733238|NCT00214422|521879331|FG002|Overall Study|Pt taken off study|0|||
144661729|NCT02402218|521611692|FG000|Overall Study|Withdrawal by Subject|1|||
144661730|NCT02402218|521611693|FG001|Overall Study|Withdrawal by Subject|1|||
144733239|NCT00214422|521879329|FG000|Overall Study|Disease progression on study|1|||
144733240|NCT00214422|521879330|FG001|Overall Study|Disease progression on study|0|||
144733241|NCT00214422|521879331|FG002|Overall Study|Disease progression on study|0|||
144733242|NCT00214422|521879329|FG000|Overall Study|Unable to make a radiation treatment|0|||
144733243|NCT00214422|521879330|FG001|Overall Study|Unable to make a radiation treatment|0|||
144733244|NCT00214422|521879331|FG002|Overall Study|Unable to make a radiation treatment|1|||
144733245|NCT02612337|521879333|FG000|Overall Study|Lack of Efficacy|1|||
144733246|NCT02612337|521879334|FG001|Overall Study|Lack of Efficacy|0|||
144733247|NCT02612337|521879333|FG000|Overall Study|Withdrawal by Subject|2|||
144733248|NCT02612337|521879334|FG001|Overall Study|Withdrawal by Subject|2|||
144733249|NCT02612337|521879333|FG000|Overall Study|Did not receive study drug|0|||
144733250|NCT02612337|521879334|FG001|Overall Study|Did not receive study drug|1|||
144733251|NCT00854100|521879339|FG000|Overall Study|Inability to complete the study visits|0|||
144733252|NCT00854100|521879340|FG001|Overall Study|Inability to complete the study visits|0|||
144733253|NCT00854100|521879341|FG002|Overall Study|Inability to complete the study visits|1|||
144733254|NCT00854100|521879339|FG000|Overall Study|Lost to Follow-up|2|||
144733255|NCT00854100|521879340|FG001|Overall Study|Lost to Follow-up|0|||
144733256|NCT00854100|521879341|FG002|Overall Study|Lost to Follow-up|3|||
144661731|NCT02402218|521611694|FG002|Overall Study|Withdrawal by Subject|1|||
144661732|NCT03011840|521611695|FG000|Overall Study|Not received PIL in post PIL phase|0|||
144661733|NCT03011840|521611696|FG001|Overall Study|Not received PIL in post PIL phase|21|||
144661734|NCT03738566|521611697|FG000|Initial Study Phase|Withdrawal by Subject|1|||
144661735|NCT03738566|521611698|FG001|Initial Study Phase|Withdrawal by Subject|1|||
144661736|NCT03738566|521611699|FG002|Initial Study Phase|Withdrawal by Subject|2|||
144661737|NCT03738566|521611700|FG003|Initial Study Phase|Withdrawal by Subject|0|||
144661738|NCT03738566|521611697|FG000|Initial Study Phase|Death|0|||
144661739|NCT03738566|521611698|FG001|Initial Study Phase|Death|1|||
144661740|NCT03738566|521611699|FG002|Initial Study Phase|Death|0|||
144733257|NCT00854100|521879339|FG000|Overall Study|Withdrawal by Subject|3|||
144733258|NCT00854100|521879340|FG001|Overall Study|Withdrawal by Subject|1|||
144733259|NCT00854100|521879341|FG002|Overall Study|Withdrawal by Subject|2|||
144661741|NCT03738566|521611700|FG003|Initial Study Phase|Death|0|||
144661742|NCT03738566|521611697|FG000|Initial Study Phase|Treatment failure|5|||
144661743|NCT03738566|521611698|FG001|Initial Study Phase|Treatment failure|0|||
144661744|NCT03738566|521611699|FG002|Initial Study Phase|Treatment failure|0|||
144661745|NCT03738566|521611700|FG003|Initial Study Phase|Treatment failure|0|||
144661746|NCT03738566|521611697|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
144661747|NCT03738566|521611698|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
144661748|NCT03738566|521611699|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
144661749|NCT03738566|521611700|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
144661750|NCT00946530|521611701|FG000|Overall Study|Withdrawal by Subject|0|||
144661751|NCT00946530|521611702|FG001|Overall Study|Withdrawal by Subject|3|||
144661752|NCT00946530|521611703|FG002|Overall Study|Withdrawal by Subject|0|||
144661753|NCT00946530|521611704|FG003|Overall Study|Withdrawal by Subject|3|||
144661754|NCT00946530|521611701|FG000|Overall Study|Physician Decision|1|||
144661755|NCT00946530|521611702|FG001|Overall Study|Physician Decision|1|||
144661756|NCT00946530|521611703|FG002|Overall Study|Physician Decision|1|||
144661757|NCT00946530|521611704|FG003|Overall Study|Physician Decision|1|||
144661758|NCT03105700|521611705|FG000|Overall Study|screen fail|3|||
144661759|NCT03105700|521611705|FG000|Overall Study|Lost to Follow-up|4|||
144661760|NCT02768194|521611706|FG000|Period 1|Adverse Event|0|||
144661761|NCT02768194|521611707|FG001|Period 1|Adverse Event|0|||
144661762|NCT02768194|521611708|FG002|Period 1|Adverse Event|0|||
144661763|NCT02768194|521611709|FG003|Period 1|Adverse Event|1|||
144661764|NCT02768194|521611710|FG004|Period 1|Adverse Event|0|||
144661765|NCT02768194|521611711|FG005|Period 1|Adverse Event|0|||
144661766|NCT02768194|521611706|FG000|Period 2|Other (Reason not specified)|1|||
144661767|NCT02768194|521611707|FG001|Period 2|Other (Reason not specified)|0|||
144661768|NCT02768194|521611708|FG002|Period 2|Other (Reason not specified)|0|||
144661769|NCT02768194|521611709|FG003|Period 2|Other (Reason not specified)|0|||
144661770|NCT02768194|521611710|FG004|Period 2|Other (Reason not specified)|0|||
144661771|NCT02768194|521611711|FG005|Period 2|Other (Reason not specified)|0|||
144661772|NCT02768194|521611706|FG000|Period 3|Other (Reason not specified)|0|||
144661773|NCT02768194|521611707|FG001|Period 3|Other (Reason not specified)|1|||
144661774|NCT02768194|521611708|FG002|Period 3|Other (Reason not specified)|0|||
144661775|NCT02768194|521611709|FG003|Period 3|Other (Reason not specified)|0|||
144661776|NCT02768194|521611710|FG004|Period 3|Other (Reason not specified)|0|||
144661777|NCT02768194|521611711|FG005|Period 3|Other (Reason not specified)|0|||
144661778|NCT01982773|521611712|FG000|Overall Study|Withdrawal by Subject|1|||
144661779|NCT01982773|521611713|FG001|Overall Study|Withdrawal by Subject|3|||
144661780|NCT01982773|521611712|FG000|Overall Study|Lost to Follow-up|7|||
144661781|NCT01982773|521611713|FG001|Overall Study|Lost to Follow-up|1|||
144661782|NCT01029886|521611714|FG000|Overall Study|Adverse Event|12|||
144661783|NCT01029886|521611715|FG001|Overall Study|Adverse Event|25|||
144661784|NCT01029886|521611714|FG000|Overall Study|Lost to Follow-up|1|||
144661785|NCT01029886|521611715|FG001|Overall Study|Lost to Follow-up|0|||
144661786|NCT01029886|521611714|FG000|Overall Study|Physician Decision|2|||
144661787|NCT01029886|521611715|FG001|Overall Study|Physician Decision|6|||
144661788|NCT01029886|521611714|FG000|Overall Study|Protocol Violation|17|||
144661789|NCT01029886|521611715|FG001|Overall Study|Protocol Violation|5|||
144661790|NCT01029886|521611714|FG000|Overall Study|Withdrawal by Subject|8|||
144661791|NCT01029886|521611715|FG001|Overall Study|Withdrawal by Subject|18|||
144661792|NCT01029886|521611714|FG000|Overall Study|Entry Criteria Not Met|13|||
144661793|NCT01029886|521611715|FG001|Overall Study|Entry Criteria Not Met|5|||
144661794|NCT01029886|521611714|FG000|Overall Study|Sponsor Decision|1|||
144661795|NCT01029886|521611715|FG001|Overall Study|Sponsor Decision|0|||
144661796|NCT01029886|521611714|FG000|Overall Study|Loss Glucose Control|7|||
144661797|NCT01029886|521611715|FG001|Overall Study|Loss Glucose Control|1|||
144661798|NCT01778127|521611718|FG000|Overall Study|Lost to Follow-up|5|||
144661799|NCT01778127|521611719|FG001|Overall Study|Lost to Follow-up|1|||
144661800|NCT01778127|521611720|FG002|Overall Study|Lost to Follow-up|2|||
144661801|NCT01778127|521611718|FG000|Overall Study|Withdrawal by Subject|3|||
144661802|NCT01778127|521611719|FG001|Overall Study|Withdrawal by Subject|1|||
144661803|NCT01778127|521611720|FG002|Overall Study|Withdrawal by Subject|4|||
144661804|NCT02720016|521611726|FG000|Overall Study|Separation of couple|6|||
144661805|NCT02720016|521611727|FG001|Overall Study|Separation of couple|8|||
144661806|NCT02720016|521611728|FG002|Overall Study|Separation of couple|2|||
144661807|NCT02720016|521611726|FG000|Overall Study|Withdrawal by Subject|6|||
144661808|NCT02720016|521611727|FG001|Overall Study|Withdrawal by Subject|6|||
144661809|NCT02720016|521611728|FG002|Overall Study|Withdrawal by Subject|4|||
144661810|NCT02720016|521611726|FG000|Overall Study|Scheduling issues|2|||
144661811|NCT02720016|521611727|FG001|Overall Study|Scheduling issues|4|||
144661812|NCT02720016|521611728|FG002|Overall Study|Scheduling issues|7|||
144661813|NCT02720016|521611726|FG000|Overall Study|Childcare|2|||
144661814|NCT02720016|521611727|FG001|Overall Study|Childcare|0|||
144661815|NCT02720016|521611728|FG002|Overall Study|Childcare|2|||
144661816|NCT02720016|521611726|FG000|Overall Study|Withdrawal by PI|2|||
144661817|NCT02720016|521611727|FG001|Overall Study|Withdrawal by PI|2|||
144661818|NCT02720016|521611728|FG002|Overall Study|Withdrawal by PI|0|||
144661819|NCT02720016|521611726|FG000|Overall Study|Moved away|2|||
144661820|NCT02720016|521611727|FG001|Overall Study|Moved away|0|||
144661821|NCT02720016|521611728|FG002|Overall Study|Moved away|0|||
144661822|NCT02720016|521611726|FG000|Overall Study|Not Primary Health Concern|0|||
144661823|NCT02720016|521611727|FG001|Overall Study|Not Primary Health Concern|0|||
144661824|NCT02720016|521611728|FG002|Overall Study|Not Primary Health Concern|2|||
144661825|NCT02720016|521611726|FG000|Overall Study|Transportation issues|0|||
144661826|NCT02720016|521611727|FG001|Overall Study|Transportation issues|0|||
144733260|NCT00854100|521879339|FG000|Overall Study|Protocol Violation|2|||
144733261|NCT00854100|521879340|FG001|Overall Study|Protocol Violation|4|||
144733262|NCT00854100|521879341|FG002|Overall Study|Protocol Violation|3|||
144661827|NCT02720016|521611728|FG002|Overall Study|Transportation issues|1|||
144661828|NCT02720016|521611726|FG000|Overall Study|Other|0|||
144661829|NCT02720016|521611727|FG001|Overall Study|Other|0|||
144661830|NCT02720016|521611728|FG002|Overall Study|Other|2|||
144661831|NCT00751114|521611731|FG000|Overall Study|Adverse Event|2|||
144661832|NCT00751114|521611732|FG001|Overall Study|Adverse Event|4|||
144661833|NCT00751114|521611731|FG000|Overall Study|Protocol Violation|8|||
144661834|NCT00751114|521611732|FG001|Overall Study|Protocol Violation|9|||
144661835|NCT00751114|521611731|FG000|Overall Study|Withdrawal by Subject|9|||
144661836|NCT00751114|521611732|FG001|Overall Study|Withdrawal by Subject|4|||
144661837|NCT00751114|521611731|FG000|Overall Study|Lost to Follow-up|4|||
144661838|NCT00751114|521611732|FG001|Overall Study|Lost to Follow-up|7|||
144661839|NCT00751114|521611731|FG000|Overall Study|Lack of Efficacy|0|||
144661840|NCT00751114|521611732|FG001|Overall Study|Lack of Efficacy|7|||
144661841|NCT00751114|521611731|FG000|Overall Study|Not Treated|13|||
144661842|NCT00751114|521611732|FG001|Overall Study|Not Treated|1|||
144661843|NCT00751114|521611731|FG000|Overall Study|Out of country for 2 months|1|||
144661844|NCT00751114|521611732|FG001|Overall Study|Out of country for 2 months|0|||
144661845|NCT00751114|521611731|FG000|Overall Study|Move to another city|1|||
144661846|NCT00751114|521611732|FG001|Overall Study|Move to another city|0|||
144661847|NCT05319080|521611733|FG000|Overall Study|Withdrawal by Subject|2|||
144661848|NCT05319080|521611733|FG000|Overall Study|Physician Decision|4|||
144661849|NCT01536119|521611734|FG000|Overall Study|Lost to Follow-up|17|||
144661850|NCT01536119|521611735|FG001|Overall Study|Lost to Follow-up|14|||
144661851|NCT00448916|521611736|FG000|Overall Study|Adverse Event|2|||
144661852|NCT00448916|521611737|FG001|Overall Study|Adverse Event|2|||
144661853|NCT00448916|521611738|FG002|Overall Study|Adverse Event|3|||
144661854|NCT00448916|521611739|FG003|Overall Study|Adverse Event|2|||
144661855|NCT00448916|521611736|FG000|Overall Study|Lack of Efficacy|1|||
144661856|NCT00448916|521611737|FG001|Overall Study|Lack of Efficacy|0|||
144661857|NCT00448916|521611738|FG002|Overall Study|Lack of Efficacy|2|||
144661858|NCT00448916|521611739|FG003|Overall Study|Lack of Efficacy|1|||
144661859|NCT00448916|521611736|FG000|Overall Study|Withdrawal by Subject|3|||
144661860|NCT00448916|521611737|FG001|Overall Study|Withdrawal by Subject|3|||
144661861|NCT00448916|521611738|FG002|Overall Study|Withdrawal by Subject|1|||
144661862|NCT00448916|521611739|FG003|Overall Study|Withdrawal by Subject|1|||
144661863|NCT00448916|521611736|FG000|Overall Study|Other|1|||
144661864|NCT00448916|521611737|FG001|Overall Study|Other|0|||
144661865|NCT00448916|521611738|FG002|Overall Study|Other|0|||
144661866|NCT00448916|521611739|FG003|Overall Study|Other|0|||
144661867|NCT00448916|521611736|FG000|Overall Study|Lost to Follow-up|0|||
144661868|NCT00448916|521611737|FG001|Overall Study|Lost to Follow-up|1|||
144661869|NCT00448916|521611738|FG002|Overall Study|Lost to Follow-up|0|||
144661870|NCT00448916|521611739|FG003|Overall Study|Lost to Follow-up|1|||
144661871|NCT00448916|521611736|FG000|Overall Study|Protocol Violation|0|||
144661872|NCT00448916|521611737|FG001|Overall Study|Protocol Violation|0|||
144661873|NCT00448916|521611738|FG002|Overall Study|Protocol Violation|0|||
144661874|NCT00448916|521611739|FG003|Overall Study|Protocol Violation|1|||
144661875|NCT03655717|521611740|FG000|Overall Study|Withdrawal by Subject|4|||
144661876|NCT03655717|521611741|FG001|Overall Study|Withdrawal by Subject|8|||
144661877|NCT03655717|521611742|FG002|Overall Study|Withdrawal by Subject|1|||
144661878|NCT03655717|521611743|FG003|Overall Study|Withdrawal by Subject|0|||
144661879|NCT03655717|521611744|FG004|Overall Study|Withdrawal by Subject|0|||
144661880|NCT03655717|521611745|FG005|Overall Study|Withdrawal by Subject|1|||
144661881|NCT03655717|521611746|FG006|Overall Study|Withdrawal by Subject|3|||
144661882|NCT03655717|521611747|FG007|Overall Study|Withdrawal by Subject|1|||
144661883|NCT03655717|521611748|FG008|Overall Study|Withdrawal by Subject|2|||
144661884|NCT03655717|521611749|FG009|Overall Study|Withdrawal by Subject|0|||
144661885|NCT03655717|521611750|FG010|Overall Study|Withdrawal by Subject|0|||
144661886|NCT03655717|521611751|FG011|Overall Study|Withdrawal by Subject|1|||
144661887|NCT03655717|521611752|FG012|Overall Study|Withdrawal by Subject|0|||
144661888|NCT03655717|521611753|FG013|Overall Study|Withdrawal by Subject|3|||
144661889|NCT03655717|521611754|FG014|Overall Study|Withdrawal by Subject|0|||
144661890|NCT03655717|521611755|FG015|Overall Study|Withdrawal by Subject|1|||
144733263|NCT00854100|521879339|FG000|Overall Study|Adverse Event|2|||
144733264|NCT00854100|521879340|FG001|Overall Study|Adverse Event|1|||
144661891|NCT03655717|521611756|FG016|Overall Study|Withdrawal by Subject|0|||
144661892|NCT03655717|521611757|FG017|Overall Study|Withdrawal by Subject|0|||
144661893|NCT03655717|521611758|FG018|Overall Study|Withdrawal by Subject|1|||
144661894|NCT03655717|521611759|FG019|Overall Study|Withdrawal by Subject|0|||
144661895|NCT03655717|521611760|FG020|Overall Study|Withdrawal by Subject|0|||
144661896|NCT03655717|521611761|FG021|Overall Study|Withdrawal by Subject|1|||
144661897|NCT03655717|521611762|FG022|Overall Study|Withdrawal by Subject|2|||
144661898|NCT03655717|521611763|FG023|Overall Study|Withdrawal by Subject|1|||
144661899|NCT03655717|521611764|FG024|Overall Study|Withdrawal by Subject|1|||
144733265|NCT00854100|521879341|FG002|Overall Study|Adverse Event|2|||
144733266|NCT02216071|521879351|FG000|Overall Study|Withdrawal by Subject|7|||
144733267|NCT02216071|521879352|FG001|Overall Study|Withdrawal by Subject|2|||
144733268|NCT02216071|521879351|FG000|Overall Study|Lost to Follow-up|3|||
144733269|NCT02216071|521879352|FG001|Overall Study|Lost to Follow-up|3|||
144733270|NCT02216071|521879351|FG000|Overall Study|Protocol Violation|3|||
144733271|NCT02216071|521879352|FG001|Overall Study|Protocol Violation|5|||
144733272|NCT02216071|521879351|FG000|Overall Study|Other|2|||
144733273|NCT02216071|521879352|FG001|Overall Study|Other|2|||
144733274|NCT04753437|521879353|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144733275|NCT04753437|521879354|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
144733276|NCT04753437|521879353|FG000|Overall Study|Liver Function Test Abnormalities|2|||
144733277|NCT04753437|521879354|FG001|Overall Study|Liver Function Test Abnormalities|4|||
144733278|NCT01066143|521880561|FG000|Overall Study|ineligible for the study|8|||
144733279|NCT00851877|521880567|FG000|Phase I-1|Death|1|||
144733280|NCT00851877|521880568|FG001|Phase I-1|Death|0|||
144733281|NCT00851877|521880569|FG002|Phase I-1|Death|0|||
144733282|NCT00851877|521880567|FG000|Phase II|Withdrawal by Subject|0|||
144733283|NCT00851877|521880568|FG001|Phase II|Withdrawal by Subject|0|||
144733284|NCT00851877|521880569|FG002|Phase II|Withdrawal by Subject|3|||
144733285|NCT00620074|521880570|FG000|Overall Study|Adverse Event|1|||
144733286|NCT00829673|521880571|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144733287|NCT00829673|521880572|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144733288|NCT03214952|521880575|FG000|Overall Study|Protocol Deviation|45|||
144733289|NCT03214952|521880575|FG000|Overall Study|Case Report Forms Uncollected|13|||
144733290|NCT00829790|521880576|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
144733291|NCT00829790|521880577|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
144733292|NCT02246166|521880578|FG000|Overall Study|Protocol Violation|1|||
144733293|NCT02246166|521880579|FG001|Overall Study|Protocol Violation|0|||
144733294|NCT03769896|521880580|FG000|Open-label Phase|Lack of Efficacy|5|||
144733295|NCT03769896|521880581|FG001|Open-label Phase|Lack of Efficacy|0|||
144733296|NCT03769896|521880580|FG000|Open-label Phase|Adverse Event|3|||
144733297|NCT03769896|521880581|FG001|Open-label Phase|Adverse Event|0|||
144733298|NCT03769896|521880580|FG000|Open-label Phase|Withdrawal by Subject|1|||
144733299|NCT03769896|521880581|FG001|Open-label Phase|Withdrawal by Subject|0|||
144733300|NCT04112823|521880586|FG000|Overall Study|Lost to Follow-up|2|||
144733301|NCT04112823|521880587|FG001|Overall Study|Lost to Follow-up|3|||
144733302|NCT00625443|521880591|FG000|Overall Study|Adverse Event|1|||
144733303|NCT00625443|521880592|FG001|Overall Study|Adverse Event|4|||
144733304|NCT00625443|521880593|FG002|Overall Study|Adverse Event|0|||
144733305|NCT00625443|521880591|FG000|Overall Study|Non-compliance with protocol|0|||
144733306|NCT00625443|521880592|FG001|Overall Study|Non-compliance with protocol|1|||
144733307|NCT00625443|521880593|FG002|Overall Study|Non-compliance with protocol|0|||
144733308|NCT00625443|521880591|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
144733309|NCT00625443|521880592|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
144733310|NCT00625443|521880593|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
144733311|NCT00625443|521880591|FG000|Overall Study|Withdrawal by Subject|0|||
144733312|NCT00625443|521880592|FG001|Overall Study|Withdrawal by Subject|1|||
144733313|NCT00625443|521880593|FG002|Overall Study|Withdrawal by Subject|2|||
144733314|NCT00625443|521880591|FG000|Overall Study|Physician Decision|0|||
144733315|NCT00625443|521880592|FG001|Overall Study|Physician Decision|4|||
144733316|NCT00625443|521880593|FG002|Overall Study|Physician Decision|2|||
144733317|NCT00625443|521880591|FG000|Overall Study|Other|0|||
144733318|NCT00625443|521880592|FG001|Overall Study|Other|1|||
144733319|NCT00625443|521880593|FG002|Overall Study|Other|1|||
144733320|NCT01182415|521880594|FG000|Overall Study|Lost to Follow-up|1|||
144733321|NCT02587962|521880599|FG000|Overall Study|Adverse Event|0|||
144733322|NCT02587962|521880600|FG001|Overall Study|Adverse Event|0|||
144733323|NCT02587962|521880601|FG002|Overall Study|Adverse Event|1|||
144215218|NCT02717455|519981626|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
144215219|NCT02717455|519981627|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
144215220|NCT02717455|519981628|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
144215221|NCT02717455|519981629|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
144215222|NCT02717455|519981624|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
144733324|NCT02587962|521880602|FG003|Overall Study|Adverse Event|0|||
144733325|NCT02587962|521880603|FG004|Overall Study|Adverse Event|0|||
144733326|NCT02587962|521880599|FG000|Overall Study|Withdrawal by Subject|0|||
144733327|NCT02587962|521880600|FG001|Overall Study|Withdrawal by Subject|0|||
144733328|NCT02587962|521880601|FG002|Overall Study|Withdrawal by Subject|1|||
144733329|NCT02587962|521880602|FG003|Overall Study|Withdrawal by Subject|1|||
144733330|NCT02587962|521880603|FG004|Overall Study|Withdrawal by Subject|4|||
144733331|NCT02587962|521880599|FG000|Overall Study|Radiological progression|2|||
144733332|NCT02587962|521880600|FG001|Overall Study|Radiological progression|2|||
144733333|NCT02587962|521880601|FG002|Overall Study|Radiological progression|2|||
144733334|NCT02587962|521880602|FG003|Overall Study|Radiological progression|5|||
144733335|NCT02587962|521880603|FG004|Overall Study|Radiological progression|10|||
144733336|NCT02587962|521880599|FG000|Overall Study|Clinical progression|0|||
144265316|NCT02357459|520173872|FG000|Overall Study|Withdrawal by Subject|5|||
144661900|NCT03655717|521611765|FG025|Overall Study|Withdrawal by Subject|0|||
144661901|NCT03655717|521611740|FG000|Overall Study|Physician Decision|3|||
144661902|NCT03655717|521611741|FG001|Overall Study|Physician Decision|3|||
144661903|NCT03655717|521611742|FG002|Overall Study|Physician Decision|0|||
144661904|NCT03655717|521611743|FG003|Overall Study|Physician Decision|0|||
144661905|NCT03655717|521611744|FG004|Overall Study|Physician Decision|0|||
144661906|NCT03655717|521611745|FG005|Overall Study|Physician Decision|0|||
144661907|NCT03655717|521611746|FG006|Overall Study|Physician Decision|0|||
144661908|NCT03655717|521611747|FG007|Overall Study|Physician Decision|0|||
144661909|NCT03655717|521611748|FG008|Overall Study|Physician Decision|0|||
144661910|NCT03655717|521611749|FG009|Overall Study|Physician Decision|1|||
144661911|NCT03655717|521611750|FG010|Overall Study|Physician Decision|0|||
144661912|NCT03655717|521611751|FG011|Overall Study|Physician Decision|0|||
144661913|NCT03655717|521611752|FG012|Overall Study|Physician Decision|0|||
144265317|NCT02357459|520173873|FG001|Overall Study|Withdrawal by Subject|3|||
144265318|NCT02357459|520173874|FG002|Overall Study|Withdrawal by Subject|3|||
144265319|NCT02357459|520173872|FG000|Overall Study|Physician Decision|0|||
144265320|NCT02357459|520173873|FG001|Overall Study|Physician Decision|2|||
144265321|NCT02357459|520173874|FG002|Overall Study|Physician Decision|0|||
144265322|NCT02357459|520173872|FG000|Overall Study|Protocol Violation|1|||
144265323|NCT02357459|520173873|FG001|Overall Study|Protocol Violation|1|||
144265324|NCT02357459|520173874|FG002|Overall Study|Protocol Violation|0|||
144265325|NCT02357459|520173872|FG000|Overall Study|Lost to Follow-up|1|||
144265326|NCT02357459|520173873|FG001|Overall Study|Lost to Follow-up|3|||
144265327|NCT02357459|520173874|FG002|Overall Study|Lost to Follow-up|0|||
144265328|NCT02357459|520173872|FG000|Overall Study|Lack of Efficacy|7|||
144265329|NCT02357459|520173873|FG001|Overall Study|Lack of Efficacy|4|||
144265330|NCT02357459|520173874|FG002|Overall Study|Lack of Efficacy|4|||
144265331|NCT02357459|520173872|FG000|Overall Study|Patient Relocated|2|||
144265332|NCT02357459|520173873|FG001|Overall Study|Patient Relocated|0|||
144265333|NCT02357459|520173874|FG002|Overall Study|Patient Relocated|0|||
144265334|NCT02357459|520173872|FG000|Overall Study|Instruction from PCP|1|||
144265335|NCT02357459|520173873|FG001|Overall Study|Instruction from PCP|0|||
144661914|NCT03655717|521611753|FG013|Overall Study|Physician Decision|0|||
144661915|NCT03655717|521611754|FG014|Overall Study|Physician Decision|0|||
144661916|NCT03655717|521611755|FG015|Overall Study|Physician Decision|0|||
144661917|NCT03655717|521611756|FG016|Overall Study|Physician Decision|0|||
144661918|NCT03655717|521611757|FG017|Overall Study|Physician Decision|0|||
144661919|NCT03655717|521611758|FG018|Overall Study|Physician Decision|0|||
144661920|NCT03655717|521611759|FG019|Overall Study|Physician Decision|1|||
144661921|NCT03655717|521611760|FG020|Overall Study|Physician Decision|0|||
144661922|NCT03655717|521611761|FG021|Overall Study|Physician Decision|0|||
144661923|NCT03655717|521611762|FG022|Overall Study|Physician Decision|0|||
144661924|NCT03655717|521611763|FG023|Overall Study|Physician Decision|1|||
144661925|NCT03655717|521611764|FG024|Overall Study|Physician Decision|0|||
144661926|NCT03655717|521611765|FG025|Overall Study|Physician Decision|0|||
144661927|NCT03655717|521611740|FG000|Overall Study|Lost to Follow-up|3|||
144661928|NCT03655717|521611741|FG001|Overall Study|Lost to Follow-up|1|||
144661929|NCT03655717|521611742|FG002|Overall Study|Lost to Follow-up|0|||
144661930|NCT03655717|521611743|FG003|Overall Study|Lost to Follow-up|1|||
144661931|NCT03655717|521611744|FG004|Overall Study|Lost to Follow-up|0|||
144661932|NCT03655717|521611745|FG005|Overall Study|Lost to Follow-up|1|||
144661933|NCT03655717|521611746|FG006|Overall Study|Lost to Follow-up|0|||
144661934|NCT03655717|521611747|FG007|Overall Study|Lost to Follow-up|0|||
144661935|NCT03655717|521611748|FG008|Overall Study|Lost to Follow-up|0|||
144661936|NCT03655717|521611749|FG009|Overall Study|Lost to Follow-up|0|||
144661937|NCT03655717|521611750|FG010|Overall Study|Lost to Follow-up|0|||
144661938|NCT03655717|521611751|FG011|Overall Study|Lost to Follow-up|1|||
144661939|NCT03655717|521611752|FG012|Overall Study|Lost to Follow-up|0|||
144661940|NCT03655717|521611753|FG013|Overall Study|Lost to Follow-up|0|||
144661941|NCT03655717|521611754|FG014|Overall Study|Lost to Follow-up|0|||
144265336|NCT02357459|520173874|FG002|Overall Study|Instruction from PCP|0|||
144265337|NCT02357459|520173872|FG000|Overall Study|Incarceration|0|||
144265338|NCT02357459|520173873|FG001|Overall Study|Incarceration|0|||
144265339|NCT02357459|520173874|FG002|Overall Study|Incarceration|1|||
144661942|NCT03655717|521611755|FG015|Overall Study|Lost to Follow-up|0|||
144661943|NCT03655717|521611756|FG016|Overall Study|Lost to Follow-up|0|||
144661944|NCT03655717|521611757|FG017|Overall Study|Lost to Follow-up|0|||
144661945|NCT03655717|521611758|FG018|Overall Study|Lost to Follow-up|0|||
144661946|NCT03655717|521611759|FG019|Overall Study|Lost to Follow-up|0|||
144661947|NCT03655717|521611760|FG020|Overall Study|Lost to Follow-up|0|||
144265340|NCT02357459|520173872|FG000|Overall Study|Pre-planned Knee surgery|0|||
144265341|NCT02357459|520173873|FG001|Overall Study|Pre-planned Knee surgery|0|||
144265342|NCT02357459|520173874|FG002|Overall Study|Pre-planned Knee surgery|2|||
144661948|NCT03655717|521611761|FG021|Overall Study|Lost to Follow-up|0|||
144661949|NCT03655717|521611762|FG022|Overall Study|Lost to Follow-up|0|||
144661950|NCT03655717|521611763|FG023|Overall Study|Lost to Follow-up|0|||
144661951|NCT03655717|521611764|FG024|Overall Study|Lost to Follow-up|0|||
144661952|NCT03655717|521611765|FG025|Overall Study|Lost to Follow-up|0|||
144215223|NCT02717455|519981625|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
144215224|NCT02717455|519981626|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
144215225|NCT02717455|519981627|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
144215226|NCT02717455|519981628|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
144215227|NCT02717455|519981629|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
144215228|NCT00733005|519981631|FG000|Overall Study|Adverse Event|0|||
144661953|NCT03521193|521611766|FG000|Overall Study|Withdrawal by Subject|8|||
144661954|NCT03521193|521611767|FG001|Overall Study|Withdrawal by Subject|0|||
144661955|NCT03521193|521611766|FG000|Overall Study|non compliant to ASA treatment|8|||
144661956|NCT03521193|521611767|FG001|Overall Study|non compliant to ASA treatment|0|||
144661957|NCT01810042|521611768|FG000|Overall Study|Lost to Follow-up|10|||
144661958|NCT01120379|521613924|FG000|One Year Timepoint|Withdrawal by Subject|41|||
144661959|NCT01120379|521613924|FG000|One Year Timepoint|Lost to Follow-up|115|||
144661960|NCT01120379|521613924|FG000|One Year Timepoint|Death|108|||
144661961|NCT01120379|521613924|FG000|One Year Timepoint|Physician Decision|9|||
144661962|NCT01120379|521613924|FG000|One Year Timepoint|Any other reason for early termination|5|||
144661963|NCT01120379|521613924|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
144661964|NCT01120379|521613924|FG000|Two Year Timepoint|Lost to Follow-up|87|||
144661965|NCT01120379|521613924|FG000|Two Year Timepoint|Death|123|||
144661966|NCT01120379|521613924|FG000|Two Year Timepoint|Physician Decision|12|||
144661967|NCT01120379|521613924|FG000|Two Year Timepoint|Any other reason for early termination|4|||
144661968|NCT01120379|521613924|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
144661969|NCT01120379|521613924|FG000|Three Year Timepoint|Lost to Follow-up|43|||
144661970|NCT01120379|521613924|FG000|Three Year Timepoint|Death|120|||
144661971|NCT01120379|521613924|FG000|Three Year Timepoint|Physician Decision|9|||
144661972|NCT01120379|521613924|FG000|Three Year Timepoint|Any other reason for early termination|17|||
144661973|NCT01120379|521613924|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
144661974|NCT01120379|521613924|FG000|Four Year Timepoint|Lost to Follow-up|10|||
144661975|NCT01120379|521613924|FG000|Four Year Timepoint|Death|131|||
144661976|NCT01120379|521613924|FG000|Four Year Timepoint|Physician Decision|5|||
144661977|NCT01120379|521613924|FG000|Four Year Timepoint|Any other reason for early termination|217|||
144661978|NCT01354353|521613925|FG000|Overall Study|Adverse Event|1|||
144661979|NCT01354353|521613926|FG001|Overall Study|Adverse Event|0|||
144661980|NCT01354353|521613927|FG002|Overall Study|Adverse Event|0|||
144661981|NCT01354353|521613928|FG003|Overall Study|Adverse Event|4|||
144661982|NCT01354353|521613929|FG004|Overall Study|Adverse Event|0|||
144661983|NCT01354353|521613930|FG005|Overall Study|Adverse Event|5|||
144661984|NCT01354353|521613925|FG000|Overall Study|Entry Criteria Not Met|0|||
144661985|NCT01354353|521613926|FG001|Overall Study|Entry Criteria Not Met|0|||
144661986|NCT01354353|521613927|FG002|Overall Study|Entry Criteria Not Met|0|||
144661987|NCT01354353|521613928|FG003|Overall Study|Entry Criteria Not Met|1|||
144661988|NCT01354353|521613929|FG004|Overall Study|Entry Criteria Not Met|1|||
144661989|NCT01354353|521613930|FG005|Overall Study|Entry Criteria Not Met|0|||
144661990|NCT01354353|521613925|FG000|Overall Study|Physician Decision|0|||
144661991|NCT01354353|521613926|FG001|Overall Study|Physician Decision|1|||
144661992|NCT01354353|521613927|FG002|Overall Study|Physician Decision|1|||
144661993|NCT01354353|521613928|FG003|Overall Study|Physician Decision|0|||
144661994|NCT01354353|521613929|FG004|Overall Study|Physician Decision|0|||
144661995|NCT01354353|521613930|FG005|Overall Study|Physician Decision|0|||
144661996|NCT01354353|521613925|FG000|Overall Study|Withdrawal by Subject|2|||
144661997|NCT01354353|521613926|FG001|Overall Study|Withdrawal by Subject|0|||
144661998|NCT01354353|521613927|FG002|Overall Study|Withdrawal by Subject|1|||
144661999|NCT01354353|521613928|FG003|Overall Study|Withdrawal by Subject|0|||
144662000|NCT01354353|521613929|FG004|Overall Study|Withdrawal by Subject|0|||
144662001|NCT01354353|521613930|FG005|Overall Study|Withdrawal by Subject|1|||
144662002|NCT00485589|521613932|FG000|Overall Study|Death|2|||
144662003|NCT00485589|521613933|FG001|Overall Study|Death|2|||
144662004|NCT00485589|521613934|FG002|Overall Study|Death|0|||
144662005|NCT00485589|521613932|FG000|Overall Study|Failure to return|6|||
144662006|NCT00485589|521613933|FG001|Overall Study|Failure to return|5|||
144662007|NCT00485589|521613934|FG002|Overall Study|Failure to return|1|||
144662008|NCT00485589|521613932|FG000|Overall Study|Protocol Violation|1|||
144662009|NCT00485589|521613933|FG001|Overall Study|Protocol Violation|0|||
144662010|NCT00485589|521613934|FG002|Overall Study|Protocol Violation|0|||
144662011|NCT00485589|521613932|FG000|Overall Study|Violation of selection criteria at entry|0|||
144662012|NCT00485589|521613933|FG001|Overall Study|Violation of selection criteria at entry|3|||
144662013|NCT00485589|521613934|FG002|Overall Study|Violation of selection criteria at entry|1|||
144662014|NCT00485589|521613932|FG000|Overall Study|Administrative/Other|1|||
144662015|NCT00485589|521613933|FG001|Overall Study|Administrative/Other|2|||
144662016|NCT00485589|521613934|FG002|Overall Study|Administrative/Other|1|||
144662017|NCT00485589|521613932|FG000|Overall Study|Insufficient therapeutic response|10|||
144662018|NCT00485589|521613933|FG001|Overall Study|Insufficient therapeutic response|3|||
144662019|NCT00485589|521613934|FG002|Overall Study|Insufficient therapeutic response|1|||
144662020|NCT00485589|521613932|FG000|Overall Study|Refused treatment/did not cooperate|1|||
144265343|NCT02357459|520173872|FG000|Overall Study|Job Commitments|0|||
144265344|NCT02357459|520173873|FG001|Overall Study|Job Commitments|0|||
144265345|NCT02357459|520173874|FG002|Overall Study|Job Commitments|1|||
144265346|NCT03246347|520173875|FG000|Overall Study|On Study|23|||
144265347|NCT02188160|520173876|FG000|Overall Study|Adverse Event|1|||
144265348|NCT02188160|520173877|FG001|Overall Study|Adverse Event|0|||
144265349|NCT02188160|520173876|FG000|Overall Study|Use of an excluded medication|0|||
144265350|NCT02188160|520173877|FG001|Overall Study|Use of an excluded medication|1|||
144265351|NCT04113694|520173878|FG000|Overall Study|Adverse Event|2|||
144265352|NCT04113694|520173878|FG000|Overall Study|Lost to Follow-up|2|||
144265353|NCT04113694|520173878|FG000|Overall Study|Withdrawal by Subject|6|||
144265354|NCT04113694|520173878|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
144265355|NCT00916578|520173879|FG000|Overall Study|Physician Decision|2|||
144265356|NCT00916578|520173879|FG000|Overall Study|Withdrawal by Subject|3|||
144265357|NCT00916578|520173879|FG000|Overall Study|Insurance Denial|2|||
144265358|NCT01022203|520173882|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
144265359|NCT01022203|520173883|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
144265360|NCT01022203|520173882|FG000|Post Treatment Assessment|Physician Decision|2|||
144265361|NCT01022203|520173883|FG001|Post Treatment Assessment|Physician Decision|0|||
144265362|NCT01022203|520173882|FG000|Post Treatment Assessment|Adverse Event|0|||
144265363|NCT01022203|520173883|FG001|Post Treatment Assessment|Adverse Event|2|||
144265364|NCT01022203|520173882|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
144265365|NCT01022203|520173883|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
144265366|NCT01228591|520173884|FG000|Baseline|Lack of Efficacy|1|||
144265367|NCT01228591|520173885|FG001|Baseline|Lack of Efficacy|2|||
144265368|NCT02699996|520173886|FG000|Overall Study|Withdrawal by Subject|5|||
144265369|NCT02699996|520173887|FG001|Overall Study|Withdrawal by Subject|2|||
144662021|NCT00485589|521613933|FG001|Overall Study|Refused treatment/did not cooperate|0|||
144662022|NCT00485589|521613934|FG002|Overall Study|Refused treatment/did not cooperate|2|||
144215229|NCT00733005|519981632|FG001|Overall Study|Adverse Event|1|||
144215230|NCT00733005|519981631|FG000|Overall Study|Treatment Failure|0|||
144215231|NCT00733005|519981632|FG001|Overall Study|Treatment Failure|1|||
144215232|NCT00733005|519981631|FG000|Overall Study|Withdrawal by Subject|0|||
144215233|NCT00733005|519981632|FG001|Overall Study|Withdrawal by Subject|1|||
144215234|NCT00733005|519981631|FG000|Overall Study|Protocol Violation|2|||
144215235|NCT00733005|519981632|FG001|Overall Study|Protocol Violation|0|||
144215236|NCT00445432|519981635|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
144215237|NCT00445432|519981636|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
144215238|NCT00445432|519981637|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
144215239|NCT00445432|519981638|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
144215240|NCT00445432|519981635|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
144215241|NCT00445432|519981636|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
144215242|NCT00445432|519981637|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
144215243|NCT00445432|519981638|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
144215244|NCT00445432|519981635|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
144215245|NCT00445432|519981636|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
144215246|NCT00445432|519981637|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
144215247|NCT00445432|519981638|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
144215248|NCT00445432|519981635|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
144215249|NCT00445432|519981636|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
144215250|NCT00445432|519981637|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
144215251|NCT00445432|519981638|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
144215252|NCT00445432|519981635|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
144215253|NCT00445432|519981636|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
144215254|NCT00445432|519981637|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
144215255|NCT00445432|519981638|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
144215256|NCT00445432|519981635|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
144265370|NCT01921517|520173888|FG000|Overall Study|Lost to Follow-up|5|||
144265371|NCT01921517|520173889|FG001|Overall Study|Lost to Follow-up|0|||
144265372|NCT01921517|520173888|FG000|Overall Study|Newly diagnosed health concern|2|||
144662023|NCT00485589|521613932|FG000|Overall Study|Withdrawal by Subject|3|||
144662024|NCT00485589|521613933|FG001|Overall Study|Withdrawal by Subject|2|||
144662025|NCT00485589|521613934|FG002|Overall Study|Withdrawal by Subject|2|||
144662026|NCT00485589|521613932|FG000|Overall Study|Adverse Event|3|||
144662027|NCT00485589|521613933|FG001|Overall Study|Adverse Event|3|||
144662028|NCT00485589|521613934|FG002|Overall Study|Adverse Event|10|||
144662029|NCT01944969|521613935|FG000|Overall Study|Adverse Event|1|||
144215257|NCT00445432|519981636|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
144215258|NCT00445432|519981637|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
144215259|NCT00445432|519981638|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
144215260|NCT00445432|519981635|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
144215261|NCT00445432|519981636|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
144662030|NCT01944969|521613935|FG000|Overall Study|Lack of Efficacy|1|||
144662031|NCT01944969|521613935|FG000|Overall Study|Non-compliance with IMP|1|||
144662032|NCT01944969|521613935|FG000|Overall Study|Administrative or other reasons|23|||
144662033|NCT01104584|521613936|FG000|Overall Study|Study drug never administered|21|||
144662034|NCT01104584|521613936|FG000|Overall Study|Study prematurely discontinued|2|||
144662035|NCT04017442|521613937|FG000|Overall Study|Withdrawal by Subject|0|||
144662036|NCT04017442|521613938|FG001|Overall Study|Withdrawal by Subject|3|||
144662037|NCT04017442|521613937|FG000|Overall Study|Lost to Follow-up|21|||
144662038|NCT04017442|521613938|FG001|Overall Study|Lost to Follow-up|19|||
144662039|NCT02586233|521613939|FG000|Overall Study|Randomized but did not receive treatment|0|||
144662040|NCT02586233|521613940|FG001|Overall Study|Randomized but did not receive treatment|1|||
144662041|NCT02586233|521613941|FG002|Overall Study|Randomized but did not receive treatment|0|||
144662042|NCT02586233|521613942|FG003|Overall Study|Randomized but did not receive treatment|0|||
144662043|NCT02586233|521613943|FG004|Overall Study|Randomized but did not receive treatment|0|||
144662044|NCT02586233|521613944|FG005|Overall Study|Randomized but did not receive treatment|2|||
144662045|NCT02586233|521613945|FG006|Overall Study|Randomized but did not receive treatment|2|||
144662046|NCT02586233|521613939|FG000|Overall Study|Death|0|||
144662047|NCT02586233|521613940|FG001|Overall Study|Death|1|||
144662048|NCT02586233|521613941|FG002|Overall Study|Death|0|||
144662049|NCT02586233|521613942|FG003|Overall Study|Death|0|||
144662050|NCT02586233|521613943|FG004|Overall Study|Death|2|||
144662051|NCT02586233|521613944|FG005|Overall Study|Death|0|||
144662052|NCT02586233|521613945|FG006|Overall Study|Death|0|||
144662053|NCT00848250|521613946|FG000|Overall Study|surgery was completed without cardiopulm|0|||
144662054|NCT00848250|521613947|FG001|Overall Study|surgery was completed without cardiopulm|1|||
144662055|NCT03421964|521613953|FG000|Overall Study|Lost to Follow-up|11|||
144662056|NCT03421964|521613954|FG001|Overall Study|Lost to Follow-up|21|||
144662057|NCT03421964|521613953|FG000|Overall Study|Withdrawal by Subject|9|||
144662058|NCT03421964|521613954|FG001|Overall Study|Withdrawal by Subject|3|||
144662059|NCT03421964|521613953|FG000|Overall Study|Incarcerated|1|||
144662060|NCT03421964|521613954|FG001|Overall Study|Incarcerated|0|||
144662061|NCT03421964|521613953|FG000|Overall Study|Inpt Treatment Facility|1|||
144662062|NCT03421964|521613954|FG001|Overall Study|Inpt Treatment Facility|1|||
144662063|NCT03421964|521613953|FG000|Overall Study|Virtual Platform Issues|1|||
144662064|NCT03421964|521613954|FG001|Overall Study|Virtual Platform Issues|1|||
144662065|NCT02938585|521613955|FG000|Overall Study|Withdrawal by parent or guardian|0|||
144662066|NCT02938585|521613956|FG001|Overall Study|Withdrawal by parent or guardian|1|||
144662067|NCT02938585|521613957|FG002|Overall Study|Withdrawal by parent or guardian|0|||
144662068|NCT02938585|521613958|FG003|Overall Study|Withdrawal by parent or guardian|0|||
144662069|NCT02938585|521613955|FG000|Overall Study|Withdrawal by Subject|0|||
144662070|NCT02938585|521613956|FG001|Overall Study|Withdrawal by Subject|0|||
144662071|NCT02938585|521613957|FG002|Overall Study|Withdrawal by Subject|0|||
144662072|NCT02938585|521613958|FG003|Overall Study|Withdrawal by Subject|5|||
144662073|NCT00213980|521613963|FG000|Overall Study|Withdrawal by Subject|3|||
144662074|NCT00213980|521613964|FG001|Overall Study|Withdrawal by Subject|1|||
144662075|NCT00213980|521613963|FG000|Overall Study|Adverse Event|1|||
144662076|NCT00213980|521613964|FG001|Overall Study|Adverse Event|1|||
144662077|NCT00213980|521613963|FG000|Overall Study|Disease progression|0|||
144662078|NCT00213980|521613964|FG001|Overall Study|Disease progression|2|||
144662079|NCT00213980|521613963|FG000|Overall Study|Developed ovarian cancer|1|||
144662080|NCT00213980|521613964|FG001|Overall Study|Developed ovarian cancer|0|||
144662081|NCT00213980|521613963|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
144662082|NCT00213980|521613964|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
144662083|NCT03607838|521613965|FG000|Overall Study|Lack of Efficacy|14|||
144662084|NCT03607838|521613966|FG001|Overall Study|Lack of Efficacy|20|||
144662085|NCT03607838|521613965|FG000|Overall Study|Withdrawal by Subject|13|||
144662086|NCT03607838|521613966|FG001|Overall Study|Withdrawal by Subject|8|||
144662087|NCT03607838|521613965|FG000|Overall Study|Lost to Follow-up|6|||
144662088|NCT03607838|521613966|FG001|Overall Study|Lost to Follow-up|11|||
144662089|NCT03607838|521613965|FG000|Overall Study|Adverse Event|2|||
144662090|NCT03607838|521613966|FG001|Overall Study|Adverse Event|2|||
144662091|NCT03607838|521613965|FG000|Overall Study|Physician Decision|2|||
144662092|NCT03607838|521613966|FG001|Overall Study|Physician Decision|0|||
144662093|NCT03607838|521613965|FG000|Overall Study|Failure to meet randomization criteria|1|||
144662094|NCT03607838|521613966|FG001|Overall Study|Failure to meet randomization criteria|2|||
144662095|NCT03607838|521613965|FG000|Overall Study|Pregnancy|1|||
144662096|NCT03607838|521613966|FG001|Overall Study|Pregnancy|0|||
144662097|NCT03607838|521613965|FG000|Overall Study|Protocol Violation|1|||
144662098|NCT03607838|521613966|FG001|Overall Study|Protocol Violation|0|||
144662099|NCT03607838|521613965|FG000|Overall Study|Due to work|1|||
144662100|NCT03607838|521613966|FG001|Overall Study|Due to work|0|||
144662101|NCT03607838|521613965|FG000|Overall Study|Litigation|0|||
144662102|NCT03607838|521613966|FG001|Overall Study|Litigation|1|||
144662103|NCT03607838|521613965|FG000|Overall Study|Temperature excursion for study drug|0|||
144662104|NCT03607838|521613966|FG001|Overall Study|Temperature excursion for study drug|1|||
144662105|NCT03607838|521613965|FG000|Overall Study|Change of mind|0|||
144662106|NCT03607838|521613966|FG001|Overall Study|Change of mind|1|||
144662107|NCT03888391|521613969|FG000|Overall Study|Lost to Follow-up|15|||
144662108|NCT00423735|521613970|FG000|Overall Study|Ineligible / No protocol treatment|8|||
144662109|NCT00423735|521613971|FG001|Overall Study|Ineligible / No protocol treatment|6|||
144662110|NCT00423735|521613972|FG002|Overall Study|Ineligible / No protocol treatment|0|||
144662111|NCT00678587|521613981|FG000|Overall Study|Adverse Event|3|||
144662112|NCT00678587|521613982|FG001|Overall Study|Adverse Event|3|||
144662113|NCT00678587|521613981|FG000|Overall Study|Lack of Efficacy|1|||
144662114|NCT00678587|521613982|FG001|Overall Study|Lack of Efficacy|0|||
144662115|NCT00678587|521613981|FG000|Overall Study|Protocol Violation|2|||
144662116|NCT00678587|521613982|FG001|Overall Study|Protocol Violation|1|||
144662117|NCT00678587|521613981|FG000|Overall Study|Study Closed/Terminated|1|||
144662118|NCT00678587|521613982|FG001|Overall Study|Study Closed/Terminated|0|||
144662119|NCT00678587|521613981|FG000|Overall Study|Lost to Follow-up|3|||
144662120|NCT00678587|521613982|FG001|Overall Study|Lost to Follow-up|5|||
144662121|NCT00678587|521613981|FG000|Overall Study|Investigator Discretion|2|||
144662122|NCT00678587|521613982|FG001|Overall Study|Investigator Discretion|6|||
144662123|NCT00678587|521613981|FG000|Overall Study|Withdrew Consent|8|||
144662124|NCT00678587|521613982|FG001|Overall Study|Withdrew Consent|3|||
144662125|NCT03806179|521613983|FG000|Overall Study|Progressive disease|0|||
144662126|NCT03806179|521613984|FG001|Overall Study|Progressive disease|2|||
144662127|NCT00077610|521613985|FG000|Overall Study|Adverse Event|9|||
144662128|NCT00077610|521613986|FG001|Overall Study|Adverse Event|7|||
144662129|NCT00077610|521613987|FG002|Overall Study|Adverse Event|1|||
144662130|NCT00077610|521613985|FG000|Overall Study|Lost to Follow-up|0|||
144662131|NCT00077610|521613986|FG001|Overall Study|Lost to Follow-up|1|||
144662132|NCT00077610|521613987|FG002|Overall Study|Lost to Follow-up|2|||
144662133|NCT00077610|521613985|FG000|Overall Study|Withdrawal by Subject|4|||
144662134|NCT00077610|521613986|FG001|Overall Study|Withdrawal by Subject|10|||
144662135|NCT00077610|521613987|FG002|Overall Study|Withdrawal by Subject|6|||
144662136|NCT00077610|521613985|FG000|Overall Study|Death|17|||
144662137|NCT00077610|521613986|FG001|Overall Study|Death|13|||
144662138|NCT00077610|521613987|FG002|Overall Study|Death|13|||
144662139|NCT00077610|521613985|FG000|Overall Study|Renal transplant|12|||
144662140|NCT00077610|521613986|FG001|Overall Study|Renal transplant|15|||
144662141|NCT00077610|521613987|FG002|Overall Study|Renal transplant|11|||
144662142|NCT00077610|521613985|FG000|Overall Study|Withdrew from dialysis care|5|||
144662143|NCT00077610|521613986|FG001|Overall Study|Withdrew from dialysis care|0|||
144662144|NCT00077610|521613987|FG002|Overall Study|Withdrew from dialysis care|3|||
144662145|NCT00077610|521613985|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144662146|NCT00077610|521613986|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144662147|NCT00077610|521613987|FG002|Overall Study|Insufficient Therapeutic Response|0|||
144662148|NCT00077610|521613985|FG000|Overall Study|Multiple blood transfusions|0|||
144662149|NCT00077610|521613986|FG001|Overall Study|Multiple blood transfusions|0|||
144662150|NCT00077610|521613987|FG002|Overall Study|Multiple blood transfusions|1|||
144662151|NCT00077610|521613985|FG000|Overall Study|Principal Investigator's decision|1|||
144662152|NCT00077610|521613986|FG001|Overall Study|Principal Investigator's decision|0|||
144662153|NCT00077610|521613987|FG002|Overall Study|Principal Investigator's decision|1|||
144662154|NCT00077610|521613985|FG000|Overall Study|Worsening of health condition|1|||
144662155|NCT00077610|521613986|FG001|Overall Study|Worsening of health condition|1|||
144662156|NCT00077610|521613987|FG002|Overall Study|Worsening of health condition|0|||
144662157|NCT00077610|521613985|FG000|Overall Study|Given Epogen in hospital|1|||
144662158|NCT00077610|521613986|FG001|Overall Study|Given Epogen in hospital|0|||
144662159|NCT00077610|521613987|FG002|Overall Study|Given Epogen in hospital|0|||
144662160|NCT00077610|521613985|FG000|Overall Study|Transferred to other unit|0|||
144662161|NCT00077610|521613986|FG001|Overall Study|Transferred to other unit|0|||
144662162|NCT00077610|521613987|FG002|Overall Study|Transferred to other unit|1|||
144662163|NCT00077610|521613985|FG000|Overall Study|Transferred to nursing home|0|||
144662164|NCT00077610|521613986|FG001|Overall Study|Transferred to nursing home|0|||
144662165|NCT00077610|521613987|FG002|Overall Study|Transferred to nursing home|1|||
144662166|NCT00077610|521613985|FG000|Overall Study|Transfer to satellite unit|1|||
144662167|NCT00077610|521613986|FG001|Overall Study|Transfer to satellite unit|0|||
144662168|NCT00077610|521613987|FG002|Overall Study|Transfer to satellite unit|0|||
144662169|NCT00077610|521613985|FG000|Overall Study|Transfer to other center for surgery|1|||
144662170|NCT00077610|521613986|FG001|Overall Study|Transfer to other center for surgery|0|||
144662171|NCT00077610|521613987|FG002|Overall Study|Transfer to other center for surgery|0|||
144662172|NCT00077610|521613985|FG000|Overall Study|Change in dialysis modality|1|||
144662173|NCT00077610|521613986|FG001|Overall Study|Change in dialysis modality|0|||
144662174|NCT00077610|521613987|FG002|Overall Study|Change in dialysis modality|0|||
144662175|NCT00077610|521613985|FG000|Overall Study|Relocation|0|||
144662176|NCT00077610|521613986|FG001|Overall Study|Relocation|8|||
144662177|NCT00077610|521613987|FG002|Overall Study|Relocation|5|||
144662178|NCT00077610|521613985|FG000|Overall Study|Financial issues|0|||
144662179|NCT00077610|521613986|FG001|Overall Study|Financial issues|1|||
144662180|NCT00077610|521613987|FG002|Overall Study|Financial issues|0|||
144662181|NCT00077610|521613985|FG000|Overall Study|Sponsors decision to withdraw|0|||
144662182|NCT00077610|521613986|FG001|Overall Study|Sponsors decision to withdraw|0|||
144215262|NCT00445432|519981637|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
144215263|NCT00445432|519981638|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
144215264|NCT02789137|519981639|FG000|Overall Study|Dropped out/Died|58|||
144215265|NCT01090414|519981640|FG000|Study 101-99|Progressive Disease|28|||
144733337|NCT02587962|521880600|FG001|Overall Study|Clinical progression|1|||
144733338|NCT02587962|521880601|FG002|Overall Study|Clinical progression|2|||
144733339|NCT02587962|521880602|FG003|Overall Study|Clinical progression|0|||
144733340|NCT02587962|521880603|FG004|Overall Study|Clinical progression|1|||
144733341|NCT01185548|521880604|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
144733342|NCT00086996|521880606|FG000|Overall Study|Adverse Event|29|||
144733343|NCT00086996|521880606|FG000|Overall Study|Death|4|||
144733344|NCT00086996|521880606|FG000|Overall Study|progression/relapse|7|||
144733345|NCT00086996|521880606|FG000|Overall Study|Withdrawal by Subject|13|||
144733346|NCT00086996|521880606|FG000|Overall Study|Other|6|||
144733347|NCT00086996|521880606|FG000|Overall Study|not eligible|5|||
144215266|NCT01090414|519981641|FG001|Study 101-99|Progressive Disease|48|||
144215267|NCT01090414|519981642|FG002|Study 101-99|Progressive Disease|10|||
144662183|NCT00077610|521613987|FG002|Overall Study|Sponsors decision to withdraw|1|||
144662184|NCT03442829|521613991|FG000|Overall Study|Scheduling clash|3|||
144662185|NCT03442829|521613992|FG001|Overall Study|Scheduling clash|1|||
144662186|NCT03442829|521613991|FG000|Overall Study|Illness unrelated to study|1|||
144662187|NCT03442829|521613992|FG001|Overall Study|Illness unrelated to study|1|||
144662188|NCT01486784|521613993|FG000|Overall Study|Withdrawal by Subject|0|||
144662189|NCT01486784|521613994|FG001|Overall Study|Withdrawal by Subject|0|||
144662190|NCT01486784|521613995|FG002|Overall Study|Withdrawal by Subject|1|||
144662191|NCT01486784|521613996|FG003|Overall Study|Withdrawal by Subject|0|||
144662192|NCT01486784|521613997|FG004|Overall Study|Withdrawal by Subject|1|||
144662193|NCT01486784|521613998|FG005|Overall Study|Withdrawal by Subject|2|||
144662194|NCT01486784|521613993|FG000|Overall Study|Subject did not meet entry criteria|0|||
144662195|NCT01486784|521613994|FG001|Overall Study|Subject did not meet entry criteria|0|||
144662196|NCT01486784|521613995|FG002|Overall Study|Subject did not meet entry criteria|0|||
144662197|NCT01486784|521613996|FG003|Overall Study|Subject did not meet entry criteria|0|||
144662198|NCT01486784|521613997|FG004|Overall Study|Subject did not meet entry criteria|1|||
144662199|NCT01486784|521613998|FG005|Overall Study|Subject did not meet entry criteria|0|||
144662200|NCT01486784|521613993|FG000|Overall Study|Death|0|||
144662201|NCT01486784|521613994|FG001|Overall Study|Death|0|||
144662202|NCT01486784|521613995|FG002|Overall Study|Death|0|||
144662203|NCT01486784|521613996|FG003|Overall Study|Death|0|||
144662204|NCT01486784|521613997|FG004|Overall Study|Death|0|||
144662205|NCT01486784|521613998|FG005|Overall Study|Death|1|||
144662206|NCT02841787|521613999|FG000|Overall Study|Lost to Follow-up|1|||
144662207|NCT02841787|521614000|FG001|Overall Study|Lost to Follow-up|0|||
144662208|NCT02841787|521614001|FG002|Overall Study|Lost to Follow-up|0|||
144662209|NCT02841787|521613999|FG000|Overall Study|Symptoms dropped below threshold|1|||
144662210|NCT02841787|521614000|FG001|Overall Study|Symptoms dropped below threshold|0|||
144662211|NCT02841787|521614001|FG002|Overall Study|Symptoms dropped below threshold|0|||
144662212|NCT02841787|521613999|FG000|Overall Study|Withdrawal by Subject|1|||
144662213|NCT02841787|521614000|FG001|Overall Study|Withdrawal by Subject|4|||
144662214|NCT02841787|521614001|FG002|Overall Study|Withdrawal by Subject|0|||
144662215|NCT03491553|521614002|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
144662216|NCT03491553|521614003|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
144662217|NCT03491553|521614004|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
144662218|NCT03491553|521614005|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
144662219|NCT03491553|521614006|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
144662220|NCT03491553|521614007|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
144662221|NCT03491553|521614002|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
144662222|NCT03491553|521614003|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
144662223|NCT03491553|521614004|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
144662224|NCT03491553|521614005|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
144662225|NCT03491553|521614006|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
144662226|NCT03491553|521614007|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
144733348|NCT02331394|521880610|FG000|Overall Study|Disease progression|1|||
144215268|NCT01090414|519981643|FG003|Study 101-99|Progressive Disease|4|||
144215269|NCT01090414|519981640|FG000|Study 101-99|Adverse Event|10|||
144215270|NCT01090414|519981641|FG001|Study 101-99|Adverse Event|28|||
144265373|NCT01921517|520173889|FG001|Overall Study|Newly diagnosed health concern|0|||
144662227|NCT03029650|521614008|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
144662228|NCT03029650|521614009|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
144662229|NCT03029650|521614008|FG000|Washout (1 Week)|Physician Decision|0|||
144662230|NCT03029650|521614009|FG001|Washout (1 Week)|Physician Decision|1|||
144662231|NCT01875367|521614010|FG000|Overall Study|Not complete at least 2 questionaries|4|||
144733349|NCT02098876|521880613|FG000|Overall Study|Withdrawal by Subject|5|||
144215271|NCT01090414|519981642|FG002|Study 101-99|Adverse Event|18|||
144733350|NCT02098876|521880614|FG001|Overall Study|Withdrawal by Subject|5|||
144215272|NCT01090414|519981643|FG003|Study 101-99|Adverse Event|0|||
144215273|NCT01090414|519981640|FG000|Study 101-99|Investigator Request|1|||
144662232|NCT01875367|521614011|FG001|Overall Study|Not complete at least 2 questionaries|2|||
144662233|NCT01875367|521614010|FG000|Overall Study|Not receive study treatment|1|||
144662234|NCT01875367|521614011|FG001|Overall Study|Not receive study treatment|0|||
144662235|NCT02237157|521614012|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
144662236|NCT02237157|521614013|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
144662237|NCT02237157|521614014|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
144662238|NCT02237157|521614015|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
144662239|NCT02237157|521614012|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
144662240|NCT02237157|521614013|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
144662241|NCT02237157|521614014|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
144662242|NCT02237157|521614015|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
144662243|NCT03628508|521614016|FG000|Overall Study|Lost to Follow-up|1|||
144662244|NCT01996748|521614017|FG000|Overall Study|Personal reason|1|||
144662245|NCT01996748|521614018|FG001|Overall Study|Personal reason|0|||
144662246|NCT01996748|521614017|FG000|Overall Study|Physician Decision|2|||
144662247|NCT01996748|521614018|FG001|Overall Study|Physician Decision|0|||
144662248|NCT01996748|521614017|FG000|Overall Study|Adverse Event|1|||
144662249|NCT01996748|521614018|FG001|Overall Study|Adverse Event|4|||
144662250|NCT01996748|521614017|FG000|Overall Study|Withdrawal by Subject|0|||
144662251|NCT01996748|521614018|FG001|Overall Study|Withdrawal by Subject|1|||
144662252|NCT01996748|521614017|FG000|Overall Study|Lost to Follow-up|4|||
144662253|NCT01996748|521614018|FG001|Overall Study|Lost to Follow-up|1|||
144662254|NCT02951988|521614019|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
144662255|NCT02951988|521614020|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
144662256|NCT02951988|521614021|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
144662257|NCT02951988|521614022|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
144662258|NCT02951988|521614019|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
144662259|NCT02951988|521614020|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
144662260|NCT02951988|521614021|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
144662261|NCT02951988|521614022|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
144662262|NCT02951988|521614019|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
144662263|NCT02951988|521614020|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
144662264|NCT02951988|521614021|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
144662265|NCT02951988|521614022|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
144662266|NCT02951988|521614019|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
144662267|NCT02951988|521614020|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
144662268|NCT02951988|521614021|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
144662269|NCT02951988|521614022|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
144662270|NCT02951988|521614019|FG000|Open-Label Treatment Period|Protocol Violation|22|||
144662271|NCT02951988|521614020|FG001|Open-Label Treatment Period|Protocol Violation|0|||
144662272|NCT02951988|521614021|FG002|Open-Label Treatment Period|Protocol Violation|0|||
144662273|NCT02951988|521614022|FG003|Open-Label Treatment Period|Protocol Violation|0|||
144662274|NCT02951988|521614019|FG000|Open-Label Treatment Period|Pregnancy|2|||
144662275|NCT02951988|521614020|FG001|Open-Label Treatment Period|Pregnancy|0|||
144662276|NCT02951988|521614021|FG002|Open-Label Treatment Period|Pregnancy|0|||
144662277|NCT02951988|521614022|FG003|Open-Label Treatment Period|Pregnancy|0|||
144662278|NCT02951988|521614019|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
144662279|NCT02951988|521614020|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
144662280|NCT02951988|521614021|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
144662281|NCT02951988|521614022|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
144662282|NCT02951988|521614019|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
144662283|NCT02951988|521614020|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
144662284|NCT02951988|521614021|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
144662285|NCT02951988|521614022|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
144662286|NCT02951988|521614019|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
144662287|NCT02951988|521614020|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
144662288|NCT02951988|521614021|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
144662289|NCT02951988|521614022|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
144662290|NCT02951988|521614019|FG000|Open-Label Treatment Period|Adverse Event|45|||
144662291|NCT02951988|521614020|FG001|Open-Label Treatment Period|Adverse Event|0|||
144662292|NCT02951988|521614021|FG002|Open-Label Treatment Period|Adverse Event|0|||
144662293|NCT02951988|521614022|FG003|Open-Label Treatment Period|Adverse Event|0|||
144662294|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
144662295|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
144662296|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
144662297|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
144662298|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
144215274|NCT01090414|519981641|FG001|Study 101-99|Investigator Request|11|||
144215275|NCT01090414|519981642|FG002|Study 101-99|Investigator Request|4|||
144215276|NCT01090414|519981643|FG003|Study 101-99|Investigator Request|0|||
144215277|NCT01090414|519981640|FG000|Study 101-99|Death|3|||
144215278|NCT01090414|519981641|FG001|Study 101-99|Death|8|||
144215279|NCT01090414|519981642|FG002|Study 101-99|Death|1|||
144215280|NCT01090414|519981643|FG003|Study 101-99|Death|0|||
144215281|NCT01090414|519981640|FG000|Study 101-99|Sponsor Discontinued Study|0|||
144215282|NCT01090414|519981641|FG001|Study 101-99|Sponsor Discontinued Study|7|||
144215283|NCT01090414|519981642|FG002|Study 101-99|Sponsor Discontinued Study|5|||
144215284|NCT01090414|519981643|FG003|Study 101-99|Sponsor Discontinued Study|0|||
144215285|NCT01090414|519981640|FG000|Study 101-99|Other (Unknown Reasons)|3|||
144215286|NCT01090414|519981641|FG001|Study 101-99|Other (Unknown Reasons)|3|||
144215287|NCT01090414|519981642|FG002|Study 101-99|Other (Unknown Reasons)|0|||
144215288|NCT01090414|519981643|FG003|Study 101-99|Other (Unknown Reasons)|0|||
144215289|NCT01090414|519981640|FG000|Study 101-99|Withdrew Consent|0|||
144215290|NCT01090414|519981641|FG001|Study 101-99|Withdrew Consent|2|||
144215291|NCT01090414|519981642|FG002|Study 101-99|Withdrew Consent|3|||
144215292|NCT01090414|519981643|FG003|Study 101-99|Withdrew Consent|1|||
144215293|NCT01090414|519981640|FG000|Study 101-99|Participant Request|3|||
144215294|NCT01090414|519981641|FG001|Study 101-99|Participant Request|1|||
144215295|NCT01090414|519981642|FG002|Study 101-99|Participant Request|0|||
144215296|NCT01090414|519981643|FG003|Study 101-99|Participant Request|0|||
144215297|NCT03639779|519981648|FG000|Overall Study|Lost to Follow-up|1|||
144215298|NCT02413229|519981649|FG000|Overall Study|Adverse Event|0|||
144215299|NCT02413229|519981650|FG001|Overall Study|Adverse Event|0|||
144215300|NCT02413229|519981651|FG002|Overall Study|Adverse Event|0|||
144215301|NCT02413229|519981652|FG003|Overall Study|Adverse Event|1|||
144215302|NCT02413229|519981653|FG004|Overall Study|Adverse Event|0|||
144215303|NCT02413229|519981654|FG005|Overall Study|Adverse Event|0|||
144215304|NCT02413229|519981655|FG006|Overall Study|Adverse Event|0|||
144215305|NCT02413229|519981656|FG007|Overall Study|Adverse Event|1|||
144215306|NCT02413229|519981649|FG000|Overall Study|Lost to Follow-up|0|||
144215307|NCT02413229|519981650|FG001|Overall Study|Lost to Follow-up|0|||
144215308|NCT02413229|519981651|FG002|Overall Study|Lost to Follow-up|1|||
144215309|NCT02413229|519981652|FG003|Overall Study|Lost to Follow-up|0|||
144215310|NCT02413229|519981653|FG004|Overall Study|Lost to Follow-up|2|||
144215311|NCT02413229|519981654|FG005|Overall Study|Lost to Follow-up|0|||
144215312|NCT02413229|519981655|FG006|Overall Study|Lost to Follow-up|0|||
144215313|NCT02413229|519981656|FG007|Overall Study|Lost to Follow-up|0|||
144215314|NCT02413229|519981649|FG000|Overall Study|Withdrawal by Subject|1|||
144215315|NCT02413229|519981650|FG001|Overall Study|Withdrawal by Subject|1|||
144215316|NCT02413229|519981651|FG002|Overall Study|Withdrawal by Subject|0|||
144215317|NCT02413229|519981652|FG003|Overall Study|Withdrawal by Subject|0|||
144215318|NCT02413229|519981653|FG004|Overall Study|Withdrawal by Subject|1|||
144215319|NCT02413229|519981654|FG005|Overall Study|Withdrawal by Subject|0|||
144215320|NCT02413229|519981655|FG006|Overall Study|Withdrawal by Subject|0|||
144215321|NCT02413229|519981656|FG007|Overall Study|Withdrawal by Subject|2|||
144215322|NCT02413229|519981649|FG000|Overall Study|Progressive Disease|0|||
144215323|NCT02413229|519981650|FG001|Overall Study|Progressive Disease|0|||
144215324|NCT02413229|519981651|FG002|Overall Study|Progressive Disease|0|||
144215325|NCT02413229|519981652|FG003|Overall Study|Progressive Disease|0|||
144215326|NCT02413229|519981653|FG004|Overall Study|Progressive Disease|0|||
144215327|NCT02413229|519981654|FG005|Overall Study|Progressive Disease|0|||
144215328|NCT02413229|519981655|FG006|Overall Study|Progressive Disease|0|||
144215329|NCT02413229|519981656|FG007|Overall Study|Progressive Disease|1|||
144215330|NCT03594071|519981657|FG000|Overall Study|Re-operation|3|||
144215331|NCT03594071|519981657|FG000|Overall Study|Missed visit|2|||
144215332|NCT03022370|519981659|FG000|Overall Study|Death|6|||
144215333|NCT03022370|519981660|FG001|Overall Study|Death|12|||
144215334|NCT03022370|519981659|FG000|Overall Study|Lost to Follow-up|174|||
144215335|NCT03022370|519981660|FG001|Overall Study|Lost to Follow-up|109|||
144215336|NCT01526655|519981663|FG000|Overall Study|Withdrawal by Subject|0|||
144215337|NCT01526655|519981664|FG001|Overall Study|Withdrawal by Subject|1|||
144215338|NCT01965860|519981665|FG000|Overall Study|Pregnancy|1|||
144215339|NCT01965860|519981666|FG001|Overall Study|Pregnancy|0|||
144215340|NCT01965860|519981667|FG002|Overall Study|Pregnancy|1|||
144215341|NCT01965860|519981665|FG000|Overall Study|Logistics|1|||
144215342|NCT01965860|519981666|FG001|Overall Study|Logistics|0|||
144215343|NCT01965860|519981667|FG002|Overall Study|Logistics|0|||
144215344|NCT02064296|519981671|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
144215345|NCT02064296|519981672|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
144215346|NCT02064296|519981673|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
144215347|NCT02064296|519981671|FG000|Intervention|Withdrawal by Subject|0|||
144215348|NCT02064296|519981672|FG001|Intervention|Withdrawal by Subject|1|||
144215349|NCT02064296|519981673|FG002|Intervention|Withdrawal by Subject|2|||
144215350|NCT03735121|519981679|FG000|Overall Study|Death|3|||
144215351|NCT03735121|519981680|FG001|Overall Study|Death|6|||
144215352|NCT03735121|519981681|FG002|Overall Study|Death|8|||
144215353|NCT03735121|519981682|FG003|Overall Study|Death|37|||
144215354|NCT03735121|519981683|FG004|Overall Study|Death|86|||
144215355|NCT03735121|519981679|FG000|Overall Study|Withdrawal by Subject|1|||
144265374|NCT01921517|520173888|FG000|Overall Study|Physician Decision|0|||
144265375|NCT01921517|520173889|FG001|Overall Study|Physician Decision|2|||
144265376|NCT01921517|520173888|FG000|Overall Study|Withdrawal by Subject|7|||
144265377|NCT01921517|520173889|FG001|Overall Study|Withdrawal by Subject|3|||
144265378|NCT01921517|520173888|FG000|Overall Study|Subject missed final imaging|1|||
144265379|NCT01921517|520173889|FG001|Overall Study|Subject missed final imaging|4|||
144265380|NCT04069715|520173892|FG000|Overall Study|Lost to Follow-up|1|||
144265381|NCT04069715|520173893|FG001|Overall Study|Lost to Follow-up|1|||
144265382|NCT04069715|520173892|FG000|Overall Study|Physician Decision|1|||
144265383|NCT04069715|520173893|FG001|Overall Study|Physician Decision|1|||
144265384|NCT04069715|520173892|FG000|Overall Study|Withdrawal by Subject|3|||
144265385|NCT04069715|520173893|FG001|Overall Study|Withdrawal by Subject|3|||
144733351|NCT02459951|521880615|FG000|Overall Study|Unable to meet holding requirement|1|||
144733352|NCT01792635|521880616|FG000|Part B|Adverse Event|0|||
144215356|NCT03735121|519981680|FG001|Overall Study|Withdrawal by Subject|1|||
144215357|NCT03735121|519981681|FG002|Overall Study|Withdrawal by Subject|3|||
144215358|NCT03735121|519981682|FG003|Overall Study|Withdrawal by Subject|4|||
144215359|NCT03735121|519981683|FG004|Overall Study|Withdrawal by Subject|2|||
144215360|NCT03735121|519981679|FG000|Overall Study|Progressive Disease|0|||
144215361|NCT03735121|519981680|FG001|Overall Study|Progressive Disease|0|||
144215362|NCT03735121|519981681|FG002|Overall Study|Progressive Disease|1|||
144215363|NCT03735121|519981682|FG003|Overall Study|Progressive Disease|0|||
144215364|NCT03735121|519981683|FG004|Overall Study|Progressive Disease|0|||
144215365|NCT03735121|519981679|FG000|Overall Study|Lost to Follow-up|0|||
144265386|NCT03205150|520173894|FG000|Overall Study|Protocol deviation|1|||
144265387|NCT03205150|520173895|FG001|Overall Study|Protocol deviation|3|||
144733353|NCT01792635|521880617|FG001|Part B|Adverse Event|0|||
144733354|NCT01792635|521880618|FG002|Part B|Adverse Event|1|||
144733355|NCT01792635|521880616|FG000|Part B|Study terminated|0|||
144733356|NCT01792635|521880617|FG001|Part B|Study terminated|4|||
144733357|NCT01792635|521880618|FG002|Part B|Study terminated|3|||
144733358|NCT00850174|521880622|FG000|Washout: One Week|Withdrawal by Subject|0|||
144265388|NCT03205150|520173896|FG002|Overall Study|Protocol deviation|0|||
144662299|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
144733359|NCT00850174|521880623|FG001|Washout: One Week|Withdrawal by Subject|2|||
144733360|NCT00850174|521880622|FG000|Second Intervention|Withdrawal by Subject|1|||
144733361|NCT00850174|521880623|FG001|Second Intervention|Withdrawal by Subject|0|||
144733362|NCT01702987|521880624|FG000|Overall Study|Withdrawal by Subject|1|||
144733363|NCT01702987|521880625|FG001|Overall Study|Withdrawal by Subject|0|||
144265389|NCT03205150|520173894|FG000|Overall Study|Patient/guardian decision|0|||
144265390|NCT03205150|520173895|FG001|Overall Study|Patient/guardian decision|3|||
144662300|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
144662301|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
144662302|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
144662303|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
144662304|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
144662305|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
144662306|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
144662307|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
144662308|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
144662309|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
144662310|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Pregnancy|0|||
144662311|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Pregnancy|1|||
144662312|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Pregnancy|1|||
144662313|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Pregnancy|0|||
144662314|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144662315|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
144662316|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
144662317|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
144662318|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144662319|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
144662320|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
144662321|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
144662322|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144662323|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Adverse Event|8|||
144662324|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Adverse Event|3|||
144733364|NCT00365846|521880627|FG000|Overall Study|Lost to Follow-up|1|||
144733365|NCT00389064|521880628|FG000|Overall Study|Adverse Event|11|||
144733366|NCT00389064|521880629|FG001|Overall Study|Adverse Event|3|||
144733367|NCT00389064|521880628|FG000|Overall Study|Lack of Efficacy|3|||
144215366|NCT03735121|519981680|FG001|Overall Study|Lost to Follow-up|0|||
144215367|NCT03735121|519981681|FG002|Overall Study|Lost to Follow-up|0|||
144265391|NCT03205150|520173896|FG002|Overall Study|Patient/guardian decision|0|||
144265392|NCT03205150|520173894|FG000|Overall Study|Adverse Event|1|||
144215368|NCT03735121|519981682|FG003|Overall Study|Lost to Follow-up|0|||
144215369|NCT03735121|519981683|FG004|Overall Study|Lost to Follow-up|1|||
144215370|NCT03735121|519981679|FG000|Overall Study|Ongoing|3|||
144215371|NCT03735121|519981680|FG001|Overall Study|Ongoing|3|||
144215372|NCT03735121|519981681|FG002|Overall Study|Ongoing|26|||
144215373|NCT03735121|519981682|FG003|Overall Study|Ongoing|83|||
144215374|NCT03735121|519981683|FG004|Overall Study|Ongoing|158|||
144215375|NCT04036110|519981693|FG000|Overall Study|Lost to Follow-up|3|||
144215376|NCT04036110|519981694|FG001|Overall Study|Lost to Follow-up|2|||
144215377|NCT04036110|519981695|FG002|Overall Study|Lost to Follow-up|1|||
144215378|NCT04036110|519981693|FG000|Overall Study|Study Suspended|4|||
144215379|NCT04036110|519981694|FG001|Overall Study|Study Suspended|5|||
144215380|NCT04036110|519981695|FG002|Overall Study|Study Suspended|1|||
144215381|NCT01107197|519981696|FG000|Overall Study|Death|12|||
144215382|NCT01107197|519981697|FG001|Overall Study|Death|10|||
144215383|NCT01107197|519981696|FG000|Overall Study|Lost to Follow-up|5|||
144215384|NCT01107197|519981697|FG001|Overall Study|Lost to Follow-up|8|||
144215385|NCT01107197|519981696|FG000|Overall Study|Withdrawal by Subject|3|||
144215386|NCT01107197|519981697|FG001|Overall Study|Withdrawal by Subject|5|||
144215387|NCT02593110|519981698|FG000|Overall Study|Withdrawal by Subject|0|||
144215388|NCT02593110|519981699|FG001|Overall Study|Withdrawal by Subject|3|||
144215389|NCT02593110|519981700|FG002|Overall Study|Withdrawal by Subject|3|||
144215390|NCT02593110|519981701|FG003|Overall Study|Withdrawal by Subject|2|||
144215391|NCT02593110|519981698|FG000|Overall Study|Death|0|||
144215392|NCT02593110|519981699|FG001|Overall Study|Death|0|||
144215393|NCT02593110|519981700|FG002|Overall Study|Death|1|||
144215394|NCT02593110|519981701|FG003|Overall Study|Death|0|||
144215395|NCT03548337|519981702|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
144215396|NCT03548337|519981703|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
144215397|NCT03548337|519981702|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
144215398|NCT03548337|519981703|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
144215399|NCT03548337|519981702|FG000|Infant Series|Lost to Follow-up|2|||
144215400|NCT03548337|519981703|FG001|Infant Series|Lost to Follow-up|1|||
144215401|NCT03548337|519981702|FG000|Infant Series|Adverse Event|0|||
144215402|NCT03548337|519981703|FG001|Infant Series|Adverse Event|2|||
144215403|NCT03548337|519981702|FG000|Infant Series|Randomized but Not Vaccinated|1|||
144215404|NCT03548337|519981703|FG001|Infant Series|Randomized but Not Vaccinated|0|||
144215405|NCT03548337|519981702|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
144215406|NCT03548337|519981703|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
144215407|NCT01911273|519981706|FG000|Overall Study|Progression of Disease|1|||
144215408|NCT01911273|519981707|FG001|Overall Study|Progression of Disease|0|||
144215409|NCT01911273|519981706|FG000|Overall Study|Withdrawal by Subject|0|||
144215410|NCT01911273|519981707|FG001|Overall Study|Withdrawal by Subject|2|||
144215411|NCT02359994|519981712|FG000|Overall Population Study|Adverse Event|1|||
144215412|NCT02359994|519981713|FG001|Overall Population Study|Adverse Event|1|||
144215413|NCT02359994|519981712|FG000|Overall Population Study|Death|1|||
144215414|NCT02359994|519981713|FG001|Overall Population Study|Death|5|||
144215415|NCT02359994|519981712|FG000|Overall Population Study|Lost to Follow-up|1|||
144215416|NCT02359994|519981713|FG001|Overall Population Study|Lost to Follow-up|1|||
144215417|NCT02359994|519981712|FG000|Overall Population Study|Withdrawal by Subject|1|||
144215418|NCT02359994|519981713|FG001|Overall Population Study|Withdrawal by Subject|0|||
144215419|NCT02359994|519981712|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
144215420|NCT02359994|519981713|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
144215421|NCT02359994|519981712|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
144215422|NCT02359994|519981713|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
144215423|NCT02359994|519981712|FG000|Extended Oncology 24-Month Survival|Death|19|||
144215424|NCT02359994|519981713|FG001|Extended Oncology 24-Month Survival|Death|21|||
144215425|NCT02359994|519981712|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
144215426|NCT02359994|519981713|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
144215427|NCT04597632|519981714|FG000|Overall Study|Withdrawal by Subject|10|||
144265393|NCT03205150|520173895|FG001|Overall Study|Adverse Event|1|||
144265394|NCT03205150|520173896|FG002|Overall Study|Adverse Event|1|||
144662325|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Adverse Event|6|||
144662326|NCT02951988|521614019|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
144215428|NCT04597632|519981714|FG000|Overall Study|Lost to Follow-up|1|||
144215429|NCT04597632|519981714|FG000|Overall Study|Death|1|||
144215430|NCT04597632|519981714|FG000|Overall Study|Adverse Event|5|||
144215431|NCT03017612|519981717|FG000|Overall Study|Adverse Event|2|||
144215432|NCT04895982|519981718|FG000|Overall Study|Withdrawal by Subject|0|||
144215433|NCT04895982|519981719|FG001|Overall Study|Withdrawal by Subject|0|||
144215434|NCT04895982|519981720|FG002|Overall Study|Withdrawal by Subject|0|||
144215435|NCT04895982|519981721|FG003|Overall Study|Withdrawal by Subject|0|||
144215436|NCT04895982|519981722|FG004|Overall Study|Withdrawal by Subject|0|||
144215437|NCT04895982|519981723|FG005|Overall Study|Withdrawal by Subject|1|||
144215438|NCT04895982|519981724|FG006|Overall Study|Withdrawal by Subject|1|||
144265395|NCT03205150|520173894|FG000|Overall Study|Lost to Follow-up|0|||
144265396|NCT03205150|520173895|FG001|Overall Study|Lost to Follow-up|0|||
144265397|NCT03205150|520173896|FG002|Overall Study|Lost to Follow-up|1|||
144265398|NCT02723188|520173897|FG000|Overall Study|Withdrawal by Subject|1|||
144265399|NCT02723188|520173898|FG001|Overall Study|Withdrawal by Subject|0|||
144265400|NCT02723188|520173899|FG002|Overall Study|Withdrawal by Subject|0|||
144265401|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
144265402|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
144265403|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
144265404|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
144265405|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
144265406|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
144265407|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
144265408|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
144265409|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
144265410|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
144265411|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
144265412|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
144265413|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
144265414|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
144265415|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
144265416|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
144265417|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
144265418|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
144265419|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
144265420|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
144265421|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
144265422|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
144265423|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
144265424|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
144265425|NCT01198002|520173902|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
144265426|NCT01198002|520173903|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
144265427|NCT01198002|520173904|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
144265428|NCT01198002|520173902|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
144265429|NCT01198002|520173903|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
144265430|NCT01198002|520173904|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
144265431|NCT01198002|520173902|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
144265432|NCT01198002|520173903|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
144265433|NCT01198002|520173904|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
144265434|NCT01198002|520173902|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
144265435|NCT01198002|520173903|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
144265436|NCT01198002|520173904|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
144265437|NCT01198002|520173902|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
144265438|NCT01198002|520173903|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
144265439|NCT01198002|520173904|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
144265440|NCT01198002|520173902|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
144265441|NCT01198002|520173903|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
144265442|NCT01198002|520173904|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
144265443|NCT01198002|520173902|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
144215439|NCT04895982|519981725|FG007|Overall Study|Withdrawal by Subject|0|||
144215440|NCT04895982|519981726|FG008|Overall Study|Withdrawal by Subject|0|||
144215441|NCT04895982|519981727|FG009|Overall Study|Withdrawal by Subject|1|||
144215442|NCT04895982|519981728|FG010|Overall Study|Withdrawal by Subject|0|||
144215443|NCT04895982|519981729|FG011|Overall Study|Withdrawal by Subject|1|||
144215444|NCT04895982|519981718|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144215445|NCT04895982|519981719|FG001|Overall Study|Withdrawal by parent/guardian|3|||
144215446|NCT04895982|519981720|FG002|Overall Study|Withdrawal by parent/guardian|3|||
144215447|NCT04895982|519981721|FG003|Overall Study|Withdrawal by parent/guardian|1|||
144265444|NCT01198002|520173903|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
144265445|NCT01198002|520173904|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
144265446|NCT03353792|520173912|FG000|Overall Study|Lost to Follow-up|1|||
144265447|NCT03353792|520173913|FG001|Overall Study|Lost to Follow-up|0|||
144265448|NCT03353792|520173912|FG000|Overall Study|Participant Unable to Manage Device|1|||
144662327|NCT02951988|521614020|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
144662328|NCT02951988|521614021|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
144215448|NCT04895982|519981722|FG004|Overall Study|Withdrawal by parent/guardian|3|||
144662329|NCT02951988|521614022|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
144215449|NCT04895982|519981723|FG005|Overall Study|Withdrawal by parent/guardian|2|||
144215450|NCT04895982|519981724|FG006|Overall Study|Withdrawal by parent/guardian|1|||
144215451|NCT04895982|519981725|FG007|Overall Study|Withdrawal by parent/guardian|0|||
144662330|NCT05836818|521614023|FG000|Overall Study|Physician Decision|1|||
144662331|NCT05836818|521614024|FG001|Overall Study|Physician Decision|1|||
144662332|NCT05836818|521614025|FG002|Overall Study|Physician Decision|0|||
144662333|NCT05836818|521614023|FG000|Overall Study|Withdrawal by Subject|0|||
144662334|NCT05836818|521614024|FG001|Overall Study|Withdrawal by Subject|0|||
144662335|NCT05836818|521614025|FG002|Overall Study|Withdrawal by Subject|1|||
144662336|NCT05836818|521614023|FG000|Overall Study|Later found to be previously vaccinated|0|||
144662337|NCT05836818|521614024|FG001|Overall Study|Later found to be previously vaccinated|1|||
144662338|NCT05836818|521614025|FG002|Overall Study|Later found to be previously vaccinated|3|||
144662339|NCT05836818|521614023|FG000|Overall Study|Pregnancy|0|||
144662340|NCT05836818|521614024|FG001|Overall Study|Pregnancy|1|||
144662341|NCT05836818|521614025|FG002|Overall Study|Pregnancy|0|||
144662342|NCT05836818|521614023|FG000|Overall Study|Allergic to vaccines|0|||
144662343|NCT05836818|521614024|FG001|Overall Study|Allergic to vaccines|1|||
144662344|NCT05836818|521614025|FG002|Overall Study|Allergic to vaccines|0|||
144662345|NCT02491073|521614026|FG000|Overall Study|screen failure|1|||
144662346|NCT02491073|521614027|FG001|Overall Study|screen failure|0|||
144662347|NCT01165021|521614028|FG000|Overall Study|Death|1|||
144662348|NCT03977727|521614029|FG000|Second Treatment|Lost to Follow-up|0|||
144662349|NCT03977727|521614030|FG001|Second Treatment|Lost to Follow-up|3|||
144662350|NCT01419665|521614031|FG000|Combination Treatment|Adverse Event|7|||
144662351|NCT01419665|521614032|FG001|Combination Treatment|Adverse Event|10|||
144662352|NCT01419665|521614031|FG000|Combination Treatment|Physician Decision|5|||
144662353|NCT01419665|521614032|FG001|Combination Treatment|Physician Decision|8|||
144662354|NCT01419665|521614031|FG000|Combination Treatment|Protocol Violation|6|||
144662355|NCT01419665|521614032|FG001|Combination Treatment|Protocol Violation|2|||
144662356|NCT01419665|521614031|FG000|Combination Treatment|disease progression|10|||
144662357|NCT01419665|521614032|FG001|Combination Treatment|disease progression|9|||
144662358|NCT01419665|521614031|FG000|Combination Treatment|Death|5|||
144662359|NCT01419665|521614032|FG001|Combination Treatment|Death|7|||
144662360|NCT01419665|521614031|FG000|Combination Treatment|administrative problems|0|||
144662361|NCT01419665|521614032|FG001|Combination Treatment|administrative problems|1|||
144662362|NCT01419665|521614031|FG000|Combination Treatment|Withdrawal by Subject|5|||
144662363|NCT01419665|521614032|FG001|Combination Treatment|Withdrawal by Subject|4|||
144662364|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
144662365|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
144662366|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
144662367|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
144662368|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
144662369|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
144662370|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
144662371|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
144662372|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
144662373|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
144662374|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
144662375|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
144662376|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|Death|1|||
144662377|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|Death|2|||
144662378|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
144662379|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
144662380|NCT01419665|521614031|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
144662381|NCT01419665|521614032|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
144662382|NCT01419665|521614031|FG000|Open Label Phase|Death|1|||
144662383|NCT01419665|521614032|FG001|Open Label Phase|Death|0|||
144662384|NCT01419665|521614031|FG000|Open Label Phase|disease progression|0|||
144662385|NCT01419665|521614032|FG001|Open Label Phase|disease progression|1|||
144662386|NCT01655823|521614034|FG000|Overall Study|Lost to Follow-up|0|||
144662387|NCT01655823|521614035|FG001|Overall Study|Lost to Follow-up|1|||
144662388|NCT01655823|521614036|FG002|Overall Study|Lost to Follow-up|0|||
144662389|NCT01655823|521614037|FG003|Overall Study|Lost to Follow-up|0|||
144662390|NCT01655823|521614038|FG004|Overall Study|Lost to Follow-up|1|||
144662391|NCT01655823|521614034|FG000|Overall Study|Withdrawal by Subject|0|||
144662392|NCT01655823|521614035|FG001|Overall Study|Withdrawal by Subject|1|||
144662393|NCT01655823|521614036|FG002|Overall Study|Withdrawal by Subject|0|||
144662394|NCT01655823|521614037|FG003|Overall Study|Withdrawal by Subject|1|||
144662395|NCT01655823|521614038|FG004|Overall Study|Withdrawal by Subject|0|||
144662396|NCT00586924|521614042|FG000|Overall Study|Adverse event/serious adverse event|0|||
144662397|NCT00586924|521614043|FG001|Overall Study|Adverse event/serious adverse event|0|||
144662398|NCT00586924|521614044|FG002|Overall Study|Adverse event/serious adverse event|0|||
144662399|NCT00586924|521614045|FG003|Overall Study|Adverse event/serious adverse event|1|||
144662400|NCT00586924|521614046|FG004|Overall Study|Adverse event/serious adverse event|0|||
144662401|NCT00586924|521614047|FG005|Overall Study|Adverse event/serious adverse event|2|||
144733368|NCT00389064|521880629|FG001|Overall Study|Lack of Efficacy|14|||
144662402|NCT00586924|521614042|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
144662403|NCT00586924|521614043|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
144662404|NCT00586924|521614044|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
144662405|NCT00586924|521614045|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
144662406|NCT00586924|521614046|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
144662407|NCT00586924|521614047|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
144662408|NCT00586924|521614042|FG000|Overall Study|Disease progression|0|||
144662409|NCT00586924|521614043|FG001|Overall Study|Disease progression|0|||
144662410|NCT00586924|521614044|FG002|Overall Study|Disease progression|0|||
144662411|NCT00586924|521614045|FG003|Overall Study|Disease progression|1|||
144662412|NCT00586924|521614046|FG004|Overall Study|Disease progression|1|||
144662413|NCT00586924|521614047|FG005|Overall Study|Disease progression|0|||
144662414|NCT00586924|521614042|FG000|Overall Study|Development of neutralizing antibodies|2|||
144662415|NCT00586924|521614043|FG001|Overall Study|Development of neutralizing antibodies|2|||
144662416|NCT00586924|521614044|FG002|Overall Study|Development of neutralizing antibodies|2|||
144662417|NCT00586924|521614045|FG003|Overall Study|Development of neutralizing antibodies|0|||
144662418|NCT00586924|521614046|FG004|Overall Study|Development of neutralizing antibodies|0|||
144662419|NCT00586924|521614047|FG005|Overall Study|Development of neutralizing antibodies|22|||
144662420|NCT00586924|521614042|FG000|Overall Study|Complete response|0|||
144662421|NCT00586924|521614043|FG001|Overall Study|Complete response|1|||
144662422|NCT00586924|521614044|FG002|Overall Study|Complete response|0|||
144662423|NCT00586924|521614045|FG003|Overall Study|Complete response|0|||
144662424|NCT00586924|521614046|FG004|Overall Study|Complete response|2|||
144662425|NCT00586924|521614047|FG005|Overall Study|Complete response|2|||
144662426|NCT00586924|521614042|FG000|Overall Study|Other|1|||
144662427|NCT00586924|521614043|FG001|Overall Study|Other|0|||
144662428|NCT00586924|521614044|FG002|Overall Study|Other|1|||
144662429|NCT00586924|521614045|FG003|Overall Study|Other|1|||
144662430|NCT00586924|521614046|FG004|Overall Study|Other|1|||
144662431|NCT00586924|521614047|FG005|Overall Study|Other|6|||
144662432|NCT04570657|521614048|FG000|Overall Study|Adverse Event|0|||
144662433|NCT04570657|521614049|FG001|Overall Study|Adverse Event|0|||
144662434|NCT04570657|521614050|FG002|Overall Study|Adverse Event|1|||
144662435|NCT04570657|521614048|FG000|Overall Study|Lost to Follow-up|0|||
144662436|NCT04570657|521614049|FG001|Overall Study|Lost to Follow-up|0|||
144662437|NCT04570657|521614050|FG002|Overall Study|Lost to Follow-up|1|||
144662438|NCT04570657|521614048|FG000|Overall Study|Physician Decision|0|||
144662439|NCT04570657|521614049|FG001|Overall Study|Physician Decision|1|||
144662440|NCT04570657|521614050|FG002|Overall Study|Physician Decision|0|||
144662441|NCT04570657|521614048|FG000|Overall Study|Withdrawal by Subject|1|||
144662442|NCT04570657|521614049|FG001|Overall Study|Withdrawal by Subject|2|||
144662443|NCT04570657|521614050|FG002|Overall Study|Withdrawal by Subject|2|||
144662444|NCT01079962|521614051|FG000|Overall Study|Adverse Event|2|||
144662445|NCT01079962|521614052|FG001|Overall Study|Adverse Event|2|||
144662446|NCT01079962|521614051|FG000|Overall Study|Withdrawal by Subject|5|||
144662447|NCT01079962|521614052|FG001|Overall Study|Withdrawal by Subject|7|||
144662448|NCT01079962|521614051|FG000|Overall Study|Protocol Violation|2|||
144662449|NCT01079962|521614052|FG001|Overall Study|Protocol Violation|2|||
144662450|NCT01079962|521614051|FG000|Overall Study|No blood pressure (BP) control|3|||
144662451|NCT01079962|521614052|FG001|Overall Study|No blood pressure (BP) control|0|||
144662452|NCT01079962|521614051|FG000|Overall Study|Inclusion/exclusion criteria|1|||
144662453|NCT01079962|521614052|FG001|Overall Study|Inclusion/exclusion criteria|3|||
144662454|NCT01079962|521614051|FG000|Overall Study|Participant not returning for next visit|1|||
144662455|NCT01079962|521614052|FG001|Overall Study|Participant not returning for next visit|0|||
144662456|NCT01079962|521614051|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
144662457|NCT01079962|521614052|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
144215452|NCT04895982|519981726|FG008|Overall Study|Withdrawal by parent/guardian|3|||
144215453|NCT04895982|519981727|FG009|Overall Study|Withdrawal by parent/guardian|0|||
144215454|NCT04895982|519981728|FG010|Overall Study|Withdrawal by parent/guardian|0|||
144215455|NCT04895982|519981729|FG011|Overall Study|Withdrawal by parent/guardian|0|||
144215456|NCT04895982|519981718|FG000|Overall Study|Other|0|||
144215457|NCT04895982|519981719|FG001|Overall Study|Other|0|||
144662458|NCT01072539|521614053|FG000|Overall Study|Treated prior to the Site Initiation|1|||
144662459|NCT01072539|521614053|FG000|Overall Study|Protocol Violation|2|||
144662460|NCT01331239|521614054|FG000|Part II: Core Study|Adverse Event|0|||
144215458|NCT04895982|519981720|FG002|Overall Study|Other|1|||
144215459|NCT04895982|519981721|FG003|Overall Study|Other|1|||
144662461|NCT01331239|521614055|FG001|Part II: Core Study|Adverse Event|3|||
144662462|NCT01331239|521614056|FG002|Part II: Core Study|Adverse Event|0|||
144662463|NCT01331239|521614054|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
144662464|NCT01331239|521614055|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
144662465|NCT01331239|521614056|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
144215460|NCT04895982|519981722|FG004|Overall Study|Other|0|||
144215461|NCT04895982|519981723|FG005|Overall Study|Other|0|||
144215462|NCT04895982|519981724|FG006|Overall Study|Other|0|||
144215463|NCT04895982|519981725|FG007|Overall Study|Other|0|||
144215464|NCT04895982|519981726|FG008|Overall Study|Other|0|||
144215465|NCT04895982|519981727|FG009|Overall Study|Other|1|||
144215466|NCT04895982|519981728|FG010|Overall Study|Other|0|||
144215467|NCT04895982|519981729|FG011|Overall Study|Other|0|||
144215468|NCT04895982|519981718|FG000|Overall Study|Protocol Violation|0|||
144215469|NCT04895982|519981719|FG001|Overall Study|Protocol Violation|0|||
144215470|NCT04895982|519981720|FG002|Overall Study|Protocol Violation|1|||
144215471|NCT04895982|519981721|FG003|Overall Study|Protocol Violation|1|||
144215472|NCT04895982|519981722|FG004|Overall Study|Protocol Violation|1|||
144215473|NCT04895982|519981723|FG005|Overall Study|Protocol Violation|0|||
144215474|NCT04895982|519981724|FG006|Overall Study|Protocol Violation|0|||
144215475|NCT04895982|519981725|FG007|Overall Study|Protocol Violation|1|||
144215476|NCT04895982|519981726|FG008|Overall Study|Protocol Violation|0|||
144215477|NCT04895982|519981727|FG009|Overall Study|Protocol Violation|0|||
144215478|NCT04895982|519981728|FG010|Overall Study|Protocol Violation|0|||
144215479|NCT04895982|519981729|FG011|Overall Study|Protocol Violation|0|||
144215480|NCT04895982|519981718|FG000|Overall Study|Lost to Follow-up|0|||
144215481|NCT04895982|519981719|FG001|Overall Study|Lost to Follow-up|0|||
144215482|NCT04895982|519981720|FG002|Overall Study|Lost to Follow-up|1|||
144215483|NCT04895982|519981721|FG003|Overall Study|Lost to Follow-up|0|||
144215484|NCT04895982|519981722|FG004|Overall Study|Lost to Follow-up|0|||
144215485|NCT04895982|519981723|FG005|Overall Study|Lost to Follow-up|1|||
144215486|NCT04895982|519981724|FG006|Overall Study|Lost to Follow-up|0|||
144215487|NCT04895982|519981725|FG007|Overall Study|Lost to Follow-up|0|||
144215488|NCT04895982|519981726|FG008|Overall Study|Lost to Follow-up|1|||
144215489|NCT04895982|519981727|FG009|Overall Study|Lost to Follow-up|0|||
144215490|NCT04895982|519981728|FG010|Overall Study|Lost to Follow-up|0|||
144215491|NCT04895982|519981729|FG011|Overall Study|Lost to Follow-up|0|||
144215492|NCT04895982|519981718|FG000|Overall Study|Refused further study procedures|0|||
144215493|NCT04895982|519981719|FG001|Overall Study|Refused further study procedures|0|||
144215494|NCT04895982|519981720|FG002|Overall Study|Refused further study procedures|1|||
144215495|NCT04895982|519981721|FG003|Overall Study|Refused further study procedures|0|||
144215496|NCT04895982|519981722|FG004|Overall Study|Refused further study procedures|0|||
144215497|NCT04895982|519981723|FG005|Overall Study|Refused further study procedures|0|||
144215498|NCT04895982|519981724|FG006|Overall Study|Refused further study procedures|0|||
144215499|NCT04895982|519981725|FG007|Overall Study|Refused further study procedures|0|||
144215500|NCT04895982|519981726|FG008|Overall Study|Refused further study procedures|0|||
144215501|NCT04895982|519981727|FG009|Overall Study|Refused further study procedures|0|||
144215502|NCT04895982|519981728|FG010|Overall Study|Refused further study procedures|0|||
144215503|NCT04895982|519981729|FG011|Overall Study|Refused further study procedures|0|||
144215504|NCT00919854|519981732|FG000|Overall Study|Adverse Event|1|||
144215505|NCT01893346|519981735|FG000|Overall Study|Lost to Follow-up|0|||
144215506|NCT01893346|519981736|FG001|Overall Study|Lost to Follow-up|1|||
144215507|NCT01893346|519981737|FG002|Overall Study|Lost to Follow-up|0|||
144215508|NCT01893346|519981738|FG003|Overall Study|Lost to Follow-up|0|||
144215509|NCT01893346|519981735|FG000|Overall Study|Protocol Violation|1|||
144215510|NCT01893346|519981736|FG001|Overall Study|Protocol Violation|0|||
144215511|NCT01893346|519981737|FG002|Overall Study|Protocol Violation|0|||
144215512|NCT01893346|519981738|FG003|Overall Study|Protocol Violation|0|||
144215513|NCT01893346|519981735|FG000|Overall Study|Withdrawal by Subject|2|||
144215514|NCT01893346|519981736|FG001|Overall Study|Withdrawal by Subject|0|||
144215515|NCT01893346|519981737|FG002|Overall Study|Withdrawal by Subject|0|||
144662466|NCT01331239|521614054|FG000|Part II: Core Study|Withdrawal by Subject|0|||
144662467|NCT01331239|521614055|FG001|Part II: Core Study|Withdrawal by Subject|2|||
144662468|NCT01331239|521614056|FG002|Part II: Core Study|Withdrawal by Subject|0|||
144662469|NCT01331239|521614054|FG000|Part II: Core Study|Administrative problems|0|||
144662470|NCT01331239|521614055|FG001|Part II: Core Study|Administrative problems|1|||
144662471|NCT01331239|521614056|FG002|Part II: Core Study|Administrative problems|0|||
144662472|NCT01008995|521614057|FG000|Controlled Period|Adverse Event|1|||
144662473|NCT01008995|521614058|FG001|Controlled Period|Adverse Event|2|||
144662474|NCT01008995|521614059|FG002|Controlled Period|Adverse Event|0|||
144662475|NCT01008995|521614060|FG003|Controlled Period|Adverse Event|0|||
144662476|NCT01008995|521614057|FG000|Controlled Period|Other|2|||
144662477|NCT01008995|521614058|FG001|Controlled Period|Other|1|||
144662478|NCT01008995|521614059|FG002|Controlled Period|Other|0|||
144662479|NCT01008995|521614060|FG003|Controlled Period|Other|0|||
144662480|NCT01008995|521614057|FG000|After Controlled Period|Adverse Event|0|||
144662481|NCT01008995|521614058|FG001|After Controlled Period|Adverse Event|0|||
144215516|NCT01893346|519981738|FG003|Overall Study|Withdrawal by Subject|0|||
144215517|NCT02296931|519981744|FG000|Overall Study|Protocol Violation|0|||
144215518|NCT02296931|519981745|FG001|Overall Study|Protocol Violation|2|||
144215519|NCT01590277|519981746|FG000|Overall Study|Withdrawal by Subject|3|||
144215520|NCT01590277|519981746|FG000|Overall Study|Withdrawal by Subject|2|||
144215521|NCT01590277|519981746|FG000|Overall Study|Withdrawal by Subject|1|||
144215522|NCT01590277|519981746|FG000|Overall Study|Withdrawal by Subject|1|||
144215523|NCT04386616|519981747|FG000|Overall Study|Death|22|||
144215524|NCT04386616|519981748|FG001|Overall Study|Death|22|||
144215525|NCT04386616|519981749|FG002|Overall Study|Death|21|||
144662482|NCT01008995|521614059|FG002|After Controlled Period|Adverse Event|1|||
144265449|NCT03353792|520173913|FG001|Overall Study|Participant Unable to Manage Device|0|||
144265450|NCT00789321|520173914|FG000|Overall Study|Adverse Event|0|||
144265451|NCT00789321|520173915|FG001|Overall Study|Adverse Event|1|||
144265452|NCT03652818|520173917|FG000|Overall Study|Adverse Event|1|||
144265453|NCT03652818|520173918|FG001|Overall Study|Adverse Event|0|||
144265454|NCT03652818|520173919|FG002|Overall Study|Adverse Event|0|||
144265455|NCT03652818|520173920|FG003|Overall Study|Adverse Event|0|||
144265456|NCT03652818|520173921|FG004|Overall Study|Adverse Event|0|||
144662483|NCT01008995|521614060|FG003|After Controlled Period|Adverse Event|1|||
144215526|NCT04386616|519981747|FG000|Overall Study|Lost to Follow-up|5|||
144215527|NCT04386616|519981748|FG001|Overall Study|Lost to Follow-up|8|||
144215528|NCT04386616|519981749|FG002|Overall Study|Lost to Follow-up|6|||
144215529|NCT04386616|519981747|FG000|Overall Study|Withdrawal by Subject|2|||
144215530|NCT04386616|519981748|FG001|Overall Study|Withdrawal by Subject|4|||
144215531|NCT04386616|519981749|FG002|Overall Study|Withdrawal by Subject|1|||
144215532|NCT04386616|519981747|FG000|Overall Study|Adverse Event|1|||
144215533|NCT04386616|519981748|FG001|Overall Study|Adverse Event|1|||
144215534|NCT04386616|519981749|FG002|Overall Study|Adverse Event|0|||
144215535|NCT01377012|519981750|FG000|Core Study|Study terminated by Sponsor|47|||
144215536|NCT01377012|519981751|FG001|Core Study|Study terminated by Sponsor|54|||
144215537|NCT01377012|519981752|FG002|Core Study|Study terminated by Sponsor|46|||
144215538|NCT01377012|519981750|FG000|Core Study|Technical problems|1|||
144215539|NCT01377012|519981751|FG001|Core Study|Technical problems|0|||
144215540|NCT01377012|519981752|FG002|Core Study|Technical problems|0|||
144215541|NCT01377012|519981750|FG000|Core Study|Withdrawal by Subject|15|||
144215542|NCT01377012|519981751|FG001|Core Study|Withdrawal by Subject|23|||
144215543|NCT01377012|519981752|FG002|Core Study|Withdrawal by Subject|18|||
144215544|NCT01377012|519981750|FG000|Core Study|Protocol Violation|7|||
144215545|NCT01377012|519981751|FG001|Core Study|Protocol Violation|3|||
144215546|NCT01377012|519981752|FG002|Core Study|Protocol Violation|2|||
144215547|NCT01377012|519981750|FG000|Core Study|Pregnancy|0|||
144215548|NCT01377012|519981751|FG001|Core Study|Pregnancy|0|||
144215549|NCT01377012|519981752|FG002|Core Study|Pregnancy|1|||
144215550|NCT01377012|519981750|FG000|Core Study|Physician Decision|5|||
144215551|NCT01377012|519981751|FG001|Core Study|Physician Decision|4|||
144215552|NCT01377012|519981752|FG002|Core Study|Physician Decision|10|||
144662484|NCT01008995|521614057|FG000|After Controlled Period|Other|0|||
144662485|NCT01008995|521614058|FG001|After Controlled Period|Other|0|||
144662486|NCT01008995|521614059|FG002|After Controlled Period|Other|1|||
144662487|NCT01008995|521614060|FG003|After Controlled Period|Other|0|||
144662488|NCT00115804|521614061|FG000|Overall Study|Adverse Event|2|||
144662489|NCT00621855|521614062|FG000|Overall Study|Adverse Event|32|||
144662490|NCT00621855|521614063|FG001|Overall Study|Adverse Event|31|||
144662491|NCT00621855|521614064|FG002|Overall Study|Adverse Event|48|||
144662492|NCT00621855|521614065|FG003|Overall Study|Adverse Event|34|||
144662493|NCT00621855|521614066|FG004|Overall Study|Adverse Event|31|||
144662494|NCT00621855|521614062|FG000|Overall Study|Lost to Follow-up|0|||
144662495|NCT00621855|521614063|FG001|Overall Study|Lost to Follow-up|1|||
144662496|NCT00621855|521614064|FG002|Overall Study|Lost to Follow-up|3|||
144662497|NCT00621855|521614065|FG003|Overall Study|Lost to Follow-up|4|||
144662498|NCT00621855|521614066|FG004|Overall Study|Lost to Follow-up|1|||
144662499|NCT00621855|521614062|FG000|Overall Study|Protocol Violation|16|||
144662500|NCT00621855|521614063|FG001|Overall Study|Protocol Violation|8|||
144662501|NCT00621855|521614064|FG002|Overall Study|Protocol Violation|6|||
144662502|NCT00621855|521614065|FG003|Overall Study|Protocol Violation|7|||
144662503|NCT00621855|521614066|FG004|Overall Study|Protocol Violation|8|||
144662504|NCT00621855|521614062|FG000|Overall Study|Withdrawal by Subject|16|||
144662505|NCT00621855|521614063|FG001|Overall Study|Withdrawal by Subject|11|||
144215553|NCT01377012|519981750|FG000|Core Study|Non-Compliant with study treatment|0|||
144215554|NCT01377012|519981751|FG001|Core Study|Non-Compliant with study treatment|0|||
144215555|NCT01377012|519981752|FG002|Core Study|Non-Compliant with study treatment|1|||
144215556|NCT01377012|519981750|FG000|Core Study|No Longer require treatment|0|||
144215557|NCT01377012|519981751|FG001|Core Study|No Longer require treatment|0|||
144265457|NCT03652818|520173917|FG000|Overall Study|Physician Decision|1|||
144662506|NCT00621855|521614064|FG002|Overall Study|Withdrawal by Subject|13|||
144662507|NCT00621855|521614065|FG003|Overall Study|Withdrawal by Subject|13|||
144215558|NCT01377012|519981752|FG002|Core Study|No Longer require treatment|1|||
144215559|NCT01377012|519981750|FG000|Core Study|Lost to Follow-up|7|||
144215560|NCT01377012|519981751|FG001|Core Study|Lost to Follow-up|5|||
144215561|NCT01377012|519981752|FG002|Core Study|Lost to Follow-up|4|||
144662508|NCT00621855|521614066|FG004|Overall Study|Withdrawal by Subject|9|||
144215562|NCT01377012|519981750|FG000|Core Study|Lack of Efficacy|41|||
144215563|NCT01377012|519981751|FG001|Core Study|Lack of Efficacy|28|||
144215564|NCT01377012|519981752|FG002|Core Study|Lack of Efficacy|37|||
144215565|NCT01377012|519981750|FG000|Core Study|Death|1|||
144265458|NCT03652818|520173918|FG001|Overall Study|Physician Decision|0|||
144265459|NCT03652818|520173919|FG002|Overall Study|Physician Decision|0|||
144265460|NCT03652818|520173920|FG003|Overall Study|Physician Decision|0|||
144662509|NCT00621855|521614062|FG000|Overall Study|Other|9|||
144662510|NCT00621855|521614063|FG001|Overall Study|Other|7|||
144265461|NCT03652818|520173921|FG004|Overall Study|Physician Decision|0|||
144265462|NCT03652818|520173917|FG000|Overall Study|Lost to Follow-up|0|||
144265463|NCT03652818|520173918|FG001|Overall Study|Lost to Follow-up|1|||
144265464|NCT03652818|520173919|FG002|Overall Study|Lost to Follow-up|2|||
144265465|NCT03652818|520173920|FG003|Overall Study|Lost to Follow-up|1|||
144265466|NCT03652818|520173921|FG004|Overall Study|Lost to Follow-up|1|||
144265467|NCT03964207|520173922|FG000|First Treatment|Withdrawal by Subject|1|||
144265468|NCT03964207|520173923|FG001|First Treatment|Withdrawal by Subject|2|||
144265469|NCT03964207|520173922|FG000|First Treatment|Protocol Violation|1|||
144265470|NCT03964207|520173923|FG001|First Treatment|Protocol Violation|0|||
144265471|NCT03964207|520173922|FG000|First Treatment|Lost to Follow-up|1|||
144265472|NCT03964207|520173923|FG001|First Treatment|Lost to Follow-up|0|||
144265473|NCT03964207|520173922|FG000|Second Treatment|Lost to Follow-up|0|||
144265474|NCT03964207|520173923|FG001|Second Treatment|Lost to Follow-up|1|||
144265475|NCT03964207|520173922|FG000|Second Treatment|Adverse Event|1|||
144265476|NCT03964207|520173923|FG001|Second Treatment|Adverse Event|2|||
144265477|NCT00830219|520173924|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144265478|NCT00830219|520173925|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
144265479|NCT01241279|520173926|FG000|Overall Study|Lost to Follow-up|0|||
144265480|NCT01241279|520173927|FG001|Overall Study|Lost to Follow-up|1|||
144265481|NCT00239720|520173931|FG000|Overall Study|Adverse Event|1|||
144265482|NCT00239720|520173932|FG001|Overall Study|Adverse Event|0|||
144265483|NCT00239720|520173931|FG000|Overall Study|Lost to Follow-up|0|||
144265484|NCT00239720|520173932|FG001|Overall Study|Lost to Follow-up|1|||
144265485|NCT01811732|520173933|FG000|Overall Study|Lost to Follow-up|24|||
144265486|NCT01811732|520173934|FG001|Overall Study|Lost to Follow-up|30|||
144265487|NCT01811732|520173933|FG000|Overall Study|Withdrawal by Subject|16|||
144265488|NCT01811732|520173934|FG001|Overall Study|Withdrawal by Subject|10|||
144265489|NCT01811732|520173933|FG000|Overall Study|Adverse Event|3|||
144265490|NCT01811732|520173934|FG001|Overall Study|Adverse Event|9|||
144265491|NCT01811732|520173933|FG000|Overall Study|Lack of Efficacy|3|||
144265492|NCT01811732|520173934|FG001|Overall Study|Lack of Efficacy|1|||
144265493|NCT01811732|520173933|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
144265494|NCT01811732|520173934|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
144265495|NCT01811732|520173933|FG000|Overall Study|Physician Decision|2|||
144265496|NCT01811732|520173934|FG001|Overall Study|Physician Decision|0|||
144265497|NCT01811732|520173933|FG000|Overall Study|Death|1|||
144265498|NCT01811732|520173934|FG001|Overall Study|Death|1|||
144265499|NCT01811732|520173933|FG000|Overall Study|Insufficient venous access|0|||
144662511|NCT00621855|521614064|FG002|Overall Study|Other|6|||
144662512|NCT00621855|521614065|FG003|Overall Study|Other|5|||
144662513|NCT00621855|521614066|FG004|Overall Study|Other|4|||
144662514|NCT00621855|521614062|FG000|Overall Study|Patients did not receive study drug|3|||
144662515|NCT00621855|521614063|FG001|Overall Study|Patients did not receive study drug|3|||
144662516|NCT00621855|521614064|FG002|Overall Study|Patients did not receive study drug|5|||
144662517|NCT00621855|521614065|FG003|Overall Study|Patients did not receive study drug|4|||
144662518|NCT00621855|521614066|FG004|Overall Study|Patients did not receive study drug|2|||
144662519|NCT01934192|521614069|FG000|Overall Study|Protocol Violation|0|||
144662520|NCT01934192|521614070|FG001|Overall Study|Protocol Violation|0|||
144662521|NCT01934192|521614071|FG002|Overall Study|Protocol Violation|0|||
144662522|NCT01934192|521614072|FG003|Overall Study|Protocol Violation|1|||
144662523|NCT01934192|521614069|FG000|Overall Study|Other: reached stopping criteria|6|||
144662524|NCT01934192|521614070|FG001|Overall Study|Other: reached stopping criteria|5|||
144662525|NCT01934192|521614071|FG002|Overall Study|Other: reached stopping criteria|1|||
144662526|NCT01934192|521614072|FG003|Overall Study|Other: reached stopping criteria|0|||
144662527|NCT01934192|521614069|FG000|Overall Study|Physician Decision|3|||
144662528|NCT01934192|521614070|FG001|Overall Study|Physician Decision|2|||
144662529|NCT01934192|521614071|FG002|Overall Study|Physician Decision|0|||
144662530|NCT01934192|521614072|FG003|Overall Study|Physician Decision|0|||
144662531|NCT01737840|521614073|FG000|Overall Study|Diagnosed with an other pathology|2|||
144662532|NCT01737840|521614074|FG001|Overall Study|Diagnosed with an other pathology|2|||
144662533|NCT00403559|521614077|FG000|Overall Study|Adverse Event|0|||
144662534|NCT00403559|521614078|FG001|Overall Study|Adverse Event|1|||
144662535|NCT00403559|521614077|FG000|Overall Study|Lost to Follow-up|3|||
144662536|NCT00403559|521614078|FG001|Overall Study|Lost to Follow-up|3|||
144662537|NCT00403559|521614077|FG000|Overall Study|Withdrawal by Subject|1|||
144265500|NCT01811732|520173934|FG001|Overall Study|Insufficient venous access|1|||
144265501|NCT01811732|520173933|FG000|Overall Study|Protocol Violation|0|||
144265502|NCT01811732|520173934|FG001|Overall Study|Protocol Violation|1|||
144265503|NCT01811732|520173933|FG000|Overall Study|Subject incarcerated|1|||
144265504|NCT01811732|520173934|FG001|Overall Study|Subject incarcerated|2|||
144265505|NCT01811732|520173933|FG000|Overall Study|Admitted to another facility|1|||
144265506|NCT01811732|520173934|FG001|Overall Study|Admitted to another facility|0|||
144265507|NCT01811732|520173933|FG000|Overall Study|Correct study drug not available on site|1|||
144265508|NCT01811732|520173934|FG001|Overall Study|Correct study drug not available on site|0|||
144662538|NCT00403559|521614078|FG001|Overall Study|Withdrawal by Subject|0|||
144662539|NCT04105244|521614081|FG000|Overall Study|Withdrawal by Subject|10|||
144662540|NCT04105244|521614082|FG001|Overall Study|Withdrawal by Subject|12|||
144662541|NCT04105244|521614081|FG000|Overall Study|Lost to Follow-up|20|||
144662542|NCT04105244|521614082|FG001|Overall Study|Lost to Follow-up|15|||
144662543|NCT04105244|521614081|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
144662544|NCT04105244|521614082|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
144662545|NCT04105244|521614081|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
144662546|NCT04105244|521614082|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
144662547|NCT02358369|521614083|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
144662548|NCT02358369|521614084|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
144215566|NCT01377012|519981751|FG001|Core Study|Death|1|||
144215567|NCT01377012|519981752|FG002|Core Study|Death|1|||
144215568|NCT01377012|519981750|FG000|Core Study|Adverse Event|10|||
144215569|NCT01377012|519981751|FG001|Core Study|Adverse Event|14|||
144215570|NCT01377012|519981752|FG002|Core Study|Adverse Event|13|||
144215571|NCT01377012|519981750|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
144215572|NCT01377012|519981751|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
144215573|NCT01377012|519981752|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
144215574|NCT01377012|519981750|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
144215575|NCT01377012|519981751|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
144215576|NCT01377012|519981752|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
144215577|NCT01377012|519981750|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
144215578|NCT01377012|519981751|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
144215579|NCT01377012|519981752|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
144215580|NCT01377012|519981750|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
144215581|NCT01377012|519981751|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
144215582|NCT01377012|519981752|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
144215583|NCT01377012|519981750|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
144215584|NCT01377012|519981751|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
144215585|NCT01377012|519981752|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
144215586|NCT01377012|519981750|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
144215587|NCT01377012|519981751|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
144662549|NCT02358369|521614085|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
144662550|NCT02358369|521614086|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
144662551|NCT02358369|521614087|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
144662552|NCT02358369|521614083|FG000|Treatment Period A/B|Adverse Event|0|||
144662553|NCT02358369|521614084|FG001|Treatment Period A/B|Adverse Event|0|||
144662554|NCT02358369|521614085|FG002|Treatment Period A/B|Adverse Event|1|||
144662555|NCT02358369|521614086|FG003|Treatment Period A/B|Adverse Event|2|||
144662556|NCT02358369|521614087|FG004|Treatment Period A/B|Adverse Event|0|||
144662557|NCT02358369|521614083|FG000|Treatment Period A/B|Death|0|||
144662558|NCT02358369|521614084|FG001|Treatment Period A/B|Death|0|||
144662559|NCT02358369|521614085|FG002|Treatment Period A/B|Death|1|||
144662560|NCT02358369|521614086|FG003|Treatment Period A/B|Death|0|||
144662561|NCT02358369|521614087|FG004|Treatment Period A/B|Death|0|||
144662562|NCT02358369|521614083|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
144662563|NCT02358369|521614084|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
144662564|NCT02358369|521614085|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
144662565|NCT02358369|521614086|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
144662566|NCT02358369|521614087|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
144662567|NCT02358369|521614083|FG000|Treatment Period C|Adverse Event|0|||
144662568|NCT02358369|521614084|FG001|Treatment Period C|Adverse Event|0|||
144662569|NCT02358369|521614085|FG002|Treatment Period C|Adverse Event|0|||
144662570|NCT02358369|521614086|FG003|Treatment Period C|Adverse Event|0|||
144662571|NCT02358369|521614087|FG004|Treatment Period C|Adverse Event|7|||
144662572|NCT03095521|521614088|FG000|Overall Study|Withdrawal by Subject|0|||
144265509|NCT01699750|520173935|FG000|Overall Study|Withdrew Consent|0|||
144662573|NCT03095521|521614089|FG001|Overall Study|Withdrawal by Subject|1|||
144662574|NCT03095521|521614088|FG000|Overall Study|Lost to Follow-up|0|||
144662575|NCT03095521|521614089|FG001|Overall Study|Lost to Follow-up|1|||
144662576|NCT00064350|521614090|FG000|Induction Treatment|Disease Progression|5|||
144662577|NCT00064350|521614091|FG001|Induction Treatment|Disease Progression|1|||
144662578|NCT00064350|521614092|FG002|Induction Treatment|Disease Progression|110|||
144662579|NCT00064350|521614090|FG000|Induction Treatment|Adverse Event|0|||
144662580|NCT00064350|521614091|FG001|Induction Treatment|Adverse Event|2|||
144662581|NCT00064350|521614092|FG002|Induction Treatment|Adverse Event|49|||
144662582|NCT00064350|521614090|FG000|Induction Treatment|Death|0|||
144662583|NCT00064350|521614091|FG001|Induction Treatment|Death|0|||
144662584|NCT00064350|521614092|FG002|Induction Treatment|Death|9|||
144662585|NCT00064350|521614090|FG000|Induction Treatment|Withdrawal by Subject|0|||
144215588|NCT01377012|519981752|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
144215589|NCT03736031|519981777|FG000|Overall Study|Death|2|||
144215590|NCT03736031|519981778|FG001|Overall Study|Death|4|||
144662586|NCT00064350|521614091|FG001|Induction Treatment|Withdrawal by Subject|0|||
144662587|NCT00064350|521614092|FG002|Induction Treatment|Withdrawal by Subject|21|||
144662588|NCT00064350|521614090|FG000|Induction Treatment|Ineligible or never started treatment|3|||
144662589|NCT00064350|521614091|FG001|Induction Treatment|Ineligible or never started treatment|6|||
144662590|NCT00064350|521614092|FG002|Induction Treatment|Ineligible or never started treatment|34|||
144215591|NCT03736031|519981777|FG000|Overall Study|Lost to Follow-up|21|||
144215592|NCT03736031|519981778|FG001|Overall Study|Lost to Follow-up|2|||
144215593|NCT03736031|519981777|FG000|Overall Study|Withdrawal by Subject|9|||
144662591|NCT00064350|521614090|FG000|Induction Treatment|Other|0|||
144662592|NCT00064350|521614091|FG001|Induction Treatment|Other|0|||
144662593|NCT00064350|521614092|FG002|Induction Treatment|Other|13|||
144662594|NCT00064350|521614090|FG000|Randomization|Adverse Event|8|||
144662595|NCT00064350|521614091|FG001|Randomization|Adverse Event|3|||
144215594|NCT03736031|519981778|FG001|Overall Study|Withdrawal by Subject|0|||
144215595|NCT00451178|519981779|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
144215596|NCT00451178|519981780|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
144215597|NCT00451178|519981779|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
144662596|NCT00064350|521614092|FG002|Randomization|Adverse Event|0|||
144662597|NCT00064350|521614090|FG000|Randomization|Death|3|||
144662598|NCT00064350|521614091|FG001|Randomization|Death|0|||
144662599|NCT00064350|521614092|FG002|Randomization|Death|0|||
144662600|NCT00064350|521614090|FG000|Randomization|Withdrawal by Subject|1|||
144662601|NCT00064350|521614091|FG001|Randomization|Withdrawal by Subject|0|||
144662602|NCT00064350|521614092|FG002|Randomization|Withdrawal by Subject|0|||
144215598|NCT00451178|519981780|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
144215599|NCT00451178|519981779|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
144215600|NCT00451178|519981780|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
144215601|NCT00451178|519981779|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
144215602|NCT00451178|519981780|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
144215603|NCT00451178|519981779|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
144215604|NCT00451178|519981780|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
144215605|NCT00451178|519981779|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
144215606|NCT00451178|519981780|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
144215607|NCT00451178|519981779|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
144215608|NCT00451178|519981780|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
144215609|NCT00451178|519981779|FG000|Prior to Maintenance Therapy|PD|2|||
144215610|NCT00451178|519981780|FG001|Prior to Maintenance Therapy|PD|0|||
144215611|NCT00451178|519981779|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
144215612|NCT00451178|519981780|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
144215613|NCT00451178|519981779|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
144215614|NCT00451178|519981780|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
144215615|NCT00451178|519981779|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
144215616|NCT00451178|519981780|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
144215617|NCT00451178|519981779|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
144215618|NCT00451178|519981780|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
144215619|NCT00451178|519981779|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
144215620|NCT00451178|519981780|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
144662603|NCT00064350|521614090|FG000|Randomization|Ineligible or never started treatment|9|||
144662604|NCT00064350|521614091|FG001|Randomization|Ineligible or never started treatment|15|||
144662605|NCT00064350|521614092|FG002|Randomization|Ineligible or never started treatment|0|||
144662606|NCT00064350|521614090|FG000|Randomization|Other|5|||
144662607|NCT00064350|521614091|FG001|Randomization|Other|0|||
144662608|NCT00064350|521614092|FG002|Randomization|Other|0|||
144733369|NCT00389064|521880628|FG000|Overall Study|Withdrawal by Subject|17|||
144733370|NCT00389064|521880629|FG001|Overall Study|Withdrawal by Subject|27|||
144733371|NCT00389064|521880628|FG000|Overall Study|Physician Decision|2|||
144733372|NCT00389064|521880629|FG001|Overall Study|Physician Decision|2|||
144733373|NCT00389064|521880628|FG000|Overall Study|Lost to Follow-up|1|||
144733374|NCT00389064|521880629|FG001|Overall Study|Lost to Follow-up|2|||
144733375|NCT00389064|521880628|FG000|Overall Study|Protocol Violation|2|||
144733376|NCT00389064|521880629|FG001|Overall Study|Protocol Violation|0|||
144733377|NCT00389064|521880628|FG000|Overall Study|Multiple Reasons|9|||
144733378|NCT00389064|521880629|FG001|Overall Study|Multiple Reasons|11|||
144733379|NCT03500692|521880634|FG000|Overall Study|Death|163|||
144215621|NCT00451178|519981779|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
144215622|NCT00451178|519981780|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
144215623|NCT00451178|519981779|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
144215624|NCT00451178|519981780|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
144662609|NCT00064350|521614090|FG000|Cross-Over|Adverse Event|0|||
144662610|NCT00064350|521614091|FG001|Cross-Over|Adverse Event|1|||
144662611|NCT00064350|521614092|FG002|Cross-Over|Adverse Event|0|||
144662612|NCT00064350|521614090|FG000|Cross-Over|Death|1|||
144662613|NCT00064350|521614091|FG001|Cross-Over|Death|3|||
144662614|NCT00064350|521614092|FG002|Cross-Over|Death|0|||
144733380|NCT03500692|521880634|FG000|Overall Study|Lost to Follow-up|75|||
144733381|NCT03500692|521880634|FG000|Overall Study|Termination Reasons|3|||
144733382|NCT04149964|521880635|FG000|Overall Study|Lost to Follow-up|19|||
144662615|NCT00064350|521614090|FG000|Cross-Over|Withdrawal by Subject|2|||
144662616|NCT00064350|521614091|FG001|Cross-Over|Withdrawal by Subject|2|||
144662617|NCT00064350|521614092|FG002|Cross-Over|Withdrawal by Subject|0|||
144662618|NCT00064350|521614090|FG000|Cross-Over|Ineligible or never started treatment|3|||
144662619|NCT00064350|521614091|FG001|Cross-Over|Ineligible or never started treatment|6|||
144662620|NCT00064350|521614092|FG002|Cross-Over|Ineligible or never started treatment|0|||
144662621|NCT00064350|521614090|FG000|Cross-Over|Other|0|||
144662622|NCT00064350|521614091|FG001|Cross-Over|Other|2|||
144662623|NCT00064350|521614092|FG002|Cross-Over|Other|0|||
144662624|NCT03600714|521614093|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
144662625|NCT01935336|521614096|FG000|Overall Study|Adverse Event|1|||
144662626|NCT01935336|521614097|FG001|Overall Study|Adverse Event|0|||
144662627|NCT01935336|521614098|FG002|Overall Study|Adverse Event|0|||
144662628|NCT01935336|521614099|FG003|Overall Study|Adverse Event|0|||
144662629|NCT01935336|521614096|FG000|Overall Study|Progressive disease|5|||
144662630|NCT01935336|521614097|FG001|Overall Study|Progressive disease|3|||
144662631|NCT01935336|521614098|FG002|Overall Study|Progressive disease|47|||
144662632|NCT01935336|521614099|FG003|Overall Study|Progressive disease|66|||
144662633|NCT00592553|521614100|FG000|Overall Study|Protocol Noncompliance|1|||
144662634|NCT00592553|521614101|FG001|Overall Study|Protocol Noncompliance|0|||
144662635|NCT00592553|521614102|FG002|Overall Study|Protocol Noncompliance|0|||
144662636|NCT01877382|521614105|FG000|Dose Escalation|Progressive disease|2|||
144662637|NCT01877382|521614106|FG001|Dose Escalation|Progressive disease|0|||
144662638|NCT01877382|521614107|FG002|Dose Escalation|Progressive disease|1|||
144662639|NCT01877382|521614108|FG003|Dose Escalation|Progressive disease|6|||
144662640|NCT01877382|521614109|FG004|Dose Escalation|Progressive disease|1|||
144662641|NCT01877382|521614110|FG005|Dose Escalation|Progressive disease|0|||
144662642|NCT01877382|521614111|FG006|Dose Escalation|Progressive disease|3|||
144662643|NCT01877382|521614112|FG007|Dose Escalation|Progressive disease|10|||
144662644|NCT01877382|521614113|FG008|Dose Escalation|Progressive disease|4|||
144662645|NCT01877382|521614114|FG009|Dose Escalation|Progressive disease|2|||
144662646|NCT01877382|521614115|FG010|Dose Escalation|Progressive disease|3|||
144662647|NCT01877382|521614116|FG011|Dose Escalation|Progressive disease|3|||
144662648|NCT01877382|521614117|FG012|Dose Escalation|Progressive disease|13|||
144662649|NCT01877382|521614118|FG013|Dose Escalation|Progressive disease|1|||
144662650|NCT01877382|521614119|FG014|Dose Escalation|Progressive disease|0|||
144662651|NCT01877382|521614105|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
144662652|NCT01877382|521614106|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662653|NCT01877382|521614107|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662654|NCT01877382|521614108|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
144662655|NCT01877382|521614109|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662656|NCT01877382|521614110|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662657|NCT01877382|521614111|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
144662658|NCT01877382|521614112|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662659|NCT01877382|521614113|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662660|NCT01877382|521614114|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662661|NCT01877382|521614115|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662662|NCT01877382|521614116|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662663|NCT01877382|521614117|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662664|NCT01877382|521614118|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662665|NCT01877382|521614119|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662666|NCT01877382|521614105|FG000|Dose Escalation|Clinical progression|0|||
144662667|NCT01877382|521614106|FG001|Dose Escalation|Clinical progression|1|||
144662668|NCT01877382|521614107|FG002|Dose Escalation|Clinical progression|0|||
144662669|NCT01877382|521614108|FG003|Dose Escalation|Clinical progression|2|||
144662670|NCT01877382|521614109|FG004|Dose Escalation|Clinical progression|0|||
144662671|NCT01877382|521614110|FG005|Dose Escalation|Clinical progression|0|||
144662672|NCT01877382|521614111|FG006|Dose Escalation|Clinical progression|1|||
144662673|NCT01877382|521614112|FG007|Dose Escalation|Clinical progression|0|||
144662674|NCT01877382|521614113|FG008|Dose Escalation|Clinical progression|0|||
144662675|NCT01877382|521614114|FG009|Dose Escalation|Clinical progression|1|||
144662676|NCT01877382|521614115|FG010|Dose Escalation|Clinical progression|0|||
144662677|NCT01877382|521614116|FG011|Dose Escalation|Clinical progression|0|||
144662678|NCT01877382|521614117|FG012|Dose Escalation|Clinical progression|2|||
144662679|NCT01877382|521614118|FG013|Dose Escalation|Clinical progression|1|||
144662680|NCT01877382|521614119|FG014|Dose Escalation|Clinical progression|0|||
144662681|NCT01877382|521614105|FG000|Dose Escalation|Adverse Event|0|||
144662682|NCT01877382|521614106|FG001|Dose Escalation|Adverse Event|0|||
144662683|NCT01877382|521614107|FG002|Dose Escalation|Adverse Event|0|||
144265510|NCT01699750|520173936|FG001|Overall Study|Withdrew Consent|1|||
144662684|NCT01877382|521614108|FG003|Dose Escalation|Adverse Event|4|||
144662685|NCT01877382|521614109|FG004|Dose Escalation|Adverse Event|1|||
144662686|NCT01877382|521614110|FG005|Dose Escalation|Adverse Event|2|||
144662687|NCT01877382|521614111|FG006|Dose Escalation|Adverse Event|1|||
144662688|NCT01877382|521614112|FG007|Dose Escalation|Adverse Event|2|||
144662689|NCT01877382|521614113|FG008|Dose Escalation|Adverse Event|0|||
144662690|NCT01877382|521614114|FG009|Dose Escalation|Adverse Event|0|||
144662691|NCT01877382|521614115|FG010|Dose Escalation|Adverse Event|0|||
144662692|NCT01877382|521614116|FG011|Dose Escalation|Adverse Event|0|||
144662693|NCT01877382|521614117|FG012|Dose Escalation|Adverse Event|1|||
144662694|NCT01877382|521614118|FG013|Dose Escalation|Adverse Event|0|||
144662695|NCT01877382|521614119|FG014|Dose Escalation|Adverse Event|0|||
144662696|NCT01877382|521614105|FG000|Dose Escalation|Withdrawal by Subject|0|||
144662697|NCT01877382|521614106|FG001|Dose Escalation|Withdrawal by Subject|0|||
144662698|NCT01877382|521614107|FG002|Dose Escalation|Withdrawal by Subject|0|||
144662699|NCT01877382|521614108|FG003|Dose Escalation|Withdrawal by Subject|0|||
144662700|NCT01877382|521614109|FG004|Dose Escalation|Withdrawal by Subject|0|||
144662701|NCT01877382|521614110|FG005|Dose Escalation|Withdrawal by Subject|3|||
144662702|NCT01877382|521614111|FG006|Dose Escalation|Withdrawal by Subject|2|||
144662703|NCT01877382|521614112|FG007|Dose Escalation|Withdrawal by Subject|1|||
144662704|NCT01877382|521614113|FG008|Dose Escalation|Withdrawal by Subject|1|||
144662705|NCT01877382|521614114|FG009|Dose Escalation|Withdrawal by Subject|0|||
144662706|NCT01877382|521614115|FG010|Dose Escalation|Withdrawal by Subject|0|||
144662707|NCT01877382|521614116|FG011|Dose Escalation|Withdrawal by Subject|0|||
144662708|NCT01877382|521614117|FG012|Dose Escalation|Withdrawal by Subject|0|||
144662709|NCT01877382|521614118|FG013|Dose Escalation|Withdrawal by Subject|0|||
144662710|NCT01877382|521614119|FG014|Dose Escalation|Withdrawal by Subject|0|||
144662711|NCT01877382|521614105|FG000|Dose Escalation|Protocol Violation|0|||
144662712|NCT01877382|521614106|FG001|Dose Escalation|Protocol Violation|0|||
144662713|NCT01877382|521614107|FG002|Dose Escalation|Protocol Violation|0|||
144662714|NCT01877382|521614108|FG003|Dose Escalation|Protocol Violation|0|||
144662715|NCT01877382|521614109|FG004|Dose Escalation|Protocol Violation|0|||
144662716|NCT01877382|521614110|FG005|Dose Escalation|Protocol Violation|0|||
144662717|NCT01877382|521614111|FG006|Dose Escalation|Protocol Violation|1|||
144662718|NCT01877382|521614112|FG007|Dose Escalation|Protocol Violation|0|||
144662719|NCT01877382|521614113|FG008|Dose Escalation|Protocol Violation|0|||
144662720|NCT01877382|521614114|FG009|Dose Escalation|Protocol Violation|0|||
144662721|NCT01877382|521614115|FG010|Dose Escalation|Protocol Violation|0|||
144662722|NCT01877382|521614116|FG011|Dose Escalation|Protocol Violation|0|||
144662723|NCT01877382|521614117|FG012|Dose Escalation|Protocol Violation|0|||
144662724|NCT01877382|521614118|FG013|Dose Escalation|Protocol Violation|0|||
144662725|NCT01877382|521614119|FG014|Dose Escalation|Protocol Violation|0|||
144662726|NCT01877382|521614105|FG000|Dose Escalation|Study terminated by sponsor|0|||
144662727|NCT01877382|521614106|FG001|Dose Escalation|Study terminated by sponsor|0|||
144662728|NCT01877382|521614107|FG002|Dose Escalation|Study terminated by sponsor|0|||
144662729|NCT01877382|521614108|FG003|Dose Escalation|Study terminated by sponsor|0|||
144662730|NCT01877382|521614109|FG004|Dose Escalation|Study terminated by sponsor|0|||
144662731|NCT01877382|521614110|FG005|Dose Escalation|Study terminated by sponsor|0|||
144733383|NCT04149964|521880636|FG001|Overall Study|Lost to Follow-up|18|||
144733384|NCT05275205|521880643|FG000|Overall Study|Adverse Event|1|||
144733385|NCT05275205|521880644|FG001|Overall Study|Adverse Event|2|||
144733386|NCT05275205|521880643|FG000|Overall Study|Physician Decision|1|||
144733387|NCT05275205|521880644|FG001|Overall Study|Physician Decision|1|||
144733388|NCT05275205|521880643|FG000|Overall Study|Withdrawal by Subject|2|||
144733389|NCT05275205|521880644|FG001|Overall Study|Withdrawal by Subject|3|||
144733390|NCT05275205|521880643|FG000|Overall Study|Death|1|||
144733391|NCT05275205|521880644|FG001|Overall Study|Death|0|||
144733392|NCT05275205|521880643|FG000|Overall Study|Patient unable to attend visits|1|||
144733393|NCT05275205|521880644|FG001|Overall Study|Patient unable to attend visits|0|||
144733394|NCT03041025|521880646|FG000|Overall Study|Adverse Event|0|||
144662732|NCT01877382|521614111|FG006|Dose Escalation|Study terminated by sponsor|0|||
144662733|NCT01877382|521614112|FG007|Dose Escalation|Study terminated by sponsor|1|||
144662734|NCT01877382|521614113|FG008|Dose Escalation|Study terminated by sponsor|1|||
144662735|NCT01877382|521614114|FG009|Dose Escalation|Study terminated by sponsor|0|||
144662736|NCT01877382|521614115|FG010|Dose Escalation|Study terminated by sponsor|0|||
144662737|NCT01877382|521614116|FG011|Dose Escalation|Study terminated by sponsor|0|||
144662738|NCT01877382|521614117|FG012|Dose Escalation|Study terminated by sponsor|3|||
144662739|NCT01877382|521614118|FG013|Dose Escalation|Study terminated by sponsor|0|||
144662740|NCT01877382|521614119|FG014|Dose Escalation|Study terminated by sponsor|0|||
144733395|NCT03041025|521880647|FG001|Overall Study|Adverse Event|0|||
144265511|NCT01699750|520173935|FG000|Overall Study|Other|0|||
144662741|NCT01877382|521614105|FG000|Dose Escalation|Death|0|||
144662742|NCT01877382|521614106|FG001|Dose Escalation|Death|0|||
144662743|NCT01877382|521614107|FG002|Dose Escalation|Death|0|||
144733396|NCT03041025|521880648|FG002|Overall Study|Adverse Event|1|||
144733397|NCT03041025|521880646|FG000|Overall Study|Lost to Follow-up|1|||
144733398|NCT03041025|521880647|FG001|Overall Study|Lost to Follow-up|0|||
144662744|NCT01877382|521614108|FG003|Dose Escalation|Death|0|||
144662745|NCT01877382|521614109|FG004|Dose Escalation|Death|0|||
144662746|NCT01877382|521614110|FG005|Dose Escalation|Death|0|||
144662747|NCT01877382|521614111|FG006|Dose Escalation|Death|0|||
144662748|NCT01877382|521614112|FG007|Dose Escalation|Death|1|||
144662749|NCT01877382|521614113|FG008|Dose Escalation|Death|0|||
144662750|NCT01877382|521614114|FG009|Dose Escalation|Death|0|||
144662751|NCT01877382|521614115|FG010|Dose Escalation|Death|0|||
144662752|NCT01877382|521614116|FG011|Dose Escalation|Death|0|||
144662753|NCT01877382|521614117|FG012|Dose Escalation|Death|1|||
144662754|NCT01877382|521614118|FG013|Dose Escalation|Death|1|||
144662755|NCT01877382|521614119|FG014|Dose Escalation|Death|0|||
144662756|NCT01877382|521614105|FG000|Dose Expansion|Progressive disease|0|||
144662757|NCT01877382|521614106|FG001|Dose Expansion|Progressive disease|0|||
144662758|NCT01877382|521614107|FG002|Dose Expansion|Progressive disease|0|||
144662759|NCT01877382|521614108|FG003|Dose Expansion|Progressive disease|0|||
144662760|NCT01877382|521614109|FG004|Dose Expansion|Progressive disease|0|||
144662761|NCT01877382|521614110|FG005|Dose Expansion|Progressive disease|0|||
144662762|NCT01877382|521614111|FG006|Dose Expansion|Progressive disease|0|||
144662763|NCT01877382|521614112|FG007|Dose Expansion|Progressive disease|0|||
144662764|NCT01877382|521614113|FG008|Dose Expansion|Progressive disease|0|||
144662765|NCT01877382|521614114|FG009|Dose Expansion|Progressive disease|0|||
144662766|NCT01877382|521614115|FG010|Dose Expansion|Progressive disease|0|||
144662767|NCT01877382|521614116|FG011|Dose Expansion|Progressive disease|0|||
144662768|NCT01877382|521614117|FG012|Dose Expansion|Progressive disease|0|||
144662769|NCT01877382|521614118|FG013|Dose Expansion|Progressive disease|0|||
144662770|NCT01877382|521614119|FG014|Dose Expansion|Progressive disease|11|||
144662771|NCT01877382|521614105|FG000|Dose Expansion|Clinical progression|0|||
144662772|NCT01877382|521614106|FG001|Dose Expansion|Clinical progression|0|||
144662773|NCT01877382|521614107|FG002|Dose Expansion|Clinical progression|0|||
144662774|NCT01877382|521614108|FG003|Dose Expansion|Clinical progression|0|||
144662775|NCT01877382|521614109|FG004|Dose Expansion|Clinical progression|0|||
144662776|NCT01877382|521614110|FG005|Dose Expansion|Clinical progression|0|||
144662777|NCT01877382|521614111|FG006|Dose Expansion|Clinical progression|0|||
144662778|NCT01877382|521614112|FG007|Dose Expansion|Clinical progression|0|||
144662779|NCT01877382|521614113|FG008|Dose Expansion|Clinical progression|0|||
144662780|NCT01877382|521614114|FG009|Dose Expansion|Clinical progression|0|||
144662781|NCT01877382|521614115|FG010|Dose Expansion|Clinical progression|0|||
144662782|NCT01877382|521614116|FG011|Dose Expansion|Clinical progression|0|||
144662783|NCT01877382|521614117|FG012|Dose Expansion|Clinical progression|0|||
144662784|NCT01877382|521614118|FG013|Dose Expansion|Clinical progression|0|||
144662785|NCT01877382|521614119|FG014|Dose Expansion|Clinical progression|6|||
144662786|NCT01877382|521614105|FG000|Dose Expansion|Adverse Event|0|||
144662787|NCT01877382|521614106|FG001|Dose Expansion|Adverse Event|0|||
144662788|NCT01877382|521614107|FG002|Dose Expansion|Adverse Event|0|||
144662789|NCT01877382|521614108|FG003|Dose Expansion|Adverse Event|0|||
144662790|NCT01877382|521614109|FG004|Dose Expansion|Adverse Event|0|||
144662791|NCT01877382|521614110|FG005|Dose Expansion|Adverse Event|0|||
144662792|NCT01877382|521614111|FG006|Dose Expansion|Adverse Event|0|||
144662793|NCT01877382|521614112|FG007|Dose Expansion|Adverse Event|0|||
144662794|NCT01877382|521614113|FG008|Dose Expansion|Adverse Event|0|||
144215625|NCT00064987|519984083|FG000|Overall Study|Physician Decision|3|||
144662795|NCT01877382|521614114|FG009|Dose Expansion|Adverse Event|0|||
144662796|NCT01877382|521614115|FG010|Dose Expansion|Adverse Event|0|||
144662797|NCT01877382|521614116|FG011|Dose Expansion|Adverse Event|0|||
144662798|NCT01877382|521614117|FG012|Dose Expansion|Adverse Event|0|||
144662799|NCT01877382|521614118|FG013|Dose Expansion|Adverse Event|0|||
144662800|NCT01877382|521614119|FG014|Dose Expansion|Adverse Event|1|||
144662801|NCT01877382|521614105|FG000|Dose Expansion|Death|0|||
144662802|NCT01877382|521614106|FG001|Dose Expansion|Death|0|||
144662803|NCT01877382|521614107|FG002|Dose Expansion|Death|0|||
144662804|NCT01877382|521614108|FG003|Dose Expansion|Death|0|||
144662805|NCT01877382|521614109|FG004|Dose Expansion|Death|0|||
144662806|NCT01877382|521614110|FG005|Dose Expansion|Death|0|||
144662807|NCT01877382|521614111|FG006|Dose Expansion|Death|0|||
144662808|NCT01877382|521614112|FG007|Dose Expansion|Death|0|||
144662809|NCT01877382|521614113|FG008|Dose Expansion|Death|0|||
144662810|NCT01877382|521614114|FG009|Dose Expansion|Death|0|||
144662811|NCT01877382|521614115|FG010|Dose Expansion|Death|0|||
144662812|NCT01877382|521614116|FG011|Dose Expansion|Death|0|||
144662813|NCT01877382|521614117|FG012|Dose Expansion|Death|0|||
144662814|NCT01877382|521614118|FG013|Dose Expansion|Death|0|||
144662815|NCT01877382|521614119|FG014|Dose Expansion|Death|1|||
144662816|NCT01877382|521614105|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662817|NCT01877382|521614106|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662818|NCT01877382|521614107|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662819|NCT01877382|521614108|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662820|NCT01877382|521614109|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144215626|NCT00064987|519984084|FG001|Overall Study|Physician Decision|0|||
144662821|NCT01877382|521614110|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662822|NCT01877382|521614111|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662823|NCT01877382|521614112|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662824|NCT01877382|521614113|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662825|NCT01877382|521614114|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662826|NCT01877382|521614115|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662827|NCT01877382|521614116|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662828|NCT01877382|521614117|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662829|NCT01877382|521614118|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
144662830|NCT01877382|521614119|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
144662831|NCT04092816|521615997|FG000|Overall Study|Lost to Follow-up|1|||
144662832|NCT04092816|521615998|FG001|Overall Study|Lost to Follow-up|2|||
144662833|NCT00369967|521616000|FG000|Overall Study|Lost to Follow-up|23|||
144662834|NCT00369967|521616001|FG001|Overall Study|Lost to Follow-up|12|||
144662835|NCT03073213|521616008|FG000|Multiple Dose Period|Protocol Violation|0|||
144662836|NCT03073213|521616009|FG001|Multiple Dose Period|Protocol Violation|0|||
144662837|NCT03073213|521616010|FG002|Multiple Dose Period|Protocol Violation|1|||
144662838|NCT02690207|521616015|FG000|Overall Study|Lost to Follow-up|48|||
144662839|NCT02690207|521616015|FG000|Overall Study|Withdrawal by Subject|46|||
144662840|NCT02690207|521616015|FG000|Overall Study|Protocol Violation|2|||
144662841|NCT02690207|521616015|FG000|Overall Study|Serious adverse event|110|||
144662842|NCT02690207|521616015|FG000|Overall Study|Non-serious Adverse Event|18|||
144662843|NCT02690207|521616015|FG000|Overall Study|Migrated/moved from study area|5|||
144662844|NCT02690207|521616015|FG000|Overall Study|Suspected HZ Episode|1|||
144662845|NCT02690207|521616015|FG000|Overall Study|Other reasons for withdrawal|23|||
144662846|NCT02282982|521616016|FG000|Overall Study|Lost to Follow-up|15|||
144662847|NCT02282982|521616016|FG000|Overall Study|Withdrew consent|2|||
144662848|NCT02282982|521616016|FG000|Overall Study|Death|4|||
144662849|NCT02282982|521616016|FG000|Overall Study|Lack of product|156|||
144662850|NCT02282982|521616016|FG000|Overall Study|Palivizumab is ended|11|||
144662851|NCT02282982|521616016|FG000|Overall Study|Other, not specified|18|||
144662852|NCT00579501|521616028|FG000|Overall Study|Death|1|||
144662853|NCT00579501|521616028|FG000|Overall Study|End of neoadjuvant therapy|25|||
144662854|NCT00579501|521616028|FG000|Overall Study|toxicity|1|||
144662855|NCT00579501|521616028|FG000|Overall Study|Secondary lesion|1|||
144662856|NCT00579501|521616028|FG000|Overall Study|Radiation therapy before surgery|1|||
144662857|NCT01089582|521616029|FG000|Overall Study|Death|2|||
144662858|NCT01089582|521616029|FG000|Overall Study|Adverse Event|15|||
144662859|NCT01089582|521616029|FG000|Overall Study|Lost to Follow-up|8|||
144662860|NCT01089582|521616029|FG000|Overall Study|Other|4|||
144662861|NCT01089582|521616029|FG000|Overall Study|Withdrawal by Subject|1|||
144662862|NCT04069156|521616030|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
144662863|NCT04069156|521616031|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
144662864|NCT04069156|521616030|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
144662865|NCT04069156|521616031|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
144662866|NCT04069156|521616030|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
144662867|NCT04069156|521616031|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
144662868|NCT04069156|521616030|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
144662869|NCT04069156|521616031|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
144662870|NCT00502320|521616032|FG000|Overall Study|Lost to Follow-up|1|||
144662871|NCT00502320|521616033|FG001|Overall Study|Lost to Follow-up|1|||
144662872|NCT00502320|521616032|FG000|Overall Study|Withdrew Consent|1|||
144662873|NCT00502320|521616033|FG001|Overall Study|Withdrew Consent|0|||
144662874|NCT00502320|521616032|FG000|Overall Study|No longer met criteria|1|||
144662875|NCT00502320|521616033|FG001|Overall Study|No longer met criteria|0|||
144662876|NCT00502320|521616032|FG000|Overall Study|Screen Failure|0|||
144662877|NCT00502320|521616033|FG001|Overall Study|Screen Failure|1|||
144662878|NCT00502320|521616032|FG000|Overall Study|Adverse Event|3|||
144662879|NCT00502320|521616033|FG001|Overall Study|Adverse Event|5|||
144662880|NCT03654755|521616039|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
144662881|NCT03654755|521616040|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
144662882|NCT03654755|521616041|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
144662883|NCT03654755|521616039|FG000|Overall Study|Withdrawal by Subject|2|||
144662884|NCT03654755|521616040|FG001|Overall Study|Withdrawal by Subject|4|||
144662885|NCT03654755|521616041|FG002|Overall Study|Withdrawal by Subject|8|||
144662886|NCT03654755|521616039|FG000|Overall Study|Lost to Follow-up|1|||
144662887|NCT03654755|521616040|FG001|Overall Study|Lost to Follow-up|3|||
144662888|NCT03654755|521616041|FG002|Overall Study|Lost to Follow-up|7|||
144662889|NCT03654755|521616039|FG000|Overall Study|Physician Decision|0|||
144662890|NCT03654755|521616040|FG001|Overall Study|Physician Decision|1|||
144662891|NCT03654755|521616041|FG002|Overall Study|Physician Decision|0|||
144662892|NCT03654755|521616039|FG000|Overall Study|Adverse Event|0|||
144662893|NCT03654755|521616040|FG001|Overall Study|Adverse Event|0|||
144662894|NCT03654755|521616041|FG002|Overall Study|Adverse Event|4|||
144662895|NCT03654755|521616039|FG000|Overall Study|Lack of Efficacy|0|||
144662896|NCT03654755|521616040|FG001|Overall Study|Lack of Efficacy|0|||
144662897|NCT03654755|521616041|FG002|Overall Study|Lack of Efficacy|1|||
144662898|NCT02394808|521616042|FG000|Period 1|Unsatisfactory lens fitting|0|||
144662899|NCT02394808|521616043|FG001|Period 1|Unsatisfactory lens fitting|1|||
144662900|NCT02394808|521616042|FG000|Period 2|Lost to Follow-up|1|||
144662901|NCT02394808|521616043|FG001|Period 2|Lost to Follow-up|0|||
144662902|NCT00089479|521616053|FG000|Overall Study|Death|108|||
144662903|NCT00089479|521616054|FG001|Overall Study|Death|75|||
144662904|NCT00089479|521616053|FG000|Overall Study|Withdrawal by Subject|86|||
144662905|NCT00089479|521616054|FG001|Overall Study|Withdrawal by Subject|107|||
144662906|NCT00089479|521616053|FG000|Overall Study|Lost to Follow-up|137|||
144662907|NCT00089479|521616054|FG001|Overall Study|Lost to Follow-up|107|||
144662908|NCT01124448|521616059|FG000|Overall Study|Lost to Follow-up|0|||
144662909|NCT01124448|521616060|FG001|Overall Study|Lost to Follow-up|3|||
144733399|NCT03041025|521880648|FG002|Overall Study|Lost to Follow-up|0|||
144215627|NCT00764881|519984085|FG000|Overall Study|Adverse Event|5|||
144215628|NCT00764881|519984086|FG001|Overall Study|Adverse Event|1|||
144215629|NCT00764881|519984085|FG000|Overall Study|Withdrawal by Subject|1|||
144215630|NCT00764881|519984086|FG001|Overall Study|Withdrawal by Subject|3|||
144215631|NCT00764881|519984085|FG000|Overall Study|Protocol Violation|2|||
144215632|NCT00764881|519984086|FG001|Overall Study|Protocol Violation|2|||
144215633|NCT00764881|519984085|FG000|Overall Study|Lost to Follow-up|2|||
144215634|NCT00764881|519984086|FG001|Overall Study|Lost to Follow-up|0|||
144215635|NCT00764881|519984085|FG000|Overall Study|Noncompliant|1|||
144215636|NCT00764881|519984086|FG001|Overall Study|Noncompliant|0|||
144215637|NCT00764881|519984085|FG000|Overall Study|Accidentally discontinued study drug|1|||
144215638|NCT00764881|519984086|FG001|Overall Study|Accidentally discontinued study drug|0|||
144215639|NCT00764881|519984085|FG000|Overall Study|Wished to become pregnant|1|||
144215640|NCT00764881|519984086|FG001|Overall Study|Wished to become pregnant|0|||
144215641|NCT00764881|519984085|FG000|Overall Study|Carcinoma detected|1|||
144215642|NCT00764881|519984086|FG001|Overall Study|Carcinoma detected|0|||
144215643|NCT00764881|519984085|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
144215644|NCT00764881|519984086|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
144215645|NCT00764881|519984085|FG000|Overall Study|no treatment or no observation|2|||
144215646|NCT00764881|519984086|FG001|Overall Study|no treatment or no observation|2|||
144215647|NCT05256134|519984093|FG000|Overall Study|Study Terminated by Sponsor|11|||
144215648|NCT05256134|519984094|FG001|Overall Study|Study Terminated by Sponsor|10|||
144215649|NCT05256134|519984093|FG000|Overall Study|Withdrawal by Subject|1|||
144215650|NCT05256134|519984094|FG001|Overall Study|Withdrawal by Subject|3|||
144215651|NCT01567462|519984095|FG000|Overall Study|Withdrawal by Subject|4|||
144215652|NCT01567462|519984096|FG001|Overall Study|Withdrawal by Subject|7|||
144215653|NCT00886015|519984097|FG000|Overall Study|Death|0|||
144215654|NCT00886015|519984098|FG001|Overall Study|Death|2|||
144215655|NCT02548156|519984103|FG000|Washout Period 1|Lost to Follow-up|0|||
144215656|NCT02548156|519984104|FG001|Washout Period 1|Lost to Follow-up|0|||
144215657|NCT02548156|519984105|FG002|Washout Period 1|Lost to Follow-up|0|||
144215658|NCT02548156|519984106|FG003|Washout Period 1|Lost to Follow-up|0|||
144215659|NCT02548156|519984107|FG004|Washout Period 1|Lost to Follow-up|1|||
144215660|NCT02548156|519984108|FG005|Washout Period 1|Lost to Follow-up|0|||
144215661|NCT01625988|519984125|FG000|Overall Study|Lost to Follow-up|5|||
144215662|NCT01625988|519984126|FG001|Overall Study|Lost to Follow-up|6|||
144215663|NCT01625988|519984125|FG000|Overall Study|Withdrawal by Subject|8|||
144215664|NCT01625988|519984126|FG001|Overall Study|Withdrawal by Subject|3|||
144215665|NCT01625988|519984125|FG000|Overall Study|Adverse Event|0|||
144215666|NCT01625988|519984126|FG001|Overall Study|Adverse Event|1|||
144215667|NCT01625988|519984125|FG000|Overall Study|Lack of Efficacy|0|||
144215668|NCT01625988|519984126|FG001|Overall Study|Lack of Efficacy|1|||
144215669|NCT01625988|519984125|FG000|Overall Study|Randomized Inappropriately|1|||
144215670|NCT01625988|519984126|FG001|Overall Study|Randomized Inappropriately|0|||
144215671|NCT01625988|519984125|FG000|Overall Study|Protocol Violation|0|||
144215672|NCT01625988|519984126|FG001|Overall Study|Protocol Violation|2|||
144215673|NCT01644617|519984129|FG000|Overall Study|Withdrawal by Subject|3|||
144215674|NCT01644617|519984130|FG001|Overall Study|Withdrawal by Subject|4|||
144215675|NCT01644617|519984131|FG002|Overall Study|Withdrawal by Subject|1|||
144215676|NCT01644617|519984129|FG000|Overall Study|Lost to Follow-up|0|||
144215677|NCT01644617|519984130|FG001|Overall Study|Lost to Follow-up|1|||
144215678|NCT01644617|519984131|FG002|Overall Study|Lost to Follow-up|0|||
144215679|NCT01644617|519984129|FG000|Overall Study|Adverse Event|3|||
144215680|NCT01644617|519984130|FG001|Overall Study|Adverse Event|0|||
144215681|NCT01644617|519984131|FG002|Overall Study|Adverse Event|6|||
144215682|NCT00444587|519984132|FG000|Overall Study|Death|2|||
144215683|NCT00444587|519984133|FG001|Overall Study|Death|1|||
144215684|NCT00444587|519984132|FG000|Overall Study|Progression of the disease|73|||
144662910|NCT01124448|521616059|FG000|Overall Study|Protocol Violation|2|||
144662911|NCT01124448|521616060|FG001|Overall Study|Protocol Violation|0|||
144662912|NCT01627067|521616064|FG000|Overall Study|Screen Failure|1|||
144662913|NCT03352414|521616068|FG000|Overall Study|Ineligible by operative criteria|12|||
144662914|NCT03352414|521616069|FG001|Overall Study|Ineligible by operative criteria|10|||
144662915|NCT02632110|521616070|FG000|Overall Study|Withdrawal by Subject|1|||
144662916|NCT02632110|521616071|FG001|Overall Study|Withdrawal by Subject|1|||
144662917|NCT02632110|521616072|FG002|Overall Study|Withdrawal by Subject|0|||
144662918|NCT02632110|521616073|FG003|Overall Study|Withdrawal by Subject|0|||
144662919|NCT02632110|521616074|FG004|Overall Study|Withdrawal by Subject|1|||
144662920|NCT02632110|521616075|FG005|Overall Study|Withdrawal by Subject|1|||
144662921|NCT02632110|521616076|FG006|Overall Study|Withdrawal by Subject|3|||
144662922|NCT02632110|521616077|FG007|Overall Study|Withdrawal by Subject|3|||
144662923|NCT02632110|521616078|FG008|Overall Study|Withdrawal by Subject|1|||
144662924|NCT02632110|521616079|FG009|Overall Study|Withdrawal by Subject|1|||
144662925|NCT00516269|521616080|FG000|Overall Study|Adverse Event|2|||
144662926|NCT00516269|521616081|FG001|Overall Study|Adverse Event|1|||
144662927|NCT00516269|521616080|FG000|Overall Study|Lost to Follow-up|0|||
144662928|NCT00516269|521616081|FG001|Overall Study|Lost to Follow-up|1|||
144662929|NCT00516269|521616080|FG000|Overall Study|Protocol Violation|0|||
144662930|NCT00516269|521616081|FG001|Overall Study|Protocol Violation|1|||
144662931|NCT00926796|521616082|FG000|Overall Study|Did not receive randomized treatment|4|||
144662932|NCT00926796|521616083|FG001|Overall Study|Did not receive randomized treatment|7|||
144662933|NCT00926796|521616082|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
144662934|NCT00926796|521616083|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
144662935|NCT00926796|521616082|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
144662936|NCT00926796|521616083|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
144662937|NCT00926796|521616082|FG000|Overall Study|Adverse Event|7|||
144662938|NCT00926796|521616083|FG001|Overall Study|Adverse Event|14|||
144662939|NCT00926796|521616082|FG000|Overall Study|Lost to Follow-up|22|||
144662940|NCT00926796|521616083|FG001|Overall Study|Lost to Follow-up|13|||
144662941|NCT00926796|521616082|FG000|Overall Study|Protocol Violation|15|||
144662942|NCT00926796|521616083|FG001|Overall Study|Protocol Violation|11|||
144662943|NCT00926796|521616082|FG000|Overall Study|Withdrawal by Subject|1|||
144662944|NCT00926796|521616083|FG001|Overall Study|Withdrawal by Subject|0|||
144662945|NCT01341652|521616084|FG000|Overall Study|Incorrect Random Assignment|0|||
144662946|NCT01341652|521616085|FG001|Overall Study|Incorrect Random Assignment|1|||
144662947|NCT01341652|521616084|FG000|Overall Study|ineligible; presence metastatic disease|0|||
144662948|NCT01341652|521616085|FG001|Overall Study|ineligible; presence metastatic disease|1|||
144662949|NCT02953782|521616092|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
144662950|NCT02953782|521616093|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
144662951|NCT02953782|521616094|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
144662952|NCT02953782|521616095|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
144662953|NCT02953782|521616096|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
144662954|NCT02953782|521616097|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
144662955|NCT02953782|521616098|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
144662956|NCT02953782|521616099|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
144662957|NCT02953782|521616092|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
144662958|NCT02953782|521616093|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
144662959|NCT02953782|521616094|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
144662960|NCT02953782|521616095|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
144662961|NCT02953782|521616096|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
144662962|NCT02953782|521616097|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
144662963|NCT02953782|521616098|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
144662964|NCT02953782|521616099|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
144662965|NCT02953782|521616092|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
144662966|NCT02953782|521616093|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
144662967|NCT02953782|521616094|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
144662968|NCT02953782|521616095|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
144662969|NCT02953782|521616096|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
144662970|NCT02953782|521616097|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
144662971|NCT02953782|521616098|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
144662972|NCT02953782|521616099|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
144662973|NCT02953782|521616092|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
144662974|NCT02953782|521616093|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
144662975|NCT02953782|521616094|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
144662976|NCT02953782|521616095|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
144662977|NCT02953782|521616096|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
144662978|NCT02953782|521616097|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
144215685|NCT00444587|519984133|FG001|Overall Study|Progression of the disease|8|||
144215686|NCT00444587|519984132|FG000|Overall Study|Refused treatment/did not cooperate|4|||
144215687|NCT00444587|519984133|FG001|Overall Study|Refused treatment/did not cooperate|1|||
144215688|NCT00444587|519984132|FG000|Overall Study|Investigator decision|3|||
144215689|NCT00444587|519984133|FG001|Overall Study|Investigator decision|0|||
144215690|NCT00444587|519984132|FG000|Overall Study|Protocol Violation|1|||
144215691|NCT00444587|519984133|FG001|Overall Study|Protocol Violation|0|||
144215692|NCT00444587|519984132|FG000|Overall Study|Missing|0|||
144215693|NCT00444587|519984133|FG001|Overall Study|Missing|5|||
144215694|NCT00196326|519984134|FG000|Overall Study|Did not meet protocol requirements|64|||
144215695|NCT00196326|519984134|FG000|Overall Study|Non-compliance with the protocol|81|||
144215696|NCT00196326|519984134|FG000|Overall Study|Physician Decision|3|||
144215697|NCT00196326|519984134|FG000|Overall Study|Withdrawal by Subject|225|||
144215698|NCT00196326|519984134|FG000|Overall Study|Adverse Event|253|||
144215699|NCT00196326|519984134|FG000|Overall Study|Pregnancy|34|||
144215700|NCT00196326|519984134|FG000|Overall Study|Lost to Follow-up|304|||
144215701|NCT00196326|519984134|FG000|Overall Study|Other|22|||
144215702|NCT01473407|519984143|FG000|Overall Study|Physician Decision|1|||
144215703|NCT01473407|519984144|FG001|Overall Study|Physician Decision|4|||
144215704|NCT01473407|519984143|FG000|Overall Study|Lost to Follow-up|10|||
144215705|NCT01473407|519984144|FG001|Overall Study|Lost to Follow-up|4|||
144215706|NCT01473407|519984143|FG000|Overall Study|Adverse Event|8|||
144215707|NCT01473407|519984144|FG001|Overall Study|Adverse Event|8|||
144215708|NCT01473407|519984143|FG000|Overall Study|Randomization Error|3|||
144215709|NCT01473407|519984144|FG001|Overall Study|Randomization Error|1|||
144215710|NCT01473407|519984143|FG000|Overall Study|Withdrawal by Subject|4|||
144215711|NCT01473407|519984144|FG001|Overall Study|Withdrawal by Subject|7|||
144215712|NCT01473407|519984143|FG000|Overall Study|Kidney Transplant|7|||
144215713|NCT01473407|519984144|FG001|Overall Study|Kidney Transplant|6|||
144215714|NCT01473407|519984143|FG000|Overall Study|Vacation/Travel|1|||
144215715|NCT01473407|519984144|FG001|Overall Study|Vacation/Travel|1|||
144215716|NCT01473407|519984143|FG000|Overall Study|Elevated Hemoglobin|1|||
144215717|NCT01473407|519984144|FG001|Overall Study|Elevated Hemoglobin|0|||
144215718|NCT01473407|519984143|FG000|Overall Study|Patient Received Aranesp|1|||
144215719|NCT01473407|519984144|FG001|Overall Study|Patient Received Aranesp|0|||
144215720|NCT01473407|519984143|FG000|Overall Study|Patient Lost Green Card Status|1|||
144215721|NCT01473407|519984144|FG001|Overall Study|Patient Lost Green Card Status|0|||
144215722|NCT01473407|519984143|FG000|Overall Study|Temperature Excursion|2|||
144215723|NCT01473407|519984144|FG001|Overall Study|Temperature Excursion|3|||
144215724|NCT01473407|519984143|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
144215725|NCT01473407|519984144|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
144215726|NCT01473407|519984143|FG000|Overall Study|Sponsor's Decision|10|||
144215727|NCT01473407|519984144|FG001|Overall Study|Sponsor's Decision|10|||
144215728|NCT01473407|519984143|FG000|Overall Study|Site Closure|1|||
144215729|NCT01473407|519984144|FG001|Overall Study|Site Closure|0|||
144215730|NCT00369941|519984145|FG000|Overall Study|Never Treated|1|||
144215731|NCT00369941|519984146|FG001|Overall Study|Never Treated|2|||
144215732|NCT00369941|519984145|FG000|Overall Study|Adverse Event|14|||
144215733|NCT00369941|519984146|FG001|Overall Study|Adverse Event|28|||
144215734|NCT00369941|519984145|FG000|Overall Study|Lack of Efficacy|6|||
144215735|NCT00369941|519984146|FG001|Overall Study|Lack of Efficacy|10|||
144215736|NCT00369941|519984145|FG000|Overall Study|Lost to Follow-up|12|||
144215737|NCT00369941|519984146|FG001|Overall Study|Lost to Follow-up|22|||
144215738|NCT00369941|519984145|FG000|Overall Study|Protocol Violation|5|||
144215739|NCT00369941|519984146|FG001|Overall Study|Protocol Violation|3|||
144215740|NCT00369941|519984145|FG000|Overall Study|Withdrawal by Subject|5|||
144215741|NCT00369941|519984146|FG001|Overall Study|Withdrawal by Subject|18|||
144265512|NCT01699750|520173936|FG001|Overall Study|Other|2|||
144265513|NCT02452047|520173937|FG000|Overall Study|Adverse Event|0|||
144265514|NCT02452047|520173938|FG001|Overall Study|Adverse Event|1|||
144265515|NCT02452047|520173939|FG002|Overall Study|Adverse Event|1|||
144265516|NCT02452047|520173937|FG000|Overall Study|Death|1|||
144265517|NCT02452047|520173938|FG001|Overall Study|Death|3|||
144215742|NCT00369941|519984145|FG000|Overall Study|Pregnancy|4|||
144215743|NCT00369941|519984146|FG001|Overall Study|Pregnancy|2|||
144215744|NCT00369941|519984145|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
144265518|NCT02452047|520173939|FG002|Overall Study|Death|1|||
144265519|NCT02452047|520173937|FG000|Overall Study|Physician Decision|1|||
144265520|NCT02452047|520173938|FG001|Overall Study|Physician Decision|0|||
144265521|NCT02452047|520173939|FG002|Overall Study|Physician Decision|0|||
144215745|NCT00369941|519984146|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
144215746|NCT00369941|519984145|FG000|Overall Study|Moved|11|||
144215747|NCT00369941|519984146|FG001|Overall Study|Moved|5|||
144215748|NCT00369941|519984145|FG000|Overall Study|Treatment with Prohibited Medication|3|||
144215749|NCT00369941|519984146|FG001|Overall Study|Treatment with Prohibited Medication|1|||
144215750|NCT00369941|519984145|FG000|Overall Study|Employment Interfered with Study Visits|1|||
144215751|NCT00369941|519984146|FG001|Overall Study|Employment Interfered with Study Visits|0|||
144215752|NCT00369941|519984145|FG000|Overall Study|Study Site Terminated|2|||
144265522|NCT02452047|520173937|FG000|Overall Study|Lost to Follow-up|1|||
144215753|NCT00369941|519984146|FG001|Overall Study|Study Site Terminated|0|||
144215754|NCT00369941|519984145|FG000|Overall Study|Miscellaneous|3|||
144215755|NCT00369941|519984146|FG001|Overall Study|Miscellaneous|3|||
144215756|NCT01027702|519984147|FG000|Overall Study|Received subsequent therapy|1|||
144215757|NCT01027702|519984148|FG001|Overall Study|Received subsequent therapy|2|||
144215758|NCT01027702|519984149|FG002|Overall Study|Received subsequent therapy|0|||
144215759|NCT01027702|519984150|FG003|Overall Study|Received subsequent therapy|4|||
144215760|NCT01027702|519984151|FG004|Overall Study|Received subsequent therapy|1|||
144215761|NCT01027702|519984152|FG005|Overall Study|Received subsequent therapy|0|||
144215762|NCT01027702|519984153|FG006|Overall Study|Received subsequent therapy|1|||
144215763|NCT01027702|519984147|FG000|Overall Study|Death|0|||
144215764|NCT01027702|519984148|FG001|Overall Study|Death|0|||
144215765|NCT01027702|519984149|FG002|Overall Study|Death|1|||
144215766|NCT01027702|519984150|FG003|Overall Study|Death|0|||
144215767|NCT01027702|519984151|FG004|Overall Study|Death|0|||
144215768|NCT01027702|519984152|FG005|Overall Study|Death|0|||
144215769|NCT01027702|519984153|FG006|Overall Study|Death|0|||
144215770|NCT00403585|519984154|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
144215771|NCT00403585|519984154|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
144215772|NCT00403585|519984154|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
144215773|NCT02964312|519984155|FG000|Overall Study|Lost to Follow-up|28|||
144215774|NCT02964312|519984155|FG000|Overall Study|Withdrawal by Subject|11|||
144215775|NCT02964312|519984155|FG000|Overall Study|Lack of Efficacy|10|||
144215776|NCT02964312|519984155|FG000|Overall Study|Did not consent to long-term FU|14|||
144215777|NCT02964312|519984155|FG000|Overall Study|Death|1|||
144215778|NCT02862730|519984166|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
144215779|NCT02862730|519984167|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
144215780|NCT02862730|519984168|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
144215781|NCT02862730|519984169|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
144215782|NCT02862730|519984170|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
144215783|NCT02862730|519984171|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
144215784|NCT02862730|519984172|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
144215785|NCT02862730|519984166|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
144215786|NCT02862730|519984167|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
144215787|NCT02862730|519984168|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
144215788|NCT02862730|519984169|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
144215789|NCT02862730|519984170|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
144215790|NCT02862730|519984171|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
144215791|NCT02862730|519984172|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
144215792|NCT02862730|519984166|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
144215793|NCT02862730|519984167|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
144215794|NCT02862730|519984168|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
144215795|NCT02862730|519984169|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
144215796|NCT02862730|519984170|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
144215797|NCT02862730|519984171|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
144215798|NCT02862730|519984172|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
144215799|NCT02862730|519984166|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
144215800|NCT02862730|519984167|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
144215801|NCT02862730|519984168|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
144215802|NCT02862730|519984169|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
144215803|NCT02862730|519984170|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
144215804|NCT02862730|519984171|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
144215805|NCT02862730|519984172|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
144215806|NCT03685344|519984173|FG000|Overall Study|Withdrawal by Subject|1|||
144215807|NCT03685344|519984174|FG001|Overall Study|Withdrawal by Subject|1|||
144215808|NCT03685344|519984175|FG002|Overall Study|Withdrawal by Subject|2|||
144215809|NCT03685344|519984176|FG003|Overall Study|Withdrawal by Subject|0|||
144215810|NCT03685344|519984173|FG000|Overall Study|Physician Decision|1|||
144215811|NCT03685344|519984174|FG001|Overall Study|Physician Decision|1|||
144215812|NCT03685344|519984175|FG002|Overall Study|Physician Decision|5|||
144215813|NCT03685344|519984176|FG003|Overall Study|Physician Decision|0|||
144215814|NCT03685344|519984173|FG000|Overall Study|Death|1|||
144215815|NCT03685344|519984174|FG001|Overall Study|Death|1|||
144215816|NCT03685344|519984175|FG002|Overall Study|Death|0|||
144265523|NCT02452047|520173938|FG001|Overall Study|Lost to Follow-up|1|||
144215817|NCT03685344|519984176|FG003|Overall Study|Death|0|||
144215818|NCT02121652|519984179|FG000|Overall Study|Lost to Follow-up|2|||
144215819|NCT02121652|519984180|FG001|Overall Study|Lost to Follow-up|1|||
144215820|NCT02121652|519984179|FG000|Overall Study|Death|1|||
144215821|NCT02121652|519984180|FG001|Overall Study|Death|0|||
144265524|NCT02452047|520173939|FG002|Overall Study|Lost to Follow-up|0|||
144215822|NCT02121652|519984179|FG000|Overall Study|Withdrawal by Subject|3|||
144733400|NCT03041025|521880646|FG000|Overall Study|Withdrawal by Subject|0|||
144733401|NCT03041025|521880647|FG001|Overall Study|Withdrawal by Subject|0|||
144662979|NCT02953782|521616098|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
144662980|NCT02953782|521616099|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
144662981|NCT02953782|521616092|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
144662982|NCT02953782|521616093|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
144662983|NCT02953782|521616094|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
144662984|NCT02953782|521616095|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
144662985|NCT02953782|521616096|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
144662986|NCT02953782|521616097|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
144662987|NCT02953782|521616098|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
144662988|NCT02953782|521616099|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
144662989|NCT02953782|521616092|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
144662990|NCT02953782|521616093|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
144662991|NCT02953782|521616094|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
144662992|NCT02953782|521616095|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
144662993|NCT02953782|521616096|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
144662994|NCT02953782|521616097|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
144662995|NCT02953782|521616098|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
144662996|NCT02953782|521616099|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
144662997|NCT02953782|521616092|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
144662998|NCT02953782|521616093|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
144662999|NCT02953782|521616094|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
144663000|NCT02953782|521616095|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
144663001|NCT02953782|521616096|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
144663002|NCT02953782|521616097|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
144663003|NCT02953782|521616098|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
144663004|NCT02953782|521616099|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
144663005|NCT02953782|521616092|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663006|NCT02953782|521616093|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663007|NCT02953782|521616094|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663008|NCT02953782|521616095|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663009|NCT02953782|521616096|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663010|NCT02953782|521616097|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663011|NCT02953782|521616098|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
144663012|NCT02953782|521616099|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
144663013|NCT02357849|521616100|FG000|Overall Study|Withdrawal by Subject|2|||
144663014|NCT02357849|521616101|FG001|Overall Study|Withdrawal by Subject|3|||
144663015|NCT04863014|521616102|FG000|Overall Study|Lost to Follow-up|3|||
144663016|NCT04863014|521616103|FG001|Overall Study|Lost to Follow-up|2|||
144663017|NCT04863014|521616102|FG000|Overall Study|Subject Decision|0|||
144663018|NCT04863014|521616103|FG001|Overall Study|Subject Decision|4|||
144663019|NCT04633473|521616104|FG000|Overall Study|Withdrawal by Subject|6|||
144663020|NCT04387136|521616105|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
144663021|NCT04387136|521616106|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
144663022|NCT03294681|521616109|FG000|Overall Study|Withdrawal by Subject|1|||
144663023|NCT03089216|521616110|FG000|Overall Study|Adverse Event|0|||
144663024|NCT03089216|521616111|FG001|Overall Study|Adverse Event|0|||
144663025|NCT03089216|521616112|FG002|Overall Study|Adverse Event|0|||
144663026|NCT03089216|521616113|FG003|Overall Study|Adverse Event|1|||
144663027|NCT00417976|521616116|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
144215823|NCT02121652|519984180|FG001|Overall Study|Withdrawal by Subject|3|||
144215824|NCT02932462|519984184|FG000|Overall Study|Adverse Event|1|||
144215825|NCT02932462|519984185|FG001|Overall Study|Adverse Event|2|||
144215826|NCT02932462|519984184|FG000|Overall Study|Lost to Follow-up|4|||
144215827|NCT02932462|519984185|FG001|Overall Study|Lost to Follow-up|1|||
144663028|NCT00417976|521616116|FG000|Overall Study|Treatment -related toxicity|2|||
144663029|NCT01348425|521616117|FG000|Overall Study|Imaging was not taken.|1|||
144663030|NCT01348425|521616118|FG001|Overall Study|Imaging was not taken.|1|||
144663031|NCT01968954|521616121|FG000|Overall Study|Adverse Event|6|||
144663032|NCT01968954|521616122|FG001|Overall Study|Adverse Event|3|||
144663033|NCT01968954|521616121|FG000|Overall Study|Death|1|||
144663034|NCT01968954|521616122|FG001|Overall Study|Death|2|||
144733402|NCT03041025|521880648|FG002|Overall Study|Withdrawal by Subject|1|||
144733403|NCT02963259|521880650|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
144215828|NCT02932462|519984184|FG000|Overall Study|Protocol Violation|0|||
144215829|NCT02932462|519984185|FG001|Overall Study|Protocol Violation|5|||
144663035|NCT01968954|521616121|FG000|Overall Study|Lost to Follow-up|6|||
144663036|NCT01968954|521616122|FG001|Overall Study|Lost to Follow-up|4|||
144663037|NCT01968954|521616121|FG000|Overall Study|Withdrawal by Subject|20|||
144663038|NCT01968954|521616122|FG001|Overall Study|Withdrawal by Subject|23|||
144663039|NCT01968954|521616121|FG000|Overall Study|Other|7|||
144663040|NCT01968954|521616122|FG001|Overall Study|Other|8|||
144215830|NCT02932462|519984184|FG000|Overall Study|Withdrawal by Subject|1|||
144215831|NCT02932462|519984185|FG001|Overall Study|Withdrawal by Subject|4|||
144215832|NCT02932462|519984184|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144215833|NCT02932462|519984185|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144215834|NCT02932462|519984184|FG000|Overall Study|Progressive Disease|1|||
144215835|NCT02932462|519984185|FG001|Overall Study|Progressive Disease|0|||
144215836|NCT01232452|519984186|FG000|Overall Study|Adverse Event|17|||
144215837|NCT01232452|519984187|FG001|Overall Study|Adverse Event|15|||
144215838|NCT01232452|519984186|FG000|Overall Study|Withdrawal by Subject|11|||
144215839|NCT01232452|519984187|FG001|Overall Study|Withdrawal by Subject|8|||
144215840|NCT01232452|519984186|FG000|Overall Study|Physician Decision|8|||
144215841|NCT01232452|519984187|FG001|Overall Study|Physician Decision|12|||
144215842|NCT01232452|519984186|FG000|Overall Study|Protocol entry criterion not met|0|||
144215843|NCT01232452|519984187|FG001|Overall Study|Protocol entry criterion not met|2|||
144215844|NCT01232452|519984186|FG000|Overall Study|Sponsor Decision|3|||
144215845|NCT01232452|519984187|FG001|Overall Study|Sponsor Decision|1|||
144215846|NCT01232452|519984186|FG000|Overall Study|Protocol Violation|0|||
144215847|NCT01232452|519984187|FG001|Overall Study|Protocol Violation|1|||
144215848|NCT02009722|519984188|FG000|Overall Study|Protocol Violation|1|||
144215849|NCT02009722|519984189|FG001|Overall Study|Protocol Violation|2|||
144215850|NCT02009722|519984188|FG000|Overall Study|Did not receive intervention|0|||
144215851|NCT02009722|519984189|FG001|Overall Study|Did not receive intervention|1|||
144215852|NCT01895777|519984190|FG000|Overall Study|Adverse Event|1|||
144215853|NCT01895777|519984191|FG001|Overall Study|Adverse Event|2|||
144215854|NCT01895777|519984190|FG000|Overall Study|Lost to Follow-up|2|||
144215855|NCT01895777|519984191|FG001|Overall Study|Lost to Follow-up|0|||
144215856|NCT01895777|519984190|FG000|Overall Study|Not treated|1|||
144215857|NCT01895777|519984191|FG001|Overall Study|Not treated|0|||
144215858|NCT01895777|519984190|FG000|Overall Study|Other reasons|3|||
144215859|NCT01895777|519984191|FG001|Overall Study|Other reasons|2|||
144215860|NCT01895777|519984190|FG000|Overall Study|Non-compliance with the CTP|2|||
144215861|NCT01895777|519984191|FG001|Overall Study|Non-compliance with the CTP|1|||
144215862|NCT03571828|519984192|FG000|Overall Study|Withdrawal by Subject|1|||
144215863|NCT03571828|519984193|FG001|Overall Study|Withdrawal by Subject|0|||
144215864|NCT03571828|519984192|FG000|Overall Study|Decision by sponsor|5|||
144215865|NCT03571828|519984193|FG001|Overall Study|Decision by sponsor|1|||
144215866|NCT03571828|519984192|FG000|Overall Study|Death|2|||
144215867|NCT03571828|519984193|FG001|Overall Study|Death|0|||
144215868|NCT02829918|519984196|FG000|Overall Study|Death|2|||
144215869|NCT02829918|519984196|FG000|Overall Study|Withdrawal by Subject|4|||
144215870|NCT02829918|519984196|FG000|Overall Study|Adverse Event|1|||
144215871|NCT02829918|519984196|FG000|Overall Study|Progression|1|||
144215872|NCT01137071|519984197|FG000|Overall Study|Disease Progression|11|||
144215873|NCT01137071|519984197|FG000|Overall Study|Withdrawal by Subject|2|||
144215874|NCT01137071|519984197|FG000|Overall Study|Wrongly Included|1|||
144215875|NCT03656744|519984198|FG000|Overall Study|Adverse Event|1|||
144215876|NCT03656744|519984199|FG001|Overall Study|Adverse Event|4|||
144215877|NCT03656744|519984200|FG002|Overall Study|Adverse Event|1|||
144215878|NCT03656744|519984198|FG000|Overall Study|Protocol Violation|1|||
144215879|NCT03656744|519984199|FG001|Overall Study|Protocol Violation|0|||
144215880|NCT03656744|519984200|FG002|Overall Study|Protocol Violation|0|||
144265525|NCT02452047|520173937|FG000|Overall Study|Withdrawal by Subject|1|||
144265526|NCT02452047|520173938|FG001|Overall Study|Withdrawal by Subject|0|||
144663041|NCT01968954|521616121|FG000|Overall Study|Protocol Violation|0|||
144215881|NCT03656744|519984198|FG000|Overall Study|Lost to Follow-up|2|||
144265527|NCT02452047|520173939|FG002|Overall Study|Withdrawal by Subject|0|||
144663042|NCT01968954|521616122|FG001|Overall Study|Protocol Violation|1|||
144663043|NCT01968954|521616121|FG000|Overall Study|Did not met inclusion criteria|0|||
144663044|NCT01968954|521616122|FG001|Overall Study|Did not met inclusion criteria|2|||
144663045|NCT01752842|521616123|FG000|Overall Study|Adverse Event|3|||
144663046|NCT01752842|521616124|FG001|Overall Study|Adverse Event|0|||
144663047|NCT01752842|521616123|FG000|Overall Study|Withdrawal by Subject|0|||
144663048|NCT01752842|521616124|FG001|Overall Study|Withdrawal by Subject|2|||
144663049|NCT03707158|521616125|FG000|Midtreatment|Lost to Follow-up|16|||
144663050|NCT03707158|521616126|FG001|Midtreatment|Lost to Follow-up|7|||
144663051|NCT03707158|521616125|FG000|Midtreatment|Withdrawal by Subject|28|||
144663052|NCT03707158|521616126|FG001|Midtreatment|Withdrawal by Subject|19|||
144733404|NCT02963259|521880650|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
144663053|NCT03707158|521616125|FG000|Posttreatment|Lost to Follow-up|0|||
144215882|NCT03656744|519984199|FG001|Overall Study|Lost to Follow-up|2|||
144215883|NCT03656744|519984200|FG002|Overall Study|Lost to Follow-up|0|||
144215884|NCT03656744|519984198|FG000|Overall Study|Withdrawal by Subject|0|||
144215885|NCT03656744|519984199|FG001|Overall Study|Withdrawal by Subject|1|||
144215886|NCT03656744|519984200|FG002|Overall Study|Withdrawal by Subject|0|||
144265528|NCT01868646|520173941|FG000|Overall Study|Do not meet inclusion criteria|3|||
144663054|NCT03707158|521616126|FG001|Posttreatment|Lost to Follow-up|5|||
144663055|NCT03707158|521616125|FG000|Follow-up|Lost to Follow-up|19|||
144663056|NCT03707158|521616126|FG001|Follow-up|Lost to Follow-up|18|||
144663057|NCT03707158|521616125|FG000|Follow-up|Withdrawal by Subject|13|||
144663058|NCT03707158|521616126|FG001|Follow-up|Withdrawal by Subject|6|||
144663059|NCT01208038|521616128|FG000|Overall Study|Withdrawal by Subject|1|||
144663060|NCT03260205|521616131|FG000|Overall Study|Adverse Event|2|||
144663061|NCT03260205|521616132|FG001|Overall Study|Adverse Event|0|||
144663062|NCT03260205|521616133|FG002|Overall Study|Adverse Event|2|||
144663063|NCT03260205|521616134|FG003|Overall Study|Adverse Event|2|||
144663064|NCT03260205|521616135|FG004|Overall Study|Adverse Event|4|||
144663065|NCT03260205|521616131|FG000|Overall Study|Lost to Follow-up|2|||
144663066|NCT03260205|521616132|FG001|Overall Study|Lost to Follow-up|2|||
144663067|NCT03260205|521616133|FG002|Overall Study|Lost to Follow-up|1|||
144663068|NCT03260205|521616134|FG003|Overall Study|Lost to Follow-up|1|||
144663069|NCT03260205|521616135|FG004|Overall Study|Lost to Follow-up|5|||
144663070|NCT03260205|521616131|FG000|Overall Study|Protocol Violation|0|||
144663071|NCT03260205|521616132|FG001|Overall Study|Protocol Violation|0|||
144663072|NCT03260205|521616133|FG002|Overall Study|Protocol Violation|2|||
144663073|NCT03260205|521616134|FG003|Overall Study|Protocol Violation|0|||
144663074|NCT03260205|521616135|FG004|Overall Study|Protocol Violation|1|||
144663075|NCT03260205|521616131|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
144663076|NCT03260205|521616132|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
144663077|NCT03260205|521616133|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
144663078|NCT03260205|521616134|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
144663079|NCT03260205|521616135|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
144663080|NCT03260205|521616131|FG000|Overall Study|Other: Unspecified|0|||
144663081|NCT03260205|521616132|FG001|Overall Study|Other: Unspecified|0|||
144663082|NCT03260205|521616133|FG002|Overall Study|Other: Unspecified|3|||
144663083|NCT03260205|521616134|FG003|Overall Study|Other: Unspecified|1|||
144663084|NCT03260205|521616135|FG004|Overall Study|Other: Unspecified|1|||
144663085|NCT03260205|521616131|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
144663086|NCT03260205|521616132|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
144663087|NCT03260205|521616133|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
144663088|NCT03260205|521616134|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
144663089|NCT03260205|521616135|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
144663090|NCT01968187|521616136|FG000|Overall Study|Adverse Event|0|||
144663091|NCT01968187|521616137|FG001|Overall Study|Adverse Event|1|||
144663092|NCT01968187|521616136|FG000|Overall Study|Randomized but not treated|1|||
144663093|NCT01968187|521616137|FG001|Overall Study|Randomized but not treated|0|||
144663094|NCT00430521|521616142|FG000|Overall Study|Adverse Event|0|||
144663095|NCT00430521|521616143|FG001|Overall Study|Adverse Event|0|||
144663096|NCT00430521|521616144|FG002|Overall Study|Adverse Event|0|||
144663097|NCT00430521|521616145|FG003|Overall Study|Adverse Event|0|||
144663098|NCT00430521|521616146|FG004|Overall Study|Adverse Event|0|||
144663099|NCT00430521|521616147|FG005|Overall Study|Adverse Event|2|||
144663100|NCT00430521|521616148|FG006|Overall Study|Adverse Event|1|||
144663101|NCT00430521|521616149|FG007|Overall Study|Adverse Event|0|||
144663102|NCT00430521|521616142|FG000|Overall Study|Lost to Follow-up|7|||
144663103|NCT00430521|521616143|FG001|Overall Study|Lost to Follow-up|8|||
144663104|NCT00430521|521616144|FG002|Overall Study|Lost to Follow-up|3|||
144663105|NCT00430521|521616145|FG003|Overall Study|Lost to Follow-up|5|||
144663106|NCT00430521|521616146|FG004|Overall Study|Lost to Follow-up|5|||
144663107|NCT00430521|521616147|FG005|Overall Study|Lost to Follow-up|2|||
144663108|NCT00430521|521616148|FG006|Overall Study|Lost to Follow-up|8|||
144663109|NCT00430521|521616149|FG007|Overall Study|Lost to Follow-up|10|||
144663110|NCT00430521|521616142|FG000|Overall Study|Pregnancy|0|||
144663111|NCT00430521|521616143|FG001|Overall Study|Pregnancy|0|||
144663112|NCT00430521|521616144|FG002|Overall Study|Pregnancy|0|||
144663113|NCT00430521|521616145|FG003|Overall Study|Pregnancy|0|||
144663114|NCT00430521|521616146|FG004|Overall Study|Pregnancy|0|||
144663115|NCT00430521|521616147|FG005|Overall Study|Pregnancy|0|||
144663116|NCT00430521|521616148|FG006|Overall Study|Pregnancy|1|||
144663117|NCT00430521|521616149|FG007|Overall Study|Pregnancy|0|||
144663118|NCT00430521|521616142|FG000|Overall Study|Vaccine Expired|0|||
144663119|NCT00430521|521616143|FG001|Overall Study|Vaccine Expired|0|||
144663120|NCT00430521|521616144|FG002|Overall Study|Vaccine Expired|0|||
144663121|NCT00430521|521616145|FG003|Overall Study|Vaccine Expired|0|||
144215887|NCT03656744|519984198|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
144663122|NCT00430521|521616146|FG004|Overall Study|Vaccine Expired|0|||
144663123|NCT00430521|521616147|FG005|Overall Study|Vaccine Expired|1|||
144663124|NCT00430521|521616148|FG006|Overall Study|Vaccine Expired|0|||
144663125|NCT00430521|521616149|FG007|Overall Study|Vaccine Expired|0|||
144663126|NCT00430521|521616142|FG000|Overall Study|Protocol Violation|1|||
144663127|NCT00430521|521616143|FG001|Overall Study|Protocol Violation|0|||
144663128|NCT00430521|521616144|FG002|Overall Study|Protocol Violation|0|||
144663129|NCT00430521|521616145|FG003|Overall Study|Protocol Violation|0|||
144663130|NCT00430521|521616146|FG004|Overall Study|Protocol Violation|0|||
144663131|NCT00430521|521616147|FG005|Overall Study|Protocol Violation|0|||
144663132|NCT00430521|521616148|FG006|Overall Study|Protocol Violation|0|||
144663133|NCT00430521|521616149|FG007|Overall Study|Protocol Violation|0|||
144733405|NCT02963259|521880650|FG000|Overall Study|Death|1|||
144265529|NCT01868646|520173942|FG001|Overall Study|Do not meet inclusion criteria|5|||
144265530|NCT00536510|520173943|FG000|Overall Study|Adverse Event|27|||
144265531|NCT00536510|520173944|FG001|Overall Study|Adverse Event|4|||
144265532|NCT00536510|520173943|FG000|Overall Study|Lost to Follow-up|11|||
144265533|NCT00536510|520173944|FG001|Overall Study|Lost to Follow-up|8|||
144265534|NCT00536510|520173943|FG000|Overall Study|Protocol Violation|4|||
144265535|NCT00536510|520173944|FG001|Overall Study|Protocol Violation|5|||
144265536|NCT00536510|520173943|FG000|Overall Study|Withdrawal by Subject|16|||
144265537|NCT00536510|520173944|FG001|Overall Study|Withdrawal by Subject|9|||
144265538|NCT00536510|520173943|FG000|Overall Study|Flushing with Product|20|||
144265539|NCT00536510|520173944|FG001|Overall Study|Flushing with Product|0|||
144265540|NCT00536510|520173943|FG000|Overall Study|Laboratory Adverse Event|2|||
144265541|NCT00536510|520173944|FG001|Overall Study|Laboratory Adverse Event|1|||
144265542|NCT00536510|520173943|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
144265543|NCT00536510|520173944|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
144265544|NCT01783743|520173945|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
144265545|NCT01783743|520173946|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
144265546|NCT01783743|520173945|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
144265547|NCT01783743|520173946|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
144265548|NCT01783743|520173945|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
144265549|NCT01783743|520173946|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
144265550|NCT02771275|520173948|FG000|Overall Study|Reoperation|3|||
144265551|NCT02771275|520173948|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
144265552|NCT05556148|520173949|FG000|Overall Study|Early Termination|29|||
144265553|NCT05556148|520173949|FG000|Overall Study|Baseline Tasks Expired|4|||
144265554|NCT05556148|520173949|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
144265555|NCT05556148|520173949|FG000|Overall Study|No Longer Wished to Participate|1|||
144265556|NCT05556148|520173949|FG000|Overall Study|Bacterial Conjunctivitis|1|||
144265557|NCT03191799|520173950|FG000|Overall Study|Withdrawal by Subject|4|||
144265558|NCT03191799|520173950|FG000|Overall Study|Physician Decision|2|||
144265559|NCT03191799|520173950|FG000|Overall Study|Lost to Follow-up|1|||
144265560|NCT03191799|520173950|FG000|Overall Study|Death|2|||
144265561|NCT00853762|520173965|FG000|Overall Study|Premature Termination|16|||
144265562|NCT00853762|520173966|FG001|Overall Study|Premature Termination|15|||
144663134|NCT00430521|521616142|FG000|Overall Study|Withdrawal by Subject|3|||
144663135|NCT00430521|521616143|FG001|Overall Study|Withdrawal by Subject|1|||
144663136|NCT00430521|521616144|FG002|Overall Study|Withdrawal by Subject|0|||
144663137|NCT00430521|521616145|FG003|Overall Study|Withdrawal by Subject|3|||
144663138|NCT00430521|521616146|FG004|Overall Study|Withdrawal by Subject|0|||
144215888|NCT03656744|519984199|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
144215889|NCT03656744|519984200|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
144215890|NCT03142191|519984202|FG000|Placebo Controlled Period|Death|0|||
144215891|NCT03142191|519984203|FG001|Placebo Controlled Period|Death|1|||
144215892|NCT03142191|519984204|FG002|Placebo Controlled Period|Death|1|||
144215893|NCT03142191|519984205|FG003|Placebo Controlled Period|Death|0|||
144215894|NCT03142191|519984206|FG004|Placebo Controlled Period|Death|0|||
144215895|NCT03142191|519984202|FG000|Placebo Controlled Period|Adverse Event|4|||
144215896|NCT03142191|519984203|FG001|Placebo Controlled Period|Adverse Event|5|||
144215897|NCT03142191|519984204|FG002|Placebo Controlled Period|Adverse Event|1|||
144215898|NCT03142191|519984205|FG003|Placebo Controlled Period|Adverse Event|0|||
144215899|NCT03142191|519984206|FG004|Placebo Controlled Period|Adverse Event|0|||
144215900|NCT03142191|519984202|FG000|Placebo Controlled Period|Progressive Disease|1|||
144215901|NCT03142191|519984203|FG001|Placebo Controlled Period|Progressive Disease|0|||
144215902|NCT03142191|519984204|FG002|Placebo Controlled Period|Progressive Disease|1|||
144215903|NCT03142191|519984205|FG003|Placebo Controlled Period|Progressive Disease|0|||
144215904|NCT03142191|519984206|FG004|Placebo Controlled Period|Progressive Disease|0|||
144215905|NCT03142191|519984202|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
144215906|NCT03142191|519984203|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
144215907|NCT03142191|519984204|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
144215908|NCT03142191|519984205|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
144215909|NCT03142191|519984206|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
144215910|NCT03142191|519984202|FG000|Placebo Controlled Period|Other Reasons|1|||
144215911|NCT03142191|519984203|FG001|Placebo Controlled Period|Other Reasons|0|||
144215912|NCT03142191|519984204|FG002|Placebo Controlled Period|Other Reasons|0|||
144215913|NCT03142191|519984205|FG003|Placebo Controlled Period|Other Reasons|0|||
144215914|NCT03142191|519984206|FG004|Placebo Controlled Period|Other Reasons|0|||
144215915|NCT03142191|519984202|FG000|Active Treatment Extension Period|Death|2|||
144215916|NCT03142191|519984203|FG001|Active Treatment Extension Period|Death|1|||
144215917|NCT03142191|519984204|FG002|Active Treatment Extension Period|Death|1|||
144215918|NCT03142191|519984205|FG003|Active Treatment Extension Period|Death|1|||
144215919|NCT03142191|519984206|FG004|Active Treatment Extension Period|Death|0|||
144215920|NCT03142191|519984202|FG000|Active Treatment Extension Period|Adverse Event|6|||
144733406|NCT02963259|521880650|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
144663139|NCT00430521|521616147|FG005|Overall Study|Withdrawal by Subject|0|||
144663140|NCT00430521|521616148|FG006|Overall Study|Withdrawal by Subject|0|||
144663141|NCT00430521|521616149|FG007|Overall Study|Withdrawal by Subject|2|||
144663142|NCT05108805|521616150|FG000|Overall Study|T-cell expansion was not successful.|5|||
144663143|NCT03162055|521618306|FG000|Overall Study|Adverse Event|6|||
144663144|NCT03162055|521618307|FG001|Overall Study|Adverse Event|5|||
144663145|NCT03162055|521618306|FG000|Overall Study|Death|3|||
144663146|NCT03162055|521618307|FG001|Overall Study|Death|3|||
144663147|NCT03162055|521618306|FG000|Overall Study|Lost to Follow-up|0|||
144663148|NCT03162055|521618307|FG001|Overall Study|Lost to Follow-up|1|||
144663149|NCT03162055|521618306|FG000|Overall Study|Study-specific withdrawal criteria|22|||
144663150|NCT03162055|521618307|FG001|Overall Study|Study-specific withdrawal criteria|14|||
144663151|NCT03162055|521618306|FG000|Overall Study|Withdrawal by Subject|17|||
144663152|NCT03162055|521618307|FG001|Overall Study|Withdrawal by Subject|2|||
144663153|NCT03162055|521618306|FG000|Overall Study|Did not receive treatment|2|||
144663154|NCT03162055|521618307|FG001|Overall Study|Did not receive treatment|0|||
144663155|NCT03162055|521618306|FG000|Overall Study|Incorrect randomization|4|||
144663156|NCT03162055|521618307|FG001|Overall Study|Incorrect randomization|3|||
144663157|NCT03162055|521618306|FG000|Overall Study|Other|8|||
144663158|NCT03162055|521618307|FG001|Overall Study|Other|15|||
144663159|NCT01993615|521618311|FG000|Overall Study|Death|1|||
144663160|NCT01993615|521618312|FG001|Overall Study|Death|0|||
144663161|NCT01617655|521618313|FG000|Overall Study|Adverse Event|2|||
144663162|NCT01617655|521618314|FG001|Overall Study|Adverse Event|3|||
144663163|NCT01617655|521618313|FG000|Overall Study|Poor compliance to protocol|1|||
144663164|NCT01617655|521618314|FG001|Overall Study|Poor compliance to protocol|4|||
144663165|NCT01617655|521618313|FG000|Overall Study|Participants moved|0|||
144663166|NCT01617655|521618314|FG001|Overall Study|Participants moved|4|||
144663167|NCT01617655|521618313|FG000|Overall Study|Consent withdrawn by participant|1|||
144663168|NCT01617655|521618314|FG001|Overall Study|Consent withdrawn by participant|1|||
144733407|NCT03243630|521880651|FG000|Overall Study|Protocol Violation|1|||
144733408|NCT03243630|521880651|FG000|Overall Study|Physician Decision|1|||
144733409|NCT00939003|521880653|FG000|Double-blind Treatment Period|Adverse Event|1|||
144663169|NCT01617655|521618313|FG000|Overall Study|Last visit outside protocol visit window|1|||
144663170|NCT01617655|521618314|FG001|Overall Study|Last visit outside protocol visit window|10|||
144663171|NCT01617655|521618313|FG000|Overall Study|Site closure|3|||
144663172|NCT01617655|521618314|FG001|Overall Study|Site closure|5|||
144663173|NCT01617655|521618313|FG000|Overall Study|Other than specified above|1|||
144733410|NCT00939003|521880654|FG001|Double-blind Treatment Period|Adverse Event|1|||
144733411|NCT00939003|521880653|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
144215921|NCT03142191|519984203|FG001|Active Treatment Extension Period|Adverse Event|5|||
144215922|NCT03142191|519984204|FG002|Active Treatment Extension Period|Adverse Event|4|||
144215923|NCT03142191|519984205|FG003|Active Treatment Extension Period|Adverse Event|1|||
144215924|NCT03142191|519984206|FG004|Active Treatment Extension Period|Adverse Event|0|||
144215925|NCT03142191|519984202|FG000|Active Treatment Extension Period|Progressive Disease|10|||
144215926|NCT03142191|519984203|FG001|Active Treatment Extension Period|Progressive Disease|5|||
144215927|NCT03142191|519984204|FG002|Active Treatment Extension Period|Progressive Disease|4|||
144215928|NCT03142191|519984205|FG003|Active Treatment Extension Period|Progressive Disease|1|||
144215929|NCT03142191|519984206|FG004|Active Treatment Extension Period|Progressive Disease|2|||
144215930|NCT03142191|519984202|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
144215931|NCT03142191|519984203|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
144215932|NCT03142191|519984204|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
144215933|NCT03142191|519984205|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
144215934|NCT03142191|519984206|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
144215935|NCT03142191|519984202|FG000|Active Treatment Extension Period|Physician Decision|2|||
144215936|NCT03142191|519984203|FG001|Active Treatment Extension Period|Physician Decision|0|||
144215937|NCT03142191|519984204|FG002|Active Treatment Extension Period|Physician Decision|0|||
144215938|NCT03142191|519984205|FG003|Active Treatment Extension Period|Physician Decision|0|||
144215939|NCT03142191|519984206|FG004|Active Treatment Extension Period|Physician Decision|0|||
144215940|NCT03142191|519984202|FG000|Active Treatment Extension Period|Other Reasons|3|||
144215941|NCT03142191|519984203|FG001|Active Treatment Extension Period|Other Reasons|3|||
144215942|NCT03142191|519984204|FG002|Active Treatment Extension Period|Other Reasons|3|||
144215943|NCT03142191|519984205|FG003|Active Treatment Extension Period|Other Reasons|8|||
144215944|NCT03142191|519984206|FG004|Active Treatment Extension Period|Other Reasons|3|||
144215945|NCT03142191|519984202|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
144215946|NCT03142191|519984203|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
144215947|NCT03142191|519984204|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
144215948|NCT03142191|519984205|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
144215949|NCT03142191|519984206|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
144215950|NCT01130493|519984207|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
144663174|NCT01617655|521618314|FG001|Overall Study|Other than specified above|2|||
144663175|NCT02924688|521618322|FG000|Overall Study|Adverse Event|9|||
144663176|NCT02924688|521618323|FG001|Overall Study|Adverse Event|3|||
144663177|NCT02924688|521618324|FG002|Overall Study|Adverse Event|2|||
144663178|NCT02924688|521618325|FG003|Overall Study|Adverse Event|2|||
144663179|NCT02924688|521618326|FG004|Overall Study|Adverse Event|3|||
144663180|NCT02924688|521618327|FG005|Overall Study|Adverse Event|2|||
144663181|NCT02924688|521618322|FG000|Overall Study|Lack of Efficacy|2|||
144663182|NCT02924688|521618323|FG001|Overall Study|Lack of Efficacy|3|||
144663183|NCT02924688|521618324|FG002|Overall Study|Lack of Efficacy|4|||
144663184|NCT02924688|521618325|FG003|Overall Study|Lack of Efficacy|2|||
144663185|NCT02924688|521618326|FG004|Overall Study|Lack of Efficacy|1|||
144663186|NCT02924688|521618327|FG005|Overall Study|Lack of Efficacy|1|||
144663187|NCT02924688|521618322|FG000|Overall Study|Protocol Violation|3|||
144663188|NCT02924688|521618323|FG001|Overall Study|Protocol Violation|7|||
144663189|NCT02924688|521618324|FG002|Overall Study|Protocol Violation|5|||
144663190|NCT02924688|521618325|FG003|Overall Study|Protocol Violation|6|||
144663191|NCT02924688|521618326|FG004|Overall Study|Protocol Violation|2|||
144663192|NCT02924688|521618327|FG005|Overall Study|Protocol Violation|2|||
144663193|NCT02924688|521618322|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
144663194|NCT02924688|521618323|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
144663195|NCT02924688|521618324|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
144663196|NCT02924688|521618325|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
144663197|NCT02924688|521618326|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
144663198|NCT02924688|521618327|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
144663199|NCT02924688|521618322|FG000|Overall Study|Lost to Follow-up|2|||
144663200|NCT02924688|521618323|FG001|Overall Study|Lost to Follow-up|4|||
144663201|NCT02924688|521618324|FG002|Overall Study|Lost to Follow-up|2|||
144663202|NCT02924688|521618325|FG003|Overall Study|Lost to Follow-up|4|||
144663203|NCT02924688|521618326|FG004|Overall Study|Lost to Follow-up|2|||
144663204|NCT02924688|521618327|FG005|Overall Study|Lost to Follow-up|4|||
144663205|NCT02924688|521618322|FG000|Overall Study|Physician Decision|2|||
144663206|NCT02924688|521618323|FG001|Overall Study|Physician Decision|1|||
144663207|NCT02924688|521618324|FG002|Overall Study|Physician Decision|0|||
144663208|NCT02924688|521618325|FG003|Overall Study|Physician Decision|1|||
144663209|NCT02924688|521618326|FG004|Overall Study|Physician Decision|1|||
144663210|NCT02924688|521618327|FG005|Overall Study|Physician Decision|1|||
144663211|NCT02924688|521618322|FG000|Overall Study|Withdrawal by Subject|14|||
144663212|NCT02924688|521618323|FG001|Overall Study|Withdrawal by Subject|13|||
144663213|NCT02924688|521618324|FG002|Overall Study|Withdrawal by Subject|9|||
144663214|NCT02924688|521618325|FG003|Overall Study|Withdrawal by Subject|12|||
144663215|NCT02924688|521618326|FG004|Overall Study|Withdrawal by Subject|13|||
144663216|NCT02924688|521618327|FG005|Overall Study|Withdrawal by Subject|14|||
144663217|NCT02370498|521618333|FG000|Overall Study|Adverse Event|10|||
144215951|NCT01130493|519984208|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
144215952|NCT01130493|519984209|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
144215953|NCT01130493|519984207|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
144215954|NCT01130493|519984208|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
144215955|NCT01130493|519984209|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
144215956|NCT01130493|519984207|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
144215957|NCT01130493|519984208|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
144215958|NCT01130493|519984209|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
144215959|NCT01130493|519984207|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
144215960|NCT01130493|519984208|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
144215961|NCT01130493|519984209|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
144215962|NCT01130493|519984207|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
144215963|NCT01130493|519984208|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
144215964|NCT01130493|519984209|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
144215965|NCT01130493|519984207|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
144215966|NCT01130493|519984208|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
144215967|NCT01130493|519984209|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
144663218|NCT02370498|521618334|FG001|Overall Study|Adverse Event|8|||
144663219|NCT02370498|521618333|FG000|Overall Study|Death|263|||
144215968|NCT01130493|519984207|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
144215969|NCT01130493|519984208|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
144663220|NCT02370498|521618334|FG001|Overall Study|Death|265|||
144663221|NCT02370498|521618333|FG000|Overall Study|Protocol Violation|1|||
144663222|NCT02370498|521618334|FG001|Overall Study|Protocol Violation|2|||
144663223|NCT02370498|521618333|FG000|Overall Study|Withdrawal by Subject|7|||
144663224|NCT02370498|521618334|FG001|Overall Study|Withdrawal by Subject|12|||
144663225|NCT02370498|521618333|FG000|Overall Study|Sponsor's decision|15|||
144663226|NCT02370498|521618334|FG001|Overall Study|Sponsor's decision|9|||
144663227|NCT03225716|521618335|FG000|Overall Study|Withdrawal by Subject|2|||
144663228|NCT03225716|521618336|FG001|Overall Study|Withdrawal by Subject|2|||
144663229|NCT03225716|521618337|FG002|Overall Study|Withdrawal by Subject|0|||
144663230|NCT03225716|521618335|FG000|Overall Study|Lack of Efficacy|1|||
144663231|NCT03225716|521618336|FG001|Overall Study|Lack of Efficacy|0|||
144663232|NCT03225716|521618337|FG002|Overall Study|Lack of Efficacy|0|||
144663233|NCT03225716|521618335|FG000|Overall Study|Adverse Event|2|||
144663234|NCT03225716|521618336|FG001|Overall Study|Adverse Event|0|||
144663235|NCT03225716|521618337|FG002|Overall Study|Adverse Event|1|||
144663236|NCT03225716|521618335|FG000|Overall Study|Study early termination by Sponsor|0|||
144663237|NCT03225716|521618336|FG001|Overall Study|Study early termination by Sponsor|0|||
144663238|NCT03225716|521618337|FG002|Overall Study|Study early termination by Sponsor|2|||
144663239|NCT01205451|521618345|FG000|Overall Study|Lost to Follow-up|1|||
144663240|NCT01205451|521618346|FG001|Overall Study|Lost to Follow-up|1|||
144663241|NCT01205451|521618345|FG000|Overall Study|Withdrawal by Subject|5|||
144663242|NCT01205451|521618346|FG001|Overall Study|Withdrawal by Subject|9|||
144663243|NCT00229203|521618350|FG000|Overall Study|Progressive disease|18|||
144663244|NCT00229203|521618351|FG001|Overall Study|Progressive disease|9|||
144663245|NCT00229203|521618350|FG000|Overall Study|Toxicity|6|||
144663246|NCT00229203|521618351|FG001|Overall Study|Toxicity|1|||
144663247|NCT00229203|521618350|FG000|Overall Study|Death|4|||
144663248|NCT00229203|521618351|FG001|Overall Study|Death|2|||
144663249|NCT00229203|521618350|FG000|Overall Study|Other|3|||
144663250|NCT00229203|521618351|FG001|Overall Study|Other|3|||
144663251|NCT00229203|521618350|FG000|Overall Study|Withdrawal by Subject|1|||
144663252|NCT00229203|521618351|FG001|Overall Study|Withdrawal by Subject|4|||
144663253|NCT03457103|521618352|FG000|Overall Study|illness/hospitalization|4|||
144663254|NCT03457103|521618353|FG001|Overall Study|illness/hospitalization|2|||
144663255|NCT03457103|521618352|FG000|Overall Study|Lost to Follow-up|2|||
144663256|NCT03457103|521618353|FG001|Overall Study|Lost to Follow-up|1|||
144663257|NCT03457103|521618352|FG000|Overall Study|Withdrawal by Subject|1|||
144663258|NCT03457103|521618353|FG001|Overall Study|Withdrawal by Subject|2|||
144663259|NCT03457103|521618352|FG000|Overall Study|financial/ insurance issues|1|||
144663260|NCT03457103|521618353|FG001|Overall Study|financial/ insurance issues|1|||
144663261|NCT02411201|521618354|FG000|Overall Study|Adverse Event|2|||
144663262|NCT02411201|521618354|FG000|Overall Study|Withdrawal by Subject|2|||
144663263|NCT02411201|521618354|FG000|Overall Study|Age group completed|2|||
144663264|NCT00798694|521618355|FG000|Overall Study|Lost to Follow-up|1|||
144663265|NCT00798694|521618356|FG001|Overall Study|Lost to Follow-up|1|||
144663266|NCT00798694|521618355|FG000|Overall Study|Physician Decision|1|||
144663267|NCT00798694|521618356|FG001|Overall Study|Physician Decision|0|||
144663268|NCT01774344|521618358|FG000|Overall Study|Withdrawal by Subject|3|||
144663269|NCT01774344|521618359|FG001|Overall Study|Withdrawal by Subject|10|||
144663270|NCT01774344|521618358|FG000|Overall Study|Protocol Violation|0|||
144663271|NCT01774344|521618359|FG001|Overall Study|Protocol Violation|1|||
144663272|NCT01774344|521618358|FG000|Overall Study|Lost to Follow-up|4|||
144663273|NCT01774344|521618359|FG001|Overall Study|Lost to Follow-up|10|||
144663274|NCT01774344|521618358|FG000|Overall Study|End of survival follow-up not available|2|||
144663275|NCT01774344|521618359|FG001|Overall Study|End of survival follow-up not available|2|||
144663276|NCT01774344|521618358|FG000|Overall Study|Data collection finished|4|||
144663277|NCT01774344|521618359|FG001|Overall Study|Data collection finished|14|||
144663278|NCT01774344|521618358|FG000|Overall Study|Other|0|||
144663279|NCT01774344|521618359|FG001|Overall Study|Other|1|||
144663280|NCT01774344|521618358|FG000|Overall Study|Did not enter Survival Follow up|49|||
144663281|NCT01774344|521618359|FG001|Overall Study|Did not enter Survival Follow up|83|||
144663282|NCT03364608|521618368|FG000|Overall Study|Withdrawal by Subject|4|||
144663283|NCT03364608|521618368|FG000|Overall Study|Protocol Violation|2|||
144663284|NCT03364608|521618368|FG000|Overall Study|Lost to Follow-up|2|||
144663285|NCT03004469|521618371|FG000|Overall Study|Adverse Event|6|||
144663286|NCT03004469|521618372|FG001|Overall Study|Adverse Event|4|||
144663287|NCT03004469|521618373|FG002|Overall Study|Adverse Event|6|||
144663288|NCT03004469|521618371|FG000|Overall Study|Lack of Efficacy|1|||
144663289|NCT03004469|521618372|FG001|Overall Study|Lack of Efficacy|0|||
144663290|NCT03004469|521618373|FG002|Overall Study|Lack of Efficacy|1|||
144663291|NCT03004469|521618371|FG000|Overall Study|Lost to Follow-up|23|||
144663292|NCT03004469|521618372|FG001|Overall Study|Lost to Follow-up|14|||
144663293|NCT03004469|521618373|FG002|Overall Study|Lost to Follow-up|6|||
144663294|NCT03004469|521618371|FG000|Overall Study|Non-Compliance with Study Drug|2|||
144663295|NCT03004469|521618372|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144663296|NCT03004469|521618373|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144663297|NCT03004469|521618371|FG000|Overall Study|Protocol Violation|0|||
144663298|NCT03004469|521618372|FG001|Overall Study|Protocol Violation|0|||
144663299|NCT03004469|521618373|FG002|Overall Study|Protocol Violation|1|||
144663300|NCT03004469|521618371|FG000|Overall Study|Withdrawal by Subject|29|||
144663301|NCT03004469|521618372|FG001|Overall Study|Withdrawal by Subject|27|||
144663302|NCT03004469|521618373|FG002|Overall Study|Withdrawal by Subject|10|||
144663303|NCT03004469|521618371|FG000|Overall Study|Other unspecified reason|0|||
144663304|NCT03004469|521618372|FG001|Overall Study|Other unspecified reason|4|||
144663305|NCT03004469|521618373|FG002|Overall Study|Other unspecified reason|1|||
144663306|NCT01163253|521618374|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
144663307|NCT01163253|521618375|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
144663308|NCT01163253|521618374|FG000|Overall Study|Study Terminated by Sponsor|978|||
144663309|NCT01163253|521618375|FG001|Overall Study|Study Terminated by Sponsor|349|||
144663310|NCT01163253|521618374|FG000|Overall Study|Protocol Violation|43|||
144663311|NCT01163253|521618375|FG001|Overall Study|Protocol Violation|12|||
144663312|NCT01163253|521618374|FG000|Overall Study|Withdrawal by Subject|199|||
144663313|NCT01163253|521618375|FG001|Overall Study|Withdrawal by Subject|50|||
144663314|NCT01163253|521618374|FG000|Overall Study|Medication Error|1|||
144663315|NCT01163253|521618375|FG001|Overall Study|Medication Error|0|||
144663316|NCT01163253|521618374|FG000|Overall Study|Lost to Follow-up|125|||
144663317|NCT01163253|521618375|FG001|Overall Study|Lost to Follow-up|23|||
144663318|NCT01163253|521618374|FG000|Overall Study|Insufficient Clinical Response|423|||
144663319|NCT01163253|521618375|FG001|Overall Study|Insufficient Clinical Response|29|||
144663320|NCT01163253|521618374|FG000|Overall Study|Adverse Event|300|||
144663321|NCT01163253|521618375|FG001|Overall Study|Adverse Event|78|||
144663322|NCT01163253|521618374|FG000|Overall Study|Death|17|||
144663323|NCT01163253|521618375|FG001|Overall Study|Death|5|||
144663324|NCT01163253|521618374|FG000|Overall Study|Ongoing|13|||
144663325|NCT01163253|521618375|FG001|Overall Study|Ongoing|4|||
144663326|NCT01163253|521618374|FG000|Overall Study|Other Unspecified|170|||
144663327|NCT01163253|521618375|FG001|Overall Study|Other Unspecified|34|||
144663328|NCT02492997|521618376|FG000|Overall Study|Withdrawal by Subject|1|||
144663329|NCT02492997|521618377|FG001|Overall Study|Withdrawal by Subject|0|||
144663330|NCT02492997|521618376|FG000|Overall Study|Gained Weight|1|||
144663331|NCT02492997|521618377|FG001|Overall Study|Gained Weight|0|||
144663332|NCT02492997|521618376|FG000|Overall Study|Lost to Follow-up|0|||
144663333|NCT02492997|521618377|FG001|Overall Study|Lost to Follow-up|1|||
144215970|NCT01130493|519984209|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
144215971|NCT01130493|519984207|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
144215972|NCT01130493|519984208|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
144215973|NCT01130493|519984209|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
144215974|NCT01130493|519984207|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
144215975|NCT01130493|519984208|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
144215976|NCT01130493|519984209|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
144215977|NCT01130493|519984207|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
144215978|NCT01130493|519984208|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
144215979|NCT01130493|519984209|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
144215980|NCT01130493|519984207|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
144215981|NCT01130493|519984208|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
144215982|NCT01130493|519984209|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
144215983|NCT01130493|519984207|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
144215984|NCT01130493|519984208|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
144215985|NCT01130493|519984209|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
144215986|NCT01130493|519984207|FG000|Part 2: OLE|Adverse Event|0|||
144215987|NCT01130493|519984208|FG001|Part 2: OLE|Adverse Event|2|||
144215988|NCT01130493|519984209|FG002|Part 2: OLE|Adverse Event|1|||
144215989|NCT01130493|519984207|FG000|Part 2: OLE|Withdrawal by Subject|0|||
144215990|NCT01130493|519984208|FG001|Part 2: OLE|Withdrawal by Subject|1|||
144215991|NCT01130493|519984209|FG002|Part 2: OLE|Withdrawal by Subject|4|||
144215992|NCT00879086|519984210|FG000|Overall Study|Adverse Event|3|||
144215993|NCT00879086|519984211|FG001|Overall Study|Adverse Event|15|||
144215994|NCT00879086|519984210|FG000|Overall Study|Participant choice|2|||
144215995|NCT00879086|519984211|FG001|Overall Study|Participant choice|2|||
144215996|NCT00879086|519984210|FG000|Overall Study|Progression of disease|40|||
144215997|NCT00879086|519984211|FG001|Overall Study|Progression of disease|26|||
144215998|NCT00879086|519984210|FG000|Overall Study|Withdrawal of consent|2|||
144215999|NCT00879086|519984211|FG001|Overall Study|Withdrawal of consent|1|||
144216000|NCT00879086|519984210|FG000|Overall Study|Other|4|||
144216001|NCT00879086|519984211|FG001|Overall Study|Other|6|||
144216002|NCT00879086|519984210|FG000|Overall Study|Death|1|||
144216003|NCT00879086|519984211|FG001|Overall Study|Death|2|||
144216004|NCT02969044|519984212|FG000|Overall Study|Withdrawal by Subject|2|||
144216005|NCT02969044|519984213|FG001|Overall Study|Withdrawal by Subject|6|||
144216006|NCT02969044|519984212|FG000|Overall Study|Adverse Event|3|||
144216007|NCT02969044|519984213|FG001|Overall Study|Adverse Event|0|||
144216008|NCT04728802|519984214|FG000|Overall Study|Withdrawal by Subject|4|||
144216009|NCT04728802|519984215|FG001|Overall Study|Withdrawal by Subject|20|||
144216010|NCT04728802|519984214|FG000|Overall Study|Physician Decision|7|||
144216011|NCT04728802|519984215|FG001|Overall Study|Physician Decision|7|||
144216012|NCT04728802|519984214|FG000|Overall Study|Protocol Violation|10|||
144216013|NCT04728802|519984215|FG001|Overall Study|Protocol Violation|4|||
144663334|NCT00209170|521618378|FG000|Overall Study|Adverse Event|0|||
144663335|NCT00209170|521618379|FG001|Overall Study|Adverse Event|1|||
144663336|NCT00209170|521618378|FG000|Overall Study|Withdrawal by Subject|2|||
144663337|NCT00209170|521618379|FG001|Overall Study|Withdrawal by Subject|1|||
144663338|NCT00209170|521618378|FG000|Overall Study|Lack of Efficacy|0|||
144663339|NCT00209170|521618379|FG001|Overall Study|Lack of Efficacy|1|||
144216014|NCT04728802|519984214|FG000|Overall Study|Transfer|1|||
144216015|NCT04728802|519984215|FG001|Overall Study|Transfer|0|||
144216016|NCT04728802|519984214|FG000|Overall Study|Death|4|||
144216017|NCT04728802|519984215|FG001|Overall Study|Death|5|||
144216018|NCT04728802|519984214|FG000|Overall Study|Other|3|||
144216019|NCT04728802|519984215|FG001|Overall Study|Other|0|||
144216020|NCT04650204|519984216|FG000|Overall Study|Study was Terminated|2|||
144216021|NCT04650204|519984217|FG001|Overall Study|Study was Terminated|1|||
144216022|NCT01330303|519984218|FG000|Period 1|Adverse Event|1|||
144216023|NCT01330303|519984219|FG001|Period 1|Adverse Event|0|||
144216024|NCT01330303|519984218|FG000|Period 1|Protocol Violation|0|||
144216025|NCT01330303|519984219|FG001|Period 1|Protocol Violation|1|||
144216026|NCT01330303|519984218|FG000|Period 1|Withdrawal by Subject|0|||
144216027|NCT01330303|519984219|FG001|Period 1|Withdrawal by Subject|1|||
144216028|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
144216029|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Off-label use|283|||
144216030|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
144216031|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
144216032|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
144216033|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
144216034|NCT01070953|519984222|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
144216035|NCT01070953|519984222|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
144216036|NCT01070953|519984222|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
144216037|NCT01070953|519984222|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
144216038|NCT01957176|519984223|FG000|Overall Study|Adverse Event|2|||
144216039|NCT01957176|519984224|FG001|Overall Study|Adverse Event|0|||
144216040|NCT01957176|519984223|FG000|Overall Study|Physician Decision|2|||
144216041|NCT01957176|519984224|FG001|Overall Study|Physician Decision|1|||
144216042|NCT01957176|519984223|FG000|Overall Study|Withdrawal by Subject|1|||
144216043|NCT01957176|519984224|FG001|Overall Study|Withdrawal by Subject|0|||
144216044|NCT00839254|519984225|FG000|Overall Study|Protocol Violation|0|||
144216045|NCT00839254|519984226|FG001|Overall Study|Protocol Violation|1|||
144216046|NCT00839254|519984227|FG002|Overall Study|Protocol Violation|1|||
144216047|NCT00839254|519984228|FG003|Overall Study|Protocol Violation|1|||
144216048|NCT00839254|519984229|FG004|Overall Study|Protocol Violation|0|||
144216049|NCT00839254|519984230|FG005|Overall Study|Protocol Violation|0|||
144216050|NCT00839254|519984231|FG006|Overall Study|Protocol Violation|1|||
144216051|NCT00839254|519984232|FG007|Overall Study|Protocol Violation|2|||
144216052|NCT00839254|519984225|FG000|Overall Study|Physician Decision|0|||
144216053|NCT00839254|519984226|FG001|Overall Study|Physician Decision|1|||
144216054|NCT00839254|519984227|FG002|Overall Study|Physician Decision|0|||
144216055|NCT00839254|519984228|FG003|Overall Study|Physician Decision|0|||
144216056|NCT00839254|519984229|FG004|Overall Study|Physician Decision|0|||
144216057|NCT00839254|519984230|FG005|Overall Study|Physician Decision|0|||
144216058|NCT00839254|519984231|FG006|Overall Study|Physician Decision|0|||
144216059|NCT00839254|519984232|FG007|Overall Study|Physician Decision|1|||
144216060|NCT00839254|519984225|FG000|Overall Study|Wrong treatment number allocation|0|||
144216061|NCT00839254|519984226|FG001|Overall Study|Wrong treatment number allocation|1|||
144216062|NCT00839254|519984227|FG002|Overall Study|Wrong treatment number allocation|0|||
144216063|NCT00839254|519984228|FG003|Overall Study|Wrong treatment number allocation|0|||
144216064|NCT00839254|519984229|FG004|Overall Study|Wrong treatment number allocation|0|||
144216065|NCT00839254|519984230|FG005|Overall Study|Wrong treatment number allocation|1|||
144216066|NCT00839254|519984231|FG006|Overall Study|Wrong treatment number allocation|0|||
144216067|NCT00839254|519984232|FG007|Overall Study|Wrong treatment number allocation|0|||
144216068|NCT00839254|519984225|FG000|Overall Study|Adverse Event|12|||
144216069|NCT00839254|519984226|FG001|Overall Study|Adverse Event|6|||
144216070|NCT00839254|519984227|FG002|Overall Study|Adverse Event|3|||
144216071|NCT00839254|519984228|FG003|Overall Study|Adverse Event|5|||
144216072|NCT00839254|519984229|FG004|Overall Study|Adverse Event|2|||
144216073|NCT00839254|519984230|FG005|Overall Study|Adverse Event|1|||
144216074|NCT00839254|519984231|FG006|Overall Study|Adverse Event|0|||
144216075|NCT00839254|519984232|FG007|Overall Study|Adverse Event|1|||
144216076|NCT00839254|519984225|FG000|Overall Study|Withdrawal by Subject|87|||
144216077|NCT00839254|519984226|FG001|Overall Study|Withdrawal by Subject|53|||
144216078|NCT00839254|519984227|FG002|Overall Study|Withdrawal by Subject|54|||
144216079|NCT00839254|519984228|FG003|Overall Study|Withdrawal by Subject|32|||
144216080|NCT00839254|519984229|FG004|Overall Study|Withdrawal by Subject|27|||
144216081|NCT00839254|519984230|FG005|Overall Study|Withdrawal by Subject|15|||
144216082|NCT00839254|519984231|FG006|Overall Study|Withdrawal by Subject|22|||
144216083|NCT00839254|519984232|FG007|Overall Study|Withdrawal by Subject|9|||
144216084|NCT00839254|519984225|FG000|Overall Study|Wrong group allocation|0|||
144216085|NCT00839254|519984226|FG001|Overall Study|Wrong group allocation|0|||
144216086|NCT00839254|519984227|FG002|Overall Study|Wrong group allocation|0|||
144216087|NCT00839254|519984228|FG003|Overall Study|Wrong group allocation|0|||
144216088|NCT00839254|519984229|FG004|Overall Study|Wrong group allocation|0|||
144663340|NCT02130427|521618380|FG000|Overall Study|Imaging results not interpretable|30|||
144663341|NCT04032171|521618382|FG000|Overall Study|Study Termination|1|||
144663342|NCT04032171|521618383|FG001|Overall Study|Study Termination|0|||
144663343|NCT00992784|521618384|FG000|Overall Study|Adverse Event|2|||
144663344|NCT00992784|521618385|FG001|Overall Study|Adverse Event|1|||
144663345|NCT00992784|521618386|FG002|Overall Study|Adverse Event|0|||
144663346|NCT00992784|521618384|FG000|Overall Study|Withdrawal by Subject|1|||
144663347|NCT00992784|521618385|FG001|Overall Study|Withdrawal by Subject|1|||
144663348|NCT00992784|521618386|FG002|Overall Study|Withdrawal by Subject|1|||
144663349|NCT00289185|521618387|FG000|Overall Study|Withdrawal by Subject|4|||
144663350|NCT00289185|521618388|FG001|Overall Study|Withdrawal by Subject|8|||
144216089|NCT00839254|519984230|FG005|Overall Study|Wrong group allocation|0|||
144216090|NCT00839254|519984231|FG006|Overall Study|Wrong group allocation|1|||
144216091|NCT00839254|519984232|FG007|Overall Study|Wrong group allocation|0|||
144216092|NCT00839254|519984225|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
144216093|NCT00839254|519984226|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
144216094|NCT00839254|519984227|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
144216095|NCT00839254|519984228|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
144216096|NCT00839254|519984229|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
144216097|NCT00839254|519984230|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
144216098|NCT00839254|519984231|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
144216099|NCT00839254|519984232|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
144216100|NCT00839254|519984225|FG000|Overall Study|Withdrawn due to non-compliance|2|||
144216101|NCT00839254|519984226|FG001|Overall Study|Withdrawn due to non-compliance|0|||
144216102|NCT00839254|519984227|FG002|Overall Study|Withdrawn due to non-compliance|0|||
144216103|NCT00839254|519984228|FG003|Overall Study|Withdrawn due to non-compliance|0|||
144216104|NCT00839254|519984229|FG004|Overall Study|Withdrawn due to non-compliance|0|||
144216105|NCT00839254|519984230|FG005|Overall Study|Withdrawn due to non-compliance|0|||
144216106|NCT00839254|519984231|FG006|Overall Study|Withdrawn due to non-compliance|0|||
144216107|NCT00839254|519984232|FG007|Overall Study|Withdrawn due to non-compliance|0|||
144216108|NCT00839254|519984225|FG000|Overall Study|Lost to Follow-up|51|||
144216109|NCT00839254|519984226|FG001|Overall Study|Lost to Follow-up|30|||
144216110|NCT00839254|519984227|FG002|Overall Study|Lost to Follow-up|32|||
144216111|NCT00839254|519984228|FG003|Overall Study|Lost to Follow-up|24|||
144216112|NCT00839254|519984229|FG004|Overall Study|Lost to Follow-up|8|||
144216113|NCT00839254|519984230|FG005|Overall Study|Lost to Follow-up|8|||
144216114|NCT00839254|519984231|FG006|Overall Study|Lost to Follow-up|4|||
144216115|NCT00839254|519984232|FG007|Overall Study|Lost to Follow-up|2|||
144663351|NCT00289185|521618387|FG000|Overall Study|Lost to Follow-up|23|||
144663352|NCT00289185|521618388|FG001|Overall Study|Lost to Follow-up|17|||
144663353|NCT00289185|521618387|FG000|Overall Study|Death|1|||
144216116|NCT01823835|519984233|FG000|Overall Study|Adverse Event|0|||
144216117|NCT01823835|519984234|FG001|Overall Study|Adverse Event|0|||
144216118|NCT01823835|519984235|FG002|Overall Study|Adverse Event|0|||
144216119|NCT01823835|519984236|FG003|Overall Study|Adverse Event|0|||
144216120|NCT01823835|519984237|FG004|Overall Study|Adverse Event|1|||
144216121|NCT01823835|519984238|FG005|Overall Study|Adverse Event|0|||
144216122|NCT01823835|519984239|FG006|Overall Study|Adverse Event|1|||
144663354|NCT00289185|521618388|FG001|Overall Study|Death|1|||
144663355|NCT03247413|521618392|FG000|Overall Study|Lost to Follow-up|28|||
144663356|NCT00642746|521618393|FG000|Overall Study|Patient unevaluable|1|||
144663357|NCT00642746|521618394|FG001|Overall Study|Patient unevaluable|0|||
144663358|NCT00424294|521618395|FG000|Overall Study|Adverse Event|4|||
144663359|NCT00424294|521618396|FG001|Overall Study|Adverse Event|10|||
144663360|NCT00424294|521618395|FG000|Overall Study|Lack of Efficacy|2|||
144663361|NCT00424294|521618396|FG001|Overall Study|Lack of Efficacy|1|||
144663362|NCT00424294|521618395|FG000|Overall Study|Withdrawal by Subject|1|||
144216123|NCT01823835|519984240|FG007|Overall Study|Adverse Event|0|||
144216124|NCT01823835|519984241|FG008|Overall Study|Adverse Event|0|||
144216125|NCT01823835|519984242|FG009|Overall Study|Adverse Event|0|||
144216126|NCT01823835|519984243|FG010|Overall Study|Adverse Event|1|||
144663363|NCT00424294|521618396|FG001|Overall Study|Withdrawal by Subject|2|||
144663364|NCT00424294|521618395|FG000|Overall Study|Other|0|||
144663365|NCT00424294|521618396|FG001|Overall Study|Other|2|||
144663366|NCT00424294|521618395|FG000|Overall Study|Randomized but not Treated|1|||
144663367|NCT00424294|521618396|FG001|Overall Study|Randomized but not Treated|0|||
144216127|NCT01823835|519984244|FG011|Overall Study|Adverse Event|2|||
144216128|NCT01823835|519984245|FG012|Overall Study|Adverse Event|0|||
144216129|NCT01823835|519984246|FG013|Overall Study|Adverse Event|0|||
144216130|NCT01823835|519984247|FG014|Overall Study|Adverse Event|0|||
144216131|NCT01823835|519984233|FG000|Overall Study|Physician Decision|0|||
144216132|NCT01823835|519984234|FG001|Overall Study|Physician Decision|0|||
144216133|NCT01823835|519984235|FG002|Overall Study|Physician Decision|0|||
144216134|NCT01823835|519984236|FG003|Overall Study|Physician Decision|0|||
144216135|NCT01823835|519984237|FG004|Overall Study|Physician Decision|0|||
144216136|NCT01823835|519984238|FG005|Overall Study|Physician Decision|0|||
144663368|NCT03337152|521618399|FG000|Overall Study|Physician Decision|1|||
144663369|NCT03337152|521618400|FG001|Overall Study|Physician Decision|0|||
144663370|NCT03337152|521618399|FG000|Overall Study|Lost to Follow-up|1|||
144663371|NCT03337152|521618400|FG001|Overall Study|Lost to Follow-up|3|||
144663372|NCT03337152|521618399|FG000|Overall Study|Adverse Event|3|||
144663373|NCT03337152|521618400|FG001|Overall Study|Adverse Event|1|||
144663374|NCT03337152|521618399|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
144663375|NCT03337152|521618400|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
144663376|NCT00976950|521618402|FG000|Overall Study|Adverse Event|3|||
144663377|NCT00976950|521618402|FG000|Overall Study|Events with no relationship to Aptivus|3|||
144663378|NCT02662985|521618411|FG000|Treatment Period 1|Adverse Event|0|||
144663379|NCT02662985|521618412|FG001|Treatment Period 1|Adverse Event|2|||
144663380|NCT02662985|521618411|FG000|Treatment Period 1|Protocol Violation|0|||
144663381|NCT02662985|521618412|FG001|Treatment Period 1|Protocol Violation|1|||
144663382|NCT02662985|521618411|FG000|Treatment Period 1|Physician Decision|1|||
144663383|NCT02662985|521618412|FG001|Treatment Period 1|Physician Decision|0|||
144663384|NCT02662985|521618411|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144663385|NCT02662985|521618412|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144663386|NCT02662985|521618411|FG000|Treatment Period 2|Lack of Efficacy|0|||
144663387|NCT02662985|521618412|FG001|Treatment Period 2|Lack of Efficacy|1|||
144663388|NCT02662985|521618411|FG000|Treatment Period 2|Lost to Follow-up|1|||
144663389|NCT02662985|521618412|FG001|Treatment Period 2|Lost to Follow-up|0|||
144663390|NCT02662985|521618411|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
144663391|NCT02662985|521618412|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
144663392|NCT02662985|521618411|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
144663393|NCT02662985|521618412|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
144663394|NCT02662985|521618411|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
144663395|NCT02662985|521618412|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
144663396|NCT02662985|521618411|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
144663397|NCT02662985|521618412|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
144663398|NCT02662985|521618411|FG000|Treatment Period 3 (Extension Period)|Death|0|||
144663399|NCT02662985|521618412|FG001|Treatment Period 3 (Extension Period)|Death|1|||
144663400|NCT02932332|521618413|FG000|Overall Study|Withdrawal by Subject|1|||
144663401|NCT02932332|521618414|FG001|Overall Study|Withdrawal by Subject|1|||
144663402|NCT02932332|521618415|FG002|Overall Study|Withdrawal by Subject|0|||
144663403|NCT02932332|521618416|FG003|Overall Study|Withdrawal by Subject|1|||
144663404|NCT02932332|521618413|FG000|Overall Study|Chest pain|0|||
144663405|NCT02932332|521618414|FG001|Overall Study|Chest pain|0|||
144663406|NCT02932332|521618415|FG002|Overall Study|Chest pain|0|||
144663407|NCT02932332|521618416|FG003|Overall Study|Chest pain|1|||
144663408|NCT02932332|521618413|FG000|Overall Study|Not Dyspneic cough|1|||
144663409|NCT02932332|521618414|FG001|Overall Study|Not Dyspneic cough|2|||
144663410|NCT02932332|521618415|FG002|Overall Study|Not Dyspneic cough|1|||
144663411|NCT02932332|521618416|FG003|Overall Study|Not Dyspneic cough|0|||
144663412|NCT01021852|521618417|FG000|Treatment Period 1|Adverse Event|3|||
144663413|NCT01021852|521618418|FG001|Treatment Period 1|Adverse Event|1|||
144663414|NCT01021852|521618419|FG002|Treatment Period 1|Adverse Event|1|||
144663415|NCT01021852|521618420|FG003|Treatment Period 1|Adverse Event|0|||
144663416|NCT01021852|521618421|FG004|Treatment Period 1|Adverse Event|2|||
144216137|NCT01823835|519984239|FG006|Overall Study|Physician Decision|0|||
144663417|NCT01021852|521618422|FG005|Treatment Period 1|Adverse Event|2|||
144663418|NCT01021852|521618423|FG006|Treatment Period 1|Adverse Event|0|||
144663419|NCT01021852|521618424|FG007|Treatment Period 1|Adverse Event|0|||
144663420|NCT01021852|521618417|FG000|Treatment Period 1|Pregnancy|0|||
144663421|NCT01021852|521618418|FG001|Treatment Period 1|Pregnancy|0|||
144663422|NCT01021852|521618419|FG002|Treatment Period 1|Pregnancy|1|||
144663423|NCT01021852|521618420|FG003|Treatment Period 1|Pregnancy|0|||
144663424|NCT01021852|521618421|FG004|Treatment Period 1|Pregnancy|0|||
144663425|NCT01021852|521618422|FG005|Treatment Period 1|Pregnancy|0|||
144663426|NCT01021852|521618423|FG006|Treatment Period 1|Pregnancy|0|||
144663427|NCT01021852|521618424|FG007|Treatment Period 1|Pregnancy|0|||
144663428|NCT01021852|521618417|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144663429|NCT01021852|521618418|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144663430|NCT01021852|521618419|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144663431|NCT01021852|521618420|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144663432|NCT01021852|521618421|FG004|Treatment Period 1|Withdrawal by Subject|1|||
144216138|NCT01823835|519984240|FG007|Overall Study|Physician Decision|0|||
144663433|NCT01021852|521618422|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144663434|NCT01021852|521618423|FG006|Treatment Period 1|Withdrawal by Subject|0|||
144663435|NCT01021852|521618424|FG007|Treatment Period 1|Withdrawal by Subject|1|||
144663436|NCT01021852|521618417|FG000|Treatment Period 1|Not Treated|0|||
144663437|NCT01021852|521618418|FG001|Treatment Period 1|Not Treated|0|||
144663438|NCT01021852|521618419|FG002|Treatment Period 1|Not Treated|0|||
144663439|NCT01021852|521618420|FG003|Treatment Period 1|Not Treated|2|||
144663440|NCT01021852|521618421|FG004|Treatment Period 1|Not Treated|0|||
144663441|NCT01021852|521618422|FG005|Treatment Period 1|Not Treated|0|||
144663442|NCT01021852|521618423|FG006|Treatment Period 1|Not Treated|0|||
144663443|NCT01021852|521618424|FG007|Treatment Period 1|Not Treated|0|||
144663444|NCT01021852|521618417|FG000|Washout Period-Placebo|Adverse Event|0|||
144663445|NCT01021852|521618418|FG001|Washout Period-Placebo|Adverse Event|0|||
144663446|NCT01021852|521618419|FG002|Washout Period-Placebo|Adverse Event|0|||
144663447|NCT01021852|521618420|FG003|Washout Period-Placebo|Adverse Event|1|||
144663448|NCT01021852|521618421|FG004|Washout Period-Placebo|Adverse Event|0|||
144663449|NCT01021852|521618422|FG005|Washout Period-Placebo|Adverse Event|1|||
144663450|NCT01021852|521618423|FG006|Washout Period-Placebo|Adverse Event|0|||
144663451|NCT01021852|521618424|FG007|Washout Period-Placebo|Adverse Event|0|||
144663452|NCT01021852|521618417|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
144663453|NCT01021852|521618418|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
144663454|NCT01021852|521618419|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
144663455|NCT01021852|521618420|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
144663456|NCT01021852|521618421|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
144663457|NCT01021852|521618422|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
144663458|NCT01021852|521618423|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
144663459|NCT01021852|521618424|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
144663460|NCT01021852|521618417|FG000|Washout Period-Placebo|Protocol Violation|0|||
144663461|NCT01021852|521618418|FG001|Washout Period-Placebo|Protocol Violation|0|||
144663462|NCT01021852|521618419|FG002|Washout Period-Placebo|Protocol Violation|0|||
144663463|NCT01021852|521618420|FG003|Washout Period-Placebo|Protocol Violation|0|||
144663464|NCT01021852|521618421|FG004|Washout Period-Placebo|Protocol Violation|0|||
144663465|NCT01021852|521618422|FG005|Washout Period-Placebo|Protocol Violation|0|||
144663466|NCT01021852|521618423|FG006|Washout Period-Placebo|Protocol Violation|1|||
144663467|NCT01021852|521618424|FG007|Washout Period-Placebo|Protocol Violation|0|||
144663468|NCT01021852|521618417|FG000|Washout Period-No Drug|Adverse Event|1|||
144663469|NCT01021852|521618418|FG001|Washout Period-No Drug|Adverse Event|0|||
144663470|NCT01021852|521618419|FG002|Washout Period-No Drug|Adverse Event|0|||
144663471|NCT01021852|521618420|FG003|Washout Period-No Drug|Adverse Event|0|||
144663472|NCT01021852|521618421|FG004|Washout Period-No Drug|Adverse Event|0|||
144663473|NCT01021852|521618422|FG005|Washout Period-No Drug|Adverse Event|1|||
144663474|NCT01021852|521618423|FG006|Washout Period-No Drug|Adverse Event|0|||
144663475|NCT01021852|521618424|FG007|Washout Period-No Drug|Adverse Event|0|||
144663476|NCT01021852|521618417|FG000|Treatment Period 2|Adverse Event|0|||
144663477|NCT01021852|521618418|FG001|Treatment Period 2|Adverse Event|1|||
144663478|NCT01021852|521618419|FG002|Treatment Period 2|Adverse Event|0|||
144663479|NCT01021852|521618420|FG003|Treatment Period 2|Adverse Event|0|||
144663480|NCT01021852|521618421|FG004|Treatment Period 2|Adverse Event|1|||
144663481|NCT01021852|521618422|FG005|Treatment Period 2|Adverse Event|0|||
144663482|NCT01021852|521618423|FG006|Treatment Period 2|Adverse Event|1|||
144663483|NCT01021852|521618424|FG007|Treatment Period 2|Adverse Event|0|||
144663484|NCT01021852|521618417|FG000|Treatment Period 2|Lack of Efficacy|0|||
144663485|NCT01021852|521618418|FG001|Treatment Period 2|Lack of Efficacy|0|||
144663486|NCT01021852|521618419|FG002|Treatment Period 2|Lack of Efficacy|0|||
144663487|NCT01021852|521618420|FG003|Treatment Period 2|Lack of Efficacy|0|||
144663488|NCT01021852|521618421|FG004|Treatment Period 2|Lack of Efficacy|0|||
144663489|NCT01021852|521618422|FG005|Treatment Period 2|Lack of Efficacy|1|||
144663490|NCT01021852|521618423|FG006|Treatment Period 2|Lack of Efficacy|0|||
144663491|NCT01021852|521618424|FG007|Treatment Period 2|Lack of Efficacy|0|||
144663492|NCT01021852|521618417|FG000|Treatment Period 2|Physician Decision|0|||
144663493|NCT01021852|521618418|FG001|Treatment Period 2|Physician Decision|0|||
144663494|NCT01021852|521618419|FG002|Treatment Period 2|Physician Decision|1|||
144663495|NCT01021852|521618420|FG003|Treatment Period 2|Physician Decision|0|||
144663496|NCT01021852|521618421|FG004|Treatment Period 2|Physician Decision|0|||
144663497|NCT01021852|521618422|FG005|Treatment Period 2|Physician Decision|0|||
144663498|NCT01021852|521618423|FG006|Treatment Period 2|Physician Decision|0|||
144663499|NCT01021852|521618424|FG007|Treatment Period 2|Physician Decision|0|||
144663500|NCT01021852|521618417|FG000|Treatment Period 2|Protocol Violation|0|||
144663501|NCT01021852|521618418|FG001|Treatment Period 2|Protocol Violation|0|||
144663502|NCT01021852|521618419|FG002|Treatment Period 2|Protocol Violation|0|||
144663503|NCT01021852|521618420|FG003|Treatment Period 2|Protocol Violation|0|||
144663504|NCT01021852|521618421|FG004|Treatment Period 2|Protocol Violation|1|||
144663505|NCT01021852|521618422|FG005|Treatment Period 2|Protocol Violation|0|||
144733412|NCT00939003|521880654|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
144733413|NCT00939003|521880653|FG000|Double-blind Treatment Period|Pregnancy|0|||
144733414|NCT00939003|521880654|FG001|Double-blind Treatment Period|Pregnancy|1|||
144663506|NCT01021852|521618423|FG006|Treatment Period 2|Protocol Violation|1|||
144663507|NCT01021852|521618424|FG007|Treatment Period 2|Protocol Violation|0|||
144663508|NCT01021852|521618417|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144663509|NCT01021852|521618418|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144663510|NCT01021852|521618419|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144663511|NCT01021852|521618420|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144663512|NCT01021852|521618421|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144733415|NCT00939003|521880653|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
144663513|NCT01021852|521618422|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144733416|NCT00939003|521880654|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
144733417|NCT00939003|521880653|FG000|Open-label Treatment Period|Adverse Event|4|||
144216139|NCT01823835|519984241|FG008|Overall Study|Physician Decision|0|||
144216140|NCT01823835|519984242|FG009|Overall Study|Physician Decision|0|||
144216141|NCT01823835|519984243|FG010|Overall Study|Physician Decision|0|||
144216142|NCT01823835|519984244|FG011|Overall Study|Physician Decision|2|||
144216143|NCT01823835|519984245|FG012|Overall Study|Physician Decision|0|||
144216144|NCT01823835|519984246|FG013|Overall Study|Physician Decision|0|||
144216145|NCT01823835|519984247|FG014|Overall Study|Physician Decision|0|||
144216146|NCT01823835|519984233|FG000|Overall Study|Progressive Disease|3|||
144216147|NCT01823835|519984234|FG001|Overall Study|Progressive Disease|4|||
144216148|NCT01823835|519984235|FG002|Overall Study|Progressive Disease|3|||
144216149|NCT01823835|519984236|FG003|Overall Study|Progressive Disease|6|||
144216150|NCT01823835|519984237|FG004|Overall Study|Progressive Disease|4|||
144216151|NCT01823835|519984238|FG005|Overall Study|Progressive Disease|6|||
144216152|NCT01823835|519984239|FG006|Overall Study|Progressive Disease|5|||
144216153|NCT01823835|519984240|FG007|Overall Study|Progressive Disease|3|||
144216154|NCT01823835|519984241|FG008|Overall Study|Progressive Disease|3|||
144216155|NCT01823835|519984242|FG009|Overall Study|Progressive Disease|18|||
144216156|NCT01823835|519984243|FG010|Overall Study|Progressive Disease|8|||
144216157|NCT01823835|519984244|FG011|Overall Study|Progressive Disease|46|||
144216158|NCT01823835|519984245|FG012|Overall Study|Progressive Disease|18|||
144216159|NCT01823835|519984246|FG013|Overall Study|Progressive Disease|4|||
144216160|NCT01823835|519984247|FG014|Overall Study|Progressive Disease|6|||
144216161|NCT01823835|519984233|FG000|Overall Study|Study Termination|0|||
144216162|NCT01823835|519984234|FG001|Overall Study|Study Termination|0|||
144216163|NCT01823835|519984235|FG002|Overall Study|Study Termination|0|||
144216164|NCT01823835|519984236|FG003|Overall Study|Study Termination|0|||
144216165|NCT01823835|519984237|FG004|Overall Study|Study Termination|1|||
144216166|NCT01823835|519984238|FG005|Overall Study|Study Termination|0|||
144216167|NCT01823835|519984239|FG006|Overall Study|Study Termination|0|||
144216168|NCT01823835|519984240|FG007|Overall Study|Study Termination|0|||
144216169|NCT01823835|519984241|FG008|Overall Study|Study Termination|0|||
144216170|NCT01823835|519984242|FG009|Overall Study|Study Termination|0|||
144216171|NCT01823835|519984243|FG010|Overall Study|Study Termination|0|||
144216172|NCT01823835|519984244|FG011|Overall Study|Study Termination|1|||
144216173|NCT01823835|519984245|FG012|Overall Study|Study Termination|0|||
144216174|NCT01823835|519984246|FG013|Overall Study|Study Termination|0|||
144216175|NCT01823835|519984247|FG014|Overall Study|Study Termination|0|||
144216176|NCT01823835|519984233|FG000|Overall Study|Withdrawal by Subject|0|||
144216177|NCT01823835|519984234|FG001|Overall Study|Withdrawal by Subject|0|||
144216178|NCT01823835|519984235|FG002|Overall Study|Withdrawal by Subject|1|||
144216179|NCT01823835|519984236|FG003|Overall Study|Withdrawal by Subject|0|||
144216180|NCT01823835|519984237|FG004|Overall Study|Withdrawal by Subject|0|||
144216181|NCT01823835|519984238|FG005|Overall Study|Withdrawal by Subject|0|||
144216182|NCT01823835|519984239|FG006|Overall Study|Withdrawal by Subject|0|||
144216183|NCT01823835|519984240|FG007|Overall Study|Withdrawal by Subject|0|||
144216184|NCT01823835|519984241|FG008|Overall Study|Withdrawal by Subject|0|||
144216185|NCT01823835|519984242|FG009|Overall Study|Withdrawal by Subject|1|||
144663514|NCT01021852|521618423|FG006|Treatment Period 2|Withdrawal by Subject|1|||
144663515|NCT01021852|521618424|FG007|Treatment Period 2|Withdrawal by Subject|2|||
144663516|NCT04533815|521618427|FG000|Overall Study|Adverse Event|2|||
144663517|NCT04533815|521618427|FG000|Overall Study|Site withdrew|5|||
144663518|NCT04167306|521618428|FG000|Overall Study|Lost to Follow-up|2|||
144663519|NCT04167306|521618429|FG001|Overall Study|Lost to Follow-up|2|||
144663520|NCT04167306|521618430|FG002|Overall Study|Lost to Follow-up|5|||
144663521|NCT04167306|521618431|FG003|Overall Study|Lost to Follow-up|5|||
144663522|NCT04167306|521618428|FG000|Overall Study|Adverse Event|13|||
144663523|NCT04167306|521618429|FG001|Overall Study|Adverse Event|14|||
144663524|NCT04167306|521618430|FG002|Overall Study|Adverse Event|5|||
144663525|NCT04167306|521618431|FG003|Overall Study|Adverse Event|4|||
144663526|NCT04167306|521618428|FG000|Overall Study|Withdrawal by Subject|4|||
144663527|NCT04167306|521618429|FG001|Overall Study|Withdrawal by Subject|6|||
144663528|NCT04167306|521618430|FG002|Overall Study|Withdrawal by Subject|8|||
144663529|NCT04167306|521618431|FG003|Overall Study|Withdrawal by Subject|3|||
144216186|NCT01823835|519984243|FG010|Overall Study|Withdrawal by Subject|1|||
144216187|NCT01823835|519984244|FG011|Overall Study|Withdrawal by Subject|2|||
144216188|NCT01823835|519984245|FG012|Overall Study|Withdrawal by Subject|1|||
144216189|NCT01823835|519984246|FG013|Overall Study|Withdrawal by Subject|0|||
144216190|NCT01823835|519984247|FG014|Overall Study|Withdrawal by Subject|0|||
144216191|NCT01320150|519984248|FG000|Overall Study|Protocol Violation|15|||
144216192|NCT01320150|519984248|FG000|Overall Study|Withdrawal by Subject|5|||
144216193|NCT01320150|519984248|FG000|Overall Study|Death|2|||
144216194|NCT01320150|519984248|FG000|Overall Study|Lost to Follow-up|44|||
144663530|NCT04167306|521618428|FG000|Overall Study|covid|1|||
144663531|NCT04167306|521618429|FG001|Overall Study|covid|1|||
144216195|NCT00985491|519984249|FG000|Overall Study|Adverse Event|8|||
144216196|NCT00985491|519984249|FG000|Overall Study|device migration|7|||
144216197|NCT00985491|519984249|FG000|Overall Study|Withdrawal by Subject|1|||
144216198|NCT00985491|519984249|FG000|Overall Study|implant failure|3|||
144216199|NCT00489827|519984255|FG000|Overall Study|Intraoperative exclusion criteria|1|||
144663532|NCT04167306|521618430|FG002|Overall Study|covid|2|||
144663533|NCT04167306|521618431|FG003|Overall Study|covid|1|||
144663534|NCT04167306|521618428|FG000|Overall Study|concomitant medication|0|||
144663535|NCT04167306|521618429|FG001|Overall Study|concomitant medication|0|||
144663536|NCT04167306|521618430|FG002|Overall Study|concomitant medication|0|||
144663537|NCT04167306|521618431|FG003|Overall Study|concomitant medication|1|||
144663538|NCT04167306|521618428|FG000|Overall Study|Alcohol treatment|0|||
144663539|NCT04167306|521618429|FG001|Overall Study|Alcohol treatment|4|||
144663540|NCT04167306|521618430|FG002|Overall Study|Alcohol treatment|3|||
144663541|NCT04167306|521618431|FG003|Overall Study|Alcohol treatment|2|||
144663542|NCT04167306|521618428|FG000|Overall Study|non-compliance|0|||
144663543|NCT04167306|521618429|FG001|Overall Study|non-compliance|0|||
144663544|NCT04167306|521618430|FG002|Overall Study|non-compliance|1|||
144663545|NCT04167306|521618431|FG003|Overall Study|non-compliance|0|||
144663546|NCT04167306|521618428|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
144663547|NCT04167306|521618429|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
144663548|NCT04167306|521618430|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
144663549|NCT04167306|521618431|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
144663550|NCT04146467|521618437|FG000|Overall Study|Adverse Event|0|||
144663551|NCT04146467|521618438|FG001|Overall Study|Adverse Event|1|||
144663552|NCT04146467|521618437|FG000|Overall Study|Lost to Follow-up|0|||
144663553|NCT04146467|521618438|FG001|Overall Study|Lost to Follow-up|2|||
144663554|NCT03731364|521618441|FG000|Overall Study|Adverse Event|0|||
144663555|NCT03731364|521618442|FG001|Overall Study|Adverse Event|0|||
144663556|NCT03731364|521618443|FG002|Overall Study|Adverse Event|1|||
144663557|NCT03731364|521618444|FG003|Overall Study|Adverse Event|2|||
144663558|NCT03731364|521618445|FG004|Overall Study|Adverse Event|1|||
144663559|NCT01189435|521618446|FG000|Overall Study|Withdrawal by Subject|1|||
144663560|NCT01189435|521618446|FG000|Overall Study|Physician Decision|1|||
144663561|NCT01253421|521618447|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
144663562|NCT01253421|521618448|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
144663563|NCT01253421|521618449|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
144663564|NCT01253421|521618450|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
144663565|NCT01253421|521618451|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
144663566|NCT01253421|521618447|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
144663567|NCT01253421|521618448|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
144663568|NCT01253421|521618449|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
144663569|NCT01253421|521618450|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
144663570|NCT01253421|521618451|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
144663571|NCT01253421|521618447|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
144663572|NCT01253421|521618448|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
144663573|NCT01253421|521618449|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
144663574|NCT01253421|521618450|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
144663575|NCT01253421|521618451|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
144663576|NCT01253421|521618447|FG000|Assessment and Scheduling|Physician Decision|1|||
144663577|NCT01253421|521618448|FG001|Assessment and Scheduling|Physician Decision|0|||
144663578|NCT01253421|521618449|FG002|Assessment and Scheduling|Physician Decision|0|||
144663579|NCT01253421|521618450|FG003|Assessment and Scheduling|Physician Decision|0|||
144663580|NCT01253421|521618451|FG004|Assessment and Scheduling|Physician Decision|0|||
144663581|NCT01253421|521618447|FG000|Drug+Scanning Visit|Physician Decision|0|||
144216200|NCT00489827|519984256|FG001|Overall Study|Intraoperative exclusion criteria|1|||
144216201|NCT00489827|519984255|FG000|Overall Study|Intraoperative exclusion criteria|1|||
144216202|NCT00489827|519984256|FG001|Overall Study|Intraoperative exclusion criteria|1|||
144216203|NCT03086551|519984261|FG000|First Intervention|Failure to meet inclusion criterion|1|||
144216204|NCT03086551|519984262|FG001|First Intervention|Failure to meet inclusion criterion|0|||
144663582|NCT01253421|521618448|FG001|Drug+Scanning Visit|Physician Decision|0|||
144663583|NCT01253421|521618449|FG002|Drug+Scanning Visit|Physician Decision|0|||
144663584|NCT01253421|521618450|FG003|Drug+Scanning Visit|Physician Decision|0|||
144663585|NCT01253421|521618451|FG004|Drug+Scanning Visit|Physician Decision|1|||
144663586|NCT00547378|521618452|FG000|Randomized Cohort|Withdrawal by Subject|7|||
144663587|NCT00547378|521618453|FG001|Randomized Cohort|Withdrawal by Subject|5|||
144663588|NCT00547378|521618454|FG002|Randomized Cohort|Withdrawal by Subject|0|||
144663589|NCT00547378|521618452|FG000|Randomized Cohort|Death|0|||
144663590|NCT00547378|521618453|FG001|Randomized Cohort|Death|1|||
144663591|NCT00547378|521618454|FG002|Randomized Cohort|Death|0|||
144663592|NCT00547378|521618452|FG000|Randomized Cohort|Lost to Follow-up|1|||
144663593|NCT00547378|521618453|FG001|Randomized Cohort|Lost to Follow-up|0|||
144663594|NCT00547378|521618454|FG002|Randomized Cohort|Lost to Follow-up|0|||
144663595|NCT00547378|521618452|FG000|Randomized Cohort|Adverse Event|1|||
144663596|NCT00547378|521618453|FG001|Randomized Cohort|Adverse Event|0|||
144663597|NCT00547378|521618454|FG002|Randomized Cohort|Adverse Event|0|||
144733418|NCT00939003|521880654|FG001|Open-label Treatment Period|Adverse Event|8|||
144663598|NCT00547378|521618452|FG000|Randomized Cohort|Other reasons|2|||
144663599|NCT00547378|521618453|FG001|Randomized Cohort|Other reasons|0|||
144663600|NCT00547378|521618454|FG002|Randomized Cohort|Other reasons|0|||
144663601|NCT00547378|521618452|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
144663602|NCT00547378|521618453|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
144663603|NCT00547378|521618454|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
144663604|NCT00547378|521618452|FG000|All Implanted Cohort|Adverse Event|4|||
144663605|NCT00547378|521618453|FG001|All Implanted Cohort|Adverse Event|10|||
144663606|NCT00547378|521618454|FG002|All Implanted Cohort|Adverse Event|17|||
144663607|NCT00547378|521618452|FG000|All Implanted Cohort|Lost to Follow-up|0|||
144216205|NCT03086551|519984261|FG000|First Intervention|Lost to Follow-up|0|||
144216206|NCT03086551|519984262|FG001|First Intervention|Lost to Follow-up|1|||
144216207|NCT03086551|519984261|FG000|Washout|Lost to Follow-up|1|||
144216208|NCT03086551|519984262|FG001|Washout|Lost to Follow-up|2|||
144216209|NCT03086551|519984261|FG000|Washout|Withdrawal by Subject|2|||
144216210|NCT03086551|519984262|FG001|Washout|Withdrawal by Subject|1|||
144216211|NCT01260701|519984263|FG000|Overall Study|Adverse Event|9|||
144216212|NCT01260701|519984263|FG000|Overall Study|Withdrawal by Subject|2|||
144216213|NCT01260701|519984263|FG000|Overall Study|Progression|53|||
144216214|NCT01260701|519984263|FG000|Overall Study|Death|2|||
144216215|NCT01260701|519984263|FG000|Overall Study|Not protocol specified|3|||
144216216|NCT01260701|519984263|FG000|Overall Study|Under review|1|||
144216217|NCT01260701|519984263|FG000|Overall Study|Ineligible|4|||
144216218|NCT01260701|519984263|FG000|Overall Study|Did not begin protocol therapy|1|||
144216219|NCT01290302|519985946|FG000|Overall Study|Adverse Event|2|||
144216220|NCT01290302|519985947|FG001|Overall Study|Adverse Event|0|||
144216221|NCT01290302|519985946|FG000|Overall Study|Withdrawal by Subject|1|||
144216222|NCT01290302|519985947|FG001|Overall Study|Withdrawal by Subject|0|||
144216223|NCT01290302|519985946|FG000|Overall Study|Physician Decision|0|||
144216224|NCT01290302|519985947|FG001|Overall Study|Physician Decision|2|||
144216225|NCT01290302|519985946|FG000|Overall Study|Expiration of time for screening window|1|||
144216226|NCT01290302|519985947|FG001|Overall Study|Expiration of time for screening window|0|||
144216227|NCT06419907|519985951|FG000|Overall Study|Protocol Violation|0|||
144216228|NCT06419907|519985952|FG001|Overall Study|Protocol Violation|3|||
144216229|NCT06419907|519985953|FG002|Overall Study|Protocol Violation|0|||
144216230|NCT06419907|519985954|FG003|Overall Study|Protocol Violation|1|||
144216231|NCT06419907|519985951|FG000|Overall Study|Lost to Follow-up|0|||
144216232|NCT06419907|519985952|FG001|Overall Study|Lost to Follow-up|0|||
144216233|NCT06419907|519985953|FG002|Overall Study|Lost to Follow-up|2|||
144216234|NCT06419907|519985954|FG003|Overall Study|Lost to Follow-up|1|||
144216235|NCT02586688|519985956|FG000|Overall Study|Lost to Follow-up|2|||
144216236|NCT02586688|519985957|FG001|Overall Study|Lost to Follow-up|1|||
144216237|NCT02586688|519985956|FG000|Overall Study|Withdrawal by Subject|1|||
144216238|NCT02586688|519985957|FG001|Overall Study|Withdrawal by Subject|1|||
144216239|NCT02586688|519985956|FG000|Overall Study|Adverse Event|3|||
144216240|NCT02586688|519985957|FG001|Overall Study|Adverse Event|1|||
144216241|NCT04856917|519985958|FG000|Overall Study|Withdrawal by Subject|4|||
144216242|NCT04856917|519985959|FG001|Overall Study|Withdrawal by Subject|3|||
144216243|NCT04856917|519985960|FG002|Overall Study|Withdrawal by Subject|1|||
144216244|NCT04856917|519985958|FG000|Overall Study|Lost to Follow-up|3|||
144216245|NCT04856917|519985959|FG001|Overall Study|Lost to Follow-up|1|||
144216246|NCT04856917|519985960|FG002|Overall Study|Lost to Follow-up|1|||
144216247|NCT04856917|519985958|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
144216248|NCT04856917|519985959|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
144216249|NCT04856917|519985960|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
144216250|NCT04856917|519985958|FG000|Overall Study|Other|1|||
144216251|NCT04856917|519985959|FG001|Overall Study|Other|1|||
144216252|NCT04856917|519985960|FG002|Overall Study|Other|0|||
144216253|NCT03560037|519985961|FG000|Overall Study|Protocol Violation|1|||
144216254|NCT03560037|519985962|FG001|Overall Study|Protocol Violation|0|||
144216255|NCT03560037|519985961|FG000|Overall Study|Physician Decision|0|||
144663608|NCT00547378|521618453|FG001|All Implanted Cohort|Lost to Follow-up|1|||
144733419|NCT00939003|521880653|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
144733420|NCT00939003|521880654|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
144663609|NCT00547378|521618454|FG002|All Implanted Cohort|Lost to Follow-up|14|||
144663610|NCT00547378|521618452|FG000|All Implanted Cohort|Death|3|||
144216256|NCT03560037|519985962|FG001|Overall Study|Physician Decision|1|||
144216257|NCT03620708|519985963|FG000|Overall Study|Lost to Follow-up|1|||
144216258|NCT03620708|519985964|FG001|Overall Study|Lost to Follow-up|1|||
144216259|NCT03620708|519985965|FG002|Overall Study|Lost to Follow-up|2|||
144216260|NCT03620708|519985963|FG000|Overall Study|Withdrawal by Subject|0|||
144216261|NCT03620708|519985964|FG001|Overall Study|Withdrawal by Subject|0|||
144216262|NCT03620708|519985965|FG002|Overall Study|Withdrawal by Subject|1|||
144216263|NCT06195930|519985968|FG000|Overall Study|Adverse Event|4|||
144216264|NCT03631199|519985969|FG000|Overall Study|Progressive disease|9|||
144216265|NCT03631199|519985970|FG001|Overall Study|Progressive disease|5|||
144216266|NCT03631199|519985971|FG002|Overall Study|Progressive disease|5|||
144216267|NCT03631199|519985972|FG003|Overall Study|Progressive disease|149|||
144216268|NCT03631199|519985973|FG004|Overall Study|Progressive disease|148|||
144216269|NCT03631199|519985969|FG000|Overall Study|Physician Decision|0|||
144216270|NCT03631199|519985970|FG001|Overall Study|Physician Decision|2|||
144216271|NCT03631199|519985971|FG002|Overall Study|Physician Decision|3|||
144216272|NCT03631199|519985972|FG003|Overall Study|Physician Decision|19|||
144663611|NCT00547378|521618453|FG001|All Implanted Cohort|Death|1|||
144663612|NCT00547378|521618454|FG002|All Implanted Cohort|Death|4|||
144663613|NCT00547378|521618452|FG000|All Implanted Cohort|Physician Decision|0|||
144663614|NCT00547378|521618453|FG001|All Implanted Cohort|Physician Decision|2|||
144663615|NCT00547378|521618454|FG002|All Implanted Cohort|Physician Decision|6|||
144663616|NCT00547378|521618452|FG000|All Implanted Cohort|Site closure|2|||
144663617|NCT00547378|521618453|FG001|All Implanted Cohort|Site closure|0|||
144663618|NCT00547378|521618454|FG002|All Implanted Cohort|Site closure|1|||
144663619|NCT00547378|521618452|FG000|All Implanted Cohort|Other reasons|1|||
144663620|NCT00547378|521618453|FG001|All Implanted Cohort|Other reasons|0|||
144663621|NCT00547378|521618454|FG002|All Implanted Cohort|Other reasons|1|||
144663622|NCT00012012|521618462|FG000|Overall Study|Protocol Violation|1|||
144663623|NCT00012012|521618463|FG001|Overall Study|Protocol Violation|1|||
144663624|NCT00012012|521618462|FG000|Overall Study|Withdrawal by Subject|0|||
144663625|NCT00012012|521618463|FG001|Overall Study|Withdrawal by Subject|2|||
144663626|NCT02034474|521618464|FG000|Overall Study|Adverse Event|3|||
144663627|NCT02034474|521618465|FG001|Overall Study|Adverse Event|2|||
144663628|NCT02034474|521618464|FG000|Overall Study|Withdrawal by Subject|1|||
144663629|NCT02034474|521618465|FG001|Overall Study|Withdrawal by Subject|2|||
144663630|NCT01391819|521618466|FG000|Overall Study|Withdrawal by Subject|56|||
144663631|NCT01391819|521618466|FG000|Overall Study|Migrated/moved from study area|82|||
144663632|NCT01391819|521618466|FG000|Overall Study|Lost to Follow-up|252|||
144663633|NCT01391819|521618466|FG000|Overall Study|Death|3|||
144663634|NCT01391819|521618466|FG000|Overall Study|Other|9|||
144663635|NCT01927419|521618467|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144663636|NCT01927419|521618468|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
144663637|NCT01927419|521618467|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
144663638|NCT01927419|521618468|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
144663639|NCT01927419|521618467|FG000|Treatment Period|Disease progression|17|||
144663640|NCT01927419|521618468|FG001|Treatment Period|Disease progression|20|||
144663641|NCT01927419|521618467|FG000|Treatment Period|Study drug toxicity|48|||
144663642|NCT01927419|521618468|FG001|Treatment Period|Study drug toxicity|10|||
144663643|NCT01927419|521618467|FG000|Treatment Period|Death|0|||
144663644|NCT01927419|521618468|FG001|Treatment Period|Death|1|||
144663645|NCT01927419|521618467|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
144663646|NCT01927419|521618468|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
144663647|NCT01927419|521618467|FG000|Treatment Period|Participant request to discontinue|12|||
144663648|NCT01927419|521618468|FG001|Treatment Period|Participant request to discontinue|4|||
144663649|NCT01927419|521618467|FG000|Treatment Period|Withdrawal by Subject|1|||
144663650|NCT01927419|521618468|FG001|Treatment Period|Withdrawal by Subject|1|||
144663651|NCT01927419|521618467|FG000|Treatment Period|Maximum Clinical Benefit|6|||
144663652|NCT01927419|521618468|FG001|Treatment Period|Maximum Clinical Benefit|2|||
144663653|NCT01927419|521618467|FG000|Treatment Period|Other reasons|3|||
144663654|NCT01927419|521618468|FG001|Treatment Period|Other reasons|4|||
144663655|NCT01927419|521618467|FG000|Treatment Period|Not Reported|1|||
144663656|NCT01927419|521618468|FG001|Treatment Period|Not Reported|1|||
144663657|NCT00995670|521618469|FG000|Overall Study|Failed arterial cannulation|1|||
144663658|NCT00995670|521618470|FG001|Overall Study|Failed arterial cannulation|0|||
144663659|NCT00995670|521618471|FG002|Overall Study|Failed arterial cannulation|3|||
144663660|NCT02164513|521618472|FG000|Overall Study|Adverse Event|162|||
144663661|NCT02164513|521618473|FG001|Overall Study|Adverse Event|180|||
144663662|NCT02164513|521618474|FG002|Overall Study|Adverse Event|111|||
144663663|NCT02164513|521618472|FG000|Overall Study|Other: Study Closed or terminated|5|||
144663664|NCT02164513|521618473|FG001|Overall Study|Other: Study Closed or terminated|2|||
144663665|NCT02164513|521618474|FG002|Overall Study|Other: Study Closed or terminated|4|||
144663666|NCT02164513|521618472|FG000|Overall Study|Lost to Follow-up|30|||
144663667|NCT02164513|521618473|FG001|Overall Study|Lost to Follow-up|36|||
144216273|NCT03631199|519985973|FG004|Overall Study|Physician Decision|13|||
144216274|NCT03631199|519985969|FG000|Overall Study|Adverse Event|1|||
144216275|NCT03631199|519985970|FG001|Overall Study|Adverse Event|1|||
144216276|NCT03631199|519985971|FG002|Overall Study|Adverse Event|0|||
144216277|NCT03631199|519985972|FG003|Overall Study|Adverse Event|28|||
144663668|NCT02164513|521618474|FG002|Overall Study|Lost to Follow-up|22|||
144663669|NCT02164513|521618472|FG000|Overall Study|Physician Decision|47|||
144663670|NCT02164513|521618473|FG001|Overall Study|Physician Decision|57|||
144663671|NCT02164513|521618474|FG002|Overall Study|Physician Decision|28|||
144663672|NCT02164513|521618472|FG000|Overall Study|Withdrawal by Subject|192|||
144663673|NCT02164513|521618473|FG001|Overall Study|Withdrawal by Subject|261|||
144663674|NCT02164513|521618474|FG002|Overall Study|Withdrawal by Subject|130|||
144663675|NCT02164513|521618472|FG000|Overall Study|Other: Reason not provided by site|1|||
144663676|NCT02164513|521618473|FG001|Overall Study|Other: Reason not provided by site|0|||
144663677|NCT02164513|521618474|FG002|Overall Study|Other: Reason not provided by site|0|||
144663678|NCT02773238|521618476|FG000|Overall Study|Lack of Efficacy|4|||
144216278|NCT03631199|519985973|FG004|Overall Study|Adverse Event|29|||
144663679|NCT02509494|521618477|FG000|Overall Study|Lost to Follow-up|8|||
144663680|NCT02509494|521618478|FG001|Overall Study|Lost to Follow-up|47|||
144663681|NCT02509494|521618479|FG002|Overall Study|Lost to Follow-up|19|||
144663682|NCT02509494|521618480|FG003|Overall Study|Lost to Follow-up|6|||
144663683|NCT02509494|521618481|FG004|Overall Study|Lost to Follow-up|3|||
144663684|NCT02509494|521618482|FG005|Overall Study|Lost to Follow-up|3|||
144663685|NCT02509494|521618483|FG006|Overall Study|Lost to Follow-up|1|||
144663686|NCT02509494|521618484|FG007|Overall Study|Lost to Follow-up|3|||
144663687|NCT02509494|521618485|FG008|Overall Study|Lost to Follow-up|1|||
144663688|NCT02509494|521618477|FG000|Overall Study|Physician Decision|2|||
144663689|NCT02509494|521618478|FG001|Overall Study|Physician Decision|1|||
144663690|NCT02509494|521618479|FG002|Overall Study|Physician Decision|0|||
144663691|NCT02509494|521618480|FG003|Overall Study|Physician Decision|0|||
144663692|NCT02509494|521618481|FG004|Overall Study|Physician Decision|0|||
144663693|NCT02509494|521618482|FG005|Overall Study|Physician Decision|0|||
144663694|NCT02509494|521618483|FG006|Overall Study|Physician Decision|0|||
144663695|NCT02509494|521618484|FG007|Overall Study|Physician Decision|0|||
144663696|NCT02509494|521618485|FG008|Overall Study|Physician Decision|0|||
144663697|NCT02509494|521618477|FG000|Overall Study|Withdrawal by Subject|4|||
144663698|NCT02509494|521618478|FG001|Overall Study|Withdrawal by Subject|17|||
144663699|NCT02509494|521618479|FG002|Overall Study|Withdrawal by Subject|7|||
144663700|NCT02509494|521618480|FG003|Overall Study|Withdrawal by Subject|5|||
144663701|NCT02509494|521618481|FG004|Overall Study|Withdrawal by Subject|0|||
144663702|NCT02509494|521618482|FG005|Overall Study|Withdrawal by Subject|6|||
144663703|NCT02509494|521618483|FG006|Overall Study|Withdrawal by Subject|1|||
144663704|NCT02509494|521618484|FG007|Overall Study|Withdrawal by Subject|2|||
144663705|NCT02509494|521618485|FG008|Overall Study|Withdrawal by Subject|1|||
144663706|NCT02509494|521618477|FG000|Overall Study|Death|0|||
144663707|NCT02509494|521618478|FG001|Overall Study|Death|1|||
144663708|NCT02509494|521618479|FG002|Overall Study|Death|0|||
144663709|NCT02509494|521618480|FG003|Overall Study|Death|0|||
144663710|NCT02509494|521618481|FG004|Overall Study|Death|1|||
144663711|NCT02509494|521618482|FG005|Overall Study|Death|0|||
144663712|NCT02509494|521618483|FG006|Overall Study|Death|0|||
144663713|NCT02509494|521618484|FG007|Overall Study|Death|1|||
144663714|NCT02509494|521618485|FG008|Overall Study|Death|0|||
144663715|NCT02509494|521618477|FG000|Overall Study|Other|0|||
144663716|NCT02509494|521618478|FG001|Overall Study|Other|4|||
144663717|NCT02509494|521618479|FG002|Overall Study|Other|5|||
144663718|NCT02509494|521618480|FG003|Overall Study|Other|0|||
144663719|NCT02509494|521618481|FG004|Overall Study|Other|0|||
144663720|NCT02509494|521618482|FG005|Overall Study|Other|0|||
144663721|NCT02509494|521618483|FG006|Overall Study|Other|0|||
144663722|NCT02509494|521618484|FG007|Overall Study|Other|0|||
144663723|NCT02509494|521618485|FG008|Overall Study|Other|0|||
144663724|NCT02509494|521618477|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144663725|NCT02509494|521618478|FG001|Overall Study|Non-Compliance With Study Drug|11|||
144663726|NCT02509494|521618479|FG002|Overall Study|Non-Compliance With Study Drug|7|||
144663727|NCT02509494|521618480|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144663728|NCT02509494|521618481|FG004|Overall Study|Non-Compliance With Study Drug|1|||
144663729|NCT02509494|521618482|FG005|Overall Study|Non-Compliance With Study Drug|2|||
144663730|NCT02509494|521618483|FG006|Overall Study|Non-Compliance With Study Drug|1|||
144663731|NCT02509494|521618484|FG007|Overall Study|Non-Compliance With Study Drug|1|||
144663732|NCT02509494|521618485|FG008|Overall Study|Non-Compliance With Study Drug|0|||
144733421|NCT00939003|521880653|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
144663733|NCT04752189|521618486|FG000|Overall Study|Withdrawal by Subject|0|||
144733422|NCT00939003|521880654|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
144733423|NCT00939003|521880653|FG000|Open-label Treatment Period|Pregnancy|1|||
144733424|NCT00939003|521880654|FG001|Open-label Treatment Period|Pregnancy|1|||
144733425|NCT00939003|521880653|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
144733426|NCT00939003|521880654|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
144733427|NCT00939003|521880653|FG000|Open-label Treatment Period|Site Closure|3|||
144663734|NCT04752189|521618487|FG001|Overall Study|Withdrawal by Subject|150|||
144663735|NCT04752189|521618486|FG000|Overall Study|Lost to Follow-up|261|||
144663736|NCT04752189|521618487|FG001|Overall Study|Lost to Follow-up|126|||
144663737|NCT00975195|521618488|FG000|Overall Study|Adverse Event|108|||
144663738|NCT00975195|521618489|FG001|Overall Study|Adverse Event|101|||
144663739|NCT00975195|521618488|FG000|Overall Study|Lack of Efficacy|6|||
144663740|NCT00975195|521618489|FG001|Overall Study|Lack of Efficacy|6|||
144663741|NCT00975195|521618488|FG000|Overall Study|Protocol Violation|27|||
144663742|NCT00975195|521618489|FG001|Overall Study|Protocol Violation|23|||
144663743|NCT00975195|521618488|FG000|Overall Study|Lost to Follow-up|9|||
144663744|NCT00975195|521618489|FG001|Overall Study|Lost to Follow-up|7|||
144663745|NCT00975195|521618488|FG000|Overall Study|Withdrawal by Subject|48|||
144663746|NCT00975195|521618489|FG001|Overall Study|Withdrawal by Subject|61|||
144663747|NCT00975195|521618488|FG000|Overall Study|Other reason not defined above|29|||
144663748|NCT00975195|521618489|FG001|Overall Study|Other reason not defined above|33|||
144663749|NCT00975195|521618488|FG000|Overall Study|Not treated|1|||
144663750|NCT00975195|521618489|FG001|Overall Study|Not treated|2|||
144663751|NCT03422133|521618490|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
144663752|NCT03422133|521618491|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
144663753|NCT03003403|521618492|FG000|Overall Study|Ineligible|8|||
144663754|NCT03003403|521618493|FG001|Overall Study|Ineligible|7|||
144663755|NCT03003403|521618492|FG000|Overall Study|Withdrawal by Subject|3|||
144663756|NCT03003403|521618493|FG001|Overall Study|Withdrawal by Subject|1|||
144663757|NCT02198651|521620320|FG000|Lead-in Period|Withdrew consent|13|||
144663758|NCT02198651|521620321|FG001|Lead-in Period|Withdrew consent|0|||
144663759|NCT02198651|521620322|FG002|Lead-in Period|Withdrew consent|0|||
144663760|NCT02198651|521620323|FG003|Lead-in Period|Withdrew consent|0|||
144663761|NCT02198651|521620324|FG004|Lead-in Period|Withdrew consent|0|||
144663762|NCT02198651|521620320|FG000|Lead-in Period|Adverse Event|2|||
144663763|NCT02198651|521620321|FG001|Lead-in Period|Adverse Event|0|||
144663764|NCT02198651|521620322|FG002|Lead-in Period|Adverse Event|0|||
144663765|NCT02198651|521620323|FG003|Lead-in Period|Adverse Event|0|||
144663766|NCT02198651|521620324|FG004|Lead-in Period|Adverse Event|0|||
144663767|NCT02198651|521620320|FG000|Lead-in Period|Other, not specified|22|||
144663768|NCT02198651|521620321|FG001|Lead-in Period|Other, not specified|0|||
144663769|NCT02198651|521620322|FG002|Lead-in Period|Other, not specified|0|||
144663770|NCT02198651|521620323|FG003|Lead-in Period|Other, not specified|0|||
144663771|NCT02198651|521620324|FG004|Lead-in Period|Other, not specified|0|||
144663772|NCT02198651|521620320|FG000|Double-blind Period|Withdrew consent|0|||
144663773|NCT02198651|521620321|FG001|Double-blind Period|Withdrew consent|4|||
144663774|NCT02198651|521620322|FG002|Double-blind Period|Withdrew consent|0|||
144663775|NCT02198651|521620323|FG003|Double-blind Period|Withdrew consent|0|||
144663776|NCT02198651|521620324|FG004|Double-blind Period|Withdrew consent|0|||
144663777|NCT02198651|521620320|FG000|Double-blind Period|Adverse Event|0|||
144663778|NCT02198651|521620321|FG001|Double-blind Period|Adverse Event|1|||
144663779|NCT02198651|521620322|FG002|Double-blind Period|Adverse Event|0|||
144663780|NCT02198651|521620323|FG003|Double-blind Period|Adverse Event|0|||
144663781|NCT02198651|521620324|FG004|Double-blind Period|Adverse Event|0|||
144663782|NCT02198651|521620320|FG000|Double-blind Period|Other, not specified|0|||
144663783|NCT02198651|521620321|FG001|Double-blind Period|Other, not specified|4|||
144663784|NCT02198651|521620322|FG002|Double-blind Period|Other, not specified|1|||
144663785|NCT02198651|521620323|FG003|Double-blind Period|Other, not specified|0|||
144663786|NCT02198651|521620324|FG004|Double-blind Period|Other, not specified|0|||
144663787|NCT02198651|521620320|FG000|Open-label Rescue Period|Withdrew consent|0|||
144663788|NCT02198651|521620321|FG001|Open-label Rescue Period|Withdrew consent|0|||
144663789|NCT02198651|521620322|FG002|Open-label Rescue Period|Withdrew consent|0|||
144663790|NCT02198651|521620323|FG003|Open-label Rescue Period|Withdrew consent|2|||
144663791|NCT02198651|521620324|FG004|Open-label Rescue Period|Withdrew consent|0|||
144663792|NCT02198651|521620320|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
144663793|NCT02198651|521620321|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
144663794|NCT02198651|521620322|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
144663795|NCT02198651|521620323|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
144663796|NCT02198651|521620324|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
144663797|NCT01175213|521620325|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
144663798|NCT01175213|521620326|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
144663799|NCT01175213|521620325|FG000|IGSC, 10%/rHuPH20|Death|1|||
144663800|NCT01175213|521620326|FG001|IGSC, 10%/rHuPH20|Death|0|||
144663801|NCT01175213|521620325|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
144663802|NCT01175213|521620326|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
144663803|NCT01175213|521620325|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
144663804|NCT01175213|521620326|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
144663805|NCT01175213|521620325|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
144663806|NCT01175213|521620326|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
144663807|NCT01175213|521620325|FG000|Safety Follow-up|Adverse Event|1|||
144663808|NCT01175213|521620326|FG001|Safety Follow-up|Adverse Event|0|||
144663809|NCT03057951|521620328|FG000|Overall Study|Adverse Event|553|||
144663810|NCT03057951|521620329|FG001|Overall Study|Adverse Event|575|||
144663811|NCT03057951|521620328|FG000|Overall Study|Protocol Violation|30|||
144663812|NCT03057951|521620329|FG001|Overall Study|Protocol Violation|24|||
144663813|NCT03057951|521620328|FG000|Overall Study|Lost to Follow-up|6|||
144663814|NCT03057951|521620329|FG001|Overall Study|Lost to Follow-up|16|||
144663815|NCT03057951|521620328|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
144663816|NCT03057951|521620329|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
144663817|NCT03057951|521620328|FG000|Overall Study|Study drug stopped, reason missing|6|||
144663818|NCT03057951|521620329|FG001|Overall Study|Study drug stopped, reason missing|1|||
144663819|NCT03057951|521620328|FG000|Overall Study|Medical advice|6|||
144663820|NCT03057951|521620329|FG001|Overall Study|Medical advice|2|||
144663821|NCT03057951|521620328|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
144663822|NCT03057951|521620329|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
144663823|NCT03057951|521620328|FG000|Overall Study|Investigator decision|2|||
144663824|NCT03057951|521620329|FG001|Overall Study|Investigator decision|0|||
144663825|NCT03057951|521620328|FG000|Overall Study|Patient decision|5|||
144216279|NCT03631199|519985969|FG000|Overall Study|Death|0|||
144216280|NCT03631199|519985970|FG001|Overall Study|Death|1|||
144216281|NCT03631199|519985971|FG002|Overall Study|Death|0|||
144216282|NCT03631199|519985972|FG003|Overall Study|Death|35|||
144216283|NCT03631199|519985973|FG004|Overall Study|Death|48|||
144216284|NCT03631199|519985969|FG000|Overall Study|Subject decision|0|||
144216285|NCT03631199|519985970|FG001|Overall Study|Subject decision|1|||
144216286|NCT03631199|519985971|FG002|Overall Study|Subject decision|0|||
144216287|NCT03631199|519985972|FG003|Overall Study|Subject decision|12|||
144216288|NCT03631199|519985973|FG004|Overall Study|Subject decision|12|||
144216289|NCT03631199|519985969|FG000|Overall Study|No treated|0|||
144216290|NCT03631199|519985970|FG001|Overall Study|No treated|0|||
144216291|NCT03631199|519985971|FG002|Overall Study|No treated|0|||
144663826|NCT03057951|521620329|FG001|Overall Study|Patient decision|2|||
144663827|NCT03057951|521620328|FG000|Overall Study|Not attending study visits|3|||
144663828|NCT03057951|521620329|FG001|Overall Study|Not attending study visits|0|||
144663829|NCT03057951|521620328|FG000|Overall Study|Patient moved away|3|||
144663830|NCT03057951|521620329|FG001|Overall Study|Patient moved away|4|||
144663831|NCT03057951|521620328|FG000|Overall Study|Other reason than stated above|23|||
144663832|NCT03057951|521620329|FG001|Overall Study|Other reason than stated above|29|||
144663833|NCT03057951|521620328|FG000|Overall Study|Not treated|2|||
144663834|NCT03057951|521620329|FG001|Overall Study|Not treated|1|||
144663835|NCT02108600|521620334|FG000|Overall Study|Withdrawal by Subject|2|||
144663836|NCT02108600|521620335|FG001|Overall Study|Withdrawal by Subject|0|||
144663837|NCT02108600|521620334|FG000|Overall Study|Lost to Follow-up|1|||
144663838|NCT02108600|521620335|FG001|Overall Study|Lost to Follow-up|1|||
144663839|NCT01295580|521620336|FG000|Overall Study|Protocol Violation|4|||
144663840|NCT01295580|521620337|FG001|Overall Study|Protocol Violation|2|||
144663841|NCT01295580|521620336|FG000|Overall Study|Withdrawal by Subject|1|||
144663842|NCT01295580|521620337|FG001|Overall Study|Withdrawal by Subject|4|||
144663843|NCT01295580|521620336|FG000|Overall Study|Adverse Event|2|||
144663844|NCT01295580|521620337|FG001|Overall Study|Adverse Event|1|||
144663845|NCT01295580|521620336|FG000|Overall Study|Lost to Follow-up|1|||
144663846|NCT01295580|521620337|FG001|Overall Study|Lost to Follow-up|0|||
144663847|NCT01295580|521620336|FG000|Overall Study|Lack of Efficacy|1|||
144663848|NCT01295580|521620337|FG001|Overall Study|Lack of Efficacy|0|||
144663849|NCT01295580|521620336|FG000|Overall Study|Other: inconvenience|1|||
144663850|NCT01295580|521620337|FG001|Overall Study|Other: inconvenience|0|||
144663851|NCT01295580|521620336|FG000|Overall Study|Other: family objection|0|||
144663852|NCT01295580|521620337|FG001|Overall Study|Other: family objection|1|||
144663853|NCT01742078|521620340|FG000|Overall Study|Withdrawal by Subject|0|||
144663854|NCT01742078|521620341|FG001|Overall Study|Withdrawal by Subject|0|||
144663855|NCT01742078|521620342|FG002|Overall Study|Withdrawal by Subject|0|||
144663856|NCT01742078|521620343|FG003|Overall Study|Withdrawal by Subject|1|||
144663857|NCT01742078|521620344|FG004|Overall Study|Withdrawal by Subject|0|||
144663858|NCT01742078|521620345|FG005|Overall Study|Withdrawal by Subject|0|||
144663859|NCT01742078|521620346|FG006|Overall Study|Withdrawal by Subject|0|||
144663860|NCT01742078|521620347|FG007|Overall Study|Withdrawal by Subject|0|||
144663861|NCT01742078|521620348|FG008|Overall Study|Withdrawal by Subject|0|||
144663862|NCT02493426|521620349|FG000|Overall Study|Withdrawal by Subject|0|||
144663863|NCT02493426|521620350|FG001|Overall Study|Withdrawal by Subject|1|||
144663864|NCT01069523|521620351|FG000|Overall Study|Withdrawal by Subject|4|||
144663865|NCT01069523|521620352|FG001|Overall Study|Withdrawal by Subject|7|||
144216292|NCT03631199|519985972|FG003|Overall Study|No treated|0|||
144216293|NCT03631199|519985973|FG004|Overall Study|No treated|1|||
144216294|NCT03631199|519985969|FG000|Overall Study|Treatment ongoing|0|||
144216295|NCT03631199|519985970|FG001|Overall Study|Treatment ongoing|1|||
144663866|NCT01025817|521620354|FG000|Completed Study Medication|Adverse Event|66|||
144663867|NCT01025817|521620355|FG001|Completed Study Medication|Adverse Event|39|||
144663868|NCT01025817|521620354|FG000|Completed Study Medication|Protocol Deviation|9|||
144663869|NCT01025817|521620355|FG001|Completed Study Medication|Protocol Deviation|8|||
144663870|NCT01025817|521620354|FG000|Completed Study Medication|Withdrawal by Subject|8|||
144663871|NCT01025817|521620355|FG001|Completed Study Medication|Withdrawal by Subject|9|||
144663872|NCT01025817|521620354|FG000|Completed Study Medication|Administrative problems|7|||
144663873|NCT01025817|521620355|FG001|Completed Study Medication|Administrative problems|5|||
144663874|NCT01025817|521620354|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
144733428|NCT00939003|521880654|FG001|Open-label Treatment Period|Site Closure|4|||
144733429|NCT03707912|521880656|FG000|Overall Study|Violation of inclusion criteria|1|||
144216296|NCT03631199|519985971|FG002|Overall Study|Treatment ongoing|1|||
144663875|NCT01025817|521620355|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
144663876|NCT01025817|521620354|FG000|Completed Study Medication|Abnormal test procedure|4|||
144663877|NCT01025817|521620355|FG001|Completed Study Medication|Abnormal test procedure|0|||
144663878|NCT01025817|521620354|FG000|Completed Study Medication|Graft loss|2|||
144663879|NCT01025817|521620355|FG001|Completed Study Medication|Graft loss|5|||
144216297|NCT03631199|519985972|FG003|Overall Study|Treatment ongoing|76|||
144216298|NCT03631199|519985973|FG004|Overall Study|Treatment ongoing|71|||
144216299|NCT03631199|519985969|FG000|Overall Study|Guardian decision|0|||
144216300|NCT03631199|519985970|FG001|Overall Study|Guardian decision|0|||
144216301|NCT03631199|519985971|FG002|Overall Study|Guardian decision|0|||
144216302|NCT03631199|519985972|FG003|Overall Study|Guardian decision|1|||
144216303|NCT03631199|519985973|FG004|Overall Study|Guardian decision|1|||
144663880|NCT01025817|521620354|FG000|Completed Study Medication|Death|2|||
144663881|NCT01025817|521620355|FG001|Completed Study Medication|Death|2|||
144663882|NCT01025817|521620354|FG000|Completed Study Medication|Abnormal lab values|0|||
144663883|NCT01025817|521620355|FG001|Completed Study Medication|Abnormal lab values|2|||
144216304|NCT03690388|519985974|FG000|Overall Study|Adverse Event|8|||
144216305|NCT03690388|519985975|FG001|Overall Study|Adverse Event|1|||
144216306|NCT03690388|519985974|FG000|Overall Study|Radiographic Progression|14|||
144216307|NCT03690388|519985975|FG001|Overall Study|Radiographic Progression|29|||
144216308|NCT03690388|519985974|FG000|Overall Study|Clinical deterioration|10|||
144216309|NCT03690388|519985975|FG001|Overall Study|Clinical deterioration|6|||
144216310|NCT03690388|519985974|FG000|Overall Study|Withdrawal by Subject|2|||
144216311|NCT03690388|519985975|FG001|Overall Study|Withdrawal by Subject|0|||
144216312|NCT03690388|519985974|FG000|Overall Study|Lack of Efficacy|1|||
144216313|NCT03690388|519985975|FG001|Overall Study|Lack of Efficacy|0|||
144216314|NCT03690388|519985974|FG000|Overall Study|Lost to Follow-up|1|||
144216315|NCT03690388|519985975|FG001|Overall Study|Lost to Follow-up|0|||
144216316|NCT00233948|519985978|FG000|Overall Study|Adverse Event|1|||
144216317|NCT00233948|519985979|FG001|Overall Study|Adverse Event|0|||
144216318|NCT00233948|519985980|FG002|Overall Study|Adverse Event|0|||
144216319|NCT00233948|519985981|FG003|Overall Study|Adverse Event|0|||
144216320|NCT00233948|519985982|FG004|Overall Study|Adverse Event|0|||
144216321|NCT00233948|519985983|FG005|Overall Study|Adverse Event|0|||
144216322|NCT03573830|519985984|FG000|Overall Study|Dropped without completing treatment|0|||
144216323|NCT03573830|519985985|FG001|Overall Study|Dropped without completing treatment|7|||
144216324|NCT03573830|519985984|FG000|Overall Study|Lost to Follow-up|4|||
144216325|NCT03573830|519985985|FG001|Overall Study|Lost to Follow-up|0|||
144216326|NCT03284723|519985990|FG000|Overall Study|Death|0|||
144216327|NCT03284723|519985991|FG001|Overall Study|Death|0|||
144216328|NCT03284723|519985992|FG002|Overall Study|Death|0|||
144216329|NCT03284723|519985993|FG003|Overall Study|Death|1|||
144216330|NCT03284723|519985994|FG004|Overall Study|Death|0|||
144216331|NCT03284723|519985995|FG005|Overall Study|Death|0|||
144216332|NCT03284723|519985996|FG006|Overall Study|Death|1|||
144216333|NCT03284723|519985997|FG007|Overall Study|Death|0|||
144216334|NCT03284723|519985998|FG008|Overall Study|Death|0|||
144216335|NCT03284723|519985999|FG009|Overall Study|Death|2|||
144663884|NCT01025817|521620354|FG000|Completed Study Medication|Subject no longer required study drug|0|||
144663885|NCT01025817|521620355|FG001|Completed Study Medication|Subject no longer required study drug|1|||
144663886|NCT01025817|521620354|FG000|Completed Study Medication|Lost to Follow-up|0|||
144663887|NCT01025817|521620355|FG001|Completed Study Medication|Lost to Follow-up|1|||
144663888|NCT01025817|521620354|FG000|Completed Study|Withdrawal by Subject|8|||
144663889|NCT01025817|521620355|FG001|Completed Study|Withdrawal by Subject|16|||
144663890|NCT01025817|521620354|FG000|Completed Study|Death|6|||
144663891|NCT01025817|521620355|FG001|Completed Study|Death|5|||
144663892|NCT01025817|521620354|FG000|Completed Study|Missing|2|||
144663893|NCT01025817|521620355|FG001|Completed Study|Missing|0|||
144663894|NCT01025817|521620354|FG000|Completed Study|Lost to Follow-up|0|||
144663895|NCT01025817|521620355|FG001|Completed Study|Lost to Follow-up|1|||
144663896|NCT00488592|521620361|FG000|Overall Study|Withdrawal by Subject|1|||
144216336|NCT03284723|519986000|FG010|Overall Study|Death|1|||
144216337|NCT03284723|519986001|FG011|Overall Study|Death|0|||
144216338|NCT03284723|519985990|FG000|Overall Study|Lost to Follow-up|0|||
144216339|NCT03284723|519985991|FG001|Overall Study|Lost to Follow-up|0|||
144216340|NCT03284723|519985992|FG002|Overall Study|Lost to Follow-up|0|||
144663897|NCT00488592|521620361|FG000|Overall Study|Disease progression|1|||
144663898|NCT00488592|521620361|FG000|Overall Study|Enrolled but not treated|1|||
144733430|NCT03707912|521880657|FG001|Overall Study|Violation of inclusion criteria|0|||
144733431|NCT02131129|521880658|FG000|Overall Study|Withdrawal by Subject|1|||
144733432|NCT02131129|521880659|FG001|Overall Study|Withdrawal by Subject|0|||
144216341|NCT03284723|519985993|FG003|Overall Study|Lost to Follow-up|0|||
144216342|NCT03284723|519985994|FG004|Overall Study|Lost to Follow-up|0|||
144216343|NCT03284723|519985995|FG005|Overall Study|Lost to Follow-up|2|||
144216344|NCT03284723|519985996|FG006|Overall Study|Lost to Follow-up|1|||
144663899|NCT00441103|521620362|FG000|Overall Study|Adverse Event|2|||
144663900|NCT00441103|521620363|FG001|Overall Study|Adverse Event|1|||
144663901|NCT00441103|521620362|FG000|Overall Study|Death|1|||
144663902|NCT00441103|521620363|FG001|Overall Study|Death|0|||
144733433|NCT02865122|521880660|FG000|Overall Study|Adverse Event|1|||
144663903|NCT00441103|521620362|FG000|Overall Study|Disease Progression|2|||
144216345|NCT03284723|519985997|FG007|Overall Study|Lost to Follow-up|0|||
144216346|NCT03284723|519985998|FG008|Overall Study|Lost to Follow-up|0|||
144216347|NCT03284723|519985999|FG009|Overall Study|Lost to Follow-up|2|||
144216348|NCT03284723|519986000|FG010|Overall Study|Lost to Follow-up|0|||
144216349|NCT03284723|519986001|FG011|Overall Study|Lost to Follow-up|0|||
144216350|NCT03284723|519985990|FG000|Overall Study|Study Terminated By Sponsor|0|||
144216351|NCT03284723|519985991|FG001|Overall Study|Study Terminated By Sponsor|0|||
144663904|NCT00441103|521620363|FG001|Overall Study|Disease Progression|0|||
144663905|NCT00441103|521620362|FG000|Overall Study|Lost to Follow-up|1|||
144663906|NCT00441103|521620363|FG001|Overall Study|Lost to Follow-up|0|||
144663907|NCT00441103|521620362|FG000|Overall Study|Protocol Violation|1|||
144663908|NCT00441103|521620363|FG001|Overall Study|Protocol Violation|0|||
144663909|NCT00441103|521620362|FG000|Overall Study|Participant unable to use Rebiject II|1|||
144663910|NCT00441103|521620363|FG001|Overall Study|Participant unable to use Rebiject II|0|||
144663911|NCT00441103|521620362|FG000|Overall Study|Participant refused MRI|1|||
144663912|NCT00441103|521620363|FG001|Overall Study|Participant refused MRI|0|||
144663913|NCT00441103|521620362|FG000|Overall Study|Inclusion criteria absent|1|||
144663914|NCT00441103|521620363|FG001|Overall Study|Inclusion criteria absent|0|||
144663915|NCT00441103|521620362|FG000|Overall Study|Non-compliant|0|||
144663916|NCT00441103|521620363|FG001|Overall Study|Non-compliant|1|||
144663917|NCT00441103|521620362|FG000|Overall Study|Participant decided to withdraw|1|||
144663918|NCT00441103|521620363|FG001|Overall Study|Participant decided to withdraw|0|||
144663919|NCT00441103|521620362|FG000|Overall Study|Participant's reason|0|||
144663920|NCT00441103|521620363|FG001|Overall Study|Participant's reason|1|||
144663921|NCT00441103|521620362|FG000|Overall Study|Participant decided to stop|0|||
144663922|NCT00441103|521620363|FG001|Overall Study|Participant decided to stop|1|||
144663923|NCT00807846|521620364|FG000|Overall Study|Adverse Event|5|||
144663924|NCT00807846|521620365|FG001|Overall Study|Adverse Event|0|||
144663925|NCT00807846|521620364|FG000|Overall Study|Lack of Efficacy|2|||
144663926|NCT00807846|521620365|FG001|Overall Study|Lack of Efficacy|0|||
144663927|NCT00807846|521620364|FG000|Overall Study|Protocol Violation|2|||
144663928|NCT00807846|521620365|FG001|Overall Study|Protocol Violation|1|||
144663929|NCT00807846|521620364|FG000|Overall Study|Withdrawal by Subject|2|||
144663930|NCT00807846|521620365|FG001|Overall Study|Withdrawal by Subject|1|||
144663931|NCT00807846|521620364|FG000|Overall Study|Other|1|||
144663932|NCT00807846|521620365|FG001|Overall Study|Other|2|||
144663933|NCT01081873|521620366|FG000|Overall Study|Death|86|||
144663934|NCT01081873|521620366|FG000|Overall Study|Withdrawal by Subject|10|||
144663935|NCT01081873|521620366|FG000|Overall Study|Lost to Follow-up|142|||
144663936|NCT01081873|521620366|FG000|Overall Study|Progression of prostate cancer|13|||
144663937|NCT01081873|521620366|FG000|Overall Study|Other|47|||
144663938|NCT04799405|521620368|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
144663939|NCT00603980|521620369|FG000|Study Qualification|Protocol Violation|3|||
144663940|NCT00603980|521620369|FG000|Study Qualification|Inconsistent data reporting|13|||
144663941|NCT00603980|521620369|FG000|Main Study|14th subject completed trial|1|||
144663942|NCT01029002|521620370|FG000|Overall Study|Lost to Follow-up|2|||
144663943|NCT01029002|521620371|FG001|Overall Study|Lost to Follow-up|4|||
144663944|NCT02683525|521620372|FG000|Overall Study|Lost to Follow-up|1|||
144663945|NCT02683525|521620372|FG000|Overall Study|Physician Decision|1|||
144663946|NCT02683525|521620372|FG000|Overall Study|Disease Progression|6|||
144663947|NCT02618928|521620375|FG000|Overall Study|Failure to Return|28|||
144663948|NCT02618928|521620375|FG000|Overall Study|Insufficient Virological Response|1|||
144663949|NCT02618928|521620375|FG000|Overall Study|Withdrawal by Subject|2|||
144663950|NCT02618928|521620375|FG000|Overall Study|Death|3|||
144663951|NCT02618928|521620375|FG000|Overall Study|Other|11|||
144663952|NCT02618928|521620375|FG000|Overall Study|Missing|6|||
144663953|NCT02618928|521620375|FG000|Overall Study|Treatment Never Started|7|||
144663954|NCT01096849|521620380|FG000|Overall Study|Consent Withdrawn|1|||
144663955|NCT01096849|521620381|FG001|Overall Study|Consent Withdrawn|4|||
144663956|NCT01096849|521620382|FG002|Overall Study|Consent Withdrawn|2|||
144663957|NCT01096849|521620380|FG000|Overall Study|Lack of Efficacy|0|||
144663958|NCT01096849|521620381|FG001|Overall Study|Lack of Efficacy|2|||
144663959|NCT01096849|521620382|FG002|Overall Study|Lack of Efficacy|0|||
144663960|NCT01096849|521620380|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
144663961|NCT01096849|521620381|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
144663962|NCT01096849|521620382|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
144663963|NCT01096849|521620380|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
144663964|NCT01096849|521620381|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
144663965|NCT01096849|521620382|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
144663966|NCT01096849|521620380|FG000|Overall Study|Administrative Reasons|0|||
144663967|NCT01096849|521620381|FG001|Overall Study|Administrative Reasons|1|||
144663968|NCT01096849|521620382|FG002|Overall Study|Administrative Reasons|2|||
144663969|NCT01096849|521620380|FG000|Overall Study|Lost to Follow-up|1|||
144663970|NCT01096849|521620381|FG001|Overall Study|Lost to Follow-up|3|||
144663971|NCT01096849|521620382|FG002|Overall Study|Lost to Follow-up|1|||
144663972|NCT00118482|521620384|FG000|Overall Study|Lost to Follow-up|7|||
144663973|NCT00118482|521620385|FG001|Overall Study|Lost to Follow-up|7|||
144663974|NCT00118482|521620384|FG000|Overall Study|Withdrawal by Subject|23|||
144663975|NCT00118482|521620385|FG001|Overall Study|Withdrawal by Subject|22|||
144663976|NCT00125190|521620386|FG000|Overall Study|Subject/Parent Decision|7|||
144663977|NCT00125190|521620386|FG000|Overall Study|Non-compliance|2|||
144663978|NCT00125190|521620386|FG000|Overall Study|Adverse Event|1|||
144663979|NCT00125190|521620386|FG000|Overall Study|Other|1|||
144663980|NCT00125190|521620386|FG000|Overall Study|Lost to Follow-up|4|||
144663981|NCT01586156|521620388|FG000|Overall Study|Pregnancy|0|||
144663982|NCT01586156|521620389|FG001|Overall Study|Pregnancy|1|||
144663983|NCT01586156|521620390|FG002|Overall Study|Pregnancy|0|||
144663984|NCT01449682|521620391|FG000|Overall Study|Death|0|||
144663985|NCT01449682|521620392|FG001|Overall Study|Death|1|||
144663986|NCT01449682|521620391|FG000|Overall Study|Adverse Event|1|||
144663987|NCT01449682|521620392|FG001|Overall Study|Adverse Event|0|||
144663988|NCT00264849|521620398|FG000|Overall Study|Adverse Event|7|||
144663989|NCT00264849|521620399|FG001|Overall Study|Adverse Event|2|||
144663990|NCT00264849|521620398|FG000|Overall Study|Withdrawal by Subject|7|||
144663991|NCT00264849|521620399|FG001|Overall Study|Withdrawal by Subject|11|||
144663992|NCT00264849|521620398|FG000|Overall Study|Protocol Violation|5|||
144663993|NCT00264849|521620399|FG001|Overall Study|Protocol Violation|3|||
144663994|NCT00264849|521620398|FG000|Overall Study|Lack of Efficacy|1|||
144663995|NCT00264849|521620399|FG001|Overall Study|Lack of Efficacy|6|||
144663996|NCT00264849|521620398|FG000|Overall Study|Lost to Follow-up|0|||
144663997|NCT00264849|521620399|FG001|Overall Study|Lost to Follow-up|2|||
144663998|NCT00264849|521620398|FG000|Overall Study|Death|0|||
144663999|NCT00264849|521620399|FG001|Overall Study|Death|1|||
144664000|NCT00264849|521620398|FG000|Overall Study|Administrative Problems|2|||
144664001|NCT00264849|521620399|FG001|Overall Study|Administrative Problems|0|||
144664002|NCT00099359|521620400|FG000|Overall Study|Death|11|||
144664003|NCT00099359|521620401|FG001|Overall Study|Death|15|||
144664004|NCT00099359|521620402|FG002|Overall Study|Death|17|||
144664005|NCT00099359|521620400|FG000|Overall Study|Withdrawal by Subject|19|||
144664006|NCT00099359|521620401|FG001|Overall Study|Withdrawal by Subject|19|||
144664007|NCT00099359|521620402|FG002|Overall Study|Withdrawal by Subject|23|||
144664008|NCT00099359|521620400|FG000|Overall Study|Lost to Follow-up|15|||
144664009|NCT00099359|521620401|FG001|Overall Study|Lost to Follow-up|24|||
144664010|NCT00099359|521620402|FG002|Overall Study|Lost to Follow-up|24|||
144664011|NCT00099359|521620400|FG000|Overall Study|moved out of area|9|||
144664012|NCT00099359|521620401|FG001|Overall Study|moved out of area|7|||
144664013|NCT00099359|521620402|FG002|Overall Study|moved out of area|4|||
144664014|NCT00717366|521620403|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
144664015|NCT00717366|521620404|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
144664016|NCT00717366|521620403|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
144664017|NCT00717366|521620404|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
144664018|NCT00717366|521620403|FG000|Core Study Period (20 Weeks)|Death|0|||
144664019|NCT00717366|521620404|FG001|Core Study Period (20 Weeks)|Death|1|||
144664020|NCT00717366|521620403|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
144664021|NCT00717366|521620404|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
144664022|NCT00717366|521620403|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
144664023|NCT00717366|521620404|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
144664024|NCT00717366|521620403|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
144664025|NCT00717366|521620404|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
144664026|NCT00717366|521620403|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
144664027|NCT00717366|521620404|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
144664028|NCT02104804|521620405|FG000|Overall Study|Did not take study medication|0|||
144664029|NCT02104804|521620406|FG001|Overall Study|Did not take study medication|1|||
144664030|NCT02104804|521620405|FG000|Overall Study|Study specific discontinuation criteria|6|||
144664031|NCT02104804|521620406|FG001|Overall Study|Study specific discontinuation criteria|1|||
144664032|NCT02104804|521620405|FG000|Overall Study|Other listed|2|||
144664033|NCT02104804|521620406|FG001|Overall Study|Other listed|1|||
144664034|NCT02104804|521620405|FG000|Overall Study|Protocol Violation|0|||
144664035|NCT02104804|521620406|FG001|Overall Study|Protocol Violation|1|||
144664036|NCT02104804|521620405|FG000|Overall Study|Adverse Event|4|||
144664037|NCT02104804|521620406|FG001|Overall Study|Adverse Event|3|||
144664038|NCT02104804|521620405|FG000|Overall Study|Withdrawal by Subject|4|||
144664039|NCT02104804|521620406|FG001|Overall Study|Withdrawal by Subject|12|||
144664040|NCT04501679|521620407|FG000|Overall Study|Pregnancy|0|||
144664041|NCT04501679|521620408|FG001|Overall Study|Pregnancy|1|||
144664042|NCT04501679|521620407|FG000|Overall Study|Adverse Event|4|||
144664043|NCT04501679|521620408|FG001|Overall Study|Adverse Event|2|||
144664044|NCT04501679|521620407|FG000|Overall Study|Withdrawal by Subject|2|||
144664045|NCT04501679|521620408|FG001|Overall Study|Withdrawal by Subject|0|||
144664046|NCT04501679|521620407|FG000|Overall Study|Physician Decision|1|||
144664047|NCT04501679|521620408|FG001|Overall Study|Physician Decision|0|||
144664048|NCT04501679|521620407|FG000|Overall Study|Lost to Follow-up|2|||
144664049|NCT04501679|521620408|FG001|Overall Study|Lost to Follow-up|0|||
144664050|NCT02121756|521620413|FG000|Overall Study|Adverse Event|3|||
144664051|NCT02121756|521620414|FG001|Overall Study|Adverse Event|0|||
144664052|NCT02121756|521620413|FG000|Overall Study|Protocol Violation|1|||
144664053|NCT02121756|521620414|FG001|Overall Study|Protocol Violation|1|||
144664054|NCT02121756|521620413|FG000|Overall Study|Physician Decision|2|||
144664055|NCT02121756|521620414|FG001|Overall Study|Physician Decision|1|||
144664056|NCT03259490|521620416|FG000|Period 1|Withdrawal by Subject|0|||
144664057|NCT03259490|521620417|FG001|Period 1|Withdrawal by Subject|1|||
144664058|NCT03259490|521620416|FG000|Period 2|Protocol Violation|1|||
144664059|NCT03259490|521620417|FG001|Period 2|Protocol Violation|0|||
144664060|NCT00434122|521620418|FG000|Overall Study|Non-compliance with protocol|0|||
144664061|NCT00434122|521620419|FG001|Overall Study|Non-compliance with protocol|1|||
144664062|NCT00434122|521620418|FG000|Overall Study|loss of subject contact|1|||
144664063|NCT00434122|521620419|FG001|Overall Study|loss of subject contact|1|||
144664064|NCT00434122|521620418|FG000|Overall Study|Personal reasons|1|||
144664065|NCT00434122|521620419|FG001|Overall Study|Personal reasons|1|||
144664066|NCT00434122|521620418|FG000|Overall Study|Large follicle size|2|||
144664067|NCT00434122|521620419|FG001|Overall Study|Large follicle size|2|||
144664068|NCT00434122|521620418|FG000|Overall Study|Low follicular response.|1|||
144664069|NCT00434122|521620419|FG001|Overall Study|Low follicular response.|2|||
144664070|NCT00434122|521620418|FG000|Overall Study|Travelling of subject.|1|||
144664071|NCT00434122|521620419|FG001|Overall Study|Travelling of subject.|0|||
144664072|NCT00255086|521620421|FG000|Overall Study|Adverse Event|1|||
144664073|NCT00255086|521620422|FG001|Overall Study|Adverse Event|1|||
144664074|NCT00255086|521620421|FG000|Overall Study|Protocol Violation|1|||
144664075|NCT00255086|521620422|FG001|Overall Study|Protocol Violation|1|||
144664076|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
144664077|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
144664078|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
144664079|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
144664080|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
144664081|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
144664082|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
144664083|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
144664084|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
144664085|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
144664086|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
144664087|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
144664088|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
144664089|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
144664090|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
144664091|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
144664092|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
144664093|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
144664094|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
144664095|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
144664096|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
144664097|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
144664098|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
144664099|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
144664100|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
144664101|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
144664102|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
144664103|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
144664104|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
144664105|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
144664106|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
144664107|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
144664108|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
144664109|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
144664110|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
144664111|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
144664112|NCT01963208|521620423|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
144664113|NCT01963208|521620424|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
144664114|NCT01963208|521620425|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
144664115|NCT01963208|521620426|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
144664116|NCT01963208|521620427|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
144664117|NCT01963208|521620428|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
144664118|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
144664119|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
144664120|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
144664121|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
144664122|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
144664123|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
144664124|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
144664125|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
144664126|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
144664127|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
144664128|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
144664129|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
144664130|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
144664131|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
144664132|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
144664133|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
144664134|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
144664135|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
144664136|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
144664137|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
144664138|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
144664139|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
144664140|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
144664141|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
144664142|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
144664143|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
144664144|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
144664145|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
144664146|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
144664147|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
144664148|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
144664149|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
144664150|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
144664151|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
144664152|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
144664153|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
144664154|NCT01963208|521620423|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
144664155|NCT01963208|521620424|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
144664156|NCT01963208|521620425|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
144664157|NCT01963208|521620426|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
144664158|NCT01963208|521620427|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
144664159|NCT01963208|521620428|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
144664160|NCT04191577|521620429|FG000|Overall Study|Withdrawal by Subject|2|||
144664161|NCT04191577|521620430|FG001|Overall Study|Withdrawal by Subject|2|||
144664162|NCT04191577|521620431|FG002|Overall Study|Withdrawal by Subject|1|||
144664163|NCT04191577|521620429|FG000|Overall Study|Physician Decision|1|||
144664164|NCT04191577|521620430|FG001|Overall Study|Physician Decision|1|||
144664165|NCT04191577|521620431|FG002|Overall Study|Physician Decision|0|||
144664166|NCT04191577|521620429|FG000|Overall Study|Adverse Event|0|||
144664167|NCT04191577|521620430|FG001|Overall Study|Adverse Event|0|||
144664168|NCT04191577|521620431|FG002|Overall Study|Adverse Event|1|||
144664169|NCT04191577|521620429|FG000|Overall Study|Death|0|||
144664170|NCT04191577|521620430|FG001|Overall Study|Death|0|||
144664171|NCT04191577|521620431|FG002|Overall Study|Death|1|||
144664172|NCT02365584|521620432|FG000|Overall Study|Adverse Event|2|||
144664173|NCT02365584|521620433|FG001|Overall Study|Adverse Event|2|||
144664174|NCT02365584|521620432|FG000|Overall Study|Withdrawal by Subject|1|||
144664175|NCT02365584|521620433|FG001|Overall Study|Withdrawal by Subject|0|||
144664176|NCT02365584|521620432|FG000|Overall Study|Disease Progression|9|||
144664177|NCT02365584|521620433|FG001|Overall Study|Disease Progression|12|||
144664178|NCT01185249|521620434|FG000|Overall Study|Patients discharged or change in status|42|||
144664179|NCT01973452|521620435|FG000|Overall Study|Lack of Efficacy|0|||
144664180|NCT01973452|521620436|FG001|Overall Study|Lack of Efficacy|1|||
144664181|NCT01973452|521620435|FG000|Overall Study|Lost to Follow-up|1|||
144664182|NCT01973452|521620436|FG001|Overall Study|Lost to Follow-up|0|||
144664183|NCT01973452|521620435|FG000|Overall Study|Withdrawal by Subject|10|||
144664184|NCT01973452|521620436|FG001|Overall Study|Withdrawal by Subject|9|||
144664185|NCT01973452|521620435|FG000|Overall Study|Ineligible|1|||
144664186|NCT01973452|521620436|FG001|Overall Study|Ineligible|1|||
144664187|NCT01973452|521620435|FG000|Overall Study|Surgery canceled by participant|5|||
144664188|NCT01973452|521620436|FG001|Overall Study|Surgery canceled by participant|3|||
144664189|NCT00406783|521620439|FG000|Overall Study|Adverse Event|4|||
144664190|NCT00406783|521620440|FG001|Overall Study|Adverse Event|4|||
144216352|NCT03284723|519985992|FG002|Overall Study|Study Terminated By Sponsor|0|||
144664191|NCT00406783|521620439|FG000|Overall Study|Treatment Failure|2|||
144664192|NCT00406783|521620440|FG001|Overall Study|Treatment Failure|3|||
144216353|NCT03284723|519985993|FG003|Overall Study|Study Terminated By Sponsor|0|||
144216354|NCT03284723|519985994|FG004|Overall Study|Study Terminated By Sponsor|1|||
144664193|NCT00406783|521620439|FG000|Overall Study|Lost to Follow-up|3|||
144664194|NCT00406783|521620440|FG001|Overall Study|Lost to Follow-up|0|||
144664195|NCT00406783|521620439|FG000|Overall Study|Withdrawal by Subject|1|||
144664196|NCT00406783|521620440|FG001|Overall Study|Withdrawal by Subject|4|||
144664197|NCT00406783|521620439|FG000|Overall Study|Protocol Violation|4|||
144664198|NCT00406783|521620440|FG001|Overall Study|Protocol Violation|4|||
144664199|NCT05294211|521620441|FG000|Overall Study|Withdrawal by Subject|3|||
144664200|NCT05294211|521620441|FG000|Overall Study|Physician Decision|2|||
144664201|NCT05294211|521620441|FG000|Overall Study|Progressed to active labor|1|||
144664202|NCT05294211|521620441|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
144664203|NCT05294211|521620441|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
144664204|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
144664205|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
144664206|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
144664207|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
144664208|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
144664209|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
144664210|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
144664211|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
144664212|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
144664213|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
144664214|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
144664215|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
144664216|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
144664217|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
144664218|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
144664219|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
144664220|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Missing|3|||
144664221|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Missing|1|||
144664222|NCT00838916|521620442|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
144664223|NCT00838916|521620443|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
144664224|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
144664225|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
144664226|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
144664227|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
144664228|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
144664229|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
144664230|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
144664231|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
144664232|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
144664233|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
144664234|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
144664235|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
144664236|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
144664237|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
144664238|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
144664239|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
144664240|NCT00838916|521620442|FG000|Follow-up Period (8 Weeks)|Missing|3|||
144664241|NCT00838916|521620443|FG001|Follow-up Period (8 Weeks)|Missing|0|||
144664242|NCT01842607|521620444|FG000|Overall Study|Adverse Event|11|||
144664243|NCT01842607|521620444|FG000|Overall Study|Lack of Efficacy|19|||
144664244|NCT01842607|521620444|FG000|Overall Study|Protocol Violation|8|||
144664245|NCT01842607|521620444|FG000|Overall Study|Protocol defined stopping criteria|2|||
144664246|NCT01842607|521620444|FG000|Overall Study|Lost to Follow-up|3|||
144664247|NCT01842607|521620444|FG000|Overall Study|Physician Decision|9|||
144664248|NCT01842607|521620444|FG000|Overall Study|Withdrawal by Subject|14|||
144664249|NCT02159469|521620445|FG000|Overall Study|Missing Completion status|1|||
144664250|NCT02159469|521620445|FG000|Overall Study|Adverse Event|5|||
144664251|NCT02159469|521620445|FG000|Overall Study|Non-compliance|2|||
144664252|NCT02159469|521620445|FG000|Overall Study|Withdrawal by Subject|9|||
144664253|NCT02159469|521620445|FG000|Overall Study|Lost to Follow-up|1|||
144664254|NCT02159469|521620445|FG000|Overall Study|Sponsor's request|2|||
144664255|NCT02159469|521620445|FG000|Overall Study|Met Stopping Criteria|3|||
144664256|NCT02159469|521620445|FG000|Overall Study|Other|1|||
144664257|NCT02159469|521620445|FG000|Overall Study|Multiple|29|||
144664258|NCT03629041|521620451|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
144664259|NCT03629041|521620452|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
144664260|NCT03629041|521620453|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
144664261|NCT03629041|521620454|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
144664262|NCT03488251|521620456|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
144664263|NCT03488251|521620457|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
144664264|NCT03488251|521620458|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
144664265|NCT03488251|521620459|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
144664266|NCT03488251|521620456|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
144664267|NCT03488251|521620457|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
144664268|NCT03488251|521620458|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
144664269|NCT03488251|521620459|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
144664270|NCT03488251|521620456|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
144664271|NCT03488251|521620457|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
144664272|NCT03488251|521620458|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
144664273|NCT03488251|521620459|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
144664274|NCT03488251|521620456|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
144664275|NCT03488251|521620457|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
144664276|NCT03488251|521620458|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
144664277|NCT03488251|521620459|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
144664278|NCT03488251|521620456|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
144664279|NCT03488251|521620457|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
144664280|NCT03488251|521620458|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
144664281|NCT03488251|521620459|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
144664282|NCT00115765|521620460|FG000|Overall Study|Withdrawal by Subject|22|||
144664283|NCT00115765|521620461|FG001|Overall Study|Withdrawal by Subject|53|||
144664284|NCT00115765|521620462|FG002|Overall Study|Withdrawal by Subject|76|||
144664285|NCT00115765|521620463|FG003|Overall Study|Withdrawal by Subject|15|||
144664286|NCT00115765|521620460|FG000|Overall Study|Physician Decision|4|||
144664287|NCT00115765|521620461|FG001|Overall Study|Physician Decision|15|||
144664288|NCT00115765|521620462|FG002|Overall Study|Physician Decision|18|||
144664289|NCT00115765|521620463|FG003|Overall Study|Physician Decision|13|||
144664290|NCT00115765|521620460|FG000|Overall Study|Lost to Follow-up|3|||
144664291|NCT00115765|521620461|FG001|Overall Study|Lost to Follow-up|20|||
144664292|NCT00115765|521620462|FG002|Overall Study|Lost to Follow-up|18|||
144664293|NCT00115765|521620463|FG003|Overall Study|Lost to Follow-up|1|||
144664294|NCT00115765|521620460|FG000|Overall Study|Other|6|||
144664295|NCT00115765|521620461|FG001|Overall Study|Other|12|||
144664296|NCT00115765|521620462|FG002|Overall Study|Other|9|||
144664297|NCT00115765|521620463|FG003|Overall Study|Other|2|||
144664298|NCT05301322|521620466|FG000|Overall Study|Adverse Event|7|||
144664299|NCT05301322|521620467|FG001|Overall Study|Adverse Event|3|||
144664300|NCT05301322|521620466|FG000|Overall Study|Death|0|||
144664301|NCT05301322|521620467|FG001|Overall Study|Death|1|||
144664302|NCT05301322|521620466|FG000|Overall Study|Lost to Follow-up|2|||
144664303|NCT05301322|521620467|FG001|Overall Study|Lost to Follow-up|1|||
144664304|NCT05301322|521620466|FG000|Overall Study|Protocol Violation|3|||
144664305|NCT05301322|521620467|FG001|Overall Study|Protocol Violation|1|||
144664306|NCT05301322|521620466|FG000|Overall Study|Withdrawal by Subject|3|||
144664307|NCT05301322|521620467|FG001|Overall Study|Withdrawal by Subject|0|||
144664308|NCT05301322|521620466|FG000|Overall Study|Other|4|||
144664309|NCT05301322|521620467|FG001|Overall Study|Other|0|||
144664310|NCT03829332|521620468|FG000|Overall Study|Death|225|||
144664311|NCT03829332|521620469|FG001|Overall Study|Death|230|||
144664312|NCT03829332|521620468|FG000|Overall Study|Lost to Follow-up|1|||
144664313|NCT03829332|521620469|FG001|Overall Study|Lost to Follow-up|3|||
144664314|NCT03829332|521620468|FG000|Overall Study|Physician Decision|1|||
144664315|NCT03829332|521620469|FG001|Overall Study|Physician Decision|0|||
144664316|NCT03829332|521620468|FG000|Overall Study|Sponsor Decision|71|||
144664317|NCT03829332|521620469|FG001|Overall Study|Sponsor Decision|72|||
144664318|NCT03829332|521620468|FG000|Overall Study|Withdrawal by Subject|11|||
144664319|NCT03829332|521620469|FG001|Overall Study|Withdrawal by Subject|9|||
144664320|NCT04095286|521620470|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664321|NCT04095286|521620471|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
144664322|NCT04095286|521620472|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664323|NCT04095286|521620473|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144733434|NCT02865122|521880661|FG001|Overall Study|Adverse Event|0|||
144733435|NCT02865122|521880662|FG002|Overall Study|Adverse Event|0|||
144733436|NCT03880266|521880663|FG000|Overall Study|Withdrawal by Subject|0|||
144733437|NCT03880266|521880664|FG001|Overall Study|Withdrawal by Subject|1|||
144733438|NCT03880266|521880665|FG002|Overall Study|Withdrawal by Subject|1|||
144733439|NCT03880266|521880666|FG003|Overall Study|Withdrawal by Subject|0|||
144664324|NCT04095286|521620474|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664325|NCT04095286|521620475|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664326|NCT04095286|521620470|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
144664327|NCT04095286|521620471|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
144664328|NCT04095286|521620472|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
144664329|NCT04095286|521620473|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
144664330|NCT04095286|521620474|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
144664331|NCT04095286|521620475|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
144664332|NCT04095286|521620470|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
144664333|NCT04095286|521620471|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
144664334|NCT04095286|521620472|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
144664335|NCT04095286|521620473|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
144664336|NCT04095286|521620474|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
144664337|NCT04095286|521620475|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
144664338|NCT04095286|521620470|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664339|NCT04095286|521620471|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664340|NCT04095286|521620472|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
144664341|NCT04095286|521620473|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664342|NCT04095286|521620474|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664343|NCT04095286|521620475|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
144664344|NCT04095286|521620470|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
144664345|NCT04095286|521620471|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
144664346|NCT04095286|521620472|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
144664347|NCT04095286|521620473|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
144664348|NCT04095286|521620474|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
144664349|NCT04095286|521620475|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
144664350|NCT00479557|521620476|FG000|Overall Study|Death|0|||
144664351|NCT00479557|521620477|FG001|Overall Study|Death|0|||
144664352|NCT00479557|521620478|FG002|Overall Study|Death|0|||
144664353|NCT00479557|521620479|FG003|Overall Study|Death|0|||
144664354|NCT00479557|521620480|FG004|Overall Study|Death|0|||
144664355|NCT00479557|521620481|FG005|Overall Study|Death|1|||
144664356|NCT00479557|521620482|FG006|Overall Study|Death|0|||
144664357|NCT00479557|521620476|FG000|Overall Study|Lack of Efficacy|1|||
144664358|NCT00479557|521620477|FG001|Overall Study|Lack of Efficacy|0|||
144664359|NCT00479557|521620478|FG002|Overall Study|Lack of Efficacy|0|||
144664360|NCT00479557|521620479|FG003|Overall Study|Lack of Efficacy|0|||
144664361|NCT00479557|521620480|FG004|Overall Study|Lack of Efficacy|0|||
144664362|NCT00479557|521620481|FG005|Overall Study|Lack of Efficacy|0|||
144664363|NCT00479557|521620482|FG006|Overall Study|Lack of Efficacy|0|||
144664364|NCT00479557|521620476|FG000|Overall Study|Lost to Follow-up|0|||
144664365|NCT00479557|521620477|FG001|Overall Study|Lost to Follow-up|2|||
144664366|NCT00479557|521620478|FG002|Overall Study|Lost to Follow-up|0|||
144664367|NCT00479557|521620479|FG003|Overall Study|Lost to Follow-up|2|||
144664368|NCT00479557|521620480|FG004|Overall Study|Lost to Follow-up|0|||
144664369|NCT00479557|521620481|FG005|Overall Study|Lost to Follow-up|0|||
144664370|NCT00479557|521620482|FG006|Overall Study|Lost to Follow-up|0|||
144664371|NCT00479557|521620476|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
144664372|NCT00479557|521620477|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
144664373|NCT00479557|521620478|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
144664374|NCT00479557|521620479|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
144664375|NCT00479557|521620480|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
144664376|NCT00479557|521620481|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
144664377|NCT00479557|521620482|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
144664378|NCT00479557|521620476|FG000|Overall Study|AE not related to Study Drug|1|||
144664379|NCT00479557|521620477|FG001|Overall Study|AE not related to Study Drug|3|||
144664380|NCT00479557|521620478|FG002|Overall Study|AE not related to Study Drug|0|||
144664381|NCT00479557|521620479|FG003|Overall Study|AE not related to Study Drug|0|||
144733440|NCT03880266|521880667|FG004|Overall Study|Withdrawal by Subject|0|||
144733441|NCT03880266|521880668|FG005|Overall Study|Withdrawal by Subject|0|||
144733442|NCT03880266|521880669|FG006|Overall Study|Withdrawal by Subject|0|||
144733443|NCT03880266|521880670|FG007|Overall Study|Withdrawal by Subject|0|||
144733444|NCT01577381|521880676|FG000|Overall Study|Discontinued|2|||
144733445|NCT01577381|521880677|FG001|Overall Study|Discontinued|1|||
144733446|NCT01577381|521880678|FG002|Overall Study|Discontinued|2|||
144664382|NCT00479557|521620480|FG004|Overall Study|AE not related to Study Drug|2|||
144664383|NCT00479557|521620481|FG005|Overall Study|AE not related to Study Drug|2|||
144664384|NCT00479557|521620482|FG006|Overall Study|AE not related to Study Drug|1|||
144664385|NCT00479557|521620476|FG000|Overall Study|Caregiver Request|2|||
144664386|NCT00479557|521620477|FG001|Overall Study|Caregiver Request|2|||
144664387|NCT00479557|521620478|FG002|Overall Study|Caregiver Request|2|||
144664388|NCT00479557|521620479|FG003|Overall Study|Caregiver Request|0|||
144664389|NCT00479557|521620480|FG004|Overall Study|Caregiver Request|1|||
144664390|NCT00479557|521620481|FG005|Overall Study|Caregiver Request|2|||
144664391|NCT00479557|521620482|FG006|Overall Study|Caregiver Request|0|||
144664392|NCT00479557|521620476|FG000|Overall Study|Investigator Request|0|||
144664393|NCT00479557|521620477|FG001|Overall Study|Investigator Request|0|||
144664394|NCT00479557|521620478|FG002|Overall Study|Investigator Request|1|||
144733447|NCT01577381|521880679|FG003|Overall Study|Discontinued|2|||
144664395|NCT00479557|521620479|FG003|Overall Study|Investigator Request|0|||
144664396|NCT00479557|521620480|FG004|Overall Study|Investigator Request|0|||
144664397|NCT00479557|521620481|FG005|Overall Study|Investigator Request|0|||
144664398|NCT00479557|521620482|FG006|Overall Study|Investigator Request|0|||
144664399|NCT00479557|521620476|FG000|Overall Study|Subject Request|3|||
144664400|NCT00479557|521620477|FG001|Overall Study|Subject Request|0|||
144664401|NCT00479557|521620478|FG002|Overall Study|Subject Request|1|||
144733448|NCT01577381|521880676|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
144733449|NCT01577381|521880677|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
144733450|NCT01577381|521880678|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
144733451|NCT01577381|521880679|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
144733452|NCT02186821|521880680|FG000|Overall Study|Adverse Event|9|||
144733453|NCT02186821|521880680|FG000|Overall Study|Death|2|||
144733454|NCT02186821|521880680|FG000|Overall Study|Disease progression|32|||
144733455|NCT02186821|521880680|FG000|Overall Study|Protocol Violation|1|||
144733456|NCT02186821|521880680|FG000|Overall Study|Physician Decision|1|||
144733457|NCT02186821|521880680|FG000|Overall Study|Study terminated by sponsor|2|||
144733458|NCT01313780|521880681|FG000|Overall Study|Lack of Efficacy|4|||
144733459|NCT01313780|521880682|FG001|Overall Study|Lack of Efficacy|2|||
144733460|NCT01313780|521880681|FG000|Overall Study|Adverse Event|6|||
144733461|NCT01313780|521880682|FG001|Overall Study|Adverse Event|11|||
144733462|NCT01313780|521880681|FG000|Overall Study|Withdrawal by Subject|2|||
144733463|NCT01313780|521880682|FG001|Overall Study|Withdrawal by Subject|8|||
144216355|NCT03284723|519985995|FG005|Overall Study|Study Terminated By Sponsor|0|||
144216356|NCT03284723|519985996|FG006|Overall Study|Study Terminated By Sponsor|0|||
144216357|NCT03284723|519985997|FG007|Overall Study|Study Terminated By Sponsor|0|||
144216358|NCT03284723|519985998|FG008|Overall Study|Study Terminated By Sponsor|1|||
144216359|NCT03284723|519985999|FG009|Overall Study|Study Terminated By Sponsor|1|||
144216360|NCT03284723|519986000|FG010|Overall Study|Study Terminated By Sponsor|1|||
144216361|NCT03284723|519986001|FG011|Overall Study|Study Terminated By Sponsor|1|||
144216362|NCT03284723|519985990|FG000|Overall Study|Withdrawal by Subject|0|||
144216363|NCT03284723|519985991|FG001|Overall Study|Withdrawal by Subject|0|||
144216364|NCT03284723|519985992|FG002|Overall Study|Withdrawal by Subject|0|||
144216365|NCT03284723|519985993|FG003|Overall Study|Withdrawal by Subject|0|||
144216366|NCT03284723|519985994|FG004|Overall Study|Withdrawal by Subject|5|||
144216367|NCT03284723|519985995|FG005|Overall Study|Withdrawal by Subject|3|||
144216368|NCT03284723|519985996|FG006|Overall Study|Withdrawal by Subject|1|||
144216369|NCT03284723|519985997|FG007|Overall Study|Withdrawal by Subject|0|||
144216370|NCT03284723|519985998|FG008|Overall Study|Withdrawal by Subject|6|||
144216371|NCT03284723|519985999|FG009|Overall Study|Withdrawal by Subject|0|||
144216372|NCT03284723|519986000|FG010|Overall Study|Withdrawal by Subject|3|||
144216373|NCT03284723|519986001|FG011|Overall Study|Withdrawal by Subject|1|||
144216374|NCT03284723|519985990|FG000|Overall Study|Other|1|||
144664402|NCT00479557|521620479|FG003|Overall Study|Subject Request|1|||
144664403|NCT00479557|521620480|FG004|Overall Study|Subject Request|1|||
144664404|NCT00479557|521620481|FG005|Overall Study|Subject Request|4|||
144664405|NCT00479557|521620482|FG006|Overall Study|Subject Request|1|||
144664406|NCT00479557|521620476|FG000|Overall Study|Other|2|||
144664407|NCT00479557|521620477|FG001|Overall Study|Other|3|||
144664408|NCT00479557|521620478|FG002|Overall Study|Other|1|||
144664409|NCT00479557|521620479|FG003|Overall Study|Other|0|||
144664410|NCT00479557|521620480|FG004|Overall Study|Other|0|||
144664411|NCT00479557|521620481|FG005|Overall Study|Other|3|||
144664412|NCT00479557|521620482|FG006|Overall Study|Other|0|||
144664413|NCT01146951|521622465|FG000|Overall Study|Adverse Event|4|||
144664414|NCT01146951|521622466|FG001|Overall Study|Adverse Event|1|||
144664415|NCT01747811|521622470|FG000|Overall Study|Lack of Efficacy|2|||
144664416|NCT01747811|521622471|FG001|Overall Study|Lack of Efficacy|4|||
144664417|NCT02064205|521622474|FG000|Overall Study|Withdrawal by Subject|1|||
144664418|NCT02700919|521622475|FG000|Overall Study|Physician Decision|1|||
144664419|NCT02700919|521622476|FG001|Overall Study|Physician Decision|0|||
144664420|NCT02700919|521622477|FG002|Overall Study|Physician Decision|0|||
144664421|NCT02700919|521622475|FG000|Overall Study|Protocol Violation|1|||
144664422|NCT02700919|521622476|FG001|Overall Study|Protocol Violation|0|||
144733464|NCT01313780|521880681|FG000|Overall Study|Protocol Violation|10|||
144733465|NCT01313780|521880682|FG001|Overall Study|Protocol Violation|4|||
144733466|NCT01313780|521880681|FG000|Overall Study|missing data|3|||
144216375|NCT03284723|519985991|FG001|Overall Study|Other|0|||
144216376|NCT03284723|519985992|FG002|Overall Study|Other|1|||
144216377|NCT03284723|519985993|FG003|Overall Study|Other|0|||
144216378|NCT03284723|519985994|FG004|Overall Study|Other|1|||
144664423|NCT02700919|521622477|FG002|Overall Study|Protocol Violation|0|||
144664424|NCT02700919|521622475|FG000|Overall Study|Adverse Event|1|||
144664425|NCT02700919|521622476|FG001|Overall Study|Adverse Event|3|||
144664426|NCT02700919|521622477|FG002|Overall Study|Adverse Event|1|||
144733467|NCT01313780|521880682|FG001|Overall Study|missing data|3|||
144733468|NCT05369208|521882066|FG000|Core Phase|Prohibited Medication Required|2|||
144733469|NCT05369208|521882066|FG000|Core Phase|Adverse Event|1|||
144216379|NCT03284723|519985995|FG005|Overall Study|Other|0|||
144216380|NCT03284723|519985996|FG006|Overall Study|Other|0|||
144216381|NCT03284723|519985997|FG007|Overall Study|Other|0|||
144216382|NCT03284723|519985998|FG008|Overall Study|Other|0|||
144664427|NCT02700919|521622475|FG000|Overall Study|Withdrawal by Subject|5|||
144664428|NCT02700919|521622476|FG001|Overall Study|Withdrawal by Subject|8|||
144664429|NCT02700919|521622477|FG002|Overall Study|Withdrawal by Subject|2|||
144664430|NCT02700919|521622475|FG000|Overall Study|Lost to Follow-up|2|||
144664431|NCT02700919|521622476|FG001|Overall Study|Lost to Follow-up|0|||
144664432|NCT02700919|521622477|FG002|Overall Study|Lost to Follow-up|0|||
144664433|NCT02700919|521622475|FG000|Overall Study|Other|2|||
144664434|NCT02700919|521622476|FG001|Overall Study|Other|1|||
144664435|NCT02700919|521622477|FG002|Overall Study|Other|1|||
144664436|NCT03434418|521622478|FG000|Overall Study|Disease Progression|11|||
144664437|NCT03434418|521622478|FG000|Overall Study|Adverse Event|2|||
144664438|NCT03434418|521622478|FG000|Overall Study|Physician Decision|1|||
144664439|NCT03434418|521622478|FG000|Overall Study|Decline in Performance Status (PS)|1|||
144664440|NCT03039738|521622481|FG000|Overall Study|Incomplete data sets|54|||
144664441|NCT03039738|521622482|FG001|Overall Study|Incomplete data sets|0|||
144664442|NCT01517412|521622485|FG000|Overall Study|Adverse Event|10|||
144664443|NCT01517412|521622486|FG001|Overall Study|Adverse Event|11|||
144664444|NCT01517412|521622485|FG000|Overall Study|Lack of Efficacy|10|||
144664445|NCT01517412|521622486|FG001|Overall Study|Lack of Efficacy|5|||
144664446|NCT01517412|521622485|FG000|Overall Study|Poor compliance to protocol|8|||
144664447|NCT01517412|521622486|FG001|Overall Study|Poor compliance to protocol|3|||
144664448|NCT01517412|521622485|FG000|Overall Study|Other than specified above|8|||
144664449|NCT01517412|521622486|FG001|Overall Study|Other than specified above|5|||
144664450|NCT02062463|521622487|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
144664451|NCT02062463|521622488|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
144664452|NCT02062463|521622489|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
144664453|NCT02062463|521622490|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
144664454|NCT02062463|521622487|FG000|Stage 2|Adverse Event|0|||
144664455|NCT02062463|521622488|FG001|Stage 2|Adverse Event|0|||
144664456|NCT02062463|521622489|FG002|Stage 2|Adverse Event|12|||
144664457|NCT02062463|521622490|FG003|Stage 2|Adverse Event|20|||
144664458|NCT02062463|521622487|FG000|Stage 2|Lack of Efficacy|0|||
144664459|NCT02062463|521622488|FG001|Stage 2|Lack of Efficacy|0|||
144664460|NCT02062463|521622489|FG002|Stage 2|Lack of Efficacy|3|||
144664461|NCT02062463|521622490|FG003|Stage 2|Lack of Efficacy|4|||
144664462|NCT02062463|521622487|FG000|Stage 2|Lost to Follow-up|0|||
144664463|NCT02062463|521622488|FG001|Stage 2|Lost to Follow-up|0|||
144664464|NCT02062463|521622489|FG002|Stage 2|Lost to Follow-up|20|||
144664465|NCT02062463|521622490|FG003|Stage 2|Lost to Follow-up|20|||
144664466|NCT02062463|521622487|FG000|Stage 2|Non-Compliance|0|||
144664467|NCT02062463|521622488|FG001|Stage 2|Non-Compliance|0|||
144664468|NCT02062463|521622489|FG002|Stage 2|Non-Compliance|0|||
144664469|NCT02062463|521622490|FG003|Stage 2|Non-Compliance|1|||
144664470|NCT02062463|521622487|FG000|Stage 2|Other than specified|0|||
144664471|NCT02062463|521622488|FG001|Stage 2|Other than specified|0|||
144664472|NCT02062463|521622489|FG002|Stage 2|Other than specified|3|||
144664473|NCT02062463|521622490|FG003|Stage 2|Other than specified|1|||
144664474|NCT02062463|521622487|FG000|Stage 2|Withdrawal by Subject|0|||
144664475|NCT02062463|521622488|FG001|Stage 2|Withdrawal by Subject|0|||
144664476|NCT02062463|521622489|FG002|Stage 2|Withdrawal by Subject|15|||
144664477|NCT02062463|521622490|FG003|Stage 2|Withdrawal by Subject|10|||
144664478|NCT04124692|521622502|FG000|Overall Study|Medical reason|0|||
144664479|NCT04124692|521622503|FG001|Overall Study|Medical reason|1|||
144664480|NCT04124692|521622502|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
144664481|NCT04124692|521622503|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
144664482|NCT04124692|521622502|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
144664483|NCT04124692|521622503|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
144664484|NCT04124692|521622502|FG000|Overall Study|Lost to Follow-up|2|||
144733470|NCT05369208|521882066|FG000|Core Phase|Lack of Efficacy|1|||
144733471|NCT04934722|521882067|FG000|Overall Study|Death|4|||
144733472|NCT04934722|521882068|FG001|Overall Study|Death|3|||
144733473|NCT04934722|521882067|FG000|Overall Study|Participants Ongoing|88|||
144733474|NCT04934722|521882068|FG001|Overall Study|Participants Ongoing|91|||
144733475|NCT00371839|521882069|FG000|Overall Study|Death|4|||
144733476|NCT00371839|521882070|FG001|Overall Study|Death|0|||
144733477|NCT00371839|521882071|FG002|Overall Study|Death|0|||
144733478|NCT00371839|521882069|FG000|Overall Study|Withdrawal by Subject|7|||
144733479|NCT00371839|521882070|FG001|Overall Study|Withdrawal by Subject|4|||
144733480|NCT00371839|521882071|FG002|Overall Study|Withdrawal by Subject|0|||
144733481|NCT00371839|521882069|FG000|Overall Study|Lost to Follow-up|6|||
144733482|NCT00371839|521882070|FG001|Overall Study|Lost to Follow-up|3|||
144265563|NCT00853762|520173967|FG002|Overall Study|Premature Termination|14|||
144664485|NCT04124692|521622503|FG001|Overall Study|Lost to Follow-up|4|||
144733483|NCT00371839|521882071|FG002|Overall Study|Lost to Follow-up|2|||
144733484|NCT01149473|521882072|FG000|First Intervention|Adverse Event|1|||
144733485|NCT01149473|521882073|FG001|First Intervention|Adverse Event|1|||
144664486|NCT04124692|521622502|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
144664487|NCT04124692|521622503|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
144664488|NCT01885078|521622504|FG000|Treatment Period|Adverse Event|52|||
144664489|NCT01885078|521622505|FG001|Treatment Period|Adverse Event|136|||
144664490|NCT01885078|521622506|FG002|Treatment Period|Adverse Event|30|||
144664491|NCT01885078|521622507|FG003|Treatment Period|Adverse Event|73|||
144733486|NCT01149473|521882072|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
144216383|NCT03284723|519985999|FG009|Overall Study|Other|0|||
144216384|NCT03284723|519986000|FG010|Overall Study|Other|1|||
144216385|NCT03284723|519986001|FG011|Overall Study|Other|0|||
144216386|NCT03284723|519985990|FG000|Overall Study|Adverse Event|0|||
144216387|NCT03284723|519985991|FG001|Overall Study|Adverse Event|0|||
144216388|NCT03284723|519985992|FG002|Overall Study|Adverse Event|0|||
144216389|NCT03284723|519985993|FG003|Overall Study|Adverse Event|0|||
144216390|NCT03284723|519985994|FG004|Overall Study|Adverse Event|0|||
144216391|NCT03284723|519985995|FG005|Overall Study|Adverse Event|0|||
144216392|NCT03284723|519985996|FG006|Overall Study|Adverse Event|0|||
144216393|NCT03284723|519985997|FG007|Overall Study|Adverse Event|0|||
144216394|NCT03284723|519985998|FG008|Overall Study|Adverse Event|1|||
144216395|NCT03284723|519985999|FG009|Overall Study|Adverse Event|0|||
144216396|NCT03284723|519986000|FG010|Overall Study|Adverse Event|0|||
144216397|NCT03284723|519986001|FG011|Overall Study|Adverse Event|0|||
144216398|NCT00615199|519986002|FG000|Overall Study|Adverse Event|3|||
144216399|NCT00615199|519986003|FG001|Overall Study|Adverse Event|1|||
144216400|NCT00615199|519986004|FG002|Overall Study|Adverse Event|1|||
144216401|NCT00615199|519986005|FG003|Overall Study|Adverse Event|0|||
144216402|NCT00615199|519986002|FG000|Overall Study|Lack of Efficacy|2|||
144216403|NCT00615199|519986003|FG001|Overall Study|Lack of Efficacy|0|||
144216404|NCT00615199|519986004|FG002|Overall Study|Lack of Efficacy|0|||
144216405|NCT00615199|519986005|FG003|Overall Study|Lack of Efficacy|1|||
144216406|NCT00615199|519986002|FG000|Overall Study|Lost to Follow-up|1|||
144216407|NCT00615199|519986003|FG001|Overall Study|Lost to Follow-up|0|||
144216408|NCT00615199|519986004|FG002|Overall Study|Lost to Follow-up|0|||
144216409|NCT00615199|519986005|FG003|Overall Study|Lost to Follow-up|0|||
144216410|NCT00615199|519986002|FG000|Overall Study|Other|0|||
144216411|NCT00615199|519986003|FG001|Overall Study|Other|0|||
144216412|NCT00615199|519986004|FG002|Overall Study|Other|0|||
144216413|NCT00615199|519986005|FG003|Overall Study|Other|1|||
144216414|NCT00615199|519986002|FG000|Overall Study|Withdrawal by Subject|2|||
144216415|NCT00615199|519986003|FG001|Overall Study|Withdrawal by Subject|1|||
144216416|NCT00615199|519986004|FG002|Overall Study|Withdrawal by Subject|0|||
144216417|NCT00615199|519986005|FG003|Overall Study|Withdrawal by Subject|0|||
144216418|NCT02653625|519986008|FG000|Overall Study|Adverse Event|1|||
144216419|NCT02653625|519986008|FG000|Overall Study|Non-compliance with Study Drug|1|||
144216420|NCT02653625|519986008|FG000|Overall Study|Protocol Violation|1|||
144216421|NCT02653625|519986008|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
144216422|NCT02090725|519986009|FG000|Overall Study|Withdrawal by Subject|1|||
144664492|NCT01885078|521622508|FG004|Treatment Period|Adverse Event|17|||
144664493|NCT01885078|521622509|FG005|Treatment Period|Adverse Event|72|||
144664494|NCT01885078|521622510|FG006|Treatment Period|Adverse Event|24|||
144664495|NCT01885078|521622511|FG007|Treatment Period|Adverse Event|5|||
144664496|NCT01885078|521622512|FG008|Treatment Period|Adverse Event|0|||
144664497|NCT01885078|521622513|FG009|Treatment Period|Adverse Event|0|||
144664498|NCT01885078|521622504|FG000|Treatment Period|Death|13|||
144664499|NCT01885078|521622505|FG001|Treatment Period|Death|33|||
144664500|NCT01885078|521622506|FG002|Treatment Period|Death|5|||
144664501|NCT01885078|521622507|FG003|Treatment Period|Death|9|||
144664502|NCT01885078|521622508|FG004|Treatment Period|Death|2|||
144664503|NCT01885078|521622509|FG005|Treatment Period|Death|10|||
144664504|NCT01885078|521622510|FG006|Treatment Period|Death|3|||
144664505|NCT01885078|521622511|FG007|Treatment Period|Death|2|||
144216423|NCT02090725|519986009|FG000|Overall Study|participants moved from area|3|||
144216424|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Other|34|||
144216425|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Other|0|||
144216426|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Other|0|||
144216427|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Other|0|||
144216428|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Death|14|||
144216429|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Death|0|||
144216430|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Death|0|||
144216431|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Death|0|||
144216432|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
144216433|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
144216434|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
144216435|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
144216436|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
144216437|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
144216438|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
144216439|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
144216440|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
144216441|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
144664506|NCT01885078|521622512|FG008|Treatment Period|Death|0|||
144664507|NCT01885078|521622513|FG009|Treatment Period|Death|0|||
144664508|NCT01885078|521622504|FG000|Treatment Period|Lack of Efficacy|12|||
144664509|NCT01885078|521622505|FG001|Treatment Period|Lack of Efficacy|33|||
144664510|NCT01885078|521622506|FG002|Treatment Period|Lack of Efficacy|10|||
144664511|NCT01885078|521622507|FG003|Treatment Period|Lack of Efficacy|23|||
144664512|NCT01885078|521622508|FG004|Treatment Period|Lack of Efficacy|24|||
144664513|NCT01885078|521622509|FG005|Treatment Period|Lack of Efficacy|58|||
144664514|NCT01885078|521622510|FG006|Treatment Period|Lack of Efficacy|9|||
144664515|NCT01885078|521622511|FG007|Treatment Period|Lack of Efficacy|5|||
144664516|NCT01885078|521622512|FG008|Treatment Period|Lack of Efficacy|0|||
144664517|NCT01885078|521622513|FG009|Treatment Period|Lack of Efficacy|0|||
144664518|NCT01885078|521622504|FG000|Treatment Period|Lost to Follow-up|16|||
144664519|NCT01885078|521622505|FG001|Treatment Period|Lost to Follow-up|19|||
144664520|NCT01885078|521622506|FG002|Treatment Period|Lost to Follow-up|7|||
144664521|NCT01885078|521622507|FG003|Treatment Period|Lost to Follow-up|9|||
144664522|NCT01885078|521622508|FG004|Treatment Period|Lost to Follow-up|2|||
144664523|NCT01885078|521622509|FG005|Treatment Period|Lost to Follow-up|8|||
144664524|NCT01885078|521622510|FG006|Treatment Period|Lost to Follow-up|2|||
144664525|NCT01885078|521622511|FG007|Treatment Period|Lost to Follow-up|0|||
144664526|NCT01885078|521622512|FG008|Treatment Period|Lost to Follow-up|0|||
144216442|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
144216443|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
144216444|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
144216445|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
144216446|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
144216447|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
144216448|NCT01995513|519986010|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
144216449|NCT01995513|519986011|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
144216450|NCT01995513|519986012|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
144216451|NCT01995513|519986013|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
144216452|NCT01995513|519986010|FG000|Period 1: Second Open Label Treatment|Other|0|||
144216453|NCT01995513|519986011|FG001|Period 1: Second Open Label Treatment|Other|2|||
144216454|NCT01995513|519986012|FG002|Period 1: Second Open Label Treatment|Other|0|||
144216455|NCT01995513|519986013|FG003|Period 1: Second Open Label Treatment|Other|0|||
144216456|NCT01995513|519986010|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
144216457|NCT01995513|519986011|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
144216458|NCT01995513|519986012|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
144216459|NCT01995513|519986013|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
144216460|NCT01995513|519986010|FG000|Period 2: Double Blind Treatment|Death|0|||
144216461|NCT01995513|519986011|FG001|Period 2: Double Blind Treatment|Death|0|||
144216462|NCT01995513|519986012|FG002|Period 2: Double Blind Treatment|Death|0|||
144216463|NCT01995513|519986013|FG003|Period 2: Double Blind Treatment|Death|1|||
144216464|NCT01995513|519986010|FG000|Period 2: Double Blind Treatment|Other|0|||
144216465|NCT01995513|519986011|FG001|Period 2: Double Blind Treatment|Other|0|||
144216466|NCT01995513|519986012|FG002|Period 2: Double Blind Treatment|Other|3|||
144216467|NCT01995513|519986013|FG003|Period 2: Double Blind Treatment|Other|3|||
144216468|NCT01995513|519986010|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
144216469|NCT01995513|519986011|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
144216470|NCT01995513|519986012|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
144216471|NCT01995513|519986013|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
144216472|NCT01995513|519986010|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
144216473|NCT01995513|519986011|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
144216474|NCT01995513|519986012|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
144216475|NCT01995513|519986013|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
144216476|NCT01995513|519986010|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
144216477|NCT01995513|519986011|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
144216478|NCT01995513|519986012|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
144216479|NCT01995513|519986013|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
144216480|NCT01995513|519986010|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
144216481|NCT01995513|519986011|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
144216482|NCT01995513|519986012|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
144664527|NCT01885078|521622513|FG009|Treatment Period|Lost to Follow-up|0|||
144664528|NCT01885078|521622504|FG000|Treatment Period|Physician Decision|19|||
144216483|NCT01995513|519986013|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
144216484|NCT01750190|519986014|FG000|Overall Study|Adverse Event|47|||
144216485|NCT01750190|519986015|FG001|Overall Study|Adverse Event|19|||
144216486|NCT01750190|519986014|FG000|Overall Study|Death|38|||
144216487|NCT01750190|519986015|FG001|Overall Study|Death|11|||
144216488|NCT01750190|519986014|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
144216489|NCT01750190|519986015|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
144664529|NCT01885078|521622505|FG001|Treatment Period|Physician Decision|21|||
144664530|NCT01885078|521622506|FG002|Treatment Period|Physician Decision|5|||
144664531|NCT01885078|521622507|FG003|Treatment Period|Physician Decision|12|||
144216490|NCT01750190|519986014|FG000|Overall Study|Lost to Follow-up|28|||
144664532|NCT01885078|521622508|FG004|Treatment Period|Physician Decision|9|||
144664533|NCT01885078|521622509|FG005|Treatment Period|Physician Decision|24|||
144664534|NCT01885078|521622510|FG006|Treatment Period|Physician Decision|4|||
144664535|NCT01885078|521622511|FG007|Treatment Period|Physician Decision|3|||
144664536|NCT01885078|521622512|FG008|Treatment Period|Physician Decision|0|||
144664537|NCT01885078|521622513|FG009|Treatment Period|Physician Decision|0|||
144664538|NCT01885078|521622504|FG000|Treatment Period|Protocol Violation|3|||
144664539|NCT01885078|521622505|FG001|Treatment Period|Protocol Violation|5|||
144664540|NCT01885078|521622506|FG002|Treatment Period|Protocol Violation|0|||
144664541|NCT01885078|521622507|FG003|Treatment Period|Protocol Violation|3|||
144664542|NCT01885078|521622508|FG004|Treatment Period|Protocol Violation|1|||
144664543|NCT01885078|521622509|FG005|Treatment Period|Protocol Violation|6|||
144664544|NCT01885078|521622510|FG006|Treatment Period|Protocol Violation|0|||
144664545|NCT01885078|521622511|FG007|Treatment Period|Protocol Violation|0|||
144664546|NCT01885078|521622512|FG008|Treatment Period|Protocol Violation|0|||
144664547|NCT01885078|521622513|FG009|Treatment Period|Protocol Violation|0|||
144664548|NCT01885078|521622504|FG000|Treatment Period|Sponsor Decision|245|||
144664549|NCT01885078|521622505|FG001|Treatment Period|Sponsor Decision|648|||
144664550|NCT01885078|521622506|FG002|Treatment Period|Sponsor Decision|49|||
144664551|NCT01885078|521622507|FG003|Treatment Period|Sponsor Decision|90|||
144664552|NCT01885078|521622508|FG004|Treatment Period|Sponsor Decision|20|||
144664553|NCT01885078|521622509|FG005|Treatment Period|Sponsor Decision|38|||
144664554|NCT01885078|521622510|FG006|Treatment Period|Sponsor Decision|162|||
144664555|NCT01885078|521622511|FG007|Treatment Period|Sponsor Decision|3|||
144664556|NCT01885078|521622512|FG008|Treatment Period|Sponsor Decision|0|||
144664557|NCT01885078|521622513|FG009|Treatment Period|Sponsor Decision|0|||
144664558|NCT01885078|521622504|FG000|Treatment Period|Withdrawal by Subject|72|||
144664559|NCT01885078|521622505|FG001|Treatment Period|Withdrawal by Subject|132|||
144664560|NCT01885078|521622506|FG002|Treatment Period|Withdrawal by Subject|25|||
144664561|NCT01885078|521622507|FG003|Treatment Period|Withdrawal by Subject|63|||
144664562|NCT01885078|521622508|FG004|Treatment Period|Withdrawal by Subject|15|||
144664563|NCT01885078|521622509|FG005|Treatment Period|Withdrawal by Subject|34|||
144664564|NCT01885078|521622510|FG006|Treatment Period|Withdrawal by Subject|17|||
144664565|NCT01885078|521622511|FG007|Treatment Period|Withdrawal by Subject|10|||
144664566|NCT01885078|521622512|FG008|Treatment Period|Withdrawal by Subject|0|||
144664567|NCT01885078|521622513|FG009|Treatment Period|Withdrawal by Subject|0|||
144664568|NCT01885078|521622504|FG000|Treatment Period|Other|0|||
144664569|NCT01885078|521622505|FG001|Treatment Period|Other|0|||
144664570|NCT01885078|521622506|FG002|Treatment Period|Other|0|||
144664571|NCT01885078|521622507|FG003|Treatment Period|Other|1|||
144664572|NCT01885078|521622508|FG004|Treatment Period|Other|0|||
144664573|NCT01885078|521622509|FG005|Treatment Period|Other|0|||
144664574|NCT01885078|521622510|FG006|Treatment Period|Other|0|||
144664575|NCT01885078|521622511|FG007|Treatment Period|Other|0|||
144664576|NCT01885078|521622512|FG008|Treatment Period|Other|0|||
144664577|NCT01885078|521622513|FG009|Treatment Period|Other|0|||
144664578|NCT01885078|521622504|FG000|Step-down Period|Sponsor Decision|0|||
144664579|NCT01885078|521622505|FG001|Step-down Period|Sponsor Decision|0|||
144664580|NCT01885078|521622506|FG002|Step-down Period|Sponsor Decision|0|||
144664581|NCT01885078|521622507|FG003|Step-down Period|Sponsor Decision|0|||
144664582|NCT01885078|521622508|FG004|Step-down Period|Sponsor Decision|0|||
144664583|NCT01885078|521622509|FG005|Step-down Period|Sponsor Decision|0|||
144664584|NCT01885078|521622510|FG006|Step-down Period|Sponsor Decision|0|||
144664585|NCT01885078|521622511|FG007|Step-down Period|Sponsor Decision|0|||
144664586|NCT01885078|521622512|FG008|Step-down Period|Sponsor Decision|1|||
144664587|NCT01885078|521622513|FG009|Step-down Period|Sponsor Decision|1|||
144664588|NCT01885078|521622504|FG000|Step-down Period|Adverse Event|0|||
144664589|NCT01885078|521622505|FG001|Step-down Period|Adverse Event|0|||
144216491|NCT01750190|519986015|FG001|Overall Study|Lost to Follow-up|7|||
144216492|NCT01750190|519986014|FG000|Overall Study|Physician Decision|16|||
144216493|NCT01750190|519986015|FG001|Overall Study|Physician Decision|17|||
144216494|NCT01750190|519986014|FG000|Overall Study|Protocol Violation|6|||
144664590|NCT01885078|521622506|FG002|Step-down Period|Adverse Event|0|||
144664591|NCT01885078|521622507|FG003|Step-down Period|Adverse Event|0|||
144664592|NCT01885078|521622508|FG004|Step-down Period|Adverse Event|0|||
144664593|NCT01885078|521622509|FG005|Step-down Period|Adverse Event|0|||
144664594|NCT01885078|521622510|FG006|Step-down Period|Adverse Event|0|||
144216495|NCT01750190|519986015|FG001|Overall Study|Protocol Violation|5|||
144664595|NCT01885078|521622511|FG007|Step-down Period|Adverse Event|0|||
144664596|NCT01885078|521622512|FG008|Step-down Period|Adverse Event|29|||
144216496|NCT01750190|519986014|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
144216497|NCT01750190|519986015|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
144216498|NCT01750190|519986014|FG000|Overall Study|Withdrawal by Subject|83|||
144216499|NCT01750190|519986015|FG001|Overall Study|Withdrawal by Subject|89|||
144664597|NCT01885078|521622513|FG009|Step-down Period|Adverse Event|38|||
144664598|NCT01885078|521622504|FG000|Step-down Period|Withdrawal by Subject|0|||
144664599|NCT01885078|521622505|FG001|Step-down Period|Withdrawal by Subject|0|||
144664600|NCT01885078|521622506|FG002|Step-down Period|Withdrawal by Subject|0|||
144664601|NCT01885078|521622507|FG003|Step-down Period|Withdrawal by Subject|0|||
144664602|NCT01885078|521622508|FG004|Step-down Period|Withdrawal by Subject|0|||
144664603|NCT01885078|521622509|FG005|Step-down Period|Withdrawal by Subject|0|||
144664604|NCT01885078|521622510|FG006|Step-down Period|Withdrawal by Subject|0|||
144664605|NCT01885078|521622511|FG007|Step-down Period|Withdrawal by Subject|0|||
144664606|NCT01885078|521622512|FG008|Step-down Period|Withdrawal by Subject|25|||
144664607|NCT01885078|521622513|FG009|Step-down Period|Withdrawal by Subject|15|||
144664608|NCT01885078|521622504|FG000|Step-down Period|Physician Decision|0|||
144664609|NCT01885078|521622505|FG001|Step-down Period|Physician Decision|0|||
144664610|NCT01885078|521622506|FG002|Step-down Period|Physician Decision|0|||
144664611|NCT01885078|521622507|FG003|Step-down Period|Physician Decision|0|||
144664612|NCT01885078|521622508|FG004|Step-down Period|Physician Decision|0|||
144664613|NCT01885078|521622509|FG005|Step-down Period|Physician Decision|0|||
144664614|NCT01885078|521622510|FG006|Step-down Period|Physician Decision|0|||
144664615|NCT01885078|521622511|FG007|Step-down Period|Physician Decision|0|||
144664616|NCT01885078|521622512|FG008|Step-down Period|Physician Decision|7|||
144664617|NCT01885078|521622513|FG009|Step-down Period|Physician Decision|2|||
144664618|NCT01885078|521622504|FG000|Step-down Period|Death|0|||
144664619|NCT01885078|521622505|FG001|Step-down Period|Death|0|||
144664620|NCT01885078|521622506|FG002|Step-down Period|Death|0|||
144664621|NCT01885078|521622507|FG003|Step-down Period|Death|0|||
144664622|NCT01885078|521622508|FG004|Step-down Period|Death|0|||
144664623|NCT01885078|521622509|FG005|Step-down Period|Death|0|||
144664624|NCT01885078|521622510|FG006|Step-down Period|Death|0|||
144664625|NCT01885078|521622511|FG007|Step-down Period|Death|0|||
144664626|NCT01885078|521622512|FG008|Step-down Period|Death|4|||
144664627|NCT01885078|521622513|FG009|Step-down Period|Death|3|||
144664628|NCT01885078|521622504|FG000|Step-down Period|Lost to Follow-up|0|||
144664629|NCT01885078|521622505|FG001|Step-down Period|Lost to Follow-up|0|||
144664630|NCT01885078|521622506|FG002|Step-down Period|Lost to Follow-up|0|||
144664631|NCT01885078|521622507|FG003|Step-down Period|Lost to Follow-up|0|||
144664632|NCT01885078|521622508|FG004|Step-down Period|Lost to Follow-up|0|||
144664633|NCT01885078|521622509|FG005|Step-down Period|Lost to Follow-up|0|||
144664634|NCT01885078|521622510|FG006|Step-down Period|Lost to Follow-up|0|||
144664635|NCT01885078|521622511|FG007|Step-down Period|Lost to Follow-up|0|||
144664636|NCT01885078|521622512|FG008|Step-down Period|Lost to Follow-up|1|||
144664637|NCT01885078|521622513|FG009|Step-down Period|Lost to Follow-up|1|||
144664638|NCT01885078|521622504|FG000|Step-down Period|Lack of Efficacy|0|||
144664639|NCT01885078|521622505|FG001|Step-down Period|Lack of Efficacy|0|||
144664640|NCT01885078|521622506|FG002|Step-down Period|Lack of Efficacy|0|||
144664641|NCT01885078|521622507|FG003|Step-down Period|Lack of Efficacy|0|||
144664642|NCT01885078|521622508|FG004|Step-down Period|Lack of Efficacy|0|||
144664643|NCT01885078|521622509|FG005|Step-down Period|Lack of Efficacy|0|||
144664644|NCT01885078|521622510|FG006|Step-down Period|Lack of Efficacy|0|||
144664645|NCT01885078|521622511|FG007|Step-down Period|Lack of Efficacy|0|||
144664646|NCT01885078|521622512|FG008|Step-down Period|Lack of Efficacy|1|||
144664647|NCT01885078|521622513|FG009|Step-down Period|Lack of Efficacy|0|||
144664648|NCT01885078|521622504|FG000|Step-down Period|Protocol Violation|0|||
144664649|NCT01885078|521622505|FG001|Step-down Period|Protocol Violation|0|||
144664650|NCT01885078|521622506|FG002|Step-down Period|Protocol Violation|0|||
144664651|NCT01885078|521622507|FG003|Step-down Period|Protocol Violation|0|||
144664652|NCT01885078|521622508|FG004|Step-down Period|Protocol Violation|0|||
144664653|NCT01885078|521622509|FG005|Step-down Period|Protocol Violation|0|||
144664654|NCT01885078|521622510|FG006|Step-down Period|Protocol Violation|0|||
144664655|NCT01885078|521622511|FG007|Step-down Period|Protocol Violation|0|||
144664656|NCT01885078|521622512|FG008|Step-down Period|Protocol Violation|1|||
144664657|NCT01885078|521622513|FG009|Step-down Period|Protocol Violation|1|||
144664658|NCT02680587|521622514|FG000|Overall Study|Withdrawal by Subject|1|||
144664659|NCT02680587|521622515|FG001|Overall Study|Withdrawal by Subject|0|||
144664660|NCT00571688|521622522|FG000|Overall Study|Lost to Follow-up|3|||
144664661|NCT00571688|521622523|FG001|Overall Study|Lost to Follow-up|6|||
144733487|NCT01149473|521882073|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
144664662|NCT00571688|521622522|FG000|Overall Study|subject did not tolerate Consta|1|||
144664663|NCT00571688|521622523|FG001|Overall Study|subject did not tolerate Consta|0|||
144664664|NCT00571688|521622522|FG000|Overall Study|subject moved out of the area|1|||
144664665|NCT00571688|521622523|FG001|Overall Study|subject moved out of the area|0|||
144664666|NCT01194869|521622524|FG000|Overall Study|Disease Progression|2|||
144664667|NCT01194869|521622524|FG000|Overall Study|Toxicity|2|||
144664668|NCT04321252|521622525|FG000|Overall Study|Withdrawal by Subject|0|||
144733488|NCT01083693|521882079|FG000|Overall Study|Adverse Event|1|||
144664669|NCT04321252|521622526|FG001|Overall Study|Withdrawal by Subject|0|||
144664670|NCT04321252|521622527|FG002|Overall Study|Withdrawal by Subject|0|||
144664671|NCT04321252|521622528|FG003|Overall Study|Withdrawal by Subject|0|||
144664672|NCT04321252|521622529|FG004|Overall Study|Withdrawal by Subject|0|||
144664673|NCT04321252|521622530|FG005|Overall Study|Withdrawal by Subject|1|||
144664674|NCT04321252|521622531|FG006|Overall Study|Withdrawal by Subject|0|||
144664675|NCT04321252|521622532|FG007|Overall Study|Withdrawal by Subject|0|||
144733489|NCT01083693|521882080|FG001|Overall Study|Adverse Event|1|||
144664676|NCT04321252|521622533|FG008|Overall Study|Withdrawal by Subject|0|||
144664677|NCT01397552|521622536|FG000|Overall Study|Adverse Event|1|||
144664678|NCT01397552|521622537|FG001|Overall Study|Adverse Event|0|||
144664679|NCT01397552|521622536|FG000|Overall Study|Withdrawal by Subject|2|||
144664680|NCT01397552|521622537|FG001|Overall Study|Withdrawal by Subject|1|||
144664681|NCT00190983|521622538|FG000|Overall Study|Inevaluable (never treated)|2|||
144664682|NCT02287402|521622539|FG000|Treatment Period|Adverse Event|17|||
144664683|NCT02287402|521622539|FG000|Treatment Period|Voluntary Withdrawal|10|||
144664684|NCT02287402|521622539|FG000|Follow-up|Lost to Follow-up|1|||
144664685|NCT02287402|521622539|FG000|Follow-up|Voluntary Withdrawal|2|||
144664686|NCT01844830|521622540|FG000|Overall Study|Withdrawal by Subject|1|||
144664687|NCT01844830|521622541|FG001|Overall Study|Withdrawal by Subject|0|||
144664688|NCT04247815|521622542|FG000|Overall Study|Adverse Event|1|||
144664689|NCT04247815|521622543|FG001|Overall Study|Adverse Event|0|||
144664690|NCT04247815|521622542|FG000|Overall Study|Withdrawal by Subject|1|||
144664691|NCT04247815|521622543|FG001|Overall Study|Withdrawal by Subject|0|||
144664692|NCT04247815|521622542|FG000|Overall Study|Protocol Violation|0|||
144664693|NCT04247815|521622543|FG001|Overall Study|Protocol Violation|1|||
144664694|NCT03150095|521622557|FG000|Overall Study|Death|0|||
144664695|NCT03150095|521622558|FG001|Overall Study|Death|1|||
144664696|NCT03150095|521622557|FG000|Overall Study|Lost to Follow-up|1|||
144664697|NCT03150095|521622558|FG001|Overall Study|Lost to Follow-up|1|||
144733490|NCT01083693|521882081|FG002|Overall Study|Adverse Event|0|||
144733491|NCT01083693|521882079|FG000|Overall Study|Lost to Follow-up|2|||
144733492|NCT01083693|521882080|FG001|Overall Study|Lost to Follow-up|0|||
144733493|NCT01083693|521882081|FG002|Overall Study|Lost to Follow-up|2|||
144733494|NCT01083693|521882079|FG000|Overall Study|Lack of effectiveness|13|||
144733495|NCT01083693|521882080|FG001|Overall Study|Lack of effectiveness|2|||
144733496|NCT01083693|521882081|FG002|Overall Study|Lack of effectiveness|2|||
144733497|NCT01083693|521882079|FG000|Overall Study|Patient Moved|0|||
144733498|NCT01083693|521882080|FG001|Overall Study|Patient Moved|1|||
144733499|NCT01083693|521882081|FG002|Overall Study|Patient Moved|0|||
144733500|NCT01083693|521882079|FG000|Overall Study|Complete remission|0|||
144733501|NCT01083693|521882080|FG001|Overall Study|Complete remission|1|||
144733502|NCT01083693|521882081|FG002|Overall Study|Complete remission|0|||
144733503|NCT01083693|521882079|FG000|Overall Study|Other medical condition/surgery|1|||
144733504|NCT01083693|521882080|FG001|Overall Study|Other medical condition/surgery|1|||
144733505|NCT01083693|521882081|FG002|Overall Study|Other medical condition/surgery|0|||
144733506|NCT01083693|521882079|FG000|Overall Study|Withdrawal by Subject|3|||
144733507|NCT01083693|521882080|FG001|Overall Study|Withdrawal by Subject|0|||
144733508|NCT01083693|521882081|FG002|Overall Study|Withdrawal by Subject|2|||
144733509|NCT01083693|521882079|FG000|Overall Study|Reason unknown|0|||
144733510|NCT01083693|521882080|FG001|Overall Study|Reason unknown|0|||
144733511|NCT01083693|521882081|FG002|Overall Study|Reason unknown|1|||
144733512|NCT04567186|521882082|FG000|Period 1|COVID-19 related|1|||
144733513|NCT04567186|521882083|FG001|Period 1|COVID-19 related|0|||
144733514|NCT04567186|521882082|FG000|Period 1|Protocol Violation|0|||
144733515|NCT04567186|521882083|FG001|Period 1|Protocol Violation|1|||
144733516|NCT04567186|521882082|FG000|Period 1|Adverse Event|0|||
144733517|NCT04567186|521882083|FG001|Period 1|Adverse Event|2|||
144733518|NCT04567186|521882082|FG000|Period 2|COVID-19 Related|0|||
144733519|NCT04567186|521882083|FG001|Period 2|COVID-19 Related|1|||
144733520|NCT04567186|521882082|FG000|Period 2|Protocol Violation|0|||
144733521|NCT04567186|521882083|FG001|Period 2|Protocol Violation|1|||
144733522|NCT04567186|521882082|FG000|Period 2|Lost to Follow-up|0|||
144733523|NCT04567186|521882083|FG001|Period 2|Lost to Follow-up|1|||
144733524|NCT04567186|521882082|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
144733525|NCT04567186|521882083|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
144733526|NCT04274686|521882084|FG000|Overall Study|Physician Decision|1|||
144664698|NCT03150095|521622557|FG000|Overall Study|Withdrawal by Subject|4|||
144664699|NCT03150095|521622558|FG001|Overall Study|Withdrawal by Subject|0|||
144733527|NCT04274686|521882085|FG001|Overall Study|Physician Decision|0|||
144733528|NCT00376623|521882086|FG000|Overall Study|Progressive disease|35|||
144733529|NCT00376623|521882087|FG001|Overall Study|Progressive disease|22|||
144733530|NCT00376623|521882088|FG002|Overall Study|Progressive disease|17|||
144733531|NCT00376623|521882086|FG000|Overall Study|Lost to Follow-up|0|||
144733532|NCT00376623|521882087|FG001|Overall Study|Lost to Follow-up|1|||
144733533|NCT00376623|521882088|FG002|Overall Study|Lost to Follow-up|0|||
144733534|NCT00376623|521882086|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
144664700|NCT03150095|521622557|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
144664701|NCT03150095|521622558|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
144733535|NCT00376623|521882087|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
144733536|NCT00376623|521882088|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
144733537|NCT00376623|521882086|FG000|Overall Study|Not treated with BI 2536|1|||
144733538|NCT00376623|521882087|FG001|Overall Study|Not treated with BI 2536|0|||
144733539|NCT00376623|521882088|FG002|Overall Study|Not treated with BI 2536|0|||
144733540|NCT00376623|521882086|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
144664702|NCT03943953|521622561|FG000|Trial of ITG 1|Lost to Follow-up|19|||
144664703|NCT03943953|521622562|FG001|Trial of ITG 1|Lost to Follow-up|1|||
144664704|NCT03943953|521622561|FG000|Trial of ITG 2|Lost to Follow-up|8|||
144664705|NCT03943953|521622562|FG001|Trial of ITG 2|Lost to Follow-up|0|||
144664706|NCT03943953|521622561|FG000|Trial of ITG 3|Lost to Follow-up|2|||
144664707|NCT03943953|521622562|FG001|Trial of ITG 3|Lost to Follow-up|0|||
144664708|NCT03943953|521622561|FG000|Trial of ITG 4|Lost to Follow-up|2|||
144664709|NCT03943953|521622562|FG001|Trial of ITG 4|Lost to Follow-up|0|||
144664710|NCT01153893|521622565|FG000|Overall Study|Adverse Event|1|||
144664711|NCT01153893|521622566|FG001|Overall Study|Adverse Event|0|||
144664712|NCT01354431|521622567|FG000|Pre-Treatment Period|Not reported|1|||
144664713|NCT01354431|521622568|FG001|Pre-Treatment Period|Not reported|0|||
144664714|NCT01354431|521622569|FG002|Pre-Treatment Period|Not reported|0|||
144664715|NCT01354431|521622567|FG000|Treatment Period|Disease Progression|50|||
144664716|NCT01354431|521622568|FG001|Treatment Period|Disease Progression|40|||
144664717|NCT01354431|521622569|FG002|Treatment Period|Disease Progression|44|||
144664718|NCT01354431|521622567|FG000|Treatment Period|Study Drug Toxicity|5|||
144664719|NCT01354431|521622568|FG001|Treatment Period|Study Drug Toxicity|8|||
144664720|NCT01354431|521622569|FG002|Treatment Period|Study Drug Toxicity|4|||
144216500|NCT01750190|519986014|FG000|Overall Study|Kidney Transplant|8|||
144664721|NCT01354431|521622567|FG000|Treatment Period|Death|0|||
144664722|NCT01354431|521622568|FG001|Treatment Period|Death|1|||
144664723|NCT01354431|521622569|FG002|Treatment Period|Death|0|||
144664724|NCT01354431|521622567|FG000|Treatment Period|AE unrelated to study drug|1|||
144664725|NCT01354431|521622568|FG001|Treatment Period|AE unrelated to study drug|2|||
144664726|NCT01354431|521622569|FG002|Treatment Period|AE unrelated to study drug|5|||
144664727|NCT01354431|521622567|FG000|Treatment Period|Participant request to discontinue|2|||
144664728|NCT01354431|521622568|FG001|Treatment Period|Participant request to discontinue|2|||
144664729|NCT01354431|521622569|FG002|Treatment Period|Participant request to discontinue|1|||
144664730|NCT01354431|521622567|FG000|Treatment Period|Participant withdrew consent|0|||
144664731|NCT01354431|521622568|FG001|Treatment Period|Participant withdrew consent|1|||
144664732|NCT01354431|521622569|FG002|Treatment Period|Participant withdrew consent|0|||
144664733|NCT01354431|521622567|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
144664734|NCT01354431|521622568|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
144664735|NCT01354431|521622569|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
144216501|NCT01750190|519986015|FG001|Overall Study|Kidney Transplant|4|||
144733541|NCT00376623|521882087|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
144733542|NCT00376623|521882088|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
144216502|NCT01750190|519986014|FG000|Overall Study|Dialysis|22|||
144216503|NCT01750190|519986015|FG001|Overall Study|Dialysis|8|||
144216504|NCT01750190|519986014|FG000|Overall Study|Other than Specified|13|||
144216505|NCT01750190|519986015|FG001|Overall Study|Other than Specified|4|||
144216506|NCT02955212|519986022|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
144216507|NCT02955212|519986023|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
144664736|NCT01551758|521622578|FG000|Overall Study|Adverse Event|29|||
144664737|NCT01551758|521622579|FG001|Overall Study|Adverse Event|43|||
144664738|NCT01551758|521622578|FG000|Overall Study|Lack of Efficacy|0|||
144664739|NCT01551758|521622579|FG001|Overall Study|Lack of Efficacy|1|||
144664740|NCT01551758|521622578|FG000|Overall Study|Protocol Violation|5|||
144664741|NCT01551758|521622579|FG001|Overall Study|Protocol Violation|6|||
144664742|NCT01551758|521622578|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
144664743|NCT01551758|521622579|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
144664744|NCT01551758|521622578|FG000|Overall Study|Lost to Follow-up|29|||
144216508|NCT02955212|519986022|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
144216509|NCT02955212|519986023|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
144216510|NCT02955212|519986022|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
144664745|NCT01551758|521622579|FG001|Overall Study|Lost to Follow-up|25|||
144664746|NCT01551758|521622578|FG000|Overall Study|Physician Decision|9|||
144664747|NCT01551758|521622579|FG001|Overall Study|Physician Decision|3|||
144664748|NCT01551758|521622578|FG000|Overall Study|Withdrawal by Subject|14|||
144664749|NCT01551758|521622579|FG001|Overall Study|Withdrawal by Subject|17|||
144664750|NCT02128763|521622580|FG000|Overall Study|Death|1|||
144216511|NCT02955212|519986023|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
144216512|NCT02955212|519986022|FG000|Period 1: Double-blind Treatment Period|Other|3|||
144216513|NCT02955212|519986023|FG001|Period 1: Double-blind Treatment Period|Other|2|||
144216514|NCT02955212|519986022|FG000|Period 2: Open-label Extension|Adverse Event|11|||
144216515|NCT02955212|519986023|FG001|Period 2: Open-label Extension|Adverse Event|7|||
144664751|NCT02128763|521622581|FG001|Overall Study|Death|0|||
144664752|NCT02128763|521622580|FG000|Overall Study|Lost to Follow-up|19|||
144664753|NCT02128763|521622581|FG001|Overall Study|Lost to Follow-up|16|||
144664754|NCT00916370|521622582|FG000|Overall Study|Death|3|||
144664755|NCT00916370|521622583|FG001|Overall Study|Death|1|||
144664756|NCT00916370|521622582|FG000|Overall Study|Withdrawal by Subject|2|||
144664757|NCT00916370|521622583|FG001|Overall Study|Withdrawal by Subject|0|||
144664758|NCT00916370|521622582|FG000|Overall Study|Physician Decision|0|||
144664759|NCT00916370|521622583|FG001|Overall Study|Physician Decision|1|||
144664760|NCT02921919|521622584|FG000|Overall Study|Other|5|||
144664761|NCT02921919|521622585|FG001|Overall Study|Other|6|||
144664762|NCT02921919|521622584|FG000|Overall Study|Lost to Follow-up|0|||
144664763|NCT02921919|521622585|FG001|Overall Study|Lost to Follow-up|1|||
144664764|NCT02921919|521622584|FG000|Overall Study|Withdrawal by Subject|5|||
144664765|NCT02921919|521622585|FG001|Overall Study|Withdrawal by Subject|1|||
144664766|NCT02921919|521622584|FG000|Overall Study|Disease Progression|47|||
144664767|NCT02921919|521622585|FG001|Overall Study|Disease Progression|38|||
144664768|NCT02921919|521622584|FG000|Overall Study|Physician Decision|3|||
144664769|NCT02921919|521622585|FG001|Overall Study|Physician Decision|2|||
144664770|NCT02921919|521622584|FG000|Overall Study|Adverse Event|6|||
144664771|NCT02921919|521622585|FG001|Overall Study|Adverse Event|4|||
144664772|NCT00980980|521622586|FG000|Overall Study|Withdrawal by Hospital|0|||
144664773|NCT00980980|521622587|FG001|Overall Study|Withdrawal by Hospital|1|||
144664774|NCT00980980|521622588|FG002|Overall Study|Withdrawal by Hospital|0|||
144664775|NCT03666858|521622590|FG000|Cohort 1|Adverse Event|1|||
144664776|NCT03666858|521622591|FG001|Cohort 1|Adverse Event|0|||
144664777|NCT03666858|521622590|FG000|Cohort 2|Adverse Event|0|||
144664778|NCT03666858|521622591|FG001|Cohort 2|Adverse Event|1|||
144664779|NCT00121992|521622592|FG000|Overall Study|Treatment not received|2|||
144664780|NCT00121992|521622593|FG001|Overall Study|Treatment not received|11|||
144664781|NCT00414960|521622594|FG000|Overall Study|Adverse Event|4|||
144664782|NCT00414960|521622595|FG001|Overall Study|Adverse Event|0|||
144664783|NCT00414960|521622594|FG000|Overall Study|Withdrawal by Subject|3|||
144664784|NCT00414960|521622595|FG001|Overall Study|Withdrawal by Subject|0|||
144664785|NCT00414960|521622594|FG000|Overall Study|Physician Decision|0|||
144664786|NCT00414960|521622595|FG001|Overall Study|Physician Decision|1|||
144664787|NCT01608724|521622596|FG000|Overall Study|Withdrawal by Subject|131|||
144664788|NCT01608724|521622596|FG000|Overall Study|Lost to Follow-up|41|||
144664789|NCT01608724|521622596|FG000|Overall Study|Study-specific discontinuation criteria|32|||
144664790|NCT01608724|521622596|FG000|Overall Study|Adverse Event|29|||
144664791|NCT01608724|521622596|FG000|Overall Study|Protocol Violation|6|||
144664792|NCT01608724|521622596|FG000|Overall Study|bood sugar too high, etc.|3|||
144664793|NCT01608724|521622596|FG000|Overall Study|Safety reasons|1|||
144664794|NCT00363246|521622597|FG000|Overall Study|Death|40|||
144664795|NCT00363246|521622597|FG000|Overall Study|Withdrawal by Subject|19|||
144664796|NCT00363246|521622597|FG000|Overall Study|Lost to Follow-up|14|||
144664797|NCT00363246|521622597|FG000|Overall Study|Bad health|6|||
144664798|NCT00363246|521622597|FG000|Overall Study|Stopped using wheelchair|11|||
144664799|NCT00363246|521622597|FG000|Overall Study|Subject expressed security concerns|2|||
144664800|NCT00363246|521622597|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
144664801|NCT00675103|521622598|FG000|Overall Study|Lack of Efficacy|2|||
144664802|NCT00675103|521622598|FG000|Overall Study|Adverse Event|1|||
144664803|NCT01244191|521622602|FG000|Overall Study|Progressive disease|295|||
144664804|NCT01244191|521622603|FG001|Overall Study|Progressive disease|350|||
144664805|NCT01244191|521622602|FG000|Overall Study|Clinical disease progression|54|||
144664806|NCT01244191|521622603|FG001|Overall Study|Clinical disease progression|36|||
144664807|NCT01244191|521622602|FG000|Overall Study|Adverse Event|65|||
144664808|NCT01244191|521622603|FG001|Overall Study|Adverse Event|48|||
144664809|NCT01244191|521622602|FG000|Overall Study|Death|22|||
144664810|NCT01244191|521622603|FG001|Overall Study|Death|29|||
144664811|NCT01244191|521622602|FG000|Overall Study|Lost to Follow-up|0|||
144664812|NCT01244191|521622603|FG001|Overall Study|Lost to Follow-up|2|||
144664813|NCT01244191|521622602|FG000|Overall Study|Protocol Violation|1|||
144664814|NCT01244191|521622603|FG001|Overall Study|Protocol Violation|2|||
144664815|NCT01244191|521622602|FG000|Overall Study|Withdrawal by Subject|31|||
144664816|NCT01244191|521622603|FG001|Overall Study|Withdrawal by Subject|23|||
144664817|NCT01244191|521622602|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
144664818|NCT01244191|521622603|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
144664819|NCT00808249|521622611|FG000|Overall Study|Adverse Event|4|||
144664820|NCT00808249|521622612|FG001|Overall Study|Adverse Event|7|||
144664821|NCT00808249|521622613|FG002|Overall Study|Adverse Event|10|||
144664822|NCT00808249|521622614|FG003|Overall Study|Adverse Event|6|||
144664823|NCT00808249|521622611|FG000|Overall Study|Lost to Follow-up|2|||
144664824|NCT00808249|521622612|FG001|Overall Study|Lost to Follow-up|3|||
144664825|NCT00808249|521622613|FG002|Overall Study|Lost to Follow-up|3|||
144664826|NCT00808249|521622614|FG003|Overall Study|Lost to Follow-up|5|||
144664827|NCT00808249|521622611|FG000|Overall Study|Withdrawal by Subject|4|||
144664828|NCT00808249|521622612|FG001|Overall Study|Withdrawal by Subject|0|||
144664829|NCT00808249|521622613|FG002|Overall Study|Withdrawal by Subject|2|||
144664830|NCT00808249|521622614|FG003|Overall Study|Withdrawal by Subject|4|||
144664831|NCT00808249|521622611|FG000|Overall Study|Protocol Violation|3|||
144664832|NCT00808249|521622612|FG001|Overall Study|Protocol Violation|3|||
144664833|NCT00808249|521622613|FG002|Overall Study|Protocol Violation|3|||
144664834|NCT00808249|521622614|FG003|Overall Study|Protocol Violation|0|||
144664835|NCT00808249|521622611|FG000|Overall Study|Lack of Efficacy|1|||
144664836|NCT00808249|521622612|FG001|Overall Study|Lack of Efficacy|1|||
144664837|NCT00808249|521622613|FG002|Overall Study|Lack of Efficacy|0|||
144664838|NCT00808249|521622614|FG003|Overall Study|Lack of Efficacy|0|||
144664839|NCT00808249|521622611|FG000|Overall Study|study specific discontinuation criteria|1|||
144664840|NCT00808249|521622612|FG001|Overall Study|study specific discontinuation criteria|0|||
144664841|NCT00808249|521622613|FG002|Overall Study|study specific discontinuation criteria|1|||
144664842|NCT00808249|521622614|FG003|Overall Study|study specific discontinuation criteria|0|||
144664843|NCT00808249|521622611|FG000|Overall Study|All other reasons|2|||
144664844|NCT00808249|521622612|FG001|Overall Study|All other reasons|1|||
144664845|NCT00808249|521622613|FG002|Overall Study|All other reasons|3|||
144664846|NCT00808249|521622614|FG003|Overall Study|All other reasons|1|||
144664847|NCT01511107|521622617|FG000|Overall Study|Ineligible|3|||
144664848|NCT01511107|521622618|FG001|Overall Study|Ineligible|2|||
144664849|NCT01511107|521622617|FG000|Overall Study|Lost to Follow-up|10|||
144664850|NCT01511107|521622618|FG001|Overall Study|Lost to Follow-up|19|||
144664851|NCT01511107|521622617|FG000|Overall Study|Withdrawal by Subject|9|||
144664852|NCT01511107|521622618|FG001|Overall Study|Withdrawal by Subject|20|||
144664853|NCT01179347|521624173|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
144664854|NCT01179347|521624174|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
144664855|NCT01179347|521624173|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
144664856|NCT01179347|521624174|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
144664857|NCT01179347|521624173|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
144664858|NCT01179347|521624174|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
144664859|NCT01179347|521624173|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
144664860|NCT01179347|521624174|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
144664861|NCT01179347|521624173|FG000|Double-blind Period (12 Weeks)|Other|2|||
144664862|NCT01179347|521624174|FG001|Double-blind Period (12 Weeks)|Other|4|||
144664863|NCT01179347|521624173|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
144664864|NCT01179347|521624174|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
144664865|NCT01179347|521624173|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
144664866|NCT01179347|521624174|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
144664867|NCT01179347|521624173|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
144664868|NCT01179347|521624174|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
144664869|NCT01179347|521624173|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
144664870|NCT01179347|521624174|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
144664871|NCT01179347|521624173|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
144664872|NCT01179347|521624174|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
144664873|NCT01179347|521624173|FG000|Open-label Period (12 Weeks)|Other|7|||
144664874|NCT01179347|521624174|FG001|Open-label Period (12 Weeks)|Other|4|||
144664875|NCT01337167|521624175|FG000|Infant Series|Adverse Event|1|||
144664876|NCT01337167|521624176|FG001|Infant Series|Adverse Event|1|||
144664877|NCT01337167|521624175|FG000|Infant Series|Death|1|||
144664878|NCT01337167|521624176|FG001|Infant Series|Death|1|||
144664879|NCT01337167|521624175|FG000|Infant Series|Lost to Follow-up|13|||
144664880|NCT01337167|521624176|FG001|Infant Series|Lost to Follow-up|7|||
144664881|NCT01337167|521624175|FG000|Infant Series|Non-compliance with study drug|2|||
144664882|NCT01337167|521624176|FG001|Infant Series|Non-compliance with study drug|1|||
144664883|NCT01337167|521624175|FG000|Infant Series|Physician Decision|3|||
144664884|NCT01337167|521624176|FG001|Infant Series|Physician Decision|1|||
144664885|NCT01337167|521624175|FG000|Infant Series|Protocol Violation|22|||
144664886|NCT01337167|521624176|FG001|Infant Series|Protocol Violation|9|||
144664887|NCT01337167|521624175|FG000|Infant Series|Withdrawal by Subject|15|||
144664888|NCT01337167|521624176|FG001|Infant Series|Withdrawal by Subject|4|||
144664889|NCT01337167|521624175|FG000|Infant Series|Randomized but not vaccinated|5|||
144664890|NCT01337167|521624176|FG001|Infant Series|Randomized but not vaccinated|3|||
144664891|NCT01337167|521624175|FG000|Interim Period|Lost to Follow-up|51|||
144664892|NCT01337167|521624176|FG001|Interim Period|Lost to Follow-up|23|||
144664893|NCT01337167|521624175|FG000|Interim Period|Non-compliance with study drug|1|||
144664894|NCT01337167|521624176|FG001|Interim Period|Non-compliance with study drug|0|||
144664895|NCT01337167|521624175|FG000|Interim Period|Physician Decision|6|||
144664896|NCT01337167|521624176|FG001|Interim Period|Physician Decision|3|||
144664897|NCT01337167|521624175|FG000|Interim Period|Protocol Violation|5|||
144664898|NCT01337167|521624176|FG001|Interim Period|Protocol Violation|3|||
144664899|NCT01337167|521624175|FG000|Interim Period|Withdrawal by Subject|18|||
144664900|NCT01337167|521624176|FG001|Interim Period|Withdrawal by Subject|10|||
144664901|NCT01337167|521624175|FG000|Interim Period|Other protocol criterion not met|0|||
144664902|NCT01337167|521624176|FG001|Interim Period|Other protocol criterion not met|1|||
144664903|NCT01337167|521624175|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
144664904|NCT01337167|521624176|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
144664905|NCT01337167|521624175|FG000|Toddler Vaccinations|Protocol Violation|0|||
144664906|NCT01337167|521624176|FG001|Toddler Vaccinations|Protocol Violation|1|||
144664907|NCT01337167|521624175|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
144664908|NCT01337167|521624176|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
144664909|NCT01646398|521624177|FG000|Overall Study|Withdrawal by Subject|1|||
144664910|NCT01646398|521624178|FG001|Overall Study|Withdrawal by Subject|0|||
144664911|NCT01827319|521624179|FG000|Overall Study|Lost to Follow-up|3|||
144664912|NCT03947255|521624181|FG000|Overall Study|Study Closure by Sponsor|2|||
144664913|NCT03947255|521624182|FG001|Overall Study|Study Closure by Sponsor|2|||
144664914|NCT03947255|521624181|FG000|Overall Study|Withdrawal by Subject|2|||
144664915|NCT03947255|521624182|FG001|Overall Study|Withdrawal by Subject|2|||
144664916|NCT03947255|521624181|FG000|Overall Study|Lost to Follow-up|2|||
144664917|NCT03947255|521624182|FG001|Overall Study|Lost to Follow-up|0|||
144216516|NCT02955212|519986022|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
144216517|NCT02955212|519986023|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
144216518|NCT02955212|519986022|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
144216519|NCT02955212|519986023|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
144664918|NCT03947255|521624181|FG000|Overall Study|Death|0|||
144664919|NCT03947255|521624182|FG001|Overall Study|Death|2|||
144664920|NCT02499575|521624183|FG000|Overall Study|Protocol Violation|0|||
144664921|NCT02499575|521624184|FG001|Overall Study|Protocol Violation|1|||
144664922|NCT00574119|521624185|FG000|Overall Study|Adverse Event|1|||
144664923|NCT00574119|521624185|FG000|Overall Study|Protocol Violation|1|||
144664924|NCT00574119|521624185|FG000|Overall Study|Withdrawal by Subject|1|||
144664925|NCT00574119|521624185|FG000|Overall Study|Physician Decision|1|||
144664926|NCT02586077|521624193|FG000|Overall Study|Withdrawal by Subject|1|||
144664927|NCT02586077|521624193|FG000|Overall Study|Physician Decision|4|||
144664928|NCT02586077|521624193|FG000|Overall Study|Lost to Follow-up|3|||
144664929|NCT01245764|521624194|FG000|Study Phase A|Other|3|||
144664930|NCT01245764|521624195|FG001|Study Phase A|Other|2|||
144664931|NCT01245764|521624196|FG002|Study Phase A|Other|3|||
144664932|NCT01245764|521624197|FG003|Study Phase A|Other|1|||
144664933|NCT01245764|521624194|FG000|Study Phase A|Protocol Violation|6|||
144664934|NCT01245764|521624195|FG001|Study Phase A|Protocol Violation|3|||
144664935|NCT01245764|521624196|FG002|Study Phase A|Protocol Violation|2|||
144664936|NCT01245764|521624197|FG003|Study Phase A|Protocol Violation|2|||
144664937|NCT01245764|521624194|FG000|Study Phase A|Lost to Follow-up|0|||
144664938|NCT01245764|521624195|FG001|Study Phase A|Lost to Follow-up|0|||
144664939|NCT01245764|521624196|FG002|Study Phase A|Lost to Follow-up|5|||
144664940|NCT01245764|521624197|FG003|Study Phase A|Lost to Follow-up|0|||
144664941|NCT00003476|521624198|FG000|Overall Study|Not evaluable|1|||
144664942|NCT03297216|521624201|FG000|Overall Study|Death|0|||
144664943|NCT03297216|521624202|FG001|Overall Study|Death|1|||
144664944|NCT03297216|521624201|FG000|Overall Study|Miscarriage|0|||
144664945|NCT03297216|521624202|FG001|Overall Study|Miscarriage|2|||
144664946|NCT03297216|521624201|FG000|Overall Study|Lost to Follow-up|3|||
144664947|NCT03297216|521624202|FG001|Overall Study|Lost to Follow-up|2|||
144664948|NCT00781963|521624203|FG000|Overall Study|Death|3|||
144664949|NCT00781963|521624204|FG001|Overall Study|Death|0|||
144664950|NCT00781963|521624203|FG000|Overall Study|Lost to Follow-up|2|||
144664951|NCT00781963|521624204|FG001|Overall Study|Lost to Follow-up|1|||
144664952|NCT00781963|521624203|FG000|Overall Study|Withdrawal by Subject|3|||
144664953|NCT00781963|521624204|FG001|Overall Study|Withdrawal by Subject|1|||
144664954|NCT00781963|521624203|FG000|Overall Study|Refused follow-up|9|||
144664955|NCT00781963|521624204|FG001|Overall Study|Refused follow-up|0|||
144216520|NCT02955212|519986022|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
144216521|NCT02955212|519986023|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
144216522|NCT02955212|519986022|FG000|Period 2: Open-label Extension|Other|2|||
144216523|NCT02955212|519986023|FG001|Period 2: Open-label Extension|Other|4|||
144216524|NCT02454933|519986032|FG000|Overall Study|Progressive disease|10|||
144216525|NCT02454933|519986033|FG001|Overall Study|Progressive disease|7|||
144216526|NCT02454933|519986032|FG000|Overall Study|Adverse Event|1|||
144664956|NCT00696436|521624208|FG000|Overall Study|Adverse Event|7|||
144664957|NCT00696436|521624209|FG001|Overall Study|Adverse Event|9|||
144664958|NCT00696436|521624210|FG002|Overall Study|Adverse Event|8|||
144664959|NCT00696436|521624211|FG003|Overall Study|Adverse Event|6|||
144664960|NCT00696436|521624212|FG004|Overall Study|Adverse Event|4|||
144216527|NCT02454933|519986033|FG001|Overall Study|Adverse Event|1|||
144216528|NCT02454933|519986032|FG000|Overall Study|Withdrawal by Subject|0|||
144216529|NCT02454933|519986033|FG001|Overall Study|Withdrawal by Subject|3|||
144216530|NCT02454933|519986032|FG000|Overall Study|Lost to Follow-up|1|||
144664961|NCT00696436|521624208|FG000|Overall Study|Protocol Violation|3|||
144664962|NCT00696436|521624209|FG001|Overall Study|Protocol Violation|2|||
144664963|NCT00696436|521624210|FG002|Overall Study|Protocol Violation|2|||
144664964|NCT00696436|521624211|FG003|Overall Study|Protocol Violation|0|||
144664965|NCT00696436|521624212|FG004|Overall Study|Protocol Violation|1|||
144664966|NCT00696436|521624208|FG000|Overall Study|Lost to Follow-up|1|||
144664967|NCT00696436|521624209|FG001|Overall Study|Lost to Follow-up|6|||
144664968|NCT00696436|521624210|FG002|Overall Study|Lost to Follow-up|2|||
144664969|NCT00696436|521624211|FG003|Overall Study|Lost to Follow-up|4|||
144664970|NCT00696436|521624212|FG004|Overall Study|Lost to Follow-up|3|||
144664971|NCT00696436|521624208|FG000|Overall Study|Withdrawal by Subject|4|||
144664972|NCT00696436|521624209|FG001|Overall Study|Withdrawal by Subject|11|||
144664973|NCT00696436|521624210|FG002|Overall Study|Withdrawal by Subject|5|||
144664974|NCT00696436|521624211|FG003|Overall Study|Withdrawal by Subject|7|||
144664975|NCT00696436|521624212|FG004|Overall Study|Withdrawal by Subject|1|||
144664976|NCT00696436|521624208|FG000|Overall Study|Lack of Efficacy|3|||
144664977|NCT00696436|521624209|FG001|Overall Study|Lack of Efficacy|1|||
144664978|NCT00696436|521624210|FG002|Overall Study|Lack of Efficacy|5|||
144664979|NCT00696436|521624211|FG003|Overall Study|Lack of Efficacy|2|||
144664980|NCT00696436|521624212|FG004|Overall Study|Lack of Efficacy|4|||
144664981|NCT00696436|521624208|FG000|Overall Study|Participant Unavailability|2|||
144664982|NCT00696436|521624209|FG001|Overall Study|Participant Unavailability|0|||
144664983|NCT00696436|521624210|FG002|Overall Study|Participant Unavailability|2|||
144664984|NCT00696436|521624211|FG003|Overall Study|Participant Unavailability|1|||
144664985|NCT00696436|521624212|FG004|Overall Study|Participant Unavailability|0|||
144664986|NCT00696436|521624208|FG000|Overall Study|Administrative Error|2|||
144664987|NCT00696436|521624209|FG001|Overall Study|Administrative Error|0|||
144664988|NCT00696436|521624210|FG002|Overall Study|Administrative Error|2|||
144664989|NCT00696436|521624211|FG003|Overall Study|Administrative Error|0|||
144664990|NCT00696436|521624212|FG004|Overall Study|Administrative Error|0|||
144664991|NCT00696436|521624208|FG000|Overall Study|Participant Non-compliance|0|||
144664992|NCT00696436|521624209|FG001|Overall Study|Participant Non-compliance|0|||
144664993|NCT00696436|521624210|FG002|Overall Study|Participant Non-compliance|1|||
144664994|NCT00696436|521624211|FG003|Overall Study|Participant Non-compliance|2|||
144664995|NCT00696436|521624212|FG004|Overall Study|Participant Non-compliance|0|||
144664996|NCT00696436|521624208|FG000|Overall Study|Administrative Decision|1|||
144664997|NCT00696436|521624209|FG001|Overall Study|Administrative Decision|0|||
144664998|NCT00696436|521624210|FG002|Overall Study|Administrative Decision|0|||
144664999|NCT00696436|521624211|FG003|Overall Study|Administrative Decision|0|||
144665000|NCT00696436|521624212|FG004|Overall Study|Administrative Decision|0|||
144665001|NCT00696436|521624208|FG000|Overall Study|Missing|0|||
144665002|NCT00696436|521624209|FG001|Overall Study|Missing|1|||
144665003|NCT00696436|521624210|FG002|Overall Study|Missing|1|||
144665004|NCT00696436|521624211|FG003|Overall Study|Missing|0|||
144665005|NCT00696436|521624212|FG004|Overall Study|Missing|0|||
144665006|NCT01830816|521624218|FG000|Overall Study|Progressive Disease|12|||
144665007|NCT01830816|521624219|FG001|Overall Study|Progressive Disease|7|||
144665008|NCT01830816|521624220|FG002|Overall Study|Progressive Disease|7|||
144665009|NCT01830816|521624218|FG000|Overall Study|Adverse Event|3|||
144665010|NCT01830816|521624219|FG001|Overall Study|Adverse Event|4|||
144665011|NCT01830816|521624220|FG002|Overall Study|Adverse Event|0|||
144665012|NCT01830816|521624218|FG000|Overall Study|Study Terminated by Sponsor|1|||
144665013|NCT01830816|521624219|FG001|Overall Study|Study Terminated by Sponsor|1|||
144665014|NCT01830816|521624220|FG002|Overall Study|Study Terminated by Sponsor|0|||
144665015|NCT01830816|521624218|FG000|Overall Study|Withdrawal by Subject|1|||
144665016|NCT01830816|521624219|FG001|Overall Study|Withdrawal by Subject|1|||
144665017|NCT01830816|521624220|FG002|Overall Study|Withdrawal by Subject|0|||
144665018|NCT01830816|521624218|FG000|Overall Study|Lost to Follow-up|0|||
144665019|NCT01830816|521624219|FG001|Overall Study|Lost to Follow-up|1|||
144665020|NCT01830816|521624220|FG002|Overall Study|Lost to Follow-up|0|||
144665021|NCT01830816|521624218|FG000|Overall Study|Symptomatic Deterioration|1|||
144665022|NCT01830816|521624219|FG001|Overall Study|Symptomatic Deterioration|0|||
144665023|NCT01830816|521624220|FG002|Overall Study|Symptomatic Deterioration|0|||
144665024|NCT01830816|521624218|FG000|Overall Study|Reason not Specified|2|||
144665025|NCT01830816|521624219|FG001|Overall Study|Reason not Specified|0|||
144665026|NCT01830816|521624220|FG002|Overall Study|Reason not Specified|0|||
144665027|NCT02716194|521624221|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
144665028|NCT02716194|521624222|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
144665029|NCT02716194|521624223|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
144665030|NCT00363051|521624227|FG000|Overall Study|Adminstrative problems|1|||
144665031|NCT00363051|521624228|FG001|Overall Study|Adminstrative problems|1|||
144665032|NCT00363051|521624227|FG000|Overall Study|Adverse Event|21|||
144665033|NCT00363051|521624228|FG001|Overall Study|Adverse Event|12|||
144665034|NCT00363051|521624227|FG000|Overall Study|New Cancer Therapy|2|||
144665035|NCT00363051|521624228|FG001|Overall Study|New Cancer Therapy|1|||
144665036|NCT00363051|521624227|FG000|Overall Study|Withdrawal by Subject|11|||
144665037|NCT00363051|521624228|FG001|Overall Study|Withdrawal by Subject|3|||
144665038|NCT00363051|521624227|FG000|Overall Study|Lost to Follow-up|0|||
144665039|NCT00363051|521624228|FG001|Overall Study|Lost to Follow-up|1|||
144665040|NCT00363051|521624227|FG000|Overall Study|Protocol Violation|0|||
144665041|NCT00363051|521624228|FG001|Overall Study|Protocol Violation|2|||
144665042|NCT00363051|521624227|FG000|Overall Study|Death|3|||
144665043|NCT00363051|521624228|FG001|Overall Study|Death|2|||
144665044|NCT00205699|521624231|FG000|Overall Study|Lost to Follow-up|1|||
144665045|NCT00205699|521624232|FG001|Overall Study|Lost to Follow-up|3|||
144665046|NCT00205699|521624233|FG002|Overall Study|Lost to Follow-up|5|||
144665047|NCT00205699|521624231|FG000|Overall Study|Adverse Event|1|||
144665048|NCT00205699|521624232|FG001|Overall Study|Adverse Event|0|||
144665049|NCT00205699|521624233|FG002|Overall Study|Adverse Event|0|||
144665050|NCT00205699|521624231|FG000|Overall Study|Withdrawal by Subject|1|||
144665051|NCT00205699|521624232|FG001|Overall Study|Withdrawal by Subject|2|||
144665052|NCT00205699|521624233|FG002|Overall Study|Withdrawal by Subject|1|||
144665053|NCT00205699|521624231|FG000|Overall Study|Lack of Efficacy|0|||
144665054|NCT00205699|521624232|FG001|Overall Study|Lack of Efficacy|1|||
144665055|NCT00205699|521624233|FG002|Overall Study|Lack of Efficacy|0|||
144665056|NCT00830115|521624237|FG000|Overall Study|Adverse Event|2|||
144665057|NCT00830115|521624237|FG000|Overall Study|Improvement/recovery|1|||
144665058|NCT01925612|521624248|FG000|Overall Study|Progressive Disease|1|||
144665059|NCT01925612|521624249|FG001|Overall Study|Progressive Disease|1|||
144665060|NCT01925612|521624250|FG002|Overall Study|Progressive Disease|1|||
144665061|NCT01925612|521624251|FG003|Overall Study|Progressive Disease|0|||
144665062|NCT01925612|521624252|FG004|Overall Study|Progressive Disease|0|||
144665063|NCT01925612|521624248|FG000|Overall Study|Adverse Event|3|||
144665064|NCT01925612|521624249|FG001|Overall Study|Adverse Event|3|||
144665065|NCT01925612|521624250|FG002|Overall Study|Adverse Event|0|||
144665066|NCT01925612|521624251|FG003|Overall Study|Adverse Event|1|||
144665067|NCT01925612|521624252|FG004|Overall Study|Adverse Event|2|||
144665068|NCT01610076|521624253|FG000|Overall Study|Technical issue with video|0|||
144665069|NCT01610076|521624254|FG001|Overall Study|Technical issue with video|1|||
144665070|NCT01610076|521624253|FG000|Overall Study|Lost to Follow-up|3|||
144665071|NCT01610076|521624254|FG001|Overall Study|Lost to Follow-up|4|||
144665072|NCT01895452|521624261|FG000|Overall Study|Adverse Event|1|||
144665073|NCT01895452|521624262|FG001|Overall Study|Adverse Event|4|||
144665074|NCT01895452|521624261|FG000|Overall Study|Lost to Follow-up|1|||
144665075|NCT01895452|521624262|FG001|Overall Study|Lost to Follow-up|5|||
144665076|NCT01895452|521624261|FG000|Overall Study|Pregnancy|0|||
144665077|NCT01895452|521624262|FG001|Overall Study|Pregnancy|1|||
144665078|NCT01895452|521624261|FG000|Overall Study|Withdrawal by Subject|2|||
144665079|NCT01895452|521624262|FG001|Overall Study|Withdrawal by Subject|14|||
144665080|NCT01895452|521624261|FG000|Overall Study|Underlying disease|0|||
144665081|NCT01895452|521624262|FG001|Overall Study|Underlying disease|3|||
144665082|NCT01895452|521624261|FG000|Overall Study|Noncompliance with study drug|0|||
144665083|NCT01895452|521624262|FG001|Overall Study|Noncompliance with study drug|1|||
144665084|NCT01653158|521624263|FG000|Overall Study|Death|0|||
144665085|NCT01653158|521624264|FG001|Overall Study|Death|0|||
144665086|NCT01653158|521624265|FG002|Overall Study|Death|0|||
144665087|NCT01653158|521624266|FG003|Overall Study|Death|1|||
144665088|NCT01653158|521624267|FG004|Overall Study|Death|0|||
144665089|NCT01653158|521624268|FG005|Overall Study|Death|0|||
144665090|NCT01653158|521624269|FG006|Overall Study|Death|0|||
144665091|NCT01653158|521624270|FG007|Overall Study|Death|2|||
144665092|NCT01653158|521624263|FG000|Overall Study|Adverse Event|0|||
144665093|NCT01653158|521624264|FG001|Overall Study|Adverse Event|0|||
144665094|NCT01653158|521624265|FG002|Overall Study|Adverse Event|0|||
144665095|NCT01653158|521624266|FG003|Overall Study|Adverse Event|1|||
144665096|NCT01653158|521624267|FG004|Overall Study|Adverse Event|0|||
144665097|NCT01653158|521624268|FG005|Overall Study|Adverse Event|0|||
144665098|NCT01653158|521624269|FG006|Overall Study|Adverse Event|0|||
144665099|NCT01653158|521624270|FG007|Overall Study|Adverse Event|3|||
144665100|NCT01653158|521624263|FG000|Overall Study|Other|0|||
144665101|NCT01653158|521624264|FG001|Overall Study|Other|0|||
144665102|NCT01653158|521624265|FG002|Overall Study|Other|0|||
144665103|NCT01653158|521624266|FG003|Overall Study|Other|0|||
144665104|NCT01653158|521624267|FG004|Overall Study|Other|0|||
144665105|NCT01653158|521624268|FG005|Overall Study|Other|0|||
144665106|NCT01653158|521624269|FG006|Overall Study|Other|0|||
144665107|NCT01653158|521624270|FG007|Overall Study|Other|1|||
144665108|NCT01653158|521624263|FG000|Overall Study|Progressive disease|0|||
144665109|NCT01653158|521624264|FG001|Overall Study|Progressive disease|0|||
144665110|NCT01653158|521624265|FG002|Overall Study|Progressive disease|0|||
144665111|NCT01653158|521624266|FG003|Overall Study|Progressive disease|0|||
144665112|NCT01653158|521624267|FG004|Overall Study|Progressive disease|1|||
144665113|NCT01653158|521624268|FG005|Overall Study|Progressive disease|1|||
144665114|NCT01653158|521624269|FG006|Overall Study|Progressive disease|2|||
144665115|NCT01653158|521624270|FG007|Overall Study|Progressive disease|9|||
144665116|NCT01653158|521624263|FG000|Overall Study|Withdrawal by Subject|1|||
144665117|NCT01653158|521624264|FG001|Overall Study|Withdrawal by Subject|0|||
144665118|NCT01653158|521624265|FG002|Overall Study|Withdrawal by Subject|0|||
144665119|NCT01653158|521624266|FG003|Overall Study|Withdrawal by Subject|0|||
144665120|NCT01653158|521624267|FG004|Overall Study|Withdrawal by Subject|0|||
144665121|NCT01653158|521624268|FG005|Overall Study|Withdrawal by Subject|0|||
144665122|NCT01653158|521624269|FG006|Overall Study|Withdrawal by Subject|0|||
144665123|NCT01653158|521624270|FG007|Overall Study|Withdrawal by Subject|0|||
144665124|NCT01360762|521624281|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
144665125|NCT01360762|521624281|FG000|Main Study Period (12-month Treatment)|Death|5|||
144665126|NCT01360762|521624281|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
144665127|NCT01360762|521624281|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
144665128|NCT01360762|521624281|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
144665129|NCT01360762|521624281|FG000|Whole Study Period|Lost to Follow-up|10|||
144665130|NCT01360762|521624281|FG000|Whole Study Period|Death|7|||
144665131|NCT01360762|521624281|FG000|Whole Study Period|Patient relapsed|18|||
144216531|NCT02454933|519986033|FG001|Overall Study|Lost to Follow-up|0|||
144216532|NCT02071225|519986039|FG000|Overall Study|Withdrawal of Consent|2|||
144216533|NCT02071225|519986039|FG000|Overall Study|Protocol Deviation|1|||
144216534|NCT02071225|519986039|FG000|Overall Study|Lost to Follow-up|2|||
144216535|NCT02071225|519986039|FG000|Overall Study|Death|25|||
144216536|NCT04753216|519986040|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
144216537|NCT04753216|519986040|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
144216538|NCT04753216|519986040|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
144216539|NCT01342081|519986041|FG000|Overall Study|Did not receive allocated intervention|0|||
144216540|NCT01342081|519986042|FG001|Overall Study|Did not receive allocated intervention|0|||
144216541|NCT01342081|519986043|FG002|Overall Study|Did not receive allocated intervention|1|||
144216542|NCT01342081|519986041|FG000|Overall Study|Adverse Event|1|||
144216543|NCT01342081|519986042|FG001|Overall Study|Adverse Event|0|||
144216544|NCT01342081|519986043|FG002|Overall Study|Adverse Event|0|||
144216545|NCT01342081|519986041|FG000|Overall Study|Physician Decision|0|||
144216546|NCT01342081|519986042|FG001|Overall Study|Physician Decision|1|||
144216547|NCT01342081|519986043|FG002|Overall Study|Physician Decision|0|||
144216548|NCT01342081|519986041|FG000|Overall Study|Withdrawal by Subject|1|||
144216549|NCT01342081|519986042|FG001|Overall Study|Withdrawal by Subject|1|||
144216550|NCT01342081|519986043|FG002|Overall Study|Withdrawal by Subject|0|||
144216551|NCT00666328|519986052|FG000|Overall Study|Death|2|||
144216552|NCT00666328|519986052|FG000|Overall Study|Lost to Follow-up|2|||
144216553|NCT00666328|519986052|FG000|Overall Study|No longer met eligibility criteria|1|||
144216554|NCT02096744|519986055|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
144216555|NCT02096744|519986056|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
144216556|NCT02096744|519986055|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
144216557|NCT02096744|519986056|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
144216558|NCT02096744|519986055|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
144216559|NCT02096744|519986056|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
144216560|NCT00625872|519986063|FG000|Overall Study|Withdrawal by Subject|1|||
144216561|NCT00625872|519986064|FG001|Overall Study|Withdrawal by Subject|0|||
144733543|NCT00376623|521882086|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
144733544|NCT00376623|521882087|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
144733545|NCT00376623|521882088|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
144733546|NCT00376623|521882086|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
144733547|NCT00376623|521882087|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
144733548|NCT00376623|521882088|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
144216562|NCT00625872|519986063|FG000|Overall Study|Does not meet inclusion criteria|1|||
144216563|NCT00625872|519986064|FG001|Overall Study|Does not meet inclusion criteria|0|||
144216564|NCT00625872|519986063|FG000|Overall Study|Terminated by sponsor|2|||
144216565|NCT00625872|519986064|FG001|Overall Study|Terminated by sponsor|5|||
144216566|NCT00625872|519986063|FG000|Overall Study|Randomized but not treated|0|||
144216567|NCT00625872|519986064|FG001|Overall Study|Randomized but not treated|1|||
144216568|NCT04208750|519986065|FG000|Overall Study|Lost to Follow-up|16|||
144216569|NCT04208750|519986066|FG001|Overall Study|Lost to Follow-up|15|||
144216570|NCT02201277|519986067|FG000|Overall Study|Death|3|||
144216571|NCT02201277|519986068|FG001|Overall Study|Death|4|||
144216572|NCT02201277|519986067|FG000|Overall Study|Lost to Follow-up|2|||
144216573|NCT02201277|519986068|FG001|Overall Study|Lost to Follow-up|1|||
144216574|NCT02201277|519986067|FG000|Overall Study|Failed retrieval|1|||
144216575|NCT02201277|519986068|FG001|Overall Study|Failed retrieval|0|||
144216576|NCT02201277|519986067|FG000|Overall Study|Physician Decision|1|||
144216577|NCT02201277|519986068|FG001|Overall Study|Physician Decision|0|||
144216578|NCT01512160|519986069|FG000|Overall Study|Lost to Follow-up|1|||
144216579|NCT01512160|519986070|FG001|Overall Study|Lost to Follow-up|0|||
144216580|NCT01512160|519986071|FG002|Overall Study|Lost to Follow-up|0|||
144216581|NCT01512160|519986072|FG003|Overall Study|Lost to Follow-up|0|||
144216582|NCT01512160|519986069|FG000|Overall Study|Withdrawal by Subject|1|||
144216583|NCT01512160|519986070|FG001|Overall Study|Withdrawal by Subject|0|||
144216584|NCT01512160|519986071|FG002|Overall Study|Withdrawal by Subject|0|||
144216585|NCT01512160|519986072|FG003|Overall Study|Withdrawal by Subject|1|||
144216586|NCT00866359|519986073|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
144216587|NCT00866359|519986074|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
144216588|NCT00866359|519986075|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
144216589|NCT00866359|519986076|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
144216590|NCT00866359|519986073|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
144733549|NCT00376623|521882086|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
144733550|NCT00376623|521882087|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
144216591|NCT00866359|519986074|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
144216592|NCT00866359|519986075|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
144216593|NCT00866359|519986076|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
144216594|NCT00866359|519986073|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
144216595|NCT00866359|519986074|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
144216596|NCT00866359|519986075|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
144216597|NCT00866359|519986076|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
144216598|NCT00866359|519986073|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
144216599|NCT00866359|519986074|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
144216600|NCT00866359|519986075|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
144216601|NCT00866359|519986076|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
144216602|NCT00866359|519986073|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
144216603|NCT00866359|519986074|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
144216604|NCT00866359|519986075|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
144216605|NCT00866359|519986076|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
144216606|NCT00866359|519986073|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
144216607|NCT00866359|519986074|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
144216608|NCT00866359|519986075|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
144216609|NCT00866359|519986076|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
144216610|NCT02163057|519986077|FG000|Overall Study|Participant Refusal to Continue|2|||
144216611|NCT02163057|519986078|FG001|Overall Study|Participant Refusal to Continue|2|||
144216612|NCT02163057|519986077|FG000|Overall Study|Participant Significant Noncompliance|0|||
144216613|NCT02163057|519986078|FG001|Overall Study|Participant Significant Noncompliance|1|||
144216614|NCT02163057|519986077|FG000|Overall Study|Progression of Disease|1|||
144216615|NCT02163057|519986078|FG001|Overall Study|Progression of Disease|2|||
144665132|NCT01360762|521624281|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
144665133|NCT01658579|521624282|FG000|Treatment Period A|Other|0|||
144665134|NCT01658579|521624283|FG001|Treatment Period A|Other|0|||
144665135|NCT01658579|521624284|FG002|Treatment Period A|Other|1|||
144665136|NCT01658579|521624285|FG003|Treatment Period A|Other|1|||
144665137|NCT01658579|521624282|FG000|Treatment Period A|Adverse Event|1|||
144665138|NCT01658579|521624283|FG001|Treatment Period A|Adverse Event|0|||
144665139|NCT01658579|521624284|FG002|Treatment Period A|Adverse Event|0|||
144665140|NCT01658579|521624285|FG003|Treatment Period A|Adverse Event|0|||
144665141|NCT01658579|521624282|FG000|Treatment Period B|Other|0|||
144665142|NCT01658579|521624283|FG001|Treatment Period B|Other|0|||
144665143|NCT01658579|521624284|FG002|Treatment Period B|Other|0|||
144665144|NCT01658579|521624285|FG003|Treatment Period B|Other|1|||
144665145|NCT04580394|521624286|FG000|First Intervention|Incorrectly Randomized|1|||
144665146|NCT04580394|521624286|FG000|First Intervention|Physician Decision|1|||
144665147|NCT04580394|521624286|FG000|First Intervention|Lost to Follow-up|1|||
144665148|NCT04580394|521624286|FG000|Washout (One Week)|Withdrawal by Subject|1|||
144665149|NCT04580394|521624286|FG000|Washout (One Week)|Adverse Event|1|||
144665150|NCT04580394|521624286|FG000|Washout (One Week)|Withdrawal by Subject|2|||
144665151|NCT04580394|521624286|FG000|Third Intervention|Adverse Event|1|||
144665152|NCT04580394|521624286|FG000|Third Intervention|Withdrawal by Subject|1|||
144665153|NCT04580394|521624286|FG000|Washout (One Week)|Withdrawal by Subject|2|||
144665154|NCT01464788|521624287|FG000|Overall Study|Lost to Follow-up|0|||
144665155|NCT01464788|521624288|FG001|Overall Study|Lost to Follow-up|1|||
144665156|NCT01464788|521624289|FG002|Overall Study|Lost to Follow-up|0|||
144665157|NCT01464788|521624287|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
144665158|NCT01464788|521624288|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
144665159|NCT01464788|521624289|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
144665160|NCT04397718|521624292|FG000|Overall Study|Death|7|||
144665161|NCT04397718|521624293|FG001|Overall Study|Death|11|||
144665162|NCT04397718|521624292|FG000|Overall Study|Lost to Follow-up|0|||
144665163|NCT04397718|521624293|FG001|Overall Study|Lost to Follow-up|4|||
144665164|NCT00304915|521624294|FG000|Overall Study|Lost to Follow-up|11|||
144665165|NCT00304915|521624295|FG001|Overall Study|Lost to Follow-up|11|||
144665166|NCT00304915|521624294|FG000|Overall Study|Death|4|||
144665167|NCT00304915|521624295|FG001|Overall Study|Death|5|||
144665168|NCT00304915|521624294|FG000|Overall Study|Withdrawal by Subject|3|||
144665169|NCT00304915|521624295|FG001|Overall Study|Withdrawal by Subject|0|||
144216616|NCT01625091|519986079|FG000|Intervention|Death|1|||
144216617|NCT01625091|519986080|FG001|Intervention|Death|1|||
144216618|NCT01625091|519986079|FG000|Intervention|Withdrawal by Subject|4|||
144216619|NCT01625091|519986080|FG001|Intervention|Withdrawal by Subject|1|||
144216620|NCT01625091|519986079|FG000|Intervention|Adverse Event|0|||
144216621|NCT01625091|519986080|FG001|Intervention|Adverse Event|2|||
144665170|NCT00973921|521624296|FG000|Overall Study|IVUS results were not available|9|||
144665171|NCT02120157|521624307|FG000|Overall Study|Death|8|||
144665172|NCT02756650|521624310|FG000|Overall Study|Physician Decision|1|||
144665173|NCT02756650|521624310|FG000|Overall Study|Adverse Event|1|||
144665174|NCT04348591|521624311|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
144665175|NCT04348591|521624312|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
144665176|NCT04348591|521624311|FG000|Imaging Session (120 Min)|Physician Decision|0|||
144665177|NCT04348591|521624312|FG001|Imaging Session (120 Min)|Physician Decision|1|||
144665178|NCT04348591|521624311|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
144216622|NCT01625091|519986079|FG000|Intervention|Lost to Follow-up|4|||
144665179|NCT04348591|521624312|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
144665180|NCT03722784|521624316|FG000|Overall Study|Withdrawal by Subject|1|||
144665181|NCT03722784|521624317|FG001|Overall Study|Withdrawal by Subject|0|||
144665182|NCT03722784|521624316|FG000|Overall Study|Physician Decision|1|||
144665183|NCT03722784|521624317|FG001|Overall Study|Physician Decision|1|||
144665184|NCT03722784|521624316|FG000|Overall Study|Protocol Violation|0|||
144665185|NCT03722784|521624317|FG001|Overall Study|Protocol Violation|1|||
144665186|NCT00438399|521624320|FG000|Overall Study|Lost to Follow-up|2|||
144665187|NCT00438399|521624321|FG001|Overall Study|Lost to Follow-up|2|||
144665188|NCT00438399|521624322|FG002|Overall Study|Lost to Follow-up|1|||
144665189|NCT00438399|521624323|FG003|Overall Study|Lost to Follow-up|1|||
144665190|NCT00438399|521624324|FG004|Overall Study|Lost to Follow-up|1|||
144665191|NCT00438399|521624325|FG005|Overall Study|Lost to Follow-up|1|||
144665192|NCT00438399|521624320|FG000|Overall Study|Adverse Event|0|||
144665193|NCT00438399|521624321|FG001|Overall Study|Adverse Event|0|||
144665194|NCT00438399|521624322|FG002|Overall Study|Adverse Event|1|||
144665195|NCT00438399|521624323|FG003|Overall Study|Adverse Event|1|||
144733551|NCT00376623|521882088|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
144733552|NCT00376623|521882086|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
144733553|NCT00376623|521882087|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
144733554|NCT00376623|521882088|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
144733555|NCT00376623|521882086|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
144216623|NCT01625091|519986080|FG001|Intervention|Lost to Follow-up|4|||
144216624|NCT01625091|519986079|FG000|Intervention|Study termination|2|||
144216625|NCT01625091|519986080|FG001|Intervention|Study termination|3|||
144216626|NCT01625091|519986079|FG000|Post-intervention|Death|0|||
144216627|NCT01625091|519986080|FG001|Post-intervention|Death|1|||
144216628|NCT01625091|519986079|FG000|Post-intervention|Lost to Follow-up|2|||
144216629|NCT01625091|519986080|FG001|Post-intervention|Lost to Follow-up|0|||
144216630|NCT01625091|519986079|FG000|Post-intervention|Study termination|2|||
144216631|NCT01625091|519986080|FG001|Post-intervention|Study termination|1|||
144216632|NCT00768248|519986081|FG000|Overall Study|Research coordinator didn't collect data|1|||
144216633|NCT00768248|519986082|FG001|Overall Study|Research coordinator didn't collect data|1|||
144216634|NCT01547390|519986089|FG000|Overall Study|Withdrawal by Subject|10|||
144216635|NCT01547390|519986090|FG001|Overall Study|Withdrawal by Subject|7|||
144216636|NCT01547390|519986089|FG000|Overall Study|termination of pregnancy|0|||
144216637|NCT01547390|519986090|FG001|Overall Study|termination of pregnancy|1|||
144216638|NCT01547390|519986089|FG000|Overall Study|Lost to Follow-up|0|||
144216639|NCT01547390|519986090|FG001|Overall Study|Lost to Follow-up|2|||
144216640|NCT01547390|519986089|FG000|Overall Study|Adverse Event|3|||
144216641|NCT01547390|519986090|FG001|Overall Study|Adverse Event|0|||
144216642|NCT01959295|519986093|FG000|Overall Study|Adverse Event|2|||
144216643|NCT01959295|519986094|FG001|Overall Study|Adverse Event|0|||
144216644|NCT01959295|519986093|FG000|Overall Study|Lost to Follow-up|0|||
144216645|NCT01959295|519986094|FG001|Overall Study|Lost to Follow-up|2|||
144216646|NCT01959295|519986093|FG000|Overall Study|Physician Decision|2|||
144733556|NCT00376623|521882087|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
144733557|NCT00376623|521882088|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
144733558|NCT00376623|521882086|FG000|Overall Study|Increase of tumour markers|0|||
144733559|NCT00376623|521882087|FG001|Overall Study|Increase of tumour markers|1|||
144733560|NCT00376623|521882088|FG002|Overall Study|Increase of tumour markers|0|||
144733561|NCT00376623|521882086|FG000|Overall Study|Bone metastasis|1|||
144733562|NCT00376623|521882087|FG001|Overall Study|Bone metastasis|0|||
144733563|NCT00376623|521882088|FG002|Overall Study|Bone metastasis|0|||
144733564|NCT03496623|521882091|FG000|Run-In Period (2 Weeks)|Death|1|||
144216647|NCT01959295|519986094|FG001|Overall Study|Physician Decision|3|||
144665196|NCT00438399|521624324|FG004|Overall Study|Adverse Event|0|||
144665197|NCT00438399|521624325|FG005|Overall Study|Adverse Event|1|||
144665198|NCT00438399|521624320|FG000|Overall Study|Withdrawal by Subject|5|||
144733565|NCT03496623|521882092|FG001|Run-In Period (2 Weeks)|Death|0|||
144733566|NCT03496623|521882093|FG002|Run-In Period (2 Weeks)|Death|0|||
144733567|NCT03496623|521882094|FG003|Run-In Period (2 Weeks)|Death|0|||
144733568|NCT03496623|521882095|FG004|Run-In Period (2 Weeks)|Death|0|||
144733569|NCT03496623|521882091|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
144216648|NCT01959295|519986093|FG000|Overall Study|Protocol Violation|16|||
144216649|NCT01959295|519986094|FG001|Overall Study|Protocol Violation|5|||
144216650|NCT01959295|519986093|FG000|Overall Study|Withdrawal by Subject|3|||
144216651|NCT01959295|519986094|FG001|Overall Study|Withdrawal by Subject|1|||
144216652|NCT01959295|519986093|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
144216653|NCT01959295|519986094|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
144265564|NCT00853762|520173968|FG003|Overall Study|Premature Termination|21|||
144216654|NCT01128179|519986095|FG000|Overall Study|Death|1|||
144665199|NCT00438399|521624321|FG001|Overall Study|Withdrawal by Subject|6|||
144216655|NCT01128179|519986096|FG001|Overall Study|Death|0|||
144265565|NCT00853762|520173965|FG000|Overall Study|Protocol Violation|0|||
144665200|NCT00438399|521624322|FG002|Overall Study|Withdrawal by Subject|3|||
144665201|NCT00438399|521624323|FG003|Overall Study|Withdrawal by Subject|2|||
144665202|NCT00438399|521624324|FG004|Overall Study|Withdrawal by Subject|2|||
144665203|NCT00438399|521624325|FG005|Overall Study|Withdrawal by Subject|2|||
144665204|NCT00438399|521624320|FG000|Overall Study|Protocol Violation|0|||
144665205|NCT00438399|521624321|FG001|Overall Study|Protocol Violation|0|||
144665206|NCT00438399|521624322|FG002|Overall Study|Protocol Violation|1|||
144665207|NCT00438399|521624323|FG003|Overall Study|Protocol Violation|0|||
144665208|NCT00438399|521624324|FG004|Overall Study|Protocol Violation|0|||
144665209|NCT00438399|521624325|FG005|Overall Study|Protocol Violation|1|||
144665210|NCT00438399|521624320|FG000|Overall Study|Subje stopped study|0|||
144665211|NCT00438399|521624321|FG001|Overall Study|Subje stopped study|0|||
144665212|NCT00438399|521624322|FG002|Overall Study|Subje stopped study|1|||
144665213|NCT00438399|521624323|FG003|Overall Study|Subje stopped study|0|||
144665214|NCT00438399|521624324|FG004|Overall Study|Subje stopped study|0|||
144665215|NCT00438399|521624325|FG005|Overall Study|Subje stopped study|0|||
144665216|NCT00438399|521624320|FG000|Overall Study|Pregnancy|0|||
144665217|NCT00438399|521624321|FG001|Overall Study|Pregnancy|0|||
144665218|NCT00438399|521624322|FG002|Overall Study|Pregnancy|0|||
144665219|NCT00438399|521624323|FG003|Overall Study|Pregnancy|0|||
144665220|NCT00438399|521624324|FG004|Overall Study|Pregnancy|0|||
144665221|NCT00438399|521624325|FG005|Overall Study|Pregnancy|1|||
144665222|NCT00438399|521624320|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
144665223|NCT00438399|521624321|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
144665224|NCT00438399|521624322|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
144665225|NCT00438399|521624323|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
144665226|NCT00438399|521624324|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
144665227|NCT00438399|521624325|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
144665228|NCT03730194|521624328|FG000|First Stage Treatment|Withdrawal by Subject|1|||
144665229|NCT03730194|521624329|FG001|First Stage Treatment|Withdrawal by Subject|1|||
144665230|NCT03730194|521624330|FG002|First Stage Treatment|Withdrawal by Subject|0|||
144665231|NCT03730194|521624331|FG003|First Stage Treatment|Withdrawal by Subject|0|||
144665232|NCT03730194|521624332|FG004|First Stage Treatment|Withdrawal by Subject|0|||
144665233|NCT03730194|521624333|FG005|First Stage Treatment|Withdrawal by Subject|0|||
144665234|NCT03730194|521624328|FG000|First Stage Treatment|Protocol Violation|3|||
144665235|NCT03730194|521624329|FG001|First Stage Treatment|Protocol Violation|3|||
144665236|NCT03730194|521624330|FG002|First Stage Treatment|Protocol Violation|0|||
144665237|NCT03730194|521624331|FG003|First Stage Treatment|Protocol Violation|0|||
144665238|NCT03730194|521624332|FG004|First Stage Treatment|Protocol Violation|0|||
144665239|NCT03730194|521624333|FG005|First Stage Treatment|Protocol Violation|0|||
144665240|NCT01255306|521625931|FG000|Overall Study|Physician Decision|1|||
144665241|NCT01255306|521625932|FG001|Overall Study|Physician Decision|1|||
144665242|NCT03363919|521625935|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
144665243|NCT03363919|521625936|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
144665244|NCT03363919|521625935|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
144665245|NCT03363919|521625936|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
144665246|NCT00571519|521625937|FG000|Overall Study|Subject withdrew consent|0|||
144665247|NCT00571519|521625938|FG001|Overall Study|Subject withdrew consent|1|||
144665248|NCT00571519|521625939|FG002|Overall Study|Subject withdrew consent|0|||
144665249|NCT00571519|521625940|FG003|Overall Study|Subject withdrew consent|2|||
144665250|NCT00571519|521625941|FG004|Overall Study|Subject withdrew consent|1|||
144665251|NCT00571519|521625942|FG005|Overall Study|Subject withdrew consent|1|||
144665252|NCT00571519|521625943|FG006|Overall Study|Subject withdrew consent|2|||
144665253|NCT00571519|521625937|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
144665254|NCT00571519|521625938|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
144665255|NCT00571519|521625939|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
144665256|NCT00571519|521625940|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
144665257|NCT00571519|521625941|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
144665258|NCT00571519|521625942|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
144665259|NCT00571519|521625943|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
144665260|NCT00571519|521625937|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
144665261|NCT00571519|521625938|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
144665262|NCT00571519|521625939|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
144665263|NCT00571519|521625940|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
144665264|NCT00571519|521625941|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
144665265|NCT00571519|521625942|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
144665266|NCT00571519|521625943|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
144665267|NCT00571519|521625937|FG000|Overall Study|Termination of study by Sponsor|2|||
144665268|NCT00571519|521625938|FG001|Overall Study|Termination of study by Sponsor|7|||
144665269|NCT00571519|521625939|FG002|Overall Study|Termination of study by Sponsor|10|||
144665270|NCT00571519|521625940|FG003|Overall Study|Termination of study by Sponsor|24|||
144733570|NCT03496623|521882092|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
144733571|NCT03496623|521882093|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
144733572|NCT03496623|521882094|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
144733573|NCT03496623|521882095|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
144733574|NCT03496623|521882091|FG000|Period 1 (12 Weeks)|Death|0|||
144733575|NCT03496623|521882092|FG001|Period 1 (12 Weeks)|Death|3|||
144733576|NCT03496623|521882093|FG002|Period 1 (12 Weeks)|Death|0|||
144733577|NCT03496623|521882094|FG003|Period 1 (12 Weeks)|Death|0|||
144733578|NCT03496623|521882095|FG004|Period 1 (12 Weeks)|Death|0|||
144733579|NCT03496623|521882091|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
144733580|NCT03496623|521882092|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
144733581|NCT03496623|521882093|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
144733582|NCT03496623|521882094|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
144733583|NCT03496623|521882095|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
144733584|NCT03496623|521882091|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144733585|NCT03496623|521882092|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
144733586|NCT03496623|521882093|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
144733587|NCT03496623|521882094|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144733588|NCT03496623|521882095|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144733589|NCT03496623|521882091|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
144733590|NCT03496623|521882092|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
144733591|NCT03496623|521882093|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
144733592|NCT03496623|521882094|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
144665271|NCT00571519|521625941|FG004|Overall Study|Termination of study by Sponsor|8|||
144665272|NCT00571519|521625942|FG005|Overall Study|Termination of study by Sponsor|9|||
144665273|NCT00571519|521625943|FG006|Overall Study|Termination of study by Sponsor|22|||
144665274|NCT00571519|521625937|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
144665275|NCT00571519|521625938|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
144665276|NCT00571519|521625939|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
144665277|NCT00571519|521625940|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
144665278|NCT00571519|521625941|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
144665279|NCT00571519|521625942|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
144665280|NCT00571519|521625943|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
144665281|NCT04656418|521625944|FG000|Overall Study|Withdrawal by Subject|1|||
144665282|NCT04656418|521625945|FG001|Overall Study|Withdrawal by Subject|3|||
144665283|NCT02475850|521625946|FG000|Overall Study|Death|155|||
144665284|NCT02475850|521625947|FG001|Overall Study|Death|141|||
144665285|NCT02475850|521625946|FG000|Overall Study|Lost to Follow-up|217|||
144665286|NCT02475850|521625947|FG001|Overall Study|Lost to Follow-up|188|||
144665287|NCT02475850|521625946|FG000|Overall Study|Withdrawal by Subject|221|||
144665288|NCT02475850|521625947|FG001|Overall Study|Withdrawal by Subject|155|||
144665289|NCT00912340|521625952|FG000|Overall Study|Adverse Event|2|||
144665290|NCT00912340|521625953|FG001|Overall Study|Adverse Event|4|||
144665291|NCT00912340|521625954|FG002|Overall Study|Adverse Event|0|||
144665292|NCT00912340|521625952|FG000|Overall Study|Protocol revised to remove arm|0|||
144665293|NCT00912340|521625953|FG001|Overall Study|Protocol revised to remove arm|0|||
144665294|NCT00912340|521625954|FG002|Overall Study|Protocol revised to remove arm|4|||
144665295|NCT01754922|521625955|FG000|Overall Study|Adverse Event|0|||
144665296|NCT01754922|521625956|FG001|Overall Study|Adverse Event|1|||
144665297|NCT01207388|521625957|FG000|Overall Study|Death|67|||
144665298|NCT01207388|521625957|FG000|Overall Study|Withdrawal by Subject|1|||
144665299|NCT00980343|521625958|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
144665300|NCT00980343|521625959|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
144665301|NCT02899377|521625964|FG000|Overall Study|Adverse Event|1|||
144665302|NCT02899377|521625965|FG001|Overall Study|Adverse Event|0|||
144665303|NCT01231607|521625966|FG000|Overall Study|Adverse Event|0|||
144665304|NCT01231607|521625967|FG001|Overall Study|Adverse Event|8|||
144665305|NCT01231607|521625968|FG002|Overall Study|Adverse Event|4|||
144665306|NCT01231607|521625969|FG003|Overall Study|Adverse Event|4|||
144665307|NCT01231607|521625970|FG004|Overall Study|Adverse Event|5|||
144665308|NCT01231607|521625966|FG000|Overall Study|Lost to Follow-up|13|||
144665309|NCT01231607|521625967|FG001|Overall Study|Lost to Follow-up|11|||
144665310|NCT01231607|521625968|FG002|Overall Study|Lost to Follow-up|10|||
144665311|NCT01231607|521625969|FG003|Overall Study|Lost to Follow-up|10|||
144665312|NCT01231607|521625970|FG004|Overall Study|Lost to Follow-up|4|||
144665313|NCT01231607|521625966|FG000|Overall Study|Physician Decision|4|||
144733593|NCT03496623|521882095|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
144733594|NCT03496623|521882091|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144733595|NCT03496623|521882092|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144733596|NCT03496623|521882093|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
144733597|NCT03496623|521882094|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144733598|NCT03496623|521882095|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
144265566|NCT00853762|520173966|FG001|Overall Study|Protocol Violation|0|||
144733599|NCT03496623|521882091|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
144733600|NCT03496623|521882092|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
144733601|NCT03496623|521882093|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
144733602|NCT03496623|521882094|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
144733603|NCT03496623|521882095|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
144733604|NCT03496623|521882091|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144733605|NCT03496623|521882092|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
144733606|NCT03496623|521882093|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144733607|NCT03496623|521882094|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144733608|NCT03496623|521882095|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144733609|NCT02543203|521882096|FG000|Overall Study|Unpalatable Fragrance|2|||
144733610|NCT02543203|521882097|FG001|Overall Study|Unpalatable Fragrance|2|||
144733611|NCT02543203|521882096|FG000|Overall Study|Lost to Follow-up|1|||
144665314|NCT01231607|521625967|FG001|Overall Study|Physician Decision|4|||
144665315|NCT01231607|521625968|FG002|Overall Study|Physician Decision|3|||
144665316|NCT01231607|521625969|FG003|Overall Study|Physician Decision|5|||
144665317|NCT01231607|521625970|FG004|Overall Study|Physician Decision|4|||
144665318|NCT01231607|521625966|FG000|Overall Study|Protocol Violation|3|||
144665319|NCT01231607|521625967|FG001|Overall Study|Protocol Violation|2|||
144665320|NCT01231607|521625968|FG002|Overall Study|Protocol Violation|0|||
144665321|NCT01231607|521625969|FG003|Overall Study|Protocol Violation|2|||
144665322|NCT01231607|521625970|FG004|Overall Study|Protocol Violation|2|||
144665323|NCT01231607|521625966|FG000|Overall Study|Withdrawal by Subject|9|||
144665324|NCT01231607|521625967|FG001|Overall Study|Withdrawal by Subject|9|||
144665325|NCT01231607|521625968|FG002|Overall Study|Withdrawal by Subject|14|||
144665326|NCT01231607|521625969|FG003|Overall Study|Withdrawal by Subject|17|||
144665327|NCT01231607|521625970|FG004|Overall Study|Withdrawal by Subject|9|||
144665328|NCT01677507|521625971|FG000|Initial Assignment|Adverse Event|0|||
144665329|NCT01677507|521625972|FG001|Initial Assignment|Adverse Event|1|||
144665330|NCT01677507|521625971|FG000|Initial Assignment|Protocol Violation|0|||
144733612|NCT02543203|521882097|FG001|Overall Study|Lost to Follow-up|0|||
144733613|NCT02543203|521882096|FG000|Overall Study|Increased Irritability|1|||
144733614|NCT02543203|521882097|FG001|Overall Study|Increased Irritability|0|||
144733615|NCT02543203|521882096|FG000|Overall Study|Family|1|||
144733616|NCT02543203|521882097|FG001|Overall Study|Family|2|||
144733617|NCT02543203|521882096|FG000|Overall Study|Negative Behavior|1|||
144733618|NCT02543203|521882097|FG001|Overall Study|Negative Behavior|0|||
144733619|NCT02543203|521882096|FG000|Overall Study|Withdrawal by Subject|0|||
144733620|NCT02543203|521882097|FG001|Overall Study|Withdrawal by Subject|1|||
144733621|NCT03020615|521882098|FG000|Overall Study|Physician Decision|3|||
144733622|NCT03020615|521882099|FG001|Overall Study|Physician Decision|1|||
144733623|NCT03020615|521882100|FG002|Overall Study|Physician Decision|2|||
144733624|NCT03020615|521882098|FG000|Overall Study|Parent/guardian/patient choice|3|||
144733625|NCT03020615|521882099|FG001|Overall Study|Parent/guardian/patient choice|0|||
144733626|NCT03020615|521882100|FG002|Overall Study|Parent/guardian/patient choice|4|||
144733627|NCT03020615|521882098|FG000|Overall Study|Screen failure|0|||
144733628|NCT03020615|521882099|FG001|Overall Study|Screen failure|0|||
144733629|NCT03020615|521882100|FG002|Overall Study|Screen failure|1|||
144733630|NCT03020615|521882098|FG000|Overall Study|Death|1|||
144733631|NCT03020615|521882099|FG001|Overall Study|Death|0|||
144733632|NCT03020615|521882100|FG002|Overall Study|Death|0|||
144733633|NCT03020615|521882098|FG000|Overall Study|Lost to Follow-up|0|||
144733634|NCT03020615|521882099|FG001|Overall Study|Lost to Follow-up|1|||
144733635|NCT03020615|521882100|FG002|Overall Study|Lost to Follow-up|0|||
144733636|NCT00089661|521882101|FG000|Overall Study|Adverse Event|0|||
144733637|NCT00089661|521882102|FG001|Overall Study|Adverse Event|2|||
144733638|NCT00089661|521882101|FG000|Overall Study|Death|1|||
144733639|NCT00089661|521882102|FG001|Overall Study|Death|0|||
144733640|NCT00089661|521882101|FG000|Overall Study|Lost to Follow-up|0|||
144733641|NCT00089661|521882102|FG001|Overall Study|Lost to Follow-up|3|||
144733642|NCT00089661|521882101|FG000|Overall Study|Withdrawal by Subject|11|||
144733643|NCT00089661|521882102|FG001|Overall Study|Withdrawal by Subject|9|||
144733644|NCT00089661|521882101|FG000|Overall Study|Disease progression|1|||
144733645|NCT00089661|521882102|FG001|Overall Study|Disease progression|3|||
144733646|NCT00089661|521882101|FG000|Overall Study|Ineligibility determined|4|||
144733647|NCT00089661|521882102|FG001|Overall Study|Ineligibility determined|4|||
144733648|NCT00089661|521882101|FG000|Overall Study|Noncompliance|2|||
144733649|NCT00089661|521882102|FG001|Overall Study|Noncompliance|4|||
144265567|NCT00853762|520173967|FG002|Overall Study|Protocol Violation|0|||
144665331|NCT01677507|521625972|FG001|Initial Assignment|Protocol Violation|1|||
144665332|NCT01677507|521625971|FG000|Second Assigment|Withdrawal by Subject|2|||
144665333|NCT01677507|521625972|FG001|Second Assigment|Withdrawal by Subject|2|||
144733650|NCT00089661|521882101|FG000|Overall Study|Other|2|||
144733651|NCT00089661|521882102|FG001|Overall Study|Other|1|||
144733652|NCT02077465|521882106|FG000|Overall Study|Withdrew Consent|0|||
144733653|NCT02077465|521882107|FG001|Overall Study|Withdrew Consent|1|||
144733654|NCT02077465|521882106|FG000|Overall Study|Lost to Follow-up|1|||
144733655|NCT02077465|521882107|FG001|Overall Study|Lost to Follow-up|0|||
144216656|NCT01128179|519986095|FG000|Overall Study|Protocol Violation|1|||
144216657|NCT01128179|519986096|FG001|Overall Study|Protocol Violation|0|||
144216658|NCT00720382|519986100|FG000|Overall Study|Adverse Event|54|||
144216659|NCT00720382|519986101|FG001|Overall Study|Adverse Event|17|||
144216660|NCT00720382|519986100|FG000|Overall Study|Lack of Efficacy|18|||
144216661|NCT00720382|519986101|FG001|Overall Study|Lack of Efficacy|7|||
144216662|NCT00720382|519986100|FG000|Overall Study|Non-Compliance|15|||
144216663|NCT00720382|519986101|FG001|Overall Study|Non-Compliance|5|||
144216664|NCT00720382|519986100|FG000|Overall Study|Withdrawal by Subject|47|||
144216665|NCT00720382|519986101|FG001|Overall Study|Withdrawal by Subject|11|||
144216666|NCT00720382|519986100|FG000|Overall Study|Lost to Follow-up|28|||
144216667|NCT00720382|519986101|FG001|Overall Study|Lost to Follow-up|14|||
144216668|NCT00720382|519986100|FG000|Overall Study|administrative|14|||
144216669|NCT00720382|519986101|FG001|Overall Study|administrative|5|||
144216670|NCT05192889|519986102|FG000|Block 1: All Eligible Patients|Death|2|||
144216671|NCT05192889|519986103|FG001|Block 1: All Eligible Patients|Death|0|||
144665334|NCT01677507|521625971|FG000|Second Assigment|Adverse Event|1|||
144665335|NCT01677507|521625972|FG001|Second Assigment|Adverse Event|3|||
144665336|NCT00259740|521625973|FG000|Overall Study|Physician Decision|1|||
144665337|NCT00259740|521625974|FG001|Overall Study|Physician Decision|1|||
144665338|NCT00259740|521625973|FG000|Overall Study|Adverse Event|0|||
144665339|NCT00259740|521625974|FG001|Overall Study|Adverse Event|2|||
144665340|NCT00259740|521625973|FG000|Overall Study|Withdrawal by Subject|2|||
144665341|NCT00259740|521625974|FG001|Overall Study|Withdrawal by Subject|6|||
144665342|NCT00259740|521625973|FG000|Overall Study|Death|1|||
144665343|NCT00259740|521625974|FG001|Overall Study|Death|1|||
144665344|NCT00259740|521625973|FG000|Overall Study|Disease progression|19|||
144665345|NCT00259740|521625974|FG001|Overall Study|Disease progression|36|||
144665346|NCT00259740|521625973|FG000|Overall Study|Ongoing|17|||
144665347|NCT00259740|521625974|FG001|Overall Study|Ongoing|3|||
144665348|NCT00259740|521625973|FG000|Overall Study|Other|3|||
144665349|NCT00259740|521625974|FG001|Overall Study|Other|0|||
144665350|NCT00259740|521625973|FG000|Overall Study|Requirement for alternative therapy|0|||
144665351|NCT00259740|521625974|FG001|Overall Study|Requirement for alternative therapy|4|||
144665352|NCT01840228|521625976|FG000|Overall Study|Lost to Follow-up|1|||
144665353|NCT01840228|521625977|FG001|Overall Study|Lost to Follow-up|1|||
144665354|NCT03495453|521625978|FG000|Overall Study|Withdrawal by Subject|0|||
144665355|NCT03495453|521625979|FG001|Overall Study|Withdrawal by Subject|1|||
144665356|NCT01103778|521625984|FG000|Overall Study|Lost to Follow-up|1|||
144665357|NCT01103778|521625984|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
144665358|NCT01103778|521625984|FG000|Overall Study|Screen failure|1|||
144665359|NCT00865189|521625985|FG000|Overall Study|Other|1|||
144665360|NCT00865189|521625986|FG001|Overall Study|Other|2|||
144665361|NCT00865189|521625985|FG000|Overall Study|Death|4|||
144665362|NCT00865189|521625986|FG001|Overall Study|Death|11|||
144665363|NCT00865189|521625985|FG000|Overall Study|Lost to Follow-up|6|||
144665364|NCT00865189|521625986|FG001|Overall Study|Lost to Follow-up|6|||
144665365|NCT00865189|521625985|FG000|Overall Study|Withdrawal by Subject|1|||
144665366|NCT00865189|521625986|FG001|Overall Study|Withdrawal by Subject|0|||
144665367|NCT05590767|521625991|FG000|Overall Study|Protocol Violation|1|||
144665368|NCT05590767|521625991|FG000|Overall Study|surgery canceled|1|||
144665369|NCT05590767|521625991|FG000|Overall Study|interscalene brachial block not performed|1|||
144665370|NCT00084929|521625992|FG000|Overall Study|ineligible - medical contraindication|1|||
144665371|NCT00084929|521625992|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
144665372|NCT00084929|521625992|FG000|Overall Study|Ineligible - Medical history|6|||
144665373|NCT00084929|521625992|FG000|Overall Study|Withdrawal by Subject|10|||
144665374|NCT00084929|521625992|FG000|Overall Study|Missing/incomplete CTC exam|9|||
144665375|NCT00084929|521625992|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
144665376|NCT00844649|521625994|FG000|Overall Study|Progressive Disease|196|||
144665377|NCT00844649|521625995|FG001|Overall Study|Progressive Disease|245|||
144665378|NCT00844649|521625994|FG000|Overall Study|Adverse Event|128|||
144665379|NCT00844649|521625995|FG001|Overall Study|Adverse Event|73|||
144665380|NCT00844649|521625994|FG000|Overall Study|Physician Decision|25|||
144665381|NCT00844649|521625995|FG001|Overall Study|Physician Decision|18|||
144665382|NCT00844649|521625994|FG000|Overall Study|Protocol Violation|10|||
144665383|NCT00844649|521625995|FG001|Overall Study|Protocol Violation|6|||
144216672|NCT05192889|519986104|FG002|Block 1: All Eligible Patients|Death|0|||
144216673|NCT05192889|519986102|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
144216674|NCT05192889|519986103|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
144665384|NCT00844649|521625994|FG000|Overall Study|Withdrawal by Subject|28|||
144665385|NCT00844649|521625995|FG001|Overall Study|Withdrawal by Subject|39|||
144665386|NCT00844649|521625994|FG000|Overall Study|Other|7|||
144665387|NCT00844649|521625995|FG001|Overall Study|Other|10|||
144665388|NCT00844649|521625994|FG000|Overall Study|Withdrew prior to starting treatment|11|||
144216675|NCT05192889|519986104|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
144216676|NCT05192889|519986102|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
144216677|NCT05192889|519986103|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
144216678|NCT05192889|519986104|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
144216679|NCT05221320|519987940|FG000|Overall Study|Lack of Efficacy|3|||
144216680|NCT05221320|519987941|FG001|Overall Study|Lack of Efficacy|7|||
144216681|NCT05221320|519987942|FG002|Overall Study|Lack of Efficacy|10|||
144216682|NCT05221320|519987943|FG003|Overall Study|Lack of Efficacy|1|||
144665389|NCT00844649|521625995|FG001|Overall Study|Withdrew prior to starting treatment|27|||
144665390|NCT00091026|521625998|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
144665391|NCT00091026|521625999|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
144665392|NCT00091026|521625998|FG000|Overall Study|Patient withdrew and never received trea|0|||
144665393|NCT00091026|521625999|FG001|Overall Study|Patient withdrew and never received trea|2|||
144665394|NCT00091026|521625998|FG000|Overall Study|Unknown-never received treatment|0|||
144665395|NCT00091026|521625999|FG001|Overall Study|Unknown-never received treatment|1|||
144665396|NCT00065442|521626002|FG000|Overall Study|Lost to Follow-up|1|||
144665397|NCT00065442|521626003|FG001|Overall Study|Lost to Follow-up|1|||
144665398|NCT00065442|521626002|FG000|Overall Study|Death|121|||
144665399|NCT00065442|521626003|FG001|Overall Study|Death|210|||
144665400|NCT00065442|521626002|FG000|Overall Study|Withdrawal by Subject|3|||
144665401|NCT00065442|521626003|FG001|Overall Study|Withdrawal by Subject|9|||
144665402|NCT01797965|521626004|FG000|Overall Study|Adverse Event|104|||
144665403|NCT01797965|521626005|FG001|Overall Study|Adverse Event|129|||
144665404|NCT01797965|521626006|FG002|Overall Study|Adverse Event|4|||
144665405|NCT01797965|521626007|FG003|Overall Study|Adverse Event|21|||
144665406|NCT01797965|521626004|FG000|Overall Study|Lost to Follow-up|9|||
144665407|NCT01797965|521626005|FG001|Overall Study|Lost to Follow-up|8|||
144665408|NCT01797965|521626006|FG002|Overall Study|Lost to Follow-up|1|||
144665409|NCT01797965|521626007|FG003|Overall Study|Lost to Follow-up|2|||
144665410|NCT01797965|521626004|FG000|Overall Study|Consent withdrawn|130|||
144665411|NCT01797965|521626005|FG001|Overall Study|Consent withdrawn|117|||
144665412|NCT01797965|521626006|FG002|Overall Study|Consent withdrawn|3|||
144665413|NCT01797965|521626007|FG003|Overall Study|Consent withdrawn|35|||
144665414|NCT01797965|521626004|FG000|Overall Study|Investigator decision|21|||
144665415|NCT01797965|521626005|FG001|Overall Study|Investigator decision|15|||
144665416|NCT01797965|521626006|FG002|Overall Study|Investigator decision|0|||
144665417|NCT01797965|521626007|FG003|Overall Study|Investigator decision|0|||
144665418|NCT01797965|521626004|FG000|Overall Study|Death|2|||
144665419|NCT01797965|521626005|FG001|Overall Study|Death|4|||
144665420|NCT01797965|521626006|FG002|Overall Study|Death|0|||
144665421|NCT01797965|521626007|FG003|Overall Study|Death|0|||
144665422|NCT01797965|521626004|FG000|Overall Study|Disease progression, defined by protocol|3|||
144665423|NCT01797965|521626005|FG001|Overall Study|Disease progression, defined by protocol|1|||
144665424|NCT01797965|521626006|FG002|Overall Study|Disease progression, defined by protocol|0|||
144665425|NCT01797965|521626007|FG003|Overall Study|Disease progression, defined by protocol|0|||
144665426|NCT01797965|521626004|FG000|Overall Study|Reason Not Specified|280|||
144665427|NCT01797965|521626005|FG001|Overall Study|Reason Not Specified|295|||
144665428|NCT01797965|521626006|FG002|Overall Study|Reason Not Specified|0|||
144665429|NCT01797965|521626007|FG003|Overall Study|Reason Not Specified|15|||
144665430|NCT00712322|521626008|FG000|Overall Study|Protocol deviation|0|||
144665431|NCT00712322|521626009|FG001|Overall Study|Protocol deviation|1|||
144665432|NCT00712322|521626010|FG002|Overall Study|Protocol deviation|0|||
144665433|NCT02670330|521626013|FG000|Overall Study|Protocol Deviation|1|||
144665434|NCT02670330|521626014|FG001|Overall Study|Protocol Deviation|0|||
144665435|NCT02670330|521626013|FG000|Overall Study|Study Terminated By Sponsor|36|||
144665436|NCT02670330|521626014|FG001|Overall Study|Study Terminated By Sponsor|43|||
144665437|NCT02670330|521626013|FG000|Overall Study|Adverse Event|1|||
144665438|NCT02670330|521626014|FG001|Overall Study|Adverse Event|3|||
144665439|NCT02670330|521626013|FG000|Overall Study|Withdrawal by Subject|34|||
144665440|NCT02670330|521626014|FG001|Overall Study|Withdrawal by Subject|29|||
144665441|NCT02670330|521626013|FG000|Overall Study|Lost to Follow-up|3|||
144665442|NCT02670330|521626014|FG001|Overall Study|Lost to Follow-up|2|||
144665443|NCT04404010|521626015|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
144665444|NCT04404010|521626016|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
144665445|NCT02802878|521626020|FG000|Overall Study|Withdrawal by Subject|3|||
144665446|NCT02802878|521626021|FG001|Overall Study|Withdrawal by Subject|3|||
144665447|NCT02802878|521626020|FG000|Overall Study|Protocol Violation|1|||
144665448|NCT02802878|521626021|FG001|Overall Study|Protocol Violation|0|||
144665449|NCT01599754|521626022|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
144665450|NCT01599754|521626023|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
144665451|NCT01599754|521626022|FG000|Overall Study|Participant noncompliance|4|||
144665452|NCT01599754|521626023|FG001|Overall Study|Participant noncompliance|4|||
144665453|NCT01599754|521626022|FG000|Overall Study|Lost to Follow-up|13|||
144665454|NCT01599754|521626023|FG001|Overall Study|Lost to Follow-up|6|||
144665455|NCT01599754|521626022|FG000|Overall Study|Death|31|||
144665456|NCT01599754|521626023|FG001|Overall Study|Death|33|||
144665457|NCT01599754|521626022|FG000|Overall Study|Adverse Event|3|||
144665458|NCT01599754|521626023|FG001|Overall Study|Adverse Event|2|||
144216683|NCT05221320|519987944|FG004|Overall Study|Lack of Efficacy|0|||
144665459|NCT01599754|521626022|FG000|Overall Study|Investigator decision|1|||
144216684|NCT05221320|519987945|FG005|Overall Study|Lack of Efficacy|0|||
144665460|NCT01599754|521626023|FG001|Overall Study|Investigator decision|3|||
144665461|NCT01599754|521626022|FG000|Overall Study|Withdrawal by Subject|24|||
144665462|NCT01599754|521626023|FG001|Overall Study|Withdrawal by Subject|25|||
144665463|NCT01599754|521626022|FG000|Overall Study|Study terminated by sponsor|282|||
144665464|NCT01599754|521626023|FG001|Overall Study|Study terminated by sponsor|285|||
144665465|NCT00702052|521626024|FG000|Overall Study|Adverse Event|23|||
144665466|NCT00702052|521626024|FG000|Overall Study|Disease Progression|30|||
144665467|NCT00702052|521626024|FG000|Overall Study|Withdrawal by Subject|5|||
144665468|NCT01577160|521626025|FG000|Overall Study|Adverse Event|9|||
144665469|NCT01577160|521626025|FG000|Overall Study|Lack of Efficacy|15|||
144665470|NCT01577160|521626025|FG000|Overall Study|Lost to Follow-up|40|||
144216685|NCT05221320|519987940|FG000|Overall Study|Physician Decision|1|||
144216686|NCT05221320|519987941|FG001|Overall Study|Physician Decision|0|||
144216687|NCT05221320|519987942|FG002|Overall Study|Physician Decision|3|||
144216688|NCT05221320|519987943|FG003|Overall Study|Physician Decision|1|||
144216689|NCT05221320|519987944|FG004|Overall Study|Physician Decision|0|||
144216690|NCT05221320|519987945|FG005|Overall Study|Physician Decision|0|||
144216691|NCT05221320|519987940|FG000|Overall Study|Withdrawal by Subject|0|||
144216692|NCT05221320|519987941|FG001|Overall Study|Withdrawal by Subject|3|||
144216693|NCT05221320|519987942|FG002|Overall Study|Withdrawal by Subject|1|||
144216694|NCT05221320|519987943|FG003|Overall Study|Withdrawal by Subject|0|||
144216695|NCT05221320|519987944|FG004|Overall Study|Withdrawal by Subject|0|||
144216696|NCT05221320|519987945|FG005|Overall Study|Withdrawal by Subject|0|||
144216697|NCT05221320|519987940|FG000|Overall Study|Death|0|||
144216698|NCT05221320|519987941|FG001|Overall Study|Death|5|||
144216699|NCT05221320|519987942|FG002|Overall Study|Death|6|||
144216700|NCT05221320|519987943|FG003|Overall Study|Death|0|||
144216701|NCT05221320|519987944|FG004|Overall Study|Death|1|||
144216702|NCT05221320|519987945|FG005|Overall Study|Death|0|||
144216703|NCT06473519|519987946|FG000|Overall Study|Lost to Follow-up|2|||
144216704|NCT06473519|519987947|FG001|Overall Study|Lost to Follow-up|5|||
144216705|NCT06473519|519987946|FG000|Overall Study|Withdrawal by Subject|1|||
144216706|NCT06473519|519987947|FG001|Overall Study|Withdrawal by Subject|4|||
144216707|NCT06473519|519987946|FG000|Overall Study|Randomized but not vaccinated|1|||
144216708|NCT06473519|519987947|FG001|Overall Study|Randomized but not vaccinated|2|||
144216709|NCT02514447|519987951|FG000|Overall Study|Withdrawal by Subject|3|||
144216710|NCT02514447|519987952|FG001|Overall Study|Withdrawal by Subject|1|||
144216711|NCT02514447|519987953|FG002|Overall Study|Withdrawal by Subject|1|||
144216712|NCT02514447|519987954|FG003|Overall Study|Withdrawal by Subject|0|||
144216713|NCT02514447|519987955|FG004|Overall Study|Withdrawal by Subject|0|||
144216714|NCT02514447|519987956|FG005|Overall Study|Withdrawal by Subject|0|||
144216715|NCT02514447|519987957|FG006|Overall Study|Withdrawal by Subject|0|||
144216716|NCT02514447|519987958|FG007|Overall Study|Withdrawal by Subject|1|||
144216717|NCT02514447|519987959|FG008|Overall Study|Withdrawal by Subject|1|||
144216718|NCT02514447|519987951|FG000|Overall Study|Death|24|||
144216719|NCT02514447|519987952|FG001|Overall Study|Death|28|||
144216720|NCT02514447|519987953|FG002|Overall Study|Death|29|||
144665471|NCT01577160|521626025|FG000|Overall Study|Withdrawal by Subject|18|||
144665472|NCT01577160|521626025|FG000|Overall Study|Subject Uncooperative|7|||
144665473|NCT01577160|521626025|FG000|Overall Study|Other|9|||
144665474|NCT00101192|521626026|FG000|Overall Study|Ineligible|6|||
144665475|NCT00101192|521626026|FG000|Overall Study|Inevaluable|1|||
144665476|NCT03670641|521626027|FG000|Overall Study|Lost to Follow-up|3|||
144665477|NCT03691610|521626028|FG000|Overall Study|Adverse Event|0|||
144665478|NCT03691610|521626029|FG001|Overall Study|Adverse Event|1|||
144665479|NCT03691610|521626030|FG002|Overall Study|Adverse Event|0|||
144665480|NCT03691610|521626031|FG003|Overall Study|Adverse Event|0|||
144665481|NCT03691610|521626028|FG000|Overall Study|Protocol Deviation|15|||
144665482|NCT03691610|521626029|FG001|Overall Study|Protocol Deviation|8|||
144665483|NCT03691610|521626030|FG002|Overall Study|Protocol Deviation|1|||
144665484|NCT03691610|521626031|FG003|Overall Study|Protocol Deviation|2|||
144665485|NCT03691610|521626028|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
144665486|NCT03691610|521626029|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
144216721|NCT02514447|519987954|FG003|Overall Study|Death|0|||
144216722|NCT02514447|519987955|FG004|Overall Study|Death|3|||
144216723|NCT02514447|519987956|FG005|Overall Study|Death|4|||
144216724|NCT02514447|519987957|FG006|Overall Study|Death|8|||
144216725|NCT02514447|519987958|FG007|Overall Study|Death|6|||
144216726|NCT02514447|519987959|FG008|Overall Study|Death|5|||
144216727|NCT02514447|519987951|FG000|Overall Study|Lost to Follow-up|1|||
144216728|NCT02514447|519987952|FG001|Overall Study|Lost to Follow-up|0|||
144216729|NCT02514447|519987953|FG002|Overall Study|Lost to Follow-up|0|||
144216730|NCT02514447|519987954|FG003|Overall Study|Lost to Follow-up|0|||
144216731|NCT02514447|519987955|FG004|Overall Study|Lost to Follow-up|0|||
144216732|NCT02514447|519987956|FG005|Overall Study|Lost to Follow-up|0|||
144216733|NCT02514447|519987957|FG006|Overall Study|Lost to Follow-up|0|||
144216734|NCT02514447|519987958|FG007|Overall Study|Lost to Follow-up|0|||
144665487|NCT03691610|521626030|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
144665488|NCT03691610|521626031|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
144665489|NCT03691610|521626028|FG000|Overall Study|Lost to Follow-up|20|||
144665490|NCT03691610|521626029|FG001|Overall Study|Lost to Follow-up|11|||
144665491|NCT03691610|521626030|FG002|Overall Study|Lost to Follow-up|5|||
144665492|NCT03691610|521626031|FG003|Overall Study|Lost to Follow-up|2|||
144665493|NCT00242580|521626035|FG000|Overall Study|Adverse Event|3|||
144665494|NCT00242580|521626036|FG001|Overall Study|Adverse Event|0|||
144665495|NCT00242580|521626037|FG002|Overall Study|Adverse Event|2|||
144665496|NCT00242580|521626035|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144665497|NCT00242580|521626036|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
144665498|NCT00242580|521626037|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
144665499|NCT00242580|521626035|FG000|Overall Study|Protocol Violation|0|||
144665500|NCT00242580|521626036|FG001|Overall Study|Protocol Violation|0|||
144665501|NCT00242580|521626037|FG002|Overall Study|Protocol Violation|1|||
144665502|NCT00242580|521626035|FG000|Overall Study|Subject withdrew consent|2|||
144665503|NCT00242580|521626036|FG001|Overall Study|Subject withdrew consent|2|||
144665504|NCT00242580|521626037|FG002|Overall Study|Subject withdrew consent|5|||
144665505|NCT00242580|521626035|FG000|Overall Study|Lost to Follow-up|0|||
144665506|NCT00242580|521626036|FG001|Overall Study|Lost to Follow-up|3|||
144665507|NCT00242580|521626037|FG002|Overall Study|Lost to Follow-up|0|||
144665508|NCT00242580|521626035|FG000|Overall Study|Death|1|||
144665509|NCT00242580|521626036|FG001|Overall Study|Death|2|||
144665510|NCT00242580|521626037|FG002|Overall Study|Death|1|||
144665511|NCT01232894|521626038|FG000|Overall Study|Lost to Follow-up|0|||
144665512|NCT01232894|521626039|FG001|Overall Study|Lost to Follow-up|1|||
144665513|NCT01232894|521626038|FG000|Overall Study|Death|1|||
144665514|NCT01232894|521626039|FG001|Overall Study|Death|0|||
144665515|NCT01232894|521626038|FG000|Overall Study|Protocol Violation|1|||
144665516|NCT01232894|521626039|FG001|Overall Study|Protocol Violation|1|||
144665517|NCT01232894|521626038|FG000|Overall Study|Withdrawal by Subject|8|||
144665518|NCT01232894|521626039|FG001|Overall Study|Withdrawal by Subject|5|||
144665519|NCT01232894|521626038|FG000|Overall Study|Physician Decision|2|||
144665520|NCT01232894|521626039|FG001|Overall Study|Physician Decision|1|||
144665521|NCT03970395|521626044|FG000|Overall Study|Withdrawal by Subject|3|||
144665522|NCT03970395|521626045|FG001|Overall Study|Withdrawal by Subject|4|||
144665523|NCT03970395|521626044|FG000|Overall Study|Lost to Follow-up|4|||
144665524|NCT03970395|521626045|FG001|Overall Study|Lost to Follow-up|8|||
144665525|NCT00929734|521626046|FG000|Overall Study|Lost to Follow-up|2|||
144665526|NCT00929734|521626047|FG001|Overall Study|Lost to Follow-up|1|||
144665527|NCT00929734|521626046|FG000|Overall Study|Withdrawal by Subject|0|||
144665528|NCT00929734|521626047|FG001|Overall Study|Withdrawal by Subject|2|||
144665529|NCT01553916|521626048|FG000|Overall Study|Withdrawal by Subject|2|||
144665530|NCT01553916|521626048|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
144665531|NCT00910429|521626053|FG000|Overall Study|Death|18|||
144665532|NCT00910429|521626054|FG001|Overall Study|Death|12|||
144665533|NCT00910429|521626053|FG000|Overall Study|Withdrawal by Subject|3|||
144665534|NCT00910429|521626054|FG001|Overall Study|Withdrawal by Subject|2|||
144665535|NCT00910429|521626053|FG000|Overall Study|Protocol Violation|1|||
144665536|NCT00910429|521626054|FG001|Overall Study|Protocol Violation|0|||
144665537|NCT00910429|521626053|FG000|Overall Study|Lost to Follow-up|2|||
144665538|NCT00910429|521626054|FG001|Overall Study|Lost to Follow-up|1|||
144665539|NCT00910429|521626053|FG000|Overall Study|Adverse Event|10|||
144665540|NCT00910429|521626054|FG001|Overall Study|Adverse Event|5|||
144665541|NCT00910429|521626053|FG000|Overall Study|Drug non-compliance|1|||
144665542|NCT00910429|521626054|FG001|Overall Study|Drug non-compliance|0|||
144665543|NCT00910429|521626053|FG000|Overall Study|Lack of Efficacy|4|||
144665544|NCT00910429|521626054|FG001|Overall Study|Lack of Efficacy|1|||
144665545|NCT01317615|521626055|FG000|Overall Study|Disease progression|25|||
144665546|NCT01317615|521626055|FG000|Overall Study|New cancer therapy|5|||
144665547|NCT01317615|521626055|FG000|Overall Study|Death|6|||
144665548|NCT01317615|521626055|FG000|Overall Study|Withdrawal by Subject|5|||
144665549|NCT01317615|521626055|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144665550|NCT01317615|521626055|FG000|Overall Study|Adverse Event|7|||
144665551|NCT04465396|521626056|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
144665552|NCT04465396|521626057|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
144665553|NCT04465396|521626058|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
144665554|NCT04465396|521626059|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
144665555|NCT00738374|521626060|FG000|Induction Treatment Phase|Adverse Event|14|||
144665556|NCT00738374|521626061|FG001|Induction Treatment Phase|Adverse Event|0|||
144665557|NCT00738374|521626062|FG002|Induction Treatment Phase|Adverse Event|0|||
144665558|NCT00738374|521626063|FG003|Induction Treatment Phase|Adverse Event|0|||
144665559|NCT00738374|521626060|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
144665560|NCT00738374|521626061|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
144665561|NCT00738374|521626062|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
144665562|NCT00738374|521626063|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
144665563|NCT00738374|521626060|FG000|Induction Treatment Phase|Physician Decision|2|||
144665564|NCT00738374|521626061|FG001|Induction Treatment Phase|Physician Decision|0|||
144665565|NCT00738374|521626062|FG002|Induction Treatment Phase|Physician Decision|0|||
144665566|NCT00738374|521626063|FG003|Induction Treatment Phase|Physician Decision|0|||
144216735|NCT02514447|519987959|FG008|Overall Study|Lost to Follow-up|1|||
144216736|NCT02514447|519987951|FG000|Overall Study|Sponsor Termination of Study|0|||
144216737|NCT02514447|519987952|FG001|Overall Study|Sponsor Termination of Study|1|||
144216738|NCT02514447|519987953|FG002|Overall Study|Sponsor Termination of Study|1|||
144216739|NCT02514447|519987954|FG003|Overall Study|Sponsor Termination of Study|0|||
144216740|NCT02514447|519987955|FG004|Overall Study|Sponsor Termination of Study|0|||
144216741|NCT02514447|519987956|FG005|Overall Study|Sponsor Termination of Study|0|||
144216742|NCT02514447|519987957|FG006|Overall Study|Sponsor Termination of Study|0|||
144216743|NCT02514447|519987958|FG007|Overall Study|Sponsor Termination of Study|0|||
144216744|NCT02514447|519987959|FG008|Overall Study|Sponsor Termination of Study|0|||
144216745|NCT02514447|519987951|FG000|Overall Study|Study completion per Investigator|1|||
144216746|NCT02514447|519987952|FG001|Overall Study|Study completion per Investigator|0|||
144216747|NCT02514447|519987953|FG002|Overall Study|Study completion per Investigator|1|||
144216748|NCT02514447|519987954|FG003|Overall Study|Study completion per Investigator|2|||
144216749|NCT02514447|519987955|FG004|Overall Study|Study completion per Investigator|0|||
144216750|NCT02514447|519987956|FG005|Overall Study|Study completion per Investigator|0|||
144216751|NCT02514447|519987957|FG006|Overall Study|Study completion per Investigator|0|||
144216752|NCT02514447|519987958|FG007|Overall Study|Study completion per Investigator|0|||
144216753|NCT02514447|519987959|FG008|Overall Study|Study completion per Investigator|1|||
144216754|NCT03300817|519987961|FG000|Overall Study|Withdrawal by Subject|1|||
144216755|NCT03300817|519987961|FG000|Overall Study|Adverse Event|1|||
144216756|NCT03300817|519987961|FG000|Overall Study|Subject Found to be Ineligible|2|||
144216757|NCT00265759|519987962|FG000|Overall Study|Withdrawal by Subject|0|||
144216758|NCT00265759|519987963|FG001|Overall Study|Withdrawal by Subject|1|||
144216759|NCT00265759|519987964|FG002|Overall Study|Withdrawal by Subject|2|||
144216760|NCT00265759|519987965|FG003|Overall Study|Withdrawal by Subject|2|||
144665567|NCT00738374|521626060|FG000|Induction Treatment Phase|Protocol Violation|2|||
144665568|NCT00738374|521626061|FG001|Induction Treatment Phase|Protocol Violation|0|||
144665569|NCT00738374|521626062|FG002|Induction Treatment Phase|Protocol Violation|0|||
144665570|NCT00738374|521626063|FG003|Induction Treatment Phase|Protocol Violation|0|||
144665571|NCT00738374|521626060|FG000|Induction Treatment Phase|Non-compliance|1|||
144665572|NCT00738374|521626061|FG001|Induction Treatment Phase|Non-compliance|0|||
144665573|NCT00738374|521626062|FG002|Induction Treatment Phase|Non-compliance|0|||
144665574|NCT00738374|521626063|FG003|Induction Treatment Phase|Non-compliance|0|||
144665575|NCT00738374|521626060|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
144665576|NCT00738374|521626061|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
144665577|NCT00738374|521626062|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
144665578|NCT00738374|521626063|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
144665579|NCT00738374|521626060|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
144665580|NCT00738374|521626061|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
144665581|NCT00738374|521626062|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
144665582|NCT00738374|521626063|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
144665583|NCT00738374|521626060|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
144665584|NCT00738374|521626061|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
144665585|NCT00738374|521626062|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
144665586|NCT00738374|521626063|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
144665587|NCT00738374|521626060|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
144665588|NCT00738374|521626061|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
144665589|NCT00738374|521626062|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
144665590|NCT00738374|521626063|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
144665591|NCT00738374|521626060|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
144665592|NCT00738374|521626061|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
144665593|NCT00738374|521626062|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
144665594|NCT00738374|521626063|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
144665595|NCT00738374|521626060|FG000|Maintenance Treatment/Observation Phase|Other|0|||
144665596|NCT00738374|521626061|FG001|Maintenance Treatment/Observation Phase|Other|1|||
144665597|NCT00738374|521626062|FG002|Maintenance Treatment/Observation Phase|Other|0|||
144665598|NCT00738374|521626063|FG003|Maintenance Treatment/Observation Phase|Other|0|||
144665599|NCT03334396|521626064|FG000|Overall Study|Adverse Event|1|||
144665600|NCT03334396|521626065|FG001|Overall Study|Adverse Event|0|||
144665601|NCT03334396|521626066|FG002|Overall Study|Adverse Event|1|||
144665602|NCT03334396|521626067|FG003|Overall Study|Adverse Event|0|||
144216761|NCT00265759|519987962|FG000|Overall Study|Cancel|0|||
144216762|NCT00265759|519987963|FG001|Overall Study|Cancel|0|||
144216763|NCT00265759|519987964|FG002|Overall Study|Cancel|0|||
144216764|NCT00265759|519987965|FG003|Overall Study|Cancel|3|||
144216765|NCT00265759|519987962|FG000|Overall Study|Ineligible|0|||
144216766|NCT00265759|519987963|FG001|Overall Study|Ineligible|0|||
144216767|NCT00265759|519987964|FG002|Overall Study|Ineligible|0|||
144216768|NCT00265759|519987965|FG003|Overall Study|Ineligible|1|||
144665603|NCT03334396|521626068|FG004|Overall Study|Adverse Event|0|||
144665604|NCT03334396|521626069|FG005|Overall Study|Adverse Event|0|||
144665605|NCT03334396|521626070|FG006|Overall Study|Adverse Event|0|||
144665606|NCT03334396|521626071|FG007|Overall Study|Adverse Event|0|||
144665607|NCT03334396|521626064|FG000|Overall Study|Lack of Efficacy|10|||
144665608|NCT03334396|521626065|FG001|Overall Study|Lack of Efficacy|4|||
144665609|NCT03334396|521626066|FG002|Overall Study|Lack of Efficacy|1|||
144665610|NCT03334396|521626067|FG003|Overall Study|Lack of Efficacy|3|||
144665611|NCT03334396|521626068|FG004|Overall Study|Lack of Efficacy|1|||
144665612|NCT03334396|521626069|FG005|Overall Study|Lack of Efficacy|0|||
144665613|NCT03334396|521626070|FG006|Overall Study|Lack of Efficacy|0|||
144665614|NCT03334396|521626071|FG007|Overall Study|Lack of Efficacy|1|||
144665615|NCT03334396|521626064|FG000|Overall Study|Lost to Follow-up|0|||
144665616|NCT03334396|521626065|FG001|Overall Study|Lost to Follow-up|0|||
144665617|NCT03334396|521626066|FG002|Overall Study|Lost to Follow-up|1|||
144665618|NCT03334396|521626067|FG003|Overall Study|Lost to Follow-up|0|||
144665619|NCT03334396|521626068|FG004|Overall Study|Lost to Follow-up|0|||
144665620|NCT03334396|521626069|FG005|Overall Study|Lost to Follow-up|0|||
144665621|NCT03334396|521626070|FG006|Overall Study|Lost to Follow-up|1|||
144665622|NCT03334396|521626071|FG007|Overall Study|Lost to Follow-up|0|||
144665623|NCT03334396|521626064|FG000|Overall Study|Physician Decision|1|||
144665624|NCT03334396|521626065|FG001|Overall Study|Physician Decision|0|||
144665625|NCT03334396|521626066|FG002|Overall Study|Physician Decision|0|||
144665626|NCT03334396|521626067|FG003|Overall Study|Physician Decision|0|||
144665627|NCT03334396|521626068|FG004|Overall Study|Physician Decision|0|||
144665628|NCT03334396|521626069|FG005|Overall Study|Physician Decision|0|||
144665629|NCT03334396|521626070|FG006|Overall Study|Physician Decision|0|||
144665630|NCT03334396|521626071|FG007|Overall Study|Physician Decision|0|||
144665631|NCT03334396|521626064|FG000|Overall Study|Withdrawal by Subject|10|||
144665632|NCT03334396|521626065|FG001|Overall Study|Withdrawal by Subject|5|||
144665633|NCT03334396|521626066|FG002|Overall Study|Withdrawal by Subject|7|||
144665634|NCT03334396|521626067|FG003|Overall Study|Withdrawal by Subject|2|||
144665635|NCT03334396|521626068|FG004|Overall Study|Withdrawal by Subject|2|||
144665636|NCT03334396|521626069|FG005|Overall Study|Withdrawal by Subject|1|||
144665637|NCT03334396|521626070|FG006|Overall Study|Withdrawal by Subject|2|||
144665638|NCT03334396|521626071|FG007|Overall Study|Withdrawal by Subject|0|||
144665639|NCT03334396|521626064|FG000|Overall Study|Pregnancy|0|||
144665640|NCT03334396|521626065|FG001|Overall Study|Pregnancy|1|||
144665641|NCT03334396|521626066|FG002|Overall Study|Pregnancy|0|||
144665642|NCT03334396|521626067|FG003|Overall Study|Pregnancy|0|||
144665643|NCT03334396|521626068|FG004|Overall Study|Pregnancy|0|||
144665644|NCT03334396|521626069|FG005|Overall Study|Pregnancy|0|||
144665645|NCT03334396|521626070|FG006|Overall Study|Pregnancy|0|||
144665646|NCT03334396|521626071|FG007|Overall Study|Pregnancy|0|||
144665647|NCT03334396|521626064|FG000|Overall Study|Ineligible|0|||
144665648|NCT03334396|521626065|FG001|Overall Study|Ineligible|1|||
144665649|NCT03334396|521626066|FG002|Overall Study|Ineligible|0|||
144665650|NCT03334396|521626067|FG003|Overall Study|Ineligible|0|||
144665651|NCT03334396|521626068|FG004|Overall Study|Ineligible|0|||
144665652|NCT03334396|521626069|FG005|Overall Study|Ineligible|0|||
144665653|NCT03334396|521626070|FG006|Overall Study|Ineligible|0|||
144665654|NCT03334396|521626071|FG007|Overall Study|Ineligible|0|||
144665655|NCT03334396|521626064|FG000|Overall Study|Started New Job|1|||
144665656|NCT03334396|521626065|FG001|Overall Study|Started New Job|0|||
144665657|NCT03334396|521626066|FG002|Overall Study|Started New Job|0|||
144665658|NCT03334396|521626067|FG003|Overall Study|Started New Job|0|||
144665659|NCT03334396|521626068|FG004|Overall Study|Started New Job|0|||
144665660|NCT03334396|521626069|FG005|Overall Study|Started New Job|0|||
144665661|NCT03334396|521626070|FG006|Overall Study|Started New Job|0|||
144665662|NCT03334396|521626071|FG007|Overall Study|Started New Job|0|||
144665663|NCT03519516|521626074|FG000|Overall Study|Adverse Event|0|||
144665664|NCT03519516|521626075|FG001|Overall Study|Adverse Event|1|||
144665665|NCT02379390|521626076|FG000|Overall Study|Adverse Event|1|||
144665666|NCT02379390|521626077|FG001|Overall Study|Adverse Event|1|||
144665667|NCT02379390|521626076|FG000|Overall Study|Investigator's decision|1|||
144665668|NCT02379390|521626077|FG001|Overall Study|Investigator's decision|0|||
144665669|NCT02379390|521626076|FG000|Overall Study|Study Termination|0|||
144665670|NCT02379390|521626077|FG001|Overall Study|Study Termination|1|||
144665671|NCT03784027|521626078|FG000|Period 1|Withdrawal by Subject|0|||
144665672|NCT03784027|521626079|FG001|Period 1|Withdrawal by Subject|1|||
144665673|NCT02126670|521628333|FG000|Overall Study|Withdrawal by Subject|1|||
144665674|NCT02126670|521628334|FG001|Overall Study|Withdrawal by Subject|0|||
144665675|NCT02126670|521628335|FG002|Overall Study|Withdrawal by Subject|0|||
144665676|NCT02126670|521628336|FG003|Overall Study|Withdrawal by Subject|1|||
144733656|NCT02481830|521882108|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
144665677|NCT01975246|521628337|FG000|Overall Study|Adverse Event|2|||
144665678|NCT01975246|521628338|FG001|Overall Study|Adverse Event|1|||
144665679|NCT01975246|521628337|FG000|Overall Study|Lack of Efficacy|1|||
144665680|NCT01975246|521628338|FG001|Overall Study|Lack of Efficacy|0|||
144665681|NCT01975246|521628337|FG000|Overall Study|Protocol Violation|1|||
144665682|NCT01975246|521628338|FG001|Overall Study|Protocol Violation|0|||
144665683|NCT01975246|521628337|FG000|Overall Study|Other than stated|0|||
144665684|NCT01975246|521628338|FG001|Overall Study|Other than stated|1|||
144665685|NCT00255034|521628339|FG000|Overall Study|Withdrawal by Subject|15|||
144665686|NCT00255034|521628340|FG001|Overall Study|Withdrawal by Subject|38|||
144665687|NCT01263093|521628341|FG000|Washout|Physician Decision|1|||
144665688|NCT01263093|521628342|FG001|Washout|Physician Decision|0|||
144665689|NCT01263093|521628341|FG000|Period 2|Adverse Event|1|||
144665690|NCT01263093|521628342|FG001|Period 2|Adverse Event|0|||
144665691|NCT00424346|521628343|FG000|Core Study|Adverse Event|5|||
144665692|NCT00424346|521628344|FG001|Core Study|Adverse Event|3|||
144665693|NCT00424346|521628345|FG002|Core Study|Adverse Event|1|||
144665694|NCT00424346|521628346|FG003|Core Study|Adverse Event|1|||
144665695|NCT00424346|521628343|FG000|Core Study|Abnormal Laboratory Values|0|||
144665696|NCT00424346|521628344|FG001|Core Study|Abnormal Laboratory Values|1|||
144665697|NCT00424346|521628345|FG002|Core Study|Abnormal Laboratory Values|0|||
144665698|NCT00424346|521628346|FG003|Core Study|Abnormal Laboratory Values|0|||
144665699|NCT00424346|521628343|FG000|Core Study|Lack of Efficacy|1|||
144665700|NCT00424346|521628344|FG001|Core Study|Lack of Efficacy|3|||
144665701|NCT00424346|521628345|FG002|Core Study|Lack of Efficacy|0|||
144665702|NCT00424346|521628346|FG003|Core Study|Lack of Efficacy|4|||
144665703|NCT00424346|521628343|FG000|Core Study|Withdrawal by Subject|1|||
144665704|NCT00424346|521628344|FG001|Core Study|Withdrawal by Subject|0|||
144665705|NCT00424346|521628345|FG002|Core Study|Withdrawal by Subject|0|||
144665706|NCT00424346|521628346|FG003|Core Study|Withdrawal by Subject|2|||
144665707|NCT00424346|521628343|FG000|Core Study|Lost to Follow-up|1|||
144665708|NCT00424346|521628344|FG001|Core Study|Lost to Follow-up|1|||
144665709|NCT00424346|521628345|FG002|Core Study|Lost to Follow-up|0|||
144665710|NCT00424346|521628346|FG003|Core Study|Lost to Follow-up|0|||
144665711|NCT00424346|521628343|FG000|Core Study|Administrative Problems|1|||
144665712|NCT00424346|521628344|FG001|Core Study|Administrative Problems|0|||
144665713|NCT00424346|521628345|FG002|Core Study|Administrative Problems|1|||
144665714|NCT00424346|521628346|FG003|Core Study|Administrative Problems|0|||
144665715|NCT00424346|521628343|FG000|Core Study|Protocol Violation|0|||
144665716|NCT00424346|521628344|FG001|Core Study|Protocol Violation|0|||
144665717|NCT00424346|521628345|FG002|Core Study|Protocol Violation|2|||
144665718|NCT00424346|521628346|FG003|Core Study|Protocol Violation|0|||
144665719|NCT00424346|521628343|FG000|Extension Phase|Adverse Event|0|||
144665720|NCT00424346|521628344|FG001|Extension Phase|Adverse Event|9|||
144665721|NCT00424346|521628345|FG002|Extension Phase|Adverse Event|5|||
144665722|NCT00424346|521628346|FG003|Extension Phase|Adverse Event|4|||
144665723|NCT00424346|521628343|FG000|Extension Phase|Lack of Efficacy|0|||
144665724|NCT00424346|521628344|FG001|Extension Phase|Lack of Efficacy|16|||
144665725|NCT00424346|521628345|FG002|Extension Phase|Lack of Efficacy|14|||
144665726|NCT00424346|521628346|FG003|Extension Phase|Lack of Efficacy|11|||
144665727|NCT00424346|521628343|FG000|Extension Phase|Withdrawal by Subject|0|||
144665728|NCT00424346|521628344|FG001|Extension Phase|Withdrawal by Subject|5|||
144665729|NCT00424346|521628345|FG002|Extension Phase|Withdrawal by Subject|3|||
144665730|NCT00424346|521628346|FG003|Extension Phase|Withdrawal by Subject|4|||
144665731|NCT00424346|521628343|FG000|Extension Phase|Lost to Follow-up|0|||
144665732|NCT00424346|521628344|FG001|Extension Phase|Lost to Follow-up|2|||
144665733|NCT00424346|521628345|FG002|Extension Phase|Lost to Follow-up|0|||
144665734|NCT00424346|521628346|FG003|Extension Phase|Lost to Follow-up|0|||
144665735|NCT00424346|521628343|FG000|Extension Phase|Administrative Problems|0|||
144665736|NCT00424346|521628344|FG001|Extension Phase|Administrative Problems|69|||
144665737|NCT00424346|521628345|FG002|Extension Phase|Administrative Problems|32|||
144665738|NCT00424346|521628346|FG003|Extension Phase|Administrative Problems|35|||
144665739|NCT00424346|521628343|FG000|Extension Phase|Death|0|||
144216769|NCT00265759|519987962|FG000|Overall Study|Bilateral disease|0|||
144216770|NCT00265759|519987963|FG001|Overall Study|Bilateral disease|0|||
144216771|NCT00265759|519987964|FG002|Overall Study|Bilateral disease|0|||
144216772|NCT00265759|519987965|FG003|Overall Study|Bilateral disease|2|||
144665740|NCT00424346|521628344|FG001|Extension Phase|Death|0|||
144665741|NCT00424346|521628345|FG002|Extension Phase|Death|0|||
144665742|NCT00424346|521628346|FG003|Extension Phase|Death|1|||
144665743|NCT00424346|521628343|FG000|Extension Phase|Protocol Violation|0|||
144216773|NCT00265759|519987962|FG000|Overall Study|Discontinued due to intolerability|0|||
144216774|NCT00265759|519987963|FG001|Overall Study|Discontinued due to intolerability|0|||
144216775|NCT00265759|519987964|FG002|Overall Study|Discontinued due to intolerability|0|||
144733657|NCT02481830|521882109|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
144665744|NCT00424346|521628344|FG001|Extension Phase|Protocol Violation|1|||
144665745|NCT00424346|521628345|FG002|Extension Phase|Protocol Violation|1|||
144665746|NCT00424346|521628346|FG003|Extension Phase|Protocol Violation|0|||
144665747|NCT04019795|521628349|FG000|Overall Study|Withdrawal by Subject|1|||
144665748|NCT04019795|521628350|FG001|Overall Study|Withdrawal by Subject|2|||
144665749|NCT04019795|521628351|FG002|Overall Study|Withdrawal by Subject|2|||
144665750|NCT04019795|521628352|FG003|Overall Study|Withdrawal by Subject|1|||
144265568|NCT00853762|520173968|FG003|Overall Study|Protocol Violation|1|||
144665751|NCT04019795|521628349|FG000|Overall Study|Lost to Follow-up|0|||
144665752|NCT04019795|521628350|FG001|Overall Study|Lost to Follow-up|1|||
144665753|NCT04019795|521628351|FG002|Overall Study|Lost to Follow-up|1|||
144665754|NCT04019795|521628352|FG003|Overall Study|Lost to Follow-up|2|||
144665755|NCT04019795|521628349|FG000|Overall Study|Treatment non-compliance|3|||
144665756|NCT04019795|521628350|FG001|Overall Study|Treatment non-compliance|1|||
144665757|NCT04019795|521628351|FG002|Overall Study|Treatment non-compliance|2|||
144665758|NCT04019795|521628352|FG003|Overall Study|Treatment non-compliance|0|||
144665759|NCT04019795|521628349|FG000|Overall Study|Physician Decision|0|||
144665760|NCT04019795|521628350|FG001|Overall Study|Physician Decision|0|||
144665761|NCT04019795|521628351|FG002|Overall Study|Physician Decision|1|||
144665762|NCT04019795|521628352|FG003|Overall Study|Physician Decision|0|||
144665763|NCT04019795|521628349|FG000|Overall Study|Adverse Event|1|||
144665764|NCT04019795|521628350|FG001|Overall Study|Adverse Event|0|||
144665765|NCT04019795|521628351|FG002|Overall Study|Adverse Event|0|||
144665766|NCT04019795|521628352|FG003|Overall Study|Adverse Event|0|||
144665767|NCT01107405|521628357|FG000|Overall Study|Adverse Event|1|||
144665768|NCT01107405|521628358|FG001|Overall Study|Adverse Event|1|||
144665769|NCT01107405|521628359|FG002|Overall Study|Adverse Event|0|||
144665770|NCT01107405|521628360|FG003|Overall Study|Adverse Event|0|||
144665771|NCT01107405|521628361|FG004|Overall Study|Adverse Event|2|||
144665772|NCT01107405|521628357|FG000|Overall Study|Withdrawal by Subject|1|||
144665773|NCT01107405|521628358|FG001|Overall Study|Withdrawal by Subject|0|||
144665774|NCT01107405|521628359|FG002|Overall Study|Withdrawal by Subject|1|||
144665775|NCT01107405|521628360|FG003|Overall Study|Withdrawal by Subject|2|||
144665776|NCT01107405|521628361|FG004|Overall Study|Withdrawal by Subject|1|||
144665777|NCT01107405|521628357|FG000|Overall Study|Protocol Violation|0|||
144665778|NCT01107405|521628358|FG001|Overall Study|Protocol Violation|0|||
144665779|NCT01107405|521628359|FG002|Overall Study|Protocol Violation|1|||
144665780|NCT01107405|521628360|FG003|Overall Study|Protocol Violation|1|||
144665781|NCT01107405|521628361|FG004|Overall Study|Protocol Violation|0|||
144665782|NCT00712933|521628367|FG000|Overall Study|Adverse Event|69|||
144665783|NCT00712933|521628367|FG000|Overall Study|Lack of Efficacy|6|||
144665784|NCT00712933|521628367|FG000|Overall Study|Lost to Follow-up|22|||
144665785|NCT00712933|521628367|FG000|Overall Study|Non-compliance with study drug|13|||
144665786|NCT00712933|521628367|FG000|Overall Study|Other Pregnancy|37|||
144665787|NCT00712933|521628367|FG000|Overall Study|Sponsor decision|14|||
144665788|NCT00712933|521628367|FG000|Overall Study|Withdrew consent|4|||
144216776|NCT00265759|519987965|FG003|Overall Study|Discontinued due to intolerability|1|||
144216777|NCT03729596|519987968|FG000|Overall Study|Death|3|||
144665789|NCT00712933|521628367|FG000|Overall Study|Hip replacement surgery|1|||
144665790|NCT00712933|521628367|FG000|Overall Study|Involved in Clinical research|3|||
144665791|NCT00712933|521628367|FG000|Overall Study|Participant hospitalized|1|||
144216778|NCT03729596|519987969|FG001|Overall Study|Death|5|||
144216779|NCT03729596|519987970|FG002|Overall Study|Death|4|||
144216780|NCT03729596|519987971|FG003|Overall Study|Death|1|||
144216781|NCT03729596|519987972|FG004|Overall Study|Death|0|||
144216782|NCT03729596|519987973|FG005|Overall Study|Death|34|||
144216783|NCT03729596|519987974|FG006|Overall Study|Death|18|||
144216784|NCT03729596|519987975|FG007|Overall Study|Death|14|||
144216785|NCT03729596|519987976|FG008|Overall Study|Death|19|||
144216786|NCT03729596|519987977|FG009|Overall Study|Death|9|||
144216787|NCT03729596|519987968|FG000|Overall Study|Lost to Follow-up|0|||
144665792|NCT00712933|521628367|FG000|Overall Study|Participant travelled overseas|2|||
144665793|NCT00712933|521628367|FG000|Overall Study|Death of patient|1|||
144665794|NCT00712933|521628367|FG000|Overall Study|Other Physician decision|1|||
144665795|NCT00712933|521628367|FG000|Overall Study|Not committed to contraception|1|||
144665796|NCT00712933|521628367|FG000|Overall Study|Participant received medication|1|||
144665797|NCT00712933|521628367|FG000|Overall Study|Physician Decision|36|||
144665798|NCT00712933|521628367|FG000|Overall Study|Protocol Violation|4|||
144216788|NCT03729596|519987969|FG001|Overall Study|Lost to Follow-up|0|||
144216789|NCT03729596|519987970|FG002|Overall Study|Lost to Follow-up|0|||
144216790|NCT03729596|519987971|FG003|Overall Study|Lost to Follow-up|0|||
144216791|NCT03729596|519987972|FG004|Overall Study|Lost to Follow-up|0|||
144216792|NCT03729596|519987973|FG005|Overall Study|Lost to Follow-up|0|||
144216793|NCT03729596|519987974|FG006|Overall Study|Lost to Follow-up|1|||
144216794|NCT03729596|519987975|FG007|Overall Study|Lost to Follow-up|0|||
144216795|NCT03729596|519987976|FG008|Overall Study|Lost to Follow-up|0|||
144216796|NCT03729596|519987977|FG009|Overall Study|Lost to Follow-up|1|||
144216797|NCT03729596|519987968|FG000|Overall Study|protocol amendment|0|||
144665799|NCT00712933|521628367|FG000|Overall Study|Withdrawal by Subject|151|||
144665800|NCT00085917|521628368|FG000|Overall Study|Adverse Event|4|||
144216798|NCT03729596|519987969|FG001|Overall Study|protocol amendment|1|||
144665801|NCT00085917|521628369|FG001|Overall Study|Adverse Event|3|||
144665802|NCT02022033|521628373|FG000|Overall Study|Physician Decision|1|||
144665803|NCT01429077|521628374|FG000|Overall Study|Lost to Follow-up|0|||
144665804|NCT01429077|521628375|FG001|Overall Study|Lost to Follow-up|3|||
144665805|NCT01413542|521628377|FG000|Overall Study|Physician Decision|1|||
144665806|NCT01413542|521628378|FG001|Overall Study|Physician Decision|0|||
144216799|NCT03729596|519987970|FG002|Overall Study|protocol amendment|3|||
144216800|NCT03729596|519987971|FG003|Overall Study|protocol amendment|6|||
144665807|NCT01413542|521628379|FG002|Overall Study|Physician Decision|3|||
144665808|NCT01413542|521628380|FG003|Overall Study|Physician Decision|0|||
144665809|NCT01413542|521628377|FG000|Overall Study|Adverse Event|0|||
144665810|NCT01413542|521628378|FG001|Overall Study|Adverse Event|0|||
144665811|NCT01413542|521628379|FG002|Overall Study|Adverse Event|0|||
144665812|NCT01413542|521628380|FG003|Overall Study|Adverse Event|1|||
144665813|NCT03084718|521628381|FG000|Overall Study|Withdrawal by Subject|4|||
144665814|NCT03084718|521628382|FG001|Overall Study|Withdrawal by Subject|3|||
144665815|NCT03084718|521628383|FG002|Overall Study|Withdrawal by Subject|4|||
144665816|NCT03084718|521628384|FG003|Overall Study|Withdrawal by Subject|0|||
144665817|NCT03084718|521628385|FG004|Overall Study|Withdrawal by Subject|0|||
144665818|NCT03084718|521628381|FG000|Overall Study|Physician Decision|1|||
144665819|NCT03084718|521628382|FG001|Overall Study|Physician Decision|0|||
144665820|NCT03084718|521628383|FG002|Overall Study|Physician Decision|0|||
144665821|NCT03084718|521628384|FG003|Overall Study|Physician Decision|0|||
144665822|NCT03084718|521628385|FG004|Overall Study|Physician Decision|0|||
144665823|NCT03084718|521628381|FG000|Overall Study|Adverse Event|3|||
144665824|NCT03084718|521628382|FG001|Overall Study|Adverse Event|5|||
144665825|NCT03084718|521628383|FG002|Overall Study|Adverse Event|5|||
144665826|NCT03084718|521628384|FG003|Overall Study|Adverse Event|8|||
144665827|NCT03084718|521628385|FG004|Overall Study|Adverse Event|2|||
144665828|NCT03084718|521628381|FG000|Overall Study|Lack of Efficacy|2|||
144665829|NCT03084718|521628382|FG001|Overall Study|Lack of Efficacy|0|||
144665830|NCT03084718|521628383|FG002|Overall Study|Lack of Efficacy|1|||
144665831|NCT03084718|521628384|FG003|Overall Study|Lack of Efficacy|4|||
144665832|NCT03084718|521628385|FG004|Overall Study|Lack of Efficacy|0|||
144665833|NCT03084718|521628381|FG000|Overall Study|Lost to Follow-up|0|||
144665834|NCT03084718|521628382|FG001|Overall Study|Lost to Follow-up|1|||
144665835|NCT03084718|521628383|FG002|Overall Study|Lost to Follow-up|0|||
144665836|NCT03084718|521628384|FG003|Overall Study|Lost to Follow-up|0|||
144665837|NCT03084718|521628385|FG004|Overall Study|Lost to Follow-up|2|||
144665838|NCT03084718|521628381|FG000|Overall Study|Protocol Violation|0|||
144665839|NCT03084718|521628382|FG001|Overall Study|Protocol Violation|0|||
144665840|NCT03084718|521628383|FG002|Overall Study|Protocol Violation|1|||
144665841|NCT03084718|521628384|FG003|Overall Study|Protocol Violation|0|||
144665842|NCT03084718|521628385|FG004|Overall Study|Protocol Violation|0|||
144665843|NCT03084718|521628381|FG000|Overall Study|Death|0|||
144665844|NCT03084718|521628382|FG001|Overall Study|Death|1|||
144665845|NCT03084718|521628383|FG002|Overall Study|Death|0|||
144665846|NCT03084718|521628384|FG003|Overall Study|Death|0|||
144665847|NCT03084718|521628385|FG004|Overall Study|Death|0|||
144665848|NCT03084718|521628381|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
144665849|NCT03084718|521628382|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
144665850|NCT03084718|521628383|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
144665851|NCT03084718|521628384|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
144665852|NCT03084718|521628385|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
144665853|NCT03341923|521628386|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
144665854|NCT03341923|521628387|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
144665855|NCT02806947|521628388|FG000|Overall Study|Withdrawal by Subject|5|||
144665856|NCT02806947|521628389|FG001|Overall Study|Withdrawal by Subject|1|||
144665857|NCT03986190|521628390|FG000|Overall Study|Withdrawal by Subject|12|||
144665858|NCT03986190|521628391|FG001|Overall Study|Withdrawal by Subject|0|||
144665859|NCT04511819|521628392|FG000|Overall Study|Non-compliance with study drug|5|||
144665860|NCT04511819|521628393|FG001|Overall Study|Non-compliance with study drug|1|||
144665861|NCT04511819|521628392|FG000|Overall Study|Withdrawal by Subject|0|||
144665862|NCT04511819|521628393|FG001|Overall Study|Withdrawal by Subject|3|||
144665863|NCT04511819|521628392|FG000|Overall Study|Adverse Event|0|||
144665864|NCT04511819|521628393|FG001|Overall Study|Adverse Event|1|||
144665865|NCT04511819|521628392|FG000|Overall Study|Protocol deviation|1|||
144665866|NCT04511819|521628393|FG001|Overall Study|Protocol deviation|0|||
144665867|NCT02767856|521628404|FG000|Overall Study|Lost to Follow-up|9|||
144665868|NCT02767856|521628405|FG001|Overall Study|Lost to Follow-up|1|||
144665869|NCT02767856|521628404|FG000|Overall Study|Withdrawal by Subject|2|||
144665870|NCT02767856|521628405|FG001|Overall Study|Withdrawal by Subject|1|||
144665871|NCT01594333|521628406|FG000|Overall Study|Death|96|||
144665872|NCT01594333|521628407|FG001|Overall Study|Death|83|||
144733658|NCT02481830|521882108|FG000|Pre-treatment|Withdrawal by Subject|0|||
144665873|NCT01594333|521628406|FG000|Overall Study|Lost to Follow-up|5|||
144665874|NCT01594333|521628407|FG001|Overall Study|Lost to Follow-up|5|||
144665875|NCT01594333|521628406|FG000|Overall Study|Withdrawal by Subject|60|||
144665876|NCT01594333|521628407|FG001|Overall Study|Withdrawal by Subject|63|||
144665877|NCT00589979|521628408|FG000|Run-In Period|Adverse Event|5|||
144665878|NCT00589979|521628409|FG001|Run-In Period|Adverse Event|0|||
144665879|NCT00589979|521628410|FG002|Run-In Period|Adverse Event|0|||
144665880|NCT00589979|521628408|FG000|Run-In Period|Protocol Violation|3|||
144665881|NCT00589979|521628409|FG001|Run-In Period|Protocol Violation|0|||
144665882|NCT00589979|521628410|FG002|Run-In Period|Protocol Violation|0|||
144665883|NCT00589979|521628408|FG000|Run-In Period|Did not qualify for randomization|54|||
144665884|NCT00589979|521628409|FG001|Run-In Period|Did not qualify for randomization|0|||
144216801|NCT03729596|519987972|FG004|Overall Study|protocol amendment|5|||
144216802|NCT03729596|519987973|FG005|Overall Study|protocol amendment|0|||
144216803|NCT03729596|519987974|FG006|Overall Study|protocol amendment|0|||
144216804|NCT03729596|519987975|FG007|Overall Study|protocol amendment|0|||
144216805|NCT03729596|519987976|FG008|Overall Study|protocol amendment|0|||
144216806|NCT03729596|519987977|FG009|Overall Study|protocol amendment|0|||
144216807|NCT03729596|519987968|FG000|Overall Study|Withdrawal by Subject|0|||
144216808|NCT03729596|519987969|FG001|Overall Study|Withdrawal by Subject|0|||
144216809|NCT03729596|519987970|FG002|Overall Study|Withdrawal by Subject|0|||
144216810|NCT03729596|519987971|FG003|Overall Study|Withdrawal by Subject|0|||
144216811|NCT03729596|519987972|FG004|Overall Study|Withdrawal by Subject|0|||
144216812|NCT03729596|519987973|FG005|Overall Study|Withdrawal by Subject|4|||
144216813|NCT03729596|519987974|FG006|Overall Study|Withdrawal by Subject|2|||
144216814|NCT03729596|519987975|FG007|Overall Study|Withdrawal by Subject|3|||
144216815|NCT03729596|519987976|FG008|Overall Study|Withdrawal by Subject|2|||
144216816|NCT03729596|519987977|FG009|Overall Study|Withdrawal by Subject|3|||
144216817|NCT03729596|519987968|FG000|Overall Study|study terminated by sponsor|0|||
144216818|NCT03729596|519987969|FG001|Overall Study|study terminated by sponsor|0|||
144216819|NCT03729596|519987970|FG002|Overall Study|study terminated by sponsor|0|||
144216820|NCT03729596|519987971|FG003|Overall Study|study terminated by sponsor|0|||
144265569|NCT00853762|520173965|FG000|Overall Study|Withdrawal by Subject|0|||
144665885|NCT00589979|521628410|FG002|Run-In Period|Did not qualify for randomization|0|||
144665886|NCT00589979|521628408|FG000|Run-In Period|Withdrawal by Subject|10|||
144665887|NCT00589979|521628409|FG001|Run-In Period|Withdrawal by Subject|0|||
144665888|NCT00589979|521628410|FG002|Run-In Period|Withdrawal by Subject|0|||
144665889|NCT00589979|521628408|FG000|Run-In Period|Informed Consent Withdrawn|4|||
144665890|NCT00589979|521628409|FG001|Run-In Period|Informed Consent Withdrawn|0|||
144665891|NCT00589979|521628410|FG002|Run-In Period|Informed Consent Withdrawn|0|||
144216821|NCT03729596|519987972|FG004|Overall Study|study terminated by sponsor|1|||
144216822|NCT03729596|519987973|FG005|Overall Study|study terminated by sponsor|3|||
144216823|NCT03729596|519987974|FG006|Overall Study|study terminated by sponsor|0|||
144216824|NCT03729596|519987975|FG007|Overall Study|study terminated by sponsor|1|||
144216825|NCT03729596|519987976|FG008|Overall Study|study terminated by sponsor|0|||
144216826|NCT03729596|519987977|FG009|Overall Study|study terminated by sponsor|0|||
144216827|NCT03713593|519987978|FG000|Overall Study|Sponsor Decision|73|||
144216828|NCT03713593|519987979|FG001|Overall Study|Sponsor Decision|41|||
144216829|NCT03713593|519987978|FG000|Overall Study|Lost to Follow-up|2|||
144216830|NCT03713593|519987979|FG001|Overall Study|Lost to Follow-up|1|||
144665892|NCT00589979|521628408|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
144665893|NCT00589979|521628409|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
144665894|NCT00589979|521628410|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
144665895|NCT00589979|521628408|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
144665896|NCT00589979|521628409|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
144665897|NCT00589979|521628410|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
144665898|NCT00589979|521628408|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
144665899|NCT00589979|521628409|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
144665900|NCT00589979|521628410|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
144665901|NCT00589979|521628408|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
144665902|NCT00589979|521628409|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
144665903|NCT00589979|521628410|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
144665904|NCT00589979|521628408|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
144665905|NCT00589979|521628409|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
144665906|NCT00589979|521628410|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
144665907|NCT00589979|521628408|FG000|Double-Blind Treatment Period 2|Other|0|||
144665908|NCT00589979|521628409|FG001|Double-Blind Treatment Period 2|Other|0|||
144665909|NCT00589979|521628410|FG002|Double-Blind Treatment Period 2|Other|1|||
144665910|NCT00589979|521628408|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
144216831|NCT03713593|519987978|FG000|Overall Study|Death|314|||
144216832|NCT03713593|519987979|FG001|Overall Study|Death|349|||
144216833|NCT03713593|519987978|FG000|Overall Study|Withdrawal by Subject|6|||
144216834|NCT03713593|519987979|FG001|Overall Study|Withdrawal by Subject|8|||
144216835|NCT03130777|519987980|FG000|Overall Study|Death|0|||
144216836|NCT03130777|519987981|FG001|Overall Study|Death|1|||
144216837|NCT03130777|519987980|FG000|Overall Study|Did not meet eligibility criteria|1|||
144265570|NCT00853762|520173966|FG001|Overall Study|Withdrawal by Subject|0|||
144665911|NCT00589979|521628409|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
144665912|NCT00589979|521628410|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
144216838|NCT03130777|519987981|FG001|Overall Study|Did not meet eligibility criteria|0|||
144216839|NCT02498613|519987982|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
144216840|NCT02498613|519987983|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
144216841|NCT02498613|519987984|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
144216842|NCT02498613|519987985|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
144665913|NCT00589979|521628408|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
144665914|NCT00589979|521628409|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
144665915|NCT00589979|521628410|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
144665916|NCT04685499|521628413|FG000|Overall Study|Study Terminated Early|1|||
144665917|NCT03176277|521628414|FG000|Part A Dose Escalation Study|Adverse Event|1|||
144665918|NCT03176277|521628415|FG001|Part A Dose Escalation Study|Adverse Event|0|||
144665919|NCT03176277|521628416|FG002|Part A Dose Escalation Study|Adverse Event|1|||
144665920|NCT03176277|521628417|FG003|Part A Dose Escalation Study|Adverse Event|0|||
144665921|NCT03176277|521628414|FG000|Part A Dose Escalation Study|Physician Decision|1|||
144665922|NCT03176277|521628415|FG001|Part A Dose Escalation Study|Physician Decision|1|||
144665923|NCT03176277|521628416|FG002|Part A Dose Escalation Study|Physician Decision|2|||
144665924|NCT03176277|521628417|FG003|Part A Dose Escalation Study|Physician Decision|0|||
144665925|NCT03176277|521628414|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
144665926|NCT03176277|521628415|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
144665927|NCT03176277|521628416|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
144665928|NCT03176277|521628417|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
144665929|NCT03176277|521628414|FG000|Part A Dose Escalation Study|Progressive disease|3|||
144665930|NCT03176277|521628415|FG001|Part A Dose Escalation Study|Progressive disease|1|||
144665931|NCT03176277|521628416|FG002|Part A Dose Escalation Study|Progressive disease|3|||
144665932|NCT03176277|521628417|FG003|Part A Dose Escalation Study|Progressive disease|0|||
144665933|NCT00634114|521628418|FG000|Overall Study|Adverse Event|6|||
144665934|NCT00634114|521628419|FG001|Overall Study|Adverse Event|8|||
144665935|NCT00634114|521628420|FG002|Overall Study|Adverse Event|3|||
144665936|NCT00634114|521628418|FG000|Overall Study|Withdrawal by Subject|9|||
144665937|NCT00634114|521628419|FG001|Overall Study|Withdrawal by Subject|6|||
144665938|NCT00634114|521628420|FG002|Overall Study|Withdrawal by Subject|11|||
144665939|NCT00634114|521628418|FG000|Overall Study|Lost to Follow-up|0|||
144665940|NCT00634114|521628419|FG001|Overall Study|Lost to Follow-up|0|||
144665941|NCT00634114|521628420|FG002|Overall Study|Lost to Follow-up|1|||
144665942|NCT00634114|521628418|FG000|Overall Study|Protocol Violation|3|||
144665943|NCT00634114|521628419|FG001|Overall Study|Protocol Violation|3|||
144665944|NCT00634114|521628420|FG002|Overall Study|Protocol Violation|1|||
144665945|NCT00634114|521628418|FG000|Overall Study|Pregnancy|1|||
144665946|NCT00634114|521628419|FG001|Overall Study|Pregnancy|0|||
144665947|NCT00634114|521628420|FG002|Overall Study|Pregnancy|0|||
144665948|NCT00634114|521628418|FG000|Overall Study|Incorrect enrolment|0|||
144665949|NCT00634114|521628419|FG001|Overall Study|Incorrect enrolment|1|||
144665950|NCT00634114|521628420|FG002|Overall Study|Incorrect enrolment|0|||
144665951|NCT00634114|521628418|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
144665952|NCT00634114|521628419|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
144665953|NCT00634114|521628420|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
144665954|NCT00634114|521628418|FG000|Overall Study|Difficult to continue|3|||
144665955|NCT00634114|521628419|FG001|Overall Study|Difficult to continue|1|||
144665956|NCT00634114|521628420|FG002|Overall Study|Difficult to continue|1|||
144665957|NCT00634114|521628418|FG000|Overall Study|Other reason|1|||
144665958|NCT00634114|521628419|FG001|Overall Study|Other reason|1|||
144665959|NCT00634114|521628420|FG002|Overall Study|Other reason|1|||
144665960|NCT03282357|521628422|FG000|Overall Study|Lost to Follow-up|3|||
144665961|NCT03282357|521628422|FG000|Overall Study|Withdrawal by Subject|4|||
144665962|NCT03282357|521628422|FG000|Overall Study|Adverse Event|1|||
144665963|NCT03282357|521628422|FG000|Overall Study|Other|9|||
144665964|NCT03550131|521628423|FG000|Overall Study|Lost to Follow-up|16|||
144665965|NCT03550131|521628424|FG001|Overall Study|Lost to Follow-up|24|||
144665966|NCT03550131|521628423|FG000|Overall Study|Withdrawal by Subject|36|||
144665967|NCT03550131|521628424|FG001|Overall Study|Withdrawal by Subject|28|||
144665968|NCT03550131|521628423|FG000|Overall Study|Illness of dyad member|10|||
144665969|NCT03550131|521628424|FG001|Overall Study|Illness of dyad member|2|||
144665970|NCT03550131|521628423|FG000|Overall Study|Death of person with dementia|4|||
144665971|NCT03550131|521628424|FG001|Overall Study|Death of person with dementia|8|||
144665972|NCT01318512|521628425|FG000|Maintenance Period (6 Months)|Death|2|||
144665973|NCT01318512|521628425|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
144665974|NCT01822691|521628430|FG000|Overall Study|Withdrawal by Subject|2|||
144665975|NCT00622869|521628431|FG000|Overall Study|Subject Withdrew Consent|13|||
144665976|NCT00622869|521628432|FG001|Overall Study|Subject Withdrew Consent|17|||
144665977|NCT00622869|521628433|FG002|Overall Study|Subject Withdrew Consent|11|||
144665978|NCT00622869|521628431|FG000|Overall Study|Administrative Problems|11|||
144665979|NCT00622869|521628432|FG001|Overall Study|Administrative Problems|17|||
144665980|NCT00622869|521628433|FG002|Overall Study|Administrative Problems|13|||
144665981|NCT00622869|521628431|FG000|Overall Study|Death|12|||
144665982|NCT00622869|521628432|FG001|Overall Study|Death|15|||
144665983|NCT00622869|521628433|FG002|Overall Study|Death|10|||
144665984|NCT00622869|521628431|FG000|Overall Study|Lost to Follow-up|2|||
144665985|NCT00622869|521628432|FG001|Overall Study|Lost to Follow-up|4|||
144665986|NCT00622869|521628433|FG002|Overall Study|Lost to Follow-up|2|||
144665987|NCT00622869|521628431|FG000|Overall Study|Graft Loss|5|||
144665988|NCT00622869|521628432|FG001|Overall Study|Graft Loss|3|||
144665989|NCT00622869|521628433|FG002|Overall Study|Graft Loss|2|||
144665990|NCT00622869|521628431|FG000|Overall Study|Missing|0|||
144665991|NCT00622869|521628432|FG001|Overall Study|Missing|1|||
144665992|NCT00622869|521628433|FG002|Overall Study|Missing|1|||
144665993|NCT00645567|521628436|FG000|Overall Study|Adverse Event|1|||
144665994|NCT04664855|521628437|FG000|Overall Study|Withdrawal by Subject|0|||
144665995|NCT04664855|521628438|FG001|Overall Study|Withdrawal by Subject|2|||
144665996|NCT02648724|521628440|FG000|Overall Study|Withdrawal by Subject|0|||
144665997|NCT02648724|521628441|FG001|Overall Study|Withdrawal by Subject|1|||
144665998|NCT02648724|521628442|FG002|Overall Study|Withdrawal by Subject|1|||
144665999|NCT02648724|521628443|FG003|Overall Study|Withdrawal by Subject|0|||
144666000|NCT02648724|521628444|FG004|Overall Study|Withdrawal by Subject|1|||
144666001|NCT02648724|521628445|FG005|Overall Study|Withdrawal by Subject|0|||
144666002|NCT02648724|521628446|FG006|Overall Study|Withdrawal by Subject|0|||
144666003|NCT02648724|521628440|FG000|Overall Study|Progressive disease|2|||
144666004|NCT02648724|521628441|FG001|Overall Study|Progressive disease|2|||
144666005|NCT02648724|521628442|FG002|Overall Study|Progressive disease|2|||
144666006|NCT02648724|521628443|FG003|Overall Study|Progressive disease|3|||
144666007|NCT02648724|521628444|FG004|Overall Study|Progressive disease|22|||
144666008|NCT02648724|521628445|FG005|Overall Study|Progressive disease|7|||
144666009|NCT02648724|521628446|FG006|Overall Study|Progressive disease|8|||
144666010|NCT02648724|521628440|FG000|Overall Study|Other reason (unknown)|1|||
144216843|NCT02498613|519987982|FG000|Overall Study|Withdrawal by Subject|3|||
144666011|NCT02648724|521628441|FG001|Overall Study|Other reason (unknown)|0|||
144666012|NCT02648724|521628442|FG002|Overall Study|Other reason (unknown)|0|||
144666013|NCT02648724|521628443|FG003|Overall Study|Other reason (unknown)|0|||
144666014|NCT02648724|521628444|FG004|Overall Study|Other reason (unknown)|0|||
144666015|NCT02648724|521628445|FG005|Overall Study|Other reason (unknown)|0|||
144666016|NCT02648724|521628446|FG006|Overall Study|Other reason (unknown)|0|||
144666017|NCT02648724|521628440|FG000|Overall Study|Protocol Violation|0|||
144666018|NCT02648724|521628441|FG001|Overall Study|Protocol Violation|0|||
144666019|NCT02648724|521628442|FG002|Overall Study|Protocol Violation|0|||
144666020|NCT02648724|521628443|FG003|Overall Study|Protocol Violation|0|||
144666021|NCT02648724|521628444|FG004|Overall Study|Protocol Violation|1|||
144666022|NCT02648724|521628445|FG005|Overall Study|Protocol Violation|0|||
144666023|NCT02648724|521628446|FG006|Overall Study|Protocol Violation|0|||
144666024|NCT02648724|521628440|FG000|Overall Study|Death|0|||
144666025|NCT02648724|521628441|FG001|Overall Study|Death|0|||
144666026|NCT02648724|521628442|FG002|Overall Study|Death|0|||
144666027|NCT02648724|521628443|FG003|Overall Study|Death|0|||
144666028|NCT02648724|521628444|FG004|Overall Study|Death|0|||
144666029|NCT02648724|521628445|FG005|Overall Study|Death|0|||
144666030|NCT02648724|521628446|FG006|Overall Study|Death|3|||
144666031|NCT02648724|521628440|FG000|Overall Study|Physician Decision|0|||
144216844|NCT02498613|519987983|FG001|Overall Study|Withdrawal by Subject|1|||
144216845|NCT02498613|519987984|FG002|Overall Study|Withdrawal by Subject|0|||
144216846|NCT02498613|519987985|FG003|Overall Study|Withdrawal by Subject|0|||
144216847|NCT05109611|519987987|FG000|Overall Study|Adverse Event|13|||
144216848|NCT05109611|519987988|FG001|Overall Study|Adverse Event|10|||
144216849|NCT05109611|519987987|FG000|Overall Study|Withdrawal by Subject|1|||
144216850|NCT05109611|519987988|FG001|Overall Study|Withdrawal by Subject|0|||
144216851|NCT05109611|519987987|FG000|Overall Study|Lost to Follow-up|1|||
144216852|NCT05109611|519987988|FG001|Overall Study|Lost to Follow-up|2|||
144216853|NCT05109611|519987987|FG000|Overall Study|Protocol Violation|0|||
144216854|NCT05109611|519987988|FG001|Overall Study|Protocol Violation|4|||
144216855|NCT05109611|519987987|FG000|Overall Study|Information unavailable|1|||
144216856|NCT05109611|519987988|FG001|Overall Study|Information unavailable|1|||
144216857|NCT03999996|519987989|FG000|Prior to Booster|Adverse Event|2|||
144216858|NCT03999996|519987990|FG001|Prior to Booster|Adverse Event|0|||
144216859|NCT03999996|519987991|FG002|Prior to Booster|Adverse Event|0|||
144216860|NCT03999996|519987992|FG003|Prior to Booster|Adverse Event|0|||
144216861|NCT03999996|519987989|FG000|Prior to Booster|Lost to Follow-up|17|||
144216862|NCT03999996|519987990|FG001|Prior to Booster|Lost to Follow-up|22|||
144666032|NCT02648724|521628441|FG001|Overall Study|Physician Decision|0|||
144666033|NCT02648724|521628442|FG002|Overall Study|Physician Decision|0|||
144666034|NCT02648724|521628443|FG003|Overall Study|Physician Decision|0|||
144666035|NCT02648724|521628444|FG004|Overall Study|Physician Decision|1|||
144666036|NCT02648724|521628445|FG005|Overall Study|Physician Decision|0|||
144666037|NCT02648724|521628446|FG006|Overall Study|Physician Decision|1|||
144666038|NCT02648724|521628440|FG000|Overall Study|Transferred to named patient program|0|||
144666039|NCT02648724|521628441|FG001|Overall Study|Transferred to named patient program|0|||
144666040|NCT02648724|521628442|FG002|Overall Study|Transferred to named patient program|0|||
144666041|NCT02648724|521628443|FG003|Overall Study|Transferred to named patient program|0|||
144666042|NCT02648724|521628444|FG004|Overall Study|Transferred to named patient program|0|||
144216863|NCT03999996|519987991|FG002|Prior to Booster|Lost to Follow-up|0|||
144216864|NCT03999996|519987992|FG003|Prior to Booster|Lost to Follow-up|0|||
144216865|NCT03999996|519987989|FG000|Prior to Booster|Withdrawal of Consent|51|||
144216866|NCT03999996|519987990|FG001|Prior to Booster|Withdrawal of Consent|8|||
144666043|NCT02648724|521628445|FG005|Overall Study|Transferred to named patient program|1|||
144666044|NCT02648724|521628446|FG006|Overall Study|Transferred to named patient program|0|||
144666045|NCT03076190|521628447|FG000|Overall Study|Lost to Follow-up|9|||
144666046|NCT03076190|521628448|FG001|Overall Study|Lost to Follow-up|34|||
144666047|NCT03076190|521628447|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
144666048|NCT03076190|521628448|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
144666049|NCT01364233|521628449|FG000|Overall Study|Lost to Follow-up|1|||
144666050|NCT00302718|521628453|FG000|Overall Study|Participant left the hospital|1|||
144666051|NCT00302718|521628454|FG001|Overall Study|Participant left the hospital|0|||
144666052|NCT00302718|521628455|FG002|Overall Study|Participant left the hospital|0|||
144666053|NCT00302718|521628456|FG003|Overall Study|Participant left the hospital|1|||
144666054|NCT00302718|521628453|FG000|Overall Study|Withdrawal by Subject|0|||
144666055|NCT00302718|521628454|FG001|Overall Study|Withdrawal by Subject|1|||
144666056|NCT00302718|521628455|FG002|Overall Study|Withdrawal by Subject|0|||
144666057|NCT00302718|521628456|FG003|Overall Study|Withdrawal by Subject|0|||
144666058|NCT00302718|521628453|FG000|Overall Study|Participant left primary care setting|0|||
144666059|NCT00302718|521628454|FG001|Overall Study|Participant left primary care setting|0|||
144666060|NCT00302718|521628455|FG002|Overall Study|Participant left primary care setting|2|||
144666061|NCT00302718|521628456|FG003|Overall Study|Participant left primary care setting|1|||
144666062|NCT00819585|521628457|FG000|Core Study|Adverse Event|2|||
144666063|NCT00819585|521628458|FG001|Core Study|Adverse Event|1|||
144666064|NCT00819585|521628459|FG002|Core Study|Adverse Event|1|||
144666065|NCT00819585|521628460|FG003|Core Study|Adverse Event|4|||
144666066|NCT00819585|521628461|FG004|Core Study|Adverse Event|1|||
144666067|NCT00819585|521628462|FG005|Core Study|Adverse Event|0|||
144666068|NCT00819585|521628463|FG006|Core Study|Adverse Event|2|||
144666069|NCT00819585|521628464|FG007|Core Study|Adverse Event|0|||
144666070|NCT00819585|521628465|FG008|Core Study|Adverse Event|0|||
144733659|NCT02481830|521882109|FG001|Pre-treatment|Withdrawal by Subject|10|||
144733660|NCT02481830|521882108|FG000|Pre-treatment|Disease Progression|1|||
144733661|NCT02481830|521882109|FG001|Pre-treatment|Disease Progression|1|||
144733662|NCT02481830|521882108|FG000|Pre-treatment|Other reasons|0|||
144733663|NCT02481830|521882109|FG001|Pre-treatment|Other reasons|1|||
144733664|NCT02481830|521882108|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
144733665|NCT02481830|521882109|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
144733666|NCT02481830|521882108|FG000|Treatment|Disease Progression|233|||
144733667|NCT02481830|521882109|FG001|Treatment|Disease Progression|171|||
144733668|NCT02481830|521882108|FG000|Treatment|Study drug toxicity|18|||
144733669|NCT02481830|521882109|FG001|Treatment|Study drug toxicity|38|||
144733670|NCT02481830|521882108|FG000|Treatment|Death|1|||
144733671|NCT02481830|521882109|FG001|Treatment|Death|1|||
144733672|NCT02481830|521882108|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
144733673|NCT02481830|521882109|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
144733674|NCT02481830|521882108|FG000|Treatment|Participants request to discontinue Study treatment|6|||
144733675|NCT02481830|521882109|FG001|Treatment|Participants request to discontinue Study treatment|34|||
144733676|NCT02481830|521882108|FG000|Treatment|Withdrawal by Subject|2|||
144733677|NCT02481830|521882109|FG001|Treatment|Withdrawal by Subject|3|||
144733678|NCT02481830|521882108|FG000|Treatment|Lost to Follow-up|1|||
144733679|NCT02481830|521882109|FG001|Treatment|Lost to Follow-up|0|||
144733680|NCT02481830|521882108|FG000|Treatment|Maximum Clinical Benefit|0|||
144733681|NCT02481830|521882109|FG001|Treatment|Maximum Clinical Benefit|5|||
144733682|NCT02481830|521882108|FG000|Treatment|Administrative reason by sponsor|1|||
144733683|NCT02481830|521882109|FG001|Treatment|Administrative reason by sponsor|1|||
144733684|NCT02481830|521882108|FG000|Treatment|Other reasons|6|||
144733685|NCT02481830|521882109|FG001|Treatment|Other reasons|1|||
144733686|NCT04627038|521882110|FG000|Overall Study|Adverse Event|36|||
144733687|NCT04627038|521882111|FG001|Overall Study|Adverse Event|8|||
144733688|NCT04627038|521882110|FG000|Overall Study|Lost to Follow-up|1|||
144733689|NCT04627038|521882111|FG001|Overall Study|Lost to Follow-up|0|||
144733690|NCT04627038|521882110|FG000|Overall Study|Physician Decision|0|||
144733691|NCT04627038|521882111|FG001|Overall Study|Physician Decision|1|||
144733692|NCT04627038|521882110|FG000|Overall Study|Protocol Violation|3|||
144733693|NCT04627038|521882111|FG001|Overall Study|Protocol Violation|1|||
144216867|NCT03999996|519987991|FG002|Prior to Booster|Withdrawal of Consent|0|||
144216868|NCT03999996|519987992|FG003|Prior to Booster|Withdrawal of Consent|0|||
144666071|NCT00819585|521628466|FG009|Core Study|Adverse Event|0|||
144666072|NCT00819585|521628467|FG010|Core Study|Adverse Event|0|||
144666073|NCT00819585|521628457|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
144666074|NCT00819585|521628458|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
144666075|NCT00819585|521628459|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
144733694|NCT04627038|521882110|FG000|Overall Study|Withdrawal by Subject|13|||
144733695|NCT04627038|521882111|FG001|Overall Study|Withdrawal by Subject|3|||
144733696|NCT04627038|521882110|FG000|Overall Study|Non-compliance with study drug|0|||
144733697|NCT04627038|521882111|FG001|Overall Study|Non-compliance with study drug|1|||
144733698|NCT04627038|521882110|FG000|Overall Study|Prohibited Concomitant Medication|1|||
144666076|NCT00819585|521628460|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
144733699|NCT04627038|521882111|FG001|Overall Study|Prohibited Concomitant Medication|0|||
144666077|NCT00819585|521628461|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
144666078|NCT00819585|521628462|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
144666079|NCT00819585|521628463|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
144666080|NCT00819585|521628464|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
144666081|NCT00819585|521628465|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
144666082|NCT00819585|521628466|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
144666083|NCT00819585|521628467|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
144666084|NCT00819585|521628457|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666085|NCT00819585|521628458|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
144666086|NCT00819585|521628459|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666087|NCT00819585|521628460|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666088|NCT00819585|521628461|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666089|NCT00819585|521628462|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666090|NCT00819585|521628463|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
144666091|NCT00819585|521628464|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666092|NCT00819585|521628465|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666093|NCT00819585|521628466|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666094|NCT00819585|521628467|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
144666095|NCT00819585|521628457|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
144666096|NCT00819585|521628458|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
144666097|NCT00819585|521628459|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
144666098|NCT00819585|521628460|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
144666099|NCT00819585|521628461|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
144666100|NCT00819585|521628462|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
144666101|NCT00819585|521628463|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
144733700|NCT01602419|521882118|FG000|Overall Study|Not treated with Wilate|9|||
144733701|NCT01602419|521882118|FG000|Overall Study|Adverse Drug Reaction|4|||
144733702|NCT01602419|521882118|FG000|Overall Study|Insurance issues|3|||
144733703|NCT01602419|521882118|FG000|Overall Study|Changed treatment centre|1|||
144733704|NCT01602419|521882118|FG000|Overall Study|Treatment centre closed|1|||
144733705|NCT01602419|521882118|FG000|Overall Study|Withdrawal by Subject|5|||
144733706|NCT01602419|521882118|FG000|Overall Study|Lost to Follow-up|6|||
144733707|NCT03956862|521882119|FG000|Overall Study|Lost to Follow-up|1|||
144733708|NCT03956862|521882120|FG001|Overall Study|Lost to Follow-up|1|||
144733709|NCT03956862|521882119|FG000|Overall Study|Withdrawal by Subject|1|||
144733710|NCT03956862|521882120|FG001|Overall Study|Withdrawal by Subject|1|||
144733711|NCT02714062|521882121|FG000|Overall Study|Adverse Event|0|||
144733712|NCT02714062|521882122|FG001|Overall Study|Adverse Event|0|||
144733713|NCT02714062|521882123|FG002|Overall Study|Adverse Event|2|||
144733714|NCT02714062|521882121|FG000|Overall Study|Withdrawal by Subject|1|||
144733715|NCT02714062|521882122|FG001|Overall Study|Withdrawal by Subject|0|||
144733716|NCT02714062|521882123|FG002|Overall Study|Withdrawal by Subject|1|||
144733717|NCT02714062|521882121|FG000|Overall Study|Protocol Violation|0|||
144733718|NCT02714062|521882122|FG001|Overall Study|Protocol Violation|1|||
144733719|NCT02714062|521882123|FG002|Overall Study|Protocol Violation|0|||
144733720|NCT01363765|521882128|FG000|Overall Study|non-diagnostic|2621|||
144733721|NCT01363765|521882129|FG001|Overall Study|non-diagnostic|1124|||
144733722|NCT01363765|521882128|FG000|Overall Study|duplicate records|736|||
144733723|NCT01363765|521882129|FG001|Overall Study|duplicate records|3177|||
144733724|NCT01363765|521882128|FG000|Overall Study|non-resident|156|||
144733725|NCT01363765|521882129|FG001|Overall Study|non-resident|76|||
144733726|NCT01363765|521882128|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
144733727|NCT01363765|521882129|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
144733728|NCT01363765|521882128|FG000|Overall Study|smear during intervention|2170|||
144733729|NCT01363765|521882129|FG001|Overall Study|smear during intervention|0|||
144733730|NCT02682784|521882137|FG000|Overall Study|Withdrawal by Subject|0|||
144733731|NCT02682784|521882138|FG001|Overall Study|Withdrawal by Subject|2|||
144733732|NCT02682784|521882139|FG002|Overall Study|Withdrawal by Subject|1|||
144733733|NCT02682784|521882140|FG003|Overall Study|Withdrawal by Subject|2|||
144216869|NCT03999996|519987989|FG000|Prior to Booster|Death|0|||
144666102|NCT00819585|521628464|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
144666103|NCT00819585|521628465|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
144666104|NCT00819585|521628466|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
144666105|NCT00819585|521628467|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
144666106|NCT00819585|521628457|FG000|Core Study|Subject Withdrew Consent|0|||
144666107|NCT00819585|521628458|FG001|Core Study|Subject Withdrew Consent|3|||
144733734|NCT02682784|521882137|FG000|Overall Study|Physician Decision|1|||
144733735|NCT02682784|521882138|FG001|Overall Study|Physician Decision|0|||
144733736|NCT02682784|521882139|FG002|Overall Study|Physician Decision|1|||
144733737|NCT02682784|521882140|FG003|Overall Study|Physician Decision|1|||
144733738|NCT02017223|521882141|FG000|Overall Study|Algorithm problems|2|||
144733739|NCT04263649|521882150|FG000|Overall Study|Adverse Event|53|||
144733740|NCT04263649|521882150|FG000|Overall Study|Lost to Follow-up|3|||
144733741|NCT04263649|521882150|FG000|Overall Study|Death|29|||
144216870|NCT03999996|519987990|FG001|Prior to Booster|Death|1|||
144216871|NCT03999996|519987991|FG002|Prior to Booster|Death|0|||
144216872|NCT03999996|519987992|FG003|Prior to Booster|Death|0|||
144216873|NCT03999996|519987989|FG000|Prior to Booster|Reason Not Specified|27|||
144216874|NCT03999996|519987990|FG001|Prior to Booster|Reason Not Specified|4|||
144216875|NCT03999996|519987991|FG002|Prior to Booster|Reason Not Specified|0|||
144216876|NCT03999996|519987992|FG003|Prior to Booster|Reason Not Specified|0|||
144216877|NCT03999996|519987989|FG000|Booster Phase|Lost to Follow-up|0|||
144216878|NCT03999996|519987990|FG001|Booster Phase|Lost to Follow-up|0|||
144216879|NCT03999996|519987991|FG002|Booster Phase|Lost to Follow-up|3|||
144216880|NCT03999996|519987992|FG003|Booster Phase|Lost to Follow-up|3|||
144216881|NCT03999996|519987989|FG000|Booster Phase|Withdrawal of Consent|0|||
144216882|NCT03999996|519987990|FG001|Booster Phase|Withdrawal of Consent|0|||
144216883|NCT03999996|519987991|FG002|Booster Phase|Withdrawal of Consent|0|||
144216884|NCT03999996|519987992|FG003|Booster Phase|Withdrawal of Consent|1|||
144216885|NCT03999996|519987989|FG000|Booster Phase|Reason Not Specified|0|||
144216886|NCT03999996|519987990|FG001|Booster Phase|Reason Not Specified|0|||
144216887|NCT03999996|519987991|FG002|Booster Phase|Reason Not Specified|0|||
144216888|NCT03999996|519987992|FG003|Booster Phase|Reason Not Specified|1|||
144216889|NCT01720225|519988003|FG000|Overall Study|Withdrawal by Subject|0|||
144216890|NCT01720225|519988004|FG001|Overall Study|Withdrawal by Subject|1|||
144216891|NCT01720225|519988003|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
144216892|NCT01720225|519988004|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
144216893|NCT00661193|519988008|FG000|Overall Study|Adverse Event|2|||
144216894|NCT00661193|519988009|FG001|Overall Study|Adverse Event|1|||
144216895|NCT00661193|519988008|FG000|Overall Study|Withdrawal by Subject|3|||
144216896|NCT00661193|519988009|FG001|Overall Study|Withdrawal by Subject|1|||
144216897|NCT00661193|519988008|FG000|Overall Study|Progression|27|||
144216898|NCT00661193|519988009|FG001|Overall Study|Progression|24|||
144216899|NCT00661193|519988008|FG000|Overall Study|Not protocol specified|1|||
144216900|NCT00661193|519988009|FG001|Overall Study|Not protocol specified|0|||
144216901|NCT03280264|519988010|FG000|Overall Study|Adverse Event|1|||
144216902|NCT03280264|519988010|FG000|Overall Study|Physician Decision|1|||
144216903|NCT03280264|519988010|FG000|Overall Study|Withdrawal by Subject|1|||
144216904|NCT00524420|519988018|FG000|Overall Study|Lack of Efficacy|1|||
144216905|NCT00524420|519988019|FG001|Overall Study|Lack of Efficacy|0|||
144216906|NCT00577863|519988020|FG000|Overall Study|Adverse Event|4|||
144216907|NCT00577863|519988021|FG001|Overall Study|Adverse Event|2|||
144216908|NCT00577863|519988020|FG000|Overall Study|Death|1|||
144216909|NCT00577863|519988021|FG001|Overall Study|Death|0|||
144216910|NCT00577863|519988020|FG000|Overall Study|Lost to Follow-up|2|||
144216911|NCT00577863|519988021|FG001|Overall Study|Lost to Follow-up|2|||
144216912|NCT00577863|519988020|FG000|Overall Study|Entry Criteria Exclusion|1|||
144216913|NCT00577863|519988021|FG001|Overall Study|Entry Criteria Exclusion|0|||
144216914|NCT00577863|519988020|FG000|Overall Study|Withdrawal by Subject|0|||
144216915|NCT00577863|519988021|FG001|Overall Study|Withdrawal by Subject|2|||
144216916|NCT00577863|519988020|FG000|Overall Study|Sponsor Decision|2|||
144216917|NCT00577863|519988021|FG001|Overall Study|Sponsor Decision|7|||
144216918|NCT00577863|519988020|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
144216919|NCT00577863|519988021|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
144216920|NCT02738138|519988025|FG000|Overall Study|Adverse Event|0|||
144216921|NCT02738138|519988026|FG001|Overall Study|Adverse Event|1|||
144666108|NCT00819585|521628459|FG002|Core Study|Subject Withdrew Consent|2|||
144666109|NCT00819585|521628460|FG003|Core Study|Subject Withdrew Consent|1|||
144666110|NCT00819585|521628461|FG004|Core Study|Subject Withdrew Consent|0|||
144666111|NCT00819585|521628462|FG005|Core Study|Subject Withdrew Consent|0|||
144666112|NCT00819585|521628463|FG006|Core Study|Subject Withdrew Consent|3|||
144666113|NCT00819585|521628464|FG007|Core Study|Subject Withdrew Consent|0|||
144666114|NCT00819585|521628465|FG008|Core Study|Subject Withdrew Consent|0|||
144666115|NCT00819585|521628466|FG009|Core Study|Subject Withdrew Consent|0|||
144666116|NCT00819585|521628467|FG010|Core Study|Subject Withdrew Consent|0|||
144216922|NCT02738138|519988025|FG000|Overall Study|Lost to Follow-up|2|||
144216923|NCT02738138|519988026|FG001|Overall Study|Lost to Follow-up|0|||
144216924|NCT02738138|519988025|FG000|Overall Study|Other - not further specified|1|||
144216925|NCT02738138|519988026|FG001|Overall Study|Other - not further specified|0|||
144216926|NCT03934541|519988037|FG000|Overall Study|Study Terminated by Sponsor|0|||
144216927|NCT03934541|519988038|FG001|Overall Study|Study Terminated by Sponsor|1|||
144666117|NCT00819585|521628457|FG000|Core Study|Lost to Follow-up|2|||
144666118|NCT00819585|521628458|FG001|Core Study|Lost to Follow-up|1|||
144666119|NCT00819585|521628459|FG002|Core Study|Lost to Follow-up|2|||
144666120|NCT00819585|521628460|FG003|Core Study|Lost to Follow-up|0|||
144733742|NCT04263649|521882150|FG000|Overall Study|Device deficiency|19|||
144733743|NCT04263649|521882150|FG000|Overall Study|other reasons|11|||
144216928|NCT03934541|519988039|FG002|Overall Study|Study Terminated by Sponsor|0|||
144216929|NCT03934541|519988040|FG003|Overall Study|Study Terminated by Sponsor|0|||
144216930|NCT02673775|519988044|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
144216931|NCT02673775|519988045|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
144666121|NCT00819585|521628461|FG004|Core Study|Lost to Follow-up|1|||
144666122|NCT00819585|521628462|FG005|Core Study|Lost to Follow-up|1|||
144666123|NCT00819585|521628463|FG006|Core Study|Lost to Follow-up|1|||
144666124|NCT00819585|521628464|FG007|Core Study|Lost to Follow-up|0|||
144666125|NCT00819585|521628465|FG008|Core Study|Lost to Follow-up|0|||
144666126|NCT00819585|521628466|FG009|Core Study|Lost to Follow-up|0|||
144666127|NCT00819585|521628467|FG010|Core Study|Lost to Follow-up|0|||
144666128|NCT00819585|521628457|FG000|Core Study|Administrative Problems|0|||
144666129|NCT00819585|521628458|FG001|Core Study|Administrative Problems|0|||
144666130|NCT00819585|521628459|FG002|Core Study|Administrative Problems|0|||
144666131|NCT00819585|521628460|FG003|Core Study|Administrative Problems|0|||
144666132|NCT00819585|521628461|FG004|Core Study|Administrative Problems|0|||
144666133|NCT00819585|521628462|FG005|Core Study|Administrative Problems|0|||
144666134|NCT00819585|521628463|FG006|Core Study|Administrative Problems|2|||
144666135|NCT00819585|521628464|FG007|Core Study|Administrative Problems|0|||
144666136|NCT00819585|521628465|FG008|Core Study|Administrative Problems|0|||
144666137|NCT00819585|521628466|FG009|Core Study|Administrative Problems|0|||
144666138|NCT00819585|521628467|FG010|Core Study|Administrative Problems|0|||
144666139|NCT00819585|521628457|FG000|Core Study|Death|0|||
144666140|NCT00819585|521628458|FG001|Core Study|Death|0|||
144666141|NCT00819585|521628459|FG002|Core Study|Death|0|||
144666142|NCT00819585|521628460|FG003|Core Study|Death|0|||
144666143|NCT00819585|521628461|FG004|Core Study|Death|0|||
144666144|NCT00819585|521628462|FG005|Core Study|Death|0|||
144666145|NCT00819585|521628463|FG006|Core Study|Death|1|||
144666146|NCT00819585|521628464|FG007|Core Study|Death|0|||
144666147|NCT00819585|521628465|FG008|Core Study|Death|0|||
144666148|NCT00819585|521628466|FG009|Core Study|Death|0|||
144666149|NCT00819585|521628467|FG010|Core Study|Death|0|||
144666150|NCT00819585|521628457|FG000|Core Study|Protocol Violation|0|||
144666151|NCT00819585|521628458|FG001|Core Study|Protocol Violation|0|||
144666152|NCT00819585|521628459|FG002|Core Study|Protocol Violation|1|||
144666153|NCT00819585|521628460|FG003|Core Study|Protocol Violation|0|||
144666154|NCT00819585|521628461|FG004|Core Study|Protocol Violation|0|||
144666155|NCT00819585|521628462|FG005|Core Study|Protocol Violation|1|||
144666156|NCT00819585|521628463|FG006|Core Study|Protocol Violation|3|||
144666157|NCT00819585|521628464|FG007|Core Study|Protocol Violation|0|||
144666158|NCT00819585|521628465|FG008|Core Study|Protocol Violation|0|||
144666159|NCT00819585|521628466|FG009|Core Study|Protocol Violation|0|||
144666160|NCT00819585|521628467|FG010|Core Study|Protocol Violation|0|||
144666161|NCT00819585|521628457|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
144666162|NCT00819585|521628458|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
144666163|NCT00819585|521628459|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
144666164|NCT00819585|521628460|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
144666165|NCT00819585|521628461|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
144666166|NCT00819585|521628462|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
144666167|NCT00819585|521628463|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
144666168|NCT00819585|521628464|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
144666169|NCT00819585|521628465|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
144666170|NCT00819585|521628466|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
144666171|NCT00819585|521628467|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
144666172|NCT00819585|521628457|FG000|Extension Study|Subject Withdrew Consent|0|||
144666173|NCT00819585|521628458|FG001|Extension Study|Subject Withdrew Consent|0|||
144666174|NCT00819585|521628459|FG002|Extension Study|Subject Withdrew Consent|0|||
144216932|NCT02673775|519988044|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
144216933|NCT02673775|519988045|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
144216934|NCT02673775|519988044|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
144216935|NCT02673775|519988045|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
144666175|NCT00819585|521628460|FG003|Extension Study|Subject Withdrew Consent|0|||
144666176|NCT00819585|521628461|FG004|Extension Study|Subject Withdrew Consent|0|||
144666177|NCT00819585|521628462|FG005|Extension Study|Subject Withdrew Consent|0|||
144666178|NCT00819585|521628463|FG006|Extension Study|Subject Withdrew Consent|0|||
144666179|NCT00819585|521628464|FG007|Extension Study|Subject Withdrew Consent|0|||
144666180|NCT00819585|521628465|FG008|Extension Study|Subject Withdrew Consent|3|||
144666181|NCT00819585|521628466|FG009|Extension Study|Subject Withdrew Consent|0|||
144666182|NCT00819585|521628467|FG010|Extension Study|Subject Withdrew Consent|1|||
144666183|NCT00819585|521628457|FG000|Extension Study|Lost to Follow-up|0|||
144666184|NCT00819585|521628458|FG001|Extension Study|Lost to Follow-up|0|||
144666185|NCT00819585|521628459|FG002|Extension Study|Lost to Follow-up|0|||
144666186|NCT00819585|521628460|FG003|Extension Study|Lost to Follow-up|0|||
144666187|NCT00819585|521628461|FG004|Extension Study|Lost to Follow-up|0|||
144666188|NCT00819585|521628462|FG005|Extension Study|Lost to Follow-up|0|||
144216936|NCT02673775|519988044|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
144666189|NCT00819585|521628463|FG006|Extension Study|Lost to Follow-up|0|||
144666190|NCT00819585|521628464|FG007|Extension Study|Lost to Follow-up|0|||
144666191|NCT00819585|521628465|FG008|Extension Study|Lost to Follow-up|2|||
144666192|NCT00819585|521628466|FG009|Extension Study|Lost to Follow-up|1|||
144666193|NCT00819585|521628467|FG010|Extension Study|Lost to Follow-up|1|||
144216937|NCT02673775|519988045|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
144216938|NCT02441686|519988046|FG000|Induction|Adverse Event|4|||
144216939|NCT02441686|519988046|FG000|Induction|Complicating disease|1|||
144216940|NCT02441686|519988046|FG000|Induction|Physician Decision|1|||
144216941|NCT02441686|519988046|FG000|Induction|Withdrawal by Subject|1|||
144216942|NCT02441686|519988046|FG000|Induction|Did not receive treatment|1|||
144216943|NCT02441686|519988046|FG000|Maintenance|Remaining on Treatment|23|||
144216944|NCT02441686|519988046|FG000|Maintenance|Physician Decision|1|||
144216945|NCT02441686|519988046|FG000|Maintenance|Adverse Event|3|||
144216946|NCT02441686|519988046|FG000|Maintenance|Progressive Disease|10|||
144216947|NCT02441686|519988046|FG000|Maintenance|Withdrawal by Subject|1|||
144216948|NCT03762239|519988047|FG000|Overall Study|Appointment to the doctor|1|||
144216949|NCT03762239|519988048|FG001|Overall Study|Appointment to the doctor|1|||
144216950|NCT04471428|519988049|FG000|Overall Study|Withdrawal by Subject|29|||
144216951|NCT04471428|519988050|FG001|Overall Study|Withdrawal by Subject|1|||
144216952|NCT04471428|519988049|FG000|Overall Study|Physician Decision|0|||
144216953|NCT04471428|519988050|FG001|Overall Study|Physician Decision|1|||
144216954|NCT04471428|519988049|FG000|Overall Study|Reason Not Specified|0|||
144216955|NCT04471428|519988050|FG001|Overall Study|Reason Not Specified|2|||
144216956|NCT04471428|519988049|FG000|Overall Study|Death|106|||
144216957|NCT04471428|519988050|FG001|Overall Study|Death|114|||
144216958|NCT04471428|519988049|FG000|Overall Study|Ongoing in the study|45|||
144216959|NCT04471428|519988050|FG001|Overall Study|Ongoing in the study|68|||
144216960|NCT00535405|519988051|FG000|Overall Study|Adverse Event|6|||
144216961|NCT00535405|519988052|FG001|Overall Study|Adverse Event|8|||
144216962|NCT00535405|519988053|FG002|Overall Study|Adverse Event|3|||
144216963|NCT00535405|519988054|FG003|Overall Study|Adverse Event|8|||
144216964|NCT00535405|519988055|FG004|Overall Study|Adverse Event|6|||
144216965|NCT00535405|519988051|FG000|Overall Study|Lost to Follow-up|1|||
144216966|NCT00535405|519988052|FG001|Overall Study|Lost to Follow-up|3|||
144216967|NCT00535405|519988053|FG002|Overall Study|Lost to Follow-up|3|||
144216968|NCT00535405|519988054|FG003|Overall Study|Lost to Follow-up|2|||
144216969|NCT00535405|519988055|FG004|Overall Study|Lost to Follow-up|1|||
144216970|NCT00535405|519988051|FG000|Overall Study|Physician Decision|3|||
144216971|NCT00535405|519988052|FG001|Overall Study|Physician Decision|2|||
144216972|NCT00535405|519988053|FG002|Overall Study|Physician Decision|0|||
144216973|NCT00535405|519988054|FG003|Overall Study|Physician Decision|1|||
144216974|NCT00535405|519988055|FG004|Overall Study|Physician Decision|1|||
144216975|NCT00535405|519988051|FG000|Overall Study|Protocol Violation|2|||
144216976|NCT00535405|519988052|FG001|Overall Study|Protocol Violation|2|||
144216977|NCT00535405|519988053|FG002|Overall Study|Protocol Violation|2|||
144216978|NCT00535405|519988054|FG003|Overall Study|Protocol Violation|1|||
144216979|NCT00535405|519988055|FG004|Overall Study|Protocol Violation|0|||
144216980|NCT00535405|519988051|FG000|Overall Study|Withdrawal by Subject|5|||
144216981|NCT00535405|519988052|FG001|Overall Study|Withdrawal by Subject|11|||
144216982|NCT00535405|519988053|FG002|Overall Study|Withdrawal by Subject|10|||
144216983|NCT00535405|519988054|FG003|Overall Study|Withdrawal by Subject|10|||
144216984|NCT00535405|519988055|FG004|Overall Study|Withdrawal by Subject|8|||
144216985|NCT03151304|519988056|FG000|Overall Study|Termination of study by Sponsor|23|||
144216986|NCT03151304|519988056|FG000|Overall Study|missing|3|||
144216987|NCT03151304|519988056|FG000|Overall Study|Withdrawal by Subject|8|||
144216988|NCT03151304|519988056|FG000|Overall Study|multiple reasons|30|||
144216989|NCT03519087|519988057|FG000|Clinic Evaluation|Physician Decision|15|||
144216990|NCT03519087|519988058|FG001|Clinic Evaluation|Physician Decision|18|||
144216991|NCT03519087|519988059|FG002|Clinic Evaluation|Physician Decision|0|||
144216992|NCT03519087|519988060|FG003|Clinic Evaluation|Physician Decision|0|||
144216993|NCT03519087|519988061|FG004|Clinic Evaluation|Physician Decision|0|||
144666194|NCT00819585|521628457|FG000|Extension Study|Death|0|||
144666195|NCT00819585|521628458|FG001|Extension Study|Death|0|||
144666196|NCT00819585|521628459|FG002|Extension Study|Death|0|||
144216994|NCT03519087|519988057|FG000|Clinic Evaluation|Protocol Violation|1|||
144216995|NCT03519087|519988058|FG001|Clinic Evaluation|Protocol Violation|0|||
144216996|NCT03519087|519988059|FG002|Clinic Evaluation|Protocol Violation|0|||
144216997|NCT03519087|519988060|FG003|Clinic Evaluation|Protocol Violation|0|||
144216998|NCT03519087|519988061|FG004|Clinic Evaluation|Protocol Violation|0|||
144216999|NCT03519087|519988057|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
144217000|NCT03519087|519988058|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
144217001|NCT03519087|519988059|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
144217002|NCT03519087|519988060|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
144217003|NCT03519087|519988061|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
144217004|NCT03519087|519988057|FG000|Re-randomization for Treatment|Not appropriate|2|||
144666197|NCT00819585|521628460|FG003|Extension Study|Death|0|||
144217005|NCT03519087|519988058|FG001|Re-randomization for Treatment|Not appropriate|3|||
144666198|NCT00819585|521628461|FG004|Extension Study|Death|0|||
144217006|NCT03519087|519988059|FG002|Re-randomization for Treatment|Not appropriate|0|||
144217007|NCT03519087|519988060|FG003|Re-randomization for Treatment|Not appropriate|0|||
144217008|NCT03519087|519988061|FG004|Re-randomization for Treatment|Not appropriate|0|||
144666199|NCT00819585|521628462|FG005|Extension Study|Death|0|||
144666200|NCT00819585|521628463|FG006|Extension Study|Death|0|||
144666201|NCT00819585|521628464|FG007|Extension Study|Death|0|||
144666202|NCT00819585|521628465|FG008|Extension Study|Death|2|||
144666203|NCT00819585|521628466|FG009|Extension Study|Death|0|||
144666204|NCT00819585|521628467|FG010|Extension Study|Death|0|||
144666205|NCT00349752|521628468|FG000|Overall Study|Adverse Event|8|||
144666206|NCT00349752|521628469|FG001|Overall Study|Adverse Event|12|||
144666207|NCT00349752|521628468|FG000|Overall Study|Lack of Efficacy|37|||
144666208|NCT00349752|521628469|FG001|Overall Study|Lack of Efficacy|42|||
144666209|NCT00349752|521628468|FG000|Overall Study|Lost to Follow-up|4|||
144666210|NCT00349752|521628469|FG001|Overall Study|Lost to Follow-up|2|||
144666211|NCT00349752|521628468|FG000|Overall Study|Personal reasons|6|||
144666212|NCT00349752|521628469|FG001|Overall Study|Personal reasons|5|||
144666213|NCT00349752|521628468|FG000|Overall Study|Other: Required exclusionary medication|0|||
144666214|NCT00349752|521628469|FG001|Overall Study|Other: Required exclusionary medication|1|||
144666215|NCT00349752|521628468|FG000|Overall Study|Other: Non compliance|0|||
144666216|NCT00349752|521628469|FG001|Overall Study|Other: Non compliance|1|||
144666217|NCT00349752|521628468|FG000|Overall Study|Other: Patient stopped steroids|0|||
144666218|NCT00349752|521628469|FG001|Overall Study|Other: Patient stopped steroids|1|||
144666219|NCT00349752|521628468|FG000|Overall Study|Other: Patient's steroid use|1|||
144666220|NCT00349752|521628469|FG001|Overall Study|Other: Patient's steroid use|0|||
144666221|NCT00349752|521628468|FG000|Overall Study|Other: Ineligible|1|||
144666222|NCT00349752|521628469|FG001|Overall Study|Other: Ineligible|0|||
144666223|NCT00349752|521628468|FG000|Overall Study|Other: Inadvertently unblinded|1|||
144666224|NCT00349752|521628469|FG001|Overall Study|Other: Inadvertently unblinded|0|||
144666225|NCT00349752|521628468|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
144666226|NCT00349752|521628469|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
144666227|NCT00632541|521628470|FG000|Overall Study|Adverse Event|7|||
144666228|NCT02927873|521628473|FG000|Overall Study|Lost to Follow-up|0|||
144666229|NCT02927873|521628474|FG001|Overall Study|Lost to Follow-up|1|||
144666230|NCT02927873|521628475|FG002|Overall Study|Lost to Follow-up|0|||
144666231|NCT02927873|521628476|FG003|Overall Study|Lost to Follow-up|0|||
144666232|NCT02927873|521628477|FG004|Overall Study|Lost to Follow-up|0|||
144666233|NCT02927873|521628478|FG005|Overall Study|Lost to Follow-up|0|||
144666234|NCT02927873|521628473|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144666235|NCT02927873|521628474|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
144666236|NCT02927873|521628475|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144666237|NCT02927873|521628476|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144666238|NCT02927873|521628477|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144666239|NCT02927873|521628478|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
144666240|NCT02927873|521628473|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666241|NCT02927873|521628474|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666242|NCT02927873|521628475|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666243|NCT02927873|521628476|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666244|NCT02927873|521628477|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666245|NCT02927873|521628478|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144666246|NCT02927873|521628473|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
144666247|NCT02927873|521628474|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
144666248|NCT02927873|521628475|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
144666249|NCT02927873|521628476|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
144666250|NCT02927873|521628477|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
144666251|NCT02927873|521628478|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
144666252|NCT02927873|521628473|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
144666253|NCT02927873|521628474|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
144666254|NCT02927873|521628475|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
144733744|NCT02057458|521882151|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
144217009|NCT03519087|519988057|FG000|Laboratory Testing|Lost to Follow-up|0|||
144666255|NCT02927873|521628476|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
144666256|NCT02927873|521628477|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
144666257|NCT02927873|521628478|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
144666258|NCT02927873|521628473|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
144666259|NCT02927873|521628474|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
144666260|NCT02927873|521628475|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
144666261|NCT02927873|521628476|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
144666262|NCT02927873|521628477|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
144666263|NCT02927873|521628478|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
144666264|NCT01766817|521628482|FG000|Overall Study|Drug-related adverse event|1|||
144666265|NCT01766817|521628483|FG001|Overall Study|Drug-related adverse event|2|||
144666266|NCT01766817|521628484|FG002|Overall Study|Drug-related adverse event|1|||
144666267|NCT01766817|521628482|FG000|Overall Study|Drug-unrelated adverse event|3|||
144666268|NCT01766817|521628483|FG001|Overall Study|Drug-unrelated adverse event|3|||
144666269|NCT01766817|521628484|FG002|Overall Study|Drug-unrelated adverse event|3|||
144666270|NCT01766817|521628482|FG000|Overall Study|Death|1|||
144666271|NCT01766817|521628483|FG001|Overall Study|Death|1|||
144666272|NCT01766817|521628484|FG002|Overall Study|Death|0|||
144666273|NCT01766817|521628482|FG000|Overall Study|Unable to take study drug|0|||
144666274|NCT01766817|521628483|FG001|Overall Study|Unable to take study drug|1|||
144666275|NCT01766817|521628484|FG002|Overall Study|Unable to take study drug|0|||
144666276|NCT01766817|521628482|FG000|Overall Study|Withdrawal by Subject|2|||
144666277|NCT01766817|521628483|FG001|Overall Study|Withdrawal by Subject|0|||
144666278|NCT01766817|521628484|FG002|Overall Study|Withdrawal by Subject|3|||
144666279|NCT01766817|521628482|FG000|Overall Study|Subject non-compliance|0|||
144666280|NCT01766817|521628483|FG001|Overall Study|Subject non-compliance|1|||
144666281|NCT01766817|521628484|FG002|Overall Study|Subject non-compliance|2|||
144666282|NCT01766817|521628482|FG000|Overall Study|Physician Decision|3|||
144666283|NCT01766817|521628483|FG001|Overall Study|Physician Decision|3|||
144666284|NCT01766817|521628484|FG002|Overall Study|Physician Decision|4|||
144666285|NCT01766817|521628482|FG000|Overall Study|Other|1|||
144666286|NCT01766817|521628483|FG001|Overall Study|Other|0|||
144666287|NCT01766817|521628484|FG002|Overall Study|Other|0|||
144666288|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
144666289|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
144666290|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
144666291|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
144666292|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
144666293|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
144666294|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
144666295|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
144666296|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
144666297|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
144666298|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
144666299|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
144666300|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
144666301|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
144666302|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
144666303|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
144666304|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
144666305|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
144666306|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
144666307|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
144666308|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
144666309|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
144666310|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
144666311|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
144666312|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
144666313|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
144666314|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
144666315|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
144666316|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
144666317|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
144666318|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
144666319|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
144666320|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
144666321|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
144666322|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
144666323|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
144666324|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
144666325|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
144666326|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
144666327|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
144666328|NCT00383721|521628485|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
144666329|NCT00383721|521628486|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
144666330|NCT00383721|521628487|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
144733745|NCT02057458|521882152|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
144217010|NCT03519087|519988058|FG001|Laboratory Testing|Lost to Follow-up|0|||
144217011|NCT03519087|519988059|FG002|Laboratory Testing|Lost to Follow-up|2|||
144217012|NCT03519087|519988060|FG003|Laboratory Testing|Lost to Follow-up|3|||
144217013|NCT03519087|519988061|FG004|Laboratory Testing|Lost to Follow-up|6|||
144217014|NCT03519087|519988057|FG000|Laboratory Testing|Protocol Violation|0|||
144217015|NCT03519087|519988058|FG001|Laboratory Testing|Protocol Violation|0|||
144217016|NCT03519087|519988059|FG002|Laboratory Testing|Protocol Violation|0|||
144217017|NCT03519087|519988060|FG003|Laboratory Testing|Protocol Violation|1|||
144217018|NCT03519087|519988061|FG004|Laboratory Testing|Protocol Violation|0|||
144217019|NCT02565511|519988063|FG000|Overall Study|Study terminated by Sponsor|35|||
144217020|NCT02565511|519988064|FG001|Overall Study|Study terminated by Sponsor|22|||
144217021|NCT02565511|519988065|FG002|Overall Study|Study terminated by Sponsor|235|||
144217022|NCT02565511|519988066|FG003|Overall Study|Study terminated by Sponsor|156|||
144217023|NCT02565511|519988063|FG000|Overall Study|Withdrawal by Subject|3|||
144217024|NCT02565511|519988064|FG001|Overall Study|Withdrawal by Subject|0|||
144217025|NCT02565511|519988065|FG002|Overall Study|Withdrawal by Subject|12|||
144217026|NCT02565511|519988066|FG003|Overall Study|Withdrawal by Subject|5|||
144217027|NCT02565511|519988063|FG000|Overall Study|Adverse Event|0|||
144217028|NCT02565511|519988064|FG001|Overall Study|Adverse Event|0|||
144217029|NCT02565511|519988065|FG002|Overall Study|Adverse Event|1|||
144217030|NCT02565511|519988066|FG003|Overall Study|Adverse Event|1|||
144217031|NCT02565511|519988063|FG000|Overall Study|Lost to Follow-up|4|||
144217032|NCT02565511|519988064|FG001|Overall Study|Lost to Follow-up|1|||
144217033|NCT02565511|519988065|FG002|Overall Study|Lost to Follow-up|0|||
144217034|NCT02565511|519988066|FG003|Overall Study|Lost to Follow-up|1|||
144217035|NCT02565511|519988063|FG000|Overall Study|Physician Decision|0|||
144217036|NCT02565511|519988064|FG001|Overall Study|Physician Decision|0|||
144217037|NCT02565511|519988065|FG002|Overall Study|Physician Decision|0|||
144217038|NCT02565511|519988066|FG003|Overall Study|Physician Decision|1|||
144217039|NCT02565511|519988063|FG000|Overall Study|Protocol deviation|0|||
144217040|NCT02565511|519988064|FG001|Overall Study|Protocol deviation|0|||
144217041|NCT02565511|519988065|FG002|Overall Study|Protocol deviation|3|||
144217042|NCT02565511|519988066|FG003|Overall Study|Protocol deviation|0|||
144217043|NCT04807400|519988067|FG000|Overall Study|Adverse Event|2|||
144217044|NCT04807400|519988068|FG001|Overall Study|Adverse Event|3|||
144217045|NCT04807400|519988069|FG002|Overall Study|Adverse Event|3|||
144217046|NCT04807400|519988067|FG000|Overall Study|Death|2|||
144217047|NCT04807400|519988068|FG001|Overall Study|Death|0|||
144217048|NCT04807400|519988069|FG002|Overall Study|Death|0|||
144217049|NCT04807400|519988067|FG000|Overall Study|Lost to Follow-up|8|||
144217050|NCT04807400|519988068|FG001|Overall Study|Lost to Follow-up|6|||
144217051|NCT04807400|519988069|FG002|Overall Study|Lost to Follow-up|6|||
144217052|NCT04807400|519988067|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144217053|NCT04807400|519988068|FG001|Overall Study|Non-Compliance With Study Drug|4|||
144217054|NCT04807400|519988069|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144217055|NCT04807400|519988067|FG000|Overall Study|Participant Decision|20|||
144217056|NCT04807400|519988068|FG001|Overall Study|Participant Decision|19|||
144217057|NCT04807400|519988069|FG002|Overall Study|Participant Decision|26|||
144666331|NCT00383721|521628488|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
144666332|NCT00383721|521628489|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
144666333|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
144666334|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
144666335|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
144666336|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
144666337|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
144666338|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
144666339|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
144666340|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
144666341|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
144666342|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
144666343|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
144666344|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
144666345|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
144666346|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
144217058|NCT04807400|519988067|FG000|Overall Study|Physician Decision|0|||
144217059|NCT04807400|519988068|FG001|Overall Study|Physician Decision|1|||
144217060|NCT04807400|519988069|FG002|Overall Study|Physician Decision|0|||
144217061|NCT04807400|519988067|FG000|Overall Study|Protocol Violation|4|||
144217062|NCT04807400|519988068|FG001|Overall Study|Protocol Violation|3|||
144217063|NCT04807400|519988069|FG002|Overall Study|Protocol Violation|7|||
144666347|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
144217064|NCT04807400|519988067|FG000|Overall Study|Withdrawal by Subject|13|||
144217065|NCT04807400|519988068|FG001|Overall Study|Withdrawal by Subject|9|||
144217066|NCT04807400|519988069|FG002|Overall Study|Withdrawal by Subject|20|||
144217067|NCT04807400|519988067|FG000|Overall Study|Mis-randomized|1|||
144217068|NCT04807400|519988068|FG001|Overall Study|Mis-randomized|0|||
144217069|NCT04807400|519988069|FG002|Overall Study|Mis-randomized|0|||
144217070|NCT01332292|519988072|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
144217071|NCT01332292|519988073|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
144217072|NCT01332292|519988072|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
144217073|NCT01332292|519988073|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
144217074|NCT01332292|519988072|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
144217075|NCT01332292|519988073|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
144217076|NCT00098774|519988075|FG000|Overall Study|Adverse Event|2|||
144217077|NCT00098774|519988075|FG000|Overall Study|Disease Progression|9|||
144217078|NCT00098774|519988075|FG000|Overall Study|Withdrawal by Subject|1|||
144217079|NCT00098774|519988075|FG000|Overall Study|Failed (to respond) during induction|4|||
144217080|NCT00098774|519988075|FG000|Overall Study|Physician Decision|2|||
144217081|NCT03910673|519988076|FG000|Overall Study|Adverse Event|0|||
144217082|NCT03910673|519988077|FG001|Overall Study|Adverse Event|0|||
144217083|NCT03910673|519988078|FG002|Overall Study|Adverse Event|0|||
144217084|NCT03910673|519988079|FG003|Overall Study|Adverse Event|2|||
144217085|NCT03910673|519988080|FG004|Overall Study|Adverse Event|0|||
144217086|NCT00796757|519988081|FG000|Overall Study|Withdrawal by Subject|14|||
144217087|NCT00796757|519988081|FG000|Overall Study|Death|61|||
144217088|NCT00796757|519988081|FG000|Overall Study|Protocol Violation|1|||
144217089|NCT00796757|519988081|FG000|Overall Study|Participant noncompliance|1|||
144217090|NCT00796757|519988081|FG000|Overall Study|Investigator's decision|2|||
144217091|NCT00796757|519988081|FG000|Overall Study|Other|7|||
144217092|NCT05022212|519988091|FG000|Overall Study|Lost to Follow-up|0|||
144217093|NCT05022212|519988092|FG001|Overall Study|Lost to Follow-up|2|||
144217094|NCT02729909|519988093|FG000|Overall Study|Lost to Follow-up|0|||
144217095|NCT02729909|519988094|FG001|Overall Study|Lost to Follow-up|1|||
144217096|NCT02729909|519988093|FG000|Overall Study|Lack of Efficacy|0|||
144217097|NCT02729909|519988094|FG001|Overall Study|Lack of Efficacy|2|||
144217098|NCT02729909|519988093|FG000|Overall Study|Significant Protocol Deviation|0|||
144217099|NCT02729909|519988094|FG001|Overall Study|Significant Protocol Deviation|2|||
144217100|NCT02729909|519988093|FG000|Overall Study|Voluntary Withdrawal|1|||
144217101|NCT02729909|519988094|FG001|Overall Study|Voluntary Withdrawal|0|||
144217102|NCT04917861|519988095|FG000|Main Study (196 Days)|Adverse Event|0|||
144217103|NCT04917861|519988096|FG001|Main Study (196 Days)|Adverse Event|1|||
144217104|NCT04917861|519988097|FG002|Main Study (196 Days)|Adverse Event|0|||
144217105|NCT04917861|519988098|FG003|Main Study (196 Days)|Adverse Event|0|||
144217106|NCT04917861|519988095|FG000|Main Study (196 Days)|Death|0|||
144217107|NCT04917861|519988096|FG001|Main Study (196 Days)|Death|0|||
144217108|NCT04917861|519988097|FG002|Main Study (196 Days)|Death|0|||
144666348|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
144666349|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
144666350|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
144666351|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
144666352|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
144666353|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
144666354|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
144666355|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
144666356|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
144666357|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
144217109|NCT04917861|519988098|FG003|Main Study (196 Days)|Death|1|||
144217110|NCT04917861|519988095|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
144217111|NCT04917861|519988096|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
144217112|NCT04917861|519988097|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
144217113|NCT04917861|519988098|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
144217114|NCT04917861|519988095|FG000|Main Study (196 Days)|Physician Decision|0|||
144217115|NCT04917861|519988096|FG001|Main Study (196 Days)|Physician Decision|0|||
144217116|NCT04917861|519988097|FG002|Main Study (196 Days)|Physician Decision|0|||
144217117|NCT04917861|519988098|FG003|Main Study (196 Days)|Physician Decision|1|||
144217118|NCT04917861|519988095|FG000|Main Study (196 Days)|Pregnancy|1|||
144217119|NCT04917861|519988096|FG001|Main Study (196 Days)|Pregnancy|1|||
144217120|NCT04917861|519988097|FG002|Main Study (196 Days)|Pregnancy|0|||
144217121|NCT04917861|519988098|FG003|Main Study (196 Days)|Pregnancy|0|||
144217122|NCT04917861|519988095|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
144217123|NCT04917861|519988096|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
144217124|NCT04917861|519988097|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
144217125|NCT04917861|519988098|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
144217126|NCT04917861|519988095|FG000|Main Study (196 Days)|Other Than Specified|1|||
144217127|NCT04917861|519988096|FG001|Main Study (196 Days)|Other Than Specified|0|||
144666358|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
144666359|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
144217128|NCT04917861|519988097|FG002|Main Study (196 Days)|Other Than Specified|1|||
144217129|NCT04917861|519988098|FG003|Main Study (196 Days)|Other Than Specified|2|||
144217130|NCT04917861|519988095|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
144217131|NCT04917861|519988096|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
144217132|NCT04917861|519988097|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
144217133|NCT04917861|519988098|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
144217134|NCT04917861|519988095|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
144217135|NCT04917861|519988096|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
144217136|NCT04917861|519988097|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
144217137|NCT04917861|519988098|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
144217138|NCT04917861|519988095|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
144217139|NCT04917861|519988096|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
144217140|NCT04917861|519988097|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
144217141|NCT04917861|519988098|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
144217142|NCT04917861|519988095|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
144217143|NCT04917861|519988096|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
144217144|NCT04917861|519988097|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
144217145|NCT04917861|519988098|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
144217146|NCT04917861|519988095|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
144217147|NCT04917861|519988096|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
144217148|NCT04917861|519988097|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
144217149|NCT04917861|519988098|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
144217150|NCT04917861|519988095|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
144217151|NCT04917861|519988096|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
144217152|NCT04917861|519988097|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
144217153|NCT04917861|519988098|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
144217154|NCT02694328|519988099|FG000|Overall Study|Adverse Event|27|||
144217155|NCT02694328|519988100|FG001|Overall Study|Adverse Event|33|||
144217156|NCT02694328|519988099|FG000|Overall Study|Withdrawal by Subject|27|||
144217157|NCT02694328|519988100|FG001|Overall Study|Withdrawal by Subject|23|||
144217158|NCT02694328|519988099|FG000|Overall Study|Lost to Follow-up|26|||
144217159|NCT02694328|519988100|FG001|Overall Study|Lost to Follow-up|22|||
144217160|NCT02694328|519988099|FG000|Overall Study|Noncompliant with study drug|11|||
144217161|NCT02694328|519988100|FG001|Overall Study|Noncompliant with study drug|8|||
144217162|NCT02694328|519988099|FG000|Overall Study|Incarceration|1|||
144217163|NCT02694328|519988100|FG001|Overall Study|Incarceration|1|||
144666360|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
144666361|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
144666362|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
144666363|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
144666364|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
144666365|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
144666366|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
144666367|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
144666368|NCT00383721|521628485|FG000|26-Week Treatment Safety Extension|Administrative|1|||
144666369|NCT00383721|521628486|FG001|26-Week Treatment Safety Extension|Administrative|2|||
144666370|NCT00383721|521628487|FG002|26-Week Treatment Safety Extension|Administrative|3|||
144666371|NCT00383721|521628488|FG003|26-Week Treatment Safety Extension|Administrative|1|||
144666372|NCT00383721|521628489|FG004|26-Week Treatment Safety Extension|Administrative|0|||
144666373|NCT03814590|521628495|FG000|Overall Study|Adverse Event|0|||
144666374|NCT03814590|521628496|FG001|Overall Study|Adverse Event|0|||
144666375|NCT03814590|521628497|FG002|Overall Study|Adverse Event|0|||
144666376|NCT03814590|521628498|FG003|Overall Study|Adverse Event|0|||
144666377|NCT03814590|521628499|FG004|Overall Study|Adverse Event|0|||
144666378|NCT03814590|521628500|FG005|Overall Study|Adverse Event|1|||
144733746|NCT02057458|521882153|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
144733747|NCT02057458|521882151|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
144217164|NCT02694328|519988099|FG000|Overall Study|Lack of Efficacy|1|||
144217165|NCT02694328|519988100|FG001|Overall Study|Lack of Efficacy|2|||
144217166|NCT02694328|519988099|FG000|Overall Study|Pregnancy|1|||
144217167|NCT02694328|519988100|FG001|Overall Study|Pregnancy|1|||
144217168|NCT02694328|519988099|FG000|Overall Study|Protocol Violation|6|||
144217169|NCT02694328|519988100|FG001|Overall Study|Protocol Violation|5|||
144217170|NCT02694328|519988099|FG000|Overall Study|Abnormal Laboratory Value|0|||
144217171|NCT02694328|519988100|FG001|Overall Study|Abnormal Laboratory Value|3|||
144217172|NCT05168202|519990247|FG000|Overall Study|Progressive Disease|4|||
144217173|NCT05168202|519990248|FG001|Overall Study|Progressive Disease|4|||
144217174|NCT05168202|519990249|FG002|Overall Study|Progressive Disease|2|||
144666379|NCT03814590|521628501|FG006|Overall Study|Adverse Event|1|||
144666380|NCT03814590|521628502|FG007|Overall Study|Adverse Event|1|||
144666381|NCT03814590|521628503|FG008|Overall Study|Adverse Event|0|||
144666382|NCT03814590|521628504|FG009|Overall Study|Adverse Event|0|||
144666383|NCT03814590|521628505|FG010|Overall Study|Adverse Event|1|||
144217175|NCT05168202|519990250|FG003|Overall Study|Progressive Disease|3|||
144217176|NCT05168202|519990251|FG004|Overall Study|Progressive Disease|2|||
144217177|NCT05168202|519990252|FG005|Overall Study|Progressive Disease|3|||
144217178|NCT05168202|519990253|FG006|Overall Study|Progressive Disease|2|||
144217179|NCT05168202|519990247|FG000|Overall Study|Adverse Event|2|||
144217180|NCT05168202|519990248|FG001|Overall Study|Adverse Event|1|||
144217181|NCT05168202|519990249|FG002|Overall Study|Adverse Event|4|||
144217182|NCT05168202|519990250|FG003|Overall Study|Adverse Event|4|||
144217183|NCT05168202|519990251|FG004|Overall Study|Adverse Event|3|||
144217184|NCT05168202|519990252|FG005|Overall Study|Adverse Event|2|||
144217185|NCT05168202|519990253|FG006|Overall Study|Adverse Event|0|||
144217186|NCT05168202|519990247|FG000|Overall Study|Lack of Efficacy|0|||
144217187|NCT05168202|519990248|FG001|Overall Study|Lack of Efficacy|1|||
144217188|NCT05168202|519990249|FG002|Overall Study|Lack of Efficacy|1|||
144217189|NCT05168202|519990250|FG003|Overall Study|Lack of Efficacy|0|||
144217190|NCT05168202|519990251|FG004|Overall Study|Lack of Efficacy|1|||
144217191|NCT05168202|519990252|FG005|Overall Study|Lack of Efficacy|2|||
144217192|NCT05168202|519990253|FG006|Overall Study|Lack of Efficacy|2|||
144217193|NCT05168202|519990247|FG000|Overall Study|Withdrawal by Subject|0|||
144217194|NCT05168202|519990248|FG001|Overall Study|Withdrawal by Subject|0|||
144217195|NCT05168202|519990249|FG002|Overall Study|Withdrawal by Subject|1|||
144217196|NCT05168202|519990250|FG003|Overall Study|Withdrawal by Subject|1|||
144217197|NCT05168202|519990251|FG004|Overall Study|Withdrawal by Subject|1|||
144217198|NCT05168202|519990252|FG005|Overall Study|Withdrawal by Subject|1|||
144217199|NCT05168202|519990253|FG006|Overall Study|Withdrawal by Subject|0|||
144217200|NCT05168202|519990247|FG000|Overall Study|Disease Relapse|0|||
144217201|NCT05168202|519990248|FG001|Overall Study|Disease Relapse|1|||
144217202|NCT05168202|519990249|FG002|Overall Study|Disease Relapse|0|||
144217203|NCT05168202|519990250|FG003|Overall Study|Disease Relapse|1|||
144217204|NCT05168202|519990251|FG004|Overall Study|Disease Relapse|1|||
144217205|NCT05168202|519990252|FG005|Overall Study|Disease Relapse|0|||
144217206|NCT05168202|519990253|FG006|Overall Study|Disease Relapse|0|||
144217207|NCT05168202|519990247|FG000|Overall Study|Other Reasons|0|||
144217208|NCT05168202|519990248|FG001|Overall Study|Other Reasons|0|||
144217209|NCT05168202|519990249|FG002|Overall Study|Other Reasons|0|||
144217210|NCT05168202|519990250|FG003|Overall Study|Other Reasons|0|||
144217211|NCT05168202|519990251|FG004|Overall Study|Other Reasons|0|||
144217212|NCT05168202|519990252|FG005|Overall Study|Other Reasons|2|||
144217213|NCT05168202|519990253|FG006|Overall Study|Other Reasons|1|||
144217214|NCT05168202|519990247|FG000|Overall Study|Physician Decision|0|||
144217215|NCT05168202|519990248|FG001|Overall Study|Physician Decision|1|||
144217216|NCT05168202|519990249|FG002|Overall Study|Physician Decision|1|||
144217217|NCT05168202|519990250|FG003|Overall Study|Physician Decision|0|||
144217218|NCT05168202|519990251|FG004|Overall Study|Physician Decision|0|||
144217219|NCT05168202|519990252|FG005|Overall Study|Physician Decision|0|||
144217220|NCT05168202|519990253|FG006|Overall Study|Physician Decision|0|||
144217221|NCT05168202|519990247|FG000|Overall Study|Study Terminated by Sponsor|0|||
144217222|NCT05168202|519990248|FG001|Overall Study|Study Terminated by Sponsor|0|||
144265571|NCT00853762|520173967|FG002|Overall Study|Withdrawal by Subject|1|||
144666384|NCT03814590|521628506|FG011|Overall Study|Adverse Event|0|||
144666385|NCT03814590|521628507|FG012|Overall Study|Adverse Event|3|||
144666386|NCT03814590|521628508|FG013|Overall Study|Adverse Event|0|||
144666387|NCT03814590|521628495|FG000|Overall Study|Lost to Follow-up|0|||
144666388|NCT03814590|521628496|FG001|Overall Study|Lost to Follow-up|2|||
144666389|NCT03814590|521628497|FG002|Overall Study|Lost to Follow-up|1|||
144666390|NCT03814590|521628498|FG003|Overall Study|Lost to Follow-up|0|||
144666391|NCT03814590|521628499|FG004|Overall Study|Lost to Follow-up|1|||
144666392|NCT03814590|521628500|FG005|Overall Study|Lost to Follow-up|1|||
144666393|NCT03814590|521628501|FG006|Overall Study|Lost to Follow-up|1|||
144666394|NCT03814590|521628502|FG007|Overall Study|Lost to Follow-up|1|||
144666395|NCT03814590|521628503|FG008|Overall Study|Lost to Follow-up|0|||
144666396|NCT03814590|521628504|FG009|Overall Study|Lost to Follow-up|0|||
144666397|NCT03814590|521628505|FG010|Overall Study|Lost to Follow-up|1|||
144666398|NCT03814590|521628506|FG011|Overall Study|Lost to Follow-up|0|||
144666399|NCT03814590|521628507|FG012|Overall Study|Lost to Follow-up|0|||
144666400|NCT03814590|521628508|FG013|Overall Study|Lost to Follow-up|1|||
144666401|NCT03814590|521628495|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666402|NCT03814590|521628496|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666403|NCT03814590|521628497|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666404|NCT03814590|521628498|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144217223|NCT05168202|519990249|FG002|Overall Study|Study Terminated by Sponsor|0|||
144217224|NCT05168202|519990250|FG003|Overall Study|Study Terminated by Sponsor|1|||
144217225|NCT05168202|519990251|FG004|Overall Study|Study Terminated by Sponsor|0|||
144217226|NCT05168202|519990252|FG005|Overall Study|Study Terminated by Sponsor|0|||
144217227|NCT05168202|519990253|FG006|Overall Study|Study Terminated by Sponsor|0|||
144217228|NCT04011722|519990257|FG000|30 Days|Death|5|||
144666405|NCT03814590|521628499|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666406|NCT03814590|521628500|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666407|NCT03814590|521628501|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666408|NCT03814590|521628502|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666409|NCT03814590|521628503|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666410|NCT03814590|521628504|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
144666411|NCT03814590|521628505|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666412|NCT03814590|521628506|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666413|NCT03814590|521628507|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666414|NCT03814590|521628508|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
144666415|NCT03814590|521628495|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144217229|NCT04011722|519990258|FG001|30 Days|Death|1|||
144217230|NCT04011722|519990257|FG000|1 Year|Death|13|||
144217231|NCT04011722|519990258|FG001|1 Year|Death|5|||
144217232|NCT04011722|519990257|FG000|1 Year|Withdrawal by Subject|8|||
144666416|NCT03814590|521628496|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144666417|NCT03814590|521628497|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144666418|NCT03814590|521628498|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144666419|NCT03814590|521628499|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144666420|NCT03814590|521628500|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
144666421|NCT03814590|521628501|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
144666422|NCT03814590|521628502|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
144666423|NCT03814590|521628503|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144666424|NCT03814590|521628504|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
144666425|NCT03814590|521628505|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
144666426|NCT03814590|521628506|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
144666427|NCT03814590|521628507|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
144666428|NCT03814590|521628508|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
144666429|NCT03814590|521628495|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666430|NCT03814590|521628496|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666431|NCT03814590|521628497|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666432|NCT03814590|521628498|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666433|NCT03814590|521628499|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666434|NCT03814590|521628500|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666435|NCT03814590|521628501|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666436|NCT03814590|521628502|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144666437|NCT03814590|521628503|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666438|NCT03814590|521628504|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144666439|NCT03814590|521628505|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666440|NCT03814590|521628506|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666441|NCT03814590|521628507|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666442|NCT03814590|521628508|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144666443|NCT03814590|521628495|FG000|Overall Study|UNKNOWN REASON|0|||
144666444|NCT03814590|521628496|FG001|Overall Study|UNKNOWN REASON|0|||
144666445|NCT03814590|521628497|FG002|Overall Study|UNKNOWN REASON|0|||
144666446|NCT03814590|521628498|FG003|Overall Study|UNKNOWN REASON|0|||
144666447|NCT03814590|521628499|FG004|Overall Study|UNKNOWN REASON|0|||
144666448|NCT03814590|521628500|FG005|Overall Study|UNKNOWN REASON|0|||
144666449|NCT03814590|521628501|FG006|Overall Study|UNKNOWN REASON|0|||
144666450|NCT03814590|521628502|FG007|Overall Study|UNKNOWN REASON|1|||
144666451|NCT03814590|521628503|FG008|Overall Study|UNKNOWN REASON|0|||
144666452|NCT03814590|521628504|FG009|Overall Study|UNKNOWN REASON|0|||
144666453|NCT03814590|521628505|FG010|Overall Study|UNKNOWN REASON|0|||
144666454|NCT03814590|521628506|FG011|Overall Study|UNKNOWN REASON|0|||
144666455|NCT03814590|521628507|FG012|Overall Study|UNKNOWN REASON|0|||
144666456|NCT03814590|521628508|FG013|Overall Study|UNKNOWN REASON|0|||
144666457|NCT03245723|521628517|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
144666458|NCT03245723|521628518|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
144666459|NCT03245723|521628517|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
144666460|NCT03245723|521628518|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
144666461|NCT03245723|521628517|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
144666462|NCT03245723|521628518|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
144666463|NCT03245723|521628517|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
144217233|NCT04011722|519990258|FG001|1 Year|Withdrawal by Subject|2|||
144217234|NCT04011722|519990257|FG000|1 Year|Missed Visit|6|||
144217235|NCT04011722|519990258|FG001|1 Year|Missed Visit|1|||
144666464|NCT03245723|521628518|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
144666465|NCT00077376|521628519|FG000|Overall Study|Adverse Event|8|||
144666466|NCT00077376|521628519|FG000|Overall Study|Withdrawal by Subject|2|||
144666467|NCT00077376|521628519|FG000|Overall Study|Death|1|||
144666468|NCT00077376|521628519|FG000|Overall Study|Physician Decision|1|||
144666469|NCT00077376|521628519|FG000|Overall Study|Alternative therapy|5|||
144666470|NCT00077376|521628519|FG000|Overall Study|Complicating disease|1|||
144666471|NCT00077376|521628519|FG000|Overall Study|Still on treatment|1|||
144666472|NCT00077376|521628519|FG000|Overall Study|Symptomatic deterioration|1|||
144666473|NCT00077376|521628519|FG000|Overall Study|Surgery|1|||
144666474|NCT00077376|521628519|FG000|Overall Study|Insurance ran out|1|||
144666475|NCT03833817|521629936|FG000|Overall Study|Withdrawal by Subject|3|||
144666476|NCT03833817|521629937|FG001|Overall Study|Withdrawal by Subject|3|||
144666477|NCT03833817|521629936|FG000|Overall Study|Lost to Follow-up|3|||
144666478|NCT03833817|521629937|FG001|Overall Study|Lost to Follow-up|3|||
144666479|NCT00884221|521629938|FG000|Overall Study|Withdrawal by Subject|0|||
144666480|NCT00884221|521629939|FG001|Overall Study|Withdrawal by Subject|3|||
144666481|NCT00884221|521629938|FG000|Overall Study|Adverse Event|6|||
144666482|NCT00884221|521629939|FG001|Overall Study|Adverse Event|3|||
144666483|NCT00884221|521629938|FG000|Overall Study|Protocol Violation|16|||
144666484|NCT00884221|521629939|FG001|Overall Study|Protocol Violation|13|||
144666485|NCT00884221|521629938|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
144666486|NCT00884221|521629939|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
144666487|NCT03287245|521629940|FG000|Overall Study|Study terminated by sponsor|3|||
144666488|NCT03287245|521629941|FG001|Overall Study|Study terminated by sponsor|0|||
144666489|NCT03287245|521629942|FG002|Overall Study|Study terminated by sponsor|3|||
144666490|NCT03287245|521629943|FG003|Overall Study|Study terminated by sponsor|1|||
144666491|NCT03287245|521629940|FG000|Overall Study|Adverse Event|1|||
144666492|NCT03287245|521629941|FG001|Overall Study|Adverse Event|0|||
144666493|NCT03287245|521629942|FG002|Overall Study|Adverse Event|0|||
144666494|NCT03287245|521629943|FG003|Overall Study|Adverse Event|0|||
144666495|NCT03287245|521629940|FG000|Overall Study|Withdrawal by Subject|8|||
144666496|NCT03287245|521629941|FG001|Overall Study|Withdrawal by Subject|3|||
144666497|NCT03287245|521629942|FG002|Overall Study|Withdrawal by Subject|3|||
144666498|NCT03287245|521629943|FG003|Overall Study|Withdrawal by Subject|0|||
144666499|NCT03287245|521629940|FG000|Overall Study|Physician Decision|3|||
144666500|NCT03287245|521629941|FG001|Overall Study|Physician Decision|2|||
144666501|NCT03287245|521629942|FG002|Overall Study|Physician Decision|0|||
144666502|NCT03287245|521629943|FG003|Overall Study|Physician Decision|0|||
144666503|NCT02701192|521629944|FG000|Overall Study|Protocol Violation|2|||
144666504|NCT02701192|521629944|FG000|Overall Study|Lost to Follow-up|4|||
144666505|NCT02862548|521629945|FG000|Randomized Phase (Up to Week 48)|Death|0|||
144666506|NCT02862548|521629946|FG001|Randomized Phase (Up to Week 48)|Death|1|||
144666507|NCT02862548|521629945|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
144666508|NCT02862548|521629946|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
144666509|NCT02862548|521629945|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
144666510|NCT02862548|521629946|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
144666511|NCT02862548|521629945|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
144666512|NCT02862548|521629946|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
144666513|NCT00880763|521629947|FG000|Extension Period (Part 2)|Adverse Event|0|||
144666514|NCT00880763|521629948|FG001|Extension Period (Part 2)|Adverse Event|0|||
144666515|NCT00880763|521629949|FG002|Extension Period (Part 2)|Adverse Event|1|||
144666516|NCT00880763|521629950|FG003|Extension Period (Part 2)|Adverse Event|1|||
144666517|NCT00880763|521629947|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
144666518|NCT00880763|521629948|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
144666519|NCT00880763|521629949|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
144666520|NCT00880763|521629950|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
144666521|NCT00880763|521629947|FG000|Extension Period (Part 2)|Physician Decision|0|||
144666522|NCT00880763|521629948|FG001|Extension Period (Part 2)|Physician Decision|1|||
144666523|NCT00880763|521629949|FG002|Extension Period (Part 2)|Physician Decision|1|||
144666524|NCT00880763|521629950|FG003|Extension Period (Part 2)|Physician Decision|0|||
144666525|NCT00880763|521629947|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
144666526|NCT00880763|521629948|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
144666527|NCT00880763|521629949|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
144666528|NCT00880763|521629950|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
144666529|NCT02667457|521629952|FG000|Overall Study|Withdrawal by Subject|1|||
144666530|NCT02667457|521629953|FG001|Overall Study|Withdrawal by Subject|0|||
144666531|NCT02667457|521629952|FG000|Overall Study|Other Reason|0|||
144666532|NCT02667457|521629953|FG001|Overall Study|Other Reason|2|||
144666533|NCT00603733|521629956|FG000|Active Phase ITT|Adverse Event|8|||
144666534|NCT00603733|521629957|FG001|Active Phase ITT|Adverse Event|7|||
144666535|NCT00603733|521629956|FG000|Active Phase ITT|Withdrawal by Subject|0|||
144666536|NCT00603733|521629957|FG001|Active Phase ITT|Withdrawal by Subject|3|||
144666537|NCT00603733|521629956|FG000|Active Phase ITT|Lost to Follow-up|0|||
144666538|NCT00603733|521629957|FG001|Active Phase ITT|Lost to Follow-up|1|||
144666539|NCT00603733|521629956|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
144666540|NCT00603733|521629957|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
144666541|NCT00603733|521629956|FG000|Active Phase ITT|Lack of Efficacy|1|||
144666542|NCT00603733|521629957|FG001|Active Phase ITT|Lack of Efficacy|2|||
144666543|NCT00603733|521629956|FG000|Active Phase ITT|Subject moved, site closed|1|||
144666544|NCT00603733|521629957|FG001|Active Phase ITT|Subject moved, site closed|1|||
144666545|NCT00603733|521629956|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
144666546|NCT00603733|521629957|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
144666547|NCT00603733|521629956|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
144666548|NCT00603733|521629957|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
144666549|NCT00603733|521629956|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
144666550|NCT00603733|521629957|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
144666551|NCT00603733|521629956|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
144666552|NCT00603733|521629957|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
144666553|NCT00603733|521629956|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
144666554|NCT00603733|521629957|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
144666555|NCT00603733|521629956|FG000|Maintenance Phase ITT|Adverse Event|3|||
144666556|NCT00603733|521629957|FG001|Maintenance Phase ITT|Adverse Event|6|||
144666557|NCT00603733|521629956|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
144666558|NCT00603733|521629957|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
144666559|NCT00603733|521629956|FG000|Maintenance Phase ITT|Protocol Violation|1|||
144666560|NCT00603733|521629957|FG001|Maintenance Phase ITT|Protocol Violation|1|||
144666561|NCT00603733|521629956|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
144666562|NCT00603733|521629957|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
144666563|NCT00603733|521629956|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
144666564|NCT00603733|521629957|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
144666565|NCT00603733|521629956|FG000|Maintenance Phase ITT|Physician Decision|0|||
144666566|NCT00603733|521629957|FG001|Maintenance Phase ITT|Physician Decision|1|||
144666567|NCT00603733|521629956|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
144666568|NCT00603733|521629957|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
144666569|NCT01253187|521629967|FG000|Period 2|Withdrawal by Subject|0|||
144666570|NCT01253187|521629968|FG001|Period 2|Withdrawal by Subject|0|||
144666571|NCT01253187|521629969|FG002|Period 2|Withdrawal by Subject|0|||
144666572|NCT01253187|521629970|FG003|Period 2|Withdrawal by Subject|0|||
144666573|NCT01253187|521629971|FG004|Period 2|Withdrawal by Subject|1|||
144666574|NCT01253187|521629972|FG005|Period 2|Withdrawal by Subject|0|||
144666575|NCT01253187|521629967|FG000|Period 3|Pregnancy|1|||
144666576|NCT01253187|521629968|FG001|Period 3|Pregnancy|0|||
144666577|NCT01253187|521629969|FG002|Period 3|Pregnancy|0|||
144666578|NCT01253187|521629970|FG003|Period 3|Pregnancy|0|||
144666579|NCT01253187|521629971|FG004|Period 3|Pregnancy|0|||
144666580|NCT01253187|521629972|FG005|Period 3|Pregnancy|0|||
144666581|NCT01253187|521629967|FG000|Period 3|difficulty with blood sampling|0|||
144666582|NCT01253187|521629968|FG001|Period 3|difficulty with blood sampling|1|||
144666583|NCT01253187|521629969|FG002|Period 3|difficulty with blood sampling|0|||
144666584|NCT01253187|521629970|FG003|Period 3|difficulty with blood sampling|0|||
144666585|NCT01253187|521629971|FG004|Period 3|difficulty with blood sampling|0|||
144666586|NCT01253187|521629972|FG005|Period 3|difficulty with blood sampling|0|||
144666587|NCT01253187|521629967|FG000|Period 3|non-compliance|0|||
144666588|NCT01253187|521629968|FG001|Period 3|non-compliance|0|||
144666589|NCT01253187|521629969|FG002|Period 3|non-compliance|0|||
144666590|NCT01253187|521629970|FG003|Period 3|non-compliance|0|||
144666591|NCT01253187|521629971|FG004|Period 3|non-compliance|1|||
144666592|NCT01253187|521629972|FG005|Period 3|non-compliance|0|||
144666593|NCT01293006|521629974|FG000|Period 2|Lost to Follow-up|1|||
144666594|NCT01293006|521629975|FG001|Period 2|Lost to Follow-up|0|||
144666595|NCT01293006|521629976|FG002|Period 2|Lost to Follow-up|0|||
144666596|NCT01293006|521629977|FG003|Period 2|Lost to Follow-up|0|||
144666597|NCT01494987|521629978|FG000|Overall Study|Adverse Event|6|||
144666598|NCT01494987|521629979|FG001|Overall Study|Adverse Event|5|||
144666599|NCT01494987|521629978|FG000|Overall Study|Hyperglycemia|6|||
144666600|NCT01494987|521629979|FG001|Overall Study|Hyperglycemia|4|||
144666601|NCT01494987|521629978|FG000|Overall Study|Investigator's Discretion|1|||
144666602|NCT01494987|521629979|FG001|Overall Study|Investigator's Discretion|2|||
144666603|NCT01494987|521629978|FG000|Overall Study|Lost to Follow-up|1|||
144666604|NCT01494987|521629979|FG001|Overall Study|Lost to Follow-up|1|||
144217236|NCT04011722|519990257|FG000|1 Year|Pending Visit|0|||
144666605|NCT01494987|521629978|FG000|Overall Study|Protocol Violation|3|||
144666606|NCT01494987|521629979|FG001|Overall Study|Protocol Violation|3|||
144666607|NCT01494987|521629978|FG000|Overall Study|Subject Non-Compliance|9|||
144666608|NCT01494987|521629979|FG001|Overall Study|Subject Non-Compliance|10|||
144666609|NCT01494987|521629978|FG000|Overall Study|Subject Withdrew Consent|2|||
144666610|NCT01494987|521629979|FG001|Overall Study|Subject Withdrew Consent|3|||
144666611|NCT00600028|521629980|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
144666612|NCT00600028|521629981|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
144666613|NCT00600028|521629980|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
144666614|NCT00600028|521629981|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
144666615|NCT00600028|521629980|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
144217237|NCT04011722|519990258|FG001|1 Year|Pending Visit|11|||
144666616|NCT00600028|521629981|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
144666617|NCT03172481|521629982|FG000|Double-blind|Withdrawal by Subject|1|||
144666618|NCT03172481|521629983|FG001|Double-blind|Withdrawal by Subject|0|||
144666619|NCT02759562|521629984|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
144666620|NCT02759562|521629985|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
144666621|NCT02759562|521629984|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
144666622|NCT02759562|521629985|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
144666623|NCT02293993|521629986|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
144666624|NCT02293993|521629987|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
144666625|NCT02293993|521629988|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
144666626|NCT02293993|521629989|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
144666627|NCT02293993|521629986|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
144666628|NCT02293993|521629987|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
144666629|NCT02293993|521629988|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
144666630|NCT02293993|521629989|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
144666631|NCT02293993|521629986|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
144666632|NCT02293993|521629987|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
144666633|NCT02293993|521629988|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
144666634|NCT02293993|521629989|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
144666635|NCT02293993|521629986|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
144666636|NCT02293993|521629987|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
144666637|NCT02293993|521629988|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
144666638|NCT02293993|521629989|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
144666639|NCT02293993|521629986|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
144666640|NCT02293993|521629987|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
144666641|NCT02293993|521629988|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
144666642|NCT02293993|521629989|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
144666643|NCT03587584|521629990|FG000|Overall Study|SOC deviations|4|||
144666644|NCT03587584|521629991|FG001|Overall Study|SOC deviations|6|||
144666645|NCT03587584|521629990|FG000|Overall Study|Incomplete data|0|||
144666646|NCT03587584|521629991|FG001|Overall Study|Incomplete data|3|||
144666647|NCT01061736|521629992|FG000|Overall Study|Dose regimen not selected|0|||
144666648|NCT01061736|521629993|FG001|Overall Study|Dose regimen not selected|0|||
144666649|NCT01061736|521629994|FG002|Overall Study|Dose regimen not selected|0|||
144666650|NCT01061736|521629995|FG003|Overall Study|Dose regimen not selected|0|||
144666651|NCT01061736|521629996|FG004|Overall Study|Dose regimen not selected|0|||
144666652|NCT01061736|521629997|FG005|Overall Study|Dose regimen not selected|0|||
144666653|NCT01061736|521629998|FG006|Overall Study|Dose regimen not selected|79|||
144666654|NCT01061736|521629999|FG007|Overall Study|Dose regimen not selected|0|||
144666655|NCT01061736|521630000|FG008|Overall Study|Dose regimen not selected|0|||
144666656|NCT01061736|521630001|FG009|Overall Study|Dose regimen not selected|0|||
144666657|NCT01061736|521629992|FG000|Overall Study|Adverse Event|13|||
144666658|NCT01061736|521629993|FG001|Overall Study|Adverse Event|1|||
144666659|NCT01061736|521629994|FG002|Overall Study|Adverse Event|3|||
144666660|NCT01061736|521629995|FG003|Overall Study|Adverse Event|2|||
144666661|NCT01061736|521629996|FG004|Overall Study|Adverse Event|4|||
144666662|NCT01061736|521629997|FG005|Overall Study|Adverse Event|1|||
144666663|NCT01061736|521629998|FG006|Overall Study|Adverse Event|4|||
144666664|NCT01061736|521629999|FG007|Overall Study|Adverse Event|63|||
144666665|NCT01061736|521630000|FG008|Overall Study|Adverse Event|67|||
144666666|NCT01061736|521630001|FG009|Overall Study|Adverse Event|34|||
144666667|NCT01061736|521629992|FG000|Overall Study|Lack of Efficacy|0|||
144666668|NCT01061736|521629993|FG001|Overall Study|Lack of Efficacy|2|||
144666669|NCT01061736|521629994|FG002|Overall Study|Lack of Efficacy|1|||
144666670|NCT01061736|521629995|FG003|Overall Study|Lack of Efficacy|1|||
144666671|NCT01061736|521629996|FG004|Overall Study|Lack of Efficacy|1|||
144666672|NCT01061736|521629997|FG005|Overall Study|Lack of Efficacy|2|||
144666673|NCT01061736|521629998|FG006|Overall Study|Lack of Efficacy|1|||
144666674|NCT01061736|521629999|FG007|Overall Study|Lack of Efficacy|9|||
144217238|NCT04011722|519990257|FG000|1 Year|Not Yet Due|0|||
144217239|NCT04011722|519990258|FG001|1 Year|Not Yet Due|9|||
144666675|NCT01061736|521630000|FG008|Overall Study|Lack of Efficacy|9|||
144666676|NCT01061736|521630001|FG009|Overall Study|Lack of Efficacy|10|||
144666677|NCT01061736|521629992|FG000|Overall Study|Poor compliance to protocol|0|||
144666678|NCT01061736|521629993|FG001|Overall Study|Poor compliance to protocol|0|||
144666679|NCT01061736|521629994|FG002|Overall Study|Poor compliance to protocol|0|||
144217240|NCT04011722|519990257|FG000|2 Year|Death|16|||
144733748|NCT02057458|521882152|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
144733749|NCT02057458|521882153|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
144733750|NCT02057458|521882151|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
144733751|NCT02057458|521882152|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
144733752|NCT02057458|521882153|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
144733753|NCT05169710|521882156|FG000|Overall Study|Adverse Event|1|||
144733754|NCT05169710|521882157|FG001|Overall Study|Adverse Event|2|||
144733755|NCT05169710|521882158|FG002|Overall Study|Adverse Event|2|||
144733756|NCT05169710|521882156|FG000|Overall Study|Lost to Follow-up|0|||
144733757|NCT05169710|521882157|FG001|Overall Study|Lost to Follow-up|0|||
144733758|NCT05169710|521882158|FG002|Overall Study|Lost to Follow-up|1|||
144733759|NCT05169710|521882156|FG000|Overall Study|Withdrawal by Subject|2|||
144733760|NCT05169710|521882157|FG001|Overall Study|Withdrawal by Subject|1|||
144733761|NCT05169710|521882158|FG002|Overall Study|Withdrawal by Subject|0|||
144733762|NCT05169710|521882156|FG000|Overall Study|Other Study Discontinuation Reason|0|||
144733763|NCT05169710|521882157|FG001|Overall Study|Other Study Discontinuation Reason|2|||
144733764|NCT05169710|521882158|FG002|Overall Study|Other Study Discontinuation Reason|0|||
144733765|NCT04400890|521882159|FG000|Overall Study|Withdrawal by Subject|3|||
144733766|NCT04400890|521882160|FG001|Overall Study|Withdrawal by Subject|2|||
144733767|NCT00846495|521882165|FG000|Overall Study|Lost to Follow-up|1|||
144733768|NCT00846495|521882166|FG001|Overall Study|Lost to Follow-up|0|||
144733769|NCT00846495|521882165|FG000|Overall Study|Adverse Event|5|||
144733770|NCT00846495|521882166|FG001|Overall Study|Adverse Event|1|||
144733771|NCT00846495|521882165|FG000|Overall Study|Lack of Efficacy|1|||
144733772|NCT00846495|521882166|FG001|Overall Study|Lack of Efficacy|2|||
144733773|NCT00846495|521882165|FG000|Overall Study|Physician Decision|1|||
144733774|NCT00846495|521882166|FG001|Overall Study|Physician Decision|0|||
144733775|NCT02158663|521882167|FG000|Overall Study|Withdrawal by Subject|5|||
144733776|NCT02158663|521882168|FG001|Overall Study|Withdrawal by Subject|4|||
144733777|NCT01265056|521882169|FG000|Initial Study Period|Withdrawal by Subject|1|||
144733778|NCT01265056|521882170|FG001|Initial Study Period|Withdrawal by Subject|1|||
144733779|NCT01265056|521882169|FG000|Initial Study Period|Withdrawal by Subject|1|||
144733780|NCT01265056|521882170|FG001|Initial Study Period|Withdrawal by Subject|1|||
144733781|NCT01265056|521882169|FG000|Follow up|Lost to Follow-up|7|||
144733782|NCT01265056|521882170|FG001|Follow up|Lost to Follow-up|3|||
144733783|NCT02711852|521882175|FG000|Overall Study|Death|5|||
144733784|NCT02711852|521882175|FG000|Overall Study|Lost to Follow-up|1|||
144666680|NCT01061736|521629995|FG003|Overall Study|Poor compliance to protocol|0|||
144666681|NCT01061736|521629996|FG004|Overall Study|Poor compliance to protocol|0|||
144666682|NCT01061736|521629997|FG005|Overall Study|Poor compliance to protocol|0|||
144666683|NCT01061736|521629998|FG006|Overall Study|Poor compliance to protocol|0|||
144666684|NCT01061736|521629999|FG007|Overall Study|Poor compliance to protocol|2|||
144666685|NCT01061736|521630000|FG008|Overall Study|Poor compliance to protocol|5|||
144666686|NCT01061736|521630001|FG009|Overall Study|Poor compliance to protocol|9|||
144666687|NCT01061736|521629992|FG000|Overall Study|Not treated|0|||
144733785|NCT02711852|521882175|FG000|Overall Study|Completed follow-up|3|||
144733786|NCT02711852|521882175|FG000|Overall Study|Withdrawal by Subject|1|||
144733787|NCT00537979|521882177|FG000|Overall Study|Adverse Event|2|||
144733788|NCT00537979|521882178|FG001|Overall Study|Adverse Event|2|||
144733789|NCT00537979|521882177|FG000|Overall Study|Withdrawal by Subject|1|||
144733790|NCT00537979|521882178|FG001|Overall Study|Withdrawal by Subject|4|||
144733791|NCT00537979|521882177|FG000|Overall Study|Lost to Follow-up|1|||
144733792|NCT00537979|521882178|FG001|Overall Study|Lost to Follow-up|4|||
144733793|NCT00537979|521882177|FG000|Overall Study|Lack of Efficacy|0|||
144733794|NCT00537979|521882178|FG001|Overall Study|Lack of Efficacy|1|||
144733795|NCT00537979|521882177|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
144733796|NCT00537979|521882178|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
144733797|NCT00537979|521882177|FG000|Overall Study|Death|0|||
144733798|NCT00537979|521882178|FG001|Overall Study|Death|3|||
144733799|NCT00537979|521882177|FG000|Overall Study|Kidney transplant|0|||
144733800|NCT00537979|521882178|FG001|Overall Study|Kidney transplant|3|||
144733801|NCT00537979|521882177|FG000|Overall Study|Heart failure|0|||
144733802|NCT00537979|521882178|FG001|Overall Study|Heart failure|1|||
144733803|NCT02601560|521882179|FG000|Overall Study|Other|0|||
144733804|NCT02601560|521882180|FG001|Overall Study|Other|0|||
144733805|NCT02601560|521882181|FG002|Overall Study|Other|0|||
144733806|NCT02601560|521882182|FG003|Overall Study|Other|0|||
144733807|NCT02601560|521882183|FG004|Overall Study|Other|0|||
144666688|NCT01061736|521629993|FG001|Overall Study|Not treated|0|||
144666689|NCT01061736|521629994|FG002|Overall Study|Not treated|0|||
144733808|NCT02601560|521882184|FG005|Overall Study|Other|0|||
144733809|NCT02601560|521882185|FG006|Overall Study|Other|1|||
144733810|NCT02601560|521882186|FG007|Overall Study|Other|0|||
144733811|NCT03459807|521882187|FG000|Overall Study|Withdrawal due to transplant|0|||
144733812|NCT03459807|521882188|FG001|Overall Study|Withdrawal due to transplant|1|||
144733813|NCT02392000|521882194|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
144733814|NCT02392000|521882194|FG000|Overall Study|Withdrawal by Subject|1|||
144666690|NCT01061736|521629995|FG003|Overall Study|Not treated|0|||
144666691|NCT01061736|521629996|FG004|Overall Study|Not treated|1|||
144666692|NCT01061736|521629997|FG005|Overall Study|Not treated|0|||
144666693|NCT01061736|521629998|FG006|Overall Study|Not treated|0|||
144666694|NCT01061736|521629999|FG007|Overall Study|Not treated|2|||
144666695|NCT01061736|521630000|FG008|Overall Study|Not treated|1|||
144666696|NCT01061736|521630001|FG009|Overall Study|Not treated|0|||
144666697|NCT01061736|521629992|FG000|Overall Study|Other than specified above|0|||
144217241|NCT04011722|519990258|FG001|2 Year|Death|1|||
144217242|NCT04011722|519990257|FG000|2 Year|Withdrawal by Subject|10|||
144217243|NCT04011722|519990258|FG001|2 Year|Withdrawal by Subject|1|||
144217244|NCT04011722|519990257|FG000|2 Year|Missed Visit|9|||
144217245|NCT04011722|519990258|FG001|2 Year|Missed Visit|0|||
144217246|NCT04011722|519990257|FG000|2 Year|Visit Pending|1|||
144217247|NCT04011722|519990258|FG001|2 Year|Visit Pending|3|||
144217248|NCT04011722|519990257|FG000|2 Year|Not Yet Due|43|||
144217249|NCT04011722|519990258|FG001|2 Year|Not Yet Due|54|||
144217250|NCT04011722|519990257|FG000|3 Year|Death|10|||
144217251|NCT04011722|519990258|FG001|3 Year|Death|0|||
144217252|NCT04011722|519990257|FG000|3 Year|Withdrawal by Subject|2|||
144217253|NCT04011722|519990258|FG001|3 Year|Withdrawal by Subject|0|||
144217254|NCT04011722|519990257|FG000|3 Year|Missed Visit|2|||
144217255|NCT04011722|519990258|FG001|3 Year|Missed Visit|0|||
144217256|NCT04011722|519990257|FG000|3 Year|Pending Visit|34|||
144666698|NCT01061736|521629993|FG001|Overall Study|Other than specified above|1|||
144666699|NCT01061736|521629994|FG002|Overall Study|Other than specified above|2|||
144666700|NCT01061736|521629995|FG003|Overall Study|Other than specified above|0|||
144666701|NCT01061736|521629996|FG004|Overall Study|Other than specified above|1|||
144666702|NCT01061736|521629997|FG005|Overall Study|Other than specified above|0|||
144666703|NCT01061736|521629998|FG006|Overall Study|Other than specified above|0|||
144666704|NCT01061736|521629999|FG007|Overall Study|Other than specified above|18|||
144666705|NCT01061736|521630000|FG008|Overall Study|Other than specified above|15|||
144666706|NCT01061736|521630001|FG009|Overall Study|Other than specified above|21|||
144666707|NCT01093755|521630005|FG000|Overall Study|Withdrawal by Subject|3|||
144666708|NCT01093755|521630006|FG001|Overall Study|Withdrawal by Subject|4|||
144666709|NCT03115112|521630007|FG000|Overall Study|Adverse Event|5|||
144666710|NCT03115112|521630008|FG001|Overall Study|Adverse Event|1|||
144666711|NCT03115112|521630007|FG000|Overall Study|Withdrawal by Subject|4|||
144666712|NCT03115112|521630008|FG001|Overall Study|Withdrawal by Subject|2|||
144666713|NCT03115112|521630007|FG000|Overall Study|Lost to Follow-up|0|||
144666714|NCT03115112|521630008|FG001|Overall Study|Lost to Follow-up|1|||
144666715|NCT03115112|521630007|FG000|Overall Study|Death|1|||
144666716|NCT03115112|521630008|FG001|Overall Study|Death|0|||
144666717|NCT03115112|521630007|FG000|Overall Study|Pregnancy|1|||
144666718|NCT03115112|521630008|FG001|Overall Study|Pregnancy|0|||
144666719|NCT03115112|521630007|FG000|Overall Study|Site closure|1|||
144666720|NCT03115112|521630008|FG001|Overall Study|Site closure|1|||
144666721|NCT01204697|521630013|FG000|Overall Study|Death|26|||
144666722|NCT01204697|521630014|FG001|Overall Study|Death|27|||
144666723|NCT01204697|521630013|FG000|Overall Study|Lost to Follow-up|3|||
144666724|NCT01204697|521630014|FG001|Overall Study|Lost to Follow-up|4|||
144666725|NCT01204697|521630013|FG000|Overall Study|Withdrawal by Subject|2|||
144666726|NCT01204697|521630014|FG001|Overall Study|Withdrawal by Subject|4|||
144666727|NCT01204697|521630013|FG000|Overall Study|Randomized, but not treated|0|||
144666728|NCT01204697|521630014|FG001|Overall Study|Randomized, but not treated|1|||
144666729|NCT00098020|521630017|FG000|Overall Study|Adverse Event|2|||
144666730|NCT00098020|521630017|FG000|Overall Study|Lost to Follow-up|1|||
144666731|NCT00098020|521630017|FG000|Overall Study|elevated liver enzymes|1|||
144217257|NCT04011722|519990258|FG001|3 Year|Pending Visit|0|||
144217258|NCT04011722|519990257|FG000|3 Year|Not Yet Due|99|||
144217259|NCT04011722|519990258|FG001|3 Year|Not Yet Due|0|||
144217260|NCT05061134|519990261|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
144217261|NCT05061134|519990262|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
144666732|NCT00098020|521630017|FG000|Overall Study|Low urine PCR|1|||
144666733|NCT00098020|521630017|FG000|Overall Study|Low epidermal growth factor receptor|1|||
144666734|NCT01453998|521630018|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
144666735|NCT01453998|521630019|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
144666736|NCT01453998|521630020|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
144666737|NCT01879319|521630023|FG000|Overall Study|Withdrawal by Subject|1|||
144666738|NCT01879319|521630024|FG001|Overall Study|Withdrawal by Subject|0|||
144666739|NCT01879319|521630023|FG000|Overall Study|Lost to Follow-up|1|||
144666740|NCT01879319|521630024|FG001|Overall Study|Lost to Follow-up|5|||
144666741|NCT03483116|521630037|FG000|Overall Study|Adverse Event|0|||
144666742|NCT03483116|521630038|FG001|Overall Study|Adverse Event|1|||
144666743|NCT03483116|521630039|FG002|Overall Study|Adverse Event|0|||
144217262|NCT05061134|519990263|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
144666744|NCT03483116|521630040|FG003|Overall Study|Adverse Event|1|||
144666745|NCT03483116|521630037|FG000|Overall Study|Protocol Violation|1|||
144666746|NCT03483116|521630038|FG001|Overall Study|Protocol Violation|0|||
144666747|NCT03483116|521630039|FG002|Overall Study|Protocol Violation|0|||
144666748|NCT03483116|521630040|FG003|Overall Study|Protocol Violation|7|||
144666749|NCT03483116|521630037|FG000|Overall Study|Lost to Follow-up|9|||
144666750|NCT03483116|521630038|FG001|Overall Study|Lost to Follow-up|4|||
144666751|NCT03483116|521630039|FG002|Overall Study|Lost to Follow-up|9|||
144666752|NCT03483116|521630040|FG003|Overall Study|Lost to Follow-up|5|||
144666753|NCT03483116|521630037|FG000|Overall Study|Death|1|||
144666754|NCT03483116|521630038|FG001|Overall Study|Death|0|||
144666755|NCT03483116|521630039|FG002|Overall Study|Death|2|||
144666756|NCT03483116|521630040|FG003|Overall Study|Death|1|||
144666757|NCT03483116|521630037|FG000|Overall Study|Withdrawal by Subject|14|||
144666758|NCT03483116|521630038|FG001|Overall Study|Withdrawal by Subject|16|||
144666759|NCT03483116|521630039|FG002|Overall Study|Withdrawal by Subject|14|||
144666760|NCT03483116|521630040|FG003|Overall Study|Withdrawal by Subject|16|||
144666761|NCT03483116|521630037|FG000|Overall Study|Unknown other reason|3|||
144666762|NCT03483116|521630038|FG001|Overall Study|Unknown other reason|2|||
144666763|NCT03483116|521630039|FG002|Overall Study|Unknown other reason|1|||
144666764|NCT03483116|521630040|FG003|Overall Study|Unknown other reason|1|||
144666765|NCT00239837|521630042|FG000|Overall Study|Lost to Follow-up|3|||
144733815|NCT02392000|521882194|FG000|Overall Study|Lost to Follow-up|8|||
144733816|NCT04384978|521882195|FG000|Overall Study|Withdrawal by Subject|4|||
144733817|NCT04384978|521882196|FG001|Overall Study|Withdrawal by Subject|0|||
144733818|NCT03197883|521882199|FG000|Overall Study|Adverse Event|1|||
144733819|NCT03197883|521882200|FG001|Overall Study|Adverse Event|1|||
144733820|NCT03197883|521882199|FG000|Overall Study|Lost to Follow-up|1|||
144733821|NCT03197883|521882200|FG001|Overall Study|Lost to Follow-up|0|||
144733822|NCT03197883|521882199|FG000|Overall Study|Protocol Violation|1|||
144733823|NCT03197883|521882200|FG001|Overall Study|Protocol Violation|0|||
144733824|NCT03197883|521882199|FG000|Overall Study|Other (Not Specified)|0|||
144733825|NCT03197883|521882200|FG001|Overall Study|Other (Not Specified)|5|||
144733826|NCT00576056|521882201|FG000|Overall Study|Adverse Event|1|||
144733827|NCT00576056|521882201|FG000|Overall Study|Death|1|||
144733828|NCT00576056|521882201|FG000|Overall Study|Lack of Efficacy|1|||
144733829|NCT00576056|521882201|FG000|Overall Study|Withdrawal by Subject|2|||
144217263|NCT05061134|519990261|FG000|Overall Study|Subject not treated|0|||
144666766|NCT00239837|521630043|FG001|Overall Study|Lost to Follow-up|7|||
144666767|NCT01838590|521630044|FG000|Overall Study|Lack of Efficacy|12|||
144666768|NCT01838590|521630045|FG001|Overall Study|Lack of Efficacy|4|||
144666769|NCT01838590|521630044|FG000|Overall Study|Lost to Follow-up|0|||
144666770|NCT01838590|521630045|FG001|Overall Study|Lost to Follow-up|1|||
144666771|NCT00536978|521630046|FG000|Overall Study|Not eligible for Adback Infusion|22|||
144666772|NCT02475395|521630049|FG000|Overall Study|Protocol Violation|30|||
144666773|NCT02475395|521630050|FG001|Overall Study|Protocol Violation|3|||
144666774|NCT00393913|521630051|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
144666775|NCT00393913|521630051|FG000|Initial Assessment|Withdrawal by Subject|16|||
144666776|NCT00393913|521630051|FG000|CPAP|Withdrawal by Subject|3|||
144666777|NCT00393913|521630051|FG000|CPAP|Physician Decision|1|||
144666778|NCT00393913|521630051|FG000|CPAP|TEchnical problem with CPAP|3|||
144666779|NCT01518244|521630052|FG000|Overall Study|Adverse Event|3|||
144666780|NCT00870818|521630053|FG000|Overall Study|Lost to Follow-up|3|||
144666781|NCT00870818|521630054|FG001|Overall Study|Lost to Follow-up|2|||
144666782|NCT00870818|521630055|FG002|Overall Study|Lost to Follow-up|1|||
144666783|NCT00870818|521630056|FG003|Overall Study|Lost to Follow-up|0|||
144666784|NCT00870818|521630057|FG004|Overall Study|Lost to Follow-up|0|||
144666785|NCT00870818|521630053|FG000|Overall Study|Withdrawal by Subject|0|||
144666786|NCT00870818|521630054|FG001|Overall Study|Withdrawal by Subject|0|||
144666787|NCT00870818|521630055|FG002|Overall Study|Withdrawal by Subject|1|||
144666788|NCT00870818|521630056|FG003|Overall Study|Withdrawal by Subject|2|||
144666789|NCT00870818|521630057|FG004|Overall Study|Withdrawal by Subject|0|||
144666790|NCT00870818|521630053|FG000|Overall Study|Terminated by sponsor|29|||
144666791|NCT00870818|521630054|FG001|Overall Study|Terminated by sponsor|70|||
144666792|NCT00870818|521630055|FG002|Overall Study|Terminated by sponsor|36|||
144733830|NCT00576056|521882201|FG000|Overall Study|did not meet eligibility criteria|8|||
144666793|NCT00870818|521630056|FG003|Overall Study|Terminated by sponsor|36|||
144666794|NCT00870818|521630057|FG004|Overall Study|Terminated by sponsor|38|||
144666795|NCT00870818|521630053|FG000|Overall Study|Other|0|||
144666796|NCT00870818|521630054|FG001|Overall Study|Other|1|||
144666797|NCT00870818|521630055|FG002|Overall Study|Other|0|||
144666798|NCT00870818|521630056|FG003|Overall Study|Other|0|||
144666799|NCT00870818|521630057|FG004|Overall Study|Other|0|||
144666800|NCT04900038|521630060|FG000|Overall Study|Adverse Event|1|||
144666801|NCT04900038|521630061|FG001|Overall Study|Adverse Event|0|||
144666802|NCT04900038|521630062|FG002|Overall Study|Adverse Event|1|||
144666803|NCT04900038|521630063|FG003|Overall Study|Adverse Event|1|||
144666804|NCT04900038|521630060|FG000|Overall Study|Withdrawal by Subject|0|||
144666805|NCT04900038|521630061|FG001|Overall Study|Withdrawal by Subject|1|||
144666806|NCT04900038|521630062|FG002|Overall Study|Withdrawal by Subject|0|||
144666807|NCT04900038|521630063|FG003|Overall Study|Withdrawal by Subject|0|||
144666808|NCT04900038|521630060|FG000|Overall Study|Study terminated by sponsor|18|||
144733831|NCT00576056|521882201|FG000|Overall Study|Physician Decision|1|||
144733832|NCT00858845|521882203|FG000|Overall Study|Patient underwent heart transplant.|0|||
144217264|NCT05061134|519990262|FG001|Overall Study|Subject not treated|0|||
144217265|NCT05061134|519990263|FG002|Overall Study|Subject not treated|2|||
144217266|NCT05061134|519990261|FG000|Overall Study|Other|0|||
144217267|NCT05061134|519990262|FG001|Overall Study|Other|0|||
144217268|NCT05061134|519990263|FG002|Overall Study|Other|9|||
144217269|NCT05061134|519990261|FG000|Overall Study|Withdrawal by Subject|9|||
144217270|NCT05061134|519990262|FG001|Overall Study|Withdrawal by Subject|8|||
144217271|NCT05061134|519990263|FG002|Overall Study|Withdrawal by Subject|5|||
144217272|NCT05061134|519990261|FG000|Overall Study|Study Terminated by Sponsor|22|||
144217273|NCT05061134|519990262|FG001|Overall Study|Study Terminated by Sponsor|14|||
144217274|NCT05061134|519990263|FG002|Overall Study|Study Terminated by Sponsor|7|||
144217275|NCT05061134|519990261|FG000|Overall Study|Progressive Disease|1|||
144217276|NCT05061134|519990262|FG001|Overall Study|Progressive Disease|2|||
144217277|NCT05061134|519990263|FG002|Overall Study|Progressive Disease|0|||
144217278|NCT05061134|519990261|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
144217279|NCT05061134|519990262|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
144217280|NCT05061134|519990263|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
144217281|NCT05061134|519990261|FG000|Overall Study|Lost to Follow-up|1|||
144217282|NCT05061134|519990262|FG001|Overall Study|Lost to Follow-up|0|||
144217283|NCT05061134|519990263|FG002|Overall Study|Lost to Follow-up|0|||
144217284|NCT05061134|519990261|FG000|Overall Study|Physician Decision|1|||
144217285|NCT05061134|519990262|FG001|Overall Study|Physician Decision|1|||
144217286|NCT05061134|519990263|FG002|Overall Study|Physician Decision|0|||
144217287|NCT05061134|519990261|FG000|Overall Study|Disease progression|1|||
144217288|NCT05061134|519990262|FG001|Overall Study|Disease progression|0|||
144217289|NCT05061134|519990263|FG002|Overall Study|Disease progression|0|||
144217290|NCT05061134|519990261|FG000|Overall Study|Death|43|||
144217291|NCT05061134|519990262|FG001|Overall Study|Death|23|||
144217292|NCT05061134|519990263|FG002|Overall Study|Death|14|||
144217293|NCT05061134|519990261|FG000|Overall Study|Database lock|2|||
144217294|NCT05061134|519990262|FG001|Overall Study|Database lock|0|||
144217295|NCT05061134|519990263|FG002|Overall Study|Database lock|0|||
144217296|NCT03410056|519990269|FG000|Overall Study|Decision by Sponsor|0|||
144217297|NCT03410056|519990270|FG001|Overall Study|Decision by Sponsor|0|||
144217298|NCT03410056|519990271|FG002|Overall Study|Decision by Sponsor|3|||
144217299|NCT03410056|519990272|FG003|Overall Study|Decision by Sponsor|0|||
144217300|NCT03410056|519990273|FG004|Overall Study|Decision by Sponsor|0|||
144217301|NCT03410056|519990274|FG005|Overall Study|Decision by Sponsor|0|||
144217302|NCT03410056|519990275|FG006|Overall Study|Decision by Sponsor|0|||
144217303|NCT03410056|519990269|FG000|Overall Study|Withdrawal by Subject|0|||
144217304|NCT03410056|519990270|FG001|Overall Study|Withdrawal by Subject|2|||
144217305|NCT03410056|519990271|FG002|Overall Study|Withdrawal by Subject|5|||
144666809|NCT04900038|521630061|FG001|Overall Study|Study terminated by sponsor|15|||
144666810|NCT04900038|521630062|FG002|Overall Study|Study terminated by sponsor|17|||
144666811|NCT04900038|521630063|FG003|Overall Study|Study terminated by sponsor|14|||
144217306|NCT03410056|519990272|FG003|Overall Study|Withdrawal by Subject|5|||
144217307|NCT03410056|519990273|FG004|Overall Study|Withdrawal by Subject|0|||
144217308|NCT03410056|519990274|FG005|Overall Study|Withdrawal by Subject|0|||
144666812|NCT04900038|521630060|FG000|Overall Study|Protocol Deviation|1|||
144666813|NCT04900038|521630061|FG001|Overall Study|Protocol Deviation|1|||
144666814|NCT04900038|521630062|FG002|Overall Study|Protocol Deviation|0|||
144666815|NCT04900038|521630063|FG003|Overall Study|Protocol Deviation|0|||
144666816|NCT04900038|521630060|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
144666817|NCT04900038|521630061|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
144666818|NCT04900038|521630062|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
144666819|NCT04900038|521630063|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
144666820|NCT04900038|521630060|FG000|Overall Study|Lost to Follow-up|0|||
144666821|NCT04900038|521630061|FG001|Overall Study|Lost to Follow-up|0|||
144666822|NCT04900038|521630062|FG002|Overall Study|Lost to Follow-up|0|||
144217309|NCT03410056|519990275|FG006|Overall Study|Withdrawal by Subject|0|||
144217310|NCT00266630|519990276|FG000|Overall Study|Adverse Event|8|||
144217311|NCT00266630|519990277|FG001|Overall Study|Adverse Event|6|||
144217312|NCT00266630|519990276|FG000|Overall Study|Lack of Efficacy|1|||
144217313|NCT00266630|519990277|FG001|Overall Study|Lack of Efficacy|4|||
144217314|NCT00266630|519990276|FG000|Overall Study|Entry Criteria not met|1|||
144265572|NCT00853762|520173968|FG003|Overall Study|Withdrawal by Subject|0|||
144217315|NCT00266630|519990277|FG001|Overall Study|Entry Criteria not met|0|||
144217316|NCT00266630|519990276|FG000|Overall Study|Protocol Violation|1|||
144217317|NCT00266630|519990277|FG001|Overall Study|Protocol Violation|3|||
144217318|NCT00266630|519990276|FG000|Overall Study|Physician Decision|1|||
144217319|NCT00266630|519990277|FG001|Overall Study|Physician Decision|2|||
144666823|NCT04900038|521630063|FG003|Overall Study|Lost to Follow-up|1|||
144666824|NCT04095442|521631381|FG000|Overall Study|Lost to Follow-up|0|||
144666825|NCT04095442|521631382|FG001|Overall Study|Lost to Follow-up|1|||
144666826|NCT04095442|521631381|FG000|Overall Study|Screen failure|1|||
144666827|NCT04095442|521631382|FG001|Overall Study|Screen failure|0|||
144265573|NCT00853762|520173965|FG000|Overall Study|Other|0|||
144666828|NCT01677624|521631387|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
144666829|NCT00804843|521631388|FG000|Overall Study|Protocol Violation|1|||
144666830|NCT00804843|521631389|FG001|Overall Study|Protocol Violation|0|||
144666831|NCT00804843|521631388|FG000|Overall Study|Adverse Event|8|||
144666832|NCT00804843|521631389|FG001|Overall Study|Adverse Event|5|||
144666833|NCT00804843|521631388|FG000|Overall Study|Withdrawal by Subject|1|||
144666834|NCT00804843|521631389|FG001|Overall Study|Withdrawal by Subject|2|||
144666835|NCT02420795|521631392|FG000|Overall Study|Withdrawal by Subject|1|||
144666836|NCT02420795|521631393|FG001|Overall Study|Withdrawal by Subject|0|||
144666837|NCT02420795|521631394|FG002|Overall Study|Withdrawal by Subject|0|||
144666838|NCT02420795|521631392|FG000|Overall Study|Adverse Event|1|||
144666839|NCT02420795|521631393|FG001|Overall Study|Adverse Event|0|||
144666840|NCT02420795|521631394|FG002|Overall Study|Adverse Event|0|||
144666841|NCT02420795|521631392|FG000|Overall Study|Progressive disease|2|||
144666842|NCT02420795|521631393|FG001|Overall Study|Progressive disease|2|||
144666843|NCT02420795|521631394|FG002|Overall Study|Progressive disease|4|||
144666844|NCT02420795|521631392|FG000|Overall Study|Death|0|||
144666845|NCT02420795|521631393|FG001|Overall Study|Death|0|||
144666846|NCT02420795|521631394|FG002|Overall Study|Death|1|||
144666847|NCT02658968|521631395|FG000|Received Rituximab|Adverse Event|0|||
144666848|NCT02658968|521631396|FG001|Received Rituximab|Adverse Event|0|||
144666849|NCT02658968|521631397|FG002|Received Rituximab|Adverse Event|0|||
144666850|NCT02658968|521631398|FG003|Received Rituximab|Adverse Event|0|||
144666851|NCT02658968|521631399|FG004|Received Rituximab|Adverse Event|1|||
144666852|NCT02658968|521631395|FG000|Received Rituximab|Progressive disease|0|||
144666853|NCT02658968|521631396|FG001|Received Rituximab|Progressive disease|0|||
144666854|NCT02658968|521631397|FG002|Received Rituximab|Progressive disease|0|||
144666855|NCT02658968|521631398|FG003|Received Rituximab|Progressive disease|0|||
144666856|NCT02658968|521631399|FG004|Received Rituximab|Progressive disease|1|||
144666857|NCT02658968|521631395|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
144666858|NCT02658968|521631396|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
144666859|NCT02658968|521631397|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
144666860|NCT02658968|521631398|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
144666861|NCT02658968|521631399|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
144666862|NCT02658968|521631395|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
144666863|NCT02658968|521631396|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
144666864|NCT02658968|521631397|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
144666865|NCT02658968|521631398|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
144666866|NCT02658968|521631399|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
144666867|NCT02658968|521631395|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
144666868|NCT02658968|521631396|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
144666869|NCT02658968|521631397|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
144666870|NCT02658968|521631398|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
144666871|NCT02658968|521631399|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
144666872|NCT02658968|521631395|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
144666873|NCT02658968|521631396|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
144666874|NCT02658968|521631397|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
144666875|NCT02658968|521631398|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
144666876|NCT02658968|521631399|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
144666877|NCT02658968|521631395|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
144666878|NCT02658968|521631396|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
144666879|NCT02658968|521631397|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
144666880|NCT02658968|521631398|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
144666881|NCT02658968|521631399|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
144666882|NCT03097614|521631403|FG000|Overall Study|Adverse Event|3|||
144666883|NCT00436982|521631404|FG000|Overall Study|Withdrawal by Subject|3|||
144666884|NCT00436982|521631405|FG001|Overall Study|Withdrawal by Subject|1|||
144666885|NCT00436982|521631404|FG000|Overall Study|Did not receive allocated intervention|0|||
144666886|NCT00436982|521631405|FG001|Overall Study|Did not receive allocated intervention|1|||
144666887|NCT00436982|521631404|FG000|Overall Study|no RSA data|1|||
144666888|NCT00436982|521631405|FG001|Overall Study|no RSA data|2|||
144666889|NCT00953225|521631409|FG000|Overall Study|Withdrawal by Subject|2|||
144666890|NCT00953225|521631410|FG001|Overall Study|Withdrawal by Subject|0|||
144666891|NCT02254551|521631413|FG000|Dose Escalation|Physician Decision|1|||
144666892|NCT02254551|521631413|FG000|Dose Escalation|Dose-limiting toxicity|2|||
144666893|NCT02215616|521631414|FG000|Overall Study|Sponsor requested to stop study drug|0|||
144666894|NCT02215616|521631415|FG001|Overall Study|Sponsor requested to stop study drug|0|||
144666895|NCT02215616|521631416|FG002|Overall Study|Sponsor requested to stop study drug|1|||
144666896|NCT02215616|521631417|FG003|Overall Study|Sponsor requested to stop study drug|4|||
144666897|NCT02215616|521631414|FG000|Overall Study|Death|1|||
144666898|NCT02215616|521631415|FG001|Overall Study|Death|0|||
144666899|NCT02215616|521631416|FG002|Overall Study|Death|0|||
144666900|NCT02215616|521631417|FG003|Overall Study|Death|0|||
144666901|NCT02215616|521631414|FG000|Overall Study|Adverse Event|7|||
144666902|NCT02215616|521631415|FG001|Overall Study|Adverse Event|4|||
144666903|NCT02215616|521631416|FG002|Overall Study|Adverse Event|9|||
144666904|NCT02215616|521631417|FG003|Overall Study|Adverse Event|2|||
144666905|NCT02215616|521631414|FG000|Overall Study|Withdrawal by Subject|1|||
144666906|NCT02215616|521631415|FG001|Overall Study|Withdrawal by Subject|8|||
144666907|NCT02215616|521631416|FG002|Overall Study|Withdrawal by Subject|2|||
144666908|NCT02215616|521631417|FG003|Overall Study|Withdrawal by Subject|5|||
144666909|NCT02215616|521631414|FG000|Overall Study|Non-compliance|0|||
144666910|NCT02215616|521631415|FG001|Overall Study|Non-compliance|2|||
144666911|NCT02215616|521631416|FG002|Overall Study|Non-compliance|1|||
144666912|NCT02215616|521631417|FG003|Overall Study|Non-compliance|0|||
144666913|NCT02215616|521631414|FG000|Overall Study|Protocol Violation|0|||
144666914|NCT02215616|521631415|FG001|Overall Study|Protocol Violation|2|||
144666915|NCT02215616|521631416|FG002|Overall Study|Protocol Violation|0|||
144666916|NCT02215616|521631417|FG003|Overall Study|Protocol Violation|0|||
144666917|NCT02215616|521631414|FG000|Overall Study|Lost to Follow-up|1|||
144666918|NCT02215616|521631415|FG001|Overall Study|Lost to Follow-up|1|||
144666919|NCT02215616|521631416|FG002|Overall Study|Lost to Follow-up|0|||
144666920|NCT02215616|521631417|FG003|Overall Study|Lost to Follow-up|1|||
144666921|NCT02215616|521631414|FG000|Overall Study|Other than specified|1|||
144666922|NCT02215616|521631415|FG001|Overall Study|Other than specified|0|||
144666923|NCT02215616|521631416|FG002|Overall Study|Other than specified|1|||
144666924|NCT02215616|521631417|FG003|Overall Study|Other than specified|1|||
144666925|NCT01634113|521631418|FG000|Overall Study|Not treated|0|||
144666926|NCT01634113|521631419|FG001|Overall Study|Not treated|0|||
144666927|NCT01634113|521631420|FG002|Overall Study|Not treated|1|||
144666928|NCT01352845|521631423|FG000|Overall Study|Lost to Follow-up|313|||
144666929|NCT01352845|521631424|FG001|Overall Study|Lost to Follow-up|92|||
144666930|NCT01352845|521631423|FG000|Overall Study|No Longer Willing to Participate|205|||
144666931|NCT01352845|521631424|FG001|Overall Study|No Longer Willing to Participate|58|||
144666932|NCT01352845|521631423|FG000|Overall Study|Withdrawal by Subject|48|||
144666933|NCT01352845|521631424|FG001|Overall Study|Withdrawal by Subject|16|||
144666934|NCT01352845|521631423|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
144666935|NCT01352845|521631424|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
144666936|NCT01352845|521631423|FG000|Overall Study|Pregnancy|27|||
144666937|NCT01352845|521631424|FG001|Overall Study|Pregnancy|7|||
144666938|NCT01352845|521631423|FG000|Overall Study|Adverse Event|22|||
144666939|NCT01352845|521631424|FG001|Overall Study|Adverse Event|6|||
144666940|NCT01352845|521631423|FG000|Overall Study|Other|17|||
144666941|NCT01352845|521631424|FG001|Overall Study|Other|7|||
144666942|NCT01352845|521631423|FG000|Overall Study|Protocol Violation|12|||
144666943|NCT01352845|521631424|FG001|Overall Study|Protocol Violation|6|||
144666944|NCT01352845|521631423|FG000|Overall Study|Death|3|||
144666945|NCT01352845|521631424|FG001|Overall Study|Death|0|||
144666946|NCT01956240|521631425|FG000|Overall Study|Lost to Follow-up|6|||
144666947|NCT01956240|521631426|FG001|Overall Study|Lost to Follow-up|20|||
144666948|NCT01956240|521631425|FG000|Overall Study|Adverse Event|17|||
144666949|NCT01956240|521631426|FG001|Overall Study|Adverse Event|4|||
144666950|NCT01957709|521631430|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
144666951|NCT00387348|521631431|FG000|Overall Study|Death|1|||
144666952|NCT00387348|521631432|FG001|Overall Study|Death|1|||
144666953|NCT00387348|521631433|FG002|Overall Study|Death|0|||
144666954|NCT00387348|521631431|FG000|Overall Study|Physician Decision|1|||
144666955|NCT00387348|521631432|FG001|Overall Study|Physician Decision|0|||
144666956|NCT00387348|521631433|FG002|Overall Study|Physician Decision|1|||
144666957|NCT00387348|521631431|FG000|Overall Study|Withdrawal by Subject|0|||
144666958|NCT00387348|521631432|FG001|Overall Study|Withdrawal by Subject|2|||
144666959|NCT00387348|521631433|FG002|Overall Study|Withdrawal by Subject|2|||
144666960|NCT00387348|521631431|FG000|Overall Study|Adverse Event|1|||
144666961|NCT00387348|521631432|FG001|Overall Study|Adverse Event|0|||
144666962|NCT00387348|521631433|FG002|Overall Study|Adverse Event|1|||
144217320|NCT00266630|519990276|FG000|Overall Study|Withdrawal by Subject|10|||
144217321|NCT00266630|519990277|FG001|Overall Study|Withdrawal by Subject|2|||
144217322|NCT00266630|519990276|FG000|Overall Study|Lost to Follow-up|1|||
144217323|NCT00266630|519990277|FG001|Overall Study|Lost to Follow-up|0|||
144217324|NCT00266630|519990276|FG000|Overall Study|Other|19|||
144666963|NCT00505752|521631436|FG000|Overall Study|Adverse Event|1|||
144666964|NCT00505752|521631437|FG001|Overall Study|Adverse Event|0|||
144666965|NCT00505752|521631438|FG002|Overall Study|Adverse Event|1|||
144666966|NCT00505752|521631439|FG003|Overall Study|Adverse Event|0|||
144666967|NCT00505752|521631436|FG000|Overall Study|Lost to Follow-up|1|||
144666968|NCT00505752|521631437|FG001|Overall Study|Lost to Follow-up|0|||
144666969|NCT00505752|521631438|FG002|Overall Study|Lost to Follow-up|0|||
144666970|NCT00505752|521631439|FG003|Overall Study|Lost to Follow-up|0|||
144666971|NCT00505752|521631436|FG000|Overall Study|Lack of ovarian response|1|||
144666972|NCT00505752|521631437|FG001|Overall Study|Lack of ovarian response|3|||
144666973|NCT00505752|521631438|FG002|Overall Study|Lack of ovarian response|0|||
144666974|NCT00505752|521631439|FG003|Overall Study|Lack of ovarian response|0|||
144666975|NCT00505752|521631436|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
144666976|NCT00505752|521631437|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
144666977|NCT00505752|521631438|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
144666978|NCT00505752|521631439|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
144666979|NCT00505752|521631436|FG000|Overall Study|No oocytes retrieved|0|||
144666980|NCT00505752|521631437|FG001|Overall Study|No oocytes retrieved|2|||
144666981|NCT00505752|521631438|FG002|Overall Study|No oocytes retrieved|0|||
144666982|NCT00505752|521631439|FG003|Overall Study|No oocytes retrieved|1|||
144666983|NCT00505752|521631436|FG000|Overall Study|No Fertilization|1|||
144666984|NCT00505752|521631437|FG001|Overall Study|No Fertilization|1|||
144666985|NCT00505752|521631438|FG002|Overall Study|No Fertilization|2|||
144733833|NCT00858845|521882204|FG001|Overall Study|Patient underwent heart transplant.|1|||
144733834|NCT03420300|521882210|FG000|Overall Study|Death|2|||
144733835|NCT05472038|521883531|FG000|Overall Study|Adverse Event|0|||
144217325|NCT00266630|519990277|FG001|Overall Study|Other|11|||
144217326|NCT05377749|519990282|FG000|3 Weeks|Lost to Follow-up|2|||
144217327|NCT05377749|519990283|FG001|3 Weeks|Lost to Follow-up|4|||
144217328|NCT05377749|519990282|FG000|3 Weeks|Withdrawal by Subject|1|||
144217329|NCT05377749|519990283|FG001|3 Weeks|Withdrawal by Subject|1|||
144217330|NCT04909853|519990284|FG000|Part 1|Assigned but not treated|0|||
144217331|NCT04909853|519990285|FG001|Part 1|Assigned but not treated|0|||
144217332|NCT04909853|519990286|FG002|Part 1|Assigned but not treated|1|||
144217333|NCT04909853|519990287|FG003|Part 1|Assigned but not treated|0|||
144217334|NCT04909853|519990284|FG000|Part 2|Adverse Event|0|||
144217335|NCT04909853|519990285|FG001|Part 2|Adverse Event|0|||
144217336|NCT04909853|519990286|FG002|Part 2|Adverse Event|0|||
144217337|NCT04909853|519990287|FG003|Part 2|Adverse Event|1|||
144217338|NCT00077207|519990288|FG000|Overall Study|Adverse Event|5|||
144217339|NCT00077207|519990288|FG000|Overall Study|Lack of Efficacy|12|||
144217340|NCT00077207|519990288|FG000|Overall Study|Physician Decision|6|||
144217341|NCT00077207|519990288|FG000|Overall Study|Withdrawal by Subject|6|||
144217342|NCT00077207|519990288|FG000|Overall Study|Ineligible|1|||
144217343|NCT02366689|519990289|FG000|Overall Study|Withdrawal by Subject|1|||
144217344|NCT02366689|519990290|FG001|Overall Study|Withdrawal by Subject|0|||
144733836|NCT05472038|521883532|FG001|Overall Study|Adverse Event|0|||
144733837|NCT05472038|521883533|FG002|Overall Study|Adverse Event|1|||
144733838|NCT05472038|521883534|FG003|Overall Study|Adverse Event|0|||
144217345|NCT02366689|519990291|FG002|Overall Study|Withdrawal by Subject|1|||
144217346|NCT02366689|519990289|FG000|Overall Study|Lost to Follow-up|3|||
144217347|NCT02366689|519990290|FG001|Overall Study|Lost to Follow-up|2|||
144217348|NCT02366689|519990291|FG002|Overall Study|Lost to Follow-up|0|||
144217349|NCT02366689|519990289|FG000|Overall Study|Pregnancy|0|||
144217350|NCT02366689|519990290|FG001|Overall Study|Pregnancy|1|||
144217351|NCT02366689|519990291|FG002|Overall Study|Pregnancy|1|||
144217352|NCT03283566|519990292|FG000|Overall Study|Lost to Follow-up|1|||
144217353|NCT03283566|519990293|FG001|Overall Study|Lost to Follow-up|2|||
144217354|NCT01996241|519990295|FG000|Overall Study|Lost to Follow-up|252|||
144217355|NCT01996241|519990296|FG001|Overall Study|Lost to Follow-up|235|||
144217356|NCT01068262|519990299|FG000|Overall Study|Adverse Event|2|||
144217357|NCT01068262|519990300|FG001|Overall Study|Adverse Event|0|||
144217358|NCT01068262|519990301|FG002|Overall Study|Adverse Event|1|||
144217359|NCT01068262|519990302|FG003|Overall Study|Adverse Event|0|||
144217360|NCT01068262|519990299|FG000|Overall Study|Protocol Violation|1|||
144217361|NCT01068262|519990300|FG001|Overall Study|Protocol Violation|0|||
144217362|NCT01068262|519990301|FG002|Overall Study|Protocol Violation|0|||
144217363|NCT01068262|519990302|FG003|Overall Study|Protocol Violation|0|||
144217364|NCT01068262|519990299|FG000|Overall Study|Withdrawal by Subject|0|||
144217365|NCT01068262|519990300|FG001|Overall Study|Withdrawal by Subject|1|||
144217366|NCT01068262|519990301|FG002|Overall Study|Withdrawal by Subject|0|||
144217367|NCT01068262|519990302|FG003|Overall Study|Withdrawal by Subject|0|||
144217368|NCT04182490|519990303|FG000|Overall Study|Withdrawal by Subject|3|||
144217369|NCT04182490|519990304|FG001|Overall Study|Withdrawal by Subject|3|||
144666986|NCT00505752|521631439|FG003|Overall Study|No Fertilization|1|||
144733839|NCT05472038|521883535|FG004|Overall Study|Adverse Event|0|||
144733840|NCT05472038|521883536|FG005|Overall Study|Adverse Event|0|||
144217370|NCT04182490|519990303|FG000|Overall Study|Lost to Follow-up|0|||
144217371|NCT04182490|519990304|FG001|Overall Study|Lost to Follow-up|1|||
144217372|NCT04182490|519990303|FG000|Overall Study|Physician Decision|0|||
144217373|NCT04182490|519990304|FG001|Overall Study|Physician Decision|1|||
144217374|NCT00853099|519990305|FG000|Double-blind Period|Adverse Event|7|||
144217375|NCT00853099|519990306|FG001|Double-blind Period|Adverse Event|9|||
144217376|NCT00853099|519990307|FG002|Double-blind Period|Adverse Event|13|||
144217377|NCT00853099|519990308|FG003|Double-blind Period|Adverse Event|0|||
144217378|NCT00853099|519990305|FG000|Double-blind Period|Withdrawal by Subject|2|||
144666987|NCT00505752|521631436|FG000|Overall Study|All embryos/blastocysts discarded|0|||
144666988|NCT00505752|521631437|FG001|Overall Study|All embryos/blastocysts discarded|0|||
144733841|NCT05472038|521883537|FG006|Overall Study|Adverse Event|0|||
144217379|NCT00853099|519990306|FG001|Double-blind Period|Withdrawal by Subject|3|||
144217380|NCT00853099|519990307|FG002|Double-blind Period|Withdrawal by Subject|0|||
144666989|NCT00505752|521631438|FG002|Overall Study|All embryos/blastocysts discarded|1|||
144666990|NCT00505752|521631439|FG003|Overall Study|All embryos/blastocysts discarded|1|||
144666991|NCT00505752|521631436|FG000|Overall Study|Other|1|||
144666992|NCT00505752|521631437|FG001|Overall Study|Other|2|||
144666993|NCT00505752|521631438|FG002|Overall Study|Other|1|||
144666994|NCT00505752|521631439|FG003|Overall Study|Other|2|||
144666995|NCT01114373|521631442|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
144666996|NCT01114373|521631443|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
144666997|NCT01114373|521631442|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
144666998|NCT01114373|521631443|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
144666999|NCT01114373|521631442|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
144667000|NCT01114373|521631443|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
144667001|NCT01114373|521631442|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
144667002|NCT01114373|521631443|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
144667003|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
144667004|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
144667005|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
144667006|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
144667007|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
144667008|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
144667009|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
144667010|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
144667011|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
144667012|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
144667013|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
144667014|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
144667015|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
144667016|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
144667017|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
144667018|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144667019|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144667020|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144667021|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
144667022|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
144667023|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
144667024|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
144667025|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
144667026|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
144667027|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
144667028|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
144667029|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
144667030|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
144667031|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
144667032|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
144667033|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
144217381|NCT00853099|519990308|FG003|Double-blind Period|Withdrawal by Subject|0|||
144217382|NCT00853099|519990305|FG000|Double-blind Period|Lack of Efficacy|14|||
144217383|NCT00853099|519990306|FG001|Double-blind Period|Lack of Efficacy|17|||
144217384|NCT00853099|519990307|FG002|Double-blind Period|Lack of Efficacy|16|||
144217385|NCT00853099|519990308|FG003|Double-blind Period|Lack of Efficacy|0|||
144217386|NCT00853099|519990305|FG000|Double-blind Period|Other|0|||
144217387|NCT00853099|519990306|FG001|Double-blind Period|Other|0|||
144217388|NCT00853099|519990307|FG002|Double-blind Period|Other|1|||
144217389|NCT00853099|519990308|FG003|Double-blind Period|Other|0|||
144217390|NCT00853099|519990305|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
144217391|NCT00853099|519990306|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
144217392|NCT00853099|519990307|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
144217393|NCT00853099|519990308|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
144217394|NCT00853099|519990305|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
144217395|NCT00853099|519990306|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
144217396|NCT00853099|519990307|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
144217397|NCT00853099|519990308|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
144217398|NCT00853099|519990305|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
144217399|NCT00853099|519990306|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
144217400|NCT00853099|519990307|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
144217401|NCT00853099|519990308|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
144667034|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
144667035|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
144733842|NCT05472038|521883538|FG007|Overall Study|Adverse Event|0|||
144667036|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
144667037|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
144667038|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
144667039|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
144667040|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
144667041|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
144667042|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
144667043|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
144667044|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
144667045|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
144667046|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
144667047|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
144667048|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
144667049|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
144667050|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
144667051|NCT03444870|521631444|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
144667052|NCT03444870|521631445|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
144667053|NCT03444870|521631446|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
144667054|NCT03444870|521631447|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
144667055|NCT03444870|521631448|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
144667056|NCT03444870|521631449|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
144667057|NCT03444870|521631444|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144667058|NCT03444870|521631445|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144667059|NCT03444870|521631446|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144667060|NCT03444870|521631447|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144667061|NCT03444870|521631448|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
144667062|NCT03444870|521631449|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
144667063|NCT03444870|521631444|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
144667064|NCT03444870|521631445|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
144667065|NCT03444870|521631446|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
144667066|NCT03444870|521631447|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
144667067|NCT03444870|521631448|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
144667068|NCT03444870|521631449|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
144667069|NCT03444870|521631444|FG000|Open-Label Extension (OLE) Period|Death|0|||
144667070|NCT03444870|521631445|FG001|Open-Label Extension (OLE) Period|Death|0|||
144667071|NCT03444870|521631446|FG002|Open-Label Extension (OLE) Period|Death|0|||
144667072|NCT03444870|521631447|FG003|Open-Label Extension (OLE) Period|Death|0|||
144667073|NCT03444870|521631448|FG004|Open-Label Extension (OLE) Period|Death|1|||
144667074|NCT03444870|521631449|FG005|Open-Label Extension (OLE) Period|Death|0|||
144667075|NCT02267278|521631450|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
144667076|NCT02267278|521631450|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
144667077|NCT02267278|521631450|FG000|Overall Study|Developed new cancer diagnoses|2|||
144667078|NCT02267278|521631450|FG000|Overall Study|prescribed prohibited medication|1|||
144667079|NCT00650091|521631451|FG000|Amended Study Design|Withdrawal by Subject|12|||
144667080|NCT00650091|521631452|FG001|Amended Study Design|Withdrawal by Subject|11|||
144667081|NCT00650091|521631453|FG002|Amended Study Design|Withdrawal by Subject|0|||
144667082|NCT00650091|521631451|FG000|Amended Study Design|Physician Decision|5|||
144667083|NCT00650091|521631452|FG001|Amended Study Design|Physician Decision|0|||
144667084|NCT00650091|521631453|FG002|Amended Study Design|Physician Decision|0|||
144667085|NCT00650091|521631451|FG000|Amended Study Design|Adverse Event|1|||
144667086|NCT00650091|521631452|FG001|Amended Study Design|Adverse Event|4|||
144667087|NCT00650091|521631453|FG002|Amended Study Design|Adverse Event|0|||
144667088|NCT00650091|521631451|FG000|Amended Study Design|Lung transplantation|4|||
144667089|NCT00650091|521631452|FG001|Amended Study Design|Lung transplantation|2|||
144667090|NCT00650091|521631453|FG002|Amended Study Design|Lung transplantation|0|||
144733843|NCT05472038|521883539|FG008|Overall Study|Adverse Event|0|||
144733844|NCT05472038|521883540|FG009|Overall Study|Adverse Event|0|||
144217402|NCT00853099|519990305|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
144217403|NCT00853099|519990306|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
144217404|NCT00853099|519990307|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
144217405|NCT00853099|519990308|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
144667091|NCT00650091|521631451|FG000|Amended Study Design|Other|1|||
144667092|NCT00650091|521631452|FG001|Amended Study Design|Other|3|||
144667093|NCT00650091|521631453|FG002|Amended Study Design|Other|0|||
144667094|NCT01170702|521631454|FG000|Overall Study|Exclusion criteria met after consent|1|||
144667095|NCT01170702|521631455|FG001|Overall Study|Exclusion criteria met after consent|2|||
144667096|NCT01170702|521631456|FG002|Overall Study|Exclusion criteria met after consent|0|||
144667097|NCT01170702|521631457|FG003|Overall Study|Exclusion criteria met after consent|2|||
144667098|NCT00469209|521631462|FG000|Overall Study|Adverse Event|1|||
144733845|NCT05472038|521883541|FG010|Overall Study|Adverse Event|0|||
144667099|NCT00469209|521631463|FG001|Overall Study|Adverse Event|0|||
144667100|NCT00469209|521631464|FG002|Overall Study|Adverse Event|1|||
144667101|NCT04268004|521631465|FG000|Overall Study|Excluded from analyses|0|||
144667102|NCT04268004|521631466|FG001|Overall Study|Excluded from analyses|1|||
144667103|NCT01082367|521631467|FG000|Double-blind Period|Administrative problems|0|||
144667104|NCT01082367|521631468|FG001|Double-blind Period|Administrative problems|1|||
144667105|NCT01082367|521631467|FG000|Double-blind Period|Lack of Efficacy|5|||
144667106|NCT01082367|521631468|FG001|Double-blind Period|Lack of Efficacy|11|||
144667107|NCT01082367|521631467|FG000|Double-blind Period|Adverse Event|0|||
144667108|NCT01082367|521631468|FG001|Double-blind Period|Adverse Event|1|||
144667109|NCT01082367|521631467|FG000|Follow-up (F-U) Period|Administrative problems|1|||
144667110|NCT01082367|521631468|FG001|Follow-up (F-U) Period|Administrative problems|0|||
144667111|NCT01082367|521631467|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
144667112|NCT01082367|521631468|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
144667113|NCT01082367|521631467|FG000|Follow-up (F-U) Period|Adverse Event|0|||
144667114|NCT01082367|521631468|FG001|Follow-up (F-U) Period|Adverse Event|1|||
144667115|NCT04724733|521631474|FG000|Overall Study|Lost to Follow-up|1|||
144667116|NCT04724733|521631475|FG001|Overall Study|Lost to Follow-up|1|||
144667117|NCT04724733|521631476|FG002|Overall Study|Lost to Follow-up|1|||
144217406|NCT00853099|519990305|FG000|Double-blind + Open-label Periods|Other|0|||
144667118|NCT03067129|521631477|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
144667119|NCT03067129|521631478|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
144667120|NCT03067129|521631479|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
144667121|NCT03067129|521631480|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
144667122|NCT03067129|521631477|FG000|Overall Study|Withdrawal by Subject|0|||
144217407|NCT00853099|519990306|FG001|Double-blind + Open-label Periods|Other|0|||
144217408|NCT00853099|519990307|FG002|Double-blind + Open-label Periods|Other|0|||
144217409|NCT00853099|519990308|FG003|Double-blind + Open-label Periods|Other|6|||
144217410|NCT01811472|519990309|FG000|Overall Study|Adverse Event|1|||
144217411|NCT01811472|519990310|FG001|Overall Study|Adverse Event|0|||
144217412|NCT01811472|519990311|FG002|Overall Study|Adverse Event|4|||
144217413|NCT01811472|519990309|FG000|Overall Study|Lost to Follow-up|0|||
144667123|NCT03067129|521631478|FG001|Overall Study|Withdrawal by Subject|0|||
144667124|NCT03067129|521631479|FG002|Overall Study|Withdrawal by Subject|1|||
144667125|NCT03067129|521631480|FG003|Overall Study|Withdrawal by Subject|2|||
144667126|NCT03067129|521631477|FG000|Overall Study|Lost to Follow-up|5|||
144667127|NCT03067129|521631478|FG001|Overall Study|Lost to Follow-up|5|||
144667128|NCT03067129|521631479|FG002|Overall Study|Lost to Follow-up|4|||
144667129|NCT03067129|521631480|FG003|Overall Study|Lost to Follow-up|3|||
144667130|NCT03372603|521631481|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
144667131|NCT03372603|521631482|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
144667132|NCT03372603|521631481|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
144667133|NCT03372603|521631482|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
144667134|NCT04929613|521631483|FG000|Overall Study|Withdrawal by Subject|12|||
144667135|NCT00664209|521631489|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
144667136|NCT00664209|521631489|FG000|Study Treatment Period|Physician Decision|4|||
144667137|NCT00664209|521631489|FG000|Study Treatment Period|Withdrawal by Subject|2|||
144667138|NCT00843843|521631490|FG000|Overall Study|Physician Decision|1|||
144667139|NCT00843843|521631491|FG001|Overall Study|Physician Decision|1|||
144667140|NCT00843843|521631490|FG000|Overall Study|Protocol Violation|1|||
144667141|NCT00843843|521631491|FG001|Overall Study|Protocol Violation|1|||
144667142|NCT00418379|521631492|FG000|Year 1|Adverse Event|9|||
144667143|NCT00418379|521631493|FG001|Year 1|Adverse Event|15|||
144667144|NCT00418379|521631494|FG002|Year 1|Adverse Event|3|||
144667145|NCT00418379|521631492|FG000|Year 1|Withdrawal by Subject|7|||
144667146|NCT00418379|521631493|FG001|Year 1|Withdrawal by Subject|8|||
144667147|NCT00418379|521631494|FG002|Year 1|Withdrawal by Subject|5|||
144667148|NCT00418379|521631492|FG000|Year 1|Any other reason not above-mentioned|2|||
144217414|NCT01811472|519990310|FG001|Overall Study|Lost to Follow-up|0|||
144667149|NCT00418379|521631493|FG001|Year 1|Any other reason not above-mentioned|5|||
144667150|NCT00418379|521631494|FG002|Year 1|Any other reason not above-mentioned|7|||
144667151|NCT00418379|521631492|FG000|Year 2|Adverse Event|5|||
144265574|NCT00853762|520173966|FG001|Overall Study|Other|2|||
144265575|NCT00853762|520173967|FG002|Overall Study|Other|0|||
144217415|NCT01811472|519990311|FG002|Overall Study|Lost to Follow-up|1|||
144217416|NCT01811472|519990309|FG000|Overall Study|Subject/guardian decision|1|||
144217417|NCT01811472|519990310|FG001|Overall Study|Subject/guardian decision|0|||
144217418|NCT01811472|519990311|FG002|Overall Study|Subject/guardian decision|0|||
144667152|NCT00418379|521631493|FG001|Year 2|Adverse Event|2|||
144667153|NCT00418379|521631494|FG002|Year 2|Adverse Event|1|||
144667154|NCT00418379|521631492|FG000|Year 2|Withdrawal by Subject|1|||
144667155|NCT00418379|521631493|FG001|Year 2|Withdrawal by Subject|1|||
144667156|NCT00418379|521631494|FG002|Year 2|Withdrawal by Subject|3|||
144265576|NCT00853762|520173968|FG003|Overall Study|Other|0|||
144667157|NCT00418379|521631492|FG000|Year 2|Any other reason not above-mentioned|2|||
144667158|NCT00418379|521631493|FG001|Year 2|Any other reason not above-mentioned|1|||
144217419|NCT03288714|519990314|FG000|Overall Study|Lost to Follow-up|2|||
144217420|NCT03288714|519990315|FG001|Overall Study|Lost to Follow-up|1|||
144217421|NCT03288714|519990314|FG000|Overall Study|Non-compliance with study schedule|2|||
144217422|NCT03288714|519990315|FG001|Overall Study|Non-compliance with study schedule|0|||
144217423|NCT03288714|519990314|FG000|Overall Study|Withdrawal by Subject|3|||
144217424|NCT03288714|519990315|FG001|Overall Study|Withdrawal by Subject|1|||
144217425|NCT03288714|519990314|FG000|Overall Study|Clinical Worsening|2|||
144217426|NCT03288714|519990315|FG001|Overall Study|Clinical Worsening|1|||
144217427|NCT03288714|519990314|FG000|Overall Study|Adverse Event|1|||
144217428|NCT03288714|519990315|FG001|Overall Study|Adverse Event|0|||
144217429|NCT04882241|519990316|FG000|Overall Study|Ongoing in study|46|||
144217430|NCT04882241|519990317|FG001|Overall Study|Ongoing in study|48|||
144217431|NCT04882241|519990318|FG002|Overall Study|Ongoing in study|0|||
144217432|NCT04882241|519990319|FG003|Overall Study|Ongoing in study|0|||
144217433|NCT04882241|519990316|FG000|Overall Study|Death|13|||
144217434|NCT04882241|519990317|FG001|Overall Study|Death|13|||
144217435|NCT04882241|519990318|FG002|Overall Study|Death|0|||
144217436|NCT04882241|519990319|FG003|Overall Study|Death|0|||
144217437|NCT05024747|519990329|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
144217438|NCT05024747|519990330|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
144217439|NCT05024747|519990329|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
144217440|NCT05024747|519990330|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
144217441|NCT05024747|519990329|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
144217442|NCT05024747|519990330|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
144217443|NCT04428034|519990331|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
144217444|NCT02556801|519990332|FG000|Overall Study|Lost to Follow-up|1|||
144217445|NCT02556801|519990333|FG001|Overall Study|Lost to Follow-up|0|||
144217446|NCT02556801|519990334|FG002|Overall Study|Lost to Follow-up|2|||
144217447|NCT02556801|519990335|FG003|Overall Study|Lost to Follow-up|0|||
144217448|NCT02556801|519990332|FG000|Overall Study|Withdrawal by Subject|1|||
144217449|NCT02556801|519990333|FG001|Overall Study|Withdrawal by Subject|1|||
144217450|NCT02556801|519990334|FG002|Overall Study|Withdrawal by Subject|1|||
144217451|NCT02556801|519990335|FG003|Overall Study|Withdrawal by Subject|0|||
144217452|NCT02556801|519990332|FG000|Overall Study|Protocol Violation|0|||
144217453|NCT02556801|519990333|FG001|Overall Study|Protocol Violation|3|||
144217454|NCT02556801|519990334|FG002|Overall Study|Protocol Violation|1|||
144217455|NCT02556801|519990335|FG003|Overall Study|Protocol Violation|1|||
144217456|NCT02556801|519990332|FG000|Overall Study|Adverse Event|0|||
144217457|NCT02556801|519990333|FG001|Overall Study|Adverse Event|2|||
144217458|NCT02556801|519990334|FG002|Overall Study|Adverse Event|0|||
144217459|NCT02556801|519990335|FG003|Overall Study|Adverse Event|3|||
144217460|NCT02556801|519990332|FG000|Overall Study|Pregnancy|0|||
144217461|NCT02556801|519990333|FG001|Overall Study|Pregnancy|1|||
144217462|NCT02556801|519990334|FG002|Overall Study|Pregnancy|0|||
144217463|NCT02556801|519990335|FG003|Overall Study|Pregnancy|0|||
144217464|NCT02556801|519990332|FG000|Overall Study|Personal reasons patient|0|||
144217465|NCT02556801|519990333|FG001|Overall Study|Personal reasons patient|0|||
144217466|NCT02556801|519990334|FG002|Overall Study|Personal reasons patient|0|||
144217467|NCT02556801|519990335|FG003|Overall Study|Personal reasons patient|1|||
144217468|NCT01942993|519990336|FG000|Overall Study|Lost to Follow-up|1|||
144217469|NCT01942993|519990336|FG000|Overall Study|Physician Decision|1|||
144217470|NCT01350271|519990340|FG000|Overall Study|Lost to Follow-up|21|||
144217471|NCT01350271|519990341|FG001|Overall Study|Lost to Follow-up|17|||
144217472|NCT01350271|519990342|FG002|Overall Study|Lost to Follow-up|26|||
144265577|NCT00853762|520173965|FG000|Overall Study|Randomised but not Treated|0|||
144667159|NCT00418379|521631494|FG002|Year 2|Any other reason not above-mentioned|6|||
144667160|NCT00418379|521631492|FG000|Year 3|Withdrawal by Subject|1|||
144667161|NCT00418379|521631493|FG001|Year 3|Withdrawal by Subject|1|||
144667162|NCT00418379|521631494|FG002|Year 3|Withdrawal by Subject|2|||
144667163|NCT00418379|521631492|FG000|Year 3|Any other reason not above-mentioned|2|||
144667164|NCT00418379|521631493|FG001|Year 3|Any other reason not above-mentioned|1|||
144667165|NCT00418379|521631494|FG002|Year 3|Any other reason not above-mentioned|1|||
144667166|NCT00418379|521631492|FG000|Year 4|Adverse Event|0|||
144217473|NCT02906670|519990343|FG000|Cohort 1, QW|Radiological Progression|1|||
144217474|NCT02906670|519990344|FG001|Cohort 1, QW|Radiological Progression|0|||
144217475|NCT02906670|519990345|FG002|Cohort 1, QW|Radiological Progression|0|||
144217476|NCT02906670|519990346|FG003|Cohort 1, QW|Radiological Progression|0|||
144217477|NCT02906670|519990347|FG004|Cohort 1, QW|Radiological Progression|0|||
144217478|NCT02906670|519990348|FG005|Cohort 1, QW|Radiological Progression|0|||
144217479|NCT02906670|519990349|FG006|Cohort 1, QW|Radiological Progression|0|||
144217480|NCT02906670|519990350|FG007|Cohort 1, QW|Radiological Progression|0|||
144217481|NCT02906670|519990351|FG008|Cohort 1, QW|Radiological Progression|0|||
144217482|NCT02906670|519990352|FG009|Cohort 1, QW|Radiological Progression|0|||
144217483|NCT02906670|519990343|FG000|Cohort 2, QW|Radiological Progression|0|||
144217484|NCT02906670|519990344|FG001|Cohort 2, QW|Radiological Progression|1|||
144217485|NCT02906670|519990345|FG002|Cohort 2, QW|Radiological Progression|0|||
144217486|NCT02906670|519990346|FG003|Cohort 2, QW|Radiological Progression|0|||
144217487|NCT02906670|519990347|FG004|Cohort 2, QW|Radiological Progression|0|||
144217488|NCT02906670|519990348|FG005|Cohort 2, QW|Radiological Progression|0|||
144217489|NCT02906670|519990349|FG006|Cohort 2, QW|Radiological Progression|0|||
144667167|NCT00418379|521631493|FG001|Year 4|Adverse Event|1|||
144667168|NCT00418379|521631494|FG002|Year 4|Adverse Event|0|||
144667169|NCT00418379|521631492|FG000|Year 4|Withdrawal by Subject|2|||
144667170|NCT00418379|521631493|FG001|Year 4|Withdrawal by Subject|3|||
144667171|NCT00418379|521631494|FG002|Year 4|Withdrawal by Subject|2|||
144667172|NCT00418379|521631492|FG000|Year 4|Any other reason not above-mentioned|1|||
144667173|NCT00418379|521631493|FG001|Year 4|Any other reason not above-mentioned|1|||
144667174|NCT00418379|521631494|FG002|Year 4|Any other reason not above-mentioned|0|||
144667175|NCT00418379|521631492|FG000|Year 5|Adverse Event|0|||
144667176|NCT00418379|521631493|FG001|Year 5|Adverse Event|1|||
144667177|NCT00418379|521631494|FG002|Year 5|Adverse Event|0|||
144667178|NCT00418379|521631492|FG000|Year 5|Any other reason not above-mentioned|2|||
144667179|NCT00418379|521631493|FG001|Year 5|Any other reason not above-mentioned|4|||
144667180|NCT00418379|521631494|FG002|Year 5|Any other reason not above-mentioned|3|||
144667181|NCT01764256|521631495|FG000|Received All Vaccinations|Adverse Event|1|||
144667182|NCT01764256|521631496|FG001|Received All Vaccinations|Adverse Event|1|||
144667183|NCT01764256|521631497|FG002|Received All Vaccinations|Adverse Event|0|||
144667184|NCT01764256|521631498|FG003|Received All Vaccinations|Adverse Event|0|||
144667185|NCT01764256|521631495|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
144667186|NCT01764256|521631496|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
144667187|NCT01764256|521631497|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
144667188|NCT01764256|521631498|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
144667189|NCT01764256|521631495|FG000|Received All Vaccinations|Lost to Follow-up|1|||
144667190|NCT01764256|521631496|FG001|Received All Vaccinations|Lost to Follow-up|0|||
144667191|NCT01764256|521631497|FG002|Received All Vaccinations|Lost to Follow-up|0|||
144667192|NCT01764256|521631498|FG003|Received All Vaccinations|Lost to Follow-up|0|||
144667193|NCT01764256|521631495|FG000|Completed Study|Lost to Follow-up|0|||
144667194|NCT01764256|521631496|FG001|Completed Study|Lost to Follow-up|0|||
144667195|NCT01764256|521631497|FG002|Completed Study|Lost to Follow-up|0|||
144667196|NCT01764256|521631498|FG003|Completed Study|Lost to Follow-up|1|||
144667197|NCT00565058|521631499|FG000|Overall Study|Adverse Event|1|||
144667198|NCT00565058|521631500|FG001|Overall Study|Adverse Event|0|||
144667199|NCT02029638|521631501|FG000|Overall Study|Death|0|||
144667200|NCT02029638|521631502|FG001|Overall Study|Death|0|||
144667201|NCT02029638|521631503|FG002|Overall Study|Death|1|||
144667202|NCT02029638|521631501|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
144667203|NCT02029638|521631502|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
144667204|NCT02029638|521631503|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
144667205|NCT01153841|521631504|FG000|Overall Study|Adverse Event|1|||
144667206|NCT01153841|521631505|FG001|Overall Study|Adverse Event|0|||
144667207|NCT01153841|521631504|FG000|Overall Study|Withdrawal by Subject|1|||
144667208|NCT01153841|521631505|FG001|Overall Study|Withdrawal by Subject|0|||
144667209|NCT01153841|521631504|FG000|Overall Study|Protocol Violation|2|||
144667210|NCT01153841|521631505|FG001|Overall Study|Protocol Violation|0|||
144667211|NCT01153841|521631504|FG000|Overall Study|Lost to Follow-up|2|||
144667212|NCT01153841|521631505|FG001|Overall Study|Lost to Follow-up|0|||
144667213|NCT03428997|521631506|FG000|Overall Study|Sponsor decision.|1|||
144667214|NCT03428997|521631506|FG000|Overall Study|Withdrawal by Subject|3|||
144667215|NCT03428997|521631506|FG000|Overall Study|Lost to Follow-up|4|||
144667216|NCT01397448|521631508|FG000|Overall Study|Adverse Event|4|||
144667217|NCT01397448|521631509|FG001|Overall Study|Adverse Event|4|||
144667218|NCT01397448|521631510|FG002|Overall Study|Adverse Event|6|||
144667219|NCT01397448|521631508|FG000|Overall Study|Withdrawal by Subject|4|||
144667220|NCT01397448|521631509|FG001|Overall Study|Withdrawal by Subject|4|||
144667221|NCT01397448|521631510|FG002|Overall Study|Withdrawal by Subject|3|||
144667222|NCT01397448|521631508|FG000|Overall Study|Lack of Efficacy|2|||
144667223|NCT01397448|521631509|FG001|Overall Study|Lack of Efficacy|0|||
144667224|NCT01397448|521631510|FG002|Overall Study|Lack of Efficacy|5|||
144667225|NCT01397448|521631508|FG000|Overall Study|Other|8|||
144667226|NCT01397448|521631509|FG001|Overall Study|Other|7|||
144667227|NCT01397448|521631510|FG002|Overall Study|Other|4|||
144667228|NCT02180217|521631515|FG000|Overall Study|Adverse Event|3|||
144667229|NCT02180217|521631516|FG001|Overall Study|Adverse Event|2|||
144667230|NCT02180217|521631517|FG002|Overall Study|Adverse Event|22|||
144733846|NCT05472038|521883542|FG011|Overall Study|Adverse Event|0|||
144667231|NCT02180217|521631515|FG000|Overall Study|Death|1|||
144667232|NCT02180217|521631516|FG001|Overall Study|Death|1|||
144667233|NCT02180217|521631517|FG002|Overall Study|Death|0|||
144667234|NCT02180217|521631515|FG000|Overall Study|Withdrawal by Subject|1|||
144667235|NCT02180217|521631516|FG001|Overall Study|Withdrawal by Subject|1|||
144667236|NCT02180217|521631517|FG002|Overall Study|Withdrawal by Subject|4|||
144667237|NCT02180217|521631515|FG000|Overall Study|Subject/Guardian decision|5|||
144667238|NCT02180217|521631516|FG001|Overall Study|Subject/Guardian decision|3|||
144733847|NCT05472038|521883531|FG000|Overall Study|Death|0|||
144733848|NCT05472038|521883532|FG001|Overall Study|Death|0|||
144217490|NCT02906670|519990350|FG007|Cohort 2, QW|Radiological Progression|0|||
144217491|NCT02906670|519990351|FG008|Cohort 2, QW|Radiological Progression|0|||
144217492|NCT02906670|519990352|FG009|Cohort 2, QW|Radiological Progression|0|||
144217493|NCT02906670|519990343|FG000|Cohort 3, QW|Radiological Progression|0|||
144217494|NCT02906670|519990344|FG001|Cohort 3, QW|Radiological Progression|0|||
144217495|NCT02906670|519990345|FG002|Cohort 3, QW|Radiological Progression|2|||
144217496|NCT02906670|519990346|FG003|Cohort 3, QW|Radiological Progression|0|||
144217497|NCT02906670|519990347|FG004|Cohort 3, QW|Radiological Progression|0|||
144217498|NCT02906670|519990348|FG005|Cohort 3, QW|Radiological Progression|0|||
144217499|NCT02906670|519990349|FG006|Cohort 3, QW|Radiological Progression|0|||
144217500|NCT02906670|519990350|FG007|Cohort 3, QW|Radiological Progression|0|||
144217501|NCT02906670|519990351|FG008|Cohort 3, QW|Radiological Progression|0|||
144733849|NCT05472038|521883533|FG002|Overall Study|Death|0|||
144733850|NCT05472038|521883534|FG003|Overall Study|Death|0|||
144733851|NCT05472038|521883535|FG004|Overall Study|Death|0|||
144667239|NCT02180217|521631517|FG002|Overall Study|Subject/Guardian decision|6|||
144733852|NCT05472038|521883536|FG005|Overall Study|Death|1|||
144733853|NCT05472038|521883537|FG006|Overall Study|Death|0|||
144733854|NCT05472038|521883538|FG007|Overall Study|Death|0|||
144733855|NCT05472038|521883539|FG008|Overall Study|Death|0|||
144733856|NCT05472038|521883540|FG009|Overall Study|Death|0|||
144733857|NCT05472038|521883541|FG010|Overall Study|Death|0|||
144733858|NCT05472038|521883542|FG011|Overall Study|Death|0|||
144217502|NCT02906670|519990352|FG009|Cohort 3, QW|Radiological Progression|0|||
144667240|NCT02180217|521631515|FG000|Overall Study|Physician Decision|1|||
144667241|NCT02180217|521631516|FG001|Overall Study|Physician Decision|1|||
144667242|NCT02180217|521631517|FG002|Overall Study|Physician Decision|6|||
144217503|NCT02906670|519990343|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217504|NCT02906670|519990344|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217505|NCT02906670|519990345|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
144217506|NCT02906670|519990346|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217507|NCT02906670|519990347|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217508|NCT02906670|519990348|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217509|NCT02906670|519990349|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217510|NCT02906670|519990350|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217511|NCT02906670|519990351|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217512|NCT02906670|519990352|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
144217513|NCT02906670|519990343|FG000|Cohort 4, Q2W|Radiological Progression|0|||
144217514|NCT02906670|519990344|FG001|Cohort 4, Q2W|Radiological Progression|0|||
144217515|NCT02906670|519990345|FG002|Cohort 4, Q2W|Radiological Progression|0|||
144217516|NCT02906670|519990346|FG003|Cohort 4, Q2W|Radiological Progression|0|||
144217517|NCT02906670|519990347|FG004|Cohort 4, Q2W|Radiological Progression|0|||
144217518|NCT02906670|519990348|FG005|Cohort 4, Q2W|Radiological Progression|1|||
144217519|NCT02906670|519990349|FG006|Cohort 4, Q2W|Radiological Progression|0|||
144217520|NCT02906670|519990350|FG007|Cohort 4, Q2W|Radiological Progression|0|||
144217521|NCT02906670|519990351|FG008|Cohort 4, Q2W|Radiological Progression|0|||
144667243|NCT02180217|521631515|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144667244|NCT02180217|521631516|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144667245|NCT02180217|521631517|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144667246|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
144667247|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
144667248|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
144667249|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
144667250|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
144667251|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
144217522|NCT02906670|519990352|FG009|Cohort 4, Q2W|Radiological Progression|0|||
144217523|NCT02906670|519990343|FG000|Cohort 4, Q2W|Clinical Progression|0|||
144217524|NCT02906670|519990344|FG001|Cohort 4, Q2W|Clinical Progression|0|||
144217525|NCT02906670|519990345|FG002|Cohort 4, Q2W|Clinical Progression|0|||
144217526|NCT02906670|519990346|FG003|Cohort 4, Q2W|Clinical Progression|0|||
144217527|NCT02906670|519990347|FG004|Cohort 4, Q2W|Clinical Progression|0|||
144217528|NCT02906670|519990348|FG005|Cohort 4, Q2W|Clinical Progression|2|||
144217529|NCT02906670|519990349|FG006|Cohort 4, Q2W|Clinical Progression|0|||
144667252|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Death|1|||
144733859|NCT05472038|521883531|FG000|Overall Study|Lost to Follow-up|1|||
144733860|NCT05472038|521883532|FG001|Overall Study|Lost to Follow-up|3|||
144733861|NCT05472038|521883533|FG002|Overall Study|Lost to Follow-up|3|||
144733862|NCT05472038|521883534|FG003|Overall Study|Lost to Follow-up|9|||
144733863|NCT05472038|521883535|FG004|Overall Study|Lost to Follow-up|2|||
144217530|NCT02906670|519990350|FG007|Cohort 4, Q2W|Clinical Progression|0|||
144217531|NCT02906670|519990351|FG008|Cohort 4, Q2W|Clinical Progression|0|||
144217532|NCT02906670|519990352|FG009|Cohort 4, Q2W|Clinical Progression|0|||
144217533|NCT02906670|519990343|FG000|Cohort 5, Q2W|Radiological Progression|0|||
144217534|NCT02906670|519990344|FG001|Cohort 5, Q2W|Radiological Progression|0|||
144217535|NCT02906670|519990345|FG002|Cohort 5, Q2W|Radiological Progression|0|||
144667253|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Death|3|||
144667254|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
144667255|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
144667256|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
144667257|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
144667258|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
144667259|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
144667260|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
144667261|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
144667262|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
144667263|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
144667264|NCT02553317|521631518|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
144667265|NCT02553317|521631519|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
144667266|NCT04093258|521631522|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
144667267|NCT04093258|521631523|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
144667268|NCT00567541|521631524|FG000|Overall Study|Adverse Event|0|||
144667269|NCT00567541|521631525|FG001|Overall Study|Adverse Event|1|||
144667270|NCT00986427|521631526|FG000|Overall Study|Lost to Follow-up|2|||
144667271|NCT00986427|521631527|FG001|Overall Study|Lost to Follow-up|0|||
144667272|NCT00986427|521631526|FG000|Overall Study|Lack of Efficacy|1|||
144667273|NCT00986427|521631527|FG001|Overall Study|Lack of Efficacy|0|||
144667274|NCT00986427|521631526|FG000|Overall Study|Withdrawal by Subject|1|||
144667275|NCT00986427|521631527|FG001|Overall Study|Withdrawal by Subject|0|||
144667276|NCT06025396|521633726|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
144667277|NCT06025396|521633727|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
144667278|NCT06025396|521633728|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
144667279|NCT06025396|521633729|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
144667280|NCT06025396|521633730|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
144667281|NCT06025396|521633726|FG000|Overall Study|Withdrawal by Subject|0|||
144667282|NCT06025396|521633727|FG001|Overall Study|Withdrawal by Subject|1|||
144667283|NCT06025396|521633728|FG002|Overall Study|Withdrawal by Subject|1|||
144667284|NCT06025396|521633729|FG003|Overall Study|Withdrawal by Subject|0|||
144667285|NCT06025396|521633730|FG004|Overall Study|Withdrawal by Subject|0|||
144667286|NCT01512108|521633731|FG000|Overall Study|Adverse Event|9|||
144667287|NCT01512108|521633732|FG001|Overall Study|Adverse Event|4|||
144667288|NCT01512108|521633731|FG000|Overall Study|Protocol Violation|1|||
144667289|NCT01512108|521633732|FG001|Overall Study|Protocol Violation|2|||
144667290|NCT01512108|521633731|FG000|Overall Study|Withdrawal Criteria|1|||
144667291|NCT01512108|521633732|FG001|Overall Study|Withdrawal Criteria|0|||
144667292|NCT01512108|521633731|FG000|Overall Study|Unclassified|11|||
144667293|NCT01512108|521633732|FG001|Overall Study|Unclassified|3|||
144667294|NCT06422377|521633737|FG000|Overall Study|Study Terminated by Sponsor|1|||
144667295|NCT01283997|521633738|FG000|Overall Study|Physician Decision|8|||
144667296|NCT01283997|521633739|FG001|Overall Study|Physician Decision|10|||
144667297|NCT01283997|521633738|FG000|Overall Study|Withdrawal by Subject|3|||
144667298|NCT01283997|521633739|FG001|Overall Study|Withdrawal by Subject|2|||
144667299|NCT01283997|521633738|FG000|Overall Study|Physically unable to continue|0|||
144667300|NCT01283997|521633739|FG001|Overall Study|Physically unable to continue|1|||
144217536|NCT02906670|519990346|FG003|Cohort 5, Q2W|Radiological Progression|0|||
144217537|NCT02906670|519990347|FG004|Cohort 5, Q2W|Radiological Progression|0|||
144217538|NCT02906670|519990348|FG005|Cohort 5, Q2W|Radiological Progression|0|||
144217539|NCT02906670|519990349|FG006|Cohort 5, Q2W|Radiological Progression|4|||
144217540|NCT02906670|519990350|FG007|Cohort 5, Q2W|Radiological Progression|0|||
144217541|NCT02906670|519990351|FG008|Cohort 5, Q2W|Radiological Progression|0|||
144217542|NCT02906670|519990352|FG009|Cohort 5, Q2W|Radiological Progression|0|||
144217543|NCT02906670|519990343|FG000|Cohort 5, Q2W|Clinical Progression|0|||
144217544|NCT02906670|519990344|FG001|Cohort 5, Q2W|Clinical Progression|0|||
144217545|NCT02906670|519990345|FG002|Cohort 5, Q2W|Clinical Progression|0|||
144217546|NCT02906670|519990346|FG003|Cohort 5, Q2W|Clinical Progression|0|||
144217547|NCT02906670|519990347|FG004|Cohort 5, Q2W|Clinical Progression|0|||
144217548|NCT02906670|519990348|FG005|Cohort 5, Q2W|Clinical Progression|0|||
144667301|NCT01283997|521633738|FG000|Overall Study|Progressive disease|1|||
144667302|NCT01283997|521633739|FG001|Overall Study|Progressive disease|0|||
144667303|NCT01283997|521633738|FG000|Overall Study|Other|4|||
144667304|NCT01283997|521633739|FG001|Overall Study|Other|4|||
144667305|NCT02017899|521633740|FG000|Overall Study|Withdrawal by Subject|0|||
144667306|NCT02017899|521633741|FG001|Overall Study|Withdrawal by Subject|0|||
144667307|NCT02017899|521633742|FG002|Overall Study|Withdrawal by Subject|0|||
144667308|NCT02017899|521633743|FG003|Overall Study|Withdrawal by Subject|1|||
144667309|NCT02017899|521633744|FG004|Overall Study|Withdrawal by Subject|1|||
144217549|NCT02906670|519990349|FG006|Cohort 5, Q2W|Clinical Progression|1|||
144217550|NCT02906670|519990350|FG007|Cohort 5, Q2W|Clinical Progression|0|||
144217551|NCT02906670|519990351|FG008|Cohort 5, Q2W|Clinical Progression|0|||
144667310|NCT02017899|521633745|FG005|Overall Study|Withdrawal by Subject|0|||
144667311|NCT02843178|521633749|FG000|Overall Study|Lost to Follow-up|8|||
144667312|NCT02843178|521633750|FG001|Overall Study|Lost to Follow-up|8|||
144667313|NCT02843178|521633751|FG002|Overall Study|Lost to Follow-up|6|||
144667314|NCT02843178|521633752|FG003|Overall Study|Lost to Follow-up|3|||
144667315|NCT02843178|521633749|FG000|Overall Study|Withdrawal by Subject|0|||
144667316|NCT02843178|521633750|FG001|Overall Study|Withdrawal by Subject|0|||
144667317|NCT02843178|521633751|FG002|Overall Study|Withdrawal by Subject|1|||
144667318|NCT02843178|521633752|FG003|Overall Study|Withdrawal by Subject|1|||
144217552|NCT02906670|519990352|FG009|Cohort 5, Q2W|Clinical Progression|0|||
144217553|NCT02906670|519990343|FG000|Cohort 5, Q2W|Adverse Event|0|||
144217554|NCT02906670|519990344|FG001|Cohort 5, Q2W|Adverse Event|0|||
144217555|NCT02906670|519990345|FG002|Cohort 5, Q2W|Adverse Event|0|||
144217556|NCT02906670|519990346|FG003|Cohort 5, Q2W|Adverse Event|0|||
144217557|NCT02906670|519990347|FG004|Cohort 5, Q2W|Adverse Event|0|||
144217558|NCT02906670|519990348|FG005|Cohort 5, Q2W|Adverse Event|0|||
144217559|NCT02906670|519990349|FG006|Cohort 5, Q2W|Adverse Event|1|||
144217560|NCT02906670|519990350|FG007|Cohort 5, Q2W|Adverse Event|0|||
144217561|NCT02906670|519990351|FG008|Cohort 5, Q2W|Adverse Event|0|||
144217562|NCT02906670|519990352|FG009|Cohort 5, Q2W|Adverse Event|0|||
144217563|NCT02906670|519990343|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217564|NCT02906670|519990344|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217565|NCT02906670|519990345|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217566|NCT02906670|519990346|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217567|NCT02906670|519990347|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217568|NCT02906670|519990348|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217569|NCT02906670|519990349|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
144217570|NCT02906670|519990350|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217571|NCT02906670|519990351|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217572|NCT02906670|519990352|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
144217573|NCT02906670|519990343|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
144217574|NCT02906670|519990344|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
144217575|NCT02906670|519990345|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
144217576|NCT02906670|519990346|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
144217577|NCT02906670|519990347|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
144217578|NCT02906670|519990348|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
144217579|NCT02906670|519990349|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
144217580|NCT02906670|519990350|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
144217581|NCT02906670|519990351|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
144217582|NCT02906670|519990352|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
144217583|NCT02906670|519990343|FG000|Cohort 5P, Q2W|Adverse Event|0|||
144217584|NCT02906670|519990344|FG001|Cohort 5P, Q2W|Adverse Event|0|||
144217585|NCT02906670|519990345|FG002|Cohort 5P, Q2W|Adverse Event|0|||
144217586|NCT02906670|519990346|FG003|Cohort 5P, Q2W|Adverse Event|0|||
144217587|NCT02906670|519990347|FG004|Cohort 5P, Q2W|Adverse Event|0|||
144667319|NCT00646113|521633753|FG000|Overall Study|Lost to Follow-up|5|||
144667320|NCT00646113|521633753|FG000|Overall Study|Adverse Event|3|||
144667321|NCT02109744|521633756|FG000|Overall Study|Death|1|||
144667322|NCT02109744|521633757|FG001|Overall Study|Death|1|||
144667323|NCT02109744|521633756|FG000|Overall Study|no marrow exam|1|||
144667324|NCT02109744|521633757|FG001|Overall Study|no marrow exam|0|||
144667325|NCT04058158|521633758|FG000|Period 1|Death|1|||
144667326|NCT04058158|521633759|FG001|Period 1|Death|0|||
144667327|NCT04058158|521633758|FG000|Period 1|Adverse Event|1|||
144667328|NCT04058158|521633759|FG001|Period 1|Adverse Event|1|||
144667329|NCT04058158|521633758|FG000|Period 1|Pregnancy|0|||
144667330|NCT04058158|521633759|FG001|Period 1|Pregnancy|1|||
144667331|NCT01149343|521633760|FG000|Overall Study|Withdrawal by Subject|1|||
144667332|NCT01149343|521633761|FG001|Overall Study|Withdrawal by Subject|1|||
144667333|NCT01149343|521633762|FG002|Overall Study|Withdrawal by Subject|1|||
144667334|NCT01149343|521633763|FG003|Overall Study|Withdrawal by Subject|5|||
144667335|NCT01149343|521633760|FG000|Overall Study|Death|10|||
144217588|NCT02906670|519990348|FG005|Cohort 5P, Q2W|Adverse Event|0|||
144217589|NCT02906670|519990349|FG006|Cohort 5P, Q2W|Adverse Event|0|||
144667336|NCT01149343|521633761|FG001|Overall Study|Death|13|||
144667337|NCT01149343|521633762|FG002|Overall Study|Death|18|||
144217590|NCT02906670|519990350|FG007|Cohort 5P, Q2W|Adverse Event|1|||
144217591|NCT02906670|519990351|FG008|Cohort 5P, Q2W|Adverse Event|0|||
144217592|NCT02906670|519990352|FG009|Cohort 5P, Q2W|Adverse Event|0|||
144217593|NCT02906670|519990343|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
144217594|NCT02906670|519990344|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
144217595|NCT02906670|519990345|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
144217596|NCT02906670|519990346|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
144217597|NCT02906670|519990347|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
144667338|NCT01149343|521633763|FG003|Overall Study|Death|18|||
144667339|NCT01149343|521633760|FG000|Overall Study|Lost to Follow-up|1|||
144667340|NCT01149343|521633761|FG001|Overall Study|Lost to Follow-up|0|||
144667341|NCT01149343|521633762|FG002|Overall Study|Lost to Follow-up|0|||
144667342|NCT01149343|521633763|FG003|Overall Study|Lost to Follow-up|1|||
144667343|NCT01149343|521633760|FG000|Overall Study|Other|8|||
144667344|NCT01149343|521633761|FG001|Overall Study|Other|10|||
144667345|NCT01149343|521633762|FG002|Overall Study|Other|2|||
144667346|NCT01149343|521633763|FG003|Overall Study|Other|14|||
144667347|NCT01149343|521633760|FG000|Overall Study|Sponsor study termination|0|||
144667348|NCT01149343|521633761|FG001|Overall Study|Sponsor study termination|0|||
144667349|NCT01149343|521633762|FG002|Overall Study|Sponsor study termination|0|||
144667350|NCT01149343|521633763|FG003|Overall Study|Sponsor study termination|2|||
144667351|NCT01149343|521633760|FG000|Overall Study|Recurrence / Progressive disease|0|||
144667352|NCT01149343|521633761|FG001|Overall Study|Recurrence / Progressive disease|0|||
144667353|NCT01149343|521633762|FG002|Overall Study|Recurrence / Progressive disease|1|||
144667354|NCT01149343|521633763|FG003|Overall Study|Recurrence / Progressive disease|0|||
144667355|NCT04624672|521633764|FG000|Overall Study|Early Study Closure|2|||
144667356|NCT04624672|521633765|FG001|Overall Study|Early Study Closure|1|||
144667357|NCT02769832|521633766|FG000|Overall Study|Death|30|||
144667358|NCT02685995|521633774|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
144667359|NCT02685995|521633775|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
144667360|NCT03625141|521633776|FG000|Overall Study|Adverse Event|0|||
144667361|NCT03625141|521633777|FG001|Overall Study|Adverse Event|2|||
144667362|NCT03625141|521633776|FG000|Overall Study|Study Terminated By Sponsor|1|||
144667363|NCT03625141|521633777|FG001|Overall Study|Study Terminated By Sponsor|13|||
144667364|NCT03625141|521633776|FG000|Overall Study|Withdrawal by Subject|3|||
144667365|NCT03625141|521633777|FG001|Overall Study|Withdrawal by Subject|0|||
144667366|NCT03625141|521633776|FG000|Overall Study|Withdrawal Of Consent|0|||
144667367|NCT03625141|521633777|FG001|Overall Study|Withdrawal Of Consent|1|||
144667368|NCT03625141|521633776|FG000|Overall Study|Death|11|||
144667369|NCT03625141|521633777|FG001|Overall Study|Death|47|||
144667370|NCT03625141|521633776|FG000|Overall Study|Progressive Disease|0|||
144667371|NCT03625141|521633777|FG001|Overall Study|Progressive Disease|2|||
144667372|NCT03250377|521633778|FG000|Overall Study|Adverse Event|2|||
144667373|NCT03250377|521633779|FG001|Overall Study|Adverse Event|4|||
144667374|NCT03250377|521633780|FG002|Overall Study|Adverse Event|0|||
144667375|NCT03250377|521633781|FG003|Overall Study|Adverse Event|4|||
144667376|NCT03250377|521633778|FG000|Overall Study|Lack of Efficacy|5|||
144667377|NCT03250377|521633779|FG001|Overall Study|Lack of Efficacy|14|||
144667378|NCT03250377|521633780|FG002|Overall Study|Lack of Efficacy|1|||
144667379|NCT03250377|521633781|FG003|Overall Study|Lack of Efficacy|3|||
144667380|NCT03250377|521633778|FG000|Overall Study|Protocol Violation|0|||
144667381|NCT03250377|521633779|FG001|Overall Study|Protocol Violation|2|||
144667382|NCT03250377|521633780|FG002|Overall Study|Protocol Violation|0|||
144667383|NCT03250377|521633781|FG003|Overall Study|Protocol Violation|1|||
144667384|NCT03250377|521633778|FG000|Overall Study|Lost to Follow-up|0|||
144667385|NCT03250377|521633779|FG001|Overall Study|Lost to Follow-up|1|||
144667386|NCT03250377|521633780|FG002|Overall Study|Lost to Follow-up|0|||
144667387|NCT03250377|521633781|FG003|Overall Study|Lost to Follow-up|0|||
144667388|NCT03250377|521633778|FG000|Overall Study|Withdrawal by Subject|7|||
144667389|NCT03250377|521633779|FG001|Overall Study|Withdrawal by Subject|7|||
144667390|NCT03250377|521633780|FG002|Overall Study|Withdrawal by Subject|0|||
144667391|NCT03250377|521633781|FG003|Overall Study|Withdrawal by Subject|4|||
144667392|NCT03250377|521633778|FG000|Overall Study|Investigator's Judgment|1|||
144667393|NCT03250377|521633779|FG001|Overall Study|Investigator's Judgment|0|||
144667394|NCT03250377|521633780|FG002|Overall Study|Investigator's Judgment|0|||
144667395|NCT03250377|521633781|FG003|Overall Study|Investigator's Judgment|0|||
144667396|NCT03250377|521633778|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
144667397|NCT03250377|521633779|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
144667398|NCT03250377|521633780|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
144667399|NCT03250377|521633781|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
144667400|NCT03250377|521633778|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
144667401|NCT03250377|521633779|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
144667402|NCT03250377|521633780|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
144667403|NCT03250377|521633781|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
144667404|NCT03250377|521633778|FG000|Overall Study|Epilepsy Surgery|0|||
144667405|NCT03250377|521633779|FG001|Overall Study|Epilepsy Surgery|1|||
144217598|NCT02906670|519990348|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
144667406|NCT03250377|521633780|FG002|Overall Study|Epilepsy Surgery|2|||
144667407|NCT03250377|521633781|FG003|Overall Study|Epilepsy Surgery|0|||
144667408|NCT03250377|521633778|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
144667409|NCT03250377|521633779|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
144217599|NCT02906670|519990349|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
144667410|NCT03250377|521633780|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
144667411|NCT03250377|521633781|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
144667412|NCT03250377|521633778|FG000|Overall Study|Request From The Sponsor|0|||
144667413|NCT03250377|521633779|FG001|Overall Study|Request From The Sponsor|1|||
144217600|NCT02906670|519990350|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
144667414|NCT03250377|521633780|FG002|Overall Study|Request From The Sponsor|0|||
144217601|NCT02906670|519990351|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
144667415|NCT03250377|521633781|FG003|Overall Study|Request From The Sponsor|0|||
144667416|NCT03250377|521633778|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
144667417|NCT03250377|521633779|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
144667418|NCT03250377|521633780|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
144667419|NCT03250377|521633781|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
144667420|NCT03250377|521633778|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
144667421|NCT03250377|521633779|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
144667422|NCT03250377|521633780|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
144667423|NCT03250377|521633781|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
144667424|NCT03250377|521633778|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
144667425|NCT03250377|521633779|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
144667426|NCT03250377|521633780|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
144667427|NCT03250377|521633781|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
144667428|NCT03250377|521633778|FG000|Overall Study|Pregnancy Event|0|||
144667429|NCT03250377|521633779|FG001|Overall Study|Pregnancy Event|1|||
144667430|NCT03250377|521633780|FG002|Overall Study|Pregnancy Event|0|||
144667431|NCT03250377|521633781|FG003|Overall Study|Pregnancy Event|0|||
144667432|NCT03250377|521633778|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
144667433|NCT03250377|521633779|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
144667434|NCT03250377|521633780|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
144667435|NCT03250377|521633781|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
144667436|NCT03250377|521633778|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
144667437|NCT03250377|521633779|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
144667438|NCT03250377|521633780|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
144667439|NCT03250377|521633781|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
144667440|NCT03250377|521633778|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
144667441|NCT03250377|521633779|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
144667442|NCT03250377|521633780|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
144667443|NCT03250377|521633781|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
144667444|NCT03250377|521633778|FG000|Overall Study|Patient requested to change hospital|0|||
144667445|NCT03250377|521633779|FG001|Overall Study|Patient requested to change hospital|0|||
144667446|NCT03250377|521633780|FG002|Overall Study|Patient requested to change hospital|0|||
144667447|NCT03250377|521633781|FG003|Overall Study|Patient requested to change hospital|1|||
144667448|NCT03250377|521633778|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
144667449|NCT03250377|521633779|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
144667450|NCT03250377|521633780|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
144667451|NCT03250377|521633781|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
144667452|NCT02168803|521633783|FG000|Overall Study|Lost to Follow-up|1|||
144667453|NCT02168803|521633784|FG001|Overall Study|Lost to Follow-up|0|||
144667454|NCT02168803|521633785|FG002|Overall Study|Lost to Follow-up|1|||
144667455|NCT02168803|521633783|FG000|Overall Study|Withdrawal by Subject|1|||
144667456|NCT02168803|521633784|FG001|Overall Study|Withdrawal by Subject|1|||
144667457|NCT02168803|521633785|FG002|Overall Study|Withdrawal by Subject|2|||
144667458|NCT02168803|521633783|FG000|Overall Study|Physician Decision|0|||
144667459|NCT02168803|521633784|FG001|Overall Study|Physician Decision|1|||
144667460|NCT02168803|521633785|FG002|Overall Study|Physician Decision|0|||
144667461|NCT02168803|521633783|FG000|Overall Study|Adverse Event|0|||
144667462|NCT02168803|521633784|FG001|Overall Study|Adverse Event|1|||
144667463|NCT02168803|521633785|FG002|Overall Study|Adverse Event|1|||
144667464|NCT02168803|521633783|FG000|Overall Study|Death|0|||
144667465|NCT02168803|521633784|FG001|Overall Study|Death|0|||
144667466|NCT02168803|521633785|FG002|Overall Study|Death|1|||
144667467|NCT02168803|521633783|FG000|Overall Study|Sponsor Decision|0|||
144667468|NCT02168803|521633784|FG001|Overall Study|Sponsor Decision|0|||
144667469|NCT02168803|521633785|FG002|Overall Study|Sponsor Decision|1|||
144667470|NCT00868166|521633786|FG000|Overall Study|Death|58|||
144667471|NCT00868166|521633787|FG001|Overall Study|Death|65|||
144667472|NCT00868166|521633786|FG000|Overall Study|Withdrawal by Subject|33|||
144667473|NCT00868166|521633787|FG001|Overall Study|Withdrawal by Subject|25|||
144667474|NCT00868166|521633786|FG000|Overall Study|Protocol Violation|1|||
144265578|NCT00853762|520173966|FG001|Overall Study|Randomised but not Treated|2|||
144667475|NCT00868166|521633787|FG001|Overall Study|Protocol Violation|0|||
144667476|NCT00868166|521633786|FG000|Overall Study|Lost to Follow-up|1|||
144667477|NCT00868166|521633787|FG001|Overall Study|Lost to Follow-up|3|||
144667478|NCT00868166|521633786|FG000|Overall Study|Adverse Event|9|||
144667479|NCT00868166|521633787|FG001|Overall Study|Adverse Event|10|||
144667480|NCT00868166|521633786|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
144667481|NCT00868166|521633787|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
144667482|NCT00868166|521633786|FG000|Overall Study|Non-compliance with IMP|1|||
144667483|NCT00868166|521633787|FG001|Overall Study|Non-compliance with IMP|1|||
144667484|NCT02034552|521633792|FG000|Overall Study|Never treated|3|||
144667485|NCT02034552|521633793|FG001|Overall Study|Never treated|2|||
144667486|NCT02034552|521633794|FG002|Overall Study|Never treated|0|||
144667487|NCT02034552|521633792|FG000|Overall Study|Radiological progression|3|||
144667488|NCT02034552|521633793|FG001|Overall Study|Radiological progression|5|||
144667489|NCT02034552|521633794|FG002|Overall Study|Radiological progression|4|||
144667490|NCT02034552|521633792|FG000|Overall Study|AE not assoc. with disease progression|1|||
144667491|NCT02034552|521633793|FG001|Overall Study|AE not assoc. with disease progression|4|||
144667492|NCT02034552|521633794|FG002|Overall Study|AE not assoc. with disease progression|2|||
144667493|NCT02034552|521633792|FG000|Overall Study|AE associated with disease progression|0|||
144667494|NCT02034552|521633793|FG001|Overall Study|AE associated with disease progression|1|||
144667495|NCT02034552|521633794|FG002|Overall Study|AE associated with disease progression|0|||
144667496|NCT02034552|521633792|FG000|Overall Study|Withdrawal by Subject|2|||
144667497|NCT02034552|521633793|FG001|Overall Study|Withdrawal by Subject|1|||
144667498|NCT02034552|521633794|FG002|Overall Study|Withdrawal by Subject|1|||
144667499|NCT02034552|521633792|FG000|Overall Study|Non-compliance with study drug|0|||
144667500|NCT02034552|521633793|FG001|Overall Study|Non-compliance with study drug|0|||
144667501|NCT02034552|521633794|FG002|Overall Study|Non-compliance with study drug|1|||
144667502|NCT02034552|521633792|FG000|Overall Study|Clinical progression|5|||
144667503|NCT02034552|521633793|FG001|Overall Study|Clinical progression|7|||
144667504|NCT02034552|521633794|FG002|Overall Study|Clinical progression|9|||
144667505|NCT02310906|521633795|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
144667506|NCT02310906|521633796|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
144667507|NCT02310906|521633797|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
144667508|NCT02310906|521633798|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
144667509|NCT02310906|521633795|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
144667510|NCT02310906|521633796|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
144667511|NCT02310906|521633797|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
144667512|NCT02310906|521633798|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
144667513|NCT02310906|521633795|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
144667514|NCT02310906|521633796|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
144667515|NCT02310906|521633797|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
144667516|NCT02310906|521633798|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
144667517|NCT02310906|521633795|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
144667518|NCT02310906|521633796|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
144667519|NCT02310906|521633797|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
144667520|NCT02310906|521633798|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
144667521|NCT03819218|521633801|FG000|Overall Study|Protocol Violation|1|||
144667522|NCT02513771|521633802|FG000|Overall Study|Lost to Follow-up|1|||
144667523|NCT02513771|521633803|FG001|Overall Study|Lost to Follow-up|1|||
144667524|NCT02513771|521633802|FG000|Overall Study|Not being able to get to clinic|1|||
144667525|NCT02513771|521633803|FG001|Overall Study|Not being able to get to clinic|0|||
144667526|NCT01797445|521633804|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
144667527|NCT01797445|521633805|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
144667528|NCT01797445|521633804|FG000|Double-Blind Phase|Adverse Event|3|||
144667529|NCT01797445|521633805|FG001|Double-Blind Phase|Adverse Event|0|||
144667530|NCT01797445|521633804|FG000|Double-Blind Phase|Death|5|||
144667531|NCT01797445|521633805|FG001|Double-Blind Phase|Death|4|||
144667532|NCT01797445|521633804|FG000|Double-Blind Phase|Pregnancy|0|||
144667533|NCT01797445|521633805|FG001|Double-Blind Phase|Pregnancy|1|||
144667534|NCT01797445|521633804|FG000|Double-Blind Phase|Lack of Efficacy|1|||
144667535|NCT01797445|521633805|FG001|Double-Blind Phase|Lack of Efficacy|2|||
144667536|NCT01797445|521633804|FG000|Double-Blind Phase|Investigator's Discretion|15|||
144667537|NCT01797445|521633805|FG001|Double-Blind Phase|Investigator's Discretion|17|||
144667538|NCT01797445|521633804|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
144667539|NCT01797445|521633805|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
144667540|NCT01797445|521633804|FG000|Double-Blind Phase|Protocol Violation|0|||
144667541|NCT01797445|521633805|FG001|Double-Blind Phase|Protocol Violation|1|||
144667542|NCT01797445|521633804|FG000|Double-Blind Phase|Withdrew Consent|20|||
144733864|NCT05472038|521883536|FG005|Overall Study|Lost to Follow-up|2|||
144733865|NCT05472038|521883537|FG006|Overall Study|Lost to Follow-up|1|||
144733866|NCT05472038|521883538|FG007|Overall Study|Lost to Follow-up|0|||
144217602|NCT02906670|519990352|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
144667543|NCT01797445|521633805|FG001|Double-Blind Phase|Withdrew Consent|35|||
144667544|NCT01797445|521633804|FG000|Double-Blind Phase|Lost to Follow-up|34|||
144667545|NCT01797445|521633805|FG001|Double-Blind Phase|Lost to Follow-up|26|||
144667546|NCT01797445|521633804|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
144667547|NCT01797445|521633805|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
144667548|NCT01878097|521633806|FG000|Baseline|Surveys not fully completed|2497|||
144667549|NCT01878097|521633807|FG001|Baseline|Surveys not fully completed|1800|||
144667550|NCT01878097|521633806|FG000|Implementation Year 1|Surveys not fully completed|3202|||
144733867|NCT05472038|521883539|FG008|Overall Study|Lost to Follow-up|1|||
144217603|NCT02906670|519990343|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
144217604|NCT02906670|519990344|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
144217605|NCT02906670|519990345|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
144217606|NCT02906670|519990346|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
144217607|NCT02906670|519990347|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
144667551|NCT01878097|521633807|FG001|Implementation Year 1|Surveys not fully completed|2549|||
144667552|NCT01878097|521633806|FG000|Implementation Year 2|Surveys not fully completed|3281|||
144667553|NCT01878097|521633807|FG001|Implementation Year 2|Surveys not fully completed|2841|||
144667554|NCT01878097|521633806|FG000|Implementation Year 3|Surveys not fully completed|3494|||
144667555|NCT01878097|521633807|FG001|Implementation Year 3|Surveys not fully completed|2980|||
144667556|NCT01878097|521633806|FG000|Implementation Year 4|Surveys not fully completed|3604|||
144667557|NCT01878097|521633807|FG001|Implementation Year 4|Surveys not fully completed|3007|||
144667558|NCT01595438|521633810|FG000|Overall Study|Lost to Follow-up|20|||
144667559|NCT01595438|521633811|FG001|Overall Study|Lost to Follow-up|20|||
144667560|NCT01595438|521633810|FG000|Overall Study|Withdrawal by Subject|12|||
144667561|NCT01595438|521633811|FG001|Overall Study|Withdrawal by Subject|12|||
144667562|NCT01595438|521633810|FG000|Overall Study|Other Eligibility criteria|11|||
144667563|NCT01595438|521633811|FG001|Overall Study|Other Eligibility criteria|9|||
144667564|NCT01280266|521633819|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
144667565|NCT01280266|521633820|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
144667566|NCT01280266|521633819|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
144667567|NCT01280266|521633820|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
144667568|NCT00830804|521633825|FG000|Overall Study|Lost to Follow-up|4|||
144667569|NCT00830804|521633825|FG000|Overall Study|Death|1|||
144667570|NCT00830804|521633825|FG000|Overall Study|Unable to get to clinic|7|||
144667571|NCT00830804|521633825|FG000|Overall Study|Consent withdrawn|2|||
144667572|NCT00830804|521633825|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
144667573|NCT00510068|521633831|FG000|Double-blind Period|Disease progression|98|||
144667574|NCT00510068|521633832|FG001|Double-blind Period|Disease progression|169|||
144667575|NCT00510068|521633831|FG000|Double-blind Period|Final primary analysis|52|||
144667576|NCT00510068|521633832|FG001|Double-blind Period|Final primary analysis|18|||
144667577|NCT00510068|521633831|FG000|Double-blind Period|Adverse Event|37|||
144667578|NCT00510068|521633832|FG001|Double-blind Period|Adverse Event|7|||
144667579|NCT00510068|521633831|FG000|Double-blind Period|Withdrawal by Subject|8|||
144667580|NCT00510068|521633832|FG001|Double-blind Period|Withdrawal by Subject|6|||
144667581|NCT00510068|521633831|FG000|Double-blind Period|Death|4|||
144667582|NCT00510068|521633832|FG001|Double-blind Period|Death|3|||
144667583|NCT00510068|521633831|FG000|Double-blind Period|Abnormal test result (s)|1|||
144667584|NCT00510068|521633832|FG001|Double-blind Period|Abnormal test result (s)|0|||
144667585|NCT00510068|521633831|FG000|Double-blind Period|Lost to Follow-up|1|||
144667586|NCT00510068|521633832|FG001|Double-blind Period|Lost to Follow-up|0|||
144667587|NCT00510068|521633831|FG000|Double-blind Period|Protocol Violation|6|||
144667588|NCT00510068|521633832|FG001|Double-blind Period|Protocol Violation|0|||
144667589|NCT00510068|521633831|FG000|Open-label Period|Disease Progression|124|||
144667590|NCT00510068|521633832|FG001|Open-label Period|Disease Progression|0|||
144667591|NCT00510068|521633831|FG000|Open-label Period|Adverse Event|46|||
144667592|NCT00510068|521633832|FG001|Open-label Period|Adverse Event|0|||
144733868|NCT05472038|521883540|FG009|Overall Study|Lost to Follow-up|0|||
144733869|NCT05472038|521883541|FG010|Overall Study|Lost to Follow-up|2|||
144733870|NCT05472038|521883542|FG011|Overall Study|Lost to Follow-up|1|||
144217608|NCT02906670|519990348|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
144217609|NCT02906670|519990349|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
144217610|NCT02906670|519990350|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
144217611|NCT02906670|519990351|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
144217612|NCT02906670|519990352|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
144217613|NCT02906670|519990343|FG000|Cohort 4P, QW|Radiological Progression|0|||
144217614|NCT02906670|519990344|FG001|Cohort 4P, QW|Radiological Progression|0|||
144217615|NCT02906670|519990345|FG002|Cohort 4P, QW|Radiological Progression|0|||
144217616|NCT02906670|519990346|FG003|Cohort 4P, QW|Radiological Progression|3|||
144217617|NCT02906670|519990347|FG004|Cohort 4P, QW|Radiological Progression|0|||
144217618|NCT02906670|519990348|FG005|Cohort 4P, QW|Radiological Progression|0|||
144733871|NCT05472038|521883531|FG000|Overall Study|Physician Decision|0|||
144217619|NCT02906670|519990349|FG006|Cohort 4P, QW|Radiological Progression|0|||
144217620|NCT02906670|519990350|FG007|Cohort 4P, QW|Radiological Progression|0|||
144217621|NCT02906670|519990351|FG008|Cohort 4P, QW|Radiological Progression|0|||
144733872|NCT05472038|521883532|FG001|Overall Study|Physician Decision|0|||
144667593|NCT00510068|521633831|FG000|Open-label Period|Withdrawal by Subject|21|||
144667594|NCT00510068|521633832|FG001|Open-label Period|Withdrawal by Subject|0|||
144667595|NCT00510068|521633831|FG000|Open-label Period|Administrative problems|17|||
144667596|NCT00510068|521633832|FG001|Open-label Period|Administrative problems|0|||
144667597|NCT00510068|521633831|FG000|Open-label Period|Death|7|||
144667598|NCT00510068|521633832|FG001|Open-label Period|Death|0|||
144667599|NCT00510068|521633831|FG000|Open-label Period|New cancer therapy|7|||
144667600|NCT00510068|521633832|FG001|Open-label Period|New cancer therapy|0|||
144733873|NCT05472038|521883533|FG002|Overall Study|Physician Decision|0|||
144733874|NCT05472038|521883534|FG003|Overall Study|Physician Decision|0|||
144667601|NCT00510068|521633831|FG000|Open-label Period|Protocol Violation|2|||
144667602|NCT00510068|521633832|FG001|Open-label Period|Protocol Violation|0|||
144667603|NCT00510068|521633831|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
144667604|NCT00510068|521633832|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
144667605|NCT00400712|521633833|FG000|Overall Study|Death|1|||
144667606|NCT00400712|521633834|FG001|Overall Study|Death|0|||
144667607|NCT00400712|521633833|FG000|Overall Study|Withdrawal by Subject|11|||
144667608|NCT00400712|521633834|FG001|Overall Study|Withdrawal by Subject|12|||
144667609|NCT00400712|521633833|FG000|Overall Study|Physician Decision|5|||
144667610|NCT00400712|521633834|FG001|Overall Study|Physician Decision|4|||
144667611|NCT00776555|521633835|FG000|Overall Study|Study terminated|3|||
144667612|NCT00776555|521633836|FG001|Overall Study|Study terminated|0|||
144667613|NCT01890512|521633839|FG000|Overall Study|Physician Decision|1|||
144667614|NCT01890512|521633839|FG000|Overall Study|Withdrawal by Subject|1|||
144667615|NCT01890512|521633839|FG000|Overall Study|Protocol Violation|1|||
144667616|NCT01529385|521633840|FG000|Overall Study|Lost to Follow-up|2|||
144667617|NCT01529385|521633841|FG001|Overall Study|Lost to Follow-up|1|||
144667618|NCT01401465|521633842|FG000|Treatment Period 1|Adverse Event|4|||
144667619|NCT01401465|521633843|FG001|Treatment Period 1|Adverse Event|1|||
144667620|NCT01401465|521633842|FG000|Treatment Period 1|Pregnancy|0|||
144667621|NCT01401465|521633843|FG001|Treatment Period 1|Pregnancy|1|||
144667622|NCT01401465|521633842|FG000|Treatment Period 1|Protocol Violation|5|||
144667623|NCT01401465|521633843|FG001|Treatment Period 1|Protocol Violation|0|||
144667624|NCT01401465|521633842|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144667625|NCT01401465|521633843|FG001|Treatment Period 1|Withdrawal by Subject|4|||
144667626|NCT01401465|521633842|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
144667627|NCT01401465|521633843|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
144667628|NCT01401465|521633842|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
144667629|NCT01401465|521633843|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
144667630|NCT01401465|521633842|FG000|Treatment Period 1|Scheduling Difficulties|1|||
144667631|NCT01401465|521633843|FG001|Treatment Period 1|Scheduling Difficulties|1|||
144667632|NCT01401465|521633842|FG000|Treatment Period 2|Lost to Follow-up|0|||
144667633|NCT01401465|521633843|FG001|Treatment Period 2|Lost to Follow-up|1|||
144667634|NCT01401465|521633842|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144667635|NCT01401465|521633843|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144667636|NCT00575094|521633846|FG000|Overall Study|Adverse Event|2|||
144667637|NCT00575094|521633846|FG000|Overall Study|Withdrawal by Subject|1|||
144667638|NCT00772382|521633847|FG000|Overall Study|Adverse Event|19|||
144667639|NCT00772382|521633847|FG000|Overall Study|Death|6|||
144667640|NCT00772382|521633847|FG000|Overall Study|Lack of Efficacy|4|||
144667641|NCT00772382|521633847|FG000|Overall Study|Physician Decision|5|||
144667642|NCT00772382|521633847|FG000|Overall Study|Protocol Violation|1|||
144667643|NCT00772382|521633847|FG000|Overall Study|Withdrawal by Subject|10|||
144667644|NCT00772382|521633847|FG000|Overall Study|Other Reasons|10|||
144667645|NCT00643604|521633848|FG000|Overall Study|Death|1|||
144667646|NCT02721251|521633851|FG000|Overall Study|Withdrawal by Subject|8|||
144667647|NCT02721251|521633852|FG001|Overall Study|Withdrawal by Subject|7|||
144667648|NCT02721251|521633853|FG002|Overall Study|Withdrawal by Subject|9|||
144667649|NCT02721251|521633851|FG000|Overall Study|poor adherence|2|||
144667650|NCT02721251|521633852|FG001|Overall Study|poor adherence|2|||
144667651|NCT02721251|521633853|FG002|Overall Study|poor adherence|2|||
144667652|NCT02921763|521633854|FG000|Overall Study|Adverse Event|4|||
144667653|NCT02921763|521633854|FG000|Overall Study|Lost to Follow-up|4|||
144667654|NCT02921763|521633854|FG000|Overall Study|Lack of Efficacy|3|||
144667655|NCT02921763|521633854|FG000|Overall Study|Protocol Violation|2|||
144667656|NCT02921763|521633854|FG000|Overall Study|Withdrawal by Subject|2|||
144667657|NCT02921763|521633854|FG000|Overall Study|Physician Decision|1|||
144667658|NCT02921763|521633854|FG000|Overall Study|No data obtained|2|||
144667659|NCT00862121|521633859|FG000|Overall Study|Adverse Event|1|||
144733875|NCT05472038|521883535|FG004|Overall Study|Physician Decision|1|||
144667660|NCT00862121|521633860|FG001|Overall Study|Adverse Event|2|||
144667661|NCT00862121|521633859|FG000|Overall Study|Lack of Efficacy|0|||
144667662|NCT00862121|521633860|FG001|Overall Study|Lack of Efficacy|3|||
144667663|NCT00862121|521633859|FG000|Overall Study|Protocol Violation|0|||
144667664|NCT00862121|521633860|FG001|Overall Study|Protocol Violation|1|||
144667665|NCT00862121|521633859|FG000|Overall Study|Exclusion criterion violation|0|||
144667666|NCT00862121|521633860|FG001|Overall Study|Exclusion criterion violation|1|||
144667667|NCT00862121|521633859|FG000|Overall Study|Incorrect randomisation|0|||
144667668|NCT00862121|521633860|FG001|Overall Study|Incorrect randomisation|1|||
144667669|NCT01582971|521633861|FG000|Overall Study|Death|2|||
144667670|NCT01582971|521633862|FG001|Overall Study|Death|1|||
144667671|NCT01582971|521633861|FG000|Overall Study|Lost to Follow-up|18|||
144667672|NCT01582971|521633862|FG001|Overall Study|Lost to Follow-up|21|||
144667673|NCT01582971|521633861|FG000|Overall Study|Withdrawal by Subject|4|||
144667674|NCT01582971|521633862|FG001|Overall Study|Withdrawal by Subject|2|||
144667675|NCT01582971|521633861|FG000|Overall Study|Other|15|||
144667676|NCT01582971|521633862|FG001|Overall Study|Other|13|||
144667677|NCT02007954|521633863|FG000|Overall Study|Received liver transplant|3|||
144667678|NCT02007954|521633863|FG000|Overall Study|Switch in treatment modality|2|||
144667679|NCT02007954|521633863|FG000|Overall Study|Disease progression and unrelated AE|1|||
144667680|NCT02007954|521633863|FG000|Overall Study|Death|1|||
144667681|NCT01054976|521633868|FG000|Overall Study|Adverse Event|16|||
144667682|NCT01054976|521633868|FG000|Overall Study|Uncooperative participations to study|7|||
144667683|NCT01054976|521633868|FG000|Overall Study|Withdrawal by Subject|4|||
144667684|NCT01054976|521633868|FG000|Overall Study|Other|8|||
144667685|NCT01195363|521633870|FG000|Overall Study|Lost to Follow-up|7|||
144667686|NCT01195363|521633871|FG001|Overall Study|Lost to Follow-up|4|||
144667687|NCT01195363|521633870|FG000|Overall Study|Adverse Event|3|||
144667688|NCT01195363|521633871|FG001|Overall Study|Adverse Event|1|||
144667689|NCT01195363|521633870|FG000|Overall Study|Lack of Efficacy|0|||
144667690|NCT01195363|521633871|FG001|Overall Study|Lack of Efficacy|4|||
144667691|NCT01195363|521633870|FG000|Overall Study|incarceration|1|||
144667692|NCT01195363|521633871|FG001|Overall Study|incarceration|0|||
144667693|NCT01763866|521633873|FG000|Overall Study|Withdrawal by Subject|2|||
144667694|NCT01763866|521633874|FG001|Overall Study|Withdrawal by Subject|1|||
144667695|NCT01763866|521633875|FG002|Overall Study|Withdrawal by Subject|4|||
144667696|NCT01763866|521633876|FG003|Overall Study|Withdrawal by Subject|0|||
144667697|NCT01763866|521633877|FG004|Overall Study|Withdrawal by Subject|0|||
144667698|NCT01763866|521633878|FG005|Overall Study|Withdrawal by Subject|3|||
144667699|NCT01763866|521633879|FG006|Overall Study|Withdrawal by Subject|4|||
144667700|NCT01763866|521633880|FG007|Overall Study|Withdrawal by Subject|0|||
144667701|NCT01763866|521633881|FG008|Overall Study|Withdrawal by Subject|1|||
144667702|NCT01763866|521633882|FG009|Overall Study|Withdrawal by Subject|1|||
144667703|NCT01763866|521633883|FG010|Overall Study|Withdrawal by Subject|2|||
144667704|NCT01763866|521633884|FG011|Overall Study|Withdrawal by Subject|2|||
144667705|NCT01763866|521633885|FG012|Overall Study|Withdrawal by Subject|2|||
144667706|NCT01763866|521633886|FG013|Overall Study|Withdrawal by Subject|0|||
144667707|NCT01763866|521633887|FG014|Overall Study|Withdrawal by Subject|6|||
144667708|NCT01763866|521633888|FG015|Overall Study|Withdrawal by Subject|3|||
144667709|NCT01763866|521633889|FG016|Overall Study|Withdrawal by Subject|0|||
144667710|NCT01763866|521633890|FG017|Overall Study|Withdrawal by Subject|1|||
144667711|NCT01763866|521633891|FG018|Overall Study|Withdrawal by Subject|1|||
144667712|NCT01763866|521633892|FG019|Overall Study|Withdrawal by Subject|1|||
144667713|NCT01763866|521633893|FG020|Overall Study|Withdrawal by Subject|2|||
144667714|NCT01763866|521633894|FG021|Overall Study|Withdrawal by Subject|1|||
144667715|NCT01763866|521633895|FG022|Overall Study|Withdrawal by Subject|2|||
144667716|NCT01763866|521633896|FG023|Overall Study|Withdrawal by Subject|1|||
144667717|NCT01763866|521633873|FG000|Overall Study|Decision by sponsor|0|||
144667718|NCT01763866|521633874|FG001|Overall Study|Decision by sponsor|0|||
144667719|NCT01763866|521633875|FG002|Overall Study|Decision by sponsor|1|||
144667720|NCT01763866|521633876|FG003|Overall Study|Decision by sponsor|0|||
144667721|NCT01763866|521633877|FG004|Overall Study|Decision by sponsor|2|||
144667722|NCT01763866|521633878|FG005|Overall Study|Decision by sponsor|0|||
144667723|NCT01763866|521633879|FG006|Overall Study|Decision by sponsor|2|||
144667724|NCT01763866|521633880|FG007|Overall Study|Decision by sponsor|0|||
144667725|NCT01763866|521633881|FG008|Overall Study|Decision by sponsor|2|||
144667726|NCT01763866|521633882|FG009|Overall Study|Decision by sponsor|0|||
144667727|NCT01763866|521633883|FG010|Overall Study|Decision by sponsor|6|||
144667728|NCT01763866|521633884|FG011|Overall Study|Decision by sponsor|0|||
144667729|NCT01763866|521633885|FG012|Overall Study|Decision by sponsor|1|||
144667730|NCT01763866|521633886|FG013|Overall Study|Decision by sponsor|0|||
144667731|NCT01763866|521633887|FG014|Overall Study|Decision by sponsor|5|||
144667732|NCT01763866|521633888|FG015|Overall Study|Decision by sponsor|0|||
144667733|NCT01763866|521633889|FG016|Overall Study|Decision by sponsor|0|||
144667734|NCT01763866|521633890|FG017|Overall Study|Decision by sponsor|0|||
144667735|NCT01763866|521633891|FG018|Overall Study|Decision by sponsor|4|||
144667736|NCT01763866|521633892|FG019|Overall Study|Decision by sponsor|0|||
144667737|NCT01763866|521633893|FG020|Overall Study|Decision by sponsor|2|||
144667738|NCT01763866|521633894|FG021|Overall Study|Decision by sponsor|0|||
144667739|NCT01763866|521633895|FG022|Overall Study|Decision by sponsor|1|||
144667740|NCT01763866|521633896|FG023|Overall Study|Decision by sponsor|0|||
144667741|NCT01763866|521633873|FG000|Overall Study|Lost to Follow-up|0|||
144667742|NCT01763866|521633874|FG001|Overall Study|Lost to Follow-up|0|||
144667743|NCT01763866|521633875|FG002|Overall Study|Lost to Follow-up|0|||
144667744|NCT01763866|521633876|FG003|Overall Study|Lost to Follow-up|0|||
144667745|NCT01763866|521633877|FG004|Overall Study|Lost to Follow-up|0|||
144667746|NCT01763866|521633878|FG005|Overall Study|Lost to Follow-up|0|||
144667747|NCT01763866|521633879|FG006|Overall Study|Lost to Follow-up|1|||
144667748|NCT01763866|521633880|FG007|Overall Study|Lost to Follow-up|0|||
144667749|NCT01763866|521633881|FG008|Overall Study|Lost to Follow-up|0|||
144667750|NCT01763866|521633882|FG009|Overall Study|Lost to Follow-up|0|||
144667751|NCT01763866|521633883|FG010|Overall Study|Lost to Follow-up|0|||
144667752|NCT01763866|521633884|FG011|Overall Study|Lost to Follow-up|0|||
144667753|NCT01763866|521633885|FG012|Overall Study|Lost to Follow-up|1|||
144667754|NCT01763866|521633886|FG013|Overall Study|Lost to Follow-up|0|||
144667755|NCT01763866|521633887|FG014|Overall Study|Lost to Follow-up|1|||
144667756|NCT01763866|521633888|FG015|Overall Study|Lost to Follow-up|0|||
144667757|NCT01763866|521633889|FG016|Overall Study|Lost to Follow-up|0|||
144667758|NCT01763866|521633890|FG017|Overall Study|Lost to Follow-up|0|||
144667759|NCT01763866|521633891|FG018|Overall Study|Lost to Follow-up|1|||
144667760|NCT01763866|521633892|FG019|Overall Study|Lost to Follow-up|1|||
144667761|NCT01763866|521633893|FG020|Overall Study|Lost to Follow-up|0|||
144667762|NCT01763866|521633894|FG021|Overall Study|Lost to Follow-up|0|||
144667763|NCT01763866|521633895|FG022|Overall Study|Lost to Follow-up|0|||
144667764|NCT01763866|521633896|FG023|Overall Study|Lost to Follow-up|1|||
144667765|NCT01763866|521633873|FG000|Overall Study|Death|0|||
144667766|NCT01763866|521633874|FG001|Overall Study|Death|0|||
144667767|NCT01763866|521633875|FG002|Overall Study|Death|0|||
144667768|NCT01763866|521633876|FG003|Overall Study|Death|0|||
144667769|NCT01763866|521633877|FG004|Overall Study|Death|0|||
144667770|NCT01763866|521633878|FG005|Overall Study|Death|0|||
144667771|NCT01763866|521633879|FG006|Overall Study|Death|0|||
144667772|NCT01763866|521633880|FG007|Overall Study|Death|0|||
144667773|NCT01763866|521633881|FG008|Overall Study|Death|0|||
144667774|NCT01763866|521633882|FG009|Overall Study|Death|0|||
144667775|NCT01763866|521633883|FG010|Overall Study|Death|0|||
144667776|NCT01763866|521633884|FG011|Overall Study|Death|0|||
144667777|NCT01763866|521633885|FG012|Overall Study|Death|0|||
144667778|NCT01763866|521633886|FG013|Overall Study|Death|0|||
144667779|NCT01763866|521633887|FG014|Overall Study|Death|0|||
144667780|NCT01763866|521633888|FG015|Overall Study|Death|0|||
144667781|NCT01763866|521633889|FG016|Overall Study|Death|1|||
144667782|NCT01763866|521633890|FG017|Overall Study|Death|0|||
144667783|NCT01763866|521633891|FG018|Overall Study|Death|0|||
144667784|NCT01763866|521633892|FG019|Overall Study|Death|0|||
144667785|NCT01763866|521633893|FG020|Overall Study|Death|0|||
144667786|NCT01763866|521633894|FG021|Overall Study|Death|0|||
144667787|NCT01763866|521633895|FG022|Overall Study|Death|0|||
144667788|NCT01763866|521633896|FG023|Overall Study|Death|0|||
144667789|NCT00171314|521633900|FG000|Overall Study|Adverse Event|44|||
144667790|NCT00171314|521633901|FG001|Overall Study|Adverse Event|41|||
144667791|NCT00171314|521633900|FG000|Overall Study|Lack of Efficacy|19|||
144667792|NCT00171314|521633901|FG001|Overall Study|Lack of Efficacy|14|||
144667793|NCT00171314|521633900|FG000|Overall Study|Withdrawal by Subject|9|||
144667794|NCT00171314|521633901|FG001|Overall Study|Withdrawal by Subject|6|||
144667795|NCT00171314|521633900|FG000|Overall Study|Abnormal Test Procedure Results|9|||
144667796|NCT00171314|521633901|FG001|Overall Study|Abnormal Test Procedure Results|3|||
144667797|NCT00171314|521633900|FG000|Overall Study|Protocol Violation|3|||
144667798|NCT00171314|521633901|FG001|Overall Study|Protocol Violation|7|||
144667799|NCT00171314|521633900|FG000|Overall Study|Administrative Problems|4|||
144667800|NCT00171314|521633901|FG001|Overall Study|Administrative Problems|3|||
144667801|NCT00171314|521633900|FG000|Overall Study|Lost to Follow-up|1|||
144667802|NCT00171314|521633901|FG001|Overall Study|Lost to Follow-up|3|||
144667803|NCT00171314|521633900|FG000|Overall Study|Death|2|||
144667804|NCT00171314|521633901|FG001|Overall Study|Death|1|||
144667805|NCT01669811|521633902|FG000|Overall Study|Investigator decision|0|||
144667806|NCT01669811|521633903|FG001|Overall Study|Investigator decision|1|||
144667807|NCT01669811|521633902|FG000|Overall Study|Withdrawal by Subject|1|||
144667808|NCT01669811|521633903|FG001|Overall Study|Withdrawal by Subject|2|||
144667809|NCT01669811|521633902|FG000|Overall Study|Adverse Event|2|||
144667810|NCT01669811|521633903|FG001|Overall Study|Adverse Event|6|||
144667811|NCT01669811|521633902|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144667812|NCT01669811|521633903|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
144667813|NCT03337139|521633904|FG000|Phase I|Withdrawal by Subject|10|||
144667814|NCT03337139|521633905|FG001|Phase I|Withdrawal by Subject|0|||
144667815|NCT03288493|521633906|FG000|Overall Study|Withdrawal by Subject|4|||
144667816|NCT03288493|521633907|FG001|Overall Study|Withdrawal by Subject|0|||
144667817|NCT03288493|521633908|FG002|Overall Study|Withdrawal by Subject|0|||
144667818|NCT03288493|521633909|FG003|Overall Study|Withdrawal by Subject|0|||
144667819|NCT03288493|521633910|FG004|Overall Study|Withdrawal by Subject|0|||
144667820|NCT03288493|521633911|FG005|Overall Study|Withdrawal by Subject|2|||
144667821|NCT03288493|521633912|FG006|Overall Study|Withdrawal by Subject|0|||
144667822|NCT03288493|521633906|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
144667823|NCT03288493|521633907|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
144217622|NCT02906670|519990352|FG009|Cohort 4P, QW|Radiological Progression|0|||
144667824|NCT03288493|521633908|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
144217623|NCT02906670|519990343|FG000|Cohort 7P, Q2W|Adverse Event|0|||
144217624|NCT02906670|519990344|FG001|Cohort 7P, Q2W|Adverse Event|0|||
144217625|NCT02906670|519990345|FG002|Cohort 7P, Q2W|Adverse Event|0|||
144217626|NCT02906670|519990346|FG003|Cohort 7P, Q2W|Adverse Event|0|||
144667825|NCT03288493|521633909|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
144667826|NCT03288493|521633910|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
144667827|NCT03288493|521633911|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
144667828|NCT03288493|521633912|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
144667829|NCT03288493|521633906|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
144667830|NCT03288493|521633907|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
144667831|NCT03288493|521633908|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
144667832|NCT03288493|521633909|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
144667833|NCT03288493|521633910|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
144667834|NCT03288493|521633911|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
144667835|NCT03288493|521633912|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
144667836|NCT03288493|521633906|FG000|Overall Study|Death|2|||
144667837|NCT03288493|521633907|FG001|Overall Study|Death|0|||
144667838|NCT03288493|521633908|FG002|Overall Study|Death|0|||
144667839|NCT03288493|521633909|FG003|Overall Study|Death|0|||
144667840|NCT03288493|521633910|FG004|Overall Study|Death|0|||
144667841|NCT03288493|521633911|FG005|Overall Study|Death|0|||
144667842|NCT03288493|521633912|FG006|Overall Study|Death|0|||
144667843|NCT03288493|521633906|FG000|Overall Study|other reason not listed above|2|||
144667844|NCT03288493|521633907|FG001|Overall Study|other reason not listed above|0|||
144667845|NCT03288493|521633908|FG002|Overall Study|other reason not listed above|0|||
144667846|NCT03288493|521633909|FG003|Overall Study|other reason not listed above|0|||
144667847|NCT03288493|521633910|FG004|Overall Study|other reason not listed above|0|||
144667848|NCT03288493|521633911|FG005|Overall Study|other reason not listed above|0|||
144667849|NCT03288493|521633912|FG006|Overall Study|other reason not listed above|0|||
144667850|NCT00949910|521635880|FG000|Overall Study|Progressive Disease|3750|||
144667851|NCT00949910|521635880|FG000|Overall Study|Symptomatic Deterioration|1088|||
144667852|NCT00949910|521635880|FG000|Overall Study|Lost to Follow-up|100|||
144667853|NCT00949910|521635880|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
144667854|NCT00949910|521635880|FG000|Overall Study|Participant Refusal|390|||
144667855|NCT00949910|521635880|FG000|Overall Study|Death Due to Malignant Disease|456|||
144667856|NCT00949910|521635880|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
144667857|NCT00949910|521635880|FG000|Overall Study|Death Due to Adverse Event|115|||
144667858|NCT00949910|521635880|FG000|Overall Study|Death Due to Toxicity|3|||
144667859|NCT00949910|521635880|FG000|Overall Study|Death from Unknown Cause|5|||
144667860|NCT00949910|521635880|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
144667861|NCT00949910|521635880|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
144667862|NCT00949910|521635880|FG000|Overall Study|Switched to Commercial Treatment|4|||
144667863|NCT00949910|521635880|FG000|Overall Study|Violation of Eligibility|23|||
144667864|NCT00949910|521635880|FG000|Overall Study|Logistical Reasons|13|||
144667865|NCT00949910|521635880|FG000|Overall Study|Non-Compliance|10|||
144667866|NCT00949910|521635880|FG000|Overall Study|Prolonged Dosing Interruption|4|||
144667867|NCT00949910|521635880|FG000|Overall Study|Adverse Event|83|||
144667868|NCT00949910|521635880|FG000|Overall Study|Serious Adverse Event|6|||
144667869|NCT00949910|521635880|FG000|Overall Study|Physician/Participant Decision|7|||
144667870|NCT00949910|521635880|FG000|Overall Study|Other|4|||
144667871|NCT00949910|521635880|FG000|Overall Study|No Data|9|||
144667872|NCT03287869|521635883|FG000|Overall Study|Adverse Event|14|||
144667873|NCT03287869|521635884|FG001|Overall Study|Adverse Event|12|||
144667874|NCT03287869|521635883|FG000|Overall Study|Lack of Efficacy|1|||
144217627|NCT02906670|519990347|FG004|Cohort 7P, Q2W|Adverse Event|0|||
144217628|NCT02906670|519990348|FG005|Cohort 7P, Q2W|Adverse Event|0|||
144217629|NCT02906670|519990349|FG006|Cohort 7P, Q2W|Adverse Event|0|||
144217630|NCT02906670|519990350|FG007|Cohort 7P, Q2W|Adverse Event|0|||
144217631|NCT02906670|519990351|FG008|Cohort 7P, Q2W|Adverse Event|0|||
144217632|NCT02906670|519990352|FG009|Cohort 7P, Q2W|Adverse Event|1|||
144217633|NCT02906670|519990343|FG000|Cohort 7P, Q2W|Physician Decision|0|||
144217634|NCT02906670|519990344|FG001|Cohort 7P, Q2W|Physician Decision|0|||
144217635|NCT02906670|519990345|FG002|Cohort 7P, Q2W|Physician Decision|0|||
144217636|NCT02906670|519990346|FG003|Cohort 7P, Q2W|Physician Decision|0|||
144217637|NCT02906670|519990347|FG004|Cohort 7P, Q2W|Physician Decision|0|||
144217638|NCT02906670|519990348|FG005|Cohort 7P, Q2W|Physician Decision|0|||
144217639|NCT02906670|519990349|FG006|Cohort 7P, Q2W|Physician Decision|0|||
144217640|NCT02906670|519990350|FG007|Cohort 7P, Q2W|Physician Decision|0|||
144217641|NCT02906670|519990351|FG008|Cohort 7P, Q2W|Physician Decision|0|||
144217642|NCT02906670|519990352|FG009|Cohort 7P, Q2W|Physician Decision|1|||
144667875|NCT03287869|521635884|FG001|Overall Study|Lack of Efficacy|0|||
144217643|NCT02906670|519990343|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217644|NCT02906670|519990344|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217645|NCT02906670|519990345|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144667876|NCT03287869|521635883|FG000|Overall Study|Lost to Follow-up|13|||
144667877|NCT03287869|521635884|FG001|Overall Study|Lost to Follow-up|19|||
144733876|NCT05472038|521883536|FG005|Overall Study|Physician Decision|0|||
144733877|NCT05472038|521883537|FG006|Overall Study|Physician Decision|0|||
144217646|NCT02906670|519990346|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144667878|NCT03287869|521635883|FG000|Overall Study|Non-Compliance With Study Drug|5|||
144667879|NCT03287869|521635884|FG001|Overall Study|Non-Compliance With Study Drug|9|||
144667880|NCT03287869|521635883|FG000|Overall Study|Progressive Disease|1|||
144667881|NCT03287869|521635884|FG001|Overall Study|Progressive Disease|0|||
144667882|NCT03287869|521635883|FG000|Overall Study|Protocol Deviation|2|||
144667883|NCT03287869|521635884|FG001|Overall Study|Protocol Deviation|1|||
144667884|NCT03287869|521635883|FG000|Overall Study|Withdrawal by Subject|36|||
144667885|NCT03287869|521635884|FG001|Overall Study|Withdrawal by Subject|43|||
144667886|NCT03287869|521635883|FG000|Overall Study|Early Closure of the Site|0|||
144667887|NCT03287869|521635884|FG001|Overall Study|Early Closure of the Site|1|||
144667888|NCT03287869|521635883|FG000|Overall Study|Physician Decision|5|||
144667889|NCT03287869|521635884|FG001|Overall Study|Physician Decision|5|||
144667890|NCT03287869|521635883|FG000|Overall Study|Reason not Specified|6|||
144667891|NCT03287869|521635884|FG001|Overall Study|Reason not Specified|3|||
144667892|NCT00640146|521635889|FG000|Overall Study|Adverse Event|2|||
144667893|NCT00640146|521635890|FG001|Overall Study|Adverse Event|0|||
144667894|NCT00640146|521635889|FG000|Overall Study|Lost to Follow-up|0|||
144667895|NCT00640146|521635890|FG001|Overall Study|Lost to Follow-up|1|||
144667896|NCT00640146|521635889|FG000|Overall Study|Lack of Efficacy|0|||
144667897|NCT00640146|521635890|FG001|Overall Study|Lack of Efficacy|1|||
144667898|NCT00640146|521635889|FG000|Overall Study|Withdrawal by Subject|1|||
144667899|NCT00640146|521635890|FG001|Overall Study|Withdrawal by Subject|1|||
144667900|NCT00640146|521635889|FG000|Overall Study|Randomized but not treated|1|||
144667901|NCT00640146|521635890|FG001|Overall Study|Randomized but not treated|3|||
144667902|NCT02455388|521635891|FG000|Overall Study|Protocol Violation|1|||
144667903|NCT02455388|521635892|FG001|Overall Study|Protocol Violation|0|||
144667904|NCT02455388|521635893|FG002|Overall Study|Protocol Violation|4|||
144667905|NCT02455388|521635891|FG000|Overall Study|Withdrawal by Subject|0|||
144667906|NCT02455388|521635892|FG001|Overall Study|Withdrawal by Subject|0|||
144667907|NCT02455388|521635893|FG002|Overall Study|Withdrawal by Subject|7|||
144667908|NCT04847141|521635894|FG000|Overall Study|Adverse Event|1|||
144667909|NCT04847141|521635895|FG001|Overall Study|Adverse Event|0|||
144667910|NCT04847141|521635896|FG002|Overall Study|Adverse Event|1|||
144667911|NCT04847141|521635894|FG000|Overall Study|Withdrawal by Subject|2|||
144667912|NCT04847141|521635895|FG001|Overall Study|Withdrawal by Subject|4|||
144667913|NCT04847141|521635896|FG002|Overall Study|Withdrawal by Subject|3|||
144667914|NCT04847141|521635894|FG000|Overall Study|Lost to Follow-up|7|||
144667915|NCT04847141|521635895|FG001|Overall Study|Lost to Follow-up|5|||
144667916|NCT04847141|521635896|FG002|Overall Study|Lost to Follow-up|7|||
144667917|NCT04847141|521635894|FG000|Overall Study|Reason not Specified|0|||
144667918|NCT04847141|521635895|FG001|Overall Study|Reason not Specified|1|||
144667919|NCT04847141|521635896|FG002|Overall Study|Reason not Specified|0|||
144667920|NCT00324740|521635897|FG000|Overall Study|Withdrawal by Subject|1|||
144667921|NCT00324740|521635898|FG001|Overall Study|Withdrawal by Subject|0|||
144667922|NCT00324740|521635899|FG002|Overall Study|Withdrawal by Subject|1|||
144667923|NCT00520299|521635902|FG000|Overall Study|Withdrawal by Subject|0|||
144667924|NCT00520299|521635903|FG001|Overall Study|Withdrawal by Subject|0|||
144667925|NCT00520299|521635904|FG002|Overall Study|Withdrawal by Subject|2|||
144667926|NCT00520299|521635902|FG000|Overall Study|Progressive disease|0|||
144667927|NCT00520299|521635903|FG001|Overall Study|Progressive disease|3|||
144667928|NCT00520299|521635904|FG002|Overall Study|Progressive disease|4|||
144667929|NCT00971425|521635908|FG000|Overall Study|Adverse Event|1|||
144667930|NCT00971425|521635909|FG001|Overall Study|Adverse Event|1|||
144667931|NCT00971425|521635908|FG000|Overall Study|Withdrawal by Subject|0|||
144667932|NCT00971425|521635909|FG001|Overall Study|Withdrawal by Subject|1|||
144667933|NCT01357980|521635912|FG000|Overall Study|Lack of Efficacy|0|||
144667934|NCT01357980|521635913|FG001|Overall Study|Lack of Efficacy|1|||
144667935|NCT01357980|521635914|FG002|Overall Study|Lack of Efficacy|0|||
144667936|NCT01357980|521635915|FG003|Overall Study|Lack of Efficacy|0|||
144667937|NCT01357980|521635912|FG000|Overall Study|Consent withdrawn|0|||
144667938|NCT01357980|521635913|FG001|Overall Study|Consent withdrawn|0|||
144667939|NCT01357980|521635914|FG002|Overall Study|Consent withdrawn|1|||
144667940|NCT01357980|521635915|FG003|Overall Study|Consent withdrawn|0|||
144667941|NCT02528253|521635916|FG000|Overall Study|Adverse Event|3|||
144667942|NCT02528253|521635917|FG001|Overall Study|Adverse Event|4|||
144667943|NCT02528253|521635918|FG002|Overall Study|Adverse Event|4|||
144667944|NCT02528253|521635919|FG003|Overall Study|Adverse Event|8|||
144667945|NCT02528253|521635920|FG004|Overall Study|Adverse Event|18|||
144667946|NCT02528253|521635916|FG000|Overall Study|Death|2|||
144667947|NCT02528253|521635917|FG001|Overall Study|Death|2|||
144667948|NCT02528253|521635918|FG002|Overall Study|Death|1|||
144667949|NCT02528253|521635919|FG003|Overall Study|Death|0|||
144667950|NCT02528253|521635920|FG004|Overall Study|Death|1|||
144667951|NCT02528253|521635916|FG000|Overall Study|Insufficient clinical response|7|||
144667952|NCT02528253|521635917|FG001|Overall Study|Insufficient clinical response|10|||
144667953|NCT02528253|521635918|FG002|Overall Study|Insufficient clinical response|13|||
144667954|NCT02528253|521635919|FG003|Overall Study|Insufficient clinical response|12|||
144667955|NCT02528253|521635920|FG004|Overall Study|Insufficient clinical response|16|||
144667956|NCT02528253|521635916|FG000|Overall Study|Lost to Follow-up|16|||
144667957|NCT02528253|521635917|FG001|Overall Study|Lost to Follow-up|9|||
144667958|NCT02528253|521635918|FG002|Overall Study|Lost to Follow-up|31|||
144667959|NCT02528253|521635919|FG003|Overall Study|Lost to Follow-up|16|||
144667960|NCT02528253|521635920|FG004|Overall Study|Lost to Follow-up|34|||
144667961|NCT02528253|521635916|FG000|Overall Study|Other|21|||
144667962|NCT02528253|521635917|FG001|Overall Study|Other|22|||
144667963|NCT02528253|521635918|FG002|Overall Study|Other|58|||
144667964|NCT02528253|521635919|FG003|Overall Study|Other|52|||
144667965|NCT02528253|521635920|FG004|Overall Study|Other|76|||
144667966|NCT02528253|521635916|FG000|Overall Study|Withdrawal by Subject|25|||
144667967|NCT02528253|521635917|FG001|Overall Study|Withdrawal by Subject|20|||
144667968|NCT02528253|521635918|FG002|Overall Study|Withdrawal by Subject|29|||
144667969|NCT02528253|521635919|FG003|Overall Study|Withdrawal by Subject|48|||
144667970|NCT02528253|521635920|FG004|Overall Study|Withdrawal by Subject|73|||
144667971|NCT02528253|521635916|FG000|Overall Study|Protocol Violation|1|||
144667972|NCT02528253|521635917|FG001|Overall Study|Protocol Violation|2|||
144667973|NCT02528253|521635918|FG002|Overall Study|Protocol Violation|4|||
144265579|NCT00853762|520173967|FG002|Overall Study|Randomised but not Treated|2|||
144265580|NCT00853762|520173968|FG003|Overall Study|Randomised but not Treated|0|||
144265581|NCT04456686|520173971|FG000|Overall Study|Adverse Event|2|||
144265582|NCT04456686|520173972|FG001|Overall Study|Adverse Event|1|||
144265583|NCT04456686|520173971|FG000|Overall Study|Lack of Efficacy|3|||
144265584|NCT04456686|520173972|FG001|Overall Study|Lack of Efficacy|1|||
144265585|NCT04456686|520173971|FG000|Overall Study|Withdrew consent|3|||
144265586|NCT04456686|520173972|FG001|Overall Study|Withdrew consent|1|||
144667974|NCT02528253|521635919|FG003|Overall Study|Protocol Violation|0|||
144667975|NCT02528253|521635920|FG004|Overall Study|Protocol Violation|4|||
144667976|NCT02528253|521635916|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
144667977|NCT02528253|521635917|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
144667978|NCT02528253|521635918|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
144667979|NCT02528253|521635919|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
144667980|NCT02528253|521635920|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
144667981|NCT00094835|521635923|FG000|Overall Study|Physician Decision|1|||
144667982|NCT00094835|521635924|FG001|Overall Study|Physician Decision|0|||
144667983|NCT00094835|521635925|FG002|Overall Study|Physician Decision|0|||
144667984|NCT00094835|521635926|FG003|Overall Study|Physician Decision|0|||
144667985|NCT00094835|521635927|FG004|Overall Study|Physician Decision|0|||
144667986|NCT00094835|521635928|FG005|Overall Study|Physician Decision|1|||
144667987|NCT00094835|521635929|FG006|Overall Study|Physician Decision|0|||
144667988|NCT00094835|521635923|FG000|Overall Study|Withdrawal by Subject|0|||
144667989|NCT00094835|521635924|FG001|Overall Study|Withdrawal by Subject|0|||
144667990|NCT00094835|521635925|FG002|Overall Study|Withdrawal by Subject|0|||
144667991|NCT00094835|521635926|FG003|Overall Study|Withdrawal by Subject|0|||
144667992|NCT00094835|521635927|FG004|Overall Study|Withdrawal by Subject|0|||
144667993|NCT00094835|521635928|FG005|Overall Study|Withdrawal by Subject|0|||
144667994|NCT00094835|521635929|FG006|Overall Study|Withdrawal by Subject|1|||
144667995|NCT00094835|521635923|FG000|Overall Study|Lost to Follow-up|0|||
144667996|NCT00094835|521635924|FG001|Overall Study|Lost to Follow-up|0|||
144667997|NCT00094835|521635925|FG002|Overall Study|Lost to Follow-up|0|||
144667998|NCT00094835|521635926|FG003|Overall Study|Lost to Follow-up|0|||
144667999|NCT00094835|521635927|FG004|Overall Study|Lost to Follow-up|1|||
144668000|NCT00094835|521635928|FG005|Overall Study|Lost to Follow-up|0|||
144668001|NCT00094835|521635929|FG006|Overall Study|Lost to Follow-up|0|||
144217647|NCT02906670|519990347|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217648|NCT02906670|519990348|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217649|NCT02906670|519990349|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217650|NCT02906670|519990350|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217651|NCT02906670|519990351|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
144217652|NCT02906670|519990352|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
144217653|NCT02906670|519990343|FG000|Cohort 5P, QW|Radiological Progression|0|||
144265587|NCT04456686|520173971|FG000|Overall Study|Physician Decision|2|||
144265588|NCT04456686|520173972|FG001|Overall Study|Physician Decision|2|||
144668002|NCT00094835|521635923|FG000|Overall Study|Death|1|||
144668003|NCT00094835|521635924|FG001|Overall Study|Death|0|||
144668004|NCT00094835|521635925|FG002|Overall Study|Death|0|||
144668005|NCT00094835|521635926|FG003|Overall Study|Death|0|||
144668006|NCT00094835|521635927|FG004|Overall Study|Death|1|||
144668007|NCT00094835|521635928|FG005|Overall Study|Death|0|||
144668008|NCT00094835|521635929|FG006|Overall Study|Death|0|||
144668009|NCT00094835|521635923|FG000|Overall Study|Non-compliance|1|||
144217654|NCT02906670|519990344|FG001|Cohort 5P, QW|Radiological Progression|0|||
144265589|NCT04456686|520173971|FG000|Overall Study|Withdrawal by Subject|5|||
144265590|NCT04456686|520173972|FG001|Overall Study|Withdrawal by Subject|1|||
144668010|NCT00094835|521635924|FG001|Overall Study|Non-compliance|2|||
144668011|NCT00094835|521635925|FG002|Overall Study|Non-compliance|2|||
144668012|NCT00094835|521635926|FG003|Overall Study|Non-compliance|0|||
144668013|NCT00094835|521635927|FG004|Overall Study|Non-compliance|2|||
144668014|NCT00094835|521635928|FG005|Overall Study|Non-compliance|2|||
144668015|NCT00094835|521635929|FG006|Overall Study|Non-compliance|1|||
144668016|NCT00094835|521635923|FG000|Overall Study|Other|1|||
144668017|NCT00094835|521635924|FG001|Overall Study|Other|1|||
144668018|NCT00094835|521635925|FG002|Overall Study|Other|1|||
144668019|NCT00094835|521635926|FG003|Overall Study|Other|1|||
144668020|NCT00094835|521635927|FG004|Overall Study|Other|0|||
144668021|NCT00094835|521635928|FG005|Overall Study|Other|0|||
144668022|NCT00094835|521635929|FG006|Overall Study|Other|0|||
144668023|NCT03472040|521635933|FG000|Overall Study|Physician Decision|0|||
144668024|NCT03472040|521635934|FG001|Overall Study|Physician Decision|3|||
144668025|NCT03472040|521635933|FG000|Overall Study|Withdrawal by Subject|10|||
144668026|NCT03472040|521635934|FG001|Overall Study|Withdrawal by Subject|23|||
144668027|NCT03472040|521635933|FG000|Overall Study|Perceived Lack of Efficacy|29|||
144668028|NCT03472040|521635934|FG001|Overall Study|Perceived Lack of Efficacy|30|||
144668029|NCT03472040|521635933|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
144668030|NCT03472040|521635934|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
144668031|NCT03472040|521635933|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
144668032|NCT03472040|521635934|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
144668033|NCT03472040|521635933|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
144668034|NCT03472040|521635934|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
144668035|NCT03472040|521635933|FG000|Overall Study|Subject Non-compliance|2|||
144668036|NCT03472040|521635934|FG001|Overall Study|Subject Non-compliance|5|||
144668037|NCT03472040|521635933|FG000|Overall Study|Discontinuation due to Rash|0|||
144668038|NCT03472040|521635934|FG001|Overall Study|Discontinuation due to Rash|1|||
144668039|NCT03472040|521635933|FG000|Overall Study|Subsequent Ineligibility|0|||
144668040|NCT03472040|521635934|FG001|Overall Study|Subsequent Ineligibility|2|||
144668041|NCT03472040|521635933|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
144668042|NCT03472040|521635934|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
144668043|NCT00225147|521635939|FG000|Open-label Phase|Lost to Follow-up|0|||
144668044|NCT00225147|521635940|FG001|Open-label Phase|Lost to Follow-up|0|||
144668045|NCT00225147|521635941|FG002|Open-label Phase|Lost to Follow-up|0|||
144668046|NCT00225147|521635942|FG003|Open-label Phase|Lost to Follow-up|4|||
144668047|NCT00225147|521635939|FG000|Open-label Phase|Withdrawal by Subject|0|||
144668048|NCT00225147|521635940|FG001|Open-label Phase|Withdrawal by Subject|0|||
144668049|NCT00225147|521635941|FG002|Open-label Phase|Withdrawal by Subject|0|||
144668050|NCT00225147|521635942|FG003|Open-label Phase|Withdrawal by Subject|6|||
144668051|NCT00433446|521635945|FG000|Overall Study|Adverse Event|4|||
144668052|NCT00433446|521635945|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
144668053|NCT00433446|521635945|FG000|Overall Study|Progression|44|||
144668054|NCT00433446|521635945|FG000|Overall Study|Other - Not Protocol specified|3|||
144668055|NCT00433446|521635945|FG000|Overall Study|Ineligible|9|||
144668056|NCT01188538|521635946|FG000|Overall Study|Lost to Follow-up|0|||
144668057|NCT01188538|521635947|FG001|Overall Study|Lost to Follow-up|1|||
144668058|NCT02501902|521635948|FG000|Overall Study|Subject Refused Further Follow-up|0|||
144668059|NCT02501902|521635949|FG001|Overall Study|Subject Refused Further Follow-up|0|||
144668060|NCT02501902|521635950|FG002|Overall Study|Subject Refused Further Follow-up|0|||
144668061|NCT02501902|521635951|FG003|Overall Study|Subject Refused Further Follow-up|0|||
144668062|NCT02501902|521635952|FG004|Overall Study|Subject Refused Further Follow-up|0|||
144668063|NCT02501902|521635953|FG005|Overall Study|Subject Refused Further Follow-up|0|||
144668064|NCT02501902|521635954|FG006|Overall Study|Subject Refused Further Follow-up|0|||
144668065|NCT02501902|521635955|FG007|Overall Study|Subject Refused Further Follow-up|1|||
144668066|NCT02501902|521635948|FG000|Overall Study|Study Terminated by Sponsor|0|||
144668067|NCT02501902|521635949|FG001|Overall Study|Study Terminated by Sponsor|3|||
144668068|NCT02501902|521635950|FG002|Overall Study|Study Terminated by Sponsor|0|||
144668069|NCT02501902|521635951|FG003|Overall Study|Study Terminated by Sponsor|1|||
144668070|NCT02501902|521635952|FG004|Overall Study|Study Terminated by Sponsor|1|||
144668071|NCT02501902|521635953|FG005|Overall Study|Study Terminated by Sponsor|0|||
144668072|NCT02501902|521635954|FG006|Overall Study|Study Terminated by Sponsor|2|||
144668073|NCT02501902|521635955|FG007|Overall Study|Study Terminated by Sponsor|4|||
144668074|NCT02501902|521635948|FG000|Overall Study|Death|3|||
144668075|NCT02501902|521635949|FG001|Overall Study|Death|4|||
144668076|NCT02501902|521635950|FG002|Overall Study|Death|4|||
144668077|NCT02501902|521635951|FG003|Overall Study|Death|10|||
144668078|NCT02501902|521635952|FG004|Overall Study|Death|10|||
144668079|NCT02501902|521635953|FG005|Overall Study|Death|11|||
144668080|NCT02501902|521635954|FG006|Overall Study|Death|7|||
144668081|NCT02501902|521635955|FG007|Overall Study|Death|15|||
144668082|NCT00688545|521635958|FG000|Overall Study|Lost to Follow-up|1|||
144668083|NCT00688545|521635959|FG001|Overall Study|Lost to Follow-up|4|||
144668084|NCT00688545|521635958|FG000|Overall Study|Insurance/cost of drug|0|||
144668085|NCT00688545|521635959|FG001|Overall Study|Insurance/cost of drug|1|||
144668086|NCT00688545|521635958|FG000|Overall Study|Withdrawal by Subject|2|||
144668087|NCT00688545|521635959|FG001|Overall Study|Withdrawal by Subject|3|||
144668088|NCT00688545|521635958|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
144668089|NCT00688545|521635959|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
144668090|NCT04295356|521635960|FG000|Overall Study|Physician Decision|1|||
144668091|NCT04295356|521635961|FG001|Overall Study|Physician Decision|0|||
144668092|NCT04295356|521635960|FG000|Overall Study|Lost to Follow-up|0|||
144668093|NCT04295356|521635961|FG001|Overall Study|Lost to Follow-up|3|||
144668094|NCT04295356|521635960|FG000|Overall Study|Protocol Violation|0|||
144668095|NCT04295356|521635961|FG001|Overall Study|Protocol Violation|1|||
144668096|NCT03004976|521635964|FG000|Overall Study|Lost to Follow-up|7|||
144668097|NCT03004976|521635965|FG001|Overall Study|Lost to Follow-up|5|||
144668098|NCT03004976|521635964|FG000|Overall Study|Physician Decision|1|||
144668099|NCT03004976|521635965|FG001|Overall Study|Physician Decision|0|||
144668100|NCT03004976|521635964|FG000|Overall Study|Withdrawal by Subject|1|||
144217655|NCT02906670|519990345|FG002|Cohort 5P, QW|Radiological Progression|0|||
144217656|NCT02906670|519990346|FG003|Cohort 5P, QW|Radiological Progression|0|||
144733878|NCT05472038|521883538|FG007|Overall Study|Physician Decision|0|||
144733879|NCT05472038|521883539|FG008|Overall Study|Physician Decision|0|||
144733880|NCT05472038|521883540|FG009|Overall Study|Physician Decision|0|||
144668101|NCT03004976|521635965|FG001|Overall Study|Withdrawal by Subject|0|||
144668102|NCT03004976|521635964|FG000|Overall Study|Death|4|||
144668103|NCT03004976|521635965|FG001|Overall Study|Death|1|||
144668104|NCT04116073|521635969|FG000|Overall Study|Withdrawal by Subject|2|||
144668105|NCT04116073|521635969|FG000|Overall Study|failed to maintained eligibility|1|||
144668106|NCT03939637|521635972|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
144668107|NCT03939637|521635973|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
144668108|NCT03939637|521635972|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
144668109|NCT03939637|521635973|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
144668110|NCT01181102|521635976|FG000|Overall Study|Adverse Event|28|||
144668111|NCT01181102|521635977|FG001|Overall Study|Adverse Event|26|||
144668112|NCT01181102|521635976|FG000|Overall Study|Lack of Efficacy|3|||
144668113|NCT01181102|521635977|FG001|Overall Study|Lack of Efficacy|1|||
144668114|NCT01181102|521635976|FG000|Overall Study|Lost to Follow-up|2|||
144668115|NCT01181102|521635977|FG001|Overall Study|Lost to Follow-up|0|||
144668116|NCT01181102|521635976|FG000|Overall Study|Physician Decision|3|||
144668117|NCT01181102|521635977|FG001|Overall Study|Physician Decision|1|||
144668118|NCT01181102|521635976|FG000|Overall Study|Protocol Violation|5|||
144668119|NCT01181102|521635977|FG001|Overall Study|Protocol Violation|6|||
144668120|NCT01181102|521635976|FG000|Overall Study|Withdrawal by Subject|10|||
144668121|NCT01181102|521635977|FG001|Overall Study|Withdrawal by Subject|12|||
144668122|NCT01309841|521635980|FG000|Overall Study|Other|0|||
144668123|NCT01309841|521635981|FG001|Overall Study|Other|1|||
144668124|NCT01309841|521635982|FG002|Overall Study|Other|1|||
144668125|NCT01309841|521635980|FG000|Overall Study|Lost to Follow-up|7|||
144668126|NCT01309841|521635981|FG001|Overall Study|Lost to Follow-up|6|||
144668127|NCT01309841|521635982|FG002|Overall Study|Lost to Follow-up|4|||
144733881|NCT05472038|521883541|FG010|Overall Study|Physician Decision|0|||
144733882|NCT05472038|521883542|FG011|Overall Study|Physician Decision|0|||
144733883|NCT05472038|521883531|FG000|Overall Study|Withdrawal by Subject|1|||
144733884|NCT05472038|521883532|FG001|Overall Study|Withdrawal by Subject|3|||
144733885|NCT05472038|521883533|FG002|Overall Study|Withdrawal by Subject|1|||
144733886|NCT05472038|521883534|FG003|Overall Study|Withdrawal by Subject|6|||
144733887|NCT05472038|521883535|FG004|Overall Study|Withdrawal by Subject|1|||
144733888|NCT05472038|521883536|FG005|Overall Study|Withdrawal by Subject|3|||
144733889|NCT05472038|521883537|FG006|Overall Study|Withdrawal by Subject|0|||
144733890|NCT05472038|521883538|FG007|Overall Study|Withdrawal by Subject|2|||
144733891|NCT05472038|521883539|FG008|Overall Study|Withdrawal by Subject|3|||
144733892|NCT05472038|521883540|FG009|Overall Study|Withdrawal by Subject|1|||
144733893|NCT05472038|521883541|FG010|Overall Study|Withdrawal by Subject|2|||
144217657|NCT02906670|519990347|FG004|Cohort 5P, QW|Radiological Progression|3|||
144217658|NCT02906670|519990348|FG005|Cohort 5P, QW|Radiological Progression|0|||
144217659|NCT02906670|519990349|FG006|Cohort 5P, QW|Radiological Progression|0|||
144217660|NCT02906670|519990350|FG007|Cohort 5P, QW|Radiological Progression|0|||
144217661|NCT02906670|519990351|FG008|Cohort 5P, QW|Radiological Progression|0|||
144217662|NCT02906670|519990352|FG009|Cohort 5P, QW|Radiological Progression|0|||
144217663|NCT01349192|519990353|FG000|Overall Study|Protocol Violation|0|||
144217664|NCT01349192|519990354|FG001|Overall Study|Protocol Violation|1|||
144217665|NCT01349192|519990353|FG000|Overall Study|Withdrawal by Subject|0|||
144217666|NCT01349192|519990354|FG001|Overall Study|Withdrawal by Subject|2|||
144217667|NCT01349192|519990353|FG000|Overall Study|Lost to Follow-up|1|||
144217668|NCT01349192|519990354|FG001|Overall Study|Lost to Follow-up|3|||
144217669|NCT01349192|519990353|FG000|Overall Study|Failure to adhere to Protocol|2|||
144217670|NCT01349192|519990354|FG001|Overall Study|Failure to adhere to Protocol|0|||
144217671|NCT01973439|519990355|FG000|Overall Study|Lost samples from one PK Day|2|||
144668128|NCT01309841|521635980|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
144668129|NCT01309841|521635981|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
144668130|NCT01309841|521635982|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
144668131|NCT01309841|521635980|FG000|Overall Study|Lack of Efficacy|0|||
144668132|NCT01309841|521635981|FG001|Overall Study|Lack of Efficacy|0|||
144668133|NCT01309841|521635982|FG002|Overall Study|Lack of Efficacy|2|||
144668134|NCT01309841|521635980|FG000|Overall Study|Adverse Event|9|||
144668135|NCT01309841|521635981|FG001|Overall Study|Adverse Event|22|||
144668136|NCT01309841|521635982|FG002|Overall Study|Adverse Event|11|||
144668137|NCT01309841|521635980|FG000|Overall Study|Death|1|||
144668138|NCT01309841|521635981|FG001|Overall Study|Death|0|||
144668139|NCT01309841|521635982|FG002|Overall Study|Death|0|||
144668140|NCT01309841|521635980|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144668141|NCT01309841|521635981|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
144668142|NCT01309841|521635982|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
144668143|NCT01309841|521635980|FG000|Overall Study|Withdrawal by Subject|17|||
144668144|NCT01309841|521635981|FG001|Overall Study|Withdrawal by Subject|6|||
144668145|NCT01309841|521635982|FG002|Overall Study|Withdrawal by Subject|13|||
144668146|NCT01309841|521635980|FG000|Overall Study|Did Not Receive Treatment|2|||
144668147|NCT01309841|521635981|FG001|Overall Study|Did Not Receive Treatment|0|||
144668148|NCT01309841|521635982|FG002|Overall Study|Did Not Receive Treatment|1|||
144668149|NCT01309841|521635980|FG000|Overall Study|Severe non-compliance with protocol|0|||
144668150|NCT01309841|521635981|FG001|Overall Study|Severe non-compliance with protocol|5|||
144668151|NCT01309841|521635982|FG002|Overall Study|Severe non-compliance with protocol|2|||
144668152|NCT05127421|521635983|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
144668153|NCT05127421|521635984|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
144668154|NCT05127421|521635985|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
144668155|NCT05127421|521635986|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
144668156|NCT05127421|521635983|FG000|4-Week Double-Blind Period|Physician Decision|1|||
144668157|NCT05127421|521635984|FG001|4-Week Double-Blind Period|Physician Decision|0|||
144668158|NCT05127421|521635985|FG002|4-Week Double-Blind Period|Physician Decision|0|||
144668159|NCT05127421|521635986|FG003|4-Week Double-Blind Period|Physician Decision|0|||
144668160|NCT05127421|521635983|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
144668161|NCT05127421|521635984|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
144668162|NCT05127421|521635985|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
144668163|NCT05127421|521635986|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
144668164|NCT05127421|521635983|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
144668165|NCT05127421|521635984|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
144668166|NCT05127421|521635985|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
144668167|NCT05127421|521635986|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
144668168|NCT05127421|521635983|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
144668169|NCT05127421|521635984|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
144668170|NCT05127421|521635985|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
144668171|NCT05127421|521635986|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
144668172|NCT05127421|521635983|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
144668173|NCT05127421|521635984|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
144668174|NCT05127421|521635985|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
144668175|NCT05127421|521635986|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
144668176|NCT05127421|521635983|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
144668177|NCT05127421|521635984|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
144668178|NCT05127421|521635985|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
144668179|NCT05127421|521635986|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
144668180|NCT05127421|521635983|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
144668181|NCT05127421|521635984|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
144668182|NCT05127421|521635985|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
144668183|NCT05127421|521635986|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
144668184|NCT01441115|521635987|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
144668185|NCT00878215|521635991|FG000|Overall Study|Determined to be ineligible|0|||
144668186|NCT00878215|521635992|FG001|Overall Study|Determined to be ineligible|10|||
144668187|NCT00878215|521635993|FG002|Overall Study|Determined to be ineligible|0|||
144668188|NCT00878215|521635994|FG003|Overall Study|Determined to be ineligible|0|||
144668189|NCT00574496|521635999|FG000|Overall Study|Withdrawal by Subject|1|||
144668190|NCT01969799|521636000|FG000|Overall Study|Adverse Event|0|||
144668191|NCT01969799|521636001|FG001|Overall Study|Adverse Event|1|||
144668192|NCT01969799|521636000|FG000|Overall Study|Death|16|||
144668193|NCT01969799|521636001|FG001|Overall Study|Death|11|||
144668194|NCT01969799|521636000|FG000|Overall Study|Lost to Follow-up|0|||
144668195|NCT01969799|521636001|FG001|Overall Study|Lost to Follow-up|2|||
144668196|NCT01969799|521636000|FG000|Overall Study|Physician Decision|1|||
144668197|NCT01969799|521636001|FG001|Overall Study|Physician Decision|0|||
144668198|NCT01681576|521636002|FG000|Period 1|Adverse Event|1|||
144668199|NCT01681576|521636003|FG001|Period 1|Adverse Event|0|||
144217672|NCT01973439|519990355|FG000|Overall Study|Vomiting after commencing once daily|1|||
144217673|NCT01973439|519990355|FG000|Overall Study|PK curve incomplete|2|||
144668200|NCT01681576|521636002|FG000|Period 1|Protocol Deviation|1|||
144668201|NCT01681576|521636003|FG001|Period 1|Protocol Deviation|0|||
144668202|NCT01681576|521636002|FG000|Period 2|subject/guardian decision|3|||
144668203|NCT01681576|521636003|FG001|Period 2|subject/guardian decision|1|||
144668204|NCT01681576|521636002|FG000|Period 2|Non-compliance with study treatment|1|||
144668205|NCT01681576|521636003|FG001|Period 2|Non-compliance with study treatment|0|||
144668206|NCT00178464|521636005|FG000|Overall Study|Withdrawal by Subject|1|||
144668207|NCT00178464|521636005|FG000|Overall Study|Physician Decision|1|||
144668208|NCT02227108|521636006|FG000|Overall Study|Did not receive treatment|2|||
144668209|NCT02227108|521636006|FG000|Overall Study|Other|3|||
144668210|NCT02227108|521636006|FG000|Overall Study|Progressive disease|17|||
144668211|NCT02227108|521636006|FG000|Overall Study|Initiation of alternative therapy|2|||
144668212|NCT02227108|521636006|FG000|Overall Study|Investigator discretion|1|||
144668213|NCT02227108|521636006|FG000|Overall Study|Adverse Event|6|||
144668214|NCT02486952|521636007|FG000|Overall Study|Not Started Induction Therapy|3|||
144668215|NCT02486952|521636007|FG000|Overall Study|Adverse Event|1|||
144668216|NCT02486952|521636007|FG000|Overall Study|Death|15|||
144668217|NCT02486952|521636007|FG000|Overall Study|Lack of Efficacy|3|||
144668218|NCT02486952|521636007|FG000|Overall Study|Lost to Follow-up|26|||
144668219|NCT02486952|521636007|FG000|Overall Study|Other|2|||
144668220|NCT04111107|521636008|FG000|Overall Study|Withdrawal by Subject|6|||
144668221|NCT04111107|521636008|FG000|Overall Study|Declining Health|5|||
144668222|NCT02260648|521636009|FG000|Overall Study|Adverse Event|3|||
144668223|NCT02260648|521636010|FG001|Overall Study|Adverse Event|0|||
144668224|NCT02260648|521636011|FG002|Overall Study|Adverse Event|1|||
144668225|NCT02260648|521636009|FG000|Overall Study|Withdrawal by Subject|1|||
144668226|NCT02260648|521636010|FG001|Overall Study|Withdrawal by Subject|1|||
144668227|NCT02260648|521636011|FG002|Overall Study|Withdrawal by Subject|0|||
144668228|NCT02260648|521636009|FG000|Overall Study|Protocol Violation|1|||
144668229|NCT02260648|521636010|FG001|Overall Study|Protocol Violation|0|||
144668230|NCT02260648|521636011|FG002|Overall Study|Protocol Violation|0|||
144668231|NCT02260648|521636009|FG000|Overall Study|Discontinue Due to Study Termination|13|||
144668232|NCT02260648|521636010|FG001|Overall Study|Discontinue Due to Study Termination|12|||
144668233|NCT02260648|521636011|FG002|Overall Study|Discontinue Due to Study Termination|7|||
144668234|NCT03956225|521636012|FG000|Overall Study|Lack of Efficacy|1|||
144668235|NCT03956225|521636013|FG001|Overall Study|Lack of Efficacy|1|||
144668236|NCT03956225|521636012|FG000|Overall Study|Lost to Follow-up|0|||
144668237|NCT03956225|521636013|FG001|Overall Study|Lost to Follow-up|1|||
144668238|NCT03956225|521636012|FG000|Overall Study|Withdrawal by Subject|2|||
144668239|NCT03956225|521636013|FG001|Overall Study|Withdrawal by Subject|1|||
144668240|NCT03956225|521636012|FG000|Overall Study|Other Reasons|2|||
144668241|NCT03956225|521636013|FG001|Overall Study|Other Reasons|1|||
144668242|NCT00594204|521636014|FG000|Overall Study|Adverse Event|15|||
144668243|NCT00594204|521636015|FG001|Overall Study|Adverse Event|3|||
144668244|NCT00594204|521636014|FG000|Overall Study|Lost to Follow-up|9|||
144668245|NCT00594204|521636015|FG001|Overall Study|Lost to Follow-up|5|||
144668246|NCT00594204|521636014|FG000|Overall Study|Withdrawal by Subject|23|||
144668247|NCT00594204|521636015|FG001|Overall Study|Withdrawal by Subject|29|||
144668248|NCT00594204|521636014|FG000|Overall Study|Other|4|||
144668249|NCT00594204|521636015|FG001|Overall Study|Other|3|||
144668250|NCT00594204|521636014|FG000|Overall Study|Lack of Efficacy|3|||
144668251|NCT00594204|521636015|FG001|Overall Study|Lack of Efficacy|4|||
144217674|NCT02038010|519990359|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
144217675|NCT02038010|519990360|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
144217676|NCT02038010|519990361|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
144668252|NCT00594204|521636014|FG000|Overall Study|Randomized but not treated|4|||
144668253|NCT00594204|521636015|FG001|Overall Study|Randomized but not treated|1|||
144668254|NCT01115738|521636016|FG000|Overall Study|Death|1|||
144668255|NCT01115738|521636017|FG001|Overall Study|Death|0|||
144668256|NCT01115738|521636018|FG002|Overall Study|Death|0|||
144668257|NCT01115738|521636016|FG000|Overall Study|Lost to Follow-up|0|||
144668258|NCT01115738|521636017|FG001|Overall Study|Lost to Follow-up|0|||
144668259|NCT01115738|521636018|FG002|Overall Study|Lost to Follow-up|1|||
144668260|NCT01115738|521636016|FG000|Overall Study|Physician Decision|18|||
144668261|NCT01115738|521636017|FG001|Overall Study|Physician Decision|15|||
144668262|NCT01115738|521636018|FG002|Overall Study|Physician Decision|17|||
144668263|NCT01115738|521636016|FG000|Overall Study|Withdrawal by Subject|6|||
144668264|NCT01115738|521636017|FG001|Overall Study|Withdrawal by Subject|6|||
144668265|NCT01115738|521636018|FG002|Overall Study|Withdrawal by Subject|9|||
144668266|NCT02702011|521636025|FG000|Overall Study|Withdrawal by Subject|0|||
144668267|NCT02702011|521636026|FG001|Overall Study|Withdrawal by Subject|1|||
144668268|NCT02702011|521636027|FG002|Overall Study|Withdrawal by Subject|0|||
144217677|NCT02038010|519990362|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
144668269|NCT02702011|521636028|FG003|Overall Study|Withdrawal by Subject|0|||
144668270|NCT02559206|521636037|FG000|Overall Study|Adverse Event|0|||
144668271|NCT02559206|521636038|FG001|Overall Study|Adverse Event|4|||
144668272|NCT02559206|521636039|FG002|Overall Study|Adverse Event|1|||
144668273|NCT02559206|521636040|FG003|Overall Study|Adverse Event|5|||
144668274|NCT02559206|521636041|FG004|Overall Study|Adverse Event|3|||
144668275|NCT02559206|521636042|FG005|Overall Study|Adverse Event|0|||
144668276|NCT02559206|521636043|FG006|Overall Study|Adverse Event|1|||
144668277|NCT02559206|521636044|FG007|Overall Study|Adverse Event|0|||
144668278|NCT02559206|521636037|FG000|Overall Study|Protocol Violation|1|||
144668279|NCT02559206|521636038|FG001|Overall Study|Protocol Violation|0|||
144668280|NCT02559206|521636039|FG002|Overall Study|Protocol Violation|1|||
144668281|NCT02559206|521636040|FG003|Overall Study|Protocol Violation|0|||
144668282|NCT02559206|521636041|FG004|Overall Study|Protocol Violation|0|||
144668283|NCT02559206|521636042|FG005|Overall Study|Protocol Violation|2|||
144668284|NCT02559206|521636043|FG006|Overall Study|Protocol Violation|0|||
144668285|NCT02559206|521636044|FG007|Overall Study|Protocol Violation|0|||
144668286|NCT02559206|521636037|FG000|Overall Study|Withdrawal by Subject|3|||
144668287|NCT02559206|521636038|FG001|Overall Study|Withdrawal by Subject|3|||
144668288|NCT02559206|521636039|FG002|Overall Study|Withdrawal by Subject|1|||
144668289|NCT02559206|521636040|FG003|Overall Study|Withdrawal by Subject|3|||
144668290|NCT02559206|521636041|FG004|Overall Study|Withdrawal by Subject|5|||
144668291|NCT02559206|521636042|FG005|Overall Study|Withdrawal by Subject|4|||
144668292|NCT02559206|521636043|FG006|Overall Study|Withdrawal by Subject|1|||
144668293|NCT02559206|521636044|FG007|Overall Study|Withdrawal by Subject|2|||
144668294|NCT02559206|521636037|FG000|Overall Study|Lost to Follow-up|3|||
144668295|NCT02559206|521636038|FG001|Overall Study|Lost to Follow-up|5|||
144668296|NCT02559206|521636039|FG002|Overall Study|Lost to Follow-up|3|||
144668297|NCT02559206|521636040|FG003|Overall Study|Lost to Follow-up|3|||
144668298|NCT02559206|521636041|FG004|Overall Study|Lost to Follow-up|2|||
144668299|NCT02559206|521636042|FG005|Overall Study|Lost to Follow-up|5|||
144668300|NCT02559206|521636043|FG006|Overall Study|Lost to Follow-up|1|||
144668301|NCT02559206|521636044|FG007|Overall Study|Lost to Follow-up|4|||
144668302|NCT02559206|521636037|FG000|Overall Study|Lack of Efficacy|1|||
144668303|NCT02559206|521636038|FG001|Overall Study|Lack of Efficacy|0|||
144668304|NCT02559206|521636039|FG002|Overall Study|Lack of Efficacy|3|||
144668305|NCT02559206|521636040|FG003|Overall Study|Lack of Efficacy|2|||
144668306|NCT02559206|521636041|FG004|Overall Study|Lack of Efficacy|2|||
144668307|NCT02559206|521636042|FG005|Overall Study|Lack of Efficacy|3|||
144668308|NCT02559206|521636043|FG006|Overall Study|Lack of Efficacy|3|||
144668309|NCT02559206|521636044|FG007|Overall Study|Lack of Efficacy|3|||
144668310|NCT02559206|521636037|FG000|Overall Study|Other Not Specified|0|||
144668311|NCT02559206|521636038|FG001|Overall Study|Other Not Specified|0|||
144668312|NCT02559206|521636039|FG002|Overall Study|Other Not Specified|0|||
144668313|NCT02559206|521636040|FG003|Overall Study|Other Not Specified|1|||
144668314|NCT02559206|521636041|FG004|Overall Study|Other Not Specified|0|||
144668315|NCT02559206|521636042|FG005|Overall Study|Other Not Specified|0|||
144668316|NCT02559206|521636043|FG006|Overall Study|Other Not Specified|0|||
144668317|NCT02559206|521636044|FG007|Overall Study|Other Not Specified|0|||
144668318|NCT01871896|521636047|FG000|Overall Study|Lost to Follow-up|1|||
144668319|NCT05691829|521637488|FG000|Overall Study|Physician Decision|2|||
144668320|NCT05691829|521637488|FG000|Overall Study|Eligibility criteria not met|3|||
144217678|NCT02038010|519990359|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
144217679|NCT02038010|519990360|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
144217680|NCT02038010|519990361|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
144217681|NCT02038010|519990362|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
144217682|NCT02038010|519990359|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
144217683|NCT02038010|519990360|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
144217684|NCT02038010|519990361|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
144217685|NCT02038010|519990362|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
144217686|NCT02038010|519990359|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
144217687|NCT02038010|519990360|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
144668321|NCT00453180|521637489|FG000|Overall Study|Lost to Follow-up|2|||
144668322|NCT00453180|521637490|FG001|Overall Study|Lost to Follow-up|1|||
144668323|NCT00453180|521637489|FG000|Overall Study|Adverse Event|1|||
144668324|NCT00453180|521637490|FG001|Overall Study|Adverse Event|2|||
144668325|NCT03326869|521637495|FG000|Overall Study|Study data has been lost to natural disa|1|||
144668326|NCT03326869|521637496|FG001|Overall Study|Study data has been lost to natural disa|1|||
144668327|NCT01002742|521637499|FG000|Overall Study|Determined to be ineligible|0|||
144668328|NCT01002742|521637500|FG001|Overall Study|Determined to be ineligible|1|||
144668329|NCT01824693|521637501|FG000|Overall Study|Death|0|||
144668330|NCT01824693|521637502|FG001|Overall Study|Death|1|||
144668331|NCT01824693|521637503|FG002|Overall Study|Death|0|||
144668332|NCT01824693|521637501|FG000|Overall Study|Physician Decision|1|||
144668333|NCT01824693|521637502|FG001|Overall Study|Physician Decision|1|||
144668334|NCT01824693|521637503|FG002|Overall Study|Physician Decision|1|||
144668335|NCT01824693|521637501|FG000|Overall Study|Withdrawal by Subject|0|||
144733894|NCT05472038|521883542|FG011|Overall Study|Withdrawal by Subject|2|||
144733895|NCT05472038|521883531|FG000|Overall Study|Protocol Violation|0|||
144668336|NCT01824693|521637502|FG001|Overall Study|Withdrawal by Subject|0|||
144668337|NCT01824693|521637503|FG002|Overall Study|Withdrawal by Subject|1|||
144668338|NCT01824693|521637501|FG000|Overall Study|Progressive Disease|0|||
144668339|NCT01824693|521637502|FG001|Overall Study|Progressive Disease|5|||
144668340|NCT01824693|521637503|FG002|Overall Study|Progressive Disease|0|||
144668341|NCT01824693|521637501|FG000|Overall Study|Ineligible|0|||
144668342|NCT01824693|521637502|FG001|Overall Study|Ineligible|0|||
144668343|NCT01824693|521637503|FG002|Overall Study|Ineligible|3|||
144668344|NCT01824693|521637501|FG000|Overall Study|No Transplant Planned|0|||
144668345|NCT01824693|521637502|FG001|Overall Study|No Transplant Planned|0|||
144668346|NCT01824693|521637503|FG002|Overall Study|No Transplant Planned|10|||
144668347|NCT02150213|521637505|FG000|Overall Study|Lost to Follow-up|1|||
144668348|NCT02150213|521637505|FG000|Overall Study|Withdrawal by Subject|1|||
144668349|NCT01297309|521637506|FG000|Overall Study|Eligibility failure|2|||
144668350|NCT01297309|521637506|FG000|Overall Study|Screen failure|2|||
144668351|NCT01297309|521637506|FG000|Overall Study|Withdrawal by Subject|5|||
144668352|NCT01297309|521637506|FG000|Overall Study|Adverse Event|1|||
144668353|NCT01297309|521637506|FG000|Overall Study|Investigator Decision|2|||
144668354|NCT01297309|521637506|FG000|Overall Study|Death|1|||
144668355|NCT01297309|521637506|FG000|Overall Study|Participant not entering extensionperiod|1|||
144668356|NCT02678312|521637507|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
144668357|NCT02678312|521637508|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
144668358|NCT02678312|521637509|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
144668359|NCT02678312|521637510|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
144668360|NCT02678312|521637511|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
144668361|NCT02678312|521637507|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
144668362|NCT02678312|521637508|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
144668363|NCT02678312|521637509|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
144668364|NCT02678312|521637510|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
144668365|NCT02678312|521637511|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
144668366|NCT02678312|521637507|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
144668367|NCT02678312|521637508|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
144668368|NCT02678312|521637509|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
144668369|NCT02678312|521637510|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
144668370|NCT02678312|521637511|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
144668371|NCT02678312|521637507|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
144668372|NCT02678312|521637508|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
144668373|NCT02678312|521637509|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
144668374|NCT02678312|521637510|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
144668375|NCT02678312|521637511|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
144668376|NCT02678312|521637507|FG000|Part 2 Double Blind Epoch|Death|0|||
144668377|NCT02678312|521637508|FG001|Part 2 Double Blind Epoch|Death|0|||
144668378|NCT02678312|521637509|FG002|Part 2 Double Blind Epoch|Death|0|||
144668379|NCT02678312|521637510|FG003|Part 2 Double Blind Epoch|Death|8|||
144668380|NCT02678312|521637511|FG004|Part 2 Double Blind Epoch|Death|12|||
144668381|NCT02678312|521637507|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
144668382|NCT02678312|521637508|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
144668383|NCT02678312|521637509|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
144668384|NCT02678312|521637510|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
144668385|NCT02678312|521637511|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
144668386|NCT02678312|521637507|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
144668387|NCT02678312|521637508|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
144668388|NCT02678312|521637509|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
144668389|NCT02678312|521637510|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
144668390|NCT02678312|521637511|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
144668391|NCT02678312|521637507|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
144668392|NCT02678312|521637508|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
144668393|NCT02678312|521637509|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
144668394|NCT02678312|521637510|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
144733896|NCT05472038|521883532|FG001|Overall Study|Protocol Violation|0|||
144668395|NCT02678312|521637511|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
144668396|NCT00656084|521637512|FG000|Overall Study|Adverse Event|4|||
144668397|NCT00656084|521637512|FG000|Overall Study|Withdrawal by Subject|1|||
144668398|NCT00656084|521637512|FG000|Overall Study|Patient Request|1|||
144668399|NCT00656084|521637512|FG000|Overall Study|Investigator Request|1|||
144668400|NCT03628599|521637513|FG000|Overall Study|Adverse Event|0|||
144668401|NCT03628599|521637514|FG001|Overall Study|Adverse Event|1|||
144668402|NCT01624506|521637515|FG000|Overall Study|Lost to Follow-up|29|||
144668403|NCT01624506|521637516|FG001|Overall Study|Lost to Follow-up|15|||
144668404|NCT01624506|521637515|FG000|Overall Study|Withdrawal by Subject|9|||
144668405|NCT01624506|521637516|FG001|Overall Study|Withdrawal by Subject|2|||
144668406|NCT01624506|521637515|FG000|Overall Study|Death|1|||
144668407|NCT01624506|521637516|FG001|Overall Study|Death|0|||
144668408|NCT01624506|521637515|FG000|Overall Study|LINX explants|23|||
144668409|NCT01624506|521637516|FG001|Overall Study|LINX explants|0|||
144668410|NCT01624506|521637515|FG000|Overall Study|Adverse Event|3|||
144668411|NCT01624506|521637516|FG001|Overall Study|Adverse Event|0|||
144668412|NCT00132314|521637517|FG000|Overall Study|Lost to Follow-up|70|||
144668413|NCT00132314|521637518|FG001|Overall Study|Lost to Follow-up|62|||
144668414|NCT00132314|521637517|FG000|Overall Study|Lacked SSN|1|||
144668415|NCT00132314|521637518|FG001|Overall Study|Lacked SSN|3|||
144668416|NCT00132314|521637517|FG000|Overall Study|Refused intervention at baseline|2|||
144668417|NCT00132314|521637518|FG001|Overall Study|Refused intervention at baseline|7|||
144668418|NCT02966353|521637527|FG000|Overall Study|Withdrawal by Subject|7|||
144668419|NCT02966353|521637527|FG000|Overall Study|Adverse Event|4|||
144668420|NCT02966353|521637527|FG000|Overall Study|Death|4|||
144668421|NCT02966353|521637527|FG000|Overall Study|Physician Decision|3|||
144668422|NCT02966353|521637527|FG000|Overall Study|Progressive disease|2|||
144668423|NCT02966353|521637527|FG000|Overall Study|Protocol deviation|2|||
144668424|NCT02514772|521637530|FG000|Overall Study|Adverse Event|1|||
144668425|NCT02514772|521637531|FG001|Overall Study|Adverse Event|0|||
144668426|NCT02514772|521637530|FG000|Overall Study|Death|0|||
144668427|NCT02514772|521637531|FG001|Overall Study|Death|1|||
144668428|NCT02514772|521637530|FG000|Overall Study|Withdrawal by Subject|2|||
144668429|NCT02514772|521637531|FG001|Overall Study|Withdrawal by Subject|1|||
144668430|NCT03024255|521637532|FG000|Overall Study|Adverse Event|1|||
144668431|NCT03024255|521637533|FG001|Overall Study|Adverse Event|4|||
144668432|NCT03024255|521637534|FG002|Overall Study|Adverse Event|8|||
144668433|NCT03024255|521637535|FG003|Overall Study|Adverse Event|0|||
144668434|NCT03024255|521637532|FG000|Overall Study|Withdrawal by Subject|3|||
144668435|NCT03024255|521637533|FG001|Overall Study|Withdrawal by Subject|1|||
144668436|NCT03024255|521637534|FG002|Overall Study|Withdrawal by Subject|0|||
144668437|NCT03024255|521637535|FG003|Overall Study|Withdrawal by Subject|3|||
144668438|NCT03024255|521637532|FG000|Overall Study|Protocol Violation|0|||
144668439|NCT03024255|521637533|FG001|Overall Study|Protocol Violation|0|||
144668440|NCT03024255|521637534|FG002|Overall Study|Protocol Violation|2|||
144668441|NCT03024255|521637535|FG003|Overall Study|Protocol Violation|0|||
144668442|NCT03024255|521637532|FG000|Overall Study|Lost to Follow-up|1|||
144668443|NCT03024255|521637533|FG001|Overall Study|Lost to Follow-up|2|||
144668444|NCT03024255|521637534|FG002|Overall Study|Lost to Follow-up|1|||
144668445|NCT03024255|521637535|FG003|Overall Study|Lost to Follow-up|1|||
144668446|NCT03024255|521637532|FG000|Overall Study|Lack of Efficacy|1|||
144668447|NCT03024255|521637533|FG001|Overall Study|Lack of Efficacy|0|||
144668448|NCT03024255|521637534|FG002|Overall Study|Lack of Efficacy|0|||
144668449|NCT03024255|521637535|FG003|Overall Study|Lack of Efficacy|0|||
144668450|NCT03024255|521637532|FG000|Overall Study|Protocol Noncompliance|1|||
144668451|NCT03024255|521637533|FG001|Overall Study|Protocol Noncompliance|1|||
144668452|NCT03024255|521637534|FG002|Overall Study|Protocol Noncompliance|0|||
144668453|NCT03024255|521637535|FG003|Overall Study|Protocol Noncompliance|1|||
144668454|NCT01415908|521637536|FG000|Overall Study|Withdrawal by Subject|1|||
144668455|NCT01415908|521637537|FG001|Overall Study|Withdrawal by Subject|0|||
144668456|NCT03728140|521637538|FG000|Overall Study|Abnormal embryo transfer operation|10|||
144668457|NCT03728140|521637539|FG001|Overall Study|Abnormal embryo transfer operation|7|||
144668458|NCT02197897|521637545|FG000|Overall Study|not eligible|1|||
144668459|NCT02384395|521637546|FG000|Overall Study|Physician Decision|4|||
144668460|NCT02384395|521637546|FG000|Overall Study|Withdrawal by Subject|3|||
144668461|NCT02384395|521637546|FG000|Overall Study|Lost to Follow-up|3|||
144668462|NCT01143714|521637551|FG000|Overall Study|Adverse Event|4|||
144668463|NCT01143714|521637552|FG001|Overall Study|Adverse Event|2|||
144668464|NCT01143714|521637551|FG000|Overall Study|Withdrawal by Subject|1|||
144668465|NCT01143714|521637552|FG001|Overall Study|Withdrawal by Subject|0|||
144668466|NCT01143714|521637551|FG000|Overall Study|Subject non-compliance|0|||
144668467|NCT01143714|521637552|FG001|Overall Study|Subject non-compliance|1|||
144668468|NCT01143714|521637551|FG000|Overall Study|wound closed = deemed healed|1|||
144668469|NCT01143714|521637552|FG001|Overall Study|wound closed = deemed healed|0|||
144668470|NCT01143714|521637551|FG000|Overall Study|wound size increased|1|||
144668471|NCT01143714|521637552|FG001|Overall Study|wound size increased|0|||
144668472|NCT01106391|521637553|FG000|Overall Study|Death|12|||
144668473|NCT01106391|521637553|FG000|Overall Study|Withdrawal by Subject|7|||
144668474|NCT00150345|521637554|FG000|Overall Study|Death|5|||
144668475|NCT00150345|521637555|FG001|Overall Study|Death|2|||
144668476|NCT00150345|521637554|FG000|Overall Study|Adverse Event|8|||
144668477|NCT00150345|521637555|FG001|Overall Study|Adverse Event|6|||
144668478|NCT00150345|521637554|FG000|Overall Study|Lack of Efficacy|5|||
144668479|NCT00150345|521637555|FG001|Overall Study|Lack of Efficacy|4|||
144668480|NCT00150345|521637554|FG000|Overall Study|Withdrawal by Subject|3|||
144668481|NCT00150345|521637555|FG001|Overall Study|Withdrawal by Subject|4|||
144668482|NCT00150345|521637554|FG000|Overall Study|Laboratory abnormality|1|||
144668483|NCT00150345|521637555|FG001|Overall Study|Laboratory abnormality|2|||
144668484|NCT00150345|521637554|FG000|Overall Study|Other|12|||
144668485|NCT00150345|521637555|FG001|Overall Study|Other|14|||
144668486|NCT03783442|521637557|FG000|Overall Study|Death|252|||
144668487|NCT03783442|521637558|FG001|Overall Study|Death|268|||
144668488|NCT03783442|521637557|FG000|Overall Study|Withdrawal by Subject|19|||
144668489|NCT03783442|521637558|FG001|Overall Study|Withdrawal by Subject|21|||
144668490|NCT03783442|521637557|FG000|Overall Study|Lost to Follow-up|7|||
144668491|NCT03783442|521637558|FG001|Overall Study|Lost to Follow-up|6|||
144668492|NCT03783442|521637557|FG000|Overall Study|Sponsor Ended Study|48|||
144668493|NCT03783442|521637558|FG001|Overall Study|Sponsor Ended Study|28|||
144668494|NCT04325906|521637559|FG000|Overall Study|Withdrawal by Subject|2|||
144668495|NCT04325906|521637560|FG001|Overall Study|Withdrawal by Subject|0|||
144668496|NCT01381718|521637561|FG000|Overall Study|Withdrawal by Subject|2|||
144668497|NCT01381718|521637562|FG001|Overall Study|Withdrawal by Subject|5|||
144668498|NCT01381718|521637561|FG000|Overall Study|Lost to Follow-up|3|||
144668499|NCT01381718|521637562|FG001|Overall Study|Lost to Follow-up|5|||
144668500|NCT01381718|521637561|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
144668501|NCT01381718|521637562|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
144668502|NCT02505542|521637567|FG000|Part A: Open-Label Period|Adverse Event|31|||
144668503|NCT02505542|521637568|FG001|Part A: Open-Label Period|Adverse Event|0|||
144668504|NCT02505542|521637569|FG002|Part A: Open-Label Period|Adverse Event|0|||
144668505|NCT02505542|521637570|FG003|Part A: Open-Label Period|Adverse Event|0|||
144668506|NCT02505542|521637567|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
144668507|NCT02505542|521637568|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
144668508|NCT02505542|521637569|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
144668509|NCT02505542|521637570|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
144668510|NCT02505542|521637567|FG000|Part A: Open-Label Period|Protocol Violation|1|||
144668511|NCT02505542|521637568|FG001|Part A: Open-Label Period|Protocol Violation|0|||
144668512|NCT02505542|521637569|FG002|Part A: Open-Label Period|Protocol Violation|0|||
144668513|NCT02505542|521637570|FG003|Part A: Open-Label Period|Protocol Violation|0|||
144668514|NCT02505542|521637567|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
144668515|NCT02505542|521637568|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
144668516|NCT02505542|521637569|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
144668517|NCT02505542|521637570|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
144668518|NCT02505542|521637567|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
144668519|NCT02505542|521637568|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
144668520|NCT02505542|521637569|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
144668521|NCT02505542|521637570|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
144668522|NCT02505542|521637567|FG000|Part A: Open-Label Period|New medical history available|1|||
144668523|NCT02505542|521637568|FG001|Part A: Open-Label Period|New medical history available|0|||
144668524|NCT02505542|521637569|FG002|Part A: Open-Label Period|New medical history available|0|||
144668525|NCT02505542|521637570|FG003|Part A: Open-Label Period|New medical history available|0|||
144668526|NCT02505542|521637567|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
144668527|NCT02505542|521637568|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
144668528|NCT02505542|521637569|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
144668529|NCT02505542|521637570|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
144668530|NCT02505542|521637567|FG000|Part A: Open-Label Period|Pregnancy|2|||
144668531|NCT02505542|521637568|FG001|Part A: Open-Label Period|Pregnancy|0|||
144668532|NCT02505542|521637569|FG002|Part A: Open-Label Period|Pregnancy|0|||
144668533|NCT02505542|521637570|FG003|Part A: Open-Label Period|Pregnancy|0|||
144668534|NCT02505542|521637567|FG000|Part A: Open-Label Period|Sponsor directive|1|||
144668535|NCT02505542|521637568|FG001|Part A: Open-Label Period|Sponsor directive|0|||
144668536|NCT02505542|521637569|FG002|Part A: Open-Label Period|Sponsor directive|0|||
144668537|NCT02505542|521637570|FG003|Part A: Open-Label Period|Sponsor directive|0|||
144668538|NCT02505542|521637567|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
144668539|NCT02505542|521637568|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
144668540|NCT02505542|521637569|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
144668541|NCT02505542|521637570|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
144668542|NCT02505542|521637567|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
144668543|NCT02505542|521637568|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
144668544|NCT02505542|521637569|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
144668545|NCT02505542|521637570|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
144668546|NCT02505542|521637567|FG000|Part A: Open-Label Period|Non-compliance|1|||
144668547|NCT02505542|521637568|FG001|Part A: Open-Label Period|Non-compliance|0|||
144668548|NCT02505542|521637569|FG002|Part A: Open-Label Period|Non-compliance|0|||
144668549|NCT02505542|521637570|FG003|Part A: Open-Label Period|Non-compliance|0|||
144668550|NCT02505542|521637567|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
144668551|NCT02505542|521637568|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
144668552|NCT02505542|521637569|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
144668553|NCT02505542|521637570|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
144668554|NCT02505542|521637567|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
144668555|NCT02505542|521637568|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
144668556|NCT02505542|521637569|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
144668557|NCT02505542|521637570|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
144668558|NCT02505542|521637567|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
144668559|NCT02505542|521637568|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
144668560|NCT02505542|521637569|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
144668561|NCT02505542|521637570|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
144668562|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Adverse Event|0|||
144668563|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Adverse Event|0|||
144668564|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Adverse Event|1|||
144668565|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Adverse Event|3|||
144668566|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
144668567|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
144668568|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
144668569|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
144668570|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
144668571|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
144668572|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
144668573|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
144668574|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
144668575|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
144668576|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
144668577|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
144668578|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
144668579|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
144668580|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
144668581|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
144668582|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
144668583|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
144668584|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
144668585|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
144668586|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
144668587|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
144668588|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
144668589|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
144668590|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Miscalculation|0|||
144668591|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Miscalculation|1|||
144668592|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Miscalculation|0|||
144668593|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Miscalculation|0|||
144668594|NCT02505542|521637567|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
144668595|NCT02505542|521637568|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
144668596|NCT02505542|521637569|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
144668597|NCT02505542|521637570|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
144668598|NCT00992186|521637571|FG000|Overall Study|Withdrawal by Subject|2|||
144668599|NCT00992186|521637571|FG000|Overall Study|Protocol Violation|1|||
144668600|NCT00992186|521637571|FG000|Overall Study|Physician Decision|1|||
144668601|NCT00992186|521637571|FG000|Overall Study|Adverse Event|9|||
144668602|NCT00992186|521637571|FG000|Overall Study|Progressive Disease|30|||
144668603|NCT00992186|521637571|FG000|Overall Study|Refusal To Receive Study Agent|3|||
144668604|NCT00168064|521637573|FG000|Overall Study|Adverse Event|26|||
144668605|NCT00168064|521637574|FG001|Overall Study|Adverse Event|22|||
144668606|NCT00168064|521637573|FG000|Overall Study|Withdrawal by Subject|3|||
144668607|NCT00168064|521637574|FG001|Overall Study|Withdrawal by Subject|4|||
144668608|NCT00168064|521637573|FG000|Overall Study|Lack of Efficacy|4|||
144668609|NCT00168064|521637574|FG001|Overall Study|Lack of Efficacy|4|||
144668610|NCT00168064|521637573|FG000|Overall Study|Lost to Follow-up|4|||
144668611|NCT00168064|521637574|FG001|Overall Study|Lost to Follow-up|3|||
144668612|NCT00168064|521637573|FG000|Overall Study|Non-compliance|2|||
144668613|NCT00168064|521637574|FG001|Overall Study|Non-compliance|3|||
144668614|NCT00168064|521637573|FG000|Overall Study|Concurrent Illness|4|||
144668615|NCT00168064|521637574|FG001|Overall Study|Concurrent Illness|3|||
144733897|NCT05472038|521883533|FG002|Overall Study|Protocol Violation|0|||
144265591|NCT04456686|520173971|FG000|Overall Study|Protocol Violation|0|||
144668616|NCT00168064|521637573|FG000|Overall Study|Subject's Best interest|2|||
144668617|NCT00168064|521637574|FG001|Overall Study|Subject's Best interest|2|||
144668618|NCT00168064|521637573|FG000|Overall Study|Various|4|||
144668619|NCT00168064|521637574|FG001|Overall Study|Various|3|||
144668620|NCT05489081|521637582|FG000|Overall Study|student left classroom|0|||
144668621|NCT05489081|521637583|FG001|Overall Study|student left classroom|1|||
144668622|NCT05489081|521637582|FG000|Overall Study|teacher left school|0|||
144668623|NCT05489081|521637583|FG001|Overall Study|teacher left school|2|||
144668624|NCT05159362|521637586|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
144668625|NCT05159362|521637587|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
144668626|NCT05159362|521637588|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
144668627|NCT02940626|521637589|FG000|Overall Study|Death|40|||
144668628|NCT02940626|521637590|FG001|Overall Study|Death|32|||
144668629|NCT02940626|521637589|FG000|Overall Study|Lost to Follow-up|5|||
144668630|NCT02940626|521637590|FG001|Overall Study|Lost to Follow-up|2|||
144668631|NCT02940626|521637589|FG000|Overall Study|Withdrawal by Subject|1|||
144668632|NCT02940626|521637590|FG001|Overall Study|Withdrawal by Subject|0|||
144668633|NCT02940626|521637589|FG000|Overall Study|Transfer to Hospice Care|1|||
144668634|NCT02940626|521637590|FG001|Overall Study|Transfer to Hospice Care|0|||
144668635|NCT02940626|521637589|FG000|Overall Study|Prohibited Concomitant Medication|0|||
144668636|NCT02940626|521637590|FG001|Overall Study|Prohibited Concomitant Medication|1|||
144668637|NCT01996904|521637591|FG000|Overall Study|Lost to Follow-up|38|||
144668638|NCT01996904|521637592|FG001|Overall Study|Lost to Follow-up|27|||
144668639|NCT01324622|521637594|FG000|Overall Study|Lost to Follow-up|7|||
144668640|NCT01324622|521637595|FG001|Overall Study|Lost to Follow-up|7|||
144668641|NCT01324622|521637594|FG000|Overall Study|Death|1|||
144668642|NCT01324622|521637595|FG001|Overall Study|Death|0|||
144668643|NCT01324622|521637594|FG000|Overall Study|Lack of Efficacy|1|||
144668644|NCT01324622|521637595|FG001|Overall Study|Lack of Efficacy|0|||
144668645|NCT00618449|521637596|FG000|Overall Study|Lost to Follow-up|98|||
144668646|NCT00618449|521637597|FG001|Overall Study|Lost to Follow-up|110|||
144668647|NCT02219087|521637598|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
144668648|NCT02219087|521637599|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
144668649|NCT00413062|521637600|FG000|Overall Study|Adverse event/serious adverse event|289|||
144668650|NCT00413062|521637601|FG001|Overall Study|Adverse event/serious adverse event|56|||
144668651|NCT00413062|521637600|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
144668652|NCT00413062|521637601|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
144668653|NCT00413062|521637600|FG000|Overall Study|Withdrawal of informed consent|111|||
144668654|NCT00413062|521637601|FG001|Overall Study|Withdrawal of informed consent|36|||
144668655|NCT00413062|521637600|FG000|Overall Study|Pregnancy|15|||
144668656|NCT00413062|521637601|FG001|Overall Study|Pregnancy|5|||
144668657|NCT00413062|521637600|FG000|Overall Study|Pregnancy wish|17|||
144668658|NCT00413062|521637601|FG001|Overall Study|Pregnancy wish|6|||
144668659|NCT00413062|521637600|FG000|Overall Study|Lost to Follow-up|175|||
144668660|NCT00413062|521637601|FG001|Overall Study|Lost to Follow-up|73|||
144668661|NCT00413062|521637600|FG000|Overall Study|Other reason|70|||
144668662|NCT00413062|521637601|FG001|Overall Study|Other reason|34|||
144668663|NCT02815293|521637604|FG000|Overall Study|Study termination by sponsor|10|||
144668664|NCT02815293|521637605|FG001|Overall Study|Study termination by sponsor|7|||
144668665|NCT02815293|521637606|FG002|Overall Study|Study termination by sponsor|0|||
144668666|NCT02815293|521637604|FG000|Overall Study|Participants not randomized|0|||
144668667|NCT02815293|521637605|FG001|Overall Study|Participants not randomized|0|||
144668668|NCT02815293|521637606|FG002|Overall Study|Participants not randomized|18|||
144668669|NCT02815293|521637604|FG000|Overall Study|Adverse Event|0|||
144668670|NCT02815293|521637605|FG001|Overall Study|Adverse Event|1|||
144668671|NCT02815293|521637606|FG002|Overall Study|Adverse Event|0|||
144668672|NCT00006604|521637607|FG000|Overall Study|Met study objective - no further FU|1|||
144668673|NCT00006604|521637608|FG001|Overall Study|Met study objective - no further FU|0|||
144668674|NCT00006604|521637609|FG002|Overall Study|Met study objective - no further FU|0|||
144668675|NCT00006604|521637610|FG003|Overall Study|Met study objective - no further FU|0|||
144668676|NCT00006604|521637611|FG004|Overall Study|Met study objective - no further FU|0|||
144668677|NCT00006604|521637612|FG005|Overall Study|Met study objective - no further FU|0|||
144668678|NCT00006604|521637613|FG006|Overall Study|Met study objective - no further FU|0|||
144668679|NCT00006604|521637614|FG007|Overall Study|Met study objective - no further FU|0|||
144668680|NCT00006604|521637615|FG008|Overall Study|Met study objective - no further FU|0|||
144668681|NCT00006604|521637616|FG009|Overall Study|Met study objective - no further FU|0|||
144668682|NCT00006604|521637617|FG010|Overall Study|Met study objective - no further FU|0|||
144668683|NCT00006604|521637618|FG011|Overall Study|Met study objective - no further FU|0|||
144668684|NCT00006604|521637619|FG012|Overall Study|Met study objective - no further FU|0|||
144668685|NCT00006604|521637620|FG013|Overall Study|Met study objective - no further FU|0|||
144668686|NCT00006604|521637621|FG014|Overall Study|Met study objective - no further FU|1|||
144668687|NCT00006604|521637622|FG015|Overall Study|Met study objective - no further FU|1|||
144668688|NCT00006604|521637623|FG016|Overall Study|Met study objective - no further FU|0|||
144668689|NCT00006604|521637607|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
144668690|NCT00006604|521637608|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
144668691|NCT00006604|521637609|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
144668692|NCT00006604|521637610|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
144668693|NCT00006604|521637611|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
144668694|NCT00006604|521637612|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
144668695|NCT00006604|521637613|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
144668696|NCT00006604|521637614|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
144668697|NCT00006604|521637615|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
144668698|NCT00006604|521637616|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
144668699|NCT00006604|521637617|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
144668700|NCT00006604|521637618|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
144668701|NCT00006604|521637619|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
144668702|NCT00006604|521637620|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
144668703|NCT00006604|521637621|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
144668704|NCT00006604|521637622|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
144668705|NCT00006604|521637623|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
144668706|NCT00006604|521637607|FG000|Overall Study|Death|0|||
144668707|NCT00006604|521637608|FG001|Overall Study|Death|0|||
144668708|NCT00006604|521637609|FG002|Overall Study|Death|0|||
144668709|NCT00006604|521637610|FG003|Overall Study|Death|0|||
144668710|NCT00006604|521637611|FG004|Overall Study|Death|0|||
144668711|NCT00006604|521637612|FG005|Overall Study|Death|0|||
144668712|NCT00006604|521637613|FG006|Overall Study|Death|0|||
144668713|NCT00006604|521637614|FG007|Overall Study|Death|0|||
144668714|NCT00006604|521637615|FG008|Overall Study|Death|0|||
144668715|NCT00006604|521637616|FG009|Overall Study|Death|1|||
144668716|NCT00006604|521637617|FG010|Overall Study|Death|1|||
144668717|NCT00006604|521637618|FG011|Overall Study|Death|1|||
144668718|NCT00006604|521637619|FG012|Overall Study|Death|0|||
144668719|NCT00006604|521637620|FG013|Overall Study|Death|0|||
144668720|NCT00006604|521637621|FG014|Overall Study|Death|0|||
144668721|NCT00006604|521637622|FG015|Overall Study|Death|0|||
144668722|NCT00006604|521637623|FG016|Overall Study|Death|0|||
144668723|NCT00006604|521637607|FG000|Overall Study|Severe debilitation, unable to continue|0|||
144668724|NCT00006604|521637608|FG001|Overall Study|Severe debilitation, unable to continue|0|||
144668725|NCT00006604|521637609|FG002|Overall Study|Severe debilitation, unable to continue|0|||
144668726|NCT00006604|521637610|FG003|Overall Study|Severe debilitation, unable to continue|0|||
144668727|NCT00006604|521637611|FG004|Overall Study|Severe debilitation, unable to continue|0|||
144668728|NCT00006604|521637612|FG005|Overall Study|Severe debilitation, unable to continue|0|||
144668729|NCT00006604|521637613|FG006|Overall Study|Severe debilitation, unable to continue|3|||
144668730|NCT00006604|521637614|FG007|Overall Study|Severe debilitation, unable to continue|0|||
144668731|NCT00006604|521637615|FG008|Overall Study|Severe debilitation, unable to continue|0|||
144668732|NCT00006604|521637616|FG009|Overall Study|Severe debilitation, unable to continue|5|||
144668733|NCT00006604|521637617|FG010|Overall Study|Severe debilitation, unable to continue|0|||
144668734|NCT00006604|521637618|FG011|Overall Study|Severe debilitation, unable to continue|2|||
144668735|NCT00006604|521637619|FG012|Overall Study|Severe debilitation, unable to continue|1|||
144668736|NCT00006604|521637620|FG013|Overall Study|Severe debilitation, unable to continue|0|||
144668737|NCT00006604|521637621|FG014|Overall Study|Severe debilitation, unable to continue|2|||
144668738|NCT00006604|521637622|FG015|Overall Study|Severe debilitation, unable to continue|0|||
144668739|NCT00006604|521637623|FG016|Overall Study|Severe debilitation, unable to continue|0|||
144668740|NCT00006604|521637607|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
144668741|NCT00006604|521637608|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
144668742|NCT00006604|521637609|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
144668743|NCT00006604|521637610|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
144668744|NCT00006604|521637611|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
144668745|NCT00006604|521637612|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
144668746|NCT00006604|521637613|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
144668747|NCT00006604|521637614|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
144668748|NCT00006604|521637615|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
144668749|NCT00006604|521637616|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
144668750|NCT00006604|521637617|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
144668751|NCT00006604|521637618|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
144668752|NCT00006604|521637619|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
144668753|NCT00006604|521637620|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
144668754|NCT00006604|521637621|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
144668755|NCT00006604|521637622|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
144668756|NCT00006604|521637623|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
144668757|NCT00006604|521637607|FG000|Overall Study|Site closing|0|||
144668758|NCT00006604|521637608|FG001|Overall Study|Site closing|0|||
144668759|NCT00006604|521637609|FG002|Overall Study|Site closing|1|||
144668760|NCT00006604|521637610|FG003|Overall Study|Site closing|1|||
144668761|NCT00006604|521637611|FG004|Overall Study|Site closing|0|||
144668762|NCT00006604|521637612|FG005|Overall Study|Site closing|0|||
144668763|NCT00006604|521637613|FG006|Overall Study|Site closing|0|||
144668764|NCT00006604|521637614|FG007|Overall Study|Site closing|1|||
144668765|NCT00006604|521637615|FG008|Overall Study|Site closing|0|||
144668766|NCT00006604|521637616|FG009|Overall Study|Site closing|0|||
144668767|NCT00006604|521637617|FG010|Overall Study|Site closing|0|||
144668768|NCT00006604|521637618|FG011|Overall Study|Site closing|1|||
144668769|NCT00006604|521637619|FG012|Overall Study|Site closing|1|||
144668770|NCT00006604|521637620|FG013|Overall Study|Site closing|1|||
144668771|NCT00006604|521637621|FG014|Overall Study|Site closing|0|||
144668772|NCT00006604|521637622|FG015|Overall Study|Site closing|0|||
144668773|NCT00006604|521637623|FG016|Overall Study|Site closing|1|||
144217688|NCT02038010|519990361|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
144668774|NCT00006604|521637607|FG000|Overall Study|Withdrawal by Subject|1|||
144668775|NCT00006604|521637608|FG001|Overall Study|Withdrawal by Subject|0|||
144668776|NCT00006604|521637609|FG002|Overall Study|Withdrawal by Subject|2|||
144668777|NCT00006604|521637610|FG003|Overall Study|Withdrawal by Subject|0|||
144668778|NCT00006604|521637611|FG004|Overall Study|Withdrawal by Subject|1|||
144668779|NCT00006604|521637612|FG005|Overall Study|Withdrawal by Subject|2|||
144668780|NCT00006604|521637613|FG006|Overall Study|Withdrawal by Subject|2|||
144668781|NCT00006604|521637614|FG007|Overall Study|Withdrawal by Subject|0|||
144668782|NCT00006604|521637615|FG008|Overall Study|Withdrawal by Subject|1|||
144668783|NCT00006604|521637616|FG009|Overall Study|Withdrawal by Subject|3|||
144668784|NCT00006604|521637617|FG010|Overall Study|Withdrawal by Subject|2|||
144668785|NCT00006604|521637618|FG011|Overall Study|Withdrawal by Subject|0|||
144668786|NCT00006604|521637619|FG012|Overall Study|Withdrawal by Subject|1|||
144668787|NCT00006604|521637620|FG013|Overall Study|Withdrawal by Subject|2|||
144668788|NCT00006604|521637621|FG014|Overall Study|Withdrawal by Subject|1|||
144668789|NCT00006604|521637622|FG015|Overall Study|Withdrawal by Subject|0|||
144668790|NCT00006604|521637623|FG016|Overall Study|Withdrawal by Subject|1|||
144668791|NCT00006604|521637607|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
144668792|NCT00006604|521637608|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
144668793|NCT00006604|521637609|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
144668794|NCT00006604|521637610|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
144668795|NCT00006604|521637611|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
144668796|NCT00006604|521637612|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
144668797|NCT00006604|521637613|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
144668798|NCT00006604|521637614|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
144668799|NCT00006604|521637615|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
144668800|NCT00006604|521637616|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
144668801|NCT00006604|521637617|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
144668802|NCT00006604|521637618|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
144668803|NCT00006604|521637619|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
144668804|NCT00006604|521637620|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
144668805|NCT00006604|521637621|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
144668806|NCT00006604|521637622|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
144668807|NCT00006604|521637623|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
144668808|NCT00006604|521637607|FG000|Overall Study|Lost to Follow-up|0|||
144668809|NCT00006604|521637608|FG001|Overall Study|Lost to Follow-up|0|||
144668810|NCT00006604|521637609|FG002|Overall Study|Lost to Follow-up|0|||
144668811|NCT00006604|521637610|FG003|Overall Study|Lost to Follow-up|0|||
144668812|NCT00006604|521637611|FG004|Overall Study|Lost to Follow-up|0|||
144668813|NCT00006604|521637612|FG005|Overall Study|Lost to Follow-up|0|||
144668814|NCT00006604|521637613|FG006|Overall Study|Lost to Follow-up|0|||
144668815|NCT00006604|521637614|FG007|Overall Study|Lost to Follow-up|1|||
144668816|NCT00006604|521637615|FG008|Overall Study|Lost to Follow-up|0|||
144668817|NCT00006604|521637616|FG009|Overall Study|Lost to Follow-up|2|||
144668818|NCT00006604|521637617|FG010|Overall Study|Lost to Follow-up|0|||
144668819|NCT00006604|521637618|FG011|Overall Study|Lost to Follow-up|0|||
144668820|NCT00006604|521637619|FG012|Overall Study|Lost to Follow-up|0|||
144668821|NCT00006604|521637620|FG013|Overall Study|Lost to Follow-up|0|||
144668822|NCT00006604|521637621|FG014|Overall Study|Lost to Follow-up|0|||
144668823|NCT00006604|521637622|FG015|Overall Study|Lost to Follow-up|1|||
144668824|NCT00006604|521637623|FG016|Overall Study|Lost to Follow-up|3|||
144668825|NCT00006604|521637607|FG000|Overall Study|Other Reason|0|||
144668826|NCT00006604|521637608|FG001|Overall Study|Other Reason|0|||
144668827|NCT00006604|521637609|FG002|Overall Study|Other Reason|0|||
144668828|NCT00006604|521637610|FG003|Overall Study|Other Reason|0|||
144668829|NCT00006604|521637611|FG004|Overall Study|Other Reason|0|||
144668830|NCT00006604|521637612|FG005|Overall Study|Other Reason|1|||
144668831|NCT00006604|521637613|FG006|Overall Study|Other Reason|0|||
144668832|NCT00006604|521637614|FG007|Overall Study|Other Reason|0|||
144668833|NCT00006604|521637615|FG008|Overall Study|Other Reason|0|||
144668834|NCT00006604|521637616|FG009|Overall Study|Other Reason|1|||
144668835|NCT00006604|521637617|FG010|Overall Study|Other Reason|0|||
144668836|NCT00006604|521637618|FG011|Overall Study|Other Reason|0|||
144668837|NCT00006604|521637619|FG012|Overall Study|Other Reason|0|||
144668838|NCT00006604|521637620|FG013|Overall Study|Other Reason|0|||
144668839|NCT00006604|521637621|FG014|Overall Study|Other Reason|0|||
144668840|NCT00006604|521637622|FG015|Overall Study|Other Reason|0|||
144668841|NCT00006604|521637623|FG016|Overall Study|Other Reason|0|||
144668842|NCT02431468|521637626|FG000|Overall Study|Adverse Event|2|||
144668843|NCT02431468|521637627|FG001|Overall Study|Adverse Event|4|||
144668844|NCT02431468|521637628|FG002|Overall Study|Adverse Event|5|||
144668845|NCT02431468|521637626|FG000|Overall Study|Withdrawal by Subject|4|||
144668846|NCT02431468|521637627|FG001|Overall Study|Withdrawal by Subject|12|||
144668847|NCT02431468|521637628|FG002|Overall Study|Withdrawal by Subject|2|||
144668848|NCT02431468|521637626|FG000|Overall Study|noncompliance, investigator termination,|2|||
144668849|NCT02431468|521637627|FG001|Overall Study|noncompliance, investigator termination,|2|||
144668850|NCT02431468|521637628|FG002|Overall Study|noncompliance, investigator termination,|2|||
144668851|NCT01361919|521637629|FG000|Overall Study|technical issues|10|||
144668852|NCT01361919|521637630|FG001|Overall Study|technical issues|12|||
144668853|NCT01361919|521637631|FG002|Overall Study|technical issues|10|||
144668854|NCT01056341|521637632|FG000|Overall Study|Treatment Intolerance|0|||
144668855|NCT01056341|521637633|FG001|Overall Study|Treatment Intolerance|2|||
144668856|NCT01056341|521637634|FG002|Overall Study|Treatment Intolerance|0|||
144668857|NCT01056341|521637635|FG003|Overall Study|Treatment Intolerance|2|||
144668858|NCT01056341|521637636|FG004|Overall Study|Treatment Intolerance|0|||
144668859|NCT01056341|521637632|FG000|Overall Study|Lack of Efficacy|32|||
144668860|NCT01056341|521637633|FG001|Overall Study|Lack of Efficacy|30|||
144668861|NCT01056341|521637634|FG002|Overall Study|Lack of Efficacy|7|||
144668862|NCT01056341|521637635|FG003|Overall Study|Lack of Efficacy|25|||
144668863|NCT01056341|521637636|FG004|Overall Study|Lack of Efficacy|9|||
144668864|NCT01056341|521637632|FG000|Overall Study|Other reasons|4|||
144668865|NCT01056341|521637633|FG001|Overall Study|Other reasons|4|||
144668866|NCT01056341|521637634|FG002|Overall Study|Other reasons|8|||
144668867|NCT01056341|521637635|FG003|Overall Study|Other reasons|9|||
144668868|NCT01056341|521637636|FG004|Overall Study|Other reasons|5|||
144668869|NCT01086150|521637637|FG000|Overall Study|Withdrawal by Subject|0|||
144668870|NCT01086150|521637638|FG001|Overall Study|Withdrawal by Subject|4|||
144668871|NCT01086150|521637639|FG002|Overall Study|Withdrawal by Subject|1|||
144668872|NCT01086150|521637637|FG000|Overall Study|Lost to Follow-up|0|||
144668873|NCT01086150|521637638|FG001|Overall Study|Lost to Follow-up|1|||
144668874|NCT01086150|521637639|FG002|Overall Study|Lost to Follow-up|0|||
144668875|NCT01086150|521637637|FG000|Overall Study|Screen Failure|0|||
144668876|NCT01086150|521637638|FG001|Overall Study|Screen Failure|1|||
144668877|NCT01086150|521637639|FG002|Overall Study|Screen Failure|0|||
144668878|NCT03543358|521637644|FG000|Overall Study|Death|1|||
144668879|NCT03543358|521637645|FG001|Overall Study|Death|0|||
144668880|NCT03543358|521637644|FG000|Overall Study|Disease Progression|1|||
144668881|NCT03543358|521637645|FG001|Overall Study|Disease Progression|0|||
144668882|NCT03543358|521637644|FG000|Overall Study|Parent Study Closure|1|||
144668883|NCT03543358|521637645|FG001|Overall Study|Parent Study Closure|0|||
144668884|NCT03589885|521637646|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
144668885|NCT03589885|521637647|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
144668886|NCT03589885|521637648|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
144668887|NCT03589885|521637649|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
144668888|NCT03589885|521637650|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
144668889|NCT03589885|521637646|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
144668890|NCT03589885|521637647|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
144668891|NCT03589885|521637648|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
144668892|NCT03589885|521637649|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
144668893|NCT03589885|521637650|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
144668894|NCT03589885|521637646|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
144668895|NCT03589885|521637647|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
144668896|NCT03589885|521637648|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
144668897|NCT03589885|521637649|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
144668898|NCT03589885|521637650|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
144668899|NCT03589885|521637646|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
144668900|NCT03589885|521637647|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
144668901|NCT03589885|521637648|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
144668902|NCT03589885|521637649|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
144668903|NCT03589885|521637650|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
144668904|NCT03589885|521637646|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
144668905|NCT03589885|521637647|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
144668906|NCT03589885|521637648|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
144668907|NCT03589885|521637649|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
144668908|NCT03589885|521637650|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
144668909|NCT03589885|521637646|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
144668910|NCT03589885|521637647|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
144668911|NCT03589885|521637648|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
144668912|NCT03589885|521637649|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
144668913|NCT03589885|521637650|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
144668914|NCT03589885|521637646|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
144668915|NCT03589885|521637647|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
144217689|NCT02038010|519990362|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
144217690|NCT02038010|519990359|FG000|Follow Up|Death|4|||
144668916|NCT03589885|521637648|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
144668917|NCT03589885|521637649|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
144217691|NCT02038010|519990360|FG001|Follow Up|Death|3|||
144668918|NCT03589885|521637650|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
144733898|NCT05472038|521883534|FG003|Overall Study|Protocol Violation|0|||
144733899|NCT05472038|521883535|FG004|Overall Study|Protocol Violation|0|||
144217692|NCT02038010|519990361|FG002|Follow Up|Death|0|||
144217693|NCT02038010|519990362|FG003|Follow Up|Death|0|||
144217694|NCT02038010|519990359|FG000|Follow Up|Other|3|||
144217695|NCT02038010|519990360|FG001|Follow Up|Other|0|||
144217696|NCT02038010|519990361|FG002|Follow Up|Other|0|||
144217697|NCT02038010|519990362|FG003|Follow Up|Other|0|||
144217698|NCT02536846|519990365|FG000|Overall Study|Withdrawal by Subject|1|||
144217699|NCT02123446|519990366|FG000|Washout Period (1 Day)|Physician Decision|1|||
144217700|NCT02123446|519990367|FG001|Washout Period (1 Day)|Physician Decision|0|||
144217701|NCT04388553|519990368|FG000|Overall Study|Protocol Violation|1|||
144217702|NCT04388553|519990369|FG001|Overall Study|Protocol Violation|0|||
144217703|NCT04604795|519990370|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
144217704|NCT04604795|519990371|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
144217705|NCT04604795|519990372|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217706|NCT04604795|519990373|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217707|NCT04604795|519990374|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217708|NCT04604795|519990375|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217709|NCT04604795|519990376|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217710|NCT04604795|519990377|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217711|NCT04604795|519990378|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217712|NCT04604795|519990379|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
144217713|NCT04604795|519990370|FG000|Part B: Up to Day 14|Adverse Event|0|||
144217714|NCT04604795|519990371|FG001|Part B: Up to Day 14|Adverse Event|0|||
144217715|NCT04604795|519990372|FG002|Part B: Up to Day 14|Adverse Event|0|||
144217716|NCT04604795|519990373|FG003|Part B: Up to Day 14|Adverse Event|0|||
144217717|NCT04604795|519990374|FG004|Part B: Up to Day 14|Adverse Event|2|||
144217718|NCT04604795|519990375|FG005|Part B: Up to Day 14|Adverse Event|1|||
144217719|NCT04604795|519990376|FG006|Part B: Up to Day 14|Adverse Event|0|||
144217720|NCT04604795|519990377|FG007|Part B: Up to Day 14|Adverse Event|0|||
144217721|NCT04604795|519990378|FG008|Part B: Up to Day 14|Adverse Event|0|||
144217722|NCT04604795|519990379|FG009|Part B: Up to Day 14|Adverse Event|0|||
144217723|NCT04604795|519990370|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217724|NCT04604795|519990371|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217725|NCT04604795|519990372|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217726|NCT04604795|519990373|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217727|NCT04604795|519990374|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217728|NCT04604795|519990375|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217729|NCT04604795|519990376|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217730|NCT04604795|519990377|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217731|NCT04604795|519990378|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
144217732|NCT04604795|519990379|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
144217733|NCT04604795|519990370|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217734|NCT04604795|519990371|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217735|NCT04604795|519990372|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217736|NCT04604795|519990373|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217737|NCT04604795|519990374|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217738|NCT04604795|519990375|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217739|NCT04604795|519990376|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217740|NCT04604795|519990377|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217741|NCT04604795|519990378|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
144217742|NCT04604795|519990379|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
144217743|NCT04604795|519990370|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217744|NCT04604795|519990371|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217745|NCT04604795|519990372|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217746|NCT04604795|519990373|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217747|NCT04604795|519990374|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217748|NCT04604795|519990375|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217749|NCT04604795|519990376|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217750|NCT04604795|519990377|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217751|NCT04604795|519990378|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
144217752|NCT04604795|519990379|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
144217753|NCT04604795|519990370|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217754|NCT04604795|519990371|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217755|NCT04604795|519990372|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217756|NCT04604795|519990373|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
144265592|NCT04456686|520173972|FG001|Overall Study|Protocol Violation|1|||
144217757|NCT04604795|519990374|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217758|NCT04604795|519990375|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217759|NCT04604795|519990376|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
144265593|NCT02456727|520173973|FG000|Overall Study|Lost to Follow-up|63|||
144265594|NCT02456727|520173974|FG001|Overall Study|Lost to Follow-up|65|||
144265595|NCT02456727|520173973|FG000|Overall Study|Death|2|||
144217760|NCT04604795|519990377|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217761|NCT04604795|519990378|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
144217762|NCT04604795|519990379|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
144217763|NCT02445963|519990389|FG000|Overall Study|Lost to Follow-up|1|||
144217764|NCT02445963|519990390|FG001|Overall Study|Lost to Follow-up|0|||
144217765|NCT02445963|519990391|FG002|Overall Study|Lost to Follow-up|0|||
144217766|NCT02445963|519990392|FG003|Overall Study|Lost to Follow-up|0|||
144217767|NCT02445963|519990389|FG000|Overall Study|Change in employment|1|||
144217768|NCT02445963|519990390|FG001|Overall Study|Change in employment|0|||
144217769|NCT02445963|519990391|FG002|Overall Study|Change in employment|0|||
144217770|NCT02445963|519990392|FG003|Overall Study|Change in employment|0|||
144217771|NCT02445963|519990389|FG000|Overall Study|Symptoms post-vaccination|0|||
144217772|NCT02445963|519990390|FG001|Overall Study|Symptoms post-vaccination|0|||
144217773|NCT02445963|519990391|FG002|Overall Study|Symptoms post-vaccination|1|||
144217774|NCT02445963|519990392|FG003|Overall Study|Symptoms post-vaccination|0|||
144217775|NCT01449812|519990396|FG000|Overall Study|Migrated/moved from study area|1|||
144217776|NCT01449812|519990397|FG001|Overall Study|Migrated/moved from study area|0|||
144217777|NCT01449812|519990398|FG002|Overall Study|Migrated/moved from study area|0|||
144217778|NCT01449812|519990396|FG000|Overall Study|Withdrawal by Subject|0|||
144217779|NCT01449812|519990397|FG001|Overall Study|Withdrawal by Subject|0|||
144217780|NCT01449812|519990398|FG002|Overall Study|Withdrawal by Subject|1|||
144217781|NCT01449812|519990396|FG000|Overall Study|Lost to Follow-up|1|||
144217782|NCT01449812|519990397|FG001|Overall Study|Lost to Follow-up|0|||
144217783|NCT01449812|519990398|FG002|Overall Study|Lost to Follow-up|0|||
144217784|NCT01855828|519990399|FG000|Overall Study|Adverse Event|1|||
144217785|NCT01855828|519990399|FG000|Overall Study|Withdrawal by Subject|1|||
144217786|NCT01866098|519990404|FG000|Overall Study|Lost to Follow-up|11|||
144217787|NCT01866098|519990405|FG001|Overall Study|Lost to Follow-up|18|||
144668919|NCT03589885|521637646|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
144668920|NCT03589885|521637647|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
144668921|NCT03589885|521637648|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
144668922|NCT03589885|521637649|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
144668923|NCT03589885|521637650|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
144668924|NCT00805545|521637651|FG000|Overall Study|Protocol Violation|3|||
144668925|NCT00805545|521637652|FG001|Overall Study|Protocol Violation|2|||
144668926|NCT00805545|521637651|FG000|Overall Study|Protocol Violation|3|||
144668927|NCT00805545|521637652|FG001|Overall Study|Protocol Violation|1|||
144668928|NCT02157506|521637657|FG000|Overall Study|Adverse Event|0|||
144668929|NCT02157506|521637658|FG001|Overall Study|Adverse Event|1|||
144668930|NCT02157506|521637659|FG002|Overall Study|Adverse Event|0|||
144668931|NCT02157506|521637660|FG003|Overall Study|Adverse Event|0|||
144668932|NCT02157506|521637661|FG004|Overall Study|Adverse Event|0|||
144668933|NCT02157506|521637657|FG000|Overall Study|Lost to Follow-up|0|||
144668934|NCT02157506|521637658|FG001|Overall Study|Lost to Follow-up|0|||
144668935|NCT02157506|521637659|FG002|Overall Study|Lost to Follow-up|1|||
144668936|NCT02157506|521637660|FG003|Overall Study|Lost to Follow-up|0|||
144668937|NCT02157506|521637661|FG004|Overall Study|Lost to Follow-up|0|||
144668938|NCT03927911|521639253|FG000|Overall Study|problems with eDiary|0|||
144668939|NCT03927911|521639254|FG001|Overall Study|problems with eDiary|1|||
144668940|NCT03927911|521639255|FG002|Overall Study|problems with eDiary|0|||
144668941|NCT03927911|521639256|FG003|Overall Study|problems with eDiary|1|||
144668942|NCT03927911|521639257|FG004|Overall Study|problems with eDiary|0|||
144668943|NCT03927911|521639258|FG005|Overall Study|problems with eDiary|4|||
144668944|NCT03927911|521639253|FG000|Overall Study|Adverse Event|0|||
144668945|NCT03927911|521639254|FG001|Overall Study|Adverse Event|0|||
144668946|NCT03927911|521639255|FG002|Overall Study|Adverse Event|0|||
144668947|NCT03927911|521639256|FG003|Overall Study|Adverse Event|0|||
144668948|NCT03927911|521639257|FG004|Overall Study|Adverse Event|0|||
144217788|NCT01866098|519990406|FG002|Overall Study|Lost to Follow-up|13|||
144217789|NCT01866098|519990404|FG000|Overall Study|Physician Decision|0|||
144217790|NCT01866098|519990405|FG001|Overall Study|Physician Decision|1|||
144217791|NCT01866098|519990406|FG002|Overall Study|Physician Decision|2|||
144217792|NCT01866098|519990404|FG000|Overall Study|Adverse Event|1|||
144217793|NCT01866098|519990405|FG001|Overall Study|Adverse Event|5|||
144217794|NCT01866098|519990406|FG002|Overall Study|Adverse Event|4|||
144668949|NCT03927911|521639258|FG005|Overall Study|Adverse Event|1|||
144668950|NCT03927911|521639253|FG000|Overall Study|not treated -study terminated by sponsor|0|||
144217795|NCT01866098|519990404|FG000|Overall Study|Protocol Violation|1|||
144217796|NCT01866098|519990405|FG001|Overall Study|Protocol Violation|0|||
144217797|NCT01866098|519990406|FG002|Overall Study|Protocol Violation|0|||
144217798|NCT01866098|519990404|FG000|Overall Study|Withdrawal by Subject|1|||
144217799|NCT01866098|519990405|FG001|Overall Study|Withdrawal by Subject|2|||
144668951|NCT03927911|521639254|FG001|Overall Study|not treated -study terminated by sponsor|1|||
144668952|NCT03927911|521639255|FG002|Overall Study|not treated -study terminated by sponsor|0|||
144668953|NCT03927911|521639256|FG003|Overall Study|not treated -study terminated by sponsor|0|||
144668954|NCT03927911|521639257|FG004|Overall Study|not treated -study terminated by sponsor|0|||
144668955|NCT03927911|521639258|FG005|Overall Study|not treated -study terminated by sponsor|0|||
144668956|NCT03927911|521639253|FG000|Overall Study|Surgery cancelled|0|||
144668957|NCT03927911|521639254|FG001|Overall Study|Surgery cancelled|0|||
144668958|NCT03927911|521639255|FG002|Overall Study|Surgery cancelled|0|||
144668959|NCT03927911|521639256|FG003|Overall Study|Surgery cancelled|1|||
144668960|NCT03927911|521639257|FG004|Overall Study|Surgery cancelled|0|||
144668961|NCT03927911|521639258|FG005|Overall Study|Surgery cancelled|1|||
144668962|NCT03927911|521639253|FG000|Overall Study|Protocol Violation|0|||
144668963|NCT03927911|521639254|FG001|Overall Study|Protocol Violation|0|||
144668964|NCT03927911|521639255|FG002|Overall Study|Protocol Violation|0|||
144668965|NCT03927911|521639256|FG003|Overall Study|Protocol Violation|0|||
144668966|NCT03927911|521639257|FG004|Overall Study|Protocol Violation|0|||
144668967|NCT03927911|521639258|FG005|Overall Study|Protocol Violation|1|||
144668968|NCT00562640|521639259|FG000|Overall Study|Death|0|||
144668969|NCT00562640|521639260|FG001|Overall Study|Death|1|||
144668970|NCT00562640|521639261|FG002|Overall Study|Death|1|||
144668971|NCT00562640|521639262|FG003|Overall Study|Death|0|||
144668972|NCT05263921|521639263|FG000|Overall Study|Other: family emergency.|0|||
144668973|NCT05263921|521639264|FG001|Overall Study|Other: family emergency.|0|||
144668974|NCT05263921|521639265|FG002|Overall Study|Other: family emergency.|1|||
144668975|NCT05263921|521639266|FG003|Overall Study|Other: family emergency.|0|||
144668976|NCT01412151|521639267|FG000|Week 0 - 306 - Treatment Period|Death|1|||
144668977|NCT01412151|521639267|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
144668978|NCT01412151|521639267|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
144668979|NCT01412151|521639267|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
144668980|NCT03127852|521639268|FG000|Overall Study|Withdrawal by Subject|4|||
144668981|NCT03127852|521639269|FG001|Overall Study|Withdrawal by Subject|1|||
144668982|NCT03127852|521639268|FG000|Overall Study|Death|1|||
144668983|NCT03127852|521639269|FG001|Overall Study|Death|1|||
144668984|NCT02670928|521639270|FG000|Overall Study|Adverse Event|3|||
144668985|NCT02670928|521639271|FG001|Overall Study|Adverse Event|1|||
144668986|NCT02670928|521639270|FG000|Overall Study|Withdrawal by Subject|4|||
144668987|NCT02670928|521639271|FG001|Overall Study|Withdrawal by Subject|0|||
144668988|NCT02670928|521639270|FG000|Overall Study|Lost to Follow-up|1|||
144668989|NCT02670928|521639271|FG001|Overall Study|Lost to Follow-up|0|||
144668990|NCT02670928|521639270|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
144668991|NCT02670928|521639271|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
144668992|NCT02591238|521639272|FG000|Overall Study|Pregnancy|1|||
144668993|NCT02591238|521639273|FG001|Overall Study|Pregnancy|0|||
144668994|NCT02591238|521639274|FG002|Overall Study|Pregnancy|0|||
144668995|NCT02591238|521639275|FG003|Overall Study|Pregnancy|0|||
144668996|NCT02591238|521639272|FG000|Overall Study|Withdrawal by Subject|0|||
144668997|NCT02591238|521639273|FG001|Overall Study|Withdrawal by Subject|0|||
144668998|NCT02591238|521639274|FG002|Overall Study|Withdrawal by Subject|0|||
144668999|NCT02591238|521639275|FG003|Overall Study|Withdrawal by Subject|1|||
144669000|NCT02591238|521639272|FG000|Overall Study|influenza|0|||
144669001|NCT02591238|521639273|FG001|Overall Study|influenza|0|||
144669002|NCT02591238|521639274|FG002|Overall Study|influenza|0|||
144669003|NCT02591238|521639275|FG003|Overall Study|influenza|1|||
144669004|NCT02591238|521639272|FG000|Overall Study|personal circumstances|0|||
144669005|NCT02591238|521639273|FG001|Overall Study|personal circumstances|0|||
144669006|NCT02591238|521639274|FG002|Overall Study|personal circumstances|0|||
144669007|NCT02591238|521639275|FG003|Overall Study|personal circumstances|1|||
144669008|NCT02591238|521639272|FG000|Overall Study|personal circumstances|0|||
144669009|NCT02591238|521639273|FG001|Overall Study|personal circumstances|1|||
144669010|NCT02591238|521639274|FG002|Overall Study|personal circumstances|0|||
144669011|NCT02591238|521639275|FG003|Overall Study|personal circumstances|0|||
144669012|NCT00525785|521639279|FG000|Overall Study|Withdrawal by Subject|1|||
144669013|NCT00525785|521639279|FG000|Overall Study|Lack of Efficacy|1|||
144669014|NCT00525785|521639279|FG000|Overall Study|Physician Decision|1|||
144669015|NCT02016898|521639280|FG000|Overall Study|Death|1|||
144669016|NCT02016898|521639281|FG001|Overall Study|Death|1|||
144669017|NCT02016898|521639280|FG000|Overall Study|Lost to Follow-up|4|||
144669018|NCT02016898|521639281|FG001|Overall Study|Lost to Follow-up|4|||
144669019|NCT00973622|521639282|FG000|Overall Study|did not attend MRI|14|||
144669020|NCT00973622|521639283|FG001|Overall Study|did not attend MRI|3|||
144217800|NCT01866098|519990406|FG002|Overall Study|Withdrawal by Subject|0|||
144217801|NCT01866098|519990404|FG000|Overall Study|Unrelated Hospitalization|2|||
144217802|NCT01866098|519990405|FG001|Overall Study|Unrelated Hospitalization|0|||
144217803|NCT01866098|519990406|FG002|Overall Study|Unrelated Hospitalization|1|||
144669021|NCT00973622|521639282|FG000|Overall Study|did not pass MRI screen|6|||
144669022|NCT00973622|521639283|FG001|Overall Study|did not pass MRI screen|0|||
144669023|NCT00973622|521639282|FG000|Overall Study|did not complete rTMS sessions|11|||
144669024|NCT00973622|521639283|FG001|Overall Study|did not complete rTMS sessions|2|||
144669025|NCT00830960|521639284|FG000|Overall Study|Death|5|||
144669026|NCT00830960|521639285|FG001|Overall Study|Death|4|||
144669027|NCT00830960|521639286|FG002|Overall Study|Death|3|||
144669028|NCT00830960|521639287|FG003|Overall Study|Death|2|||
144669029|NCT00830960|521639288|FG004|Overall Study|Death|6|||
144669030|NCT00830960|521639289|FG005|Overall Study|Death|1|||
144669031|NCT00830960|521639284|FG000|Overall Study|Lost to Follow-up|1|||
144669032|NCT00830960|521639285|FG001|Overall Study|Lost to Follow-up|1|||
144669033|NCT00830960|521639286|FG002|Overall Study|Lost to Follow-up|1|||
144669034|NCT00830960|521639287|FG003|Overall Study|Lost to Follow-up|0|||
144669035|NCT00830960|521639288|FG004|Overall Study|Lost to Follow-up|0|||
144669036|NCT00830960|521639289|FG005|Overall Study|Lost to Follow-up|1|||
144669037|NCT00830960|521639284|FG000|Overall Study|Withdrawal by Subject|19|||
144669038|NCT00830960|521639285|FG001|Overall Study|Withdrawal by Subject|19|||
144669039|NCT00830960|521639286|FG002|Overall Study|Withdrawal by Subject|18|||
144669040|NCT00830960|521639287|FG003|Overall Study|Withdrawal by Subject|23|||
144669041|NCT00830960|521639288|FG004|Overall Study|Withdrawal by Subject|16|||
144669042|NCT00830960|521639289|FG005|Overall Study|Withdrawal by Subject|21|||
144669043|NCT00830960|521639284|FG000|Overall Study|Sponsor Decision|1|||
144669044|NCT00830960|521639285|FG001|Overall Study|Sponsor Decision|2|||
144669045|NCT00830960|521639286|FG002|Overall Study|Sponsor Decision|3|||
144669046|NCT00830960|521639287|FG003|Overall Study|Sponsor Decision|4|||
144669047|NCT00830960|521639288|FG004|Overall Study|Sponsor Decision|5|||
144669048|NCT00830960|521639289|FG005|Overall Study|Sponsor Decision|7|||
144669049|NCT00830960|521639284|FG000|Overall Study|No study drug received|7|||
144669050|NCT00830960|521639285|FG001|Overall Study|No study drug received|2|||
144669051|NCT00830960|521639286|FG002|Overall Study|No study drug received|4|||
144669052|NCT00830960|521639287|FG003|Overall Study|No study drug received|3|||
144669053|NCT00830960|521639288|FG004|Overall Study|No study drug received|5|||
144669054|NCT00830960|521639289|FG005|Overall Study|No study drug received|7|||
144669055|NCT03074149|521639290|FG000|Overall Study|Reason unknown|22|||
144669056|NCT03074149|521639291|FG001|Overall Study|Reason unknown|35|||
144669057|NCT03074149|521639290|FG000|Overall Study|Death|10|||
144669058|NCT03074149|521639291|FG001|Overall Study|Death|45|||
144669059|NCT02855450|521639296|FG000|Overall Study|Adverse Event|1|||
144669060|NCT02855450|521639297|FG001|Overall Study|Adverse Event|0|||
144669061|NCT02855450|521639296|FG000|Overall Study|Lost to Follow-up|4|||
144669062|NCT02855450|521639297|FG001|Overall Study|Lost to Follow-up|0|||
144669063|NCT01504971|521639298|FG000|Overall Study|Physician Decision|13|||
144669064|NCT01803711|521639305|FG000|Overall Study|Adverse Event|1|||
144669065|NCT01803711|521639306|FG001|Overall Study|Adverse Event|1|||
144669066|NCT00225212|521639307|FG000|Overall Study|Disease progression|2|||
144669067|NCT00225212|521639307|FG000|Overall Study|Death|1|||
144669068|NCT00225212|521639307|FG000|Overall Study|Adverse Event|2|||
144669069|NCT00225212|521639307|FG000|Overall Study|Intercurrent illness|1|||
144669070|NCT01376245|521639310|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
144669071|NCT01376245|521639311|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
144669072|NCT01376245|521639312|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
144669073|NCT01376245|521639313|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
144669074|NCT01376245|521639314|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
144669075|NCT01376245|521639310|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
144669076|NCT01376245|521639311|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
144669077|NCT01376245|521639312|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
144669078|NCT01376245|521639313|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
144669079|NCT01376245|521639314|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
144669080|NCT01376245|521639310|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
144669081|NCT01376245|521639311|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
144669082|NCT01376245|521639312|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
144669083|NCT01376245|521639313|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
144669084|NCT01376245|521639314|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
144669085|NCT01376245|521639310|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
144669086|NCT01376245|521639311|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
144669087|NCT01376245|521639312|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
144669088|NCT01376245|521639313|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
144669089|NCT01376245|521639314|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
144669090|NCT01376245|521639310|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
144669091|NCT01376245|521639311|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
144669092|NCT01376245|521639312|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
144669093|NCT01376245|521639313|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
144669094|NCT01376245|521639314|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
144669095|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
144669096|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
144669097|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
144669098|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
144669099|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
144217804|NCT01866098|519990404|FG000|Overall Study|Non-compliance|1|||
144217805|NCT01866098|519990405|FG001|Overall Study|Non-compliance|0|||
144669100|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
144669101|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
144669102|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
144669103|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
144669104|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
144669105|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
144669106|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
144669107|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
144669108|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
144669109|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
144669110|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
144669111|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
144669112|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
144669113|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
144669114|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
144669115|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144669116|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
144669117|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144669118|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
144669119|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
144669120|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
144669121|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
144669122|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
144669123|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
144669124|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
144669125|NCT01376245|521639310|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144669126|NCT01376245|521639311|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
144669127|NCT01376245|521639312|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
144669128|NCT01376245|521639313|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
144669129|NCT01376245|521639314|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
144669130|NCT01357889|521639315|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
144669131|NCT01357889|521639316|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
144669132|NCT01357889|521639315|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
144669133|NCT01357889|521639316|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
144669134|NCT01357889|521639315|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
144669135|NCT01357889|521639316|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
144669136|NCT01357889|521639315|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
144669137|NCT01357889|521639316|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
144669138|NCT01357889|521639315|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
144669139|NCT01357889|521639316|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
144669140|NCT01357889|521639315|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
144669141|NCT01357889|521639316|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
144669142|NCT01357889|521639315|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
144669143|NCT01357889|521639316|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
144669144|NCT01357889|521639315|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
144669145|NCT01357889|521639316|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
144669146|NCT01357889|521639315|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
144669147|NCT01357889|521639316|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
144669148|NCT01357889|521639315|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
144669149|NCT01357889|521639316|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
144669150|NCT01357889|521639315|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
144669151|NCT01357889|521639316|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
144217806|NCT01866098|519990406|FG002|Overall Study|Non-compliance|1|||
144217807|NCT01866098|519990404|FG000|Overall Study|Pregnancy|2|||
144217808|NCT01866098|519990405|FG001|Overall Study|Pregnancy|0|||
144217809|NCT01866098|519990406|FG002|Overall Study|Pregnancy|0|||
144217810|NCT01866098|519990404|FG000|Overall Study|Death|0|||
144217811|NCT01866098|519990405|FG001|Overall Study|Death|1|||
144217812|NCT01866098|519990406|FG002|Overall Study|Death|0|||
144217813|NCT04239027|519990407|FG000|Overall Study|Adverse Event|4|||
144217814|NCT04239027|519990407|FG000|Overall Study|Withdrawal by Subject|9|||
144217815|NCT04239027|519990407|FG000|Overall Study|Death|1|||
144217816|NCT04239027|519990407|FG000|Overall Study|Physician Decision|9|||
144217817|NCT04239027|519990407|FG000|Overall Study|Lost to Follow-up|2|||
144217818|NCT04239027|519990407|FG000|Overall Study|Lack of Efficacy|1|||
144217819|NCT02517463|519990414|FG000|Overall Study|Lost to Follow-up|5|||
144669152|NCT01357889|521639315|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
144217820|NCT02517463|519990415|FG001|Overall Study|Lost to Follow-up|2|||
144217821|NCT03449446|519990416|FG000|Overall Study|Randomized but Never Treated|0|||
144217822|NCT03449446|519990417|FG001|Overall Study|Randomized but Never Treated|0|||
144217823|NCT03449446|519990418|FG002|Overall Study|Randomized but Never Treated|1|||
144217824|NCT03449446|519990419|FG003|Overall Study|Randomized but Never Treated|1|||
144217825|NCT03449446|519990420|FG004|Overall Study|Randomized but Never Treated|1|||
144217826|NCT03449446|519990421|FG005|Overall Study|Randomized but Never Treated|0|||
144733900|NCT05472038|521883536|FG005|Overall Study|Protocol Violation|0|||
144733901|NCT05472038|521883537|FG006|Overall Study|Protocol Violation|0|||
144733902|NCT05472038|521883538|FG007|Overall Study|Protocol Violation|1|||
144733903|NCT05472038|521883539|FG008|Overall Study|Protocol Violation|1|||
144733904|NCT05472038|521883540|FG009|Overall Study|Protocol Violation|1|||
144733905|NCT05472038|521883541|FG010|Overall Study|Protocol Violation|1|||
144217827|NCT03449446|519990422|FG006|Overall Study|Randomized but Never Treated|0|||
144217828|NCT03449446|519990416|FG000|Overall Study|Unknown Reason|33|||
144217829|NCT03449446|519990417|FG001|Overall Study|Unknown Reason|1|||
144217830|NCT03449446|519990418|FG002|Overall Study|Unknown Reason|1|||
144217831|NCT03449446|519990419|FG003|Overall Study|Unknown Reason|1|||
144217832|NCT03449446|519990420|FG004|Overall Study|Unknown Reason|2|||
144217833|NCT03449446|519990421|FG005|Overall Study|Unknown Reason|2|||
144217834|NCT03449446|519990422|FG006|Overall Study|Unknown Reason|0|||
144217835|NCT03449446|519990416|FG000|Overall Study|Withdrew Consent|1|||
144217836|NCT03449446|519990417|FG001|Overall Study|Withdrew Consent|3|||
144217837|NCT03449446|519990418|FG002|Overall Study|Withdrew Consent|1|||
144217838|NCT03449446|519990419|FG003|Overall Study|Withdrew Consent|4|||
144217839|NCT03449446|519990420|FG004|Overall Study|Withdrew Consent|4|||
144217840|NCT03449446|519990421|FG005|Overall Study|Withdrew Consent|4|||
144217841|NCT03449446|519990422|FG006|Overall Study|Withdrew Consent|1|||
144217842|NCT03449446|519990416|FG000|Overall Study|Adverse Event|1|||
144217843|NCT03449446|519990417|FG001|Overall Study|Adverse Event|2|||
144217844|NCT03449446|519990418|FG002|Overall Study|Adverse Event|1|||
144217845|NCT03449446|519990419|FG003|Overall Study|Adverse Event|0|||
144217846|NCT03449446|519990420|FG004|Overall Study|Adverse Event|0|||
144217847|NCT03449446|519990421|FG005|Overall Study|Adverse Event|2|||
144669153|NCT01357889|521639316|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
144669154|NCT01357889|521639315|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
144669155|NCT01357889|521639316|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
144669156|NCT01335698|521639317|FG000|Treatment Stage 1|Lack of Efficacy|3|||
144669157|NCT01335698|521639318|FG001|Treatment Stage 1|Lack of Efficacy|1|||
144669158|NCT01335698|521639319|FG002|Treatment Stage 1|Lack of Efficacy|3|||
144669159|NCT01335698|521639320|FG003|Treatment Stage 1|Lack of Efficacy|3|||
144669160|NCT01335698|521639321|FG004|Treatment Stage 1|Lack of Efficacy|1|||
144669161|NCT01335698|521639317|FG000|Treatment Stage 1|Adverse Event|1|||
144669162|NCT01335698|521639318|FG001|Treatment Stage 1|Adverse Event|2|||
144669163|NCT01335698|521639319|FG002|Treatment Stage 1|Adverse Event|2|||
144669164|NCT01335698|521639320|FG003|Treatment Stage 1|Adverse Event|1|||
144669165|NCT01335698|521639321|FG004|Treatment Stage 1|Adverse Event|1|||
144669166|NCT01335698|521639317|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
144669167|NCT01335698|521639318|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
144669168|NCT01335698|521639319|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
144669169|NCT01335698|521639320|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
144669170|NCT01335698|521639321|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
144669171|NCT01335698|521639317|FG000|Treatment Stage 1|Lost to Follow-up|1|||
144669172|NCT01335698|521639318|FG001|Treatment Stage 1|Lost to Follow-up|1|||
144669173|NCT01335698|521639319|FG002|Treatment Stage 1|Lost to Follow-up|0|||
144669174|NCT01335698|521639320|FG003|Treatment Stage 1|Lost to Follow-up|0|||
144669175|NCT01335698|521639321|FG004|Treatment Stage 1|Lost to Follow-up|0|||
144669176|NCT01335698|521639317|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
144669177|NCT01335698|521639318|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
144669178|NCT01335698|521639319|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
144669179|NCT01335698|521639320|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
144217848|NCT03449446|519990422|FG006|Overall Study|Adverse Event|0|||
144217849|NCT03449446|519990416|FG000|Overall Study|Lost to Follow-up|0|||
144733906|NCT05472038|521883542|FG011|Overall Study|Protocol Violation|1|||
144669180|NCT01335698|521639321|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
144217850|NCT03449446|519990417|FG001|Overall Study|Lost to Follow-up|0|||
144217851|NCT03449446|519990418|FG002|Overall Study|Lost to Follow-up|2|||
144669181|NCT01335698|521639317|FG000|Treatment Stage 1|No longer meets study criteria|1|||
144669182|NCT01335698|521639318|FG001|Treatment Stage 1|No longer meets study criteria|1|||
144669183|NCT01335698|521639319|FG002|Treatment Stage 1|No longer meets study criteria|0|||
144217852|NCT03449446|519990419|FG003|Overall Study|Lost to Follow-up|1|||
144217853|NCT03449446|519990420|FG004|Overall Study|Lost to Follow-up|3|||
144265596|NCT02456727|520173974|FG001|Overall Study|Death|1|||
144669184|NCT01335698|521639320|FG003|Treatment Stage 1|No longer meets study criteria|1|||
144669185|NCT01335698|521639321|FG004|Treatment Stage 1|No longer meets study criteria|0|||
144669186|NCT01335698|521639317|FG000|Treatment Stage 1|Other|1|||
144217854|NCT03449446|519990421|FG005|Overall Study|Lost to Follow-up|0|||
144217855|NCT03449446|519990422|FG006|Overall Study|Lost to Follow-up|0|||
144217856|NCT03449446|519990416|FG000|Overall Study|Investigator's Discretion|0|||
144217857|NCT03449446|519990417|FG001|Overall Study|Investigator's Discretion|1|||
144217858|NCT03449446|519990418|FG002|Overall Study|Investigator's Discretion|1|||
144217859|NCT03449446|519990419|FG003|Overall Study|Investigator's Discretion|2|||
144217860|NCT03449446|519990420|FG004|Overall Study|Investigator's Discretion|0|||
144217861|NCT03449446|519990421|FG005|Overall Study|Investigator's Discretion|0|||
144217862|NCT03449446|519990422|FG006|Overall Study|Investigator's Discretion|0|||
144217863|NCT03449446|519990416|FG000|Overall Study|Non Compliance with Study Drug|1|||
144217864|NCT03449446|519990417|FG001|Overall Study|Non Compliance with Study Drug|0|||
144217865|NCT03449446|519990418|FG002|Overall Study|Non Compliance with Study Drug|0|||
144217866|NCT03449446|519990419|FG003|Overall Study|Non Compliance with Study Drug|0|||
144217867|NCT03449446|519990420|FG004|Overall Study|Non Compliance with Study Drug|0|||
144217868|NCT03449446|519990421|FG005|Overall Study|Non Compliance with Study Drug|0|||
144217869|NCT03449446|519990422|FG006|Overall Study|Non Compliance with Study Drug|0|||
144217870|NCT03449446|519990416|FG000|Overall Study|Protocol Violation|0|||
144217871|NCT03449446|519990417|FG001|Overall Study|Protocol Violation|0|||
144217872|NCT03449446|519990418|FG002|Overall Study|Protocol Violation|0|||
144217873|NCT03449446|519990419|FG003|Overall Study|Protocol Violation|0|||
144217874|NCT03449446|519990420|FG004|Overall Study|Protocol Violation|1|||
144217875|NCT03449446|519990421|FG005|Overall Study|Protocol Violation|1|||
144217876|NCT03449446|519990422|FG006|Overall Study|Protocol Violation|0|||
144217877|NCT03449446|519990416|FG000|Overall Study|Death|0|||
144217878|NCT03449446|519990417|FG001|Overall Study|Death|0|||
144217879|NCT03449446|519990418|FG002|Overall Study|Death|0|||
144217880|NCT03449446|519990419|FG003|Overall Study|Death|0|||
144217881|NCT03449446|519990420|FG004|Overall Study|Death|1|||
144217882|NCT03449446|519990421|FG005|Overall Study|Death|0|||
144217883|NCT03449446|519990422|FG006|Overall Study|Death|0|||
144217884|NCT03172494|519990423|FG000|Overall Study|Adverse Event|5|||
144217885|NCT03172494|519990424|FG001|Overall Study|Adverse Event|1|||
144217886|NCT03172494|519990425|FG002|Overall Study|Adverse Event|15|||
144217887|NCT03172494|519990423|FG000|Overall Study|Protocol Violation|3|||
144217888|NCT03172494|519990424|FG001|Overall Study|Protocol Violation|2|||
144217889|NCT03172494|519990425|FG002|Overall Study|Protocol Violation|1|||
144217890|NCT03172494|519990423|FG000|Overall Study|Lack of Efficacy|0|||
144217891|NCT03172494|519990424|FG001|Overall Study|Lack of Efficacy|0|||
144217892|NCT03172494|519990425|FG002|Overall Study|Lack of Efficacy|4|||
144217893|NCT03172494|519990423|FG000|Overall Study|Pregnancy|0|||
144217894|NCT03172494|519990424|FG001|Overall Study|Pregnancy|1|||
144217895|NCT03172494|519990425|FG002|Overall Study|Pregnancy|0|||
144217896|NCT03172494|519990423|FG000|Overall Study|Withdrawal by Subject|10|||
144217897|NCT03172494|519990424|FG001|Overall Study|Withdrawal by Subject|8|||
144217898|NCT03172494|519990425|FG002|Overall Study|Withdrawal by Subject|8|||
144217899|NCT03172494|519990423|FG000|Overall Study|Severe hypoglycaemic episode|0|||
144669187|NCT01335698|521639318|FG001|Treatment Stage 1|Other|0|||
144669188|NCT01335698|521639319|FG002|Treatment Stage 1|Other|0|||
144669189|NCT01335698|521639320|FG003|Treatment Stage 1|Other|1|||
144669190|NCT01335698|521639321|FG004|Treatment Stage 1|Other|0|||
144669191|NCT01335698|521639317|FG000|Treatment Stage 2|Lack of Efficacy|2|||
144669192|NCT01335698|521639318|FG001|Treatment Stage 2|Lack of Efficacy|1|||
144217900|NCT03172494|519990424|FG001|Overall Study|Severe hypoglycaemic episode|0|||
144217901|NCT03172494|519990425|FG002|Overall Study|Severe hypoglycaemic episode|1|||
144217902|NCT03172494|519990423|FG000|Overall Study|Non-compliance towards treatment|2|||
144217903|NCT03172494|519990424|FG001|Overall Study|Non-compliance towards treatment|0|||
144217904|NCT03172494|519990425|FG002|Overall Study|Non-compliance towards treatment|0|||
144217905|NCT00143390|519990426|FG000|Overall Study|Death|2|||
144217906|NCT00143390|519990427|FG001|Overall Study|Death|0|||
144217907|NCT00143390|519990426|FG000|Overall Study|Not meeting entry criteria|2|||
144217908|NCT00143390|519990427|FG001|Overall Study|Not meeting entry criteria|5|||
144217909|NCT00143390|519990426|FG000|Overall Study|Withdrawal by Subject|4|||
144217910|NCT00143390|519990427|FG001|Overall Study|Withdrawal by Subject|4|||
144669193|NCT01335698|521639319|FG002|Treatment Stage 2|Lack of Efficacy|3|||
144217911|NCT00143390|519990426|FG000|Overall Study|Progressive disease|119|||
144217912|NCT00143390|519990427|FG001|Overall Study|Progressive disease|115|||
144217913|NCT00143390|519990426|FG000|Overall Study|Protocol Violation|2|||
144217914|NCT00143390|519990427|FG001|Overall Study|Protocol Violation|0|||
144217915|NCT00143390|519990426|FG000|Overall Study|Study termination|10|||
144217916|NCT00143390|519990427|FG001|Overall Study|Study termination|15|||
144669194|NCT01335698|521639320|FG003|Treatment Stage 2|Lack of Efficacy|1|||
144217917|NCT00143390|519990426|FG000|Overall Study|Adverse Event|9|||
144669195|NCT01335698|521639321|FG004|Treatment Stage 2|Lack of Efficacy|0|||
144217918|NCT00143390|519990427|FG001|Overall Study|Adverse Event|8|||
144217919|NCT00143390|519990426|FG000|Overall Study|Other|1|||
144217920|NCT00143390|519990427|FG001|Overall Study|Other|2|||
144217921|NCT02764151|519990430|FG000|Overall Study|Subject refused further follow-up|0|||
144217922|NCT02764151|519990431|FG001|Overall Study|Subject refused further follow-up|0|||
144217923|NCT02764151|519990432|FG002|Overall Study|Subject refused further follow-up|0|||
144669196|NCT01335698|521639317|FG000|Treatment Stage 2|Adverse Event|2|||
144669197|NCT01335698|521639318|FG001|Treatment Stage 2|Adverse Event|0|||
144669198|NCT01335698|521639319|FG002|Treatment Stage 2|Adverse Event|0|||
144669199|NCT01335698|521639320|FG003|Treatment Stage 2|Adverse Event|3|||
144669200|NCT01335698|521639321|FG004|Treatment Stage 2|Adverse Event|0|||
144669201|NCT01335698|521639317|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
144669202|NCT01335698|521639318|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
144669203|NCT01335698|521639319|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
144669204|NCT01335698|521639320|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
144669205|NCT01335698|521639321|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
144669206|NCT01335698|521639317|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
144669207|NCT01335698|521639318|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
144669208|NCT01335698|521639319|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
144669209|NCT01335698|521639320|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
144669210|NCT01335698|521639321|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
144669211|NCT01335698|521639317|FG000|Treatment Stage 2|Lost to Follow-up|1|||
144669212|NCT01335698|521639318|FG001|Treatment Stage 2|Lost to Follow-up|0|||
144669213|NCT01335698|521639319|FG002|Treatment Stage 2|Lost to Follow-up|0|||
144669214|NCT01335698|521639320|FG003|Treatment Stage 2|Lost to Follow-up|0|||
144669215|NCT01335698|521639321|FG004|Treatment Stage 2|Lost to Follow-up|0|||
144669216|NCT01335698|521639317|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
144669217|NCT01335698|521639318|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
144669218|NCT01335698|521639319|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
144669219|NCT01335698|521639320|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
144669220|NCT01335698|521639321|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
144669221|NCT01335698|521639317|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
144669222|NCT01335698|521639318|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
144669223|NCT01335698|521639319|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
144669224|NCT01335698|521639320|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
144669225|NCT01335698|521639321|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
144669226|NCT01335698|521639317|FG000|Treatment Stage 2|Switched to another formulation|1|||
144669227|NCT01335698|521639318|FG001|Treatment Stage 2|Switched to another formulation|1|||
144669228|NCT01335698|521639319|FG002|Treatment Stage 2|Switched to another formulation|0|||
144669229|NCT01335698|521639320|FG003|Treatment Stage 2|Switched to another formulation|0|||
144669230|NCT01335698|521639321|FG004|Treatment Stage 2|Switched to another formulation|0|||
144669231|NCT00585923|521639322|FG000|Overall Study|Physician decided not to continue|31|||
144669232|NCT00585923|521639323|FG001|Overall Study|Physician decided not to continue|33|||
144669233|NCT00138424|521639326|FG000|Overall Study|Physician Decision|0|||
144669234|NCT00138424|521639327|FG001|Overall Study|Physician Decision|1|||
144669235|NCT00138424|521639328|FG002|Overall Study|Physician Decision|0|||
144669236|NCT00138424|521639329|FG003|Overall Study|Physician Decision|0|||
144669237|NCT04311177|521639330|FG000|Overall Study|Adverse Event|3|||
144669238|NCT04311177|521639331|FG001|Overall Study|Adverse Event|1|||
144669239|NCT04311177|521639330|FG000|Overall Study|Physician Decision|4|||
144669240|NCT04311177|521639331|FG001|Overall Study|Physician Decision|3|||
144669241|NCT04311177|521639330|FG000|Overall Study|Withdrawal by Subject|1|||
144669242|NCT04311177|521639331|FG001|Overall Study|Withdrawal by Subject|0|||
144669243|NCT02176291|521639336|FG000|Overall Study|Death|1|||
144669244|NCT02176291|521639337|FG001|Overall Study|Death|0|||
144669245|NCT02176291|521639336|FG000|Overall Study|non compliance with protocol|2|||
144669246|NCT02176291|521639337|FG001|Overall Study|non compliance with protocol|0|||
144669247|NCT02176291|521639336|FG000|Overall Study|Withdrawal by Subject|2|||
144669248|NCT02176291|521639337|FG001|Overall Study|Withdrawal by Subject|0|||
144669249|NCT03448224|521639338|FG000|Overall Study|Provided same answer to every question|1|||
144669250|NCT03448224|521639339|FG001|Overall Study|Provided same answer to every question|0|||
144669251|NCT03498287|521639342|FG000|Overall Study|Withdrawal by Subject|3|||
144669252|NCT03498287|521639343|FG001|Overall Study|Withdrawal by Subject|0|||
144669253|NCT03498287|521639342|FG000|Overall Study|Protocol Violation|0|||
144669254|NCT03498287|521639343|FG001|Overall Study|Protocol Violation|4|||
144669255|NCT03498287|521639342|FG000|Overall Study|Adverse Event|0|||
144669256|NCT03498287|521639343|FG001|Overall Study|Adverse Event|1|||
144669257|NCT01714817|521639344|FG000|Year 1 Period|Lack of Efficacy|11|||
144669258|NCT01714817|521639345|FG001|Year 1 Period|Lack of Efficacy|9|||
144669259|NCT01714817|521639344|FG000|Year 1 Period|Adverse Event|20|||
144669260|NCT01714817|521639345|FG001|Year 1 Period|Adverse Event|17|||
144669261|NCT01714817|521639344|FG000|Year 1 Period|Withdrawal by Subject|6|||
144669262|NCT01714817|521639345|FG001|Year 1 Period|Withdrawal by Subject|7|||
144669263|NCT01714817|521639344|FG000|Year 1 Period|Death|1|||
144669264|NCT01714817|521639345|FG001|Year 1 Period|Death|1|||
144669265|NCT01714817|521639344|FG000|Year 1 Period|Lost to Follow-up|0|||
144669266|NCT01714817|521639345|FG001|Year 1 Period|Lost to Follow-up|2|||
144669267|NCT01714817|521639344|FG000|Year 1 Period|Poor / non-compliance|0|||
144669268|NCT01714817|521639345|FG001|Year 1 Period|Poor / non-compliance|1|||
144669269|NCT01714817|521639344|FG000|Year 1 Period|Pregnancy|2|||
144669270|NCT01714817|521639345|FG001|Year 1 Period|Pregnancy|0|||
144669271|NCT01714817|521639344|FG000|Year 1 Period|Participant no longer meets criteria|6|||
144669272|NCT01714817|521639345|FG001|Year 1 Period|Participant no longer meets criteria|2|||
144669273|NCT01714817|521639344|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
144669274|NCT01714817|521639345|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
144669275|NCT01714817|521639344|FG000|Year 1 Period|Change in Concomitant Medication|0|||
144669276|NCT01714817|521639345|FG001|Year 1 Period|Change in Concomitant Medication|1|||
144669277|NCT01714817|521639344|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
144669278|NCT01714817|521639345|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
144669279|NCT01714817|521639344|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
144669280|NCT01714817|521639345|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
144669281|NCT01714817|521639344|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
144669282|NCT01714817|521639345|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
144669283|NCT01714817|521639344|FG000|Year 2 Period|Lack of Efficacy|4|||
144669284|NCT01714817|521639345|FG001|Year 2 Period|Lack of Efficacy|12|||
144669285|NCT01714817|521639344|FG000|Year 2 Period|Adverse Event|7|||
144669286|NCT01714817|521639345|FG001|Year 2 Period|Adverse Event|6|||
144669287|NCT01714817|521639344|FG000|Year 2 Period|Participant request to stop treatment|4|||
144669288|NCT01714817|521639345|FG001|Year 2 Period|Participant request to stop treatment|4|||
144669289|NCT01714817|521639344|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
144669290|NCT01714817|521639345|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
144669291|NCT01714817|521639344|FG000|Year 2 Period|Participant withdrew consent|1|||
144669292|NCT01714817|521639345|FG001|Year 2 Period|Participant withdrew consent|5|||
144669293|NCT01714817|521639344|FG000|Year 2 Period|Participant no longer meets criteria|1|||
144669294|NCT01714817|521639345|FG001|Year 2 Period|Participant no longer meets criteria|4|||
144669295|NCT01714817|521639344|FG000|Year 2 Period|Lost to Follow-up|2|||
144669296|NCT01714817|521639345|FG001|Year 2 Period|Lost to Follow-up|0|||
144669297|NCT01714817|521639344|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
144669298|NCT01714817|521639345|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
144669299|NCT01714817|521639344|FG000|Year 2 Period|Pregnancy|1|||
144669300|NCT01714817|521639345|FG001|Year 2 Period|Pregnancy|1|||
144669301|NCT01714817|521639344|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
144669302|NCT01714817|521639345|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
144669303|NCT01714817|521639344|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
144669304|NCT01714817|521639345|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
144669305|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
144669306|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
144669307|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
144669308|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
144669309|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
144669310|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
144669311|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
144669312|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
144669313|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
144669314|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
144669315|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
144669316|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
144669317|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
144669318|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
144669319|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
144669320|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
144669321|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
144669322|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
144669323|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
144669324|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
144669325|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
144669326|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
144669327|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
144669328|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
144669329|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
144669330|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
144669331|NCT01714817|521639344|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
144669332|NCT01714817|521639345|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
144669333|NCT01740388|521639348|FG000|Overall Study|Withdrawal by Subject|1|||
144669334|NCT01740388|521639349|FG001|Overall Study|Withdrawal by Subject|2|||
144669335|NCT01740388|521639348|FG000|Overall Study|Lost to Follow-up|2|||
144669336|NCT01740388|521639349|FG001|Overall Study|Lost to Follow-up|0|||
144669337|NCT01740388|521639348|FG000|Overall Study|Physician Decision|2|||
144217924|NCT02764151|519990433|FG003|Overall Study|Subject refused further follow-up|1|||
144217925|NCT02764151|519990430|FG000|Overall Study|Other|0|||
144217926|NCT02764151|519990431|FG001|Overall Study|Other|0|||
144217927|NCT02764151|519990432|FG002|Overall Study|Other|0|||
144217928|NCT02764151|519990433|FG003|Overall Study|Other|2|||
144217929|NCT01450683|519990434|FG000|Overall Study|Adverse Event|2|||
144217930|NCT02108912|519990436|FG000|Overall Study|Lost to Follow-up|1|||
144217931|NCT02108912|519990437|FG001|Overall Study|Lost to Follow-up|1|||
144217932|NCT02108912|519990436|FG000|Overall Study|lack of transportation|1|||
144217933|NCT02108912|519990437|FG001|Overall Study|lack of transportation|0|||
144217934|NCT02108912|519990436|FG000|Overall Study|high blood pressure|1|||
144217935|NCT02108912|519990437|FG001|Overall Study|high blood pressure|0|||
144217936|NCT03180645|519990438|FG000|Overall Study|Adverse Event|0|||
144217937|NCT03180645|519990439|FG001|Overall Study|Adverse Event|1|||
144217938|NCT03180645|519990440|FG002|Overall Study|Adverse Event|2|||
144217939|NCT00852202|519990441|FG000|Overall Study|Adverse Event|2|||
144217940|NCT00852202|519990442|FG001|Overall Study|Adverse Event|3|||
144217941|NCT00852202|519990443|FG002|Overall Study|Adverse Event|7|||
144217942|NCT00852202|519990441|FG000|Overall Study|Lack of Efficacy|4|||
144217943|NCT00852202|519990442|FG001|Overall Study|Lack of Efficacy|1|||
144669338|NCT01740388|521639349|FG001|Overall Study|Physician Decision|6|||
144669339|NCT01740388|521639348|FG000|Overall Study|Subjects missing data, completed|41|||
144669340|NCT01740388|521639349|FG001|Overall Study|Subjects missing data, completed|36|||
144669341|NCT04142216|521639350|FG000|Overall Study|Hospitalization|0|||
144669342|NCT04142216|521639351|FG001|Overall Study|Hospitalization|2|||
144669343|NCT04142216|521639350|FG000|Overall Study|Death|3|||
144669344|NCT04142216|521639351|FG001|Overall Study|Death|1|||
144669345|NCT04142216|521639350|FG000|Overall Study|Referral to another hemodialysis unit|3|||
144669346|NCT04142216|521639351|FG001|Overall Study|Referral to another hemodialysis unit|2|||
144669347|NCT04142216|521639350|FG000|Overall Study|Use of clove|0|||
144669348|NCT04142216|521639351|FG001|Overall Study|Use of clove|1|||
144669349|NCT01641991|521639352|FG000|Overall Study|Physician Decision|0|||
144669350|NCT01641991|521639353|FG001|Overall Study|Physician Decision|1|||
144669351|NCT01641991|521639354|FG002|Overall Study|Physician Decision|7|||
144669352|NCT01641991|521639355|FG003|Overall Study|Physician Decision|5|||
144669353|NCT01641991|521639352|FG000|Overall Study|Withdrawal by Subject|4|||
144669354|NCT01641991|521639353|FG001|Overall Study|Withdrawal by Subject|2|||
144669355|NCT01641991|521639354|FG002|Overall Study|Withdrawal by Subject|1|||
144669356|NCT01641991|521639355|FG003|Overall Study|Withdrawal by Subject|5|||
144669357|NCT01641991|521639352|FG000|Overall Study|Adverse Event|2|||
144669358|NCT01641991|521639353|FG001|Overall Study|Adverse Event|1|||
144669359|NCT01641991|521639354|FG002|Overall Study|Adverse Event|2|||
144669360|NCT01641991|521639355|FG003|Overall Study|Adverse Event|1|||
144669361|NCT01641991|521639352|FG000|Overall Study|Lost to Follow-up|0|||
144669362|NCT01641991|521639353|FG001|Overall Study|Lost to Follow-up|2|||
144669363|NCT01641991|521639354|FG002|Overall Study|Lost to Follow-up|3|||
144669364|NCT01641991|521639355|FG003|Overall Study|Lost to Follow-up|1|||
144669365|NCT01641991|521639352|FG000|Overall Study|Protocol Violation|1|||
144669366|NCT01641991|521639353|FG001|Overall Study|Protocol Violation|1|||
144733907|NCT05472038|521883531|FG000|Overall Study|Not vaccinated|0|||
144733908|NCT05472038|521883532|FG001|Overall Study|Not vaccinated|0|||
144733909|NCT05472038|521883533|FG002|Overall Study|Not vaccinated|0|||
144733910|NCT05472038|521883534|FG003|Overall Study|Not vaccinated|1|||
144733911|NCT05472038|521883535|FG004|Overall Study|Not vaccinated|0|||
144733912|NCT05472038|521883536|FG005|Overall Study|Not vaccinated|0|||
144733913|NCT05472038|521883537|FG006|Overall Study|Not vaccinated|0|||
144733914|NCT05472038|521883538|FG007|Overall Study|Not vaccinated|0|||
144733915|NCT05472038|521883539|FG008|Overall Study|Not vaccinated|0|||
144733916|NCT05472038|521883540|FG009|Overall Study|Not vaccinated|0|||
144217944|NCT00852202|519990443|FG002|Overall Study|Lack of Efficacy|2|||
144217945|NCT00852202|519990441|FG000|Overall Study|Protocol Violation|2|||
144217946|NCT00852202|519990442|FG001|Overall Study|Protocol Violation|2|||
144733917|NCT05472038|521883541|FG010|Overall Study|Not vaccinated|0|||
144733918|NCT05472038|521883542|FG011|Overall Study|Not vaccinated|0|||
144733919|NCT03235739|521883545|FG000|Overall Study|Withdrawal by Subject|2|||
144733920|NCT03235739|521883546|FG001|Overall Study|Withdrawal by Subject|2|||
144733921|NCT03235739|521883545|FG000|Overall Study|Physician Decision|0|||
144733922|NCT03235739|521883546|FG001|Overall Study|Physician Decision|1|||
144733923|NCT00467896|521883547|FG000|Overall Study|Consent Withdrawal|18|||
144733924|NCT00467896|521883547|FG000|Overall Study|Adverse Event|7|||
144733925|NCT00467896|521883547|FG000|Overall Study|Serious Adverse Event|13|||
144217947|NCT00852202|519990443|FG002|Overall Study|Protocol Violation|7|||
144217948|NCT00852202|519990441|FG000|Overall Study|Withdrawal by Subject|3|||
144217949|NCT00852202|519990442|FG001|Overall Study|Withdrawal by Subject|1|||
144217950|NCT00852202|519990443|FG002|Overall Study|Withdrawal by Subject|2|||
144217951|NCT00852202|519990441|FG000|Overall Study|Lost to Follow-up|5|||
144217952|NCT00852202|519990442|FG001|Overall Study|Lost to Follow-up|5|||
144733926|NCT00467896|521883547|FG000|Overall Study|Non-compliance|3|||
144733927|NCT00467896|521883547|FG000|Overall Study|Changed therapy|2|||
144733928|NCT00467896|521883547|FG000|Overall Study|Patient received transplant|2|||
144733929|NCT00467896|521883547|FG000|Overall Study|Patient had atrial septostomy|1|||
144733930|NCT00467896|521883547|FG000|Overall Study|Patient weaned off iloprost|1|||
144733931|NCT00467896|521883547|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
144733932|NCT00467896|521883547|FG000|Overall Study|Started intravenous prostacyclin|1|||
144733933|NCT00467896|521883547|FG000|Overall Study|Started inhaled Remodulin|1|||
144733934|NCT00467896|521883547|FG000|Overall Study|Patient had no improvement|1|||
144733935|NCT03772522|521883548|FG000|Pre-intervention|Withdrawal by Subject|3|||
144733936|NCT03772522|521883549|FG001|Pre-intervention|Withdrawal by Subject|4|||
144733937|NCT03772522|521883548|FG000|Intervention|Withdrawal by Subject|1|||
144733938|NCT03772522|521883549|FG001|Intervention|Withdrawal by Subject|0|||
144733939|NCT03772522|521883548|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
144733940|NCT03772522|521883549|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
144733941|NCT03818581|521883552|FG000|Overall Study|Adverse Event|1|||
144733942|NCT03818581|521883553|FG001|Overall Study|Adverse Event|0|||
144733943|NCT03818581|521883554|FG002|Overall Study|Adverse Event|0|||
144733944|NCT03818581|521883555|FG003|Overall Study|Adverse Event|0|||
144733945|NCT03818581|521883556|FG004|Overall Study|Adverse Event|0|||
144733946|NCT03818581|521883552|FG000|Overall Study|Covid-19|2|||
144733947|NCT03818581|521883553|FG001|Overall Study|Covid-19|0|||
144733948|NCT03818581|521883554|FG002|Overall Study|Covid-19|0|||
144733949|NCT03818581|521883555|FG003|Overall Study|Covid-19|0|||
144733950|NCT03818581|521883556|FG004|Overall Study|Covid-19|1|||
144733951|NCT03818581|521883552|FG000|Overall Study|Withdrawal by Subject|0|||
144733952|NCT03818581|521883553|FG001|Overall Study|Withdrawal by Subject|0|||
144733953|NCT03818581|521883554|FG002|Overall Study|Withdrawal by Subject|0|||
144733954|NCT03818581|521883555|FG003|Overall Study|Withdrawal by Subject|0|||
144733955|NCT03818581|521883556|FG004|Overall Study|Withdrawal by Subject|1|||
144733956|NCT03818581|521883552|FG000|Overall Study|No longer met study criteria|0|||
144733957|NCT03818581|521883553|FG001|Overall Study|No longer met study criteria|0|||
144733958|NCT03818581|521883554|FG002|Overall Study|No longer met study criteria|0|||
144733959|NCT03818581|521883555|FG003|Overall Study|No longer met study criteria|0|||
144733960|NCT03818581|521883556|FG004|Overall Study|No longer met study criteria|1|||
144733961|NCT00218257|521883559|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
144733962|NCT00218257|521883560|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
144733963|NCT02096211|521883561|FG000|Overall Study|Death|2|||
144733964|NCT02096211|521883561|FG000|Overall Study|Withdrawal by Subject|8|||
144733965|NCT02096211|521883561|FG000|Overall Study|Revision of implant|7|||
144733966|NCT02096211|521883561|FG000|Overall Study|Lost to Follow-up|43|||
144733967|NCT01439880|521883566|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
144733968|NCT01439880|521883567|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
144733969|NCT01439880|521883566|FG000|SOC-controlled Period (Year 1)|Death|2|||
144733970|NCT01439880|521883567|FG001|SOC-controlled Period (Year 1)|Death|1|||
144733971|NCT01439880|521883566|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
144733972|NCT01439880|521883567|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
144733973|NCT01439880|521883566|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
144733974|NCT01439880|521883567|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
144733975|NCT01439880|521883566|FG000|SOC-controlled Period (Year 1)|Other|8|||
144733976|NCT01439880|521883567|FG001|SOC-controlled Period (Year 1)|Other|13|||
144733977|NCT01439880|521883566|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
144733978|NCT01439880|521883567|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
144733979|NCT01439880|521883566|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
144733980|NCT01439880|521883567|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
144733981|NCT01439880|521883566|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
144733982|NCT01439880|521883567|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
144733983|NCT01439880|521883566|FG000|All-IP Period (Years 2 to 5)|Death|3|||
144733984|NCT01439880|521883567|FG001|All-IP Period (Years 2 to 5)|Death|13|||
144669367|NCT01641991|521639354|FG002|Overall Study|Protocol Violation|3|||
144669368|NCT01641991|521639355|FG003|Overall Study|Protocol Violation|0|||
144669369|NCT01641991|521639352|FG000|Overall Study|Pregnancy|0|||
144669370|NCT01641991|521639353|FG001|Overall Study|Pregnancy|0|||
144669371|NCT01641991|521639354|FG002|Overall Study|Pregnancy|1|||
144669372|NCT01641991|521639355|FG003|Overall Study|Pregnancy|0|||
144669373|NCT01641991|521639352|FG000|Overall Study|no longer eligible|2|||
144669374|NCT01641991|521639353|FG001|Overall Study|no longer eligible|1|||
144669375|NCT01641991|521639354|FG002|Overall Study|no longer eligible|0|||
144669376|NCT01641991|521639355|FG003|Overall Study|no longer eligible|4|||
144669377|NCT02555657|521639356|FG000|Overall Study|Death|274|||
144669378|NCT02555657|521639357|FG001|Overall Study|Death|262|||
144733985|NCT01439880|521883566|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
144217953|NCT00852202|519990443|FG002|Overall Study|Lost to Follow-up|6|||
144669379|NCT02555657|521639356|FG000|Overall Study|Physician Decision|0|||
144733986|NCT01439880|521883567|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
144733987|NCT01439880|521883566|FG000|All-IP Period (Years 2 to 5)|Other|14|||
144733988|NCT01439880|521883567|FG001|All-IP Period (Years 2 to 5)|Other|31|||
144733989|NCT01439880|521883566|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
144733990|NCT01439880|521883567|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
144669380|NCT02555657|521639357|FG001|Overall Study|Physician Decision|1|||
144669381|NCT02555657|521639356|FG000|Overall Study|Sponsor Decision|27|||
144669382|NCT02555657|521639357|FG001|Overall Study|Sponsor Decision|15|||
144669383|NCT02555657|521639356|FG000|Overall Study|Withdrawal by Subject|11|||
144669384|NCT02555657|521639357|FG001|Overall Study|Withdrawal by Subject|32|||
144669385|NCT01578785|521639363|FG000|Overall Study|Withdrawal by Subject|0|||
144669386|NCT01578785|521639364|FG001|Overall Study|Withdrawal by Subject|1|||
144669387|NCT01578785|521639363|FG000|Overall Study|Study terminated by sponsor|59|||
144669388|NCT01578785|521639364|FG001|Overall Study|Study terminated by sponsor|118|||
144669389|NCT01164865|521639369|FG000|Overall Study|Lost to Follow-up|2|||
144669390|NCT01164865|521639370|FG001|Overall Study|Lost to Follow-up|1|||
144669391|NCT00599027|521639371|FG000|Overall Study|Withdrawal by Subject|1|||
144669392|NCT00599027|521639372|FG001|Overall Study|Withdrawal by Subject|1|||
144669393|NCT00599027|521639371|FG000|Overall Study|Adverse Event|0|||
144669394|NCT00599027|521639372|FG001|Overall Study|Adverse Event|1|||
144669395|NCT00599027|521639371|FG000|Overall Study|Treatment Failure|0|||
144669396|NCT00599027|521639372|FG001|Overall Study|Treatment Failure|1|||
144669397|NCT00475540|521639373|FG000|36 Months|Lost to Follow-up|4|||
144669398|NCT00475540|521639374|FG001|36 Months|Lost to Follow-up|4|||
144669399|NCT00475540|521639373|FG000|36 Months|Death|1|||
144669400|NCT00475540|521639374|FG001|36 Months|Death|2|||
144669401|NCT00475540|521639373|FG000|36 Months|Censored due to reoperation|3|||
144669402|NCT00475540|521639374|FG001|36 Months|Censored due to reoperation|0|||
144669403|NCT00377429|521639375|FG000|Overall Study|Withdrawal by Subject|5|||
144733991|NCT03874715|521883568|FG000|Overall Study|Adverse Event|2|||
144733992|NCT03874715|521883569|FG001|Overall Study|Adverse Event|0|||
144733993|NCT03874715|521883568|FG000|Overall Study|Poor compliance to protocol|5|||
144733994|NCT03874715|521883569|FG001|Overall Study|Poor compliance to protocol|1|||
144733995|NCT03874715|521883568|FG000|Overall Study|Withdrawal by Subject|1|||
144733996|NCT03874715|521883569|FG001|Overall Study|Withdrawal by Subject|0|||
144733997|NCT03874715|521883568|FG000|Overall Study|Other-unspecified|1|||
144733998|NCT03874715|521883569|FG001|Overall Study|Other-unspecified|0|||
144733999|NCT00328926|521883572|FG000|Overall Study|Pregnancy|2|||
144734000|NCT00328926|521883573|FG001|Overall Study|Pregnancy|1|||
144734001|NCT00328926|521883574|FG002|Overall Study|Pregnancy|0|||
144734002|NCT00328926|521883572|FG000|Overall Study|Lost to Follow-up|0|||
144734003|NCT00328926|521883573|FG001|Overall Study|Lost to Follow-up|1|||
144669404|NCT00377429|521639375|FG000|Overall Study|Adverse Event|8|||
144669405|NCT00377429|521639375|FG000|Overall Study|Physician Decision|1|||
144669406|NCT00377429|521639375|FG000|Overall Study|Patient non-compliance|1|||
144669407|NCT02394795|521639378|FG000|Overall Study|Adverse Event|92|||
144669408|NCT02394795|521639379|FG001|Overall Study|Adverse Event|70|||
144669409|NCT02394795|521639378|FG000|Overall Study|Lost to Follow-up|0|||
144669410|NCT02394795|521639379|FG001|Overall Study|Lost to Follow-up|1|||
144669411|NCT02394795|521639378|FG000|Overall Study|Withdrawal by Subject|17|||
144669412|NCT02394795|521639379|FG001|Overall Study|Withdrawal by Subject|26|||
144669413|NCT02394795|521639378|FG000|Overall Study|Lack of Efficacy|181|||
144669414|NCT02394795|521639379|FG001|Overall Study|Lack of Efficacy|211|||
144669415|NCT02394795|521639378|FG000|Overall Study|Death|4|||
144669416|NCT02394795|521639379|FG001|Overall Study|Death|5|||
144669417|NCT02394795|521639378|FG000|Overall Study|Physician Decision|109|||
144669418|NCT02394795|521639379|FG001|Overall Study|Physician Decision|93|||
144669419|NCT02939599|521639386|FG000|Overall Study|Adverse Event|1|||
144669420|NCT02939599|521639387|FG001|Overall Study|Adverse Event|0|||
144669421|NCT02939599|521639386|FG000|Overall Study|Study Terminated By Sponsor|2|||
144669422|NCT02939599|521639387|FG001|Overall Study|Study Terminated By Sponsor|2|||
144669423|NCT02133742|521639399|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
144669424|NCT02133742|521639399|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
144669425|NCT02133742|521639399|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
144669426|NCT02133742|521639399|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
144669427|NCT02133742|521639399|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
144669428|NCT03479216|521639400|FG000|Overall Study|Withdrawal by Subject|3|||
144669429|NCT03479216|521639401|FG001|Overall Study|Withdrawal by Subject|2|||
144669430|NCT03479216|521639400|FG000|Overall Study|Physician Decision|2|||
144669431|NCT03479216|521639401|FG001|Overall Study|Physician Decision|3|||
144669432|NCT02031432|521639402|FG000|Overall Study|Protocol Violation|1|||
144669433|NCT02031432|521639402|FG000|Overall Study|Lack of Efficacy|5|||
144669434|NCT02031432|521639402|FG000|Overall Study|Cancer Progression|2|||
144669435|NCT02031432|521639402|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
144669436|NCT02031432|521639402|FG000|Overall Study|Adverse Event|8|||
144669437|NCT02031432|521639402|FG000|Overall Study|Withdrawal by Subject|5|||
144669438|NCT02031432|521639402|FG000|Overall Study|Lost to Follow-up|1|||
144734004|NCT00328926|521883574|FG002|Overall Study|Lost to Follow-up|0|||
144669439|NCT02031432|521639402|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
144669440|NCT02031432|521639402|FG000|Overall Study|Death|10|||
144669441|NCT02148211|521639403|FG000|Overall Study|Lost to Follow-up|352|||
144734005|NCT00328926|521883572|FG000|Overall Study|Death|0|||
144734006|NCT00328926|521883573|FG001|Overall Study|Death|0|||
144669442|NCT02726113|521639404|FG000|Total Enrollment|Physician Decision|0|||
144669443|NCT02726113|521639405|FG001|Total Enrollment|Physician Decision|1|||
144669444|NCT02726113|521639404|FG000|Total Enrollment|Protocol Violation|1|||
144669445|NCT02726113|521639405|FG001|Total Enrollment|Protocol Violation|0|||
144669446|NCT02726113|521639404|FG000|Total Enrollment|Withdrawal by Subject|2|||
144669447|NCT02726113|521639405|FG001|Total Enrollment|Withdrawal by Subject|1|||
144734007|NCT00328926|521883574|FG002|Overall Study|Death|1|||
144734008|NCT00328926|521883572|FG000|Overall Study|In vitro fertilization treatment|0|||
144734009|NCT00328926|521883573|FG001|Overall Study|In vitro fertilization treatment|0|||
144734010|NCT00328926|521883574|FG002|Overall Study|In vitro fertilization treatment|1|||
144734011|NCT00328926|521883572|FG000|Overall Study|Lack of ovarian response|0|||
144734012|NCT00328926|521883573|FG001|Overall Study|Lack of ovarian response|1|||
144734013|NCT00328926|521883574|FG002|Overall Study|Lack of ovarian response|0|||
144734014|NCT02269657|521883575|FG000|Overall Study|Protocol Violation|3|||
144734015|NCT02956460|521883576|FG000|Lens 1|Lost to Follow-up|1|||
144734016|NCT02956460|521883577|FG001|Lens 1|Lost to Follow-up|0|||
144734017|NCT00834249|521883578|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
144734018|NCT00834249|521883579|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
144734019|NCT00834249|521883578|FG000|Second Intervention|Adverse Event|1|||
144734020|NCT00834249|521883579|FG001|Second Intervention|Adverse Event|0|||
144734021|NCT03450057|521883582|FG000|Overall Study|Death|17|||
144734022|NCT03450057|521883582|FG000|Overall Study|ICF withdrawal|4|||
144734023|NCT03450057|521883582|FG000|Overall Study|Lost to Follow-up|2|||
144734024|NCT00573066|521883583|FG000|Overall Study|Exclusion criteria|18|||
144734025|NCT00573066|521883583|FG000|Overall Study|IV malfunction|1|||
144734026|NCT00573066|521883583|FG000|Overall Study|Postoperative bleeding|1|||
144734027|NCT04129346|521883584|FG000|Overall Study|Death|1|||
144734028|NCT04129346|521883585|FG001|Overall Study|Death|0|||
144265597|NCT02456727|520173973|FG000|Overall Study|Withdrawal by Subject|1|||
144265598|NCT02456727|520173974|FG001|Overall Study|Withdrawal by Subject|10|||
144265599|NCT02456727|520173973|FG000|Overall Study|Never Initiated Treatment|43|||
144265600|NCT02456727|520173974|FG001|Overall Study|Never Initiated Treatment|30|||
144265601|NCT02513550|520173975|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
144265602|NCT02513550|520173976|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
144265603|NCT02513550|520173977|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
144265604|NCT02513550|520173978|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
144265605|NCT02513550|520173979|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
144265606|NCT02513550|520173980|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
144265607|NCT02513550|520173975|FG000|Double Blind Treatment Period|Adverse Event|5|||
144265608|NCT02513550|520173976|FG001|Double Blind Treatment Period|Adverse Event|13|||
144265609|NCT02513550|520173977|FG002|Double Blind Treatment Period|Adverse Event|17|||
144265610|NCT02513550|520173978|FG003|Double Blind Treatment Period|Adverse Event|0|||
144669448|NCT02726113|521639404|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
144669449|NCT02726113|521639405|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
144669450|NCT02726113|521639404|FG000|Genomic Analysis|Protocol Violation|1|||
144669451|NCT02726113|521639405|FG001|Genomic Analysis|Protocol Violation|0|||
144669452|NCT02726113|521639404|FG000|Genomic Analysis|Withdrawal by Subject|2|||
144669453|NCT02726113|521639405|FG001|Genomic Analysis|Withdrawal by Subject|1|||
144669454|NCT02726113|521639404|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
144669455|NCT02726113|521639405|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
144669456|NCT01617187|521639406|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
144669457|NCT01617187|521639407|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
144669458|NCT01617187|521639408|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
144669459|NCT01617187|521639409|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
144669460|NCT01617187|521639406|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
144669461|NCT01617187|521639407|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
144669462|NCT01617187|521639408|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
144669463|NCT01617187|521639409|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
144669464|NCT01617187|521639406|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
144669465|NCT01617187|521639407|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
144669466|NCT01617187|521639408|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
144734029|NCT05755282|521883586|FG000|Overall Study|Protocol Violation|0|||
144734030|NCT05755282|521883587|FG001|Overall Study|Protocol Violation|1|||
144265611|NCT02513550|520173979|FG004|Double Blind Treatment Period|Adverse Event|1|||
144265612|NCT02513550|520173980|FG005|Double Blind Treatment Period|Adverse Event|0|||
144734031|NCT01015703|521883588|FG000|Overall Study|Withdrawal by Subject|0|||
144734032|NCT01015703|521883589|FG001|Overall Study|Withdrawal by Subject|1|||
144265613|NCT02513550|520173975|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
144734033|NCT01015703|521883590|FG002|Overall Study|Withdrawal by Subject|0|||
144734034|NCT01015703|521883591|FG003|Overall Study|Withdrawal by Subject|0|||
144734035|NCT01015703|521883592|FG004|Overall Study|Withdrawal by Subject|0|||
144734036|NCT01015703|521883588|FG000|Overall Study|Adverse Event|1|||
144734037|NCT01015703|521883589|FG001|Overall Study|Adverse Event|0|||
144734038|NCT01015703|521883590|FG002|Overall Study|Adverse Event|0|||
144734039|NCT01015703|521883591|FG003|Overall Study|Adverse Event|0|||
144734040|NCT01015703|521883592|FG004|Overall Study|Adverse Event|0|||
144734041|NCT01015703|521883588|FG000|Overall Study|Protocol Violation|1|||
144734042|NCT01015703|521883589|FG001|Overall Study|Protocol Violation|0|||
144734043|NCT01015703|521883590|FG002|Overall Study|Protocol Violation|0|||
144734044|NCT01015703|521883591|FG003|Overall Study|Protocol Violation|0|||
144734045|NCT01015703|521883592|FG004|Overall Study|Protocol Violation|0|||
144734046|NCT02646124|521883593|FG000|Overall Study|Lost to Follow-up|0|||
144734047|NCT02646124|521883594|FG001|Overall Study|Lost to Follow-up|2|||
144734048|NCT00857454|521883596|FG000|Overall Study|Withdrawal by Subject|2|||
144734049|NCT00857454|521883596|FG000|Overall Study|Lost to Follow-up|1|||
144734050|NCT00857454|521883596|FG000|Overall Study|Adverse Event|2|||
144734051|NCT00857454|521883596|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
144734052|NCT00857454|521883596|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
144734053|NCT00857454|521883596|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
144734054|NCT03154047|521883597|FG000|Overall Study|Death|1|||
144734055|NCT03154047|521883597|FG000|Overall Study|Study terminated by sponsor|76|||
144734056|NCT03154047|521883597|FG000|Overall Study|Withdrawal by Subject|3|||
144734057|NCT00365365|521883598|FG000|Overall Study|Randomized but not treated|0|||
144734058|NCT00365365|521883599|FG001|Overall Study|Randomized but not treated|2|||
144734059|NCT00365365|521883600|FG002|Overall Study|Randomized but not treated|0|||
144734060|NCT00365365|521883598|FG000|Overall Study|Poor compliance to protocol|0|||
144734061|NCT00365365|521883599|FG001|Overall Study|Poor compliance to protocol|1|||
144734062|NCT00365365|521883600|FG002|Overall Study|Poor compliance to protocol|0|||
144734063|NCT00365365|521883598|FG000|Overall Study|Lost to Follow-up|3|||
144734064|NCT00365365|521883599|FG001|Overall Study|Lost to Follow-up|3|||
144734065|NCT00365365|521883600|FG002|Overall Study|Lost to Follow-up|3|||
144734066|NCT00365365|521883598|FG000|Overall Study|Death|1|||
144734067|NCT00365365|521883599|FG001|Overall Study|Death|3|||
144734068|NCT00365365|521883600|FG002|Overall Study|Death|0|||
144734069|NCT00365365|521883598|FG000|Overall Study|Subject's request|11|||
144734070|NCT00365365|521883599|FG001|Overall Study|Subject's request|13|||
144734071|NCT00365365|521883600|FG002|Overall Study|Subject's request|1|||
144734072|NCT00365365|521883598|FG000|Overall Study|Disease progression/relapse|9|||
144734073|NCT00365365|521883599|FG001|Overall Study|Disease progression/relapse|6|||
144734074|NCT00365365|521883600|FG002|Overall Study|Disease progression/relapse|7|||
144734075|NCT00365365|521883598|FG000|Overall Study|Adverse Event|6|||
144734076|NCT00365365|521883599|FG001|Overall Study|Adverse Event|6|||
144734077|NCT00365365|521883600|FG002|Overall Study|Adverse Event|3|||
144734078|NCT00365365|521883598|FG000|Overall Study|Moved|2|||
144734079|NCT00365365|521883599|FG001|Overall Study|Moved|0|||
144734080|NCT00365365|521883600|FG002|Overall Study|Moved|0|||
144734081|NCT00365365|521883598|FG000|Overall Study|New cancer|1|||
144734082|NCT00365365|521883599|FG001|Overall Study|New cancer|0|||
144734083|NCT00365365|521883600|FG002|Overall Study|New cancer|0|||
144734084|NCT00365365|521883598|FG000|Overall Study|Withdrew consent|1|||
144734085|NCT00365365|521883599|FG001|Overall Study|Withdrew consent|1|||
144734086|NCT00365365|521883600|FG002|Overall Study|Withdrew consent|0|||
144734087|NCT00365365|521883598|FG000|Overall Study|Second malignancy|0|||
144734088|NCT00365365|521883599|FG001|Overall Study|Second malignancy|1|||
144734089|NCT00365365|521883600|FG002|Overall Study|Second malignancy|0|||
144734090|NCT00365365|521883598|FG000|Overall Study|Patient/physician decision|0|||
144734091|NCT00365365|521883599|FG001|Overall Study|Patient/physician decision|0|||
144734092|NCT00365365|521883600|FG002|Overall Study|Patient/physician decision|1|||
144734093|NCT01693523|521883604|FG000|Overall Study|Adverse Event|2|||
144734094|NCT01693523|521883605|FG001|Overall Study|Adverse Event|1|||
144734095|NCT01693523|521883606|FG002|Overall Study|Adverse Event|0|||
144734096|NCT01693523|521883604|FG000|Overall Study|Death|0|||
144217954|NCT00852202|519990441|FG000|Overall Study|pregnancy,moving away and surgery|1|||
144217955|NCT00852202|519990442|FG001|Overall Study|pregnancy,moving away and surgery|0|||
144217956|NCT00852202|519990443|FG002|Overall Study|pregnancy,moving away and surgery|2|||
144217957|NCT00001521|519992204|FG000|Overall Study|Withdrawal by Subject|3|||
144217958|NCT00001521|519992205|FG001|Overall Study|Withdrawal by Subject|3|||
144734097|NCT01693523|521883605|FG001|Overall Study|Death|1|||
144734098|NCT01693523|521883606|FG002|Overall Study|Death|1|||
144734099|NCT01693523|521883604|FG000|Overall Study|Lost to Follow-up|0|||
144734100|NCT01693523|521883605|FG001|Overall Study|Lost to Follow-up|0|||
144734101|NCT01693523|521883606|FG002|Overall Study|Lost to Follow-up|4|||
144734102|NCT01693523|521883604|FG000|Overall Study|Physician Decision|0|||
144734103|NCT01693523|521883605|FG001|Overall Study|Physician Decision|0|||
144734104|NCT01693523|521883606|FG002|Overall Study|Physician Decision|1|||
144734105|NCT01693523|521883604|FG000|Overall Study|Withdrawal by Subject|1|||
144734106|NCT01693523|521883605|FG001|Overall Study|Withdrawal by Subject|2|||
144734107|NCT01693523|521883606|FG002|Overall Study|Withdrawal by Subject|2|||
144734108|NCT01693523|521883604|FG000|Overall Study|Lack of compliance study medication|1|||
144734109|NCT01693523|521883605|FG001|Overall Study|Lack of compliance study medication|2|||
144669467|NCT01617187|521639409|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
144669468|NCT01617187|521639406|FG000|Treatment Through Study Completion|Adverse Event|1|||
144669469|NCT01617187|521639407|FG001|Treatment Through Study Completion|Adverse Event|1|||
144669470|NCT01617187|521639408|FG002|Treatment Through Study Completion|Adverse Event|0|||
144734110|NCT01693523|521883606|FG002|Overall Study|Lack of compliance study medication|0|||
144734111|NCT01693523|521883604|FG000|Overall Study|Chemotherapy was held|1|||
144734112|NCT01693523|521883605|FG001|Overall Study|Chemotherapy was held|2|||
144734113|NCT01693523|521883606|FG002|Overall Study|Chemotherapy was held|0|||
144734114|NCT00834418|521883607|FG000|Overall Study|Adverse Event|0|||
144734115|NCT00834418|521883608|FG001|Overall Study|Adverse Event|2|||
144734116|NCT02472366|521883610|FG000|Overall Study|Lost to Follow-up|1|||
144734117|NCT02472366|521883611|FG001|Overall Study|Lost to Follow-up|0|||
144734118|NCT04247282|521883617|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
144734119|NCT04247282|521883618|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
144734120|NCT04247282|521883619|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
144734121|NCT04247282|521883620|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
144734122|NCT04247282|521883617|FG000|Overall Study|Refused further treatment|0|||
144734123|NCT04247282|521883618|FG001|Overall Study|Refused further treatment|1|||
144734124|NCT04247282|521883619|FG002|Overall Study|Refused further treatment|0|||
144734125|NCT04247282|521883620|FG003|Overall Study|Refused further treatment|0|||
144734126|NCT01313273|521883621|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
144734127|NCT01313273|521883622|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
144734128|NCT01313273|521883621|FG000|Overall Study|Withdrawal by Subject|1|||
144734129|NCT01313273|521883622|FG001|Overall Study|Withdrawal by Subject|0|||
144734130|NCT01313273|521883621|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
144734131|NCT01313273|521883622|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
144734132|NCT03687736|521883623|FG000|Overall Study|Lost to Follow-up|7|||
144734133|NCT03687736|521883623|FG000|Overall Study|Withdrawal by Subject|3|||
144734134|NCT00794963|521883625|FG000|Overall Study|Withdrawal by Subject|1|||
144734135|NCT00794963|521883626|FG001|Overall Study|Withdrawal by Subject|4|||
144734136|NCT03375463|521883627|FG000|Period 1|Lost to Follow-up|0|||
144734137|NCT03375463|521883628|FG001|Period 1|Lost to Follow-up|0|||
144734138|NCT03375463|521883629|FG002|Period 1|Lost to Follow-up|1|||
144669471|NCT01617187|521639409|FG003|Treatment Through Study Completion|Adverse Event|1|||
144669472|NCT01617187|521639406|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
144669473|NCT01617187|521639407|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
144669474|NCT01617187|521639408|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
144669475|NCT01617187|521639409|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
144669476|NCT01617187|521639406|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
144669477|NCT01617187|521639407|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
144669478|NCT01617187|521639408|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
144669479|NCT01617187|521639409|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
144669480|NCT01617187|521639406|FG000|Treatment Through Study Completion|Protocol Violation|1|||
144669481|NCT01617187|521639407|FG001|Treatment Through Study Completion|Protocol Violation|0|||
144669482|NCT01617187|521639408|FG002|Treatment Through Study Completion|Protocol Violation|0|||
144669483|NCT01617187|521639409|FG003|Treatment Through Study Completion|Protocol Violation|1|||
144669484|NCT02554253|521639416|FG000|Overall Study|ineligible after enrollment|1|||
144669485|NCT02554253|521639417|FG001|Overall Study|ineligible after enrollment|0|||
144669486|NCT02554253|521639416|FG000|Overall Study|converted to transcatheter procedure|0|||
144669487|NCT02554253|521639417|FG001|Overall Study|converted to transcatheter procedure|1|||
144669488|NCT02554253|521639416|FG000|Overall Study|received both drugs|0|||
144669489|NCT02554253|521639417|FG001|Overall Study|received both drugs|1|||
144669490|NCT01736254|521639419|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
144669491|NCT01736254|521639419|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
144669492|NCT01561560|521639420|FG000|First Two Weeks of Wear|Time/job conflict|0|||
144669493|NCT01561560|521639421|FG001|First Two Weeks of Wear|Time/job conflict|1|||
144669494|NCT01561560|521639420|FG000|First Two Weeks of Wear|Adverse Event|0|||
144669495|NCT01561560|521639421|FG001|First Two Weeks of Wear|Adverse Event|1|||
144669496|NCT01561560|521639420|FG000|Second Two Weeks of Wear|Adverse Event|0|||
144669497|NCT01561560|521639421|FG001|Second Two Weeks of Wear|Adverse Event|1|||
144217959|NCT00001521|519992204|FG000|Overall Study|Physician Decision|1|||
144217960|NCT00001521|519992205|FG001|Overall Study|Physician Decision|1|||
144217961|NCT00001521|519992204|FG000|Overall Study|Noncompliant|6|||
144669498|NCT03862131|521639422|FG000|Overall Study|Lost to Follow-up|1|||
144669499|NCT03862131|521639423|FG001|Overall Study|Lost to Follow-up|0|||
144669500|NCT03862131|521639424|FG002|Overall Study|Lost to Follow-up|1|||
144669501|NCT03862131|521639422|FG000|Overall Study|Determined to be ineligible|0|||
144669502|NCT03862131|521639423|FG001|Overall Study|Determined to be ineligible|0|||
144669503|NCT03862131|521639424|FG002|Overall Study|Determined to be ineligible|5|||
144734139|NCT03375463|521883630|FG003|Period 1|Lost to Follow-up|0|||
144734140|NCT03375463|521883631|FG004|Period 1|Lost to Follow-up|0|||
144217962|NCT00001521|519992205|FG001|Overall Study|Noncompliant|3|||
144669504|NCT03862131|521639422|FG000|Overall Study|Death|4|||
144669505|NCT03862131|521639423|FG001|Overall Study|Death|4|||
144669506|NCT03862131|521639424|FG002|Overall Study|Death|0|||
144669507|NCT03862131|521639422|FG000|Overall Study|Withdrawal by Subject|5|||
144669508|NCT03862131|521639423|FG001|Overall Study|Withdrawal by Subject|3|||
144669509|NCT03862131|521639424|FG002|Overall Study|Withdrawal by Subject|0|||
144669510|NCT03862131|521639422|FG000|Overall Study|Physician Decision|0|||
144669511|NCT03862131|521639423|FG001|Overall Study|Physician Decision|1|||
144669512|NCT03862131|521639424|FG002|Overall Study|Physician Decision|0|||
144669513|NCT00859573|521641445|FG000|Overall Study|Withdrawal by Subject|4|||
144669514|NCT00859573|521641446|FG001|Overall Study|Withdrawal by Subject|1|||
144669515|NCT00859573|521641445|FG000|Overall Study|Physician Decision|1|||
144669516|NCT00859573|521641446|FG001|Overall Study|Physician Decision|1|||
144669517|NCT03488238|521641447|FG000|Overall Study|Equipment malfunction|1|||
144669518|NCT03488238|521641447|FG000|Overall Study|Adverse Event|1|||
144669519|NCT01316939|521641448|FG000|Overall Study|Study closed/terminated|26|||
144669520|NCT01316939|521641449|FG001|Overall Study|Study closed/terminated|25|||
144669521|NCT01316939|521641450|FG002|Overall Study|Study closed/terminated|23|||
144669522|NCT01316939|521641448|FG000|Overall Study|Lack of Efficacy|24|||
144669523|NCT01316939|521641449|FG001|Overall Study|Lack of Efficacy|25|||
144669524|NCT01316939|521641450|FG002|Overall Study|Lack of Efficacy|25|||
144669525|NCT01316939|521641448|FG000|Overall Study|Adverse Event|9|||
144669526|NCT01316939|521641449|FG001|Overall Study|Adverse Event|12|||
144669527|NCT01316939|521641450|FG002|Overall Study|Adverse Event|11|||
144669528|NCT01316939|521641448|FG000|Overall Study|Withdrawal by Subject|1|||
144669529|NCT01316939|521641449|FG001|Overall Study|Withdrawal by Subject|3|||
144669530|NCT01316939|521641450|FG002|Overall Study|Withdrawal by Subject|6|||
144669531|NCT01316939|521641448|FG000|Overall Study|Physician Decision|2|||
144669532|NCT01316939|521641449|FG001|Overall Study|Physician Decision|2|||
144669533|NCT01316939|521641450|FG002|Overall Study|Physician Decision|1|||
144669534|NCT01316939|521641448|FG000|Overall Study|Lost to Follow-up|0|||
144669535|NCT01316939|521641449|FG001|Overall Study|Lost to Follow-up|0|||
144669536|NCT01316939|521641450|FG002|Overall Study|Lost to Follow-up|2|||
144669537|NCT01316939|521641448|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
144669538|NCT01316939|521641449|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
144669539|NCT01316939|521641450|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
144669540|NCT01316939|521641448|FG000|Overall Study|Protocol Violation|0|||
144669541|NCT01316939|521641449|FG001|Overall Study|Protocol Violation|1|||
144669542|NCT01316939|521641450|FG002|Overall Study|Protocol Violation|0|||
144669543|NCT01432457|521641451|FG000|Overall Study|Adverse Event|7|||
144734141|NCT03375463|521883632|FG005|Period 1|Lost to Follow-up|0|||
144734142|NCT03375463|521883627|FG000|Period 1|Adverse Event|0|||
144734143|NCT03375463|521883628|FG001|Period 1|Adverse Event|0|||
144734144|NCT03375463|521883629|FG002|Period 1|Adverse Event|0|||
144734145|NCT03375463|521883630|FG003|Period 1|Adverse Event|0|||
144734146|NCT03375463|521883631|FG004|Period 1|Adverse Event|1|||
144734147|NCT03375463|521883632|FG005|Period 1|Adverse Event|0|||
144734148|NCT03375463|521883627|FG000|Period 2|Lost to Follow-up|1|||
144734149|NCT03375463|521883628|FG001|Period 2|Lost to Follow-up|1|||
144734150|NCT03375463|521883629|FG002|Period 2|Lost to Follow-up|0|||
144734151|NCT03375463|521883630|FG003|Period 2|Lost to Follow-up|0|||
144734152|NCT03375463|521883631|FG004|Period 2|Lost to Follow-up|0|||
144734153|NCT03375463|521883632|FG005|Period 2|Lost to Follow-up|0|||
144734154|NCT01827163|521883633|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
144734155|NCT01827163|521883633|FG000|Overall Study|Adverse Event|9|||
144734156|NCT01037114|521883634|FG000|Year 20|Others|1|||
144734157|NCT02294604|521883640|FG000|Overall Study|Did not provide samples for culture|0|||
144669544|NCT01432457|521641452|FG001|Overall Study|Adverse Event|10|||
144669545|NCT01432457|521641453|FG002|Overall Study|Adverse Event|16|||
144734158|NCT02294604|521883641|FG001|Overall Study|Did not provide samples for culture|1|||
144669546|NCT01432457|521641451|FG000|Overall Study|Lack of Efficacy|2|||
144669547|NCT01432457|521641452|FG001|Overall Study|Lack of Efficacy|1|||
144669548|NCT01432457|521641453|FG002|Overall Study|Lack of Efficacy|1|||
144669549|NCT01432457|521641451|FG000|Overall Study|Lost to Follow-up|11|||
144669550|NCT01432457|521641452|FG001|Overall Study|Lost to Follow-up|15|||
144734159|NCT02294604|521883642|FG002|Overall Study|Did not provide samples for culture|0|||
144734160|NCT02294604|521883640|FG000|Overall Study|Culture contamination|1|||
144734161|NCT02294604|521883641|FG001|Overall Study|Culture contamination|2|||
144217963|NCT04848480|519992206|FG000|Main Phase (26 Weeks)|Death|1|||
144217964|NCT04848480|519992207|FG001|Main Phase (26 Weeks)|Death|0|||
144217965|NCT04848480|519992206|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
144669551|NCT01432457|521641453|FG002|Overall Study|Lost to Follow-up|20|||
144669552|NCT01432457|521641451|FG000|Overall Study|Protocol Violation|3|||
144669553|NCT01432457|521641452|FG001|Overall Study|Protocol Violation|2|||
144669554|NCT01432457|521641453|FG002|Overall Study|Protocol Violation|6|||
144669555|NCT01432457|521641451|FG000|Overall Study|Withdrawal by Subject|6|||
144734162|NCT02294604|521883642|FG002|Overall Study|Culture contamination|0|||
144734163|NCT01401647|521883653|FG000|Overall Study|Withdrawal by Subject|1|||
144734164|NCT01401647|521883654|FG001|Overall Study|Withdrawal by Subject|5|||
144669556|NCT01432457|521641452|FG001|Overall Study|Withdrawal by Subject|11|||
144669557|NCT01432457|521641453|FG002|Overall Study|Withdrawal by Subject|9|||
144669558|NCT01432457|521641451|FG000|Overall Study|Reasons not defined|2|||
144669559|NCT01432457|521641452|FG001|Overall Study|Reasons not defined|3|||
144669560|NCT01432457|521641453|FG002|Overall Study|Reasons not defined|4|||
144669561|NCT01432457|521641451|FG000|Overall Study|Did not take study drug|6|||
144669562|NCT01432457|521641452|FG001|Overall Study|Did not take study drug|6|||
144669563|NCT01432457|521641453|FG002|Overall Study|Did not take study drug|3|||
144669564|NCT00093470|521641475|FG000|Overall Study|Disease progression|39|||
144669565|NCT00093470|521641476|FG001|Overall Study|Disease progression|0|||
144669566|NCT00093470|521641475|FG000|Overall Study|Adverse Event|15|||
144669567|NCT00093470|521641476|FG001|Overall Study|Adverse Event|0|||
144669568|NCT00093470|521641475|FG000|Overall Study|Death|2|||
144669569|NCT00093470|521641476|FG001|Overall Study|Death|0|||
144669570|NCT00093470|521641475|FG000|Overall Study|Withdrawal by Subject|8|||
144669571|NCT00093470|521641476|FG001|Overall Study|Withdrawal by Subject|0|||
144669572|NCT00093470|521641475|FG000|Overall Study|Alternative therapy|2|||
144669573|NCT00093470|521641476|FG001|Overall Study|Alternative therapy|0|||
144669574|NCT00093470|521641475|FG000|Overall Study|Other complicating disease|3|||
144669575|NCT00093470|521641476|FG001|Overall Study|Other complicating disease|0|||
144669576|NCT00093470|521641475|FG000|Overall Study|Physician Decision|2|||
144669577|NCT00093470|521641476|FG001|Overall Study|Physician Decision|0|||
144669578|NCT00093470|521641475|FG000|Overall Study|Never started treatment|1|||
144669579|NCT00093470|521641476|FG001|Overall Study|Never started treatment|0|||
144669580|NCT00093470|521641475|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
144669581|NCT00093470|521641476|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
144669582|NCT05905601|521641477|FG000|Overall Study|Lost to Follow-up|1|||
144669583|NCT05905601|521641478|FG001|Overall Study|Lost to Follow-up|3|||
144669584|NCT00877006|521641479|FG000|Treatment Period|Death|2|||
144669585|NCT00877006|521641480|FG001|Treatment Period|Death|1|||
144669586|NCT00877006|521641479|FG000|Treatment Period|Adverse Event|10|||
144669587|NCT00877006|521641480|FG001|Treatment Period|Adverse Event|3|||
144669588|NCT00877006|521641479|FG000|Treatment Period|Withdrawal by Subject|2|||
144669589|NCT00877006|521641480|FG001|Treatment Period|Withdrawal by Subject|3|||
144669590|NCT00877006|521641479|FG000|Treatment Period|Protocol Violation|1|||
144669591|NCT00877006|521641480|FG001|Treatment Period|Protocol Violation|0|||
144669592|NCT00877006|521641479|FG000|Treatment Period|Lost to Follow-up|0|||
144669593|NCT00877006|521641480|FG001|Treatment Period|Lost to Follow-up|1|||
144669594|NCT00877006|521641479|FG000|Treatment Period|Disease Progression|1|||
144669595|NCT00877006|521641480|FG001|Treatment Period|Disease Progression|2|||
144669596|NCT00877006|521641479|FG000|Treatment Period|Started New Treatment Regimen|2|||
144669597|NCT00877006|521641480|FG001|Treatment Period|Started New Treatment Regimen|5|||
144669598|NCT00877006|521641479|FG000|Treatment Period|Other|4|||
144669599|NCT00877006|521641480|FG001|Treatment Period|Other|4|||
144669600|NCT00877006|521641479|FG000|Treatment Period|Randomized but Not Treated|3|||
144669601|NCT00877006|521641480|FG001|Treatment Period|Randomized but Not Treated|8|||
144669602|NCT00877006|521641479|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
144669603|NCT00877006|521641480|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
144669604|NCT00877006|521641479|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
144669605|NCT00877006|521641480|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
144669606|NCT00877006|521641479|FG000|Long-Term Follow-up Period|Death|26|||
144669607|NCT00877006|521641480|FG001|Long-Term Follow-up Period|Death|18|||
144669608|NCT00877006|521641479|FG000|Long-Term Follow-up Period|Other|7|||
144669609|NCT00877006|521641480|FG001|Long-Term Follow-up Period|Other|9|||
144669610|NCT03583606|521641481|FG000|Overall Study|Lost to Follow-up|0|||
144669611|NCT03583606|521641482|FG001|Overall Study|Lost to Follow-up|1|||
144669612|NCT03583606|521641483|FG002|Overall Study|Lost to Follow-up|0|||
144669613|NCT03583606|521641481|FG000|Overall Study|Ineligible at baseline|1|||
144669614|NCT03583606|521641482|FG001|Overall Study|Ineligible at baseline|0|||
144669615|NCT03583606|521641483|FG002|Overall Study|Ineligible at baseline|0|||
144669616|NCT00817206|521641488|FG000|Overall Study|Adverse Event|10|||
144669617|NCT00817206|521641489|FG001|Overall Study|Adverse Event|3|||
144669618|NCT00817206|521641488|FG000|Overall Study|Protocol Violation|0|||
144669619|NCT00817206|521641489|FG001|Overall Study|Protocol Violation|2|||
144669620|NCT00817206|521641488|FG000|Overall Study|Lost to Follow-up|0|||
144669621|NCT00817206|521641489|FG001|Overall Study|Lost to Follow-up|1|||
144669622|NCT00817206|521641488|FG000|Overall Study|Death|2|||
144669623|NCT00817206|521641489|FG001|Overall Study|Death|0|||
144669624|NCT00817206|521641488|FG000|Overall Study|Withdrawal by Subject|7|||
144669625|NCT00817206|521641489|FG001|Overall Study|Withdrawal by Subject|3|||
144669626|NCT00817206|521641488|FG000|Overall Study|Physician Decision|2|||
144669627|NCT00817206|521641489|FG001|Overall Study|Physician Decision|0|||
144669628|NCT00126581|521641490|FG000|Overall Study|Adverse Event|3|||
144669629|NCT00126581|521641491|FG001|Overall Study|Adverse Event|7|||
144669630|NCT00126581|521641490|FG000|Overall Study|Death|3|||
144669631|NCT00126581|521641491|FG001|Overall Study|Death|2|||
144669632|NCT00126581|521641490|FG000|Overall Study|Withdrawal by Subject|1|||
144669633|NCT00126581|521641491|FG001|Overall Study|Withdrawal by Subject|4|||
144669634|NCT00126581|521641490|FG000|Overall Study|Alternative therapy|3|||
144669635|NCT00126581|521641491|FG001|Overall Study|Alternative therapy|3|||
144669636|NCT00126581|521641490|FG000|Overall Study|Other illness/MD discretion|3|||
144669637|NCT00126581|521641491|FG001|Overall Study|Other illness/MD discretion|4|||
144669638|NCT00793182|521641492|FG000|Overall Study|Adverse Event|0|||
144669639|NCT00793182|521641493|FG001|Overall Study|Adverse Event|1|||
144669640|NCT01188096|521641495|FG000|Overall Study|progression of disease|4|||
144669641|NCT01188096|521641495|FG000|Overall Study|Withdrawal by Subject|2|||
144669642|NCT00851253|521641496|FG000|Overall Study|Disease Progression|1|||
144669643|NCT00851253|521641497|FG001|Overall Study|Disease Progression|0|||
144669644|NCT01779648|521641498|FG000|Overall Study|Protocol Violation|1|||
144669645|NCT01779648|521641499|FG001|Overall Study|Protocol Violation|0|||
144669646|NCT03485222|521641500|FG000|Overall Study|Death|0|||
144669647|NCT03485222|521641501|FG001|Overall Study|Death|1|||
144669648|NCT03485222|521641500|FG000|Overall Study|Lost to Follow-up|2|||
144669649|NCT03485222|521641501|FG001|Overall Study|Lost to Follow-up|1|||
144669650|NCT00367341|521641505|FG000|Overall Study|Physician Decision|1|||
144669651|NCT00367341|521641506|FG001|Overall Study|Physician Decision|0|||
144669652|NCT00367341|521641505|FG000|Overall Study|Protocol Violation|1|||
144669653|NCT00367341|521641506|FG001|Overall Study|Protocol Violation|0|||
144669654|NCT02119026|521641509|FG000|1st-line Treatment|Adverse Event|9|||
144669655|NCT02119026|521641510|FG001|1st-line Treatment|Adverse Event|14|||
144669656|NCT02119026|521641509|FG000|1st-line Treatment|Physician Decision|3|||
144669657|NCT02119026|521641510|FG001|1st-line Treatment|Physician Decision|8|||
144669658|NCT02119026|521641509|FG000|1st-line Treatment|Withdrawal by Subject|4|||
144669659|NCT02119026|521641510|FG001|1st-line Treatment|Withdrawal by Subject|10|||
144669660|NCT02119026|521641509|FG000|1st-line Treatment|Patient condition or compliance|6|||
144669661|NCT02119026|521641510|FG001|1st-line Treatment|Patient condition or compliance|4|||
144669662|NCT02119026|521641509|FG000|1st-line Treatment|Surgery of metastases|2|||
144669663|NCT02119026|521641510|FG001|1st-line Treatment|Surgery of metastases|1|||
144669664|NCT02119026|521641509|FG000|1st-line Treatment|Death|2|||
144669665|NCT02119026|521641510|FG001|1st-line Treatment|Death|1|||
144669666|NCT02119026|521641509|FG000|2nd-line Treatment|Lost to Follow-up|2|||
144669667|NCT02119026|521641510|FG001|2nd-line Treatment|Lost to Follow-up|0|||
144669668|NCT02119026|521641509|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
144669669|NCT02119026|521641510|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
144669670|NCT02119026|521641509|FG000|2nd-line Treatment|Adverse Event|4|||
144669671|NCT02119026|521641510|FG001|2nd-line Treatment|Adverse Event|1|||
144669672|NCT01373918|521641511|FG000|Overall Study|Physician Decision|0|||
144669673|NCT01373918|521641512|FG001|Overall Study|Physician Decision|1|||
144669674|NCT00340834|521641513|FG000|Core Phase of Study|Adverse Event|26|||
144669675|NCT00340834|521641514|FG001|Core Phase of Study|Adverse Event|9|||
144669676|NCT00340834|521641515|FG002|Core Phase of Study|Adverse Event|9|||
144669677|NCT00340834|521641516|FG003|Core Phase of Study|Adverse Event|0|||
144669678|NCT00340834|521641517|FG004|Core Phase of Study|Adverse Event|0|||
144669679|NCT00340834|521641513|FG000|Core Phase of Study|Withdrawal by Subject|11|||
144669680|NCT00340834|521641514|FG001|Core Phase of Study|Withdrawal by Subject|9|||
144669681|NCT00340834|521641515|FG002|Core Phase of Study|Withdrawal by Subject|16|||
144669682|NCT00340834|521641516|FG003|Core Phase of Study|Withdrawal by Subject|0|||
144669683|NCT00340834|521641517|FG004|Core Phase of Study|Withdrawal by Subject|0|||
144669684|NCT00340834|521641513|FG000|Core Phase of Study|Administrative Problems|6|||
144669685|NCT00340834|521641514|FG001|Core Phase of Study|Administrative Problems|2|||
144669686|NCT00340834|521641515|FG002|Core Phase of Study|Administrative Problems|7|||
144669687|NCT00340834|521641516|FG003|Core Phase of Study|Administrative Problems|0|||
144669688|NCT00340834|521641517|FG004|Core Phase of Study|Administrative Problems|0|||
144669689|NCT00340834|521641513|FG000|Core Phase of Study|Lack of Efficacy|3|||
144669690|NCT00340834|521641514|FG001|Core Phase of Study|Lack of Efficacy|3|||
144669691|NCT00340834|521641515|FG002|Core Phase of Study|Lack of Efficacy|7|||
144669692|NCT00340834|521641516|FG003|Core Phase of Study|Lack of Efficacy|0|||
144669693|NCT00340834|521641517|FG004|Core Phase of Study|Lack of Efficacy|0|||
144669694|NCT00340834|521641513|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
144669695|NCT00340834|521641514|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
144669696|NCT00340834|521641515|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
144669697|NCT00340834|521641516|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
144669698|NCT00340834|521641517|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
144669699|NCT00340834|521641513|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
144669700|NCT00340834|521641514|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
144669701|NCT00340834|521641515|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
144669702|NCT00340834|521641516|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
144669703|NCT00340834|521641517|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
144669704|NCT00340834|521641513|FG000|Core Phase of Study|Lost to Follow-up|1|||
144669705|NCT00340834|521641514|FG001|Core Phase of Study|Lost to Follow-up|1|||
144669706|NCT00340834|521641515|FG002|Core Phase of Study|Lost to Follow-up|4|||
144669707|NCT00340834|521641516|FG003|Core Phase of Study|Lost to Follow-up|0|||
144669708|NCT00340834|521641517|FG004|Core Phase of Study|Lost to Follow-up|0|||
144734165|NCT01401647|521883655|FG002|Overall Study|Withdrawal by Subject|2|||
144669709|NCT00340834|521641513|FG000|Core Phase of Study|Death|2|||
144669710|NCT00340834|521641514|FG001|Core Phase of Study|Death|0|||
144669711|NCT00340834|521641515|FG002|Core Phase of Study|Death|0|||
144669712|NCT00340834|521641516|FG003|Core Phase of Study|Death|0|||
144669713|NCT00340834|521641517|FG004|Core Phase of Study|Death|0|||
144669714|NCT00340834|521641513|FG000|Core Phase of Study|Protocol Violation|0|||
144669715|NCT00340834|521641514|FG001|Core Phase of Study|Protocol Violation|0|||
144669716|NCT00340834|521641515|FG002|Core Phase of Study|Protocol Violation|2|||
144669717|NCT00340834|521641516|FG003|Core Phase of Study|Protocol Violation|0|||
144669718|NCT00340834|521641517|FG004|Core Phase of Study|Protocol Violation|0|||
144669719|NCT00340834|521641513|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
144669720|NCT00340834|521641514|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
144669721|NCT00340834|521641515|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
144669722|NCT00340834|521641516|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
144669723|NCT00340834|521641517|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
144669724|NCT00340834|521641513|FG000|Extension Phase of Study|Subject withdrew consent|26|||
144669725|NCT00340834|521641514|FG001|Extension Phase of Study|Subject withdrew consent|31|||
144669726|NCT00340834|521641515|FG002|Extension Phase of Study|Subject withdrew consent|0|||
144669727|NCT00340834|521641516|FG003|Extension Phase of Study|Subject withdrew consent|12|||
144669728|NCT00340834|521641517|FG004|Extension Phase of Study|Subject withdrew consent|15|||
144669729|NCT00340834|521641513|FG000|Extension Phase of Study|Adverse Event|21|||
144669730|NCT00340834|521641514|FG001|Extension Phase of Study|Adverse Event|22|||
144669731|NCT00340834|521641515|FG002|Extension Phase of Study|Adverse Event|0|||
144669732|NCT00340834|521641516|FG003|Extension Phase of Study|Adverse Event|19|||
144669733|NCT00340834|521641517|FG004|Extension Phase of Study|Adverse Event|7|||
144669734|NCT00340834|521641513|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
144669735|NCT00340834|521641514|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
144669736|NCT00340834|521641515|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
144669737|NCT00340834|521641516|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
144669738|NCT00340834|521641517|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
144669739|NCT00340834|521641513|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
144669740|NCT00340834|521641514|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
144669741|NCT00340834|521641515|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
144669742|NCT00340834|521641516|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
144669743|NCT00340834|521641517|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
144669744|NCT00340834|521641513|FG000|Extension Phase of Study|Lost to Follow-up|1|||
144669745|NCT00340834|521641514|FG001|Extension Phase of Study|Lost to Follow-up|1|||
144669746|NCT00340834|521641515|FG002|Extension Phase of Study|Lost to Follow-up|0|||
144669747|NCT00340834|521641516|FG003|Extension Phase of Study|Lost to Follow-up|2|||
144669748|NCT00340834|521641517|FG004|Extension Phase of Study|Lost to Follow-up|3|||
144669749|NCT00340834|521641513|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
144669750|NCT00340834|521641514|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
144669751|NCT00340834|521641515|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
144669752|NCT00340834|521641516|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
144669753|NCT00340834|521641517|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
144669754|NCT00340834|521641513|FG000|Extension Phase of Study|Administrative problems|3|||
144669755|NCT00340834|521641514|FG001|Extension Phase of Study|Administrative problems|0|||
144669756|NCT00340834|521641515|FG002|Extension Phase of Study|Administrative problems|0|||
144669757|NCT00340834|521641516|FG003|Extension Phase of Study|Administrative problems|1|||
144669758|NCT00340834|521641517|FG004|Extension Phase of Study|Administrative problems|1|||
144669759|NCT00340834|521641513|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
144669760|NCT00340834|521641514|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
144669761|NCT00340834|521641515|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
144734166|NCT01401647|521883653|FG000|Overall Study|Lost to Follow-up|3|||
144734167|NCT01401647|521883654|FG001|Overall Study|Lost to Follow-up|3|||
144734168|NCT01401647|521883655|FG002|Overall Study|Lost to Follow-up|1|||
144734169|NCT00473330|521883657|FG000|Core Study|Adverse Event|4|||
144669762|NCT00340834|521641516|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
144669763|NCT00340834|521641517|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
144669764|NCT00340834|521641513|FG000|Extension Phase of Study|Protocol Violation|3|||
144669765|NCT00340834|521641514|FG001|Extension Phase of Study|Protocol Violation|0|||
144669766|NCT00340834|521641515|FG002|Extension Phase of Study|Protocol Violation|0|||
144669767|NCT00340834|521641516|FG003|Extension Phase of Study|Protocol Violation|0|||
144669768|NCT00340834|521641517|FG004|Extension Phase of Study|Protocol Violation|0|||
144669769|NCT00340834|521641513|FG000|Extension Phase of Study|Death|0|||
144669770|NCT00340834|521641514|FG001|Extension Phase of Study|Death|0|||
144669771|NCT00340834|521641515|FG002|Extension Phase of Study|Death|0|||
144669772|NCT00340834|521641516|FG003|Extension Phase of Study|Death|0|||
144734170|NCT00473330|521883658|FG001|Core Study|Adverse Event|4|||
144734171|NCT00473330|521883659|FG002|Core Study|Adverse Event|1|||
144669773|NCT00340834|521641517|FG004|Extension Phase of Study|Death|1|||
144669774|NCT00291499|521641518|FG000|Overall Study|Adverse Event|3|||
144669775|NCT00291499|521641519|FG001|Overall Study|Adverse Event|8|||
144669776|NCT00291499|521641518|FG000|Overall Study|Change to other therapy|2|||
144669777|NCT00291499|521641519|FG001|Overall Study|Change to other therapy|1|||
144669778|NCT00291499|521641518|FG000|Overall Study|Intercurrent illness|1|||
144669779|NCT00291499|521641519|FG001|Overall Study|Intercurrent illness|0|||
144669780|NCT00291499|521641518|FG000|Overall Study|Protocol Violation|2|||
144669781|NCT00291499|521641519|FG001|Overall Study|Protocol Violation|2|||
144669782|NCT00291499|521641518|FG000|Overall Study|Other reasons|1|||
144669783|NCT00291499|521641519|FG001|Overall Study|Other reasons|4|||
144669784|NCT02786836|521641522|FG000|Overall Study|Death|1|||
144669785|NCT02786836|521641522|FG000|Overall Study|Lack of Efficacy|2|||
144669786|NCT02786836|521641522|FG000|Overall Study|Protocol Violation|3|||
144669787|NCT02786836|521641522|FG000|Overall Study|Withdrawal by Subject|3|||
144669788|NCT02786836|521641522|FG000|Overall Study|Liver Transplantation|2|||
144669789|NCT02786836|521641522|FG000|Overall Study|Device or Pharmacy Issues|3|||
144669790|NCT01387074|521641525|FG000|Overall Study|Lost to Follow-up|7|||
144669791|NCT01387074|521641525|FG000|Overall Study|Lack of Efficacy|1|||
144669792|NCT01532570|521641535|FG000|Overall Study|Lack of Efficacy|1|||
144669793|NCT01532570|521641536|FG001|Overall Study|Lack of Efficacy|0|||
144669794|NCT01532570|521641537|FG002|Overall Study|Lack of Efficacy|0|||
144669795|NCT01532570|521641538|FG003|Overall Study|Lack of Efficacy|0|||
144669796|NCT01532570|521641535|FG000|Overall Study|Withdrawal by Subject|0|||
144669797|NCT01532570|521641536|FG001|Overall Study|Withdrawal by Subject|1|||
144669798|NCT01532570|521641537|FG002|Overall Study|Withdrawal by Subject|0|||
144669799|NCT01532570|521641538|FG003|Overall Study|Withdrawal by Subject|0|||
144669800|NCT03892707|521641541|FG000|Overall Study|Screen failure|6|||
144669801|NCT03892707|521641542|FG001|Overall Study|Screen failure|0|||
144669802|NCT03892707|521641541|FG000|Overall Study|Pain resolution|0|||
144669803|NCT03892707|521641542|FG001|Overall Study|Pain resolution|4|||
144669804|NCT03892707|521641541|FG000|Overall Study|Withdrawal by Subject|0|||
144669805|NCT03892707|521641542|FG001|Overall Study|Withdrawal by Subject|1|||
144669806|NCT03892707|521641541|FG000|Overall Study|Other (long business trip)|0|||
144669807|NCT03892707|521641542|FG001|Overall Study|Other (long business trip)|1|||
144669808|NCT05224076|521641546|FG000|Overall Study|Lost to Follow-up|24|||
144669809|NCT01807949|521641548|FG000|Overall Study|Adverse Event|1|||
144669810|NCT01807949|521641549|FG001|Overall Study|Adverse Event|2|||
144669811|NCT01807949|521641550|FG002|Overall Study|Adverse Event|2|||
144669812|NCT01807949|521641548|FG000|Overall Study|Withdrawal by Subject|1|||
144669813|NCT01807949|521641549|FG001|Overall Study|Withdrawal by Subject|2|||
144669814|NCT01807949|521641550|FG002|Overall Study|Withdrawal by Subject|2|||
144669815|NCT01807949|521641548|FG000|Overall Study|Non-Compliance|0|||
144669816|NCT01807949|521641549|FG001|Overall Study|Non-Compliance|0|||
144669817|NCT01807949|521641550|FG002|Overall Study|Non-Compliance|1|||
144669818|NCT01807949|521641548|FG000|Overall Study|Undefined|0|||
144669819|NCT01807949|521641549|FG001|Overall Study|Undefined|1|||
144669820|NCT01807949|521641550|FG002|Overall Study|Undefined|2|||
144669821|NCT01807949|521641548|FG000|Overall Study|Randomized But Not Treated|0|||
144669822|NCT01807949|521641549|FG001|Overall Study|Randomized But Not Treated|2|||
144669823|NCT01807949|521641550|FG002|Overall Study|Randomized But Not Treated|2|||
144669824|NCT04190186|521641551|FG000|Overall Study|ILR is no longer functioning|0|||
144669825|NCT04190186|521641552|FG001|Overall Study|ILR is no longer functioning|1|||
144669826|NCT04190186|521641551|FG000|Overall Study|Lost to Follow-up|0|||
144669827|NCT04190186|521641552|FG001|Overall Study|Lost to Follow-up|1|||
144669828|NCT04190186|521641551|FG000|Overall Study|Withdrawal by Subject|2|||
144669829|NCT04190186|521641552|FG001|Overall Study|Withdrawal by Subject|0|||
144669830|NCT04190186|521641551|FG000|Overall Study|Subject choice to explant|1|||
144669831|NCT04190186|521641552|FG001|Overall Study|Subject choice to explant|0|||
144669832|NCT04190186|521641551|FG000|Overall Study|Physician Decision|0|||
144669833|NCT04190186|521641552|FG001|Overall Study|Physician Decision|1|||
144669834|NCT04190186|521641551|FG000|Overall Study|Study was stopped|4|||
144669835|NCT04190186|521641552|FG001|Overall Study|Study was stopped|5|||
144669836|NCT01665768|521641553|FG000|Overall Study|Adverse Event|3|||
144669837|NCT01665768|521641553|FG000|Overall Study|Lack of Efficacy|19|||
144669838|NCT01665768|521641553|FG000|Overall Study|Withdrawal by Subject|1|||
144669839|NCT02151682|521641554|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
144669840|NCT02151682|521641555|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
144669841|NCT02151682|521641556|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
144669842|NCT02151682|521641557|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
144217966|NCT04848480|519992207|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
144217967|NCT04848480|519992206|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
144669843|NCT02151682|521641558|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
144669844|NCT02151682|521641559|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
144669845|NCT02151682|521641554|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
144669846|NCT02151682|521641555|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
144734172|NCT00473330|521883657|FG000|Core Study|Death|6|||
144669847|NCT02151682|521641556|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
144669848|NCT02151682|521641557|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
144669849|NCT02151682|521641558|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
144669850|NCT02151682|521641559|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
144669851|NCT02151682|521641554|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
144669852|NCT02151682|521641555|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
144669853|NCT02151682|521641556|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
144669854|NCT02151682|521641557|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
144669855|NCT02151682|521641558|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
144669856|NCT02151682|521641559|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
144669857|NCT02151682|521641554|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
144669858|NCT02151682|521641555|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
144669859|NCT02151682|521641556|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
144669860|NCT02151682|521641557|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
144669861|NCT02151682|521641558|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
144669862|NCT02151682|521641559|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
144669863|NCT02151682|521641554|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
144669864|NCT02151682|521641555|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
144669865|NCT02151682|521641556|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
144669866|NCT02151682|521641557|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
144669867|NCT02151682|521641558|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
144669868|NCT02151682|521641559|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
144669869|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
144669870|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
144669871|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
144669872|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
144669873|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
144669874|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
144669875|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
144669876|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
144669877|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
144669878|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
144669879|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
144669880|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
144669881|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
144669882|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
144669883|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
144669884|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
144669885|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
144669886|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
144669887|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
144669888|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
144669889|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
144669890|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
144669891|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
144669892|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
144669893|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
144669894|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
144669895|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
144669896|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
144669897|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
144669898|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
144669899|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
144669900|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
144669901|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
144669902|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
144669903|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
144669904|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
144669905|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
144669906|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
144734173|NCT00473330|521883658|FG001|Core Study|Death|4|||
144734174|NCT00473330|521883659|FG002|Core Study|Death|4|||
144734175|NCT00473330|521883657|FG000|Core Study|Lost to Follow-up|5|||
144217968|NCT04848480|519992207|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
144217969|NCT04848480|519992206|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
144217970|NCT04848480|519992207|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
144669907|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
144669908|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
144669909|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
144669910|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
144669911|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
144669912|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
144669913|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
144669914|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
144669915|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
144669916|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
144669917|NCT02151682|521641554|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
144669918|NCT02151682|521641555|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
144669919|NCT02151682|521641556|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
144669920|NCT02151682|521641557|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
144669921|NCT02151682|521641558|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
144669922|NCT02151682|521641559|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
144669923|NCT02151682|521641554|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
144669924|NCT02151682|521641555|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
144669925|NCT02151682|521641556|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
144669926|NCT02151682|521641557|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
144669927|NCT02151682|521641558|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
144669928|NCT02151682|521641559|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
144669929|NCT02151682|521641554|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
144669930|NCT02151682|521641555|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
144669931|NCT02151682|521641556|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
144669932|NCT02151682|521641557|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
144669933|NCT02151682|521641558|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
144669934|NCT02151682|521641559|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
144669935|NCT02151682|521641554|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
144669936|NCT02151682|521641555|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
144669937|NCT02151682|521641556|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
144669938|NCT02151682|521641557|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
144669939|NCT02151682|521641558|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
144669940|NCT02151682|521641559|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
144669941|NCT02151682|521641554|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
144669942|NCT02151682|521641555|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
144669943|NCT02151682|521641556|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
144669944|NCT02151682|521641557|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
144669945|NCT02151682|521641558|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
144669946|NCT02151682|521641559|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
144669947|NCT03260894|521641560|FG000|Overall Study|Death|6|||
144669948|NCT03260894|521641561|FG001|Overall Study|Death|8|||
144669949|NCT03260894|521641560|FG000|Overall Study|Withdrawal by Subject|4|||
144669950|NCT03260894|521641561|FG001|Overall Study|Withdrawal by Subject|11|||
144669951|NCT03260894|521641560|FG000|Overall Study|On-going at clinical cut off date|36|||
144669952|NCT03260894|521641561|FG001|Overall Study|On-going at clinical cut off date|31|||
144669953|NCT02378883|521641562|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
144669954|NCT02378883|521641562|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
144669955|NCT02378883|521641562|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
144669956|NCT02378883|521641562|FG000|30 Day Follow-Up|Physician Decision|2|||
144669957|NCT02378883|521641562|FG000|30 Day Follow-Up|Missed Visit|2|||
144669958|NCT02378883|521641562|FG000|30 Day Follow-Up|Death|1|||
144669959|NCT02378883|521641562|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
144669960|NCT02378883|521641562|FG000|12 Months Follow-Up|Death|2|||
144669961|NCT02677220|521641566|FG000|Overall Study|Adverse Event|1|||
144669962|NCT00050622|521641567|FG000|Overall Study|Adverse Event|1|||
144669963|NCT04581863|521641570|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
144669964|NCT04581863|521641571|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
144669965|NCT01170221|521641572|FG000|Overall Study|Lost to Follow-up|22|||
144669966|NCT01170221|521641573|FG001|Overall Study|Lost to Follow-up|21|||
144669967|NCT01170221|521641572|FG000|Overall Study|Withdrawal by Subject|9|||
144669968|NCT01170221|521641573|FG001|Overall Study|Withdrawal by Subject|7|||
144669969|NCT01170221|521641572|FG000|Overall Study|Subject completed only screening and LFU|1|||
144669970|NCT01170221|521641573|FG001|Overall Study|Subject completed only screening and LFU|0|||
144669971|NCT01170221|521641572|FG000|Overall Study|Randomized but not treated|1|||
144669972|NCT01170221|521641573|FG001|Overall Study|Randomized but not treated|0|||
144669973|NCT02693691|521641574|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
144734176|NCT00473330|521883658|FG001|Core Study|Lost to Follow-up|5|||
144734177|NCT00473330|521883659|FG002|Core Study|Lost to Follow-up|10|||
144734178|NCT00473330|521883657|FG000|Core Study|Physician Decision|2|||
144734179|NCT00473330|521883658|FG001|Core Study|Physician Decision|1|||
144734180|NCT00473330|521883659|FG002|Core Study|Physician Decision|3|||
144669974|NCT02693691|521641574|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
144669975|NCT02693691|521641574|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
144669976|NCT02693691|521641574|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
144669977|NCT02693691|521641574|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
144669978|NCT02693691|521641574|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
144669979|NCT02693691|521641574|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
144669980|NCT02727660|521641576|FG000|Overall Study|Lack of Efficacy|40|||
144669981|NCT02727660|521641577|FG001|Overall Study|Lack of Efficacy|40|||
144669982|NCT02727660|521641578|FG002|Overall Study|Lack of Efficacy|70|||
144669983|NCT02727660|521641576|FG000|Overall Study|Adverse Event|28|||
144669984|NCT02727660|521641577|FG001|Overall Study|Adverse Event|21|||
144669985|NCT02727660|521641578|FG002|Overall Study|Adverse Event|32|||
144669986|NCT02727660|521641576|FG000|Overall Study|Withdrawal by Subject|26|||
144669987|NCT02727660|521641577|FG001|Overall Study|Withdrawal by Subject|25|||
144669988|NCT02727660|521641578|FG002|Overall Study|Withdrawal by Subject|30|||
144669989|NCT02727660|521641576|FG000|Overall Study|Physician Decision|3|||
144669990|NCT02727660|521641577|FG001|Overall Study|Physician Decision|8|||
144669991|NCT02727660|521641578|FG002|Overall Study|Physician Decision|14|||
144669992|NCT02727660|521641576|FG000|Overall Study|Lost to Follow-up|5|||
144669993|NCT02727660|521641577|FG001|Overall Study|Lost to Follow-up|9|||
144669994|NCT02727660|521641578|FG002|Overall Study|Lost to Follow-up|8|||
144669995|NCT02727660|521641576|FG000|Overall Study|Protocol Violation|7|||
144669996|NCT02727660|521641577|FG001|Overall Study|Protocol Violation|5|||
144669997|NCT02727660|521641578|FG002|Overall Study|Protocol Violation|5|||
144669998|NCT02727660|521641576|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
144669999|NCT02727660|521641577|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
144670000|NCT02727660|521641578|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
144670001|NCT02727660|521641576|FG000|Overall Study|Administrative Reasons|2|||
144670002|NCT02727660|521641577|FG001|Overall Study|Administrative Reasons|3|||
144670003|NCT02727660|521641578|FG002|Overall Study|Administrative Reasons|4|||
144670004|NCT00050960|521641579|FG000|Overall Study|Progressive Disease|137|||
144670005|NCT00050960|521641580|FG001|Overall Study|Progressive Disease|93|||
144670006|NCT00050960|521641579|FG000|Overall Study|Stable Disease|19|||
144670007|NCT00050960|521641580|FG001|Overall Study|Stable Disease|48|||
144670008|NCT00050960|521641579|FG000|Overall Study|Partial Response|14|||
144670009|NCT00050960|521641580|FG001|Overall Study|Partial Response|19|||
144670010|NCT00050960|521641579|FG000|Overall Study|Complete Response|0|||
144670011|NCT00050960|521641580|FG001|Overall Study|Complete Response|2|||
144670012|NCT00050960|521641579|FG000|Overall Study|Adverse Event|62|||
144670013|NCT00050960|521641580|FG001|Overall Study|Adverse Event|61|||
144670014|NCT00050960|521641579|FG000|Overall Study|Lost to Follow-up|0|||
144670015|NCT00050960|521641580|FG001|Overall Study|Lost to Follow-up|1|||
144670016|NCT00050960|521641579|FG000|Overall Study|Withdrawal by Subject|23|||
144670017|NCT00050960|521641580|FG001|Overall Study|Withdrawal by Subject|18|||
144670018|NCT00050960|521641579|FG000|Overall Study|Administrative|31|||
144670019|NCT00050960|521641580|FG001|Overall Study|Administrative|46|||
144670020|NCT00050960|521641579|FG000|Overall Study|Non-compliance|3|||
144670021|NCT00050960|521641580|FG001|Overall Study|Non-compliance|1|||
144670022|NCT00050960|521641579|FG000|Overall Study|Death|13|||
144734181|NCT00473330|521883657|FG000|Core Study|Subject Non-compliance|1|||
144217971|NCT04848480|519992206|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
144670023|NCT00050960|521641580|FG001|Overall Study|Death|15|||
144670024|NCT00764946|521641586|FG000|Overall Study|Lack of Efficacy|1|||
144670025|NCT00764946|521641587|FG001|Overall Study|Lack of Efficacy|0|||
144670026|NCT00764946|521641588|FG002|Overall Study|Lack of Efficacy|0|||
144670027|NCT00764946|521641586|FG000|Overall Study|Lost to Follow-up|3|||
144670028|NCT00764946|521641587|FG001|Overall Study|Lost to Follow-up|4|||
144670029|NCT00764946|521641588|FG002|Overall Study|Lost to Follow-up|0|||
144217972|NCT04848480|519992207|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
144217973|NCT04848480|519992206|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
144670030|NCT00764946|521641586|FG000|Overall Study|Physician Decision|2|||
144670031|NCT00764946|521641587|FG001|Overall Study|Physician Decision|4|||
144670032|NCT00764946|521641588|FG002|Overall Study|Physician Decision|0|||
144670033|NCT00764946|521641586|FG000|Overall Study|Adverse Event|3|||
144670034|NCT00764946|521641587|FG001|Overall Study|Adverse Event|2|||
144670035|NCT00764946|521641588|FG002|Overall Study|Adverse Event|1|||
144670036|NCT00764946|521641586|FG000|Overall Study|Withdrawal by Subject|3|||
144670037|NCT00764946|521641587|FG001|Overall Study|Withdrawal by Subject|6|||
144670038|NCT00764946|521641588|FG002|Overall Study|Withdrawal by Subject|2|||
144670039|NCT00764946|521641586|FG000|Overall Study|Never Treated|1|||
144670040|NCT00764946|521641587|FG001|Overall Study|Never Treated|1|||
144670041|NCT00764946|521641588|FG002|Overall Study|Never Treated|1|||
144670042|NCT01162304|521641589|FG000|Overall Study|Beck scale to high|11|||
144734182|NCT00473330|521883658|FG001|Core Study|Subject Non-compliance|2|||
144734183|NCT00473330|521883659|FG002|Core Study|Subject Non-compliance|1|||
144734184|NCT00473330|521883657|FG000|Core Study|Subject Required Other Therapy|0|||
144734185|NCT00473330|521883658|FG001|Core Study|Subject Required Other Therapy|1|||
144734186|NCT00473330|521883659|FG002|Core Study|Subject Required Other Therapy|3|||
144734187|NCT00473330|521883657|FG000|Core Study|Subject's Decision|9|||
144734188|NCT00473330|521883658|FG001|Core Study|Subject's Decision|8|||
144734189|NCT00473330|521883659|FG002|Core Study|Subject's Decision|19|||
144734190|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
144734191|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
144734192|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
144734193|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Death|2|||
144734194|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Death|0|||
144734195|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Death|0|||
144734196|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
144734197|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
144734198|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
144734199|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
144734200|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
144734201|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
144734202|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
144734203|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
144734204|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
144734205|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
144734206|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
144734207|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
144734208|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
144734209|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
144734210|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
144734211|NCT00473330|521883657|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
144734212|NCT00473330|521883658|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
144734213|NCT00473330|521883659|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
144734214|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
144734215|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
144734216|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
144734217|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Death|2|||
144734218|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Death|2|||
144734219|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Death|1|||
144734220|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
144734221|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
144734222|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
144734223|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
144734224|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
144734225|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
144734226|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
144734227|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
144734228|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
144734229|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
144734230|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
144734231|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
144734232|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
144734233|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
144734234|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
144734235|NCT00473330|521883657|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
144734236|NCT00473330|521883658|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
144734237|NCT00473330|521883659|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
144734238|NCT01975948|521883660|FG000|Overall Study|Withdrawal by Subject|17|||
144734239|NCT01975948|521883661|FG001|Overall Study|Withdrawal by Subject|21|||
144734240|NCT01975948|521883662|FG002|Overall Study|Withdrawal by Subject|7|||
144734241|NCT01975948|521883663|FG003|Overall Study|Withdrawal by Subject|6|||
144734242|NCT00836056|521883669|FG000|First Intervention|Adverse Event|1|||
144734243|NCT00836056|521883670|FG001|First Intervention|Adverse Event|0|||
144734244|NCT01079988|521883671|FG000|Overall Study|Lost to Follow-up|0|||
144734245|NCT01079988|521883672|FG001|Overall Study|Lost to Follow-up|0|||
144734246|NCT01079988|521883673|FG002|Overall Study|Lost to Follow-up|0|||
144734247|NCT01079988|521883674|FG003|Overall Study|Lost to Follow-up|1|||
144217974|NCT04848480|519992207|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
144670043|NCT03454412|521641590|FG000|Baseline Assesment|Physician Decision|12|||
144670044|NCT01167582|521641591|FG000|Overall Study|Lost to Follow-up|0|||
144670045|NCT01167582|521641592|FG001|Overall Study|Lost to Follow-up|1|||
144670046|NCT01928485|521641593|FG000|Overall Study|Physician Decision|0|||
144670047|NCT01928485|521641594|FG001|Overall Study|Physician Decision|1|||
144670048|NCT00039741|521641595|FG000|Overall Study|Death|0|||
144670049|NCT00039741|521641596|FG001|Overall Study|Death|1|||
144670050|NCT00039741|521641597|FG002|Overall Study|Death|0|||
144670051|NCT00039741|521641598|FG003|Overall Study|Death|0|||
144670052|NCT00039741|521641595|FG000|Overall Study|Lost to Follow-up|3|||
144670053|NCT00039741|521641596|FG001|Overall Study|Lost to Follow-up|1|||
144670054|NCT00039741|521641597|FG002|Overall Study|Lost to Follow-up|5|||
144670055|NCT00039741|521641598|FG003|Overall Study|Lost to Follow-up|2|||
144670056|NCT00039741|521641595|FG000|Overall Study|Confounding medical condition|1|||
144670057|NCT00039741|521641596|FG001|Overall Study|Confounding medical condition|0|||
144670058|NCT00039741|521641597|FG002|Overall Study|Confounding medical condition|0|||
144670059|NCT00039741|521641598|FG003|Overall Study|Confounding medical condition|0|||
144670060|NCT00039741|521641595|FG000|Overall Study|Not able to get to clinic|5|||
144670061|NCT00039741|521641596|FG001|Overall Study|Not able to get to clinic|2|||
144670062|NCT00039741|521641597|FG002|Overall Study|Not able to get to clinic|0|||
144670063|NCT00039741|521641598|FG003|Overall Study|Not able to get to clinic|3|||
144670064|NCT00039741|521641595|FG000|Overall Study|Moved|3|||
144670065|NCT00039741|521641596|FG001|Overall Study|Moved|2|||
144670066|NCT00039741|521641597|FG002|Overall Study|Moved|3|||
144670067|NCT00039741|521641598|FG003|Overall Study|Moved|6|||
144670068|NCT00039741|521641595|FG000|Overall Study|Non-compliance with protocol|1|||
144670069|NCT00039741|521641596|FG001|Overall Study|Non-compliance with protocol|0|||
144670070|NCT00039741|521641597|FG002|Overall Study|Non-compliance with protocol|1|||
144670071|NCT00039741|521641598|FG003|Overall Study|Non-compliance with protocol|0|||
144670072|NCT00039741|521641595|FG000|Overall Study|Withdrew consent|0|||
144670073|NCT00039741|521641596|FG001|Overall Study|Withdrew consent|5|||
144670074|NCT00039741|521641597|FG002|Overall Study|Withdrew consent|0|||
144670075|NCT00039741|521641598|FG003|Overall Study|Withdrew consent|1|||
144670076|NCT00039741|521641595|FG000|Overall Study|Missed final visit|2|||
144670077|NCT00039741|521641596|FG001|Overall Study|Missed final visit|1|||
144670078|NCT00039741|521641597|FG002|Overall Study|Missed final visit|2|||
144670079|NCT00039741|521641598|FG003|Overall Study|Missed final visit|2|||
144670080|NCT00946881|521641599|FG000|First Treatment|Withdrawal by Subject|1|||
144670081|NCT00946881|521641599|FG000|First Treatment|Patient relocated to another state|1|||
144670082|NCT00946881|521641599|FG000|Retreatment|Withdrawal by Subject|1|||
144670083|NCT00293423|521641600|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
144670084|NCT00293423|521641601|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
144670085|NCT00293423|521641600|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
144670086|NCT00293423|521641601|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
144670087|NCT00293423|521641600|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
144670088|NCT00293423|521641601|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
144670089|NCT00293423|521641600|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
144670090|NCT00293423|521641601|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
144670091|NCT00293423|521641600|FG000|Surgical Resection|processing error during surgical resection|1|||
144670092|NCT00293423|521641601|FG001|Surgical Resection|processing error during surgical resection|0|||
144670093|NCT00293423|521641600|FG000|Surgical Resection|Withdrawal by Subject|4|||
144670094|NCT00293423|521641601|FG001|Surgical Resection|Withdrawal by Subject|0|||
144670095|NCT00293423|521641600|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
144670096|NCT00293423|521641601|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
144670097|NCT00964158|521641602|FG000|Overall Study|Lost to Follow-up|0|||
144670098|NCT00964158|521641603|FG001|Overall Study|Lost to Follow-up|1|||
144670099|NCT00964158|521641604|FG002|Overall Study|Lost to Follow-up|2|||
144670100|NCT00964158|521641602|FG000|Overall Study|Withdrawal by Subject|0|||
144670101|NCT00964158|521641603|FG001|Overall Study|Withdrawal by Subject|0|||
144670102|NCT00964158|521641604|FG002|Overall Study|Withdrawal by Subject|6|||
144670103|NCT00507416|521641605|FG000|Overall Study|Adverse Event|58|||
144670104|NCT00507416|521641606|FG001|Overall Study|Adverse Event|67|||
144670105|NCT00507416|521641607|FG002|Overall Study|Adverse Event|65|||
144670106|NCT00507416|521641605|FG000|Overall Study|Protocol Violation|1|||
144670107|NCT00507416|521641606|FG001|Overall Study|Protocol Violation|2|||
144670108|NCT00507416|521641607|FG002|Overall Study|Protocol Violation|0|||
144670109|NCT00507416|521641605|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
144217975|NCT03176134|519992208|FG000|Overall Study|Lost to Follow-up|0|||
144670110|NCT00507416|521641606|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
144670111|NCT00507416|521641607|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
144670112|NCT00507416|521641605|FG000|Overall Study|Progressive Disease|20|||
144670113|NCT00507416|521641606|FG001|Overall Study|Progressive Disease|10|||
144670114|NCT00507416|521641607|FG002|Overall Study|Progressive Disease|13|||
144670115|NCT00507416|521641605|FG000|Overall Study|Patient declined further treatment|18|||
144734248|NCT01079988|521883675|FG004|Overall Study|Lost to Follow-up|0|||
144670116|NCT00507416|521641606|FG001|Overall Study|Patient declined further treatment|14|||
144670117|NCT00507416|521641607|FG002|Overall Study|Patient declined further treatment|11|||
144670118|NCT00507416|521641605|FG000|Overall Study|Other|11|||
144670119|NCT00507416|521641606|FG001|Overall Study|Other|16|||
144670120|NCT00507416|521641607|FG002|Overall Study|Other|13|||
144670121|NCT00507416|521641605|FG000|Overall Study|Did not Receive Study Treatment|3|||
144670122|NCT00507416|521641606|FG001|Overall Study|Did not Receive Study Treatment|9|||
144670123|NCT00507416|521641607|FG002|Overall Study|Did not Receive Study Treatment|4|||
144670124|NCT01182337|521641608|FG000|Overall Study|Withdrawal by Subject|3|||
144670125|NCT01182337|521641609|FG001|Overall Study|Withdrawal by Subject|1|||
144670126|NCT01182337|521641608|FG000|Overall Study|Lost to Follow-up|0|||
144670127|NCT01182337|521641609|FG001|Overall Study|Lost to Follow-up|1|||
144670128|NCT01021813|521641610|FG000|DB Treatment Phase|Adverse Event|60|||
144670129|NCT01021813|521641611|FG001|DB Treatment Phase|Adverse Event|22|||
144670130|NCT01021813|521641612|FG002|DB Treatment Phase|Adverse Event|0|||
144670131|NCT01021813|521641613|FG003|DB Treatment Phase|Adverse Event|0|||
144670132|NCT01021813|521641614|FG004|DB Treatment Phase|Adverse Event|0|||
144670133|NCT01021813|521641610|FG000|DB Treatment Phase|Lack of Efficacy|44|||
144670134|NCT01021813|521641611|FG001|DB Treatment Phase|Lack of Efficacy|28|||
144670135|NCT01021813|521641612|FG002|DB Treatment Phase|Lack of Efficacy|0|||
144670136|NCT01021813|521641613|FG003|DB Treatment Phase|Lack of Efficacy|0|||
144670137|NCT01021813|521641614|FG004|DB Treatment Phase|Lack of Efficacy|0|||
144670138|NCT01021813|521641610|FG000|DB Treatment Phase|Lost to Follow-up|14|||
144670139|NCT01021813|521641611|FG001|DB Treatment Phase|Lost to Follow-up|12|||
144670140|NCT01021813|521641612|FG002|DB Treatment Phase|Lost to Follow-up|0|||
144670141|NCT01021813|521641613|FG003|DB Treatment Phase|Lost to Follow-up|0|||
144670142|NCT01021813|521641614|FG004|DB Treatment Phase|Lost to Follow-up|0|||
144670143|NCT01021813|521641610|FG000|DB Treatment Phase|Physician Decision|17|||
144670144|NCT01021813|521641611|FG001|DB Treatment Phase|Physician Decision|8|||
144670145|NCT01021813|521641612|FG002|DB Treatment Phase|Physician Decision|0|||
144670146|NCT01021813|521641613|FG003|DB Treatment Phase|Physician Decision|0|||
144670147|NCT01021813|521641614|FG004|DB Treatment Phase|Physician Decision|0|||
144670148|NCT01021813|521641610|FG000|DB Treatment Phase|Pregnancy|1|||
144670149|NCT01021813|521641611|FG001|DB Treatment Phase|Pregnancy|0|||
144670150|NCT01021813|521641612|FG002|DB Treatment Phase|Pregnancy|0|||
144670151|NCT01021813|521641613|FG003|DB Treatment Phase|Pregnancy|0|||
144670152|NCT01021813|521641614|FG004|DB Treatment Phase|Pregnancy|0|||
144670153|NCT01021813|521641610|FG000|DB Treatment Phase|Protocol Violation|4|||
144670154|NCT01021813|521641611|FG001|DB Treatment Phase|Protocol Violation|3|||
144670155|NCT01021813|521641612|FG002|DB Treatment Phase|Protocol Violation|0|||
144670156|NCT01021813|521641613|FG003|DB Treatment Phase|Protocol Violation|0|||
144670157|NCT01021813|521641614|FG004|DB Treatment Phase|Protocol Violation|0|||
144670158|NCT01021813|521641610|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
144670159|NCT01021813|521641611|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
144670160|NCT01021813|521641612|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
144670161|NCT01021813|521641613|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
144670162|NCT01021813|521641614|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
144670163|NCT01021813|521641610|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
144670164|NCT01021813|521641611|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
144670165|NCT01021813|521641612|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
144670166|NCT01021813|521641613|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
144670167|NCT01021813|521641614|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
144670168|NCT01021813|521641610|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
144670169|NCT01021813|521641611|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
144670170|NCT01021813|521641612|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
144670171|NCT01021813|521641613|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
144670172|NCT01021813|521641614|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
144670173|NCT01021813|521641610|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
144670174|NCT01021813|521641611|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
144670175|NCT01021813|521641612|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
144670176|NCT01021813|521641613|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
144670177|NCT01021813|521641614|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
144670178|NCT01021813|521641610|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
144670179|NCT01021813|521641611|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
144670180|NCT01021813|521641612|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
144670181|NCT01021813|521641613|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
144670182|NCT01021813|521641614|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
144670183|NCT01021813|521641610|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
144670184|NCT01021813|521641611|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
144670185|NCT01021813|521641612|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
144670186|NCT01021813|521641613|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
144670187|NCT01021813|521641614|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
144217976|NCT03176134|519992209|FG001|Overall Study|Lost to Follow-up|2|||
144670188|NCT03103906|521641615|FG000|Overall Study|Adverse Event|2|||
144670189|NCT03103906|521641616|FG001|Overall Study|Adverse Event|3|||
144670190|NCT03103906|521641615|FG000|Overall Study|Other|2|||
144670191|NCT03103906|521641616|FG001|Overall Study|Other|0|||
144670192|NCT00764478|521641617|FG000|Overall Study|Adverse Event|1|||
144670193|NCT00764478|521641618|FG001|Overall Study|Adverse Event|1|||
144670194|NCT00764478|521641619|FG002|Overall Study|Adverse Event|1|||
144670195|NCT00764478|521641617|FG000|Overall Study|Withdrawal by Subject|7|||
144670196|NCT00764478|521641618|FG001|Overall Study|Withdrawal by Subject|12|||
144670197|NCT00764478|521641619|FG002|Overall Study|Withdrawal by Subject|1|||
144670198|NCT00764478|521641617|FG000|Overall Study|Lost to Follow-up|7|||
144670199|NCT00764478|521641618|FG001|Overall Study|Lost to Follow-up|8|||
144670200|NCT00764478|521641619|FG002|Overall Study|Lost to Follow-up|5|||
144670201|NCT00764478|521641617|FG000|Overall Study|Protocol Violation|0|||
144670202|NCT00764478|521641618|FG001|Overall Study|Protocol Violation|1|||
144670203|NCT00764478|521641619|FG002|Overall Study|Protocol Violation|1|||
144670204|NCT03571256|521641620|FG000|Overall Study|Adverse Event|3|||
144670205|NCT03571256|521641621|FG001|Overall Study|Adverse Event|0|||
144670206|NCT03571256|521641622|FG002|Overall Study|Adverse Event|1|||
144670207|NCT03571256|521641620|FG000|Overall Study|Withdrawal by Subject|3|||
144670208|NCT03571256|521641621|FG001|Overall Study|Withdrawal by Subject|1|||
144670209|NCT03571256|521641622|FG002|Overall Study|Withdrawal by Subject|1|||
144670210|NCT03571256|521641620|FG000|Overall Study|Other than specified|0|||
144670211|NCT03571256|521641621|FG001|Overall Study|Other than specified|1|||
144670212|NCT03571256|521641622|FG002|Overall Study|Other than specified|1|||
144670213|NCT03571256|521641620|FG000|Overall Study|Protocol Violation|0|||
144670214|NCT03571256|521641621|FG001|Overall Study|Protocol Violation|1|||
144670215|NCT03571256|521641622|FG002|Overall Study|Protocol Violation|1|||
144670216|NCT02270684|521641625|FG000|Overall Study|Lost to Follow-up|0|||
144670217|NCT02270684|521641626|FG001|Overall Study|Lost to Follow-up|3|||
144670218|NCT02270684|521641625|FG000|Overall Study|Study terminated|1|||
144670219|NCT02270684|521641626|FG001|Overall Study|Study terminated|0|||
144670220|NCT01181778|521641633|FG000|Overall Study|Physician Decision|48|||
144670221|NCT01265420|521641635|FG000|Overall Study|Lost to Follow-up|1|||
144670222|NCT04507776|521643324|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
144670223|NCT01711541|521643327|FG000|Overall Study|Cancel prior to treatment|0|||
144670224|NCT01711541|521643328|FG001|Overall Study|Cancel prior to treatment|0|||
144670225|NCT01711541|521643329|FG002|Overall Study|Cancel prior to treatment|0|||
144670226|NCT01711541|521643330|FG003|Overall Study|Cancel prior to treatment|1|||
144670227|NCT01711541|521643331|FG004|Overall Study|Cancel prior to treatment|0|||
144670228|NCT01711541|521643327|FG000|Overall Study|Ineligible|0|||
144670229|NCT01711541|521643328|FG001|Overall Study|Ineligible|1|||
144670230|NCT01711541|521643329|FG002|Overall Study|Ineligible|0|||
144670231|NCT01711541|521643330|FG003|Overall Study|Ineligible|0|||
144670232|NCT01711541|521643331|FG004|Overall Study|Ineligible|0|||
144670233|NCT02141217|521643332|FG000|Overall Study|Adverse Event|1|||
144670234|NCT02141217|521643333|FG001|Overall Study|Adverse Event|2|||
144670235|NCT02141217|521643332|FG000|Overall Study|Protocol Violation|1|||
144670236|NCT02141217|521643333|FG001|Overall Study|Protocol Violation|4|||
144670237|NCT02141217|521643332|FG000|Overall Study|Withdrawal by Subject|6|||
144670238|NCT02141217|521643333|FG001|Overall Study|Withdrawal by Subject|0|||
144670239|NCT02141217|521643332|FG000|Overall Study|Lost to Follow-up|1|||
144670240|NCT02141217|521643333|FG001|Overall Study|Lost to Follow-up|1|||
144670241|NCT02141217|521643332|FG000|Overall Study|Physician Decision|1|||
144670242|NCT02141217|521643333|FG001|Overall Study|Physician Decision|0|||
144670243|NCT02141217|521643332|FG000|Overall Study|Surgical Intervention|1|||
144670244|NCT02141217|521643333|FG001|Overall Study|Surgical Intervention|1|||
144670245|NCT04603391|521643334|FG000|First Intervention (4 Days)|Adverse Event|1|||
144670246|NCT04603391|521643335|FG001|First Intervention (4 Days)|Adverse Event|0|||
144670247|NCT04603391|521643334|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
144670248|NCT04603391|521643335|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
144670249|NCT02759861|521643336|FG000|Overall Study|Death|1|||
144670250|NCT00618995|521643337|FG000|Period 1|Adverse Event|0|||
144670251|NCT00618995|521643338|FG001|Period 1|Adverse Event|0|||
144670252|NCT00618995|521643339|FG002|Period 1|Adverse Event|1|||
144670253|NCT00618995|521643340|FG003|Period 1|Adverse Event|0|||
144670254|NCT00618995|521643337|FG000|Period 1|Protocol Violation|0|||
144670255|NCT00618995|521643338|FG001|Period 1|Protocol Violation|1|||
144670256|NCT00618995|521643339|FG002|Period 1|Protocol Violation|1|||
144670257|NCT00618995|521643340|FG003|Period 1|Protocol Violation|0|||
144670258|NCT00618995|521643337|FG000|Period 2|Protocol Violation|0|||
144670259|NCT00618995|521643338|FG001|Period 2|Protocol Violation|0|||
144670260|NCT00618995|521643339|FG002|Period 2|Protocol Violation|1|||
144670261|NCT00618995|521643340|FG003|Period 2|Protocol Violation|0|||
144670262|NCT00618995|521643337|FG000|Period 4|Adverse Event|1|||
144670263|NCT00618995|521643338|FG001|Period 4|Adverse Event|0|||
144670264|NCT00618995|521643339|FG002|Period 4|Adverse Event|0|||
144670265|NCT00618995|521643340|FG003|Period 4|Adverse Event|0|||
144670266|NCT01306032|521643343|FG000|First Intervention|Adverse Event|1|||
144670267|NCT01306032|521643344|FG001|First Intervention|Adverse Event|0|||
144670268|NCT01306032|521643345|FG002|First Intervention|Adverse Event|1|||
144670269|NCT01306032|521643346|FG003|First Intervention|Adverse Event|0|||
144670270|NCT01306032|521643347|FG004|First Intervention|Adverse Event|0|||
144670271|NCT01306032|521643348|FG005|First Intervention|Adverse Event|1|||
144670272|NCT01306032|521643343|FG000|First Intervention|Withdrawal by Subject|0|||
144670273|NCT01306032|521643344|FG001|First Intervention|Withdrawal by Subject|2|||
144670274|NCT01306032|521643345|FG002|First Intervention|Withdrawal by Subject|0|||
144670275|NCT01306032|521643346|FG003|First Intervention|Withdrawal by Subject|1|||
144670276|NCT01306032|521643347|FG004|First Intervention|Withdrawal by Subject|0|||
144670277|NCT01306032|521643348|FG005|First Intervention|Withdrawal by Subject|0|||
144670278|NCT01306032|521643343|FG000|First Intervention|Death|0|||
144670279|NCT01306032|521643344|FG001|First Intervention|Death|0|||
144670280|NCT01306032|521643345|FG002|First Intervention|Death|1|||
144670281|NCT01306032|521643346|FG003|First Intervention|Death|0|||
144670282|NCT01306032|521643347|FG004|First Intervention|Death|0|||
144670283|NCT01306032|521643348|FG005|First Intervention|Death|0|||
144670284|NCT01306032|521643343|FG000|First Intervention|Ineligible|0|||
144670285|NCT01306032|521643344|FG001|First Intervention|Ineligible|0|||
144670286|NCT01306032|521643345|FG002|First Intervention|Ineligible|0|||
144670287|NCT01306032|521643346|FG003|First Intervention|Ineligible|0|||
144670288|NCT01306032|521643347|FG004|First Intervention|Ineligible|0|||
144670289|NCT01306032|521643348|FG005|First Intervention|Ineligible|1|||
144670290|NCT01306032|521643343|FG000|First Intervention|Progressive disease|0|||
144670291|NCT01306032|521643344|FG001|First Intervention|Progressive disease|0|||
144670292|NCT01306032|521643345|FG002|First Intervention|Progressive disease|0|||
144670293|NCT01306032|521643346|FG003|First Intervention|Progressive disease|0|||
144670294|NCT01306032|521643347|FG004|First Intervention|Progressive disease|2|||
144670295|NCT01306032|521643348|FG005|First Intervention|Progressive disease|0|||
144670296|NCT01306032|521643343|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
144670297|NCT01306032|521643344|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
144670298|NCT01306032|521643345|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
144670299|NCT01306032|521643346|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
144670300|NCT01306032|521643347|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
144670301|NCT01306032|521643348|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
144670302|NCT01306032|521643343|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
144670303|NCT01306032|521643344|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
144670304|NCT01306032|521643345|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
144670305|NCT01306032|521643346|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
144670306|NCT01306032|521643347|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
144670307|NCT01306032|521643348|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
144670308|NCT02988219|521643349|FG000|Overall Study|Lack of Efficacy|1|||
144670309|NCT02988219|521643350|FG001|Overall Study|Lack of Efficacy|1|||
144670310|NCT02988219|521643349|FG000|Overall Study|Withdrawal by Subject|0|||
144670311|NCT02988219|521643350|FG001|Overall Study|Withdrawal by Subject|2|||
144670312|NCT01213264|521643351|FG000|Overall Study|Adverse Event|1|||
144670313|NCT01213264|521643352|FG001|Overall Study|Adverse Event|0|||
144670314|NCT01213264|521643353|FG002|Overall Study|Adverse Event|0|||
144670315|NCT01213264|521643351|FG000|Overall Study|Lost to Follow-up|1|||
144670316|NCT01213264|521643352|FG001|Overall Study|Lost to Follow-up|2|||
144670317|NCT01213264|521643353|FG002|Overall Study|Lost to Follow-up|6|||
144670318|NCT01522443|521643355|FG000|Overall Study|No longer receiving clinical benefit|36|||
144670319|NCT01522443|521643356|FG001|Overall Study|No longer receiving clinical benefit|28|||
144670320|NCT01522443|521643355|FG000|Overall Study|Adverse Event|10|||
144670321|NCT01522443|521643356|FG001|Overall Study|Adverse Event|15|||
144670322|NCT01522443|521643355|FG000|Overall Study|Withdrawal by Subject|5|||
144670323|NCT01522443|521643356|FG001|Overall Study|Withdrawal by Subject|8|||
144670324|NCT01522443|521643355|FG000|Overall Study|No study treatment given|1|||
144670325|NCT01522443|521643356|FG001|Overall Study|No study treatment given|1|||
144670326|NCT01522443|521643355|FG000|Overall Study|Other|1|||
144670327|NCT01522443|521643356|FG001|Overall Study|Other|3|||
144670328|NCT00290589|521643358|FG000|Overall Study|Lost to Follow-up|2|||
144670329|NCT00290589|521643359|FG001|Overall Study|Lost to Follow-up|2|||
144670330|NCT00318565|521643360|FG000|Overall Study|Excluded per protocol|24|||
144670331|NCT00691093|521643361|FG000|Overall Study|Adverse Event|1|||
144670332|NCT00691093|521643361|FG000|Overall Study|Lost to Follow-up|1|||
144670333|NCT00691093|521643361|FG000|Overall Study|Lack of Efficacy|1|||
144670334|NCT00691093|521643361|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
144670335|NCT01588353|521643362|FG000|Step2|Withdrawal by Subject|0|||
144670336|NCT01588353|521643363|FG001|Step2|Withdrawal by Subject|1|||
144670337|NCT01588353|521643364|FG002|Step2|Withdrawal by Subject|0|||
144670338|NCT01588353|521643362|FG000|Step3|Adverse Event|0|||
144670339|NCT01588353|521643363|FG001|Step3|Adverse Event|0|||
144670340|NCT01588353|521643364|FG002|Step3|Adverse Event|2|||
144670341|NCT03814005|521643365|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
144670342|NCT03814005|521643366|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
144734249|NCT01079988|521883671|FG000|Overall Study|Lack of Efficacy|1|||
144734250|NCT01079988|521883672|FG001|Overall Study|Lack of Efficacy|0|||
144734251|NCT01079988|521883673|FG002|Overall Study|Lack of Efficacy|0|||
144734252|NCT01079988|521883674|FG003|Overall Study|Lack of Efficacy|0|||
144734253|NCT01079988|521883675|FG004|Overall Study|Lack of Efficacy|0|||
144734254|NCT01079988|521883671|FG000|Overall Study|Other|0|||
144734255|NCT01079988|521883672|FG001|Overall Study|Other|0|||
144734256|NCT01079988|521883673|FG002|Overall Study|Other|0|||
144734257|NCT01079988|521883674|FG003|Overall Study|Other|2|||
144734258|NCT01079988|521883675|FG004|Overall Study|Other|1|||
144734259|NCT01001208|521883676|FG000|Overall Study|Adverse Event|10|||
144734260|NCT01001208|521883677|FG001|Overall Study|Adverse Event|5|||
144734261|NCT01001208|521883676|FG000|Overall Study|Lost to Follow-up|5|||
144734262|NCT01001208|521883677|FG001|Overall Study|Lost to Follow-up|9|||
144734263|NCT01001208|521883676|FG000|Overall Study|Physician Decision|1|||
144734264|NCT01001208|521883677|FG001|Overall Study|Physician Decision|0|||
144734265|NCT01001208|521883676|FG000|Overall Study|Withdrawal by Subject|4|||
144734266|NCT01001208|521883677|FG001|Overall Study|Withdrawal by Subject|5|||
144734267|NCT01001208|521883676|FG000|Overall Study|Ineligibility Determined|4|||
144734268|NCT01001208|521883677|FG001|Overall Study|Ineligibility Determined|2|||
144734269|NCT01001208|521883676|FG000|Overall Study|Noncompliance|4|||
144734270|NCT01001208|521883677|FG001|Overall Study|Noncompliance|7|||
144734271|NCT01001208|521883676|FG000|Overall Study|Disease Progression|0|||
144734272|NCT01001208|521883677|FG001|Overall Study|Disease Progression|3|||
144734273|NCT01001208|521883676|FG000|Overall Study|Other|0|||
144734274|NCT01001208|521883677|FG001|Overall Study|Other|2|||
144734275|NCT00833937|521883678|FG000|Washout|Withdrawal by Subject|1|||
144734276|NCT00833937|521883679|FG001|Washout|Withdrawal by Subject|0|||
144734277|NCT02032888|521883682|FG000|Treatment Period|Poor compliance/noncompliance|1|||
144734278|NCT02032888|521883683|FG001|Treatment Period|Poor compliance/noncompliance|1|||
144734279|NCT02032888|521883684|FG002|Treatment Period|Poor compliance/noncompliance|0|||
144734280|NCT02032888|521883682|FG000|Treatment Period|Other|1|||
144734281|NCT02032888|521883683|FG001|Treatment Period|Other|1|||
144734282|NCT02032888|521883684|FG002|Treatment Period|Other|0|||
144734283|NCT02032888|521883682|FG000|Follow-up Period|Lost to Follow-up|1|||
144734284|NCT02032888|521883683|FG001|Follow-up Period|Lost to Follow-up|1|||
144734285|NCT02032888|521883684|FG002|Follow-up Period|Lost to Follow-up|0|||
144734286|NCT02032888|521883682|FG000|Follow-up Period|Death|1|||
144734287|NCT02032888|521883683|FG001|Follow-up Period|Death|1|||
144734288|NCT02032888|521883684|FG002|Follow-up Period|Death|0|||
144734289|NCT02032888|521883682|FG000|Follow-up Period|Other|1|||
144734290|NCT02032888|521883683|FG001|Follow-up Period|Other|0|||
144734291|NCT02032888|521883684|FG002|Follow-up Period|Other|0|||
144734292|NCT01697696|521883685|FG000|Overall Study|Study terminated by sponsor|0|||
144734293|NCT01697696|521883686|FG001|Overall Study|Study terminated by sponsor|3|||
144734294|NCT01697696|521883685|FG000|Overall Study|Protocol deviation|1|||
144734295|NCT01697696|521883686|FG001|Overall Study|Protocol deviation|0|||
144734296|NCT01697696|521883685|FG000|Overall Study|Physician Decision|1|||
144734297|NCT01697696|521883686|FG001|Overall Study|Physician Decision|0|||
144734298|NCT01697696|521883685|FG000|Overall Study|Death|4|||
144734299|NCT01697696|521883686|FG001|Overall Study|Death|2|||
144734300|NCT01697696|521883685|FG000|Overall Study|Lost to Follow-up|10|||
144734301|NCT01697696|521883686|FG001|Overall Study|Lost to Follow-up|7|||
144734302|NCT01697696|521883685|FG000|Overall Study|Subject/guardian decision|31|||
144734303|NCT01697696|521883686|FG001|Overall Study|Subject/guardian decision|35|||
144734304|NCT02272777|521883687|FG000|Overall Study|Adverse Event|0|||
144734305|NCT02272777|521883688|FG001|Overall Study|Adverse Event|1|||
144734306|NCT02272777|521883687|FG000|Overall Study|Withdrawal by Subject|0|||
144734307|NCT02272777|521883688|FG001|Overall Study|Withdrawal by Subject|3|||
144734308|NCT02272777|521883687|FG000|Overall Study|Lost to Follow-up|2|||
144734309|NCT02272777|521883688|FG001|Overall Study|Lost to Follow-up|0|||
144734310|NCT02272777|521883687|FG000|Overall Study|Other|2|||
144734311|NCT02272777|521883688|FG001|Overall Study|Other|0|||
144734312|NCT03020641|521883689|FG000|Overall Study|Lost to Follow-up|0|||
144734313|NCT03020641|521883690|FG001|Overall Study|Lost to Follow-up|1|||
144734314|NCT03020641|521883689|FG000|Overall Study|Converted to open surgery|2|||
144734315|NCT03020641|521883690|FG001|Overall Study|Converted to open surgery|1|||
144734316|NCT03020641|521883689|FG000|Overall Study|for surgery not performed|0|||
144734317|NCT03020641|521883690|FG001|Overall Study|for surgery not performed|1|||
144217977|NCT03176134|519992210|FG002|Overall Study|Lost to Follow-up|0|||
144217978|NCT03176134|519992211|FG003|Overall Study|Lost to Follow-up|0|||
144734318|NCT04611789|521883691|FG000|Overall Study|Lost to Follow-up|1|||
144734319|NCT04611789|521883692|FG001|Overall Study|Lost to Follow-up|0|||
144734320|NCT04611789|521883693|FG002|Overall Study|Lost to Follow-up|0|||
144734321|NCT02175095|521885380|FG000|Overall Study|Withdrawal by Subject|3|||
144734322|NCT00462345|521885381|FG000|Overall Study|Withdrawal by Subject|2|||
144734323|NCT00462345|521885381|FG000|Overall Study|Did not complete second course|1|||
144734324|NCT02869867|521885382|FG000|Overall Study|Protocol Violation|1|||
144734325|NCT02869867|521885383|FG001|Overall Study|Protocol Violation|0|||
144734326|NCT02869867|521885382|FG000|Overall Study|Lost to Follow-up|5|||
144734327|NCT02869867|521885383|FG001|Overall Study|Lost to Follow-up|5|||
144670343|NCT03814005|521643367|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
144670344|NCT03814005|521643365|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
144670345|NCT03814005|521643366|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
144670346|NCT03814005|521643367|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
144670347|NCT03814005|521643365|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
144670348|NCT03814005|521643366|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
144670349|NCT03814005|521643367|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
144670350|NCT03814005|521643365|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
144670351|NCT03814005|521643366|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
144670352|NCT03814005|521643367|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
144670353|NCT03814005|521643365|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
144670354|NCT03814005|521643366|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
144670355|NCT03814005|521643367|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
144670356|NCT03814005|521643365|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
144670357|NCT03814005|521643366|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
144670358|NCT03814005|521643367|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
144670359|NCT00810810|521643368|FG000|Overall Study|Withdrawal by Subject|0|||
144670360|NCT00810810|521643369|FG001|Overall Study|Withdrawal by Subject|8|||
144670361|NCT00810810|521643370|FG002|Overall Study|Withdrawal by Subject|10|||
144670362|NCT00810810|521643371|FG003|Overall Study|Withdrawal by Subject|8|||
144670363|NCT00810810|521643368|FG000|Overall Study|Physician Decision|0|||
144670364|NCT00810810|521643369|FG001|Overall Study|Physician Decision|3|||
144670365|NCT00810810|521643370|FG002|Overall Study|Physician Decision|1|||
144670366|NCT00810810|521643371|FG003|Overall Study|Physician Decision|5|||
144670367|NCT01896856|521643372|FG000|Overall Study|Transportation issues / Non-compliance|0|||
144670368|NCT01896856|521643373|FG001|Overall Study|Transportation issues / Non-compliance|0|||
144670369|NCT01896856|521643374|FG002|Overall Study|Transportation issues / Non-compliance|1|||
144670370|NCT01896856|521643375|FG003|Overall Study|Transportation issues / Non-compliance|0|||
144670371|NCT01896856|521643376|FG004|Overall Study|Transportation issues / Non-compliance|0|||
144670372|NCT01896856|521643377|FG005|Overall Study|Transportation issues / Non-compliance|0|||
144670373|NCT02563925|521643380|FG000|Overall Study|Withdrawal by Subject|2|||
144670374|NCT00282867|521643381|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
144670375|NCT00282867|521643382|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
144670376|NCT00282867|521643383|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
144670377|NCT01700985|521643384|FG000|Overall Study|Incarcerated|0|||
144670378|NCT01700985|521643385|FG001|Overall Study|Incarcerated|1|||
144670379|NCT01409993|521643386|FG000|Overall Study|Adverse Event|4|||
144670380|NCT01409993|521643387|FG001|Overall Study|Adverse Event|4|||
144670381|NCT01409993|521643388|FG002|Overall Study|Adverse Event|3|||
144670382|NCT01409993|521643389|FG003|Overall Study|Adverse Event|1|||
144670383|NCT01409993|521643386|FG000|Overall Study|Withdrawal by Subject|0|||
144670384|NCT01409993|521643387|FG001|Overall Study|Withdrawal by Subject|0|||
144670385|NCT01409993|521643388|FG002|Overall Study|Withdrawal by Subject|0|||
144670386|NCT01409993|521643389|FG003|Overall Study|Withdrawal by Subject|4|||
144670387|NCT01409993|521643386|FG000|Overall Study|Lost to Follow-up|0|||
144670388|NCT01409993|521643387|FG001|Overall Study|Lost to Follow-up|1|||
144670389|NCT01409993|521643388|FG002|Overall Study|Lost to Follow-up|0|||
144670390|NCT01409993|521643389|FG003|Overall Study|Lost to Follow-up|0|||
144670391|NCT00965146|521643390|FG000|Overall Study|Death|7|||
144670392|NCT00965146|521643390|FG000|Overall Study|Lost to Follow-up|22|||
144670393|NCT00965146|521643390|FG000|Overall Study|Withdrawal by Subject|17|||
144670394|NCT00965146|521643390|FG000|Overall Study|Unable to return|1|||
144670395|NCT00965146|521643390|FG000|Overall Study|Unwilling to return|11|||
144670396|NCT00965146|521643390|FG000|Overall Study|Intercurrent illness|1|||
144670397|NCT00965146|521643390|FG000|Overall Study|Revision / Removal of Study Implant|6|||
144670398|NCT00965146|521643390|FG000|Overall Study|Overall Study Termination|145|||
144670399|NCT05067452|521643391|FG000|Overall Study|Lost to Follow-up|0|||
144670400|NCT05067452|521643392|FG001|Overall Study|Lost to Follow-up|4|||
144670401|NCT00067470|521643393|FG000|Overall Study|Withdrawal by Subject|0|||
144670402|NCT00067470|521643394|FG001|Overall Study|Withdrawal by Subject|1|||
144670403|NCT01135017|521643395|FG000|Overall Study|Adverse Event|3|||
144670404|NCT01135017|521643396|FG001|Overall Study|Adverse Event|8|||
144670405|NCT01135017|521643395|FG000|Overall Study|Other than above|3|||
144670406|NCT01135017|521643396|FG001|Overall Study|Other than above|4|||
144670407|NCT01148693|521643397|FG000|Overall Study|Attempts for cannulation were failed|13|||
144670408|NCT01148693|521643398|FG001|Overall Study|Attempts for cannulation were failed|10|||
144670409|NCT03699631|521643402|FG000|Overall Study|Adverse Event|3|||
144670410|NCT01767519|521643403|FG000|Overall Study|Other Reasons|4|||
144670411|NCT01767519|521643404|FG001|Overall Study|Other Reasons|4|||
144670412|NCT01767519|521643405|FG002|Overall Study|Other Reasons|2|||
144670413|NCT01767519|521643403|FG000|Overall Study|Protocol Violation|0|||
144670414|NCT01767519|521643404|FG001|Overall Study|Protocol Violation|3|||
144670415|NCT01767519|521643405|FG002|Overall Study|Protocol Violation|0|||
144670416|NCT01767519|521643403|FG000|Overall Study|Personal Reasons|1|||
144734328|NCT00461786|521885387|FG000|Overall Study|Entry Criteria Not Met|2|||
144734329|NCT00461786|521885387|FG000|Overall Study|Inevaluable (Never Treated)|1|||
144734330|NCT00835991|521885390|FG000|First Intervention|Adverse Event|0|||
144734331|NCT00835991|521885391|FG001|First Intervention|Adverse Event|1|||
144734332|NCT00835991|521885390|FG000|Washout|Protocol Violation|0|||
144734333|NCT00835991|521885391|FG001|Washout|Protocol Violation|2|||
144734334|NCT00835991|521885390|FG000|Washout|Withdrawal by Subject|3|||
144734335|NCT00835991|521885391|FG001|Washout|Withdrawal by Subject|1|||
144734336|NCT00272779|521885394|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
144734337|NCT00272779|521885395|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
144734338|NCT00272779|521885394|FG000|Baseline Through Week 48|Death before Week 48|4|||
144734339|NCT00272779|521885395|FG001|Baseline Through Week 48|Death before Week 48|4|||
144734340|NCT00272779|521885394|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
144734341|NCT00272779|521885395|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
144734342|NCT00272779|521885394|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
144734343|NCT00272779|521885395|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
144734344|NCT00272779|521885394|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
144734345|NCT00272779|521885395|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
144734346|NCT00272779|521885394|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
144734347|NCT00272779|521885395|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
144734348|NCT00272779|521885394|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
144734349|NCT00272779|521885395|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
144734350|NCT00272779|521885394|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
144734351|NCT00272779|521885395|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
144734352|NCT00272779|521885394|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
144734353|NCT00272779|521885395|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
144734354|NCT00272779|521885394|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
144734355|NCT00272779|521885395|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
144734356|NCT00272779|521885394|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
144734357|NCT00272779|521885395|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
144734358|NCT00272779|521885394|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
144734359|NCT00272779|521885395|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
144734360|NCT00272779|521885394|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
144734361|NCT00272779|521885395|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
144734362|NCT00272779|521885394|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
144734363|NCT00272779|521885395|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
144734364|NCT00272779|521885394|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
144734365|NCT00272779|521885395|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
144734366|NCT00272779|521885394|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
144734367|NCT00272779|521885395|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
144734368|NCT00272779|521885394|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
144734369|NCT00272779|521885395|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
144734370|NCT00272779|521885394|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
144734371|NCT00272779|521885395|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
144734372|NCT00272779|521885394|FG000|Baseline Through Week 48|Continuing treatment|385|||
144734373|NCT00272779|521885395|FG001|Baseline Through Week 48|Continuing treatment|368|||
144734374|NCT00272779|521885394|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
144734375|NCT00272779|521885395|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
144734376|NCT00272779|521885394|FG000|Baseline Through Week 48|Never treated|2|||
144734377|NCT00272779|521885395|FG001|Baseline Through Week 48|Never treated|3|||
144734378|NCT00272779|521885394|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
144734379|NCT00272779|521885395|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
144734380|NCT00272779|521885394|FG000|Baseline Through Week 96|Death before Week 96|6|||
144734381|NCT00272779|521885395|FG001|Baseline Through Week 96|Death before Week 96|5|||
144734382|NCT00272779|521885394|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
144734383|NCT00272779|521885395|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
144734384|NCT00272779|521885394|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
144734385|NCT00272779|521885395|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
144734386|NCT00272779|521885394|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
144734387|NCT00272779|521885395|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
144734388|NCT00272779|521885394|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
144734389|NCT00272779|521885395|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
144734390|NCT00272779|521885394|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
144734391|NCT00272779|521885395|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
144217979|NCT03176134|519992212|FG004|Overall Study|Lost to Follow-up|0|||
144734392|NCT00272779|521885394|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
144734393|NCT00272779|521885395|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
144734394|NCT00272779|521885394|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
144734395|NCT00272779|521885395|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
144734396|NCT00272779|521885394|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
144734397|NCT00272779|521885395|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
144734398|NCT00272779|521885394|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
144734399|NCT00272779|521885395|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
144734400|NCT00272779|521885394|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
144734401|NCT00272779|521885395|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
144734402|NCT00272779|521885394|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
144734403|NCT00272779|521885395|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
144734404|NCT00272779|521885394|FG000|Baseline Through Week 96|Never treated|2|||
144734405|NCT00272779|521885395|FG001|Baseline Through Week 96|Never treated|3|||
144734406|NCT00272779|521885394|FG000|Baseline Through Week 96|Continuing on treatment|61|||
144734407|NCT00272779|521885395|FG001|Baseline Through Week 96|Continuing on treatment|38|||
144734408|NCT02440711|521885396|FG000|Second Intervention|Lost to Follow-up|1|||
144734409|NCT02440711|521885397|FG001|Second Intervention|Lost to Follow-up|0|||
144734410|NCT02146105|521885400|FG000|Overall Study|Adverse Event|1|||
144734411|NCT02146105|521885400|FG000|Overall Study|Withdrawal by Subject|5|||
144734412|NCT03935880|521885404|FG000|Overall Study|Lost to Follow-up|0|||
144734413|NCT03935880|521885405|FG001|Overall Study|Lost to Follow-up|1|||
144734414|NCT02476994|521885406|FG000|Overall Study|Based on feedback from FDA|1|||
144734415|NCT02476994|521885407|FG001|Overall Study|Based on feedback from FDA|0|||
144734416|NCT02563561|521885408|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
144734417|NCT02563561|521885409|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
144734418|NCT02563561|521885410|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
144734419|NCT02563561|521885408|FG000|Overall Study|Withdrew of Consent|1|||
144734420|NCT02563561|521885409|FG001|Overall Study|Withdrew of Consent|1|||
144734421|NCT02563561|521885410|FG002|Overall Study|Withdrew of Consent|2|||
144734422|NCT02563561|521885408|FG000|Overall Study|Lost to Follow-up|1|||
144734423|NCT02563561|521885409|FG001|Overall Study|Lost to Follow-up|1|||
144734424|NCT02563561|521885410|FG002|Overall Study|Lost to Follow-up|0|||
144734425|NCT02563561|521885408|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
144734426|NCT02563561|521885409|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
144734427|NCT02563561|521885410|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
144734428|NCT02563561|521885408|FG000|Overall Study|Investigator Decision|3|||
144734429|NCT02563561|521885409|FG001|Overall Study|Investigator Decision|4|||
144734430|NCT02563561|521885410|FG002|Overall Study|Investigator Decision|2|||
144734431|NCT02563561|521885408|FG000|Overall Study|Sponsor Decision|5|||
144734432|NCT02563561|521885409|FG001|Overall Study|Sponsor Decision|2|||
144734433|NCT02563561|521885410|FG002|Overall Study|Sponsor Decision|4|||
144734434|NCT02563561|521885408|FG000|Overall Study|Other|1|||
144734435|NCT02563561|521885409|FG001|Overall Study|Other|5|||
144734436|NCT02563561|521885410|FG002|Overall Study|Other|2|||
144734437|NCT02718326|521885413|FG000|Overall Study|Adverse Event|4|||
144734438|NCT02718326|521885414|FG001|Overall Study|Adverse Event|9|||
144734439|NCT02718326|521885415|FG002|Overall Study|Adverse Event|0|||
144734440|NCT02718326|521885413|FG000|Overall Study|Death|8|||
144734441|NCT02718326|521885414|FG001|Overall Study|Death|1|||
144734442|NCT02718326|521885415|FG002|Overall Study|Death|2|||
144734443|NCT02718326|521885413|FG000|Overall Study|Withdrawal by Subject|4|||
144734444|NCT02718326|521885414|FG001|Overall Study|Withdrawal by Subject|9|||
144734445|NCT02718326|521885415|FG002|Overall Study|Withdrawal by Subject|6|||
144734446|NCT02718326|521885413|FG000|Overall Study|Lost to Follow-up|18|||
144734447|NCT02718326|521885414|FG001|Overall Study|Lost to Follow-up|5|||
144734448|NCT02718326|521885415|FG002|Overall Study|Lost to Follow-up|14|||
144734449|NCT02718326|521885413|FG000|Overall Study|Protocol Deviation|1|||
144734450|NCT02718326|521885414|FG001|Overall Study|Protocol Deviation|0|||
144734451|NCT02718326|521885415|FG002|Overall Study|Protocol Deviation|0|||
144734452|NCT02718326|521885413|FG000|Overall Study|Pregnancy|1|||
144734453|NCT02718326|521885414|FG001|Overall Study|Pregnancy|0|||
144734454|NCT02718326|521885415|FG002|Overall Study|Pregnancy|0|||
144734455|NCT03122535|521885416|FG000|Overall Study|Lost to Follow-up|68|||
144734456|NCT03122535|521885417|FG001|Overall Study|Lost to Follow-up|68|||
144734457|NCT03122535|521885416|FG000|Overall Study|Physician Decision|3|||
144734458|NCT03122535|521885417|FG001|Overall Study|Physician Decision|3|||
144217980|NCT03176134|519992213|FG005|Overall Study|Lost to Follow-up|0|||
144217981|NCT03176134|519992214|FG006|Overall Study|Lost to Follow-up|0|||
144734459|NCT03122535|521885416|FG000|Overall Study|Withdrawal by Subject|2|||
144734460|NCT03122535|521885417|FG001|Overall Study|Withdrawal by Subject|2|||
144734461|NCT00984022|521885420|FG000|Overall Study|Lost to Follow-up|10|||
144734462|NCT00984022|521885421|FG001|Overall Study|Lost to Follow-up|14|||
144734463|NCT00573443|521885422|FG000|Double-Blind Phase|Lost to Follow-up|1|||
144734464|NCT00573443|521885423|FG001|Double-Blind Phase|Lost to Follow-up|3|||
144734465|NCT00573443|521885424|FG002|Double-Blind Phase|Lost to Follow-up|2|||
144734466|NCT00573443|521885422|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
144670417|NCT01767519|521643404|FG001|Overall Study|Personal Reasons|0|||
144670418|NCT01767519|521643405|FG002|Overall Study|Personal Reasons|0|||
144670419|NCT01767519|521643403|FG000|Overall Study|Lost to Follow-up|3|||
144670420|NCT01767519|521643404|FG001|Overall Study|Lost to Follow-up|1|||
144670421|NCT01767519|521643405|FG002|Overall Study|Lost to Follow-up|2|||
144670422|NCT01767519|521643403|FG000|Overall Study|Lack of Efficacy|1|||
144670423|NCT01767519|521643404|FG001|Overall Study|Lack of Efficacy|0|||
144670424|NCT01767519|521643405|FG002|Overall Study|Lack of Efficacy|0|||
144670425|NCT01767519|521643403|FG000|Overall Study|Adverse Event|5|||
144670426|NCT01767519|521643404|FG001|Overall Study|Adverse Event|5|||
144670427|NCT01767519|521643405|FG002|Overall Study|Adverse Event|1|||
144670428|NCT03101514|521643408|FG000|Overall Study|Withdrawal by Subject|4|||
144670429|NCT03101514|521643408|FG000|Overall Study|Protocol Violation|2|||
144670430|NCT03101514|521643408|FG000|Overall Study|patient's information was incomplete|1|||
144670431|NCT02247401|521643409|FG000|Overall Study|Adverse Event|1|||
144670432|NCT02247401|521643410|FG001|Overall Study|Adverse Event|0|||
144670433|NCT02247401|521643411|FG002|Overall Study|Adverse Event|0|||
144670434|NCT02247401|521643409|FG000|Overall Study|Withdrawal by Subject|4|||
144670435|NCT02247401|521643410|FG001|Overall Study|Withdrawal by Subject|1|||
144670436|NCT02247401|521643411|FG002|Overall Study|Withdrawal by Subject|1|||
144670437|NCT02247401|521643409|FG000|Overall Study|Lost to Follow-up|1|||
144670438|NCT02247401|521643410|FG001|Overall Study|Lost to Follow-up|1|||
144670439|NCT02247401|521643411|FG002|Overall Study|Lost to Follow-up|1|||
144670440|NCT03695393|521643414|FG000|Overall Study|Death|3|||
144670441|NCT03695393|521643415|FG001|Overall Study|Death|1|||
144670442|NCT03695393|521643414|FG000|Overall Study|Lost to Follow-up|0|||
144670443|NCT03695393|521643415|FG001|Overall Study|Lost to Follow-up|1|||
144670444|NCT00673894|521643418|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
144670445|NCT00673894|521643419|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
144670446|NCT00673894|521643418|FG000|First Intervention 4 Weeks|Adverse Event|1|||
144670447|NCT00673894|521643419|FG001|First Intervention 4 Weeks|Adverse Event|0|||
144670448|NCT00493974|521643420|FG000|Overall Study|Death|1|||
144670449|NCT00493974|521643421|FG001|Overall Study|Death|2|||
144670450|NCT00493974|521643420|FG000|Overall Study|Withdrawal by Subject|8|||
144670451|NCT00493974|521643421|FG001|Overall Study|Withdrawal by Subject|6|||
144670452|NCT00493974|521643420|FG000|Overall Study|Lost to Follow-up|4|||
144670453|NCT00493974|521643421|FG001|Overall Study|Lost to Follow-up|6|||
144670454|NCT02807363|521643422|FG000|Dosing Period|Adverse Event|0|||
144670455|NCT02807363|521643423|FG001|Dosing Period|Adverse Event|1|||
144670456|NCT02807363|521643424|FG002|Dosing Period|Adverse Event|0|||
144670457|NCT02807363|521643425|FG003|Dosing Period|Adverse Event|0|||
144670458|NCT00966693|521643426|FG000|Overall Study|Adverse Event|0|||
144670459|NCT00966693|521643427|FG001|Overall Study|Adverse Event|0|||
144670460|NCT00966693|521643428|FG002|Overall Study|Adverse Event|1|||
144670461|NCT00966693|521643429|FG003|Overall Study|Adverse Event|2|||
144670462|NCT00966693|521643426|FG000|Overall Study|Death|0|||
144670463|NCT00966693|521643427|FG001|Overall Study|Death|0|||
144670464|NCT00966693|521643428|FG002|Overall Study|Death|1|||
144670465|NCT00966693|521643429|FG003|Overall Study|Death|0|||
144670466|NCT00966693|521643426|FG000|Overall Study|Withdrawal by Subject|1|||
144670467|NCT00966693|521643427|FG001|Overall Study|Withdrawal by Subject|0|||
144670468|NCT00966693|521643428|FG002|Overall Study|Withdrawal by Subject|0|||
144670469|NCT00966693|521643429|FG003|Overall Study|Withdrawal by Subject|5|||
144670470|NCT00966693|521643426|FG000|Overall Study|Disease Progression|0|||
144670471|NCT00966693|521643427|FG001|Overall Study|Disease Progression|0|||
144670472|NCT00966693|521643428|FG002|Overall Study|Disease Progression|1|||
144670473|NCT00966693|521643429|FG003|Overall Study|Disease Progression|16|||
144670474|NCT00192036|521643430|FG000|Overall Study|Protocol Violation|3|||
144670475|NCT00192036|521643430|FG000|Overall Study|Adverse Event|6|||
144670476|NCT00192036|521643430|FG000|Overall Study|Patient/Physician Perception|1|||
144670477|NCT00192036|521643430|FG000|Overall Study|Objective Tumor Progression|4|||
144670478|NCT00192036|521643430|FG000|Overall Study|Clinical Disease Progression|1|||
144670479|NCT00192036|521643430|FG000|Overall Study|Death|1|||
144670480|NCT00192036|521643430|FG000|Overall Study|Unknown or Not Specified|5|||
144670481|NCT03371732|521643431|FG000|Overall Study|Withdrawal by Subject|9|||
144670482|NCT03371732|521643432|FG001|Overall Study|Withdrawal by Subject|3|||
144670483|NCT03371732|521643431|FG000|Overall Study|Refusal to continue|3|||
144670484|NCT03371732|521643432|FG001|Overall Study|Refusal to continue|4|||
144670485|NCT00405821|521643435|FG000|Overall Study|Death|5|||
144670486|NCT00405821|521643436|FG001|Overall Study|Death|7|||
144670487|NCT00405821|521643435|FG000|Overall Study|Lost to Follow-up|7|||
144670488|NCT00405821|521643436|FG001|Overall Study|Lost to Follow-up|7|||
144670489|NCT00405821|521643435|FG000|Overall Study|Protocol Violation|1|||
144670490|NCT00405821|521643436|FG001|Overall Study|Protocol Violation|0|||
144670491|NCT00405821|521643435|FG000|Overall Study|initiated ART|9|||
144670492|NCT00405821|521643436|FG001|Overall Study|initiated ART|8|||
144670493|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
144670494|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
144670495|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
144734467|NCT00573443|521885423|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
144734468|NCT00573443|521885424|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
144734469|NCT00573443|521885422|FG000|Double-Blind Phase|Adverse Event|1|||
144734470|NCT00573443|521885423|FG001|Double-Blind Phase|Adverse Event|5|||
144734471|NCT00573443|521885424|FG002|Double-Blind Phase|Adverse Event|0|||
144670496|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
144670497|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
144670498|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
144670499|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
144670500|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
144670501|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
144670502|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
144670503|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
144670504|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
144670505|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
144670506|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
144670507|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
144670508|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
144670509|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
144670510|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
144670511|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
144670512|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
144670513|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
144670514|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
144670515|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
144670516|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
144670517|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
144670518|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
144670519|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
144670520|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
144670521|NCT00476996|521643438|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
144670522|NCT00476996|521643439|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
144670523|NCT00476996|521643440|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
144670524|NCT00476996|521643441|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
144670525|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
144670526|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
144670527|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
144670528|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
144670529|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
144670530|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
144670531|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
144670532|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
144670533|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Death|0|||
144670534|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Death|0|||
144670535|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Death|0|||
144670536|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Death|7|||
144670537|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
144670538|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
144670539|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
144670540|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
144670541|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
144670542|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
144670543|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
144670544|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
144670545|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
144670546|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
144670547|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
144670548|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
144734472|NCT00573443|521885422|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
144734473|NCT00573443|521885423|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
144734474|NCT00573443|521885424|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
144734475|NCT00573443|521885422|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
144217982|NCT03176134|519992215|FG007|Overall Study|Lost to Follow-up|0|||
144217983|NCT03176134|519992208|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144217984|NCT03176134|519992209|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144217985|NCT03176134|519992210|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
144217986|NCT03176134|519992211|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144670549|NCT00476996|521643438|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
144734476|NCT00573443|521885423|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
144734477|NCT00573443|521885424|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
144734478|NCT00573443|521885422|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
144734479|NCT00573443|521885423|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
144734480|NCT00573443|521885424|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
144734481|NCT00573443|521885422|FG000|Double-Blind Phase|Protocol Violation|0|||
144670550|NCT00476996|521643439|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
144670551|NCT00476996|521643440|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
144670552|NCT00476996|521643441|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
144670553|NCT01033487|521643444|FG000|Fourth Intervention Period|Adverse Event|0|||
144670554|NCT01033487|521643445|FG001|Fourth Intervention Period|Adverse Event|0|||
144670555|NCT01033487|521643446|FG002|Fourth Intervention Period|Adverse Event|0|||
144670556|NCT01033487|521643447|FG003|Fourth Intervention Period|Adverse Event|0|||
144670557|NCT01033487|521643448|FG004|Fourth Intervention Period|Adverse Event|0|||
144670558|NCT01033487|521643449|FG005|Fourth Intervention Period|Adverse Event|0|||
144670559|NCT01033487|521643450|FG006|Fourth Intervention Period|Adverse Event|0|||
144670560|NCT01033487|521643451|FG007|Fourth Intervention Period|Adverse Event|0|||
144670561|NCT01033487|521643452|FG008|Fourth Intervention Period|Adverse Event|1|||
144670562|NCT01033487|521643453|FG009|Fourth Intervention Period|Adverse Event|0|||
144670563|NCT01769469|521643458|FG000|Overall Study|Consent Withdrawn|5|||
144670564|NCT01769469|521643458|FG000|Overall Study|Moved Out Of Area|3|||
144670565|NCT01769469|521643458|FG000|Overall Study|Lost to Follow-up|17|||
144670566|NCT01769469|521643458|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
144670567|NCT01769469|521643458|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
144670568|NCT02447458|521643464|FG000|Overall Study|Other|0|||
144670569|NCT02447458|521643465|FG001|Overall Study|Other|0|||
144670570|NCT02447458|521643466|FG002|Overall Study|Other|1|||
144670571|NCT02447458|521643467|FG003|Overall Study|Other|0|||
144670572|NCT02447458|521643468|FG004|Overall Study|Other|0|||
144670573|NCT02447458|521643469|FG005|Overall Study|Other|0|||
144670574|NCT03094832|521643476|FG000|Overall Study|Lost to Follow-up|0|||
144670575|NCT03094832|521643477|FG001|Overall Study|Lost to Follow-up|0|||
144670576|NCT03094832|521643478|FG002|Overall Study|Lost to Follow-up|0|||
144670577|NCT03094832|521643479|FG003|Overall Study|Lost to Follow-up|1|||
144670578|NCT03094832|521643480|FG004|Overall Study|Lost to Follow-up|1|||
144670579|NCT03094832|521643476|FG000|Overall Study|Death|1|||
144670580|NCT03094832|521643477|FG001|Overall Study|Death|0|||
144670581|NCT03094832|521643478|FG002|Overall Study|Death|0|||
144670582|NCT03094832|521643479|FG003|Overall Study|Death|0|||
144670583|NCT03094832|521643480|FG004|Overall Study|Death|0|||
144670584|NCT03094832|521643476|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144734482|NCT00573443|521885423|FG001|Double-Blind Phase|Protocol Violation|2|||
144734483|NCT00573443|521885424|FG002|Double-Blind Phase|Protocol Violation|1|||
144734484|NCT00573443|521885422|FG000|Double-Blind Phase|Other|0|||
144734485|NCT00573443|521885423|FG001|Double-Blind Phase|Other|2|||
144734486|NCT00573443|521885424|FG002|Double-Blind Phase|Other|3|||
144734487|NCT00573443|521885422|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
144734488|NCT00573443|521885423|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
144734489|NCT00573443|521885424|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
144734490|NCT00573443|521885422|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
144734491|NCT00573443|521885423|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
144734492|NCT00573443|521885424|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
144734493|NCT00573443|521885422|FG000|Open-Label Extension Phase|Adverse Event|3|||
144734494|NCT00573443|521885423|FG001|Open-Label Extension Phase|Adverse Event|0|||
144734495|NCT00573443|521885424|FG002|Open-Label Extension Phase|Adverse Event|0|||
144734496|NCT00573443|521885422|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
144734497|NCT00573443|521885423|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
144734498|NCT00573443|521885424|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
144734499|NCT00573443|521885422|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
144734500|NCT00573443|521885423|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
144734501|NCT00573443|521885424|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
144734502|NCT00573443|521885422|FG000|Open-Label Extension Phase|Protocol Violation|2|||
144734503|NCT00573443|521885423|FG001|Open-Label Extension Phase|Protocol Violation|0|||
144734504|NCT00573443|521885424|FG002|Open-Label Extension Phase|Protocol Violation|0|||
144670585|NCT03094832|521643477|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144670586|NCT03094832|521643478|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144670587|NCT03094832|521643479|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144670588|NCT03094832|521643480|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144670589|NCT03094832|521643476|FG000|Overall Study|Other|13|||
144670590|NCT03094832|521643477|FG001|Overall Study|Other|20|||
144734505|NCT00573443|521885422|FG000|Open-Label Extension Phase|Other|2|||
144734506|NCT00573443|521885423|FG001|Open-Label Extension Phase|Other|0|||
144734507|NCT00573443|521885424|FG002|Open-Label Extension Phase|Other|0|||
144734508|NCT01796171|521885427|FG000|Enrolled|Death|0|||
144734509|NCT01796171|521885428|FG001|Enrolled|Death|0|||
144734510|NCT01796171|521885429|FG002|Enrolled|Death|0|||
144734511|NCT01796171|521885430|FG003|Enrolled|Death|0|||
144734512|NCT01796171|521885431|FG004|Enrolled|Death|0|||
144734513|NCT01796171|521885432|FG005|Enrolled|Death|0|||
144734514|NCT01796171|521885433|FG006|Enrolled|Death|0|||
144734515|NCT01796171|521885434|FG007|Enrolled|Death|0|||
144734516|NCT01796171|521885435|FG008|Enrolled|Death|0|||
144734517|NCT01796171|521885436|FG009|Enrolled|Death|0|||
144734518|NCT01796171|521885437|FG010|Enrolled|Death|0|||
144734519|NCT01796171|521885438|FG011|Enrolled|Death|0|||
144734520|NCT01796171|521885439|FG012|Enrolled|Death|0|||
144734521|NCT01796171|521885440|FG013|Enrolled|Death|0|||
144734522|NCT01796171|521885441|FG014|Enrolled|Death|1|||
144734523|NCT01796171|521885427|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
144734524|NCT01796171|521885428|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
144734525|NCT01796171|521885429|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
144734526|NCT01796171|521885430|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
144734527|NCT01796171|521885431|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
144734528|NCT01796171|521885432|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
144734529|NCT01796171|521885433|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
144734530|NCT01796171|521885434|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
144734531|NCT01796171|521885435|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
144734532|NCT01796171|521885436|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
144734533|NCT01796171|521885437|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
144734534|NCT01796171|521885438|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
144734535|NCT01796171|521885439|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
144734536|NCT01796171|521885440|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
144734537|NCT01796171|521885441|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
144734538|NCT01796171|521885427|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734539|NCT01796171|521885428|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734540|NCT01796171|521885429|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734541|NCT01796171|521885430|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734542|NCT01796171|521885431|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734543|NCT01796171|521885432|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734544|NCT01796171|521885433|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734545|NCT01796171|521885434|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734546|NCT01796171|521885435|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734547|NCT01796171|521885436|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734548|NCT01796171|521885437|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734549|NCT01796171|521885438|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734550|NCT01796171|521885439|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734551|NCT01796171|521885440|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
144734552|NCT01796171|521885441|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
144734553|NCT01796171|521885427|FG000|Treatment Period With Betalutin|Progressive disease|0|||
144734554|NCT01796171|521885428|FG001|Treatment Period With Betalutin|Progressive disease|1|||
144670591|NCT03094832|521643478|FG002|Overall Study|Other|1|||
144670592|NCT03094832|521643479|FG003|Overall Study|Other|7|||
144670593|NCT03094832|521643480|FG004|Overall Study|Other|1|||
144670594|NCT02674685|521643483|FG000|Overall Study|Withdrawal by Subject|4|||
144670595|NCT03148756|521643485|FG000|Overall Study|Study Terminated|0|||
144670596|NCT03148756|521643486|FG001|Overall Study|Study Terminated|1|||
144670597|NCT05406440|521645646|FG000|Overall Study|Lost to Follow-up|0|||
144670598|NCT05406440|521645647|FG001|Overall Study|Lost to Follow-up|0|||
144670599|NCT05406440|521645648|FG002|Overall Study|Lost to Follow-up|0|||
144670600|NCT05406440|521645649|FG003|Overall Study|Lost to Follow-up|0|||
144670601|NCT05406440|521645650|FG004|Overall Study|Lost to Follow-up|2|||
144670602|NCT05406440|521645651|FG005|Overall Study|Lost to Follow-up|0|||
144670603|NCT05406440|521645652|FG006|Overall Study|Lost to Follow-up|0|||
144670604|NCT05406440|521645646|FG000|Overall Study|Physician Decision|0|||
144670605|NCT05406440|521645647|FG001|Overall Study|Physician Decision|0|||
144670606|NCT05406440|521645648|FG002|Overall Study|Physician Decision|0|||
144670607|NCT05406440|521645649|FG003|Overall Study|Physician Decision|0|||
144670608|NCT05406440|521645650|FG004|Overall Study|Physician Decision|1|||
144670609|NCT05406440|521645651|FG005|Overall Study|Physician Decision|0|||
144670610|NCT05406440|521645652|FG006|Overall Study|Physician Decision|0|||
144670611|NCT05406440|521645646|FG000|Overall Study|Withdrawal by Subject|0|||
144734555|NCT01796171|521885429|FG002|Treatment Period With Betalutin|Progressive disease|0|||
144734556|NCT01796171|521885430|FG003|Treatment Period With Betalutin|Progressive disease|0|||
144734557|NCT01796171|521885431|FG004|Treatment Period With Betalutin|Progressive disease|0|||
144734558|NCT01796171|521885432|FG005|Treatment Period With Betalutin|Progressive disease|0|||
144734559|NCT01796171|521885433|FG006|Treatment Period With Betalutin|Progressive disease|0|||
144734560|NCT01796171|521885434|FG007|Treatment Period With Betalutin|Progressive disease|0|||
144670612|NCT05406440|521645647|FG001|Overall Study|Withdrawal by Subject|0|||
144670613|NCT05406440|521645648|FG002|Overall Study|Withdrawal by Subject|0|||
144670614|NCT05406440|521645649|FG003|Overall Study|Withdrawal by Subject|0|||
144734561|NCT01796171|521885435|FG008|Treatment Period With Betalutin|Progressive disease|0|||
144734562|NCT01796171|521885436|FG009|Treatment Period With Betalutin|Progressive disease|0|||
144734563|NCT01796171|521885437|FG010|Treatment Period With Betalutin|Progressive disease|0|||
144670615|NCT05406440|521645650|FG004|Overall Study|Withdrawal by Subject|0|||
144670616|NCT05406440|521645651|FG005|Overall Study|Withdrawal by Subject|2|||
144670617|NCT05406440|521645652|FG006|Overall Study|Withdrawal by Subject|0|||
144670618|NCT03943446|521645654|FG000|Overall Study|Lost to Follow-up|0|||
144670619|NCT03943446|521645655|FG001|Overall Study|Lost to Follow-up|0|||
144670620|NCT03943446|521645656|FG002|Overall Study|Lost to Follow-up|1|||
144670621|NCT03943446|521645654|FG000|Overall Study|Withdrawal by Subject|1|||
144670622|NCT03943446|521645655|FG001|Overall Study|Withdrawal by Subject|1|||
144670623|NCT03943446|521645656|FG002|Overall Study|Withdrawal by Subject|2|||
144670624|NCT03943446|521645654|FG000|Overall Study|Study Terminated by Sponsor|1|||
144670625|NCT03943446|521645655|FG001|Overall Study|Study Terminated by Sponsor|2|||
144670626|NCT03943446|521645656|FG002|Overall Study|Study Terminated by Sponsor|1|||
144670627|NCT03943446|521645654|FG000|Overall Study|Reason not Specified|5|||
144670628|NCT03943446|521645655|FG001|Overall Study|Reason not Specified|1|||
144670629|NCT03943446|521645656|FG002|Overall Study|Reason not Specified|3|||
144670630|NCT01281189|521645662|FG000|Overall Study|Adverse Event|7|||
144670631|NCT01281189|521645663|FG001|Overall Study|Adverse Event|9|||
144670632|NCT01281189|521645662|FG000|Overall Study|Lost to Follow-up|6|||
144670633|NCT01281189|521645663|FG001|Overall Study|Lost to Follow-up|4|||
144670634|NCT01281189|521645662|FG000|Overall Study|Withdrawal by Subject|21|||
144670635|NCT01281189|521645663|FG001|Overall Study|Withdrawal by Subject|24|||
144670636|NCT01281189|521645662|FG000|Overall Study|Physician Decision|2|||
144670637|NCT01281189|521645663|FG001|Overall Study|Physician Decision|3|||
144670638|NCT01281189|521645662|FG000|Overall Study|Death|103|||
144670639|NCT01281189|521645663|FG001|Overall Study|Death|91|||
144670640|NCT01281189|521645662|FG000|Overall Study|Other|8|||
144670641|NCT01281189|521645663|FG001|Overall Study|Other|12|||
144670642|NCT05355818|521645664|FG000|Overall Study|Adverse Event|1|||
144670643|NCT05355818|521645665|FG001|Overall Study|Adverse Event|1|||
144670644|NCT05355818|521645664|FG000|Overall Study|Lack of Efficacy|2|||
144670645|NCT05355818|521645665|FG001|Overall Study|Lack of Efficacy|1|||
144670646|NCT05355818|521645664|FG000|Overall Study|Lost to Follow-up|0|||
144670647|NCT05355818|521645665|FG001|Overall Study|Lost to Follow-up|1|||
144670648|NCT01136746|521645666|FG000|Overall Study|Lost to Follow-up|0|||
144670649|NCT01136746|521645667|FG001|Overall Study|Lost to Follow-up|2|||
144670650|NCT01136746|521645666|FG000|Overall Study|Protocol Violation|2|||
144670651|NCT01136746|521645667|FG001|Overall Study|Protocol Violation|1|||
144670652|NCT01136746|521645666|FG000|Overall Study|Death|1|||
144670653|NCT01136746|521645667|FG001|Overall Study|Death|0|||
144670654|NCT01175590|521645668|FG000|Overall Study|Lost to Follow-up|1|||
144670655|NCT01175590|521645669|FG001|Overall Study|Lost to Follow-up|0|||
144670656|NCT01175590|521645668|FG000|Overall Study|Withdrawal by Subject|0|||
144670657|NCT01175590|521645669|FG001|Overall Study|Withdrawal by Subject|2|||
144670658|NCT01175590|521645668|FG000|Overall Study|Adverse Event|4|||
144670659|NCT01175590|521645669|FG001|Overall Study|Adverse Event|0|||
144670660|NCT01175590|521645668|FG000|Overall Study|Physician Decision|1|||
144670661|NCT01175590|521645669|FG001|Overall Study|Physician Decision|4|||
144670662|NCT01175590|521645668|FG000|Overall Study|Lack of Efficacy|1|||
144670663|NCT01175590|521645669|FG001|Overall Study|Lack of Efficacy|1|||
144670664|NCT01175590|521645668|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
144670665|NCT01175590|521645669|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
144670666|NCT01175590|521645668|FG000|Overall Study|Treated not as randomized|3|||
144670667|NCT01175590|521645669|FG001|Overall Study|Treated not as randomized|2|||
144670668|NCT01175590|521645668|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
144670669|NCT01175590|521645669|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
144670670|NCT01175590|521645668|FG000|Overall Study|Protocol Violation|0|||
144670671|NCT01175590|521645669|FG001|Overall Study|Protocol Violation|1|||
144670672|NCT00092677|521645675|FG000|Overall Study|Lost to Follow-up|0|||
144670673|NCT00092677|521645676|FG001|Overall Study|Lost to Follow-up|2|||
144670674|NCT00092677|521645675|FG000|Overall Study|Adminstrative|5|||
144670675|NCT00092677|521645676|FG001|Overall Study|Adminstrative|9|||
144670676|NCT01090102|521645677|FG000|First 12 Weeks|Withdrawal by Subject|1|||
144670677|NCT01090102|521645678|FG001|First 12 Weeks|Withdrawal by Subject|1|||
144670678|NCT01090102|521645677|FG000|First 12 Weeks|Adverse Event|2|||
144670679|NCT01090102|521645678|FG001|First 12 Weeks|Adverse Event|0|||
144670680|NCT01090102|521645677|FG000|First 12 Weeks|Death|1|||
144670681|NCT01090102|521645678|FG001|First 12 Weeks|Death|1|||
144670682|NCT01090102|521645677|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
144670683|NCT01090102|521645678|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
144670684|NCT01601704|521645679|FG000|Overall Study|Randomized but not dispensed study med|1|||
144670685|NCT01601704|521645680|FG001|Overall Study|Randomized but not dispensed study med|4|||
144670686|NCT03518034|521645683|FG000|Overall Study|Not Treated|5|||
144670687|NCT03518034|521645684|FG001|Overall Study|Not Treated|1|||
144670688|NCT03518034|521645683|FG000|Overall Study|Withdrawal by Subject|309|||
144670689|NCT03518034|521645684|FG001|Overall Study|Withdrawal by Subject|351|||
144670690|NCT03518034|521645683|FG000|Overall Study|Lost to Follow-up|446|||
144670691|NCT03518034|521645684|FG001|Overall Study|Lost to Follow-up|458|||
144670692|NCT03518034|521645683|FG000|Overall Study|Adverse Event|138|||
144670693|NCT03518034|521645684|FG001|Overall Study|Adverse Event|130|||
144670694|NCT03518034|521645683|FG000|Overall Study|Lack of Efficacy|11|||
144670695|NCT03518034|521645684|FG001|Overall Study|Lack of Efficacy|23|||
144670696|NCT03518034|521645683|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
144670697|NCT03518034|521645684|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
144670698|NCT03518034|521645683|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
144670699|NCT03518034|521645684|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
144670700|NCT03518034|521645683|FG000|Overall Study|Other, Not Specified|84|||
144670701|NCT03518034|521645684|FG001|Overall Study|Other, Not Specified|53|||
144670702|NCT03518034|521645683|FG000|Overall Study|Reason Missing|2|||
144670703|NCT03518034|521645684|FG001|Overall Study|Reason Missing|3|||
144670704|NCT00010803|521645690|FG000|Overall Study|Withdrawal by Subject|97|||
144670705|NCT00010803|521645691|FG001|Overall Study|Withdrawal by Subject|98|||
144670706|NCT01019252|521645692|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
144670707|NCT01019252|521645693|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
144670708|NCT01019252|521645692|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
144670709|NCT01019252|521645693|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
144670710|NCT01019252|521645692|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
144670711|NCT01019252|521645693|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
144670712|NCT01019252|521645692|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
144670713|NCT01019252|521645693|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
144670714|NCT04671342|521645694|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
144670715|NCT04671342|521645694|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
144670716|NCT04671342|521645694|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
144670717|NCT04671342|521645694|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
144670718|NCT04671342|521645694|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
144670719|NCT04671342|521645694|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
144670720|NCT02273037|521645696|FG000|Overall Study|Lost to Follow-up|1|||
144670721|NCT02273037|521645697|FG001|Overall Study|Lost to Follow-up|0|||
144670722|NCT02273037|521645696|FG000|Overall Study|Delivered before monitoring initiated|1|||
144670723|NCT02273037|521645697|FG001|Overall Study|Delivered before monitoring initiated|3|||
144670724|NCT02273037|521645696|FG000|Overall Study|Breech delivery|2|||
144670725|NCT02273037|521645697|FG001|Overall Study|Breech delivery|3|||
144670726|NCT02273037|521645696|FG000|Overall Study|Multiple delivery|2|||
144670727|NCT02273037|521645697|FG001|Overall Study|Multiple delivery|2|||
144670728|NCT02273037|521645696|FG000|Overall Study|Other complication|2|||
144670729|NCT02273037|521645697|FG001|Overall Study|Other complication|0|||
144670730|NCT02062398|521645698|FG000|Overall Study|Implant removal|1|||
144670731|NCT00415519|521645701|FG000|Overall Study|Adverse Event|1|||
144670732|NCT00415519|521645702|FG001|Overall Study|Adverse Event|0|||
144670733|NCT00415519|521645701|FG000|Overall Study|Withdrawal by Subject|2|||
144670734|NCT00415519|521645702|FG001|Overall Study|Withdrawal by Subject|0|||
144670735|NCT00415519|521645701|FG000|Overall Study|Patient's convenience|1|||
144670736|NCT00415519|521645702|FG001|Overall Study|Patient's convenience|0|||
144734564|NCT01796171|521885438|FG011|Treatment Period With Betalutin|Progressive disease|0|||
144734565|NCT01796171|521885439|FG012|Treatment Period With Betalutin|Progressive disease|0|||
144734566|NCT01796171|521885440|FG013|Treatment Period With Betalutin|Progressive disease|0|||
144734567|NCT01796171|521885441|FG014|Treatment Period With Betalutin|Progressive disease|0|||
144734568|NCT01796171|521885427|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734569|NCT01796171|521885428|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734570|NCT01796171|521885429|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734571|NCT01796171|521885430|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734572|NCT01796171|521885431|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734573|NCT01796171|521885432|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734574|NCT01796171|521885433|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734575|NCT01796171|521885434|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734576|NCT01796171|521885435|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
144734577|NCT01796171|521885436|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734578|NCT01796171|521885437|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
144734579|NCT01796171|521885438|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
144734580|NCT01796171|521885439|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734581|NCT01796171|521885440|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734582|NCT01796171|521885441|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
144734583|NCT01796171|521885427|FG000|Treatment Period With Betalutin|Physician Decision|0|||
144217987|NCT03176134|519992212|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144217988|NCT03176134|519992213|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144670737|NCT03351478|521645707|FG000|Overall Study|At the subject's own request|11|||
144670738|NCT03351478|521645708|FG001|Overall Study|At the subject's own request|12|||
144670739|NCT03351478|521645709|FG002|Overall Study|At the subject's own request|5|||
144670740|NCT03351478|521645707|FG000|Overall Study|Adverse Event|1|||
144670741|NCT03351478|521645708|FG001|Overall Study|Adverse Event|2|||
144670742|NCT03351478|521645709|FG002|Overall Study|Adverse Event|1|||
144670743|NCT03351478|521645707|FG000|Overall Study|Poor compliance to protocol|1|||
144670744|NCT03351478|521645708|FG001|Overall Study|Poor compliance to protocol|0|||
144670745|NCT03351478|521645709|FG002|Overall Study|Poor compliance to protocol|0|||
144670746|NCT03351478|521645707|FG000|Overall Study|Reason not Specified|1|||
144670747|NCT03351478|521645708|FG001|Overall Study|Reason not Specified|3|||
144670748|NCT03351478|521645709|FG002|Overall Study|Reason not Specified|0|||
144670749|NCT03351478|521645707|FG000|Overall Study|Lost to Follow-up|0|||
144670750|NCT03351478|521645708|FG001|Overall Study|Lost to Follow-up|0|||
144670751|NCT03351478|521645709|FG002|Overall Study|Lost to Follow-up|1|||
144670752|NCT03911869|521645710|FG000|Safety Lead-in Phase|Death|7|||
144670753|NCT03911869|521645711|FG001|Safety Lead-in Phase|Death|0|||
144670754|NCT03911869|521645712|FG002|Safety Lead-in Phase|Death|0|||
144670755|NCT03911869|521645710|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
144670756|NCT03911869|521645711|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
144670757|NCT03911869|521645712|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
144670758|NCT03911869|521645710|FG000|Safety Lead-in Phase|Other|1|||
144670759|NCT03911869|521645711|FG001|Safety Lead-in Phase|Other|0|||
144670760|NCT03911869|521645712|FG002|Safety Lead-in Phase|Other|0|||
144670761|NCT03911869|521645710|FG000|Phase 2|Death|0|||
144670762|NCT03911869|521645711|FG001|Phase 2|Death|3|||
144670763|NCT03911869|521645712|FG002|Phase 2|Death|0|||
144670764|NCT03325556|521645716|FG000|Open-label Period|Lack of Response in OL period|70|||
144670765|NCT03325556|521645717|FG001|Open-label Period|Lack of Response in OL period|0|||
144670766|NCT03325556|521645718|FG002|Open-label Period|Lack of Response in OL period|0|||
144670767|NCT03325556|521645716|FG000|Open-label Period|Adverse Event|27|||
144670768|NCT03325556|521645717|FG001|Open-label Period|Adverse Event|0|||
144670769|NCT03325556|521645718|FG002|Open-label Period|Adverse Event|0|||
144670770|NCT03325556|521645716|FG000|Open-label Period|Death|1|||
144670771|NCT03325556|521645717|FG001|Open-label Period|Death|0|||
144670772|NCT03325556|521645718|FG002|Open-label Period|Death|0|||
144670773|NCT03325556|521645716|FG000|Open-label Period|Lost to Follow-up|1|||
144670774|NCT03325556|521645717|FG001|Open-label Period|Lost to Follow-up|0|||
144670775|NCT03325556|521645718|FG002|Open-label Period|Lost to Follow-up|0|||
144670776|NCT03325556|521645716|FG000|Open-label Period|Non-compliance with study drug|5|||
144670777|NCT03325556|521645717|FG001|Open-label Period|Non-compliance with study drug|0|||
144670778|NCT03325556|521645718|FG002|Open-label Period|Non-compliance with study drug|0|||
144670779|NCT03325556|521645716|FG000|Open-label Period|Use of prohibited medication|1|||
144670780|NCT03325556|521645717|FG001|Open-label Period|Use of prohibited medication|0|||
144670781|NCT03325556|521645718|FG002|Open-label Period|Use of prohibited medication|0|||
144670782|NCT03325556|521645716|FG000|Open-label Period|Protocol Violation|4|||
144670783|NCT03325556|521645717|FG001|Open-label Period|Protocol Violation|0|||
144670784|NCT03325556|521645718|FG002|Open-label Period|Protocol Violation|0|||
144670785|NCT03325556|521645716|FG000|Open-label Period|Withdrawal by Subject|17|||
144670786|NCT03325556|521645717|FG001|Open-label Period|Withdrawal by Subject|0|||
144670787|NCT03325556|521645718|FG002|Open-label Period|Withdrawal by Subject|0|||
144670788|NCT03325556|521645716|FG000|Open-label Period|Not otherwise specified|8|||
144670789|NCT03325556|521645717|FG001|Open-label Period|Not otherwise specified|0|||
144670790|NCT03325556|521645718|FG002|Open-label Period|Not otherwise specified|0|||
144670791|NCT03325556|521645716|FG000|Open-label Period|Administrative discont. at study termination|41|||
144670792|NCT03325556|521645717|FG001|Open-label Period|Administrative discont. at study termination|0|||
144670793|NCT03325556|521645718|FG002|Open-label Period|Administrative discont. at study termination|0|||
144670794|NCT03325556|521645716|FG000|Double-blind Period|Relapse|0|||
144670795|NCT03325556|521645717|FG001|Double-blind Period|Relapse|15|||
144265614|NCT02513550|520173976|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
144670796|NCT03325556|521645718|FG002|Double-blind Period|Relapse|34|||
144670797|NCT03325556|521645716|FG000|Double-blind Period|Adverse Event|0|||
144670798|NCT03325556|521645717|FG001|Double-blind Period|Adverse Event|3|||
144670799|NCT03325556|521645718|FG002|Double-blind Period|Adverse Event|1|||
144670800|NCT03325556|521645716|FG000|Double-blind Period|Noncompliance with study drug|0|||
144670801|NCT03325556|521645717|FG001|Double-blind Period|Noncompliance with study drug|0|||
144670802|NCT03325556|521645718|FG002|Double-blind Period|Noncompliance with study drug|1|||
144670803|NCT03325556|521645716|FG000|Double-blind Period|Use of prohibited medication|0|||
144670804|NCT03325556|521645717|FG001|Double-blind Period|Use of prohibited medication|1|||
144670805|NCT03325556|521645718|FG002|Double-blind Period|Use of prohibited medication|0|||
144670806|NCT03325556|521645716|FG000|Double-blind Period|Physician Decision|0|||
144670807|NCT03325556|521645717|FG001|Double-blind Period|Physician Decision|0|||
144670808|NCT03325556|521645718|FG002|Double-blind Period|Physician Decision|1|||
144670809|NCT03325556|521645716|FG000|Double-blind Period|Withdrawal by Subject|0|||
144670810|NCT03325556|521645717|FG001|Double-blind Period|Withdrawal by Subject|6|||
144670811|NCT03325556|521645718|FG002|Double-blind Period|Withdrawal by Subject|4|||
144670812|NCT03325556|521645716|FG000|Double-blind Period|Not otherwise specified|0|||
144670813|NCT03325556|521645717|FG001|Double-blind Period|Not otherwise specified|1|||
144670814|NCT03325556|521645718|FG002|Double-blind Period|Not otherwise specified|5|||
144670815|NCT03325556|521645716|FG000|Double-blind Period|Administrative discont. at study termination|0|||
144670816|NCT03325556|521645717|FG001|Double-blind Period|Administrative discont. at study termination|35|||
144670817|NCT03325556|521645718|FG002|Double-blind Period|Administrative discont. at study termination|31|||
144670818|NCT01705587|521645719|FG000|Overall Study|Withdrawal by Subject|0|||
144670819|NCT01705587|521645720|FG001|Overall Study|Withdrawal by Subject|1|||
144670820|NCT02227849|521645721|FG000|Overall Study|Adverse Event|4|||
144670821|NCT02227849|521645721|FG000|Overall Study|Physician Decision|1|||
144670822|NCT02227849|521645721|FG000|Overall Study|Withdrawal by Subject|3|||
144670823|NCT00762268|521645724|FG000|Overall Study|Withdrawal by Subject|3|||
144670824|NCT00762268|521645725|FG001|Overall Study|Withdrawal by Subject|3|||
144670825|NCT02533401|521645726|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
144670826|NCT02533401|521645726|FG000|Overall Study|Death|5|||
144670827|NCT02533401|521645726|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
144670828|NCT02533401|521645726|FG000|Overall Study|Lost to Follow-up|1|||
144670829|NCT02533401|521645726|FG000|Overall Study|Violation of Selection Criteria|1|||
144670830|NCT00881361|521645733|FG000|Overall Study|Terminated prior to surgery|27|||
144670831|NCT00881361|521645734|FG001|Overall Study|Terminated prior to surgery|7|||
144670832|NCT00881361|521645735|FG002|Overall Study|Terminated prior to surgery|0|||
144670833|NCT00881361|521645733|FG000|Overall Study|Ineligible|17|||
144670834|NCT00881361|521645734|FG001|Overall Study|Ineligible|2|||
144670835|NCT00881361|521645735|FG002|Overall Study|Ineligible|2|||
144670836|NCT02137837|521645736|FG000|Overall Study|Adverse Event|0|||
144670837|NCT02137837|521645737|FG001|Overall Study|Adverse Event|2|||
144670838|NCT02137837|521645738|FG002|Overall Study|Adverse Event|1|||
144670839|NCT02137837|521645736|FG000|Overall Study|Refusal unrelated to adverse event|2|||
144670840|NCT02137837|521645737|FG001|Overall Study|Refusal unrelated to adverse event|2|||
144670841|NCT02137837|521645738|FG002|Overall Study|Refusal unrelated to adverse event|1|||
144670842|NCT02137837|521645736|FG000|Overall Study|Progression/relapse|9|||
144670843|NCT02137837|521645737|FG001|Overall Study|Progression/relapse|7|||
144670844|NCT02137837|521645738|FG002|Overall Study|Progression/relapse|7|||
144670845|NCT02137837|521645736|FG000|Overall Study|Not protocol specified|2|||
144670846|NCT02137837|521645737|FG001|Overall Study|Not protocol specified|1|||
144670847|NCT02137837|521645738|FG002|Overall Study|Not protocol specified|3|||
144670848|NCT01181141|521645743|FG000|Overall Study|Adverse Event|2|||
144670849|NCT01181141|521645744|FG001|Overall Study|Adverse Event|1|||
144670850|NCT01181141|521645743|FG000|Overall Study|Lack of Efficacy|1|||
144670851|NCT01181141|521645744|FG001|Overall Study|Lack of Efficacy|0|||
144670852|NCT01181141|521645743|FG000|Overall Study|Lost to Follow-up|1|||
144670853|NCT01181141|521645744|FG001|Overall Study|Lost to Follow-up|1|||
144670854|NCT01181141|521645743|FG000|Overall Study|Physician Decision|2|||
144670855|NCT01181141|521645744|FG001|Overall Study|Physician Decision|0|||
144670856|NCT01181141|521645743|FG000|Overall Study|Protocol Violation|3|||
144670857|NCT01181141|521645744|FG001|Overall Study|Protocol Violation|1|||
144670858|NCT01181141|521645743|FG000|Overall Study|Withdrawal by Subject|3|||
144670859|NCT01181141|521645744|FG001|Overall Study|Withdrawal by Subject|1|||
144670860|NCT01329341|521645745|FG000|Overall Study|Withdrawal by Subject|44|||
144670861|NCT03017846|521645748|FG000|Overall Study|Lost to Follow-up|3|||
144670862|NCT03017846|521645748|FG000|Overall Study|Adverse Event|2|||
144670863|NCT05014542|521645752|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
144670864|NCT05014542|521645753|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
144670865|NCT05014542|521645752|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
144670866|NCT05014542|521645753|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
144670867|NCT05014542|521645752|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
144670868|NCT05014542|521645753|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
144670869|NCT05014542|521645752|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
144670870|NCT05014542|521645753|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
144670871|NCT01438307|521645754|FG000|Overall Study|Death|1|||
144670872|NCT01438307|521645755|FG001|Overall Study|Death|1|||
144670873|NCT00555568|521645756|FG000|Overall Study|Lost to Follow-up|26|||
144670874|NCT00555568|521645757|FG001|Overall Study|Lost to Follow-up|16|||
144670875|NCT00555568|521645758|FG002|Overall Study|Lost to Follow-up|16|||
144670876|NCT00936117|521645760|FG000|Overall Study|Adverse Event|7|||
144670877|NCT00936117|521645760|FG000|Overall Study|Unable to continue oral medication|3|||
144670878|NCT01342952|521645761|FG000|Overall Study|Adverse Event|0|||
144670879|NCT01342952|521645762|FG001|Overall Study|Adverse Event|5|||
144734584|NCT01796171|521885428|FG001|Treatment Period With Betalutin|Physician Decision|0|||
144670880|NCT01342952|521645763|FG002|Overall Study|Adverse Event|1|||
144670881|NCT01342952|521645764|FG003|Overall Study|Adverse Event|0|||
144670882|NCT01342952|521645761|FG000|Overall Study|Lost to Follow-up|0|||
144670883|NCT01342952|521645762|FG001|Overall Study|Lost to Follow-up|2|||
144670884|NCT01342952|521645763|FG002|Overall Study|Lost to Follow-up|0|||
144670885|NCT01342952|521645764|FG003|Overall Study|Lost to Follow-up|0|||
144670886|NCT01342952|521645761|FG000|Overall Study|Withdrawal by Subject|1|||
144670887|NCT01342952|521645762|FG001|Overall Study|Withdrawal by Subject|1|||
144670888|NCT01342952|521645763|FG002|Overall Study|Withdrawal by Subject|0|||
144670889|NCT01342952|521645764|FG003|Overall Study|Withdrawal by Subject|0|||
144670890|NCT01342952|521645761|FG000|Overall Study|Physician Decision|3|||
144670891|NCT01342952|521645762|FG001|Overall Study|Physician Decision|3|||
144670892|NCT01342952|521645763|FG002|Overall Study|Physician Decision|1|||
144670893|NCT01342952|521645764|FG003|Overall Study|Physician Decision|0|||
144670894|NCT00426556|521645767|FG000|Phase I - Core Phase|Disease Progression|0|||
144670895|NCT00426556|521645768|FG001|Phase I - Core Phase|Disease Progression|6|||
144670896|NCT00426556|521645769|FG002|Phase I - Core Phase|Disease Progression|2|||
144670897|NCT00426556|521645770|FG003|Phase I - Core Phase|Disease Progression|0|||
144670898|NCT00426556|521645767|FG000|Phase I - Core Phase|Adverse Event|1|||
144670899|NCT00426556|521645768|FG001|Phase I - Core Phase|Adverse Event|3|||
144670900|NCT00426556|521645769|FG002|Phase I - Core Phase|Adverse Event|1|||
144670901|NCT00426556|521645770|FG003|Phase I - Core Phase|Adverse Event|0|||
144670902|NCT00426556|521645767|FG000|Phase I - Core Phase|Death|0|||
144670903|NCT00426556|521645768|FG001|Phase I - Core Phase|Death|1|||
144670904|NCT00426556|521645769|FG002|Phase I - Core Phase|Death|0|||
144670905|NCT00426556|521645770|FG003|Phase I - Core Phase|Death|0|||
144670906|NCT00426556|521645767|FG000|Phase I - Extension Phase|Adverse Event|0|||
144670907|NCT00426556|521645768|FG001|Phase I - Extension Phase|Adverse Event|1|||
144670908|NCT00426556|521645769|FG002|Phase I - Extension Phase|Adverse Event|1|||
144670909|NCT00426556|521645770|FG003|Phase I - Extension Phase|Adverse Event|0|||
144670910|NCT00426556|521645767|FG000|Phase I - Extension Phase|Disease Progression|5|||
144670911|NCT00426556|521645768|FG001|Phase I - Extension Phase|Disease Progression|5|||
144670912|NCT00426556|521645769|FG002|Phase I - Extension Phase|Disease Progression|6|||
144670913|NCT00426556|521645770|FG003|Phase I - Extension Phase|Disease Progression|0|||
144670914|NCT00426556|521645767|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
144670915|NCT00426556|521645768|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
144670916|NCT00426556|521645769|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
144670917|NCT00426556|521645770|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
144670918|NCT00426556|521645767|FG000|Phase II - Core Phase|Disease Progression|0|||
144670919|NCT00426556|521645768|FG001|Phase II - Core Phase|Disease Progression|0|||
144670920|NCT00426556|521645769|FG002|Phase II - Core Phase|Disease Progression|0|||
144670921|NCT00426556|521645770|FG003|Phase II - Core Phase|Disease Progression|16|||
144670922|NCT00426556|521645767|FG000|Phase II - Core Phase|Adverse Event|0|||
144670923|NCT00426556|521645768|FG001|Phase II - Core Phase|Adverse Event|0|||
144670924|NCT00426556|521645769|FG002|Phase II - Core Phase|Adverse Event|0|||
144670925|NCT00426556|521645770|FG003|Phase II - Core Phase|Adverse Event|8|||
144670926|NCT00426556|521645767|FG000|Phase II - Extension Phase|Disease Progression|0|||
144670927|NCT00426556|521645768|FG001|Phase II - Extension Phase|Disease Progression|0|||
144670928|NCT00426556|521645769|FG002|Phase II - Extension Phase|Disease Progression|0|||
144670929|NCT00426556|521645770|FG003|Phase II - Extension Phase|Disease Progression|21|||
144670930|NCT00426556|521645767|FG000|Phase II - Extension Phase|Adverse Event|0|||
144670931|NCT00426556|521645768|FG001|Phase II - Extension Phase|Adverse Event|0|||
144670932|NCT00426556|521645769|FG002|Phase II - Extension Phase|Adverse Event|0|||
144670933|NCT00426556|521645770|FG003|Phase II - Extension Phase|Adverse Event|2|||
144670934|NCT03970824|521645774|FG000|Overall Study|Withdrawal by Subject|1|||
144670935|NCT03970824|521645775|FG001|Overall Study|Withdrawal by Subject|1|||
144670936|NCT03970824|521645776|FG002|Overall Study|Withdrawal by Subject|3|||
144670937|NCT03970824|521645774|FG000|Overall Study|Lost to Follow-up|0|||
144670938|NCT03970824|521645775|FG001|Overall Study|Lost to Follow-up|2|||
144670939|NCT03970824|521645776|FG002|Overall Study|Lost to Follow-up|1|||
144670940|NCT03970824|521645774|FG000|Overall Study|Adverse Event|1|||
144670941|NCT03970824|521645775|FG001|Overall Study|Adverse Event|0|||
144670942|NCT03970824|521645776|FG002|Overall Study|Adverse Event|0|||
144670943|NCT00416312|521645777|FG000|Overall Study|tumors not visible on imaging|2|||
144670944|NCT00105560|521645780|FG000|Overall Study|Lost to Follow-up|1|||
144670945|NCT01192204|521645782|FG000|Overall Study|could not keep recall appointments|1|||
144670946|NCT01192204|521645783|FG001|Overall Study|could not keep recall appointments|0|||
144670947|NCT02146248|521645784|FG000|Overall Study|Withdrawal by Subject|2|||
144670948|NCT01315847|521645785|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
144670949|NCT01315847|521645786|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
144670950|NCT01315847|521645785|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
144670951|NCT01315847|521645786|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
144670952|NCT04169061|521645788|FG000|Overall Study|Adverse Event|2|||
144670953|NCT04169061|521645788|FG000|Overall Study|Death|1|||
144670954|NCT04169061|521645788|FG000|Overall Study|Withdrawal by Subject|1|||
144670955|NCT04169061|521645788|FG000|Overall Study|Protocol Violation|1|||
144670956|NCT04585451|521645789|FG000|Overall Study|Withdrawal by Subject|26|||
144670957|NCT04585451|521645790|FG001|Overall Study|Withdrawal by Subject|0|||
144670958|NCT02188719|521645791|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
144670959|NCT02188719|521645792|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
144670960|NCT02188719|521645793|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
144670961|NCT02188719|521645794|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
144670962|NCT02581982|521645795|FG000|Overall Study|Lack of Efficacy|12|||
144670963|NCT02581982|521645795|FG000|Overall Study|Adverse Event|3|||
144670964|NCT02581982|521645795|FG000|Overall Study|Physician Decision|1|||
144670965|NCT00862654|521645800|FG000|Overall Study|Lack of Efficacy|1|||
144670966|NCT00862654|521645801|FG001|Overall Study|Lack of Efficacy|0|||
144670967|NCT00862654|521645802|FG002|Overall Study|Lack of Efficacy|1|||
144670968|NCT00862654|521645803|FG003|Overall Study|Lack of Efficacy|0|||
144670969|NCT00862654|521645800|FG000|Overall Study|Lost to Follow-up|1|||
144670970|NCT00862654|521645801|FG001|Overall Study|Lost to Follow-up|2|||
144670971|NCT00862654|521645802|FG002|Overall Study|Lost to Follow-up|1|||
144670972|NCT00862654|521645803|FG003|Overall Study|Lost to Follow-up|3|||
144670973|NCT00862654|521645800|FG000|Overall Study|Adverse Event|0|||
144670974|NCT00862654|521645801|FG001|Overall Study|Adverse Event|1|||
144670975|NCT00862654|521645802|FG002|Overall Study|Adverse Event|1|||
144670976|NCT00862654|521645803|FG003|Overall Study|Adverse Event|0|||
144670977|NCT00862654|521645800|FG000|Overall Study|Pregnancy|1|||
144670978|NCT00862654|521645801|FG001|Overall Study|Pregnancy|1|||
144670979|NCT00862654|521645802|FG002|Overall Study|Pregnancy|0|||
144670980|NCT00862654|521645803|FG003|Overall Study|Pregnancy|0|||
144670981|NCT00862654|521645800|FG000|Overall Study|Withdrawal by Subject|2|||
144670982|NCT00862654|521645801|FG001|Overall Study|Withdrawal by Subject|2|||
144670983|NCT00862654|521645802|FG002|Overall Study|Withdrawal by Subject|2|||
144670984|NCT00862654|521645803|FG003|Overall Study|Withdrawal by Subject|3|||
144670985|NCT00862654|521645800|FG000|Overall Study|Subject mistake|0|||
144670986|NCT00862654|521645801|FG001|Overall Study|Subject mistake|1|||
144670987|NCT00862654|521645802|FG002|Overall Study|Subject mistake|0|||
144670988|NCT00862654|521645803|FG003|Overall Study|Subject mistake|0|||
144670989|NCT00862654|521645800|FG000|Overall Study|Familly constraint|0|||
144670990|NCT00862654|521645801|FG001|Overall Study|Familly constraint|1|||
144670991|NCT00862654|521645802|FG002|Overall Study|Familly constraint|0|||
144670992|NCT00862654|521645803|FG003|Overall Study|Familly constraint|0|||
144670993|NCT00862654|521645800|FG000|Overall Study|Never used study drugs|1|||
144670994|NCT00862654|521645801|FG001|Overall Study|Never used study drugs|0|||
144670995|NCT00862654|521645802|FG002|Overall Study|Never used study drugs|0|||
144670996|NCT00862654|521645803|FG003|Overall Study|Never used study drugs|0|||
144670997|NCT00862654|521645800|FG000|Overall Study|Included after end of inclusions|0|||
144670998|NCT00862654|521645801|FG001|Overall Study|Included after end of inclusions|0|||
144670999|NCT00862654|521645802|FG002|Overall Study|Included after end of inclusions|1|||
144671000|NCT00862654|521645803|FG003|Overall Study|Included after end of inclusions|0|||
144671001|NCT03954444|521645804|FG000|Overall Study|Withdrawal by Subject|5|||
144671002|NCT03954444|521645805|FG001|Overall Study|Withdrawal by Subject|5|||
144671003|NCT03954444|521645806|FG002|Overall Study|Withdrawal by Subject|5|||
144671004|NCT03954444|521645804|FG000|Overall Study|Adverse Event|1|||
144671005|NCT03954444|521645805|FG001|Overall Study|Adverse Event|3|||
144671006|NCT03954444|521645806|FG002|Overall Study|Adverse Event|2|||
144671007|NCT03954444|521645804|FG000|Overall Study|Protocol Violation|0|||
144671008|NCT03954444|521645805|FG001|Overall Study|Protocol Violation|3|||
144671009|NCT03954444|521645806|FG002|Overall Study|Protocol Violation|5|||
144671010|NCT03954444|521645804|FG000|Overall Study|Use of prohibited therapy|1|||
144671011|NCT03954444|521645805|FG001|Overall Study|Use of prohibited therapy|1|||
144671012|NCT03954444|521645806|FG002|Overall Study|Use of prohibited therapy|2|||
144671013|NCT03954444|521645804|FG000|Overall Study|Lost to Follow-up|1|||
144671014|NCT03954444|521645805|FG001|Overall Study|Lost to Follow-up|0|||
144671015|NCT03954444|521645806|FG002|Overall Study|Lost to Follow-up|1|||
144671016|NCT03954444|521645804|FG000|Overall Study|Non-compliant with study drug application|2|||
144671017|NCT03954444|521645805|FG001|Overall Study|Non-compliant with study drug application|2|||
144671018|NCT03954444|521645806|FG002|Overall Study|Non-compliant with study drug application|0|||
144671019|NCT03954444|521645804|FG000|Overall Study|Administrative reasons|0|||
144671020|NCT03954444|521645805|FG001|Overall Study|Administrative reasons|0|||
144671021|NCT03954444|521645806|FG002|Overall Study|Administrative reasons|1|||
144671022|NCT03954444|521645804|FG000|Overall Study|Miscellaneous|3|||
144671023|NCT03954444|521645805|FG001|Overall Study|Miscellaneous|2|||
144671024|NCT03954444|521645806|FG002|Overall Study|Miscellaneous|1|||
144671025|NCT00903370|521645808|FG000|Overall Study|Death|13|||
144671026|NCT00903370|521645809|FG001|Overall Study|Death|10|||
144671027|NCT00903370|521645808|FG000|Overall Study|Withdrawal by Subject|9|||
144671028|NCT00903370|521645809|FG001|Overall Study|Withdrawal by Subject|6|||
144671029|NCT00903370|521645808|FG000|Overall Study|Lost to Follow-up|6|||
144671030|NCT00903370|521645809|FG001|Overall Study|Lost to Follow-up|8|||
144671031|NCT04186663|521645810|FG000|Overall Study|Lost to Follow-up|1|||
144671032|NCT04186663|521645810|FG000|Overall Study|Unable to complete blood draw|3|||
144671033|NCT00719862|521645815|FG000|Overall Study|Adverse Event|1|||
144671034|NCT00719862|521645816|FG001|Overall Study|Adverse Event|2|||
144671035|NCT00719862|521645815|FG000|Overall Study|Lack of Efficacy|3|||
144671036|NCT00719862|521645816|FG001|Overall Study|Lack of Efficacy|0|||
144671037|NCT00719862|521645815|FG000|Overall Study|Non-Compliance|1|||
144671038|NCT00719862|521645816|FG001|Overall Study|Non-Compliance|0|||
144671039|NCT00719862|521645815|FG000|Overall Study|Withdrawal by Subject|1|||
144671040|NCT00719862|521645816|FG001|Overall Study|Withdrawal by Subject|0|||
144671041|NCT00719862|521645815|FG000|Overall Study|Lost to Follow-up|0|||
144671042|NCT00719862|521645816|FG001|Overall Study|Lost to Follow-up|1|||
144671043|NCT00719862|521645815|FG000|Overall Study|Other|2|||
144671044|NCT00719862|521645816|FG001|Overall Study|Other|3|||
144671045|NCT01184846|521645817|FG000|Overall Study|Adverse Event|2|||
144671046|NCT01184846|521645817|FG000|Overall Study|Insufficient response|1|||
144671047|NCT01999946|521645818|FG000|Overall Study|Participant not released from jail|2|||
144671048|NCT01999946|521645819|FG001|Overall Study|Participant not released from jail|2|||
144671049|NCT01999946|521645820|FG002|Overall Study|Participant not released from jail|0|||
144671050|NCT01999946|521645818|FG000|Overall Study|Not included in primary outcome analysis|0|||
144671051|NCT01999946|521645819|FG001|Overall Study|Not included in primary outcome analysis|0|||
144671052|NCT01999946|521645820|FG002|Overall Study|Not included in primary outcome analysis|79|||
144671053|NCT00719953|521645823|FG000|Overall Study|Adverse Event|4|||
144671054|NCT01626989|521645824|FG000|Screening Period|Screen Failure|15|||
144671055|NCT01626989|521645825|FG001|Screening Period|Screen Failure|0|||
144671056|NCT01626989|521645826|FG002|Screening Period|Screen Failure|0|||
144671057|NCT01626989|521645824|FG000|Screening Period|Withdrawal by Subject|2|||
144671058|NCT01626989|521645825|FG001|Screening Period|Withdrawal by Subject|0|||
144671059|NCT01626989|521645826|FG002|Screening Period|Withdrawal by Subject|0|||
144671060|NCT02947022|521645829|FG000|Overall Study|Study Stopped|1|||
144671061|NCT01770145|521647667|FG000|Baseline|Adverse Event|20|||
144671062|NCT01770145|521647667|FG000|Baseline|Withdrawal by Subject|1|||
144671063|NCT01770145|521647667|FG000|Baseline|Lost to Follow-up|1|||
144671064|NCT01770145|521647667|FG000|Baseline|Unable to define optimal dose|4|||
144671065|NCT01770145|521647667|FG000|Treatment|Adverse Event|3|||
144671066|NCT01770145|521647667|FG000|Treatment|Withdrawal by Subject|1|||
144671067|NCT04268303|521647668|FG000|Overall Study|Lost to Follow-up|1|||
144671068|NCT04268303|521647669|FG001|Overall Study|Lost to Follow-up|1|||
144671069|NCT04268303|521647670|FG002|Overall Study|Lost to Follow-up|2|||
144671070|NCT04268303|521647668|FG000|Overall Study|Withdrawal by Subject|0|||
144671071|NCT04268303|521647669|FG001|Overall Study|Withdrawal by Subject|1|||
144671072|NCT04268303|521647670|FG002|Overall Study|Withdrawal by Subject|1|||
144671073|NCT04268303|521647668|FG000|Overall Study|Adverse Event|2|||
144671074|NCT04268303|521647669|FG001|Overall Study|Adverse Event|0|||
144671075|NCT04268303|521647670|FG002|Overall Study|Adverse Event|0|||
144671076|NCT00355134|521647671|FG000|Core Phase|Withdrawal by Subject|35|||
144671077|NCT00355134|521647672|FG001|Core Phase|Withdrawal by Subject|24|||
144671078|NCT00355134|521647673|FG002|Core Phase|Withdrawal by Subject|35|||
144671079|NCT00355134|521647674|FG003|Core Phase|Withdrawal by Subject|0|||
144671080|NCT00355134|521647675|FG004|Core Phase|Withdrawal by Subject|0|||
144671081|NCT00355134|521647671|FG000|Core Phase|Adverse Event|28|||
144671082|NCT00355134|521647672|FG001|Core Phase|Adverse Event|22|||
144671083|NCT00355134|521647673|FG002|Core Phase|Adverse Event|16|||
144671084|NCT00355134|521647674|FG003|Core Phase|Adverse Event|0|||
144671085|NCT00355134|521647675|FG004|Core Phase|Adverse Event|0|||
144671086|NCT00355134|521647671|FG000|Core Phase|Lost to Follow-up|17|||
144671087|NCT00355134|521647672|FG001|Core Phase|Lost to Follow-up|13|||
144671088|NCT00355134|521647673|FG002|Core Phase|Lost to Follow-up|21|||
144671089|NCT00355134|521647674|FG003|Core Phase|Lost to Follow-up|0|||
144671090|NCT00355134|521647675|FG004|Core Phase|Lost to Follow-up|0|||
144671091|NCT00355134|521647671|FG000|Core Phase|Abnormal laboratory value(s)|19|||
144671092|NCT00355134|521647672|FG001|Core Phase|Abnormal laboratory value(s)|14|||
144671093|NCT00355134|521647673|FG002|Core Phase|Abnormal laboratory value(s)|2|||
144671094|NCT00355134|521647674|FG003|Core Phase|Abnormal laboratory value(s)|0|||
144671095|NCT00355134|521647675|FG004|Core Phase|Abnormal laboratory value(s)|0|||
144671096|NCT00355134|521647671|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
144671097|NCT00355134|521647672|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
144671098|NCT00355134|521647673|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
144671099|NCT00355134|521647674|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
144671100|NCT00355134|521647675|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
144671101|NCT00355134|521647671|FG000|Core Phase|Administrative problems|5|||
144671102|NCT00355134|521647672|FG001|Core Phase|Administrative problems|3|||
144734585|NCT01796171|521885429|FG002|Treatment Period With Betalutin|Physician Decision|0|||
144734586|NCT01796171|521885430|FG003|Treatment Period With Betalutin|Physician Decision|0|||
144734587|NCT01796171|521885431|FG004|Treatment Period With Betalutin|Physician Decision|0|||
144265615|NCT02513550|520173977|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
144671103|NCT00355134|521647673|FG002|Core Phase|Administrative problems|5|||
144671104|NCT00355134|521647674|FG003|Core Phase|Administrative problems|0|||
144734588|NCT01796171|521885432|FG005|Treatment Period With Betalutin|Physician Decision|0|||
144671105|NCT00355134|521647675|FG004|Core Phase|Administrative problems|0|||
144671106|NCT00355134|521647671|FG000|Core Phase|Protocol Violation|3|||
144671107|NCT00355134|521647672|FG001|Core Phase|Protocol Violation|2|||
144671108|NCT00355134|521647673|FG002|Core Phase|Protocol Violation|2|||
144671109|NCT00355134|521647674|FG003|Core Phase|Protocol Violation|0|||
144671110|NCT00355134|521647675|FG004|Core Phase|Protocol Violation|0|||
144671111|NCT00355134|521647671|FG000|Core Phase|Abnormal test procedure result(s)|1|||
144671112|NCT00355134|521647672|FG001|Core Phase|Abnormal test procedure result(s)|2|||
144734589|NCT01796171|521885433|FG006|Treatment Period With Betalutin|Physician Decision|0|||
144671113|NCT00355134|521647673|FG002|Core Phase|Abnormal test procedure result(s)|1|||
144671114|NCT00355134|521647674|FG003|Core Phase|Abnormal test procedure result(s)|0|||
144671115|NCT00355134|521647675|FG004|Core Phase|Abnormal test procedure result(s)|0|||
144671116|NCT00355134|521647671|FG000|Core Phase|Condition no longer requires study drug|1|||
144671117|NCT00355134|521647672|FG001|Core Phase|Condition no longer requires study drug|0|||
144671118|NCT00355134|521647673|FG002|Core Phase|Condition no longer requires study drug|1|||
144671119|NCT00355134|521647674|FG003|Core Phase|Condition no longer requires study drug|0|||
144671120|NCT00355134|521647675|FG004|Core Phase|Condition no longer requires study drug|0|||
144671121|NCT00355134|521647671|FG000|Extension Phase|Withdrawal by Subject|7|||
144671122|NCT00355134|521647672|FG001|Extension Phase|Withdrawal by Subject|11|||
144671123|NCT00355134|521647673|FG002|Extension Phase|Withdrawal by Subject|0|||
144671124|NCT00355134|521647674|FG003|Extension Phase|Withdrawal by Subject|7|||
144671125|NCT00355134|521647675|FG004|Extension Phase|Withdrawal by Subject|5|||
144671126|NCT00355134|521647671|FG000|Extension Phase|Adverse Event|13|||
144671127|NCT00355134|521647672|FG001|Extension Phase|Adverse Event|9|||
144671128|NCT00355134|521647673|FG002|Extension Phase|Adverse Event|0|||
144671129|NCT00355134|521647674|FG003|Extension Phase|Adverse Event|3|||
144671130|NCT00355134|521647675|FG004|Extension Phase|Adverse Event|5|||
144671131|NCT00355134|521647671|FG000|Extension Phase|Lost to Follow-up|2|||
144671132|NCT00355134|521647672|FG001|Extension Phase|Lost to Follow-up|6|||
144671133|NCT00355134|521647673|FG002|Extension Phase|Lost to Follow-up|0|||
144671134|NCT00355134|521647674|FG003|Extension Phase|Lost to Follow-up|2|||
144671135|NCT00355134|521647675|FG004|Extension Phase|Lost to Follow-up|4|||
144671136|NCT00355134|521647671|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
144671137|NCT00355134|521647672|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
144671138|NCT00355134|521647673|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
144671139|NCT00355134|521647674|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
144671140|NCT00355134|521647675|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
144671141|NCT00355134|521647671|FG000|Extension Phase|Administrative problems|2|||
144671142|NCT00355134|521647672|FG001|Extension Phase|Administrative problems|4|||
144671143|NCT00355134|521647673|FG002|Extension Phase|Administrative problems|0|||
144671144|NCT00355134|521647674|FG003|Extension Phase|Administrative problems|1|||
144671145|NCT00355134|521647675|FG004|Extension Phase|Administrative problems|1|||
144671146|NCT00355134|521647671|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
144671147|NCT00355134|521647672|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
144671148|NCT00355134|521647673|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
144671149|NCT00355134|521647674|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
144671150|NCT00355134|521647675|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
144671151|NCT00355134|521647671|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
144671152|NCT00355134|521647672|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
144671153|NCT00355134|521647673|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
144671154|NCT00355134|521647674|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
144671155|NCT00355134|521647675|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
144671156|NCT00355134|521647671|FG000|Extension Phase|Protocol Violation|0|||
144671157|NCT00355134|521647672|FG001|Extension Phase|Protocol Violation|0|||
144671158|NCT00355134|521647673|FG002|Extension Phase|Protocol Violation|0|||
144671159|NCT00355134|521647674|FG003|Extension Phase|Protocol Violation|1|||
144671160|NCT00355134|521647675|FG004|Extension Phase|Protocol Violation|0|||
144671161|NCT03621189|521647681|FG000|Overall Study|Withdrawal by Subject|0|||
144671162|NCT03621189|521647682|FG001|Overall Study|Withdrawal by Subject|3|||
144671163|NCT03621189|521647681|FG000|Overall Study|Physician Decision|0|||
144671164|NCT03621189|521647682|FG001|Overall Study|Physician Decision|2|||
144671165|NCT01135394|521647683|FG000|Screening|Lost to Follow-up|2|||
144671166|NCT01135394|521647683|FG000|Screening|Withdrawal by Subject|10|||
144671167|NCT01135394|521647683|FG000|Screening|Screening failure|16|||
144671168|NCT01135394|521647683|FG000|Screening|Physician Decision|5|||
144671169|NCT01135394|521647683|FG000|Baseline Assessment|Withdrawal by Subject|9|||
144671170|NCT01135394|521647683|FG000|Baseline Assessment|Physician Decision|3|||
144671171|NCT01135394|521647683|FG000|Baseline Assessment|Lost to Follow-up|2|||
144671172|NCT01135394|521647683|FG000|Baseline Assessment|Adverse Event|1|||
144671173|NCT01135394|521647683|FG000|Study Treatment|Withdrawal by Subject|1|||
144671174|NCT01135394|521647683|FG000|Study Treatment|Physician Decision|1|||
144671175|NCT01135394|521647683|FG000|Study Treatment|Adverse Event|2|||
144671176|NCT04432376|521647684|FG000|Double-blind Treatment Period|Adverse Event|2|||
144671177|NCT04432376|521647685|FG001|Double-blind Treatment Period|Adverse Event|6|||
144671178|NCT04432376|521647686|FG002|Double-blind Treatment Period|Adverse Event|0|||
144671179|NCT04432376|521647684|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
144671180|NCT04432376|521647685|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
144671181|NCT04432376|521647686|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
144671182|NCT04432376|521647684|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
144671183|NCT04432376|521647685|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
144671184|NCT04432376|521647686|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144671185|NCT04432376|521647684|FG000|Double-blind Treatment Period|Protocol Violation|0|||
144671186|NCT04432376|521647685|FG001|Double-blind Treatment Period|Protocol Violation|1|||
144671187|NCT04432376|521647686|FG002|Double-blind Treatment Period|Protocol Violation|0|||
144671188|NCT04432376|521647684|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
144671189|NCT04432376|521647685|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
144671190|NCT04432376|521647686|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
144671191|NCT02088541|521647687|FG000|Overall Study|Adverse Event|3|||
144671192|NCT02088541|521647688|FG001|Overall Study|Adverse Event|0|||
144671193|NCT02088541|521647689|FG002|Overall Study|Adverse Event|3|||
144671194|NCT02088541|521647690|FG003|Overall Study|Adverse Event|3|||
144671195|NCT02088541|521647691|FG004|Overall Study|Adverse Event|0|||
144671196|NCT02088541|521647687|FG000|Overall Study|Death|51|||
144671197|NCT02088541|521647688|FG001|Overall Study|Death|21|||
144671198|NCT02088541|521647689|FG002|Overall Study|Death|85|||
144671199|NCT02088541|521647690|FG003|Overall Study|Death|28|||
144671200|NCT02088541|521647691|FG004|Overall Study|Death|38|||
144671201|NCT02088541|521647687|FG000|Overall Study|Lost to Follow-up|2|||
144671202|NCT02088541|521647688|FG001|Overall Study|Lost to Follow-up|0|||
144671203|NCT02088541|521647689|FG002|Overall Study|Lost to Follow-up|1|||
144671204|NCT02088541|521647690|FG003|Overall Study|Lost to Follow-up|0|||
144671205|NCT02088541|521647691|FG004|Overall Study|Lost to Follow-up|0|||
144671206|NCT02088541|521647687|FG000|Overall Study|Physician Decision|2|||
144671207|NCT02088541|521647688|FG001|Overall Study|Physician Decision|1|||
144671208|NCT02088541|521647689|FG002|Overall Study|Physician Decision|2|||
144671209|NCT02088541|521647690|FG003|Overall Study|Physician Decision|0|||
144671210|NCT02088541|521647691|FG004|Overall Study|Physician Decision|2|||
144671211|NCT02088541|521647687|FG000|Overall Study|Disease progression|7|||
144671212|NCT02088541|521647688|FG001|Overall Study|Disease progression|1|||
144671213|NCT02088541|521647689|FG002|Overall Study|Disease progression|2|||
144671214|NCT02088541|521647690|FG003|Overall Study|Disease progression|3|||
144671215|NCT02088541|521647691|FG004|Overall Study|Disease progression|1|||
144671216|NCT02088541|521647687|FG000|Overall Study|Study terminated by sponsor|1|||
144671217|NCT02088541|521647688|FG001|Overall Study|Study terminated by sponsor|1|||
144671218|NCT02088541|521647689|FG002|Overall Study|Study terminated by sponsor|12|||
144671219|NCT02088541|521647690|FG003|Overall Study|Study terminated by sponsor|2|||
144671220|NCT02088541|521647691|FG004|Overall Study|Study terminated by sponsor|6|||
144671221|NCT02088541|521647687|FG000|Overall Study|Withdrawal by Subject|3|||
144671222|NCT02088541|521647688|FG001|Overall Study|Withdrawal by Subject|2|||
144671223|NCT02088541|521647689|FG002|Overall Study|Withdrawal by Subject|9|||
144671224|NCT02088541|521647690|FG003|Overall Study|Withdrawal by Subject|7|||
144671225|NCT02088541|521647691|FG004|Overall Study|Withdrawal by Subject|10|||
144671226|NCT02088541|521647687|FG000|Overall Study|Other|2|||
144671227|NCT02088541|521647688|FG001|Overall Study|Other|1|||
144671228|NCT02088541|521647689|FG002|Overall Study|Other|3|||
144671229|NCT02088541|521647690|FG003|Overall Study|Other|1|||
144671230|NCT02088541|521647691|FG004|Overall Study|Other|1|||
144671231|NCT05742841|521647692|FG000|Overall Study|Withdrawal by Subject|1|||
144671232|NCT05742841|521647692|FG000|Overall Study|Lost to Follow-up|1|||
144671233|NCT04134728|521647693|FG000|Overall Study|Adverse Event|3|||
144671234|NCT04134728|521647694|FG001|Overall Study|Adverse Event|2|||
144671235|NCT04134728|521647695|FG002|Overall Study|Adverse Event|9|||
144671236|NCT04134728|521647696|FG003|Overall Study|Adverse Event|0|||
144671237|NCT04134728|521647697|FG004|Overall Study|Adverse Event|0|||
144671238|NCT04134728|521647698|FG005|Overall Study|Adverse Event|0|||
144671239|NCT04134728|521647693|FG000|Overall Study|Lack of Efficacy|3|||
144671240|NCT04134728|521647694|FG001|Overall Study|Lack of Efficacy|3|||
144671241|NCT04134728|521647695|FG002|Overall Study|Lack of Efficacy|1|||
144671242|NCT04134728|521647696|FG003|Overall Study|Lack of Efficacy|2|||
144671243|NCT04134728|521647697|FG004|Overall Study|Lack of Efficacy|0|||
144671244|NCT04134728|521647698|FG005|Overall Study|Lack of Efficacy|0|||
144671245|NCT04134728|521647693|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
144671246|NCT04134728|521647694|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144671247|NCT04134728|521647695|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
144671248|NCT04134728|521647696|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144671249|NCT04134728|521647697|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144671250|NCT04134728|521647698|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144671251|NCT04134728|521647693|FG000|Overall Study|Protocol Deviation|0|||
144671252|NCT04134728|521647694|FG001|Overall Study|Protocol Deviation|0|||
144671253|NCT04134728|521647695|FG002|Overall Study|Protocol Deviation|1|||
144671254|NCT04134728|521647696|FG003|Overall Study|Protocol Deviation|0|||
144671255|NCT04134728|521647697|FG004|Overall Study|Protocol Deviation|0|||
144671256|NCT04134728|521647698|FG005|Overall Study|Protocol Deviation|0|||
144671257|NCT04134728|521647693|FG000|Overall Study|Informed Consent Withdrawn|3|||
144671258|NCT04134728|521647694|FG001|Overall Study|Informed Consent Withdrawn|6|||
144671259|NCT04134728|521647695|FG002|Overall Study|Informed Consent Withdrawn|8|||
144671260|NCT04134728|521647696|FG003|Overall Study|Informed Consent Withdrawn|1|||
144671261|NCT04134728|521647697|FG004|Overall Study|Informed Consent Withdrawn|1|||
144671262|NCT04134728|521647698|FG005|Overall Study|Informed Consent Withdrawn|0|||
144671263|NCT04134728|521647693|FG000|Overall Study|Physician Decision|2|||
144671264|NCT04134728|521647694|FG001|Overall Study|Physician Decision|0|||
144671265|NCT04134728|521647695|FG002|Overall Study|Physician Decision|0|||
144671266|NCT04134728|521647696|FG003|Overall Study|Physician Decision|0|||
144671267|NCT04134728|521647697|FG004|Overall Study|Physician Decision|0|||
144671268|NCT04134728|521647698|FG005|Overall Study|Physician Decision|0|||
144671269|NCT04134728|521647693|FG000|Overall Study|Lost to Follow-up|1|||
144671270|NCT04134728|521647694|FG001|Overall Study|Lost to Follow-up|2|||
144671271|NCT04134728|521647695|FG002|Overall Study|Lost to Follow-up|1|||
144671272|NCT04134728|521647696|FG003|Overall Study|Lost to Follow-up|0|||
144671273|NCT04134728|521647697|FG004|Overall Study|Lost to Follow-up|0|||
144671274|NCT04134728|521647698|FG005|Overall Study|Lost to Follow-up|1|||
144671275|NCT04134728|521647693|FG000|Overall Study|Investigator Site Closed|0|||
144671276|NCT04134728|521647694|FG001|Overall Study|Investigator Site Closed|1|||
144671277|NCT04134728|521647695|FG002|Overall Study|Investigator Site Closed|1|||
144671278|NCT04134728|521647696|FG003|Overall Study|Investigator Site Closed|0|||
144671279|NCT04134728|521647697|FG004|Overall Study|Investigator Site Closed|0|||
144671280|NCT04134728|521647698|FG005|Overall Study|Investigator Site Closed|0|||
144671281|NCT00379236|521647699|FG000|Double-blind|Adverse Event|11|||
144671282|NCT00379236|521647700|FG001|Double-blind|Adverse Event|6|||
144671283|NCT00379236|521647701|FG002|Double-blind|Adverse Event|0|||
144671284|NCT00379236|521647699|FG000|Double-blind|Protocol Violation|3|||
144671285|NCT00379236|521647700|FG001|Double-blind|Protocol Violation|3|||
144671286|NCT00379236|521647701|FG002|Double-blind|Protocol Violation|0|||
144671287|NCT00379236|521647699|FG000|Double-blind|Withdrawal by Subject|12|||
144671288|NCT00379236|521647700|FG001|Double-blind|Withdrawal by Subject|13|||
144671289|NCT00379236|521647701|FG002|Double-blind|Withdrawal by Subject|0|||
144671290|NCT00379236|521647699|FG000|Double-blind|Lost to Follow-up|4|||
144671291|NCT00379236|521647700|FG001|Double-blind|Lost to Follow-up|3|||
144671292|NCT00379236|521647701|FG002|Double-blind|Lost to Follow-up|0|||
144671293|NCT00379236|521647699|FG000|Double-blind|Use of exclusionary medication|1|||
144671294|NCT00379236|521647700|FG001|Double-blind|Use of exclusionary medication|2|||
144671295|NCT00379236|521647701|FG002|Double-blind|Use of exclusionary medication|0|||
144671296|NCT00379236|521647699|FG000|Double-blind|Other|3|||
144671297|NCT00379236|521647700|FG001|Double-blind|Other|7|||
144671298|NCT00379236|521647701|FG002|Double-blind|Other|0|||
144671299|NCT00379236|521647699|FG000|Double-blind|Data could not be retrieved|2|||
144671300|NCT00379236|521647700|FG001|Double-blind|Data could not be retrieved|2|||
144671301|NCT00379236|521647701|FG002|Double-blind|Data could not be retrieved|0|||
144671302|NCT00379236|521647699|FG000|Open-label Extension|Adverse Event|0|||
144671303|NCT00379236|521647700|FG001|Open-label Extension|Adverse Event|0|||
144671304|NCT00379236|521647701|FG002|Open-label Extension|Adverse Event|13|||
144671305|NCT00379236|521647699|FG000|Open-label Extension|Protocol Violation|0|||
144671306|NCT00379236|521647700|FG001|Open-label Extension|Protocol Violation|0|||
144671307|NCT00379236|521647701|FG002|Open-label Extension|Protocol Violation|7|||
144671308|NCT00379236|521647699|FG000|Open-label Extension|Withdrawal by Subject|0|||
144671309|NCT00379236|521647700|FG001|Open-label Extension|Withdrawal by Subject|0|||
144671310|NCT00379236|521647701|FG002|Open-label Extension|Withdrawal by Subject|13|||
144671311|NCT00379236|521647699|FG000|Open-label Extension|Lost to Follow-up|0|||
144671312|NCT00379236|521647700|FG001|Open-label Extension|Lost to Follow-up|0|||
144671313|NCT00379236|521647701|FG002|Open-label Extension|Lost to Follow-up|12|||
144671314|NCT00379236|521647699|FG000|Open-label Extension|Use of exclusionary medication|0|||
144671315|NCT00379236|521647700|FG001|Open-label Extension|Use of exclusionary medication|0|||
144671316|NCT00379236|521647701|FG002|Open-label Extension|Use of exclusionary medication|3|||
144671317|NCT00379236|521647699|FG000|Open-label Extension|Other|0|||
144671318|NCT00379236|521647700|FG001|Open-label Extension|Other|0|||
144671319|NCT00379236|521647701|FG002|Open-label Extension|Other|7|||
144671320|NCT00801892|521647707|FG000|Main Study Period|Withdrawal by Subject|0|||
144671321|NCT00801892|521647708|FG001|Main Study Period|Withdrawal by Subject|1|||
144671322|NCT00801892|521647707|FG000|Sham Crossover Period|Lost to Follow-up|0|||
144671323|NCT00801892|521647708|FG001|Sham Crossover Period|Lost to Follow-up|2|||
144671324|NCT00728936|521647709|FG000|Overall Study|Withdrawal by Subject|0|||
144671325|NCT00728936|521647710|FG001|Overall Study|Withdrawal by Subject|0|||
144671326|NCT00728936|521647711|FG002|Overall Study|Withdrawal by Subject|0|||
144671327|NCT00728936|521647712|FG003|Overall Study|Withdrawal by Subject|0|||
144217989|NCT03176134|519992214|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
144217990|NCT03176134|519992215|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
144671328|NCT00728936|521647713|FG004|Overall Study|Withdrawal by Subject|0|||
144671329|NCT00728936|521647714|FG005|Overall Study|Withdrawal by Subject|1|||
144671330|NCT00728936|521647715|FG006|Overall Study|Withdrawal by Subject|0|||
144671331|NCT00438464|521647716|FG000|Overall Study|Terminated Early|14|||
144671332|NCT00438464|521647717|FG001|Overall Study|Terminated Early|5|||
144217991|NCT01499095|519992218|FG000|Overall Study|Randomized But Not Treated|1|||
144671333|NCT00438464|521647716|FG000|Overall Study|Incomplete data submission|0|||
144671334|NCT00438464|521647717|FG001|Overall Study|Incomplete data submission|2|||
144671335|NCT02905825|521647722|FG000|Overall Study|Protocol Violation|11|||
144671336|NCT02905825|521647722|FG000|Overall Study|Device Malfunction|1|||
144671337|NCT03657810|521647725|FG000|Overall Study|Adverse Event|0|||
144671338|NCT03657810|521647726|FG001|Overall Study|Adverse Event|1|||
144671339|NCT03657810|521647727|FG002|Overall Study|Adverse Event|0|||
144671340|NCT03657810|521647725|FG000|Overall Study|Lack of Efficacy|4|||
144671341|NCT03657810|521647726|FG001|Overall Study|Lack of Efficacy|1|||
144671342|NCT03657810|521647727|FG002|Overall Study|Lack of Efficacy|3|||
144671343|NCT03657810|521647725|FG000|Overall Study|Protocol Violation|1|||
144671344|NCT03657810|521647726|FG001|Overall Study|Protocol Violation|0|||
144671345|NCT03657810|521647727|FG002|Overall Study|Protocol Violation|0|||
144671346|NCT03657810|521647725|FG000|Overall Study|Lost to Follow-up|0|||
144671347|NCT03657810|521647726|FG001|Overall Study|Lost to Follow-up|1|||
144671348|NCT03657810|521647727|FG002|Overall Study|Lost to Follow-up|0|||
144671349|NCT03657810|521647725|FG000|Overall Study|Not provided|0|||
144671350|NCT03657810|521647726|FG001|Overall Study|Not provided|1|||
144671351|NCT03657810|521647727|FG002|Overall Study|Not provided|0|||
144671352|NCT00985738|521647728|FG000|Overall Study|Study closed prematurely|8|||
144671353|NCT00985738|521647729|FG001|Overall Study|Study closed prematurely|8|||
144671354|NCT00510484|521647731|FG000|Wash-out Period|Adverse Event|0|||
144671355|NCT00510484|521647732|FG001|Wash-out Period|Adverse Event|1|||
144671356|NCT01590212|521647733|FG000|Overall Study|Withdrawal by Subject|2|||
144671357|NCT01590212|521647734|FG001|Overall Study|Withdrawal by Subject|2|||
144671358|NCT01590212|521647735|FG002|Overall Study|Withdrawal by Subject|2|||
144671359|NCT01590212|521647733|FG000|Overall Study|Lost to Follow-up|1|||
144671360|NCT01590212|521647734|FG001|Overall Study|Lost to Follow-up|2|||
144671361|NCT01590212|521647735|FG002|Overall Study|Lost to Follow-up|3|||
144671362|NCT04897594|521647736|FG000|Overall Study|Lost to Follow-up|0|||
144671363|NCT04897594|521647737|FG001|Overall Study|Lost to Follow-up|1|||
144671364|NCT04897594|521647738|FG002|Overall Study|Lost to Follow-up|1|||
144671365|NCT04897594|521647736|FG000|Overall Study|Sponsor Decision|0|||
144671366|NCT04897594|521647737|FG001|Overall Study|Sponsor Decision|0|||
144671367|NCT04897594|521647738|FG002|Overall Study|Sponsor Decision|1|||
144671368|NCT04897594|521647736|FG000|Overall Study|Withdrawal by Subject|1|||
144671369|NCT04897594|521647737|FG001|Overall Study|Withdrawal by Subject|0|||
144671370|NCT04897594|521647738|FG002|Overall Study|Withdrawal by Subject|1|||
144671371|NCT01457924|521647743|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
144671372|NCT01457924|521647744|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
144671373|NCT01457924|521647745|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
144671374|NCT01457924|521647746|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
144671375|NCT01457924|521647747|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
144671376|NCT01457924|521647743|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
144671377|NCT01457924|521647744|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
144671378|NCT01457924|521647745|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
144671379|NCT01457924|521647746|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
144671380|NCT01457924|521647747|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
144671381|NCT01457924|521647743|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
144671382|NCT01457924|521647744|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
144671383|NCT01457924|521647745|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
144671384|NCT01457924|521647746|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
144671385|NCT01457924|521647747|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
144671386|NCT01457924|521647743|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
144671387|NCT01457924|521647744|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
144671388|NCT01457924|521647745|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
144671389|NCT01457924|521647746|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
144671390|NCT01457924|521647747|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
144671391|NCT01457924|521647743|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
144671392|NCT01457924|521647744|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
144671393|NCT01457924|521647745|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
144671394|NCT01457924|521647746|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
144671395|NCT01457924|521647747|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
144671396|NCT01457924|521647743|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
144671397|NCT01457924|521647744|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
144671398|NCT01457924|521647745|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
144734590|NCT01796171|521885434|FG007|Treatment Period With Betalutin|Physician Decision|0|||
144734591|NCT01796171|521885435|FG008|Treatment Period With Betalutin|Physician Decision|0|||
144734592|NCT01796171|521885436|FG009|Treatment Period With Betalutin|Physician Decision|0|||
144671399|NCT01457924|521647746|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
144671400|NCT01457924|521647747|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
144671401|NCT01457924|521647743|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
144671402|NCT01457924|521647744|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
144734593|NCT01796171|521885437|FG010|Treatment Period With Betalutin|Physician Decision|5|||
144671403|NCT01457924|521647745|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
144671404|NCT01457924|521647746|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
144671405|NCT01457924|521647747|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
144671406|NCT01457924|521647743|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
144671407|NCT01457924|521647744|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
144671408|NCT01457924|521647745|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
144671409|NCT01457924|521647746|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
144671410|NCT01457924|521647747|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
144671411|NCT01457924|521647743|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
144671412|NCT01457924|521647744|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
144671413|NCT01457924|521647745|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
144671414|NCT01457924|521647746|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
144671415|NCT01457924|521647747|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
144671416|NCT01457924|521647743|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
144671417|NCT01457924|521647744|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
144671418|NCT01457924|521647745|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
144671419|NCT01457924|521647746|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
144671420|NCT01457924|521647747|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
144671421|NCT01457924|521647743|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
144671422|NCT01457924|521647744|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
144671423|NCT01457924|521647745|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
144671424|NCT01457924|521647746|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
144671425|NCT01457924|521647747|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
144671426|NCT01457924|521647743|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
144671427|NCT01457924|521647744|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
144671428|NCT01457924|521647745|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
144671429|NCT01457924|521647746|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
144671430|NCT01457924|521647747|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
144671431|NCT01457924|521647743|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
144671432|NCT01457924|521647744|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
144671433|NCT01457924|521647745|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
144671434|NCT01457924|521647746|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
144671435|NCT01457924|521647747|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
144671436|NCT00448760|521647748|FG000|Overall Study|Death|3|||
144671437|NCT00118911|521647749|FG000|Overall Study|Withdrawal by Subject|2|||
144671438|NCT00118911|521647750|FG001|Overall Study|Withdrawal by Subject|5|||
144671439|NCT05507580|521647751|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144671440|NCT05507580|521647752|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
144671441|NCT05507580|521647753|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
144671442|NCT05507580|521647754|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
144671443|NCT05507580|521647755|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
144671444|NCT05507580|521647756|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
144671445|NCT05507580|521647751|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
144671446|NCT05507580|521647752|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
144671447|NCT05507580|521647753|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144671448|NCT05507580|521647754|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144671449|NCT05507580|521647755|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144671450|NCT05507580|521647756|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144671451|NCT05507580|521647751|FG000|Double-Blind Treatment Period|Other, not specified|5|||
144671452|NCT05507580|521647752|FG001|Double-Blind Treatment Period|Other, not specified|4|||
144671453|NCT05507580|521647753|FG002|Double-Blind Treatment Period|Other, not specified|0|||
144671454|NCT05507580|521647754|FG003|Double-Blind Treatment Period|Other, not specified|0|||
144671455|NCT05507580|521647755|FG004|Double-Blind Treatment Period|Other, not specified|0|||
144671456|NCT05507580|521647756|FG005|Double-Blind Treatment Period|Other, not specified|0|||
144671457|NCT05507580|521647751|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
144671458|NCT05507580|521647752|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
144671459|NCT05507580|521647753|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
144671460|NCT05507580|521647754|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
144671461|NCT05507580|521647755|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
144671462|NCT05507580|521647756|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
144671463|NCT05507580|521647751|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
144671464|NCT05507580|521647752|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
144671465|NCT05507580|521647753|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
144671466|NCT05507580|521647754|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
144671467|NCT05507580|521647755|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
144671468|NCT05507580|521647756|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
144671469|NCT05507580|521647751|FG000|Single-Blind Treatment Period|Other, not specified|0|||
144671470|NCT05507580|521647752|FG001|Single-Blind Treatment Period|Other, not specified|0|||
144671471|NCT05507580|521647753|FG002|Single-Blind Treatment Period|Other, not specified|2|||
144671472|NCT05507580|521647754|FG003|Single-Blind Treatment Period|Other, not specified|7|||
144671473|NCT05507580|521647755|FG004|Single-Blind Treatment Period|Other, not specified|3|||
144217992|NCT01499095|519992219|FG001|Overall Study|Randomized But Not Treated|1|||
144217993|NCT01499095|519992218|FG000|Overall Study|Adverse Event|12|||
144217994|NCT01499095|519992219|FG001|Overall Study|Adverse Event|7|||
144217995|NCT01499095|519992218|FG000|Overall Study|Lack of Efficacy|2|||
144217996|NCT01499095|519992219|FG001|Overall Study|Lack of Efficacy|1|||
144671474|NCT05507580|521647756|FG005|Single-Blind Treatment Period|Other, not specified|5|||
144671475|NCT00270998|521647758|FG000|3 Month Follow-up|Adverse Event|1|||
144671476|NCT00270998|521647759|FG001|3 Month Follow-up|Adverse Event|0|||
144671477|NCT00270998|521647760|FG002|3 Month Follow-up|Adverse Event|0|||
144671478|NCT00270998|521647758|FG000|3 Month Follow-up|Lack of Efficacy|1|||
144671479|NCT00270998|521647759|FG001|3 Month Follow-up|Lack of Efficacy|2|||
144671480|NCT00270998|521647760|FG002|3 Month Follow-up|Lack of Efficacy|1|||
144671481|NCT00270998|521647758|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
144671482|NCT00270998|521647759|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
144671483|NCT00270998|521647760|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
144734594|NCT01796171|521885438|FG011|Treatment Period With Betalutin|Physician Decision|1|||
144734595|NCT01796171|521885439|FG012|Treatment Period With Betalutin|Physician Decision|1|||
144734596|NCT01796171|521885440|FG013|Treatment Period With Betalutin|Physician Decision|0|||
144734597|NCT01796171|521885441|FG014|Treatment Period With Betalutin|Physician Decision|0|||
144734598|NCT01796171|521885427|FG000|Treatment Period With Betalutin|Death|0|||
144734599|NCT01796171|521885428|FG001|Treatment Period With Betalutin|Death|0|||
144734600|NCT01796171|521885429|FG002|Treatment Period With Betalutin|Death|0|||
144734601|NCT01796171|521885430|FG003|Treatment Period With Betalutin|Death|0|||
144734602|NCT01796171|521885431|FG004|Treatment Period With Betalutin|Death|0|||
144734603|NCT01796171|521885432|FG005|Treatment Period With Betalutin|Death|0|||
144734604|NCT01796171|521885433|FG006|Treatment Period With Betalutin|Death|0|||
144734605|NCT01796171|521885434|FG007|Treatment Period With Betalutin|Death|0|||
144734606|NCT01796171|521885435|FG008|Treatment Period With Betalutin|Death|0|||
144734607|NCT01796171|521885436|FG009|Treatment Period With Betalutin|Death|0|||
144734608|NCT01796171|521885437|FG010|Treatment Period With Betalutin|Death|2|||
144734609|NCT01796171|521885438|FG011|Treatment Period With Betalutin|Death|0|||
144734610|NCT01796171|521885439|FG012|Treatment Period With Betalutin|Death|0|||
144734611|NCT01796171|521885440|FG013|Treatment Period With Betalutin|Death|0|||
144734612|NCT01796171|521885441|FG014|Treatment Period With Betalutin|Death|0|||
144734613|NCT01796171|521885427|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
144734614|NCT01796171|521885428|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
144734615|NCT01796171|521885429|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
144734616|NCT01796171|521885430|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
144734617|NCT01796171|521885431|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
144734618|NCT01796171|521885432|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
144734619|NCT01796171|521885433|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
144734620|NCT01796171|521885434|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
144734621|NCT01796171|521885435|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
144734622|NCT01796171|521885436|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
144734623|NCT01796171|521885437|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
144734624|NCT01796171|521885438|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
144734625|NCT01796171|521885439|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
144734626|NCT01796171|521885440|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
144734627|NCT01796171|521885441|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
144734628|NCT01796171|521885427|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734629|NCT01796171|521885428|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734630|NCT01796171|521885429|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734631|NCT01796171|521885430|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734632|NCT01796171|521885431|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734633|NCT01796171|521885432|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734634|NCT01796171|521885433|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734635|NCT01796171|521885434|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734636|NCT01796171|521885435|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734637|NCT01796171|521885436|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734638|NCT01796171|521885437|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
144734639|NCT01796171|521885438|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
144734640|NCT01796171|521885439|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734641|NCT01796171|521885440|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144734642|NCT01796171|521885441|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
144217997|NCT01499095|519992218|FG000|Overall Study|Protocol Violation|6|||
144217998|NCT01499095|519992219|FG001|Overall Study|Protocol Violation|7|||
144671484|NCT00270998|521647758|FG000|3 Month Follow-up|Pessary did not fit|12|||
144671485|NCT00270998|521647759|FG001|3 Month Follow-up|Pessary did not fit|0|||
144671486|NCT00270998|521647760|FG002|3 Month Follow-up|Pessary did not fit|0|||
144734643|NCT01796171|521885427|FG000|Follow-up Period|Start of further anticancer therapy|4|||
144734644|NCT01796171|521885428|FG001|Follow-up Period|Start of further anticancer therapy|25|||
144734645|NCT01796171|521885429|FG002|Follow-up Period|Start of further anticancer therapy|2|||
144734646|NCT01796171|521885430|FG003|Follow-up Period|Start of further anticancer therapy|1|||
144734647|NCT01796171|521885431|FG004|Follow-up Period|Start of further anticancer therapy|2|||
144734648|NCT01796171|521885432|FG005|Follow-up Period|Start of further anticancer therapy|2|||
144734649|NCT01796171|521885433|FG006|Follow-up Period|Start of further anticancer therapy|1|||
144734650|NCT01796171|521885434|FG007|Follow-up Period|Start of further anticancer therapy|15|||
144734651|NCT01796171|521885435|FG008|Follow-up Period|Start of further anticancer therapy|2|||
144734652|NCT01796171|521885436|FG009|Follow-up Period|Start of further anticancer therapy|0|||
144734653|NCT01796171|521885437|FG010|Follow-up Period|Start of further anticancer therapy|0|||
144734654|NCT01796171|521885438|FG011|Follow-up Period|Start of further anticancer therapy|0|||
144734655|NCT01796171|521885439|FG012|Follow-up Period|Start of further anticancer therapy|0|||
144734656|NCT01796171|521885440|FG013|Follow-up Period|Start of further anticancer therapy|0|||
144734657|NCT01796171|521885441|FG014|Follow-up Period|Start of further anticancer therapy|0|||
144734658|NCT01796171|521885427|FG000|Follow-up Period|Progressive disease|0|||
144734659|NCT01796171|521885428|FG001|Follow-up Period|Progressive disease|1|||
144734660|NCT01796171|521885429|FG002|Follow-up Period|Progressive disease|0|||
144734661|NCT01796171|521885430|FG003|Follow-up Period|Progressive disease|0|||
144734662|NCT01796171|521885431|FG004|Follow-up Period|Progressive disease|0|||
144734663|NCT01796171|521885432|FG005|Follow-up Period|Progressive disease|0|||
144734664|NCT01796171|521885433|FG006|Follow-up Period|Progressive disease|0|||
144734665|NCT01796171|521885434|FG007|Follow-up Period|Progressive disease|3|||
144734666|NCT01796171|521885435|FG008|Follow-up Period|Progressive disease|0|||
144734667|NCT01796171|521885436|FG009|Follow-up Period|Progressive disease|0|||
144734668|NCT01796171|521885437|FG010|Follow-up Period|Progressive disease|0|||
144734669|NCT01796171|521885438|FG011|Follow-up Period|Progressive disease|0|||
144734670|NCT01796171|521885439|FG012|Follow-up Period|Progressive disease|0|||
144734671|NCT01796171|521885440|FG013|Follow-up Period|Progressive disease|0|||
144734672|NCT01796171|521885441|FG014|Follow-up Period|Progressive disease|0|||
144734673|NCT01796171|521885427|FG000|Follow-up Period|Physician Decision|0|||
144734674|NCT01796171|521885428|FG001|Follow-up Period|Physician Decision|2|||
144734675|NCT01796171|521885429|FG002|Follow-up Period|Physician Decision|0|||
144734676|NCT01796171|521885430|FG003|Follow-up Period|Physician Decision|0|||
144734677|NCT01796171|521885431|FG004|Follow-up Period|Physician Decision|0|||
144734678|NCT01796171|521885432|FG005|Follow-up Period|Physician Decision|0|||
144734679|NCT01796171|521885433|FG006|Follow-up Period|Physician Decision|0|||
144734680|NCT01796171|521885434|FG007|Follow-up Period|Physician Decision|0|||
144734681|NCT01796171|521885435|FG008|Follow-up Period|Physician Decision|0|||
144734682|NCT01796171|521885436|FG009|Follow-up Period|Physician Decision|0|||
144734683|NCT01796171|521885437|FG010|Follow-up Period|Physician Decision|5|||
144734684|NCT01796171|521885438|FG011|Follow-up Period|Physician Decision|0|||
144734685|NCT01796171|521885439|FG012|Follow-up Period|Physician Decision|0|||
144734686|NCT01796171|521885440|FG013|Follow-up Period|Physician Decision|0|||
144734687|NCT01796171|521885441|FG014|Follow-up Period|Physician Decision|0|||
144734688|NCT01796171|521885427|FG000|Follow-up Period|Withdrawal by Subject|0|||
144734689|NCT01796171|521885428|FG001|Follow-up Period|Withdrawal by Subject|1|||
144734690|NCT01796171|521885429|FG002|Follow-up Period|Withdrawal by Subject|0|||
144734691|NCT01796171|521885430|FG003|Follow-up Period|Withdrawal by Subject|0|||
144734692|NCT01796171|521885431|FG004|Follow-up Period|Withdrawal by Subject|0|||
144734693|NCT01796171|521885432|FG005|Follow-up Period|Withdrawal by Subject|1|||
144734694|NCT01796171|521885433|FG006|Follow-up Period|Withdrawal by Subject|0|||
144734695|NCT01796171|521885434|FG007|Follow-up Period|Withdrawal by Subject|0|||
144734696|NCT01796171|521885435|FG008|Follow-up Period|Withdrawal by Subject|0|||
144734697|NCT01796171|521885436|FG009|Follow-up Period|Withdrawal by Subject|0|||
144734698|NCT01796171|521885437|FG010|Follow-up Period|Withdrawal by Subject|3|||
144734699|NCT01796171|521885438|FG011|Follow-up Period|Withdrawal by Subject|1|||
144734700|NCT01796171|521885439|FG012|Follow-up Period|Withdrawal by Subject|0|||
144734701|NCT01796171|521885440|FG013|Follow-up Period|Withdrawal by Subject|0|||
144734702|NCT01796171|521885441|FG014|Follow-up Period|Withdrawal by Subject|0|||
144734703|NCT01796171|521885427|FG000|Follow-up Period|Death|0|||
144734704|NCT01796171|521885428|FG001|Follow-up Period|Death|0|||
144217999|NCT01499095|519992218|FG000|Overall Study|Received Rescue Therapy|32|||
144218000|NCT01499095|519992219|FG001|Overall Study|Received Rescue Therapy|40|||
144734705|NCT01796171|521885429|FG002|Follow-up Period|Death|0|||
144734706|NCT01796171|521885430|FG003|Follow-up Period|Death|0|||
144734707|NCT01796171|521885431|FG004|Follow-up Period|Death|0|||
144734708|NCT01796171|521885432|FG005|Follow-up Period|Death|0|||
144734709|NCT01796171|521885433|FG006|Follow-up Period|Death|1|||
144218001|NCT01499095|519992218|FG000|Overall Study|Diverse Reasons|22|||
144218002|NCT01499095|519992219|FG001|Overall Study|Diverse Reasons|25|||
144734710|NCT01796171|521885434|FG007|Follow-up Period|Death|0|||
144734711|NCT01796171|521885435|FG008|Follow-up Period|Death|0|||
144734712|NCT01796171|521885436|FG009|Follow-up Period|Death|0|||
144734713|NCT01796171|521885437|FG010|Follow-up Period|Death|17|||
144734714|NCT01796171|521885438|FG011|Follow-up Period|Death|9|||
144734715|NCT01796171|521885439|FG012|Follow-up Period|Death|1|||
144734716|NCT01796171|521885440|FG013|Follow-up Period|Death|0|||
144734717|NCT01796171|521885441|FG014|Follow-up Period|Death|0|||
144734718|NCT01796171|521885427|FG000|Follow-up Period|Patient transferred to other hospital|0|||
144734719|NCT01796171|521885428|FG001|Follow-up Period|Patient transferred to other hospital|1|||
144734720|NCT01796171|521885429|FG002|Follow-up Period|Patient transferred to other hospital|0|||
144734721|NCT01796171|521885430|FG003|Follow-up Period|Patient transferred to other hospital|0|||
144734722|NCT01796171|521885431|FG004|Follow-up Period|Patient transferred to other hospital|0|||
144734723|NCT01796171|521885432|FG005|Follow-up Period|Patient transferred to other hospital|0|||
144734724|NCT01796171|521885433|FG006|Follow-up Period|Patient transferred to other hospital|0|||
144734725|NCT01796171|521885434|FG007|Follow-up Period|Patient transferred to other hospital|0|||
144734726|NCT01796171|521885435|FG008|Follow-up Period|Patient transferred to other hospital|0|||
144734727|NCT01796171|521885436|FG009|Follow-up Period|Patient transferred to other hospital|0|||
144734728|NCT01796171|521885437|FG010|Follow-up Period|Patient transferred to other hospital|0|||
144734729|NCT01796171|521885438|FG011|Follow-up Period|Patient transferred to other hospital|0|||
144734730|NCT01796171|521885439|FG012|Follow-up Period|Patient transferred to other hospital|0|||
144734731|NCT01796171|521885440|FG013|Follow-up Period|Patient transferred to other hospital|0|||
144734732|NCT01796171|521885441|FG014|Follow-up Period|Patient transferred to other hospital|0|||
144734733|NCT01796171|521885427|FG000|Follow-up Period|Sponsor Decision|0|||
144734734|NCT01796171|521885428|FG001|Follow-up Period|Sponsor Decision|0|||
144671487|NCT00270998|521647758|FG000|3 Month Follow-up|Personal/family health|1|||
144671488|NCT00270998|521647759|FG001|3 Month Follow-up|Personal/family health|1|||
144671489|NCT00270998|521647760|FG002|3 Month Follow-up|Personal/family health|0|||
144671490|NCT00270998|521647758|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
144671491|NCT00270998|521647759|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
144671492|NCT00270998|521647760|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
144671493|NCT00270998|521647758|FG000|12 Month Follow-up|Lack of Efficacy|5|||
144671494|NCT00270998|521647759|FG001|12 Month Follow-up|Lack of Efficacy|4|||
144671495|NCT00270998|521647760|FG002|12 Month Follow-up|Lack of Efficacy|3|||
144671496|NCT00270998|521647758|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
144671497|NCT00270998|521647759|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
144671498|NCT00270998|521647760|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
144671499|NCT00270998|521647758|FG000|12 Month Follow-up|Pessary did not fit|1|||
144671500|NCT00270998|521647759|FG001|12 Month Follow-up|Pessary did not fit|0|||
144671501|NCT00270998|521647760|FG002|12 Month Follow-up|Pessary did not fit|0|||
144671502|NCT00270998|521647758|FG000|12 Month Follow-up|Personal/family health|0|||
144671503|NCT00270998|521647759|FG001|12 Month Follow-up|Personal/family health|5|||
144671504|NCT00270998|521647760|FG002|12 Month Follow-up|Personal/family health|1|||
144671505|NCT00270998|521647758|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
144671506|NCT00270998|521647759|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
144671507|NCT00270998|521647760|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
144671508|NCT00493467|521647761|FG000|Overall Study|Death|1|||
144671509|NCT03395223|521647762|FG000|Overall Study|Lost to Follow-up|3|||
144671510|NCT03395223|521647762|FG000|Overall Study|Other|1|||
144671511|NCT01074658|521647766|FG000|Overall Study|No implant attempted|19|||
144671512|NCT00432562|521647770|FG000|Overall Study|Death|3|||
144671513|NCT00432562|521647771|FG001|Overall Study|Death|0|||
144671514|NCT00425100|521647775|FG000|Overall Study|Adverse Event|36|||
144671515|NCT00425100|521647775|FG000|Overall Study|Lack of Efficacy|4|||
144671516|NCT00425100|521647775|FG000|Overall Study|Lost to Follow-up|2|||
144671517|NCT00425100|521647775|FG000|Overall Study|Protocol Violation|4|||
144671518|NCT00425100|521647775|FG000|Overall Study|Withdrawal by Subject|7|||
144671519|NCT05425719|521647782|FG000|Overall Study|Lost to Follow-up|4|||
144671520|NCT05425719|521647783|FG001|Overall Study|Lost to Follow-up|0|||
144671521|NCT05425719|521647782|FG000|Overall Study|Withdrew consent|1|||
144671522|NCT05425719|521647783|FG001|Overall Study|Withdrew consent|1|||
144671523|NCT00555906|521647784|FG000|Phase 1|Objective Progression or Relapse|3|||
144671524|NCT00555906|521647785|FG001|Phase 1|Objective Progression or Relapse|5|||
144671525|NCT00555906|521647786|FG002|Phase 1|Objective Progression or Relapse|3|||
144671526|NCT00555906|521647787|FG003|Phase 1|Objective Progression or Relapse|1|||
144671527|NCT00555906|521647788|FG004|Phase 1|Objective Progression or Relapse|0|||
144671528|NCT00555906|521647784|FG000|Phase 1|Global Deterioration of Health Status|0|||
144671529|NCT00555906|521647785|FG001|Phase 1|Global Deterioration of Health Status|1|||
144671530|NCT00555906|521647786|FG002|Phase 1|Global Deterioration of Health Status|1|||
144671531|NCT00555906|521647787|FG003|Phase 1|Global Deterioration of Health Status|1|||
144671532|NCT00555906|521647788|FG004|Phase 1|Global Deterioration of Health Status|0|||
144671533|NCT00555906|521647784|FG000|Phase 1|Adverse Event|0|||
144671534|NCT00555906|521647785|FG001|Phase 1|Adverse Event|0|||
144671535|NCT00555906|521647786|FG002|Phase 1|Adverse Event|3|||
144671536|NCT00555906|521647787|FG003|Phase 1|Adverse Event|2|||
144671537|NCT00555906|521647788|FG004|Phase 1|Adverse Event|0|||
144671538|NCT00555906|521647784|FG000|Phase 1|Withdrawal by Subject|0|||
144671539|NCT00555906|521647785|FG001|Phase 1|Withdrawal by Subject|0|||
144671540|NCT00555906|521647786|FG002|Phase 1|Withdrawal by Subject|0|||
144671541|NCT00555906|521647787|FG003|Phase 1|Withdrawal by Subject|1|||
144734735|NCT01796171|521885429|FG002|Follow-up Period|Sponsor Decision|0|||
144734736|NCT01796171|521885430|FG003|Follow-up Period|Sponsor Decision|0|||
144734737|NCT01796171|521885431|FG004|Follow-up Period|Sponsor Decision|0|||
144734738|NCT01796171|521885432|FG005|Follow-up Period|Sponsor Decision|0|||
144734739|NCT01796171|521885433|FG006|Follow-up Period|Sponsor Decision|0|||
144734740|NCT01796171|521885434|FG007|Follow-up Period|Sponsor Decision|0|||
144734741|NCT01796171|521885435|FG008|Follow-up Period|Sponsor Decision|0|||
144734742|NCT01796171|521885436|FG009|Follow-up Period|Sponsor Decision|0|||
144734743|NCT01796171|521885437|FG010|Follow-up Period|Sponsor Decision|40|||
144734744|NCT01796171|521885438|FG011|Follow-up Period|Sponsor Decision|15|||
144734745|NCT01796171|521885439|FG012|Follow-up Period|Sponsor Decision|7|||
144734746|NCT01796171|521885440|FG013|Follow-up Period|Sponsor Decision|0|||
144734747|NCT01796171|521885441|FG014|Follow-up Period|Sponsor Decision|0|||
144734748|NCT00418561|521885442|FG000|Overall Study|Participant's (guardian's) decision|0|||
144734749|NCT00418561|521885443|FG001|Overall Study|Participant's (guardian's) decision|1|||
144734750|NCT00418561|521885444|FG002|Overall Study|Participant's (guardian's) decision|0|||
144734751|NCT00829309|521885445|FG000|Washout: 7 Days|Protocol Violation|1|||
144734752|NCT00829309|521885446|FG001|Washout: 7 Days|Protocol Violation|0|||
144734753|NCT01705574|521885447|FG000|Double-Blind Phase|Lost to Follow-up|12|||
144734754|NCT01705574|521885448|FG001|Double-Blind Phase|Lost to Follow-up|16|||
144734755|NCT01705574|521885449|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144734756|NCT01705574|521885450|FG003|Double-Blind Phase|Lost to Follow-up|0|||
144734757|NCT01705574|521885447|FG000|Double-Blind Phase|Adverse Event|3|||
144734758|NCT01705574|521885448|FG001|Double-Blind Phase|Adverse Event|10|||
144734759|NCT01705574|521885449|FG002|Double-Blind Phase|Adverse Event|0|||
144734760|NCT01705574|521885450|FG003|Double-Blind Phase|Adverse Event|0|||
144734761|NCT01705574|521885447|FG000|Double-Blind Phase|Withdrew Consent|8|||
144734762|NCT01705574|521885448|FG001|Double-Blind Phase|Withdrew Consent|5|||
144734763|NCT01705574|521885449|FG002|Double-Blind Phase|Withdrew Consent|0|||
144671542|NCT00555906|521647788|FG004|Phase 1|Withdrawal by Subject|0|||
144671543|NCT00555906|521647784|FG000|Phase 2|Adverse Event|0|||
144671544|NCT00555906|521647785|FG001|Phase 2|Adverse Event|0|||
144671545|NCT00555906|521647786|FG002|Phase 2|Adverse Event|0|||
144671546|NCT00555906|521647787|FG003|Phase 2|Adverse Event|0|||
144671547|NCT00555906|521647788|FG004|Phase 2|Adverse Event|4|||
144671548|NCT00555906|521647784|FG000|Phase 2|Global Deterioration of Health Status|0|||
144671549|NCT00555906|521647785|FG001|Phase 2|Global Deterioration of Health Status|0|||
144671550|NCT00555906|521647786|FG002|Phase 2|Global Deterioration of Health Status|0|||
144671551|NCT00555906|521647787|FG003|Phase 2|Global Deterioration of Health Status|0|||
144734764|NCT01705574|521885450|FG003|Double-Blind Phase|Withdrew Consent|0|||
144734765|NCT01705574|521885447|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
144734766|NCT01705574|521885448|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
144734767|NCT01705574|521885449|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
144734768|NCT01705574|521885450|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
144734769|NCT01705574|521885447|FG000|Double-Blind Phase|Pregnancy|1|||
144734770|NCT01705574|521885448|FG001|Double-Blind Phase|Pregnancy|1|||
144734771|NCT01705574|521885449|FG002|Double-Blind Phase|Pregnancy|0|||
144734772|NCT01705574|521885450|FG003|Double-Blind Phase|Pregnancy|0|||
144734773|NCT01705574|521885447|FG000|Double-Blind Phase|Protocol Violation|1|||
144734774|NCT01705574|521885448|FG001|Double-Blind Phase|Protocol Violation|0|||
144734775|NCT01705574|521885449|FG002|Double-Blind Phase|Protocol Violation|0|||
144734776|NCT01705574|521885450|FG003|Double-Blind Phase|Protocol Violation|0|||
144734777|NCT01705574|521885447|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
144734778|NCT01705574|521885448|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
144734779|NCT01705574|521885449|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
144734780|NCT01705574|521885450|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
144734781|NCT01705574|521885447|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
144734782|NCT01705574|521885448|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
144734783|NCT01705574|521885449|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
144734784|NCT01705574|521885450|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
144734785|NCT01705574|521885447|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
144734786|NCT01705574|521885448|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
144734787|NCT01705574|521885449|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
144734788|NCT01705574|521885450|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
144734789|NCT01705574|521885447|FG000|Open-Label Extension Phase|Adverse Event|3|||
144734790|NCT01705574|521885448|FG001|Open-Label Extension Phase|Adverse Event|0|||
144734791|NCT01705574|521885449|FG002|Open-Label Extension Phase|Adverse Event|0|||
144734792|NCT01705574|521885450|FG003|Open-Label Extension Phase|Adverse Event|1|||
144734793|NCT01705574|521885447|FG000|Open-Label Extension Phase|Death|2|||
144734794|NCT01705574|521885448|FG001|Open-Label Extension Phase|Death|0|||
144734795|NCT01705574|521885449|FG002|Open-Label Extension Phase|Death|1|||
144734796|NCT01705574|521885450|FG003|Open-Label Extension Phase|Death|0|||
144734797|NCT01705574|521885447|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
144734798|NCT01705574|521885448|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
144671552|NCT00555906|521647788|FG004|Phase 2|Global Deterioration of Health Status|2|||
144671553|NCT00555906|521647784|FG000|Phase 2|Objective Progression or Relapse|0|||
144671554|NCT00555906|521647785|FG001|Phase 2|Objective Progression or Relapse|0|||
144671555|NCT00555906|521647786|FG002|Phase 2|Objective Progression or Relapse|0|||
144671556|NCT00555906|521647787|FG003|Phase 2|Objective Progression or Relapse|0|||
144671557|NCT00555906|521647788|FG004|Phase 2|Objective Progression or Relapse|16|||
144671558|NCT00555906|521647784|FG000|Phase 2|Withdrawal by Subject|0|||
144671559|NCT00555906|521647785|FG001|Phase 2|Withdrawal by Subject|0|||
144671560|NCT00555906|521647786|FG002|Phase 2|Withdrawal by Subject|0|||
144671561|NCT00555906|521647787|FG003|Phase 2|Withdrawal by Subject|0|||
144671562|NCT00555906|521647788|FG004|Phase 2|Withdrawal by Subject|2|||
144671563|NCT00555906|521647784|FG000|Phase 2|Other|0|||
144671564|NCT00555906|521647785|FG001|Phase 2|Other|0|||
144671565|NCT00555906|521647786|FG002|Phase 2|Other|0|||
144671566|NCT00555906|521647787|FG003|Phase 2|Other|0|||
144671567|NCT00555906|521647788|FG004|Phase 2|Other|6|||
144734799|NCT01705574|521885449|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
144734800|NCT01705574|521885450|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
144734801|NCT01705574|521885447|FG000|Open-Label Extension Phase|Physician Decision|0|||
144734802|NCT01705574|521885448|FG001|Open-Label Extension Phase|Physician Decision|0|||
144734803|NCT01705574|521885449|FG002|Open-Label Extension Phase|Physician Decision|2|||
144734804|NCT01705574|521885450|FG003|Open-Label Extension Phase|Physician Decision|0|||
144734805|NCT01705574|521885447|FG000|Open-Label Extension Phase|Pregnancy|0|||
144734806|NCT01705574|521885448|FG001|Open-Label Extension Phase|Pregnancy|0|||
144734807|NCT01705574|521885449|FG002|Open-Label Extension Phase|Pregnancy|1|||
144734808|NCT01705574|521885450|FG003|Open-Label Extension Phase|Pregnancy|1|||
144734809|NCT00777023|521885451|FG000|Overall Study|Adverse Event|15|||
144734810|NCT00777023|521885452|FG001|Overall Study|Adverse Event|21|||
144734811|NCT00777023|521885453|FG002|Overall Study|Adverse Event|8|||
144734812|NCT00777023|521885451|FG000|Overall Study|Lack of Efficacy|1|||
144734813|NCT00777023|521885452|FG001|Overall Study|Lack of Efficacy|0|||
144734814|NCT00777023|521885453|FG002|Overall Study|Lack of Efficacy|14|||
144734815|NCT00777023|521885451|FG000|Overall Study|Protocol Violation|2|||
144734816|NCT00777023|521885452|FG001|Overall Study|Protocol Violation|1|||
144734817|NCT00777023|521885453|FG002|Overall Study|Protocol Violation|1|||
144734818|NCT00777023|521885451|FG000|Overall Study|Lost to Follow-up|2|||
144734819|NCT00777023|521885452|FG001|Overall Study|Lost to Follow-up|3|||
144734820|NCT00777023|521885453|FG002|Overall Study|Lost to Follow-up|3|||
144734821|NCT00777023|521885451|FG000|Overall Study|Death|0|||
144734822|NCT00777023|521885452|FG001|Overall Study|Death|1|||
144734823|NCT00777023|521885453|FG002|Overall Study|Death|0|||
144734824|NCT00777023|521885451|FG000|Overall Study|Withdrawal by Subject|7|||
144734825|NCT00777023|521885452|FG001|Overall Study|Withdrawal by Subject|7|||
144734826|NCT00777023|521885453|FG002|Overall Study|Withdrawal by Subject|8|||
144734827|NCT00777023|521885451|FG000|Overall Study|Missing data|1|||
144734828|NCT00777023|521885452|FG001|Overall Study|Missing data|1|||
144734829|NCT00777023|521885453|FG002|Overall Study|Missing data|0|||
144734830|NCT00777023|521885451|FG000|Overall Study|Reasons not specified|4|||
144734831|NCT00777023|521885452|FG001|Overall Study|Reasons not specified|4|||
144734832|NCT00777023|521885453|FG002|Overall Study|Reasons not specified|2|||
144734833|NCT00777023|521885451|FG000|Overall Study|Last dose date unknown|3|||
144734834|NCT00777023|521885452|FG001|Overall Study|Last dose date unknown|3|||
144734835|NCT00777023|521885453|FG002|Overall Study|Last dose date unknown|1|||
144734836|NCT02678286|521885456|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
144734837|NCT02678286|521885457|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
144734838|NCT02678286|521885456|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
144734839|NCT02678286|521885457|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
144734840|NCT02678286|521885456|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
144734841|NCT02678286|521885457|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
144734842|NCT02678286|521885456|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
144734843|NCT02678286|521885457|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
144734844|NCT02678286|521885456|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
144734845|NCT02678286|521885457|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
144734846|NCT01273805|521885458|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
144734847|NCT01273805|521885459|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
144734848|NCT03620747|521885460|FG000|Overall Study|Participant decision|7|||
144734849|NCT03620747|521885460|FG000|Overall Study|Adverse Event|6|||
144734850|NCT03620747|521885460|FG000|Overall Study|Lack of Efficacy|1|||
144734851|NCT03620747|521885460|FG000|Overall Study|Poor compliance to protocol|2|||
144734852|NCT03620747|521885460|FG000|Overall Study|Other-unspecified|3|||
144734853|NCT01513174|521885464|FG000|Overall Study|Inclusion Error|1|||
144734854|NCT01513174|521885465|FG001|Overall Study|Inclusion Error|7|||
144734855|NCT01513174|521885464|FG000|Overall Study|Not receive study treatment|3|||
144734856|NCT01513174|521885465|FG001|Overall Study|Not receive study treatment|1|||
144734857|NCT00635492|521885466|FG000|Overall Study|Death|12|||
144734858|NCT00635492|521885467|FG001|Overall Study|Death|40|||
144734859|NCT00635492|521885466|FG000|Overall Study|Lost to Follow-up|151|||
144671568|NCT00555906|521647784|FG000|Phase 2|Randomized but not Treated|0|||
144671569|NCT00555906|521647785|FG001|Phase 2|Randomized but not Treated|0|||
144671570|NCT00555906|521647786|FG002|Phase 2|Randomized but not Treated|0|||
144671571|NCT00555906|521647787|FG003|Phase 2|Randomized but not Treated|0|||
144671572|NCT00555906|521647788|FG004|Phase 2|Randomized but not Treated|2|||
144671573|NCT02193828|521647789|FG000|Overall Study|Withdrawal by Subject|0|||
144671574|NCT02193828|521647790|FG001|Overall Study|Withdrawal by Subject|0|||
144671575|NCT02193828|521647791|FG002|Overall Study|Withdrawal by Subject|1|||
144671576|NCT02193828|521647792|FG003|Overall Study|Withdrawal by Subject|1|||
144671577|NCT03219567|521647793|FG000|Overall Study|Withdrawal by Subject|0|||
144671578|NCT03219567|521647794|FG001|Overall Study|Withdrawal by Subject|1|||
144671579|NCT00889681|521647795|FG000|Overall Study|Not meeting qualification Criteria|2|||
144671580|NCT00889681|521647795|FG000|Overall Study|Insurance disapproval|1|||
144671581|NCT01313208|521647796|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
144671582|NCT01313208|521647797|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
144671583|NCT01313208|521647796|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
144671584|NCT01313208|521647797|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
144671585|NCT01313208|521647796|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
144671586|NCT01313208|521647797|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
144671587|NCT01313208|521647796|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
144671588|NCT01313208|521647797|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
144671589|NCT01313208|521647796|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
144671590|NCT01313208|521647797|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
144671591|NCT01313208|521647796|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
144671592|NCT01313208|521647797|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
144671593|NCT01313208|521647796|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
144671594|NCT01313208|521647797|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
144671595|NCT01313208|521647796|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
144671596|NCT01313208|521647797|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
144671597|NCT01313208|521647796|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
144671598|NCT01313208|521647797|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
144671599|NCT01957787|521647798|FG000|Overall Study|Death|18|||
144671600|NCT01957787|521647798|FG000|Overall Study|Lost to Follow-up|3|||
144671601|NCT01957787|521647798|FG000|Overall Study|Withdrawal by Subject|3|||
144671602|NCT01957787|521647798|FG000|Overall Study|Entered Hospice or Similar Program|2|||
144671603|NCT01957787|521647798|FG000|Overall Study|Index Tumor(s) Resected|2|||
144671604|NCT01957787|521647798|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
144671605|NCT01957787|521647798|FG000|Overall Study|Local therapy, not cryoablation|6|||
144671606|NCT05109702|521647799|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
144671607|NCT05109702|521647800|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
144671608|NCT05109702|521647801|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
144671609|NCT05109702|521647799|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
144671610|NCT05109702|521647800|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
144671611|NCT05109702|521647801|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
144671612|NCT05109702|521647799|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
144671613|NCT05109702|521647800|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
144671614|NCT05109702|521647801|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
144671615|NCT05109702|521647799|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
144671616|NCT05109702|521647800|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
144671617|NCT05109702|521647801|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
144671618|NCT05109702|521647799|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
144671619|NCT05109702|521647800|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
144671620|NCT05109702|521647801|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
144671621|NCT01392378|521647802|FG000|Infant Series|Adverse Event|0|||
144671622|NCT01392378|521647803|FG001|Infant Series|Adverse Event|0|||
144671623|NCT01392378|521647804|FG002|Infant Series|Adverse Event|0|||
144671624|NCT01392378|521647805|FG003|Infant Series|Adverse Event|1|||
144671625|NCT01392378|521647806|FG004|Infant Series|Adverse Event|0|||
144671626|NCT01392378|521647802|FG000|Infant Series|Lost to Follow-up|0|||
144671627|NCT01392378|521647803|FG001|Infant Series|Lost to Follow-up|0|||
144671628|NCT01392378|521647804|FG002|Infant Series|Lost to Follow-up|0|||
144671629|NCT01392378|521647805|FG003|Infant Series|Lost to Follow-up|1|||
144671630|NCT01392378|521647806|FG004|Infant Series|Lost to Follow-up|0|||
144671631|NCT01392378|521647802|FG000|Infant Series|Protocol Violation|0|||
144671632|NCT01392378|521647803|FG001|Infant Series|Protocol Violation|1|||
144734860|NCT00635492|521885467|FG001|Overall Study|Lost to Follow-up|172|||
144671633|NCT01392378|521647804|FG002|Infant Series|Protocol Violation|0|||
144671634|NCT01392378|521647805|FG003|Infant Series|Protocol Violation|0|||
144218003|NCT01499095|519992218|FG000|Overall Study|Lost to Follow-up|6|||
144671635|NCT01392378|521647806|FG004|Infant Series|Protocol Violation|0|||
144671636|NCT01392378|521647802|FG000|Infant Series|Withdrawal by Parent|4|||
144671637|NCT01392378|521647803|FG001|Infant Series|Withdrawal by Parent|1|||
144671638|NCT01392378|521647804|FG002|Infant Series|Withdrawal by Parent|0|||
144671639|NCT01392378|521647805|FG003|Infant Series|Withdrawal by Parent|0|||
144734861|NCT00635492|521885466|FG000|Overall Study|Physician Decision|32|||
144218004|NCT01499095|519992219|FG001|Overall Study|Lost to Follow-up|4|||
144218005|NCT01499095|519992218|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
144671640|NCT01392378|521647806|FG004|Infant Series|Withdrawal by Parent|0|||
144671641|NCT01392378|521647802|FG000|After Infant Series|Lost to Follow-up|0|||
144671642|NCT01392378|521647803|FG001|After Infant Series|Lost to Follow-up|0|||
144671643|NCT01392378|521647804|FG002|After Infant Series|Lost to Follow-up|1|||
144671644|NCT01392378|521647805|FG003|After Infant Series|Lost to Follow-up|0|||
144671645|NCT01392378|521647806|FG004|After Infant Series|Lost to Follow-up|0|||
144671646|NCT01392378|521647802|FG000|After Infant Series|Withdrawal by Parent|0|||
144671647|NCT01392378|521647803|FG001|After Infant Series|Withdrawal by Parent|1|||
144671648|NCT01392378|521647804|FG002|After Infant Series|Withdrawal by Parent|1|||
144671649|NCT01392378|521647805|FG003|After Infant Series|Withdrawal by Parent|0|||
144671650|NCT01392378|521647806|FG004|After Infant Series|Withdrawal by Parent|1|||
144671651|NCT01392378|521647802|FG000|Toddler Dose|Lost to Follow-up|0|||
144671652|NCT01392378|521647803|FG001|Toddler Dose|Lost to Follow-up|0|||
144671653|NCT01392378|521647804|FG002|Toddler Dose|Lost to Follow-up|0|||
144671654|NCT01392378|521647805|FG003|Toddler Dose|Lost to Follow-up|1|||
144671655|NCT01392378|521647806|FG004|Toddler Dose|Lost to Follow-up|0|||
144671656|NCT01392378|521647802|FG000|Toddler Dose|Withdrawal by Parent|0|||
144671657|NCT01392378|521647803|FG001|Toddler Dose|Withdrawal by Parent|1|||
144671658|NCT01392378|521647804|FG002|Toddler Dose|Withdrawal by Parent|0|||
144671659|NCT01392378|521647805|FG003|Toddler Dose|Withdrawal by Parent|1|||
144671660|NCT01392378|521647806|FG004|Toddler Dose|Withdrawal by Parent|1|||
144671661|NCT00788697|521647809|FG000|Overall Study|No study drug administered|12|||
144671662|NCT00788697|521647809|FG000|Overall Study|Training Patients|74|||
144671663|NCT00788697|521647809|FG000|Overall Study|no truth standard procedure available|5|||
144671664|NCT00788697|521647809|FG000|Overall Study|Technically inadequate truth standard|1|||
144671665|NCT00788697|521647809|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
144671666|NCT01998880|521647813|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
144671667|NCT01998880|521647814|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
144671668|NCT01998880|521647813|FG000|Overall Study|Disease Progression|1|||
144671669|NCT01998880|521647814|FG001|Overall Study|Disease Progression|8|||
144671670|NCT01998880|521647813|FG000|Overall Study|Withdrew Consent|2|||
144671671|NCT01998880|521647814|FG001|Overall Study|Withdrew Consent|1|||
144671672|NCT01998880|521647813|FG000|Overall Study|Death|3|||
144671673|NCT01998880|521647814|FG001|Overall Study|Death|6|||
144671674|NCT01998880|521647813|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144671675|NCT01998880|521647814|FG001|Overall Study|Insufficient Therapeutic Response|5|||
144671676|NCT01998880|521647813|FG000|Overall Study|Administrative/Other|1|||
144671677|NCT01998880|521647814|FG001|Overall Study|Administrative/Other|1|||
144671678|NCT01998880|521647813|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
144671679|NCT01998880|521647814|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
144671680|NCT01998880|521647813|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
144671681|NCT01998880|521647814|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
144671682|NCT01998880|521647813|FG000|Overall Study|Did Not Receive Treatment|3|||
144671683|NCT01998880|521647814|FG001|Overall Study|Did Not Receive Treatment|2|||
144671684|NCT00004732|521647815|FG000|Overall Study|Withdrawal by Subject|36|||
144671685|NCT00004732|521647816|FG001|Overall Study|Withdrawal by Subject|64|||
144671686|NCT00004732|521647815|FG000|Overall Study|Lost to Follow-up|33|||
144671687|NCT00004732|521647816|FG001|Overall Study|Lost to Follow-up|47|||
144671688|NCT01688635|521647817|FG000|Washout 1|Withdrawal by Subject|1|||
144671689|NCT01688635|521647818|FG001|Washout 1|Withdrawal by Subject|0|||
144671690|NCT01688635|521647817|FG000|Washout 1|Adverse Event|0|||
144671691|NCT01688635|521647818|FG001|Washout 1|Adverse Event|1|||
144671692|NCT01688635|521647817|FG000|Washout 1|Physician Decision|0|||
144671693|NCT01688635|521647818|FG001|Washout 1|Physician Decision|1|||
144671694|NCT01688635|521647817|FG000|Washout 2|Physician Decision|1|||
144671695|NCT01688635|521647818|FG001|Washout 2|Physician Decision|0|||
144671696|NCT01688635|521647817|FG000|Washout 2|Withdrawal by Subject|1|||
144671697|NCT01688635|521647818|FG001|Washout 2|Withdrawal by Subject|0|||
144671698|NCT01688635|521647817|FG000|Washout 2|Sponsor Decision|1|||
144671699|NCT01688635|521647818|FG001|Washout 2|Sponsor Decision|2|||
144671700|NCT01688635|521647817|FG000|Washout 3|Withdrawal by Subject|1|||
144671701|NCT01688635|521647818|FG001|Washout 3|Withdrawal by Subject|0|||
144218006|NCT01499095|519992219|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
144218007|NCT01499095|519992218|FG000|Overall Study|Hypoglycemia|3|||
144218008|NCT01499095|519992219|FG001|Overall Study|Hypoglycemia|1|||
144671702|NCT02713789|521647819|FG000|Overall Study|Lost to Follow-up|0|||
144671703|NCT02713789|521647820|FG001|Overall Study|Lost to Follow-up|1|||
144671704|NCT02713789|521647821|FG002|Overall Study|Lost to Follow-up|1|||
144671705|NCT01742091|521649267|FG000|Overall Study|Adverse Event|0|||
144671706|NCT01742091|521649268|FG001|Overall Study|Adverse Event|0|||
144671707|NCT01742091|521649269|FG002|Overall Study|Adverse Event|0|||
144671708|NCT01742091|521649270|FG003|Overall Study|Adverse Event|0|||
144671709|NCT01742091|521649271|FG004|Overall Study|Adverse Event|1|||
144671710|NCT01742091|521649272|FG005|Overall Study|Adverse Event|0|||
144671711|NCT01742091|521649267|FG000|Overall Study|Physician Decision|0|||
144734862|NCT00635492|521885467|FG001|Overall Study|Physician Decision|22|||
144734863|NCT00635492|521885466|FG000|Overall Study|Sponsor decision|2|||
144734864|NCT00635492|521885467|FG001|Overall Study|Sponsor decision|3|||
144734865|NCT00635492|521885466|FG000|Overall Study|Withdrawal by Subject|82|||
144734866|NCT00635492|521885467|FG001|Overall Study|Withdrawal by Subject|45|||
144734867|NCT01900626|521885468|FG000|Overall Study|study was closed due to low enrollment|1|||
144734868|NCT01900626|521885469|FG001|Overall Study|study was closed due to low enrollment|1|||
144734869|NCT00467363|521885475|FG000|Overall Study|Lost to Follow-up|80|||
144734870|NCT00467363|521885476|FG001|Overall Study|Lost to Follow-up|70|||
144734871|NCT04533594|521885477|FG000|Overall Study|Death|26|||
144734872|NCT03925532|521885478|FG000|Overall Study|Lost to Follow-up|1|||
144734873|NCT02689505|521885479|FG000|Overall Study|Progressive disease|2|||
144734874|NCT02689505|521885480|FG001|Overall Study|Progressive disease|2|||
144734875|NCT02689505|521885481|FG002|Overall Study|Progressive disease|3|||
144734876|NCT02689505|521885482|FG003|Overall Study|Progressive disease|9|||
144734877|NCT02689505|521885483|FG004|Overall Study|Progressive disease|1|||
144734878|NCT02689505|521885479|FG000|Overall Study|Dose Limiting Toxicity|0|||
144734879|NCT02689505|521885480|FG001|Overall Study|Dose Limiting Toxicity|1|||
144734880|NCT02689505|521885481|FG002|Overall Study|Dose Limiting Toxicity|0|||
144734881|NCT02689505|521885482|FG003|Overall Study|Dose Limiting Toxicity|0|||
144734882|NCT02689505|521885483|FG004|Overall Study|Dose Limiting Toxicity|2|||
144734883|NCT02689505|521885479|FG000|Overall Study|Other AE or clinical progression|0|||
144734884|NCT02689505|521885480|FG001|Overall Study|Other AE or clinical progression|2|||
144734885|NCT02689505|521885481|FG002|Overall Study|Other AE or clinical progression|0|||
144734886|NCT02689505|521885482|FG003|Overall Study|Other AE or clinical progression|2|||
144734887|NCT02689505|521885483|FG004|Overall Study|Other AE or clinical progression|0|||
144734888|NCT04405570|521885487|FG000|Overall Study|Adverse Event|0|||
144734889|NCT04405570|521885488|FG001|Overall Study|Adverse Event|1|||
144734890|NCT04405570|521885489|FG002|Overall Study|Adverse Event|1|||
144734891|NCT04405570|521885490|FG003|Overall Study|Adverse Event|1|||
144734892|NCT04405570|521885487|FG000|Overall Study|Lost to Follow-up|0|||
144734893|NCT04405570|521885488|FG001|Overall Study|Lost to Follow-up|1|||
144734894|NCT04405570|521885489|FG002|Overall Study|Lost to Follow-up|0|||
144734895|NCT04405570|521885490|FG003|Overall Study|Lost to Follow-up|0|||
144734896|NCT04405570|521885487|FG000|Overall Study|Physician Decision|0|||
144734897|NCT04405570|521885488|FG001|Overall Study|Physician Decision|0|||
144734898|NCT04405570|521885489|FG002|Overall Study|Physician Decision|1|||
144734899|NCT04405570|521885490|FG003|Overall Study|Physician Decision|0|||
144734900|NCT04405570|521885487|FG000|Overall Study|Withdrawal by Subject|0|||
144734901|NCT04405570|521885488|FG001|Overall Study|Withdrawal by Subject|1|||
144734902|NCT04405570|521885489|FG002|Overall Study|Withdrawal by Subject|1|||
144734903|NCT04405570|521885490|FG003|Overall Study|Withdrawal by Subject|0|||
144734904|NCT04405570|521885487|FG000|Overall Study|Randomized not dosed|0|||
144734905|NCT04405570|521885488|FG001|Overall Study|Randomized not dosed|2|||
144734906|NCT04405570|521885489|FG002|Overall Study|Randomized not dosed|0|||
144734907|NCT04405570|521885490|FG003|Overall Study|Randomized not dosed|0|||
144734908|NCT00723710|521885491|FG000|Overall Study|Disease progression|48|||
144734909|NCT00723710|521885491|FG000|Overall Study|Adverse Event|88|||
144734910|NCT00723710|521885491|FG000|Overall Study|Withdrawal by Subject|36|||
144734911|NCT00723710|521885491|FG000|Overall Study|Physician Decision|2|||
144734912|NCT02335658|521885499|FG000|Overall Study|Adverse Event|18|||
144734913|NCT02335658|521885500|FG001|Overall Study|Adverse Event|12|||
144734914|NCT02335658|521885499|FG000|Overall Study|Lack of Efficacy|4|||
144734915|NCT02335658|521885500|FG001|Overall Study|Lack of Efficacy|5|||
144734916|NCT02335658|521885499|FG000|Overall Study|Pregnancy|1|||
144734917|NCT02335658|521885500|FG001|Overall Study|Pregnancy|0|||
144734918|NCT02335658|521885499|FG000|Overall Study|Withdrawal by Subject|13|||
144734919|NCT02335658|521885500|FG001|Overall Study|Withdrawal by Subject|21|||
144734920|NCT02335658|521885499|FG000|Overall Study|non-compliance|2|||
144734921|NCT02335658|521885500|FG001|Overall Study|non-compliance|3|||
144734922|NCT02335658|521885499|FG000|Overall Study|other reason|2|||
144734923|NCT02335658|521885500|FG001|Overall Study|other reason|3|||
144734924|NCT01424644|521885501|FG000|Overall Study|Adverse Event|2|||
144734925|NCT01424644|521885502|FG001|Overall Study|Adverse Event|0|||
144734926|NCT01424644|521885501|FG000|Overall Study|Withdrawal by Subject|9|||
144734927|NCT01424644|521885502|FG001|Overall Study|Withdrawal by Subject|12|||
144734928|NCT01424644|521885501|FG000|Overall Study|Lost to Follow-up|16|||
144734929|NCT01424644|521885502|FG001|Overall Study|Lost to Follow-up|12|||
144734930|NCT01424644|521885501|FG000|Overall Study|Protocol Violation|4|||
144734931|NCT01424644|521885502|FG001|Overall Study|Protocol Violation|3|||
144734932|NCT01424644|521885501|FG000|Overall Study|Administrative Reason|1|||
144734933|NCT01424644|521885502|FG001|Overall Study|Administrative Reason|0|||
144734934|NCT01424644|521885501|FG000|Overall Study|Unable to Classify|1|||
144734935|NCT01424644|521885502|FG001|Overall Study|Unable to Classify|0|||
144734936|NCT05593965|521885503|FG000|1st Intervention (1 Day)|Technical error|1|||
144734937|NCT05593965|521885504|FG001|1st Intervention (1 Day)|Technical error|0|||
144734938|NCT03616106|521885507|FG000|Overall Study|Removed by PI|6|||
144734939|NCT03616106|521885508|FG001|Overall Study|Removed by PI|0|||
144734940|NCT03616106|521885507|FG000|Overall Study|Withdrawal by Subject|1|||
144734941|NCT03616106|521885508|FG001|Overall Study|Withdrawal by Subject|1|||
144734942|NCT03616106|521885507|FG000|Overall Study|Lost to Follow-up|7|||
144734943|NCT03616106|521885508|FG001|Overall Study|Lost to Follow-up|0|||
144734944|NCT01880593|521885509|FG000|Overall Study|Adverse Event|1|||
144734945|NCT01880593|521885510|FG001|Overall Study|Adverse Event|0|||
144734946|NCT01880593|521885509|FG000|Overall Study|Lack of Efficacy|1|||
144734947|NCT01880593|521885510|FG001|Overall Study|Lack of Efficacy|5|||
144734948|NCT01880593|521885509|FG000|Overall Study|Withdrawal by Subject|6|||
144734949|NCT01880593|521885510|FG001|Overall Study|Withdrawal by Subject|1|||
144734950|NCT02066922|521885513|FG000|Overall Study|Adverse Event|1|||
144734951|NCT00440297|521885515|FG000|Overall Study|Adverse Event|8|||
144734952|NCT00440297|521885516|FG001|Overall Study|Adverse Event|5|||
144734953|NCT00440297|521885515|FG000|Overall Study|Lost to Follow-up|1|||
144734954|NCT00440297|521885516|FG001|Overall Study|Lost to Follow-up|0|||
144734955|NCT00440297|521885515|FG000|Overall Study|Physician Decision|1|||
144734956|NCT00440297|521885516|FG001|Overall Study|Physician Decision|0|||
144734957|NCT00440297|521885515|FG000|Overall Study|Protocol Violation|11|||
144734958|NCT00440297|521885516|FG001|Overall Study|Protocol Violation|7|||
144734959|NCT00440297|521885515|FG000|Overall Study|Withdrawal by Subject|1|||
144734960|NCT00440297|521885516|FG001|Overall Study|Withdrawal by Subject|6|||
144734961|NCT00440297|521885515|FG000|Overall Study|Randomized by mistake|1|||
144734962|NCT00440297|521885516|FG001|Overall Study|Randomized by mistake|0|||
144734963|NCT02445339|521885517|FG000|Overall Study|Physician Decision|1|||
144734964|NCT02445339|521885518|FG001|Overall Study|Physician Decision|0|||
144734965|NCT02445339|521885517|FG000|Overall Study|Lost to Follow-up|11|||
144734966|NCT02445339|521885518|FG001|Overall Study|Lost to Follow-up|15|||
144734967|NCT03206177|521885519|FG000|Overall Study|Withdrawal by Subject|1|||
144734968|NCT02024932|521885520|FG000|Overall Study|Adverse Event|2|||
144734969|NCT02024932|521885521|FG001|Overall Study|Adverse Event|3|||
144734970|NCT02024932|521885522|FG002|Overall Study|Adverse Event|0|||
144734971|NCT02024932|521885523|FG003|Overall Study|Adverse Event|0|||
144734972|NCT02024932|521885524|FG004|Overall Study|Adverse Event|2|||
144734973|NCT02024932|521885525|FG005|Overall Study|Adverse Event|0|||
144734974|NCT02024932|521885520|FG000|Overall Study|Abnormal laboratory value|0|||
144734975|NCT02024932|521885521|FG001|Overall Study|Abnormal laboratory value|0|||
144734976|NCT02024932|521885522|FG002|Overall Study|Abnormal laboratory value|0|||
144734977|NCT02024932|521885523|FG003|Overall Study|Abnormal laboratory value|2|||
144734978|NCT02024932|521885524|FG004|Overall Study|Abnormal laboratory value|0|||
144734979|NCT02024932|521885525|FG005|Overall Study|Abnormal laboratory value|0|||
144734980|NCT00727961|521885527|FG000|Overall Study|Lost to Follow-up|1|||
144734981|NCT00727961|521885527|FG000|Overall Study|Adverse Event|4|||
144734982|NCT00727961|521885527|FG000|Overall Study|Patient's refusal|2|||
144734983|NCT00727961|521885527|FG000|Overall Study|Progression|30|||
144734984|NCT03238781|521885528|FG000|Overall Study|Adverse Event|1|||
144734985|NCT03238781|521885529|FG001|Overall Study|Adverse Event|1|||
144734986|NCT03238781|521885530|FG002|Overall Study|Adverse Event|2|||
144734987|NCT03238781|521885528|FG000|Overall Study|Lost to Follow-up|2|||
144734988|NCT03238781|521885529|FG001|Overall Study|Lost to Follow-up|1|||
144734989|NCT03238781|521885530|FG002|Overall Study|Lost to Follow-up|2|||
144734990|NCT03238781|521885528|FG000|Overall Study|Withdrawal by Subject|23|||
144734991|NCT03238781|521885529|FG001|Overall Study|Withdrawal by Subject|14|||
144734992|NCT03238781|521885530|FG002|Overall Study|Withdrawal by Subject|16|||
144734993|NCT03238781|521885528|FG000|Overall Study|Decision by sponsor|0|||
144671712|NCT01742091|521649268|FG001|Overall Study|Physician Decision|0|||
144671713|NCT01742091|521649269|FG002|Overall Study|Physician Decision|0|||
144671714|NCT01742091|521649270|FG003|Overall Study|Physician Decision|0|||
144671715|NCT01742091|521649271|FG004|Overall Study|Physician Decision|0|||
144671716|NCT01742091|521649272|FG005|Overall Study|Physician Decision|1|||
144671717|NCT01742091|521649267|FG000|Overall Study|Withdrawal by Subject|0|||
144671718|NCT01742091|521649268|FG001|Overall Study|Withdrawal by Subject|0|||
144671719|NCT01742091|521649269|FG002|Overall Study|Withdrawal by Subject|0|||
144671720|NCT01742091|521649270|FG003|Overall Study|Withdrawal by Subject|1|||
144671721|NCT01742091|521649271|FG004|Overall Study|Withdrawal by Subject|0|||
144671722|NCT01742091|521649272|FG005|Overall Study|Withdrawal by Subject|0|||
144671723|NCT01742091|521649267|FG000|Overall Study|Lost to Follow-up|0|||
144734994|NCT03238781|521885529|FG001|Overall Study|Decision by sponsor|1|||
144734995|NCT03238781|521885530|FG002|Overall Study|Decision by sponsor|0|||
144734996|NCT03161405|521885531|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
144218009|NCT01499095|519992218|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
144734997|NCT00837486|521885532|FG000|Blinded-treatment Phase|Physician Decision|1|||
144671724|NCT01742091|521649268|FG001|Overall Study|Lost to Follow-up|0|||
144671725|NCT01742091|521649269|FG002|Overall Study|Lost to Follow-up|0|||
144734998|NCT00837486|521885533|FG001|Blinded-treatment Phase|Physician Decision|0|||
144734999|NCT00837486|521885532|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
144735000|NCT00837486|521885533|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
144735001|NCT00837486|521885532|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
144671726|NCT01742091|521649270|FG003|Overall Study|Lost to Follow-up|0|||
144671727|NCT01742091|521649271|FG004|Overall Study|Lost to Follow-up|0|||
144671728|NCT01742091|521649272|FG005|Overall Study|Lost to Follow-up|1|||
144671729|NCT00212758|521649275|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
144671730|NCT00212758|521649276|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
144671731|NCT00212758|521649275|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
144671732|NCT00212758|521649276|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
144671733|NCT02574481|521649277|FG000|Overall Study|Withdrawal by Subject|29|||
144671734|NCT02574481|521649278|FG001|Overall Study|Withdrawal by Subject|15|||
144671735|NCT02574481|521649279|FG002|Overall Study|Withdrawal by Subject|4|||
144671736|NCT02574481|521649280|FG003|Overall Study|Withdrawal by Subject|1|||
144671737|NCT02574481|521649277|FG000|Overall Study|Adverse Event|5|||
144671738|NCT02574481|521649278|FG001|Overall Study|Adverse Event|1|||
144671739|NCT02574481|521649279|FG002|Overall Study|Adverse Event|1|||
144671740|NCT02574481|521649280|FG003|Overall Study|Adverse Event|0|||
144671741|NCT02574481|521649277|FG000|Overall Study|Visit Missed|15|||
144671742|NCT02574481|521649278|FG001|Overall Study|Visit Missed|7|||
144671743|NCT02574481|521649279|FG002|Overall Study|Visit Missed|5|||
144671744|NCT02574481|521649280|FG003|Overall Study|Visit Missed|0|||
144671745|NCT02574481|521649277|FG000|Overall Study|Other|7|||
144671746|NCT02574481|521649278|FG001|Overall Study|Other|2|||
144671747|NCT02574481|521649279|FG002|Overall Study|Other|0|||
144671748|NCT02574481|521649280|FG003|Overall Study|Other|0|||
144671749|NCT02574481|521649277|FG000|Overall Study|Death|48|||
144671750|NCT02574481|521649278|FG001|Overall Study|Death|26|||
144671751|NCT02574481|521649279|FG002|Overall Study|Death|12|||
144671752|NCT02574481|521649280|FG003|Overall Study|Death|4|||
144671753|NCT02574481|521649277|FG000|Overall Study|Physician Decision|5|||
144671754|NCT02574481|521649278|FG001|Overall Study|Physician Decision|2|||
144671755|NCT02574481|521649279|FG002|Overall Study|Physician Decision|0|||
144671756|NCT02574481|521649280|FG003|Overall Study|Physician Decision|0|||
144671757|NCT02574481|521649277|FG000|Overall Study|Lost to Follow-up|5|||
144671758|NCT02574481|521649278|FG001|Overall Study|Lost to Follow-up|1|||
144671759|NCT02574481|521649279|FG002|Overall Study|Lost to Follow-up|3|||
144671760|NCT02574481|521649280|FG003|Overall Study|Lost to Follow-up|0|||
144671761|NCT01105936|521649281|FG000|Period 1|Adverse Event|0|||
144671762|NCT01105936|521649282|FG001|Period 1|Adverse Event|0|||
144671763|NCT01105936|521649283|FG002|Period 1|Adverse Event|0|||
144671764|NCT01105936|521649284|FG003|Period 1|Adverse Event|1|||
144671765|NCT01105936|521649281|FG000|Period 2|Adverse Event|1|||
144671766|NCT01105936|521649282|FG001|Period 2|Adverse Event|0|||
144671767|NCT01105936|521649283|FG002|Period 2|Adverse Event|0|||
144671768|NCT01105936|521649284|FG003|Period 2|Adverse Event|0|||
144671769|NCT01105936|521649281|FG000|Period 3|Protocol Violation|0|||
144671770|NCT01105936|521649282|FG001|Period 3|Protocol Violation|2|||
144671771|NCT01105936|521649283|FG002|Period 3|Protocol Violation|0|||
144671772|NCT01105936|521649284|FG003|Period 3|Protocol Violation|0|||
144671773|NCT03382262|521649287|FG000|Overall Study|Physician Decision|0|||
144671774|NCT03382262|521649288|FG001|Overall Study|Physician Decision|0|||
144671775|NCT03382262|521649289|FG002|Overall Study|Physician Decision|1|||
144671776|NCT03382262|521649290|FG003|Overall Study|Physician Decision|0|||
144671777|NCT03382262|521649287|FG000|Overall Study|Withdrawal by Subject|0|||
144671778|NCT03382262|521649288|FG001|Overall Study|Withdrawal by Subject|0|||
144735002|NCT00837486|521885533|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
144735003|NCT00837486|521885532|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
144735004|NCT00837486|521885533|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
144735005|NCT02655679|521885534|FG000|Overall Study|Adverse Event|0|||
144735006|NCT02655679|521885535|FG001|Overall Study|Adverse Event|1|||
144735007|NCT02655679|521885536|FG002|Overall Study|Adverse Event|0|||
144671779|NCT03382262|521649289|FG002|Overall Study|Withdrawal by Subject|0|||
144671780|NCT03382262|521649290|FG003|Overall Study|Withdrawal by Subject|1|||
144671781|NCT02940860|521649291|FG000|Overall Study|Non-serious AE|1|||
144671782|NCT02940860|521649292|FG001|Overall Study|Non-serious AE|2|||
144671783|NCT02940860|521649291|FG000|Overall Study|Serious AE|7|||
144671784|NCT02940860|521649292|FG001|Overall Study|Serious AE|3|||
144671785|NCT02940860|521649291|FG000|Overall Study|Withdrawal by Subject|19|||
144671786|NCT02940860|521649292|FG001|Overall Study|Withdrawal by Subject|9|||
144671787|NCT02940860|521649291|FG000|Overall Study|Lost to Follow-up|13|||
144671788|NCT02940860|521649292|FG001|Overall Study|Lost to Follow-up|7|||
144671789|NCT02940860|521649291|FG000|Overall Study|Physician Decision|5|||
144671790|NCT02940860|521649292|FG001|Overall Study|Physician Decision|3|||
144671791|NCT02940860|521649291|FG000|Overall Study|Sponsor Decision|0|||
144671792|NCT02940860|521649292|FG001|Overall Study|Sponsor Decision|1|||
144671793|NCT02940860|521649291|FG000|Overall Study|Protocol Violation|0|||
144671794|NCT02940860|521649292|FG001|Overall Study|Protocol Violation|2|||
144671795|NCT02940860|521649291|FG000|Overall Study|Death|3|||
144671796|NCT02940860|521649292|FG001|Overall Study|Death|2|||
144671797|NCT02940860|521649291|FG000|Overall Study|Moved, poor venous access, transport|6|||
144671798|NCT02940860|521649292|FG001|Overall Study|Moved, poor venous access, transport|4|||
144671799|NCT02940860|521649291|FG000|Overall Study|Not treated|2|||
144735008|NCT02655679|521885537|FG003|Overall Study|Adverse Event|0|||
144735009|NCT02655679|521885538|FG004|Overall Study|Adverse Event|0|||
144735010|NCT02655679|521885534|FG000|Overall Study|Withdrawal by Subject|1|||
144735011|NCT02655679|521885535|FG001|Overall Study|Withdrawal by Subject|1|||
144735012|NCT02655679|521885536|FG002|Overall Study|Withdrawal by Subject|0|||
144735013|NCT02655679|521885537|FG003|Overall Study|Withdrawal by Subject|3|||
144735014|NCT02655679|521885538|FG004|Overall Study|Withdrawal by Subject|1|||
144735015|NCT02655679|521885534|FG000|Overall Study|Inability to Comply with the Protocol|1|||
144735016|NCT02655679|521885535|FG001|Overall Study|Inability to Comply with the Protocol|0|||
144735017|NCT02655679|521885536|FG002|Overall Study|Inability to Comply with the Protocol|0|||
144735018|NCT02655679|521885537|FG003|Overall Study|Inability to Comply with the Protocol|0|||
144735019|NCT02655679|521885538|FG004|Overall Study|Inability to Comply with the Protocol|0|||
144735020|NCT02655679|521885534|FG000|Overall Study|Lost to Follow-up|0|||
144735021|NCT02655679|521885535|FG001|Overall Study|Lost to Follow-up|1|||
144735022|NCT02655679|521885536|FG002|Overall Study|Lost to Follow-up|1|||
144735023|NCT02655679|521885537|FG003|Overall Study|Lost to Follow-up|1|||
144735024|NCT02655679|521885538|FG004|Overall Study|Lost to Follow-up|0|||
144735025|NCT02655679|521885534|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144735026|NCT02655679|521885535|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144735027|NCT02655679|521885536|FG002|Overall Study|Other Miscellaneous Reasons|0|||
144735028|NCT02655679|521885537|FG003|Overall Study|Other Miscellaneous Reasons|0|||
144735029|NCT02655679|521885538|FG004|Overall Study|Other Miscellaneous Reasons|0|||
144735030|NCT01421277|521885539|FG000|Overall Study|Lack of qualifying event|0|||
144735031|NCT01421277|521885540|FG001|Overall Study|Lack of qualifying event|61|||
144735032|NCT01421277|521885539|FG000|Overall Study|Incomplete baseline data|0|||
144735033|NCT01421277|521885540|FG001|Overall Study|Incomplete baseline data|31|||
144735034|NCT02039908|521885541|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
144735035|NCT02039908|521885542|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
144735036|NCT02039908|521885543|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
144735037|NCT02039908|521885544|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
144735038|NCT02039908|521885541|FG000|Phase 1-Summer|Protocol Violation|6|||
144735039|NCT02039908|521885542|FG001|Phase 1-Summer|Protocol Violation|0|||
144735040|NCT02039908|521885543|FG002|Phase 1-Summer|Protocol Violation|0|||
144735041|NCT02039908|521885544|FG003|Phase 1-Summer|Protocol Violation|0|||
144735042|NCT02039908|521885541|FG000|Phase 2-School Year|Lost to Follow-up|0|||
144735043|NCT02039908|521885542|FG001|Phase 2-School Year|Lost to Follow-up|0|||
144735044|NCT02039908|521885543|FG002|Phase 2-School Year|Lost to Follow-up|1|||
144735045|NCT02039908|521885544|FG003|Phase 2-School Year|Lost to Follow-up|3|||
144735046|NCT02039908|521885541|FG000|Phase 2-School Year|Protocol Violation|0|||
144735047|NCT02039908|521885542|FG001|Phase 2-School Year|Protocol Violation|0|||
144735048|NCT02039908|521885543|FG002|Phase 2-School Year|Protocol Violation|3|||
144735049|NCT02039908|521885544|FG003|Phase 2-School Year|Protocol Violation|0|||
144735050|NCT02039908|521885541|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
144735051|NCT02039908|521885542|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
144735052|NCT02039908|521885543|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
144735053|NCT02039908|521885544|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
144735054|NCT01597245|521885545|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
144735055|NCT01597245|521885546|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
144735056|NCT01597245|521885547|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
144735057|NCT01597245|521885548|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
144735058|NCT01597245|521885549|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735059|NCT01597245|521885550|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735060|NCT01597245|521885551|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735061|NCT01597245|521885552|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735062|NCT01597245|521885553|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735063|NCT01597245|521885554|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735064|NCT01597245|521885555|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735065|NCT01597245|521885556|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735066|NCT01597245|521885557|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735067|NCT01597245|521885558|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735068|NCT01597245|521885559|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735069|NCT01597245|521885560|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735070|NCT01597245|521885561|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735071|NCT01597245|521885562|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735072|NCT01597245|521885563|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735073|NCT01597245|521885564|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144735074|NCT01597245|521885565|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
144218010|NCT01499095|519992219|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
144735075|NCT01597245|521885545|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
144735076|NCT01597245|521885546|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
144735077|NCT01597245|521885547|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
144735078|NCT01597245|521885548|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
144735079|NCT01597245|521885549|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735080|NCT01597245|521885550|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735081|NCT01597245|521885551|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735082|NCT01597245|521885552|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735083|NCT01597245|521885553|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735084|NCT01597245|521885554|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735085|NCT01597245|521885555|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735086|NCT01597245|521885556|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735087|NCT01597245|521885557|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735088|NCT01597245|521885558|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735089|NCT01597245|521885559|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735090|NCT01597245|521885560|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735091|NCT01597245|521885561|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735092|NCT01597245|521885562|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735093|NCT01597245|521885563|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735094|NCT01597245|521885564|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735095|NCT01597245|521885565|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
144735096|NCT01597245|521885545|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
144735097|NCT01597245|521885546|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
144735098|NCT01597245|521885547|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
144735099|NCT01597245|521885548|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
144735100|NCT01597245|521885549|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735101|NCT01597245|521885550|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735102|NCT01597245|521885551|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735103|NCT01597245|521885552|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735104|NCT01597245|521885553|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735105|NCT01597245|521885554|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735106|NCT01597245|521885555|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735107|NCT01597245|521885556|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735108|NCT01597245|521885557|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735109|NCT01597245|521885558|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735110|NCT01597245|521885559|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735111|NCT01597245|521885560|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735112|NCT01597245|521885561|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735113|NCT01597245|521885562|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735114|NCT01597245|521885563|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735115|NCT01597245|521885564|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735116|NCT01597245|521885565|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
144735117|NCT01597245|521885545|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
144735118|NCT01597245|521885546|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
144735119|NCT01597245|521885547|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
144735120|NCT01597245|521885548|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735121|NCT01597245|521885549|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735122|NCT01597245|521885550|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735123|NCT01597245|521885551|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735124|NCT01597245|521885552|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735125|NCT01597245|521885553|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735126|NCT01597245|521885554|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735127|NCT01597245|521885555|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735128|NCT01597245|521885556|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735129|NCT01597245|521885557|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735130|NCT01597245|521885558|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735131|NCT01597245|521885559|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735132|NCT01597245|521885560|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735133|NCT01597245|521885561|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735134|NCT01597245|521885562|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735135|NCT01597245|521885563|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735136|NCT01597245|521885564|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735137|NCT01597245|521885565|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
144735138|NCT01597245|521885545|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
144218011|NCT01499095|519992218|FG000|Overall Study|Change in Injection Schedule|2|||
144218012|NCT01499095|519992219|FG001|Overall Study|Change in Injection Schedule|0|||
144218013|NCT01499095|519992218|FG000|Overall Study|Perceived Lack of Efficacy|1|||
144218014|NCT01499095|519992219|FG001|Overall Study|Perceived Lack of Efficacy|1|||
144218015|NCT04358081|519992220|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
144218016|NCT04358081|519992221|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
144218017|NCT04358081|519992222|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
144265616|NCT02513550|520173978|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
144265617|NCT02513550|520173979|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
144265618|NCT02513550|520173980|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
144265619|NCT02513550|520173975|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
144265620|NCT02513550|520173976|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
144671800|NCT02940860|521649292|FG001|Overall Study|Not treated|2|||
144671801|NCT04702984|521649295|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
144671802|NCT06000501|521649296|FG000|Overall Study|Screen failure|3|||
144671803|NCT06000501|521649296|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
144671804|NCT06000501|521649296|FG000|Overall Study|Physician Decision|4|||
144671805|NCT06000501|521649296|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
144671806|NCT06000501|521649296|FG000|Overall Study|Scheduling issues|2|||
144671807|NCT03496662|521649297|FG000|Overall Study|Adverse Event|0|||
144671808|NCT03496662|521649298|FG001|Overall Study|Adverse Event|0|||
144671809|NCT03496662|521649299|FG002|Overall Study|Adverse Event|4|||
144671810|NCT03496662|521649297|FG000|Overall Study|Withdrawal by Subject|1|||
144671811|NCT03496662|521649298|FG001|Overall Study|Withdrawal by Subject|0|||
144671812|NCT03496662|521649299|FG002|Overall Study|Withdrawal by Subject|2|||
144671813|NCT03496662|521649297|FG000|Overall Study|Death|0|||
144671814|NCT03496662|521649298|FG001|Overall Study|Death|0|||
144671815|NCT03496662|521649299|FG002|Overall Study|Death|2|||
144671816|NCT03496662|521649297|FG000|Overall Study|Noncompliance|0|||
144671817|NCT03496662|521649298|FG001|Overall Study|Noncompliance|0|||
144671818|NCT03496662|521649299|FG002|Overall Study|Noncompliance|1|||
144671819|NCT01248364|521649300|FG000|Overall Study|Adverse Event|0|||
144671820|NCT01248364|521649301|FG001|Overall Study|Adverse Event|1|||
144671821|NCT01248364|521649302|FG002|Overall Study|Adverse Event|0|||
144671822|NCT01248364|521649303|FG003|Overall Study|Adverse Event|0|||
144671823|NCT02559713|521649304|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
144671824|NCT01374217|521649307|FG000|Overall Study|Lack of Efficacy|13|||
144671825|NCT03495817|521649308|FG000|26 Week Open Label|Adverse Event|3|||
144671826|NCT03495817|521649308|FG000|26 Week Open Label|Withdrawal by Subject|4|||
144671827|NCT03495817|521649308|FG000|26 Week Open Label|Lost to Follow-up|1|||
144671828|NCT03495817|521649308|FG000|26 Week Extension|Lost to Follow-up|2|||
144671829|NCT01117012|521649313|FG000|Overall Study|Adverse Event|0|||
144671830|NCT01117012|521649314|FG001|Overall Study|Adverse Event|1|||
144671831|NCT01117012|521649313|FG000|Overall Study|Death|1|||
144671832|NCT01117012|521649314|FG001|Overall Study|Death|1|||
144671833|NCT01117012|521649313|FG000|Overall Study|Withdrawal by Subject|3|||
144671834|NCT01117012|521649314|FG001|Overall Study|Withdrawal by Subject|0|||
144671835|NCT01117012|521649313|FG000|Overall Study|Undefined|4|||
144671836|NCT01117012|521649314|FG001|Overall Study|Undefined|3|||
144671837|NCT00187889|521649318|FG000|Overall Study|Withdrawal by Subject|6|||
144671838|NCT00187889|521649319|FG001|Overall Study|Withdrawal by Subject|4|||
144671839|NCT04046341|521649321|FG000|Overall Study|Lost to Follow-up|2|||
144671840|NCT04046341|521649321|FG000|Overall Study|Withdrawal by Subject|1|||
144671841|NCT04377672|521649322|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
144671842|NCT00405652|521649325|FG000|Overall Study|Adverse Event|4|||
144671843|NCT03505749|521649327|FG000|Overall Study|Lost to Follow-up|7|||
144671844|NCT03505749|521649328|FG001|Overall Study|Lost to Follow-up|11|||
144671845|NCT03505749|521649327|FG000|Overall Study|Withdrawal by Subject|6|||
144671846|NCT03505749|521649328|FG001|Overall Study|Withdrawal by Subject|0|||
144671847|NCT03505749|521649327|FG000|Overall Study|Discharged from treatment|3|||
144671848|NCT03505749|521649328|FG001|Overall Study|Discharged from treatment|6|||
144671849|NCT00435994|521649330|FG000|Overall Study|Lost to Follow-up|7|||
144671850|NCT00435994|521649331|FG001|Overall Study|Lost to Follow-up|0|||
144671851|NCT00435994|521649332|FG002|Overall Study|Lost to Follow-up|0|||
144671852|NCT01151540|521649333|FG000|Overall Study|Other|2|||
144671853|NCT01151540|521649333|FG000|Overall Study|Adverse event, non-fatal|4|||
144671854|NCT01151540|521649333|FG000|Overall Study|Withdrawal by Subject|7|||
144671855|NCT03846219|521649335|FG000|Overall Study|Withdrawal by Subject|3|||
144671856|NCT03846219|521649336|FG001|Overall Study|Withdrawal by Subject|2|||
144671857|NCT03846219|521649337|FG002|Overall Study|Withdrawal by Subject|2|||
144671858|NCT03846219|521649335|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
144671859|NCT03846219|521649336|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
144671860|NCT03846219|521649337|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
144671861|NCT03846219|521649335|FG000|Overall Study|Physician Decision|0|||
144671862|NCT03846219|521649336|FG001|Overall Study|Physician Decision|0|||
144671863|NCT03846219|521649337|FG002|Overall Study|Physician Decision|2|||
144671864|NCT02322411|521649338|FG000|Overall Study|Lost to Follow-up|4|||
144671865|NCT02322411|521649339|FG001|Overall Study|Lost to Follow-up|7|||
144671866|NCT02322411|521649338|FG000|Overall Study|Withdrawal by Subject|1|||
144671867|NCT02322411|521649339|FG001|Overall Study|Withdrawal by Subject|0|||
144671868|NCT02248857|521649343|FG000|3 Month|Withdrawal by Subject|9|||
144671869|NCT02248857|521649344|FG001|3 Month|Withdrawal by Subject|3|||
144671870|NCT02248857|521649345|FG002|3 Month|Withdrawal by Subject|4|||
144671871|NCT02248857|521649343|FG000|3 Month|Unable to reach for 3 month|35|||
144671872|NCT02248857|521649344|FG001|3 Month|Unable to reach for 3 month|29|||
144671873|NCT02248857|521649345|FG002|3 Month|Unable to reach for 3 month|26|||
144671874|NCT02248857|521649343|FG000|3 Month|Partially completed, unable to finish|2|||
144671875|NCT02248857|521649344|FG001|3 Month|Partially completed, unable to finish|2|||
144671876|NCT02248857|521649345|FG002|3 Month|Partially completed, unable to finish|1|||
144671877|NCT02248857|521649343|FG000|6 Month|Lost to Follow-up|27|||
144671878|NCT02248857|521649344|FG001|6 Month|Lost to Follow-up|26|||
144671879|NCT02248857|521649345|FG002|6 Month|Lost to Follow-up|15|||
144671880|NCT02248857|521649343|FG000|6 Month|Partially completed, unable to finish|0|||
144671881|NCT02248857|521649344|FG001|6 Month|Partially completed, unable to finish|1|||
144671882|NCT02248857|521649345|FG002|6 Month|Partially completed, unable to finish|0|||
144671883|NCT02248857|521649343|FG000|6 Month|Withdrawal by Subject|0|||
144671884|NCT02248857|521649344|FG001|6 Month|Withdrawal by Subject|2|||
144671885|NCT02248857|521649345|FG002|6 Month|Withdrawal by Subject|2|||
144671886|NCT02248857|521649343|FG000|6 Month|Death|1|||
144671887|NCT02248857|521649344|FG001|6 Month|Death|0|||
144671888|NCT02248857|521649345|FG002|6 Month|Death|0|||
144671889|NCT02261883|521649346|FG000|Overall Study|Death|3|||
144671890|NCT02261883|521649347|FG001|Overall Study|Death|2|||
144671891|NCT02261883|521649346|FG000|Overall Study|Physician Decision|1|||
144671892|NCT02261883|521649347|FG001|Overall Study|Physician Decision|0|||
144671893|NCT02261883|521649346|FG000|Overall Study|Protocol Violation|1|||
144671894|NCT02261883|521649347|FG001|Overall Study|Protocol Violation|0|||
144671895|NCT02261883|521649346|FG000|Overall Study|Withdrawal by Subject|0|||
144671896|NCT02261883|521649347|FG001|Overall Study|Withdrawal by Subject|1|||
144671897|NCT02261883|521649346|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
144671898|NCT02261883|521649347|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
144671899|NCT02671461|521649348|FG000|Treatment|Adverse Event|0|||
144671900|NCT02671461|521649349|FG001|Treatment|Adverse Event|0|||
144671901|NCT02671461|521649350|FG002|Treatment|Adverse Event|1|||
144671902|NCT02671461|521649348|FG000|Treatment|Administrative Reason by Sponsor|1|||
144671903|NCT02671461|521649349|FG001|Treatment|Administrative Reason by Sponsor|3|||
144671904|NCT02671461|521649350|FG002|Treatment|Administrative Reason by Sponsor|4|||
144671905|NCT02671461|521649348|FG000|Treatment|Randomized, not treated|1|||
144671906|NCT02671461|521649349|FG001|Treatment|Randomized, not treated|0|||
144671907|NCT02671461|521649350|FG002|Treatment|Randomized, not treated|0|||
144671908|NCT02671461|521649348|FG000|Follow-up|Withdrawal by Subject|1|||
144671909|NCT02671461|521649349|FG001|Follow-up|Withdrawal by Subject|0|||
144671910|NCT02671461|521649350|FG002|Follow-up|Withdrawal by Subject|0|||
144671911|NCT02671461|521649348|FG000|Follow-up|Lost to Follow-up|0|||
144671912|NCT02671461|521649349|FG001|Follow-up|Lost to Follow-up|0|||
144671913|NCT02671461|521649350|FG002|Follow-up|Lost to Follow-up|1|||
144671914|NCT02671461|521649348|FG000|Follow-up|Administrative Reason by Sponsor|0|||
144671915|NCT02671461|521649349|FG001|Follow-up|Administrative Reason by Sponsor|1|||
144671916|NCT02671461|521649350|FG002|Follow-up|Administrative Reason by Sponsor|0|||
144671917|NCT01412060|521649351|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
144671918|NCT01412060|521649352|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
144671919|NCT01412060|521649353|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
144671920|NCT01412060|521649351|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
144671921|NCT01412060|521649352|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
144671922|NCT01412060|521649353|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
144671923|NCT01412060|521649351|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
144671924|NCT01412060|521649352|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
144671925|NCT01412060|521649353|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
144671926|NCT01412060|521649351|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
144671927|NCT01412060|521649352|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
144671928|NCT01412060|521649353|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
144671929|NCT01412060|521649351|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
144671930|NCT01412060|521649352|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
144671931|NCT01412060|521649353|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
144671932|NCT01412060|521649351|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
144671933|NCT01412060|521649352|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
144671934|NCT01412060|521649353|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
144671935|NCT01412060|521649351|FG000|Period Between RIP and SP|Adverse Event|4|||
144671936|NCT01412060|521649352|FG001|Period Between RIP and SP|Adverse Event|0|||
144671937|NCT01412060|521649353|FG002|Period Between RIP and SP|Adverse Event|0|||
144671938|NCT01412060|521649351|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
144671939|NCT01412060|521649352|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
144671940|NCT01412060|521649353|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
144671941|NCT01412060|521649351|FG000|Period Between RIP and SP|Protocol Violation|2|||
144671942|NCT01412060|521649352|FG001|Period Between RIP and SP|Protocol Violation|0|||
144671943|NCT01412060|521649353|FG002|Period Between RIP and SP|Protocol Violation|0|||
144671944|NCT01412060|521649351|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
144671945|NCT01412060|521649352|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
144671946|NCT01412060|521649353|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
144671947|NCT01412060|521649351|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
144671948|NCT01412060|521649352|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
144671949|NCT01412060|521649353|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
144671950|NCT01412060|521649351|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
144671951|NCT01412060|521649352|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
144671952|NCT01412060|521649353|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
144671953|NCT01412060|521649351|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
144671954|NCT01412060|521649352|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
144671955|NCT01412060|521649353|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
144671956|NCT01412060|521649351|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
144671957|NCT01412060|521649352|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
144671958|NCT01412060|521649353|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
144671959|NCT01412060|521649351|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
144671960|NCT01412060|521649352|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
144671961|NCT01412060|521649353|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
144671962|NCT01412060|521649351|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
144671963|NCT01412060|521649352|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
144671964|NCT01412060|521649353|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
144671965|NCT01412060|521649351|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
144671966|NCT01412060|521649352|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
144671967|NCT01412060|521649353|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
144671968|NCT01412060|521649351|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
144671969|NCT01412060|521649352|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
144671970|NCT01412060|521649353|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
144671971|NCT01412060|521649351|FG000|Period Between SP and DBP|Protocol Violation|2|||
144671972|NCT01412060|521649352|FG001|Period Between SP and DBP|Protocol Violation|0|||
144671973|NCT01412060|521649353|FG002|Period Between SP and DBP|Protocol Violation|0|||
144671974|NCT01412060|521649351|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
144671975|NCT01412060|521649352|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
144671976|NCT01412060|521649353|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
144671977|NCT01412060|521649351|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
144671978|NCT01412060|521649352|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
144671979|NCT01412060|521649353|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
144671980|NCT01412060|521649351|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
144671981|NCT01412060|521649352|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
144671982|NCT01412060|521649353|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
144671983|NCT01412060|521649351|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
144671984|NCT01412060|521649352|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
144671985|NCT01412060|521649353|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
144671986|NCT01412060|521649351|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
144671987|NCT01412060|521649352|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
144671988|NCT01412060|521649353|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
144671989|NCT01412060|521649351|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
144671990|NCT01412060|521649352|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
144671991|NCT01412060|521649353|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
144671992|NCT01412060|521649351|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
144671993|NCT01412060|521649352|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
144671994|NCT01412060|521649353|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
144671995|NCT01412060|521649351|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
144671996|NCT01412060|521649352|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
144265621|NCT02513550|520173977|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
144671997|NCT01412060|521649353|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
144671998|NCT01412060|521649351|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
144671999|NCT01412060|521649352|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
144672000|NCT01412060|521649353|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
144672001|NCT01412060|521649351|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
144672002|NCT01412060|521649352|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
144672003|NCT01412060|521649353|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
144672004|NCT03549117|521649363|FG000|Overall Study|Withdrawal by Subject|1|||
144672005|NCT03549117|521649364|FG001|Overall Study|Withdrawal by Subject|0|||
144672006|NCT02661464|521649365|FG000|Overall Study|Lost to Follow-up|28|||
144672007|NCT02661464|521649366|FG001|Overall Study|Lost to Follow-up|0|||
144735139|NCT01597245|521885546|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735140|NCT01597245|521885547|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144672008|NCT02661464|521649367|FG002|Overall Study|Lost to Follow-up|0|||
144672009|NCT02661464|521649368|FG003|Overall Study|Lost to Follow-up|0|||
144672010|NCT02661464|521649365|FG000|Overall Study|Withdrawal by Subject|3|||
144672011|NCT02661464|521649366|FG001|Overall Study|Withdrawal by Subject|1|||
144672012|NCT02661464|521649367|FG002|Overall Study|Withdrawal by Subject|0|||
144672013|NCT02661464|521649368|FG003|Overall Study|Withdrawal by Subject|0|||
144672014|NCT02661464|521649365|FG000|Overall Study|Participants terminated prematurely|288|||
144672015|NCT02661464|521649366|FG001|Overall Study|Participants terminated prematurely|52|||
144672016|NCT02661464|521649367|FG002|Overall Study|Participants terminated prematurely|1|||
144672017|NCT02661464|521649368|FG003|Overall Study|Participants terminated prematurely|1|||
144672018|NCT02661464|521649365|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
144672019|NCT02661464|521649366|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
144672020|NCT02661464|521649367|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
144672021|NCT02661464|521649368|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
144672022|NCT00014911|521649369|FG000|Overall Study|Adverse Event|1|||
144672023|NCT00014911|521649369|FG000|Overall Study|Lost to Follow-up|1|||
144672024|NCT00014911|521649369|FG000|Overall Study|Withdrawal by Subject|6|||
144672025|NCT00014911|521649369|FG000|Overall Study|Unknown Reasons|2|||
144672026|NCT00014911|521649369|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
144672027|NCT01924299|521649375|FG000|Period 2|Withdrawal by Subject|1|||
144672028|NCT01924299|521649376|FG001|Period 2|Withdrawal by Subject|0|||
144672029|NCT01924299|521649375|FG000|Period 2|Adverse Event|0|||
144672030|NCT01924299|521649376|FG001|Period 2|Adverse Event|1|||
144672031|NCT00141037|521649382|FG000|Overall Study|Physician Decision|1|||
144672032|NCT00141037|521649383|FG001|Overall Study|Physician Decision|2|||
144672033|NCT00141037|521649382|FG000|Overall Study|Lost to Follow-up|3|||
144672034|NCT00141037|521649383|FG001|Overall Study|Lost to Follow-up|1|||
144672035|NCT00141037|521649382|FG000|Overall Study|Protocol Violation|0|||
144672036|NCT00141037|521649383|FG001|Overall Study|Protocol Violation|2|||
144672037|NCT00141037|521649382|FG000|Overall Study|Withdrawal by Subject|2|||
144672038|NCT00141037|521649383|FG001|Overall Study|Withdrawal by Subject|1|||
144672039|NCT00141037|521649382|FG000|Overall Study|Other|0|||
144672040|NCT00141037|521649383|FG001|Overall Study|Other|1|||
144672041|NCT00141037|521649382|FG000|Overall Study|Moved from area|1|||
144672042|NCT00141037|521649383|FG001|Overall Study|Moved from area|7|||
144672043|NCT00141037|521649382|FG000|Overall Study|Graft Failure|3|||
144672044|NCT00141037|521649383|FG001|Overall Study|Graft Failure|4|||
144672045|NCT00888615|521649384|FG000|Overall Study|No treatment|2|||
144672046|NCT00637377|521649385|FG000|Overall Study|Adverse Event|2|||
144672047|NCT00637377|521649386|FG001|Overall Study|Adverse Event|6|||
144672048|NCT00637377|521649387|FG002|Overall Study|Adverse Event|8|||
144672049|NCT00637377|521649388|FG003|Overall Study|Adverse Event|9|||
144672050|NCT00637377|521649385|FG000|Overall Study|Death|1|||
144735141|NCT01597245|521885548|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
144735142|NCT01597245|521885549|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735143|NCT01597245|521885550|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735144|NCT01597245|521885551|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735145|NCT01597245|521885552|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735146|NCT01597245|521885553|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735147|NCT01597245|521885554|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735148|NCT01597245|521885555|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735149|NCT01597245|521885556|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735150|NCT01597245|521885557|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735151|NCT01597245|521885558|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735152|NCT01597245|521885559|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144218018|NCT04358081|519992220|FG000|Treatment Phase of Study|Adverse Event|1|||
144218019|NCT04358081|519992221|FG001|Treatment Phase of Study|Adverse Event|0|||
144218020|NCT04358081|519992222|FG002|Treatment Phase of Study|Adverse Event|1|||
144218021|NCT04358081|519992220|FG000|Treatment Phase of Study|Physician Decision|2|||
144672051|NCT00637377|521649386|FG001|Overall Study|Death|3|||
144672052|NCT00637377|521649387|FG002|Overall Study|Death|2|||
144672053|NCT00637377|521649388|FG003|Overall Study|Death|1|||
144672054|NCT00637377|521649385|FG000|Overall Study|Lack of Efficacy|0|||
144672055|NCT00637377|521649386|FG001|Overall Study|Lack of Efficacy|0|||
144672056|NCT00637377|521649387|FG002|Overall Study|Lack of Efficacy|1|||
144672057|NCT00637377|521649388|FG003|Overall Study|Lack of Efficacy|1|||
144672058|NCT00637377|521649385|FG000|Overall Study|Lost to Follow-up|4|||
144672059|NCT00637377|521649386|FG001|Overall Study|Lost to Follow-up|1|||
144672060|NCT00637377|521649387|FG002|Overall Study|Lost to Follow-up|2|||
144672061|NCT00637377|521649388|FG003|Overall Study|Lost to Follow-up|2|||
144672062|NCT00637377|521649385|FG000|Overall Study|Protocol Violation|2|||
144672063|NCT00637377|521649386|FG001|Overall Study|Protocol Violation|1|||
144218022|NCT04358081|519992221|FG001|Treatment Phase of Study|Physician Decision|0|||
144672064|NCT00637377|521649387|FG002|Overall Study|Protocol Violation|1|||
144672065|NCT00637377|521649388|FG003|Overall Study|Protocol Violation|0|||
144672066|NCT00637377|521649385|FG000|Overall Study|Withdrawal by Subject|11|||
144672067|NCT00637377|521649386|FG001|Overall Study|Withdrawal by Subject|15|||
144672068|NCT00637377|521649387|FG002|Overall Study|Withdrawal by Subject|13|||
144672069|NCT00637377|521649388|FG003|Overall Study|Withdrawal by Subject|11|||
144672070|NCT00637377|521649385|FG000|Overall Study|Other (no further information available)|7|||
144672071|NCT00637377|521649386|FG001|Overall Study|Other (no further information available)|6|||
144672072|NCT00637377|521649387|FG002|Overall Study|Other (no further information available)|10|||
144672073|NCT00637377|521649388|FG003|Overall Study|Other (no further information available)|5|||
144672074|NCT01293084|521649391|FG000|Overall Study|Physician Decision|3|||
144672075|NCT01293084|521649391|FG000|Overall Study|Withdrawal by Subject|2|||
144672076|NCT02293902|521649395|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
144672077|NCT02293902|521649396|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
144672078|NCT02293902|521649397|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
144672079|NCT02293902|521649398|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
144672080|NCT02293902|521649399|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
144672081|NCT02293902|521649395|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
144672082|NCT02293902|521649396|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
144672083|NCT02293902|521649397|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
144672084|NCT02293902|521649398|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
144672085|NCT02293902|521649399|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
144672086|NCT02293902|521649395|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
144672087|NCT02293902|521649396|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
144672088|NCT02293902|521649397|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
144735153|NCT01597245|521885560|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735154|NCT01597245|521885561|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735155|NCT01597245|521885562|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735156|NCT01597245|521885563|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735157|NCT01597245|521885564|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735158|NCT01597245|521885565|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
144735159|NCT01597245|521885545|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
144735160|NCT01597245|521885546|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
144735161|NCT01597245|521885547|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
144735162|NCT01597245|521885548|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735163|NCT01597245|521885549|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735164|NCT01597245|521885550|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735165|NCT01597245|521885551|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735166|NCT01597245|521885552|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735167|NCT01597245|521885553|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735168|NCT01597245|521885554|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735169|NCT01597245|521885555|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735170|NCT01597245|521885556|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735171|NCT01597245|521885557|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735172|NCT01597245|521885558|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735173|NCT01597245|521885559|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735174|NCT01597245|521885560|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735175|NCT01597245|521885561|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735176|NCT01597245|521885562|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735177|NCT01597245|521885563|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735178|NCT01597245|521885564|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735179|NCT01597245|521885565|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
144735180|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735181|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735182|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144218023|NCT04358081|519992222|FG002|Treatment Phase of Study|Physician Decision|1|||
144672089|NCT02293902|521649398|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
144672090|NCT02293902|521649399|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
144672091|NCT02293902|521649395|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
144672092|NCT02293902|521649396|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
144672093|NCT02293902|521649397|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
144672094|NCT02293902|521649398|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
144672095|NCT02293902|521649399|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
144672096|NCT02293902|521649395|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
144218024|NCT04358081|519992220|FG000|Treatment Phase of Study|Protocol Violation|1|||
144672097|NCT02293902|521649396|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
144735183|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735184|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735185|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
144735186|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
144735187|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735188|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735189|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144218025|NCT04358081|519992221|FG001|Treatment Phase of Study|Protocol Violation|0|||
144218026|NCT04358081|519992222|FG002|Treatment Phase of Study|Protocol Violation|0|||
144218027|NCT04358081|519992220|FG000|Study Completion Phase|Death|0|||
144218028|NCT04358081|519992221|FG001|Study Completion Phase|Death|0|||
144218029|NCT04358081|519992222|FG002|Study Completion Phase|Death|1|||
144672098|NCT02293902|521649397|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
144672099|NCT02293902|521649398|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
144672100|NCT02293902|521649399|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
144672101|NCT04021706|521651058|FG000|Overall Study|Adverse Event|2|||
144672102|NCT04021706|521651059|FG001|Overall Study|Adverse Event|0|||
144672103|NCT04021706|521651058|FG000|Overall Study|Withdrawal by Subject|1|||
144672104|NCT04021706|521651059|FG001|Overall Study|Withdrawal by Subject|2|||
144672105|NCT04021706|521651058|FG000|Overall Study|Physician Decision|1|||
144672106|NCT04021706|521651059|FG001|Overall Study|Physician Decision|0|||
144672107|NCT01375647|521651060|FG000|Overall Study|Lost to Follow-up|3|||
144672108|NCT01375647|521651061|FG001|Overall Study|Lost to Follow-up|3|||
144672109|NCT01375647|521651062|FG002|Overall Study|Lost to Follow-up|7|||
144672110|NCT01375647|521651063|FG003|Overall Study|Lost to Follow-up|10|||
144672111|NCT01375647|521651060|FG000|Overall Study|Death|1|||
144672112|NCT01375647|521651061|FG001|Overall Study|Death|2|||
144672113|NCT01375647|521651062|FG002|Overall Study|Death|1|||
144672114|NCT01375647|521651063|FG003|Overall Study|Death|0|||
144672115|NCT01375647|521651060|FG000|Overall Study|Withdrawal by Subject|17|||
144672116|NCT01375647|521651061|FG001|Overall Study|Withdrawal by Subject|20|||
144672117|NCT01375647|521651062|FG002|Overall Study|Withdrawal by Subject|26|||
144672118|NCT01375647|521651063|FG003|Overall Study|Withdrawal by Subject|14|||
144672119|NCT01375647|521651060|FG000|Overall Study|Physician Decision|1|||
144672120|NCT01375647|521651061|FG001|Overall Study|Physician Decision|0|||
144672121|NCT01375647|521651062|FG002|Overall Study|Physician Decision|0|||
144672122|NCT01375647|521651063|FG003|Overall Study|Physician Decision|0|||
144672123|NCT02332798|521651066|FG000|Overall Study|Unwilling to Participate in Study|0|||
144672124|NCT02332798|521651067|FG001|Overall Study|Unwilling to Participate in Study|1|||
144672125|NCT02332798|521651068|FG002|Overall Study|Unwilling to Participate in Study|1|||
144672126|NCT02332798|521651066|FG000|Overall Study|Positive Urine Drug Test|0|||
144672127|NCT02332798|521651067|FG001|Overall Study|Positive Urine Drug Test|1|||
144672128|NCT02332798|521651068|FG002|Overall Study|Positive Urine Drug Test|0|||
144672129|NCT02332798|521651066|FG000|Overall Study|Abnormal Laboratory Findings|1|||
144672130|NCT02332798|521651067|FG001|Overall Study|Abnormal Laboratory Findings|0|||
144672131|NCT02332798|521651068|FG002|Overall Study|Abnormal Laboratory Findings|0|||
144672132|NCT00595868|521651069|FG000|Overall Study|Lost to Follow-up|45|||
144672133|NCT00595868|521651070|FG001|Overall Study|Lost to Follow-up|50|||
144672134|NCT01102140|521651071|FG000|Overall Study|Lost to Follow-up|1|||
144672135|NCT01102140|521651072|FG001|Overall Study|Lost to Follow-up|0|||
144672136|NCT01102140|521651071|FG000|Overall Study|Investigator terminated study|2|||
144672137|NCT01102140|521651072|FG001|Overall Study|Investigator terminated study|2|||
144672138|NCT03788967|521651075|FG000|Overall Study|Lost to Follow-up|14|||
144672139|NCT03788967|521651076|FG001|Overall Study|Lost to Follow-up|10|||
144672140|NCT03788967|521651075|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
144672141|NCT03788967|521651076|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
144672142|NCT03788967|521651075|FG000|Overall Study|Participant Withdrawal of Consent|13|||
144672143|NCT03788967|521651076|FG001|Overall Study|Participant Withdrawal of Consent|5|||
144672144|NCT03788967|521651075|FG000|Overall Study|Adverse Event|1|||
144672145|NCT03788967|521651076|FG001|Overall Study|Adverse Event|1|||
144672146|NCT03788967|521651075|FG000|Overall Study|COVID-19|1|||
144672147|NCT03788967|521651076|FG001|Overall Study|COVID-19|2|||
144672148|NCT00462488|521651077|FG000|Overall Study|Protocol Violation|1|||
144672149|NCT00462488|521651078|FG001|Overall Study|Protocol Violation|0|||
144672150|NCT00462488|521651077|FG000|Overall Study|Lack of Efficacy|19|||
144672151|NCT00462488|521651078|FG001|Overall Study|Lack of Efficacy|17|||
144672152|NCT02707601|521651085|FG000|Overall Study|Death|0|||
144672153|NCT02707601|521651086|FG001|Overall Study|Death|1|||
144672154|NCT02707601|521651085|FG000|Overall Study|Lack of Efficacy|0|||
144672155|NCT02707601|521651086|FG001|Overall Study|Lack of Efficacy|1|||
144672156|NCT02707601|521651085|FG000|Overall Study|Investigator's Discretion|1|||
144672157|NCT02707601|521651086|FG001|Overall Study|Investigator's Discretion|0|||
144672158|NCT02707601|521651085|FG000|Overall Study|Withdrew Consent|0|||
144672159|NCT02707601|521651086|FG001|Overall Study|Withdrew Consent|1|||
144672160|NCT02707601|521651085|FG000|Overall Study|Lost to Follow-up|1|||
144735190|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735191|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735192|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735193|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735194|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735195|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735196|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735197|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735198|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735199|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735200|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
144735201|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735202|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735203|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735204|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735205|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
144735206|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
144735207|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
144735208|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
144735209|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735210|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
144735211|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735212|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735213|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735214|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735215|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735216|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735217|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735218|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735219|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735220|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735221|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
144735222|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735223|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735224|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735225|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735226|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735227|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
144735228|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144672161|NCT02707601|521651086|FG001|Overall Study|Lost to Follow-up|1|||
144672162|NCT02707601|521651085|FG000|Overall Study|Participants Randomized but Not Treated|2|||
144672163|NCT02707601|521651086|FG001|Overall Study|Participants Randomized but Not Treated|0|||
144672164|NCT00608881|521651089|FG000|Overall Study|Death|22|||
144672165|NCT00608881|521651090|FG001|Overall Study|Death|13|||
144672166|NCT00608881|521651089|FG000|Overall Study|Adverse Event|5|||
144672167|NCT00608881|521651090|FG001|Overall Study|Adverse Event|3|||
144672168|NCT00608881|521651089|FG000|Overall Study|Lost to Follow-up|28|||
144672169|NCT00608881|521651090|FG001|Overall Study|Lost to Follow-up|14|||
144672170|NCT00608881|521651089|FG000|Overall Study|Withdrawal by Subject|18|||
144672171|NCT00608881|521651090|FG001|Overall Study|Withdrawal by Subject|29|||
144672172|NCT00608881|521651089|FG000|Overall Study|Physician Decision|5|||
144672173|NCT00608881|521651090|FG001|Overall Study|Physician Decision|5|||
144672174|NCT00608881|521651089|FG000|Overall Study|Institutionalized|1|||
144672175|NCT00608881|521651090|FG001|Overall Study|Institutionalized|2|||
144672176|NCT00511108|521651091|FG000|Overall Study|Adverse Event|2|||
144672177|NCT00511108|521651092|FG001|Overall Study|Adverse Event|0|||
144672178|NCT00511108|521651093|FG002|Overall Study|Adverse Event|1|||
144672179|NCT00511108|521651094|FG003|Overall Study|Adverse Event|2|||
144672180|NCT00511108|521651091|FG000|Overall Study|Lost to Follow-up|0|||
144672181|NCT00511108|521651092|FG001|Overall Study|Lost to Follow-up|2|||
144672182|NCT00511108|521651093|FG002|Overall Study|Lost to Follow-up|1|||
144672183|NCT00511108|521651094|FG003|Overall Study|Lost to Follow-up|0|||
144672184|NCT00511108|521651091|FG000|Overall Study|Physician Decision|0|||
144672185|NCT00511108|521651092|FG001|Overall Study|Physician Decision|0|||
144672186|NCT00511108|521651093|FG002|Overall Study|Physician Decision|0|||
144672187|NCT00511108|521651094|FG003|Overall Study|Physician Decision|1|||
144672188|NCT00511108|521651091|FG000|Overall Study|Withdrawal by Subject|4|||
144672189|NCT00511108|521651092|FG001|Overall Study|Withdrawal by Subject|0|||
144672190|NCT00511108|521651093|FG002|Overall Study|Withdrawal by Subject|3|||
144672191|NCT00511108|521651094|FG003|Overall Study|Withdrawal by Subject|2|||
144672192|NCT02147691|521651095|FG000|Overall Study|Withdrawal by Subject|2|||
144672193|NCT02147691|521651096|FG001|Overall Study|Withdrawal by Subject|0|||
144672194|NCT02147691|521651095|FG000|Overall Study|Adverse Event|2|||
144672195|NCT02147691|521651096|FG001|Overall Study|Adverse Event|0|||
144672196|NCT02147691|521651095|FG000|Overall Study|Lost to Follow-up|0|||
144672197|NCT02147691|521651096|FG001|Overall Study|Lost to Follow-up|1|||
144672198|NCT01628393|521651097|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
144672199|NCT01628393|521651098|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144672200|NCT01628393|521651099|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144672201|NCT01628393|521651100|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144672202|NCT01628393|521651101|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
144672203|NCT01628393|521651097|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
144672204|NCT01628393|521651098|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
144672205|NCT01628393|521651099|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
144672206|NCT01628393|521651100|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
144672207|NCT01628393|521651101|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
144672208|NCT01628393|521651097|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
144672209|NCT01628393|521651098|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
144672210|NCT01628393|521651099|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
144672211|NCT01628393|521651100|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
144672212|NCT01628393|521651101|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
144672213|NCT01628393|521651097|FG000|Blinded Active Extension Period|Adverse Event|0|||
144672214|NCT01628393|521651098|FG001|Blinded Active Extension Period|Adverse Event|1|||
144672215|NCT01628393|521651099|FG002|Blinded Active Extension Period|Adverse Event|0|||
144672216|NCT01628393|521651100|FG003|Blinded Active Extension Period|Adverse Event|2|||
144672217|NCT01628393|521651101|FG004|Blinded Active Extension Period|Adverse Event|2|||
144672218|NCT01628393|521651097|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
144672219|NCT01628393|521651098|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
144672220|NCT01628393|521651099|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
144672221|NCT01628393|521651100|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
144672222|NCT01628393|521651101|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
144672223|NCT01628393|521651097|FG000|Blinded Active Extension Period|Physician Decision|0|||
144672224|NCT01628393|521651098|FG001|Blinded Active Extension Period|Physician Decision|3|||
144672225|NCT01628393|521651099|FG002|Blinded Active Extension Period|Physician Decision|0|||
144672226|NCT01628393|521651100|FG003|Blinded Active Extension Period|Physician Decision|1|||
144672227|NCT01628393|521651101|FG004|Blinded Active Extension Period|Physician Decision|0|||
144672228|NCT01628393|521651097|FG000|Blinded Active Extension Period|Protocol Violation|0|||
144672229|NCT01628393|521651098|FG001|Blinded Active Extension Period|Protocol Violation|0|||
144672230|NCT01628393|521651099|FG002|Blinded Active Extension Period|Protocol Violation|2|||
144672231|NCT01628393|521651100|FG003|Blinded Active Extension Period|Protocol Violation|1|||
144672232|NCT01628393|521651101|FG004|Blinded Active Extension Period|Protocol Violation|0|||
144672233|NCT01628393|521651097|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
144672234|NCT01628393|521651098|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
144672235|NCT01628393|521651099|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
144672236|NCT01628393|521651100|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
144672237|NCT01628393|521651101|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
144672238|NCT00561340|521651102|FG000|Overall Study|refused to drink pediasure|6|||
144672239|NCT00561340|521651103|FG001|Overall Study|refused to drink pediasure|0|||
144672240|NCT01989754|521651104|FG000|Overall Study|Withdrawal by Subject|10|||
144672241|NCT01989754|521651105|FG001|Overall Study|Withdrawal by Subject|14|||
144672242|NCT01989754|521651104|FG000|Overall Study|Lost to Follow-up|28|||
144672243|NCT01989754|521651105|FG001|Overall Study|Lost to Follow-up|20|||
144672244|NCT01989754|521651104|FG000|Overall Study|Closed Site|1|||
144672245|NCT01989754|521651105|FG001|Overall Study|Closed Site|1|||
144672246|NCT01369225|521651108|FG000|Overall Study|Withdrawal by Subject|1|||
144672247|NCT01369225|521651109|FG001|Overall Study|Withdrawal by Subject|0|||
144672248|NCT01369225|521651110|FG002|Overall Study|Withdrawal by Subject|2|||
144672249|NCT01369225|521651111|FG003|Overall Study|Withdrawal by Subject|1|||
144672250|NCT01369225|521651112|FG004|Overall Study|Withdrawal by Subject|0|||
144672251|NCT01369225|521651113|FG005|Overall Study|Withdrawal by Subject|0|||
144672252|NCT01369225|521651108|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
144672253|NCT01369225|521651109|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
144672254|NCT01369225|521651110|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
144672255|NCT01369225|521651111|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
144672256|NCT01369225|521651112|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
144672257|NCT01369225|521651113|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
144672258|NCT01369225|521651108|FG000|Overall Study|Other|1|||
144672259|NCT01369225|521651109|FG001|Overall Study|Other|0|||
144672260|NCT01369225|521651110|FG002|Overall Study|Other|0|||
144672261|NCT01369225|521651111|FG003|Overall Study|Other|0|||
144672262|NCT01369225|521651112|FG004|Overall Study|Other|1|||
144672263|NCT01369225|521651113|FG005|Overall Study|Other|0|||
144218030|NCT04358081|519992220|FG000|Study Completion Phase|Lost to Follow-up|1|||
144218031|NCT04358081|519992221|FG001|Study Completion Phase|Lost to Follow-up|0|||
144672264|NCT01369225|521651108|FG000|Overall Study|Adverse Event|0|||
144672265|NCT01369225|521651109|FG001|Overall Study|Adverse Event|0|||
144672266|NCT01369225|521651110|FG002|Overall Study|Adverse Event|0|||
144672267|NCT01369225|521651111|FG003|Overall Study|Adverse Event|1|||
144672268|NCT01369225|521651112|FG004|Overall Study|Adverse Event|1|||
144672269|NCT01369225|521651113|FG005|Overall Study|Adverse Event|0|||
144672270|NCT00105183|521651117|FG000|Overall Study|Death|19|||
144672271|NCT00105183|521651118|FG001|Overall Study|Death|13|||
144672272|NCT00105183|521651119|FG002|Overall Study|Death|15|||
144672273|NCT00105183|521651117|FG000|Overall Study|Withdrawal by Subject|1|||
144672274|NCT00105183|521651118|FG001|Overall Study|Withdrawal by Subject|1|||
144672275|NCT00105183|521651119|FG002|Overall Study|Withdrawal by Subject|4|||
144672276|NCT00105183|521651117|FG000|Overall Study|Physician Decision|1|||
144672277|NCT00105183|521651118|FG001|Overall Study|Physician Decision|2|||
144672278|NCT00105183|521651119|FG002|Overall Study|Physician Decision|3|||
144672279|NCT00105183|521651117|FG000|Overall Study|Lost to Follow-up|0|||
144672280|NCT00105183|521651118|FG001|Overall Study|Lost to Follow-up|1|||
144672281|NCT00105183|521651119|FG002|Overall Study|Lost to Follow-up|1|||
144672282|NCT00105183|521651117|FG000|Overall Study|Other reason|1|||
144672283|NCT00105183|521651118|FG001|Overall Study|Other reason|2|||
144672284|NCT00105183|521651119|FG002|Overall Study|Other reason|0|||
144672285|NCT01467661|521651121|FG000|Overall Study|Adverse Event|16|||
144672286|NCT01467661|521651121|FG000|Overall Study|Withdrawal by Subject|1|||
144672287|NCT01467661|521651121|FG000|Overall Study|Lack of Efficacy|3|||
144672288|NCT01467661|521651121|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
144672289|NCT03037307|521651122|FG000|Period 1|Did Not Meet Study Criteria|0|||
144672290|NCT03037307|521651123|FG001|Period 1|Did Not Meet Study Criteria|0|||
144672291|NCT03037307|521651124|FG002|Period 1|Did Not Meet Study Criteria|0|||
144672292|NCT03037307|521651125|FG003|Period 1|Did Not Meet Study Criteria|1|||
144672293|NCT03037307|521651126|FG004|Period 1|Did Not Meet Study Criteria|0|||
144672294|NCT03037307|521651127|FG005|Period 1|Did Not Meet Study Criteria|0|||
144672295|NCT01855945|521651130|FG000|Overall Study|Adverse Event|0|||
144672296|NCT01855945|521651131|FG001|Overall Study|Adverse Event|0|||
144672297|NCT01855945|521651132|FG002|Overall Study|Adverse Event|0|||
144672298|NCT01855945|521651133|FG003|Overall Study|Adverse Event|0|||
144672299|NCT01855945|521651134|FG004|Overall Study|Adverse Event|0|||
144672300|NCT01855945|521651135|FG005|Overall Study|Adverse Event|0|||
144672301|NCT01855945|521651136|FG006|Overall Study|Adverse Event|1|||
144672302|NCT01855945|521651137|FG007|Overall Study|Adverse Event|0|||
144672303|NCT01855945|521651138|FG008|Overall Study|Adverse Event|0|||
144672304|NCT01855945|521651139|FG009|Overall Study|Adverse Event|0|||
144672305|NCT01855945|521651140|FG010|Overall Study|Adverse Event|0|||
144672306|NCT01855945|521651141|FG011|Overall Study|Adverse Event|0|||
144672307|NCT01855945|521651130|FG000|Overall Study|Death|0|||
144672308|NCT01855945|521651131|FG001|Overall Study|Death|0|||
144672309|NCT01855945|521651132|FG002|Overall Study|Death|0|||
144672310|NCT01855945|521651133|FG003|Overall Study|Death|0|||
144672311|NCT01855945|521651134|FG004|Overall Study|Death|0|||
144672312|NCT01855945|521651135|FG005|Overall Study|Death|0|||
144672313|NCT01855945|521651136|FG006|Overall Study|Death|2|||
144672314|NCT01855945|521651137|FG007|Overall Study|Death|0|||
144672315|NCT01855945|521651138|FG008|Overall Study|Death|0|||
144672316|NCT01855945|521651139|FG009|Overall Study|Death|0|||
144672317|NCT01855945|521651140|FG010|Overall Study|Death|0|||
144672318|NCT01855945|521651141|FG011|Overall Study|Death|0|||
144672319|NCT01855945|521651130|FG000|Overall Study|Lost to Follow-up|11|||
144672320|NCT01855945|521651131|FG001|Overall Study|Lost to Follow-up|10|||
144672321|NCT01855945|521651132|FG002|Overall Study|Lost to Follow-up|7|||
144672322|NCT01855945|521651133|FG003|Overall Study|Lost to Follow-up|3|||
144218032|NCT04358081|519992222|FG002|Study Completion Phase|Lost to Follow-up|1|||
144218033|NCT01368497|519992223|FG000|Overall Study|Lost to Follow-up|2|||
144218034|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
144672323|NCT01855945|521651134|FG004|Overall Study|Lost to Follow-up|0|||
144672324|NCT01855945|521651135|FG005|Overall Study|Lost to Follow-up|3|||
144672325|NCT01855945|521651136|FG006|Overall Study|Lost to Follow-up|4|||
144672326|NCT01855945|521651137|FG007|Overall Study|Lost to Follow-up|7|||
144672327|NCT01855945|521651138|FG008|Overall Study|Lost to Follow-up|2|||
144672328|NCT01855945|521651139|FG009|Overall Study|Lost to Follow-up|0|||
144672329|NCT01855945|521651140|FG010|Overall Study|Lost to Follow-up|0|||
144672330|NCT01855945|521651141|FG011|Overall Study|Lost to Follow-up|2|||
144218035|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
144218036|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
144672331|NCT01855945|521651130|FG000|Overall Study|Other - Unclassified|1|||
144672332|NCT01855945|521651131|FG001|Overall Study|Other - Unclassified|1|||
144672333|NCT01855945|521651132|FG002|Overall Study|Other - Unclassified|1|||
144672334|NCT01855945|521651133|FG003|Overall Study|Other - Unclassified|0|||
144672335|NCT01855945|521651134|FG004|Overall Study|Other - Unclassified|0|||
144672336|NCT01855945|521651135|FG005|Overall Study|Other - Unclassified|0|||
144218037|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
144672337|NCT01855945|521651136|FG006|Overall Study|Other - Unclassified|2|||
144672338|NCT01855945|521651137|FG007|Overall Study|Other - Unclassified|1|||
144672339|NCT01855945|521651138|FG008|Overall Study|Other - Unclassified|0|||
144672340|NCT01855945|521651139|FG009|Overall Study|Other - Unclassified|0|||
144672341|NCT01855945|521651140|FG010|Overall Study|Other - Unclassified|1|||
144672342|NCT01855945|521651141|FG011|Overall Study|Other - Unclassified|0|||
144672343|NCT01855945|521651130|FG000|Overall Study|Withdrawal by Subject|4|||
144672344|NCT01855945|521651131|FG001|Overall Study|Withdrawal by Subject|0|||
144672345|NCT01855945|521651132|FG002|Overall Study|Withdrawal by Subject|4|||
144672346|NCT01855945|521651133|FG003|Overall Study|Withdrawal by Subject|1|||
144672347|NCT01855945|521651134|FG004|Overall Study|Withdrawal by Subject|1|||
144672348|NCT01855945|521651135|FG005|Overall Study|Withdrawal by Subject|0|||
144672349|NCT01855945|521651136|FG006|Overall Study|Withdrawal by Subject|1|||
144672350|NCT01855945|521651137|FG007|Overall Study|Withdrawal by Subject|0|||
144672351|NCT01855945|521651138|FG008|Overall Study|Withdrawal by Subject|0|||
144672352|NCT01855945|521651139|FG009|Overall Study|Withdrawal by Subject|2|||
144672353|NCT01855945|521651140|FG010|Overall Study|Withdrawal by Subject|4|||
144672354|NCT01855945|521651141|FG011|Overall Study|Withdrawal by Subject|1|||
144672355|NCT02156804|521651142|FG000|Overall Study|Withdrawal by Subject|1|||
144672356|NCT02260388|521651145|FG000|Overall Study|Lost to Follow-up|2|||
144672357|NCT02260388|521651146|FG001|Overall Study|Lost to Follow-up|8|||
144672358|NCT02260388|521651147|FG002|Overall Study|Lost to Follow-up|3|||
144672359|NCT02260388|521651148|FG003|Overall Study|Lost to Follow-up|4|||
144672360|NCT00389441|521651149|FG000|Overall Study|Adverse Event|7|||
144672361|NCT00389441|521651149|FG000|Overall Study|Death|4|||
144672362|NCT00389441|521651149|FG000|Overall Study|Lost to Follow-up|2|||
144672363|NCT00389441|521651149|FG000|Overall Study|Withdrawal by Subject|4|||
144672364|NCT00389441|521651149|FG000|Overall Study|Physician Decision|1|||
144672365|NCT00389441|521651149|FG000|Overall Study|Protocol Violation|1|||
144672366|NCT00389441|521651149|FG000|Overall Study|Global deterioration of health status|4|||
144672367|NCT00389441|521651149|FG000|Overall Study|Objective progression or relapse|26|||
144672368|NCT00389441|521651149|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
144672369|NCT00389441|521651149|FG000|Overall Study|Clinical progression|1|||
144672370|NCT00305604|521651151|FG000|Overall Study|Adverse Event|6|||
144672371|NCT00305604|521651152|FG001|Overall Study|Adverse Event|3|||
144672372|NCT00305604|521651151|FG000|Overall Study|Lack of Efficacy|11|||
144672373|NCT00305604|521651152|FG001|Overall Study|Lack of Efficacy|18|||
144672374|NCT00305604|521651151|FG000|Overall Study|Lost to Follow-up|0|||
144672375|NCT00305604|521651152|FG001|Overall Study|Lost to Follow-up|4|||
144672376|NCT00305604|521651151|FG000|Overall Study|Protocol Violation|2|||
144672377|NCT00305604|521651152|FG001|Overall Study|Protocol Violation|1|||
144672378|NCT00305604|521651151|FG000|Overall Study|Withdrawal by Subject|12|||
144672379|NCT00305604|521651152|FG001|Overall Study|Withdrawal by Subject|21|||
144672380|NCT00305604|521651151|FG000|Overall Study|Patient moved|1|||
144672381|NCT00305604|521651152|FG001|Overall Study|Patient moved|0|||
144672382|NCT00636441|521651153|FG000|Overall Study|Adverse Event|0|||
144672383|NCT00636441|521651154|FG001|Overall Study|Adverse Event|1|||
144672384|NCT00636441|521651155|FG002|Overall Study|Adverse Event|1|||
144672385|NCT00636441|521651156|FG003|Overall Study|Adverse Event|0|||
144672386|NCT00636441|521651157|FG004|Overall Study|Adverse Event|0|||
144672387|NCT00636441|521651158|FG005|Overall Study|Adverse Event|1|||
144672388|NCT00636441|521651159|FG006|Overall Study|Adverse Event|0|||
144672389|NCT00636441|521651153|FG000|Overall Study|Late, ineligible|0|||
144672390|NCT00636441|521651154|FG001|Overall Study|Late, ineligible|0|||
144672391|NCT00636441|521651155|FG002|Overall Study|Late, ineligible|0|||
144672392|NCT00636441|521651156|FG003|Overall Study|Late, ineligible|0|||
144672393|NCT00636441|521651157|FG004|Overall Study|Late, ineligible|0|||
144672394|NCT00636441|521651158|FG005|Overall Study|Late, ineligible|0|||
144672395|NCT00636441|521651159|FG006|Overall Study|Late, ineligible|1|||
144218038|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
144218039|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
144672396|NCT00636441|521651153|FG000|Overall Study|Screen Failure|0|||
144672397|NCT00636441|521651154|FG001|Overall Study|Screen Failure|0|||
144672398|NCT00636441|521651155|FG002|Overall Study|Screen Failure|0|||
144672399|NCT00636441|521651156|FG003|Overall Study|Screen Failure|0|||
144672400|NCT00636441|521651157|FG004|Overall Study|Screen Failure|0|||
144672401|NCT00636441|521651158|FG005|Overall Study|Screen Failure|0|||
144735229|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144218040|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
144672402|NCT00636441|521651159|FG006|Overall Study|Screen Failure|17|||
144672403|NCT00753623|521651161|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
144672404|NCT00753623|521651162|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
144672405|NCT00753623|521651161|FG000|Phase I (14 Days)|Physician Decision|1|||
144672406|NCT00753623|521651162|FG001|Phase I (14 Days)|Physician Decision|2|||
144672407|NCT00753623|521651161|FG000|Phase I (14 Days)|Adverse Event|0|||
144672408|NCT00753623|521651162|FG001|Phase I (14 Days)|Adverse Event|1|||
144735230|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
144735231|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735232|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
144735233|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
144735234|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
144735235|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735236|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735237|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735238|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735239|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735240|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735241|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735242|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
144735243|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735244|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735245|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735246|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735247|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
144735248|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
144735249|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
144735250|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
144735251|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
144735252|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
144735253|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
144735254|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
144735255|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
144735256|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735257|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735258|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735259|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735260|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735261|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735262|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735263|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
144735264|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735265|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735266|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735267|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735268|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
144735269|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
144735270|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
144735271|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735272|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
144735273|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
144735274|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
144735275|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
144265622|NCT02513550|520173978|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
144265623|NCT02513550|520173979|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
144735276|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
144735277|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735278|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735279|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735280|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735281|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735282|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735283|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735284|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
144735285|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735286|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735287|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735288|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144265624|NCT02513550|520173980|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
144265625|NCT02513550|520173975|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144265626|NCT02513550|520173976|FG001|Double Blind Treatment Period|Protocol Violation|1|||
144735289|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
144735290|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735291|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735292|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735293|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
144735294|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
144735295|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
144735296|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735297|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
144735298|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735299|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735300|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735301|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735302|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735303|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735304|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735305|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
144735306|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735307|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735308|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735309|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735310|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
144735311|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
144735312|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
144735313|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735314|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
144735315|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
144735316|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
144735317|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
144735318|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
144735319|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144672409|NCT00753623|521651161|FG000|Washout (7 Days)|Physician Decision|1|||
144672410|NCT00753623|521651162|FG001|Washout (7 Days)|Physician Decision|0|||
144672411|NCT00753623|521651161|FG000|Phase II (14 Days)|Physician Decision|0|||
144672412|NCT00753623|521651162|FG001|Phase II (14 Days)|Physician Decision|1|||
144672413|NCT03332303|521651163|FG000|Overall Study|Participant did not dose|1|||
144672414|NCT03332303|521651164|FG001|Overall Study|Participant did not dose|2|||
144672415|NCT03332303|521651165|FG002|Overall Study|Participant did not dose|0|||
144672416|NCT03332303|521651163|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
144672417|NCT03332303|521651164|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
144672418|NCT03332303|521651165|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
144672419|NCT03332303|521651163|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
144672420|NCT03332303|521651164|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
144672421|NCT03332303|521651165|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
144672422|NCT03332303|521651163|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
144672423|NCT03332303|521651164|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
144672424|NCT03332303|521651165|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
144672425|NCT03332303|521651163|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
144672426|NCT03332303|521651164|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
144672427|NCT03332303|521651165|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
144672428|NCT03332303|521651163|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
144672429|NCT03332303|521651164|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
144672430|NCT03332303|521651165|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
144672431|NCT03332303|521651163|FG000|Overall Study|Participant had a significant protocol deviation|0|||
144672432|NCT03332303|521651164|FG001|Overall Study|Participant had a significant protocol deviation|1|||
144672433|NCT03332303|521651165|FG002|Overall Study|Participant had a significant protocol deviation|0|||
144672434|NCT00326417|521651167|FG000|Overall Study|Withdrawal by Subject|0|||
144672435|NCT00326417|521651168|FG001|Overall Study|Withdrawal by Subject|0|||
144672436|NCT00326417|521651169|FG002|Overall Study|Withdrawal by Subject|1|||
144672437|NCT00326417|521651170|FG003|Overall Study|Withdrawal by Subject|0|||
144672438|NCT00326417|521651167|FG000|Overall Study|Arm Closed|7|||
144672439|NCT00326417|521651168|FG001|Overall Study|Arm Closed|0|||
144735320|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735321|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735322|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735323|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735324|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735325|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735326|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
144735327|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735328|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735329|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735330|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735331|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735332|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
144735333|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735334|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735335|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
144735336|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
144735337|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
144735338|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
144735339|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735340|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735341|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735342|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735343|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735344|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735345|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735346|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735347|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
144735348|NCT01597245|521885545|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735349|NCT01597245|521885546|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735350|NCT01597245|521885547|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735351|NCT01597245|521885548|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735352|NCT01597245|521885549|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735353|NCT01597245|521885550|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735354|NCT01597245|521885551|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735355|NCT01597245|521885552|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735356|NCT01597245|521885553|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735357|NCT01597245|521885554|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735358|NCT01597245|521885555|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
144735359|NCT01597245|521885556|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735360|NCT01597245|521885557|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735361|NCT01597245|521885558|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735362|NCT01597245|521885559|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735363|NCT01597245|521885560|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735364|NCT01597245|521885561|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735365|NCT01597245|521885562|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735366|NCT01597245|521885563|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735367|NCT01597245|521885564|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735368|NCT01597245|521885565|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
144735369|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735370|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735371|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144672440|NCT00326417|521651169|FG002|Overall Study|Arm Closed|0|||
144672441|NCT00326417|521651170|FG003|Overall Study|Arm Closed|3|||
144672442|NCT00326417|521651167|FG000|Overall Study|Death|7|||
144672443|NCT00326417|521651168|FG001|Overall Study|Death|0|||
144672444|NCT00326417|521651169|FG002|Overall Study|Death|0|||
144672445|NCT00326417|521651170|FG003|Overall Study|Death|0|||
144672446|NCT00844285|521651171|FG000|Overall Study|Other|0|||
144672447|NCT00844285|521651172|FG001|Overall Study|Other|1|||
144672448|NCT00844285|521651173|FG002|Overall Study|Other|0|||
144672449|NCT00844285|521651171|FG000|Overall Study|Other than specified|95|||
144672450|NCT00844285|521651172|FG001|Overall Study|Other than specified|129|||
144672451|NCT00844285|521651173|FG002|Overall Study|Other than specified|12|||
144672452|NCT00844285|521651171|FG000|Overall Study|Site closure|256|||
144672453|NCT00844285|521651172|FG001|Overall Study|Site closure|450|||
144672454|NCT00844285|521651173|FG002|Overall Study|Site closure|50|||
144672455|NCT00844285|521651171|FG000|Overall Study|Follow-up < 8 years|16|||
144672456|NCT00844285|521651172|FG001|Overall Study|Follow-up < 8 years|23|||
144672457|NCT00844285|521651173|FG002|Overall Study|Follow-up < 8 years|4|||
144672458|NCT00844285|521651171|FG000|Overall Study|Protocol Violation|26|||
144672459|NCT00844285|521651172|FG001|Overall Study|Protocol Violation|28|||
144672460|NCT00844285|521651173|FG002|Overall Study|Protocol Violation|54|||
144672461|NCT00844285|521651171|FG000|Overall Study|Death|22|||
144672462|NCT00844285|521651172|FG001|Overall Study|Death|21|||
144672463|NCT00844285|521651173|FG002|Overall Study|Death|8|||
144672464|NCT00844285|521651171|FG000|Overall Study|Withdrew Consent|344|||
144672465|NCT00844285|521651172|FG001|Overall Study|Withdrew Consent|466|||
144672466|NCT00844285|521651173|FG002|Overall Study|Withdrew Consent|70|||
144672467|NCT00844285|521651171|FG000|Overall Study|Lost to Follow-up|330|||
144672468|NCT00844285|521651172|FG001|Overall Study|Lost to Follow-up|486|||
144672469|NCT00844285|521651173|FG002|Overall Study|Lost to Follow-up|74|||
144672470|NCT04682353|521651174|FG000|Overall Study|Lost to Follow-up|0|||
144672471|NCT04682353|521651175|FG001|Overall Study|Lost to Follow-up|1|||
144672472|NCT04682353|521651176|FG002|Overall Study|Lost to Follow-up|0|||
144672473|NCT04682353|521651177|FG003|Overall Study|Lost to Follow-up|1|||
144672474|NCT04682353|521651174|FG000|Overall Study|Personal reasons|0|||
144672475|NCT04682353|521651175|FG001|Overall Study|Personal reasons|1|||
144672476|NCT04682353|521651176|FG002|Overall Study|Personal reasons|0|||
144672477|NCT04682353|521651177|FG003|Overall Study|Personal reasons|0|||
144672478|NCT01586806|521651178|FG000|Overall Study|Protocol Violation|0|||
144672479|NCT01586806|521651179|FG001|Overall Study|Protocol Violation|1|||
144672480|NCT01586806|521651180|FG002|Overall Study|Protocol Violation|0|||
144672481|NCT01586806|521651178|FG000|Overall Study|Withdrawal by Subject|1|||
144672482|NCT01586806|521651179|FG001|Overall Study|Withdrawal by Subject|0|||
144672483|NCT01586806|521651180|FG002|Overall Study|Withdrawal by Subject|0|||
144672484|NCT01586806|521651178|FG000|Overall Study|Lost to Follow-up|2|||
144672485|NCT01586806|521651179|FG001|Overall Study|Lost to Follow-up|3|||
144672486|NCT01586806|521651180|FG002|Overall Study|Lost to Follow-up|2|||
144672487|NCT02849626|521651181|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
144672488|NCT02849626|521651182|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
144672489|NCT02849626|521651183|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
144672490|NCT02849626|521651184|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
144672491|NCT02849626|521651181|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
144672492|NCT02849626|521651182|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
144672493|NCT02849626|521651183|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
144672494|NCT02849626|521651184|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
144672495|NCT02849626|521651181|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
144672496|NCT02849626|521651182|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
144672497|NCT02849626|521651183|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
144672498|NCT02849626|521651184|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
144672499|NCT02849626|521651181|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
144672500|NCT02849626|521651182|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
144672501|NCT02849626|521651183|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
144672502|NCT02849626|521651184|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
144672503|NCT02849626|521651181|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
144672504|NCT02849626|521651182|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
144672505|NCT02849626|521651183|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
144672506|NCT02849626|521651184|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
144672507|NCT02849626|521651181|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
144672508|NCT02849626|521651182|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
144672509|NCT02849626|521651183|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
144672510|NCT02849626|521651184|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
144672511|NCT02849626|521651181|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
144672512|NCT02849626|521651182|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
144672513|NCT02849626|521651183|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
144672514|NCT02849626|521651184|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
144672515|NCT02849626|521651181|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
144672516|NCT02849626|521651182|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
144672517|NCT02849626|521651183|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
144672518|NCT02849626|521651184|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
144672519|NCT02849626|521651181|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
144672520|NCT02849626|521651182|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
144672521|NCT02849626|521651183|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
144672522|NCT02849626|521651184|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
144672523|NCT02849626|521651181|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
144672524|NCT02849626|521651182|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
144672525|NCT02849626|521651183|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
144672526|NCT02849626|521651184|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
144672527|NCT02849626|521651181|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
144265627|NCT02513550|520173977|FG002|Double Blind Treatment Period|Protocol Violation|4|||
144672528|NCT02849626|521651182|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
144672529|NCT02849626|521651183|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
144672530|NCT02849626|521651184|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
144672531|NCT01185704|521651185|FG000|Overall Study|Randomized but not treated|3|||
144672532|NCT01185704|521651186|FG001|Overall Study|Randomized but not treated|3|||
144672533|NCT01185704|521651185|FG000|Overall Study|Lack of ovarian response|5|||
144672534|NCT01185704|521651186|FG001|Overall Study|Lack of ovarian response|1|||
144672535|NCT01185704|521651185|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
144672536|NCT01185704|521651186|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
144672537|NCT01185704|521651185|FG000|Overall Study|Ectopic pregnancy|0|||
144672538|NCT01185704|521651186|FG001|Overall Study|Ectopic pregnancy|1|||
144672539|NCT04176445|521651189|FG000|Overall Study|Adverse Event|0|||
144672540|NCT04176445|521651190|FG001|Overall Study|Adverse Event|1|||
144672541|NCT04176445|521651189|FG000|Overall Study|change plans weaning after first intervention|0|||
144672542|NCT04176445|521651190|FG001|Overall Study|change plans weaning after first intervention|1|||
144672543|NCT00367432|521651191|FG000|First Period (16 Weeks)|Adverse Event|6|||
144672544|NCT00367432|521651192|FG001|First Period (16 Weeks)|Adverse Event|0|||
144672545|NCT00367432|521651191|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
144672546|NCT00367432|521651192|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
144672547|NCT00367432|521651191|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
144672548|NCT00367432|521651192|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
144672549|NCT00367432|521651191|FG000|First Period (16 Weeks)|Other Reason|2|||
144672550|NCT00367432|521651192|FG001|First Period (16 Weeks)|Other Reason|0|||
144672551|NCT00367432|521651191|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
144672552|NCT00367432|521651192|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
144672553|NCT00367432|521651191|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
144672554|NCT00367432|521651192|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
144672555|NCT00367432|521651191|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
144672556|NCT00367432|521651192|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
144672557|NCT00367432|521651191|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
144672558|NCT00367432|521651192|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
144672559|NCT00367432|521651191|FG000|Second Period (up to 54 Months)|Other Reason|6|||
144672560|NCT00367432|521651192|FG001|Second Period (up to 54 Months)|Other Reason|2|||
144672561|NCT05567393|521651193|FG000|Overall Study|Voluntary Withdrawal|0|||
144672562|NCT05567393|521651194|FG001|Overall Study|Voluntary Withdrawal|0|||
144672563|NCT05567393|521651195|FG002|Overall Study|Voluntary Withdrawal|0|||
144672564|NCT05567393|521651196|FG003|Overall Study|Voluntary Withdrawal|0|||
144672565|NCT05567393|521651197|FG004|Overall Study|Voluntary Withdrawal|0|||
144672566|NCT05567393|521651198|FG005|Overall Study|Voluntary Withdrawal|0|||
144672567|NCT05567393|521651199|FG006|Overall Study|Voluntary Withdrawal|0|||
144672568|NCT05567393|521651200|FG007|Overall Study|Voluntary Withdrawal|0|||
144672569|NCT05567393|521651201|FG008|Overall Study|Voluntary Withdrawal|0|||
144672570|NCT05567393|521651202|FG009|Overall Study|Voluntary Withdrawal|0|||
144672571|NCT05567393|521651203|FG010|Overall Study|Voluntary Withdrawal|0|||
144672572|NCT05567393|521651204|FG011|Overall Study|Voluntary Withdrawal|0|||
144672573|NCT05567393|521651205|FG012|Overall Study|Voluntary Withdrawal|0|||
144672574|NCT05567393|521651206|FG013|Overall Study|Voluntary Withdrawal|1|||
144672575|NCT05567393|521651207|FG014|Overall Study|Voluntary Withdrawal|0|||
144672576|NCT05567393|521651208|FG015|Overall Study|Voluntary Withdrawal|0|||
144672577|NCT05567393|521651209|FG016|Overall Study|Voluntary Withdrawal|0|||
144672578|NCT05567393|521651210|FG017|Overall Study|Voluntary Withdrawal|0|||
144672579|NCT02177175|521651213|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
144672580|NCT02177175|521651214|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
144672581|NCT04199793|521651215|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
144672582|NCT04199793|521651216|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
144672583|NCT04199793|521651215|FG000|Overall Study|Withdrawal by Subject|1|||
144672584|NCT04199793|521651216|FG001|Overall Study|Withdrawal by Subject|1|||
144672585|NCT03820726|521651217|FG000|Overall Study|Other than listed|23|||
144672586|NCT03820726|521651217|FG000|Overall Study|Withdrawal by Subject|37|||
144672587|NCT03820726|521651217|FG000|Overall Study|Lost to Follow-up|3|||
144672588|NCT03820726|521651217|FG000|Overall Study|Protocol deviation|1|||
144672589|NCT03820726|521651217|FG000|Overall Study|Adverse Event|146|||
144672590|NCT03820726|521651217|FG000|Overall Study|Not treated|1|||
144672591|NCT00345540|521651221|FG000|Overall Study|Withdrawal by Subject|1|||
144672592|NCT01406652|521651222|FG000|Overall Study|Lost-to-follow-up|3|||
144672593|NCT01406652|521651223|FG001|Overall Study|Lost-to-follow-up|4|||
144672594|NCT01406652|521651222|FG000|Overall Study|Withdrawal by Subject|2|||
144672595|NCT01406652|521651223|FG001|Overall Study|Withdrawal by Subject|2|||
144672596|NCT01406652|521651222|FG000|Overall Study|Insufficient follow-up|5|||
144672597|NCT01406652|521651223|FG001|Overall Study|Insufficient follow-up|4|||
144672598|NCT01406652|521651222|FG000|Overall Study|Infection not sure|10|||
144672599|NCT01406652|521651223|FG001|Overall Study|Infection not sure|10|||
144672600|NCT00628758|521651224|FG000|Overall Study|Adverse Event|2|||
144672601|NCT00628758|521651225|FG001|Overall Study|Adverse Event|3|||
144672602|NCT00628758|521651224|FG000|Overall Study|Withdrawal by Subject|6|||
144672603|NCT00628758|521651225|FG001|Overall Study|Withdrawal by Subject|3|||
144672604|NCT00628758|521651224|FG000|Overall Study|Death|1|||
144672605|NCT00628758|521651225|FG001|Overall Study|Death|0|||
144672606|NCT00628758|521651224|FG000|Overall Study|Protocol Violation|5|||
144672607|NCT00628758|521651225|FG001|Overall Study|Protocol Violation|1|||
144672608|NCT00628758|521651224|FG000|Overall Study|Lost to Follow-up|25|||
144672609|NCT00628758|521651225|FG001|Overall Study|Lost to Follow-up|31|||
144672610|NCT00628758|521651224|FG000|Overall Study|Pregnancy|2|||
144672611|NCT00628758|521651225|FG001|Overall Study|Pregnancy|2|||
144672612|NCT00628758|521651224|FG000|Overall Study|Investigator Moved|3|||
144672613|NCT00628758|521651225|FG001|Overall Study|Investigator Moved|0|||
144672614|NCT00628758|521651224|FG000|Overall Study|Treatment Failure|0|||
144672615|NCT00628758|521651225|FG001|Overall Study|Treatment Failure|2|||
144672616|NCT04179786|521651226|FG000|Overall Study|Withdrawal by Subject|8|||
144672617|NCT01938001|521651227|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
144672618|NCT01938001|521651228|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
144672619|NCT01938001|521651227|FG000|Pre-Treatment|Death|1|||
144672620|NCT01938001|521651228|FG001|Pre-Treatment|Death|0|||
144672621|NCT01938001|521651227|FG000|Treatment|Death|2|||
144672622|NCT01938001|521651228|FG001|Treatment|Death|0|||
144672623|NCT01938001|521651227|FG000|Treatment|Adverse Event|14|||
144672624|NCT01938001|521651228|FG001|Treatment|Adverse Event|8|||
144672625|NCT01938001|521651227|FG000|Treatment|Progressive Disease|21|||
144672626|NCT01938001|521651228|FG001|Treatment|Progressive Disease|54|||
144672627|NCT01938001|521651227|FG000|Treatment|Withdrawal by Subject|13|||
144672628|NCT01938001|521651228|FG001|Treatment|Withdrawal by Subject|7|||
144672629|NCT01938001|521651227|FG000|Treatment|Other reasons|2|||
144672630|NCT01938001|521651228|FG001|Treatment|Other reasons|1|||
144672631|NCT03310580|521651229|FG000|Overall Study|Adverse Event|0|||
144672632|NCT03310580|521651230|FG001|Overall Study|Adverse Event|1|||
144672633|NCT03310580|521651231|FG002|Overall Study|Adverse Event|0|||
144672634|NCT03175562|521651232|FG000|Overall Study|Adverse Event|1|||
144672635|NCT03175562|521651232|FG000|Overall Study|Lost to Follow-up|3|||
144672636|NCT03175562|521651232|FG000|Overall Study|Withdrawal by Subject|7|||
144672637|NCT03175562|521651232|FG000|Overall Study|Other (Not Specified)|5|||
144672638|NCT01230749|521651233|FG000|Overall Study|Adverse Event|0|||
144672639|NCT01230749|521651234|FG001|Overall Study|Adverse Event|0|||
144672640|NCT01230749|521651235|FG002|Overall Study|Adverse Event|0|||
144672641|NCT01230749|521651236|FG003|Overall Study|Adverse Event|1|||
144672642|NCT01230749|521651233|FG000|Overall Study|Physician Decision|0|||
144672643|NCT01230749|521651234|FG001|Overall Study|Physician Decision|0|||
144672644|NCT01230749|521651235|FG002|Overall Study|Physician Decision|1|||
144672645|NCT01230749|521651236|FG003|Overall Study|Physician Decision|0|||
144672646|NCT01230749|521651233|FG000|Overall Study|Withdrawal by Subject|0|||
144672647|NCT01230749|521651234|FG001|Overall Study|Withdrawal by Subject|1|||
144672648|NCT01230749|521651235|FG002|Overall Study|Withdrawal by Subject|0|||
144672649|NCT01230749|521651236|FG003|Overall Study|Withdrawal by Subject|0|||
144672650|NCT01230749|521651233|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
144672651|NCT01230749|521651234|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
144672652|NCT01230749|521651235|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
144672653|NCT01230749|521651236|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
144700137|NCT00948896|521754509|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
144700138|NCT00948896|521754510|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
144700139|NCT00948896|521754511|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
144700140|NCT00948896|521754512|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
144700141|NCT00948896|521754513|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
144700142|NCT00948896|521754514|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
144700143|NCT00948896|521754507|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
144700144|NCT00948896|521754508|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
144735372|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144700145|NCT00948896|521754509|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
144735373|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735374|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735375|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144700146|NCT00948896|521754510|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
144700147|NCT00948896|521754511|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
144700148|NCT00948896|521754512|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
144700149|NCT00948896|521754513|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
144700150|NCT00948896|521754514|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
144700151|NCT00948896|521754507|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
144700152|NCT00948896|521754508|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
144700153|NCT00948896|521754509|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
144700154|NCT00948896|521754510|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
144700155|NCT00948896|521754511|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
144700156|NCT00948896|521754512|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
144672654|NCT02688153|521653460|FG000|Overall Study|Death|7|||
144672655|NCT02688153|521653461|FG001|Overall Study|Death|5|||
144672656|NCT02688153|521653460|FG000|Overall Study|Withdrawal by Subject|4|||
144672657|NCT02688153|521653461|FG001|Overall Study|Withdrawal by Subject|2|||
144672658|NCT02688153|521653460|FG000|Overall Study|Valve Explant|1|||
144672659|NCT02688153|521653461|FG001|Overall Study|Valve Explant|0|||
144672660|NCT02688153|521653460|FG000|Overall Study|Conversion to Commercial Valve|3|||
144672661|NCT02688153|521653461|FG001|Overall Study|Conversion to Commercial Valve|0|||
144672662|NCT00107172|521653462|FG000|Overall Study|Withdrawal by Subject|1|||
144672663|NCT00107172|521653463|FG001|Overall Study|Withdrawal by Subject|0|||
144672664|NCT00107172|521653462|FG000|Overall Study|Death|0|||
144672665|NCT00107172|521653463|FG001|Overall Study|Death|2|||
144672666|NCT00107172|521653462|FG000|Overall Study|Other Reason|4|||
144672667|NCT00107172|521653463|FG001|Overall Study|Other Reason|3|||
144672668|NCT03750240|521653465|FG000|Overall Study|Technical Difficulties|2|||
144672669|NCT02848313|521653466|FG000|Overall Study|Adverse Event|1|||
144672670|NCT02848313|521653467|FG001|Overall Study|Adverse Event|2|||
144672671|NCT02848313|521653466|FG000|Overall Study|Lack of Efficacy|0|||
144672672|NCT02848313|521653467|FG001|Overall Study|Lack of Efficacy|1|||
144672673|NCT02848313|521653466|FG000|Overall Study|Withdrawal by Subject|1|||
144672674|NCT02848313|521653467|FG001|Overall Study|Withdrawal by Subject|1|||
144672675|NCT02848313|521653466|FG000|Overall Study|Lost to follow up|1|||
144672676|NCT02848313|521653467|FG001|Overall Study|Lost to follow up|0|||
144672677|NCT01544478|521653468|FG000|Overall Study|Adverse Event|1|||
144672678|NCT01544478|521653468|FG000|Overall Study|Death|1|||
144672679|NCT01544478|521653468|FG000|Overall Study|Lost to Follow-up|48|||
144672680|NCT01544478|521653468|FG000|Overall Study|Physician Decision|15|||
144672681|NCT01544478|521653468|FG000|Overall Study|Pregnancy|1|||
144672682|NCT01544478|521653468|FG000|Overall Study|Withdrawal by Subject|52|||
144672683|NCT03510910|521653470|FG000|Overall Study|Incomplete Survey|2|||
144672684|NCT03510910|521653471|FG001|Overall Study|Incomplete Survey|3|||
144672685|NCT01673490|521653475|FG000|Overall Study|Lost to Follow-up|1|||
144672686|NCT01673490|521653475|FG000|Overall Study|Adverse Event|3|||
144672687|NCT01673490|521653475|FG000|Overall Study|Withdrawal by Subject|3|||
144672688|NCT04914819|521653476|FG000|Overall Study|Pregnancy|3|||
144672689|NCT04914819|521653477|FG001|Overall Study|Pregnancy|1|||
144672690|NCT04914819|521653476|FG000|Overall Study|Discontinued study|4|||
144672691|NCT04914819|521653477|FG001|Overall Study|Discontinued study|1|||
144672692|NCT04914819|521653476|FG000|Overall Study|Lost to Follow-up|7|||
144672693|NCT04914819|521653477|FG001|Overall Study|Lost to Follow-up|0|||
144672694|NCT02715804|521653479|FG000|Overall Study|Death|222|||
144672695|NCT02715804|521653480|FG001|Overall Study|Death|106|||
144672696|NCT02715804|521653479|FG000|Overall Study|Withdrawal by Subject|5|||
144672697|NCT02715804|521653480|FG001|Overall Study|Withdrawal by Subject|4|||
144672698|NCT02715804|521653479|FG000|Overall Study|Other than specified|2|||
144672699|NCT02715804|521653480|FG001|Overall Study|Other than specified|3|||
144672700|NCT04038385|521653481|FG000|Overall Study|Completed baseline assessment only|7|||
144672701|NCT04038385|521653482|FG001|Overall Study|Completed baseline assessment only|4|||
144672702|NCT04038385|521653481|FG000|Overall Study|Moved out of area|4|||
144672703|NCT04038385|521653482|FG001|Overall Study|Moved out of area|2|||
144672704|NCT04038385|521653481|FG000|Overall Study|Discontinued study involvement|6|||
144672705|NCT04038385|521653482|FG001|Overall Study|Discontinued study involvement|1|||
144672706|NCT01625611|521653485|FG000|Overall Study|No adlib drinks Lab 1|3|||
144672707|NCT01625611|521653486|FG001|Overall Study|No adlib drinks Lab 1|0|||
144672708|NCT01625611|521653485|FG000|Overall Study|Technical issues with PET|1|||
144672709|NCT01625611|521653486|FG001|Overall Study|Technical issues with PET|0|||
144672710|NCT01625611|521653485|FG000|Overall Study|Unable to complete study procedures|1|||
144672711|NCT01625611|521653486|FG001|Overall Study|Unable to complete study procedures|0|||
144672712|NCT01625611|521653485|FG000|Overall Study|Withdrawal by Subject|3|||
144672713|NCT01625611|521653486|FG001|Overall Study|Withdrawal by Subject|0|||
144672714|NCT02038790|521653487|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
144672715|NCT02038790|521653488|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
144672716|NCT00948194|521653489|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
144672717|NCT00948194|521653490|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
144672718|NCT02431793|521653491|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
144672719|NCT02431793|521653492|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
144672720|NCT02431793|521653493|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
144672721|NCT02431793|521653491|FG000|Overall Study|Withdrawal by Subject|7|||
144672722|NCT02431793|521653492|FG001|Overall Study|Withdrawal by Subject|5|||
144672723|NCT02431793|521653493|FG002|Overall Study|Withdrawal by Subject|5|||
144672724|NCT02431793|521653491|FG000|Overall Study|Lost to Follow-up|101|||
144672725|NCT02431793|521653492|FG001|Overall Study|Lost to Follow-up|122|||
144672726|NCT02431793|521653493|FG002|Overall Study|Lost to Follow-up|104|||
144672727|NCT00233324|521653494|FG000|Main Study|Death|68|||
144672728|NCT00233324|521653495|FG001|Main Study|Death|60|||
144735376|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144672729|NCT00233324|521653496|FG002|Main Study|Death|62|||
144672730|NCT00233324|521653497|FG003|Main Study|Death|47|||
144672731|NCT00233324|521653494|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
144672732|NCT00233324|521653495|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
144672733|NCT00233324|521653496|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
144672734|NCT00233324|521653497|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
144672735|NCT00233324|521653494|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
144672736|NCT00233324|521653495|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
144672737|NCT00233324|521653496|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
144672738|NCT00233324|521653497|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
144672739|NCT03170258|521653511|FG000|Overall Study|Physician Decision|4|||
144672740|NCT03170258|521653512|FG001|Overall Study|Physician Decision|0|||
144672741|NCT03170258|521653511|FG000|Overall Study|Equipment issues|1|||
144672742|NCT03170258|521653512|FG001|Overall Study|Equipment issues|0|||
144672743|NCT03170258|521653511|FG000|Overall Study|Medication|1|||
144672744|NCT03170258|521653512|FG001|Overall Study|Medication|0|||
144672745|NCT03170258|521653511|FG000|Overall Study|Sleep issues|1|||
144672746|NCT03170258|521653512|FG001|Overall Study|Sleep issues|0|||
144672747|NCT01563107|521653513|FG000|Overall Study|Physician Decision|0|||
144672748|NCT01563107|521653514|FG001|Overall Study|Physician Decision|1|||
144672749|NCT01563107|521653515|FG002|Overall Study|Physician Decision|1|||
144672750|NCT01563107|521653516|FG003|Overall Study|Physician Decision|3|||
144672751|NCT01563107|521653513|FG000|Overall Study|Withdrawal by Subject|1|||
144672752|NCT01563107|521653514|FG001|Overall Study|Withdrawal by Subject|2|||
144672753|NCT01563107|521653515|FG002|Overall Study|Withdrawal by Subject|1|||
144672754|NCT01563107|521653516|FG003|Overall Study|Withdrawal by Subject|2|||
144672755|NCT03907969|521653518|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
144672756|NCT03907969|521653519|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
144672757|NCT03907969|521653520|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
144672758|NCT03907969|521653521|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
144672759|NCT03907969|521653522|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
144672760|NCT03907969|521653523|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
144672761|NCT03907969|521653524|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
144672762|NCT03907969|521653525|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
144672763|NCT03907969|521653526|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
144672764|NCT03907969|521653527|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
144672765|NCT03907969|521653528|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
144672766|NCT03907969|521653518|FG000|Monotherapy Part A|Progressive Disease|0|||
144672767|NCT03907969|521653519|FG001|Monotherapy Part A|Progressive Disease|1|||
144672768|NCT03907969|521653520|FG002|Monotherapy Part A|Progressive Disease|0|||
144672769|NCT03907969|521653521|FG003|Monotherapy Part A|Progressive Disease|0|||
144672770|NCT03907969|521653522|FG004|Monotherapy Part A|Progressive Disease|0|||
144672771|NCT03907969|521653523|FG005|Monotherapy Part A|Progressive Disease|1|||
144672772|NCT03907969|521653524|FG006|Monotherapy Part A|Progressive Disease|2|||
144672773|NCT03907969|521653525|FG007|Monotherapy Part A|Progressive Disease|0|||
144672774|NCT03907969|521653526|FG008|Monotherapy Part A|Progressive Disease|0|||
144672775|NCT03907969|521653527|FG009|Monotherapy Part A|Progressive Disease|0|||
144672776|NCT03907969|521653528|FG010|Monotherapy Part A|Progressive Disease|0|||
144672777|NCT03907969|521653518|FG000|Monotherapy Part A|Death|0|||
144672778|NCT03907969|521653519|FG001|Monotherapy Part A|Death|0|||
144672779|NCT03907969|521653520|FG002|Monotherapy Part A|Death|1|||
144672780|NCT03907969|521653521|FG003|Monotherapy Part A|Death|1|||
144672781|NCT03907969|521653522|FG004|Monotherapy Part A|Death|0|||
144672782|NCT03907969|521653523|FG005|Monotherapy Part A|Death|1|||
144672783|NCT03907969|521653524|FG006|Monotherapy Part A|Death|0|||
144672784|NCT03907969|521653525|FG007|Monotherapy Part A|Death|0|||
144672785|NCT03907969|521653526|FG008|Monotherapy Part A|Death|0|||
144672786|NCT03907969|521653527|FG009|Monotherapy Part A|Death|0|||
144672787|NCT03907969|521653528|FG010|Monotherapy Part A|Death|0|||
144672788|NCT03907969|521653518|FG000|Combination Therapy Part A|Adverse Event|0|||
144672789|NCT03907969|521653519|FG001|Combination Therapy Part A|Adverse Event|0|||
144672790|NCT03907969|521653520|FG002|Combination Therapy Part A|Adverse Event|0|||
144672791|NCT03907969|521653521|FG003|Combination Therapy Part A|Adverse Event|0|||
144672792|NCT03907969|521653522|FG004|Combination Therapy Part A|Adverse Event|0|||
144218041|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
144672793|NCT03907969|521653523|FG005|Combination Therapy Part A|Adverse Event|0|||
144672794|NCT03907969|521653524|FG006|Combination Therapy Part A|Adverse Event|0|||
144672795|NCT03907969|521653525|FG007|Combination Therapy Part A|Adverse Event|0|||
144672796|NCT03907969|521653526|FG008|Combination Therapy Part A|Adverse Event|0|||
144672797|NCT03907969|521653527|FG009|Combination Therapy Part A|Adverse Event|1|||
144672798|NCT03907969|521653528|FG010|Combination Therapy Part A|Adverse Event|1|||
144672799|NCT03907969|521653518|FG000|Combination Therapy Part A|Progressive disease|0|||
144672800|NCT03907969|521653519|FG001|Combination Therapy Part A|Progressive disease|0|||
144218042|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
144672801|NCT03907969|521653520|FG002|Combination Therapy Part A|Progressive disease|0|||
144672802|NCT03907969|521653521|FG003|Combination Therapy Part A|Progressive disease|0|||
144672803|NCT03907969|521653522|FG004|Combination Therapy Part A|Progressive disease|0|||
144672804|NCT03907969|521653523|FG005|Combination Therapy Part A|Progressive disease|0|||
144672805|NCT03907969|521653524|FG006|Combination Therapy Part A|Progressive disease|0|||
144672806|NCT03907969|521653525|FG007|Combination Therapy Part A|Progressive disease|1|||
144672807|NCT03907969|521653526|FG008|Combination Therapy Part A|Progressive disease|0|||
144672808|NCT03907969|521653527|FG009|Combination Therapy Part A|Progressive disease|2|||
144672809|NCT03907969|521653528|FG010|Combination Therapy Part A|Progressive disease|3|||
144672810|NCT03907969|521653518|FG000|Combination Therapy Part A|Death|0|||
144672811|NCT03907969|521653519|FG001|Combination Therapy Part A|Death|0|||
144672812|NCT03907969|521653520|FG002|Combination Therapy Part A|Death|0|||
144672813|NCT03907969|521653521|FG003|Combination Therapy Part A|Death|0|||
144672814|NCT03907969|521653522|FG004|Combination Therapy Part A|Death|0|||
144672815|NCT03907969|521653523|FG005|Combination Therapy Part A|Death|0|||
144672816|NCT03907969|521653524|FG006|Combination Therapy Part A|Death|0|||
144672817|NCT03907969|521653525|FG007|Combination Therapy Part A|Death|0|||
144672818|NCT03907969|521653526|FG008|Combination Therapy Part A|Death|1|||
144672819|NCT03907969|521653527|FG009|Combination Therapy Part A|Death|0|||
144672820|NCT03907969|521653528|FG010|Combination Therapy Part A|Death|1|||
144672821|NCT03907969|521653518|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
144672822|NCT03907969|521653519|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
144672823|NCT03907969|521653520|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
144672824|NCT03907969|521653521|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
144672825|NCT03907969|521653522|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
144672826|NCT03907969|521653523|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
144672827|NCT03907969|521653524|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
144672828|NCT03907969|521653525|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
144672829|NCT03907969|521653526|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
144672830|NCT03907969|521653527|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
144672831|NCT03907969|521653528|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
144672832|NCT03907969|521653518|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
144672833|NCT03907969|521653519|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
144672834|NCT03907969|521653520|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
144672835|NCT03907969|521653521|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
144672836|NCT03907969|521653522|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
144672837|NCT03907969|521653523|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
144672838|NCT03907969|521653524|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
144672839|NCT03907969|521653525|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
144672840|NCT03907969|521653526|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
144672841|NCT03907969|521653527|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
144672842|NCT03907969|521653528|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
144672843|NCT03907969|521653518|FG000|Combination Therapy Part A|Physician Decision|0|||
144672844|NCT03907969|521653519|FG001|Combination Therapy Part A|Physician Decision|0|||
144672845|NCT03907969|521653520|FG002|Combination Therapy Part A|Physician Decision|0|||
144672846|NCT03907969|521653521|FG003|Combination Therapy Part A|Physician Decision|0|||
144672847|NCT03907969|521653522|FG004|Combination Therapy Part A|Physician Decision|0|||
144672848|NCT03907969|521653523|FG005|Combination Therapy Part A|Physician Decision|0|||
144672849|NCT03907969|521653524|FG006|Combination Therapy Part A|Physician Decision|0|||
144672850|NCT03907969|521653525|FG007|Combination Therapy Part A|Physician Decision|1|||
144672851|NCT03907969|521653526|FG008|Combination Therapy Part A|Physician Decision|0|||
144672852|NCT03907969|521653527|FG009|Combination Therapy Part A|Physician Decision|0|||
144672853|NCT03907969|521653528|FG010|Combination Therapy Part A|Physician Decision|1|||
144672854|NCT00063986|521653532|FG000|Overall Study|Withdrawal by Subject|1|||
144672855|NCT00063986|521653532|FG000|Overall Study|Ineligible|1|||
144672856|NCT00063986|521653532|FG000|Overall Study|Intra-operatively ineligible|4|||
144672857|NCT00247273|521653540|FG000|Overall Study|Adverse Event|85|||
144672858|NCT00247273|521653541|FG001|Overall Study|Adverse Event|80|||
144672859|NCT00247273|521653540|FG000|Overall Study|Physician Decision|6|||
144672860|NCT00247273|521653541|FG001|Overall Study|Physician Decision|3|||
144672861|NCT00247273|521653540|FG000|Overall Study|Lost to Follow-up|7|||
144672862|NCT00247273|521653541|FG001|Overall Study|Lost to Follow-up|7|||
144672863|NCT00247273|521653540|FG000|Overall Study|Withdrawal by Subject|46|||
144672864|NCT00247273|521653541|FG001|Overall Study|Withdrawal by Subject|47|||
144672865|NCT00247273|521653540|FG000|Overall Study|Did not take any study drug|2|||
144672866|NCT00247273|521653541|FG001|Overall Study|Did not take any study drug|0|||
144672867|NCT01419015|521653542|FG000|Overall Study|Death|2|||
144672868|NCT04209530|521653543|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
144672869|NCT04209530|521653544|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
144672870|NCT04209530|521653543|FG000|Overall Study|Withdrawal by Subject|0|||
144672871|NCT04209530|521653544|FG001|Overall Study|Withdrawal by Subject|1|||
144672872|NCT00607919|521653545|FG000|Acute Phase|Adverse Event|9|||
144672873|NCT00607919|521653546|FG001|Acute Phase|Adverse Event|2|||
144672874|NCT00607919|521653545|FG000|Acute Phase|Entry Criteria Not Met|1|||
144672875|NCT00607919|521653546|FG001|Acute Phase|Entry Criteria Not Met|1|||
144735377|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144672876|NCT00607919|521653545|FG000|Acute Phase|Lack of Efficacy|1|||
144672877|NCT00607919|521653546|FG001|Acute Phase|Lack of Efficacy|2|||
144672878|NCT00607919|521653545|FG000|Acute Phase|Lost to Follow-up|9|||
144672879|NCT00607919|521653546|FG001|Acute Phase|Lost to Follow-up|3|||
144672880|NCT00607919|521653545|FG000|Acute Phase|Parent/Caregiver Decision|6|||
144672881|NCT00607919|521653546|FG001|Acute Phase|Parent/Caregiver Decision|4|||
144672882|NCT00607919|521653545|FG000|Acute Phase|Protocol Violation|5|||
144672883|NCT00607919|521653546|FG001|Acute Phase|Protocol Violation|1|||
144672884|NCT00607919|521653545|FG000|Acute Phase|Withdrawal by Subject|3|||
144672885|NCT00607919|521653546|FG001|Acute Phase|Withdrawal by Subject|3|||
144672886|NCT00607919|521653545|FG000|Open-Label Phase|Adverse Event|1|||
144672887|NCT00607919|521653546|FG001|Open-Label Phase|Adverse Event|5|||
144672888|NCT00607919|521653545|FG000|Open-Label Phase|Lost to Follow-up|4|||
144672889|NCT00607919|521653546|FG001|Open-Label Phase|Lost to Follow-up|1|||
144672890|NCT00607919|521653545|FG000|Open-Label Phase|Protocol Violation|2|||
144672891|NCT00607919|521653546|FG001|Open-Label Phase|Protocol Violation|2|||
144672892|NCT00607919|521653545|FG000|Open-Label Phase|Withdrawal by Subject|2|||
144672893|NCT00607919|521653546|FG001|Open-Label Phase|Withdrawal by Subject|2|||
144672894|NCT00607919|521653545|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
144672895|NCT00607919|521653546|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
144672896|NCT01527110|521653547|FG000|Overall Study|Adverse Event|1|||
144672897|NCT01709708|521653548|FG000|Overall Study|Protocol Violation|1|||
144672898|NCT01709708|521653549|FG001|Overall Study|Protocol Violation|2|||
144672899|NCT00527072|521653550|FG000|Overall Study|Adverse Event|13|||
144672900|NCT00527072|521653550|FG000|Overall Study|Lack of Efficacy|11|||
144672901|NCT00527072|521653550|FG000|Overall Study|Lost to Follow-up|3|||
144672902|NCT00527072|521653550|FG000|Overall Study|Protocol Violation|2|||
144672903|NCT00527072|521653550|FG000|Overall Study|Withdrawal by Subject|7|||
144672904|NCT02007252|521653551|FG000|Overall Study|Administrative problems|3|||
144672905|NCT02007252|521653552|FG001|Overall Study|Administrative problems|7|||
144672906|NCT02007252|521653551|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144672907|NCT02007252|521653552|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144672908|NCT02007252|521653551|FG000|Overall Study|Adverse Event|7|||
144672909|NCT02007252|521653552|FG001|Overall Study|Adverse Event|4|||
144672910|NCT02657434|521653553|FG000|Overall Study|Study Terminated By Sponsor|64|||
144672911|NCT02657434|521653554|FG001|Overall Study|Study Terminated By Sponsor|82|||
144672912|NCT02657434|521653553|FG000|Overall Study|Death|189|||
144672913|NCT02657434|521653554|FG001|Overall Study|Death|190|||
144672914|NCT02657434|521653553|FG000|Overall Study|Lost to Follow-up|2|||
144672915|NCT02657434|521653554|FG001|Overall Study|Lost to Follow-up|2|||
144672916|NCT02657434|521653553|FG000|Overall Study|Randomization by Error|2|||
144672917|NCT02657434|521653554|FG001|Overall Study|Randomization by Error|0|||
144672918|NCT02657434|521653553|FG000|Overall Study|Withdrawal by Subject|28|||
144672919|NCT02657434|521653554|FG001|Overall Study|Withdrawal by Subject|17|||
144672920|NCT02657434|521653553|FG000|Overall Study|Protocol Violation|1|||
144672921|NCT02657434|521653554|FG001|Overall Study|Protocol Violation|0|||
144672922|NCT02657434|521653553|FG000|Overall Study|Physician Decision|0|||
144672923|NCT02657434|521653554|FG001|Overall Study|Physician Decision|1|||
144672924|NCT01998958|521653561|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672925|NCT01998958|521653562|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
144672926|NCT01998958|521653563|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672927|NCT01998958|521653564|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672928|NCT01998958|521653565|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672929|NCT01998958|521653566|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672930|NCT01998958|521653567|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672931|NCT01998958|521653568|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144735378|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735379|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735380|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144672932|NCT01998958|521653569|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672933|NCT01998958|521653570|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672934|NCT01998958|521653571|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672935|NCT01998958|521653572|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144735381|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144672936|NCT01998958|521653573|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672937|NCT01998958|521653574|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672938|NCT01998958|521653575|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672939|NCT01998958|521653576|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672940|NCT01998958|521653577|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672941|NCT01998958|521653578|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672942|NCT01998958|521653579|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672943|NCT01998958|521653580|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672944|NCT01998958|521653581|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672945|NCT01998958|521653582|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144265628|NCT02513550|520173978|FG003|Double Blind Treatment Period|Protocol Violation|0|||
144265629|NCT02513550|520173979|FG004|Double Blind Treatment Period|Protocol Violation|0|||
144265630|NCT02513550|520173980|FG005|Double Blind Treatment Period|Protocol Violation|0|||
144265631|NCT02513550|520173975|FG000|Double Blind Treatment Period|Physician Decision|2|||
144672946|NCT01998958|521653583|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672947|NCT01998958|521653584|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672948|NCT01998958|521653585|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672949|NCT01998958|521653586|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672950|NCT01998958|521653587|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672951|NCT01998958|521653588|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672952|NCT01998958|521653589|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672953|NCT01998958|521653590|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672954|NCT01998958|521653591|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672955|NCT01998958|521653592|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
144672956|NCT01998958|521653561|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672957|NCT01998958|521653562|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
144672958|NCT01998958|521653563|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672959|NCT01998958|521653564|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672960|NCT01998958|521653565|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672961|NCT01998958|521653566|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672962|NCT01998958|521653567|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672963|NCT01998958|521653568|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672964|NCT01998958|521653569|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672965|NCT01998958|521653570|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672966|NCT01998958|521653571|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672967|NCT01998958|521653572|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672968|NCT01998958|521653573|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672969|NCT01998958|521653574|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672970|NCT01998958|521653575|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672971|NCT01998958|521653576|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672972|NCT01998958|521653577|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672973|NCT01998958|521653578|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672974|NCT01998958|521653579|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672975|NCT01998958|521653580|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672976|NCT01998958|521653581|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672977|NCT01998958|521653582|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672978|NCT01998958|521653583|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672979|NCT01998958|521653584|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672980|NCT01998958|521653585|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672981|NCT01998958|521653586|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672982|NCT01998958|521653587|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672983|NCT01998958|521653588|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672984|NCT01998958|521653589|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672985|NCT01998958|521653590|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672986|NCT01998958|521653591|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672987|NCT01998958|521653592|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
144672988|NCT01998958|521653561|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
144672989|NCT01998958|521653562|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
144672990|NCT01998958|521653563|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
144672991|NCT01998958|521653564|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
144672992|NCT01998958|521653565|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
144672993|NCT01998958|521653566|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
144672994|NCT01998958|521653567|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
144672995|NCT01998958|521653568|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
144672996|NCT01998958|521653569|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
144265632|NCT02513550|520173976|FG001|Double Blind Treatment Period|Physician Decision|0|||
144672997|NCT01998958|521653570|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
144672998|NCT01998958|521653571|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
144672999|NCT01998958|521653572|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
144673000|NCT01998958|521653573|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
144673001|NCT01998958|521653574|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
144673002|NCT01998958|521653575|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
144673003|NCT01998958|521653576|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
144673004|NCT01998958|521653577|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
144673005|NCT01998958|521653578|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
144673006|NCT01998958|521653579|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
144673007|NCT01998958|521653580|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
144673008|NCT01998958|521653581|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
144673009|NCT01998958|521653582|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
144673010|NCT01998958|521653583|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
144673011|NCT01998958|521653584|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
144673012|NCT01998958|521653585|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
144673013|NCT01998958|521653586|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
144265633|NCT02513550|520173977|FG002|Double Blind Treatment Period|Physician Decision|4|||
144218043|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
144218044|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
144218045|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
144218046|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
144218047|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
144218048|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
144218049|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
144673014|NCT01998958|521653587|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
144673015|NCT01998958|521653588|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
144673016|NCT01998958|521653589|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
144673017|NCT01998958|521653590|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
144673018|NCT01998958|521653591|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
144673019|NCT01998958|521653592|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
144673020|NCT01998958|521653561|FG000|Period 1 (Panel A and B)|Other|1|||
144673021|NCT01998958|521653562|FG001|Period 1 (Panel A and B)|Other|0|||
144673022|NCT01998958|521653563|FG002|Period 1 (Panel A and B)|Other|0|||
144673023|NCT01998958|521653564|FG003|Period 1 (Panel A and B)|Other|0|||
144673024|NCT01998958|521653565|FG004|Period 1 (Panel A and B)|Other|0|||
144673025|NCT01998958|521653566|FG005|Period 1 (Panel A and B)|Other|0|||
144673026|NCT01998958|521653567|FG006|Period 1 (Panel A and B)|Other|0|||
144673027|NCT01998958|521653568|FG007|Period 1 (Panel A and B)|Other|0|||
144673028|NCT01998958|521653569|FG008|Period 1 (Panel A and B)|Other|0|||
144673029|NCT01998958|521653570|FG009|Period 1 (Panel A and B)|Other|0|||
144673030|NCT01998958|521653571|FG010|Period 1 (Panel A and B)|Other|0|||
144673031|NCT01998958|521653572|FG011|Period 1 (Panel A and B)|Other|0|||
144673032|NCT01998958|521653573|FG012|Period 1 (Panel A and B)|Other|0|||
144673033|NCT01998958|521653574|FG013|Period 1 (Panel A and B)|Other|0|||
144673034|NCT01998958|521653575|FG014|Period 1 (Panel A and B)|Other|0|||
144673035|NCT01998958|521653576|FG015|Period 1 (Panel A and B)|Other|0|||
144673036|NCT01998958|521653577|FG016|Period 1 (Panel A and B)|Other|0|||
144673037|NCT01998958|521653578|FG017|Period 1 (Panel A and B)|Other|0|||
144673038|NCT01998958|521653579|FG018|Period 1 (Panel A and B)|Other|0|||
144673039|NCT01998958|521653580|FG019|Period 1 (Panel A and B)|Other|0|||
144673040|NCT01998958|521653581|FG020|Period 1 (Panel A and B)|Other|0|||
144673041|NCT01998958|521653582|FG021|Period 1 (Panel A and B)|Other|0|||
144673042|NCT01998958|521653583|FG022|Period 1 (Panel A and B)|Other|0|||
144673043|NCT01998958|521653584|FG023|Period 1 (Panel A and B)|Other|0|||
144673044|NCT01998958|521653585|FG024|Period 1 (Panel A and B)|Other|0|||
144673045|NCT01998958|521653586|FG025|Period 1 (Panel A and B)|Other|0|||
144673046|NCT01998958|521653587|FG026|Period 1 (Panel A and B)|Other|0|||
144673047|NCT01998958|521653588|FG027|Period 1 (Panel A and B)|Other|0|||
144673048|NCT01998958|521653589|FG028|Period 1 (Panel A and B)|Other|0|||
144673049|NCT01998958|521653590|FG029|Period 1 (Panel A and B)|Other|0|||
144673050|NCT01998958|521653591|FG030|Period 1 (Panel A and B)|Other|0|||
144673051|NCT01998958|521653592|FG031|Period 1 (Panel A and B)|Other|0|||
144673052|NCT01998958|521653561|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
144673053|NCT01998958|521653562|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
144673054|NCT01998958|521653563|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
144673055|NCT01998958|521653564|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
144673056|NCT01998958|521653565|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
144673057|NCT01998958|521653566|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
144673058|NCT01998958|521653567|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
144673059|NCT01998958|521653568|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
144673060|NCT01998958|521653569|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
144673061|NCT01998958|521653570|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
144673062|NCT01998958|521653571|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
144673063|NCT01998958|521653572|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
144673064|NCT01998958|521653573|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
144673065|NCT01998958|521653574|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
144673066|NCT01998958|521653575|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
144673067|NCT01998958|521653576|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
144673068|NCT01998958|521653577|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
144673069|NCT01998958|521653578|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
144673070|NCT01998958|521653579|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
144673071|NCT01998958|521653580|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
144673072|NCT01998958|521653581|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
144218050|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
144673073|NCT01998958|521653582|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
144673074|NCT01998958|521653583|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
144673075|NCT01998958|521653584|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
144673076|NCT01998958|521653585|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
144673077|NCT01998958|521653586|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
144673078|NCT01998958|521653587|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
144673079|NCT01998958|521653588|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
144673080|NCT01998958|521653589|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
144673081|NCT01998958|521653590|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
144673082|NCT01998958|521653591|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
144673083|NCT01998958|521653592|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
144673084|NCT01998958|521653561|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673085|NCT01998958|521653562|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673086|NCT01998958|521653563|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673087|NCT01998958|521653564|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673088|NCT01998958|521653565|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673089|NCT01998958|521653566|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673090|NCT01998958|521653567|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673091|NCT01998958|521653568|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673092|NCT01998958|521653569|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673093|NCT01998958|521653570|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673094|NCT01998958|521653571|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673095|NCT01998958|521653572|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673096|NCT01998958|521653573|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673097|NCT01998958|521653574|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673098|NCT01998958|521653575|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
144673099|NCT01998958|521653576|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673100|NCT01998958|521653577|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673101|NCT01998958|521653578|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673102|NCT01998958|521653579|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
144673103|NCT01998958|521653580|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673104|NCT01998958|521653581|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673105|NCT01998958|521653582|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673106|NCT01998958|521653583|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673107|NCT01998958|521653584|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673108|NCT01998958|521653585|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673109|NCT01998958|521653586|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673110|NCT01998958|521653587|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673111|NCT01998958|521653588|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673112|NCT01998958|521653589|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673113|NCT01998958|521653590|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673114|NCT01998958|521653591|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673115|NCT01998958|521653592|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
144673116|NCT01998958|521653561|FG000|Open Label Phase (Optional)|Adverse Event|0|||
144673117|NCT01998958|521653562|FG001|Open Label Phase (Optional)|Adverse Event|0|||
144673118|NCT01998958|521653563|FG002|Open Label Phase (Optional)|Adverse Event|0|||
144673119|NCT01998958|521653564|FG003|Open Label Phase (Optional)|Adverse Event|0|||
144673120|NCT01998958|521653565|FG004|Open Label Phase (Optional)|Adverse Event|0|||
144673121|NCT01998958|521653566|FG005|Open Label Phase (Optional)|Adverse Event|0|||
144673122|NCT01998958|521653567|FG006|Open Label Phase (Optional)|Adverse Event|0|||
144673123|NCT01998958|521653568|FG007|Open Label Phase (Optional)|Adverse Event|0|||
144673124|NCT01998958|521653569|FG008|Open Label Phase (Optional)|Adverse Event|0|||
144673125|NCT01998958|521653570|FG009|Open Label Phase (Optional)|Adverse Event|0|||
144673126|NCT01998958|521653571|FG010|Open Label Phase (Optional)|Adverse Event|0|||
144673127|NCT01998958|521653572|FG011|Open Label Phase (Optional)|Adverse Event|0|||
144673128|NCT01998958|521653573|FG012|Open Label Phase (Optional)|Adverse Event|0|||
144673129|NCT01998958|521653574|FG013|Open Label Phase (Optional)|Adverse Event|0|||
144673130|NCT01998958|521653575|FG014|Open Label Phase (Optional)|Adverse Event|0|||
144673131|NCT01998958|521653576|FG015|Open Label Phase (Optional)|Adverse Event|0|||
144673132|NCT01998958|521653577|FG016|Open Label Phase (Optional)|Adverse Event|0|||
144673133|NCT01998958|521653578|FG017|Open Label Phase (Optional)|Adverse Event|0|||
144673134|NCT01998958|521653579|FG018|Open Label Phase (Optional)|Adverse Event|0|||
144673135|NCT01998958|521653580|FG019|Open Label Phase (Optional)|Adverse Event|0|||
144673136|NCT01998958|521653581|FG020|Open Label Phase (Optional)|Adverse Event|0|||
144673137|NCT01998958|521653582|FG021|Open Label Phase (Optional)|Adverse Event|0|||
144673138|NCT01998958|521653583|FG022|Open Label Phase (Optional)|Adverse Event|0|||
144673139|NCT01998958|521653584|FG023|Open Label Phase (Optional)|Adverse Event|1|||
144673140|NCT01998958|521653585|FG024|Open Label Phase (Optional)|Adverse Event|0|||
144673141|NCT01998958|521653586|FG025|Open Label Phase (Optional)|Adverse Event|0|||
144673142|NCT01998958|521653587|FG026|Open Label Phase (Optional)|Adverse Event|0|||
144673143|NCT01998958|521653588|FG027|Open Label Phase (Optional)|Adverse Event|0|||
144673144|NCT01998958|521653589|FG028|Open Label Phase (Optional)|Adverse Event|0|||
144673145|NCT01998958|521653590|FG029|Open Label Phase (Optional)|Adverse Event|0|||
144673146|NCT01998958|521653591|FG030|Open Label Phase (Optional)|Adverse Event|0|||
144673147|NCT01998958|521653592|FG031|Open Label Phase (Optional)|Adverse Event|0|||
144218051|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
144218052|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
144218053|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
144218054|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
144673148|NCT01998958|521653561|FG000|Open Label Phase (Optional)|Other|0|||
144673149|NCT01998958|521653562|FG001|Open Label Phase (Optional)|Other|0|||
144673150|NCT01998958|521653563|FG002|Open Label Phase (Optional)|Other|0|||
144218055|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
144673151|NCT01998958|521653564|FG003|Open Label Phase (Optional)|Other|0|||
144673152|NCT01998958|521653565|FG004|Open Label Phase (Optional)|Other|0|||
144673153|NCT01998958|521653566|FG005|Open Label Phase (Optional)|Other|0|||
144673154|NCT01998958|521653567|FG006|Open Label Phase (Optional)|Other|0|||
144673155|NCT01998958|521653568|FG007|Open Label Phase (Optional)|Other|0|||
144673156|NCT01998958|521653569|FG008|Open Label Phase (Optional)|Other|0|||
144673157|NCT01998958|521653570|FG009|Open Label Phase (Optional)|Other|0|||
144673158|NCT01998958|521653571|FG010|Open Label Phase (Optional)|Other|0|||
144673159|NCT01998958|521653572|FG011|Open Label Phase (Optional)|Other|0|||
144673160|NCT01998958|521653573|FG012|Open Label Phase (Optional)|Other|0|||
144673161|NCT01998958|521653574|FG013|Open Label Phase (Optional)|Other|0|||
144673162|NCT01998958|521653575|FG014|Open Label Phase (Optional)|Other|0|||
144673163|NCT01998958|521653576|FG015|Open Label Phase (Optional)|Other|0|||
144673164|NCT01998958|521653577|FG016|Open Label Phase (Optional)|Other|0|||
144673165|NCT01998958|521653578|FG017|Open Label Phase (Optional)|Other|0|||
144673166|NCT01998958|521653579|FG018|Open Label Phase (Optional)|Other|0|||
144673167|NCT01998958|521653580|FG019|Open Label Phase (Optional)|Other|0|||
144673168|NCT01998958|521653581|FG020|Open Label Phase (Optional)|Other|0|||
144673169|NCT01998958|521653582|FG021|Open Label Phase (Optional)|Other|0|||
144673170|NCT01998958|521653583|FG022|Open Label Phase (Optional)|Other|5|||
144673171|NCT01998958|521653584|FG023|Open Label Phase (Optional)|Other|1|||
144673172|NCT01998958|521653585|FG024|Open Label Phase (Optional)|Other|0|||
144673173|NCT01998958|521653586|FG025|Open Label Phase (Optional)|Other|0|||
144673174|NCT01998958|521653587|FG026|Open Label Phase (Optional)|Other|0|||
144673175|NCT01998958|521653588|FG027|Open Label Phase (Optional)|Other|0|||
144673176|NCT01998958|521653589|FG028|Open Label Phase (Optional)|Other|0|||
144673177|NCT01998958|521653590|FG029|Open Label Phase (Optional)|Other|0|||
144673178|NCT01998958|521653591|FG030|Open Label Phase (Optional)|Other|0|||
144673179|NCT01998958|521653592|FG031|Open Label Phase (Optional)|Other|0|||
144673180|NCT01998958|521653561|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673181|NCT01998958|521653562|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673182|NCT01998958|521653563|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673183|NCT01998958|521653564|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673184|NCT01998958|521653565|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673185|NCT01998958|521653566|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673186|NCT01998958|521653567|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673187|NCT01998958|521653568|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673188|NCT01998958|521653569|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673189|NCT01998958|521653570|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673190|NCT01998958|521653571|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673191|NCT01998958|521653572|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673192|NCT01998958|521653573|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673193|NCT01998958|521653574|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673194|NCT01998958|521653575|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673195|NCT01998958|521653576|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673196|NCT01998958|521653577|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673197|NCT01998958|521653578|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673198|NCT01998958|521653579|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673199|NCT01998958|521653580|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673200|NCT01998958|521653581|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
144735382|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
144735383|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
144735384|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
144218056|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
144218057|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
144218058|NCT01130532|519992224|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
144218059|NCT01130532|519992225|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
144218060|NCT01130532|519992226|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
144218061|NCT01130532|519992227|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
144218062|NCT01130532|519992224|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
144218063|NCT01130532|519992225|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
144218064|NCT01130532|519992226|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
144218065|NCT01130532|519992227|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
144673201|NCT01998958|521653582|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673202|NCT01998958|521653583|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
144673203|NCT01998958|521653584|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673204|NCT01998958|521653585|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673205|NCT01998958|521653586|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673206|NCT01998958|521653587|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673207|NCT01998958|521653588|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673208|NCT01998958|521653589|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673209|NCT01998958|521653590|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673210|NCT01998958|521653591|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
144218066|NCT01130532|519992224|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
144673211|NCT01998958|521653592|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
144673212|NCT01998958|521653561|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673213|NCT01998958|521653562|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673214|NCT01998958|521653563|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673215|NCT01998958|521653564|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673216|NCT01998958|521653565|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673217|NCT01998958|521653566|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673218|NCT01998958|521653567|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673219|NCT01998958|521653568|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673220|NCT01998958|521653569|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673221|NCT01998958|521653570|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673222|NCT01998958|521653571|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673223|NCT01998958|521653572|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673224|NCT01998958|521653573|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673225|NCT01998958|521653574|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673226|NCT01998958|521653575|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673227|NCT01998958|521653576|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673228|NCT01998958|521653577|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673229|NCT01998958|521653578|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673230|NCT01998958|521653579|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673231|NCT01998958|521653580|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673232|NCT01998958|521653581|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673233|NCT01998958|521653582|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
144673234|NCT01998958|521653583|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
144673235|NCT01998958|521653584|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673236|NCT01998958|521653585|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673237|NCT01998958|521653586|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673238|NCT01998958|521653587|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673239|NCT01998958|521653588|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673240|NCT01998958|521653589|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673241|NCT01998958|521653590|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673242|NCT01998958|521653591|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673243|NCT01998958|521653592|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
144673244|NCT01998958|521653561|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673245|NCT01998958|521653562|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673246|NCT01998958|521653563|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673247|NCT01998958|521653564|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673248|NCT01998958|521653565|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673249|NCT01998958|521653566|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673250|NCT01998958|521653567|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673251|NCT01998958|521653568|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673252|NCT01998958|521653569|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673253|NCT01998958|521653570|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673254|NCT01998958|521653571|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673255|NCT01998958|521653572|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673256|NCT01998958|521653573|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673257|NCT01998958|521653574|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673258|NCT01998958|521653575|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673259|NCT01998958|521653576|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673260|NCT01998958|521653577|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673261|NCT01998958|521653578|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673262|NCT01998958|521653579|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673263|NCT01998958|521653580|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673264|NCT01998958|521653581|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673265|NCT01998958|521653582|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
144673266|NCT01998958|521653583|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
144673267|NCT01998958|521653584|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
144673268|NCT01998958|521653585|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673269|NCT01998958|521653586|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673270|NCT01998958|521653587|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673271|NCT01998958|521653588|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673272|NCT01998958|521653589|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673273|NCT01998958|521653590|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673274|NCT01998958|521653591|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673275|NCT01998958|521653592|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
144673276|NCT02432703|521653593|FG000|Overall Study|Adverse Event|1|||
144673277|NCT02432703|521653594|FG001|Overall Study|Adverse Event|4|||
144673278|NCT02432703|521653593|FG000|Overall Study|Lack of Efficacy|1|||
144673279|NCT02432703|521653594|FG001|Overall Study|Lack of Efficacy|0|||
144673280|NCT02432703|521653593|FG000|Overall Study|Lost to Follow-up|5|||
144673281|NCT02432703|521653594|FG001|Overall Study|Lost to Follow-up|3|||
144673282|NCT02432703|521653593|FG000|Overall Study|Withdrawal by Subject|9|||
144673283|NCT02432703|521653594|FG001|Overall Study|Withdrawal by Subject|6|||
144673284|NCT02432703|521653593|FG000|Overall Study|Other|6|||
144673285|NCT02432703|521653594|FG001|Overall Study|Other|5|||
144673286|NCT00724815|521653597|FG000|Overall Study|Randomized, not treated|31|||
144673287|NCT00724815|521653598|FG001|Overall Study|Randomized, not treated|30|||
144673288|NCT00724815|521653597|FG000|Overall Study|Adverse Event|5|||
144673289|NCT00724815|521653598|FG001|Overall Study|Adverse Event|3|||
144673290|NCT00724815|521653597|FG000|Overall Study|Lost to Follow-up|4|||
144673291|NCT00724815|521653598|FG001|Overall Study|Lost to Follow-up|1|||
144673292|NCT00724815|521653597|FG000|Overall Study|Other Various|3|||
144673293|NCT00724815|521653598|FG001|Overall Study|Other Various|5|||
144673294|NCT00810043|521653599|FG000|Overall Study|Withdrawal by Subject|1|||
144673295|NCT00810043|521653600|FG001|Overall Study|Withdrawal by Subject|0|||
144673296|NCT00810043|521653601|FG002|Overall Study|Withdrawal by Subject|2|||
144673297|NCT00810043|521653599|FG000|Overall Study|Lost to Follow-up|1|||
144673298|NCT00810043|521653600|FG001|Overall Study|Lost to Follow-up|0|||
144673299|NCT00810043|521653601|FG002|Overall Study|Lost to Follow-up|0|||
144673300|NCT00810043|521653599|FG000|Overall Study|Physician Decision|0|||
144673301|NCT00810043|521653600|FG001|Overall Study|Physician Decision|0|||
144673302|NCT00810043|521653601|FG002|Overall Study|Physician Decision|2|||
144673303|NCT00810043|521653599|FG000|Overall Study|Death|2|||
144673304|NCT00810043|521653600|FG001|Overall Study|Death|0|||
144673305|NCT00810043|521653601|FG002|Overall Study|Death|0|||
144673306|NCT00810043|521653599|FG000|Overall Study|Unrelated medical problem|0|||
144673307|NCT00810043|521653600|FG001|Overall Study|Unrelated medical problem|1|||
144673308|NCT00810043|521653601|FG002|Overall Study|Unrelated medical problem|0|||
144673309|NCT00810043|521653599|FG000|Overall Study|Non-medical problem|0|||
144673310|NCT00810043|521653600|FG001|Overall Study|Non-medical problem|0|||
144673311|NCT00810043|521653601|FG002|Overall Study|Non-medical problem|1|||
144673312|NCT00810043|521653599|FG000|Overall Study|No longer met enrollment criteria|0|||
144673313|NCT00810043|521653600|FG001|Overall Study|No longer met enrollment criteria|0|||
144673314|NCT00810043|521653601|FG002|Overall Study|No longer met enrollment criteria|3|||
144673315|NCT02001688|521653602|FG000|Overall Study|Withdrawal by Subject|0|||
144673316|NCT02001688|521653603|FG001|Overall Study|Withdrawal by Subject|0|||
144673317|NCT02001688|521653604|FG002|Overall Study|Withdrawal by Subject|1|||
144673318|NCT02001688|521653602|FG000|Overall Study|Adverse Event|0|||
144673319|NCT02001688|521653603|FG001|Overall Study|Adverse Event|1|||
144673320|NCT02001688|521653604|FG002|Overall Study|Adverse Event|0|||
144673321|NCT00445341|521653605|FG000|Overall Study|refused further treatment|1|||
144673322|NCT00445341|521653605|FG000|Overall Study|taken off treatment too early|1|||
144673323|NCT03051217|521653606|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
144673324|NCT03051217|521653607|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144673325|NCT03051217|521653608|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
144673326|NCT03051217|521653609|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144673327|NCT03051217|521653610|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144673328|NCT03051217|521653611|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144673329|NCT03051217|521653612|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144673330|NCT03051217|521653606|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
144673331|NCT03051217|521653607|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
144673332|NCT03051217|521653608|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
144673333|NCT03051217|521653609|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
144673334|NCT03051217|521653610|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
144673335|NCT03051217|521653611|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
144673336|NCT03051217|521653612|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
144218067|NCT01130532|519992225|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
144673337|NCT03051217|521653606|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
144673338|NCT03051217|521653607|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
144673339|NCT03051217|521653608|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
144673340|NCT03051217|521653609|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144673341|NCT03051217|521653610|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144673342|NCT03051217|521653611|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144673343|NCT03051217|521653612|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144218068|NCT01130532|519992226|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
144673344|NCT03051217|521653606|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
144673345|NCT03051217|521653607|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
144673346|NCT03051217|521653608|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
144673347|NCT03051217|521653609|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
144673348|NCT03051217|521653610|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
144673349|NCT03051217|521653611|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
144673350|NCT03051217|521653612|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
144673351|NCT03051217|521653606|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
144218069|NCT01130532|519992227|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
144673352|NCT03051217|521653607|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
144673353|NCT03051217|521653608|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
144673354|NCT03051217|521653609|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
144673355|NCT03051217|521653610|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
144673356|NCT03051217|521653611|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
144673357|NCT03051217|521653612|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
144673358|NCT03051217|521653606|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
144673359|NCT03051217|521653607|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
144673360|NCT03051217|521653608|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
144673361|NCT03051217|521653609|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
144673362|NCT03051217|521653610|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
144673363|NCT03051217|521653611|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
144673364|NCT03051217|521653612|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
144673365|NCT03051217|521653606|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
144673366|NCT03051217|521653607|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
144673367|NCT03051217|521653608|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
144673368|NCT03051217|521653609|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
144673369|NCT03051217|521653610|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
144673370|NCT03051217|521653611|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
144673371|NCT03051217|521653612|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
144673372|NCT03051217|521653606|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
144673373|NCT03051217|521653607|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
144673374|NCT03051217|521653608|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
144673375|NCT03051217|521653609|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
144673376|NCT03051217|521653610|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
144673377|NCT03051217|521653611|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
144673378|NCT03051217|521653612|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
144673379|NCT00641706|521653615|FG000|Overall Study|Adverse Event|2|||
144673380|NCT00641706|521653616|FG001|Overall Study|Adverse Event|1|||
144673381|NCT00641706|521653615|FG000|Overall Study|Withdrawal by Subject|6|||
144673382|NCT00641706|521653616|FG001|Overall Study|Withdrawal by Subject|1|||
144673383|NCT00641706|521653615|FG000|Overall Study|Clinical Decline|1|||
144673384|NCT00641706|521653616|FG001|Overall Study|Clinical Decline|0|||
144673385|NCT00641706|521653615|FG000|Overall Study|Lead Investigator Decision|0|||
144673386|NCT00641706|521653616|FG001|Overall Study|Lead Investigator Decision|1|||
144673387|NCT01675141|521653617|FG000|Overall Study|Lenalidomide outside NIH|3|||
144673388|NCT01675141|521653617|FG000|Overall Study|Withdrawal by Subject|3|||
144673389|NCT01675141|521653617|FG000|Overall Study|Physician Decision|4|||
144673390|NCT01675141|521653617|FG000|Overall Study|No treatment, per protocol|1|||
144673391|NCT05441540|521653618|FG000|Overall Study|Withdrawal by Subject|2|||
144673392|NCT04539262|521653619|FG000|Overall Study|Adverse Event|0|||
144673393|NCT04539262|521653620|FG001|Overall Study|Adverse Event|0|||
144673394|NCT04539262|521653621|FG002|Overall Study|Adverse Event|1|||
144673395|NCT04539262|521653622|FG003|Overall Study|Adverse Event|0|||
144673396|NCT04539262|521653623|FG004|Overall Study|Adverse Event|0|||
144673397|NCT04539262|521653624|FG005|Overall Study|Adverse Event|0|||
144673398|NCT04539262|521653625|FG006|Overall Study|Adverse Event|0|||
144673399|NCT04539262|521653626|FG007|Overall Study|Adverse Event|0|||
144673400|NCT04539262|521653619|FG000|Overall Study|Withdrew Consent|0|||
144673401|NCT04539262|521653620|FG001|Overall Study|Withdrew Consent|0|||
144673402|NCT04539262|521653621|FG002|Overall Study|Withdrew Consent|0|||
144673403|NCT04539262|521653622|FG003|Overall Study|Withdrew Consent|1|||
144673404|NCT04539262|521653623|FG004|Overall Study|Withdrew Consent|0|||
144673405|NCT04539262|521653624|FG005|Overall Study|Withdrew Consent|0|||
144673406|NCT04539262|521653625|FG006|Overall Study|Withdrew Consent|0|||
144673407|NCT04539262|521653626|FG007|Overall Study|Withdrew Consent|0|||
144673408|NCT04539262|521653619|FG000|Overall Study|Randomized, Not treated|0|||
144673409|NCT04539262|521653620|FG001|Overall Study|Randomized, Not treated|1|||
144673410|NCT04539262|521653621|FG002|Overall Study|Randomized, Not treated|0|||
144673411|NCT04539262|521653622|FG003|Overall Study|Randomized, Not treated|0|||
144673412|NCT04539262|521653623|FG004|Overall Study|Randomized, Not treated|0|||
144673413|NCT04539262|521653624|FG005|Overall Study|Randomized, Not treated|0|||
144673414|NCT04539262|521653625|FG006|Overall Study|Randomized, Not treated|1|||
144673415|NCT04539262|521653626|FG007|Overall Study|Randomized, Not treated|0|||
144673416|NCT00294684|521653627|FG000|Overall Study|Lost to Follow-up|5|||
144673417|NCT00294684|521653628|FG001|Overall Study|Lost to Follow-up|8|||
144673418|NCT02443805|521653629|FG000|Overall Study|Adverse Event|100|||
144673419|NCT02443805|521653630|FG001|Overall Study|Adverse Event|18|||
144673420|NCT02443805|521653629|FG000|Overall Study|Withdrawal by Subject|73|||
144673421|NCT02443805|521653630|FG001|Overall Study|Withdrawal by Subject|74|||
144673422|NCT02443805|521653629|FG000|Overall Study|Lost to Follow-up|19|||
144673423|NCT02443805|521653630|FG001|Overall Study|Lost to Follow-up|14|||
144673424|NCT02443805|521653629|FG000|Overall Study|Pregnancy|6|||
144673425|NCT02443805|521653630|FG001|Overall Study|Pregnancy|5|||
144673426|NCT02443805|521653629|FG000|Overall Study|Protocol Violation|2|||
144673427|NCT02443805|521653630|FG001|Overall Study|Protocol Violation|4|||
144673428|NCT02443805|521653629|FG000|Overall Study|Lack of Efficacy|1|||
144673429|NCT02443805|521653630|FG001|Overall Study|Lack of Efficacy|1|||
144673430|NCT02443805|521653629|FG000|Overall Study|Non-compliance with study drug|6|||
144673431|NCT02443805|521653630|FG001|Overall Study|Non-compliance with study drug|4|||
144673432|NCT02443805|521653629|FG000|Overall Study|Withdrawal by parent/guardian|3|||
144673433|NCT02443805|521653630|FG001|Overall Study|Withdrawal by parent/guardian|5|||
144673434|NCT02443805|521653629|FG000|Overall Study|Any other reason not above-mentioned|3|||
144673435|NCT02443805|521653630|FG001|Overall Study|Any other reason not above-mentioned|2|||
144673436|NCT00968708|521653631|FG000|Overall Study|Adverse Event|169|||
144673437|NCT00968708|521653632|FG001|Overall Study|Adverse Event|150|||
144673438|NCT00968708|521653631|FG000|Overall Study|Major Protocol Deviation|0|||
144673439|NCT00968708|521653632|FG001|Overall Study|Major Protocol Deviation|1|||
144673440|NCT00968708|521653631|FG000|Overall Study|Lost to Follow-up|19|||
144673441|NCT00968708|521653632|FG001|Overall Study|Lost to Follow-up|11|||
144673442|NCT00968708|521653631|FG000|Overall Study|Voluntary Withdrawal|104|||
144673443|NCT00968708|521653632|FG001|Overall Study|Voluntary Withdrawal|101|||
144673444|NCT00968708|521653631|FG000|Overall Study|Investigator Discretion|0|||
144673445|NCT00968708|521653632|FG001|Overall Study|Investigator Discretion|1|||
144673446|NCT00968708|521653631|FG000|Overall Study|Other|26|||
144673447|NCT00968708|521653632|FG001|Overall Study|Other|34|||
144673448|NCT02708966|521653633|FG000|Overall Study|Lost to Follow-up|2|||
144673449|NCT02708966|521653634|FG001|Overall Study|Lost to Follow-up|2|||
144673450|NCT02076334|521653639|FG000|Overall Study|Protocol Violation|1|||
144673451|NCT02076334|521653640|FG001|Overall Study|Protocol Violation|0|||
144673452|NCT02076334|521653641|FG002|Overall Study|Protocol Violation|0|||
144673453|NCT02076334|521653642|FG003|Overall Study|Protocol Violation|0|||
144673454|NCT02076334|521653639|FG000|Overall Study|Lost to Follow-up|0|||
144673455|NCT02076334|521653640|FG001|Overall Study|Lost to Follow-up|1|||
144673456|NCT02076334|521653641|FG002|Overall Study|Lost to Follow-up|1|||
144673457|NCT02076334|521653642|FG003|Overall Study|Lost to Follow-up|0|||
144673458|NCT02076334|521653639|FG000|Overall Study|muscle soreness|0|||
144673459|NCT02076334|521653640|FG001|Overall Study|muscle soreness|0|||
144673460|NCT02076334|521653641|FG002|Overall Study|muscle soreness|0|||
144673461|NCT02076334|521653642|FG003|Overall Study|muscle soreness|1|||
144673462|NCT03205982|521653643|FG000|Overall Study|Lost to Follow-up|20|||
144673463|NCT03205982|521653644|FG001|Overall Study|Lost to Follow-up|19|||
144673464|NCT03205982|521653643|FG000|Overall Study|Withdrawal by Subject|4|||
144673465|NCT03205982|521653644|FG001|Overall Study|Withdrawal by Subject|3|||
144673466|NCT03205982|521653643|FG000|Overall Study|Withdrawal by PI|0|||
144673467|NCT03205982|521653644|FG001|Overall Study|Withdrawal by PI|1|||
144673468|NCT00994162|521653647|FG000|Overall Study|Withdrawal by Subject|1|||
144673469|NCT00994162|521653647|FG000|Overall Study|Lost to Follow-up|2|||
144673470|NCT00994162|521653647|FG000|Overall Study|Product Complaint|1|||
144673471|NCT00994162|521653647|FG000|Overall Study|Poor Compliance|5|||
144673472|NCT00994162|521653647|FG000|Overall Study|Lack of Response|3|||
144673473|NCT00994162|521653647|FG000|Overall Study|Discharged from Hospital|4|||
144673474|NCT00994162|521653647|FG000|Overall Study|Death|2|||
144673475|NCT00994162|521653647|FG000|Overall Study|Care Transferred to Another Physician|2|||
144673476|NCT00994162|521653647|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
144673477|NCT00994162|521653647|FG000|Overall Study|Physician Decision|2|||
144673478|NCT00994162|521653647|FG000|Overall Study|Surrounding Wound Erythematous|1|||
144673479|NCT00994162|521653647|FG000|Overall Study|Machine Losing Vaccum|1|||
144673480|NCT00994162|521653647|FG000|Overall Study|Patient Lived Too Far Away|1|||
144673481|NCT00994162|521653647|FG000|Overall Study|Above Knee Amputation|1|||
144673482|NCT00994162|521653647|FG000|Overall Study|Reason Not Reported By Site|1|||
144673483|NCT02983799|521653648|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
144673484|NCT02983799|521653649|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
144673485|NCT02983799|521653650|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
144673486|NCT02983799|521653651|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
144673487|NCT02983799|521653652|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
144673488|NCT02983799|521653648|FG000|Overall Study|Death|20|||
144673489|NCT02983799|521653649|FG001|Overall Study|Death|5|||
144673490|NCT02983799|521653650|FG002|Overall Study|Death|23|||
144673491|NCT02983799|521653651|FG003|Overall Study|Death|47|||
144673492|NCT02983799|521653652|FG004|Overall Study|Death|7|||
144673493|NCT02983799|521653648|FG000|Overall Study|Withdrawal by Subject|1|||
144673494|NCT02983799|521653649|FG001|Overall Study|Withdrawal by Subject|0|||
144673495|NCT02983799|521653650|FG002|Overall Study|Withdrawal by Subject|3|||
144673496|NCT02983799|521653651|FG003|Overall Study|Withdrawal by Subject|4|||
144673497|NCT02983799|521653652|FG004|Overall Study|Withdrawal by Subject|1|||
144673498|NCT02983799|521653648|FG000|Overall Study|Protocol Violation|0|||
144673499|NCT02983799|521653649|FG001|Overall Study|Protocol Violation|1|||
144673500|NCT02983799|521653650|FG002|Overall Study|Protocol Violation|0|||
144735385|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735386|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735387|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735388|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735389|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
144735390|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735391|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735392|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735393|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735394|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735395|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735396|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735397|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735398|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735399|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735400|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735401|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735402|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735403|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
144735404|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
144735405|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
144735406|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735407|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735408|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735409|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735410|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
144735411|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735412|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735413|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735414|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735415|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735416|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735417|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735418|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735419|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735420|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735421|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735422|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735423|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735424|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735425|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
144735426|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
144735427|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735428|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735429|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735430|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735431|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
144735432|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735433|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735434|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735435|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735436|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735437|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735438|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735439|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735440|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735441|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735442|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735443|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735444|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735445|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144265634|NCT02513550|520173978|FG003|Double Blind Treatment Period|Physician Decision|0|||
144735446|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
144735447|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
144218070|NCT01130532|519992224|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
144673501|NCT02983799|521653651|FG003|Overall Study|Protocol Violation|0|||
144673502|NCT02983799|521653652|FG004|Overall Study|Protocol Violation|1|||
144673503|NCT02983799|521653648|FG000|Overall Study|Lost to Follow-up|1|||
144673504|NCT02983799|521653649|FG001|Overall Study|Lost to Follow-up|0|||
144673505|NCT02983799|521653650|FG002|Overall Study|Lost to Follow-up|1|||
144673506|NCT02983799|521653651|FG003|Overall Study|Lost to Follow-up|0|||
144673507|NCT02983799|521653652|FG004|Overall Study|Lost to Follow-up|0|||
144673508|NCT03136367|521653663|FG000|T1 Consultation|discontinued mistakenly included|2|||
144673509|NCT03136367|521653664|FG001|T1 Consultation|discontinued mistakenly included|6|||
144673510|NCT03136367|521653665|FG002|T1 Consultation|discontinued mistakenly included|1|||
144673511|NCT03136367|521653663|FG000|T1 Consultation|Discontinued other|0|||
144673512|NCT03136367|521653664|FG001|T1 Consultation|Discontinued other|1|||
144673513|NCT03136367|521653665|FG002|T1 Consultation|Discontinued other|0|||
144673514|NCT03136367|521653663|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
144673515|NCT03136367|521653664|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
144673516|NCT03136367|521653665|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
144673517|NCT03136367|521653663|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
144673518|NCT03136367|521653664|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
144673519|NCT03136367|521653665|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
144673520|NCT03136367|521653663|FG000|T2 Post-consultation|Discontinued other|0|||
144673521|NCT03136367|521653664|FG001|T2 Post-consultation|Discontinued other|2|||
144673522|NCT03136367|521653665|FG002|T2 Post-consultation|Discontinued other|6|||
144673523|NCT03136367|521653663|FG000|T2 Post-consultation|Discontinued transferred care|0|||
144673524|NCT03136367|521653664|FG001|T2 Post-consultation|Discontinued transferred care|0|||
144673525|NCT03136367|521653665|FG002|T2 Post-consultation|Discontinued transferred care|3|||
144673526|NCT03136367|521653663|FG000|T2 Post-consultation|Discontinued lost contact|0|||
144673527|NCT03136367|521653664|FG001|T2 Post-consultation|Discontinued lost contact|1|||
144673528|NCT03136367|521653665|FG002|T2 Post-consultation|Discontinued lost contact|0|||
144673529|NCT03136367|521653663|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
144673530|NCT03136367|521653664|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
144673531|NCT03136367|521653665|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
144673532|NCT03136367|521653663|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
144673533|NCT03136367|521653664|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
144673534|NCT03136367|521653665|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
144673535|NCT03136367|521653663|FG000|T3 1 Week After Surgery|other discontinued|2|||
144673536|NCT03136367|521653664|FG001|T3 1 Week After Surgery|other discontinued|4|||
144673537|NCT03136367|521653665|FG002|T3 1 Week After Surgery|other discontinued|3|||
144673538|NCT03136367|521653663|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
144673539|NCT03136367|521653664|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
144673540|NCT03136367|521653665|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
144673541|NCT03136367|521653663|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
144673542|NCT03136367|521653664|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
144673543|NCT03136367|521653665|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
144673544|NCT03136367|521653663|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
144673545|NCT03136367|521653664|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
144673546|NCT03136367|521653665|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
144673547|NCT03136367|521653663|FG000|T4 12 Weeks After Surgery|Death|0|||
144673548|NCT03136367|521653664|FG001|T4 12 Weeks After Surgery|Death|1|||
144673549|NCT03136367|521653665|FG002|T4 12 Weeks After Surgery|Death|3|||
144673550|NCT03136367|521653663|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
144673551|NCT03136367|521653664|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
144673552|NCT03136367|521653665|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
144673553|NCT03136367|521653663|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
144673554|NCT03136367|521653664|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
144673555|NCT03136367|521653665|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
144673556|NCT03136367|521653663|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
144673557|NCT03136367|521653664|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
144673558|NCT03136367|521653665|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
144673559|NCT03136367|521653663|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
144673560|NCT03136367|521653664|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
144673561|NCT03136367|521653665|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
144673562|NCT03136367|521653663|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
144673563|NCT03136367|521653664|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
144673564|NCT03136367|521653665|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
144673565|NCT03136367|521653663|FG000|T5 1 Year After Surgery|Death|0|||
144673566|NCT03136367|521653664|FG001|T5 1 Year After Surgery|Death|0|||
144673567|NCT03136367|521653665|FG002|T5 1 Year After Surgery|Death|1|||
144735448|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735449|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735450|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735451|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735452|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
144735453|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735454|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735455|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735456|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735457|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735458|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735459|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735460|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735461|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735462|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735463|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735464|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735465|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735466|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
144735467|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
144735468|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
144735469|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735470|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735471|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735472|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735473|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
144735474|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735475|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735476|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735477|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735478|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735479|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735480|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735481|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735482|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
144673568|NCT03136367|521653663|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
144673569|NCT03136367|521653664|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
144673570|NCT03136367|521653665|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
144673571|NCT03136367|521653663|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
144673572|NCT03136367|521653664|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
144673573|NCT03136367|521653665|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
144673574|NCT03136367|521653663|FG000|T5 1 Year After Surgery|study ended before due|31|||
144673575|NCT03136367|521653664|FG001|T5 1 Year After Surgery|study ended before due|103|||
144673576|NCT03136367|521653665|FG002|T5 1 Year After Surgery|study ended before due|110|||
144673577|NCT03136367|521653663|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
144673578|NCT03136367|521653664|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
144673579|NCT03136367|521653665|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
144673580|NCT03307629|521653669|FG000|Overall Study|Withdrawal by Subject|0|||
144673581|NCT03307629|521653670|FG001|Overall Study|Withdrawal by Subject|0|||
144673582|NCT03307629|521653671|FG002|Overall Study|Withdrawal by Subject|0|||
144673583|NCT03307629|521653672|FG003|Overall Study|Withdrawal by Subject|2|||
144673584|NCT03307629|521653669|FG000|Overall Study|Disease Progression|0|||
144673585|NCT03307629|521653670|FG001|Overall Study|Disease Progression|0|||
144673586|NCT03307629|521653671|FG002|Overall Study|Disease Progression|0|||
144673587|NCT03307629|521653672|FG003|Overall Study|Disease Progression|3|||
144673588|NCT03307629|521653669|FG000|Overall Study|Death|0|||
144673589|NCT03307629|521653670|FG001|Overall Study|Death|3|||
144673590|NCT03307629|521653671|FG002|Overall Study|Death|0|||
144673591|NCT03307629|521653672|FG003|Overall Study|Death|1|||
144673592|NCT02853032|521653673|FG000|Overall Study|Adverse Event|4|||
144673593|NCT02853032|521653674|FG001|Overall Study|Adverse Event|0|||
144673594|NCT02853032|521653673|FG000|Overall Study|Withdrawal by Subject|3|||
144673595|NCT02853032|521653674|FG001|Overall Study|Withdrawal by Subject|1|||
144673596|NCT02853032|521653673|FG000|Overall Study|Requested to withdraw from all treatment|2|||
144673597|NCT02853032|521653674|FG001|Overall Study|Requested to withdraw from all treatment|2|||
144673598|NCT02146833|521653675|FG000|Overall Study|Death|10|||
144673599|NCT02146833|521653675|FG000|Overall Study|No longer consented to study treatment|1|||
144673600|NCT03726333|521653676|FG000|Overall Study|Progressive Disease|0|||
144735483|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735484|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735485|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735486|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735487|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735488|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
144735489|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
144735490|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735491|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735492|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735493|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735494|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
144735495|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735496|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735497|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735498|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735499|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735500|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735501|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735502|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735503|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735504|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735505|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735506|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735507|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735508|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735509|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
144735510|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
144735511|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735512|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735513|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735514|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735515|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
144735516|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735517|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144673601|NCT03726333|521653677|FG001|Overall Study|Progressive Disease|0|||
144673602|NCT03726333|521653678|FG002|Overall Study|Progressive Disease|1|||
144673603|NCT03726333|521653679|FG003|Overall Study|Progressive Disease|0|||
144673604|NCT03726333|521653680|FG004|Overall Study|Progressive Disease|0|||
144673605|NCT03682055|521655711|FG000|Overall Study|Lack of Efficacy|1|||
144673606|NCT03682055|521655712|FG001|Overall Study|Lack of Efficacy|2|||
144673607|NCT03682055|521655713|FG002|Overall Study|Lack of Efficacy|1|||
144673608|NCT03682055|521655714|FG003|Overall Study|Lack of Efficacy|2|||
144673609|NCT03682055|521655715|FG004|Overall Study|Lack of Efficacy|1|||
144673610|NCT03682055|521655716|FG005|Overall Study|Lack of Efficacy|3|||
144673611|NCT03682055|521655711|FG000|Overall Study|Withdrawal by Subject|0|||
144673612|NCT03682055|521655712|FG001|Overall Study|Withdrawal by Subject|0|||
144673613|NCT03682055|521655713|FG002|Overall Study|Withdrawal by Subject|0|||
144673614|NCT03682055|521655714|FG003|Overall Study|Withdrawal by Subject|0|||
144673615|NCT03682055|521655715|FG004|Overall Study|Withdrawal by Subject|0|||
144673616|NCT03682055|521655716|FG005|Overall Study|Withdrawal by Subject|1|||
144673617|NCT03682055|521655711|FG000|Overall Study|Termination of Study by Sponsor|0|||
144673618|NCT03682055|521655712|FG001|Overall Study|Termination of Study by Sponsor|0|||
144735518|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735519|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735520|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735521|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735522|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144218071|NCT01130532|519992225|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
144673619|NCT03682055|521655713|FG002|Overall Study|Termination of Study by Sponsor|0|||
144673620|NCT03682055|521655714|FG003|Overall Study|Termination of Study by Sponsor|0|||
144673621|NCT03682055|521655715|FG004|Overall Study|Termination of Study by Sponsor|0|||
144673622|NCT03682055|521655716|FG005|Overall Study|Termination of Study by Sponsor|3|||
144673623|NCT02687711|521655717|FG000|Overall Study|Adverse Event|89|||
144218072|NCT01130532|519992226|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
144218073|NCT01130532|519992227|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
144218074|NCT01130532|519992224|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
144673624|NCT02687711|521655717|FG000|Overall Study|Lack of Efficacy|70|||
144673625|NCT02687711|521655717|FG000|Overall Study|Lost to Follow-up|20|||
144673626|NCT02687711|521655717|FG000|Overall Study|Consent withdrawn|15|||
144673627|NCT02687711|521655717|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
144673628|NCT02687711|521655717|FG000|Overall Study|Too expensive|4|||
144673629|NCT02687711|521655717|FG000|Overall Study|Participant moved abroad|1|||
144673630|NCT02687711|521655717|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
144673631|NCT02687711|521655717|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
144673632|NCT02687711|521655717|FG000|Overall Study|Disliked taste|1|||
144673633|NCT02687711|521655717|FG000|Overall Study|Low mood|1|||
144673634|NCT02687711|521655717|FG000|Overall Study|Side effects|1|||
144673635|NCT02687711|521655717|FG000|Overall Study|Change of Hospital|1|||
144673636|NCT02687711|521655717|FG000|Overall Study|Liver Encephalopathy|1|||
144673637|NCT02687711|521655717|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
144673638|NCT02687711|521655717|FG000|Overall Study|Withdrawn due to intake interruption|1|||
144673639|NCT02687711|521655717|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
144673640|NCT02687711|521655717|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
144673641|NCT02687711|521655717|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
144673642|NCT00191386|521655718|FG000|Overall Study|Adverse Event|16|||
144673643|NCT00191386|521655718|FG000|Overall Study|Lost to Follow-up|1|||
144673644|NCT00191386|521655718|FG000|Overall Study|Entry Criteria Exclusion|3|||
144673645|NCT00191386|521655718|FG000|Overall Study|Protocol Violation|18|||
144673646|NCT00191386|521655718|FG000|Overall Study|Withdrawal by Subject|96|||
144673647|NCT00191386|521655718|FG000|Overall Study|Physician Decision|11|||
144673648|NCT00191386|521655718|FG000|Overall Study|Lack of Efficacy|15|||
144673649|NCT03706040|521655719|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
144673650|NCT03706040|521655720|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
144673651|NCT03706040|521655721|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
144673652|NCT03706040|521655722|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
144673653|NCT03706040|521655723|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
144673654|NCT03706040|521655724|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
144673655|NCT03706040|521655725|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
144673656|NCT03706040|521655719|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
144673657|NCT03706040|521655720|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
144673658|NCT03706040|521655721|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
144673659|NCT03706040|521655722|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
144673660|NCT03706040|521655723|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
144673661|NCT03706040|521655724|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
144673662|NCT03706040|521655725|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
144673663|NCT03706040|521655719|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
144673664|NCT03706040|521655720|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
144673665|NCT03706040|521655721|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
144673666|NCT03706040|521655722|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
144673667|NCT03706040|521655723|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
144673668|NCT03706040|521655724|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
144673669|NCT03706040|521655725|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
144673670|NCT03706040|521655719|FG000|Period A (Week 0 to Week 16)|Other|2|||
144673671|NCT03706040|521655720|FG001|Period A (Week 0 to Week 16)|Other|0|||
144673672|NCT03706040|521655721|FG002|Period A (Week 0 to Week 16)|Other|2|||
144673673|NCT03706040|521655722|FG003|Period A (Week 0 to Week 16)|Other|0|||
144673674|NCT03706040|521655723|FG004|Period A (Week 0 to Week 16)|Other|0|||
144673675|NCT03706040|521655724|FG005|Period A (Week 0 to Week 16)|Other|0|||
144673676|NCT03706040|521655725|FG006|Period A (Week 0 to Week 16)|Other|0|||
144673677|NCT03706040|521655719|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
144673678|NCT03706040|521655720|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
144673679|NCT03706040|521655721|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
144673680|NCT03706040|521655722|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
144673681|NCT03706040|521655723|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
144673682|NCT03706040|521655724|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
144218075|NCT01130532|519992225|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
144673683|NCT03706040|521655725|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
144673684|NCT03706040|521655719|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
144673685|NCT03706040|521655720|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
144673686|NCT03706040|521655721|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
144673687|NCT03706040|521655722|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
144673688|NCT03706040|521655723|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
144673689|NCT03706040|521655724|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
144673690|NCT03706040|521655725|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
144673691|NCT03706040|521655719|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144673692|NCT03706040|521655720|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144673693|NCT03706040|521655721|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144673694|NCT03706040|521655722|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144673695|NCT03706040|521655723|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
144673696|NCT03706040|521655724|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
144673697|NCT03706040|521655725|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
144673698|NCT03706040|521655719|FG000|Period B (Week 16 to Week 52)|Other|0|||
144673699|NCT03706040|521655720|FG001|Period B (Week 16 to Week 52)|Other|0|||
144673700|NCT03706040|521655721|FG002|Period B (Week 16 to Week 52)|Other|0|||
144673701|NCT03706040|521655722|FG003|Period B (Week 16 to Week 52)|Other|4|||
144673702|NCT03706040|521655723|FG004|Period B (Week 16 to Week 52)|Other|5|||
144673703|NCT03706040|521655724|FG005|Period B (Week 16 to Week 52)|Other|23|||
144673704|NCT03706040|521655725|FG006|Period B (Week 16 to Week 52)|Other|17|||
144673705|NCT00927758|521655726|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
144673706|NCT00927758|521655727|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
144673707|NCT00927758|521655728|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
144673708|NCT00927758|521655729|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
144673709|NCT00927758|521655730|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
144673710|NCT00927758|521655731|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
144673711|NCT00927758|521655726|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
144673712|NCT00927758|521655727|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
144673713|NCT00927758|521655728|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
144673714|NCT00927758|521655729|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
144673715|NCT00927758|521655730|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
144673716|NCT00927758|521655731|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
144673717|NCT00439725|521655733|FG000|Treatment Period|Withdrawal by Subject|22|||
144673718|NCT00439725|521655734|FG001|Treatment Period|Withdrawal by Subject|19|||
144673719|NCT00439725|521655733|FG000|Treatment Period|Study terminated by sponsor|156|||
144673720|NCT00439725|521655734|FG001|Treatment Period|Study terminated by sponsor|148|||
144673721|NCT00439725|521655733|FG000|Treatment Period|Site closed by investigator|1|||
144673722|NCT00439725|521655734|FG001|Treatment Period|Site closed by investigator|2|||
144673723|NCT00439725|521655733|FG000|Treatment Period|Adverse Event|39|||
144673724|NCT00439725|521655734|FG001|Treatment Period|Adverse Event|18|||
144673725|NCT00439725|521655733|FG000|Treatment Period|Physician Decision|1|||
144673726|NCT00439725|521655734|FG001|Treatment Period|Physician Decision|1|||
144673727|NCT00439725|521655733|FG000|Treatment Period|Protocol Violation|2|||
144673728|NCT00439725|521655734|FG001|Treatment Period|Protocol Violation|1|||
144673729|NCT00439725|521655733|FG000|Treatment Period|Clinical endpoint reached|6|||
144673730|NCT00439725|521655734|FG001|Treatment Period|Clinical endpoint reached|50|||
144673731|NCT00439725|521655733|FG000|Treatment Period|Technical problems|1|||
144673732|NCT00439725|521655734|FG001|Treatment Period|Technical problems|0|||
144673733|NCT00439725|521655733|FG000|Treatment Period|Lost to Follow-up|1|||
144673734|NCT00439725|521655734|FG001|Treatment Period|Lost to Follow-up|1|||
144673735|NCT00439725|521655733|FG000|Treatment Period|Participant convenience|1|||
144673736|NCT00439725|521655734|FG001|Treatment Period|Participant convenience|0|||
144673737|NCT00439725|521655733|FG000|Treatment Period|Protocol driven decision point|1|||
144673738|NCT00439725|521655734|FG001|Treatment Period|Protocol driven decision point|1|||
144673739|NCT00439725|521655733|FG000|Treatment Period|Death|1|||
144673740|NCT00439725|521655734|FG001|Treatment Period|Death|1|||
144673741|NCT00439725|521655733|FG000|Treatment Period|Participant did not receive treatment|4|||
144673742|NCT00439725|521655734|FG001|Treatment Period|Participant did not receive treatment|4|||
144673743|NCT00439725|521655733|FG000|Observational Period|Withdrawal by Subject|2|||
144673744|NCT00439725|521655734|FG001|Observational Period|Withdrawal by Subject|2|||
144673745|NCT00439725|521655733|FG000|Observational Period|Lost to Follow-up|0|||
144673746|NCT00439725|521655734|FG001|Observational Period|Lost to Follow-up|1|||
144673747|NCT00439725|521655733|FG000|Observational Period|Death|0|||
144673748|NCT00439725|521655734|FG001|Observational Period|Death|2|||
144673749|NCT00439725|521655733|FG000|Observational Period|Study termination by sponsor|1|||
144673750|NCT00439725|521655734|FG001|Observational Period|Study termination by sponsor|1|||
144673751|NCT00439725|521655733|FG000|Observational Period|Clinical endpoint reached|3|||
144673752|NCT00439725|521655734|FG001|Observational Period|Clinical endpoint reached|1|||
144673753|NCT00439725|521655733|FG000|Observational Period|Technical problems|1|||
144673754|NCT00439725|521655734|FG001|Observational Period|Technical problems|0|||
144673755|NCT00439725|521655733|FG000|Observational Period|Participant convenience|1|||
144673756|NCT00439725|521655734|FG001|Observational Period|Participant convenience|0|||
144673757|NCT03077243|521655735|FG000|Overall Study|Death|1|||
144673758|NCT03077243|521655736|FG001|Overall Study|Death|2|||
144673759|NCT03077243|521655737|FG002|Overall Study|Death|0|||
144673760|NCT03077243|521655738|FG003|Overall Study|Death|0|||
144673761|NCT03077243|521655735|FG000|Overall Study|Withdrawal by Subject|1|||
144673762|NCT03077243|521655736|FG001|Overall Study|Withdrawal by Subject|3|||
144673763|NCT03077243|521655737|FG002|Overall Study|Withdrawal by Subject|0|||
144673764|NCT03077243|521655738|FG003|Overall Study|Withdrawal by Subject|0|||
144673765|NCT03077243|521655735|FG000|Overall Study|Physician Decision|1|||
144673766|NCT03077243|521655736|FG001|Overall Study|Physician Decision|0|||
144673767|NCT03077243|521655737|FG002|Overall Study|Physician Decision|0|||
144735523|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735524|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735525|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735526|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735527|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735528|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735529|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735530|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
144735531|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
144735532|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735533|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735534|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735535|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735536|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
144735537|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735538|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735539|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735540|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735541|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735542|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735543|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735544|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735545|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735546|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735547|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735548|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735549|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735550|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735551|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
144735552|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
144735553|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735554|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735555|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735556|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735557|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
144735558|NCT01597245|521885545|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735559|NCT01597245|521885546|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735560|NCT01597245|521885547|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735561|NCT01597245|521885548|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735562|NCT01597245|521885549|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735563|NCT01597245|521885550|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735564|NCT01597245|521885551|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735565|NCT01597245|521885552|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735566|NCT01597245|521885553|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735567|NCT01597245|521885554|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735568|NCT01597245|521885555|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735569|NCT01597245|521885556|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735570|NCT01597245|521885557|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735571|NCT01597245|521885558|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
144735572|NCT01597245|521885559|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735573|NCT01597245|521885560|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735574|NCT01597245|521885561|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735575|NCT01597245|521885562|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735576|NCT01597245|521885563|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735577|NCT01597245|521885564|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735578|NCT01597245|521885565|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
144735579|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735580|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735581|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735582|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735583|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735584|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735585|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735586|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144265635|NCT02513550|520173979|FG004|Double Blind Treatment Period|Physician Decision|0|||
144265636|NCT02513550|520173980|FG005|Double Blind Treatment Period|Physician Decision|0|||
144265637|NCT02513550|520173975|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
144265638|NCT02513550|520173976|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
144265639|NCT02513550|520173977|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
144265640|NCT02513550|520173978|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
144265641|NCT02513550|520173979|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
144265642|NCT02513550|520173980|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
144265643|NCT02513550|520173975|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
144265644|NCT02513550|520173976|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
144673768|NCT03077243|521655738|FG003|Overall Study|Physician Decision|0|||
144673769|NCT03077243|521655735|FG000|Overall Study|Research at two study sites terminated early|0|||
144673770|NCT03077243|521655736|FG001|Overall Study|Research at two study sites terminated early|0|||
144673771|NCT03077243|521655737|FG002|Overall Study|Research at two study sites terminated early|0|||
144673772|NCT03077243|521655738|FG003|Overall Study|Research at two study sites terminated early|69|||
144673773|NCT03984812|521655739|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673774|NCT03984812|521655740|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673775|NCT03984812|521655741|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
144673776|NCT03984812|521655742|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673777|NCT03984812|521655743|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673778|NCT03984812|521655744|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673779|NCT03984812|521655745|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673780|NCT03984812|521655746|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673781|NCT03984812|521655747|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673782|NCT03984812|521655748|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673783|NCT03984812|521655749|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
144673784|NCT03276572|521655750|FG000|Overall Study|In follow-up|0|||
144673785|NCT03276572|521655751|FG001|Overall Study|In follow-up|0|||
144673786|NCT03276572|521655752|FG002|Overall Study|In follow-up|0|||
144673787|NCT03276572|521655753|FG003|Overall Study|In follow-up|0|||
144673788|NCT03276572|521655754|FG004|Overall Study|In follow-up|0|||
144673789|NCT03276572|521655755|FG005|Overall Study|In follow-up|1|||
144673790|NCT03276572|521655756|FG006|Overall Study|In follow-up|1|||
144673791|NCT03276572|521655750|FG000|Overall Study|Lost to Follow-up|0|||
144673792|NCT03276572|521655751|FG001|Overall Study|Lost to Follow-up|0|||
144673793|NCT03276572|521655752|FG002|Overall Study|Lost to Follow-up|0|||
144673794|NCT03276572|521655753|FG003|Overall Study|Lost to Follow-up|0|||
144673795|NCT03276572|521655754|FG004|Overall Study|Lost to Follow-up|0|||
144673796|NCT03276572|521655755|FG005|Overall Study|Lost to Follow-up|0|||
144673797|NCT03276572|521655756|FG006|Overall Study|Lost to Follow-up|1|||
144673798|NCT02954952|521655769|FG000|Overall Study|Withdrawal by Subject|1|||
144673799|NCT02954952|521655770|FG001|Overall Study|Withdrawal by Subject|0|||
144673800|NCT02954952|521655771|FG002|Overall Study|Withdrawal by Subject|0|||
144673801|NCT02954952|521655769|FG000|Overall Study|No data collected|0|||
144673802|NCT02954952|521655770|FG001|Overall Study|No data collected|1|||
144673803|NCT02954952|521655771|FG002|Overall Study|No data collected|0|||
144673804|NCT01392742|521655772|FG000|Overall Study|Premature study termination|42|||
144673805|NCT01392742|521655772|FG000|Overall Study|Failure to return|35|||
144673806|NCT01392742|521655772|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
144673807|NCT01392742|521655772|FG000|Overall Study|Lost to Follow-up|34|||
144673808|NCT01392742|521655772|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
144673809|NCT01392742|521655772|FG000|Overall Study|ITR and Protocol deviation|1|||
144673810|NCT01392742|521655772|FG000|Overall Study|Adverse event/intercurrent illness|17|||
144673811|NCT01392742|521655772|FG000|Overall Study|Protocol Violation|14|||
144673812|NCT01392742|521655772|FG000|Overall Study|Other|3|||
144673813|NCT01392742|521655772|FG000|Overall Study|Missing information|13|||
144673814|NCT00109772|521655775|FG000|Double-blind Treatment|Adverse Event|14|||
144673815|NCT00109772|521655776|FG001|Double-blind Treatment|Adverse Event|5|||
144673816|NCT00109772|521655775|FG000|Double-blind Treatment|Lack of Efficacy|1|||
144673817|NCT00109772|521655776|FG001|Double-blind Treatment|Lack of Efficacy|0|||
144673818|NCT00109772|521655775|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
144673819|NCT00109772|521655776|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
144673820|NCT00109772|521655775|FG000|Double-blind Treatment|Lost to Follow-up|2|||
144673821|NCT00109772|521655776|FG001|Double-blind Treatment|Lost to Follow-up|3|||
144673822|NCT00109772|521655775|FG000|Double-blind Treatment|Protocol Violation|0|||
144673823|NCT00109772|521655776|FG001|Double-blind Treatment|Protocol Violation|1|||
144673824|NCT00109772|521655775|FG000|Double-blind Treatment|Other|0|||
144673825|NCT00109772|521655776|FG001|Double-blind Treatment|Other|4|||
144265645|NCT02513550|520173977|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
144673826|NCT00109772|521655775|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
144673827|NCT00109772|521655776|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
144673828|NCT00109772|521655775|FG000|Open-label Extension|Adverse Event|10|||
144673829|NCT00109772|521655776|FG001|Open-label Extension|Adverse Event|19|||
144735587|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735588|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735589|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735590|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735591|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735592|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735593|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735594|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
144735595|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
144735596|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
144735597|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
144735598|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
144735599|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
144735600|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735601|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735602|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735603|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735604|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735605|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735606|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735607|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735608|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735609|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735610|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735611|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735612|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735613|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735614|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735615|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735616|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
144735617|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
144735618|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
144735619|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
144735620|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
144735621|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735622|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735623|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735624|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144673830|NCT00109772|521655775|FG000|Open-label Extension|Lack of Efficacy|19|||
144673831|NCT00109772|521655776|FG001|Open-label Extension|Lack of Efficacy|11|||
144673832|NCT00109772|521655775|FG000|Open-label Extension|Withdrawal by Subject|9|||
144673833|NCT00109772|521655776|FG001|Open-label Extension|Withdrawal by Subject|6|||
144673834|NCT00109772|521655775|FG000|Open-label Extension|Lost to Follow-up|1|||
144673835|NCT00109772|521655776|FG001|Open-label Extension|Lost to Follow-up|0|||
144673836|NCT00109772|521655775|FG000|Open-label Extension|Death|0|||
144673837|NCT00109772|521655776|FG001|Open-label Extension|Death|1|||
144673838|NCT00109772|521655775|FG000|Open-label Extension|Protocol Violation|2|||
144673839|NCT00109772|521655776|FG001|Open-label Extension|Protocol Violation|2|||
144673840|NCT00109772|521655775|FG000|Open-label Extension|Other|4|||
144673841|NCT00109772|521655776|FG001|Open-label Extension|Other|10|||
144673842|NCT00064077|521655793|FG000|Overall Study|Improper prior treatment|1|||
144673843|NCT00064077|521655794|FG001|Overall Study|Improper prior treatment|0|||
144673844|NCT00064077|521655795|FG002|Overall Study|Improper prior treatment|0|||
144673845|NCT00064077|521655796|FG003|Overall Study|Improper prior treatment|0|||
144673846|NCT00064077|521655793|FG000|Overall Study|Poor risk|2|||
144673847|NCT00064077|521655794|FG001|Overall Study|Poor risk|0|||
144673848|NCT00064077|521655795|FG002|Overall Study|Poor risk|1|||
144673849|NCT00064077|521655796|FG003|Overall Study|Poor risk|1|||
144673850|NCT00064077|521655793|FG000|Overall Study|Pathology|10|||
144673851|NCT00064077|521655794|FG001|Overall Study|Pathology|7|||
144735625|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735626|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144673852|NCT00064077|521655795|FG002|Overall Study|Pathology|3|||
144673853|NCT00064077|521655796|FG003|Overall Study|Pathology|4|||
144673854|NCT00064077|521655793|FG000|Overall Study|No surgery|0|||
144673855|NCT00064077|521655794|FG001|Overall Study|No surgery|0|||
144673856|NCT00064077|521655795|FG002|Overall Study|No surgery|1|||
144673857|NCT00064077|521655796|FG003|Overall Study|No surgery|0|||
144673858|NCT00064077|521655793|FG000|Overall Study|No tumor|0|||
144735627|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735628|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735629|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735630|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735631|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735632|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735633|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735634|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735635|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735636|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735637|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
144735638|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735639|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
144735640|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
144735641|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
144735642|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735643|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735644|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735645|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735646|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735647|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735648|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735649|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735650|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735651|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735652|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735653|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735654|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735655|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735656|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735657|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735658|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735659|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
144735660|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
144735661|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
144735662|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
144735663|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735664|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735665|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735666|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735667|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735668|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735669|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735670|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144673859|NCT00064077|521655794|FG001|Overall Study|No tumor|0|||
144673860|NCT00064077|521655795|FG002|Overall Study|No tumor|1|||
144673861|NCT00064077|521655796|FG003|Overall Study|No tumor|0|||
144673862|NCT00064077|521655793|FG000|Overall Study|Other reasons|2|||
144673863|NCT00064077|521655794|FG001|Overall Study|Other reasons|2|||
144673864|NCT00064077|521655795|FG002|Overall Study|Other reasons|1|||
144673865|NCT00064077|521655796|FG003|Overall Study|Other reasons|2|||
144673866|NCT03673956|521655797|FG000|Overall Study|Lost to Follow-up|1|||
144673867|NCT03673956|521655798|FG001|Overall Study|Lost to Follow-up|0|||
144673868|NCT03673956|521655799|FG002|Overall Study|Lost to Follow-up|0|||
144673869|NCT03673956|521655800|FG003|Overall Study|Lost to Follow-up|0|||
144673870|NCT03673956|521655797|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
144673871|NCT03673956|521655798|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
144673872|NCT03673956|521655799|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
144673873|NCT03673956|521655800|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
144673874|NCT01156532|521655803|FG000|Overall Study|Family Reasons|1|||
144673875|NCT01156532|521655803|FG000|Overall Study|Lost to Follow-up|1|||
144673876|NCT01809197|521655804|FG000|Overall Study|Lost to Follow-up|4|||
144673877|NCT01809197|521655805|FG001|Overall Study|Lost to Follow-up|2|||
144673878|NCT01809197|521655804|FG000|Overall Study|Adverse Event|2|||
144673879|NCT01809197|521655805|FG001|Overall Study|Adverse Event|3|||
144673880|NCT01809197|521655804|FG000|Overall Study|Failed slit lamp exam|1|||
144673881|NCT01809197|521655805|FG001|Overall Study|Failed slit lamp exam|0|||
144673882|NCT01809197|521655804|FG000|Overall Study|Non-Compliance|1|||
144673883|NCT01809197|521655805|FG001|Overall Study|Non-Compliance|1|||
144673884|NCT01809197|521655804|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
144673885|NCT01809197|521655805|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
144673886|NCT01809197|521655804|FG000|Overall Study|Withdrawal by Subject|1|||
144673887|NCT01809197|521655805|FG001|Overall Study|Withdrawal by Subject|1|||
144673888|NCT01809197|521655804|FG000|Overall Study|Product not available|0|||
144673889|NCT01809197|521655805|FG001|Overall Study|Product not available|1|||
144673890|NCT03228394|521655806|FG000|Overall Study|Lost to Follow-up|0|||
144673891|NCT03228394|521655807|FG001|Overall Study|Lost to Follow-up|0|||
144673892|NCT03228394|521655808|FG002|Overall Study|Lost to Follow-up|1|||
144673893|NCT03228394|521655809|FG003|Overall Study|Lost to Follow-up|1|||
144673894|NCT03228394|521655810|FG004|Overall Study|Lost to Follow-up|0|||
144673895|NCT03228394|521655811|FG005|Overall Study|Lost to Follow-up|0|||
144673896|NCT03228394|521655812|FG006|Overall Study|Lost to Follow-up|2|||
144673897|NCT03228394|521655813|FG007|Overall Study|Lost to Follow-up|0|||
144673898|NCT03228394|521655806|FG000|Overall Study|Withdrawal by Subject|0|||
144673899|NCT03228394|521655807|FG001|Overall Study|Withdrawal by Subject|0|||
144673900|NCT03228394|521655808|FG002|Overall Study|Withdrawal by Subject|1|||
144673901|NCT03228394|521655809|FG003|Overall Study|Withdrawal by Subject|0|||
144673902|NCT03228394|521655810|FG004|Overall Study|Withdrawal by Subject|0|||
144673903|NCT03228394|521655811|FG005|Overall Study|Withdrawal by Subject|0|||
144673904|NCT03228394|521655812|FG006|Overall Study|Withdrawal by Subject|1|||
144673905|NCT03228394|521655813|FG007|Overall Study|Withdrawal by Subject|3|||
144673906|NCT03228394|521655806|FG000|Overall Study|Protocol Violation|0|||
144673907|NCT03228394|521655807|FG001|Overall Study|Protocol Violation|0|||
144673908|NCT03228394|521655808|FG002|Overall Study|Protocol Violation|0|||
144673909|NCT03228394|521655809|FG003|Overall Study|Protocol Violation|1|||
144673910|NCT03228394|521655810|FG004|Overall Study|Protocol Violation|0|||
144673911|NCT03228394|521655811|FG005|Overall Study|Protocol Violation|0|||
144673912|NCT03228394|521655812|FG006|Overall Study|Protocol Violation|0|||
144673913|NCT03228394|521655813|FG007|Overall Study|Protocol Violation|0|||
144673914|NCT03228394|521655806|FG000|Overall Study|Physician Decision|0|||
144673915|NCT03228394|521655807|FG001|Overall Study|Physician Decision|0|||
144673916|NCT03228394|521655808|FG002|Overall Study|Physician Decision|0|||
144673917|NCT03228394|521655809|FG003|Overall Study|Physician Decision|0|||
144673918|NCT03228394|521655810|FG004|Overall Study|Physician Decision|0|||
144673919|NCT03228394|521655811|FG005|Overall Study|Physician Decision|0|||
144673920|NCT03228394|521655812|FG006|Overall Study|Physician Decision|1|||
144673921|NCT03228394|521655813|FG007|Overall Study|Physician Decision|0|||
144673922|NCT03228394|521655806|FG000|Overall Study|Noncompliance|0|||
144673923|NCT03228394|521655807|FG001|Overall Study|Noncompliance|0|||
144673924|NCT03228394|521655808|FG002|Overall Study|Noncompliance|0|||
144673925|NCT03228394|521655809|FG003|Overall Study|Noncompliance|0|||
144673926|NCT03228394|521655810|FG004|Overall Study|Noncompliance|0|||
144673927|NCT03228394|521655811|FG005|Overall Study|Noncompliance|0|||
144673928|NCT03228394|521655812|FG006|Overall Study|Noncompliance|1|||
144673929|NCT03228394|521655813|FG007|Overall Study|Noncompliance|0|||
144673930|NCT01851863|521655816|FG000|Overall Study|Did not receive study medication|2|||
144673931|NCT01851863|521655817|FG001|Overall Study|Did not receive study medication|5|||
144673932|NCT01851863|521655818|FG002|Overall Study|Did not receive study medication|3|||
144673933|NCT01851863|521655819|FG003|Overall Study|Did not receive study medication|0|||
144673934|NCT01851863|521655816|FG000|Overall Study|Lost to Follow-up|3|||
144673935|NCT01851863|521655817|FG001|Overall Study|Lost to Follow-up|4|||
144673936|NCT01851863|521655818|FG002|Overall Study|Lost to Follow-up|2|||
144673937|NCT01851863|521655819|FG003|Overall Study|Lost to Follow-up|3|||
144673938|NCT03379376|521655820|FG000|Overall Study|Lost to Follow-up|2|||
144673939|NCT03379376|521655820|FG000|Overall Study|Did not wish to complete follow up|1|||
144673940|NCT03379376|521655820|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
144673941|NCT03379376|521655820|FG000|Overall Study|Death|1|||
144673942|NCT01611298|521655821|FG000|Overall Study|Relapsed|2|||
144673943|NCT01296698|521655822|FG000|Overall Study|Adverse Event|1|||
144673944|NCT01296698|521655823|FG001|Overall Study|Adverse Event|0|||
144673945|NCT01296698|521655822|FG000|Overall Study|Death|1|||
144673946|NCT01296698|521655823|FG001|Overall Study|Death|0|||
144735671|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144218076|NCT01130532|519992226|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
144218077|NCT01130532|519992227|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
144673947|NCT01296698|521655822|FG000|Overall Study|Lost to Follow-up|19|||
144673948|NCT01296698|521655823|FG001|Overall Study|Lost to Follow-up|1|||
144673949|NCT01296698|521655822|FG000|Overall Study|Withdrawal by Subject|12|||
144673950|NCT01296698|521655823|FG001|Overall Study|Withdrawal by Subject|0|||
144673951|NCT01296698|521655822|FG000|Overall Study|Difficulty Contacting Subject|2|||
144673952|NCT01296698|521655823|FG001|Overall Study|Difficulty Contacting Subject|0|||
144673953|NCT01296698|521655822|FG000|Overall Study|Study Terminated by Sponsor|209|||
144673954|NCT01296698|521655823|FG001|Overall Study|Study Terminated by Sponsor|12|||
144735672|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735673|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735674|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735675|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735676|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735677|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735678|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735679|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
144735680|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735681|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
144735682|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
144735683|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
144735684|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735685|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735686|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735687|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735688|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735689|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735690|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735691|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735692|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735693|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735694|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735695|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735696|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735697|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735698|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735699|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735700|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
144735701|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735702|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
144735703|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
144735704|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
144735705|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735706|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735707|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735708|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735709|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735710|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144673955|NCT03639987|521655826|FG000|Overall Study|Study terminated by sponsor|26|||
144673956|NCT03639987|521655827|FG001|Overall Study|Study terminated by sponsor|25|||
144673957|NCT03639987|521655826|FG000|Overall Study|Lost to Follow-up|0|||
144673958|NCT03639987|521655827|FG001|Overall Study|Lost to Follow-up|1|||
144673959|NCT04294095|521655839|FG000|Overall Study|Adverse Event|1|||
144673960|NCT04294095|521655840|FG001|Overall Study|Adverse Event|0|||
144673961|NCT02224638|521655843|FG000|Overall Study|Adverse Event|1|||
144673962|NCT02224638|521655844|FG001|Overall Study|Adverse Event|1|||
144673963|NCT00861380|521655845|FG000|Overall Study|Withdrawal Information not recorded|8427|||
144673964|NCT00861380|521655846|FG001|Overall Study|Withdrawal Information not recorded|9112|||
144673965|NCT00861380|521655847|FG002|Overall Study|Withdrawal Information not recorded|8872|||
144673966|NCT00861380|521655848|FG003|Overall Study|Withdrawal Information not recorded|3689|||
144673967|NCT00861380|521655849|FG004|Overall Study|Withdrawal Information not recorded|1812|||
144673968|NCT00861380|521655850|FG005|Overall Study|Withdrawal Information not recorded|6249|||
144673969|NCT00861380|521655851|FG006|Overall Study|Withdrawal Information not recorded|3020|||
144673970|NCT01998399|521655854|FG000|Overall Study|Lost to Follow-up|1|||
144673971|NCT01998399|521655855|FG001|Overall Study|Lost to Follow-up|3|||
144673972|NCT01998399|521655854|FG000|Overall Study|Death|4|||
144673973|NCT01998399|521655855|FG001|Overall Study|Death|2|||
144673974|NCT01998399|521655854|FG000|Overall Study|Study stopped before dosing completed|3|||
144673975|NCT01998399|521655855|FG001|Overall Study|Study stopped before dosing completed|3|||
144673976|NCT01998399|521655854|FG000|Overall Study|Withdrawal by Subject|0|||
144673977|NCT01998399|521655855|FG001|Overall Study|Withdrawal by Subject|1|||
144673978|NCT00376246|521655865|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
144673979|NCT00376246|521655866|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
144673980|NCT00376246|521655865|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
144673981|NCT00376246|521655866|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
144735711|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735712|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735713|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735714|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735715|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735716|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735717|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735718|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735719|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735720|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735721|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
144735722|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735723|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735724|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
144735725|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
144735726|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735727|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735728|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735729|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735730|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144673982|NCT00376246|521655865|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
144673983|NCT00376246|521655866|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144673984|NCT01455415|521655872|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
144673985|NCT01455415|521655873|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
144673986|NCT01455415|521655872|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
144673987|NCT01455415|521655873|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
144673988|NCT01455415|521655872|FG000|Period 1|Drug Error not Associated to AE|0|||
144673989|NCT01455415|521655873|FG001|Period 1|Drug Error not Associated to AE|1|||
144673990|NCT01455415|521655872|FG000|Period 1|AE Not Related to Study Drug|2|||
144673991|NCT01455415|521655873|FG001|Period 1|AE Not Related to Study Drug|6|||
144673992|NCT01455415|521655872|FG000|Period 1|Withdrawal by Subject|4|||
144673993|NCT01455415|521655873|FG001|Period 1|Withdrawal by Subject|5|||
144673994|NCT01455415|521655872|FG000|Period 1|Unspecified Reason|1|||
144673995|NCT01455415|521655873|FG001|Period 1|Unspecified Reason|1|||
144673996|NCT01455415|521655872|FG000|Period 1|Protocol Violation|0|||
144673997|NCT01455415|521655873|FG001|Period 1|Protocol Violation|2|||
144673998|NCT01455415|521655872|FG000|Washout|AE Related to Study Drug|2|||
144673999|NCT01455415|521655873|FG001|Washout|AE Related to Study Drug|0|||
144674000|NCT01455415|521655872|FG000|Washout|Lost to Follow-up|1|||
144674001|NCT01455415|521655873|FG001|Washout|Lost to Follow-up|0|||
144674002|NCT01455415|521655872|FG000|Washout|Drug Error not Associated to AE|2|||
144674003|NCT01455415|521655873|FG001|Washout|Drug Error not Associated to AE|1|||
144674004|NCT01455415|521655872|FG000|Washout|AE Not Related to Study Drug|2|||
144674005|NCT01455415|521655873|FG001|Washout|AE Not Related to Study Drug|3|||
144674006|NCT01455415|521655872|FG000|Washout|Unspecified Reason|1|||
144674007|NCT01455415|521655873|FG001|Washout|Unspecified Reason|2|||
144674008|NCT01455415|521655872|FG000|Washout|Protocol Violation|0|||
144674009|NCT01455415|521655873|FG001|Washout|Protocol Violation|1|||
144674010|NCT01455415|521655872|FG000|Period 2|AE Related to Study Drug|1|||
144674011|NCT01455415|521655873|FG001|Period 2|AE Related to Study Drug|2|||
144674012|NCT01455415|521655872|FG000|Period 2|Lost to Follow-up|2|||
144674013|NCT01455415|521655873|FG001|Period 2|Lost to Follow-up|1|||
144674014|NCT01455415|521655872|FG000|Period 2|AE Not Related to Study Drug|2|||
144674015|NCT01455415|521655873|FG001|Period 2|AE Not Related to Study Drug|1|||
144674016|NCT01455415|521655872|FG000|Period 2|Lack of Efficacy|2|||
144674017|NCT01455415|521655873|FG001|Period 2|Lack of Efficacy|0|||
144674018|NCT01455415|521655872|FG000|Period 2|Withdrawal by Subject|2|||
144674019|NCT01455415|521655873|FG001|Period 2|Withdrawal by Subject|3|||
144674020|NCT01455415|521655872|FG000|Period 2|Unspecified Reason|2|||
144674021|NCT01455415|521655873|FG001|Period 2|Unspecified Reason|3|||
144735731|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735732|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735733|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735734|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735735|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144674022|NCT01455415|521655872|FG000|Period 2|Protocol Violation|2|||
144674023|NCT01455415|521655873|FG001|Period 2|Protocol Violation|0|||
144674024|NCT01455415|521655872|FG000|Follow-up|AE Related to Study Drug|0|||
144674025|NCT01455415|521655873|FG001|Follow-up|AE Related to Study Drug|1|||
144674026|NCT01455415|521655872|FG000|Follow-up|Lack of Efficacy|0|||
144674027|NCT01455415|521655873|FG001|Follow-up|Lack of Efficacy|1|||
144674028|NCT01455415|521655872|FG000|Follow-up|Withdrawal by Subject|2|||
144218078|NCT02762929|519992228|FG000|Overall Study|Adverse Event|0|||
144674029|NCT01455415|521655873|FG001|Follow-up|Withdrawal by Subject|0|||
144674030|NCT01455415|521655872|FG000|Follow-up|Unspecified Reason|1|||
144674031|NCT01455415|521655873|FG001|Follow-up|Unspecified Reason|0|||
144674032|NCT02762708|521655874|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
144674033|NCT02762708|521655875|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
144674034|NCT02762708|521655876|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
144674035|NCT02762708|521655877|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
144674036|NCT01468701|521655882|FG000|Overall Study|Not eligible|91|||
144674037|NCT01468701|521655883|FG001|Overall Study|Not eligible|140|||
144218079|NCT02762929|519992229|FG001|Overall Study|Adverse Event|0|||
144218080|NCT02762929|519992230|FG002|Overall Study|Adverse Event|0|||
144674038|NCT01468701|521655884|FG002|Overall Study|Not eligible|29|||
144674039|NCT01468701|521655885|FG003|Overall Study|Not eligible|12|||
144674040|NCT01468701|521655886|FG004|Overall Study|Not eligible|22|||
144674041|NCT01468701|521655887|FG005|Overall Study|Not eligible|2|||
144674042|NCT01468701|521655888|FG006|Overall Study|Not eligible|39|||
144674043|NCT01468701|521655889|FG007|Overall Study|Not eligible|1|||
144674044|NCT01468701|521655890|FG008|Overall Study|Not eligible|40|||
144674045|NCT01468701|521655891|FG009|Overall Study|Not eligible|126|||
144674046|NCT01468701|521655892|FG010|Overall Study|Not eligible|39|||
144674047|NCT01468701|521655893|FG011|Overall Study|Not eligible|33|||
144674048|NCT01468701|521655894|FG012|Overall Study|Not eligible|1|||
144674049|NCT01468701|521655895|FG013|Overall Study|Not eligible|19|||
144674050|NCT01468701|521655896|FG014|Overall Study|Not eligible|1|||
144674051|NCT01468701|521655897|FG015|Overall Study|Not eligible|32|||
144674052|NCT01468701|521655898|FG016|Overall Study|Not eligible|0|||
144674053|NCT01468701|521655882|FG000|Overall Study|Lost to Follow-up|306|||
144674054|NCT01468701|521655883|FG001|Overall Study|Lost to Follow-up|0|||
144674055|NCT01468701|521655884|FG002|Overall Study|Lost to Follow-up|0|||
144674056|NCT01468701|521655885|FG003|Overall Study|Lost to Follow-up|0|||
144674057|NCT01468701|521655886|FG004|Overall Study|Lost to Follow-up|0|||
144674058|NCT01468701|521655887|FG005|Overall Study|Lost to Follow-up|0|||
144674059|NCT01468701|521655888|FG006|Overall Study|Lost to Follow-up|0|||
144674060|NCT01468701|521655889|FG007|Overall Study|Lost to Follow-up|0|||
144674061|NCT01468701|521655890|FG008|Overall Study|Lost to Follow-up|215|||
144674062|NCT01468701|521655891|FG009|Overall Study|Lost to Follow-up|309|||
144674063|NCT01468701|521655892|FG010|Overall Study|Lost to Follow-up|224|||
144674064|NCT01468701|521655893|FG011|Overall Study|Lost to Follow-up|212|||
144674065|NCT01468701|521655894|FG012|Overall Study|Lost to Follow-up|11|||
144674066|NCT01468701|521655895|FG013|Overall Study|Lost to Follow-up|164|||
144674067|NCT01468701|521655896|FG014|Overall Study|Lost to Follow-up|17|||
144674068|NCT01468701|521655897|FG015|Overall Study|Lost to Follow-up|127|||
144674069|NCT01468701|521655898|FG016|Overall Study|Lost to Follow-up|1|||
144674070|NCT01468701|521655882|FG000|Overall Study|Withdrawal by Subject|165|||
144674071|NCT01468701|521655883|FG001|Overall Study|Withdrawal by Subject|0|||
144674072|NCT01468701|521655884|FG002|Overall Study|Withdrawal by Subject|0|||
144674073|NCT01468701|521655885|FG003|Overall Study|Withdrawal by Subject|0|||
144674074|NCT01468701|521655886|FG004|Overall Study|Withdrawal by Subject|0|||
144674075|NCT01468701|521655887|FG005|Overall Study|Withdrawal by Subject|0|||
144674076|NCT01468701|521655888|FG006|Overall Study|Withdrawal by Subject|0|||
144674077|NCT01468701|521655889|FG007|Overall Study|Withdrawal by Subject|0|||
144674078|NCT01468701|521655890|FG008|Overall Study|Withdrawal by Subject|83|||
144674079|NCT01468701|521655891|FG009|Overall Study|Withdrawal by Subject|88|||
144674080|NCT01468701|521655892|FG010|Overall Study|Withdrawal by Subject|100|||
144674081|NCT01468701|521655893|FG011|Overall Study|Withdrawal by Subject|114|||
144674082|NCT01468701|521655894|FG012|Overall Study|Withdrawal by Subject|9|||
144674083|NCT01468701|521655895|FG013|Overall Study|Withdrawal by Subject|47|||
144674084|NCT01468701|521655896|FG014|Overall Study|Withdrawal by Subject|6|||
144674085|NCT01468701|521655897|FG015|Overall Study|Withdrawal by Subject|31|||
144674086|NCT01468701|521655898|FG016|Overall Study|Withdrawal by Subject|0|||
144674087|NCT01468701|521655882|FG000|Overall Study|Other reasons than listed|437|||
144674088|NCT01468701|521655883|FG001|Overall Study|Other reasons than listed|0|||
144674089|NCT01468701|521655884|FG002|Overall Study|Other reasons than listed|0|||
144674090|NCT01468701|521655885|FG003|Overall Study|Other reasons than listed|0|||
144674091|NCT01468701|521655886|FG004|Overall Study|Other reasons than listed|0|||
144674092|NCT01468701|521655887|FG005|Overall Study|Other reasons than listed|0|||
144674093|NCT01468701|521655888|FG006|Overall Study|Other reasons than listed|0|||
144674094|NCT01468701|521655889|FG007|Overall Study|Other reasons than listed|0|||
144674095|NCT01468701|521655890|FG008|Overall Study|Other reasons than listed|318|||
144674096|NCT01468701|521655891|FG009|Overall Study|Other reasons than listed|658|||
144674097|NCT01468701|521655892|FG010|Overall Study|Other reasons than listed|433|||
144674098|NCT01468701|521655893|FG011|Overall Study|Other reasons than listed|504|||
144674099|NCT01468701|521655894|FG012|Overall Study|Other reasons than listed|28|||
144674100|NCT01468701|521655895|FG013|Overall Study|Other reasons than listed|239|||
144674101|NCT01468701|521655896|FG014|Overall Study|Other reasons than listed|39|||
144674102|NCT01468701|521655897|FG015|Overall Study|Other reasons than listed|172|||
144674103|NCT01468701|521655898|FG016|Overall Study|Other reasons than listed|0|||
144674104|NCT01468701|521655882|FG000|Overall Study|No end of study case report form|0|||
144674105|NCT01468701|521655883|FG001|Overall Study|No end of study case report form|0|||
144674106|NCT01468701|521655884|FG002|Overall Study|No end of study case report form|0|||
144674107|NCT01468701|521655885|FG003|Overall Study|No end of study case report form|0|||
144674108|NCT01468701|521655886|FG004|Overall Study|No end of study case report form|0|||
144674109|NCT01468701|521655887|FG005|Overall Study|No end of study case report form|0|||
144674110|NCT01468701|521655888|FG006|Overall Study|No end of study case report form|0|||
144674111|NCT01468701|521655889|FG007|Overall Study|No end of study case report form|0|||
144674112|NCT01468701|521655890|FG008|Overall Study|No end of study case report form|4|||
144674113|NCT01468701|521655891|FG009|Overall Study|No end of study case report form|1|||
144674114|NCT01468701|521655892|FG010|Overall Study|No end of study case report form|2|||
144674115|NCT01468701|521655893|FG011|Overall Study|No end of study case report form|3|||
144674116|NCT01468701|521655894|FG012|Overall Study|No end of study case report form|0|||
144674117|NCT01468701|521655895|FG013|Overall Study|No end of study case report form|1|||
144674118|NCT01468701|521655896|FG014|Overall Study|No end of study case report form|0|||
144674119|NCT01468701|521655897|FG015|Overall Study|No end of study case report form|0|||
144674120|NCT01468701|521655898|FG016|Overall Study|No end of study case report form|0|||
144674121|NCT01468701|521655882|FG000|Overall Study|Not being followed up|0|||
144674122|NCT01468701|521655883|FG001|Overall Study|Not being followed up|4963|||
144674123|NCT01468701|521655884|FG002|Overall Study|Not being followed up|1755|||
144674124|NCT01468701|521655885|FG003|Overall Study|Not being followed up|703|||
144674125|NCT01468701|521655886|FG004|Overall Study|Not being followed up|1714|||
144674126|NCT01468701|521655887|FG005|Overall Study|Not being followed up|126|||
144674127|NCT01468701|521655888|FG006|Overall Study|Not being followed up|1170|||
144674128|NCT01468701|521655889|FG007|Overall Study|Not being followed up|4|||
144674129|NCT01468701|521655890|FG008|Overall Study|Not being followed up|0|||
144674130|NCT01468701|521655891|FG009|Overall Study|Not being followed up|0|||
144674131|NCT01468701|521655892|FG010|Overall Study|Not being followed up|0|||
144674132|NCT01468701|521655893|FG011|Overall Study|Not being followed up|0|||
144674133|NCT01468701|521655894|FG012|Overall Study|Not being followed up|0|||
144674134|NCT01468701|521655895|FG013|Overall Study|Not being followed up|0|||
144674135|NCT01468701|521655896|FG014|Overall Study|Not being followed up|0|||
144674136|NCT01468701|521655897|FG015|Overall Study|Not being followed up|0|||
144674137|NCT01468701|521655898|FG016|Overall Study|Not being followed up|0|||
144674138|NCT02679781|521655899|FG000|Overall Study|Lost to Follow-up|1|||
144674139|NCT02679781|521655900|FG001|Overall Study|Lost to Follow-up|2|||
144674140|NCT02679781|521655899|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
144674141|NCT02679781|521655900|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
144674142|NCT01822223|521655903|FG000|Overall Study|Death|0|||
144674143|NCT01822223|521655904|FG001|Overall Study|Death|1|||
144674144|NCT00631540|521655913|FG000|Overall Study|Withdrawal by Subject|5|||
144674145|NCT00631540|521655913|FG000|Overall Study|Death|4|||
144674146|NCT00631540|521655913|FG000|Overall Study|Lost to Follow-up|2|||
144674147|NCT00631540|521655913|FG000|Overall Study|Core Lab Data Unavailable|3|||
144674148|NCT00970268|521655914|FG000|Overall Study|Withdrawal by Subject|12|||
144674149|NCT00970268|521655915|FG001|Overall Study|Withdrawal by Subject|19|||
144674150|NCT00970268|521655914|FG000|Overall Study|Adverse Event|15|||
144674151|NCT00970268|521655915|FG001|Overall Study|Adverse Event|12|||
144674152|NCT00970268|521655914|FG000|Overall Study|Lack of Efficacy|3|||
144674153|NCT00970268|521655915|FG001|Overall Study|Lack of Efficacy|6|||
144674154|NCT00970268|521655914|FG000|Overall Study|Protocol Violation|4|||
144674155|NCT00970268|521655915|FG001|Overall Study|Protocol Violation|7|||
144674156|NCT00970268|521655914|FG000|Overall Study|Other Reason|3|||
144674157|NCT00970268|521655915|FG001|Overall Study|Other Reason|1|||
144674158|NCT00970268|521655914|FG000|Overall Study|COPD Exacerbation|4|||
144674159|NCT00970268|521655915|FG001|Overall Study|COPD Exacerbation|2|||
144674160|NCT00970268|521655914|FG000|Overall Study|Lost to Follow-up|1|||
144674161|NCT00970268|521655915|FG001|Overall Study|Lost to Follow-up|2|||
144674162|NCT00970268|521655914|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
144674163|NCT00970268|521655915|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
144674164|NCT02091921|521655920|FG000|Overall Study|Adverse Event|3|||
144674165|NCT02483078|521655925|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
144674166|NCT02483078|521655926|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
144674167|NCT02483078|521655925|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
144674168|NCT02483078|521655926|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
144674169|NCT02483078|521655925|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
144674170|NCT02483078|521655926|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
144674171|NCT02483078|521655925|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
144674172|NCT02483078|521655926|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
144674173|NCT02483078|521655925|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
144674174|NCT02483078|521655926|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
144674175|NCT02483078|521655925|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
144735736|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735737|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735738|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735739|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735740|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735741|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735742|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
144735743|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735744|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735745|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
144735746|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
144735747|NCT01597245|521885545|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735748|NCT01597245|521885546|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735749|NCT01597245|521885547|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735750|NCT01597245|521885548|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735751|NCT01597245|521885549|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735752|NCT01597245|521885550|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735753|NCT01597245|521885551|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735754|NCT01597245|521885552|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735755|NCT01597245|521885553|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735756|NCT01597245|521885554|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735757|NCT01597245|521885555|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735758|NCT01597245|521885556|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735759|NCT01597245|521885557|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735760|NCT01597245|521885558|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735761|NCT01597245|521885559|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735762|NCT01597245|521885560|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735763|NCT01597245|521885561|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735764|NCT01597245|521885562|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735765|NCT01597245|521885563|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735766|NCT01597245|521885564|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
144735767|NCT01597245|521885565|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
144735768|NCT00731783|521885566|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
144735769|NCT00731783|521885567|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
144735770|NCT00731783|521885566|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
144735771|NCT00731783|521885567|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
144735772|NCT00731783|521885566|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
144735773|NCT00731783|521885567|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
144735774|NCT00731783|521885566|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
144735775|NCT00731783|521885567|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
144735776|NCT01802320|521885568|FG000|Overall Study|Death|1|||
144735777|NCT01802320|521885568|FG000|Overall Study|Withdrawal by Subject|1|||
144735778|NCT02847650|521887361|FG000|Overall Study|Adverse Event|2|||
144735779|NCT02847650|521887362|FG001|Overall Study|Adverse Event|4|||
144735780|NCT02847650|521887361|FG000|Overall Study|Lost to Follow-up|1|||
144735781|NCT02847650|521887362|FG001|Overall Study|Lost to Follow-up|0|||
144735782|NCT02847650|521887361|FG000|Overall Study|Protocol Violation|0|||
144735783|NCT02847650|521887362|FG001|Overall Study|Protocol Violation|1|||
144735784|NCT02847650|521887361|FG000|Overall Study|Withdrawal by Subject|1|||
144735785|NCT02847650|521887362|FG001|Overall Study|Withdrawal by Subject|1|||
144735786|NCT03255733|521887363|FG000|Overall Study|Lost to Follow-up|4|||
144735787|NCT02378935|521887364|FG000|Overall Study|Lack of Efficacy|10|||
144735788|NCT02378935|521887365|FG001|Overall Study|Lack of Efficacy|0|||
144735789|NCT02378935|521887366|FG002|Overall Study|Lack of Efficacy|2|||
144735790|NCT02378935|521887367|FG003|Overall Study|Lack of Efficacy|6|||
144735791|NCT02378935|521887368|FG004|Overall Study|Lack of Efficacy|0|||
144735792|NCT02378935|521887369|FG005|Overall Study|Lack of Efficacy|0|||
144735793|NCT02378935|521887370|FG006|Overall Study|Lack of Efficacy|0|||
144735794|NCT02378935|521887364|FG000|Overall Study|Death|0|||
144735795|NCT02378935|521887365|FG001|Overall Study|Death|0|||
144735796|NCT02378935|521887366|FG002|Overall Study|Death|1|||
144265646|NCT02513550|520173978|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
144735797|NCT02378935|521887367|FG003|Overall Study|Death|0|||
144735798|NCT02378935|521887368|FG004|Overall Study|Death|0|||
144735799|NCT02378935|521887369|FG005|Overall Study|Death|0|||
144735800|NCT02378935|521887370|FG006|Overall Study|Death|0|||
144735801|NCT02659150|521887371|FG000|Subject Enrollment|Physician Decision|3|||
144735802|NCT02659150|521887371|FG000|Subject Enrollment|Withdrawal by Subject|2|||
144735803|NCT02659150|521887371|FG000|Baseline Imaging|Withdrawal by Subject|1|||
144735804|NCT02659150|521887371|FG000|Baseline Imaging|Physician Decision|1|||
144735805|NCT02659150|521887371|FG000|Study Drug Dosing|Adverse Event|1|||
144735806|NCT03699020|521887375|FG000|Overall Study|Withdrawal by Subject|3|||
144674176|NCT02483078|521655926|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
144674177|NCT04876599|521655927|FG000|Overall Study|Missed|2|||
144674178|NCT04876599|521655928|FG001|Overall Study|Missed|0|||
144674179|NCT04876599|521655927|FG000|Overall Study|Declined|2|||
144674180|NCT04876599|521655928|FG001|Overall Study|Declined|3|||
144674181|NCT03366844|521657880|FG000|Overall Study|Physician Decision|1|||
144674182|NCT03366844|521657880|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
144674183|NCT02580240|521657886|FG000|Overall Study|Physician Decision|2|||
144674184|NCT02580240|521657887|FG001|Overall Study|Physician Decision|0|||
144674185|NCT00653328|521657888|FG000|Overall Study|Withdrawal by Subject|1|||
144674186|NCT00653328|521657888|FG000|Overall Study|Adverse Event|2|||
144674187|NCT00653328|521657888|FG000|Overall Study|Disease progression|10|||
144674188|NCT00653328|521657888|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
144674189|NCT02911519|521657889|FG000|Overall Study|Lost to Follow-up|2|||
144674190|NCT02911519|521657890|FG001|Overall Study|Lost to Follow-up|2|||
144674191|NCT02911519|521657889|FG000|Overall Study|Death|0|||
144674192|NCT02911519|521657890|FG001|Overall Study|Death|2|||
144674193|NCT01237223|521657897|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
144674194|NCT01237223|521657898|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
144674195|NCT01237223|521657899|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
144674196|NCT01237223|521657900|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
144674197|NCT01237223|521657901|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
144674198|NCT01237223|521657902|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
144674199|NCT01237223|521657897|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
144674200|NCT01237223|521657898|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
144674201|NCT01237223|521657899|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
144674202|NCT01237223|521657900|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
144674203|NCT01237223|521657901|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
144674204|NCT01237223|521657902|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
144674205|NCT01237223|521657897|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
144674206|NCT01237223|521657898|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
144674207|NCT01237223|521657899|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
144674208|NCT01237223|521657900|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
144674209|NCT01237223|521657901|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
144674210|NCT01237223|521657902|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
144674211|NCT01237223|521657897|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
144674212|NCT01237223|521657898|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
144674213|NCT01237223|521657899|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
144674214|NCT01237223|521657900|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
144674215|NCT01237223|521657901|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
144674216|NCT01237223|521657902|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
144674217|NCT01237223|521657897|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
144674218|NCT01237223|521657898|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
144674219|NCT01237223|521657899|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
144674220|NCT01237223|521657900|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
144674221|NCT01237223|521657901|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
144674222|NCT01237223|521657902|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
144674223|NCT01237223|521657897|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
144674224|NCT01237223|521657898|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
144674225|NCT01237223|521657899|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
144674226|NCT01237223|521657900|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
144674227|NCT01237223|521657901|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
144674228|NCT01237223|521657902|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
144674229|NCT01237223|521657897|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
144674230|NCT01237223|521657898|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
144674231|NCT01237223|521657899|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
144674232|NCT01237223|521657900|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
144674233|NCT01237223|521657901|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
144674234|NCT01237223|521657902|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
144674235|NCT01237223|521657897|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
144674236|NCT01237223|521657898|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
144674237|NCT01237223|521657899|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
144674238|NCT01237223|521657900|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
144674239|NCT01237223|521657901|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
144735807|NCT03699020|521887376|FG001|Overall Study|Withdrawal by Subject|2|||
144674240|NCT01237223|521657902|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
144674241|NCT01237223|521657897|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
144674242|NCT01237223|521657898|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
144674243|NCT01237223|521657899|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
144674244|NCT01237223|521657900|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
144674245|NCT01237223|521657901|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
144674246|NCT01237223|521657902|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
144674247|NCT01237223|521657897|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
144674248|NCT01237223|521657898|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
144674249|NCT01237223|521657899|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
144674250|NCT01237223|521657900|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
144674251|NCT01237223|521657901|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
144674252|NCT01237223|521657902|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
144674253|NCT00813917|521657906|FG000|Overall Study|Adverse Event|0|||
144674254|NCT00813917|521657907|FG001|Overall Study|Adverse Event|1|||
144674255|NCT00813917|521657906|FG000|Overall Study|Withdrawal by Subject|3|||
144674256|NCT00813917|521657907|FG001|Overall Study|Withdrawal by Subject|4|||
144674257|NCT00813917|521657906|FG000|Overall Study|Lost to Follow-up|3|||
144674258|NCT00813917|521657907|FG001|Overall Study|Lost to Follow-up|1|||
144674259|NCT01359046|521657908|FG000|Overall Study|Did not receive allocated intervention|6|||
144674260|NCT01359046|521657909|FG001|Overall Study|Did not receive allocated intervention|6|||
144674261|NCT01359046|521657908|FG000|Overall Study|Physician Decision|1|||
144674262|NCT01359046|521657909|FG001|Overall Study|Physician Decision|11|||
144674263|NCT00792701|521657910|FG000|Overall Study|Adverse Event|0|||
144674264|NCT00792701|521657911|FG001|Overall Study|Adverse Event|22|||
144674265|NCT00792701|521657910|FG000|Overall Study|Ineligible|1|||
144674266|NCT00792701|521657911|FG001|Overall Study|Ineligible|3|||
144674267|NCT00792701|521657910|FG000|Overall Study|Withdrawal by Subject|1|||
144674268|NCT00792701|521657911|FG001|Overall Study|Withdrawal by Subject|19|||
144674269|NCT00792701|521657910|FG000|Overall Study|Not protocol specified|17|||
144674270|NCT00792701|521657911|FG001|Overall Study|Not protocol specified|0|||
144674271|NCT00615914|521657912|FG000|Overall Study|Adverse Event|274|||
144674272|NCT00615914|521657912|FG000|Overall Study|Death|20|||
144674273|NCT00615914|521657912|FG000|Overall Study|Lack of Efficacy|59|||
144674274|NCT00615914|521657912|FG000|Overall Study|Lost to Follow-up|187|||
144674275|NCT00615914|521657912|FG000|Overall Study|Withdrawal by Subject|16|||
144674276|NCT00615914|521657912|FG000|Overall Study|Physician Decision|4|||
144674277|NCT00615914|521657912|FG000|Overall Study|No data was collected.|65|||
144674278|NCT00615914|521657912|FG000|Overall Study|No treatment|2|||
144674279|NCT00615914|521657912|FG000|Overall Study|Irregularly enrolled patients|10|||
144674280|NCT00802867|521657915|FG000|Overall Study|Lost to Follow-up|6|||
144674281|NCT00802867|521657915|FG000|Overall Study|Protocol Violation|6|||
144674282|NCT00802867|521657915|FG000|Overall Study|Withdrawal by Subject|1|||
144674283|NCT04075396|521657916|FG000|Overall Study|Death|11|||
144674284|NCT04075396|521657917|FG001|Overall Study|Death|9|||
144674285|NCT04075396|521657916|FG000|Overall Study|Withdrawal by Subject|1|||
144674286|NCT04075396|521657917|FG001|Overall Study|Withdrawal by Subject|2|||
144674287|NCT04075396|521657916|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
144674288|NCT04075396|521657917|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
144674289|NCT04075396|521657916|FG000|Overall Study|Enrolled but not-treated|0|||
144674290|NCT04075396|521657917|FG001|Overall Study|Enrolled but not-treated|1|||
144674291|NCT03000686|521657920|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
144674292|NCT03000686|521657921|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
144674293|NCT03000686|521657922|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
144674294|NCT03000686|521657923|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
144674295|NCT02920450|521657924|FG000|Overall Study|Death|1|||
144674296|NCT02920450|521657925|FG001|Overall Study|Death|0|||
144674297|NCT02920450|521657926|FG002|Overall Study|Death|0|||
144674298|NCT02920450|521657927|FG003|Overall Study|Death|0|||
144674299|NCT02920450|521657924|FG000|Overall Study|Withdrawal by Subject|1|||
144674300|NCT02920450|521657925|FG001|Overall Study|Withdrawal by Subject|0|||
144674301|NCT02920450|521657926|FG002|Overall Study|Withdrawal by Subject|0|||
144674302|NCT02920450|521657927|FG003|Overall Study|Withdrawal by Subject|0|||
144674303|NCT01112982|521657935|FG000|Overall Study|Withdrawal by Subject|1|||
144674304|NCT01112982|521657935|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
144674305|NCT01981109|521657938|FG000|Overall Study|Death|36|||
144674306|NCT01981109|521657938|FG000|Overall Study|Withdrawal by Subject|40|||
144674307|NCT01981109|521657938|FG000|Overall Study|Lost to Follow-up|9|||
144674308|NCT01981109|521657938|FG000|Overall Study|No Discontinuation Documentation|37|||
144674309|NCT01981109|521657938|FG000|Overall Study|Study Termination|100|||
144674310|NCT01981109|521657938|FG000|Overall Study|No data available|2|||
144674311|NCT02023268|521657939|FG000|Overall Study|Lack of Efficacy|0|||
144674312|NCT02023268|521657940|FG001|Overall Study|Lack of Efficacy|1|||
144735808|NCT02246920|521887377|FG000|Overall Study|Adverse Event|3|||
144735809|NCT02246920|521887378|FG001|Overall Study|Adverse Event|1|||
144735810|NCT02246920|521887379|FG002|Overall Study|Adverse Event|1|||
144735811|NCT02246920|521887377|FG000|Overall Study|Lost to Follow-up|2|||
144735812|NCT02246920|521887378|FG001|Overall Study|Lost to Follow-up|1|||
144735813|NCT02246920|521887379|FG002|Overall Study|Lost to Follow-up|0|||
144735814|NCT02246920|521887377|FG000|Overall Study|Protocol Violation|2|||
144735815|NCT02246920|521887378|FG001|Overall Study|Protocol Violation|5|||
144735816|NCT02246920|521887379|FG002|Overall Study|Protocol Violation|1|||
144735817|NCT02246920|521887377|FG000|Overall Study|Withdrawal by Subject|0|||
144735818|NCT02246920|521887378|FG001|Overall Study|Withdrawal by Subject|0|||
144735819|NCT02246920|521887379|FG002|Overall Study|Withdrawal by Subject|1|||
144735820|NCT00448019|521887380|FG000|Overall Study|Withdrawal by Subject|3|||
144735821|NCT00448019|521887380|FG000|Overall Study|Disease progression|1|||
144735822|NCT00448019|521887380|FG000|Overall Study|Death|2|||
144735823|NCT00448019|521887380|FG000|Overall Study|Insurance Issues|1|||
144735824|NCT02647944|521887385|FG000|Overall Study|Withdrawal by Subject|0|||
144735825|NCT02647944|521887386|FG001|Overall Study|Withdrawal by Subject|3|||
144735826|NCT02647944|521887385|FG000|Overall Study|Adverse Event|2|||
144735827|NCT02647944|521887386|FG001|Overall Study|Adverse Event|0|||
144735828|NCT02760368|521887388|FG000|Overall Study|Withdrawal by Subject|8|||
144735829|NCT02760368|521887389|FG001|Overall Study|Withdrawal by Subject|12|||
144735830|NCT02760368|521887390|FG002|Overall Study|Withdrawal by Subject|9|||
144735831|NCT02760368|521887388|FG000|Overall Study|Screen Failure|0|||
144735832|NCT02760368|521887389|FG001|Overall Study|Screen Failure|0|||
144735833|NCT02760368|521887390|FG002|Overall Study|Screen Failure|1|||
144674313|NCT02023268|521657939|FG000|Overall Study|Adverse Event|0|||
144674314|NCT02023268|521657940|FG001|Overall Study|Adverse Event|2|||
144674315|NCT02023268|521657939|FG000|Overall Study|Withdrawal by Subject|0|||
144674316|NCT02023268|521657940|FG001|Overall Study|Withdrawal by Subject|1|||
144674317|NCT03407170|521657941|FG000|Overall Study|Adverse Event|1|||
144674318|NCT00126672|521657944|FG000|Overall Study|Adverse Event|4|||
144674319|NCT00126672|521657944|FG000|Overall Study|Lost to Follow-up|4|||
144674320|NCT01001234|521657945|FG000|Overall Study|Withdrawal by Subject|2|||
144674321|NCT01001234|521657946|FG001|Overall Study|Withdrawal by Subject|0|||
144674322|NCT01001234|521657947|FG002|Overall Study|Withdrawal by Subject|3|||
144674323|NCT01001234|521657948|FG003|Overall Study|Withdrawal by Subject|0|||
144674324|NCT01001234|521657949|FG004|Overall Study|Withdrawal by Subject|0|||
144674325|NCT01001234|521657945|FG000|Overall Study|Protocol Violation|34|||
144674326|NCT01001234|521657946|FG001|Overall Study|Protocol Violation|3|||
144735834|NCT02760368|521887388|FG000|Overall Study|Death|0|||
144735835|NCT02760368|521887389|FG001|Overall Study|Death|1|||
144735836|NCT02760368|521887390|FG002|Overall Study|Death|0|||
144735837|NCT02760368|521887388|FG000|Overall Study|Withdrawal by Sponsor|0|||
144735838|NCT02760368|521887389|FG001|Overall Study|Withdrawal by Sponsor|0|||
144735839|NCT02760368|521887390|FG002|Overall Study|Withdrawal by Sponsor|1|||
144735840|NCT02902211|521887398|FG000|First Three Months|Withdrawal by Subject|7|||
144735841|NCT02902211|521887399|FG001|First Three Months|Withdrawal by Subject|3|||
144735842|NCT03181594|521887400|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
144735843|NCT03181594|521887400|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
144735844|NCT03181594|521887400|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
144735845|NCT03181594|521887400|FG000|Initial Study Protocol (12-month FU)|Death|1|||
144735846|NCT03181594|521887400|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
144735847|NCT03181594|521887400|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
144735848|NCT01200810|521887403|FG000|Overall Study|Physician Decision|1|||
144735849|NCT01200810|521887404|FG001|Overall Study|Physician Decision|0|||
144735850|NCT01200810|521887403|FG000|Overall Study|Withdrawal by Subject|1|||
144735851|NCT01200810|521887404|FG001|Overall Study|Withdrawal by Subject|2|||
144735852|NCT01200810|521887403|FG000|Overall Study|Sponsor stopped making study drug|3|||
144735853|NCT01200810|521887404|FG001|Overall Study|Sponsor stopped making study drug|3|||
144735854|NCT00904215|521887406|FG000|Overall Study|Adverse Event|25|||
144735855|NCT00904215|521887406|FG000|Overall Study|Protocol Violation|10|||
144735856|NCT00904215|521887406|FG000|Overall Study|Lost to Follow-up|63|||
144735857|NCT00904215|521887406|FG000|Overall Study|Withdrawal by Subject|9|||
144297088|NCT01182350|520292441|FG002|Overall Study|Unevaluable for Biopsy|0|||
144735858|NCT00904215|521887406|FG000|Overall Study|Other|28|||
144735859|NCT00960297|521887407|FG000|Overall Study|Physician Decision|1|||
144735860|NCT00960297|521887407|FG000|Overall Study|Venous port infection|1|||
144735861|NCT00960297|521887407|FG000|Overall Study|Disease progression|1|||
144735862|NCT03247972|521887417|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
144674327|NCT01001234|521657947|FG002|Overall Study|Protocol Violation|19|||
144674328|NCT01001234|521657948|FG003|Overall Study|Protocol Violation|18|||
144674329|NCT01001234|521657949|FG004|Overall Study|Protocol Violation|0|||
144674330|NCT01001234|521657945|FG000|Overall Study|Lost to Follow-up|0|||
144735863|NCT03247972|521887417|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
144735864|NCT02576938|521887418|FG000|Overall Study|Adverse Event|5|||
144735865|NCT02576938|521887419|FG001|Overall Study|Adverse Event|3|||
144674331|NCT01001234|521657946|FG001|Overall Study|Lost to Follow-up|0|||
144674332|NCT01001234|521657947|FG002|Overall Study|Lost to Follow-up|1|||
144674333|NCT01001234|521657948|FG003|Overall Study|Lost to Follow-up|2|||
144674334|NCT01001234|521657949|FG004|Overall Study|Lost to Follow-up|0|||
144674335|NCT01001234|521657945|FG000|Overall Study|Physician Decision|1|||
144674336|NCT01001234|521657946|FG001|Overall Study|Physician Decision|0|||
144674337|NCT01001234|521657947|FG002|Overall Study|Physician Decision|0|||
144674338|NCT01001234|521657948|FG003|Overall Study|Physician Decision|0|||
144674339|NCT01001234|521657949|FG004|Overall Study|Physician Decision|0|||
144674340|NCT01001234|521657945|FG000|Overall Study|Not Treated: Adverse Event|1|||
144674341|NCT01001234|521657946|FG001|Overall Study|Not Treated: Adverse Event|0|||
144674342|NCT01001234|521657947|FG002|Overall Study|Not Treated: Adverse Event|0|||
144674343|NCT01001234|521657948|FG003|Overall Study|Not Treated: Adverse Event|0|||
144674344|NCT01001234|521657949|FG004|Overall Study|Not Treated: Adverse Event|0|||
144674345|NCT01001234|521657945|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
144674346|NCT01001234|521657946|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
144674347|NCT01001234|521657947|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
144674348|NCT01001234|521657948|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
144674349|NCT01001234|521657949|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
144674350|NCT01001234|521657945|FG000|Overall Study|Not Treated: Protocol Violation|3|||
144674351|NCT01001234|521657946|FG001|Overall Study|Not Treated: Protocol Violation|0|||
144674352|NCT01001234|521657947|FG002|Overall Study|Not Treated: Protocol Violation|0|||
144674353|NCT01001234|521657948|FG003|Overall Study|Not Treated: Protocol Violation|0|||
144674354|NCT01001234|521657949|FG004|Overall Study|Not Treated: Protocol Violation|0|||
144674355|NCT01001234|521657945|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
144674356|NCT01001234|521657946|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
144674357|NCT01001234|521657947|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
144674358|NCT01001234|521657948|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
144674359|NCT01001234|521657949|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
144674360|NCT01001234|521657945|FG000|Overall Study|Not Treated: Pregnancy|3|||
144674361|NCT01001234|521657946|FG001|Overall Study|Not Treated: Pregnancy|0|||
144674362|NCT01001234|521657947|FG002|Overall Study|Not Treated: Pregnancy|0|||
144674363|NCT01001234|521657948|FG003|Overall Study|Not Treated: Pregnancy|0|||
144674364|NCT01001234|521657949|FG004|Overall Study|Not Treated: Pregnancy|0|||
144674365|NCT01001234|521657945|FG000|Overall Study|Not Treated: Physician Decision|37|||
144674366|NCT01001234|521657946|FG001|Overall Study|Not Treated: Physician Decision|4|||
144674367|NCT01001234|521657947|FG002|Overall Study|Not Treated: Physician Decision|0|||
144674368|NCT01001234|521657948|FG003|Overall Study|Not Treated: Physician Decision|0|||
144674369|NCT01001234|521657949|FG004|Overall Study|Not Treated: Physician Decision|0|||
144674370|NCT01001234|521657945|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
144674371|NCT01001234|521657946|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
144674372|NCT01001234|521657947|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
144674373|NCT01001234|521657948|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
144674374|NCT01001234|521657949|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
144674375|NCT00928512|521657952|FG000|Overall Study|Adverse Event|4|||
144674376|NCT00928512|521657953|FG001|Overall Study|Adverse Event|3|||
144674377|NCT00928512|521657954|FG002|Overall Study|Adverse Event|2|||
144674378|NCT00928512|521657955|FG003|Overall Study|Adverse Event|8|||
144674379|NCT00928512|521657956|FG004|Overall Study|Adverse Event|6|||
144674380|NCT00928512|521657952|FG000|Overall Study|Lack of Efficacy|2|||
144674381|NCT00928512|521657953|FG001|Overall Study|Lack of Efficacy|0|||
144674382|NCT00928512|521657954|FG002|Overall Study|Lack of Efficacy|4|||
144674383|NCT00928512|521657955|FG003|Overall Study|Lack of Efficacy|7|||
144674384|NCT00928512|521657956|FG004|Overall Study|Lack of Efficacy|3|||
144674385|NCT00928512|521657952|FG000|Overall Study|Protocol Violation|0|||
144674386|NCT00928512|521657953|FG001|Overall Study|Protocol Violation|1|||
144674387|NCT00928512|521657954|FG002|Overall Study|Protocol Violation|0|||
144674388|NCT00928512|521657955|FG003|Overall Study|Protocol Violation|1|||
144674389|NCT00928512|521657956|FG004|Overall Study|Protocol Violation|3|||
144674390|NCT00928512|521657952|FG000|Overall Study|Withdrawal by Subject|3|||
144674391|NCT00928512|521657953|FG001|Overall Study|Withdrawal by Subject|0|||
144674392|NCT00928512|521657954|FG002|Overall Study|Withdrawal by Subject|3|||
144674393|NCT00928512|521657955|FG003|Overall Study|Withdrawal by Subject|4|||
144674394|NCT00928512|521657956|FG004|Overall Study|Withdrawal by Subject|0|||
144674395|NCT00928512|521657952|FG000|Overall Study|Lost to Follow-up|1|||
144674396|NCT00928512|521657953|FG001|Overall Study|Lost to Follow-up|1|||
144674397|NCT00928512|521657954|FG002|Overall Study|Lost to Follow-up|2|||
144674398|NCT00928512|521657955|FG003|Overall Study|Lost to Follow-up|1|||
144674399|NCT00928512|521657956|FG004|Overall Study|Lost to Follow-up|3|||
144674400|NCT00928512|521657952|FG000|Overall Study|Administrative Problems|0|||
144674401|NCT00928512|521657953|FG001|Overall Study|Administrative Problems|1|||
144674402|NCT00928512|521657954|FG002|Overall Study|Administrative Problems|0|||
144674403|NCT00928512|521657955|FG003|Overall Study|Administrative Problems|0|||
144674404|NCT00928512|521657956|FG004|Overall Study|Administrative Problems|0|||
144674405|NCT04153929|521657957|FG000|Overall Study|Other than listed|2|||
144674406|NCT04153929|521657958|FG001|Overall Study|Other than listed|2|||
144674407|NCT04153929|521657959|FG002|Overall Study|Other than listed|0|||
144674408|NCT04153929|521657960|FG003|Overall Study|Other than listed|1|||
144674409|NCT04153929|521657961|FG004|Overall Study|Other than listed|0|||
144674410|NCT04153929|521657962|FG005|Overall Study|Other than listed|2|||
144674411|NCT04153929|521657963|FG006|Overall Study|Other than listed|2|||
144674412|NCT04153929|521657964|FG007|Overall Study|Other than listed|1|||
144674413|NCT04153929|521657957|FG000|Overall Study|Lost to Follow-up|2|||
144674414|NCT04153929|521657958|FG001|Overall Study|Lost to Follow-up|1|||
144674415|NCT04153929|521657959|FG002|Overall Study|Lost to Follow-up|0|||
144674416|NCT04153929|521657960|FG003|Overall Study|Lost to Follow-up|1|||
144674417|NCT04153929|521657961|FG004|Overall Study|Lost to Follow-up|1|||
144674418|NCT04153929|521657962|FG005|Overall Study|Lost to Follow-up|0|||
144674419|NCT04153929|521657963|FG006|Overall Study|Lost to Follow-up|0|||
144674420|NCT04153929|521657964|FG007|Overall Study|Lost to Follow-up|0|||
144674421|NCT04153929|521657957|FG000|Overall Study|Withdrawal by Subject|3|||
144674422|NCT04153929|521657958|FG001|Overall Study|Withdrawal by Subject|1|||
144674423|NCT04153929|521657959|FG002|Overall Study|Withdrawal by Subject|0|||
144674424|NCT04153929|521657960|FG003|Overall Study|Withdrawal by Subject|3|||
144674425|NCT04153929|521657961|FG004|Overall Study|Withdrawal by Subject|1|||
144674426|NCT04153929|521657962|FG005|Overall Study|Withdrawal by Subject|0|||
144674427|NCT04153929|521657963|FG006|Overall Study|Withdrawal by Subject|1|||
144674428|NCT04153929|521657964|FG007|Overall Study|Withdrawal by Subject|0|||
144674429|NCT04153929|521657957|FG000|Overall Study|Protocol Violation|0|||
144674430|NCT04153929|521657958|FG001|Overall Study|Protocol Violation|0|||
144674431|NCT04153929|521657959|FG002|Overall Study|Protocol Violation|0|||
144674432|NCT04153929|521657960|FG003|Overall Study|Protocol Violation|0|||
144674433|NCT04153929|521657961|FG004|Overall Study|Protocol Violation|0|||
144674434|NCT04153929|521657962|FG005|Overall Study|Protocol Violation|0|||
144674435|NCT04153929|521657963|FG006|Overall Study|Protocol Violation|1|||
144674436|NCT04153929|521657964|FG007|Overall Study|Protocol Violation|2|||
144674437|NCT04153929|521657957|FG000|Overall Study|Adverse Event|3|||
144674438|NCT04153929|521657958|FG001|Overall Study|Adverse Event|5|||
144674439|NCT04153929|521657959|FG002|Overall Study|Adverse Event|5|||
144674440|NCT04153929|521657960|FG003|Overall Study|Adverse Event|11|||
144674441|NCT04153929|521657961|FG004|Overall Study|Adverse Event|15|||
144674442|NCT04153929|521657962|FG005|Overall Study|Adverse Event|4|||
144674443|NCT04153929|521657963|FG006|Overall Study|Adverse Event|8|||
144674444|NCT04153929|521657964|FG007|Overall Study|Adverse Event|2|||
144674445|NCT04153929|521657957|FG000|Overall Study|Not treated|1|||
144674446|NCT04153929|521657958|FG001|Overall Study|Not treated|0|||
144674447|NCT04153929|521657959|FG002|Overall Study|Not treated|0|||
144674448|NCT04153929|521657960|FG003|Overall Study|Not treated|0|||
144674449|NCT04153929|521657961|FG004|Overall Study|Not treated|0|||
144674450|NCT04153929|521657962|FG005|Overall Study|Not treated|0|||
144674451|NCT04153929|521657963|FG006|Overall Study|Not treated|1|||
144674452|NCT04153929|521657964|FG007|Overall Study|Not treated|0|||
144674453|NCT04083794|521657965|FG000|Overall Study|Lost to Follow-up|9|||
144674454|NCT01975675|521657968|FG000|Overall Study|Death|0|||
144674455|NCT01975675|521657969|FG001|Overall Study|Death|1|||
144674456|NCT01975675|521657970|FG002|Overall Study|Death|0|||
144674457|NCT01975675|521657971|FG003|Overall Study|Death|0|||
144674458|NCT00224003|521657972|FG000|Overall Study|Adverse Event|1|||
144674459|NCT00224003|521657972|FG000|Overall Study|Protocol Violation|2|||
144674460|NCT00224003|521657972|FG000|Overall Study|Withdrawal by Subject|1|||
144674461|NCT00224003|521657972|FG000|Overall Study|unk|3|||
144674462|NCT00729326|521657979|FG000|Overall Study|Lost to Follow-up|2|||
144674463|NCT00729326|521657980|FG001|Overall Study|Lost to Follow-up|0|||
144674464|NCT00729326|521657979|FG000|Overall Study|Physician Decision|0|||
144674465|NCT00729326|521657980|FG001|Overall Study|Physician Decision|1|||
144674466|NCT00729326|521657979|FG000|Overall Study|Protocol Violation|3|||
144674467|NCT00729326|521657980|FG001|Overall Study|Protocol Violation|2|||
144674468|NCT00729326|521657979|FG000|Overall Study|Subject Decision|4|||
144674469|NCT00729326|521657980|FG001|Overall Study|Subject Decision|4|||
144674470|NCT00729326|521657979|FG000|Overall Study|Sponsor Decision|1|||
144674471|NCT00729326|521657980|FG001|Overall Study|Sponsor Decision|2|||
144674472|NCT01235728|521657981|FG000|Overall Study|Protocol Violation|0|||
144674473|NCT01235728|521657982|FG001|Overall Study|Protocol Violation|0|||
144674474|NCT01235728|521657983|FG002|Overall Study|Protocol Violation|0|||
144674475|NCT01235728|521657984|FG003|Overall Study|Protocol Violation|1|||
144674476|NCT01235728|521657985|FG004|Overall Study|Protocol Violation|0|||
144674477|NCT01235728|521657986|FG005|Overall Study|Protocol Violation|0|||
144674478|NCT01235728|521657987|FG006|Overall Study|Protocol Violation|0|||
144674479|NCT01235728|521657988|FG007|Overall Study|Protocol Violation|0|||
144674480|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
144674481|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
144674482|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
144674483|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
144674484|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
144674485|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
144735866|NCT02576938|521887420|FG002|Overall Study|Adverse Event|6|||
144735867|NCT02576938|521887418|FG000|Overall Study|Protocol Violation|1|||
144735868|NCT02576938|521887419|FG001|Overall Study|Protocol Violation|1|||
144735869|NCT02576938|521887420|FG002|Overall Study|Protocol Violation|1|||
144735870|NCT02576938|521887418|FG000|Overall Study|Withdrawal by Subject|3|||
144735871|NCT02576938|521887419|FG001|Overall Study|Withdrawal by Subject|2|||
144735872|NCT02576938|521887420|FG002|Overall Study|Withdrawal by Subject|4|||
144735873|NCT02576938|521887418|FG000|Overall Study|Lack of Efficacy|9|||
144735874|NCT02576938|521887419|FG001|Overall Study|Lack of Efficacy|4|||
144735875|NCT02576938|521887420|FG002|Overall Study|Lack of Efficacy|0|||
144735876|NCT02576938|521887418|FG000|Overall Study|Lost to Follow-up|2|||
144735877|NCT02576938|521887419|FG001|Overall Study|Lost to Follow-up|0|||
144735878|NCT02576938|521887420|FG002|Overall Study|Lost to Follow-up|1|||
144735879|NCT02576938|521887418|FG000|Overall Study|Physician Decision|0|||
144735880|NCT02576938|521887419|FG001|Overall Study|Physician Decision|1|||
144735881|NCT02576938|521887420|FG002|Overall Study|Physician Decision|0|||
144735882|NCT02576938|521887418|FG000|Overall Study|Met Exclusion Criteria|0|||
144735883|NCT02576938|521887419|FG001|Overall Study|Met Exclusion Criteria|1|||
144735884|NCT02576938|521887420|FG002|Overall Study|Met Exclusion Criteria|0|||
144735885|NCT03500341|521887423|FG000|Overall Study|Withdrawn prior to Completion|2|||
144735886|NCT00968812|521887424|FG000|Overall Study|Adverse Event|30|||
144735887|NCT00968812|521887425|FG001|Overall Study|Adverse Event|46|||
144735888|NCT00968812|521887426|FG002|Overall Study|Adverse Event|33|||
144735889|NCT00968812|521887424|FG000|Overall Study|Death|2|||
144735890|NCT00968812|521887425|FG001|Overall Study|Death|2|||
144735891|NCT00968812|521887426|FG002|Overall Study|Death|1|||
144735892|NCT00968812|521887424|FG000|Overall Study|Lack of Efficacy|9|||
144735893|NCT00968812|521887425|FG001|Overall Study|Lack of Efficacy|7|||
144735894|NCT00968812|521887426|FG002|Overall Study|Lack of Efficacy|16|||
144735895|NCT00968812|521887424|FG000|Overall Study|Lost to Follow-up|17|||
144735896|NCT00968812|521887425|FG001|Overall Study|Lost to Follow-up|12|||
144735897|NCT00968812|521887426|FG002|Overall Study|Lost to Follow-up|11|||
144735898|NCT00968812|521887424|FG000|Overall Study|Physician Decision|8|||
144735899|NCT00968812|521887425|FG001|Overall Study|Physician Decision|5|||
144735900|NCT00968812|521887426|FG002|Overall Study|Physician Decision|9|||
144735901|NCT00968812|521887424|FG000|Overall Study|Protocol Violation|7|||
144735902|NCT00968812|521887425|FG001|Overall Study|Protocol Violation|4|||
144735903|NCT00968812|521887426|FG002|Overall Study|Protocol Violation|3|||
144735904|NCT00968812|521887424|FG000|Overall Study|Withdrawal by Subject|17|||
144735905|NCT00968812|521887425|FG001|Overall Study|Withdrawal by Subject|23|||
144735906|NCT00968812|521887426|FG002|Overall Study|Withdrawal by Subject|25|||
144735907|NCT00968812|521887424|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
144735908|NCT00968812|521887425|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
144735909|NCT00968812|521887426|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
144735910|NCT00968812|521887424|FG000|Overall Study|Noncompliance with study drug|4|||
144735911|NCT00968812|521887425|FG001|Overall Study|Noncompliance with study drug|1|||
144735912|NCT00968812|521887426|FG002|Overall Study|Noncompliance with study drug|6|||
144735913|NCT00968812|521887424|FG000|Overall Study|Unable to take rescue therapy|12|||
144735914|NCT00968812|521887425|FG001|Overall Study|Unable to take rescue therapy|12|||
144735915|NCT00968812|521887426|FG002|Overall Study|Unable to take rescue therapy|17|||
144735916|NCT00968812|521887424|FG000|Overall Study|Other|25|||
144735917|NCT00968812|521887425|FG001|Overall Study|Other|37|||
144735918|NCT00968812|521887426|FG002|Overall Study|Other|40|||
144735919|NCT00838630|521887429|FG000|First Intervention|Adverse Event|1|||
144735920|NCT00838630|521887430|FG001|First Intervention|Adverse Event|0|||
144735921|NCT00838630|521887429|FG000|Washout: 7 Days|Protocol Violation|1|||
144735922|NCT00838630|521887430|FG001|Washout: 7 Days|Protocol Violation|0|||
144735923|NCT00640562|521887431|FG000|Overall Study|Adverse Event|8|||
144735924|NCT00640562|521887432|FG001|Overall Study|Adverse Event|5|||
144735925|NCT00640562|521887431|FG000|Overall Study|Lack of Efficacy|1|||
144735926|NCT00640562|521887432|FG001|Overall Study|Lack of Efficacy|4|||
144735927|NCT00640562|521887431|FG000|Overall Study|Protocol Violation|2|||
144735928|NCT00640562|521887432|FG001|Overall Study|Protocol Violation|4|||
144735929|NCT00640562|521887431|FG000|Overall Study|Withdrawal by Subject|6|||
144735930|NCT00640562|521887432|FG001|Overall Study|Withdrawal by Subject|10|||
144735931|NCT00640562|521887431|FG000|Overall Study|Known risperidone intolerance|0|||
144735932|NCT00640562|521887432|FG001|Overall Study|Known risperidone intolerance|1|||
144735933|NCT00640562|521887431|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
144735934|NCT00640562|521887432|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
144735935|NCT00640562|521887431|FG000|Overall Study|Low study drug dose|0|||
144735936|NCT00640562|521887432|FG001|Overall Study|Low study drug dose|1|||
144218081|NCT02762929|519992231|FG003|Overall Study|Adverse Event|1|||
144218082|NCT02762929|519992232|FG004|Overall Study|Adverse Event|0|||
144735937|NCT00640562|521887431|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
144735938|NCT00640562|521887432|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
144735939|NCT00448591|521887433|FG000|Overall Study|Withdrawal by Subject|178|||
144735940|NCT00448591|521887433|FG000|Overall Study|Progressive Disease|1382|||
144218083|NCT02762929|519992233|FG005|Overall Study|Adverse Event|0|||
144735941|NCT00448591|521887433|FG000|Overall Study|Adverse Event|382|||
144735942|NCT00448591|521887433|FG000|Overall Study|Protocol Violation|41|||
144735943|NCT00448591|521887433|FG000|Overall Study|Lost to Follow-up|19|||
144735944|NCT00448591|521887433|FG000|Overall Study|Treatment Regimen Completed|70|||
144735945|NCT00448591|521887433|FG000|Overall Study|Other|154|||
144735946|NCT00448591|521887433|FG000|Overall Study|Termination of Study|70|||
144735947|NCT02937870|521887434|FG000|Overall Study|Adverse Event|1|||
144735948|NCT02937870|521887434|FG000|Overall Study|Protocol Deviation|2|||
144735949|NCT03098394|521887438|FG000|Overall Study|Pregnancy|0|||
144735950|NCT03098394|521887439|FG001|Overall Study|Pregnancy|1|||
144735951|NCT00609674|521887440|FG000|Overall Study|Adverse Event|1|||
144674486|NCT00996593|521657989|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
144674487|NCT00996593|521657989|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
144674488|NCT00996593|521657989|FG000|Long-Term Follow-Up|Site Closed|1|||
144674489|NCT01202760|521657990|FG000|Overall Study|Entry Criteria Not Met|0|||
144674490|NCT01202760|521657991|FG001|Overall Study|Entry Criteria Not Met|3|||
144674491|NCT01202760|521657992|FG002|Overall Study|Entry Criteria Not Met|1|||
144674492|NCT01202760|521657990|FG000|Overall Study|Adverse Event|11|||
144674493|NCT01202760|521657991|FG001|Overall Study|Adverse Event|9|||
144674494|NCT01202760|521657992|FG002|Overall Study|Adverse Event|10|||
144674495|NCT01202760|521657990|FG000|Overall Study|Death|2|||
144674496|NCT01202760|521657991|FG001|Overall Study|Death|1|||
144674497|NCT01202760|521657992|FG002|Overall Study|Death|0|||
144735952|NCT00609674|521887441|FG001|Overall Study|Adverse Event|1|||
144735953|NCT00609674|521887440|FG000|Overall Study|Protocol Violation|3|||
144735954|NCT00609674|521887441|FG001|Overall Study|Protocol Violation|5|||
144735955|NCT00609674|521887440|FG000|Overall Study|Lost to Follow-up|1|||
144735956|NCT00609674|521887441|FG001|Overall Study|Lost to Follow-up|0|||
144735957|NCT00609674|521887440|FG000|Overall Study|Withdrew consent|2|||
144735958|NCT00609674|521887441|FG001|Overall Study|Withdrew consent|1|||
144735959|NCT00571064|521887445|FG000|Overall Study|Adverse Event|13|||
144735960|NCT00571064|521887445|FG000|Overall Study|Protocol Violation|4|||
144674498|NCT01202760|521657990|FG000|Overall Study|Lack of Efficacy|6|||
144674499|NCT01202760|521657991|FG001|Overall Study|Lack of Efficacy|8|||
144674500|NCT01202760|521657992|FG002|Overall Study|Lack of Efficacy|7|||
144674501|NCT01202760|521657990|FG000|Overall Study|Lost to Follow-up|0|||
144674502|NCT01202760|521657991|FG001|Overall Study|Lost to Follow-up|2|||
144674503|NCT01202760|521657992|FG002|Overall Study|Lost to Follow-up|1|||
144674504|NCT01202760|521657990|FG000|Overall Study|Parent / Caregiver Decision|0|||
144674505|NCT01202760|521657991|FG001|Overall Study|Parent / Caregiver Decision|1|||
144674506|NCT01202760|521657992|FG002|Overall Study|Parent / Caregiver Decision|0|||
144674507|NCT01202760|521657990|FG000|Overall Study|Withdrawal by Subject|17|||
144674508|NCT01202760|521657991|FG001|Overall Study|Withdrawal by Subject|18|||
144674509|NCT01202760|521657992|FG002|Overall Study|Withdrawal by Subject|14|||
144674510|NCT01202760|521657990|FG000|Overall Study|Physician Decision|0|||
144674511|NCT01202760|521657991|FG001|Overall Study|Physician Decision|1|||
144674512|NCT01202760|521657992|FG002|Overall Study|Physician Decision|0|||
144674513|NCT01202760|521657990|FG000|Overall Study|Protocol Violation|7|||
144674514|NCT01202760|521657991|FG001|Overall Study|Protocol Violation|5|||
144674515|NCT01202760|521657992|FG002|Overall Study|Protocol Violation|2|||
144674516|NCT01202760|521657990|FG000|Overall Study|Sponsor Decision|4|||
144674517|NCT01202760|521657991|FG001|Overall Study|Sponsor Decision|4|||
144674518|NCT01202760|521657992|FG002|Overall Study|Sponsor Decision|0|||
144674519|NCT00871572|521657993|FG000|Overall Study|Adverse Event|0|||
144674520|NCT00871572|521657994|FG001|Overall Study|Adverse Event|2|||
144735961|NCT00571064|521887445|FG000|Overall Study|Withdrawal by Subject|2|||
144735962|NCT00571064|521887445|FG000|Overall Study|Other|2|||
144735963|NCT00244764|521887446|FG000|Overall Study|Adverse Event|37|||
144735964|NCT00244764|521887446|FG000|Overall Study|Lost to Follow-up|23|||
144735965|NCT00244764|521887446|FG000|Overall Study|Withdrawal by Subject|12|||
144735966|NCT00244764|521887446|FG000|Overall Study|Disease Progression|13|||
144735967|NCT00244764|521887446|FG000|Overall Study|Protocol Violation|2|||
144735968|NCT00244764|521887446|FG000|Overall Study|Death|1|||
144735969|NCT00244764|521887446|FG000|Overall Study|Off Study Medication for >21 Days|1|||
144735970|NCT00244764|521887446|FG000|Overall Study|Declining Performance Status|1|||
144735971|NCT00244764|521887446|FG000|Overall Study|Participant was Hospitalized until Death|1|||
144735972|NCT00244764|521887446|FG000|Overall Study|Primary Investigator Discretion|2|||
144735973|NCT00244764|521887446|FG000|Overall Study|Sponsor Terminated Study|2|||
144735974|NCT00244764|521887446|FG000|Overall Study|Developed Secondary Malignancy|1|||
144735975|NCT00003659|521887455|FG000|Overall Study|Withdrawal by Subject|3|||
144674521|NCT00871572|521657995|FG002|Overall Study|Adverse Event|0|||
144674522|NCT00871572|521657996|FG003|Overall Study|Adverse Event|3|||
144674523|NCT00871572|521657993|FG000|Overall Study|Investigator Decision|0|||
144674524|NCT00871572|521657994|FG001|Overall Study|Investigator Decision|1|||
144674525|NCT00871572|521657995|FG002|Overall Study|Investigator Decision|0|||
144674526|NCT00871572|521657996|FG003|Overall Study|Investigator Decision|1|||
144674527|NCT00871572|521657993|FG000|Overall Study|Lost to Follow-up|0|||
144674528|NCT00871572|521657994|FG001|Overall Study|Lost to Follow-up|1|||
144735976|NCT04022954|521887456|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
144735977|NCT04022954|521887456|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
144735978|NCT04022954|521887456|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
144735979|NCT03017885|521887457|FG000|Overall Study|Adverse Event|2|||
144735980|NCT03017885|521887458|FG001|Overall Study|Adverse Event|0|||
144735981|NCT03017885|521887459|FG002|Overall Study|Adverse Event|0|||
144735982|NCT03017885|521887460|FG003|Overall Study|Adverse Event|0|||
144735983|NCT03017885|521887461|FG004|Overall Study|Adverse Event|0|||
144735984|NCT03017885|521887462|FG005|Overall Study|Adverse Event|0|||
144735985|NCT03017885|521887457|FG000|Overall Study|Progression of disease|4|||
144735986|NCT03017885|521887458|FG001|Overall Study|Progression of disease|3|||
144735987|NCT03017885|521887459|FG002|Overall Study|Progression of disease|4|||
144735988|NCT03017885|521887460|FG003|Overall Study|Progression of disease|0|||
144735989|NCT03017885|521887461|FG004|Overall Study|Progression of disease|0|||
144735990|NCT03017885|521887462|FG005|Overall Study|Progression of disease|0|||
144735991|NCT03017885|521887457|FG000|Overall Study|Other than listed|1|||
144735992|NCT03017885|521887458|FG001|Overall Study|Other than listed|2|||
144735993|NCT03017885|521887459|FG002|Overall Study|Other than listed|1|||
144735994|NCT03017885|521887460|FG003|Overall Study|Other than listed|0|||
144735995|NCT03017885|521887461|FG004|Overall Study|Other than listed|0|||
144735996|NCT03017885|521887462|FG005|Overall Study|Other than listed|0|||
144735997|NCT03017885|521887457|FG000|Overall Study|Lost to Follow-up|2|||
144735998|NCT03017885|521887458|FG001|Overall Study|Lost to Follow-up|0|||
144735999|NCT03017885|521887459|FG002|Overall Study|Lost to Follow-up|3|||
144736000|NCT03017885|521887460|FG003|Overall Study|Lost to Follow-up|0|||
144736001|NCT03017885|521887461|FG004|Overall Study|Lost to Follow-up|0|||
144736002|NCT03017885|521887462|FG005|Overall Study|Lost to Follow-up|0|||
144736003|NCT03017885|521887457|FG000|Overall Study|Change to other anti-cancer therapy|0|||
144736004|NCT03017885|521887458|FG001|Overall Study|Change to other anti-cancer therapy|0|||
144736005|NCT03017885|521887459|FG002|Overall Study|Change to other anti-cancer therapy|1|||
144736006|NCT03017885|521887460|FG003|Overall Study|Change to other anti-cancer therapy|0|||
144736007|NCT03017885|521887461|FG004|Overall Study|Change to other anti-cancer therapy|0|||
144736008|NCT03017885|521887462|FG005|Overall Study|Change to other anti-cancer therapy|0|||
144736009|NCT02648438|521887466|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144736010|NCT02648438|521887467|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
144736011|NCT02648438|521887468|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
144736012|NCT02648438|521887466|FG000|Overall Study|Protocol Violation|2|||
144736013|NCT02648438|521887467|FG001|Overall Study|Protocol Violation|0|||
144736014|NCT02648438|521887468|FG002|Overall Study|Protocol Violation|0|||
144736015|NCT02648438|521887466|FG000|Overall Study|Withdrawal by Subject|1|||
144736016|NCT02648438|521887467|FG001|Overall Study|Withdrawal by Subject|1|||
144736017|NCT02648438|521887468|FG002|Overall Study|Withdrawal by Subject|0|||
144736018|NCT03138967|521887469|FG000|Overall Study|Death|0|||
144736019|NCT03138967|521887470|FG001|Overall Study|Death|1|||
144736020|NCT03138967|521887469|FG000|Overall Study|Physician Decision|1|||
144736021|NCT03138967|521887470|FG001|Overall Study|Physician Decision|3|||
144736022|NCT04604275|521887471|FG000|Washout-1 Week|Withdrawal by Subject|1|||
144736023|NCT04604275|521887472|FG001|Washout-1 Week|Withdrawal by Subject|0|||
144736024|NCT05615935|521887473|FG000|Overall Study|Lost to Follow-up|1|||
144736025|NCT05615935|521887474|FG001|Overall Study|Lost to Follow-up|1|||
144736026|NCT04499963|521887475|FG000|Overall Study|Adverse Event|3|||
144736027|NCT04499963|521887476|FG001|Overall Study|Adverse Event|0|||
144736028|NCT04499963|521887475|FG000|Overall Study|Death|3|||
144736029|NCT04499963|521887476|FG001|Overall Study|Death|0|||
144736030|NCT04499963|521887475|FG000|Overall Study|Lack of Efficacy|7|||
144736031|NCT04499963|521887476|FG001|Overall Study|Lack of Efficacy|0|||
144736032|NCT04499963|521887475|FG000|Overall Study|Lost to Follow-up|2|||
144736033|NCT04499963|521887476|FG001|Overall Study|Lost to Follow-up|0|||
144736034|NCT03546842|521887477|FG000|Overall Study|Protocol Violation|1|||
144736035|NCT03546842|521887477|FG000|Overall Study|Withdrawal by Subject|2|||
144736036|NCT01474551|521887481|FG000|Overall Study|Death|1|||
144736037|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
144736038|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
144736039|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
144736040|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
144736041|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
144736042|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
144736043|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
144736044|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
144736045|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
144736046|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
144736047|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
144736048|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
144736049|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
144736050|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
144736051|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
144736052|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
144736053|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
144736054|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
144736055|NCT01045161|521887482|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
144736056|NCT01045161|521887483|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
144736057|NCT01045161|521887484|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
144736058|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
144736059|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
144736060|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
144736061|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
144736062|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
144736063|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
144736064|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
144736065|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
144736066|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
144736067|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
144736068|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
144736069|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
144736070|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
144736071|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
144736072|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
144736073|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
144736074|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
144736075|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
144736076|NCT01045161|521887482|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
144736077|NCT01045161|521887483|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
144736078|NCT01045161|521887484|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
144736079|NCT03686033|521887485|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
144736080|NCT03686033|521887486|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
144736081|NCT03686033|521887487|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
144736082|NCT03686033|521887488|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
144736083|NCT03686033|521887489|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
144736084|NCT03686033|521887490|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
144736085|NCT01854047|521887491|FG000|Overall Study|Lack of Efficacy|1|||
144736086|NCT01854047|521887492|FG001|Overall Study|Lack of Efficacy|0|||
144736087|NCT01854047|521887493|FG002|Overall Study|Lack of Efficacy|0|||
144736088|NCT01854047|521887494|FG003|Overall Study|Lack of Efficacy|0|||
144736089|NCT01854047|521887495|FG004|Overall Study|Lack of Efficacy|0|||
144736090|NCT01854047|521887491|FG000|Overall Study|Poor compliance to protocol|3|||
144736091|NCT01854047|521887492|FG001|Overall Study|Poor compliance to protocol|0|||
144736092|NCT01854047|521887493|FG002|Overall Study|Poor compliance to protocol|2|||
144736093|NCT01854047|521887494|FG003|Overall Study|Poor compliance to protocol|0|||
144736094|NCT01854047|521887495|FG004|Overall Study|Poor compliance to protocol|0|||
144736095|NCT01854047|521887491|FG000|Overall Study|Adverse Event|5|||
144736096|NCT01854047|521887492|FG001|Overall Study|Adverse Event|4|||
144736097|NCT01854047|521887493|FG002|Overall Study|Adverse Event|6|||
144736098|NCT01854047|521887494|FG003|Overall Study|Adverse Event|10|||
144736099|NCT01854047|521887495|FG004|Overall Study|Adverse Event|7|||
144736100|NCT01854047|521887491|FG000|Overall Study|Randomized but not treated|0|||
144736101|NCT01854047|521887492|FG001|Overall Study|Randomized but not treated|1|||
144736102|NCT01854047|521887493|FG002|Overall Study|Randomized but not treated|2|||
144736103|NCT01854047|521887494|FG003|Overall Study|Randomized but not treated|0|||
144736104|NCT01854047|521887495|FG004|Overall Study|Randomized but not treated|4|||
144736105|NCT01854047|521887491|FG000|Overall Study|Other than specified above|3|||
144736106|NCT01854047|521887492|FG001|Overall Study|Other than specified above|3|||
144736107|NCT01854047|521887493|FG002|Overall Study|Other than specified above|3|||
144736108|NCT01854047|521887494|FG003|Overall Study|Other than specified above|5|||
144736109|NCT01854047|521887495|FG004|Overall Study|Other than specified above|8|||
144736110|NCT03031847|521887496|FG000|Overall Study|Death|1|||
144736111|NCT03031847|521887497|FG001|Overall Study|Death|1|||
144736112|NCT03031847|521887498|FG002|Overall Study|Death|2|||
144736113|NCT03031847|521887499|FG003|Overall Study|Death|3|||
144736114|NCT03031847|521887496|FG000|Overall Study|Lost to Follow-up|1|||
144736115|NCT03031847|521887497|FG001|Overall Study|Lost to Follow-up|1|||
144736116|NCT03031847|521887498|FG002|Overall Study|Lost to Follow-up|2|||
144736117|NCT03031847|521887499|FG003|Overall Study|Lost to Follow-up|3|||
144736118|NCT01353664|521887500|FG000|Overall Study|Other|3|||
144736119|NCT01353664|521887500|FG000|Overall Study|Disease Progression|16|||
144736120|NCT02089997|521887503|FG000|Overall Study|Case report forms uncollected|99|||
144736121|NCT02089997|521887503|FG000|Overall Study|Protocol Violation|147|||
144736122|NCT02242201|521887510|FG000|Overall Study|preoperative identified neuropathy|2|||
144736123|NCT02242201|521887511|FG001|Overall Study|preoperative identified neuropathy|0|||
144736124|NCT02242201|521887512|FG002|Overall Study|preoperative identified neuropathy|0|||
144736125|NCT02242201|521887510|FG000|Overall Study|planned post-op anticoagulation|1|||
144736126|NCT02242201|521887511|FG001|Overall Study|planned post-op anticoagulation|0|||
144736127|NCT02242201|521887512|FG002|Overall Study|planned post-op anticoagulation|0|||
144736128|NCT02242201|521887510|FG000|Overall Study|changed surgical procedure|1|||
144736129|NCT02242201|521887511|FG001|Overall Study|changed surgical procedure|0|||
144736130|NCT02242201|521887512|FG002|Overall Study|changed surgical procedure|0|||
144736131|NCT02242201|521887510|FG000|Overall Study|postponed surgery|0|||
144736132|NCT02242201|521887511|FG001|Overall Study|postponed surgery|0|||
144736133|NCT02242201|521887512|FG002|Overall Study|postponed surgery|1|||
144736134|NCT02242201|521887510|FG000|Overall Study|preoperative opioid consumption|0|||
144674529|NCT00871572|521657995|FG002|Overall Study|Lost to Follow-up|0|||
144674530|NCT00871572|521657996|FG003|Overall Study|Lost to Follow-up|1|||
144674531|NCT00871572|521657993|FG000|Overall Study|Protocol Violation|0|||
144674532|NCT00871572|521657994|FG001|Overall Study|Protocol Violation|0|||
144674533|NCT00871572|521657995|FG002|Overall Study|Protocol Violation|1|||
144674534|NCT00871572|521657996|FG003|Overall Study|Protocol Violation|1|||
144674535|NCT00871572|521657993|FG000|Overall Study|Sponsor Decision|1|||
144674536|NCT00871572|521657994|FG001|Overall Study|Sponsor Decision|0|||
144674537|NCT00871572|521657995|FG002|Overall Study|Sponsor Decision|0|||
144674538|NCT00871572|521657996|FG003|Overall Study|Sponsor Decision|0|||
144674539|NCT00871572|521657993|FG000|Overall Study|Withdrawal by Subject|1|||
144674540|NCT00871572|521657994|FG001|Overall Study|Withdrawal by Subject|2|||
144674541|NCT00871572|521657995|FG002|Overall Study|Withdrawal by Subject|3|||
144674542|NCT00871572|521657996|FG003|Overall Study|Withdrawal by Subject|1|||
144674543|NCT01654523|521657997|FG000|Overall Study|Withdrawal by Subject|1|||
144674544|NCT04354155|521658000|FG000|Overall Study|Withdrawal by Subject|1|||
144674545|NCT04354155|521658000|FG000|Overall Study|Did not meet criteria for study intervention|1|||
144674546|NCT01686958|521658001|FG000|Overall Study|Withdrawal by Subject|1|||
144674547|NCT02810951|521658004|FG000|Overall Study|Adverse Event|1|||
144674548|NCT03199638|521658005|FG000|Overall Study|inability to drink glutamine during regularly|0|||
144674549|NCT03199638|521658006|FG001|Overall Study|inability to drink glutamine during regularly|2|||
144674550|NCT01575899|521658007|FG000|Overall Study|Lost to Follow-up|3|||
144674551|NCT01575899|521658008|FG001|Overall Study|Lost to Follow-up|4|||
144674552|NCT01575899|521658009|FG002|Overall Study|Lost to Follow-up|2|||
144674553|NCT01575899|521658007|FG000|Overall Study|Protocol Violation|2|||
144674554|NCT01575899|521658008|FG001|Overall Study|Protocol Violation|1|||
144674555|NCT01575899|521658009|FG002|Overall Study|Protocol Violation|0|||
144674556|NCT03097029|521658010|FG000|Overall Study|Withdrawal by Subject|1|||
144674557|NCT02807844|521658011|FG000|Overall Study|Physician Decision|0|||
144674558|NCT02807844|521658012|FG001|Overall Study|Physician Decision|0|||
144674559|NCT02807844|521658013|FG002|Overall Study|Physician Decision|0|||
144674560|NCT02807844|521658014|FG003|Overall Study|Physician Decision|0|||
144674561|NCT02807844|521658015|FG004|Overall Study|Physician Decision|0|||
144674562|NCT02807844|521658016|FG005|Overall Study|Physician Decision|0|||
144674563|NCT02807844|521658017|FG006|Overall Study|Physician Decision|3|||
144674564|NCT02807844|521658018|FG007|Overall Study|Physician Decision|0|||
144674565|NCT02807844|521658019|FG008|Overall Study|Physician Decision|1|||
144674566|NCT02807844|521658020|FG009|Overall Study|Physician Decision|2|||
144674567|NCT02807844|521658011|FG000|Overall Study|Death|0|||
144674568|NCT02807844|521658012|FG001|Overall Study|Death|0|||
144674569|NCT02807844|521658013|FG002|Overall Study|Death|2|||
144674570|NCT02807844|521658014|FG003|Overall Study|Death|4|||
144674571|NCT02807844|521658015|FG004|Overall Study|Death|1|||
144674572|NCT02807844|521658016|FG005|Overall Study|Death|2|||
144674573|NCT02807844|521658017|FG006|Overall Study|Death|1|||
144674574|NCT02807844|521658018|FG007|Overall Study|Death|2|||
144674575|NCT02807844|521658019|FG008|Overall Study|Death|0|||
144674576|NCT02807844|521658020|FG009|Overall Study|Death|1|||
144736135|NCT02242201|521887511|FG001|Overall Study|preoperative opioid consumption|1|||
144736136|NCT02242201|521887512|FG002|Overall Study|preoperative opioid consumption|0|||
144736137|NCT02374853|521887515|FG000|Overall Study|Surgery Cancelled|5|||
144736138|NCT02374853|521887516|FG001|Overall Study|Surgery Cancelled|11|||
144736139|NCT02281084|521887517|FG000|Overall Study|Death|21|||
144736140|NCT02281084|521887518|FG001|Overall Study|Death|18|||
144736141|NCT02281084|521887519|FG002|Overall Study|Death|3|||
144736142|NCT02281084|521887520|FG003|Overall Study|Death|5|||
144736143|NCT02281084|521887517|FG000|Overall Study|Adverse Event|1|||
144674577|NCT02807844|521658011|FG000|Overall Study|Withdrawal by Subject|0|||
144674578|NCT02807844|521658012|FG001|Overall Study|Withdrawal by Subject|0|||
144674579|NCT02807844|521658013|FG002|Overall Study|Withdrawal by Subject|2|||
144674580|NCT02807844|521658014|FG003|Overall Study|Withdrawal by Subject|1|||
144674581|NCT02807844|521658015|FG004|Overall Study|Withdrawal by Subject|1|||
144674582|NCT02807844|521658016|FG005|Overall Study|Withdrawal by Subject|0|||
144674583|NCT02807844|521658017|FG006|Overall Study|Withdrawal by Subject|1|||
144674584|NCT02807844|521658018|FG007|Overall Study|Withdrawal by Subject|0|||
144674585|NCT02807844|521658019|FG008|Overall Study|Withdrawal by Subject|0|||
144674586|NCT02807844|521658020|FG009|Overall Study|Withdrawal by Subject|0|||
144674587|NCT02807844|521658011|FG000|Overall Study|Progressive disease|5|||
144674588|NCT02807844|521658012|FG001|Overall Study|Progressive disease|12|||
144674589|NCT02807844|521658013|FG002|Overall Study|Progressive disease|8|||
144674590|NCT02807844|521658014|FG003|Overall Study|Progressive disease|8|||
144674591|NCT02807844|521658015|FG004|Overall Study|Progressive disease|3|||
144674592|NCT02807844|521658016|FG005|Overall Study|Progressive disease|8|||
144674593|NCT02807844|521658017|FG006|Overall Study|Progressive disease|14|||
144674594|NCT02807844|521658018|FG007|Overall Study|Progressive disease|17|||
144674595|NCT02807844|521658019|FG008|Overall Study|Progressive disease|19|||
144674596|NCT02807844|521658020|FG009|Overall Study|Progressive disease|15|||
144674597|NCT02807844|521658011|FG000|Overall Study|Adverse Event|1|||
144674598|NCT02807844|521658012|FG001|Overall Study|Adverse Event|0|||
144674599|NCT02807844|521658013|FG002|Overall Study|Adverse Event|0|||
144674600|NCT02807844|521658014|FG003|Overall Study|Adverse Event|0|||
144674601|NCT02807844|521658015|FG004|Overall Study|Adverse Event|1|||
144674602|NCT02807844|521658016|FG005|Overall Study|Adverse Event|1|||
144674603|NCT02807844|521658017|FG006|Overall Study|Adverse Event|1|||
144674604|NCT02807844|521658018|FG007|Overall Study|Adverse Event|1|||
144674605|NCT02807844|521658019|FG008|Overall Study|Adverse Event|1|||
144674606|NCT02807844|521658020|FG009|Overall Study|Adverse Event|2|||
144674607|NCT00373490|521658021|FG000|Overall Study|Adverse Event|0|||
144674608|NCT00373490|521658022|FG001|Overall Study|Adverse Event|1|||
144674609|NCT00373490|521658021|FG000|Overall Study|Lack of Efficacy|9|||
144674610|NCT00373490|521658022|FG001|Overall Study|Lack of Efficacy|4|||
144674611|NCT00373490|521658021|FG000|Overall Study|Withdrawal by Subject|0|||
144674612|NCT00373490|521658022|FG001|Overall Study|Withdrawal by Subject|1|||
144674613|NCT00108953|521658023|FG000|Follow-up|Death|18|||
144674614|NCT00108953|521658024|FG001|Follow-up|Death|26|||
144674615|NCT00108953|521658023|FG000|Follow-up|Lost to Follow-up|1|||
144674616|NCT00108953|521658024|FG001|Follow-up|Lost to Follow-up|1|||
144674617|NCT00108953|521658023|FG000|Follow-up|Study terminated by sponsor|10|||
144674618|NCT00108953|521658024|FG001|Follow-up|Study terminated by sponsor|6|||
144674619|NCT00719537|521658025|FG000|Overall Study|Withdrawal by Subject|1|||
144674620|NCT00719537|521658026|FG001|Overall Study|Withdrawal by Subject|0|||
144674621|NCT00719537|521658025|FG000|Overall Study|Lost to Follow-up|0|||
144674622|NCT00719537|521658026|FG001|Overall Study|Lost to Follow-up|1|||
144674623|NCT01068717|521658029|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
144674624|NCT01068717|521658030|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
144674625|NCT01068717|521658031|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
144674626|NCT01068717|521658032|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
144674627|NCT03700736|521658036|FG000|Overall Study|Pregnancy|1|||
144674628|NCT03700736|521658037|FG001|Overall Study|Pregnancy|1|||
144674629|NCT03700736|521658036|FG000|Overall Study|Withdrawal by Subject|2|||
144674630|NCT03700736|521658037|FG001|Overall Study|Withdrawal by Subject|6|||
144674631|NCT01410799|521658039|FG000|Overall Study|PI decision|13|||
144674632|NCT04126031|521658041|FG000|Part A|Withdrawal by Subject|0|||
144674633|NCT04126031|521658042|FG001|Part A|Withdrawal by Subject|0|||
144674634|NCT04126031|521658043|FG002|Part A|Withdrawal by Subject|1|||
144674635|NCT04126031|521658044|FG003|Part A|Withdrawal by Subject|0|||
144674636|NCT04126031|521658045|FG004|Part A|Withdrawal by Subject|0|||
144674637|NCT04126031|521658046|FG005|Part A|Withdrawal by Subject|0|||
144674638|NCT04126031|521658041|FG000|Part A|Other|1|||
144674639|NCT04126031|521658042|FG001|Part A|Other|0|||
144674640|NCT04126031|521658043|FG002|Part A|Other|0|||
144674641|NCT04126031|521658044|FG003|Part A|Other|0|||
144674642|NCT04126031|521658045|FG004|Part A|Other|0|||
144674643|NCT04126031|521658046|FG005|Part A|Other|0|||
144674644|NCT04126031|521658041|FG000|Part B|Adverse Event|0|||
144674645|NCT04126031|521658042|FG001|Part B|Adverse Event|0|||
144674646|NCT04126031|521658043|FG002|Part B|Adverse Event|0|||
144674647|NCT04126031|521658044|FG003|Part B|Adverse Event|0|||
144674648|NCT04126031|521658045|FG004|Part B|Adverse Event|0|||
144674649|NCT04126031|521658046|FG005|Part B|Adverse Event|2|||
144674650|NCT04126031|521658041|FG000|Part B|Pre-existing hypertransaminasemia|0|||
144674651|NCT04126031|521658042|FG001|Part B|Pre-existing hypertransaminasemia|0|||
144674652|NCT04126031|521658043|FG002|Part B|Pre-existing hypertransaminasemia|0|||
144674653|NCT04126031|521658044|FG003|Part B|Pre-existing hypertransaminasemia|0|||
144736144|NCT02281084|521887518|FG001|Overall Study|Adverse Event|0|||
144736145|NCT02281084|521887519|FG002|Overall Study|Adverse Event|0|||
144736146|NCT02281084|521887520|FG003|Overall Study|Adverse Event|0|||
144674654|NCT04126031|521658045|FG004|Part B|Pre-existing hypertransaminasemia|1|||
144674655|NCT04126031|521658046|FG005|Part B|Pre-existing hypertransaminasemia|0|||
144674656|NCT00617656|521658047|FG000|Overall Study|Inclusion error|4|||
144674657|NCT00617656|521658048|FG001|Overall Study|Inclusion error|4|||
144674658|NCT00617656|521658049|FG002|Overall Study|Inclusion error|0|||
144674659|NCT00617656|521658050|FG003|Overall Study|Inclusion error|0|||
144674660|NCT00617656|521658047|FG000|Overall Study|Missing data|44|||
144674661|NCT00617656|521658048|FG001|Overall Study|Missing data|30|||
144674662|NCT00617656|521658049|FG002|Overall Study|Missing data|13|||
144674663|NCT00617656|521658050|FG003|Overall Study|Missing data|6|||
144674664|NCT00617656|521658047|FG000|Overall Study|Withdrawal by Subject|0|||
144736147|NCT02281084|521887517|FG000|Overall Study|Withdrawal by Subject|2|||
144736148|NCT02281084|521887518|FG001|Overall Study|Withdrawal by Subject|2|||
144736149|NCT02281084|521887519|FG002|Overall Study|Withdrawal by Subject|0|||
144736150|NCT02281084|521887520|FG003|Overall Study|Withdrawal by Subject|0|||
144736151|NCT02281084|521887517|FG000|Overall Study|Site Closure by Sponsor|5|||
144736152|NCT02281084|521887518|FG001|Overall Study|Site Closure by Sponsor|1|||
144736153|NCT02281084|521887519|FG002|Overall Study|Site Closure by Sponsor|2|||
144736154|NCT02281084|521887520|FG003|Overall Study|Site Closure by Sponsor|0|||
144736155|NCT02305758|521887521|FG000|Overall Study|Death|27|||
144736156|NCT02305758|521887522|FG001|Overall Study|Death|27|||
144736157|NCT02305758|521887521|FG000|Overall Study|Withdrew consent|9|||
144736158|NCT02305758|521887522|FG001|Overall Study|Withdrew consent|2|||
144736159|NCT02305758|521887521|FG000|Overall Study|Lost to Follow-up|6|||
144736160|NCT02305758|521887522|FG001|Overall Study|Lost to Follow-up|1|||
144736161|NCT02305758|521887521|FG000|Overall Study|Study Terminated by Sponsor|21|||
144736162|NCT02305758|521887522|FG001|Overall Study|Study Terminated by Sponsor|34|||
144736163|NCT02305758|521887521|FG000|Overall Study|Other, not specified|2|||
144736164|NCT02305758|521887522|FG001|Overall Study|Other, not specified|1|||
144736165|NCT01518972|521888824|FG000|Overall Study|Lost to Follow-up|2|||
144736166|NCT01518972|521888825|FG001|Overall Study|Lost to Follow-up|1|||
144736167|NCT01518972|521888824|FG000|Overall Study|Withdrawal by Subject|1|||
144736168|NCT01518972|521888825|FG001|Overall Study|Withdrawal by Subject|0|||
144736169|NCT01518972|521888824|FG000|Overall Study|Moved from area|1|||
144736170|NCT01518972|521888825|FG001|Overall Study|Moved from area|0|||
144736171|NCT01518972|521888824|FG000|Overall Study|Transportation problems|1|||
144736172|NCT01518972|521888825|FG001|Overall Study|Transportation problems|0|||
144736173|NCT01518972|521888824|FG000|Overall Study|Exclusionary medical condition|1|||
144736174|NCT01518972|521888825|FG001|Overall Study|Exclusionary medical condition|0|||
144736175|NCT01518972|521888824|FG000|Overall Study|Missed safety visits|0|||
144736176|NCT01518972|521888825|FG001|Overall Study|Missed safety visits|1|||
144736177|NCT01518972|521888824|FG000|Overall Study|Exclusionary medication|0|||
144736178|NCT01518972|521888825|FG001|Overall Study|Exclusionary medication|1|||
144736179|NCT01518972|521888824|FG000|Overall Study|Declined medication starting on day 12|0|||
144736180|NCT01518972|521888825|FG001|Overall Study|Declined medication starting on day 12|1|||
144736181|NCT02159950|521888830|FG000|Overall Study|Adverse Event|0|||
144736182|NCT02159950|521888831|FG001|Overall Study|Adverse Event|1|||
144736183|NCT02159950|521888830|FG000|Overall Study|Progression|0|||
144736184|NCT02159950|521888831|FG001|Overall Study|Progression|1|||
144736185|NCT02258074|521888833|FG000|Overall Study|Withdrawal by Subject|1|||
144736186|NCT02258074|521888834|FG001|Overall Study|Withdrawal by Subject|0|||
144736187|NCT02258074|521888835|FG002|Overall Study|Withdrawal by Subject|0|||
144736188|NCT02258074|521888836|FG003|Overall Study|Withdrawal by Subject|0|||
144736189|NCT05446870|521888837|FG000|Overall Study|Death|6|||
144736190|NCT05446870|521888838|FG001|Overall Study|Death|5|||
144736191|NCT05446870|521888837|FG000|Overall Study|Lost to Follow-up|0|||
144736192|NCT05446870|521888838|FG001|Overall Study|Lost to Follow-up|1|||
144736193|NCT05446870|521888837|FG000|Overall Study|Physician Decision|52|||
144736194|NCT05446870|521888838|FG001|Overall Study|Physician Decision|53|||
144736195|NCT05446870|521888837|FG000|Overall Study|Withdrawal by Subject|3|||
144736196|NCT05446870|521888838|FG001|Overall Study|Withdrawal by Subject|3|||
144736197|NCT04108858|521888840|FG000|Overall Study|Adverse Event|1|||
144736198|NCT01005745|521888841|FG000|Overall Study|No TIL growth|1|||
144736199|NCT01005745|521888841|FG000|Overall Study|Disease progressed during TIL growth|3|||
144736200|NCT01005745|521888841|FG000|Overall Study|Death prior to treatment|1|||
144736201|NCT01005745|521888841|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
144736202|NCT01208337|521888846|FG000|Overall Study|Death|3|||
144736203|NCT03663179|521888850|FG000|Overall Study|Withdrawal by Subject|2|||
144736204|NCT03663179|521888851|FG001|Overall Study|Withdrawal by Subject|0|||
144736205|NCT03663179|521888850|FG000|Overall Study|Lost to Follow-up|1|||
144736206|NCT03663179|521888851|FG001|Overall Study|Lost to Follow-up|1|||
144736207|NCT03663179|521888850|FG000|Overall Study|Revealed exclusionary condition|1|||
144736208|NCT03663179|521888851|FG001|Overall Study|Revealed exclusionary condition|0|||
144736209|NCT01615198|521888855|FG000|Overall Study|Withdrawal by Subject|5|||
144736210|NCT01615198|521888856|FG001|Overall Study|Withdrawal by Subject|5|||
144736211|NCT01615198|521888855|FG000|Overall Study|Protocol deviation|1|||
144736212|NCT01615198|521888856|FG001|Overall Study|Protocol deviation|1|||
144736213|NCT01615198|521888855|FG000|Overall Study|Physician Decision|5|||
144736214|NCT01615198|521888856|FG001|Overall Study|Physician Decision|1|||
144736215|NCT01615198|521888855|FG000|Overall Study|Lost to Follow-up|1|||
144736216|NCT01615198|521888856|FG001|Overall Study|Lost to Follow-up|1|||
144736217|NCT01615198|521888855|FG000|Overall Study|Lack of Efficacy|1|||
144736218|NCT01615198|521888856|FG001|Overall Study|Lack of Efficacy|6|||
144736219|NCT01615198|521888855|FG000|Overall Study|Adverse Event|11|||
144736220|NCT01615198|521888856|FG001|Overall Study|Adverse Event|5|||
144736221|NCT01686438|521888857|FG000|Overall Study|Lost to Follow-up|8|||
144736222|NCT01686438|521888858|FG001|Overall Study|Lost to Follow-up|9|||
144736223|NCT01686438|521888859|FG002|Overall Study|Lost to Follow-up|10|||
144736224|NCT01686438|521888857|FG000|Overall Study|Adverse Event|0|||
144674665|NCT00617656|521658048|FG001|Overall Study|Withdrawal by Subject|2|||
144674666|NCT00617656|521658049|FG002|Overall Study|Withdrawal by Subject|0|||
144674667|NCT00617656|521658050|FG003|Overall Study|Withdrawal by Subject|0|||
144674668|NCT01826448|521660162|FG000|Overall Study|Adverse Event|1|||
144674669|NCT01826448|521660163|FG001|Overall Study|Adverse Event|3|||
144674670|NCT01826448|521660162|FG000|Overall Study|Disease progression|2|||
144674671|NCT01826448|521660163|FG001|Overall Study|Disease progression|4|||
144674672|NCT01826448|521660162|FG000|Overall Study|Withdrawal by Subject|1|||
144674673|NCT01826448|521660163|FG001|Overall Study|Withdrawal by Subject|0|||
144674674|NCT01826448|521660162|FG000|Overall Study|Physician Decision|0|||
144674675|NCT01826448|521660163|FG001|Overall Study|Physician Decision|1|||
144674676|NCT01826448|521660162|FG000|Overall Study|2 active cancers|0|||
144674677|NCT01826448|521660163|FG001|Overall Study|2 active cancers|1|||
144674678|NCT00880100|521660164|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
144674679|NCT00880100|521660164|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
144674680|NCT00880100|521660164|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
144674681|NCT02971007|521660168|FG000|Overall Study|Adverse Event|1|||
144674682|NCT02971007|521660169|FG001|Overall Study|Adverse Event|0|||
144674683|NCT02971007|521660170|FG002|Overall Study|Adverse Event|0|||
144674684|NCT02971007|521660168|FG000|Overall Study|Lost to Follow-up|0|||
144674685|NCT02971007|521660169|FG001|Overall Study|Lost to Follow-up|1|||
144674686|NCT02971007|521660170|FG002|Overall Study|Lost to Follow-up|1|||
144674687|NCT02971007|521660168|FG000|Overall Study|Withdrawal by Subject|0|||
144674688|NCT02971007|521660169|FG001|Overall Study|Withdrawal by Subject|1|||
144674689|NCT02971007|521660170|FG002|Overall Study|Withdrawal by Subject|0|||
144674690|NCT02971007|521660168|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
144674691|NCT02971007|521660169|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
144674692|NCT02971007|521660170|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
144674693|NCT02971007|521660168|FG000|Overall Study|Patient discontinued study drug|0|||
144674694|NCT02971007|521660169|FG001|Overall Study|Patient discontinued study drug|1|||
144674695|NCT02971007|521660170|FG002|Overall Study|Patient discontinued study drug|0|||
144674696|NCT00784459|521660175|FG000|Overall Study|Adverse Event|0|||
144674697|NCT00784459|521660176|FG001|Overall Study|Adverse Event|2|||
144674698|NCT02431702|521660177|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
144674699|NCT02431702|521660178|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
144674700|NCT02431702|521660179|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
144674701|NCT02431702|521660180|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
144674702|NCT02431702|521660181|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
144674703|NCT02431702|521660182|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
144674704|NCT02431702|521660183|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
144674705|NCT02431702|521660177|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
144674706|NCT02431702|521660178|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
144674707|NCT02431702|521660179|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
144674708|NCT02431702|521660180|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
144674709|NCT02431702|521660181|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
144674710|NCT02431702|521660182|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
144674711|NCT02431702|521660183|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
144674712|NCT02431702|521660177|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
144674713|NCT02431702|521660178|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
144674714|NCT02431702|521660179|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
144674715|NCT02431702|521660180|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
144674716|NCT02431702|521660181|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
144674717|NCT02431702|521660182|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
144674718|NCT02431702|521660183|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
144674719|NCT02431702|521660177|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
144674720|NCT02431702|521660178|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
144674721|NCT02431702|521660179|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
144674722|NCT02431702|521660180|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
144674723|NCT02431702|521660181|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
144674724|NCT02431702|521660182|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
144218084|NCT02762929|519992228|FG000|Overall Study|Lost to Follow-up|1|||
144218085|NCT02762929|519992229|FG001|Overall Study|Lost to Follow-up|2|||
144218086|NCT02762929|519992230|FG002|Overall Study|Lost to Follow-up|0|||
144674725|NCT02431702|521660183|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
144674726|NCT02431702|521660177|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
144674727|NCT02431702|521660178|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
144674728|NCT02431702|521660179|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
144674729|NCT02431702|521660180|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
144218087|NCT02762929|519992231|FG003|Overall Study|Lost to Follow-up|1|||
144674730|NCT02431702|521660181|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
144674731|NCT02431702|521660182|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
144736225|NCT01686438|521888858|FG001|Overall Study|Adverse Event|0|||
144736226|NCT01686438|521888859|FG002|Overall Study|Adverse Event|1|||
144736227|NCT01686438|521888857|FG000|Overall Study|Protocol Violation|0|||
144736228|NCT01686438|521888858|FG001|Overall Study|Protocol Violation|0|||
144736229|NCT01686438|521888859|FG002|Overall Study|Protocol Violation|1|||
144736230|NCT01686438|521888857|FG000|Overall Study|Withdrawal by Subject|0|||
144736231|NCT01686438|521888858|FG001|Overall Study|Withdrawal by Subject|0|||
144736232|NCT01686438|521888859|FG002|Overall Study|Withdrawal by Subject|1|||
144736233|NCT00984126|521888860|FG000|Overall Study|Protocol Violation|0|||
144736234|NCT00984126|521888861|FG001|Overall Study|Protocol Violation|0|||
144736235|NCT00984126|521888862|FG002|Overall Study|Protocol Violation|1|||
144736236|NCT00984126|521888863|FG003|Overall Study|Protocol Violation|2|||
144736237|NCT00984126|521888860|FG000|Overall Study|Adverse Event|0|||
144736238|NCT00984126|521888861|FG001|Overall Study|Adverse Event|0|||
144736239|NCT00984126|521888862|FG002|Overall Study|Adverse Event|0|||
144736240|NCT00984126|521888863|FG003|Overall Study|Adverse Event|2|||
144736241|NCT00984126|521888860|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
144736242|NCT00984126|521888861|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
144736243|NCT00984126|521888862|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
144736244|NCT00984126|521888863|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
144736245|NCT00984126|521888860|FG000|Overall Study|Withdrawal criteria|0|||
144736246|NCT00984126|521888861|FG001|Overall Study|Withdrawal criteria|1|||
144736247|NCT00984126|521888862|FG002|Overall Study|Withdrawal criteria|3|||
144736248|NCT00984126|521888863|FG003|Overall Study|Withdrawal criteria|9|||
144736249|NCT01029340|521888867|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
144736250|NCT01029340|521888868|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
144736251|NCT01029340|521888869|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
144736252|NCT01029340|521888870|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
144736253|NCT01029340|521888871|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
144736254|NCT01029340|521888872|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
144736255|NCT01029340|521888867|FG000|Part B Treatment Period|Protocol Violation|0|||
144736256|NCT01029340|521888868|FG001|Part B Treatment Period|Protocol Violation|0|||
144736257|NCT01029340|521888869|FG002|Part B Treatment Period|Protocol Violation|1|||
144736258|NCT01029340|521888870|FG003|Part B Treatment Period|Protocol Violation|0|||
144736259|NCT01029340|521888871|FG004|Part B Treatment Period|Protocol Violation|0|||
144736260|NCT01029340|521888872|FG005|Part B Treatment Period|Protocol Violation|0|||
144736261|NCT01029340|521888867|FG000|Extension Period|Adverse Event|0|||
144736262|NCT01029340|521888868|FG001|Extension Period|Adverse Event|0|||
144736263|NCT01029340|521888869|FG002|Extension Period|Adverse Event|0|||
144736264|NCT01029340|521888870|FG003|Extension Period|Adverse Event|0|||
144736265|NCT01029340|521888871|FG004|Extension Period|Adverse Event|0|||
144736266|NCT01029340|521888872|FG005|Extension Period|Adverse Event|1|||
144736267|NCT01029340|521888867|FG000|Extension Period|starting another study|0|||
144736268|NCT01029340|521888868|FG001|Extension Period|starting another study|0|||
144736269|NCT01029340|521888869|FG002|Extension Period|starting another study|0|||
144736270|NCT01029340|521888870|FG003|Extension Period|starting another study|0|||
144736271|NCT01029340|521888871|FG004|Extension Period|starting another study|0|||
144736272|NCT01029340|521888872|FG005|Extension Period|starting another study|8|||
144736273|NCT01029340|521888867|FG000|Extension Period|non-compliance|0|||
144736274|NCT01029340|521888868|FG001|Extension Period|non-compliance|0|||
144736275|NCT01029340|521888869|FG002|Extension Period|non-compliance|0|||
144736276|NCT01029340|521888870|FG003|Extension Period|non-compliance|0|||
144736277|NCT01029340|521888871|FG004|Extension Period|non-compliance|0|||
144736278|NCT01029340|521888872|FG005|Extension Period|non-compliance|1|||
144736279|NCT01029340|521888867|FG000|Extension Period|Withdrawal by Subject|0|||
144736280|NCT01029340|521888868|FG001|Extension Period|Withdrawal by Subject|0|||
144736281|NCT01029340|521888869|FG002|Extension Period|Withdrawal by Subject|0|||
144736282|NCT01029340|521888870|FG003|Extension Period|Withdrawal by Subject|0|||
144736283|NCT01029340|521888871|FG004|Extension Period|Withdrawal by Subject|0|||
144218088|NCT02762929|519992232|FG004|Overall Study|Lost to Follow-up|0|||
144218089|NCT02762929|519992233|FG005|Overall Study|Lost to Follow-up|0|||
144218090|NCT02762929|519992228|FG000|Overall Study|Withdrawal by Subject|0|||
144218091|NCT02762929|519992229|FG001|Overall Study|Withdrawal by Subject|1|||
144218092|NCT02762929|519992230|FG002|Overall Study|Withdrawal by Subject|0|||
144736284|NCT01029340|521888872|FG005|Extension Period|Withdrawal by Subject|1|||
144736285|NCT01029340|521888867|FG000|Extension Period|Physician Decision|0|||
144736286|NCT01029340|521888868|FG001|Extension Period|Physician Decision|0|||
144736287|NCT01029340|521888869|FG002|Extension Period|Physician Decision|0|||
144736288|NCT01029340|521888870|FG003|Extension Period|Physician Decision|0|||
144736289|NCT01029340|521888871|FG004|Extension Period|Physician Decision|0|||
144736290|NCT01029340|521888872|FG005|Extension Period|Physician Decision|1|||
144736291|NCT01864174|521888873|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
144736292|NCT01864174|521888874|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
144736293|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
144218093|NCT02762929|519992231|FG003|Overall Study|Withdrawal by Subject|0|||
144674732|NCT02431702|521660183|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
144674733|NCT02431702|521660177|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
144674734|NCT02431702|521660178|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
144674735|NCT02431702|521660179|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
144674736|NCT02431702|521660180|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
144674737|NCT02431702|521660181|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
144674738|NCT02431702|521660182|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
144674739|NCT02431702|521660183|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
144674740|NCT02431702|521660177|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
144674741|NCT02431702|521660178|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
144674742|NCT02431702|521660179|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
144674743|NCT02431702|521660180|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
144674744|NCT02431702|521660181|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
144674745|NCT02431702|521660182|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
144674746|NCT02431702|521660183|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
144674747|NCT02431702|521660177|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
144674748|NCT02431702|521660178|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
144674749|NCT02431702|521660179|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
144674750|NCT02431702|521660180|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
144674751|NCT02431702|521660181|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
144674752|NCT02431702|521660182|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
144674753|NCT02431702|521660183|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
144674754|NCT02431702|521660177|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
144674755|NCT02431702|521660178|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
144674756|NCT02431702|521660179|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
144674757|NCT02431702|521660180|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
144674758|NCT02431702|521660181|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
144674759|NCT02431702|521660182|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
144674760|NCT02431702|521660183|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
144674761|NCT02431702|521660177|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
144674762|NCT02431702|521660178|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
144674763|NCT02431702|521660179|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
144674764|NCT02431702|521660180|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
144674765|NCT02431702|521660181|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
144674766|NCT02431702|521660182|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
144674767|NCT02431702|521660183|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
144674768|NCT02431702|521660177|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
144674769|NCT02431702|521660178|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
144674770|NCT02431702|521660179|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
144674771|NCT02431702|521660180|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
144674772|NCT02431702|521660181|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
144674773|NCT02431702|521660182|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
144674774|NCT02431702|521660183|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
144674775|NCT02431702|521660177|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
144674776|NCT02431702|521660178|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
144674777|NCT02431702|521660179|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
144674778|NCT02431702|521660180|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
144674779|NCT02431702|521660181|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
144674780|NCT02431702|521660182|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
144674781|NCT02431702|521660183|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
144674782|NCT02431702|521660177|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
144674783|NCT02431702|521660178|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
144674784|NCT02431702|521660179|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
144674785|NCT02431702|521660180|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
144674786|NCT02431702|521660181|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
144674787|NCT02431702|521660182|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
144674788|NCT02431702|521660183|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
144674789|NCT02431702|521660177|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
144674790|NCT02431702|521660178|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
144674791|NCT02431702|521660179|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
144674792|NCT02431702|521660180|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
144674793|NCT02431702|521660181|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
144674794|NCT02431702|521660182|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
144674795|NCT02431702|521660183|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
144674796|NCT02431702|521660177|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
144674797|NCT02431702|521660178|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
144674798|NCT02431702|521660179|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
144674799|NCT02431702|521660180|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
144674800|NCT02431702|521660181|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
144674801|NCT02431702|521660182|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
144674802|NCT02431702|521660183|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
144674803|NCT03551626|521660184|FG000|Overall Study|Adverse Event|88|||
144674804|NCT03551626|521660184|FG000|Overall Study|Disease relapse|18|||
144674805|NCT03551626|521660184|FG000|Overall Study|Withdrawal of informed consent|6|||
144674806|NCT03551626|521660184|FG000|Overall Study|Patient decision|5|||
144674807|NCT03551626|521660184|FG000|Overall Study|Physician Decision|4|||
144674808|NCT03551626|521660184|FG000|Overall Study|Lost to Follow-up|3|||
144674809|NCT03551626|521660184|FG000|Overall Study|Pregnancy|1|||
144674810|NCT03551626|521660184|FG000|Overall Study|Protocol deviation|1|||
144674811|NCT03551626|521660184|FG000|Overall Study|Technical problems|1|||
144674812|NCT01017549|521660187|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
144674813|NCT01017549|521660187|FG000|One-year Follow-up|Lost to Follow-up|2|||
144674814|NCT01017549|521660187|FG000|One-year Follow-up|Withdrawal by Subject|5|||
144674815|NCT01017549|521660187|FG000|5 Year Follow-up|Lost to Follow-up|9|||
144674816|NCT01017549|521660187|FG000|5 Year Follow-up|Mastectomy|3|||
144674817|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
144674818|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
144674819|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
144674820|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
144674821|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
144674822|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
144674823|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
144674824|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
144674825|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
144674826|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
144674827|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
144674828|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
144674829|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
144674830|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
144674831|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
144674832|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
144674833|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
144674834|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
144674835|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
144674836|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
144674837|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
144674838|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
144674839|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
144674840|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
144674841|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
144674842|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Other|1|||
144674843|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Other|0|||
144674844|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Other|0|||
144674845|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Other|0|||
144674846|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Other|1|||
144674847|NCT02980692|521660190|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
144674848|NCT02980692|521660191|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
144674849|NCT02980692|521660192|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
144674850|NCT02980692|521660193|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
144674851|NCT02980692|521660194|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
144674852|NCT02980692|521660190|FG000|Double-blind Follow-up Period|Adverse Event|0|||
144674853|NCT02980692|521660191|FG001|Double-blind Follow-up Period|Adverse Event|0|||
144674854|NCT02980692|521660192|FG002|Double-blind Follow-up Period|Adverse Event|0|||
144674855|NCT02980692|521660193|FG003|Double-blind Follow-up Period|Adverse Event|1|||
144674856|NCT02980692|521660194|FG004|Double-blind Follow-up Period|Adverse Event|1|||
144674857|NCT02980692|521660190|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
144736294|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
144218094|NCT02762929|519992232|FG004|Overall Study|Withdrawal by Subject|0|||
144218095|NCT02762929|519992233|FG005|Overall Study|Withdrawal by Subject|0|||
144674858|NCT02980692|521660191|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
144674859|NCT02980692|521660192|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
144674860|NCT02980692|521660193|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
144674861|NCT02980692|521660194|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
144674862|NCT02980692|521660190|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
144674863|NCT02980692|521660191|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
144674864|NCT02980692|521660192|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
144674865|NCT02980692|521660193|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
144674866|NCT02980692|521660194|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
144674867|NCT02980692|521660190|FG000|Double-blind Follow-up Period|Pregnancy|0|||
144674868|NCT02980692|521660191|FG001|Double-blind Follow-up Period|Pregnancy|0|||
144674869|NCT02980692|521660192|FG002|Double-blind Follow-up Period|Pregnancy|1|||
144674870|NCT02980692|521660193|FG003|Double-blind Follow-up Period|Pregnancy|1|||
144674871|NCT02980692|521660194|FG004|Double-blind Follow-up Period|Pregnancy|0|||
144674872|NCT02980692|521660190|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
144674873|NCT02980692|521660191|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
144674874|NCT02980692|521660192|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
144674875|NCT02980692|521660193|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
144674876|NCT02980692|521660194|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
144674877|NCT02980692|521660190|FG000|Double-blind Follow-up Period|Other|0|||
144674878|NCT02980692|521660191|FG001|Double-blind Follow-up Period|Other|0|||
144674879|NCT02980692|521660192|FG002|Double-blind Follow-up Period|Other|1|||
144674880|NCT02980692|521660193|FG003|Double-blind Follow-up Period|Other|1|||
144674881|NCT02980692|521660194|FG004|Double-blind Follow-up Period|Other|3|||
144674882|NCT03725293|521660198|FG000|Overall Study|Physician Decision|9|||
144674883|NCT03725293|521660199|FG001|Overall Study|Physician Decision|6|||
144674884|NCT03725293|521660198|FG000|Overall Study|alternative vascular access needs|1|||
144674885|NCT03725293|521660199|FG001|Overall Study|alternative vascular access needs|2|||
144674886|NCT03725293|521660198|FG000|Overall Study|venous anatomy screen failures|2|||
144674887|NCT03725293|521660199|FG001|Overall Study|venous anatomy screen failures|1|||
144674888|NCT03363165|521660200|FG000|3-month Follow-up|Death|0|||
144674889|NCT03363165|521660201|FG001|3-month Follow-up|Death|1|||
144674890|NCT03363165|521660200|FG000|6-month Follow-up|Death|0|||
144674891|NCT03363165|521660201|FG001|6-month Follow-up|Death|1|||
144674892|NCT03363165|521660200|FG000|6-month Follow-up|Withdrawal by Subject|1|||
144674893|NCT03363165|521660201|FG001|6-month Follow-up|Withdrawal by Subject|1|||
144674894|NCT03363165|521660200|FG000|12-month Follow-up|Death|1|||
144674895|NCT03363165|521660201|FG001|12-month Follow-up|Death|1|||
144674896|NCT03363165|521660200|FG000|12-month Follow-up|Withdrawal by Subject|1|||
144674897|NCT03363165|521660201|FG001|12-month Follow-up|Withdrawal by Subject|1|||
144674898|NCT02255760|521660202|FG000|Overall Study|Lost to Follow-up|0|||
144674899|NCT02255760|521660203|FG001|Overall Study|Lost to Follow-up|1|||
144674900|NCT02255760|521660204|FG002|Overall Study|Lost to Follow-up|0|||
144674901|NCT02255760|521660205|FG003|Overall Study|Lost to Follow-up|0|||
144674902|NCT02255760|521660206|FG004|Overall Study|Lost to Follow-up|0|||
144674903|NCT00618813|521660207|FG000|Overall Study|Lack of Efficacy|1|||
144674904|NCT00618813|521660207|FG000|Overall Study|Physician Decision|2|||
144674905|NCT00618813|521660207|FG000|Overall Study|Withdrawal by Subject|1|||
144674906|NCT00425113|521660208|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
144674907|NCT00425113|521660209|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
144674908|NCT00425113|521660208|FG000|Overall Study|diagnosis of abdominal TB|0|||
144674909|NCT00425113|521660209|FG001|Overall Study|diagnosis of abdominal TB|1|||
144674910|NCT00425113|521660208|FG000|Overall Study|missing study drug more than 14 days|0|||
144674911|NCT00425113|521660209|FG001|Overall Study|missing study drug more than 14 days|1|||
144674912|NCT00425113|521660208|FG000|Overall Study|Withdrawal by Subject|1|||
144674913|NCT00425113|521660209|FG001|Overall Study|Withdrawal by Subject|0|||
144674914|NCT00879437|521660212|FG000|Overall Study|Protocol Violation|0|||
144674915|NCT00879437|521660213|FG001|Overall Study|Protocol Violation|1|||
144674916|NCT00879437|521660212|FG000|Overall Study|Death|1|||
144674917|NCT00879437|521660213|FG001|Overall Study|Death|0|||
144674918|NCT00268463|521660214|FG000|Overall Study|study terminated due to low accrual|10|||
144674919|NCT00268463|521660215|FG001|Overall Study|study terminated due to low accrual|12|||
144674920|NCT00961116|521660216|FG000|Washout Period of 7 Days|Adverse Event|1|||
144674921|NCT00961116|521660217|FG001|Washout Period of 7 Days|Adverse Event|1|||
144674922|NCT00961116|521660216|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
144674923|NCT00961116|521660217|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144265647|NCT02513550|520173979|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
144674924|NCT00961116|521660216|FG000|Washout Period of 7 Days|Protocol Violation|0|||
144674925|NCT00961116|521660217|FG001|Washout Period of 7 Days|Protocol Violation|1|||
144674926|NCT00615459|521660218|FG000|Period I|Adverse Event|2|||
144674927|NCT00615459|521660219|FG001|Period I|Adverse Event|0|||
144674928|NCT00615459|521660220|FG002|Period I|Adverse Event|1|||
144674929|NCT00615459|521660221|FG003|Period I|Adverse Event|0|||
144674930|NCT00615459|521660218|FG000|Period I|Subject withdrew consent|1|||
144674931|NCT00615459|521660219|FG001|Period I|Subject withdrew consent|0|||
144674932|NCT00615459|521660220|FG002|Period I|Subject withdrew consent|0|||
144674933|NCT00615459|521660221|FG003|Period I|Subject withdrew consent|1|||
144674934|NCT00615459|521660218|FG000|Period I|Abnormal test procedure results|1|||
144674935|NCT00615459|521660219|FG001|Period I|Abnormal test procedure results|1|||
144674936|NCT00615459|521660220|FG002|Period I|Abnormal test procedure results|1|||
144674937|NCT00615459|521660221|FG003|Period I|Abnormal test procedure results|0|||
144674938|NCT00615459|521660218|FG000|Period II|Adverse Event|1|||
144674939|NCT00615459|521660219|FG001|Period II|Adverse Event|0|||
144674940|NCT00615459|521660220|FG002|Period II|Adverse Event|0|||
144674941|NCT00615459|521660221|FG003|Period II|Adverse Event|0|||
144674942|NCT00615459|521660218|FG000|Period II|Lost to Follow-up|0|||
144674943|NCT00615459|521660219|FG001|Period II|Lost to Follow-up|0|||
144674944|NCT00615459|521660220|FG002|Period II|Lost to Follow-up|0|||
144674945|NCT00615459|521660221|FG003|Period II|Lost to Follow-up|1|||
144674946|NCT00615459|521660218|FG000|Period III|Adverse Event|0|||
144674947|NCT00615459|521660219|FG001|Period III|Adverse Event|1|||
144674948|NCT00615459|521660220|FG002|Period III|Adverse Event|0|||
144674949|NCT00615459|521660221|FG003|Period III|Adverse Event|0|||
144674950|NCT00615459|521660218|FG000|Period III|Administrative problems|0|||
144674951|NCT00615459|521660219|FG001|Period III|Administrative problems|1|||
144674952|NCT00615459|521660220|FG002|Period III|Administrative problems|1|||
144674953|NCT00615459|521660221|FG003|Period III|Administrative problems|0|||
144674954|NCT00615459|521660218|FG000|Period III|Unsatisfactory therapeutic effect|0|||
144674955|NCT00615459|521660219|FG001|Period III|Unsatisfactory therapeutic effect|1|||
144674956|NCT00615459|521660220|FG002|Period III|Unsatisfactory therapeutic effect|0|||
144674957|NCT00615459|521660221|FG003|Period III|Unsatisfactory therapeutic effect|0|||
144674958|NCT00918346|521660224|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
144674959|NCT00918346|521660225|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
144674960|NCT03238352|521660226|FG000|Overall Study|Lost to Follow-up|0|||
144674961|NCT03238352|521660227|FG001|Overall Study|Lost to Follow-up|2|||
144674962|NCT03238352|521660228|FG002|Overall Study|Lost to Follow-up|1|||
144674963|NCT03238352|521660226|FG000|Overall Study|Withdrawal by Subject|0|||
144674964|NCT03238352|521660227|FG001|Overall Study|Withdrawal by Subject|1|||
144674965|NCT03238352|521660228|FG002|Overall Study|Withdrawal by Subject|0|||
144674966|NCT00709124|521660229|FG000|Overall Study|Death|3|||
144674967|NCT00709124|521660230|FG001|Overall Study|Death|1|||
144674968|NCT00709124|521660229|FG000|Overall Study|encephalopathy; can't do assessment|1|||
144674969|NCT00709124|521660230|FG001|Overall Study|encephalopathy; can't do assessment|0|||
144674970|NCT00753688|521660237|FG000|Overall Study|Death|102|||
144674971|NCT00753688|521660238|FG001|Overall Study|Death|203|||
144674972|NCT00753688|521660237|FG000|Overall Study|Missing|4|||
144674973|NCT00753688|521660238|FG001|Overall Study|Missing|9|||
144674974|NCT00753688|521660237|FG000|Overall Study|Participant Withdrew Consent|2|||
144674975|NCT00753688|521660238|FG001|Overall Study|Participant Withdrew Consent|2|||
144674976|NCT00753688|521660237|FG000|Overall Study|Ongoing - in Follow-up|15|||
144674977|NCT00753688|521660238|FG001|Overall Study|Ongoing - in Follow-up|31|||
144674978|NCT00753688|521660237|FG000|Overall Study|Adverse Event|0|||
144674979|NCT00753688|521660238|FG001|Overall Study|Adverse Event|1|||
144674980|NCT03803202|521660242|FG000|Overall Study|Other|0|||
144674981|NCT03803202|521660243|FG001|Overall Study|Other|1|||
144674982|NCT03803202|521660244|FG002|Overall Study|Other|0|||
144674983|NCT03803202|521660245|FG003|Overall Study|Other|0|||
144674984|NCT03803202|521660246|FG004|Overall Study|Other|0|||
144674985|NCT03803202|521660247|FG005|Overall Study|Other|0|||
144674986|NCT03803202|521660248|FG006|Overall Study|Other|0|||
144674987|NCT03803202|521660249|FG007|Overall Study|Other|0|||
144674988|NCT03803202|521660250|FG008|Overall Study|Other|0|||
144674989|NCT03803202|521660242|FG000|Overall Study|Death|0|||
144674990|NCT03803202|521660243|FG001|Overall Study|Death|0|||
144674991|NCT03803202|521660244|FG002|Overall Study|Death|0|||
144674992|NCT03803202|521660245|FG003|Overall Study|Death|0|||
144674993|NCT03803202|521660246|FG004|Overall Study|Death|0|||
144674994|NCT03803202|521660247|FG005|Overall Study|Death|1|||
144674995|NCT03803202|521660248|FG006|Overall Study|Death|0|||
144674996|NCT03803202|521660249|FG007|Overall Study|Death|0|||
144674997|NCT03803202|521660250|FG008|Overall Study|Death|0|||
144674998|NCT03803202|521660242|FG000|Overall Study|Withdrawal by Subject|0|||
144736295|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
144736296|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
144674999|NCT03803202|521660243|FG001|Overall Study|Withdrawal by Subject|0|||
144675000|NCT03803202|521660244|FG002|Overall Study|Withdrawal by Subject|1|||
144675001|NCT03803202|521660245|FG003|Overall Study|Withdrawal by Subject|0|||
144675002|NCT03803202|521660246|FG004|Overall Study|Withdrawal by Subject|0|||
144675003|NCT03803202|521660247|FG005|Overall Study|Withdrawal by Subject|0|||
144675004|NCT03803202|521660248|FG006|Overall Study|Withdrawal by Subject|0|||
144675005|NCT03803202|521660249|FG007|Overall Study|Withdrawal by Subject|1|||
144675006|NCT03803202|521660250|FG008|Overall Study|Withdrawal by Subject|0|||
144736297|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
144736298|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
144736299|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Death|1|||
144736300|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Death|0|||
144736301|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
144736302|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
144736303|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
144736304|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
144736305|NCT01864174|521888873|FG000|Double Blind - Compliant Randomized|Other|6|||
144736306|NCT01864174|521888874|FG001|Double Blind - Compliant Randomized|Other|10|||
144736307|NCT01864174|521888873|FG000|Off Treatment Follow-Up|Other|2|||
144736308|NCT01864174|521888874|FG001|Off Treatment Follow-Up|Other|0|||
144736309|NCT01864174|521888873|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
144736310|NCT01864174|521888874|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
144736311|NCT02648347|521888875|FG000|Overall Study|Death|174|||
144736312|NCT02648347|521888876|FG001|Overall Study|Death|167|||
144675007|NCT03803202|521660242|FG000|Overall Study|Lost to Follow-up|0|||
144675008|NCT03803202|521660243|FG001|Overall Study|Lost to Follow-up|0|||
144675009|NCT03803202|521660244|FG002|Overall Study|Lost to Follow-up|0|||
144675010|NCT03803202|521660245|FG003|Overall Study|Lost to Follow-up|1|||
144736313|NCT02648347|521888875|FG000|Overall Study|Withdrawal by Subject|16|||
144736314|NCT02648347|521888876|FG001|Overall Study|Withdrawal by Subject|9|||
144736315|NCT02648347|521888875|FG000|Overall Study|Lost to Follow-up|18|||
144736316|NCT02648347|521888876|FG001|Overall Study|Lost to Follow-up|21|||
144736317|NCT02648347|521888875|FG000|Overall Study|Missing|1|||
144736318|NCT02648347|521888876|FG001|Overall Study|Missing|0|||
144736319|NCT01723397|521888881|FG000|Study Period 1|Protocol Violation|0|||
144736320|NCT01723397|521888882|FG001|Study Period 1|Protocol Violation|1|||
144736321|NCT01723397|521888881|FG000|Study Period 2|Protocol Violation|0|||
144736322|NCT01723397|521888882|FG001|Study Period 2|Protocol Violation|1|||
144736323|NCT02739997|521888886|FG000|Overall Study|Death|1|||
144736324|NCT02739997|521888886|FG000|Overall Study|Withdrawal by Subject|1|||
144736325|NCT00468286|521888889|FG000|Overall Study|Adverse Event|1|||
144736326|NCT00468286|521888890|FG001|Overall Study|Adverse Event|6|||
144736327|NCT00468286|521888889|FG000|Overall Study|Protocol Violation|2|||
144736328|NCT00468286|521888890|FG001|Overall Study|Protocol Violation|2|||
144736329|NCT00468286|521888889|FG000|Overall Study|Withdrawal by Subject|4|||
144736330|NCT00468286|521888890|FG001|Overall Study|Withdrawal by Subject|3|||
144736331|NCT00468286|521888889|FG000|Overall Study|Physician Decision|0|||
144736332|NCT00468286|521888890|FG001|Overall Study|Physician Decision|1|||
144736333|NCT02196675|521888891|FG000|Overall Study|Withdrawal by Subject|1|||
144736334|NCT02196675|521888892|FG001|Overall Study|Withdrawal by Subject|0|||
144736335|NCT02196675|521888893|FG002|Overall Study|Withdrawal by Subject|0|||
144736336|NCT02196675|521888891|FG000|Overall Study|Intra-operative surgical exclusion|1|||
144736337|NCT02196675|521888892|FG001|Overall Study|Intra-operative surgical exclusion|1|||
144736338|NCT02196675|521888893|FG002|Overall Study|Intra-operative surgical exclusion|0|||
144736339|NCT02196675|521888891|FG000|Overall Study|Protocol Violation|0|||
144736340|NCT02196675|521888892|FG001|Overall Study|Protocol Violation|1|||
144736341|NCT02196675|521888893|FG002|Overall Study|Protocol Violation|0|||
144736342|NCT02196675|521888891|FG000|Overall Study|Death|0|||
144736343|NCT02196675|521888892|FG001|Overall Study|Death|0|||
144736344|NCT02196675|521888893|FG002|Overall Study|Death|1|||
144736345|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
144736346|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
144736347|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
144736348|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
144736349|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
144218096|NCT02762929|519992228|FG000|Overall Study|exclusionary medication disclosed late|0|||
144218097|NCT02762929|519992229|FG001|Overall Study|exclusionary medication disclosed late|0|||
144675011|NCT03803202|521660246|FG004|Overall Study|Lost to Follow-up|1|||
144675012|NCT03803202|521660247|FG005|Overall Study|Lost to Follow-up|0|||
144675013|NCT03803202|521660248|FG006|Overall Study|Lost to Follow-up|1|||
144675014|NCT03803202|521660249|FG007|Overall Study|Lost to Follow-up|0|||
144675015|NCT03803202|521660250|FG008|Overall Study|Lost to Follow-up|0|||
144675016|NCT01125293|521660251|FG000|Overall Study|Disease Progression|1|||
144675017|NCT01125293|521660252|FG001|Overall Study|Disease Progression|3|||
144675018|NCT01125293|521660253|FG002|Overall Study|Disease Progression|4|||
144675019|NCT01125293|521660254|FG003|Overall Study|Disease Progression|3|||
144675020|NCT01125293|521660255|FG004|Overall Study|Disease Progression|5|||
144675021|NCT01125293|521660256|FG005|Overall Study|Disease Progression|12|||
144675022|NCT01125293|521660251|FG000|Overall Study|Adverse Event|1|||
144675023|NCT01125293|521660252|FG001|Overall Study|Adverse Event|0|||
144675024|NCT01125293|521660253|FG002|Overall Study|Adverse Event|0|||
144675025|NCT01125293|521660254|FG003|Overall Study|Adverse Event|0|||
144675026|NCT01125293|521660255|FG004|Overall Study|Adverse Event|2|||
144675027|NCT01125293|521660256|FG005|Overall Study|Adverse Event|8|||
144675028|NCT01125293|521660251|FG000|Overall Study|Symptomatic Deterioration|1|||
144675029|NCT01125293|521660252|FG001|Overall Study|Symptomatic Deterioration|0|||
144675030|NCT01125293|521660253|FG002|Overall Study|Symptomatic Deterioration|0|||
144675031|NCT01125293|521660254|FG003|Overall Study|Symptomatic Deterioration|0|||
144675032|NCT01125293|521660255|FG004|Overall Study|Symptomatic Deterioration|0|||
144675033|NCT01125293|521660256|FG005|Overall Study|Symptomatic Deterioration|0|||
144675034|NCT01125293|521660251|FG000|Overall Study|Death|0|||
144675035|NCT01125293|521660252|FG001|Overall Study|Death|0|||
144675036|NCT01125293|521660253|FG002|Overall Study|Death|0|||
144675037|NCT01125293|521660254|FG003|Overall Study|Death|0|||
144675038|NCT01125293|521660255|FG004|Overall Study|Death|1|||
144675039|NCT01125293|521660256|FG005|Overall Study|Death|0|||
144675040|NCT01125293|521660251|FG000|Overall Study|Withdrawal by Subject|0|||
144675041|NCT01125293|521660252|FG001|Overall Study|Withdrawal by Subject|0|||
144675042|NCT01125293|521660253|FG002|Overall Study|Withdrawal by Subject|0|||
144675043|NCT01125293|521660254|FG003|Overall Study|Withdrawal by Subject|0|||
144675044|NCT01125293|521660255|FG004|Overall Study|Withdrawal by Subject|2|||
144675045|NCT01125293|521660256|FG005|Overall Study|Withdrawal by Subject|1|||
144675046|NCT01125293|521660251|FG000|Overall Study|Physician Decision|0|||
144675047|NCT01125293|521660252|FG001|Overall Study|Physician Decision|0|||
144675048|NCT01125293|521660253|FG002|Overall Study|Physician Decision|0|||
144675049|NCT01125293|521660254|FG003|Overall Study|Physician Decision|0|||
144675050|NCT01125293|521660255|FG004|Overall Study|Physician Decision|0|||
144675051|NCT01125293|521660256|FG005|Overall Study|Physician Decision|2|||
144675052|NCT00260429|521660261|FG000|Overall Study|failure to follow appointments|1|||
144675053|NCT00260429|521660262|FG001|Overall Study|failure to follow appointments|0|||
144675054|NCT00260429|521660261|FG000|Overall Study|scheduled hand surgery|1|||
144675055|NCT00260429|521660262|FG001|Overall Study|scheduled hand surgery|0|||
144675056|NCT00659126|521660263|FG000|Overall Study|Adverse Event|2|||
144675057|NCT00659126|521660264|FG001|Overall Study|Adverse Event|2|||
144675058|NCT00659126|521660263|FG000|Overall Study|Screen failure|1|||
144675059|NCT00659126|521660264|FG001|Overall Study|Screen failure|1|||
144675060|NCT00659126|521660263|FG000|Overall Study|Technical problems with MRI|0|||
144675061|NCT00659126|521660264|FG001|Overall Study|Technical problems with MRI|1|||
144675062|NCT02633046|521660270|FG000|Overall Study|Adverse Event|8|||
144675063|NCT02633046|521660270|FG000|Overall Study|Physician Decision|7|||
144675064|NCT02633046|521660270|FG000|Overall Study|Withdrawal by Subject|8|||
144675065|NCT02633046|521660270|FG000|Overall Study|Increased proteinuria|2|||
144675066|NCT02633046|521660270|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
144675067|NCT02633046|521660270|FG000|Overall Study|Mutual decision patient and physician|1|||
144675068|NCT00617591|521660273|FG000|Overall Study|Withdrew consent during Induction|4|||
144675069|NCT00617591|521660273|FG000|Overall Study|Withdrew consent during Maintenance|6|||
144675070|NCT00587301|521660278|FG000|Overall Study|Screen Failure|9|||
144675071|NCT00587301|521660278|FG000|Overall Study|Lost to Follow-up|22|||
144675072|NCT00587301|521660278|FG000|Overall Study|Withdrawal by Subject|7|||
144675073|NCT00587301|521660278|FG000|Overall Study|Protocol Violation|7|||
144675074|NCT01496274|521660279|FG000|Overall Study|Protocol Violation|0|||
144675075|NCT01496274|521660280|FG001|Overall Study|Protocol Violation|1|||
144675076|NCT01496274|521660279|FG000|Overall Study|Adverse Event|1|||
144675077|NCT01496274|521660280|FG001|Overall Study|Adverse Event|1|||
144675078|NCT01496274|521660279|FG000|Overall Study|Withdrawal by Subject|2|||
144675079|NCT01496274|521660280|FG001|Overall Study|Withdrawal by Subject|0|||
144675080|NCT01496274|521660279|FG000|Overall Study|Lost to Follow-up|0|||
144675081|NCT01496274|521660280|FG001|Overall Study|Lost to Follow-up|3|||
144675082|NCT02758613|521660282|FG000|Treatment|Physician and Sponsor Decision|1|||
144675083|NCT02758613|521660283|FG001|Treatment|Physician and Sponsor Decision|0|||
144675084|NCT02758613|521660284|FG002|Treatment|Physician and Sponsor Decision|0|||
144675085|NCT02758613|521660285|FG003|Treatment|Physician and Sponsor Decision|0|||
144675086|NCT02758613|521660282|FG000|Treatment|Withdrawal by Subject|1|||
144675087|NCT02758613|521660283|FG001|Treatment|Withdrawal by Subject|0|||
144675088|NCT02758613|521660284|FG002|Treatment|Withdrawal by Subject|1|||
144675089|NCT02758613|521660285|FG003|Treatment|Withdrawal by Subject|0|||
144675090|NCT01400139|521660286|FG000|HYD Core Study|Adverse Event|210|||
144675091|NCT01400139|521660286|FG000|HYD Core Study|Lack of Efficacy|59|||
144675092|NCT01400139|521660286|FG000|HYD Core Study|Withdrawal by Subject|114|||
144675093|NCT01400139|521660286|FG000|HYD Core Study|Lost to Follow-up|39|||
144675094|NCT01400139|521660286|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
144675095|NCT01400139|521660286|FG000|HYD Core Study|Administrative|56|||
144675096|NCT01400139|521660286|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
144675097|NCT01400139|521660286|FG000|HYD Extension Period|Adverse Event|8|||
144675098|NCT01400139|521660286|FG000|HYD Extension Period|Withdrawal by Subject|5|||
144675099|NCT01400139|521660286|FG000|HYD Extension Period|Administrative|10|||
144675100|NCT00418717|521660287|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
144675101|NCT00418717|521660287|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
144675102|NCT00351819|521660288|FG000|Overall Study|Lost to Follow-up|4|||
144675103|NCT00351819|521660289|FG001|Overall Study|Lost to Follow-up|4|||
144675104|NCT00351819|521660288|FG000|Overall Study|Withdrawal by Subject|0|||
144675105|NCT00351819|521660289|FG001|Overall Study|Withdrawal by Subject|4|||
144675106|NCT00351819|521660288|FG000|Overall Study|Elevated PSA|1|||
144675107|NCT00351819|521660289|FG001|Overall Study|Elevated PSA|1|||
144675108|NCT00351819|521660288|FG000|Overall Study|Traumatic ankle fracture|1|||
144675109|NCT00351819|521660289|FG001|Overall Study|Traumatic ankle fracture|0|||
144675110|NCT00351819|521660288|FG000|Overall Study|Unprofessional behavior|1|||
144675111|NCT00351819|521660289|FG001|Overall Study|Unprofessional behavior|0|||
144675112|NCT00351819|521660288|FG000|Overall Study|Non-compliance|0|||
144675113|NCT00351819|521660289|FG001|Overall Study|Non-compliance|1|||
144675114|NCT00351819|521660288|FG000|Overall Study|Incarcerated|0|||
144675115|NCT00351819|521660289|FG001|Overall Study|Incarcerated|1|||
144675116|NCT00351819|521660288|FG000|Overall Study|Enrolled in another trial|0|||
144675117|NCT00351819|521660289|FG001|Overall Study|Enrolled in another trial|1|||
144675118|NCT00249795|521660292|FG000|Overall Study|Not treated|16|||
144675119|NCT00249795|521660293|FG001|Overall Study|Not treated|14|||
144675120|NCT00249795|521660292|FG000|Overall Study|Symptomatic hypotension|127|||
144675121|NCT00249795|521660293|FG001|Overall Study|Symptomatic hypotension|64|||
144675122|NCT00249795|521660292|FG000|Overall Study|Other Serious Adverse Event|84|||
144675123|NCT00249795|521660293|FG001|Overall Study|Other Serious Adverse Event|93|||
144675124|NCT00249795|521660292|FG000|Overall Study|Qualifying condition not present|26|||
144675125|NCT00249795|521660293|FG001|Overall Study|Qualifying condition not present|29|||
144675126|NCT00249795|521660292|FG000|Overall Study|Withdrawal by Subject|678|||
144675127|NCT00249795|521660293|FG001|Overall Study|Withdrawal by Subject|742|||
144675128|NCT00249795|521660292|FG000|Overall Study|Thromboembolic / outcome event|39|||
144675129|NCT00249795|521660293|FG001|Overall Study|Thromboembolic / outcome event|45|||
144675130|NCT00249795|521660292|FG000|Overall Study|Oral anticoagulant required|2|||
144675131|NCT00249795|521660293|FG001|Overall Study|Oral anticoagulant required|0|||
144675132|NCT00249795|521660292|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
144675133|NCT00249795|521660293|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
144675134|NCT00249795|521660292|FG000|Overall Study|Non-compliance|71|||
144675135|NCT00249795|521660293|FG001|Overall Study|Non-compliance|69|||
144675136|NCT00249795|521660292|FG000|Overall Study|Study drug intolerance|3|||
144675137|NCT00249795|521660293|FG001|Overall Study|Study drug intolerance|3|||
144675138|NCT00249795|521660292|FG000|Overall Study|Other adverse events (non-serious)|188|||
144675139|NCT00249795|521660293|FG001|Overall Study|Other adverse events (non-serious)|159|||
144675140|NCT00249795|521660292|FG000|Overall Study|Physician withdrew consent|71|||
144675141|NCT00249795|521660293|FG001|Overall Study|Physician withdrew consent|63|||
144675142|NCT00249795|521660292|FG000|Overall Study|Surgery / procedure|4|||
144675143|NCT00249795|521660293|FG001|Overall Study|Surgery / procedure|5|||
144675144|NCT00249795|521660292|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
144675145|NCT00249795|521660293|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
144675146|NCT00249795|521660292|FG000|Overall Study|Lightheadedness / dizziness|15|||
144675147|NCT00249795|521660293|FG001|Overall Study|Lightheadedness / dizziness|11|||
144675148|NCT00249795|521660292|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
144675149|NCT00249795|521660293|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
144675150|NCT00249795|521660292|FG000|Overall Study|Other contraindicated medication|1|||
144675151|NCT00249795|521660293|FG001|Overall Study|Other contraindicated medication|1|||
144675152|NCT00249795|521660292|FG000|Overall Study|Event related to cardiac condition|17|||
144675153|NCT00249795|521660293|FG001|Overall Study|Event related to cardiac condition|16|||
144675154|NCT00249795|521660292|FG000|Overall Study|Patient not wish to continue after May08|4|||
144675155|NCT00249795|521660293|FG001|Overall Study|Patient not wish to continue after May08|6|||
144675156|NCT00249795|521660292|FG000|Overall Study|Site not agree to continue after May08|1|||
144675157|NCT00249795|521660293|FG001|Overall Study|Site not agree to continue after May08|1|||
144675158|NCT00249795|521660292|FG000|Overall Study|Lost to Follow-up|0|||
144675159|NCT00249795|521660293|FG001|Overall Study|Lost to Follow-up|2|||
144675160|NCT00249795|521660292|FG000|Overall Study|Missing|0|||
144675161|NCT00249795|521660293|FG001|Overall Study|Missing|1|||
144675162|NCT01142193|521660298|FG000|Overall Study|Adverse Event|12|||
144675163|NCT01142193|521660299|FG001|Overall Study|Adverse Event|4|||
144675164|NCT01142193|521660298|FG000|Overall Study|Lack of Efficacy|2|||
144675165|NCT01142193|521660299|FG001|Overall Study|Lack of Efficacy|1|||
144675166|NCT01142193|521660298|FG000|Overall Study|Physician Decision|1|||
144675167|NCT01142193|521660299|FG001|Overall Study|Physician Decision|1|||
144675168|NCT01142193|521660298|FG000|Overall Study|Withdrawal by Subject|4|||
144675169|NCT01142193|521660299|FG001|Overall Study|Withdrawal by Subject|3|||
144675170|NCT01142193|521660298|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
144675171|NCT01142193|521660299|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
144675172|NCT01142193|521660298|FG000|Overall Study|Other|1|||
144675173|NCT01142193|521660299|FG001|Overall Study|Other|2|||
144675174|NCT03549429|521660300|FG000|Overall Study|Protocol Violation|5|||
144675175|NCT03549429|521660301|FG001|Overall Study|Protocol Violation|3|||
144675176|NCT01425749|521660302|FG000|Overall Study|progression of melanoma|0|||
144675177|NCT01425749|521660303|FG001|Overall Study|progression of melanoma|1|||
144675178|NCT02910219|521660304|FG000|Overall Study|Withdrawal by Subject|1|||
144736350|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
144736351|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
144736352|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
144736353|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
144736354|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
144736355|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
144736356|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
144736357|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
144736358|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
144736359|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
144736360|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
144736361|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
144736362|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
144736363|NCT02009163|521888896|FG000|Open-label Period (Non-randomized)|Other|13|||
144736364|NCT02009163|521888897|FG001|Open-label Period (Non-randomized)|Other|0|||
144736365|NCT02009163|521888898|FG002|Open-label Period (Non-randomized)|Other|0|||
144736366|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
144736367|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
144736368|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
144736369|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
144736370|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
144736371|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
144736372|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Adverse Event|0|||
144736373|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Adverse Event|0|||
144736374|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Adverse Event|6|||
144736375|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
144736376|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
144736377|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
144736378|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
144736379|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
144736380|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
144736381|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Pregnancy|0|||
144736382|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Pregnancy|0|||
144736383|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Pregnancy|2|||
144736384|NCT02009163|521888896|FG000|Randomized-withdrawal Period|Other|0|||
144736385|NCT02009163|521888897|FG001|Randomized-withdrawal Period|Other|9|||
144736386|NCT02009163|521888898|FG002|Randomized-withdrawal Period|Other|5|||
144736387|NCT02453386|521888899|FG000|Overall Study|Adverse Event|22|||
144736388|NCT02453386|521888900|FG001|Overall Study|Adverse Event|30|||
144736389|NCT02453386|521888901|FG002|Overall Study|Adverse Event|15|||
144736390|NCT02453386|521888899|FG000|Overall Study|Protocol Violation|1|||
144736391|NCT02453386|521888900|FG001|Overall Study|Protocol Violation|0|||
144736392|NCT02453386|521888901|FG002|Overall Study|Protocol Violation|1|||
144736393|NCT02453386|521888899|FG000|Overall Study|Withdrawal by Subject|10|||
144736394|NCT02453386|521888900|FG001|Overall Study|Withdrawal by Subject|9|||
144736395|NCT02453386|521888901|FG002|Overall Study|Withdrawal by Subject|9|||
144736396|NCT02453386|521888899|FG000|Overall Study|Sponsor Terminated Study|14|||
144736397|NCT02453386|521888900|FG001|Overall Study|Sponsor Terminated Study|8|||
144736398|NCT02453386|521888901|FG002|Overall Study|Sponsor Terminated Study|11|||
144736399|NCT02453386|521888899|FG000|Overall Study|Subject Terminated by Sponsor|1|||
144736400|NCT02453386|521888900|FG001|Overall Study|Subject Terminated by Sponsor|1|||
144736401|NCT02453386|521888901|FG002|Overall Study|Subject Terminated by Sponsor|1|||
144736402|NCT02453386|521888899|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
144736403|NCT02453386|521888900|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
144736404|NCT02453386|521888901|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
144736405|NCT02453386|521888899|FG000|Overall Study|Lost to Follow-up|0|||
144736406|NCT02453386|521888900|FG001|Overall Study|Lost to Follow-up|0|||
144736407|NCT02453386|521888901|FG002|Overall Study|Lost to Follow-up|1|||
144736408|NCT02453386|521888899|FG000|Overall Study|Other|1|||
144736409|NCT02453386|521888900|FG001|Overall Study|Other|0|||
144736410|NCT02453386|521888901|FG002|Overall Study|Other|1|||
144736411|NCT00838279|521888902|FG000|Washout|Protocol Violation|1|||
144736412|NCT00838279|521888903|FG001|Washout|Protocol Violation|0|||
144736413|NCT00838279|521888902|FG000|Washout|Withdrawal by Subject|0|||
144736414|NCT00838279|521888903|FG001|Washout|Withdrawal by Subject|1|||
144736415|NCT01415986|521888904|FG000|Overall Study|Lost to Follow-up|1|||
144736416|NCT00465270|521888905|FG000|Overall Study|Death|7|||
144736417|NCT00465270|521888906|FG001|Overall Study|Death|11|||
144736418|NCT00465270|521888905|FG000|Overall Study|Withdrawal by Subject|34|||
144736419|NCT00465270|521888906|FG001|Overall Study|Withdrawal by Subject|78|||
144736420|NCT00465270|521888905|FG000|Overall Study|Lost to Follow-up|60|||
144736421|NCT00465270|521888906|FG001|Overall Study|Lost to Follow-up|67|||
144736422|NCT00465270|521888905|FG000|Overall Study|Investigator request|3|||
144736423|NCT00465270|521888906|FG001|Overall Study|Investigator request|4|||
144736424|NCT02388191|521888919|FG000|Overall Study|Patient did not receive IUD|1|||
144736425|NCT02388191|521888920|FG001|Overall Study|Patient did not receive IUD|0|||
144736426|NCT03173547|521888923|FG000|Overall Study|Adverse Event|2|||
144736427|NCT03173547|521888924|FG001|Overall Study|Adverse Event|0|||
144736428|NCT03173547|521888923|FG000|Overall Study|Withdrawal by Subject|2|||
144736429|NCT03173547|521888924|FG001|Overall Study|Withdrawal by Subject|2|||
144736430|NCT00657553|521888925|FG000|Overall Study|low accrual, no analysis run|5|||
144736431|NCT00657553|521888926|FG001|Overall Study|low accrual, no analysis run|5|||
144736432|NCT03273153|521888927|FG000|Overall Study|Adverse Event|1|||
144736433|NCT03273153|521888928|FG001|Overall Study|Adverse Event|2|||
144736434|NCT03273153|521888927|FG000|Overall Study|Missing|0|||
144736435|NCT03273153|521888928|FG001|Overall Study|Missing|2|||
144736436|NCT03273153|521888927|FG000|Overall Study|Other|3|||
144736437|NCT03273153|521888928|FG001|Overall Study|Other|2|||
144736438|NCT03273153|521888927|FG000|Overall Study|Symptomatic Deterioration|0|||
144736439|NCT03273153|521888928|FG001|Overall Study|Symptomatic Deterioration|1|||
144736440|NCT03273153|521888927|FG000|Overall Study|Progressive Disease|6|||
144736441|NCT03273153|521888928|FG001|Overall Study|Progressive Disease|5|||
144736442|NCT03273153|521888927|FG000|Overall Study|Physician Decision|1|||
144736443|NCT03273153|521888928|FG001|Overall Study|Physician Decision|3|||
144736444|NCT03273153|521888927|FG000|Overall Study|Study Terminated by Sponsor|112|||
144736445|NCT03273153|521888928|FG001|Overall Study|Study Terminated by Sponsor|102|||
144736446|NCT03273153|521888927|FG000|Overall Study|Withdrawal by Subject|26|||
144736447|NCT03273153|521888928|FG001|Overall Study|Withdrawal by Subject|25|||
144736448|NCT03273153|521888927|FG000|Overall Study|Protocol Deviation|3|||
144736449|NCT03273153|521888928|FG001|Overall Study|Protocol Deviation|0|||
144736450|NCT03273153|521888927|FG000|Overall Study|Lost to Follow-up|6|||
144736451|NCT03273153|521888928|FG001|Overall Study|Lost to Follow-up|11|||
144736452|NCT03273153|521888927|FG000|Overall Study|Death|66|||
144736453|NCT03273153|521888928|FG001|Overall Study|Death|69|||
144736454|NCT01237054|521888931|FG000|Overall Study|imaging 10C0096|1|||
144736455|NCT00838539|521888932|FG000|Overall Study|Disease Progression|2|||
144736456|NCT00838539|521888933|FG001|Overall Study|Disease Progression|4|||
144736457|NCT00838539|521888934|FG002|Overall Study|Disease Progression|3|||
144736458|NCT00838539|521888935|FG003|Overall Study|Disease Progression|2|||
144736459|NCT00838539|521888936|FG004|Overall Study|Disease Progression|4|||
144736460|NCT00838539|521888937|FG005|Overall Study|Disease Progression|2|||
144736461|NCT00838539|521888938|FG006|Overall Study|Disease Progression|3|||
144736462|NCT00838539|521888939|FG007|Overall Study|Disease Progression|4|||
144736463|NCT00838539|521888940|FG008|Overall Study|Disease Progression|4|||
144736464|NCT00838539|521888941|FG009|Overall Study|Disease Progression|5|||
144736465|NCT00838539|521888942|FG010|Overall Study|Disease Progression|1|||
144736466|NCT00838539|521888943|FG011|Overall Study|Disease Progression|4|||
144736467|NCT00838539|521888932|FG000|Overall Study|Adverse Event|1|||
144736468|NCT00838539|521888933|FG001|Overall Study|Adverse Event|1|||
144736469|NCT00838539|521888934|FG002|Overall Study|Adverse Event|1|||
144736470|NCT00838539|521888935|FG003|Overall Study|Adverse Event|1|||
144736471|NCT00838539|521888936|FG004|Overall Study|Adverse Event|2|||
144736472|NCT00838539|521888937|FG005|Overall Study|Adverse Event|1|||
144736473|NCT00838539|521888938|FG006|Overall Study|Adverse Event|0|||
144736474|NCT00838539|521888939|FG007|Overall Study|Adverse Event|2|||
144736475|NCT00838539|521888940|FG008|Overall Study|Adverse Event|0|||
144736476|NCT00838539|521888941|FG009|Overall Study|Adverse Event|1|||
144736477|NCT00838539|521888942|FG010|Overall Study|Adverse Event|2|||
144736478|NCT00838539|521888943|FG011|Overall Study|Adverse Event|0|||
144736479|NCT00838539|521888932|FG000|Overall Study|Withdrawal by Subject|0|||
144736480|NCT00838539|521888933|FG001|Overall Study|Withdrawal by Subject|1|||
144736481|NCT00838539|521888934|FG002|Overall Study|Withdrawal by Subject|0|||
144736482|NCT00838539|521888935|FG003|Overall Study|Withdrawal by Subject|0|||
144736483|NCT00838539|521888936|FG004|Overall Study|Withdrawal by Subject|0|||
144736484|NCT00838539|521888937|FG005|Overall Study|Withdrawal by Subject|0|||
144736485|NCT00838539|521888938|FG006|Overall Study|Withdrawal by Subject|0|||
144736486|NCT00838539|521888939|FG007|Overall Study|Withdrawal by Subject|0|||
144297089|NCT01182350|520292442|FG003|Overall Study|Unevaluable for Biopsy|0|||
144736487|NCT00838539|521888940|FG008|Overall Study|Withdrawal by Subject|0|||
144736488|NCT00838539|521888941|FG009|Overall Study|Withdrawal by Subject|1|||
144736489|NCT00838539|521888942|FG010|Overall Study|Withdrawal by Subject|2|||
144736490|NCT00838539|521888943|FG011|Overall Study|Withdrawal by Subject|0|||
144736491|NCT00838539|521888932|FG000|Overall Study|Death|0|||
144736492|NCT00838539|521888933|FG001|Overall Study|Death|0|||
144736493|NCT00838539|521888934|FG002|Overall Study|Death|0|||
144736494|NCT00838539|521888935|FG003|Overall Study|Death|0|||
144736495|NCT00838539|521888936|FG004|Overall Study|Death|0|||
144736496|NCT00838539|521888937|FG005|Overall Study|Death|0|||
144736497|NCT00838539|521888938|FG006|Overall Study|Death|1|||
144736498|NCT00838539|521888939|FG007|Overall Study|Death|0|||
144736499|NCT00838539|521888940|FG008|Overall Study|Death|0|||
144736500|NCT00838539|521888941|FG009|Overall Study|Death|0|||
144736501|NCT00838539|521888942|FG010|Overall Study|Death|0|||
144736502|NCT00838539|521888943|FG011|Overall Study|Death|0|||
144736503|NCT00838539|521888932|FG000|Overall Study|Physician Decision|0|||
144736504|NCT00838539|521888933|FG001|Overall Study|Physician Decision|0|||
144736505|NCT00838539|521888934|FG002|Overall Study|Physician Decision|0|||
144736506|NCT00838539|521888935|FG003|Overall Study|Physician Decision|0|||
144736507|NCT00838539|521888936|FG004|Overall Study|Physician Decision|0|||
144736508|NCT00838539|521888937|FG005|Overall Study|Physician Decision|0|||
144736509|NCT00838539|521888938|FG006|Overall Study|Physician Decision|0|||
144736510|NCT00838539|521888939|FG007|Overall Study|Physician Decision|0|||
144736511|NCT00838539|521888940|FG008|Overall Study|Physician Decision|1|||
144736512|NCT00838539|521888941|FG009|Overall Study|Physician Decision|0|||
144736513|NCT00838539|521888942|FG010|Overall Study|Physician Decision|0|||
144736514|NCT00838539|521888943|FG011|Overall Study|Physician Decision|0|||
144736515|NCT00838539|521888932|FG000|Overall Study|Clinical Progression|0|||
144736516|NCT00838539|521888933|FG001|Overall Study|Clinical Progression|0|||
144736517|NCT00838539|521888934|FG002|Overall Study|Clinical Progression|0|||
144736518|NCT00838539|521888935|FG003|Overall Study|Clinical Progression|0|||
144736519|NCT00838539|521888936|FG004|Overall Study|Clinical Progression|0|||
144736520|NCT00838539|521888937|FG005|Overall Study|Clinical Progression|0|||
144736521|NCT00838539|521888938|FG006|Overall Study|Clinical Progression|1|||
144736522|NCT00838539|521888939|FG007|Overall Study|Clinical Progression|0|||
144736523|NCT00838539|521888940|FG008|Overall Study|Clinical Progression|0|||
144736524|NCT00838539|521888941|FG009|Overall Study|Clinical Progression|0|||
144736525|NCT00838539|521888942|FG010|Overall Study|Clinical Progression|0|||
144736526|NCT00838539|521888943|FG011|Overall Study|Clinical Progression|0|||
144736527|NCT00838539|521888932|FG000|Overall Study|Symptomatic Deterioration|0|||
144736528|NCT00838539|521888933|FG001|Overall Study|Symptomatic Deterioration|0|||
144736529|NCT00838539|521888934|FG002|Overall Study|Symptomatic Deterioration|1|||
144736530|NCT00838539|521888935|FG003|Overall Study|Symptomatic Deterioration|1|||
144736531|NCT00838539|521888936|FG004|Overall Study|Symptomatic Deterioration|0|||
144736532|NCT00838539|521888937|FG005|Overall Study|Symptomatic Deterioration|1|||
144736533|NCT00838539|521888938|FG006|Overall Study|Symptomatic Deterioration|0|||
144736534|NCT00838539|521888939|FG007|Overall Study|Symptomatic Deterioration|0|||
144736535|NCT00838539|521888940|FG008|Overall Study|Symptomatic Deterioration|0|||
144736536|NCT00838539|521888941|FG009|Overall Study|Symptomatic Deterioration|1|||
144736537|NCT00838539|521888942|FG010|Overall Study|Symptomatic Deterioration|0|||
144736538|NCT00838539|521888943|FG011|Overall Study|Symptomatic Deterioration|0|||
144736539|NCT01908205|521888944|FG000|Overall Study|Lost to Follow-up|2|||
144736540|NCT01908205|521888945|FG001|Overall Study|Lost to Follow-up|0|||
144736541|NCT01908205|521888944|FG000|Overall Study|Withdrawal by Subject|3|||
144736542|NCT01908205|521888945|FG001|Overall Study|Withdrawal by Subject|1|||
144736543|NCT05323396|521888946|FG000|Overall Study|Lost to Follow-up|1|||
144736544|NCT05323396|521888947|FG001|Overall Study|Lost to Follow-up|35|||
144736545|NCT05323396|521888946|FG000|Overall Study|Pregnancy|1|||
144736546|NCT05323396|521888947|FG001|Overall Study|Pregnancy|0|||
144736547|NCT04659603|521888952|FG000|Overall Study|Study terminated by sponsor|0|||
144736548|NCT04659603|521888953|FG001|Overall Study|Study terminated by sponsor|0|||
144736549|NCT04659603|521888954|FG002|Overall Study|Study terminated by sponsor|2|||
144736550|NCT04659603|521888952|FG000|Overall Study|Withdrawal by Subject|0|||
144675179|NCT02910219|521660305|FG001|Overall Study|Withdrawal by Subject|1|||
144675180|NCT02096042|521660306|FG000|Overall Study|Disease Progression|1|||
144675181|NCT02096042|521660307|FG001|Overall Study|Disease Progression|0|||
144675182|NCT02096042|521660308|FG002|Overall Study|Disease Progression|0|||
144675183|NCT00701441|521660311|FG000|Overall Study|failure in cpap compliance|0|||
144675184|NCT00701441|521660312|FG001|Overall Study|failure in cpap compliance|4|||
144675185|NCT04209400|521660314|FG000|Overall Study|Withdrawal by Subject|0|||
144675186|NCT04209400|521660315|FG001|Overall Study|Withdrawal by Subject|1|||
144675187|NCT00795509|521660320|FG000|Overall Study|Protocol Violation|31|||
144675188|NCT01203787|521660321|FG000|Overall Study|Death|12|||
144675189|NCT01203787|521660322|FG001|Overall Study|Death|10|||
144675190|NCT01203787|521660321|FG000|Overall Study|Withdrawal by Subject|6|||
144675191|NCT01203787|521660322|FG001|Overall Study|Withdrawal by Subject|2|||
144736551|NCT04659603|521888953|FG001|Overall Study|Withdrawal by Subject|5|||
144218098|NCT02762929|519992230|FG002|Overall Study|exclusionary medication disclosed late|0|||
144218099|NCT02762929|519992231|FG003|Overall Study|exclusionary medication disclosed late|1|||
144675192|NCT01203787|521660321|FG000|Overall Study|Lost to Follow-up|2|||
144675193|NCT01203787|521660322|FG001|Overall Study|Lost to Follow-up|0|||
144675194|NCT01203787|521660321|FG000|Overall Study|Adverse Event|11|||
144675195|NCT01203787|521660322|FG001|Overall Study|Adverse Event|15|||
144736552|NCT04659603|521888954|FG002|Overall Study|Withdrawal by Subject|0|||
144736553|NCT04659603|521888952|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
144675196|NCT01079195|521660323|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
144736554|NCT04659603|521888953|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
144736555|NCT04659603|521888954|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
144736556|NCT00095212|521888955|FG000|Overall Study|Withdrawal by Subject|1|||
144218100|NCT02762929|519992232|FG004|Overall Study|exclusionary medication disclosed late|0|||
144675197|NCT01079195|521660323|FG000|Overall Study|No Documentation Available|437|||
144675198|NCT01079195|521660323|FG000|Overall Study|Adverse Event|157|||
144675199|NCT01079195|521660323|FG000|Overall Study|Reason Unknown|39|||
144675200|NCT01079195|521660323|FG000|Overall Study|Withdrawal by Subject|18|||
144675201|NCT01079195|521660323|FG000|Overall Study|Financial Reasons|15|||
144675202|NCT01079195|521660323|FG000|Overall Study|Lack of Effectiveness|12|||
144675203|NCT01079195|521660323|FG000|Overall Study|Physician Decision|4|||
144675204|NCT01079195|521660323|FG000|Overall Study|Improved Status of Participant|4|||
144675205|NCT01079195|521660323|FG000|Overall Study|No Follow-up Documentation Available|4|||
144675206|NCT01079195|521660323|FG000|Overall Study|Non-compliance|2|||
144675207|NCT03693404|521660326|FG000|Overall Study|Withdrawal by Subject|1|||
144675208|NCT03693404|521660327|FG001|Overall Study|Withdrawal by Subject|0|||
144675209|NCT03693404|521660326|FG000|Overall Study|Lost to Follow-up|0|||
144736557|NCT00095212|521888956|FG001|Overall Study|Withdrawal by Subject|3|||
144736558|NCT03681470|521888957|FG000|Overall Study|Lack of Efficacy|3|||
144736559|NCT03681470|521888957|FG000|Overall Study|Lost to Follow-up|1|||
144736560|NCT03681470|521888957|FG000|Overall Study|Protocol Violation|3|||
144736561|NCT03681470|521888957|FG000|Overall Study|Withdrawal by Subject|1|||
144736562|NCT01136174|521888958|FG000|Overall Study|Adverse Event|0|||
144736563|NCT01136174|521888959|FG001|Overall Study|Adverse Event|0|||
144736564|NCT01136174|521888960|FG002|Overall Study|Adverse Event|0|||
144736565|NCT01136174|521888961|FG003|Overall Study|Adverse Event|4|||
144736566|NCT00811655|521888962|FG000|Overall Study|Physician Decision|1|||
144736567|NCT02820350|521888963|FG000|Overall Study|Withdrawal by Subject|3|||
144736568|NCT02820350|521888963|FG000|Overall Study|Death|4|||
144736569|NCT01754597|521888964|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
144736570|NCT01754597|521888965|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
144736571|NCT00819741|521888968|FG000|Overall Study|Adverse Event|5|||
144736572|NCT00819741|521888969|FG001|Overall Study|Adverse Event|2|||
144736573|NCT00819741|521888968|FG000|Overall Study|Lack of Efficacy|0|||
144736574|NCT00819741|521888969|FG001|Overall Study|Lack of Efficacy|2|||
144736575|NCT00819741|521888968|FG000|Overall Study|Lost to Follow-up|3|||
144736576|NCT00819741|521888969|FG001|Overall Study|Lost to Follow-up|1|||
144736577|NCT00819741|521888968|FG000|Overall Study|Protocol Violation|3|||
144736578|NCT00819741|521888969|FG001|Overall Study|Protocol Violation|4|||
144736579|NCT00819741|521888968|FG000|Overall Study|Withdrawal by Subject|2|||
144736580|NCT00819741|521888969|FG001|Overall Study|Withdrawal by Subject|2|||
144736581|NCT00819741|521888968|FG000|Overall Study|Unclassified|6|||
144736582|NCT00819741|521888969|FG001|Overall Study|Unclassified|0|||
144736583|NCT00819741|521888968|FG000|Overall Study|Reasons unknown|3|||
144736584|NCT00819741|521888969|FG001|Overall Study|Reasons unknown|3|||
144736585|NCT00119015|521888970|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
144736586|NCT00119015|521888971|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
144736587|NCT00119015|521888972|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
144736588|NCT02222818|521890363|FG000|Period 1|Eligibility criteria not met|0|||
144736589|NCT02222818|521890364|FG001|Period 1|Eligibility criteria not met|3|||
144736590|NCT00934050|521890365|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
144736591|NCT00934050|521890366|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
144736592|NCT00934050|521890367|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
144736593|NCT00934050|521890368|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
144736594|NCT00934050|521890369|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
144736595|NCT00934050|521890370|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
144736596|NCT00934050|521890365|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
144736597|NCT00934050|521890366|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
144736598|NCT00934050|521890367|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
144736599|NCT00934050|521890368|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
144736600|NCT00934050|521890369|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
144736601|NCT00934050|521890370|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
144736602|NCT00934050|521890365|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
144736603|NCT00934050|521890366|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
144265648|NCT02513550|520173980|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
144265649|NCT02513550|520173975|FG000|Double Blind Treatment Period|Due to personal business|2|||
144675210|NCT03693404|521660327|FG001|Overall Study|Lost to Follow-up|5|||
144675211|NCT03693404|521660326|FG000|Overall Study|Excluded from Analysis|0|||
144675212|NCT03693404|521660327|FG001|Overall Study|Excluded from Analysis|1|||
144675213|NCT05200455|521660328|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
144265650|NCT02513550|520173976|FG001|Double Blind Treatment Period|Due to personal business|0|||
144675214|NCT01602549|521660331|FG000|Overall Study|Protocol Violation|0|||
144675215|NCT01602549|521660332|FG001|Overall Study|Protocol Violation|1|||
144675216|NCT01602549|521660331|FG000|Overall Study|Withdrawal by Subject|1|||
144736604|NCT00934050|521890367|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
144736605|NCT00934050|521890368|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
144736606|NCT00934050|521890369|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
144736607|NCT00934050|521890370|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
144736608|NCT00934050|521890365|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
144736609|NCT00934050|521890366|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
144736610|NCT00934050|521890367|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
144736611|NCT00934050|521890368|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
144736612|NCT00934050|521890369|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
144736613|NCT00934050|521890370|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
144736614|NCT00934050|521890365|FG000|Enrolled After 15 Dec 2009|Death|0|||
144736615|NCT00934050|521890366|FG001|Enrolled After 15 Dec 2009|Death|0|||
144736616|NCT00934050|521890367|FG002|Enrolled After 15 Dec 2009|Death|0|||
144736617|NCT00934050|521890368|FG003|Enrolled After 15 Dec 2009|Death|0|||
144736618|NCT00934050|521890369|FG004|Enrolled After 15 Dec 2009|Death|0|||
144736619|NCT00934050|521890370|FG005|Enrolled After 15 Dec 2009|Death|1|||
144736620|NCT00934050|521890365|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
144736621|NCT00934050|521890366|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
144736622|NCT00934050|521890367|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
144736623|NCT00934050|521890368|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
144736624|NCT00934050|521890369|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
144736625|NCT00934050|521890370|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
144736626|NCT00934050|521890365|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
144736627|NCT00934050|521890366|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
144736628|NCT00934050|521890367|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
144736629|NCT00934050|521890368|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
144736630|NCT00934050|521890369|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
144736631|NCT00934050|521890370|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
144736632|NCT02149420|521890373|FG000|Core Study|Administrative problems|0|||
144736633|NCT02149420|521890374|FG001|Core Study|Administrative problems|1|||
144736634|NCT02149420|521890375|FG002|Core Study|Administrative problems|2|||
144736635|NCT02149420|521890373|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
144736636|NCT02149420|521890374|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
144736637|NCT02149420|521890375|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
144736638|NCT01111461|521890376|FG000|Overall Study|Adverse Event|32|||
144736639|NCT01111461|521890376|FG000|Overall Study|Participant choice|11|||
144736640|NCT01111461|521890376|FG000|Overall Study|Lost to Follow-up|1|||
144736641|NCT01111461|521890376|FG000|Overall Study|Withdrawal by Subject|1|||
144736642|NCT01111461|521890376|FG000|Overall Study|Other|6|||
144736643|NCT00834067|521890379|FG000|Washout of 21 Days|Protocol Violation|0|||
144736644|NCT00834067|521890380|FG001|Washout of 21 Days|Protocol Violation|1|||
144736645|NCT00440518|521890382|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
144736646|NCT00440518|521890383|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
144736647|NCT00440518|521890384|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
144736648|NCT00440518|521890382|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
144736649|NCT00440518|521890383|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
144736650|NCT00440518|521890384|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
144736651|NCT00440518|521890382|FG000|Randomized /Titration Period|Protocol Deviation|1|||
144736652|NCT00440518|521890383|FG001|Randomized /Titration Period|Protocol Deviation|0|||
144736653|NCT00440518|521890384|FG002|Randomized /Titration Period|Protocol Deviation|0|||
144736654|NCT00440518|521890382|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
144265651|NCT02513550|520173977|FG002|Double Blind Treatment Period|Due to personal business|1|||
144265652|NCT02513550|520173978|FG003|Double Blind Treatment Period|Due to personal business|0|||
144265653|NCT02513550|520173979|FG004|Double Blind Treatment Period|Due to personal business|0|||
144265654|NCT02513550|520173980|FG005|Double Blind Treatment Period|Due to personal business|0|||
144265655|NCT02513550|520173975|FG000|Double Blind Treatment Period|Death|1|||
144265656|NCT02513550|520173976|FG001|Double Blind Treatment Period|Death|0|||
144265657|NCT02513550|520173977|FG002|Double Blind Treatment Period|Death|2|||
144265658|NCT02513550|520173978|FG003|Double Blind Treatment Period|Death|0|||
144265659|NCT02513550|520173979|FG004|Double Blind Treatment Period|Death|0|||
144265660|NCT02513550|520173980|FG005|Double Blind Treatment Period|Death|0|||
144265661|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
144265662|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
144265663|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
144265664|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144265665|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144265666|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
144265667|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
144736655|NCT00440518|521890383|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
144736656|NCT00440518|521890384|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
144736657|NCT00440518|521890382|FG000|Randomized /Titration Period|Other|1|||
144736658|NCT00440518|521890383|FG001|Randomized /Titration Period|Other|0|||
144736659|NCT00440518|521890384|FG002|Randomized /Titration Period|Other|0|||
144736660|NCT00440518|521890382|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
144736661|NCT00440518|521890383|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
144736662|NCT00440518|521890384|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
144675217|NCT01602549|521660332|FG001|Overall Study|Withdrawal by Subject|0|||
144675218|NCT00807014|521660333|FG000|Overall Study|Participant Considered Disease Cured|13|||
144675219|NCT00807014|521660334|FG001|Overall Study|Participant Considered Disease Cured|2|||
144675220|NCT00807014|521660333|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
144675221|NCT00807014|521660334|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
144675222|NCT00807014|521660333|FG000|Overall Study|Protocol Violation|2|||
144675223|NCT00807014|521660334|FG001|Overall Study|Protocol Violation|8|||
144675224|NCT00807014|521660333|FG000|Overall Study|Adverse Event|0|||
144675225|NCT00807014|521660334|FG001|Overall Study|Adverse Event|2|||
144675226|NCT00807014|521660333|FG000|Overall Study|Lost to Follow-up|9|||
144675227|NCT00807014|521660334|FG001|Overall Study|Lost to Follow-up|7|||
144675228|NCT00807014|521660333|FG000|Overall Study|Recovery|1|||
144675229|NCT00807014|521660334|FG001|Overall Study|Recovery|0|||
144675230|NCT00807014|521660333|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
144675231|NCT00807014|521660334|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
144675232|NCT00651313|521660335|FG000|Overall Study|Adverse Event|0|||
144675233|NCT00651313|521660336|FG001|Overall Study|Adverse Event|1|||
144675234|NCT00651313|521660335|FG000|Overall Study|Withdrawal by Subject|3|||
144675235|NCT00651313|521660336|FG001|Overall Study|Withdrawal by Subject|1|||
144675236|NCT00651313|521660335|FG000|Overall Study|Lost to Follow-up|1|||
144675237|NCT00651313|521660336|FG001|Overall Study|Lost to Follow-up|1|||
144675238|NCT00651313|521660335|FG000|Overall Study|Adminstrative Discontinuation|2|||
144675239|NCT00651313|521660336|FG001|Overall Study|Adminstrative Discontinuation|3|||
144675240|NCT00892957|521660338|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
144675241|NCT00892957|521660339|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
144675242|NCT00892957|521660338|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
144675243|NCT00892957|521660339|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
144675244|NCT00676208|521660351|FG000|Overall Study|Lost to Follow-up|0|||
144675245|NCT00676208|521660352|FG001|Overall Study|Lost to Follow-up|2|||
144675246|NCT00676208|521660351|FG000|Overall Study|Incomplete data|2|||
144675247|NCT00676208|521660352|FG001|Overall Study|Incomplete data|4|||
144675248|NCT01946412|521660353|FG000|Overall Study|Adverse Event|1|||
144675249|NCT01946412|521660353|FG000|Overall Study|Non-Compliance|1|||
144675250|NCT01946412|521660353|FG000|Overall Study|Continued with commercial Kalydeco|2|||
144675251|NCT01946412|521660353|FG000|Overall Study|Difficulty in swallowing|1|||
144675252|NCT00323310|521662805|FG000|Overall Study|Withdrawal by Subject|1|||
144675253|NCT00323310|521662805|FG000|Overall Study|a parent refused blood draw|1|||
144675254|NCT00323310|521662805|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
144675255|NCT00446641|521662806|FG000|Overall Study|Withdrawal by Subject|8|||
144675256|NCT00446641|521662807|FG001|Overall Study|Withdrawal by Subject|3|||
144675257|NCT00446641|521662806|FG000|Overall Study|poor compliance|8|||
144675258|NCT00446641|521662807|FG001|Overall Study|poor compliance|6|||
144675259|NCT00446641|521662806|FG000|Overall Study|Lost to Follow-up|1|||
144675260|NCT00446641|521662807|FG001|Overall Study|Lost to Follow-up|1|||
144675261|NCT03565991|521662809|FG000|Overall Study|Other|11|||
144675262|NCT03565991|521662810|FG001|Overall Study|Other|0|||
144675263|NCT03565991|521662809|FG000|Overall Study|Global deterioration of health status|14|||
144675264|NCT03565991|521662810|FG001|Overall Study|Global deterioration of health status|4|||
144675265|NCT03565991|521662809|FG000|Overall Study|Withdrawal by Subject|2|||
144675266|NCT03565991|521662810|FG001|Overall Study|Withdrawal by Subject|6|||
144675267|NCT03565991|521662809|FG000|Overall Study|Progressive disease|121|||
144675268|NCT03565991|521662810|FG001|Overall Study|Progressive disease|29|||
144675269|NCT03565991|521662809|FG000|Overall Study|Death|3|||
144675270|NCT03565991|521662810|FG001|Overall Study|Death|0|||
144675271|NCT03565991|521662809|FG000|Overall Study|Adverse Event|7|||
144675272|NCT03565991|521662810|FG001|Overall Study|Adverse Event|2|||
144675273|NCT00086385|521662813|FG000|Overall Study|Death|2|||
144675274|NCT00086385|521662814|FG001|Overall Study|Death|2|||
144675275|NCT00086385|521662815|FG002|Overall Study|Death|1|||
144675276|NCT00086385|521662816|FG003|Overall Study|Death|1|||
144675277|NCT03424044|521662821|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675278|NCT03424044|521662822|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675279|NCT03424044|521662823|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
144675280|NCT03424044|521662824|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675281|NCT03424044|521662825|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675282|NCT03424044|521662826|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675283|NCT03424044|521662827|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675284|NCT03424044|521662828|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675285|NCT03424044|521662829|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
144675286|NCT03424044|521662821|FG000|First Intervention (76 Hours)|Adverse Event|0|||
144736663|NCT00440518|521890382|FG000|Randomized /Titration Period|Adverse Event|2|||
144675287|NCT03424044|521662822|FG001|First Intervention (76 Hours)|Adverse Event|0|||
144675288|NCT03424044|521662823|FG002|First Intervention (76 Hours)|Adverse Event|0|||
144675289|NCT03424044|521662824|FG003|First Intervention (76 Hours)|Adverse Event|0|||
144736664|NCT00440518|521890383|FG001|Randomized /Titration Period|Adverse Event|3|||
144675290|NCT03424044|521662825|FG004|First Intervention (76 Hours)|Adverse Event|1|||
144675291|NCT03424044|521662826|FG005|First Intervention (76 Hours)|Adverse Event|0|||
144675292|NCT03424044|521662827|FG006|First Intervention (76 Hours)|Adverse Event|0|||
144675293|NCT03424044|521662828|FG007|First Intervention (76 Hours)|Adverse Event|0|||
144675294|NCT03424044|521662829|FG008|First Intervention (76 Hours)|Adverse Event|0|||
144675295|NCT03424044|521662821|FG000|First Intervention (76 Hours)|device issues|0|||
144675296|NCT03424044|521662822|FG001|First Intervention (76 Hours)|device issues|0|||
144675297|NCT03424044|521662823|FG002|First Intervention (76 Hours)|device issues|0|||
144675298|NCT03424044|521662824|FG003|First Intervention (76 Hours)|device issues|0|||
144675299|NCT03424044|521662825|FG004|First Intervention (76 Hours)|device issues|0|||
144675300|NCT03424044|521662826|FG005|First Intervention (76 Hours)|device issues|0|||
144675301|NCT03424044|521662827|FG006|First Intervention (76 Hours)|device issues|1|||
144675302|NCT03424044|521662828|FG007|First Intervention (76 Hours)|device issues|1|||
144675303|NCT03424044|521662829|FG008|First Intervention (76 Hours)|device issues|1|||
144675304|NCT03424044|521662821|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
144675305|NCT03424044|521662822|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
144675306|NCT03424044|521662823|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
144675307|NCT03424044|521662824|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
144675308|NCT03424044|521662825|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
144675309|NCT03424044|521662826|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
144675310|NCT03424044|521662827|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
144675311|NCT03424044|521662828|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
144675312|NCT03424044|521662829|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
144675313|NCT03424044|521662821|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675314|NCT03424044|521662822|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675315|NCT03424044|521662823|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675316|NCT03424044|521662824|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
144675317|NCT03424044|521662825|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675318|NCT03424044|521662826|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675319|NCT03424044|521662827|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675320|NCT03424044|521662828|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675321|NCT03424044|521662829|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
144675322|NCT00402285|521662830|FG000|Overall Study|insufficient RNA quality|7|||
144675323|NCT00402285|521662831|FG001|Overall Study|insufficient RNA quality|6|||
144675324|NCT00402285|521662832|FG002|Overall Study|insufficient RNA quality|2|||
144675325|NCT02471586|521662841|FG000|Overall Study|Lost to Follow-up|3|||
144675326|NCT02471586|521662842|FG001|Overall Study|Lost to Follow-up|8|||
144675327|NCT02471586|521662843|FG002|Overall Study|Lost to Follow-up|4|||
144675328|NCT02471586|521662841|FG000|Overall Study|Death|2|||
144675329|NCT02471586|521662842|FG001|Overall Study|Death|2|||
144675330|NCT02471586|521662843|FG002|Overall Study|Death|0|||
144675331|NCT04839393|521662854|FG000|Overall Study|Adverse Event|0|||
144675332|NCT04839393|521662855|FG001|Overall Study|Adverse Event|0|||
144675333|NCT04839393|521662856|FG002|Overall Study|Adverse Event|2|||
144675334|NCT04839393|521662854|FG000|Overall Study|Withdrawal by participant|0|||
144675335|NCT04839393|521662855|FG001|Overall Study|Withdrawal by participant|0|||
144675336|NCT04839393|521662856|FG002|Overall Study|Withdrawal by participant|1|||
144675337|NCT00254163|521662863|FG000|Overall Study|Adverse Event|29|||
144675338|NCT00254163|521662864|FG001|Overall Study|Adverse Event|26|||
144675339|NCT00254163|521662863|FG000|Overall Study|Patient request/withdrew consent|6|||
144675340|NCT00254163|521662864|FG001|Overall Study|Patient request/withdrew consent|4|||
144675341|NCT00254163|521662863|FG000|Overall Study|Investigator request|1|||
144675342|NCT00254163|521662864|FG001|Overall Study|Investigator request|3|||
144675343|NCT00254163|521662863|FG000|Overall Study|Failed entry|1|||
144675344|NCT00254163|521662864|FG001|Overall Study|Failed entry|3|||
144675345|NCT00254163|521662863|FG000|Overall Study|Progressive disease|0|||
144675346|NCT00254163|521662864|FG001|Overall Study|Progressive disease|1|||
144675347|NCT00254163|521662863|FG000|Overall Study|Death|0|||
144675348|NCT00254163|521662864|FG001|Overall Study|Death|1|||
144675349|NCT00254163|521662863|FG000|Overall Study|Other|8|||
144675350|NCT00254163|521662864|FG001|Overall Study|Other|8|||
144675351|NCT00633893|521662865|FG000|Overall Study|Death|1|||
144675352|NCT00633893|521662866|FG001|Overall Study|Death|3|||
144675353|NCT00633893|521662867|FG002|Overall Study|Death|9|||
144675354|NCT00633893|521662865|FG000|Overall Study|Adverse Event|65|||
144675355|NCT00633893|521662866|FG001|Overall Study|Adverse Event|58|||
144265668|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
144675356|NCT00633893|521662867|FG002|Overall Study|Adverse Event|126|||
144675357|NCT00633893|521662865|FG000|Overall Study|Withdrawal by Subject|7|||
144675358|NCT00633893|521662866|FG001|Overall Study|Withdrawal by Subject|12|||
144675359|NCT00633893|521662867|FG002|Overall Study|Withdrawal by Subject|6|||
144675360|NCT00633893|521662865|FG000|Overall Study|Lost to Follow-up|2|||
144675361|NCT00633893|521662866|FG001|Overall Study|Lost to Follow-up|4|||
144675362|NCT00633893|521662867|FG002|Overall Study|Lost to Follow-up|8|||
144675363|NCT00633893|521662865|FG000|Overall Study|Poor/non-compliance|5|||
144675364|NCT00633893|521662866|FG001|Overall Study|Poor/non-compliance|12|||
144675365|NCT00633893|521662867|FG002|Overall Study|Poor/non-compliance|3|||
144675366|NCT00633893|521662865|FG000|Overall Study|Pregnancy|2|||
144675367|NCT00633893|521662866|FG001|Overall Study|Pregnancy|1|||
144675368|NCT00633893|521662867|FG002|Overall Study|Pregnancy|1|||
144675369|NCT00633893|521662865|FG000|Overall Study|Not meet/no longer meets criteria|4|||
144675370|NCT00633893|521662866|FG001|Overall Study|Not meet/no longer meets criteria|6|||
144675371|NCT00633893|521662867|FG002|Overall Study|Not meet/no longer meets criteria|4|||
144675372|NCT00633893|521662865|FG000|Overall Study|Other|28|||
144675373|NCT00633893|521662866|FG001|Overall Study|Other|33|||
144675374|NCT00633893|521662867|FG002|Overall Study|Other|31|||
144675375|NCT00239356|521662868|FG000|Overall Study|Lack of Efficacy|1|||
144675376|NCT00239356|521662869|FG001|Overall Study|Lack of Efficacy|0|||
144675377|NCT00239356|521662868|FG000|Overall Study|Adverse Event|6|||
144675378|NCT00239356|521662869|FG001|Overall Study|Adverse Event|0|||
144675379|NCT00239356|521662868|FG000|Overall Study|Withdrawal by Subject|15|||
144675380|NCT00239356|521662869|FG001|Overall Study|Withdrawal by Subject|6|||
144675381|NCT00239356|521662868|FG000|Overall Study|Lost to Follow-up|3|||
144675382|NCT00239356|521662869|FG001|Overall Study|Lost to Follow-up|0|||
144675383|NCT00239356|521662868|FG000|Overall Study|poor/non-compliance|2|||
144675384|NCT00239356|521662869|FG001|Overall Study|poor/non-compliance|0|||
144675385|NCT00239356|521662868|FG000|Overall Study|Pregnancy|1|||
144675386|NCT00239356|521662869|FG001|Overall Study|Pregnancy|0|||
144675387|NCT00239356|521662868|FG000|Overall Study|Administrative reason|0|||
144675388|NCT00239356|521662869|FG001|Overall Study|Administrative reason|1|||
144675389|NCT00239356|521662868|FG000|Overall Study|Drug available on market|11|||
144675390|NCT00239356|521662869|FG001|Overall Study|Drug available on market|2|||
144675391|NCT00369278|521662870|FG000|Overall Study|Adverse Event|14|||
144675392|NCT00369278|521662871|FG001|Overall Study|Adverse Event|11|||
144675393|NCT00369278|521662870|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144675394|NCT00369278|521662871|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
144675395|NCT00369278|521662870|FG000|Overall Study|Protocol Violation|2|||
144675396|NCT00369278|521662871|FG001|Overall Study|Protocol Violation|1|||
144675397|NCT00369278|521662870|FG000|Overall Study|Withdrawal by Subject|2|||
144675398|NCT00369278|521662871|FG001|Overall Study|Withdrawal by Subject|2|||
144675399|NCT00369278|521662870|FG000|Overall Study|Lost to Follow-up|1|||
144675400|NCT00369278|521662871|FG001|Overall Study|Lost to Follow-up|0|||
144675401|NCT00369278|521662870|FG000|Overall Study|Graft loss|1|||
144675402|NCT00369278|521662871|FG001|Overall Study|Graft loss|2|||
144675403|NCT02044822|521662872|FG000|Overall Study|Study Terminated by Sponsor|77|||
144675404|NCT02044822|521662872|FG000|Overall Study|Investigator's Discretion|10|||
144675405|NCT02044822|521662872|FG000|Overall Study|Withdrew Consent|3|||
144675406|NCT02044822|521662872|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
144675407|NCT02044822|521662872|FG000|Overall Study|Lost to Follow-up|1|||
144675408|NCT03417505|521662875|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
144675409|NCT03417505|521662876|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
144675410|NCT02025530|521662877|FG000|Overall Study|No longer met elligibility criteria|5|||
144675411|NCT02025530|521662878|FG001|Overall Study|No longer met elligibility criteria|1|||
144675412|NCT01444898|521662890|FG000|Overall Study|Withdrawal by Subject|1|||
144675413|NCT03235726|521662891|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675414|NCT03235726|521662892|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675415|NCT03235726|521662893|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675416|NCT03235726|521662894|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675417|NCT03235726|521662895|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
144675418|NCT03235726|521662896|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675419|NCT03235726|521662897|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675420|NCT03235726|521662898|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675421|NCT03235726|521662899|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675422|NCT03235726|521662900|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
144675423|NCT03235726|521662891|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675424|NCT03235726|521662892|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675425|NCT03235726|521662893|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675426|NCT03235726|521662894|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675427|NCT03235726|521662895|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
144675428|NCT03235726|521662896|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675429|NCT03235726|521662897|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675430|NCT03235726|521662898|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675431|NCT03235726|521662899|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675432|NCT03235726|521662900|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
144675433|NCT00443846|521662901|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
144675434|NCT00443846|521662902|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
144675435|NCT00443846|521662901|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
144736665|NCT00440518|521890384|FG002|Randomized /Titration Period|Adverse Event|0|||
144736666|NCT00440518|521890382|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
144736667|NCT00440518|521890383|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
144736668|NCT00440518|521890384|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
144736669|NCT00440518|521890382|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
144736670|NCT00440518|521890383|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
144736671|NCT00440518|521890384|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
144736672|NCT00440518|521890382|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
144736673|NCT00440518|521890383|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
144736674|NCT00440518|521890384|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
144736675|NCT00440518|521890382|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
144736676|NCT00440518|521890383|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
144736677|NCT00440518|521890384|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
144736678|NCT00440518|521890382|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
144736679|NCT00440518|521890383|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
144736680|NCT00440518|521890384|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
144736681|NCT00440518|521890382|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
144736682|NCT00440518|521890383|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
144736683|NCT00440518|521890384|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
144736684|NCT03570749|521890385|FG000|Overall Study|Ongoing|26|||
144736685|NCT03570749|521890386|FG001|Overall Study|Ongoing|25|||
144736686|NCT03570749|521890387|FG002|Overall Study|Ongoing|25|||
144736687|NCT03570749|521890388|FG003|Overall Study|Ongoing|26|||
144736688|NCT03570749|521890389|FG004|Overall Study|Ongoing|140|||
144736689|NCT03570749|521890390|FG005|Overall Study|Ongoing|142|||
144736690|NCT03570749|521890391|FG006|Overall Study|Ongoing|220|||
144736691|NCT03570749|521890385|FG000|Overall Study|Adverse Event|0|||
144736692|NCT03570749|521890386|FG001|Overall Study|Adverse Event|0|||
144736693|NCT03570749|521890387|FG002|Overall Study|Adverse Event|0|||
144736694|NCT03570749|521890388|FG003|Overall Study|Adverse Event|0|||
144736695|NCT03570749|521890389|FG004|Overall Study|Adverse Event|2|||
144736696|NCT03570749|521890390|FG005|Overall Study|Adverse Event|3|||
144736697|NCT03570749|521890391|FG006|Overall Study|Adverse Event|6|||
144736698|NCT03570749|521890385|FG000|Overall Study|Lack of Efficacy|0|||
144736699|NCT03570749|521890386|FG001|Overall Study|Lack of Efficacy|0|||
144736700|NCT03570749|521890387|FG002|Overall Study|Lack of Efficacy|0|||
144736701|NCT03570749|521890388|FG003|Overall Study|Lack of Efficacy|0|||
144736702|NCT03570749|521890389|FG004|Overall Study|Lack of Efficacy|8|||
144736703|NCT03570749|521890390|FG005|Overall Study|Lack of Efficacy|2|||
144736704|NCT03570749|521890391|FG006|Overall Study|Lack of Efficacy|7|||
144736705|NCT03570749|521890385|FG000|Overall Study|Lost to Follow-up|0|||
144736706|NCT03570749|521890386|FG001|Overall Study|Lost to Follow-up|0|||
144736707|NCT03570749|521890387|FG002|Overall Study|Lost to Follow-up|0|||
144736708|NCT03570749|521890388|FG003|Overall Study|Lost to Follow-up|0|||
144736709|NCT03570749|521890389|FG004|Overall Study|Lost to Follow-up|5|||
144736710|NCT03570749|521890390|FG005|Overall Study|Lost to Follow-up|10|||
144736711|NCT03570749|521890391|FG006|Overall Study|Lost to Follow-up|10|||
144736712|NCT03570749|521890385|FG000|Overall Study|Pregnancy|0|||
144736713|NCT03570749|521890386|FG001|Overall Study|Pregnancy|0|||
144736714|NCT03570749|521890387|FG002|Overall Study|Pregnancy|0|||
144736715|NCT03570749|521890388|FG003|Overall Study|Pregnancy|0|||
144736716|NCT03570749|521890389|FG004|Overall Study|Pregnancy|0|||
144736717|NCT03570749|521890390|FG005|Overall Study|Pregnancy|1|||
144736718|NCT03570749|521890391|FG006|Overall Study|Pregnancy|1|||
144736719|NCT03570749|521890385|FG000|Overall Study|Screen Fail|0|||
144736720|NCT03570749|521890386|FG001|Overall Study|Screen Fail|0|||
144736721|NCT03570749|521890387|FG002|Overall Study|Screen Fail|0|||
144736722|NCT03570749|521890388|FG003|Overall Study|Screen Fail|0|||
144736723|NCT03570749|521890389|FG004|Overall Study|Screen Fail|0|||
144736724|NCT03570749|521890390|FG005|Overall Study|Screen Fail|0|||
144736725|NCT03570749|521890391|FG006|Overall Study|Screen Fail|1|||
144736726|NCT03570749|521890385|FG000|Overall Study|Withdrawal by Subject|2|||
144736727|NCT03570749|521890386|FG001|Overall Study|Withdrawal by Subject|3|||
144736728|NCT03570749|521890387|FG002|Overall Study|Withdrawal by Subject|2|||
144736729|NCT03570749|521890388|FG003|Overall Study|Withdrawal by Subject|1|||
144736730|NCT03570749|521890389|FG004|Overall Study|Withdrawal by Subject|17|||
144736731|NCT03570749|521890390|FG005|Overall Study|Withdrawal by Subject|12|||
144736732|NCT03570749|521890391|FG006|Overall Study|Withdrawal by Subject|15|||
144736733|NCT03570749|521890385|FG000|Overall Study|Other|0|||
144736734|NCT03570749|521890386|FG001|Overall Study|Other|0|||
144736735|NCT03570749|521890387|FG002|Overall Study|Other|0|||
144736736|NCT03570749|521890388|FG003|Overall Study|Other|0|||
144736737|NCT03570749|521890389|FG004|Overall Study|Other|17|||
144736738|NCT03570749|521890390|FG005|Overall Study|Other|14|||
144218101|NCT02762929|519992233|FG005|Overall Study|exclusionary medication disclosed late|0|||
144218102|NCT02656303|519992235|FG000|Overall Study|Adverse Event|3|||
144218103|NCT02656303|519992236|FG001|Overall Study|Adverse Event|2|||
144675436|NCT00443846|521662902|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
144675437|NCT00443846|521662901|FG000|Overall Study|Adverse Event|0|||
144675438|NCT00443846|521662902|FG001|Overall Study|Adverse Event|1|||
144675439|NCT00443846|521662901|FG000|Overall Study|Personal reason|8|||
144675440|NCT00443846|521662902|FG001|Overall Study|Personal reason|3|||
144675441|NCT00443846|521662901|FG000|Overall Study|Lost to Follow-up|1|||
144675442|NCT00443846|521662902|FG001|Overall Study|Lost to Follow-up|2|||
144675443|NCT00391807|521662909|FG000|Overall Study|Did not receive study medication|23|||
144675444|NCT00391807|521662909|FG000|Overall Study|Adverse Event|177|||
144675445|NCT00391807|521662909|FG000|Overall Study|Pregnancy|25|||
144675446|NCT00391807|521662909|FG000|Overall Study|Lost to Follow-up|227|||
144675447|NCT00391807|521662909|FG000|Overall Study|Withdrawal by Subject|147|||
144675448|NCT00391807|521662909|FG000|Overall Study|Protocol Violation|20|||
144675449|NCT00391807|521662909|FG000|Overall Study|Various|96|||
144675450|NCT04583969|521662910|FG000|Overall Study|Death|31|||
144675451|NCT04583969|521662911|FG001|Overall Study|Death|38|||
144675452|NCT04583969|521662910|FG000|Overall Study|Lost to Follow-up|16|||
144675453|NCT04583969|521662911|FG001|Overall Study|Lost to Follow-up|13|||
144675454|NCT04583969|521662910|FG000|Overall Study|Protocol Violation|1|||
144675455|NCT04583969|521662911|FG001|Overall Study|Protocol Violation|0|||
144675456|NCT04583969|521662910|FG000|Overall Study|Withdrawal by Subject|3|||
144675457|NCT04583969|521662911|FG001|Overall Study|Withdrawal by Subject|3|||
144675458|NCT04583969|521662910|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
144675459|NCT04583969|521662911|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
144675460|NCT04583969|521662910|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
144675461|NCT04583969|521662911|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
144675462|NCT04583969|521662910|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
144675463|NCT04583969|521662911|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
144675464|NCT04583969|521662910|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
144675465|NCT04583969|521662911|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
144675466|NCT04583969|521662910|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
144675467|NCT04583969|521662911|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
144675468|NCT02143141|521662914|FG000|Overall Study|pain scores at 24 hours not collected|1|||
144675469|NCT02143141|521662915|FG001|Overall Study|pain scores at 24 hours not collected|0|||
144675470|NCT03862495|521662916|FG000|Overall Study|Lost to Follow-up|37|||
144675471|NCT03862495|521662917|FG001|Overall Study|Lost to Follow-up|35|||
144675472|NCT04397796|521662918|FG000|Overall Study|Death|3|||
144675473|NCT04397796|521662919|FG001|Overall Study|Death|1|||
144675474|NCT01057862|521662920|FG000|Overall Study|Withdrawal by Subject|1|||
144675475|NCT01057862|521662921|FG001|Overall Study|Withdrawal by Subject|2|||
144675476|NCT00003838|521662924|FG000|Overall Study|Death|0|||
144675477|NCT00003838|521662925|FG001|Overall Study|Death|12|||
144675478|NCT00003838|521662926|FG002|Overall Study|Death|7|||
144675479|NCT00003838|521662924|FG000|Overall Study|Lost to Follow-up|0|||
144675480|NCT00003838|521662925|FG001|Overall Study|Lost to Follow-up|1|||
144675481|NCT00003838|521662926|FG002|Overall Study|Lost to Follow-up|1|||
144675482|NCT00003838|521662924|FG000|Overall Study|Disease Progression|0|||
144675483|NCT00003838|521662925|FG001|Overall Study|Disease Progression|12|||
144675484|NCT00003838|521662926|FG002|Overall Study|Disease Progression|0|||
144675485|NCT01819506|521662927|FG000|Overall Study|Physician Decision|5|||
144675486|NCT01819506|521662928|FG001|Overall Study|Physician Decision|2|||
144675487|NCT01819506|521662927|FG000|Overall Study|Withdrawal by Subject|3|||
144675488|NCT01819506|521662928|FG001|Overall Study|Withdrawal by Subject|3|||
144675489|NCT00770224|521662931|FG000|Step 1: Induction|Adverse Event|3|||
144675490|NCT00770224|521662932|FG001|Step 1: Induction|Adverse Event|0|||
144675491|NCT00770224|521662931|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
144675492|NCT00770224|521662932|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
144675493|NCT00770224|521662931|FG000|Step 1: Induction|Other reason not protocol specified|2|||
144675494|NCT00770224|521662932|FG001|Step 1: Induction|Other reason not protocol specified|0|||
144675495|NCT00770224|521662931|FG000|Step 1: Induction|Ineligible|2|||
144675496|NCT00770224|521662932|FG001|Step 1: Induction|Ineligible|0|||
144736739|NCT03570749|521890391|FG006|Overall Study|Other|21|||
144736740|NCT03616535|521890392|FG000|Overall Study|Death|2|||
144675497|NCT00770224|521662931|FG000|Step 1: Induction|No protocol treatment given|1|||
144675498|NCT00770224|521662932|FG001|Step 1: Induction|No protocol treatment given|0|||
144675499|NCT00770224|521662931|FG000|Step 2: Maintenance|Adverse Event|0|||
144675500|NCT00770224|521662932|FG001|Step 2: Maintenance|Adverse Event|10|||
144675501|NCT00770224|521662931|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
144675502|NCT00770224|521662932|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
144675503|NCT00770224|521662931|FG000|Step 2: Maintenance|Progression/relapse|0|||
144675504|NCT00770224|521662932|FG001|Step 2: Maintenance|Progression/relapse|1|||
144675505|NCT00770224|521662931|FG000|Step 2: Maintenance|Death|0|||
144675506|NCT00770224|521662932|FG001|Step 2: Maintenance|Death|2|||
144675507|NCT00770224|521662931|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
144675508|NCT00770224|521662932|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
144218104|NCT02656303|519992237|FG002|Overall Study|Adverse Event|0|||
144736741|NCT03616535|521890393|FG001|Overall Study|Death|0|||
144736742|NCT03616535|521890394|FG002|Overall Study|Death|0|||
144736743|NCT03616535|521890395|FG003|Overall Study|Death|1|||
144736744|NCT03616535|521890392|FG000|Overall Study|Lost to Follow-up|2|||
144736745|NCT03616535|521890393|FG001|Overall Study|Lost to Follow-up|1|||
144736746|NCT03616535|521890394|FG002|Overall Study|Lost to Follow-up|0|||
144736747|NCT03616535|521890395|FG003|Overall Study|Lost to Follow-up|2|||
144736748|NCT03616535|521890392|FG000|Overall Study|Withdrawal by Subject|1|||
144736749|NCT03616535|521890393|FG001|Overall Study|Withdrawal by Subject|2|||
144736750|NCT03616535|521890394|FG002|Overall Study|Withdrawal by Subject|5|||
144736751|NCT03616535|521890395|FG003|Overall Study|Withdrawal by Subject|1|||
144736752|NCT03616535|521890392|FG000|Overall Study|Not specified or change in eligibility|2|||
144736753|NCT03616535|521890393|FG001|Overall Study|Not specified or change in eligibility|3|||
144736754|NCT03616535|521890394|FG002|Overall Study|Not specified or change in eligibility|3|||
144736755|NCT03616535|521890395|FG003|Overall Study|Not specified or change in eligibility|1|||
144736756|NCT00804856|521890396|FG000|Overall Study|Progressive Disease|3|||
144736757|NCT00804856|521890397|FG001|Overall Study|Progressive Disease|2|||
144736758|NCT00804856|521890398|FG002|Overall Study|Progressive Disease|4|||
144736759|NCT00804856|521890399|FG003|Overall Study|Progressive Disease|6|||
144736760|NCT00804856|521890400|FG004|Overall Study|Progressive Disease|4|||
144736761|NCT00804856|521890401|FG005|Overall Study|Progressive Disease|1|||
144736762|NCT00804856|521890402|FG006|Overall Study|Progressive Disease|8|||
144736763|NCT00804856|521890403|FG007|Overall Study|Progressive Disease|2|||
144736764|NCT00804856|521890404|FG008|Overall Study|Progressive Disease|4|||
144736765|NCT00804856|521890405|FG009|Overall Study|Progressive Disease|5|||
144736766|NCT00804856|521890406|FG010|Overall Study|Progressive Disease|12|||
144736767|NCT00804856|521890407|FG011|Overall Study|Progressive Disease|2|||
144736768|NCT00804856|521890408|FG012|Overall Study|Progressive Disease|2|||
144736769|NCT00804856|521890409|FG013|Overall Study|Progressive Disease|26|||
144736770|NCT00804856|521890410|FG014|Overall Study|Progressive Disease|20|||
144736771|NCT00804856|521890396|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736772|NCT00804856|521890397|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736773|NCT00804856|521890398|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736774|NCT00804856|521890399|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736775|NCT00804856|521890400|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144736776|NCT00804856|521890401|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736777|NCT00804856|521890402|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736778|NCT00804856|521890403|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736779|NCT00804856|521890404|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736780|NCT00804856|521890405|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736781|NCT00804856|521890406|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736782|NCT00804856|521890407|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736783|NCT00804856|521890408|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736784|NCT00804856|521890409|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
144736785|NCT00804856|521890410|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
144736786|NCT00804856|521890396|FG000|Overall Study|Other Adverse Event|1|||
144736787|NCT00804856|521890397|FG001|Overall Study|Other Adverse Event|1|||
144736788|NCT00804856|521890398|FG002|Overall Study|Other Adverse Event|1|||
144736789|NCT00804856|521890399|FG003|Overall Study|Other Adverse Event|2|||
144736790|NCT00804856|521890400|FG004|Overall Study|Other Adverse Event|2|||
144736791|NCT00804856|521890401|FG005|Overall Study|Other Adverse Event|1|||
144736792|NCT00804856|521890402|FG006|Overall Study|Other Adverse Event|3|||
144736793|NCT00804856|521890403|FG007|Overall Study|Other Adverse Event|0|||
144736794|NCT00804856|521890404|FG008|Overall Study|Other Adverse Event|0|||
144736795|NCT00804856|521890405|FG009|Overall Study|Other Adverse Event|1|||
144736796|NCT00804856|521890406|FG010|Overall Study|Other Adverse Event|5|||
144736797|NCT00804856|521890407|FG011|Overall Study|Other Adverse Event|2|||
144736798|NCT00804856|521890408|FG012|Overall Study|Other Adverse Event|0|||
144736799|NCT00804856|521890409|FG013|Overall Study|Other Adverse Event|6|||
144736800|NCT00804856|521890410|FG014|Overall Study|Other Adverse Event|13|||
144736801|NCT00804856|521890396|FG000|Overall Study|Non compliance with protocol|0|||
144736802|NCT00804856|521890397|FG001|Overall Study|Non compliance with protocol|0|||
144736803|NCT00804856|521890398|FG002|Overall Study|Non compliance with protocol|0|||
144736804|NCT00804856|521890399|FG003|Overall Study|Non compliance with protocol|0|||
144736805|NCT00804856|521890400|FG004|Overall Study|Non compliance with protocol|0|||
144736806|NCT00804856|521890401|FG005|Overall Study|Non compliance with protocol|0|||
144736807|NCT00804856|521890402|FG006|Overall Study|Non compliance with protocol|0|||
144736808|NCT00804856|521890403|FG007|Overall Study|Non compliance with protocol|0|||
144736809|NCT00804856|521890404|FG008|Overall Study|Non compliance with protocol|0|||
144265669|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
144736810|NCT00804856|521890405|FG009|Overall Study|Non compliance with protocol|0|||
144736811|NCT00804856|521890406|FG010|Overall Study|Non compliance with protocol|0|||
144736812|NCT00804856|521890407|FG011|Overall Study|Non compliance with protocol|0|||
144736813|NCT00804856|521890408|FG012|Overall Study|Non compliance with protocol|0|||
144736814|NCT00804856|521890409|FG013|Overall Study|Non compliance with protocol|2|||
144675509|NCT00770224|521662931|FG000|Step 2: Maintenance|Ineligible|0|||
144218105|NCT02656303|519992235|FG000|Overall Study|Death|12|||
144218106|NCT02656303|519992236|FG001|Overall Study|Death|4|||
144675510|NCT00770224|521662932|FG001|Step 2: Maintenance|Ineligible|2|||
144675511|NCT04737759|521662933|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
144675512|NCT04737759|521662934|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
144675513|NCT04737759|521662933|FG000|Overall Study|Death|2|||
144675514|NCT04737759|521662934|FG001|Overall Study|Death|0|||
144675515|NCT04737759|521662933|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
144675516|NCT04737759|521662934|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
144675517|NCT04737759|521662933|FG000|Overall Study|Lost to Follow-up|4|||
144675518|NCT04737759|521662934|FG001|Overall Study|Lost to Follow-up|12|||
144675519|NCT01484561|521662943|FG000|Overall Study|Lack of Efficacy|3|||
144675520|NCT01484561|521662944|FG001|Overall Study|Lack of Efficacy|1|||
144675521|NCT01484561|521662943|FG000|Overall Study|Lost to Follow-up|1|||
144675522|NCT01484561|521662944|FG001|Overall Study|Lost to Follow-up|0|||
144675523|NCT01484561|521662943|FG000|Overall Study|Withdrawal by Subject|3|||
144675524|NCT01484561|521662944|FG001|Overall Study|Withdrawal by Subject|0|||
144675525|NCT01484561|521662943|FG000|Overall Study|Other|1|||
144675526|NCT01484561|521662944|FG001|Overall Study|Other|1|||
144675527|NCT01484561|521662943|FG000|Overall Study|Adverse Event|1|||
144675528|NCT01484561|521662944|FG001|Overall Study|Adverse Event|4|||
144675529|NCT03371251|521662945|FG000|Overall Study|Withdrawal by Subject|1|||
144675530|NCT03371251|521662946|FG001|Overall Study|Withdrawal by Subject|0|||
144675531|NCT03371251|521662947|FG002|Overall Study|Withdrawal by Subject|1|||
144675532|NCT03371251|521662948|FG003|Overall Study|Withdrawal by Subject|0|||
144675533|NCT03371251|521662949|FG004|Overall Study|Withdrawal by Subject|2|||
144675534|NCT03371251|521662950|FG005|Overall Study|Withdrawal by Subject|2|||
144675535|NCT03371251|521662945|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
144675536|NCT03371251|521662946|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
144675537|NCT03371251|521662947|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
144675538|NCT03371251|521662948|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
144675539|NCT03371251|521662949|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
144675540|NCT03371251|521662950|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
144675541|NCT03371251|521662945|FG000|Overall Study|Adverse Event|0|||
144675542|NCT03371251|521662946|FG001|Overall Study|Adverse Event|0|||
144675543|NCT03371251|521662947|FG002|Overall Study|Adverse Event|0|||
144675544|NCT03371251|521662948|FG003|Overall Study|Adverse Event|0|||
144675545|NCT03371251|521662949|FG004|Overall Study|Adverse Event|1|||
144675546|NCT03371251|521662950|FG005|Overall Study|Adverse Event|0|||
144675547|NCT03371251|521662945|FG000|Overall Study|Decision by Sponsor|0|||
144675548|NCT03371251|521662946|FG001|Overall Study|Decision by Sponsor|0|||
144675549|NCT03371251|521662947|FG002|Overall Study|Decision by Sponsor|0|||
144675550|NCT03371251|521662948|FG003|Overall Study|Decision by Sponsor|0|||
144675551|NCT03371251|521662949|FG004|Overall Study|Decision by Sponsor|2|||
144675552|NCT03371251|521662950|FG005|Overall Study|Decision by Sponsor|0|||
144675553|NCT00114218|521662951|FG000|Overall Study|Wrong Cell Type|2|||
144675554|NCT00114218|521662951|FG000|Overall Study|Wrong Primary|1|||
144675555|NCT00114218|521662951|FG000|Overall Study|Never Treated|1|||
144675556|NCT00291187|521662952|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
144675557|NCT00291187|521662953|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
144675558|NCT00291187|521662954|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
144675559|NCT00291187|521662955|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
144675560|NCT01505114|521662956|FG000|Overall Study|Withdrawal by Subject|5|||
144675561|NCT01505114|521662957|FG001|Overall Study|Withdrawal by Subject|4|||
144675562|NCT01505114|521662958|FG002|Overall Study|Withdrawal by Subject|4|||
144675563|NCT01505114|521662959|FG003|Overall Study|Withdrawal by Subject|7|||
144675564|NCT01505114|521662956|FG000|Overall Study|Death|1|||
144675565|NCT01505114|521662957|FG001|Overall Study|Death|0|||
144675566|NCT01505114|521662958|FG002|Overall Study|Death|0|||
144675567|NCT01505114|521662959|FG003|Overall Study|Death|1|||
144675568|NCT01505114|521662956|FG000|Overall Study|unable to adhere to visit schedule|3|||
144675569|NCT01505114|521662957|FG001|Overall Study|unable to adhere to visit schedule|2|||
144218107|NCT02656303|519992237|FG002|Overall Study|Death|1|||
144675570|NCT01505114|521662958|FG002|Overall Study|unable to adhere to visit schedule|3|||
144675571|NCT01505114|521662959|FG003|Overall Study|unable to adhere to visit schedule|3|||
144675572|NCT01505114|521662956|FG000|Overall Study|Lost to Follow-up|11|||
144675573|NCT01505114|521662957|FG001|Overall Study|Lost to Follow-up|5|||
144675574|NCT01505114|521662958|FG002|Overall Study|Lost to Follow-up|8|||
144675575|NCT01505114|521662959|FG003|Overall Study|Lost to Follow-up|7|||
144675576|NCT01505114|521662956|FG000|Overall Study|relocated|4|||
144675577|NCT01505114|521662957|FG001|Overall Study|relocated|2|||
144675578|NCT01505114|521662958|FG002|Overall Study|relocated|2|||
144218108|NCT02656303|519992235|FG000|Overall Study|Lack of Efficacy|1|||
144736815|NCT00804856|521890410|FG014|Overall Study|Non compliance with protocol|0|||
144736816|NCT00804856|521890396|FG000|Overall Study|Refused to continue medication|0|||
144736817|NCT00804856|521890397|FG001|Overall Study|Refused to continue medication|0|||
144736818|NCT00804856|521890398|FG002|Overall Study|Refused to continue medication|0|||
144736819|NCT00804856|521890399|FG003|Overall Study|Refused to continue medication|1|||
144736820|NCT00804856|521890400|FG004|Overall Study|Refused to continue medication|1|||
144736821|NCT00804856|521890401|FG005|Overall Study|Refused to continue medication|0|||
144736822|NCT00804856|521890402|FG006|Overall Study|Refused to continue medication|0|||
144736823|NCT00804856|521890403|FG007|Overall Study|Refused to continue medication|0|||
144736824|NCT00804856|521890404|FG008|Overall Study|Refused to continue medication|0|||
144736825|NCT00804856|521890405|FG009|Overall Study|Refused to continue medication|0|||
144736826|NCT00804856|521890406|FG010|Overall Study|Refused to continue medication|3|||
144736827|NCT00804856|521890407|FG011|Overall Study|Refused to continue medication|0|||
144736828|NCT00804856|521890408|FG012|Overall Study|Refused to continue medication|1|||
144736829|NCT00804856|521890409|FG013|Overall Study|Refused to continue medication|1|||
144736830|NCT00804856|521890410|FG014|Overall Study|Refused to continue medication|5|||
144736831|NCT00804856|521890396|FG000|Overall Study|Other reason than listed above|0|||
144736832|NCT00804856|521890397|FG001|Overall Study|Other reason than listed above|0|||
144736833|NCT00804856|521890398|FG002|Overall Study|Other reason than listed above|0|||
144736834|NCT00804856|521890399|FG003|Overall Study|Other reason than listed above|0|||
144736835|NCT00804856|521890400|FG004|Overall Study|Other reason than listed above|0|||
144736836|NCT00804856|521890401|FG005|Overall Study|Other reason than listed above|1|||
144736837|NCT00804856|521890402|FG006|Overall Study|Other reason than listed above|0|||
144736838|NCT00804856|521890403|FG007|Overall Study|Other reason than listed above|0|||
144736839|NCT00804856|521890404|FG008|Overall Study|Other reason than listed above|1|||
144736840|NCT00804856|521890405|FG009|Overall Study|Other reason than listed above|0|||
144736841|NCT00804856|521890406|FG010|Overall Study|Other reason than listed above|3|||
144736842|NCT00804856|521890407|FG011|Overall Study|Other reason than listed above|1|||
144736843|NCT00804856|521890408|FG012|Overall Study|Other reason than listed above|1|||
144736844|NCT00804856|521890409|FG013|Overall Study|Other reason than listed above|10|||
144736845|NCT00804856|521890410|FG014|Overall Study|Other reason than listed above|3|||
144736846|NCT00455312|521890411|FG000|Overall Study|Death|0|||
144736847|NCT00455312|521890412|FG001|Overall Study|Death|1|||
144736848|NCT03343535|521890413|FG000|Overall Study|Lost to Follow-up|1|||
144736849|NCT03343535|521890413|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
144736850|NCT03343535|521890413|FG000|Overall Study|Death|12|||
144736851|NCT03868891|521890414|FG000|Overall Study|Adverse Event|1|||
144736852|NCT03868891|521890415|FG001|Overall Study|Adverse Event|0|||
144736853|NCT03868891|521890414|FG000|Overall Study|Lost to Follow-up|2|||
144736854|NCT03868891|521890415|FG001|Overall Study|Lost to Follow-up|1|||
144736855|NCT03868891|521890414|FG000|Overall Study|COVID-19 Restrictions|1|||
144736856|NCT03868891|521890415|FG001|Overall Study|COVID-19 Restrictions|2|||
144736857|NCT03552393|521890420|FG000|Core Period|Kidney Transplant|1|||
144736858|NCT03552393|521890420|FG000|Core Period|Prohibited Medication|1|||
144736859|NCT03552393|521890420|FG000|Safety Extension Period|Kidney Transplant|4|||
144736860|NCT02601625|521890424|FG000|Overall Study|Lost to Follow-up|0|||
144736861|NCT02601625|521890425|FG001|Overall Study|Lost to Follow-up|0|||
144736862|NCT02601625|521890426|FG002|Overall Study|Lost to Follow-up|1|||
144736863|NCT02601625|521890427|FG003|Overall Study|Lost to Follow-up|1|||
144736864|NCT00359281|521890428|FG000|Overall Study|Adverse Event|1|||
144736865|NCT00359281|521890429|FG001|Overall Study|Adverse Event|0|||
144736866|NCT00359281|521890430|FG002|Overall Study|Adverse Event|0|||
144736867|NCT00359281|521890431|FG003|Overall Study|Adverse Event|0|||
144736868|NCT00359281|521890432|FG004|Overall Study|Adverse Event|0|||
144736869|NCT00359281|521890433|FG005|Overall Study|Adverse Event|0|||
144736870|NCT00359281|521890434|FG006|Overall Study|Adverse Event|1|||
144736871|NCT00359281|521890435|FG007|Overall Study|Adverse Event|0|||
144736872|NCT00359281|521890436|FG008|Overall Study|Adverse Event|0|||
144736873|NCT00359281|521890428|FG000|Overall Study|Withdrawal by Subject|0|||
144736874|NCT00359281|521890429|FG001|Overall Study|Withdrawal by Subject|0|||
144736875|NCT00359281|521890430|FG002|Overall Study|Withdrawal by Subject|0|||
144736876|NCT00359281|521890431|FG003|Overall Study|Withdrawal by Subject|0|||
144736877|NCT00359281|521890432|FG004|Overall Study|Withdrawal by Subject|0|||
144736878|NCT00359281|521890433|FG005|Overall Study|Withdrawal by Subject|0|||
144736879|NCT00359281|521890434|FG006|Overall Study|Withdrawal by Subject|1|||
144736880|NCT00359281|521890435|FG007|Overall Study|Withdrawal by Subject|0|||
144218109|NCT02656303|519992236|FG001|Overall Study|Lack of Efficacy|0|||
144736881|NCT00359281|521890436|FG008|Overall Study|Withdrawal by Subject|0|||
144736882|NCT01289262|521890440|FG000|Overall Study|Lost to Follow-up|29|||
144736883|NCT01289262|521890441|FG001|Overall Study|Lost to Follow-up|16|||
144736884|NCT01289262|521890440|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
144736885|NCT01289262|521890441|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
144218110|NCT02656303|519992237|FG002|Overall Study|Lack of Efficacy|0|||
144218111|NCT02656303|519992235|FG000|Overall Study|Non-Compliance with Study|1|||
144736886|NCT04608188|521890444|FG000|Overall Study|Withdrawal by Subject|4|||
144675579|NCT01505114|521662959|FG003|Overall Study|relocated|3|||
144675580|NCT01505114|521662956|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
144675581|NCT01505114|521662957|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
144675582|NCT01505114|521662958|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
144675583|NCT01505114|521662959|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
144675584|NCT01505114|521662956|FG000|Overall Study|staff safety concerns|0|||
144675585|NCT01505114|521662957|FG001|Overall Study|staff safety concerns|0|||
144675586|NCT01505114|521662958|FG002|Overall Study|staff safety concerns|0|||
144675587|NCT01505114|521662959|FG003|Overall Study|staff safety concerns|1|||
144675588|NCT01505114|521662956|FG000|Overall Study|investigator decision|1|||
144675589|NCT01505114|521662957|FG001|Overall Study|investigator decision|0|||
144675590|NCT01505114|521662958|FG002|Overall Study|investigator decision|1|||
144675591|NCT01505114|521662959|FG003|Overall Study|investigator decision|0|||
144675592|NCT01040845|521662961|FG000|Overall Study|Withdrawal by Subject|1|||
144675593|NCT01040845|521662962|FG001|Overall Study|Withdrawal by Subject|1|||
144675594|NCT01040845|521662961|FG000|Overall Study|Physician Decision|1|||
144675595|NCT01040845|521662962|FG001|Overall Study|Physician Decision|0|||
144675596|NCT04362813|521662963|FG000|Overall Study|Death|12|||
144675597|NCT04362813|521662964|FG001|Overall Study|Death|16|||
144675598|NCT04362813|521662963|FG000|Overall Study|Withdrawal by Subject|3|||
144675599|NCT04362813|521662964|FG001|Overall Study|Withdrawal by Subject|1|||
144675600|NCT04362813|521662963|FG000|Overall Study|Protocol Violation|0|||
144675601|NCT04362813|521662964|FG001|Overall Study|Protocol Violation|3|||
144675602|NCT04362813|521662963|FG000|Overall Study|Lost to Follow-up|1|||
144675603|NCT04362813|521662964|FG001|Overall Study|Lost to Follow-up|1|||
144675604|NCT04362813|521662963|FG000|Overall Study|Enrolled but did not receive treatment|2|||
144675605|NCT04362813|521662964|FG001|Overall Study|Enrolled but did not receive treatment|4|||
144675606|NCT02999100|521662968|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
144675607|NCT02999100|521662969|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
144675608|NCT02999100|521662970|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
144675609|NCT02999100|521662971|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
144675610|NCT02999100|521662972|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
144675611|NCT02999100|521662973|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
144675612|NCT02999100|521662968|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
144675613|NCT02999100|521662969|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
144675614|NCT02999100|521662970|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
144675615|NCT02999100|521662971|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
144675616|NCT02999100|521662972|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
144675617|NCT02999100|521662973|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
144675618|NCT02999100|521662968|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
144675619|NCT02999100|521662969|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
144675620|NCT02999100|521662970|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
144675621|NCT02999100|521662971|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
144675622|NCT02999100|521662972|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
144675623|NCT02999100|521662973|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
144675624|NCT03595384|521662974|FG000|Overall Study|Other time commitments|8|||
144675625|NCT03595384|521662974|FG000|Overall Study|Changes to session time|7|||
144675626|NCT03595384|521662974|FG000|Overall Study|Relocation out of country|1|||
144675627|NCT00293241|521662975|FG000|Overall Study|Lost to Follow-up|9|||
144675628|NCT00293241|521662976|FG001|Overall Study|Lost to Follow-up|16|||
144675629|NCT00293241|521662975|FG000|Overall Study|Physician Decision|23|||
144675630|NCT00293241|521662976|FG001|Overall Study|Physician Decision|17|||
144675631|NCT00293241|521662975|FG000|Overall Study|Withdrawal by Subject|4|||
144675632|NCT00293241|521662976|FG001|Overall Study|Withdrawal by Subject|8|||
144675633|NCT01270958|521662978|FG000|Overall Study|Lost to Follow-up|2|||
144675634|NCT01270958|521662978|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
144675635|NCT02925312|521662979|FG000|Overall Study|Lost to Follow-up|25|||
144675636|NCT02925312|521662980|FG001|Overall Study|Lost to Follow-up|0|||
144675637|NCT02925312|521662979|FG000|Overall Study|Adverse Event|2|||
144675638|NCT02925312|521662980|FG001|Overall Study|Adverse Event|0|||
144675639|NCT02142504|521662981|FG000|Overall Study|Protocol Violation|2|||
144675640|NCT02142504|521662982|FG001|Overall Study|Protocol Violation|1|||
144675641|NCT02142504|521662983|FG002|Overall Study|Protocol Violation|2|||
144675642|NCT02142504|521662981|FG000|Overall Study|Adverse Event|2|||
144675643|NCT02142504|521662982|FG001|Overall Study|Adverse Event|3|||
144675644|NCT02142504|521662983|FG002|Overall Study|Adverse Event|4|||
144675645|NCT02142504|521662981|FG000|Overall Study|Lost to Follow-up|12|||
144675646|NCT02142504|521662982|FG001|Overall Study|Lost to Follow-up|19|||
144675647|NCT02142504|521662983|FG002|Overall Study|Lost to Follow-up|17|||
144675648|NCT02142504|521662981|FG000|Overall Study|Withdrawal by Subject|7|||
144675649|NCT02142504|521662982|FG001|Overall Study|Withdrawal by Subject|9|||
144675650|NCT02142504|521662983|FG002|Overall Study|Withdrawal by Subject|11|||
144675651|NCT02142504|521662981|FG000|Overall Study|Pregnancy|4|||
144675652|NCT02142504|521662982|FG001|Overall Study|Pregnancy|4|||
144675653|NCT02142504|521662983|FG002|Overall Study|Pregnancy|2|||
144736887|NCT04608188|521890445|FG001|Overall Study|Withdrawal by Subject|8|||
144736888|NCT01250912|521890449|FG000|Overall Study|Lost to Follow-up|1|||
144736889|NCT01218867|521890454|FG000|Overall Study|Death during treatment|0|||
144675654|NCT02142504|521662981|FG000|Overall Study|Physician Decision|0|||
144675655|NCT02142504|521662982|FG001|Overall Study|Physician Decision|1|||
144736890|NCT01218867|521890455|FG001|Overall Study|Death during treatment|0|||
144736891|NCT01218867|521890456|FG002|Overall Study|Death during treatment|0|||
144736892|NCT01218867|521890457|FG003|Overall Study|Death during treatment|0|||
144736893|NCT01218867|521890458|FG004|Overall Study|Death during treatment|0|||
144736894|NCT01218867|521890459|FG005|Overall Study|Death during treatment|0|||
144736895|NCT01218867|521890460|FG006|Overall Study|Death during treatment|1|||
144736896|NCT01218867|521890461|FG007|Overall Study|Death during treatment|0|||
144736897|NCT01218867|521890462|FG008|Overall Study|Death during treatment|0|||
144736898|NCT01218867|521890463|FG009|Overall Study|Death during treatment|0|||
144736899|NCT01218867|521890464|FG010|Overall Study|Death during treatment|0|||
144736900|NCT03792477|521890465|FG000|Overall Study|Adverse Event|0|||
144736901|NCT03792477|521890466|FG001|Overall Study|Adverse Event|0|||
144736902|NCT03792477|521890467|FG002|Overall Study|Adverse Event|0|||
144736903|NCT03792477|521890468|FG003|Overall Study|Adverse Event|1|||
144736904|NCT03792477|521890469|FG004|Overall Study|Adverse Event|0|||
144736905|NCT03792477|521890465|FG000|Overall Study|Lost to Follow-up|0|||
144736906|NCT03792477|521890466|FG001|Overall Study|Lost to Follow-up|0|||
144736907|NCT03792477|521890467|FG002|Overall Study|Lost to Follow-up|2|||
144736908|NCT03792477|521890468|FG003|Overall Study|Lost to Follow-up|0|||
144736909|NCT03792477|521890469|FG004|Overall Study|Lost to Follow-up|0|||
144736910|NCT03792477|521890465|FG000|Overall Study|Other|0|||
144736911|NCT03792477|521890466|FG001|Overall Study|Other|0|||
144736912|NCT03792477|521890467|FG002|Overall Study|Other|0|||
144736913|NCT03792477|521890468|FG003|Overall Study|Other|0|||
144736914|NCT03792477|521890469|FG004|Overall Study|Other|1|||
144736915|NCT00840411|521890471|FG000|First Intervention|Adverse Event|1|||
144736916|NCT00840411|521890472|FG001|First Intervention|Adverse Event|0|||
144736917|NCT00840411|521890471|FG000|Washout|Withdrawal by Subject|1|||
144736918|NCT00840411|521890472|FG001|Washout|Withdrawal by Subject|0|||
144736919|NCT04419311|521890474|FG000|Overall Study|Lost to Follow-up|1|||
144736920|NCT04419311|521890475|FG001|Overall Study|Lost to Follow-up|0|||
144736921|NCT03233724|521890478|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
144736922|NCT03233724|521890479|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
144675656|NCT02142504|521662983|FG002|Overall Study|Physician Decision|3|||
144675657|NCT02142504|521662981|FG000|Overall Study|Reason Not Specified|4|||
144675658|NCT02142504|521662982|FG001|Overall Study|Reason Not Specified|5|||
144675659|NCT02142504|521662983|FG002|Overall Study|Reason Not Specified|4|||
144675660|NCT01225172|521662987|FG000|Overall Study|Subject decision to stop|1|||
144675661|NCT01225172|521662988|FG001|Overall Study|Subject decision to stop|0|||
144675662|NCT01225172|521662987|FG000|Overall Study|Subject request to discontinue treatment|3|||
144675663|NCT01225172|521662988|FG001|Overall Study|Subject request to discontinue treatment|1|||
144675664|NCT01225172|521662987|FG000|Overall Study|Subject no longer meets study criteria|1|||
144675665|NCT01225172|521662988|FG001|Overall Study|Subject no longer meets study criteria|0|||
144675666|NCT01225172|521662987|FG000|Overall Study|Withdrawal by Subject|1|||
144675667|NCT01225172|521662988|FG001|Overall Study|Withdrawal by Subject|0|||
144675668|NCT03404518|521662989|FG000|Overall Study|Lost to Follow-up|28|||
144675669|NCT03404518|521662990|FG001|Overall Study|Lost to Follow-up|30|||
144675670|NCT03404518|521662989|FG000|Overall Study|Protocol Violation|13|||
144675671|NCT03404518|521662990|FG001|Overall Study|Protocol Violation|6|||
144736923|NCT03233724|521890480|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
144736924|NCT03233724|521890481|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
144736925|NCT03233724|521890482|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
144736926|NCT03233724|521890478|FG000|Phase I Dose Escalation|Best interest of participant|1|||
144736927|NCT03233724|521890479|FG001|Phase I Dose Escalation|Best interest of participant|1|||
144736928|NCT03233724|521890480|FG002|Phase I Dose Escalation|Best interest of participant|1|||
144736929|NCT03233724|521890481|FG003|Phase I Dose Escalation|Best interest of participant|0|||
144736930|NCT03233724|521890482|FG004|Phase I Dose Escalation|Best interest of participant|0|||
144736931|NCT03233724|521890478|FG000|Phase I Dose Escalation|Physician Decision|0|||
144675672|NCT02079519|521662991|FG000|Overall Study|Disease Progression|9|||
144675673|NCT02079519|521662991|FG000|Overall Study|Adverse Event|1|||
144675674|NCT01576406|521662992|FG000|Overall Study|Lost to Follow-up|1|||
144675675|NCT01576406|521662993|FG001|Overall Study|Lost to Follow-up|2|||
144736932|NCT03233724|521890479|FG001|Phase I Dose Escalation|Physician Decision|0|||
144736933|NCT03233724|521890480|FG002|Phase I Dose Escalation|Physician Decision|1|||
144736934|NCT03233724|521890481|FG003|Phase I Dose Escalation|Physician Decision|0|||
144736935|NCT03233724|521890482|FG004|Phase I Dose Escalation|Physician Decision|0|||
144736936|NCT03233724|521890478|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
144736937|NCT03233724|521890479|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
144736938|NCT03233724|521890480|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
144736939|NCT03233724|521890481|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
144736940|NCT03233724|521890482|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
144736941|NCT03122457|521890485|FG000|Overall Study|Withdrawal by Subject|6|||
144736942|NCT00651820|521890486|FG000|Overall Study|Lost to Follow-up|2|||
144736943|NCT01921062|521890487|FG000|Overall Study|Withdrawal by Subject|0|||
144736944|NCT01921062|521890488|FG001|Overall Study|Withdrawal by Subject|7|||
144736945|NCT01921062|521890487|FG000|Overall Study|Adverse Event|5|||
144736946|NCT01921062|521890488|FG001|Overall Study|Adverse Event|6|||
144736947|NCT01921062|521890487|FG000|Overall Study|Protocol Violation|0|||
144736948|NCT01921062|521890488|FG001|Overall Study|Protocol Violation|1|||
144736949|NCT01921062|521890487|FG000|Overall Study|VMIQ score > 72|4|||
144736950|NCT01921062|521890488|FG001|Overall Study|VMIQ score > 72|1|||
144736951|NCT01921062|521890487|FG000|Overall Study|Logistic error|0|||
144736952|NCT01921062|521890488|FG001|Overall Study|Logistic error|1|||
144736953|NCT01911676|521890489|FG000|Period 1 of Study|Withdrawal by Subject|4|||
144736954|NCT01911676|521890490|FG001|Period 1 of Study|Withdrawal by Subject|2|||
144736955|NCT01911676|521890491|FG002|Period 1 of Study|Withdrawal by Subject|1|||
144736956|NCT01911676|521890492|FG003|Period 1 of Study|Withdrawal by Subject|2|||
144736957|NCT01911676|521890489|FG000|Period 1 of Study|Physician Decision|2|||
144736958|NCT01911676|521890490|FG001|Period 1 of Study|Physician Decision|0|||
144736959|NCT01911676|521890491|FG002|Period 1 of Study|Physician Decision|0|||
144736960|NCT01911676|521890492|FG003|Period 1 of Study|Physician Decision|1|||
144736961|NCT01911676|521890489|FG000|Period 2 of Study|Physician Decision|2|||
144736962|NCT01911676|521890490|FG001|Period 2 of Study|Physician Decision|0|||
144736963|NCT01911676|521890491|FG002|Period 2 of Study|Physician Decision|0|||
144736964|NCT01911676|521890492|FG003|Period 2 of Study|Physician Decision|1|||
144736965|NCT01911676|521890489|FG000|Period 2 of Study|Lost to Follow-up|0|||
144736966|NCT01911676|521890490|FG001|Period 2 of Study|Lost to Follow-up|0|||
144736967|NCT01911676|521890491|FG002|Period 2 of Study|Lost to Follow-up|0|||
144736968|NCT01911676|521890492|FG003|Period 2 of Study|Lost to Follow-up|1|||
144736969|NCT01169558|521890493|FG000|Overall Study|Disease progression|98|||
144736970|NCT01169558|521890493|FG000|Overall Study|Adverse Event|25|||
144736971|NCT01169558|521890493|FG000|Overall Study|Withdrawal of Consent|8|||
144736972|NCT01169558|521890493|FG000|Overall Study|Medical Decision|7|||
144736973|NCT01169558|521890493|FG000|Overall Study|Stable Disease|4|||
144736974|NCT01169558|521890493|FG000|Overall Study|Lost to Follow-up|4|||
144736975|NCT01169558|521890493|FG000|Overall Study|Need for Surgery|4|||
144736976|NCT01169558|521890493|FG000|Overall Study|Non-compliance|2|||
144736977|NCT01169558|521890493|FG000|Overall Study|Protocol Violation|2|||
144736978|NCT01169558|521890493|FG000|Overall Study|Partial response|2|||
144736979|NCT03134222|521890494|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
144736980|NCT03134222|521890495|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
144736981|NCT03134222|521890496|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
144218112|NCT02656303|519992236|FG001|Overall Study|Non-Compliance with Study|1|||
144218113|NCT02656303|519992237|FG002|Overall Study|Non-Compliance with Study|0|||
144218114|NCT02656303|519992235|FG000|Overall Study|Investigator Decision|2|||
144218115|NCT02656303|519992236|FG001|Overall Study|Investigator Decision|1|||
144218116|NCT02656303|519992237|FG002|Overall Study|Investigator Decision|0|||
144218117|NCT02656303|519992235|FG000|Overall Study|Progressive Disease|25|||
144218118|NCT02656303|519992236|FG001|Overall Study|Progressive Disease|14|||
144736982|NCT03134222|521890497|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
144736983|NCT03134222|521890498|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
144736984|NCT03134222|521890494|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
144736985|NCT03134222|521890495|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
144736986|NCT03134222|521890496|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
144736987|NCT03134222|521890497|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
144736988|NCT03134222|521890498|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
144736989|NCT03134222|521890494|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
144736990|NCT03134222|521890495|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
144736991|NCT03134222|521890496|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
144736992|NCT03134222|521890497|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
144218119|NCT02656303|519992237|FG002|Overall Study|Progressive Disease|10|||
144218120|NCT02656303|519992235|FG000|Overall Study|Study Terminated by Sponsor|20|||
144736993|NCT03134222|521890498|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
144736994|NCT03134222|521890494|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
144736995|NCT03134222|521890495|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
144736996|NCT03134222|521890496|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
144736997|NCT03134222|521890497|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
144736998|NCT03134222|521890498|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
144736999|NCT03134222|521890494|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
144218121|NCT02656303|519992236|FG001|Overall Study|Study Terminated by Sponsor|7|||
144675676|NCT01576406|521662994|FG002|Overall Study|Lost to Follow-up|0|||
144675677|NCT01576406|521662995|FG003|Overall Study|Lost to Follow-up|0|||
144675678|NCT01576406|521662996|FG004|Overall Study|Lost to Follow-up|0|||
144675679|NCT01576406|521662997|FG005|Overall Study|Lost to Follow-up|0|||
144675680|NCT01576406|521662992|FG000|Overall Study|Death|3|||
144675681|NCT01576406|521662993|FG001|Overall Study|Death|4|||
144675682|NCT01576406|521662994|FG002|Overall Study|Death|8|||
144675683|NCT01576406|521662995|FG003|Overall Study|Death|5|||
144675684|NCT01576406|521662996|FG004|Overall Study|Death|7|||
144675685|NCT01576406|521662997|FG005|Overall Study|Death|9|||
144675686|NCT01576406|521662992|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
144675687|NCT01576406|521662993|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
144675688|NCT01576406|521662994|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
144675689|NCT01576406|521662995|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
144675690|NCT01576406|521662996|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
144675691|NCT01576406|521662997|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
144675692|NCT01576406|521662992|FG000|Overall Study|Withdrawal the consent|2|||
144675693|NCT01576406|521662993|FG001|Overall Study|Withdrawal the consent|2|||
144675694|NCT01576406|521662994|FG002|Overall Study|Withdrawal the consent|5|||
144675695|NCT01576406|521662995|FG003|Overall Study|Withdrawal the consent|1|||
144675696|NCT01576406|521662996|FG004|Overall Study|Withdrawal the consent|1|||
144675697|NCT01576406|521662997|FG005|Overall Study|Withdrawal the consent|3|||
144675698|NCT01576406|521662992|FG000|Overall Study|Other|0|||
144675699|NCT01576406|521662993|FG001|Overall Study|Other|0|||
144675700|NCT01576406|521662994|FG002|Overall Study|Other|2|||
144675701|NCT01576406|521662995|FG003|Overall Study|Other|2|||
144675702|NCT01576406|521662996|FG004|Overall Study|Other|0|||
144675703|NCT01576406|521662997|FG005|Overall Study|Other|0|||
144675704|NCT00669032|521663000|FG000|Overall Study|Lost to Follow-up|6|||
144675705|NCT00669032|521663001|FG001|Overall Study|Lost to Follow-up|5|||
144675706|NCT00669032|521663000|FG000|Overall Study|Lack of Efficacy|8|||
144675707|NCT00669032|521663001|FG001|Overall Study|Lack of Efficacy|19|||
144675708|NCT00669032|521663000|FG000|Overall Study|Withdrawal by Subject|12|||
144675709|NCT00669032|521663001|FG001|Overall Study|Withdrawal by Subject|13|||
144675710|NCT00669032|521663000|FG000|Overall Study|Adverse Event|12|||
144675711|NCT00669032|521663001|FG001|Overall Study|Adverse Event|16|||
144675712|NCT00669032|521663000|FG000|Overall Study|Physician Decision|1|||
144675713|NCT00669032|521663001|FG001|Overall Study|Physician Decision|1|||
144675714|NCT00669032|521663000|FG000|Overall Study|No fulfilment of the selection criteria|5|||
144675715|NCT00669032|521663001|FG001|Overall Study|No fulfilment of the selection criteria|5|||
144675716|NCT00642018|521663002|FG000|Overall Study|Adverse Event|11|||
144675717|NCT00642018|521663003|FG001|Overall Study|Adverse Event|36|||
144675718|NCT00642018|521663002|FG000|Overall Study|Withdrawal by Subject|4|||
144675719|NCT00642018|521663003|FG001|Overall Study|Withdrawal by Subject|10|||
144675720|NCT00642018|521663002|FG000|Overall Study|Progressive Disease|13|||
144675721|NCT00642018|521663003|FG001|Overall Study|Progressive Disease|18|||
144675722|NCT00642018|521663002|FG000|Overall Study|Physician Decision|0|||
144675723|NCT00642018|521663003|FG001|Overall Study|Physician Decision|10|||
144675724|NCT00642018|521663002|FG000|Overall Study|Protocol Violation|0|||
144675725|NCT00642018|521663003|FG001|Overall Study|Protocol Violation|1|||
144675726|NCT00642018|521663002|FG000|Overall Study|Death|0|||
144675727|NCT00642018|521663003|FG001|Overall Study|Death|3|||
144675728|NCT00642018|521663002|FG000|Overall Study|Entry Criteria Not Met|0|||
144675729|NCT00642018|521663003|FG001|Overall Study|Entry Criteria Not Met|1|||
144675730|NCT01607073|521663004|FG000|Overall Study|Adverse Event|1|||
144675731|NCT00131664|521663005|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
144675732|NCT00131664|521663006|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
144675733|NCT00131664|521663007|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
144675734|NCT00131664|521663008|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
144675735|NCT00131664|521663009|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
144675736|NCT00131664|521663010|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
144675737|NCT00131664|521663005|FG000|First Period (First 6 Months)|Death|0|||
144675738|NCT00131664|521663006|FG001|First Period (First 6 Months)|Death|1|||
144675739|NCT00131664|521663007|FG002|First Period (First 6 Months)|Death|0|||
144675740|NCT00131664|521663008|FG003|First Period (First 6 Months)|Death|0|||
144265670|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
144737000|NCT03134222|521890495|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
144675741|NCT00131664|521663009|FG004|First Period (First 6 Months)|Death|0|||
144675742|NCT00131664|521663010|FG005|First Period (First 6 Months)|Death|0|||
144675743|NCT00131664|521663005|FG000|First Period (First 6 Months)|Protocol Violation|2|||
144675744|NCT00131664|521663006|FG001|First Period (First 6 Months)|Protocol Violation|2|||
144675745|NCT00131664|521663007|FG002|First Period (First 6 Months)|Protocol Violation|1|||
144675746|NCT00131664|521663008|FG003|First Period (First 6 Months)|Protocol Violation|0|||
144675747|NCT00131664|521663009|FG004|First Period (First 6 Months)|Protocol Violation|0|||
144675748|NCT00131664|521663010|FG005|First Period (First 6 Months)|Protocol Violation|0|||
144675749|NCT00131664|521663005|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
144737001|NCT03134222|521890496|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
144737002|NCT03134222|521890497|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
144737003|NCT03134222|521890498|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
144737004|NCT03134222|521890494|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
144737005|NCT03134222|521890495|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
144737006|NCT03134222|521890496|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
144737007|NCT03134222|521890497|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
144737008|NCT03134222|521890498|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
144737009|NCT03134222|521890494|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
144737010|NCT03134222|521890495|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
144737011|NCT03134222|521890496|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
144737012|NCT03134222|521890497|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
144737013|NCT03134222|521890498|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
144737014|NCT03134222|521890494|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
144737015|NCT03134222|521890495|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
144737016|NCT03134222|521890496|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
144675750|NCT00131664|521663006|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
144675751|NCT00131664|521663007|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
144675752|NCT00131664|521663008|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
144675753|NCT00131664|521663009|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
144675754|NCT00131664|521663010|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
144675755|NCT00131664|521663005|FG000|First Period (First 6 Months)|Adverse Event|9|||
144675756|NCT00131664|521663006|FG001|First Period (First 6 Months)|Adverse Event|4|||
144675757|NCT00131664|521663007|FG002|First Period (First 6 Months)|Adverse Event|5|||
144675758|NCT00131664|521663008|FG003|First Period (First 6 Months)|Adverse Event|0|||
144675759|NCT00131664|521663009|FG004|First Period (First 6 Months)|Adverse Event|0|||
144675760|NCT00131664|521663010|FG005|First Period (First 6 Months)|Adverse Event|0|||
144675761|NCT00131664|521663005|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
144675762|NCT00131664|521663006|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
144675763|NCT00131664|521663007|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
144675764|NCT00131664|521663008|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
144675765|NCT00131664|521663009|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
144675766|NCT00131664|521663010|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
144675767|NCT00131664|521663005|FG000|First Period (First 6 Months)|Administrative reasons|2|||
144675768|NCT00131664|521663006|FG001|First Period (First 6 Months)|Administrative reasons|0|||
144675769|NCT00131664|521663007|FG002|First Period (First 6 Months)|Administrative reasons|5|||
144675770|NCT00131664|521663008|FG003|First Period (First 6 Months)|Administrative reasons|0|||
144675771|NCT00131664|521663009|FG004|First Period (First 6 Months)|Administrative reasons|0|||
144675772|NCT00131664|521663010|FG005|First Period (First 6 Months)|Administrative reasons|0|||
144675773|NCT00131664|521663005|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
144675774|NCT00131664|521663006|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
144675775|NCT00131664|521663007|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
144675776|NCT00131664|521663008|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
144675777|NCT00131664|521663009|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
144675778|NCT00131664|521663010|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
144675779|NCT00131664|521663005|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
144675780|NCT00131664|521663006|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
144675781|NCT00131664|521663007|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
144675782|NCT00131664|521663008|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
144675783|NCT00131664|521663009|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
144675784|NCT00131664|521663010|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
144675785|NCT00131664|521663005|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
144675786|NCT00131664|521663006|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
144675787|NCT00131664|521663007|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
144675788|NCT00131664|521663008|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
144675789|NCT00131664|521663009|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
144675790|NCT00131664|521663010|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
144675791|NCT00131664|521663005|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
144675792|NCT00131664|521663006|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
144675793|NCT00131664|521663007|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
144737017|NCT03134222|521890497|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
144737018|NCT03134222|521890498|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
144737019|NCT02605928|521890499|FG000|Overall Study|Model tuning phase|28|||
144265671|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
144265672|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
144218122|NCT02656303|519992237|FG002|Overall Study|Study Terminated by Sponsor|5|||
144218123|NCT02656303|519992235|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
144218124|NCT02656303|519992236|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
144675794|NCT00131664|521663008|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
144675795|NCT00131664|521663009|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
144675796|NCT00131664|521663010|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
144675797|NCT00131664|521663005|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
144675798|NCT00131664|521663006|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
144675799|NCT00131664|521663007|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
144675800|NCT00131664|521663008|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
144675801|NCT00131664|521663009|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
144675802|NCT00131664|521663010|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
144675803|NCT00131664|521663005|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
144675804|NCT00131664|521663006|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
144675805|NCT00131664|521663007|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
144675806|NCT00131664|521663008|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
144675807|NCT00131664|521663009|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
144675808|NCT00131664|521663010|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
144675809|NCT01280812|521664437|FG000|Overall Study|Withdrawal by Subject|2|||
144675810|NCT01280812|521664438|FG001|Overall Study|Withdrawal by Subject|1|||
144675811|NCT01280812|521664439|FG002|Overall Study|Withdrawal by Subject|0|||
144675812|NCT01280812|521664437|FG000|Overall Study|Lost to Follow-up|1|||
144675813|NCT01280812|521664438|FG001|Overall Study|Lost to Follow-up|1|||
144675814|NCT01280812|521664439|FG002|Overall Study|Lost to Follow-up|1|||
144675815|NCT00959894|521664442|FG000|Overall Study|Lost to Follow-up|10|||
144675816|NCT00959894|521664442|FG000|Overall Study|Adverse Event|3|||
144675817|NCT00959894|521664442|FG000|Overall Study|Withdrawal by Subject|1|||
144675818|NCT00959894|521664442|FG000|Overall Study|Need for contraindicated medication|1|||
144675819|NCT00959894|521664442|FG000|Overall Study|Subject moved out of town|1|||
144675820|NCT01376388|521664443|FG000|Overall Study|Adverse Event|13|||
144675821|NCT01376388|521664443|FG000|Overall Study|Lack of Efficacy|2|||
144675822|NCT01376388|521664443|FG000|Overall Study|Withdrawal by Subject|3|||
144675823|NCT02009930|521664451|FG000|Overall Study|withdrawn|5|||
144675824|NCT02959970|521664454|FG000|Overall Study|Adverse Event|1|||
144675825|NCT02959970|521664455|FG001|Overall Study|Adverse Event|0|||
144675826|NCT02959970|521664454|FG000|Overall Study|Withdrawal by Subject|0|||
144675827|NCT02959970|521664455|FG001|Overall Study|Withdrawal by Subject|2|||
144675828|NCT02959970|521664454|FG000|Overall Study|Lost to Follow-up|1|||
144675829|NCT02959970|521664455|FG001|Overall Study|Lost to Follow-up|5|||
144675830|NCT00666536|521664456|FG000|Overall Study|Adverse Event|9|||
144675831|NCT00666536|521664457|FG001|Overall Study|Adverse Event|19|||
144675832|NCT00666536|521664456|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144675833|NCT00666536|521664457|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144675834|NCT00666536|521664456|FG000|Overall Study|Protocol deviation(s)|8|||
144675835|NCT00666536|521664457|FG001|Overall Study|Protocol deviation(s)|6|||
144675836|NCT00666536|521664456|FG000|Overall Study|Withdrawal by Subject|10|||
144675837|NCT00666536|521664457|FG001|Overall Study|Withdrawal by Subject|9|||
144675838|NCT00666536|521664456|FG000|Overall Study|Lost to Follow-up|4|||
144675839|NCT00666536|521664457|FG001|Overall Study|Lost to Follow-up|3|||
144675840|NCT03805971|521664458|FG000|Overall Study|Withdrawal by Subject|1|||
144675841|NCT03805971|521664458|FG000|Overall Study|Protocol Violation|2|||
144675842|NCT02741310|521664462|FG000|Overall Study|Sponsor Decision|2|||
144675843|NCT02741310|521664463|FG001|Overall Study|Sponsor Decision|2|||
144675844|NCT05091918|521664464|FG000|Overall Study|Adverse Event|1|||
144675845|NCT05091918|521664464|FG000|Overall Study|Withdrawal by Subject|81|||
144675846|NCT01784211|521664468|FG000|Part A (Days 1-15)|Adverse Event|1|||
144675847|NCT01784211|521664469|FG001|Part A (Days 1-15)|Adverse Event|1|||
144675848|NCT01784211|521664470|FG002|Part A (Days 1-15)|Adverse Event|0|||
144675849|NCT01784211|521664471|FG003|Part A (Days 1-15)|Adverse Event|0|||
144675850|NCT01784211|521664472|FG004|Part A (Days 1-15)|Adverse Event|0|||
144675851|NCT01784211|521664473|FG005|Part A (Days 1-15)|Adverse Event|0|||
144675852|NCT01784211|521664468|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
144675853|NCT01784211|521664469|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
144675854|NCT01784211|521664470|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
144675855|NCT01784211|521664471|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
144675856|NCT01784211|521664472|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
144675857|NCT01784211|521664473|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
144675858|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
144675859|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
144675860|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
144675861|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
144675862|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
144675863|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
144675864|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
144675865|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
144675866|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
144675867|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
144675868|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
144675869|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
144675870|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
144675871|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
144675872|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
144675873|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
144675874|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
144675875|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
144675876|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
144675877|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
144675878|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
144675879|NCT01001572|521664476|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
144675880|NCT01001572|521664477|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
144675881|NCT01001572|521664478|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
144675882|NCT01001572|521664476|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
144675883|NCT01001572|521664477|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
144675884|NCT01001572|521664478|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
144675885|NCT01001572|521664476|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144675886|NCT01001572|521664477|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
144675887|NCT01001572|521664478|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
144675888|NCT01001572|521664476|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
144675889|NCT01001572|521664477|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
144675890|NCT01001572|521664478|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
144675891|NCT01001572|521664476|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
144675892|NCT01001572|521664477|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
144675893|NCT01001572|521664478|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
144675894|NCT01001572|521664476|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
144675895|NCT01001572|521664477|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
144675896|NCT01001572|521664478|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
144675897|NCT01001572|521664476|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144675898|NCT01001572|521664477|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144675899|NCT01001572|521664478|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
144675900|NCT01094808|521664479|FG000|Overall Study|Withdrawal by Subject|1|||
144675901|NCT01094808|521664480|FG001|Overall Study|Withdrawal by Subject|1|||
144675902|NCT01094808|521664481|FG002|Overall Study|Withdrawal by Subject|0|||
144675903|NCT00282568|521664490|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
144675904|NCT00282568|521664490|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
144675905|NCT00282568|521664490|FG000|Extended Treatment Period|Adverse Event|17|||
144675906|NCT00282568|521664490|FG000|Extended Treatment Period|Non-compliance|4|||
144675907|NCT00282568|521664490|FG000|Extended Treatment Period|Physician Decision|1|||
144675908|NCT00282568|521664490|FG000|Extended Treatment Period|Lost to Follow-up|2|||
144675909|NCT00990249|521664495|FG000|Overall Study|Disease Progression|8|||
144675910|NCT00990249|521664495|FG000|Overall Study|Non-Compliance|1|||
144675911|NCT00990249|521664495|FG000|Overall Study|Death|2|||
144675912|NCT00990249|521664495|FG000|Overall Study|Not treated|2|||
144675913|NCT02873208|521664496|FG000|Overall Study|Withdrawal by Subject|36|||
144675914|NCT02873208|521664496|FG000|Overall Study|Lost to Follow-up|22|||
144675915|NCT02873208|521664496|FG000|Overall Study|Adverse Event|15|||
144675916|NCT02873208|521664496|FG000|Overall Study|Non-compliance with study drug|12|||
144675917|NCT02873208|521664496|FG000|Overall Study|Protocol Violation|8|||
144675918|NCT02873208|521664496|FG000|Overall Study|Pregnancy|2|||
144675919|NCT02873208|521664496|FG000|Overall Study|Incarceration|1|||
144675920|NCT02873208|521664496|FG000|Overall Study|Lack of Efficacy|1|||
144675921|NCT02873208|521664496|FG000|Overall Study|Physician Decision|1|||
144675922|NCT00415584|521664497|FG000|Overall Study|Withdrawal by Subject|1|||
144218125|NCT02656303|519992237|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
144218126|NCT02656303|519992235|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
144675923|NCT01831804|521664498|FG000|Overall Study|Adverse Event|0|||
144675924|NCT01831804|521664499|FG001|Overall Study|Adverse Event|0|||
144675925|NCT01831804|521664500|FG002|Overall Study|Adverse Event|0|||
144675926|NCT01831804|521664501|FG003|Overall Study|Adverse Event|0|||
144675927|NCT01831804|521664502|FG004|Overall Study|Adverse Event|0|||
144675928|NCT01831804|521664503|FG005|Overall Study|Adverse Event|0|||
144675929|NCT01831804|521664504|FG006|Overall Study|Adverse Event|1|||
144675930|NCT01831804|521664505|FG007|Overall Study|Adverse Event|0|||
144737020|NCT02605928|521890499|FG000|Overall Study|Lack of Efficacy|5|||
144737021|NCT02530905|521890511|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
144737022|NCT02530905|521890512|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
144737023|NCT02530905|521890513|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
144737024|NCT01231906|521890515|FG000|Overall Study|Lack of Efficacy|75|||
144737025|NCT01231906|521890516|FG001|Overall Study|Lack of Efficacy|68|||
144737026|NCT01231906|521890515|FG000|Overall Study|Lost to Follow-up|1|||
144737027|NCT01231906|521890516|FG001|Overall Study|Lost to Follow-up|0|||
144737028|NCT01231906|521890515|FG000|Overall Study|Physician Decision|34|||
144737029|NCT01231906|521890516|FG001|Overall Study|Physician Decision|24|||
144737030|NCT01231906|521890515|FG000|Overall Study|Withdrawal by Subject|0|||
144737031|NCT01231906|521890516|FG001|Overall Study|Withdrawal by Subject|4|||
144737032|NCT01231906|521890515|FG000|Overall Study|Ineligible|10|||
144737033|NCT01231906|521890516|FG001|Overall Study|Ineligible|3|||
144737034|NCT01231906|521890515|FG000|Overall Study|No treatment|1|||
144737035|NCT01231906|521890516|FG001|Overall Study|No treatment|2|||
144737036|NCT01110005|521890517|FG000|Overall Study|ineligible|1|||
144737037|NCT01110005|521890518|FG001|Overall Study|ineligible|2|||
144737038|NCT01110005|521890517|FG000|Overall Study|missing consent|3|||
144737039|NCT01110005|521890518|FG001|Overall Study|missing consent|2|||
144737040|NCT01110005|521890517|FG000|Overall Study|Withdrawal by Subject|0|||
144737041|NCT01110005|521890518|FG001|Overall Study|Withdrawal by Subject|1|||
144737042|NCT02441309|521890521|FG000|Overall Study|Disease progression|2|||
144737043|NCT02441309|521890522|FG001|Overall Study|Disease progression|1|||
144737044|NCT02441309|521890523|FG002|Overall Study|Disease progression|2|||
144737045|NCT02441309|521890521|FG000|Overall Study|Adverse Event|0|||
144737046|NCT02441309|521890522|FG001|Overall Study|Adverse Event|1|||
144737047|NCT02441309|521890523|FG002|Overall Study|Adverse Event|0|||
144737048|NCT02441309|521890521|FG000|Overall Study|Withdrawal by Subject|1|||
144737049|NCT02441309|521890522|FG001|Overall Study|Withdrawal by Subject|0|||
144737050|NCT02441309|521890523|FG002|Overall Study|Withdrawal by Subject|1|||
144218127|NCT02656303|519992236|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
144218128|NCT02656303|519992237|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
144218129|NCT02656303|519992235|FG000|Overall Study|Reason not Specified|1|||
144218130|NCT02656303|519992236|FG001|Overall Study|Reason not Specified|1|||
144675931|NCT01831804|521664506|FG008|Overall Study|Adverse Event|1|||
144675932|NCT01831804|521664498|FG000|Overall Study|Protocol Violation|0|||
144675933|NCT01831804|521664499|FG001|Overall Study|Protocol Violation|0|||
144675934|NCT01831804|521664500|FG002|Overall Study|Protocol Violation|2|||
144675935|NCT01831804|521664501|FG003|Overall Study|Protocol Violation|0|||
144675936|NCT01831804|521664502|FG004|Overall Study|Protocol Violation|0|||
144675937|NCT01831804|521664503|FG005|Overall Study|Protocol Violation|0|||
144675938|NCT01831804|521664504|FG006|Overall Study|Protocol Violation|0|||
144675939|NCT01831804|521664505|FG007|Overall Study|Protocol Violation|0|||
144675940|NCT01831804|521664506|FG008|Overall Study|Protocol Violation|0|||
144675941|NCT01831804|521664498|FG000|Overall Study|Protocol defined stopping criteria|1|||
144675942|NCT01831804|521664499|FG001|Overall Study|Protocol defined stopping criteria|1|||
144675943|NCT01831804|521664500|FG002|Overall Study|Protocol defined stopping criteria|3|||
144675944|NCT01831804|521664501|FG003|Overall Study|Protocol defined stopping criteria|0|||
144675945|NCT01831804|521664502|FG004|Overall Study|Protocol defined stopping criteria|1|||
144675946|NCT01831804|521664503|FG005|Overall Study|Protocol defined stopping criteria|0|||
144675947|NCT01831804|521664504|FG006|Overall Study|Protocol defined stopping criteria|0|||
144675948|NCT01831804|521664505|FG007|Overall Study|Protocol defined stopping criteria|0|||
144675949|NCT01831804|521664506|FG008|Overall Study|Protocol defined stopping criteria|0|||
144675950|NCT01831804|521664498|FG000|Overall Study|Lost to Follow-up|0|||
144675951|NCT01831804|521664499|FG001|Overall Study|Lost to Follow-up|0|||
144675952|NCT01831804|521664500|FG002|Overall Study|Lost to Follow-up|1|||
144675953|NCT01831804|521664501|FG003|Overall Study|Lost to Follow-up|0|||
144675954|NCT01831804|521664502|FG004|Overall Study|Lost to Follow-up|0|||
144675955|NCT01831804|521664503|FG005|Overall Study|Lost to Follow-up|0|||
144737051|NCT02658084|521890528|FG000|Overall Study|Withdrawal by Subject|1|||
144737052|NCT02658084|521890529|FG001|Overall Study|Withdrawal by Subject|0|||
144737053|NCT02658084|521890528|FG000|Overall Study|Study Termination|1|||
144737054|NCT02658084|521890529|FG001|Overall Study|Study Termination|0|||
144737055|NCT03290781|521890531|FG000|Overall Study|Adverse Event|5|||
144737056|NCT03290781|521890532|FG001|Overall Study|Adverse Event|7|||
144737057|NCT03290781|521890533|FG002|Overall Study|Adverse Event|4|||
144737058|NCT03290781|521890534|FG003|Overall Study|Adverse Event|1|||
144675956|NCT01831804|521664504|FG006|Overall Study|Lost to Follow-up|0|||
144737059|NCT03290781|521890535|FG004|Overall Study|Adverse Event|0|||
144737060|NCT03290781|521890536|FG005|Overall Study|Adverse Event|0|||
144737061|NCT03290781|521890537|FG006|Overall Study|Adverse Event|0|||
144737062|NCT03290781|521890531|FG000|Overall Study|Death|0|||
144675957|NCT01831804|521664505|FG007|Overall Study|Lost to Follow-up|0|||
144737063|NCT03290781|521890532|FG001|Overall Study|Death|0|||
144737064|NCT03290781|521890533|FG002|Overall Study|Death|1|||
144737065|NCT03290781|521890534|FG003|Overall Study|Death|0|||
144737066|NCT03290781|521890535|FG004|Overall Study|Death|1|||
144737067|NCT03290781|521890536|FG005|Overall Study|Death|0|||
144675958|NCT01831804|521664506|FG008|Overall Study|Lost to Follow-up|1|||
144675959|NCT01831804|521664498|FG000|Overall Study|Investigator discretion|0|||
144675960|NCT01831804|521664499|FG001|Overall Study|Investigator discretion|0|||
144675961|NCT01831804|521664500|FG002|Overall Study|Investigator discretion|0|||
144675962|NCT01831804|521664501|FG003|Overall Study|Investigator discretion|0|||
144675963|NCT01831804|521664502|FG004|Overall Study|Investigator discretion|1|||
144675964|NCT01831804|521664503|FG005|Overall Study|Investigator discretion|0|||
144675965|NCT01831804|521664504|FG006|Overall Study|Investigator discretion|0|||
144675966|NCT01831804|521664505|FG007|Overall Study|Investigator discretion|1|||
144675967|NCT01831804|521664506|FG008|Overall Study|Investigator discretion|0|||
144675968|NCT01831804|521664498|FG000|Overall Study|Withdrew Consent|0|||
144675969|NCT01831804|521664499|FG001|Overall Study|Withdrew Consent|1|||
144675970|NCT01831804|521664500|FG002|Overall Study|Withdrew Consent|0|||
144675971|NCT01831804|521664501|FG003|Overall Study|Withdrew Consent|0|||
144675972|NCT01831804|521664502|FG004|Overall Study|Withdrew Consent|0|||
144675973|NCT01831804|521664503|FG005|Overall Study|Withdrew Consent|0|||
144675974|NCT01831804|521664504|FG006|Overall Study|Withdrew Consent|0|||
144675975|NCT01831804|521664505|FG007|Overall Study|Withdrew Consent|2|||
144675976|NCT01831804|521664506|FG008|Overall Study|Withdrew Consent|0|||
144675977|NCT00563368|521664507|FG000|Overall Study|Lost to Follow-up|14|||
144675978|NCT00563368|521664508|FG001|Overall Study|Lost to Follow-up|14|||
144675979|NCT00563368|521664509|FG002|Overall Study|Lost to Follow-up|12|||
144675980|NCT00563368|521664510|FG003|Overall Study|Lost to Follow-up|6|||
144675981|NCT00563368|521664511|FG004|Overall Study|Lost to Follow-up|9|||
144675982|NCT00563368|521664512|FG005|Overall Study|Lost to Follow-up|8|||
144675983|NCT00563368|521664513|FG006|Overall Study|Lost to Follow-up|9|||
144675984|NCT00563368|521664507|FG000|Overall Study|Adverse Event|3|||
144675985|NCT00563368|521664508|FG001|Overall Study|Adverse Event|4|||
144675986|NCT00563368|521664509|FG002|Overall Study|Adverse Event|5|||
144675987|NCT00563368|521664510|FG003|Overall Study|Adverse Event|9|||
144675988|NCT00563368|521664511|FG004|Overall Study|Adverse Event|6|||
144675989|NCT00563368|521664512|FG005|Overall Study|Adverse Event|10|||
144675990|NCT00563368|521664513|FG006|Overall Study|Adverse Event|17|||
144675991|NCT00563368|521664507|FG000|Overall Study|Withdrawal by Subject|11|||
144675992|NCT00563368|521664508|FG001|Overall Study|Withdrawal by Subject|6|||
144675993|NCT00563368|521664509|FG002|Overall Study|Withdrawal by Subject|5|||
144675994|NCT00563368|521664510|FG003|Overall Study|Withdrawal by Subject|7|||
144675995|NCT00563368|521664511|FG004|Overall Study|Withdrawal by Subject|8|||
144675996|NCT00563368|521664512|FG005|Overall Study|Withdrawal by Subject|5|||
144675997|NCT00563368|521664513|FG006|Overall Study|Withdrawal by Subject|4|||
144675998|NCT00563368|521664507|FG000|Overall Study|protocol non-compliance|1|||
144675999|NCT00563368|521664508|FG001|Overall Study|protocol non-compliance|1|||
144676000|NCT00563368|521664509|FG002|Overall Study|protocol non-compliance|2|||
144676001|NCT00563368|521664510|FG003|Overall Study|protocol non-compliance|1|||
144676002|NCT00563368|521664511|FG004|Overall Study|protocol non-compliance|0|||
144676003|NCT00563368|521664512|FG005|Overall Study|protocol non-compliance|1|||
144676004|NCT00563368|521664513|FG006|Overall Study|protocol non-compliance|3|||
144676005|NCT00563368|521664507|FG000|Overall Study|Pregnancy|1|||
144676006|NCT00563368|521664508|FG001|Overall Study|Pregnancy|0|||
144676007|NCT00563368|521664509|FG002|Overall Study|Pregnancy|1|||
144676008|NCT00563368|521664510|FG003|Overall Study|Pregnancy|2|||
144676009|NCT00563368|521664511|FG004|Overall Study|Pregnancy|1|||
144676010|NCT00563368|521664512|FG005|Overall Study|Pregnancy|2|||
144676011|NCT00563368|521664513|FG006|Overall Study|Pregnancy|0|||
144676012|NCT00563368|521664507|FG000|Overall Study|requirement for restricted medication|0|||
144676013|NCT00563368|521664508|FG001|Overall Study|requirement for restricted medication|0|||
144676014|NCT00563368|521664509|FG002|Overall Study|requirement for restricted medication|2|||
144676015|NCT00563368|521664510|FG003|Overall Study|requirement for restricted medication|0|||
144737068|NCT03290781|521890537|FG006|Overall Study|Death|0|||
144737069|NCT03290781|521890531|FG000|Overall Study|Withdrawal by Subject|6|||
144737070|NCT03290781|521890532|FG001|Overall Study|Withdrawal by Subject|5|||
144676016|NCT00563368|521664511|FG004|Overall Study|requirement for restricted medication|0|||
144676017|NCT00563368|521664512|FG005|Overall Study|requirement for restricted medication|0|||
144676018|NCT00563368|521664513|FG006|Overall Study|requirement for restricted medication|0|||
144676019|NCT00563368|521664507|FG000|Overall Study|Other|5|||
144676020|NCT00563368|521664508|FG001|Overall Study|Other|5|||
144737071|NCT03290781|521890533|FG002|Overall Study|Withdrawal by Subject|9|||
144737072|NCT03290781|521890534|FG003|Overall Study|Withdrawal by Subject|10|||
144737073|NCT03290781|521890535|FG004|Overall Study|Withdrawal by Subject|1|||
144737074|NCT03290781|521890536|FG005|Overall Study|Withdrawal by Subject|2|||
144676021|NCT00563368|521664509|FG002|Overall Study|Other|3|||
144676022|NCT00563368|521664510|FG003|Overall Study|Other|4|||
144676023|NCT00563368|521664511|FG004|Overall Study|Other|4|||
144676024|NCT00563368|521664512|FG005|Overall Study|Other|4|||
144676025|NCT00563368|521664513|FG006|Overall Study|Other|0|||
144676026|NCT01061567|521664514|FG000|Overall Study|Adverse Event|32|||
144676027|NCT01061567|521664514|FG000|Overall Study|Death|2|||
144676028|NCT01061567|521664514|FG000|Overall Study|Lack of Efficacy|3|||
144265673|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
144676029|NCT01061567|521664514|FG000|Overall Study|Lost to Follow-up|24|||
144676030|NCT01061567|521664514|FG000|Overall Study|Protocol Violation|1|||
144676031|NCT01061567|521664514|FG000|Overall Study|Withdrawal by Subject|11|||
144676032|NCT01061567|521664514|FG000|Overall Study|Other reason than stated above|3|||
144676033|NCT02640755|521664515|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
144676034|NCT02640755|521664516|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
144676035|NCT02640755|521664515|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
144676036|NCT02640755|521664516|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
144676037|NCT02640755|521664515|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
144676038|NCT02640755|521664516|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
144676039|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
144676040|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
144676041|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
144676042|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
144676043|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
144676044|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
144676045|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
144676046|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
144676047|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
144676048|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
144676049|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
144676050|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
144676051|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
144676052|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
144676053|NCT03434041|521664517|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
144676054|NCT03434041|521664518|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
144676055|NCT03434041|521664517|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
144676056|NCT03434041|521664518|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
144676057|NCT03434041|521664517|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
144676058|NCT03434041|521664518|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
144676059|NCT03434041|521664517|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
144676060|NCT03434041|521664518|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
144676061|NCT03447821|521664519|FG000|Overall Study|Withdrawal by Subject|1|||
144676062|NCT03447821|521664520|FG001|Overall Study|Withdrawal by Subject|1|||
144676063|NCT03447821|521664521|FG002|Overall Study|Withdrawal by Subject|0|||
144676064|NCT03447821|521664519|FG000|Overall Study|Lost to Follow-up|0|||
144676065|NCT03447821|521664520|FG001|Overall Study|Lost to Follow-up|0|||
144676066|NCT03447821|521664521|FG002|Overall Study|Lost to Follow-up|1|||
144676067|NCT01732107|521664524|FG000|Overall Study|Adverse Event|2|||
144676068|NCT01732107|521664524|FG000|Overall Study|Disease Progression|8|||
144676069|NCT01732107|521664524|FG000|Overall Study|Physician Decision|1|||
144676070|NCT01732107|521664524|FG000|Overall Study|Withdrawal by Subject|2|||
144676071|NCT02959190|521664525|FG000|Open Label|Adverse Event|5|||
144676072|NCT02959190|521664526|FG001|Open Label|Adverse Event|7|||
144676073|NCT02959190|521664527|FG002|Open Label|Adverse Event|3|||
144676074|NCT02959190|521664528|FG003|Open Label|Adverse Event|4|||
144676075|NCT02959190|521664525|FG000|Open Label|Pregnancy|0|||
144676076|NCT02959190|521664526|FG001|Open Label|Pregnancy|1|||
144676077|NCT02959190|521664527|FG002|Open Label|Pregnancy|0|||
144676078|NCT02959190|521664528|FG003|Open Label|Pregnancy|0|||
144676079|NCT02959190|521664525|FG000|Open Label|Withdrawal by Subject|2|||
144265674|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
144265675|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
144265676|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144265677|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144265678|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
144265679|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
144265680|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
144265681|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
144265682|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
144265683|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
144265684|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
144265685|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
144676080|NCT02959190|521664526|FG001|Open Label|Withdrawal by Subject|8|||
144676081|NCT02959190|521664527|FG002|Open Label|Withdrawal by Subject|0|||
144265686|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
144265687|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
144676082|NCT02959190|521664528|FG003|Open Label|Withdrawal by Subject|0|||
144676083|NCT02959190|521664525|FG000|Open Label|Physician Decision|0|||
144676084|NCT02959190|521664526|FG001|Open Label|Physician Decision|0|||
144676085|NCT02959190|521664527|FG002|Open Label|Physician Decision|1|||
144676086|NCT02959190|521664528|FG003|Open Label|Physician Decision|0|||
144676087|NCT02959190|521664525|FG000|Open Label|Protocol Violation|0|||
144676088|NCT02959190|521664526|FG001|Open Label|Protocol Violation|0|||
144676089|NCT02959190|521664527|FG002|Open Label|Protocol Violation|0|||
144676090|NCT02959190|521664528|FG003|Open Label|Protocol Violation|2|||
144676091|NCT02959190|521664525|FG000|Post Treatment Follow Up|Adverse Event|1|||
144676092|NCT02959190|521664526|FG001|Post Treatment Follow Up|Adverse Event|1|||
144676093|NCT02959190|521664527|FG002|Post Treatment Follow Up|Adverse Event|0|||
144676094|NCT02959190|521664528|FG003|Post Treatment Follow Up|Adverse Event|0|||
144676095|NCT02959190|521664525|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
144676096|NCT02959190|521664526|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
144676097|NCT02959190|521664527|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
144676098|NCT02959190|521664528|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
144676099|NCT04445688|521664529|FG000|Washout (One Week)|Adverse Event|2|||
144676100|NCT04445688|521664529|FG000|Washout (One Week)|Withdrawal by Subject|1|||
144676101|NCT01235507|521664532|FG000|Overall Study|Adverse Event|1|||
144676102|NCT01235507|521664532|FG000|Overall Study|Withdrawal by Subject|1|||
144676103|NCT02017704|521664538|FG000|Overall Study|Withdrawal by Subject|2|||
144676104|NCT02017704|521664539|FG001|Overall Study|Withdrawal by Subject|0|||
144676105|NCT01963780|521664540|FG000|Overall Study|Death|7|||
144676106|NCT01000025|521664544|FG000|Overall Study|Adverse Event|43|||
144676107|NCT01000025|521664545|FG001|Overall Study|Adverse Event|2|||
144676108|NCT01000025|521664544|FG000|Overall Study|Withdrawal by Subject|13|||
144676109|NCT01000025|521664545|FG001|Overall Study|Withdrawal by Subject|8|||
144676110|NCT01000025|521664544|FG000|Overall Study|Death|23|||
144676111|NCT01000025|521664545|FG001|Overall Study|Death|13|||
144676112|NCT01000025|521664544|FG000|Overall Study|Lack of Efficacy|363|||
144676113|NCT01000025|521664545|FG001|Overall Study|Lack of Efficacy|208|||
144676114|NCT01000025|521664544|FG000|Overall Study|Intercurrent Illness|26|||
144676115|NCT01000025|521664545|FG001|Overall Study|Intercurrent Illness|7|||
144676116|NCT04423757|521664546|FG000|Overall Study|Adverse Event|2|||
144676117|NCT04423757|521664547|FG001|Overall Study|Adverse Event|0|||
144676118|NCT04423757|521664546|FG000|Overall Study|Not treated|1|||
144676119|NCT04423757|521664547|FG001|Overall Study|Not treated|1|||
144676120|NCT02738580|521664548|FG000|Overall Study|Adverse Event|1|||
144676121|NCT02738580|521664549|FG001|Overall Study|Adverse Event|0|||
144676122|NCT02738580|521664548|FG000|Overall Study|Lack of Efficacy|3|||
144676123|NCT02738580|521664549|FG001|Overall Study|Lack of Efficacy|2|||
144676124|NCT02738580|521664548|FG000|Overall Study|Withdrawal by Subject|0|||
144676125|NCT02738580|521664549|FG001|Overall Study|Withdrawal by Subject|1|||
144676126|NCT02738580|521664548|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
144676127|NCT02738580|521664549|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
144676128|NCT01250756|521664552|FG000|Infant Series|Withdrawal by Subject|4|||
144676129|NCT01250756|521664553|FG001|Infant Series|Withdrawal by Subject|5|||
144676130|NCT01250756|521664552|FG000|Infant Series|Randomized, Not Vaccinated|2|||
144676131|NCT01250756|521664553|FG001|Infant Series|Randomized, Not Vaccinated|2|||
144676132|NCT01250756|521664552|FG000|Infant Series|Other|22|||
144676133|NCT01250756|521664553|FG001|Infant Series|Other|0|||
144676134|NCT01250756|521664552|FG000|After Infant Series|Adverse Event|5|||
144676135|NCT01250756|521664553|FG001|After Infant Series|Adverse Event|2|||
144676136|NCT01250756|521664552|FG000|After Infant Series|Withdrawal by Subject|4|||
144676137|NCT01250756|521664553|FG001|After Infant Series|Withdrawal by Subject|1|||
144676138|NCT01250756|521664552|FG000|After Infant Series|Other|2|||
144676139|NCT01250756|521664553|FG001|After Infant Series|Other|1|||
144676140|NCT01250756|521664552|FG000|Toddler Dose|Adverse Event|0|||
144676141|NCT01250756|521664553|FG001|Toddler Dose|Adverse Event|1|||
144676142|NCT01250756|521664552|FG000|After Toddler Dose|Adverse Event|0|||
144676143|NCT01250756|521664553|FG001|After Toddler Dose|Adverse Event|1|||
144676144|NCT02228564|521664554|FG000|Overall Study|Withdrawal by Subject|10|||
144676145|NCT02228564|521664554|FG000|Overall Study|Death|11|||
144676146|NCT02228564|521664554|FG000|Overall Study|Physician Decision|5|||
144676147|NCT02228564|521664554|FG000|Overall Study|Lost to Follow-up|17|||
144676148|NCT02228564|521664554|FG000|Overall Study|Other|6|||
144676149|NCT04114539|521664558|FG000|Overall Study|Adverse Event|14|||
144676150|NCT04114539|521664558|FG000|Overall Study|Lost to Follow-up|2|||
144676151|NCT04114539|521664558|FG000|Overall Study|Non-compliance with Protocol|2|||
144737075|NCT03290781|521890537|FG006|Overall Study|Withdrawal by Subject|0|||
144676152|NCT04114539|521664558|FG000|Overall Study|Non-compliance with Study Drug|1|||
144676153|NCT04114539|521664558|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
144676154|NCT04114539|521664558|FG000|Overall Study|Withdrew consent|10|||
144676155|NCT04114539|521664558|FG000|Overall Study|Others not specified|5|||
144676156|NCT04114539|521664558|FG000|Overall Study|Investigator Decision|2|||
144737076|NCT03290781|521890531|FG000|Overall Study|Physician Decision|0|||
144676157|NCT04285853|521664559|FG000|Overall Study|Withdrawal by Subject|1|||
144676158|NCT04285853|521664560|FG001|Overall Study|Withdrawal by Subject|0|||
144676159|NCT04285853|521664559|FG000|Overall Study|Lost to Follow-up|9|||
144676160|NCT04285853|521664560|FG001|Overall Study|Lost to Follow-up|5|||
144676161|NCT01072448|521664561|FG000|Overall Study|Adverse Event|9|||
144676162|NCT01072448|521664562|FG001|Overall Study|Adverse Event|10|||
144676163|NCT01072448|521664561|FG000|Overall Study|Subject withdrew consent|4|||
144676164|NCT01072448|521664562|FG001|Overall Study|Subject withdrew consent|9|||
144676165|NCT01072448|521664561|FG000|Overall Study|Protocol deviation|3|||
144676166|NCT01072448|521664562|FG001|Overall Study|Protocol deviation|4|||
144676167|NCT01072448|521664561|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144676168|NCT01072448|521664562|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144676169|NCT01072448|521664561|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144676170|NCT01072448|521664562|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144676171|NCT01072448|521664561|FG000|Overall Study|Lost to Follow-up|1|||
144676172|NCT01072448|521664562|FG001|Overall Study|Lost to Follow-up|1|||
144676173|NCT01072448|521664561|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144676174|NCT01072448|521664562|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144676175|NCT01072448|521664561|FG000|Overall Study|Death|0|||
144676176|NCT01072448|521664562|FG001|Overall Study|Death|2|||
144676177|NCT02460978|521664567|FG000|Overall Study|Adverse Event|17|||
144676178|NCT02460978|521664568|FG001|Overall Study|Adverse Event|11|||
144676179|NCT02460978|521664569|FG002|Overall Study|Adverse Event|11|||
144676180|NCT02460978|521664567|FG000|Overall Study|Withdrawal by Subject|5|||
144676181|NCT02460978|521664568|FG001|Overall Study|Withdrawal by Subject|5|||
144676182|NCT02460978|521664569|FG002|Overall Study|Withdrawal by Subject|14|||
144676183|NCT02460978|521664567|FG000|Overall Study|Lost to Follow-up|2|||
144676184|NCT02460978|521664568|FG001|Overall Study|Lost to Follow-up|3|||
144676185|NCT02460978|521664569|FG002|Overall Study|Lost to Follow-up|1|||
144676186|NCT02460978|521664567|FG000|Overall Study|Protocol Violation|1|||
144676187|NCT02460978|521664568|FG001|Overall Study|Protocol Violation|1|||
144676188|NCT02460978|521664569|FG002|Overall Study|Protocol Violation|1|||
144676189|NCT02460978|521664567|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
144676190|NCT02460978|521664568|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
144676191|NCT02460978|521664569|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
144676192|NCT02460978|521664567|FG000|Overall Study|Pregnancy|0|||
144676193|NCT02460978|521664568|FG001|Overall Study|Pregnancy|0|||
144676194|NCT02460978|521664569|FG002|Overall Study|Pregnancy|2|||
144676195|NCT00588523|521664573|FG000|Overall Study|Not treated|3|||
144676196|NCT01459068|521664576|FG000|Overall Study|Withdrawal by Subject|8|||
144676197|NCT01459068|521664577|FG001|Overall Study|Withdrawal by Subject|18|||
144676198|NCT01459068|521664576|FG000|Overall Study|Lost to Follow-up|31|||
144676199|NCT01459068|521664577|FG001|Overall Study|Lost to Follow-up|15|||
144676200|NCT01459068|521664576|FG000|Overall Study|Death|0|||
144676201|NCT01459068|521664577|FG001|Overall Study|Death|1|||
144676202|NCT01015820|521664580|FG000|Overall Study|Suboptimal measurements|1|||
144676203|NCT01015820|521664581|FG001|Overall Study|Suboptimal measurements|0|||
144676204|NCT01313078|521664582|FG000|Overall Study|Death|1|||
144676205|NCT01313078|521664582|FG000|Overall Study|Discontinued study drug|1|||
144676206|NCT01313078|521664582|FG000|Overall Study|Withdrawal by Subject|1|||
144676207|NCT00937326|521667031|FG000|Overall Study|Adverse Event|0|||
144676208|NCT00937326|521667032|FG001|Overall Study|Adverse Event|3|||
144676209|NCT00937326|521667033|FG002|Overall Study|Adverse Event|1|||
144676210|NCT00937326|521667034|FG003|Overall Study|Adverse Event|1|||
144676211|NCT00937326|521667035|FG004|Overall Study|Adverse Event|2|||
144676212|NCT00937326|521667031|FG000|Overall Study|Death|0|||
144676213|NCT00937326|521667032|FG001|Overall Study|Death|0|||
144676214|NCT00937326|521667033|FG002|Overall Study|Death|1|||
144676215|NCT00937326|521667034|FG003|Overall Study|Death|0|||
144676216|NCT00937326|521667035|FG004|Overall Study|Death|0|||
144676217|NCT00937326|521667031|FG000|Overall Study|Withdrawal by Subject|3|||
144676218|NCT00937326|521667032|FG001|Overall Study|Withdrawal by Subject|4|||
144676219|NCT00937326|521667033|FG002|Overall Study|Withdrawal by Subject|1|||
144676220|NCT00937326|521667034|FG003|Overall Study|Withdrawal by Subject|4|||
144676221|NCT00937326|521667035|FG004|Overall Study|Withdrawal by Subject|3|||
144676222|NCT00937326|521667031|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
144676223|NCT00937326|521667032|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
144676224|NCT00937326|521667033|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
144676225|NCT00937326|521667034|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
144676226|NCT00937326|521667035|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
144676227|NCT02578992|521667036|FG000|Overall Study|equipment not available or malfunction|3|||
144676228|NCT02578992|521667037|FG001|Overall Study|equipment not available or malfunction|3|||
144676229|NCT00790218|521667038|FG000|Overall Study|Death|1|||
144676230|NCT00790218|521667039|FG001|Overall Study|Death|0|||
144676231|NCT00790218|521667040|FG002|Overall Study|Death|0|||
144676232|NCT02443155|521667041|FG000|Overall Study|Adverse Event|3|||
144676233|NCT02443155|521667042|FG001|Overall Study|Adverse Event|4|||
144676234|NCT02443155|521667043|FG002|Overall Study|Adverse Event|1|||
144676235|NCT02443155|521667044|FG003|Overall Study|Adverse Event|2|||
144676236|NCT02443155|521667041|FG000|Overall Study|Unclassified|0|||
144676237|NCT02443155|521667042|FG001|Overall Study|Unclassified|0|||
144737077|NCT03290781|521890532|FG001|Overall Study|Physician Decision|1|||
144737078|NCT03290781|521890533|FG002|Overall Study|Physician Decision|0|||
144737079|NCT03290781|521890534|FG003|Overall Study|Physician Decision|0|||
144737080|NCT03290781|521890535|FG004|Overall Study|Physician Decision|0|||
144737081|NCT03290781|521890536|FG005|Overall Study|Physician Decision|0|||
144737082|NCT03290781|521890537|FG006|Overall Study|Physician Decision|0|||
144737083|NCT03290781|521890531|FG000|Overall Study|Site Terminated by Sponsor|1|||
144737084|NCT03290781|521890532|FG001|Overall Study|Site Terminated by Sponsor|0|||
144737085|NCT03290781|521890533|FG002|Overall Study|Site Terminated by Sponsor|2|||
144737086|NCT03290781|521890534|FG003|Overall Study|Site Terminated by Sponsor|1|||
144737087|NCT03290781|521890535|FG004|Overall Study|Site Terminated by Sponsor|0|||
144737088|NCT03290781|521890536|FG005|Overall Study|Site Terminated by Sponsor|0|||
144737089|NCT03290781|521890537|FG006|Overall Study|Site Terminated by Sponsor|0|||
144737090|NCT03290781|521890531|FG000|Overall Study|Lost to Follow-up|0|||
144737091|NCT03290781|521890532|FG001|Overall Study|Lost to Follow-up|0|||
144737092|NCT03290781|521890533|FG002|Overall Study|Lost to Follow-up|0|||
144737093|NCT03290781|521890534|FG003|Overall Study|Lost to Follow-up|1|||
144737094|NCT03290781|521890535|FG004|Overall Study|Lost to Follow-up|0|||
144737095|NCT03290781|521890536|FG005|Overall Study|Lost to Follow-up|0|||
144737096|NCT03290781|521890537|FG006|Overall Study|Lost to Follow-up|0|||
144737097|NCT03290781|521890531|FG000|Overall Study|Protocol Deviation|2|||
144737098|NCT03290781|521890532|FG001|Overall Study|Protocol Deviation|0|||
144737099|NCT03290781|521890533|FG002|Overall Study|Protocol Deviation|0|||
144737100|NCT03290781|521890534|FG003|Overall Study|Protocol Deviation|1|||
144737101|NCT03290781|521890535|FG004|Overall Study|Protocol Deviation|0|||
144737102|NCT03290781|521890536|FG005|Overall Study|Protocol Deviation|0|||
144737103|NCT03290781|521890537|FG006|Overall Study|Protocol Deviation|0|||
144737104|NCT03290781|521890531|FG000|Overall Study|Disease Relapse|32|||
144737105|NCT03290781|521890532|FG001|Overall Study|Disease Relapse|5|||
144737106|NCT03290781|521890533|FG002|Overall Study|Disease Relapse|38|||
144737107|NCT03290781|521890534|FG003|Overall Study|Disease Relapse|7|||
144737108|NCT03290781|521890535|FG004|Overall Study|Disease Relapse|3|||
144737109|NCT03290781|521890536|FG005|Overall Study|Disease Relapse|1|||
144737110|NCT03290781|521890537|FG006|Overall Study|Disease Relapse|4|||
144737111|NCT03290781|521890531|FG000|Overall Study|Other|3|||
144737112|NCT03290781|521890532|FG001|Overall Study|Other|0|||
144737113|NCT03290781|521890533|FG002|Overall Study|Other|2|||
144737114|NCT03290781|521890534|FG003|Overall Study|Other|2|||
144737115|NCT03290781|521890535|FG004|Overall Study|Other|0|||
144737116|NCT03290781|521890536|FG005|Overall Study|Other|0|||
144737117|NCT03290781|521890537|FG006|Overall Study|Other|0|||
144737118|NCT01588236|521890542|FG000|Overall Study|Adverse Event|5|||
144737119|NCT01588236|521890543|FG001|Overall Study|Adverse Event|4|||
144737120|NCT01588236|521890544|FG002|Overall Study|Adverse Event|1|||
144737121|NCT01588236|521890542|FG000|Overall Study|Lost to Follow-up|8|||
144737122|NCT01588236|521890543|FG001|Overall Study|Lost to Follow-up|13|||
144737123|NCT01588236|521890544|FG002|Overall Study|Lost to Follow-up|6|||
144737124|NCT01588236|521890542|FG000|Overall Study|Physician Decision|1|||
144737125|NCT01588236|521890543|FG001|Overall Study|Physician Decision|2|||
144737126|NCT01588236|521890544|FG002|Overall Study|Physician Decision|0|||
144737127|NCT01588236|521890542|FG000|Overall Study|Protocol Violation|0|||
144737128|NCT01588236|521890543|FG001|Overall Study|Protocol Violation|1|||
144737129|NCT01588236|521890544|FG002|Overall Study|Protocol Violation|1|||
144737130|NCT01588236|521890542|FG000|Overall Study|Withdrawal by Subject|14|||
144737131|NCT01588236|521890543|FG001|Overall Study|Withdrawal by Subject|16|||
144737132|NCT01588236|521890544|FG002|Overall Study|Withdrawal by Subject|18|||
144737133|NCT01588236|521890542|FG000|Overall Study|Exclusion Criteria met during study|2|||
144737134|NCT01588236|521890543|FG001|Overall Study|Exclusion Criteria met during study|1|||
144737135|NCT01588236|521890544|FG002|Overall Study|Exclusion Criteria met during study|0|||
144737136|NCT01588236|521890542|FG000|Overall Study|sponsor decision|1|||
144737137|NCT01588236|521890543|FG001|Overall Study|sponsor decision|6|||
144737138|NCT01588236|521890544|FG002|Overall Study|sponsor decision|2|||
144737139|NCT02674152|521892017|FG000|Overall Study|Personal Reasons|1|||
144737140|NCT02674152|521892018|FG001|Overall Study|Personal Reasons|0|||
144737141|NCT02674152|521892019|FG002|Overall Study|Personal Reasons|0|||
144737142|NCT02674152|521892020|FG003|Overall Study|Personal Reasons|1|||
144737143|NCT02674152|521892021|FG004|Overall Study|Personal Reasons|1|||
144737144|NCT02674152|521892017|FG000|Overall Study|Other adverse event or clinical progression|0|||
144737145|NCT02674152|521892018|FG001|Overall Study|Other adverse event or clinical progression|1|||
144737146|NCT02674152|521892019|FG002|Overall Study|Other adverse event or clinical progression|0|||
144737147|NCT02674152|521892020|FG003|Overall Study|Other adverse event or clinical progression|3|||
144737148|NCT02674152|521892021|FG004|Overall Study|Other adverse event or clinical progression|0|||
144737149|NCT02674152|521892017|FG000|Overall Study|Dose-limiting toxicity|0|||
144737150|NCT02674152|521892018|FG001|Overall Study|Dose-limiting toxicity|0|||
144737151|NCT02674152|521892019|FG002|Overall Study|Dose-limiting toxicity|0|||
144737152|NCT02674152|521892020|FG003|Overall Study|Dose-limiting toxicity|0|||
144737153|NCT02674152|521892021|FG004|Overall Study|Dose-limiting toxicity|1|||
144737154|NCT02674152|521892017|FG000|Overall Study|Progressive Disease|2|||
144737155|NCT02674152|521892018|FG001|Overall Study|Progressive Disease|1|||
144676238|NCT02443155|521667043|FG002|Overall Study|Unclassified|2|||
144676239|NCT02443155|521667044|FG003|Overall Study|Unclassified|1|||
144676240|NCT02443155|521667041|FG000|Overall Study|Withdrawal by Subject|4|||
144676241|NCT02443155|521667042|FG001|Overall Study|Withdrawal by Subject|7|||
144676242|NCT02443155|521667043|FG002|Overall Study|Withdrawal by Subject|3|||
144676243|NCT02443155|521667044|FG003|Overall Study|Withdrawal by Subject|9|||
144676244|NCT02443155|521667041|FG000|Overall Study|Pregnancy|3|||
144676245|NCT02443155|521667042|FG001|Overall Study|Pregnancy|1|||
144676246|NCT02443155|521667043|FG002|Overall Study|Pregnancy|1|||
144676247|NCT02443155|521667044|FG003|Overall Study|Pregnancy|2|||
144676248|NCT02443155|521667041|FG000|Overall Study|Lost to Follow-up|1|||
144676249|NCT02443155|521667042|FG001|Overall Study|Lost to Follow-up|2|||
144676250|NCT02443155|521667043|FG002|Overall Study|Lost to Follow-up|0|||
144676251|NCT02443155|521667044|FG003|Overall Study|Lost to Follow-up|1|||
144676252|NCT02443155|521667041|FG000|Overall Study|Protocol Violation|1|||
144676253|NCT02443155|521667042|FG001|Overall Study|Protocol Violation|0|||
144676254|NCT02443155|521667043|FG002|Overall Study|Protocol Violation|1|||
144676255|NCT02443155|521667044|FG003|Overall Study|Protocol Violation|1|||
144676256|NCT02443155|521667041|FG000|Overall Study|Death|0|||
144676257|NCT02443155|521667042|FG001|Overall Study|Death|0|||
144676258|NCT02443155|521667043|FG002|Overall Study|Death|1|||
144676259|NCT02443155|521667044|FG003|Overall Study|Death|0|||
144676260|NCT00693420|521667047|FG000|Overall Study|Adverse Event|4|||
144676261|NCT00693420|521667048|FG001|Overall Study|Adverse Event|4|||
144676262|NCT00693420|521667047|FG000|Overall Study|Lost to Follow-up|0|||
144676263|NCT00693420|521667048|FG001|Overall Study|Lost to Follow-up|3|||
144676264|NCT00693420|521667047|FG000|Overall Study|Withdrawal by Subject|1|||
144676265|NCT00693420|521667048|FG001|Overall Study|Withdrawal by Subject|0|||
144676266|NCT00693420|521667047|FG000|Overall Study|Protocol Violation|0|||
144676267|NCT00693420|521667048|FG001|Overall Study|Protocol Violation|2|||
144676268|NCT00693420|521667047|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
144676269|NCT00693420|521667048|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
144676270|NCT00693420|521667047|FG000|Overall Study|Personal Reasons|1|||
144676271|NCT00693420|521667048|FG001|Overall Study|Personal Reasons|4|||
144676272|NCT03250624|521667051|FG000|Overall Study|Lack of Efficacy|1|||
144676273|NCT03250624|521667052|FG001|Overall Study|Lack of Efficacy|4|||
144676274|NCT03250624|521667051|FG000|Overall Study|Adverse Event|0|||
144676275|NCT03250624|521667052|FG001|Overall Study|Adverse Event|1|||
144676276|NCT03250624|521667051|FG000|Overall Study|Other|1|||
144676277|NCT03250624|521667052|FG001|Overall Study|Other|2|||
144676278|NCT00509028|521667055|FG000|Overall Study|Adverse Event|2|||
144676279|NCT00509028|521667056|FG001|Overall Study|Adverse Event|0|||
144676280|NCT00509028|521667055|FG000|Overall Study|Withdrawal by Subject|4|||
144676281|NCT00509028|521667056|FG001|Overall Study|Withdrawal by Subject|3|||
144676282|NCT00509028|521667055|FG000|Overall Study|Lost to Follow-up|0|||
144676283|NCT00509028|521667056|FG001|Overall Study|Lost to Follow-up|1|||
144676284|NCT00509028|521667055|FG000|Overall Study|Protocol Violation|4|||
144676285|NCT00509028|521667056|FG001|Overall Study|Protocol Violation|2|||
144676286|NCT00509028|521667055|FG000|Overall Study|Non-compliance|2|||
144676287|NCT00509028|521667056|FG001|Overall Study|Non-compliance|1|||
144676288|NCT00948428|521667057|FG000|Overall Study|Withdrawal by Subject|6|||
144676289|NCT00948428|521667058|FG001|Overall Study|Withdrawal by Subject|12|||
144676290|NCT00948428|521667059|FG002|Overall Study|Withdrawal by Subject|7|||
144676291|NCT00948428|521667057|FG000|Overall Study|Adverse Event|6|||
144676292|NCT00948428|521667058|FG001|Overall Study|Adverse Event|3|||
144676293|NCT00948428|521667059|FG002|Overall Study|Adverse Event|0|||
144676294|NCT00948428|521667057|FG000|Overall Study|Lost to Follow-up|2|||
144676295|NCT00948428|521667058|FG001|Overall Study|Lost to Follow-up|1|||
144737156|NCT02674152|521892019|FG002|Overall Study|Progressive Disease|1|||
144737157|NCT02674152|521892020|FG003|Overall Study|Progressive Disease|13|||
144737158|NCT02674152|521892021|FG004|Overall Study|Progressive Disease|2|||
144737159|NCT02674152|521892017|FG000|Overall Study|Adverse Event|0|||
144737160|NCT02674152|521892018|FG001|Overall Study|Adverse Event|0|||
144737161|NCT02674152|521892019|FG002|Overall Study|Adverse Event|1|||
144676296|NCT00948428|521667059|FG002|Overall Study|Lost to Follow-up|1|||
144676297|NCT00948428|521667057|FG000|Overall Study|Death|2|||
144676298|NCT00948428|521667058|FG001|Overall Study|Death|0|||
144676299|NCT00948428|521667059|FG002|Overall Study|Death|0|||
144676300|NCT00948428|521667057|FG000|Overall Study|Intercurrent Illness|1|||
144676301|NCT00948428|521667058|FG001|Overall Study|Intercurrent Illness|0|||
144676302|NCT00948428|521667059|FG002|Overall Study|Intercurrent Illness|0|||
144676303|NCT00948428|521667057|FG000|Overall Study|Non-compliance|1|||
144676304|NCT00948428|521667058|FG001|Overall Study|Non-compliance|2|||
144676305|NCT00948428|521667059|FG002|Overall Study|Non-compliance|0|||
144676306|NCT05283499|521667062|FG000|Overall Study|Did not receive intervention|1|||
144676307|NCT05283499|521667063|FG001|Overall Study|Did not receive intervention|2|||
144737162|NCT02674152|521892020|FG003|Overall Study|Adverse Event|0|||
144737163|NCT02674152|521892021|FG004|Overall Study|Adverse Event|1|||
144676308|NCT02408484|521667064|FG000|Overall Study|Withdrawal by Subject|3|||
144676309|NCT02408484|521667064|FG000|Overall Study|Not treated during study period|1|||
144676310|NCT05516134|521667067|FG000|Overall Study|Lost to Follow-up|1|||
144676311|NCT05516134|521667068|FG001|Overall Study|Lost to Follow-up|0|||
144676312|NCT05516134|521667069|FG002|Overall Study|Lost to Follow-up|0|||
144676313|NCT01510028|521667072|FG000|Overall Study|Lack of Efficacy|1|||
144676314|NCT01510028|521667073|FG001|Overall Study|Lack of Efficacy|0|||
144676315|NCT01510028|521667074|FG002|Overall Study|Lack of Efficacy|0|||
144676316|NCT01510028|521667075|FG003|Overall Study|Lack of Efficacy|0|||
144676317|NCT01355497|521667076|FG000|Overall Study|Death|19|||
144676318|NCT01355497|521667077|FG001|Overall Study|Death|18|||
144676319|NCT01355497|521667076|FG000|Overall Study|Lost to Follow-up|3|||
144676320|NCT01355497|521667077|FG001|Overall Study|Lost to Follow-up|0|||
144676321|NCT01355497|521667076|FG000|Overall Study|Protocol Violation|0|||
144676322|NCT01355497|521667077|FG001|Overall Study|Protocol Violation|1|||
144676323|NCT01355497|521667076|FG000|Overall Study|other-not provided|9|||
144676324|NCT01355497|521667077|FG001|Overall Study|other-not provided|4|||
144676325|NCT01355497|521667076|FG000|Overall Study|Withdrawal by Subject|12|||
144676326|NCT01355497|521667077|FG001|Overall Study|Withdrawal by Subject|20|||
144676327|NCT01355497|521667076|FG000|Overall Study|noncompliance|1|||
144676328|NCT01355497|521667077|FG001|Overall Study|noncompliance|2|||
144676329|NCT01355497|521667076|FG000|Overall Study|progressive disease|11|||
144676330|NCT01355497|521667077|FG001|Overall Study|progressive disease|8|||
144676331|NCT01355497|521667076|FG000|Overall Study|Adverse Event|11|||
144676332|NCT01355497|521667077|FG001|Overall Study|Adverse Event|10|||
144676333|NCT01100658|521667079|FG000|Overall Study|Withdrawal by Subject|1|||
144676334|NCT01548417|521667080|FG000|Overall Study|Withdrawal by Subject|0|||
144676335|NCT01548417|521667081|FG001|Overall Study|Withdrawal by Subject|2|||
144676336|NCT02057068|521667090|FG000|Overall Study|Withdrawal by Subject|2|||
144218131|NCT02656303|519992237|FG002|Overall Study|Reason not Specified|2|||
144218132|NCT03041311|519992240|FG000|Overall Study|Death|39|||
144218133|NCT03041311|519992241|FG001|Overall Study|Death|42|||
144218134|NCT03041311|519992240|FG000|Overall Study|Lost to Follow-up|0|||
144218135|NCT03041311|519992241|FG001|Overall Study|Lost to Follow-up|1|||
144676337|NCT02057068|521667091|FG001|Overall Study|Withdrawal by Subject|2|||
144676338|NCT02057068|521667090|FG000|Overall Study|Caregiver (CG) Health|0|||
144676339|NCT02057068|521667091|FG001|Overall Study|Caregiver (CG) Health|2|||
144676340|NCT02057068|521667090|FG000|Overall Study|Carepartner (CP) Health|4|||
144676341|NCT02057068|521667091|FG001|Overall Study|Carepartner (CP) Health|2|||
144676342|NCT02057068|521667090|FG000|Overall Study|Lost to Follow-up|2|||
144676343|NCT02057068|521667091|FG001|Overall Study|Lost to Follow-up|2|||
144676344|NCT00865046|521667092|FG000|Overall Study|Lost to Follow-up|1|||
144676345|NCT00865046|521667093|FG001|Overall Study|Lost to Follow-up|4|||
144676346|NCT00865046|521667094|FG002|Overall Study|Lost to Follow-up|0|||
144676347|NCT00865046|521667092|FG000|Overall Study|Death|0|||
144676348|NCT00865046|521667093|FG001|Overall Study|Death|1|||
144676349|NCT00865046|521667094|FG002|Overall Study|Death|1|||
144676350|NCT00865046|521667092|FG000|Overall Study|Withdrawal by Subject|5|||
144676351|NCT00865046|521667093|FG001|Overall Study|Withdrawal by Subject|0|||
144676352|NCT00865046|521667094|FG002|Overall Study|Withdrawal by Subject|0|||
144218136|NCT03041311|519992240|FG000|Overall Study|Withdrawal by Subject|8|||
144218137|NCT03041311|519992241|FG001|Overall Study|Withdrawal by Subject|5|||
144218138|NCT03041311|519992240|FG000|Overall Study|Sponsor Terminated Study|2|||
144218139|NCT03041311|519992241|FG001|Overall Study|Sponsor Terminated Study|4|||
144218140|NCT03041311|519992240|FG000|Overall Study|Disease Progression|3|||
144218141|NCT03041311|519992241|FG001|Overall Study|Disease Progression|1|||
144218142|NCT03041311|519992240|FG000|Overall Study|Randomized in error, did not receive drug|2|||
144676353|NCT04685538|521667098|FG000|Overall Study|Adverse Event|0|||
144676354|NCT04685538|521667099|FG001|Overall Study|Adverse Event|1|||
144676355|NCT04685538|521667098|FG000|Overall Study|Lost to Follow-up|0|||
144676356|NCT04685538|521667099|FG001|Overall Study|Lost to Follow-up|2|||
144218143|NCT03041311|519992241|FG001|Overall Study|Randomized in error, did not receive drug|0|||
144676357|NCT03168555|521667101|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
144676358|NCT03168555|521667101|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
144218144|NCT00443729|519992242|FG000|Overall Study|Never Treated|0|||
144218145|NCT00443729|519992243|FG001|Overall Study|Never Treated|1|||
144218146|NCT00443729|519992242|FG000|Overall Study|Lack of Efficacy|4|||
144218147|NCT00443729|519992243|FG001|Overall Study|Lack of Efficacy|2|||
144218148|NCT00443729|519992242|FG000|Overall Study|Lost to Follow-up|0|||
144676359|NCT03168555|521667101|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
144676360|NCT03168555|521667101|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
144676361|NCT01587274|521667104|FG000|Overall Study|Lost to Follow-up|4|||
144676362|NCT01587274|521667105|FG001|Overall Study|Lost to Follow-up|5|||
144676363|NCT01587274|521667106|FG002|Overall Study|Lost to Follow-up|3|||
144676364|NCT01421069|521667107|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
144218149|NCT00443729|519992243|FG001|Overall Study|Lost to Follow-up|1|||
144218150|NCT00443729|519992242|FG000|Overall Study|Physician Decision|2|||
144218151|NCT00443729|519992243|FG001|Overall Study|Physician Decision|1|||
144676365|NCT01421069|521667107|FG000|Parent Study|Failed to return|3|||
144676366|NCT01421069|521667107|FG000|Parent Study|Withdrawal by Subject|1|||
144676367|NCT01421069|521667107|FG000|Parent Study|Lost to Follow-up|2|||
144737164|NCT02571907|521892022|FG000|Overall Study|Death|4|||
144737165|NCT02571907|521892022|FG000|Overall Study|Lost to Follow-up|3|||
144737166|NCT02571907|521892022|FG000|Overall Study|Withdrawal by Subject|3|||
144737167|NCT05265624|521892023|FG000|Overall Study|Lost to Follow-up|3|||
144737168|NCT05265624|521892024|FG001|Overall Study|Lost to Follow-up|0|||
144737169|NCT05265624|521892023|FG000|Overall Study|Withdrawal by Subject|1|||
144737170|NCT05265624|521892024|FG001|Overall Study|Withdrawal by Subject|0|||
144737171|NCT00001703|521892025|FG000|Overall Study|progressed disease|2|||
144737172|NCT00001703|521892025|FG000|Overall Study|No evidence of disease|1|||
144737173|NCT00001703|521892025|FG000|Overall Study|recurrent disease|2|||
144737174|NCT03071575|521892026|FG000|Overall Study|Death|0|||
144737175|NCT03071575|521892027|FG001|Overall Study|Death|1|||
144737176|NCT03071575|521892026|FG000|Overall Study|Lost to Follow-up|5|||
144737177|NCT03071575|521892027|FG001|Overall Study|Lost to Follow-up|11|||
144737178|NCT03071575|521892026|FG000|Overall Study|Withdrawal by Subject|4|||
144737179|NCT03071575|521892027|FG001|Overall Study|Withdrawal by Subject|2|||
144737180|NCT00834795|521892032|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
144737181|NCT00834795|521892033|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
144737182|NCT00834795|521892032|FG000|Second Intervention|Adverse Event|1|||
144737183|NCT00834795|521892033|FG001|Second Intervention|Adverse Event|0|||
144737184|NCT00579345|521892034|FG000|Overall Study|Withdrawal by Subject|2|||
144737185|NCT00579345|521892035|FG001|Overall Study|Withdrawal by Subject|0|||
144737186|NCT00579345|521892036|FG002|Overall Study|Withdrawal by Subject|0|||
144737187|NCT00579345|521892037|FG003|Overall Study|Withdrawal by Subject|0|||
144737188|NCT00579345|521892038|FG004|Overall Study|Withdrawal by Subject|0|||
144737189|NCT00579345|521892039|FG005|Overall Study|Withdrawal by Subject|0|||
144737190|NCT00579345|521892040|FG006|Overall Study|Withdrawal by Subject|0|||
144737191|NCT00579345|521892041|FG007|Overall Study|Withdrawal by Subject|1|||
144737192|NCT00579345|521892034|FG000|Overall Study|Lost to Follow-up|1|||
144737193|NCT00579345|521892035|FG001|Overall Study|Lost to Follow-up|0|||
144737194|NCT00579345|521892036|FG002|Overall Study|Lost to Follow-up|0|||
144737195|NCT00579345|521892037|FG003|Overall Study|Lost to Follow-up|0|||
144737196|NCT00579345|521892038|FG004|Overall Study|Lost to Follow-up|0|||
144737197|NCT00579345|521892039|FG005|Overall Study|Lost to Follow-up|0|||
144737198|NCT00579345|521892040|FG006|Overall Study|Lost to Follow-up|0|||
144737199|NCT00579345|521892041|FG007|Overall Study|Lost to Follow-up|0|||
144737200|NCT00579345|521892034|FG000|Overall Study|Adverse Event|0|||
144737201|NCT00579345|521892035|FG001|Overall Study|Adverse Event|0|||
144737202|NCT00579345|521892036|FG002|Overall Study|Adverse Event|1|||
144737203|NCT00579345|521892037|FG003|Overall Study|Adverse Event|0|||
144737204|NCT00579345|521892038|FG004|Overall Study|Adverse Event|0|||
144737205|NCT00579345|521892039|FG005|Overall Study|Adverse Event|0|||
144737206|NCT00579345|521892040|FG006|Overall Study|Adverse Event|0|||
144737207|NCT00579345|521892041|FG007|Overall Study|Adverse Event|0|||
144737208|NCT00579345|521892034|FG000|Overall Study|Protocol Violation|1|||
144737209|NCT00579345|521892035|FG001|Overall Study|Protocol Violation|0|||
144737210|NCT00579345|521892036|FG002|Overall Study|Protocol Violation|0|||
144737211|NCT00579345|521892037|FG003|Overall Study|Protocol Violation|0|||
144737212|NCT00579345|521892038|FG004|Overall Study|Protocol Violation|0|||
144737213|NCT00579345|521892039|FG005|Overall Study|Protocol Violation|0|||
144737214|NCT00579345|521892040|FG006|Overall Study|Protocol Violation|0|||
144737215|NCT00579345|521892041|FG007|Overall Study|Protocol Violation|1|||
144737216|NCT00579345|521892034|FG000|Overall Study|Death|1|||
144737217|NCT00579345|521892035|FG001|Overall Study|Death|1|||
144737218|NCT00579345|521892036|FG002|Overall Study|Death|1|||
144737219|NCT00579345|521892037|FG003|Overall Study|Death|1|||
144737220|NCT00579345|521892038|FG004|Overall Study|Death|0|||
144737221|NCT00579345|521892039|FG005|Overall Study|Death|0|||
144737222|NCT00579345|521892040|FG006|Overall Study|Death|0|||
144737223|NCT00579345|521892041|FG007|Overall Study|Death|0|||
144218152|NCT00443729|519992242|FG000|Overall Study|Protocol Violation|1|||
144218153|NCT00443729|519992243|FG001|Overall Study|Protocol Violation|1|||
144218154|NCT00443729|519992242|FG000|Overall Study|Withdrawal by Subject|3|||
144218155|NCT00443729|519992243|FG001|Overall Study|Withdrawal by Subject|1|||
144737224|NCT03447353|521892045|FG000|Overall Study|Failure at Screening Visit|2|||
144737225|NCT03447353|521892045|FG000|Overall Study|Lost to Follow-up|4|||
144737226|NCT03447353|521892045|FG000|Overall Study|Scheduling Conflicts|3|||
144737227|NCT03447353|521892045|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
144737228|NCT02057835|521892046|FG000|Overall Study|Withdrawal by Subject|0|||
144737229|NCT02057835|521892047|FG001|Overall Study|Withdrawal by Subject|2|||
144737230|NCT02057835|521892048|FG002|Overall Study|Withdrawal by Subject|0|||
144737231|NCT02057835|521892049|FG003|Overall Study|Withdrawal by Subject|0|||
144737232|NCT02057835|521892050|FG004|Overall Study|Withdrawal by Subject|0|||
144737233|NCT02057835|521892051|FG005|Overall Study|Withdrawal by Subject|0|||
144737234|NCT02057835|521892052|FG006|Overall Study|Withdrawal by Subject|0|||
144737235|NCT02057835|521892053|FG007|Overall Study|Withdrawal by Subject|0|||
144737236|NCT02057835|521892054|FG008|Overall Study|Withdrawal by Subject|0|||
144737237|NCT02057835|521892055|FG009|Overall Study|Withdrawal by Subject|0|||
144737238|NCT02267187|521892056|FG000|Overall Study|Physician Decision|2|||
144737239|NCT02267187|521892056|FG000|Overall Study|Screen fail|3|||
144265688|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
144265689|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
144676368|NCT01421069|521667107|FG000|Parent Study|Lack of Efficacy|1|||
144676369|NCT01421069|521667107|FG000|Overall Period for Extension Study|Other|2|||
144676370|NCT01421069|521667107|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
144676371|NCT01421069|521667107|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
144676372|NCT01421069|521667107|FG000|Overall Period for Extension Study|Pregnancy|1|||
144676373|NCT01421069|521667107|FG000|Overall Period for Extension Study|Adverse Event|1|||
144676374|NCT01421069|521667107|FG000|Overall Period for Extension Study|Protocol Violation|1|||
144676375|NCT01421069|521667107|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
144676376|NCT01421069|521667107|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
144676377|NCT01421069|521667107|FG000|Active Treatment Period|Other|1|||
144676378|NCT01421069|521667107|FG000|Active Treatment Period|No longer willing to participate in study|8|||
144676379|NCT01421069|521667107|FG000|Active Treatment Period|Insufficient clinical response|1|||
144676380|NCT01421069|521667107|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
144676381|NCT01421069|521667107|FG000|Active Treatment Period|Pregnancy|1|||
144676382|NCT01421069|521667107|FG000|Active Treatment Period|Adverse Event|1|||
144676383|NCT01421069|521667107|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
144676384|NCT01421069|521667107|FG000|Active Treatment Period|Enrolled in observational period|29|||
144676385|NCT01421069|521667107|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
144676386|NCT01421069|521667107|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
144676387|NCT01421069|521667107|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
144676388|NCT01421069|521667107|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
144676389|NCT01421069|521667107|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
144676390|NCT01421069|521667107|FG000|2b. Retreatment Period|Protocol Violation|1|||
144676391|NCT01421069|521667107|FG000|Observational Period|Other|1|||
144676392|NCT01421069|521667107|FG000|Observational Period|No longer willing to participate in study|4|||
144676393|NCT01421069|521667107|FG000|Observational Period|Lost to Follow-up|3|||
144676394|NCT01641081|521667108|FG000|Period 1|Sponsor request (potential unblinding)|0|||
144676395|NCT01641081|521667109|FG001|Period 1|Sponsor request (potential unblinding)|0|||
144676396|NCT01641081|521667110|FG002|Period 1|Sponsor request (potential unblinding)|0|||
144676397|NCT01641081|521667111|FG003|Period 1|Sponsor request (potential unblinding)|0|||
144676398|NCT01641081|521667112|FG004|Period 1|Sponsor request (potential unblinding)|0|||
144676399|NCT01641081|521667113|FG005|Period 1|Sponsor request (potential unblinding)|0|||
144676400|NCT01641081|521667114|FG006|Period 1|Sponsor request (potential unblinding)|1|||
144676401|NCT01641081|521667115|FG007|Period 1|Sponsor request (potential unblinding)|0|||
144676402|NCT01641081|521667116|FG008|Period 1|Sponsor request (potential unblinding)|0|||
144676403|NCT01641081|521667117|FG009|Period 1|Sponsor request (potential unblinding)|0|||
144676404|NCT01641081|521667108|FG000|Period 1|Protocol Violation|0|||
144676405|NCT01641081|521667109|FG001|Period 1|Protocol Violation|0|||
144676406|NCT01641081|521667110|FG002|Period 1|Protocol Violation|0|||
144676407|NCT01641081|521667111|FG003|Period 1|Protocol Violation|0|||
144676408|NCT01641081|521667112|FG004|Period 1|Protocol Violation|1|||
144676409|NCT01641081|521667113|FG005|Period 1|Protocol Violation|0|||
144676410|NCT01641081|521667114|FG006|Period 1|Protocol Violation|0|||
144676411|NCT01641081|521667115|FG007|Period 1|Protocol Violation|1|||
144676412|NCT01641081|521667116|FG008|Period 1|Protocol Violation|0|||
144676413|NCT01641081|521667117|FG009|Period 1|Protocol Violation|0|||
144676414|NCT01641081|521667108|FG000|Period 1|Adverse Event|1|||
144676415|NCT01641081|521667109|FG001|Period 1|Adverse Event|0|||
144676416|NCT01641081|521667110|FG002|Period 1|Adverse Event|0|||
144676417|NCT01641081|521667111|FG003|Period 1|Adverse Event|0|||
144676418|NCT01641081|521667112|FG004|Period 1|Adverse Event|0|||
144676419|NCT01641081|521667113|FG005|Period 1|Adverse Event|0|||
144676420|NCT01641081|521667114|FG006|Period 1|Adverse Event|0|||
144676421|NCT01641081|521667115|FG007|Period 1|Adverse Event|2|||
144676422|NCT01641081|521667116|FG008|Period 1|Adverse Event|0|||
144676423|NCT01641081|521667117|FG009|Period 1|Adverse Event|0|||
144676424|NCT01641081|521667108|FG000|Period 2|Adverse Event|0|||
144676425|NCT01641081|521667109|FG001|Period 2|Adverse Event|0|||
144676426|NCT01641081|521667110|FG002|Period 2|Adverse Event|0|||
144676427|NCT01641081|521667111|FG003|Period 2|Adverse Event|0|||
144676428|NCT01641081|521667112|FG004|Period 2|Adverse Event|0|||
144676429|NCT01641081|521667113|FG005|Period 2|Adverse Event|1|||
144676430|NCT01641081|521667114|FG006|Period 2|Adverse Event|0|||
144676431|NCT01641081|521667115|FG007|Period 2|Adverse Event|0|||
144676432|NCT01641081|521667116|FG008|Period 2|Adverse Event|0|||
144676433|NCT01641081|521667117|FG009|Period 2|Adverse Event|0|||
144676434|NCT01641081|521667108|FG000|Period 2|Withdrawal by Subject|0|||
144676435|NCT01641081|521667109|FG001|Period 2|Withdrawal by Subject|0|||
144676436|NCT01641081|521667110|FG002|Period 2|Withdrawal by Subject|0|||
144676437|NCT01641081|521667111|FG003|Period 2|Withdrawal by Subject|1|||
144676438|NCT01641081|521667112|FG004|Period 2|Withdrawal by Subject|0|||
144676439|NCT01641081|521667113|FG005|Period 2|Withdrawal by Subject|0|||
144676440|NCT01641081|521667114|FG006|Period 2|Withdrawal by Subject|2|||
144676441|NCT01641081|521667115|FG007|Period 2|Withdrawal by Subject|0|||
144218156|NCT01842438|519992244|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
144218157|NCT01842438|519992245|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
144676442|NCT01641081|521667116|FG008|Period 2|Withdrawal by Subject|0|||
144676443|NCT01641081|521667117|FG009|Period 2|Withdrawal by Subject|0|||
144676444|NCT01641081|521667108|FG000|Period 2|Protocol Violation|1|||
144676445|NCT01641081|521667109|FG001|Period 2|Protocol Violation|0|||
144676446|NCT01641081|521667110|FG002|Period 2|Protocol Violation|0|||
144676447|NCT01641081|521667111|FG003|Period 2|Protocol Violation|0|||
144676448|NCT01641081|521667112|FG004|Period 2|Protocol Violation|0|||
144676449|NCT01641081|521667113|FG005|Period 2|Protocol Violation|0|||
144676450|NCT01641081|521667114|FG006|Period 2|Protocol Violation|0|||
144676451|NCT01641081|521667115|FG007|Period 2|Protocol Violation|0|||
144676452|NCT01641081|521667116|FG008|Period 2|Protocol Violation|0|||
144676453|NCT01641081|521667117|FG009|Period 2|Protocol Violation|0|||
144676454|NCT01641081|521667108|FG000|Period 3|Adverse Event|0|||
144676455|NCT01641081|521667109|FG001|Period 3|Adverse Event|0|||
144676456|NCT01641081|521667110|FG002|Period 3|Adverse Event|1|||
144676457|NCT01641081|521667111|FG003|Period 3|Adverse Event|0|||
144676458|NCT01641081|521667112|FG004|Period 3|Adverse Event|0|||
144676459|NCT01641081|521667113|FG005|Period 3|Adverse Event|0|||
144676460|NCT01641081|521667114|FG006|Period 3|Adverse Event|0|||
144676461|NCT01641081|521667115|FG007|Period 3|Adverse Event|0|||
144676462|NCT01641081|521667116|FG008|Period 3|Adverse Event|0|||
144676463|NCT01641081|521667117|FG009|Period 3|Adverse Event|0|||
144676464|NCT01641081|521667108|FG000|Period 3|Withdrawal by Subject|0|||
144676465|NCT01641081|521667109|FG001|Period 3|Withdrawal by Subject|0|||
144676466|NCT01641081|521667110|FG002|Period 3|Withdrawal by Subject|0|||
144676467|NCT01641081|521667111|FG003|Period 3|Withdrawal by Subject|0|||
144676468|NCT01641081|521667112|FG004|Period 3|Withdrawal by Subject|0|||
144676469|NCT01641081|521667113|FG005|Period 3|Withdrawal by Subject|0|||
144676470|NCT01641081|521667114|FG006|Period 3|Withdrawal by Subject|0|||
144676471|NCT01641081|521667115|FG007|Period 3|Withdrawal by Subject|0|||
144676472|NCT01641081|521667116|FG008|Period 3|Withdrawal by Subject|1|||
144676473|NCT01641081|521667117|FG009|Period 3|Withdrawal by Subject|0|||
144676474|NCT01641081|521667108|FG000|Period 4|Adverse Event|0|||
144676475|NCT01641081|521667109|FG001|Period 4|Adverse Event|1|||
144676476|NCT01641081|521667110|FG002|Period 4|Adverse Event|0|||
144676477|NCT01641081|521667111|FG003|Period 4|Adverse Event|1|||
144676478|NCT01641081|521667112|FG004|Period 4|Adverse Event|0|||
144676479|NCT01641081|521667113|FG005|Period 4|Adverse Event|0|||
144676480|NCT01641081|521667114|FG006|Period 4|Adverse Event|0|||
144676481|NCT01641081|521667115|FG007|Period 4|Adverse Event|0|||
144676482|NCT01641081|521667116|FG008|Period 4|Adverse Event|0|||
144676483|NCT01641081|521667117|FG009|Period 4|Adverse Event|0|||
144676484|NCT01641081|521667108|FG000|Period 5|Adverse Event|0|||
144676485|NCT01641081|521667109|FG001|Period 5|Adverse Event|0|||
144676486|NCT01641081|521667110|FG002|Period 5|Adverse Event|2|||
144676487|NCT01641081|521667111|FG003|Period 5|Adverse Event|0|||
144676488|NCT01641081|521667112|FG004|Period 5|Adverse Event|0|||
144676489|NCT01641081|521667113|FG005|Period 5|Adverse Event|0|||
144676490|NCT01641081|521667114|FG006|Period 5|Adverse Event|0|||
144676491|NCT01641081|521667115|FG007|Period 5|Adverse Event|0|||
144676492|NCT01641081|521667116|FG008|Period 5|Adverse Event|0|||
144676493|NCT01641081|521667117|FG009|Period 5|Adverse Event|0|||
144676494|NCT03383614|521667122|FG000|Overall Study|Withdrawal by Subject|0|||
144676495|NCT03383614|521667123|FG001|Overall Study|Withdrawal by Subject|1|||
144676496|NCT03383614|521667124|FG002|Overall Study|Withdrawal by Subject|0|||
144676497|NCT03383614|521667125|FG003|Overall Study|Withdrawal by Subject|0|||
144676498|NCT01749800|521667126|FG000|Overall Study|not meeting inclusion criteria|3|||
144676499|NCT01749800|521667127|FG001|Overall Study|not meeting inclusion criteria|0|||
144676500|NCT01749800|521667128|FG002|Overall Study|not meeting inclusion criteria|0|||
144676501|NCT01749800|521667126|FG000|Overall Study|Withdrawal by Subject|0|||
144676502|NCT01749800|521667127|FG001|Overall Study|Withdrawal by Subject|1|||
144676503|NCT01749800|521667128|FG002|Overall Study|Withdrawal by Subject|0|||
144676504|NCT00841672|521667130|FG000|Overall Study|Adverse Event|7|||
144676505|NCT00841672|521667131|FG001|Overall Study|Adverse Event|16|||
144676506|NCT00841672|521667130|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144676507|NCT00841672|521667131|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144676508|NCT00841672|521667130|FG000|Overall Study|Subject withdrew consent|2|||
144676509|NCT00841672|521667131|FG001|Overall Study|Subject withdrew consent|4|||
144676510|NCT00841672|521667130|FG000|Overall Study|Lost to Follow-up|1|||
144676511|NCT00841672|521667131|FG001|Overall Study|Lost to Follow-up|1|||
144676512|NCT00841672|521667130|FG000|Overall Study|Administrative problems|9|||
144676513|NCT00841672|521667131|FG001|Overall Study|Administrative problems|9|||
144676514|NCT00841672|521667130|FG000|Overall Study|Misrandomized|1|||
144676515|NCT00841672|521667131|FG001|Overall Study|Misrandomized|0|||
144676516|NCT00841672|521667130|FG000|Overall Study|Protocol Deviation|0|||
144676517|NCT00841672|521667131|FG001|Overall Study|Protocol Deviation|1|||
144676518|NCT01451398|521667132|FG000|Overall Study|Adverse Event|7|||
144676519|NCT01451398|521667133|FG001|Overall Study|Adverse Event|9|||
144676520|NCT01451398|521667132|FG000|Overall Study|Protocol Violation|1|||
144676521|NCT01451398|521667133|FG001|Overall Study|Protocol Violation|2|||
144676522|NCT01451398|521667132|FG000|Overall Study|Physician Decision|1|||
144676523|NCT01451398|521667133|FG001|Overall Study|Physician Decision|1|||
144676524|NCT01451398|521667132|FG000|Overall Study|Withdrawal by Subject|10|||
144676525|NCT01451398|521667133|FG001|Overall Study|Withdrawal by Subject|14|||
144676526|NCT01451398|521667132|FG000|Overall Study|Lost to Follow-up|6|||
144676527|NCT01451398|521667133|FG001|Overall Study|Lost to Follow-up|4|||
144676528|NCT01451398|521667132|FG000|Overall Study|Non-compliance with study drug|1|||
144676529|NCT01451398|521667133|FG001|Overall Study|Non-compliance with study drug|3|||
144676530|NCT01451398|521667132|FG000|Overall Study|Non-compliance with protocol|1|||
144676531|NCT01451398|521667133|FG001|Overall Study|Non-compliance with protocol|1|||
144676532|NCT01451398|521667132|FG000|Overall Study|Moved out of country|0|||
144676533|NCT01451398|521667133|FG001|Overall Study|Moved out of country|1|||
144676534|NCT01451398|521667132|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
144676535|NCT01451398|521667133|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
144676536|NCT01451398|521667132|FG000|Overall Study|Lack of Efficacy|0|||
144676537|NCT01451398|521667133|FG001|Overall Study|Lack of Efficacy|1|||
144676538|NCT00422669|521667134|FG000|Overall Study|The study was terminated early.|98|||
144676539|NCT00422669|521667135|FG001|Overall Study|The study was terminated early.|100|||
144676540|NCT00422669|521667136|FG002|Overall Study|The study was terminated early.|7|||
144676541|NCT02709109|521667137|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
144676542|NCT02709109|521667138|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
144676543|NCT02709109|521667139|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
144676544|NCT02709109|521667140|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
144676545|NCT02709109|521667137|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
144676546|NCT02709109|521667138|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
144676547|NCT02709109|521667139|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
144676548|NCT02709109|521667140|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
144676549|NCT02709109|521667137|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
144676550|NCT02709109|521667138|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
144676551|NCT02709109|521667139|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
144676552|NCT02709109|521667140|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
144676553|NCT02709109|521667137|FG000|Washout Period (28 Days)|Other|2|||
144676554|NCT02709109|521667138|FG001|Washout Period (28 Days)|Other|2|||
144676555|NCT02709109|521667139|FG002|Washout Period (28 Days)|Other|3|||
144676556|NCT02709109|521667140|FG003|Washout Period (28 Days)|Other|0|||
144676557|NCT02709109|521667137|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
144676558|NCT02709109|521667138|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
144676559|NCT02709109|521667139|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
144676560|NCT02709109|521667140|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
144676561|NCT02709109|521667137|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
144676562|NCT02709109|521667138|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
144676563|NCT02709109|521667139|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
144676564|NCT02709109|521667140|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
144676565|NCT02709109|521667137|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
144676566|NCT02709109|521667138|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
144676567|NCT02709109|521667139|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
144676568|NCT02709109|521667140|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
144676569|NCT02709109|521667137|FG000|Treatment Period 2 (28 Days)|Other|0|||
144676570|NCT02709109|521667138|FG001|Treatment Period 2 (28 Days)|Other|0|||
144676571|NCT02709109|521667139|FG002|Treatment Period 2 (28 Days)|Other|1|||
144676572|NCT02709109|521667140|FG003|Treatment Period 2 (28 Days)|Other|0|||
144676573|NCT01928082|521667145|FG000|Overall Study|Study terminated.|1|||
144676574|NCT01815580|521667149|FG000|Overall Study|Lost to Follow-up|4|||
144676575|NCT01815580|521667150|FG001|Overall Study|Lost to Follow-up|7|||
144676576|NCT01815580|521667149|FG000|Overall Study|Withdrawal by Subject|3|||
144676577|NCT01815580|521667150|FG001|Overall Study|Withdrawal by Subject|4|||
144676578|NCT01815580|521667149|FG000|Overall Study|Excluded from analysis|5|||
144676579|NCT01815580|521667150|FG001|Overall Study|Excluded from analysis|4|||
144676580|NCT00166517|521667154|FG000|Overall Study|Lost to Follow-up|1|||
144676581|NCT00166517|521667155|FG001|Overall Study|Lost to Follow-up|0|||
144676582|NCT00166517|521667154|FG000|Overall Study|Protocol Violation|4|||
144676583|NCT00166517|521667155|FG001|Overall Study|Protocol Violation|1|||
144737240|NCT03025087|521892057|FG000|Overall Study|Physician Decision|3|||
144676584|NCT00166517|521667154|FG000|Overall Study|Withdrawal by Subject|0|||
144676585|NCT00166517|521667155|FG001|Overall Study|Withdrawal by Subject|1|||
144676586|NCT03094611|521667159|FG000|Overall Study|Lack of Efficacy|1|||
144676587|NCT03094611|521667159|FG000|Overall Study|Stem Cell Transplant|1|||
144676588|NCT02186561|521667160|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
144676589|NCT02186561|521667160|FG000|Enrollment|Enrollment Cap Reached|5|||
144676590|NCT02186561|521667160|FG000|Enrollment|Insurance Denial|2|||
144676591|NCT02186561|521667160|FG000|Enrollment|Withdrawal by Subject|2|||
144676592|NCT02186561|521667160|FG000|Enrollment|Investigator Withdrew Consent|1|||
144676593|NCT02186561|521667160|FG000|30-Day Post Index Procedure Visit|Death|1|||
144676594|NCT02186561|521667160|FG000|1- Year Post Index Procedure Visit|Death|1|||
144676595|NCT02186561|521667160|FG000|1- Year Post Index Procedure Visit|Missed|1|||
144676596|NCT00842361|521667161|FG000|Overall Study|Protocol Violation|1|||
144676597|NCT00842361|521667162|FG001|Overall Study|Protocol Violation|0|||
144676598|NCT00842361|521667161|FG000|Overall Study|Unclassified|0|||
144676599|NCT00842361|521667162|FG001|Overall Study|Unclassified|2|||
144676600|NCT02023112|521667163|FG000|Overall Study|Withdrawal by Subject|2|||
144676601|NCT02023112|521667164|FG001|Overall Study|Withdrawal by Subject|1|||
144676602|NCT03136484|521667165|FG000|Overall Study|Withdrawal by Subject|19|||
144676603|NCT03136484|521667166|FG001|Overall Study|Withdrawal by Subject|14|||
144676604|NCT03136484|521667165|FG000|Overall Study|Lost to Follow-up|7|||
144676605|NCT03136484|521667166|FG001|Overall Study|Lost to Follow-up|8|||
144676606|NCT03136484|521667165|FG000|Overall Study|Death|1|||
144676607|NCT03136484|521667166|FG001|Overall Study|Death|0|||
144676608|NCT01449955|521667171|FG000|Overall Study|Withdrawal by Subject|1|||
144676609|NCT01449955|521667172|FG001|Overall Study|Withdrawal by Subject|2|||
144676610|NCT01601470|521667173|FG000|Period 2 - LCZ696|Physician Decision|1|||
144676611|NCT01176240|521667176|FG000|Study 306A|Lack of Efficacy|2|||
144676612|NCT01176240|521667177|FG001|Study 306A|Lack of Efficacy|1|||
144676613|NCT01176240|521667176|FG000|Study 306A|Protocol Violation|0|||
144676614|NCT01176240|521667177|FG001|Study 306A|Protocol Violation|1|||
144676615|NCT01176240|521667176|FG000|Study 306A|Withdrawal by Subject|0|||
144676616|NCT01176240|521667177|FG001|Study 306A|Withdrawal by Subject|1|||
144676617|NCT01176240|521667176|FG000|Study 306A|Stop due to diverse problems|1|||
144676618|NCT01176240|521667177|FG001|Study 306A|Stop due to diverse problems|0|||
144676619|NCT01176240|521667176|FG000|Study 306B|Lack of Efficacy|5|||
144676620|NCT01176240|521667177|FG001|Study 306B|Lack of Efficacy|3|||
144676621|NCT01176240|521667176|FG000|Study 306B|Adverse Event|10|||
144676622|NCT01176240|521667177|FG001|Study 306B|Adverse Event|5|||
144676623|NCT01176240|521667176|FG000|Study 306B|Protocol Violation|2|||
144676624|NCT01176240|521667177|FG001|Study 306B|Protocol Violation|3|||
144676625|NCT01176240|521667176|FG000|Study 306B|Withdrawal by Subject|4|||
144676626|NCT01176240|521667177|FG001|Study 306B|Withdrawal by Subject|1|||
144676627|NCT01176240|521667176|FG000|Study 306B|Physician Decision|2|||
144676628|NCT01176240|521667177|FG001|Study 306B|Physician Decision|1|||
144676629|NCT01176240|521667176|FG000|Study 306B|Supine Hypertension|1|||
144676630|NCT01176240|521667177|FG001|Study 306B|Supine Hypertension|2|||
144676631|NCT01176240|521667176|FG000|Study 306B|Lost to Follow-up|0|||
144676632|NCT01176240|521667177|FG001|Study 306B|Lost to Follow-up|1|||
144676633|NCT01176240|521667176|FG000|Study 306B|withdrew prior to dosing|2|||
144676634|NCT01176240|521667177|FG001|Study 306B|withdrew prior to dosing|1|||
144676635|NCT02650895|521667183|FG000|Overall Study|Withdrawal by Subject|0|||
144676636|NCT02650895|521667184|FG001|Overall Study|Withdrawal by Subject|1|||
144676637|NCT02650895|521667185|FG002|Overall Study|Withdrawal by Subject|0|||
144676638|NCT02650895|521667186|FG003|Overall Study|Withdrawal by Subject|0|||
144676639|NCT02650895|521667187|FG004|Overall Study|Withdrawal by Subject|0|||
144676640|NCT02650895|521667188|FG005|Overall Study|Withdrawal by Subject|0|||
144676641|NCT03627494|521667189|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
144676642|NCT03627494|521667190|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676643|NCT03627494|521667191|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
144676644|NCT03627494|521667192|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676645|NCT03627494|521667193|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676646|NCT03627494|521667194|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
144265690|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
144676647|NCT03627494|521667195|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676648|NCT03627494|521667196|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676649|NCT03627494|521667197|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676650|NCT03627494|521667198|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676651|NCT03627494|521667199|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676652|NCT03627494|521667200|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
144676653|NCT03627494|521667189|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676654|NCT03627494|521667190|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676655|NCT03627494|521667191|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676656|NCT03627494|521667192|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676657|NCT03627494|521667193|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676658|NCT03627494|521667194|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676659|NCT03627494|521667195|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676660|NCT03627494|521667196|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
144737241|NCT03025087|521892058|FG001|Overall Study|Physician Decision|3|||
144676661|NCT03627494|521667197|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
144676662|NCT03627494|521667198|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676663|NCT03627494|521667199|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676664|NCT03627494|521667200|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
144676665|NCT03627494|521667189|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676666|NCT03627494|521667190|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
144737242|NCT03025087|521892059|FG002|Overall Study|Physician Decision|0|||
144218158|NCT01842438|519992244|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
144218159|NCT01842438|519992245|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
144218160|NCT01842438|519992244|FG000|T2: 6month Follow-up|Death|0|||
144218161|NCT01842438|519992245|FG001|T2: 6month Follow-up|Death|1|||
144218162|NCT00782626|519992249|FG000|Overall Study|Adverse Event|1|||
144676667|NCT03627494|521667191|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676668|NCT03627494|521667192|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676669|NCT03627494|521667193|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676670|NCT03627494|521667194|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676671|NCT03627494|521667195|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676672|NCT03627494|521667196|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676673|NCT03627494|521667197|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676674|NCT03627494|521667198|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
144676675|NCT03627494|521667199|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
144676676|NCT03627494|521667200|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
144676677|NCT03906136|521669165|FG000|Overall Study|Adverse Event|1|||
144676678|NCT03906136|521669166|FG001|Overall Study|Adverse Event|0|||
144676679|NCT03906136|521669165|FG000|Overall Study|Lost to Follow-up|7|||
144676680|NCT03906136|521669166|FG001|Overall Study|Lost to Follow-up|4|||
144676681|NCT03906136|521669165|FG000|Overall Study|Physician Decision|1|||
144676682|NCT03906136|521669166|FG001|Overall Study|Physician Decision|0|||
144676683|NCT03906136|521669165|FG000|Overall Study|Withdrawal by Subject|3|||
144676684|NCT03906136|521669166|FG001|Overall Study|Withdrawal by Subject|7|||
144676685|NCT00405275|521669170|FG000|Overall Study|Death|1|||
144676686|NCT00405275|521669171|FG001|Overall Study|Death|0|||
144676687|NCT00405275|521669170|FG000|Overall Study|Lost to Follow-up|5|||
144676688|NCT00405275|521669171|FG001|Overall Study|Lost to Follow-up|1|||
144676689|NCT00405275|521669170|FG000|Overall Study|Withdrawal by Subject|7|||
144676690|NCT00405275|521669171|FG001|Overall Study|Withdrawal by Subject|9|||
144676691|NCT00405275|521669170|FG000|Overall Study|Unwilling to continue|10|||
144676692|NCT00405275|521669171|FG001|Overall Study|Unwilling to continue|9|||
144676693|NCT01308853|521669172|FG000|Overall Study|Adverse Event|1|||
144676694|NCT01308853|521669172|FG000|Overall Study|Lost to Follow-up|2|||
144676695|NCT01308853|521669172|FG000|Overall Study|Insertion of permanent implants|1|||
144676696|NCT02853123|521669175|FG000|Treatment Period 1|Adverse Event|0|||
144676697|NCT02853123|521669176|FG001|Treatment Period 1|Adverse Event|3|||
144676698|NCT02853123|521669175|FG000|Washout Period|Worsening of COPD|0|||
144676699|NCT02853123|521669176|FG001|Washout Period|Worsening of COPD|3|||
144676700|NCT02853123|521669175|FG000|Washout Period|Adverse Event|1|||
144676701|NCT02853123|521669176|FG001|Washout Period|Adverse Event|0|||
144676702|NCT00106249|521669178|FG000|Overall Study|Lost to Follow-up|3|||
144676703|NCT00106249|521669179|FG001|Overall Study|Lost to Follow-up|2|||
144676704|NCT01117181|521669180|FG000|Overall Study|Lost to Follow-up|1|||
144676705|NCT01117181|521669181|FG001|Overall Study|Lost to Follow-up|0|||
144676706|NCT01117181|521669180|FG000|Overall Study|Withdrawal by Subject|0|||
144676707|NCT01117181|521669181|FG001|Overall Study|Withdrawal by Subject|2|||
144676708|NCT01495689|521669185|FG000|Overall Study|Death|0|||
144676709|NCT01495689|521669186|FG001|Overall Study|Death|1|||
144676710|NCT01495689|521669185|FG000|Overall Study|Withdrawal by Subject|3|||
144676711|NCT01495689|521669186|FG001|Overall Study|Withdrawal by Subject|0|||
144676712|NCT01495689|521669185|FG000|Overall Study|Lost to Follow-up|7|||
144676713|NCT01495689|521669186|FG001|Overall Study|Lost to Follow-up|6|||
144676714|NCT00517413|521669193|FG000|Overall Study|Adverse Event|7|||
144676715|NCT00517413|521669193|FG000|Overall Study|Death|13|||
144676716|NCT00517413|521669193|FG000|Overall Study|Protocol Violation|15|||
144676717|NCT00517413|521669193|FG000|Overall Study|Withdrawal by Subject|2|||
144676718|NCT00517413|521669193|FG000|Overall Study|Failure to return|1|||
144676719|NCT00517413|521669193|FG000|Overall Study|Other-Reasons|23|||
144676720|NCT00606177|521669194|FG000|Overall Study|Adverse Event|9|||
144676721|NCT00606177|521669195|FG001|Overall Study|Adverse Event|5|||
144676722|NCT00606177|521669194|FG000|Overall Study|Lack of Efficacy|3|||
144676723|NCT00606177|521669195|FG001|Overall Study|Lack of Efficacy|7|||
144676724|NCT00606177|521669194|FG000|Overall Study|Physician Decision|1|||
144218163|NCT00782626|519992249|FG000|Overall Study|Progressive Disease|5|||
144218164|NCT00782626|519992249|FG000|Overall Study|Other Complicating Disease|1|||
144218165|NCT04054765|519992250|FG000|Baseline|Withdrawal by Subject|5|||
144676725|NCT00606177|521669195|FG001|Overall Study|Physician Decision|0|||
144676726|NCT00606177|521669194|FG000|Overall Study|Protocol Violation|1|||
144676727|NCT00606177|521669195|FG001|Overall Study|Protocol Violation|4|||
144676728|NCT00606177|521669194|FG000|Overall Study|Withdrawal by Subject|5|||
144218166|NCT04054765|519992251|FG001|Baseline|Withdrawal by Subject|3|||
144218167|NCT04054765|519992250|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
144676729|NCT00606177|521669195|FG001|Overall Study|Withdrawal by Subject|6|||
144676730|NCT00606177|521669194|FG000|Overall Study|Progression to depressive phase|6|||
144676731|NCT00606177|521669195|FG001|Overall Study|Progression to depressive phase|1|||
144676732|NCT00606177|521669194|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
144676733|NCT00606177|521669195|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
144676734|NCT00606177|521669194|FG000|Overall Study|Change of residence or other commitments|1|||
144265691|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Death|0|||
144265692|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Death|0|||
144265693|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Death|1|||
144265694|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Death|0|||
144676735|NCT00606177|521669195|FG001|Overall Study|Change of residence or other commitments|1|||
144676736|NCT00136357|521669196|FG000|Overall Study|Withdrawal by Subject|3|||
144676737|NCT00136357|521669197|FG001|Overall Study|Withdrawal by Subject|2|||
144676738|NCT02603172|521669203|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676739|NCT02603172|521669204|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676740|NCT02603172|521669205|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
144676741|NCT02603172|521669206|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676742|NCT02603172|521669207|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676743|NCT02603172|521669208|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676744|NCT02603172|521669209|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676745|NCT02603172|521669210|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
144676746|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Death|3|||
144676747|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Death|0|||
144676748|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Death|0|||
144676749|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Death|0|||
144676750|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Death|0|||
144676751|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
144676752|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
144676753|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
144676754|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
144676755|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
144676756|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
144676757|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
144676758|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
144676759|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
144676760|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
144676761|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Other|0|||
144676762|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Other|0|||
144676763|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Other|1|||
144676764|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Other|0|||
144676765|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Other|0|||
144676766|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
144676767|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
144676768|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
144676769|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
144676770|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
144676771|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
144676772|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
144676773|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
144676774|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
144676775|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
144676776|NCT01224106|521669213|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
144676777|NCT01224106|521669214|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144676778|NCT01224106|521669215|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
144676779|NCT01224106|521669216|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144676780|NCT01224106|521669217|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144676781|NCT01224106|521669213|FG000|Open-Label Extension (OLE) Phase|Death|0|||
144676782|NCT01224106|521669214|FG001|Open-Label Extension (OLE) Phase|Death|0|||
144676783|NCT01224106|521669215|FG002|Open-Label Extension (OLE) Phase|Death|0|||
144676784|NCT01224106|521669216|FG003|Open-Label Extension (OLE) Phase|Death|1|||
144676785|NCT01224106|521669217|FG004|Open-Label Extension (OLE) Phase|Death|3|||
144676786|NCT01224106|521669213|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
144676787|NCT01224106|521669214|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
144737243|NCT03025087|521892060|FG003|Overall Study|Physician Decision|0|||
144737244|NCT03025087|521892061|FG004|Overall Study|Physician Decision|0|||
144737245|NCT03025087|521892057|FG000|Overall Study|Withdrawal by Subject|1|||
144737246|NCT03025087|521892058|FG001|Overall Study|Withdrawal by Subject|1|||
144737247|NCT03025087|521892059|FG002|Overall Study|Withdrawal by Subject|0|||
144737248|NCT03025087|521892060|FG003|Overall Study|Withdrawal by Subject|0|||
144737249|NCT03025087|521892061|FG004|Overall Study|Withdrawal by Subject|0|||
144737250|NCT03025087|521892057|FG000|Overall Study|Unable to complete MRI|2|||
144737251|NCT03025087|521892058|FG001|Overall Study|Unable to complete MRI|2|||
144737252|NCT03025087|521892059|FG002|Overall Study|Unable to complete MRI|0|||
144676788|NCT01224106|521669215|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
144676789|NCT01224106|521669216|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
144676790|NCT01224106|521669217|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
144676791|NCT01224106|521669213|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
144676792|NCT01224106|521669214|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
144676793|NCT01224106|521669215|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
144676794|NCT01224106|521669216|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
144676795|NCT01224106|521669217|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
144676796|NCT01224106|521669213|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
144676797|NCT01224106|521669214|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
144676798|NCT01224106|521669215|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
144676799|NCT01224106|521669216|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
144676800|NCT01224106|521669217|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
144676801|NCT01224106|521669213|FG000|Open-Label Extension (OLE) Phase|Other|0|||
144676802|NCT01224106|521669214|FG001|Open-Label Extension (OLE) Phase|Other|0|||
144676803|NCT01224106|521669215|FG002|Open-Label Extension (OLE) Phase|Other|0|||
144676804|NCT01224106|521669216|FG003|Open-Label Extension (OLE) Phase|Other|5|||
144676805|NCT01224106|521669217|FG004|Open-Label Extension (OLE) Phase|Other|3|||
144676806|NCT00441727|521669218|FG000|Overall Study|Protocol Violation|19|||
144676807|NCT00441727|521669219|FG001|Overall Study|Protocol Violation|28|||
144676808|NCT00441727|521669220|FG002|Overall Study|Protocol Violation|32|||
144676809|NCT00441727|521669218|FG000|Overall Study|Adverse Event|26|||
144676810|NCT00441727|521669219|FG001|Overall Study|Adverse Event|33|||
144676811|NCT00441727|521669220|FG002|Overall Study|Adverse Event|28|||
144676812|NCT00441727|521669218|FG000|Overall Study|Lack of Efficacy|7|||
144676813|NCT00441727|521669219|FG001|Overall Study|Lack of Efficacy|8|||
144676814|NCT00441727|521669220|FG002|Overall Study|Lack of Efficacy|48|||
144676815|NCT00441727|521669218|FG000|Overall Study|Withdrawal by Subject|40|||
144676816|NCT00441727|521669219|FG001|Overall Study|Withdrawal by Subject|34|||
144676817|NCT00441727|521669220|FG002|Overall Study|Withdrawal by Subject|47|||
144676818|NCT00441727|521669218|FG000|Overall Study|Lost to Follow-up|5|||
144676819|NCT00441727|521669219|FG001|Overall Study|Lost to Follow-up|6|||
144676820|NCT00441727|521669220|FG002|Overall Study|Lost to Follow-up|5|||
144676821|NCT00441727|521669218|FG000|Overall Study|Safety Reasons|3|||
144676822|NCT00441727|521669219|FG001|Overall Study|Safety Reasons|1|||
144676823|NCT00441727|521669220|FG002|Overall Study|Safety Reasons|3|||
144676824|NCT00441727|521669218|FG000|Overall Study|Various reason specified|6|||
144676825|NCT00441727|521669219|FG001|Overall Study|Various reason specified|8|||
144676826|NCT00441727|521669220|FG002|Overall Study|Various reason specified|5|||
144676827|NCT02133001|521669221|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
144676828|NCT02133001|521669222|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
144676829|NCT02133001|521669221|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
144676830|NCT02133001|521669222|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
144676831|NCT02133001|521669221|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
144676832|NCT02133001|521669222|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
144676833|NCT02133001|521669221|FG000|Double Blind (Day 1-25)|Other|2|||
144676834|NCT02133001|521669222|FG001|Double Blind (Day 1-25)|Other|2|||
144676835|NCT02133001|521669221|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
144676836|NCT02133001|521669222|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
144676837|NCT02133001|521669221|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
144676838|NCT02133001|521669222|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
144676839|NCT02133001|521669221|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
144676840|NCT02133001|521669222|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
144676841|NCT02133001|521669221|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
144676842|NCT02133001|521669222|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
144676843|NCT04211961|521669223|FG000|Overall Study|Death|0|||
144676844|NCT04211961|521669224|FG001|Overall Study|Death|1|||
144676845|NCT04211961|521669223|FG000|Overall Study|Lost to Follow-up|0|||
144676846|NCT04211961|521669224|FG001|Overall Study|Lost to Follow-up|1|||
144676847|NCT04211961|521669223|FG000|Overall Study|Withdrawal by Subject|0|||
144676848|NCT04211961|521669224|FG001|Overall Study|Withdrawal by Subject|1|||
144676849|NCT03210220|521669227|FG000|Overall Study|Physician Decision|1|||
144676850|NCT03210220|521669228|FG001|Overall Study|Physician Decision|0|||
144676851|NCT00420342|521669229|FG000|Overall Study|Lost to Follow-up|1|||
144676852|NCT00420342|521669230|FG001|Overall Study|Lost to Follow-up|0|||
144676853|NCT00420342|521669231|FG002|Overall Study|Lost to Follow-up|1|||
144676854|NCT00420342|521669229|FG000|Overall Study|Withdrawal by Subject|0|||
144676855|NCT00420342|521669230|FG001|Overall Study|Withdrawal by Subject|2|||
144737253|NCT03025087|521892060|FG003|Overall Study|Unable to complete MRI|0|||
144676856|NCT00420342|521669231|FG002|Overall Study|Withdrawal by Subject|0|||
144676857|NCT00839436|521669232|FG000|Overall Study|Developed exclusionary condition|1|||
144676858|NCT00839436|521669233|FG001|Overall Study|Developed exclusionary condition|0|||
144676859|NCT00839436|521669234|FG002|Overall Study|Developed exclusionary condition|0|||
144676860|NCT00839436|521669232|FG000|Overall Study|Withdrawal by Subject|0|||
144676861|NCT00839436|521669233|FG001|Overall Study|Withdrawal by Subject|1|||
144676862|NCT00839436|521669234|FG002|Overall Study|Withdrawal by Subject|0|||
144676863|NCT00839436|521669232|FG000|Overall Study|Study drug no longer available|0|||
144676864|NCT00839436|521669233|FG001|Overall Study|Study drug no longer available|0|||
144676865|NCT00839436|521669234|FG002|Overall Study|Study drug no longer available|1|||
144737254|NCT03025087|521892061|FG004|Overall Study|Unable to complete MRI|0|||
144737255|NCT04299087|521892062|FG000|Overall Study|Lost to Follow-up|2|||
144737256|NCT04299087|521892063|FG001|Overall Study|Lost to Follow-up|1|||
144737257|NCT00508651|521892064|FG000|Overall Study|Lost to Follow-up|3|||
144737258|NCT00508651|521892065|FG001|Overall Study|Lost to Follow-up|1|||
144737259|NCT00508651|521892064|FG000|Overall Study|Withdrawal by Subject|1|||
144737260|NCT00508651|521892065|FG001|Overall Study|Withdrawal by Subject|1|||
144737261|NCT01376037|521892067|FG000|Overall Study|Lost to Follow-up|0|||
144737262|NCT01376037|521892068|FG001|Overall Study|Lost to Follow-up|2|||
144737263|NCT01701674|521892069|FG000|Overall Study|Unable to safely complete treatment|1|||
144737264|NCT05604170|521892070|FG000|Overall Study|Lack of Efficacy|5|||
144737265|NCT05604170|521892070|FG000|Overall Study|Adverse Event|6|||
144737266|NCT05604170|521892070|FG000|Overall Study|Physician Decision|6|||
144737267|NCT05604170|521892070|FG000|Overall Study|Lost to Follow-up|6|||
144737268|NCT05604170|521892070|FG000|Overall Study|Withdrawal by Subject|11|||
144737269|NCT05604170|521892070|FG000|Overall Study|Early study termination by sponsor|77|||
144737270|NCT05604170|521892070|FG000|Overall Study|Other|6|||
144737271|NCT03697109|521892071|FG000|Open-label (OL) Phase|Adverse Event|24|||
144737272|NCT03697109|521892072|FG001|Open-label (OL) Phase|Adverse Event|0|||
144737273|NCT03697109|521892073|FG002|Open-label (OL) Phase|Adverse Event|0|||
144737274|NCT03697109|521892071|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
144737275|NCT03697109|521892072|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
144737276|NCT03697109|521892073|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
144737277|NCT03697109|521892071|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
144737278|NCT03697109|521892072|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
144737279|NCT03697109|521892073|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
144737280|NCT03697109|521892071|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
144737281|NCT03697109|521892072|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
144218168|NCT04054765|519992251|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
144218169|NCT04054765|519992250|FG000|3-month Follow up|Withdrawal by Subject|0|||
144218170|NCT04054765|519992251|FG001|3-month Follow up|Withdrawal by Subject|3|||
144218171|NCT04054765|519992250|FG000|6-month Follow up|Lost to Follow-up|32|||
144218172|NCT04054765|519992251|FG001|6-month Follow up|Lost to Follow-up|32|||
144218173|NCT04688671|519992254|FG000|Overall Study|Adverse Event|3|||
144218174|NCT04688671|519992255|FG001|Overall Study|Adverse Event|1|||
144218175|NCT04688671|519992254|FG000|Overall Study|Withdrawal by Subject|3|||
144218176|NCT04688671|519992255|FG001|Overall Study|Withdrawal by Subject|1|||
144218177|NCT04688671|519992254|FG000|Overall Study|Lack of Efficacy|1|||
144218178|NCT04688671|519992255|FG001|Overall Study|Lack of Efficacy|1|||
144676866|NCT05784129|521669235|FG000|Overall Study|Study terminated by sponsor|2|||
144676867|NCT05784129|521669236|FG001|Overall Study|Study terminated by sponsor|2|||
144676868|NCT02580591|521669238|FG000|Overall Study|Adverse Event|0|||
144676869|NCT02580591|521669239|FG001|Overall Study|Adverse Event|1|||
144676870|NCT02580591|521669240|FG002|Overall Study|Adverse Event|2|||
144676871|NCT02580591|521669241|FG003|Overall Study|Adverse Event|5|||
144676872|NCT02580591|521669238|FG000|Overall Study|Protocol Violation|3|||
144676873|NCT02580591|521669239|FG001|Overall Study|Protocol Violation|2|||
144676874|NCT02580591|521669240|FG002|Overall Study|Protocol Violation|1|||
144676875|NCT02580591|521669241|FG003|Overall Study|Protocol Violation|1|||
144676876|NCT02580591|521669238|FG000|Overall Study|Lost to Follow-up|5|||
144676877|NCT02580591|521669239|FG001|Overall Study|Lost to Follow-up|3|||
144676878|NCT02580591|521669240|FG002|Overall Study|Lost to Follow-up|3|||
144676879|NCT02580591|521669241|FG003|Overall Study|Lost to Follow-up|1|||
144676880|NCT02580591|521669238|FG000|Overall Study|Withdrawal by Subject|6|||
144676881|NCT02580591|521669239|FG001|Overall Study|Withdrawal by Subject|1|||
144676882|NCT02580591|521669240|FG002|Overall Study|Withdrawal by Subject|2|||
144676883|NCT02580591|521669241|FG003|Overall Study|Withdrawal by Subject|3|||
144676884|NCT02580591|521669238|FG000|Overall Study|Not treated|1|||
144676885|NCT02580591|521669239|FG001|Overall Study|Not treated|1|||
144676886|NCT02580591|521669240|FG002|Overall Study|Not treated|0|||
144676887|NCT02580591|521669241|FG003|Overall Study|Not treated|0|||
144676888|NCT02580591|521669238|FG000|Overall Study|Other than specified|3|||
144737282|NCT03697109|521892073|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
144737283|NCT03697109|521892071|FG000|Open-label (OL) Phase|Physician Decision|2|||
144737284|NCT03697109|521892072|FG001|Open-label (OL) Phase|Physician Decision|0|||
144737285|NCT03697109|521892073|FG002|Open-label (OL) Phase|Physician Decision|0|||
144737286|NCT03697109|521892071|FG000|Open-label (OL) Phase|Death|2|||
144737287|NCT03697109|521892072|FG001|Open-label (OL) Phase|Death|0|||
144737288|NCT03697109|521892073|FG002|Open-label (OL) Phase|Death|0|||
144737289|NCT03697109|521892071|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
144737290|NCT03697109|521892072|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
144737291|NCT03697109|521892073|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
144218179|NCT04688671|519992254|FG000|Overall Study|Protocol Violation|1|||
144676889|NCT02580591|521669239|FG001|Overall Study|Other than specified|2|||
144676890|NCT02580591|521669240|FG002|Overall Study|Other than specified|5|||
144676891|NCT02580591|521669241|FG003|Overall Study|Other than specified|2|||
144737292|NCT03697109|521892071|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
144676892|NCT01599806|521669245|FG000|Overall Study|Lost to Follow-up|20|||
144676893|NCT01599806|521669246|FG001|Overall Study|Lost to Follow-up|20|||
144676894|NCT01599806|521669245|FG000|Overall Study|Withdrawal by Subject|12|||
144676895|NCT01599806|521669246|FG001|Overall Study|Withdrawal by Subject|12|||
144676896|NCT01599806|521669245|FG000|Overall Study|Other Eligibility criteria|11|||
144676897|NCT01599806|521669246|FG001|Overall Study|Other Eligibility criteria|9|||
144676898|NCT03006926|521669250|FG000|Overall Study|Adverse Event|0|||
144676899|NCT03006926|521669251|FG001|Overall Study|Adverse Event|27|||
144676900|NCT03006926|521669250|FG000|Overall Study|Withdrawal by Subject|0|||
144676901|NCT03006926|521669251|FG001|Overall Study|Withdrawal by Subject|1|||
144676902|NCT03006926|521669250|FG000|Overall Study|Radiological Disease Progression|0|||
144676903|NCT03006926|521669251|FG001|Overall Study|Radiological Disease Progression|52|||
144676904|NCT03006926|521669250|FG000|Overall Study|Clinical Disease Progression|0|||
144676905|NCT03006926|521669251|FG001|Overall Study|Clinical Disease Progression|10|||
144676906|NCT03006926|521669250|FG000|Overall Study|Other|0|||
144676907|NCT03006926|521669251|FG001|Overall Study|Other|8|||
144676908|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
144676909|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
144676910|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
144676911|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
144676912|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
144676913|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
144676914|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
144676915|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
144676916|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
144676917|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
144676918|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
144676919|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
144676920|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
144676921|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
144676922|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
144676923|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
144676924|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
144676925|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
144676926|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
144676927|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
144676928|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
144676929|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
144676930|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
144676931|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
144676932|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
144676933|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
144676934|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
144676935|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
144676936|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
144676937|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
144676938|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
144676939|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
144676940|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
144676941|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
144676942|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
144676943|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
144676944|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
144676945|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
144676946|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
144676947|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
144676948|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
144676949|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
144676950|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
144676951|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
144676952|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
144676953|NCT03689972|521669252|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
144676954|NCT03689972|521669253|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
144676955|NCT03689972|521669254|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
144676956|NCT03689972|521669255|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
144676957|NCT03689972|521669256|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
144676958|NCT03689972|521669252|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
144676959|NCT03689972|521669253|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
144676960|NCT03689972|521669254|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
144676961|NCT03689972|521669255|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
144676962|NCT03689972|521669256|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
144676963|NCT03689972|521669252|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
144676964|NCT03689972|521669253|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
144676965|NCT03689972|521669254|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
144676966|NCT03689972|521669255|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
144676967|NCT03689972|521669256|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
144676968|NCT03689972|521669252|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
144676969|NCT03689972|521669253|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
144676970|NCT03689972|521669254|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
144676971|NCT03689972|521669255|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
144676972|NCT03689972|521669256|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
144676973|NCT03689972|521669252|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
144676974|NCT03689972|521669253|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
144676975|NCT03689972|521669254|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
144676976|NCT03689972|521669255|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
144676977|NCT03689972|521669256|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
144676978|NCT03689972|521669252|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
144676979|NCT03689972|521669253|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
144676980|NCT03689972|521669254|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
144676981|NCT03689972|521669255|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
144676982|NCT03689972|521669256|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
144676983|NCT03689972|521669252|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
144676984|NCT03689972|521669253|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
144676985|NCT03689972|521669254|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
144676986|NCT03689972|521669255|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
144676987|NCT03689972|521669256|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
144676988|NCT03689972|521669252|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
144676989|NCT03689972|521669253|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
144676990|NCT03689972|521669254|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
144676991|NCT03689972|521669255|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
144676992|NCT03689972|521669256|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
144676993|NCT03689972|521669252|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
144676994|NCT03689972|521669253|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
144676995|NCT03689972|521669254|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
144676996|NCT03689972|521669255|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
144676997|NCT03689972|521669256|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
144676998|NCT03689972|521669252|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
144676999|NCT03689972|521669253|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
144677000|NCT03689972|521669254|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
144677001|NCT03689972|521669255|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
144677002|NCT03689972|521669256|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
144677003|NCT02417064|521669257|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
144677004|NCT02417064|521669258|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
144677005|NCT02417064|521669259|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
144677006|NCT02417064|521669257|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
144677007|NCT02417064|521669258|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
144677008|NCT02417064|521669259|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
144677009|NCT02417064|521669257|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
144677010|NCT02417064|521669258|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
144677011|NCT02417064|521669259|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
144677012|NCT02417064|521669257|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
144677013|NCT02417064|521669258|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
144677014|NCT02417064|521669259|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
144677015|NCT02417064|521669257|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
144677016|NCT02417064|521669258|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
144677017|NCT02417064|521669259|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
144677018|NCT02417064|521669257|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
144677019|NCT02417064|521669258|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
144677020|NCT02417064|521669259|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
144677021|NCT02417064|521669257|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
144677022|NCT02417064|521669258|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
144218180|NCT04688671|519992255|FG001|Overall Study|Protocol Violation|0|||
144677023|NCT02417064|521669259|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
144677024|NCT02417064|521669257|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
144677025|NCT02417064|521669258|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
144677026|NCT02417064|521669259|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
144677027|NCT02417064|521669257|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
144677028|NCT02417064|521669258|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
144677029|NCT02417064|521669259|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
144677030|NCT02417064|521669257|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
144677031|NCT02417064|521669258|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
144677032|NCT02417064|521669259|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
144677033|NCT02417064|521669257|FG000|Follow-up Phase (24 Weeks)|Other|2|||
144677034|NCT02417064|521669258|FG001|Follow-up Phase (24 Weeks)|Other|2|||
144677035|NCT02417064|521669259|FG002|Follow-up Phase (24 Weeks)|Other|3|||
144677036|NCT04882072|521669260|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
144677037|NCT04882072|521669261|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
144677038|NCT04882072|521669260|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
144677039|NCT04882072|521669261|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
144677040|NCT04882072|521669260|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
144677041|NCT04882072|521669261|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
144677042|NCT00732641|521669262|FG000|Overall Study|Relapse or Progressive Disease|65|||
144677043|NCT00732641|521669263|FG001|Overall Study|Relapse or Progressive Disease|101|||
144677044|NCT00732641|521669262|FG000|Overall Study|Serious Adverse Events|12|||
144677045|NCT00732641|521669263|FG001|Overall Study|Serious Adverse Events|3|||
144677046|NCT00732641|521669262|FG000|Overall Study|Physician Decision|6|||
144677047|NCT00732641|521669263|FG001|Overall Study|Physician Decision|0|||
144677048|NCT00732641|521669262|FG000|Overall Study|Withdrawal by Subject|4|||
144677049|NCT00732641|521669263|FG001|Overall Study|Withdrawal by Subject|2|||
144677050|NCT00732641|521669262|FG000|Overall Study|Unable to Complete|1|||
144677051|NCT00732641|521669263|FG001|Overall Study|Unable to Complete|1|||
144677052|NCT00732641|521669262|FG000|Overall Study|Other|18|||
144677053|NCT00732641|521669263|FG001|Overall Study|Other|5|||
144677054|NCT01192100|521669264|FG000|Overall Study|Withdrawal by Subject|0|||
144677055|NCT01192100|521669265|FG001|Overall Study|Withdrawal by Subject|0|||
144677056|NCT01192100|521669266|FG002|Overall Study|Withdrawal by Subject|0|||
144677057|NCT01192100|521669267|FG003|Overall Study|Withdrawal by Subject|0|||
144677058|NCT01192100|521669268|FG004|Overall Study|Withdrawal by Subject|1|||
144677059|NCT01192100|521669269|FG005|Overall Study|Withdrawal by Subject|0|||
144677060|NCT01192100|521669264|FG000|Overall Study|Protocol Violation|0|||
144677061|NCT01192100|521669265|FG001|Overall Study|Protocol Violation|0|||
144677062|NCT01192100|521669266|FG002|Overall Study|Protocol Violation|0|||
144677063|NCT01192100|521669267|FG003|Overall Study|Protocol Violation|1|||
144677064|NCT01192100|521669268|FG004|Overall Study|Protocol Violation|0|||
144677065|NCT01192100|521669269|FG005|Overall Study|Protocol Violation|0|||
144677066|NCT02475629|521669270|FG000|Overall Study|Adverse Event|1|||
144677067|NCT02475629|521669270|FG000|Overall Study|Death|4|||
144677068|NCT02475629|521669270|FG000|Overall Study|Physician Decision|1|||
144677069|NCT02475629|521669270|FG000|Overall Study|Withdrawal by Subject|1|||
144677070|NCT02475629|521669270|FG000|Overall Study|Lost to Follow-up|1|||
144677071|NCT02475629|521669270|FG000|Overall Study|Subject non-compliance|1|||
144677072|NCT01095666|521669271|FG000|Overall Study|Lack of Efficacy|0|||
144677073|NCT01095666|521669272|FG001|Overall Study|Lack of Efficacy|0|||
144677074|NCT01095666|521669273|FG002|Overall Study|Lack of Efficacy|1|||
144677075|NCT01095666|521669271|FG000|Overall Study|Adverse Event|2|||
144677076|NCT01095666|521669272|FG001|Overall Study|Adverse Event|1|||
144677077|NCT01095666|521669273|FG002|Overall Study|Adverse Event|3|||
144677078|NCT01095666|521669271|FG000|Overall Study|Lost to Follow-up|2|||
144677079|NCT01095666|521669272|FG001|Overall Study|Lost to Follow-up|2|||
144677080|NCT01095666|521669273|FG002|Overall Study|Lost to Follow-up|0|||
144677081|NCT01095666|521669271|FG000|Overall Study|Withdrawal by Subject|6|||
144677082|NCT01095666|521669272|FG001|Overall Study|Withdrawal by Subject|6|||
144677083|NCT01095666|521669273|FG002|Overall Study|Withdrawal by Subject|1|||
144677084|NCT01095666|521669271|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
144677085|NCT01095666|521669272|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
144677086|NCT01095666|521669273|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
144677087|NCT00924729|521669286|FG000|Overall Study|insufficient volume for analysis|1|||
144218181|NCT04688671|519992254|FG000|Overall Study|Lost to Follow-up|0|||
144218182|NCT04688671|519992255|FG001|Overall Study|Lost to Follow-up|1|||
144677088|NCT00924729|521669287|FG001|Overall Study|insufficient volume for analysis|0|||
144677089|NCT00924729|521669286|FG000|Overall Study|Protocol Violation|1|||
144677090|NCT00924729|521669287|FG001|Overall Study|Protocol Violation|0|||
144677091|NCT01814826|521669290|FG000|Overall Study|Other|3|||
144677092|NCT01814826|521669291|FG001|Overall Study|Other|5|||
144677093|NCT01814826|521669292|FG002|Overall Study|Other|0|||
144677094|NCT01814826|521669290|FG000|Overall Study|Death|29|||
144677095|NCT01814826|521669291|FG001|Overall Study|Death|24|||
144677096|NCT01814826|521669292|FG002|Overall Study|Death|3|||
144737293|NCT03697109|521892072|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
144737294|NCT03697109|521892073|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
144737295|NCT03697109|521892071|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
144737296|NCT03697109|521892072|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
144737297|NCT03697109|521892073|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
144677097|NCT02917629|521669293|FG000|Overall Study|Withdrawal by Subject|0|||
144677098|NCT02917629|521669294|FG001|Overall Study|Withdrawal by Subject|1|||
144677099|NCT03339401|521669295|FG000|Overall Study|Death|2|||
144737298|NCT03032172|521892074|FG000|Treatment Period|Adverse Event|0|||
144737299|NCT03032172|521892075|FG001|Treatment Period|Adverse Event|1|||
144737300|NCT03032172|521892076|FG002|Treatment Period|Adverse Event|0|||
144737301|NCT03032172|521892077|FG003|Treatment Period|Adverse Event|0|||
144737302|NCT03032172|521892078|FG004|Treatment Period|Adverse Event|0|||
144737303|NCT03032172|521892079|FG005|Treatment Period|Adverse Event|0|||
144737304|NCT03032172|521892080|FG006|Treatment Period|Adverse Event|0|||
144737305|NCT03032172|521892081|FG007|Treatment Period|Adverse Event|0|||
144737306|NCT03032172|521892074|FG000|Treatment Period|Lack of Efficacy|0|||
144737307|NCT03032172|521892075|FG001|Treatment Period|Lack of Efficacy|1|||
144737308|NCT03032172|521892076|FG002|Treatment Period|Lack of Efficacy|0|||
144737309|NCT03032172|521892077|FG003|Treatment Period|Lack of Efficacy|0|||
144737310|NCT03032172|521892078|FG004|Treatment Period|Lack of Efficacy|0|||
144737311|NCT03032172|521892079|FG005|Treatment Period|Lack of Efficacy|0|||
144737312|NCT03032172|521892080|FG006|Treatment Period|Lack of Efficacy|0|||
144737313|NCT03032172|521892081|FG007|Treatment Period|Lack of Efficacy|0|||
144737314|NCT03032172|521892074|FG000|Treatment Period|Non-compliance With Study Drug|0|||
144737315|NCT03032172|521892075|FG001|Treatment Period|Non-compliance With Study Drug|1|||
144737316|NCT03032172|521892076|FG002|Treatment Period|Non-compliance With Study Drug|0|||
144737317|NCT03032172|521892077|FG003|Treatment Period|Non-compliance With Study Drug|0|||
144737318|NCT03032172|521892078|FG004|Treatment Period|Non-compliance With Study Drug|0|||
144737319|NCT03032172|521892079|FG005|Treatment Period|Non-compliance With Study Drug|0|||
144737320|NCT03032172|521892080|FG006|Treatment Period|Non-compliance With Study Drug|0|||
144737321|NCT03032172|521892081|FG007|Treatment Period|Non-compliance With Study Drug|0|||
144737322|NCT03032172|521892074|FG000|Treatment Period|Reason Not Specified|0|||
144737323|NCT03032172|521892075|FG001|Treatment Period|Reason Not Specified|4|||
144737324|NCT03032172|521892076|FG002|Treatment Period|Reason Not Specified|1|||
144737325|NCT03032172|521892077|FG003|Treatment Period|Reason Not Specified|0|||
144737326|NCT03032172|521892078|FG004|Treatment Period|Reason Not Specified|0|||
144737327|NCT03032172|521892079|FG005|Treatment Period|Reason Not Specified|0|||
144737328|NCT03032172|521892080|FG006|Treatment Period|Reason Not Specified|0|||
144737329|NCT03032172|521892081|FG007|Treatment Period|Reason Not Specified|0|||
144737330|NCT03032172|521892074|FG000|Treatment Period|Physician Decision|0|||
144737331|NCT03032172|521892075|FG001|Treatment Period|Physician Decision|2|||
144737332|NCT03032172|521892076|FG002|Treatment Period|Physician Decision|1|||
144737333|NCT03032172|521892077|FG003|Treatment Period|Physician Decision|0|||
144737334|NCT03032172|521892078|FG004|Treatment Period|Physician Decision|0|||
144737335|NCT03032172|521892079|FG005|Treatment Period|Physician Decision|0|||
144737336|NCT03032172|521892080|FG006|Treatment Period|Physician Decision|0|||
144737337|NCT03032172|521892081|FG007|Treatment Period|Physician Decision|0|||
144737338|NCT03032172|521892074|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
144737339|NCT03032172|521892075|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
144737340|NCT03032172|521892076|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
144737341|NCT03032172|521892077|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
144737342|NCT03032172|521892078|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
144737343|NCT03032172|521892079|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
144677100|NCT03339401|521669296|FG001|Overall Study|Death|1|||
144677101|NCT03339401|521669295|FG000|Overall Study|Withdrawal by Subject|2|||
144677102|NCT03339401|521669296|FG001|Overall Study|Withdrawal by Subject|0|||
144677103|NCT03339401|521669295|FG000|Overall Study|Study terminated|4|||
144677104|NCT03339401|521669296|FG001|Overall Study|Study terminated|3|||
144677105|NCT03339401|521669295|FG000|Overall Study|Investigator Decision|1|||
144677106|NCT03339401|521669296|FG001|Overall Study|Investigator Decision|0|||
144737344|NCT03032172|521892080|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
144677107|NCT00718523|521669297|FG000|Overall Study|Withdrawal by Subject|5|||
144677108|NCT00718523|521669298|FG001|Overall Study|Withdrawal by Subject|7|||
144677109|NCT00718523|521669297|FG000|Overall Study|Death|13|||
144737345|NCT03032172|521892081|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
144737346|NCT03032172|521892074|FG000|Treatment Period|Withdrawal by Subject|2|||
144737347|NCT03032172|521892075|FG001|Treatment Period|Withdrawal by Subject|0|||
144737348|NCT03032172|521892076|FG002|Treatment Period|Withdrawal by Subject|3|||
144737349|NCT03032172|521892077|FG003|Treatment Period|Withdrawal by Subject|0|||
144677110|NCT00718523|521669298|FG001|Overall Study|Death|17|||
144677111|NCT01042938|521669299|FG000|Overall Study|Withdrawal by Subject|1|||
144677112|NCT01042938|521669300|FG001|Overall Study|Withdrawal by Subject|1|||
144677113|NCT01042938|521669299|FG000|Overall Study|Protocol Violation|1|||
144677114|NCT01042938|521669300|FG001|Overall Study|Protocol Violation|1|||
144677115|NCT01042938|521669299|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
144677116|NCT01042938|521669300|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
144677117|NCT03032510|521669301|FG000|Overall Study|Adverse Event|5|||
144677118|NCT03032510|521669302|FG001|Overall Study|Adverse Event|2|||
144677119|NCT03032510|521669301|FG000|Overall Study|Lost to Follow-up|8|||
144677120|NCT03032510|521669302|FG001|Overall Study|Lost to Follow-up|7|||
144677121|NCT03032510|521669301|FG000|Overall Study|Withdrawal by Subject|8|||
144677122|NCT03032510|521669302|FG001|Overall Study|Withdrawal by Subject|7|||
144677123|NCT03032510|521669301|FG000|Overall Study|Subject noncompliance|4|||
144677124|NCT03032510|521669302|FG001|Overall Study|Subject noncompliance|2|||
144677125|NCT03032510|521669301|FG000|Overall Study|Physician Decision|2|||
144677126|NCT03032510|521669302|FG001|Overall Study|Physician Decision|0|||
144677127|NCT00856986|521669303|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
144677128|NCT00856986|521669304|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
144677129|NCT00856986|521669305|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
144677130|NCT00856986|521669306|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
144677131|NCT00856986|521669307|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
144677132|NCT00856986|521669303|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
144677133|NCT00856986|521669304|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
144677134|NCT00856986|521669305|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
144677135|NCT00856986|521669306|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
144677136|NCT00856986|521669307|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
144677137|NCT00856986|521669303|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
144677138|NCT00856986|521669304|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
144677139|NCT00856986|521669305|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
144677140|NCT00856986|521669306|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
144677141|NCT00856986|521669307|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
144677142|NCT00856986|521669303|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
144677143|NCT00856986|521669304|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
144677144|NCT00856986|521669305|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
144677145|NCT00856986|521669306|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
144677146|NCT00856986|521669307|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
144677147|NCT00856986|521669303|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
144677148|NCT00856986|521669304|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
144677149|NCT00856986|521669305|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
144677150|NCT00856986|521669306|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
144677151|NCT00856986|521669307|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
144677152|NCT00856986|521669303|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
144677153|NCT00856986|521669304|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
144677154|NCT00856986|521669305|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
144677155|NCT00856986|521669306|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
144677156|NCT00856986|521669307|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
144677157|NCT00856986|521669303|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
144677158|NCT00856986|521669304|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
144677159|NCT00856986|521669305|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
144677160|NCT00856986|521669306|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
144677161|NCT00856986|521669307|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
144677162|NCT00856986|521669303|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
144677163|NCT00856986|521669304|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
144677164|NCT00856986|521669305|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
144677165|NCT00856986|521669306|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
144677166|NCT00856986|521669307|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
144677167|NCT00856986|521669303|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
144265695|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Death|0|||
144677168|NCT00856986|521669304|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
144677169|NCT00856986|521669305|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
144677170|NCT00856986|521669306|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
144677171|NCT00856986|521669307|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
144677172|NCT00856986|521669303|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
144677173|NCT00856986|521669304|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
144677174|NCT00856986|521669305|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
144677175|NCT00856986|521669306|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
144677176|NCT00856986|521669307|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
144677177|NCT00856986|521669303|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
144677178|NCT00856986|521669304|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
144677179|NCT00856986|521669305|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
144677180|NCT00856986|521669306|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
144677181|NCT00856986|521669307|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
144677182|NCT00856986|521669303|FG000|Main Period, Weeks 0-26|Unclassified|7|||
144677183|NCT00856986|521669304|FG001|Main Period, Weeks 0-26|Unclassified|6|||
144677184|NCT00856986|521669305|FG002|Main Period, Weeks 0-26|Unclassified|7|||
144677185|NCT00856986|521669306|FG003|Main Period, Weeks 0-26|Unclassified|0|||
144677186|NCT00856986|521669307|FG004|Main Period, Weeks 0-26|Unclassified|0|||
144677187|NCT00856986|521669303|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
144677188|NCT00856986|521669304|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
144677189|NCT00856986|521669305|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
144677190|NCT00856986|521669306|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
144677191|NCT00856986|521669307|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
144677192|NCT00856986|521669303|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
144677193|NCT00856986|521669304|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
144677194|NCT00856986|521669305|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
144677195|NCT00856986|521669306|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
144677196|NCT00856986|521669307|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
144677197|NCT00856986|521669303|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
144677198|NCT00856986|521669304|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
144677199|NCT00856986|521669305|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
144677200|NCT00856986|521669306|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
144677201|NCT00856986|521669307|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
144677202|NCT00856986|521669303|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
144677203|NCT00856986|521669304|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
144677204|NCT00856986|521669305|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
144677205|NCT00856986|521669306|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
144677206|NCT00856986|521669307|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
144677207|NCT00856986|521669303|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
144677208|NCT00856986|521669304|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
144677209|NCT00856986|521669305|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
144677210|NCT00856986|521669306|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
144677211|NCT00856986|521669307|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
144677212|NCT00856986|521669303|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
144677213|NCT00856986|521669304|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
144677214|NCT00856986|521669305|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
144677215|NCT00856986|521669306|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
144677216|NCT00856986|521669307|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
144677217|NCT05041062|521669308|FG000|Overall Study|Adverse Event|2|||
144677218|NCT04018612|521669309|FG000|Overall Study|Withdrawal by Subject|1|||
144677219|NCT04018612|521669310|FG001|Overall Study|Withdrawal by Subject|0|||
144677220|NCT04018612|521669311|FG002|Overall Study|Withdrawal by Subject|1|||
144677221|NCT02999191|521669313|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
144677222|NCT02999191|521669314|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
144677223|NCT02999191|521669315|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
144677224|NCT01802515|521669325|FG000|Overall Study|Withdrawal by Subject|3|||
144677225|NCT01802515|521669326|FG001|Overall Study|Withdrawal by Subject|0|||
144677226|NCT01802515|521669327|FG002|Overall Study|Withdrawal by Subject|0|||
144677227|NCT01906476|521669330|FG000|Overall Study|Lost to Follow-up|17|||
144677228|NCT01906476|521669331|FG001|Overall Study|Lost to Follow-up|16|||
144677229|NCT01993667|521669333|FG000|Overall Study|Insufficient data to analyze|16|||
144677230|NCT01993667|521669334|FG001|Overall Study|Insufficient data to analyze|16|||
144677231|NCT01993667|521669333|FG000|Overall Study|Insufficient altitude reached|3|||
144677232|NCT01993667|521669334|FG001|Overall Study|Insufficient altitude reached|1|||
144677233|NCT01993667|521669333|FG000|Overall Study|Lost to Follow-up|2|||
144677234|NCT01993667|521669334|FG001|Overall Study|Lost to Follow-up|2|||
144677235|NCT01931150|521669335|FG000|Overall Study|Withdrawal by Subject|1|||
144677236|NCT01931150|521669336|FG001|Overall Study|Withdrawal by Subject|2|||
144677237|NCT00922974|521671186|FG000|Phase II Component|Protocol Violation|2|||
144677238|NCT00922974|521671187|FG001|Phase II Component|Protocol Violation|0|||
144677239|NCT00922974|521671186|FG000|Phase II Component|Not evaluable for treatment review|5|||
144677240|NCT00922974|521671187|FG001|Phase II Component|Not evaluable for treatment review|0|||
144677241|NCT00922974|521671186|FG000|Phase III Component|Protocol Violation|8|||
144677242|NCT00922974|521671187|FG001|Phase III Component|Protocol Violation|6|||
144677243|NCT02944513|521671188|FG000|Overall Study|Withdrawal by Subject|4|||
144677244|NCT02944513|521671189|FG001|Overall Study|Withdrawal by Subject|1|||
144677245|NCT00731666|521671192|FG000|Overall Study|Adverse Event|2|||
144677246|NCT00731666|521671192|FG000|Overall Study|Lost to Follow-up|8|||
144677247|NCT00731666|521671192|FG000|Overall Study|Withdrawal by Subject|2|||
144677248|NCT00088595|521671193|FG000|Overall Study|Adverse Event|11|||
144265696|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Death|0|||
144677249|NCT00088595|521671193|FG000|Overall Study|Withdrawal by Subject|8|||
144677250|NCT00088595|521671193|FG000|Overall Study|Ongoing (After Core)|7|||
144677251|NCT00088595|521671193|FG000|Overall Study|New Cancer Therapy|2|||
144265697|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
144677252|NCT00608894|521671197|FG000|Overall Study|Withdrawal by Subject|0|||
144677253|NCT00608894|521671198|FG001|Overall Study|Withdrawal by Subject|2|||
144677254|NCT01473355|521671207|FG000|Overall Study|Protocol Violation|2|||
144677255|NCT01473355|521671207|FG000|Overall Study|Adverse Event|2|||
144677256|NCT01473355|521671207|FG000|Overall Study|Lost to Follow-up|2|||
144677257|NCT02809118|521671208|FG000|Overall Study|Withdrawal by Subject|0|||
144677258|NCT02809118|521671209|FG001|Overall Study|Withdrawal by Subject|1|||
144677259|NCT02809118|521671210|FG002|Overall Study|Withdrawal by Subject|1|||
144677260|NCT01235338|521671211|FG000|Overall Study|Adverse Event|3|||
144677261|NCT01235338|521671212|FG001|Overall Study|Adverse Event|2|||
144677262|NCT01235338|521671211|FG000|Overall Study|Protocol Violation|1|||
144677263|NCT01235338|521671212|FG001|Overall Study|Protocol Violation|1|||
144677264|NCT01235338|521671211|FG000|Overall Study|Withdrawal by Subject|5|||
144677265|NCT01235338|521671212|FG001|Overall Study|Withdrawal by Subject|0|||
144677266|NCT01235338|521671211|FG000|Overall Study|Exclusion criteria violations|1|||
144677267|NCT01235338|521671212|FG001|Overall Study|Exclusion criteria violations|1|||
144677268|NCT01235338|521671211|FG000|Overall Study|Positive drug screen|0|||
144677269|NCT01235338|521671212|FG001|Overall Study|Positive drug screen|1|||
144677270|NCT01235338|521671211|FG000|Overall Study|Prohibited meds|1|||
144677271|NCT01235338|521671212|FG001|Overall Study|Prohibited meds|0|||
144677272|NCT02436915|521671216|FG000|Overall Study|Withdrawal by Subject|0|||
144677273|NCT02436915|521671217|FG001|Overall Study|Withdrawal by Subject|1|||
144677274|NCT01843205|521671220|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
144677275|NCT01843205|521671221|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
144677276|NCT00446797|521671222|FG000|Overall Study|Lack of Efficacy|0|||
144677277|NCT00446797|521671223|FG001|Overall Study|Lack of Efficacy|2|||
144677278|NCT00446797|521671222|FG000|Overall Study|Lost to Follow-up|5|||
144677279|NCT00446797|521671223|FG001|Overall Study|Lost to Follow-up|3|||
144677280|NCT00446797|521671222|FG000|Overall Study|Withdrawal by Subject|2|||
144677281|NCT00446797|521671223|FG001|Overall Study|Withdrawal by Subject|2|||
144677282|NCT00446797|521671222|FG000|Overall Study|Protocol Violation|1|||
144677283|NCT00446797|521671223|FG001|Overall Study|Protocol Violation|3|||
144677284|NCT00446797|521671222|FG000|Overall Study|subject entered at another site|0|||
144677285|NCT00446797|521671223|FG001|Overall Study|subject entered at another site|1|||
144677286|NCT00446797|521671222|FG000|Overall Study|did not meet entrance criteria|0|||
144677287|NCT00446797|521671223|FG001|Overall Study|did not meet entrance criteria|1|||
144677288|NCT01440972|521671226|FG000|Overall Study|Withdrawal by Subject|3|||
144677289|NCT01440972|521671227|FG001|Overall Study|Withdrawal by Subject|2|||
144677290|NCT03933215|521671228|FG000|Overall Study|Other|6|||
144677291|NCT03933215|521671228|FG000|Overall Study|Sponsor decision|5|||
144677292|NCT03933215|521671228|FG000|Overall Study|Protocol Violation|5|||
144677293|NCT03933215|521671228|FG000|Overall Study|Withdrawal by Subject|6|||
144677294|NCT03933215|521671228|FG000|Overall Study|Lost to Follow-up|6|||
144677295|NCT03933215|521671228|FG000|Overall Study|Enrolled but not treated|38|||
144677296|NCT02473289|521671229|FG000|Overall Study|Adverse Event|2|||
144677297|NCT02473289|521671230|FG001|Overall Study|Adverse Event|3|||
144677298|NCT02473289|521671229|FG000|Overall Study|Lost to Follow-up|1|||
144677299|NCT02473289|521671230|FG001|Overall Study|Lost to Follow-up|1|||
144677300|NCT02473289|521671229|FG000|Overall Study|Protocol Violation|0|||
144677301|NCT02473289|521671230|FG001|Overall Study|Protocol Violation|1|||
144677302|NCT02473289|521671229|FG000|Overall Study|Withdrawal of consent|6|||
144677303|NCT02473289|521671230|FG001|Overall Study|Withdrawal of consent|7|||
144677304|NCT02473289|521671229|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
144677305|NCT02473289|521671230|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
144677306|NCT02473289|521671229|FG000|Overall Study|Other|2|||
144677307|NCT02473289|521671230|FG001|Overall Study|Other|0|||
144677308|NCT00407550|521671231|FG000|Overall Study|Adverse Event|0|||
144677309|NCT00407550|521671232|FG001|Overall Study|Adverse Event|1|||
144677310|NCT00407550|521671231|FG000|Overall Study|Withdrawal by Subject|0|||
144677311|NCT00407550|521671232|FG001|Overall Study|Withdrawal by Subject|2|||
144677312|NCT00407550|521671231|FG000|Overall Study|Death|1|||
144677313|NCT00407550|521671232|FG001|Overall Study|Death|0|||
144677314|NCT00407550|521671231|FG000|Overall Study|Insurance or Other medical condition|2|||
144677315|NCT00407550|521671232|FG001|Overall Study|Insurance or Other medical condition|1|||
144677316|NCT01266070|521671233|FG000|Overall Study|Adverse Event|3|||
144677317|NCT01266070|521671233|FG000|Overall Study|Protocol Violation|1|||
144677318|NCT01838213|521671234|FG000|Overall Study|Ineligible|166|||
144677319|NCT01838213|521671235|FG001|Overall Study|Ineligible|191|||
144677320|NCT02918318|521671236|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
144677321|NCT02918318|521671237|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
144677322|NCT02918318|521671238|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
144677323|NCT02918318|521671239|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
144677324|NCT02918318|521671240|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
144677325|NCT02918318|521671236|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
144677326|NCT02918318|521671237|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
144677327|NCT02918318|521671238|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
144677328|NCT02918318|521671239|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
144677329|NCT02918318|521671240|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
144677330|NCT02918318|521671236|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
144677331|NCT02918318|521671237|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
144677332|NCT02918318|521671238|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
144677333|NCT02918318|521671239|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
144677334|NCT02918318|521671240|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
144677335|NCT02918318|521671236|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
144677336|NCT02918318|521671237|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
144677337|NCT02918318|521671238|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
144677338|NCT02918318|521671239|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
144677339|NCT02918318|521671240|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
144677340|NCT02918318|521671236|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
144677341|NCT02918318|521671237|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
144677342|NCT02918318|521671238|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
144677343|NCT02918318|521671239|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
144677344|NCT02918318|521671240|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
144677345|NCT02918318|521671236|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
144677346|NCT02918318|521671237|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
144677347|NCT02918318|521671238|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
144677348|NCT02918318|521671239|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
144677349|NCT02918318|521671240|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
144265698|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
144265699|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
144265700|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
144265701|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
144265702|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
144265703|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
144265704|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
144265705|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
144265706|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
144265707|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
144265708|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
144265709|NCT02513550|520173975|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
144265710|NCT02513550|520173976|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
144677350|NCT02918318|521671236|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
144677351|NCT02918318|521671237|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
144677352|NCT02918318|521671238|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
144677353|NCT02918318|521671239|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
144677354|NCT02918318|521671240|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
144677355|NCT02918318|521671236|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
144677356|NCT02918318|521671237|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
144677357|NCT02918318|521671238|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
144677358|NCT02918318|521671239|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
144677359|NCT02918318|521671240|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
144677360|NCT02918318|521671236|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
144677361|NCT02918318|521671237|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
144677362|NCT02918318|521671238|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
144677363|NCT02918318|521671239|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
144677364|NCT02918318|521671240|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
144677365|NCT02918318|521671236|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
144677366|NCT02918318|521671237|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
144677367|NCT02918318|521671238|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
144677368|NCT02918318|521671239|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
144677369|NCT02918318|521671240|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
144677370|NCT02918318|521671236|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
144677371|NCT02918318|521671237|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
144677372|NCT02918318|521671238|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
144677373|NCT02918318|521671239|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
144677374|NCT02918318|521671240|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
144677375|NCT02918318|521671236|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
144265711|NCT02513550|520173977|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
144265712|NCT02513550|520173978|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
144265713|NCT02513550|520173979|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
144677376|NCT02918318|521671237|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
144677377|NCT02918318|521671238|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
144677378|NCT02918318|521671239|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
144677379|NCT02918318|521671240|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
144677380|NCT03185819|521671241|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
144677381|NCT03185819|521671242|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
144677382|NCT03185819|521671243|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
144677383|NCT03185819|521671244|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
144677384|NCT03185819|521671241|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
144677385|NCT03185819|521671242|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
144677386|NCT03185819|521671243|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
144677387|NCT03185819|521671244|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
144677388|NCT03185819|521671241|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
144677389|NCT03185819|521671242|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
144677390|NCT03185819|521671243|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
144677391|NCT03185819|521671244|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
144677392|NCT03185819|521671241|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
144677393|NCT03185819|521671242|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
144677394|NCT03185819|521671243|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
144677395|NCT03185819|521671244|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
144677396|NCT03185819|521671241|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
144677397|NCT03185819|521671242|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
144677398|NCT03185819|521671243|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
144677399|NCT03185819|521671244|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
144677400|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
144677401|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
144677402|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
144677403|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
144677404|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
144677405|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
144677406|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
144677407|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
144677408|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
144677409|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
144677410|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
144677411|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
144677412|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
144677413|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
144677414|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
144677415|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
144677416|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
144677417|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
144677418|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
144677419|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
144677420|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
144677421|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
144677422|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
144677423|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
144677424|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
144677425|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
144677426|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
144677427|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
144677428|NCT03185819|521671241|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
144677429|NCT03185819|521671242|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
144677430|NCT03185819|521671243|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
144677431|NCT03185819|521671244|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
144677432|NCT03097133|521671245|FG000|Overall Study|Lost to Follow-up|3|||
144677433|NCT03097133|521671246|FG001|Overall Study|Lost to Follow-up|2|||
144677434|NCT03097133|521671245|FG000|Overall Study|Withdrawal by Subject|2|||
144677435|NCT03097133|521671246|FG001|Overall Study|Withdrawal by Subject|5|||
144737350|NCT03032172|521892078|FG004|Treatment Period|Withdrawal by Subject|0|||
144737351|NCT03032172|521892079|FG005|Treatment Period|Withdrawal by Subject|0|||
144737352|NCT03032172|521892080|FG006|Treatment Period|Withdrawal by Subject|0|||
144737353|NCT03032172|521892081|FG007|Treatment Period|Withdrawal by Subject|0|||
144737354|NCT03032172|521892074|FG000|Open-label Extension Period|Death|0|||
144737355|NCT03032172|521892075|FG001|Open-label Extension Period|Death|0|||
144265714|NCT02513550|520173980|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
144677436|NCT03097133|521671245|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
144677437|NCT03097133|521671246|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
144677438|NCT03097133|521671245|FG000|Overall Study|Other|3|||
144677439|NCT03097133|521671246|FG001|Overall Study|Other|2|||
144677440|NCT03097133|521671245|FG000|Overall Study|Adverse Event|1|||
144677441|NCT03097133|521671246|FG001|Overall Study|Adverse Event|0|||
144677442|NCT02910089|521671249|FG000|Overall Study|Lost insurance eligibility|22|||
144677443|NCT02910089|521671250|FG001|Overall Study|Lost insurance eligibility|16|||
144677444|NCT00732238|521671251|FG000|Overall Study|Bacteremia|4|||
144677445|NCT00732238|521671252|FG001|Overall Study|Bacteremia|1|||
144677446|NCT00732238|521671251|FG000|Overall Study|Asymptomatic bacteriuria|1|||
144677447|NCT00732238|521671252|FG001|Overall Study|Asymptomatic bacteriuria|0|||
144677448|NCT02939976|521671253|FG000|Overall Study|Lost to Follow-up|7|||
144677449|NCT02939976|521671254|FG001|Overall Study|Lost to Follow-up|1|||
144677450|NCT02939976|521671255|FG002|Overall Study|Lost to Follow-up|1|||
144677451|NCT02939976|521671256|FG003|Overall Study|Lost to Follow-up|2|||
144677452|NCT02939976|521671253|FG000|Overall Study|Withdrawal by Subject|4|||
144677453|NCT02939976|521671254|FG001|Overall Study|Withdrawal by Subject|0|||
144677454|NCT02939976|521671255|FG002|Overall Study|Withdrawal by Subject|2|||
144677455|NCT02939976|521671256|FG003|Overall Study|Withdrawal by Subject|4|||
144677456|NCT02939976|521671253|FG000|Overall Study|Due to early study closure|4|||
144677457|NCT02939976|521671254|FG001|Overall Study|Due to early study closure|3|||
144677458|NCT02939976|521671255|FG002|Overall Study|Due to early study closure|2|||
144677459|NCT02939976|521671256|FG003|Overall Study|Due to early study closure|3|||
144677460|NCT04080752|521671257|FG000|Overall Study|Adverse Event|2|||
144677461|NCT04080752|521671258|FG001|Overall Study|Adverse Event|3|||
144677462|NCT04080752|521671257|FG000|Overall Study|Lack of Efficacy|1|||
144677463|NCT04080752|521671258|FG001|Overall Study|Lack of Efficacy|0|||
144677464|NCT04080752|521671257|FG000|Overall Study|Lost to Follow-up|1|||
144677465|NCT04080752|521671258|FG001|Overall Study|Lost to Follow-up|0|||
144677466|NCT04080752|521671257|FG000|Overall Study|Pregnancy|0|||
144677467|NCT04080752|521671258|FG001|Overall Study|Pregnancy|1|||
144677468|NCT04080752|521671257|FG000|Overall Study|Withdrawal by Subject|7|||
144677469|NCT04080752|521671258|FG001|Overall Study|Withdrawal by Subject|0|||
144677470|NCT04080752|521671257|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144677471|NCT04080752|521671258|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144677472|NCT04080752|521671257|FG000|Overall Study|Other|2|||
144677473|NCT04080752|521671258|FG001|Overall Study|Other|1|||
144677474|NCT01585168|521671259|FG000|Overall Study|Lost to Follow-up|3|||
144677475|NCT01585168|521671260|FG001|Overall Study|Lost to Follow-up|1|||
144677476|NCT01585168|521671261|FG002|Overall Study|Lost to Follow-up|1|||
144677477|NCT01585168|521671262|FG003|Overall Study|Lost to Follow-up|1|||
144677478|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
144677479|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
144677480|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
144677481|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
144677482|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
144677483|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
144677484|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
144677485|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
144677486|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
144677487|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
144677488|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
144677489|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
144677490|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
144677491|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
144677492|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
144677493|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
144677494|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
144677495|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
144677496|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
144677497|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
144677498|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
144677499|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
144677500|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
144677501|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
144677502|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Other|0|||
144677503|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Other|1|||
144677504|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Other|0|||
144677505|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Other|0|||
144677506|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
144677507|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
144677508|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
144677509|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
144677510|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
144677511|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
144677512|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
144677513|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
144677514|NCT01194414|521671263|FG000|24 Weeks Double Blind Period|Death|0|||
144677515|NCT01194414|521671264|FG001|24 Weeks Double Blind Period|Death|1|||
144677516|NCT01194414|521671265|FG002|24 Weeks Double Blind Period|Death|0|||
144677517|NCT01194414|521671266|FG003|24 Weeks Double Blind Period|Death|0|||
144677518|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
144677519|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
144677520|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
144677521|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
144677522|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
144677523|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
144677524|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
144677525|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
144677526|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
144677527|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
144677528|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
144677529|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
144677530|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
144677531|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
144677532|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
144677533|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
144677534|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
144677535|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
144677536|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
144677537|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
144677538|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
144677539|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
144677540|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
144677541|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
144677542|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Other|2|||
144677543|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Other|1|||
144677544|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Other|0|||
144677545|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Other|0|||
144677546|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
144677547|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
144677548|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
144677549|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
144677550|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
144677551|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
144677552|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
144677553|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
144677554|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
144677555|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
144677556|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
144677557|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
144677558|NCT01194414|521671263|FG000|72 Weeks Open Label Extension|Death|1|||
144677559|NCT01194414|521671264|FG001|72 Weeks Open Label Extension|Death|2|||
144677560|NCT01194414|521671265|FG002|72 Weeks Open Label Extension|Death|0|||
144677561|NCT01194414|521671266|FG003|72 Weeks Open Label Extension|Death|2|||
144677562|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
144677563|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
144677564|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
144677565|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
144677566|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
144677567|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
144677568|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
144677569|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
144677570|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
144737356|NCT03032172|521892076|FG002|Open-label Extension Period|Death|0|||
144677571|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
144677572|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
144677573|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
144677574|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
144677575|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
144677576|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
144677577|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
144677578|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
144677579|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
144677580|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
144677581|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
144677582|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
144677583|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
144218183|NCT01626690|519992256|FG000|Overall Study|Protocol Violation|1|||
144218184|NCT01626690|519992257|FG001|Overall Study|Protocol Violation|0|||
144677584|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
144677585|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
144677586|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
144677587|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
144677588|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
144677589|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
144677590|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
144677591|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
144677592|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
144677593|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
144677594|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
144677595|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
144677596|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
144677597|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
144677598|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
144677599|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
144677600|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
144677601|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
144677602|NCT03605836|521671267|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
144677603|NCT03605836|521671268|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
144677604|NCT03605836|521671269|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
144677605|NCT03605836|521671270|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
144677606|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
144677607|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
144677608|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
144677609|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
144677610|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
144677611|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
144677612|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
144677613|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
144677614|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
144677615|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
144677616|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
144677617|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
144677618|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
144677619|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
144677620|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
144677621|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
144677622|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
144677623|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
144677624|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
144677625|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
144218185|NCT01626690|519992256|FG000|Overall Study|Adverse Event|1|||
144218186|NCT01626690|519992257|FG001|Overall Study|Adverse Event|0|||
144218187|NCT04720053|519992258|FG000|Overall Study|Lost to Follow-up|12|||
144218188|NCT03908125|519992260|FG000|Overall Study|Withdrawal by Subject|92|||
144677626|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
144677627|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
144677628|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
144677629|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
144677630|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
144218189|NCT03908125|519992260|FG000|Overall Study|Lost to Follow-up|8|||
144737357|NCT03032172|521892077|FG003|Open-label Extension Period|Death|0|||
144737358|NCT03032172|521892078|FG004|Open-label Extension Period|Death|0|||
144737359|NCT03032172|521892079|FG005|Open-label Extension Period|Death|0|||
144737360|NCT03032172|521892080|FG006|Open-label Extension Period|Death|0|||
144737361|NCT03032172|521892081|FG007|Open-label Extension Period|Death|2|||
144737362|NCT03032172|521892074|FG000|Open-label Extension Period|Reason Not Specified|0|||
144737363|NCT03032172|521892075|FG001|Open-label Extension Period|Reason Not Specified|0|||
144737364|NCT03032172|521892076|FG002|Open-label Extension Period|Reason Not Specified|0|||
144677631|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
144677632|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
144677633|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
144677634|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
144677635|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
144677636|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
144677637|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
144677638|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
144677639|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
144677640|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
144677641|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
144677642|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
144677643|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
144677644|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
144677645|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
144677646|NCT03605836|521671267|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
144677647|NCT03605836|521671268|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
144677648|NCT03605836|521671269|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
144677649|NCT03605836|521671270|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
144677650|NCT02977507|521671272|FG000|Overall Study|Protocol Deviation|1|||
144677651|NCT02977507|521671273|FG001|Overall Study|Protocol Deviation|0|||
144677652|NCT02977507|521671272|FG000|Overall Study|Lost to Follow-up|1|||
144677653|NCT02977507|521671273|FG001|Overall Study|Lost to Follow-up|0|||
144677654|NCT00654420|521671274|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
144677655|NCT00654420|521671275|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
144677656|NCT00654420|521671276|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
144677657|NCT00654420|521671277|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
144677658|NCT00654420|521671274|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
144677659|NCT00654420|521671275|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
144677660|NCT00654420|521671276|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
144677661|NCT00654420|521671277|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
144677662|NCT00654420|521671274|FG000|Phase II|Adverse Event|0|||
144677663|NCT00654420|521671275|FG001|Phase II|Adverse Event|0|||
144677664|NCT00654420|521671276|FG002|Phase II|Adverse Event|3|||
144677665|NCT00654420|521671277|FG003|Phase II|Adverse Event|3|||
144677666|NCT00654420|521671274|FG000|Phase II|Lost to Follow-up|0|||
144677667|NCT00654420|521671275|FG001|Phase II|Lost to Follow-up|0|||
144677668|NCT00654420|521671276|FG002|Phase II|Lost to Follow-up|0|||
144677669|NCT00654420|521671277|FG003|Phase II|Lost to Follow-up|1|||
144677670|NCT00654420|521671274|FG000|Phase II|Physician Decision|0|||
144677671|NCT00654420|521671275|FG001|Phase II|Physician Decision|0|||
144677672|NCT00654420|521671276|FG002|Phase II|Physician Decision|0|||
144677673|NCT00654420|521671277|FG003|Phase II|Physician Decision|4|||
144677674|NCT00654420|521671274|FG000|Phase II|Progressive Disease|0|||
144677675|NCT00654420|521671275|FG001|Phase II|Progressive Disease|0|||
144677676|NCT00654420|521671276|FG002|Phase II|Progressive Disease|29|||
144677677|NCT00654420|521671277|FG003|Phase II|Progressive Disease|29|||
144677678|NCT00654420|521671274|FG000|Phase II|Withdrawal by Subject|0|||
144737365|NCT03032172|521892077|FG003|Open-label Extension Period|Reason Not Specified|0|||
144737366|NCT03032172|521892078|FG004|Open-label Extension Period|Reason Not Specified|0|||
144737367|NCT03032172|521892079|FG005|Open-label Extension Period|Reason Not Specified|5|||
144677679|NCT00654420|521671275|FG001|Phase II|Withdrawal by Subject|0|||
144677680|NCT00654420|521671276|FG002|Phase II|Withdrawal by Subject|4|||
144677681|NCT00654420|521671277|FG003|Phase II|Withdrawal by Subject|1|||
144677682|NCT00654420|521671274|FG000|Phase II|Missing Disposition Record|0|||
144677683|NCT00654420|521671275|FG001|Phase II|Missing Disposition Record|0|||
144677684|NCT00654420|521671276|FG002|Phase II|Missing Disposition Record|1|||
144677685|NCT00654420|521671277|FG003|Phase II|Missing Disposition Record|0|||
144677686|NCT00741260|521671286|FG000|Overall Study|Disease Progression|3|||
144677687|NCT00741260|521671287|FG001|Overall Study|Disease Progression|5|||
144677688|NCT00741260|521671288|FG002|Overall Study|Disease Progression|3|||
144677689|NCT00741260|521671289|FG003|Overall Study|Disease Progression|3|||
144677690|NCT00741260|521671290|FG004|Overall Study|Disease Progression|5|||
144677691|NCT00741260|521671291|FG005|Overall Study|Disease Progression|37|||
144677692|NCT00741260|521671292|FG006|Overall Study|Disease Progression|4|||
144737368|NCT03032172|521892080|FG006|Open-label Extension Period|Reason Not Specified|3|||
144737369|NCT03032172|521892081|FG007|Open-label Extension Period|Reason Not Specified|0|||
144737370|NCT03032172|521892074|FG000|Open-label Extension Period|Pregnancy|0|||
144737371|NCT03032172|521892075|FG001|Open-label Extension Period|Pregnancy|0|||
144737372|NCT03032172|521892076|FG002|Open-label Extension Period|Pregnancy|0|||
144737373|NCT03032172|521892077|FG003|Open-label Extension Period|Pregnancy|0|||
144737374|NCT03032172|521892078|FG004|Open-label Extension Period|Pregnancy|0|||
144737375|NCT03032172|521892079|FG005|Open-label Extension Period|Pregnancy|0|||
144737376|NCT03032172|521892080|FG006|Open-label Extension Period|Pregnancy|1|||
144737377|NCT03032172|521892081|FG007|Open-label Extension Period|Pregnancy|0|||
144737378|NCT03032172|521892074|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
144737379|NCT03032172|521892075|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
144737380|NCT03032172|521892076|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
144737381|NCT03032172|521892077|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
144737382|NCT03032172|521892078|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
144737383|NCT03032172|521892079|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
144737384|NCT03032172|521892080|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
144737385|NCT03032172|521892081|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
144737386|NCT06284525|521892084|FG000|Overall Study|Withdrawal by Subject|1|||
144737387|NCT00834522|521892085|FG000|Washout|Adverse Event|1|||
144737388|NCT00834522|521892086|FG001|Washout|Adverse Event|0|||
144737389|NCT00834522|521892085|FG000|Washout|Withdrawal by Subject|2|||
144737390|NCT00834522|521892086|FG001|Washout|Withdrawal by Subject|1|||
144737391|NCT04516967|521892087|FG000|Core Phase|Adverse Event|2|||
144737392|NCT04516967|521892088|FG001|Core Phase|Adverse Event|1|||
144737393|NCT04516967|521892089|FG002|Core Phase|Adverse Event|0|||
144737394|NCT04516967|521892087|FG000|Core Phase|Physician Decision|1|||
144737395|NCT04516967|521892088|FG001|Core Phase|Physician Decision|1|||
144737396|NCT04516967|521892089|FG002|Core Phase|Physician Decision|0|||
144737397|NCT04516967|521892087|FG000|Core Phase|Lack of Efficacy|7|||
144737398|NCT04516967|521892088|FG001|Core Phase|Lack of Efficacy|18|||
144737399|NCT04516967|521892089|FG002|Core Phase|Lack of Efficacy|0|||
144737400|NCT03165994|521892090|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
144737401|NCT03165994|521892090|FG000|Overall Study|Death|2|||
144737402|NCT03165994|521892090|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
144737403|NCT03165994|521892090|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
144737404|NCT03165994|521892090|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
144737405|NCT03165994|521892090|FG000|Overall Study|Miscellaneous|1|||
144737406|NCT00519194|521892091|FG000|Overall Study|Withdrawal by Subject|9|||
144737407|NCT00519194|521892091|FG000|Overall Study|Death|9|||
144737408|NCT00519194|521892091|FG000|Overall Study|Lost to Follow-up|3|||
144737409|NCT00561015|521892094|FG000|Overall Study|Adverse Event|0|||
144737410|NCT00561015|521892095|FG001|Overall Study|Adverse Event|0|||
144737411|NCT00561015|521892096|FG002|Overall Study|Adverse Event|0|||
144737412|NCT00561015|521892097|FG003|Overall Study|Adverse Event|0|||
144737413|NCT00561015|521892098|FG004|Overall Study|Adverse Event|1|||
144737414|NCT00561015|521892099|FG005|Overall Study|Adverse Event|0|||
144737415|NCT00561015|521892094|FG000|Overall Study|Lost to Follow-up|2|||
144737416|NCT00561015|521892095|FG001|Overall Study|Lost to Follow-up|0|||
144737417|NCT00561015|521892096|FG002|Overall Study|Lost to Follow-up|0|||
144737418|NCT00561015|521892097|FG003|Overall Study|Lost to Follow-up|1|||
144737419|NCT00561015|521892098|FG004|Overall Study|Lost to Follow-up|0|||
144737420|NCT00561015|521892099|FG005|Overall Study|Lost to Follow-up|3|||
144737421|NCT00561015|521892094|FG000|Overall Study|Participant non-compliance|2|||
144737422|NCT00561015|521892095|FG001|Overall Study|Participant non-compliance|0|||
144737423|NCT00561015|521892096|FG002|Overall Study|Participant non-compliance|0|||
144737424|NCT00561015|521892097|FG003|Overall Study|Participant non-compliance|0|||
144737425|NCT00561015|521892098|FG004|Overall Study|Participant non-compliance|0|||
144737426|NCT00561015|521892099|FG005|Overall Study|Participant non-compliance|0|||
144737427|NCT02545283|521892102|FG000|Overall Study|Lost to Follow-up|2|||
144737428|NCT02545283|521892103|FG001|Overall Study|Lost to Follow-up|4|||
144737429|NCT02545283|521892102|FG000|Overall Study|Withdrawal by Subject|5|||
144737430|NCT02545283|521892103|FG001|Overall Study|Withdrawal by Subject|9|||
144737431|NCT02545283|521892102|FG000|Overall Study|Death|109|||
144737432|NCT02545283|521892103|FG001|Overall Study|Death|211|||
144737433|NCT02545283|521892102|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
144737434|NCT02545283|521892103|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
144737435|NCT02545283|521892102|FG000|Overall Study|Study Terminated By Sponsor|33|||
144737436|NCT02545283|521892103|FG001|Overall Study|Study Terminated By Sponsor|71|||
144737437|NCT00583453|521892104|FG000|Overall Study|discontinued intervention|0|||
144737438|NCT00583453|521892105|FG001|Overall Study|discontinued intervention|2|||
144737439|NCT02436005|521892106|FG000|Second Intervention|Adverse Event|0|||
144737440|NCT02436005|521892107|FG001|Second Intervention|Adverse Event|1|||
144737441|NCT00905606|521892108|FG000|Period 1|Adverse Event|0|||
144737442|NCT00905606|521892109|FG001|Period 1|Adverse Event|1|||
144737443|NCT00905606|521892108|FG000|Washout|Withdrawal by Subject|1|||
144737444|NCT00905606|521892109|FG001|Washout|Withdrawal by Subject|0|||
144737445|NCT03635320|521892110|FG000|Overall Study|not implanted the device|1|||
144737446|NCT03635320|521892111|FG001|Overall Study|not implanted the device|2|||
144737447|NCT03635320|521892110|FG000|Overall Study|Withdrawal by Subject|11|||
144737448|NCT03635320|521892111|FG001|Overall Study|Withdrawal by Subject|6|||
144737449|NCT01558635|521892115|FG000|Overall Study|Death|1|||
144737450|NCT01558635|521892115|FG000|Overall Study|Withdrawal by Subject|2|||
144737451|NCT01558635|521892115|FG000|Overall Study|Physician Decision|1|||
144737452|NCT01558635|521892115|FG000|Overall Study|Subject received other treatment|1|||
144737453|NCT01558635|521892115|FG000|Overall Study|Reveal XT was explanted|1|||
144737454|NCT01158118|521892116|FG000|Overall Study|Screen failure|1|||
144737455|NCT01158118|521892117|FG001|Overall Study|Screen failure|0|||
144737456|NCT01158118|521892116|FG000|Overall Study|Donor match was a screen failure|0|||
144737457|NCT01158118|521892117|FG001|Overall Study|Donor match was a screen failure|1|||
144737458|NCT01158118|521892116|FG000|Overall Study|Suffered stroke prior to transplant|0|||
144737459|NCT01158118|521892117|FG001|Overall Study|Suffered stroke prior to transplant|1|||
144737460|NCT01158118|521892116|FG000|Overall Study|Death|0|||
144737461|NCT01158118|521892117|FG001|Overall Study|Death|1|||
144737462|NCT04994535|521892118|FG000|Overall Study|Lost to Follow-up|7|||
144737463|NCT04994535|521892119|FG001|Overall Study|Lost to Follow-up|7|||
144737464|NCT04994535|521892118|FG000|Overall Study|Withdrawal by Subject|10|||
144737465|NCT04994535|521892119|FG001|Overall Study|Withdrawal by Subject|7|||
144737466|NCT04994535|521892118|FG000|Overall Study|Other|1|||
144737467|NCT04994535|521892119|FG001|Overall Study|Other|1|||
144737468|NCT00905840|521892122|FG000|Overall Study|Lost to Follow-up|11|||
144737469|NCT00905840|521892122|FG000|Overall Study|Death|3|||
144737470|NCT00905840|521892122|FG000|Overall Study|Withdrawal by Subject|1|||
144737471|NCT00905840|521892122|FG000|Overall Study|Adverse Event|1|||
144737472|NCT01175018|521892125|FG000|Overall Study|Adverse Event|3|||
144737473|NCT01175018|521892126|FG001|Overall Study|Adverse Event|1|||
144737474|NCT03872128|521892133|FG000|Overall Study|Dropped out before treatment|1|||
144737475|NCT03872128|521892134|FG001|Overall Study|Dropped out before treatment|0|||
144737476|NCT03872128|521892135|FG002|Overall Study|Dropped out before treatment|4|||
144737477|NCT03872128|521892133|FG000|Overall Study|Lost to Follow-up|2|||
144737478|NCT03872128|521892134|FG001|Overall Study|Lost to Follow-up|5|||
144737479|NCT03872128|521892135|FG002|Overall Study|Lost to Follow-up|8|||
144737480|NCT03285594|521892139|FG000|Overall Study|At the Participant's Own Request|10|||
144737481|NCT03285594|521892140|FG001|Overall Study|At the Participant's Own Request|5|||
144737482|NCT03285594|521892141|FG002|Overall Study|At the Participant's Own Request|21|||
144737483|NCT03285594|521892139|FG000|Overall Study|Adverse Event|2|||
144737484|NCT03285594|521892140|FG001|Overall Study|Adverse Event|2|||
144737485|NCT03285594|521892141|FG002|Overall Study|Adverse Event|6|||
144737486|NCT03285594|521892139|FG000|Overall Study|Poor Compliance to Protocol|0|||
144737487|NCT03285594|521892140|FG001|Overall Study|Poor Compliance to Protocol|0|||
144737488|NCT03285594|521892141|FG002|Overall Study|Poor Compliance to Protocol|1|||
144737489|NCT03285594|521892139|FG000|Overall Study|Lost to Follow-up|0|||
144737490|NCT03285594|521892140|FG001|Overall Study|Lost to Follow-up|0|||
144737491|NCT03285594|521892141|FG002|Overall Study|Lost to Follow-up|1|||
144737492|NCT03285594|521892139|FG000|Overall Study|Reason Not Specified|3|||
144737493|NCT03285594|521892140|FG001|Overall Study|Reason Not Specified|4|||
144737494|NCT03285594|521892141|FG002|Overall Study|Reason Not Specified|8|||
144737495|NCT02838420|521892145|FG000|Overall Study|Ongoing in Study|113|||
144737496|NCT02838420|521892146|FG001|Overall Study|Ongoing in Study|45|||
144737497|NCT02838420|521892145|FG000|Overall Study|Lost to Follow-up|1|||
144737498|NCT02838420|521892146|FG001|Overall Study|Lost to Follow-up|0|||
144737499|NCT02838420|521892145|FG000|Overall Study|Withdrawal by Subject|3|||
144737500|NCT02838420|521892146|FG001|Overall Study|Withdrawal by Subject|4|||
144737501|NCT02838420|521892145|FG000|Overall Study|Death|8|||
144737502|NCT02838420|521892146|FG001|Overall Study|Death|13|||
144737503|NCT03419403|521892147|FG000|Overall Study|Withdrawal by Subject|5|||
144737504|NCT03419403|521892148|FG001|Overall Study|Withdrawal by Subject|2|||
144737505|NCT03419403|521892149|FG002|Overall Study|Withdrawal by Subject|5|||
144737506|NCT03419403|521892150|FG003|Overall Study|Withdrawal by Subject|1|||
144737507|NCT03419403|521892147|FG000|Overall Study|Progressive disease (per protocol)|0|||
144737508|NCT03419403|521892148|FG001|Overall Study|Progressive disease (per protocol)|2|||
144737509|NCT03419403|521892149|FG002|Overall Study|Progressive disease (per protocol)|2|||
144737510|NCT03419403|521892150|FG003|Overall Study|Progressive disease (per protocol)|0|||
144737511|NCT03419403|521892147|FG000|Overall Study|Other, not specified|6|||
144265715|NCT01408706|520173981|FG000|Overall Study|Physician Decision|1|||
144265716|NCT01408706|520173982|FG001|Overall Study|Physician Decision|0|||
144737512|NCT03419403|521892148|FG001|Overall Study|Other, not specified|4|||
144737513|NCT03419403|521892149|FG002|Overall Study|Other, not specified|5|||
144737514|NCT03419403|521892150|FG003|Overall Study|Other, not specified|1|||
144737515|NCT03419403|521892147|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
144737516|NCT03419403|521892148|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
144737517|NCT03419403|521892149|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
144677693|NCT00741260|521671286|FG000|Overall Study|Death|0|||
144677694|NCT00741260|521671287|FG001|Overall Study|Death|1|||
144677695|NCT00741260|521671288|FG002|Overall Study|Death|0|||
144677696|NCT00741260|521671289|FG003|Overall Study|Death|1|||
144677697|NCT00741260|521671290|FG004|Overall Study|Death|2|||
144677698|NCT00741260|521671291|FG005|Overall Study|Death|2|||
144677699|NCT00741260|521671292|FG006|Overall Study|Death|1|||
144677700|NCT00741260|521671286|FG000|Overall Study|Withdrawal by Subject|0|||
144677701|NCT00741260|521671287|FG001|Overall Study|Withdrawal by Subject|0|||
144677702|NCT00741260|521671288|FG002|Overall Study|Withdrawal by Subject|0|||
144677703|NCT00741260|521671289|FG003|Overall Study|Withdrawal by Subject|0|||
144677704|NCT00741260|521671290|FG004|Overall Study|Withdrawal by Subject|1|||
144677705|NCT00741260|521671291|FG005|Overall Study|Withdrawal by Subject|3|||
144677706|NCT00741260|521671292|FG006|Overall Study|Withdrawal by Subject|1|||
144677707|NCT00741260|521671286|FG000|Overall Study|Physician Decision|1|||
144677708|NCT00741260|521671287|FG001|Overall Study|Physician Decision|1|||
144677709|NCT00741260|521671288|FG002|Overall Study|Physician Decision|0|||
144677710|NCT00741260|521671289|FG003|Overall Study|Physician Decision|0|||
144677711|NCT00741260|521671290|FG004|Overall Study|Physician Decision|0|||
144677712|NCT00741260|521671291|FG005|Overall Study|Physician Decision|0|||
144677713|NCT00741260|521671292|FG006|Overall Study|Physician Decision|0|||
144677714|NCT00741260|521671286|FG000|Overall Study|Other|2|||
144677715|NCT00741260|521671287|FG001|Overall Study|Other|1|||
144677716|NCT00741260|521671288|FG002|Overall Study|Other|1|||
144677717|NCT00741260|521671289|FG003|Overall Study|Other|2|||
144677718|NCT00741260|521671290|FG004|Overall Study|Other|1|||
144677719|NCT00741260|521671291|FG005|Overall Study|Other|3|||
144677720|NCT00741260|521671292|FG006|Overall Study|Other|1|||
144677721|NCT02565615|521671293|FG000|Overall Study|Death|0|||
144677722|NCT02565615|521671294|FG001|Overall Study|Death|1|||
144677723|NCT02565615|521671295|FG002|Overall Study|Death|0|||
144677724|NCT02565615|521671296|FG003|Overall Study|Death|0|||
144677725|NCT02565615|521671297|FG004|Overall Study|Death|4|||
144677726|NCT02565615|521671293|FG000|Overall Study|Not willing to participate in study|2|||
144677727|NCT02565615|521671294|FG001|Overall Study|Not willing to participate in study|21|||
144677728|NCT02565615|521671295|FG002|Overall Study|Not willing to participate in study|0|||
144677729|NCT02565615|521671296|FG003|Overall Study|Not willing to participate in study|1|||
144677730|NCT02565615|521671297|FG004|Overall Study|Not willing to participate in study|169|||
144677731|NCT02565615|521671293|FG000|Overall Study|Lost to Follow-up|0|||
144677732|NCT02565615|521671294|FG001|Overall Study|Lost to Follow-up|4|||
144677733|NCT02565615|521671295|FG002|Overall Study|Lost to Follow-up|0|||
144677734|NCT02565615|521671296|FG003|Overall Study|Lost to Follow-up|1|||
144677735|NCT02565615|521671297|FG004|Overall Study|Lost to Follow-up|765|||
144677736|NCT02565615|521671293|FG000|Overall Study|Not meeting eligibility criteria|0|||
144677737|NCT02565615|521671294|FG001|Overall Study|Not meeting eligibility criteria|7|||
144677738|NCT02565615|521671295|FG002|Overall Study|Not meeting eligibility criteria|0|||
144677739|NCT02565615|521671296|FG003|Overall Study|Not meeting eligibility criteria|0|||
144677740|NCT02565615|521671297|FG004|Overall Study|Not meeting eligibility criteria|25|||
144677741|NCT02565615|521671293|FG000|Overall Study|Reason not defined|0|||
144677742|NCT02565615|521671294|FG001|Overall Study|Reason not defined|2|||
144677743|NCT02565615|521671295|FG002|Overall Study|Reason not defined|0|||
144677744|NCT02565615|521671296|FG003|Overall Study|Reason not defined|1|||
144677745|NCT02565615|521671297|FG004|Overall Study|Reason not defined|62|||
144677746|NCT02565615|521671293|FG000|Overall Study|Adverse Event|1|||
144677747|NCT02565615|521671294|FG001|Overall Study|Adverse Event|1|||
144677748|NCT02565615|521671295|FG002|Overall Study|Adverse Event|0|||
144677749|NCT02565615|521671296|FG003|Overall Study|Adverse Event|0|||
144677750|NCT02565615|521671297|FG004|Overall Study|Adverse Event|9|||
144677751|NCT02565615|521671293|FG000|Overall Study|Untreated|0|||
144677752|NCT02565615|521671294|FG001|Overall Study|Untreated|0|||
144677753|NCT02565615|521671295|FG002|Overall Study|Untreated|0|||
144677754|NCT02565615|521671296|FG003|Overall Study|Untreated|0|||
144677755|NCT02565615|521671297|FG004|Overall Study|Untreated|567|||
144677756|NCT05563714|521671298|FG000|Overall Study|Death|2|||
144677757|NCT05563714|521671299|FG001|Overall Study|Death|2|||
144677758|NCT05563714|521671300|FG002|Overall Study|Death|0|||
144677759|NCT05563714|521671301|FG003|Overall Study|Death|0|||
144677760|NCT05563714|521671298|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
144677761|NCT05563714|521671299|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
144677762|NCT05563714|521671300|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
144677763|NCT05563714|521671301|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
144677764|NCT05563714|521671298|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
144677765|NCT05563714|521671299|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
144677766|NCT05563714|521671300|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
144700157|NCT00948896|521754513|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
144700158|NCT00948896|521754514|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
144677767|NCT05563714|521671301|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
144677768|NCT05563714|521671298|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
144677769|NCT05563714|521671299|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
144677770|NCT05563714|521671300|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
144677771|NCT05563714|521671301|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
144677772|NCT05563714|521671298|FG000|Overall Study|Lost to Follow-up|22|||
144677773|NCT05563714|521671299|FG001|Overall Study|Lost to Follow-up|19|||
144677774|NCT05563714|521671300|FG002|Overall Study|Lost to Follow-up|0|||
144677775|NCT05563714|521671301|FG003|Overall Study|Lost to Follow-up|0|||
144677776|NCT02427100|521671305|FG000|Overall Study|Lost to Follow-up|0|||
144677777|NCT02427100|521671306|FG001|Overall Study|Lost to Follow-up|2|||
144677778|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
144677779|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
144677780|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
144677781|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
144677782|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
144677783|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
144677784|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
144677785|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
144677786|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
144677787|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
144677788|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
144677789|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
144677790|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
144677791|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
144677792|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
144677793|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
144677794|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
144677795|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
144677796|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
144677797|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
144677798|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
144677799|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
144677800|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
144677801|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
144677802|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
144677803|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
144677804|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
144677805|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
144677806|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
144677807|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
144677808|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
144677809|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
144677810|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
144677811|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
144677812|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
144677813|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
144677814|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
144677815|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
144677816|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
144677817|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
144737518|NCT03419403|521892150|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
144737519|NCT04887415|521892151|FG000|Overall Study|Lost to Follow-up|2|||
144737520|NCT05646251|521892152|FG000|Overall Study|Physician Decision|1|||
144677818|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
144677819|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
144677820|NCT02120352|521671307|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
144677821|NCT02120352|521671308|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
144677822|NCT02120352|521671309|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
144677823|NCT02120352|521671310|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
144677824|NCT02120352|521671311|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
144677825|NCT02120352|521671312|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
144677826|NCT02120352|521671313|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
144677827|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
144677828|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
144677829|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
144677830|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
144677831|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
144265717|NCT01222104|520173983|FG000|Overall Study|Lost to Follow-up|37|||
144265718|NCT01222104|520173983|FG000|Overall Study|Death|10|||
144265719|NCT00888654|520173984|FG000|Overall Study|Problems swallowing oral meds.|1|||
144265720|NCT00888654|520173984|FG000|Overall Study|Not enough oral meds before surgery|3|||
144265721|NCT00888654|520173984|FG000|Overall Study|Surgery aborted|2|||
144677832|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
144677833|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
144677834|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
144677835|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
144677836|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
144677837|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
144677838|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
144677839|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
144677840|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
144677841|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
144677842|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
144677843|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
144677844|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
144677845|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
144677846|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
144677847|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
144677848|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
144677849|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
144677850|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
144677851|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
144677852|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
144677853|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
144677854|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
144677855|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
144677856|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
144677857|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
144677858|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
144677859|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
144677860|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
144677861|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
144677862|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
144677863|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
144677864|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
144677865|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
144677866|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
144677867|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
144677868|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
144677869|NCT02120352|521671307|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
144677870|NCT02120352|521671308|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
144677871|NCT02120352|521671309|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
144677872|NCT02120352|521671310|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
144677873|NCT02120352|521671311|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
144677874|NCT02120352|521671312|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
144677875|NCT02120352|521671313|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
144677876|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
144677877|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
144677878|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
144677879|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
144677880|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
144677881|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
144677882|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
144677883|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
144677884|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
144677885|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
144677886|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
144677887|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
144677888|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
144677889|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
144677890|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
144677891|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
144677892|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
144677893|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
144677894|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
144677895|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
144677896|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
144677897|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
144677898|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
144677899|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
144677900|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
144677901|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
144677902|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
144677903|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
144677904|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
144677905|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
144677906|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
144677907|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
144677908|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
144677909|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
144677910|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
144677911|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
144677912|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
144677913|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
144677914|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
144677915|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
144677916|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
144677917|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
144677918|NCT02120352|521671307|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
144677919|NCT02120352|521671308|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
144677920|NCT02120352|521671309|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
144677921|NCT02120352|521671310|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
144677922|NCT02120352|521671311|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
144677923|NCT02120352|521671312|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
144677924|NCT02120352|521671313|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
144677925|NCT02120352|521671307|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
144677926|NCT02120352|521671308|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
144677927|NCT02120352|521671309|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
144677928|NCT02120352|521671310|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
144677929|NCT02120352|521671311|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
144677930|NCT02120352|521671312|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
144677931|NCT02120352|521671313|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
144677932|NCT01610206|521671316|FG000|Overall Study|Adverse Event|10|||
144677933|NCT01610206|521671317|FG001|Overall Study|Adverse Event|30|||
144677934|NCT00196196|521671318|FG000|Overall Study|Withdrawal by Subject|2|||
144677935|NCT00196196|521671318|FG000|Overall Study|Did not have required condition (hydroce|5|||
144677936|NCT03034057|521671321|FG000|Overall Study|Withdrawal by Subject|10|||
144677937|NCT03034057|521671321|FG000|Overall Study|Protocol Violation|1|||
144677938|NCT03034057|521671321|FG000|Overall Study|Not defined|2|||
144677939|NCT03034057|521671321|FG000|Overall Study|Lost to Follow-up|19|||
144677940|NCT03034057|521671321|FG000|Overall Study|Adverse Event|22|||
144677941|NCT03034057|521671321|FG000|Overall Study|Medication error without associated AE|1|||
144677942|NCT03271307|521671322|FG000|Overall Study|Lost to Follow-up|0|||
144677943|NCT03271307|521671323|FG001|Overall Study|Lost to Follow-up|0|||
144677944|NCT03271307|521671324|FG002|Overall Study|Lost to Follow-up|0|||
144677945|NCT03271307|521671325|FG003|Overall Study|Lost to Follow-up|28|||
144677946|NCT03271307|521671326|FG004|Overall Study|Lost to Follow-up|91|||
144677947|NCT02671760|521671329|FG000|Overall Study|Lost to Follow-up|0|||
144677948|NCT02671760|521671330|FG001|Overall Study|Lost to Follow-up|1|||
144677949|NCT02671760|521671331|FG002|Overall Study|Lost to Follow-up|0|||
144677950|NCT02566109|521671332|FG000|Overall Study|Withdrawal by Subject|1|||
144677951|NCT01041404|521671335|FG000|Overall Study|Adverse Event|45|||
144677952|NCT01041404|521671336|FG001|Overall Study|Adverse Event|35|||
144677953|NCT01041404|521671335|FG000|Overall Study|Lack of Efficacy|200|||
144677954|NCT01041404|521671336|FG001|Overall Study|Lack of Efficacy|210|||
144737521|NCT05646251|521892153|FG001|Overall Study|Physician Decision|0|||
144737522|NCT05646251|521892154|FG002|Overall Study|Physician Decision|2|||
144737523|NCT00773253|521892155|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
144737524|NCT00773253|521892156|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
144737525|NCT01566721|521892157|FG000|Treatment Period|Withdrawal by Subject|35|||
144737526|NCT01566721|521892158|FG001|Treatment Period|Withdrawal by Subject|9|||
144737527|NCT01566721|521892157|FG000|Treatment Period|Disease Progression/Recurrence|37|||
144737528|NCT01566721|521892158|FG001|Treatment Period|Disease Progression/Recurrence|13|||
144737529|NCT01566721|521892157|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
144737530|NCT01566721|521892158|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
144737531|NCT01566721|521892157|FG000|Treatment Period|Other|13|||
144737532|NCT01566721|521892158|FG001|Treatment Period|Other|2|||
144737533|NCT01566721|521892157|FG000|Treatment Period|Lack of Compliance|5|||
144737534|NCT01566721|521892158|FG001|Treatment Period|Lack of Compliance|1|||
144737535|NCT01566721|521892157|FG000|Treatment Period|Adverse Event|100|||
144737536|NCT01566721|521892158|FG001|Treatment Period|Adverse Event|30|||
144737537|NCT01566721|521892157|FG000|Treatment Period|Pregnancy|1|||
144737538|NCT01566721|521892158|FG001|Treatment Period|Pregnancy|0|||
144737539|NCT01566721|521892157|FG000|Safety Follow-up|Physician Decision|6|||
144737540|NCT01566721|521892158|FG001|Safety Follow-up|Physician Decision|4|||
144737541|NCT01566721|521892157|FG000|Safety Follow-up|Lost to Follow-up|101|||
144737542|NCT01566721|521892158|FG001|Safety Follow-up|Lost to Follow-up|48|||
144737543|NCT01566721|521892157|FG000|Safety Follow-up|Withdrawal by Subject|155|||
144737544|NCT01566721|521892158|FG001|Safety Follow-up|Withdrawal by Subject|49|||
144737545|NCT01566721|521892157|FG000|Safety Follow-up|Death|28|||
144737546|NCT01566721|521892158|FG001|Safety Follow-up|Death|4|||
144737547|NCT01566721|521892157|FG000|Safety Follow-up|Non-compliance|7|||
144737548|NCT01566721|521892158|FG001|Safety Follow-up|Non-compliance|3|||
144737549|NCT01566721|521892157|FG000|Safety Follow-up|Protocol Violation|7|||
144737550|NCT01566721|521892158|FG001|Safety Follow-up|Protocol Violation|0|||
144737551|NCT01566721|521892157|FG000|Safety Follow-up|Site closure|2|||
144737552|NCT01566721|521892158|FG001|Safety Follow-up|Site closure|3|||
144737553|NCT01566721|521892157|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
144737554|NCT01566721|521892158|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
144737555|NCT01566721|521892157|FG000|Safety Follow-up|Missing|7|||
144737556|NCT01566721|521892158|FG001|Safety Follow-up|Missing|2|||
144737557|NCT01566721|521892157|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
144737558|NCT01566721|521892158|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
144737559|NCT01566721|521892157|FG000|Safety Follow-up|Sponsor decision|1|||
144737560|NCT01566721|521892158|FG001|Safety Follow-up|Sponsor decision|0|||
144737561|NCT01566721|521892157|FG000|Safety Follow-up|Adverse Event|8|||
144737562|NCT01566721|521892158|FG001|Safety Follow-up|Adverse Event|4|||
144737563|NCT00446563|521892159|FG000|Overall Study|Adverse Event|4|||
144737564|NCT00446563|521892160|FG001|Overall Study|Adverse Event|3|||
144737565|NCT00446563|521892159|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144737566|NCT00446563|521892160|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144737567|NCT00446563|521892159|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144737568|NCT00446563|521892160|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144677955|NCT01041404|521671335|FG000|Overall Study|Violation of Selection Criteria|0|||
144677956|NCT01041404|521671336|FG001|Overall Study|Violation of Selection Criteria|1|||
144677957|NCT01041404|521671335|FG000|Overall Study|Protocol Violation|4|||
144677958|NCT01041404|521671336|FG001|Overall Study|Protocol Violation|0|||
144677959|NCT01041404|521671335|FG000|Overall Study|Withdrawal by Subject|29|||
144677960|NCT01041404|521671336|FG001|Overall Study|Withdrawal by Subject|23|||
144677961|NCT01041404|521671335|FG000|Overall Study|Failure to Return|1|||
144677962|NCT01041404|521671336|FG001|Overall Study|Failure to Return|2|||
144677963|NCT01041404|521671335|FG000|Overall Study|Other|11|||
144677964|NCT01041404|521671336|FG001|Overall Study|Other|23|||
144677965|NCT01685203|521671337|FG000|Overall Study|Lost to Follow-up|3|||
144677966|NCT01685203|521671338|FG001|Overall Study|Lost to Follow-up|3|||
144677967|NCT01685203|521671339|FG002|Overall Study|Lost to Follow-up|0|||
144677968|NCT01685203|521671340|FG003|Overall Study|Lost to Follow-up|1|||
144677969|NCT01685203|521671341|FG004|Overall Study|Lost to Follow-up|0|||
144677970|NCT01685203|521671342|FG005|Overall Study|Lost to Follow-up|0|||
144677971|NCT01685203|521671343|FG006|Overall Study|Lost to Follow-up|0|||
144677972|NCT01685203|521671337|FG000|Overall Study|Adverse Event|0|||
144677973|NCT01685203|521671338|FG001|Overall Study|Adverse Event|0|||
144677974|NCT01685203|521671339|FG002|Overall Study|Adverse Event|0|||
144677975|NCT01685203|521671340|FG003|Overall Study|Adverse Event|0|||
144737569|NCT00446563|521892159|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144737570|NCT00446563|521892160|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144737571|NCT00446563|521892159|FG000|Overall Study|Withdrawal by Subject|2|||
144737572|NCT00446563|521892160|FG001|Overall Study|Withdrawal by Subject|1|||
144737573|NCT00446563|521892159|FG000|Overall Study|Administrative problems|0|||
144677976|NCT01685203|521671341|FG004|Overall Study|Adverse Event|0|||
144737574|NCT00446563|521892160|FG001|Overall Study|Administrative problems|1|||
144737575|NCT02409355|521892163|FG000|Overall Study|Withdrawal by Subject|1|||
144737576|NCT02409355|521892164|FG001|Overall Study|Withdrawal by Subject|0|||
144218190|NCT02262325|519992261|FG000|Overall Study|Death|16|||
144677977|NCT01685203|521671342|FG005|Overall Study|Adverse Event|2|||
144677978|NCT01685203|521671343|FG006|Overall Study|Adverse Event|0|||
144677979|NCT01685203|521671337|FG000|Overall Study|Adverse event and withdrew consent|1|||
144677980|NCT01685203|521671338|FG001|Overall Study|Adverse event and withdrew consent|0|||
144677981|NCT01685203|521671339|FG002|Overall Study|Adverse event and withdrew consent|0|||
144677982|NCT01685203|521671340|FG003|Overall Study|Adverse event and withdrew consent|0|||
144677983|NCT01685203|521671341|FG004|Overall Study|Adverse event and withdrew consent|0|||
144677984|NCT01685203|521671342|FG005|Overall Study|Adverse event and withdrew consent|0|||
144677985|NCT01685203|521671343|FG006|Overall Study|Adverse event and withdrew consent|0|||
144677986|NCT01685203|521671337|FG000|Overall Study|Patient's decision|0|||
144677987|NCT01685203|521671338|FG001|Overall Study|Patient's decision|0|||
144677988|NCT01685203|521671339|FG002|Overall Study|Patient's decision|0|||
144677989|NCT01685203|521671340|FG003|Overall Study|Patient's decision|0|||
144677990|NCT01685203|521671341|FG004|Overall Study|Patient's decision|0|||
144677991|NCT01685203|521671342|FG005|Overall Study|Patient's decision|1|||
144677992|NCT01685203|521671343|FG006|Overall Study|Patient's decision|0|||
144677993|NCT00383708|521671344|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
144677994|NCT00383708|521671344|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
144677995|NCT00383708|521671344|FG000|Run-in Period|Protocol Violation|4|||
144677996|NCT00383708|521671344|FG000|Run-in Period|Adverse Event|2|||
144677997|NCT00383708|521671344|FG000|Run-in Period|Claustrophobia|1|||
144677998|NCT00383708|521671344|FG000|Co-administration Period|Adverse Event|5|||
144677999|NCT00318370|521671345|FG000|Period 1|Lack of Efficacy|5|||
144678000|NCT00318370|521671346|FG001|Period 1|Lack of Efficacy|0|||
144678001|NCT00318370|521671347|FG002|Period 1|Lack of Efficacy|0|||
144678002|NCT00318370|521671345|FG000|Period 1|Physician Decision|1|||
144678003|NCT00318370|521671346|FG001|Period 1|Physician Decision|0|||
144678004|NCT00318370|521671347|FG002|Period 1|Physician Decision|0|||
144678005|NCT00318370|521671345|FG000|Period 1|Withdrawal by Subject|1|||
144678006|NCT00318370|521671346|FG001|Period 1|Withdrawal by Subject|0|||
144678007|NCT00318370|521671347|FG002|Period 1|Withdrawal by Subject|0|||
144678008|NCT00318370|521671345|FG000|Period 2|Adverse Event|0|||
144678009|NCT00318370|521671346|FG001|Period 2|Adverse Event|3|||
144678010|NCT00318370|521671347|FG002|Period 2|Adverse Event|0|||
144678011|NCT00318370|521671345|FG000|Period 2|Lack of Efficacy|0|||
144678012|NCT00318370|521671346|FG001|Period 2|Lack of Efficacy|5|||
144678013|NCT00318370|521671347|FG002|Period 2|Lack of Efficacy|0|||
144678014|NCT00318370|521671345|FG000|Period 2|Physician Decision|0|||
144678015|NCT00318370|521671346|FG001|Period 2|Physician Decision|1|||
144678016|NCT00318370|521671347|FG002|Period 2|Physician Decision|0|||
144678017|NCT00318370|521671345|FG000|Period 2|Withdrawal by Subject|0|||
144678018|NCT00318370|521671346|FG001|Period 2|Withdrawal by Subject|1|||
144678019|NCT00318370|521671347|FG002|Period 2|Withdrawal by Subject|0|||
144678020|NCT00318370|521671345|FG000|Period 2|Other|0|||
144678021|NCT00318370|521671346|FG001|Period 2|Other|1|||
144678022|NCT00318370|521671347|FG002|Period 2|Other|0|||
144678023|NCT00318370|521671345|FG000|Period 3|Adverse Event|0|||
144678024|NCT00318370|521671346|FG001|Period 3|Adverse Event|0|||
144678025|NCT00318370|521671347|FG002|Period 3|Adverse Event|1|||
144678026|NCT00318370|521671345|FG000|Period 3|Lack of Efficacy|0|||
144678027|NCT00318370|521671346|FG001|Period 3|Lack of Efficacy|0|||
144678028|NCT00318370|521671347|FG002|Period 3|Lack of Efficacy|24|||
144678029|NCT00318370|521671345|FG000|Period 3|Death|0|||
144678030|NCT00318370|521671346|FG001|Period 3|Death|0|||
144678031|NCT00318370|521671347|FG002|Period 3|Death|1|||
144678032|NCT00318370|521671345|FG000|Period 3|Physician Decision|0|||
144678033|NCT00318370|521671346|FG001|Period 3|Physician Decision|0|||
144678034|NCT00318370|521671347|FG002|Period 3|Physician Decision|1|||
144678035|NCT00318370|521671345|FG000|Period 3|Withdrawal by Subject|0|||
144678036|NCT00318370|521671346|FG001|Period 3|Withdrawal by Subject|0|||
144678037|NCT00318370|521671347|FG002|Period 3|Withdrawal by Subject|3|||
144678038|NCT00318370|521671345|FG000|Period 3|Other|0|||
144678039|NCT00318370|521671346|FG001|Period 3|Other|0|||
144678040|NCT00318370|521671347|FG002|Period 3|Other|3|||
144678041|NCT01750840|521671350|FG000|Overall Study|Lost to Follow-up|4|||
144678042|NCT01997281|521671351|FG000|Overall Study|Withdrawal by Subject|1|||
144678043|NCT01997281|521671352|FG001|Overall Study|Withdrawal by Subject|0|||
144678044|NCT03619837|521671355|FG000|Screening|received organs from HCV-negative donors|47|||
144678045|NCT03619837|521671355|FG000|Screening|died on the wait-list|2|||
144678046|NCT03619837|521671355|FG000|Screening|remained on the wait list|40|||
144678047|NCT03619837|521671355|FG000|Screening|didn't meet eligibility criteria|3|||
144678048|NCT03619837|521671355|FG000|Screening|withdrew consent|2|||
144678049|NCT03619837|521671355|FG000|Screening|never listed for HCV-viremic donor|1|||
144678050|NCT03619837|521671355|FG000|Screening|developed exclusion criteria|2|||
144678051|NCT03619837|521671355|FG000|Screening|excluded by the investigator due to non-compliance|1|||
144678052|NCT00880607|521671356|FG000|Overall Study|Physician Decision|2|||
144678053|NCT00880607|521671357|FG001|Overall Study|Physician Decision|2|||
144678054|NCT00880607|521671356|FG000|Overall Study|Protocol Violation|2|||
144678055|NCT00880607|521671357|FG001|Overall Study|Protocol Violation|1|||
144678056|NCT00880607|521671356|FG000|Overall Study|surgery did not extend past L1 level|3|||
144678057|NCT00880607|521671357|FG001|Overall Study|surgery did not extend past L1 level|0|||
144678058|NCT00981682|521671365|FG000|Overall Study|Adverse Event|48|||
144678059|NCT00981682|521671365|FG000|Overall Study|Withdrawal by Subject|52|||
144678060|NCT00981682|521671365|FG000|Overall Study|Lost to Follow-up|14|||
144678061|NCT00981682|521671365|FG000|Overall Study|Lack of Efficacy|13|||
144737577|NCT02409355|521892163|FG000|Overall Study|Death|1|||
144737578|NCT02409355|521892164|FG001|Overall Study|Death|1|||
144678062|NCT00981682|521671365|FG000|Overall Study|Protocol Violation|6|||
144678063|NCT00981682|521671365|FG000|Overall Study|administrative|9|||
144678064|NCT01696396|521672857|FG000|Overall Study|Withdrawal by Subject|19|||
144678065|NCT01696396|521672858|FG001|Overall Study|Withdrawal by Subject|5|||
144678066|NCT01696396|521672859|FG002|Overall Study|Withdrawal by Subject|19|||
144678067|NCT01696396|521672860|FG003|Overall Study|Withdrawal by Subject|11|||
144678068|NCT01696396|521672857|FG000|Overall Study|Decision by Sponsor|3|||
144678069|NCT01696396|521672858|FG001|Overall Study|Decision by Sponsor|1|||
144678070|NCT01696396|521672859|FG002|Overall Study|Decision by Sponsor|2|||
144678071|NCT01696396|521672860|FG003|Overall Study|Decision by Sponsor|2|||
144678072|NCT01696396|521672857|FG000|Overall Study|Lost to Follow-up|9|||
144678073|NCT01696396|521672858|FG001|Overall Study|Lost to Follow-up|1|||
144678074|NCT01696396|521672859|FG002|Overall Study|Lost to Follow-up|4|||
144678075|NCT01696396|521672860|FG003|Overall Study|Lost to Follow-up|1|||
144678076|NCT01696396|521672857|FG000|Overall Study|Death|0|||
144678077|NCT01696396|521672858|FG001|Overall Study|Death|0|||
144678078|NCT01696396|521672859|FG002|Overall Study|Death|1|||
144678079|NCT01696396|521672860|FG003|Overall Study|Death|0|||
144678080|NCT02371980|521672866|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
144678081|NCT02371980|521672867|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
144678082|NCT02371980|521672868|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
144678083|NCT02371980|521672869|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
144678084|NCT02371980|521672870|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
144678085|NCT02371980|521672866|FG000|Open-label Period|Significant Protocol Deviation|19|||
144678086|NCT02371980|521672867|FG001|Open-label Period|Significant Protocol Deviation|0|||
144678087|NCT02371980|521672868|FG002|Open-label Period|Significant Protocol Deviation|0|||
144678088|NCT02371980|521672869|FG003|Open-label Period|Significant Protocol Deviation|0|||
144678089|NCT02371980|521672870|FG004|Open-label Period|Significant Protocol Deviation|0|||
144678090|NCT02371980|521672866|FG000|Open-label Period|Noncompliance with Study Drug|10|||
144678091|NCT02371980|521672867|FG001|Open-label Period|Noncompliance with Study Drug|0|||
144678092|NCT02371980|521672868|FG002|Open-label Period|Noncompliance with Study Drug|0|||
144678093|NCT02371980|521672869|FG003|Open-label Period|Noncompliance with Study Drug|0|||
144678094|NCT02371980|521672870|FG004|Open-label Period|Noncompliance with Study Drug|0|||
144678095|NCT02371980|521672866|FG000|Open-label Period|Lost to Follow-up|55|||
144678096|NCT02371980|521672867|FG001|Open-label Period|Lost to Follow-up|0|||
144678097|NCT02371980|521672868|FG002|Open-label Period|Lost to Follow-up|0|||
144678098|NCT02371980|521672869|FG003|Open-label Period|Lost to Follow-up|0|||
144678099|NCT02371980|521672870|FG004|Open-label Period|Lost to Follow-up|0|||
144678100|NCT02371980|521672866|FG000|Open-label Period|Voluntary Withdrawal|91|||
144678101|NCT02371980|521672867|FG001|Open-label Period|Voluntary Withdrawal|0|||
144678102|NCT02371980|521672868|FG002|Open-label Period|Voluntary Withdrawal|0|||
144678103|NCT02371980|521672869|FG003|Open-label Period|Voluntary Withdrawal|0|||
144678104|NCT02371980|521672870|FG004|Open-label Period|Voluntary Withdrawal|0|||
144678105|NCT02371980|521672866|FG000|Open-label Period|Pregnancy|1|||
144678106|NCT02371980|521672867|FG001|Open-label Period|Pregnancy|0|||
144678107|NCT02371980|521672868|FG002|Open-label Period|Pregnancy|0|||
144678108|NCT02371980|521672869|FG003|Open-label Period|Pregnancy|0|||
144678109|NCT02371980|521672870|FG004|Open-label Period|Pregnancy|0|||
144678110|NCT02371980|521672866|FG000|Open-label Period|Lack of Efficacy|116|||
144678111|NCT02371980|521672867|FG001|Open-label Period|Lack of Efficacy|0|||
144678112|NCT02371980|521672868|FG002|Open-label Period|Lack of Efficacy|0|||
144737579|NCT02409355|521892163|FG000|Overall Study|Study terminated by Sponsor|2|||
144737580|NCT02409355|521892164|FG001|Overall Study|Study terminated by Sponsor|3|||
144737581|NCT04115293|521894213|FG000|Overall Study|Adverse Event|0|||
144737582|NCT04115293|521894214|FG001|Overall Study|Adverse Event|2|||
144737583|NCT04115293|521894213|FG000|Overall Study|Withdrawal by Subject|2|||
144737584|NCT04115293|521894214|FG001|Overall Study|Withdrawal by Subject|1|||
144737585|NCT04115293|521894213|FG000|Overall Study|Physician Decision|1|||
144737586|NCT04115293|521894214|FG001|Overall Study|Physician Decision|0|||
144737587|NCT04115293|521894213|FG000|Overall Study|Death|1|||
144737588|NCT04115293|521894214|FG001|Overall Study|Death|1|||
144678113|NCT02371980|521672869|FG003|Open-label Period|Lack of Efficacy|0|||
144678114|NCT02371980|521672870|FG004|Open-label Period|Lack of Efficacy|0|||
144678115|NCT02371980|521672866|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
144678116|NCT02371980|521672867|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
144678117|NCT02371980|521672868|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
144678118|NCT02371980|521672869|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
144678119|NCT02371980|521672870|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
144678120|NCT02371980|521672866|FG000|Open-label Period|Reason not Specified|9|||
144678121|NCT02371980|521672867|FG001|Open-label Period|Reason not Specified|0|||
144678122|NCT02371980|521672868|FG002|Open-label Period|Reason not Specified|0|||
144678123|NCT02371980|521672869|FG003|Open-label Period|Reason not Specified|0|||
144737589|NCT02286739|521894215|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
144678124|NCT02371980|521672870|FG004|Open-label Period|Reason not Specified|0|||
144678125|NCT02371980|521672866|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
144678126|NCT02371980|521672867|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
144678127|NCT02371980|521672868|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
144678128|NCT02371980|521672869|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
144678129|NCT02371980|521672870|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
144678130|NCT02371980|521672866|FG000|Double-blind Period|Significant Protocol Deviation|0|||
144678131|NCT02371980|521672867|FG001|Double-blind Period|Significant Protocol Deviation|2|||
144678132|NCT02371980|521672868|FG002|Double-blind Period|Significant Protocol Deviation|7|||
144678133|NCT02371980|521672869|FG003|Double-blind Period|Significant Protocol Deviation|3|||
144678134|NCT02371980|521672870|FG004|Double-blind Period|Significant Protocol Deviation|3|||
144678135|NCT02371980|521672866|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
144678136|NCT02371980|521672867|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
144678137|NCT02371980|521672868|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
144678138|NCT02371980|521672869|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
144678139|NCT02371980|521672870|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
144678140|NCT02371980|521672866|FG000|Double-blind Period|Lost to Follow-up|0|||
144678141|NCT02371980|521672867|FG001|Double-blind Period|Lost to Follow-up|8|||
144678142|NCT02371980|521672868|FG002|Double-blind Period|Lost to Follow-up|8|||
144678143|NCT02371980|521672869|FG003|Double-blind Period|Lost to Follow-up|6|||
144678144|NCT02371980|521672870|FG004|Double-blind Period|Lost to Follow-up|5|||
144678145|NCT02371980|521672866|FG000|Double-blind Period|Voluntary Withdrawal|0|||
144678146|NCT02371980|521672867|FG001|Double-blind Period|Voluntary Withdrawal|12|||
144678147|NCT02371980|521672868|FG002|Double-blind Period|Voluntary Withdrawal|8|||
144678148|NCT02371980|521672869|FG003|Double-blind Period|Voluntary Withdrawal|9|||
144678149|NCT02371980|521672870|FG004|Double-blind Period|Voluntary Withdrawal|11|||
144678150|NCT02371980|521672866|FG000|Double-blind Period|Relapse|0|||
144678151|NCT02371980|521672867|FG001|Double-blind Period|Relapse|50|||
144678152|NCT02371980|521672868|FG002|Double-blind Period|Relapse|25|||
144678153|NCT02371980|521672869|FG003|Double-blind Period|Relapse|25|||
144678154|NCT02371980|521672870|FG004|Double-blind Period|Relapse|26|||
144678155|NCT02371980|521672866|FG000|Double-blind Period|Reason not Specified|0|||
144678156|NCT02371980|521672867|FG001|Double-blind Period|Reason not Specified|3|||
144678157|NCT02371980|521672868|FG002|Double-blind Period|Reason not Specified|3|||
144678158|NCT02371980|521672869|FG003|Double-blind Period|Reason not Specified|2|||
144678159|NCT02371980|521672870|FG004|Double-blind Period|Reason not Specified|1|||
144678160|NCT02371980|521672866|FG000|Double-blind Period|Missing|0|||
144678161|NCT02371980|521672867|FG001|Double-blind Period|Missing|1|||
144678162|NCT02371980|521672868|FG002|Double-blind Period|Missing|0|||
144678163|NCT02371980|521672869|FG003|Double-blind Period|Missing|0|||
144678164|NCT02371980|521672870|FG004|Double-blind Period|Missing|0|||
144678165|NCT02712008|521672871|FG000|Baseline (Day 1) up to Week 12|Death|3|||
144678166|NCT02712008|521672872|FG001|Baseline (Day 1) up to Week 12|Death|0|||
144678167|NCT02712008|521672873|FG002|Baseline (Day 1) up to Week 12|Death|0|||
144678168|NCT02712008|521672874|FG003|Baseline (Day 1) up to Week 12|Death|0|||
144678169|NCT02712008|521672875|FG004|Baseline (Day 1) up to Week 12|Death|0|||
144678170|NCT02712008|521672876|FG005|Baseline (Day 1) up to Week 12|Death|0|||
144678171|NCT02712008|521672877|FG006|Baseline (Day 1) up to Week 12|Death|0|||
144678172|NCT02712008|521672878|FG007|Baseline (Day 1) up to Week 12|Death|0|||
144678173|NCT02712008|521672871|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144678174|NCT02712008|521672872|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
144678175|NCT02712008|521672873|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
144678176|NCT02712008|521672874|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144678177|NCT02712008|521672875|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144678178|NCT02712008|521672876|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144678179|NCT02712008|521672877|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144678180|NCT02712008|521672878|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
144678181|NCT02712008|521672871|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
144678182|NCT02712008|521672872|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144678183|NCT02712008|521672873|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
144678184|NCT02712008|521672874|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144678185|NCT02712008|521672875|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144678186|NCT02712008|521672876|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144678187|NCT02712008|521672877|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144218191|NCT02262325|519992261|FG000|Overall Study|Lost to Follow-up|1|||
144678188|NCT02712008|521672878|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
144678189|NCT02712008|521672871|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144678190|NCT02712008|521672872|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144218192|NCT02815995|519992262|FG000|Overall Study|Disease Progression|3|||
144218193|NCT02815995|519992263|FG001|Overall Study|Disease Progression|7|||
144218194|NCT02815995|519992264|FG002|Overall Study|Disease Progression|2|||
144218195|NCT02815995|519992265|FG003|Overall Study|Disease Progression|4|||
144737590|NCT02286739|521894216|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
144737591|NCT02286739|521894215|FG000|Overall Study|No Verasense type documented|0|||
144737592|NCT02286739|521894216|FG001|Overall Study|No Verasense type documented|23|||
144737593|NCT02286739|521894215|FG000|Overall Study|Adverse Event|1|||
144737594|NCT02286739|521894216|FG001|Overall Study|Adverse Event|2|||
144737595|NCT02286739|521894215|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
144737596|NCT02286739|521894216|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
144737597|NCT02635750|521894221|FG000|Part 1, Period 2|Adverse Event|1|||
144737598|NCT02635750|521894222|FG001|Part 1, Period 2|Adverse Event|0|||
144737599|NCT02635750|521894223|FG002|Part 1, Period 2|Adverse Event|0|||
144737600|NCT02642653|521894227|FG000|Overall Study|Adverse Event|2|||
144737601|NCT02642653|521894228|FG001|Overall Study|Adverse Event|0|||
144737602|NCT02875392|521894229|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
144737603|NCT02875392|521894230|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
144737604|NCT00834717|521894236|FG000|First Intervention|Adverse Event|1|||
144737605|NCT00834717|521894237|FG001|First Intervention|Adverse Event|0|||
144737606|NCT00834717|521894236|FG000|First Intervention|Withdrawal by Subject|0|||
144737607|NCT00834717|521894237|FG001|First Intervention|Withdrawal by Subject|1|||
144737608|NCT02699866|521894247|FG000|Overall Study|Withdrawal by Subject|3|||
144737609|NCT02699866|521894247|FG000|Overall Study|Physician Decision|2|||
144737610|NCT02699866|521894247|FG000|Overall Study|Adverse Event|3|||
144737611|NCT02849457|521894248|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
144737612|NCT02849457|521894249|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
144737613|NCT02849457|521894250|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
144737614|NCT02849457|521894251|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
144737615|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
144737616|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
144737617|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
144737618|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
144737619|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
144737620|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
144737621|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
144737622|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
144737623|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
144737624|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
144737625|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
144737626|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
144737627|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
144737628|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
144737629|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
144737630|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
144737631|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
144737632|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
144737633|NCT01667679|521894252|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
144737634|NCT01667679|521894253|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
144737635|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
144737636|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
144737637|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
144737638|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
144737639|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
144737640|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
144737641|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
144737642|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
144218196|NCT02815995|519992266|FG004|Overall Study|Disease Progression|3|||
144218197|NCT02815995|519992267|FG005|Overall Study|Disease Progression|9|||
144218198|NCT02815995|519992268|FG006|Overall Study|Disease Progression|3|||
144678191|NCT02712008|521672873|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
144678192|NCT02712008|521672874|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144678193|NCT02712008|521672875|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144678194|NCT02712008|521672876|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144678195|NCT02712008|521672877|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144678196|NCT02712008|521672878|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
144678197|NCT02712008|521672871|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144678198|NCT02712008|521672872|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
144678199|NCT02712008|521672873|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144737643|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
144737644|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
144737645|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
144737646|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
144737647|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
144737648|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
144737649|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
144737650|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
144737651|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
144737652|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
144737653|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
144737654|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
144737655|NCT01667679|521894252|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
144737656|NCT01667679|521894253|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
144737657|NCT01294917|521894256|FG000|Overall Study|Relocation|5|||
144737658|NCT01294917|521894256|FG000|Overall Study|Inconvenience|1|||
144737659|NCT03733444|521894259|FG000|Overall Study|Adverse Event|8|||
144737660|NCT03733444|521894260|FG001|Overall Study|Adverse Event|10|||
144737661|NCT03733444|521894261|FG002|Overall Study|Adverse Event|5|||
144737662|NCT03733444|521894259|FG000|Overall Study|Death|20|||
144737663|NCT03733444|521894260|FG001|Overall Study|Death|19|||
144737664|NCT03733444|521894261|FG002|Overall Study|Death|11|||
144737665|NCT03733444|521894259|FG000|Overall Study|Lost to Follow-up|3|||
144737666|NCT03733444|521894260|FG001|Overall Study|Lost to Follow-up|0|||
144737667|NCT03733444|521894261|FG002|Overall Study|Lost to Follow-up|1|||
144737668|NCT03733444|521894259|FG000|Overall Study|Lack of Efficacy|0|||
144737669|NCT03733444|521894260|FG001|Overall Study|Lack of Efficacy|1|||
144737670|NCT03733444|521894261|FG002|Overall Study|Lack of Efficacy|1|||
144737671|NCT03733444|521894259|FG000|Overall Study|Physician Decision|2|||
144737672|NCT03733444|521894260|FG001|Overall Study|Physician Decision|1|||
144737673|NCT03733444|521894261|FG002|Overall Study|Physician Decision|0|||
144737674|NCT03733444|521894259|FG000|Overall Study|Protocol Violation|2|||
144737675|NCT03733444|521894260|FG001|Overall Study|Protocol Violation|1|||
144737676|NCT03733444|521894261|FG002|Overall Study|Protocol Violation|0|||
144737677|NCT03733444|521894259|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
144737678|NCT03733444|521894260|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
144737679|NCT03733444|521894261|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
144737680|NCT03733444|521894259|FG000|Overall Study|Study Terminated by Sponsor|203|||
144737681|NCT03733444|521894260|FG001|Overall Study|Study Terminated by Sponsor|209|||
144737682|NCT03733444|521894261|FG002|Overall Study|Study Terminated by Sponsor|221|||
144737683|NCT03733444|521894259|FG000|Overall Study|Withdrawal by Subject|19|||
144737684|NCT03733444|521894260|FG001|Overall Study|Withdrawal by Subject|18|||
144737685|NCT03733444|521894261|FG002|Overall Study|Withdrawal by Subject|16|||
144737686|NCT03733444|521894259|FG000|Overall Study|Miscellaneous|1|||
144737687|NCT03733444|521894260|FG001|Overall Study|Miscellaneous|0|||
144737688|NCT03733444|521894261|FG002|Overall Study|Miscellaneous|1|||
144737689|NCT03733444|521894259|FG000|Overall Study|Not Treated|1|||
144737690|NCT03733444|521894260|FG001|Overall Study|Not Treated|2|||
144737691|NCT03733444|521894261|FG002|Overall Study|Not Treated|1|||
144737692|NCT00796653|521894263|FG000|Overall Study|Adverse Event|19|||
144737693|NCT00796653|521894264|FG001|Overall Study|Adverse Event|16|||
144737694|NCT00796653|521894265|FG002|Overall Study|Adverse Event|16|||
144737695|NCT00796653|521894266|FG003|Overall Study|Adverse Event|16|||
144737696|NCT00796653|521894263|FG000|Overall Study|Lost to Follow-up|2|||
144737697|NCT00796653|521894264|FG001|Overall Study|Lost to Follow-up|1|||
144737698|NCT00796653|521894265|FG002|Overall Study|Lost to Follow-up|2|||
144737699|NCT00796653|521894266|FG003|Overall Study|Lost to Follow-up|3|||
144737700|NCT00796653|521894263|FG000|Overall Study|Withdrawal by Subject|16|||
144737701|NCT00796653|521894264|FG001|Overall Study|Withdrawal by Subject|8|||
144737702|NCT00796653|521894265|FG002|Overall Study|Withdrawal by Subject|8|||
144737703|NCT00796653|521894266|FG003|Overall Study|Withdrawal by Subject|13|||
144737704|NCT00796653|521894263|FG000|Overall Study|Lack of Efficacy|8|||
144737705|NCT00796653|521894264|FG001|Overall Study|Lack of Efficacy|1|||
144737706|NCT00796653|521894265|FG002|Overall Study|Lack of Efficacy|3|||
144737707|NCT00796653|521894266|FG003|Overall Study|Lack of Efficacy|2|||
144737708|NCT00796653|521894263|FG000|Overall Study|Non compliance with protocol|2|||
144737709|NCT00796653|521894264|FG001|Overall Study|Non compliance with protocol|2|||
144737710|NCT00796653|521894265|FG002|Overall Study|Non compliance with protocol|0|||
144737711|NCT00796653|521894266|FG003|Overall Study|Non compliance with protocol|2|||
144737712|NCT00796653|521894263|FG000|Overall Study|Other reason not described above|4|||
144737713|NCT00796653|521894264|FG001|Overall Study|Other reason not described above|9|||
144737714|NCT00796653|521894265|FG002|Overall Study|Other reason not described above|7|||
144737715|NCT00796653|521894266|FG003|Overall Study|Other reason not described above|4|||
144737716|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
144678200|NCT02712008|521672874|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144678201|NCT02712008|521672875|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144678202|NCT02712008|521672876|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144678203|NCT02712008|521672877|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144678204|NCT02712008|521672878|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
144678205|NCT02712008|521672871|FG000|From Week 12 up to Week 36|Adverse Event|0|||
144678206|NCT02712008|521672872|FG001|From Week 12 up to Week 36|Adverse Event|0|||
144678207|NCT02712008|521672873|FG002|From Week 12 up to Week 36|Adverse Event|0|||
144678208|NCT02712008|521672874|FG003|From Week 12 up to Week 36|Adverse Event|0|||
144678209|NCT02712008|521672875|FG004|From Week 12 up to Week 36|Adverse Event|1|||
144678210|NCT02712008|521672876|FG005|From Week 12 up to Week 36|Adverse Event|0|||
144678211|NCT02712008|521672877|FG006|From Week 12 up to Week 36|Adverse Event|0|||
144678212|NCT02712008|521672878|FG007|From Week 12 up to Week 36|Adverse Event|2|||
144678213|NCT02712008|521672871|FG000|From Week 12 up to Week 36|Death|1|||
144678214|NCT02712008|521672872|FG001|From Week 12 up to Week 36|Death|0|||
144678215|NCT02712008|521672873|FG002|From Week 12 up to Week 36|Death|0|||
144678216|NCT02712008|521672874|FG003|From Week 12 up to Week 36|Death|0|||
144678217|NCT02712008|521672875|FG004|From Week 12 up to Week 36|Death|0|||
144678218|NCT02712008|521672876|FG005|From Week 12 up to Week 36|Death|0|||
144678219|NCT02712008|521672877|FG006|From Week 12 up to Week 36|Death|1|||
144678220|NCT02712008|521672878|FG007|From Week 12 up to Week 36|Death|0|||
144678221|NCT02712008|521672871|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
144678222|NCT02712008|521672872|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
144678223|NCT02712008|521672873|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
144678224|NCT02712008|521672874|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
144678225|NCT02712008|521672875|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
144678226|NCT02712008|521672876|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
144678227|NCT02712008|521672877|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
144678228|NCT02712008|521672878|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
144678229|NCT02712008|521672871|FG000|From Week 12 up to Week 36|Physician Decision|0|||
144678230|NCT02712008|521672872|FG001|From Week 12 up to Week 36|Physician Decision|0|||
144678231|NCT02712008|521672873|FG002|From Week 12 up to Week 36|Physician Decision|0|||
144678232|NCT02712008|521672874|FG003|From Week 12 up to Week 36|Physician Decision|1|||
144678233|NCT02712008|521672875|FG004|From Week 12 up to Week 36|Physician Decision|1|||
144678234|NCT02712008|521672876|FG005|From Week 12 up to Week 36|Physician Decision|0|||
144678235|NCT02712008|521672877|FG006|From Week 12 up to Week 36|Physician Decision|0|||
144678236|NCT02712008|521672878|FG007|From Week 12 up to Week 36|Physician Decision|0|||
144678237|NCT02712008|521672871|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
144678238|NCT02712008|521672872|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
144678239|NCT02712008|521672873|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
144678240|NCT02712008|521672874|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
144678241|NCT02712008|521672875|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
144678242|NCT02712008|521672876|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
144678243|NCT02712008|521672877|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
144678244|NCT02712008|521672878|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
144678245|NCT01731990|521672879|FG000|Overall Study|Adverse Event|1|||
144678246|NCT01731990|521672880|FG001|Overall Study|Adverse Event|5|||
144678247|NCT01731990|521672879|FG000|Overall Study|Withdrawal by Subject|1|||
144678248|NCT01731990|521672880|FG001|Overall Study|Withdrawal by Subject|1|||
144678249|NCT01731990|521672879|FG000|Overall Study|Protocol deviation|1|||
144678250|NCT01731990|521672880|FG001|Overall Study|Protocol deviation|2|||
144678251|NCT01731990|521672879|FG000|Overall Study|Death|1|||
144678252|NCT01731990|521672880|FG001|Overall Study|Death|0|||
144678253|NCT01131078|521672885|FG000|Overall Study|Adverse Event|22|||
144678254|NCT01131078|521672886|FG001|Overall Study|Adverse Event|12|||
144678255|NCT01131078|521672887|FG002|Overall Study|Adverse Event|17|||
144678256|NCT01131078|521672885|FG000|Overall Study|Progressive Disease|58|||
144678257|NCT01131078|521672886|FG001|Overall Study|Progressive Disease|77|||
144678258|NCT01131078|521672887|FG002|Overall Study|Progressive Disease|71|||
144678259|NCT01131078|521672885|FG000|Overall Study|Protocol Violation|1|||
144678260|NCT01131078|521672886|FG001|Overall Study|Protocol Violation|0|||
144678261|NCT01131078|521672887|FG002|Overall Study|Protocol Violation|0|||
144678262|NCT01131078|521672885|FG000|Overall Study|Lost to Follow-up|1|||
144678263|NCT01131078|521672886|FG001|Overall Study|Lost to Follow-up|1|||
144678264|NCT01131078|521672887|FG002|Overall Study|Lost to Follow-up|1|||
144678265|NCT01131078|521672885|FG000|Overall Study|Withdrawal by Subject|2|||
144678266|NCT01131078|521672886|FG001|Overall Study|Withdrawal by Subject|4|||
144678267|NCT01131078|521672887|FG002|Overall Study|Withdrawal by Subject|3|||
144678268|NCT01131078|521672885|FG000|Overall Study|Non-compliance|3|||
144678269|NCT01131078|521672886|FG001|Overall Study|Non-compliance|0|||
144678270|NCT01131078|521672887|FG002|Overall Study|Non-compliance|0|||
144678271|NCT01131078|521672885|FG000|Overall Study|Physician Decision|10|||
144678272|NCT01131078|521672886|FG001|Overall Study|Physician Decision|6|||
144678273|NCT01131078|521672887|FG002|Overall Study|Physician Decision|8|||
144678274|NCT01131078|521672885|FG000|Overall Study|Death|4|||
144678275|NCT01131078|521672886|FG001|Overall Study|Death|0|||
144218199|NCT02815995|519992269|FG007|Overall Study|Disease Progression|1|||
144218200|NCT02815995|519992262|FG000|Overall Study|Adverse Event|1|||
144218201|NCT02815995|519992263|FG001|Overall Study|Adverse Event|2|||
144218202|NCT02815995|519992264|FG002|Overall Study|Adverse Event|2|||
144218203|NCT02815995|519992265|FG003|Overall Study|Adverse Event|0|||
144218204|NCT02815995|519992266|FG004|Overall Study|Adverse Event|0|||
144218205|NCT02815995|519992267|FG005|Overall Study|Adverse Event|1|||
144218206|NCT02815995|519992268|FG006|Overall Study|Adverse Event|0|||
144218207|NCT02815995|519992269|FG007|Overall Study|Adverse Event|0|||
144265722|NCT00888654|520173984|FG000|Overall Study|Withdrawal by Subject|1|||
144678276|NCT01131078|521672887|FG002|Overall Study|Death|2|||
144678277|NCT01131078|521672885|FG000|Overall Study|Other|0|||
144678278|NCT01131078|521672886|FG001|Overall Study|Other|1|||
144678279|NCT01131078|521672887|FG002|Overall Study|Other|0|||
144678280|NCT03267511|521672888|FG000|Overall Study|Lost to Follow-up|0|||
144678281|NCT03267511|521672889|FG001|Overall Study|Lost to Follow-up|0|||
144678282|NCT03267511|521672890|FG002|Overall Study|Lost to Follow-up|0|||
144678283|NCT03267511|521672891|FG003|Overall Study|Lost to Follow-up|1|||
144678284|NCT01594749|521672892|FG000|Overall Study|Adverse Event|2|||
144678285|NCT01594749|521672893|FG001|Overall Study|Adverse Event|1|||
144678286|NCT01594749|521672892|FG000|Overall Study|Withdrawal by Subject|2|||
144678287|NCT01594749|521672893|FG001|Overall Study|Withdrawal by Subject|2|||
144678288|NCT01594749|521672892|FG000|Overall Study|Protocol Violation|2|||
144678289|NCT01594749|521672893|FG001|Overall Study|Protocol Violation|0|||
144678290|NCT01594749|521672892|FG000|Overall Study|Physician Decision|1|||
144678291|NCT01594749|521672893|FG001|Overall Study|Physician Decision|1|||
144678292|NCT01594749|521672892|FG000|Overall Study|Non-compliance with Protocol|0|||
144678293|NCT01594749|521672893|FG001|Overall Study|Non-compliance with Protocol|1|||
144678294|NCT01594749|521672892|FG000|Overall Study|Lost to Follow-up|1|||
144678295|NCT01594749|521672893|FG001|Overall Study|Lost to Follow-up|0|||
144678296|NCT01594749|521672892|FG000|Overall Study|Death|9|||
144678297|NCT01594749|521672893|FG001|Overall Study|Death|3|||
144678298|NCT01594749|521672892|FG000|Overall Study|Not Treated|4|||
144678299|NCT01594749|521672893|FG001|Overall Study|Not Treated|10|||
144678300|NCT01594749|521672892|FG000|Overall Study|Lost Source Documentation|1|||
144678301|NCT01594749|521672893|FG001|Overall Study|Lost Source Documentation|0|||
144678302|NCT00364351|521672894|FG000|Overall Study|Adverse Event|90|||
144678303|NCT00364351|521672895|FG001|Overall Study|Adverse Event|44|||
144678304|NCT00364351|521672894|FG000|Overall Study|Condition under investigation worsened|469|||
144678305|NCT00364351|521672895|FG001|Overall Study|Condition under investigation worsened|497|||
144678306|NCT00364351|521672894|FG000|Overall Study|Prohibited concomitant medication|0|||
144678307|NCT00364351|521672895|FG001|Overall Study|Prohibited concomitant medication|2|||
144678308|NCT00364351|521672894|FG000|Overall Study|Lost to Follow-up|1|||
144678309|NCT00364351|521672895|FG001|Overall Study|Lost to Follow-up|1|||
144678310|NCT00364351|521672894|FG000|Overall Study|Withdrawal by Subject|30|||
144678311|NCT00364351|521672895|FG001|Overall Study|Withdrawal by Subject|29|||
144678312|NCT00364351|521672894|FG000|Overall Study|Incorrect enrollment|1|||
144678313|NCT00364351|521672895|FG001|Overall Study|Incorrect enrollment|1|||
144678314|NCT00364351|521672894|FG000|Overall Study|Sponsor decision|1|||
144678315|NCT00364351|521672895|FG001|Overall Study|Sponsor decision|0|||
144678316|NCT00364351|521672894|FG000|Overall Study|Poor treatment compliance|0|||
144678317|NCT00364351|521672895|FG001|Overall Study|Poor treatment compliance|3|||
144678318|NCT00364351|521672894|FG000|Overall Study|Investigator error|0|||
144678319|NCT00364351|521672895|FG001|Overall Study|Investigator error|2|||
144678320|NCT00364351|521672894|FG000|Overall Study|Patient could not travel to site|0|||
144678321|NCT00364351|521672895|FG001|Overall Study|Patient could not travel to site|1|||
144678322|NCT00364351|521672894|FG000|Overall Study|Randomised treatment not started|0|||
144678323|NCT00364351|521672895|FG001|Overall Study|Randomised treatment not started|3|||
144678324|NCT00653068|521672896|FG000|Overall Study|Death|9|||
144678325|NCT00653068|521672896|FG000|Overall Study|Lack of Efficacy|34|||
144678326|NCT00653068|521672896|FG000|Overall Study|Physician Decision|4|||
144678327|NCT00653068|521672896|FG000|Overall Study|Withdrawal by Subject|1|||
144678328|NCT00653068|521672896|FG000|Overall Study|Ineligible|2|||
144678329|NCT02177786|521672897|FG000|Overall Study|Withdrew Consent|2|||
144678330|NCT02177786|521672898|FG001|Overall Study|Withdrew Consent|6|||
144678331|NCT02177786|521672899|FG002|Overall Study|Withdrew Consent|9|||
144678332|NCT02177786|521672900|FG003|Overall Study|Withdrew Consent|5|||
144678333|NCT02177786|521672897|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
144678334|NCT02177786|521672898|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
144678335|NCT02177786|521672899|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
144678336|NCT02177786|521672900|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
144678337|NCT02177786|521672897|FG000|Overall Study|Adverse Event|1|||
144678338|NCT02177786|521672898|FG001|Overall Study|Adverse Event|1|||
144678339|NCT02177786|521672899|FG002|Overall Study|Adverse Event|2|||
144678340|NCT02177786|521672900|FG003|Overall Study|Adverse Event|3|||
144218208|NCT02815995|519992262|FG000|Overall Study|Pregnancy|0|||
144218209|NCT02815995|519992263|FG001|Overall Study|Pregnancy|0|||
144218210|NCT02815995|519992264|FG002|Overall Study|Pregnancy|0|||
144678341|NCT02177786|521672897|FG000|Overall Study|Death|1|||
144265723|NCT00888654|520173984|FG000|Overall Study|Inelig. due to contraindication of med|1|||
144265724|NCT00888654|520173984|FG000|Overall Study|Change in surg date|1|||
144265725|NCT00888654|520173984|FG000|Overall Study|Stopped meds due to headaches|1|||
144265726|NCT01418339|520173985|FG000|Overall Study|Adverse Event|5|||
144265727|NCT01418339|520173986|FG001|Overall Study|Adverse Event|2|||
144265728|NCT01418339|520173985|FG000|Overall Study|Subject Withdrew Consent|1|||
144265729|NCT01418339|520173986|FG001|Overall Study|Subject Withdrew Consent|2|||
144265730|NCT01418339|520173985|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
144678342|NCT02177786|521672898|FG001|Overall Study|Death|1|||
144678343|NCT02177786|521672899|FG002|Overall Study|Death|1|||
144678344|NCT02177786|521672900|FG003|Overall Study|Death|1|||
144678345|NCT02177786|521672897|FG000|Overall Study|Lost to Follow-up|0|||
144678346|NCT02177786|521672898|FG001|Overall Study|Lost to Follow-up|0|||
144678347|NCT02177786|521672899|FG002|Overall Study|Lost to Follow-up|2|||
144678348|NCT02177786|521672900|FG003|Overall Study|Lost to Follow-up|2|||
144678349|NCT02177786|521672897|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144678350|NCT02177786|521672898|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144678351|NCT02177786|521672899|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144678352|NCT02177786|521672900|FG003|Overall Study|Non-Compliance with Study Drug|1|||
144678353|NCT02177786|521672897|FG000|Overall Study|Protocol Violation|0|||
144678354|NCT02177786|521672898|FG001|Overall Study|Protocol Violation|0|||
144678355|NCT02177786|521672899|FG002|Overall Study|Protocol Violation|2|||
144678356|NCT02177786|521672900|FG003|Overall Study|Protocol Violation|0|||
144678357|NCT02177786|521672897|FG000|Overall Study|Progressive Disease|0|||
144678358|NCT02177786|521672898|FG001|Overall Study|Progressive Disease|1|||
144678359|NCT02177786|521672899|FG002|Overall Study|Progressive Disease|0|||
144678360|NCT02177786|521672900|FG003|Overall Study|Progressive Disease|0|||
144678361|NCT02177786|521672897|FG000|Overall Study|Missing study completion status|0|||
144678362|NCT02177786|521672898|FG001|Overall Study|Missing study completion status|1|||
144678363|NCT02177786|521672899|FG002|Overall Study|Missing study completion status|0|||
144678364|NCT02177786|521672900|FG003|Overall Study|Missing study completion status|0|||
144678365|NCT01305941|521672901|FG000|Overall Study|Adverse Event|6|||
144678366|NCT01305941|521672901|FG000|Overall Study|Clinical decline|2|||
144678367|NCT01305941|521672901|FG000|Overall Study|Withdrawal by Subject|1|||
144678368|NCT01305941|521672901|FG000|Overall Study|Death|1|||
144678369|NCT03950440|521672902|FG000|Overall Study|Death|8|||
144678370|NCT03950440|521672903|FG001|Overall Study|Death|2|||
144678371|NCT03950440|521672904|FG002|Overall Study|Death|1|||
144678372|NCT02892734|521672905|FG000|Treatment on Study|Progressive Disease|2|||
144678373|NCT02892734|521672905|FG000|Follow up for 2 Years|Death|2|||
144678374|NCT02892734|521672905|FG000|Follow up for 2 Years|Study closed early|1|||
144678375|NCT02043509|521672906|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
144678376|NCT02043509|521672907|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
144678377|NCT02043509|521672906|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
144678378|NCT02043509|521672907|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
144678379|NCT02043509|521672906|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
144678380|NCT02043509|521672907|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
144678381|NCT02043509|521672906|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
144678382|NCT02043509|521672907|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
144678383|NCT00608244|521672912|FG000|Overall Study|Adverse Event|1|||
144678384|NCT00608244|521672912|FG000|Overall Study|Low trough levels|1|||
144678385|NCT01977040|521672921|FG000|Overall Study|Vasa previa not confirmed|2|||
144678386|NCT01685060|521672922|FG000|Overall Study|Rollover patients|16|||
144678387|NCT01685060|521672922|FG000|Overall Study|Adverse Event|12|||
144678388|NCT01685060|521672922|FG000|Overall Study|Progressive disease|69|||
144678389|NCT01685060|521672922|FG000|Overall Study|Physician Decision|14|||
144678390|NCT01685060|521672922|FG000|Overall Study|Subject/guardian decision|20|||
144678391|NCT01685060|521672922|FG000|Overall Study|Lost to Follow-up|1|||
144678392|NCT01685060|521672922|FG000|Overall Study|Death|8|||
144678393|NCT03597503|521672923|FG000|Overall Study|Withdrawal by Subject|0|||
144678394|NCT03597503|521672924|FG001|Overall Study|Withdrawal by Subject|2|||
144678395|NCT03597503|521672923|FG000|Overall Study|Lost to Follow-up|1|||
144678396|NCT03597503|521672924|FG001|Overall Study|Lost to Follow-up|2|||
144678397|NCT03597503|521672923|FG000|Overall Study|Protocol Violation|1|||
144678398|NCT03597503|521672924|FG001|Overall Study|Protocol Violation|0|||
144678399|NCT02000219|521672927|FG000|14-Week Study Period|Physician Decision|1|||
144678400|NCT02000219|521672927|FG000|14-Week Study Period|Adverse Event|1|||
144678401|NCT02000219|521672927|FG000|14-Week Study Period|Underwent transplantation|1|||
144678402|NCT02000219|521672927|FG000|Continuation Period|Withdrawal by Subject|1|||
144678403|NCT02000219|521672927|FG000|Continuation Period|Had liver transplant|2|||
144678404|NCT02000219|521672927|FG000|Continuation Period|Non-compliance with study drug|2|||
144678405|NCT00634751|521672930|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
144678406|NCT00634751|521672931|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
144678407|NCT00634751|521672932|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
144678408|NCT00634751|521672933|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
144678409|NCT00634751|521672930|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
144678410|NCT00634751|521672931|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
144737717|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
144737718|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
144265731|NCT01418339|520173986|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
144265732|NCT02204917|520173989|FG000|Overall Study|Protocol Violation|1|||
144265733|NCT00909844|520173990|FG000|Overall Study|Adverse Event|1|||
144265734|NCT00909844|520173990|FG000|Overall Study|Withdrawal by Subject|1|||
144265735|NCT00909844|520173990|FG000|Overall Study|Lost to Follow-up|2|||
144265736|NCT02219685|520173991|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
144265737|NCT02219685|520173992|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
144265738|NCT02219685|520173991|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
144265739|NCT02219685|520173992|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
144265740|NCT00698815|520173993|FG000|Overall Study|Death|1|||
144265741|NCT00698815|520173994|FG001|Overall Study|Death|2|||
144265742|NCT00698815|520173995|FG002|Overall Study|Death|4|||
144265743|NCT00698815|520173993|FG000|Overall Study|Withdrawal by Subject|6|||
144265744|NCT00698815|520173994|FG001|Overall Study|Withdrawal by Subject|3|||
144265745|NCT00698815|520173995|FG002|Overall Study|Withdrawal by Subject|2|||
144265746|NCT00698815|520173993|FG000|Overall Study|MD discretion|2|||
144265747|NCT00698815|520173994|FG001|Overall Study|MD discretion|7|||
144265748|NCT00698815|520173995|FG002|Overall Study|MD discretion|2|||
144678411|NCT00634751|521672932|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
144265749|NCT00698815|520173993|FG000|Overall Study|Did not receive protocol treatment|1|||
144265750|NCT00698815|520173994|FG001|Overall Study|Did not receive protocol treatment|2|||
144265751|NCT00698815|520173995|FG002|Overall Study|Did not receive protocol treatment|2|||
144265752|NCT00706004|520173996|FG000|Overall Study|Did not meet eligibility criteria|2|||
144265753|NCT00297648|520173997|FG000|Overall Study|Adverse Event|13|||
144265754|NCT00297648|520173997|FG000|Overall Study|Lack of Efficacy|18|||
144265755|NCT00297648|520173997|FG000|Overall Study|Lost to Follow-up|1|||
144265756|NCT00297648|520173997|FG000|Overall Study|Withdrawal by Subject|3|||
144265757|NCT00297648|520173997|FG000|Overall Study|Other: Incompliance|1|||
144265758|NCT03575702|520173998|FG000|Overall Study|Withdrawal by Subject|1|||
144265759|NCT03575702|520173999|FG001|Overall Study|Withdrawal by Subject|1|||
144678412|NCT00634751|521672933|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
144678413|NCT00634751|521672930|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
144678414|NCT00634751|521672931|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
144678415|NCT00634751|521672932|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
144678416|NCT00634751|521672933|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
144678417|NCT03938636|521672936|FG000|Overall Study|Protocol Violation|0|||
144678418|NCT03938636|521672937|FG001|Overall Study|Protocol Violation|1|||
144678419|NCT03938636|521672938|FG002|Overall Study|Protocol Violation|1|||
144678420|NCT03938636|521672936|FG000|Overall Study|Subject withdrew due to death in family|0|||
144678421|NCT03938636|521672937|FG001|Overall Study|Subject withdrew due to death in family|1|||
144678422|NCT03938636|521672938|FG002|Overall Study|Subject withdrew due to death in family|0|||
144678423|NCT03938636|521672936|FG000|Overall Study|Missed visit|0|||
144678424|NCT03938636|521672937|FG001|Overall Study|Missed visit|1|||
144678425|NCT03938636|521672938|FG002|Overall Study|Missed visit|0|||
144678426|NCT03938636|521672936|FG000|Overall Study|Adverse Event|0|||
144678427|NCT03938636|521672937|FG001|Overall Study|Adverse Event|0|||
144678428|NCT03938636|521672938|FG002|Overall Study|Adverse Event|1|||
144678429|NCT03938636|521672936|FG000|Overall Study|Lost to Follow-up|0|||
144678430|NCT03938636|521672937|FG001|Overall Study|Lost to Follow-up|0|||
144678431|NCT03938636|521672938|FG002|Overall Study|Lost to Follow-up|1|||
144678432|NCT01518309|521672939|FG000|Overall Study|Adverse Event|6|||
144678433|NCT01518309|521672939|FG000|Overall Study|Death|6|||
144678434|NCT01518309|521672939|FG000|Overall Study|Lack of Efficacy|7|||
144678435|NCT01518309|521672939|FG000|Overall Study|Withdrawal by Subject|6|||
144678436|NCT01518309|521672939|FG000|Overall Study|Physician Decision|3|||
144678437|NCT01518309|521672939|FG000|Overall Study|Sponsor Decision|2|||
144678438|NCT01518309|521672939|FG000|Overall Study|Not in Predefined Categories|9|||
144678439|NCT00863317|521672940|FG000|Overall Study|Lost to Follow-up|8|||
144678440|NCT00863317|521672941|FG001|Overall Study|Lost to Follow-up|9|||
144265760|NCT03575702|520173998|FG000|Overall Study|Lost to Follow-up|1|||
144265761|NCT03575702|520173999|FG001|Overall Study|Lost to Follow-up|2|||
144265762|NCT03575702|520173998|FG000|Overall Study|Protocol Violation|0|||
144678441|NCT02579863|521672942|FG000|Overall Study|Final Disposition Unknown|2|||
144678442|NCT02579863|521672943|FG001|Overall Study|Final Disposition Unknown|1|||
144265763|NCT03575702|520173999|FG001|Overall Study|Protocol Violation|1|||
144265764|NCT03575702|520173998|FG000|Overall Study|Patient non compliance|4|||
144678443|NCT02579863|521672942|FG000|Overall Study|Adverse Event|18|||
144265765|NCT03575702|520173999|FG001|Overall Study|Patient non compliance|0|||
144678444|NCT02579863|521672943|FG001|Overall Study|Adverse Event|11|||
144678445|NCT02579863|521672942|FG000|Overall Study|Death|31|||
144678446|NCT02579863|521672943|FG001|Overall Study|Death|29|||
144678447|NCT02579863|521672942|FG000|Overall Study|Lost to Follow-up|2|||
144265766|NCT01900444|520174000|FG000|Overall Study|Protocol Violation|2|||
144678448|NCT02579863|521672943|FG001|Overall Study|Lost to Follow-up|1|||
144678449|NCT02579863|521672942|FG000|Overall Study|Physician Decision|1|||
144737719|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
144678450|NCT02579863|521672943|FG001|Overall Study|Physician Decision|2|||
144678451|NCT02579863|521672942|FG000|Overall Study|Screen Failure|0|||
144678452|NCT02579863|521672943|FG001|Overall Study|Screen Failure|2|||
144678453|NCT02579863|521672942|FG000|Overall Study|Study Terminated at Selected Sites|82|||
144678454|NCT02579863|521672943|FG001|Overall Study|Study Terminated at Selected Sites|88|||
144678455|NCT02579863|521672942|FG000|Overall Study|Withdrawal by Subject|20|||
144678456|NCT02579863|521672943|FG001|Overall Study|Withdrawal by Subject|20|||
144678457|NCT00216086|521672946|FG000|Overall Study|Protocol Violation|1|||
144678458|NCT00216086|521672946|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
144678459|NCT00216086|521672946|FG000|Overall Study|Social Reasons|2|||
144678460|NCT00038142|521672947|FG000|Overall Study|Ineligible|1|||
144678461|NCT00038142|521672948|FG001|Overall Study|Ineligible|0|||
144678462|NCT00038142|521672947|FG000|Overall Study|Progressive Disease|11|||
144678463|NCT00038142|521672948|FG001|Overall Study|Progressive Disease|7|||
144678464|NCT00038142|521672947|FG000|Overall Study|Death|1|||
144678465|NCT00038142|521672948|FG001|Overall Study|Death|0|||
144678466|NCT00038142|521672947|FG000|Overall Study|Adverse Event|1|||
144678467|NCT00038142|521672948|FG001|Overall Study|Adverse Event|0|||
144678468|NCT00038142|521672947|FG000|Overall Study|Unknown Reason|8|||
144678469|NCT00038142|521672948|FG001|Overall Study|Unknown Reason|0|||
144678470|NCT00809614|521672949|FG000|Overall Study|Lack of Efficacy|2|||
144678471|NCT00809614|521672950|FG001|Overall Study|Lack of Efficacy|3|||
144678472|NCT00809614|521672949|FG000|Overall Study|Withdrawal by Subject|1|||
144678473|NCT00809614|521672950|FG001|Overall Study|Withdrawal by Subject|1|||
144678474|NCT01080625|521672951|FG000|Overall Study|Physician Decision|0|||
144678475|NCT01080625|521672952|FG001|Overall Study|Physician Decision|2|||
144678476|NCT01080625|521672953|FG002|Overall Study|Physician Decision|1|||
144678477|NCT00364832|521672956|FG000|Core Period|Early Withdrawals|2|||
144678478|NCT00364832|521672957|FG001|Core Period|Early Withdrawals|2|||
144678479|NCT00364832|521672958|FG002|Core Period|Early Withdrawals|1|||
144678480|NCT00364832|521672959|FG003|Core Period|Early Withdrawals|1|||
144678481|NCT00364832|521672960|FG004|Core Period|Early Withdrawals|0|||
144678482|NCT00364832|521672961|FG005|Core Period|Early Withdrawals|0|||
144678483|NCT00364832|521672962|FG006|Core Period|Early Withdrawals|4|||
144678484|NCT00364832|521672963|FG007|Core Period|Early Withdrawals|1|||
144678485|NCT00364832|521672964|FG008|Core Period|Early Withdrawals|0|||
144678486|NCT00364832|521672965|FG009|Core Period|Early Withdrawals|0|||
144678487|NCT00364832|521672966|FG010|Core Period|Early Withdrawals|0|||
144678488|NCT00364832|521672967|FG011|Core Period|Early Withdrawals|0|||
144678489|NCT00364832|521672956|FG000|Extension Year 1|Early Withdrawals|0|||
144678490|NCT00364832|521672957|FG001|Extension Year 1|Early Withdrawals|0|||
144678491|NCT00364832|521672958|FG002|Extension Year 1|Early Withdrawals|0|||
144678492|NCT00364832|521672959|FG003|Extension Year 1|Early Withdrawals|0|||
144678493|NCT00364832|521672960|FG004|Extension Year 1|Early Withdrawals|0|||
144678494|NCT00364832|521672961|FG005|Extension Year 1|Early Withdrawals|0|||
144678495|NCT00364832|521672962|FG006|Extension Year 1|Early Withdrawals|0|||
144678496|NCT00364832|521672963|FG007|Extension Year 1|Early Withdrawals|0|||
144678497|NCT00364832|521672964|FG008|Extension Year 1|Early Withdrawals|0|||
144678498|NCT00364832|521672965|FG009|Extension Year 1|Early Withdrawals|4|||
144678499|NCT00364832|521672966|FG010|Extension Year 1|Early Withdrawals|2|||
144678500|NCT00364832|521672967|FG011|Extension Year 1|Early Withdrawals|10|||
144678501|NCT00364832|521672956|FG000|Extension Year 2|Early Withdrawals|0|||
144678502|NCT00364832|521672957|FG001|Extension Year 2|Early Withdrawals|0|||
144678503|NCT00364832|521672958|FG002|Extension Year 2|Early Withdrawals|0|||
144678504|NCT00364832|521672959|FG003|Extension Year 2|Early Withdrawals|0|||
144678505|NCT00364832|521672960|FG004|Extension Year 2|Early Withdrawals|0|||
144678506|NCT00364832|521672961|FG005|Extension Year 2|Early Withdrawals|0|||
144678507|NCT00364832|521672962|FG006|Extension Year 2|Early Withdrawals|0|||
144678508|NCT00364832|521672963|FG007|Extension Year 2|Early Withdrawals|0|||
144678509|NCT00364832|521672964|FG008|Extension Year 2|Early Withdrawals|0|||
144678510|NCT00364832|521672965|FG009|Extension Year 2|Early Withdrawals|5|||
144678511|NCT00364832|521672966|FG010|Extension Year 2|Early Withdrawals|5|||
144678512|NCT00364832|521672967|FG011|Extension Year 2|Early Withdrawals|3|||
144678513|NCT03745989|521672975|FG000|Overall Study|Death|3|||
144678514|NCT03745989|521672976|FG001|Overall Study|Death|7|||
144678515|NCT03745989|521672977|FG002|Overall Study|Death|4|||
144678516|NCT03745989|521672975|FG000|Overall Study|Lost to Follow-up|0|||
144678517|NCT03745989|521672976|FG001|Overall Study|Lost to Follow-up|2|||
144678518|NCT03745989|521672977|FG002|Overall Study|Lost to Follow-up|0|||
144678519|NCT03745989|521672975|FG000|Overall Study|Sponsor Decision|0|||
144678520|NCT03745989|521672976|FG001|Overall Study|Sponsor Decision|2|||
144678521|NCT03745989|521672977|FG002|Overall Study|Sponsor Decision|8|||
144678522|NCT03745989|521672975|FG000|Overall Study|Withdrawal by Subject|0|||
144678523|NCT03745989|521672976|FG001|Overall Study|Withdrawal by Subject|1|||
144678524|NCT03745989|521672977|FG002|Overall Study|Withdrawal by Subject|3|||
144678525|NCT00481988|521672984|FG000|Overall Study|Withdrawal by Subject|1|||
144678526|NCT00481988|521672985|FG001|Overall Study|Withdrawal by Subject|1|||
144678527|NCT00910728|521672999|FG000|Overall Study|Lack of Efficacy|2|||
144678528|NCT00910728|521673000|FG001|Overall Study|Lack of Efficacy|3|||
144678529|NCT00910728|521673001|FG002|Overall Study|Lack of Efficacy|1|||
144678530|NCT00910728|521673002|FG003|Overall Study|Lack of Efficacy|2|||
144678531|NCT00910728|521673003|FG004|Overall Study|Lack of Efficacy|1|||
144678532|NCT00910728|521673004|FG005|Overall Study|Lack of Efficacy|0|||
144678533|NCT00910728|521673005|FG006|Overall Study|Lack of Efficacy|2|||
144678534|NCT00910728|521673006|FG007|Overall Study|Lack of Efficacy|2|||
144678535|NCT00910728|521673007|FG008|Overall Study|Lack of Efficacy|2|||
144678536|NCT00910728|521672999|FG000|Overall Study|Withdrawal by Subject|0|||
144678537|NCT00910728|521673000|FG001|Overall Study|Withdrawal by Subject|0|||
144678538|NCT00910728|521673001|FG002|Overall Study|Withdrawal by Subject|0|||
144678539|NCT00910728|521673002|FG003|Overall Study|Withdrawal by Subject|0|||
144678540|NCT00910728|521673003|FG004|Overall Study|Withdrawal by Subject|3|||
144678541|NCT00910728|521673004|FG005|Overall Study|Withdrawal by Subject|1|||
144678542|NCT00910728|521673005|FG006|Overall Study|Withdrawal by Subject|2|||
144678543|NCT00910728|521673006|FG007|Overall Study|Withdrawal by Subject|0|||
144678544|NCT00910728|521673007|FG008|Overall Study|Withdrawal by Subject|0|||
144678545|NCT00910728|521672999|FG000|Overall Study|(not specified)|2|||
144678546|NCT00910728|521673000|FG001|Overall Study|(not specified)|0|||
144678547|NCT00910728|521673001|FG002|Overall Study|(not specified)|1|||
144678548|NCT00910728|521673002|FG003|Overall Study|(not specified)|0|||
144678549|NCT00910728|521673003|FG004|Overall Study|(not specified)|1|||
144678550|NCT00910728|521673004|FG005|Overall Study|(not specified)|0|||
144678551|NCT00910728|521673005|FG006|Overall Study|(not specified)|0|||
144678552|NCT00910728|521673006|FG007|Overall Study|(not specified)|0|||
144678553|NCT00910728|521673007|FG008|Overall Study|(not specified)|0|||
144678554|NCT00910728|521672999|FG000|Overall Study|Adverse Event|2|||
144678555|NCT00910728|521673000|FG001|Overall Study|Adverse Event|0|||
144678556|NCT00910728|521673001|FG002|Overall Study|Adverse Event|1|||
144678557|NCT00910728|521673002|FG003|Overall Study|Adverse Event|1|||
144678558|NCT00910728|521673003|FG004|Overall Study|Adverse Event|0|||
144678559|NCT00910728|521673004|FG005|Overall Study|Adverse Event|0|||
144678560|NCT00910728|521673005|FG006|Overall Study|Adverse Event|2|||
144678561|NCT00910728|521673006|FG007|Overall Study|Adverse Event|1|||
144678562|NCT00910728|521673007|FG008|Overall Study|Adverse Event|1|||
144678563|NCT03997760|521673008|FG000|Overall Study|Protocol Deviation|0|||
144678564|NCT03997760|521673009|FG001|Overall Study|Protocol Deviation|1|||
144678565|NCT03997760|521673010|FG002|Overall Study|Protocol Deviation|0|||
144678566|NCT03997760|521673011|FG003|Overall Study|Protocol Deviation|0|||
144678567|NCT01915095|521673012|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
144678568|NCT01915095|521673013|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
144678569|NCT01915095|521673014|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
144678570|NCT01915095|521673015|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
144678571|NCT01915095|521673016|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
144678572|NCT00361218|521673017|FG000|Overall Study|Lost to Follow-up|11|||
144678573|NCT00361218|521673017|FG000|Overall Study|Personal Reasons|7|||
144678574|NCT00361218|521673017|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
144678575|NCT04968353|521673020|FG000|Overall Study|Non-compliance|1|||
144678576|NCT04968353|521673021|FG001|Overall Study|Non-compliance|0|||
144678577|NCT04968353|521673022|FG002|Overall Study|Non-compliance|2|||
144678578|NCT04968353|521673023|FG003|Overall Study|Non-compliance|0|||
144678579|NCT02896192|521673024|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
144678580|NCT02896192|521673024|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
144678581|NCT02896192|521673024|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
144678582|NCT00368472|521673028|FG000|Overall Study|Adverse Event|22|||
144678583|NCT00368472|521673028|FG000|Overall Study|Medication non-compliance|4|||
144678584|NCT00368472|521673028|FG000|Overall Study|Protocol Violation|2|||
144678585|NCT00368472|521673028|FG000|Overall Study|Request of Investigator or Sponsor|3|||
144678586|NCT00368472|521673028|FG000|Overall Study|Withdrawal by Subject|40|||
144678587|NCT00368472|521673028|FG000|Overall Study|Diary non-compliance|1|||
144678588|NCT00368472|521673028|FG000|Overall Study|Other|32|||
144678589|NCT00368472|521673028|FG000|Overall Study|Missing Final Disposition Date|1|||
144678590|NCT04315298|521675066|FG000|Overall Study|Withdrawal by Subject|0|||
144678591|NCT04315298|521675067|FG001|Overall Study|Withdrawal by Subject|0|||
144678592|NCT04315298|521675068|FG002|Overall Study|Withdrawal by Subject|0|||
144678593|NCT04315298|521675069|FG003|Overall Study|Withdrawal by Subject|2|||
144678594|NCT04315298|521675070|FG004|Overall Study|Withdrawal by Subject|2|||
144678595|NCT04315298|521675071|FG005|Overall Study|Withdrawal by Subject|2|||
144678596|NCT04315298|521675072|FG006|Overall Study|Withdrawal by Subject|0|||
144678597|NCT04315298|521675073|FG007|Overall Study|Withdrawal by Subject|1|||
144678598|NCT04315298|521675074|FG008|Overall Study|Withdrawal by Subject|1|||
144678599|NCT04315298|521675075|FG009|Overall Study|Withdrawal by Subject|1|||
144678600|NCT04315298|521675076|FG010|Overall Study|Withdrawal by Subject|0|||
144678601|NCT04315298|521675077|FG011|Overall Study|Withdrawal by Subject|0|||
144678602|NCT04315298|521675078|FG012|Overall Study|Withdrawal by Subject|0|||
144678603|NCT04315298|521675079|FG013|Overall Study|Withdrawal by Subject|0|||
144678604|NCT04315298|521675080|FG014|Overall Study|Withdrawal by Subject|0|||
144265767|NCT01900444|520174000|FG000|Overall Study|Lost to Follow-up|1|||
144265768|NCT00072384|520174001|FG000|Overall Study|Physician Decision|1|||
144265769|NCT00072384|520174001|FG000|Overall Study|Ineligible|8|||
144265770|NCT01255163|520174002|FG000|Overall Study|Withdrawal by Subject|1|||
144265771|NCT01255163|520174003|FG001|Overall Study|Withdrawal by Subject|0|||
144265772|NCT01255163|520174002|FG000|Overall Study|Lost to Follow-up|2|||
144265773|NCT01255163|520174003|FG001|Overall Study|Lost to Follow-up|0|||
144265774|NCT01255163|520174002|FG000|Overall Study|Adverse Event|0|||
144265775|NCT01255163|520174003|FG001|Overall Study|Adverse Event|2|||
144265776|NCT01255163|520174002|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
144265777|NCT01255163|520174003|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
144265778|NCT00490035|520174004|FG000|Overall Study|AE, non-serious non-fatal|3|||
144265779|NCT00490035|520174005|FG001|Overall Study|AE, non-serious non-fatal|4|||
144265780|NCT00490035|520174006|FG002|Overall Study|AE, non-serious non-fatal|4|||
144265781|NCT00490035|520174007|FG003|Overall Study|AE, non-serious non-fatal|5|||
144265782|NCT00490035|520174004|FG000|Overall Study|Lost to Follow-up|2|||
144265783|NCT00490035|520174005|FG001|Overall Study|Lost to Follow-up|0|||
144265784|NCT00490035|520174006|FG002|Overall Study|Lost to Follow-up|1|||
144265785|NCT00490035|520174007|FG003|Overall Study|Lost to Follow-up|0|||
144265786|NCT00490035|520174004|FG000|Overall Study|Withdrawal by Subject|2|||
144265787|NCT00490035|520174005|FG001|Overall Study|Withdrawal by Subject|1|||
144265788|NCT00490035|520174006|FG002|Overall Study|Withdrawal by Subject|1|||
144265789|NCT00490035|520174007|FG003|Overall Study|Withdrawal by Subject|0|||
144265790|NCT00490035|520174004|FG000|Overall Study|Other reason|0|||
144265791|NCT00490035|520174005|FG001|Overall Study|Other reason|1|||
144265792|NCT00490035|520174006|FG002|Overall Study|Other reason|3|||
144678605|NCT04315298|521675081|FG015|Overall Study|Withdrawal by Subject|0|||
144678606|NCT04315298|521675082|FG016|Overall Study|Withdrawal by Subject|0|||
144678607|NCT04315298|521675083|FG017|Overall Study|Withdrawal by Subject|0|||
144678608|NCT04315298|521675084|FG018|Overall Study|Withdrawal by Subject|0|||
144678609|NCT04315298|521675066|FG000|Overall Study|Physician Decision|0|||
144678610|NCT04315298|521675067|FG001|Overall Study|Physician Decision|0|||
144678611|NCT04315298|521675068|FG002|Overall Study|Physician Decision|0|||
144678612|NCT04315298|521675069|FG003|Overall Study|Physician Decision|0|||
144678613|NCT04315298|521675070|FG004|Overall Study|Physician Decision|1|||
144678614|NCT04315298|521675071|FG005|Overall Study|Physician Decision|0|||
144678615|NCT04315298|521675072|FG006|Overall Study|Physician Decision|0|||
144678616|NCT04315298|521675073|FG007|Overall Study|Physician Decision|0|||
144678617|NCT04315298|521675074|FG008|Overall Study|Physician Decision|0|||
144678618|NCT04315298|521675075|FG009|Overall Study|Physician Decision|0|||
144678619|NCT04315298|521675076|FG010|Overall Study|Physician Decision|0|||
144678620|NCT04315298|521675077|FG011|Overall Study|Physician Decision|0|||
144678621|NCT04315298|521675078|FG012|Overall Study|Physician Decision|0|||
144678622|NCT04315298|521675079|FG013|Overall Study|Physician Decision|0|||
144678623|NCT04315298|521675080|FG014|Overall Study|Physician Decision|0|||
144678624|NCT04315298|521675081|FG015|Overall Study|Physician Decision|0|||
144678625|NCT04315298|521675082|FG016|Overall Study|Physician Decision|0|||
144678626|NCT04315298|521675083|FG017|Overall Study|Physician Decision|0|||
144678627|NCT04315298|521675084|FG018|Overall Study|Physician Decision|0|||
144678628|NCT04315298|521675066|FG000|Overall Study|Lost to Follow-up|5|||
144678629|NCT04315298|521675067|FG001|Overall Study|Lost to Follow-up|10|||
144678630|NCT04315298|521675068|FG002|Overall Study|Lost to Follow-up|6|||
144678631|NCT04315298|521675069|FG003|Overall Study|Lost to Follow-up|8|||
144678632|NCT04315298|521675070|FG004|Overall Study|Lost to Follow-up|12|||
144678633|NCT04315298|521675071|FG005|Overall Study|Lost to Follow-up|13|||
144678634|NCT04315298|521675072|FG006|Overall Study|Lost to Follow-up|9|||
144265793|NCT00490035|520174007|FG003|Overall Study|Other reason|1|||
144265794|NCT00490035|520174004|FG000|Overall Study|AE, serious fatal|1|||
144265795|NCT00490035|520174005|FG001|Overall Study|AE, serious fatal|0|||
144265796|NCT00490035|520174006|FG002|Overall Study|AE, serious fatal|0|||
144265797|NCT00490035|520174007|FG003|Overall Study|AE, serious fatal|0|||
144265798|NCT00490035|520174004|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
144265799|NCT00490035|520174005|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
144265800|NCT00490035|520174006|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
144265801|NCT00490035|520174007|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
144265802|NCT00490035|520174004|FG000|Overall Study|AE of unknown type|0|||
144265803|NCT00490035|520174005|FG001|Overall Study|AE of unknown type|0|||
144265804|NCT00490035|520174006|FG002|Overall Study|AE of unknown type|2|||
144265805|NCT00490035|520174007|FG003|Overall Study|AE of unknown type|0|||
144265806|NCT06058390|520174008|FG000|Overall Study|Lost to Follow-up|0|||
144678635|NCT04315298|521675073|FG007|Overall Study|Lost to Follow-up|16|||
144678636|NCT04315298|521675074|FG008|Overall Study|Lost to Follow-up|14|||
144678637|NCT04315298|521675075|FG009|Overall Study|Lost to Follow-up|0|||
144678638|NCT04315298|521675076|FG010|Overall Study|Lost to Follow-up|2|||
144265807|NCT06058390|520174009|FG001|Overall Study|Lost to Follow-up|0|||
144265808|NCT06058390|520174010|FG002|Overall Study|Lost to Follow-up|2|||
144265809|NCT06058390|520174011|FG003|Overall Study|Lost to Follow-up|1|||
144678639|NCT04315298|521675077|FG011|Overall Study|Lost to Follow-up|1|||
144678640|NCT04315298|521675078|FG012|Overall Study|Lost to Follow-up|0|||
144678641|NCT04315298|521675079|FG013|Overall Study|Lost to Follow-up|0|||
144678642|NCT04315298|521675080|FG014|Overall Study|Lost to Follow-up|0|||
144678643|NCT04315298|521675081|FG015|Overall Study|Lost to Follow-up|2|||
144678644|NCT04315298|521675082|FG016|Overall Study|Lost to Follow-up|0|||
144678645|NCT04315298|521675083|FG017|Overall Study|Lost to Follow-up|0|||
144678646|NCT04315298|521675084|FG018|Overall Study|Lost to Follow-up|0|||
144678647|NCT04315298|521675066|FG000|Overall Study|Death|24|||
144678648|NCT04315298|521675067|FG001|Overall Study|Death|60|||
144678649|NCT04315298|521675068|FG002|Overall Study|Death|49|||
144678650|NCT04315298|521675069|FG003|Overall Study|Death|59|||
144678651|NCT04315298|521675070|FG004|Overall Study|Death|70|||
144678652|NCT04315298|521675071|FG005|Overall Study|Death|114|||
144678653|NCT04315298|521675072|FG006|Overall Study|Death|9|||
144678654|NCT04315298|521675073|FG007|Overall Study|Death|12|||
144678655|NCT04315298|521675074|FG008|Overall Study|Death|21|||
144678656|NCT04315298|521675075|FG009|Overall Study|Death|16|||
144678657|NCT04315298|521675076|FG010|Overall Study|Death|40|||
144678658|NCT04315298|521675077|FG011|Overall Study|Death|40|||
144678659|NCT04315298|521675078|FG012|Overall Study|Death|3|||
144678660|NCT04315298|521675079|FG013|Overall Study|Death|4|||
144678661|NCT04315298|521675080|FG014|Overall Study|Death|6|||
144678662|NCT04315298|521675081|FG015|Overall Study|Death|4|||
144678663|NCT04315298|521675082|FG016|Overall Study|Death|3|||
144678664|NCT04315298|521675083|FG017|Overall Study|Death|1|||
144678665|NCT04315298|521675084|FG018|Overall Study|Death|0|||
144678666|NCT01199198|521675085|FG000|Overall Study|Adverse Event|3|||
144678667|NCT01199198|521675086|FG001|Overall Study|Adverse Event|0|||
144678668|NCT01199198|521675085|FG000|Overall Study|Lost to Follow-up|1|||
144678669|NCT01199198|521675086|FG001|Overall Study|Lost to Follow-up|5|||
144678670|NCT01199198|521675085|FG000|Overall Study|Withdrawal by Subject|1|||
144678671|NCT01199198|521675086|FG001|Overall Study|Withdrawal by Subject|2|||
144678672|NCT01199198|521675085|FG000|Overall Study|ICU Transfer|1|||
144678673|NCT01199198|521675086|FG001|Overall Study|ICU Transfer|2|||
144678674|NCT01199198|521675085|FG000|Overall Study|Hospice-care transfer|1|||
144678675|NCT01199198|521675086|FG001|Overall Study|Hospice-care transfer|2|||
144678676|NCT00736385|521675087|FG000|Overall Study|Withdrawal by Subject|2|||
144678677|NCT00736385|521675088|FG001|Overall Study|Withdrawal by Subject|2|||
144678678|NCT00736385|521675087|FG000|Overall Study|Adverse Event|0|||
144678679|NCT00736385|521675088|FG001|Overall Study|Adverse Event|1|||
144678680|NCT01183104|521675089|FG000|Overall Study|Adverse Event|8|||
144678681|NCT01183104|521675090|FG001|Overall Study|Adverse Event|6|||
144678682|NCT01183104|521675089|FG000|Overall Study|Death|0|||
144678683|NCT01183104|521675090|FG001|Overall Study|Death|1|||
144678684|NCT01183104|521675089|FG000|Overall Study|Lost to Follow-up|14|||
144678685|NCT01183104|521675090|FG001|Overall Study|Lost to Follow-up|7|||
144678686|NCT01183104|521675089|FG000|Overall Study|Physician Decision|5|||
144678687|NCT01183104|521675090|FG001|Overall Study|Physician Decision|8|||
144678688|NCT01183104|521675089|FG000|Overall Study|Withdrawal by Subject|6|||
144678689|NCT01183104|521675090|FG001|Overall Study|Withdrawal by Subject|11|||
144678690|NCT01183104|521675089|FG000|Overall Study|Nonparticipation in Extension Study|39|||
144678691|NCT01183104|521675090|FG001|Overall Study|Nonparticipation in Extension Study|50|||
144678692|NCT01183104|521675089|FG000|Overall Study|Did not receive study drug|5|||
144678693|NCT01183104|521675090|FG001|Overall Study|Did not receive study drug|9|||
144678694|NCT01957215|521675091|FG000|Overall Study|Adverse Event|2|||
144678695|NCT01957215|521675092|FG001|Overall Study|Adverse Event|2|||
144678696|NCT01957215|521675091|FG000|Overall Study|Lost to Follow-up|3|||
144678697|NCT01957215|521675092|FG001|Overall Study|Lost to Follow-up|3|||
144678698|NCT01957215|521675091|FG000|Overall Study|Protocol Violation|1|||
144678699|NCT01957215|521675092|FG001|Overall Study|Protocol Violation|2|||
144678700|NCT01957215|521675091|FG000|Overall Study|Withdrawal by Subject|7|||
144678701|NCT01957215|521675092|FG001|Overall Study|Withdrawal by Subject|5|||
144678702|NCT00688623|521675098|FG000|Overall Study|Adverse Event|22|||
144678703|NCT00688623|521675098|FG000|Overall Study|abnormal lab value|1|||
144678704|NCT00688623|521675098|FG000|Overall Study|Withdrawal by Subject|4|||
144678705|NCT00688623|521675098|FG000|Overall Study|Death|3|||
144678706|NCT00688623|521675098|FG000|Overall Study|disease progression|23|||
144678707|NCT00688623|521675098|FG000|Overall Study|Protocol Violation|2|||
144218211|NCT02815995|519992265|FG003|Overall Study|Pregnancy|0|||
144218212|NCT02815995|519992266|FG004|Overall Study|Pregnancy|0|||
144678708|NCT02667236|521675099|FG000|Overall Study|Adverse Event|1|||
144678709|NCT02667236|521675100|FG001|Overall Study|Adverse Event|1|||
144678710|NCT02667236|521675099|FG000|Overall Study|Withdrawal by Subject|2|||
144678711|NCT02667236|521675100|FG001|Overall Study|Withdrawal by Subject|0|||
144678712|NCT04402385|521675103|FG000|Overall Study|Withdrawal by Subject|4|||
144678713|NCT04402385|521675104|FG001|Overall Study|Withdrawal by Subject|4|||
144678714|NCT04402385|521675103|FG000|Overall Study|Lost to Follow-up|1|||
144678715|NCT04402385|521675104|FG001|Overall Study|Lost to Follow-up|1|||
144678716|NCT04402385|521675103|FG000|Overall Study|Physician Decision|0|||
144678717|NCT04402385|521675104|FG001|Overall Study|Physician Decision|1|||
144678718|NCT03654560|521675105|FG000|Overall Study|Death|3|||
144678719|NCT03654560|521675106|FG001|Overall Study|Death|1|||
144678720|NCT03654560|521675105|FG000|Overall Study|Lost to Follow-up|1|||
144678721|NCT03654560|521675106|FG001|Overall Study|Lost to Follow-up|0|||
144678722|NCT01119963|521675110|FG000|Overall Study|Lost to Follow-up|1|||
144678723|NCT01119963|521675111|FG001|Overall Study|Lost to Follow-up|1|||
144678724|NCT01156363|521675122|FG000|Overall Study|Adverse Event|6|||
144678725|NCT01156363|521675122|FG000|Overall Study|Insufficient Therapeutic Response|5|||
144678726|NCT01156363|521675122|FG000|Overall Study|Failure to Return|1|||
144678727|NCT01156363|521675122|FG000|Overall Study|Refused Treatment|4|||
144678728|NCT01156363|521675122|FG000|Overall Study|Other|6|||
144678729|NCT04159701|521675128|FG000|Period 1: Treatment Period|Pregnancy|1|||
144678730|NCT04159701|521675129|FG001|Period 1: Treatment Period|Pregnancy|0|||
144678731|NCT04159701|521675128|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
144678732|NCT04159701|521675129|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
144678733|NCT04159701|521675128|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
144678734|NCT04159701|521675129|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
144678735|NCT04159701|521675128|FG000|Washout Period|site terminated by sponsor|0|||
144678736|NCT04159701|521675129|FG001|Washout Period|site terminated by sponsor|1|||
144678737|NCT04159701|521675128|FG000|Washout Period|study terminated by sponsor|10|||
144678738|NCT04159701|521675129|FG001|Washout Period|study terminated by sponsor|3|||
144678739|NCT04159701|521675128|FG000|Washout Period|Withdrawal by Subject|1|||
144678740|NCT04159701|521675129|FG001|Washout Period|Withdrawal by Subject|0|||
144678741|NCT04159701|521675128|FG000|Washout Period|Inadvertent Enrollment|1|||
144678742|NCT04159701|521675129|FG001|Washout Period|Inadvertent Enrollment|0|||
144678743|NCT04159701|521675128|FG000|Washout Period|Miscellaneous|1|||
144678744|NCT04159701|521675129|FG001|Washout Period|Miscellaneous|0|||
144678745|NCT04159701|521675128|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
144678746|NCT04159701|521675129|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
144678747|NCT04159701|521675128|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
144678748|NCT04159701|521675129|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
144678749|NCT04159701|521675128|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
144678750|NCT04159701|521675129|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
144678751|NCT04159701|521675128|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
144678752|NCT04159701|521675129|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
144678753|NCT04159701|521675128|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
144678754|NCT04159701|521675129|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
144678755|NCT01782885|521675135|FG000|Overall Study|Lost to Follow-up|4|||
144678756|NCT01782885|521675136|FG001|Overall Study|Lost to Follow-up|6|||
144678757|NCT01849562|521675137|FG000|Overall Study|Lost to Follow-up|1|||
144678758|NCT01849562|521675138|FG001|Overall Study|Lost to Follow-up|0|||
144678759|NCT01849562|521675139|FG002|Overall Study|Lost to Follow-up|0|||
144678760|NCT01849562|521675137|FG000|Overall Study|Non-compliance with Study Drug|1|||
144678761|NCT01849562|521675138|FG001|Overall Study|Non-compliance with Study Drug|0|||
144678762|NCT01849562|521675139|FG002|Overall Study|Non-compliance with Study Drug|0|||
144678763|NCT01024920|521675142|FG000|Overall Study|Progressive disease|47|||
144678764|NCT01024920|521675143|FG001|Overall Study|Progressive disease|25|||
144678765|NCT01024920|521675142|FG000|Overall Study|Adverse Event|8|||
144678766|NCT01024920|521675143|FG001|Overall Study|Adverse Event|4|||
144678767|NCT01024920|521675142|FG000|Overall Study|Lost to Follow-up|0|||
144678768|NCT01024920|521675143|FG001|Overall Study|Lost to Follow-up|1|||
144678769|NCT01024920|521675142|FG000|Overall Study|Patient refusal to continue|4|||
144678770|NCT01024920|521675143|FG001|Overall Study|Patient refusal to continue|0|||
144678771|NCT01024920|521675142|FG000|Overall Study|Other than listed|5|||
144678772|NCT01024920|521675143|FG001|Overall Study|Other than listed|1|||
144678773|NCT01024920|521675142|FG000|Overall Study|Not treated|3|||
144678774|NCT01024920|521675143|FG001|Overall Study|Not treated|0|||
144678775|NCT01024920|521675142|FG000|Overall Study|Protocol Violation|0|||
144678776|NCT01024920|521675143|FG001|Overall Study|Protocol Violation|1|||
144678777|NCT00633360|521675144|FG000|Overall Study|Lost to Follow-up|1|||
144678778|NCT00633360|521675145|FG001|Overall Study|Lost to Follow-up|1|||
144678779|NCT00633360|521675144|FG000|Overall Study|Adverse Event|3|||
144678780|NCT00633360|521675145|FG001|Overall Study|Adverse Event|1|||
144678781|NCT00633360|521675144|FG000|Overall Study|Protocol Violation|0|||
144678782|NCT00633360|521675145|FG001|Overall Study|Protocol Violation|1|||
144678783|NCT00610207|521675146|FG000|Overall Study|Lost to Follow-up|3|||
144678784|NCT03236506|521675151|FG000|Overall Study|Death|1|||
144678785|NCT03236506|521675152|FG001|Overall Study|Death|1|||
144678786|NCT03236506|521675153|FG002|Overall Study|Death|1|||
144678787|NCT03236506|521675151|FG000|Overall Study|Withdrawal by Subject|3|||
144678788|NCT03236506|521675152|FG001|Overall Study|Withdrawal by Subject|3|||
144678789|NCT03236506|521675153|FG002|Overall Study|Withdrawal by Subject|4|||
144678790|NCT03236506|521675151|FG000|Overall Study|Did not initiate treatment|2|||
144678791|NCT03236506|521675152|FG001|Overall Study|Did not initiate treatment|1|||
144678792|NCT03236506|521675153|FG002|Overall Study|Did not initiate treatment|2|||
144678793|NCT01594411|521675166|FG000|Overall Study|Lost to Follow-up|2|||
144678794|NCT01929707|521675170|FG000|Intervention Period 1|Lost to Follow-up|0|||
144678795|NCT01929707|521675171|FG001|Intervention Period 1|Lost to Follow-up|0|||
144737720|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
144678796|NCT01929707|521675172|FG002|Intervention Period 1|Lost to Follow-up|0|||
144678797|NCT01929707|521675173|FG003|Intervention Period 1|Lost to Follow-up|1|||
144678798|NCT01929707|521675174|FG004|Intervention Period 1|Lost to Follow-up|0|||
144678799|NCT01929707|521675175|FG005|Intervention Period 1|Lost to Follow-up|0|||
144678800|NCT01929707|521675176|FG006|Intervention Period 1|Lost to Follow-up|0|||
144678801|NCT01929707|521675177|FG007|Intervention Period 1|Lost to Follow-up|0|||
144678802|NCT01929707|521675170|FG000|Intervention Period 1|Withdrawal by Subject|0|||
144678803|NCT01929707|521675171|FG001|Intervention Period 1|Withdrawal by Subject|0|||
144678804|NCT01929707|521675172|FG002|Intervention Period 1|Withdrawal by Subject|0|||
144678805|NCT01929707|521675173|FG003|Intervention Period 1|Withdrawal by Subject|2|||
144678806|NCT01929707|521675174|FG004|Intervention Period 1|Withdrawal by Subject|0|||
144678807|NCT01929707|521675175|FG005|Intervention Period 1|Withdrawal by Subject|0|||
144678808|NCT01929707|521675176|FG006|Intervention Period 1|Withdrawal by Subject|0|||
144678809|NCT01929707|521675177|FG007|Intervention Period 1|Withdrawal by Subject|0|||
144678810|NCT01929707|521675170|FG000|Intervention Period 2|Withdrawal by Subject|0|||
144678811|NCT01929707|521675171|FG001|Intervention Period 2|Withdrawal by Subject|0|||
144678812|NCT01929707|521675172|FG002|Intervention Period 2|Withdrawal by Subject|0|||
144678813|NCT01929707|521675173|FG003|Intervention Period 2|Withdrawal by Subject|0|||
144678814|NCT01929707|521675174|FG004|Intervention Period 2|Withdrawal by Subject|0|||
144678815|NCT01929707|521675175|FG005|Intervention Period 2|Withdrawal by Subject|2|||
144678816|NCT01929707|521675176|FG006|Intervention Period 2|Withdrawal by Subject|0|||
144678817|NCT01929707|521675177|FG007|Intervention Period 2|Withdrawal by Subject|0|||
144678818|NCT00437203|521675178|FG000|Overall Study|Death|0|||
144678819|NCT00437203|521675179|FG001|Overall Study|Death|0|||
144678820|NCT00437203|521675180|FG002|Overall Study|Death|1|||
144678821|NCT00437203|521675181|FG003|Overall Study|Death|0|||
144678822|NCT00437203|521675182|FG004|Overall Study|Death|0|||
144678823|NCT00437203|521675183|FG005|Overall Study|Death|0|||
144678824|NCT00437203|521675184|FG006|Overall Study|Death|0|||
144678825|NCT00437203|521675185|FG007|Overall Study|Death|1|||
144678826|NCT00437203|521675186|FG008|Overall Study|Death|0|||
144678827|NCT00437203|521675187|FG009|Overall Study|Death|1|||
144678828|NCT00437203|521675178|FG000|Overall Study|Adverse Event|1|||
144678829|NCT00437203|521675179|FG001|Overall Study|Adverse Event|1|||
144678830|NCT00437203|521675180|FG002|Overall Study|Adverse Event|0|||
144678831|NCT00437203|521675181|FG003|Overall Study|Adverse Event|0|||
144678832|NCT00437203|521675182|FG004|Overall Study|Adverse Event|0|||
144678833|NCT00437203|521675183|FG005|Overall Study|Adverse Event|0|||
144678834|NCT00437203|521675184|FG006|Overall Study|Adverse Event|0|||
144678835|NCT00437203|521675185|FG007|Overall Study|Adverse Event|1|||
144678836|NCT00437203|521675186|FG008|Overall Study|Adverse Event|0|||
144678837|NCT00437203|521675187|FG009|Overall Study|Adverse Event|1|||
144678838|NCT00437203|521675178|FG000|Overall Study|Study terminated by sponsor|0|||
144678839|NCT00437203|521675179|FG001|Overall Study|Study terminated by sponsor|0|||
144678840|NCT00437203|521675180|FG002|Overall Study|Study terminated by sponsor|0|||
144678841|NCT00437203|521675181|FG003|Overall Study|Study terminated by sponsor|0|||
144678842|NCT00437203|521675182|FG004|Overall Study|Study terminated by sponsor|0|||
144678843|NCT00437203|521675183|FG005|Overall Study|Study terminated by sponsor|0|||
144678844|NCT00437203|521675184|FG006|Overall Study|Study terminated by sponsor|0|||
144678845|NCT00437203|521675185|FG007|Overall Study|Study terminated by sponsor|0|||
144678846|NCT00437203|521675186|FG008|Overall Study|Study terminated by sponsor|1|||
144678847|NCT00437203|521675187|FG009|Overall Study|Study terminated by sponsor|0|||
144678848|NCT00437203|521675178|FG000|Overall Study|Objective progression or relapse|5|||
144678849|NCT00437203|521675179|FG001|Overall Study|Objective progression or relapse|6|||
144678850|NCT00437203|521675180|FG002|Overall Study|Objective progression or relapse|2|||
144678851|NCT00437203|521675181|FG003|Overall Study|Objective progression or relapse|3|||
144678852|NCT00437203|521675182|FG004|Overall Study|Objective progression or relapse|3|||
144678853|NCT00437203|521675183|FG005|Overall Study|Objective progression or relapse|3|||
144678854|NCT00437203|521675184|FG006|Overall Study|Objective progression or relapse|6|||
144678855|NCT00437203|521675185|FG007|Overall Study|Objective progression or relapse|1|||
144678856|NCT00437203|521675186|FG008|Overall Study|Objective progression or relapse|2|||
144678857|NCT00437203|521675187|FG009|Overall Study|Objective progression or relapse|2|||
144678858|NCT00437203|521675178|FG000|Overall Study|Other|0|||
144678859|NCT00437203|521675179|FG001|Overall Study|Other|1|||
144678860|NCT00437203|521675180|FG002|Overall Study|Other|0|||
144678861|NCT00437203|521675181|FG003|Overall Study|Other|0|||
144678862|NCT00437203|521675182|FG004|Overall Study|Other|0|||
144678863|NCT00437203|521675183|FG005|Overall Study|Other|0|||
144678864|NCT00437203|521675184|FG006|Overall Study|Other|1|||
144678865|NCT00437203|521675185|FG007|Overall Study|Other|0|||
144678866|NCT00437203|521675186|FG008|Overall Study|Other|0|||
144678867|NCT00437203|521675187|FG009|Overall Study|Other|0|||
144678868|NCT00431496|521675194|FG000|Overall Study|Adverse Event|3|||
144678869|NCT00431496|521675194|FG000|Overall Study|Lost to Follow-up|1|||
144678870|NCT00431496|521675194|FG000|Overall Study|Withdrawal by Subject|2|||
144678871|NCT00431496|521675194|FG000|Overall Study|Protocol-specified criteria|5|||
144678872|NCT02343952|521675195|FG000|Study Treatment|Disease Progression|23|||
144678873|NCT02343952|521675195|FG000|Study Treatment|Death|3|||
144678874|NCT02343952|521675195|FG000|Study Treatment|Adverse Event|19|||
144678875|NCT02343952|521675195|FG000|Study Treatment|Withdrawal by Subject|7|||
144678876|NCT02343952|521675195|FG000|Study Treatment|other complicating Diseases|1|||
144678877|NCT02343952|521675195|FG000|Follow up|Withdrawal by Subject|3|||
144678878|NCT02343952|521675195|FG000|Follow up|Death|33|||
144678879|NCT02343952|521675195|FG000|Follow up|Patient does not meet eligibility for study.|1|||
144678880|NCT02343952|521675195|FG000|Follow up|Research department closed by the practice.|5|||
144678881|NCT02343952|521675195|FG000|Follow up|Patient went home to Russia|1|||
144678882|NCT02343952|521675195|FG000|Follow up|Disease Progression|1|||
144678883|NCT02343952|521675195|FG000|Follow up|study terminated|1|||
144678884|NCT02067533|521675196|FG000|Overall Study|Lost to Follow-up|4|||
144678885|NCT02067533|521675197|FG001|Overall Study|Lost to Follow-up|2|||
144678886|NCT00565812|521675198|FG000|Overall Study|Death|2|||
144678887|NCT00565812|521675199|FG001|Overall Study|Death|1|||
144678888|NCT00565812|521675200|FG002|Overall Study|Death|3|||
144678889|NCT00565812|521675198|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
144678890|NCT00565812|521675199|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
144678891|NCT00565812|521675200|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
144678892|NCT00565812|521675198|FG000|Overall Study|Lost to Follow-up|10|||
144678893|NCT00565812|521675199|FG001|Overall Study|Lost to Follow-up|8|||
144678894|NCT00565812|521675200|FG002|Overall Study|Lost to Follow-up|8|||
144678895|NCT00565812|521675198|FG000|Overall Study|Withdrawal by Subject|58|||
144678896|NCT00565812|521675199|FG001|Overall Study|Withdrawal by Subject|47|||
144678897|NCT00565812|521675200|FG002|Overall Study|Withdrawal by Subject|48|||
144678898|NCT00565812|521675198|FG000|Overall Study|Work Schedule|5|||
144678899|NCT00565812|521675199|FG001|Overall Study|Work Schedule|3|||
144678900|NCT00565812|521675200|FG002|Overall Study|Work Schedule|1|||
144678901|NCT00565812|521675198|FG000|Overall Study|Protocol Violation|2|||
144678902|NCT00565812|521675199|FG001|Overall Study|Protocol Violation|6|||
144678903|NCT00565812|521675200|FG002|Overall Study|Protocol Violation|4|||
144678904|NCT00565812|521675198|FG000|Overall Study|Adverse Event|41|||
144678905|NCT00565812|521675199|FG001|Overall Study|Adverse Event|54|||
144678906|NCT00565812|521675200|FG002|Overall Study|Adverse Event|40|||
144678907|NCT00565812|521675198|FG000|Overall Study|Jury Duty|1|||
144678908|NCT00565812|521675199|FG001|Overall Study|Jury Duty|0|||
144678909|NCT00565812|521675200|FG002|Overall Study|Jury Duty|0|||
144678910|NCT00565812|521675198|FG000|Overall Study|Relocated Out of Area|5|||
144678911|NCT00565812|521675199|FG001|Overall Study|Relocated Out of Area|8|||
144678912|NCT00565812|521675200|FG002|Overall Study|Relocated Out of Area|9|||
144678913|NCT00565812|521675198|FG000|Overall Study|Sponsor Decision|1|||
144678914|NCT00565812|521675199|FG001|Overall Study|Sponsor Decision|5|||
144678915|NCT00565812|521675200|FG002|Overall Study|Sponsor Decision|1|||
144678916|NCT00565812|521675198|FG000|Overall Study|Domestic Reasons|7|||
144678917|NCT00565812|521675199|FG001|Overall Study|Domestic Reasons|1|||
144678918|NCT00565812|521675200|FG002|Overall Study|Domestic Reasons|3|||
144678919|NCT00565812|521675198|FG000|Overall Study|Research Site Closure|6|||
144678920|NCT00565812|521675199|FG001|Overall Study|Research Site Closure|1|||
144678921|NCT00565812|521675200|FG002|Overall Study|Research Site Closure|8|||
144678922|NCT00565812|521675198|FG000|Overall Study|Surgical Intervention|0|||
144678923|NCT00565812|521675199|FG001|Overall Study|Surgical Intervention|1|||
144678924|NCT00565812|521675200|FG002|Overall Study|Surgical Intervention|2|||
144678925|NCT00565812|521675198|FG000|Overall Study|Low Compliance|1|||
144678926|NCT00565812|521675199|FG001|Overall Study|Low Compliance|0|||
144678927|NCT00565812|521675200|FG002|Overall Study|Low Compliance|1|||
144678928|NCT00565812|521675198|FG000|Overall Study|Follow-up Visit Not Completed|2|||
144678929|NCT00565812|521675199|FG001|Overall Study|Follow-up Visit Not Completed|0|||
144678930|NCT00565812|521675200|FG002|Overall Study|Follow-up Visit Not Completed|1|||
144678931|NCT00565812|521675198|FG000|Overall Study|Physician Decision|2|||
144678932|NCT00565812|521675199|FG001|Overall Study|Physician Decision|0|||
144678933|NCT00565812|521675200|FG002|Overall Study|Physician Decision|0|||
144678934|NCT00845845|521675201|FG000|Overall Study|Lost to Follow-up|0|||
144678935|NCT00845845|521675202|FG001|Overall Study|Lost to Follow-up|4|||
144678936|NCT00479167|521675203|FG000|Overall Study|Withdrawal by Subject|1|||
144678937|NCT01570309|521675206|FG000|Overall Study|Withdrawal by Subject|3|||
144678938|NCT01570309|521675207|FG001|Overall Study|Withdrawal by Subject|3|||
144265810|NCT06058390|520174008|FG000|Overall Study|Physician Decision|0|||
144678939|NCT00560794|521675208|FG000|Overall Study|Adverse Event|2|||
144265811|NCT06058390|520174009|FG001|Overall Study|Physician Decision|0|||
144678940|NCT00560794|521675208|FG000|Overall Study|Patient was not Compliant|1|||
144678941|NCT00560794|521675208|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
144265812|NCT06058390|520174010|FG002|Overall Study|Physician Decision|0|||
144678942|NCT00560794|521675208|FG000|Overall Study|Hematological Relapse|1|||
144678943|NCT00560794|521675208|FG000|Overall Study|Received Bone Marrow Transplant|6|||
144678944|NCT04857892|521675209|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
144678945|NCT04857892|521675210|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
144678946|NCT04857892|521675211|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
144678947|NCT04857892|521675212|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
144678948|NCT04857892|521675213|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
144678949|NCT04857892|521675209|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
144678950|NCT04857892|521675210|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
144678951|NCT04857892|521675211|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
144678952|NCT04857892|521675212|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
144678953|NCT04857892|521675213|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
144678954|NCT04857892|521675209|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
144678955|NCT04857892|521675210|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
144678956|NCT04857892|521675211|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
144678957|NCT04857892|521675212|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
144678958|NCT04857892|521675213|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
144678959|NCT02384993|521675218|FG000|Overall Study|Adverse Event|0|||
144678960|NCT02384993|521675219|FG001|Overall Study|Adverse Event|1|||
144678961|NCT04095793|521675220|FG000|Overall Study|Adverse Event|3|||
144678962|NCT04095793|521675220|FG000|Overall Study|Study Terminated by Sponsor|103|||
144678963|NCT04095793|521675220|FG000|Overall Study|Withdrawal by Subject|4|||
144678964|NCT04507360|521677102|FG000|Week 1|Lost to Follow-up|0|||
144678965|NCT04507360|521677103|FG001|Week 1|Lost to Follow-up|0|||
144678966|NCT04507360|521677104|FG002|Week 1|Lost to Follow-up|0|||
144678967|NCT04507360|521677105|FG003|Week 1|Lost to Follow-up|0|||
144678968|NCT04507360|521677106|FG004|Week 1|Lost to Follow-up|0|||
144678969|NCT04507360|521677107|FG005|Week 1|Lost to Follow-up|0|||
144678970|NCT04507360|521677108|FG006|Week 1|Lost to Follow-up|0|||
144678971|NCT04507360|521677109|FG007|Week 1|Lost to Follow-up|0|||
144678972|NCT04507360|521677110|FG008|Week 1|Lost to Follow-up|72|||
144678973|NCT04507360|521677111|FG009|Week 1|Lost to Follow-up|22|||
144678974|NCT04507360|521677112|FG010|Week 1|Lost to Follow-up|10|||
144678975|NCT04507360|521677102|FG000|Week 2|Lost to Follow-up|0|||
144678976|NCT04507360|521677103|FG001|Week 2|Lost to Follow-up|0|||
144678977|NCT04507360|521677104|FG002|Week 2|Lost to Follow-up|0|||
144678978|NCT04507360|521677105|FG003|Week 2|Lost to Follow-up|0|||
144678979|NCT04507360|521677106|FG004|Week 2|Lost to Follow-up|0|||
144678980|NCT04507360|521677107|FG005|Week 2|Lost to Follow-up|0|||
144678981|NCT04507360|521677108|FG006|Week 2|Lost to Follow-up|0|||
144678982|NCT04507360|521677109|FG007|Week 2|Lost to Follow-up|0|||
144678983|NCT04507360|521677110|FG008|Week 2|Lost to Follow-up|121|||
144678984|NCT04507360|521677111|FG009|Week 2|Lost to Follow-up|85|||
144678985|NCT04507360|521677112|FG010|Week 2|Lost to Follow-up|82|||
144678986|NCT04507360|521677102|FG000|Week 3|Lost to Follow-up|0|||
144678987|NCT04507360|521677103|FG001|Week 3|Lost to Follow-up|0|||
144218213|NCT02815995|519992267|FG005|Overall Study|Pregnancy|0|||
144218214|NCT02815995|519992268|FG006|Overall Study|Pregnancy|1|||
144218215|NCT02815995|519992269|FG007|Overall Study|Pregnancy|0|||
144218216|NCT01071915|519992270|FG000|Overall Study|Adverse Event|3|||
144218217|NCT01071915|519992270|FG000|Overall Study|Physician Decision|2|||
144218218|NCT01071915|519992270|FG000|Overall Study|Withdrawal by Subject|2|||
144218219|NCT01071915|519992270|FG000|Overall Study|Miscellaneous Reasons|2|||
144218220|NCT00114140|519992271|FG000|Overall Study|Protocol Violation|7|||
144218221|NCT00110396|519992272|FG000|Overall Study|Adverse Event|15|||
144218222|NCT00110396|519992272|FG000|Overall Study|Lost to Follow-up|1|||
144218223|NCT00110396|519992272|FG000|Overall Study|Administration of plasmapheresis|1|||
144218224|NCT00110396|519992272|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
144218225|NCT00110396|519992272|FG000|Overall Study|Lack of Efficacy|1|||
144218226|NCT00110396|519992272|FG000|Overall Study|Decided not to continue treatment|1|||
144218227|NCT00110396|519992272|FG000|Overall Study|Patient non-compliance|1|||
144218228|NCT00110396|519992272|FG000|Overall Study|Patient refused to continue|1|||
144218229|NCT00110396|519992272|FG000|Overall Study|Patient refused to participate|1|||
144218230|NCT00110396|519992272|FG000|Overall Study|Patient will|1|||
144218231|NCT00110396|519992272|FG000|Overall Study|Patient's decision|1|||
144218232|NCT00110396|519992272|FG000|Overall Study|Participation in MS vaccine study|1|||
144218233|NCT00110396|519992272|FG000|Overall Study|Pregnancy|1|||
144218234|NCT00110396|519992272|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
144218235|NCT00110396|519992272|FG000|Overall Study|Protocol Violation|2|||
144218236|NCT00110396|519992272|FG000|Overall Study|Patient refused to come back|1|||
144218237|NCT00110396|519992272|FG000|Overall Study|The patient has refused|2|||
144218238|NCT00110396|519992272|FG000|Overall Study|The patient has refused to visit site|1|||
144218239|NCT00110396|519992272|FG000|Overall Study|Patient is to be administered copaxone|1|||
144218240|NCT02414958|519992275|FG000|Overall Study|Adverse Event|6|||
144218241|NCT02414958|519992276|FG001|Overall Study|Adverse Event|6|||
144218242|NCT02414958|519992277|FG002|Overall Study|Adverse Event|3|||
144218243|NCT02414958|519992275|FG000|Overall Study|Protocol Violation|10|||
144218244|NCT02414958|519992276|FG001|Overall Study|Protocol Violation|3|||
144218245|NCT02414958|519992277|FG002|Overall Study|Protocol Violation|1|||
144218246|NCT02414958|519992275|FG000|Overall Study|Lost to Follow-up|7|||
144218247|NCT02414958|519992276|FG001|Overall Study|Lost to Follow-up|4|||
144218248|NCT02414958|519992277|FG002|Overall Study|Lost to Follow-up|0|||
144218249|NCT02414958|519992275|FG000|Overall Study|Withdrawal by Subject|5|||
144218250|NCT02414958|519992276|FG001|Overall Study|Withdrawal by Subject|3|||
144218251|NCT02414958|519992277|FG002|Overall Study|Withdrawal by Subject|5|||
144218252|NCT02414958|519992275|FG000|Overall Study|Other than specified|4|||
144678988|NCT04507360|521677104|FG002|Week 3|Lost to Follow-up|0|||
144678989|NCT04507360|521677105|FG003|Week 3|Lost to Follow-up|0|||
144678990|NCT04507360|521677106|FG004|Week 3|Lost to Follow-up|0|||
144678991|NCT04507360|521677107|FG005|Week 3|Lost to Follow-up|0|||
144678992|NCT04507360|521677108|FG006|Week 3|Lost to Follow-up|0|||
144678993|NCT04507360|521677109|FG007|Week 3|Lost to Follow-up|0|||
144678994|NCT04507360|521677110|FG008|Week 3|Lost to Follow-up|123|||
144678995|NCT04507360|521677111|FG009|Week 3|Lost to Follow-up|92|||
144678996|NCT04507360|521677112|FG010|Week 3|Lost to Follow-up|84|||
144678997|NCT04507360|521677102|FG000|Week 4|Lost to Follow-up|0|||
144678998|NCT04507360|521677103|FG001|Week 4|Lost to Follow-up|0|||
144678999|NCT04507360|521677104|FG002|Week 4|Lost to Follow-up|0|||
144679000|NCT04507360|521677105|FG003|Week 4|Lost to Follow-up|0|||
144679001|NCT04507360|521677106|FG004|Week 4|Lost to Follow-up|0|||
144679002|NCT04507360|521677107|FG005|Week 4|Lost to Follow-up|0|||
144679003|NCT04507360|521677108|FG006|Week 4|Lost to Follow-up|0|||
144679004|NCT04507360|521677109|FG007|Week 4|Lost to Follow-up|0|||
144679005|NCT04507360|521677110|FG008|Week 4|Lost to Follow-up|131|||
144679006|NCT04507360|521677111|FG009|Week 4|Lost to Follow-up|115|||
144679007|NCT04507360|521677112|FG010|Week 4|Lost to Follow-up|102|||
144679008|NCT04507360|521677102|FG000|Week 5|Lost to Follow-up|0|||
144679009|NCT04507360|521677103|FG001|Week 5|Lost to Follow-up|0|||
144679010|NCT04507360|521677104|FG002|Week 5|Lost to Follow-up|0|||
144679011|NCT04507360|521677105|FG003|Week 5|Lost to Follow-up|0|||
144679012|NCT04507360|521677106|FG004|Week 5|Lost to Follow-up|0|||
144679013|NCT04507360|521677107|FG005|Week 5|Lost to Follow-up|0|||
144679014|NCT04507360|521677108|FG006|Week 5|Lost to Follow-up|0|||
144679015|NCT04507360|521677109|FG007|Week 5|Lost to Follow-up|0|||
144679016|NCT04507360|521677110|FG008|Week 5|Lost to Follow-up|103|||
144679017|NCT04507360|521677111|FG009|Week 5|Lost to Follow-up|135|||
144679018|NCT04507360|521677112|FG010|Week 5|Lost to Follow-up|143|||
144679019|NCT04507360|521677102|FG000|Week 8|Lost to Follow-up|0|||
144679020|NCT04507360|521677103|FG001|Week 8|Lost to Follow-up|0|||
144679021|NCT04507360|521677104|FG002|Week 8|Lost to Follow-up|0|||
144679022|NCT04507360|521677105|FG003|Week 8|Lost to Follow-up|0|||
144679023|NCT04507360|521677106|FG004|Week 8|Lost to Follow-up|0|||
144679024|NCT04507360|521677107|FG005|Week 8|Lost to Follow-up|0|||
144679025|NCT04507360|521677108|FG006|Week 8|Lost to Follow-up|0|||
144679026|NCT04507360|521677109|FG007|Week 8|Lost to Follow-up|0|||
144679027|NCT04507360|521677110|FG008|Week 8|Lost to Follow-up|139|||
144679028|NCT04507360|521677111|FG009|Week 8|Lost to Follow-up|145|||
144679029|NCT04507360|521677112|FG010|Week 8|Lost to Follow-up|152|||
144679030|NCT01004159|521677113|FG000|Overall Study|Adverse Event|2|||
144679031|NCT01004159|521677113|FG000|Overall Study|Disease Progression|18|||
144679032|NCT04483544|521677115|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
144679033|NCT04483544|521677115|FG000|Post-Treatment|Admitted to hospice|2|||
144679034|NCT04483544|521677115|FG000|Post-Treatment|Study terminated|3|||
144679035|NCT04072575|521677118|FG000|Overall Study|Physician Decision|1|||
144679036|NCT04072575|521677118|FG000|Overall Study|Adverse Event|7|||
144679037|NCT04072575|521677118|FG000|Overall Study|Withdrawal by Subject|14|||
144679038|NCT04072575|521677118|FG000|Overall Study|Other|2|||
144679039|NCT02498392|521677119|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
144679040|NCT02498392|521677120|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
144679041|NCT02498392|521677119|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
144679042|NCT02498392|521677120|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
144679043|NCT02498392|521677119|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
144679044|NCT02498392|521677120|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
144679045|NCT02498392|521677119|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
144679046|NCT02498392|521677120|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
144679047|NCT02498392|521677119|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
144679048|NCT02498392|521677120|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
144679049|NCT02498392|521677119|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
144679050|NCT02498392|521677120|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
144679051|NCT02244619|521677121|FG000|Overall Study|Did not receive study intervention|8|||
144679052|NCT02244619|521677122|FG001|Overall Study|Did not receive study intervention|21|||
144679053|NCT03135262|521677123|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
144679054|NCT03135262|521677124|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
144679055|NCT03135262|521677125|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
144679056|NCT03135262|521677126|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
144679057|NCT03135262|521677127|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
144679058|NCT03135262|521677123|FG000|Overall Study|Progression of disease|0|||
144679059|NCT03135262|521677124|FG001|Overall Study|Progression of disease|0|||
144679060|NCT03135262|521677125|FG002|Overall Study|Progression of disease|0|||
144679061|NCT03135262|521677126|FG003|Overall Study|Progression of disease|1|||
144679062|NCT03135262|521677127|FG004|Overall Study|Progression of disease|0|||
144679063|NCT03135262|521677123|FG000|Overall Study|Death|6|||
144265813|NCT06058390|520174011|FG003|Overall Study|Physician Decision|1|||
144265814|NCT06058390|520174008|FG000|Overall Study|Participants did not receive any study intervention|0|||
144265815|NCT06058390|520174009|FG001|Overall Study|Participants did not receive any study intervention|0|||
144265816|NCT06058390|520174010|FG002|Overall Study|Participants did not receive any study intervention|0|||
144265817|NCT06058390|520174011|FG003|Overall Study|Participants did not receive any study intervention|1|||
144265818|NCT01211145|520174014|FG000|Overall Study|Reason not specified|3|||
144265819|NCT01211145|520174015|FG001|Overall Study|Reason not specified|2|||
144265820|NCT01211145|520174016|FG002|Overall Study|Reason not specified|2|||
144265821|NCT01211145|520174017|FG003|Overall Study|Reason not specified|1|||
144265822|NCT01211145|520174014|FG000|Overall Study|Lost to Follow-up|3|||
144265823|NCT01211145|520174015|FG001|Overall Study|Lost to Follow-up|2|||
144265824|NCT01211145|520174016|FG002|Overall Study|Lost to Follow-up|1|||
144679064|NCT03135262|521677124|FG001|Overall Study|Death|2|||
144679065|NCT03135262|521677125|FG002|Overall Study|Death|2|||
144679066|NCT03135262|521677126|FG003|Overall Study|Death|2|||
144679067|NCT03135262|521677127|FG004|Overall Study|Death|0|||
144679068|NCT03135262|521677123|FG000|Overall Study|Withdrawal by Subject|0|||
144679069|NCT03135262|521677124|FG001|Overall Study|Withdrawal by Subject|0|||
144679070|NCT03135262|521677125|FG002|Overall Study|Withdrawal by Subject|1|||
144679071|NCT03135262|521677126|FG003|Overall Study|Withdrawal by Subject|0|||
144679072|NCT03135262|521677127|FG004|Overall Study|Withdrawal by Subject|1|||
144679073|NCT03135262|521677123|FG000|Overall Study|Study terminated by sponsor|2|||
144679074|NCT03135262|521677124|FG001|Overall Study|Study terminated by sponsor|4|||
144679075|NCT03135262|521677125|FG002|Overall Study|Study terminated by sponsor|4|||
144679076|NCT03135262|521677126|FG003|Overall Study|Study terminated by sponsor|3|||
144679077|NCT03135262|521677127|FG004|Overall Study|Study terminated by sponsor|0|||
144679078|NCT03285490|521677128|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
144679079|NCT03285490|521677129|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
144679080|NCT03285490|521677128|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
144679081|NCT03285490|521677129|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
144679082|NCT02728206|521677130|FG000|Overall Study|Death|1|||
144679083|NCT00735072|521677131|FG000|Overall Study|interrupted study med during ARV change|1|||
144679084|NCT00735072|521677132|FG001|Overall Study|interrupted study med during ARV change|0|||
144679085|NCT00735072|521677131|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
144679086|NCT00735072|521677132|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
144679087|NCT00429572|521677135|FG000|Overall Study|Disease progression|1|||
144679088|NCT02773368|521677136|FG000|Overall Study|Lost to Follow-up|4|||
144679089|NCT02773368|521677137|FG001|Overall Study|Lost to Follow-up|1|||
144679090|NCT02773368|521677136|FG000|Overall Study|Withdrawal by Subject|5|||
144679091|NCT02773368|521677137|FG001|Overall Study|Withdrawal by Subject|1|||
144679092|NCT02773368|521677136|FG000|Overall Study|Unclassified|1|||
144679093|NCT02773368|521677137|FG001|Overall Study|Unclassified|1|||
144679094|NCT02773368|521677136|FG000|Overall Study|Missing|0|||
144679095|NCT02773368|521677137|FG001|Overall Study|Missing|1|||
144679096|NCT01366534|521677138|FG000|Overall Study|Lost to Follow-up|1|||
144679097|NCT01366534|521677139|FG001|Overall Study|Lost to Follow-up|0|||
144679098|NCT01366534|521677140|FG002|Overall Study|Lost to Follow-up|0|||
144679099|NCT01366534|521677138|FG000|Overall Study|Migrated|1|||
144679100|NCT01366534|521677139|FG001|Overall Study|Migrated|1|||
144679101|NCT01366534|521677140|FG002|Overall Study|Migrated|0|||
144679102|NCT01366534|521677138|FG000|Overall Study|Declined challenged|0|||
144679103|NCT01366534|521677139|FG001|Overall Study|Declined challenged|1|||
144679104|NCT01366534|521677140|FG002|Overall Study|Declined challenged|0|||
144679105|NCT01929018|521677141|FG000|Overall Study|Lost to Follow-up|1|||
144679106|NCT01929018|521677142|FG001|Overall Study|Lost to Follow-up|0|||
144679107|NCT01929018|521677141|FG000|Overall Study|Hospitalization|0|||
144679108|NCT01929018|521677142|FG001|Overall Study|Hospitalization|1|||
144679109|NCT01047436|521677146|FG000|Overall Study|Protocol Violation|1|||
144679110|NCT01047436|521677147|FG001|Overall Study|Protocol Violation|0|||
144679111|NCT01678313|521677150|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
144679112|NCT01678313|521677151|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
144265825|NCT01211145|520174017|FG003|Overall Study|Lost to Follow-up|2|||
144265826|NCT01211145|520174014|FG000|Overall Study|Study-specific withdrawal criteria|1|||
144265827|NCT01211145|520174015|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144265828|NCT01211145|520174016|FG002|Overall Study|Study-specific withdrawal criteria|0|||
144679113|NCT01678313|521677150|FG000|Completed the 3-month Therapy|Physician Decision|3|||
144679114|NCT01678313|521677151|FG001|Completed the 3-month Therapy|Physician Decision|4|||
144679115|NCT01678313|521677150|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
144679116|NCT01678313|521677151|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
144679117|NCT01678313|521677150|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
144679118|NCT01678313|521677151|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
144679119|NCT02635867|521677154|FG000|Overall Study|Lost to Follow-up|4|||
144679120|NCT02635867|521677155|FG001|Overall Study|Lost to Follow-up|3|||
144679121|NCT02635867|521677156|FG002|Overall Study|Lost to Follow-up|3|||
144679122|NCT02635867|521677157|FG003|Overall Study|Lost to Follow-up|4|||
144679123|NCT02635867|521677158|FG004|Overall Study|Lost to Follow-up|1|||
144737721|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
144737722|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
144737723|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
144737724|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
144737725|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
144737726|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
144737727|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
144737728|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
144737729|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
144737730|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
144737731|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
144737732|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
144737733|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
144737734|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
144737735|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
144737736|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Death|0|||
144737737|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Death|1|||
144737738|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Death|0|||
144737739|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Death|0|||
144737740|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
144737741|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
144737742|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
144737743|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
144737744|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
144737745|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
144737746|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
144737747|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
144737748|NCT01940341|521894269|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
144737749|NCT01940341|521894270|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
144737750|NCT01940341|521894271|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
144737751|NCT01940341|521894272|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
144737752|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
144737753|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
144737754|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
144737755|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
144737756|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
144737757|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
144737758|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
144737759|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
144737760|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
144737761|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
144737762|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
144737763|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
144737764|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
144737765|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
144218253|NCT02414958|519992276|FG001|Overall Study|Other than specified|4|||
144218254|NCT02414958|519992277|FG002|Overall Study|Other than specified|5|||
144218255|NCT00245466|519992282|FG000|Overall Study|Adverse Event|2|||
144218256|NCT00245466|519992283|FG001|Overall Study|Adverse Event|8|||
144218257|NCT00245466|519992284|FG002|Overall Study|Adverse Event|4|||
144218258|NCT00245466|519992282|FG000|Overall Study|Low prostate specific antigen suppr|16|||
144218259|NCT00245466|519992283|FG001|Overall Study|Low prostate specific antigen suppr|14|||
144218260|NCT00245466|519992284|FG002|Overall Study|Low prostate specific antigen suppr|5|||
144218261|NCT00245466|519992282|FG000|Overall Study|Insufficient testosterone suppr|12|||
144218262|NCT00245466|519992283|FG001|Overall Study|Insufficient testosterone suppr|12|||
144218263|NCT00245466|519992284|FG002|Overall Study|Insufficient testosterone suppr|21|||
144218264|NCT00245466|519992282|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
144218265|NCT00245466|519992283|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
144218266|NCT00245466|519992284|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
144218267|NCT00245466|519992282|FG000|Overall Study|Withdrawal by Subject|2|||
144218268|NCT00245466|519992283|FG001|Overall Study|Withdrawal by Subject|2|||
144737766|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
144737767|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
144737768|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
144737769|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
144737770|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
144737771|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
144737772|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
144737773|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
144737774|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
144737775|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
144737776|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
144737777|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
144737778|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
144737779|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
144737780|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
144737781|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
144737782|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
144737783|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
144737784|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
144737785|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
144737786|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
144737787|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
144737788|NCT01940341|521894269|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
144737789|NCT01940341|521894270|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
144737790|NCT01940341|521894271|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
144737791|NCT01940341|521894272|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
144737792|NCT02414152|521894273|FG000|Overall Study|Withdrawal by Subject|1|||
144737793|NCT02414152|521894273|FG000|Overall Study|Lack of Efficacy|1|||
144737794|NCT01576042|521894277|FG000|Overall Study|Physician Decision|2|||
144737795|NCT01576042|521894278|FG001|Overall Study|Physician Decision|0|||
144737796|NCT03769025|521894284|FG000|Overall Study|Withdrawal by Subject|1|||
144737797|NCT03769025|521894285|FG001|Overall Study|Withdrawal by Subject|1|||
144679124|NCT01131130|521677160|FG000|Period 1 - Baseline|Pregnancy|1|||
144679125|NCT01131130|521677160|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
144679126|NCT03981744|521677161|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
144679127|NCT03981744|521677162|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
144679128|NCT03981744|521677163|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
144679129|NCT03981744|521677164|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
144679130|NCT03981744|521677161|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
144679131|NCT03981744|521677162|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
144679132|NCT03981744|521677163|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
144679133|NCT03981744|521677164|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
144679134|NCT03981744|521677161|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
144679135|NCT03981744|521677162|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
144679136|NCT03981744|521677163|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
144679137|NCT03981744|521677164|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
144679138|NCT02782104|521677165|FG000|Overall Study|Other|215|||
144679139|NCT02782104|521677165|FG000|Overall Study|Induction Day 28 Non Responder|9|||
144679140|NCT02782104|521677165|FG000|Overall Study|Non-Compliance with Study Drug|2|||
144679141|NCT02782104|521677165|FG000|Overall Study|Death|8|||
144679142|NCT02782104|521677165|FG000|Overall Study|Pregnancy|6|||
144679143|NCT02782104|521677165|FG000|Overall Study|Withdrawal by Subject|63|||
144679144|NCT02782104|521677165|FG000|Overall Study|Protocol Violation|7|||
144679145|NCT02782104|521677165|FG000|Overall Study|Lack of Efficacy|61|||
144679146|NCT02782104|521677165|FG000|Overall Study|Lost to Follow-up|23|||
144679147|NCT02782104|521677165|FG000|Overall Study|Adverse Event|74|||
144679148|NCT04338321|521677166|FG000|Overall Study|Adverse Event|4|||
144679149|NCT04338321|521677167|FG001|Overall Study|Adverse Event|10|||
144679150|NCT04338321|521677166|FG000|Overall Study|Death|1|||
144679151|NCT04338321|521677167|FG001|Overall Study|Death|1|||
144679152|NCT04338321|521677166|FG000|Overall Study|Lost to Follow-up|4|||
144679153|NCT04338321|521677167|FG001|Overall Study|Lost to Follow-up|9|||
144679154|NCT04338321|521677166|FG000|Overall Study|Withdrawal by Subject|45|||
144679155|NCT04338321|521677167|FG001|Overall Study|Withdrawal by Subject|69|||
144679156|NCT04338321|521677166|FG000|Overall Study|Physician Decision|5|||
144679157|NCT04338321|521677167|FG001|Overall Study|Physician Decision|9|||
144679158|NCT04338321|521677166|FG000|Overall Study|Other|3|||
144679159|NCT04338321|521677167|FG001|Overall Study|Other|10|||
144679160|NCT03464136|521677168|FG000|Overall Study|Lost to Follow-up|5|||
144737798|NCT03769025|521894284|FG000|Overall Study|Lost to Follow-up|4|||
144737799|NCT03769025|521894285|FG001|Overall Study|Lost to Follow-up|3|||
144679161|NCT03464136|521677169|FG001|Overall Study|Lost to Follow-up|8|||
144679162|NCT03464136|521677168|FG000|Overall Study|Withdrawal by Subject|16|||
144679163|NCT03464136|521677169|FG001|Overall Study|Withdrawal by Subject|13|||
144737800|NCT02911701|521894290|FG000|Overall Study|Withdrawal by Subject|2|||
144679164|NCT03464136|521677168|FG000|Overall Study|Death|1|||
144679165|NCT03464136|521677169|FG001|Overall Study|Death|0|||
144679166|NCT03464136|521677168|FG000|Overall Study|Other|8|||
144679167|NCT03464136|521677169|FG001|Overall Study|Other|4|||
144679168|NCT02438787|521677170|FG000|Overall Study|Adverse Event|1|||
144679169|NCT02438787|521677171|FG001|Overall Study|Adverse Event|0|||
144679170|NCT02438787|521677172|FG002|Overall Study|Adverse Event|2|||
144679171|NCT02438787|521677170|FG000|Overall Study|Lack of Efficacy|1|||
144679172|NCT02438787|521677171|FG001|Overall Study|Lack of Efficacy|2|||
144679173|NCT02438787|521677172|FG002|Overall Study|Lack of Efficacy|0|||
144679174|NCT02438787|521677170|FG000|Overall Study|Lost to Follow-up|0|||
144679175|NCT02438787|521677171|FG001|Overall Study|Lost to Follow-up|1|||
144679176|NCT02438787|521677172|FG002|Overall Study|Lost to Follow-up|0|||
144679177|NCT02438787|521677170|FG000|Overall Study|Protocol Violation|0|||
144679178|NCT02438787|521677171|FG001|Overall Study|Protocol Violation|0|||
144679179|NCT02438787|521677172|FG002|Overall Study|Protocol Violation|1|||
144679180|NCT02438787|521677170|FG000|Overall Study|Withdrawal by Subject|15|||
144679181|NCT02438787|521677171|FG001|Overall Study|Withdrawal by Subject|7|||
144679182|NCT02438787|521677172|FG002|Overall Study|Withdrawal by Subject|10|||
144679183|NCT02438787|521677170|FG000|Overall Study|Study discontinued by sponsor|64|||
144679184|NCT02438787|521677171|FG001|Overall Study|Study discontinued by sponsor|72|||
144679185|NCT02438787|521677172|FG002|Overall Study|Study discontinued by sponsor|69|||
144679186|NCT02438787|521677170|FG000|Overall Study|Other|0|||
144679187|NCT02438787|521677171|FG001|Overall Study|Other|1|||
144679188|NCT02438787|521677172|FG002|Overall Study|Other|0|||
144679189|NCT02438787|521677170|FG000|Overall Study|Site terminated by sponsor|0|||
144679190|NCT02438787|521677171|FG001|Overall Study|Site terminated by sponsor|0|||
144679191|NCT02438787|521677172|FG002|Overall Study|Site terminated by sponsor|1|||
144679192|NCT03375203|521677173|FG000|Overall Study|Protocol Violation|0|||
144679193|NCT03375203|521677174|FG001|Overall Study|Protocol Violation|0|||
144679194|NCT03375203|521677175|FG002|Overall Study|Protocol Violation|1|||
144679195|NCT03375203|521677176|FG003|Overall Study|Protocol Violation|0|||
144679196|NCT03375203|521677177|FG004|Overall Study|Protocol Violation|0|||
144679197|NCT03375203|521677173|FG000|Overall Study|Adverse Event|2|||
144679198|NCT03375203|521677174|FG001|Overall Study|Adverse Event|3|||
144679199|NCT03375203|521677175|FG002|Overall Study|Adverse Event|0|||
144679200|NCT03375203|521677176|FG003|Overall Study|Adverse Event|2|||
144679201|NCT03375203|521677177|FG004|Overall Study|Adverse Event|2|||
144679202|NCT03375203|521677173|FG000|Overall Study|Withdrawal by Subject|3|||
144679203|NCT03375203|521677174|FG001|Overall Study|Withdrawal by Subject|0|||
144679204|NCT03375203|521677175|FG002|Overall Study|Withdrawal by Subject|1|||
144679205|NCT03375203|521677176|FG003|Overall Study|Withdrawal by Subject|0|||
144679206|NCT03375203|521677177|FG004|Overall Study|Withdrawal by Subject|2|||
144679207|NCT03375203|521677173|FG000|Overall Study|Non-compliance with study drug|1|||
144679208|NCT03375203|521677174|FG001|Overall Study|Non-compliance with study drug|0|||
144679209|NCT03375203|521677175|FG002|Overall Study|Non-compliance with study drug|0|||
144679210|NCT03375203|521677176|FG003|Overall Study|Non-compliance with study drug|0|||
144679211|NCT03375203|521677177|FG004|Overall Study|Non-compliance with study drug|0|||
144679212|NCT03375203|521677173|FG000|Overall Study|Randomized, not treated.|0|||
144679213|NCT03375203|521677174|FG001|Overall Study|Randomized, not treated.|1|||
144679214|NCT03375203|521677175|FG002|Overall Study|Randomized, not treated.|0|||
144679215|NCT03375203|521677176|FG003|Overall Study|Randomized, not treated.|0|||
144679216|NCT03375203|521677177|FG004|Overall Study|Randomized, not treated.|0|||
144679217|NCT03107793|521677178|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
144679218|NCT03107793|521677179|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
144679219|NCT03107793|521677180|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
144679220|NCT03107793|521677181|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
144679221|NCT03107793|521677182|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
144679222|NCT03107793|521677178|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
144679223|NCT03107793|521677179|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
144679224|NCT03107793|521677180|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
144679225|NCT03107793|521677181|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
144679226|NCT03107793|521677182|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
144679227|NCT03107793|521677178|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
144679228|NCT03107793|521677179|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
144679229|NCT03107793|521677180|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
144679230|NCT03107793|521677181|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
144679231|NCT03107793|521677182|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
144679232|NCT03107793|521677178|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
144679233|NCT03107793|521677179|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144679234|NCT03107793|521677180|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144679235|NCT03107793|521677181|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144679236|NCT03107793|521677182|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144679237|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144679238|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
144679239|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
144737801|NCT02911701|521894291|FG001|Overall Study|Withdrawal by Subject|4|||
144737802|NCT02911701|521894290|FG000|Overall Study|Adverse Event|1|||
144737803|NCT02911701|521894291|FG001|Overall Study|Adverse Event|0|||
144737804|NCT01302548|521894292|FG000|Overall Study|Lost to Follow-up|2|||
144737805|NCT01302548|521894293|FG001|Overall Study|Lost to Follow-up|1|||
144737806|NCT03482882|521894294|FG000|Overall Study|Adverse Event|3|||
144737807|NCT03482882|521894294|FG000|Overall Study|Lost to Follow-up|1|||
144737808|NCT03482882|521894294|FG000|Overall Study|Protocol Violation|2|||
144737809|NCT03482882|521894294|FG000|Overall Study|Not further specified|1|||
144737810|NCT04646213|521894295|FG000|Overall Study|Physician Decision|3|||
144737811|NCT04646213|521894295|FG000|Overall Study|Withdrawal by Subject|2|||
144737812|NCT00415363|521894300|FG000|Overall Study|Withdrawal by Subject|4|||
144737813|NCT00415363|521894301|FG001|Overall Study|Withdrawal by Subject|4|||
144737814|NCT00415363|521894300|FG000|Overall Study|Adverse Event|4|||
144737815|NCT00415363|521894301|FG001|Overall Study|Adverse Event|4|||
144737816|NCT00415363|521894300|FG000|Overall Study|Lost to Follow-up|2|||
144737817|NCT00415363|521894301|FG001|Overall Study|Lost to Follow-up|1|||
144737818|NCT00415363|521894300|FG000|Overall Study|Physician Decision|3|||
144737819|NCT00415363|521894301|FG001|Overall Study|Physician Decision|1|||
144737820|NCT00415363|521894300|FG000|Overall Study|Death|16|||
144737821|NCT00415363|521894301|FG001|Overall Study|Death|12|||
144737822|NCT00415363|521894300|FG000|Overall Study|Progressive disease|26|||
144737823|NCT00415363|521894301|FG001|Overall Study|Progressive disease|32|||
144737824|NCT03123471|521894304|FG000|Placebo-controlled Phase|Adverse Event|3|||
144737825|NCT03123471|521894305|FG001|Placebo-controlled Phase|Adverse Event|8|||
144737826|NCT03123471|521894304|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
144737827|NCT03123471|521894305|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
144737828|NCT03123471|521894304|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
144737829|NCT03123471|521894305|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
144737830|NCT03123471|521894304|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
144737831|NCT03123471|521894305|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
144737832|NCT03123471|521894304|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
144737833|NCT03123471|521894305|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
144737834|NCT03123471|521894304|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
144737835|NCT03123471|521894305|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
144737836|NCT03123471|521894304|FG000|Placebo-controlled Phase|Miscellaneous|0|||
144737837|NCT03123471|521894305|FG001|Placebo-controlled Phase|Miscellaneous|1|||
144737838|NCT03123471|521894304|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
144737839|NCT03123471|521894305|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
144737840|NCT03123471|521894304|FG000|Apremilast Extension Phase|Adverse Event|1|||
144737841|NCT03123471|521894305|FG001|Apremilast Extension Phase|Adverse Event|5|||
144737842|NCT03123471|521894304|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
144737843|NCT03123471|521894305|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
144737844|NCT03123471|521894304|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
144737845|NCT03123471|521894305|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
144737846|NCT01686477|521894306|FG000|Feeding Intervention|Death|1|||
144737847|NCT01686477|521894307|FG001|Feeding Intervention|Death|0|||
144737848|NCT01686477|521894308|FG002|Feeding Intervention|Death|1|||
144737849|NCT01686477|521894306|FG000|Feeding Intervention|Withdrawal by Subject|0|||
144737850|NCT01686477|521894307|FG001|Feeding Intervention|Withdrawal by Subject|6|||
144737851|NCT01686477|521894308|FG002|Feeding Intervention|Withdrawal by Subject|0|||
144737852|NCT01686477|521894306|FG000|Feeding Intervention|Physician Decision|1|||
144737853|NCT01686477|521894307|FG001|Feeding Intervention|Physician Decision|2|||
144737854|NCT01686477|521894308|FG002|Feeding Intervention|Physician Decision|0|||
144737855|NCT01686477|521894306|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
144737856|NCT01686477|521894307|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
144737857|NCT01686477|521894308|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
144737858|NCT01686477|521894306|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
144737859|NCT01686477|521894307|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
144737860|NCT01686477|521894308|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
144737861|NCT01686477|521894306|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
144218269|NCT00245466|519992284|FG002|Overall Study|Withdrawal by Subject|1|||
144218270|NCT00245466|519992282|FG000|Overall Study|Lost to Follow-up|3|||
144737862|NCT01686477|521894307|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
144218271|NCT00245466|519992283|FG001|Overall Study|Lost to Follow-up|0|||
144218272|NCT00245466|519992284|FG002|Overall Study|Lost to Follow-up|0|||
144218273|NCT00245466|519992282|FG000|Overall Study|Disease progression|0|||
144218274|NCT00245466|519992283|FG001|Overall Study|Disease progression|3|||
144737863|NCT01686477|521894308|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
144737864|NCT01686477|521894306|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
144737865|NCT01686477|521894307|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
144737866|NCT01686477|521894308|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
144737867|NCT01686477|521894306|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
144737868|NCT01686477|521894307|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
144679240|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144679241|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144679242|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
144679243|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
144679244|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
144679245|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
144679246|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
144679247|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
144679248|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
144679249|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
144679250|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
144679251|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
144679252|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144679253|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
144679254|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
144679255|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144679256|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144679257|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
144679258|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
144679259|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
144679260|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
144679261|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
144679262|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
144679263|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
144679264|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
144679265|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
144679266|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
144679267|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144679268|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
144679269|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144679270|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144679271|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144679272|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
144679273|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
144679274|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
144679275|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
144679276|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
144679277|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
144679278|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
144679279|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
144679280|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
144679281|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
144679282|NCT03107793|521677178|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
144679283|NCT03107793|521677179|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
144679284|NCT03107793|521677180|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
144679285|NCT03107793|521677181|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
144679286|NCT03107793|521677182|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
144679287|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
144679288|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
144679289|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
144679290|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
144679291|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
144679292|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
144679293|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
144679294|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
144679295|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
144679296|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
144679297|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
144679298|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
144737869|NCT01686477|521894308|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
144737870|NCT01686477|521894306|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
144737871|NCT01686477|521894307|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
144679299|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
144679300|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
144679301|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
144679302|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Death|0|||
144679303|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Death|0|||
144679304|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Death|0|||
144679305|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Death|0|||
144679306|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Death|1|||
144679307|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
144679308|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
144679309|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
144679310|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
144679311|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
144679312|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
144679313|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
144679314|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
144679315|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
144679316|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
144679317|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
144679318|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
144679319|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
144679320|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
144679321|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
144679322|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
144679323|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
144679324|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
144679325|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
144679326|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
144679327|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
144679328|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
144679329|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
144679330|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
144679331|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
144679332|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Other|0|||
144679333|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Other|0|||
144679334|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Other|0|||
144679335|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Other|1|||
144679336|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Other|3|||
144679337|NCT03107793|521677178|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
144679338|NCT03107793|521677179|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
144679339|NCT03107793|521677180|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
144679340|NCT03107793|521677181|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
144679341|NCT03107793|521677182|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
144679342|NCT01872897|521677189|FG000|Overall Study|Withdrawal by Subject|1|||
144679343|NCT01872897|521677190|FG001|Overall Study|Withdrawal by Subject|0|||
144679344|NCT02418585|521677195|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
144679345|NCT02418585|521677196|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
144679346|NCT02418585|521677195|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
144679347|NCT02418585|521677196|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
144679348|NCT02418585|521677195|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
144679349|NCT02418585|521677196|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
144679350|NCT02418585|521677195|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
144679351|NCT02418585|521677196|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
144679352|NCT02418585|521677195|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
144679353|NCT02418585|521677196|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
144679354|NCT02418585|521677195|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
144679355|NCT02418585|521677196|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
144679356|NCT02418585|521677195|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
144679357|NCT02418585|521677196|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
144679358|NCT02418585|521677195|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
144679359|NCT02418585|521677196|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
144679360|NCT02418585|521677195|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
144679361|NCT02418585|521677196|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
144679362|NCT02418585|521677195|FG000|Follow-up Phase (24 Weeks)|Other|3|||
144679363|NCT02418585|521677196|FG001|Follow-up Phase (24 Weeks)|Other|2|||
144679364|NCT02040857|521677197|FG000|Overall Study|Adverse Event|14|||
144679365|NCT02040857|521677197|FG000|Overall Study|Physician Decision|5|||
144679366|NCT02040857|521677197|FG000|Overall Study|Withdrawal by Subject|31|||
144218275|NCT00245466|519992284|FG002|Overall Study|Disease progression|1|||
144218276|NCT00245466|519992282|FG000|Overall Study|Protocol Violation|1|||
144679367|NCT02040857|521677197|FG000|Overall Study|patient non-compliance|3|||
144679368|NCT02040857|521677197|FG000|Overall Study|Lost to Follow-up|2|||
144679369|NCT02040857|521677197|FG000|Overall Study|recurrence|4|||
144679370|NCT02040857|521677197|FG000|Overall Study|ineligible|1|||
144679371|NCT00329784|521677198|FG000|Overall Study|Lost to Follow-up|0|||
144679372|NCT00329784|521677199|FG001|Overall Study|Lost to Follow-up|1|||
144679373|NCT00329784|521677200|FG002|Overall Study|Lost to Follow-up|0|||
144679374|NCT00329784|521677201|FG003|Overall Study|Lost to Follow-up|0|||
144679375|NCT00329784|521677198|FG000|Overall Study|Withdrawal by Subject|4|||
144679376|NCT00329784|521677199|FG001|Overall Study|Withdrawal by Subject|2|||
144679377|NCT00329784|521677200|FG002|Overall Study|Withdrawal by Subject|0|||
144679378|NCT00329784|521677201|FG003|Overall Study|Withdrawal by Subject|0|||
144679379|NCT00329784|521677198|FG000|Overall Study|Other|1|||
144679380|NCT00329784|521677199|FG001|Overall Study|Other|2|||
144679381|NCT00329784|521677200|FG002|Overall Study|Other|0|||
144679382|NCT00329784|521677201|FG003|Overall Study|Other|0|||
144679383|NCT01098032|521677202|FG000|Overall Study|Withdrawal by Subject|1|||
144679384|NCT01098032|521677203|FG001|Overall Study|Withdrawal by Subject|1|||
144679385|NCT03152110|521677226|FG000|Overall Study|Withdrawal by Subject|3|||
144679386|NCT00552344|521677229|FG000|Overall Study|Lack of Efficacy|55|||
144679387|NCT00552344|521677229|FG000|Overall Study|Loss of efficacy|75|||
144679388|NCT00552344|521677229|FG000|Overall Study|Lost to Follow-up|8|||
144679389|NCT00552344|521677229|FG000|Overall Study|Withdrawal by Subject|48|||
144679390|NCT00552344|521677229|FG000|Overall Study|SAE, non-fatal|6|||
144679391|NCT00552344|521677229|FG000|Overall Study|AE, non-serious non-fatal|38|||
144679392|NCT00552344|521677229|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
144679393|NCT00552344|521677229|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
144679394|NCT00552344|521677229|FG000|Overall Study|Other Reason|22|||
144679395|NCT01634100|521677230|FG000|Overall Study|Withdrawal by Subject|1|||
144679396|NCT01634100|521677231|FG001|Overall Study|Withdrawal by Subject|0|||
144679397|NCT01634100|521677232|FG002|Overall Study|Withdrawal by Subject|1|||
144679398|NCT01634100|521677233|FG003|Overall Study|Withdrawal by Subject|0|||
144679399|NCT01634100|521677234|FG004|Overall Study|Withdrawal by Subject|0|||
144679400|NCT01634100|521677235|FG005|Overall Study|Withdrawal by Subject|0|||
144679401|NCT00471276|521677236|FG000|Overall Study|Death|2|||
144679402|NCT00471276|521677236|FG000|Overall Study|Adverse Event|16|||
144679403|NCT00471276|521677236|FG000|Overall Study|Protocol Violation|1|||
144679404|NCT00471276|521677236|FG000|Overall Study|Objective progression or relapse|54|||
144679405|NCT00471276|521677236|FG000|Overall Study|Global deterioration of health status|1|||
144679406|NCT00471276|521677236|FG000|Overall Study|Other|3|||
144679407|NCT00471276|521677236|FG000|Overall Study|Refused treatment|6|||
144679408|NCT00744991|521677237|FG000|Overall Study|Progressive Disease|11|||
144679409|NCT00744991|521677237|FG000|Overall Study|Withdrawal by Subject|8|||
144679410|NCT00744991|521677237|FG000|Overall Study|Physician Decision|3|||
144679411|NCT00744991|521677237|FG000|Overall Study|Adverse Event|2|||
144679412|NCT00744991|521677237|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
144679413|NCT01662986|521677238|FG000|Overall Study|Adverse Event|5|||
144679414|NCT01662986|521677239|FG001|Overall Study|Adverse Event|4|||
144679415|NCT01662986|521677238|FG000|Overall Study|Protocol Violation|2|||
144679416|NCT01662986|521677239|FG001|Overall Study|Protocol Violation|3|||
144679417|NCT01662986|521677238|FG000|Overall Study|Lost to Follow-up|5|||
144679418|NCT01662986|521677239|FG001|Overall Study|Lost to Follow-up|4|||
144679419|NCT01662986|521677238|FG000|Overall Study|Withdrawal by Subject|2|||
144679420|NCT01662986|521677239|FG001|Overall Study|Withdrawal by Subject|2|||
144679421|NCT01662986|521677238|FG000|Overall Study|Not Treated|1|||
144679422|NCT01662986|521677239|FG001|Overall Study|Not Treated|0|||
144679423|NCT01662986|521677238|FG000|Overall Study|Other than stated above|3|||
144679424|NCT01662986|521677239|FG001|Overall Study|Other than stated above|0|||
144679425|NCT01487863|521677240|FG000|Overall Study|Death|19|||
144679426|NCT01487863|521677241|FG001|Overall Study|Death|19|||
144679427|NCT01975376|521677242|FG000|Overall Study|Adverse Event|5|||
144679428|NCT01975376|521677243|FG001|Overall Study|Adverse Event|5|||
144679429|NCT01975376|521677242|FG000|Overall Study|Death|65|||
144679430|NCT01975376|521677243|FG001|Overall Study|Death|72|||
144679431|NCT01975376|521677242|FG000|Overall Study|Lost to Follow-up|70|||
144679432|NCT01975376|521677243|FG001|Overall Study|Lost to Follow-up|66|||
144679433|NCT01975376|521677242|FG000|Overall Study|Withdrew consent|68|||
144679434|NCT01975376|521677243|FG001|Overall Study|Withdrew consent|62|||
144679435|NCT01975376|521677242|FG000|Overall Study|Other|2|||
144679436|NCT01975376|521677243|FG001|Overall Study|Other|4|||
144218277|NCT00245466|519992283|FG001|Overall Study|Protocol Violation|2|||
144218278|NCT00245466|519992284|FG002|Overall Study|Protocol Violation|2|||
144679437|NCT01975376|521677242|FG000|Overall Study|Randomized, Not Treated|16|||
144679438|NCT01975376|521677243|FG001|Overall Study|Randomized, Not Treated|8|||
144679439|NCT04449276|521677244|FG000|Overall Study|Adverse Event|1|||
144679440|NCT04449276|521677245|FG001|Overall Study|Adverse Event|2|||
144679441|NCT04449276|521677246|FG002|Overall Study|Adverse Event|0|||
144679442|NCT04449276|521677247|FG003|Overall Study|Adverse Event|0|||
144679443|NCT04449276|521677248|FG004|Overall Study|Adverse Event|2|||
144679444|NCT04449276|521677249|FG005|Overall Study|Adverse Event|0|||
144679445|NCT04449276|521677250|FG006|Overall Study|Adverse Event|0|||
144679446|NCT04449276|521677251|FG007|Overall Study|Adverse Event|1|||
144679447|NCT04449276|521677244|FG000|Overall Study|Withdrawal by Subject|2|||
144679448|NCT04449276|521677245|FG001|Overall Study|Withdrawal by Subject|0|||
144679449|NCT04449276|521677246|FG002|Overall Study|Withdrawal by Subject|0|||
144679450|NCT04449276|521677247|FG003|Overall Study|Withdrawal by Subject|1|||
144679451|NCT04449276|521677248|FG004|Overall Study|Withdrawal by Subject|0|||
144679452|NCT04449276|521677249|FG005|Overall Study|Withdrawal by Subject|0|||
144679453|NCT04449276|521677250|FG006|Overall Study|Withdrawal by Subject|0|||
144679454|NCT04449276|521677251|FG007|Overall Study|Withdrawal by Subject|0|||
144679455|NCT04449276|521677244|FG000|Overall Study|Other|0|||
144679456|NCT04449276|521677245|FG001|Overall Study|Other|2|||
144679457|NCT04449276|521677246|FG002|Overall Study|Other|3|||
144679458|NCT04449276|521677247|FG003|Overall Study|Other|2|||
144679459|NCT04449276|521677248|FG004|Overall Study|Other|0|||
144679460|NCT04449276|521677249|FG005|Overall Study|Other|0|||
144679461|NCT04449276|521677250|FG006|Overall Study|Other|0|||
144679462|NCT04449276|521677251|FG007|Overall Study|Other|1|||
144679463|NCT01614795|521677252|FG000|Overall Study|Adverse Event|0|||
144679464|NCT01614795|521677253|FG001|Overall Study|Adverse Event|0|||
144679465|NCT01614795|521677254|FG002|Overall Study|Adverse Event|1|||
144679466|NCT01614795|521677255|FG003|Overall Study|Adverse Event|1|||
144679467|NCT01614795|521677252|FG000|Overall Study|Lack of Efficacy|10|||
144679468|NCT01614795|521677253|FG001|Overall Study|Lack of Efficacy|10|||
144679469|NCT01614795|521677254|FG002|Overall Study|Lack of Efficacy|9|||
144679470|NCT01614795|521677255|FG003|Overall Study|Lack of Efficacy|8|||
144679471|NCT01614795|521677252|FG000|Overall Study|Physician Decision|1|||
144679472|NCT01614795|521677253|FG001|Overall Study|Physician Decision|0|||
144679473|NCT01614795|521677254|FG002|Overall Study|Physician Decision|1|||
144679474|NCT01614795|521677255|FG003|Overall Study|Physician Decision|1|||
144679475|NCT01614795|521677252|FG000|Overall Study|Withdrawal by Subject|0|||
144679476|NCT01614795|521677253|FG001|Overall Study|Withdrawal by Subject|1|||
144679477|NCT01614795|521677254|FG002|Overall Study|Withdrawal by Subject|0|||
144679478|NCT01614795|521677255|FG003|Overall Study|Withdrawal by Subject|2|||
144679479|NCT01614795|521677252|FG000|Overall Study|Ineligible|0|||
144679480|NCT01614795|521677253|FG001|Overall Study|Ineligible|1|||
144679481|NCT01614795|521677254|FG002|Overall Study|Ineligible|0|||
144679482|NCT01614795|521677255|FG003|Overall Study|Ineligible|0|||
144679483|NCT00044213|521677258|FG000|Overall Study|Withdrawal by Subject|50|||
144679484|NCT00044213|521677259|FG001|Overall Study|Withdrawal by Subject|65|||
144679485|NCT00044213|521677260|FG002|Overall Study|Withdrawal by Subject|91|||
144679486|NCT00044213|521677261|FG003|Overall Study|Withdrawal by Subject|83|||
144679487|NCT00044213|521677258|FG000|Overall Study|Death|42|||
144679488|NCT00044213|521677259|FG001|Overall Study|Death|42|||
144679489|NCT00044213|521677260|FG002|Overall Study|Death|42|||
144679490|NCT00044213|521677261|FG003|Overall Study|Death|49|||
144679491|NCT00044213|521677258|FG000|Overall Study|Lost to Follow-up|8|||
144679492|NCT00044213|521677259|FG001|Overall Study|Lost to Follow-up|5|||
144679493|NCT00044213|521677260|FG002|Overall Study|Lost to Follow-up|5|||
144679494|NCT00044213|521677261|FG003|Overall Study|Lost to Follow-up|4|||
144679495|NCT00098865|521679604|FG000|Overall Study|Progressive Disease|6|||
144679496|NCT00098865|521679604|FG000|Overall Study|Adverse Event|2|||
144679497|NCT00098865|521679604|FG000|Overall Study|Alternative Therapy|1|||
144679498|NCT03050307|521679605|FG000|Overall Study|Adverse Event|4|||
144679499|NCT03050307|521679606|FG001|Overall Study|Adverse Event|2|||
144679500|NCT03050307|521679605|FG000|Overall Study|Significant Protocol Deviation|0|||
144679501|NCT03050307|521679606|FG001|Overall Study|Significant Protocol Deviation|1|||
144737872|NCT01686477|521894308|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
144737873|NCT01686477|521894306|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
144679502|NCT03050307|521679605|FG000|Overall Study|Lost to Follow-up|0|||
144679503|NCT03050307|521679606|FG001|Overall Study|Lost to Follow-up|1|||
144679504|NCT03050307|521679605|FG000|Overall Study|Voluntary Withdrawal|3|||
144679505|NCT03050307|521679606|FG001|Overall Study|Voluntary Withdrawal|4|||
144679506|NCT03050307|521679605|FG000|Overall Study|Reason not Specified|1|||
144679507|NCT03050307|521679606|FG001|Overall Study|Reason not Specified|1|||
144679508|NCT00439309|521679607|FG000|Follow-Up|Death|1|||
144679509|NCT00439309|521679608|FG001|Follow-Up|Death|0|||
144679510|NCT00439309|521679607|FG000|Follow-Up|Lost to Follow-up|2|||
144679511|NCT00439309|521679608|FG001|Follow-Up|Lost to Follow-up|0|||
144679512|NCT00439309|521679607|FG000|Follow-Up|Withdrawal by Subject|0|||
144679513|NCT00439309|521679608|FG001|Follow-Up|Withdrawal by Subject|1|||
144679514|NCT00439309|521679607|FG000|Follow-Up|Late response by subject|0|||
144679515|NCT00439309|521679608|FG001|Follow-Up|Late response by subject|1|||
144679516|NCT00430027|521679610|FG000|Overall Study|Study terminated|8|||
144679517|NCT00464620|521679611|FG000|Overall Study|Physician Decision|1|||
144679518|NCT00464620|521679612|FG001|Overall Study|Physician Decision|0|||
144679519|NCT00464620|521679613|FG002|Overall Study|Physician Decision|0|||
144679520|NCT00464620|521679611|FG000|Overall Study|Withdrawal by Subject|1|||
144679521|NCT00464620|521679612|FG001|Overall Study|Withdrawal by Subject|0|||
144679522|NCT00464620|521679613|FG002|Overall Study|Withdrawal by Subject|3|||
144679523|NCT00464620|521679611|FG000|Overall Study|Ineligible sarcoma subtype|0|||
144679524|NCT00464620|521679612|FG001|Overall Study|Ineligible sarcoma subtype|2|||
144679525|NCT00464620|521679613|FG002|Overall Study|Ineligible sarcoma subtype|2|||
144679526|NCT00464620|521679611|FG000|Overall Study|Use of prohibited concomitant medication|0|||
144679527|NCT00464620|521679612|FG001|Overall Study|Use of prohibited concomitant medication|0|||
144679528|NCT00464620|521679613|FG002|Overall Study|Use of prohibited concomitant medication|2|||
144679529|NCT04984876|521679618|FG000|Overall Study|Subject decision|2|||
144679530|NCT04984876|521679619|FG001|Overall Study|Subject decision|10|||
144679531|NCT04984876|521679620|FG002|Overall Study|Subject decision|3|||
144679532|NCT04984876|521679621|FG003|Overall Study|Subject decision|3|||
144679533|NCT04984876|521679622|FG004|Overall Study|Subject decision|3|||
144679534|NCT04984876|521679623|FG005|Overall Study|Subject decision|0|||
144679535|NCT04984876|521679618|FG000|Overall Study|Guardian decision|0|||
144679536|NCT04984876|521679619|FG001|Overall Study|Guardian decision|1|||
144679537|NCT04984876|521679620|FG002|Overall Study|Guardian decision|0|||
144679538|NCT04984876|521679621|FG003|Overall Study|Guardian decision|2|||
144679539|NCT04984876|521679622|FG004|Overall Study|Guardian decision|0|||
144679540|NCT04984876|521679623|FG005|Overall Study|Guardian decision|1|||
144679541|NCT04984876|521679618|FG000|Overall Study|Lost to Follow-up|0|||
144679542|NCT04984876|521679619|FG001|Overall Study|Lost to Follow-up|0|||
144679543|NCT04984876|521679620|FG002|Overall Study|Lost to Follow-up|1|||
144679544|NCT04984876|521679621|FG003|Overall Study|Lost to Follow-up|1|||
144679545|NCT04984876|521679622|FG004|Overall Study|Lost to Follow-up|0|||
144679546|NCT04984876|521679623|FG005|Overall Study|Lost to Follow-up|0|||
144679547|NCT04984876|521679618|FG000|Overall Study|Physician Decision|1|||
144679548|NCT04984876|521679619|FG001|Overall Study|Physician Decision|0|||
144679549|NCT04984876|521679620|FG002|Overall Study|Physician Decision|0|||
144679550|NCT04984876|521679621|FG003|Overall Study|Physician Decision|1|||
144679551|NCT04984876|521679622|FG004|Overall Study|Physician Decision|0|||
144679552|NCT04984876|521679623|FG005|Overall Study|Physician Decision|0|||
144679553|NCT04984876|521679618|FG000|Overall Study|Adverse Event|0|||
144679554|NCT04984876|521679619|FG001|Overall Study|Adverse Event|0|||
144679555|NCT04984876|521679620|FG002|Overall Study|Adverse Event|1|||
144679556|NCT04984876|521679621|FG003|Overall Study|Adverse Event|0|||
144679557|NCT04984876|521679622|FG004|Overall Study|Adverse Event|0|||
144679558|NCT04984876|521679623|FG005|Overall Study|Adverse Event|0|||
144679559|NCT02204410|521679624|FG000|Overall Study|Lost to Follow-up|5|||
144679560|NCT02204410|521679624|FG000|Overall Study|Physician Decision|2|||
144679561|NCT02204410|521679624|FG000|Overall Study|Protocol Violation|1|||
144679562|NCT02204410|521679624|FG000|Overall Study|Withdrawal by Subject|3|||
144679563|NCT00209092|521679631|FG000|Overall Study|Progression of disease|7|||
144679564|NCT00209092|521679632|FG001|Overall Study|Progression of disease|1|||
144679565|NCT00209092|521679631|FG000|Overall Study|Adverse Event|0|||
144679566|NCT00209092|521679632|FG001|Overall Study|Adverse Event|1|||
144679567|NCT00209092|521679631|FG000|Overall Study|Withdrawal by Subject|1|||
144679568|NCT00209092|521679632|FG001|Overall Study|Withdrawal by Subject|0|||
144679569|NCT01462045|521679635|FG000|Overall Study|Family matter|0|||
144679570|NCT01462045|521679636|FG001|Overall Study|Family matter|1|||
144679571|NCT01462045|521679637|FG002|Overall Study|Family matter|0|||
144679572|NCT02828644|521679638|FG000|Overall Study|Lost to Follow-up|23|||
144679573|NCT02828644|521679639|FG001|Overall Study|Lost to Follow-up|22|||
144679574|NCT02996110|521679640|FG000|Pre-Treatment|Other Reasons|0|||
144679575|NCT02996110|521679641|FG001|Pre-Treatment|Other Reasons|1|||
144679576|NCT02996110|521679642|FG002|Pre-Treatment|Other Reasons|0|||
144679577|NCT02996110|521679643|FG003|Pre-Treatment|Other Reasons|0|||
144679578|NCT02996110|521679644|FG004|Pre-Treatment|Other Reasons|1|||
144679579|NCT02996110|521679640|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
144679580|NCT02996110|521679641|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
144679581|NCT02996110|521679642|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
144679582|NCT02996110|521679643|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
144679583|NCT02996110|521679644|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
144679584|NCT02996110|521679640|FG000|Track 1|Disease Progression|15|||
144679585|NCT02996110|521679641|FG001|Track 1|Disease Progression|17|||
144679586|NCT02996110|521679642|FG002|Track 1|Disease Progression|0|||
144679587|NCT02996110|521679643|FG003|Track 1|Disease Progression|0|||
144679588|NCT02996110|521679644|FG004|Track 1|Disease Progression|0|||
144679589|NCT02996110|521679640|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
144679590|NCT02996110|521679641|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
144679591|NCT02996110|521679642|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
144679592|NCT02996110|521679643|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
144679593|NCT02996110|521679644|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
144679594|NCT02996110|521679640|FG000|Track 1|Study Drug Toxicity|5|||
144679595|NCT02996110|521679641|FG001|Track 1|Study Drug Toxicity|3|||
144679596|NCT02996110|521679642|FG002|Track 1|Study Drug Toxicity|0|||
144679597|NCT02996110|521679643|FG003|Track 1|Study Drug Toxicity|0|||
144679598|NCT02996110|521679644|FG004|Track 1|Study Drug Toxicity|0|||
144737874|NCT01686477|521894307|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
144737875|NCT01686477|521894308|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
144737876|NCT05341622|521894310|FG000|Overall Study|Death|0|||
144737877|NCT05341622|521894311|FG001|Overall Study|Death|0|||
144737878|NCT05341622|521894312|FG002|Overall Study|Death|0|||
144737879|NCT05341622|521894313|FG003|Overall Study|Death|0|||
144737880|NCT05341622|521894314|FG004|Overall Study|Death|1|||
144737881|NCT05341622|521894315|FG005|Overall Study|Death|0|||
144737882|NCT05341622|521894316|FG006|Overall Study|Death|0|||
144737883|NCT05341622|521894317|FG007|Overall Study|Death|1|||
144737884|NCT05341622|521894310|FG000|Overall Study|Invalid Address|0|||
144737885|NCT05341622|521894311|FG001|Overall Study|Invalid Address|1|||
144737886|NCT05341622|521894312|FG002|Overall Study|Invalid Address|0|||
144737887|NCT05341622|521894313|FG003|Overall Study|Invalid Address|0|||
144737888|NCT05341622|521894314|FG004|Overall Study|Invalid Address|0|||
144737889|NCT05341622|521894315|FG005|Overall Study|Invalid Address|0|||
144737890|NCT05341622|521894316|FG006|Overall Study|Invalid Address|0|||
144737891|NCT05341622|521894317|FG007|Overall Study|Invalid Address|0|||
144737892|NCT05341622|521894310|FG000|Overall Study|Ineligible|26|||
144737893|NCT05341622|521894311|FG001|Overall Study|Ineligible|21|||
144737894|NCT05341622|521894312|FG002|Overall Study|Ineligible|28|||
144737895|NCT05341622|521894313|FG003|Overall Study|Ineligible|24|||
144737896|NCT05341622|521894314|FG004|Overall Study|Ineligible|29|||
144737897|NCT05341622|521894315|FG005|Overall Study|Ineligible|31|||
144737898|NCT05341622|521894316|FG006|Overall Study|Ineligible|28|||
144737899|NCT05341622|521894317|FG007|Overall Study|Ineligible|26|||
144737900|NCT02957942|521894318|FG000|Overall Study|Withdrawal by Subject|0|||
144737901|NCT02957942|521894319|FG001|Overall Study|Withdrawal by Subject|1|||
144737902|NCT02957942|521894318|FG000|Overall Study|Practicing experiment protocol|0|||
144737903|NCT02957942|521894319|FG001|Overall Study|Practicing experiment protocol|6|||
144737904|NCT01249651|521894323|FG000|Overall Study|Withdrawal by Subject|4|||
144737905|NCT01249651|521894323|FG000|Overall Study|Adverse Event|1|||
144737906|NCT01249651|521894323|FG000|Overall Study|Protocol Violation|1|||
144737907|NCT01249651|521894323|FG000|Overall Study|Sponsor Decision|1|||
144737908|NCT03801707|521894338|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
144737909|NCT00787254|521894341|FG000|Overall Study|Adverse Event|24|||
144737910|NCT00787254|521894342|FG001|Overall Study|Adverse Event|23|||
144737911|NCT00787254|521894341|FG000|Overall Study|Protocol Violation|26|||
144737912|NCT00787254|521894342|FG001|Overall Study|Protocol Violation|23|||
144737913|NCT00787254|521894341|FG000|Overall Study|Withdrawal by Subject|16|||
144737914|NCT00787254|521894342|FG001|Overall Study|Withdrawal by Subject|11|||
144737915|NCT00787254|521894341|FG000|Overall Study|Lack of Efficacy|4|||
144737916|NCT00787254|521894342|FG001|Overall Study|Lack of Efficacy|15|||
144737917|NCT00787254|521894341|FG000|Overall Study|NSAIDs discontinuation|1|||
144737918|NCT00787254|521894342|FG001|Overall Study|NSAIDs discontinuation|2|||
144737919|NCT00787254|521894341|FG000|Overall Study|Institution closed|1|||
144737920|NCT00787254|521894342|FG001|Overall Study|Institution closed|0|||
144737921|NCT00787254|521894341|FG000|Overall Study|Physician Decision|4|||
144737922|NCT00787254|521894342|FG001|Overall Study|Physician Decision|8|||
144737923|NCT04544410|521894343|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
144737924|NCT04544410|521894344|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
144737925|NCT04544410|521894343|FG000|Double-blind Treatment Period|Adverse Event|1|||
144737926|NCT04544410|521894344|FG001|Double-blind Treatment Period|Adverse Event|0|||
144737927|NCT04544410|521894343|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
144737928|NCT04544410|521894344|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
144737929|NCT04544410|521894343|FG000|Double-blind Treatment Period|Protocol Violation|1|||
144737930|NCT04544410|521894344|FG001|Double-blind Treatment Period|Protocol Violation|0|||
144737931|NCT04544410|521894343|FG000|Open-Label Treatment Period|Study Terminated|15|||
144737932|NCT04544410|521894344|FG001|Open-Label Treatment Period|Study Terminated|19|||
144737933|NCT04544410|521894343|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
144218279|NCT00245466|519992282|FG000|Overall Study|Death|0|||
144218280|NCT00245466|519992283|FG001|Overall Study|Death|2|||
144218281|NCT00245466|519992284|FG002|Overall Study|Death|0|||
144218282|NCT00245466|519992282|FG000|Overall Study|Administrative reasons|0|||
144218283|NCT00245466|519992283|FG001|Overall Study|Administrative reasons|1|||
144218284|NCT00245466|519992284|FG002|Overall Study|Administrative reasons|0|||
144218285|NCT03885661|519992285|FG000|Overall Study|Withdrawal by Subject|0|||
144737934|NCT04544410|521894344|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
144737935|NCT04544410|521894343|FG000|Open-Label Treatment Period|Adverse Event|0|||
144737936|NCT04544410|521894344|FG001|Open-Label Treatment Period|Adverse Event|1|||
144737937|NCT04544410|521894343|FG000|Open-Label Treatment Period|Physician Decision|1|||
144737938|NCT04544410|521894344|FG001|Open-Label Treatment Period|Physician Decision|0|||
144737939|NCT04544410|521894343|FG000|Open-Label Treatment Period|Other|0|||
144218286|NCT03885661|519992286|FG001|Overall Study|Withdrawal by Subject|1|||
144218287|NCT03885661|519992285|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
144737940|NCT04544410|521894344|FG001|Open-Label Treatment Period|Other|1|||
144737941|NCT02430480|521894345|FG000|Overall Study|Death|1|||
144679599|NCT02996110|521679640|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
144679600|NCT02996110|521679641|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
144679601|NCT02996110|521679642|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
144679602|NCT02996110|521679643|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
144679603|NCT02996110|521679644|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
144679604|NCT02996110|521679640|FG000|Track 1|Administrative Reason by Sponsor|0|||
144679605|NCT02996110|521679641|FG001|Track 1|Administrative Reason by Sponsor|1|||
144679606|NCT02996110|521679642|FG002|Track 1|Administrative Reason by Sponsor|0|||
144679607|NCT02996110|521679643|FG003|Track 1|Administrative Reason by Sponsor|0|||
144679608|NCT02996110|521679644|FG004|Track 1|Administrative Reason by Sponsor|0|||
144679609|NCT02996110|521679640|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
144679610|NCT02996110|521679641|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
144679611|NCT02996110|521679642|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
144679612|NCT02996110|521679643|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
144679613|NCT02996110|521679644|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
144679614|NCT02996110|521679640|FG000|Track 2|Disease Progression|33|||
144679615|NCT02996110|521679641|FG001|Track 2|Disease Progression|26|||
144679616|NCT02996110|521679642|FG002|Track 2|Disease Progression|19|||
144679617|NCT02996110|521679643|FG003|Track 2|Disease Progression|16|||
144679618|NCT02996110|521679644|FG004|Track 2|Disease Progression|15|||
144679619|NCT02996110|521679640|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
144679620|NCT02996110|521679641|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
144679621|NCT02996110|521679642|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
144679622|NCT02996110|521679643|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
144679623|NCT02996110|521679644|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
144679624|NCT02996110|521679640|FG000|Track 2|Death|0|||
144679625|NCT02996110|521679641|FG001|Track 2|Death|0|||
144679626|NCT02996110|521679642|FG002|Track 2|Death|1|||
144679627|NCT02996110|521679643|FG003|Track 2|Death|0|||
144679628|NCT02996110|521679644|FG004|Track 2|Death|1|||
144679629|NCT02996110|521679640|FG000|Track 2|Study Drug Toxicity|4|||
144679630|NCT02996110|521679641|FG001|Track 2|Study Drug Toxicity|1|||
144679631|NCT02996110|521679642|FG002|Track 2|Study Drug Toxicity|4|||
144679632|NCT02996110|521679643|FG003|Track 2|Study Drug Toxicity|1|||
144679633|NCT02996110|521679644|FG004|Track 2|Study Drug Toxicity|0|||
144679634|NCT02996110|521679640|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
144679635|NCT02996110|521679641|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
144679636|NCT02996110|521679642|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
144679637|NCT02996110|521679643|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
144679638|NCT02996110|521679644|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
144679639|NCT02996110|521679640|FG000|Track 2|Participant Withdrew Consent|1|||
144679640|NCT02996110|521679641|FG001|Track 2|Participant Withdrew Consent|2|||
144679641|NCT02996110|521679642|FG002|Track 2|Participant Withdrew Consent|3|||
144679642|NCT02996110|521679643|FG003|Track 2|Participant Withdrew Consent|1|||
144679643|NCT02996110|521679644|FG004|Track 2|Participant Withdrew Consent|1|||
144679644|NCT02996110|521679640|FG000|Track 2|Other Reasons|0|||
144679645|NCT02996110|521679641|FG001|Track 2|Other Reasons|0|||
144679646|NCT02996110|521679642|FG002|Track 2|Other Reasons|1|||
144679647|NCT02996110|521679643|FG003|Track 2|Other Reasons|0|||
144679648|NCT02996110|521679644|FG004|Track 2|Other Reasons|1|||
144679649|NCT00524043|521679645|FG000|Overall Study|Lack of Efficacy|15|||
144679650|NCT00524043|521679646|FG001|Overall Study|Lack of Efficacy|13|||
144679651|NCT00524043|521679647|FG002|Overall Study|Lack of Efficacy|14|||
144679652|NCT00524043|521679645|FG000|Overall Study|Withdrawal by Subject|5|||
144679653|NCT00524043|521679646|FG001|Overall Study|Withdrawal by Subject|7|||
144679654|NCT00524043|521679647|FG002|Overall Study|Withdrawal by Subject|7|||
144679655|NCT00524043|521679645|FG000|Overall Study|Adverse Event|5|||
144679656|NCT00524043|521679646|FG001|Overall Study|Adverse Event|2|||
144679657|NCT00524043|521679647|FG002|Overall Study|Adverse Event|7|||
144679658|NCT00524043|521679645|FG000|Overall Study|Lost to Follow-up|3|||
144679659|NCT00524043|521679646|FG001|Overall Study|Lost to Follow-up|5|||
144679660|NCT00524043|521679647|FG002|Overall Study|Lost to Follow-up|3|||
144679661|NCT00524043|521679645|FG000|Overall Study|Various (eg, incarceration)|2|||
144679662|NCT00524043|521679646|FG001|Overall Study|Various (eg, incarceration)|1|||
144679663|NCT00524043|521679647|FG002|Overall Study|Various (eg, incarceration)|0|||
144679664|NCT01536418|521679654|FG000|Overall Study|Protocol Violation|2|||
144679665|NCT01536418|521679655|FG001|Overall Study|Protocol Violation|3|||
144679666|NCT01536418|521679654|FG000|Overall Study|Physician Decision|1|||
144679667|NCT01536418|521679655|FG001|Overall Study|Physician Decision|3|||
144679668|NCT01536418|521679654|FG000|Overall Study|Study closed/terminated|41|||
144679669|NCT01536418|521679655|FG001|Overall Study|Study closed/terminated|37|||
144679670|NCT01536418|521679654|FG000|Overall Study|Lack of Efficacy|10|||
144679671|NCT01536418|521679655|FG001|Overall Study|Lack of Efficacy|16|||
144679672|NCT01536418|521679654|FG000|Overall Study|Adverse Event|9|||
144679673|NCT01536418|521679655|FG001|Overall Study|Adverse Event|4|||
144679674|NCT01536418|521679654|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
144737942|NCT02430480|521894345|FG000|Overall Study|Anesthesia concerns|1|||
144737943|NCT02430480|521894345|FG000|Overall Study|Progressed on treatment|1|||
144737944|NCT03761173|521894346|FG000|Overall Study|Lost to Follow-up|93|||
144737945|NCT03761173|521894346|FG000|Overall Study|Withdrawal by Subject|74|||
144737946|NCT03761173|521894346|FG000|Overall Study|Death|45|||
144737947|NCT03761173|521894346|FG000|Overall Study|Withdrawal for Other Reasons|29|||
144737948|NCT03761173|521894346|FG000|Overall Study|Protocol Violation|1|||
144737949|NCT00316186|521894347|FG000|Overall Study|Adverse Event|6|||
144737950|NCT00316186|521894347|FG000|Overall Study|Disease Progression|4|||
144737951|NCT00316186|521894347|FG000|Overall Study|Lost to Follow-up|1|||
144737952|NCT00316186|521894347|FG000|Overall Study|Other|1|||
144737953|NCT04493684|521894350|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
144737954|NCT04493684|521894351|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737955|NCT04493684|521894352|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
144737956|NCT04493684|521894353|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737957|NCT04493684|521894354|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737958|NCT04493684|521894355|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
144737959|NCT04493684|521894356|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737960|NCT04493684|521894357|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737961|NCT04493684|521894358|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737962|NCT04493684|521894359|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737963|NCT04493684|521894360|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737964|NCT04493684|521894361|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737965|NCT04493684|521894362|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737966|NCT04493684|521894363|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737967|NCT04493684|521894364|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737968|NCT04493684|521894365|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737969|NCT04493684|521894366|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
144737970|NCT04493684|521894350|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
144737971|NCT04493684|521894351|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737972|NCT04493684|521894352|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737973|NCT04493684|521894353|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737974|NCT04493684|521894354|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737975|NCT04493684|521894355|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737976|NCT04493684|521894356|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737977|NCT04493684|521894357|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737978|NCT04493684|521894358|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737979|NCT04493684|521894359|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737980|NCT04493684|521894360|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737981|NCT04493684|521894361|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737982|NCT04493684|521894362|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737983|NCT04493684|521894363|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737984|NCT04493684|521894364|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737985|NCT04493684|521894365|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737986|NCT04493684|521894366|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
144737987|NCT04493684|521894350|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737988|NCT04493684|521894351|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737989|NCT04493684|521894352|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737990|NCT04493684|521894353|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737991|NCT04493684|521894354|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737992|NCT04493684|521894355|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737993|NCT04493684|521894356|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
144679675|NCT01536418|521679655|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
144679676|NCT01536418|521679654|FG000|Overall Study|Withdrawal by Subject|5|||
144679677|NCT01536418|521679655|FG001|Overall Study|Withdrawal by Subject|3|||
144679678|NCT02658149|521679660|FG000|Overall Study|Physician Decision|1|||
144679679|NCT02658149|521679661|FG001|Overall Study|Physician Decision|0|||
144679680|NCT00711412|521679664|FG000|Induction Treatment|Death|2|||
144679681|NCT00711412|521679664|FG000|Induction Treatment|Adverse Event|1|||
144679682|NCT00711412|521679664|FG000|Induction Treatment|Other|1|||
144679683|NCT00711412|521679664|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
144737994|NCT04493684|521894357|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737995|NCT04493684|521894358|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737996|NCT04493684|521894359|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737997|NCT04493684|521894360|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144679684|NCT00711412|521679664|FG000|Evaluated for Combination Treatment|Death|1|||
144679685|NCT00711412|521679664|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
144679686|NCT00711412|521679664|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
144679687|NCT00711412|521679664|FG000|Combination Treatment|Progressive Disease|1|||
144679688|NCT00711412|521679664|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
144679689|NCT00711412|521679664|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
144679690|NCT00711412|521679664|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
144679691|NCT00711412|521679664|FG000|Evaluation for Response and Surgery|Death|1|||
144679692|NCT00711412|521679664|FG000|Survival Follow up Until Death|Other|12|||
144679693|NCT04097028|521679669|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
144679694|NCT04097028|521679669|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
144679695|NCT04097028|521679669|FG000|Overall Study|Disease Progression prior to Surgery|2|||
144679696|NCT04097028|521679669|FG000|Overall Study|Adverse Event prior to Surgery|1|||
144679697|NCT03687827|521679670|FG000|Treatment Period 1|Death|0|||
144679698|NCT03687827|521679671|FG001|Treatment Period 1|Death|1|||
144679699|NCT03687827|521679670|FG000|Treatment Period 1|Lost to Follow-up|2|||
144679700|NCT03687827|521679671|FG001|Treatment Period 1|Lost to Follow-up|2|||
144679701|NCT03687827|521679670|FG000|Treatment Period 1|Physician Decision|5|||
144679702|NCT03687827|521679671|FG001|Treatment Period 1|Physician Decision|2|||
144679703|NCT03687827|521679670|FG000|Treatment Period 1|Withdrawal by Subject|7|||
144679704|NCT03687827|521679671|FG001|Treatment Period 1|Withdrawal by Subject|3|||
144679705|NCT03687827|521679670|FG000|Treatment Period 2|Physician Decision|4|||
144679706|NCT03687827|521679671|FG001|Treatment Period 2|Physician Decision|1|||
144679707|NCT03687827|521679670|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144679708|NCT03687827|521679671|FG001|Treatment Period 2|Withdrawal by Subject|2|||
144679709|NCT00911144|521679674|FG000|Overall Study|Withdrawal by Subject|16|||
144679710|NCT00911144|521679675|FG001|Overall Study|Withdrawal by Subject|5|||
144679711|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
144679712|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
144679713|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
144679714|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
144679715|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
144679716|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
144679717|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
144679718|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
144679719|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
144679720|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
144679721|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
144679722|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
144679723|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
144679724|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
144679725|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
144679726|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
144679727|NCT01291511|521679676|FG000|Cross-Titration and Stabilization Phase|Death|1|||
144679728|NCT01291511|521679677|FG001|Cross-Titration and Stabilization Phase|Death|0|||
144679729|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
144679730|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
144679731|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
144679732|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
144679733|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
144679734|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
144679735|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
144679736|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
144679737|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
144679738|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
144679739|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
144679740|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
144679741|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
144679742|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
144679743|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
144679744|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
144679745|NCT01291511|521679676|FG000|Double-blind Relapse Prevention Phase|Death|1|||
144679746|NCT01291511|521679677|FG001|Double-blind Relapse Prevention Phase|Death|0|||
144679747|NCT00047008|521679678|FG000|Overall Study|Withdrawn consent|2|||
144679748|NCT00047008|521679679|FG001|Overall Study|Withdrawn consent|3|||
144218288|NCT03885661|519992286|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
144218289|NCT05064397|519992287|FG000|Overall Study|Adverse Event|4|||
144218290|NCT05064397|519992287|FG000|Overall Study|Lack of Efficacy|12|||
144218291|NCT05064397|519992287|FG000|Overall Study|Withdrawal by Subject|3|||
144679749|NCT00047008|521679678|FG000|Overall Study|Ineligible|9|||
144679750|NCT00047008|521679679|FG001|Overall Study|Ineligible|8|||
144679751|NCT02565576|521679682|FG000|Overall Study|abnormal lab value|2|||
144679752|NCT02565576|521679683|FG001|Overall Study|abnormal lab value|0|||
144679753|NCT02565576|521679682|FG000|Overall Study|subject / guardian decision|1|||
144679754|NCT02565576|521679683|FG001|Overall Study|subject / guardian decision|3|||
144679755|NCT02565576|521679682|FG000|Overall Study|Lost to Follow-up|1|||
144679756|NCT02565576|521679683|FG001|Overall Study|Lost to Follow-up|0|||
144679757|NCT02565576|521679682|FG000|Overall Study|Death|0|||
144679758|NCT02565576|521679683|FG001|Overall Study|Death|2|||
144679759|NCT02565576|521679682|FG000|Overall Study|Adverse Event|1|||
144679760|NCT02565576|521679683|FG001|Overall Study|Adverse Event|0|||
144679761|NCT00981292|521679684|FG000|Day 1|Protocol Violation|1|||
144679762|NCT00981292|521679685|FG001|Day 1|Protocol Violation|0|||
144679763|NCT00981292|521679686|FG002|Day 1|Protocol Violation|0|||
144679764|NCT00981292|521679687|FG003|Day 1|Protocol Violation|0|||
144679765|NCT00981292|521679688|FG004|Day 1|Protocol Violation|0|||
144679766|NCT00981292|521679689|FG005|Day 1|Protocol Violation|2|||
144679767|NCT00981292|521679684|FG000|Day 2|Protocol Violation|2|||
144679768|NCT00981292|521679685|FG001|Day 2|Protocol Violation|0|||
144679769|NCT00981292|521679686|FG002|Day 2|Protocol Violation|0|||
144679770|NCT00981292|521679687|FG003|Day 2|Protocol Violation|0|||
144679771|NCT00981292|521679688|FG004|Day 2|Protocol Violation|0|||
144679772|NCT00981292|521679689|FG005|Day 2|Protocol Violation|0|||
144679773|NCT00981292|521679684|FG000|Day 3|Protocol Violation|0|||
144679774|NCT00981292|521679685|FG001|Day 3|Protocol Violation|0|||
144679775|NCT00981292|521679686|FG002|Day 3|Protocol Violation|0|||
144679776|NCT00981292|521679687|FG003|Day 3|Protocol Violation|0|||
144679777|NCT00981292|521679688|FG004|Day 3|Protocol Violation|0|||
144679778|NCT00981292|521679689|FG005|Day 3|Protocol Violation|1|||
144679779|NCT00939341|521679690|FG000|Overall Study|Adverse Event|15|||
144679780|NCT00939341|521679690|FG000|Overall Study|Pregnancy|1|||
144679781|NCT00939341|521679690|FG000|Overall Study|Lost to Follow-up|23|||
144679782|NCT00939341|521679690|FG000|Overall Study|Withdrawal by Subject|13|||
144679783|NCT00939341|521679690|FG000|Overall Study|Protocol Violation|6|||
144679784|NCT00939341|521679690|FG000|Overall Study|Incorrect enrolment|8|||
144679785|NCT02437162|521679692|FG000|Overall Study|Protocol Violation|0|||
144679786|NCT02437162|521679693|FG001|Overall Study|Protocol Violation|1|||
144679787|NCT02437162|521679694|FG002|Overall Study|Protocol Violation|0|||
144679788|NCT02437162|521679692|FG000|Overall Study|Randomized but not treated|0|||
144679789|NCT02437162|521679693|FG001|Overall Study|Randomized but not treated|0|||
144679790|NCT02437162|521679694|FG002|Overall Study|Randomized but not treated|1|||
144679791|NCT02437162|521679692|FG000|Overall Study|Study discontinued by Sponsor|93|||
144679792|NCT02437162|521679693|FG001|Overall Study|Study discontinued by Sponsor|98|||
144679793|NCT02437162|521679694|FG002|Overall Study|Study discontinued by Sponsor|97|||
144679794|NCT02437162|521679692|FG000|Overall Study|Withdrawal by Subject|13|||
144679795|NCT02437162|521679693|FG001|Overall Study|Withdrawal by Subject|7|||
144679796|NCT02437162|521679694|FG002|Overall Study|Withdrawal by Subject|9|||
144679797|NCT02437162|521679692|FG000|Overall Study|Adverse Event|0|||
144679798|NCT02437162|521679693|FG001|Overall Study|Adverse Event|1|||
144679799|NCT02437162|521679694|FG002|Overall Study|Adverse Event|0|||
144679800|NCT02437162|521679692|FG000|Overall Study|Lost to Follow-up|1|||
144679801|NCT02437162|521679693|FG001|Overall Study|Lost to Follow-up|0|||
144679802|NCT02437162|521679694|FG002|Overall Study|Lost to Follow-up|1|||
144679803|NCT02437162|521679692|FG000|Overall Study|Death|0|||
144679804|NCT02437162|521679693|FG001|Overall Study|Death|1|||
144679805|NCT02437162|521679694|FG002|Overall Study|Death|0|||
144679806|NCT02437162|521679692|FG000|Overall Study|Other|0|||
144679807|NCT02437162|521679693|FG001|Overall Study|Other|0|||
144679808|NCT02437162|521679694|FG002|Overall Study|Other|1|||
144679809|NCT03412565|521679699|FG000|Overall Study|Lost to Follow-up|0|||
144679810|NCT03412565|521679700|FG001|Overall Study|Lost to Follow-up|0|||
144679811|NCT03412565|521679701|FG002|Overall Study|Lost to Follow-up|1|||
144679812|NCT03412565|521679702|FG003|Overall Study|Lost to Follow-up|0|||
144679813|NCT03412565|521679699|FG000|Overall Study|Physician Decision|0|||
144679814|NCT03412565|521679700|FG001|Overall Study|Physician Decision|0|||
144679815|NCT03412565|521679701|FG002|Overall Study|Physician Decision|0|||
144679816|NCT03412565|521679702|FG003|Overall Study|Physician Decision|1|||
144679817|NCT03412565|521679699|FG000|Overall Study|Withdrawal by Subject|0|||
144679818|NCT03412565|521679700|FG001|Overall Study|Withdrawal by Subject|4|||
144679819|NCT03412565|521679701|FG002|Overall Study|Withdrawal by Subject|5|||
144679820|NCT03412565|521679702|FG003|Overall Study|Withdrawal by Subject|5|||
144679821|NCT03412565|521679699|FG000|Overall Study|Death|1|||
144679822|NCT03412565|521679700|FG001|Overall Study|Death|3|||
144679823|NCT03412565|521679701|FG002|Overall Study|Death|4|||
144679824|NCT03412565|521679702|FG003|Overall Study|Death|5|||
144679825|NCT03412565|521679699|FG000|Overall Study|Data collection ended|0|||
144679826|NCT03412565|521679700|FG001|Overall Study|Data collection ended|41|||
144679827|NCT03412565|521679701|FG002|Overall Study|Data collection ended|41|||
144679828|NCT03412565|521679702|FG003|Overall Study|Data collection ended|40|||
144679829|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
144679830|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
144218292|NCT05064397|519992287|FG000|Overall Study|Lost to Follow-up|1|||
144218293|NCT05064397|519992287|FG000|Overall Study|Other reasons|3|||
144679831|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
144679832|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
144679833|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
144679834|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
144679835|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
144679836|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
144679837|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
144679838|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
144679839|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
144679840|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
144679841|NCT03321526|521679703|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
144679842|NCT03321526|521679704|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
144679843|NCT03321526|521679703|FG000|Follow-up Phase (2 Weeks)|Other|24|||
144679844|NCT03321526|521679704|FG001|Follow-up Phase (2 Weeks)|Other|24|||
144679845|NCT00246376|521679708|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
144679846|NCT00246376|521679709|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
144679847|NCT00246376|521679710|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
144679848|NCT00246376|521679711|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
144679849|NCT00246376|521679712|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
144679850|NCT00246376|521679708|FG000|Overall Study|Adverse Event|2|||
144679851|NCT00246376|521679709|FG001|Overall Study|Adverse Event|3|||
144679852|NCT00246376|521679710|FG002|Overall Study|Adverse Event|1|||
144679853|NCT00246376|521679711|FG003|Overall Study|Adverse Event|3|||
144679854|NCT00246376|521679712|FG004|Overall Study|Adverse Event|1|||
144679855|NCT00246376|521679708|FG000|Overall Study|Lost to Follow-up|2|||
144679856|NCT00246376|521679709|FG001|Overall Study|Lost to Follow-up|11|||
144679857|NCT00246376|521679710|FG002|Overall Study|Lost to Follow-up|11|||
144679858|NCT00246376|521679711|FG003|Overall Study|Lost to Follow-up|16|||
144679859|NCT00246376|521679712|FG004|Overall Study|Lost to Follow-up|13|||
144679860|NCT04599972|521679715|FG000|Overall Study|Withdrawal by Subject|6|||
144679861|NCT04599972|521679716|FG001|Overall Study|Withdrawal by Subject|1|||
144679862|NCT04599972|521679715|FG000|Overall Study|Adverse Event|1|||
144679863|NCT04599972|521679716|FG001|Overall Study|Adverse Event|1|||
144679864|NCT04599972|521679715|FG000|Overall Study|Lost to Follow-up|1|||
144679865|NCT04599972|521679716|FG001|Overall Study|Lost to Follow-up|6|||
144679866|NCT04599972|521679715|FG000|Overall Study|Protocol Violation|1|||
144679867|NCT04599972|521679716|FG001|Overall Study|Protocol Violation|0|||
144679868|NCT04599972|521679715|FG000|Overall Study|Other reason|1|||
144679869|NCT04599972|521679716|FG001|Overall Study|Other reason|0|||
144679870|NCT00638690|521679717|FG000|Overall Study|Death|655|||
144679871|NCT00638690|521679718|FG001|Overall Study|Death|335|||
144679872|NCT00638690|521679717|FG000|Overall Study|Withdrawal by Subject|22|||
144679873|NCT00638690|521679718|FG001|Overall Study|Withdrawal by Subject|5|||
144679874|NCT00638690|521679717|FG000|Overall Study|Lost to Follow-up|4|||
144679875|NCT00638690|521679718|FG001|Overall Study|Lost to Follow-up|2|||
144679876|NCT02348840|521679719|FG000|Overall Study|Withdrawal by Subject|2|||
144679877|NCT02348840|521679720|FG001|Overall Study|Withdrawal by Subject|1|||
144679878|NCT02348840|521679721|FG002|Overall Study|Withdrawal by Subject|0|||
144679879|NCT02348840|521679722|FG003|Overall Study|Withdrawal by Subject|0|||
144679880|NCT00373880|521679723|FG000|Overall Study|Physician Decision|3|||
144679881|NCT00373880|521679723|FG000|Overall Study|Arrested|1|||
144679882|NCT00373880|521679723|FG000|Overall Study|Protocol Violation|14|||
144679883|NCT01347073|521679724|FG000|Overall Study|Adverse Event|1|||
144679884|NCT01347073|521679724|FG000|Overall Study|Liver Transplant|1|||
144679885|NCT00621244|521679725|FG000|Overall Study|Withdrawal by Subject|7|||
144679886|NCT00621244|521679726|FG001|Overall Study|Withdrawal by Subject|3|||
144679887|NCT00621244|521679727|FG002|Overall Study|Withdrawal by Subject|3|||
144679888|NCT00621244|521679728|FG003|Overall Study|Withdrawal by Subject|3|||
144679889|NCT00621244|521679725|FG000|Overall Study|Disease progression|44|||
144218294|NCT02232984|519992288|FG000|Overall Study|Withdrawal by Subject|5|||
144679890|NCT00621244|521679726|FG001|Overall Study|Disease progression|20|||
144679891|NCT00621244|521679727|FG002|Overall Study|Disease progression|20|||
144679892|NCT00621244|521679728|FG003|Overall Study|Disease progression|15|||
144679893|NCT00621244|521679725|FG000|Overall Study|Death|3|||
144679894|NCT00621244|521679726|FG001|Overall Study|Death|3|||
144679895|NCT00621244|521679727|FG002|Overall Study|Death|1|||
144679896|NCT00621244|521679728|FG003|Overall Study|Death|1|||
144679897|NCT00621244|521679725|FG000|Overall Study|Adverse Event|27|||
144679898|NCT00621244|521679726|FG001|Overall Study|Adverse Event|7|||
144679899|NCT00621244|521679727|FG002|Overall Study|Adverse Event|9|||
144679900|NCT00621244|521679728|FG003|Overall Study|Adverse Event|2|||
144218295|NCT02232984|519992288|FG000|Overall Study|Death|1|||
144679901|NCT00621244|521679725|FG000|Overall Study|Administrative problems|5|||
144679902|NCT00621244|521679726|FG001|Overall Study|Administrative problems|1|||
144679903|NCT00621244|521679727|FG002|Overall Study|Administrative problems|0|||
144679904|NCT00621244|521679728|FG003|Overall Study|Administrative problems|2|||
144679905|NCT02865928|521679729|FG000|Overall Study|Withdrawal by Subject|1|||
144679906|NCT02865928|521679730|FG001|Overall Study|Withdrawal by Subject|0|||
144679907|NCT02865928|521679729|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
144679908|NCT02865928|521679730|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
144679909|NCT02865928|521679729|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
144679910|NCT02865928|521679730|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
144679911|NCT01925014|521679731|FG000|Overall Study|Inappropriate enrollment|4|||
144679912|NCT01925014|521679732|FG001|Overall Study|Inappropriate enrollment|6|||
144679913|NCT01925014|521679731|FG000|Overall Study|Withdrawal by Subject|5|||
144679914|NCT01925014|521679732|FG001|Overall Study|Withdrawal by Subject|13|||
144679915|NCT01690988|521679735|FG000|Overall Study|Withdrawal by Subject|2|||
144679916|NCT01690988|521679736|FG001|Overall Study|Withdrawal by Subject|2|||
144679917|NCT01690988|521679737|FG002|Overall Study|Withdrawal by Subject|3|||
144679918|NCT01690988|521679735|FG000|Overall Study|Physician Decision|0|||
144679919|NCT01690988|521679736|FG001|Overall Study|Physician Decision|0|||
144679920|NCT01690988|521679737|FG002|Overall Study|Physician Decision|1|||
144679921|NCT01690988|521679735|FG000|Overall Study|Operation Cancelled|1|||
144679922|NCT01690988|521679736|FG001|Overall Study|Operation Cancelled|1|||
144679923|NCT01690988|521679737|FG002|Overall Study|Operation Cancelled|0|||
144679924|NCT01690988|521679735|FG000|Overall Study|Determined ineligible|1|||
144679925|NCT01690988|521679736|FG001|Overall Study|Determined ineligible|0|||
144679926|NCT01690988|521679737|FG002|Overall Study|Determined ineligible|0|||
144679927|NCT01690988|521679735|FG000|Overall Study|Death|1|||
144679928|NCT01690988|521679736|FG001|Overall Study|Death|1|||
144679929|NCT01690988|521679737|FG002|Overall Study|Death|1|||
144679930|NCT01690988|521679735|FG000|Overall Study|Sedated|1|||
144679931|NCT01690988|521679736|FG001|Overall Study|Sedated|1|||
144679932|NCT01690988|521679737|FG002|Overall Study|Sedated|2|||
144679933|NCT00312728|521679745|FG000|Overall Study|Progressive disease|53|||
144679934|NCT00312728|521679745|FG000|Overall Study|Adverse Event|32|||
144679935|NCT00312728|521679745|FG000|Overall Study|Withdrawal by Subject|10|||
144679936|NCT00312728|521679745|FG000|Overall Study|Required non-protocol cancer treatment|2|||
144679937|NCT00312728|521679745|FG000|Overall Study|Protocol Violation|2|||
144679938|NCT00312728|521679745|FG000|Overall Study|Other|10|||
144679939|NCT00312728|521679745|FG000|Overall Study|Other|1|||
144679940|NCT03696576|521679746|FG000|Overall Study|Soreness of throat after therapy|1|||
144679941|NCT03696576|521679747|FG001|Overall Study|Soreness of throat after therapy|1|||
144737998|NCT04493684|521894361|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144737999|NCT04493684|521894362|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144738000|NCT04493684|521894363|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144738001|NCT04493684|521894364|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144738002|NCT04493684|521894365|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144738003|NCT04493684|521894366|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
144738004|NCT04493684|521894350|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
144738005|NCT04493684|521894351|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738006|NCT04493684|521894352|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738007|NCT04493684|521894353|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738008|NCT04493684|521894354|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738009|NCT04493684|521894355|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738010|NCT04493684|521894356|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738011|NCT04493684|521894357|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738012|NCT04493684|521894358|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738013|NCT04493684|521894359|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738014|NCT04493684|521894360|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738015|NCT04493684|521894361|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738016|NCT04493684|521894362|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738017|NCT04493684|521894363|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738018|NCT04493684|521894364|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738019|NCT04493684|521894365|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144218296|NCT02232984|519992288|FG000|Overall Study|Investigator withdrawal|10|||
144679942|NCT03696576|521679746|FG000|Overall Study|Lost to Follow-up|2|||
144679943|NCT03696576|521679747|FG001|Overall Study|Lost to Follow-up|4|||
144679944|NCT00179517|521679753|FG000|Overall Study|Withdrawal by Subject|2|||
144679945|NCT00179517|521679754|FG001|Overall Study|Withdrawal by Subject|1|||
144679946|NCT00023712|521679755|FG000|Overall Study|Not platinum sensitive|1|||
144679947|NCT00023712|521679756|FG001|Overall Study|Not platinum sensitive|0|||
144679948|NCT00023712|521679755|FG000|Overall Study|Never treated|1|||
144679949|NCT00023712|521679756|FG001|Overall Study|Never treated|1|||
144679950|NCT02963766|521679763|FG000|Double-Blind Period|Adverse Event|1|||
144679951|NCT02963766|521679764|FG001|Double-Blind Period|Adverse Event|0|||
144679952|NCT02963766|521679765|FG002|Double-Blind Period|Adverse Event|1|||
144679953|NCT02963766|521679763|FG000|Double-Blind Period|Physician Decision|1|||
144679954|NCT02963766|521679764|FG001|Double-Blind Period|Physician Decision|0|||
144679955|NCT02963766|521679765|FG002|Double-Blind Period|Physician Decision|0|||
144679956|NCT02963766|521679763|FG000|Double-Blind Period|Withdrawal by Subject|1|||
144679957|NCT02963766|521679764|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144679958|NCT02963766|521679765|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144679959|NCT02963766|521679763|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
144679960|NCT02963766|521679764|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
144679961|NCT02963766|521679765|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
144679962|NCT02963766|521679763|FG000|Double-Blind Period|Protocol Violation|1|||
144679963|NCT02963766|521679764|FG001|Double-Blind Period|Protocol Violation|0|||
144679964|NCT02963766|521679765|FG002|Double-Blind Period|Protocol Violation|0|||
144679965|NCT02963766|521679763|FG000|Double-Blind Period|Lost to Follow-up|0|||
144679966|NCT02963766|521679764|FG001|Double-Blind Period|Lost to Follow-up|1|||
144679967|NCT02963766|521679765|FG002|Double-Blind Period|Lost to Follow-up|0|||
144679968|NCT02963766|521679763|FG000|Open Label Extension (OLE)|Physician Decision|1|||
144679969|NCT02963766|521679764|FG001|Open Label Extension (OLE)|Physician Decision|2|||
144679970|NCT02963766|521679765|FG002|Open Label Extension (OLE)|Physician Decision|2|||
144679971|NCT02963766|521679763|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
144679972|NCT02963766|521679764|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
144679973|NCT02963766|521679765|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
144679974|NCT00499460|521679769|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
144679975|NCT00499460|521679770|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
144679976|NCT00499460|521679769|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
144679977|NCT00499460|521679770|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
144679978|NCT00499460|521679769|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
144679979|NCT00499460|521679770|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
144679980|NCT03209362|521679772|FG000|Overall Study|Adverse Event|0|||
144679981|NCT03209362|521679773|FG001|Overall Study|Adverse Event|1|||
144679982|NCT03209362|521679772|FG000|Overall Study|Lost to Follow-up|0|||
144679983|NCT03209362|521679773|FG001|Overall Study|Lost to Follow-up|1|||
144679984|NCT03209362|521679772|FG000|Overall Study|Withdrawal by Subject|2|||
144679985|NCT03209362|521679773|FG001|Overall Study|Withdrawal by Subject|0|||
144679986|NCT03209362|521679772|FG000|Overall Study|Other|0|||
144679987|NCT03209362|521679773|FG001|Overall Study|Other|1|||
144679988|NCT00251589|521679774|FG000|Overall Study|Adverse Event|5|||
144679989|NCT00251589|521679775|FG001|Overall Study|Adverse Event|1|||
144679990|NCT00251589|521679776|FG002|Overall Study|Adverse Event|2|||
144679991|NCT00251589|521679777|FG003|Overall Study|Adverse Event|1|||
144679992|NCT00251589|521679774|FG000|Overall Study|Withdrawal by Subject|1|||
144679993|NCT00251589|521679775|FG001|Overall Study|Withdrawal by Subject|1|||
144679994|NCT00251589|521679776|FG002|Overall Study|Withdrawal by Subject|0|||
144679995|NCT00251589|521679777|FG003|Overall Study|Withdrawal by Subject|0|||
144679996|NCT00251589|521679774|FG000|Overall Study|Discontinued due to progressive disease|9|||
144679997|NCT00251589|521679775|FG001|Overall Study|Discontinued due to progressive disease|1|||
144679998|NCT00251589|521679776|FG002|Overall Study|Discontinued due to progressive disease|0|||
144679999|NCT00251589|521679777|FG003|Overall Study|Discontinued due to progressive disease|1|||
144680000|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Adverse Event|22|||
144680001|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Adverse Event|0|||
144680002|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
144680003|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
144680004|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
144680005|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
144680006|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
144680007|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
144680008|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
144680009|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
144680010|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
144680011|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
144680012|NCT02493868|521679780|FG000|Induction Phase: DE Participants|Other|8|||
144680013|NCT02493868|521679781|FG001|Induction Phase: DE Participants|Other|0|||
144680014|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
144680015|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
144680016|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
144680017|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
144680018|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
144680019|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
144680020|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
144738020|NCT04493684|521894366|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
144738021|NCT04493684|521894350|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738022|NCT04493684|521894351|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738023|NCT04493684|521894352|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738024|NCT04493684|521894353|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738025|NCT04493684|521894354|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738026|NCT04493684|521894355|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
144738027|NCT04493684|521894356|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738028|NCT04493684|521894357|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738029|NCT04493684|521894358|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738030|NCT04493684|521894359|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738031|NCT04493684|521894360|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738032|NCT04493684|521894361|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738033|NCT04493684|521894362|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738034|NCT04493684|521894363|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738035|NCT04493684|521894364|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738036|NCT04493684|521894365|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738037|NCT04493684|521894366|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
144738038|NCT04493684|521894350|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738039|NCT04493684|521894351|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738040|NCT04493684|521894352|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738041|NCT04493684|521894353|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738042|NCT04493684|521894354|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738043|NCT04493684|521894355|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738044|NCT04493684|521894356|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738045|NCT04493684|521894357|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738046|NCT04493684|521894358|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738047|NCT04493684|521894359|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738048|NCT04493684|521894360|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738049|NCT04493684|521894361|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
144738050|NCT04493684|521894362|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738051|NCT04493684|521894363|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738052|NCT04493684|521894364|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738053|NCT04493684|521894365|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738054|NCT04493684|521894366|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
144738055|NCT04493684|521894350|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738056|NCT04493684|521894351|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738057|NCT04493684|521894352|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738058|NCT04493684|521894353|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738059|NCT04493684|521894354|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738060|NCT04493684|521894355|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738061|NCT04493684|521894356|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738062|NCT04493684|521894357|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738063|NCT04493684|521894358|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738064|NCT04493684|521894359|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738065|NCT04493684|521894360|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738066|NCT04493684|521894361|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738067|NCT04493684|521894362|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738068|NCT04493684|521894363|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738069|NCT04493684|521894364|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738070|NCT04493684|521894365|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
144738071|NCT04493684|521894366|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
144738072|NCT04493684|521894350|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738073|NCT04493684|521894351|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738074|NCT04493684|521894352|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738075|NCT04493684|521894353|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738076|NCT04493684|521894354|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738077|NCT04493684|521894355|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738078|NCT04493684|521894356|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738079|NCT04493684|521894357|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738080|NCT04493684|521894358|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738081|NCT04493684|521894359|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144680021|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
144680022|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
144680023|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
144680024|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
144680025|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
144680026|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
144680027|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
144680028|NCT02493868|521679780|FG000|Optimization Phase: DE+TE Participants|Other|10|||
144680029|NCT02493868|521679781|FG001|Optimization Phase: DE+TE Participants|Other|2|||
144680030|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
144680031|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
144680032|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
144680033|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
144680034|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
144680035|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
144680036|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
144680037|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
144680038|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
144680039|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
144680040|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
144680041|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
144680042|NCT02493868|521679780|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
144680043|NCT02493868|521679781|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
144680044|NCT02493868|521679780|FG000|Follow-up Phase|Lost to Follow-up|1|||
144680045|NCT02493868|521679781|FG001|Follow-up Phase|Lost to Follow-up|0|||
144680046|NCT02493868|521679780|FG000|Follow-up Phase|Withdrawal by Subject|3|||
144680047|NCT02493868|521679781|FG001|Follow-up Phase|Withdrawal by Subject|0|||
144680048|NCT02493868|521679780|FG000|Follow-up Phase|Investigator Decision|5|||
144680049|NCT02493868|521679781|FG001|Follow-up Phase|Investigator Decision|1|||
144680050|NCT02493868|521679780|FG000|Follow-up Phase|Other|2|||
144680051|NCT02493868|521679781|FG001|Follow-up Phase|Other|1|||
144680052|NCT02407236|521679782|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
144680053|NCT02407236|521679783|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
144680054|NCT02407236|521679784|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
144680055|NCT02407236|521679785|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
144680056|NCT02407236|521679786|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
144680057|NCT02407236|521679787|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
144680058|NCT02407236|521679788|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
144680059|NCT02407236|521679789|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
144680060|NCT02407236|521679790|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
144680061|NCT02407236|521679791|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
144680062|NCT02407236|521679792|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
144680063|NCT02407236|521679793|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
144680064|NCT02407236|521679794|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
144680065|NCT02407236|521679782|FG000|Induction Study (8 Weeks)|Death|0|||
144680066|NCT02407236|521679783|FG001|Induction Study (8 Weeks)|Death|0|||
144680067|NCT02407236|521679784|FG002|Induction Study (8 Weeks)|Death|1|||
144680068|NCT02407236|521679785|FG003|Induction Study (8 Weeks)|Death|0|||
144680069|NCT02407236|521679786|FG004|Induction Study (8 Weeks)|Death|0|||
144680070|NCT02407236|521679787|FG005|Induction Study (8 Weeks)|Death|0|||
144680071|NCT02407236|521679788|FG006|Induction Study (8 Weeks)|Death|0|||
144680072|NCT02407236|521679789|FG007|Induction Study (8 Weeks)|Death|0|||
144680073|NCT02407236|521679790|FG008|Induction Study (8 Weeks)|Death|0|||
144680074|NCT02407236|521679791|FG009|Induction Study (8 Weeks)|Death|0|||
144680075|NCT02407236|521679792|FG010|Induction Study (8 Weeks)|Death|0|||
144680076|NCT02407236|521679793|FG011|Induction Study (8 Weeks)|Death|0|||
144680077|NCT02407236|521679794|FG012|Induction Study (8 Weeks)|Death|0|||
144680078|NCT02407236|521679782|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
144680079|NCT02407236|521679783|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
144680080|NCT02407236|521679784|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
144680081|NCT02407236|521679785|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680082|NCT02407236|521679786|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680083|NCT02407236|521679787|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680084|NCT02407236|521679788|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144218297|NCT02232984|519992288|FG000|Overall Study|Device implant unsuccessful|53|||
144680085|NCT02407236|521679789|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680086|NCT02407236|521679790|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680087|NCT02407236|521679791|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680088|NCT02407236|521679792|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680089|NCT02407236|521679793|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144218298|NCT02232984|519992288|FG000|Overall Study|not disclosed by site|7|||
144680090|NCT02407236|521679794|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
144680091|NCT02407236|521679782|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680092|NCT02407236|521679783|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680093|NCT02407236|521679784|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
144680094|NCT02407236|521679785|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680095|NCT02407236|521679786|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680096|NCT02407236|521679787|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680097|NCT02407236|521679788|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680098|NCT02407236|521679789|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680099|NCT02407236|521679790|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680100|NCT02407236|521679791|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680101|NCT02407236|521679792|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680102|NCT02407236|521679793|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680103|NCT02407236|521679794|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
144680104|NCT02407236|521679782|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
144680105|NCT02407236|521679783|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
144680106|NCT02407236|521679784|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
144680107|NCT02407236|521679785|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
144680108|NCT02407236|521679786|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
144680109|NCT02407236|521679787|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
144680110|NCT02407236|521679788|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
144680111|NCT02407236|521679789|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
144680112|NCT02407236|521679790|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
144680113|NCT02407236|521679791|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
144680114|NCT02407236|521679792|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
144680115|NCT02407236|521679793|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
144680116|NCT02407236|521679794|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
144680117|NCT02407236|521679782|FG000|Induction Study (8 Weeks)|Other|2|||
144680118|NCT02407236|521679783|FG001|Induction Study (8 Weeks)|Other|1|||
144680119|NCT02407236|521679784|FG002|Induction Study (8 Weeks)|Other|5|||
144680120|NCT02407236|521679785|FG003|Induction Study (8 Weeks)|Other|0|||
144680121|NCT02407236|521679786|FG004|Induction Study (8 Weeks)|Other|0|||
144680122|NCT02407236|521679787|FG005|Induction Study (8 Weeks)|Other|0|||
144680123|NCT02407236|521679788|FG006|Induction Study (8 Weeks)|Other|0|||
144680124|NCT02407236|521679789|FG007|Induction Study (8 Weeks)|Other|0|||
144680125|NCT02407236|521679790|FG008|Induction Study (8 Weeks)|Other|0|||
144680126|NCT02407236|521679791|FG009|Induction Study (8 Weeks)|Other|0|||
144680127|NCT02407236|521679792|FG010|Induction Study (8 Weeks)|Other|0|||
144680128|NCT02407236|521679793|FG011|Induction Study (8 Weeks)|Other|0|||
144680129|NCT02407236|521679794|FG012|Induction Study (8 Weeks)|Other|0|||
144680130|NCT02407236|521679782|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680131|NCT02407236|521679783|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680132|NCT02407236|521679784|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680133|NCT02407236|521679785|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
144680134|NCT02407236|521679786|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
144680135|NCT02407236|521679787|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
144680136|NCT02407236|521679788|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
144680137|NCT02407236|521679789|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
144680138|NCT02407236|521679790|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680139|NCT02407236|521679791|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680140|NCT02407236|521679792|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680141|NCT02407236|521679793|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680142|NCT02407236|521679794|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
144680143|NCT02407236|521679782|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680144|NCT02407236|521679783|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680145|NCT02407236|521679784|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680146|NCT02407236|521679785|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
144680147|NCT02407236|521679786|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
144680148|NCT02407236|521679787|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
144680149|NCT02407236|521679788|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
144680150|NCT02407236|521679789|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
144680151|NCT02407236|521679790|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680152|NCT02407236|521679791|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680153|NCT02407236|521679792|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680154|NCT02407236|521679793|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680155|NCT02407236|521679794|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
144680156|NCT02407236|521679782|FG000|Maintenance Study (44 Weeks)|Other|0|||
144680157|NCT02407236|521679783|FG001|Maintenance Study (44 Weeks)|Other|0|||
144738082|NCT04493684|521894360|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738083|NCT04493684|521894361|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144680158|NCT02407236|521679784|FG002|Maintenance Study (44 Weeks)|Other|0|||
144680159|NCT02407236|521679785|FG003|Maintenance Study (44 Weeks)|Other|5|||
144680160|NCT02407236|521679786|FG004|Maintenance Study (44 Weeks)|Other|7|||
144680161|NCT02407236|521679787|FG005|Maintenance Study (44 Weeks)|Other|8|||
144680162|NCT02407236|521679788|FG006|Maintenance Study (44 Weeks)|Other|4|||
144680163|NCT02407236|521679789|FG007|Maintenance Study (44 Weeks)|Other|6|||
144680164|NCT02407236|521679790|FG008|Maintenance Study (44 Weeks)|Other|0|||
144680165|NCT02407236|521679791|FG009|Maintenance Study (44 Weeks)|Other|0|||
144680166|NCT02407236|521679792|FG010|Maintenance Study (44 Weeks)|Other|0|||
144680167|NCT02407236|521679793|FG011|Maintenance Study (44 Weeks)|Other|0|||
144680168|NCT02407236|521679794|FG012|Maintenance Study (44 Weeks)|Other|0|||
144680169|NCT02407236|521679782|FG000|Maintenance Study (44 Weeks)|Death|0|||
144680170|NCT02407236|521679783|FG001|Maintenance Study (44 Weeks)|Death|0|||
144680171|NCT02407236|521679784|FG002|Maintenance Study (44 Weeks)|Death|0|||
144680172|NCT02407236|521679785|FG003|Maintenance Study (44 Weeks)|Death|0|||
144680173|NCT02407236|521679786|FG004|Maintenance Study (44 Weeks)|Death|0|||
144680174|NCT02407236|521679787|FG005|Maintenance Study (44 Weeks)|Death|0|||
144680175|NCT02407236|521679788|FG006|Maintenance Study (44 Weeks)|Death|0|||
144680176|NCT02407236|521679789|FG007|Maintenance Study (44 Weeks)|Death|1|||
144680177|NCT02407236|521679790|FG008|Maintenance Study (44 Weeks)|Death|0|||
144680178|NCT02407236|521679791|FG009|Maintenance Study (44 Weeks)|Death|0|||
144680179|NCT02407236|521679792|FG010|Maintenance Study (44 Weeks)|Death|0|||
144680180|NCT02407236|521679793|FG011|Maintenance Study (44 Weeks)|Death|0|||
144680181|NCT02407236|521679794|FG012|Maintenance Study (44 Weeks)|Death|0|||
144680182|NCT02407236|521679782|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680183|NCT02407236|521679783|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680184|NCT02407236|521679784|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680185|NCT02407236|521679785|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680186|NCT02407236|521679786|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680187|NCT02407236|521679787|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680188|NCT02407236|521679788|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680189|NCT02407236|521679789|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
144680190|NCT02407236|521679790|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
144680191|NCT02407236|521679791|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
144680192|NCT02407236|521679792|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
144680193|NCT02407236|521679793|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
144680194|NCT02407236|521679794|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
144680195|NCT02407236|521679782|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680196|NCT02407236|521679783|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680197|NCT02407236|521679784|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680198|NCT02407236|521679785|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680199|NCT02407236|521679786|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680200|NCT02407236|521679787|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680201|NCT02407236|521679788|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680202|NCT02407236|521679789|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680203|NCT02407236|521679790|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680204|NCT02407236|521679791|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680205|NCT02407236|521679792|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
144680206|NCT02407236|521679793|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680207|NCT02407236|521679794|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
144680208|NCT02407236|521679782|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680209|NCT02407236|521679783|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680210|NCT02407236|521679784|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680211|NCT02407236|521679785|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680212|NCT02407236|521679786|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680213|NCT02407236|521679787|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680214|NCT02407236|521679788|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680215|NCT02407236|521679789|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
144680216|NCT02407236|521679790|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
144680217|NCT02407236|521679791|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
144680218|NCT02407236|521679792|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
144680219|NCT02407236|521679793|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
144680220|NCT02407236|521679794|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
144680221|NCT02407236|521679782|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
144680222|NCT02407236|521679783|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
144680223|NCT02407236|521679784|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
144680224|NCT02407236|521679785|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
144680225|NCT02407236|521679786|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
144680226|NCT02407236|521679787|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
144680227|NCT02407236|521679788|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
144680228|NCT02407236|521679789|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
144738084|NCT04493684|521894362|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738085|NCT04493684|521894363|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738086|NCT04493684|521894364|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738087|NCT04493684|521894365|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
144738088|NCT04493684|521894366|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
144738089|NCT01963728|521894367|FG000|Overall Study|Study terminated early|0|||
144738090|NCT01963728|521894368|FG001|Overall Study|Study terminated early|1|||
144738091|NCT00594035|521895851|FG000|Overall Study|Lost to Follow-up|1|||
144738092|NCT00594035|521895852|FG001|Overall Study|Lost to Follow-up|1|||
144738093|NCT00594035|521895851|FG000|Overall Study|Withdrawal by Subject|1|||
144738094|NCT00594035|521895852|FG001|Overall Study|Withdrawal by Subject|0|||
144738095|NCT00594035|521895851|FG000|Overall Study|Subject transferred to nursing home|0|||
144738096|NCT00594035|521895852|FG001|Overall Study|Subject transferred to nursing home|1|||
144680229|NCT02407236|521679790|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
144680230|NCT02407236|521679791|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
144680231|NCT02407236|521679792|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
144680232|NCT02407236|521679793|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
144680233|NCT02407236|521679794|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
144680234|NCT01627782|521679799|FG000|Overall Study|Adverse Event|1|||
144680235|NCT01627782|521679800|FG001|Overall Study|Adverse Event|2|||
144680236|NCT01627782|521679801|FG002|Overall Study|Adverse Event|0|||
144680237|NCT01627782|521679802|FG003|Overall Study|Adverse Event|1|||
144680238|NCT01627782|521679799|FG000|Overall Study|Lack of Efficacy|11|||
144680239|NCT01627782|521679800|FG001|Overall Study|Lack of Efficacy|1|||
144680240|NCT01627782|521679801|FG002|Overall Study|Lack of Efficacy|15|||
144680241|NCT01627782|521679802|FG003|Overall Study|Lack of Efficacy|2|||
144680242|NCT01627782|521679799|FG000|Overall Study|Protocol Violation|1|||
144680243|NCT01627782|521679800|FG001|Overall Study|Protocol Violation|0|||
144680244|NCT01627782|521679801|FG002|Overall Study|Protocol Violation|0|||
144680245|NCT01627782|521679802|FG003|Overall Study|Protocol Violation|0|||
144680246|NCT01627782|521679799|FG000|Overall Study|Withdrawal by Subject|2|||
144680247|NCT01627782|521679800|FG001|Overall Study|Withdrawal by Subject|1|||
144680248|NCT01627782|521679801|FG002|Overall Study|Withdrawal by Subject|0|||
144680249|NCT01627782|521679802|FG003|Overall Study|Withdrawal by Subject|0|||
144680250|NCT01627782|521679799|FG000|Overall Study|Other|0|||
144680251|NCT01627782|521679800|FG001|Overall Study|Other|2|||
144680252|NCT01627782|521679801|FG002|Overall Study|Other|0|||
144680253|NCT01627782|521679802|FG003|Overall Study|Other|3|||
144680254|NCT01627782|521679799|FG000|Overall Study|Randomized But Not Treated|1|||
144680255|NCT01627782|521679800|FG001|Overall Study|Randomized But Not Treated|0|||
144680256|NCT01627782|521679801|FG002|Overall Study|Randomized But Not Treated|0|||
144680257|NCT01627782|521679802|FG003|Overall Study|Randomized But Not Treated|0|||
144680258|NCT00643448|521679803|FG000|Overall Study|Lack of Efficacy|2|||
144680259|NCT00643448|521679804|FG001|Overall Study|Lack of Efficacy|0|||
144680260|NCT00643448|521679805|FG002|Overall Study|Lack of Efficacy|4|||
144680261|NCT00643448|521679803|FG000|Overall Study|Adverse Event|2|||
144680262|NCT00643448|521679804|FG001|Overall Study|Adverse Event|2|||
144680263|NCT00643448|521679805|FG002|Overall Study|Adverse Event|2|||
144680264|NCT00643448|521679803|FG000|Overall Study|QTcF>550 ms|0|||
144680265|NCT00643448|521679804|FG001|Overall Study|QTcF>550 ms|3|||
144680266|NCT00643448|521679805|FG002|Overall Study|QTcF>550 ms|0|||
144680267|NCT02177812|521679809|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
144680268|NCT02177812|521679810|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
144680269|NCT02177812|521679811|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
144680270|NCT02177812|521679812|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
144738097|NCT00594035|521895851|FG000|Overall Study|Subject couldn't return due to job|0|||
144218299|NCT02232984|519992288|FG000|Overall Study|Protocol Violation|1|||
144680271|NCT02177812|521679813|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
144680272|NCT02177812|521679814|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
144680273|NCT02177812|521679815|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
144738098|NCT00594035|521895852|FG001|Overall Study|Subject couldn't return due to job|1|||
144738099|NCT00795821|521895853|FG000|Acute Treatment Phase|Adverse Event|23|||
144738100|NCT00795821|521895854|FG001|Acute Treatment Phase|Adverse Event|4|||
144738101|NCT00795821|521895853|FG000|Acute Treatment Phase|Death|1|||
144738102|NCT00795821|521895854|FG001|Acute Treatment Phase|Death|0|||
144738103|NCT00795821|521895853|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
144218300|NCT00769379|519992291|FG000|Overall Study|No follow up data mapped to Other.|3|||
144680274|NCT02177812|521679816|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
144680275|NCT02177812|521679817|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
144680276|NCT02177812|521679809|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680277|NCT02177812|521679810|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680278|NCT02177812|521679811|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680279|NCT02177812|521679812|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680280|NCT02177812|521679813|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680281|NCT02177812|521679814|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
144738104|NCT00795821|521895854|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
144738105|NCT00795821|521895853|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
144738106|NCT00795821|521895854|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
144738107|NCT00795821|521895853|FG000|Acute Treatment Phase|Physician Decision|1|||
144738108|NCT00795821|521895854|FG001|Acute Treatment Phase|Physician Decision|1|||
144738109|NCT00795821|521895853|FG000|Acute Treatment Phase|Protocol Violation|1|||
144738110|NCT00795821|521895854|FG001|Acute Treatment Phase|Protocol Violation|2|||
144738111|NCT00795821|521895853|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
144738112|NCT00795821|521895854|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
144738113|NCT00795821|521895853|FG000|Long-term Extension Phase|Adverse Event|25|||
144738114|NCT00795821|521895854|FG001|Long-term Extension Phase|Adverse Event|32|||
144738115|NCT00795821|521895853|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
144738116|NCT00795821|521895854|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
144738117|NCT00795821|521895853|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
144738118|NCT00795821|521895854|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
144738119|NCT00795821|521895853|FG000|Long-term Extension Phase|Physician Decision|1|||
144738120|NCT00795821|521895854|FG001|Long-term Extension Phase|Physician Decision|2|||
144738121|NCT00795821|521895853|FG000|Long-term Extension Phase|Protocol Violation|3|||
144738122|NCT00795821|521895854|FG001|Long-term Extension Phase|Protocol Violation|5|||
144738123|NCT00795821|521895853|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
144738124|NCT00795821|521895854|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
144738125|NCT00795821|521895853|FG000|Taper Phase|Adverse Event|2|||
144738126|NCT00795821|521895854|FG001|Taper Phase|Adverse Event|0|||
144738127|NCT00795821|521895853|FG000|Taper Phase|Lost to Follow-up|1|||
144738128|NCT00795821|521895854|FG001|Taper Phase|Lost to Follow-up|0|||
144738129|NCT00795821|521895853|FG000|Taper Phase|Physician Decision|2|||
144738130|NCT00795821|521895854|FG001|Taper Phase|Physician Decision|0|||
144738131|NCT00795821|521895853|FG000|Taper Phase|Withdrawal by Subject|4|||
144738132|NCT00795821|521895854|FG001|Taper Phase|Withdrawal by Subject|0|||
144738133|NCT00712959|521895861|FG000|Overall Study|Protocol Violation|3|||
144738134|NCT00712959|521895862|FG001|Overall Study|Protocol Violation|1|||
144738135|NCT00712959|521895861|FG000|Overall Study|Lost to Follow-up|13|||
144738136|NCT00712959|521895862|FG001|Overall Study|Lost to Follow-up|2|||
144738137|NCT00712959|521895861|FG000|Overall Study|Withdrawal by Subject|3|||
144738138|NCT00712959|521895862|FG001|Overall Study|Withdrawal by Subject|0|||
144738139|NCT02255149|521895865|FG000|Overall Study|Lost to Follow-up|2|||
144738140|NCT02255149|521895865|FG000|Overall Study|Withdrawal by Subject|1|||
144738141|NCT02255149|521895865|FG000|Overall Study|Withdrawal by PI|1|||
144738142|NCT02255149|521895865|FG000|Overall Study|Implant Failure|1|||
144738143|NCT02328040|521895867|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
144738144|NCT02328040|521895868|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
144738145|NCT02301975|521895873|FG000|Overall Study|Adverse Event|8|||
144738146|NCT02301975|521895874|FG001|Overall Study|Adverse Event|3|||
144680282|NCT02177812|521679815|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
144680283|NCT02177812|521679816|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680284|NCT02177812|521679817|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
144680285|NCT02177812|521679809|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
144680286|NCT02177812|521679810|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
144680287|NCT02177812|521679811|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
144680288|NCT02177812|521679812|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
144680289|NCT02177812|521679813|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
144680290|NCT02177812|521679814|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
144680291|NCT02177812|521679815|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
144680292|NCT02177812|521679816|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
144680293|NCT02177812|521679817|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
144680294|NCT00089999|521679818|FG000|Overall Study|Adverse Event|4|||
144738147|NCT02301975|521895875|FG002|Overall Study|Adverse Event|2|||
144738148|NCT02301975|521895873|FG000|Overall Study|Lack of Efficacy|1|||
144738149|NCT02301975|521895874|FG001|Overall Study|Lack of Efficacy|1|||
144738150|NCT02301975|521895875|FG002|Overall Study|Lack of Efficacy|1|||
144680295|NCT00089999|521679819|FG001|Overall Study|Adverse Event|7|||
144680296|NCT00089999|521679818|FG000|Overall Study|Withdrawal by Subject|0|||
144738151|NCT02301975|521895873|FG000|Overall Study|Protocol Violation|3|||
144738152|NCT02301975|521895874|FG001|Overall Study|Protocol Violation|5|||
144738153|NCT02301975|521895875|FG002|Overall Study|Protocol Violation|3|||
144738154|NCT02301975|521895873|FG000|Overall Study|Lost to Follow-up|0|||
144738155|NCT02301975|521895874|FG001|Overall Study|Lost to Follow-up|2|||
144738156|NCT02301975|521895875|FG002|Overall Study|Lost to Follow-up|2|||
144738157|NCT02301975|521895873|FG000|Overall Study|Physician Decision|4|||
144738158|NCT02301975|521895874|FG001|Overall Study|Physician Decision|2|||
144738159|NCT02301975|521895875|FG002|Overall Study|Physician Decision|3|||
144738160|NCT02301975|521895873|FG000|Overall Study|Withdrawal by Subject|15|||
144680297|NCT00089999|521679819|FG001|Overall Study|Withdrawal by Subject|4|||
144680298|NCT00089999|521679818|FG000|Overall Study|Lost to Follow-up|2|||
144680299|NCT00089999|521679819|FG001|Overall Study|Lost to Follow-up|1|||
144738161|NCT02301975|521895874|FG001|Overall Study|Withdrawal by Subject|12|||
144738162|NCT02301975|521895875|FG002|Overall Study|Withdrawal by Subject|11|||
144680300|NCT00089999|521679818|FG000|Overall Study|Radiological Progression of Cancer|52|||
144680301|NCT00089999|521679819|FG001|Overall Study|Radiological Progression of Cancer|44|||
144680302|NCT00089999|521679818|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
144680303|NCT00089999|521679819|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
144680304|NCT00089999|521679818|FG000|Overall Study|Death|3|||
144680305|NCT00089999|521679819|FG001|Overall Study|Death|3|||
144680306|NCT00089999|521679818|FG000|Overall Study|Poor General Condition|1|||
144680307|NCT00089999|521679819|FG001|Overall Study|Poor General Condition|0|||
144680308|NCT00089999|521679818|FG000|Overall Study|Clinical Progression|1|||
144680309|NCT00089999|521679819|FG001|Overall Study|Clinical Progression|2|||
144680310|NCT00089999|521679818|FG000|Overall Study|Physician Decision|2|||
144680311|NCT00089999|521679819|FG001|Overall Study|Physician Decision|2|||
144680312|NCT00089999|521679818|FG000|Overall Study|Patient Underwent Surgery|2|||
144680313|NCT00089999|521679819|FG001|Overall Study|Patient Underwent Surgery|0|||
144680314|NCT00089999|521679818|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
144680315|NCT00089999|521679819|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
144680316|NCT03039569|521679821|FG000|Overall Study|Lost to Follow-up|5|||
144680317|NCT03039569|521679822|FG001|Overall Study|Lost to Follow-up|4|||
144680318|NCT01167153|521679825|FG000|Overall Study|Non-effective therapy|1|||
144680319|NCT01167153|521679826|FG001|Overall Study|Non-effective therapy|4|||
144680320|NCT01167153|521679825|FG000|Overall Study|AE including clinical laboratory AE|2|||
144680321|NCT01167153|521679826|FG001|Overall Study|AE including clinical laboratory AE|8|||
144680322|NCT01167153|521679825|FG000|Overall Study|Hypotension|1|||
144680323|NCT01167153|521679826|FG001|Overall Study|Hypotension|0|||
144680324|NCT01167153|521679825|FG000|Overall Study|Lost to Follow-up|7|||
144680325|NCT01167153|521679826|FG001|Overall Study|Lost to Follow-up|9|||
144680326|NCT01167153|521679825|FG000|Overall Study|Non-compliance to concomitant medication|0|||
144680327|NCT01167153|521679826|FG001|Overall Study|Non-compliance to concomitant medication|2|||
144680328|NCT01167153|521679825|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
144680329|NCT01167153|521679826|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
144680330|NCT01167153|521679825|FG000|Overall Study|Withdrawal consent|1|||
144680331|NCT01167153|521679826|FG001|Overall Study|Withdrawal consent|1|||
144680332|NCT01167153|521679825|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
144680333|NCT01167153|521679826|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
144680334|NCT03695471|521681803|FG000|Overall Study|Cancellation|1|||
144680335|NCT02859558|521681804|FG000|Step 1|Not Eligible|0|||
144680336|NCT02859558|521681805|FG001|Step 1|Not Eligible|0|||
144680337|NCT02859558|521681806|FG002|Step 1|Not Eligible|0|||
144680338|NCT02859558|521681807|FG003|Step 1|Not Eligible|0|||
144680339|NCT02859558|521681808|FG004|Step 1|Not Eligible|3|||
144680340|NCT02859558|521681804|FG000|Step 1|Lost to Follow-up|1|||
144680341|NCT02859558|521681805|FG001|Step 1|Lost to Follow-up|3|||
144680342|NCT02859558|521681806|FG002|Step 1|Lost to Follow-up|3|||
144680343|NCT02859558|521681807|FG003|Step 1|Lost to Follow-up|0|||
144680344|NCT02859558|521681808|FG004|Step 1|Lost to Follow-up|0|||
144680345|NCT02859558|521681804|FG000|Step 1|Did Not Return to Clinic|2|||
144680346|NCT02859558|521681805|FG001|Step 1|Did Not Return to Clinic|3|||
144680347|NCT02859558|521681806|FG002|Step 1|Did Not Return to Clinic|4|||
144680348|NCT02859558|521681807|FG003|Step 1|Did Not Return to Clinic|0|||
144680349|NCT02859558|521681808|FG004|Step 1|Did Not Return to Clinic|0|||
144680350|NCT02859558|521681804|FG000|Step 1|Moved|0|||
144680351|NCT02859558|521681805|FG001|Step 1|Moved|1|||
144680352|NCT02859558|521681806|FG002|Step 1|Moved|1|||
144680353|NCT02859558|521681807|FG003|Step 1|Moved|0|||
144680354|NCT02859558|521681808|FG004|Step 1|Moved|0|||
144680355|NCT02859558|521681804|FG000|Step 1|Withdrawal By Participant|1|||
144680356|NCT02859558|521681805|FG001|Step 1|Withdrawal By Participant|2|||
144680357|NCT02859558|521681806|FG002|Step 1|Withdrawal By Participant|1|||
144680358|NCT02859558|521681807|FG003|Step 1|Withdrawal By Participant|0|||
144680359|NCT02859558|521681808|FG004|Step 1|Withdrawal By Participant|0|||
144680360|NCT02859558|521681804|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
144680361|NCT02859558|521681805|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
144680362|NCT02859558|521681806|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
144738163|NCT04278560|521895877|FG000|Overall Study|Adverse Event|1|||
144680363|NCT02859558|521681807|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
144680364|NCT02859558|521681808|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
144680365|NCT02859558|521681804|FG000|Step 1|Incarceration|0|||
144680366|NCT02859558|521681805|FG001|Step 1|Incarceration|1|||
144680367|NCT02859558|521681806|FG002|Step 1|Incarceration|0|||
144680368|NCT02859558|521681807|FG003|Step 1|Incarceration|0|||
144680369|NCT02859558|521681808|FG004|Step 1|Incarceration|0|||
144680370|NCT02859558|521681804|FG000|Step 1|Non-Adherence to Study Drug|2|||
144680371|NCT02859558|521681805|FG001|Step 1|Non-Adherence to Study Drug|0|||
144680372|NCT02859558|521681806|FG002|Step 1|Non-Adherence to Study Drug|1|||
144680373|NCT02859558|521681807|FG003|Step 1|Non-Adherence to Study Drug|0|||
144680374|NCT02859558|521681808|FG004|Step 1|Non-Adherence to Study Drug|0|||
144680375|NCT02859558|521681804|FG000|Step 1|Non-Adherence to Study Requirements|3|||
144680376|NCT02859558|521681805|FG001|Step 1|Non-Adherence to Study Requirements|1|||
144738164|NCT04278560|521895878|FG001|Overall Study|Adverse Event|2|||
144680377|NCT02859558|521681806|FG002|Step 1|Non-Adherence to Study Requirements|0|||
144680378|NCT02859558|521681807|FG003|Step 1|Non-Adherence to Study Requirements|0|||
144680379|NCT02859558|521681808|FG004|Step 1|Non-Adherence to Study Requirements|0|||
144680380|NCT02859558|521681804|FG000|Step 1|Virologic Failure|2|||
144680381|NCT02859558|521681805|FG001|Step 1|Virologic Failure|1|||
144680382|NCT02859558|521681806|FG002|Step 1|Virologic Failure|1|||
144680383|NCT02859558|521681807|FG003|Step 1|Virologic Failure|0|||
144680384|NCT02859558|521681808|FG004|Step 1|Virologic Failure|0|||
144680385|NCT02859558|521681804|FG000|Step 2|Lost to Follow-up|3|||
144680386|NCT02859558|521681805|FG001|Step 2|Lost to Follow-up|3|||
144680387|NCT02859558|521681806|FG002|Step 2|Lost to Follow-up|1|||
144680388|NCT02859558|521681807|FG003|Step 2|Lost to Follow-up|0|||
144680389|NCT02859558|521681808|FG004|Step 2|Lost to Follow-up|0|||
144680390|NCT02859558|521681804|FG000|Step 2|Withdrawal by Subject|0|||
144680391|NCT02859558|521681805|FG001|Step 2|Withdrawal by Subject|1|||
144680392|NCT02859558|521681806|FG002|Step 2|Withdrawal by Subject|1|||
144680393|NCT02859558|521681807|FG003|Step 2|Withdrawal by Subject|0|||
144680394|NCT02859558|521681808|FG004|Step 2|Withdrawal by Subject|0|||
144680395|NCT02859558|521681804|FG000|Step 2|Unexpected Closure of Site|0|||
144680396|NCT02859558|521681805|FG001|Step 2|Unexpected Closure of Site|1|||
144680397|NCT02859558|521681806|FG002|Step 2|Unexpected Closure of Site|1|||
144680398|NCT02859558|521681807|FG003|Step 2|Unexpected Closure of Site|0|||
144680399|NCT02859558|521681808|FG004|Step 2|Unexpected Closure of Site|0|||
144680400|NCT02859558|521681804|FG000|Step 2|Death|1|||
144680401|NCT02859558|521681805|FG001|Step 2|Death|0|||
144680402|NCT02859558|521681806|FG002|Step 2|Death|0|||
144680403|NCT02859558|521681807|FG003|Step 2|Death|0|||
144680404|NCT02859558|521681808|FG004|Step 2|Death|0|||
144680405|NCT02859558|521681804|FG000|Step 2|Incarceration|0|||
144680406|NCT02859558|521681805|FG001|Step 2|Incarceration|0|||
144680407|NCT02859558|521681806|FG002|Step 2|Incarceration|1|||
144680408|NCT02859558|521681807|FG003|Step 2|Incarceration|0|||
144680409|NCT02859558|521681808|FG004|Step 2|Incarceration|0|||
144680410|NCT01998906|521681809|FG000|Overall Study|Participants ongoing in follow-up|77|||
144680411|NCT01998906|521681810|FG001|Overall Study|Participants ongoing in follow-up|60|||
144680412|NCT01998906|521681811|FG002|Overall Study|Participants ongoing in follow-up|58|||
144680413|NCT01998906|521681809|FG000|Overall Study|Death|21|||
144680414|NCT01998906|521681810|FG001|Overall Study|Death|30|||
144738165|NCT04278560|521895877|FG000|Overall Study|Withdrawal by Subject|0|||
144738166|NCT04278560|521895878|FG001|Overall Study|Withdrawal by Subject|1|||
144738167|NCT00163657|521895879|FG000|Overall Study|Death|12|||
144738168|NCT00163657|521895880|FG001|Overall Study|Death|14|||
144738169|NCT00163657|521895881|FG002|Overall Study|Death|19|||
144738170|NCT00163657|521895879|FG000|Overall Study|graft loss|4|||
144738171|NCT00163657|521895880|FG001|Overall Study|graft loss|1|||
144738172|NCT00163657|521895881|FG002|Overall Study|graft loss|2|||
144738173|NCT00163657|521895879|FG000|Overall Study|Withdrawal by Subject|2|||
144738174|NCT00163657|521895880|FG001|Overall Study|Withdrawal by Subject|3|||
144738175|NCT00163657|521895881|FG002|Overall Study|Withdrawal by Subject|2|||
144738176|NCT00163657|521895879|FG000|Overall Study|Physician Decision|0|||
144738177|NCT00163657|521895880|FG001|Overall Study|Physician Decision|1|||
144738178|NCT00163657|521895881|FG002|Overall Study|Physician Decision|1|||
144738179|NCT00163657|521895879|FG000|Overall Study|Non Compliance|1|||
144738180|NCT00163657|521895880|FG001|Overall Study|Non Compliance|0|||
144738181|NCT00163657|521895881|FG002|Overall Study|Non Compliance|0|||
144738182|NCT00163657|521895879|FG000|Overall Study|Lost to Follow-up|1|||
144738183|NCT00163657|521895880|FG001|Overall Study|Lost to Follow-up|3|||
144738184|NCT00163657|521895881|FG002|Overall Study|Lost to Follow-up|10|||
144738185|NCT00163657|521895879|FG000|Overall Study|Other reason|0|||
144738186|NCT00163657|521895880|FG001|Overall Study|Other reason|1|||
144738187|NCT00163657|521895881|FG002|Overall Study|Other reason|3|||
144680415|NCT01998906|521681811|FG002|Overall Study|Death|17|||
144680416|NCT01998906|521681809|FG000|Overall Study|Lack of Efficacy|10|||
144680417|NCT01998906|521681810|FG001|Overall Study|Lack of Efficacy|9|||
144680418|NCT01998906|521681811|FG002|Overall Study|Lack of Efficacy|8|||
144680419|NCT01998906|521681809|FG000|Overall Study|Failure to return|0|||
144680420|NCT01998906|521681810|FG001|Overall Study|Failure to return|2|||
144738188|NCT01319383|521895882|FG000|Overall Study|No ex vivo or in vivo response|4|||
144680421|NCT01998906|521681811|FG002|Overall Study|Failure to return|4|||
144680422|NCT01998906|521681809|FG000|Overall Study|Violation of Selection Criteria|0|||
144680423|NCT01998906|521681810|FG001|Overall Study|Violation of Selection Criteria|0|||
144680424|NCT01998906|521681811|FG002|Overall Study|Violation of Selection Criteria|1|||
144680425|NCT01998906|521681809|FG000|Overall Study|Withdrawal by Subject|1|||
144680426|NCT01998906|521681810|FG001|Overall Study|Withdrawal by Subject|4|||
144680427|NCT01998906|521681811|FG002|Overall Study|Withdrawal by Subject|3|||
144738189|NCT01319383|521895883|FG001|Overall Study|No ex vivo or in vivo response|0|||
144680428|NCT01998906|521681809|FG000|Overall Study|Administrative/Other|2|||
144680429|NCT01998906|521681810|FG001|Overall Study|Administrative/Other|1|||
144680430|NCT01998906|521681811|FG002|Overall Study|Administrative/Other|3|||
144680431|NCT01998906|521681809|FG000|Overall Study|Other|3|||
144738190|NCT01319383|521895882|FG000|Overall Study|Physician Decision|3|||
144738191|NCT01319383|521895883|FG001|Overall Study|Physician Decision|0|||
144738192|NCT01319383|521895882|FG000|Overall Study|Lack of Efficacy|5|||
144738193|NCT01319383|521895883|FG001|Overall Study|Lack of Efficacy|9|||
144738194|NCT01319383|521895882|FG000|Overall Study|No in vivo response to interval doses|0|||
144738195|NCT01319383|521895883|FG001|Overall Study|No in vivo response to interval doses|1|||
144738196|NCT03600805|521895896|FG000|Overall Study|Adverse Event|2|||
144738197|NCT03600805|521895897|FG001|Overall Study|Adverse Event|1|||
144738198|NCT03600805|521895898|FG002|Overall Study|Adverse Event|1|||
144738199|NCT03600805|521895899|FG003|Overall Study|Adverse Event|7|||
144738200|NCT03600805|521895896|FG000|Overall Study|Lack of Efficacy|2|||
144738201|NCT03600805|521895897|FG001|Overall Study|Lack of Efficacy|1|||
144738202|NCT03600805|521895898|FG002|Overall Study|Lack of Efficacy|0|||
144738203|NCT03600805|521895899|FG003|Overall Study|Lack of Efficacy|0|||
144738204|NCT03600805|521895896|FG000|Overall Study|Withdrawal by Subject|1|||
144738205|NCT03600805|521895897|FG001|Overall Study|Withdrawal by Subject|0|||
144738206|NCT03600805|521895898|FG002|Overall Study|Withdrawal by Subject|0|||
144738207|NCT03600805|521895899|FG003|Overall Study|Withdrawal by Subject|1|||
144738208|NCT03600805|521895896|FG000|Overall Study|Other unspecified|14|||
144738209|NCT03600805|521895897|FG001|Overall Study|Other unspecified|6|||
144738210|NCT03600805|521895898|FG002|Overall Study|Other unspecified|7|||
144738211|NCT03600805|521895899|FG003|Overall Study|Other unspecified|11|||
144738212|NCT06195579|521895900|FG000|Overall Study|Withdrawal by Subject|1|||
144738213|NCT03123094|521895902|FG000|Overall Study|Withdrawal by Subject|0|||
144738214|NCT03123094|521895903|FG001|Overall Study|Withdrawal by Subject|2|||
144738215|NCT03123094|521895904|FG002|Overall Study|Withdrawal by Subject|1|||
144738216|NCT03123094|521895905|FG003|Overall Study|Withdrawal by Subject|0|||
144738217|NCT03123094|521895906|FG004|Overall Study|Withdrawal by Subject|1|||
144738218|NCT01735994|521895907|FG000|Overall Study|Withdrawal by Subject|6|||
144738219|NCT01735994|521895908|FG001|Overall Study|Withdrawal by Subject|4|||
144738220|NCT01735994|521895907|FG000|Overall Study|Injury|2|||
144738221|NCT01735994|521895908|FG001|Overall Study|Injury|0|||
144738222|NCT01735994|521895907|FG000|Overall Study|Kicked off team|5|||
144738223|NCT01735994|521895908|FG001|Overall Study|Kicked off team|0|||
144738224|NCT01735994|521895907|FG000|Overall Study|Lost to Follow-up|50|||
144738225|NCT01735994|521895908|FG001|Overall Study|Lost to Follow-up|62|||
144738226|NCT02682238|521895913|FG000|Overall Study|Lost to Follow-up|0|||
144738227|NCT02682238|521895914|FG001|Overall Study|Lost to Follow-up|2|||
144738228|NCT02682238|521895913|FG000|Overall Study|Withdrawal by Subject|1|||
144738229|NCT02682238|521895914|FG001|Overall Study|Withdrawal by Subject|0|||
144738230|NCT02682238|521895913|FG000|Overall Study|Adverse Event|1|||
144738231|NCT02682238|521895914|FG001|Overall Study|Adverse Event|0|||
144738232|NCT02682238|521895913|FG000|Overall Study|Non-compliance with Study Drug|1|||
144738233|NCT02682238|521895914|FG001|Overall Study|Non-compliance with Study Drug|0|||
144738234|NCT02682238|521895913|FG000|Overall Study|Non-compliance with Protocol|0|||
144738235|NCT02682238|521895914|FG001|Overall Study|Non-compliance with Protocol|2|||
144738236|NCT01370317|521895915|FG000|Overall Study|Participant withdrew consent|1|||
144738237|NCT01370317|521895916|FG001|Overall Study|Participant withdrew consent|0|||
144738238|NCT01370317|521895915|FG000|Overall Study|Protocol deviation|0|||
144738239|NCT01370317|521895916|FG001|Overall Study|Protocol deviation|1|||
144738240|NCT03128723|521895917|FG000|Overall Study|Withdrawal by Subject|2|||
144738241|NCT02909907|521895919|FG000|Overall Study|Withdrawal by Subject|0|||
144738242|NCT02909907|521895920|FG001|Overall Study|Withdrawal by Subject|1|||
144738243|NCT00075478|521895921|FG000|Overall Study|not eligible|1|||
144738244|NCT00075478|521895922|FG001|Overall Study|not eligible|0|||
144738245|NCT00075478|521895921|FG000|Overall Study|Physician Decision|0|||
144738246|NCT00075478|521895922|FG001|Overall Study|Physician Decision|1|||
144738247|NCT02075463|521895926|FG000|Overall Study|Adverse Event|3|||
144738248|NCT02075463|521895926|FG000|Overall Study|Par. reached stopping criteria|4|||
144738249|NCT02075463|521895926|FG000|Overall Study|Withdrawal by Subject|1|||
144738250|NCT00392665|521895927|FG000|Overall Study|Death|16|||
144738251|NCT00392665|521895928|FG001|Overall Study|Death|14|||
144738252|NCT00392665|521895927|FG000|Overall Study|Lost to Follow-up|1|||
144738253|NCT00392665|521895928|FG001|Overall Study|Lost to Follow-up|1|||
144738254|NCT02294786|521895935|FG000|Overall Study|Withdrawal by Subject|0|||
144738255|NCT02294786|521895936|FG001|Overall Study|Withdrawal by Subject|1|||
144738256|NCT02294786|521895935|FG000|Overall Study|Physician Decision|6|||
144738257|NCT02294786|521895936|FG001|Overall Study|Physician Decision|7|||
144738258|NCT02294786|521895935|FG000|Overall Study|Lost to Follow-up|1|||
144738259|NCT02294786|521895936|FG001|Overall Study|Lost to Follow-up|2|||
144738260|NCT02294786|521895935|FG000|Overall Study|Protocol Violation|1|||
144738261|NCT02294786|521895936|FG001|Overall Study|Protocol Violation|0|||
144738262|NCT02294786|521895935|FG000|Overall Study|Adverse Event|1|||
144738263|NCT02294786|521895936|FG001|Overall Study|Adverse Event|1|||
144738264|NCT02294786|521895935|FG000|Overall Study|Death|2|||
144738265|NCT02294786|521895936|FG001|Overall Study|Death|3|||
144738266|NCT01778010|521895937|FG000|Overall Study|Withdrawal by Subject|2|||
144738267|NCT01778010|521895937|FG000|Overall Study|abnormal ECG before meds|1|||
144738268|NCT01778010|521895937|FG000|Overall Study|Arrested|1|||
144738269|NCT01778010|521895937|FG000|Overall Study|rash while on placebo|1|||
144738270|NCT02558491|521895945|FG000|First Invention|Withdrawal by Subject|3|||
144738271|NCT02558491|521895946|FG001|First Invention|Withdrawal by Subject|1|||
144738272|NCT02558491|521895945|FG000|First Invention|Data collection issues|1|||
144738273|NCT02558491|521895946|FG001|First Invention|Data collection issues|0|||
144738274|NCT02558491|521895945|FG000|First Invention|Stopping criteria|0|||
144738275|NCT02558491|521895946|FG001|First Invention|Stopping criteria|1|||
144738276|NCT02558491|521895945|FG000|First Invention|Changed parameters during trial|1|||
144738277|NCT02558491|521895946|FG001|First Invention|Changed parameters during trial|0|||
144738278|NCT02558491|521895945|FG000|Second Intervention|Withdrawal by Subject|1|||
144738279|NCT02558491|521895946|FG001|Second Intervention|Withdrawal by Subject|0|||
144738280|NCT02558491|521895945|FG000|Second Intervention|Stopping Criteria|1|||
144738281|NCT02558491|521895946|FG001|Second Intervention|Stopping Criteria|0|||
144738282|NCT00834431|521895947|FG000|First Intervention|Adverse Event|0|||
144738283|NCT00834431|521895948|FG001|First Intervention|Adverse Event|1|||
144738284|NCT00834431|521895947|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
144738285|NCT00834431|521895948|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
144738286|NCT03637764|521895949|FG000|Overall Study|Adverse Event|2|||
144738287|NCT03637764|521895950|FG001|Overall Study|Adverse Event|0|||
144738288|NCT03637764|521895951|FG002|Overall Study|Adverse Event|0|||
144738289|NCT03637764|521895952|FG003|Overall Study|Adverse Event|1|||
144738290|NCT03637764|521895949|FG000|Overall Study|Progressive Disease|23|||
144738291|NCT03637764|521895950|FG001|Overall Study|Progressive Disease|23|||
144738292|NCT03637764|521895951|FG002|Overall Study|Progressive Disease|18|||
144738293|NCT03637764|521895952|FG003|Overall Study|Progressive Disease|31|||
144738294|NCT03637764|521895949|FG000|Overall Study|Withdrawal by Subject|1|||
144738295|NCT03637764|521895950|FG001|Overall Study|Withdrawal by Subject|3|||
144738296|NCT03637764|521895951|FG002|Overall Study|Withdrawal by Subject|0|||
144738297|NCT03637764|521895952|FG003|Overall Study|Withdrawal by Subject|1|||
144680432|NCT01998906|521681810|FG001|Overall Study|Other|8|||
144680433|NCT01998906|521681811|FG002|Overall Study|Other|4|||
144680434|NCT01572844|521681812|FG000|Overall Study|Physician Decision|1|||
144680435|NCT01572844|521681813|FG001|Overall Study|Physician Decision|1|||
144680436|NCT01938391|521681816|FG000|6 Month Follow up|Withdrawal by Subject|1|||
144680437|NCT01938391|521681816|FG000|12 Month Follow up|Physician Decision|1|||
144680438|NCT01938391|521681816|FG000|12 Month Follow up|Withdrawal by Subject|1|||
144680439|NCT01077193|521681817|FG000|Overall Study|Lost to Follow-up|1|||
144680440|NCT01077193|521681817|FG000|Overall Study|Withdrawal by Subject|2|||
144680441|NCT01077193|521681817|FG000|Overall Study|Lack of Efficacy|1|||
144680442|NCT01077193|521681817|FG000|Overall Study|Study Terminated by Sponsor|40|||
144738298|NCT00835263|521895953|FG000|Second Intervention|Adverse Event|1|||
144738299|NCT00835263|521895954|FG001|Second Intervention|Adverse Event|0|||
144738300|NCT03987191|521895955|FG000|Overall Study|COVID-19 related research disruption|0|||
144738301|NCT03987191|521895956|FG001|Overall Study|COVID-19 related research disruption|2|||
144738302|NCT01020474|521895957|FG000|Overall Study|Adverse Event|4|||
144738303|NCT01020474|521895958|FG001|Overall Study|Adverse Event|4|||
144738304|NCT01020474|521895957|FG000|Overall Study|Protocol Violation|0|||
144738305|NCT01020474|521895958|FG001|Overall Study|Protocol Violation|2|||
144738306|NCT01020474|521895957|FG000|Overall Study|Withdrawal by Subject|5|||
144738307|NCT01020474|521895958|FG001|Overall Study|Withdrawal by Subject|7|||
144738308|NCT01020474|521895957|FG000|Overall Study|Other Reasons|1|||
144738309|NCT01020474|521895958|FG001|Overall Study|Other Reasons|1|||
144738310|NCT01020474|521895957|FG000|Overall Study|Insufficient Clinical Response|0|||
144738311|NCT01020474|521895958|FG001|Overall Study|Insufficient Clinical Response|3|||
144738312|NCT03406156|521895959|FG000|Overall Study|Death|9|||
144738313|NCT03406156|521895960|FG001|Overall Study|Death|3|||
144738314|NCT03406156|521895959|FG000|Overall Study|Withdrawal by Subject|1|||
144738315|NCT03406156|521895960|FG001|Overall Study|Withdrawal by Subject|2|||
144738316|NCT03406156|521895959|FG000|Overall Study|COVID-19 infection|1|||
144680443|NCT02234050|521681836|FG000|Overall Study|Lack of Efficacy|38|||
144680444|NCT02234050|521681837|FG001|Overall Study|Lack of Efficacy|22|||
144680445|NCT02234050|521681836|FG000|Overall Study|Adverse Event|13|||
144680446|NCT02234050|521681837|FG001|Overall Study|Adverse Event|1|||
144738317|NCT03406156|521895960|FG001|Overall Study|COVID-19 infection|0|||
144738318|NCT03406156|521895959|FG000|Overall Study|Non-compliance with study procedures|1|||
144738319|NCT03406156|521895960|FG001|Overall Study|Non-compliance with study procedures|1|||
144738320|NCT03406156|521895959|FG000|Overall Study|Lost to Follow-up|0|||
144738321|NCT03406156|521895960|FG001|Overall Study|Lost to Follow-up|2|||
144680447|NCT02234050|521681836|FG000|Overall Study|Withdrawal by Subject|4|||
144738322|NCT03406156|521895959|FG000|Overall Study|Other, not specified|72|||
144680448|NCT02234050|521681837|FG001|Overall Study|Withdrawal by Subject|2|||
144680449|NCT02234050|521681836|FG000|Overall Study|Sponsor's decision|6|||
144680450|NCT02234050|521681837|FG001|Overall Study|Sponsor's decision|0|||
144680451|NCT01680991|521681839|FG000|Overall Study|Adverse Event|1|||
144738323|NCT03406156|521895960|FG001|Overall Study|Other, not specified|28|||
144738324|NCT00835536|521895961|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
144680452|NCT01680991|521681840|FG001|Overall Study|Adverse Event|0|||
144680453|NCT01680991|521681841|FG002|Overall Study|Adverse Event|0|||
144738325|NCT00835536|521895962|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
144738326|NCT01983969|521895963|FG000|Overall Study|Disease Progression|0|||
144738327|NCT01983969|521895964|FG001|Overall Study|Disease Progression|1|||
144738328|NCT01983969|521895965|FG002|Overall Study|Disease Progression|0|||
144265829|NCT01211145|520174017|FG003|Overall Study|Study-specific withdrawal criteria|0|||
144265830|NCT01211145|520174014|FG000|Overall Study|Severe noncompliance to protocol|1|||
144265831|NCT01211145|520174015|FG001|Overall Study|Severe noncompliance to protocol|0|||
144265832|NCT01211145|520174016|FG002|Overall Study|Severe noncompliance to protocol|0|||
144265833|NCT01211145|520174017|FG003|Overall Study|Severe noncompliance to protocol|0|||
144680454|NCT01680991|521681839|FG000|Overall Study|Death|1|||
144738329|NCT00268203|521895966|FG000|Overall Study|Lost to Follow-up|92|||
144738330|NCT00268203|521895966|FG000|Overall Study|Withdrawal by Subject|9|||
144738331|NCT00268203|521895966|FG000|Overall Study|Received Other NHL Therapy|7|||
144680455|NCT01680991|521681840|FG001|Overall Study|Death|0|||
144680456|NCT01680991|521681841|FG002|Overall Study|Death|1|||
144680457|NCT01680991|521681839|FG000|Overall Study|Protocol Violation|0|||
144680458|NCT01680991|521681840|FG001|Overall Study|Protocol Violation|1|||
144680459|NCT01680991|521681841|FG002|Overall Study|Protocol Violation|0|||
144680460|NCT01680991|521681839|FG000|Overall Study|Withdrawal by Subject|5|||
144680461|NCT01680991|521681840|FG001|Overall Study|Withdrawal by Subject|1|||
144680462|NCT01680991|521681841|FG002|Overall Study|Withdrawal by Subject|0|||
144680463|NCT01680991|521681839|FG000|Overall Study|Progressive disease (PD)|0|||
144680464|NCT01680991|521681840|FG001|Overall Study|Progressive disease (PD)|10|||
144680465|NCT01680991|521681841|FG002|Overall Study|Progressive disease (PD)|0|||
144680466|NCT01680991|521681839|FG000|Overall Study|Physician Decision|0|||
144680467|NCT01680991|521681840|FG001|Overall Study|Physician Decision|7|||
144680468|NCT01680991|521681841|FG002|Overall Study|Physician Decision|2|||
144680469|NCT01680991|521681839|FG000|Overall Study|Bad physical condition|0|||
144680470|NCT01680991|521681840|FG001|Overall Study|Bad physical condition|0|||
144680471|NCT01680991|521681841|FG002|Overall Study|Bad physical condition|1|||
144680472|NCT01680991|521681839|FG000|Overall Study|PD confirmed in other hospital|1|||
144680473|NCT01680991|521681840|FG001|Overall Study|PD confirmed in other hospital|0|||
144680474|NCT01680991|521681841|FG002|Overall Study|PD confirmed in other hospital|0|||
144680475|NCT06073054|521681842|FG000|Overall Study|Withdrawal by Subject|2|||
144680476|NCT03149029|521681843|FG000|Overall Study|Adverse Event|2|||
144680477|NCT03149029|521681844|FG001|Overall Study|Adverse Event|0|||
144680478|NCT00068822|521681845|FG000|First Randomized Intervention|Lost to Follow-up|1|||
144680479|NCT00068822|521681846|FG001|First Randomized Intervention|Lost to Follow-up|2|||
144680480|NCT01408732|521681847|FG000|Overall Study|Withdrawal by Subject|2|||
144680481|NCT01408732|521681848|FG001|Overall Study|Withdrawal by Subject|2|||
144680482|NCT00424099|521681849|FG000|Overall Study|Adverse Event|0|||
144680483|NCT00424099|521681850|FG001|Overall Study|Adverse Event|1|||
144680484|NCT00424099|521681851|FG002|Overall Study|Adverse Event|1|||
144680485|NCT00424099|521681852|FG003|Overall Study|Adverse Event|0|||
144680486|NCT00424099|521681849|FG000|Overall Study|Death|0|||
144680487|NCT00424099|521681850|FG001|Overall Study|Death|1|||
144680488|NCT00424099|521681851|FG002|Overall Study|Death|0|||
144680489|NCT00424099|521681852|FG003|Overall Study|Death|0|||
144680490|NCT00424099|521681849|FG000|Overall Study|Illness|2|||
144680491|NCT00424099|521681850|FG001|Overall Study|Illness|0|||
144680492|NCT00424099|521681851|FG002|Overall Study|Illness|1|||
144680493|NCT00424099|521681852|FG003|Overall Study|Illness|4|||
144680494|NCT00424099|521681849|FG000|Overall Study|Lost to Follow-up|0|||
144680495|NCT00424099|521681850|FG001|Overall Study|Lost to Follow-up|0|||
144680496|NCT00424099|521681851|FG002|Overall Study|Lost to Follow-up|3|||
144680497|NCT00424099|521681852|FG003|Overall Study|Lost to Follow-up|0|||
144680498|NCT00424099|521681849|FG000|Overall Study|Hospitalized|1|||
144680499|NCT00424099|521681850|FG001|Overall Study|Hospitalized|2|||
144680500|NCT00424099|521681851|FG002|Overall Study|Hospitalized|1|||
144680501|NCT00424099|521681852|FG003|Overall Study|Hospitalized|3|||
144680502|NCT00424099|521681849|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
144738332|NCT00268203|521895966|FG000|Overall Study|Progressive Disease|359|||
144738333|NCT00268203|521895966|FG000|Overall Study|Death|84|||
144738334|NCT00268203|521895966|FG000|Overall Study|Reason Not Specified|34|||
144265834|NCT01211145|520174014|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
144680503|NCT00424099|521681850|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
144680504|NCT00424099|521681851|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
144680505|NCT00424099|521681852|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
144680506|NCT00424099|521681849|FG000|Overall Study|Withdrawal by Subject|1|||
144738335|NCT00268203|521895966|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
144680507|NCT00424099|521681850|FG001|Overall Study|Withdrawal by Subject|9|||
144680508|NCT00424099|521681851|FG002|Overall Study|Withdrawal by Subject|4|||
144680509|NCT00424099|521681852|FG003|Overall Study|Withdrawal by Subject|6|||
144680510|NCT00424099|521681849|FG000|Overall Study|Physician Decision|0|||
144680511|NCT00424099|521681850|FG001|Overall Study|Physician Decision|0|||
144680512|NCT00424099|521681851|FG002|Overall Study|Physician Decision|1|||
144738336|NCT00950989|521895967|FG000|Overall Study|Death|0|||
144738337|NCT00950989|521895968|FG001|Overall Study|Death|0|||
144738338|NCT00950989|521895969|FG002|Overall Study|Death|1|||
144738339|NCT00950989|521895970|FG003|Overall Study|Death|0|||
144738340|NCT00950989|521895967|FG000|Overall Study|Administrative Decision|0|||
144738341|NCT00950989|521895968|FG001|Overall Study|Administrative Decision|1|||
144738342|NCT00950989|521895969|FG002|Overall Study|Administrative Decision|0|||
144738343|NCT00950989|521895970|FG003|Overall Study|Administrative Decision|0|||
144738344|NCT00950989|521895967|FG000|Overall Study|Disease Progression|0|||
144738345|NCT00950989|521895968|FG001|Overall Study|Disease Progression|0|||
144738346|NCT00950989|521895969|FG002|Overall Study|Disease Progression|1|||
144738347|NCT00950989|521895970|FG003|Overall Study|Disease Progression|0|||
144738348|NCT00950989|521895967|FG000|Overall Study|Withdrawal by Subject|2|||
144738349|NCT00950989|521895968|FG001|Overall Study|Withdrawal by Subject|1|||
144738350|NCT00950989|521895969|FG002|Overall Study|Withdrawal by Subject|0|||
144738351|NCT00950989|521895970|FG003|Overall Study|Withdrawal by Subject|0|||
144738352|NCT00950989|521895967|FG000|Overall Study|Adverse Event|2|||
144738353|NCT00950989|521895968|FG001|Overall Study|Adverse Event|1|||
144738354|NCT00950989|521895969|FG002|Overall Study|Adverse Event|1|||
144738355|NCT00950989|521895970|FG003|Overall Study|Adverse Event|0|||
144738356|NCT00813592|521895971|FG000|Overall Study|Disease assessment was not completed per|2|||
144738357|NCT03873272|521895974|FG000|Overall Study|Withdrawal by Subject|2|||
144738358|NCT03873272|521895975|FG001|Overall Study|Withdrawal by Subject|0|||
144738359|NCT03873272|521895976|FG002|Overall Study|Withdrawal by Subject|1|||
144738360|NCT03873272|521895974|FG000|Overall Study|Death|0|||
144738361|NCT03873272|521895975|FG001|Overall Study|Death|2|||
144738362|NCT03873272|521895976|FG002|Overall Study|Death|1|||
144738363|NCT05152576|521895981|FG000|Overall Study|Lost to Follow-up|3|||
144738364|NCT05152576|521895982|FG001|Overall Study|Lost to Follow-up|0|||
144738365|NCT05152576|521895983|FG002|Overall Study|Lost to Follow-up|0|||
144738366|NCT05152576|521895984|FG003|Overall Study|Lost to Follow-up|1|||
144738367|NCT05152576|521895981|FG000|Overall Study|Withdrawal by Subject|0|||
144738368|NCT05152576|521895982|FG001|Overall Study|Withdrawal by Subject|1|||
144738369|NCT05152576|521895983|FG002|Overall Study|Withdrawal by Subject|0|||
144738370|NCT05152576|521895984|FG003|Overall Study|Withdrawal by Subject|1|||
144738371|NCT05152576|521895981|FG000|Overall Study|Other|2|||
144738372|NCT05152576|521895982|FG001|Overall Study|Other|0|||
144738373|NCT05152576|521895983|FG002|Overall Study|Other|0|||
144738374|NCT05152576|521895984|FG003|Overall Study|Other|0|||
144738375|NCT00859430|521895985|FG000|First Intervention|Withdrawal by Subject|0|||
144738376|NCT00859430|521895986|FG001|First Intervention|Withdrawal by Subject|1|||
144738377|NCT01660243|521897415|FG000|Overall Study|Adverse Event|1|||
144738378|NCT01660243|521897416|FG001|Overall Study|Adverse Event|0|||
144738379|NCT01660243|521897417|FG002|Overall Study|Adverse Event|1|||
144738380|NCT01660243|521897418|FG003|Overall Study|Adverse Event|0|||
144738381|NCT01660243|521897415|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
144738382|NCT01660243|521897416|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
144738383|NCT01660243|521897417|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
144738384|NCT01660243|521897418|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
144738385|NCT01660243|521897415|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
144738386|NCT01660243|521897416|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
144738387|NCT01660243|521897417|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
144738388|NCT01660243|521897418|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
144738389|NCT01660243|521897415|FG000|Overall Study|Randomization error|0|||
144738390|NCT01660243|521897416|FG001|Overall Study|Randomization error|0|||
144738391|NCT01660243|521897417|FG002|Overall Study|Randomization error|0|||
144738392|NCT01660243|521897418|FG003|Overall Study|Randomization error|1|||
144738393|NCT01531894|521897441|FG000|Overall Study|Physician Decision|8|||
144738394|NCT01531894|521897441|FG000|Overall Study|Death|1|||
144738395|NCT03086460|521897442|FG000|Study Participants|Lost to Follow-up|2|||
144738396|NCT03086460|521897442|FG000|Study Participants|Protocol Violation|1|||
144738397|NCT03086460|521897442|FG000|Study Participants|Withdrawal by Subject|6|||
144738398|NCT03086460|521897442|FG000|Treatment A|Lost to Follow-up|1|||
144738399|NCT03086460|521897442|FG000|Treatment A|Protocol Violation|1|||
144738400|NCT03086460|521897442|FG000|Treatment A|Withdrawal by Subject|2|||
144738401|NCT03086460|521897442|FG000|Treatment C|Withdrawal by Subject|2|||
144738402|NCT03086460|521897442|FG000|Treatment E|Lost to Follow-up|1|||
144738403|NCT03086460|521897442|FG000|Treatment E|Withdrawal by Subject|3|||
144738404|NCT01987765|521897443|FG000|Overall Study|Protocol Violation|65|||
144738405|NCT01987765|521897443|FG000|Overall Study|Lost to Follow-up|37|||
144738406|NCT03049748|521897446|FG000|Overall Study|Lost to Follow-up|1|||
144738407|NCT03049748|521897447|FG001|Overall Study|Lost to Follow-up|0|||
144738408|NCT03049748|521897446|FG000|Overall Study|Death|3|||
144738409|NCT03049748|521897447|FG001|Overall Study|Death|0|||
144738410|NCT03049748|521897446|FG000|Overall Study|Withdrawal by Subject|0|||
144738411|NCT03049748|521897447|FG001|Overall Study|Withdrawal by Subject|3|||
144738412|NCT03049748|521897446|FG000|Overall Study|Protocol Violation|0|||
144680513|NCT00424099|521681852|FG003|Overall Study|Physician Decision|0|||
144680514|NCT00424099|521681849|FG000|Overall Study|Missing|0|||
144680515|NCT00424099|521681850|FG001|Overall Study|Missing|0|||
144680516|NCT00424099|521681851|FG002|Overall Study|Missing|1|||
144680517|NCT00424099|521681852|FG003|Overall Study|Missing|0|||
144680518|NCT03377452|521681853|FG000|Overall Study|Refused assessment|0|||
144680519|NCT03377452|521681854|FG001|Overall Study|Refused assessment|2|||
144680520|NCT03377452|521681853|FG000|Overall Study|Lost to Follow-up|5|||
144680521|NCT03377452|521681854|FG001|Overall Study|Lost to Follow-up|4|||
144680522|NCT00764322|521681855|FG000|Overall Study|Withdrawal by Subject|11|||
144680523|NCT00764322|521681855|FG000|Overall Study|No CYP2D6 genotyping|9|||
144680524|NCT00796003|521681856|FG000|Overall Study|Disease Progression|2|||
144680525|NCT00796003|521681857|FG001|Overall Study|Disease Progression|13|||
144680526|NCT00796003|521681856|FG000|Overall Study|Adverse Event|1|||
144680527|NCT00796003|521681857|FG001|Overall Study|Adverse Event|7|||
144680528|NCT00796003|521681856|FG000|Overall Study|Specified organ function not met|0|||
144680529|NCT00796003|521681857|FG001|Overall Study|Specified organ function not met|1|||
144680530|NCT00796003|521681856|FG000|Overall Study|Physician Decision|0|||
144680531|NCT00796003|521681857|FG001|Overall Study|Physician Decision|4|||
144680532|NCT00796003|521681856|FG000|Overall Study|Withdrawal by Subject|0|||
144680533|NCT00796003|521681857|FG001|Overall Study|Withdrawal by Subject|1|||
144680534|NCT00796003|521681856|FG000|Overall Study|Other|0|||
144680535|NCT00796003|521681857|FG001|Overall Study|Other|1|||
144680536|NCT00796003|521681856|FG000|Overall Study|Participants Not treated|0|||
144680537|NCT00796003|521681857|FG001|Overall Study|Participants Not treated|2|||
144680538|NCT03345342|521681858|FG000|Open-Label Phase|Adverse Event|30|||
144680539|NCT03345342|521681859|FG001|Open-Label Phase|Adverse Event|0|||
144680540|NCT03345342|521681860|FG002|Open-Label Phase|Adverse Event|0|||
144680541|NCT03345342|521681861|FG003|Open-Label Phase|Adverse Event|0|||
144680542|NCT03345342|521681862|FG004|Open-Label Phase|Adverse Event|0|||
144680543|NCT03345342|521681858|FG000|Open-Label Phase|Death|1|||
144680544|NCT03345342|521681859|FG001|Open-Label Phase|Death|0|||
144680545|NCT03345342|521681860|FG002|Open-Label Phase|Death|0|||
144680546|NCT03345342|521681861|FG003|Open-Label Phase|Death|0|||
144680547|NCT03345342|521681862|FG004|Open-Label Phase|Death|0|||
144680548|NCT03345342|521681858|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
144680549|NCT03345342|521681859|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
144680550|NCT03345342|521681860|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
144680551|NCT03345342|521681861|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
144680552|NCT03345342|521681862|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
144680553|NCT03345342|521681858|FG000|Open-Label Phase|Lack of Efficacy|6|||
144680554|NCT03345342|521681859|FG001|Open-Label Phase|Lack of Efficacy|0|||
144680555|NCT03345342|521681860|FG002|Open-Label Phase|Lack of Efficacy|0|||
144680556|NCT03345342|521681861|FG003|Open-Label Phase|Lack of Efficacy|0|||
144680557|NCT03345342|521681862|FG004|Open-Label Phase|Lack of Efficacy|0|||
144680558|NCT03345342|521681858|FG000|Open-Label Phase|Lost to Follow-up|9|||
144680559|NCT03345342|521681859|FG001|Open-Label Phase|Lost to Follow-up|0|||
144680560|NCT03345342|521681860|FG002|Open-Label Phase|Lost to Follow-up|0|||
144680561|NCT03345342|521681861|FG003|Open-Label Phase|Lost to Follow-up|0|||
144680562|NCT03345342|521681862|FG004|Open-Label Phase|Lost to Follow-up|0|||
144680563|NCT03345342|521681858|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
144680564|NCT03345342|521681859|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
144680565|NCT03345342|521681860|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
144680566|NCT03345342|521681861|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
144680567|NCT03345342|521681862|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
144680568|NCT03345342|521681858|FG000|Open-Label Phase|Physician Decision|4|||
144680569|NCT03345342|521681859|FG001|Open-Label Phase|Physician Decision|0|||
144680570|NCT03345342|521681860|FG002|Open-Label Phase|Physician Decision|0|||
144680571|NCT03345342|521681861|FG003|Open-Label Phase|Physician Decision|0|||
144680572|NCT03345342|521681862|FG004|Open-Label Phase|Physician Decision|0|||
144680573|NCT03345342|521681858|FG000|Open-Label Phase|Protocol Violation|8|||
144680574|NCT03345342|521681859|FG001|Open-Label Phase|Protocol Violation|0|||
144680575|NCT03345342|521681860|FG002|Open-Label Phase|Protocol Violation|0|||
144680576|NCT03345342|521681861|FG003|Open-Label Phase|Protocol Violation|0|||
144680577|NCT03345342|521681862|FG004|Open-Label Phase|Protocol Violation|0|||
144680578|NCT03345342|521681858|FG000|Open-Label Phase|Withdrawal by Subject|57|||
144680579|NCT03345342|521681859|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144680580|NCT03345342|521681860|FG002|Open-Label Phase|Withdrawal by Subject|0|||
144680581|NCT03345342|521681861|FG003|Open-Label Phase|Withdrawal by Subject|0|||
144218301|NCT00769379|519992292|FG001|Overall Study|No follow up data mapped to Other.|13|||
144218302|NCT00344448|519992295|FG000|Screening|Withdrawal by Subject|0|||
144218303|NCT00344448|519992296|FG001|Screening|Withdrawal by Subject|1|||
144680582|NCT03345342|521681862|FG004|Open-Label Phase|Withdrawal by Subject|0|||
144680583|NCT03345342|521681858|FG000|Open-Label Phase|Other|15|||
144680584|NCT03345342|521681859|FG001|Open-Label Phase|Other|0|||
144680585|NCT03345342|521681860|FG002|Open-Label Phase|Other|0|||
144680586|NCT03345342|521681861|FG003|Open-Label Phase|Other|0|||
144680587|NCT03345342|521681862|FG004|Open-Label Phase|Other|0|||
144680588|NCT03345342|521681858|FG000|Double-Blind Phase|Adverse Event|0|||
144680589|NCT03345342|521681859|FG001|Double-Blind Phase|Adverse Event|1|||
144680590|NCT03345342|521681860|FG002|Double-Blind Phase|Adverse Event|6|||
144680591|NCT03345342|521681861|FG003|Double-Blind Phase|Adverse Event|0|||
144680592|NCT03345342|521681862|FG004|Double-Blind Phase|Adverse Event|0|||
144680593|NCT03345342|521681858|FG000|Double-Blind Phase|Death|0|||
144680594|NCT03345342|521681859|FG001|Double-Blind Phase|Death|2|||
144680595|NCT03345342|521681860|FG002|Double-Blind Phase|Death|1|||
144680596|NCT03345342|521681861|FG003|Double-Blind Phase|Death|0|||
144680597|NCT03345342|521681862|FG004|Double-Blind Phase|Death|0|||
144680598|NCT03345342|521681858|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
144680599|NCT03345342|521681859|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
144680600|NCT03345342|521681860|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
144680601|NCT03345342|521681861|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
144680602|NCT03345342|521681862|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
144680603|NCT03345342|521681858|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144680604|NCT03345342|521681859|FG001|Double-Blind Phase|Lost to Follow-up|1|||
144680605|NCT03345342|521681860|FG002|Double-Blind Phase|Lost to Follow-up|7|||
144680606|NCT03345342|521681861|FG003|Double-Blind Phase|Lost to Follow-up|0|||
144680607|NCT03345342|521681862|FG004|Double-Blind Phase|Lost to Follow-up|0|||
144680608|NCT03345342|521681858|FG000|Double-Blind Phase|Physician Decision|0|||
144680609|NCT03345342|521681859|FG001|Double-Blind Phase|Physician Decision|1|||
144680610|NCT03345342|521681860|FG002|Double-Blind Phase|Physician Decision|4|||
144680611|NCT03345342|521681861|FG003|Double-Blind Phase|Physician Decision|0|||
144680612|NCT03345342|521681862|FG004|Double-Blind Phase|Physician Decision|0|||
144680613|NCT03345342|521681858|FG000|Double-Blind Phase|Protocol Violation|0|||
144680614|NCT03345342|521681859|FG001|Double-Blind Phase|Protocol Violation|0|||
144680615|NCT03345342|521681860|FG002|Double-Blind Phase|Protocol Violation|1|||
144680616|NCT03345342|521681861|FG003|Double-Blind Phase|Protocol Violation|0|||
144680617|NCT03345342|521681862|FG004|Double-Blind Phase|Protocol Violation|0|||
144680618|NCT03345342|521681858|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
144680619|NCT03345342|521681859|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
144680620|NCT03345342|521681860|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
144680621|NCT03345342|521681861|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144680622|NCT03345342|521681862|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
144680623|NCT03345342|521681858|FG000|Double-Blind Phase|Other|0|||
144680624|NCT03345342|521681859|FG001|Double-Blind Phase|Other|1|||
144680625|NCT03345342|521681860|FG002|Double-Blind Phase|Other|3|||
144680626|NCT03345342|521681861|FG003|Double-Blind Phase|Other|0|||
144680627|NCT03345342|521681862|FG004|Double-Blind Phase|Other|0|||
144680628|NCT03345342|521681858|FG000|Follow-Up Phase|Adverse Event|0|||
144680629|NCT03345342|521681859|FG001|Follow-Up Phase|Adverse Event|0|||
144680630|NCT03345342|521681860|FG002|Follow-Up Phase|Adverse Event|0|||
144680631|NCT03345342|521681861|FG003|Follow-Up Phase|Adverse Event|0|||
144680632|NCT03345342|521681862|FG004|Follow-Up Phase|Adverse Event|4|||
144680633|NCT03345342|521681858|FG000|Follow-Up Phase|Lost to Follow-up|0|||
144680634|NCT03345342|521681859|FG001|Follow-Up Phase|Lost to Follow-up|0|||
144680635|NCT03345342|521681860|FG002|Follow-Up Phase|Lost to Follow-up|0|||
144680636|NCT03345342|521681861|FG003|Follow-Up Phase|Lost to Follow-up|0|||
144680637|NCT03345342|521681862|FG004|Follow-Up Phase|Lost to Follow-up|6|||
144680638|NCT03345342|521681858|FG000|Follow-Up Phase|Physician Decision|0|||
144680639|NCT03345342|521681859|FG001|Follow-Up Phase|Physician Decision|0|||
144680640|NCT03345342|521681860|FG002|Follow-Up Phase|Physician Decision|0|||
144680641|NCT03345342|521681861|FG003|Follow-Up Phase|Physician Decision|0|||
144680642|NCT03345342|521681862|FG004|Follow-Up Phase|Physician Decision|5|||
144680643|NCT03345342|521681858|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
144680644|NCT03345342|521681859|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
144680645|NCT03345342|521681860|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
144680646|NCT03345342|521681861|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
144680647|NCT03345342|521681862|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
144680648|NCT03345342|521681858|FG000|Follow-Up Phase|Other|0|||
144680649|NCT03345342|521681859|FG001|Follow-Up Phase|Other|0|||
144680650|NCT03345342|521681860|FG002|Follow-Up Phase|Other|0|||
144680651|NCT03345342|521681861|FG003|Follow-Up Phase|Other|3|||
144680652|NCT03345342|521681862|FG004|Follow-Up Phase|Other|1|||
144680653|NCT03277105|521681863|FG000|Overall Study|Death|129|||
144680654|NCT03277105|521681864|FG001|Overall Study|Death|124|||
144680655|NCT03277105|521681863|FG000|Overall Study|Lost to Follow-up|2|||
144680656|NCT03277105|521681864|FG001|Overall Study|Lost to Follow-up|4|||
144738413|NCT03049748|521897447|FG001|Overall Study|Protocol Violation|2|||
144680657|NCT03277105|521681863|FG000|Overall Study|Withdrawal by Subject|10|||
144680658|NCT03277105|521681864|FG001|Overall Study|Withdrawal by Subject|10|||
144680659|NCT03277105|521681863|FG000|Overall Study|Other|118|||
144680660|NCT03277105|521681864|FG001|Overall Study|Other|125|||
144680661|NCT01989572|521681865|FG000|Overall Study|Lack of Efficacy|35|||
144680662|NCT01989572|521681866|FG001|Overall Study|Lack of Efficacy|48|||
144680663|NCT01989572|521681867|FG002|Overall Study|Lack of Efficacy|48|||
144680664|NCT01989572|521681868|FG003|Overall Study|Lack of Efficacy|43|||
144680665|NCT01989572|521681869|FG004|Overall Study|Lack of Efficacy|71|||
144680666|NCT01989572|521681870|FG005|Overall Study|Lack of Efficacy|79|||
144680667|NCT01989572|521681865|FG000|Overall Study|Adverse Event|2|||
144680668|NCT01989572|521681866|FG001|Overall Study|Adverse Event|1|||
144680669|NCT01989572|521681867|FG002|Overall Study|Adverse Event|3|||
144680670|NCT01989572|521681868|FG003|Overall Study|Adverse Event|0|||
144680671|NCT01989572|521681869|FG004|Overall Study|Adverse Event|3|||
144680672|NCT01989572|521681870|FG005|Overall Study|Adverse Event|0|||
144680673|NCT01989572|521681865|FG000|Overall Study|Death|0|||
144680674|NCT01989572|521681866|FG001|Overall Study|Death|0|||
144680675|NCT01989572|521681867|FG002|Overall Study|Death|0|||
144680676|NCT01989572|521681868|FG003|Overall Study|Death|0|||
144680677|NCT01989572|521681869|FG004|Overall Study|Death|1|||
144680678|NCT01989572|521681870|FG005|Overall Study|Death|0|||
144680679|NCT01989572|521681865|FG000|Overall Study|Withdrawal by Subject|4|||
144680680|NCT01989572|521681866|FG001|Overall Study|Withdrawal by Subject|1|||
144680681|NCT01989572|521681867|FG002|Overall Study|Withdrawal by Subject|5|||
144680682|NCT01989572|521681868|FG003|Overall Study|Withdrawal by Subject|1|||
144680683|NCT01989572|521681869|FG004|Overall Study|Withdrawal by Subject|12|||
144680684|NCT01989572|521681870|FG005|Overall Study|Withdrawal by Subject|4|||
144680685|NCT01989572|521681865|FG000|Overall Study|complicating disease|1|||
144680686|NCT01989572|521681866|FG001|Overall Study|complicating disease|1|||
144680687|NCT01989572|521681867|FG002|Overall Study|complicating disease|2|||
144680688|NCT01989572|521681868|FG003|Overall Study|complicating disease|0|||
144680689|NCT01989572|521681869|FG004|Overall Study|complicating disease|1|||
144680690|NCT01989572|521681870|FG005|Overall Study|complicating disease|0|||
144680691|NCT01989572|521681865|FG000|Overall Study|error|2|||
144680692|NCT01989572|521681866|FG001|Overall Study|error|1|||
144680693|NCT01989572|521681867|FG002|Overall Study|error|1|||
144680694|NCT01989572|521681868|FG003|Overall Study|error|1|||
144680695|NCT01989572|521681869|FG004|Overall Study|error|1|||
144680696|NCT01989572|521681870|FG005|Overall Study|error|1|||
144680697|NCT01989572|521681865|FG000|Overall Study|maximum dose reached|0|||
144680698|NCT01989572|521681866|FG001|Overall Study|maximum dose reached|1|||
144680699|NCT01989572|521681867|FG002|Overall Study|maximum dose reached|0|||
144680700|NCT01989572|521681868|FG003|Overall Study|maximum dose reached|0|||
144680701|NCT01989572|521681869|FG004|Overall Study|maximum dose reached|1|||
144680702|NCT01989572|521681870|FG005|Overall Study|maximum dose reached|0|||
144680703|NCT01989572|521681865|FG000|Overall Study|unknown/not specify|3|||
144680704|NCT01989572|521681866|FG001|Overall Study|unknown/not specify|4|||
144680705|NCT01989572|521681867|FG002|Overall Study|unknown/not specify|1|||
144680706|NCT01989572|521681868|FG003|Overall Study|unknown/not specify|3|||
144680707|NCT01989572|521681869|FG004|Overall Study|unknown/not specify|3|||
144680708|NCT01989572|521681870|FG005|Overall Study|unknown/not specify|5|||
144680709|NCT01989572|521681865|FG000|Overall Study|not start protocol therapy|5|||
144680710|NCT01989572|521681866|FG001|Overall Study|not start protocol therapy|1|||
144680711|NCT01989572|521681867|FG002|Overall Study|not start protocol therapy|2|||
144680712|NCT01989572|521681868|FG003|Overall Study|not start protocol therapy|3|||
144680713|NCT01989572|521681869|FG004|Overall Study|not start protocol therapy|4|||
144680714|NCT01989572|521681870|FG005|Overall Study|not start protocol therapy|18|||
144680715|NCT01989572|521681865|FG000|Overall Study|alternative therapy|3|||
144680716|NCT01989572|521681866|FG001|Overall Study|alternative therapy|0|||
144680717|NCT01989572|521681867|FG002|Overall Study|alternative therapy|0|||
144680718|NCT01989572|521681868|FG003|Overall Study|alternative therapy|0|||
144680719|NCT01989572|521681869|FG004|Overall Study|alternative therapy|1|||
144680720|NCT01989572|521681870|FG005|Overall Study|alternative therapy|3|||
144680721|NCT02280096|521681871|FG000|Overall Study|Pregnancy|1|||
144680722|NCT02280096|521681872|FG001|Overall Study|Pregnancy|0|||
144680723|NCT02280096|521681871|FG000|Overall Study|Functional neurological disorder|1|||
144680724|NCT02280096|521681872|FG001|Overall Study|Functional neurological disorder|0|||
144680725|NCT02280096|521681871|FG000|Overall Study|Lack of attachment|0|||
144680726|NCT02280096|521681872|FG001|Overall Study|Lack of attachment|1|||
144680727|NCT01466062|521681878|FG000|Overall Study|Adverse Event|1|||
144680728|NCT01466062|521681878|FG000|Overall Study|Withdrawal by Subject|1|||
144680729|NCT00338806|521681879|FG000|Acute Phase|Withdrawal by Subject|0|||
144680730|NCT00338806|521681880|FG001|Acute Phase|Withdrawal by Subject|1|||
144680731|NCT00338806|521681879|FG000|Follow-up|Lost to Follow-up|1|||
144680732|NCT00338806|521681880|FG001|Follow-up|Lost to Follow-up|3|||
144680733|NCT01512693|521681891|FG000|Overall Study|Withdrawal by Subject|0|||
144680734|NCT01512693|521681892|FG001|Overall Study|Withdrawal by Subject|1|||
144680735|NCT04731922|521681902|FG000|Overall Study|Adverse Event|0|||
144680736|NCT04731922|521681903|FG001|Overall Study|Adverse Event|0|||
144680737|NCT04731922|521681904|FG002|Overall Study|Adverse Event|0|||
144680738|NCT04731922|521681905|FG003|Overall Study|Adverse Event|0|||
144680739|NCT04731922|521681906|FG004|Overall Study|Adverse Event|0|||
144680740|NCT04731922|521681907|FG005|Overall Study|Adverse Event|0|||
144680741|NCT04731922|521681908|FG006|Overall Study|Adverse Event|0|||
144680742|NCT04731922|521681909|FG007|Overall Study|Adverse Event|0|||
144680743|NCT04731922|521681910|FG008|Overall Study|Adverse Event|0|||
144680744|NCT04731922|521681911|FG009|Overall Study|Adverse Event|0|||
144680745|NCT04731922|521681912|FG010|Overall Study|Adverse Event|1|||
144265835|NCT01211145|520174015|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
144680746|NCT04731922|521681913|FG011|Overall Study|Adverse Event|0|||
144680747|NCT04731922|521681914|FG012|Overall Study|Adverse Event|0|||
144680748|NCT04731922|521681915|FG013|Overall Study|Adverse Event|0|||
144680749|NCT04731922|521681916|FG014|Overall Study|Adverse Event|0|||
144680750|NCT04731922|521681917|FG015|Overall Study|Adverse Event|0|||
144680751|NCT04731922|521681918|FG016|Overall Study|Adverse Event|0|||
144680752|NCT04731922|521681902|FG000|Overall Study|Lost to Follow-up|0|||
144680753|NCT04731922|521681903|FG001|Overall Study|Lost to Follow-up|0|||
144680754|NCT04731922|521681904|FG002|Overall Study|Lost to Follow-up|0|||
144680755|NCT04731922|521681905|FG003|Overall Study|Lost to Follow-up|1|||
144680756|NCT04731922|521681906|FG004|Overall Study|Lost to Follow-up|0|||
144680757|NCT04731922|521681907|FG005|Overall Study|Lost to Follow-up|1|||
144680758|NCT04731922|521681908|FG006|Overall Study|Lost to Follow-up|0|||
144680759|NCT04731922|521681909|FG007|Overall Study|Lost to Follow-up|0|||
144680760|NCT04731922|521681910|FG008|Overall Study|Lost to Follow-up|0|||
144680761|NCT04731922|521681911|FG009|Overall Study|Lost to Follow-up|0|||
144680762|NCT04731922|521681912|FG010|Overall Study|Lost to Follow-up|0|||
144680763|NCT04731922|521681913|FG011|Overall Study|Lost to Follow-up|0|||
144680764|NCT04731922|521681914|FG012|Overall Study|Lost to Follow-up|0|||
144680765|NCT04731922|521681915|FG013|Overall Study|Lost to Follow-up|0|||
144680766|NCT04731922|521681916|FG014|Overall Study|Lost to Follow-up|0|||
144680767|NCT04731922|521681917|FG015|Overall Study|Lost to Follow-up|0|||
144680768|NCT04731922|521681918|FG016|Overall Study|Lost to Follow-up|0|||
144680769|NCT04731922|521681902|FG000|Overall Study|Withdrawal by Subject|1|||
144680770|NCT04731922|521681903|FG001|Overall Study|Withdrawal by Subject|0|||
144680771|NCT04731922|521681904|FG002|Overall Study|Withdrawal by Subject|0|||
144680772|NCT04731922|521681905|FG003|Overall Study|Withdrawal by Subject|0|||
144680773|NCT04731922|521681906|FG004|Overall Study|Withdrawal by Subject|1|||
144680774|NCT04731922|521681907|FG005|Overall Study|Withdrawal by Subject|0|||
144680775|NCT04731922|521681908|FG006|Overall Study|Withdrawal by Subject|1|||
144680776|NCT04731922|521681909|FG007|Overall Study|Withdrawal by Subject|0|||
144680777|NCT04731922|521681910|FG008|Overall Study|Withdrawal by Subject|0|||
144680778|NCT04731922|521681911|FG009|Overall Study|Withdrawal by Subject|0|||
144680779|NCT04731922|521681912|FG010|Overall Study|Withdrawal by Subject|0|||
144680780|NCT04731922|521681913|FG011|Overall Study|Withdrawal by Subject|0|||
144680781|NCT04731922|521681914|FG012|Overall Study|Withdrawal by Subject|0|||
144680782|NCT04731922|521681915|FG013|Overall Study|Withdrawal by Subject|1|||
144680783|NCT04731922|521681916|FG014|Overall Study|Withdrawal by Subject|0|||
144680784|NCT04731922|521681917|FG015|Overall Study|Withdrawal by Subject|0|||
144680785|NCT04731922|521681918|FG016|Overall Study|Withdrawal by Subject|0|||
144680786|NCT04731922|521681902|FG000|Overall Study|Other|0|||
144680787|NCT04731922|521681903|FG001|Overall Study|Other|0|||
144680788|NCT04731922|521681904|FG002|Overall Study|Other|0|||
144680789|NCT04731922|521681905|FG003|Overall Study|Other|0|||
144680790|NCT04731922|521681906|FG004|Overall Study|Other|0|||
144680791|NCT04731922|521681907|FG005|Overall Study|Other|0|||
144680792|NCT04731922|521681908|FG006|Overall Study|Other|1|||
144680793|NCT04731922|521681909|FG007|Overall Study|Other|0|||
144680794|NCT04731922|521681910|FG008|Overall Study|Other|0|||
144680795|NCT04731922|521681911|FG009|Overall Study|Other|0|||
144680796|NCT04731922|521681912|FG010|Overall Study|Other|0|||
144680797|NCT04731922|521681913|FG011|Overall Study|Other|0|||
144680798|NCT04731922|521681914|FG012|Overall Study|Other|0|||
144680799|NCT04731922|521681915|FG013|Overall Study|Other|0|||
144680800|NCT04731922|521681916|FG014|Overall Study|Other|0|||
144680801|NCT04731922|521681917|FG015|Overall Study|Other|0|||
144680802|NCT04731922|521681918|FG016|Overall Study|Other|0|||
144680803|NCT01819194|521681920|FG000|Overall Study|Loss of study articles|2|||
144680804|NCT00045630|521681926|FG000|Overall Study|Adverse Event|1|||
144680805|NCT00045630|521681926|FG000|Overall Study|Refusal unrelated to adverse event|1|||
144738414|NCT03049748|521897446|FG000|Overall Study|Moved out of state (relocation)|0|||
144680806|NCT00045630|521681926|FG000|Overall Study|Progression/relapse|1|||
144738415|NCT03049748|521897447|FG001|Overall Study|Moved out of state (relocation)|1|||
144738416|NCT03502811|521897450|FG000|Overall Study|Death|157|||
144680807|NCT00045630|521681926|FG000|Overall Study|Death|1|||
144680808|NCT00045630|521681926|FG000|Overall Study|Ineligible|2|||
144680809|NCT00981747|521681927|FG000|Losartan|Withdrawal by Subject|1|||
144680810|NCT00981747|521681927|FG000|Losartan|Death|1|||
144680811|NCT00981747|521681927|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
144680812|NCT00701103|521681928|FG000|Overall Study|Adverse Event|0|||
144680813|NCT00701103|521681929|FG001|Overall Study|Adverse Event|0|||
144680814|NCT00701103|521681930|FG002|Overall Study|Adverse Event|1|||
144680815|NCT00701103|521681931|FG003|Overall Study|Adverse Event|1|||
144680816|NCT00701103|521681932|FG004|Overall Study|Adverse Event|0|||
144680817|NCT00701103|521681933|FG005|Overall Study|Adverse Event|1|||
144680818|NCT00701103|521681934|FG006|Overall Study|Adverse Event|1|||
144680819|NCT00701103|521681935|FG007|Overall Study|Adverse Event|0|||
144680820|NCT00701103|521681936|FG008|Overall Study|Adverse Event|0|||
144680821|NCT00701103|521681937|FG009|Overall Study|Adverse Event|2|||
144680822|NCT00701103|521681938|FG010|Overall Study|Adverse Event|0|||
144680823|NCT00701103|521681928|FG000|Overall Study|Progressive Disease|5|||
144680824|NCT00701103|521681929|FG001|Overall Study|Progressive Disease|2|||
144680825|NCT00701103|521681930|FG002|Overall Study|Progressive Disease|6|||
144680826|NCT00701103|521681931|FG003|Overall Study|Progressive Disease|5|||
144680827|NCT00701103|521681932|FG004|Overall Study|Progressive Disease|6|||
144680828|NCT00701103|521681933|FG005|Overall Study|Progressive Disease|5|||
144680829|NCT00701103|521681934|FG006|Overall Study|Progressive Disease|7|||
144680830|NCT00701103|521681935|FG007|Overall Study|Progressive Disease|7|||
144680831|NCT00701103|521681936|FG008|Overall Study|Progressive Disease|8|||
144680832|NCT00701103|521681937|FG009|Overall Study|Progressive Disease|8|||
144680833|NCT00701103|521681938|FG010|Overall Study|Progressive Disease|11|||
144680834|NCT00701103|521681928|FG000|Overall Study|Withdrawal by Subject|0|||
144680835|NCT00701103|521681929|FG001|Overall Study|Withdrawal by Subject|1|||
144680836|NCT00701103|521681930|FG002|Overall Study|Withdrawal by Subject|1|||
144680837|NCT00701103|521681931|FG003|Overall Study|Withdrawal by Subject|0|||
144680838|NCT00701103|521681932|FG004|Overall Study|Withdrawal by Subject|0|||
144680839|NCT00701103|521681933|FG005|Overall Study|Withdrawal by Subject|0|||
144680840|NCT00701103|521681934|FG006|Overall Study|Withdrawal by Subject|0|||
144680841|NCT00701103|521681935|FG007|Overall Study|Withdrawal by Subject|0|||
144680842|NCT00701103|521681936|FG008|Overall Study|Withdrawal by Subject|0|||
144680843|NCT00701103|521681937|FG009|Overall Study|Withdrawal by Subject|0|||
144680844|NCT00701103|521681938|FG010|Overall Study|Withdrawal by Subject|0|||
144680845|NCT00701103|521681928|FG000|Overall Study|Other|0|||
144680846|NCT00701103|521681929|FG001|Overall Study|Other|0|||
144680847|NCT00701103|521681930|FG002|Overall Study|Other|0|||
144680848|NCT00701103|521681931|FG003|Overall Study|Other|0|||
144680849|NCT00701103|521681932|FG004|Overall Study|Other|0|||
144680850|NCT00701103|521681933|FG005|Overall Study|Other|0|||
144680851|NCT00701103|521681934|FG006|Overall Study|Other|0|||
144680852|NCT00701103|521681935|FG007|Overall Study|Other|0|||
144680853|NCT00701103|521681936|FG008|Overall Study|Other|1|||
144680854|NCT00701103|521681937|FG009|Overall Study|Other|1|||
144680855|NCT00701103|521681938|FG010|Overall Study|Other|0|||
144680856|NCT01448707|521681944|FG000|Overall Study|Adverse Event|3|||
144680857|NCT01448707|521681945|FG001|Overall Study|Adverse Event|1|||
144680858|NCT01448707|521681944|FG000|Overall Study|Lost to Follow-up|2|||
144680859|NCT01448707|521681945|FG001|Overall Study|Lost to Follow-up|6|||
144680860|NCT01448707|521681944|FG000|Overall Study|Withdrawal by Subject|6|||
144680861|NCT01448707|521681945|FG001|Overall Study|Withdrawal by Subject|7|||
144680862|NCT01448707|521681944|FG000|Overall Study|Other|7|||
144680863|NCT01448707|521681945|FG001|Overall Study|Other|4|||
144680864|NCT02033850|521681950|FG000|Overall Study|Death|1|||
144680865|NCT02033850|521681951|FG001|Overall Study|Death|0|||
144680866|NCT02033850|521681950|FG000|Overall Study|unrelated medical reason|1|||
144680867|NCT02033850|521681951|FG001|Overall Study|unrelated medical reason|1|||
144680868|NCT02820038|521681955|FG000|Overall Study|Lost to Follow-up|7|||
144680869|NCT02820038|521681956|FG001|Overall Study|Lost to Follow-up|11|||
144680870|NCT02820038|521681957|FG002|Overall Study|Lost to Follow-up|2|||
144680871|NCT02820038|521681958|FG003|Overall Study|Lost to Follow-up|9|||
144680872|NCT02820038|521681955|FG000|Overall Study|Withdrawal by Subject|3|||
144680873|NCT02820038|521681956|FG001|Overall Study|Withdrawal by Subject|14|||
144680874|NCT02820038|521681957|FG002|Overall Study|Withdrawal by Subject|3|||
144680875|NCT02820038|521681958|FG003|Overall Study|Withdrawal by Subject|13|||
144680876|NCT00441480|521681961|FG000|Overall Study|Protocol Violation|1|||
144680877|NCT00441480|521681962|FG001|Overall Study|Protocol Violation|1|||
144680878|NCT00441480|521681961|FG000|Overall Study|Withdrawal by Subject|2|||
144680879|NCT00441480|521681962|FG001|Overall Study|Withdrawal by Subject|3|||
144680880|NCT02623699|521681963|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680881|NCT02623699|521681964|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
144680882|NCT02623699|521681965|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680883|NCT02623699|521681966|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680884|NCT02623699|521681967|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680885|NCT02623699|521681968|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680886|NCT02623699|521681969|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144265836|NCT01211145|520174016|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
144680887|NCT02623699|521681970|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680888|NCT02623699|521681971|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680889|NCT02623699|521681972|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680890|NCT02623699|521681973|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680891|NCT02623699|521681974|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
144680892|NCT02623699|521681963|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680893|NCT02623699|521681964|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680894|NCT02623699|521681965|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680895|NCT02623699|521681966|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680896|NCT02623699|521681967|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680897|NCT02623699|521681968|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680898|NCT02623699|521681969|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
144680899|NCT02623699|521681970|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680900|NCT02623699|521681971|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680901|NCT02623699|521681972|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680902|NCT02623699|521681973|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144218304|NCT00344448|519992295|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
144218305|NCT00344448|519992296|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
144218306|NCT00344448|519992295|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
144218307|NCT00344448|519992296|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
144680903|NCT02623699|521681974|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
144680904|NCT02623699|521681963|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680905|NCT02623699|521681964|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680906|NCT02623699|521681965|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680907|NCT02623699|521681966|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680908|NCT02623699|521681967|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680909|NCT02623699|521681968|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
144680910|NCT02623699|521681969|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680911|NCT02623699|521681970|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680912|NCT02623699|521681971|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680913|NCT02623699|521681972|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680914|NCT02623699|521681973|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680915|NCT02623699|521681974|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
144680916|NCT02623699|521681963|FG000|Part B (Up to 289 Days)|Death|0|||
144680917|NCT02623699|521681964|FG001|Part B (Up to 289 Days)|Death|0|||
144680918|NCT02623699|521681965|FG002|Part B (Up to 289 Days)|Death|0|||
144680919|NCT02623699|521681966|FG003|Part B (Up to 289 Days)|Death|0|||
144680920|NCT02623699|521681967|FG004|Part B (Up to 289 Days)|Death|0|||
144680921|NCT02623699|521681968|FG005|Part B (Up to 289 Days)|Death|1|||
144680922|NCT02623699|521681969|FG006|Part B (Up to 289 Days)|Death|1|||
144680923|NCT02623699|521681970|FG007|Part B (Up to 289 Days)|Death|0|||
144680924|NCT02623699|521681971|FG008|Part B (Up to 289 Days)|Death|1|||
144680925|NCT02623699|521681972|FG009|Part B (Up to 289 Days)|Death|0|||
144680926|NCT02623699|521681973|FG010|Part B (Up to 289 Days)|Death|0|||
144680927|NCT02623699|521681974|FG011|Part B (Up to 289 Days)|Death|0|||
144680928|NCT02623699|521681963|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
144680929|NCT02623699|521681964|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
144680930|NCT02623699|521681965|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
144680931|NCT02623699|521681966|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
144680932|NCT02623699|521681967|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
144680933|NCT02623699|521681968|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
144680934|NCT02623699|521681969|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
144680935|NCT02623699|521681970|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
144680936|NCT02623699|521681971|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
144680937|NCT02623699|521681972|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
144680938|NCT02623699|521681973|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
144680939|NCT02623699|521681974|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
144680940|NCT02623699|521681963|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680941|NCT02623699|521681964|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680942|NCT02623699|521681965|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680943|NCT02623699|521681966|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680944|NCT02623699|521681967|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680945|NCT02623699|521681968|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680946|NCT02623699|521681969|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680947|NCT02623699|521681970|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680948|NCT02623699|521681971|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680949|NCT02623699|521681972|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
144680950|NCT02623699|521681973|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
144680951|NCT02623699|521681974|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
144680952|NCT02623699|521681963|FG000|Part C (Up to 236 Days)|Death|0|||
144680953|NCT02623699|521681964|FG001|Part C (Up to 236 Days)|Death|0|||
144680954|NCT02623699|521681965|FG002|Part C (Up to 236 Days)|Death|0|||
144680955|NCT02623699|521681966|FG003|Part C (Up to 236 Days)|Death|0|||
144738417|NCT03502811|521897450|FG000|Overall Study|Withdrawal by Subject|105|||
144218308|NCT00344448|519992295|FG000|Open Label|Withdrawal by Subject|1|||
144218309|NCT00344448|519992296|FG001|Open Label|Withdrawal by Subject|1|||
144680956|NCT02623699|521681967|FG004|Part C (Up to 236 Days)|Death|0|||
144680957|NCT02623699|521681968|FG005|Part C (Up to 236 Days)|Death|0|||
144680958|NCT02623699|521681969|FG006|Part C (Up to 236 Days)|Death|0|||
144680959|NCT02623699|521681970|FG007|Part C (Up to 236 Days)|Death|0|||
144680960|NCT02623699|521681971|FG008|Part C (Up to 236 Days)|Death|0|||
144680961|NCT02623699|521681972|FG009|Part C (Up to 236 Days)|Death|0|||
144680962|NCT02623699|521681973|FG010|Part C (Up to 236 Days)|Death|0|||
144680963|NCT02623699|521681974|FG011|Part C (Up to 236 Days)|Death|1|||
144680964|NCT02623699|521681963|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
144738418|NCT03502811|521897450|FG000|Overall Study|Lost to Follow-up|26|||
144680965|NCT02623699|521681964|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
144680966|NCT02623699|521681965|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
144680967|NCT02623699|521681966|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
144680968|NCT02623699|521681967|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
144680969|NCT02623699|521681968|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
144680970|NCT02623699|521681969|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
144680971|NCT02623699|521681970|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
144680972|NCT02623699|521681971|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
144680973|NCT02623699|521681972|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
144680974|NCT02623699|521681973|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
144680975|NCT02623699|521681974|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
144680976|NCT00033371|521681975|FG000|Overall Study|Adverse Event|1|||
144680977|NCT00033371|521681976|FG001|Overall Study|Adverse Event|5|||
144680978|NCT00033371|521681975|FG000|Overall Study|Lost to Follow-up|2|||
144680979|NCT00033371|521681976|FG001|Overall Study|Lost to Follow-up|1|||
144680980|NCT00033371|521681975|FG000|Overall Study|Withdrawal by Subject|3|||
144680981|NCT00033371|521681976|FG001|Overall Study|Withdrawal by Subject|3|||
144680982|NCT00033371|521681975|FG000|Overall Study|Disease Progression|0|||
144680983|NCT00033371|521681976|FG001|Overall Study|Disease Progression|1|||
144680984|NCT01390038|521681977|FG000|Overall Study|Death|1|||
144680985|NCT01390038|521681977|FG000|Overall Study|Lost to Follow-up|1|||
144680986|NCT01390038|521681977|FG000|Overall Study|Withdrawal by Subject|4|||
144680987|NCT01390038|521681977|FG000|Overall Study|Simpliciti System Removal|2|||
144680988|NCT01922739|521681978|FG000|Titration/Adjustment Period|Adverse Event|3|||
144680989|NCT01922739|521681978|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
144680990|NCT01922739|521681978|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
144680991|NCT01922739|521681978|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
144680992|NCT01922739|521681978|FG000|Open-label Treatment Period|Adverse Event|6|||
144680993|NCT01922739|521681978|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
144680994|NCT01922739|521681978|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
144680995|NCT01922739|521681978|FG000|Open-label Treatment Period|Protocol Violation|5|||
144680996|NCT01922739|521681978|FG000|Open-label Treatment Period|Pregnancy|1|||
144680997|NCT01922739|521681978|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
144680998|NCT01922739|521681978|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
144680999|NCT01922739|521681978|FG000|Open-label Treatment Period|Physician Decision|1|||
144681000|NCT01922739|521681978|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
144681001|NCT01927068|521681979|FG000|Overall Study|Death|37|||
144681002|NCT01927068|521681980|FG001|Overall Study|Death|3|||
144681003|NCT01927068|521681979|FG000|Overall Study|Withdrawal by Subject|50|||
144681004|NCT01927068|521681980|FG001|Overall Study|Withdrawal by Subject|3|||
144681005|NCT01927068|521681979|FG000|Overall Study|Lost to Follow-up|10|||
144681006|NCT01927068|521681980|FG001|Overall Study|Lost to Follow-up|2|||
144681007|NCT01927068|521681979|FG000|Overall Study|Physician Decision|9|||
144681008|NCT01927068|521681980|FG001|Overall Study|Physician Decision|0|||
144681009|NCT01927068|521681979|FG000|Overall Study|Missed last follow-up visit|2|||
144681010|NCT01927068|521681980|FG001|Overall Study|Missed last follow-up visit|0|||
144681011|NCT04489940|521681981|FG000|Overall Study|Other|2|||
144681012|NCT04489940|521681981|FG000|Overall Study|Withdrawal by Subject|2|||
144681013|NCT04489940|521681981|FG000|Overall Study|Death|5|||
144681014|NCT04489940|521681981|FG000|Overall Study|Lost to Follow-up|1|||
144681015|NCT02725268|521681982|FG000|Overall Study|Death|58|||
144681016|NCT02725268|521681983|FG001|Overall Study|Death|59|||
144681017|NCT02725268|521681984|FG002|Overall Study|Death|30|||
144681018|NCT02725268|521681985|FG003|Overall Study|Death|16|||
144681019|NCT02725268|521681982|FG000|Overall Study|Lost to Follow-up|4|||
144681020|NCT02725268|521681983|FG001|Overall Study|Lost to Follow-up|3|||
144681021|NCT02725268|521681984|FG002|Overall Study|Lost to Follow-up|0|||
144681022|NCT02725268|521681985|FG003|Overall Study|Lost to Follow-up|1|||
144681023|NCT02725268|521681982|FG000|Overall Study|Site Terminated by Sponsor|0|||
144681024|NCT02725268|521681983|FG001|Overall Study|Site Terminated by Sponsor|1|||
144681025|NCT02725268|521681984|FG002|Overall Study|Site Terminated by Sponsor|0|||
144681026|NCT02725268|521681985|FG003|Overall Study|Site Terminated by Sponsor|0|||
144681027|NCT02725268|521681982|FG000|Overall Study|Withdrawal by Subject|8|||
144681028|NCT02725268|521681983|FG001|Overall Study|Withdrawal by Subject|6|||
144681029|NCT02725268|521681984|FG002|Overall Study|Withdrawal by Subject|8|||
144681030|NCT02725268|521681985|FG003|Overall Study|Withdrawal by Subject|1|||
144681031|NCT02725268|521681982|FG000|Overall Study|Reason not Specified|2|||
144681032|NCT02725268|521681983|FG001|Overall Study|Reason not Specified|1|||
144738419|NCT03502811|521897450|FG000|Overall Study|No Visits (Missed)|31|||
144738420|NCT00604162|521897451|FG000|Overall Study|Physician Decision|3|||
144681033|NCT02725268|521681984|FG002|Overall Study|Reason not Specified|0|||
144681034|NCT02725268|521681985|FG003|Overall Study|Reason not Specified|0|||
144681035|NCT04498468|521681986|FG000|Overall Study|Lost to Follow-up|3|||
144681036|NCT02224274|521681988|FG000|Overall Study|Death|1|||
144681037|NCT02224274|521681989|FG001|Overall Study|Death|0|||
144681038|NCT00814307|521681990|FG000|Overall Study|Randomized but not treated|1|||
144681039|NCT00814307|521681991|FG001|Overall Study|Randomized but not treated|0|||
144681040|NCT00814307|521681992|FG002|Overall Study|Randomized but not treated|0|||
144681041|NCT00814307|521681993|FG003|Overall Study|Randomized but not treated|0|||
144738421|NCT00604162|521897451|FG000|Overall Study|Withdrawal by Subject|1|||
144738422|NCT00736190|521897458|FG000|Overall Study|Pregnancy|1|||
144681042|NCT00814307|521681990|FG000|Overall Study|Adverse Event|3|||
144681043|NCT00814307|521681991|FG001|Overall Study|Adverse Event|9|||
144681044|NCT00814307|521681992|FG002|Overall Study|Adverse Event|3|||
144681045|NCT00814307|521681993|FG003|Overall Study|Adverse Event|2|||
144681046|NCT00814307|521681990|FG000|Overall Study|Lack of Efficacy|1|||
144681047|NCT00814307|521681991|FG001|Overall Study|Lack of Efficacy|1|||
144681048|NCT00814307|521681992|FG002|Overall Study|Lack of Efficacy|3|||
144681049|NCT00814307|521681993|FG003|Overall Study|Lack of Efficacy|4|||
144681050|NCT00814307|521681990|FG000|Overall Study|Other|1|||
144681051|NCT00814307|521681991|FG001|Overall Study|Other|2|||
144681052|NCT00814307|521681992|FG002|Overall Study|Other|0|||
144681053|NCT00814307|521681993|FG003|Overall Study|Other|1|||
144681054|NCT00814307|521681990|FG000|Overall Study|Protocol Violation|2|||
144681055|NCT00814307|521681991|FG001|Overall Study|Protocol Violation|8|||
144681056|NCT00814307|521681992|FG002|Overall Study|Protocol Violation|1|||
144681057|NCT00814307|521681993|FG003|Overall Study|Protocol Violation|1|||
144681058|NCT00814307|521681990|FG000|Overall Study|Withdrawal by Subject|4|||
144681059|NCT00814307|521681991|FG001|Overall Study|Withdrawal by Subject|6|||
144681060|NCT00814307|521681992|FG002|Overall Study|Withdrawal by Subject|0|||
144681061|NCT00814307|521681993|FG003|Overall Study|Withdrawal by Subject|2|||
144681062|NCT00814307|521681990|FG000|Overall Study|Death|0|||
144681063|NCT00814307|521681991|FG001|Overall Study|Death|1|||
144681064|NCT00814307|521681992|FG002|Overall Study|Death|0|||
144681065|NCT00814307|521681993|FG003|Overall Study|Death|0|||
144681066|NCT02290340|521681996|FG000|Overall Study|Lost to Follow-up|0|||
144681067|NCT02290340|521681997|FG001|Overall Study|Lost to Follow-up|0|||
144681068|NCT02290340|521681998|FG002|Overall Study|Lost to Follow-up|0|||
144681069|NCT02290340|521681999|FG003|Overall Study|Lost to Follow-up|1|||
144681070|NCT02290340|521681996|FG000|Overall Study|Withdrawal by Subject|1|||
144681071|NCT02290340|521681997|FG001|Overall Study|Withdrawal by Subject|0|||
144681072|NCT02290340|521681998|FG002|Overall Study|Withdrawal by Subject|0|||
144681073|NCT02290340|521681999|FG003|Overall Study|Withdrawal by Subject|0|||
144681074|NCT02290340|521681996|FG000|Overall Study|Other|1|||
144681075|NCT02290340|521681997|FG001|Overall Study|Other|0|||
144681076|NCT02290340|521681998|FG002|Overall Study|Other|0|||
144681077|NCT02290340|521681999|FG003|Overall Study|Other|1|||
144681078|NCT02571972|521682002|FG000|Overall Study|Protocol Violation|2|||
144681079|NCT02571972|521682002|FG000|Overall Study|Withdrawal by Subject|2|||
144681080|NCT03039192|521682005|FG000|Overall Study|Lost to Follow-up|4|||
144681081|NCT03039192|521682006|FG001|Overall Study|Lost to Follow-up|4|||
144681082|NCT03039192|521682005|FG000|Overall Study|Adverse event, serious fatal|0|||
144681083|NCT03039192|521682006|FG001|Overall Study|Adverse event, serious fatal|1|||
144681084|NCT03039192|521682005|FG000|Overall Study|Adverse event, non-fatal|0|||
144681085|NCT03039192|521682006|FG001|Overall Study|Adverse event, non-fatal|2|||
144681086|NCT03039192|521682005|FG000|Overall Study|Withdrawal by Subject|6|||
144681087|NCT03039192|521682006|FG001|Overall Study|Withdrawal by Subject|9|||
144681088|NCT03039192|521682005|FG000|Overall Study|Discontinued from treatment phase|19|||
144681089|NCT03039192|521682006|FG001|Overall Study|Discontinued from treatment phase|12|||
144681090|NCT03039192|521682005|FG000|Overall Study|Other|3|||
144681091|NCT03039192|521682006|FG001|Overall Study|Other|2|||
144681092|NCT00766142|521683659|FG000|Overall Study|Protocol Violation|4|||
144681093|NCT01432756|521683660|FG000|Overall Study|Lost to Follow-up|1|||
144681094|NCT01432756|521683661|FG001|Overall Study|Lost to Follow-up|0|||
144681095|NCT01432756|521683662|FG002|Overall Study|Lost to Follow-up|2|||
144681096|NCT01432756|521683663|FG003|Overall Study|Lost to Follow-up|1|||
144681097|NCT00777257|521683677|FG000|Overall Study|Adverse Event|3|||
144681098|NCT00777257|521683678|FG001|Overall Study|Adverse Event|1|||
144681099|NCT00777257|521683679|FG002|Overall Study|Adverse Event|0|||
144681100|NCT00777257|521683677|FG000|Overall Study|Lost to Follow-up|3|||
144681101|NCT00777257|521683678|FG001|Overall Study|Lost to Follow-up|3|||
144681102|NCT00777257|521683679|FG002|Overall Study|Lost to Follow-up|2|||
144681103|NCT00777257|521683677|FG000|Overall Study|Protocol Violation|2|||
144681104|NCT00777257|521683678|FG001|Overall Study|Protocol Violation|2|||
144681105|NCT00777257|521683679|FG002|Overall Study|Protocol Violation|2|||
144681106|NCT00777257|521683677|FG000|Overall Study|Withdrawal by Subject|3|||
144681107|NCT00777257|521683678|FG001|Overall Study|Withdrawal by Subject|6|||
144681108|NCT00777257|521683679|FG002|Overall Study|Withdrawal by Subject|5|||
144681109|NCT02973997|521683684|FG000|Overall Study|Withdrawal by Subject|4|||
144681110|NCT02973997|521683685|FG001|Overall Study|Withdrawal by Subject|0|||
144681111|NCT02973997|521683684|FG000|Overall Study|Adverse Event|4|||
144681112|NCT02973997|521683685|FG001|Overall Study|Adverse Event|1|||
144681113|NCT02973997|521683684|FG000|Overall Study|Disease Progression|11|||
144681114|NCT02973997|521683685|FG001|Overall Study|Disease Progression|20|||
144681115|NCT02973997|521683684|FG000|Overall Study|Alternative Therapy|3|||
144681116|NCT02973997|521683685|FG001|Overall Study|Alternative Therapy|0|||
144681117|NCT02973997|521683684|FG000|Overall Study|Other complicating disease|0|||
144681118|NCT02973997|521683685|FG001|Overall Study|Other complicating disease|1|||
144681119|NCT02973997|521683684|FG000|Overall Study|Death|0|||
144681120|NCT02973997|521683685|FG001|Overall Study|Death|1|||
144681121|NCT01431521|521683686|FG000|Overall Study|Withdrawal by Subject|0|||
144681122|NCT01431521|521683687|FG001|Overall Study|Withdrawal by Subject|0|||
144681123|NCT01431521|521683688|FG002|Overall Study|Withdrawal by Subject|1|||
144681124|NCT01431521|521683689|FG003|Overall Study|Withdrawal by Subject|0|||
144681125|NCT00444951|521683690|FG000|Overall Study|Lost to Follow-up|1|||
144681126|NCT00444951|521683691|FG001|Overall Study|Lost to Follow-up|1|||
144681127|NCT00444951|521683692|FG002|Overall Study|Lost to Follow-up|0|||
144681128|NCT00444951|521683690|FG000|Overall Study|Withdrawal by Subject|4|||
144681129|NCT00444951|521683691|FG001|Overall Study|Withdrawal by Subject|5|||
144681130|NCT00444951|521683692|FG002|Overall Study|Withdrawal by Subject|3|||
144681131|NCT00366444|521683694|FG000|Overall Study|Withdrawal by Subject|1|||
144681132|NCT00366444|521683695|FG001|Overall Study|Withdrawal by Subject|1|||
144681133|NCT00366444|521683694|FG000|Overall Study|Lack of Efficacy|0|||
144681134|NCT00366444|521683695|FG001|Overall Study|Lack of Efficacy|1|||
144681135|NCT06048809|521683703|FG000|Overall Study|Adverse Event|2|||
144681136|NCT06048809|521683704|FG001|Overall Study|Adverse Event|0|||
144681137|NCT06048809|521683703|FG000|Overall Study|Withdrawal by Subject|1|||
144681138|NCT06048809|521683704|FG001|Overall Study|Withdrawal by Subject|1|||
144681139|NCT02352090|521683710|FG000|Overall Study|general malaise|1|||
144681140|NCT02352090|521683711|FG001|Overall Study|general malaise|0|||
144681141|NCT02352090|521683712|FG002|Overall Study|general malaise|0|||
144681142|NCT02352090|521683710|FG000|Overall Study|non-specified mild side-effects|0|||
144681143|NCT02352090|521683711|FG001|Overall Study|non-specified mild side-effects|0|||
144681144|NCT02352090|521683712|FG002|Overall Study|non-specified mild side-effects|2|||
144681145|NCT05179057|521683713|FG000|Overall Study|Adverse Event|3|||
144681146|NCT05179057|521683714|FG001|Overall Study|Adverse Event|2|||
144681147|NCT05179057|521683713|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
144681148|NCT05179057|521683714|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
144681149|NCT05179057|521683713|FG000|Overall Study|Study terminated|13|||
144681150|NCT05179057|521683714|FG001|Overall Study|Study terminated|7|||
144681151|NCT05179057|521683713|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
144681152|NCT05179057|521683714|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
144681153|NCT05179057|521683713|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
144681154|NCT05179057|521683714|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
144681155|NCT03146403|521683724|FG000|Overall Study|Withdrawal by Subject|0|||
144681156|NCT03146403|521683725|FG001|Overall Study|Withdrawal by Subject|3|||
144681157|NCT03146403|521683724|FG000|Overall Study|Lost to Follow-up|2|||
144681158|NCT03146403|521683725|FG001|Overall Study|Lost to Follow-up|0|||
144681159|NCT02182999|521683727|FG000|Overall Study|Adverse Event|4|||
144681160|NCT02182999|521683728|FG001|Overall Study|Adverse Event|3|||
144681161|NCT02182999|521683727|FG000|Overall Study|Physician Decision|1|||
144681162|NCT02182999|521683728|FG001|Overall Study|Physician Decision|0|||
144681163|NCT02252588|521683730|FG000|Overall Study|Withdrawal by Subject|4|||
144681164|NCT02252588|521683731|FG001|Overall Study|Withdrawal by Subject|0|||
144681165|NCT03039790|521683733|FG000|Overall Study|Lost to Follow-up|2|||
144681166|NCT03039790|521683734|FG001|Overall Study|Lost to Follow-up|0|||
144681167|NCT03039790|521683735|FG002|Overall Study|Lost to Follow-up|1|||
144681168|NCT03039790|521683736|FG003|Overall Study|Lost to Follow-up|1|||
144681169|NCT03039790|521683737|FG004|Overall Study|Lost to Follow-up|0|||
144681170|NCT03039790|521683738|FG005|Overall Study|Lost to Follow-up|1|||
144681171|NCT03039790|521683739|FG006|Overall Study|Lost to Follow-up|1|||
144681172|NCT03039790|521683740|FG007|Overall Study|Lost to Follow-up|1|||
144681173|NCT03039790|521683741|FG008|Overall Study|Lost to Follow-up|0|||
144681174|NCT03039790|521683742|FG009|Overall Study|Lost to Follow-up|1|||
144681175|NCT03039790|521683743|FG010|Overall Study|Lost to Follow-up|1|||
144681176|NCT03039790|521683744|FG011|Overall Study|Lost to Follow-up|0|||
144681177|NCT03039790|521683745|FG012|Overall Study|Lost to Follow-up|1|||
144681178|NCT03039790|521683746|FG013|Overall Study|Lost to Follow-up|0|||
144681179|NCT03039790|521683747|FG014|Overall Study|Lost to Follow-up|3|||
144681180|NCT03039790|521683748|FG015|Overall Study|Lost to Follow-up|1|||
144681181|NCT03039790|521683749|FG016|Overall Study|Lost to Follow-up|2|||
144681182|NCT03039790|521683750|FG017|Overall Study|Lost to Follow-up|2|||
144681183|NCT03039790|521683751|FG018|Overall Study|Lost to Follow-up|1|||
144681184|NCT03039790|521683752|FG019|Overall Study|Lost to Follow-up|3|||
144681185|NCT03039790|521683733|FG000|Overall Study|Withdrawal of Consent|1|||
144681186|NCT03039790|521683734|FG001|Overall Study|Withdrawal of Consent|0|||
144681187|NCT03039790|521683735|FG002|Overall Study|Withdrawal of Consent|0|||
144681188|NCT03039790|521683736|FG003|Overall Study|Withdrawal of Consent|1|||
144218310|NCT00344448|519992295|FG000|Open Label|Study terminated|1|||
144218311|NCT00344448|519992296|FG001|Open Label|Study terminated|0|||
144681189|NCT03039790|521683737|FG004|Overall Study|Withdrawal of Consent|0|||
144681190|NCT03039790|521683738|FG005|Overall Study|Withdrawal of Consent|0|||
144681191|NCT03039790|521683739|FG006|Overall Study|Withdrawal of Consent|0|||
144681192|NCT03039790|521683740|FG007|Overall Study|Withdrawal of Consent|0|||
144681193|NCT03039790|521683741|FG008|Overall Study|Withdrawal of Consent|0|||
144681194|NCT03039790|521683742|FG009|Overall Study|Withdrawal of Consent|1|||
144681195|NCT03039790|521683743|FG010|Overall Study|Withdrawal of Consent|0|||
144681196|NCT03039790|521683744|FG011|Overall Study|Withdrawal of Consent|0|||
144681197|NCT03039790|521683745|FG012|Overall Study|Withdrawal of Consent|2|||
144681198|NCT03039790|521683746|FG013|Overall Study|Withdrawal of Consent|0|||
144681199|NCT03039790|521683747|FG014|Overall Study|Withdrawal of Consent|1|||
144681200|NCT03039790|521683748|FG015|Overall Study|Withdrawal of Consent|5|||
144681201|NCT03039790|521683749|FG016|Overall Study|Withdrawal of Consent|3|||
144681202|NCT03039790|521683750|FG017|Overall Study|Withdrawal of Consent|0|||
144681203|NCT03039790|521683751|FG018|Overall Study|Withdrawal of Consent|2|||
144681204|NCT03039790|521683752|FG019|Overall Study|Withdrawal of Consent|5|||
144681205|NCT03039790|521683733|FG000|Overall Study|Death|0|||
144681206|NCT03039790|521683734|FG001|Overall Study|Death|0|||
144681207|NCT03039790|521683735|FG002|Overall Study|Death|0|||
144681208|NCT03039790|521683736|FG003|Overall Study|Death|0|||
144681209|NCT03039790|521683737|FG004|Overall Study|Death|0|||
144681210|NCT03039790|521683738|FG005|Overall Study|Death|0|||
144681211|NCT03039790|521683739|FG006|Overall Study|Death|0|||
144681212|NCT03039790|521683740|FG007|Overall Study|Death|0|||
144681213|NCT03039790|521683741|FG008|Overall Study|Death|0|||
144681214|NCT03039790|521683742|FG009|Overall Study|Death|0|||
144681215|NCT03039790|521683743|FG010|Overall Study|Death|0|||
144681216|NCT03039790|521683744|FG011|Overall Study|Death|0|||
144681217|NCT03039790|521683745|FG012|Overall Study|Death|0|||
144681218|NCT03039790|521683746|FG013|Overall Study|Death|0|||
144681219|NCT03039790|521683747|FG014|Overall Study|Death|0|||
144681220|NCT03039790|521683748|FG015|Overall Study|Death|1|||
144681221|NCT03039790|521683749|FG016|Overall Study|Death|3|||
144681222|NCT03039790|521683750|FG017|Overall Study|Death|0|||
144681223|NCT03039790|521683751|FG018|Overall Study|Death|2|||
144681224|NCT03039790|521683752|FG019|Overall Study|Death|0|||
144681225|NCT03039790|521683733|FG000|Overall Study|Reason, not Specified|1|||
144681226|NCT03039790|521683734|FG001|Overall Study|Reason, not Specified|0|||
144681227|NCT03039790|521683735|FG002|Overall Study|Reason, not Specified|0|||
144681228|NCT03039790|521683736|FG003|Overall Study|Reason, not Specified|0|||
144681229|NCT03039790|521683737|FG004|Overall Study|Reason, not Specified|0|||
144681230|NCT03039790|521683738|FG005|Overall Study|Reason, not Specified|0|||
144681231|NCT03039790|521683739|FG006|Overall Study|Reason, not Specified|0|||
144681232|NCT03039790|521683740|FG007|Overall Study|Reason, not Specified|0|||
144681233|NCT03039790|521683741|FG008|Overall Study|Reason, not Specified|0|||
144681234|NCT03039790|521683742|FG009|Overall Study|Reason, not Specified|0|||
144681235|NCT03039790|521683743|FG010|Overall Study|Reason, not Specified|0|||
144681236|NCT03039790|521683744|FG011|Overall Study|Reason, not Specified|0|||
144681237|NCT03039790|521683745|FG012|Overall Study|Reason, not Specified|0|||
144681238|NCT03039790|521683746|FG013|Overall Study|Reason, not Specified|0|||
144681239|NCT03039790|521683747|FG014|Overall Study|Reason, not Specified|0|||
144681240|NCT03039790|521683748|FG015|Overall Study|Reason, not Specified|0|||
144681241|NCT03039790|521683749|FG016|Overall Study|Reason, not Specified|2|||
144681242|NCT03039790|521683750|FG017|Overall Study|Reason, not Specified|0|||
144681243|NCT03039790|521683751|FG018|Overall Study|Reason, not Specified|1|||
144681244|NCT03039790|521683752|FG019|Overall Study|Reason, not Specified|0|||
144681245|NCT00498368|521683762|FG000|Overall Study|Withdrawal by Subject|3|||
144681246|NCT00498368|521683763|FG001|Overall Study|Withdrawal by Subject|2|||
144681247|NCT02266004|521683764|FG000|Overall Study|unrelated adverse event|1|||
144681248|NCT02266004|521683764|FG000|Overall Study|Physician Decision|1|||
144681249|NCT00537771|521683769|FG000|Overall Study|Withdrawal by Subject|6|||
144681250|NCT00537771|521683770|FG001|Overall Study|Withdrawal by Subject|23|||
144681251|NCT00537771|521683769|FG000|Overall Study|Adverse Event|8|||
144681252|NCT00537771|521683770|FG001|Overall Study|Adverse Event|15|||
144681253|NCT00537771|521683769|FG000|Overall Study|Lost to Follow-up|9|||
144681254|NCT00537771|521683770|FG001|Overall Study|Lost to Follow-up|15|||
144681255|NCT00537771|521683769|FG000|Overall Study|Protocol Violation|2|||
144265837|NCT01211145|520174017|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
144681256|NCT00537771|521683770|FG001|Overall Study|Protocol Violation|6|||
144681257|NCT00537771|521683769|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
144681258|NCT00537771|521683770|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
144681259|NCT02736929|521683774|FG000|Main Study|Lost to Follow-up|7|||
144681260|NCT02736929|521683775|FG001|Main Study|Lost to Follow-up|1|||
144681261|NCT02736929|521683776|FG002|Main Study|Lost to Follow-up|0|||
144681262|NCT02736929|521683774|FG000|Main Study|Withdrawal by Subject|1|||
144681263|NCT02736929|521683775|FG001|Main Study|Withdrawal by Subject|1|||
144681264|NCT02736929|521683776|FG002|Main Study|Withdrawal by Subject|0|||
144681265|NCT02736929|521683774|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
144681266|NCT02736929|521683775|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
144681267|NCT02736929|521683776|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
144681268|NCT00693693|521683779|FG000|Overall Study|Lost to Follow-up|1|||
144681269|NCT00693693|521683780|FG001|Overall Study|Lost to Follow-up|1|||
144681270|NCT00693693|521683781|FG002|Overall Study|Lost to Follow-up|2|||
144681271|NCT02465489|521683782|FG000|Overall Study|Adverse Event|5|||
144681272|NCT00285649|521683783|FG000|Overall Study|Lost to Follow-up|6|||
144681273|NCT00285649|521683784|FG001|Overall Study|Lost to Follow-up|4|||
144681274|NCT00285649|521683785|FG002|Overall Study|Lost to Follow-up|4|||
144681275|NCT00285649|521683783|FG000|Overall Study|Withdrawal by Subject|3|||
144681276|NCT00285649|521683784|FG001|Overall Study|Withdrawal by Subject|2|||
144681277|NCT00285649|521683785|FG002|Overall Study|Withdrawal by Subject|2|||
144681278|NCT02972593|521683786|FG000|Overall Study|Lost to Follow-up|19|||
144681279|NCT02972593|521683787|FG001|Overall Study|Lost to Follow-up|15|||
144681280|NCT02972593|521683786|FG000|Overall Study|Protocol Violation|1|||
144681281|NCT02972593|521683787|FG001|Overall Study|Protocol Violation|0|||
144681282|NCT02203916|521683797|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
144681283|NCT02203916|521683798|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
144681284|NCT02203916|521683799|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
144681285|NCT02203916|521683797|FG000|Overall Study|Major Protocol Deviation|1|||
144681286|NCT02203916|521683798|FG001|Overall Study|Major Protocol Deviation|1|||
144681287|NCT02203916|521683799|FG002|Overall Study|Major Protocol Deviation|0|||
144681288|NCT02203916|521683797|FG000|Overall Study|Lost to Follow-up|0|||
144681289|NCT02203916|521683798|FG001|Overall Study|Lost to Follow-up|1|||
144681290|NCT02203916|521683799|FG002|Overall Study|Lost to Follow-up|0|||
144681291|NCT02203916|521683797|FG000|Overall Study|Voluntary Withdrawal|3|||
144681292|NCT02203916|521683798|FG001|Overall Study|Voluntary Withdrawal|3|||
144681293|NCT02203916|521683799|FG002|Overall Study|Voluntary Withdrawal|8|||
144681294|NCT02203916|521683797|FG000|Overall Study|Lack of Efficacy|3|||
144681295|NCT02203916|521683798|FG001|Overall Study|Lack of Efficacy|0|||
144681296|NCT02203916|521683799|FG002|Overall Study|Lack of Efficacy|0|||
144681297|NCT02203916|521683797|FG000|Overall Study|Reason Not Specified|0|||
144681298|NCT02203916|521683798|FG001|Overall Study|Reason Not Specified|2|||
144681299|NCT02203916|521683799|FG002|Overall Study|Reason Not Specified|1|||
144681300|NCT00414973|521683800|FG000|Overall Study|Withdrawal by Subject|14|||
144681301|NCT00414973|521683801|FG001|Overall Study|Withdrawal by Subject|4|||
144681302|NCT00414973|521683802|FG002|Overall Study|Withdrawal by Subject|1|||
144681303|NCT00414973|521683803|FG003|Overall Study|Withdrawal by Subject|0|||
144681304|NCT00414973|521683800|FG000|Overall Study|Adverse Event|10|||
144681305|NCT00414973|521683801|FG001|Overall Study|Adverse Event|0|||
144681306|NCT00414973|521683802|FG002|Overall Study|Adverse Event|1|||
144681307|NCT00414973|521683803|FG003|Overall Study|Adverse Event|0|||
144681308|NCT00414973|521683800|FG000|Overall Study|Protocol Violation|3|||
144681309|NCT00414973|521683801|FG001|Overall Study|Protocol Violation|4|||
144681310|NCT00414973|521683802|FG002|Overall Study|Protocol Violation|0|||
144681311|NCT00414973|521683803|FG003|Overall Study|Protocol Violation|0|||
144681312|NCT00414973|521683800|FG000|Overall Study|Lost to Follow-up|0|||
144681313|NCT00414973|521683801|FG001|Overall Study|Lost to Follow-up|2|||
144681314|NCT00414973|521683802|FG002|Overall Study|Lost to Follow-up|0|||
144681315|NCT00414973|521683803|FG003|Overall Study|Lost to Follow-up|0|||
144681316|NCT00414973|521683800|FG000|Overall Study|Sponsor Decision|1|||
144681317|NCT00414973|521683801|FG001|Overall Study|Sponsor Decision|0|||
144681318|NCT00414973|521683802|FG002|Overall Study|Sponsor Decision|0|||
144681319|NCT00414973|521683803|FG003|Overall Study|Sponsor Decision|0|||
144681320|NCT00414973|521683800|FG000|Overall Study|Death|0|||
144681321|NCT00414973|521683801|FG001|Overall Study|Death|0|||
144681322|NCT00414973|521683802|FG002|Overall Study|Death|1|||
144681323|NCT00414973|521683803|FG003|Overall Study|Death|0|||
144681324|NCT03215667|521683804|FG000|Overall Study|Physician Decision|4|||
144681325|NCT01810380|521683807|FG000|Overall Study|Randomised not treated|2|||
144681326|NCT01810380|521683808|FG001|Overall Study|Randomised not treated|1|||
144681327|NCT01810380|521683809|FG002|Overall Study|Randomised not treated|1|||
144681328|NCT01810380|521683807|FG000|Overall Study|Adverse Event|11|||
144681329|NCT01810380|521683808|FG001|Overall Study|Adverse Event|14|||
144681330|NCT01810380|521683809|FG002|Overall Study|Adverse Event|4|||
144681331|NCT01810380|521683807|FG000|Overall Study|Lack of Efficacy|24|||
144681332|NCT01810380|521683808|FG001|Overall Study|Lack of Efficacy|10|||
144738423|NCT00736190|521897458|FG000|Overall Study|Withdrawal by Subject|1|||
144738424|NCT00736190|521897458|FG000|Overall Study|Adverse Event|1|||
144681333|NCT01810380|521683809|FG002|Overall Study|Lack of Efficacy|11|||
144681334|NCT01810380|521683807|FG000|Overall Study|Protocol Violation|1|||
144681335|NCT01810380|521683808|FG001|Overall Study|Protocol Violation|0|||
144681336|NCT01810380|521683809|FG002|Overall Study|Protocol Violation|1|||
144681337|NCT01810380|521683807|FG000|Overall Study|Withdrawal by Subject|6|||
144681338|NCT01810380|521683808|FG001|Overall Study|Withdrawal by Subject|0|||
144681339|NCT01810380|521683809|FG002|Overall Study|Withdrawal by Subject|6|||
144681340|NCT01810380|521683807|FG000|Overall Study|Administrative or other reasons|11|||
144681341|NCT01810380|521683808|FG001|Overall Study|Administrative or other reasons|13|||
144681342|NCT01810380|521683809|FG002|Overall Study|Administrative or other reasons|9|||
144738425|NCT00673660|521897459|FG000|Overall Study|Lost to Follow-up|107|||
144681343|NCT00614991|521683810|FG000|Overall Study|Adverse Event|3|||
144681344|NCT00614991|521683811|FG001|Overall Study|Adverse Event|3|||
144681345|NCT00614991|521683812|FG002|Overall Study|Adverse Event|0|||
144738426|NCT01527006|521897460|FG000|Core Study|Adverse Event|0|||
144681346|NCT00614991|521683813|FG003|Overall Study|Adverse Event|0|||
144681347|NCT00614991|521683814|FG004|Overall Study|Adverse Event|1|||
144738427|NCT01527006|521897461|FG001|Core Study|Adverse Event|2|||
144681348|NCT00614991|521683815|FG005|Overall Study|Adverse Event|0|||
144681349|NCT03799627|521683816|FG000|Overall Study|Adverse Event|1|||
144681350|NCT03799627|521683817|FG001|Overall Study|Adverse Event|2|||
144681351|NCT03799627|521683818|FG002|Overall Study|Adverse Event|0|||
144681352|NCT03799627|521683819|FG003|Overall Study|Adverse Event|0|||
144681353|NCT03799627|521683820|FG004|Overall Study|Adverse Event|2|||
144681354|NCT03799627|521683821|FG005|Overall Study|Adverse Event|5|||
144681355|NCT03799627|521683822|FG006|Overall Study|Adverse Event|0|||
144681356|NCT03799627|521683823|FG007|Overall Study|Adverse Event|2|||
144681357|NCT03799627|521683824|FG008|Overall Study|Adverse Event|0|||
144681358|NCT03799627|521683816|FG000|Overall Study|Physician Decision|2|||
144681359|NCT03799627|521683817|FG001|Overall Study|Physician Decision|2|||
144681360|NCT03799627|521683818|FG002|Overall Study|Physician Decision|0|||
144681361|NCT03799627|521683819|FG003|Overall Study|Physician Decision|0|||
144681362|NCT03799627|521683820|FG004|Overall Study|Physician Decision|2|||
144681363|NCT03799627|521683821|FG005|Overall Study|Physician Decision|2|||
144681364|NCT03799627|521683822|FG006|Overall Study|Physician Decision|0|||
144681365|NCT03799627|521683823|FG007|Overall Study|Physician Decision|0|||
144681366|NCT03799627|521683824|FG008|Overall Study|Physician Decision|0|||
144681367|NCT03799627|521683816|FG000|Overall Study|Withdrawal by Subject|1|||
144681368|NCT03799627|521683817|FG001|Overall Study|Withdrawal by Subject|1|||
144681369|NCT03799627|521683818|FG002|Overall Study|Withdrawal by Subject|0|||
144681370|NCT03799627|521683819|FG003|Overall Study|Withdrawal by Subject|2|||
144681371|NCT03799627|521683820|FG004|Overall Study|Withdrawal by Subject|0|||
144681372|NCT03799627|521683821|FG005|Overall Study|Withdrawal by Subject|3|||
144681373|NCT03799627|521683822|FG006|Overall Study|Withdrawal by Subject|0|||
144681374|NCT03799627|521683823|FG007|Overall Study|Withdrawal by Subject|0|||
144681375|NCT03799627|521683824|FG008|Overall Study|Withdrawal by Subject|0|||
144681376|NCT03799627|521683816|FG000|Overall Study|Lack of Efficacy|0|||
144681377|NCT03799627|521683817|FG001|Overall Study|Lack of Efficacy|0|||
144681378|NCT03799627|521683818|FG002|Overall Study|Lack of Efficacy|0|||
144681379|NCT03799627|521683819|FG003|Overall Study|Lack of Efficacy|1|||
144681380|NCT03799627|521683820|FG004|Overall Study|Lack of Efficacy|0|||
144681381|NCT03799627|521683821|FG005|Overall Study|Lack of Efficacy|0|||
144681382|NCT03799627|521683822|FG006|Overall Study|Lack of Efficacy|0|||
144681383|NCT03799627|521683823|FG007|Overall Study|Lack of Efficacy|0|||
144681384|NCT03799627|521683824|FG008|Overall Study|Lack of Efficacy|0|||
144681385|NCT03799627|521683816|FG000|Overall Study|Lost to Follow-up|0|||
144681386|NCT03799627|521683817|FG001|Overall Study|Lost to Follow-up|0|||
144681387|NCT03799627|521683818|FG002|Overall Study|Lost to Follow-up|0|||
144681388|NCT03799627|521683819|FG003|Overall Study|Lost to Follow-up|0|||
144681389|NCT03799627|521683820|FG004|Overall Study|Lost to Follow-up|0|||
144681390|NCT03799627|521683821|FG005|Overall Study|Lost to Follow-up|0|||
144681391|NCT03799627|521683822|FG006|Overall Study|Lost to Follow-up|1|||
144681392|NCT03799627|521683823|FG007|Overall Study|Lost to Follow-up|0|||
144681393|NCT03799627|521683824|FG008|Overall Study|Lost to Follow-up|1|||
144681394|NCT03799627|521683816|FG000|Overall Study|Death|0|||
144681395|NCT03799627|521683817|FG001|Overall Study|Death|0|||
144681396|NCT03799627|521683818|FG002|Overall Study|Death|0|||
144681397|NCT03799627|521683819|FG003|Overall Study|Death|1|||
144681398|NCT03799627|521683820|FG004|Overall Study|Death|0|||
144681399|NCT03799627|521683821|FG005|Overall Study|Death|0|||
144681400|NCT03799627|521683822|FG006|Overall Study|Death|0|||
144681401|NCT03799627|521683823|FG007|Overall Study|Death|0|||
144681402|NCT03799627|521683824|FG008|Overall Study|Death|0|||
144681403|NCT03799627|521683816|FG000|Overall Study|Study Drug Put on Hold|1|||
144681404|NCT03799627|521683817|FG001|Overall Study|Study Drug Put on Hold|0|||
144681405|NCT03799627|521683818|FG002|Overall Study|Study Drug Put on Hold|0|||
144681406|NCT03799627|521683819|FG003|Overall Study|Study Drug Put on Hold|0|||
144681407|NCT03799627|521683820|FG004|Overall Study|Study Drug Put on Hold|0|||
144681408|NCT03799627|521683821|FG005|Overall Study|Study Drug Put on Hold|0|||
144681409|NCT03799627|521683822|FG006|Overall Study|Study Drug Put on Hold|0|||
144681410|NCT03799627|521683823|FG007|Overall Study|Study Drug Put on Hold|0|||
144681411|NCT03799627|521683824|FG008|Overall Study|Study Drug Put on Hold|0|||
144681412|NCT03799627|521683816|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
144738428|NCT01527006|521897460|FG000|Core Study|Lost to Follow-up|0|||
144738429|NCT01527006|521897461|FG001|Core Study|Lost to Follow-up|1|||
144265838|NCT01211145|520174014|FG000|Overall Study|Patient decision|2|||
144681413|NCT03799627|521683817|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
144681414|NCT03799627|521683818|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
144681415|NCT03799627|521683819|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
144681416|NCT03799627|521683820|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
144738430|NCT01527006|521897460|FG000|Core Study|Subject Choice|1|||
144681417|NCT03799627|521683821|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
144681418|NCT03799627|521683822|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
144681419|NCT03799627|521683823|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
144265839|NCT01211145|520174015|FG001|Overall Study|Patient decision|1|||
144681420|NCT03799627|521683824|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
144681421|NCT03799627|521683816|FG000|Overall Study|Kidney Transplantation|1|||
144681422|NCT03799627|521683817|FG001|Overall Study|Kidney Transplantation|0|||
144681423|NCT03799627|521683818|FG002|Overall Study|Kidney Transplantation|0|||
144681424|NCT03799627|521683819|FG003|Overall Study|Kidney Transplantation|1|||
144681425|NCT03799627|521683820|FG004|Overall Study|Kidney Transplantation|1|||
144681426|NCT03799627|521683821|FG005|Overall Study|Kidney Transplantation|0|||
144681427|NCT03799627|521683822|FG006|Overall Study|Kidney Transplantation|0|||
144681428|NCT03799627|521683823|FG007|Overall Study|Kidney Transplantation|0|||
144681429|NCT03799627|521683824|FG008|Overall Study|Kidney Transplantation|0|||
144681430|NCT03799627|521683816|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
144681431|NCT03799627|521683817|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
144681432|NCT03799627|521683818|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
144681433|NCT03799627|521683819|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
144681434|NCT03799627|521683820|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
144681435|NCT03799627|521683821|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
144681436|NCT03799627|521683822|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
144681437|NCT03799627|521683823|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
144681438|NCT03799627|521683824|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
144681439|NCT03799627|521683816|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681440|NCT03799627|521683817|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
144681441|NCT03799627|521683818|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681442|NCT03799627|521683819|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681443|NCT03799627|521683820|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681444|NCT03799627|521683821|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681445|NCT03799627|521683822|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681446|NCT03799627|521683823|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681447|NCT03799627|521683824|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
144681448|NCT03799627|521683816|FG000|Overall Study|Met Exclusion Criteria|0|||
144681449|NCT03799627|521683817|FG001|Overall Study|Met Exclusion Criteria|0|||
144681450|NCT03799627|521683818|FG002|Overall Study|Met Exclusion Criteria|0|||
144681451|NCT03799627|521683819|FG003|Overall Study|Met Exclusion Criteria|1|||
144681452|NCT03799627|521683820|FG004|Overall Study|Met Exclusion Criteria|0|||
144681453|NCT03799627|521683821|FG005|Overall Study|Met Exclusion Criteria|0|||
144681454|NCT03799627|521683822|FG006|Overall Study|Met Exclusion Criteria|0|||
144681455|NCT03799627|521683823|FG007|Overall Study|Met Exclusion Criteria|0|||
144681456|NCT03799627|521683824|FG008|Overall Study|Met Exclusion Criteria|0|||
144681457|NCT03799627|521683816|FG000|Overall Study|Investigational Product Noncompliance|0|||
144681458|NCT03799627|521683817|FG001|Overall Study|Investigational Product Noncompliance|0|||
144681459|NCT03799627|521683818|FG002|Overall Study|Investigational Product Noncompliance|0|||
144681460|NCT03799627|521683819|FG003|Overall Study|Investigational Product Noncompliance|1|||
144681461|NCT03799627|521683820|FG004|Overall Study|Investigational Product Noncompliance|0|||
144681462|NCT03799627|521683821|FG005|Overall Study|Investigational Product Noncompliance|0|||
144681463|NCT03799627|521683822|FG006|Overall Study|Investigational Product Noncompliance|0|||
144681464|NCT03799627|521683823|FG007|Overall Study|Investigational Product Noncompliance|0|||
144681465|NCT03799627|521683824|FG008|Overall Study|Investigational Product Noncompliance|0|||
144681466|NCT03799627|521683816|FG000|Overall Study|Participant Relocation|0|||
144681467|NCT03799627|521683817|FG001|Overall Study|Participant Relocation|0|||
144681468|NCT03799627|521683818|FG002|Overall Study|Participant Relocation|0|||
144681469|NCT03799627|521683819|FG003|Overall Study|Participant Relocation|1|||
144681470|NCT03799627|521683820|FG004|Overall Study|Participant Relocation|0|||
144681471|NCT03799627|521683821|FG005|Overall Study|Participant Relocation|1|||
144681472|NCT03799627|521683822|FG006|Overall Study|Participant Relocation|0|||
144681473|NCT03799627|521683823|FG007|Overall Study|Participant Relocation|0|||
144681474|NCT03799627|521683824|FG008|Overall Study|Participant Relocation|0|||
144681475|NCT03799627|521683816|FG000|Overall Study|Eurofin Issue|0|||
144681476|NCT03799627|521683817|FG001|Overall Study|Eurofin Issue|0|||
144681477|NCT03799627|521683818|FG002|Overall Study|Eurofin Issue|0|||
144681478|NCT03799627|521683819|FG003|Overall Study|Eurofin Issue|0|||
144681479|NCT03799627|521683820|FG004|Overall Study|Eurofin Issue|1|||
144681480|NCT03799627|521683821|FG005|Overall Study|Eurofin Issue|0|||
144681481|NCT03799627|521683822|FG006|Overall Study|Eurofin Issue|0|||
144681482|NCT03799627|521683823|FG007|Overall Study|Eurofin Issue|0|||
144681483|NCT03799627|521683824|FG008|Overall Study|Eurofin Issue|0|||
144738431|NCT01527006|521897461|FG001|Core Study|Subject Choice|0|||
144681484|NCT03799627|521683816|FG000|Overall Study|Noncompliance with Site Instructions|0|||
144681485|NCT03799627|521683817|FG001|Overall Study|Noncompliance with Site Instructions|0|||
144681486|NCT03799627|521683818|FG002|Overall Study|Noncompliance with Site Instructions|0|||
144681487|NCT03799627|521683819|FG003|Overall Study|Noncompliance with Site Instructions|0|||
144681488|NCT03799627|521683820|FG004|Overall Study|Noncompliance with Site Instructions|1|||
144738432|NCT01527006|521897460|FG000|Core Study|Inadequate Therapeutic Effect|1|||
144738433|NCT01527006|521897461|FG001|Core Study|Inadequate Therapeutic Effect|0|||
144738434|NCT01527006|521897460|FG000|Core Study|Withdrawal by Subject|0|||
144681489|NCT03799627|521683821|FG005|Overall Study|Noncompliance with Site Instructions|0|||
144681490|NCT03799627|521683822|FG006|Overall Study|Noncompliance with Site Instructions|0|||
144681491|NCT03799627|521683823|FG007|Overall Study|Noncompliance with Site Instructions|0|||
144681492|NCT03799627|521683824|FG008|Overall Study|Noncompliance with Site Instructions|0|||
144681493|NCT03799627|521683816|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681494|NCT03799627|521683817|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681495|NCT03799627|521683818|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681496|NCT03799627|521683819|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681497|NCT03799627|521683820|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
144681498|NCT03799627|521683821|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681499|NCT03799627|521683822|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681500|NCT03799627|521683823|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681501|NCT03799627|521683824|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
144681502|NCT03799627|521683816|FG000|Overall Study|Changes In Hemoglobin Values|1|||
144681503|NCT03799627|521683817|FG001|Overall Study|Changes In Hemoglobin Values|2|||
144681504|NCT03799627|521683818|FG002|Overall Study|Changes In Hemoglobin Values|1|||
144681505|NCT03799627|521683819|FG003|Overall Study|Changes In Hemoglobin Values|0|||
144681506|NCT03799627|521683820|FG004|Overall Study|Changes In Hemoglobin Values|0|||
144681507|NCT03799627|521683821|FG005|Overall Study|Changes In Hemoglobin Values|2|||
144681508|NCT03799627|521683822|FG006|Overall Study|Changes In Hemoglobin Values|1|||
144681509|NCT03799627|521683823|FG007|Overall Study|Changes In Hemoglobin Values|0|||
144681510|NCT03799627|521683824|FG008|Overall Study|Changes In Hemoglobin Values|1|||
144681511|NCT00422240|521683829|FG000|Overall Study|Lack of Efficacy|1|||
144681512|NCT00422240|521683830|FG001|Overall Study|Lack of Efficacy|2|||
144681513|NCT00422240|521683831|FG002|Overall Study|Lack of Efficacy|0|||
144681514|NCT00422240|521683832|FG003|Overall Study|Lack of Efficacy|1|||
144681515|NCT00422240|521683829|FG000|Overall Study|Adverse Event|11|||
144681516|NCT00422240|521683830|FG001|Overall Study|Adverse Event|4|||
144681517|NCT00422240|521683831|FG002|Overall Study|Adverse Event|5|||
144681518|NCT00422240|521683832|FG003|Overall Study|Adverse Event|2|||
144681519|NCT00422240|521683829|FG000|Overall Study|Subject request|21|||
144681520|NCT00422240|521683830|FG001|Overall Study|Subject request|17|||
144681521|NCT00422240|521683831|FG002|Overall Study|Subject request|18|||
144681522|NCT00422240|521683832|FG003|Overall Study|Subject request|30|||
144681523|NCT00422240|521683829|FG000|Overall Study|Protocol Violation|0|||
144681524|NCT00422240|521683830|FG001|Overall Study|Protocol Violation|1|||
144681525|NCT00422240|521683831|FG002|Overall Study|Protocol Violation|0|||
144681526|NCT00422240|521683832|FG003|Overall Study|Protocol Violation|1|||
144681527|NCT00422240|521683829|FG000|Overall Study|Lost to Follow-up|31|||
144681528|NCT00422240|521683830|FG001|Overall Study|Lost to Follow-up|32|||
144681529|NCT00422240|521683831|FG002|Overall Study|Lost to Follow-up|19|||
144681530|NCT00422240|521683832|FG003|Overall Study|Lost to Follow-up|34|||
144681531|NCT00422240|521683829|FG000|Overall Study|Other|1|||
144681532|NCT00422240|521683830|FG001|Overall Study|Other|0|||
144681533|NCT00422240|521683831|FG002|Overall Study|Other|0|||
144681534|NCT00422240|521683832|FG003|Overall Study|Other|1|||
144681535|NCT00422240|521683829|FG000|Overall Study|Pregnancy|3|||
144681536|NCT00422240|521683830|FG001|Overall Study|Pregnancy|1|||
144681537|NCT00422240|521683831|FG002|Overall Study|Pregnancy|1|||
144681538|NCT00422240|521683832|FG003|Overall Study|Pregnancy|2|||
144681539|NCT00441012|521683833|FG000|Overall Study|Adverse Event|0|||
144681540|NCT00441012|521683834|FG001|Overall Study|Adverse Event|1|||
144681541|NCT00441012|521683833|FG000|Overall Study|Lost to Follow-up|3|||
144681542|NCT00441012|521683834|FG001|Overall Study|Lost to Follow-up|3|||
144681543|NCT00441012|521683833|FG000|Overall Study|Protocol Violation|10|||
144681544|NCT00441012|521683834|FG001|Overall Study|Protocol Violation|9|||
144681545|NCT00441012|521683833|FG000|Overall Study|Withdrawal by Subject|4|||
144681546|NCT00441012|521683834|FG001|Overall Study|Withdrawal by Subject|0|||
144681547|NCT00441012|521683833|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
144681548|NCT00441012|521683834|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
144681549|NCT01624467|521683835|FG000|Overall Study|Withdrawal by Subject|2|||
144681550|NCT01624467|521683835|FG000|Overall Study|Lost to Follow-up|1|||
144681551|NCT01624467|521683835|FG000|Overall Study|Adverse Event|7|||
144681552|NCT01624467|521683835|FG000|Overall Study|Progressive Disease|19|||
144681553|NCT01624467|521683835|FG000|Overall Study|Per Sponsor Requirement|1|||
144681554|NCT01624467|521683835|FG000|Overall Study|Subject Withdrew from Treatment|1|||
144681555|NCT00262314|521683840|FG000|Overall Study|Changing physicians|38|||
144681556|NCT00262314|521683840|FG000|Overall Study|Death|12|||
144681557|NCT00262314|521683840|FG000|Overall Study|Patient's decision|92|||
144681558|NCT00262314|521683840|FG000|Overall Study|Other|95|||
144681559|NCT00262314|521683840|FG000|Overall Study|Lost to Follow-up|70|||
144681560|NCT00262314|521683840|FG000|Overall Study|Administrative withdrawal|30|||
144681561|NCT05104749|521683841|FG000|Overall Study|Lost to Follow-up|2|||
144681562|NCT05104749|521683842|FG001|Overall Study|Lost to Follow-up|3|||
144681563|NCT03964493|521683843|FG000|Overall Study|Withdrawal by Subject|4|||
144681564|NCT03964493|521683844|FG001|Overall Study|Withdrawal by Subject|1|||
144681565|NCT03964493|521683843|FG000|Overall Study|Lost to Follow-up|13|||
144681566|NCT03964493|521683844|FG001|Overall Study|Lost to Follow-up|4|||
144681567|NCT00887068|521683845|FG000|Overall Study|Withdrawal by Subject|2|||
144681568|NCT00887068|521683846|FG001|Overall Study|Withdrawal by Subject|0|||
144681569|NCT00887068|521683845|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
144681570|NCT00887068|521683846|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
144681571|NCT03073200|521683854|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144681572|NCT03073200|521683855|FG001|Double Blind Treatment Period|Protocol Violation|0|||
144681573|NCT03073200|521683856|FG002|Double Blind Treatment Period|Protocol Violation|0|||
144681574|NCT03073200|521683857|FG003|Double Blind Treatment Period|Protocol Violation|0|||
144681575|NCT03073200|521683858|FG004|Double Blind Treatment Period|Protocol Violation|0|||
144681576|NCT03073200|521683859|FG005|Double Blind Treatment Period|Protocol Violation|0|||
144681577|NCT03073200|521683860|FG006|Double Blind Treatment Period|Protocol Violation|0|||
144681578|NCT03073200|521683861|FG007|Double Blind Treatment Period|Protocol Violation|0|||
144681579|NCT03073200|521683862|FG008|Double Blind Treatment Period|Protocol Violation|0|||
144681580|NCT03073200|521683863|FG009|Double Blind Treatment Period|Protocol Violation|0|||
144681581|NCT03073200|521683864|FG010|Double Blind Treatment Period|Protocol Violation|0|||
144681582|NCT03073200|521683865|FG011|Double Blind Treatment Period|Protocol Violation|0|||
144681583|NCT03073200|521683866|FG012|Double Blind Treatment Period|Protocol Violation|0|||
144681584|NCT03073200|521683867|FG013|Double Blind Treatment Period|Protocol Violation|0|||
144681585|NCT03073200|521683868|FG014|Double Blind Treatment Period|Protocol Violation|0|||
144681586|NCT03073200|521683854|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681587|NCT03073200|521683855|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
144681588|NCT03073200|521683856|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681589|NCT03073200|521683857|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681590|NCT03073200|521683858|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681591|NCT03073200|521683859|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681592|NCT03073200|521683860|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681593|NCT03073200|521683861|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681594|NCT03073200|521683862|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681595|NCT03073200|521683863|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681596|NCT03073200|521683864|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681597|NCT03073200|521683865|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681598|NCT03073200|521683866|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681599|NCT03073200|521683867|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681600|NCT03073200|521683868|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
144681601|NCT03073200|521683854|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
144681602|NCT03073200|521683855|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681603|NCT03073200|521683856|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681604|NCT03073200|521683857|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681605|NCT03073200|521683858|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681606|NCT03073200|521683859|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681607|NCT03073200|521683860|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681608|NCT03073200|521683861|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681609|NCT03073200|521683862|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681610|NCT03073200|521683863|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681611|NCT03073200|521683864|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681612|NCT03073200|521683865|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681613|NCT03073200|521683866|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681614|NCT03073200|521683867|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681615|NCT03073200|521683868|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
144681616|NCT03073200|521683854|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681617|NCT03073200|521683855|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681618|NCT03073200|521683856|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681619|NCT03073200|521683857|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
144681620|NCT03073200|521683858|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
144681621|NCT03073200|521683859|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681622|NCT03073200|521683860|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681623|NCT03073200|521683861|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681624|NCT03073200|521683862|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681625|NCT03073200|521683863|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681626|NCT03073200|521683864|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681627|NCT03073200|521683865|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681628|NCT03073200|521683866|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681629|NCT03073200|521683867|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681630|NCT03073200|521683868|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
144681631|NCT03073200|521683854|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
144218312|NCT04194645|519992303|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218313|NCT04194645|519992304|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218314|NCT04194645|519992305|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218315|NCT04194645|519992306|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218316|NCT04194645|519992307|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218317|NCT04194645|519992308|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218318|NCT04194645|519992309|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218319|NCT04194645|519992310|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144681632|NCT03073200|521683855|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
144681633|NCT03073200|521683856|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
144681634|NCT03073200|521683857|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
144681635|NCT03073200|521683858|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
144681636|NCT03073200|521683859|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
144681637|NCT03073200|521683860|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
144681638|NCT03073200|521683861|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
144681639|NCT03073200|521683862|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
144681640|NCT03073200|521683863|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
144681641|NCT03073200|521683864|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
144681642|NCT03073200|521683865|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
144681643|NCT03073200|521683866|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
144681644|NCT03073200|521683867|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
144681645|NCT03073200|521683868|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
144681646|NCT03073200|521683854|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681647|NCT03073200|521683855|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681648|NCT03073200|521683856|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681649|NCT03073200|521683857|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681650|NCT03073200|521683858|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
144681651|NCT03073200|521683859|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681652|NCT03073200|521683860|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681653|NCT03073200|521683861|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681654|NCT03073200|521683862|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681655|NCT03073200|521683863|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681656|NCT03073200|521683864|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681657|NCT03073200|521683865|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681658|NCT03073200|521683866|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681659|NCT03073200|521683867|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681660|NCT03073200|521683868|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
144681661|NCT03073200|521683854|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681662|NCT03073200|521683855|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681663|NCT03073200|521683856|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681664|NCT03073200|521683857|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
144681665|NCT03073200|521683858|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
144681666|NCT03073200|521683859|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681667|NCT03073200|521683860|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681668|NCT03073200|521683861|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681669|NCT03073200|521683862|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681670|NCT03073200|521683863|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681671|NCT03073200|521683864|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681672|NCT03073200|521683865|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681673|NCT03073200|521683866|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681674|NCT03073200|521683867|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681675|NCT03073200|521683868|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
144681676|NCT03073200|521683854|FG000|Extension Period|Lost to Follow-up|0|||
144681677|NCT03073200|521683855|FG001|Extension Period|Lost to Follow-up|0|||
144681678|NCT03073200|521683856|FG002|Extension Period|Lost to Follow-up|0|||
144681679|NCT03073200|521683857|FG003|Extension Period|Lost to Follow-up|0|||
144681680|NCT03073200|521683858|FG004|Extension Period|Lost to Follow-up|0|||
144681681|NCT03073200|521683859|FG005|Extension Period|Lost to Follow-up|0|||
144681682|NCT03073200|521683860|FG006|Extension Period|Lost to Follow-up|1|||
144681683|NCT03073200|521683861|FG007|Extension Period|Lost to Follow-up|1|||
144681684|NCT03073200|521683862|FG008|Extension Period|Lost to Follow-up|0|||
144681685|NCT03073200|521683863|FG009|Extension Period|Lost to Follow-up|0|||
144681686|NCT03073200|521683864|FG010|Extension Period|Lost to Follow-up|0|||
144681687|NCT03073200|521683865|FG011|Extension Period|Lost to Follow-up|0|||
144265840|NCT01211145|520174016|FG002|Overall Study|Patient decision|0|||
144265841|NCT01211145|520174017|FG003|Overall Study|Patient decision|2|||
144681688|NCT03073200|521683866|FG012|Extension Period|Lost to Follow-up|0|||
144681689|NCT03073200|521683867|FG013|Extension Period|Lost to Follow-up|0|||
144681690|NCT03073200|521683868|FG014|Extension Period|Lost to Follow-up|0|||
144681691|NCT03073200|521683854|FG000|Extension Period|Sponsor Decision|0|||
144681692|NCT03073200|521683855|FG001|Extension Period|Sponsor Decision|0|||
144681693|NCT03073200|521683856|FG002|Extension Period|Sponsor Decision|0|||
144681694|NCT03073200|521683857|FG003|Extension Period|Sponsor Decision|0|||
144681695|NCT03073200|521683858|FG004|Extension Period|Sponsor Decision|0|||
144681696|NCT03073200|521683859|FG005|Extension Period|Sponsor Decision|0|||
144681697|NCT03073200|521683860|FG006|Extension Period|Sponsor Decision|0|||
144681698|NCT03073200|521683861|FG007|Extension Period|Sponsor Decision|0|||
144681699|NCT03073200|521683862|FG008|Extension Period|Sponsor Decision|1|||
144681700|NCT03073200|521683863|FG009|Extension Period|Sponsor Decision|0|||
144681701|NCT03073200|521683864|FG010|Extension Period|Sponsor Decision|0|||
144681702|NCT03073200|521683865|FG011|Extension Period|Sponsor Decision|0|||
144681703|NCT03073200|521683866|FG012|Extension Period|Sponsor Decision|0|||
144681704|NCT03073200|521683867|FG013|Extension Period|Sponsor Decision|0|||
144681705|NCT03073200|521683868|FG014|Extension Period|Sponsor Decision|0|||
144681706|NCT03073200|521683854|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
144681707|NCT03073200|521683855|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
144681708|NCT03073200|521683856|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
144681709|NCT03073200|521683857|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
144681710|NCT03073200|521683858|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
144681711|NCT03073200|521683859|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
144681712|NCT03073200|521683860|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
144681713|NCT03073200|521683861|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
144681714|NCT03073200|521683862|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
144681715|NCT03073200|521683863|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
144681716|NCT03073200|521683864|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
144681717|NCT03073200|521683865|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
144681718|NCT03073200|521683866|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
144681719|NCT03073200|521683867|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
144681720|NCT03073200|521683868|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
144681721|NCT03073200|521683854|FG000|Extension Period|Withdrawal by Subject|0|||
144681722|NCT03073200|521683855|FG001|Extension Period|Withdrawal by Subject|0|||
144681723|NCT03073200|521683856|FG002|Extension Period|Withdrawal by Subject|0|||
144681724|NCT03073200|521683857|FG003|Extension Period|Withdrawal by Subject|0|||
144681725|NCT03073200|521683858|FG004|Extension Period|Withdrawal by Subject|0|||
144681726|NCT03073200|521683859|FG005|Extension Period|Withdrawal by Subject|0|||
144681727|NCT03073200|521683860|FG006|Extension Period|Withdrawal by Subject|1|||
144681728|NCT03073200|521683861|FG007|Extension Period|Withdrawal by Subject|2|||
144681729|NCT03073200|521683862|FG008|Extension Period|Withdrawal by Subject|0|||
144681730|NCT03073200|521683863|FG009|Extension Period|Withdrawal by Subject|0|||
144681731|NCT03073200|521683864|FG010|Extension Period|Withdrawal by Subject|0|||
144681732|NCT03073200|521683865|FG011|Extension Period|Withdrawal by Subject|0|||
144681733|NCT03073200|521683866|FG012|Extension Period|Withdrawal by Subject|0|||
144681734|NCT03073200|521683867|FG013|Extension Period|Withdrawal by Subject|0|||
144681735|NCT03073200|521683868|FG014|Extension Period|Withdrawal by Subject|0|||
144681736|NCT03073200|521683854|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681737|NCT03073200|521683855|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681738|NCT03073200|521683856|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681739|NCT03073200|521683857|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681740|NCT03073200|521683858|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681741|NCT03073200|521683859|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681742|NCT03073200|521683860|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681743|NCT03073200|521683861|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681744|NCT03073200|521683862|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681745|NCT03073200|521683863|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681746|NCT03073200|521683864|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681747|NCT03073200|521683865|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
144681748|NCT03073200|521683866|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681749|NCT03073200|521683867|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681750|NCT03073200|521683868|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
144681751|NCT03073200|521683854|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681752|NCT03073200|521683855|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144738435|NCT01527006|521897461|FG001|Core Study|Withdrawal by Subject|1|||
144681753|NCT03073200|521683856|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681754|NCT03073200|521683857|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681755|NCT03073200|521683858|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681756|NCT03073200|521683859|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681757|NCT03073200|521683860|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681758|NCT03073200|521683861|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681759|NCT03073200|521683862|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681760|NCT03073200|521683863|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681761|NCT03073200|521683864|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681762|NCT03073200|521683865|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
144681763|NCT03073200|521683866|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681764|NCT03073200|521683867|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681765|NCT03073200|521683868|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
144681766|NCT03073200|521683854|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681767|NCT03073200|521683855|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681768|NCT03073200|521683856|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681769|NCT03073200|521683857|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681770|NCT03073200|521683858|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681771|NCT03073200|521683859|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681772|NCT03073200|521683860|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681773|NCT03073200|521683861|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681774|NCT03073200|521683862|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681775|NCT03073200|521683863|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681776|NCT03073200|521683864|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
144681777|NCT03073200|521683865|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
144681778|NCT03073200|521683866|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681779|NCT03073200|521683867|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681780|NCT03073200|521683868|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
144681781|NCT03073200|521683854|FG000|Randomized Withdrawal Period|Adverse Event|0|||
144681782|NCT03073200|521683855|FG001|Randomized Withdrawal Period|Adverse Event|0|||
144681783|NCT03073200|521683856|FG002|Randomized Withdrawal Period|Adverse Event|0|||
144681784|NCT03073200|521683857|FG003|Randomized Withdrawal Period|Adverse Event|0|||
144681785|NCT03073200|521683858|FG004|Randomized Withdrawal Period|Adverse Event|0|||
144681786|NCT03073200|521683859|FG005|Randomized Withdrawal Period|Adverse Event|0|||
144681787|NCT03073200|521683860|FG006|Randomized Withdrawal Period|Adverse Event|0|||
144681788|NCT03073200|521683861|FG007|Randomized Withdrawal Period|Adverse Event|0|||
144681789|NCT03073200|521683862|FG008|Randomized Withdrawal Period|Adverse Event|0|||
144681790|NCT03073200|521683863|FG009|Randomized Withdrawal Period|Adverse Event|0|||
144681791|NCT03073200|521683864|FG010|Randomized Withdrawal Period|Adverse Event|1|||
144681792|NCT03073200|521683865|FG011|Randomized Withdrawal Period|Adverse Event|0|||
144681793|NCT03073200|521683866|FG012|Randomized Withdrawal Period|Adverse Event|0|||
144681794|NCT03073200|521683867|FG013|Randomized Withdrawal Period|Adverse Event|0|||
144681795|NCT03073200|521683868|FG014|Randomized Withdrawal Period|Adverse Event|0|||
144681796|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681797|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681798|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681799|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681800|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681801|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681802|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681803|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681804|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681805|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681806|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681807|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681808|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681809|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
144681810|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
144681811|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681812|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681813|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681814|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681815|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681816|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681817|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681818|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681819|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681820|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681821|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681822|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681823|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144681824|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
144681825|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144265842|NCT00427908|520174018|FG000|Primary Phase|Lost to Follow-up|4|||
144681826|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144265843|NCT00427908|520174019|FG001|Primary Phase|Lost to Follow-up|0|||
144681827|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681828|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681829|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681830|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681831|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681832|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681833|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681834|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681835|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681836|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681837|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681838|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681839|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
144681840|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
144681841|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681842|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681843|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681844|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681845|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681846|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681847|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681848|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681849|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681850|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681851|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681852|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681853|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681854|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
144681855|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144681856|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681857|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681858|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681859|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681860|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681861|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681862|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681863|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681864|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681865|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681866|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681867|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681868|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681869|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
144681870|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
144681871|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681872|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681873|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681874|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681875|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681876|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681877|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681878|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681879|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681880|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681881|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681882|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681883|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681884|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
144681885|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
144681886|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681887|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681888|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681889|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681890|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681891|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681892|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681893|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681894|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681895|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681896|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681897|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681898|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681899|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
144681900|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144681901|NCT03073200|521683854|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681902|NCT03073200|521683855|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681903|NCT03073200|521683856|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681904|NCT03073200|521683857|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681905|NCT03073200|521683858|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681906|NCT03073200|521683859|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681907|NCT03073200|521683860|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681908|NCT03073200|521683861|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681909|NCT03073200|521683862|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681910|NCT03073200|521683863|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681911|NCT03073200|521683864|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681912|NCT03073200|521683865|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681913|NCT03073200|521683866|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681914|NCT03073200|521683867|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
144681915|NCT03073200|521683868|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
144681916|NCT04888507|521685514|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
144681917|NCT00636155|521685515|FG000|Overall Study|Adverse Event|8|||
144681918|NCT00636155|521685515|FG000|Overall Study|Lack of Efficacy|1|||
144681919|NCT00636155|521685515|FG000|Overall Study|Withdrawal by Subject|3|||
144681920|NCT00636155|521685515|FG000|Overall Study|Stem cell transplant|1|||
144681921|NCT00636155|521685515|FG000|Overall Study|Physician Decision|5|||
144681922|NCT00400946|521685516|FG000|Overall Study|Ineligible|0|||
144681923|NCT00400946|521685517|FG001|Overall Study|Ineligible|0|||
144681924|NCT00400946|521685518|FG002|Overall Study|Ineligible|0|||
144681925|NCT00400946|521685519|FG003|Overall Study|Ineligible|5|||
144681926|NCT00400946|521685520|FG004|Overall Study|Ineligible|1|||
144681927|NCT00400946|521685516|FG000|Overall Study|Induction Failure|0|||
144681928|NCT00400946|521685517|FG001|Overall Study|Induction Failure|0|||
144681929|NCT00400946|521685518|FG002|Overall Study|Induction Failure|0|||
144681930|NCT00400946|521685519|FG003|Overall Study|Induction Failure|11|||
144681931|NCT00400946|521685520|FG004|Overall Study|Induction Failure|8|||
144681932|NCT00400946|521685516|FG000|Overall Study|Induction Death|0|||
144681933|NCT00400946|521685517|FG001|Overall Study|Induction Death|0|||
144681934|NCT00400946|521685518|FG002|Overall Study|Induction Death|0|||
144681935|NCT00400946|521685519|FG003|Overall Study|Induction Death|13|||
144681936|NCT00400946|521685520|FG004|Overall Study|Induction Death|3|||
144681937|NCT00400946|521685516|FG000|Overall Study|Lost to Follow-up|1|||
144681938|NCT00400946|521685517|FG001|Overall Study|Lost to Follow-up|1|||
144681939|NCT00400946|521685518|FG002|Overall Study|Lost to Follow-up|0|||
144681940|NCT00400946|521685519|FG003|Overall Study|Lost to Follow-up|0|||
144681941|NCT00400946|521685520|FG004|Overall Study|Lost to Follow-up|1|||
144681942|NCT00400946|521685516|FG000|Overall Study|Remission Death|1|||
144681943|NCT00400946|521685517|FG001|Overall Study|Remission Death|1|||
144681944|NCT00400946|521685518|FG002|Overall Study|Remission Death|0|||
144681945|NCT00400946|521685519|FG003|Overall Study|Remission Death|0|||
144681946|NCT00400946|521685520|FG004|Overall Study|Remission Death|1|||
144681947|NCT00400946|521685516|FG000|Overall Study|Relapse|9|||
144681948|NCT00400946|521685517|FG001|Overall Study|Relapse|2|||
144681949|NCT00400946|521685518|FG002|Overall Study|Relapse|1|||
144681950|NCT00400946|521685519|FG003|Overall Study|Relapse|1|||
144681951|NCT00400946|521685520|FG004|Overall Study|Relapse|5|||
144681952|NCT00400946|521685516|FG000|Overall Study|Transplant in CR1|0|||
144681953|NCT00400946|521685517|FG001|Overall Study|Transplant in CR1|0|||
144681954|NCT00400946|521685518|FG002|Overall Study|Transplant in CR1|0|||
144681955|NCT00400946|521685519|FG003|Overall Study|Transplant in CR1|10|||
144738436|NCT01527006|521897460|FG000|Core Study|Other|0|||
144738437|NCT01527006|521897461|FG001|Core Study|Other|2|||
144681956|NCT00400946|521685520|FG004|Overall Study|Transplant in CR1|1|||
144681957|NCT00400946|521685516|FG000|Overall Study|Withdrawal by Subject|2|||
144681958|NCT00400946|521685517|FG001|Overall Study|Withdrawal by Subject|5|||
144681959|NCT00400946|521685518|FG002|Overall Study|Withdrawal by Subject|1|||
144681960|NCT00400946|521685519|FG003|Overall Study|Withdrawal by Subject|5|||
144681961|NCT00400946|521685520|FG004|Overall Study|Withdrawal by Subject|8|||
144681962|NCT00400946|521685516|FG000|Overall Study|Clinical|1|||
144681963|NCT00400946|521685517|FG001|Overall Study|Clinical|2|||
144681964|NCT00400946|521685518|FG002|Overall Study|Clinical|0|||
144681965|NCT00400946|521685519|FG003|Overall Study|Clinical|2|||
144681966|NCT00400946|521685520|FG004|Overall Study|Clinical|9|||
144681967|NCT00400946|521685516|FG000|Overall Study|Other|0|||
144681968|NCT00400946|521685517|FG001|Overall Study|Other|0|||
144681969|NCT00400946|521685518|FG002|Overall Study|Other|0|||
144681970|NCT00400946|521685519|FG003|Overall Study|Other|0|||
144681971|NCT00400946|521685520|FG004|Overall Study|Other|1|||
144681972|NCT05643170|521685521|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
144681973|NCT05643170|521685521|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
144681974|NCT02358863|521685522|FG000|Overall Study|Physician Decision|3|||
144681975|NCT01673373|521685528|FG000|Overall Study|Death|2|||
144681976|NCT02632344|521685529|FG000|Overall Study|Adverse Event|3|||
144681977|NCT02632344|521685529|FG000|Overall Study|Lack of Efficacy|3|||
144681978|NCT02632344|521685529|FG000|Overall Study|Withdrawal by Subject|2|||
144681979|NCT05426460|521685534|FG000|Overall Study|Protocol Violation|1|||
144681980|NCT05426460|521685535|FG001|Overall Study|Protocol Violation|1|||
144681981|NCT05426460|521685536|FG002|Overall Study|Protocol Violation|1|||
144681982|NCT05426460|521685537|FG003|Overall Study|Protocol Violation|0|||
144681983|NCT02000622|521685538|FG000|Overall Study|Withdrawal by Subject|5|||
144681984|NCT02000622|521685539|FG001|Overall Study|Withdrawal by Subject|7|||
144681985|NCT02000622|521685538|FG000|Overall Study|Lost to Follow-up|4|||
144681986|NCT02000622|521685539|FG001|Overall Study|Lost to Follow-up|0|||
144681987|NCT02000622|521685538|FG000|Overall Study|Death|159|||
144681988|NCT02000622|521685539|FG001|Overall Study|Death|73|||
144681989|NCT02000622|521685538|FG000|Overall Study|Withdrawn due to site closure|1|||
144681990|NCT02000622|521685539|FG001|Overall Study|Withdrawn due to site closure|0|||
144681991|NCT01405027|521685540|FG000|Overall Study|Withdrawn consent|3|||
144681992|NCT01405027|521685541|FG001|Overall Study|Withdrawn consent|0|||
144681993|NCT01405027|521685540|FG000|Overall Study|Lost to Follow-up|16|||
144681994|NCT01405027|521685541|FG001|Overall Study|Lost to Follow-up|24|||
144681995|NCT01405027|521685540|FG000|Overall Study|Investigator judgement|0|||
144681996|NCT01405027|521685541|FG001|Overall Study|Investigator judgement|2|||
144681997|NCT01405027|521685540|FG000|Overall Study|Death|1|||
144681998|NCT01405027|521685541|FG001|Overall Study|Death|0|||
144681999|NCT01405027|521685540|FG000|Overall Study|Other or Unknown|12|||
144682000|NCT01405027|521685541|FG001|Overall Study|Other or Unknown|25|||
144682001|NCT04960202|521685550|FG000|Overall Study|Other|5|||
144682002|NCT04960202|521685551|FG001|Overall Study|Other|0|||
144682003|NCT04960202|521685550|FG000|Overall Study|Withdrawal by Subject|37|||
144682004|NCT04960202|521685551|FG001|Overall Study|Withdrawal by Subject|43|||
144682005|NCT04960202|521685550|FG000|Overall Study|Lost to Follow-up|20|||
144682006|NCT04960202|521685551|FG001|Overall Study|Lost to Follow-up|16|||
144682007|NCT04960202|521685550|FG000|Overall Study|Death|0|||
144682008|NCT04960202|521685551|FG001|Overall Study|Death|15|||
144682009|NCT02158728|521685552|FG000|Overall Study|no procedure according to CIP done|3|||
144682010|NCT02158728|521685552|FG000|Overall Study|no qualified dataset|24|||
144682011|NCT03558828|521685553|FG000|Overall Study|Lost to Follow-up|4|||
144682012|NCT03558828|521685554|FG001|Overall Study|Lost to Follow-up|3|||
144682013|NCT03558828|521685555|FG002|Overall Study|Lost to Follow-up|3|||
144682014|NCT03558828|521685556|FG003|Overall Study|Lost to Follow-up|5|||
144682015|NCT03558828|521685557|FG004|Overall Study|Lost to Follow-up|2|||
144682016|NCT03558828|521685558|FG005|Overall Study|Lost to Follow-up|3|||
144682017|NCT03558828|521685553|FG000|Overall Study|dropped before the intervention|1|||
144682018|NCT03558828|521685554|FG001|Overall Study|dropped before the intervention|1|||
144682019|NCT03558828|521685555|FG002|Overall Study|dropped before the intervention|0|||
144682020|NCT03558828|521685556|FG003|Overall Study|dropped before the intervention|0|||
144218320|NCT04194645|519992311|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218321|NCT04194645|519992312|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
144218322|NCT04194645|519992313|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218323|NCT04194645|519992314|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218324|NCT04194645|519992315|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144682021|NCT03558828|521685557|FG004|Overall Study|dropped before the intervention|0|||
144682022|NCT03558828|521685558|FG005|Overall Study|dropped before the intervention|0|||
144682023|NCT00673816|521685559|FG000|Overall Study|Adverse Event|1|||
144682024|NCT00673816|521685559|FG000|Overall Study|Withdrawal by Subject|1|||
144682025|NCT00589602|521685560|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
144682026|NCT03887052|521685561|FG000|Overall Study|Adverse Event|2|||
144218325|NCT04194645|519992316|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144682027|NCT03887052|521685561|FG000|Overall Study|Physician Decision|2|||
144682028|NCT03887052|521685561|FG000|Overall Study|Withdrawal by Subject|3|||
144682029|NCT03887052|521685561|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
144682030|NCT03887052|521685561|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
144682031|NCT01804842|521685562|FG000|Overall Study|Adverse Event|1|||
144682032|NCT01804842|521685563|FG001|Overall Study|Adverse Event|1|||
144682033|NCT01804842|521685564|FG002|Overall Study|Adverse Event|0|||
144682034|NCT01804842|521685562|FG000|Overall Study|Lost to Follow-up|1|||
144682035|NCT01804842|521685563|FG001|Overall Study|Lost to Follow-up|0|||
144682036|NCT01804842|521685564|FG002|Overall Study|Lost to Follow-up|0|||
144682037|NCT01804842|521685562|FG000|Overall Study|Non-Compliance|1|||
144682038|NCT01804842|521685563|FG001|Overall Study|Non-Compliance|1|||
144682039|NCT01804842|521685564|FG002|Overall Study|Non-Compliance|0|||
144682040|NCT01804842|521685562|FG000|Overall Study|Personal Reason|0|||
144682041|NCT01804842|521685563|FG001|Overall Study|Personal Reason|0|||
144682042|NCT01804842|521685564|FG002|Overall Study|Personal Reason|1|||
144682043|NCT02365506|521685565|FG000|Overall Study|Investigator's Discretion|0|||
144682044|NCT02365506|521685566|FG001|Overall Study|Investigator's Discretion|0|||
144682045|NCT02365506|521685567|FG002|Overall Study|Investigator's Discretion|1|||
144682046|NCT03774875|521685568|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
144682047|NCT03774875|521685569|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
144682048|NCT03774875|521685568|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
144682049|NCT03774875|521685569|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
144682050|NCT03774875|521685568|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
144682051|NCT03774875|521685569|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
144682052|NCT03774875|521685568|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
144682053|NCT03774875|521685569|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
144682054|NCT03774875|521685568|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
144682055|NCT03774875|521685569|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
144682056|NCT03774875|521685568|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
144682057|NCT03774875|521685569|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
144682058|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
144682059|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
144682060|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
144682061|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
144682062|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
144682063|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
144682064|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
144682065|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
144682066|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
144682067|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
144682068|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
144682069|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
144682070|NCT03774875|521685568|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
144682071|NCT03774875|521685569|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
144682072|NCT02148952|521685572|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
144682073|NCT02148952|521685573|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
144682074|NCT02148952|521685572|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
144682075|NCT02148952|521685573|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
144682076|NCT02148952|521685572|FG000|Follow-Up|Lost to Follow-up|219|||
144682077|NCT02148952|521685573|FG001|Follow-Up|Lost to Follow-up|231|||
144682078|NCT02148952|521685572|FG000|Follow-Up|Withdrawal by Subject|46|||
144682079|NCT02148952|521685573|FG001|Follow-Up|Withdrawal by Subject|48|||
144682080|NCT01764022|521685574|FG000|Overall Study|Death|3|||
144682081|NCT01764022|521685575|FG001|Overall Study|Death|5|||
144682082|NCT01764022|521685574|FG000|Overall Study|Withdrawal by Subject|2|||
144682083|NCT01764022|521685575|FG001|Overall Study|Withdrawal by Subject|6|||
144682084|NCT01764022|521685574|FG000|Overall Study|Lack of Efficacy|0|||
144682085|NCT01764022|521685575|FG001|Overall Study|Lack of Efficacy|1|||
144682086|NCT01764022|521685574|FG000|Overall Study|Physician Decision|0|||
144682087|NCT01764022|521685575|FG001|Overall Study|Physician Decision|2|||
144682088|NCT01764022|521685574|FG000|Overall Study|Lost to Follow-up|2|||
144682089|NCT01764022|521685575|FG001|Overall Study|Lost to Follow-up|0|||
144682090|NCT01764022|521685574|FG000|Overall Study|Protocol Violation|1|||
144682091|NCT01764022|521685575|FG001|Overall Study|Protocol Violation|0|||
144682092|NCT00623766|521685579|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
144682093|NCT00623766|521685580|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
144682094|NCT00623766|521685579|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
144738438|NCT01527006|521897460|FG000|Extension Phase|Adverse Event|4|||
144738439|NCT01527006|521897461|FG001|Extension Phase|Adverse Event|2|||
144265844|NCT00427908|520174020|FG002|Primary Phase|Lost to Follow-up|2|||
144682095|NCT00623766|521685580|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
144682096|NCT00623766|521685579|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
144682097|NCT00623766|521685580|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
144682098|NCT00623766|521685579|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
144682099|NCT00623766|521685580|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
144682100|NCT00623766|521685579|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
144682101|NCT00623766|521685580|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
144682102|NCT04247828|521685585|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
144682103|NCT00893763|521685586|FG000|Overall Study|extubated|110|||
144682104|NCT00893763|521685587|FG001|Overall Study|extubated|110|||
144682105|NCT03934203|521685591|FG000|Overall Study|Adverse Event|0|||
144682106|NCT03934203|521685592|FG001|Overall Study|Adverse Event|0|||
144682107|NCT03934203|521685593|FG002|Overall Study|Adverse Event|1|||
144682108|NCT03934203|521685594|FG003|Overall Study|Adverse Event|0|||
144682109|NCT03934203|521685595|FG004|Overall Study|Adverse Event|1|||
144682110|NCT03934203|521685596|FG005|Overall Study|Adverse Event|0|||
144682111|NCT03934203|521685597|FG006|Overall Study|Adverse Event|2|||
144682112|NCT03934203|521685598|FG007|Overall Study|Adverse Event|0|||
144682113|NCT03934203|521685599|FG008|Overall Study|Adverse Event|0|||
144682114|NCT03934203|521685600|FG009|Overall Study|Adverse Event|0|||
144682115|NCT03934203|521685601|FG010|Overall Study|Adverse Event|0|||
144682116|NCT03934203|521685602|FG011|Overall Study|Adverse Event|0|||
144682117|NCT03934203|521685603|FG012|Overall Study|Adverse Event|0|||
144682118|NCT03934203|521685604|FG013|Overall Study|Adverse Event|1|||
144682119|NCT03934203|521685605|FG014|Overall Study|Adverse Event|0|||
144682120|NCT00608842|521685606|FG000|Overall Study|Participant's Request|0|||
144682121|NCT00608842|521685607|FG001|Overall Study|Participant's Request|1|||
144682122|NCT00608842|521685608|FG002|Overall Study|Participant's Request|2|||
144682123|NCT00608842|521685609|FG003|Overall Study|Participant's Request|1|||
144682124|NCT00608842|521685606|FG000|Overall Study|Lost to Follow-up|1|||
144682125|NCT00608842|521685607|FG001|Overall Study|Lost to Follow-up|0|||
144682126|NCT00608842|521685608|FG002|Overall Study|Lost to Follow-up|0|||
144682127|NCT00608842|521685609|FG003|Overall Study|Lost to Follow-up|0|||
144682128|NCT00899678|521685610|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
144682129|NCT00899678|521685611|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
144682130|NCT00899678|521685612|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
144682131|NCT00899678|521685610|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
144682132|NCT00899678|521685611|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
144682133|NCT00899678|521685612|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
144682134|NCT00899678|521685610|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
144682135|NCT00899678|521685611|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
144682136|NCT00899678|521685612|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
144682137|NCT00899678|521685610|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
144682138|NCT00899678|521685611|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
144682139|NCT00899678|521685612|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
144682140|NCT00899678|521685610|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
144682141|NCT00899678|521685611|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
144682142|NCT00899678|521685612|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
144682143|NCT00899678|521685610|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
144682144|NCT00899678|521685611|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
144682145|NCT00899678|521685612|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
144682146|NCT00899678|521685610|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
144682147|NCT00899678|521685611|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
144682148|NCT00899678|521685612|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
144682149|NCT00899678|521685610|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
144682150|NCT00899678|521685611|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
144682151|NCT00899678|521685612|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
144682152|NCT00899678|521685610|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
144682153|NCT00899678|521685611|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
144682154|NCT00899678|521685612|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
144682155|NCT02699125|521685615|FG000|Placebo|Lost to Follow-up|2|||
144682156|NCT02699125|521685616|FG001|Placebo|Lost to Follow-up|0|||
144682157|NCT02699125|521685615|FG000|Placebo|Protocol Violation|1|||
144682158|NCT02699125|521685616|FG001|Placebo|Protocol Violation|0|||
144682159|NCT02699125|521685615|FG000|Placebo|Withdrawal by Subject|0|||
144682160|NCT02699125|521685616|FG001|Placebo|Withdrawal by Subject|4|||
144682161|NCT02699125|521685615|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
144682162|NCT02699125|521685616|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
144682163|NCT04445051|521685620|FG000|Overall Study|Adverse Event|0|||
144682164|NCT04445051|521685621|FG001|Overall Study|Adverse Event|0|||
144682165|NCT04445051|521685622|FG002|Overall Study|Adverse Event|1|||
144682166|NCT04445051|521685623|FG003|Overall Study|Adverse Event|0|||
144682167|NCT04445051|521685624|FG004|Overall Study|Adverse Event|0|||
144682168|NCT04445051|521685625|FG005|Overall Study|Adverse Event|0|||
144682169|NCT02092324|521685632|FG000|Overall Study|Adverse Event|1|||
144682170|NCT02092324|521685632|FG000|Overall Study|Lack of Efficacy|6|||
144682171|NCT02092324|521685632|FG000|Overall Study|Proceed to Transplant|3|||
144682172|NCT02092324|521685632|FG000|Overall Study|Physician Decision|7|||
144682173|NCT02092324|521685632|FG000|Overall Study|Misdiagnosis|2|||
144682174|NCT00398138|521685635|FG000|Overall Study|Adverse Event|2|||
144738440|NCT01527006|521897460|FG000|Extension Phase|Lost to Follow-up|0|||
144682175|NCT04973085|521685640|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
144682176|NCT04973085|521685641|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
144682177|NCT03924427|521685647|FG000|Overall Study|Adverse Event|4|||
144682178|NCT03924427|521685647|FG000|Overall Study|Lack of Efficacy|1|||
144682179|NCT03924427|521685647|FG000|Overall Study|Withdrawal by Subject|1|||
144682180|NCT01316380|521685655|FG000|Overall Study|Adverse Event|0|||
144682181|NCT01316380|521685656|FG001|Overall Study|Adverse Event|2|||
144682182|NCT01316380|521685657|FG002|Overall Study|Adverse Event|1|||
144682183|NCT01316380|521685655|FG000|Overall Study|Protocol Violation|0|||
144682184|NCT01316380|521685656|FG001|Overall Study|Protocol Violation|0|||
144682185|NCT01316380|521685657|FG002|Overall Study|Protocol Violation|1|||
144682186|NCT01316380|521685655|FG000|Overall Study|Withdrawal by Subject|1|||
144682187|NCT01316380|521685656|FG001|Overall Study|Withdrawal by Subject|2|||
144682188|NCT01316380|521685657|FG002|Overall Study|Withdrawal by Subject|0|||
144682189|NCT01316380|521685655|FG000|Overall Study|Other|0|||
144682190|NCT01316380|521685656|FG001|Overall Study|Other|1|||
144682191|NCT01316380|521685657|FG002|Overall Study|Other|1|||
144682192|NCT01316380|521685655|FG000|Overall Study|Not treated|1|||
144682193|NCT01316380|521685656|FG001|Overall Study|Not treated|0|||
144682194|NCT01316380|521685657|FG002|Overall Study|Not treated|0|||
144682195|NCT00149890|521685658|FG000|Overall Study|Adverse Event|1|||
144682196|NCT00149890|521685659|FG001|Overall Study|Adverse Event|8|||
144682197|NCT00149890|521685658|FG000|Overall Study|Lack of Efficacy|8|||
144682198|NCT00149890|521685659|FG001|Overall Study|Lack of Efficacy|9|||
144682199|NCT00149890|521685658|FG000|Overall Study|Protocol Violation|1|||
144682200|NCT00149890|521685659|FG001|Overall Study|Protocol Violation|0|||
144682201|NCT00149890|521685658|FG000|Overall Study|Lost to Follow-up|1|||
144682202|NCT00149890|521685659|FG001|Overall Study|Lost to Follow-up|0|||
144682203|NCT00149890|521685658|FG000|Overall Study|Graft Loss|2|||
144682204|NCT00149890|521685659|FG001|Overall Study|Graft Loss|1|||
144682205|NCT01387594|521685660|FG000|Overall Study|Withdrawal by Subject|0|||
144682206|NCT01387594|521685661|FG001|Overall Study|Withdrawal by Subject|2|||
144682207|NCT01387594|521685660|FG000|Overall Study|Lost to Follow-up|0|||
144682208|NCT01387594|521685661|FG001|Overall Study|Lost to Follow-up|1|||
144682209|NCT01365091|521685662|FG000|Period 1|Adverse Event|1|||
144682210|NCT01365091|521685663|FG001|Period 1|Adverse Event|0|||
144682211|NCT01365091|521685664|FG002|Period 1|Adverse Event|2|||
144682212|NCT01365091|521685665|FG003|Period 1|Adverse Event|3|||
144682213|NCT01365091|521685662|FG000|Period 1|Positive test result for drugs of abuse|1|||
144682214|NCT01365091|521685663|FG001|Period 1|Positive test result for drugs of abuse|0|||
144682215|NCT01365091|521685664|FG002|Period 1|Positive test result for drugs of abuse|0|||
144682216|NCT01365091|521685665|FG003|Period 1|Positive test result for drugs of abuse|0|||
144682217|NCT01365091|521685662|FG000|Period 1|No longer met study criteria|0|||
144682218|NCT01365091|521685663|FG001|Period 1|No longer met study criteria|1|||
144682219|NCT01365091|521685664|FG002|Period 1|No longer met study criteria|0|||
144682220|NCT01365091|521685665|FG003|Period 1|No longer met study criteria|0|||
144682221|NCT01365091|521685662|FG000|Period 1|Withdrawal by Subject|0|||
144682222|NCT01365091|521685663|FG001|Period 1|Withdrawal by Subject|1|||
144682223|NCT01365091|521685664|FG002|Period 1|Withdrawal by Subject|0|||
144682224|NCT01365091|521685665|FG003|Period 1|Withdrawal by Subject|0|||
144682225|NCT01365091|521685662|FG000|Period 1|Personal reasons|0|||
144682226|NCT01365091|521685663|FG001|Period 1|Personal reasons|0|||
144682227|NCT01365091|521685664|FG002|Period 1|Personal reasons|1|||
144682228|NCT01365091|521685665|FG003|Period 1|Personal reasons|0|||
144682229|NCT01365091|521685662|FG000|Period 2|Withdrawal by Subject|1|||
144682230|NCT01365091|521685663|FG001|Period 2|Withdrawal by Subject|0|||
144682231|NCT01365091|521685664|FG002|Period 2|Withdrawal by Subject|0|||
144682232|NCT01365091|521685665|FG003|Period 2|Withdrawal by Subject|0|||
144682233|NCT01365091|521685662|FG000|Period 2|Adverse Event|0|||
144682234|NCT01365091|521685663|FG001|Period 2|Adverse Event|0|||
144682235|NCT01365091|521685664|FG002|Period 2|Adverse Event|1|||
144682236|NCT01365091|521685665|FG003|Period 2|Adverse Event|0|||
144682237|NCT05116683|521685666|FG000|Overall Study|Physician Decision|4|||
144682238|NCT01474889|521685668|FG000|Overall Study|Physician Decision|1|||
144682239|NCT01474889|521685669|FG001|Overall Study|Physician Decision|0|||
144265845|NCT00427908|520174021|FG003|Primary Phase|Lost to Follow-up|0|||
144682240|NCT01474889|521685670|FG002|Overall Study|Physician Decision|0|||
144682241|NCT01474889|521685668|FG000|Overall Study|Did not meet inclusion|1|||
144682242|NCT01474889|521685669|FG001|Overall Study|Did not meet inclusion|0|||
144682243|NCT01474889|521685670|FG002|Overall Study|Did not meet inclusion|0|||
144682244|NCT01474889|521685668|FG000|Overall Study|Withdrawal by Subject|0|||
144682245|NCT01474889|521685669|FG001|Overall Study|Withdrawal by Subject|1|||
144682246|NCT01474889|521685670|FG002|Overall Study|Withdrawal by Subject|0|||
144682247|NCT00901394|521685671|FG000|Overall Study|Physician Decision|1|||
144682248|NCT00901394|521685672|FG001|Overall Study|Physician Decision|1|||
144682249|NCT00901394|521685673|FG002|Overall Study|Physician Decision|2|||
144682250|NCT04964557|521685675|FG000|Overall Study|Withdrawal by Subject|3|||
144682251|NCT04964557|521685676|FG001|Overall Study|Withdrawal by Subject|2|||
144682252|NCT04964557|521685675|FG000|Overall Study|Lost to Follow-up|1|||
144682253|NCT04964557|521685676|FG001|Overall Study|Lost to Follow-up|2|||
144682254|NCT04964557|521685675|FG000|Overall Study|Physician Decision|2|||
144682255|NCT04964557|521685676|FG001|Overall Study|Physician Decision|0|||
144682256|NCT04964557|521685675|FG000|Overall Study|Death|3|||
144682257|NCT04964557|521685676|FG001|Overall Study|Death|0|||
144682258|NCT04964557|521685675|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
144682259|NCT04964557|521685676|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
144682260|NCT02569398|521685679|FG000|Overall Study|Adverse Event|0|||
144682261|NCT02569398|521685680|FG001|Overall Study|Adverse Event|1|||
144682262|NCT02569398|521685681|FG002|Overall Study|Adverse Event|6|||
144682263|NCT02569398|521685679|FG000|Overall Study|Withdrawal by Subject|43|||
144682264|NCT02569398|521685680|FG001|Overall Study|Withdrawal by Subject|43|||
144682265|NCT02569398|521685681|FG002|Overall Study|Withdrawal by Subject|30|||
144682266|NCT02569398|521685679|FG000|Overall Study|Study terminated by sponsor|130|||
144682267|NCT02569398|521685680|FG001|Overall Study|Study terminated by sponsor|131|||
144682268|NCT02569398|521685681|FG002|Overall Study|Study terminated by sponsor|134|||
144682269|NCT02569398|521685679|FG000|Overall Study|Other|12|||
144682270|NCT02569398|521685680|FG001|Overall Study|Other|14|||
144682271|NCT02569398|521685681|FG002|Overall Study|Other|13|||
144682272|NCT03559192|521685682|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
144682273|NCT03559192|521685683|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
144682274|NCT03559192|521685684|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
144682275|NCT03559192|521685682|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
144682276|NCT03559192|521685683|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
144682277|NCT03559192|521685684|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
144682278|NCT03559192|521685682|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
144682279|NCT03559192|521685683|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
144682280|NCT03559192|521685684|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
144682281|NCT03559192|521685682|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
144682282|NCT03559192|521685683|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
144682283|NCT03559192|521685684|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
144682284|NCT03559192|521685682|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
144682285|NCT03559192|521685683|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
144682286|NCT03559192|521685684|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
144682287|NCT03559192|521685682|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
144682288|NCT03559192|521685683|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
144682289|NCT03559192|521685684|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
144682290|NCT03559192|521685682|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
144682291|NCT03559192|521685683|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
144682292|NCT03559192|521685684|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
144682293|NCT03559192|521685682|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
144682294|NCT03559192|521685683|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
144682295|NCT03559192|521685684|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
144682296|NCT03559192|521685682|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
144682297|NCT03559192|521685683|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
144682298|NCT03559192|521685684|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
144682299|NCT04924114|521687633|FG000|Overall Study|Withdrawal by Subject|0|||
144682300|NCT04924114|521687634|FG001|Overall Study|Withdrawal by Subject|2|||
144682301|NCT04924114|521687635|FG002|Overall Study|Withdrawal by Subject|2|||
144682302|NCT04924114|521687636|FG003|Overall Study|Withdrawal by Subject|0|||
144682303|NCT04924114|521687637|FG004|Overall Study|Withdrawal by Subject|2|||
144682304|NCT03671148|521687639|FG000|Overall Study|Adverse Event|3|||
144682305|NCT03671148|521687640|FG001|Overall Study|Adverse Event|2|||
144682306|NCT03671148|521687639|FG000|Overall Study|Withdrawal by Subject|8|||
144682307|NCT03671148|521687640|FG001|Overall Study|Withdrawal by Subject|2|||
144682308|NCT03671148|521687639|FG000|Overall Study|Lost to Follow-up|1|||
144682309|NCT03671148|521687640|FG001|Overall Study|Lost to Follow-up|2|||
144682310|NCT03671148|521687639|FG000|Overall Study|Lack of Efficacy|7|||
144682311|NCT03671148|521687640|FG001|Overall Study|Lack of Efficacy|2|||
144682312|NCT03671148|521687639|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
144682313|NCT03671148|521687640|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
144682314|NCT03671148|521687639|FG000|Overall Study|Other|1|||
144738441|NCT01527006|521897461|FG001|Extension Phase|Lost to Follow-up|1|||
144738442|NCT01527006|521897460|FG000|Extension Phase|Subject Choice|1|||
144738443|NCT01527006|521897461|FG001|Extension Phase|Subject Choice|1|||
144682315|NCT03671148|521687640|FG001|Overall Study|Other|0|||
144682316|NCT03671148|521687639|FG000|Overall Study|Incomplete Randomization Visit|1|||
144738444|NCT01527006|521897460|FG000|Extension Phase|Inadequate therapeutic effect|1|||
144738445|NCT01527006|521897461|FG001|Extension Phase|Inadequate therapeutic effect|1|||
144682317|NCT03671148|521687640|FG001|Overall Study|Incomplete Randomization Visit|0|||
144682318|NCT03878160|521687644|FG000|Overall Study|Lost to Follow-up|1|||
144682319|NCT03878160|521687645|FG001|Overall Study|Lost to Follow-up|1|||
144682320|NCT03878160|521687646|FG002|Overall Study|Lost to Follow-up|1|||
144682321|NCT03878160|521687644|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
144682322|NCT03878160|521687645|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
144682323|NCT03878160|521687646|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
144682324|NCT00413777|521687652|FG000|Fixed-dose Period|Lost to Follow-up|1|||
144682325|NCT00413777|521687653|FG001|Fixed-dose Period|Lost to Follow-up|1|||
144682326|NCT00413777|521687652|FG000|Fixed-dose Period|Adverse Event|2|||
144682327|NCT00413777|521687653|FG001|Fixed-dose Period|Adverse Event|1|||
144682328|NCT00413777|521687652|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
144682329|NCT00413777|521687653|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
144682330|NCT00413777|521687652|FG000|Fixed-dose Period|Withdrew Consent|0|||
144682331|NCT00413777|521687653|FG001|Fixed-dose Period|Withdrew Consent|1|||
144682332|NCT05505734|521687654|FG000|Overall Study|Withdrawal by Subject|51|||
144682333|NCT05505734|521687655|FG001|Overall Study|Withdrawal by Subject|64|||
144682334|NCT05505734|521687654|FG000|Overall Study|Adverse Event|6|||
144682335|NCT05505734|521687655|FG001|Overall Study|Adverse Event|20|||
144682336|NCT05505734|521687654|FG000|Overall Study|Protocol Violation|8|||
144682337|NCT05505734|521687655|FG001|Overall Study|Protocol Violation|15|||
144682338|NCT05505734|521687654|FG000|Overall Study|Lack of therapeutic response|0|||
144682339|NCT05505734|521687655|FG001|Overall Study|Lack of therapeutic response|1|||
144682340|NCT05505734|521687654|FG000|Overall Study|Lost to Follow-up|247|||
144682341|NCT05505734|521687655|FG001|Overall Study|Lost to Follow-up|237|||
144682342|NCT05505734|521687654|FG000|Overall Study|Physician Decision|22|||
144682343|NCT05505734|521687655|FG001|Overall Study|Physician Decision|13|||
144682344|NCT05505734|521687654|FG000|Overall Study|Death|2|||
144682345|NCT05505734|521687655|FG001|Overall Study|Death|1|||
144682346|NCT05505734|521687654|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144682347|NCT05505734|521687655|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144682348|NCT05505734|521687654|FG000|Overall Study|Pregnancy|1|||
144682349|NCT05505734|521687655|FG001|Overall Study|Pregnancy|0|||
144682350|NCT05505734|521687654|FG000|Overall Study|Other|17|||
144682351|NCT05505734|521687655|FG001|Overall Study|Other|13|||
144682352|NCT02974621|521687657|FG000|Overall Study|Didn't receive study treatment|1|||
144682353|NCT02974621|521687658|FG001|Overall Study|Didn't receive study treatment|10|||
144682354|NCT00732472|521687659|FG000|Overall Study|Adverse Event|0|||
144682355|NCT00732472|521687660|FG001|Overall Study|Adverse Event|1|||
144682356|NCT00732472|521687661|FG002|Overall Study|Adverse Event|1|||
144682357|NCT00732472|521687662|FG003|Overall Study|Adverse Event|1|||
144682358|NCT00732472|521687659|FG000|Overall Study|Protocol Violation|0|||
144682359|NCT00732472|521687660|FG001|Overall Study|Protocol Violation|0|||
144682360|NCT00732472|521687661|FG002|Overall Study|Protocol Violation|0|||
144682361|NCT00732472|521687662|FG003|Overall Study|Protocol Violation|1|||
144682362|NCT00732472|521687659|FG000|Overall Study|Withdrawal by Subject|0|||
144682363|NCT00732472|521687660|FG001|Overall Study|Withdrawal by Subject|2|||
144682364|NCT00732472|521687661|FG002|Overall Study|Withdrawal by Subject|0|||
144682365|NCT00732472|521687662|FG003|Overall Study|Withdrawal by Subject|1|||
144682366|NCT02155712|521687664|FG000|Overall Study|Death|12|||
144682367|NCT02155712|521687665|FG001|Overall Study|Death|0|||
144682368|NCT02155712|521687664|FG000|Overall Study|Lost to Follow-up|37|||
144682369|NCT02155712|521687665|FG001|Overall Study|Lost to Follow-up|22|||
144682370|NCT02155712|521687664|FG000|Overall Study|Revision of device|4|||
144682371|NCT02155712|521687665|FG001|Overall Study|Revision of device|3|||
144682372|NCT02155712|521687664|FG000|Overall Study|Withdrawal by Subject|39|||
144682373|NCT02155712|521687665|FG001|Overall Study|Withdrawal by Subject|21|||
144682374|NCT02155712|521687664|FG000|Overall Study|Site termination|77|||
144682375|NCT02155712|521687665|FG001|Overall Study|Site termination|19|||
144682376|NCT02155712|521687664|FG000|Overall Study|Sponsor terminated study early|150|||
144682377|NCT02155712|521687665|FG001|Overall Study|Sponsor terminated study early|0|||
144682378|NCT02155712|521687664|FG000|Overall Study|Missed final 5-year protocol visit|0|||
144682379|NCT02155712|521687665|FG001|Overall Study|Missed final 5-year protocol visit|32|||
144682380|NCT02155712|521687664|FG000|Overall Study|Censored because surgery cancelled|6|||
144682381|NCT02155712|521687665|FG001|Overall Study|Censored because surgery cancelled|10|||
144682382|NCT02155712|521687664|FG000|Overall Study|Censored because study device was not implanted|61|||
144682383|NCT02155712|521687665|FG001|Overall Study|Censored because study device was not implanted|66|||
144682384|NCT02155712|521687664|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
144682385|NCT02155712|521687665|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
144682386|NCT01266876|521687666|FG000|Overall Study|Adverse Event|0|||
144682387|NCT01266876|521687667|FG001|Overall Study|Adverse Event|0|||
144682388|NCT01266876|521687668|FG002|Overall Study|Adverse Event|0|||
144682389|NCT01266876|521687669|FG003|Overall Study|Adverse Event|1|||
144682390|NCT01266876|521687670|FG004|Overall Study|Adverse Event|0|||
144682391|NCT01058395|521687671|FG000|Overall Study|Death|2|||
144682392|NCT01058395|521687672|FG001|Overall Study|Death|1|||
144682393|NCT01058395|521687671|FG000|Overall Study|Lost to Follow-up|1|||
144682394|NCT01058395|521687672|FG001|Overall Study|Lost to Follow-up|0|||
144682395|NCT04288089|521687673|FG000|Overall Study|Ongoing Treatment|2|||
144682396|NCT04288089|521687674|FG001|Overall Study|Ongoing Treatment|1|||
144682397|NCT04288089|521687675|FG002|Overall Study|Ongoing Treatment|1|||
144682398|NCT04288089|521687676|FG003|Overall Study|Ongoing Treatment|4|||
144682399|NCT00976963|521687677|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
144682400|NCT00976963|521687678|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
144682401|NCT00976963|521687677|FG000|Overall Study|administrative error|1|||
144682402|NCT00976963|521687678|FG001|Overall Study|administrative error|0|||
144682403|NCT00976963|521687677|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
144682404|NCT00976963|521687678|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
144682405|NCT02768103|521687681|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
144682406|NCT00557323|521687682|FG000|Overall Study|Death|3|||
144682407|NCT00557323|521687682|FG000|Overall Study|Withdrawal by Subject|2|||
144682408|NCT00557323|521687682|FG000|Overall Study|Administrative change|2|||
144682409|NCT01025232|521687683|FG000|Overall Study|Study drug no longer available|3|||
144682410|NCT01025232|521687684|FG001|Overall Study|Study drug no longer available|6|||
144682411|NCT03748420|521687685|FG000|Overall Study|No 12 month medication adherence data available|0|||
144682412|NCT03748420|521687686|FG001|Overall Study|No 12 month medication adherence data available|1|||
144682413|NCT03748420|521687685|FG000|Overall Study|Death|24|||
144682414|NCT03748420|521687686|FG001|Overall Study|Death|28|||
144682415|NCT03748420|521687685|FG000|Overall Study|Lost to Follow-up|231|||
144682416|NCT03748420|521687686|FG001|Overall Study|Lost to Follow-up|230|||
144682417|NCT04007367|521687687|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
144682418|NCT04007367|521687688|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
144682419|NCT04007367|521687689|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
144682420|NCT04007367|521687687|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
144682421|NCT04007367|521687688|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
144682422|NCT04007367|521687689|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
144682423|NCT04007367|521687687|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
144682424|NCT04007367|521687688|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
144682425|NCT04007367|521687689|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
144682426|NCT04007367|521687687|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
144682427|NCT04007367|521687688|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
144682428|NCT04007367|521687689|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
144682429|NCT04007367|521687687|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
144682430|NCT04007367|521687688|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
144682431|NCT04007367|521687689|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
144682432|NCT04043416|521687690|FG000|Washout|Change in health condition|0|||
144682433|NCT04043416|521687691|FG001|Washout|Change in health condition|1|||
144682434|NCT00372489|521687693|FG000|Overall Study|Adverse Event|18|||
144682435|NCT00372489|521687693|FG000|Overall Study|Lack of Efficacy|1|||
144682436|NCT00372489|521687693|FG000|Overall Study|Lost to Follow-up|3|||
144682437|NCT00372489|521687693|FG000|Overall Study|Physician Decision|3|||
144682438|NCT00372489|521687693|FG000|Overall Study|Withdrawal by Subject|5|||
144682439|NCT00372489|521687693|FG000|Overall Study|Patient Relocation|2|||
144682440|NCT00372489|521687693|FG000|Overall Study|Renal transplant|6|||
144682441|NCT00372489|521687693|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
144682442|NCT04476108|521687694|FG000|Overall Study|Adverse Event|4|||
144682443|NCT04476108|521687695|FG001|Overall Study|Adverse Event|1|||
144682444|NCT04476108|521687694|FG000|Overall Study|Lost to Follow-up|1|||
144682445|NCT04476108|521687695|FG001|Overall Study|Lost to Follow-up|0|||
144682446|NCT04476108|521687694|FG000|Overall Study|Inadvertent Enrollment|1|||
144682447|NCT04476108|521687695|FG001|Overall Study|Inadvertent Enrollment|0|||
144682448|NCT04476108|521687694|FG000|Overall Study|Protocol Violation|1|||
144682449|NCT04476108|521687695|FG001|Overall Study|Protocol Violation|1|||
144218326|NCT04194645|519992317|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
144218327|NCT03076775|519992318|FG000|Overall Study|Lost to Follow-up|1|||
144218328|NCT03076775|519992319|FG001|Overall Study|Lost to Follow-up|0|||
144218329|NCT01783886|519992320|FG000|Overall Study|Lost to Follow-up|0|||
144682450|NCT04476108|521687694|FG000|Overall Study|Withdrawal by Subject|1|||
144682451|NCT04476108|521687695|FG001|Overall Study|Withdrawal by Subject|1|||
144218330|NCT01783886|519992321|FG001|Overall Study|Lost to Follow-up|3|||
144682452|NCT04259346|521687696|FG000|Overall Study|Lost to Follow-up|1|||
144682453|NCT04259346|521687697|FG001|Overall Study|Lost to Follow-up|3|||
144682454|NCT04259346|521687696|FG000|Overall Study|Protocol Violation|1|||
144218331|NCT01783886|519992322|FG002|Overall Study|Lost to Follow-up|0|||
144265846|NCT00427908|520174018|FG000|Primary Phase|Withdrawal by Subject|1|||
144682455|NCT04259346|521687697|FG001|Overall Study|Protocol Violation|0|||
144682456|NCT04259346|521687696|FG000|Overall Study|Withdrawal by Subject|1|||
144682457|NCT04259346|521687697|FG001|Overall Study|Withdrawal by Subject|0|||
144682458|NCT04259346|521687696|FG000|Overall Study|Adverse Event|1|||
144682459|NCT04259346|521687697|FG001|Overall Study|Adverse Event|1|||
144682460|NCT00085644|521687698|FG000|Double-Blind Period|Adverse Event|5|||
144682461|NCT00085644|521687699|FG001|Double-Blind Period|Adverse Event|2|||
144682462|NCT00085644|521687700|FG002|Double-Blind Period|Adverse Event|0|||
144218332|NCT01783886|519992320|FG000|Overall Study|Protocol deviation|0|||
144218333|NCT01783886|519992321|FG001|Overall Study|Protocol deviation|0|||
144682463|NCT00085644|521687698|FG000|Double-Blind Period|Withdrawal by Subject|3|||
144682464|NCT00085644|521687699|FG001|Double-Blind Period|Withdrawal by Subject|0|||
144682465|NCT00085644|521687700|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144682466|NCT00085644|521687698|FG000|Double-Blind Period|Lost to Follow-up|2|||
144682467|NCT00085644|521687699|FG001|Double-Blind Period|Lost to Follow-up|1|||
144682468|NCT00085644|521687700|FG002|Double-Blind Period|Lost to Follow-up|0|||
144682469|NCT00085644|521687698|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
144682470|NCT00085644|521687699|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
144682471|NCT00085644|521687700|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
144682472|NCT00085644|521687698|FG000|Double-Blind Period|Contemplating pregnancy|1|||
144682473|NCT00085644|521687699|FG001|Double-Blind Period|Contemplating pregnancy|0|||
144682474|NCT00085644|521687700|FG002|Double-Blind Period|Contemplating pregnancy|0|||
144682475|NCT00085644|521687698|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
144682476|NCT00085644|521687699|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
144682477|NCT00085644|521687700|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
144682478|NCT00085644|521687698|FG000|Open-Label Period|Adverse Event|0|||
144682479|NCT00085644|521687699|FG001|Open-Label Period|Adverse Event|0|||
144682480|NCT00085644|521687700|FG002|Open-Label Period|Adverse Event|38|||
144682481|NCT00085644|521687698|FG000|Open-Label Period|Withdrawal by Subject|0|||
144682482|NCT00085644|521687699|FG001|Open-Label Period|Withdrawal by Subject|0|||
144682483|NCT00085644|521687700|FG002|Open-Label Period|Withdrawal by Subject|29|||
144682484|NCT00085644|521687698|FG000|Open-Label Period|Lost to Follow-up|0|||
144682485|NCT00085644|521687699|FG001|Open-Label Period|Lost to Follow-up|0|||
144682486|NCT00085644|521687700|FG002|Open-Label Period|Lost to Follow-up|13|||
144682487|NCT00085644|521687698|FG000|Open-Label Period|Lack of Efficacy|0|||
144682488|NCT00085644|521687699|FG001|Open-Label Period|Lack of Efficacy|0|||
144682489|NCT00085644|521687700|FG002|Open-Label Period|Lack of Efficacy|15|||
144682490|NCT00085644|521687698|FG000|Open-Label Period|Pregnancy|0|||
144682491|NCT00085644|521687699|FG001|Open-Label Period|Pregnancy|0|||
144682492|NCT00085644|521687700|FG002|Open-Label Period|Pregnancy|3|||
144682493|NCT00085644|521687698|FG000|Open-Label Period|Contemplating pregnancy|0|||
144682494|NCT00085644|521687699|FG001|Open-Label Period|Contemplating pregnancy|0|||
144682495|NCT00085644|521687700|FG002|Open-Label Period|Contemplating pregnancy|3|||
144682496|NCT00085644|521687698|FG000|Open-Label Period|Protocol Violation|0|||
144682497|NCT00085644|521687699|FG001|Open-Label Period|Protocol Violation|0|||
144682498|NCT00085644|521687700|FG002|Open-Label Period|Protocol Violation|4|||
144682499|NCT00085644|521687698|FG000|Open-Label Period|Personal reason|0|||
144682500|NCT00085644|521687699|FG001|Open-Label Period|Personal reason|0|||
144682501|NCT00085644|521687700|FG002|Open-Label Period|Personal reason|4|||
144682502|NCT03330106|521687701|FG000|Part A|Withdrawal by Subject|1|||
144682503|NCT03330106|521687702|FG001|Part A|Withdrawal by Subject|1|||
144682504|NCT03330106|521687703|FG002|Part A|Withdrawal by Subject|0|||
144682505|NCT03330106|521687704|FG003|Part A|Withdrawal by Subject|0|||
144682506|NCT03330106|521687701|FG000|Part A|Death|2|||
144682507|NCT03330106|521687702|FG001|Part A|Death|1|||
144682508|NCT03330106|521687703|FG002|Part A|Death|0|||
144682509|NCT03330106|521687704|FG003|Part A|Death|0|||
144682510|NCT03330106|521687701|FG000|Part A|Adverse Event|0|||
144682511|NCT03330106|521687702|FG001|Part A|Adverse Event|1|||
144682512|NCT03330106|521687703|FG002|Part A|Adverse Event|0|||
144682513|NCT03330106|521687704|FG003|Part A|Adverse Event|0|||
144682514|NCT03330106|521687701|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
144682515|NCT03330106|521687702|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
144682516|NCT03330106|521687703|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
144682517|NCT03330106|521687704|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
144682518|NCT03330106|521687701|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
144682519|NCT03330106|521687702|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
144682520|NCT03330106|521687703|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
144682521|NCT03330106|521687704|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
144682522|NCT03330106|521687701|FG000|Part A|Progressive Disease|0|||
144682523|NCT03330106|521687702|FG001|Part A|Progressive Disease|1|||
144682524|NCT03330106|521687703|FG002|Part A|Progressive Disease|0|||
144682525|NCT03330106|521687704|FG003|Part A|Progressive Disease|0|||
144682526|NCT03330106|521687701|FG000|Part B|Lost to Follow-up|0|||
144682527|NCT03330106|521687702|FG001|Part B|Lost to Follow-up|0|||
144682528|NCT03330106|521687703|FG002|Part B|Lost to Follow-up|0|||
144682529|NCT03330106|521687704|FG003|Part B|Lost to Follow-up|1|||
144682530|NCT03330106|521687701|FG000|Part B|Withdrawal by Subject|0|||
144682531|NCT03330106|521687702|FG001|Part B|Withdrawal by Subject|0|||
144682532|NCT03330106|521687703|FG002|Part B|Withdrawal by Subject|4|||
144682533|NCT03330106|521687704|FG003|Part B|Withdrawal by Subject|0|||
144682534|NCT03330106|521687701|FG000|Part B|Death|0|||
144682535|NCT03330106|521687702|FG001|Part B|Death|0|||
144682536|NCT03330106|521687703|FG002|Part B|Death|2|||
144682537|NCT03330106|521687704|FG003|Part B|Death|0|||
144682538|NCT03330106|521687701|FG000|Part B|Clinical Progression|0|||
144682539|NCT03330106|521687702|FG001|Part B|Clinical Progression|0|||
144682540|NCT03330106|521687703|FG002|Part B|Clinical Progression|1|||
144682541|NCT03330106|521687704|FG003|Part B|Clinical Progression|1|||
144682542|NCT03330106|521687701|FG000|Part B|Symptomatic Deterioration|0|||
144682543|NCT03330106|521687702|FG001|Part B|Symptomatic Deterioration|0|||
144682544|NCT03330106|521687703|FG002|Part B|Symptomatic Deterioration|0|||
144682545|NCT03330106|521687704|FG003|Part B|Symptomatic Deterioration|1|||
144682546|NCT03330106|521687701|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
144682547|NCT03330106|521687702|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
144682548|NCT03330106|521687703|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
144682549|NCT03330106|521687704|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
144682550|NCT03330106|521687701|FG000|Part B|Progressive Disease|0|||
144682551|NCT03330106|521687702|FG001|Part B|Progressive Disease|0|||
144682552|NCT03330106|521687703|FG002|Part B|Progressive Disease|11|||
144682553|NCT03330106|521687704|FG003|Part B|Progressive Disease|4|||
144682554|NCT00486889|521687705|FG000|Overall Study|Death|3|||
144682555|NCT00486889|521687705|FG000|Overall Study|Non-compliant|2|||
144682556|NCT00486889|521687705|FG000|Overall Study|Withdrawal by Subject|6|||
144682557|NCT03198728|521687706|FG000|Overall Study|Adverse Event|10|||
144682558|NCT03198728|521687707|FG001|Overall Study|Adverse Event|5|||
144682559|NCT03198728|521687706|FG000|Overall Study|Lost to Follow-up|21|||
144682560|NCT03198728|521687707|FG001|Overall Study|Lost to Follow-up|7|||
144682561|NCT03198728|521687706|FG000|Overall Study|Physician Decision|7|||
144682562|NCT03198728|521687707|FG001|Overall Study|Physician Decision|2|||
144682563|NCT03198728|521687706|FG000|Overall Study|Withdrawal by Subject|14|||
144682564|NCT03198728|521687707|FG001|Overall Study|Withdrawal by Subject|10|||
144682565|NCT03446612|521687708|FG000|Overall Study|Protocol defined stopping criteria|0|||
144682566|NCT03446612|521687709|FG001|Overall Study|Protocol defined stopping criteria|1|||
144682567|NCT01437267|521687711|FG000|Overall Study|Withdrawal by Subject|0|||
144682568|NCT01437267|521687712|FG001|Overall Study|Withdrawal by Subject|0|||
144682569|NCT01437267|521687713|FG002|Overall Study|Withdrawal by Subject|0|||
144682570|NCT01437267|521687714|FG003|Overall Study|Withdrawal by Subject|1|||
144682571|NCT01437267|521687715|FG004|Overall Study|Withdrawal by Subject|0|||
144682572|NCT01437267|521687716|FG005|Overall Study|Withdrawal by Subject|0|||
144682573|NCT01437267|521687711|FG000|Overall Study|Protocol Violation|0|||
144682574|NCT01437267|521687712|FG001|Overall Study|Protocol Violation|1|||
144682575|NCT01437267|521687713|FG002|Overall Study|Protocol Violation|0|||
144682576|NCT01437267|521687714|FG003|Overall Study|Protocol Violation|0|||
144682577|NCT01437267|521687715|FG004|Overall Study|Protocol Violation|0|||
144682578|NCT01437267|521687716|FG005|Overall Study|Protocol Violation|0|||
144682579|NCT00333970|521687719|FG000|Overall Study|Withdrawal by Subject|13|||
144682580|NCT00333970|521687720|FG001|Overall Study|Withdrawal by Subject|7|||
144682581|NCT03148795|521687724|FG000|Overall Study|Progressive Disease|1|||
144682582|NCT04228445|521687732|FG000|Overall Study|Lost to Follow-up|1|||
144682583|NCT04228445|521687733|FG001|Overall Study|Lost to Follow-up|1|||
144682584|NCT04228445|521687732|FG000|Overall Study|Physician Decision|1|||
144682585|NCT04228445|521687733|FG001|Overall Study|Physician Decision|2|||
144682586|NCT04228445|521687732|FG000|Overall Study|Withdrawal by Subject|0|||
144682587|NCT04228445|521687733|FG001|Overall Study|Withdrawal by Subject|1|||
144682588|NCT04228445|521687732|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
144682589|NCT04228445|521687733|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
144682590|NCT03418376|521687734|FG000|Overall Study|Musculoskeletal injury|1|||
144682591|NCT03418376|521687735|FG001|Overall Study|Musculoskeletal injury|2|||
144682592|NCT03418376|521687736|FG002|Overall Study|Musculoskeletal injury|1|||
144682593|NCT03418376|521687737|FG003|Overall Study|Musculoskeletal injury|0|||
144682594|NCT03418376|521687734|FG000|Overall Study|Personal reasons|0|||
144682595|NCT03418376|521687735|FG001|Overall Study|Personal reasons|2|||
144682596|NCT03418376|521687736|FG002|Overall Study|Personal reasons|2|||
144682597|NCT03418376|521687737|FG003|Overall Study|Personal reasons|1|||
144682598|NCT03418376|521687734|FG000|Overall Study|Exacerbation|0|||
144682599|NCT03418376|521687735|FG001|Overall Study|Exacerbation|1|||
144682600|NCT03418376|521687736|FG002|Overall Study|Exacerbation|0|||
144682601|NCT03418376|521687737|FG003|Overall Study|Exacerbation|0|||
144682602|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
144682603|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
144682604|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
144682605|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
144682606|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
144682607|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
144682608|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
144682609|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
144682610|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
144682611|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
144682612|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
144682613|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
144682614|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
144682615|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
144682616|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
144682617|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
144682618|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
144682619|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
144682620|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
144682621|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
144682622|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
144682623|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
144682624|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
144682625|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
144682626|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
144682627|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
144682628|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
144682629|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
144682630|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
144682631|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
144682632|NCT04757376|521687740|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
144682633|NCT04757376|521687741|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
144682634|NCT04757376|521687742|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
144682635|NCT04757376|521687743|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
144682636|NCT04757376|521687744|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
144682637|NCT04757376|521687740|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
144682638|NCT04757376|521687741|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
144682639|NCT04757376|521687742|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
144682640|NCT04757376|521687743|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
144682641|NCT04757376|521687744|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
144682642|NCT01307046|521687745|FG000|Overall Study|Adverse Event|3|||
144682643|NCT01307046|521687746|FG001|Overall Study|Adverse Event|3|||
144682644|NCT01307046|521687745|FG000|Overall Study|Lack of Efficacy|0|||
144682645|NCT01307046|521687746|FG001|Overall Study|Lack of Efficacy|2|||
144682646|NCT01307046|521687745|FG000|Overall Study|Physician Decision|2|||
144682647|NCT01307046|521687746|FG001|Overall Study|Physician Decision|0|||
144682648|NCT01307046|521687745|FG000|Overall Study|Withdrawal by Subject|1|||
144682649|NCT01307046|521687746|FG001|Overall Study|Withdrawal by Subject|1|||
144682650|NCT01307046|521687745|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
144682651|NCT01307046|521687746|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
144682652|NCT01307046|521687745|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
144682653|NCT01307046|521687746|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
144682654|NCT02574520|521687747|FG000|Overall Study|Not dosed|2|||
144682655|NCT02574520|521687748|FG001|Overall Study|Not dosed|0|||
144682656|NCT02574520|521687749|FG002|Overall Study|Not dosed|5|||
144682657|NCT02574520|521687750|FG003|Overall Study|Not dosed|4|||
144682658|NCT02574520|521687747|FG000|Overall Study|Adverse Event|0|||
144682659|NCT02574520|521687748|FG001|Overall Study|Adverse Event|0|||
144682660|NCT02574520|521687749|FG002|Overall Study|Adverse Event|0|||
144682661|NCT02574520|521687750|FG003|Overall Study|Adverse Event|1|||
144682662|NCT02574520|521687747|FG000|Overall Study|Withdrawal by Subject|0|||
144682663|NCT02574520|521687748|FG001|Overall Study|Withdrawal by Subject|0|||
144682664|NCT02574520|521687749|FG002|Overall Study|Withdrawal by Subject|0|||
144682665|NCT02574520|521687750|FG003|Overall Study|Withdrawal by Subject|1|||
144738446|NCT01527006|521897460|FG000|Extension Phase|Other|0|||
144738447|NCT01527006|521897461|FG001|Extension Phase|Other|3|||
144738448|NCT00834340|521897463|FG000|Washout|Adverse Event|1|||
144738449|NCT00834340|521897464|FG001|Washout|Adverse Event|0|||
144738450|NCT00834340|521897463|FG000|Washout|Withdrawal by Subject|1|||
144738451|NCT00834340|521897464|FG001|Washout|Withdrawal by Subject|0|||
144738452|NCT00395694|521897465|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
144738453|NCT00395694|521897466|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
144738454|NCT00395694|521897465|FG000|Continuation Phase|Adverse Event|1|||
144738455|NCT00395694|521897466|FG001|Continuation Phase|Adverse Event|0|||
144738456|NCT00395694|521897465|FG000|Continuation Phase|Lack of Efficacy|12|||
144738457|NCT00395694|521897466|FG001|Continuation Phase|Lack of Efficacy|11|||
144682666|NCT02574520|521687747|FG000|Overall Study|Other|0|||
144682667|NCT02574520|521687748|FG001|Overall Study|Other|0|||
144682668|NCT02574520|521687749|FG002|Overall Study|Other|0|||
144682669|NCT02574520|521687750|FG003|Overall Study|Other|2|||
144682670|NCT03935594|521687762|FG000|Overall Study|Physician Decision|3|||
144682671|NCT01435122|521687763|FG000|Overall Study|Early withdrawal due to toxicity|8|||
144682672|NCT01190020|521687764|FG000|Overall Study|Adverse Event|2|||
144682673|NCT01190020|521687765|FG001|Overall Study|Adverse Event|0|||
144682674|NCT01190020|521687764|FG000|Overall Study|Lost to Follow-up|2|||
144682675|NCT01190020|521687765|FG001|Overall Study|Lost to Follow-up|0|||
144682676|NCT01190020|521687764|FG000|Overall Study|Withdrawal by Subject|3|||
144682677|NCT01190020|521687765|FG001|Overall Study|Withdrawal by Subject|0|||
144682678|NCT00796224|521687766|FG000|Overall Study|Adverse Event|1|||
144682679|NCT00796224|521687767|FG001|Overall Study|Adverse Event|0|||
144682680|NCT00796224|521687766|FG000|Overall Study|Protocol Violation|0|||
144682681|NCT00796224|521687767|FG001|Overall Study|Protocol Violation|1|||
144682682|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
144682683|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
144682684|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
144682685|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
144682686|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
144682687|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
144682688|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
144682689|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
144682690|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
144682691|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
144682692|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
144682693|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
144682694|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
144682695|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144682696|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144682697|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144682698|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
144682699|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
144682700|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
144682701|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
144682702|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
144682703|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
144682704|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
144682705|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
144682706|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
144682707|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
144682708|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
144682709|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
144682710|NCT03227224|521687770|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
144682711|NCT03227224|521687771|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
144682712|NCT03227224|521687772|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
144682713|NCT03227224|521687773|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
144682714|NCT03227224|521687770|FG000|Follow-up Phase (2 Weeks)|Other|4|||
144682715|NCT03227224|521687771|FG001|Follow-up Phase (2 Weeks)|Other|4|||
144682716|NCT03227224|521687772|FG002|Follow-up Phase (2 Weeks)|Other|6|||
144682717|NCT03227224|521687773|FG003|Follow-up Phase (2 Weeks)|Other|3|||
144682718|NCT04195750|521687774|FG000|Overall Study|Death|245|||
144218334|NCT01783886|519992322|FG002|Overall Study|Protocol deviation|2|||
144218335|NCT01783886|519992320|FG000|Overall Study|Withdrawal of consent by participant|1|||
144682719|NCT04195750|521687775|FG001|Overall Study|Death|253|||
144682720|NCT04195750|521687776|FG002|Overall Study|Death|5|||
144682721|NCT04195750|521687774|FG000|Overall Study|Physician Decision|0|||
144682722|NCT04195750|521687775|FG001|Overall Study|Physician Decision|1|||
144682723|NCT04195750|521687776|FG002|Overall Study|Physician Decision|0|||
144682724|NCT04195750|521687774|FG000|Overall Study|Withdrawal by Subject|9|||
144682725|NCT04195750|521687775|FG001|Overall Study|Withdrawal by Subject|8|||
144218336|NCT01783886|519992321|FG001|Overall Study|Withdrawal of consent by participant|3|||
144738458|NCT00395694|521897465|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
144682726|NCT04195750|521687776|FG002|Overall Study|Withdrawal by Subject|0|||
144682727|NCT04195750|521687774|FG000|Overall Study|Ongoing|120|||
144682728|NCT04195750|521687775|FG001|Overall Study|Ongoing|110|||
144682729|NCT04195750|521687776|FG002|Overall Study|Ongoing|4|||
144218337|NCT01783886|519992322|FG002|Overall Study|Withdrawal of consent by participant|4|||
144218338|NCT01783886|519992320|FG000|Overall Study|Adverse Event|4|||
144682730|NCT02406027|521687777|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
144682731|NCT02406027|521687778|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
144682732|NCT02406027|521687779|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
144682733|NCT02406027|521687780|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
144682734|NCT02406027|521687781|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
144682735|NCT02406027|521687782|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
144682736|NCT02406027|521687783|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
144682737|NCT02406027|521687777|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
144682738|NCT02406027|521687778|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
144682739|NCT02406027|521687779|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
144682740|NCT02406027|521687780|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
144682741|NCT02406027|521687781|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
144682742|NCT02406027|521687782|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
144682743|NCT02406027|521687783|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
144682744|NCT02406027|521687777|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
144682745|NCT02406027|521687778|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
144682746|NCT02406027|521687779|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
144682747|NCT02406027|521687780|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
144682748|NCT02406027|521687781|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
144682749|NCT02406027|521687782|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
144682750|NCT02406027|521687783|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
144682751|NCT02406027|521687777|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
144682752|NCT02406027|521687778|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
144682753|NCT02406027|521687779|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
144682754|NCT02406027|521687780|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
144682755|NCT02406027|521687781|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
144682756|NCT02406027|521687782|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
144682757|NCT02406027|521687783|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
144682758|NCT02406027|521687777|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
144682759|NCT02406027|521687778|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
144682760|NCT02406027|521687779|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
144682761|NCT02406027|521687780|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
144682762|NCT02406027|521687781|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
144682763|NCT02406027|521687782|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
144682764|NCT02406027|521687783|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
144682765|NCT02406027|521687777|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
144682766|NCT02406027|521687778|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
144682767|NCT02406027|521687779|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
144682768|NCT02406027|521687780|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
144682769|NCT02406027|521687781|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
144682770|NCT02406027|521687782|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
144682771|NCT02406027|521687783|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
144682772|NCT02406027|521687777|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
144682773|NCT02406027|521687778|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
144682774|NCT02406027|521687779|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
144682775|NCT02406027|521687780|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
144682776|NCT02406027|521687781|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
144682777|NCT02406027|521687782|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
144682778|NCT02406027|521687783|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
144682779|NCT02406027|521687777|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
144682780|NCT02406027|521687778|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
144682781|NCT02406027|521687779|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
144682782|NCT02406027|521687780|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
144682783|NCT02406027|521687781|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
144682784|NCT02406027|521687782|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
144682785|NCT02406027|521687783|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
144682786|NCT02406027|521687777|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
144682787|NCT02406027|521687778|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
144218339|NCT01783886|519992321|FG001|Overall Study|Adverse Event|5|||
144218340|NCT01783886|519992322|FG002|Overall Study|Adverse Event|4|||
144218341|NCT04542057|519992323|FG000|Overall Study|Death|3|||
144218342|NCT04542057|519992324|FG001|Overall Study|Death|1|||
144738459|NCT00395694|521897466|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
144682788|NCT02406027|521687779|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
144218343|NCT04542057|519992323|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
144682789|NCT02406027|521687780|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
144682790|NCT02406027|521687781|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
144682791|NCT02406027|521687782|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
144682792|NCT02406027|521687783|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
144682793|NCT02406027|521687777|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
144682794|NCT02406027|521687778|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
144682795|NCT02406027|521687779|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
144682796|NCT02406027|521687780|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
144682797|NCT02406027|521687781|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
144682798|NCT02406027|521687782|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
144682799|NCT02406027|521687783|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
144682800|NCT03782376|521687784|FG000|Overall Study|Lost to Follow-up|2|||
144682801|NCT03782376|521687785|FG001|Overall Study|Lost to Follow-up|2|||
144682802|NCT03782376|521687784|FG000|Overall Study|Withdrawal by Subject|7|||
144682803|NCT03782376|521687785|FG001|Overall Study|Withdrawal by Subject|11|||
144682804|NCT03782376|521687784|FG000|Overall Study|Death|1|||
144682805|NCT03782376|521687785|FG001|Overall Study|Death|0|||
144682806|NCT03782376|521687784|FG000|Overall Study|Other|16|||
144682807|NCT03782376|521687785|FG001|Overall Study|Other|17|||
144682808|NCT03277794|521687788|FG000|Overall Study|Lost to Follow-up|2|||
144682809|NCT03277794|521687789|FG001|Overall Study|Lost to Follow-up|4|||
144682810|NCT03277794|521687788|FG000|Overall Study|Withdrew due to high acuity|1|||
144682811|NCT03277794|521687789|FG001|Overall Study|Withdrew due to high acuity|0|||
144682812|NCT02254304|521687791|FG000|Overall Study|Adverse Event|2|||
144682813|NCT02254304|521687792|FG001|Overall Study|Adverse Event|1|||
144682814|NCT02254304|521687791|FG000|Overall Study|Lost to Follow-up|2|||
144682815|NCT02254304|521687792|FG001|Overall Study|Lost to Follow-up|2|||
144682816|NCT02254304|521687791|FG000|Overall Study|Protocol Violation|1|||
144682817|NCT02254304|521687792|FG001|Overall Study|Protocol Violation|0|||
144682818|NCT02254304|521687791|FG000|Overall Study|Withdrawal by Subject|3|||
144682819|NCT02254304|521687792|FG001|Overall Study|Withdrawal by Subject|0|||
144682820|NCT02254304|521687791|FG000|Overall Study|Injection site pain and Injection fear|1|||
144682821|NCT02254304|521687792|FG001|Overall Study|Injection site pain and Injection fear|0|||
144682822|NCT02254304|521687791|FG000|Overall Study|Personal causes|4|||
144682823|NCT02254304|521687792|FG001|Overall Study|Personal causes|1|||
144682824|NCT02254304|521687791|FG000|Overall Study|Personal decision|1|||
144682825|NCT02254304|521687792|FG001|Overall Study|Personal decision|0|||
144682826|NCT05166603|521687793|FG000|Overall Study|Withdrawal by Subject|68|||
144682827|NCT05166603|521687794|FG001|Overall Study|Withdrawal by Subject|0|||
144682828|NCT03287830|521689572|FG000|Overall Study|Withdrawal by Subject|1|||
144682829|NCT03287830|521689573|FG001|Overall Study|Withdrawal by Subject|1|||
144682830|NCT03287830|521689572|FG000|Overall Study|not meeting inclusion criteria|5|||
144682831|NCT03287830|521689573|FG001|Overall Study|not meeting inclusion criteria|12|||
144682832|NCT02136134|521689579|FG000|Overall Study|Death|170|||
144682833|NCT02136134|521689580|FG001|Overall Study|Death|148|||
144682834|NCT02136134|521689579|FG000|Overall Study|Withdrawal by Subject|19|||
144682835|NCT02136134|521689580|FG001|Overall Study|Withdrawal by Subject|10|||
144682836|NCT02136134|521689579|FG000|Overall Study|Lost to Follow-up|3|||
144682837|NCT02136134|521689580|FG001|Overall Study|Lost to Follow-up|3|||
144682838|NCT02136134|521689579|FG000|Overall Study|Uspecified|55|||
144682839|NCT02136134|521689580|FG001|Overall Study|Uspecified|90|||
144682840|NCT03070119|521689583|FG000|Overall Study|Adverse Event|0|||
144682841|NCT03070119|521689584|FG001|Overall Study|Adverse Event|0|||
144682842|NCT03070119|521689585|FG002|Overall Study|Adverse Event|1|||
144682843|NCT03070119|521689583|FG000|Overall Study|Lost to Follow-up|0|||
144682844|NCT03070119|521689584|FG001|Overall Study|Lost to Follow-up|1|||
144682845|NCT03070119|521689585|FG002|Overall Study|Lost to Follow-up|0|||
144682846|NCT03070119|521689583|FG000|Overall Study|Consent Withdrawn|6|||
144682847|NCT03070119|521689584|FG001|Overall Study|Consent Withdrawn|5|||
144682848|NCT03070119|521689585|FG002|Overall Study|Consent Withdrawn|3|||
144682849|NCT03070119|521689583|FG000|Overall Study|Investigator Decision|0|||
144682850|NCT03070119|521689584|FG001|Overall Study|Investigator Decision|0|||
144682851|NCT03070119|521689585|FG002|Overall Study|Investigator Decision|1|||
144682852|NCT03070119|521689583|FG000|Overall Study|Death|7|||
144265847|NCT00427908|520174019|FG001|Primary Phase|Withdrawal by Subject|2|||
144682853|NCT03070119|521689584|FG001|Overall Study|Death|14|||
144682854|NCT03070119|521689585|FG002|Overall Study|Death|5|||
144682855|NCT03070119|521689583|FG000|Overall Study|Disease Progression|5|||
144682856|NCT03070119|521689584|FG001|Overall Study|Disease Progression|7|||
144682857|NCT03070119|521689585|FG002|Overall Study|Disease Progression|7|||
144682858|NCT03070119|521689583|FG000|Overall Study|Reason not Specified|2|||
144682859|NCT03070119|521689584|FG001|Overall Study|Reason not Specified|2|||
144682860|NCT03070119|521689585|FG002|Overall Study|Reason not Specified|1|||
144682861|NCT05180721|521689586|FG000|Overall Study|Lost to Follow-up|4|||
144682862|NCT03575351|521689587|FG000|Overall Study|Adverse Event|1|||
144682863|NCT03575351|521689588|FG001|Overall Study|Adverse Event|0|||
144682864|NCT03575351|521689587|FG000|Overall Study|Death|2|||
144682865|NCT03575351|521689588|FG001|Overall Study|Death|2|||
144682866|NCT03575351|521689587|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
144682867|NCT03575351|521689588|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
144682868|NCT03575351|521689587|FG000|Overall Study|Lack of Efficacy|28|||
144682869|NCT03575351|521689588|FG001|Overall Study|Lack of Efficacy|0|||
144682870|NCT03575351|521689587|FG000|Overall Study|Withdrawal by Subject|1|||
144682871|NCT03575351|521689588|FG001|Overall Study|Withdrawal by Subject|1|||
144682872|NCT03575351|521689587|FG000|Overall Study|Physician Decision|3|||
144682873|NCT03575351|521689588|FG001|Overall Study|Physician Decision|0|||
144682874|NCT03575351|521689587|FG000|Overall Study|Disease relapse|15|||
144682875|NCT03575351|521689588|FG001|Overall Study|Disease relapse|6|||
144682876|NCT03575351|521689587|FG000|Overall Study|Study drug manufacturing failure|0|||
144682877|NCT03575351|521689588|FG001|Overall Study|Study drug manufacturing failure|1|||
144682878|NCT03575351|521689587|FG000|Overall Study|other reasons|5|||
144682879|NCT03575351|521689588|FG001|Overall Study|other reasons|0|||
144682880|NCT01688999|521689589|FG000|Overall Study|Withdrawal by Subject|5|||
144682881|NCT01688999|521689590|FG001|Overall Study|Withdrawal by Subject|1|||
144682882|NCT01688999|521689591|FG002|Overall Study|Withdrawal by Subject|1|||
144682883|NCT01688999|521689589|FG000|Overall Study|Adverse Event|2|||
144682884|NCT01688999|521689590|FG001|Overall Study|Adverse Event|0|||
144682885|NCT01688999|521689591|FG002|Overall Study|Adverse Event|2|||
144682886|NCT01688999|521689589|FG000|Overall Study|Ineligible/Not treated|1|||
144682887|NCT01688999|521689590|FG001|Overall Study|Ineligible/Not treated|0|||
144682888|NCT01688999|521689591|FG002|Overall Study|Ineligible/Not treated|0|||
144682889|NCT01855425|521689610|FG000|Overall Study|Physician Decision|20|||
144682890|NCT01600105|521689614|FG000|Total Participants|Withdrawal by Subject|1|||
144682891|NCT01600105|521689615|FG001|Total Participants|Withdrawal by Subject|0|||
144682892|NCT01600105|521689614|FG000|Total Participants|No images in PACS|10|||
144682893|NCT01600105|521689615|FG001|Total Participants|No images in PACS|0|||
144682894|NCT01600105|521689614|FG000|Total Participants|Insufficient image quality|30|||
144682895|NCT01600105|521689615|FG001|Total Participants|Insufficient image quality|10|||
144682896|NCT01600105|521689614|FG000|Sub Study I|Insufficient image quality|0|||
144682897|NCT01600105|521689615|FG001|Sub Study I|Insufficient image quality|10|||
144682898|NCT01600105|521689614|FG000|Sub Study II|Withdrawal by Subject|1|||
144682899|NCT01600105|521689615|FG001|Sub Study II|Withdrawal by Subject|0|||
144682900|NCT01600105|521689614|FG000|Sub Study II|No images in PACS|1|||
144682901|NCT01600105|521689615|FG001|Sub Study II|No images in PACS|0|||
144682902|NCT01600105|521689614|FG000|Sub Study II|Insufficient image quality|3|||
144682903|NCT01600105|521689615|FG001|Sub Study II|Insufficient image quality|0|||
144682904|NCT01600105|521689614|FG000|Sub Study III|Insufficient image quality|5|||
144682905|NCT01600105|521689615|FG001|Sub Study III|Insufficient image quality|0|||
144682906|NCT01600105|521689614|FG000|Sub Study V|Poor Image Quality|2|||
144682907|NCT01600105|521689615|FG001|Sub Study V|Poor Image Quality|0|||
144682908|NCT01263444|521689616|FG000|Overall Study|Adverse Event|8|||
144682909|NCT01263444|521689616|FG000|Overall Study|Withdrawal by Subject|1|||
144682910|NCT01263444|521689616|FG000|Overall Study|Protocol Violation|1|||
144738460|NCT00395694|521897465|FG000|Continuation Phase|Poor Compliance|1|||
144682911|NCT01899768|521689618|FG000|Part A|Adverse Event|2|||
144682912|NCT01899768|521689618|FG000|Part A|Withdrawal by Subject|1|||
144682913|NCT01899768|521689618|FG000|Part B|Adverse Event|1|||
144682914|NCT01899768|521689618|FG000|Part B|Withdrawal by Subject|1|||
144682915|NCT01196091|521689619|FG000|Overall Study|Adverse Event|22|||
144682916|NCT01196091|521689620|FG001|Overall Study|Adverse Event|27|||
144738461|NCT00395694|521897466|FG001|Continuation Phase|Poor Compliance|0|||
144738462|NCT00395694|521897465|FG000|Continuation Phase|Withdrawal by Subject|0|||
144738463|NCT00395694|521897466|FG001|Continuation Phase|Withdrawal by Subject|2|||
144738464|NCT04238754|521897469|FG000|Washout - 1 Week|Lost to Follow-up|1|||
144738465|NCT04238754|521897470|FG001|Washout - 1 Week|Lost to Follow-up|0|||
144682917|NCT01196091|521689621|FG002|Overall Study|Adverse Event|26|||
144682918|NCT01196091|521689619|FG000|Overall Study|Death|3|||
144682919|NCT01196091|521689620|FG001|Overall Study|Death|2|||
144682920|NCT01196091|521689621|FG002|Overall Study|Death|2|||
144738466|NCT02159183|521897471|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
144218344|NCT04542057|519992324|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
144218345|NCT04542057|519992323|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
144682921|NCT01196091|521689619|FG000|Overall Study|Entry Criteria Not Met|11|||
144218346|NCT04542057|519992324|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
144218347|NCT04542057|519992323|FG000|Overall Study|Adverse Event|15|||
144682922|NCT01196091|521689620|FG001|Overall Study|Entry Criteria Not Met|11|||
144682923|NCT01196091|521689621|FG002|Overall Study|Entry Criteria Not Met|10|||
144682924|NCT01196091|521689619|FG000|Overall Study|Lack of Efficacy|15|||
144218348|NCT04542057|519992324|FG001|Overall Study|Adverse Event|6|||
144682925|NCT01196091|521689620|FG001|Overall Study|Lack of Efficacy|12|||
144682926|NCT01196091|521689621|FG002|Overall Study|Lack of Efficacy|17|||
144682927|NCT01196091|521689619|FG000|Overall Study|Lost to Follow-up|5|||
144738467|NCT02159183|521897472|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
144738468|NCT02159183|521897471|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
144738469|NCT02159183|521897472|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
144738470|NCT02159183|521897471|FG000|Analysis After the 36 Months Follow-up|Death|0|||
144738471|NCT02159183|521897472|FG001|Analysis After the 36 Months Follow-up|Death|1|||
144738472|NCT02159183|521897471|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
144738473|NCT02159183|521897472|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
144738474|NCT02159183|521897471|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
144738475|NCT02159183|521897472|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
144738476|NCT01244620|521897476|FG000|Overall Study|Study terminated|4|||
144738477|NCT01244620|521897477|FG001|Overall Study|Study terminated|4|||
144738478|NCT01244620|521897478|FG002|Overall Study|Study terminated|4|||
144738479|NCT01244620|521897479|FG003|Overall Study|Study terminated|4|||
144738480|NCT00840073|521897481|FG000|Second Intervention|Missed 72 hour blood draw|1|||
144738481|NCT00840073|521897482|FG001|Second Intervention|Missed 72 hour blood draw|1|||
144738482|NCT02321098|521897483|FG000|12 Weeks Treament|Lost to Follow-up|1|||
144738483|NCT02321098|521897484|FG001|12 Weeks Treament|Lost to Follow-up|1|||
144738484|NCT02321098|521897485|FG002|12 Weeks Treament|Lost to Follow-up|0|||
144738485|NCT02321098|521897483|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
144738486|NCT02321098|521897484|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
144738487|NCT02321098|521897485|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
144682928|NCT01196091|521689620|FG001|Overall Study|Lost to Follow-up|5|||
144682929|NCT01196091|521689621|FG002|Overall Study|Lost to Follow-up|6|||
144682930|NCT01196091|521689619|FG000|Overall Study|Parent/Caregiver Decision|0|||
144682931|NCT01196091|521689620|FG001|Overall Study|Parent/Caregiver Decision|0|||
144682932|NCT01196091|521689621|FG002|Overall Study|Parent/Caregiver Decision|1|||
144682933|NCT01196091|521689619|FG000|Overall Study|Withdrawal by Subject|16|||
144682934|NCT01196091|521689620|FG001|Overall Study|Withdrawal by Subject|19|||
144682935|NCT01196091|521689621|FG002|Overall Study|Withdrawal by Subject|22|||
144682936|NCT01196091|521689619|FG000|Overall Study|Physician Decision|3|||
144682937|NCT01196091|521689620|FG001|Overall Study|Physician Decision|3|||
144682938|NCT01196091|521689621|FG002|Overall Study|Physician Decision|4|||
144682939|NCT01196091|521689619|FG000|Overall Study|Protocol Violation|1|||
144682940|NCT01196091|521689620|FG001|Overall Study|Protocol Violation|3|||
144682941|NCT01196091|521689621|FG002|Overall Study|Protocol Violation|3|||
144682942|NCT01196091|521689619|FG000|Overall Study|Sponsor Decision|6|||
144682943|NCT01196091|521689620|FG001|Overall Study|Sponsor Decision|5|||
144682944|NCT01196091|521689621|FG002|Overall Study|Sponsor Decision|4|||
144682945|NCT01196091|521689619|FG000|Overall Study|Excluded Site|5|||
144682946|NCT01196091|521689620|FG001|Overall Study|Excluded Site|11|||
144682947|NCT01196091|521689621|FG002|Overall Study|Excluded Site|8|||
144682948|NCT01196091|521689619|FG000|Overall Study|Randomized, No Study Drug Received|1|||
144682949|NCT01196091|521689620|FG001|Overall Study|Randomized, No Study Drug Received|0|||
144682950|NCT01196091|521689621|FG002|Overall Study|Randomized, No Study Drug Received|1|||
144682951|NCT00355615|521689623|FG000|Randomized Double Blind Period|Adverse Event|1|||
144682952|NCT00355615|521689624|FG001|Randomized Double Blind Period|Adverse Event|0|||
144682953|NCT00355615|521689625|FG002|Randomized Double Blind Period|Adverse Event|0|||
144682954|NCT00355615|521689626|FG003|Randomized Double Blind Period|Adverse Event|0|||
144682955|NCT00355615|521689627|FG004|Randomized Double Blind Period|Adverse Event|0|||
144682956|NCT00355615|521689623|FG000|Randomized Double Blind Period|Protocol Violation|0|||
144682957|NCT00355615|521689624|FG001|Randomized Double Blind Period|Protocol Violation|0|||
144682958|NCT00355615|521689625|FG002|Randomized Double Blind Period|Protocol Violation|1|||
144682959|NCT00355615|521689626|FG003|Randomized Double Blind Period|Protocol Violation|1|||
144682960|NCT00355615|521689627|FG004|Randomized Double Blind Period|Protocol Violation|0|||
144682961|NCT00355615|521689623|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
144682962|NCT00355615|521689624|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
144682963|NCT00355615|521689625|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
144682964|NCT00355615|521689626|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
144682965|NCT00355615|521689627|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
144682966|NCT00355615|521689623|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
144682967|NCT00355615|521689624|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
144682968|NCT00355615|521689625|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
144682969|NCT00355615|521689626|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
144682970|NCT00355615|521689627|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
144682971|NCT00355615|521689623|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
144682972|NCT00355615|521689624|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
144682973|NCT00355615|521689625|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
144682974|NCT00355615|521689626|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
144738488|NCT02321098|521897483|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
144738489|NCT02321098|521897484|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
144218349|NCT04542057|519992323|FG000|Overall Study|COVID-19 adverse event|6|||
144218350|NCT04542057|519992324|FG001|Overall Study|COVID-19 adverse event|4|||
144218351|NCT04542057|519992323|FG000|Overall Study|Lack of Efficacy|2|||
144682975|NCT00355615|521689627|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
144682976|NCT00355615|521689623|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
144682977|NCT00355615|521689624|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
144682978|NCT00355615|521689625|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
144682979|NCT00355615|521689626|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
144682980|NCT00355615|521689627|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
144682981|NCT02324049|521689636|FG000|Part C|Study terminated|11|||
144682982|NCT02159365|521689638|FG000|Overall Study|Disease Progression|23|||
144682983|NCT02159365|521689638|FG000|Overall Study|Other reasons|11|||
144682984|NCT02159365|521689638|FG000|Overall Study|Administrative reason by Sponsor|9|||
144682985|NCT02159365|521689638|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
144682986|NCT02159365|521689638|FG000|Overall Study|Study drug toxicity|7|||
144682987|NCT02159365|521689638|FG000|Overall Study|Maximum clinical benefit|3|||
144682988|NCT02159365|521689638|FG000|Overall Study|Subject request to discontinue treatment|3|||
144682989|NCT02159365|521689638|FG000|Overall Study|Subject withdrew consent|3|||
144682990|NCT02159365|521689638|FG000|Overall Study|Death|1|||
144682991|NCT02159365|521689638|FG000|Overall Study|Lost to Follow-up|1|||
144682992|NCT00796549|521689639|FG000|Overall Study|Adverse Event|11|||
144682993|NCT00796549|521689639|FG000|Overall Study|not entered|149|||
144682994|NCT00796549|521689639|FG000|Overall Study|Other|2|||
144682995|NCT00796549|521689639|FG000|Overall Study|Progressive disease|56|||
144682996|NCT04051944|521689643|FG000|Overall Study|Study ending|1|||
144682997|NCT04051944|521689644|FG001|Overall Study|Study ending|1|||
144682998|NCT04051944|521689643|FG000|Overall Study|Early study termination by participant|1|||
144682999|NCT04051944|521689644|FG001|Overall Study|Early study termination by participant|0|||
144683000|NCT04051944|521689643|FG000|Overall Study|Withdrawal by Subject|2|||
144683001|NCT04051944|521689644|FG001|Overall Study|Withdrawal by Subject|2|||
144683002|NCT04051944|521689643|FG000|Overall Study|Lack of Efficacy|3|||
144683003|NCT04051944|521689644|FG001|Overall Study|Lack of Efficacy|0|||
144683004|NCT04051944|521689643|FG000|Overall Study|Adverse event, non- fatal|1|||
144683005|NCT04051944|521689644|FG001|Overall Study|Adverse event, non- fatal|1|||
144683006|NCT03083470|521689645|FG000|Overall Study|Lost to Follow-up|0|||
144683007|NCT03083470|521689646|FG001|Overall Study|Lost to Follow-up|0|||
144683008|NCT03083470|521689647|FG002|Overall Study|Lost to Follow-up|0|||
144683009|NCT03083470|521689648|FG003|Overall Study|Lost to Follow-up|0|||
144683010|NCT03083470|521689649|FG004|Overall Study|Lost to Follow-up|1|||
144683011|NCT03083470|521689645|FG000|Overall Study|Withdrawal by Subject|0|||
144683012|NCT03083470|521689646|FG001|Overall Study|Withdrawal by Subject|0|||
144683013|NCT03083470|521689647|FG002|Overall Study|Withdrawal by Subject|0|||
144683014|NCT03083470|521689648|FG003|Overall Study|Withdrawal by Subject|0|||
144683015|NCT03083470|521689649|FG004|Overall Study|Withdrawal by Subject|1|||
144683016|NCT03077711|521689650|FG000|Overall Study|Lost to Follow-up|2|||
144683017|NCT03077711|521689651|FG001|Overall Study|Lost to Follow-up|2|||
144683018|NCT03077711|521689650|FG000|Overall Study|noncompliant taking medication|2|||
144683019|NCT03077711|521689651|FG001|Overall Study|noncompliant taking medication|0|||
144683020|NCT01526928|521689652|FG000|Overall Study|Progressive Disease|35|||
144683021|NCT01526928|521689653|FG001|Overall Study|Progressive Disease|17|||
144683022|NCT01526928|521689654|FG002|Overall Study|Progressive Disease|150|||
144683023|NCT01526928|521689655|FG003|Overall Study|Progressive Disease|182|||
144683024|NCT01526928|521689656|FG004|Overall Study|Progressive Disease|76|||
144683025|NCT01526928|521689657|FG005|Overall Study|Progressive Disease|4|||
144683026|NCT01526928|521689652|FG000|Overall Study|Adverse Event|2|||
144683027|NCT01526928|521689653|FG001|Overall Study|Adverse Event|1|||
144683028|NCT01526928|521689654|FG002|Overall Study|Adverse Event|29|||
144683029|NCT01526928|521689655|FG003|Overall Study|Adverse Event|40|||
144683030|NCT01526928|521689656|FG004|Overall Study|Adverse Event|13|||
144683031|NCT01526928|521689657|FG005|Overall Study|Adverse Event|2|||
144683032|NCT01526928|521689652|FG000|Overall Study|Death|0|||
144683033|NCT01526928|521689653|FG001|Overall Study|Death|0|||
144683034|NCT01526928|521689654|FG002|Overall Study|Death|3|||
144683035|NCT01526928|521689655|FG003|Overall Study|Death|0|||
144683036|NCT01526928|521689656|FG004|Overall Study|Death|0|||
144683037|NCT01526928|521689657|FG005|Overall Study|Death|0|||
144683038|NCT01526928|521689652|FG000|Overall Study|Withdrawal by Subject|1|||
144683039|NCT01526928|521689653|FG001|Overall Study|Withdrawal by Subject|0|||
144683040|NCT01526928|521689654|FG002|Overall Study|Withdrawal by Subject|13|||
144683041|NCT01526928|521689655|FG003|Overall Study|Withdrawal by Subject|11|||
144683042|NCT01526928|521689656|FG004|Overall Study|Withdrawal by Subject|3|||
144683043|NCT01526928|521689657|FG005|Overall Study|Withdrawal by Subject|0|||
144683044|NCT01526928|521689652|FG000|Overall Study|Physician Decision|0|||
144683045|NCT01526928|521689653|FG001|Overall Study|Physician Decision|0|||
144683046|NCT01526928|521689654|FG002|Overall Study|Physician Decision|2|||
144683047|NCT01526928|521689655|FG003|Overall Study|Physician Decision|5|||
144683048|NCT01526928|521689656|FG004|Overall Study|Physician Decision|0|||
144683049|NCT01526928|521689657|FG005|Overall Study|Physician Decision|0|||
144738490|NCT02321098|521897485|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
144738491|NCT02321098|521897483|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
144738492|NCT02321098|521897484|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
144738493|NCT02321098|521897485|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
144738494|NCT01663233|521897486|FG000|Overall Study|Withdrawal by Subject|3|||
144738495|NCT01663233|521897487|FG001|Overall Study|Withdrawal by Subject|2|||
144738496|NCT01663233|521897486|FG000|Overall Study|Protocol Deviation|1|||
144738497|NCT01663233|521897487|FG001|Overall Study|Protocol Deviation|4|||
144738498|NCT01663233|521897486|FG000|Overall Study|Lost to Follow-up|0|||
144738499|NCT01663233|521897487|FG001|Overall Study|Lost to Follow-up|1|||
144738500|NCT00556322|521897490|FG000|Overall Study|Insufficient therapeutic response|158|||
144738501|NCT00556322|521897491|FG001|Overall Study|Insufficient therapeutic response|168|||
144738502|NCT00556322|521897490|FG000|Overall Study|Adverse Event|7|||
144738503|NCT00556322|521897491|FG001|Overall Study|Adverse Event|4|||
144738504|NCT00556322|521897490|FG000|Overall Study|Other|4|||
144738505|NCT00556322|521897491|FG001|Overall Study|Other|1|||
144738506|NCT00556322|521897490|FG000|Overall Study|Lost to Follow-up|5|||
144738507|NCT00556322|521897491|FG001|Overall Study|Lost to Follow-up|3|||
144738508|NCT00556322|521897490|FG000|Overall Study|Withdrawal by Subject|19|||
144738509|NCT00556322|521897491|FG001|Overall Study|Withdrawal by Subject|7|||
144738510|NCT00556322|521897490|FG000|Overall Study|Protocol Violation|5|||
144738511|NCT00556322|521897491|FG001|Overall Study|Protocol Violation|1|||
144738512|NCT00556322|521897490|FG000|Overall Study|Ongoing at data cutoff|3|||
144738513|NCT00556322|521897491|FG001|Overall Study|Ongoing at data cutoff|5|||
144738514|NCT00556322|521897490|FG000|Overall Study|Death|20|||
144738515|NCT00556322|521897491|FG001|Overall Study|Death|14|||
144738516|NCT01788423|521897492|FG000|Overall Study|See Comments in Completed (above)|0|||
144738517|NCT01788423|521897493|FG001|Overall Study|See Comments in Completed (above)|4|||
144738518|NCT01788423|521897494|FG002|Overall Study|See Comments in Completed (above)|5|||
144738519|NCT03249454|521897495|FG000|Overall Study|Withdrawal by Subject|0|||
144738520|NCT03249454|521897496|FG001|Overall Study|Withdrawal by Subject|0|||
144738521|NCT03249454|521897497|FG002|Overall Study|Withdrawal by Subject|0|||
144738522|NCT03249454|521897498|FG003|Overall Study|Withdrawal by Subject|0|||
144738523|NCT03249454|521897499|FG004|Overall Study|Withdrawal by Subject|0|||
144738524|NCT03249454|521897500|FG005|Overall Study|Withdrawal by Subject|0|||
144738525|NCT03249454|521897501|FG006|Overall Study|Withdrawal by Subject|0|||
144738526|NCT03249454|521897502|FG007|Overall Study|Withdrawal by Subject|0|||
144738527|NCT03249454|521897503|FG008|Overall Study|Withdrawal by Subject|0|||
144738528|NCT03249454|521897504|FG009|Overall Study|Withdrawal by Subject|1|||
144738529|NCT03249454|521897505|FG010|Overall Study|Withdrawal by Subject|1|||
144738530|NCT00705666|521897514|FG000|Overall Study|No post-treatment questionnaire|279|||
144738531|NCT00705666|521897514|FG000|Overall Study|Withdrawal by Subject|21|||
144738532|NCT00705666|521897514|FG000|Overall Study|Physician Decision|7|||
144738533|NCT00705666|521897514|FG000|Overall Study|Lost to Follow-up|5|||
144738534|NCT00705666|521897514|FG000|Overall Study|Death|1|||
144738535|NCT00705666|521897514|FG000|Overall Study|Adverse Event|4|||
144738536|NCT00705666|521897514|FG000|Overall Study|Other|12|||
144738537|NCT00705666|521897514|FG000|Overall Study|Other|2|||
144738538|NCT00705666|521897514|FG000|Overall Study|Lack of data|3|||
144738539|NCT00705666|521897514|FG000|Overall Study|Untreated|5|||
144738540|NCT02105272|521897516|FG000|Overall Study|Adverse Event|1|||
144738541|NCT02105272|521897517|FG001|Overall Study|Adverse Event|2|||
144738542|NCT02105272|521897516|FG000|Overall Study|Physician Decision|0|||
144738543|NCT02105272|521897517|FG001|Overall Study|Physician Decision|1|||
144738544|NCT02105272|521897516|FG000|Overall Study|Protocol Violation|2|||
144738545|NCT02105272|521897517|FG001|Overall Study|Protocol Violation|0|||
144218352|NCT04542057|519992324|FG001|Overall Study|Lack of Efficacy|5|||
144218353|NCT04542057|519992323|FG000|Overall Study|Study terminated by sponsor|1|||
144218354|NCT04542057|519992324|FG001|Overall Study|Study terminated by sponsor|0|||
144218355|NCT04542057|519992323|FG000|Overall Study|Investigator discretion|2|||
144218356|NCT04542057|519992324|FG001|Overall Study|Investigator discretion|1|||
144218357|NCT04542057|519992323|FG000|Overall Study|Withdrawal by Subject|52|||
144218358|NCT04542057|519992324|FG001|Overall Study|Withdrawal by Subject|30|||
144218359|NCT04542057|519992323|FG000|Overall Study|Lost to Follow-up|8|||
144218360|NCT04542057|519992324|FG001|Overall Study|Lost to Follow-up|11|||
144218361|NCT04542057|519992323|FG000|Overall Study|Other|2|||
144738546|NCT02105272|521897516|FG000|Overall Study|Withdrawal by Subject|2|||
144738547|NCT02105272|521897517|FG001|Overall Study|Withdrawal by Subject|0|||
144738548|NCT02964039|521897528|FG000|Overall Study|Medical reason unrelated to study participation|1|||
144218362|NCT04542057|519992324|FG001|Overall Study|Other|2|||
144218363|NCT00104572|519992325|FG000|Overall Study|Withdrawal by Subject|3|||
144265848|NCT00427908|520174020|FG002|Primary Phase|Withdrawal by Subject|1|||
144265849|NCT00427908|520174021|FG003|Primary Phase|Withdrawal by Subject|0|||
144738549|NCT02964039|521897529|FG001|Overall Study|Medical reason unrelated to study participation|0|||
144738550|NCT02964039|521897530|FG002|Overall Study|Medical reason unrelated to study participation|3|||
144738551|NCT02964039|521897528|FG000|Overall Study|Research shutdown due to pandemic|2|||
144738552|NCT02964039|521897529|FG001|Overall Study|Research shutdown due to pandemic|0|||
144683050|NCT01526928|521689652|FG000|Overall Study|Other Reason|0|||
144683051|NCT01526928|521689653|FG001|Overall Study|Other Reason|1|||
144683052|NCT01526928|521689654|FG002|Overall Study|Other Reason|11|||
144683053|NCT01526928|521689655|FG003|Overall Study|Other Reason|4|||
144683054|NCT01526928|521689656|FG004|Overall Study|Other Reason|1|||
144683055|NCT01526928|521689657|FG005|Overall Study|Other Reason|0|||
144683056|NCT01526928|521689652|FG000|Overall Study|Lost to Follow-up|0|||
144683057|NCT01526928|521689653|FG001|Overall Study|Lost to Follow-up|0|||
144683058|NCT01526928|521689654|FG002|Overall Study|Lost to Follow-up|0|||
144683059|NCT01526928|521689655|FG003|Overall Study|Lost to Follow-up|1|||
144683060|NCT01526928|521689656|FG004|Overall Study|Lost to Follow-up|0|||
144683061|NCT01526928|521689657|FG005|Overall Study|Lost to Follow-up|0|||
144683062|NCT01526928|521689652|FG000|Overall Study|Protocol Deviation|0|||
144683063|NCT01526928|521689653|FG001|Overall Study|Protocol Deviation|0|||
144683064|NCT01526928|521689654|FG002|Overall Study|Protocol Deviation|0|||
144683065|NCT01526928|521689655|FG003|Overall Study|Protocol Deviation|2|||
144683066|NCT01526928|521689656|FG004|Overall Study|Protocol Deviation|0|||
144683067|NCT01526928|521689657|FG005|Overall Study|Protocol Deviation|0|||
144683068|NCT01526928|521689652|FG000|Overall Study|Missing|0|||
144683069|NCT01526928|521689653|FG001|Overall Study|Missing|0|||
144683070|NCT01526928|521689654|FG002|Overall Study|Missing|1|||
144683071|NCT01526928|521689655|FG003|Overall Study|Missing|0|||
144683072|NCT01526928|521689656|FG004|Overall Study|Missing|2|||
144683073|NCT01526928|521689657|FG005|Overall Study|Missing|0|||
144683074|NCT00736450|521689658|FG000|Overall Study|Not ABC gene eligible|19|||
144683075|NCT00736450|521689658|FG000|Overall Study|Withdrawal by Subject|5|||
144683076|NCT00736450|521689658|FG000|Overall Study|Physician Decision|1|||
144683077|NCT04157751|521689659|FG000|Overall Study|Withdrawal by Subject|12|||
144683078|NCT04157751|521689660|FG001|Overall Study|Withdrawal by Subject|17|||
144683079|NCT04157751|521689659|FG000|Overall Study|Lost to Follow-up|6|||
144683080|NCT04157751|521689660|FG001|Overall Study|Lost to Follow-up|2|||
144683081|NCT04157751|521689659|FG000|Overall Study|Adverse Event|34|||
144683082|NCT04157751|521689660|FG001|Overall Study|Adverse Event|23|||
144683083|NCT04157751|521689659|FG000|Overall Study|Not treated|1|||
144683084|NCT04157751|521689660|FG001|Overall Study|Not treated|5|||
144683085|NCT04157751|521689659|FG000|Overall Study|Other reason not stated above|10|||
144683086|NCT04157751|521689660|FG001|Overall Study|Other reason not stated above|10|||
144683087|NCT01332851|521689663|FG000|Overall Study|Withdrawal by Subject|4|||
144683088|NCT01332851|521689664|FG001|Overall Study|Withdrawal by Subject|2|||
144683089|NCT01332851|521689663|FG000|Overall Study|Lost to Follow-up|7|||
144683090|NCT01332851|521689664|FG001|Overall Study|Lost to Follow-up|11|||
144683091|NCT03299166|521689665|FG000|Overall Study|Adverse Event|9|||
144683092|NCT03299166|521689666|FG001|Overall Study|Adverse Event|4|||
144683093|NCT03299166|521689665|FG000|Overall Study|Withdrawal by Subject|6|||
144683094|NCT03299166|521689666|FG001|Overall Study|Withdrawal by Subject|5|||
144683095|NCT03299166|521689665|FG000|Overall Study|Physician Decision|1|||
144683096|NCT03299166|521689666|FG001|Overall Study|Physician Decision|1|||
144683097|NCT03299166|521689665|FG000|Overall Study|Sponsor Decision|3|||
144683098|NCT03299166|521689666|FG001|Overall Study|Sponsor Decision|0|||
144683099|NCT03299166|521689665|FG000|Overall Study|Lost to Follow-up|2|||
144683100|NCT03299166|521689666|FG001|Overall Study|Lost to Follow-up|4|||
144683101|NCT03299166|521689665|FG000|Overall Study|Randomization Error|0|||
144683102|NCT03299166|521689666|FG001|Overall Study|Randomization Error|1|||
144683103|NCT03299166|521689665|FG000|Overall Study|Subject unable to return due to COVID|1|||
144683104|NCT03299166|521689666|FG001|Overall Study|Subject unable to return due to COVID|0|||
144683105|NCT03299166|521689665|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
144683106|NCT03299166|521689666|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
144683107|NCT01302691|521689667|FG000|Overall Study|Adverse Event|2|||
144683108|NCT01302691|521689668|FG001|Overall Study|Adverse Event|0|||
144683109|NCT01302691|521689667|FG000|Overall Study|Death|0|||
144683110|NCT01302691|521689668|FG001|Overall Study|Death|1|||
144683111|NCT01302691|521689667|FG000|Overall Study|Lost to Follow-up|1|||
144683112|NCT01302691|521689668|FG001|Overall Study|Lost to Follow-up|0|||
144683113|NCT01302691|521689667|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
144683114|NCT01302691|521689668|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
144683115|NCT01302691|521689667|FG000|Overall Study|Physician Decision|0|||
144683116|NCT01302691|521689668|FG001|Overall Study|Physician Decision|1|||
144683117|NCT01302691|521689667|FG000|Overall Study|Protocol Violation|1|||
144683118|NCT01302691|521689668|FG001|Overall Study|Protocol Violation|0|||
144683119|NCT02829775|521689669|FG000|Overall Study|Death|1|||
144683120|NCT02829775|521689669|FG000|Overall Study|Withdrawal by Subject|3|||
144683121|NCT02829775|521689669|FG000|Overall Study|Disease remission|1|||
144683122|NCT03796195|521689670|FG000|Overall Study|Study closed early|1|||
144683123|NCT00062647|521689671|FG000|Overall Study|Death|2|||
144683124|NCT00062647|521689672|FG001|Overall Study|Death|2|||
144683125|NCT00062647|521689671|FG000|Overall Study|Adverse Event|1|||
144683126|NCT00062647|521689672|FG001|Overall Study|Adverse Event|1|||
144683127|NCT00062647|521689671|FG000|Overall Study|Withdrawal by Subject|2|||
144683128|NCT00062647|521689672|FG001|Overall Study|Withdrawal by Subject|1|||
144683129|NCT00062647|521689671|FG000|Overall Study|Protocol Violation|1|||
144683130|NCT00062647|521689672|FG001|Overall Study|Protocol Violation|0|||
144683131|NCT00062647|521689671|FG000|Overall Study|Lost to Follow-up|1|||
144683132|NCT00062647|521689672|FG001|Overall Study|Lost to Follow-up|2|||
144683133|NCT00062647|521689671|FG000|Overall Study|Failed continuation criteria|4|||
144683134|NCT00062647|521689672|FG001|Overall Study|Failed continuation criteria|2|||
144683135|NCT00062647|521689671|FG000|Overall Study|Other|4|||
144683136|NCT00062647|521689672|FG001|Overall Study|Other|4|||
144683137|NCT00062647|521689671|FG000|Overall Study|Never received study treatment|1|||
144683138|NCT00062647|521689672|FG001|Overall Study|Never received study treatment|1|||
144683139|NCT02392468|521689678|FG000|Overall Study|Adverse Event|0|||
144683140|NCT02392468|521689679|FG001|Overall Study|Adverse Event|1|||
144683141|NCT02392468|521689680|FG002|Overall Study|Adverse Event|0|||
144683142|NCT02392468|521689681|FG003|Overall Study|Adverse Event|0|||
144683143|NCT02392468|521689682|FG004|Overall Study|Adverse Event|0|||
144683144|NCT02392468|521689683|FG005|Overall Study|Adverse Event|1|||
144683145|NCT01039428|521689684|FG000|Overall Study|Protocol Violation|1|||
144683146|NCT01039428|521689685|FG001|Overall Study|Protocol Violation|0|||
144683147|NCT01039428|521689684|FG000|Overall Study|Withdrawal by Subject|1|||
144683148|NCT01039428|521689685|FG001|Overall Study|Withdrawal by Subject|0|||
144683149|NCT01313039|521689686|FG000|Overall Study|Physician Decision|1|||
144683150|NCT01313039|521689686|FG000|Overall Study|Adverse Event|1|||
144683151|NCT01678560|521689689|FG000|Overall Study|Physician Decision|4|||
144683152|NCT01678560|521689690|FG001|Overall Study|Physician Decision|4|||
144683153|NCT01678560|521689689|FG000|Overall Study|Death|0|||
144683154|NCT01678560|521689690|FG001|Overall Study|Death|1|||
144683155|NCT01678560|521689689|FG000|Overall Study|Withdrawal by Subject|0|||
144683156|NCT01678560|521689690|FG001|Overall Study|Withdrawal by Subject|1|||
144683157|NCT02201472|521689691|FG000|Overall Study|Lack of Efficacy|2|||
144683158|NCT02470429|521689692|FG000|Overall Study|Adverse Event|1|||
144683159|NCT02470429|521689693|FG001|Overall Study|Adverse Event|0|||
144683160|NCT02470429|521689692|FG000|Overall Study|Withdrawal by Subject|1|||
144683161|NCT02470429|521689693|FG001|Overall Study|Withdrawal by Subject|0|||
144683162|NCT01300767|521689694|FG000|Overall Study|Discomfort|2|||
144683163|NCT01300767|521689694|FG000|Overall Study|Biomicroscopy|1|||
144683164|NCT01300767|521689694|FG000|Overall Study|Unacceptable fit|1|||
144683165|NCT00117572|521689695|FG000|Overall Study|Site withdrew before starting treatment|2|||
144683166|NCT00117572|521689696|FG001|Overall Study|Site withdrew before starting treatment|3|||
144683167|NCT00117572|521689695|FG000|Overall Study|Withdrawal by Subject|3|||
144683168|NCT00117572|521689696|FG001|Overall Study|Withdrawal by Subject|3|||
144683169|NCT00117572|521689695|FG000|Overall Study|Protocol Violation|1|||
144683170|NCT00117572|521689696|FG001|Overall Study|Protocol Violation|0|||
144683171|NCT01188811|521689699|FG000|Overall Study|Withdrawal by Subject|0|||
144683172|NCT01188811|521689700|FG001|Overall Study|Withdrawal by Subject|2|||
144683173|NCT01188811|521689699|FG000|Overall Study|Adverse Event|6|||
144683174|NCT01188811|521689700|FG001|Overall Study|Adverse Event|0|||
144683175|NCT01602744|521689701|FG000|Overall Study|Death|17|||
144683176|NCT01602744|521689702|FG001|Overall Study|Death|15|||
144683177|NCT01602744|521689701|FG000|Overall Study|Lost to Follow-up|13|||
144683178|NCT01602744|521689702|FG001|Overall Study|Lost to Follow-up|8|||
144683179|NCT00804986|521689703|FG000|Overall Study|Adverse Event|0|||
144683180|NCT00804986|521689704|FG001|Overall Study|Adverse Event|1|||
144683181|NCT00804986|521689705|FG002|Overall Study|Adverse Event|2|||
144683182|NCT00804986|521689706|FG003|Overall Study|Adverse Event|1|||
144683183|NCT00804986|521689707|FG004|Overall Study|Adverse Event|3|||
144683184|NCT00804986|521689708|FG005|Overall Study|Adverse Event|0|||
144683185|NCT00804986|521689703|FG000|Overall Study|Lack of Efficacy|0|||
144683186|NCT00804986|521689704|FG001|Overall Study|Lack of Efficacy|0|||
144683187|NCT00804986|521689705|FG002|Overall Study|Lack of Efficacy|0|||
144683188|NCT00804986|521689706|FG003|Overall Study|Lack of Efficacy|1|||
144683189|NCT00804986|521689707|FG004|Overall Study|Lack of Efficacy|0|||
144683190|NCT00804986|521689708|FG005|Overall Study|Lack of Efficacy|3|||
144683191|NCT00804986|521689703|FG000|Overall Study|Lost to Follow-up|0|||
144683192|NCT00804986|521689704|FG001|Overall Study|Lost to Follow-up|0|||
144683193|NCT00804986|521689705|FG002|Overall Study|Lost to Follow-up|0|||
144683194|NCT00804986|521689706|FG003|Overall Study|Lost to Follow-up|1|||
144218364|NCT00104572|519992326|FG001|Overall Study|Withdrawal by Subject|3|||
144683195|NCT00804986|521689707|FG004|Overall Study|Lost to Follow-up|1|||
144683196|NCT00804986|521689708|FG005|Overall Study|Lost to Follow-up|3|||
144265850|NCT00427908|520174018|FG000|Primary Phase|Adverse Event|0|||
144683197|NCT00804986|521689703|FG000|Overall Study|Protocol Violation|0|||
144683198|NCT00804986|521689704|FG001|Overall Study|Protocol Violation|1|||
144683199|NCT00804986|521689705|FG002|Overall Study|Protocol Violation|0|||
144683200|NCT00804986|521689706|FG003|Overall Study|Protocol Violation|1|||
144683201|NCT00804986|521689707|FG004|Overall Study|Protocol Violation|0|||
144683202|NCT00804986|521689708|FG005|Overall Study|Protocol Violation|0|||
144683203|NCT00804986|521689703|FG000|Overall Study|Withdrawal by Subject|0|||
144683204|NCT00804986|521689704|FG001|Overall Study|Withdrawal by Subject|3|||
144683205|NCT00804986|521689705|FG002|Overall Study|Withdrawal by Subject|0|||
144738553|NCT02964039|521897530|FG002|Overall Study|Research shutdown due to pandemic|1|||
144738554|NCT02964039|521897528|FG000|Overall Study|Withdrawal by Subject|0|||
144738555|NCT02964039|521897529|FG001|Overall Study|Withdrawal by Subject|1|||
144738556|NCT02964039|521897530|FG002|Overall Study|Withdrawal by Subject|0|||
144738557|NCT02964039|521897528|FG000|Overall Study|Lost to Follow-up|1|||
144738558|NCT02964039|521897529|FG001|Overall Study|Lost to Follow-up|0|||
144683206|NCT00804986|521689706|FG003|Overall Study|Withdrawal by Subject|3|||
144683207|NCT00804986|521689707|FG004|Overall Study|Withdrawal by Subject|5|||
144683208|NCT00804986|521689708|FG005|Overall Study|Withdrawal by Subject|3|||
144683209|NCT00804986|521689703|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
144683210|NCT00804986|521689704|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
144683211|NCT00804986|521689705|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
144683212|NCT00804986|521689706|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
144683213|NCT00804986|521689707|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
144683214|NCT00804986|521689708|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
144683215|NCT00804986|521689703|FG000|Overall Study|Sponsor Decision|0|||
144683216|NCT00804986|521689704|FG001|Overall Study|Sponsor Decision|1|||
144683217|NCT00804986|521689705|FG002|Overall Study|Sponsor Decision|0|||
144683218|NCT00804986|521689706|FG003|Overall Study|Sponsor Decision|0|||
144683219|NCT00804986|521689707|FG004|Overall Study|Sponsor Decision|0|||
144683220|NCT00804986|521689708|FG005|Overall Study|Sponsor Decision|0|||
144683221|NCT00804986|521689703|FG000|Overall Study|Physician Decision|1|||
144683222|NCT00804986|521689704|FG001|Overall Study|Physician Decision|0|||
144683223|NCT00804986|521689705|FG002|Overall Study|Physician Decision|0|||
144683224|NCT00804986|521689706|FG003|Overall Study|Physician Decision|0|||
144683225|NCT00804986|521689707|FG004|Overall Study|Physician Decision|0|||
144683226|NCT00804986|521689708|FG005|Overall Study|Physician Decision|0|||
144683227|NCT00654368|521689709|FG000|Overall Study|Ineligibility determined|6|||
144683228|NCT00654368|521689710|FG001|Overall Study|Ineligibility determined|0|||
144683229|NCT00654368|521689711|FG002|Overall Study|Ineligibility determined|0|||
144683230|NCT00654368|521689709|FG000|Overall Study|Protocol deviation|3|||
144683231|NCT00654368|521689710|FG001|Overall Study|Protocol deviation|2|||
144683232|NCT00654368|521689711|FG002|Overall Study|Protocol deviation|1|||
144683233|NCT00654368|521689709|FG000|Overall Study|Non-compliance|2|||
144683234|NCT00654368|521689710|FG001|Overall Study|Non-compliance|1|||
144683235|NCT00654368|521689711|FG002|Overall Study|Non-compliance|2|||
144683236|NCT00654368|521689709|FG000|Overall Study|Withdrawal by Subject|5|||
144683237|NCT00654368|521689710|FG001|Overall Study|Withdrawal by Subject|2|||
144683238|NCT00654368|521689711|FG002|Overall Study|Withdrawal by Subject|2|||
144683239|NCT00654368|521689709|FG000|Overall Study|Disease progression|21|||
144683240|NCT00654368|521689710|FG001|Overall Study|Disease progression|31|||
144683241|NCT00654368|521689711|FG002|Overall Study|Disease progression|13|||
144683242|NCT00654368|521689709|FG000|Overall Study|Requirement for alternative therapy|1|||
144683243|NCT00654368|521689710|FG001|Overall Study|Requirement for alternative therapy|1|||
144683244|NCT00654368|521689711|FG002|Overall Study|Requirement for alternative therapy|1|||
144683245|NCT00654368|521689709|FG000|Overall Study|Physician Decision|0|||
144683246|NCT00654368|521689710|FG001|Overall Study|Physician Decision|0|||
144683247|NCT00654368|521689711|FG002|Overall Study|Physician Decision|2|||
144683248|NCT00654368|521689709|FG000|Overall Study|Death|1|||
144683249|NCT00654368|521689710|FG001|Overall Study|Death|0|||
144683250|NCT00654368|521689711|FG002|Overall Study|Death|0|||
144683251|NCT00654368|521689709|FG000|Overall Study|Pregnancy|0|||
144683252|NCT00654368|521689710|FG001|Overall Study|Pregnancy|0|||
144683253|NCT00654368|521689711|FG002|Overall Study|Pregnancy|2|||
144683254|NCT00654368|521689709|FG000|Overall Study|Other|0|||
144683255|NCT00654368|521689710|FG001|Overall Study|Other|2|||
144683256|NCT00654368|521689711|FG002|Overall Study|Other|3|||
144683257|NCT00654368|521689709|FG000|Overall Study|Adverse Event|14|||
144683258|NCT00654368|521689710|FG001|Overall Study|Adverse Event|9|||
144738559|NCT02964039|521897530|FG002|Overall Study|Lost to Follow-up|1|||
144738560|NCT05479058|521897531|FG000|Overall Study|Withdrawal by Subject|1|||
144738561|NCT05479058|521897532|FG001|Overall Study|Withdrawal by Subject|1|||
144738562|NCT05479058|521897531|FG000|Overall Study|Study terminated by sponsor|10|||
144738563|NCT05479058|521897532|FG001|Overall Study|Study terminated by sponsor|10|||
144738564|NCT05630885|521897533|FG000|Study Completion|Took prohibited medications|2|||
144738565|NCT05630885|521897534|FG001|Study Completion|Took prohibited medications|0|||
144683259|NCT00654368|521689711|FG002|Overall Study|Adverse Event|6|||
144683260|NCT00959699|521689713|FG000|Treatment Period|Adverse Event|3|||
144683261|NCT00959699|521689714|FG001|Treatment Period|Adverse Event|13|||
144683262|NCT00959699|521689713|FG000|Treatment Period|Lack of Efficacy|15|||
144683263|NCT00959699|521689714|FG001|Treatment Period|Lack of Efficacy|6|||
144683264|NCT00959699|521689713|FG000|Treatment Period|Lost to Follow-up|0|||
144683265|NCT00959699|521689714|FG001|Treatment Period|Lost to Follow-up|1|||
144683266|NCT00959699|521689713|FG000|Treatment Period|Withdrawal by Subject|1|||
144683267|NCT00959699|521689714|FG001|Treatment Period|Withdrawal by Subject|3|||
144683268|NCT00959699|521689713|FG000|Treatment Period|Non-Compliance with Protocol|0|||
144683269|NCT00959699|521689714|FG001|Treatment Period|Non-Compliance with Protocol|1|||
144683270|NCT00959699|521689713|FG000|Treatment Period|Did not receive treatment|0|||
144683271|NCT00959699|521689714|FG001|Treatment Period|Did not receive treatment|1|||
144683272|NCT00959699|521689713|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
144683273|NCT00959699|521689714|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
144218365|NCT00104572|519992327|FG002|Overall Study|Withdrawal by Subject|0|||
144218366|NCT00940316|519992330|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
144218367|NCT00940316|519992331|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
144218368|NCT00940316|519992332|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
144683274|NCT00959699|521689713|FG000|Follow-up Period|Lost to Follow-up|3|||
144683275|NCT00959699|521689714|FG001|Follow-up Period|Lost to Follow-up|2|||
144683276|NCT00959699|521689713|FG000|Follow-up Period|Withdrawal by Subject|3|||
144683277|NCT00959699|521689714|FG001|Follow-up Period|Withdrawal by Subject|4|||
144683278|NCT00606294|521689717|FG000|Overall Study|Withdrawal by Subject|36|||
144683279|NCT00606294|521689718|FG001|Overall Study|Withdrawal by Subject|0|||
144683280|NCT01976624|521689719|FG000|Overall Study|Participants contraindicated|2|||
144683281|NCT01976624|521689719|FG000|Overall Study|Participants age less than 19 years|12|||
144683282|NCT00712270|521689720|FG000|Overall Study|Withdrawal by Subject|11|||
144683283|NCT00712270|521689720|FG000|Overall Study|Screen Failure|3|||
144683284|NCT03954704|521689723|FG000|Overall Study|Death|1|||
144683285|NCT03954704|521689724|FG001|Overall Study|Death|1|||
144683286|NCT03954704|521689725|FG002|Overall Study|Death|1|||
144683287|NCT03954704|521689726|FG003|Overall Study|Death|3|||
144683288|NCT03954704|521689727|FG004|Overall Study|Death|2|||
144683289|NCT03954704|521689728|FG005|Overall Study|Death|2|||
144683290|NCT03954704|521689729|FG006|Overall Study|Death|0|||
144683291|NCT03954704|521689723|FG000|Overall Study|Withdrew Consent|0|||
144683292|NCT03954704|521689724|FG001|Overall Study|Withdrew Consent|0|||
144683293|NCT03954704|521689725|FG002|Overall Study|Withdrew Consent|1|||
144683294|NCT03954704|521689726|FG003|Overall Study|Withdrew Consent|0|||
144683295|NCT03954704|521689727|FG004|Overall Study|Withdrew Consent|0|||
144683296|NCT03954704|521689728|FG005|Overall Study|Withdrew Consent|1|||
144683297|NCT03954704|521689729|FG006|Overall Study|Withdrew Consent|0|||
144683298|NCT03954704|521689723|FG000|Overall Study|Lost to Follow-up|0|||
144683299|NCT03954704|521689724|FG001|Overall Study|Lost to Follow-up|0|||
144683300|NCT03954704|521689725|FG002|Overall Study|Lost to Follow-up|0|||
144683301|NCT03954704|521689726|FG003|Overall Study|Lost to Follow-up|0|||
144683302|NCT03954704|521689727|FG004|Overall Study|Lost to Follow-up|0|||
144738566|NCT05630885|521897533|FG000|Study Completion|Non-compliance with study drug|1|||
144738567|NCT05630885|521897534|FG001|Study Completion|Non-compliance with study drug|0|||
144738568|NCT05630885|521897533|FG000|Study Completion|Adverse Event|1|||
144738569|NCT05630885|521897534|FG001|Study Completion|Adverse Event|0|||
144738570|NCT05630885|521897533|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
144738571|NCT05630885|521897534|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
144738572|NCT05630885|521897533|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
144738573|NCT05630885|521897534|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
144738574|NCT01103713|521897535|FG000|Overall Study|Lost to Follow-up|2|||
144738575|NCT01103713|521897535|FG000|Overall Study|Withdrawal by Subject|8|||
144738576|NCT01103713|521897535|FG000|Overall Study|Study terminated by sponsor|2|||
144738577|NCT01103713|521897535|FG000|Overall Study|Other|1|||
144738578|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Adverse Event|11|||
144738579|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Adverse Event|23|||
144738580|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Adverse Event|29|||
144738581|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Adverse Event|2|||
144738582|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Adverse Event|8|||
144738583|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
144738584|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
144738585|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
144738586|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
144738587|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
144218369|NCT00940316|519992330|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
144218370|NCT00940316|519992331|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
144218371|NCT00940316|519992332|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
144218372|NCT00940316|519992330|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
144218373|NCT00940316|519992331|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
144683303|NCT03954704|521689728|FG005|Overall Study|Lost to Follow-up|0|||
144683304|NCT03954704|521689729|FG006|Overall Study|Lost to Follow-up|1|||
144683305|NCT03954704|521689723|FG000|Overall Study|Study Terminated by Sponsor|0|||
144683306|NCT03954704|521689724|FG001|Overall Study|Study Terminated by Sponsor|0|||
144683307|NCT03954704|521689725|FG002|Overall Study|Study Terminated by Sponsor|1|||
144683308|NCT03954704|521689726|FG003|Overall Study|Study Terminated by Sponsor|0|||
144738588|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
144738589|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
144738590|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
144683309|NCT03954704|521689727|FG004|Overall Study|Study Terminated by Sponsor|1|||
144683310|NCT03954704|521689728|FG005|Overall Study|Study Terminated by Sponsor|4|||
144218374|NCT00940316|519992332|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
144218375|NCT00940316|519992330|FG000|Treated After Cycle 5|Adverse Event|0|||
144218376|NCT00940316|519992331|FG001|Treated After Cycle 5|Adverse Event|0|||
144218377|NCT00940316|519992332|FG002|Treated After Cycle 5|Adverse Event|1|||
144683311|NCT03954704|521689729|FG006|Overall Study|Study Terminated by Sponsor|2|||
144683312|NCT03954704|521689723|FG000|Overall Study|Enrolled but not Treated|0|||
144683313|NCT03954704|521689724|FG001|Overall Study|Enrolled but not Treated|0|||
144683314|NCT03954704|521689725|FG002|Overall Study|Enrolled but not Treated|0|||
144683315|NCT03954704|521689726|FG003|Overall Study|Enrolled but not Treated|0|||
144683316|NCT03954704|521689727|FG004|Overall Study|Enrolled but not Treated|0|||
144683317|NCT03954704|521689728|FG005|Overall Study|Enrolled but not Treated|1|||
144683318|NCT03954704|521689729|FG006|Overall Study|Enrolled but not Treated|0|||
144683319|NCT01388491|521689730|FG000|Overall Study|Adverse Event|10|||
144683320|NCT01388491|521689731|FG001|Overall Study|Adverse Event|9|||
144683321|NCT01388491|521689730|FG000|Overall Study|Sponsor Request|9|||
144683322|NCT01388491|521689731|FG001|Overall Study|Sponsor Request|7|||
144683323|NCT01388491|521689730|FG000|Overall Study|Withdrawal by Subject|6|||
144683324|NCT01388491|521689731|FG001|Overall Study|Withdrawal by Subject|10|||
144683325|NCT01388491|521689730|FG000|Overall Study|Lost to Follow-up|4|||
144683326|NCT01388491|521689731|FG001|Overall Study|Lost to Follow-up|3|||
144683327|NCT01388491|521689730|FG000|Overall Study|Protocol Violation|2|||
144683328|NCT01388491|521689731|FG001|Overall Study|Protocol Violation|0|||
144683329|NCT01388491|521689730|FG000|Overall Study|Noncompliance|2|||
144683330|NCT01388491|521689731|FG001|Overall Study|Noncompliance|0|||
144683331|NCT01388491|521689730|FG000|Overall Study|Pregnancy|1|||
144683332|NCT01388491|521689731|FG001|Overall Study|Pregnancy|0|||
144683333|NCT04035473|521689732|FG000|Screening/Baseline|Death|0|||
144683334|NCT04035473|521689733|FG001|Screening/Baseline|Death|1|||
144683335|NCT04035473|521689732|FG000|Screening/Baseline|Adverse Event|0|||
144683336|NCT04035473|521689733|FG001|Screening/Baseline|Adverse Event|1|||
144683337|NCT04035473|521689732|FG000|Follow-up Period|Adverse Event|2|||
144683338|NCT04035473|521689733|FG001|Follow-up Period|Adverse Event|0|||
144683339|NCT00112840|521689734|FG000|Overall Study|Physician Decision|1|||
144683340|NCT00112840|521689735|FG001|Overall Study|Physician Decision|0|||
144683341|NCT00112840|521689736|FG002|Overall Study|Physician Decision|0|||
144683342|NCT00112840|521689734|FG000|Overall Study|Withdrawal by Subject|1|||
144683343|NCT00112840|521689735|FG001|Overall Study|Withdrawal by Subject|0|||
144683344|NCT00112840|521689736|FG002|Overall Study|Withdrawal by Subject|1|||
144683345|NCT00112840|521689734|FG000|Overall Study|Protocol Violation|0|||
144683346|NCT00112840|521689735|FG001|Overall Study|Protocol Violation|0|||
144683347|NCT00112840|521689736|FG002|Overall Study|Protocol Violation|5|||
144683348|NCT03595176|521689737|FG000|Overall Study|Death|0|||
144683349|NCT03595176|521689738|FG001|Overall Study|Death|2|||
144683350|NCT03595176|521689737|FG000|Overall Study|Lost to Follow-up|0|||
144683351|NCT03595176|521689738|FG001|Overall Study|Lost to Follow-up|1|||
144683352|NCT00397891|521689741|FG000|Overall Study|Withdrawal by Subject|1|||
144683353|NCT00397891|521689742|FG001|Overall Study|Withdrawal by Subject|0|||
144683354|NCT00397891|521689743|FG002|Overall Study|Withdrawal by Subject|0|||
144683355|NCT00397891|521689744|FG003|Overall Study|Withdrawal by Subject|0|||
144683356|NCT00397891|521689745|FG004|Overall Study|Withdrawal by Subject|1|||
144683357|NCT00412113|521689746|FG000|Overall Study|Adverse Event|11|||
144683358|NCT00412113|521689747|FG001|Overall Study|Adverse Event|15|||
144683359|NCT00412113|521689746|FG000|Overall Study|did not receive treatment|1|||
144683360|NCT00412113|521689747|FG001|Overall Study|did not receive treatment|0|||
144683361|NCT02531633|521692163|FG000|Part A (52 Weeks)|Sponsor request|24|||
144683362|NCT02531633|521692164|FG001|Part A (52 Weeks)|Sponsor request|24|||
144683363|NCT02531633|521692165|FG002|Part A (52 Weeks)|Sponsor request|18|||
144683364|NCT02531633|521692166|FG003|Part A (52 Weeks)|Sponsor request|18|||
144683365|NCT02531633|521692167|FG004|Part A (52 Weeks)|Sponsor request|19|||
144683366|NCT02531633|521692168|FG005|Part A (52 Weeks)|Sponsor request|0|||
144683367|NCT02531633|521692169|FG006|Part A (52 Weeks)|Sponsor request|0|||
144683368|NCT02531633|521692170|FG007|Part A (52 Weeks)|Sponsor request|0|||
144683369|NCT02531633|521692171|FG008|Part A (52 Weeks)|Sponsor request|0|||
144683370|NCT02531633|521692172|FG009|Part A (52 Weeks)|Sponsor request|0|||
144683371|NCT02531633|521692163|FG000|Part A (52 Weeks)|Protocol Violation|1|||
144683372|NCT02531633|521692164|FG001|Part A (52 Weeks)|Protocol Violation|0|||
144683373|NCT02531633|521692165|FG002|Part A (52 Weeks)|Protocol Violation|0|||
144683374|NCT02531633|521692166|FG003|Part A (52 Weeks)|Protocol Violation|0|||
144683375|NCT02531633|521692167|FG004|Part A (52 Weeks)|Protocol Violation|0|||
144218378|NCT00940316|519992330|FG000|Treated After Cycle 5|Progressive disease|0|||
144218379|NCT00940316|519992331|FG001|Treated After Cycle 5|Progressive disease|1|||
144218380|NCT00940316|519992332|FG002|Treated After Cycle 5|Progressive disease|0|||
144683376|NCT02531633|521692168|FG005|Part A (52 Weeks)|Protocol Violation|0|||
144683377|NCT02531633|521692169|FG006|Part A (52 Weeks)|Protocol Violation|0|||
144683378|NCT02531633|521692170|FG007|Part A (52 Weeks)|Protocol Violation|0|||
144683379|NCT02531633|521692171|FG008|Part A (52 Weeks)|Protocol Violation|0|||
144683380|NCT02531633|521692172|FG009|Part A (52 Weeks)|Protocol Violation|0|||
144218381|NCT03404674|519992334|FG000|Overall Study|Inability to Attend Future Visits|0|||
144738591|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
144738592|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
144738593|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
144683381|NCT02531633|521692163|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
144683382|NCT02531633|521692164|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
144683383|NCT02531633|521692165|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
144683384|NCT02531633|521692166|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
144683385|NCT02531633|521692167|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
144683386|NCT02531633|521692168|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
144683387|NCT02531633|521692169|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
144683388|NCT02531633|521692170|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
144683389|NCT02531633|521692171|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
144683390|NCT02531633|521692172|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
144683391|NCT02531633|521692163|FG000|Part A (52 Weeks)|Physician Decision|1|||
144683392|NCT02531633|521692164|FG001|Part A (52 Weeks)|Physician Decision|4|||
144683393|NCT02531633|521692165|FG002|Part A (52 Weeks)|Physician Decision|3|||
144683394|NCT02531633|521692166|FG003|Part A (52 Weeks)|Physician Decision|1|||
144683395|NCT02531633|521692167|FG004|Part A (52 Weeks)|Physician Decision|0|||
144683396|NCT02531633|521692168|FG005|Part A (52 Weeks)|Physician Decision|0|||
144683397|NCT02531633|521692169|FG006|Part A (52 Weeks)|Physician Decision|0|||
144683398|NCT02531633|521692170|FG007|Part A (52 Weeks)|Physician Decision|0|||
144683399|NCT02531633|521692171|FG008|Part A (52 Weeks)|Physician Decision|0|||
144683400|NCT02531633|521692172|FG009|Part A (52 Weeks)|Physician Decision|0|||
144683401|NCT02531633|521692163|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
144683402|NCT02531633|521692164|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
144683403|NCT02531633|521692165|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
144683404|NCT02531633|521692166|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
144683405|NCT02531633|521692167|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
144683406|NCT02531633|521692168|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
144683407|NCT02531633|521692169|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
144683408|NCT02531633|521692170|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
144683409|NCT02531633|521692171|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
144683410|NCT02531633|521692172|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
144683411|NCT02531633|521692163|FG000|Part A (52 Weeks)|Other|2|||
144683412|NCT02531633|521692164|FG001|Part A (52 Weeks)|Other|0|||
144683413|NCT02531633|521692165|FG002|Part A (52 Weeks)|Other|0|||
144683414|NCT02531633|521692166|FG003|Part A (52 Weeks)|Other|0|||
144683415|NCT02531633|521692167|FG004|Part A (52 Weeks)|Other|0|||
144683416|NCT02531633|521692168|FG005|Part A (52 Weeks)|Other|0|||
144683417|NCT02531633|521692169|FG006|Part A (52 Weeks)|Other|0|||
144683418|NCT02531633|521692170|FG007|Part A (52 Weeks)|Other|0|||
144683419|NCT02531633|521692171|FG008|Part A (52 Weeks)|Other|0|||
144683420|NCT02531633|521692172|FG009|Part A (52 Weeks)|Other|0|||
144683421|NCT02531633|521692163|FG000|Part B (104 Weeks)|Sponsor request|0|||
144683422|NCT02531633|521692164|FG001|Part B (104 Weeks)|Sponsor request|0|||
144683423|NCT02531633|521692165|FG002|Part B (104 Weeks)|Sponsor request|0|||
144683424|NCT02531633|521692166|FG003|Part B (104 Weeks)|Sponsor request|0|||
144683425|NCT02531633|521692167|FG004|Part B (104 Weeks)|Sponsor request|0|||
144683426|NCT02531633|521692168|FG005|Part B (104 Weeks)|Sponsor request|8|||
144683427|NCT02531633|521692169|FG006|Part B (104 Weeks)|Sponsor request|5|||
144683428|NCT02531633|521692170|FG007|Part B (104 Weeks)|Sponsor request|3|||
144683429|NCT02531633|521692171|FG008|Part B (104 Weeks)|Sponsor request|5|||
144683430|NCT02531633|521692172|FG009|Part B (104 Weeks)|Sponsor request|4|||
144683431|NCT02531633|521692163|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
144683432|NCT02531633|521692164|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
144683433|NCT02531633|521692165|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
144683434|NCT02531633|521692166|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
144683435|NCT02531633|521692167|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
144683436|NCT02531633|521692168|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
144683437|NCT02531633|521692169|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
144683438|NCT02531633|521692170|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
144683439|NCT02531633|521692171|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
144738594|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
144738595|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
144683440|NCT02531633|521692172|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
144683441|NCT02903966|521692173|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
144683442|NCT02903966|521692174|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
144683443|NCT02903966|521692173|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
144738596|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
144683444|NCT02903966|521692174|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
144683445|NCT02903966|521692173|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
144683446|NCT02903966|521692174|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
144683447|NCT01320033|521692175|FG000|Overall Study|Lack of Efficacy|0|||
144683448|NCT01320033|521692176|FG001|Overall Study|Lack of Efficacy|0|||
144683449|NCT01320033|521692177|FG002|Overall Study|Lack of Efficacy|1|||
144683450|NCT01320033|521692175|FG000|Overall Study|Adverse Event|9|||
144738597|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
144738598|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
144738599|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
144738600|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
144738601|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
144738602|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
144738603|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
144738604|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
144738605|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
144738606|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
144738607|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
144738608|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
144738609|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
144738610|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
144738611|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
144738612|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
144738613|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Move|0|||
144738614|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Move|1|||
144738615|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Move|0|||
144738616|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Move|0|||
144738617|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Move|0|||
144738618|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
144738619|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
144738620|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
144738621|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
144738622|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
144738623|NCT00318461|521897538|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
144738624|NCT00318461|521897539|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
144738625|NCT00318461|521897540|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
144738626|NCT00318461|521897541|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
144738627|NCT00318461|521897542|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
144738628|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Work commitment|0|||
144738629|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Work commitment|0|||
144738630|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Work commitment|0|||
144738631|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Work commitment|0|||
144738632|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Work commitment|1|||
144738633|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Investigator decision|0|||
144738634|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Investigator decision|0|||
144738635|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Investigator decision|0|||
144738636|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Investigator decision|0|||
144738637|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Investigator decision|1|||
144738638|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Lack of time|1|||
144738639|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Lack of time|0|||
144738640|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Lack of time|0|||
144738641|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Lack of time|0|||
144738642|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Lack of time|0|||
144683451|NCT01320033|521692176|FG001|Overall Study|Adverse Event|7|||
144683452|NCT01320033|521692177|FG002|Overall Study|Adverse Event|8|||
144683453|NCT01320033|521692175|FG000|Overall Study|Withdrawal by Subject|22|||
144683454|NCT01320033|521692176|FG001|Overall Study|Withdrawal by Subject|23|||
144683455|NCT01320033|521692177|FG002|Overall Study|Withdrawal by Subject|23|||
144683456|NCT01320033|521692175|FG000|Overall Study|Protocol Violation|3|||
144683457|NCT01320033|521692176|FG001|Overall Study|Protocol Violation|5|||
144683458|NCT01320033|521692177|FG002|Overall Study|Protocol Violation|3|||
144683459|NCT01320033|521692175|FG000|Overall Study|Lost to Follow-up|22|||
144683460|NCT01320033|521692176|FG001|Overall Study|Lost to Follow-up|26|||
144683461|NCT01320033|521692177|FG002|Overall Study|Lost to Follow-up|17|||
144683462|NCT01320033|521692175|FG000|Overall Study|Other|2|||
144683463|NCT01320033|521692176|FG001|Overall Study|Other|3|||
144683464|NCT01320033|521692177|FG002|Overall Study|Other|1|||
144683465|NCT00963469|521692178|FG000|Overall Study|Adverse Event|15|||
144683466|NCT00963469|521692179|FG001|Overall Study|Adverse Event|11|||
144683467|NCT00963469|521692180|FG002|Overall Study|Adverse Event|1|||
144683468|NCT00963469|521692178|FG000|Overall Study|Lack of Efficacy|10|||
144683469|NCT00963469|521692179|FG001|Overall Study|Lack of Efficacy|7|||
144683470|NCT00963469|521692180|FG002|Overall Study|Lack of Efficacy|2|||
144683471|NCT00963469|521692178|FG000|Overall Study|Lost to Follow-up|1|||
144738643|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
144738644|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
144738645|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
144265851|NCT00427908|520174019|FG001|Primary Phase|Adverse Event|1|||
144738646|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
144738647|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
144738648|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
144683472|NCT00963469|521692179|FG001|Overall Study|Lost to Follow-up|1|||
144683473|NCT00963469|521692180|FG002|Overall Study|Lost to Follow-up|0|||
144683474|NCT00963469|521692178|FG000|Overall Study|Protocol Violation|5|||
144683475|NCT00963469|521692179|FG001|Overall Study|Protocol Violation|5|||
144683476|NCT00963469|521692180|FG002|Overall Study|Protocol Violation|3|||
144683477|NCT00963469|521692178|FG000|Overall Study|Withdrawal by Subject|4|||
144683478|NCT00963469|521692179|FG001|Overall Study|Withdrawal by Subject|1|||
144683479|NCT00963469|521692180|FG002|Overall Study|Withdrawal by Subject|1|||
144683480|NCT00963469|521692178|FG000|Overall Study|Pre-randomization Adverse Event|1|||
144683481|NCT00963469|521692179|FG001|Overall Study|Pre-randomization Adverse Event|2|||
144683482|NCT00963469|521692180|FG002|Overall Study|Pre-randomization Adverse Event|0|||
144683483|NCT00963469|521692178|FG000|Overall Study|Moved|1|||
144683484|NCT00963469|521692179|FG001|Overall Study|Moved|0|||
144683485|NCT00963469|521692180|FG002|Overall Study|Moved|0|||
144683486|NCT00963469|521692178|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
144683487|NCT00963469|521692179|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
144683488|NCT00963469|521692180|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
144683489|NCT04969900|521692189|FG000|Overall Study|Physician Decision|1|||
144683490|NCT04969900|521692190|FG001|Overall Study|Physician Decision|1|||
144683491|NCT04969900|521692189|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
144683492|NCT04969900|521692190|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
144683493|NCT03381274|521692194|FG000|Overall Study|Death|2|||
144683494|NCT03381274|521692195|FG001|Overall Study|Death|9|||
144683495|NCT03381274|521692196|FG002|Overall Study|Death|3|||
144683496|NCT03381274|521692197|FG003|Overall Study|Death|2|||
144683497|NCT03381274|521692198|FG004|Overall Study|Death|3|||
144683498|NCT03381274|521692194|FG000|Overall Study|Lost to Follow-up|0|||
144683499|NCT03381274|521692195|FG001|Overall Study|Lost to Follow-up|0|||
144683500|NCT03381274|521692196|FG002|Overall Study|Lost to Follow-up|0|||
144683501|NCT03381274|521692197|FG003|Overall Study|Lost to Follow-up|1|||
144683502|NCT03381274|521692198|FG004|Overall Study|Lost to Follow-up|0|||
144683503|NCT03381274|521692194|FG000|Overall Study|Withdrawal by Subject|2|||
144683504|NCT03381274|521692195|FG001|Overall Study|Withdrawal by Subject|1|||
144683505|NCT03381274|521692196|FG002|Overall Study|Withdrawal by Subject|3|||
144683506|NCT03381274|521692197|FG003|Overall Study|Withdrawal by Subject|1|||
144683507|NCT03381274|521692198|FG004|Overall Study|Withdrawal by Subject|0|||
144683508|NCT03381274|521692194|FG000|Overall Study|Other|1|||
144683509|NCT03381274|521692195|FG001|Overall Study|Other|11|||
144683510|NCT03381274|521692196|FG002|Overall Study|Other|0|||
144683511|NCT03381274|521692197|FG003|Overall Study|Other|2|||
144683512|NCT03381274|521692198|FG004|Overall Study|Other|2|||
144683513|NCT04992507|521692203|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
144683514|NCT04992507|521692204|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
144683515|NCT04992507|521692203|FG000|Overall Study|Death|0|||
144683516|NCT04992507|521692204|FG001|Overall Study|Death|1|||
144683517|NCT01852591|521692205|FG000|Overall Study|Withdrawal by Subject|2|||
144683518|NCT01852591|521692205|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
144683519|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
144683520|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
144683521|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Death|1|||
144683522|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Death|1|||
144683523|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
144683524|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
144683525|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
144683526|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
144683527|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
144683528|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
144683529|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
144683530|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
144683531|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
144683532|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
144683533|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
144683534|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
144683535|NCT03728881|521692208|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
144683536|NCT03728881|521692209|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
144683537|NCT03728881|521692208|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
144683538|NCT03728881|521692209|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
144683539|NCT03728881|521692208|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
144683540|NCT03728881|521692209|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
144683541|NCT04517253|521692212|FG000|Primary Treatment Period|Adverse Event|1|||
144683542|NCT04517253|521692213|FG001|Primary Treatment Period|Adverse Event|0|||
144683543|NCT04517253|521692214|FG002|Primary Treatment Period|Adverse Event|0|||
144683544|NCT04517253|521692212|FG000|Primary Treatment Period|Death|0|||
144683545|NCT04517253|521692213|FG001|Primary Treatment Period|Death|1|||
144683546|NCT04517253|521692214|FG002|Primary Treatment Period|Death|0|||
144683547|NCT04517253|521692212|FG000|Maintenance Period|Withdrawal by Subject|1|||
144683548|NCT04517253|521692213|FG001|Maintenance Period|Withdrawal by Subject|0|||
144683549|NCT04517253|521692214|FG002|Maintenance Period|Withdrawal by Subject|0|||
144683550|NCT04517253|521692212|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
144683551|NCT04517253|521692213|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
144683552|NCT04517253|521692214|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
144683553|NCT04651777|521692217|FG000|Overall Study|Adverse Event|1|||
144683554|NCT04651777|521692217|FG000|Overall Study|Withdrawal by Subject|2|||
144683555|NCT06048367|521692218|FG000|Overall Study|Withdrawal by Subject|0|||
144683556|NCT06048367|521692219|FG001|Overall Study|Withdrawal by Subject|1|||
144683557|NCT06048367|521692220|FG002|Overall Study|Withdrawal by Subject|0|||
144683558|NCT06048367|521692221|FG003|Overall Study|Withdrawal by Subject|0|||
144683559|NCT06048367|521692222|FG004|Overall Study|Withdrawal by Subject|0|||
144683560|NCT06048367|521692218|FG000|Overall Study|Withdrawal by Subject|0|||
144683561|NCT06048367|521692219|FG001|Overall Study|Withdrawal by Subject|0|||
144683562|NCT06048367|521692220|FG002|Overall Study|Withdrawal by Subject|1|||
144683563|NCT06048367|521692221|FG003|Overall Study|Withdrawal by Subject|0|||
144683564|NCT06048367|521692222|FG004|Overall Study|Withdrawal by Subject|0|||
144683565|NCT06048367|521692218|FG000|Overall Study|Withdrawal by Subject|0|||
144683566|NCT06048367|521692219|FG001|Overall Study|Withdrawal by Subject|0|||
144683567|NCT06048367|521692220|FG002|Overall Study|Withdrawal by Subject|0|||
144683568|NCT06048367|521692221|FG003|Overall Study|Withdrawal by Subject|1|||
144683569|NCT06048367|521692222|FG004|Overall Study|Withdrawal by Subject|0|||
144683570|NCT06048367|521692218|FG000|Overall Study|Withdrawal by Subject|0|||
144683571|NCT06048367|521692219|FG001|Overall Study|Withdrawal by Subject|0|||
144683572|NCT06048367|521692220|FG002|Overall Study|Withdrawal by Subject|0|||
144683573|NCT06048367|521692221|FG003|Overall Study|Withdrawal by Subject|1|||
144683574|NCT06048367|521692222|FG004|Overall Study|Withdrawal by Subject|0|||
144683575|NCT03233308|521692227|FG000|Overall Study|Adverse Event|1|||
144683576|NCT03233308|521692227|FG000|Overall Study|Protocol Violation|1|||
144683577|NCT05016037|521692228|FG000|Overall Study|Lost to Follow-up|2|||
144683578|NCT03715205|521692229|FG000|Overall Study|Death|13|||
144683579|NCT03715205|521692229|FG000|Overall Study|Lost to Follow-up|2|||
144683580|NCT03715205|521692229|FG000|Overall Study|Physician Decision|93|||
144683581|NCT03715205|521692229|FG000|Overall Study|Withdrawal by Subject|26|||
144683582|NCT02756845|521692230|FG000|Overall Study|Death|12|||
144683583|NCT02756845|521692231|FG001|Overall Study|Death|2|||
144683584|NCT02756845|521692230|FG000|Overall Study|Withdrawal by Subject|1|||
144683585|NCT02756845|521692231|FG001|Overall Study|Withdrawal by Subject|0|||
144683586|NCT03342404|521692232|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
144683587|NCT03342404|521692233|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
144683588|NCT03342404|521692232|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
144683589|NCT03342404|521692233|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
144683590|NCT03342404|521692232|FG000|Blinded Treatment Phase|Adverse Event|5|||
144683591|NCT03342404|521692233|FG001|Blinded Treatment Phase|Adverse Event|4|||
144683592|NCT03342404|521692232|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
144683593|NCT03342404|521692233|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
144683594|NCT03342404|521692232|FG000|Blinded Treatment Phase|Other reasons|1|||
144683595|NCT03342404|521692233|FG001|Blinded Treatment Phase|Other reasons|0|||
144683596|NCT03342404|521692232|FG000|Blinded Treatment Phase|Physician Decision|1|||
144683597|NCT03342404|521692233|FG001|Blinded Treatment Phase|Physician Decision|0|||
144683598|NCT03342404|521692232|FG000|Blinded Treatment Phase|Death|1|||
144683599|NCT03342404|521692233|FG001|Blinded Treatment Phase|Death|0|||
144683600|NCT03342404|521692232|FG000|Open-Label Phase|Lost to Follow-up|0|||
144683601|NCT03342404|521692233|FG001|Open-Label Phase|Lost to Follow-up|1|||
144683602|NCT03342404|521692232|FG000|Open-Label Phase|Other reasons|0|||
144683603|NCT03342404|521692233|FG001|Open-Label Phase|Other reasons|1|||
144683604|NCT03342404|521692232|FG000|Open-Label Phase|Adverse Event|0|||
144683605|NCT03342404|521692233|FG001|Open-Label Phase|Adverse Event|3|||
144683606|NCT03342404|521692232|FG000|Open-Label Phase|Withdrawal by Subject|0|||
144683607|NCT03342404|521692233|FG001|Open-Label Phase|Withdrawal by Subject|6|||
144683608|NCT00850135|521692238|FG000|Overall Study|Physician Decision|1|||
144265852|NCT00427908|520174020|FG002|Primary Phase|Adverse Event|0|||
144683609|NCT02253992|521692239|FG000|Overall Study|Study drug toxicity|1|||
144683610|NCT02253992|521692240|FG001|Overall Study|Study drug toxicity|0|||
144683611|NCT02253992|521692241|FG002|Overall Study|Study drug toxicity|10|||
144683612|NCT02253992|521692239|FG000|Overall Study|Disease progression|4|||
144683613|NCT02253992|521692240|FG001|Overall Study|Disease progression|3|||
144683614|NCT02253992|521692241|FG002|Overall Study|Disease progression|98|||
144683615|NCT02253992|521692239|FG000|Overall Study|Withdrawal by Subject|0|||
144683616|NCT02253992|521692240|FG001|Overall Study|Withdrawal by Subject|0|||
144683617|NCT02253992|521692241|FG002|Overall Study|Withdrawal by Subject|3|||
144683618|NCT02253992|521692239|FG000|Overall Study|Adverse Event|0|||
144738649|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
144738650|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
144738651|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
144738652|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
144738653|NCT00318461|521897538|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
144738654|NCT00318461|521897539|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
144738655|NCT00318461|521897540|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
144738656|NCT00318461|521897541|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
144738657|NCT00318461|521897542|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
144738658|NCT00318461|521897538|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
144738659|NCT00318461|521897539|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
144738660|NCT00318461|521897540|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
144738661|NCT00318461|521897541|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
144738662|NCT00318461|521897542|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
144738663|NCT00318461|521897538|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
144738664|NCT00318461|521897539|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
144738665|NCT00318461|521897540|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
144738666|NCT00318461|521897541|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
144738667|NCT00318461|521897542|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
144738668|NCT00318461|521897538|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
144738669|NCT00318461|521897539|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
144738670|NCT00318461|521897540|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
144218382|NCT03404674|519992335|FG001|Overall Study|Inability to Attend Future Visits|1|||
144218383|NCT03404674|519992336|FG002|Overall Study|Inability to Attend Future Visits|1|||
144218384|NCT03404674|519992337|FG003|Overall Study|Inability to Attend Future Visits|0|||
144218385|NCT03404674|519992338|FG004|Overall Study|Inability to Attend Future Visits|0|||
144218386|NCT03404674|519992339|FG005|Overall Study|Inability to Attend Future Visits|0|||
144218387|NCT03404674|519992334|FG000|Overall Study|Behavioral Problems|0|||
144218388|NCT03404674|519992335|FG001|Overall Study|Behavioral Problems|0|||
144683619|NCT02253992|521692240|FG001|Overall Study|Adverse Event|0|||
144683620|NCT02253992|521692241|FG002|Overall Study|Adverse Event|8|||
144683621|NCT02253992|521692239|FG000|Overall Study|Death|0|||
144683622|NCT02253992|521692240|FG001|Overall Study|Death|0|||
144683623|NCT02253992|521692241|FG002|Overall Study|Death|1|||
144683624|NCT02253992|521692239|FG000|Overall Study|Subject discontinued study drug|1|||
144683625|NCT02253992|521692240|FG001|Overall Study|Subject discontinued study drug|0|||
144683626|NCT02253992|521692241|FG002|Overall Study|Subject discontinued study drug|1|||
144683627|NCT02253992|521692239|FG000|Overall Study|Completed treatment as per protocol|0|||
144683628|NCT02253992|521692240|FG001|Overall Study|Completed treatment as per protocol|1|||
144683629|NCT02253992|521692241|FG002|Overall Study|Completed treatment as per protocol|22|||
144683630|NCT02253992|521692239|FG000|Overall Study|Other|0|||
144683631|NCT02253992|521692240|FG001|Overall Study|Other|0|||
144683632|NCT02253992|521692241|FG002|Overall Study|Other|1|||
144683633|NCT00772889|521692242|FG000|Overall Study|Adverse Event|7|||
144683634|NCT00772889|521692243|FG001|Overall Study|Adverse Event|4|||
144683635|NCT00772889|521692244|FG002|Overall Study|Adverse Event|0|||
144683636|NCT00772889|521692242|FG000|Overall Study|Withdrawal by Subject|9|||
144683637|NCT00772889|521692243|FG001|Overall Study|Withdrawal by Subject|8|||
144683638|NCT00772889|521692244|FG002|Overall Study|Withdrawal by Subject|9|||
144683639|NCT00772889|521692242|FG000|Overall Study|Lost to Follow-up|6|||
144683640|NCT00772889|521692243|FG001|Overall Study|Lost to Follow-up|6|||
144683641|NCT00772889|521692244|FG002|Overall Study|Lost to Follow-up|7|||
144683642|NCT03323086|521692245|FG000|Overall Study|Lost to Follow-up|3|||
144683643|NCT03323086|521692246|FG001|Overall Study|Lost to Follow-up|2|||
144683644|NCT03523715|521692249|FG000|Overall Study|Lost to Follow-up|11|||
144683645|NCT03523715|521692250|FG001|Overall Study|Lost to Follow-up|14|||
144683646|NCT03523715|521692249|FG000|Overall Study|Did not meet inclusion criteria|1|||
144683647|NCT03523715|521692250|FG001|Overall Study|Did not meet inclusion criteria|0|||
144683648|NCT03523715|521692249|FG000|Overall Study|Internally inconsistent reporting|0|||
144683649|NCT03523715|521692250|FG001|Overall Study|Internally inconsistent reporting|2|||
144683650|NCT00606229|521692251|FG000|Overall Study|Adverse Event|11|||
144683651|NCT00606229|521692251|FG000|Overall Study|Lack of Efficacy|1|||
144683652|NCT00606229|521692251|FG000|Overall Study|Withdrawal by Subject|4|||
144683653|NCT00606229|521692251|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
144683654|NCT00606229|521692251|FG000|Overall Study|change of residence or other commitments|2|||
144683655|NCT02139280|521692252|FG000|Overall Study|No longer eligible|2|||
144683656|NCT02139280|521692253|FG001|Overall Study|No longer eligible|0|||
144683657|NCT05559203|521692254|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
144683658|NCT00422903|521692258|FG000|Overall Study|Disease Progression|3|||
144683659|NCT00422903|521692259|FG001|Overall Study|Disease Progression|1|||
144683660|NCT00422903|521692258|FG000|Overall Study|Adverse Event|0|||
144738671|NCT00318461|521897541|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
144738672|NCT00318461|521897542|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
144738673|NCT00318461|521897538|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
144738674|NCT00318461|521897539|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
144738675|NCT00318461|521897540|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
144738676|NCT00318461|521897541|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
144738677|NCT00318461|521897542|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
144738678|NCT00318461|521897538|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
144738679|NCT00318461|521897539|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
144738680|NCT00318461|521897540|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
144738681|NCT00318461|521897541|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
144738682|NCT00318461|521897542|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
144738683|NCT01848938|521897547|FG000|Overall Study|Lost to Follow-up|1|||
144738684|NCT01848938|521897548|FG001|Overall Study|Lost to Follow-up|1|||
144738685|NCT00207090|521897551|FG000|Overall Study|Study drug toxicity|3|||
144738686|NCT00207090|521897551|FG000|Overall Study|Chest wall mass larger|1|||
144738687|NCT00207090|521897551|FG000|Overall Study|Disease progression/relapse|2|||
144738688|NCT00207090|521897551|FG000|Overall Study|Physician Decision|1|||
144738689|NCT00841698|521897554|FG000|First Intervention|Withdrawal by Subject|1|||
144738690|NCT00841698|521897555|FG001|First Intervention|Withdrawal by Subject|0|||
144738691|NCT01929863|521897560|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
144738692|NCT01929863|521897561|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
144738693|NCT01929863|521897560|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
144738694|NCT01929863|521897561|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
144738695|NCT01929863|521897560|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
144738696|NCT01929863|521897561|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
144738697|NCT00251979|521897562|FG000|Overall Study|Protocol Violation|3|||
144738698|NCT00251979|521897563|FG001|Overall Study|Protocol Violation|5|||
144738699|NCT00251979|521897562|FG000|Overall Study|Adverse Event|11|||
144738700|NCT00251979|521897563|FG001|Overall Study|Adverse Event|17|||
144738701|NCT00251979|521897562|FG000|Overall Study|Withdrawal by Subject|13|||
144738702|NCT00251979|521897563|FG001|Overall Study|Withdrawal by Subject|7|||
144738703|NCT00251979|521897562|FG000|Overall Study|Lost to Follow-up|8|||
144738704|NCT00251979|521897563|FG001|Overall Study|Lost to Follow-up|6|||
144738705|NCT00251979|521897562|FG000|Overall Study|Death|3|||
144738706|NCT00251979|521897563|FG001|Overall Study|Death|5|||
144738707|NCT05776901|521899223|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
144738708|NCT00665925|521899225|FG000|Overall Study|Lack of Efficacy|10|||
144738709|NCT00665925|521899226|FG001|Overall Study|Lack of Efficacy|8|||
144738710|NCT00665925|521899227|FG002|Overall Study|Lack of Efficacy|9|||
144738711|NCT00665925|521899228|FG003|Overall Study|Lack of Efficacy|8|||
144738712|NCT00665925|521899225|FG000|Overall Study|Lost to Follow-up|1|||
144738713|NCT00665925|521899226|FG001|Overall Study|Lost to Follow-up|2|||
144738714|NCT00665925|521899227|FG002|Overall Study|Lost to Follow-up|2|||
144738715|NCT00665925|521899228|FG003|Overall Study|Lost to Follow-up|2|||
144738716|NCT00665925|521899225|FG000|Overall Study|Withdrawal by Subject|2|||
144738717|NCT00665925|521899226|FG001|Overall Study|Withdrawal by Subject|2|||
144738718|NCT00665925|521899227|FG002|Overall Study|Withdrawal by Subject|3|||
144738719|NCT00665925|521899228|FG003|Overall Study|Withdrawal by Subject|2|||
144738720|NCT00665925|521899225|FG000|Overall Study|Physician Decision|0|||
144738721|NCT00665925|521899226|FG001|Overall Study|Physician Decision|0|||
144738722|NCT00665925|521899227|FG002|Overall Study|Physician Decision|1|||
144738723|NCT00665925|521899228|FG003|Overall Study|Physician Decision|2|||
144738724|NCT00665925|521899225|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
144738725|NCT00665925|521899226|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
144738726|NCT00665925|521899227|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
144738727|NCT00665925|521899228|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
144738728|NCT00665925|521899225|FG000|Overall Study|Adverse Event|1|||
144738729|NCT00665925|521899226|FG001|Overall Study|Adverse Event|5|||
144738730|NCT00665925|521899227|FG002|Overall Study|Adverse Event|10|||
144738731|NCT00665925|521899228|FG003|Overall Study|Adverse Event|5|||
144738732|NCT00665925|521899225|FG000|Overall Study|Enrolled by mistake|0|||
144738733|NCT00665925|521899226|FG001|Overall Study|Enrolled by mistake|0|||
144738734|NCT00665925|521899227|FG002|Overall Study|Enrolled by mistake|0|||
144738735|NCT00665925|521899228|FG003|Overall Study|Enrolled by mistake|1|||
144738736|NCT00665925|521899225|FG000|Overall Study|Due to exclusion criteria|1|||
144738737|NCT00665925|521899226|FG001|Overall Study|Due to exclusion criteria|0|||
144738738|NCT00665925|521899227|FG002|Overall Study|Due to exclusion criteria|0|||
144738739|NCT00665925|521899228|FG003|Overall Study|Due to exclusion criteria|0|||
144738740|NCT01492439|521899231|FG000|Overall Study|Withdrew from RTE|4|||
144738741|NCT01492439|521899232|FG001|Overall Study|Withdrew from RTE|9|||
144738742|NCT00824291|521899233|FG000|Overall Study|Adverse Event|15|||
144738743|NCT00824291|521899234|FG001|Overall Study|Adverse Event|6|||
144738744|NCT00824291|521899233|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
144738745|NCT00824291|521899234|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
144738746|NCT00824291|521899233|FG000|Overall Study|Lost to Follow-up|11|||
144738747|NCT00824291|521899234|FG001|Overall Study|Lost to Follow-up|9|||
144738748|NCT00824291|521899233|FG000|Overall Study|Non-compliance|1|||
144683661|NCT00422903|521692259|FG001|Overall Study|Adverse Event|2|||
144683662|NCT00422903|521692258|FG000|Overall Study|Informed Consent Withdrawn|1|||
144683663|NCT00422903|521692259|FG001|Overall Study|Informed Consent Withdrawn|2|||
144683664|NCT01947894|521692264|FG000|Overall Study|Other|3|||
144683665|NCT01947894|521692265|FG001|Overall Study|Other|4|||
144738749|NCT00824291|521899234|FG001|Overall Study|Non-compliance|1|||
144738750|NCT00824291|521899233|FG000|Overall Study|Protocol Violation|4|||
144683666|NCT01947894|521692266|FG002|Overall Study|Other|3|||
144683667|NCT01947894|521692264|FG000|Overall Study|Withdrawal by Subject|12|||
144683668|NCT01947894|521692265|FG001|Overall Study|Withdrawal by Subject|4|||
144683669|NCT01947894|521692266|FG002|Overall Study|Withdrawal by Subject|1|||
144683670|NCT01947894|521692264|FG000|Overall Study|Death|12|||
144683671|NCT01947894|521692265|FG001|Overall Study|Death|1|||
144683672|NCT01947894|521692266|FG002|Overall Study|Death|0|||
144683673|NCT01947894|521692264|FG000|Overall Study|Physician Decision|2|||
144683674|NCT01947894|521692265|FG001|Overall Study|Physician Decision|0|||
144683675|NCT01947894|521692266|FG002|Overall Study|Physician Decision|0|||
144683676|NCT01947894|521692264|FG000|Overall Study|Adverse Event|5|||
144683677|NCT01947894|521692265|FG001|Overall Study|Adverse Event|1|||
144683678|NCT01947894|521692266|FG002|Overall Study|Adverse Event|0|||
144738751|NCT00824291|521899234|FG001|Overall Study|Protocol Violation|1|||
144738752|NCT00824291|521899233|FG000|Overall Study|Withdrawal by Subject|14|||
144738753|NCT00824291|521899234|FG001|Overall Study|Withdrawal by Subject|8|||
144738754|NCT00824291|521899233|FG000|Overall Study|Lack of Efficacy|7|||
144738755|NCT00824291|521899234|FG001|Overall Study|Lack of Efficacy|8|||
144738756|NCT00824291|521899233|FG000|Overall Study|Participant on prohibited medication|1|||
144738757|NCT00824291|521899234|FG001|Overall Study|Participant on prohibited medication|0|||
144738758|NCT00123734|521899235|FG000|Overall Study|Death|3|||
144738759|NCT00123734|521899235|FG000|Overall Study|Lost to Follow-up|3|||
144738760|NCT00123734|521899235|FG000|Overall Study|Dropout|1|||
144738761|NCT00123734|521899235|FG000|Overall Study|Withdrawal by Subject|1|||
144738762|NCT00113386|521899236|FG000|Overall Study|Withdrawal by Subject|1|||
144738763|NCT00113386|521899237|FG001|Overall Study|Withdrawal by Subject|0|||
144738764|NCT00113386|521899236|FG000|Overall Study|Physician Decision|0|||
144738765|NCT00113386|521899237|FG001|Overall Study|Physician Decision|1|||
144738766|NCT00113386|521899236|FG000|Overall Study|Toxicity|3|||
144738767|NCT00113386|521899237|FG001|Overall Study|Toxicity|0|||
144683679|NCT01947894|521692264|FG000|Overall Study|Switched to other growth hormone brand|53|||
144683680|NCT01947894|521692265|FG001|Overall Study|Switched to other growth hormone brand|8|||
144683681|NCT01947894|521692266|FG002|Overall Study|Switched to other growth hormone brand|23|||
144683682|NCT01249157|521692267|FG000|Overall Study|Withdrawal by Subject|1|||
144683683|NCT03630016|521692268|FG000|Overall Study|Poor Sensor Placement|1|||
144683684|NCT00090766|521692269|FG000|Overall Study|Nephrectomy Planned|0|||
144683685|NCT00090766|521692270|FG001|Overall Study|Nephrectomy Planned|0|||
144683686|NCT00090766|521692271|FG002|Overall Study|Nephrectomy Planned|1|||
144683687|NCT00090766|521692269|FG000|Overall Study|Death|1|||
144683688|NCT00090766|521692270|FG001|Overall Study|Death|0|||
144683689|NCT00090766|521692271|FG002|Overall Study|Death|0|||
144683690|NCT00090766|521692269|FG000|Overall Study|Admin|0|||
144683691|NCT00090766|521692270|FG001|Overall Study|Admin|2|||
144683692|NCT00090766|521692271|FG002|Overall Study|Admin|0|||
144683693|NCT00090766|521692269|FG000|Overall Study|Lost to Follow-up|2|||
144683694|NCT00090766|521692270|FG001|Overall Study|Lost to Follow-up|0|||
144683695|NCT00090766|521692271|FG002|Overall Study|Lost to Follow-up|2|||
144683696|NCT02774291|521692272|FG000|Overall Study|Lost to Follow-up|1|||
144683697|NCT01894776|521692273|FG000|Overall Study|Withdrawal by Subject|1|||
144683698|NCT02485860|521692274|FG000|Overall Study|Lost to Follow-up|4|||
144683699|NCT02485860|521692275|FG001|Overall Study|Lost to Follow-up|1|||
144683700|NCT02485860|521692274|FG000|Overall Study|Physician Decision|1|||
144738768|NCT00113386|521899236|FG000|Overall Study|Ineligible|1|||
144738769|NCT00113386|521899237|FG001|Overall Study|Ineligible|2|||
144738770|NCT00113386|521899236|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
144738771|NCT00113386|521899237|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
144738772|NCT01648582|521899238|FG000|Overall Study|Adverse Event|6|||
144738773|NCT01648582|521899239|FG001|Overall Study|Adverse Event|11|||
144738774|NCT01648582|521899240|FG002|Overall Study|Adverse Event|2|||
144738775|NCT01648582|521899238|FG000|Overall Study|Lost to Follow-up|9|||
144738776|NCT01648582|521899239|FG001|Overall Study|Lost to Follow-up|6|||
144738777|NCT01648582|521899240|FG002|Overall Study|Lost to Follow-up|8|||
144738778|NCT01648582|521899238|FG000|Overall Study|Protocol Violation|1|||
144738779|NCT01648582|521899239|FG001|Overall Study|Protocol Violation|2|||
144738780|NCT01648582|521899240|FG002|Overall Study|Protocol Violation|1|||
144683701|NCT02485860|521692275|FG001|Overall Study|Physician Decision|2|||
144683702|NCT02485860|521692274|FG000|Overall Study|Health context (COVID-19)|1|||
144683703|NCT02485860|521692275|FG001|Overall Study|Health context (COVID-19)|0|||
144683704|NCT03325010|521692278|FG000|Overall Study|Adverse Event|3|||
144738781|NCT01648582|521899238|FG000|Overall Study|Withdrawal by Subject|15|||
144738782|NCT01648582|521899239|FG001|Overall Study|Withdrawal by Subject|17|||
144683705|NCT03325010|521692279|FG001|Overall Study|Adverse Event|8|||
144683706|NCT03325010|521692278|FG000|Overall Study|Protocol Violation|1|||
144683707|NCT03325010|521692279|FG001|Overall Study|Protocol Violation|8|||
144683708|NCT03325010|521692278|FG000|Overall Study|Withdrawal by Subject|1|||
144683709|NCT03325010|521692279|FG001|Overall Study|Withdrawal by Subject|3|||
144683710|NCT03325010|521692278|FG000|Overall Study|Lost to Follow-up|1|||
144683711|NCT03325010|521692279|FG001|Overall Study|Lost to Follow-up|0|||
144683712|NCT03325010|521692278|FG000|Overall Study|Physician Decision|1|||
144683713|NCT03325010|521692279|FG001|Overall Study|Physician Decision|1|||
144683714|NCT03325010|521692278|FG000|Overall Study|Lack of Efficacy|2|||
144683715|NCT03325010|521692279|FG001|Overall Study|Lack of Efficacy|0|||
144683716|NCT00471315|521692280|FG000|Overall Study|Adverse Event|7|||
144683717|NCT00471315|521692280|FG000|Overall Study|Withdrawal by Subject|1|||
144683718|NCT00113555|521692287|FG000|Overall Study|Baseline Failure|59|||
144683719|NCT00113555|521692287|FG000|Overall Study|Permanently Explanted|7|||
144683720|NCT00113555|521692287|FG000|Overall Study|Death|1|||
144683721|NCT00113555|521692287|FG000|Overall Study|Missed Followup|4|||
144683722|NCT00113555|521692287|FG000|Overall Study|Lost to Follow-up|8|||
144683723|NCT00609167|521692288|FG000|Overall Study|Withdrawal by Subject|1|||
144683724|NCT00609167|521692289|FG001|Overall Study|Withdrawal by Subject|0|||
144683725|NCT00609167|521692288|FG000|Overall Study|Lack of Efficacy|1|||
144683726|NCT00609167|521692289|FG001|Overall Study|Lack of Efficacy|0|||
144683727|NCT00609167|521692288|FG000|Overall Study|Adverse Event|5|||
144683728|NCT00609167|521692289|FG001|Overall Study|Adverse Event|1|||
144683729|NCT00609167|521692288|FG000|Overall Study|Disease Progression|1|||
144683730|NCT00609167|521692289|FG001|Overall Study|Disease Progression|0|||
144683731|NCT00609167|521692288|FG000|Overall Study|Stem Cell Transplant|0|||
144683732|NCT00609167|521692289|FG001|Overall Study|Stem Cell Transplant|6|||
144683733|NCT03898323|521692290|FG000|Overall Study|Physician Decision|1|||
144683734|NCT03858686|521692300|FG000|Period 1|Adverse Event|1|||
144683735|NCT03858686|521692301|FG001|Period 1|Adverse Event|1|||
144683736|NCT03858686|521692300|FG000|Period 1|Lack of compliance|0|||
144683737|NCT03858686|521692301|FG001|Period 1|Lack of compliance|1|||
144683738|NCT03858686|521692300|FG000|Period 1|Adverse Event|0|||
144683739|NCT03858686|521692301|FG001|Period 1|Adverse Event|1|||
144683740|NCT03858686|521692300|FG000|Period 2|Adverse Event|0|||
144683741|NCT03858686|521692301|FG001|Period 2|Adverse Event|1|||
144683742|NCT03864627|521692305|FG000|Overall Study|Adverse Event|0|||
144683743|NCT03864627|521692306|FG001|Overall Study|Adverse Event|1|||
144683744|NCT03864627|521692305|FG000|Overall Study|Lack of Efficacy|0|||
144683745|NCT03864627|521692306|FG001|Overall Study|Lack of Efficacy|1|||
144683746|NCT03864627|521692305|FG000|Overall Study|Lost to Follow-up|0|||
144683747|NCT03864627|521692306|FG001|Overall Study|Lost to Follow-up|1|||
144683748|NCT03864627|521692305|FG000|Overall Study|Withdrawal by Subject|4|||
144683749|NCT03864627|521692306|FG001|Overall Study|Withdrawal by Subject|8|||
144683750|NCT03864627|521692305|FG000|Overall Study|Study terminated by sponsor|0|||
144683751|NCT03864627|521692306|FG001|Overall Study|Study terminated by sponsor|1|||
144683752|NCT02735044|521692307|FG000|Overall Study|Adverse Event|3|||
144683753|NCT02735044|521692308|FG001|Overall Study|Adverse Event|3|||
144683754|NCT02735044|521692307|FG000|Overall Study|Lack of Efficacy|1|||
144683755|NCT02735044|521692308|FG001|Overall Study|Lack of Efficacy|0|||
144683756|NCT02735044|521692307|FG000|Overall Study|Poor compliance to protocol|7|||
144683757|NCT02735044|521692308|FG001|Overall Study|Poor compliance to protocol|7|||
144683758|NCT02735044|521692307|FG000|Overall Study|Randomized and not treated|0|||
144683759|NCT02735044|521692308|FG001|Overall Study|Randomized and not treated|2|||
144683760|NCT02735044|521692307|FG000|Overall Study|Other, not specified above|5|||
144683761|NCT02735044|521692308|FG001|Overall Study|Other, not specified above|11|||
144683762|NCT01682759|521692309|FG000|Overall Study|Death|2|||
144738783|NCT01648582|521899240|FG002|Overall Study|Withdrawal by Subject|17|||
144738784|NCT01648582|521899238|FG000|Overall Study|Physician Decision|0|||
144738785|NCT01648582|521899239|FG001|Overall Study|Physician Decision|1|||
144683763|NCT01682759|521692310|FG001|Overall Study|Death|1|||
144683764|NCT01682759|521692309|FG000|Overall Study|Lost to Follow-up|10|||
144738786|NCT01648582|521899240|FG002|Overall Study|Physician Decision|3|||
144738787|NCT01648582|521899238|FG000|Overall Study|Death|1|||
144218389|NCT03404674|519992336|FG002|Overall Study|Behavioral Problems|1|||
144218390|NCT03404674|519992337|FG003|Overall Study|Behavioral Problems|0|||
144218391|NCT03404674|519992338|FG004|Overall Study|Behavioral Problems|0|||
144683765|NCT01682759|521692310|FG001|Overall Study|Lost to Follow-up|13|||
144683766|NCT01682759|521692309|FG000|Overall Study|Physician Decision|1|||
144683767|NCT01682759|521692310|FG001|Overall Study|Physician Decision|1|||
144683768|NCT01682759|521692309|FG000|Overall Study|Withdrawal by Subject|56|||
144683769|NCT01682759|521692310|FG001|Overall Study|Withdrawal by Subject|55|||
144683770|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
144683771|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
144683772|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Death|0|||
144683773|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Death|4|||
144683774|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
144683775|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
144738788|NCT01648582|521899239|FG001|Overall Study|Death|0|||
144738789|NCT01648582|521899240|FG002|Overall Study|Death|0|||
144738790|NCT01648582|521899238|FG000|Overall Study|Sponsor Decision|0|||
144738791|NCT01648582|521899239|FG001|Overall Study|Sponsor Decision|1|||
144738792|NCT01648582|521899240|FG002|Overall Study|Sponsor Decision|1|||
144738793|NCT03673670|521899241|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
144738794|NCT03673670|521899242|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
144738795|NCT03673670|521899243|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
144738796|NCT03673670|521899244|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
144738797|NCT03673670|521899245|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
144738798|NCT03673670|521899246|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
144738799|NCT03673670|521899241|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
144738800|NCT03673670|521899242|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
144738801|NCT03673670|521899243|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
144738802|NCT03673670|521899244|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
144738803|NCT03673670|521899245|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
144738804|NCT03673670|521899246|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
144738805|NCT03673670|521899241|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
144738806|NCT03673670|521899242|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
144738807|NCT03673670|521899243|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
144738808|NCT03673670|521899244|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
144738809|NCT03673670|521899245|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
144738810|NCT03673670|521899246|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
144738811|NCT03673670|521899241|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
144738812|NCT03673670|521899242|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
144738813|NCT03673670|521899243|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
144738814|NCT03673670|521899244|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
144738815|NCT03673670|521899245|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
144738816|NCT03673670|521899246|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
144738817|NCT03673670|521899241|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
144738818|NCT03673670|521899242|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
144738819|NCT03673670|521899243|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
144738820|NCT03673670|521899244|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
144738821|NCT03673670|521899245|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
144738822|NCT03673670|521899246|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
144738823|NCT03673670|521899241|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
144738824|NCT03673670|521899242|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
144738825|NCT03673670|521899243|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
144738826|NCT03673670|521899244|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
144738827|NCT03673670|521899245|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
144738828|NCT03673670|521899246|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
144738829|NCT03673670|521899241|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
144738830|NCT03673670|521899242|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
144738831|NCT03673670|521899243|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
144738832|NCT03673670|521899244|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
144738833|NCT03673670|521899245|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
144738834|NCT03673670|521899246|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
144738835|NCT04408794|521899247|FG000|Overall Study|Adverse Event|43|||
144738836|NCT04408794|521899247|FG000|Overall Study|Infrequent study drug usage|43|||
144738837|NCT04408794|521899247|FG000|Overall Study|Lack of Efficacy|61|||
144738838|NCT04408794|521899247|FG000|Overall Study|Lost to Follow-up|33|||
144738839|NCT04408794|521899247|FG000|Overall Study|Non-compliance|6|||
144738840|NCT04408794|521899247|FG000|Overall Study|Physician Decision|1|||
144738841|NCT04408794|521899247|FG000|Overall Study|Pregnancy|6|||
144738842|NCT04408794|521899247|FG000|Overall Study|Protocol Deviation|9|||
144738843|NCT04408794|521899247|FG000|Overall Study|Sheehan-STS Result|1|||
144738844|NCT04408794|521899247|FG000|Overall Study|Withdrawal by Subject|57|||
144738845|NCT04408794|521899247|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
144738846|NCT04408794|521899247|FG000|Overall Study|Never Treated Migraine|5|||
144738847|NCT03437265|521899248|FG000|Overall Study|Protocol Violation|6|||
144738848|NCT01444378|521899255|FG000|Overall Study|Lost to Follow-up|1|||
144738849|NCT01444378|521899255|FG000|Overall Study|Withdrawal by Subject|1|||
144738850|NCT01444378|521899255|FG000|Overall Study|Death|3|||
144738851|NCT01444378|521899255|FG000|Overall Study|Administrative Closure Of The Study|2|||
144738852|NCT01444378|521899255|FG000|Overall Study|Missed Visits|10|||
144738853|NCT00927069|521899256|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
144738854|NCT00927069|521899257|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
144738855|NCT00927069|521899258|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
144738856|NCT00927069|521899259|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
144738857|NCT00927069|521899256|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
144738858|NCT00927069|521899257|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
144738859|NCT00927069|521899258|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
144738860|NCT00927069|521899259|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
144738861|NCT00927069|521899256|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
144683776|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
144683777|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
144683778|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
144683779|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
144683780|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
144683781|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
144683782|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
144683783|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
144683784|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Other|4|||
144683785|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Other|3|||
144683786|NCT03517722|521692313|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
144683787|NCT03517722|521692314|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
144683788|NCT03517722|521692313|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
144683789|NCT03517722|521692314|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
144683790|NCT03517722|521692313|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
144683791|NCT03517722|521692314|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
144683792|NCT03517722|521692313|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
144683793|NCT03517722|521692314|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
144683794|NCT03517722|521692313|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
144683795|NCT03517722|521692314|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
144683796|NCT02422186|521692315|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
144683797|NCT02422186|521692316|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
144683798|NCT02422186|521692315|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
144683799|NCT02422186|521692316|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
144683800|NCT02422186|521692315|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
144683801|NCT02422186|521692316|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
144683802|NCT02422186|521692315|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
144683803|NCT02422186|521692316|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
144683804|NCT02422186|521692315|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
144683805|NCT02422186|521692316|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
144683806|NCT02422186|521692315|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
144683807|NCT02422186|521692316|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
144683808|NCT02422186|521692315|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
144683809|NCT02422186|521692316|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
144683810|NCT02422186|521692315|FG000|Follow-up Phase (2 Weeks)|Other|3|||
144683811|NCT02422186|521692316|FG001|Follow-up Phase (2 Weeks)|Other|0|||
144683812|NCT03074318|521692317|FG000|Overall Study|Adverse Event|0|||
144683813|NCT03074318|521692318|FG001|Overall Study|Adverse Event|1|||
144683814|NCT03074318|521692319|FG002|Overall Study|Adverse Event|1|||
144683815|NCT03074318|521692320|FG003|Overall Study|Adverse Event|1|||
144683816|NCT03074318|521692317|FG000|Overall Study|Death|1|||
144683817|NCT03074318|521692318|FG001|Overall Study|Death|0|||
144683818|NCT03074318|521692319|FG002|Overall Study|Death|0|||
144683819|NCT03074318|521692320|FG003|Overall Study|Death|0|||
144683820|NCT03074318|521692317|FG000|Overall Study|Withdrawal by Subject|1|||
144683821|NCT03074318|521692318|FG001|Overall Study|Withdrawal by Subject|2|||
144683822|NCT03074318|521692319|FG002|Overall Study|Withdrawal by Subject|2|||
144683823|NCT03074318|521692320|FG003|Overall Study|Withdrawal by Subject|4|||
144683824|NCT03074318|521692317|FG000|Overall Study|Trial Closure|2|||
144683825|NCT03074318|521692318|FG001|Overall Study|Trial Closure|2|||
144683826|NCT03074318|521692319|FG002|Overall Study|Trial Closure|3|||
144683827|NCT03074318|521692320|FG003|Overall Study|Trial Closure|11|||
144683828|NCT01226472|521692324|FG000|Overall Study|Progressive Disease|1|||
144683829|NCT00952419|521692325|FG000|Overall Study|Adverse Event|2|||
144683830|NCT00952419|521692326|FG001|Overall Study|Adverse Event|0|||
144683831|NCT00952419|521692327|FG002|Overall Study|Adverse Event|0|||
144683832|NCT00952419|521692325|FG000|Overall Study|Protocol Violation|3|||
144683833|NCT00952419|521692326|FG001|Overall Study|Protocol Violation|7|||
144683834|NCT00952419|521692327|FG002|Overall Study|Protocol Violation|0|||
144683835|NCT00952419|521692325|FG000|Overall Study|Withdrawal by Subject|1|||
144683836|NCT00952419|521692326|FG001|Overall Study|Withdrawal by Subject|3|||
144683837|NCT00952419|521692327|FG002|Overall Study|Withdrawal by Subject|0|||
144683838|NCT03573804|521692330|FG000|Overall Study|claustrophobia or MRI table problems|10|||
144683839|NCT03661983|521693696|FG000|Open Label Stabilization Phase|Adverse Event|5|||
144683840|NCT03661983|521693697|FG001|Open Label Stabilization Phase|Adverse Event|0|||
144683841|NCT03661983|521693698|FG002|Open Label Stabilization Phase|Adverse Event|0|||
144683842|NCT03661983|521693699|FG003|Open Label Stabilization Phase|Adverse Event|0|||
144683843|NCT03661983|521693696|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
144683844|NCT03661983|521693697|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
144683845|NCT03661983|521693698|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
144683846|NCT03661983|521693699|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
144683847|NCT03661983|521693696|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
144683848|NCT03661983|521693697|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
144683849|NCT03661983|521693698|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
144683850|NCT03661983|521693699|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
144683851|NCT03661983|521693696|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
144683852|NCT03661983|521693697|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
144683853|NCT03661983|521693698|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
144683854|NCT03661983|521693699|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
144683855|NCT03661983|521693696|FG000|Double-blind Randomized Phase|Adverse Event|0|||
144683856|NCT03661983|521693697|FG001|Double-blind Randomized Phase|Adverse Event|1|||
144683857|NCT03661983|521693698|FG002|Double-blind Randomized Phase|Adverse Event|0|||
144683858|NCT03661983|521693699|FG003|Double-blind Randomized Phase|Adverse Event|0|||
144683859|NCT03661983|521693696|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
144683860|NCT03661983|521693697|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
144683861|NCT03661983|521693698|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
144683862|NCT03661983|521693699|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
144683863|NCT03661983|521693696|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
144683864|NCT03661983|521693697|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
144683865|NCT03661983|521693698|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
144683866|NCT03661983|521693699|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
144683867|NCT03661983|521693696|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
144683868|NCT03661983|521693697|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
144683869|NCT03661983|521693698|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
144683870|NCT03661983|521693699|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
144683871|NCT02045979|521693700|FG000|Overall Study|Informed Consent Withdrawn|2|||
144683872|NCT02045979|521693701|FG001|Overall Study|Informed Consent Withdrawn|0|||
144683873|NCT02045979|521693702|FG002|Overall Study|Informed Consent Withdrawn|1|||
144683874|NCT02045979|521693700|FG000|Overall Study|not specified above|0|||
144683875|NCT02045979|521693701|FG001|Overall Study|not specified above|1|||
144683876|NCT02045979|521693702|FG002|Overall Study|not specified above|0|||
144683877|NCT00378534|521693703|FG000|Overall Study|Participants did not receive transplant|3|||
144683878|NCT00378534|521693704|FG001|Overall Study|Participants did not receive transplant|0|||
144683879|NCT04423718|521693707|FG000|Main Study|Adverse Event|9|||
144683880|NCT04423718|521693708|FG001|Main Study|Adverse Event|5|||
144683881|NCT04423718|521693709|FG002|Main Study|Adverse Event|8|||
144683882|NCT04423718|521693707|FG000|Main Study|Physician Decision|3|||
144683883|NCT04423718|521693708|FG001|Main Study|Physician Decision|3|||
144683884|NCT04423718|521693709|FG002|Main Study|Physician Decision|2|||
144683885|NCT04423718|521693707|FG000|Main Study|Protocol Violation|0|||
144683886|NCT04423718|521693708|FG001|Main Study|Protocol Violation|0|||
144683887|NCT04423718|521693709|FG002|Main Study|Protocol Violation|1|||
144683888|NCT04423718|521693707|FG000|Main Study|Lost to Follow-up|3|||
144683889|NCT04423718|521693708|FG001|Main Study|Lost to Follow-up|3|||
144683890|NCT04423718|521693709|FG002|Main Study|Lost to Follow-up|4|||
144683891|NCT04423718|521693707|FG000|Main Study|Lack of Efficacy|2|||
144683892|NCT04423718|521693708|FG001|Main Study|Lack of Efficacy|1|||
144683893|NCT04423718|521693709|FG002|Main Study|Lack of Efficacy|0|||
144683894|NCT04423718|521693707|FG000|Main Study|Withdrawal by Subject|14|||
144683895|NCT04423718|521693708|FG001|Main Study|Withdrawal by Subject|20|||
144683896|NCT04423718|521693709|FG002|Main Study|Withdrawal by Subject|20|||
144683897|NCT04423718|521693707|FG000|Main Study|Death|10|||
144683898|NCT04423718|521693708|FG001|Main Study|Death|7|||
144683899|NCT04423718|521693709|FG002|Main Study|Death|7|||
144683900|NCT04423718|521693707|FG000|Main Study|COVID-19 pandemic|2|||
144683901|NCT04423718|521693708|FG001|Main Study|COVID-19 pandemic|2|||
144683902|NCT04423718|521693709|FG002|Main Study|COVID-19 pandemic|2|||
144683903|NCT04423718|521693707|FG000|Main Study|Other|7|||
144683904|NCT04423718|521693708|FG001|Main Study|Other|3|||
144683905|NCT04423718|521693709|FG002|Main Study|Other|2|||
144683906|NCT04423718|521693707|FG000|Extension Phase|Other|1|||
144683907|NCT04423718|521693708|FG001|Extension Phase|Other|0|||
144683908|NCT04423718|521693709|FG002|Extension Phase|Other|0|||
144683909|NCT04423718|521693707|FG000|Extension Phase|Logistical problems|0|||
144683910|NCT04423718|521693708|FG001|Extension Phase|Logistical problems|1|||
144683911|NCT04423718|521693709|FG002|Extension Phase|Logistical problems|1|||
144683912|NCT04423718|521693707|FG000|Extension Phase|Physician Decision|1|||
144683913|NCT04423718|521693708|FG001|Extension Phase|Physician Decision|0|||
144683914|NCT04423718|521693709|FG002|Extension Phase|Physician Decision|1|||
144683915|NCT04423718|521693707|FG000|Extension Phase|Lack of Efficacy|2|||
144683916|NCT04423718|521693708|FG001|Extension Phase|Lack of Efficacy|0|||
144738862|NCT00927069|521899257|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
144683917|NCT04423718|521693709|FG002|Extension Phase|Lack of Efficacy|1|||
144738863|NCT00927069|521899258|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
144683918|NCT04423718|521693707|FG000|Extension Phase|Lost to Follow-up|0|||
144683919|NCT04423718|521693708|FG001|Extension Phase|Lost to Follow-up|2|||
144683920|NCT04423718|521693709|FG002|Extension Phase|Lost to Follow-up|3|||
144683921|NCT04423718|521693707|FG000|Extension Phase|Adverse Event|2|||
144683922|NCT04423718|521693708|FG001|Extension Phase|Adverse Event|3|||
144683923|NCT04423718|521693709|FG002|Extension Phase|Adverse Event|1|||
144683924|NCT04423718|521693707|FG000|Extension Phase|Death|4|||
144683925|NCT04423718|521693708|FG001|Extension Phase|Death|7|||
144683926|NCT04423718|521693709|FG002|Extension Phase|Death|2|||
144683927|NCT04423718|521693707|FG000|Extension Phase|Withdrawal by Subject|11|||
144683928|NCT04423718|521693708|FG001|Extension Phase|Withdrawal by Subject|11|||
144683929|NCT04423718|521693709|FG002|Extension Phase|Withdrawal by Subject|7|||
144683930|NCT00425945|521693710|FG000|Overall Study|Concern about Supplement|2|||
144683931|NCT00425945|521693711|FG001|Overall Study|Concern about Supplement|0|||
144683932|NCT00425945|521693710|FG000|Overall Study|Inconvenience|0|||
144683933|NCT00425945|521693711|FG001|Overall Study|Inconvenience|2|||
144683934|NCT00425945|521693710|FG000|Overall Study|Lost to Follow-up|0|||
144683935|NCT00425945|521693711|FG001|Overall Study|Lost to Follow-up|2|||
144683936|NCT00425945|521693710|FG000|Overall Study|Began hypertension medication|1|||
144683937|NCT00425945|521693711|FG001|Overall Study|Began hypertension medication|0|||
144683938|NCT00425945|521693710|FG000|Overall Study|Began cancer treatments|1|||
144683939|NCT00425945|521693711|FG001|Overall Study|Began cancer treatments|0|||
144683940|NCT00425945|521693710|FG000|Overall Study|Moved from area|0|||
144683941|NCT00425945|521693711|FG001|Overall Study|Moved from area|1|||
144683942|NCT02881151|521693712|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
144683943|NCT03258593|521693714|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
144683944|NCT03258593|521693715|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
144683945|NCT03258593|521693716|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
144683946|NCT03258593|521693717|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
144683947|NCT03258593|521693714|FG000|Run-In Maintenance Phase|Disease progression|3|||
144683948|NCT03258593|521693715|FG001|Run-In Maintenance Phase|Disease progression|0|||
144683949|NCT03258593|521693716|FG002|Run-In Maintenance Phase|Disease progression|0|||
144683950|NCT03258593|521693717|FG003|Run-In Maintenance Phase|Disease progression|0|||
144683951|NCT03258593|521693714|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
144683952|NCT03258593|521693715|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
144683953|NCT03258593|521693716|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
144683954|NCT03258593|521693717|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
144683955|NCT03258593|521693714|FG000|Expansion Maintenance Phase|Physician Decision|0|||
144683956|NCT03258593|521693715|FG001|Expansion Maintenance Phase|Physician Decision|1|||
144683957|NCT03258593|521693716|FG002|Expansion Maintenance Phase|Physician Decision|0|||
144683958|NCT03258593|521693717|FG003|Expansion Maintenance Phase|Physician Decision|0|||
144683959|NCT03657576|521693721|FG000|Overall Study|Death|0|||
144683960|NCT03657576|521693722|FG001|Overall Study|Death|1|||
144683961|NCT03657576|521693723|FG002|Overall Study|Death|1|||
144683962|NCT03657576|521693724|FG003|Overall Study|Death|0|||
144683963|NCT03657576|521693725|FG004|Overall Study|Death|0|||
144683964|NCT03657576|521693726|FG005|Overall Study|Death|0|||
144683965|NCT03657576|521693721|FG000|Overall Study|Withdrawal by Subject|0|||
144683966|NCT03657576|521693722|FG001|Overall Study|Withdrawal by Subject|0|||
144683967|NCT03657576|521693723|FG002|Overall Study|Withdrawal by Subject|0|||
144683968|NCT03657576|521693724|FG003|Overall Study|Withdrawal by Subject|1|||
144683969|NCT03657576|521693725|FG004|Overall Study|Withdrawal by Subject|0|||
144683970|NCT03657576|521693726|FG005|Overall Study|Withdrawal by Subject|0|||
144683971|NCT03657576|521693721|FG000|Overall Study|Screen Fail|0|||
144683972|NCT03657576|521693722|FG001|Overall Study|Screen Fail|0|||
144683973|NCT03657576|521693723|FG002|Overall Study|Screen Fail|0|||
144683974|NCT03657576|521693724|FG003|Overall Study|Screen Fail|0|||
144683975|NCT03657576|521693725|FG004|Overall Study|Screen Fail|0|||
144683976|NCT03657576|521693726|FG005|Overall Study|Screen Fail|5|||
144683977|NCT03657576|521693721|FG000|Overall Study|Disease Progression|1|||
144683978|NCT03657576|521693722|FG001|Overall Study|Disease Progression|1|||
144683979|NCT03657576|521693723|FG002|Overall Study|Disease Progression|0|||
144738864|NCT00927069|521899259|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
144738865|NCT00927069|521899256|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
144683980|NCT03657576|521693724|FG003|Overall Study|Disease Progression|5|||
144683981|NCT03657576|521693725|FG004|Overall Study|Disease Progression|0|||
144683982|NCT03657576|521693726|FG005|Overall Study|Disease Progression|0|||
144683983|NCT03657576|521693721|FG000|Overall Study|Insurance Coverage|0|||
144683984|NCT03657576|521693722|FG001|Overall Study|Insurance Coverage|0|||
144265853|NCT00427908|520174021|FG003|Primary Phase|Adverse Event|0|||
144265854|NCT04202497|520174025|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
144265855|NCT04202497|520174026|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
144265856|NCT04202497|520174027|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
144265857|NCT04202497|520174028|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
144265858|NCT04344301|520174029|FG000|Overall Study|Withdrawal by Subject|1|||
144683985|NCT03657576|521693723|FG002|Overall Study|Insurance Coverage|0|||
144683986|NCT03657576|521693724|FG003|Overall Study|Insurance Coverage|1|||
144683987|NCT03657576|521693725|FG004|Overall Study|Insurance Coverage|0|||
144265859|NCT04344301|520174030|FG001|Overall Study|Withdrawal by Subject|0|||
144265860|NCT04344301|520174029|FG000|Overall Study|Death|0|||
144265861|NCT04344301|520174030|FG001|Overall Study|Death|1|||
144265862|NCT03163446|520176403|FG000|Overall Study|Unable to return for Day 180 visit|2|||
144265863|NCT03163446|520176404|FG001|Overall Study|Unable to return for Day 180 visit|0|||
144265864|NCT03163446|520176403|FG000|Overall Study|Withdrawal by Subject|2|||
144265865|NCT03163446|520176404|FG001|Overall Study|Withdrawal by Subject|6|||
144265866|NCT03163446|520176403|FG000|Overall Study|Death|16|||
144265867|NCT03163446|520176404|FG001|Overall Study|Death|5|||
144265868|NCT03163446|520176403|FG000|Overall Study|Lost to Follow-up|6|||
144265869|NCT03163446|520176404|FG001|Overall Study|Lost to Follow-up|5|||
144265870|NCT03163446|520176403|FG000|Overall Study|Physician Decision|1|||
144265871|NCT03163446|520176404|FG001|Overall Study|Physician Decision|1|||
144265872|NCT03163446|520176403|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
144265873|NCT03163446|520176404|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
144265874|NCT03638128|520176405|FG000|Overall Study|Withdrawal by Subject|1|||
144265875|NCT03638128|520176406|FG001|Overall Study|Withdrawal by Subject|7|||
144265876|NCT03638128|520176407|FG002|Overall Study|Withdrawal by Subject|6|||
144265877|NCT03638128|520176405|FG000|Overall Study|Sponsor Decision|15|||
144683988|NCT03657576|521693726|FG005|Overall Study|Insurance Coverage|0|||
144683989|NCT04437511|521693727|FG000|Overall Study|Adverse Event|50|||
144683990|NCT04437511|521693728|FG001|Overall Study|Adverse Event|21|||
144683991|NCT04437511|521693727|FG000|Overall Study|Death|15|||
144683992|NCT04437511|521693728|FG001|Overall Study|Death|10|||
144683993|NCT04437511|521693727|FG000|Overall Study|Lost to Follow-up|11|||
144683994|NCT04437511|521693728|FG001|Overall Study|Lost to Follow-up|11|||
144683995|NCT04437511|521693727|FG000|Overall Study|Physician Decision|19|||
144683996|NCT04437511|521693728|FG001|Overall Study|Physician Decision|10|||
144683997|NCT04437511|521693727|FG000|Overall Study|Progressive Disease|4|||
144683998|NCT04437511|521693728|FG001|Overall Study|Progressive Disease|7|||
144683999|NCT04437511|521693727|FG000|Overall Study|Withdrawal by Subject|111|||
144684000|NCT04437511|521693728|FG001|Overall Study|Withdrawal by Subject|94|||
144684001|NCT04437511|521693727|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
144684002|NCT04437511|521693728|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
144684003|NCT04437511|521693727|FG000|Overall Study|Continuing Study|7|||
144684004|NCT04437511|521693728|FG001|Overall Study|Continuing Study|5|||
144684005|NCT05618808|521693731|FG000|Overall Study|Withdrawal by Subject|3|||
144684006|NCT05618808|521693732|FG001|Overall Study|Withdrawal by Subject|1|||
144684007|NCT05618808|521693733|FG002|Overall Study|Withdrawal by Subject|3|||
144684008|NCT04284787|521693734|FG000|Overall Study|Disease Progression|9|||
144684009|NCT04284787|521693735|FG001|Overall Study|Disease Progression|12|||
144684010|NCT04284787|521693734|FG000|Overall Study|Physician Decision|12|||
144684011|NCT04284787|521693735|FG001|Overall Study|Physician Decision|7|||
144684012|NCT04284787|521693734|FG000|Overall Study|Transplant|5|||
144684013|NCT04284787|521693735|FG001|Overall Study|Transplant|4|||
144684014|NCT04284787|521693734|FG000|Overall Study|Death|1|||
144684015|NCT04284787|521693735|FG001|Overall Study|Death|2|||
144684016|NCT04284787|521693734|FG000|Overall Study|Adverse Event|0|||
144684017|NCT04284787|521693735|FG001|Overall Study|Adverse Event|4|||
144684018|NCT04284787|521693734|FG000|Overall Study|Non-adherence|2|||
144684019|NCT04284787|521693735|FG001|Overall Study|Non-adherence|0|||
144684020|NCT04284787|521693734|FG000|Overall Study|Lack of Efficacy|2|||
144684021|NCT04284787|521693735|FG001|Overall Study|Lack of Efficacy|0|||
144684022|NCT01874353|521693736|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
144684023|NCT01874353|521693737|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
144684024|NCT01874353|521693738|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
144684025|NCT01874353|521693739|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
144684026|NCT01874353|521693736|FG000|Overall Study|Lost to Follow-up|2|||
144684027|NCT01874353|521693737|FG001|Overall Study|Lost to Follow-up|2|||
144684028|NCT01874353|521693738|FG002|Overall Study|Lost to Follow-up|2|||
144684029|NCT01874353|521693739|FG003|Overall Study|Lost to Follow-up|0|||
144684030|NCT01874353|521693736|FG000|Overall Study|Death|110|||
144684031|NCT01874353|521693737|FG001|Overall Study|Death|60|||
144684032|NCT01874353|521693738|FG002|Overall Study|Death|13|||
144684033|NCT01874353|521693739|FG003|Overall Study|Death|7|||
144684034|NCT01874353|521693736|FG000|Overall Study|Withdrawal by Subject|13|||
144684035|NCT01874353|521693737|FG001|Overall Study|Withdrawal by Subject|11|||
144684036|NCT01874353|521693738|FG002|Overall Study|Withdrawal by Subject|0|||
144684037|NCT01874353|521693739|FG003|Overall Study|Withdrawal by Subject|0|||
144684038|NCT04088331|521693744|FG000|Overall Study|Lost to Follow-up|3|||
144684039|NCT04088331|521693744|FG000|Overall Study|Withdrawal by Subject|7|||
144684040|NCT04088331|521693744|FG000|Overall Study|Adverse Event|4|||
144738866|NCT00927069|521899257|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
144738867|NCT00927069|521899258|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
144684041|NCT01996865|521693746|FG000|Induction Period|Protocol Violation|1|||
144684042|NCT01996865|521693747|FG001|Induction Period|Protocol Violation|0|||
144684043|NCT01996865|521693748|FG002|Induction Period|Protocol Violation|0|||
144684044|NCT01996865|521693746|FG000|Induction Period|Progressive Disease|4|||
144684045|NCT01996865|521693747|FG001|Induction Period|Progressive Disease|0|||
144684046|NCT01996865|521693748|FG002|Induction Period|Progressive Disease|0|||
144684047|NCT01996865|521693746|FG000|Induction Period|Lost to Follow-up|10|||
144684048|NCT01996865|521693747|FG001|Induction Period|Lost to Follow-up|0|||
144684049|NCT01996865|521693748|FG002|Induction Period|Lost to Follow-up|0|||
144684050|NCT01996865|521693746|FG000|Induction Period|Other Reasons|13|||
144684051|NCT01996865|521693747|FG001|Induction Period|Other Reasons|0|||
144684052|NCT01996865|521693748|FG002|Induction Period|Other Reasons|0|||
144684053|NCT01996865|521693746|FG000|Induction Period|Adverse Event|20|||
144684054|NCT01996865|521693747|FG001|Induction Period|Adverse Event|0|||
144684055|NCT01996865|521693748|FG002|Induction Period|Adverse Event|0|||
144684056|NCT01996865|521693746|FG000|Induction Period|Withdrawal by Subject|60|||
144684057|NCT01996865|521693747|FG001|Induction Period|Withdrawal by Subject|0|||
144684058|NCT01996865|521693748|FG002|Induction Period|Withdrawal by Subject|0|||
144684059|NCT01996865|521693746|FG000|Induction Period|Death|111|||
144684060|NCT01996865|521693747|FG001|Induction Period|Death|0|||
144684061|NCT01996865|521693748|FG002|Induction Period|Death|0|||
144684062|NCT01996865|521693746|FG000|Maintenance Period|Protocol Violation|0|||
144684063|NCT01996865|521693747|FG001|Maintenance Period|Protocol Violation|1|||
144684064|NCT01996865|521693748|FG002|Maintenance Period|Protocol Violation|1|||
144684065|NCT01996865|521693746|FG000|Maintenance Period|Other reasons|0|||
144684066|NCT01996865|521693747|FG001|Maintenance Period|Other reasons|8|||
144684067|NCT01996865|521693748|FG002|Maintenance Period|Other reasons|5|||
144684068|NCT01996865|521693746|FG000|Maintenance Period|Progressive Disease|0|||
144684069|NCT01996865|521693747|FG001|Maintenance Period|Progressive Disease|6|||
144684070|NCT01996865|521693748|FG002|Maintenance Period|Progressive Disease|23|||
144684071|NCT01996865|521693746|FG000|Maintenance Period|Withdrawal by Subject|0|||
144684072|NCT01996865|521693747|FG001|Maintenance Period|Withdrawal by Subject|18|||
144684073|NCT01996865|521693748|FG002|Maintenance Period|Withdrawal by Subject|4|||
144684074|NCT01996865|521693746|FG000|Maintenance Period|Adverse Event|0|||
144684075|NCT01996865|521693747|FG001|Maintenance Period|Adverse Event|7|||
144684076|NCT01996865|521693748|FG002|Maintenance Period|Adverse Event|7|||
144684077|NCT01996865|521693746|FG000|Maintenance Period|Death|0|||
144684078|NCT01996865|521693747|FG001|Maintenance Period|Death|15|||
144684079|NCT01996865|521693748|FG002|Maintenance Period|Death|3|||
144684080|NCT01996865|521693746|FG000|Maintenance Period|Lost to Follow-up|0|||
144684081|NCT01996865|521693747|FG001|Maintenance Period|Lost to Follow-up|2|||
144684082|NCT01996865|521693748|FG002|Maintenance Period|Lost to Follow-up|0|||
144684083|NCT03733249|521693749|FG000|Overall Study|Death|7|||
144684084|NCT03733249|521693749|FG000|Overall Study|Disease relapse|16|||
144684085|NCT03733249|521693749|FG000|Overall Study|Lost to Follow-up|4|||
144684086|NCT03733249|521693749|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
144684087|NCT03733249|521693749|FG000|Overall Study|Withdrawal by Subject|1|||
144684088|NCT02750501|521693752|FG000|Overall Study|Adverse Event|4|||
144684089|NCT02750501|521693752|FG000|Overall Study|Physician Decision|1|||
144684090|NCT02750501|521693752|FG000|Overall Study|Protocol Violation|1|||
144684091|NCT02750501|521693752|FG000|Overall Study|G-tube came out|1|||
144684092|NCT02750501|521693752|FG000|Overall Study|Non-compliant use of PERT|1|||
144684093|NCT03685643|521693753|FG000|Overall Study|Lost to Follow-up|14|||
144684094|NCT03685643|521693754|FG001|Overall Study|Lost to Follow-up|22|||
144684095|NCT03797144|521693755|FG000|Enrollment|Protocol Violation|4|||
144684096|NCT03797144|521693756|FG001|Enrollment|Protocol Violation|1|||
144684097|NCT03797144|521693755|FG000|Surgery|Protocol Violation|1|||
144684098|NCT03797144|521693756|FG001|Surgery|Protocol Violation|0|||
144684099|NCT03797144|521693755|FG000|3 Month|Early termination cut-off date|2|||
144684100|NCT03797144|521693756|FG001|3 Month|Early termination cut-off date|0|||
144684101|NCT03797144|521693755|FG000|12 Month|Early termination cut-off date|8|||
144684102|NCT03797144|521693756|FG001|12 Month|Early termination cut-off date|9|||
144684103|NCT03797144|521693755|FG000|24 Month|Early termination cut-off date|1|||
144684104|NCT03797144|521693756|FG001|24 Month|Early termination cut-off date|1|||
144684105|NCT04430036|521693757|FG000|Safety Run in Phase|Progression of disease|2|||
144684106|NCT00376675|521693758|FG000|Overall Study|Withdrawal by Subject|9|||
144684107|NCT00376675|521693759|FG001|Overall Study|Withdrawal by Subject|2|||
144684108|NCT00376675|521693758|FG000|Overall Study|Adverse Event|10|||
144684109|NCT00376675|521693759|FG001|Overall Study|Adverse Event|5|||
144684110|NCT00376675|521693758|FG000|Overall Study|Other Reason|1|||
144684111|NCT00376675|521693759|FG001|Overall Study|Other Reason|7|||
144684112|NCT00423592|521693767|FG000|Overall Study|Adverse Event (through Week 12)|2|||
144684113|NCT00423592|521693767|FG000|Overall Study|Adverse Event (post Week 12)|5|||
144684114|NCT00002981|521693772|FG000|Overall Study|Inevaluable|6|||
144684115|NCT00255008|521693773|FG000|Overall Study|Adverse Event|1|||
144684116|NCT00255008|521693774|FG001|Overall Study|Adverse Event|1|||
144684117|NCT00255008|521693775|FG002|Overall Study|Adverse Event|2|||
144684118|NCT00255008|521693776|FG003|Overall Study|Adverse Event|0|||
144684119|NCT00255008|521693773|FG000|Overall Study|Lost to Follow-up|1|||
144684120|NCT00255008|521693774|FG001|Overall Study|Lost to Follow-up|0|||
144738868|NCT00927069|521899259|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
144738869|NCT00927069|521899256|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
144738870|NCT00927069|521899257|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
144738871|NCT00927069|521899258|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
144738872|NCT00927069|521899259|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
144738873|NCT01913405|521899260|FG000|Overall Study|Withdrawal by Subject|1|||
144738874|NCT01913405|521899260|FG000|Overall Study|Adverse Event|1|||
144738875|NCT03261167|521899261|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
144738876|NCT03261167|521899262|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
144738877|NCT03261167|521899261|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
144738878|NCT03261167|521899262|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
144738879|NCT03261167|521899261|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
144738880|NCT03261167|521899262|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
144738881|NCT03261167|521899261|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
144738882|NCT03261167|521899262|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
144738883|NCT03261167|521899261|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
144738884|NCT03261167|521899262|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
144738885|NCT02645409|521899267|FG000|Overall Study|Withdrawal by Subject|3|||
144738886|NCT02645409|521899268|FG001|Overall Study|Withdrawal by Subject|0|||
144738887|NCT02645409|521899267|FG000|Overall Study|Physician Decision|1|||
144738888|NCT02645409|521899268|FG001|Overall Study|Physician Decision|0|||
144738889|NCT02089685|521899273|FG000|Overall Study|Adverse Event|1|||
144738890|NCT02089685|521899274|FG001|Overall Study|Adverse Event|0|||
144738891|NCT02089685|521899275|FG002|Overall Study|Adverse Event|0|||
144738892|NCT02089685|521899276|FG003|Overall Study|Adverse Event|0|||
144738893|NCT02089685|521899277|FG004|Overall Study|Adverse Event|1|||
144738894|NCT02089685|521899278|FG005|Overall Study|Adverse Event|0|||
144738895|NCT02089685|521899273|FG000|Overall Study|Clinical Progression|4|||
144738896|NCT02089685|521899274|FG001|Overall Study|Clinical Progression|0|||
144738897|NCT02089685|521899275|FG002|Overall Study|Clinical Progression|0|||
144738898|NCT02089685|521899276|FG003|Overall Study|Clinical Progression|5|||
144738899|NCT02089685|521899277|FG004|Overall Study|Clinical Progression|1|||
144738900|NCT02089685|521899278|FG005|Overall Study|Clinical Progression|2|||
144738901|NCT02089685|521899273|FG000|Overall Study|Excluded Medication|1|||
144738902|NCT02089685|521899274|FG001|Overall Study|Excluded Medication|0|||
144738903|NCT02089685|521899275|FG002|Overall Study|Excluded Medication|0|||
144738904|NCT02089685|521899276|FG003|Overall Study|Excluded Medication|11|||
144738905|NCT02089685|521899277|FG004|Overall Study|Excluded Medication|2|||
144738906|NCT02089685|521899278|FG005|Overall Study|Excluded Medication|1|||
144738907|NCT02089685|521899273|FG000|Overall Study|Progressive disease|13|||
144738908|NCT02089685|521899274|FG001|Overall Study|Progressive disease|10|||
144738909|NCT02089685|521899275|FG002|Overall Study|Progressive disease|3|||
144738910|NCT02089685|521899276|FG003|Overall Study|Progressive disease|51|||
144738911|NCT02089685|521899277|FG004|Overall Study|Progressive disease|17|||
144738912|NCT02089685|521899278|FG005|Overall Study|Progressive disease|12|||
144738913|NCT02089685|521899273|FG000|Overall Study|Follow up ended by sponsor|2|||
144738914|NCT02089685|521899274|FG001|Overall Study|Follow up ended by sponsor|2|||
144738915|NCT02089685|521899275|FG002|Overall Study|Follow up ended by sponsor|0|||
144738916|NCT02089685|521899276|FG003|Overall Study|Follow up ended by sponsor|70|||
144738917|NCT02089685|521899277|FG004|Overall Study|Follow up ended by sponsor|26|||
144738918|NCT02089685|521899278|FG005|Overall Study|Follow up ended by sponsor|26|||
144738919|NCT02089685|521899273|FG000|Overall Study|Withdrawal by Subject|0|||
144738920|NCT02089685|521899274|FG001|Overall Study|Withdrawal by Subject|2|||
144738921|NCT02089685|521899275|FG002|Overall Study|Withdrawal by Subject|0|||
144738922|NCT02089685|521899276|FG003|Overall Study|Withdrawal by Subject|8|||
144738923|NCT02089685|521899277|FG004|Overall Study|Withdrawal by Subject|1|||
144738924|NCT02089685|521899278|FG005|Overall Study|Withdrawal by Subject|1|||
144738925|NCT02089685|521899273|FG000|Overall Study|Status not recorded|1|||
144218392|NCT03404674|519992339|FG005|Overall Study|Behavioral Problems|0|||
144738926|NCT02089685|521899274|FG001|Overall Study|Status not recorded|0|||
144738927|NCT02089685|521899275|FG002|Overall Study|Status not recorded|0|||
144738928|NCT02089685|521899276|FG003|Overall Study|Status not recorded|0|||
144738929|NCT02089685|521899277|FG004|Overall Study|Status not recorded|1|||
144738930|NCT02089685|521899278|FG005|Overall Study|Status not recorded|0|||
144738931|NCT02089685|521899273|FG000|Overall Study|Death|0|||
144738932|NCT02089685|521899274|FG001|Overall Study|Death|0|||
144738933|NCT02089685|521899275|FG002|Overall Study|Death|0|||
144738934|NCT02089685|521899276|FG003|Overall Study|Death|7|||
144738935|NCT02089685|521899277|FG004|Overall Study|Death|2|||
144738936|NCT02089685|521899278|FG005|Overall Study|Death|5|||
144738937|NCT02089685|521899273|FG000|Overall Study|Lost to Follow-up|0|||
144738938|NCT02089685|521899274|FG001|Overall Study|Lost to Follow-up|0|||
144738939|NCT02089685|521899275|FG002|Overall Study|Lost to Follow-up|0|||
144738940|NCT02089685|521899276|FG003|Overall Study|Lost to Follow-up|1|||
144738941|NCT02089685|521899277|FG004|Overall Study|Lost to Follow-up|0|||
144738942|NCT02089685|521899278|FG005|Overall Study|Lost to Follow-up|0|||
144738943|NCT02089685|521899273|FG000|Overall Study|Physician Decision|0|||
144738944|NCT02089685|521899274|FG001|Overall Study|Physician Decision|0|||
144738945|NCT02089685|521899275|FG002|Overall Study|Physician Decision|0|||
144738946|NCT02089685|521899276|FG003|Overall Study|Physician Decision|0|||
144738947|NCT02089685|521899277|FG004|Overall Study|Physician Decision|0|||
144738948|NCT02089685|521899278|FG005|Overall Study|Physician Decision|4|||
144738949|NCT02089685|521899273|FG000|Overall Study|Screen failure|1|||
144738950|NCT02089685|521899274|FG001|Overall Study|Screen failure|0|||
144738951|NCT02089685|521899275|FG002|Overall Study|Screen failure|0|||
144738952|NCT02089685|521899276|FG003|Overall Study|Screen failure|0|||
144738953|NCT02089685|521899277|FG004|Overall Study|Screen failure|0|||
144738954|NCT02089685|521899278|FG005|Overall Study|Screen failure|0|||
144738955|NCT00505622|521899286|FG000|Overall Study|Adverse Event|5|||
144738956|NCT00505622|521899287|FG001|Overall Study|Adverse Event|6|||
144738957|NCT00505622|521899288|FG002|Overall Study|Adverse Event|4|||
144738958|NCT00505622|521899286|FG000|Overall Study|Protocol Violation|1|||
144738959|NCT00505622|521899287|FG001|Overall Study|Protocol Violation|1|||
144738960|NCT00505622|521899288|FG002|Overall Study|Protocol Violation|0|||
144738961|NCT00505622|521899286|FG000|Overall Study|Withdrawal by Subject|0|||
144738962|NCT00505622|521899287|FG001|Overall Study|Withdrawal by Subject|3|||
144738963|NCT00505622|521899288|FG002|Overall Study|Withdrawal by Subject|2|||
144738964|NCT00505622|521899286|FG000|Overall Study|Study termination by sponsor|115|||
144738965|NCT00505622|521899287|FG001|Overall Study|Study termination by sponsor|98|||
144738966|NCT00505622|521899288|FG002|Overall Study|Study termination by sponsor|90|||
144738967|NCT03084471|521899289|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
144738968|NCT03084471|521899289|FG000|Overall Study|Condition under investigation worsened|84|||
144738969|NCT03084471|521899289|FG000|Overall Study|Lack of therapeutic response|2|||
144738970|NCT03084471|521899289|FG000|Overall Study|Protocol Violation|1|||
144738971|NCT03084471|521899289|FG000|Overall Study|Adverse Event|73|||
144738972|NCT03084471|521899289|FG000|Overall Study|Withdrawal by Subject|12|||
144738973|NCT03084471|521899289|FG000|Overall Study|Disease relapse|181|||
144738974|NCT03084471|521899289|FG000|Overall Study|Subjective disease progression|359|||
144738975|NCT03084471|521899289|FG000|Overall Study|Other (as recorded)|33|||
144738976|NCT03084471|521899289|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
144738977|NCT01757392|521899294|FG000|Overall Study|Withdrawal by Subject|1|||
144738978|NCT01757392|521899294|FG000|Overall Study|Screen Fail|3|||
144738979|NCT01878292|521899303|FG000|Randomized|Protocol Violation|1|||
144738980|NCT01878292|521899304|FG001|Randomized|Protocol Violation|0|||
144738981|NCT01878292|521899305|FG002|Randomized|Protocol Violation|0|||
144738982|NCT01878292|521899303|FG000|Randomized|Lost to Follow-up|1|||
144738983|NCT01878292|521899304|FG001|Randomized|Lost to Follow-up|0|||
144738984|NCT01878292|521899305|FG002|Randomized|Lost to Follow-up|0|||
144738985|NCT01878292|521899303|FG000|Randomized|Adverse Event|1|||
144738986|NCT01878292|521899304|FG001|Randomized|Adverse Event|0|||
144738987|NCT01878292|521899305|FG002|Randomized|Adverse Event|0|||
144738988|NCT01878292|521899303|FG000|Double-blind Treatment Period|Other Reasons|2|||
144738989|NCT01878292|521899304|FG001|Double-blind Treatment Period|Other Reasons|0|||
144738990|NCT01878292|521899305|FG002|Double-blind Treatment Period|Other Reasons|0|||
144738991|NCT01878292|521899303|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
144738992|NCT01878292|521899304|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
144738993|NCT01878292|521899305|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
144738994|NCT01878292|521899303|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
144738995|NCT01878292|521899304|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
144738996|NCT01878292|521899305|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
144738997|NCT01878292|521899303|FG000|Double-blind Treatment Period|Protocol Violation|3|||
144738998|NCT01878292|521899304|FG001|Double-blind Treatment Period|Protocol Violation|4|||
144738999|NCT01878292|521899305|FG002|Double-blind Treatment Period|Protocol Violation|2|||
144739000|NCT01878292|521899303|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
144739001|NCT01878292|521899304|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
144739002|NCT01878292|521899305|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
144739003|NCT01878292|521899303|FG000|Double-blind Treatment Period|Adverse Event|4|||
144739004|NCT01878292|521899304|FG001|Double-blind Treatment Period|Adverse Event|9|||
144739005|NCT01878292|521899305|FG002|Double-blind Treatment Period|Adverse Event|8|||
144739006|NCT01878292|521899303|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
144739007|NCT01878292|521899304|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
144739008|NCT01878292|521899305|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
144739009|NCT00830024|521899308|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
144739010|NCT00830024|521899309|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
144739011|NCT02619682|521899310|FG000|Overall Study|Withdrawal by Subject|3|||
144739012|NCT02619682|521899310|FG000|Overall Study|Lack of Efficacy|8|||
144739013|NCT02619682|521899310|FG000|Overall Study|new secondary cancer|1|||
144739014|NCT02619682|521899310|FG000|Overall Study|post surgery complications|2|||
144739015|NCT02358538|521899311|FG000|Through Week 26|Adverse Event|0|||
144739016|NCT02358538|521899312|FG001|Through Week 26|Adverse Event|1|||
144739017|NCT02358538|521899313|FG002|Through Week 26|Adverse Event|1|||
144265878|NCT03638128|520176406|FG001|Overall Study|Sponsor Decision|12|||
144684121|NCT00255008|521693775|FG002|Overall Study|Lost to Follow-up|1|||
144684122|NCT00255008|521693776|FG003|Overall Study|Lost to Follow-up|2|||
144684123|NCT00255008|521693773|FG000|Overall Study|Did not meet viral reduction criteria|4|||
144684124|NCT00255008|521693774|FG001|Overall Study|Did not meet viral reduction criteria|5|||
144684125|NCT00255008|521693775|FG002|Overall Study|Did not meet viral reduction criteria|0|||
144684126|NCT00255008|521693776|FG003|Overall Study|Did not meet viral reduction criteria|1|||
144684127|NCT00255008|521693773|FG000|Overall Study|Withdrew consent|0|||
144684128|NCT00255008|521693774|FG001|Overall Study|Withdrew consent|0|||
144684129|NCT00255008|521693775|FG002|Overall Study|Withdrew consent|2|||
144684130|NCT00255008|521693776|FG003|Overall Study|Withdrew consent|0|||
144684131|NCT00255008|521693773|FG000|Overall Study|Sponsor request|18|||
144684132|NCT00255008|521693774|FG001|Overall Study|Sponsor request|3|||
144684133|NCT00255008|521693775|FG002|Overall Study|Sponsor request|8|||
144684134|NCT00255008|521693776|FG003|Overall Study|Sponsor request|17|||
144684135|NCT00255008|521693773|FG000|Overall Study|Adverse lab experience|1|||
144684136|NCT00255008|521693774|FG001|Overall Study|Adverse lab experience|0|||
144684137|NCT00255008|521693775|FG002|Overall Study|Adverse lab experience|0|||
144684138|NCT00255008|521693776|FG003|Overall Study|Adverse lab experience|0|||
144684139|NCT00255008|521693773|FG000|Overall Study|Other|7|||
144684140|NCT00255008|521693774|FG001|Overall Study|Other|0|||
144684141|NCT00255008|521693775|FG002|Overall Study|Other|3|||
144684142|NCT00255008|521693776|FG003|Overall Study|Other|2|||
144684143|NCT01833806|521693780|FG000|Overall Study|Alternative treatment|2|||
144684144|NCT01833806|521693780|FG000|Overall Study|Death|5|||
144684145|NCT01833806|521693780|FG000|Overall Study|Physician Decision|1|||
144684146|NCT01833806|521693780|FG000|Overall Study|Lost to Follow-up|1|||
144684147|NCT03457636|521693781|FG000|Overall Study|Lost to Follow-up|2|||
144684148|NCT05083949|521693782|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
144684149|NCT05083949|521693783|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
144684150|NCT05083949|521693782|FG000|Period 1|Adverse Event|1|||
144684151|NCT05083949|521693783|FG001|Period 1|Adverse Event|1|||
144684152|NCT05083949|521693782|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
144684153|NCT05083949|521693783|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
144684154|NCT05083949|521693782|FG000|Period 2|Adverse Event|0|||
144684155|NCT05083949|521693783|FG001|Period 2|Adverse Event|2|||
144684156|NCT00707486|521693788|FG000|Overall Study|Withdrawal by Subject|1|||
144684157|NCT01885104|521693795|FG000|Overall Study|Withdrawal of Consent|1|||
144684158|NCT01885104|521693796|FG001|Overall Study|Withdrawal of Consent|0|||
144684159|NCT01885104|521693795|FG000|Overall Study|Lost to Follow-up|0|||
144684160|NCT01885104|521693796|FG001|Overall Study|Lost to Follow-up|1|||
144684161|NCT01885104|521693795|FG000|Overall Study|Physician Decision|1|||
144684162|NCT01885104|521693796|FG001|Overall Study|Physician Decision|0|||
144684163|NCT04350372|521693800|FG000|Overall Study|Death|1|||
144684164|NCT04474366|521693801|FG000|Overall Study|Lost to Follow-up|2|||
144684165|NCT04474366|521693802|FG001|Overall Study|Lost to Follow-up|5|||
144684166|NCT00320190|521693803|FG000|First 12 Months|Completed but did not enter extension|5|||
144684167|NCT00320190|521693804|FG001|First 12 Months|Completed but did not enter extension|3|||
144684168|NCT00320190|521693803|FG000|First 12 Months|Sponsor terminated study|2|||
144684169|NCT00320190|521693804|FG001|First 12 Months|Sponsor terminated study|2|||
144684170|NCT00320190|521693803|FG000|First 12 Months|Lost to Follow-up|0|||
144684171|NCT00320190|521693804|FG001|First 12 Months|Lost to Follow-up|1|||
144684172|NCT00320190|521693803|FG000|First 12 Months|Enrollment failure|0|||
144684173|NCT00320190|521693804|FG001|First 12 Months|Enrollment failure|1|||
144684174|NCT00320190|521693803|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
144684175|NCT00320190|521693804|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
144684176|NCT00320190|521693803|FG000|First 12 Months|Investigator request|0|||
144684177|NCT00320190|521693804|FG001|First 12 Months|Investigator request|1|||
144684178|NCT00320190|521693803|FG000|First 12 Months|Study drug toxicity|0|||
144684179|NCT00320190|521693804|FG001|First 12 Months|Study drug toxicity|1|||
144684180|NCT00320190|521693803|FG000|First 12 Months|Withdrawal by Subject|0|||
144684181|NCT00320190|521693804|FG001|First 12 Months|Withdrawal by Subject|1|||
144684182|NCT00320190|521693803|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
144684183|NCT00320190|521693804|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
144684184|NCT00320190|521693803|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
144684185|NCT00320190|521693804|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
144684186|NCT00320190|521693803|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
144684187|NCT00320190|521693804|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
144684188|NCT05307523|521693806|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
144265879|NCT03638128|520176407|FG002|Overall Study|Sponsor Decision|19|||
144684189|NCT05307523|521693807|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
144684190|NCT05307523|521693806|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
144684191|NCT05307523|521693807|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
144684192|NCT04412668|521693810|FG000|Overall Study|Death - multiple comorbidities|2|||
144684193|NCT04412668|521693811|FG001|Overall Study|Death - multiple comorbidities|0|||
144739018|NCT02358538|521899314|FG003|Through Week 26|Adverse Event|2|||
144684194|NCT04412668|521693812|FG002|Overall Study|Death - multiple comorbidities|0|||
144684195|NCT04412668|521693810|FG000|Overall Study|Withdrawal by Subject|3|||
144684196|NCT04412668|521693811|FG001|Overall Study|Withdrawal by Subject|0|||
144684197|NCT04412668|521693812|FG002|Overall Study|Withdrawal by Subject|0|||
144684198|NCT04412668|521693810|FG000|Overall Study|Other than Specified|2|||
144684199|NCT04412668|521693811|FG001|Overall Study|Other than Specified|0|||
144684200|NCT04412668|521693812|FG002|Overall Study|Other than Specified|0|||
144684201|NCT00102804|521693813|FG000|Overall Study|Progressive Disease (PD)|307|||
144684202|NCT00102804|521693814|FG001|Overall Study|Progressive Disease (PD)|196|||
144684203|NCT00102804|521693813|FG000|Overall Study|Withdrawal by Subject|46|||
144684204|NCT00102804|521693814|FG001|Overall Study|Withdrawal by Subject|7|||
144684205|NCT00102804|521693813|FG000|Overall Study|Adverse Event|37|||
144684206|NCT00102804|521693814|FG001|Overall Study|Adverse Event|3|||
144684207|NCT00102804|521693813|FG000|Overall Study|Physician Decision|24|||
144684208|NCT00102804|521693814|FG001|Overall Study|Physician Decision|6|||
144684209|NCT00102804|521693813|FG000|Overall Study|Death|5|||
144684210|NCT00102804|521693814|FG001|Overall Study|Death|6|||
144684211|NCT00102804|521693813|FG000|Overall Study|Enrollment Criteria Not Met|6|||
144684212|NCT00102804|521693814|FG001|Overall Study|Enrollment Criteria Not Met|0|||
144684213|NCT00102804|521693813|FG000|Overall Study|Lost to Follow-up|4|||
144684214|NCT00102804|521693814|FG001|Overall Study|Lost to Follow-up|1|||
144684215|NCT00102804|521693813|FG000|Overall Study|Protocol Violation|2|||
144684216|NCT00102804|521693814|FG001|Overall Study|Protocol Violation|1|||
144684217|NCT00102804|521693813|FG000|Overall Study|Satisfactory Response|2|||
144684218|NCT00102804|521693814|FG001|Overall Study|Satisfactory Response|0|||
144684219|NCT00102804|521693813|FG000|Overall Study|Sponsor Decision|1|||
144684220|NCT00102804|521693814|FG001|Overall Study|Sponsor Decision|0|||
144684221|NCT00102804|521693813|FG000|Overall Study|Alive, Receiving Treatment|7|||
144684222|NCT00102804|521693814|FG001|Overall Study|Alive, Receiving Treatment|2|||
144684223|NCT02299206|521693819|FG000|Overall Study|Lost to Follow-up|1|||
144684224|NCT02299206|521693819|FG000|Overall Study|Withdrawal by Subject|1|||
144684225|NCT00683774|521693820|FG000|Overall Study|Withdrawal by Subject|0|||
144684226|NCT00683774|521693821|FG001|Overall Study|Withdrawal by Subject|1|||
144684227|NCT00683774|521693820|FG000|Overall Study|Physician Decision|3|||
144684228|NCT00683774|521693821|FG001|Overall Study|Physician Decision|0|||
144684229|NCT02875366|521693822|FG000|Overall Study|Adverse Event|0|||
144684230|NCT02875366|521693823|FG001|Overall Study|Adverse Event|2|||
144684231|NCT02875366|521693822|FG000|Overall Study|Noncompliance|0|||
144684232|NCT02875366|521693823|FG001|Overall Study|Noncompliance|1|||
144684233|NCT00691054|521693824|FG000|Overall Study|Withdrawal by Subject|1|||
144684234|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
144684235|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144684236|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144684237|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144684238|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144684239|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
144684240|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
144684241|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144684242|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144684243|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144684244|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144684245|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
144684246|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
144684247|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144684248|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144684249|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144684250|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144684251|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
144684252|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Other|14|||
144684253|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Other|0|||
144684254|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Other|0|||
144684255|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Other|0|||
144684256|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Other|0|||
144684257|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Other|0|||
144684258|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
144684259|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
144684260|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
144684261|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
144684262|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
144684263|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
144684264|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
144684265|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144684266|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144684267|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144684268|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144684269|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
144684270|NCT02141854|521693826|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
144684271|NCT02141854|521693827|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144684272|NCT02141854|521693828|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144684273|NCT02141854|521693829|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144684274|NCT02141854|521693830|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144684275|NCT02141854|521693831|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
144684276|NCT02141854|521693826|FG000|Treatment Period|Protocol Violation|0|||
144684277|NCT02141854|521693827|FG001|Treatment Period|Protocol Violation|1|||
144684278|NCT02141854|521693828|FG002|Treatment Period|Protocol Violation|0|||
144684279|NCT02141854|521693829|FG003|Treatment Period|Protocol Violation|2|||
144684280|NCT02141854|521693830|FG004|Treatment Period|Protocol Violation|2|||
144684281|NCT02141854|521693831|FG005|Treatment Period|Protocol Violation|1|||
144684282|NCT02141854|521693826|FG000|Treatment Period|Noncompliance|0|||
144684283|NCT02141854|521693827|FG001|Treatment Period|Noncompliance|0|||
144684284|NCT02141854|521693828|FG002|Treatment Period|Noncompliance|0|||
144684285|NCT02141854|521693829|FG003|Treatment Period|Noncompliance|1|||
144684286|NCT02141854|521693830|FG004|Treatment Period|Noncompliance|0|||
144684287|NCT02141854|521693831|FG005|Treatment Period|Noncompliance|0|||
144684288|NCT02141854|521693826|FG000|Treatment Period|Lack of Efficacy|0|||
144684289|NCT02141854|521693827|FG001|Treatment Period|Lack of Efficacy|0|||
144684290|NCT02141854|521693828|FG002|Treatment Period|Lack of Efficacy|0|||
144684291|NCT02141854|521693829|FG003|Treatment Period|Lack of Efficacy|1|||
144684292|NCT02141854|521693830|FG004|Treatment Period|Lack of Efficacy|1|||
144684293|NCT02141854|521693831|FG005|Treatment Period|Lack of Efficacy|7|||
144684294|NCT02141854|521693826|FG000|Treatment Period|Pregnancy|0|||
144684295|NCT02141854|521693827|FG001|Treatment Period|Pregnancy|1|||
144684296|NCT02141854|521693828|FG002|Treatment Period|Pregnancy|0|||
144684297|NCT02141854|521693829|FG003|Treatment Period|Pregnancy|0|||
144684298|NCT02141854|521693830|FG004|Treatment Period|Pregnancy|0|||
144684299|NCT02141854|521693831|FG005|Treatment Period|Pregnancy|0|||
144684300|NCT02141854|521693826|FG000|Treatment Period|Other|0|||
144684301|NCT02141854|521693827|FG001|Treatment Period|Other|1|||
144684302|NCT02141854|521693828|FG002|Treatment Period|Other|2|||
144684303|NCT02141854|521693829|FG003|Treatment Period|Other|0|||
144684304|NCT02141854|521693830|FG004|Treatment Period|Other|1|||
144684305|NCT02141854|521693831|FG005|Treatment Period|Other|2|||
144684306|NCT02141854|521693826|FG000|Treatment Period|Adverse Event|0|||
144684307|NCT02141854|521693827|FG001|Treatment Period|Adverse Event|2|||
144684308|NCT02141854|521693828|FG002|Treatment Period|Adverse Event|2|||
144684309|NCT02141854|521693829|FG003|Treatment Period|Adverse Event|0|||
144684310|NCT02141854|521693830|FG004|Treatment Period|Adverse Event|2|||
144684311|NCT02141854|521693831|FG005|Treatment Period|Adverse Event|2|||
144684312|NCT02141854|521693826|FG000|Treatment Period|Withdrawal by Subject|0|||
144684313|NCT02141854|521693827|FG001|Treatment Period|Withdrawal by Subject|2|||
144684314|NCT02141854|521693828|FG002|Treatment Period|Withdrawal by Subject|3|||
144684315|NCT02141854|521693829|FG003|Treatment Period|Withdrawal by Subject|3|||
144684316|NCT02141854|521693830|FG004|Treatment Period|Withdrawal by Subject|4|||
144684317|NCT02141854|521693831|FG005|Treatment Period|Withdrawal by Subject|7|||
144684318|NCT02141854|521693826|FG000|Treatment Period|Disease progression|0|||
144684319|NCT02141854|521693827|FG001|Treatment Period|Disease progression|2|||
144684320|NCT02141854|521693828|FG002|Treatment Period|Disease progression|1|||
144684321|NCT02141854|521693829|FG003|Treatment Period|Disease progression|3|||
144684322|NCT02141854|521693830|FG004|Treatment Period|Disease progression|0|||
144684323|NCT02141854|521693831|FG005|Treatment Period|Disease progression|18|||
144684324|NCT02141854|521693826|FG000|Treatment Period|Lost to Follow-up|0|||
144684325|NCT02141854|521693827|FG001|Treatment Period|Lost to Follow-up|1|||
144684326|NCT02141854|521693828|FG002|Treatment Period|Lost to Follow-up|1|||
144684327|NCT02141854|521693829|FG003|Treatment Period|Lost to Follow-up|1|||
144684328|NCT02141854|521693830|FG004|Treatment Period|Lost to Follow-up|0|||
144684329|NCT02141854|521693831|FG005|Treatment Period|Lost to Follow-up|1|||
144684330|NCT01868594|521693832|FG000|Overall Study|Do not meet inclusion criteria|4|||
144684331|NCT01868594|521693833|FG001|Overall Study|Do not meet inclusion criteria|3|||
144684332|NCT01201967|521693836|FG000|Overall Study|Lost to Follow-up|6|||
144684333|NCT01201967|521693837|FG001|Overall Study|Lost to Follow-up|5|||
144684334|NCT02116361|521693840|FG000|Overall Study|Pregnancy|0|||
144739019|NCT02358538|521899311|FG000|Through Week 26|Lack of Efficacy|1|||
144684335|NCT02116361|521693841|FG001|Overall Study|Pregnancy|0|||
144684336|NCT02116361|521693842|FG002|Overall Study|Pregnancy|0|||
144684337|NCT02116361|521693843|FG003|Overall Study|Pregnancy|1|||
144684338|NCT02116361|521693840|FG000|Overall Study|Protocol Violation|1|||
144684339|NCT02116361|521693841|FG001|Overall Study|Protocol Violation|0|||
144684340|NCT02116361|521693842|FG002|Overall Study|Protocol Violation|0|||
144684341|NCT02116361|521693843|FG003|Overall Study|Protocol Violation|2|||
144684342|NCT02116361|521693840|FG000|Overall Study|Physician Decision|2|||
144684343|NCT02116361|521693841|FG001|Overall Study|Physician Decision|3|||
144739020|NCT02358538|521899312|FG001|Through Week 26|Lack of Efficacy|1|||
144739021|NCT02358538|521899313|FG002|Through Week 26|Lack of Efficacy|3|||
144739022|NCT02358538|521899314|FG003|Through Week 26|Lack of Efficacy|3|||
144739023|NCT02358538|521899311|FG000|Through Week 26|Withdrawal by Subject|1|||
144684344|NCT02116361|521693842|FG002|Overall Study|Physician Decision|0|||
144684345|NCT02116361|521693843|FG003|Overall Study|Physician Decision|0|||
144684346|NCT02116361|521693840|FG000|Overall Study|Adverse Event|1|||
144684347|NCT02116361|521693841|FG001|Overall Study|Adverse Event|0|||
144684348|NCT02116361|521693842|FG002|Overall Study|Adverse Event|0|||
144684349|NCT02116361|521693843|FG003|Overall Study|Adverse Event|3|||
144684350|NCT02116361|521693840|FG000|Overall Study|Other Reasons|3|||
144684351|NCT02116361|521693841|FG001|Overall Study|Other Reasons|3|||
144684352|NCT02116361|521693842|FG002|Overall Study|Other Reasons|3|||
144684353|NCT02116361|521693843|FG003|Overall Study|Other Reasons|3|||
144684354|NCT02116361|521693840|FG000|Overall Study|Lack of Efficacy|5|||
144684355|NCT02116361|521693841|FG001|Overall Study|Lack of Efficacy|7|||
144684356|NCT02116361|521693842|FG002|Overall Study|Lack of Efficacy|4|||
144684357|NCT02116361|521693843|FG003|Overall Study|Lack of Efficacy|3|||
144684358|NCT02116361|521693840|FG000|Overall Study|Lost to Follow-up|4|||
144684359|NCT02116361|521693841|FG001|Overall Study|Lost to Follow-up|5|||
144684360|NCT02116361|521693842|FG002|Overall Study|Lost to Follow-up|7|||
144684361|NCT02116361|521693843|FG003|Overall Study|Lost to Follow-up|5|||
144684362|NCT02116361|521693840|FG000|Overall Study|Personal Reasons|6|||
144684363|NCT02116361|521693841|FG001|Overall Study|Personal Reasons|6|||
144684364|NCT02116361|521693842|FG002|Overall Study|Personal Reasons|4|||
144684365|NCT02116361|521693843|FG003|Overall Study|Personal Reasons|9|||
144684366|NCT02116361|521693840|FG000|Overall Study|Investigator Decision - Relapse|9|||
144684367|NCT02116361|521693841|FG001|Overall Study|Investigator Decision - Relapse|7|||
144684368|NCT02116361|521693842|FG002|Overall Study|Investigator Decision - Relapse|8|||
144684369|NCT02116361|521693843|FG003|Overall Study|Investigator Decision - Relapse|5|||
144684370|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
144684371|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
144684372|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
144684373|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
144684374|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Other|13|||
144684375|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
144684376|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
144684377|NCT02497287|521693844|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
144684378|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
144684379|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
144684380|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
144684381|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
144684382|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
144684383|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
144684384|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
144684385|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
144684386|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
144684387|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
144684388|NCT02497287|521693844|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
144684389|NCT02497287|521693844|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
144684390|NCT02497287|521693844|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
144684391|NCT02497287|521693844|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
144684392|NCT02497287|521693844|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
144684393|NCT02497287|521693844|FG000|Follow-up Phase (4 Week)|Other|1|||
144684394|NCT02659098|521693845|FG000|Overall Study|Withdrawal by Subject|7|||
144684395|NCT04363944|521693846|FG000|Overall Study|Withdrawal by Subject|2|||
144684396|NCT04363944|521693847|FG001|Overall Study|Withdrawal by Subject|0|||
144684397|NCT01592773|521695248|FG000|Overall Study|Study Terminated by Sponsor|582|||
144684398|NCT01592773|521695248|FG000|Overall Study|Withdrawal by Subject|35|||
144684399|NCT01592773|521695248|FG000|Overall Study|Lost to Follow-up|19|||
144684400|NCT01592773|521695248|FG000|Overall Study|Adverse Event|17|||
144684401|NCT01592773|521695248|FG000|Overall Study|Lack of Efficacy|9|||
144684402|NCT01592773|521695248|FG000|Overall Study|Protocol Violation|2|||
144684403|NCT01592773|521695248|FG000|Overall Study|Inclusion/exclusion not meet|1|||
144684404|NCT01592773|521695248|FG000|Overall Study|Other Reason|1|||
144684405|NCT04418427|521695250|FG000|Overall Study|Death|0|||
144684406|NCT04418427|521695251|FG001|Overall Study|Death|1|||
144684407|NCT04418427|521695252|FG002|Overall Study|Death|0|||
144684408|NCT04418427|521695250|FG000|Overall Study|Lost to Follow-up|0|||
144739024|NCT02358538|521899312|FG001|Through Week 26|Withdrawal by Subject|0|||
144684409|NCT04418427|521695251|FG001|Overall Study|Lost to Follow-up|2|||
144684410|NCT04418427|521695252|FG002|Overall Study|Lost to Follow-up|2|||
144684411|NCT04418427|521695250|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
144684412|NCT04418427|521695251|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
144739025|NCT02358538|521899313|FG002|Through Week 26|Withdrawal by Subject|0|||
144739026|NCT02358538|521899314|FG003|Through Week 26|Withdrawal by Subject|0|||
144739027|NCT02358538|521899311|FG000|Through Week 26|Non-Compliance|0|||
144739028|NCT02358538|521899312|FG001|Through Week 26|Non-Compliance|0|||
144739029|NCT02358538|521899313|FG002|Through Week 26|Non-Compliance|1|||
144739030|NCT02358538|521899314|FG003|Through Week 26|Non-Compliance|0|||
144739031|NCT02358538|521899311|FG000|Through Week 26|Family did not see benefit from IP|1|||
144739032|NCT02358538|521899312|FG001|Through Week 26|Family did not see benefit from IP|0|||
144739033|NCT02358538|521899313|FG002|Through Week 26|Family did not see benefit from IP|0|||
144739034|NCT02358538|521899314|FG003|Through Week 26|Family did not see benefit from IP|0|||
144739035|NCT02358538|521899311|FG000|52 Week Extension Period|Lack of Efficacy|0|||
144739036|NCT02358538|521899312|FG001|52 Week Extension Period|Lack of Efficacy|0|||
144739037|NCT02358538|521899313|FG002|52 Week Extension Period|Lack of Efficacy|2|||
144739038|NCT02358538|521899314|FG003|52 Week Extension Period|Lack of Efficacy|4|||
144739039|NCT06999265|521899315|FG000|Overall Study|Lost to Follow-up|1|||
144739040|NCT06999265|521899316|FG001|Overall Study|Lost to Follow-up|1|||
144739041|NCT00730691|521899317|FG000|Overall Study|Adverse Event|4|||
144739042|NCT00730691|521899318|FG001|Overall Study|Adverse Event|8|||
144739043|NCT00730691|521899319|FG002|Overall Study|Adverse Event|11|||
144739044|NCT00730691|521899320|FG003|Overall Study|Adverse Event|11|||
144739045|NCT00730691|521899321|FG004|Overall Study|Adverse Event|23|||
144739046|NCT00730691|521899317|FG000|Overall Study|Lack of Efficacy|4|||
144739047|NCT00730691|521899318|FG001|Overall Study|Lack of Efficacy|4|||
144739048|NCT00730691|521899319|FG002|Overall Study|Lack of Efficacy|2|||
144739049|NCT00730691|521899320|FG003|Overall Study|Lack of Efficacy|1|||
144739050|NCT00730691|521899321|FG004|Overall Study|Lack of Efficacy|1|||
144739051|NCT00730691|521899317|FG000|Overall Study|Non-compliance with Study Drug|6|||
144739052|NCT00730691|521899318|FG001|Overall Study|Non-compliance with Study Drug|1|||
144739053|NCT00730691|521899319|FG002|Overall Study|Non-compliance with Study Drug|6|||
144739054|NCT00730691|521899320|FG003|Overall Study|Non-compliance with Study Drug|3|||
144739055|NCT00730691|521899321|FG004|Overall Study|Non-compliance with Study Drug|3|||
144739056|NCT00730691|521899317|FG000|Overall Study|Protocol Deviations|3|||
144739057|NCT00730691|521899318|FG001|Overall Study|Protocol Deviations|5|||
144739058|NCT00730691|521899319|FG002|Overall Study|Protocol Deviations|3|||
144684413|NCT04418427|521695252|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
144684414|NCT04418427|521695250|FG000|Overall Study|Pre-existing medical condition|0|||
144684415|NCT04418427|521695251|FG001|Overall Study|Pre-existing medical condition|1|||
144684416|NCT04418427|521695252|FG002|Overall Study|Pre-existing medical condition|0|||
144684417|NCT04076579|521695259|FG000|Overall Study|Adverse Event|2|||
144684418|NCT04076579|521695260|FG001|Overall Study|Adverse Event|0|||
144684419|NCT04076579|521695259|FG000|Overall Study|discontinued due to toxicity|1|||
144684420|NCT04076579|521695260|FG001|Overall Study|discontinued due to toxicity|0|||
144684421|NCT04076579|521695259|FG000|Overall Study|Physician Decision|1|||
144684422|NCT04076579|521695260|FG001|Overall Study|Physician Decision|0|||
144684423|NCT04076579|521695259|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
144684424|NCT04076579|521695260|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
144684425|NCT04076579|521695259|FG000|Overall Study|Noncompliance|0|||
144684426|NCT04076579|521695260|FG001|Overall Study|Noncompliance|1|||
144684427|NCT04076579|521695259|FG000|Overall Study|Withdrawal by Subject|0|||
144684428|NCT04076579|521695260|FG001|Overall Study|Withdrawal by Subject|2|||
144684429|NCT03793010|521695261|FG000|Overall Study|Withdrawal by Subject|5|||
144684430|NCT03793010|521695262|FG001|Overall Study|Withdrawal by Subject|7|||
144684431|NCT03793010|521695261|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
144684432|NCT03793010|521695262|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
144684433|NCT03793010|521695261|FG000|Overall Study|Lost to Follow-up|1|||
144684434|NCT03793010|521695262|FG001|Overall Study|Lost to Follow-up|2|||
144684435|NCT03793010|521695261|FG000|Overall Study|Patient couldn't sit still for injection|1|||
144684436|NCT03793010|521695262|FG001|Overall Study|Patient couldn't sit still for injection|0|||
144684437|NCT03793010|521695261|FG000|Overall Study|Withdrew to pursue other treatment|1|||
144684438|NCT03793010|521695262|FG001|Overall Study|Withdrew to pursue other treatment|0|||
144684439|NCT03793010|521695261|FG000|Overall Study|Did not meet eligibility criteria|1|||
144739059|NCT00730691|521899320|FG003|Overall Study|Protocol Deviations|7|||
144739060|NCT00730691|521899321|FG004|Overall Study|Protocol Deviations|5|||
144739061|NCT00730691|521899317|FG000|Overall Study|Withdrawal of Consent|7|||
144684440|NCT03793010|521695262|FG001|Overall Study|Did not meet eligibility criteria|0|||
144684441|NCT00186121|521695268|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
144684442|NCT00186121|521695268|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
144739062|NCT00730691|521899318|FG001|Overall Study|Withdrawal of Consent|9|||
144739063|NCT00730691|521899319|FG002|Overall Study|Withdrawal of Consent|3|||
144739064|NCT00730691|521899320|FG003|Overall Study|Withdrawal of Consent|6|||
144739065|NCT00730691|521899321|FG004|Overall Study|Withdrawal of Consent|3|||
144739066|NCT00730691|521899317|FG000|Overall Study|Lost to Follow-up|11|||
144739067|NCT00730691|521899318|FG001|Overall Study|Lost to Follow-up|8|||
144739068|NCT00730691|521899319|FG002|Overall Study|Lost to Follow-up|13|||
144739069|NCT00730691|521899320|FG003|Overall Study|Lost to Follow-up|15|||
144739070|NCT00730691|521899321|FG004|Overall Study|Lost to Follow-up|13|||
144739071|NCT00730691|521899317|FG000|Overall Study|Other|1|||
144684443|NCT00186121|521695268|FG000|Overall Study|Not eligible (no treatment)|1|||
144684444|NCT01370499|521695269|FG000|Overall Study|Adverse Event|38|||
144684445|NCT01370499|521695270|FG001|Overall Study|Adverse Event|12|||
144684446|NCT01370499|521695269|FG000|Overall Study|Lack of Efficacy|4|||
144684447|NCT01370499|521695270|FG001|Overall Study|Lack of Efficacy|2|||
144684448|NCT01370499|521695269|FG000|Overall Study|Lost to Follow-up|2|||
144684449|NCT01370499|521695270|FG001|Overall Study|Lost to Follow-up|1|||
144684450|NCT01370499|521695269|FG000|Overall Study|Physician Decision|3|||
144684451|NCT01370499|521695270|FG001|Overall Study|Physician Decision|3|||
144684452|NCT01370499|521695269|FG000|Overall Study|Protocol Violation|5|||
144684453|NCT01370499|521695270|FG001|Overall Study|Protocol Violation|4|||
144684454|NCT01370499|521695269|FG000|Overall Study|Withdrawal by Subject|18|||
144684455|NCT01370499|521695270|FG001|Overall Study|Withdrawal by Subject|7|||
144684456|NCT01370499|521695269|FG000|Overall Study|Sponsor Decision|41|||
144684457|NCT01370499|521695270|FG001|Overall Study|Sponsor Decision|15|||
144684458|NCT00887822|521695271|FG000|Overall Study|Insufficient therapeutic response|53|||
144684459|NCT00887822|521695272|FG001|Overall Study|Insufficient therapeutic response|55|||
144684460|NCT00887822|521695271|FG000|Overall Study|Adverse Event|14|||
144684461|NCT00887822|521695272|FG001|Overall Study|Adverse Event|17|||
144684462|NCT00887822|521695271|FG000|Overall Study|Failure to return|11|||
144684463|NCT00887822|521695272|FG001|Overall Study|Failure to return|11|||
144684464|NCT00887822|521695271|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
144684465|NCT00887822|521695272|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
144684466|NCT00887822|521695271|FG000|Overall Study|Administrative/Other than specified|5|||
144684467|NCT00887822|521695272|FG001|Overall Study|Administrative/Other than specified|4|||
144684468|NCT00887822|521695271|FG000|Overall Study|Death|2|||
144684469|NCT00887822|521695272|FG001|Overall Study|Death|3|||
144684470|NCT00887822|521695271|FG000|Overall Study|Protocol Violation|0|||
144684471|NCT00887822|521695272|FG001|Overall Study|Protocol Violation|1|||
144684472|NCT00887822|521695271|FG000|Overall Study|Randomized but not treated|0|||
144684473|NCT00887822|521695272|FG001|Overall Study|Randomized but not treated|1|||
144684474|NCT05815758|521695273|FG000|Overall Study|Adverse Event|6|||
144684475|NCT05815758|521695274|FG001|Overall Study|Adverse Event|2|||
144684476|NCT05815758|521695273|FG000|Overall Study|Lost to Follow-up|14|||
144684477|NCT05815758|521695274|FG001|Overall Study|Lost to Follow-up|1|||
144684478|NCT05815758|521695273|FG000|Overall Study|Withdrawal by Subject|6|||
144684479|NCT05815758|521695274|FG001|Overall Study|Withdrawal by Subject|6|||
144684480|NCT05815758|521695273|FG000|Overall Study|Protocol Violation|1|||
144684481|NCT05815758|521695274|FG001|Overall Study|Protocol Violation|1|||
144684482|NCT05815758|521695273|FG000|Overall Study|Discontinued|4|||
144684483|NCT05815758|521695274|FG001|Overall Study|Discontinued|4|||
144684484|NCT04124952|521695275|FG000|Overall Study|Lost to Follow-up|1|||
144684485|NCT03261037|521695279|FG000|Overall Study|Withdrawal by Subject|2|||
144684486|NCT03261037|521695280|FG001|Overall Study|Withdrawal by Subject|13|||
144684487|NCT03261037|521695281|FG002|Overall Study|Withdrawal by Subject|0|||
144684488|NCT03261037|521695282|FG003|Overall Study|Withdrawal by Subject|18|||
144684489|NCT03261037|521695279|FG000|Overall Study|Non-compliance with study procedures|0|||
144684490|NCT03261037|521695280|FG001|Overall Study|Non-compliance with study procedures|2|||
144684491|NCT03261037|521695281|FG002|Overall Study|Non-compliance with study procedures|0|||
144684492|NCT03261037|521695282|FG003|Overall Study|Non-compliance with study procedures|6|||
144684493|NCT03261037|521695279|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
144684494|NCT03261037|521695280|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
144684495|NCT03261037|521695281|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
144684496|NCT03261037|521695282|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
144684497|NCT03261037|521695279|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
144684498|NCT03261037|521695280|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
144684499|NCT03261037|521695281|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
144684500|NCT03261037|521695282|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
144684501|NCT03261037|521695279|FG000|Overall Study|Diagnosed but protocol deviation|1|||
144684502|NCT03261037|521695280|FG001|Overall Study|Diagnosed but protocol deviation|0|||
144684503|NCT03261037|521695281|FG002|Overall Study|Diagnosed but protocol deviation|0|||
144684504|NCT03261037|521695282|FG003|Overall Study|Diagnosed but protocol deviation|0|||
144684505|NCT03261037|521695279|FG000|Overall Study|Participant did not want to continue the study|0|||
144684506|NCT03261037|521695280|FG001|Overall Study|Participant did not want to continue the study|1|||
144684507|NCT03261037|521695281|FG002|Overall Study|Participant did not want to continue the study|0|||
144684508|NCT03261037|521695282|FG003|Overall Study|Participant did not want to continue the study|0|||
144739072|NCT00730691|521899318|FG001|Overall Study|Other|1|||
144739073|NCT00730691|521899319|FG002|Overall Study|Other|1|||
144265880|NCT03638128|520176405|FG000|Overall Study|Lost to Follow-up|0|||
144684509|NCT03261037|521695279|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
144739074|NCT00730691|521899320|FG003|Overall Study|Other|2|||
144684510|NCT03261037|521695280|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
144684511|NCT03261037|521695281|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
144684512|NCT03261037|521695282|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
144684513|NCT03261037|521695279|FG000|Overall Study|Participant presented clinical improvement|0|||
144684514|NCT03261037|521695280|FG001|Overall Study|Participant presented clinical improvement|2|||
144684515|NCT03261037|521695281|FG002|Overall Study|Participant presented clinical improvement|0|||
144684516|NCT03261037|521695282|FG003|Overall Study|Participant presented clinical improvement|0|||
144684517|NCT03261037|521695279|FG000|Overall Study|Technical difficulties|0|||
144684518|NCT03261037|521695280|FG001|Overall Study|Technical difficulties|0|||
144684519|NCT03261037|521695281|FG002|Overall Study|Technical difficulties|0|||
144684520|NCT03261037|521695282|FG003|Overall Study|Technical difficulties|1|||
144684521|NCT03261037|521695279|FG000|Overall Study|Equipment failed to work|0|||
144684522|NCT03261037|521695280|FG001|Overall Study|Equipment failed to work|0|||
144684523|NCT03261037|521695281|FG002|Overall Study|Equipment failed to work|0|||
144684524|NCT03261037|521695282|FG003|Overall Study|Equipment failed to work|1|||
144684525|NCT03261037|521695279|FG000|Overall Study|End of study for participant and no follow up|0|||
144684526|NCT03261037|521695280|FG001|Overall Study|End of study for participant and no follow up|0|||
144684527|NCT03261037|521695281|FG002|Overall Study|End of study for participant and no follow up|0|||
144684528|NCT03261037|521695282|FG003|Overall Study|End of study for participant and no follow up|1|||
144684529|NCT03261037|521695279|FG000|Overall Study|Participant was too weak to continue in study|1|||
144684530|NCT03261037|521695280|FG001|Overall Study|Participant was too weak to continue in study|0|||
144684531|NCT03261037|521695281|FG002|Overall Study|Participant was too weak to continue in study|0|||
144684532|NCT03261037|521695282|FG003|Overall Study|Participant was too weak to continue in study|0|||
144684533|NCT01222767|521695287|FG000|Overall Study|Progressive disease|13|||
144684534|NCT01222767|521695287|FG000|Overall Study|Adverse Event|2|||
144684535|NCT01222767|521695287|FG000|Overall Study|Surgical resection|1|||
144684536|NCT01222767|521695287|FG000|Overall Study|Never treated|1|||
144684537|NCT00723489|521695288|FG000|Overall Study|Physician Decision|0|||
144684538|NCT00723489|521695289|FG001|Overall Study|Physician Decision|1|||
144684539|NCT00723489|521695290|FG002|Overall Study|Physician Decision|0|||
144684540|NCT00723489|521695291|FG003|Overall Study|Physician Decision|0|||
144684541|NCT00723489|521695288|FG000|Overall Study|Pregnancy|0|||
144684542|NCT00723489|521695289|FG001|Overall Study|Pregnancy|0|||
144684543|NCT00723489|521695290|FG002|Overall Study|Pregnancy|0|||
144684544|NCT00723489|521695291|FG003|Overall Study|Pregnancy|1|||
144684545|NCT00723489|521695288|FG000|Overall Study|Withdrawal by Subject|0|||
144684546|NCT00723489|521695289|FG001|Overall Study|Withdrawal by Subject|0|||
144684547|NCT00723489|521695290|FG002|Overall Study|Withdrawal by Subject|0|||
144684548|NCT00723489|521695291|FG003|Overall Study|Withdrawal by Subject|1|||
144684549|NCT00723489|521695288|FG000|Overall Study|Seropositive at baseline|1|||
144684550|NCT00723489|521695289|FG001|Overall Study|Seropositive at baseline|0|||
144684551|NCT00723489|521695290|FG002|Overall Study|Seropositive at baseline|0|||
144684552|NCT00723489|521695291|FG003|Overall Study|Seropositive at baseline|0|||
144684553|NCT00723489|521695288|FG000|Overall Study|Prohibited Medication|0|||
144684554|NCT00723489|521695289|FG001|Overall Study|Prohibited Medication|0|||
144684555|NCT00723489|521695290|FG002|Overall Study|Prohibited Medication|0|||
144684556|NCT00723489|521695291|FG003|Overall Study|Prohibited Medication|1|||
144684557|NCT00723489|521695288|FG000|Overall Study|Samples Collected Out of Window|0|||
144684558|NCT00723489|521695289|FG001|Overall Study|Samples Collected Out of Window|3|||
144684559|NCT00723489|521695290|FG002|Overall Study|Samples Collected Out of Window|0|||
144684560|NCT00723489|521695291|FG003|Overall Study|Samples Collected Out of Window|0|||
144684561|NCT02559115|521695292|FG000|Overall Study|Withdrawal by Subject|3|||
144684562|NCT02354690|521695299|FG000|Overall Study|Physician Decision|1|||
144684563|NCT05492877|521695304|FG000|Overall Study|Adverse Event|11|||
144684564|NCT05492877|521695305|FG001|Overall Study|Adverse Event|7|||
144684565|NCT05492877|521695304|FG000|Overall Study|Death|1|||
144684566|NCT05492877|521695305|FG001|Overall Study|Death|0|||
144684567|NCT05492877|521695304|FG000|Overall Study|Lost to Follow-up|1|||
144684568|NCT05492877|521695305|FG001|Overall Study|Lost to Follow-up|1|||
144684569|NCT05492877|521695304|FG000|Overall Study|Physician Decision|1|||
144684570|NCT05492877|521695305|FG001|Overall Study|Physician Decision|2|||
144684571|NCT05492877|521695304|FG000|Overall Study|Protocol Violation|1|||
144684572|NCT05492877|521695305|FG001|Overall Study|Protocol Violation|1|||
144684573|NCT05492877|521695304|FG000|Overall Study|Withdrawal by Subject|3|||
144684574|NCT05492877|521695305|FG001|Overall Study|Withdrawal by Subject|7|||
144265881|NCT03638128|520176406|FG001|Overall Study|Lost to Follow-up|0|||
144265882|NCT03638128|520176407|FG002|Overall Study|Lost to Follow-up|1|||
144684575|NCT05492877|521695304|FG000|Overall Study|Reason not specified|6|||
144684576|NCT05492877|521695305|FG001|Overall Study|Reason not specified|4|||
144684577|NCT00515099|521695307|FG000|Overall Study|Lost to Follow-up|0|||
144684578|NCT00515099|521695308|FG001|Overall Study|Lost to Follow-up|4|||
144684579|NCT00515099|521695307|FG000|Overall Study|Withdrawal by Subject|2|||
144684580|NCT00515099|521695308|FG001|Overall Study|Withdrawal by Subject|0|||
144684581|NCT00515099|521695307|FG000|Overall Study|IRB Recommendation|1|||
144739075|NCT00730691|521899321|FG004|Overall Study|Other|2|||
144739076|NCT02178787|521899322|FG000|Overall Study|Lost to Follow-up|1|||
144739077|NCT02178787|521899323|FG001|Overall Study|Lost to Follow-up|0|||
144739078|NCT02178787|521899322|FG000|Overall Study|Withdrawal by Subject|0|||
144739079|NCT02178787|521899323|FG001|Overall Study|Withdrawal by Subject|2|||
144739080|NCT02178787|521899322|FG000|Overall Study|No TCD window|3|||
144739081|NCT02178787|521899323|FG001|Overall Study|No TCD window|7|||
144739082|NCT02178787|521899322|FG000|Overall Study|Physician Decision|1|||
144739083|NCT02178787|521899323|FG001|Overall Study|Physician Decision|0|||
144739084|NCT02554890|521899324|FG000|Double-blind|Adverse Event|45|||
144739085|NCT02554890|521899325|FG001|Double-blind|Adverse Event|51|||
144739086|NCT02554890|521899324|FG000|Double-blind|Death|6|||
144739087|NCT02554890|521899325|FG001|Double-blind|Death|4|||
144739088|NCT02554890|521899324|FG000|Double-blind|Protocol Violation|1|||
144739089|NCT02554890|521899325|FG001|Double-blind|Protocol Violation|1|||
144739090|NCT02554890|521899324|FG000|Double-blind|Physician Decision|4|||
144739091|NCT02554890|521899325|FG001|Double-blind|Physician Decision|3|||
144739092|NCT02554890|521899324|FG000|Double-blind|Subject/Guardian decision|21|||
144739093|NCT02554890|521899325|FG001|Double-blind|Subject/Guardian decision|16|||
144739094|NCT02554890|521899324|FG000|Double-blind|Lost to Follow-up|7|||
144739095|NCT02554890|521899325|FG001|Double-blind|Lost to Follow-up|5|||
144739096|NCT02554890|521899324|FG000|Double-blind|Technical problems|1|||
144739097|NCT02554890|521899325|FG001|Double-blind|Technical problems|0|||
144739098|NCT02554890|521899324|FG000|Double-blind|Withdrawal by Subject|5|||
144739099|NCT02554890|521899325|FG001|Double-blind|Withdrawal by Subject|6|||
144739100|NCT02554890|521899324|FG000|Double-blind|Noncompliance with study treatment|6|||
144739101|NCT02554890|521899325|FG001|Double-blind|Noncompliance with study treatment|5|||
144739102|NCT02554890|521899324|FG000|Open-label|Adverse Event|0|||
144739103|NCT02554890|521899325|FG001|Open-label|Adverse Event|30|||
144739104|NCT02554890|521899324|FG000|Open-label|Death|0|||
144739105|NCT02554890|521899325|FG001|Open-label|Death|1|||
144739106|NCT02554890|521899324|FG000|Open-label|Physician Decision|0|||
144739107|NCT02554890|521899325|FG001|Open-label|Physician Decision|1|||
144739108|NCT02554890|521899324|FG000|Open-label|Subject/Guardian decision|0|||
144739109|NCT02554890|521899325|FG001|Open-label|Subject/Guardian decision|11|||
144739110|NCT02554890|521899324|FG000|Open-label|Lost to Follow-up|0|||
144739111|NCT02554890|521899325|FG001|Open-label|Lost to Follow-up|7|||
144739112|NCT02554890|521899324|FG000|Open-label|Technical problems|0|||
144739113|NCT02554890|521899325|FG001|Open-label|Technical problems|1|||
144739114|NCT02554890|521899324|FG000|Open-label|Withdrawal by Subject|0|||
144739115|NCT02554890|521899325|FG001|Open-label|Withdrawal by Subject|1|||
144739116|NCT03649477|521899331|FG000|Overall Study|Adverse Event|2|||
144739117|NCT03649477|521899332|FG001|Overall Study|Adverse Event|0|||
144739118|NCT03649477|521899333|FG002|Overall Study|Adverse Event|0|||
144739119|NCT01030133|521899334|FG000|Overall Study|failed to experience pain at level 7/10|2|||
144739120|NCT01030133|521899335|FG001|Overall Study|failed to experience pain at level 7/10|2|||
144739121|NCT03114891|521899346|FG000|First Treatment Round|Lost to Follow-up|0|||
144684582|NCT00515099|521695308|FG001|Overall Study|IRB Recommendation|0|||
144684583|NCT00592072|521695309|FG000|Wash Out Period|Lost to Follow-up|1|||
144684584|NCT00592072|521695310|FG001|Wash Out Period|Lost to Follow-up|1|||
144684585|NCT03369704|521695311|FG000|Treatment Epoch|technical problems|1|||
144684586|NCT03369704|521695312|FG001|Treatment Epoch|technical problems|0|||
144684587|NCT03369704|521695311|FG000|Treatment Epoch|Protocol Violation|1|||
144684588|NCT03369704|521695312|FG001|Treatment Epoch|Protocol Violation|0|||
144684589|NCT03369704|521695311|FG000|Treatment Epoch|Lost to Follow-up|0|||
144684590|NCT03369704|521695312|FG001|Treatment Epoch|Lost to Follow-up|1|||
144684591|NCT03369704|521695311|FG000|Treatment Epoch|Lack of Efficacy|0|||
144684592|NCT03369704|521695312|FG001|Treatment Epoch|Lack of Efficacy|2|||
144684593|NCT03369704|521695311|FG000|Treatment Epoch|Adverse Event|2|||
144684594|NCT03369704|521695312|FG001|Treatment Epoch|Adverse Event|0|||
144684595|NCT03369704|521695311|FG000|Follow-up Epoch|Lost to Follow-up|1|||
144739122|NCT03114891|521899347|FG001|First Treatment Round|Lost to Follow-up|1|||
144739123|NCT03114891|521899348|FG002|First Treatment Round|Lost to Follow-up|1|||
144739124|NCT03114891|521899349|FG003|First Treatment Round|Lost to Follow-up|0|||
144739125|NCT03114891|521899346|FG000|First Treatment Round|Withdrawal by Subject|0|||
144739126|NCT03114891|521899347|FG001|First Treatment Round|Withdrawal by Subject|2|||
144739127|NCT03114891|521899348|FG002|First Treatment Round|Withdrawal by Subject|0|||
144739128|NCT03114891|521899349|FG003|First Treatment Round|Withdrawal by Subject|1|||
144739129|NCT03114891|521899346|FG000|3 Week Break|Lost to Follow-up|1|||
144739130|NCT03114891|521899347|FG001|3 Week Break|Lost to Follow-up|0|||
144739131|NCT03114891|521899348|FG002|3 Week Break|Lost to Follow-up|0|||
144739132|NCT03114891|521899349|FG003|3 Week Break|Lost to Follow-up|1|||
144739133|NCT03114891|521899346|FG000|3 Week Break|Withdrawal by Subject|0|||
144739134|NCT03114891|521899347|FG001|3 Week Break|Withdrawal by Subject|1|||
144739135|NCT03114891|521899348|FG002|3 Week Break|Withdrawal by Subject|0|||
144684596|NCT03369704|521695312|FG001|Follow-up Epoch|Lost to Follow-up|0|||
144684597|NCT05333289|521695314|FG000|Overall Study|Other|1|||
144739136|NCT03114891|521899349|FG003|3 Week Break|Withdrawal by Subject|0|||
144684598|NCT05333289|521695315|FG001|Overall Study|Other|0|||
144739137|NCT03114891|521899346|FG000|Second Treatment Round|Lost to Follow-up|1|||
144739138|NCT03114891|521899347|FG001|Second Treatment Round|Lost to Follow-up|0|||
144739139|NCT03114891|521899348|FG002|Second Treatment Round|Lost to Follow-up|0|||
144739140|NCT03114891|521899349|FG003|Second Treatment Round|Lost to Follow-up|0|||
144739141|NCT03114891|521899346|FG000|Second Treatment Round|Physician Decision|1|||
144739142|NCT03114891|521899347|FG001|Second Treatment Round|Physician Decision|0|||
144739143|NCT03114891|521899348|FG002|Second Treatment Round|Physician Decision|0|||
144739144|NCT03114891|521899349|FG003|Second Treatment Round|Physician Decision|0|||
144739145|NCT00682461|521900864|FG000|Overall Study|Adverse Event|5|||
144739146|NCT00682461|521900865|FG001|Overall Study|Adverse Event|7|||
144739147|NCT00682461|521900864|FG000|Overall Study|Lost to Follow-up|8|||
144739148|NCT00682461|521900865|FG001|Overall Study|Lost to Follow-up|5|||
144739149|NCT00682461|521900864|FG000|Overall Study|Withdrawal by Subject|12|||
144739150|NCT00682461|521900865|FG001|Overall Study|Withdrawal by Subject|19|||
144739151|NCT00835705|521900867|FG000|First Intervention|Difficulty with vein|1|||
144739152|NCT00835705|521900868|FG001|First Intervention|Difficulty with vein|0|||
144739153|NCT00835705|521900867|FG000|Second Intervention|Difficulty with vein|1|||
144739154|NCT00835705|521900868|FG001|Second Intervention|Difficulty with vein|0|||
144739155|NCT01750294|521900869|FG000|Overall Study|Withdrawal by Subject|1|||
144739156|NCT01750294|521900869|FG000|Overall Study|Safety Endpoint|1|||
144739157|NCT04035187|521900870|FG000|Overall Study|Withdrawal by Subject|2|||
144739158|NCT04035187|521900871|FG001|Overall Study|Withdrawal by Subject|1|||
144739159|NCT04035187|521900872|FG002|Overall Study|Withdrawal by Subject|0|||
144739160|NCT04035187|521900873|FG003|Overall Study|Withdrawal by Subject|0|||
144739161|NCT04035187|521900870|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
144739162|NCT04035187|521900871|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
144739163|NCT04035187|521900872|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
144739164|NCT04035187|521900873|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
144739165|NCT01116739|521900874|FG000|Overall Study|Child had 2 years of HS|110|||
144739166|NCT01116739|521900875|FG001|Overall Study|Child had 2 years of HS|128|||
144739167|NCT01116739|521900874|FG000|Overall Study|Withdrawal by Subject|6|||
144684599|NCT05333289|521695316|FG002|Overall Study|Other|0|||
144684600|NCT05333289|521695317|FG003|Overall Study|Other|1|||
144684601|NCT05333289|521695318|FG004|Overall Study|Other|1|||
144684602|NCT05333289|521695319|FG005|Overall Study|Other|2|||
144684603|NCT05333289|521695320|FG006|Overall Study|Other|2|||
144684604|NCT05333289|521695321|FG007|Overall Study|Other|0|||
144684605|NCT05333289|521695314|FG000|Overall Study|Withdrawal by Subject|1|||
144684606|NCT05333289|521695315|FG001|Overall Study|Withdrawal by Subject|2|||
144684607|NCT05333289|521695316|FG002|Overall Study|Withdrawal by Subject|2|||
144684608|NCT05333289|521695317|FG003|Overall Study|Withdrawal by Subject|1|||
144684609|NCT05333289|521695318|FG004|Overall Study|Withdrawal by Subject|1|||
144684610|NCT05333289|521695319|FG005|Overall Study|Withdrawal by Subject|2|||
144684611|NCT05333289|521695320|FG006|Overall Study|Withdrawal by Subject|1|||
144684612|NCT05333289|521695321|FG007|Overall Study|Withdrawal by Subject|3|||
144684613|NCT05333289|521695314|FG000|Overall Study|Protocol Violation|1|||
144684614|NCT05333289|521695315|FG001|Overall Study|Protocol Violation|0|||
144684615|NCT05333289|521695316|FG002|Overall Study|Protocol Violation|0|||
144684616|NCT05333289|521695317|FG003|Overall Study|Protocol Violation|0|||
144684617|NCT05333289|521695318|FG004|Overall Study|Protocol Violation|0|||
144684618|NCT05333289|521695319|FG005|Overall Study|Protocol Violation|0|||
144684619|NCT05333289|521695320|FG006|Overall Study|Protocol Violation|0|||
144684620|NCT05333289|521695321|FG007|Overall Study|Protocol Violation|0|||
144684621|NCT05333289|521695314|FG000|Overall Study|Physician Decision|0|||
144684622|NCT05333289|521695315|FG001|Overall Study|Physician Decision|0|||
144739168|NCT01116739|521900875|FG001|Overall Study|Withdrawal by Subject|0|||
144739169|NCT01116739|521900874|FG000|Overall Study|child too young|2|||
144739170|NCT01116739|521900875|FG001|Overall Study|child too young|6|||
144739171|NCT01116739|521900874|FG000|Overall Study|child not enrolled in head start|10|||
144739172|NCT01116739|521900875|FG001|Overall Study|child not enrolled in head start|2|||
144739173|NCT01116739|521900874|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
144739174|NCT01116739|521900875|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
144739175|NCT01624233|521900876|FG000|Period 2 - Induction|Adverse Event|1|||
144739176|NCT01624233|521900876|FG000|Period 3 - Maintenance|Adverse Event|2|||
144739177|NCT01624233|521900876|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
144739178|NCT01624233|521900876|FG000|Period 3 - Maintenance|Physician Decision|2|||
144739179|NCT01624233|521900876|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
144739180|NCT01624233|521900876|FG000|Period 4 - Drug Free Period|Relapsed|61|||
144684623|NCT05333289|521695316|FG002|Overall Study|Physician Decision|1|||
144684624|NCT05333289|521695317|FG003|Overall Study|Physician Decision|0|||
144684625|NCT05333289|521695318|FG004|Overall Study|Physician Decision|0|||
144265883|NCT00611806|520176409|FG000|Overall Study|Withdrawal by Subject|8|||
144684626|NCT05333289|521695319|FG005|Overall Study|Physician Decision|2|||
144684627|NCT05333289|521695320|FG006|Overall Study|Physician Decision|0|||
144684628|NCT05333289|521695321|FG007|Overall Study|Physician Decision|0|||
144684629|NCT05333289|521695314|FG000|Overall Study|Lost to Follow-up|6|||
144684630|NCT05333289|521695315|FG001|Overall Study|Lost to Follow-up|0|||
144684631|NCT05333289|521695316|FG002|Overall Study|Lost to Follow-up|1|||
144684632|NCT05333289|521695317|FG003|Overall Study|Lost to Follow-up|6|||
144684633|NCT05333289|521695318|FG004|Overall Study|Lost to Follow-up|3|||
144684634|NCT05333289|521695319|FG005|Overall Study|Lost to Follow-up|3|||
144684635|NCT05333289|521695320|FG006|Overall Study|Lost to Follow-up|2|||
144684636|NCT05333289|521695321|FG007|Overall Study|Lost to Follow-up|1|||
144684637|NCT05333289|521695314|FG000|Overall Study|Death|1|||
144684638|NCT05333289|521695315|FG001|Overall Study|Death|0|||
144684639|NCT05333289|521695316|FG002|Overall Study|Death|0|||
144684640|NCT05333289|521695317|FG003|Overall Study|Death|0|||
144684641|NCT05333289|521695318|FG004|Overall Study|Death|0|||
144684642|NCT05333289|521695319|FG005|Overall Study|Death|0|||
144684643|NCT05333289|521695320|FG006|Overall Study|Death|0|||
144684644|NCT05333289|521695321|FG007|Overall Study|Death|0|||
144684645|NCT01842334|521695322|FG000|Overall Study|Withdrawal by Subject|3|||
144684646|NCT01842334|521695323|FG001|Overall Study|Withdrawal by Subject|3|||
144684647|NCT01842334|521695322|FG000|Overall Study|Moved away mid-study|0|||
144684648|NCT01842334|521695323|FG001|Overall Study|Moved away mid-study|1|||
144684649|NCT00942422|521695324|FG000|Overall Study|Withdrawal by Subject|1|||
144684650|NCT00942422|521695324|FG000|Overall Study|Death|1|||
144684651|NCT00942422|521695324|FG000|Overall Study|Progressive diease|1|||
144684652|NCT02943668|521695325|FG000|Overall Study|Disease Progression|1|||
144684653|NCT00572728|521695330|FG000|Overall Study|Withdrawal by Subject|10|||
144684654|NCT00572728|521695330|FG000|Overall Study|Ineligible|3|||
144684655|NCT00572728|521695330|FG000|Overall Study|Enrolled under Amendment 4|5|||
144684656|NCT00572728|521695330|FG000|Overall Study|Offstudy due to complicating disease|1|||
144684657|NCT00572728|521695330|FG000|Overall Study|FLT1 not completed|4|||
144684658|NCT00572728|521695330|FG000|Overall Study|First Chemotherapy not initiated|2|||
144684659|NCT00572728|521695330|FG000|Overall Study|FLT2 not completed|5|||
144684660|NCT00572728|521695330|FG000|Overall Study|Second chemotherapy not initiated|1|||
144684661|NCT00572728|521695330|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
144684662|NCT00572728|521695330|FG000|Overall Study|Pathology missing|1|||
144684663|NCT02724111|521695331|FG000|Overall Study|Protocol Violation|2|||
144684664|NCT02724111|521695332|FG001|Overall Study|Protocol Violation|5|||
144684665|NCT02996500|521695333|FG000|Overall Study|Adverse Event|1|||
144684666|NCT02996500|521695334|FG001|Overall Study|Adverse Event|1|||
144684667|NCT02996500|521695335|FG002|Overall Study|Adverse Event|4|||
144684668|NCT02996500|521695336|FG003|Overall Study|Adverse Event|3|||
144684669|NCT02996500|521695337|FG004|Overall Study|Adverse Event|1|||
144684670|NCT02996500|521695338|FG005|Overall Study|Adverse Event|2|||
144684671|NCT02996500|521695333|FG000|Overall Study|Lack of Efficacy|0|||
144684672|NCT02996500|521695334|FG001|Overall Study|Lack of Efficacy|0|||
144684673|NCT02996500|521695335|FG002|Overall Study|Lack of Efficacy|0|||
144684674|NCT02996500|521695336|FG003|Overall Study|Lack of Efficacy|0|||
144684675|NCT02996500|521695337|FG004|Overall Study|Lack of Efficacy|2|||
144684676|NCT02996500|521695338|FG005|Overall Study|Lack of Efficacy|0|||
144684677|NCT02996500|521695333|FG000|Overall Study|Lost to Follow-up|1|||
144684678|NCT02996500|521695334|FG001|Overall Study|Lost to Follow-up|0|||
144684679|NCT02996500|521695335|FG002|Overall Study|Lost to Follow-up|0|||
144684680|NCT02996500|521695336|FG003|Overall Study|Lost to Follow-up|0|||
144684681|NCT02996500|521695337|FG004|Overall Study|Lost to Follow-up|0|||
144684682|NCT02996500|521695338|FG005|Overall Study|Lost to Follow-up|1|||
144684683|NCT02996500|521695333|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144684684|NCT02996500|521695334|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144684685|NCT02996500|521695335|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
144684686|NCT02996500|521695336|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
144684687|NCT02996500|521695337|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
144684688|NCT02996500|521695338|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
144684689|NCT02996500|521695333|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144684690|NCT02996500|521695334|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144684691|NCT02996500|521695335|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144684692|NCT02996500|521695336|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144684693|NCT02996500|521695337|FG004|Overall Study|Non-Compliance With Study Drug|0|||
144684694|NCT02996500|521695338|FG005|Overall Study|Non-Compliance With Study Drug|1|||
144684695|NCT02996500|521695333|FG000|Overall Study|Progressive Disease|1|||
144684696|NCT02996500|521695334|FG001|Overall Study|Progressive Disease|0|||
144684697|NCT02996500|521695335|FG002|Overall Study|Progressive Disease|0|||
144684698|NCT02996500|521695336|FG003|Overall Study|Progressive Disease|0|||
144684699|NCT02996500|521695337|FG004|Overall Study|Progressive Disease|0|||
144684700|NCT02996500|521695338|FG005|Overall Study|Progressive Disease|0|||
144684701|NCT02996500|521695333|FG000|Overall Study|Other|2|||
144684702|NCT02996500|521695334|FG001|Overall Study|Other|0|||
144684703|NCT02996500|521695335|FG002|Overall Study|Other|2|||
144684704|NCT02996500|521695336|FG003|Overall Study|Other|0|||
144684705|NCT02996500|521695337|FG004|Overall Study|Other|0|||
144684706|NCT02996500|521695338|FG005|Overall Study|Other|0|||
144684707|NCT02996500|521695333|FG000|Overall Study|Protocol Violation|0|||
144739181|NCT01624233|521900876|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
144739182|NCT01624233|521900876|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
144739183|NCT01624233|521900876|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
144739184|NCT01624233|521900876|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
144739185|NCT01624233|521900876|FG000|Period 6: Follow-up|Adverse Event|3|||
144739186|NCT01624233|521900876|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
144739187|NCT01624233|521900876|FG000|Period 6: Follow-up|Physician Decision|1|||
144739188|NCT01624233|521900876|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
144739189|NCT05090839|521900879|FG000|Overall Study|Lost to Follow-up|2|||
144739190|NCT05090839|521900880|FG001|Overall Study|Lost to Follow-up|3|||
144739191|NCT05090839|521900881|FG002|Overall Study|Lost to Follow-up|1|||
144739192|NCT05090839|521900882|FG003|Overall Study|Lost to Follow-up|1|||
144739193|NCT05710718|521900883|FG000|Overall Study|Withdrawal by Subject|5|||
144739194|NCT05710718|521900884|FG001|Overall Study|Withdrawal by Subject|1|||
144739195|NCT05710718|521900883|FG000|Overall Study|Lost to Follow-up|0|||
144739196|NCT05710718|521900884|FG001|Overall Study|Lost to Follow-up|1|||
144739197|NCT05710718|521900883|FG000|Overall Study|Death|0|||
144739198|NCT05710718|521900884|FG001|Overall Study|Death|1|||
144739199|NCT01528696|521900886|FG000|Overall Study|See detailed description|18|||
144739200|NCT01528696|521900887|FG001|Overall Study|See detailed description|19|||
144739201|NCT01056484|521900888|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
144739202|NCT01056484|521900889|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
144739203|NCT01056484|521900888|FG000|Randomized Controlled Trial|Physician Decision|1|||
144739204|NCT01056484|521900889|FG001|Randomized Controlled Trial|Physician Decision|0|||
144739205|NCT01056484|521900888|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
144739206|NCT01056484|521900889|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
144739207|NCT00835575|521900891|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
144739208|NCT00835575|521900892|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
144739209|NCT03606174|521900897|FG000|Overall Study|Death|37|||
144739210|NCT03606174|521900898|FG001|Overall Study|Death|15|||
144739211|NCT03606174|521900899|FG002|Overall Study|Death|15|||
144739212|NCT03606174|521900900|FG003|Overall Study|Death|7|||
144739213|NCT03606174|521900901|FG004|Overall Study|Death|35|||
144739214|NCT03606174|521900902|FG005|Overall Study|Death|12|||
144739215|NCT03606174|521900903|FG006|Overall Study|Death|35|||
144739216|NCT03606174|521900904|FG007|Overall Study|Death|8|||
144739217|NCT03606174|521900905|FG008|Overall Study|Death|5|||
144739218|NCT03606174|521900906|FG009|Overall Study|Death|3|||
144739219|NCT03606174|521900907|FG010|Overall Study|Death|0|||
144739220|NCT03606174|521900897|FG000|Overall Study|Lost to Follow-up|0|||
144739221|NCT03606174|521900898|FG001|Overall Study|Lost to Follow-up|0|||
144739222|NCT03606174|521900899|FG002|Overall Study|Lost to Follow-up|0|||
144739223|NCT03606174|521900900|FG003|Overall Study|Lost to Follow-up|0|||
144739224|NCT03606174|521900901|FG004|Overall Study|Lost to Follow-up|1|||
144739225|NCT03606174|521900902|FG005|Overall Study|Lost to Follow-up|1|||
144739226|NCT03606174|521900903|FG006|Overall Study|Lost to Follow-up|0|||
144739227|NCT03606174|521900904|FG007|Overall Study|Lost to Follow-up|0|||
144739228|NCT03606174|521900905|FG008|Overall Study|Lost to Follow-up|0|||
144739229|NCT03606174|521900906|FG009|Overall Study|Lost to Follow-up|0|||
144739230|NCT03606174|521900907|FG010|Overall Study|Lost to Follow-up|0|||
144739231|NCT03606174|521900897|FG000|Overall Study|Withdrawal by Subject|6|||
144739232|NCT03606174|521900898|FG001|Overall Study|Withdrawal by Subject|0|||
144739233|NCT03606174|521900899|FG002|Overall Study|Withdrawal by Subject|0|||
144739234|NCT03606174|521900900|FG003|Overall Study|Withdrawal by Subject|1|||
144739235|NCT03606174|521900901|FG004|Overall Study|Withdrawal by Subject|2|||
144739236|NCT03606174|521900902|FG005|Overall Study|Withdrawal by Subject|1|||
144218393|NCT03404674|519992334|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
144218394|NCT03404674|519992335|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
144218395|NCT03404674|519992336|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
144684708|NCT02996500|521695334|FG001|Overall Study|Protocol Violation|0|||
144684709|NCT02996500|521695335|FG002|Overall Study|Protocol Violation|0|||
144684710|NCT02996500|521695336|FG003|Overall Study|Protocol Violation|1|||
144684711|NCT02996500|521695337|FG004|Overall Study|Protocol Violation|0|||
144684712|NCT02996500|521695338|FG005|Overall Study|Protocol Violation|0|||
144684713|NCT02996500|521695333|FG000|Overall Study|Withdrawal by Subject|3|||
144684714|NCT02996500|521695334|FG001|Overall Study|Withdrawal by Subject|0|||
144684715|NCT02996500|521695335|FG002|Overall Study|Withdrawal by Subject|3|||
144684716|NCT02996500|521695336|FG003|Overall Study|Withdrawal by Subject|0|||
144684717|NCT02996500|521695337|FG004|Overall Study|Withdrawal by Subject|2|||
144684718|NCT02996500|521695338|FG005|Overall Study|Withdrawal by Subject|0|||
144684719|NCT00322387|521695340|FG000|Treatment Period|Adverse Event|0|||
144684720|NCT00322387|521695341|FG001|Treatment Period|Adverse Event|1|||
144684721|NCT00322387|521695340|FG000|Follow-up Period|Final assessment not done|1|||
144684722|NCT00322387|521695341|FG001|Follow-up Period|Final assessment not done|3|||
144684723|NCT00322387|521695340|FG000|Follow-up Period|Death|1|||
144684724|NCT00322387|521695341|FG001|Follow-up Period|Death|0|||
144684725|NCT00126425|521695349|FG000|Overall Study|Withdrawal by Subject|17|||
144739237|NCT03606174|521900903|FG006|Overall Study|Withdrawal by Subject|4|||
144739238|NCT03606174|521900904|FG007|Overall Study|Withdrawal by Subject|0|||
144739239|NCT03606174|521900905|FG008|Overall Study|Withdrawal by Subject|0|||
144739240|NCT03606174|521900906|FG009|Overall Study|Withdrawal by Subject|0|||
144739241|NCT03606174|521900907|FG010|Overall Study|Withdrawal by Subject|1|||
144739242|NCT03606174|521900897|FG000|Overall Study|Study Terminated by Sponsor|5|||
144739243|NCT03606174|521900898|FG001|Overall Study|Study Terminated by Sponsor|7|||
144739244|NCT03606174|521900899|FG002|Overall Study|Study Terminated by Sponsor|3|||
144739245|NCT03606174|521900900|FG003|Overall Study|Study Terminated by Sponsor|0|||
144739246|NCT03606174|521900901|FG004|Overall Study|Study Terminated by Sponsor|11|||
144739247|NCT03606174|521900902|FG005|Overall Study|Study Terminated by Sponsor|6|||
144739248|NCT03606174|521900903|FG006|Overall Study|Study Terminated by Sponsor|12|||
144739249|NCT03606174|521900904|FG007|Overall Study|Study Terminated by Sponsor|1|||
144739250|NCT03606174|521900905|FG008|Overall Study|Study Terminated by Sponsor|3|||
144739251|NCT03606174|521900906|FG009|Overall Study|Study Terminated by Sponsor|1|||
144739252|NCT03606174|521900907|FG010|Overall Study|Study Terminated by Sponsor|2|||
144739253|NCT03606174|521900897|FG000|Overall Study|Miscellaneous|1|||
144739254|NCT03606174|521900898|FG001|Overall Study|Miscellaneous|1|||
144739255|NCT03606174|521900899|FG002|Overall Study|Miscellaneous|0|||
144739256|NCT03606174|521900900|FG003|Overall Study|Miscellaneous|1|||
144739257|NCT03606174|521900901|FG004|Overall Study|Miscellaneous|4|||
144739258|NCT03606174|521900902|FG005|Overall Study|Miscellaneous|7|||
144739259|NCT03606174|521900903|FG006|Overall Study|Miscellaneous|5|||
144739260|NCT03606174|521900904|FG007|Overall Study|Miscellaneous|0|||
144739261|NCT03606174|521900905|FG008|Overall Study|Miscellaneous|0|||
144739262|NCT03606174|521900906|FG009|Overall Study|Miscellaneous|0|||
144739263|NCT03606174|521900907|FG010|Overall Study|Miscellaneous|1|||
144739264|NCT01609257|521900908|FG000|Overall Study|Lost to Follow-up|2|||
144739265|NCT01609257|521900909|FG001|Overall Study|Lost to Follow-up|1|||
144739266|NCT01609257|521900908|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
144739267|NCT01609257|521900909|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
144739268|NCT01609257|521900908|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
144739269|NCT01609257|521900909|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
144739270|NCT03499353|521900912|FG000|Treatment|Adverse Event|3|||
144739271|NCT03499353|521900912|FG000|Treatment|Progressive Disease|10|||
144739272|NCT03499353|521900912|FG000|Treatment|Other|1|||
144739273|NCT03499353|521900912|FG000|Treatment|Withdrawal by Subject|2|||
144739274|NCT03499353|521900912|FG000|Long-Term Follow-up|Death|2|||
144739275|NCT03499353|521900912|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
144739276|NCT03499353|521900912|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
144739277|NCT01896934|521900915|FG000|Overall Study|Adverse Event|1|||
144739278|NCT01896934|521900915|FG000|Overall Study|Withdrawal by Subject|1|||
144739279|NCT00716625|521900916|FG000|Overall Study|Safety was not Assessable|1|||
144739280|NCT05014828|521900917|FG000|Overall Study|Study Completed by Sponsor|16|||
144739281|NCT05014828|521900918|FG001|Overall Study|Study Completed by Sponsor|16|||
144684726|NCT00126425|521695350|FG001|Overall Study|Withdrawal by Subject|1|||
144684727|NCT00126425|521695349|FG000|Overall Study|Lost to Follow-up|8|||
144684728|NCT00126425|521695350|FG001|Overall Study|Lost to Follow-up|4|||
144684729|NCT00126425|521695349|FG000|Overall Study|Protocol Violation|9|||
144684730|NCT00126425|521695350|FG001|Overall Study|Protocol Violation|6|||
144684731|NCT00126425|521695349|FG000|Overall Study|Adverse Event|1|||
144684732|NCT00126425|521695350|FG001|Overall Study|Adverse Event|0|||
144684733|NCT00126425|521695349|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
144684734|NCT00126425|521695350|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
144684735|NCT00126425|521695349|FG000|Overall Study|Other|5|||
144684736|NCT00126425|521695350|FG001|Overall Study|Other|0|||
144684737|NCT01855919|521697170|FG000|Overall Study|Adverse Event|16|||
144684738|NCT01855919|521697171|FG001|Overall Study|Adverse Event|8|||
144684739|NCT01855919|521697170|FG000|Overall Study|Lack of Efficacy|1|||
144684740|NCT01855919|521697171|FG001|Overall Study|Lack of Efficacy|3|||
144684741|NCT01855919|521697170|FG000|Overall Study|Withdrawal by Subject|4|||
144684742|NCT01855919|521697171|FG001|Overall Study|Withdrawal by Subject|10|||
144684743|NCT01855919|521697170|FG000|Overall Study|Entry Criteria Not Met|1|||
144684744|NCT01855919|521697171|FG001|Overall Study|Entry Criteria Not Met|1|||
144684745|NCT01855919|521697170|FG000|Overall Study|Protocol Violation|1|||
144684746|NCT01855919|521697171|FG001|Overall Study|Protocol Violation|4|||
144684747|NCT03455530|521697172|FG000|Overall Study|Withdrawal by Subject|9|||
144684748|NCT03455530|521697173|FG001|Overall Study|Withdrawal by Subject|1|||
144684749|NCT03455530|521697174|FG002|Overall Study|Withdrawal by Subject|3|||
144739282|NCT05014828|521900919|FG002|Overall Study|Study Completed by Sponsor|3|||
144739283|NCT05014828|521900920|FG003|Overall Study|Study Completed by Sponsor|3|||
144739284|NCT05014828|521900917|FG000|Overall Study|Death|11|||
144684750|NCT03455530|521697175|FG003|Overall Study|Withdrawal by Subject|3|||
144684751|NCT00740116|521697180|FG000|Overall Study|Withdrawal by Subject|1|||
144739285|NCT05014828|521900918|FG001|Overall Study|Death|6|||
144739286|NCT05014828|521900919|FG002|Overall Study|Death|0|||
144739287|NCT05014828|521900920|FG003|Overall Study|Death|0|||
144739288|NCT05014828|521900917|FG000|Overall Study|Lost to Follow-up|0|||
144684752|NCT00740116|521697181|FG001|Overall Study|Withdrawal by Subject|1|||
144684753|NCT00740116|521697180|FG000|Overall Study|Protocol Violation|1|||
144684754|NCT00740116|521697181|FG001|Overall Study|Protocol Violation|4|||
144684755|NCT01293123|521697182|FG000|Overall Study|Lost to Follow-up|0|||
144684756|NCT01293123|521697183|FG001|Overall Study|Lost to Follow-up|1|||
144684757|NCT00121485|521697184|FG000|Overall Study|Not implanted|1|||
144684758|NCT00121485|521697185|FG001|Overall Study|Not implanted|5|||
144684759|NCT00121485|521697184|FG000|Overall Study|Crossover|0|||
144684760|NCT00121485|521697185|FG001|Overall Study|Crossover|2|||
144684761|NCT01888965|521697186|FG000|Overall Study|Adverse Event|5|||
144684762|NCT01888965|521697186|FG000|Overall Study|Lack of Efficacy|4|||
144684763|NCT00908895|521697187|FG000|Overall Study|Lost to Follow-up|1|||
144684764|NCT00908895|521697188|FG001|Overall Study|Lost to Follow-up|3|||
144684765|NCT00908895|521697187|FG000|Overall Study|algodystrophy|2|||
144684766|NCT00908895|521697188|FG001|Overall Study|algodystrophy|2|||
144684767|NCT00908895|521697187|FG000|Overall Study|Adverse Event|1|||
144684768|NCT00908895|521697188|FG001|Overall Study|Adverse Event|1|||
144684769|NCT02608099|521697191|FG000|Overall Study|Ablation procedure not initiated|3|||
144684770|NCT02608099|521697192|FG001|Overall Study|Ablation procedure not initiated|2|||
144684771|NCT01952041|521697196|FG000|Overall Study|Lost to Follow-up|9|||
144684772|NCT01952041|521697197|FG001|Overall Study|Lost to Follow-up|16|||
144684773|NCT01952041|521697196|FG000|Overall Study|Withdrawal by Subject|7|||
144684774|NCT01952041|521697197|FG001|Overall Study|Withdrawal by Subject|5|||
144684775|NCT01952041|521697196|FG000|Overall Study|Death|1|||
144684776|NCT01952041|521697197|FG001|Overall Study|Death|0|||
144684777|NCT01736176|521697198|FG000|Overall Study|Adverse Event|3|||
144684778|NCT01736176|521697198|FG000|Overall Study|Withdrawal by Subject|4|||
144684779|NCT01736176|521697198|FG000|Overall Study|Lack of Efficacy|3|||
144684780|NCT01736176|521697198|FG000|Overall Study|Unable to Complete PEG Placement|1|||
144684781|NCT03650387|521697199|FG000|Overall Study|Withdrawal by Subject|13|||
144684782|NCT03650387|521697199|FG000|Overall Study|Lost to Follow-up|12|||
144684783|NCT03650387|521697199|FG000|Overall Study|Adverse Event (Not related)|1|||
144684784|NCT03650387|521697199|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
144684785|NCT00417248|521697200|FG000|Overall Study|Study Terminated|6|||
144684786|NCT00417248|521697200|FG000|Overall Study|Death|1|||
144684787|NCT00417248|521697200|FG000|Overall Study|Lack of Efficacy|1|||
144684788|NCT01569568|521697201|FG000|Overall Study|Physician Decision|0|||
144684789|NCT01569568|521697202|FG001|Overall Study|Physician Decision|2|||
144684790|NCT00934791|521697203|FG000|Overall Study|Withdrawal by Subject|1|||
144684791|NCT00934791|521697204|FG001|Overall Study|Withdrawal by Subject|0|||
144684792|NCT02425891|521697206|FG000|Overall Study|Death|333|||
144684793|NCT02425891|521697207|FG001|Overall Study|Death|314|||
144684794|NCT02425891|521697206|FG000|Overall Study|Lost to Follow-up|4|||
144684795|NCT02425891|521697207|FG001|Overall Study|Lost to Follow-up|6|||
144684796|NCT02425891|521697206|FG000|Overall Study|Non-Compliance|1|||
144684797|NCT02425891|521697207|FG001|Overall Study|Non-Compliance|1|||
144684798|NCT02425891|521697206|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
144684799|NCT02425891|521697207|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
144684800|NCT02425891|521697206|FG000|Overall Study|Physician Decision|0|||
144684801|NCT02425891|521697207|FG001|Overall Study|Physician Decision|1|||
144684802|NCT02425891|521697206|FG000|Overall Study|Protocol Violation|1|||
144684803|NCT02425891|521697207|FG001|Overall Study|Protocol Violation|1|||
144684804|NCT02425891|521697206|FG000|Overall Study|Study Terminated By Sponsor|85|||
144684805|NCT02425891|521697207|FG001|Overall Study|Study Terminated By Sponsor|95|||
144684806|NCT02425891|521697206|FG000|Overall Study|Withdrawal by Subject|27|||
144684807|NCT02425891|521697207|FG001|Overall Study|Withdrawal by Subject|32|||
144684808|NCT00166504|521697211|FG000|Overall Study|Adverse Event|3|||
144684809|NCT00166504|521697212|FG001|Overall Study|Adverse Event|3|||
144684810|NCT00166504|521697211|FG000|Overall Study|Lost to Follow-up|1|||
144684811|NCT00166504|521697212|FG001|Overall Study|Lost to Follow-up|1|||
144684812|NCT00166504|521697211|FG000|Overall Study|Withdrawal by Subject|1|||
144684813|NCT00166504|521697212|FG001|Overall Study|Withdrawal by Subject|0|||
144684814|NCT03345849|521697213|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
144684815|NCT03345849|521697214|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
144684816|NCT03345849|521697215|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
144684817|NCT03345849|521697216|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
144684818|NCT03345849|521697213|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
144684819|NCT03345849|521697214|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
144684820|NCT03345849|521697215|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
144684821|NCT03345849|521697216|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
144684822|NCT03345849|521697213|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
144684823|NCT03345849|521697214|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
144684824|NCT03345849|521697215|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
144684825|NCT03345849|521697216|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
144684826|NCT03345849|521697213|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
144684827|NCT03345849|521697214|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
144684828|NCT03345849|521697215|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
144684829|NCT03345849|521697216|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
144684830|NCT03345849|521697213|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
144684831|NCT03345849|521697214|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
144684832|NCT03345849|521697215|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
144684833|NCT03345849|521697216|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
144684834|NCT03345849|521697213|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
144684835|NCT03345849|521697214|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
144684836|NCT03345849|521697215|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
144684837|NCT03345849|521697216|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
144684838|NCT03345849|521697213|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
144684839|NCT03345849|521697214|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
144684840|NCT03345849|521697215|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
144684841|NCT03345849|521697216|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
144684842|NCT03345849|521697213|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
144684843|NCT03345849|521697214|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
144684844|NCT03345849|521697215|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
144684845|NCT03345849|521697216|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
144684846|NCT03345849|521697213|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
144684847|NCT03345849|521697214|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
144684848|NCT03345849|521697215|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
144684849|NCT03345849|521697216|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
144684850|NCT03345849|521697213|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
144684851|NCT03345849|521697214|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
144684852|NCT03345849|521697215|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
144684853|NCT03345849|521697216|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
144684854|NCT03345849|521697213|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
144684855|NCT03345849|521697214|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
144684856|NCT03345849|521697215|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
144684857|NCT03345849|521697216|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
144684858|NCT02943577|521697217|FG000|Overall Study|Protocol Violation|0|||
144684859|NCT02943577|521697218|FG001|Overall Study|Protocol Violation|1|||
144684860|NCT02943577|521697217|FG000|Overall Study|Adverse Event|3|||
144684861|NCT02943577|521697218|FG001|Overall Study|Adverse Event|2|||
144684862|NCT02943577|521697217|FG000|Overall Study|Lost to Follow-up|0|||
144684863|NCT02943577|521697218|FG001|Overall Study|Lost to Follow-up|1|||
144684864|NCT02943577|521697217|FG000|Overall Study|Withdrawal by Subject|1|||
144684865|NCT02943577|521697218|FG001|Overall Study|Withdrawal by Subject|1|||
144684866|NCT02943577|521697217|FG000|Overall Study|Pregnancy|1|||
144684867|NCT02943577|521697218|FG001|Overall Study|Pregnancy|0|||
144684868|NCT01944462|521697223|FG000|PPPP Educational Program|Lost to Follow-up|60|||
144684869|NCT05298774|521697226|FG000|Overall Study|Physician Decision|3|||
144684870|NCT05298774|521697226|FG000|Overall Study|Withdrawal by Subject|2|||
144684871|NCT05298774|521697226|FG000|Overall Study|Lost to Follow-up|3|||
144684872|NCT05298774|521697226|FG000|Overall Study|Screen failure|1|||
144684873|NCT00081263|521697228|FG000|Overall Study|clerical error|1|||
144684874|NCT00081263|521697229|FG001|Overall Study|clerical error|0|||
144684875|NCT00081263|521697228|FG000|Overall Study|wrong cell type|7|||
144684876|NCT00081263|521697229|FG001|Overall Study|wrong cell type|5|||
144684877|NCT00081263|521697228|FG000|Overall Study|improper pre-protocol therapy|0|||
144684878|NCT00081263|521697229|FG001|Overall Study|improper pre-protocol therapy|1|||
144684879|NCT00081263|521697228|FG000|Overall Study|Inadequate pathology|0|||
144684880|NCT00081263|521697229|FG001|Overall Study|Inadequate pathology|1|||
144684881|NCT00081263|521697228|FG000|Overall Study|Never treated|4|||
144684882|NCT00081263|521697229|FG001|Overall Study|Never treated|5|||
144684883|NCT00081263|521697228|FG000|Overall Study|Inadequate data|5|||
144684884|NCT00081263|521697229|FG001|Overall Study|Inadequate data|10|||
144684885|NCT01267955|521697232|FG000|Stage 1 (6 Months)|Death|3|||
144739289|NCT05014828|521900918|FG001|Overall Study|Lost to Follow-up|0|||
144739290|NCT05014828|521900919|FG002|Overall Study|Lost to Follow-up|2|||
144739291|NCT05014828|521900920|FG003|Overall Study|Lost to Follow-up|0|||
144739292|NCT05014828|521900917|FG000|Overall Study|Miscellaneous.|0|||
144739293|NCT05014828|521900918|FG001|Overall Study|Miscellaneous.|1|||
144739294|NCT05014828|521900919|FG002|Overall Study|Miscellaneous.|0|||
144739295|NCT05014828|521900920|FG003|Overall Study|Miscellaneous.|0|||
144739296|NCT00933686|521900923|FG000|Overall Study|Protocol Violation|0|||
144739297|NCT00933686|521900924|FG001|Overall Study|Protocol Violation|1|||
144739298|NCT00933686|521900923|FG000|Overall Study|Lost to Follow-up|2|||
144739299|NCT00933686|521900924|FG001|Overall Study|Lost to Follow-up|2|||
144739300|NCT00933686|521900923|FG000|Overall Study|Withdrawal by Subject|6|||
144739301|NCT00933686|521900924|FG001|Overall Study|Withdrawal by Subject|5|||
144739302|NCT00933686|521900923|FG000|Overall Study|Adverse Event|1|||
144265884|NCT00611806|520176410|FG001|Overall Study|Withdrawal by Subject|2|||
144684886|NCT01267955|521697232|FG000|Stage 2 (6 Months)|Death|5|||
144684887|NCT01267955|521697232|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
144684888|NCT05564039|521697233|FG000|Overall Study|Adverse Event|1|||
144684889|NCT05564039|521697234|FG001|Overall Study|Adverse Event|0|||
144684890|NCT05564039|521697233|FG000|Overall Study|Death|1|||
144684891|NCT05564039|521697234|FG001|Overall Study|Death|1|||
144684892|NCT05564039|521697233|FG000|Overall Study|Lost to Follow-up|3|||
144684893|NCT05564039|521697234|FG001|Overall Study|Lost to Follow-up|2|||
144684894|NCT05564039|521697233|FG000|Overall Study|Withdrawal by Subject|2|||
144684895|NCT05564039|521697234|FG001|Overall Study|Withdrawal by Subject|0|||
144684896|NCT05564039|521697233|FG000|Overall Study|Inadvertent enrollment|3|||
144684897|NCT05564039|521697234|FG001|Overall Study|Inadvertent enrollment|6|||
144684898|NCT04785144|521697235|FG000|Overall Study|Withdrawal by Subject|4|||
144684899|NCT04785144|521697236|FG001|Overall Study|Withdrawal by Subject|1|||
144684900|NCT04785144|521697237|FG002|Overall Study|Withdrawal by Subject|0|||
144684901|NCT04785144|521697238|FG003|Overall Study|Withdrawal by Subject|0|||
144684902|NCT04785144|521697239|FG004|Overall Study|Withdrawal by Subject|0|||
144684903|NCT04785144|521697240|FG005|Overall Study|Withdrawal by Subject|2|||
144684904|NCT04785144|521697241|FG006|Overall Study|Withdrawal by Subject|2|||
144684905|NCT04785144|521697242|FG007|Overall Study|Withdrawal by Subject|0|||
144684906|NCT04785144|521697243|FG008|Overall Study|Withdrawal by Subject|1|||
144684907|NCT04785144|521697244|FG009|Overall Study|Withdrawal by Subject|0|||
144684908|NCT04785144|521697235|FG000|Overall Study|Lost to Follow-up|1|||
144684909|NCT04785144|521697236|FG001|Overall Study|Lost to Follow-up|0|||
144684910|NCT04785144|521697237|FG002|Overall Study|Lost to Follow-up|0|||
144684911|NCT04785144|521697238|FG003|Overall Study|Lost to Follow-up|0|||
144684912|NCT04785144|521697239|FG004|Overall Study|Lost to Follow-up|1|||
144684913|NCT04785144|521697240|FG005|Overall Study|Lost to Follow-up|2|||
144684914|NCT04785144|521697241|FG006|Overall Study|Lost to Follow-up|1|||
144684915|NCT04785144|521697242|FG007|Overall Study|Lost to Follow-up|2|||
144684916|NCT04785144|521697243|FG008|Overall Study|Lost to Follow-up|4|||
144684917|NCT04785144|521697244|FG009|Overall Study|Lost to Follow-up|1|||
144684918|NCT04785144|521697235|FG000|Overall Study|Protocol Violation|0|||
144684919|NCT04785144|521697236|FG001|Overall Study|Protocol Violation|0|||
144684920|NCT04785144|521697237|FG002|Overall Study|Protocol Violation|0|||
144684921|NCT04785144|521697238|FG003|Overall Study|Protocol Violation|0|||
144684922|NCT04785144|521697239|FG004|Overall Study|Protocol Violation|0|||
144684923|NCT04785144|521697240|FG005|Overall Study|Protocol Violation|0|||
144684924|NCT04785144|521697241|FG006|Overall Study|Protocol Violation|1|||
144684925|NCT04785144|521697242|FG007|Overall Study|Protocol Violation|0|||
144684926|NCT04785144|521697243|FG008|Overall Study|Protocol Violation|0|||
144684927|NCT04785144|521697244|FG009|Overall Study|Protocol Violation|0|||
144684928|NCT04785144|521697235|FG000|Overall Study|Physician Decision|0|||
144684929|NCT04785144|521697236|FG001|Overall Study|Physician Decision|0|||
144684930|NCT04785144|521697237|FG002|Overall Study|Physician Decision|0|||
144684931|NCT04785144|521697238|FG003|Overall Study|Physician Decision|0|||
144684932|NCT04785144|521697239|FG004|Overall Study|Physician Decision|0|||
144684933|NCT04785144|521697240|FG005|Overall Study|Physician Decision|0|||
144684934|NCT04785144|521697241|FG006|Overall Study|Physician Decision|0|||
144684935|NCT04785144|521697242|FG007|Overall Study|Physician Decision|0|||
144684936|NCT04785144|521697243|FG008|Overall Study|Physician Decision|0|||
144684937|NCT04785144|521697244|FG009|Overall Study|Physician Decision|1|||
144684938|NCT04785144|521697235|FG000|Overall Study|Unable to continue due to work schedule|0|||
144684939|NCT04785144|521697236|FG001|Overall Study|Unable to continue due to work schedule|0|||
144684940|NCT04785144|521697237|FG002|Overall Study|Unable to continue due to work schedule|0|||
144684941|NCT04785144|521697238|FG003|Overall Study|Unable to continue due to work schedule|0|||
144684942|NCT04785144|521697239|FG004|Overall Study|Unable to continue due to work schedule|0|||
144684943|NCT04785144|521697240|FG005|Overall Study|Unable to continue due to work schedule|0|||
144684944|NCT04785144|521697241|FG006|Overall Study|Unable to continue due to work schedule|0|||
144684945|NCT04785144|521697242|FG007|Overall Study|Unable to continue due to work schedule|0|||
144684946|NCT04785144|521697243|FG008|Overall Study|Unable to continue due to work schedule|0|||
144684947|NCT04785144|521697244|FG009|Overall Study|Unable to continue due to work schedule|1|||
144684948|NCT01263470|521697245|FG000|Overall Study|Adverse Event|2|||
144684949|NCT01263470|521697246|FG001|Overall Study|Adverse Event|2|||
144684950|NCT01263470|521697247|FG002|Overall Study|Adverse Event|1|||
144684951|NCT01263470|521697248|FG003|Overall Study|Adverse Event|1|||
144684952|NCT01263470|521697249|FG004|Overall Study|Adverse Event|2|||
144684953|NCT01263470|521697250|FG005|Overall Study|Adverse Event|2|||
144684954|NCT01263470|521697245|FG000|Overall Study|Protocol Violation|0|||
144684955|NCT01263470|521697246|FG001|Overall Study|Protocol Violation|1|||
144684956|NCT01263470|521697247|FG002|Overall Study|Protocol Violation|0|||
144265885|NCT00611806|520176409|FG000|Overall Study|Adverse Event|2|||
144684957|NCT01263470|521697248|FG003|Overall Study|Protocol Violation|0|||
144684958|NCT01263470|521697249|FG004|Overall Study|Protocol Violation|0|||
144684959|NCT01263470|521697250|FG005|Overall Study|Protocol Violation|1|||
144684960|NCT01263470|521697245|FG000|Overall Study|Withdrawal by Subject|0|||
144684961|NCT01263470|521697246|FG001|Overall Study|Withdrawal by Subject|1|||
144739303|NCT00933686|521900924|FG001|Overall Study|Adverse Event|1|||
144739304|NCT00933686|521900923|FG000|Overall Study|Physician Decision|1|||
144739305|NCT00933686|521900924|FG001|Overall Study|Physician Decision|0|||
144739306|NCT00933686|521900923|FG000|Overall Study|Failure to show up at endpoint visits|0|||
144739307|NCT00933686|521900924|FG001|Overall Study|Failure to show up at endpoint visits|2|||
144739308|NCT01383486|521900925|FG000|Overall Study|Lost to Follow-up|10|||
144739309|NCT01383486|521900925|FG000|Overall Study|Incomplete information for analysis|2|||
144739310|NCT01383486|521900925|FG000|Overall Study|Did not take any product|6|||
144739311|NCT00245063|521900926|FG000|Overall Study|Adverse Event|6|||
144739312|NCT00245063|521900927|FG001|Overall Study|Adverse Event|5|||
144739313|NCT00245063|521900926|FG000|Overall Study|Death|1|||
144739314|NCT00245063|521900927|FG001|Overall Study|Death|0|||
144739315|NCT01839279|521900929|FG000|Overall Study|Adverse Event|4|||
144739316|NCT01839279|521900930|FG001|Overall Study|Adverse Event|1|||
144739317|NCT01839279|521900931|FG002|Overall Study|Adverse Event|1|||
144739318|NCT01839279|521900929|FG000|Overall Study|Withdrawal by Subject|4|||
144739319|NCT01839279|521900930|FG001|Overall Study|Withdrawal by Subject|1|||
144739320|NCT01839279|521900931|FG002|Overall Study|Withdrawal by Subject|1|||
144739321|NCT01839279|521900929|FG000|Overall Study|Classified as 'Other'|5|||
144739322|NCT01839279|521900930|FG001|Overall Study|Classified as 'Other'|0|||
144739323|NCT01839279|521900931|FG002|Overall Study|Classified as 'Other'|0|||
144739324|NCT03276754|521900935|FG000|Overall Study|Withdrawal of informed consent|4|||
144684962|NCT01263470|521697247|FG002|Overall Study|Withdrawal by Subject|1|||
144739325|NCT03276754|521900935|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
144739326|NCT03276754|521900935|FG000|Overall Study|Lost to Follow-up|27|||
144684963|NCT01263470|521697248|FG003|Overall Study|Withdrawal by Subject|2|||
144684964|NCT01263470|521697249|FG004|Overall Study|Withdrawal by Subject|0|||
144684965|NCT01263470|521697250|FG005|Overall Study|Withdrawal by Subject|2|||
144684966|NCT01263470|521697245|FG000|Overall Study|Lack of Efficacy|0|||
144684967|NCT01263470|521697246|FG001|Overall Study|Lack of Efficacy|0|||
144684968|NCT01263470|521697247|FG002|Overall Study|Lack of Efficacy|2|||
144684969|NCT01263470|521697248|FG003|Overall Study|Lack of Efficacy|0|||
144684970|NCT01263470|521697249|FG004|Overall Study|Lack of Efficacy|0|||
144684971|NCT01263470|521697250|FG005|Overall Study|Lack of Efficacy|0|||
144684972|NCT01263470|521697245|FG000|Overall Study|Participant Unavailability|0|||
144684973|NCT01263470|521697246|FG001|Overall Study|Participant Unavailability|1|||
144684974|NCT01263470|521697247|FG002|Overall Study|Participant Unavailability|0|||
144684975|NCT01263470|521697248|FG003|Overall Study|Participant Unavailability|0|||
144684976|NCT01263470|521697249|FG004|Overall Study|Participant Unavailability|0|||
144684977|NCT01263470|521697250|FG005|Overall Study|Participant Unavailability|0|||
144684978|NCT01263470|521697245|FG000|Overall Study|Study Drug Non-compliance|0|||
144684979|NCT01263470|521697246|FG001|Overall Study|Study Drug Non-compliance|0|||
144684980|NCT01263470|521697247|FG002|Overall Study|Study Drug Non-compliance|0|||
144684981|NCT01263470|521697248|FG003|Overall Study|Study Drug Non-compliance|0|||
144684982|NCT01263470|521697249|FG004|Overall Study|Study Drug Non-compliance|1|||
144684983|NCT01263470|521697250|FG005|Overall Study|Study Drug Non-compliance|0|||
144684984|NCT00712712|521697251|FG000|Overall Study|Protocol Violation|11|||
144684985|NCT00712712|521697251|FG000|Overall Study|Radiofrequency not done|3|||
144684986|NCT00712712|521697251|FG000|Overall Study|Death|8|||
144684987|NCT00712712|521697251|FG000|Overall Study|Withdrawal by Subject|1|||
144684988|NCT03662789|521697252|FG000|Overall Study|Lost to Follow-up|1|||
144684989|NCT03662789|521697253|FG001|Overall Study|Lost to Follow-up|2|||
144684990|NCT03662789|521697252|FG000|Overall Study|Could not perform treadmill test|4|||
144684991|NCT03662789|521697253|FG001|Overall Study|Could not perform treadmill test|4|||
144684992|NCT03662789|521697252|FG000|Overall Study|Death|0|||
144684993|NCT03662789|521697253|FG001|Overall Study|Death|1|||
144684994|NCT03598140|521697254|FG000|Overall Study|enrolled but didn't start|1|||
144684995|NCT03598140|521697255|FG001|Overall Study|enrolled but didn't start|0|||
144684996|NCT05304611|521697256|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
144684997|NCT05304611|521697257|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
144684998|NCT05304611|521697258|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
144684999|NCT05304611|521697259|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
144685000|NCT05304611|521697260|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
144685001|NCT05304611|521697261|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
144685002|NCT05304611|521697262|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
144685003|NCT05304611|521697263|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
144685004|NCT05304611|521697264|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
144685005|NCT05304611|521697265|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
144685006|NCT05304611|521697266|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
144685007|NCT05304611|521697267|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
144739327|NCT03276754|521900935|FG000|Overall Study|No data reported at Month 24|31|||
144739328|NCT03276754|521900935|FG000|Overall Study|Death|39|||
144739329|NCT01058668|521900936|FG000|Double-blind Treatment Phase|Adverse Event|8|||
144739330|NCT01058668|521900937|FG001|Double-blind Treatment Phase|Adverse Event|15|||
144739331|NCT01058668|521900938|FG002|Double-blind Treatment Phase|Adverse Event|25|||
144685008|NCT05304611|521697256|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
144685009|NCT05304611|521697257|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
144685010|NCT05304611|521697258|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
144685011|NCT05304611|521697259|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
144685012|NCT05304611|521697260|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
144685013|NCT05304611|521697261|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
144685014|NCT05304611|521697262|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
144685015|NCT05304611|521697263|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
144685016|NCT05304611|521697264|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
144685017|NCT05304611|521697265|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
144685018|NCT05304611|521697266|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
144685019|NCT05304611|521697267|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
144685020|NCT05304611|521697256|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
144685021|NCT05304611|521697257|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
144685022|NCT05304611|521697258|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
144685023|NCT05304611|521697259|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
144685024|NCT05304611|521697260|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
144685025|NCT05304611|521697261|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
144685026|NCT05304611|521697262|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
144685027|NCT05304611|521697263|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
144685028|NCT05304611|521697264|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
144685029|NCT05304611|521697265|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
144685030|NCT05304611|521697266|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
144685031|NCT05304611|521697267|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
144685032|NCT00963820|521697268|FG000|Dose Escalation Phase|Progressive Disease|3|||
144685033|NCT00963820|521697269|FG001|Dose Escalation Phase|Progressive Disease|3|||
144685034|NCT00963820|521697270|FG002|Dose Escalation Phase|Progressive Disease|3|||
144685035|NCT00963820|521697271|FG003|Dose Escalation Phase|Progressive Disease|3|||
144685036|NCT00963820|521697272|FG004|Dose Escalation Phase|Progressive Disease|4|||
144685037|NCT00963820|521697273|FG005|Dose Escalation Phase|Progressive Disease|3|||
144685038|NCT00963820|521697274|FG006|Dose Escalation Phase|Progressive Disease|3|||
144685039|NCT00963820|521697275|FG007|Dose Escalation Phase|Progressive Disease|2|||
144685040|NCT00963820|521697276|FG008|Dose Escalation Phase|Progressive Disease|0|||
144685041|NCT00963820|521697277|FG009|Dose Escalation Phase|Progressive Disease|0|||
144685042|NCT00963820|521697278|FG010|Dose Escalation Phase|Progressive Disease|0|||
144685043|NCT00963820|521697279|FG011|Dose Escalation Phase|Progressive Disease|0|||
144685044|NCT00963820|521697268|FG000|Dose Escalation Phase|Adverse Event|0|||
144685045|NCT00963820|521697269|FG001|Dose Escalation Phase|Adverse Event|0|||
144685046|NCT00963820|521697270|FG002|Dose Escalation Phase|Adverse Event|0|||
144685047|NCT00963820|521697271|FG003|Dose Escalation Phase|Adverse Event|0|||
144685048|NCT00963820|521697272|FG004|Dose Escalation Phase|Adverse Event|0|||
144685049|NCT00963820|521697273|FG005|Dose Escalation Phase|Adverse Event|0|||
144685050|NCT00963820|521697274|FG006|Dose Escalation Phase|Adverse Event|3|||
144685051|NCT00963820|521697275|FG007|Dose Escalation Phase|Adverse Event|1|||
144685052|NCT00963820|521697276|FG008|Dose Escalation Phase|Adverse Event|0|||
144685053|NCT00963820|521697277|FG009|Dose Escalation Phase|Adverse Event|0|||
144685054|NCT00963820|521697278|FG010|Dose Escalation Phase|Adverse Event|0|||
144685055|NCT00963820|521697279|FG011|Dose Escalation Phase|Adverse Event|0|||
144685056|NCT00963820|521697268|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
144685057|NCT00963820|521697269|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
144685058|NCT00963820|521697270|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
144685059|NCT00963820|521697271|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144685060|NCT00963820|521697272|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
144685061|NCT00963820|521697273|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
144685062|NCT00963820|521697274|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
144685063|NCT00963820|521697275|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
144685064|NCT00963820|521697276|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
144685065|NCT00963820|521697277|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
144685066|NCT00963820|521697278|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
144685067|NCT00963820|521697279|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
144739332|NCT01058668|521900936|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
144685068|NCT00963820|521697268|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685069|NCT00963820|521697269|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685070|NCT00963820|521697270|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685071|NCT00963820|521697271|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685072|NCT00963820|521697272|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685073|NCT00963820|521697273|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685074|NCT00963820|521697274|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
144739333|NCT01058668|521900937|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
144685075|NCT00963820|521697275|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685076|NCT00963820|521697276|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685077|NCT00963820|521697277|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685078|NCT00963820|521697278|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685079|NCT00963820|521697279|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
144685080|NCT00963820|521697268|FG000|Expansion Phase|Progressive Disease|0|||
144685081|NCT00963820|521697269|FG001|Expansion Phase|Progressive Disease|0|||
144685082|NCT00963820|521697270|FG002|Expansion Phase|Progressive Disease|0|||
144685083|NCT00963820|521697271|FG003|Expansion Phase|Progressive Disease|0|||
144685084|NCT00963820|521697272|FG004|Expansion Phase|Progressive Disease|0|||
144685085|NCT00963820|521697273|FG005|Expansion Phase|Progressive Disease|0|||
144685086|NCT00963820|521697274|FG006|Expansion Phase|Progressive Disease|0|||
144685087|NCT00963820|521697275|FG007|Expansion Phase|Progressive Disease|0|||
144685088|NCT00963820|521697276|FG008|Expansion Phase|Progressive Disease|8|||
144685089|NCT00963820|521697277|FG009|Expansion Phase|Progressive Disease|6|||
144685090|NCT00963820|521697278|FG010|Expansion Phase|Progressive Disease|4|||
144685091|NCT00963820|521697279|FG011|Expansion Phase|Progressive Disease|2|||
144685092|NCT00963820|521697268|FG000|Expansion Phase|Adverse Event|0|||
144685093|NCT00963820|521697269|FG001|Expansion Phase|Adverse Event|0|||
144685094|NCT00963820|521697270|FG002|Expansion Phase|Adverse Event|0|||
144685095|NCT00963820|521697271|FG003|Expansion Phase|Adverse Event|0|||
144685096|NCT00963820|521697272|FG004|Expansion Phase|Adverse Event|0|||
144685097|NCT00963820|521697273|FG005|Expansion Phase|Adverse Event|0|||
144685098|NCT00963820|521697274|FG006|Expansion Phase|Adverse Event|0|||
144685099|NCT00963820|521697275|FG007|Expansion Phase|Adverse Event|0|||
144685100|NCT00963820|521697276|FG008|Expansion Phase|Adverse Event|1|||
144685101|NCT00963820|521697277|FG009|Expansion Phase|Adverse Event|3|||
144685102|NCT00963820|521697278|FG010|Expansion Phase|Adverse Event|0|||
144685103|NCT00963820|521697279|FG011|Expansion Phase|Adverse Event|0|||
144685104|NCT00963820|521697268|FG000|Expansion Phase|Withdrawal by Subject|0|||
144685105|NCT00963820|521697269|FG001|Expansion Phase|Withdrawal by Subject|0|||
144685106|NCT00963820|521697270|FG002|Expansion Phase|Withdrawal by Subject|0|||
144685107|NCT00963820|521697271|FG003|Expansion Phase|Withdrawal by Subject|0|||
144685108|NCT00963820|521697272|FG004|Expansion Phase|Withdrawal by Subject|0|||
144685109|NCT00963820|521697273|FG005|Expansion Phase|Withdrawal by Subject|0|||
144685110|NCT00963820|521697274|FG006|Expansion Phase|Withdrawal by Subject|0|||
144685111|NCT00963820|521697275|FG007|Expansion Phase|Withdrawal by Subject|0|||
144685112|NCT00963820|521697276|FG008|Expansion Phase|Withdrawal by Subject|1|||
144685113|NCT00963820|521697277|FG009|Expansion Phase|Withdrawal by Subject|0|||
144685114|NCT00963820|521697278|FG010|Expansion Phase|Withdrawal by Subject|1|||
144685115|NCT00963820|521697279|FG011|Expansion Phase|Withdrawal by Subject|1|||
144685116|NCT00963820|521697268|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685117|NCT00963820|521697269|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685118|NCT00963820|521697270|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685119|NCT00963820|521697271|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685120|NCT00963820|521697272|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685121|NCT00963820|521697273|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685122|NCT00963820|521697274|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685123|NCT00963820|521697275|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685124|NCT00963820|521697276|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685125|NCT00963820|521697277|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685126|NCT00963820|521697278|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
144685127|NCT00963820|521697279|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
144685128|NCT04556175|521697283|FG000|Overall Study|Study terminated due to COVID-19|8|||
144685129|NCT04556175|521697284|FG001|Overall Study|Study terminated due to COVID-19|8|||
144685130|NCT05549505|521697286|FG000|Overall Study|Lost to Follow-up|2|||
144685131|NCT05549505|521697287|FG001|Overall Study|Lost to Follow-up|0|||
144685132|NCT05549505|521697286|FG000|Overall Study|Withdrawal by Subject|3|||
144685133|NCT05549505|521697287|FG001|Overall Study|Withdrawal by Subject|3|||
144685134|NCT05549505|521697286|FG000|Overall Study|Other: Miscellaneous|3|||
144685135|NCT05549505|521697287|FG001|Overall Study|Other: Miscellaneous|6|||
144685136|NCT00397631|521697297|FG000|Overall Study|Adverse Event|5|||
144685137|NCT00397631|521697298|FG001|Overall Study|Adverse Event|6|||
144685138|NCT00397631|521697297|FG000|Overall Study|Lack of Efficacy|7|||
144685139|NCT00397631|521697298|FG001|Overall Study|Lack of Efficacy|10|||
144685140|NCT00397631|521697297|FG000|Overall Study|Lost to Follow-up|8|||
144685141|NCT00397631|521697298|FG001|Overall Study|Lost to Follow-up|9|||
144685142|NCT00397631|521697297|FG000|Overall Study|Physician Decision|2|||
144685143|NCT00397631|521697298|FG001|Overall Study|Physician Decision|0|||
144685144|NCT00397631|521697297|FG000|Overall Study|Protocol Violation|0|||
144685145|NCT00397631|521697298|FG001|Overall Study|Protocol Violation|1|||
144685146|NCT00397631|521697297|FG000|Overall Study|Withdrawal by Subject|7|||
144685147|NCT00397631|521697298|FG001|Overall Study|Withdrawal by Subject|14|||
144685148|NCT00397631|521697297|FG000|Overall Study|protocol discontinuation criteria|1|||
144685149|NCT00397631|521697298|FG001|Overall Study|protocol discontinuation criteria|4|||
144685150|NCT01738594|521697299|FG000|Registration and Treatment Start|Adverse Event|0|||
144739334|NCT01058668|521900938|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
144739335|NCT01058668|521900936|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
144739336|NCT01058668|521900937|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
144739337|NCT01058668|521900938|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
144739338|NCT01058668|521900936|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
144739339|NCT01058668|521900937|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
144739340|NCT01058668|521900938|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
144739341|NCT01058668|521900936|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
144739342|NCT01058668|521900937|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
144739343|NCT01058668|521900938|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
144739344|NCT01058668|521900936|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
144739345|NCT01058668|521900937|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
144739346|NCT01058668|521900938|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
144739347|NCT00316277|521900939|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
144739348|NCT00316277|521900940|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
144739349|NCT00316277|521900939|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
144739350|NCT00316277|521900940|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
144739351|NCT00316277|521900939|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
144739352|NCT00316277|521900940|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
144739353|NCT00316277|521900939|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
144739354|NCT00316277|521900940|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
144739355|NCT00316277|521900939|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
144739356|NCT00316277|521900940|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
144739357|NCT02911792|521900943|FG000|Overall Study|Lost to Follow-up|3|||
144739358|NCT02911792|521900944|FG001|Overall Study|Lost to Follow-up|3|||
144739359|NCT02911792|521900945|FG002|Overall Study|Lost to Follow-up|3|||
144739360|NCT02911792|521900946|FG003|Overall Study|Lost to Follow-up|3|||
144739361|NCT00796328|521900947|FG000|Overall Study|experienced hypotension requiring tx|6|||
144739362|NCT03199963|521900951|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
144739363|NCT03199963|521900952|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
144739364|NCT03199963|521900951|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
144739365|NCT03199963|521900952|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
144739366|NCT03199963|521900951|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
144739367|NCT03199963|521900952|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
144739368|NCT03199963|521900951|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
144739369|NCT03199963|521900952|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
144739370|NCT03199963|521900951|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
144739371|NCT03199963|521900952|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
144739372|NCT03199963|521900951|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
144739373|NCT03199963|521900952|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
144739374|NCT00107991|521900955|FG000|Eligibility Assessment|Disease not severe enough|7|||
144739375|NCT00107991|521900955|FG000|Eligibility Assessment|Unwilling to participate|7|||
144739376|NCT00107991|521900955|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
144739377|NCT00107991|521900955|FG000|Eligibility Assessment|Abnormal labs|2|||
144739378|NCT00107991|521900955|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
144739379|NCT00107991|521900955|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
144739380|NCT00107991|521900955|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
144739381|NCT00107991|521900955|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
144739382|NCT00107991|521900955|FG000|12 Week Treatment Period|Adverse Event|1|||
144739383|NCT00107991|521900955|FG000|12 Week Treatment Period|Protocol Violation|1|||
144739384|NCT00107991|521900955|FG000|12 Week Treatment Period|Incarcerated|1|||
144739385|NCT00107991|521900955|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
144218396|NCT03404674|519992337|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
144218397|NCT03404674|519992338|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
144218398|NCT03404674|519992339|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
144218399|NCT02324582|519992340|FG000|Overall Study|Screen Failures|0|||
144685151|NCT01738594|521697300|FG001|Registration and Treatment Start|Adverse Event|1|||
144685152|NCT01738594|521697301|FG002|Registration and Treatment Start|Adverse Event|0|||
144685153|NCT01738594|521697302|FG003|Registration and Treatment Start|Adverse Event|0|||
144685154|NCT01738594|521697303|FG004|Registration and Treatment Start|Adverse Event|0|||
144685155|NCT01738594|521697304|FG005|Registration and Treatment Start|Adverse Event|0|||
144685156|NCT01738594|521697305|FG006|Registration and Treatment Start|Adverse Event|0|||
144685157|NCT01738594|521697306|FG007|Registration and Treatment Start|Adverse Event|0|||
144685158|NCT01738594|521697299|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144685159|NCT01738594|521697300|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144685160|NCT01738594|521697301|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144739386|NCT01535222|521900956|FG000|Overall Study|Inclusion/exclusion|0|||
144739387|NCT01535222|521900957|FG001|Overall Study|Inclusion/exclusion|0|||
144739388|NCT01535222|521900958|FG002|Overall Study|Inclusion/exclusion|1|||
144739389|NCT01535222|521900959|FG003|Overall Study|Inclusion/exclusion|0|||
144739390|NCT01535222|521900960|FG004|Overall Study|Inclusion/exclusion|0|||
144739391|NCT01535222|521900961|FG005|Overall Study|Inclusion/exclusion|0|||
144739392|NCT03669861|521900962|FG000|Overall Study|Disease Flare|5|||
144739393|NCT03669861|521900962|FG000|Overall Study|Lack of Efficacy|2|||
144739394|NCT02760927|521900963|FG000|Overall Study|Tube Slippage from Device|1|||
144739395|NCT03256695|521900964|FG000|Overall Study|Adverse Event|8|||
144739396|NCT03256695|521900964|FG000|Overall Study|Death|2|||
144739397|NCT03256695|521900964|FG000|Overall Study|Withdrawal by Subject|14|||
144739398|NCT03256695|521900964|FG000|Overall Study|Non-compliance with study drug|1|||
144739399|NCT03256695|521900964|FG000|Overall Study|Lost to Follow-up|3|||
144739400|NCT03256695|521900964|FG000|Overall Study|Lack of Efficacy|3|||
144218400|NCT02324582|519992341|FG001|Overall Study|Screen Failures|5|||
144218401|NCT02290405|519992344|FG000|Overall Study|Withdrawal by Subject|1|||
144218402|NCT02290405|519992345|FG001|Overall Study|Withdrawal by Subject|0|||
144218403|NCT02016183|519992346|FG000|Overall Study|Case Report Forms Uncollected|13|||
144218404|NCT02016183|519992346|FG000|Overall Study|Protocol Violation|52|||
144685161|NCT01738594|521697302|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144685162|NCT01738594|521697303|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144685163|NCT01738594|521697304|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
144685164|NCT01738594|521697305|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144685165|NCT01738594|521697306|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
144685166|NCT01738594|521697299|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685167|NCT01738594|521697300|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
144685168|NCT01738594|521697301|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685169|NCT01738594|521697302|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685170|NCT01738594|521697303|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685171|NCT01738594|521697304|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685172|NCT01738594|521697305|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685173|NCT01738594|521697306|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
144685174|NCT01738594|521697299|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685175|NCT01738594|521697300|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685176|NCT01738594|521697301|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685177|NCT01738594|521697302|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685178|NCT01738594|521697303|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685179|NCT01738594|521697304|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
144685180|NCT01738594|521697305|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685181|NCT01738594|521697306|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
144685182|NCT01738594|521697299|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685183|NCT01738594|521697300|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685184|NCT01738594|521697301|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685185|NCT01738594|521697302|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685186|NCT01738594|521697303|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685187|NCT01738594|521697304|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
144685188|NCT01738594|521697305|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685189|NCT01738594|521697306|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
144685190|NCT01738594|521697299|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685191|NCT01738594|521697300|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685192|NCT01738594|521697301|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685193|NCT01738594|521697302|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685194|NCT01738594|521697303|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
144685195|NCT01738594|521697304|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685196|NCT01738594|521697305|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685197|NCT01738594|521697306|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
144685198|NCT01738594|521697299|FG000|Follow up for 1 Year|Death|0|||
144685199|NCT01738594|521697300|FG001|Follow up for 1 Year|Death|0|||
144685200|NCT01738594|521697301|FG002|Follow up for 1 Year|Death|0|||
144685201|NCT01738594|521697302|FG003|Follow up for 1 Year|Death|0|||
144685202|NCT01738594|521697303|FG004|Follow up for 1 Year|Death|0|||
144739401|NCT03256695|521900964|FG000|Overall Study|Protocol Violation|5|||
144739402|NCT03256695|521900964|FG000|Overall Study|Other than specified|3|||
144739403|NCT03930732|521900965|FG000|Overall Study|Adverse Event|9|||
144739404|NCT03930732|521900966|FG001|Overall Study|Adverse Event|7|||
144739405|NCT03930732|521900965|FG000|Overall Study|Poor compliance to protocol|0|||
144739406|NCT03930732|521900966|FG001|Overall Study|Poor compliance to protocol|1|||
144739407|NCT03930732|521900965|FG000|Overall Study|Withdrawal by Subject|23|||
144218405|NCT00996489|519992347|FG000|Overall Study|Device failure|45|||
144218406|NCT00996489|519992347|FG000|Overall Study|Discontinued|116|||
144218407|NCT00770328|519992359|FG000|Overall Study|Adverse Event|11|||
144218408|NCT00770328|519992360|FG001|Overall Study|Adverse Event|2|||
144218409|NCT00770328|519992359|FG000|Overall Study|Lost to Follow-up|2|||
144218410|NCT00770328|519992360|FG001|Overall Study|Lost to Follow-up|2|||
144218411|NCT03541317|519992363|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
144685203|NCT01738594|521697304|FG005|Follow up for 1 Year|Death|1|||
144685204|NCT01738594|521697305|FG006|Follow up for 1 Year|Death|0|||
144685205|NCT01738594|521697306|FG007|Follow up for 1 Year|Death|0|||
144685206|NCT01738594|521697299|FG000|Follow up for 1 Year|Other|0|||
144685207|NCT01738594|521697300|FG001|Follow up for 1 Year|Other|0|||
144685208|NCT01738594|521697301|FG002|Follow up for 1 Year|Other|0|||
144685209|NCT01738594|521697302|FG003|Follow up for 1 Year|Other|0|||
144685210|NCT01738594|521697303|FG004|Follow up for 1 Year|Other|0|||
144685211|NCT01738594|521697304|FG005|Follow up for 1 Year|Other|2|||
144685212|NCT01738594|521697305|FG006|Follow up for 1 Year|Other|0|||
144685213|NCT01738594|521697306|FG007|Follow up for 1 Year|Other|0|||
144685214|NCT00403390|521697308|FG000|Overall Study|Withdrawal by Subject|1|||
144685215|NCT00403390|521697309|FG001|Overall Study|Withdrawal by Subject|0|||
144685216|NCT00403390|521697308|FG000|Overall Study|samples lost|1|||
144685217|NCT00403390|521697309|FG001|Overall Study|samples lost|0|||
144685218|NCT00403390|521697308|FG000|Overall Study|non-compliant|1|||
144685219|NCT00403390|521697309|FG001|Overall Study|non-compliant|0|||
144685220|NCT01878175|521697310|FG000|Overall Study|Developed contraindicated health problem|2|||
144685221|NCT01796106|521697311|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
144685222|NCT01796106|521697312|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
144685223|NCT01108068|521697313|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
144685224|NCT01108068|521697314|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
144685225|NCT00836953|521697315|FG000|Overall Study|Withdrawal by Subject|1|||
144685226|NCT00836953|521697315|FG000|Overall Study|Lost to Follow-up|1|||
144685227|NCT02201251|521697316|FG000|Overall Study|Adverse Event|1|||
144685228|NCT02201251|521697317|FG001|Overall Study|Adverse Event|1|||
144685229|NCT02201251|521697316|FG000|Overall Study|Protocol Violation|1|||
144685230|NCT02201251|521697317|FG001|Overall Study|Protocol Violation|0|||
144685231|NCT02201251|521697316|FG000|Overall Study|Noncompliance with Study Drug|0|||
144685232|NCT02201251|521697317|FG001|Overall Study|Noncompliance with Study Drug|1|||
144685233|NCT02201251|521697316|FG000|Overall Study|Withdrawal by Subject|2|||
144685234|NCT02201251|521697317|FG001|Overall Study|Withdrawal by Subject|1|||
144685235|NCT02711553|521697318|FG000|Overall Study|Withdrawal by Subject|2|||
144685236|NCT02711553|521697319|FG001|Overall Study|Withdrawal by Subject|1|||
144685237|NCT02711553|521697320|FG002|Overall Study|Withdrawal by Subject|1|||
144685238|NCT02711553|521697321|FG003|Overall Study|Withdrawal by Subject|0|||
144685239|NCT02711553|521697318|FG000|Overall Study|Lost to Follow-up|3|||
144685240|NCT02711553|521697319|FG001|Overall Study|Lost to Follow-up|3|||
144685241|NCT02711553|521697320|FG002|Overall Study|Lost to Follow-up|6|||
144685242|NCT02711553|521697321|FG003|Overall Study|Lost to Follow-up|3|||
144685243|NCT02711553|521697318|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
144685244|NCT02711553|521697319|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
144685245|NCT02711553|521697320|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
144685246|NCT02711553|521697321|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
144685247|NCT01828567|521697322|FG000|Overall Study|Lost to Follow-up|27|||
144685248|NCT01828567|521697323|FG001|Overall Study|Lost to Follow-up|9|||
144685249|NCT01828567|521697322|FG000|Overall Study|Excluded - did not meet criteria|4|||
144685250|NCT01828567|521697323|FG001|Overall Study|Excluded - did not meet criteria|1|||
144685251|NCT02332876|521697324|FG000|Overall Study|Lost to Follow-up|1|||
144685252|NCT02332876|521697325|FG001|Overall Study|Lost to Follow-up|1|||
144685253|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
144685254|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
144685255|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
144685256|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
144685257|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
144685258|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144685259|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144685260|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144685261|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
144685262|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
144685263|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
144685264|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144685265|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
144685266|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
144685267|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
144218412|NCT03541317|519992364|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
144218413|NCT03541317|519992365|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
144739408|NCT03930732|521900966|FG001|Overall Study|Withdrawal by Subject|11|||
144739409|NCT03930732|521900965|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
144739410|NCT03930732|521900966|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
144739411|NCT03930732|521900965|FG000|Overall Study|Other reason not related to COVID-19|5|||
144739412|NCT03930732|521900966|FG001|Overall Study|Other reason not related to COVID-19|8|||
144739413|NCT00835692|521900969|FG000|First Intervention|Withdrawal by Subject|1|||
144739414|NCT00835692|521900970|FG001|First Intervention|Withdrawal by Subject|0|||
144739415|NCT03808376|521900975|FG000|Overall Study|Withdrawal by Subject|10|||
144739416|NCT00700739|521900976|FG000|Overall Study|Lost to Follow-up|4|||
144739417|NCT00700739|521900977|FG001|Overall Study|Lost to Follow-up|4|||
144739418|NCT00185458|521900979|FG000|Contraception Phase|Adverse Event|37|||
144739419|NCT00185458|521900979|FG000|Contraception Phase|Lost to Follow-up|10|||
144739420|NCT00185458|521900979|FG000|Contraception Phase|Protocol Violation|2|||
144739421|NCT00185458|521900979|FG000|Contraception Phase|Physician Decision|2|||
144739422|NCT00185458|521900979|FG000|Contraception Phase|Withdrawal by Subject|7|||
144739423|NCT00185458|521900979|FG000|HRT Phase|Adverse Event|18|||
144739424|NCT00185458|521900979|FG000|HRT Phase|Lost to Follow-up|4|||
144739425|NCT00185458|521900979|FG000|HRT Phase|Protocol Violation|2|||
144739426|NCT00185458|521900979|FG000|HRT Phase|Withdrawal by Subject|3|||
144739427|NCT01348789|521900980|FG000|Overall Study|Protocol Violation|2|||
144739428|NCT01348789|521900980|FG000|Overall Study|Withdrawal by Subject|2|||
144739429|NCT00323882|521900981|FG000|Overall Study|Adverse Event|2|||
144739430|NCT00323882|521900982|FG001|Overall Study|Adverse Event|1|||
144739431|NCT00323882|521900983|FG002|Overall Study|Adverse Event|1|||
144739432|NCT00323882|521900984|FG003|Overall Study|Adverse Event|1|||
144739433|NCT00323882|521900985|FG004|Overall Study|Adverse Event|3|||
144739434|NCT00323882|521900981|FG000|Overall Study|Disease Progression|6|||
144739435|NCT00323882|521900982|FG001|Overall Study|Disease Progression|4|||
144739436|NCT00323882|521900983|FG002|Overall Study|Disease Progression|10|||
144739437|NCT00323882|521900984|FG003|Overall Study|Disease Progression|5|||
144739438|NCT00323882|521900985|FG004|Overall Study|Disease Progression|22|||
144739439|NCT00323882|521900981|FG000|Overall Study|Death|0|||
144739440|NCT00323882|521900982|FG001|Overall Study|Death|1|||
144739441|NCT00323882|521900983|FG002|Overall Study|Death|1|||
144739442|NCT00323882|521900984|FG003|Overall Study|Death|0|||
144739443|NCT00323882|521900985|FG004|Overall Study|Death|5|||
144739444|NCT00323882|521900981|FG000|Overall Study|Lost to Follow-up|0|||
144739445|NCT00323882|521900982|FG001|Overall Study|Lost to Follow-up|0|||
144739446|NCT00323882|521900983|FG002|Overall Study|Lost to Follow-up|1|||
144739447|NCT00323882|521900984|FG003|Overall Study|Lost to Follow-up|0|||
144739448|NCT00323882|521900985|FG004|Overall Study|Lost to Follow-up|1|||
144739449|NCT00323882|521900981|FG000|Overall Study|Other|0|||
144739450|NCT00323882|521900982|FG001|Overall Study|Other|0|||
144739451|NCT00323882|521900983|FG002|Overall Study|Other|0|||
144739452|NCT00323882|521900984|FG003|Overall Study|Other|1|||
144739453|NCT00323882|521900985|FG004|Overall Study|Other|1|||
144218414|NCT03541317|519992366|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
144218415|NCT03541317|519992367|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
144218416|NCT03541317|519992368|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
144218417|NCT02286843|519992369|FG000|Overall Study|Not Treated|4|||
144739454|NCT03503318|521900988|FG000|Overall Study|Death|1|||
144739455|NCT03503318|521900989|FG001|Overall Study|Death|0|||
144739456|NCT03503318|521900990|FG002|Overall Study|Death|4|||
144739457|NCT03503318|521900988|FG000|Overall Study|Adverse Event|3|||
144739458|NCT03503318|521900989|FG001|Overall Study|Adverse Event|4|||
144739459|NCT03503318|521900990|FG002|Overall Study|Adverse Event|2|||
144739460|NCT03503318|521900988|FG000|Overall Study|Withdrawal by Subject|12|||
144739461|NCT03503318|521900989|FG001|Overall Study|Withdrawal by Subject|17|||
144739462|NCT03503318|521900990|FG002|Overall Study|Withdrawal by Subject|16|||
144739463|NCT03503318|521900988|FG000|Overall Study|Protocol Violation|5|||
144218418|NCT02286843|519992369|FG000|Overall Study|Protocol Violation|1|||
144218419|NCT02286843|519992369|FG000|Overall Study|Withdrawal by Subject|1|||
144218420|NCT03164616|519992370|FG000|Overall Study|Death|250|||
144218421|NCT03164616|519992371|FG001|Overall Study|Death|264|||
144218422|NCT03164616|519992372|FG002|Overall Study|Death|279|||
144739464|NCT03503318|521900989|FG001|Overall Study|Protocol Violation|0|||
144739465|NCT03503318|521900990|FG002|Overall Study|Protocol Violation|3|||
144739466|NCT03503318|521900988|FG000|Overall Study|Lost to Follow-up|17|||
144739467|NCT03503318|521900989|FG001|Overall Study|Lost to Follow-up|15|||
144739468|NCT03503318|521900990|FG002|Overall Study|Lost to Follow-up|12|||
144739469|NCT03503318|521900988|FG000|Overall Study|Other than specified|1|||
144739470|NCT03503318|521900989|FG001|Overall Study|Other than specified|3|||
144739471|NCT03503318|521900990|FG002|Overall Study|Other than specified|3|||
144739472|NCT00429416|521900993|FG000|Overall Study|Death|1|||
144739473|NCT03600376|521900997|FG000|Overall Study|Adverse Event|1|||
144739474|NCT03600376|521900998|FG001|Overall Study|Adverse Event|1|||
144739475|NCT03600376|521900997|FG000|Overall Study|Transferred to other facility|1|||
144739476|NCT03600376|521900998|FG001|Overall Study|Transferred to other facility|0|||
144739477|NCT03600376|521900997|FG000|Overall Study|Investigator Decision|0|||
144739478|NCT03600376|521900998|FG001|Overall Study|Investigator Decision|4|||
144739479|NCT03600376|521900997|FG000|Overall Study|Determined to be ineligible for study|0|||
144739480|NCT03600376|521900998|FG001|Overall Study|Determined to be ineligible for study|1|||
144739481|NCT03804983|521900999|FG000|Overall Study|Adverse Event|0|||
144739482|NCT03804983|521901000|FG001|Overall Study|Adverse Event|1|||
144739483|NCT03804983|521900999|FG000|Overall Study|Family Obligation|1|||
144739484|NCT03804983|521901000|FG001|Overall Study|Family Obligation|0|||
144739485|NCT02152163|521901001|FG000|Overall Study|Physician Decision|12|||
144739486|NCT02152163|521901002|FG001|Overall Study|Physician Decision|13|||
144739487|NCT00424047|521901006|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
144739488|NCT00424047|521901007|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
144739489|NCT00424047|521901006|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
144739490|NCT00424047|521901007|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
144739491|NCT00424047|521901006|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
144739492|NCT00424047|521901007|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
144739493|NCT00424047|521901006|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
144739494|NCT00424047|521901007|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
144739495|NCT00424047|521901006|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
144739496|NCT00424047|521901007|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
144739497|NCT00424047|521901006|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
144739498|NCT00424047|521901007|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
144739499|NCT00424047|521901006|FG000|On Study at Time of Unblinding|Adverse Event|22|||
144739500|NCT00424047|521901007|FG001|On Study at Time of Unblinding|Adverse Event|12|||
144739501|NCT00424047|521901006|FG000|On Study at Time of Unblinding|Progression of disease|92|||
144739502|NCT00424047|521901007|FG001|On Study at Time of Unblinding|Progression of disease|128|||
144739503|NCT00424047|521901006|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
144739504|NCT00424047|521901007|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
144739505|NCT00424047|521901006|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
144739506|NCT00424047|521901007|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
144739507|NCT00424047|521901006|FG000|On Study at Time of Unblinding|Death|11|||
144739508|NCT00424047|521901007|FG001|On Study at Time of Unblinding|Death|11|||
144739509|NCT00424047|521901006|FG000|On Study at Time of Unblinding|Other|5|||
144739510|NCT00424047|521901007|FG001|On Study at Time of Unblinding|Other|4|||
144739511|NCT00424047|521901006|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
144739512|NCT00424047|521901007|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
144739513|NCT00424047|521901006|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
144739514|NCT00424047|521901007|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
144739515|NCT00424047|521901006|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
144739516|NCT00424047|521901007|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
144739517|NCT00424047|521901006|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
144739518|NCT00424047|521901007|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
144739519|NCT00424047|521901006|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
144739520|NCT00424047|521901007|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
144739521|NCT01154231|521901009|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
144739522|NCT01154231|521901009|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
144739523|NCT01958294|521902882|FG000|Overall Study|Clinical Circumstances|2|||
144739524|NCT03599193|521902883|FG000|Overall Study|Adverse Event|0|||
144739525|NCT03599193|521902884|FG001|Overall Study|Adverse Event|2|||
144739526|NCT03599193|521902883|FG000|Overall Study|Withdrawal by Subject|1|||
144739527|NCT03599193|521902884|FG001|Overall Study|Withdrawal by Subject|0|||
144739528|NCT03599193|521902883|FG000|Overall Study|Protocol Violation|1|||
144739529|NCT03599193|521902884|FG001|Overall Study|Protocol Violation|0|||
144218423|NCT03164616|519992370|FG000|Overall Study|Lost to Follow-up|2|||
144739530|NCT03599193|521902883|FG000|Overall Study|Lost to Follow-up|0|||
144739531|NCT03599193|521902884|FG001|Overall Study|Lost to Follow-up|1|||
144739532|NCT05511935|521902885|FG000|Overall Study|Lost to Follow-up|9|||
144739533|NCT05511935|521902886|FG001|Overall Study|Lost to Follow-up|27|||
144739534|NCT04241458|521902889|FG000|Overall Study|Withdrawal by Subject|0|||
144739535|NCT04241458|521902890|FG001|Overall Study|Withdrawal by Subject|0|||
144739536|NCT04241458|521902891|FG002|Overall Study|Withdrawal by Subject|0|||
144739537|NCT04241458|521902892|FG003|Overall Study|Withdrawal by Subject|0|||
144739538|NCT04241458|521902893|FG004|Overall Study|Withdrawal by Subject|1|||
144218424|NCT03164616|519992371|FG001|Overall Study|Lost to Follow-up|2|||
144218425|NCT03164616|519992372|FG002|Overall Study|Lost to Follow-up|2|||
144218426|NCT03164616|519992370|FG000|Overall Study|Withdrawal by Subject|6|||
144739539|NCT00334815|521902894|FG000|Overall Study|Adverse Event|3|||
144739540|NCT00334815|521902895|FG001|Overall Study|Adverse Event|2|||
144739541|NCT00334815|521902894|FG000|Overall Study|Death|0|||
144739542|NCT00334815|521902895|FG001|Overall Study|Death|2|||
144739543|NCT00334815|521902894|FG000|Overall Study|Progression|1|||
144739544|NCT00334815|521902895|FG001|Overall Study|Progression|0|||
144739545|NCT00334815|521902894|FG000|Overall Study|ineligible|1|||
144739546|NCT00334815|521902895|FG001|Overall Study|ineligible|1|||
144685268|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
144685269|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
144685270|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
144685271|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
144685272|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
144685273|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
144685274|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
144685275|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
144685276|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
144685277|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Screen failure|0|||
144685278|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Screen failure|1|||
144685279|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Screen failure|2|||
144685280|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Screen failure|0|||
144685281|NCT02614261|521697326|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
144685282|NCT02614261|521697327|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
144685283|NCT02614261|521697328|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
144685284|NCT02614261|521697329|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144685285|NCT02614261|521697326|FG000|Open-Label Extension Phase|Adverse Event|23|||
144685286|NCT02614261|521697327|FG001|Open-Label Extension Phase|Adverse Event|12|||
144685287|NCT02614261|521697328|FG002|Open-Label Extension Phase|Adverse Event|11|||
144685288|NCT02614261|521697329|FG003|Open-Label Extension Phase|Adverse Event|0|||
144685289|NCT02614261|521697326|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
144685290|NCT02614261|521697327|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
144685291|NCT02614261|521697328|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
144685292|NCT02614261|521697329|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
144685293|NCT02614261|521697326|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
144685294|NCT02614261|521697327|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
144685295|NCT02614261|521697328|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
144685296|NCT02614261|521697329|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
144685297|NCT02614261|521697326|FG000|Open-Label Extension Phase|Physician Decision|2|||
144685298|NCT02614261|521697327|FG001|Open-Label Extension Phase|Physician Decision|0|||
144685299|NCT02614261|521697328|FG002|Open-Label Extension Phase|Physician Decision|0|||
144685300|NCT02614261|521697329|FG003|Open-Label Extension Phase|Physician Decision|0|||
144685301|NCT02614261|521697326|FG000|Open-Label Extension Phase|Pregnancy|1|||
144685302|NCT02614261|521697327|FG001|Open-Label Extension Phase|Pregnancy|2|||
144685303|NCT02614261|521697328|FG002|Open-Label Extension Phase|Pregnancy|1|||
144685304|NCT02614261|521697329|FG003|Open-Label Extension Phase|Pregnancy|0|||
144685305|NCT02614261|521697326|FG000|Open-Label Extension Phase|Protocol Violation|3|||
144685306|NCT02614261|521697327|FG001|Open-Label Extension Phase|Protocol Violation|4|||
144685307|NCT02614261|521697328|FG002|Open-Label Extension Phase|Protocol Violation|1|||
144685308|NCT02614261|521697329|FG003|Open-Label Extension Phase|Protocol Violation|0|||
144685309|NCT02614261|521697326|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
144685310|NCT02614261|521697327|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
144685311|NCT02614261|521697328|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
144685312|NCT02614261|521697329|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
144685313|NCT02614261|521697326|FG000|Follow-up Phase|Adverse Event|2|||
144685314|NCT02614261|521697327|FG001|Follow-up Phase|Adverse Event|0|||
144685315|NCT02614261|521697328|FG002|Follow-up Phase|Adverse Event|1|||
144685316|NCT02614261|521697329|FG003|Follow-up Phase|Adverse Event|0|||
144685317|NCT02614261|521697326|FG000|Follow-up Phase|Lost to Follow-up|12|||
144685318|NCT02614261|521697327|FG001|Follow-up Phase|Lost to Follow-up|5|||
144685319|NCT02614261|521697328|FG002|Follow-up Phase|Lost to Follow-up|2|||
144685320|NCT02614261|521697329|FG003|Follow-up Phase|Lost to Follow-up|0|||
144685321|NCT02614261|521697326|FG000|Follow-up Phase|Physician Decision|5|||
144685322|NCT02614261|521697327|FG001|Follow-up Phase|Physician Decision|1|||
144685323|NCT02614261|521697328|FG002|Follow-up Phase|Physician Decision|0|||
144685324|NCT02614261|521697329|FG003|Follow-up Phase|Physician Decision|0|||
144685325|NCT02614261|521697326|FG000|Follow-up Phase|Pregnancy|0|||
144685326|NCT02614261|521697327|FG001|Follow-up Phase|Pregnancy|1|||
144685327|NCT02614261|521697328|FG002|Follow-up Phase|Pregnancy|0|||
144685328|NCT02614261|521697329|FG003|Follow-up Phase|Pregnancy|0|||
144685329|NCT02614261|521697326|FG000|Follow-up Phase|Protocol Violation|1|||
144685330|NCT02614261|521697327|FG001|Follow-up Phase|Protocol Violation|0|||
144685331|NCT02614261|521697328|FG002|Follow-up Phase|Protocol Violation|0|||
144685332|NCT02614261|521697329|FG003|Follow-up Phase|Protocol Violation|0|||
144685333|NCT02614261|521697326|FG000|Follow-up Phase|Withdrawal by Subject|12|||
144685334|NCT02614261|521697327|FG001|Follow-up Phase|Withdrawal by Subject|4|||
144685335|NCT02614261|521697328|FG002|Follow-up Phase|Withdrawal by Subject|11|||
144685336|NCT02614261|521697329|FG003|Follow-up Phase|Withdrawal by Subject|0|||
144685337|NCT02614261|521697326|FG000|Israel Addendum|Withdrawal by Subject|0|||
144685338|NCT02614261|521697327|FG001|Israel Addendum|Withdrawal by Subject|0|||
144685339|NCT02614261|521697328|FG002|Israel Addendum|Withdrawal by Subject|0|||
144685340|NCT02614261|521697329|FG003|Israel Addendum|Withdrawal by Subject|4|||
144685341|NCT03231228|521697331|FG000|Overall Study|Lost to Follow-up|2|||
144218427|NCT03164616|519992371|FG001|Overall Study|Withdrawal by Subject|7|||
144218428|NCT03164616|519992372|FG002|Overall Study|Withdrawal by Subject|16|||
144218429|NCT00111241|519992376|FG000|Overall Study|Lost to Follow-up|1|||
144218430|NCT00111241|519992377|FG001|Overall Study|Lost to Follow-up|0|||
144218431|NCT00111241|519992376|FG000|Overall Study|Withdrawal by Subject|4|||
144218432|NCT00111241|519992377|FG001|Overall Study|Withdrawal by Subject|0|||
144685342|NCT03231228|521697332|FG001|Overall Study|Lost to Follow-up|0|||
144685343|NCT03231228|521697331|FG000|Overall Study|Physician Decision|1|||
144685344|NCT03231228|521697332|FG001|Overall Study|Physician Decision|0|||
144685345|NCT03128307|521697339|FG000|Overall Study|Lost to Follow-up|29|||
144685346|NCT03128307|521697339|FG000|Overall Study|Withdrawal by Subject|5|||
144685347|NCT03399786|521697340|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
144685348|NCT03399786|521697341|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144685349|NCT03399786|521697342|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144685350|NCT03399786|521697343|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144685351|NCT03399786|521697340|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
144685352|NCT03399786|521697341|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
144685353|NCT03399786|521697342|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
144685354|NCT03399786|521697343|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
144685355|NCT03399786|521697340|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
144685356|NCT03399786|521697341|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
144685357|NCT03399786|521697342|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
144685358|NCT03399786|521697343|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
144685359|NCT03037489|521698955|FG000|Overall Study|Adverse Event|4|||
144685360|NCT03037489|521698956|FG001|Overall Study|Adverse Event|0|||
144685361|NCT03037489|521698955|FG000|Overall Study|Withdrawal by Subject|3|||
144685362|NCT03037489|521698956|FG001|Overall Study|Withdrawal by Subject|0|||
144685363|NCT02499172|521698957|FG000|Overall Study|Financial reason|0|||
144685364|NCT02499172|521698958|FG001|Overall Study|Financial reason|0|||
144685365|NCT02499172|521698959|FG002|Overall Study|Financial reason|523|||
144685366|NCT02499172|521698960|FG003|Overall Study|Financial reason|436|||
144685367|NCT02499172|521698957|FG000|Overall Study|Lost to Follow-up|65|||
144685368|NCT02499172|521698958|FG001|Overall Study|Lost to Follow-up|64|||
144685369|NCT02499172|521698959|FG002|Overall Study|Lost to Follow-up|0|||
144685370|NCT02499172|521698960|FG003|Overall Study|Lost to Follow-up|0|||
144685371|NCT00724243|521698963|FG000|Overall Study|Lack of Efficacy|10|||
144685372|NCT00724243|521698963|FG000|Overall Study|Adverse Event|5|||
144685373|NCT04610827|521698965|FG000|Overall Study|Withdrawal by Subject|1|||
144685374|NCT04610827|521698966|FG001|Overall Study|Withdrawal by Subject|1|||
144685375|NCT04610827|521698967|FG002|Overall Study|Withdrawal by Subject|0|||
144685376|NCT01997892|521698968|FG000|Overall Study|Physician Decision|2|||
144685377|NCT01997892|521698968|FG000|Overall Study|Lost to Follow-up|6|||
144685378|NCT01997892|521698968|FG000|Overall Study|Death|14|||
144685379|NCT01997892|521698968|FG000|Overall Study|Renal transplant|8|||
144685380|NCT01997892|521698968|FG000|Overall Study|Other|3|||
144685381|NCT01997892|521698968|FG000|Overall Study|Study completion data not recorded|35|||
144685382|NCT02710422|521698969|FG000|Overall Study|Termination of study|9|||
144685383|NCT02710422|521698970|FG001|Overall Study|Termination of study|9|||
144685384|NCT01654224|521698995|FG000|Overall Study|Lost to Follow-up|2|||
144685385|NCT01654224|521698996|FG001|Overall Study|Lost to Follow-up|2|||
144685386|NCT01654224|521698995|FG000|Overall Study|Did not receive allocation|1|||
144685387|NCT01654224|521698996|FG001|Overall Study|Did not receive allocation|8|||
144685388|NCT01654224|521698995|FG000|Overall Study|Insufficient blood sample|3|||
144685389|NCT01654224|521698996|FG001|Overall Study|Insufficient blood sample|2|||
144685390|NCT03763942|521698997|FG000|Overall Study|Lost to Follow-up|114|||
144685391|NCT03763942|521698998|FG001|Overall Study|Lost to Follow-up|54|||
144685392|NCT03763942|521698997|FG000|Overall Study|Protocol Violation|1|||
144685393|NCT03763942|521698998|FG001|Overall Study|Protocol Violation|0|||
144685394|NCT03763942|521698997|FG000|Overall Study|Withdrawal by Subject|2|||
144685395|NCT03763942|521698998|FG001|Overall Study|Withdrawal by Subject|0|||
144685396|NCT03763942|521698997|FG000|Overall Study|Other|2|||
144685397|NCT03763942|521698998|FG001|Overall Study|Other|3|||
144685398|NCT02145429|521698999|FG000|Overall Study|Death|4|||
144685399|NCT02145429|521699000|FG001|Overall Study|Death|5|||
144685400|NCT02145429|521698999|FG000|Overall Study|Lost to Follow-up|4|||
144685401|NCT02145429|521699000|FG001|Overall Study|Lost to Follow-up|3|||
144685402|NCT02145429|521698999|FG000|Overall Study|Withdrawal by Subject|8|||
144685403|NCT02145429|521699000|FG001|Overall Study|Withdrawal by Subject|3|||
144218433|NCT00111241|519992376|FG000|Overall Study|Protocol Violation|9|||
144218434|NCT00111241|519992377|FG001|Overall Study|Protocol Violation|8|||
144685404|NCT02200510|521699001|FG000|Overall Study|Death|1|||
144685405|NCT02200510|521699002|FG001|Overall Study|Death|1|||
144685406|NCT02200510|521699001|FG000|Overall Study|Protocol Violation|0|||
144685407|NCT02200510|521699002|FG001|Overall Study|Protocol Violation|1|||
144685408|NCT02200510|521699001|FG000|Overall Study|Lost to Follow-up|7|||
144685409|NCT02200510|521699002|FG001|Overall Study|Lost to Follow-up|1|||
144685410|NCT02200510|521699001|FG000|Overall Study|potential COI - joined study team|1|||
144685411|NCT02200510|521699002|FG001|Overall Study|potential COI - joined study team|0|||
144685412|NCT00939055|521699003|FG000|Overall Study|Discontinuation prior to procedure|4|||
144685413|NCT00939055|521699004|FG001|Overall Study|Discontinuation prior to procedure|0|||
144685414|NCT00584987|521699005|FG000|Overall Study|Protocol Violation|1|||
144685415|NCT00584987|521699006|FG001|Overall Study|Protocol Violation|1|||
144685416|NCT00584987|521699007|FG002|Overall Study|Protocol Violation|1|||
144685417|NCT00584987|521699008|FG003|Overall Study|Protocol Violation|0|||
144685418|NCT00584987|521699005|FG000|Overall Study|Adverse Event|0|||
144685419|NCT00584987|521699006|FG001|Overall Study|Adverse Event|0|||
144685420|NCT00584987|521699007|FG002|Overall Study|Adverse Event|0|||
144685421|NCT00584987|521699008|FG003|Overall Study|Adverse Event|1|||
144685422|NCT02274311|521699012|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
144685423|NCT04564027|521699019|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
144685424|NCT04564027|521699020|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
144685425|NCT04564027|521699021|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
144685426|NCT04564027|521699022|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
144685427|NCT05827978|521699023|FG000|Overall Study|Adverse Event|1|||
144685428|NCT05827978|521699024|FG001|Overall Study|Adverse Event|0|||
144685429|NCT05827978|521699025|FG002|Overall Study|Adverse Event|0|||
144685430|NCT05827978|521699026|FG003|Overall Study|Adverse Event|1|||
144685431|NCT05827978|521699027|FG004|Overall Study|Adverse Event|0|||
144685432|NCT05827978|521699028|FG005|Overall Study|Adverse Event|0|||
144685433|NCT05827978|521699023|FG000|Overall Study|Death|1|||
144685434|NCT05827978|521699024|FG001|Overall Study|Death|5|||
144685435|NCT05827978|521699025|FG002|Overall Study|Death|2|||
144685436|NCT05827978|521699026|FG003|Overall Study|Death|3|||
144685437|NCT05827978|521699027|FG004|Overall Study|Death|1|||
144685438|NCT05827978|521699028|FG005|Overall Study|Death|3|||
144685439|NCT05827978|521699023|FG000|Overall Study|Lost to Follow-up|57|||
144685440|NCT05827978|521699024|FG001|Overall Study|Lost to Follow-up|88|||
144685441|NCT05827978|521699025|FG002|Overall Study|Lost to Follow-up|54|||
144685442|NCT05827978|521699026|FG003|Overall Study|Lost to Follow-up|47|||
144685443|NCT05827978|521699027|FG004|Overall Study|Lost to Follow-up|25|||
144685444|NCT05827978|521699028|FG005|Overall Study|Lost to Follow-up|10|||
144685445|NCT05827978|521699023|FG000|Overall Study|Noncompliance with Study Procedures|0|||
144685446|NCT05827978|521699024|FG001|Overall Study|Noncompliance with Study Procedures|1|||
144685447|NCT05827978|521699025|FG002|Overall Study|Noncompliance with Study Procedures|1|||
144685448|NCT05827978|521699026|FG003|Overall Study|Noncompliance with Study Procedures|1|||
144685449|NCT05827978|521699027|FG004|Overall Study|Noncompliance with Study Procedures|1|||
144685450|NCT05827978|521699028|FG005|Overall Study|Noncompliance with Study Procedures|0|||
144685451|NCT05827978|521699023|FG000|Overall Study|Physician Decision|2|||
144685452|NCT05827978|521699024|FG001|Overall Study|Physician Decision|0|||
144685453|NCT05827978|521699025|FG002|Overall Study|Physician Decision|1|||
144685454|NCT05827978|521699026|FG003|Overall Study|Physician Decision|2|||
144685455|NCT05827978|521699027|FG004|Overall Study|Physician Decision|1|||
144685456|NCT05827978|521699028|FG005|Overall Study|Physician Decision|1|||
144685457|NCT05827978|521699023|FG000|Overall Study|Protocol Violation|5|||
144685458|NCT05827978|521699024|FG001|Overall Study|Protocol Violation|2|||
144685459|NCT05827978|521699025|FG002|Overall Study|Protocol Violation|0|||
144685460|NCT05827978|521699026|FG003|Overall Study|Protocol Violation|0|||
144685461|NCT05827978|521699027|FG004|Overall Study|Protocol Violation|0|||
144685462|NCT05827978|521699028|FG005|Overall Study|Protocol Violation|0|||
144685463|NCT05827978|521699023|FG000|Overall Study|Withdrawal by Subject|17|||
144685464|NCT05827978|521699024|FG001|Overall Study|Withdrawal by Subject|16|||
144685465|NCT05827978|521699025|FG002|Overall Study|Withdrawal by Subject|10|||
144685466|NCT05827978|521699026|FG003|Overall Study|Withdrawal by Subject|12|||
144685467|NCT05827978|521699027|FG004|Overall Study|Withdrawal by Subject|10|||
144685468|NCT05827978|521699028|FG005|Overall Study|Withdrawal by Subject|9|||
144685469|NCT05827978|521699023|FG000|Overall Study|Other Than Specified|0|||
144685470|NCT05827978|521699024|FG001|Overall Study|Other Than Specified|0|||
144685471|NCT05827978|521699025|FG002|Overall Study|Other Than Specified|1|||
144685472|NCT05827978|521699026|FG003|Overall Study|Other Than Specified|0|||
144685473|NCT05827978|521699027|FG004|Overall Study|Other Than Specified|2|||
144685474|NCT05827978|521699028|FG005|Overall Study|Other Than Specified|0|||
144685475|NCT04566445|521699029|FG000|Overall Study|Death|4|||
144685476|NCT04566445|521699030|FG001|Overall Study|Death|1|||
144685477|NCT04566445|521699031|FG002|Overall Study|Death|1|||
144685478|NCT04566445|521699029|FG000|Overall Study|Lost to Follow-up|3|||
144685479|NCT04566445|521699030|FG001|Overall Study|Lost to Follow-up|1|||
144739547|NCT00334815|521902894|FG000|Overall Study|patient refused treatment|0|||
144685480|NCT04566445|521699031|FG002|Overall Study|Lost to Follow-up|1|||
144685481|NCT04566445|521699029|FG000|Overall Study|Study terminated by sponsor|11|||
144685482|NCT04566445|521699030|FG001|Overall Study|Study terminated by sponsor|17|||
144685483|NCT04566445|521699031|FG002|Overall Study|Study terminated by sponsor|32|||
144685484|NCT04566445|521699029|FG000|Overall Study|Withdrawal by Subject|12|||
144685485|NCT04566445|521699030|FG001|Overall Study|Withdrawal by Subject|14|||
144685486|NCT04566445|521699031|FG002|Overall Study|Withdrawal by Subject|13|||
144218435|NCT00111241|519992376|FG000|Overall Study|Adverse Event|1|||
144218436|NCT00111241|519992377|FG001|Overall Study|Adverse Event|0|||
144218437|NCT04502212|519992378|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
144218438|NCT04502212|519992378|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
144218439|NCT01808573|519992394|FG000|Overall Study|Death|212|||
144218440|NCT01808573|519992395|FG001|Overall Study|Death|240|||
144218441|NCT01808573|519992394|FG000|Overall Study|Withdrawal by Subject|12|||
144685487|NCT04566445|521699029|FG000|Overall Study|Randomized but not treated due to AE|2|||
144685488|NCT04566445|521699030|FG001|Overall Study|Randomized but not treated due to AE|1|||
144739548|NCT00334815|521902895|FG001|Overall Study|patient refused treatment|1|||
144739549|NCT00334815|521902894|FG000|Overall Study|Physician Decision|2|||
144739550|NCT00334815|521902895|FG001|Overall Study|Physician Decision|4|||
144739551|NCT06144424|521902896|FG000|Overall Study|Withdrawal by Subject|2|||
144739552|NCT06144424|521902897|FG001|Overall Study|Withdrawal by Subject|0|||
144739553|NCT06144424|521902896|FG000|Overall Study|Incarceration|1|||
144739554|NCT06144424|521902897|FG001|Overall Study|Incarceration|0|||
144739555|NCT03121586|521902898|FG000|Overall Study|Study terminated by sponsor|0|||
144739556|NCT03121586|521902899|FG001|Overall Study|Study terminated by sponsor|0|||
144739557|NCT03121586|521902900|FG002|Overall Study|Study terminated by sponsor|99|||
144739558|NCT03121586|521902898|FG000|Overall Study|Withdrawal by Subject|37|||
144739559|NCT03121586|521902899|FG001|Overall Study|Withdrawal by Subject|14|||
144739560|NCT03121586|521902900|FG002|Overall Study|Withdrawal by Subject|9|||
144739561|NCT03121586|521902898|FG000|Overall Study|Not further specified|6|||
144739562|NCT03121586|521902899|FG001|Overall Study|Not further specified|11|||
144739563|NCT03121586|521902900|FG002|Overall Study|Not further specified|10|||
144685489|NCT04566445|521699031|FG002|Overall Study|Randomized but not treated due to AE|0|||
144685490|NCT04566445|521699029|FG000|Overall Study|Adverse Event|1|||
144685491|NCT04566445|521699030|FG001|Overall Study|Adverse Event|1|||
144685492|NCT04566445|521699031|FG002|Overall Study|Adverse Event|0|||
144685493|NCT00610714|521699034|FG000|Overall Study|Adverse Event|3|||
144685494|NCT00610714|521699035|FG001|Overall Study|Adverse Event|1|||
144685495|NCT00610714|521699034|FG000|Overall Study|Death|12|||
144685496|NCT00610714|521699035|FG001|Overall Study|Death|18|||
144685497|NCT00610714|521699034|FG000|Overall Study|Withdrawal by Subject|9|||
144685498|NCT00610714|521699035|FG001|Overall Study|Withdrawal by Subject|3|||
144685499|NCT00610714|521699034|FG000|Overall Study|Study completion at 120 PFS events|2|||
144685500|NCT00610714|521699035|FG001|Overall Study|Study completion at 120 PFS events|2|||
144685501|NCT01327573|521699036|FG000|Overall Study|Physician Decision|3|||
144685502|NCT01327573|521699037|FG001|Overall Study|Physician Decision|1|||
144685503|NCT01108263|521699038|FG000|Overall Study|Adverse Event|0|||
144685504|NCT01108263|521699039|FG001|Overall Study|Adverse Event|1|||
144685505|NCT00729560|521699040|FG000|Overall Study|Withdrawal by Subject|3|||
144685506|NCT00829010|521699043|FG000|Overall Study|Adverse Event|1|||
144685507|NCT00829010|521699044|FG001|Overall Study|Adverse Event|0|||
144685508|NCT00829010|521699045|FG002|Overall Study|Adverse Event|0|||
144685509|NCT00829010|521699046|FG003|Overall Study|Adverse Event|0|||
144685510|NCT00829010|521699047|FG004|Overall Study|Adverse Event|0|||
144685511|NCT00829010|521699043|FG000|Overall Study|Withdrawal by Subject|0|||
144685512|NCT00829010|521699044|FG001|Overall Study|Withdrawal by Subject|1|||
144685513|NCT00829010|521699045|FG002|Overall Study|Withdrawal by Subject|1|||
144685514|NCT00829010|521699046|FG003|Overall Study|Withdrawal by Subject|0|||
144685515|NCT00829010|521699047|FG004|Overall Study|Withdrawal by Subject|2|||
144685516|NCT00829010|521699043|FG000|Overall Study|Lost to Follow-up|1|||
144685517|NCT00829010|521699044|FG001|Overall Study|Lost to Follow-up|0|||
144685518|NCT00829010|521699045|FG002|Overall Study|Lost to Follow-up|2|||
144685519|NCT00829010|521699046|FG003|Overall Study|Lost to Follow-up|0|||
144685520|NCT00829010|521699047|FG004|Overall Study|Lost to Follow-up|0|||
144685521|NCT00829010|521699043|FG000|Overall Study|Fatality|5|||
144685522|NCT00829010|521699044|FG001|Overall Study|Fatality|4|||
144685523|NCT00829010|521699045|FG002|Overall Study|Fatality|0|||
144685524|NCT00829010|521699046|FG003|Overall Study|Fatality|3|||
144685525|NCT00829010|521699047|FG004|Overall Study|Fatality|0|||
144739564|NCT03121586|521902898|FG000|Overall Study|Adverse Event|16|||
144739565|NCT03121586|521902899|FG001|Overall Study|Adverse Event|5|||
144739566|NCT03121586|521902900|FG002|Overall Study|Adverse Event|6|||
144739567|NCT03121586|521902898|FG000|Overall Study|Protocol Violation|0|||
144685526|NCT00829010|521699043|FG000|Overall Study|Migrated/Moved from study area|3|||
144685527|NCT00829010|521699044|FG001|Overall Study|Migrated/Moved from study area|4|||
144685528|NCT00829010|521699045|FG002|Overall Study|Migrated/Moved from study area|0|||
144685529|NCT00829010|521699046|FG003|Overall Study|Migrated/Moved from study area|5|||
144685530|NCT00829010|521699047|FG004|Overall Study|Migrated/Moved from study area|0|||
144685531|NCT01029691|521699048|FG000|Continued APAP to Delivery|Death|0|||
144685532|NCT01029691|521699049|FG001|Continued APAP to Delivery|Death|0|||
144739568|NCT03121586|521902899|FG001|Overall Study|Protocol Violation|5|||
144739569|NCT03121586|521902900|FG002|Overall Study|Protocol Violation|0|||
144685533|NCT01029691|521699050|FG002|Continued APAP to Delivery|Death|1|||
144685534|NCT01023516|521699052|FG000|Overall Study|Voluntary discontinuation|7|||
144739570|NCT03121586|521902898|FG000|Overall Study|Lack of Efficacy|3|||
144739571|NCT03121586|521902899|FG001|Overall Study|Lack of Efficacy|3|||
144739572|NCT03121586|521902900|FG002|Overall Study|Lack of Efficacy|1|||
144739573|NCT03121586|521902898|FG000|Overall Study|Physician Decision|2|||
144739574|NCT03121586|521902899|FG001|Overall Study|Physician Decision|2|||
144739575|NCT03121586|521902900|FG002|Overall Study|Physician Decision|0|||
144739576|NCT03121586|521902898|FG000|Overall Study|Noncompliance with study drug|5|||
144739577|NCT03121586|521902899|FG001|Overall Study|Noncompliance with study drug|3|||
144739578|NCT03121586|521902900|FG002|Overall Study|Noncompliance with study drug|5|||
144739579|NCT03121586|521902898|FG000|Overall Study|Lost to Follow-up|4|||
144739580|NCT03121586|521902899|FG001|Overall Study|Lost to Follow-up|2|||
144739581|NCT03121586|521902900|FG002|Overall Study|Lost to Follow-up|0|||
144739582|NCT03121586|521902898|FG000|Overall Study|Death|2|||
144739583|NCT03121586|521902899|FG001|Overall Study|Death|0|||
144739584|NCT03121586|521902900|FG002|Overall Study|Death|0|||
144739585|NCT06381102|521902901|FG000|Washout 5 Days|Withdrawal by Subject|0|||
144739586|NCT06381102|521902902|FG001|Washout 5 Days|Withdrawal by Subject|2|||
144739587|NCT02832063|521902903|FG000|Overall Study|Adverse Event|2|||
144739588|NCT02832063|521902904|FG001|Overall Study|Adverse Event|1|||
144739589|NCT02832063|521902903|FG000|Overall Study|Physician Decision|5|||
144739590|NCT02832063|521902904|FG001|Overall Study|Physician Decision|7|||
144739591|NCT02832063|521902903|FG000|Overall Study|Lost to Follow-up|15|||
144739592|NCT02832063|521902904|FG001|Overall Study|Lost to Follow-up|8|||
144739593|NCT02832063|521902903|FG000|Overall Study|Withdrawal by Subject|10|||
144739594|NCT02832063|521902904|FG001|Overall Study|Withdrawal by Subject|21|||
144739595|NCT02832063|521902903|FG000|Overall Study|Other|2|||
144739596|NCT02832063|521902904|FG001|Overall Study|Other|1|||
144739597|NCT03733730|521902905|FG000|Overall Study|Lost to Follow-up|1|||
144739598|NCT03733730|521902906|FG001|Overall Study|Lost to Follow-up|32|||
144739599|NCT03733730|521902905|FG000|Overall Study|Other|1|||
144739600|NCT03733730|521902906|FG001|Overall Study|Other|0|||
144739601|NCT03733730|521902905|FG000|Overall Study|Adverse Event|0|||
144739602|NCT03733730|521902906|FG001|Overall Study|Adverse Event|4|||
144739603|NCT03733730|521902905|FG000|Overall Study|Death|0|||
144739604|NCT03733730|521902906|FG001|Overall Study|Death|5|||
144739605|NCT03733730|521902905|FG000|Overall Study|Withdrawal by Subject|0|||
144739606|NCT03733730|521902906|FG001|Overall Study|Withdrawal by Subject|8|||
144739607|NCT00772603|521902907|FG000|Overall Study|Withdrawal by Subject|11|||
144739608|NCT00772603|521902908|FG001|Overall Study|Withdrawal by Subject|10|||
144739609|NCT00772603|521902909|FG002|Overall Study|Withdrawal by Subject|6|||
144739610|NCT00772603|521902907|FG000|Overall Study|Adverse Event|37|||
144739611|NCT00772603|521902908|FG001|Overall Study|Adverse Event|18|||
144739612|NCT00772603|521902909|FG002|Overall Study|Adverse Event|10|||
144739613|NCT00772603|521902907|FG000|Overall Study|Subject Non-compliance|1|||
144739614|NCT00772603|521902908|FG001|Overall Study|Subject Non-compliance|6|||
144739615|NCT00772603|521902909|FG002|Overall Study|Subject Non-compliance|4|||
144739616|NCT00772603|521902907|FG000|Overall Study|Protocol Violation|0|||
144739617|NCT00772603|521902908|FG001|Overall Study|Protocol Violation|1|||
144685535|NCT01023516|521699053|FG001|Overall Study|Voluntary discontinuation|5|||
144685536|NCT01023516|521699052|FG000|Overall Study|Adverse Event|9|||
144685537|NCT01023516|521699053|FG001|Overall Study|Adverse Event|6|||
144685538|NCT01023516|521699052|FG000|Overall Study|Safety reason|0|||
144685539|NCT01023516|521699053|FG001|Overall Study|Safety reason|3|||
144685540|NCT01023516|521699052|FG000|Overall Study|Study-specific criteria|4|||
144685541|NCT01023516|521699053|FG001|Overall Study|Study-specific criteria|2|||
144685542|NCT01023516|521699052|FG000|Overall Study|Incorrect enrolment|4|||
144685543|NCT01023516|521699053|FG001|Overall Study|Incorrect enrolment|2|||
144685544|NCT02060903|521699058|FG000|Overall Study|Lost to Follow-up|4|||
144685545|NCT02060903|521699059|FG001|Overall Study|Lost to Follow-up|0|||
144739618|NCT00772603|521902909|FG002|Overall Study|Protocol Violation|1|||
144685546|NCT02060903|521699058|FG000|Overall Study|Withdrawal by Subject|0|||
144685547|NCT02060903|521699059|FG001|Overall Study|Withdrawal by Subject|7|||
144685548|NCT00137267|521699060|FG000|Overall Study|Lost to Follow-up|15|||
144739619|NCT00772603|521902907|FG000|Overall Study|Lost to Follow-up|1|||
144739620|NCT00772603|521902908|FG001|Overall Study|Lost to Follow-up|5|||
144739621|NCT00772603|521902909|FG002|Overall Study|Lost to Follow-up|2|||
144739622|NCT00772603|521902907|FG000|Overall Study|Physician Decision|0|||
144739623|NCT00772603|521902908|FG001|Overall Study|Physician Decision|0|||
144685549|NCT00137267|521699061|FG001|Overall Study|Lost to Follow-up|21|||
144685550|NCT00638989|521699063|FG000|Overall Study|Lost to Follow-up|0|||
144685551|NCT00638989|521699064|FG001|Overall Study|Lost to Follow-up|0|||
144685552|NCT00638989|521699065|FG002|Overall Study|Lost to Follow-up|1|||
144685553|NCT05245071|521699067|FG000|Overall Study|Progressive disease|18|||
144739624|NCT00772603|521902909|FG002|Overall Study|Physician Decision|1|||
144739625|NCT00772603|521902907|FG000|Overall Study|Other|2|||
144739626|NCT00772603|521902908|FG001|Overall Study|Other|0|||
144739627|NCT00772603|521902909|FG002|Overall Study|Other|2|||
144739628|NCT00446966|521902912|FG000|Overall Study|Lost to Follow-up|10|||
144739629|NCT00446966|521902913|FG001|Overall Study|Lost to Follow-up|7|||
144739630|NCT01440803|521902914|FG000|Overall Study|Met study stopping rule|2|||
144739631|NCT01440803|521902915|FG001|Overall Study|Met study stopping rule|1|||
144739632|NCT01440803|521902914|FG000|Overall Study|Lost to Follow-up|0|||
144739633|NCT01440803|521902915|FG001|Overall Study|Lost to Follow-up|2|||
144739634|NCT01440803|521902914|FG000|Overall Study|Withdrawal by Subject|0|||
144739635|NCT01440803|521902915|FG001|Overall Study|Withdrawal by Subject|1|||
144739636|NCT00443651|521902916|FG000|Overall Study|Death|1|||
144739637|NCT00443651|521902917|FG001|Overall Study|Death|5|||
144739638|NCT00443651|521902916|FG000|Overall Study|Adverse Event|5|||
144739639|NCT00443651|521902917|FG001|Overall Study|Adverse Event|6|||
144739640|NCT00443651|521902916|FG000|Overall Study|Lost to Follow-up|18|||
144739641|NCT00443651|521902917|FG001|Overall Study|Lost to Follow-up|12|||
144218442|NCT01808573|519992395|FG001|Overall Study|Withdrawal by Subject|10|||
144218443|NCT01808573|519992394|FG000|Overall Study|Lost to Follow-up|3|||
144218444|NCT01808573|519992395|FG001|Overall Study|Lost to Follow-up|0|||
144218445|NCT01808573|519992394|FG000|Overall Study|Discontinuation of study by sponsor|79|||
144218446|NCT01808573|519992395|FG001|Overall Study|Discontinuation of study by sponsor|64|||
144218447|NCT01808573|519992394|FG000|Overall Study|Randomized in Error|1|||
144218448|NCT01808573|519992395|FG001|Overall Study|Randomized in Error|0|||
144218449|NCT01523002|519992398|FG000|Period 1|Withdrawal by Subject|1|||
144218450|NCT01523002|519992399|FG001|Period 1|Withdrawal by Subject|3|||
144218451|NCT01523002|519992398|FG000|Period 1|Lost to Follow-up|1|||
144218452|NCT01523002|519992399|FG001|Period 1|Lost to Follow-up|0|||
144218453|NCT01523002|519992398|FG000|Period 1|Adverse Event|0|||
144218454|NCT01523002|519992399|FG001|Period 1|Adverse Event|8|||
144739642|NCT00443651|521902916|FG000|Overall Study|Patient's/Guardian's Decision|58|||
144739643|NCT00443651|521902917|FG001|Overall Study|Patient's/Guardian's Decision|30|||
144739644|NCT00443651|521902916|FG000|Overall Study|Physician Decision|13|||
144739645|NCT00443651|521902917|FG001|Overall Study|Physician Decision|4|||
144739646|NCT00443651|521902916|FG000|Overall Study|Pregnancy|0|||
144739647|NCT00443651|521902917|FG001|Overall Study|Pregnancy|1|||
144739648|NCT01564394|521902918|FG000|Overall Study|Withdrawal by Subject|6|||
144739649|NCT01564394|521902919|FG001|Overall Study|Withdrawal by Subject|10|||
144739650|NCT00859521|521902920|FG000|Washout|Withdrawal by Subject|0|||
144739651|NCT00859521|521902921|FG001|Washout|Withdrawal by Subject|1|||
144739652|NCT02125461|521902922|FG000|Overall Study|Withdrawal by Subject|30|||
144739653|NCT02125461|521902923|FG001|Overall Study|Withdrawal by Subject|16|||
144739654|NCT02125461|521902922|FG000|Overall Study|Lost to Follow-up|8|||
144739655|NCT02125461|521902923|FG001|Overall Study|Lost to Follow-up|3|||
144739656|NCT02125461|521902922|FG000|Overall Study|Death|260|||
144739657|NCT02125461|521902923|FG001|Overall Study|Death|149|||
144739658|NCT02125461|521902922|FG000|Overall Study|Missing Termination Reason|0|||
144739659|NCT02125461|521902923|FG001|Overall Study|Missing Termination Reason|1|||
144739660|NCT02888756|521902924|FG000|Analytical Treatment Interruption|Physician Decision|10|||
144739661|NCT02888756|521902925|FG001|Analytical Treatment Interruption|Physician Decision|6|||
144739662|NCT02888756|521902926|FG002|Analytical Treatment Interruption|Physician Decision|5|||
144739663|NCT01547286|521902936|FG000|Overall Study|Did not meet all eligibility criteria|1|||
144739664|NCT01547286|521902936|FG000|Overall Study|Physician Decision|1|||
144739665|NCT03415308|521902940|FG000|Overall Study|Lost to Follow-up|0|||
144739666|NCT03415308|521902941|FG001|Overall Study|Lost to Follow-up|0|||
144739667|NCT03415308|521902942|FG002|Overall Study|Lost to Follow-up|1|||
144739668|NCT03415308|521902940|FG000|Overall Study|Scheduling Conflicts|0|||
144739669|NCT03415308|521902941|FG001|Overall Study|Scheduling Conflicts|0|||
144739670|NCT03415308|521902942|FG002|Overall Study|Scheduling Conflicts|7|||
144739671|NCT01471353|521902943|FG000|Overall Study|remain on study|3|||
144739672|NCT00836472|521902944|FG000|Washout|Adverse Event|1|||
144739673|NCT00836472|521902945|FG001|Washout|Adverse Event|2|||
144739674|NCT00836472|521902944|FG000|Washout|Withdrawal by Subject|1|||
144739675|NCT00836472|521902945|FG001|Washout|Withdrawal by Subject|1|||
144218455|NCT01523002|519992398|FG000|Period 2|Withdrawal by Subject|4|||
144218456|NCT01523002|519992399|FG001|Period 2|Withdrawal by Subject|1|||
144218457|NCT01523002|519992398|FG000|Period 2|Adverse Event|2|||
144218458|NCT01523002|519992399|FG001|Period 2|Adverse Event|5|||
144218459|NCT01523002|519992398|FG000|Period 3|Withdrawal by Subject|1|||
144218460|NCT01523002|519992399|FG001|Period 3|Withdrawal by Subject|0|||
144218461|NCT01523002|519992398|FG000|Period 3|Adverse Event|3|||
144739676|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
144739677|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
144739678|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
144739679|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
144739680|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144218462|NCT01523002|519992399|FG001|Period 3|Adverse Event|0|||
144218463|NCT05101343|519992403|FG000|Overall Study|Withdrawal by Subject|2|||
144739681|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739682|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144218464|NCT05101343|519992404|FG001|Overall Study|Withdrawal by Subject|1|||
144739683|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144218465|NCT06082843|519994393|FG000|Overall Study|Withdrawal by Subject|0|||
144739684|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739685|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739686|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739687|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739688|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739689|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
144739690|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
144739691|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
144739692|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
144739693|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
144739694|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739695|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739696|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739697|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739698|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739699|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739700|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739701|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739702|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739703|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
144739704|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
144739705|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739706|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
144739707|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739708|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739709|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739710|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739711|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739712|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739713|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739714|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739715|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739716|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739717|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
144739718|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
144739719|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
144739720|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
144739721|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739722|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739723|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739724|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739725|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739726|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739727|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739728|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739729|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739730|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739731|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
144739732|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
144739733|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739734|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
144685554|NCT05245071|521699067|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
144685555|NCT05245071|521699067|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
144685556|NCT01602822|521699068|FG000|Overall Study|Adverse Event|11|||
144685557|NCT00853112|521699071|FG000|Overall Study|Randomized but not treated|0|||
144685558|NCT00853112|521699072|FG001|Overall Study|Randomized but not treated|1|||
144685559|NCT00853112|521699073|FG002|Overall Study|Randomized but not treated|0|||
144685560|NCT00853112|521699074|FG003|Overall Study|Randomized but not treated|2|||
144685561|NCT00853112|521699075|FG004|Overall Study|Randomized but not treated|0|||
144685562|NCT00853112|521699076|FG005|Overall Study|Randomized but not treated|0|||
144685563|NCT00853112|521699077|FG006|Overall Study|Randomized but not treated|1|||
144739735|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739736|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144685564|NCT02477800|521699080|FG000|Placebo-Controlled Period|Adverse Event|16|||
144739737|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739738|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144685565|NCT02477800|521699081|FG001|Placebo-Controlled Period|Adverse Event|25|||
144685566|NCT02477800|521699082|FG002|Placebo-Controlled Period|Adverse Event|28|||
144685567|NCT02477800|521699083|FG003|Placebo-Controlled Period|Adverse Event|0|||
144685568|NCT02477800|521699084|FG004|Placebo-Controlled Period|Adverse Event|0|||
144685569|NCT02477800|521699085|FG005|Placebo-Controlled Period|Adverse Event|0|||
144685570|NCT02477800|521699086|FG006|Placebo-Controlled Period|Adverse Event|0|||
144685571|NCT02477800|521699080|FG000|Placebo-Controlled Period|Change of Treatment|1|||
144685572|NCT02477800|521699081|FG001|Placebo-Controlled Period|Change of Treatment|2|||
144685573|NCT02477800|521699082|FG002|Placebo-Controlled Period|Change of Treatment|1|||
144685574|NCT02477800|521699083|FG003|Placebo-Controlled Period|Change of Treatment|0|||
144685575|NCT02477800|521699084|FG004|Placebo-Controlled Period|Change of Treatment|0|||
144685576|NCT02477800|521699085|FG005|Placebo-Controlled Period|Change of Treatment|0|||
144685577|NCT02477800|521699086|FG006|Placebo-Controlled Period|Change of Treatment|0|||
144685578|NCT02477800|521699080|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
144685579|NCT02477800|521699081|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
144685580|NCT02477800|521699082|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
144685581|NCT02477800|521699083|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
144685582|NCT02477800|521699084|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
144685583|NCT02477800|521699085|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
144685584|NCT02477800|521699086|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
144685585|NCT02477800|521699080|FG000|Placebo-Controlled Period|Death|0|||
144685586|NCT02477800|521699081|FG001|Placebo-Controlled Period|Death|3|||
144685587|NCT02477800|521699082|FG002|Placebo-Controlled Period|Death|2|||
144685588|NCT02477800|521699083|FG003|Placebo-Controlled Period|Death|0|||
144685589|NCT02477800|521699084|FG004|Placebo-Controlled Period|Death|0|||
144685590|NCT02477800|521699085|FG005|Placebo-Controlled Period|Death|0|||
144685591|NCT02477800|521699086|FG006|Placebo-Controlled Period|Death|0|||
144685592|NCT02477800|521699080|FG000|Placebo-Controlled Period|Disease Progression|1|||
144685593|NCT02477800|521699081|FG001|Placebo-Controlled Period|Disease Progression|0|||
144685594|NCT02477800|521699082|FG002|Placebo-Controlled Period|Disease Progression|1|||
144685595|NCT02477800|521699083|FG003|Placebo-Controlled Period|Disease Progression|0|||
144685596|NCT02477800|521699084|FG004|Placebo-Controlled Period|Disease Progression|0|||
144685597|NCT02477800|521699085|FG005|Placebo-Controlled Period|Disease Progression|0|||
144685598|NCT02477800|521699086|FG006|Placebo-Controlled Period|Disease Progression|0|||
144685599|NCT02477800|521699080|FG000|Placebo-Controlled Period|Investigator Decision|3|||
144685600|NCT02477800|521699081|FG001|Placebo-Controlled Period|Investigator Decision|2|||
144685601|NCT02477800|521699082|FG002|Placebo-Controlled Period|Investigator Decision|1|||
144685602|NCT02477800|521699083|FG003|Placebo-Controlled Period|Investigator Decision|0|||
144685603|NCT02477800|521699084|FG004|Placebo-Controlled Period|Investigator Decision|0|||
144685604|NCT02477800|521699085|FG005|Placebo-Controlled Period|Investigator Decision|0|||
144685605|NCT02477800|521699086|FG006|Placebo-Controlled Period|Investigator Decision|0|||
144685606|NCT02477800|521699080|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
144685607|NCT02477800|521699081|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
144685608|NCT02477800|521699082|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
144685609|NCT02477800|521699083|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
144685610|NCT02477800|521699084|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
144685611|NCT02477800|521699085|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
144685612|NCT02477800|521699086|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
144685613|NCT02477800|521699080|FG000|Placebo-Controlled Period|Relocation|2|||
144685614|NCT02477800|521699081|FG001|Placebo-Controlled Period|Relocation|0|||
144685615|NCT02477800|521699082|FG002|Placebo-Controlled Period|Relocation|0|||
144685616|NCT02477800|521699083|FG003|Placebo-Controlled Period|Relocation|0|||
144685617|NCT02477800|521699084|FG004|Placebo-Controlled Period|Relocation|0|||
144685618|NCT02477800|521699085|FG005|Placebo-Controlled Period|Relocation|0|||
144685619|NCT02477800|521699086|FG006|Placebo-Controlled Period|Relocation|0|||
144685620|NCT02477800|521699080|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
144685621|NCT02477800|521699081|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
144685622|NCT02477800|521699082|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
144685623|NCT02477800|521699083|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
144685624|NCT02477800|521699084|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
144685625|NCT02477800|521699085|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
144685626|NCT02477800|521699086|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
144685627|NCT02477800|521699080|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
144685628|NCT02477800|521699081|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
144685629|NCT02477800|521699082|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
144685630|NCT02477800|521699083|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
144685631|NCT02477800|521699084|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
144685632|NCT02477800|521699085|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
144739739|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144685633|NCT02477800|521699086|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
144685634|NCT02477800|521699080|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
144685635|NCT02477800|521699081|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
144739740|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739741|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739742|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739743|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739744|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739745|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
144739746|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
144739747|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739748|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
144739749|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739750|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739751|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739752|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739753|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739754|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739755|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739756|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739757|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739758|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739759|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
144739760|NCT01695239|521902946|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
144739761|NCT01695239|521902947|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739762|NCT01695239|521902948|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739763|NCT01695239|521902949|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739764|NCT01695239|521902950|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739765|NCT01695239|521902951|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739766|NCT01695239|521902952|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739767|NCT01695239|521902953|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739768|NCT01695239|521902954|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739769|NCT01695239|521902955|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739770|NCT01695239|521902956|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739771|NCT01695239|521902957|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739772|NCT01695239|521902958|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739773|NCT01695239|521902959|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
144739774|NCT01695239|521902946|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739775|NCT01695239|521902947|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739776|NCT01695239|521902948|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739777|NCT01695239|521902949|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739778|NCT01695239|521902950|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739779|NCT01695239|521902951|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739780|NCT01695239|521902952|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739781|NCT01695239|521902953|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
144739782|NCT01695239|521902954|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739783|NCT01695239|521902955|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739784|NCT01695239|521902956|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739785|NCT01695239|521902957|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739786|NCT01695239|521902958|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739787|NCT01695239|521902959|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
144739788|NCT01695239|521902946|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739789|NCT01695239|521902947|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739790|NCT01695239|521902948|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739791|NCT01695239|521902949|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739792|NCT01695239|521902950|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739793|NCT01695239|521902951|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144218466|NCT06082843|519994394|FG001|Overall Study|Withdrawal by Subject|2|||
144218467|NCT06082843|519994393|FG000|Overall Study|Study terminated by sponsor|12|||
144218468|NCT06082843|519994394|FG001|Overall Study|Study terminated by sponsor|8|||
144218469|NCT05878093|519994396|FG000|Overall Study|Withdrawal by Subject|3|||
144218470|NCT05878093|519994397|FG001|Overall Study|Withdrawal by Subject|1|||
144218471|NCT04100018|519994403|FG000|Pre-Treatment Period|Not Reported|0|||
144218472|NCT04100018|519994404|FG001|Pre-Treatment Period|Not Reported|4|||
144218473|NCT04100018|519994403|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
144739794|NCT01695239|521902952|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144218474|NCT04100018|519994404|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
144218475|NCT04100018|519994403|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
144739795|NCT01695239|521902953|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
144739796|NCT01695239|521902954|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739797|NCT01695239|521902955|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739798|NCT01695239|521902956|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739799|NCT01695239|521902957|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739800|NCT01695239|521902958|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739801|NCT01695239|521902959|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
144739802|NCT01695239|521902946|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739803|NCT01695239|521902947|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739804|NCT01695239|521902948|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739805|NCT01695239|521902949|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739806|NCT01695239|521902950|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739807|NCT01695239|521902951|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739808|NCT01695239|521902952|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739809|NCT01695239|521902953|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
144739810|NCT01695239|521902954|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739811|NCT01695239|521902955|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739812|NCT01695239|521902956|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739813|NCT01695239|521902957|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739814|NCT01695239|521902958|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739815|NCT01695239|521902959|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
144739816|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739817|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739818|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739819|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739820|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739821|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739822|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739823|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739824|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
144739825|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
144739826|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739827|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739828|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739829|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
144739830|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
144739831|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
144739832|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
144739833|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
144739834|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
144739835|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
144739836|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
144739837|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
144739838|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
144739839|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
144739840|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
144739841|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
144739842|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
144739843|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
144739844|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739845|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739846|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144265886|NCT00611806|520176410|FG001|Overall Study|Adverse Event|1|||
144265887|NCT00611806|520176409|FG000|Overall Study|Lost to Follow-up|6|||
144739847|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739848|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739849|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739850|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739851|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739852|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
144739853|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
144739854|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739855|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739856|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144265888|NCT00611806|520176410|FG001|Overall Study|Lost to Follow-up|0|||
144739857|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
144739858|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
144739859|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
144739860|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
144739861|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
144739862|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
144739863|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
144739864|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
144739865|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
144739866|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
144739867|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
144739868|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
144739869|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
144739870|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
144739871|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
144739872|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739873|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739874|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739875|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739876|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739877|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739878|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739879|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739880|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
144739881|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
144739882|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739883|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739884|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739885|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
144739886|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739887|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739888|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739889|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739890|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739891|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739892|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739893|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739894|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
144739895|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
144739896|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739897|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739898|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739899|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
144739900|NCT01695239|521902946|FG000|Extension Long-Term Extension Periods|Death|0|||
144739901|NCT01695239|521902947|FG001|Extension Long-Term Extension Periods|Death|0|||
144739902|NCT01695239|521902948|FG002|Extension Long-Term Extension Periods|Death|0|||
144739903|NCT01695239|521902949|FG003|Extension Long-Term Extension Periods|Death|0|||
144739904|NCT01695239|521902950|FG004|Extension Long-Term Extension Periods|Death|0|||
144739905|NCT01695239|521902951|FG005|Extension Long-Term Extension Periods|Death|0|||
144739906|NCT01695239|521902952|FG006|Extension Long-Term Extension Periods|Death|0|||
144739907|NCT01695239|521902953|FG007|Extension Long-Term Extension Periods|Death|0|||
144739908|NCT01695239|521902954|FG008|Extension Long-Term Extension Periods|Death|1|||
144739909|NCT01695239|521902955|FG009|Extension Long-Term Extension Periods|Death|0|||
144739910|NCT01695239|521902956|FG010|Extension Long-Term Extension Periods|Death|0|||
144739911|NCT01695239|521902957|FG011|Extension Long-Term Extension Periods|Death|0|||
144739912|NCT01695239|521902958|FG012|Extension Long-Term Extension Periods|Death|0|||
144739913|NCT01695239|521902959|FG013|Extension Long-Term Extension Periods|Death|0|||
144739914|NCT01695239|521902946|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739915|NCT01695239|521902947|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739916|NCT01695239|521902948|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739917|NCT01695239|521902949|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739918|NCT01695239|521902950|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739919|NCT01695239|521902951|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739920|NCT01695239|521902952|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739921|NCT01695239|521902953|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144218476|NCT04100018|519994404|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
144685636|NCT02477800|521699082|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
144685637|NCT02477800|521699083|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
144685638|NCT02477800|521699084|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
144685639|NCT02477800|521699085|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
144685640|NCT02477800|521699086|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
144685641|NCT02477800|521699080|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
144685642|NCT02477800|521699081|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
144685643|NCT02477800|521699082|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
144685644|NCT02477800|521699083|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144685645|NCT02477800|521699084|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144685646|NCT02477800|521699085|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144685647|NCT02477800|521699086|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
144685648|NCT02477800|521699080|FG000|Placebo-Controlled Period|Reason not Specified|161|||
144685649|NCT02477800|521699081|FG001|Placebo-Controlled Period|Reason not Specified|161|||
144685650|NCT02477800|521699082|FG002|Placebo-Controlled Period|Reason not Specified|189|||
144685651|NCT02477800|521699083|FG003|Placebo-Controlled Period|Reason not Specified|0|||
144685652|NCT02477800|521699084|FG004|Placebo-Controlled Period|Reason not Specified|0|||
144685653|NCT02477800|521699085|FG005|Placebo-Controlled Period|Reason not Specified|0|||
144685654|NCT02477800|521699086|FG006|Placebo-Controlled Period|Reason not Specified|0|||
144685655|NCT02477800|521699080|FG000|Long Term Extension Period|Adverse Event|0|||
144685656|NCT02477800|521699081|FG001|Long Term Extension Period|Adverse Event|0|||
144685657|NCT02477800|521699082|FG002|Long Term Extension Period|Adverse Event|0|||
144685658|NCT02477800|521699083|FG003|Long Term Extension Period|Adverse Event|6|||
144685659|NCT02477800|521699084|FG004|Long Term Extension Period|Adverse Event|2|||
144685660|NCT02477800|521699085|FG005|Long Term Extension Period|Adverse Event|4|||
144685661|NCT02477800|521699086|FG006|Long Term Extension Period|Adverse Event|3|||
144685662|NCT02477800|521699080|FG000|Long Term Extension Period|Death|0|||
144685663|NCT02477800|521699081|FG001|Long Term Extension Period|Death|0|||
144685664|NCT02477800|521699082|FG002|Long Term Extension Period|Death|0|||
144685665|NCT02477800|521699083|FG003|Long Term Extension Period|Death|1|||
144685666|NCT02477800|521699084|FG004|Long Term Extension Period|Death|1|||
144685667|NCT02477800|521699085|FG005|Long Term Extension Period|Death|1|||
144685668|NCT02477800|521699086|FG006|Long Term Extension Period|Death|2|||
144685669|NCT02477800|521699080|FG000|Long Term Extension Period|Consent Withdrawn|0|||
144685670|NCT02477800|521699081|FG001|Long Term Extension Period|Consent Withdrawn|0|||
144685671|NCT02477800|521699082|FG002|Long Term Extension Period|Consent Withdrawn|0|||
144685672|NCT02477800|521699083|FG003|Long Term Extension Period|Consent Withdrawn|10|||
144685673|NCT02477800|521699084|FG004|Long Term Extension Period|Consent Withdrawn|4|||
144685674|NCT02477800|521699085|FG005|Long Term Extension Period|Consent Withdrawn|13|||
144685675|NCT02477800|521699086|FG006|Long Term Extension Period|Consent Withdrawn|16|||
144685676|NCT02477800|521699080|FG000|Long Term Extension Period|Disease Progression|0|||
144685677|NCT02477800|521699081|FG001|Long Term Extension Period|Disease Progression|0|||
144685678|NCT02477800|521699082|FG002|Long Term Extension Period|Disease Progression|0|||
144685679|NCT02477800|521699083|FG003|Long Term Extension Period|Disease Progression|3|||
144685680|NCT02477800|521699084|FG004|Long Term Extension Period|Disease Progression|1|||
144685681|NCT02477800|521699085|FG005|Long Term Extension Period|Disease Progression|1|||
144685682|NCT02477800|521699086|FG006|Long Term Extension Period|Disease Progression|0|||
144685683|NCT02477800|521699080|FG000|Long Term Extension Period|Investigator Decision|0|||
144685684|NCT02477800|521699081|FG001|Long Term Extension Period|Investigator Decision|0|||
144685685|NCT02477800|521699082|FG002|Long Term Extension Period|Investigator Decision|0|||
144685686|NCT02477800|521699083|FG003|Long Term Extension Period|Investigator Decision|0|||
144685687|NCT02477800|521699084|FG004|Long Term Extension Period|Investigator Decision|0|||
144685688|NCT02477800|521699085|FG005|Long Term Extension Period|Investigator Decision|0|||
144685689|NCT02477800|521699086|FG006|Long Term Extension Period|Investigator Decision|2|||
144685690|NCT02477800|521699080|FG000|Long Term Extension Period|Lost to Follow-up|0|||
144685691|NCT02477800|521699081|FG001|Long Term Extension Period|Lost to Follow-up|0|||
144685692|NCT02477800|521699082|FG002|Long Term Extension Period|Lost to Follow-up|0|||
144685693|NCT02477800|521699083|FG003|Long Term Extension Period|Lost to Follow-up|0|||
144685694|NCT02477800|521699084|FG004|Long Term Extension Period|Lost to Follow-up|1|||
144685695|NCT02477800|521699085|FG005|Long Term Extension Period|Lost to Follow-up|3|||
144685696|NCT02477800|521699086|FG006|Long Term Extension Period|Lost to Follow-up|0|||
144685697|NCT02477800|521699080|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
144685698|NCT02477800|521699081|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
144685699|NCT02477800|521699082|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
144685700|NCT02477800|521699083|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
144685701|NCT02477800|521699084|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
144685702|NCT02477800|521699085|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
144685703|NCT02477800|521699086|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
144685704|NCT02477800|521699080|FG000|Long Term Extension Period|Study Visit Burden|0|||
144685705|NCT02477800|521699081|FG001|Long Term Extension Period|Study Visit Burden|0|||
144739922|NCT01695239|521902954|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739923|NCT01695239|521902955|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144739924|NCT01695239|521902956|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
144685706|NCT02477800|521699082|FG002|Long Term Extension Period|Study Visit Burden|0|||
144685707|NCT02477800|521699083|FG003|Long Term Extension Period|Study Visit Burden|3|||
144685708|NCT02477800|521699084|FG004|Long Term Extension Period|Study Visit Burden|0|||
144685709|NCT02477800|521699085|FG005|Long Term Extension Period|Study Visit Burden|2|||
144685710|NCT02477800|521699086|FG006|Long Term Extension Period|Study Visit Burden|2|||
144685711|NCT02477800|521699080|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
144685712|NCT02477800|521699081|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
144685713|NCT02477800|521699082|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
144685714|NCT02477800|521699083|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
144685715|NCT02477800|521699084|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
144685716|NCT02477800|521699085|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
144685717|NCT02477800|521699086|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
144685718|NCT02477800|521699080|FG000|Long Term Extension Period|Reason not Specified|0|||
144685719|NCT02477800|521699081|FG001|Long Term Extension Period|Reason not Specified|0|||
144685720|NCT02477800|521699082|FG002|Long Term Extension Period|Reason not Specified|0|||
144685721|NCT02477800|521699083|FG003|Long Term Extension Period|Reason not Specified|126|||
144685722|NCT02477800|521699084|FG004|Long Term Extension Period|Reason not Specified|140|||
144685723|NCT02477800|521699085|FG005|Long Term Extension Period|Reason not Specified|270|||
144685724|NCT02477800|521699086|FG006|Long Term Extension Period|Reason not Specified|224|||
144685725|NCT02871791|521699087|FG000|Phase 1b|Death|0|||
144685726|NCT02871791|521699088|FG001|Phase 1b|Death|1|||
144685727|NCT02871791|521699087|FG000|Phase 1b|progressive disease|6|||
144685728|NCT02871791|521699088|FG001|Phase 1b|progressive disease|2|||
144685729|NCT02871791|521699087|FG000|Phase 2|Death|1|||
144685730|NCT02871791|521699088|FG001|Phase 2|Death|0|||
144685731|NCT02871791|521699087|FG000|Phase 2|Lost to Follow-up|2|||
144685732|NCT02871791|521699088|FG001|Phase 2|Lost to Follow-up|0|||
144685733|NCT01426009|521699091|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
144685734|NCT01426009|521699091|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
144685735|NCT01426009|521699091|FG000|Washout 1|Withdrawal by Subject|1|||
144685736|NCT01426009|521699091|FG000|Washout 1|Personal Reasons|1|||
144685737|NCT01426009|521699091|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
144685738|NCT01426009|521699091|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
144685739|NCT01426009|521699091|FG000|Washout 2|electrive surgery|1|||
144685740|NCT01426009|521699091|FG000|Washout 3|personal reasons|1|||
144685741|NCT01426009|521699091|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
144685742|NCT01426009|521699091|FG000|Washout 4|Lost to Follow-up|1|||
144685743|NCT02010567|521699097|FG000|Overall Study|Adverse Event|0|||
144685744|NCT02010567|521699098|FG001|Overall Study|Adverse Event|0|||
144685745|NCT02010567|521699099|FG002|Overall Study|Adverse Event|1|||
144685746|NCT02010567|521699100|FG003|Overall Study|Adverse Event|0|||
144685747|NCT02010567|521699101|FG004|Overall Study|Adverse Event|1|||
144685748|NCT00118040|521699106|FG000|Overall Study|Adverse Event|0|||
144685749|NCT00118040|521699107|FG001|Overall Study|Adverse Event|1|||
144685750|NCT00118040|521699108|FG002|Overall Study|Adverse Event|0|||
144685751|NCT00118040|521699106|FG000|Overall Study|Withdrawal by Subject|0|||
144685752|NCT00118040|521699107|FG001|Overall Study|Withdrawal by Subject|0|||
144685753|NCT00118040|521699108|FG002|Overall Study|Withdrawal by Subject|2|||
144685754|NCT00118040|521699106|FG000|Overall Study|Medical Contraindication|0|||
144685755|NCT00118040|521699107|FG001|Overall Study|Medical Contraindication|0|||
144685756|NCT00118040|521699108|FG002|Overall Study|Medical Contraindication|1|||
144685757|NCT00118040|521699106|FG000|Overall Study|Non-Compliant Participant|1|||
144685758|NCT00118040|521699107|FG001|Overall Study|Non-Compliant Participant|1|||
144685759|NCT00118040|521699108|FG002|Overall Study|Non-Compliant Participant|2|||
144685760|NCT00118040|521699106|FG000|Overall Study|Other|0|||
144685761|NCT00118040|521699107|FG001|Overall Study|Other|0|||
144685762|NCT00118040|521699108|FG002|Overall Study|Other|1|||
144685763|NCT02415595|521699113|FG000|Overall Study|Administrative reason by sponsor|39|||
144685764|NCT02415595|521699114|FG001|Overall Study|Administrative reason by sponsor|40|||
144685765|NCT02415595|521699115|FG002|Overall Study|Administrative reason by sponsor|41|||
144685766|NCT02415595|521699116|FG003|Overall Study|Administrative reason by sponsor|39|||
144685767|NCT02415595|521699113|FG000|Overall Study|Adverse Event|1|||
144685768|NCT02415595|521699114|FG001|Overall Study|Adverse Event|3|||
144685769|NCT02415595|521699115|FG002|Overall Study|Adverse Event|5|||
144685770|NCT02415595|521699116|FG003|Overall Study|Adverse Event|10|||
144685771|NCT02415595|521699113|FG000|Overall Study|Lack of Efficacy|4|||
144685772|NCT02415595|521699114|FG001|Overall Study|Lack of Efficacy|4|||
144739925|NCT01695239|521902957|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
144265889|NCT00903201|520176411|FG000|Overall Study|Adverse Event|1|||
144685773|NCT02415595|521699115|FG002|Overall Study|Lack of Efficacy|0|||
144685774|NCT02415595|521699116|FG003|Overall Study|Lack of Efficacy|0|||
144685775|NCT02415595|521699113|FG000|Overall Study|Lost to Follow-up|1|||
144739926|NCT01695239|521902958|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
144739927|NCT01695239|521902959|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
144739928|NCT01695239|521902946|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739929|NCT01695239|521902947|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144218477|NCT04100018|519994403|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
144218478|NCT04100018|519994404|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
144685776|NCT02415595|521699114|FG001|Overall Study|Lost to Follow-up|3|||
144685777|NCT02415595|521699115|FG002|Overall Study|Lost to Follow-up|1|||
144685778|NCT02415595|521699116|FG003|Overall Study|Lost to Follow-up|1|||
144685779|NCT02415595|521699113|FG000|Overall Study|Poor/Non-compliance|1|||
144685780|NCT02415595|521699114|FG001|Overall Study|Poor/Non-compliance|0|||
144685781|NCT02415595|521699115|FG002|Overall Study|Poor/Non-compliance|1|||
144685782|NCT02415595|521699116|FG003|Overall Study|Poor/Non-compliance|0|||
144685783|NCT02415595|521699113|FG000|Overall Study|Reached stopping criteria|0|||
144685784|NCT02415595|521699114|FG001|Overall Study|Reached stopping criteria|1|||
144685785|NCT02415595|521699115|FG002|Overall Study|Reached stopping criteria|1|||
144685786|NCT02415595|521699116|FG003|Overall Study|Reached stopping criteria|0|||
144685787|NCT02415595|521699113|FG000|Overall Study|Withdrawal by Subject|4|||
144685788|NCT02415595|521699114|FG001|Overall Study|Withdrawal by Subject|0|||
144685789|NCT02415595|521699115|FG002|Overall Study|Withdrawal by Subject|1|||
144685790|NCT02415595|521699116|FG003|Overall Study|Withdrawal by Subject|3|||
144685791|NCT02415595|521699113|FG000|Overall Study|Other|0|||
144685792|NCT02415595|521699114|FG001|Overall Study|Other|1|||
144685793|NCT02415595|521699115|FG002|Overall Study|Other|1|||
144685794|NCT02415595|521699116|FG003|Overall Study|Other|0|||
144685795|NCT03512275|521699119|FG000|Overall Study|Withdrawal by Subject|1|||
144685796|NCT03512275|521699120|FG001|Overall Study|Withdrawal by Subject|3|||
144685797|NCT03512275|521699119|FG000|Overall Study|Physician Decision|0|||
144685798|NCT03512275|521699120|FG001|Overall Study|Physician Decision|1|||
144685799|NCT03512275|521699119|FG000|Overall Study|Lost to Follow-up|0|||
144685800|NCT03512275|521699120|FG001|Overall Study|Lost to Follow-up|3|||
144685801|NCT03512275|521699119|FG000|Overall Study|Other|1|||
144685802|NCT03512275|521699120|FG001|Overall Study|Other|0|||
144685803|NCT04063865|521699121|FG000|Overall Study|Physician Decision|1|||
144685804|NCT04063865|521699122|FG001|Overall Study|Physician Decision|3|||
144685805|NCT04063865|521699121|FG000|Overall Study|Study Closed Prior to Completion|4|||
144685806|NCT04063865|521699122|FG001|Overall Study|Study Closed Prior to Completion|4|||
144685807|NCT04063865|521699121|FG000|Overall Study|Withdrawal by Subject|1|||
144685808|NCT04063865|521699122|FG001|Overall Study|Withdrawal by Subject|1|||
144685809|NCT01700140|521699123|FG000|Overall Study|Use of rescue drugs|3|||
144685810|NCT01700140|521699124|FG001|Overall Study|Use of rescue drugs|3|||
144685811|NCT01700140|521699125|FG002|Overall Study|Use of rescue drugs|1|||
144685812|NCT01700140|521699123|FG000|Overall Study|Discontinuation of radiotherapy|1|||
144685813|NCT01700140|521699124|FG001|Overall Study|Discontinuation of radiotherapy|0|||
144685814|NCT01700140|521699125|FG002|Overall Study|Discontinuation of radiotherapy|0|||
144685815|NCT01700140|521699123|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
144685816|NCT01700140|521699124|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
144685817|NCT01700140|521699125|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
144685818|NCT01700140|521699123|FG000|Overall Study|Aggravation of symptoms|1|||
144685819|NCT01700140|521699124|FG001|Overall Study|Aggravation of symptoms|0|||
144685820|NCT01700140|521699125|FG002|Overall Study|Aggravation of symptoms|0|||
144685821|NCT01700140|521699123|FG000|Overall Study|Adverse Event|0|||
144685822|NCT01700140|521699124|FG001|Overall Study|Adverse Event|1|||
144685823|NCT01700140|521699125|FG002|Overall Study|Adverse Event|0|||
144685824|NCT01700140|521699123|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
144685825|NCT01700140|521699124|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
144685826|NCT01700140|521699125|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
144685827|NCT01060124|521699126|FG000|Overall Study|Other|16|||
144685828|NCT01060124|521699126|FG000|Overall Study|Adverse Event|14|||
144685829|NCT01060124|521699126|FG000|Overall Study|Withdrawal by Subject|7|||
144218479|NCT04100018|519994403|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
144685830|NCT01708915|521699132|FG000|Overall Study|Adverse Event|1|||
144685831|NCT01708915|521699133|FG001|Overall Study|Adverse Event|0|||
144739930|NCT01695239|521902948|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144685832|NCT01708915|521699134|FG002|Overall Study|Adverse Event|9|||
144685833|NCT01708915|521699135|FG003|Overall Study|Adverse Event|13|||
144685834|NCT01708915|521699132|FG000|Overall Study|Lack of Efficacy|84|||
144685835|NCT01708915|521699133|FG001|Overall Study|Lack of Efficacy|60|||
144685836|NCT01708915|521699134|FG002|Overall Study|Lack of Efficacy|35|||
144685837|NCT01708915|521699135|FG003|Overall Study|Lack of Efficacy|15|||
144685838|NCT01708915|521699132|FG000|Overall Study|Protocol Violation|0|||
144685839|NCT01708915|521699133|FG001|Overall Study|Protocol Violation|0|||
144685840|NCT01708915|521699134|FG002|Overall Study|Protocol Violation|0|||
144739931|NCT01695239|521902949|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144685841|NCT01708915|521699135|FG003|Overall Study|Protocol Violation|1|||
144685842|NCT01708915|521699132|FG000|Overall Study|Withdrawal by Subject|0|||
144218480|NCT04100018|519994404|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
144218481|NCT04100018|519994403|FG000|Treatment Period|Ongoing Treatment|1|||
144218482|NCT04100018|519994404|FG001|Treatment Period|Ongoing Treatment|0|||
144218483|NCT04100018|519994403|FG000|Treatment Period|Other Reason|26|||
144218484|NCT04100018|519994404|FG001|Treatment Period|Other Reason|37|||
144218485|NCT04100018|519994403|FG000|Treatment Period|Completed treatment as per protocol|1|||
144218486|NCT04100018|519994404|FG001|Treatment Period|Completed treatment as per protocol|2|||
144218487|NCT04100018|519994403|FG000|Treatment Period|Maximum clinical benefit|3|||
144218488|NCT04100018|519994404|FG001|Treatment Period|Maximum clinical benefit|0|||
144218489|NCT04100018|519994403|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
144218490|NCT04100018|519994404|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
144218491|NCT04100018|519994403|FG000|Treatment Period|Study drug toxicity|67|||
144685843|NCT01708915|521699133|FG001|Overall Study|Withdrawal by Subject|1|||
144685844|NCT01708915|521699134|FG002|Overall Study|Withdrawal by Subject|2|||
144685845|NCT01708915|521699135|FG003|Overall Study|Withdrawal by Subject|2|||
144685846|NCT01708915|521699132|FG000|Overall Study|Other reasons than stated above|1|||
144685847|NCT01708915|521699133|FG001|Overall Study|Other reasons than stated above|1|||
144685848|NCT01708915|521699134|FG002|Overall Study|Other reasons than stated above|0|||
144685849|NCT01708915|521699135|FG003|Overall Study|Other reasons than stated above|2|||
144685850|NCT00374127|521699138|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
144685851|NCT00374127|521699138|FG000|Overall Study|Blood could not be drawn.|2|||
144685852|NCT00374127|521699138|FG000|Overall Study|Protocol Violation|5|||
144685853|NCT00374127|521699138|FG000|Overall Study|Pregnancy|1|||
144685854|NCT02059174|521700771|FG000|Period 1|Withdrawal by Subject|0|||
144685855|NCT02059174|521700772|FG001|Period 1|Withdrawal by Subject|2|||
144685856|NCT02059174|521700771|FG000|Period 2|Withdrawal by Subject|0|||
144685857|NCT02059174|521700772|FG001|Period 2|Withdrawal by Subject|2|||
144685858|NCT02059174|521700771|FG000|Period 2|Protocol Violation|1|||
144685859|NCT02059174|521700772|FG001|Period 2|Protocol Violation|0|||
144685860|NCT02059174|521700771|FG000|Period 3|Physician Decision|1|||
144685861|NCT02059174|521700772|FG001|Period 3|Physician Decision|0|||
144685862|NCT02306148|521700773|FG000|Overall Study|Adverse Event|12|||
144685863|NCT02306148|521700774|FG001|Overall Study|Adverse Event|6|||
144685864|NCT02306148|521700773|FG000|Overall Study|Lost to Follow-up|1|||
144685865|NCT02306148|521700774|FG001|Overall Study|Lost to Follow-up|4|||
144685866|NCT04167514|521700781|FG000|Overall Study|Adverse event, not serious|0|||
144685867|NCT04167514|521700782|FG001|Overall Study|Adverse event, not serious|1|||
144685868|NCT04167514|521700781|FG000|Overall Study|Lost to Follow-up|1|||
144685869|NCT04167514|521700782|FG001|Overall Study|Lost to Follow-up|0|||
144685870|NCT04167514|521700781|FG000|Overall Study|Participant Decision|2|||
144685871|NCT04167514|521700782|FG001|Overall Study|Participant Decision|4|||
144685872|NCT04167514|521700781|FG000|Overall Study|Physician Decision|3|||
144685873|NCT04167514|521700782|FG001|Overall Study|Physician Decision|2|||
144685874|NCT04167514|521700781|FG000|Overall Study|Death|14|||
144685875|NCT04167514|521700782|FG001|Overall Study|Death|18|||
144685876|NCT04167514|521700781|FG000|Overall Study|Enrolled but treatment not administered|2|||
144685877|NCT04167514|521700782|FG001|Overall Study|Enrolled but treatment not administered|0|||
144685878|NCT04167514|521700781|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
144685879|NCT04167514|521700782|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
144685880|NCT04167514|521700781|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
144685881|NCT04167514|521700782|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
144685882|NCT00290355|521700783|FG000|Overall Study|Serious adverse event|7|||
144685883|NCT00290355|521700784|FG001|Overall Study|Serious adverse event|4|||
144685884|NCT00290355|521700783|FG000|Overall Study|Study product reactogenicity|1|||
144685885|NCT00290355|521700784|FG001|Overall Study|Study product reactogenicity|0|||
144685886|NCT00290355|521700783|FG000|Overall Study|Protocol Violation|1|||
144685887|NCT00290355|521700784|FG001|Overall Study|Protocol Violation|0|||
144685888|NCT00290355|521700783|FG000|Overall Study|Withdrawal by Subject|2|||
144739932|NCT01695239|521902950|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144218492|NCT04100018|519994404|FG001|Treatment Period|Study drug toxicity|28|||
144218493|NCT04100018|519994403|FG000|Treatment Period|Disease Progression|284|||
144685889|NCT00290355|521700784|FG001|Overall Study|Withdrawal by Subject|0|||
144685890|NCT00290355|521700783|FG000|Overall Study|Migrated / moved from the study area|1|||
144739933|NCT01695239|521902951|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144218494|NCT04100018|519994404|FG001|Treatment Period|Disease Progression|327|||
144218495|NCT04100018|519994403|FG000|Treatment Period|Administrative reasons by sponsor|16|||
144218496|NCT04100018|519994404|FG001|Treatment Period|Administrative reasons by sponsor|30|||
144218497|NCT04100018|519994403|FG000|Treatment Period|Poor/Non-Compliance|1|||
144218498|NCT04100018|519994404|FG001|Treatment Period|Poor/Non-Compliance|0|||
144685891|NCT00290355|521700784|FG001|Overall Study|Migrated / moved from the study area|0|||
144685892|NCT00290355|521700783|FG000|Overall Study|Lost to Follow-up|3|||
144739934|NCT01695239|521902952|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739935|NCT01695239|521902953|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739936|NCT01695239|521902954|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739937|NCT01695239|521902955|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739938|NCT01695239|521902956|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739939|NCT01695239|521902957|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144739940|NCT01695239|521902958|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
144739941|NCT01695239|521902959|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
144739942|NCT01695239|521902946|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739943|NCT01695239|521902947|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739944|NCT01695239|521902948|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739945|NCT01695239|521902949|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739946|NCT01695239|521902950|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739947|NCT01695239|521902951|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739948|NCT01695239|521902952|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739949|NCT01695239|521902953|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739950|NCT01695239|521902954|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739951|NCT01695239|521902955|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739952|NCT01695239|521902956|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739953|NCT01695239|521902957|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739954|NCT01695239|521902958|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
144739955|NCT01695239|521902959|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
144739956|NCT01695239|521902946|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739957|NCT01695239|521902947|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739958|NCT01695239|521902948|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739959|NCT01695239|521902949|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739960|NCT01695239|521902950|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739961|NCT01695239|521902951|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739962|NCT01695239|521902952|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739963|NCT01695239|521902953|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739964|NCT01695239|521902954|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739965|NCT01695239|521902955|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144218499|NCT04100018|519994403|FG000|Treatment Period|Lost to Follow-up|2|||
144218500|NCT04100018|519994404|FG001|Treatment Period|Lost to Follow-up|2|||
144739966|NCT01695239|521902956|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739967|NCT01695239|521902957|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739968|NCT01695239|521902958|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
144739969|NCT01695239|521902959|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
144739970|NCT03913377|521902961|FG000|Period 1|Test Article no longer available|0|||
144739971|NCT03913377|521902962|FG001|Period 1|Test Article no longer available|1|||
144739972|NCT03913377|521902963|FG002|Period 1|Test Article no longer available|0|||
144739973|NCT03913377|521902961|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
144739974|NCT03913377|521902962|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
144739975|NCT03913377|521902963|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
144739976|NCT05239195|521902964|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
144739977|NCT05239195|521902965|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
144739978|NCT03552484|521902968|FG000|Overall Study|Death|6|||
144739979|NCT03552484|521902969|FG001|Overall Study|Death|4|||
144739980|NCT03552484|521902968|FG000|Overall Study|Lost to Follow-up|0|||
144739981|NCT03552484|521902969|FG001|Overall Study|Lost to Follow-up|16|||
144739982|NCT02241551|521902970|FG000|Overall Study|Adverse Event|1|||
144739983|NCT02241551|521902971|FG001|Overall Study|Adverse Event|0|||
144739984|NCT01015287|521902972|FG000|Overall Study|Death|21|||
144739985|NCT01015287|521902973|FG001|Overall Study|Death|16|||
144739986|NCT01015287|521902972|FG000|Overall Study|Adverse Event|1|||
144739987|NCT01015287|521902973|FG001|Overall Study|Adverse Event|0|||
144739988|NCT01015287|521902972|FG000|Overall Study|Sponsor Decision|3|||
144739989|NCT01015287|521902973|FG001|Overall Study|Sponsor Decision|7|||
144739990|NCT01015287|521902972|FG000|Overall Study|Physician Decision|19|||
144739991|NCT01015287|521902973|FG001|Overall Study|Physician Decision|21|||
144739992|NCT01015287|521902972|FG000|Overall Study|Withdrawal by Subject|14|||
144218501|NCT04100018|519994403|FG000|Treatment Period|Death|16|||
144218502|NCT04100018|519994404|FG001|Treatment Period|Death|11|||
144218503|NCT04100018|519994403|FG000|Treatment Period|Participant withdrew consent|10|||
144218504|NCT04100018|519994404|FG001|Treatment Period|Participant withdrew consent|10|||
144739993|NCT01015287|521902973|FG001|Overall Study|Withdrawal by Subject|19|||
144739994|NCT01015287|521902972|FG000|Overall Study|Entry Criteria not Met|11|||
144739995|NCT01015287|521902973|FG001|Overall Study|Entry Criteria not Met|14|||
144218505|NCT04100018|519994403|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
144739996|NCT01015287|521902972|FG000|Overall Study|Lost to Follow-up|2|||
144739997|NCT01015287|521902973|FG001|Overall Study|Lost to Follow-up|1|||
144739998|NCT01015287|521902972|FG000|Overall Study|Protocol Violation|1|||
144739999|NCT01015287|521902973|FG001|Overall Study|Protocol Violation|1|||
144740000|NCT01592240|521902974|FG000|Overall Study|Adverse Event|1|||
144740001|NCT01592240|521902975|FG001|Overall Study|Adverse Event|0|||
144740002|NCT01592240|521902976|FG002|Overall Study|Adverse Event|0|||
144740003|NCT01592240|521902977|FG003|Overall Study|Adverse Event|1|||
144740004|NCT01592240|521902978|FG004|Overall Study|Adverse Event|1|||
144740005|NCT01592240|521902979|FG005|Overall Study|Adverse Event|0|||
144740006|NCT01592240|521902980|FG006|Overall Study|Adverse Event|0|||
144740007|NCT01592240|521902974|FG000|Overall Study|Death|0|||
144740008|NCT01592240|521902975|FG001|Overall Study|Death|1|||
144740009|NCT01592240|521902976|FG002|Overall Study|Death|0|||
144740010|NCT01592240|521902977|FG003|Overall Study|Death|0|||
144740011|NCT01592240|521902978|FG004|Overall Study|Death|0|||
144740012|NCT01592240|521902979|FG005|Overall Study|Death|0|||
144740013|NCT01592240|521902980|FG006|Overall Study|Death|0|||
144740014|NCT01592240|521902974|FG000|Overall Study|Lost to Follow-up|1|||
144740015|NCT01592240|521902975|FG001|Overall Study|Lost to Follow-up|3|||
144740016|NCT01592240|521902976|FG002|Overall Study|Lost to Follow-up|1|||
144740017|NCT01592240|521902977|FG003|Overall Study|Lost to Follow-up|0|||
144740018|NCT01592240|521902978|FG004|Overall Study|Lost to Follow-up|3|||
144740019|NCT01592240|521902979|FG005|Overall Study|Lost to Follow-up|2|||
144740020|NCT01592240|521902980|FG006|Overall Study|Lost to Follow-up|0|||
144740021|NCT01592240|521902974|FG000|Overall Study|Protocol Violation|0|||
144740022|NCT01592240|521902975|FG001|Overall Study|Protocol Violation|0|||
144740023|NCT01592240|521902976|FG002|Overall Study|Protocol Violation|0|||
144740024|NCT01592240|521902977|FG003|Overall Study|Protocol Violation|0|||
144740025|NCT01592240|521902978|FG004|Overall Study|Protocol Violation|0|||
144740026|NCT01592240|521902979|FG005|Overall Study|Protocol Violation|1|||
144740027|NCT01592240|521902980|FG006|Overall Study|Protocol Violation|0|||
144740028|NCT01592240|521902974|FG000|Overall Study|Withdrawal by Subject|0|||
144740029|NCT01592240|521902975|FG001|Overall Study|Withdrawal by Subject|4|||
144740030|NCT01592240|521902976|FG002|Overall Study|Withdrawal by Subject|4|||
144740031|NCT01592240|521902977|FG003|Overall Study|Withdrawal by Subject|1|||
144740032|NCT01592240|521902978|FG004|Overall Study|Withdrawal by Subject|3|||
144740033|NCT01592240|521902979|FG005|Overall Study|Withdrawal by Subject|0|||
144740034|NCT01592240|521902980|FG006|Overall Study|Withdrawal by Subject|2|||
144740035|NCT01592240|521902974|FG000|Overall Study|Other|0|||
144740036|NCT01592240|521902975|FG001|Overall Study|Other|3|||
144740037|NCT01592240|521902976|FG002|Overall Study|Other|1|||
144740038|NCT01592240|521902977|FG003|Overall Study|Other|1|||
144740039|NCT01592240|521902978|FG004|Overall Study|Other|0|||
144740040|NCT01592240|521902979|FG005|Overall Study|Other|0|||
144740041|NCT01592240|521902980|FG006|Overall Study|Other|1|||
144740042|NCT01592240|521902974|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
144740043|NCT01592240|521902975|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
144740044|NCT01592240|521902976|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
144740045|NCT01592240|521902977|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
144740046|NCT01592240|521902978|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
144740047|NCT01592240|521902979|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
144740048|NCT01592240|521902980|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
144740049|NCT01117623|521902981|FG000|Overall Study|Adverse Event|0|||
144740050|NCT01117623|521902982|FG001|Overall Study|Adverse Event|2|||
144740051|NCT01117623|521902983|FG002|Overall Study|Adverse Event|4|||
144740052|NCT01117623|521902984|FG003|Overall Study|Adverse Event|0|||
144740053|NCT01117623|521902985|FG004|Overall Study|Adverse Event|2|||
144740054|NCT01117623|521902986|FG005|Overall Study|Adverse Event|0|||
144740055|NCT01117623|521902987|FG006|Overall Study|Adverse Event|0|||
144740056|NCT01117623|521902988|FG007|Overall Study|Adverse Event|2|||
144740057|NCT01117623|521902981|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
144740058|NCT01117623|521902982|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
144265890|NCT00903201|520176412|FG001|Overall Study|Adverse Event|4|||
144265891|NCT00903201|520176413|FG002|Overall Study|Adverse Event|0|||
144265892|NCT00903201|520176411|FG000|Overall Study|Protocol Violation|2|||
144740059|NCT01117623|521902983|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
144740060|NCT01117623|521902984|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
144740061|NCT01117623|521902985|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
144740062|NCT01117623|521902986|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
144265893|NCT00903201|520176412|FG001|Overall Study|Protocol Violation|1|||
144265894|NCT00903201|520176413|FG002|Overall Study|Protocol Violation|0|||
144740063|NCT01117623|521902987|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
144740064|NCT01117623|521902988|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
144740065|NCT01117623|521902981|FG000|Overall Study|Withdrawal by Subject|0|||
144740066|NCT01117623|521902982|FG001|Overall Study|Withdrawal by Subject|0|||
144740067|NCT01117623|521902983|FG002|Overall Study|Withdrawal by Subject|2|||
144265895|NCT00903201|520176411|FG000|Overall Study|Lost to Follow-up|0|||
144740068|NCT01117623|521902984|FG003|Overall Study|Withdrawal by Subject|0|||
144740069|NCT01117623|521902985|FG004|Overall Study|Withdrawal by Subject|0|||
144740070|NCT01117623|521902986|FG005|Overall Study|Withdrawal by Subject|1|||
144740071|NCT01117623|521902987|FG006|Overall Study|Withdrawal by Subject|1|||
144740072|NCT01117623|521902988|FG007|Overall Study|Withdrawal by Subject|1|||
144740073|NCT01117623|521902981|FG000|Overall Study|Non-compliance with study medication|0|||
144740074|NCT01117623|521902982|FG001|Overall Study|Non-compliance with study medication|0|||
144740075|NCT01117623|521902983|FG002|Overall Study|Non-compliance with study medication|0|||
144740076|NCT01117623|521902984|FG003|Overall Study|Non-compliance with study medication|0|||
144740077|NCT01117623|521902985|FG004|Overall Study|Non-compliance with study medication|0|||
144740078|NCT01117623|521902986|FG005|Overall Study|Non-compliance with study medication|0|||
144740079|NCT01117623|521902987|FG006|Overall Study|Non-compliance with study medication|0|||
144740080|NCT01117623|521902988|FG007|Overall Study|Non-compliance with study medication|1|||
144740081|NCT01117623|521902981|FG000|Overall Study|Invest. text: completed all planned txs|0|||
144740082|NCT01117623|521902982|FG001|Overall Study|Invest. text: completed all planned txs|0|||
144740083|NCT01117623|521902983|FG002|Overall Study|Invest. text: completed all planned txs|0|||
144740084|NCT01117623|521902984|FG003|Overall Study|Invest. text: completed all planned txs|0|||
144740085|NCT01117623|521902985|FG004|Overall Study|Invest. text: completed all planned txs|0|||
144740086|NCT01117623|521902986|FG005|Overall Study|Invest. text: completed all planned txs|1|||
144740087|NCT01117623|521902987|FG006|Overall Study|Invest. text: completed all planned txs|0|||
144740088|NCT01117623|521902988|FG007|Overall Study|Invest. text: completed all planned txs|0|||
144740089|NCT00469898|521902996|FG000|Overall Study|Adverse Event|7|||
144740090|NCT00469898|521902996|FG000|Overall Study|Withdrawal by Subject|4|||
144740091|NCT00469898|521902996|FG000|Overall Study|Death|4|||
144740092|NCT00469898|521902996|FG000|Overall Study|Disease progression|9|||
144740093|NCT00469898|521902996|FG000|Overall Study|Decreased performance status|1|||
144740094|NCT01205035|521903001|FG000|Overall Study|Withdrawal by Subject|1|||
144740095|NCT01205035|521903002|FG001|Overall Study|Withdrawal by Subject|0|||
144740096|NCT01205035|521903001|FG000|Overall Study|Physician Decision|1|||
144740097|NCT01205035|521903002|FG001|Overall Study|Physician Decision|0|||
144740098|NCT00928057|521903003|FG000|Overall Study|Adverse Event|1|||
144740099|NCT00928057|521903004|FG001|Overall Study|Adverse Event|2|||
144740100|NCT00928057|521903003|FG000|Overall Study|Withdrawal by Subject|1|||
144740101|NCT00928057|521903004|FG001|Overall Study|Withdrawal by Subject|0|||
144740102|NCT00928057|521903003|FG000|Overall Study|Lost to Follow-up|0|||
144740103|NCT00928057|521903004|FG001|Overall Study|Lost to Follow-up|1|||
144740104|NCT00928057|521903003|FG000|Overall Study|Protocol Violation|0|||
144740105|NCT00928057|521903004|FG001|Overall Study|Protocol Violation|1|||
144740106|NCT03246503|521903005|FG000|Overall Study|Lost to Follow-up|23|||
144740107|NCT03246503|521903005|FG000|Overall Study|Withdrawal by Subject|20|||
144740108|NCT03246503|521903005|FG000|Overall Study|Physician Decision|5|||
144740109|NCT03246503|521903005|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
144740110|NCT02751424|521903013|FG000|Part 2|Adverse Event|0|||
144740111|NCT02751424|521903014|FG001|Part 2|Adverse Event|0|||
144740112|NCT02751424|521903015|FG002|Part 2|Adverse Event|0|||
144740113|NCT02751424|521903016|FG003|Part 2|Adverse Event|0|||
144740114|NCT02751424|521903017|FG004|Part 2|Adverse Event|0|||
144740115|NCT02751424|521903018|FG005|Part 2|Adverse Event|0|||
144740116|NCT02751424|521903019|FG006|Part 2|Adverse Event|0|||
144740117|NCT02751424|521903020|FG007|Part 2|Adverse Event|5|||
144740118|NCT02751424|521903021|FG008|Part 2|Adverse Event|0|||
144740119|NCT02197416|521903022|FG000|Overall Study|Other reasons|0|||
144740120|NCT02197416|521903023|FG001|Overall Study|Other reasons|2|||
144740121|NCT02197416|521903024|FG002|Overall Study|Other reasons|5|||
144740122|NCT02197416|521903022|FG000|Overall Study|Withdrawal by Subject|0|||
144740123|NCT02197416|521903023|FG001|Overall Study|Withdrawal by Subject|2|||
144740124|NCT02197416|521903024|FG002|Overall Study|Withdrawal by Subject|1|||
144740125|NCT02197416|521903022|FG000|Overall Study|Protocol Violation|1|||
144740126|NCT02197416|521903023|FG001|Overall Study|Protocol Violation|0|||
144740127|NCT02197416|521903024|FG002|Overall Study|Protocol Violation|1|||
144740128|NCT02197416|521903022|FG000|Overall Study|Adverse Event|0|||
144740129|NCT02197416|521903023|FG001|Overall Study|Adverse Event|0|||
144740130|NCT02197416|521903024|FG002|Overall Study|Adverse Event|1|||
144740131|NCT02451696|521903025|FG000|Overall Study|Surgery postponed|1|||
144740132|NCT02451696|521903026|FG001|Overall Study|Surgery postponed|0|||
144740133|NCT01557751|521903027|FG000|Overall Study|Physician Decision|3|||
144740134|NCT01204294|521903029|FG000|Overall Study|Adverse Event|2|||
144740135|NCT01204294|521903030|FG001|Overall Study|Adverse Event|6|||
144740136|NCT01204294|521903031|FG002|Overall Study|Adverse Event|0|||
144740137|NCT01204294|521903032|FG003|Overall Study|Adverse Event|7|||
144740138|NCT01204294|521903033|FG004|Overall Study|Adverse Event|1|||
144740139|NCT01204294|521903034|FG005|Overall Study|Adverse Event|4|||
144740140|NCT01204294|521903035|FG006|Overall Study|Adverse Event|0|||
144740141|NCT01204294|521903029|FG000|Overall Study|Protocol Violation|1|||
144740142|NCT01204294|521903030|FG001|Overall Study|Protocol Violation|0|||
144740143|NCT01204294|521903031|FG002|Overall Study|Protocol Violation|2|||
144740144|NCT01204294|521903032|FG003|Overall Study|Protocol Violation|1|||
144740145|NCT01204294|521903033|FG004|Overall Study|Protocol Violation|0|||
144265896|NCT00903201|520176412|FG001|Overall Study|Lost to Follow-up|1|||
144740146|NCT01204294|521903034|FG005|Overall Study|Protocol Violation|0|||
144740147|NCT01204294|521903035|FG006|Overall Study|Protocol Violation|0|||
144740148|NCT01204294|521903029|FG000|Overall Study|Withdrawal by Subject|0|||
144740149|NCT01204294|521903030|FG001|Overall Study|Withdrawal by Subject|2|||
144740150|NCT01204294|521903031|FG002|Overall Study|Withdrawal by Subject|2|||
144740151|NCT01204294|521903032|FG003|Overall Study|Withdrawal by Subject|1|||
144740152|NCT01204294|521903033|FG004|Overall Study|Withdrawal by Subject|1|||
144740153|NCT01204294|521903034|FG005|Overall Study|Withdrawal by Subject|1|||
144740154|NCT01204294|521903035|FG006|Overall Study|Withdrawal by Subject|2|||
144740155|NCT01204294|521903029|FG000|Overall Study|Lack of Efficacy|0|||
144740156|NCT01204294|521903030|FG001|Overall Study|Lack of Efficacy|0|||
144740157|NCT01204294|521903031|FG002|Overall Study|Lack of Efficacy|0|||
144740158|NCT01204294|521903032|FG003|Overall Study|Lack of Efficacy|2|||
144740159|NCT01204294|521903033|FG004|Overall Study|Lack of Efficacy|0|||
144740160|NCT01204294|521903034|FG005|Overall Study|Lack of Efficacy|0|||
144740161|NCT01204294|521903035|FG006|Overall Study|Lack of Efficacy|0|||
144740162|NCT01204294|521903029|FG000|Overall Study|Other (house moving)|0|||
144740163|NCT01204294|521903030|FG001|Overall Study|Other (house moving)|0|||
144740164|NCT01204294|521903031|FG002|Overall Study|Other (house moving)|1|||
144740165|NCT01204294|521903032|FG003|Overall Study|Other (house moving)|0|||
144740166|NCT01204294|521903033|FG004|Overall Study|Other (house moving)|0|||
144740167|NCT01204294|521903034|FG005|Overall Study|Other (house moving)|0|||
144740168|NCT01204294|521903035|FG006|Overall Study|Other (house moving)|0|||
144740169|NCT04590027|521903036|FG000|Overall Study|Lost to Follow-up|17|||
144740170|NCT04590027|521903037|FG001|Overall Study|Lost to Follow-up|14|||
144740171|NCT04590027|521903036|FG000|Overall Study|Protocol Violation|0|||
144740172|NCT04590027|521903037|FG001|Overall Study|Protocol Violation|3|||
144740173|NCT05099380|521903038|FG000|Overall Study|Subject enrolled in error|1|||
144740174|NCT05099380|521903039|FG001|Overall Study|Subject enrolled in error|0|||
144740175|NCT05099380|521903038|FG000|Overall Study|Study Procedure|1|||
144740176|NCT05099380|521903039|FG001|Overall Study|Study Procedure|0|||
144740177|NCT05099380|521903038|FG000|Overall Study|Protocol Violation|1|||
144740178|NCT05099380|521903039|FG001|Overall Study|Protocol Violation|0|||
144740179|NCT05099380|521903038|FG000|Overall Study|Adverse Event|1|||
144740180|NCT05099380|521903039|FG001|Overall Study|Adverse Event|1|||
144740181|NCT05099380|521903038|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
144740182|NCT05099380|521903039|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
144740183|NCT00840216|521903040|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
144740184|NCT00840216|521903041|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
144740185|NCT00466167|521903046|FG000|Overall Study|Adverse Event|8|||
144740186|NCT00466167|521903047|FG001|Overall Study|Adverse Event|8|||
144740187|NCT00466167|521903048|FG002|Overall Study|Adverse Event|7|||
144740188|NCT00466167|521903046|FG000|Overall Study|Lack of Efficacy|2|||
144740189|NCT00466167|521903047|FG001|Overall Study|Lack of Efficacy|0|||
144740190|NCT00466167|521903048|FG002|Overall Study|Lack of Efficacy|3|||
144740191|NCT00466167|521903046|FG000|Overall Study|Protocol Violation|1|||
144740192|NCT00466167|521903047|FG001|Overall Study|Protocol Violation|1|||
144740193|NCT00466167|521903048|FG002|Overall Study|Protocol Violation|2|||
144740194|NCT00466167|521903046|FG000|Overall Study|Lost to Follow-up|3|||
144740195|NCT00466167|521903047|FG001|Overall Study|Lost to Follow-up|2|||
144740196|NCT00466167|521903048|FG002|Overall Study|Lost to Follow-up|2|||
144740197|NCT00466167|521903046|FG000|Overall Study|Withdrawal by Subject|4|||
144740198|NCT00466167|521903047|FG001|Overall Study|Withdrawal by Subject|1|||
144740199|NCT00466167|521903048|FG002|Overall Study|Withdrawal by Subject|6|||
144740200|NCT00466167|521903046|FG000|Overall Study|patient did not meet inclusion criteria|1|||
144740201|NCT00466167|521903047|FG001|Overall Study|patient did not meet inclusion criteria|0|||
144740202|NCT00466167|521903048|FG002|Overall Study|patient did not meet inclusion criteria|1|||
144740203|NCT00466167|521903046|FG000|Overall Study|Not treated|1|||
144740204|NCT00466167|521903047|FG001|Overall Study|Not treated|0|||
144740205|NCT00466167|521903048|FG002|Overall Study|Not treated|0|||
144740206|NCT00935012|521903049|FG000|Overall Study|Death|19|||
144740207|NCT00935012|521903049|FG000|Overall Study|Withdrawal by Subject|3|||
144740208|NCT00935012|521903049|FG000|Overall Study|Other|5|||
144740209|NCT00935012|521903049|FG000|Overall Study|Adverse Event|2|||
144218506|NCT04100018|519994404|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
144740210|NCT01370733|521903054|FG000|Overall Study|Withdrawal by Subject|8|||
144740211|NCT01370733|521903055|FG001|Overall Study|Withdrawal by Subject|8|||
144740212|NCT01370733|521903054|FG000|Overall Study|Lost to Follow-up|3|||
144218507|NCT04100018|519994403|FG000|Treatment Period|Adverse Event|14|||
144740213|NCT01370733|521903055|FG001|Overall Study|Lost to Follow-up|0|||
144740214|NCT01370733|521903054|FG000|Overall Study|Adverse Event|2|||
144740215|NCT01370733|521903055|FG001|Overall Study|Adverse Event|4|||
144740216|NCT01370733|521903054|FG000|Overall Study|Lack of Efficacy|3|||
144740217|NCT01370733|521903055|FG001|Overall Study|Lack of Efficacy|5|||
144740218|NCT01370733|521903054|FG000|Overall Study|Physician Decision|0|||
144740219|NCT01370733|521903055|FG001|Overall Study|Physician Decision|2|||
144740220|NCT01370733|521903054|FG000|Overall Study|Protocol Violation|1|||
144740221|NCT01370733|521903055|FG001|Overall Study|Protocol Violation|3|||
144218508|NCT04100018|519994404|FG001|Treatment Period|Adverse Event|6|||
144218509|NCT04100018|519994403|FG000|Treatment Period|Lack of Efficacy|4|||
144218510|NCT04100018|519994404|FG001|Treatment Period|Lack of Efficacy|2|||
144218511|NCT03989102|519994405|FG000|Year 1|Withdrawal by Subject|6|||
144218512|NCT03989102|519994406|FG001|Year 1|Withdrawal by Subject|2|||
144218513|NCT03989102|519994407|FG002|Year 1|Withdrawal by Subject|7|||
144218514|NCT03989102|519994405|FG000|Year 1|Lost to Follow-up|5|||
144218515|NCT03989102|519994406|FG001|Year 1|Lost to Follow-up|2|||
144218516|NCT03989102|519994407|FG002|Year 1|Lost to Follow-up|5|||
144265897|NCT00903201|520176413|FG002|Overall Study|Lost to Follow-up|0|||
144265898|NCT00903201|520176411|FG000|Overall Study|Physician Decision|1|||
144685893|NCT00290355|521700784|FG001|Overall Study|Lost to Follow-up|1|||
144685894|NCT00290355|521700783|FG000|Overall Study|Other|2|||
144685895|NCT00290355|521700784|FG001|Overall Study|Other|0|||
144685896|NCT00033514|521700785|FG000|Overall Study|Lost to Follow-up|1|||
144685897|NCT00033514|521700786|FG001|Overall Study|Lost to Follow-up|1|||
144685898|NCT00033514|521700785|FG000|Overall Study|Withdrawal by Subject|0|||
144685899|NCT00033514|521700786|FG001|Overall Study|Withdrawal by Subject|3|||
144685900|NCT03225833|521700787|FG000|Overall Study|Adverse Event|0|||
144685901|NCT03225833|521700788|FG001|Overall Study|Adverse Event|1|||
144685902|NCT03225833|521700789|FG002|Overall Study|Adverse Event|2|||
144685903|NCT03225833|521700790|FG003|Overall Study|Adverse Event|0|||
144685904|NCT03225833|521700791|FG004|Overall Study|Adverse Event|0|||
144685905|NCT03225833|521700792|FG005|Overall Study|Adverse Event|2|||
144685906|NCT03225833|521700787|FG000|Overall Study|Withdrawal by Subject|1|||
144685907|NCT03225833|521700788|FG001|Overall Study|Withdrawal by Subject|0|||
144685908|NCT03225833|521700789|FG002|Overall Study|Withdrawal by Subject|0|||
144685909|NCT03225833|521700790|FG003|Overall Study|Withdrawal by Subject|0|||
144685910|NCT03225833|521700791|FG004|Overall Study|Withdrawal by Subject|1|||
144685911|NCT03225833|521700792|FG005|Overall Study|Withdrawal by Subject|0|||
144685912|NCT03225833|521700787|FG000|Overall Study|Termination of Study by Sponsor|4|||
144685913|NCT03225833|521700788|FG001|Overall Study|Termination of Study by Sponsor|0|||
144685914|NCT03225833|521700789|FG002|Overall Study|Termination of Study by Sponsor|0|||
144685915|NCT03225833|521700790|FG003|Overall Study|Termination of Study by Sponsor|0|||
144685916|NCT03225833|521700791|FG004|Overall Study|Termination of Study by Sponsor|0|||
144685917|NCT03225833|521700792|FG005|Overall Study|Termination of Study by Sponsor|7|||
144685918|NCT03225833|521700787|FG000|Overall Study|Sponsor Decision|0|||
144685919|NCT03225833|521700788|FG001|Overall Study|Sponsor Decision|0|||
144685920|NCT03225833|521700789|FG002|Overall Study|Sponsor Decision|0|||
144685921|NCT03225833|521700790|FG003|Overall Study|Sponsor Decision|0|||
144685922|NCT03225833|521700791|FG004|Overall Study|Sponsor Decision|0|||
144685923|NCT03225833|521700792|FG005|Overall Study|Sponsor Decision|1|||
144685924|NCT00808028|521700793|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
144685925|NCT00808028|521700794|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
144685926|NCT00808028|521700795|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
144685927|NCT00808028|521700796|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
144685928|NCT00808028|521700793|FG000|Stage 1 (6 Months)|Other|1|||
144685929|NCT00808028|521700794|FG001|Stage 1 (6 Months)|Other|0|||
144685930|NCT00808028|521700795|FG002|Stage 1 (6 Months)|Other|2|||
144685931|NCT00808028|521700796|FG003|Stage 1 (6 Months)|Other|4|||
144685932|NCT00808028|521700793|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
144685933|NCT00808028|521700794|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
144685934|NCT00808028|521700795|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
144685935|NCT00808028|521700796|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
144685936|NCT00808028|521700793|FG000|Stage 1 (6 Months)|Adverse Event|0|||
144685937|NCT00808028|521700794|FG001|Stage 1 (6 Months)|Adverse Event|0|||
144685938|NCT00808028|521700795|FG002|Stage 1 (6 Months)|Adverse Event|1|||
144685939|NCT00808028|521700796|FG003|Stage 1 (6 Months)|Adverse Event|2|||
144685940|NCT00808028|521700793|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
144685941|NCT00808028|521700794|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
144685942|NCT00808028|521700795|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
144685943|NCT00808028|521700796|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
144685944|NCT00808028|521700793|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
144685945|NCT00808028|521700794|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
144685946|NCT00808028|521700795|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
144685947|NCT00808028|521700796|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
144685948|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
144685949|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
144685950|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
144685951|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
144685952|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
144685953|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
144218517|NCT03989102|519994405|FG000|Year 1|Subject met withdrawal criteria|1|||
144218518|NCT03989102|519994406|FG001|Year 1|Subject met withdrawal criteria|0|||
144685954|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
144685955|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
144218519|NCT03989102|519994407|FG002|Year 1|Subject met withdrawal criteria|1|||
144218520|NCT03989102|519994405|FG000|Year 2|Lost to Follow-up|7|||
144218521|NCT03989102|519994406|FG001|Year 2|Lost to Follow-up|3|||
144218522|NCT03989102|519994407|FG002|Year 2|Lost to Follow-up|4|||
144218523|NCT03989102|519994405|FG000|Year 2|Withdrawal by Subject|3|||
144218524|NCT03989102|519994406|FG001|Year 2|Withdrawal by Subject|1|||
144740222|NCT06539676|521903058|FG000|Overall Study|Early study termination|1|||
144740223|NCT06539676|521903059|FG001|Overall Study|Early study termination|0|||
144740224|NCT06539676|521903060|FG002|Overall Study|Early study termination|6|||
144740225|NCT04078022|521903061|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
144740226|NCT04078022|521903062|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
144740227|NCT00191815|521903063|FG000|Overall Study|Adverse Event|2|||
144740228|NCT00191815|521903063|FG000|Overall Study|Disease progression or relapse|24|||
144740229|NCT00191815|521903063|FG000|Overall Study|Death|2|||
144740230|NCT00191815|521903063|FG000|Overall Study|Protocol Violation|3|||
144740231|NCT00191815|521903063|FG000|Overall Study|Physician Decision|2|||
144740232|NCT00191815|521903063|FG000|Overall Study|Withdrawal by Subject|7|||
144740233|NCT03644550|521903064|FG000|Overall Study|Withdrawal by Subject|3|||
144740234|NCT03644550|521903064|FG000|Overall Study|Progressive disease|15|||
144740235|NCT01097577|521903066|FG000|Overall Study|Adverse Event|0|||
144740236|NCT01097577|521903067|FG001|Overall Study|Adverse Event|1|||
144740237|NCT01952691|521904162|FG000|Overall Study|Lost to Follow-up|2|||
144740238|NCT00199901|521904163|FG000|Overall Study|Protocol Violation|2|||
144740239|NCT00199901|521904164|FG001|Overall Study|Protocol Violation|0|||
144740240|NCT00199901|521904163|FG000|Overall Study|Withdrawal by Subject|1|||
144218525|NCT03989102|519994407|FG002|Year 2|Withdrawal by Subject|2|||
144218526|NCT03989102|519994405|FG000|Year 2|Subject non-compliant|3|||
144218527|NCT03989102|519994406|FG001|Year 2|Subject non-compliant|2|||
144218528|NCT03989102|519994407|FG002|Year 2|Subject non-compliant|0|||
144218529|NCT03989102|519994405|FG000|Year 2|Travel|1|||
144685956|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
144685957|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
144685958|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
144685959|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
144685960|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
144685961|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
144685962|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
144685963|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
144685964|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
144685965|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
144685966|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
144685967|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
144685968|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
144685969|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
144685970|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
144685971|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
144685972|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
144685973|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
144685974|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
144685975|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
144685976|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
144685977|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
144685978|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
144685979|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
144685980|NCT00808028|521700793|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
144685981|NCT00808028|521700794|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
144685982|NCT00808028|521700795|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
144685983|NCT00808028|521700796|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
144685984|NCT03093350|521700798|FG000|Overall Study|Death|1|||
144685985|NCT03093350|521700798|FG000|Overall Study|Signed consent, never began treartment|1|||
144685986|NCT00777036|521700799|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
144685987|NCT00777036|521700800|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
144685988|NCT00777036|521700801|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
144685989|NCT00777036|521700802|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
144740241|NCT00199901|521904164|FG001|Overall Study|Withdrawal by Subject|0|||
144218530|NCT03989102|519994406|FG001|Year 2|Travel|0|||
144218531|NCT03989102|519994407|FG002|Year 2|Travel|1|||
144218532|NCT03989102|519994405|FG000|Year 2|P16 missing|4|||
144218533|NCT03989102|519994406|FG001|Year 2|P16 missing|2|||
144685990|NCT00777036|521700799|FG000|On Treatment|Administrative Reason By Sponsor|1|||
144740242|NCT00199901|521904163|FG000|Overall Study|Progressive Disease|24|||
144740243|NCT00199901|521904164|FG001|Overall Study|Progressive Disease|24|||
144740244|NCT02566850|521904171|FG000|Overall Study|Protocol Violation|1|||
144740245|NCT00798603|521904172|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
144218534|NCT03989102|519994407|FG002|Year 2|P16 missing|1|||
144218535|NCT03989102|519994405|FG000|Year 2|P11 missing|1|||
144218536|NCT03989102|519994406|FG001|Year 2|P11 missing|3|||
144218537|NCT03989102|519994407|FG002|Year 2|P11 missing|7|||
144218538|NCT03989102|519994405|FG000|Year 2|Definitive displacement outside the study site|0|||
144218539|NCT03989102|519994406|FG001|Year 2|Definitive displacement outside the study site|1|||
144218540|NCT03989102|519994407|FG002|Year 2|Definitive displacement outside the study site|0|||
144218541|NCT03989102|519994405|FG000|Year 2|Subject missed last study visit|0|||
144218542|NCT03989102|519994406|FG001|Year 2|Subject missed last study visit|1|||
144218543|NCT03989102|519994407|FG002|Year 2|Subject missed last study visit|0|||
144218544|NCT03989102|519994405|FG000|Year 2|Death|0|||
144218545|NCT03989102|519994406|FG001|Year 2|Death|1|||
144218546|NCT03989102|519994407|FG002|Year 2|Death|0|||
144218547|NCT03989102|519994405|FG000|Year 2|Subject not reachable|0|||
144218548|NCT03989102|519994406|FG001|Year 2|Subject not reachable|0|||
144218549|NCT03989102|519994407|FG002|Year 2|Subject not reachable|1|||
144218550|NCT03989102|519994405|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
144218551|NCT03989102|519994406|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
144218552|NCT03989102|519994407|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
144218553|NCT03989102|519994405|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
144218554|NCT03989102|519994406|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
144218555|NCT03989102|519994407|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
144218556|NCT03989102|519994405|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
144218557|NCT03989102|519994406|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
144218558|NCT03989102|519994407|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
144218559|NCT03989102|519994405|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
144218560|NCT03989102|519994406|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
144218561|NCT03989102|519994407|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
144218562|NCT03989102|519994405|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
144218563|NCT03989102|519994406|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
144218564|NCT03989102|519994407|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
144218565|NCT03989102|519994405|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
144218566|NCT03989102|519994406|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
144218567|NCT03989102|519994407|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
144218568|NCT01290068|519994413|FG000|Overall Study|Adverse Event|1|||
144218569|NCT01290068|519994414|FG001|Overall Study|Adverse Event|3|||
144218570|NCT01290068|519994413|FG000|Overall Study|Lost to Follow-up|3|||
144218571|NCT01290068|519994414|FG001|Overall Study|Lost to Follow-up|0|||
144218572|NCT01290068|519994413|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
144218573|NCT01290068|519994414|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
144218574|NCT01290068|519994413|FG000|Overall Study|Other|3|||
144218575|NCT01290068|519994414|FG001|Overall Study|Other|1|||
144218576|NCT03718832|519994417|FG000|Analysis Sample|Withdrawal by Subject|18|||
144218577|NCT03718832|519994418|FG001|Analysis Sample|Withdrawal by Subject|15|||
144218578|NCT03718832|519994417|FG000|Analysis Sample|Legal hold on data|1|||
144218579|NCT03718832|519994418|FG001|Analysis Sample|Legal hold on data|0|||
144218580|NCT03718832|519994417|FG000|Analysis Sample|Participant from treated household|0|||
144218581|NCT03718832|519994418|FG001|Analysis Sample|Participant from treated household|1|||
144218582|NCT03718832|519994417|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
144218583|NCT03718832|519994418|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
144218584|NCT03052751|519994419|FG000|Dosing Period 1|Adverse Event|0|||
144218585|NCT03052751|519994420|FG001|Dosing Period 1|Adverse Event|1|||
144218586|NCT03052751|519994421|FG002|Dosing Period 1|Adverse Event|0|||
144218587|NCT03052751|519994422|FG003|Dosing Period 1|Adverse Event|0|||
144218588|NCT03052751|519994423|FG004|Dosing Period 1|Adverse Event|0|||
144218589|NCT03052751|519994424|FG005|Dosing Period 1|Adverse Event|0|||
144685991|NCT00777036|521700800|FG001|On Treatment|Administrative Reason By Sponsor|0|||
144685992|NCT00777036|521700801|FG002|On Treatment|Administrative Reason By Sponsor|9|||
144685993|NCT00777036|521700802|FG003|On Treatment|Administrative Reason By Sponsor|0|||
144685994|NCT00777036|521700799|FG000|On Treatment|Failure to Meet Study Criteria|0|||
144685995|NCT00777036|521700800|FG001|On Treatment|Failure to Meet Study Criteria|1|||
144685996|NCT00777036|521700801|FG002|On Treatment|Failure to Meet Study Criteria|4|||
144685997|NCT00777036|521700802|FG003|On Treatment|Failure to Meet Study Criteria|0|||
144685998|NCT00777036|521700799|FG000|On Treatment|Pregnancy|1|||
144685999|NCT00777036|521700800|FG001|On Treatment|Pregnancy|0|||
144686000|NCT00777036|521700801|FG002|On Treatment|Pregnancy|1|||
144686001|NCT00777036|521700802|FG003|On Treatment|Pregnancy|0|||
144218590|NCT03052751|519994419|FG000|Dosing Period 2|Adverse Event|0|||
144218591|NCT03052751|519994420|FG001|Dosing Period 2|Adverse Event|0|||
144218592|NCT03052751|519994421|FG002|Dosing Period 2|Adverse Event|3|||
144218593|NCT03052751|519994422|FG003|Dosing Period 2|Adverse Event|0|||
144265899|NCT00903201|520176412|FG001|Overall Study|Physician Decision|0|||
144686002|NCT00777036|521700799|FG000|On Treatment|Non-compliance with Study Drug|1|||
144686003|NCT00777036|521700800|FG001|On Treatment|Non-compliance with Study Drug|0|||
144740246|NCT00798603|521904172|FG000|Overall Study|Withdrawal by Subject|10|||
144740247|NCT00798603|521904172|FG000|Overall Study|Adverse Event|22|||
144740248|NCT00798603|521904172|FG000|Overall Study|Physician Decision|1|||
144740249|NCT00798603|521904172|FG000|Overall Study|Lack of insurance coverage|1|||
144740250|NCT00373256|521904175|FG000|Overall Study|Adverse Event (AE)|1|||
144740251|NCT00373256|521904176|FG001|Overall Study|Adverse Event (AE)|5|||
144740252|NCT00373256|521904175|FG000|Overall Study|Lost to Follow-up|2|||
144740253|NCT00373256|521904176|FG001|Overall Study|Lost to Follow-up|1|||
144740254|NCT00373256|521904175|FG000|Overall Study|Death|9|||
144740255|NCT00373256|521904176|FG001|Overall Study|Death|8|||
144740256|NCT00373256|521904175|FG000|Overall Study|Objective Progression or Relapse|111|||
144740257|NCT00373256|521904176|FG001|Overall Study|Objective Progression or Relapse|104|||
144740258|NCT00373256|521904175|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
144740259|NCT00373256|521904176|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
144740260|NCT00373256|521904175|FG000|Overall Study|Other|73|||
144740261|NCT00373256|521904176|FG001|Overall Study|Other|107|||
144740262|NCT00373256|521904175|FG000|Overall Study|Protocol Violation|0|||
144740263|NCT00373256|521904176|FG001|Overall Study|Protocol Violation|2|||
144740264|NCT00373256|521904175|FG000|Overall Study|Study Terminated by Sponsor|41|||
144740265|NCT00373256|521904176|FG001|Overall Study|Study Terminated by Sponsor|13|||
144740266|NCT04372238|521904177|FG000|Overall Study|Duplicate|3|||
144740267|NCT04372238|521904178|FG001|Overall Study|Duplicate|3|||
144740268|NCT04372238|521904177|FG000|Overall Study|Did not consent for data linkage|6|||
144740269|NCT04372238|521904178|FG001|Overall Study|Did not consent for data linkage|10|||
144740270|NCT00081653|521904183|FG000|Overall Study|Adverse Event|23|||
144740271|NCT00081653|521904184|FG001|Overall Study|Adverse Event|17|||
144740272|NCT00081653|521904183|FG000|Overall Study|Lost to Follow-up|2|||
144740273|NCT00081653|521904184|FG001|Overall Study|Lost to Follow-up|4|||
144740274|NCT00081653|521904183|FG000|Overall Study|Refused Treatment|18|||
144740275|NCT00081653|521904184|FG001|Overall Study|Refused Treatment|14|||
144740276|NCT00081653|521904183|FG000|Overall Study|Low bone mineral density|1|||
144740277|NCT00081653|521904184|FG001|Overall Study|Low bone mineral density|0|||
144740278|NCT00081653|521904183|FG000|Overall Study|Bone loss|2|||
144740279|NCT00081653|521904184|FG001|Overall Study|Bone loss|0|||
144740280|NCT00081653|521904183|FG000|Overall Study|Participant leaving country|1|||
144740281|NCT00081653|521904184|FG001|Overall Study|Participant leaving country|0|||
144740282|NCT00081653|521904183|FG000|Overall Study|Loss of bone mass|0|||
144740283|NCT00081653|521904184|FG001|Overall Study|Loss of bone mass|2|||
144740284|NCT02663349|521904185|FG000|Overall Study|Withdrawal by Subject|6|||
144740285|NCT03206749|521904187|FG000|Overall Study|Withdrawal of consent|5|||
144740286|NCT03206749|521904188|FG001|Overall Study|Withdrawal of consent|3|||
144740287|NCT03206749|521904189|FG002|Overall Study|Withdrawal of consent|6|||
144740288|NCT03206749|521904187|FG000|Overall Study|Lost to Follow-up|0|||
144740289|NCT03206749|521904188|FG001|Overall Study|Lost to Follow-up|0|||
144740290|NCT03206749|521904189|FG002|Overall Study|Lost to Follow-up|1|||
144740291|NCT02752074|521904190|FG000|Overall Study|Lost to Follow-up|1|||
144740292|NCT02752074|521904191|FG001|Overall Study|Lost to Follow-up|4|||
144740293|NCT02752074|521904190|FG000|Overall Study|Death|146|||
144740294|NCT02752074|521904191|FG001|Overall Study|Death|129|||
144740295|NCT02752074|521904190|FG000|Overall Study|Withdrawal by Subject|9|||
144740296|NCT02752074|521904191|FG001|Overall Study|Withdrawal by Subject|10|||
144740297|NCT00488774|521904192|FG000|Overall Study|Withdrawal of consent|2|||
144740298|NCT00488774|521904193|FG001|Overall Study|Withdrawal of consent|2|||
144740299|NCT00488774|521904194|FG002|Overall Study|Withdrawal of consent|2|||
144218594|NCT03052751|519994423|FG004|Dosing Period 2|Adverse Event|0|||
144218595|NCT03052751|519994424|FG005|Dosing Period 2|Adverse Event|0|||
144218596|NCT03052751|519994419|FG000|Observation Period|Adverse Event|0|||
144218597|NCT03052751|519994420|FG001|Observation Period|Adverse Event|0|||
144218598|NCT03052751|519994421|FG002|Observation Period|Adverse Event|0|||
144740300|NCT00488774|521904195|FG003|Overall Study|Withdrawal of consent|0|||
144740301|NCT00488774|521904192|FG000|Overall Study|Other|6|||
144740302|NCT00488774|521904193|FG001|Overall Study|Other|3|||
144740303|NCT00488774|521904194|FG002|Overall Study|Other|2|||
144740304|NCT00488774|521904195|FG003|Overall Study|Other|2|||
144740305|NCT00488774|521904192|FG000|Overall Study|Lost to Follow-up|0|||
144740306|NCT00488774|521904193|FG001|Overall Study|Lost to Follow-up|0|||
144740307|NCT00488774|521904194|FG002|Overall Study|Lost to Follow-up|1|||
144218599|NCT03052751|519994422|FG003|Observation Period|Adverse Event|0|||
144218600|NCT03052751|519994423|FG004|Observation Period|Adverse Event|1|||
144218601|NCT03052751|519994424|FG005|Observation Period|Adverse Event|0|||
144740308|NCT00488774|521904195|FG003|Overall Study|Lost to Follow-up|1|||
144218602|NCT00970593|519994425|FG000|Overall Study|Adverse Event|1|||
144740309|NCT05523895|521904196|FG000|Overall Study|Adverse Event|2|||
144740310|NCT05523895|521904197|FG001|Overall Study|Adverse Event|1|||
144740311|NCT05523895|521904198|FG002|Overall Study|Adverse Event|1|||
144740312|NCT05523895|521904196|FG000|Overall Study|Lost to Follow-up|0|||
144740313|NCT05523895|521904197|FG001|Overall Study|Lost to Follow-up|1|||
144740314|NCT05523895|521904198|FG002|Overall Study|Lost to Follow-up|2|||
144740315|NCT05523895|521904196|FG000|Overall Study|Noncompliance with study drug|1|||
144686004|NCT00777036|521700801|FG002|On Treatment|Non-compliance with Study Drug|1|||
144686005|NCT00777036|521700802|FG003|On Treatment|Non-compliance with Study Drug|0|||
144686006|NCT00777036|521700799|FG000|On Treatment|Maximum Clinical Benefit|2|||
144686007|NCT00777036|521700800|FG001|On Treatment|Maximum Clinical Benefit|0|||
144686008|NCT00777036|521700801|FG002|On Treatment|Maximum Clinical Benefit|5|||
144686009|NCT00777036|521700802|FG003|On Treatment|Maximum Clinical Benefit|0|||
144686010|NCT00777036|521700799|FG000|On Treatment|Withdrawal by Subject|0|||
144686011|NCT00777036|521700800|FG001|On Treatment|Withdrawal by Subject|2|||
144686012|NCT00777036|521700801|FG002|On Treatment|Withdrawal by Subject|2|||
144686013|NCT00777036|521700802|FG003|On Treatment|Withdrawal by Subject|0|||
144686014|NCT00777036|521700799|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
144686015|NCT00777036|521700800|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
144686016|NCT00777036|521700801|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
144686017|NCT00777036|521700802|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
144686018|NCT00777036|521700799|FG000|On Treatment|Death|0|||
144686019|NCT00777036|521700800|FG001|On Treatment|Death|2|||
144686020|NCT00777036|521700801|FG002|On Treatment|Death|0|||
144686021|NCT00777036|521700802|FG003|On Treatment|Death|0|||
144686022|NCT00777036|521700799|FG000|On Treatment|Study Drug Toxicity|1|||
144686023|NCT00777036|521700800|FG001|On Treatment|Study Drug Toxicity|0|||
144686024|NCT00777036|521700801|FG002|On Treatment|Study Drug Toxicity|4|||
144686025|NCT00777036|521700802|FG003|On Treatment|Study Drug Toxicity|0|||
144686026|NCT00777036|521700799|FG000|On Treatment|Progressive Disease|6|||
144686027|NCT00777036|521700800|FG001|On Treatment|Progressive Disease|4|||
144686028|NCT00777036|521700801|FG002|On Treatment|Progressive Disease|7|||
144686029|NCT00777036|521700802|FG003|On Treatment|Progressive Disease|0|||
144686030|NCT00777036|521700799|FG000|On Treatment|Not Reported|0|||
144686031|NCT00777036|521700800|FG001|On Treatment|Not Reported|0|||
144686032|NCT00777036|521700801|FG002|On Treatment|Not Reported|2|||
144686033|NCT00777036|521700802|FG003|On Treatment|Not Reported|0|||
144686034|NCT00777036|521700799|FG000|On Treatment|Site Closed|0|||
144686035|NCT00777036|521700800|FG001|On Treatment|Site Closed|1|||
144686036|NCT00777036|521700801|FG002|On Treatment|Site Closed|1|||
144686037|NCT00777036|521700802|FG003|On Treatment|Site Closed|0|||
144686038|NCT00777036|521700799|FG000|Follow-Up|Withdrawal by Subject|0|||
144686039|NCT00777036|521700800|FG001|Follow-Up|Withdrawal by Subject|0|||
144686040|NCT00777036|521700801|FG002|Follow-Up|Withdrawal by Subject|5|||
144686041|NCT00777036|521700802|FG003|Follow-Up|Withdrawal by Subject|0|||
144686042|NCT00777036|521700799|FG000|Follow-Up|Death|1|||
144686043|NCT00777036|521700800|FG001|Follow-Up|Death|9|||
144686044|NCT00777036|521700801|FG002|Follow-Up|Death|0|||
144686045|NCT00777036|521700802|FG003|Follow-Up|Death|0|||
144686046|NCT00777036|521700799|FG000|Follow-Up|Lost to Follow-up|3|||
144686047|NCT00777036|521700800|FG001|Follow-Up|Lost to Follow-up|0|||
144686048|NCT00777036|521700801|FG002|Follow-Up|Lost to Follow-up|0|||
144686049|NCT00777036|521700802|FG003|Follow-Up|Lost to Follow-up|0|||
144686050|NCT00777036|521700799|FG000|Follow-Up|Reason Not Specified|4|||
144686051|NCT00777036|521700800|FG001|Follow-Up|Reason Not Specified|0|||
144686052|NCT00777036|521700801|FG002|Follow-Up|Reason Not Specified|13|||
144686053|NCT00777036|521700802|FG003|Follow-Up|Reason Not Specified|0|||
144686054|NCT00777036|521700799|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
144686055|NCT00777036|521700800|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
144686056|NCT00777036|521700801|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
144686057|NCT00777036|521700802|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
144686058|NCT01553591|521700803|FG000|Overall Study|Voluntarily withdrew|94|||
144686059|NCT01553591|521700804|FG001|Overall Study|Voluntarily withdrew|79|||
144686060|NCT01553591|521700805|FG002|Overall Study|Voluntarily withdrew|96|||
144686061|NCT01553591|521700803|FG000|Overall Study|Adverse Event|36|||
144686062|NCT01553591|521700804|FG001|Overall Study|Adverse Event|45|||
144686063|NCT01553591|521700805|FG002|Overall Study|Adverse Event|16|||
144686064|NCT01553591|521700803|FG000|Overall Study|Lost to Follow-up|25|||
144686065|NCT01553591|521700804|FG001|Overall Study|Lost to Follow-up|23|||
144686066|NCT01553591|521700805|FG002|Overall Study|Lost to Follow-up|16|||
144686067|NCT01553591|521700803|FG000|Overall Study|Physician decision: other|11|||
144686068|NCT01553591|521700804|FG001|Overall Study|Physician decision: other|14|||
144686069|NCT01553591|521700805|FG002|Overall Study|Physician decision: other|16|||
144686070|NCT01553591|521700803|FG000|Overall Study|Physician decision: lack of efficacy|2|||
144686071|NCT01553591|521700804|FG001|Overall Study|Physician decision: lack of efficacy|3|||
144686072|NCT01553591|521700805|FG002|Overall Study|Physician decision: lack of efficacy|7|||
144686073|NCT01553591|521700803|FG000|Overall Study|Protocol Violation|3|||
144686074|NCT01553591|521700804|FG001|Overall Study|Protocol Violation|4|||
144740316|NCT05523895|521904197|FG001|Overall Study|Noncompliance with study drug|1|||
144686075|NCT01553591|521700805|FG002|Overall Study|Protocol Violation|4|||
144686076|NCT01553591|521700803|FG000|Overall Study|Sponsor decision|1|||
144686077|NCT01553591|521700804|FG001|Overall Study|Sponsor decision|0|||
144686078|NCT01553591|521700805|FG002|Overall Study|Sponsor decision|3|||
144686079|NCT01553591|521700803|FG000|Overall Study|Randomized and never dispensed drug|0|||
144686080|NCT01553591|521700804|FG001|Overall Study|Randomized and never dispensed drug|1|||
144740317|NCT05523895|521904198|FG002|Overall Study|Noncompliance with study drug|1|||
144740318|NCT05523895|521904196|FG000|Overall Study|Protocol Violation|0|||
144740319|NCT05523895|521904197|FG001|Overall Study|Protocol Violation|2|||
144740320|NCT05523895|521904198|FG002|Overall Study|Protocol Violation|0|||
144740321|NCT05523895|521904196|FG000|Overall Study|Withdrawal by Subject|1|||
144740322|NCT05523895|521904197|FG001|Overall Study|Withdrawal by Subject|3|||
144740323|NCT05523895|521904198|FG002|Overall Study|Withdrawal by Subject|1|||
144740324|NCT05523895|521904196|FG000|Overall Study|Not further specified|0|||
144740325|NCT05523895|521904197|FG001|Overall Study|Not further specified|3|||
144740326|NCT05523895|521904198|FG002|Overall Study|Not further specified|1|||
144740327|NCT03674892|521904199|FG000|Overall Study|Lack of Efficacy|5|||
144740328|NCT03674892|521904199|FG000|Overall Study|Lost to Follow-up|3|||
144740329|NCT03674892|521904199|FG000|Overall Study|Migraine|2|||
144740330|NCT03674892|521904199|FG000|Overall Study|Excessive Tearing|1|||
144740331|NCT03674892|521904199|FG000|Overall Study|Increased Eye Pain|1|||
144740332|NCT03674892|521904199|FG000|Overall Study|Increased Facial Pain|1|||
144740333|NCT03674892|521904199|FG000|Overall Study|Sinus Irritation|1|||
144740334|NCT03674892|521904199|FG000|Overall Study|Sinus Infection|1|||
144740335|NCT01959672|521904202|FG000|Overall Study|Death|1|||
144740336|NCT00848536|521904203|FG000|Overall Study|Adverse Event|2|||
144740337|NCT00848536|521904204|FG001|Overall Study|Adverse Event|2|||
144740338|NCT00848536|521904203|FG000|Overall Study|Withdrawal by Subject|0|||
144740339|NCT00848536|521904204|FG001|Overall Study|Withdrawal by Subject|1|||
144740340|NCT00848536|521904203|FG000|Overall Study|Protocol Violation|0|||
144740341|NCT00848536|521904204|FG001|Overall Study|Protocol Violation|1|||
144686081|NCT01553591|521700805|FG002|Overall Study|Randomized and never dispensed drug|0|||
144686082|NCT04005755|521700814|FG000|Overall Study|Adverse Event|6|||
144686083|NCT04005755|521700814|FG000|Overall Study|Physician Decision|3|||
144686084|NCT04005755|521700814|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
144686085|NCT04005755|521700814|FG000|Overall Study|Withdrawal by Subject|3|||
144686086|NCT04005755|521700814|FG000|Overall Study|Lost to Follow-up|1|||
144686087|NCT02289833|521700816|FG000|Overall Study|Study discontinuation|0|||
144686088|NCT02289833|521700817|FG001|Overall Study|Study discontinuation|1|||
144686089|NCT02289833|521700816|FG000|Overall Study|Lost to Follow-up|4|||
144686090|NCT02289833|521700817|FG001|Overall Study|Lost to Follow-up|0|||
144686091|NCT02289833|521700816|FG000|Overall Study|Death|23|||
144686092|NCT02289833|521700817|FG001|Overall Study|Death|16|||
144686093|NCT02723019|521700818|FG000|Overall Study|Death|17|||
144686094|NCT02723019|521700819|FG001|Overall Study|Death|13|||
144686095|NCT02723019|521700818|FG000|Overall Study|Withdrawal by Subject|11|||
144686096|NCT02723019|521700819|FG001|Overall Study|Withdrawal by Subject|7|||
144686097|NCT02723019|521700818|FG000|Overall Study|Lost to Follow-up|57|||
144686098|NCT02723019|521700819|FG001|Overall Study|Lost to Follow-up|70|||
144686099|NCT00958191|521700820|FG000|Overall Study|Death|4|||
144686100|NCT00958191|521700820|FG000|Overall Study|Lost to Follow-up|5|||
144686101|NCT00958191|521700820|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
144686102|NCT00958191|521700820|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
144686103|NCT00958191|521700820|FG000|Overall Study|Revision of study device|4|||
144686104|NCT00958191|521700820|FG000|Overall Study|Site termination|11|||
144686105|NCT00958191|521700820|FG000|Overall Study|No 5 yr x-rays|56|||
144686106|NCT02202161|521700823|FG000|Overall Study|Adverse Event|1|||
144686107|NCT02202161|521700824|FG001|Overall Study|Adverse Event|1|||
144686108|NCT02202161|521700825|FG002|Overall Study|Adverse Event|0|||
144686109|NCT02202161|521700826|FG003|Overall Study|Adverse Event|0|||
144686110|NCT02202161|521700827|FG004|Overall Study|Adverse Event|0|||
144686111|NCT02202161|521700828|FG005|Overall Study|Adverse Event|1|||
144686112|NCT02202161|521700829|FG006|Overall Study|Adverse Event|0|||
144686113|NCT02202161|521700830|FG007|Overall Study|Adverse Event|0|||
144686114|NCT02202161|521700823|FG000|Overall Study|Did not meet continuation criteria|0|||
144686115|NCT02202161|521700824|FG001|Overall Study|Did not meet continuation criteria|0|||
144686116|NCT02202161|521700825|FG002|Overall Study|Did not meet continuation criteria|0|||
144740342|NCT00848536|521904203|FG000|Overall Study|Noncompliance|1|||
144740343|NCT00848536|521904204|FG001|Overall Study|Noncompliance|0|||
144740344|NCT00848536|521904203|FG000|Overall Study|Inadequate Control of IOP|1|||
144740345|NCT00848536|521904204|FG001|Overall Study|Inadequate Control of IOP|1|||
144740346|NCT00848536|521904203|FG000|Overall Study|Patient Moved|0|||
144740347|NCT00848536|521904204|FG001|Overall Study|Patient Moved|2|||
144740348|NCT02842853|521904205|FG000|Overall Study|Non-compliance with the protocol|3|||
144740349|NCT02842853|521904206|FG001|Overall Study|Non-compliance with the protocol|7|||
144740350|NCT02842853|521904207|FG002|Overall Study|Non-compliance with the protocol|2|||
144740351|NCT02842853|521904208|FG003|Overall Study|Non-compliance with the protocol|5|||
144740352|NCT02842853|521904205|FG000|Overall Study|Subject met exclusion criteria|0|||
144740353|NCT02842853|521904206|FG001|Overall Study|Subject met exclusion criteria|1|||
144740354|NCT02842853|521904207|FG002|Overall Study|Subject met exclusion criteria|0|||
144740355|NCT02842853|521904208|FG003|Overall Study|Subject met exclusion criteria|0|||
144740356|NCT02842853|521904205|FG000|Overall Study|Withdrawal by Subject|11|||
144740357|NCT02842853|521904206|FG001|Overall Study|Withdrawal by Subject|13|||
144740358|NCT02842853|521904207|FG002|Overall Study|Withdrawal by Subject|9|||
144740359|NCT02842853|521904208|FG003|Overall Study|Withdrawal by Subject|8|||
144740360|NCT02842853|521904205|FG000|Overall Study|Lost to Follow-up|9|||
144740361|NCT02842853|521904206|FG001|Overall Study|Lost to Follow-up|13|||
144740362|NCT02842853|521904207|FG002|Overall Study|Lost to Follow-up|10|||
144740363|NCT02842853|521904208|FG003|Overall Study|Lost to Follow-up|11|||
144740364|NCT04089553|521904209|FG000|Overall Study|Death|1|||
144740365|NCT04089553|521904210|FG001|Overall Study|Death|1|||
144740366|NCT04089553|521904209|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
144740367|NCT04089553|521904210|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
144740368|NCT04089553|521904209|FG000|Overall Study|Withdrawal by Subject|3|||
144740369|NCT04089553|521904210|FG001|Overall Study|Withdrawal by Subject|3|||
144740370|NCT04089553|521904209|FG000|Overall Study|Physician Decision|1|||
144740371|NCT04089553|521904210|FG001|Overall Study|Physician Decision|0|||
144740372|NCT04089553|521904209|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
144740373|NCT04089553|521904210|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
144740374|NCT04089553|521904209|FG000|Overall Study|Other|1|||
144740375|NCT04089553|521904210|FG001|Overall Study|Other|0|||
144740376|NCT04089553|521904209|FG000|Overall Study|Adverse Event|1|||
144740377|NCT04089553|521904210|FG001|Overall Study|Adverse Event|1|||
144740378|NCT01175135|521904218|FG000|Overall Study|Adverse Event|2|||
144740379|NCT01175135|521904219|FG001|Overall Study|Adverse Event|5|||
144740380|NCT01175135|521904220|FG002|Overall Study|Adverse Event|3|||
144740381|NCT01175135|521904221|FG003|Overall Study|Adverse Event|4|||
144740382|NCT01175135|521904218|FG000|Overall Study|Death|1|||
144740383|NCT01175135|521904219|FG001|Overall Study|Death|0|||
144740384|NCT01175135|521904220|FG002|Overall Study|Death|0|||
144740385|NCT01175135|521904221|FG003|Overall Study|Death|0|||
144740386|NCT01175135|521904218|FG000|Overall Study|Lack of Efficacy|4|||
144740387|NCT01175135|521904219|FG001|Overall Study|Lack of Efficacy|5|||
144740388|NCT01175135|521904220|FG002|Overall Study|Lack of Efficacy|0|||
144686117|NCT02202161|521700826|FG003|Overall Study|Did not meet continuation criteria|0|||
144686118|NCT02202161|521700827|FG004|Overall Study|Did not meet continuation criteria|0|||
144686119|NCT02202161|521700828|FG005|Overall Study|Did not meet continuation criteria|0|||
144686120|NCT02202161|521700829|FG006|Overall Study|Did not meet continuation criteria|0|||
144686121|NCT02202161|521700830|FG007|Overall Study|Did not meet continuation criteria|3|||
144686122|NCT02202161|521700823|FG000|Overall Study|Physician Decision|0|||
144686123|NCT02202161|521700824|FG001|Overall Study|Physician Decision|0|||
144686124|NCT02202161|521700825|FG002|Overall Study|Physician Decision|0|||
144686125|NCT02202161|521700826|FG003|Overall Study|Physician Decision|0|||
144686126|NCT02202161|521700827|FG004|Overall Study|Physician Decision|0|||
144686127|NCT02202161|521700828|FG005|Overall Study|Physician Decision|0|||
144686128|NCT02202161|521700829|FG006|Overall Study|Physician Decision|0|||
144686129|NCT02202161|521700830|FG007|Overall Study|Physician Decision|3|||
144686130|NCT02202161|521700823|FG000|Overall Study|Withdrawal by Subject|0|||
144686131|NCT02202161|521700824|FG001|Overall Study|Withdrawal by Subject|0|||
144686132|NCT02202161|521700825|FG002|Overall Study|Withdrawal by Subject|0|||
144686133|NCT02202161|521700826|FG003|Overall Study|Withdrawal by Subject|0|||
144686134|NCT02202161|521700827|FG004|Overall Study|Withdrawal by Subject|1|||
144686135|NCT02202161|521700828|FG005|Overall Study|Withdrawal by Subject|0|||
144686136|NCT02202161|521700829|FG006|Overall Study|Withdrawal by Subject|0|||
144686137|NCT02202161|521700830|FG007|Overall Study|Withdrawal by Subject|0|||
144686138|NCT00832091|521700831|FG000|Overall Study|Adverse Event|1|||
144686139|NCT00832091|521700832|FG001|Overall Study|Adverse Event|1|||
144740389|NCT01175135|521904221|FG003|Overall Study|Lack of Efficacy|5|||
144740390|NCT01175135|521904218|FG000|Overall Study|Lost to Follow-up|1|||
144740391|NCT01175135|521904219|FG001|Overall Study|Lost to Follow-up|2|||
144740392|NCT01175135|521904220|FG002|Overall Study|Lost to Follow-up|0|||
144740393|NCT01175135|521904221|FG003|Overall Study|Lost to Follow-up|0|||
144740394|NCT01175135|521904218|FG000|Overall Study|Protocol Violation|1|||
144740395|NCT01175135|521904219|FG001|Overall Study|Protocol Violation|1|||
144740396|NCT01175135|521904220|FG002|Overall Study|Protocol Violation|0|||
144740397|NCT01175135|521904221|FG003|Overall Study|Protocol Violation|0|||
144740398|NCT01175135|521904218|FG000|Overall Study|Withdrawal by Subject|4|||
144740399|NCT01175135|521904219|FG001|Overall Study|Withdrawal by Subject|8|||
144686140|NCT00832091|521700831|FG000|Overall Study|Protocol Violation|1|||
144686141|NCT00832091|521700832|FG001|Overall Study|Protocol Violation|0|||
144740400|NCT01175135|521904220|FG002|Overall Study|Withdrawal by Subject|5|||
144740401|NCT01175135|521904221|FG003|Overall Study|Withdrawal by Subject|5|||
144740402|NCT01175135|521904218|FG000|Overall Study|Other|3|||
144686142|NCT00832091|521700831|FG000|Overall Study|Withdrawal by Subject|2|||
144686143|NCT00832091|521700832|FG001|Overall Study|Withdrawal by Subject|1|||
144686144|NCT00832091|521700831|FG000|Overall Study|Prohibited Medication|1|||
144686145|NCT00832091|521700832|FG001|Overall Study|Prohibited Medication|0|||
144740403|NCT01175135|521904219|FG001|Overall Study|Other|1|||
144740404|NCT01175135|521904220|FG002|Overall Study|Other|3|||
144740405|NCT01175135|521904221|FG003|Overall Study|Other|0|||
144740406|NCT01175135|521904218|FG000|Overall Study|Randomized But Not Treated|0|||
144740407|NCT01175135|521904219|FG001|Overall Study|Randomized But Not Treated|0|||
144740408|NCT01175135|521904220|FG002|Overall Study|Randomized But Not Treated|1|||
144740409|NCT01175135|521904221|FG003|Overall Study|Randomized But Not Treated|0|||
144740410|NCT01572662|521904222|FG000|Overall Study|Withdrawal by Subject|1|||
144740411|NCT01572662|521904223|FG001|Overall Study|Withdrawal by Subject|0|||
144740412|NCT01572662|521904222|FG000|Overall Study|Physician Decision|0|||
144740413|NCT01572662|521904223|FG001|Overall Study|Physician Decision|1|||
144740414|NCT03364192|521904224|FG000|Overall Study|Ineligible|10|||
144740415|NCT03364192|521904224|FG000|Overall Study|Withdrawal by Subject|5|||
144740416|NCT03364192|521904224|FG000|Overall Study|Lost to Follow-up|1|||
144740417|NCT03446768|521904227|FG000|Overall Study|Withdrawal by Subject|0|||
144740418|NCT03446768|521904228|FG001|Overall Study|Withdrawal by Subject|1|||
144740419|NCT04547192|521904229|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
144740420|NCT04547192|521904230|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
144740421|NCT04547192|521904231|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
144740422|NCT04547192|521904232|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
144740423|NCT04547192|521904229|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
144740424|NCT04547192|521904230|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
144740425|NCT04547192|521904231|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
144740426|NCT04547192|521904232|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
144740427|NCT04547192|521904229|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
144740428|NCT04547192|521904230|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
144740429|NCT04547192|521904231|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
144740430|NCT04547192|521904232|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
144740431|NCT04547192|521904229|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
144740432|NCT04547192|521904230|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
144740433|NCT04547192|521904231|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
144740434|NCT04547192|521904232|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
144740435|NCT04547192|521904229|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
144740436|NCT04547192|521904230|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
144740437|NCT04547192|521904231|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
144740438|NCT04547192|521904232|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
144740439|NCT01442155|521904235|FG000|Overall Study|Complete remission|35|||
144740440|NCT01442155|521904235|FG000|Overall Study|Recurrence|26|||
144740441|NCT01442155|521904235|FG000|Overall Study|Adverse Event|2|||
144740442|NCT01442155|521904235|FG000|Overall Study|Lost to Follow-up|2|||
144740443|NCT01590563|521904238|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
144740444|NCT02699463|521904243|FG000|Overall Study|Lost to Follow-up|11|||
144740445|NCT02699463|521904244|FG001|Overall Study|Lost to Follow-up|8|||
144740446|NCT02699463|521904243|FG000|Overall Study|Withdrawal by Subject|4|||
144740447|NCT02699463|521904244|FG001|Overall Study|Withdrawal by Subject|1|||
144740448|NCT02488239|521904245|FG000|Overall Study|Death|3|||
144740449|NCT02488239|521904245|FG000|Overall Study|Withdrawal by Subject|3|||
144740450|NCT02488239|521904245|FG000|Overall Study|Physician Decision|2|||
144740451|NCT02488239|521904245|FG000|Overall Study|Consent ineligible|1|||
144740452|NCT02488239|521904245|FG000|Overall Study|Did not undergo implant procedure|1|||
144686146|NCT04554394|521700833|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
144686147|NCT04554394|521700834|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
144686148|NCT04554394|521700833|FG000|Overall Study|Withdrawal by Subject|2|||
144686149|NCT04554394|521700834|FG001|Overall Study|Withdrawal by Subject|2|||
144686150|NCT04554394|521700833|FG000|Overall Study|Lost to Follow-up|2|||
144686151|NCT04554394|521700834|FG001|Overall Study|Lost to Follow-up|2|||
144686152|NCT04554394|521700833|FG000|Overall Study|Physician Decision|1|||
144686153|NCT04554394|521700834|FG001|Overall Study|Physician Decision|1|||
144686154|NCT01766401|521700835|FG000|Overall Study|Adverse Event|7|||
144686155|NCT01766401|521700836|FG001|Overall Study|Adverse Event|22|||
144686156|NCT01766401|521700835|FG000|Overall Study|Lack of Efficacy|1|||
144686157|NCT01766401|521700836|FG001|Overall Study|Lack of Efficacy|2|||
144686158|NCT01766401|521700835|FG000|Overall Study|Protocol Violation|3|||
144686159|NCT01766401|521700836|FG001|Overall Study|Protocol Violation|8|||
144686160|NCT01766401|521700835|FG000|Overall Study|Withdrawal by Subject|15|||
144686161|NCT01766401|521700836|FG001|Overall Study|Withdrawal by Subject|12|||
144686162|NCT01766401|521700835|FG000|Overall Study|Lost to Follow-up|10|||
144686163|NCT01766401|521700836|FG001|Overall Study|Lost to Follow-up|11|||
144686164|NCT01766401|521700835|FG000|Overall Study|Pregnancy|1|||
144686165|NCT01766401|521700836|FG001|Overall Study|Pregnancy|1|||
144686166|NCT04107935|521700837|FG000|Overall Study|Death|1|||
144686167|NCT04107935|521700838|FG001|Overall Study|Death|0|||
144740453|NCT02294981|521904246|FG000|Overall Study|Lost to Follow-up|1|||
144740454|NCT00909038|521904249|FG000|Overall Study|Protocol Violation|187|||
144686168|NCT01021553|521700840|FG000|Overall Study|Adverse Event|1|||
144740455|NCT00909038|521904249|FG000|Overall Study|Non-evaluable Subjects|230|||
144686169|NCT01021553|521700841|FG001|Overall Study|Adverse Event|0|||
144740456|NCT03214588|521904252|FG000|Overall Study|Adverse Event|1|||
144740457|NCT03214588|521904253|FG001|Overall Study|Adverse Event|0|||
144740458|NCT03214588|521904254|FG002|Overall Study|Adverse Event|2|||
144740459|NCT03214588|521904252|FG000|Overall Study|Reason Not Specified|0|||
144740460|NCT03214588|521904253|FG001|Overall Study|Reason Not Specified|1|||
144740461|NCT03214588|521904254|FG002|Overall Study|Reason Not Specified|0|||
144265900|NCT00903201|520176413|FG002|Overall Study|Physician Decision|1|||
144265901|NCT00903201|520176411|FG000|Overall Study|Withdrawal by Subject|1|||
144265902|NCT00903201|520176412|FG001|Overall Study|Withdrawal by Subject|0|||
144265903|NCT00903201|520176413|FG002|Overall Study|Withdrawal by Subject|1|||
144686170|NCT01021553|521700842|FG002|Overall Study|Adverse Event|0|||
144686171|NCT01021553|521700840|FG000|Overall Study|Lack of Efficacy|2|||
144686172|NCT01021553|521700841|FG001|Overall Study|Lack of Efficacy|2|||
144686173|NCT01021553|521700842|FG002|Overall Study|Lack of Efficacy|0|||
144686174|NCT01021553|521700840|FG000|Overall Study|Protocol Violation|0|||
144686175|NCT01021553|521700841|FG001|Overall Study|Protocol Violation|2|||
144686176|NCT01021553|521700842|FG002|Overall Study|Protocol Violation|2|||
144686177|NCT01021553|521700840|FG000|Overall Study|Lost to Follow-up|0|||
144686178|NCT01021553|521700841|FG001|Overall Study|Lost to Follow-up|0|||
144686179|NCT01021553|521700842|FG002|Overall Study|Lost to Follow-up|1|||
144686180|NCT01021553|521700840|FG000|Overall Study|Withdrawal by Subject|1|||
144686181|NCT01021553|521700841|FG001|Overall Study|Withdrawal by Subject|1|||
144686182|NCT01021553|521700842|FG002|Overall Study|Withdrawal by Subject|0|||
144686183|NCT01950364|521700843|FG000|Overall Study|Adverse Event|3|||
144686184|NCT01950364|521700844|FG001|Overall Study|Adverse Event|0|||
144686185|NCT01950364|521700843|FG000|Overall Study|Stem Cell Transplant|2|||
144686186|NCT01950364|521700844|FG001|Overall Study|Stem Cell Transplant|6|||
144686187|NCT01950364|521700843|FG000|Overall Study|Disease Progression|5|||
144686188|NCT01950364|521700844|FG001|Overall Study|Disease Progression|2|||
144686189|NCT01950364|521700843|FG000|Overall Study|Withdrawal by Subject|0|||
144686190|NCT01950364|521700844|FG001|Overall Study|Withdrawal by Subject|1|||
144686191|NCT01950364|521700843|FG000|Overall Study|Protocol Violation|0|||
144686192|NCT01950364|521700844|FG001|Overall Study|Protocol Violation|1|||
144686193|NCT00935701|521700845|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
144686194|NCT02877134|521700849|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686195|NCT02877134|521700850|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
144686196|NCT02877134|521700851|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686197|NCT02877134|521700852|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686198|NCT02877134|521700853|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686199|NCT02877134|521700854|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
144686200|NCT02877134|521700855|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686201|NCT02877134|521700856|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686202|NCT02877134|521700857|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686203|NCT02877134|521700858|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686204|NCT02877134|521700859|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686205|NCT02877134|521700860|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
144686206|NCT02877134|521700849|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686207|NCT02877134|521700850|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
144686208|NCT02877134|521700851|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686209|NCT02877134|521700852|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
144686210|NCT02877134|521700853|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686211|NCT02877134|521700854|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686212|NCT02877134|521700855|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
144686213|NCT02877134|521700856|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686214|NCT02877134|521700857|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686215|NCT02877134|521700858|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686216|NCT02877134|521700859|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686217|NCT02877134|521700860|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
144686218|NCT02877134|521700849|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
144686219|NCT02877134|521700850|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
144686220|NCT02877134|521700851|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
144686221|NCT02877134|521700852|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
144686222|NCT02877134|521700853|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
144686223|NCT02877134|521700854|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
144686224|NCT02877134|521700855|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
144686225|NCT02877134|521700856|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
144686226|NCT02877134|521700857|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
144686227|NCT02877134|521700858|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
144686228|NCT02877134|521700859|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
144686229|NCT02877134|521700860|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
144686230|NCT02877134|521700849|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
144265904|NCT00329108|520176414|FG000|Overall Study|Adverse Event|2|||
144686231|NCT02877134|521700850|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
144686232|NCT02877134|521700851|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
144686233|NCT02877134|521700852|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
144686234|NCT02877134|521700853|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
144686235|NCT02877134|521700854|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
144686236|NCT02877134|521700855|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
144686237|NCT02877134|521700856|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
144686238|NCT02877134|521700857|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
144686239|NCT02877134|521700858|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
144686240|NCT02877134|521700859|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
144686241|NCT02877134|521700860|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
144686242|NCT02877134|521700849|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686243|NCT02877134|521700850|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686244|NCT02877134|521700851|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686245|NCT02877134|521700852|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686246|NCT02877134|521700853|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686247|NCT02877134|521700854|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686248|NCT02877134|521700855|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686249|NCT02877134|521700856|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686250|NCT02877134|521700857|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
144686251|NCT02877134|521700858|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686252|NCT02877134|521700859|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686253|NCT02877134|521700860|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
144686254|NCT02877134|521700849|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144686255|NCT02877134|521700850|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144686256|NCT02877134|521700851|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144686257|NCT02877134|521700852|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144686258|NCT02877134|521700853|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144686259|NCT02877134|521700854|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144740462|NCT01895335|521904255|FG000|Overall Study|Adverse Event|106|||
144740463|NCT01895335|521904255|FG000|Overall Study|Lack of Efficacy|53|||
144740464|NCT01895335|521904255|FG000|Overall Study|Poor Compliance to Protocol|11|||
144740465|NCT01895335|521904255|FG000|Overall Study|Included But Not treated|1|||
144740466|NCT01895335|521904255|FG000|Overall Study|Other than Specified Above|44|||
144740467|NCT01794845|521904256|FG000|Overall Study|Withdrawal by Subject|1|||
144740468|NCT02139826|521904257|FG000|Overall Study|Adverse Event|1|||
144740469|NCT00436163|521904258|FG000|Overall Study|Lost to Follow-up|2|||
144740470|NCT00436163|521904258|FG000|Overall Study|Adverse Event|1|||
144740471|NCT03719040|521904259|FG000|Overall Study|Withdrawal by Subject|177|||
144740472|NCT03719040|521904259|FG000|Overall Study|Lost to Follow-up|26|||
144740473|NCT04063878|521904262|FG000|Overall Study|Withdrawal by Subject|2|||
144740474|NCT04063878|521904262|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
144740475|NCT02751827|521904263|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
144740476|NCT02751827|521904264|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
144740477|NCT02751827|521904265|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
144740478|NCT01841554|521904266|FG000|Overall Study|Death|7|||
144740479|NCT01841554|521904266|FG000|Overall Study|No Implantation|1|||
144740480|NCT01841554|521904266|FG000|Overall Study|Discontinued Follow Up|5|||
144740481|NCT01841554|521904266|FG000|Overall Study|Study exit due to secondary intervention|6|||
144740482|NCT01838681|521904267|FG000|Period A|Adverse Event|39|||
144740483|NCT01838681|521904268|FG001|Period A|Adverse Event|0|||
144740484|NCT01838681|521904269|FG002|Period A|Adverse Event|0|||
144740485|NCT01838681|521904270|FG003|Period A|Adverse Event|0|||
144740486|NCT01838681|521904267|FG000|Period A|Lack of Efficacy|21|||
144740487|NCT01838681|521904268|FG001|Period A|Lack of Efficacy|0|||
144740488|NCT01838681|521904269|FG002|Period A|Lack of Efficacy|0|||
144740489|NCT01838681|521904270|FG003|Period A|Lack of Efficacy|0|||
144740490|NCT01838681|521904267|FG000|Period A|Early response|148|||
144740491|NCT01838681|521904268|FG001|Period A|Early response|0|||
144740492|NCT01838681|521904269|FG002|Period A|Early response|0|||
144740493|NCT01838681|521904270|FG003|Period A|Early response|0|||
144740494|NCT01838681|521904267|FG000|Period A|Withdrawal by Subject|70|||
144740495|NCT01838681|521904268|FG001|Period A|Withdrawal by Subject|0|||
144740496|NCT01838681|521904269|FG002|Period A|Withdrawal by Subject|0|||
144740497|NCT01838681|521904270|FG003|Period A|Withdrawal by Subject|0|||
144740498|NCT01838681|521904267|FG000|Period A|Protocol Violation|16|||
144740499|NCT01838681|521904268|FG001|Period A|Protocol Violation|0|||
144740500|NCT01838681|521904269|FG002|Period A|Protocol Violation|0|||
144740501|NCT01838681|521904270|FG003|Period A|Protocol Violation|0|||
144740502|NCT01838681|521904267|FG000|Period A|Non-compliance with IMP|6|||
144740503|NCT01838681|521904268|FG001|Period A|Non-compliance with IMP|0|||
144740504|NCT01838681|521904269|FG002|Period A|Non-compliance with IMP|0|||
144740505|NCT01838681|521904270|FG003|Period A|Non-compliance with IMP|0|||
144740506|NCT01838681|521904267|FG000|Period A|Lost to Follow-up|4|||
144740507|NCT01838681|521904268|FG001|Period A|Lost to Follow-up|0|||
144740508|NCT01838681|521904269|FG002|Period A|Lost to Follow-up|0|||
144740509|NCT01838681|521904270|FG003|Period A|Lost to Follow-up|0|||
144740510|NCT01838681|521904267|FG000|Period A|Withdrawal before treatment|4|||
144218603|NCT00970593|519994426|FG001|Overall Study|Adverse Event|1|||
144218604|NCT00970593|519994427|FG002|Overall Study|Adverse Event|0|||
144218605|NCT00970593|519994428|FG003|Overall Study|Adverse Event|0|||
144218606|NCT00970593|519994429|FG004|Overall Study|Adverse Event|0|||
144218607|NCT00970593|519994430|FG005|Overall Study|Adverse Event|0|||
144218608|NCT00970593|519994431|FG006|Overall Study|Adverse Event|0|||
144218609|NCT00970593|519994425|FG000|Overall Study|Discontinuation of study by sponsor|0|||
144218610|NCT00970593|519994426|FG001|Overall Study|Discontinuation of study by sponsor|0|||
144218611|NCT00970593|519994427|FG002|Overall Study|Discontinuation of study by sponsor|5|||
144218612|NCT00970593|519994428|FG003|Overall Study|Discontinuation of study by sponsor|0|||
144218613|NCT00970593|519994429|FG004|Overall Study|Discontinuation of study by sponsor|0|||
144218614|NCT00970593|519994430|FG005|Overall Study|Discontinuation of study by sponsor|0|||
144218615|NCT00970593|519994431|FG006|Overall Study|Discontinuation of study by sponsor|2|||
144218616|NCT00970593|519994425|FG000|Overall Study|Withdrawal by Subject|0|||
144218617|NCT00970593|519994426|FG001|Overall Study|Withdrawal by Subject|0|||
144218618|NCT00970593|519994427|FG002|Overall Study|Withdrawal by Subject|1|||
144218619|NCT00970593|519994428|FG003|Overall Study|Withdrawal by Subject|0|||
144218620|NCT00970593|519994429|FG004|Overall Study|Withdrawal by Subject|0|||
144218621|NCT00970593|519994430|FG005|Overall Study|Withdrawal by Subject|0|||
144218622|NCT00970593|519994431|FG006|Overall Study|Withdrawal by Subject|0|||
144218623|NCT04108299|519994432|FG000|Overall Study|Not interested in participating|2|||
144218624|NCT04108299|519994433|FG001|Overall Study|Not interested in participating|1|||
144218625|NCT04108299|519994434|FG002|Overall Study|Not interested in participating|2|||
144218626|NCT04108299|519994435|FG003|Overall Study|Not interested in participating|1|||
144218627|NCT04123405|519994436|FG000|Overall Study|Adverse Event|1|||
144218628|NCT04123405|519994437|FG001|Overall Study|Adverse Event|2|||
144218629|NCT04123405|519994438|FG002|Overall Study|Adverse Event|3|||
144218630|NCT04123405|519994439|FG003|Overall Study|Adverse Event|3|||
144218631|NCT04123405|519994436|FG000|Overall Study|Exclusion criteria met|1|||
144218632|NCT04123405|519994437|FG001|Overall Study|Exclusion criteria met|2|||
144218633|NCT04123405|519994438|FG002|Overall Study|Exclusion criteria met|0|||
144218634|NCT04123405|519994439|FG003|Overall Study|Exclusion criteria met|2|||
144218635|NCT04123405|519994436|FG000|Overall Study|Withdrawal by Subject|1|||
144218636|NCT04123405|519994437|FG001|Overall Study|Withdrawal by Subject|3|||
144218637|NCT04123405|519994438|FG002|Overall Study|Withdrawal by Subject|0|||
144218638|NCT04123405|519994439|FG003|Overall Study|Withdrawal by Subject|2|||
144218639|NCT04123405|519994436|FG000|Overall Study|Contact to subject lost|0|||
144218640|NCT04123405|519994437|FG001|Overall Study|Contact to subject lost|0|||
144218641|NCT04123405|519994438|FG002|Overall Study|Contact to subject lost|0|||
144218642|NCT04123405|519994439|FG003|Overall Study|Contact to subject lost|1|||
144218643|NCT04123405|519994436|FG000|Overall Study|screening failure|1|||
144218644|NCT04123405|519994437|FG001|Overall Study|screening failure|0|||
144218645|NCT04123405|519994438|FG002|Overall Study|screening failure|0|||
144686260|NCT02877134|521700855|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
144686261|NCT02877134|521700856|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
144686262|NCT02877134|521700857|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
144686263|NCT02877134|521700858|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
144686264|NCT02877134|521700859|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
144686265|NCT02877134|521700860|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
144686266|NCT02877134|521700849|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686267|NCT02877134|521700850|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144218646|NCT04123405|519994439|FG003|Overall Study|screening failure|0|||
144218647|NCT00662649|519994440|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
144218648|NCT00662649|519994441|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
144218649|NCT00662649|519994442|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
144218650|NCT00662649|519994443|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
144218651|NCT00662649|519994444|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
144686268|NCT02877134|521700851|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144218652|NCT00662649|519994440|FG000|Core Study (24 Months)|Adverse Event|22|||
144218653|NCT00662649|519994441|FG001|Core Study (24 Months)|Adverse Event|13|||
144218654|NCT00662649|519994442|FG002|Core Study (24 Months)|Adverse Event|18|||
144218655|NCT00662649|519994443|FG003|Core Study (24 Months)|Adverse Event|0|||
144218656|NCT00662649|519994444|FG004|Core Study (24 Months)|Adverse Event|0|||
144218657|NCT00662649|519994440|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
144218658|NCT00662649|519994441|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
144218659|NCT00662649|519994442|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
144218660|NCT00662649|519994443|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
144218661|NCT00662649|519994444|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
144218662|NCT00662649|519994440|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
144218663|NCT00662649|519994441|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
144218664|NCT00662649|519994442|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
144218665|NCT00662649|519994443|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
144686269|NCT02877134|521700852|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686270|NCT02877134|521700853|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686271|NCT02877134|521700854|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686272|NCT02877134|521700855|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686273|NCT02877134|521700856|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
144686274|NCT02877134|521700857|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
144686275|NCT02877134|521700858|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
144686276|NCT02877134|521700859|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686277|NCT02877134|521700860|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
144686278|NCT02877134|521700849|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
144686279|NCT02877134|521700850|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
144686280|NCT02877134|521700851|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
144686281|NCT02877134|521700852|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
144686282|NCT02877134|521700853|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
144686283|NCT02877134|521700854|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
144686284|NCT02877134|521700855|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
144686285|NCT02877134|521700856|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
144686286|NCT02877134|521700857|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
144686287|NCT02877134|521700858|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
144686288|NCT02877134|521700859|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
144686289|NCT02877134|521700860|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
144686290|NCT04048876|521700863|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
144686291|NCT04048876|521700864|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
144686292|NCT04048876|521700865|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
144686293|NCT04048876|521700866|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
144686294|NCT04048876|521700863|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
144686295|NCT04048876|521700864|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
144686296|NCT04048876|521700865|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
144686297|NCT04048876|521700866|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
144686298|NCT04048876|521700863|FG000|Placebo Controlled Phase|Adverse Event|0|||
144686299|NCT04048876|521700864|FG001|Placebo Controlled Phase|Adverse Event|1|||
144686300|NCT04048876|521700865|FG002|Placebo Controlled Phase|Adverse Event|0|||
144686301|NCT04048876|521700866|FG003|Placebo Controlled Phase|Adverse Event|0|||
144686302|NCT04048876|521700863|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
144686303|NCT04048876|521700864|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
144686304|NCT04048876|521700865|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
144686305|NCT04048876|521700866|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
144686306|NCT01347840|521700871|FG000|Overall Study|Withdrawal by Subject|1|||
144686307|NCT01222416|521700872|FG000|Overall Study|ineligible;metastasis|3|||
144686308|NCT01222416|521700873|FG001|Overall Study|ineligible;metastasis|0|||
144686309|NCT01222416|521700872|FG000|Overall Study|Adverse Event|4|||
144686310|NCT01222416|521700873|FG001|Overall Study|Adverse Event|0|||
144686311|NCT01222416|521700872|FG000|Overall Study|Withdrawal by Subject|5|||
144686312|NCT01222416|521700873|FG001|Overall Study|Withdrawal by Subject|0|||
144686313|NCT01222416|521700872|FG000|Overall Study|scheduling|6|||
144686314|NCT01222416|521700873|FG001|Overall Study|scheduling|0|||
144686315|NCT01222416|521700872|FG000|Overall Study|missed view/scan|1|||
144686316|NCT01222416|521700873|FG001|Overall Study|missed view/scan|0|||
144686317|NCT01222416|521700872|FG000|Overall Study|Death|1|||
144686318|NCT01222416|521700873|FG001|Overall Study|Death|0|||
144686319|NCT00518336|521700874|FG000|Year 7|Lost to Follow-up|2|||
144686320|NCT00518336|521700875|FG001|Year 7|Lost to Follow-up|0|||
144686321|NCT00518336|521700874|FG000|Year 7|Could not attend in time|0|||
144686322|NCT00518336|521700875|FG001|Year 7|Could not attend in time|3|||
144686323|NCT00518336|521700874|FG000|Year 8|Lost to Follow-up|1|||
144686324|NCT00518336|521700875|FG001|Year 8|Lost to Follow-up|1|||
144686325|NCT00518336|521700874|FG000|Year 8|Could not attend in time|0|||
144686326|NCT00518336|521700875|FG001|Year 8|Could not attend in time|1|||
144686327|NCT00518336|521700874|FG000|Year 9|Migrated/moved from study area|1|||
144686328|NCT00518336|521700875|FG001|Year 9|Migrated/moved from study area|1|||
144686329|NCT00518336|521700874|FG000|Year 9|Lost to Follow-up|3|||
144686330|NCT00518336|521700875|FG001|Year 9|Lost to Follow-up|0|||
144686331|NCT00518336|521700874|FG000|Year 9|Personal reasons|1|||
144686332|NCT00518336|521700875|FG001|Year 9|Personal reasons|0|||
144686333|NCT00703781|521700876|FG000|Overall Study|Withdrawal by Subject|1|||
144686334|NCT00703781|521700877|FG001|Overall Study|Withdrawal by Subject|2|||
144686335|NCT00703781|521700876|FG000|Overall Study|Cancelled surgery|1|||
144686336|NCT00703781|521700877|FG001|Overall Study|Cancelled surgery|0|||
144686337|NCT02683668|521700881|FG000|Period 2|Withdrawal by Subject|0|||
144686338|NCT02683668|521700882|FG001|Period 2|Withdrawal by Subject|1|||
144686339|NCT02683668|521700883|FG002|Period 2|Withdrawal by Subject|0|||
144686340|NCT04223778|521700884|FG000|Overall Study|Death|1|||
144686341|NCT04223778|521700885|FG001|Overall Study|Death|1|||
144686342|NCT04223778|521700884|FG000|Overall Study|Lost to Follow-up|4|||
144686343|NCT04223778|521700885|FG001|Overall Study|Lost to Follow-up|5|||
144686344|NCT04223778|521700884|FG000|Overall Study|Physician Decision|10|||
144686345|NCT04223778|521700885|FG001|Overall Study|Physician Decision|6|||
144686346|NCT04223778|521700884|FG000|Overall Study|Withdrawal by Subject|35|||
144686347|NCT04223778|521700885|FG001|Overall Study|Withdrawal by Subject|17|||
144686348|NCT04223778|521700884|FG000|Overall Study|Not Reported|7|||
144686349|NCT04223778|521700885|FG001|Overall Study|Not Reported|8|||
144686350|NCT03893630|521700888|FG000|Overall Study|Lost to Follow-up|5|||
144686351|NCT03893630|521700889|FG001|Overall Study|Lost to Follow-up|4|||
144686352|NCT03893630|521700890|FG002|Overall Study|Lost to Follow-up|2|||
144686353|NCT03893630|521700888|FG000|Overall Study|Withdrawal by Subject|3|||
144686354|NCT03893630|521700889|FG001|Overall Study|Withdrawal by Subject|6|||
144686355|NCT03893630|521700890|FG002|Overall Study|Withdrawal by Subject|3|||
144686356|NCT03893630|521700888|FG000|Overall Study|Discontinued Intervention|0|||
144686357|NCT03893630|521700889|FG001|Overall Study|Discontinued Intervention|4|||
144686358|NCT03893630|521700890|FG002|Overall Study|Discontinued Intervention|2|||
144686359|NCT03053180|521702676|FG000|Overall Study|Failure to Return|1|||
144686360|NCT03958149|521702678|FG000|Overall Study|Withdrawal by Subject|0|||
144686361|NCT03958149|521702679|FG001|Overall Study|Withdrawal by Subject|1|||
144686362|NCT00621764|521702681|FG000|Overall Study|Protocol Violation|0|||
144686363|NCT00621764|521702682|FG001|Overall Study|Protocol Violation|0|||
144686364|NCT00621764|521702683|FG002|Overall Study|Protocol Violation|0|||
144686365|NCT00621764|521702684|FG003|Overall Study|Protocol Violation|1|||
144686366|NCT03031327|521702691|FG000|Overall Study|Withdrawal by Subject|0|||
144686367|NCT03031327|521702692|FG001|Overall Study|Withdrawal by Subject|1|||
144686368|NCT03031327|521702693|FG002|Overall Study|Withdrawal by Subject|1|||
144686369|NCT00211536|521702694|FG000|Overall Study|Withdrawal by Subject|2|||
144686370|NCT00211536|521702695|FG001|Overall Study|Withdrawal by Subject|2|||
144686371|NCT00211536|521702694|FG000|Overall Study|Physician Decision|0|||
144686372|NCT00211536|521702695|FG001|Overall Study|Physician Decision|5|||
144686373|NCT00211536|521702694|FG000|Overall Study|Adverse Event|2|||
144686374|NCT00211536|521702695|FG001|Overall Study|Adverse Event|0|||
144686375|NCT00669240|521702696|FG000|Overall Study|Lack of Efficacy|33|||
144686376|NCT00669240|521702696|FG000|Overall Study|Withdrawal by Subject|42|||
144686377|NCT00669240|521702696|FG000|Overall Study|Lost to Follow-up|34|||
144686378|NCT00669240|521702696|FG000|Overall Study|Adverse Event|21|||
144686379|NCT00669240|521702696|FG000|Overall Study|Other|19|||
144686380|NCT00669240|521702696|FG000|Overall Study|Enrolled but not treated|15|||
144686381|NCT00669240|521702696|FG000|Overall Study|Enrolled but no dosing record|1|||
144686382|NCT00364611|521702698|FG000|Overall Study|Did not receive study medication|0|||
144686383|NCT00364611|521702699|FG001|Overall Study|Did not receive study medication|1|||
144686384|NCT00364611|521702698|FG000|Overall Study|Adverse Event|7|||
144686385|NCT00364611|521702699|FG001|Overall Study|Adverse Event|4|||
144686386|NCT00364611|521702698|FG000|Overall Study|Participant's Request|3|||
144686387|NCT00364611|521702699|FG001|Overall Study|Participant's Request|4|||
144686388|NCT00364611|521702698|FG000|Overall Study|Disease Progression|38|||
144686389|NCT00364611|521702699|FG001|Overall Study|Disease Progression|8|||
144686390|NCT00364611|521702698|FG000|Overall Study|Investigator decision|2|||
144686391|NCT00364611|521702699|FG001|Overall Study|Investigator decision|2|||
144686392|NCT00364611|521702698|FG000|Overall Study|Found Ineligible|1|||
144686393|NCT00364611|521702699|FG001|Overall Study|Found Ineligible|0|||
144686394|NCT00364611|521702698|FG000|Overall Study|Presumed CR on Study|0|||
144686395|NCT00364611|521702699|FG001|Overall Study|Presumed CR on Study|1|||
144686396|NCT00364611|521702698|FG000|Overall Study|Receiving Liver Ablation|0|||
144686397|NCT00364611|521702699|FG001|Overall Study|Receiving Liver Ablation|1|||
144686398|NCT02759939|521702704|FG000|Overall Study|Missing data on first outcome assessed|11|||
144686399|NCT02759939|521702705|FG001|Overall Study|Missing data on first outcome assessed|2|||
144686400|NCT02759939|521702706|FG002|Overall Study|Missing data on first outcome assessed|5|||
144686401|NCT02759939|521702707|FG003|Overall Study|Missing data on first outcome assessed|2|||
144686402|NCT02759939|521702704|FG000|Overall Study|Ineligible for T2 and T3|310|||
144686403|NCT02759939|521702705|FG001|Overall Study|Ineligible for T2 and T3|179|||
144686404|NCT02759939|521702706|FG002|Overall Study|Ineligible for T2 and T3|366|||
144686405|NCT02759939|521702707|FG003|Overall Study|Ineligible for T2 and T3|391|||
144218666|NCT00662649|519994444|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
144218667|NCT00662649|519994440|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
144265905|NCT00329108|520176415|FG001|Overall Study|Adverse Event|2|||
144686406|NCT02759939|521702704|FG000|Overall Study|Lost to Follow-up|735|||
144686407|NCT02759939|521702705|FG001|Overall Study|Lost to Follow-up|791|||
144686408|NCT02759939|521702706|FG002|Overall Study|Lost to Follow-up|783|||
144686409|NCT02759939|521702707|FG003|Overall Study|Lost to Follow-up|650|||
144686410|NCT04397757|521702709|FG000|Overall Study|Death|3|||
144686411|NCT04397757|521702710|FG001|Overall Study|Death|11|||
144686412|NCT04397757|521702709|FG000|Overall Study|Withdrawal by Subject|2|||
144686413|NCT04397757|521702710|FG001|Overall Study|Withdrawal by Subject|0|||
144686414|NCT04397757|521702709|FG000|Overall Study|Lost to Follow-up|4|||
144686415|NCT04397757|521702710|FG001|Overall Study|Lost to Follow-up|3|||
144686416|NCT00087594|521702711|FG000|Overall Study|Adverse Event|2|||
144686417|NCT00087594|521702712|FG001|Overall Study|Adverse Event|3|||
144686418|NCT00087594|521702711|FG000|Overall Study|Lost to Follow-up|0|||
144686419|NCT00087594|521702712|FG001|Overall Study|Lost to Follow-up|2|||
144686420|NCT00087594|521702711|FG000|Overall Study|Withdrawal by Subject|4|||
144686421|NCT00087594|521702712|FG001|Overall Study|Withdrawal by Subject|2|||
144686422|NCT00087594|521702711|FG000|Overall Study|Lack of Efficacy|2|||
144686423|NCT00087594|521702712|FG001|Overall Study|Lack of Efficacy|5|||
144686424|NCT02094612|521702713|FG000|Overall Study|Lost to Follow-up|47|||
144686425|NCT02094612|521702714|FG001|Overall Study|Lost to Follow-up|47|||
144686426|NCT02094612|521702713|FG000|Overall Study|Never started ADHD medication|32|||
144686427|NCT02094612|521702714|FG001|Overall Study|Never started ADHD medication|23|||
144686428|NCT02646891|521702715|FG000|Overall Study|Adverse Event|0|||
144686429|NCT02646891|521702716|FG001|Overall Study|Adverse Event|1|||
144686430|NCT02646891|521702717|FG002|Overall Study|Adverse Event|0|||
144686431|NCT02646891|521702718|FG003|Overall Study|Adverse Event|0|||
144686432|NCT02646891|521702719|FG004|Overall Study|Adverse Event|0|||
144686433|NCT02646891|521702720|FG005|Overall Study|Adverse Event|0|||
144686434|NCT02646891|521702721|FG006|Overall Study|Adverse Event|0|||
144686435|NCT02646891|521702722|FG007|Overall Study|Adverse Event|0|||
144686436|NCT02646891|521702723|FG008|Overall Study|Adverse Event|0|||
144686437|NCT02646891|521702724|FG009|Overall Study|Adverse Event|0|||
144686438|NCT02646891|521702715|FG000|Overall Study|Lost to Follow-up|0|||
144686439|NCT02646891|521702716|FG001|Overall Study|Lost to Follow-up|0|||
144686440|NCT02646891|521702717|FG002|Overall Study|Lost to Follow-up|0|||
144686441|NCT02646891|521702718|FG003|Overall Study|Lost to Follow-up|0|||
144686442|NCT02646891|521702719|FG004|Overall Study|Lost to Follow-up|0|||
144686443|NCT02646891|521702720|FG005|Overall Study|Lost to Follow-up|0|||
144686444|NCT02646891|521702721|FG006|Overall Study|Lost to Follow-up|2|||
144686445|NCT02646891|521702722|FG007|Overall Study|Lost to Follow-up|2|||
144686446|NCT02646891|521702723|FG008|Overall Study|Lost to Follow-up|2|||
144686447|NCT02646891|521702724|FG009|Overall Study|Lost to Follow-up|2|||
144686448|NCT02646891|521702715|FG000|Overall Study|Protocol Violation|0|||
144686449|NCT02646891|521702716|FG001|Overall Study|Protocol Violation|0|||
144686450|NCT02646891|521702717|FG002|Overall Study|Protocol Violation|0|||
144686451|NCT02646891|521702718|FG003|Overall Study|Protocol Violation|0|||
144686452|NCT02646891|521702719|FG004|Overall Study|Protocol Violation|0|||
144686453|NCT02646891|521702720|FG005|Overall Study|Protocol Violation|0|||
144686454|NCT02646891|521702721|FG006|Overall Study|Protocol Violation|1|||
144686455|NCT02646891|521702722|FG007|Overall Study|Protocol Violation|1|||
144686456|NCT02646891|521702723|FG008|Overall Study|Protocol Violation|0|||
144686457|NCT02646891|521702724|FG009|Overall Study|Protocol Violation|0|||
144686458|NCT02646891|521702715|FG000|Overall Study|Withdrawal by Subject|2|||
144686459|NCT02646891|521702716|FG001|Overall Study|Withdrawal by Subject|0|||
144686460|NCT02646891|521702717|FG002|Overall Study|Withdrawal by Subject|1|||
144686461|NCT02646891|521702718|FG003|Overall Study|Withdrawal by Subject|0|||
144686462|NCT02646891|521702719|FG004|Overall Study|Withdrawal by Subject|0|||
144686463|NCT02646891|521702720|FG005|Overall Study|Withdrawal by Subject|0|||
144686464|NCT02646891|521702721|FG006|Overall Study|Withdrawal by Subject|5|||
144686465|NCT02646891|521702722|FG007|Overall Study|Withdrawal by Subject|9|||
144686466|NCT02646891|521702723|FG008|Overall Study|Withdrawal by Subject|7|||
144686467|NCT02646891|521702724|FG009|Overall Study|Withdrawal by Subject|3|||
144686468|NCT02646891|521702715|FG000|Overall Study|Death|0|||
144686469|NCT02646891|521702716|FG001|Overall Study|Death|0|||
144686470|NCT02646891|521702717|FG002|Overall Study|Death|0|||
144686471|NCT02646891|521702718|FG003|Overall Study|Death|0|||
144686472|NCT02646891|521702719|FG004|Overall Study|Death|0|||
144686473|NCT02646891|521702720|FG005|Overall Study|Death|0|||
144686474|NCT02646891|521702721|FG006|Overall Study|Death|1|||
144686475|NCT02646891|521702722|FG007|Overall Study|Death|1|||
144686476|NCT02646891|521702723|FG008|Overall Study|Death|1|||
144686477|NCT02646891|521702724|FG009|Overall Study|Death|0|||
144686478|NCT01542632|521702725|FG000|Overall Study|Withdrawal of Consent|0|||
144686479|NCT01542632|521702726|FG001|Overall Study|Withdrawal of Consent|0|||
144686480|NCT01542632|521702727|FG002|Overall Study|Withdrawal of Consent|0|||
144686481|NCT01542632|521702728|FG003|Overall Study|Withdrawal of Consent|2|||
144686482|NCT01542632|521702729|FG004|Overall Study|Withdrawal of Consent|3|||
144686483|NCT01542632|521702730|FG005|Overall Study|Withdrawal of Consent|0|||
144686484|NCT01542632|521702725|FG000|Overall Study|Adverse Event|0|||
144686485|NCT01542632|521702726|FG001|Overall Study|Adverse Event|0|||
144686486|NCT01542632|521702727|FG002|Overall Study|Adverse Event|1|||
144686487|NCT01542632|521702728|FG003|Overall Study|Adverse Event|0|||
144686488|NCT01542632|521702729|FG004|Overall Study|Adverse Event|0|||
144686489|NCT01542632|521702730|FG005|Overall Study|Adverse Event|0|||
144686490|NCT01542632|521702725|FG000|Overall Study|Lost to Follow-up|0|||
144686491|NCT01542632|521702726|FG001|Overall Study|Lost to Follow-up|1|||
144686492|NCT01542632|521702727|FG002|Overall Study|Lost to Follow-up|0|||
144686493|NCT01542632|521702728|FG003|Overall Study|Lost to Follow-up|0|||
144740511|NCT01838681|521904268|FG001|Period A|Withdrawal before treatment|0|||
144740512|NCT01838681|521904269|FG002|Period A|Withdrawal before treatment|0|||
144740513|NCT01838681|521904270|FG003|Period A|Withdrawal before treatment|0|||
144740514|NCT01838681|521904267|FG000|Period A|Administrative or other reasons|17|||
144686494|NCT01542632|521702729|FG004|Overall Study|Lost to Follow-up|0|||
144686495|NCT01542632|521702730|FG005|Overall Study|Lost to Follow-up|0|||
144686496|NCT01542632|521702725|FG000|Overall Study|Sponsor/Investigator Decision|0|||
144686497|NCT01542632|521702726|FG001|Overall Study|Sponsor/Investigator Decision|0|||
144686498|NCT01542632|521702727|FG002|Overall Study|Sponsor/Investigator Decision|0|||
144686499|NCT01542632|521702728|FG003|Overall Study|Sponsor/Investigator Decision|0|||
144686500|NCT01542632|521702729|FG004|Overall Study|Sponsor/Investigator Decision|1|||
144686501|NCT01542632|521702730|FG005|Overall Study|Sponsor/Investigator Decision|0|||
144686502|NCT03991936|521702731|FG000|Overall Study|Lost to Follow-up|1|||
144686503|NCT03991936|521702732|FG001|Overall Study|Lost to Follow-up|1|||
144686504|NCT03991936|521702733|FG002|Overall Study|Lost to Follow-up|1|||
144686505|NCT03991936|521702734|FG003|Overall Study|Lost to Follow-up|1|||
144686506|NCT03991936|521702735|FG004|Overall Study|Lost to Follow-up|1|||
144686507|NCT00508001|521702746|FG000|Overall Study|Adverse Event|2|||
144686508|NCT00508001|521702747|FG001|Overall Study|Adverse Event|0|||
144686509|NCT00508001|521702748|FG002|Overall Study|Adverse Event|4|||
144686510|NCT00508001|521702746|FG000|Overall Study|condition under investigation worsened|13|||
144686511|NCT00508001|521702747|FG001|Overall Study|condition under investigation worsened|7|||
144686512|NCT00508001|521702748|FG002|Overall Study|condition under investigation worsened|1|||
144686513|NCT00508001|521702746|FG000|Overall Study|Death|0|||
144686514|NCT00508001|521702747|FG001|Overall Study|Death|1|||
144686515|NCT00508001|521702748|FG002|Overall Study|Death|1|||
144686516|NCT00508001|521702746|FG000|Overall Study|Withdrawal by Subject|4|||
144686517|NCT00508001|521702747|FG001|Overall Study|Withdrawal by Subject|4|||
144686518|NCT00508001|521702748|FG002|Overall Study|Withdrawal by Subject|1|||
144686519|NCT01599585|521702749|FG000|Overall Study|Withdrawal by Subject|16|||
144686520|NCT01599585|521702750|FG001|Overall Study|Withdrawal by Subject|9|||
144686521|NCT01599585|521702749|FG000|Overall Study|Lost to Follow-up|3|||
144686522|NCT01599585|521702750|FG001|Overall Study|Lost to Follow-up|5|||
144686523|NCT01599585|521702749|FG000|Overall Study|randomized did not start treatment|3|||
144686524|NCT01599585|521702750|FG001|Overall Study|randomized did not start treatment|3|||
144686525|NCT00611767|521702751|FG000|Overall Study|Withdrawal by Subject|4|||
144686526|NCT00611767|521702752|FG001|Overall Study|Withdrawal by Subject|1|||
144686527|NCT00611767|521702751|FG000|Overall Study|Thiopental not available|3|||
144686528|NCT00611767|521702752|FG001|Overall Study|Thiopental not available|0|||
144686529|NCT00611767|521702751|FG000|Overall Study|didn't like the medication|1|||
144686530|NCT00611767|521702752|FG001|Overall Study|didn't like the medication|1|||
144686531|NCT00611767|521702751|FG000|Overall Study|Physician Decision|1|||
144686532|NCT00611767|521702752|FG001|Overall Study|Physician Decision|0|||
144686533|NCT03442595|521702753|FG000|Overall Study|Lost to Follow-up|94|||
144686534|NCT03442595|521702754|FG001|Overall Study|Lost to Follow-up|0|||
144686535|NCT01642004|521702755|FG000|Randomization|Adverse Event unrelated to study drug|1|||
144686536|NCT01642004|521702756|FG001|Randomization|Adverse Event unrelated to study drug|0|||
144686537|NCT01642004|521702755|FG000|Randomization|Participant withdrew consent|1|||
144686538|NCT01642004|521702756|FG001|Randomization|Participant withdrew consent|6|||
144686539|NCT01642004|521702755|FG000|Randomization|No longer meets study criteria|2|||
144686540|NCT01642004|521702756|FG001|Randomization|No longer meets study criteria|2|||
144686541|NCT01642004|521702755|FG000|Treatment|Disease progression|95|||
144686542|NCT01642004|521702756|FG001|Treatment|Disease progression|79|||
144686543|NCT01642004|521702755|FG000|Treatment|Study drug toxicity|10|||
144686544|NCT01642004|521702756|FG001|Treatment|Study drug toxicity|13|||
144686545|NCT01642004|521702755|FG000|Treatment|Death|1|||
144686546|NCT01642004|521702756|FG001|Treatment|Death|1|||
144686547|NCT01642004|521702755|FG000|Treatment|Adverse event unrelated to study drug|9|||
144686548|NCT01642004|521702756|FG001|Treatment|Adverse event unrelated to study drug|13|||
144686549|NCT01642004|521702755|FG000|Treatment|Maximum clinical benefit|1|||
144686550|NCT01642004|521702756|FG001|Treatment|Maximum clinical benefit|9|||
144686551|NCT01642004|521702755|FG000|Treatment|Poor/non-compliance|1|||
144686552|NCT01642004|521702756|FG001|Treatment|Poor/non-compliance|0|||
144686553|NCT01642004|521702755|FG000|Treatment|No longer meets study criteria|1|||
144686554|NCT01642004|521702756|FG001|Treatment|No longer meets study criteria|2|||
144686555|NCT01642004|521702755|FG000|Treatment|Other reasons|2|||
144686556|NCT01642004|521702756|FG001|Treatment|Other reasons|0|||
144686557|NCT01642004|521702755|FG000|Treatment|Not reported|0|||
144686558|NCT01642004|521702756|FG001|Treatment|Not reported|3|||
144686559|NCT01642004|521702755|FG000|Treatment|Participant request to discontinue study treatment|6|||
144686560|NCT01642004|521702756|FG001|Treatment|Participant request to discontinue study treatment|4|||
144686561|NCT01642004|521702755|FG000|Treatment|Participant withdrew consent|5|||
144686562|NCT01642004|521702756|FG001|Treatment|Participant withdrew consent|5|||
144686563|NCT01818765|521702759|FG000|Overall Study|Death|2|||
144740515|NCT01838681|521904268|FG001|Period A|Administrative or other reasons|0|||
144740516|NCT01838681|521904269|FG002|Period A|Administrative or other reasons|0|||
144740517|NCT01838681|521904270|FG003|Period A|Administrative or other reasons|0|||
144686564|NCT02005211|521702762|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
144686565|NCT02005211|521702763|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
144740518|NCT01838681|521904267|FG000|Period B/A+|Adverse Event|0|||
144740519|NCT01838681|521904268|FG001|Period B/A+|Adverse Event|13|||
144740520|NCT01838681|521904269|FG002|Period B/A+|Adverse Event|27|||
144265906|NCT00329108|520176414|FG000|Overall Study|Lack of Efficacy|3|||
144265907|NCT00329108|520176415|FG001|Overall Study|Lack of Efficacy|3|||
144265908|NCT00329108|520176414|FG000|Overall Study|Withdrawal by Subject|0|||
144686566|NCT02005211|521702764|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
144686567|NCT02005211|521702765|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
144686568|NCT02005211|521702766|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
144686569|NCT02005211|521702767|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
144686570|NCT02005211|521702768|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
144686571|NCT00952588|521702769|FG000|Overall Study|Death|28|||
144686572|NCT00952588|521702770|FG001|Overall Study|Death|13|||
144686573|NCT00952588|521702769|FG000|Overall Study|Withdrawal by Subject|2|||
144686574|NCT00952588|521702770|FG001|Overall Study|Withdrawal by Subject|5|||
144686575|NCT00952588|521702769|FG000|Overall Study|Adverse Event|2|||
144686576|NCT00952588|521702770|FG001|Overall Study|Adverse Event|3|||
144686577|NCT00952588|521702769|FG000|Overall Study|Lost to Follow-up|2|||
144686578|NCT00952588|521702770|FG001|Overall Study|Lost to Follow-up|0|||
144686579|NCT00952588|521702769|FG000|Overall Study|Physician Decision|0|||
144686580|NCT00952588|521702770|FG001|Overall Study|Physician Decision|1|||
144686581|NCT00952588|521702769|FG000|Overall Study|Lack of Efficacy|2|||
144686582|NCT00952588|521702770|FG001|Overall Study|Lack of Efficacy|2|||
144686583|NCT01197794|521702771|FG000|Overall Study|Adverse Event|3|||
144686584|NCT01197794|521702772|FG001|Overall Study|Adverse Event|2|||
144686585|NCT01197794|521702773|FG002|Overall Study|Adverse Event|4|||
144686586|NCT01197794|521702774|FG003|Overall Study|Adverse Event|4|||
144686587|NCT01197794|521702775|FG004|Overall Study|Adverse Event|4|||
144686588|NCT01197794|521702776|FG005|Overall Study|Adverse Event|2|||
144686589|NCT01197794|521702777|FG006|Overall Study|Adverse Event|3|||
144686590|NCT01197794|521702771|FG000|Overall Study|Protocol Violation|0|||
144686591|NCT01197794|521702772|FG001|Overall Study|Protocol Violation|0|||
144686592|NCT01197794|521702773|FG002|Overall Study|Protocol Violation|0|||
144686593|NCT01197794|521702774|FG003|Overall Study|Protocol Violation|0|||
144686594|NCT01197794|521702775|FG004|Overall Study|Protocol Violation|2|||
144686595|NCT01197794|521702776|FG005|Overall Study|Protocol Violation|0|||
144686596|NCT01197794|521702777|FG006|Overall Study|Protocol Violation|1|||
144686597|NCT01197794|521702771|FG000|Overall Study|Development of study withdrawal criteria|3|||
144686598|NCT01197794|521702772|FG001|Overall Study|Development of study withdrawal criteria|0|||
144686599|NCT01197794|521702773|FG002|Overall Study|Development of study withdrawal criteria|0|||
144686600|NCT01197794|521702774|FG003|Overall Study|Development of study withdrawal criteria|1|||
144686601|NCT01197794|521702775|FG004|Overall Study|Development of study withdrawal criteria|0|||
144686602|NCT01197794|521702776|FG005|Overall Study|Development of study withdrawal criteria|0|||
144686603|NCT01197794|521702777|FG006|Overall Study|Development of study withdrawal criteria|1|||
144686604|NCT01197794|521702771|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
144686605|NCT01197794|521702772|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
144686606|NCT01197794|521702773|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
144686607|NCT01197794|521702774|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
144686608|NCT01197794|521702775|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
144686609|NCT01197794|521702776|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
144686610|NCT01197794|521702777|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
144686611|NCT01197794|521702771|FG000|Overall Study|Withdrawal by Subject|3|||
144686612|NCT01197794|521702772|FG001|Overall Study|Withdrawal by Subject|3|||
144686613|NCT01197794|521702773|FG002|Overall Study|Withdrawal by Subject|4|||
144686614|NCT01197794|521702774|FG003|Overall Study|Withdrawal by Subject|1|||
144686615|NCT01197794|521702775|FG004|Overall Study|Withdrawal by Subject|1|||
144686616|NCT01197794|521702776|FG005|Overall Study|Withdrawal by Subject|5|||
144686617|NCT01197794|521702777|FG006|Overall Study|Withdrawal by Subject|6|||
144686618|NCT01197794|521702771|FG000|Overall Study|Lost to Follow-up|1|||
144686619|NCT01197794|521702772|FG001|Overall Study|Lost to Follow-up|1|||
144740521|NCT01838681|521904270|FG003|Period B/A+|Adverse Event|16|||
144740522|NCT01838681|521904267|FG000|Period B/A+|Lack of Efficacy|0|||
144740523|NCT01838681|521904268|FG001|Period B/A+|Lack of Efficacy|9|||
144740524|NCT01838681|521904269|FG002|Period B/A+|Lack of Efficacy|11|||
144740525|NCT01838681|521904270|FG003|Period B/A+|Lack of Efficacy|6|||
144740526|NCT01838681|521904267|FG000|Period B/A+|Withdrawal by Subject|0|||
144740527|NCT01838681|521904268|FG001|Period B/A+|Withdrawal by Subject|28|||
144740528|NCT01838681|521904269|FG002|Period B/A+|Withdrawal by Subject|35|||
144686620|NCT01197794|521702773|FG002|Overall Study|Lost to Follow-up|0|||
144686621|NCT01197794|521702774|FG003|Overall Study|Lost to Follow-up|1|||
144686622|NCT01197794|521702775|FG004|Overall Study|Lost to Follow-up|0|||
144686623|NCT01197794|521702776|FG005|Overall Study|Lost to Follow-up|1|||
144686624|NCT01197794|521702777|FG006|Overall Study|Lost to Follow-up|0|||
144686625|NCT01197794|521702771|FG000|Overall Study|Other|1|||
144686626|NCT01197794|521702772|FG001|Overall Study|Other|1|||
144740529|NCT01838681|521904270|FG003|Period B/A+|Withdrawal by Subject|47|||
144740530|NCT01838681|521904267|FG000|Period B/A+|Protocol Violation|0|||
144740531|NCT01838681|521904268|FG001|Period B/A+|Protocol Violation|1|||
144686627|NCT01197794|521702773|FG002|Overall Study|Other|3|||
144686628|NCT01197794|521702774|FG003|Overall Study|Other|0|||
144686629|NCT01197794|521702775|FG004|Overall Study|Other|2|||
144686630|NCT01197794|521702776|FG005|Overall Study|Other|2|||
144686631|NCT01197794|521702777|FG006|Overall Study|Other|4|||
144686632|NCT01055457|521702778|FG000|Overall Study|Lost to Follow-up|0|||
144686633|NCT01055457|521702779|FG001|Overall Study|Lost to Follow-up|1|||
144686634|NCT01055457|521702780|FG002|Overall Study|Lost to Follow-up|0|||
144686635|NCT01055457|521702781|FG003|Overall Study|Lost to Follow-up|0|||
144686636|NCT01055457|521702782|FG004|Overall Study|Lost to Follow-up|0|||
144686637|NCT01055457|521702783|FG005|Overall Study|Lost to Follow-up|1|||
144686638|NCT01055457|521702784|FG006|Overall Study|Lost to Follow-up|0|||
144686639|NCT01055457|521702785|FG007|Overall Study|Lost to Follow-up|0|||
144686640|NCT01055457|521702786|FG008|Overall Study|Lost to Follow-up|0|||
144686641|NCT01055457|521702787|FG009|Overall Study|Lost to Follow-up|0|||
144686642|NCT01055457|521702778|FG000|Overall Study|Protocol Violation|0|||
144686643|NCT01055457|521702779|FG001|Overall Study|Protocol Violation|0|||
144686644|NCT01055457|521702780|FG002|Overall Study|Protocol Violation|1|||
144686645|NCT01055457|521702781|FG003|Overall Study|Protocol Violation|1|||
144686646|NCT01055457|521702782|FG004|Overall Study|Protocol Violation|1|||
144686647|NCT01055457|521702783|FG005|Overall Study|Protocol Violation|2|||
144686648|NCT01055457|521702784|FG006|Overall Study|Protocol Violation|1|||
144686649|NCT01055457|521702785|FG007|Overall Study|Protocol Violation|0|||
144686650|NCT01055457|521702786|FG008|Overall Study|Protocol Violation|0|||
144686651|NCT01055457|521702787|FG009|Overall Study|Protocol Violation|1|||
144686652|NCT01055457|521702778|FG000|Overall Study|Subject Disinterest|0|||
144686653|NCT01055457|521702779|FG001|Overall Study|Subject Disinterest|0|||
144686654|NCT01055457|521702780|FG002|Overall Study|Subject Disinterest|0|||
144686655|NCT01055457|521702781|FG003|Overall Study|Subject Disinterest|0|||
144686656|NCT01055457|521702782|FG004|Overall Study|Subject Disinterest|0|||
144686657|NCT01055457|521702783|FG005|Overall Study|Subject Disinterest|0|||
144686658|NCT01055457|521702784|FG006|Overall Study|Subject Disinterest|0|||
144686659|NCT01055457|521702785|FG007|Overall Study|Subject Disinterest|1|||
144686660|NCT01055457|521702786|FG008|Overall Study|Subject Disinterest|0|||
144686661|NCT01055457|521702787|FG009|Overall Study|Subject Disinterest|0|||
144686662|NCT01055457|521702778|FG000|Overall Study|Subject Ineligible|1|||
144686663|NCT01055457|521702779|FG001|Overall Study|Subject Ineligible|0|||
144686664|NCT01055457|521702780|FG002|Overall Study|Subject Ineligible|1|||
144686665|NCT01055457|521702781|FG003|Overall Study|Subject Ineligible|0|||
144686666|NCT01055457|521702782|FG004|Overall Study|Subject Ineligible|1|||
144686667|NCT01055457|521702783|FG005|Overall Study|Subject Ineligible|0|||
144686668|NCT01055457|521702784|FG006|Overall Study|Subject Ineligible|0|||
144686669|NCT01055457|521702785|FG007|Overall Study|Subject Ineligible|0|||
144686670|NCT01055457|521702786|FG008|Overall Study|Subject Ineligible|0|||
144686671|NCT01055457|521702787|FG009|Overall Study|Subject Ineligible|0|||
144686672|NCT01055457|521702778|FG000|Overall Study|Discomfort|0|||
144686673|NCT01055457|521702779|FG001|Overall Study|Discomfort|0|||
144686674|NCT01055457|521702780|FG002|Overall Study|Discomfort|0|||
144686675|NCT01055457|521702781|FG003|Overall Study|Discomfort|0|||
144686676|NCT01055457|521702782|FG004|Overall Study|Discomfort|1|||
144686677|NCT01055457|521702783|FG005|Overall Study|Discomfort|0|||
144686678|NCT01055457|521702784|FG006|Overall Study|Discomfort|0|||
144686679|NCT01055457|521702785|FG007|Overall Study|Discomfort|0|||
144686680|NCT01055457|521702786|FG008|Overall Study|Discomfort|0|||
144686681|NCT01055457|521702787|FG009|Overall Study|Discomfort|0|||
144686682|NCT01055457|521702778|FG000|Overall Study|Pregnancy|0|||
144686683|NCT01055457|521702779|FG001|Overall Study|Pregnancy|0|||
144686684|NCT01055457|521702780|FG002|Overall Study|Pregnancy|0|||
144686685|NCT01055457|521702781|FG003|Overall Study|Pregnancy|1|||
144686686|NCT01055457|521702782|FG004|Overall Study|Pregnancy|0|||
144686687|NCT01055457|521702783|FG005|Overall Study|Pregnancy|0|||
144686688|NCT01055457|521702784|FG006|Overall Study|Pregnancy|0|||
144686689|NCT01055457|521702785|FG007|Overall Study|Pregnancy|0|||
144686690|NCT01055457|521702786|FG008|Overall Study|Pregnancy|0|||
144218668|NCT00662649|519994441|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
144218669|NCT00662649|519994442|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
144686691|NCT01055457|521702787|FG009|Overall Study|Pregnancy|0|||
144686692|NCT01055457|521702778|FG000|Overall Study|Adverse Event|0|||
144218670|NCT00662649|519994443|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
144686693|NCT01055457|521702779|FG001|Overall Study|Adverse Event|0|||
144686694|NCT01055457|521702780|FG002|Overall Study|Adverse Event|0|||
144686695|NCT01055457|521702781|FG003|Overall Study|Adverse Event|1|||
144686696|NCT01055457|521702782|FG004|Overall Study|Adverse Event|0|||
144686697|NCT01055457|521702783|FG005|Overall Study|Adverse Event|0|||
144686698|NCT01055457|521702784|FG006|Overall Study|Adverse Event|0|||
144686699|NCT01055457|521702785|FG007|Overall Study|Adverse Event|0|||
144686700|NCT01055457|521702786|FG008|Overall Study|Adverse Event|0|||
144686701|NCT01055457|521702787|FG009|Overall Study|Adverse Event|0|||
144686702|NCT04055844|521702788|FG000|Overall Study|Adverse Event|12|||
144686703|NCT04055844|521702788|FG000|Overall Study|Poor Performance|1|||
144686704|NCT04055844|521702788|FG000|Overall Study|Death|1|||
144686705|NCT02187224|521702797|FG000|Overall Study|Did not show up for test day|1|||
144686706|NCT02187224|521702798|FG001|Overall Study|Did not show up for test day|0|||
144686707|NCT01010776|521702802|FG000|Main Phase|Withdrawal by Subject|14|||
144686708|NCT01010776|521702802|FG000|Main Phase|Lack of Efficacy|8|||
144686709|NCT01010776|521702802|FG000|Main Phase|Adverse Event|7|||
144686710|NCT01010776|521702802|FG000|Main Phase|Lost to Follow-up|6|||
144686711|NCT01010776|521702802|FG000|Main Phase|Non-compliance to study medication|5|||
144686712|NCT01010776|521702802|FG000|Main Phase|Selection failure|2|||
144686713|NCT01010776|521702802|FG000|Main Phase|Inform consent withdrawal|1|||
144686714|NCT01010776|521702802|FG000|Main Phase|Other|1|||
144686715|NCT01010776|521702802|FG000|Main Phase|Did not received study medication|5|||
144686716|NCT01010776|521702802|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
144686717|NCT01010776|521702802|FG000|Extension Phase|Other|3|||
144686718|NCT03267576|521702808|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
144686719|NCT03267576|521702809|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
144686720|NCT03267576|521702808|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
144686721|NCT03267576|521702809|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
144686722|NCT01846208|521702810|FG000|Overall Study|Withdrew prior to treatment|1|||
144686723|NCT01846208|521702811|FG001|Overall Study|Withdrew prior to treatment|1|||
144686724|NCT01846208|521702812|FG002|Overall Study|Withdrew prior to treatment|1|||
144686725|NCT01846208|521702810|FG000|Overall Study|Dosing Symptoms|1|||
144686726|NCT01846208|521702811|FG001|Overall Study|Dosing Symptoms|2|||
144686727|NCT01846208|521702812|FG002|Overall Study|Dosing Symptoms|6|||
144686728|NCT01846208|521702810|FG000|Overall Study|Withdrawal by Subject|5|||
144686729|NCT01846208|521702811|FG001|Overall Study|Withdrawal by Subject|0|||
144686730|NCT01846208|521702812|FG002|Overall Study|Withdrawal by Subject|0|||
144686731|NCT01846208|521702810|FG000|Overall Study|Non-compliance|1|||
144686732|NCT01846208|521702811|FG001|Overall Study|Non-compliance|1|||
144686733|NCT01846208|521702812|FG002|Overall Study|Non-compliance|0|||
144686734|NCT01846208|521702810|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
144686735|NCT01846208|521702811|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
144686736|NCT01846208|521702812|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
144686737|NCT01846208|521702810|FG000|Overall Study|Refused SU OFC|0|||
144686738|NCT01846208|521702811|FG001|Overall Study|Refused SU OFC|0|||
144686739|NCT01846208|521702812|FG002|Overall Study|Refused SU OFC|1|||
144686740|NCT01268514|521702813|FG000|Overall Study|Adverse Event|20|||
144686741|NCT01268514|521702813|FG000|Overall Study|Death|8|||
144686742|NCT01268514|521702813|FG000|Overall Study|Lost to Follow-up|5|||
144686743|NCT01268514|521702813|FG000|Overall Study|Withdrawal by Subject|3|||
144686744|NCT01268514|521702813|FG000|Overall Study|Withdrawal by Surgeon|5|||
144686745|NCT01432938|521702814|FG000|First Intervention|Protocol Violation|1|||
144686746|NCT01432938|521702815|FG001|First Intervention|Protocol Violation|0|||
144686747|NCT01432938|521702814|FG000|First Intervention|Physician Decision|1|||
144686748|NCT01432938|521702815|FG001|First Intervention|Physician Decision|0|||
144686749|NCT01432938|521702814|FG000|Second Intervention|Adverse Event|1|||
144686750|NCT01432938|521702815|FG001|Second Intervention|Adverse Event|0|||
144686751|NCT01424306|521702816|FG000|Overall Study|Protocol Violation|0|||
144686752|NCT01424306|521702817|FG001|Overall Study|Protocol Violation|0|||
144686753|NCT01424306|521702818|FG002|Overall Study|Protocol Violation|0|||
144686754|NCT01424306|521702819|FG003|Overall Study|Protocol Violation|0|||
144686755|NCT01424306|521702820|FG004|Overall Study|Protocol Violation|1|||
144686756|NCT01424306|521702821|FG005|Overall Study|Protocol Violation|0|||
144686757|NCT01875874|521702825|FG000|Overall Study|Death|3|||
144686758|NCT03344562|521702828|FG000|Overall Study|Withdrawal by Subject|2|||
144686759|NCT03344562|521702829|FG001|Overall Study|Withdrawal by Subject|0|||
144686760|NCT02736474|521702830|FG000|Overall Study|Lost to Follow-up|0|||
144686761|NCT02736474|521702831|FG001|Overall Study|Lost to Follow-up|1|||
144686762|NCT02463331|521702832|FG000|Overall Study|Adverse Event|4|||
144686763|NCT02463331|521702833|FG001|Overall Study|Adverse Event|2|||
144686764|NCT02463331|521702832|FG000|Overall Study|Lost to Follow-up|1|||
144686765|NCT02463331|521702833|FG001|Overall Study|Lost to Follow-up|1|||
144686766|NCT02463331|521702832|FG000|Overall Study|Pregnancy|2|||
144686767|NCT02463331|521702833|FG001|Overall Study|Pregnancy|3|||
144686768|NCT02463331|521702832|FG000|Overall Study|Lack of Efficacy|6|||
144686769|NCT02463331|521702833|FG001|Overall Study|Lack of Efficacy|0|||
144686770|NCT02463331|521702832|FG000|Overall Study|Physician Decision|3|||
144686771|NCT02463331|521702833|FG001|Overall Study|Physician Decision|0|||
144686772|NCT02382276|521702834|FG000|Overall Study|Withdrawal by Subject|4|||
144686773|NCT02382276|521702835|FG001|Overall Study|Withdrawal by Subject|8|||
144686774|NCT02382276|521702836|FG002|Overall Study|Withdrawal by Subject|5|||
144686775|NCT02382276|521702834|FG000|Overall Study|Adverse Event|7|||
144686776|NCT02382276|521702835|FG001|Overall Study|Adverse Event|2|||
144686777|NCT02382276|521702836|FG002|Overall Study|Adverse Event|32|||
144686778|NCT02382276|521702834|FG000|Overall Study|Physician Decision|0|||
144686779|NCT02382276|521702835|FG001|Overall Study|Physician Decision|0|||
144686780|NCT02382276|521702836|FG002|Overall Study|Physician Decision|2|||
144686781|NCT04191096|521702841|FG000|Overall Study|Death|102|||
144686782|NCT04191096|521702842|FG001|Overall Study|Death|89|||
144686783|NCT04191096|521702841|FG000|Overall Study|Lost to Follow-up|1|||
144686784|NCT04191096|521702842|FG001|Overall Study|Lost to Follow-up|1|||
144686785|NCT04191096|521702841|FG000|Overall Study|Withdrawal by Subject|5|||
144740532|NCT01838681|521904269|FG002|Period B/A+|Protocol Violation|4|||
144740533|NCT01838681|521904270|FG003|Period B/A+|Protocol Violation|6|||
144740534|NCT01838681|521904267|FG000|Period B/A+|Non-compliance with IMP|0|||
144740535|NCT01838681|521904268|FG001|Period B/A+|Non-compliance with IMP|2|||
144740536|NCT01838681|521904269|FG002|Period B/A+|Non-compliance with IMP|3|||
144740537|NCT01838681|521904270|FG003|Period B/A+|Non-compliance with IMP|3|||
144740538|NCT01838681|521904267|FG000|Period B/A+|Lost to Follow-up|0|||
144740539|NCT01838681|521904268|FG001|Period B/A+|Lost to Follow-up|2|||
144740540|NCT01838681|521904269|FG002|Period B/A+|Lost to Follow-up|5|||
144740541|NCT01838681|521904270|FG003|Period B/A+|Lost to Follow-up|11|||
144740542|NCT01838681|521904267|FG000|Period B/A+|Withdrawal before treatment|0|||
144740543|NCT01838681|521904268|FG001|Period B/A+|Withdrawal before treatment|1|||
144740544|NCT01838681|521904269|FG002|Period B/A+|Withdrawal before treatment|0|||
144740545|NCT01838681|521904270|FG003|Period B/A+|Withdrawal before treatment|0|||
144740546|NCT01838681|521904267|FG000|Period B/A+|Administrative or other reasons|0|||
144740547|NCT01838681|521904268|FG001|Period B/A+|Administrative or other reasons|6|||
144740548|NCT01838681|521904269|FG002|Period B/A+|Administrative or other reasons|10|||
144740549|NCT01838681|521904270|FG003|Period B/A+|Administrative or other reasons|28|||
144740550|NCT00796562|521904271|FG000|Overall Study|Death|49|||
144740551|NCT00312897|521904274|FG000|Overall Study|Adverse Event|1|||
144740552|NCT00312897|521904275|FG001|Overall Study|Adverse Event|0|||
144740553|NCT00312897|521904274|FG000|Overall Study|Lost to Follow-up|2|||
144740554|NCT00312897|521904275|FG001|Overall Study|Lost to Follow-up|0|||
144740555|NCT00312897|521904274|FG000|Overall Study|Physician Decision|1|||
144740556|NCT00312897|521904275|FG001|Overall Study|Physician Decision|0|||
144740557|NCT00312897|521904274|FG000|Overall Study|Withdrawal by Subject|1|||
144740558|NCT00312897|521904275|FG001|Overall Study|Withdrawal by Subject|3|||
144740559|NCT00312897|521904274|FG000|Overall Study|Pregnancy|1|||
144740560|NCT00312897|521904275|FG001|Overall Study|Pregnancy|0|||
144740561|NCT00312897|521904274|FG000|Overall Study|discontinued prior to getting treatment|0|||
144740562|NCT00312897|521904275|FG001|Overall Study|discontinued prior to getting treatment|3|||
144740563|NCT01473953|521904278|FG000|Overall Study|Other|1|||
144740564|NCT01473953|521904279|FG001|Overall Study|Other|0|||
144740565|NCT01473953|521904280|FG002|Overall Study|Other|0|||
144740566|NCT01473953|521904281|FG003|Overall Study|Other|0|||
144740567|NCT01473953|521904282|FG004|Overall Study|Other|0|||
144740568|NCT03100344|521904283|FG000|Overall Study|Adverse Event|0|||
144740569|NCT03100344|521904284|FG001|Overall Study|Adverse Event|3|||
144740570|NCT03100344|521904285|FG002|Overall Study|Adverse Event|2|||
144740571|NCT03100344|521904286|FG003|Overall Study|Adverse Event|3|||
144740572|NCT03100344|521904283|FG000|Overall Study|Lack of Efficacy|2|||
144740573|NCT03100344|521904284|FG001|Overall Study|Lack of Efficacy|0|||
144740574|NCT03100344|521904285|FG002|Overall Study|Lack of Efficacy|0|||
144740575|NCT03100344|521904286|FG003|Overall Study|Lack of Efficacy|0|||
144740576|NCT03100344|521904283|FG000|Overall Study|Protocol Violation|1|||
144740577|NCT03100344|521904284|FG001|Overall Study|Protocol Violation|0|||
144740578|NCT03100344|521904285|FG002|Overall Study|Protocol Violation|0|||
144740579|NCT03100344|521904286|FG003|Overall Study|Protocol Violation|0|||
144740580|NCT03100344|521904283|FG000|Overall Study|Withdrawal by Subject|10|||
144740581|NCT03100344|521904284|FG001|Overall Study|Withdrawal by Subject|7|||
144740582|NCT03100344|521904285|FG002|Overall Study|Withdrawal by Subject|4|||
144740583|NCT03100344|521904286|FG003|Overall Study|Withdrawal by Subject|8|||
144740584|NCT03100344|521904283|FG000|Overall Study|Lost to Follow-up|1|||
144740585|NCT03100344|521904284|FG001|Overall Study|Lost to Follow-up|1|||
144740586|NCT03100344|521904285|FG002|Overall Study|Lost to Follow-up|1|||
144740587|NCT03100344|521904286|FG003|Overall Study|Lost to Follow-up|1|||
144740588|NCT04633564|521904287|FG000|Period 1|Adverse Event|28|||
144740589|NCT04633564|521904288|FG001|Period 1|Adverse Event|19|||
144740590|NCT04633564|521904287|FG000|Period 1|Death|8|||
144740591|NCT04633564|521904288|FG001|Period 1|Death|7|||
144740592|NCT04633564|521904287|FG000|Period 1|Lost to Follow-up|3|||
144740593|NCT04633564|521904288|FG001|Period 1|Lost to Follow-up|5|||
144740594|NCT04633564|521904287|FG000|Period 1|Physician Decision|4|||
144740595|NCT04633564|521904288|FG001|Period 1|Physician Decision|12|||
144740596|NCT04633564|521904287|FG000|Period 1|Protocol Violation|0|||
144740597|NCT04633564|521904288|FG001|Period 1|Protocol Violation|1|||
144740598|NCT04633564|521904287|FG000|Period 1|Withdrawal by Subject|10|||
144740599|NCT04633564|521904288|FG001|Period 1|Withdrawal by Subject|8|||
144740600|NCT04633564|521904287|FG000|Period 1|Progressive disease|47|||
144740601|NCT04633564|521904288|FG001|Period 1|Progressive disease|51|||
144740602|NCT04633564|521904287|FG000|Period 1|Terminated by Sponsor|8|||
144740603|NCT04633564|521904288|FG001|Period 1|Terminated by Sponsor|6|||
144740604|NCT04633564|521904287|FG000|Period 2|Adverse Event|3|||
144740605|NCT04633564|521904288|FG001|Period 2|Adverse Event|4|||
144740606|NCT04633564|521904287|FG000|Period 2|Death|0|||
144740607|NCT04633564|521904288|FG001|Period 2|Death|2|||
144740608|NCT04633564|521904287|FG000|Period 2|Lost to Follow-up|0|||
144740609|NCT04633564|521904288|FG001|Period 2|Lost to Follow-up|1|||
144740610|NCT04633564|521904287|FG000|Period 2|Physician Decision|2|||
144740611|NCT04633564|521904288|FG001|Period 2|Physician Decision|4|||
144740612|NCT04633564|521904287|FG000|Period 2|Withdrawal by Subject|5|||
144686786|NCT04191096|521702842|FG001|Overall Study|Withdrawal by Subject|5|||
144686787|NCT04191096|521702841|FG000|Overall Study|Participants Ongoing|518|||
144686788|NCT04191096|521702842|FG001|Overall Study|Participants Ongoing|530|||
144218671|NCT00662649|519994444|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
144218672|NCT00662649|519994440|FG000|Core Study (24 Months)|Protocol Violation|5|||
144218673|NCT00662649|519994441|FG001|Core Study (24 Months)|Protocol Violation|5|||
144218674|NCT00662649|519994442|FG002|Core Study (24 Months)|Protocol Violation|4|||
144218675|NCT00662649|519994443|FG003|Core Study (24 Months)|Protocol Violation|0|||
144218676|NCT00662649|519994444|FG004|Core Study (24 Months)|Protocol Violation|0|||
144218677|NCT00662649|519994440|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
144218678|NCT00662649|519994441|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
144218679|NCT00662649|519994442|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
144218680|NCT00662649|519994443|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
144218681|NCT00662649|519994444|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
144218682|NCT00662649|519994440|FG000|Core Study (24 Months)|Death|1|||
144218683|NCT00662649|519994441|FG001|Core Study (24 Months)|Death|0|||
144218684|NCT00662649|519994442|FG002|Core Study (24 Months)|Death|2|||
144218685|NCT00662649|519994443|FG003|Core Study (24 Months)|Death|0|||
144218686|NCT00662649|519994444|FG004|Core Study (24 Months)|Death|0|||
144218687|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
144218688|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
144218689|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
144218690|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
144218691|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
144218692|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
144218693|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
144218694|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
144218695|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
144218696|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
144218697|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
144218698|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
144218699|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
144218700|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
144218701|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
144218702|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
144218703|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
144218704|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
144218705|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
144218706|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
144218707|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
144218708|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
144218709|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
144218710|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
144218711|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
144218712|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
144218713|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
144218714|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
144218715|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
144218716|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
144218717|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
144218718|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
144218719|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
144218720|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
144218721|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
144218722|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
144218723|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
144218724|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
144218725|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
144218726|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
144686789|NCT02972658|521704712|FG000|Overall Study|Adverse Event|0|||
144686790|NCT02972658|521704713|FG001|Overall Study|Adverse Event|3|||
144218727|NCT00662649|519994440|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
144218728|NCT00662649|519994441|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
144218729|NCT00662649|519994442|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
144218730|NCT00662649|519994443|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
144218731|NCT00662649|519994444|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
144740613|NCT04633564|521904288|FG001|Period 2|Withdrawal by Subject|1|||
144740614|NCT04633564|521904287|FG000|Period 2|Progressive Disease|74|||
144740615|NCT04633564|521904288|FG001|Period 2|Progressive Disease|82|||
144740616|NCT04633564|521904287|FG000|Period 2|Terminated by Sponsor|9|||
144740617|NCT04633564|521904288|FG001|Period 2|Terminated by Sponsor|3|||
144740618|NCT01010503|521904289|FG000|Overall Study|Adverse Event|1|||
144740619|NCT01010503|521904289|FG000|Overall Study|Death|1|||
144740620|NCT03578809|521905746|FG000|Overall Study|Death|0|||
144740621|NCT03578809|521905747|FG001|Overall Study|Death|2|||
144740622|NCT03578809|521905748|FG002|Overall Study|Death|0|||
144740623|NCT03578809|521905749|FG003|Overall Study|Death|1|||
144740624|NCT03578809|521905746|FG000|Overall Study|Lost to Follow-up|0|||
144740625|NCT03578809|521905747|FG001|Overall Study|Lost to Follow-up|1|||
144740626|NCT03578809|521905748|FG002|Overall Study|Lost to Follow-up|0|||
144740627|NCT03578809|521905749|FG003|Overall Study|Lost to Follow-up|0|||
144740628|NCT03578809|521905746|FG000|Overall Study|Withdrawal by Subject|3|||
144740629|NCT03578809|521905747|FG001|Overall Study|Withdrawal by Subject|5|||
144740630|NCT03578809|521905748|FG002|Overall Study|Withdrawal by Subject|2|||
144740631|NCT03578809|521905749|FG003|Overall Study|Withdrawal by Subject|0|||
144740632|NCT03578809|521905746|FG000|Overall Study|Other|3|||
144740633|NCT03578809|521905747|FG001|Overall Study|Other|6|||
144740634|NCT03578809|521905748|FG002|Overall Study|Other|2|||
144740635|NCT03578809|521905749|FG003|Overall Study|Other|8|||
144740636|NCT00830258|521905750|FG000|First Intervention|Adverse Event|1|||
144740637|NCT00830258|521905751|FG001|First Intervention|Adverse Event|0|||
144740638|NCT00830258|521905750|FG000|Washout: 7 Days|Protocol Violation|1|||
144740639|NCT00830258|521905751|FG001|Washout: 7 Days|Protocol Violation|0|||
144740640|NCT01403194|521905754|FG000|Overall Study|Screen Failure|2|||
144740641|NCT01403194|521905754|FG000|Overall Study|Lost to Follow-up|8|||
144740642|NCT04692155|521905757|FG000|Overall Study|Death|1|||
144740643|NCT00274651|521905758|FG000|Overall Study|Adverse Event|6|||
144740644|NCT00274651|521905759|FG001|Overall Study|Adverse Event|3|||
144740645|NCT00274651|521905758|FG000|Overall Study|Lack of Efficacy|13|||
144740646|NCT00274651|521905759|FG001|Overall Study|Lack of Efficacy|6|||
144740647|NCT00274651|521905758|FG000|Overall Study|Death|1|||
144740648|NCT00274651|521905759|FG001|Overall Study|Death|3|||
144740649|NCT00274651|521905758|FG000|Overall Study|Withdrawal by Subject|0|||
144740650|NCT00274651|521905759|FG001|Overall Study|Withdrawal by Subject|1|||
144740651|NCT00274651|521905758|FG000|Overall Study|Physician Decision|8|||
144740652|NCT00274651|521905759|FG001|Overall Study|Physician Decision|7|||
144740653|NCT00918645|521905760|FG000|Overall Study|Withdrawal by Subject|1|||
144740654|NCT01604941|521905761|FG000|Overall Study|Adverse Event|1|||
144740655|NCT01604941|521905762|FG001|Overall Study|Adverse Event|2|||
144740656|NCT01604941|521905763|FG002|Overall Study|Adverse Event|0|||
144740657|NCT01604941|521905764|FG003|Overall Study|Adverse Event|0|||
144740658|NCT01604941|521905765|FG004|Overall Study|Adverse Event|1|||
144740659|NCT01604941|521905766|FG005|Overall Study|Adverse Event|5|||
144740660|NCT01604941|521905761|FG000|Overall Study|Non-compliance|1|||
144740661|NCT01604941|521905762|FG001|Overall Study|Non-compliance|0|||
144740662|NCT01604941|521905763|FG002|Overall Study|Non-compliance|0|||
144740663|NCT01604941|521905764|FG003|Overall Study|Non-compliance|0|||
144740664|NCT01604941|521905765|FG004|Overall Study|Non-compliance|0|||
144740665|NCT01604941|521905766|FG005|Overall Study|Non-compliance|0|||
144740666|NCT01604941|521905761|FG000|Overall Study|Participant Decision|0|||
144740667|NCT01604941|521905762|FG001|Overall Study|Participant Decision|0|||
144740668|NCT01604941|521905763|FG002|Overall Study|Participant Decision|0|||
144740669|NCT01604941|521905764|FG003|Overall Study|Participant Decision|0|||
144740670|NCT01604941|521905765|FG004|Overall Study|Participant Decision|0|||
144740671|NCT01604941|521905766|FG005|Overall Study|Participant Decision|2|||
144740672|NCT01604941|521905761|FG000|Overall Study|Early Study Termination|9|||
144740673|NCT01604941|521905762|FG001|Overall Study|Early Study Termination|2|||
144740674|NCT01604941|521905763|FG002|Overall Study|Early Study Termination|3|||
144740675|NCT01604941|521905764|FG003|Overall Study|Early Study Termination|3|||
144740676|NCT01604941|521905765|FG004|Overall Study|Early Study Termination|0|||
144740677|NCT01604941|521905766|FG005|Overall Study|Early Study Termination|0|||
144740678|NCT03236311|521905767|FG000|Overall Study|Study terminated by sponsor|0|||
144740679|NCT03236311|521905768|FG001|Overall Study|Study terminated by sponsor|2|||
144740680|NCT03236311|521905767|FG000|Overall Study|Adverse Event|0|||
144740681|NCT03236311|521905768|FG001|Overall Study|Adverse Event|1|||
144740682|NCT00909753|521905770|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
144740683|NCT00909753|521905771|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
144740684|NCT00909753|521905770|FG000|Period: Second Intervention|Protocol Violation|1|||
144740685|NCT00909753|521905771|FG001|Period: Second Intervention|Protocol Violation|0|||
144740686|NCT00841542|521905772|FG000|Period 1|Adverse Event|1|||
144740687|NCT00841542|521905773|FG001|Period 1|Adverse Event|0|||
144740688|NCT04345653|521905774|FG000|Overall Study|Withdrawal by Subject|2|||
144740689|NCT01647828|521905779|FG000|Overall Study|Death|3|||
144740690|NCT01647828|521905780|FG001|Overall Study|Death|4|||
144740691|NCT01647828|521905781|FG002|Overall Study|Death|4|||
144740692|NCT01647828|521905782|FG003|Overall Study|Death|5|||
144218732|NCT00545714|519994447|FG000|Induction Phase (6 Months)|Physician Decision|3|||
144218733|NCT00545714|519994447|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
144218734|NCT00545714|519994447|FG000|Induction Phase (6 Months)|Disease Progression|1|||
144218735|NCT00545714|519994447|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
144218736|NCT00545714|519994447|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
144218737|NCT00545714|519994447|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
144218738|NCT00545714|519994447|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
144218739|NCT00545714|519994447|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
144218740|NCT00545714|519994447|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
144218741|NCT00545714|519994447|FG000|Maintenance Phase (36 Months)|Death|2|||
144218742|NCT04176250|519994458|FG000|Overall Study|Adverse Event|0|||
144686791|NCT02972658|521704714|FG002|Overall Study|Adverse Event|0|||
144686792|NCT02972658|521704715|FG003|Overall Study|Adverse Event|2|||
144686793|NCT02972658|521704712|FG000|Overall Study|Other-determined by Investigator|1|||
144686794|NCT02972658|521704713|FG001|Overall Study|Other-determined by Investigator|1|||
144686795|NCT02972658|521704714|FG002|Overall Study|Other-determined by Investigator|0|||
144686796|NCT02972658|521704715|FG003|Overall Study|Other-determined by Investigator|0|||
144686797|NCT02972658|521704712|FG000|Overall Study|Death|0|||
144686798|NCT02972658|521704713|FG001|Overall Study|Death|0|||
144686799|NCT02972658|521704714|FG002|Overall Study|Death|0|||
144686800|NCT02972658|521704715|FG003|Overall Study|Death|1|||
144686801|NCT02972658|521704712|FG000|Overall Study|Lost to Follow-up|0|||
144686802|NCT02972658|521704713|FG001|Overall Study|Lost to Follow-up|1|||
144686803|NCT02972658|521704714|FG002|Overall Study|Lost to Follow-up|1|||
144686804|NCT02972658|521704715|FG003|Overall Study|Lost to Follow-up|2|||
144686805|NCT02972658|521704712|FG000|Overall Study|Progressive Disease|0|||
144686806|NCT02972658|521704713|FG001|Overall Study|Progressive Disease|1|||
144686807|NCT02972658|521704714|FG002|Overall Study|Progressive Disease|0|||
144686808|NCT02972658|521704715|FG003|Overall Study|Progressive Disease|1|||
144686809|NCT02972658|521704712|FG000|Overall Study|Withdrawal by Subject|4|||
144686810|NCT02972658|521704713|FG001|Overall Study|Withdrawal by Subject|4|||
144686811|NCT02972658|521704714|FG002|Overall Study|Withdrawal by Subject|1|||
144686812|NCT02972658|521704715|FG003|Overall Study|Withdrawal by Subject|6|||
144686813|NCT02972658|521704712|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
144686814|NCT02972658|521704713|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
144686815|NCT02972658|521704714|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
144686816|NCT02972658|521704715|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
144686817|NCT02972658|521704712|FG000|Overall Study|Sponsor Decision|70|||
144686818|NCT02972658|521704713|FG001|Overall Study|Sponsor Decision|127|||
144686819|NCT02972658|521704714|FG002|Overall Study|Sponsor Decision|72|||
144686820|NCT02972658|521704715|FG003|Overall Study|Sponsor Decision|119|||
144686821|NCT02785588|521704716|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
144686822|NCT02785588|521704716|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
144686823|NCT02583399|521704717|FG000|Overall Study|Able to be discharged|3|||
144686824|NCT02583399|521704717|FG000|Overall Study|Wanted to use a restricted medication|3|||
144686825|NCT01004861|521704718|FG000|Overall Study|Disease progression|3|||
144686826|NCT01004861|521704719|FG001|Overall Study|Disease progression|4|||
144686827|NCT01004861|521704720|FG002|Overall Study|Disease progression|5|||
144686828|NCT01004861|521704721|FG003|Overall Study|Disease progression|4|||
144686829|NCT01004861|521704722|FG004|Overall Study|Disease progression|4|||
144686830|NCT01004861|521704723|FG005|Overall Study|Disease progression|4|||
144686831|NCT01004861|521704724|FG006|Overall Study|Disease progression|5|||
144686832|NCT01004861|521704725|FG007|Overall Study|Disease progression|1|||
144686833|NCT01004861|521704726|FG008|Overall Study|Disease progression|4|||
144686834|NCT01004861|521704727|FG009|Overall Study|Disease progression|7|||
144686835|NCT01004861|521704728|FG010|Overall Study|Disease progression|6|||
144686836|NCT01004861|521704729|FG011|Overall Study|Disease progression|3|||
144686837|NCT01004861|521704730|FG012|Overall Study|Disease progression|8|||
144686838|NCT01004861|521704718|FG000|Overall Study|Physician Decision|0|||
144218743|NCT04176250|519994459|FG001|Overall Study|Adverse Event|1|||
144218744|NCT04176250|519994460|FG002|Overall Study|Adverse Event|0|||
144218745|NCT04176250|519994461|FG003|Overall Study|Adverse Event|1|||
144218746|NCT04176250|519994462|FG004|Overall Study|Adverse Event|0|||
144218747|NCT04176250|519994463|FG005|Overall Study|Adverse Event|1|||
144686839|NCT01004861|521704719|FG001|Overall Study|Physician Decision|2|||
144265909|NCT00329108|520176415|FG001|Overall Study|Withdrawal by Subject|2|||
144686840|NCT01004861|521704720|FG002|Overall Study|Physician Decision|1|||
144686841|NCT01004861|521704721|FG003|Overall Study|Physician Decision|1|||
144686842|NCT01004861|521704722|FG004|Overall Study|Physician Decision|1|||
144686843|NCT01004861|521704723|FG005|Overall Study|Physician Decision|0|||
144686844|NCT01004861|521704724|FG006|Overall Study|Physician Decision|0|||
144686845|NCT01004861|521704725|FG007|Overall Study|Physician Decision|1|||
144686846|NCT01004861|521704726|FG008|Overall Study|Physician Decision|0|||
144686847|NCT01004861|521704727|FG009|Overall Study|Physician Decision|0|||
144686848|NCT01004861|521704728|FG010|Overall Study|Physician Decision|0|||
144686849|NCT01004861|521704729|FG011|Overall Study|Physician Decision|0|||
144686850|NCT01004861|521704730|FG012|Overall Study|Physician Decision|3|||
144740693|NCT01647828|521905783|FG004|Overall Study|Death|6|||
144740694|NCT01647828|521905784|FG005|Overall Study|Death|3|||
144740695|NCT01647828|521905785|FG006|Overall Study|Death|10|||
144740696|NCT01647828|521905786|FG007|Overall Study|Death|60|||
144740697|NCT01647828|521905787|FG008|Overall Study|Death|71|||
144740698|NCT01647828|521905779|FG000|Overall Study|Withdrawal by Subject|2|||
144740699|NCT01647828|521905780|FG001|Overall Study|Withdrawal by Subject|0|||
144740700|NCT01647828|521905781|FG002|Overall Study|Withdrawal by Subject|0|||
144740701|NCT01647828|521905782|FG003|Overall Study|Withdrawal by Subject|1|||
144740702|NCT01647828|521905783|FG004|Overall Study|Withdrawal by Subject|0|||
144740703|NCT01647828|521905784|FG005|Overall Study|Withdrawal by Subject|0|||
144740704|NCT01647828|521905785|FG006|Overall Study|Withdrawal by Subject|1|||
144740705|NCT01647828|521905786|FG007|Overall Study|Withdrawal by Subject|0|||
144740706|NCT01647828|521905787|FG008|Overall Study|Withdrawal by Subject|2|||
144740707|NCT01647828|521905779|FG000|Overall Study|Study terminated by Sponsor|0|||
144740708|NCT01647828|521905780|FG001|Overall Study|Study terminated by Sponsor|0|||
144740709|NCT01647828|521905781|FG002|Overall Study|Study terminated by Sponsor|0|||
144740710|NCT01647828|521905782|FG003|Overall Study|Study terminated by Sponsor|0|||
144740711|NCT01647828|521905783|FG004|Overall Study|Study terminated by Sponsor|0|||
144740712|NCT01647828|521905784|FG005|Overall Study|Study terminated by Sponsor|0|||
144740713|NCT01647828|521905785|FG006|Overall Study|Study terminated by Sponsor|1|||
144740714|NCT01647828|521905786|FG007|Overall Study|Study terminated by Sponsor|26|||
144740715|NCT01647828|521905787|FG008|Overall Study|Study terminated by Sponsor|16|||
144740716|NCT01647828|521905779|FG000|Overall Study|Lost to Follow-up|0|||
144740717|NCT01647828|521905780|FG001|Overall Study|Lost to Follow-up|0|||
144740718|NCT01647828|521905781|FG002|Overall Study|Lost to Follow-up|0|||
144740719|NCT01647828|521905782|FG003|Overall Study|Lost to Follow-up|0|||
144740720|NCT01647828|521905783|FG004|Overall Study|Lost to Follow-up|0|||
144740721|NCT01647828|521905784|FG005|Overall Study|Lost to Follow-up|0|||
144740722|NCT01647828|521905785|FG006|Overall Study|Lost to Follow-up|0|||
144740723|NCT01647828|521905786|FG007|Overall Study|Lost to Follow-up|2|||
144740724|NCT01647828|521905787|FG008|Overall Study|Lost to Follow-up|0|||
144740725|NCT00418938|521905788|FG000|Overall Study|Reimbursement|1|||
144740726|NCT00418938|521905789|FG001|Overall Study|Reimbursement|0|||
144740727|NCT00418938|521905788|FG000|Overall Study|Administrative decision|3|||
144740728|NCT00418938|521905789|FG001|Overall Study|Administrative decision|3|||
144740729|NCT00418938|521905788|FG000|Overall Study|Withdrawal by Subject|16|||
144740730|NCT00418938|521905789|FG001|Overall Study|Withdrawal by Subject|15|||
144740731|NCT00418938|521905788|FG000|Overall Study|Lost to Follow-up|1|||
144740732|NCT00418938|521905789|FG001|Overall Study|Lost to Follow-up|3|||
144740733|NCT00418938|521905788|FG000|Overall Study|Adverse Event|1|||
144740734|NCT00418938|521905789|FG001|Overall Study|Adverse Event|1|||
144740735|NCT00418938|521905788|FG000|Overall Study|On-going|1|||
144740736|NCT00418938|521905789|FG001|Overall Study|On-going|1|||
144740737|NCT00418938|521905788|FG000|Overall Study|Ineligibility Determined|1|||
144740738|NCT00418938|521905789|FG001|Overall Study|Ineligibility Determined|0|||
144740739|NCT00115063|521905792|FG000|Overall Study|Lost to Follow-up|98|||
144740740|NCT00115063|521905793|FG001|Overall Study|Lost to Follow-up|104|||
144740741|NCT00115063|521905792|FG000|Overall Study|Death|1|||
144740742|NCT00115063|521905793|FG001|Overall Study|Death|0|||
144740743|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
144740744|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
144740745|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
144740746|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
144740747|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
144740748|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
144740749|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Death|9|||
144740750|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Death|7|||
144740751|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Death|14|||
144740752|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Death|7|||
144740753|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Death|0|||
144218748|NCT04176250|519994458|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
144218749|NCT04176250|519994459|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
144740754|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Death|0|||
144218750|NCT04176250|519994460|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
144740755|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
144740756|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
144740757|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
144740758|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
144740759|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
144740760|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
144740761|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Other Event|49|||
144740762|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Other Event|52|||
144740763|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Other Event|41|||
144740764|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Other Event|58|||
144740765|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Other Event|0|||
144218751|NCT04176250|519994461|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
144218752|NCT04176250|519994462|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
144218753|NCT04176250|519994463|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
144218754|NCT04176250|519994458|FG000|Overall Study|Withdrawal by Subject|0|||
144218755|NCT04176250|519994459|FG001|Overall Study|Withdrawal by Subject|0|||
144218756|NCT04176250|519994460|FG002|Overall Study|Withdrawal by Subject|0|||
144218757|NCT04176250|519994461|FG003|Overall Study|Withdrawal by Subject|0|||
144218758|NCT04176250|519994462|FG004|Overall Study|Withdrawal by Subject|0|||
144218759|NCT04176250|519994463|FG005|Overall Study|Withdrawal by Subject|1|||
144218760|NCT04176250|519994458|FG000|Overall Study|Randomized in error|0|||
144218761|NCT04176250|519994459|FG001|Overall Study|Randomized in error|0|||
144218762|NCT04176250|519994460|FG002|Overall Study|Randomized in error|0|||
144218763|NCT04176250|519994461|FG003|Overall Study|Randomized in error|0|||
144218764|NCT04176250|519994462|FG004|Overall Study|Randomized in error|1|||
144218765|NCT04176250|519994463|FG005|Overall Study|Randomized in error|0|||
144218766|NCT01431079|519994468|FG000|Overall Study|Lost to Follow-up|35|||
144218767|NCT01431079|519994469|FG001|Overall Study|Lost to Follow-up|39|||
144218768|NCT02790437|519994470|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
144218769|NCT02790437|519994471|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
144218770|NCT02790437|519994470|FG000|Overall Study|Adverse Event|1|||
144218771|NCT02790437|519994471|FG001|Overall Study|Adverse Event|0|||
144218772|NCT02790437|519994470|FG000|Overall Study|Withdrawal by Subject|1|||
144218773|NCT02790437|519994471|FG001|Overall Study|Withdrawal by Subject|0|||
144218774|NCT01202175|519994472|FG000|Overall Study|Lost to Follow-up|2|||
144218775|NCT01202175|519994472|FG000|Overall Study|Withdrawal by Subject|1|||
144218776|NCT01202175|519994472|FG000|Overall Study|Adverse Event|2|||
144218777|NCT01960257|519994476|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
144218778|NCT01960257|519994477|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
144218779|NCT01960257|519994478|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
144218780|NCT01960257|519994476|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
144218781|NCT01960257|519994477|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
144218782|NCT01960257|519994478|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
144218783|NCT01960257|519994476|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
144218784|NCT01960257|519994477|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
144218785|NCT01960257|519994478|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
144218786|NCT01125189|519994479|FG000|Treatment Period|Lack of Efficacy|15|||
144218787|NCT01125189|519994480|FG001|Treatment Period|Lack of Efficacy|18|||
144218788|NCT01125189|519994481|FG002|Treatment Period|Lack of Efficacy|25|||
144218789|NCT01125189|519994479|FG000|Treatment Period|Adverse Event|7|||
144218790|NCT01125189|519994480|FG001|Treatment Period|Adverse Event|8|||
144218791|NCT01125189|519994481|FG002|Treatment Period|Adverse Event|8|||
144218792|NCT01125189|519994479|FG000|Treatment Period|Withdrawal by Subject|3|||
144218793|NCT01125189|519994480|FG001|Treatment Period|Withdrawal by Subject|1|||
144218794|NCT01125189|519994481|FG002|Treatment Period|Withdrawal by Subject|1|||
144218795|NCT01125189|519994479|FG000|Treatment Period|Death|1|||
144218796|NCT01125189|519994480|FG001|Treatment Period|Death|0|||
144218797|NCT01125189|519994481|FG002|Treatment Period|Death|0|||
144218798|NCT01125189|519994479|FG000|Treatment Period|Lost to Follow-up|1|||
144218799|NCT01125189|519994480|FG001|Treatment Period|Lost to Follow-up|2|||
144218800|NCT01125189|519994481|FG002|Treatment Period|Lost to Follow-up|1|||
144218801|NCT01125189|519994479|FG000|Treatment Period|Poor compliance/noncompliance|0|||
144218802|NCT01125189|519994480|FG001|Treatment Period|Poor compliance/noncompliance|1|||
144686851|NCT01004861|521704718|FG000|Overall Study|Adverse Event|0|||
144686852|NCT01004861|521704719|FG001|Overall Study|Adverse Event|0|||
144218803|NCT01125189|519994481|FG002|Treatment Period|Poor compliance/noncompliance|0|||
144218804|NCT01125189|519994479|FG000|Treatment Period|Participants requested to discontinue|1|||
144218805|NCT01125189|519994480|FG001|Treatment Period|Participants requested to discontinue|3|||
144218806|NCT01125189|519994481|FG002|Treatment Period|Participants requested to discontinue|4|||
144218807|NCT01125189|519994479|FG000|Treatment Period|Other reasons|1|||
144218808|NCT01125189|519994480|FG001|Treatment Period|Other reasons|1|||
144218809|NCT01125189|519994481|FG002|Treatment Period|Other reasons|0|||
144218810|NCT01125189|519994479|FG000|Treatment Period|Completed 24 week treatment period only|2|||
144218811|NCT01125189|519994480|FG001|Treatment Period|Completed 24 week treatment period only|1|||
144218812|NCT01125189|519994481|FG002|Treatment Period|Completed 24 week treatment period only|2|||
144218813|NCT01125189|519994479|FG000|Follow up Period|Withdrawal by Subject|3|||
144218814|NCT01125189|519994480|FG001|Follow up Period|Withdrawal by Subject|2|||
144218815|NCT01125189|519994481|FG002|Follow up Period|Withdrawal by Subject|5|||
144218816|NCT01125189|519994479|FG000|Follow up Period|Death|1|||
144218817|NCT01125189|519994480|FG001|Follow up Period|Death|0|||
144218818|NCT01125189|519994481|FG002|Follow up Period|Death|0|||
144218819|NCT01125189|519994479|FG000|Follow up Period|Lost to Follow-up|12|||
144218820|NCT01125189|519994480|FG001|Follow up Period|Lost to Follow-up|9|||
144218821|NCT01125189|519994481|FG002|Follow up Period|Lost to Follow-up|6|||
144686853|NCT01004861|521704720|FG002|Overall Study|Adverse Event|0|||
144740766|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Other Event|0|||
144740767|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
144740768|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
144740769|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
144740770|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
144740771|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
144740772|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
144740773|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
144740774|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
144740775|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
144740776|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
144740777|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
144740778|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
144740779|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
144740780|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
144740781|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
144740782|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
144740783|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
144740784|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
144740785|NCT00205777|521905796|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
144740786|NCT00205777|521905797|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
144740787|NCT00205777|521905798|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
144740788|NCT00205777|521905799|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
144740789|NCT00205777|521905800|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
144740790|NCT00205777|521905801|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
144740791|NCT00205777|521905796|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
144740792|NCT00205777|521905797|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
144740793|NCT00205777|521905798|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
144740794|NCT00205777|521905799|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
144740795|NCT00205777|521905800|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
144740796|NCT00205777|521905801|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
144740797|NCT00205777|521905796|FG000|Completed Core Study, Entered SE I|Other Event|52|||
144740798|NCT00205777|521905797|FG001|Completed Core Study, Entered SE I|Other Event|46|||
144740799|NCT00205777|521905798|FG002|Completed Core Study, Entered SE I|Other Event|47|||
144740800|NCT00205777|521905799|FG003|Completed Core Study, Entered SE I|Other Event|50|||
144740801|NCT00205777|521905800|FG004|Completed Core Study, Entered SE I|Other Event|0|||
144740802|NCT00205777|521905801|FG005|Completed Core Study, Entered SE I|Other Event|0|||
144740803|NCT00205777|521905796|FG000|Study Extension I|Adverse Event|57|||
144740804|NCT00205777|521905797|FG001|Study Extension I|Adverse Event|0|||
144740805|NCT00205777|521905798|FG002|Study Extension I|Adverse Event|0|||
144740806|NCT00205777|521905799|FG003|Study Extension I|Adverse Event|61|||
144740807|NCT00205777|521905800|FG004|Study Extension I|Adverse Event|58|||
144740808|NCT00205777|521905801|FG005|Study Extension I|Adverse Event|0|||
144740809|NCT00205777|521905796|FG000|Study Extension I|Death|5|||
144740810|NCT00205777|521905797|FG001|Study Extension I|Death|0|||
144740811|NCT00205777|521905798|FG002|Study Extension I|Death|0|||
144740812|NCT00205777|521905799|FG003|Study Extension I|Death|1|||
144740813|NCT00205777|521905800|FG004|Study Extension I|Death|2|||
144740814|NCT00205777|521905801|FG005|Study Extension I|Death|0|||
144740815|NCT00205777|521905796|FG000|Study Extension I|Withdrawal by Subject|99|||
144740816|NCT00205777|521905797|FG001|Study Extension I|Withdrawal by Subject|0|||
144740817|NCT00205777|521905798|FG002|Study Extension I|Withdrawal by Subject|0|||
144740818|NCT00205777|521905799|FG003|Study Extension I|Withdrawal by Subject|106|||
144740819|NCT00205777|521905800|FG004|Study Extension I|Withdrawal by Subject|89|||
144740820|NCT00205777|521905801|FG005|Study Extension I|Withdrawal by Subject|0|||
144740821|NCT00205777|521905796|FG000|Study Extension I|Protocol Violation|4|||
144740822|NCT00205777|521905797|FG001|Study Extension I|Protocol Violation|0|||
144740823|NCT00205777|521905798|FG002|Study Extension I|Protocol Violation|0|||
144740824|NCT00205777|521905799|FG003|Study Extension I|Protocol Violation|8|||
144740825|NCT00205777|521905800|FG004|Study Extension I|Protocol Violation|8|||
144740826|NCT00205777|521905801|FG005|Study Extension I|Protocol Violation|0|||
144740827|NCT00205777|521905796|FG000|Study Extension I|Lack of Efficacy|0|||
144740828|NCT00205777|521905797|FG001|Study Extension I|Lack of Efficacy|0|||
144740829|NCT00205777|521905798|FG002|Study Extension I|Lack of Efficacy|0|||
144740830|NCT00205777|521905799|FG003|Study Extension I|Lack of Efficacy|1|||
144740831|NCT00205777|521905800|FG004|Study Extension I|Lack of Efficacy|2|||
144740832|NCT00205777|521905801|FG005|Study Extension I|Lack of Efficacy|0|||
144740833|NCT00205777|521905796|FG000|Study Extension I|Failed to return|15|||
144740834|NCT00205777|521905797|FG001|Study Extension I|Failed to return|0|||
144740835|NCT00205777|521905798|FG002|Study Extension I|Failed to return|0|||
144740836|NCT00205777|521905799|FG003|Study Extension I|Failed to return|17|||
144740837|NCT00205777|521905800|FG004|Study Extension I|Failed to return|13|||
144740838|NCT00205777|521905801|FG005|Study Extension I|Failed to return|0|||
144740839|NCT00205777|521905796|FG000|Study Extension I|Other Event|34|||
144740840|NCT00205777|521905797|FG001|Study Extension I|Other Event|0|||
144740841|NCT00205777|521905798|FG002|Study Extension I|Other Event|0|||
144740842|NCT00205777|521905799|FG003|Study Extension I|Other Event|34|||
144740843|NCT00205777|521905800|FG004|Study Extension I|Other Event|29|||
144740844|NCT00205777|521905801|FG005|Study Extension I|Other Event|0|||
144740845|NCT00205777|521905796|FG000|Study Extension I|Withdrawn as per protocol|0|||
144740846|NCT00205777|521905797|FG001|Study Extension I|Withdrawn as per protocol|0|||
144740847|NCT00205777|521905798|FG002|Study Extension I|Withdrawn as per protocol|1070|||
144740848|NCT00205777|521905799|FG003|Study Extension I|Withdrawn as per protocol|0|||
144740849|NCT00205777|521905800|FG004|Study Extension I|Withdrawn as per protocol|0|||
144740850|NCT00205777|521905801|FG005|Study Extension I|Withdrawn as per protocol|0|||
144740851|NCT00205777|521905796|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
144740852|NCT00205777|521905797|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
144740853|NCT00205777|521905798|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
144740854|NCT00205777|521905799|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
144740855|NCT00205777|521905800|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
144740856|NCT00205777|521905801|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
144740857|NCT00205777|521905796|FG000|Study Extension II|Adverse Event|0|||
144740858|NCT00205777|521905797|FG001|Study Extension II|Adverse Event|0|||
144740859|NCT00205777|521905798|FG002|Study Extension II|Adverse Event|0|||
144740860|NCT00205777|521905799|FG003|Study Extension II|Adverse Event|14|||
144740861|NCT00205777|521905800|FG004|Study Extension II|Adverse Event|0|||
144740862|NCT00205777|521905801|FG005|Study Extension II|Adverse Event|30|||
144740863|NCT00205777|521905796|FG000|Study Extension II|Death|0|||
144740864|NCT00205777|521905797|FG001|Study Extension II|Death|0|||
144740865|NCT00205777|521905798|FG002|Study Extension II|Death|0|||
144740866|NCT00205777|521905799|FG003|Study Extension II|Death|2|||
144740867|NCT00205777|521905800|FG004|Study Extension II|Death|0|||
144740868|NCT00205777|521905801|FG005|Study Extension II|Death|5|||
144740869|NCT00205777|521905796|FG000|Study Extension II|Withdrawal by Subject|0|||
144740870|NCT00205777|521905797|FG001|Study Extension II|Withdrawal by Subject|0|||
144740871|NCT00205777|521905798|FG002|Study Extension II|Withdrawal by Subject|0|||
144740872|NCT00205777|521905799|FG003|Study Extension II|Withdrawal by Subject|35|||
144740873|NCT00205777|521905800|FG004|Study Extension II|Withdrawal by Subject|0|||
144740874|NCT00205777|521905801|FG005|Study Extension II|Withdrawal by Subject|59|||
144740875|NCT00205777|521905796|FG000|Study Extension II|Protocol Violation|0|||
144740876|NCT00205777|521905797|FG001|Study Extension II|Protocol Violation|0|||
144740877|NCT00205777|521905798|FG002|Study Extension II|Protocol Violation|0|||
144740878|NCT00205777|521905799|FG003|Study Extension II|Protocol Violation|1|||
144740879|NCT00205777|521905800|FG004|Study Extension II|Protocol Violation|0|||
144740880|NCT00205777|521905801|FG005|Study Extension II|Protocol Violation|10|||
144740881|NCT00205777|521905796|FG000|Study Extension II|Lack of Efficacy|0|||
144740882|NCT00205777|521905797|FG001|Study Extension II|Lack of Efficacy|0|||
144740883|NCT00205777|521905798|FG002|Study Extension II|Lack of Efficacy|0|||
144740884|NCT00205777|521905799|FG003|Study Extension II|Lack of Efficacy|0|||
144740885|NCT00205777|521905800|FG004|Study Extension II|Lack of Efficacy|0|||
144740886|NCT00205777|521905801|FG005|Study Extension II|Lack of Efficacy|1|||
144740887|NCT00205777|521905796|FG000|Study Extension II|Failed to return|0|||
144740888|NCT00205777|521905797|FG001|Study Extension II|Failed to return|0|||
144740889|NCT00205777|521905798|FG002|Study Extension II|Failed to return|0|||
144740890|NCT00205777|521905799|FG003|Study Extension II|Failed to return|14|||
144740891|NCT00205777|521905800|FG004|Study Extension II|Failed to return|0|||
144740892|NCT00205777|521905801|FG005|Study Extension II|Failed to return|26|||
144740893|NCT00205777|521905796|FG000|Study Extension II|Other Event|0|||
144740894|NCT00205777|521905797|FG001|Study Extension II|Other Event|0|||
144740895|NCT00205777|521905798|FG002|Study Extension II|Other Event|0|||
144740896|NCT00205777|521905799|FG003|Study Extension II|Other Event|12|||
144740897|NCT00205777|521905800|FG004|Study Extension II|Other Event|0|||
144740898|NCT00205777|521905801|FG005|Study Extension II|Other Event|20|||
144740899|NCT00205777|521905796|FG000|Study Extension II|Enrolled but not treated|0|||
144740900|NCT00205777|521905797|FG001|Study Extension II|Enrolled but not treated|0|||
144740901|NCT00205777|521905798|FG002|Study Extension II|Enrolled but not treated|0|||
144740902|NCT00205777|521905799|FG003|Study Extension II|Enrolled but not treated|71|||
144740903|NCT00205777|521905800|FG004|Study Extension II|Enrolled but not treated|0|||
144740904|NCT00205777|521905801|FG005|Study Extension II|Enrolled but not treated|131|||
144740905|NCT01316055|521905804|FG000|Overall Study|Lost to Follow-up|1|||
144740906|NCT01316055|521905805|FG001|Overall Study|Lost to Follow-up|0|||
144740907|NCT01316055|521905806|FG002|Overall Study|Lost to Follow-up|0|||
144740908|NCT00003470|521905807|FG000|Overall Study|Not evaluable|6|||
144740909|NCT01442376|521905809|FG000|Overall Study|Adverse Event|0|||
144740910|NCT01442376|521905810|FG001|Overall Study|Adverse Event|3|||
144740911|NCT01442376|521905811|FG002|Overall Study|Adverse Event|2|||
144740912|NCT01442376|521905809|FG000|Overall Study|Death|0|||
144740913|NCT01442376|521905810|FG001|Overall Study|Death|1|||
144740914|NCT01442376|521905811|FG002|Overall Study|Death|1|||
144740915|NCT01442376|521905809|FG000|Overall Study|Withdrawal of consent|0|||
144740916|NCT01442376|521905810|FG001|Overall Study|Withdrawal of consent|0|||
144740917|NCT01442376|521905811|FG002|Overall Study|Withdrawal of consent|1|||
144740918|NCT01442376|521905809|FG000|Overall Study|Patients not treated|2|||
144740919|NCT01442376|521905810|FG001|Overall Study|Patients not treated|3|||
144740920|NCT01442376|521905811|FG002|Overall Study|Patients not treated|1|||
144740921|NCT01442376|521905809|FG000|Overall Study|Not eligible for subsequent cycles|1|||
144740922|NCT01442376|521905810|FG001|Overall Study|Not eligible for subsequent cycles|2|||
144740923|NCT01442376|521905811|FG002|Overall Study|Not eligible for subsequent cycles|0|||
144740924|NCT00863330|521905812|FG000|Overall Study|study terminated early due to administra|6|||
144740925|NCT04404725|521905813|FG000|First Intervention|Withdrawal by Subject|0|||
144740926|NCT04404725|521905814|FG001|First Intervention|Withdrawal by Subject|2|||
144740927|NCT04404725|521905813|FG000|Second Intervention|Adverse Event|1|||
144740928|NCT04404725|521905814|FG001|Second Intervention|Adverse Event|1|||
144740929|NCT04404725|521905813|FG000|Second Intervention|Withdrawal by Subject|0|||
144740930|NCT04404725|521905814|FG001|Second Intervention|Withdrawal by Subject|1|||
144740931|NCT01075516|521905815|FG000|Overall Study|Death|5|||
144740932|NCT01075516|521905816|FG001|Overall Study|Death|9|||
144740933|NCT01075516|521905815|FG000|Overall Study|Lost to Follow-up|10|||
144740934|NCT01075516|521905816|FG001|Overall Study|Lost to Follow-up|2|||
144740935|NCT01075516|521905815|FG000|Overall Study|Withdrawal by Subject|3|||
144740936|NCT01075516|521905816|FG001|Overall Study|Withdrawal by Subject|5|||
144740937|NCT02252016|521905817|FG000|Overall Study|Lost to Follow-up|2|||
144740938|NCT02252016|521905818|FG001|Overall Study|Lost to Follow-up|1|||
144740939|NCT02252016|521905817|FG000|Overall Study|Physician Decision|1|||
144740940|NCT02252016|521905818|FG001|Overall Study|Physician Decision|0|||
144740941|NCT02252016|521905817|FG000|Overall Study|Withdrawal by Subject|0|||
144740942|NCT02252016|521905818|FG001|Overall Study|Withdrawal by Subject|2|||
144740943|NCT01825798|521905820|FG000|Overall Study|Adverse Event|1|||
144740944|NCT01825798|521905821|FG001|Overall Study|Adverse Event|5|||
144740945|NCT01825798|521905820|FG000|Overall Study|Lost to Follow-up|1|||
144740946|NCT01825798|521905821|FG001|Overall Study|Lost to Follow-up|0|||
144740947|NCT00834873|521905828|FG000|First Intervention|Adverse Event|0|||
144740948|NCT00834873|521905829|FG001|First Intervention|Adverse Event|1|||
144740949|NCT02055547|521905830|FG000|Overall Study|Protocol Violation|0|||
144740950|NCT02055547|521905831|FG001|Overall Study|Protocol Violation|0|||
144740951|NCT02055547|521905832|FG002|Overall Study|Protocol Violation|1|||
144740952|NCT02055547|521905833|FG003|Overall Study|Protocol Violation|0|||
144740953|NCT02055547|521905834|FG004|Overall Study|Protocol Violation|0|||
144740954|NCT02055547|521905835|FG005|Overall Study|Protocol Violation|0|||
144686854|NCT01004861|521704721|FG003|Overall Study|Adverse Event|1|||
144686855|NCT01004861|521704722|FG004|Overall Study|Adverse Event|0|||
144686856|NCT01004861|521704723|FG005|Overall Study|Adverse Event|2|||
144686857|NCT01004861|521704724|FG006|Overall Study|Adverse Event|1|||
144686858|NCT01004861|521704725|FG007|Overall Study|Adverse Event|1|||
144686859|NCT01004861|521704726|FG008|Overall Study|Adverse Event|13|||
144686860|NCT01004861|521704727|FG009|Overall Study|Adverse Event|1|||
144686861|NCT01004861|521704728|FG010|Overall Study|Adverse Event|1|||
144686862|NCT01004861|521704729|FG011|Overall Study|Adverse Event|0|||
144686863|NCT01004861|521704730|FG012|Overall Study|Adverse Event|2|||
144686864|NCT01004861|521704718|FG000|Overall Study|Protocol Violation|0|||
144686865|NCT01004861|521704719|FG001|Overall Study|Protocol Violation|0|||
144686866|NCT01004861|521704720|FG002|Overall Study|Protocol Violation|0|||
144686867|NCT01004861|521704721|FG003|Overall Study|Protocol Violation|0|||
144686868|NCT01004861|521704722|FG004|Overall Study|Protocol Violation|1|||
144686869|NCT01004861|521704723|FG005|Overall Study|Protocol Violation|0|||
144686870|NCT01004861|521704724|FG006|Overall Study|Protocol Violation|0|||
144686871|NCT01004861|521704725|FG007|Overall Study|Protocol Violation|0|||
144686872|NCT01004861|521704726|FG008|Overall Study|Protocol Violation|0|||
144686873|NCT01004861|521704727|FG009|Overall Study|Protocol Violation|0|||
144686874|NCT01004861|521704728|FG010|Overall Study|Protocol Violation|0|||
144686875|NCT01004861|521704729|FG011|Overall Study|Protocol Violation|0|||
144686876|NCT01004861|521704730|FG012|Overall Study|Protocol Violation|0|||
144686877|NCT01004861|521704718|FG000|Overall Study|Lost to Follow-up|0|||
144740955|NCT02055547|521905836|FG006|Overall Study|Protocol Violation|1|||
144740956|NCT02055547|521905837|FG007|Overall Study|Protocol Violation|0|||
144740957|NCT02055547|521905838|FG008|Overall Study|Protocol Violation|0|||
144740958|NCT02055547|521905839|FG009|Overall Study|Protocol Violation|0|||
144740959|NCT02055547|521905840|FG010|Overall Study|Protocol Violation|0|||
144740960|NCT02055547|521905841|FG011|Overall Study|Protocol Violation|0|||
144740961|NCT02055547|521905842|FG012|Overall Study|Protocol Violation|0|||
144740962|NCT02055547|521905843|FG013|Overall Study|Protocol Violation|0|||
144740963|NCT02055547|521905844|FG014|Overall Study|Protocol Violation|0|||
144740964|NCT02055547|521905845|FG015|Overall Study|Protocol Violation|0|||
144740965|NCT02055547|521905846|FG016|Overall Study|Protocol Violation|0|||
144686878|NCT01004861|521704719|FG001|Overall Study|Lost to Follow-up|0|||
144686879|NCT01004861|521704720|FG002|Overall Study|Lost to Follow-up|0|||
144686880|NCT01004861|521704721|FG003|Overall Study|Lost to Follow-up|0|||
144740966|NCT02055547|521905847|FG017|Overall Study|Protocol Violation|0|||
144686881|NCT01004861|521704722|FG004|Overall Study|Lost to Follow-up|0|||
144686882|NCT01004861|521704723|FG005|Overall Study|Lost to Follow-up|0|||
144686883|NCT01004861|521704724|FG006|Overall Study|Lost to Follow-up|0|||
144686884|NCT01004861|521704725|FG007|Overall Study|Lost to Follow-up|1|||
144686885|NCT01004861|521704726|FG008|Overall Study|Lost to Follow-up|3|||
144686886|NCT01004861|521704727|FG009|Overall Study|Lost to Follow-up|0|||
144686887|NCT01004861|521704728|FG010|Overall Study|Lost to Follow-up|0|||
144686888|NCT01004861|521704729|FG011|Overall Study|Lost to Follow-up|1|||
144686889|NCT01004861|521704730|FG012|Overall Study|Lost to Follow-up|0|||
144686890|NCT01004861|521704718|FG000|Overall Study|Non-compliance|0|||
144686891|NCT01004861|521704719|FG001|Overall Study|Non-compliance|0|||
144686892|NCT01004861|521704720|FG002|Overall Study|Non-compliance|0|||
144686893|NCT01004861|521704721|FG003|Overall Study|Non-compliance|0|||
144686894|NCT01004861|521704722|FG004|Overall Study|Non-compliance|0|||
144686895|NCT01004861|521704723|FG005|Overall Study|Non-compliance|0|||
144686896|NCT01004861|521704724|FG006|Overall Study|Non-compliance|0|||
144686897|NCT01004861|521704725|FG007|Overall Study|Non-compliance|0|||
144686898|NCT01004861|521704726|FG008|Overall Study|Non-compliance|5|||
144686899|NCT01004861|521704727|FG009|Overall Study|Non-compliance|0|||
144686900|NCT01004861|521704728|FG010|Overall Study|Non-compliance|0|||
144686901|NCT01004861|521704729|FG011|Overall Study|Non-compliance|0|||
144686902|NCT01004861|521704730|FG012|Overall Study|Non-compliance|1|||
144686903|NCT01004861|521704718|FG000|Overall Study|Other|0|||
144686904|NCT01004861|521704719|FG001|Overall Study|Other|0|||
144686905|NCT01004861|521704720|FG002|Overall Study|Other|0|||
144686906|NCT01004861|521704721|FG003|Overall Study|Other|0|||
144686907|NCT01004861|521704722|FG004|Overall Study|Other|0|||
144686908|NCT01004861|521704723|FG005|Overall Study|Other|0|||
144686909|NCT01004861|521704724|FG006|Overall Study|Other|0|||
144686910|NCT01004861|521704725|FG007|Overall Study|Other|0|||
144686911|NCT01004861|521704726|FG008|Overall Study|Other|0|||
144686912|NCT01004861|521704727|FG009|Overall Study|Other|2|||
144686913|NCT01004861|521704728|FG010|Overall Study|Other|1|||
144686914|NCT01004861|521704729|FG011|Overall Study|Other|2|||
144686915|NCT01004861|521704730|FG012|Overall Study|Other|3|||
144686916|NCT01004861|521704718|FG000|Overall Study|Patient decision|0|||
144686917|NCT01004861|521704719|FG001|Overall Study|Patient decision|0|||
144686918|NCT01004861|521704720|FG002|Overall Study|Patient decision|0|||
144686919|NCT01004861|521704721|FG003|Overall Study|Patient decision|0|||
144686920|NCT01004861|521704722|FG004|Overall Study|Patient decision|1|||
144686921|NCT01004861|521704723|FG005|Overall Study|Patient decision|0|||
144686922|NCT01004861|521704724|FG006|Overall Study|Patient decision|1|||
144686923|NCT01004861|521704725|FG007|Overall Study|Patient decision|0|||
144686924|NCT01004861|521704726|FG008|Overall Study|Patient decision|7|||
144686925|NCT01004861|521704727|FG009|Overall Study|Patient decision|1|||
144686926|NCT01004861|521704728|FG010|Overall Study|Patient decision|1|||
144686927|NCT01004861|521704729|FG011|Overall Study|Patient decision|2|||
144686928|NCT01004861|521704730|FG012|Overall Study|Patient decision|3|||
144686929|NCT01004861|521704718|FG000|Overall Study|Transitioned to Phase 4 study|0|||
144686930|NCT01004861|521704719|FG001|Overall Study|Transitioned to Phase 4 study|0|||
144686931|NCT01004861|521704720|FG002|Overall Study|Transitioned to Phase 4 study|0|||
144686932|NCT01004861|521704721|FG003|Overall Study|Transitioned to Phase 4 study|0|||
144686933|NCT01004861|521704722|FG004|Overall Study|Transitioned to Phase 4 study|0|||
144686934|NCT01004861|521704723|FG005|Overall Study|Transitioned to Phase 4 study|0|||
144686935|NCT01004861|521704724|FG006|Overall Study|Transitioned to Phase 4 study|0|||
144686936|NCT01004861|521704725|FG007|Overall Study|Transitioned to Phase 4 study|0|||
144686937|NCT01004861|521704726|FG008|Overall Study|Transitioned to Phase 4 study|2|||
144686938|NCT01004861|521704727|FG009|Overall Study|Transitioned to Phase 4 study|0|||
144686939|NCT01004861|521704728|FG010|Overall Study|Transitioned to Phase 4 study|0|||
144686940|NCT01004861|521704729|FG011|Overall Study|Transitioned to Phase 4 study|0|||
144686941|NCT01004861|521704730|FG012|Overall Study|Transitioned to Phase 4 study|0|||
144686942|NCT01004861|521704718|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686943|NCT01004861|521704719|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686944|NCT01004861|521704720|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686945|NCT01004861|521704721|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686946|NCT01004861|521704722|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686947|NCT01004861|521704723|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686948|NCT01004861|521704724|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686949|NCT01004861|521704725|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686950|NCT01004861|521704726|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
144686951|NCT01004861|521704727|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686952|NCT01004861|521704728|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144700159|NCT00948896|521754507|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144740967|NCT02055547|521905848|FG018|Overall Study|Protocol Violation|0|||
144740968|NCT02055547|521905830|FG000|Overall Study|Physician Decision|0|||
144740969|NCT02055547|521905831|FG001|Overall Study|Physician Decision|1|||
144740970|NCT02055547|521905832|FG002|Overall Study|Physician Decision|1|||
144740971|NCT02055547|521905833|FG003|Overall Study|Physician Decision|0|||
144740972|NCT02055547|521905834|FG004|Overall Study|Physician Decision|1|||
144740973|NCT02055547|521905835|FG005|Overall Study|Physician Decision|0|||
144740974|NCT02055547|521905836|FG006|Overall Study|Physician Decision|0|||
144740975|NCT02055547|521905837|FG007|Overall Study|Physician Decision|0|||
144740976|NCT02055547|521905838|FG008|Overall Study|Physician Decision|0|||
144740977|NCT02055547|521905839|FG009|Overall Study|Physician Decision|1|||
144740978|NCT02055547|521905840|FG010|Overall Study|Physician Decision|1|||
144740979|NCT02055547|521905841|FG011|Overall Study|Physician Decision|0|||
144740980|NCT02055547|521905842|FG012|Overall Study|Physician Decision|0|||
144740981|NCT02055547|521905843|FG013|Overall Study|Physician Decision|0|||
144740982|NCT02055547|521905844|FG014|Overall Study|Physician Decision|0|||
144740983|NCT02055547|521905845|FG015|Overall Study|Physician Decision|0|||
144740984|NCT02055547|521905846|FG016|Overall Study|Physician Decision|0|||
144740985|NCT02055547|521905847|FG017|Overall Study|Physician Decision|0|||
144740986|NCT02055547|521905848|FG018|Overall Study|Physician Decision|0|||
144740987|NCT02055547|521905830|FG000|Overall Study|Adverse Event|0|||
144740988|NCT02055547|521905831|FG001|Overall Study|Adverse Event|0|||
144740989|NCT02055547|521905832|FG002|Overall Study|Adverse Event|0|||
144740990|NCT02055547|521905833|FG003|Overall Study|Adverse Event|0|||
144740991|NCT02055547|521905834|FG004|Overall Study|Adverse Event|0|||
144740992|NCT02055547|521905835|FG005|Overall Study|Adverse Event|0|||
144740993|NCT02055547|521905836|FG006|Overall Study|Adverse Event|1|||
144740994|NCT02055547|521905837|FG007|Overall Study|Adverse Event|0|||
144740995|NCT02055547|521905838|FG008|Overall Study|Adverse Event|1|||
144740996|NCT02055547|521905839|FG009|Overall Study|Adverse Event|0|||
144740997|NCT02055547|521905840|FG010|Overall Study|Adverse Event|0|||
144740998|NCT02055547|521905841|FG011|Overall Study|Adverse Event|0|||
144740999|NCT02055547|521905842|FG012|Overall Study|Adverse Event|0|||
144741000|NCT02055547|521905843|FG013|Overall Study|Adverse Event|0|||
144741001|NCT02055547|521905844|FG014|Overall Study|Adverse Event|0|||
144741002|NCT02055547|521905845|FG015|Overall Study|Adverse Event|0|||
144741003|NCT02055547|521905846|FG016|Overall Study|Adverse Event|0|||
144741004|NCT02055547|521905847|FG017|Overall Study|Adverse Event|0|||
144741005|NCT02055547|521905848|FG018|Overall Study|Adverse Event|0|||
144741006|NCT02055547|521905830|FG000|Overall Study|Withdrawal by Subject|0|||
144741007|NCT02055547|521905831|FG001|Overall Study|Withdrawal by Subject|0|||
144741008|NCT02055547|521905832|FG002|Overall Study|Withdrawal by Subject|0|||
144741009|NCT02055547|521905833|FG003|Overall Study|Withdrawal by Subject|0|||
144741010|NCT02055547|521905834|FG004|Overall Study|Withdrawal by Subject|0|||
144741011|NCT02055547|521905835|FG005|Overall Study|Withdrawal by Subject|1|||
144741012|NCT02055547|521905836|FG006|Overall Study|Withdrawal by Subject|0|||
144741013|NCT02055547|521905837|FG007|Overall Study|Withdrawal by Subject|0|||
144741014|NCT02055547|521905838|FG008|Overall Study|Withdrawal by Subject|1|||
144218822|NCT01125189|519994479|FG000|Follow up Period|Other reasons|4|||
144218823|NCT01125189|519994480|FG001|Follow up Period|Other reasons|4|||
144218824|NCT01125189|519994481|FG002|Follow up Period|Other reasons|5|||
144218825|NCT00856193|519994482|FG000|Period 2|Abnormal test procedure results|0|||
144218826|NCT00856193|519994483|FG001|Period 2|Abnormal test procedure results|1|||
144218827|NCT00856193|519994482|FG000|Period 2|Lost to Follow-up|0|||
144218828|NCT00856193|519994483|FG001|Period 2|Lost to Follow-up|1|||
144218829|NCT00129545|519994484|FG000|Overall Study|Death|5|||
144218830|NCT00129545|519994485|FG001|Overall Study|Death|60|||
144218831|NCT00129545|519994486|FG002|Overall Study|Death|44|||
144218832|NCT00129545|519994484|FG000|Overall Study|Withdrawal by Subject|3|||
144218833|NCT00129545|519994485|FG001|Overall Study|Withdrawal by Subject|18|||
144218834|NCT00129545|519994486|FG002|Overall Study|Withdrawal by Subject|44|||
144218835|NCT00129545|519994484|FG000|Overall Study|Lost to Follow-up|2|||
144218836|NCT00129545|519994485|FG001|Overall Study|Lost to Follow-up|22|||
144218837|NCT00129545|519994486|FG002|Overall Study|Lost to Follow-up|13|||
144218838|NCT00129545|519994484|FG000|Overall Study|Physician Decision|0|||
144218839|NCT00129545|519994485|FG001|Overall Study|Physician Decision|3|||
144218840|NCT00129545|519994486|FG002|Overall Study|Physician Decision|10|||
144218841|NCT00129545|519994484|FG000|Overall Study|Device not implanted|16|||
144218842|NCT00129545|519994485|FG001|Overall Study|Device not implanted|61|||
144218843|NCT00129545|519994486|FG002|Overall Study|Device not implanted|0|||
144741015|NCT02055547|521905839|FG009|Overall Study|Withdrawal by Subject|0|||
144741016|NCT02055547|521905840|FG010|Overall Study|Withdrawal by Subject|0|||
144741017|NCT02055547|521905841|FG011|Overall Study|Withdrawal by Subject|0|||
144741018|NCT02055547|521905842|FG012|Overall Study|Withdrawal by Subject|0|||
144218844|NCT00065156|519994496|FG000|Overall Study|Adverse Event|37|||
144741019|NCT02055547|521905843|FG013|Overall Study|Withdrawal by Subject|1|||
144741020|NCT02055547|521905844|FG014|Overall Study|Withdrawal by Subject|0|||
144741021|NCT02055547|521905845|FG015|Overall Study|Withdrawal by Subject|1|||
144741022|NCT02055547|521905846|FG016|Overall Study|Withdrawal by Subject|0|||
144686953|NCT01004861|521704729|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686954|NCT01004861|521704730|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
144686955|NCT01004861|521704718|FG000|Overall Study|Patient withdrew|0|||
144686956|NCT01004861|521704719|FG001|Overall Study|Patient withdrew|0|||
144686957|NCT01004861|521704720|FG002|Overall Study|Patient withdrew|0|||
144686958|NCT01004861|521704721|FG003|Overall Study|Patient withdrew|0|||
144686959|NCT01004861|521704722|FG004|Overall Study|Patient withdrew|0|||
144686960|NCT01004861|521704723|FG005|Overall Study|Patient withdrew|0|||
144686961|NCT01004861|521704724|FG006|Overall Study|Patient withdrew|0|||
144686962|NCT01004861|521704725|FG007|Overall Study|Patient withdrew|0|||
144686963|NCT01004861|521704726|FG008|Overall Study|Patient withdrew|1|||
144686964|NCT01004861|521704727|FG009|Overall Study|Patient withdrew|0|||
144686965|NCT01004861|521704728|FG010|Overall Study|Patient withdrew|0|||
144686966|NCT01004861|521704729|FG011|Overall Study|Patient withdrew|0|||
144686967|NCT01004861|521704730|FG012|Overall Study|Patient withdrew|0|||
144686968|NCT01004861|521704718|FG000|Overall Study|Surgical resection|0|||
144686969|NCT01004861|521704719|FG001|Overall Study|Surgical resection|0|||
144686970|NCT01004861|521704720|FG002|Overall Study|Surgical resection|0|||
144686971|NCT01004861|521704721|FG003|Overall Study|Surgical resection|0|||
144686972|NCT01004861|521704722|FG004|Overall Study|Surgical resection|0|||
144686973|NCT01004861|521704723|FG005|Overall Study|Surgical resection|0|||
144686974|NCT01004861|521704724|FG006|Overall Study|Surgical resection|0|||
144686975|NCT01004861|521704725|FG007|Overall Study|Surgical resection|0|||
144686976|NCT01004861|521704726|FG008|Overall Study|Surgical resection|1|||
144686977|NCT01004861|521704727|FG009|Overall Study|Surgical resection|0|||
144686978|NCT01004861|521704728|FG010|Overall Study|Surgical resection|0|||
144686979|NCT01004861|521704729|FG011|Overall Study|Surgical resection|0|||
144686980|NCT01004861|521704730|FG012|Overall Study|Surgical resection|0|||
144686981|NCT01004861|521704718|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686982|NCT01004861|521704719|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686983|NCT01004861|521704720|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686984|NCT01004861|521704721|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686985|NCT01004861|521704722|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686986|NCT01004861|521704723|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686987|NCT01004861|521704724|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686988|NCT01004861|521704725|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686989|NCT01004861|521704726|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
144686990|NCT01004861|521704727|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686991|NCT01004861|521704728|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686992|NCT01004861|521704729|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686993|NCT01004861|521704730|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
144686994|NCT01004861|521704718|FG000|Overall Study|Study termination by Sponsor|0|||
144686995|NCT01004861|521704719|FG001|Overall Study|Study termination by Sponsor|0|||
144686996|NCT01004861|521704720|FG002|Overall Study|Study termination by Sponsor|0|||
144686997|NCT01004861|521704721|FG003|Overall Study|Study termination by Sponsor|0|||
144686998|NCT01004861|521704722|FG004|Overall Study|Study termination by Sponsor|0|||
144686999|NCT01004861|521704723|FG005|Overall Study|Study termination by Sponsor|0|||
144687000|NCT01004861|521704724|FG006|Overall Study|Study termination by Sponsor|0|||
144687001|NCT01004861|521704725|FG007|Overall Study|Study termination by Sponsor|0|||
144687002|NCT01004861|521704726|FG008|Overall Study|Study termination by Sponsor|1|||
144687003|NCT01004861|521704727|FG009|Overall Study|Study termination by Sponsor|0|||
144687004|NCT01004861|521704728|FG010|Overall Study|Study termination by Sponsor|0|||
144687005|NCT01004861|521704729|FG011|Overall Study|Study termination by Sponsor|0|||
144687006|NCT01004861|521704730|FG012|Overall Study|Study termination by Sponsor|0|||
144687007|NCT00003389|521704731|FG000|Overall Study|Disease progression|6|||
144687008|NCT00003389|521704732|FG001|Overall Study|Disease progression|1|||
144687009|NCT00003389|521704731|FG000|Overall Study|Adverse Event|13|||
144687010|NCT00003389|521704732|FG001|Overall Study|Adverse Event|2|||
144687011|NCT00003389|521704731|FG000|Overall Study|Death|0|||
144687012|NCT00003389|521704732|FG001|Overall Study|Death|3|||
144687013|NCT00003389|521704731|FG000|Overall Study|Withdrawal by Subject|12|||
144687014|NCT00003389|521704732|FG001|Overall Study|Withdrawal by Subject|5|||
144687015|NCT00003389|521704731|FG000|Overall Study|Alternative therapy|2|||
144687016|NCT00003389|521704732|FG001|Overall Study|Alternative therapy|1|||
144741023|NCT02055547|521905847|FG017|Overall Study|Withdrawal by Subject|0|||
144741024|NCT02055547|521905848|FG018|Overall Study|Withdrawal by Subject|0|||
144687017|NCT00003389|521704731|FG000|Overall Study|Complicating disease|1|||
144687018|NCT00003389|521704732|FG001|Overall Study|Complicating disease|0|||
144687019|NCT00003389|521704731|FG000|Overall Study|Off-treatment reason missing|31|||
144741025|NCT02055547|521905830|FG000|Overall Study|Lost to Follow-up|0|||
144741026|NCT02055547|521905831|FG001|Overall Study|Lost to Follow-up|0|||
144218845|NCT00065156|519994496|FG000|Overall Study|Lack of Efficacy|52|||
144218846|NCT00065156|519994496|FG000|Overall Study|Withdrawal by Subject|8|||
144218847|NCT00065156|519994496|FG000|Overall Study|Lost to Follow-up|1|||
144218848|NCT00065156|519994496|FG000|Overall Study|Death|11|||
144218849|NCT00065156|519994496|FG000|Overall Study|Study Closed by Sponsor|2|||
144218850|NCT00065156|519994496|FG000|Overall Study|Disease Progression|7|||
144218851|NCT00065156|519994496|FG000|Overall Study|Investigator Decision|2|||
144218852|NCT00065156|519994496|FG000|Overall Study|Non-Compliance|2|||
144218853|NCT00065156|519994496|FG000|Overall Study|Loss of Response|1|||
144218854|NCT00065156|519994496|FG000|Overall Study|Secondary Malign Disease|1|||
144218855|NCT00100828|519994497|FG000|Overall Study|Physician Decision|6|||
144218856|NCT01176513|519994498|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
144218857|NCT00952731|519994499|FG000|Overall Study|Drug supply expired|1|||
144218858|NCT00952731|519994500|FG001|Overall Study|Drug supply expired|0|||
144218859|NCT01184079|519994501|FG000|Overall Study|Lost to Follow-up|14|||
144218860|NCT01184079|519994502|FG001|Overall Study|Lost to Follow-up|2|||
144218861|NCT04233073|519994503|FG000|Overall Study|Death|5|||
144218862|NCT00041132|519994504|FG000|Overall Study|Adverse Event|19|||
144218863|NCT00041132|519994504|FG000|Overall Study|Death|1|||
144218864|NCT00041132|519994504|FG000|Overall Study|Not Eligible|7|||
144218865|NCT00041132|519994504|FG000|Overall Study|Withdrawal by Subject|1|||
144687020|NCT00003389|521704732|FG001|Overall Study|Off-treatment reason missing|21|||
144687021|NCT00003389|521704731|FG000|Overall Study|Ineligible|33|||
144687022|NCT00003389|521704732|FG001|Overall Study|Ineligible|27|||
144687023|NCT02554721|521704733|FG000|Overall Study|Adverse Event|1|||
144687024|NCT02554721|521704734|FG001|Overall Study|Adverse Event|0|||
144687025|NCT02554721|521704735|FG002|Overall Study|Adverse Event|0|||
144687026|NCT02554721|521704736|FG003|Overall Study|Adverse Event|0|||
144687027|NCT02554721|521704737|FG004|Overall Study|Adverse Event|1|||
144687028|NCT02554721|521704733|FG000|Overall Study|Noncompliance|0|||
144687029|NCT02554721|521704734|FG001|Overall Study|Noncompliance|0|||
144687030|NCT02554721|521704735|FG002|Overall Study|Noncompliance|0|||
144687031|NCT02554721|521704736|FG003|Overall Study|Noncompliance|0|||
144687032|NCT02554721|521704737|FG004|Overall Study|Noncompliance|1|||
144687033|NCT00686699|521704738|FG000|Treatment Period 1|Adverse Event|0|||
144687034|NCT00686699|521704739|FG001|Treatment Period 1|Adverse Event|2|||
144687035|NCT01693562|521704741|FG000|Escalation Phase|Withdrawal by Subject|0|||
144687036|NCT01693562|521704742|FG001|Escalation Phase|Withdrawal by Subject|1|||
144687037|NCT01693562|521704743|FG002|Escalation Phase|Withdrawal by Subject|0|||
144687038|NCT01693562|521704744|FG003|Escalation Phase|Withdrawal by Subject|0|||
144687039|NCT01693562|521704745|FG004|Escalation Phase|Withdrawal by Subject|0|||
144687040|NCT01693562|521704746|FG005|Escalation Phase|Withdrawal by Subject|2|||
144687041|NCT01693562|521704747|FG006|Escalation Phase|Withdrawal by Subject|0|||
144687042|NCT01693562|521704748|FG007|Escalation Phase|Withdrawal by Subject|0|||
144687043|NCT01693562|521704749|FG008|Escalation Phase|Withdrawal by Subject|0|||
144687044|NCT01693562|521704750|FG009|Escalation Phase|Withdrawal by Subject|0|||
144687045|NCT01693562|521704751|FG010|Escalation Phase|Withdrawal by Subject|0|||
144687046|NCT01693562|521704752|FG011|Escalation Phase|Withdrawal by Subject|0|||
144687047|NCT01693562|521704753|FG012|Escalation Phase|Withdrawal by Subject|0|||
144687048|NCT01693562|521704754|FG013|Escalation Phase|Withdrawal by Subject|0|||
144687049|NCT01693562|521704755|FG014|Escalation Phase|Withdrawal by Subject|0|||
144687050|NCT01693562|521704756|FG015|Escalation Phase|Withdrawal by Subject|0|||
144687051|NCT01693562|521704757|FG016|Escalation Phase|Withdrawal by Subject|0|||
144687052|NCT01693562|521704758|FG017|Escalation Phase|Withdrawal by Subject|0|||
144687053|NCT01693562|521704759|FG018|Escalation Phase|Withdrawal by Subject|0|||
144687054|NCT01693562|521704760|FG019|Escalation Phase|Withdrawal by Subject|0|||
144687055|NCT01693562|521704761|FG020|Escalation Phase|Withdrawal by Subject|0|||
144687056|NCT01693562|521704762|FG021|Escalation Phase|Withdrawal by Subject|0|||
144687057|NCT01693562|521704763|FG022|Escalation Phase|Withdrawal by Subject|0|||
144687058|NCT01693562|521704741|FG000|Escalation Phase|Death|4|||
144687059|NCT01693562|521704742|FG001|Escalation Phase|Death|2|||
144687060|NCT01693562|521704743|FG002|Escalation Phase|Death|0|||
144687061|NCT01693562|521704744|FG003|Escalation Phase|Death|3|||
144687062|NCT01693562|521704745|FG004|Escalation Phase|Death|6|||
144687063|NCT01693562|521704746|FG005|Escalation Phase|Death|4|||
144687064|NCT01693562|521704747|FG006|Escalation Phase|Death|0|||
144687065|NCT01693562|521704748|FG007|Escalation Phase|Death|0|||
144687066|NCT01693562|521704749|FG008|Escalation Phase|Death|0|||
144687067|NCT01693562|521704750|FG009|Escalation Phase|Death|0|||
144687068|NCT01693562|521704751|FG010|Escalation Phase|Death|0|||
144687069|NCT01693562|521704752|FG011|Escalation Phase|Death|0|||
144687070|NCT01693562|521704753|FG012|Escalation Phase|Death|0|||
144218866|NCT00041132|519994504|FG000|Overall Study|Physician Decision|2|||
144218867|NCT00995774|519994508|FG000|Training Period 2|Withdrawal by Subject|2|||
144687071|NCT01693562|521704754|FG013|Escalation Phase|Death|0|||
144687072|NCT01693562|521704755|FG014|Escalation Phase|Death|0|||
144218868|NCT00995774|519994509|FG001|Training Period 2|Withdrawal by Subject|0|||
144218869|NCT01256502|519994510|FG000|Overall Study|Had scaffold removed|4|||
144218870|NCT01256502|519994510|FG000|Overall Study|Personal reasons|5|||
144218871|NCT01256502|519994510|FG000|Overall Study|Protocol deviation|1|||
144218872|NCT03953612|519994511|FG000|Overall Study|Randomized but did not start|1|||
144218873|NCT03953612|519994512|FG001|Overall Study|Randomized but did not start|1|||
144218874|NCT03953612|519994513|FG002|Overall Study|Randomized but did not start|1|||
144218875|NCT03953612|519994511|FG000|Overall Study|Withdrawal by Subject|2|||
144218876|NCT03953612|519994512|FG001|Overall Study|Withdrawal by Subject|1|||
144218877|NCT03953612|519994513|FG002|Overall Study|Withdrawal by Subject|0|||
144218878|NCT00489255|519994514|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
144218879|NCT00489255|519994515|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
144218880|NCT00489255|519994514|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
144218881|NCT00489255|519994515|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
144218882|NCT00489255|519994514|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
144218883|NCT00489255|519994515|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
144218884|NCT00489255|519994514|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
144218885|NCT00489255|519994515|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
144218886|NCT00489255|519994514|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
144218887|NCT00489255|519994515|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
144218888|NCT00489255|519994514|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
144218889|NCT00489255|519994515|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
144218890|NCT00489255|519994514|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
144218891|NCT00489255|519994515|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
144218892|NCT00489255|519994514|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
144218893|NCT00489255|519994515|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
144218894|NCT00489255|519994514|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
144218895|NCT00489255|519994515|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
144218896|NCT00489255|519994514|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
144218897|NCT00489255|519994515|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
144218898|NCT03485352|519994516|FG000|Overall Study|Lost to Follow-up|9|||
144218899|NCT02905032|519994529|FG000|Overall Study|Withdrawal by Subject|2|||
144218900|NCT02905032|519994530|FG001|Overall Study|Withdrawal by Subject|0|||
144218901|NCT02905032|519994531|FG002|Overall Study|Withdrawal by Subject|0|||
144218902|NCT02905032|519994529|FG000|Overall Study|Protocol Violation|6|||
144218903|NCT02905032|519994530|FG001|Overall Study|Protocol Violation|12|||
144218904|NCT02905032|519994531|FG002|Overall Study|Protocol Violation|0|||
144218905|NCT00739063|519994535|FG000|Overall Study|Screen failures|8|||
144218906|NCT04779879|519994536|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
144218907|NCT04779879|519994537|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
144218908|NCT04779879|519994538|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
144218909|NCT04779879|519994539|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
144218910|NCT04779879|519994540|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
144218911|NCT04779879|519994541|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
144218912|NCT04779879|519994536|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
144218913|NCT04779879|519994537|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
144218914|NCT04779879|519994538|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
144218915|NCT04779879|519994539|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
144218916|NCT04779879|519994540|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
144218917|NCT04779879|519994541|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
144218918|NCT04779879|519994536|FG000|Part C: Up to Week 36|Death|0|||
144218919|NCT04779879|519994537|FG001|Part C: Up to Week 36|Death|0|||
144687073|NCT01693562|521704756|FG015|Escalation Phase|Death|0|||
144687074|NCT01693562|521704757|FG016|Escalation Phase|Death|0|||
144687075|NCT01693562|521704758|FG017|Escalation Phase|Death|0|||
144687076|NCT01693562|521704759|FG018|Escalation Phase|Death|0|||
144687077|NCT01693562|521704760|FG019|Escalation Phase|Death|0|||
144687078|NCT01693562|521704761|FG020|Escalation Phase|Death|0|||
144687079|NCT01693562|521704762|FG021|Escalation Phase|Death|0|||
144687080|NCT01693562|521704763|FG022|Escalation Phase|Death|0|||
144687081|NCT01693562|521704741|FG000|Escalation Phase|Lost to Follow-up|0|||
144687082|NCT01693562|521704742|FG001|Escalation Phase|Lost to Follow-up|1|||
144687083|NCT01693562|521704743|FG002|Escalation Phase|Lost to Follow-up|1|||
144687084|NCT01693562|521704744|FG003|Escalation Phase|Lost to Follow-up|0|||
144218920|NCT04779879|519994538|FG002|Part C: Up to Week 36|Death|0|||
144218921|NCT04779879|519994539|FG003|Part C: Up to Week 36|Death|0|||
144218922|NCT04779879|519994540|FG004|Part C: Up to Week 36|Death|0|||
144218923|NCT04779879|519994541|FG005|Part C: Up to Week 36|Death|1|||
144218924|NCT04779879|519994536|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
144687085|NCT01693562|521704745|FG004|Escalation Phase|Lost to Follow-up|0|||
144218925|NCT04779879|519994537|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
144218926|NCT04779879|519994538|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
144218927|NCT04779879|519994539|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
144218928|NCT04779879|519994540|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
144687086|NCT01693562|521704746|FG005|Escalation Phase|Lost to Follow-up|0|||
144687087|NCT01693562|521704747|FG006|Escalation Phase|Lost to Follow-up|0|||
144687088|NCT01693562|521704748|FG007|Escalation Phase|Lost to Follow-up|0|||
144687089|NCT01693562|521704749|FG008|Escalation Phase|Lost to Follow-up|0|||
144218929|NCT04779879|519994541|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
144218930|NCT02854527|519994542|FG000|Overall Study|Adverse Event|0|||
144218931|NCT02854527|519994543|FG001|Overall Study|Adverse Event|0|||
144218932|NCT02854527|519994544|FG002|Overall Study|Adverse Event|0|||
144218933|NCT02854527|519994545|FG003|Overall Study|Adverse Event|0|||
144218934|NCT02854527|519994546|FG004|Overall Study|Adverse Event|1|||
144218935|NCT02854527|519994547|FG005|Overall Study|Adverse Event|0|||
144218936|NCT02854527|519994548|FG006|Overall Study|Adverse Event|0|||
144687090|NCT01693562|521704750|FG009|Escalation Phase|Lost to Follow-up|0|||
144687091|NCT01693562|521704751|FG010|Escalation Phase|Lost to Follow-up|0|||
144687092|NCT01693562|521704752|FG011|Escalation Phase|Lost to Follow-up|0|||
144687093|NCT01693562|521704753|FG012|Escalation Phase|Lost to Follow-up|0|||
144687094|NCT01693562|521704754|FG013|Escalation Phase|Lost to Follow-up|0|||
144687095|NCT01693562|521704755|FG014|Escalation Phase|Lost to Follow-up|0|||
144687096|NCT01693562|521704756|FG015|Escalation Phase|Lost to Follow-up|0|||
144687097|NCT01693562|521704757|FG016|Escalation Phase|Lost to Follow-up|0|||
144687098|NCT01693562|521704758|FG017|Escalation Phase|Lost to Follow-up|0|||
144687099|NCT01693562|521704759|FG018|Escalation Phase|Lost to Follow-up|0|||
144687100|NCT01693562|521704760|FG019|Escalation Phase|Lost to Follow-up|0|||
144687101|NCT01693562|521704761|FG020|Escalation Phase|Lost to Follow-up|0|||
144687102|NCT01693562|521704762|FG021|Escalation Phase|Lost to Follow-up|0|||
144687103|NCT01693562|521704763|FG022|Escalation Phase|Lost to Follow-up|0|||
144687104|NCT01693562|521704741|FG000|Escalation Phase|Other|0|||
144687105|NCT01693562|521704742|FG001|Escalation Phase|Other|0|||
144687106|NCT01693562|521704743|FG002|Escalation Phase|Other|2|||
144687107|NCT01693562|521704744|FG003|Escalation Phase|Other|0|||
144687108|NCT01693562|521704745|FG004|Escalation Phase|Other|0|||
144687109|NCT01693562|521704746|FG005|Escalation Phase|Other|1|||
144687110|NCT01693562|521704747|FG006|Escalation Phase|Other|0|||
144687111|NCT01693562|521704748|FG007|Escalation Phase|Other|0|||
144687112|NCT01693562|521704749|FG008|Escalation Phase|Other|0|||
144687113|NCT01693562|521704750|FG009|Escalation Phase|Other|0|||
144687114|NCT01693562|521704751|FG010|Escalation Phase|Other|0|||
144687115|NCT01693562|521704752|FG011|Escalation Phase|Other|0|||
144687116|NCT01693562|521704753|FG012|Escalation Phase|Other|0|||
144687117|NCT01693562|521704754|FG013|Escalation Phase|Other|0|||
144687118|NCT01693562|521704755|FG014|Escalation Phase|Other|0|||
144687119|NCT01693562|521704756|FG015|Escalation Phase|Other|0|||
144687120|NCT01693562|521704757|FG016|Escalation Phase|Other|0|||
144687121|NCT01693562|521704758|FG017|Escalation Phase|Other|0|||
144687122|NCT01693562|521704759|FG018|Escalation Phase|Other|0|||
144687123|NCT01693562|521704760|FG019|Escalation Phase|Other|0|||
144687124|NCT01693562|521704761|FG020|Escalation Phase|Other|0|||
144687125|NCT01693562|521704762|FG021|Escalation Phase|Other|0|||
144687126|NCT01693562|521704763|FG022|Escalation Phase|Other|0|||
144687127|NCT01693562|521704741|FG000|Exploration Phase|Withdrawal by Subject|0|||
144687128|NCT01693562|521704742|FG001|Exploration Phase|Withdrawal by Subject|0|||
144687129|NCT01693562|521704743|FG002|Exploration Phase|Withdrawal by Subject|0|||
144687130|NCT01693562|521704744|FG003|Exploration Phase|Withdrawal by Subject|0|||
144687131|NCT01693562|521704745|FG004|Exploration Phase|Withdrawal by Subject|0|||
144687132|NCT01693562|521704746|FG005|Exploration Phase|Withdrawal by Subject|0|||
144687133|NCT01693562|521704747|FG006|Exploration Phase|Withdrawal by Subject|2|||
144687134|NCT01693562|521704748|FG007|Exploration Phase|Withdrawal by Subject|0|||
144687135|NCT01693562|521704749|FG008|Exploration Phase|Withdrawal by Subject|0|||
144687136|NCT01693562|521704750|FG009|Exploration Phase|Withdrawal by Subject|0|||
144687137|NCT01693562|521704751|FG010|Exploration Phase|Withdrawal by Subject|0|||
144687138|NCT01693562|521704752|FG011|Exploration Phase|Withdrawal by Subject|0|||
144687139|NCT01693562|521704753|FG012|Exploration Phase|Withdrawal by Subject|0|||
144687140|NCT01693562|521704754|FG013|Exploration Phase|Withdrawal by Subject|0|||
144687141|NCT01693562|521704755|FG014|Exploration Phase|Withdrawal by Subject|0|||
144687142|NCT01693562|521704756|FG015|Exploration Phase|Withdrawal by Subject|0|||
144687143|NCT01693562|521704757|FG016|Exploration Phase|Withdrawal by Subject|0|||
144687144|NCT01693562|521704758|FG017|Exploration Phase|Withdrawal by Subject|0|||
144687145|NCT01693562|521704759|FG018|Exploration Phase|Withdrawal by Subject|0|||
144687146|NCT01693562|521704760|FG019|Exploration Phase|Withdrawal by Subject|0|||
144687147|NCT01693562|521704761|FG020|Exploration Phase|Withdrawal by Subject|0|||
144687148|NCT01693562|521704762|FG021|Exploration Phase|Withdrawal by Subject|0|||
144687149|NCT01693562|521704763|FG022|Exploration Phase|Withdrawal by Subject|0|||
144687150|NCT01693562|521704741|FG000|Exploration Phase|Death|0|||
144687151|NCT01693562|521704742|FG001|Exploration Phase|Death|0|||
144687152|NCT01693562|521704743|FG002|Exploration Phase|Death|0|||
144687153|NCT01693562|521704744|FG003|Exploration Phase|Death|0|||
144687154|NCT01693562|521704745|FG004|Exploration Phase|Death|0|||
144687155|NCT01693562|521704746|FG005|Exploration Phase|Death|0|||
144687156|NCT01693562|521704747|FG006|Exploration Phase|Death|17|||
144687157|NCT01693562|521704748|FG007|Exploration Phase|Death|0|||
144687158|NCT01693562|521704749|FG008|Exploration Phase|Death|0|||
144687159|NCT01693562|521704750|FG009|Exploration Phase|Death|0|||
144218937|NCT02854527|519994549|FG007|Overall Study|Adverse Event|0|||
144218938|NCT02854527|519994550|FG008|Overall Study|Adverse Event|0|||
144687160|NCT01693562|521704751|FG010|Exploration Phase|Death|0|||
144687161|NCT01693562|521704752|FG011|Exploration Phase|Death|0|||
144741027|NCT02055547|521905832|FG002|Overall Study|Lost to Follow-up|1|||
144741028|NCT02055547|521905833|FG003|Overall Study|Lost to Follow-up|0|||
144741029|NCT02055547|521905834|FG004|Overall Study|Lost to Follow-up|0|||
144741030|NCT02055547|521905835|FG005|Overall Study|Lost to Follow-up|0|||
144741031|NCT02055547|521905836|FG006|Overall Study|Lost to Follow-up|0|||
144741032|NCT02055547|521905837|FG007|Overall Study|Lost to Follow-up|0|||
144741033|NCT02055547|521905838|FG008|Overall Study|Lost to Follow-up|0|||
144741034|NCT02055547|521905839|FG009|Overall Study|Lost to Follow-up|0|||
144741035|NCT02055547|521905840|FG010|Overall Study|Lost to Follow-up|0|||
144741036|NCT02055547|521905841|FG011|Overall Study|Lost to Follow-up|0|||
144741037|NCT02055547|521905842|FG012|Overall Study|Lost to Follow-up|0|||
144741038|NCT02055547|521905843|FG013|Overall Study|Lost to Follow-up|0|||
144687162|NCT01693562|521704753|FG012|Exploration Phase|Death|0|||
144687163|NCT01693562|521704754|FG013|Exploration Phase|Death|0|||
144687164|NCT01693562|521704755|FG014|Exploration Phase|Death|0|||
144687165|NCT01693562|521704756|FG015|Exploration Phase|Death|0|||
144687166|NCT01693562|521704757|FG016|Exploration Phase|Death|0|||
144687167|NCT01693562|521704758|FG017|Exploration Phase|Death|0|||
144687168|NCT01693562|521704759|FG018|Exploration Phase|Death|0|||
144687169|NCT01693562|521704760|FG019|Exploration Phase|Death|0|||
144687170|NCT01693562|521704761|FG020|Exploration Phase|Death|0|||
144687171|NCT01693562|521704762|FG021|Exploration Phase|Death|0|||
144687172|NCT01693562|521704763|FG022|Exploration Phase|Death|0|||
144687173|NCT01693562|521704741|FG000|Exploration Phase|Other|0|||
144687174|NCT01693562|521704742|FG001|Exploration Phase|Other|0|||
144687175|NCT01693562|521704743|FG002|Exploration Phase|Other|0|||
144687176|NCT01693562|521704744|FG003|Exploration Phase|Other|0|||
144687177|NCT01693562|521704745|FG004|Exploration Phase|Other|0|||
144687178|NCT01693562|521704746|FG005|Exploration Phase|Other|0|||
144687179|NCT01693562|521704747|FG006|Exploration Phase|Other|2|||
144687180|NCT01693562|521704748|FG007|Exploration Phase|Other|0|||
144687181|NCT01693562|521704749|FG008|Exploration Phase|Other|0|||
144687182|NCT01693562|521704750|FG009|Exploration Phase|Other|0|||
144687183|NCT01693562|521704751|FG010|Exploration Phase|Other|0|||
144687184|NCT01693562|521704752|FG011|Exploration Phase|Other|0|||
144687185|NCT01693562|521704753|FG012|Exploration Phase|Other|0|||
144687186|NCT01693562|521704754|FG013|Exploration Phase|Other|0|||
144687187|NCT01693562|521704755|FG014|Exploration Phase|Other|0|||
144687188|NCT01693562|521704756|FG015|Exploration Phase|Other|0|||
144687189|NCT01693562|521704757|FG016|Exploration Phase|Other|0|||
144687190|NCT01693562|521704758|FG017|Exploration Phase|Other|0|||
144687191|NCT01693562|521704759|FG018|Exploration Phase|Other|0|||
144687192|NCT01693562|521704760|FG019|Exploration Phase|Other|0|||
144687193|NCT01693562|521704761|FG020|Exploration Phase|Other|0|||
144687194|NCT01693562|521704762|FG021|Exploration Phase|Other|0|||
144687195|NCT01693562|521704763|FG022|Exploration Phase|Other|0|||
144687196|NCT01693562|521704741|FG000|Expansion Phase|Withdrawal by Subject|0|||
144687197|NCT01693562|521704742|FG001|Expansion Phase|Withdrawal by Subject|0|||
144687198|NCT01693562|521704743|FG002|Expansion Phase|Withdrawal by Subject|0|||
144687199|NCT01693562|521704744|FG003|Expansion Phase|Withdrawal by Subject|0|||
144687200|NCT01693562|521704745|FG004|Expansion Phase|Withdrawal by Subject|0|||
144687201|NCT01693562|521704746|FG005|Expansion Phase|Withdrawal by Subject|0|||
144687202|NCT01693562|521704747|FG006|Expansion Phase|Withdrawal by Subject|0|||
144687203|NCT01693562|521704748|FG007|Expansion Phase|Withdrawal by Subject|16|||
144687204|NCT01693562|521704749|FG008|Expansion Phase|Withdrawal by Subject|2|||
144687205|NCT01693562|521704750|FG009|Expansion Phase|Withdrawal by Subject|54|||
144687206|NCT01693562|521704751|FG010|Expansion Phase|Withdrawal by Subject|2|||
144687207|NCT01693562|521704752|FG011|Expansion Phase|Withdrawal by Subject|2|||
144687208|NCT01693562|521704753|FG012|Expansion Phase|Withdrawal by Subject|3|||
144687209|NCT01693562|521704754|FG013|Expansion Phase|Withdrawal by Subject|5|||
144687210|NCT01693562|521704755|FG014|Expansion Phase|Withdrawal by Subject|16|||
144687211|NCT01693562|521704756|FG015|Expansion Phase|Withdrawal by Subject|7|||
144687212|NCT01693562|521704757|FG016|Expansion Phase|Withdrawal by Subject|40|||
144687213|NCT01693562|521704758|FG017|Expansion Phase|Withdrawal by Subject|4|||
144687214|NCT01693562|521704759|FG018|Expansion Phase|Withdrawal by Subject|8|||
144687215|NCT01693562|521704760|FG019|Expansion Phase|Withdrawal by Subject|3|||
144687216|NCT01693562|521704761|FG020|Expansion Phase|Withdrawal by Subject|1|||
144687217|NCT01693562|521704762|FG021|Expansion Phase|Withdrawal by Subject|8|||
144687218|NCT01693562|521704763|FG022|Expansion Phase|Withdrawal by Subject|1|||
144687219|NCT01693562|521704741|FG000|Expansion Phase|Death|0|||
144687220|NCT01693562|521704742|FG001|Expansion Phase|Death|0|||
144687221|NCT01693562|521704743|FG002|Expansion Phase|Death|0|||
144687222|NCT01693562|521704744|FG003|Expansion Phase|Death|0|||
144687223|NCT01693562|521704745|FG004|Expansion Phase|Death|0|||
144687224|NCT01693562|521704746|FG005|Expansion Phase|Death|0|||
144687225|NCT01693562|521704747|FG006|Expansion Phase|Death|0|||
144687226|NCT01693562|521704748|FG007|Expansion Phase|Death|42|||
144687227|NCT01693562|521704749|FG008|Expansion Phase|Death|17|||
144687228|NCT01693562|521704750|FG009|Expansion Phase|Death|208|||
144741039|NCT02055547|521905844|FG014|Overall Study|Lost to Follow-up|0|||
144741040|NCT02055547|521905845|FG015|Overall Study|Lost to Follow-up|0|||
144741041|NCT02055547|521905846|FG016|Overall Study|Lost to Follow-up|0|||
144741042|NCT02055547|521905847|FG017|Overall Study|Lost to Follow-up|0|||
144741043|NCT02055547|521905848|FG018|Overall Study|Lost to Follow-up|0|||
144741044|NCT02911025|521905851|FG000|Overall Study|Lost to Follow-up|3|||
144741045|NCT06647173|521905853|FG000|Overall Study|Lost to Follow-up|24|||
144741046|NCT02923349|521905854|FG000|Overall Study|Other|1|||
144741047|NCT02923349|521905855|FG001|Overall Study|Other|2|||
144741048|NCT02923349|521905856|FG002|Overall Study|Other|4|||
144741049|NCT02923349|521905857|FG003|Overall Study|Other|1|||
144741050|NCT02923349|521905858|FG004|Overall Study|Other|3|||
144741051|NCT02923349|521905859|FG005|Overall Study|Other|0|||
144741052|NCT02923349|521905860|FG006|Overall Study|Other|1|||
144741053|NCT02923349|521905854|FG000|Overall Study|Withdrawal by Subject|2|||
144741054|NCT02923349|521905855|FG001|Overall Study|Withdrawal by Subject|2|||
144741055|NCT02923349|521905856|FG002|Overall Study|Withdrawal by Subject|8|||
144741056|NCT02923349|521905857|FG003|Overall Study|Withdrawal by Subject|10|||
144741057|NCT02923349|521905858|FG004|Overall Study|Withdrawal by Subject|12|||
144741058|NCT02923349|521905859|FG005|Overall Study|Withdrawal by Subject|3|||
144741059|NCT02923349|521905860|FG006|Overall Study|Withdrawal by Subject|0|||
144741060|NCT02923349|521905854|FG000|Overall Study|Physician Decision|0|||
144741061|NCT02923349|521905855|FG001|Overall Study|Physician Decision|0|||
144741062|NCT02923349|521905856|FG002|Overall Study|Physician Decision|0|||
144741063|NCT02923349|521905857|FG003|Overall Study|Physician Decision|1|||
144741064|NCT02923349|521905858|FG004|Overall Study|Physician Decision|1|||
144741065|NCT02923349|521905859|FG005|Overall Study|Physician Decision|0|||
144741066|NCT02923349|521905860|FG006|Overall Study|Physician Decision|2|||
144741067|NCT02923349|521905854|FG000|Overall Study|Lost to Follow-up|0|||
144741068|NCT02923349|521905855|FG001|Overall Study|Lost to Follow-up|0|||
144741069|NCT02923349|521905856|FG002|Overall Study|Lost to Follow-up|3|||
144741070|NCT02923349|521905857|FG003|Overall Study|Lost to Follow-up|0|||
144741071|NCT02923349|521905858|FG004|Overall Study|Lost to Follow-up|1|||
144741072|NCT02923349|521905859|FG005|Overall Study|Lost to Follow-up|1|||
144741073|NCT02923349|521905860|FG006|Overall Study|Lost to Follow-up|0|||
144741074|NCT02923349|521905854|FG000|Overall Study|Death|1|||
144741075|NCT02923349|521905855|FG001|Overall Study|Death|0|||
144741076|NCT02923349|521905856|FG002|Overall Study|Death|2|||
144741077|NCT02923349|521905857|FG003|Overall Study|Death|4|||
144741078|NCT02923349|521905858|FG004|Overall Study|Death|2|||
144741079|NCT02923349|521905859|FG005|Overall Study|Death|3|||
144741080|NCT02923349|521905860|FG006|Overall Study|Death|0|||
144741081|NCT01120028|521905863|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
144741082|NCT01120028|521905864|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
144741083|NCT01120028|521905865|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
144741084|NCT01120028|521905866|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
144741085|NCT01120028|521905863|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
144741086|NCT01120028|521905864|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
144741087|NCT01120028|521905865|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
144741088|NCT01120028|521905866|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
144741089|NCT03250117|521905867|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
144741090|NCT03250117|521905868|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
144741091|NCT03250117|521905869|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
144741092|NCT03250117|521905870|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
144741093|NCT01248728|521905871|FG000|Overall Study|Adverse Event|1|||
144741094|NCT01248728|521905872|FG001|Overall Study|Adverse Event|1|||
144741095|NCT01248728|521905871|FG000|Overall Study|Withdrawal by Subject|2|||
144741096|NCT01248728|521905872|FG001|Overall Study|Withdrawal by Subject|1|||
144741097|NCT01248728|521905871|FG000|Overall Study|Lack of Efficacy|1|||
144741098|NCT01248728|521905872|FG001|Overall Study|Lack of Efficacy|0|||
144741099|NCT02011945|521905873|FG000|Overall Study|Participant requested to Discontinue|0|||
144741100|NCT02011945|521905874|FG001|Overall Study|Participant requested to Discontinue|1|||
144741101|NCT02011945|521905875|FG002|Overall Study|Participant requested to Discontinue|1|||
144741102|NCT02011945|521905873|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
144741103|NCT02011945|521905874|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
144741104|NCT02011945|521905875|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
144741105|NCT02011945|521905873|FG000|Overall Study|Study Drug Toxicity|0|||
144741106|NCT02011945|521905874|FG001|Overall Study|Study Drug Toxicity|0|||
144741107|NCT02011945|521905875|FG002|Overall Study|Study Drug Toxicity|1|||
144741108|NCT02011945|521905873|FG000|Overall Study|Treatment Failure|0|||
144741109|NCT02011945|521905874|FG001|Overall Study|Treatment Failure|7|||
144741110|NCT02011945|521905875|FG002|Overall Study|Treatment Failure|6|||
144741111|NCT02011945|521905873|FG000|Overall Study|No Longer Meets Study Criteria|1|||
144741112|NCT02011945|521905874|FG001|Overall Study|No Longer Meets Study Criteria|0|||
144741113|NCT02011945|521905875|FG002|Overall Study|No Longer Meets Study Criteria|0|||
144741114|NCT02011945|521905873|FG000|Overall Study|Proceeded to stem cell transplant|0|||
144741115|NCT02011945|521905874|FG001|Overall Study|Proceeded to stem cell transplant|0|||
144741116|NCT02011945|521905875|FG002|Overall Study|Proceeded to stem cell transplant|1|||
144741117|NCT02011945|521905873|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
144741118|NCT02011945|521905874|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
144741119|NCT02011945|521905875|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
144741120|NCT00902538|521905876|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
144741121|NCT00902538|521905877|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
144741122|NCT00902538|521905878|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
144741123|NCT00902538|521905879|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
144741124|NCT00902538|521905880|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
144741125|NCT00902538|521905881|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
144741126|NCT00902538|521905876|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
144741127|NCT00902538|521905877|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
144741128|NCT00902538|521905878|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
144741129|NCT00902538|521905879|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
144741130|NCT00902538|521905880|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
144741131|NCT00902538|521905881|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
144741132|NCT00902538|521905876|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
144741133|NCT00902538|521905877|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
144741134|NCT00902538|521905878|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
144741135|NCT00902538|521905879|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
144741136|NCT00902538|521905880|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
144741137|NCT00902538|521905881|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
144741138|NCT00902538|521905876|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
144741139|NCT00902538|521905877|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
144741140|NCT00902538|521905878|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
144741141|NCT00902538|521905879|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
144741142|NCT00902538|521905880|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
144741143|NCT00902538|521905881|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
144741144|NCT00902538|521905876|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
144741145|NCT00902538|521905877|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
144741146|NCT00902538|521905878|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
144741147|NCT00902538|521905879|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
144741148|NCT00902538|521905880|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
144741149|NCT00902538|521905881|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
144741150|NCT00902538|521905876|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
144741151|NCT00902538|521905877|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
144741152|NCT00902538|521905878|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
144741153|NCT00902538|521905879|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
144741154|NCT00902538|521905880|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
144741155|NCT00902538|521905881|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
144741156|NCT00902538|521905876|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
144741157|NCT00902538|521905877|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
144741158|NCT00902538|521905878|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
144741159|NCT00902538|521905879|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
144741160|NCT00902538|521905880|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
144741161|NCT00902538|521905881|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
144741162|NCT00902538|521905876|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
144741163|NCT00902538|521905877|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
144741164|NCT00902538|521905878|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
144687229|NCT01693562|521704751|FG010|Expansion Phase|Death|30|||
144687230|NCT01693562|521704752|FG011|Expansion Phase|Death|8|||
144687231|NCT01693562|521704753|FG012|Expansion Phase|Death|19|||
144687232|NCT01693562|521704754|FG013|Expansion Phase|Death|42|||
144687233|NCT01693562|521704755|FG014|Expansion Phase|Death|23|||
144687234|NCT01693562|521704756|FG015|Expansion Phase|Death|23|||
144687235|NCT01693562|521704757|FG016|Expansion Phase|Death|128|||
144687236|NCT01693562|521704758|FG017|Expansion Phase|Death|16|||
144687237|NCT01693562|521704759|FG018|Expansion Phase|Death|36|||
144687238|NCT01693562|521704760|FG019|Expansion Phase|Death|16|||
144687239|NCT01693562|521704761|FG020|Expansion Phase|Death|17|||
144687240|NCT01693562|521704762|FG021|Expansion Phase|Death|35|||
144687241|NCT01693562|521704763|FG022|Expansion Phase|Death|7|||
144687242|NCT01693562|521704741|FG000|Expansion Phase|Lost to Follow-up|0|||
144687243|NCT01693562|521704742|FG001|Expansion Phase|Lost to Follow-up|0|||
144687244|NCT01693562|521704743|FG002|Expansion Phase|Lost to Follow-up|0|||
144687245|NCT01693562|521704744|FG003|Expansion Phase|Lost to Follow-up|0|||
144687246|NCT01693562|521704745|FG004|Expansion Phase|Lost to Follow-up|0|||
144687247|NCT01693562|521704746|FG005|Expansion Phase|Lost to Follow-up|0|||
144687248|NCT01693562|521704747|FG006|Expansion Phase|Lost to Follow-up|0|||
144741165|NCT00902538|521905879|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
144741166|NCT00902538|521905880|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
144741167|NCT00902538|521905881|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
144741168|NCT00902538|521905876|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
144741169|NCT00902538|521905877|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
144741170|NCT00902538|521905878|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
144741171|NCT00902538|521905879|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
144741172|NCT00902538|521905880|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
144741173|NCT00902538|521905881|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
144741174|NCT00902538|521905876|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
144741175|NCT00902538|521905877|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
144741176|NCT00902538|521905878|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
144741177|NCT00902538|521905879|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
144218939|NCT02854527|519994551|FG009|Overall Study|Adverse Event|0|||
144218940|NCT02854527|519994542|FG000|Overall Study|Lost to Follow-up|0|||
144218941|NCT02854527|519994543|FG001|Overall Study|Lost to Follow-up|0|||
144687249|NCT01693562|521704748|FG007|Expansion Phase|Lost to Follow-up|1|||
144687250|NCT01693562|521704749|FG008|Expansion Phase|Lost to Follow-up|2|||
144687251|NCT01693562|521704750|FG009|Expansion Phase|Lost to Follow-up|10|||
144687252|NCT01693562|521704751|FG010|Expansion Phase|Lost to Follow-up|4|||
144687253|NCT01693562|521704752|FG011|Expansion Phase|Lost to Follow-up|4|||
144687254|NCT01693562|521704753|FG012|Expansion Phase|Lost to Follow-up|1|||
144687255|NCT01693562|521704754|FG013|Expansion Phase|Lost to Follow-up|3|||
144687256|NCT01693562|521704755|FG014|Expansion Phase|Lost to Follow-up|0|||
144687257|NCT01693562|521704756|FG015|Expansion Phase|Lost to Follow-up|1|||
144687258|NCT01693562|521704757|FG016|Expansion Phase|Lost to Follow-up|1|||
144687259|NCT01693562|521704758|FG017|Expansion Phase|Lost to Follow-up|0|||
144687260|NCT01693562|521704759|FG018|Expansion Phase|Lost to Follow-up|2|||
144687261|NCT01693562|521704760|FG019|Expansion Phase|Lost to Follow-up|1|||
144687262|NCT01693562|521704761|FG020|Expansion Phase|Lost to Follow-up|2|||
144687263|NCT01693562|521704762|FG021|Expansion Phase|Lost to Follow-up|2|||
144687264|NCT01693562|521704763|FG022|Expansion Phase|Lost to Follow-up|1|||
144687265|NCT01693562|521704741|FG000|Expansion Phase|Other|0|||
144687266|NCT01693562|521704742|FG001|Expansion Phase|Other|0|||
144687267|NCT01693562|521704743|FG002|Expansion Phase|Other|0|||
144687268|NCT01693562|521704744|FG003|Expansion Phase|Other|0|||
144687269|NCT01693562|521704745|FG004|Expansion Phase|Other|0|||
144687270|NCT01693562|521704746|FG005|Expansion Phase|Other|0|||
144687271|NCT01693562|521704747|FG006|Expansion Phase|Other|0|||
144687272|NCT01693562|521704748|FG007|Expansion Phase|Other|3|||
144687273|NCT01693562|521704749|FG008|Expansion Phase|Other|1|||
144687274|NCT01693562|521704750|FG009|Expansion Phase|Other|28|||
144687275|NCT01693562|521704751|FG010|Expansion Phase|Other|4|||
144687276|NCT01693562|521704752|FG011|Expansion Phase|Other|7|||
144687277|NCT01693562|521704753|FG012|Expansion Phase|Other|0|||
144687278|NCT01693562|521704754|FG013|Expansion Phase|Other|1|||
144687279|NCT01693562|521704755|FG014|Expansion Phase|Other|1|||
144687280|NCT01693562|521704756|FG015|Expansion Phase|Other|0|||
144687281|NCT01693562|521704757|FG016|Expansion Phase|Other|28|||
144687282|NCT01693562|521704758|FG017|Expansion Phase|Other|0|||
144687283|NCT01693562|521704759|FG018|Expansion Phase|Other|1|||
144687284|NCT01693562|521704760|FG019|Expansion Phase|Other|0|||
144687285|NCT01693562|521704761|FG020|Expansion Phase|Other|1|||
144687286|NCT01693562|521704762|FG021|Expansion Phase|Other|17|||
144687287|NCT01693562|521704763|FG022|Expansion Phase|Other|1|||
144687288|NCT04097925|521704764|FG000|Overall Study|Withdrawal by Subject|1|||
144687289|NCT04657003|521704766|FG000|Overall Study|Adverse Event|5|||
144687290|NCT04657003|521704767|FG001|Overall Study|Adverse Event|1|||
144687291|NCT04657003|521704768|FG002|Overall Study|Adverse Event|5|||
144687292|NCT04657003|521704766|FG000|Overall Study|Death|0|||
144687293|NCT04657003|521704767|FG001|Overall Study|Death|2|||
144687294|NCT04657003|521704768|FG002|Overall Study|Death|0|||
144741178|NCT00902538|521905880|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
144741179|NCT00902538|521905881|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
144687295|NCT04657003|521704766|FG000|Overall Study|Lost to Follow-up|8|||
144687296|NCT04657003|521704767|FG001|Overall Study|Lost to Follow-up|4|||
144687297|NCT04657003|521704768|FG002|Overall Study|Lost to Follow-up|10|||
144687298|NCT04657003|521704766|FG000|Overall Study|Other - As Reported by Investigator|3|||
144687299|NCT04657003|521704767|FG001|Overall Study|Other - As Reported by Investigator|2|||
144687300|NCT04657003|521704768|FG002|Overall Study|Other - As Reported by Investigator|2|||
144687301|NCT04657003|521704766|FG000|Overall Study|Pregnancy|2|||
144687302|NCT04657003|521704767|FG001|Overall Study|Pregnancy|0|||
144687303|NCT04657003|521704768|FG002|Overall Study|Pregnancy|2|||
144687304|NCT04657003|521704766|FG000|Overall Study|Withdrawal by Subject|16|||
144687305|NCT04657003|521704767|FG001|Overall Study|Withdrawal by Subject|7|||
144218942|NCT02854527|519994544|FG002|Overall Study|Lost to Follow-up|0|||
144687306|NCT04657003|521704768|FG002|Overall Study|Withdrawal by Subject|10|||
144687307|NCT01823991|521704771|FG000|Overall Study|Withdrawal by Subject|8|||
144741180|NCT00902538|521905876|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
144687308|NCT01823991|521704772|FG001|Overall Study|Withdrawal by Subject|5|||
144687309|NCT00768040|521704773|FG000|Overall Study|Adverse Event|3|||
144687310|NCT00768040|521704774|FG001|Overall Study|Adverse Event|2|||
144687311|NCT00768040|521704773|FG000|Overall Study|Abnormal laboratory value|1|||
144687312|NCT00768040|521704774|FG001|Overall Study|Abnormal laboratory value|1|||
144687313|NCT02185040|521704778|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
144687314|NCT02185040|521704779|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
144687315|NCT02185040|521704780|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
144687316|NCT02185040|521704781|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
144687317|NCT02185040|521704782|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
144687318|NCT02185040|521704783|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
144687319|NCT02185040|521704784|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
144687320|NCT02185040|521704778|FG000|Part 1 Treatment Phase|Adverse Event|1|||
144687321|NCT02185040|521704779|FG001|Part 1 Treatment Phase|Adverse Event|0|||
144687322|NCT02185040|521704780|FG002|Part 1 Treatment Phase|Adverse Event|0|||
144687323|NCT02185040|521704781|FG003|Part 1 Treatment Phase|Adverse Event|2|||
144687324|NCT02185040|521704782|FG004|Part 1 Treatment Phase|Adverse Event|3|||
144687325|NCT02185040|521704783|FG005|Part 1 Treatment Phase|Adverse Event|0|||
144687326|NCT02185040|521704784|FG006|Part 1 Treatment Phase|Adverse Event|0|||
144687327|NCT02185040|521704778|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
144687328|NCT02185040|521704779|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
144687329|NCT02185040|521704780|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
144687330|NCT02185040|521704781|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
144687331|NCT02185040|521704782|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
144687332|NCT02185040|521704783|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
144687333|NCT02185040|521704784|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
144687334|NCT02185040|521704778|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
144687335|NCT02185040|521704779|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
144687336|NCT02185040|521704780|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
144687337|NCT02185040|521704781|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
144687338|NCT02185040|521704782|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
144687339|NCT02185040|521704783|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
144687340|NCT02185040|521704784|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
144687341|NCT02185040|521704778|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
144687342|NCT02185040|521704779|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
144687343|NCT02185040|521704780|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
144687344|NCT02185040|521704781|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
144687345|NCT02185040|521704782|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
144687346|NCT02185040|521704783|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
144687347|NCT02185040|521704784|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
144687348|NCT02185040|521704778|FG000|Active Treatment Extension Phase|Adverse Event|0|||
144687349|NCT02185040|521704779|FG001|Active Treatment Extension Phase|Adverse Event|0|||
144687350|NCT02185040|521704780|FG002|Active Treatment Extension Phase|Adverse Event|0|||
144687351|NCT02185040|521704781|FG003|Active Treatment Extension Phase|Adverse Event|0|||
144687352|NCT02185040|521704782|FG004|Active Treatment Extension Phase|Adverse Event|0|||
144687353|NCT02185040|521704783|FG005|Active Treatment Extension Phase|Adverse Event|1|||
144687354|NCT02185040|521704784|FG006|Active Treatment Extension Phase|Adverse Event|4|||
144687355|NCT02185040|521704778|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
144687356|NCT02185040|521704779|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
144687357|NCT02185040|521704780|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
144687358|NCT02185040|521704781|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
144687359|NCT02185040|521704782|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
144687360|NCT02185040|521704783|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
144687361|NCT02185040|521704784|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
144687362|NCT02185040|521704778|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
144687363|NCT02185040|521704779|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
144687364|NCT02185040|521704780|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
144218943|NCT02854527|519994545|FG003|Overall Study|Lost to Follow-up|1|||
144218944|NCT02854527|519994546|FG004|Overall Study|Lost to Follow-up|0|||
144687365|NCT02185040|521704781|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
144687366|NCT02185040|521704782|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
144687367|NCT02185040|521704783|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
144687368|NCT02185040|521704784|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
144687369|NCT03347279|521704785|FG000|Overall Study|Withdrawal by Subject|8|||
144687370|NCT03347279|521704786|FG001|Overall Study|Withdrawal by Subject|15|||
144687371|NCT03347279|521704785|FG000|Overall Study|Death|0|||
144687372|NCT03347279|521704786|FG001|Overall Study|Death|2|||
144687373|NCT03347279|521704785|FG000|Overall Study|Lost to Follow-up|5|||
144687374|NCT03347279|521704786|FG001|Overall Study|Lost to Follow-up|2|||
144687375|NCT03347279|521704785|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
144218945|NCT02854527|519994547|FG005|Overall Study|Lost to Follow-up|0|||
144687376|NCT03347279|521704786|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
144687377|NCT02987205|521704790|FG000|Overall Study|Adverse Event|1|||
144687378|NCT02987205|521704790|FG000|Overall Study|Withdrawal by Subject|3|||
144687379|NCT03558503|521704791|FG000|Overall Study|Adverse Event|1|||
144687380|NCT03558503|521704791|FG000|Overall Study|Death|1|||
144687381|NCT03558503|521704791|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
144687382|NCT02773849|521704793|FG000|Overall Study|Lost to Follow-up|11|||
144687383|NCT02773849|521704793|FG000|Overall Study|Death|26|||
144687384|NCT02773849|521704793|FG000|Overall Study|Withdrawal by Subject|5|||
144687385|NCT02773849|521704793|FG000|Overall Study|Withdrawal of Consent|9|||
144687386|NCT02773849|521704793|FG000|Overall Study|Other: not due to lack of tolerability|11|||
144687387|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
144687388|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
144687389|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
144687390|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
144687391|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Death|38|||
144687392|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Death|10|||
144687393|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
144687394|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
144687395|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
144687396|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
144687397|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
144687398|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
144687399|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
144687400|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
144687401|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
144687402|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
144687403|NCT02421939|521704806|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
144687404|NCT02421939|521704807|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
144687405|NCT02421939|521704806|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
144687406|NCT02421939|521704807|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
144687407|NCT02421939|521704806|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
144687408|NCT02421939|521704807|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
144687409|NCT02421939|521704806|FG000|Long Term Follow up: up to 3 Years|Death|118|||
144687410|NCT02421939|521704807|FG001|Long Term Follow up: up to 3 Years|Death|65|||
144687411|NCT02421939|521704806|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
144687412|NCT02421939|521704807|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
144687413|NCT01685372|521704808|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
144687414|NCT01685372|521704809|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
144687415|NCT00103207|521704810|FG000|Overall Study|Adverse Event|3|||
144687416|NCT00103207|521704810|FG000|Overall Study|Death|1|||
144687417|NCT00103207|521704810|FG000|Overall Study|Withdrawal by Subject|2|||
144687418|NCT00103207|521704810|FG000|Overall Study|Other complicating disease|1|||
144687419|NCT00103207|521704810|FG000|Overall Study|Ineligible|4|||
144687420|NCT00103207|521704810|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
144687421|NCT00129376|521704811|FG000|Overall Study|Adverse Event|1|||
144687422|NCT00129376|521704811|FG000|Overall Study|Lack of Efficacy|1|||
144687423|NCT02061540|521704812|FG000|Overall Study|Adverse Event|2|||
144687424|NCT02061540|521704812|FG000|Overall Study|Withdrawal by Subject|2|||
144687425|NCT02718625|521704820|FG000|Overall Study|Adverse Event|0|||
144687426|NCT02718625|521704821|FG001|Overall Study|Adverse Event|1|||
144687427|NCT02718625|521704820|FG000|Overall Study|Termination of Study by Sponsor|0|||
144687428|NCT02718625|521704821|FG001|Overall Study|Termination of Study by Sponsor|1|||
144687429|NCT00811395|521704822|FG000|Extension Treatment|Adverse Event|1|||
144687430|NCT00811395|521704823|FG001|Extension Treatment|Adverse Event|2|||
144687431|NCT00811395|521704824|FG002|Extension Treatment|Adverse Event|2|||
144687432|NCT00811395|521704825|FG003|Extension Treatment|Adverse Event|2|||
144687433|NCT00811395|521704826|FG004|Extension Treatment|Adverse Event|0|||
144687434|NCT00811395|521704827|FG005|Extension Treatment|Adverse Event|1|||
144687435|NCT00811395|521704822|FG000|Extension Treatment|Progressive disease|1|||
144687436|NCT00811395|521704823|FG001|Extension Treatment|Progressive disease|1|||
144687437|NCT00811395|521704824|FG002|Extension Treatment|Progressive disease|0|||
144687438|NCT00811395|521704825|FG003|Extension Treatment|Progressive disease|0|||
144687439|NCT00811395|521704826|FG004|Extension Treatment|Progressive disease|0|||
144687440|NCT00811395|521704827|FG005|Extension Treatment|Progressive disease|0|||
144687441|NCT00811395|521704822|FG000|Extension Treatment|Participant did not wish to continue|0|||
144687442|NCT00811395|521704823|FG001|Extension Treatment|Participant did not wish to continue|3|||
144687443|NCT00811395|521704824|FG002|Extension Treatment|Participant did not wish to continue|0|||
144741181|NCT00902538|521905877|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
144687444|NCT00811395|521704825|FG003|Extension Treatment|Participant did not wish to continue|1|||
144741182|NCT00902538|521905878|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
144218946|NCT02854527|519994548|FG006|Overall Study|Lost to Follow-up|0|||
144218947|NCT02854527|519994549|FG007|Overall Study|Lost to Follow-up|0|||
144218948|NCT02854527|519994550|FG008|Overall Study|Lost to Follow-up|0|||
144218949|NCT02854527|519994551|FG009|Overall Study|Lost to Follow-up|0|||
144218950|NCT01682811|519994554|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
144218951|NCT01682811|519994555|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
144218952|NCT01682811|519994556|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
144218953|NCT01682811|519994557|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
144687445|NCT00811395|521704826|FG004|Extension Treatment|Participant did not wish to continue|0|||
144687446|NCT00811395|521704827|FG005|Extension Treatment|Participant did not wish to continue|1|||
144687447|NCT00811395|521704822|FG000|Extension Treatment|Other than above|0|||
144687448|NCT00811395|521704823|FG001|Extension Treatment|Other than above|0|||
144687449|NCT00811395|521704824|FG002|Extension Treatment|Other than above|1|||
144687450|NCT00811395|521704825|FG003|Extension Treatment|Other than above|0|||
144687451|NCT00811395|521704826|FG004|Extension Treatment|Other than above|0|||
144687452|NCT00811395|521704827|FG005|Extension Treatment|Other than above|0|||
144687453|NCT01562327|521704832|FG000|Overall Study|Adverse Event|2|||
144687454|NCT01562327|521704832|FG000|Overall Study|Lack of Efficacy|1|||
144687455|NCT01562327|521704832|FG000|Overall Study|Participant drop-out|1|||
144687456|NCT01562327|521704832|FG000|Overall Study|Infusion not received at 6 month window|4|||
144687457|NCT01947127|521704833|FG000|Overall Study|Protocol Violation|18|||
144687458|NCT01947127|521704834|FG001|Overall Study|Protocol Violation|38|||
144687459|NCT01947127|521704833|FG000|Overall Study|Withdrawal by Subject|1|||
144687460|NCT01947127|521704834|FG001|Overall Study|Withdrawal by Subject|1|||
144687461|NCT01947127|521704833|FG000|Overall Study|Data loss|4|||
144687462|NCT01947127|521704834|FG001|Overall Study|Data loss|4|||
144687463|NCT00170846|521704835|FG000|Overall Study|Subject withdrew Informed Consent|5|||
144687464|NCT00170846|521704836|FG001|Overall Study|Subject withdrew Informed Consent|12|||
144687465|NCT00170846|521704837|FG002|Overall Study|Subject withdrew Informed Consent|8|||
144687466|NCT00170846|521704835|FG000|Overall Study|Lost to Follow-up|6|||
144687467|NCT00170846|521704836|FG001|Overall Study|Lost to Follow-up|3|||
144687468|NCT00170846|521704837|FG002|Overall Study|Lost to Follow-up|2|||
144687469|NCT00170846|521704835|FG000|Overall Study|Death|0|||
144687470|NCT00170846|521704836|FG001|Overall Study|Death|3|||
144687471|NCT00170846|521704837|FG002|Overall Study|Death|3|||
144687472|NCT00170846|521704835|FG000|Overall Study|Reason Missing|0|||
144687473|NCT00170846|521704836|FG001|Overall Study|Reason Missing|1|||
144687474|NCT00170846|521704837|FG002|Overall Study|Reason Missing|0|||
144687475|NCT00528840|521704840|FG000|Overall Study|Lost to Follow-up|10|||
144687476|NCT00528840|521704840|FG000|Overall Study|Adverse Event|1|||
144687477|NCT00528840|521704840|FG000|Overall Study|Withdrawal by Subject|17|||
144687478|NCT00528840|521704840|FG000|Overall Study|Death|2|||
144687479|NCT00528840|521704840|FG000|Overall Study|Administrative Reasons|1|||
144687480|NCT00528840|521704840|FG000|Overall Study|Other|2|||
144687481|NCT01603628|521704847|FG000|Overall Study|Personal Reasons|1|||
144687482|NCT01603628|521704848|FG001|Overall Study|Personal Reasons|1|||
144687483|NCT01603628|521704849|FG002|Overall Study|Personal Reasons|2|||
144687484|NCT01603628|521704847|FG000|Overall Study|Protocol Violation|1|||
144687485|NCT01603628|521704848|FG001|Overall Study|Protocol Violation|1|||
144687486|NCT01603628|521704849|FG002|Overall Study|Protocol Violation|0|||
144687487|NCT01603628|521704847|FG000|Overall Study|Lost to Follow-up|0|||
144687488|NCT01603628|521704848|FG001|Overall Study|Lost to Follow-up|1|||
144687489|NCT01603628|521704849|FG002|Overall Study|Lost to Follow-up|0|||
144687490|NCT01603628|521704847|FG000|Overall Study|Other Miscellaneous Reason|1|||
144687491|NCT01603628|521704848|FG001|Overall Study|Other Miscellaneous Reason|0|||
144687492|NCT01603628|521704849|FG002|Overall Study|Other Miscellaneous Reason|0|||
144687493|NCT02795182|521704854|FG000|Overall Study|Death|5|||
144687494|NCT02795182|521704855|FG001|Overall Study|Death|4|||
144687495|NCT02795182|521704856|FG002|Overall Study|Death|4|||
144218954|NCT01682811|519994558|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
144687496|NCT02795182|521704857|FG003|Overall Study|Death|18|||
144687497|NCT02795182|521704854|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
144687498|NCT02795182|521704855|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
144687499|NCT02795182|521704856|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
144687500|NCT02795182|521704857|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
144687501|NCT02795182|521704854|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
144687502|NCT02795182|521704855|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
144687503|NCT02795182|521704856|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
144687504|NCT02795182|521704857|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
144687505|NCT02795182|521704854|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
144687506|NCT02795182|521704855|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
144687507|NCT02795182|521704856|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
144218955|NCT01682811|519994559|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
144218956|NCT01682811|519994560|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
144687508|NCT02795182|521704857|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
144687509|NCT02795182|521704854|FG000|Overall Study|Withdrawal by Subject|4|||
144687510|NCT02795182|521704855|FG001|Overall Study|Withdrawal by Subject|0|||
144687511|NCT02795182|521704856|FG002|Overall Study|Withdrawal by Subject|0|||
144687512|NCT02795182|521704857|FG003|Overall Study|Withdrawal by Subject|3|||
144687513|NCT02795182|521704854|FG000|Overall Study|Lost to Follow-up|0|||
144687514|NCT02795182|521704855|FG001|Overall Study|Lost to Follow-up|0|||
144687515|NCT02795182|521704856|FG002|Overall Study|Lost to Follow-up|1|||
144687516|NCT02795182|521704857|FG003|Overall Study|Lost to Follow-up|1|||
144687517|NCT02795182|521704854|FG000|Overall Study|Roll Over to Long Term Extension|3|||
144687518|NCT02795182|521704855|FG001|Overall Study|Roll Over to Long Term Extension|3|||
144687519|NCT02795182|521704856|FG002|Overall Study|Roll Over to Long Term Extension|2|||
144687520|NCT02795182|521704857|FG003|Overall Study|Roll Over to Long Term Extension|5|||
144687521|NCT02795182|521704854|FG000|Overall Study|Progressive Disease|0|||
144687522|NCT02795182|521704855|FG001|Overall Study|Progressive Disease|1|||
144687523|NCT02795182|521704856|FG002|Overall Study|Progressive Disease|0|||
144687524|NCT02795182|521704857|FG003|Overall Study|Progressive Disease|4|||
144687525|NCT02795182|521704854|FG000|Overall Study|Physician Decision|0|||
144687526|NCT02795182|521704855|FG001|Overall Study|Physician Decision|0|||
144687527|NCT02795182|521704856|FG002|Overall Study|Physician Decision|0|||
144687528|NCT02795182|521704857|FG003|Overall Study|Physician Decision|1|||
144687529|NCT00398086|521704860|FG000|Overall Study|Unacceptable Toxicity|2|||
144687530|NCT00398086|521704861|FG001|Overall Study|Unacceptable Toxicity|8|||
144687531|NCT00398086|521704862|FG002|Overall Study|Unacceptable Toxicity|2|||
144687532|NCT00398086|521704860|FG000|Overall Study|Adverse Event|1|||
144687533|NCT00398086|521704861|FG001|Overall Study|Adverse Event|4|||
144687534|NCT00398086|521704862|FG002|Overall Study|Adverse Event|0|||
144687535|NCT00398086|521704860|FG000|Overall Study|Physician Decision|1|||
144687536|NCT00398086|521704861|FG001|Overall Study|Physician Decision|4|||
144687537|NCT00398086|521704862|FG002|Overall Study|Physician Decision|0|||
144687538|NCT00398086|521704860|FG000|Overall Study|Withdrawal by Subject|5|||
144687539|NCT00398086|521704861|FG001|Overall Study|Withdrawal by Subject|7|||
144687540|NCT00398086|521704862|FG002|Overall Study|Withdrawal by Subject|0|||
144687541|NCT00696774|521704863|FG000|Period II|Adverse Event|0|||
144687542|NCT00696774|521704864|FG001|Period II|Adverse Event|0|||
144687543|NCT00696774|521704865|FG002|Period II|Adverse Event|15|||
144687544|NCT00696774|521704863|FG000|Period II|Lost to Follow-up|0|||
144687545|NCT00696774|521704864|FG001|Period II|Lost to Follow-up|0|||
144687546|NCT00696774|521704865|FG002|Period II|Lost to Follow-up|4|||
144687547|NCT00696774|521704863|FG000|Period II|Protocol Violation|0|||
144687548|NCT00696774|521704864|FG001|Period II|Protocol Violation|0|||
144687549|NCT00696774|521704865|FG002|Period II|Protocol Violation|11|||
144687550|NCT00696774|521704863|FG000|Period II|Withdrawal by Subject|0|||
144687551|NCT00696774|521704864|FG001|Period II|Withdrawal by Subject|0|||
144687552|NCT00696774|521704865|FG002|Period II|Withdrawal by Subject|4|||
144687553|NCT00696774|521704863|FG000|Period II|Sponsor Decision|0|||
144687554|NCT00696774|521704864|FG001|Period II|Sponsor Decision|0|||
144687555|NCT00696774|521704865|FG002|Period II|Sponsor Decision|0|||
144687556|NCT00696774|521704863|FG000|Period II|Lack of Efficacy|0|||
144687557|NCT00696774|521704864|FG001|Period II|Lack of Efficacy|0|||
144687558|NCT00696774|521704865|FG002|Period II|Lack of Efficacy|2|||
144687559|NCT00696774|521704863|FG000|Period III|Adverse Event|1|||
144687560|NCT00696774|521704864|FG001|Period III|Adverse Event|1|||
144687561|NCT00696774|521704865|FG002|Period III|Adverse Event|0|||
144687562|NCT00696774|521704863|FG000|Period III|Lost to Follow-up|2|||
144687563|NCT00696774|521704864|FG001|Period III|Lost to Follow-up|1|||
144687564|NCT00696774|521704865|FG002|Period III|Lost to Follow-up|0|||
144687565|NCT00696774|521704863|FG000|Period III|Protocol Violation|1|||
144687566|NCT00696774|521704864|FG001|Period III|Protocol Violation|1|||
144687567|NCT00696774|521704865|FG002|Period III|Protocol Violation|0|||
144687568|NCT00696774|521704863|FG000|Period III|Withdrawal by Subject|1|||
144687569|NCT00696774|521704864|FG001|Period III|Withdrawal by Subject|2|||
144687570|NCT00696774|521704865|FG002|Period III|Withdrawal by Subject|0|||
144687571|NCT00696774|521704863|FG000|Period III|Sponsor Decision|2|||
144687572|NCT00696774|521704864|FG001|Period III|Sponsor Decision|0|||
144687573|NCT00696774|521704865|FG002|Period III|Sponsor Decision|0|||
144687574|NCT00696774|521704863|FG000|Period III|Lack of Efficacy|0|||
144687575|NCT00696774|521704864|FG001|Period III|Lack of Efficacy|2|||
144687576|NCT00696774|521704865|FG002|Period III|Lack of Efficacy|0|||
144687577|NCT02087241|521704866|FG000|Overall Study|Death|2|||
144687578|NCT02087241|521704867|FG001|Overall Study|Death|1|||
144687579|NCT02087241|521704868|FG002|Overall Study|Death|1|||
144687580|NCT02087241|521704869|FG003|Overall Study|Death|1|||
144687581|NCT02087241|521704866|FG000|Overall Study|Withdrawal by Subject|1|||
144687582|NCT02087241|521704867|FG001|Overall Study|Withdrawal by Subject|0|||
144687583|NCT02087241|521704868|FG002|Overall Study|Withdrawal by Subject|0|||
144687584|NCT02087241|521704869|FG003|Overall Study|Withdrawal by Subject|1|||
144218957|NCT01682811|519994554|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
144687585|NCT02087241|521704866|FG000|Overall Study|Progressive Disease|0|||
144687586|NCT02087241|521704867|FG001|Overall Study|Progressive Disease|0|||
144687587|NCT02087241|521704868|FG002|Overall Study|Progressive Disease|0|||
144687588|NCT02087241|521704869|FG003|Overall Study|Progressive Disease|1|||
144687589|NCT02087241|521704866|FG000|Overall Study|Study Terminated by Sponsor|0|||
144687590|NCT02087241|521704867|FG001|Overall Study|Study Terminated by Sponsor|2|||
144687591|NCT02087241|521704868|FG002|Overall Study|Study Terminated by Sponsor|0|||
144687592|NCT02087241|521704869|FG003|Overall Study|Study Terminated by Sponsor|4|||
144687593|NCT02181504|521704870|FG000|Overall Study|Adverse Event|1|||
144687594|NCT02181504|521704871|FG001|Overall Study|Adverse Event|1|||
144687595|NCT02181504|521704872|FG002|Overall Study|Adverse Event|1|||
144687596|NCT00998985|521704881|FG000|Overall Study|Withdrawal by Subject|0|||
144687597|NCT00998985|521704882|FG001|Overall Study|Withdrawal by Subject|0|||
144687598|NCT00998985|521704883|FG002|Overall Study|Withdrawal by Subject|0|||
144687599|NCT00998985|521704884|FG003|Overall Study|Withdrawal by Subject|0|||
144687600|NCT00998985|521704885|FG004|Overall Study|Withdrawal by Subject|0|||
144687601|NCT00998985|521704886|FG005|Overall Study|Withdrawal by Subject|0|||
144687602|NCT00998985|521704887|FG006|Overall Study|Withdrawal by Subject|0|||
144687603|NCT00998985|521704888|FG007|Overall Study|Withdrawal by Subject|0|||
144687604|NCT00998985|521704889|FG008|Overall Study|Withdrawal by Subject|1|||
144687605|NCT00998985|521704890|FG009|Overall Study|Withdrawal by Subject|0|||
144687606|NCT00998985|521704891|FG010|Overall Study|Withdrawal by Subject|0|||
144687607|NCT00998985|521704892|FG011|Overall Study|Withdrawal by Subject|0|||
144687608|NCT00998985|521704893|FG012|Overall Study|Withdrawal by Subject|0|||
144687609|NCT00998985|521704894|FG013|Overall Study|Withdrawal by Subject|0|||
144687610|NCT00998985|521704881|FG000|Overall Study|Protocol Violation|0|||
144687611|NCT00998985|521704882|FG001|Overall Study|Protocol Violation|0|||
144687612|NCT00998985|521704883|FG002|Overall Study|Protocol Violation|0|||
144687613|NCT00998985|521704884|FG003|Overall Study|Protocol Violation|0|||
144687614|NCT00998985|521704885|FG004|Overall Study|Protocol Violation|0|||
144687615|NCT00998985|521704886|FG005|Overall Study|Protocol Violation|1|||
144687616|NCT00998985|521704887|FG006|Overall Study|Protocol Violation|0|||
144687617|NCT00998985|521704888|FG007|Overall Study|Protocol Violation|0|||
144687618|NCT00998985|521704889|FG008|Overall Study|Protocol Violation|0|||
144687619|NCT00998985|521704890|FG009|Overall Study|Protocol Violation|0|||
144687620|NCT00998985|521704891|FG010|Overall Study|Protocol Violation|0|||
144687621|NCT00998985|521704892|FG011|Overall Study|Protocol Violation|0|||
144687622|NCT00998985|521704893|FG012|Overall Study|Protocol Violation|0|||
144687623|NCT00998985|521704894|FG013|Overall Study|Protocol Violation|0|||
144687624|NCT01040728|521704896|FG000|Overall Study|Adverse Event|4|||
144687625|NCT01040728|521704897|FG001|Overall Study|Adverse Event|8|||
144687626|NCT01040728|521704898|FG002|Overall Study|Adverse Event|0|||
144687627|NCT01040728|521704899|FG003|Overall Study|Adverse Event|4|||
144687628|NCT01040728|521704896|FG000|Overall Study|Withdrawal by Subject|0|||
144687629|NCT01040728|521704897|FG001|Overall Study|Withdrawal by Subject|1|||
144687630|NCT01040728|521704898|FG002|Overall Study|Withdrawal by Subject|1|||
144687631|NCT01040728|521704899|FG003|Overall Study|Withdrawal by Subject|0|||
144687632|NCT01040728|521704896|FG000|Overall Study|Protocol Violation|0|||
144687633|NCT01040728|521704897|FG001|Overall Study|Protocol Violation|0|||
144687634|NCT01040728|521704898|FG002|Overall Study|Protocol Violation|0|||
144687635|NCT01040728|521704899|FG003|Overall Study|Protocol Violation|1|||
144687636|NCT01040728|521704896|FG000|Overall Study|Lack of Efficacy|0|||
144687637|NCT01040728|521704897|FG001|Overall Study|Lack of Efficacy|1|||
144687638|NCT01040728|521704898|FG002|Overall Study|Lack of Efficacy|0|||
144687639|NCT01040728|521704899|FG003|Overall Study|Lack of Efficacy|1|||
144687640|NCT01040728|521704896|FG000|Overall Study|Other reasons not listed above|0|||
144687641|NCT01040728|521704897|FG001|Overall Study|Other reasons not listed above|1|||
144687642|NCT01040728|521704898|FG002|Overall Study|Other reasons not listed above|0|||
144687643|NCT01040728|521704899|FG003|Overall Study|Other reasons not listed above|0|||
144687644|NCT01012037|521704902|FG000|Overall Study|Adverse Event|0|||
144687645|NCT01012037|521704903|FG001|Overall Study|Adverse Event|8|||
144687646|NCT01012037|521704904|FG002|Overall Study|Adverse Event|3|||
144687647|NCT01012037|521704902|FG000|Overall Study|Protocol Violation|0|||
144687648|NCT01012037|521704903|FG001|Overall Study|Protocol Violation|3|||
144687649|NCT01012037|521704904|FG002|Overall Study|Protocol Violation|5|||
144687650|NCT01012037|521704902|FG000|Overall Study|Withdrawal by Subject|0|||
144687651|NCT01012037|521704903|FG001|Overall Study|Withdrawal by Subject|4|||
144687652|NCT01012037|521704904|FG002|Overall Study|Withdrawal by Subject|1|||
144687653|NCT01012037|521704902|FG000|Overall Study|Other reason (not specified)|1|||
144687654|NCT01012037|521704903|FG001|Overall Study|Other reason (not specified)|1|||
144687655|NCT01012037|521704904|FG002|Overall Study|Other reason (not specified)|1|||
144687656|NCT02583711|521704905|FG000|Overall Study|Withdrawal by Subject|0|||
144687657|NCT02583711|521704906|FG001|Overall Study|Withdrawal by Subject|10|||
144687658|NCT02583711|521704907|FG002|Overall Study|Withdrawal by Subject|0|||
144687659|NCT02573012|521704911|FG000|Overall Study|Adverse Event|5|||
144741183|NCT00902538|521905879|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
144741184|NCT00902538|521905880|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
144687660|NCT02573012|521704912|FG001|Overall Study|Adverse Event|5|||
144687661|NCT02573012|521704911|FG000|Overall Study|Lack of Efficacy|5|||
144687662|NCT02573012|521704912|FG001|Overall Study|Lack of Efficacy|4|||
144687663|NCT02573012|521704911|FG000|Overall Study|Non-compliance|1|||
144687664|NCT02573012|521704912|FG001|Overall Study|Non-compliance|2|||
144687665|NCT02573012|521704911|FG000|Overall Study|Withdrawal by Subject|2|||
144687666|NCT02573012|521704912|FG001|Overall Study|Withdrawal by Subject|2|||
144687667|NCT02573012|521704911|FG000|Overall Study|Study Ended per Protocol|1|||
144687668|NCT02573012|521704912|FG001|Overall Study|Study Ended per Protocol|0|||
144687669|NCT02573012|521704911|FG000|Overall Study|Physician Decision|1|||
144687670|NCT02573012|521704912|FG001|Overall Study|Physician Decision|2|||
144687671|NCT00882362|521704913|FG000|Overall Study|Adverse Event|13|||
144687672|NCT00882362|521704914|FG001|Overall Study|Adverse Event|10|||
144687673|NCT00882362|521704913|FG000|Overall Study|Withdrawal by Subject|13|||
144687674|NCT00882362|521704914|FG001|Overall Study|Withdrawal by Subject|10|||
144687675|NCT00882362|521704913|FG000|Overall Study|Lack of Efficacy|3|||
144687676|NCT00882362|521704914|FG001|Overall Study|Lack of Efficacy|0|||
144687677|NCT00882362|521704913|FG000|Overall Study|Protocol Violation|7|||
144687678|NCT00882362|521704914|FG001|Overall Study|Protocol Violation|2|||
144687679|NCT00882362|521704913|FG000|Overall Study|Pregnancy|1|||
144687680|NCT00882362|521704914|FG001|Overall Study|Pregnancy|0|||
144687681|NCT00882362|521704913|FG000|Overall Study|Physician Decision|5|||
144687682|NCT00882362|521704914|FG001|Overall Study|Physician Decision|1|||
144687683|NCT00882362|521704913|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
144687684|NCT00882362|521704914|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
144687685|NCT00882362|521704913|FG000|Overall Study|change of residence or other commitments|5|||
144687686|NCT00882362|521704914|FG001|Overall Study|change of residence or other commitments|0|||
144687687|NCT02096471|521704915|FG000|Overall Study|Adverse Event|1|||
144687688|NCT02096471|521704915|FG000|Overall Study|Lack of Efficacy|7|||
144687689|NCT02096471|521704915|FG000|Overall Study|Withdrawal by Subject|3|||
144687690|NCT02096471|521704915|FG000|Overall Study|Non-Compliant|2|||
144687691|NCT01465958|521706110|FG000|Run-in Phase|Protocol Violation|1|||
144687692|NCT01465958|521706111|FG001|Run-in Phase|Protocol Violation|0|||
144687693|NCT01465958|521706110|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
144687694|NCT01465958|521706111|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
144687695|NCT05158244|521706112|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
144687696|NCT05158244|521706113|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
144687697|NCT05158244|521706114|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
144687698|NCT05158244|521706115|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
144687699|NCT05158244|521706116|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
144687700|NCT05158244|521706112|FG000|Overall Study|Withdrawal by Subject|0|||
144687701|NCT05158244|521706113|FG001|Overall Study|Withdrawal by Subject|0|||
144687702|NCT05158244|521706114|FG002|Overall Study|Withdrawal by Subject|1|||
144687703|NCT05158244|521706115|FG003|Overall Study|Withdrawal by Subject|0|||
144687704|NCT05158244|521706116|FG004|Overall Study|Withdrawal by Subject|0|||
144687705|NCT03818399|521706121|FG000|Overall Study|Lost to Follow-up|11|||
144687706|NCT03818399|521706121|FG000|Overall Study|Withdrawal by Subject|1|||
144687707|NCT03818399|521706121|FG000|Overall Study|Protocol Violation|2|||
144687708|NCT00141297|521706122|FG000|Overall Study|Adverse Event|0|||
144687709|NCT00141297|521706123|FG001|Overall Study|Adverse Event|0|||
144687710|NCT00141297|521706124|FG002|Overall Study|Adverse Event|1|||
144687711|NCT00141297|521706125|FG003|Overall Study|Adverse Event|0|||
144687712|NCT00141297|521706126|FG004|Overall Study|Adverse Event|1|||
144687713|NCT00141297|521706127|FG005|Overall Study|Adverse Event|1|||
144687714|NCT00141297|521706128|FG006|Overall Study|Adverse Event|0|||
144687715|NCT00141297|521706129|FG007|Overall Study|Adverse Event|1|||
144687716|NCT00141297|521706130|FG008|Overall Study|Adverse Event|1|||
144687717|NCT00141297|521706131|FG009|Overall Study|Adverse Event|0|||
144687718|NCT00141297|521706122|FG000|Overall Study|Death|1|||
144687719|NCT00141297|521706123|FG001|Overall Study|Death|0|||
144687720|NCT00141297|521706124|FG002|Overall Study|Death|0|||
144687721|NCT00141297|521706125|FG003|Overall Study|Death|0|||
144687722|NCT00141297|521706126|FG004|Overall Study|Death|0|||
144687723|NCT00141297|521706127|FG005|Overall Study|Death|0|||
144687724|NCT00141297|521706128|FG006|Overall Study|Death|0|||
144687725|NCT00141297|521706129|FG007|Overall Study|Death|0|||
144687726|NCT00141297|521706130|FG008|Overall Study|Death|1|||
144687727|NCT00141297|521706131|FG009|Overall Study|Death|0|||
144687728|NCT00141297|521706122|FG000|Overall Study|Withdrawal by Subject|0|||
144687729|NCT00141297|521706123|FG001|Overall Study|Withdrawal by Subject|0|||
144687730|NCT00141297|521706124|FG002|Overall Study|Withdrawal by Subject|0|||
144687731|NCT00141297|521706125|FG003|Overall Study|Withdrawal by Subject|0|||
144687732|NCT00141297|521706126|FG004|Overall Study|Withdrawal by Subject|0|||
144687733|NCT00141297|521706127|FG005|Overall Study|Withdrawal by Subject|0|||
144687734|NCT00141297|521706128|FG006|Overall Study|Withdrawal by Subject|0|||
144687735|NCT00141297|521706129|FG007|Overall Study|Withdrawal by Subject|0|||
144687736|NCT00141297|521706130|FG008|Overall Study|Withdrawal by Subject|1|||
144687737|NCT00141297|521706131|FG009|Overall Study|Withdrawal by Subject|0|||
144741185|NCT00902538|521905881|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
144741186|NCT00902538|521905876|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
144741187|NCT00902538|521905877|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
144741188|NCT00902538|521905878|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
144741189|NCT00902538|521905879|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
144741190|NCT00902538|521905880|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
144741191|NCT00902538|521905881|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
144741192|NCT00902538|521905876|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
144741193|NCT00902538|521905877|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
144741194|NCT00902538|521905878|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
144741195|NCT00902538|521905879|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
144741196|NCT00902538|521905880|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
144741197|NCT00902538|521905881|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
144741198|NCT00902538|521905876|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
144741199|NCT00902538|521905877|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
144741200|NCT00902538|521905878|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
144741201|NCT00902538|521905879|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
144741202|NCT00902538|521905880|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
144741203|NCT00902538|521905881|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
144741204|NCT00902538|521905876|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
144741205|NCT00902538|521905877|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
144741206|NCT00902538|521905878|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
144741207|NCT00902538|521905879|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
144741208|NCT00902538|521905880|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
144741209|NCT00902538|521905881|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
144741210|NCT00902538|521905876|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
144741211|NCT00902538|521905877|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
144741212|NCT00902538|521905878|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
144741213|NCT00902538|521905879|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
144741214|NCT00902538|521905880|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
144741215|NCT00902538|521905881|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
144741216|NCT00902538|521905876|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
144741217|NCT00902538|521905877|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
144741218|NCT00902538|521905878|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
144741219|NCT00902538|521905879|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
144741220|NCT00902538|521905880|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
144741221|NCT00902538|521905881|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
144741222|NCT00849797|521905882|FG000|First Intervention|bad veins|1|||
144741223|NCT00849797|521905883|FG001|First Intervention|bad veins|0|||
144741224|NCT00849797|521905882|FG000|First Intervention|Adverse Event|0|||
144741225|NCT00849797|521905883|FG001|First Intervention|Adverse Event|1|||
144741226|NCT00849797|521905882|FG000|Washout: One Week|Withdrawal by Subject|0|||
144741227|NCT00849797|521905883|FG001|Washout: One Week|Withdrawal by Subject|2|||
144741228|NCT00679081|521905884|FG000|Overall Study|Lost to Follow-up|1|||
144741229|NCT00725322|521905885|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
144741230|NCT00725322|521905886|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
144741231|NCT00725322|521905885|FG000|Washout (28 Days)|Protocol Violation|0|||
144741232|NCT00725322|521905886|FG001|Washout (28 Days)|Protocol Violation|1|||
144741233|NCT01279486|521905889|FG000|Overall Study|Lost to Follow-up|1|||
144741234|NCT04198363|521905892|FG000|Overall Study|Adverse Event|1|||
144741235|NCT04198363|521905893|FG001|Overall Study|Adverse Event|1|||
144741236|NCT04198363|521905892|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
144741237|NCT04198363|521905893|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
144741238|NCT04198363|521905892|FG000|Overall Study|Reason not Specified|1|||
144741239|NCT04198363|521905893|FG001|Overall Study|Reason not Specified|0|||
144741240|NCT03067987|521905896|FG000|Overall Study|Lost to Follow-up|7|||
144741241|NCT03067987|521905897|FG001|Overall Study|Lost to Follow-up|10|||
144741242|NCT03067987|521905896|FG000|Overall Study|Protocol Violation|1|||
144741243|NCT03067987|521905897|FG001|Overall Study|Protocol Violation|2|||
144741244|NCT03067987|521905896|FG000|Overall Study|Withdrawal by Subject|2|||
144741245|NCT03067987|521905897|FG001|Overall Study|Withdrawal by Subject|1|||
144741246|NCT04827394|521905901|FG000|Overall Study|Physician Decision|0|||
144741247|NCT04827394|521905902|FG001|Overall Study|Physician Decision|2|||
144741248|NCT01404988|521905903|FG000|Overall Study|Death|2|||
144741249|NCT01404988|521905904|FG001|Overall Study|Death|0|||
144741250|NCT01404988|521905905|FG002|Overall Study|Death|2|||
144741251|NCT01404988|521905903|FG000|Overall Study|Adverse Event|1|||
144741252|NCT01404988|521905904|FG001|Overall Study|Adverse Event|0|||
144741253|NCT01404988|521905905|FG002|Overall Study|Adverse Event|0|||
144741254|NCT01404988|521905903|FG000|Overall Study|Withdrawal by Subject|2|||
144741255|NCT01404988|521905904|FG001|Overall Study|Withdrawal by Subject|2|||
144741256|NCT01404988|521905905|FG002|Overall Study|Withdrawal by Subject|0|||
144741257|NCT01404988|521905903|FG000|Overall Study|Lost to Follow-up|1|||
144741258|NCT01404988|521905904|FG001|Overall Study|Lost to Follow-up|2|||
144741259|NCT01404988|521905905|FG002|Overall Study|Lost to Follow-up|1|||
144741260|NCT00829764|521905906|FG000|First Intervention|Adverse Event|1|||
144741261|NCT00829764|521905907|FG001|First Intervention|Adverse Event|0|||
144741262|NCT00829764|521905906|FG000|First Intervention|Withdrawal by Subject|1|||
144741263|NCT00829764|521905907|FG001|First Intervention|Withdrawal by Subject|1|||
144741264|NCT04594252|521905908|FG000|Overall Study|Adverse Event|0|||
144741265|NCT04594252|521905909|FG001|Overall Study|Adverse Event|2|||
144265910|NCT00329108|520176414|FG000|Overall Study|symptomatic deterioration|1|||
144265911|NCT00329108|520176415|FG001|Overall Study|symptomatic deterioration|1|||
144265912|NCT00329108|520176414|FG000|Overall Study|Subject no longer willing to participate|2|||
144265913|NCT00329108|520176415|FG001|Overall Study|Subject no longer willing to participate|2|||
144265914|NCT00329108|520176414|FG000|Overall Study|study terminated by sponsor|1|||
144687738|NCT00141297|521706122|FG000|Overall Study|Other|0|||
144687739|NCT00141297|521706123|FG001|Overall Study|Other|0|||
144741266|NCT00477594|521905910|FG000|Year 1 and Year 2|Adverse Event|4|||
144741267|NCT00477594|521905911|FG001|Year 1 and Year 2|Adverse Event|2|||
144741268|NCT00477594|521905910|FG000|Year 1 and Year 2|Physician Decision|2|||
144741269|NCT00477594|521905911|FG001|Year 1 and Year 2|Physician Decision|1|||
144741270|NCT00477594|521905910|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
144741271|NCT00477594|521905911|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
144741272|NCT00477594|521905910|FG000|Year 1 and Year 2|Other|1|||
144741273|NCT00477594|521905911|FG001|Year 1 and Year 2|Other|0|||
144741274|NCT00477594|521905910|FG000|Year 3|Adverse Event|1|||
144265915|NCT00329108|520176415|FG001|Overall Study|study terminated by sponsor|0|||
144687740|NCT00141297|521706124|FG002|Overall Study|Other|0|||
144687741|NCT00141297|521706125|FG003|Overall Study|Other|1|||
144687742|NCT00141297|521706126|FG004|Overall Study|Other|5|||
144687743|NCT00141297|521706127|FG005|Overall Study|Other|0|||
144687744|NCT00141297|521706128|FG006|Overall Study|Other|0|||
144687745|NCT00141297|521706129|FG007|Overall Study|Other|0|||
144687746|NCT00141297|521706130|FG008|Overall Study|Other|2|||
144687747|NCT00141297|521706131|FG009|Overall Study|Other|0|||
144687748|NCT00141297|521706122|FG000|Overall Study|Progressive Disease|2|||
144687749|NCT00141297|521706123|FG001|Overall Study|Progressive Disease|3|||
144687750|NCT00141297|521706124|FG002|Overall Study|Progressive Disease|6|||
144687751|NCT00141297|521706125|FG003|Overall Study|Progressive Disease|2|||
144687752|NCT00141297|521706126|FG004|Overall Study|Progressive Disease|15|||
144687753|NCT00141297|521706127|FG005|Overall Study|Progressive Disease|2|||
144687754|NCT00141297|521706128|FG006|Overall Study|Progressive Disease|3|||
144687755|NCT00141297|521706129|FG007|Overall Study|Progressive Disease|3|||
144687756|NCT00141297|521706130|FG008|Overall Study|Progressive Disease|15|||
144687757|NCT00141297|521706131|FG009|Overall Study|Progressive Disease|6|||
144687758|NCT00141297|521706122|FG000|Overall Study|Transitioned|0|||
144687759|NCT00141297|521706123|FG001|Overall Study|Transitioned|0|||
144687760|NCT00141297|521706124|FG002|Overall Study|Transitioned|0|||
144687761|NCT00141297|521706125|FG003|Overall Study|Transitioned|0|||
144687762|NCT00141297|521706126|FG004|Overall Study|Transitioned|1|||
144687763|NCT00141297|521706127|FG005|Overall Study|Transitioned|0|||
144687764|NCT00141297|521706128|FG006|Overall Study|Transitioned|0|||
144687765|NCT00141297|521706129|FG007|Overall Study|Transitioned|0|||
144687766|NCT00141297|521706130|FG008|Overall Study|Transitioned|0|||
144687767|NCT00141297|521706131|FG009|Overall Study|Transitioned|0|||
144687768|NCT02561273|521706132|FG000|Overall Study|Protocol Violation|1|||
144687769|NCT02561273|521706133|FG001|Overall Study|Protocol Violation|0|||
144687770|NCT02447952|521706134|FG000|Overall Study|Adverse Event|2|||
144687771|NCT02447952|521706134|FG000|Overall Study|Physician Decision|1|||
144687772|NCT02447952|521706134|FG000|Overall Study|Withdrawal by Subject|4|||
144687773|NCT01969565|521706135|FG000|Overall Study|Withdrawal by Subject|1|||
144687774|NCT01756833|521706140|FG000|Overall Study|Withdrawal by Subject|4|||
144687775|NCT01756833|521706141|FG001|Overall Study|Withdrawal by Subject|3|||
144687776|NCT00461552|521706142|FG000|Overall Study|Drug Dispensing error|0|||
144687777|NCT00461552|521706143|FG001|Overall Study|Drug Dispensing error|2|||
144687778|NCT01289028|521706145|FG000|Overall Study|Progressive Disease|49|||
144687779|NCT01289028|521706145|FG000|Overall Study|Adverse Event|14|||
144741275|NCT00477594|521905911|FG001|Year 3|Adverse Event|0|||
144741276|NCT00477594|521905910|FG000|Year 3|Withdrawal by Subject|1|||
144741277|NCT00477594|521905911|FG001|Year 3|Withdrawal by Subject|0|||
144741278|NCT00477594|521905910|FG000|Follow-up Period|Withdrawal by Subject|2|||
144741279|NCT00477594|521905911|FG001|Follow-up Period|Withdrawal by Subject|1|||
144741280|NCT00477594|521905910|FG000|Follow-up Period|Other|1|||
144741281|NCT00477594|521905911|FG001|Follow-up Period|Other|0|||
144741282|NCT02488109|521908367|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
144741283|NCT02488109|521908368|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
144741284|NCT02488109|521908367|FG000|12-month Follow-Up|Lost to Follow-up|4|||
144741285|NCT02488109|521908368|FG001|12-month Follow-Up|Lost to Follow-up|7|||
144741286|NCT02302716|521908369|FG000|Overall Study|Adverse Event|1|||
144741287|NCT02302716|521908370|FG001|Overall Study|Adverse Event|1|||
144741288|NCT02302716|521908369|FG000|Overall Study|Death|0|||
144741289|NCT02302716|521908370|FG001|Overall Study|Death|1|||
144741290|NCT02302716|521908369|FG000|Overall Study|Lack of Efficacy|0|||
144687780|NCT01289028|521706145|FG000|Overall Study|Withdrawal by Subject|6|||
144741291|NCT02302716|521908370|FG001|Overall Study|Lack of Efficacy|1|||
144741292|NCT02302716|521908369|FG000|Overall Study|Lost to Follow-up|2|||
144741293|NCT02302716|521908370|FG001|Overall Study|Lost to Follow-up|4|||
144741294|NCT02302716|521908369|FG000|Overall Study|Physician Decision|3|||
144741295|NCT02302716|521908370|FG001|Overall Study|Physician Decision|4|||
144741296|NCT02302716|521908369|FG000|Overall Study|Withdrawal by Subject|13|||
144741297|NCT02302716|521908370|FG001|Overall Study|Withdrawal by Subject|7|||
144741298|NCT02302716|521908369|FG000|Overall Study|Protocol Violation|0|||
144741299|NCT02302716|521908370|FG001|Overall Study|Protocol Violation|1|||
144741300|NCT02727192|521908382|FG000|Overall Study|Lost to Follow-up|1|||
144741301|NCT02727192|521908383|FG001|Overall Study|Lost to Follow-up|0|||
144741302|NCT02727192|521908384|FG002|Overall Study|Lost to Follow-up|0|||
144741303|NCT02392195|521908388|FG000|Overall Study|Lost to Follow-up|4|||
144741304|NCT02392195|521908388|FG000|Overall Study|Withdrawal by Subject|4|||
144741305|NCT00545792|521908391|FG000|Overall Study|Withdrawal by Subject|1|||
144741306|NCT05041361|521908392|FG000|Overall Study|Lost to Follow-up|1|||
144687781|NCT01289028|521706145|FG000|Overall Study|Death|4|||
144687782|NCT01289028|521706145|FG000|Overall Study|Lack of Efficacy|2|||
144687783|NCT01289028|521706145|FG000|Overall Study|No longer required|2|||
144687784|NCT01289028|521706145|FG000|Overall Study|Lost to Follow-up|2|||
144687785|NCT01289028|521706145|FG000|Overall Study|New Cancer Therapy|2|||
144687786|NCT01289028|521706145|FG000|Overall Study|Abnormal Lab Value|1|||
144687787|NCT01289028|521706145|FG000|Overall Study|Missing reason for discon|1|||
144687788|NCT03117309|521706146|FG000|Overall Study|Not meeting inclusion criteria|0|||
144687789|NCT03117309|521706147|FG001|Overall Study|Not meeting inclusion criteria|1|||
144687790|NCT02120469|521706150|FG000|Overall Study|HER-2/neu-amplified|1|||
144687791|NCT02120469|521706151|FG001|Overall Study|HER-2/neu-amplified|0|||
144687792|NCT02120469|521706152|FG002|Overall Study|HER-2/neu-amplified|1|||
144687793|NCT00415623|521706153|FG000|Overall Study|Adverse Event|3|||
144687794|NCT00415623|521706154|FG001|Overall Study|Adverse Event|4|||
144687795|NCT00415623|521706153|FG000|Overall Study|Death|1|||
144687796|NCT00415623|521706154|FG001|Overall Study|Death|0|||
144687797|NCT00415623|521706153|FG000|Overall Study|Withdrawal by Subject|1|||
144687798|NCT00415623|521706154|FG001|Overall Study|Withdrawal by Subject|1|||
144687799|NCT01369069|521706155|FG000|Overall Study|Lost to Follow-up|8|||
144687800|NCT01369069|521706156|FG001|Overall Study|Lost to Follow-up|9|||
144687801|NCT01369069|521706155|FG000|Overall Study|Withdrawal by Subject|9|||
144687802|NCT01369069|521706156|FG001|Overall Study|Withdrawal by Subject|7|||
144687803|NCT01809327|521706157|FG000|Overall Study|Lost to Follow-up|5|||
144687804|NCT01809327|521706158|FG001|Overall Study|Lost to Follow-up|2|||
144687805|NCT01809327|521706159|FG002|Overall Study|Lost to Follow-up|4|||
144687806|NCT01809327|521706160|FG003|Overall Study|Lost to Follow-up|2|||
144687807|NCT01809327|521706161|FG004|Overall Study|Lost to Follow-up|3|||
144687808|NCT01809327|521706157|FG000|Overall Study|Withdrawal by Subject|6|||
144687809|NCT01809327|521706158|FG001|Overall Study|Withdrawal by Subject|4|||
144687810|NCT01809327|521706159|FG002|Overall Study|Withdrawal by Subject|4|||
144687811|NCT01809327|521706160|FG003|Overall Study|Withdrawal by Subject|2|||
144687812|NCT01809327|521706161|FG004|Overall Study|Withdrawal by Subject|5|||
144687813|NCT01809327|521706157|FG000|Overall Study|Adverse Event|4|||
144687814|NCT01809327|521706158|FG001|Overall Study|Adverse Event|3|||
144687815|NCT01809327|521706159|FG002|Overall Study|Adverse Event|7|||
144687816|NCT01809327|521706160|FG003|Overall Study|Adverse Event|4|||
144687817|NCT01809327|521706161|FG004|Overall Study|Adverse Event|8|||
144687818|NCT01809327|521706157|FG000|Overall Study|Death|1|||
144687819|NCT01809327|521706158|FG001|Overall Study|Death|0|||
144687820|NCT01809327|521706159|FG002|Overall Study|Death|0|||
144687821|NCT01809327|521706160|FG003|Overall Study|Death|0|||
144687822|NCT01809327|521706161|FG004|Overall Study|Death|0|||
144687823|NCT01809327|521706157|FG000|Overall Study|Protocol Violation|0|||
144741307|NCT05041361|521908393|FG001|Overall Study|Lost to Follow-up|3|||
144741308|NCT01642277|521908394|FG000|Overall Study|Adverse Event|10|||
144741309|NCT01642277|521908395|FG001|Overall Study|Adverse Event|0|||
144741310|NCT01642277|521908394|FG000|Overall Study|Physician Decision|2|||
144741311|NCT01642277|521908395|FG001|Overall Study|Physician Decision|0|||
144741312|NCT01642277|521908394|FG000|Overall Study|Protocol Violation|1|||
144741313|NCT01642277|521908395|FG001|Overall Study|Protocol Violation|0|||
144741314|NCT01642277|521908394|FG000|Overall Study|Withdrawal by Subject|11|||
144741315|NCT01642277|521908395|FG001|Overall Study|Withdrawal by Subject|0|||
144741316|NCT03679598|521908396|FG000|Overall Study|Adverse Event|2|||
144741317|NCT03679598|521908397|FG001|Overall Study|Adverse Event|0|||
144741318|NCT03605342|521908398|FG000|Overall Study|Withdrawal by Subject|9|||
144741319|NCT03605342|521908399|FG001|Overall Study|Withdrawal by Subject|7|||
144741320|NCT03605342|521908398|FG000|Overall Study|Lost to Follow-up|1|||
144741321|NCT03605342|521908399|FG001|Overall Study|Lost to Follow-up|1|||
144687824|NCT01809327|521706158|FG001|Overall Study|Protocol Violation|1|||
144687825|NCT01809327|521706159|FG002|Overall Study|Protocol Violation|0|||
144687826|NCT01809327|521706160|FG003|Overall Study|Protocol Violation|0|||
144687827|NCT01809327|521706161|FG004|Overall Study|Protocol Violation|0|||
144687828|NCT01809327|521706157|FG000|Overall Study|Physician Decision|1|||
144687829|NCT01809327|521706158|FG001|Overall Study|Physician Decision|1|||
144687830|NCT01809327|521706159|FG002|Overall Study|Physician Decision|0|||
144687831|NCT01809327|521706160|FG003|Overall Study|Physician Decision|0|||
144687832|NCT01809327|521706161|FG004|Overall Study|Physician Decision|0|||
144687833|NCT01809327|521706157|FG000|Overall Study|Pregnancy|1|||
144687834|NCT01809327|521706158|FG001|Overall Study|Pregnancy|0|||
144218958|NCT01682811|519994555|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
144218959|NCT01682811|519994556|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
144218960|NCT01682811|519994557|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
144687835|NCT01809327|521706159|FG002|Overall Study|Pregnancy|0|||
144687836|NCT01809327|521706160|FG003|Overall Study|Pregnancy|0|||
144687837|NCT01809327|521706161|FG004|Overall Study|Pregnancy|0|||
144687838|NCT01809327|521706157|FG000|Overall Study|Other|14|||
144687839|NCT01809327|521706158|FG001|Overall Study|Other|15|||
144687840|NCT01809327|521706159|FG002|Overall Study|Other|7|||
144687841|NCT01809327|521706160|FG003|Overall Study|Other|4|||
144687842|NCT01809327|521706161|FG004|Overall Study|Other|9|||
144687843|NCT00805142|521706164|FG000|Titration Period|Adverse Event|3|||
144687844|NCT00805142|521706165|FG001|Titration Period|Adverse Event|3|||
144687845|NCT00805142|521706164|FG000|Titration Period|Lack of Efficacy|1|||
144687846|NCT00805142|521706165|FG001|Titration Period|Lack of Efficacy|1|||
144687847|NCT00805142|521706164|FG000|Titration Period|Lost to Follow-up|0|||
144687848|NCT00805142|521706165|FG001|Titration Period|Lost to Follow-up|1|||
144687849|NCT00805142|521706164|FG000|Titration Period|Disease Progression|2|||
144687850|NCT00805142|521706165|FG001|Titration Period|Disease Progression|1|||
144687851|NCT00805142|521706164|FG000|Titration Period|Withdrawal of consent|0|||
144687852|NCT00805142|521706165|FG001|Titration Period|Withdrawal of consent|1|||
144687853|NCT00805142|521706164|FG000|Titration Period|Other|0|||
144687854|NCT00805142|521706165|FG001|Titration Period|Other|3|||
144687855|NCT00805142|521706164|FG000|Maintenance Period|Adverse Event|0|||
144687856|NCT00805142|521706165|FG001|Maintenance Period|Adverse Event|1|||
144687857|NCT00805142|521706164|FG000|Maintenance Period|Other|0|||
144687858|NCT00805142|521706165|FG001|Maintenance Period|Other|1|||
144687859|NCT02545049|521706168|FG000|Overall Study|Withdrawal by Subject|1|||
144687860|NCT02545049|521706169|FG001|Overall Study|Withdrawal by Subject|7|||
144687861|NCT02545049|521706168|FG000|Overall Study|Lost to Follow-up|4|||
144687862|NCT02545049|521706169|FG001|Overall Study|Lost to Follow-up|6|||
144687863|NCT02545049|521706168|FG000|Overall Study|GCP violations|37|||
144687864|NCT02545049|521706169|FG001|Overall Study|GCP violations|48|||
144687865|NCT02985684|521706170|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
144687866|NCT02985684|521706170|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
144687867|NCT02985684|521706170|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
144687868|NCT00424463|521706172|FG000|Overall Study|Adverse Event|2|||
144687869|NCT00424463|521706173|FG001|Overall Study|Adverse Event|3|||
144687870|NCT00424463|521706174|FG002|Overall Study|Adverse Event|2|||
144687871|NCT00424463|521706172|FG000|Overall Study|Physician Decision|0|||
144687872|NCT00424463|521706173|FG001|Overall Study|Physician Decision|2|||
144687873|NCT00424463|521706174|FG002|Overall Study|Physician Decision|2|||
144687874|NCT00424463|521706172|FG000|Overall Study|Withdrawal by Subject|4|||
144687875|NCT00424463|521706173|FG001|Overall Study|Withdrawal by Subject|2|||
144687876|NCT00424463|521706174|FG002|Overall Study|Withdrawal by Subject|5|||
144687877|NCT00424463|521706172|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
144687878|NCT00424463|521706173|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
144687879|NCT00424463|521706174|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
144687880|NCT00424463|521706172|FG000|Overall Study|Patient's convenience|0|||
144687881|NCT00424463|521706173|FG001|Overall Study|Patient's convenience|0|||
144687882|NCT00424463|521706174|FG002|Overall Study|Patient's convenience|1|||
144687883|NCT02449915|521706175|FG000|Overall Study|Exclusion criteria - drug use|1|||
144687884|NCT02449915|521706176|FG001|Overall Study|Exclusion criteria - drug use|0|||
144687885|NCT02449915|521706175|FG000|Overall Study|Withdrawal by Subject|0|||
144687886|NCT02449915|521706176|FG001|Overall Study|Withdrawal by Subject|2|||
144687887|NCT02449915|521706175|FG000|Overall Study|Intraoperative surgical findings|1|||
144687888|NCT02449915|521706176|FG001|Overall Study|Intraoperative surgical findings|1|||
144687889|NCT02449915|521706175|FG000|Overall Study|Abnormal preop lab|0|||
144687890|NCT02449915|521706176|FG001|Overall Study|Abnormal preop lab|1|||
144687891|NCT01436357|521706177|FG000|Overall Study|Death|5|||
144687892|NCT01436357|521706178|FG001|Overall Study|Death|1|||
144687893|NCT01436357|521706177|FG000|Overall Study|Enrolled but not vaccinated|1|||
144218961|NCT01682811|519994558|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
144687894|NCT01436357|521706178|FG001|Overall Study|Enrolled but not vaccinated|1|||
144687895|NCT01436357|521706177|FG000|Overall Study|Incarceration|18|||
144687896|NCT01436357|521706178|FG001|Overall Study|Incarceration|20|||
144687897|NCT01436357|521706177|FG000|Overall Study|Lost to Follow-up|67|||
144687898|NCT01436357|521706178|FG001|Overall Study|Lost to Follow-up|61|||
144687899|NCT01436357|521706177|FG000|Overall Study|Protocol Violation|1|||
144687900|NCT01436357|521706178|FG001|Overall Study|Protocol Violation|0|||
144218962|NCT01682811|519994559|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
144218963|NCT01682811|519994560|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
144218964|NCT01682811|519994554|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
144218965|NCT01682811|519994555|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
144218966|NCT01682811|519994556|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
144687901|NCT01436357|521706177|FG000|Overall Study|Withdrawal by Subject|26|||
144687902|NCT01436357|521706178|FG001|Overall Study|Withdrawal by Subject|38|||
144218967|NCT01682811|519994557|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
144218968|NCT01682811|519994558|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
144687903|NCT01436357|521706177|FG000|Overall Study|Physician Decision|3|||
144687904|NCT01436357|521706178|FG001|Overall Study|Physician Decision|4|||
144687905|NCT01436357|521706177|FG000|Overall Study|Moved out of area|1|||
144687906|NCT01436357|521706178|FG001|Overall Study|Moved out of area|2|||
144687907|NCT01436357|521706177|FG000|Overall Study|Subject in rehab|0|||
144687908|NCT01436357|521706178|FG001|Overall Study|Subject in rehab|1|||
144687909|NCT00656799|521706180|FG000|Overall Study|Death|2|||
144687910|NCT04144140|521707413|FG000|Overall Study|Other|0|||
144687911|NCT04144140|521707414|FG001|Overall Study|Other|0|||
144687912|NCT04144140|521707415|FG002|Overall Study|Other|0|||
144687913|NCT04144140|521707416|FG003|Overall Study|Other|0|||
144687914|NCT04144140|521707417|FG004|Overall Study|Other|0|||
144687915|NCT04144140|521707418|FG005|Overall Study|Other|1|||
144687916|NCT04144140|521707419|FG006|Overall Study|Other|0|||
144687917|NCT02408016|521707422|FG000|Overall Study|Death|6|||
144687918|NCT02408016|521707423|FG001|Overall Study|Death|1|||
144687919|NCT02408016|521707424|FG002|Overall Study|Death|0|||
144687920|NCT02408016|521707422|FG000|Overall Study|Physician Decision|0|||
144687921|NCT02408016|521707423|FG001|Overall Study|Physician Decision|2|||
144687922|NCT02408016|521707424|FG002|Overall Study|Physician Decision|0|||
144687923|NCT03557801|521707426|FG000|Overall Study|Protocol Violation|1|||
144687924|NCT03557801|521707427|FG001|Overall Study|Protocol Violation|0|||
144687925|NCT03557801|521707428|FG002|Overall Study|Protocol Violation|0|||
144687926|NCT03557801|521707426|FG000|Overall Study|Withdrawal by Subject|1|||
144687927|NCT03557801|521707427|FG001|Overall Study|Withdrawal by Subject|0|||
144687928|NCT03557801|521707428|FG002|Overall Study|Withdrawal by Subject|3|||
144687929|NCT03557801|521707426|FG000|Overall Study|Lost to Follow-up|0|||
144687930|NCT03557801|521707427|FG001|Overall Study|Lost to Follow-up|1|||
144687931|NCT03557801|521707428|FG002|Overall Study|Lost to Follow-up|0|||
144687932|NCT02807376|521707431|FG000|Overall Study|Intra-operative exclusion criteria|3|||
144687933|NCT02807376|521707432|FG001|Overall Study|Intra-operative exclusion criteria|0|||
144687934|NCT02807376|521707431|FG000|Overall Study|Lost to Follow-up|0|||
144687935|NCT02807376|521707432|FG001|Overall Study|Lost to Follow-up|1|||
144687936|NCT00846027|521707433|FG000|Overall Study|Death|3|||
144687937|NCT00846027|521707433|FG000|Overall Study|Disease Progression|30|||
144687938|NCT00846027|521707433|FG000|Overall Study|Toxicity|12|||
144687939|NCT00846027|521707433|FG000|Overall Study|Patient Decision|7|||
144687940|NCT00846027|521707433|FG000|Overall Study|Investigator Discretion|29|||
144687941|NCT00846027|521707433|FG000|Overall Study|Protocol Violation|2|||
144687942|NCT00846027|521707433|FG000|Overall Study|Subject Not Treated|7|||
144687943|NCT03228836|521707438|FG000|Overall Study|Adverse Event|3|||
144687944|NCT03228836|521707438|FG000|Overall Study|Withdrawal by Subject|1|||
144687945|NCT03228836|521707438|FG000|Overall Study|Death|1|||
144687946|NCT03228836|521707438|FG000|Overall Study|Physician Decision|1|||
144687947|NCT03228836|521707438|FG000|Overall Study|Disease Progression|7|||
144687948|NCT03228836|521707438|FG000|Overall Study|Other|4|||
144687949|NCT00203294|521707441|FG000|Overall Study|Withdrawal by Subject|8|||
144687950|NCT00203294|521707442|FG001|Overall Study|Withdrawal by Subject|13|||
144687951|NCT00886587|521707443|FG000|Overall Study|Adverse Event|2|||
144687952|NCT00886587|521707444|FG001|Overall Study|Adverse Event|1|||
144687953|NCT00886587|521707443|FG000|Overall Study|Protocol Violation|2|||
144687954|NCT00886587|521707444|FG001|Overall Study|Protocol Violation|0|||
144687955|NCT00886587|521707443|FG000|Overall Study|Withdrawal by Subject|0|||
144218969|NCT01682811|519994559|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
144218970|NCT01682811|519994560|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
144218971|NCT01682811|519994554|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
144687956|NCT00886587|521707444|FG001|Overall Study|Withdrawal by Subject|1|||
144687957|NCT00808132|521707447|FG000|Overall Study|Adverse Event|34|||
144218972|NCT01682811|519994555|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
144218973|NCT01682811|519994556|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
144687958|NCT00808132|521707448|FG001|Overall Study|Adverse Event|33|||
144687959|NCT00808132|521707449|FG002|Overall Study|Adverse Event|16|||
144687960|NCT00808132|521707450|FG003|Overall Study|Adverse Event|31|||
144687961|NCT00808132|521707451|FG004|Overall Study|Adverse Event|33|||
144687962|NCT00808132|521707447|FG000|Overall Study|Death|0|||
144687963|NCT00808132|521707448|FG001|Overall Study|Death|0|||
144687964|NCT00808132|521707449|FG002|Overall Study|Death|0|||
144687965|NCT00808132|521707450|FG003|Overall Study|Death|0|||
144265916|NCT00329108|520176414|FG000|Overall Study|withdrew patient after SAE resolved|1|||
144687966|NCT00808132|521707451|FG004|Overall Study|Death|1|||
144687967|NCT00808132|521707447|FG000|Overall Study|Physician Decision|0|||
144741322|NCT03428750|521908400|FG000|Overall Study|Withdrawal by Subject|11|||
144741323|NCT03428750|521908401|FG001|Overall Study|Withdrawal by Subject|10|||
144741324|NCT03428750|521908400|FG000|Overall Study|Lost to Follow-up|3|||
144741325|NCT03428750|521908401|FG001|Overall Study|Lost to Follow-up|9|||
144741326|NCT03428750|521908400|FG000|Overall Study|Adverse Event|9|||
144741327|NCT03428750|521908401|FG001|Overall Study|Adverse Event|1|||
144741328|NCT03428750|521908400|FG000|Overall Study|Protocol Violation|1|||
144741329|NCT03428750|521908401|FG001|Overall Study|Protocol Violation|0|||
144741330|NCT03428750|521908400|FG000|Overall Study|Administrative|0|||
144741331|NCT03428750|521908401|FG001|Overall Study|Administrative|1|||
144741332|NCT01919112|521908402|FG000|Secondary Analysis-day 30|Death|1|||
144741333|NCT01919112|521908403|FG001|Secondary Analysis-day 30|Death|1|||
144741334|NCT01919112|521908404|FG002|Secondary Analysis-day 30|Death|1|||
144741335|NCT01919112|521908402|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
144741336|NCT01919112|521908403|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
144741337|NCT01919112|521908404|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
144741338|NCT02554877|521908407|FG000|Overall Study|Adverse Event|2|||
144741339|NCT02554877|521908408|FG001|Overall Study|Adverse Event|0|||
144741340|NCT02554877|521908409|FG002|Overall Study|Adverse Event|0|||
144741341|NCT02554877|521908410|FG003|Overall Study|Adverse Event|1|||
144741342|NCT02554877|521908407|FG000|Overall Study|Lost to Follow-up|1|||
144741343|NCT02554877|521908408|FG001|Overall Study|Lost to Follow-up|1|||
144741344|NCT02554877|521908409|FG002|Overall Study|Lost to Follow-up|1|||
144741345|NCT02554877|521908410|FG003|Overall Study|Lost to Follow-up|2|||
144741346|NCT02554877|521908407|FG000|Overall Study|Did not meet entrance criteria|0|||
144741347|NCT02554877|521908408|FG001|Overall Study|Did not meet entrance criteria|0|||
144741348|NCT02554877|521908409|FG002|Overall Study|Did not meet entrance criteria|1|||
144741349|NCT02554877|521908410|FG003|Overall Study|Did not meet entrance criteria|0|||
144741350|NCT02554877|521908407|FG000|Overall Study|No longer met eligibility criteria|1|||
144741351|NCT02554877|521908408|FG001|Overall Study|No longer met eligibility criteria|0|||
144741352|NCT02554877|521908409|FG002|Overall Study|No longer met eligibility criteria|1|||
144741353|NCT02554877|521908410|FG003|Overall Study|No longer met eligibility criteria|1|||
144741354|NCT02554877|521908407|FG000|Overall Study|Protocol Violation|3|||
144741355|NCT02554877|521908408|FG001|Overall Study|Protocol Violation|1|||
144741356|NCT02554877|521908409|FG002|Overall Study|Protocol Violation|1|||
144741357|NCT02554877|521908410|FG003|Overall Study|Protocol Violation|0|||
144741358|NCT02554877|521908407|FG000|Overall Study|Other|1|||
144741359|NCT02554877|521908408|FG001|Overall Study|Other|3|||
144741360|NCT02554877|521908409|FG002|Overall Study|Other|0|||
144741361|NCT02554877|521908410|FG003|Overall Study|Other|3|||
144741362|NCT02554877|521908407|FG000|Overall Study|Insufficient clinical response|4|||
144741363|NCT02554877|521908408|FG001|Overall Study|Insufficient clinical response|0|||
144741364|NCT02554877|521908409|FG002|Overall Study|Insufficient clinical response|0|||
144741365|NCT02554877|521908410|FG003|Overall Study|Insufficient clinical response|0|||
144741366|NCT02554877|521908407|FG000|Overall Study|No longer willing to participate|0|||
144741367|NCT02554877|521908408|FG001|Overall Study|No longer willing to participate|2|||
144741368|NCT02554877|521908409|FG002|Overall Study|No longer willing to participate|2|||
144741369|NCT02554877|521908410|FG003|Overall Study|No longer willing to participate|0|||
144741370|NCT04474405|521908411|FG000|Overall Study|Withdrawal by Subject|0|||
144741371|NCT04474405|521908412|FG001|Overall Study|Withdrawal by Subject|0|||
144741372|NCT04474405|521908413|FG002|Overall Study|Withdrawal by Subject|1|||
144741373|NCT04474405|521908414|FG003|Overall Study|Withdrawal by Subject|0|||
144741374|NCT04474405|521908415|FG004|Overall Study|Withdrawal by Subject|1|||
144741375|NCT04474405|521908416|FG005|Overall Study|Withdrawal by Subject|0|||
144741376|NCT04474405|521908411|FG000|Overall Study|Other|0|||
144741377|NCT04474405|521908412|FG001|Overall Study|Other|0|||
144741378|NCT04474405|521908413|FG002|Overall Study|Other|0|||
144741379|NCT04474405|521908414|FG003|Overall Study|Other|0|||
144741380|NCT04474405|521908415|FG004|Overall Study|Other|3|||
144265917|NCT00329108|520176415|FG001|Overall Study|withdrew patient after SAE resolved|0|||
144265918|NCT00329108|520176414|FG000|Overall Study|Protocol Violation|0|||
144741381|NCT04474405|521908416|FG005|Overall Study|Other|0|||
144741382|NCT05133180|521908417|FG000|Overall Study|Withdrawal of consent|1|||
144741383|NCT05133180|521908418|FG001|Overall Study|Withdrawal of consent|1|||
144741384|NCT05133180|521908417|FG000|Overall Study|Lost to Follow-up|1|||
144741385|NCT05133180|521908418|FG001|Overall Study|Lost to Follow-up|1|||
144741386|NCT05133180|521908417|FG000|Overall Study|Documented disease progression|0|||
144741387|NCT05133180|521908418|FG001|Overall Study|Documented disease progression|1|||
144741388|NCT03366792|521908419|FG000|Overall Study|Withdrawal by Subject|7|||
144741389|NCT03366792|521908419|FG000|Overall Study|Lost to Follow-up|2|||
144741390|NCT03366792|521908419|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
144741391|NCT03366792|521908419|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
144741392|NCT01808651|521908420|FG000|Study Period 1|Lost to Follow-up|1|||
144741393|NCT01808651|521908421|FG001|Study Period 1|Lost to Follow-up|3|||
144741394|NCT01808651|521908422|FG002|Study Period 1|Lost to Follow-up|0|||
144741395|NCT01808651|521908420|FG000|Study Period 1|Protocol Violation|1|||
144741396|NCT01808651|521908421|FG001|Study Period 1|Protocol Violation|0|||
144218974|NCT01682811|519994557|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
144218975|NCT01682811|519994558|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
144218976|NCT01682811|519994559|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
144218977|NCT01682811|519994560|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
144218978|NCT02603146|519996301|FG000|Overall Study|Lost to Follow-up|5|||
144218979|NCT02603146|519996302|FG001|Overall Study|Lost to Follow-up|6|||
144218980|NCT02603146|519996301|FG000|Overall Study|Withdrawal by Subject|8|||
144218981|NCT02603146|519996302|FG001|Overall Study|Withdrawal by Subject|10|||
144218982|NCT02603146|519996301|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
144218983|NCT02603146|519996302|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
144218984|NCT02603146|519996301|FG000|Overall Study|Participant moved|2|||
144218985|NCT02603146|519996302|FG001|Overall Study|Participant moved|0|||
144218986|NCT02603146|519996301|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
144218987|NCT02603146|519996302|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
144218988|NCT05126693|519996303|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
144218989|NCT05126693|519996304|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
144218990|NCT05126693|519996303|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
144218991|NCT05126693|519996304|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
144218992|NCT05126693|519996303|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
144218993|NCT05126693|519996304|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
144218994|NCT02719184|519996315|FG000|Overall Study|Other than listed|1|||
144218995|NCT02719184|519996316|FG001|Overall Study|Other than listed|12|||
144218996|NCT02719184|519996317|FG002|Overall Study|Other than listed|13|||
144218997|NCT02719184|519996318|FG003|Overall Study|Other than listed|22|||
144218998|NCT02719184|519996319|FG004|Overall Study|Other than listed|9|||
144218999|NCT02719184|519996315|FG000|Overall Study|Withdrawal by Subject|5|||
144219000|NCT02719184|519996316|FG001|Overall Study|Withdrawal by Subject|3|||
144219001|NCT02719184|519996317|FG002|Overall Study|Withdrawal by Subject|6|||
144219002|NCT02719184|519996318|FG003|Overall Study|Withdrawal by Subject|6|||
144219003|NCT02719184|519996319|FG004|Overall Study|Withdrawal by Subject|0|||
144219004|NCT02719184|519996315|FG000|Overall Study|Lost to Follow-up|0|||
144219005|NCT02719184|519996316|FG001|Overall Study|Lost to Follow-up|4|||
144219006|NCT02719184|519996317|FG002|Overall Study|Lost to Follow-up|1|||
144219007|NCT02719184|519996318|FG003|Overall Study|Lost to Follow-up|3|||
144219008|NCT02719184|519996319|FG004|Overall Study|Lost to Follow-up|0|||
144219009|NCT02719184|519996315|FG000|Overall Study|Protocol Violation|0|||
144219010|NCT02719184|519996316|FG001|Overall Study|Protocol Violation|3|||
144219011|NCT02719184|519996317|FG002|Overall Study|Protocol Violation|0|||
144219012|NCT02719184|519996318|FG003|Overall Study|Protocol Violation|2|||
144219013|NCT02719184|519996319|FG004|Overall Study|Protocol Violation|0|||
144219014|NCT02719184|519996315|FG000|Overall Study|Adverse Event|0|||
144219015|NCT02719184|519996316|FG001|Overall Study|Adverse Event|0|||
144265919|NCT00329108|520176415|FG001|Overall Study|Protocol Violation|2|||
144687968|NCT00808132|521707448|FG001|Overall Study|Physician Decision|1|||
144687969|NCT00808132|521707449|FG002|Overall Study|Physician Decision|0|||
144687970|NCT00808132|521707450|FG003|Overall Study|Physician Decision|0|||
144687971|NCT00808132|521707451|FG004|Overall Study|Physician Decision|0|||
144687972|NCT00808132|521707447|FG000|Overall Study|Lost to Follow-up|8|||
144687973|NCT00808132|521707448|FG001|Overall Study|Lost to Follow-up|10|||
144687974|NCT00808132|521707449|FG002|Overall Study|Lost to Follow-up|11|||
144687975|NCT00808132|521707450|FG003|Overall Study|Lost to Follow-up|8|||
144687976|NCT00808132|521707451|FG004|Overall Study|Lost to Follow-up|9|||
144687977|NCT00808132|521707447|FG000|Overall Study|Protocol Violation|8|||
144687978|NCT00808132|521707448|FG001|Overall Study|Protocol Violation|9|||
144687979|NCT00808132|521707449|FG002|Overall Study|Protocol Violation|4|||
144741397|NCT01808651|521908422|FG002|Study Period 1|Protocol Violation|1|||
144219016|NCT02719184|519996317|FG002|Overall Study|Adverse Event|0|||
144219017|NCT02719184|519996318|FG003|Overall Study|Adverse Event|3|||
144219018|NCT02719184|519996319|FG004|Overall Study|Adverse Event|0|||
144219019|NCT00470535|519996323|FG000|Overall Study|Disease Progression|13|||
144219020|NCT00470535|519996323|FG000|Overall Study|Withdrawal by Subject|1|||
144219021|NCT00470535|519996323|FG000|Overall Study|Adverse Event|1|||
144219022|NCT00470535|519996323|FG000|Overall Study|Death|1|||
144219023|NCT00470535|519996323|FG000|Overall Study|Other|2|||
144219024|NCT01026194|519996329|FG000|Period 1：Double Blind Period|Adverse Event|2|||
144219025|NCT01026194|519996330|FG001|Period 1：Double Blind Period|Adverse Event|1|||
144687980|NCT00808132|521707450|FG003|Overall Study|Protocol Violation|9|||
144687981|NCT00808132|521707451|FG004|Overall Study|Protocol Violation|5|||
144687982|NCT00808132|521707447|FG000|Overall Study|Withdrawal by Subject|27|||
144687983|NCT00808132|521707448|FG001|Overall Study|Withdrawal by Subject|18|||
144219026|NCT01026194|519996329|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
144219027|NCT01026194|519996330|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
144219028|NCT01026194|519996329|FG000|Period 1：Double Blind Period|Physician Decision|0|||
144219029|NCT01026194|519996330|FG001|Period 1：Double Blind Period|Physician Decision|4|||
144219030|NCT01026194|519996329|FG000|Period 2：Open-label Period|Adverse Event|4|||
144219031|NCT01026194|519996330|FG001|Period 2：Open-label Period|Adverse Event|5|||
144265920|NCT01094288|520176416|FG000|Overall Study|Adverse Event|0|||
144741398|NCT01808651|521908420|FG000|Study Period 1|Physician Decision|3|||
144741399|NCT01808651|521908421|FG001|Study Period 1|Physician Decision|2|||
144741400|NCT01808651|521908422|FG002|Study Period 1|Physician Decision|0|||
144741401|NCT01808651|521908420|FG000|Study Period 1|Lack of Efficacy|2|||
144741402|NCT01808651|521908421|FG001|Study Period 1|Lack of Efficacy|1|||
144741403|NCT01808651|521908422|FG002|Study Period 1|Lack of Efficacy|0|||
144741404|NCT01808651|521908420|FG000|Study Period 1|Adverse Event|10|||
144741405|NCT01808651|521908421|FG001|Study Period 1|Adverse Event|4|||
144741406|NCT01808651|521908422|FG002|Study Period 1|Adverse Event|1|||
144741407|NCT01808651|521908420|FG000|Study Period 1|Participant Decision|9|||
144741408|NCT01808651|521908421|FG001|Study Period 1|Participant Decision|7|||
144741409|NCT01808651|521908422|FG002|Study Period 1|Participant Decision|3|||
144741410|NCT00216736|521908432|FG000|Overall Study|Lost to Follow-up|1|||
144741411|NCT00216736|521908433|FG001|Overall Study|Lost to Follow-up|1|||
144741412|NCT02622386|521908434|FG000|First Assignment|Withdrawal by Subject|3|||
144741413|NCT02622386|521908435|FG001|First Assignment|Withdrawal by Subject|2|||
144741414|NCT02622386|521908434|FG000|Washout|Withdrawal by Subject|4|||
144741415|NCT02622386|521908435|FG001|Washout|Withdrawal by Subject|4|||
144741416|NCT02622386|521908434|FG000|Second Assignment|Withdrawal by Subject|0|||
144741417|NCT02622386|521908435|FG001|Second Assignment|Withdrawal by Subject|2|||
144741418|NCT02890992|521908436|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741419|NCT02890992|521908437|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
144741420|NCT02890992|521908438|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741421|NCT02890992|521908439|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741422|NCT02890992|521908440|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741423|NCT02890992|521908441|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741424|NCT02890992|521908442|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741425|NCT02890992|521908443|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
144741426|NCT02890992|521908436|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
144741427|NCT02890992|521908437|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
144741428|NCT02890992|521908438|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
144741429|NCT02890992|521908439|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
144741430|NCT02890992|521908440|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
144741431|NCT02890992|521908441|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
144741432|NCT02890992|521908442|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
144741433|NCT02890992|521908443|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
144741434|NCT02890992|521908436|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
144741435|NCT02890992|521908437|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
144219032|NCT01026194|519996329|FG000|Period 2：Open-label Period|Physician Decision|3|||
144219033|NCT01026194|519996330|FG001|Period 2：Open-label Period|Physician Decision|1|||
144219034|NCT01026194|519996329|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
144219035|NCT01026194|519996330|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
144219036|NCT02515331|519996333|FG000|Overall Study|Withdrawal by Subject|0|||
144219037|NCT02515331|519996334|FG001|Overall Study|Withdrawal by Subject|0|||
144219038|NCT02515331|519996335|FG002|Overall Study|Withdrawal by Subject|1|||
144219039|NCT02515331|519996333|FG000|Overall Study|Protocol deviation|0|||
144219040|NCT02515331|519996334|FG001|Overall Study|Protocol deviation|0|||
144219041|NCT02515331|519996335|FG002|Overall Study|Protocol deviation|3|||
144219042|NCT02515331|519996333|FG000|Overall Study|Adverse Event|2|||
144219043|NCT02515331|519996334|FG001|Overall Study|Adverse Event|0|||
144219044|NCT02515331|519996335|FG002|Overall Study|Adverse Event|0|||
144219045|NCT00124748|519996336|FG000|Overall Study|Adverse Event|8|||
144219046|NCT00124748|519996337|FG001|Overall Study|Adverse Event|39|||
144219047|NCT00124748|519996336|FG000|Overall Study|Abnormal laboratory Value|2|||
144219048|NCT00124748|519996337|FG001|Overall Study|Abnormal laboratory Value|2|||
144741436|NCT02890992|521908438|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
144741437|NCT02890992|521908439|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
144741438|NCT02890992|521908440|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
144219049|NCT00124748|519996336|FG000|Overall Study|Abnormal Procedure|0|||
144741439|NCT02890992|521908441|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
144741440|NCT02890992|521908442|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
144741441|NCT02890992|521908443|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
144219050|NCT00124748|519996337|FG001|Overall Study|Abnormal Procedure|1|||
144741442|NCT00918684|521908445|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
144741443|NCT00918684|521908445|FG000|Treatment Phase|Lack of Efficacy|6|||
144219051|NCT00124748|519996336|FG000|Overall Study|Lack of Efficacy|20|||
144741444|NCT00918684|521908445|FG000|Treatment Phase|Lost to Follow-up|2|||
144741445|NCT00918684|521908445|FG000|Treatment Phase|Physician Decision|8|||
144741446|NCT00918684|521908445|FG000|Treatment Phase|Protocol Violation|1|||
144219052|NCT00124748|519996337|FG001|Overall Study|Lack of Efficacy|41|||
144219053|NCT00124748|519996336|FG000|Overall Study|No longer requires study drug|1|||
144219054|NCT00124748|519996337|FG001|Overall Study|No longer requires study drug|1|||
144741447|NCT00918684|521908445|FG000|Treatment Phase|Withdrawal by Subject|8|||
144741448|NCT01051349|521908446|FG000|Overall Study|Adverse Event|88|||
144741449|NCT01051349|521908446|FG000|Overall Study|Consent Withdrawn|54|||
144741450|NCT01051349|521908446|FG000|Overall Study|Investigator Decision|6|||
144741451|NCT01051349|521908446|FG000|Overall Study|Lost to Follow-up|6|||
144741452|NCT01051349|521908446|FG000|Overall Study|Subject non-compliance|7|||
144741453|NCT01051349|521908446|FG000|Overall Study|Reason not Specified|12|||
144741454|NCT00402103|521908447|FG000|Overall Study|Adverse Event|60|||
144741455|NCT00402103|521908448|FG001|Overall Study|Adverse Event|7|||
144741456|NCT00402103|521908447|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144741457|NCT00402103|521908448|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144741458|NCT00402103|521908447|FG000|Overall Study|Condition no longer requires study drug|2|||
144741459|NCT00402103|521908448|FG001|Overall Study|Condition no longer requires study drug|0|||
144741460|NCT00402103|521908447|FG000|Overall Study|Protocol Deviation|8|||
144741461|NCT00402103|521908448|FG001|Overall Study|Protocol Deviation|0|||
144741462|NCT00402103|521908447|FG000|Overall Study|Patient withdrew consent|12|||
144741463|NCT00402103|521908448|FG001|Overall Study|Patient withdrew consent|1|||
144741464|NCT00402103|521908447|FG000|Overall Study|Lost to Follow-up|6|||
144741465|NCT00402103|521908448|FG001|Overall Study|Lost to Follow-up|3|||
144741466|NCT00402103|521908447|FG000|Overall Study|Administrative problems|2|||
144741467|NCT00402103|521908448|FG001|Overall Study|Administrative problems|0|||
144741468|NCT00484679|521908449|FG000|Overall Study|Withdrawal by Subject|3|||
144741469|NCT00418145|521908450|FG000|Overall Study|study terminated|6|||
144741470|NCT03480763|521908451|FG000|Overall Study|Withdrawal by Subject|18|||
144741471|NCT03480763|521908452|FG001|Overall Study|Withdrawal by Subject|10|||
144741472|NCT03480763|521908451|FG000|Overall Study|Lost to Follow-up|4|||
144741473|NCT03480763|521908452|FG001|Overall Study|Lost to Follow-up|7|||
144741474|NCT03480763|521908451|FG000|Overall Study|non-study pneumococcal vaccine|1|||
144741475|NCT03480763|521908452|FG001|Overall Study|non-study pneumococcal vaccine|0|||
144741476|NCT03480763|521908451|FG000|Overall Study|oncological treatment|0|||
144741477|NCT03480763|521908452|FG001|Overall Study|oncological treatment|2|||
144741478|NCT03480763|521908451|FG000|Overall Study|pain with vaccination|1|||
144741479|NCT03480763|521908452|FG001|Overall Study|pain with vaccination|0|||
144741480|NCT00463684|521908453|FG000|Overall Study|Withdrawal by Subject|1|||
144741481|NCT00463684|521908453|FG000|Overall Study|Lost to Follow-up|3|||
144741482|NCT02462837|521908455|FG000|Overall Study|pt developed hives|1|||
144741483|NCT02462837|521908456|FG001|Overall Study|pt developed hives|0|||
144741484|NCT02462837|521908455|FG000|Overall Study|Withdrawal by Subject|1|||
144741485|NCT02462837|521908456|FG001|Overall Study|Withdrawal by Subject|0|||
144219055|NCT00124748|519996336|FG000|Overall Study|Protocol Violation|3|||
144219056|NCT00124748|519996337|FG001|Overall Study|Protocol Violation|1|||
144219057|NCT00124748|519996336|FG000|Overall Study|Withdrawal by Subject|5|||
144219058|NCT00124748|519996337|FG001|Overall Study|Withdrawal by Subject|15|||
144219059|NCT00124748|519996336|FG000|Overall Study|Lost to Follow-up|2|||
144219060|NCT00124748|519996337|FG001|Overall Study|Lost to Follow-up|7|||
144219061|NCT00124748|519996336|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
144219062|NCT00124748|519996337|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
144219063|NCT00124748|519996336|FG000|Overall Study|Death|1|||
144219064|NCT00124748|519996337|FG001|Overall Study|Death|3|||
144219065|NCT00322712|519996338|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
144219066|NCT03889886|519996339|FG000|Overall Study|Other|0|||
144219067|NCT03889886|519996340|FG001|Overall Study|Other|1|||
144219068|NCT03889886|519996341|FG002|Overall Study|Other|0|||
144219069|NCT03889886|519996342|FG003|Overall Study|Other|1|||
144219070|NCT03889886|519996339|FG000|Overall Study|Withdrawal by Subject|0|||
144219071|NCT03889886|519996340|FG001|Overall Study|Withdrawal by Subject|0|||
144219072|NCT03889886|519996341|FG002|Overall Study|Withdrawal by Subject|1|||
144219073|NCT03889886|519996342|FG003|Overall Study|Withdrawal by Subject|0|||
144219074|NCT03889886|519996339|FG000|Overall Study|Adverse Event|0|||
144219075|NCT03889886|519996340|FG001|Overall Study|Adverse Event|0|||
144219076|NCT03889886|519996341|FG002|Overall Study|Adverse Event|0|||
144219077|NCT03889886|519996342|FG003|Overall Study|Adverse Event|6|||
144219078|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
144219079|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
144219080|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
144219081|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144741486|NCT01075282|521908460|FG000|Overall Study|Withdrawal by Subject|11|||
144741487|NCT01075282|521908461|FG001|Overall Study|Withdrawal by Subject|7|||
144741488|NCT01075282|521908462|FG002|Overall Study|Withdrawal by Subject|11|||
144741489|NCT01075282|521908460|FG000|Overall Study|Adverse Event|9|||
144741490|NCT01075282|521908461|FG001|Overall Study|Adverse Event|8|||
144219082|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
144219083|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
144219084|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219085|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219086|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144741491|NCT01075282|521908462|FG002|Overall Study|Adverse Event|5|||
144741492|NCT01075282|521908460|FG000|Overall Study|Entry Criteria Not Met|3|||
144741493|NCT01075282|521908461|FG001|Overall Study|Entry Criteria Not Met|2|||
144741494|NCT01075282|521908462|FG002|Overall Study|Entry Criteria Not Met|0|||
144741495|NCT01075282|521908460|FG000|Overall Study|Lost to Follow-up|3|||
144741496|NCT01075282|521908461|FG001|Overall Study|Lost to Follow-up|3|||
144741497|NCT01075282|521908462|FG002|Overall Study|Lost to Follow-up|3|||
144741498|NCT01075282|521908460|FG000|Overall Study|Physician Decision|3|||
144741499|NCT01075282|521908461|FG001|Overall Study|Physician Decision|3|||
144741500|NCT01075282|521908462|FG002|Overall Study|Physician Decision|3|||
144741501|NCT01075282|521908460|FG000|Overall Study|Lack of Efficacy|1|||
144741502|NCT01075282|521908461|FG001|Overall Study|Lack of Efficacy|1|||
144741503|NCT01075282|521908462|FG002|Overall Study|Lack of Efficacy|0|||
144741504|NCT01075282|521908460|FG000|Overall Study|Treatment Non-compliance|1|||
144741505|NCT01075282|521908461|FG001|Overall Study|Treatment Non-compliance|2|||
144741506|NCT01075282|521908462|FG002|Overall Study|Treatment Non-compliance|2|||
144741507|NCT01075282|521908460|FG000|Overall Study|Protocol Violation|0|||
144741508|NCT01075282|521908461|FG001|Overall Study|Protocol Violation|2|||
144741509|NCT01075282|521908462|FG002|Overall Study|Protocol Violation|1|||
144741510|NCT01075282|521908460|FG000|Overall Study|Death|0|||
144741511|NCT01075282|521908461|FG001|Overall Study|Death|1|||
144741512|NCT01075282|521908462|FG002|Overall Study|Death|2|||
144741513|NCT02336074|521908463|FG000|Overall Study|Adverse Event|0|||
144741514|NCT02336074|521908464|FG001|Overall Study|Adverse Event|2|||
144741515|NCT01252953|521908465|FG000|Overall Study|Withdrawal by Subject|16|||
144741516|NCT01252953|521908466|FG001|Overall Study|Withdrawal by Subject|17|||
144741517|NCT01252953|521908465|FG000|Overall Study|Lost to Follow-up|22|||
144741518|NCT01252953|521908466|FG001|Overall Study|Lost to Follow-up|21|||
144741519|NCT02679729|521908467|FG000|Overall Study|Lost to Follow-up|0|||
144741520|NCT02679729|521908468|FG001|Overall Study|Lost to Follow-up|1|||
144741521|NCT02679729|521908469|FG002|Overall Study|Lost to Follow-up|0|||
144741522|NCT02679729|521908470|FG003|Overall Study|Lost to Follow-up|0|||
144741523|NCT02679729|521908471|FG004|Overall Study|Lost to Follow-up|1|||
144741524|NCT02679729|521908472|FG005|Overall Study|Lost to Follow-up|0|||
144741525|NCT02679729|521908473|FG006|Overall Study|Lost to Follow-up|0|||
144741526|NCT02679729|521908474|FG007|Overall Study|Lost to Follow-up|0|||
144741527|NCT02679729|521908475|FG008|Overall Study|Lost to Follow-up|0|||
144741528|NCT02679729|521908467|FG000|Overall Study|Participant decision|0|||
144741529|NCT02679729|521908468|FG001|Overall Study|Participant decision|1|||
144741530|NCT02679729|521908469|FG002|Overall Study|Participant decision|0|||
144741531|NCT02679729|521908470|FG003|Overall Study|Participant decision|0|||
144741532|NCT02679729|521908471|FG004|Overall Study|Participant decision|0|||
144741533|NCT02679729|521908472|FG005|Overall Study|Participant decision|0|||
144741534|NCT02679729|521908473|FG006|Overall Study|Participant decision|1|||
144741535|NCT02679729|521908474|FG007|Overall Study|Participant decision|0|||
144741536|NCT02679729|521908475|FG008|Overall Study|Participant decision|0|||
144741537|NCT00906399|521908493|FG000|Year 1|Randomized But Not Treated|0|||
144741538|NCT00906399|521908494|FG001|Year 1|Randomized But Not Treated|1|||
144741539|NCT00906399|521908495|FG002|Year 1|Randomized But Not Treated|3|||
144741540|NCT00906399|521908496|FG003|Year 1|Randomized But Not Treated|0|||
144741541|NCT00906399|521908497|FG004|Year 1|Randomized But Not Treated|0|||
144741542|NCT00906399|521908498|FG005|Year 1|Randomized But Not Treated|0|||
144741543|NCT00906399|521908499|FG006|Year 1|Randomized But Not Treated|0|||
144741544|NCT00906399|521908493|FG000|Year 1|Adverse Event|4|||
144741545|NCT00906399|521908494|FG001|Year 1|Adverse Event|22|||
144741546|NCT00906399|521908495|FG002|Year 1|Adverse Event|24|||
144741547|NCT00906399|521908496|FG003|Year 1|Adverse Event|0|||
144741548|NCT00906399|521908497|FG004|Year 1|Adverse Event|0|||
144741549|NCT00906399|521908498|FG005|Year 1|Adverse Event|0|||
144741550|NCT00906399|521908499|FG006|Year 1|Adverse Event|0|||
144741551|NCT00906399|521908493|FG000|Year 1|Lost to Follow-up|4|||
144741552|NCT00906399|521908494|FG001|Year 1|Lost to Follow-up|4|||
144741553|NCT00906399|521908495|FG002|Year 1|Lost to Follow-up|2|||
144741554|NCT00906399|521908496|FG003|Year 1|Lost to Follow-up|0|||
144741555|NCT00906399|521908497|FG004|Year 1|Lost to Follow-up|0|||
144741556|NCT00906399|521908498|FG005|Year 1|Lost to Follow-up|0|||
144741557|NCT00906399|521908499|FG006|Year 1|Lost to Follow-up|0|||
144741558|NCT00906399|521908493|FG000|Year 1|Withdrawal by Subject|30|||
144741559|NCT00906399|521908494|FG001|Year 1|Withdrawal by Subject|32|||
144741560|NCT00906399|521908495|FG002|Year 1|Withdrawal by Subject|36|||
144741561|NCT00906399|521908496|FG003|Year 1|Withdrawal by Subject|0|||
144741562|NCT00906399|521908497|FG004|Year 1|Withdrawal by Subject|0|||
144741563|NCT00906399|521908498|FG005|Year 1|Withdrawal by Subject|0|||
144741564|NCT00906399|521908499|FG006|Year 1|Withdrawal by Subject|0|||
144741565|NCT00906399|521908493|FG000|Year 1|Physician Decision|0|||
144741566|NCT00906399|521908494|FG001|Year 1|Physician Decision|1|||
144741567|NCT00906399|521908495|FG002|Year 1|Physician Decision|3|||
144741568|NCT00906399|521908496|FG003|Year 1|Physician Decision|0|||
144741569|NCT00906399|521908497|FG004|Year 1|Physician Decision|0|||
144741570|NCT00906399|521908498|FG005|Year 1|Physician Decision|0|||
144741571|NCT00906399|521908499|FG006|Year 1|Physician Decision|0|||
144741572|NCT00906399|521908493|FG000|Year 1|Death|2|||
144687984|NCT00808132|521707449|FG002|Overall Study|Withdrawal by Subject|2|||
144687985|NCT00808132|521707450|FG003|Overall Study|Withdrawal by Subject|7|||
144687986|NCT00808132|521707451|FG004|Overall Study|Withdrawal by Subject|16|||
144687987|NCT00808132|521707447|FG000|Overall Study|Other|6|||
144687988|NCT00808132|521707448|FG001|Overall Study|Other|4|||
144687989|NCT00808132|521707449|FG002|Overall Study|Other|6|||
144687990|NCT00808132|521707450|FG003|Overall Study|Other|2|||
144687991|NCT00808132|521707451|FG004|Overall Study|Other|15|||
144687992|NCT00808132|521707447|FG000|Overall Study|Randomized, but not treated|10|||
144687993|NCT00808132|521707448|FG001|Overall Study|Randomized, but not treated|7|||
144687994|NCT00808132|521707449|FG002|Overall Study|Randomized, but not treated|9|||
144687995|NCT00808132|521707450|FG003|Overall Study|Randomized, but not treated|8|||
144687996|NCT00808132|521707451|FG004|Overall Study|Randomized, but not treated|9|||
144687997|NCT00808132|521707447|FG000|Overall Study|Unsatisfactory response|5|||
144687998|NCT00808132|521707448|FG001|Overall Study|Unsatisfactory response|6|||
144687999|NCT00808132|521707449|FG002|Overall Study|Unsatisfactory response|6|||
144688000|NCT00808132|521707450|FG003|Overall Study|Unsatisfactory response|4|||
144688001|NCT00808132|521707451|FG004|Overall Study|Unsatisfactory response|12|||
144688002|NCT00033293|521707452|FG000|Overall Study|Death|0|||
144688003|NCT00033293|521707453|FG001|Overall Study|Death|1|||
144688004|NCT00033293|521707452|FG000|Overall Study|Lack of Efficacy|5|||
144688005|NCT00033293|521707453|FG001|Overall Study|Lack of Efficacy|8|||
144688006|NCT00033293|521707452|FG000|Overall Study|Lost to Follow-up|0|||
144688007|NCT00033293|521707453|FG001|Overall Study|Lost to Follow-up|1|||
144688008|NCT00033293|521707452|FG000|Overall Study|Physician Decision|3|||
144688009|NCT00033293|521707453|FG001|Overall Study|Physician Decision|1|||
144688010|NCT00033293|521707452|FG000|Overall Study|Withdrawal by Subject|1|||
144688011|NCT00033293|521707453|FG001|Overall Study|Withdrawal by Subject|0|||
144688012|NCT00033293|521707452|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
144688013|NCT00033293|521707453|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
144688014|NCT00033293|521707452|FG000|Overall Study|Treatment refused|0|||
144688015|NCT00033293|521707453|FG001|Overall Study|Treatment refused|6|||
144688016|NCT00890201|521707454|FG000|Overall Study|Protocol Violation|5|||
144688017|NCT00890201|521707455|FG001|Overall Study|Protocol Violation|56|||
144688018|NCT00887913|521707456|FG000|Overall Study|Withdrawal by Subject|6|||
144688019|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
144688020|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
144688021|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
144688022|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
144688023|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
144688024|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
144688025|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
144688026|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
144688027|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Death|0|||
144688028|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Death|0|||
144688029|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Death|0|||
144688030|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Death|1|||
144688031|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Death|1|||
144688032|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Death|0|||
144688033|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Death|2|||
144688034|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Death|0|||
144688035|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688036|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688037|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688038|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
144688039|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688040|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688041|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688042|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
144688043|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688044|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688045|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688046|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
144688047|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688048|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688049|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688050|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
144688051|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
144688052|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
144688053|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
144688054|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
144688055|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
144688056|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
144688057|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
144219087|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219088|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219089|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219090|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219091|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219092|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219093|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219094|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
144219095|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
144219096|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219097|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
144688058|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
144688059|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
144688060|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
144688061|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
144688062|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
144688063|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
144688064|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
144688065|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
144688066|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
144219098|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
144219099|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
144219100|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
144219101|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144265921|NCT01094288|520176417|FG001|Overall Study|Adverse Event|3|||
144688067|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
144688068|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
144688069|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
144688070|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
144688071|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
144688072|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
144688073|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
144688074|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
144688075|NCT02442765|521707457|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
144688076|NCT02442765|521707458|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
144688077|NCT02442765|521707459|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
144688078|NCT02442765|521707460|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
144688079|NCT02442765|521707461|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
144688080|NCT02442765|521707462|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
144688081|NCT02442765|521707463|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
144688082|NCT02442765|521707464|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
144688083|NCT01200758|521707467|FG000|Stage I|Death|0|||
144688084|NCT01200758|521707468|FG001|Stage I|Death|1|||
144688085|NCT01200758|521707469|FG002|Stage I|Death|0|||
144688086|NCT01200758|521707470|FG003|Stage I|Death|0|||
144688087|NCT01200758|521707467|FG000|Stage I|Physician Decision|1|||
144688088|NCT01200758|521707468|FG001|Stage I|Physician Decision|1|||
144688089|NCT01200758|521707469|FG002|Stage I|Physician Decision|0|||
144688090|NCT01200758|521707470|FG003|Stage I|Physician Decision|0|||
144688091|NCT01200758|521707467|FG000|Stage I|Lack of Efficacy|2|||
144688092|NCT01200758|521707468|FG001|Stage I|Lack of Efficacy|1|||
144688093|NCT01200758|521707469|FG002|Stage I|Lack of Efficacy|0|||
144688094|NCT01200758|521707470|FG003|Stage I|Lack of Efficacy|0|||
144688095|NCT01200758|521707467|FG000|Stage I|Adverse Event|5|||
144688096|NCT01200758|521707468|FG001|Stage I|Adverse Event|5|||
144688097|NCT01200758|521707469|FG002|Stage I|Adverse Event|0|||
144688098|NCT01200758|521707470|FG003|Stage I|Adverse Event|0|||
144688099|NCT01200758|521707467|FG000|Stage I|Withdrawal by Subject|1|||
144688100|NCT01200758|521707468|FG001|Stage I|Withdrawal by Subject|2|||
144688101|NCT01200758|521707469|FG002|Stage I|Withdrawal by Subject|0|||
144688102|NCT01200758|521707470|FG003|Stage I|Withdrawal by Subject|0|||
144688103|NCT01200758|521707467|FG000|Stage I|Disease Progression|9|||
144688104|NCT01200758|521707468|FG001|Stage I|Disease Progression|7|||
144688105|NCT01200758|521707469|FG002|Stage I|Disease Progression|0|||
144688106|NCT01200758|521707470|FG003|Stage I|Disease Progression|0|||
144688107|NCT01200758|521707467|FG000|Stage 2|Disease Progression|0|||
144688108|NCT01200758|521707468|FG001|Stage 2|Disease Progression|0|||
144688109|NCT01200758|521707469|FG002|Stage 2|Disease Progression|16|||
144688110|NCT01200758|521707470|FG003|Stage 2|Disease Progression|21|||
144688111|NCT01200758|521707467|FG000|Stage 2|Lack of Efficacy|0|||
144688112|NCT01200758|521707468|FG001|Stage 2|Lack of Efficacy|0|||
144688113|NCT01200758|521707469|FG002|Stage 2|Lack of Efficacy|4|||
144688114|NCT01200758|521707470|FG003|Stage 2|Lack of Efficacy|2|||
144688115|NCT01200758|521707467|FG000|Stage 2|Physician Decision|0|||
144688116|NCT01200758|521707468|FG001|Stage 2|Physician Decision|0|||
144688117|NCT01200758|521707469|FG002|Stage 2|Physician Decision|5|||
144741573|NCT00906399|521908494|FG001|Year 1|Death|1|||
144741574|NCT00906399|521908495|FG002|Year 1|Death|1|||
144741575|NCT00906399|521908496|FG003|Year 1|Death|0|||
144741576|NCT00906399|521908497|FG004|Year 1|Death|0|||
144741577|NCT00906399|521908498|FG005|Year 1|Death|0|||
144741578|NCT00906399|521908499|FG006|Year 1|Death|0|||
144741579|NCT00906399|521908493|FG000|Year 1|Other|4|||
144741580|NCT00906399|521908494|FG001|Year 1|Other|2|||
144741581|NCT00906399|521908495|FG002|Year 1|Other|7|||
144265922|NCT01094288|520176418|FG002|Overall Study|Adverse Event|1|||
144265923|NCT01094288|520176419|FG003|Overall Study|Adverse Event|1|||
144265924|NCT01094288|520176420|FG004|Overall Study|Adverse Event|0|||
144265925|NCT01094288|520176421|FG005|Overall Study|Adverse Event|0|||
144265926|NCT01094288|520176422|FG006|Overall Study|Adverse Event|0|||
144265927|NCT01094288|520176423|FG007|Overall Study|Adverse Event|0|||
144265928|NCT01094288|520176416|FG000|Overall Study|Withdrawal by Subject|0|||
144265929|NCT01094288|520176417|FG001|Overall Study|Withdrawal by Subject|1|||
144265930|NCT01094288|520176418|FG002|Overall Study|Withdrawal by Subject|2|||
144265931|NCT01094288|520176419|FG003|Overall Study|Withdrawal by Subject|0|||
144265932|NCT01094288|520176420|FG004|Overall Study|Withdrawal by Subject|0|||
144265933|NCT01094288|520176421|FG005|Overall Study|Withdrawal by Subject|0|||
144265934|NCT01094288|520176422|FG006|Overall Study|Withdrawal by Subject|0|||
144265935|NCT01094288|520176423|FG007|Overall Study|Withdrawal by Subject|2|||
144265936|NCT01094288|520176416|FG000|Overall Study|Initiation of Alternative Therapy|0|||
144265937|NCT01094288|520176417|FG001|Overall Study|Initiation of Alternative Therapy|0|||
144265938|NCT01094288|520176418|FG002|Overall Study|Initiation of Alternative Therapy|1|||
144265939|NCT01094288|520176419|FG003|Overall Study|Initiation of Alternative Therapy|0|||
144265940|NCT01094288|520176420|FG004|Overall Study|Initiation of Alternative Therapy|0|||
144265941|NCT01094288|520176421|FG005|Overall Study|Initiation of Alternative Therapy|0|||
144265942|NCT01094288|520176422|FG006|Overall Study|Initiation of Alternative Therapy|0|||
144265943|NCT01094288|520176423|FG007|Overall Study|Initiation of Alternative Therapy|0|||
144265944|NCT01094288|520176416|FG000|Overall Study|Reason not Specified|2|||
144265945|NCT01094288|520176417|FG001|Overall Study|Reason not Specified|3|||
144265946|NCT01094288|520176418|FG002|Overall Study|Reason not Specified|0|||
144265947|NCT01094288|520176419|FG003|Overall Study|Reason not Specified|1|||
144265948|NCT01094288|520176420|FG004|Overall Study|Reason not Specified|0|||
144265949|NCT01094288|520176421|FG005|Overall Study|Reason not Specified|0|||
144265950|NCT01094288|520176422|FG006|Overall Study|Reason not Specified|0|||
144265951|NCT01094288|520176423|FG007|Overall Study|Reason not Specified|0|||
144688118|NCT01200758|521707470|FG003|Stage 2|Physician Decision|7|||
144688119|NCT01200758|521707467|FG000|Stage 2|Adverse Event|0|||
144688120|NCT01200758|521707468|FG001|Stage 2|Adverse Event|0|||
144688121|NCT01200758|521707469|FG002|Stage 2|Adverse Event|5|||
144688122|NCT01200758|521707470|FG003|Stage 2|Adverse Event|9|||
144688123|NCT01200758|521707467|FG000|Stage 2|Withdrawal by Subject|0|||
144688124|NCT01200758|521707468|FG001|Stage 2|Withdrawal by Subject|0|||
144688125|NCT01200758|521707469|FG002|Stage 2|Withdrawal by Subject|4|||
144688126|NCT01200758|521707470|FG003|Stage 2|Withdrawal by Subject|1|||
144688127|NCT01200758|521707467|FG000|Stage 2|Lost to Follow-up|0|||
144688128|NCT01200758|521707468|FG001|Stage 2|Lost to Follow-up|0|||
144688129|NCT01200758|521707469|FG002|Stage 2|Lost to Follow-up|3|||
144688130|NCT01200758|521707470|FG003|Stage 2|Lost to Follow-up|1|||
144688131|NCT01200758|521707467|FG000|Stage 2|Protocol Violation|0|||
144688132|NCT01200758|521707468|FG001|Stage 2|Protocol Violation|0|||
144688133|NCT01200758|521707469|FG002|Stage 2|Protocol Violation|1|||
144688134|NCT01200758|521707470|FG003|Stage 2|Protocol Violation|4|||
144688135|NCT01200758|521707467|FG000|Stage 2|Death|0|||
144688136|NCT01200758|521707468|FG001|Stage 2|Death|0|||
144688137|NCT01200758|521707469|FG002|Stage 2|Death|3|||
144688138|NCT01200758|521707470|FG003|Stage 2|Death|5|||
144688139|NCT00598585|521707471|FG000|Overall Study|Lost to Follow-up|1|||
144688140|NCT00598585|521707472|FG001|Overall Study|Lost to Follow-up|0|||
144688141|NCT00545584|521707473|FG000|Overall Study|Only one reason for discontinuation|62|||
144265952|NCT01094288|520176416|FG000|Overall Study|Ongoing Participants|0|||
144688142|NCT00545584|521707474|FG001|Overall Study|Only one reason for discontinuation|61|||
144265953|NCT01094288|520176417|FG001|Overall Study|Ongoing Participants|3|||
144688143|NCT00545584|521707475|FG002|Overall Study|Only one reason for discontinuation|48|||
144688144|NCT00545584|521707473|FG000|Overall Study|Two or more reasons for discontinuation|17|||
144688145|NCT00545584|521707474|FG001|Overall Study|Two or more reasons for discontinuation|19|||
144741582|NCT00906399|521908496|FG003|Year 1|Other|0|||
144265954|NCT01094288|520176418|FG002|Overall Study|Ongoing Participants|0|||
144688146|NCT00545584|521707475|FG002|Overall Study|Two or more reasons for discontinuation|8|||
144688147|NCT03525613|521707478|FG000|Overall Study|Adverse Event|11|||
144688148|NCT03525613|521707479|FG001|Overall Study|Adverse Event|8|||
144688149|NCT03525613|521707480|FG002|Overall Study|Adverse Event|3|||
144741583|NCT00906399|521908497|FG004|Year 1|Other|0|||
144741584|NCT00906399|521908498|FG005|Year 1|Other|0|||
144741585|NCT00906399|521908499|FG006|Year 1|Other|0|||
144741586|NCT00906399|521908493|FG000|Year 2|Adverse Event|0|||
144741587|NCT00906399|521908494|FG001|Year 2|Adverse Event|0|||
144741588|NCT00906399|521908495|FG002|Year 2|Adverse Event|0|||
144219102|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219103|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219104|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219105|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219106|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219107|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219108|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219109|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219110|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219111|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
144219112|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
144219113|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
144219114|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
144219115|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
144219116|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
144219117|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
144219118|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219119|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219120|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144265955|NCT01094288|520176419|FG003|Overall Study|Ongoing Participants|0|||
144688150|NCT03525613|521707481|FG003|Overall Study|Adverse Event|3|||
144688151|NCT03525613|521707478|FG000|Overall Study|Lost to Follow-up|4|||
144688152|NCT03525613|521707479|FG001|Overall Study|Lost to Follow-up|5|||
144688153|NCT03525613|521707480|FG002|Overall Study|Lost to Follow-up|3|||
144688154|NCT03525613|521707481|FG003|Overall Study|Lost to Follow-up|2|||
144688155|NCT03525613|521707478|FG000|Overall Study|Physician Decision|0|||
144688156|NCT03525613|521707479|FG001|Overall Study|Physician Decision|1|||
144688157|NCT03525613|521707480|FG002|Overall Study|Physician Decision|0|||
144688158|NCT03525613|521707481|FG003|Overall Study|Physician Decision|1|||
144688159|NCT03525613|521707478|FG000|Overall Study|Consent Withdrawal|25|||
144688160|NCT03525613|521707479|FG001|Overall Study|Consent Withdrawal|16|||
144688161|NCT03525613|521707480|FG002|Overall Study|Consent Withdrawal|12|||
144688162|NCT03525613|521707481|FG003|Overall Study|Consent Withdrawal|9|||
144688163|NCT03525613|521707478|FG000|Overall Study|Death|20|||
144688164|NCT03525613|521707479|FG001|Overall Study|Death|9|||
144688165|NCT03525613|521707480|FG002|Overall Study|Death|7|||
144688166|NCT03525613|521707481|FG003|Overall Study|Death|1|||
144688167|NCT03525613|521707478|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
144688168|NCT03525613|521707479|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
144688169|NCT03525613|521707480|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
144688170|NCT03525613|521707481|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
144688171|NCT00135694|521707485|FG000|Overall Study|Adverse Event|17|||
144688172|NCT00135694|521707486|FG001|Overall Study|Adverse Event|4|||
144688173|NCT00135694|521707487|FG002|Overall Study|Adverse Event|0|||
144688174|NCT00135694|521707485|FG000|Overall Study|Death|14|||
144688175|NCT00135694|521707486|FG001|Overall Study|Death|1|||
144688176|NCT00135694|521707487|FG002|Overall Study|Death|2|||
144688177|NCT00135694|521707485|FG000|Overall Study|Lost to Follow-up|8|||
144688178|NCT00135694|521707486|FG001|Overall Study|Lost to Follow-up|7|||
144688179|NCT00135694|521707487|FG002|Overall Study|Lost to Follow-up|1|||
144688180|NCT00135694|521707485|FG000|Overall Study|Withdrawal by Subject|41|||
144688181|NCT00135694|521707486|FG001|Overall Study|Withdrawal by Subject|7|||
144688182|NCT00135694|521707487|FG002|Overall Study|Withdrawal by Subject|4|||
144688183|NCT00135694|521707485|FG000|Overall Study|Protocol Violation|19|||
144688184|NCT00135694|521707486|FG001|Overall Study|Protocol Violation|1|||
144688185|NCT00135694|521707487|FG002|Overall Study|Protocol Violation|0|||
144688186|NCT00135694|521707485|FG000|Overall Study|Hepatitis C related reasons|39|||
144688187|NCT00135694|521707486|FG001|Overall Study|Hepatitis C related reasons|1|||
144688188|NCT00135694|521707487|FG002|Overall Study|Hepatitis C related reasons|0|||
144688189|NCT00135694|521707485|FG000|Overall Study|Ineligible for Random assignment|42|||
144688190|NCT00135694|521707486|FG001|Overall Study|Ineligible for Random assignment|0|||
144688191|NCT00135694|521707487|FG002|Overall Study|Ineligible for Random assignment|0|||
144688192|NCT02584660|521707488|FG000|Overall Study|Adverse Event|4|||
144688193|NCT02584660|521707489|FG001|Overall Study|Adverse Event|0|||
144688194|NCT02584660|521707488|FG000|Overall Study|Lost to Follow-up|3|||
144688195|NCT02584660|521707489|FG001|Overall Study|Lost to Follow-up|4|||
144688196|NCT02584660|521707488|FG000|Overall Study|Protocol Violation|0|||
144688197|NCT02584660|521707489|FG001|Overall Study|Protocol Violation|1|||
144688198|NCT02584660|521707488|FG000|Overall Study|Withdrawal by Subject|0|||
144688199|NCT02584660|521707489|FG001|Overall Study|Withdrawal by Subject|2|||
144688200|NCT02584660|521707488|FG000|Overall Study|Other|0|||
144688201|NCT02584660|521707489|FG001|Overall Study|Other|1|||
144741589|NCT00906399|521908496|FG003|Year 2|Adverse Event|9|||
144265956|NCT01094288|520176420|FG004|Overall Study|Ongoing Participants|0|||
144688202|NCT00374452|521707490|FG000|Overall Study|Left clinic before intervention started|4|||
144688203|NCT00374452|521707491|FG001|Overall Study|Left clinic before intervention started|1|||
144688204|NCT00374452|521707490|FG000|Overall Study|Change in job role before intervention|0|||
144688205|NCT00374452|521707491|FG001|Overall Study|Change in job role before intervention|1|||
144688206|NCT00374452|521707490|FG000|Overall Study|Left clinic after intervention started|1|||
144688207|NCT00374452|521707491|FG001|Overall Study|Left clinic after intervention started|1|||
144688208|NCT00374452|521707490|FG000|Overall Study|Withdrawal by Subject|0|||
144688209|NCT00374452|521707491|FG001|Overall Study|Withdrawal by Subject|2|||
144688210|NCT01601873|521707494|FG000|Overall Study|Lost to Follow-up|2|||
144688211|NCT01601873|521707495|FG001|Overall Study|Lost to Follow-up|3|||
144688212|NCT03196973|521707496|FG000|Overall Study|Adverse Event|1|||
144688213|NCT03196973|521707497|FG001|Overall Study|Adverse Event|1|||
144688214|NCT03196973|521707498|FG002|Overall Study|Adverse Event|2|||
144688215|NCT03196973|521707496|FG000|Overall Study|Lack of Efficacy|2|||
144688216|NCT03196973|521707497|FG001|Overall Study|Lack of Efficacy|6|||
144688217|NCT03196973|521707498|FG002|Overall Study|Lack of Efficacy|1|||
144688218|NCT03196973|521707496|FG000|Overall Study|Lost to Follow-up|4|||
144688219|NCT03196973|521707497|FG001|Overall Study|Lost to Follow-up|3|||
144688220|NCT03196973|521707498|FG002|Overall Study|Lost to Follow-up|2|||
144688221|NCT03196973|521707496|FG000|Overall Study|Consent withdrawn|2|||
144688222|NCT03196973|521707497|FG001|Overall Study|Consent withdrawn|1|||
144688223|NCT03196973|521707498|FG002|Overall Study|Consent withdrawn|0|||
144688224|NCT03196973|521707496|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
144688225|NCT03196973|521707497|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
144688226|NCT03196973|521707498|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
144688227|NCT01610414|521707505|FG000|Study Start - Month 13|Serious Adverse Event|65|||
144688228|NCT01610414|521707506|FG001|Study Start - Month 13|Serious Adverse Event|67|||
144688229|NCT01610414|521707505|FG000|Study Start - Month 13|Adverse Event|14|||
144688230|NCT01610414|521707506|FG001|Study Start - Month 13|Adverse Event|14|||
144688231|NCT01610414|521707505|FG000|Study Start - Month 13|Protocol Violation|3|||
144688232|NCT01610414|521707506|FG001|Study Start - Month 13|Protocol Violation|1|||
144688233|NCT01610414|521707505|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
144688234|NCT01610414|521707506|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
144688235|NCT01610414|521707505|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
144688236|NCT01610414|521707506|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
144688237|NCT01610414|521707505|FG000|Study Start - Month 13|Lost to Follow-up|4|||
144688238|NCT01610414|521707506|FG001|Study Start - Month 13|Lost to Follow-up|6|||
144688239|NCT01610414|521707505|FG000|Study Start - Month 13|Suspected HZ episode|1|||
144688240|NCT01610414|521707506|FG001|Study Start - Month 13|Suspected HZ episode|3|||
144688241|NCT01610414|521707505|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
144688242|NCT01610414|521707506|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
144688243|NCT01610414|521707505|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
144688244|NCT01610414|521707506|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
144688245|NCT01610414|521707505|FG000|Month 13 - Month 25|Adverse Event|8|||
144688246|NCT01610414|521707506|FG001|Month 13 - Month 25|Adverse Event|4|||
144688247|NCT01610414|521707505|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
144688248|NCT01610414|521707506|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
144688249|NCT01610414|521707505|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
144688250|NCT01610414|521707506|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
144688251|NCT01610414|521707505|FG000|Month 13 - Month 25|Protocol Violation|0|||
144688252|NCT01610414|521707506|FG001|Month 13 - Month 25|Protocol Violation|2|||
144688253|NCT01610414|521707505|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
144688254|NCT01610414|521707506|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
144688255|NCT01610414|521707505|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
144688256|NCT01610414|521707506|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
144688257|NCT01610414|521707505|FG000|After Month 25|Study end not reached|48|||
144688258|NCT01610414|521707506|FG001|After Month 25|Study end not reached|53|||
144688259|NCT02483611|521707515|FG000|Overall Study|Protocol Violation|0|||
144688260|NCT02483611|521707516|FG001|Overall Study|Protocol Violation|0|||
144688261|NCT02483611|521707517|FG002|Overall Study|Protocol Violation|1|||
144688262|NCT02520141|521707524|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
144688263|NCT02036476|521707529|FG000|Overall Study|Withdrawal by Subject|2|||
144688264|NCT02036476|521707529|FG000|Overall Study|Progressive Disease|4|||
144741590|NCT00906399|521908497|FG004|Year 2|Adverse Event|8|||
144741591|NCT00906399|521908498|FG005|Year 2|Adverse Event|11|||
144741592|NCT00906399|521908499|FG006|Year 2|Adverse Event|6|||
144741593|NCT00906399|521908493|FG000|Year 2|Lost to Follow-up|0|||
144741594|NCT00906399|521908494|FG001|Year 2|Lost to Follow-up|0|||
144219121|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144688265|NCT02036476|521707529|FG000|Overall Study|Unacceptable Toxicity|2|||
144688266|NCT02168816|521707530|FG000|Overall Study|Lost to Follow-up|2|||
144688267|NCT02168816|521707531|FG001|Overall Study|Lost to Follow-up|2|||
144688268|NCT01984294|521707536|FG000|Overall Study|Randomized but Never Treated|0|||
144688269|NCT01984294|521707537|FG001|Overall Study|Randomized but Never Treated|0|||
144741595|NCT00906399|521908495|FG002|Year 2|Lost to Follow-up|0|||
144688270|NCT01984294|521707538|FG002|Overall Study|Randomized but Never Treated|1|||
144688271|NCT01984294|521707536|FG000|Overall Study|Lack of Efficacy|4|||
144688272|NCT01984294|521707537|FG001|Overall Study|Lack of Efficacy|2|||
144688273|NCT01984294|521707538|FG002|Overall Study|Lack of Efficacy|6|||
144688274|NCT01984294|521707536|FG000|Overall Study|Adverse Event|0|||
144688275|NCT01984294|521707537|FG001|Overall Study|Adverse Event|1|||
144688276|NCT01984294|521707538|FG002|Overall Study|Adverse Event|0|||
144688277|NCT01066546|521707539|FG000|Overall Study|Study terminated by sponsor|5|||
144688278|NCT03452397|521707540|FG000|Overall Study|Adverse Event|1|||
144688279|NCT03452397|521707541|FG001|Overall Study|Adverse Event|0|||
144688280|NCT03452397|521707542|FG002|Overall Study|Adverse Event|0|||
144688281|NCT03452397|521707543|FG003|Overall Study|Adverse Event|0|||
144688282|NCT03452397|521707540|FG000|Overall Study|Administrative reason|0|||
144688283|NCT03452397|521707541|FG001|Overall Study|Administrative reason|0|||
144688284|NCT03452397|521707542|FG002|Overall Study|Administrative reason|1|||
144688285|NCT03452397|521707543|FG003|Overall Study|Administrative reason|1|||
144688286|NCT03452397|521707540|FG000|Overall Study|Withdrawal by Subject|0|||
144688287|NCT03452397|521707541|FG001|Overall Study|Withdrawal by Subject|0|||
144688288|NCT03452397|521707542|FG002|Overall Study|Withdrawal by Subject|1|||
144688289|NCT03452397|521707543|FG003|Overall Study|Withdrawal by Subject|0|||
144688290|NCT00125268|521707544|FG000|Overall Study|Withdrawal by Subject|1|||
144688291|NCT00125268|521707545|FG001|Overall Study|Withdrawal by Subject|1|||
144688292|NCT01021423|521707547|FG000|Overall Study|Study terminated|4|||
144688293|NCT01021423|521707548|FG001|Overall Study|Study terminated|5|||
144688294|NCT03756285|521707550|FG000|Overall Study|Lost to Follow-up|0|||
144688295|NCT03756285|521707551|FG001|Overall Study|Lost to Follow-up|1|||
144688296|NCT03756285|521707550|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
144688297|NCT03756285|521707551|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
144688298|NCT03756285|521707550|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
144688299|NCT03756285|521707551|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
144688300|NCT00286156|521707552|FG000|Overall Study|Missed 12 month visit|0|||
144688301|NCT00286156|521707553|FG001|Overall Study|Missed 12 month visit|0|||
144688302|NCT00286156|521707554|FG002|Overall Study|Missed 12 month visit|1|||
144688303|NCT00286156|521707552|FG000|Overall Study|AE: pulmonary embolus|0|||
144688304|NCT00286156|521707553|FG001|Overall Study|AE: pulmonary embolus|1|||
144688305|NCT00286156|521707554|FG002|Overall Study|AE: pulmonary embolus|0|||
144688306|NCT00286156|521707552|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
144688307|NCT00286156|521707553|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
144688308|NCT00286156|521707554|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
144688309|NCT00286156|521707552|FG000|Overall Study|AE: pneumonia|1|||
144688310|NCT00286156|521707553|FG001|Overall Study|AE: pneumonia|0|||
144688311|NCT00286156|521707554|FG002|Overall Study|AE: pneumonia|0|||
144688312|NCT06334055|521707555|FG000|Overall Study|Adverse Event|4|||
144688313|NCT06334055|521707555|FG000|Overall Study|Disqualified|72|||
144688314|NCT05281094|521707556|FG000|Overall Study|Adverse Event|1|||
144688315|NCT05281094|521707557|FG001|Overall Study|Adverse Event|0|||
144688316|NCT05281094|521707556|FG000|Overall Study|Lost to Follow-up|29|||
144688317|NCT05281094|521707557|FG001|Overall Study|Lost to Follow-up|22|||
144688318|NCT05281094|521707556|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
144688319|NCT05281094|521707557|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
144688320|NCT05281094|521707556|FG000|Overall Study|Death|1|||
144688321|NCT05281094|521707557|FG001|Overall Study|Death|2|||
144688322|NCT05281094|521707556|FG000|Overall Study|Not pre-specified reason|8|||
144688323|NCT05281094|521707557|FG001|Overall Study|Not pre-specified reason|5|||
144688324|NCT00945945|521710434|FG000|Overall Study|Adverse Event|15|||
144688325|NCT00945945|521710435|FG001|Overall Study|Adverse Event|35|||
144688326|NCT00945945|521710434|FG000|Overall Study|Withdrawal by Subject|7|||
144688327|NCT00945945|521710435|FG001|Overall Study|Withdrawal by Subject|10|||
144688328|NCT00945945|521710434|FG000|Overall Study|Lost to Follow-up|4|||
144688329|NCT00945945|521710435|FG001|Overall Study|Lost to Follow-up|5|||
144688330|NCT00945945|521710434|FG000|Overall Study|Lack of Efficacy|6|||
144688331|NCT00945945|521710435|FG001|Overall Study|Lack of Efficacy|2|||
144688332|NCT00945945|521710434|FG000|Overall Study|Protocol Violation|4|||
144688333|NCT00945945|521710435|FG001|Overall Study|Protocol Violation|2|||
144688334|NCT00945945|521710434|FG000|Overall Study|Entry Criteria Not Met|0|||
144688335|NCT00945945|521710435|FG001|Overall Study|Entry Criteria Not Met|1|||
144688336|NCT01066819|521710436|FG000|Overall Study|Adverse Event|18|||
144741596|NCT00906399|521908496|FG003|Year 2|Lost to Follow-up|1|||
144741597|NCT00906399|521908497|FG004|Year 2|Lost to Follow-up|4|||
144688337|NCT01066819|521710437|FG001|Overall Study|Adverse Event|1|||
144688338|NCT01066819|521710438|FG002|Overall Study|Adverse Event|6|||
144688339|NCT01066819|521710439|FG003|Overall Study|Adverse Event|0|||
144688340|NCT01066819|521710440|FG004|Overall Study|Adverse Event|0|||
144688341|NCT01066819|521710441|FG005|Overall Study|Adverse Event|0|||
144688342|NCT01066819|521710436|FG000|Overall Study|Death|5|||
144688343|NCT01066819|521710437|FG001|Overall Study|Death|0|||
144688344|NCT01066819|521710438|FG002|Overall Study|Death|1|||
144688345|NCT01066819|521710439|FG003|Overall Study|Death|0|||
144688346|NCT01066819|521710440|FG004|Overall Study|Death|0|||
144688347|NCT01066819|521710441|FG005|Overall Study|Death|0|||
144688348|NCT01066819|521710436|FG000|Overall Study|Lack of Efficacy|22|||
144688349|NCT01066819|521710437|FG001|Overall Study|Lack of Efficacy|1|||
144688350|NCT01066819|521710438|FG002|Overall Study|Lack of Efficacy|2|||
144688351|NCT01066819|521710439|FG003|Overall Study|Lack of Efficacy|1|||
144688352|NCT01066819|521710440|FG004|Overall Study|Lack of Efficacy|0|||
144688353|NCT01066819|521710441|FG005|Overall Study|Lack of Efficacy|0|||
144688354|NCT01066819|521710436|FG000|Overall Study|Physician Decision|6|||
144688355|NCT01066819|521710437|FG001|Overall Study|Physician Decision|2|||
144688356|NCT01066819|521710438|FG002|Overall Study|Physician Decision|3|||
144688357|NCT01066819|521710439|FG003|Overall Study|Physician Decision|0|||
144688358|NCT01066819|521710440|FG004|Overall Study|Physician Decision|0|||
144688359|NCT01066819|521710441|FG005|Overall Study|Physician Decision|0|||
144688360|NCT01066819|521710436|FG000|Overall Study|Protocol Violation|12|||
144688361|NCT01066819|521710437|FG001|Overall Study|Protocol Violation|6|||
144688362|NCT01066819|521710438|FG002|Overall Study|Protocol Violation|0|||
144688363|NCT01066819|521710439|FG003|Overall Study|Protocol Violation|0|||
144688364|NCT01066819|521710440|FG004|Overall Study|Protocol Violation|0|||
144688365|NCT01066819|521710441|FG005|Overall Study|Protocol Violation|0|||
144688366|NCT01066819|521710436|FG000|Overall Study|Withdrawal by Subject|29|||
144688367|NCT01066819|521710437|FG001|Overall Study|Withdrawal by Subject|11|||
144688368|NCT01066819|521710438|FG002|Overall Study|Withdrawal by Subject|6|||
144688369|NCT01066819|521710439|FG003|Overall Study|Withdrawal by Subject|0|||
144741598|NCT00906399|521908498|FG005|Year 2|Lost to Follow-up|2|||
144741599|NCT00906399|521908499|FG006|Year 2|Lost to Follow-up|4|||
144741600|NCT00906399|521908493|FG000|Year 2|Withdrawal by Subject|0|||
144219122|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219123|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219124|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219125|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219126|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219127|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219128|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
144219129|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219130|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
144219131|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
144219132|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219133|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
144219134|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
144219135|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219136|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219137|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219138|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219139|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219140|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219141|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219142|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219143|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219144|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219145|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
144219146|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219147|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219148|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
144219149|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
144219150|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144688370|NCT01066819|521710440|FG004|Overall Study|Withdrawal by Subject|0|||
144741601|NCT00906399|521908494|FG001|Year 2|Withdrawal by Subject|0|||
144219151|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219152|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219153|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219154|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219155|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144265957|NCT01094288|520176421|FG005|Overall Study|Ongoing Participants|0|||
144265958|NCT01094288|520176422|FG006|Overall Study|Ongoing Participants|0|||
144688371|NCT01066819|521710441|FG005|Overall Study|Withdrawal by Subject|0|||
144688372|NCT01066819|521710436|FG000|Overall Study|Administrative|6|||
144688373|NCT01066819|521710437|FG001|Overall Study|Administrative|4|||
144688374|NCT01066819|521710438|FG002|Overall Study|Administrative|2|||
144688375|NCT01066819|521710439|FG003|Overall Study|Administrative|0|||
144741602|NCT00906399|521908495|FG002|Year 2|Withdrawal by Subject|0|||
144741603|NCT00906399|521908496|FG003|Year 2|Withdrawal by Subject|17|||
144741604|NCT00906399|521908497|FG004|Year 2|Withdrawal by Subject|18|||
144219156|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219157|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219158|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219159|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219160|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219161|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144219162|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
144265959|NCT01094288|520176423|FG007|Overall Study|Ongoing Participants|0|||
144265960|NCT02611882|520176426|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
144688376|NCT01066819|521710440|FG004|Overall Study|Administrative|0|||
144688377|NCT01066819|521710441|FG005|Overall Study|Administrative|0|||
144688378|NCT01066819|521710436|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
144688379|NCT01066819|521710437|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
144688380|NCT01066819|521710438|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
144688381|NCT01066819|521710439|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
144688382|NCT01066819|521710440|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
144688383|NCT01066819|521710441|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
144688384|NCT01066819|521710436|FG000|Overall Study|Early termination|2|||
144688385|NCT01066819|521710437|FG001|Overall Study|Early termination|0|||
144688386|NCT01066819|521710438|FG002|Overall Study|Early termination|0|||
144688387|NCT01066819|521710439|FG003|Overall Study|Early termination|0|||
144688388|NCT01066819|521710440|FG004|Overall Study|Early termination|0|||
144688389|NCT01066819|521710441|FG005|Overall Study|Early termination|0|||
144688390|NCT01066819|521710436|FG000|Overall Study|Failed to return|298|||
144688391|NCT01066819|521710437|FG001|Overall Study|Failed to return|107|||
144688392|NCT01066819|521710438|FG002|Overall Study|Failed to return|68|||
144688393|NCT01066819|521710439|FG003|Overall Study|Failed to return|7|||
144688394|NCT01066819|521710440|FG004|Overall Study|Failed to return|2|||
144688395|NCT01066819|521710441|FG005|Overall Study|Failed to return|3|||
144688396|NCT01066819|521710436|FG000|Overall Study|Lab test not done|9|||
144688397|NCT01066819|521710437|FG001|Overall Study|Lab test not done|0|||
144688398|NCT01066819|521710438|FG002|Overall Study|Lab test not done|2|||
144688399|NCT01066819|521710439|FG003|Overall Study|Lab test not done|1|||
144688400|NCT01066819|521710440|FG004|Overall Study|Lab test not done|0|||
144688401|NCT01066819|521710441|FG005|Overall Study|Lab test not done|0|||
144688402|NCT01066819|521710436|FG000|Overall Study|Miscellaneous|28|||
144688403|NCT01066819|521710437|FG001|Overall Study|Miscellaneous|10|||
144688404|NCT01066819|521710438|FG002|Overall Study|Miscellaneous|18|||
144688405|NCT01066819|521710439|FG003|Overall Study|Miscellaneous|1|||
144688406|NCT01066819|521710440|FG004|Overall Study|Miscellaneous|0|||
144688407|NCT01066819|521710441|FG005|Overall Study|Miscellaneous|0|||
144688408|NCT01066819|521710436|FG000|Overall Study|Non responders|123|||
144688409|NCT01066819|521710437|FG001|Overall Study|Non responders|2|||
144688410|NCT01066819|521710438|FG002|Overall Study|Non responders|7|||
144688411|NCT01066819|521710439|FG003|Overall Study|Non responders|2|||
144688412|NCT01066819|521710440|FG004|Overall Study|Non responders|0|||
144688413|NCT01066819|521710441|FG005|Overall Study|Non responders|1|||
144688414|NCT01066819|521710436|FG000|Overall Study|Not categorised|9|||
144688415|NCT01066819|521710437|FG001|Overall Study|Not categorised|2|||
144688416|NCT01066819|521710438|FG002|Overall Study|Not categorised|6|||
144688417|NCT01066819|521710439|FG003|Overall Study|Not categorised|1|||
144688418|NCT01066819|521710440|FG004|Overall Study|Not categorised|0|||
144688419|NCT01066819|521710441|FG005|Overall Study|Not categorised|0|||
144688420|NCT01066819|521710436|FG000|Overall Study|Relapse|16|||
144688421|NCT01066819|521710437|FG001|Overall Study|Relapse|4|||
144688422|NCT01066819|521710438|FG002|Overall Study|Relapse|3|||
144688423|NCT01066819|521710439|FG003|Overall Study|Relapse|0|||
144688424|NCT01066819|521710440|FG004|Overall Study|Relapse|0|||
144688425|NCT01066819|521710441|FG005|Overall Study|Relapse|0|||
144688426|NCT01066819|521710436|FG000|Overall Study|Results not available|1|||
144688427|NCT01066819|521710437|FG001|Overall Study|Results not available|0|||
144688428|NCT01066819|521710438|FG002|Overall Study|Results not available|0|||
144688429|NCT01066819|521710439|FG003|Overall Study|Results not available|0|||
144688430|NCT01066819|521710440|FG004|Overall Study|Results not available|0|||
144688431|NCT01066819|521710441|FG005|Overall Study|Results not available|0|||
144219163|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144265961|NCT02611882|520176427|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
144265962|NCT02611882|520176428|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
144265963|NCT01389232|520176429|FG000|Overall Study|Had scaffold removed|15|||
144265964|NCT01389232|520176429|FG000|Overall Study|Personal reasons|2|||
144688432|NCT01066819|521710436|FG000|Overall Study|Screen failure|1|||
144688433|NCT01066819|521710437|FG001|Overall Study|Screen failure|0|||
144688434|NCT01066819|521710438|FG002|Overall Study|Screen failure|0|||
144688435|NCT01066819|521710439|FG003|Overall Study|Screen failure|0|||
144688436|NCT01066819|521710440|FG004|Overall Study|Screen failure|0|||
144688437|NCT01066819|521710441|FG005|Overall Study|Screen failure|0|||
144741605|NCT00906399|521908498|FG005|Year 2|Withdrawal by Subject|27|||
144741606|NCT00906399|521908499|FG006|Year 2|Withdrawal by Subject|13|||
144741607|NCT00906399|521908493|FG000|Year 2|Physician Decision|0|||
144741608|NCT00906399|521908494|FG001|Year 2|Physician Decision|0|||
144741609|NCT00906399|521908495|FG002|Year 2|Physician Decision|0|||
144741610|NCT00906399|521908496|FG003|Year 2|Physician Decision|0|||
144741611|NCT00906399|521908497|FG004|Year 2|Physician Decision|2|||
144741612|NCT00906399|521908498|FG005|Year 2|Physician Decision|6|||
144741613|NCT00906399|521908499|FG006|Year 2|Physician Decision|3|||
144741614|NCT00906399|521908493|FG000|Year 2|Death|0|||
144741615|NCT00906399|521908494|FG001|Year 2|Death|0|||
144741616|NCT00906399|521908495|FG002|Year 2|Death|0|||
144741617|NCT00906399|521908496|FG003|Year 2|Death|1|||
144741618|NCT00906399|521908497|FG004|Year 2|Death|0|||
144741619|NCT00906399|521908498|FG005|Year 2|Death|0|||
144741620|NCT00906399|521908499|FG006|Year 2|Death|3|||
144741621|NCT00906399|521908493|FG000|Year 2|Other|0|||
144741622|NCT00906399|521908494|FG001|Year 2|Other|0|||
144741623|NCT00906399|521908495|FG002|Year 2|Other|0|||
144741624|NCT00906399|521908496|FG003|Year 2|Other|2|||
144741625|NCT00906399|521908497|FG004|Year 2|Other|3|||
144741626|NCT00906399|521908498|FG005|Year 2|Other|1|||
144741627|NCT00906399|521908499|FG006|Year 2|Other|0|||
144741628|NCT00748566|521908502|FG000|Overall Study|Adverse Event|49|||
144741629|NCT00748566|521908502|FG000|Overall Study|Death|1|||
144741630|NCT00748566|521908502|FG000|Overall Study|Lack of Efficacy|12|||
144741631|NCT00748566|521908502|FG000|Overall Study|Lost to Follow-up|1|||
144741632|NCT00748566|521908502|FG000|Overall Study|Protocol Violation|13|||
144741633|NCT00748566|521908502|FG000|Overall Study|Withdrawal by Subject|22|||
144741634|NCT00748566|521908502|FG000|Overall Study|Study terminated by sponsor|5|||
144741635|NCT00748566|521908502|FG000|Overall Study|Other|9|||
144741636|NCT00624286|521908505|FG000|Overall Study|Protocol Deviation|7|||
144741637|NCT00624286|521908506|FG001|Overall Study|Protocol Deviation|9|||
144741638|NCT00624286|521908505|FG000|Overall Study|Adverse Event|6|||
144741639|NCT00624286|521908506|FG001|Overall Study|Adverse Event|3|||
144741640|NCT00624286|521908505|FG000|Overall Study|Withdrawal by Subject|5|||
144741641|NCT00624286|521908506|FG001|Overall Study|Withdrawal by Subject|4|||
144741642|NCT00624286|521908505|FG000|Overall Study|Lost to Follow-up|3|||
144741643|NCT00624286|521908506|FG001|Overall Study|Lost to Follow-up|2|||
144741644|NCT00624286|521908505|FG000|Overall Study|Administrative problems|3|||
144741645|NCT00624286|521908506|FG001|Overall Study|Administrative problems|0|||
144741646|NCT00624286|521908505|FG000|Overall Study|Lack of Efficacy|1|||
144741647|NCT00624286|521908506|FG001|Overall Study|Lack of Efficacy|6|||
144741648|NCT00624286|521908505|FG000|Overall Study|Not stated|0|||
144741649|NCT00624286|521908506|FG001|Overall Study|Not stated|1|||
144741650|NCT00624286|521908505|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144741651|NCT00624286|521908506|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144741652|NCT00624286|521908505|FG000|Overall Study|Death|0|||
144741653|NCT00624286|521908506|FG001|Overall Study|Death|1|||
144741654|NCT03488108|521908510|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
144741655|NCT03488108|521908511|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
144741656|NCT03488108|521908510|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
144741657|NCT03488108|521908511|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
144741658|NCT00858780|521908516|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
144741659|NCT00858780|521908517|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
144741660|NCT00858780|521908518|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
144741661|NCT00858780|521908519|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
144741662|NCT00858780|521908520|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
144741663|NCT00858780|521908516|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
144741664|NCT00858780|521908517|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
144741665|NCT00858780|521908518|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
144741666|NCT00858780|521908519|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
144741667|NCT00858780|521908520|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
144741668|NCT00858780|521908516|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
144219164|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144741669|NCT00858780|521908517|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
144741670|NCT00858780|521908518|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
144741671|NCT00858780|521908519|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
144741672|NCT00858780|521908520|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
144741673|NCT00858780|521908516|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
144741674|NCT00858780|521908517|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
144741675|NCT00858780|521908518|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
144741676|NCT00858780|521908519|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
144741677|NCT00858780|521908520|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
144741678|NCT00858780|521908516|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
144741679|NCT00858780|521908517|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
144688438|NCT01066819|521710436|FG000|Overall Study|Spontaneous cure|1|||
144688439|NCT01066819|521710437|FG001|Overall Study|Spontaneous cure|0|||
144688440|NCT01066819|521710438|FG002|Overall Study|Spontaneous cure|0|||
144688441|NCT01066819|521710439|FG003|Overall Study|Spontaneous cure|0|||
144688442|NCT01066819|521710440|FG004|Overall Study|Spontaneous cure|0|||
144688443|NCT01066819|521710441|FG005|Overall Study|Spontaneous cure|0|||
144688444|NCT01066819|521710436|FG000|Overall Study|Treatment never started|85|||
144688445|NCT01066819|521710437|FG001|Overall Study|Treatment never started|19|||
144688446|NCT01066819|521710438|FG002|Overall Study|Treatment never started|19|||
144688447|NCT01066819|521710439|FG003|Overall Study|Treatment never started|3|||
144688448|NCT01066819|521710440|FG004|Overall Study|Treatment never started|2|||
144688449|NCT01066819|521710441|FG005|Overall Study|Treatment never started|2|||
144688450|NCT01066819|521710436|FG000|Overall Study|Treatment stopped|12|||
144688451|NCT01066819|521710437|FG001|Overall Study|Treatment stopped|1|||
144688452|NCT01066819|521710438|FG002|Overall Study|Treatment stopped|2|||
144688453|NCT01066819|521710439|FG003|Overall Study|Treatment stopped|1|||
144688454|NCT01066819|521710440|FG004|Overall Study|Treatment stopped|0|||
144688455|NCT01066819|521710441|FG005|Overall Study|Treatment stopped|0|||
144688456|NCT01066819|521710436|FG000|Overall Study|Other|5|||
144688457|NCT01066819|521710437|FG001|Overall Study|Other|1|||
144688458|NCT01066819|521710438|FG002|Overall Study|Other|1|||
144688459|NCT01066819|521710439|FG003|Overall Study|Other|0|||
144688460|NCT01066819|521710440|FG004|Overall Study|Other|0|||
144688461|NCT01066819|521710441|FG005|Overall Study|Other|0|||
144688462|NCT00805194|521710442|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
144688463|NCT00805194|521710443|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
144688464|NCT00805194|521710442|FG000|Overall Study|Worsening or AE of underlying disease|64|||
144688465|NCT00805194|521710443|FG001|Overall Study|Worsening or AE of underlying disease|70|||
144688466|NCT00805194|521710442|FG000|Overall Study|Other AE|84|||
144688467|NCT00805194|521710443|FG001|Overall Study|Other AE|73|||
144688468|NCT00805194|521710442|FG000|Overall Study|Protocol Violation|9|||
144688469|NCT00805194|521710443|FG001|Overall Study|Protocol Violation|9|||
144688470|NCT00805194|521710442|FG000|Overall Study|Lost to Follow-up|5|||
144688471|NCT00805194|521710443|FG001|Overall Study|Lost to Follow-up|5|||
144688472|NCT00805194|521710442|FG000|Overall Study|Withdrawal by Subject|60|||
144688473|NCT00805194|521710443|FG001|Overall Study|Withdrawal by Subject|42|||
144688474|NCT00805194|521710442|FG000|Overall Study|Not treated|3|||
144688475|NCT00805194|521710443|FG001|Overall Study|Not treated|4|||
144688476|NCT00805194|521710442|FG000|Overall Study|Reasons other than stated above|20|||
144688477|NCT00805194|521710443|FG001|Overall Study|Reasons other than stated above|16|||
144688478|NCT00718887|521710444|FG000|Overall Study|Withdrawal by Subject|3|||
144688479|NCT00718887|521710445|FG001|Overall Study|Withdrawal by Subject|2|||
144688480|NCT00718887|521710444|FG000|Overall Study|Not identified|2|||
144688481|NCT00718887|521710445|FG001|Overall Study|Not identified|7|||
144688482|NCT00948389|521710448|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
144688483|NCT00948389|521710449|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
144688484|NCT00948389|521710450|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
144688485|NCT00948389|521710451|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
144688486|NCT00948389|521710452|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
144688487|NCT00948389|521710448|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
144688488|NCT00948389|521710449|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
144688489|NCT00948389|521710450|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
144688490|NCT00948389|521710451|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
144688491|NCT00948389|521710452|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
144688492|NCT00948389|521710448|FG000|Overall Study|Both Progression and Toxicity|1|||
144688493|NCT00948389|521710449|FG001|Overall Study|Both Progression and Toxicity|0|||
144688494|NCT00948389|521710450|FG002|Overall Study|Both Progression and Toxicity|0|||
144688495|NCT00948389|521710451|FG003|Overall Study|Both Progression and Toxicity|0|||
144688496|NCT00948389|521710452|FG004|Overall Study|Both Progression and Toxicity|0|||
144688497|NCT00568399|521710454|FG000|Overall Study|Death|2|||
144688498|NCT00568399|521710454|FG000|Overall Study|Adverse Event|5|||
144688499|NCT00568399|521710454|FG000|Overall Study|Withdrawal by Subject|8|||
144688500|NCT02967562|521710455|FG000|Overall Study|Consent not obtained|1|||
144688501|NCT02967562|521710456|FG001|Overall Study|Consent not obtained|0|||
144688502|NCT02967562|521710455|FG000|Overall Study|High leak precluding analysis|1|||
144688503|NCT02967562|521710456|FG001|Overall Study|High leak precluding analysis|1|||
144688504|NCT01488994|521710457|FG000|Overall Study|Withdrawal by Subject|0|||
144688505|NCT01488994|521710458|FG001|Overall Study|Withdrawal by Subject|1|||
144688506|NCT01611558|521710459|FG000|Induction Phase|Study drug toxicity|15|||
144688507|NCT01611558|521710459|FG000|Induction Phase|Disease progression|18|||
144688508|NCT01611558|521710459|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
144688509|NCT01611558|521710459|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
144688510|NCT01611558|521710459|FG000|Induction Phase|Death|1|||
144688511|NCT01611558|521710459|FG000|Maintenance Phase|Withdrawal by Subject|1|||
144688512|NCT01611558|521710459|FG000|Maintenance Phase|Elevated Uric acid|1|||
144688513|NCT04005885|521710460|FG000|First Intervention|Withdrawal by Subject|1|||
144688514|NCT04005885|521710461|FG001|First Intervention|Withdrawal by Subject|1|||
144688515|NCT04005885|521710460|FG000|Second Intervention|Withdrawal by Subject|0|||
144688516|NCT04005885|521710461|FG001|Second Intervention|Withdrawal by Subject|2|||
144688517|NCT01412333|521710462|FG000|Overall Study|Adverse Event|40|||
144688518|NCT01412333|521710463|FG001|Overall Study|Adverse Event|42|||
144688519|NCT01412333|521710462|FG000|Overall Study|Death|5|||
144688520|NCT01412333|521710463|FG001|Overall Study|Death|6|||
144688521|NCT01412333|521710462|FG000|Overall Study|Lack of Efficacy|22|||
144688522|NCT01412333|521710463|FG001|Overall Study|Lack of Efficacy|10|||
144688523|NCT01412333|521710462|FG000|Overall Study|Lost to Follow-up|15|||
144688524|NCT01412333|521710463|FG001|Overall Study|Lost to Follow-up|12|||
144688525|NCT01412333|521710462|FG000|Overall Study|Non-Compliance|3|||
144688526|NCT01412333|521710463|FG001|Overall Study|Non-Compliance|7|||
144688527|NCT01412333|521710462|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144688528|NCT01412333|521710463|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144688529|NCT01412333|521710462|FG000|Overall Study|Other|30|||
144688530|NCT01412333|521710463|FG001|Overall Study|Other|33|||
144688531|NCT01412333|521710462|FG000|Overall Study|Physician Decision|11|||
144688532|NCT01412333|521710463|FG001|Overall Study|Physician Decision|16|||
144688533|NCT01412333|521710462|FG000|Overall Study|Pregnancy|6|||
144688534|NCT01412333|521710463|FG001|Overall Study|Pregnancy|4|||
144688535|NCT01412333|521710462|FG000|Overall Study|Protocol Violation|1|||
144688536|NCT01412333|521710463|FG001|Overall Study|Protocol Violation|2|||
144688537|NCT01412333|521710462|FG000|Overall Study|Study Terminated By Sponsor|3|||
144688538|NCT01412333|521710463|FG001|Overall Study|Study Terminated By Sponsor|2|||
144688539|NCT01412333|521710462|FG000|Overall Study|Withdrawal by Subject|51|||
144688540|NCT01412333|521710463|FG001|Overall Study|Withdrawal by Subject|54|||
144688541|NCT01412333|521710462|FG000|Overall Study|Missing|1|||
144688542|NCT01412333|521710463|FG001|Overall Study|Missing|3|||
144688543|NCT00750867|521710464|FG000|Overall Study|Adverse Event|2|||
144688544|NCT00474539|521710465|FG000|Infant Series|Withdrawal by Subject|3|||
144688545|NCT00474539|521710466|FG001|Infant Series|Withdrawal by Subject|4|||
144688546|NCT00474539|521710465|FG000|Infant Series|Randomization error|5|||
144688547|NCT00474539|521710466|FG001|Infant Series|Randomization error|0|||
144688548|NCT00474539|521710465|FG000|Infant Series|Lost to Follow-up|2|||
144688549|NCT00474539|521710466|FG001|Infant Series|Lost to Follow-up|1|||
144688550|NCT00474539|521710465|FG000|Infant Series|Protocol Violation|0|||
144688551|NCT00474539|521710466|FG001|Infant Series|Protocol Violation|1|||
144688552|NCT00474539|521710465|FG000|After Infant Series|Lost to Follow-up|3|||
144688553|NCT00474539|521710466|FG001|After Infant Series|Lost to Follow-up|0|||
144688554|NCT00474539|521710465|FG000|After Infant Series|Withdrawal by Subject|1|||
144688555|NCT00474539|521710466|FG001|After Infant Series|Withdrawal by Subject|0|||
144688556|NCT00474539|521710465|FG000|Toddler Dose|Protocol Violation|1|||
144688557|NCT00474539|521710466|FG001|Toddler Dose|Protocol Violation|0|||
144688558|NCT03018340|521710467|FG000|Overall Study|Adverse Event|1|||
144688559|NCT03018340|521710468|FG001|Overall Study|Adverse Event|2|||
144688560|NCT03018340|521710467|FG000|Overall Study|Withdrawal by Subject|0|||
144688561|NCT03018340|521710468|FG001|Overall Study|Withdrawal by Subject|8|||
144688562|NCT03018340|521710467|FG000|Overall Study|Lack of Efficacy|0|||
144688563|NCT03018340|521710468|FG001|Overall Study|Lack of Efficacy|1|||
144688564|NCT03018340|521710467|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
144688565|NCT03018340|521710468|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
144688566|NCT03018340|521710467|FG000|Overall Study|Lost to Follow-up|1|||
144688567|NCT03018340|521710468|FG001|Overall Study|Lost to Follow-up|7|||
144688568|NCT03018340|521710467|FG000|Overall Study|Protocol Violation|3|||
144688569|NCT03018340|521710468|FG001|Overall Study|Protocol Violation|7|||
144688570|NCT03018340|521710467|FG000|Overall Study|Not further specified|0|||
144688571|NCT03018340|521710468|FG001|Overall Study|Not further specified|1|||
144688572|NCT01836549|521710469|FG000|Overall Study|Did not receive study drug|0|||
144688573|NCT01836549|521710470|FG001|Overall Study|Did not receive study drug|0|||
144688574|NCT01836549|521710471|FG002|Overall Study|Did not receive study drug|1|||
144688575|NCT01836549|521710472|FG003|Overall Study|Did not receive study drug|0|||
144688576|NCT01836549|521710473|FG004|Overall Study|Did not receive study drug|0|||
144688577|NCT01836549|521710474|FG005|Overall Study|Did not receive study drug|0|||
144741680|NCT00858780|521908518|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
144688578|NCT01836549|521710475|FG006|Overall Study|Did not receive study drug|0|||
144688579|NCT01836549|521710469|FG000|Overall Study|Patient declared ineligible|0|||
144688580|NCT01836549|521710470|FG001|Overall Study|Patient declared ineligible|0|||
144688581|NCT01836549|521710471|FG002|Overall Study|Patient declared ineligible|0|||
144688582|NCT01836549|521710472|FG003|Overall Study|Patient declared ineligible|1|||
144688583|NCT01836549|521710473|FG004|Overall Study|Patient declared ineligible|0|||
144688584|NCT01836549|521710474|FG005|Overall Study|Patient declared ineligible|0|||
144688585|NCT01836549|521710475|FG006|Overall Study|Patient declared ineligible|0|||
144688586|NCT01836549|521710469|FG000|Overall Study|Patient inevaluable to start therapy|0|||
144688587|NCT01836549|521710470|FG001|Overall Study|Patient inevaluable to start therapy|0|||
144688588|NCT01836549|521710471|FG002|Overall Study|Patient inevaluable to start therapy|0|||
144688589|NCT01836549|521710472|FG003|Overall Study|Patient inevaluable to start therapy|0|||
144688590|NCT01836549|521710473|FG004|Overall Study|Patient inevaluable to start therapy|0|||
144688591|NCT01836549|521710474|FG005|Overall Study|Patient inevaluable to start therapy|0|||
144688592|NCT01836549|521710475|FG006|Overall Study|Patient inevaluable to start therapy|1|||
144688593|NCT04652102|521710476|FG000|Overall Study|Adverse Event|14|||
144688594|NCT04652102|521710477|FG001|Overall Study|Adverse Event|13|||
144688595|NCT04652102|521710476|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
144688596|NCT04652102|521710477|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
144688597|NCT04652102|521710476|FG000|Overall Study|Physician Decision|78|||
144688598|NCT04652102|521710477|FG001|Overall Study|Physician Decision|40|||
144688599|NCT04652102|521710476|FG000|Overall Study|Study Ended by Sponsor|64|||
144688600|NCT04652102|521710477|FG001|Overall Study|Study Ended by Sponsor|17|||
144688601|NCT04652102|521710476|FG000|Overall Study|Withdrawal by Subject|4625|||
144688602|NCT04652102|521710477|FG001|Overall Study|Withdrawal by Subject|5594|||
144688603|NCT04652102|521710476|FG000|Overall Study|Lost to Follow-up|2019|||
144688604|NCT04652102|521710477|FG001|Overall Study|Lost to Follow-up|1082|||
144688605|NCT04652102|521710476|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
144688606|NCT04652102|521710477|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
144688607|NCT04652102|521710476|FG000|Overall Study|Miscellaneous|80|||
144688608|NCT04652102|521710477|FG001|Overall Study|Miscellaneous|64|||
144688609|NCT02192190|521710482|FG000|Overall Study|Adverse Event|1|||
144688610|NCT02192190|521710483|FG001|Overall Study|Adverse Event|1|||
144688611|NCT02192190|521710484|FG002|Overall Study|Adverse Event|0|||
144688612|NCT02192190|521710485|FG003|Overall Study|Adverse Event|0|||
144688613|NCT02192190|521710486|FG004|Overall Study|Adverse Event|0|||
144688614|NCT02192190|521710487|FG005|Overall Study|Adverse Event|0|||
144688615|NCT02192190|521710482|FG000|Overall Study|Lost to Follow-up|3|||
144688616|NCT02192190|521710483|FG001|Overall Study|Lost to Follow-up|3|||
144688617|NCT02192190|521710484|FG002|Overall Study|Lost to Follow-up|2|||
144688618|NCT02192190|521710485|FG003|Overall Study|Lost to Follow-up|1|||
144688619|NCT02192190|521710486|FG004|Overall Study|Lost to Follow-up|4|||
144688620|NCT02192190|521710487|FG005|Overall Study|Lost to Follow-up|3|||
144688621|NCT02192190|521710482|FG000|Overall Study|Physician Decision|2|||
144688622|NCT02192190|521710483|FG001|Overall Study|Physician Decision|0|||
144688623|NCT02192190|521710484|FG002|Overall Study|Physician Decision|0|||
144688624|NCT02192190|521710485|FG003|Overall Study|Physician Decision|0|||
144688625|NCT02192190|521710486|FG004|Overall Study|Physician Decision|0|||
144688626|NCT02192190|521710487|FG005|Overall Study|Physician Decision|0|||
144688627|NCT02192190|521710482|FG000|Overall Study|Terminated by Sponsor|43|||
144688628|NCT02192190|521710483|FG001|Overall Study|Terminated by Sponsor|23|||
144688629|NCT02192190|521710484|FG002|Overall Study|Terminated by Sponsor|20|||
144688630|NCT02192190|521710485|FG003|Overall Study|Terminated by Sponsor|23|||
144688631|NCT02192190|521710486|FG004|Overall Study|Terminated by Sponsor|21|||
144688632|NCT02192190|521710487|FG005|Overall Study|Terminated by Sponsor|23|||
144688633|NCT02192190|521710482|FG000|Overall Study|Withdrawal by Subject|4|||
144688634|NCT02192190|521710483|FG001|Overall Study|Withdrawal by Subject|1|||
144688635|NCT02192190|521710484|FG002|Overall Study|Withdrawal by Subject|2|||
144688636|NCT02192190|521710485|FG003|Overall Study|Withdrawal by Subject|1|||
144688637|NCT02192190|521710486|FG004|Overall Study|Withdrawal by Subject|5|||
144688638|NCT02192190|521710487|FG005|Overall Study|Withdrawal by Subject|3|||
144741681|NCT00858780|521908519|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
144741682|NCT00858780|521908520|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
144741683|NCT00858780|521908516|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
144741684|NCT00858780|521908517|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
144741685|NCT00858780|521908518|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
144741686|NCT00858780|521908519|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
144741687|NCT00858780|521908520|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
144741688|NCT02615249|521908521|FG000|Overall Study|Withdrawal by Subject|1|||
144741689|NCT05098743|521908523|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
144741690|NCT05098743|521908524|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
144741691|NCT05098743|521908523|FG000|Overall Study|Lost to Follow-up|1|||
144741692|NCT05098743|521908524|FG001|Overall Study|Lost to Follow-up|2|||
144741693|NCT01456221|521908525|FG000|Overall Study|Withdrawal by Subject|56|||
144741694|NCT01456221|521908526|FG001|Overall Study|Withdrawal by Subject|49|||
144741695|NCT01456221|521908525|FG000|Overall Study|Lost to Follow-up|1|||
144741696|NCT01456221|521908526|FG001|Overall Study|Lost to Follow-up|4|||
144741697|NCT01456221|521908525|FG000|Overall Study|Received medication|3|||
144688639|NCT02192190|521710482|FG000|Overall Study|Could not Keep Visit Schedule|1|||
144688640|NCT02192190|521710483|FG001|Overall Study|Could not Keep Visit Schedule|0|||
144688641|NCT02192190|521710484|FG002|Overall Study|Could not Keep Visit Schedule|0|||
144688642|NCT02192190|521710485|FG003|Overall Study|Could not Keep Visit Schedule|0|||
144688643|NCT02192190|521710486|FG004|Overall Study|Could not Keep Visit Schedule|0|||
144688644|NCT02192190|521710487|FG005|Overall Study|Could not Keep Visit Schedule|0|||
144688645|NCT02192190|521710482|FG000|Overall Study|Positive Drug Screen|0|||
144688646|NCT02192190|521710483|FG001|Overall Study|Positive Drug Screen|0|||
144741698|NCT01456221|521908526|FG001|Overall Study|Received medication|2|||
144741699|NCT01456221|521908525|FG000|Overall Study|Incomplete data|4|||
144741700|NCT01456221|521908526|FG001|Overall Study|Incomplete data|2|||
144741701|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
144741702|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
144741703|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
144741704|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
144741705|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
144741706|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741707|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741708|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741709|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741710|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741711|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741712|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741713|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741714|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741715|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741716|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741717|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741718|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741719|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741720|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741721|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741722|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741723|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741724|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741725|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741726|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
144741727|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741728|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
144688647|NCT02192190|521710484|FG002|Overall Study|Positive Drug Screen|0|||
144688648|NCT02192190|521710485|FG003|Overall Study|Positive Drug Screen|1|||
144688649|NCT02192190|521710486|FG004|Overall Study|Positive Drug Screen|0|||
144688650|NCT02192190|521710487|FG005|Overall Study|Positive Drug Screen|0|||
144688651|NCT02192190|521710482|FG000|Overall Study|Inadequate Pain Relief|0|||
144688652|NCT02192190|521710483|FG001|Overall Study|Inadequate Pain Relief|1|||
144688653|NCT02192190|521710484|FG002|Overall Study|Inadequate Pain Relief|1|||
144688654|NCT02192190|521710485|FG003|Overall Study|Inadequate Pain Relief|0|||
144688655|NCT02192190|521710486|FG004|Overall Study|Inadequate Pain Relief|0|||
144688656|NCT02192190|521710487|FG005|Overall Study|Inadequate Pain Relief|0|||
144688657|NCT02607865|521710488|FG000|Overall Study|Lost to Follow-up|9|||
144688658|NCT02607865|521710489|FG001|Overall Study|Lost to Follow-up|7|||
144688659|NCT02607865|521710490|FG002|Overall Study|Lost to Follow-up|7|||
144688660|NCT02607865|521710491|FG003|Overall Study|Lost to Follow-up|5|||
144688661|NCT02607865|521710488|FG000|Overall Study|Withdrawal by Subject|18|||
144688662|NCT02607865|521710489|FG001|Overall Study|Withdrawal by Subject|18|||
144688663|NCT02607865|521710490|FG002|Overall Study|Withdrawal by Subject|17|||
144688664|NCT02607865|521710491|FG003|Overall Study|Withdrawal by Subject|8|||
144688665|NCT02607865|521710488|FG000|Overall Study|Death|5|||
144688666|NCT02607865|521710489|FG001|Overall Study|Death|4|||
144265965|NCT01389232|520176429|FG000|Overall Study|Adverse Event|1|||
144265966|NCT01389232|520176429|FG000|Overall Study|Death|1|||
144688667|NCT02607865|521710490|FG002|Overall Study|Death|1|||
144688668|NCT02607865|521710491|FG003|Overall Study|Death|3|||
144688669|NCT02607865|521710488|FG000|Overall Study|Unclassified|1|||
144688670|NCT02607865|521710489|FG001|Overall Study|Unclassified|1|||
144688671|NCT02607865|521710490|FG002|Overall Study|Unclassified|2|||
144265967|NCT01317940|520176430|FG000|Overall Study|Death|1|||
144265968|NCT01317940|520176431|FG001|Overall Study|Death|0|||
144688672|NCT02607865|521710491|FG003|Overall Study|Unclassified|0|||
144688673|NCT03227692|521710492|FG000|Overall Study|Protocol Violation|1|||
144688674|NCT03227692|521710493|FG001|Overall Study|Protocol Violation|1|||
144688675|NCT03227692|521710492|FG000|Overall Study|Lost to Follow-up|4|||
144688676|NCT03227692|521710493|FG001|Overall Study|Lost to Follow-up|2|||
144688677|NCT03227692|521710492|FG000|Overall Study|Adverse Event|0|||
144688678|NCT03227692|521710493|FG001|Overall Study|Adverse Event|2|||
144265969|NCT01317940|520176432|FG002|Overall Study|Death|1|||
144688679|NCT01657253|521710494|FG000|Overall Study|Lost to Follow-up|6|||
144688680|NCT01657253|521710495|FG001|Overall Study|Lost to Follow-up|5|||
144688681|NCT01657253|521710494|FG000|Overall Study|Withdrawal by Subject|11|||
144688682|NCT01657253|521710495|FG001|Overall Study|Withdrawal by Subject|12|||
144688683|NCT01657253|521710494|FG000|Overall Study|Adverse Event|0|||
144688684|NCT01657253|521710495|FG001|Overall Study|Adverse Event|1|||
144688685|NCT01970540|521710496|FG000|Overall Study|Non-treatment-related AE|0|||
144688686|NCT01970540|521710497|FG001|Overall Study|Non-treatment-related AE|0|||
144688687|NCT01970540|521710498|FG002|Overall Study|Non-treatment-related AE|1|||
144688688|NCT01970540|521710496|FG000|Overall Study|Progressive disease|55|||
144688689|NCT01970540|521710497|FG001|Overall Study|Progressive disease|23|||
144688690|NCT01970540|521710498|FG002|Overall Study|Progressive disease|10|||
144688691|NCT01970540|521710496|FG000|Overall Study|Treatment delay over protocol|0|||
144688692|NCT01970540|521710497|FG001|Overall Study|Treatment delay over protocol|0|||
144688693|NCT01970540|521710498|FG002|Overall Study|Treatment delay over protocol|1|||
144688694|NCT01970540|521710496|FG000|Overall Study|Physician Decision|7|||
144688695|NCT01970540|521710497|FG001|Overall Study|Physician Decision|2|||
144688696|NCT01970540|521710498|FG002|Overall Study|Physician Decision|0|||
144688697|NCT01970540|521710496|FG000|Overall Study|Clinical progression|0|||
144688698|NCT01970540|521710497|FG001|Overall Study|Clinical progression|1|||
144688699|NCT01970540|521710498|FG002|Overall Study|Clinical progression|1|||
144688700|NCT01970540|521710496|FG000|Overall Study|End of study|2|||
144688701|NCT01970540|521710497|FG001|Overall Study|End of study|0|||
144688702|NCT01970540|521710498|FG002|Overall Study|End of study|2|||
144688703|NCT01970540|521710496|FG000|Overall Study|Adverse Event|0|||
144688704|NCT01970540|521710497|FG001|Overall Study|Adverse Event|2|||
144688705|NCT01970540|521710498|FG002|Overall Study|Adverse Event|1|||
144688706|NCT01970540|521710496|FG000|Overall Study|Treatment-related AE|4|||
144688707|NCT01970540|521710497|FG001|Overall Study|Treatment-related AE|0|||
144688708|NCT01970540|521710498|FG002|Overall Study|Treatment-related AE|2|||
144688709|NCT01970540|521710496|FG000|Overall Study|Withdrawal by Subject|4|||
144688710|NCT01970540|521710497|FG001|Overall Study|Withdrawal by Subject|0|||
144688711|NCT01970540|521710498|FG002|Overall Study|Withdrawal by Subject|1|||
144688712|NCT01970540|521710496|FG000|Overall Study|Clinical deterioration|1|||
144688713|NCT01970540|521710497|FG001|Overall Study|Clinical deterioration|0|||
144688714|NCT01970540|521710498|FG002|Overall Study|Clinical deterioration|0|||
144688715|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Adverse Event|30|||
144688716|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Adverse Event|25|||
144688717|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Adverse Event|23|||
144688718|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Adverse Event|14|||
144688719|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Death|0|||
144688720|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Death|0|||
144688721|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Death|1|||
144688722|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Death|0|||
144688723|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Physician Decision|0|||
144688724|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Physician Decision|1|||
144688725|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Physician Decision|0|||
144688726|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Physician Decision|1|||
144688727|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
144688728|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
144688729|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
144688730|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
144688731|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Other|6|||
144688732|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Other|1|||
144688733|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Other|0|||
144688734|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Other|2|||
144688735|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
144688736|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
144688737|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
144688738|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
144688739|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
144688740|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
144688741|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
144688742|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
144688743|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
144688744|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
144688745|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
144688746|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
144688747|NCT00242710|521710499|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
144688748|NCT00242710|521710500|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
144688749|NCT00242710|521710501|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
144688750|NCT00242710|521710502|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
144688751|NCT00242710|521710499|FG000|Period Between Core Study and Extension|Adverse Event|2|||
144688752|NCT00242710|521710500|FG001|Period Between Core Study and Extension|Adverse Event|3|||
144688753|NCT00242710|521710501|FG002|Period Between Core Study and Extension|Adverse Event|5|||
144688754|NCT00242710|521710502|FG003|Period Between Core Study and Extension|Adverse Event|2|||
144688755|NCT00242710|521710499|FG000|Period Between Core Study and Extension|Physician Decision|1|||
144688756|NCT00242710|521710500|FG001|Period Between Core Study and Extension|Physician Decision|1|||
144688757|NCT00242710|521710501|FG002|Period Between Core Study and Extension|Physician Decision|0|||
144688758|NCT00242710|521710502|FG003|Period Between Core Study and Extension|Physician Decision|0|||
144688759|NCT00242710|521710499|FG000|Period Between Core Study and Extension|Other|24|||
144688760|NCT00242710|521710500|FG001|Period Between Core Study and Extension|Other|24|||
144688761|NCT00242710|521710501|FG002|Period Between Core Study and Extension|Other|9|||
144688762|NCT00242710|521710502|FG003|Period Between Core Study and Extension|Other|11|||
144688763|NCT00242710|521710499|FG000|Period Between Core Study and Extension|Extension not Available|17|||
144688764|NCT00242710|521710500|FG001|Period Between Core Study and Extension|Extension not Available|21|||
144688765|NCT00242710|521710501|FG002|Period Between Core Study and Extension|Extension not Available|8|||
144688766|NCT00242710|521710502|FG003|Period Between Core Study and Extension|Extension not Available|7|||
144688767|NCT00242710|521710499|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
144688768|NCT00242710|521710500|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
144688769|NCT00242710|521710501|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
144688770|NCT00242710|521710502|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
144688771|NCT00242710|521710499|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
144741729|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741730|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741731|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741732|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741733|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741734|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741735|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741736|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741737|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741738|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741739|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741740|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741741|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741742|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741743|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741744|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741745|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741746|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741747|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741748|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741749|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741750|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741751|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741752|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
144741753|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741754|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
144741755|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741756|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741757|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741758|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741759|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741760|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741761|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741762|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741763|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741764|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741765|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741766|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741767|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741768|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741769|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741770|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741771|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741772|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741773|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741774|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741775|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741776|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741777|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741778|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
144741779|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
144741780|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741781|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
144741782|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
144741783|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
144741784|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741785|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144688772|NCT00242710|521710500|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
144688773|NCT00242710|521710501|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
144688774|NCT00242710|521710502|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
144688775|NCT00242710|521710499|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
144688776|NCT00242710|521710500|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
144688777|NCT00242710|521710501|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
144688778|NCT00242710|521710502|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
144688779|NCT00242710|521710499|FG000|Study Extension (up to Year 2)|Death|0|||
144688780|NCT00242710|521710500|FG001|Study Extension (up to Year 2)|Death|0|||
144688781|NCT00242710|521710501|FG002|Study Extension (up to Year 2)|Death|0|||
144688782|NCT00242710|521710502|FG003|Study Extension (up to Year 2)|Death|1|||
144688783|NCT00242710|521710499|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
144688784|NCT00242710|521710500|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
144688785|NCT00242710|521710501|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
144688786|NCT00242710|521710502|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
144688787|NCT00242710|521710499|FG000|Study Extension (up to Year 2)|Other|3|||
144688788|NCT00242710|521710500|FG001|Study Extension (up to Year 2)|Other|5|||
144688789|NCT00242710|521710501|FG002|Study Extension (up to Year 2)|Other|4|||
144688790|NCT00242710|521710502|FG003|Study Extension (up to Year 2)|Other|3|||
144688791|NCT00242710|521710499|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
144688792|NCT00242710|521710500|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
144688793|NCT00242710|521710501|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
144688794|NCT00242710|521710502|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
144688795|NCT00242710|521710499|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
144688796|NCT00242710|521710500|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
144688797|NCT00242710|521710501|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
144688798|NCT00242710|521710502|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
144688799|NCT00579527|521710503|FG000|Overall Study|Death|4|||
144688800|NCT00381706|521710504|FG000|Overall Study|Never treated|7|||
144688801|NCT00381706|521710505|FG001|Overall Study|Never treated|2|||
144688802|NCT00381706|521710506|FG002|Overall Study|Never treated|1|||
144688803|NCT00550615|521710508|FG000|Overall Study|Withdrawal by Subject|0|||
144688804|NCT00550615|521710509|FG001|Overall Study|Withdrawal by Subject|0|||
144688805|NCT00550615|521710510|FG002|Overall Study|Withdrawal by Subject|2|||
144688806|NCT00550615|521710511|FG003|Overall Study|Withdrawal by Subject|3|||
144688807|NCT00550615|521710508|FG000|Overall Study|Not evaluable|0|||
144688808|NCT00550615|521710509|FG001|Overall Study|Not evaluable|0|||
144688809|NCT00550615|521710510|FG002|Overall Study|Not evaluable|2|||
144688810|NCT00550615|521710511|FG003|Overall Study|Not evaluable|7|||
144688811|NCT02405091|521710514|FG000|Overall Study|Adverse Event|16|||
144688812|NCT02405091|521710515|FG001|Overall Study|Adverse Event|10|||
144688813|NCT02405091|521710516|FG002|Overall Study|Adverse Event|0|||
144688814|NCT02405091|521710514|FG000|Overall Study|Protocol Violation|1|||
144688815|NCT02405091|521710515|FG001|Overall Study|Protocol Violation|0|||
144688816|NCT02405091|521710516|FG002|Overall Study|Protocol Violation|0|||
144688817|NCT02405091|521710514|FG000|Overall Study|Noncompliance|1|||
144688818|NCT02405091|521710515|FG001|Overall Study|Noncompliance|6|||
144688819|NCT02405091|521710516|FG002|Overall Study|Noncompliance|2|||
144688820|NCT02405091|521710514|FG000|Overall Study|Withdrawal by Subject|4|||
144688821|NCT02405091|521710515|FG001|Overall Study|Withdrawal by Subject|8|||
144688822|NCT02405091|521710516|FG002|Overall Study|Withdrawal by Subject|0|||
144688823|NCT02405091|521710514|FG000|Overall Study|Death|0|||
144688824|NCT02405091|521710515|FG001|Overall Study|Death|1|||
144688825|NCT02405091|521710516|FG002|Overall Study|Death|0|||
144688826|NCT02405091|521710514|FG000|Overall Study|Lost to Follow-up|5|||
144688827|NCT02405091|521710515|FG001|Overall Study|Lost to Follow-up|6|||
144688828|NCT02405091|521710516|FG002|Overall Study|Lost to Follow-up|0|||
144688829|NCT02405091|521710514|FG000|Overall Study|Physician Decision|2|||
144688830|NCT02405091|521710515|FG001|Overall Study|Physician Decision|2|||
144688831|NCT02405091|521710516|FG002|Overall Study|Physician Decision|0|||
144688832|NCT01948791|521710524|FG000|Overall Study|Adverse Event|12|||
144688833|NCT01948791|521710524|FG000|Overall Study|Lack of Efficacy|3|||
144688834|NCT01948791|521710524|FG000|Overall Study|Protocol Violation|2|||
144265970|NCT01317940|520176433|FG003|Overall Study|Death|0|||
144265971|NCT01317940|520176434|FG004|Overall Study|Death|0|||
144688835|NCT01948791|521710524|FG000|Overall Study|Withdrawal by Subject|5|||
144688836|NCT01948791|521710524|FG000|Overall Study|Lost to Follow-up|6|||
144688837|NCT01948791|521710524|FG000|Overall Study|Management issues|1|||
144688838|NCT01948791|521710524|FG000|Overall Study|Others|7|||
144688839|NCT01948791|521710524|FG000|Overall Study|Screening failure|35|||
144688840|NCT00247962|521710536|FG000|Overall Study|Adverse Event|15|||
144688841|NCT00247962|521710537|FG001|Overall Study|Adverse Event|12|||
144688842|NCT00247962|521710536|FG000|Overall Study|Lost to Follow-up|3|||
144688843|NCT00247962|521710537|FG001|Overall Study|Lost to Follow-up|1|||
144688844|NCT00247962|521710536|FG000|Overall Study|Physician Decision|0|||
144688845|NCT00247962|521710537|FG001|Overall Study|Physician Decision|1|||
144688846|NCT00247962|521710536|FG000|Overall Study|Protocol Violation|1|||
144688847|NCT00247962|521710537|FG001|Overall Study|Protocol Violation|1|||
144688848|NCT00247962|521710536|FG000|Overall Study|Withdrawal by Subject|3|||
144688849|NCT00247962|521710537|FG001|Overall Study|Withdrawal by Subject|2|||
144688850|NCT00247962|521710536|FG000|Overall Study|Lack of Efficacy|4|||
144688851|NCT00247962|521710537|FG001|Overall Study|Lack of Efficacy|2|||
144688852|NCT01955005|521710538|FG000|Overall Study|Withdrawal by Subject|3|||
144688853|NCT01955005|521710539|FG001|Overall Study|Withdrawal by Subject|5|||
144688854|NCT02555722|521710544|FG000|Week 2|Adverse Event|0|||
144688855|NCT02555722|521710545|FG001|Week 2|Adverse Event|1|||
144688856|NCT02555722|521710544|FG000|Week 2|Withdrawal by Subject|1|||
144688857|NCT02555722|521710545|FG001|Week 2|Withdrawal by Subject|0|||
144688858|NCT02555722|521710544|FG000|Month 1|Lens Discomfort|1|||
144688859|NCT02555722|521710545|FG001|Month 1|Lens Discomfort|0|||
144688860|NCT02555722|521710544|FG000|Month 2|Withdrawal by Subject|3|||
144688861|NCT02555722|521710545|FG001|Month 2|Withdrawal by Subject|0|||
144688862|NCT02555722|521710544|FG000|Month 2|Lost to Follow-up|1|||
144688863|NCT02555722|521710545|FG001|Month 2|Lost to Follow-up|0|||
144688864|NCT00702949|521710546|FG000|Overall Study|Refusal|3|||
144688865|NCT00702949|521710547|FG001|Overall Study|Refusal|2|||
144688866|NCT00702949|521710548|FG002|Overall Study|Refusal|2|||
144688867|NCT00702949|521710546|FG000|Overall Study|Adverse Event|1|||
144688868|NCT00702949|521710547|FG001|Overall Study|Adverse Event|6|||
144688869|NCT00702949|521710548|FG002|Overall Study|Adverse Event|3|||
144688870|NCT00702949|521710546|FG000|Overall Study|Other Medical Reason/unknown|1|||
144688871|NCT00702949|521710547|FG001|Overall Study|Other Medical Reason/unknown|1|||
144688872|NCT00702949|521710548|FG002|Overall Study|Other Medical Reason/unknown|3|||
144688873|NCT01469637|521710549|FG000|First Intervention|Unacceptable behavior|0|||
144688874|NCT01469637|521710550|FG001|First Intervention|Unacceptable behavior|1|||
144688875|NCT01469637|521710549|FG000|Second Intervention|Incarcerated|1|||
144688876|NCT01469637|521710550|FG001|Second Intervention|Incarcerated|0|||
144688877|NCT01371721|521710551|FG000|Overall Study|Adverse Event|5|||
144688878|NCT01371721|521710552|FG001|Overall Study|Adverse Event|4|||
144688879|NCT01371721|521710553|FG002|Overall Study|Adverse Event|5|||
144688880|NCT01371721|521710551|FG000|Overall Study|Protocol Violation|6|||
144688881|NCT01371721|521710552|FG001|Overall Study|Protocol Violation|4|||
144688882|NCT01371721|521710553|FG002|Overall Study|Protocol Violation|5|||
144688883|NCT01371721|521710551|FG000|Overall Study|Lost to Follow-up|8|||
144688884|NCT01371721|521710552|FG001|Overall Study|Lost to Follow-up|2|||
144688885|NCT01371721|521710553|FG002|Overall Study|Lost to Follow-up|6|||
144688886|NCT01371721|521710551|FG000|Overall Study|Withdrawal by Subject|5|||
144688887|NCT01371721|521710552|FG001|Overall Study|Withdrawal by Subject|7|||
144688888|NCT01371721|521710553|FG002|Overall Study|Withdrawal by Subject|11|||
144688889|NCT01371721|521710551|FG000|Overall Study|Other|2|||
144688890|NCT01371721|521710552|FG001|Overall Study|Other|3|||
144688891|NCT01371721|521710553|FG002|Overall Study|Other|0|||
144688892|NCT01371721|521710551|FG000|Overall Study|Lack of Efficacy|2|||
144688893|NCT01371721|521710552|FG001|Overall Study|Lack of Efficacy|4|||
144688894|NCT01371721|521710553|FG002|Overall Study|Lack of Efficacy|3|||
144688895|NCT01371721|521710551|FG000|Overall Study|Randomized but not treated|1|||
144688896|NCT01371721|521710552|FG001|Overall Study|Randomized but not treated|0|||
144688897|NCT01371721|521710553|FG002|Overall Study|Randomized but not treated|0|||
144688898|NCT00826540|521710558|FG000|Overall Study|ineligible|3|||
144688899|NCT00826540|521710558|FG000|Overall Study|Withdrawal by Subject|1|||
144688900|NCT02802735|521710559|FG000|Overall Study|Withdrawal by Subject|0|||
144688901|NCT02802735|521710560|FG001|Overall Study|Withdrawal by Subject|1|||
144688902|NCT02802735|521710561|FG002|Overall Study|Withdrawal by Subject|0|||
144688903|NCT02802735|521710562|FG003|Overall Study|Withdrawal by Subject|0|||
144688904|NCT02802735|521710563|FG004|Overall Study|Withdrawal by Subject|0|||
144688905|NCT01166386|521710564|FG000|Overall Study|Withdrawal by Subject|3|||
144688906|NCT01166386|521710565|FG001|Overall Study|Withdrawal by Subject|5|||
144265972|NCT01317940|520176435|FG005|Overall Study|Death|0|||
144688907|NCT03922711|521710566|FG000|Overall Study|Adverse Event|3|||
144688908|NCT03922711|521710567|FG001|Overall Study|Adverse Event|2|||
144688909|NCT03922711|521710568|FG002|Overall Study|Adverse Event|2|||
144688910|NCT03922711|521710566|FG000|Overall Study|Protocol Violation|1|||
144265973|NCT01317940|520176430|FG000|Overall Study|Lost to Follow-up|0|||
144688911|NCT03922711|521710567|FG001|Overall Study|Protocol Violation|0|||
144688912|NCT03922711|521710568|FG002|Overall Study|Protocol Violation|0|||
144688913|NCT03922711|521710566|FG000|Overall Study|Withdrawal by Subject|0|||
144688914|NCT03922711|521710567|FG001|Overall Study|Withdrawal by Subject|3|||
144688915|NCT03922711|521710568|FG002|Overall Study|Withdrawal by Subject|1|||
144688916|NCT03922711|521710566|FG000|Overall Study|Not further specified|0|||
144688917|NCT03922711|521710567|FG001|Overall Study|Not further specified|0|||
144688918|NCT03922711|521710568|FG002|Overall Study|Not further specified|1|||
144688919|NCT02390362|521710569|FG000|Overall Study|Withdrawal by Subject|0|||
144688920|NCT02390362|521710570|FG001|Overall Study|Withdrawal by Subject|1|||
144688921|NCT04009824|521710571|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
144688922|NCT04009824|521710572|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
144688923|NCT04009824|521710573|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
144688924|NCT04009824|521710574|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
144688925|NCT04009824|521710575|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
144688926|NCT01024946|521710576|FG000|Overall Study|Screen Failure|3|||
144688927|NCT01024946|521710576|FG000|Overall Study|Withdrawal by Subject|1|||
144688928|NCT01024946|521710576|FG000|Overall Study|Adverse Event|1|||
144688929|NCT02608892|521710586|FG000|Overall Study|Lost to Follow-up|1|||
144688930|NCT02608892|521710587|FG001|Overall Study|Lost to Follow-up|0|||
144688931|NCT02590406|521710588|FG000|Overall Study|Adverse Event|1|||
144688932|NCT02590406|521710589|FG001|Overall Study|Adverse Event|0|||
144688933|NCT02590406|521710588|FG000|Overall Study|Saturometer malfunction|0|||
144688934|NCT02590406|521710589|FG001|Overall Study|Saturometer malfunction|1|||
144688935|NCT03032523|521710590|FG000|Overall Study|Withdrawal by Subject|2|||
144688936|NCT03032523|521710591|FG001|Overall Study|Withdrawal by Subject|2|||
144688937|NCT03032523|521710590|FG000|Overall Study|Physician Decision|1|||
144688938|NCT03032523|521710591|FG001|Overall Study|Physician Decision|0|||
144741786|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741787|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741788|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741789|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741790|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741791|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741792|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741793|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741794|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741795|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144688939|NCT00957723|521710594|FG000|Overall Study|Death|3|||
144688940|NCT00957723|521710594|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
144688941|NCT00957723|521710594|FG000|Overall Study|Lost to Follow-up|8|||
144688942|NCT00957723|521710594|FG000|Overall Study|Withdrawal by Subject|24|||
144688943|NCT00957723|521710594|FG000|Overall Study|Investigative Site Terminated|61|||
144688944|NCT00957723|521710594|FG000|Overall Study|Intercurrent Illness|2|||
144688945|NCT00957723|521710594|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
144688946|NCT00984009|521710595|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
144688947|NCT00281528|521710596|FG000|Overall Study|Progressive Disease|28|||
144688948|NCT00281528|521710597|FG001|Overall Study|Progressive Disease|18|||
144688949|NCT00281528|521710598|FG002|Overall Study|Progressive Disease|27|||
144688950|NCT00281528|521710596|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
144688951|NCT00281528|521710597|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
144688952|NCT00281528|521710598|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
144688953|NCT00281528|521710596|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
144688954|NCT00281528|521710597|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
144688955|NCT00281528|521710598|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
144688956|NCT00281528|521710596|FG000|Overall Study|Physician Decision|11|||
144688957|NCT00281528|521710597|FG001|Overall Study|Physician Decision|4|||
144688958|NCT00281528|521710598|FG002|Overall Study|Physician Decision|5|||
144688959|NCT00281528|521710596|FG000|Overall Study|Protocol Violation|1|||
144688960|NCT00281528|521710597|FG001|Overall Study|Protocol Violation|0|||
144688961|NCT00281528|521710598|FG002|Overall Study|Protocol Violation|1|||
144688962|NCT00281528|521710596|FG000|Overall Study|Withdrawal by Subject|5|||
144688963|NCT00281528|521710597|FG001|Overall Study|Withdrawal by Subject|5|||
144688964|NCT00281528|521710598|FG002|Overall Study|Withdrawal by Subject|7|||
144688965|NCT00281528|521710596|FG000|Overall Study|Other|6|||
144688966|NCT00281528|521710597|FG001|Overall Study|Other|3|||
144688967|NCT00281528|521710598|FG002|Overall Study|Other|5|||
144688968|NCT02178592|521710599|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
144688969|NCT02178592|521710600|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
144688970|NCT02178592|521710599|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
144688971|NCT02178592|521710600|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
144741796|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741797|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741798|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741799|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741800|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741801|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144688972|NCT02178592|521710599|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
144688973|NCT02178592|521710600|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
144688974|NCT02178592|521710599|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
144688975|NCT02178592|521710600|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
144688976|NCT02178592|521710599|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
144688977|NCT02178592|521710600|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
144741802|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741803|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144741804|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
144688978|NCT02178592|521710599|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
144688979|NCT02178592|521710600|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
144688980|NCT02178592|521710599|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
144688981|NCT02178592|521710600|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
144688982|NCT02178592|521710599|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
144688983|NCT02178592|521710600|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
144688984|NCT02178592|521710599|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
144688985|NCT02178592|521710600|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
144688986|NCT02178592|521710599|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
144688987|NCT02178592|521710600|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
144688988|NCT02178592|521710599|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
144688989|NCT02178592|521710600|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
144688990|NCT02178592|521710599|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
144688991|NCT02178592|521710600|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
144688992|NCT01225211|521710602|FG000|Overall Study|Adverse Event|0|||
144688993|NCT01225211|521710603|FG001|Overall Study|Adverse Event|0|||
144688994|NCT01225211|521710604|FG002|Overall Study|Adverse Event|1|||
144688995|NCT01225211|521710605|FG003|Overall Study|Adverse Event|0|||
144688996|NCT01225211|521710606|FG004|Overall Study|Adverse Event|0|||
144688997|NCT01225211|521710607|FG005|Overall Study|Adverse Event|0|||
144688998|NCT01225211|521710608|FG006|Overall Study|Adverse Event|0|||
144688999|NCT01225211|521710609|FG007|Overall Study|Adverse Event|0|||
144689000|NCT01225211|521710610|FG008|Overall Study|Adverse Event|0|||
144689001|NCT01225211|521710611|FG009|Overall Study|Adverse Event|1|||
144689002|NCT01225211|521710602|FG000|Overall Study|Withdrawal by Subject|0|||
144689003|NCT01225211|521710603|FG001|Overall Study|Withdrawal by Subject|0|||
144689004|NCT01225211|521710604|FG002|Overall Study|Withdrawal by Subject|0|||
144689005|NCT01225211|521710605|FG003|Overall Study|Withdrawal by Subject|0|||
144689006|NCT01225211|521710606|FG004|Overall Study|Withdrawal by Subject|0|||
144689007|NCT01225211|521710607|FG005|Overall Study|Withdrawal by Subject|0|||
144689008|NCT01225211|521710608|FG006|Overall Study|Withdrawal by Subject|1|||
144689009|NCT01225211|521710609|FG007|Overall Study|Withdrawal by Subject|0|||
144689010|NCT01225211|521710610|FG008|Overall Study|Withdrawal by Subject|1|||
144689011|NCT01225211|521710611|FG009|Overall Study|Withdrawal by Subject|3|||
144689012|NCT01225211|521710602|FG000|Overall Study|Other|0|||
144689013|NCT01225211|521710603|FG001|Overall Study|Other|0|||
144689014|NCT01225211|521710604|FG002|Overall Study|Other|0|||
144689015|NCT01225211|521710605|FG003|Overall Study|Other|0|||
144689016|NCT01225211|521710606|FG004|Overall Study|Other|0|||
144689017|NCT01225211|521710607|FG005|Overall Study|Other|0|||
144689018|NCT01225211|521710608|FG006|Overall Study|Other|0|||
144689019|NCT01225211|521710609|FG007|Overall Study|Other|0|||
144689020|NCT01225211|521710610|FG008|Overall Study|Other|0|||
144689021|NCT01225211|521710611|FG009|Overall Study|Other|1|||
144689022|NCT00537810|521710625|FG000|Overall Study|Withdrawal by Subject|4|||
144689023|NCT00537810|521710626|FG001|Overall Study|Withdrawal by Subject|11|||
144689024|NCT00537810|521710627|FG002|Overall Study|Withdrawal by Subject|4|||
144689025|NCT00537810|521710628|FG003|Overall Study|Withdrawal by Subject|3|||
144689026|NCT00537810|521710625|FG000|Overall Study|Medically withdrawn|2|||
144689027|NCT00537810|521710626|FG001|Overall Study|Medically withdrawn|2|||
144689028|NCT00537810|521710627|FG002|Overall Study|Medically withdrawn|0|||
144689029|NCT00537810|521710628|FG003|Overall Study|Medically withdrawn|1|||
144689030|NCT03258762|521710637|FG000|Overall Study|Lost to Follow-up|0|||
144689031|NCT03258762|521710638|FG001|Overall Study|Lost to Follow-up|1|||
144689032|NCT01711359|521710639|FG000|Treatment Period|Withdrawal by Subject|18|||
144689033|NCT01711359|521710640|FG001|Treatment Period|Withdrawal by Subject|7|||
144689034|NCT01711359|521710641|FG002|Treatment Period|Withdrawal by Subject|13|||
144689035|NCT01711359|521710639|FG000|Treatment Period|Lack of Efficacy|13|||
144689036|NCT01711359|521710640|FG001|Treatment Period|Lack of Efficacy|2|||
144689037|NCT01711359|521710641|FG002|Treatment Period|Lack of Efficacy|2|||
144689038|NCT01711359|521710639|FG000|Treatment Period|Adverse Event|8|||
144689039|NCT01711359|521710640|FG001|Treatment Period|Adverse Event|10|||
144689040|NCT01711359|521710641|FG002|Treatment Period|Adverse Event|24|||
144689041|NCT01711359|521710639|FG000|Treatment Period|Physician Decision|4|||
144689042|NCT01711359|521710640|FG001|Treatment Period|Physician Decision|3|||
144689043|NCT01711359|521710641|FG002|Treatment Period|Physician Decision|2|||
144689044|NCT01711359|521710639|FG000|Treatment Period|Death|3|||
144689045|NCT01711359|521710640|FG001|Treatment Period|Death|0|||
144689046|NCT01711359|521710641|FG002|Treatment Period|Death|0|||
144265974|NCT01317940|520176431|FG001|Overall Study|Lost to Follow-up|0|||
144689047|NCT01711359|521710639|FG000|Treatment Period|Entry Criteria Not Met|1|||
144689048|NCT01711359|521710640|FG001|Treatment Period|Entry Criteria Not Met|0|||
144689049|NCT01711359|521710641|FG002|Treatment Period|Entry Criteria Not Met|0|||
144689050|NCT01711359|521710639|FG000|Treatment Period|Sponsor Decision|1|||
144689051|NCT01711359|521710640|FG001|Treatment Period|Sponsor Decision|0|||
144689052|NCT01711359|521710641|FG002|Treatment Period|Sponsor Decision|0|||
144689053|NCT01711359|521710639|FG000|Treatment Period|Lost to Follow-up|1|||
144689054|NCT01711359|521710640|FG001|Treatment Period|Lost to Follow-up|1|||
144689055|NCT01711359|521710641|FG002|Treatment Period|Lost to Follow-up|1|||
144689056|NCT01711359|521710639|FG000|Treatment Period|Randomized, Not Treated|3|||
144689057|NCT01711359|521710640|FG001|Treatment Period|Randomized, Not Treated|1|||
144689058|NCT01711359|521710641|FG002|Treatment Period|Randomized, Not Treated|0|||
144689059|NCT00554840|521710642|FG000|Overall Study|Physician Decision|0|||
144689060|NCT00554840|521710643|FG001|Overall Study|Physician Decision|1|||
144689061|NCT02698176|521710644|FG000|Overall Study|Progressive disease|4|||
144689062|NCT02698176|521710645|FG001|Overall Study|Progressive disease|3|||
144689063|NCT02698176|521710646|FG002|Overall Study|Progressive disease|1|||
144689064|NCT02698176|521710647|FG003|Overall Study|Progressive disease|0|||
144689065|NCT02698176|521710644|FG000|Overall Study|Adverse Event|2|||
144689066|NCT02698176|521710645|FG001|Overall Study|Adverse Event|0|||
144689067|NCT02698176|521710646|FG002|Overall Study|Adverse Event|0|||
144689068|NCT02698176|521710647|FG003|Overall Study|Adverse Event|0|||
144689069|NCT02698176|521710644|FG000|Overall Study|Clinical progression|3|||
144689070|NCT02698176|521710645|FG001|Overall Study|Clinical progression|0|||
144689071|NCT02698176|521710646|FG002|Overall Study|Clinical progression|0|||
144689072|NCT02698176|521710647|FG003|Overall Study|Clinical progression|0|||
144689073|NCT00925522|521710648|FG000|Overall Study|study closed -- business decision|20|||
144689074|NCT02561572|521710653|FG000|Overall Study|Inadequate time before surgery|2|||
144689075|NCT02561572|521710654|FG001|Overall Study|Inadequate time before surgery|1|||
144689076|NCT02561572|521710653|FG000|Overall Study|Protocol Violation|0|||
144689077|NCT02561572|521710654|FG001|Overall Study|Protocol Violation|1|||
144689078|NCT00795717|521710655|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
144689079|NCT00795717|521710656|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
144689080|NCT00795717|521710655|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
144689081|NCT00795717|521710656|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
144689082|NCT00795717|521710655|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
144689083|NCT00795717|521710656|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
144689084|NCT00795717|521710655|FG000|Phase II|too busy|0|||
144689085|NCT00795717|521710656|FG001|Phase II|too busy|1|||
144689086|NCT00410514|521710657|FG000|Overall Study|Adverse Event|2|||
144689087|NCT00410514|521710658|FG001|Overall Study|Adverse Event|2|||
144689088|NCT00410514|521710659|FG002|Overall Study|Adverse Event|2|||
144689089|NCT00410514|521710657|FG000|Overall Study|Protocol Violation|0|||
144689090|NCT00410514|521710658|FG001|Overall Study|Protocol Violation|1|||
144689091|NCT00410514|521710659|FG002|Overall Study|Protocol Violation|1|||
144689092|NCT00410514|521710657|FG000|Overall Study|Lost to Follow-up|0|||
144689093|NCT00410514|521710658|FG001|Overall Study|Lost to Follow-up|0|||
144689094|NCT00410514|521710659|FG002|Overall Study|Lost to Follow-up|2|||
144689095|NCT00410514|521710657|FG000|Overall Study|Non-compliant with study procedures|0|||
144689096|NCT00410514|521710658|FG001|Overall Study|Non-compliant with study procedures|0|||
144689097|NCT00410514|521710659|FG002|Overall Study|Non-compliant with study procedures|2|||
144689098|NCT02691468|521710662|FG000|Overall Study|Bronchial blocker use|2|||
144689099|NCT02691468|521710663|FG001|Overall Study|Bronchial blocker use|1|||
144689100|NCT02691468|521710662|FG000|Overall Study|Lost to Follow-up|2|||
144689101|NCT02691468|521710663|FG001|Overall Study|Lost to Follow-up|1|||
144689102|NCT02691468|521710662|FG000|Overall Study|Failure to advance FOB|2|||
144689103|NCT02691468|521710663|FG001|Overall Study|Failure to advance FOB|0|||
144689104|NCT00394654|521710664|FG000|Overall Study|Lost to Follow-up|1|||
144689105|NCT00394654|521710665|FG001|Overall Study|Lost to Follow-up|0|||
144689106|NCT00394654|521710664|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
144689107|NCT00394654|521710665|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
144689108|NCT02886338|521710666|FG000|Overall Study|Withdrawal by Subject|1|||
144689109|NCT00631969|521710670|FG000|Overall Study|Adverse Event|3|||
144689110|NCT00631969|521710671|FG001|Overall Study|Adverse Event|1|||
144689111|NCT00631969|521710670|FG000|Overall Study|Lack of Efficacy|2|||
144689112|NCT00631969|521710671|FG001|Overall Study|Lack of Efficacy|8|||
144689113|NCT00631969|521710670|FG000|Overall Study|Lost to Follow-up|2|||
144689114|NCT00631969|521710671|FG001|Overall Study|Lost to Follow-up|1|||
144689115|NCT00631969|521710670|FG000|Overall Study|Protocol Violation|1|||
144689116|NCT00631969|521710671|FG001|Overall Study|Protocol Violation|1|||
144689117|NCT00631969|521710670|FG000|Overall Study|Consent Withdrawn|5|||
144689118|NCT00631969|521710671|FG001|Overall Study|Consent Withdrawn|7|||
144689119|NCT00631969|521710670|FG000|Overall Study|Noncompliant With Study Medication|0|||
144689120|NCT00631969|521710671|FG001|Overall Study|Noncompliant With Study Medication|1|||
144689121|NCT00631969|521710670|FG000|Overall Study|No Drug Exposure|2|||
144689122|NCT00631969|521710671|FG001|Overall Study|No Drug Exposure|2|||
144689123|NCT00957034|521710672|FG000|Overall Study|Adverse Event|0|||
144689124|NCT00957034|521710673|FG001|Overall Study|Adverse Event|1|||
144689125|NCT00957034|521710674|FG002|Overall Study|Adverse Event|1|||
144689126|NCT00957034|521710672|FG000|Overall Study|Sponsor Terminated Study|6|||
144689127|NCT00957034|521710673|FG001|Overall Study|Sponsor Terminated Study|1|||
144689128|NCT00957034|521710674|FG002|Overall Study|Sponsor Terminated Study|5|||
144689129|NCT00957034|521710672|FG000|Overall Study|Withdrawal by Subject|0|||
144689130|NCT00957034|521710673|FG001|Overall Study|Withdrawal by Subject|2|||
144741805|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
144741806|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
144741807|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
144741808|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
144741809|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
144741810|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741811|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741812|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741813|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741814|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741815|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741816|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741817|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741818|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741819|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144219165|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219166|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144689131|NCT00957034|521710674|FG002|Overall Study|Withdrawal by Subject|0|||
144689132|NCT02390167|521712464|FG000|Overall Study|Lost to Follow-up|1|||
144689133|NCT01265719|521712465|FG000|Overall Study|Does not meet entrance criteria|0|||
144689134|NCT01265719|521712466|FG001|Overall Study|Does not meet entrance criteria|3|||
144689135|NCT01265719|521712465|FG000|Overall Study|Other reasons|2|||
144689136|NCT01265719|521712466|FG001|Overall Study|Other reasons|0|||
144689137|NCT01265719|521712465|FG000|Overall Study|Withdrawal by Subject|8|||
144689138|NCT01265719|521712466|FG001|Overall Study|Withdrawal by Subject|3|||
144689139|NCT01265719|521712465|FG000|Overall Study|Lost to Follow-up|2|||
144689140|NCT01265719|521712466|FG001|Overall Study|Lost to Follow-up|7|||
144689141|NCT01265719|521712465|FG000|Overall Study|Adverse Event|2|||
144689142|NCT01265719|521712466|FG001|Overall Study|Adverse Event|0|||
144689143|NCT00027027|521712468|FG000|Overall Study|Adverse Event|0|||
144689144|NCT00027027|521712469|FG001|Overall Study|Adverse Event|0|||
144689145|NCT00027027|521712470|FG002|Overall Study|Adverse Event|1|||
144689146|NCT00027027|521712471|FG003|Overall Study|Adverse Event|0|||
144689147|NCT00027027|521712472|FG004|Overall Study|Adverse Event|1|||
144689148|NCT00027027|521712468|FG000|Overall Study|Admitted for Signs of PD|0|||
144689149|NCT00027027|521712469|FG001|Overall Study|Admitted for Signs of PD|0|||
144689150|NCT00027027|521712470|FG002|Overall Study|Admitted for Signs of PD|0|||
144689151|NCT00027027|521712471|FG003|Overall Study|Admitted for Signs of PD|0|||
144689152|NCT00027027|521712472|FG004|Overall Study|Admitted for Signs of PD|1|||
144689153|NCT00027027|521712468|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
144689154|NCT00027027|521712469|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
144689155|NCT00027027|521712470|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
144689156|NCT00027027|521712471|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
144689157|NCT00027027|521712472|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
144689158|NCT00027027|521712468|FG000|Overall Study|PD Requiring Surgery|0|||
144689159|NCT00027027|521712469|FG001|Overall Study|PD Requiring Surgery|0|||
144689160|NCT00027027|521712470|FG002|Overall Study|PD Requiring Surgery|1|||
144689161|NCT00027027|521712471|FG003|Overall Study|PD Requiring Surgery|0|||
144689162|NCT00027027|521712472|FG004|Overall Study|PD Requiring Surgery|0|||
144689163|NCT00027027|521712468|FG000|Overall Study|Physician Decision Due To PD|2|||
144689164|NCT00027027|521712469|FG001|Overall Study|Physician Decision Due To PD|3|||
144689165|NCT00027027|521712470|FG002|Overall Study|Physician Decision Due To PD|2|||
144689166|NCT00027027|521712471|FG003|Overall Study|Physician Decision Due To PD|3|||
144689167|NCT00027027|521712472|FG004|Overall Study|Physician Decision Due To PD|5|||
144689168|NCT00027027|521712468|FG000|Overall Study|Withdrawal by Subject|0|||
144689169|NCT00027027|521712469|FG001|Overall Study|Withdrawal by Subject|0|||
144689170|NCT00027027|521712470|FG002|Overall Study|Withdrawal by Subject|0|||
144689171|NCT00027027|521712471|FG003|Overall Study|Withdrawal by Subject|0|||
144689172|NCT00027027|521712472|FG004|Overall Study|Withdrawal by Subject|1|||
144689173|NCT02039687|521712476|FG000|Overall Study|Adverse Event|0|||
144689174|NCT02039687|521712477|FG001|Overall Study|Adverse Event|0|||
144689175|NCT02039687|521712478|FG002|Overall Study|Adverse Event|1|||
144689176|NCT02039687|521712479|FG003|Overall Study|Adverse Event|0|||
144689177|NCT02039687|521712476|FG000|Overall Study|Withdrawal by Subject|0|||
144689178|NCT02039687|521712477|FG001|Overall Study|Withdrawal by Subject|1|||
144689179|NCT02039687|521712478|FG002|Overall Study|Withdrawal by Subject|0|||
144689180|NCT02039687|521712479|FG003|Overall Study|Withdrawal by Subject|0|||
144689181|NCT02039687|521712476|FG000|Overall Study|treatment assignment could not be confir|0|||
144741820|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144219167|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
144689182|NCT02039687|521712477|FG001|Overall Study|treatment assignment could not be confir|0|||
144265975|NCT01317940|520176432|FG002|Overall Study|Lost to Follow-up|1|||
144219168|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144689183|NCT02039687|521712478|FG002|Overall Study|treatment assignment could not be confir|2|||
144689184|NCT02039687|521712479|FG003|Overall Study|treatment assignment could not be confir|0|||
144689185|NCT00959192|521712484|FG000|Overall Study|Adverse Event|1|||
144689186|NCT00959192|521712485|FG001|Overall Study|Adverse Event|1|||
144689187|NCT00959192|521712486|FG002|Overall Study|Adverse Event|1|||
144689188|NCT00959192|521712487|FG003|Overall Study|Adverse Event|0|||
144689189|NCT00959192|521712484|FG000|Overall Study|Investigator Request|1|||
144689190|NCT00959192|521712485|FG001|Overall Study|Investigator Request|0|||
144689191|NCT00959192|521712486|FG002|Overall Study|Investigator Request|0|||
144689192|NCT00959192|521712487|FG003|Overall Study|Investigator Request|0|||
144689193|NCT00959192|521712484|FG000|Overall Study|Caregiver Request|0|||
144689194|NCT00959192|521712485|FG001|Overall Study|Caregiver Request|0|||
144689195|NCT00959192|521712486|FG002|Overall Study|Caregiver Request|2|||
144689196|NCT00959192|521712487|FG003|Overall Study|Caregiver Request|1|||
144689197|NCT00532441|521712488|FG000|Overall Study|Death|1|||
144689198|NCT00532441|521712489|FG001|Overall Study|Death|0|||
144689199|NCT01967134|521712490|FG000|Overall Study|Lost to Follow-up|0|||
144689200|NCT01967134|521712491|FG001|Overall Study|Lost to Follow-up|1|||
144689201|NCT01967134|521712492|FG002|Overall Study|Lost to Follow-up|0|||
144689202|NCT05466240|521712494|FG000|Overall Study|Adverse Event|1|||
144689203|NCT05466240|521712495|FG001|Overall Study|Adverse Event|0|||
144689204|NCT05466240|521712494|FG000|Overall Study|Withdrawal by Subject|1|||
144689205|NCT05466240|521712495|FG001|Overall Study|Withdrawal by Subject|0|||
144689206|NCT00305773|521712496|FG000|Overall Study|Death|3|||
144689207|NCT00305773|521712497|FG001|Overall Study|Death|2|||
144689208|NCT00305773|521712496|FG000|Overall Study|Adverse Event|1|||
144689209|NCT00305773|521712497|FG001|Overall Study|Adverse Event|2|||
144689210|NCT00305773|521712496|FG000|Overall Study|Alternative Treatment|4|||
144689211|NCT00305773|521712497|FG001|Overall Study|Alternative Treatment|4|||
144689212|NCT00305773|521712496|FG000|Overall Study|Physician Decision|1|||
144689213|NCT00305773|521712497|FG001|Overall Study|Physician Decision|1|||
144689214|NCT00305773|521712496|FG000|Overall Study|Withdrawal by Subject|1|||
144689215|NCT00305773|521712497|FG001|Overall Study|Withdrawal by Subject|4|||
144689216|NCT00305773|521712496|FG000|Overall Study|Disease Progression|1|||
144689217|NCT00305773|521712497|FG001|Overall Study|Disease Progression|3|||
144689218|NCT00305773|521712496|FG000|Overall Study|All other reasons|3|||
144689219|NCT00305773|521712497|FG001|Overall Study|All other reasons|2|||
144689220|NCT02679222|521712498|FG000|Overall Study|No time for project|1|||
144689221|NCT00303329|521712499|FG000|Overall Study|Adverse Event|7|||
144689222|NCT00303329|521712500|FG001|Overall Study|Adverse Event|14|||
144689223|NCT00303329|521712499|FG000|Overall Study|Abnormal Laboratory Values|0|||
144689224|NCT00303329|521712500|FG001|Overall Study|Abnormal Laboratory Values|1|||
144689225|NCT00303329|521712499|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
144689226|NCT00303329|521712500|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144689227|NCT00303329|521712499|FG000|Overall Study|Condition no longer requires study drug|0|||
144689228|NCT00303329|521712500|FG001|Overall Study|Condition no longer requires study drug|8|||
144689229|NCT00303329|521712499|FG000|Overall Study|Protocol Violation|3|||
144689230|NCT00303329|521712500|FG001|Overall Study|Protocol Violation|0|||
144689231|NCT00303329|521712499|FG000|Overall Study|Withdrawal by Subject|9|||
144689232|NCT00303329|521712500|FG001|Overall Study|Withdrawal by Subject|15|||
144689233|NCT00303329|521712499|FG000|Overall Study|Lost to Follow-up|0|||
144689234|NCT00303329|521712500|FG001|Overall Study|Lost to Follow-up|1|||
144689235|NCT00303329|521712499|FG000|Overall Study|Administrative problems|1|||
144689236|NCT00303329|521712500|FG001|Overall Study|Administrative problems|0|||
144689237|NCT00303329|521712499|FG000|Overall Study|Death|2|||
144689238|NCT00303329|521712500|FG001|Overall Study|Death|12|||
144689239|NCT00303329|521712499|FG000|Overall Study|Stopped at end of core|3|||
144689240|NCT00303329|521712500|FG001|Overall Study|Stopped at end of core|9|||
144689241|NCT00303329|521712499|FG000|Overall Study|Stopped at end of extension 1|1|||
144689242|NCT00303329|521712500|FG001|Overall Study|Stopped at end of extension 1|0|||
144689243|NCT04735432|521712503|FG000|Overall Study|Other - due to personal reason|1|||
144689244|NCT04735432|521712504|FG001|Overall Study|Other - due to personal reason|0|||
144689245|NCT04735432|521712503|FG000|Overall Study|Adverse Event|2|||
144689246|NCT04735432|521712504|FG001|Overall Study|Adverse Event|0|||
144219169|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219170|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219171|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219172|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144689247|NCT00626327|521712505|FG000|Overall Study|Withdrawal by Subject|21|||
144689248|NCT00626327|521712506|FG001|Overall Study|Withdrawal by Subject|29|||
144689249|NCT00626327|521712507|FG002|Overall Study|Withdrawal by Subject|30|||
144689250|NCT00626327|521712505|FG000|Overall Study|Adverse Event|1|||
144689251|NCT00626327|521712506|FG001|Overall Study|Adverse Event|0|||
144689252|NCT00626327|521712507|FG002|Overall Study|Adverse Event|0|||
144741821|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144689253|NCT00626327|521712505|FG000|Overall Study|Lost to Follow-up|24|||
144219173|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219174|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144689254|NCT00626327|521712506|FG001|Overall Study|Lost to Follow-up|21|||
144689255|NCT00626327|521712507|FG002|Overall Study|Lost to Follow-up|23|||
144689256|NCT00626327|521712505|FG000|Overall Study|Inappropriate enrollment|4|||
144689257|NCT00626327|521712506|FG001|Overall Study|Inappropriate enrollment|5|||
144689258|NCT00626327|521712507|FG002|Overall Study|Inappropriate enrollment|3|||
144689259|NCT00626327|521712505|FG000|Overall Study|Administrative Reason|2|||
144689260|NCT00626327|521712506|FG001|Overall Study|Administrative Reason|0|||
144689261|NCT00626327|521712507|FG002|Overall Study|Administrative Reason|6|||
144689262|NCT00626327|521712505|FG000|Overall Study|Protocol Violation|26|||
144689263|NCT00626327|521712506|FG001|Overall Study|Protocol Violation|4|||
144689264|NCT00626327|521712507|FG002|Overall Study|Protocol Violation|26|||
144689265|NCT00775138|521712511|FG000|Overall Study|Withdrawal by Subject|0|||
144689266|NCT00775138|521712512|FG001|Overall Study|Withdrawal by Subject|0|||
144689267|NCT00775138|521712513|FG002|Overall Study|Withdrawal by Subject|2|||
144689268|NCT00775138|521712514|FG003|Overall Study|Withdrawal by Subject|2|||
144689269|NCT00775138|521712511|FG000|Overall Study|Adverse Event|0|||
144689270|NCT00775138|521712512|FG001|Overall Study|Adverse Event|0|||
144689271|NCT00775138|521712513|FG002|Overall Study|Adverse Event|1|||
144689272|NCT00775138|521712514|FG003|Overall Study|Adverse Event|0|||
144689273|NCT00535236|521712515|FG000|Overall Study|Adverse Event|1|||
144689274|NCT00535236|521712516|FG001|Overall Study|Adverse Event|0|||
144689275|NCT00535236|521712517|FG002|Overall Study|Adverse Event|9|||
144689276|NCT00535236|521712518|FG003|Overall Study|Adverse Event|3|||
144689277|NCT00535236|521712519|FG004|Overall Study|Adverse Event|3|||
144689278|NCT00535236|521712520|FG005|Overall Study|Adverse Event|0|||
144689279|NCT00535236|521712521|FG006|Overall Study|Adverse Event|5|||
144689280|NCT00535236|521712522|FG007|Overall Study|Adverse Event|1|||
144689281|NCT00535236|521712523|FG008|Overall Study|Adverse Event|2|||
144689282|NCT00535236|521712524|FG009|Overall Study|Adverse Event|1|||
144689283|NCT00535236|521712515|FG000|Overall Study|Lost to Follow-up|1|||
144689284|NCT00535236|521712516|FG001|Overall Study|Lost to Follow-up|2|||
144689285|NCT00535236|521712517|FG002|Overall Study|Lost to Follow-up|0|||
144689286|NCT00535236|521712518|FG003|Overall Study|Lost to Follow-up|0|||
144689287|NCT00535236|521712519|FG004|Overall Study|Lost to Follow-up|2|||
144689288|NCT00535236|521712520|FG005|Overall Study|Lost to Follow-up|0|||
144689289|NCT00535236|521712521|FG006|Overall Study|Lost to Follow-up|0|||
144689290|NCT00535236|521712522|FG007|Overall Study|Lost to Follow-up|0|||
144689291|NCT00535236|521712523|FG008|Overall Study|Lost to Follow-up|6|||
144689292|NCT00535236|521712524|FG009|Overall Study|Lost to Follow-up|1|||
144689293|NCT00535236|521712515|FG000|Overall Study|Physician Decision|0|||
144689294|NCT00535236|521712516|FG001|Overall Study|Physician Decision|0|||
144689295|NCT00535236|521712517|FG002|Overall Study|Physician Decision|0|||
144689296|NCT00535236|521712518|FG003|Overall Study|Physician Decision|0|||
144689297|NCT00535236|521712519|FG004|Overall Study|Physician Decision|1|||
144689298|NCT00535236|521712520|FG005|Overall Study|Physician Decision|0|||
144689299|NCT00535236|521712521|FG006|Overall Study|Physician Decision|1|||
144689300|NCT00535236|521712522|FG007|Overall Study|Physician Decision|0|||
144689301|NCT00535236|521712523|FG008|Overall Study|Physician Decision|0|||
144689302|NCT00535236|521712524|FG009|Overall Study|Physician Decision|0|||
144689303|NCT00535236|521712515|FG000|Overall Study|Protocol Violation|2|||
144689304|NCT00535236|521712516|FG001|Overall Study|Protocol Violation|0|||
144689305|NCT00535236|521712517|FG002|Overall Study|Protocol Violation|1|||
144689306|NCT00535236|521712518|FG003|Overall Study|Protocol Violation|0|||
144689307|NCT00535236|521712519|FG004|Overall Study|Protocol Violation|0|||
144689308|NCT00535236|521712520|FG005|Overall Study|Protocol Violation|0|||
144689309|NCT00535236|521712521|FG006|Overall Study|Protocol Violation|0|||
144689310|NCT00535236|521712522|FG007|Overall Study|Protocol Violation|0|||
144741822|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741823|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741824|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144219175|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219176|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144689311|NCT00535236|521712523|FG008|Overall Study|Protocol Violation|1|||
144689312|NCT00535236|521712524|FG009|Overall Study|Protocol Violation|0|||
144689313|NCT00535236|521712515|FG000|Overall Study|Withdrawal by Subject|3|||
144689314|NCT00535236|521712516|FG001|Overall Study|Withdrawal by Subject|0|||
144741825|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144689315|NCT00535236|521712517|FG002|Overall Study|Withdrawal by Subject|2|||
144689316|NCT00535236|521712518|FG003|Overall Study|Withdrawal by Subject|1|||
144689317|NCT00535236|521712519|FG004|Overall Study|Withdrawal by Subject|6|||
144689318|NCT00535236|521712520|FG005|Overall Study|Withdrawal by Subject|1|||
144689319|NCT00535236|521712521|FG006|Overall Study|Withdrawal by Subject|5|||
144689320|NCT00535236|521712522|FG007|Overall Study|Withdrawal by Subject|0|||
144689321|NCT00535236|521712523|FG008|Overall Study|Withdrawal by Subject|4|||
144689322|NCT00535236|521712524|FG009|Overall Study|Withdrawal by Subject|2|||
144689323|NCT04880642|521712525|FG000|Randomization|Withdrawal by Subject|2|||
144689324|NCT04880642|521712526|FG001|Randomization|Withdrawal by Subject|3|||
144689325|NCT04880642|521712525|FG000|Treatment Period|Adverse Event|0|||
144689326|NCT04880642|521712526|FG001|Treatment Period|Adverse Event|1|||
144689327|NCT04880642|521712525|FG000|Treatment Period|Death|6|||
144689328|NCT04880642|521712526|FG001|Treatment Period|Death|6|||
144689329|NCT04880642|521712525|FG000|Treatment Period|Lost to Follow-up|1|||
144219177|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219178|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219179|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
144219180|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219181|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
144219182|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219183|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219184|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219185|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219186|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219187|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219188|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219189|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219190|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219191|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219192|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219193|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219194|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219195|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219196|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
144219197|NCT00758524|519996345|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219198|NCT00758524|519996346|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
144219199|NCT00758524|519996347|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219200|NCT00758524|519996348|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219201|NCT00758524|519996349|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219202|NCT00758524|519996350|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219203|NCT00758524|519996351|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219204|NCT00758524|519996352|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219205|NCT00758524|519996353|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219206|NCT00758524|519996354|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219207|NCT00758524|519996355|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219208|NCT00758524|519996356|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219209|NCT00758524|519996357|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219210|NCT00758524|519996358|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219211|NCT00758524|519996359|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219212|NCT00758524|519996360|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219213|NCT00758524|519996361|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
144219214|NCT00758524|519996345|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219215|NCT00758524|519996346|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219216|NCT00758524|519996347|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219217|NCT00758524|519996348|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219218|NCT00758524|519996349|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219219|NCT00758524|519996350|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219220|NCT00758524|519996351|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219221|NCT00758524|519996352|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219222|NCT00758524|519996353|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
144219223|NCT00758524|519996354|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219224|NCT00758524|519996355|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219225|NCT00758524|519996356|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219226|NCT00758524|519996357|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219227|NCT00758524|519996358|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219228|NCT00758524|519996359|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219229|NCT00758524|519996360|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219230|NCT00758524|519996361|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
144219231|NCT00758524|519996345|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219232|NCT00758524|519996346|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144265976|NCT01317940|520176433|FG003|Overall Study|Lost to Follow-up|1|||
144265977|NCT01317940|520176434|FG004|Overall Study|Lost to Follow-up|1|||
144265978|NCT01317940|520176435|FG005|Overall Study|Lost to Follow-up|0|||
144265979|NCT01317940|520176430|FG000|Overall Study|Change in therapy plan|0|||
144265980|NCT01317940|520176431|FG001|Overall Study|Change in therapy plan|0|||
144265981|NCT01317940|520176432|FG002|Overall Study|Change in therapy plan|3|||
144265982|NCT01317940|520176433|FG003|Overall Study|Change in therapy plan|0|||
144265983|NCT01317940|520176434|FG004|Overall Study|Change in therapy plan|0|||
144265984|NCT01317940|520176435|FG005|Overall Study|Change in therapy plan|0|||
144265985|NCT00945243|520176437|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
144265986|NCT03256578|520176438|FG000|Overall Study|Excluded Post Randomization|66|||
144265987|NCT03256578|520176439|FG001|Overall Study|Excluded Post Randomization|56|||
144265988|NCT02371616|520176440|FG000|Overall Study|Protocol Violation|2|||
144265989|NCT02371616|520176441|FG001|Overall Study|Protocol Violation|1|||
144265990|NCT02371616|520176440|FG000|Overall Study|Adverse Event|0|||
144265991|NCT02371616|520176441|FG001|Overall Study|Adverse Event|1|||
144265992|NCT02371616|520176440|FG000|Overall Study|Withdrawal of Consent|1|||
144265993|NCT02371616|520176441|FG001|Overall Study|Withdrawal of Consent|0|||
144265994|NCT02371616|520176440|FG000|Overall Study|Other (Not specified)|1|||
144265995|NCT02371616|520176441|FG001|Overall Study|Other (Not specified)|5|||
144265996|NCT00754741|520176444|FG000|Overall Study|Died or disenrolled|57|||
144265997|NCT00754741|520176445|FG001|Overall Study|Died or disenrolled|69|||
144265998|NCT00754741|520176446|FG002|Overall Study|Died or disenrolled|54|||
144265999|NCT04152200|520176448|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
144266000|NCT04152200|520176449|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
144266001|NCT04969289|520176450|FG000|Overall Study|Lost to Follow-up|13|||
144266002|NCT04969289|520176451|FG001|Overall Study|Lost to Follow-up|9|||
144266003|NCT00593814|520176452|FG000|Overall Study|Death|7|||
144266004|NCT00593814|520176453|FG001|Overall Study|Death|0|||
144266005|NCT00593814|520176452|FG000|Overall Study|Withdrawal by Subject|7|||
144266006|NCT00593814|520176453|FG001|Overall Study|Withdrawal by Subject|0|||
144266007|NCT00593814|520176452|FG000|Overall Study|Lost to Follow-up|7|||
144266008|NCT00593814|520176453|FG001|Overall Study|Lost to Follow-up|0|||
144266009|NCT00593814|520176452|FG000|Overall Study|Physician Decision|3|||
144266010|NCT00593814|520176453|FG001|Overall Study|Physician Decision|0|||
144266011|NCT03028142|520176454|FG000|Overall Study|Adverse Event|1|||
144266012|NCT03028142|520176455|FG001|Overall Study|Adverse Event|1|||
144266013|NCT03028142|520176456|FG002|Overall Study|Adverse Event|0|||
144266014|NCT03028142|520176457|FG003|Overall Study|Adverse Event|0|||
144266015|NCT03028142|520176458|FG004|Overall Study|Adverse Event|0|||
144266016|NCT03028142|520176459|FG005|Overall Study|Adverse Event|1|||
144266017|NCT03028142|520176454|FG000|Overall Study|Withdrawal by Subject|0|||
144266018|NCT03028142|520176455|FG001|Overall Study|Withdrawal by Subject|0|||
144266019|NCT03028142|520176456|FG002|Overall Study|Withdrawal by Subject|0|||
144266020|NCT03028142|520176457|FG003|Overall Study|Withdrawal by Subject|0|||
144266021|NCT03028142|520176458|FG004|Overall Study|Withdrawal by Subject|1|||
144266022|NCT03028142|520176459|FG005|Overall Study|Withdrawal by Subject|0|||
144266023|NCT00643760|520176462|FG000|Overall Study|Adverse Event|11|||
144266024|NCT00643760|520176463|FG001|Overall Study|Adverse Event|5|||
144266025|NCT00643760|520176464|FG002|Overall Study|Adverse Event|12|||
144266026|NCT00643760|520176465|FG003|Overall Study|Adverse Event|21|||
144266027|NCT00643760|520176466|FG004|Overall Study|Adverse Event|6|||
144266028|NCT00643760|520176462|FG000|Overall Study|Lack of Efficacy|3|||
144266029|NCT00643760|520176463|FG001|Overall Study|Lack of Efficacy|1|||
144219233|NCT00758524|519996347|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219234|NCT00758524|519996348|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219235|NCT00758524|519996349|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219236|NCT00758524|519996350|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219237|NCT00758524|519996351|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
144219238|NCT00758524|519996352|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219239|NCT00758524|519996353|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144266030|NCT00643760|520176464|FG002|Overall Study|Lack of Efficacy|0|||
144266031|NCT00643760|520176465|FG003|Overall Study|Lack of Efficacy|4|||
144266032|NCT00643760|520176466|FG004|Overall Study|Lack of Efficacy|3|||
144266033|NCT00643760|520176462|FG000|Overall Study|Protocol Violation|7|||
144266034|NCT00643760|520176463|FG001|Overall Study|Protocol Violation|6|||
144266035|NCT00643760|520176464|FG002|Overall Study|Protocol Violation|4|||
144266036|NCT00643760|520176465|FG003|Overall Study|Protocol Violation|4|||
144266037|NCT00643760|520176466|FG004|Overall Study|Protocol Violation|6|||
144266038|NCT00643760|520176462|FG000|Overall Study|Lost to Follow-up|6|||
144266039|NCT00643760|520176463|FG001|Overall Study|Lost to Follow-up|2|||
144266040|NCT00643760|520176464|FG002|Overall Study|Lost to Follow-up|1|||
144266041|NCT00643760|520176465|FG003|Overall Study|Lost to Follow-up|3|||
144266042|NCT00643760|520176466|FG004|Overall Study|Lost to Follow-up|3|||
144266043|NCT00643760|520176462|FG000|Overall Study|Investigator Discretion|0|||
144219240|NCT00758524|519996354|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219241|NCT00758524|519996355|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219242|NCT00758524|519996356|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219243|NCT00758524|519996357|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144741826|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144219244|NCT00758524|519996358|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219245|NCT00758524|519996359|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219246|NCT00758524|519996360|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219247|NCT00758524|519996361|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
144219248|NCT00276484|519996362|FG000|Overall Study|Adverse Event|4|||
144219249|NCT00276484|519996363|FG001|Overall Study|Adverse Event|7|||
144219250|NCT00276484|519996362|FG000|Overall Study|Lost to Follow-up|1|||
144219251|NCT00276484|519996363|FG001|Overall Study|Lost to Follow-up|1|||
144219252|NCT00276484|519996362|FG000|Overall Study|Protocol Violation|0|||
144219253|NCT00276484|519996363|FG001|Overall Study|Protocol Violation|1|||
144219254|NCT00276484|519996362|FG000|Overall Study|Withdrawal by Subject|4|||
144219255|NCT00276484|519996363|FG001|Overall Study|Withdrawal by Subject|3|||
144219256|NCT00276484|519996362|FG000|Overall Study|Could not take time off work|0|||
144219257|NCT00276484|519996363|FG001|Overall Study|Could not take time off work|1|||
144219258|NCT04747470|519996376|FG000|Overall Study|Death|0|||
144219259|NCT04747470|519996377|FG001|Overall Study|Death|3|||
144219260|NCT04747470|519996378|FG002|Overall Study|Death|2|||
144219261|NCT04747470|519996379|FG003|Overall Study|Death|2|||
144219262|NCT04747470|519996380|FG004|Overall Study|Death|2|||
144219263|NCT04747470|519996381|FG005|Overall Study|Death|0|||
144219264|NCT04747470|519996382|FG006|Overall Study|Death|0|||
144219265|NCT04747470|519996383|FG007|Overall Study|Death|0|||
144219266|NCT04747470|519996384|FG008|Overall Study|Death|0|||
144219267|NCT04747470|519996385|FG009|Overall Study|Death|0|||
144219268|NCT04747470|519996386|FG010|Overall Study|Death|0|||
144219269|NCT04747470|519996376|FG000|Overall Study|Withdrew Consent|0|||
144219270|NCT04747470|519996377|FG001|Overall Study|Withdrew Consent|0|||
144219271|NCT04747470|519996378|FG002|Overall Study|Withdrew Consent|0|||
144219272|NCT04747470|519996379|FG003|Overall Study|Withdrew Consent|1|||
144219273|NCT04747470|519996380|FG004|Overall Study|Withdrew Consent|0|||
144219274|NCT04747470|519996381|FG005|Overall Study|Withdrew Consent|0|||
144219275|NCT04747470|519996382|FG006|Overall Study|Withdrew Consent|0|||
144219276|NCT04747470|519996383|FG007|Overall Study|Withdrew Consent|0|||
144219277|NCT04747470|519996384|FG008|Overall Study|Withdrew Consent|0|||
144219278|NCT04747470|519996385|FG009|Overall Study|Withdrew Consent|0|||
144219279|NCT04747470|519996386|FG010|Overall Study|Withdrew Consent|0|||
144219280|NCT04747470|519996376|FG000|Overall Study|Study Terminated by Sponsor|0|||
144219281|NCT04747470|519996377|FG001|Overall Study|Study Terminated by Sponsor|0|||
144219282|NCT04747470|519996378|FG002|Overall Study|Study Terminated by Sponsor|1|||
144219283|NCT04747470|519996379|FG003|Overall Study|Study Terminated by Sponsor|0|||
144219284|NCT04747470|519996380|FG004|Overall Study|Study Terminated by Sponsor|2|||
144219285|NCT04747470|519996381|FG005|Overall Study|Study Terminated by Sponsor|0|||
144219286|NCT04747470|519996382|FG006|Overall Study|Study Terminated by Sponsor|0|||
144219287|NCT04747470|519996383|FG007|Overall Study|Study Terminated by Sponsor|0|||
144219288|NCT04747470|519996384|FG008|Overall Study|Study Terminated by Sponsor|0|||
144219289|NCT04747470|519996385|FG009|Overall Study|Study Terminated by Sponsor|0|||
144219290|NCT04747470|519996386|FG010|Overall Study|Study Terminated by Sponsor|0|||
144219291|NCT03749330|519996391|FG000|Overall Study|Clinicians left work in the CICU|0|||
144219292|NCT03749330|519996392|FG001|Overall Study|Clinicians left work in the CICU|2|||
144219293|NCT03749330|519996393|FG002|Overall Study|Clinicians left work in the CICU|0|||
144219294|NCT03749330|519996394|FG003|Overall Study|Clinicians left work in the CICU|0|||
144219295|NCT03749330|519996395|FG004|Overall Study|Clinicians left work in the CICU|0|||
144219296|NCT03749330|519996396|FG005|Overall Study|Clinicians left work in the CICU|0|||
144219297|NCT01518322|519996397|FG000|Overall Study|FeNO measurement was missing|13|||
144219298|NCT01269918|519996398|FG000|Overall Study|Did not receive study drug|0|||
144219299|NCT01269918|519996399|FG001|Overall Study|Did not receive study drug|3|||
144219300|NCT04660331|519996400|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
144219301|NCT04660331|519996401|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
144219302|NCT04660331|519996402|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
144219303|NCT01487525|519996405|FG000|Overall Study|Withdrawal by Subject|0|||
144219304|NCT01487525|519996406|FG001|Overall Study|Withdrawal by Subject|1|||
144219305|NCT01640249|519996407|FG000|Period 1|Withdrawal by Subject|1|||
144219306|NCT01640249|519996408|FG001|Period 1|Withdrawal by Subject|0|||
144219307|NCT01640249|519996409|FG002|Period 1|Withdrawal by Subject|0|||
144219308|NCT01640249|519996410|FG003|Period 1|Withdrawal by Subject|0|||
144219309|NCT01640249|519996411|FG004|Period 1|Withdrawal by Subject|0|||
144219310|NCT01640249|519996412|FG005|Period 1|Withdrawal by Subject|1|||
144219311|NCT01640249|519996413|FG006|Period 1|Withdrawal by Subject|0|||
144219312|NCT01870778|519996414|FG000|Overall Study|Withdrawal by Subject|8|||
144219313|NCT01870778|519996415|FG001|Overall Study|Withdrawal by Subject|7|||
144219314|NCT01870778|519996414|FG000|Overall Study|Lost to Follow-up|0|||
144219315|NCT01870778|519996415|FG001|Overall Study|Lost to Follow-up|2|||
144219316|NCT01215136|519996416|FG000|Overall Study|Adverse Event|2|||
144219317|NCT01215136|519996417|FG001|Overall Study|Adverse Event|9|||
144219318|NCT01215136|519996416|FG000|Overall Study|Disease Progression|3|||
144219319|NCT01215136|519996417|FG001|Overall Study|Disease Progression|14|||
144219320|NCT01215136|519996416|FG000|Overall Study|Symptomatic Deterioration|1|||
144219321|NCT01215136|519996417|FG001|Overall Study|Symptomatic Deterioration|1|||
144219322|NCT01215136|519996416|FG000|Overall Study|Death|0|||
144219323|NCT01215136|519996417|FG001|Overall Study|Death|2|||
144219324|NCT01215136|519996416|FG000|Overall Study|Withdrawal by Subject|0|||
144219325|NCT01215136|519996417|FG001|Overall Study|Withdrawal by Subject|1|||
144219326|NCT02308124|519996418|FG000|Overall Study|Lost to Follow-up|6|||
144219327|NCT02308124|519996419|FG001|Overall Study|Lost to Follow-up|6|||
144219328|NCT02308124|519996420|FG002|Overall Study|Lost to Follow-up|6|||
144219329|NCT02308124|519996418|FG000|Overall Study|Adverse Event|0|||
144219330|NCT02308124|519996419|FG001|Overall Study|Adverse Event|2|||
144219331|NCT02308124|519996420|FG002|Overall Study|Adverse Event|2|||
144219332|NCT02553772|519996427|FG000|Overall Study|Adverse Event|2|||
144219333|NCT02553772|519996428|FG001|Overall Study|Adverse Event|3|||
144219334|NCT02553772|519996427|FG000|Overall Study|Lost to Follow-up|2|||
144219335|NCT02553772|519996428|FG001|Overall Study|Lost to Follow-up|1|||
144219336|NCT02553772|519996427|FG000|Overall Study|Withdrawal of Consent|1|||
144266044|NCT00643760|520176463|FG001|Overall Study|Investigator Discretion|0|||
144266045|NCT00643760|520176464|FG002|Overall Study|Investigator Discretion|0|||
144266046|NCT00643760|520176465|FG003|Overall Study|Investigator Discretion|2|||
144266047|NCT00643760|520176466|FG004|Overall Study|Investigator Discretion|0|||
144266048|NCT00643760|520176462|FG000|Overall Study|Withdrawal by Subject|3|||
144266049|NCT00643760|520176463|FG001|Overall Study|Withdrawal by Subject|1|||
144266050|NCT00643760|520176464|FG002|Overall Study|Withdrawal by Subject|2|||
144266051|NCT00643760|520176465|FG003|Overall Study|Withdrawal by Subject|4|||
144266052|NCT00643760|520176466|FG004|Overall Study|Withdrawal by Subject|1|||
144266053|NCT01249417|520176478|FG000|Randomised Population|Study treatment not received|0|||
144266054|NCT01249417|520176479|FG001|Randomised Population|Study treatment not received|0|||
144266055|NCT01249417|520176480|FG002|Randomised Population|Study treatment not received|2|||
144266056|NCT01249417|520176478|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
144266057|NCT01249417|520176479|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
144266058|NCT01249417|520176480|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
144266059|NCT01249417|520176478|FG000|Treatment Phase - ITT Population|Other|0|||
144266060|NCT01249417|520176479|FG001|Treatment Phase - ITT Population|Other|0|||
144266061|NCT01249417|520176480|FG002|Treatment Phase - ITT Population|Other|1|||
144266062|NCT01249417|520176478|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
144266063|NCT01249417|520176479|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
144266064|NCT01249417|520176480|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
144266065|NCT01249417|520176478|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
144266066|NCT01249417|520176479|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
144266067|NCT01249417|520176480|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
144266068|NCT01249417|520176478|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
144266069|NCT01249417|520176479|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
144266070|NCT01249417|520176480|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
144266071|NCT00917124|520176481|FG000|Overall Study|Protocol Violation|4|||
144266072|NCT00917124|520176482|FG001|Overall Study|Protocol Violation|6|||
144266073|NCT03769649|520176487|FG000|Overall Study|Lost to Follow-up|4|||
144266074|NCT02858401|520176491|FG000|Overall Study|Withdrew Consent|0|||
144266075|NCT02858401|520176492|FG001|Overall Study|Withdrew Consent|0|||
144266076|NCT02858401|520176493|FG002|Overall Study|Withdrew Consent|0|||
144266077|NCT02858401|520176494|FG003|Overall Study|Withdrew Consent|0|||
144266078|NCT02858401|520176495|FG004|Overall Study|Withdrew Consent|0|||
144266079|NCT02858401|520176496|FG005|Overall Study|Withdrew Consent|1|||
144266080|NCT02858401|520176497|FG006|Overall Study|Withdrew Consent|0|||
144219337|NCT02553772|519996428|FG001|Overall Study|Withdrawal of Consent|1|||
144219338|NCT02553772|519996427|FG000|Overall Study|Lack of Efficacy|1|||
144219339|NCT02553772|519996428|FG001|Overall Study|Lack of Efficacy|0|||
144266081|NCT02858401|520176491|FG000|Overall Study|Lost to Follow-up|0|||
144266082|NCT02858401|520176492|FG001|Overall Study|Lost to Follow-up|1|||
144266083|NCT02858401|520176493|FG002|Overall Study|Lost to Follow-up|0|||
144266084|NCT02858401|520176494|FG003|Overall Study|Lost to Follow-up|0|||
144219340|NCT02553772|519996427|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144266085|NCT02858401|520176495|FG004|Overall Study|Lost to Follow-up|0|||
144266086|NCT02858401|520176496|FG005|Overall Study|Lost to Follow-up|0|||
144266087|NCT02858401|520176497|FG006|Overall Study|Lost to Follow-up|0|||
144266088|NCT00748241|520176498|FG000|Overall Study|Implant failure|1|||
144266089|NCT00748241|520176498|FG000|Overall Study|Lost to Follow-up|5|||
144266090|NCT00748241|520176498|FG000|Overall Study|Death|2|||
144266091|NCT02974868|520176504|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
144741827|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741828|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741829|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741830|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
144741831|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|moved|0|||
144741832|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|moved|1|||
144741833|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|moved|1|||
144741834|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|moved|0|||
144219341|NCT02553772|519996428|FG001|Overall Study|Other Miscellaneous Reasons|1|||
144219342|NCT05724589|519996429|FG000|Overall Study|Lost to Follow-up|1|||
144219343|NCT00610129|519996430|FG000|Overall Study|Not treated since patients ineligible|3|||
144741835|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|moved|0|||
144741836|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|moved|0|||
144741837|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|moved|0|||
144219344|NCT02273388|519996435|FG000|Overall Study|Adverse Event|0|||
144219345|NCT02273388|519996436|FG001|Overall Study|Adverse Event|0|||
144219346|NCT02273388|519996437|FG002|Overall Study|Adverse Event|0|||
144219347|NCT02273388|519996438|FG003|Overall Study|Adverse Event|0|||
144219348|NCT02273388|519996439|FG004|Overall Study|Adverse Event|0|||
144219349|NCT02273388|519996440|FG005|Overall Study|Adverse Event|0|||
144219350|NCT02273388|519996441|FG006|Overall Study|Adverse Event|1|||
144219351|NCT02273388|519996442|FG007|Overall Study|Adverse Event|2|||
144219352|NCT02273388|519996443|FG008|Overall Study|Adverse Event|0|||
144219353|NCT02273388|519996444|FG009|Overall Study|Adverse Event|0|||
144219354|NCT02273388|519996445|FG010|Overall Study|Adverse Event|0|||
144219355|NCT02273388|519996446|FG011|Overall Study|Adverse Event|0|||
144219356|NCT02273388|519996435|FG000|Overall Study|Adverse Event study disease worse|4|||
144219357|NCT02273388|519996436|FG001|Overall Study|Adverse Event study disease worse|3|||
144219358|NCT02273388|519996437|FG002|Overall Study|Adverse Event study disease worse|3|||
144219359|NCT02273388|519996438|FG003|Overall Study|Adverse Event study disease worse|2|||
144219360|NCT02273388|519996439|FG004|Overall Study|Adverse Event study disease worse|4|||
144219361|NCT02273388|519996440|FG005|Overall Study|Adverse Event study disease worse|3|||
144219362|NCT02273388|519996441|FG006|Overall Study|Adverse Event study disease worse|14|||
144219363|NCT02273388|519996442|FG007|Overall Study|Adverse Event study disease worse|6|||
144219364|NCT02273388|519996443|FG008|Overall Study|Adverse Event study disease worse|6|||
144219365|NCT02273388|519996444|FG009|Overall Study|Adverse Event study disease worse|5|||
144219366|NCT02273388|519996445|FG010|Overall Study|Adverse Event study disease worse|10|||
144219367|NCT02273388|519996446|FG011|Overall Study|Adverse Event study disease worse|1|||
144219368|NCT02273388|519996435|FG000|Overall Study|Sponsor decision|0|||
144219369|NCT02273388|519996436|FG001|Overall Study|Sponsor decision|0|||
144219370|NCT02273388|519996437|FG002|Overall Study|Sponsor decision|0|||
144219371|NCT02273388|519996438|FG003|Overall Study|Sponsor decision|0|||
144219372|NCT02273388|519996439|FG004|Overall Study|Sponsor decision|0|||
144219373|NCT02273388|519996440|FG005|Overall Study|Sponsor decision|0|||
144219374|NCT02273388|519996441|FG006|Overall Study|Sponsor decision|0|||
144219375|NCT02273388|519996442|FG007|Overall Study|Sponsor decision|0|||
144219376|NCT02273388|519996443|FG008|Overall Study|Sponsor decision|0|||
144219377|NCT02273388|519996444|FG009|Overall Study|Sponsor decision|0|||
144219378|NCT02273388|519996445|FG010|Overall Study|Sponsor decision|0|||
144219379|NCT02273388|519996446|FG011|Overall Study|Sponsor decision|1|||
144219380|NCT01042093|519996447|FG000|Overall Study|Protocol Violation|2|||
144219381|NCT01042093|519996448|FG001|Overall Study|Protocol Violation|2|||
144219382|NCT01042093|519996449|FG002|Overall Study|Protocol Violation|2|||
144219383|NCT01042093|519996450|FG003|Overall Study|Protocol Violation|3|||
144219384|NCT01042093|519996447|FG000|Overall Study|Withdrawal by Subject|0|||
144219385|NCT01042093|519996448|FG001|Overall Study|Withdrawal by Subject|0|||
144219386|NCT01042093|519996449|FG002|Overall Study|Withdrawal by Subject|0|||
144219387|NCT01042093|519996450|FG003|Overall Study|Withdrawal by Subject|1|||
144219388|NCT04331808|519996451|FG000|Overall Study|Withdrew consent|1|||
144219389|NCT04331808|519996452|FG001|Overall Study|Withdrew consent|0|||
144219390|NCT04331808|519996453|FG002|Overall Study|Withdrew consent|2|||
144219391|NCT04331808|519996454|FG003|Overall Study|Withdrew consent|3|||
144219392|NCT01329900|519996458|FG000|Overall Study|Elevated creatinine/renal function|1|||
144219393|NCT00141778|519996463|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
144219394|NCT00141778|519996464|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
144219395|NCT00141778|519996465|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
144219396|NCT00141778|519996463|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
144219397|NCT00141778|519996464|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
144219398|NCT00141778|519996465|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
144219399|NCT00141778|519996463|FG000|Started Study Medication|Withdrawal by Subject|0|||
144219400|NCT00141778|519996464|FG001|Started Study Medication|Withdrawal by Subject|2|||
144219401|NCT00141778|519996465|FG002|Started Study Medication|Withdrawal by Subject|0|||
144219402|NCT00141778|519996463|FG000|Started Study Medication|Difficulty Swallowing|0|||
144741838|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|moved|0|||
144741839|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|moved|0|||
144741840|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|moved|0|||
144741841|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|moved|0|||
144741842|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|moved|0|||
144741843|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|moved|0|||
144741844|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|moved|0|||
144741845|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|moved|0|||
144741846|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|moved|0|||
144741847|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|moved|0|||
144741848|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|moved|0|||
144741849|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|moved|0|||
144741850|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|moved|0|||
144741851|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|moved|0|||
144741852|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|moved|0|||
144741853|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|moved|0|||
144741854|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|moved|0|||
144741855|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|moved|0|||
144741856|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|moved|0|||
144741857|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741858|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741859|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741860|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
144741861|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741862|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741863|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741864|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741865|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741866|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741867|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741868|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741869|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741870|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741871|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741872|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741873|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741874|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741875|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741876|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741877|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741878|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741879|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741880|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741881|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144219403|NCT00141778|519996464|FG001|Started Study Medication|Difficulty Swallowing|1|||
144219404|NCT00141778|519996465|FG002|Started Study Medication|Difficulty Swallowing|0|||
144219405|NCT00141778|519996463|FG000|Started Study Medication|Chest Discomfort|0|||
144219406|NCT00141778|519996464|FG001|Started Study Medication|Chest Discomfort|0|||
144219407|NCT00141778|519996465|FG002|Started Study Medication|Chest Discomfort|1|||
144219408|NCT03493685|519998514|FG000|Overall Study|Death|4|||
144219409|NCT03493685|519998515|FG001|Overall Study|Death|3|||
144219410|NCT03493685|519998514|FG000|Overall Study|Lost to Follow-up|3|||
144219411|NCT03493685|519998515|FG001|Overall Study|Lost to Follow-up|2|||
144219412|NCT03493685|519998514|FG000|Overall Study|Physician Decision|2|||
144219413|NCT03493685|519998515|FG001|Overall Study|Physician Decision|0|||
144219414|NCT03493685|519998514|FG000|Overall Study|Withdrawal by Subject|7|||
144219415|NCT03493685|519998515|FG001|Overall Study|Withdrawal by Subject|11|||
144219416|NCT04452669|519998516|FG000|Overall Study|Death|1|||
144219417|NCT04452669|519998517|FG001|Overall Study|Death|4|||
144219418|NCT04467840|519998518|FG000|Overall Study|Death|35|||
144219419|NCT04467840|519998519|FG001|Overall Study|Death|39|||
144219420|NCT04467840|519998518|FG000|Overall Study|Withdrawal by Subject|8|||
144219421|NCT04467840|519998519|FG001|Overall Study|Withdrawal by Subject|4|||
144219422|NCT04467840|519998518|FG000|Overall Study|Adverse Event|2|||
144219423|NCT04467840|519998519|FG001|Overall Study|Adverse Event|0|||
144219424|NCT04467840|519998518|FG000|Overall Study|Lost to Follow-up|1|||
144219425|NCT04467840|519998519|FG001|Overall Study|Lost to Follow-up|3|||
144219426|NCT04467840|519998518|FG000|Overall Study|Physician Decision|1|||
144219427|NCT04467840|519998519|FG001|Overall Study|Physician Decision|0|||
144266092|NCT02974868|520176505|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
144266093|NCT02974868|520176506|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
144266094|NCT02974868|520176507|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
144266095|NCT02974868|520176504|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
144266096|NCT02974868|520176505|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
144266097|NCT02974868|520176506|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
144266098|NCT02974868|520176507|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
144266099|NCT02974868|520176504|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
144266100|NCT02974868|520176505|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
144266101|NCT02974868|520176506|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
144266102|NCT02974868|520176507|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
144266103|NCT02974868|520176504|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
144266104|NCT02974868|520176505|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
144266105|NCT02974868|520176506|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
144266106|NCT02974868|520176507|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
144266107|NCT02674516|520176508|FG000|Overall Study|Lost to Follow-up|3|||
144266108|NCT02674516|520176509|FG001|Overall Study|Lost to Follow-up|0|||
144266109|NCT02674516|520176508|FG000|Overall Study|Protocol Violation|0|||
144266110|NCT02674516|520176509|FG001|Overall Study|Protocol Violation|4|||
144266111|NCT02674516|520176508|FG000|Overall Study|Knowledge of study hypothesis|1|||
144266112|NCT02674516|520176509|FG001|Overall Study|Knowledge of study hypothesis|0|||
144266113|NCT01064479|520176510|FG000|Overall Study|Death|10|||
144266114|NCT01064479|520176511|FG001|Overall Study|Death|11|||
144266115|NCT01064479|520176510|FG000|Overall Study|Withdrawal by Subject|2|||
144689330|NCT04880642|521712526|FG001|Treatment Period|Lost to Follow-up|0|||
144689331|NCT04880642|521712525|FG000|Treatment Period|Protocol Violation|0|||
144689332|NCT04880642|521712526|FG001|Treatment Period|Protocol Violation|1|||
144689333|NCT04880642|521712525|FG000|Treatment Period|Withdrawal by Subject|5|||
144689334|NCT04880642|521712526|FG001|Treatment Period|Withdrawal by Subject|3|||
144689335|NCT04880642|521712525|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
144689336|NCT04880642|521712526|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
144689337|NCT04880642|521712525|FG000|Follow-up|Death|4|||
144689338|NCT04880642|521712526|FG001|Follow-up|Death|3|||
144689339|NCT04880642|521712525|FG000|Follow-up|Withdrawal by Subject|1|||
144689340|NCT04880642|521712526|FG001|Follow-up|Withdrawal by Subject|0|||
144689341|NCT01716585|521712527|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
144689342|NCT01716585|521712528|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
144689343|NCT01716585|521712527|FG000|Double-blind Treatment|Adverse Event|2|||
144689344|NCT01716585|521712528|FG001|Double-blind Treatment|Adverse Event|1|||
144689345|NCT01716585|521712527|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
144689346|NCT01716585|521712528|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
144689347|NCT01716585|521712527|FG000|Double-blind Treatment|Lost to Follow-up|2|||
144689348|NCT01716585|521712528|FG001|Double-blind Treatment|Lost to Follow-up|0|||
144689349|NCT01716585|521712527|FG000|Double-blind Treatment|Subject Noncompliant|1|||
144689350|NCT01716585|521712528|FG001|Double-blind Treatment|Subject Noncompliant|0|||
144689351|NCT01716585|521712527|FG000|Double-blind Treatment|Other|1|||
144689352|NCT01716585|521712528|FG001|Double-blind Treatment|Other|0|||
144689353|NCT01716585|521712527|FG000|Open-label Treatment|Adverse Event|0|||
144689354|NCT01716585|521712528|FG001|Open-label Treatment|Adverse Event|2|||
144689355|NCT01716585|521712527|FG000|Open-label Treatment|Virologic Failure|0|||
144689356|NCT01716585|521712528|FG001|Open-label Treatment|Virologic Failure|2|||
144689357|NCT01716585|521712527|FG000|Open-label Treatment|Withdrawal by Subject|0|||
144689358|NCT01716585|521712528|FG001|Open-label Treatment|Withdrawal by Subject|3|||
144689359|NCT02275052|521712529|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144689360|NCT02275052|521712530|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144689361|NCT02275052|521712531|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144689362|NCT02275052|521712532|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144689363|NCT02275052|521712529|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
144689364|NCT02275052|521712530|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
144689365|NCT02275052|521712531|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
144689366|NCT02275052|521712532|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
144689367|NCT02275052|521712529|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
144689368|NCT02275052|521712530|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
144689369|NCT02275052|521712531|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144689370|NCT02275052|521712532|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
144689371|NCT02275052|521712529|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
144689372|NCT02275052|521712530|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
144689373|NCT02275052|521712531|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
144741882|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
144741883|NCT00112437|521908528|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741884|NCT00112437|521908529|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741885|NCT00112437|521908530|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741886|NCT00112437|521908531|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741887|NCT00112437|521908532|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
144741888|NCT00112437|521908533|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741889|NCT00112437|521908534|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741890|NCT00112437|521908535|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741891|NCT00112437|521908536|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741892|NCT00112437|521908537|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741893|NCT00112437|521908538|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741894|NCT00112437|521908539|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741895|NCT00112437|521908540|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741896|NCT00112437|521908541|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741897|NCT00112437|521908542|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144219428|NCT04467840|519998518|FG000|Overall Study|Other|1|||
144219429|NCT04467840|519998519|FG001|Overall Study|Other|5|||
144689374|NCT02275052|521712532|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
144689375|NCT02275052|521712529|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
144689376|NCT02275052|521712530|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
144689377|NCT02275052|521712531|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
144689378|NCT02275052|521712532|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
144689379|NCT02275052|521712529|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
144689380|NCT02275052|521712530|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
144689381|NCT02275052|521712531|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
144689382|NCT02275052|521712532|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
144689383|NCT02275052|521712529|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
144689384|NCT02275052|521712530|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
144689385|NCT02275052|521712531|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
144689386|NCT02275052|521712532|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
144689387|NCT02275052|521712529|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
144689388|NCT02275052|521712530|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
144689389|NCT02275052|521712531|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
144689390|NCT02275052|521712532|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
144689391|NCT02275052|521712529|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144689392|NCT02275052|521712530|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
144689393|NCT02275052|521712531|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
144689394|NCT02275052|521712532|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
144689395|NCT02275052|521712529|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
144689396|NCT02275052|521712530|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
144689397|NCT02275052|521712531|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
144689398|NCT02275052|521712532|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
144689399|NCT02275052|521712529|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144689400|NCT02275052|521712530|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144689401|NCT02275052|521712531|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
144689402|NCT02275052|521712532|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
144689403|NCT00561795|521712533|FG000|Overall Study|Adverse Event|3|||
144689404|NCT00561795|521712534|FG001|Overall Study|Adverse Event|3|||
144689405|NCT00561795|521712535|FG002|Overall Study|Adverse Event|0|||
144689406|NCT00561795|521712536|FG003|Overall Study|Adverse Event|0|||
144689407|NCT00561795|521712533|FG000|Overall Study|Study Closed/Terminated|0|||
144689408|NCT00561795|521712534|FG001|Overall Study|Study Closed/Terminated|3|||
144689409|NCT00561795|521712535|FG002|Overall Study|Study Closed/Terminated|0|||
144689410|NCT00561795|521712536|FG003|Overall Study|Study Closed/Terminated|0|||
144689411|NCT00561795|521712533|FG000|Overall Study|Physician Decision|1|||
144689412|NCT00561795|521712534|FG001|Overall Study|Physician Decision|0|||
144689413|NCT00561795|521712535|FG002|Overall Study|Physician Decision|0|||
144689414|NCT00561795|521712536|FG003|Overall Study|Physician Decision|0|||
144741898|NCT00112437|521908543|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741899|NCT00112437|521908544|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741900|NCT00112437|521908545|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741901|NCT00112437|521908546|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741902|NCT00112437|521908547|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741903|NCT00112437|521908548|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144219430|NCT04467840|519998518|FG000|Overall Study|Missing study completion status|3|||
144689415|NCT05102734|521712539|FG000|Overall Study|Did not require vasopressors|1|||
144689416|NCT05102734|521712540|FG001|Overall Study|Did not require vasopressors|0|||
144689417|NCT05102734|521712539|FG000|Overall Study|Did not have functioning PA catheter|1|||
144689418|NCT05102734|521712540|FG001|Overall Study|Did not have functioning PA catheter|0|||
144689419|NCT05102734|521712539|FG000|Overall Study|Inadequate video quality|2|||
144689420|NCT05102734|521712540|FG001|Overall Study|Inadequate video quality|0|||
144689421|NCT04235959|521712541|FG000|Overall Study|Protocol Violation|0|||
144689422|NCT04235959|521712542|FG001|Overall Study|Protocol Violation|1|||
144689423|NCT04235959|521712543|FG002|Overall Study|Protocol Violation|0|||
144689424|NCT04235959|521712541|FG000|Overall Study|Adverse Event|1|||
144689425|NCT04235959|521712542|FG001|Overall Study|Adverse Event|0|||
144689426|NCT04235959|521712543|FG002|Overall Study|Adverse Event|0|||
144689427|NCT03288987|521712544|FG000|Overall Study|Protocol Violation|10|||
144689428|NCT03288987|521712545|FG001|Overall Study|Protocol Violation|4|||
144689429|NCT03055806|521712548|FG000|Overall Study|Adverse Event|0|||
144689430|NCT03055806|521712549|FG001|Overall Study|Adverse Event|0|||
144689431|NCT03055806|521712550|FG002|Overall Study|Adverse Event|1|||
144689432|NCT03055806|521712551|FG003|Overall Study|Adverse Event|1|||
144689433|NCT03055806|521712548|FG000|Overall Study|Lost to Follow-up|0|||
144689434|NCT03055806|521712549|FG001|Overall Study|Lost to Follow-up|3|||
144689435|NCT03055806|521712550|FG002|Overall Study|Lost to Follow-up|6|||
144689436|NCT03055806|521712551|FG003|Overall Study|Lost to Follow-up|7|||
144689437|NCT03055806|521712548|FG000|Overall Study|Physician Decision|1|||
144689438|NCT03055806|521712549|FG001|Overall Study|Physician Decision|0|||
144689439|NCT03055806|521712550|FG002|Overall Study|Physician Decision|0|||
144689440|NCT03055806|521712551|FG003|Overall Study|Physician Decision|1|||
144689441|NCT03055806|521712548|FG000|Overall Study|Protocol Violation|1|||
144689442|NCT03055806|521712549|FG001|Overall Study|Protocol Violation|0|||
144689443|NCT03055806|521712550|FG002|Overall Study|Protocol Violation|0|||
144689444|NCT03055806|521712551|FG003|Overall Study|Protocol Violation|0|||
144689445|NCT03055806|521712548|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
144689446|NCT03055806|521712549|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
144689447|NCT03055806|521712550|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
144689448|NCT03055806|521712551|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
144689449|NCT03055806|521712548|FG000|Overall Study|Withdrawal of consent to continue study|2|||
144689450|NCT03055806|521712549|FG001|Overall Study|Withdrawal of consent to continue study|3|||
144689451|NCT03055806|521712550|FG002|Overall Study|Withdrawal of consent to continue study|4|||
144689452|NCT03055806|521712551|FG003|Overall Study|Withdrawal of consent to continue study|6|||
144689453|NCT03055806|521712548|FG000|Overall Study|Partner not willing to try intercourse|1|||
144689454|NCT03055806|521712549|FG001|Overall Study|Partner not willing to try intercourse|0|||
144689455|NCT03055806|521712550|FG002|Overall Study|Partner not willing to try intercourse|0|||
144689456|NCT03055806|521712551|FG003|Overall Study|Partner not willing to try intercourse|0|||
144689457|NCT04905563|521712552|FG000|Overall Study|Withdrawal by Subject|1|||
144689458|NCT04905563|521712553|FG001|Overall Study|Withdrawal by Subject|0|||
144689459|NCT04905563|521712552|FG000|Overall Study|Standard of care orders entered by resident|1|||
144689460|NCT04905563|521712553|FG001|Overall Study|Standard of care orders entered by resident|0|||
144689461|NCT04905563|521712552|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
144689462|NCT04905563|521712553|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
144689463|NCT04905563|521712552|FG000|Overall Study|Withdrawal by Subject|0|||
144689464|NCT04905563|521712553|FG001|Overall Study|Withdrawal by Subject|1|||
144689465|NCT01797302|521712554|FG000|Overall Study|Lost to Follow-up|16|||
144689466|NCT01797302|521712555|FG001|Overall Study|Lost to Follow-up|23|||
144689467|NCT01797302|521712556|FG002|Overall Study|Lost to Follow-up|22|||
144689468|NCT01797302|521712554|FG000|Overall Study|Withdrawal by Subject|1|||
144689469|NCT01797302|521712555|FG001|Overall Study|Withdrawal by Subject|3|||
144689470|NCT01797302|521712556|FG002|Overall Study|Withdrawal by Subject|4|||
144689471|NCT01051856|521712561|FG000|Overall Study|Withdrawal by Subject|1|||
144689472|NCT01051856|521712562|FG001|Overall Study|Withdrawal by Subject|0|||
144689473|NCT00672139|521712563|FG000|Overall Study|Death|14|||
144689474|NCT00672139|521712564|FG001|Overall Study|Death|23|||
144689475|NCT00672139|521712563|FG000|Overall Study|Withdrawal by Subject|2|||
144689476|NCT00672139|521712564|FG001|Overall Study|Withdrawal by Subject|11|||
144689477|NCT00672139|521712563|FG000|Overall Study|Adverse Event|4|||
144689478|NCT00672139|521712564|FG001|Overall Study|Adverse Event|7|||
144689479|NCT00672139|521712563|FG000|Overall Study|Physician Decision|2|||
144689480|NCT00672139|521712564|FG001|Overall Study|Physician Decision|0|||
144689481|NCT00672139|521712563|FG000|Overall Study|Lack of Efficacy|4|||
144689482|NCT00672139|521712564|FG001|Overall Study|Lack of Efficacy|1|||
144689483|NCT00672139|521712563|FG000|Overall Study|Protocol Violation|1|||
144689484|NCT00672139|521712564|FG001|Overall Study|Protocol Violation|1|||
144689485|NCT00672139|521712563|FG000|Overall Study|hospice discharge, caregiver requests|3|||
144689486|NCT00672139|521712564|FG001|Overall Study|hospice discharge, caregiver requests|2|||
144689487|NCT02381795|521712565|FG000|Overall Study|Withdrawal by Subject|1|||
144689488|NCT02381795|521712565|FG000|Overall Study|Study Terminated|2|||
144689489|NCT02176226|521712568|FG000|Overall Study|Lost to Follow-up|3|||
144741904|NCT00112437|521908549|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741905|NCT00112437|521908550|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741906|NCT00112437|521908551|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741907|NCT00112437|521908552|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741908|NCT00112437|521908553|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
144741909|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
144266116|NCT01064479|520176511|FG001|Overall Study|Withdrawal by Subject|2|||
144689490|NCT02176226|521712568|FG000|Overall Study|Withdrew prior to treatment|6|||
144689491|NCT01072500|521712573|FG000|Overall Study|Death|2|||
144689492|NCT01072500|521712574|FG001|Overall Study|Death|2|||
144689493|NCT01072500|521712573|FG000|Overall Study|Lost to Follow-up|5|||
144689494|NCT01072500|521712574|FG001|Overall Study|Lost to Follow-up|2|||
144689495|NCT01072500|521712573|FG000|Overall Study|Withdrawal by Subject|17|||
144689496|NCT01072500|521712574|FG001|Overall Study|Withdrawal by Subject|10|||
144689497|NCT02908841|521712575|FG000|Overall Study|Physician Decision|4|||
144689498|NCT02908841|521712576|FG001|Overall Study|Physician Decision|0|||
144689499|NCT03798366|521712588|FG000|Overall Study|Lost to Follow-up|0|||
144689500|NCT03798366|521712589|FG001|Overall Study|Lost to Follow-up|1|||
144689501|NCT00523744|521712597|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
144689502|NCT00523744|521712597|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
144689503|NCT00523744|521712597|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
144689504|NCT00523744|521712597|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
144689505|NCT00523744|521712597|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
144689506|NCT00523744|521712597|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
144689507|NCT00542425|521712601|FG000|Initial 24 Weeks|Administrative reasons|0|||
144689508|NCT00542425|521712602|FG001|Initial 24 Weeks|Administrative reasons|0|||
144689509|NCT00542425|521712603|FG002|Initial 24 Weeks|Administrative reasons|1|||
144689510|NCT00542425|521712604|FG003|Initial 24 Weeks|Administrative reasons|1|||
144689511|NCT00542425|521712605|FG004|Initial 24 Weeks|Administrative reasons|0|||
144689512|NCT00542425|521712601|FG000|Initial 24 Weeks|Adverse Event|0|||
144689513|NCT00542425|521712602|FG001|Initial 24 Weeks|Adverse Event|1|||
144689514|NCT00542425|521712603|FG002|Initial 24 Weeks|Adverse Event|1|||
144689515|NCT00542425|521712604|FG003|Initial 24 Weeks|Adverse Event|3|||
144689516|NCT00542425|521712605|FG004|Initial 24 Weeks|Adverse Event|2|||
144689517|NCT00542425|521712601|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
144689518|NCT00542425|521712602|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
144689519|NCT00542425|521712603|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
144689520|NCT00542425|521712604|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
144689521|NCT00542425|521712605|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
144689522|NCT00542425|521712601|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
144689523|NCT00542425|521712602|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
144689524|NCT00542425|521712603|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
144689525|NCT00542425|521712604|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
144689526|NCT00542425|521712605|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
144689527|NCT00542425|521712601|FG000|Initial 24 Weeks|Non-compliance|0|||
144689528|NCT00542425|521712602|FG001|Initial 24 Weeks|Non-compliance|0|||
144689529|NCT00542425|521712603|FG002|Initial 24 Weeks|Non-compliance|0|||
144689530|NCT00542425|521712604|FG003|Initial 24 Weeks|Non-compliance|1|||
144689531|NCT00542425|521712605|FG004|Initial 24 Weeks|Non-compliance|1|||
144689532|NCT00542425|521712601|FG000|Initial 24 Weeks|Protocol Violation|0|||
144689533|NCT00542425|521712602|FG001|Initial 24 Weeks|Protocol Violation|0|||
144689534|NCT00542425|521712603|FG002|Initial 24 Weeks|Protocol Violation|0|||
144689535|NCT00542425|521712604|FG003|Initial 24 Weeks|Protocol Violation|1|||
144689536|NCT00542425|521712605|FG004|Initial 24 Weeks|Protocol Violation|0|||
144689537|NCT00542425|521712601|FG000|Initial 24 Weeks|Refusal of treatment|2|||
144689538|NCT00542425|521712602|FG001|Initial 24 Weeks|Refusal of treatment|2|||
144689539|NCT00542425|521712603|FG002|Initial 24 Weeks|Refusal of treatment|1|||
144689540|NCT00542425|521712604|FG003|Initial 24 Weeks|Refusal of treatment|4|||
144689541|NCT00542425|521712605|FG004|Initial 24 Weeks|Refusal of treatment|1|||
144689542|NCT00542425|521712601|FG000|Initial 24 Weeks|Other|0|||
144689543|NCT00542425|521712602|FG001|Initial 24 Weeks|Other|2|||
144689544|NCT00542425|521712603|FG002|Initial 24 Weeks|Other|1|||
144689545|NCT00542425|521712604|FG003|Initial 24 Weeks|Other|0|||
144689546|NCT00542425|521712605|FG004|Initial 24 Weeks|Other|0|||
144689547|NCT00542425|521712601|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
144741910|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
144689548|NCT00542425|521712602|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
144689549|NCT00542425|521712603|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
144689550|NCT00542425|521712604|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
144689551|NCT00542425|521712605|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
144689552|NCT00542425|521712601|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
144689553|NCT00542425|521712602|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
144689554|NCT00542425|521712603|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
144689555|NCT00542425|521712604|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
144689556|NCT00542425|521712605|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
144689557|NCT00542425|521712601|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
144689558|NCT00542425|521712602|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
144689559|NCT00542425|521712603|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
144689560|NCT00542425|521712604|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
144689561|NCT00542425|521712605|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
144689562|NCT00542425|521712601|FG000|Extended 24 Weeks of Treatment|Other|1|||
144689563|NCT00542425|521712602|FG001|Extended 24 Weeks of Treatment|Other|1|||
144689564|NCT00542425|521712603|FG002|Extended 24 Weeks of Treatment|Other|0|||
144689565|NCT00542425|521712604|FG003|Extended 24 Weeks of Treatment|Other|0|||
144689566|NCT00542425|521712605|FG004|Extended 24 Weeks of Treatment|Other|1|||
144689567|NCT00590031|521712608|FG000|Overall Study|Adverse Event|3|||
144689568|NCT00590031|521712608|FG000|Overall Study|Withdrawal by Subject|1|||
144689569|NCT00590031|521712608|FG000|Overall Study|Metastatic Disease|1|||
144689570|NCT00590031|521712608|FG000|Overall Study|Admin Hold|1|||
144689571|NCT00472043|521712609|FG000|Overall Study|Withdrawal by Subject|1|||
144689572|NCT00472043|521712610|FG001|Overall Study|Withdrawal by Subject|0|||
144689573|NCT00472043|521712609|FG000|Overall Study|Death|1|||
144689574|NCT00472043|521712610|FG001|Overall Study|Death|0|||
144689575|NCT02975206|521712616|FG000|Overall Study|Withdrawal by Subject|14|||
144689576|NCT02975206|521712617|FG001|Overall Study|Withdrawal by Subject|11|||
144689577|NCT02975206|521712618|FG002|Overall Study|Withdrawal by Subject|11|||
144689578|NCT02975206|521712616|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
144689579|NCT02975206|521712617|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
144689580|NCT02975206|521712618|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
144689581|NCT01981096|521712619|FG000|Overall Study|Parent illness|1|||
144689582|NCT01981096|521712620|FG001|Overall Study|Parent illness|0|||
144689583|NCT01981096|521712619|FG000|Overall Study|Withdrawal by Subject|0|||
144689584|NCT01981096|521712620|FG001|Overall Study|Withdrawal by Subject|1|||
144689585|NCT01981096|521712619|FG000|Overall Study|Lost to Follow-up|2|||
144689586|NCT01981096|521712620|FG001|Overall Study|Lost to Follow-up|0|||
144689587|NCT00866606|521712621|FG000|Overall Study|Lost to Follow-up|3|||
144689588|NCT00866606|521712621|FG000|Overall Study|Adverse Event|1|||
144689589|NCT00392210|521712636|FG000|First Voiding Trial|Physician Decision|2|||
144689590|NCT00392210|521712637|FG001|First Voiding Trial|Physician Decision|2|||
144689591|NCT03049852|521712638|FG000|Overall Study|Lost to Follow-up|0|||
144689592|NCT03049852|521712639|FG001|Overall Study|Lost to Follow-up|1|||
144689593|NCT03049852|521712640|FG002|Overall Study|Lost to Follow-up|0|||
144689594|NCT02067104|521712641|FG000|Overall Study|Study termination due to low accrual|4|||
144689595|NCT02067104|521712642|FG001|Overall Study|Study termination due to low accrual|5|||
144689596|NCT01987609|521712643|FG000|Overall Study|Adverse Event|1|||
144689597|NCT02610231|521712644|FG000|Overall Study|Withdrawal by Subject|27|||
144689598|NCT02610231|521712644|FG000|Overall Study|Adverse Event|20|||
144689599|NCT02610231|521712644|FG000|Overall Study|Death|5|||
144689600|NCT02610231|521712644|FG000|Overall Study|Surgery|2|||
144689601|NCT02610231|521712644|FG000|Overall Study|Physician Decision|1|||
144689602|NCT02610231|521712644|FG000|Overall Study|Non Compliance|2|||
144689603|NCT02610231|521712644|FG000|Overall Study|Other|3|||
144689604|NCT00806494|521712650|FG000|Overall Study|Adverse Event|29|||
144689605|NCT00806494|521712650|FG000|Overall Study|Lack of Efficacy|6|||
144689606|NCT00806494|521712650|FG000|Overall Study|Lost to Follow-up|10|||
144689607|NCT00806494|521712650|FG000|Overall Study|Other|30|||
144689608|NCT00806494|521712650|FG000|Overall Study|Withdrawal by Subject|5|||
144689609|NCT01279954|521712653|FG000|Overall Study|Lack of Efficacy|3|||
144689610|NCT01279954|521712654|FG001|Overall Study|Lack of Efficacy|4|||
144689611|NCT02140762|521712655|FG000|Overall Study|Adverse Event|1|||
144689612|NCT02140762|521712656|FG001|Overall Study|Adverse Event|1|||
144689613|NCT02140762|521712655|FG000|Overall Study|Lost to Follow-up|9|||
144689614|NCT02140762|521712656|FG001|Overall Study|Lost to Follow-up|5|||
144689615|NCT02140762|521712655|FG000|Overall Study|Protocol Violation|1|||
144689616|NCT02140762|521712656|FG001|Overall Study|Protocol Violation|1|||
144689617|NCT02140762|521712655|FG000|Overall Study|Withdrawal by Subject|6|||
144689618|NCT02140762|521712656|FG001|Overall Study|Withdrawal by Subject|4|||
144689619|NCT02140762|521712655|FG000|Overall Study|Other|0|||
144689620|NCT02140762|521712656|FG001|Overall Study|Other|1|||
144689621|NCT02709889|521712657|FG000|Overall Study|Withdrawal by Subject|11|||
144689622|NCT02709889|521712658|FG001|Overall Study|Withdrawal by Subject|10|||
144689623|NCT02709889|521712659|FG002|Overall Study|Withdrawal by Subject|2|||
144689624|NCT02709889|521712660|FG003|Overall Study|Withdrawal by Subject|12|||
144689625|NCT02709889|521712657|FG000|Overall Study|Death|25|||
144689626|NCT02709889|521712658|FG001|Overall Study|Death|38|||
144689627|NCT02709889|521712659|FG002|Overall Study|Death|4|||
144689628|NCT02709889|521712660|FG003|Overall Study|Death|44|||
144689629|NCT02709889|521712657|FG000|Overall Study|Physician Decision|1|||
144689630|NCT02709889|521712658|FG001|Overall Study|Physician Decision|2|||
144689631|NCT02709889|521712659|FG002|Overall Study|Physician Decision|3|||
144741911|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
144266117|NCT01064479|520176510|FG000|Overall Study|Disease progression|1|||
144689632|NCT02709889|521712660|FG003|Overall Study|Physician Decision|5|||
144741912|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
144689633|NCT02709889|521712657|FG000|Overall Study|Lost to Follow-up|2|||
144689634|NCT02709889|521712658|FG001|Overall Study|Lost to Follow-up|0|||
144689635|NCT02709889|521712659|FG002|Overall Study|Lost to Follow-up|0|||
144689636|NCT02709889|521712660|FG003|Overall Study|Lost to Follow-up|4|||
144689637|NCT02709889|521712657|FG000|Overall Study|Study Terminated by Sponsor|4|||
144689638|NCT02709889|521712658|FG001|Overall Study|Study Terminated by Sponsor|6|||
144689639|NCT02709889|521712659|FG002|Overall Study|Study Terminated by Sponsor|2|||
144741913|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
144741914|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
144741915|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
144741916|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
144689640|NCT02709889|521712660|FG003|Overall Study|Study Terminated by Sponsor|17|||
144689641|NCT02709889|521712657|FG000|Overall Study|Other, Not Specified|0|||
144689642|NCT02709889|521712658|FG001|Overall Study|Other, Not Specified|1|||
144689643|NCT02709889|521712659|FG002|Overall Study|Other, Not Specified|1|||
144689644|NCT02709889|521712660|FG003|Overall Study|Other, Not Specified|6|||
144689645|NCT00122317|521712664|FG000|Overall Study|Death|3|||
144689646|NCT00122317|521712664|FG000|Overall Study|Adverse Event|4|||
144689647|NCT00122317|521712664|FG000|Overall Study|Physician Decision|2|||
144689648|NCT00122317|521712664|FG000|Overall Study|patient non-compliance|1|||
144689649|NCT00122317|521712664|FG000|Overall Study|Withdrawal by Subject|1|||
144689650|NCT03458234|521712665|FG000|Overall Study|Withdrawal by Subject|1|||
144689651|NCT04728815|521712670|FG000|Overall Study|Lost to Follow-up|3|||
144689652|NCT04728815|521712671|FG001|Overall Study|Lost to Follow-up|0|||
144689653|NCT04728815|521712672|FG002|Overall Study|Lost to Follow-up|0|||
144689654|NCT04728815|521712673|FG003|Overall Study|Lost to Follow-up|1|||
144689655|NCT04728815|521712674|FG004|Overall Study|Lost to Follow-up|1|||
144689656|NCT04728815|521712675|FG005|Overall Study|Lost to Follow-up|0|||
144689657|NCT04728815|521712676|FG006|Overall Study|Lost to Follow-up|2|||
144689658|NCT04728815|521712677|FG007|Overall Study|Lost to Follow-up|0|||
144689659|NCT04728815|521712670|FG000|Overall Study|Physician Decision|0|||
144689660|NCT04728815|521712671|FG001|Overall Study|Physician Decision|0|||
144689661|NCT04728815|521712672|FG002|Overall Study|Physician Decision|1|||
144689662|NCT04728815|521712673|FG003|Overall Study|Physician Decision|0|||
144689663|NCT04728815|521712674|FG004|Overall Study|Physician Decision|0|||
144689664|NCT04728815|521712675|FG005|Overall Study|Physician Decision|0|||
144689665|NCT04728815|521712676|FG006|Overall Study|Physician Decision|0|||
144689666|NCT04728815|521712677|FG007|Overall Study|Physician Decision|0|||
144689667|NCT04728815|521712670|FG000|Overall Study|Treatment drop|0|||
144689668|NCT04728815|521712671|FG001|Overall Study|Treatment drop|2|||
144689669|NCT04728815|521712672|FG002|Overall Study|Treatment drop|1|||
144689670|NCT04728815|521712673|FG003|Overall Study|Treatment drop|0|||
144689671|NCT04728815|521712674|FG004|Overall Study|Treatment drop|3|||
144689672|NCT04728815|521712675|FG005|Overall Study|Treatment drop|1|||
144689673|NCT04728815|521712676|FG006|Overall Study|Treatment drop|3|||
144689674|NCT04728815|521712677|FG007|Overall Study|Treatment drop|0|||
144689675|NCT04728815|521712670|FG000|Overall Study|Study drop|0|||
144689676|NCT04728815|521712671|FG001|Overall Study|Study drop|3|||
144689677|NCT04728815|521712672|FG002|Overall Study|Study drop|3|||
144689678|NCT04728815|521712673|FG003|Overall Study|Study drop|0|||
144689679|NCT04728815|521712674|FG004|Overall Study|Study drop|0|||
144689680|NCT04728815|521712675|FG005|Overall Study|Study drop|0|||
144689681|NCT04728815|521712676|FG006|Overall Study|Study drop|7|||
144741917|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
144741918|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
144741919|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
144741920|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
144741921|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
144741922|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
144689682|NCT04728815|521712677|FG007|Overall Study|Study drop|0|||
144689683|NCT05315297|521712678|FG000|Overall Study|Lost to Follow-up|6|||
144689684|NCT05315297|521712679|FG001|Overall Study|Lost to Follow-up|4|||
144689685|NCT05315297|521712678|FG000|Overall Study|Withdrawal by Subject|0|||
144689686|NCT05315297|521712679|FG001|Overall Study|Withdrawal by Subject|1|||
144741923|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
144741924|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
144689687|NCT00027846|521714354|FG000|Overall Study|Lost to Follow-up|0|||
144689688|NCT00027846|521714355|FG001|Overall Study|Lost to Follow-up|41|||
144689689|NCT00027846|521714356|FG002|Overall Study|Lost to Follow-up|9|||
144689690|NCT00027846|521714354|FG000|Overall Study|Withdrawal by Subject|0|||
144689691|NCT00027846|521714355|FG001|Overall Study|Withdrawal by Subject|14|||
144689692|NCT00027846|521714356|FG002|Overall Study|Withdrawal by Subject|7|||
144689693|NCT00027846|521714354|FG000|Overall Study|Ineligible for study|2|||
144689694|NCT00027846|521714355|FG001|Overall Study|Ineligible for study|6|||
144689695|NCT00027846|521714356|FG002|Overall Study|Ineligible for study|14|||
144689696|NCT00027846|521714354|FG000|Overall Study|Entry into another COG therapeutic study|0|||
144741925|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
144741926|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
144219431|NCT04467840|519998519|FG001|Overall Study|Missing study completion status|1|||
144219432|NCT05201794|519998524|FG000|Overall Study|Withdrawal by Subject|13|||
144219433|NCT05201794|519998525|FG001|Overall Study|Withdrawal by Subject|12|||
144689697|NCT00027846|521714355|FG001|Overall Study|Entry into another COG therapeutic study|5|||
144219434|NCT05201794|519998526|FG002|Overall Study|Withdrawal by Subject|14|||
144219435|NCT05201794|519998527|FG003|Overall Study|Withdrawal by Subject|0|||
144219436|NCT05201794|519998524|FG000|Overall Study|Adverse Event|5|||
144219437|NCT05201794|519998525|FG001|Overall Study|Adverse Event|5|||
144219438|NCT05201794|519998526|FG002|Overall Study|Adverse Event|4|||
144219439|NCT05201794|519998527|FG003|Overall Study|Adverse Event|0|||
144219440|NCT05201794|519998524|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
144219441|NCT05201794|519998525|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
144219442|NCT05201794|519998526|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
144219443|NCT05201794|519998527|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144219444|NCT05201794|519998524|FG000|Overall Study|Non-Compliance With Study Drug|2|||
144219445|NCT05201794|519998525|FG001|Overall Study|Non-Compliance With Study Drug|3|||
144219446|NCT05201794|519998526|FG002|Overall Study|Non-Compliance With Study Drug|3|||
144219447|NCT05201794|519998527|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144219448|NCT05201794|519998524|FG000|Overall Study|Physician Decision|1|||
144219449|NCT05201794|519998525|FG001|Overall Study|Physician Decision|3|||
144219450|NCT05201794|519998526|FG002|Overall Study|Physician Decision|2|||
144219451|NCT05201794|519998527|FG003|Overall Study|Physician Decision|0|||
144219452|NCT05201794|519998524|FG000|Overall Study|Lost to Follow-up|2|||
144219453|NCT05201794|519998525|FG001|Overall Study|Lost to Follow-up|2|||
144219454|NCT05201794|519998526|FG002|Overall Study|Lost to Follow-up|0|||
144219455|NCT05201794|519998527|FG003|Overall Study|Lost to Follow-up|0|||
144219456|NCT05201794|519998524|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
144219457|NCT05201794|519998525|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
144219458|NCT05201794|519998526|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
144219459|NCT05201794|519998527|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
144219460|NCT05201794|519998524|FG000|Overall Study|Protocol Violation|2|||
144219461|NCT05201794|519998525|FG001|Overall Study|Protocol Violation|0|||
144219462|NCT05201794|519998526|FG002|Overall Study|Protocol Violation|1|||
144219463|NCT05201794|519998527|FG003|Overall Study|Protocol Violation|0|||
144219464|NCT05201794|519998524|FG000|Overall Study|Death|1|||
144219465|NCT05201794|519998525|FG001|Overall Study|Death|0|||
144219466|NCT05201794|519998526|FG002|Overall Study|Death|0|||
144219467|NCT05201794|519998527|FG003|Overall Study|Death|0|||
144219468|NCT05201794|519998524|FG000|Overall Study|Site Terminated By Sponsor|0|||
144689698|NCT00027846|521714356|FG002|Overall Study|Entry into another COG therapeutic study|2|||
144689699|NCT00027846|521714354|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
144689700|NCT00027846|521714355|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
144689701|NCT00027846|521714356|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
144689702|NCT04335929|521714357|FG000|Overall Study|Lost to Follow-up|10|||
144689703|NCT02889861|521714374|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
144689704|NCT01005966|521714375|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
144689705|NCT01005966|521714376|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
144689706|NCT01005966|521714377|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
144689707|NCT01005966|521714378|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
144689708|NCT01005966|521714379|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
144689709|NCT01005966|521714375|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
144689710|NCT01005966|521714376|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
144689711|NCT01005966|521714377|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
144689712|NCT01005966|521714378|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
144689713|NCT01005966|521714379|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
144689714|NCT01005966|521714375|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
144689715|NCT01005966|521714376|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
144689716|NCT01005966|521714377|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
144219469|NCT05201794|519998525|FG001|Overall Study|Site Terminated By Sponsor|1|||
144219470|NCT05201794|519998526|FG002|Overall Study|Site Terminated By Sponsor|0|||
144219471|NCT05201794|519998527|FG003|Overall Study|Site Terminated By Sponsor|0|||
144219472|NCT05201794|519998524|FG000|Overall Study|Other|3|||
144219473|NCT05201794|519998525|FG001|Overall Study|Other|3|||
144219474|NCT05201794|519998526|FG002|Overall Study|Other|3|||
144219475|NCT05201794|519998527|FG003|Overall Study|Other|0|||
144219476|NCT05201794|519998524|FG000|Overall Study|Randomized But Not Treated|1|||
144219477|NCT05201794|519998525|FG001|Overall Study|Randomized But Not Treated|2|||
144219478|NCT05201794|519998526|FG002|Overall Study|Randomized But Not Treated|1|||
144219479|NCT05201794|519998527|FG003|Overall Study|Randomized But Not Treated|0|||
144219480|NCT04653454|519998532|FG000|Overall Study|Withdrawal by Subject|1|||
144219481|NCT04653454|519998532|FG000|Overall Study|Physician Decision|40|||
144219482|NCT02848001|519998533|FG000|Overall Study|other reasons|0|||
144219483|NCT02848001|519998534|FG001|Overall Study|other reasons|0|||
144219484|NCT02848001|519998535|FG002|Overall Study|other reasons|1|||
144219485|NCT02848001|519998536|FG003|Overall Study|other reasons|0|||
144741927|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
144741928|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
144741929|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
144741930|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
144689717|NCT01005966|521714378|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
144689718|NCT01005966|521714379|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
144741931|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
144741932|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
144741933|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
144741934|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
144741935|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741936|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741937|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741938|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741939|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741940|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
144741941|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
144741942|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741943|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741944|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
144741945|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741946|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741947|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741948|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741949|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741950|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741951|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144689719|NCT01005966|521714375|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
144689720|NCT01005966|521714376|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
144689721|NCT01005966|521714377|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
144689722|NCT01005966|521714378|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
144689723|NCT01005966|521714379|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
144689724|NCT01005966|521714375|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144689725|NCT01005966|521714376|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144689726|NCT01005966|521714377|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144689727|NCT01005966|521714378|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
144689728|NCT01005966|521714379|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144689729|NCT01005966|521714375|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144689730|NCT01005966|521714376|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144689731|NCT01005966|521714377|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
144689732|NCT01005966|521714378|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144689733|NCT01005966|521714379|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
144689734|NCT01005966|521714375|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
144689735|NCT01005966|521714376|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
144689736|NCT01005966|521714377|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
144689737|NCT01005966|521714378|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
144689738|NCT01005966|521714379|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
144689739|NCT01005966|521714375|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
144689740|NCT01005966|521714376|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
144689741|NCT01005966|521714377|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
144689742|NCT01005966|521714378|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
144689743|NCT01005966|521714379|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
144689744|NCT01005966|521714375|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
144689745|NCT01005966|521714376|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
144689746|NCT01005966|521714377|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
144689747|NCT01005966|521714378|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
144689748|NCT01005966|521714379|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
144689749|NCT01451203|521714380|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
144689750|NCT01451203|521714381|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
144689751|NCT01451203|521714380|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
144689752|NCT01451203|521714381|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
144689753|NCT01451203|521714380|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
144689754|NCT01451203|521714381|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
144689755|NCT01451203|521714380|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
144689756|NCT01451203|521714381|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
144741952|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741953|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741954|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741955|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741956|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144689757|NCT01451203|521714380|FG000|Double-blind Treatment Period|Adverse Event|6|||
144689758|NCT01451203|521714381|FG001|Double-blind Treatment Period|Adverse Event|9|||
144689759|NCT01451203|521714380|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
144689760|NCT01451203|521714381|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
144689761|NCT01451203|521714380|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
144689762|NCT01451203|521714381|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
144689763|NCT01451203|521714380|FG000|Double-blind Treatment Period|Investigator decision|2|||
144689764|NCT01451203|521714381|FG001|Double-blind Treatment Period|Investigator decision|0|||
144689765|NCT01451203|521714380|FG000|Post-treatment Period|Consent withdrawn|2|||
144689766|NCT01451203|521714381|FG001|Post-treatment Period|Consent withdrawn|4|||
144689767|NCT01451203|521714380|FG000|Post-treatment Period|Lack of Efficacy|12|||
144689768|NCT01451203|521714381|FG001|Post-treatment Period|Lack of Efficacy|28|||
144689769|NCT01451203|521714380|FG000|Post-treatment Period|Adverse Event|0|||
144689770|NCT01451203|521714381|FG001|Post-treatment Period|Adverse Event|1|||
144689771|NCT01451203|521714380|FG000|Post-treatment Period|Investigator decision|0|||
144689772|NCT01451203|521714381|FG001|Post-treatment Period|Investigator decision|1|||
144689773|NCT02146274|521714382|FG000|Overall Study|Protocol Violation|73|||
144689774|NCT00443534|521714383|FG000|Overall Study|Lack of Efficacy|67|||
144689775|NCT00443534|521714383|FG000|Overall Study|Adverse Event|16|||
144689776|NCT00443534|521714383|FG000|Overall Study|Death|9|||
144689777|NCT00443534|521714383|FG000|Overall Study|Withdrawal by Subject|8|||
144689778|NCT00443534|521714383|FG000|Overall Study|Study Terminated by Sponsor|12|||
144689779|NCT00443534|521714383|FG000|Overall Study|Other|10|||
144689780|NCT00443534|521714383|FG000|Overall Study|Enrolled, Not Treated|1|||
144689781|NCT02516605|521714384|FG000|Overall Study|Protocol Violation|0|||
144689782|NCT02516605|521714385|FG001|Overall Study|Protocol Violation|0|||
144689783|NCT02516605|521714386|FG002|Overall Study|Protocol Violation|0|||
144689784|NCT02516605|521714387|FG003|Overall Study|Protocol Violation|0|||
144689785|NCT02516605|521714388|FG004|Overall Study|Protocol Violation|1|||
144689786|NCT02516605|521714384|FG000|Overall Study|Withdrawal by Subject|0|||
144689787|NCT02516605|521714385|FG001|Overall Study|Withdrawal by Subject|0|||
144689788|NCT02516605|521714386|FG002|Overall Study|Withdrawal by Subject|0|||
144689789|NCT02516605|521714387|FG003|Overall Study|Withdrawal by Subject|1|||
144689790|NCT02516605|521714388|FG004|Overall Study|Withdrawal by Subject|0|||
144689791|NCT01710709|521714389|FG000|Overall Study|Lost to Follow-up|29|||
144689792|NCT01710709|521714389|FG000|Overall Study|Adverse Event|48|||
144689793|NCT01710709|521714389|FG000|Overall Study|Participant met withdrawal criteria|33|||
144689794|NCT01710709|521714389|FG000|Overall Study|Participant withdrawn by investigator|2|||
144689795|NCT01710709|521714389|FG000|Overall Study|Withdrawal by Subject|53|||
144689796|NCT01710709|521714389|FG000|Overall Study|Protocol Violation|5|||
144689797|NCT01710709|521714389|FG000|Overall Study|Lack of Efficacy|3|||
144689798|NCT01731951|521714392|FG000|Overall Study|Documented Disease Progression|1|||
144689799|NCT01731951|521714393|FG001|Overall Study|Documented Disease Progression|0|||
144689800|NCT01731951|521714394|FG002|Overall Study|Documented Disease Progression|0|||
144689801|NCT01731951|521714395|FG003|Overall Study|Documented Disease Progression|0|||
144689802|NCT01731951|521714396|FG004|Overall Study|Documented Disease Progression|0|||
144689803|NCT01731951|521714397|FG005|Overall Study|Documented Disease Progression|0|||
144689804|NCT01731951|521714392|FG000|Overall Study|Lost to Follow-up|2|||
144689805|NCT01731951|521714393|FG001|Overall Study|Lost to Follow-up|0|||
144689806|NCT01731951|521714394|FG002|Overall Study|Lost to Follow-up|0|||
144689807|NCT01731951|521714395|FG003|Overall Study|Lost to Follow-up|1|||
144689808|NCT01731951|521714396|FG004|Overall Study|Lost to Follow-up|3|||
144689809|NCT01731951|521714397|FG005|Overall Study|Lost to Follow-up|1|||
144689810|NCT01731951|521714392|FG000|Overall Study|Withdrawal of Consent|1|||
144689811|NCT01731951|521714393|FG001|Overall Study|Withdrawal of Consent|0|||
144689812|NCT01731951|521714394|FG002|Overall Study|Withdrawal of Consent|0|||
144689813|NCT01731951|521714395|FG003|Overall Study|Withdrawal of Consent|0|||
144689814|NCT01731951|521714396|FG004|Overall Study|Withdrawal of Consent|0|||
144689815|NCT01731951|521714397|FG005|Overall Study|Withdrawal of Consent|2|||
144689816|NCT01731951|521714392|FG000|Overall Study|Death|13|||
144689817|NCT01731951|521714393|FG001|Overall Study|Death|15|||
144689818|NCT01731951|521714394|FG002|Overall Study|Death|9|||
144689819|NCT01731951|521714395|FG003|Overall Study|Death|8|||
144689820|NCT01731951|521714396|FG004|Overall Study|Death|9|||
144689821|NCT01731951|521714397|FG005|Overall Study|Death|6|||
144219486|NCT02848001|519998537|FG004|Overall Study|other reasons|4|||
144689822|NCT00253747|521714398|FG000|Overall Study|Lost to Follow-up|13|||
144689823|NCT00253747|521714399|FG001|Overall Study|Lost to Follow-up|14|||
144689824|NCT00253747|521714398|FG000|Overall Study|Withdrawal by Subject|10|||
144689825|NCT00253747|521714399|FG001|Overall Study|Withdrawal by Subject|11|||
144689826|NCT00253747|521714398|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
144689827|NCT00253747|521714399|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
144689828|NCT04601194|521714400|FG000|Overall Study|Lost to Follow-up|7|||
144689829|NCT02630459|521714401|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
144689830|NCT02630459|521714402|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
144689831|NCT02630459|521714403|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
144689832|NCT02630459|521714404|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
144689833|NCT02630459|521714405|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
144689834|NCT02630459|521714406|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
144689835|NCT02630459|521714407|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
144689836|NCT02630459|521714408|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
144689837|NCT02630459|521714401|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689838|NCT02630459|521714402|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689839|NCT02630459|521714403|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
144689840|NCT02630459|521714404|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689841|NCT02630459|521714405|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689842|NCT02630459|521714406|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689843|NCT02630459|521714407|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689844|NCT02630459|521714408|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
144689845|NCT02630459|521714401|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
144689846|NCT02630459|521714402|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
144689847|NCT02630459|521714403|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
144689848|NCT02630459|521714404|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
144689849|NCT02630459|521714405|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
144689850|NCT02630459|521714406|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
144689851|NCT02630459|521714407|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
144689852|NCT02630459|521714408|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
144689853|NCT02630459|521714401|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
144689854|NCT02630459|521714402|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689855|NCT02630459|521714403|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689856|NCT02630459|521714404|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689857|NCT02630459|521714405|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689858|NCT02630459|521714406|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689859|NCT02630459|521714407|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689860|NCT02630459|521714408|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
144689861|NCT02630459|521714401|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
144689862|NCT02630459|521714402|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
144689863|NCT02630459|521714403|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
144689864|NCT02630459|521714404|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
144689865|NCT02630459|521714405|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
144689866|NCT02630459|521714406|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
144689867|NCT02630459|521714407|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
144689868|NCT02630459|521714408|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
144689869|NCT02630459|521714401|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
144689870|NCT02630459|521714402|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
144689871|NCT02630459|521714403|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
144689872|NCT02630459|521714404|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
144689873|NCT02630459|521714405|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
144689874|NCT02630459|521714406|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
144689875|NCT02630459|521714407|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
144689876|NCT02630459|521714408|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
144689877|NCT02630459|521714401|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689878|NCT02630459|521714402|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689879|NCT02630459|521714403|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689880|NCT02630459|521714404|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689881|NCT02630459|521714405|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
144689882|NCT02630459|521714406|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689883|NCT02630459|521714407|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689884|NCT02630459|521714408|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
144689885|NCT00348686|521714411|FG000|Overall Study|Withdrawal by Subject|45|||
144689886|NCT00348686|521714411|FG000|Overall Study|Adverse Event|5|||
144689887|NCT00348686|521714411|FG000|Overall Study|Protocol Violation|6|||
144689888|NCT00348686|521714411|FG000|Overall Study|Lost to Follow-up|2|||
144689889|NCT00348686|521714411|FG000|Overall Study|Multiple Reasons|8|||
144689890|NCT01258738|521714414|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
144689891|NCT01258738|521714415|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
144689892|NCT01258738|521714414|FG000|Double-blind Period|Withdrawal by Subject|2|||
144689893|NCT01258738|521714415|FG001|Double-blind Period|Withdrawal by Subject|2|||
144689894|NCT01258738|521714414|FG000|Double-blind Period|Protocol Violation|1|||
144741957|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144219487|NCT02848001|519998538|FG005|Overall Study|other reasons|1|||
144219488|NCT02848001|519998539|FG006|Overall Study|other reasons|0|||
144219489|NCT02848001|519998540|FG007|Overall Study|other reasons|2|||
144219490|NCT02848001|519998541|FG008|Overall Study|other reasons|2|||
144689895|NCT01258738|521714415|FG001|Double-blind Period|Protocol Violation|1|||
144689896|NCT01258738|521714414|FG000|Double-blind Period|Adverse Event|3|||
144689897|NCT01258738|521714415|FG001|Double-blind Period|Adverse Event|1|||
144689898|NCT01258738|521714414|FG000|Open-label Period|Did not meet inclusion criteria|0|||
144689899|NCT01258738|521714415|FG001|Open-label Period|Did not meet inclusion criteria|1|||
144689900|NCT01258738|521714414|FG000|Open-label Period|Insufficient clinical response|5|||
144689901|NCT01258738|521714415|FG001|Open-label Period|Insufficient clinical response|3|||
144689902|NCT01258738|521714414|FG000|Open-label Period|Lost to Follow-up|0|||
144689903|NCT01258738|521714415|FG001|Open-label Period|Lost to Follow-up|2|||
144689904|NCT01258738|521714414|FG000|Open-label Period|Withdrawal by Subject|5|||
144689905|NCT01258738|521714415|FG001|Open-label Period|Withdrawal by Subject|6|||
144689906|NCT01258738|521714414|FG000|Open-label Period|Protocol Violation|2|||
144689907|NCT01258738|521714415|FG001|Open-label Period|Protocol Violation|2|||
144689908|NCT01258738|521714414|FG000|Open-label Period|Adverse Event|4|||
144689909|NCT01258738|521714415|FG001|Open-label Period|Adverse Event|5|||
144689910|NCT01258738|521714414|FG000|Open-label Period|Other Reasons|0|||
144689911|NCT01258738|521714415|FG001|Open-label Period|Other Reasons|1|||
144689912|NCT01258738|521714414|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
144689913|NCT01258738|521714415|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
144689914|NCT02418000|521714416|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
144689915|NCT02418000|521714417|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689916|NCT02418000|521714418|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689917|NCT02418000|521714419|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689918|NCT02418000|521714420|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689919|NCT02418000|521714416|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
144689920|NCT02418000|521714417|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
144689921|NCT02418000|521714418|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
144689922|NCT02418000|521714419|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
144689923|NCT02418000|521714420|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
144689924|NCT02418000|521714416|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
144689925|NCT02418000|521714417|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
144689926|NCT02418000|521714418|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
144689927|NCT02418000|521714419|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
144689928|NCT02418000|521714420|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
144689929|NCT02418000|521714416|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689930|NCT02418000|521714417|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
144689931|NCT02418000|521714418|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689932|NCT02418000|521714419|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689933|NCT02418000|521714420|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
144689934|NCT02418000|521714416|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
144689935|NCT02418000|521714417|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
144689936|NCT02418000|521714418|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
144689937|NCT02418000|521714419|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
144689938|NCT02418000|521714420|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
144689939|NCT02418000|521714416|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689940|NCT02418000|521714417|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689941|NCT02418000|521714418|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
144219491|NCT02848001|519998542|FG009|Overall Study|other reasons|3|||
144219492|NCT02848001|519998543|FG010|Overall Study|other reasons|0|||
144219493|NCT02848001|519998544|FG011|Overall Study|other reasons|1|||
144219494|NCT02848001|519998545|FG012|Overall Study|other reasons|1|||
144219495|NCT02848001|519998546|FG013|Overall Study|other reasons|0|||
144219496|NCT02848001|519998547|FG014|Overall Study|other reasons|0|||
144219497|NCT02848001|519998548|FG015|Overall Study|other reasons|2|||
144219498|NCT02848001|519998549|FG016|Overall Study|other reasons|1|||
144219499|NCT02848001|519998533|FG000|Overall Study|Lack of Efficacy|0|||
144219500|NCT02848001|519998534|FG001|Overall Study|Lack of Efficacy|1|||
144219501|NCT02848001|519998535|FG002|Overall Study|Lack of Efficacy|1|||
144219502|NCT02848001|519998536|FG003|Overall Study|Lack of Efficacy|2|||
144219503|NCT02848001|519998537|FG004|Overall Study|Lack of Efficacy|3|||
144219504|NCT02848001|519998538|FG005|Overall Study|Lack of Efficacy|0|||
144219505|NCT02848001|519998539|FG006|Overall Study|Lack of Efficacy|1|||
144219506|NCT02848001|519998540|FG007|Overall Study|Lack of Efficacy|0|||
144219507|NCT02848001|519998541|FG008|Overall Study|Lack of Efficacy|0|||
144219508|NCT02848001|519998542|FG009|Overall Study|Lack of Efficacy|1|||
144219509|NCT02848001|519998543|FG010|Overall Study|Lack of Efficacy|0|||
144689942|NCT02418000|521714419|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689943|NCT02418000|521714420|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144219510|NCT02848001|519998544|FG011|Overall Study|Lack of Efficacy|2|||
144219511|NCT02848001|519998545|FG012|Overall Study|Lack of Efficacy|0|||
144219512|NCT02848001|519998546|FG013|Overall Study|Lack of Efficacy|2|||
144219513|NCT02848001|519998547|FG014|Overall Study|Lack of Efficacy|2|||
144219514|NCT02848001|519998548|FG015|Overall Study|Lack of Efficacy|0|||
144219515|NCT02848001|519998549|FG016|Overall Study|Lack of Efficacy|0|||
144219516|NCT02848001|519998533|FG000|Overall Study|Progressive Disease|2|||
144219517|NCT02848001|519998534|FG001|Overall Study|Progressive Disease|1|||
144219518|NCT02848001|519998535|FG002|Overall Study|Progressive Disease|0|||
144689944|NCT02418000|521714416|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689945|NCT02418000|521714417|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689946|NCT02418000|521714418|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689947|NCT02418000|521714419|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
144689948|NCT02418000|521714420|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689949|NCT02418000|521714416|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
144689950|NCT02418000|521714417|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
144689951|NCT02418000|521714418|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
144689952|NCT02418000|521714419|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
144689953|NCT02418000|521714420|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
144689954|NCT02418000|521714416|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689955|NCT02418000|521714417|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689956|NCT02418000|521714418|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689957|NCT02418000|521714419|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
144689958|NCT02418000|521714420|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
144689959|NCT00689611|521714421|FG000|Overall Study|Death|6|||
144689960|NCT00689611|521714422|FG001|Overall Study|Death|9|||
144689961|NCT00689611|521714421|FG000|Overall Study|Withdrawal by Subject|8|||
144689962|NCT00689611|521714422|FG001|Overall Study|Withdrawal by Subject|9|||
144689963|NCT00689611|521714421|FG000|Overall Study|Lost to Follow-up|27|||
144689964|NCT00689611|521714422|FG001|Overall Study|Lost to Follow-up|28|||
144689965|NCT00490815|521714423|FG000|Overall Study|Adverse Event|2|||
144689966|NCT00490815|521714424|FG001|Overall Study|Adverse Event|3|||
144689967|NCT00490815|521714423|FG000|Overall Study|Withdrawal by Subject|4|||
144689968|NCT00490815|521714424|FG001|Overall Study|Withdrawal by Subject|0|||
144689969|NCT00490815|521714423|FG000|Overall Study|Lost to Follow-up|1|||
144689970|NCT00490815|521714424|FG001|Overall Study|Lost to Follow-up|3|||
144689971|NCT00490815|521714423|FG000|Overall Study|Death|1|||
144689972|NCT00490815|521714424|FG001|Overall Study|Death|3|||
144689973|NCT00732199|521714437|FG000|Overall Study|Withdrawal by Subject|25|||
144689974|NCT00732199|521714438|FG001|Overall Study|Withdrawal by Subject|18|||
144689975|NCT00732199|521714437|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
144689976|NCT00732199|521714438|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
144689977|NCT02870348|521714449|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
144689978|NCT01038635|521714452|FG000|Overall Study|Disease Progression|2|||
144689979|NCT01038635|521714453|FG001|Overall Study|Disease Progression|0|||
144689980|NCT01038635|521714454|FG002|Overall Study|Disease Progression|0|||
144689981|NCT01038635|521714455|FG003|Overall Study|Disease Progression|0|||
144689982|NCT01038635|521714456|FG004|Overall Study|Disease Progression|0|||
144689983|NCT01038635|521714457|FG005|Overall Study|Disease Progression|0|||
144689984|NCT01038635|521714458|FG006|Overall Study|Disease Progression|1|||
144689985|NCT01038635|521714459|FG007|Overall Study|Disease Progression|4|||
144689986|NCT01038635|521714460|FG008|Overall Study|Disease Progression|0|||
144689987|NCT01038635|521714452|FG000|Overall Study|Death|0|||
144689988|NCT01038635|521714453|FG001|Overall Study|Death|0|||
144689989|NCT01038635|521714454|FG002|Overall Study|Death|0|||
144689990|NCT01038635|521714455|FG003|Overall Study|Death|0|||
144689991|NCT01038635|521714456|FG004|Overall Study|Death|1|||
144689992|NCT01038635|521714457|FG005|Overall Study|Death|0|||
144689993|NCT01038635|521714458|FG006|Overall Study|Death|1|||
144689994|NCT01038635|521714459|FG007|Overall Study|Death|1|||
144689995|NCT01038635|521714460|FG008|Overall Study|Death|2|||
144689996|NCT01227252|521714461|FG000|Overall Study|Sponsor Decision|0|||
144689997|NCT01227252|521714462|FG001|Overall Study|Sponsor Decision|1|||
144689998|NCT01227252|521714463|FG002|Overall Study|Sponsor Decision|0|||
144689999|NCT01227252|521714464|FG003|Overall Study|Sponsor Decision|0|||
144690000|NCT01227252|521714461|FG000|Overall Study|Lost to Follow-up|0|||
144690001|NCT01227252|521714462|FG001|Overall Study|Lost to Follow-up|1|||
144219519|NCT02848001|519998536|FG003|Overall Study|Progressive Disease|4|||
144266118|NCT01064479|520176511|FG001|Overall Study|Disease progression|1|||
144266119|NCT01064479|520176510|FG000|Overall Study|Toxicity|1|||
144266120|NCT01064479|520176511|FG001|Overall Study|Toxicity|1|||
144690002|NCT01227252|521714463|FG002|Overall Study|Lost to Follow-up|0|||
144690003|NCT01227252|521714464|FG003|Overall Study|Lost to Follow-up|0|||
144690004|NCT01227252|521714461|FG000|Overall Study|Withdrawal by Subject|0|||
144690005|NCT01227252|521714462|FG001|Overall Study|Withdrawal by Subject|1|||
144690006|NCT01227252|521714463|FG002|Overall Study|Withdrawal by Subject|0|||
144690007|NCT01227252|521714464|FG003|Overall Study|Withdrawal by Subject|0|||
144741958|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144690008|NCT01034709|521714466|FG000|Overall Study|Protocol Violation|9|||
144690009|NCT01034709|521714467|FG001|Overall Study|Protocol Violation|16|||
144690010|NCT01060150|521714470|FG000|Overall Study|Adverse Event|6|||
144690011|NCT01060150|521714470|FG000|Overall Study|Lost to Follow-up|1|||
144690012|NCT01060150|521714470|FG000|Overall Study|Protocol Violation|6|||
144690013|NCT01060150|521714470|FG000|Overall Study|Withdrawal by Subject|8|||
144690014|NCT01060150|521714470|FG000|Overall Study|Enrolled, but not treated|2|||
144690015|NCT02516306|521714471|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
144690016|NCT02516306|521714472|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
144690017|NCT02364999|521714474|FG000|Overall Study|Death|136|||
144690018|NCT02364999|521714475|FG001|Overall Study|Death|138|||
144690019|NCT02364999|521714474|FG000|Overall Study|Lost to Follow-up|10|||
144690020|NCT02364999|521714475|FG001|Overall Study|Lost to Follow-up|15|||
144690021|NCT02364999|521714474|FG000|Overall Study|Protocol Violation|3|||
144690022|NCT02364999|521714475|FG001|Overall Study|Protocol Violation|2|||
144690023|NCT02364999|521714474|FG000|Overall Study|Withdrawal by Subject|14|||
144690024|NCT02364999|521714475|FG001|Overall Study|Withdrawal by Subject|14|||
144690025|NCT02364999|521714474|FG000|Overall Study|Other|0|||
144690026|NCT02364999|521714475|FG001|Overall Study|Other|1|||
144690027|NCT02364999|521714474|FG000|Overall Study|Randomized but did not receive treatment|2|||
144690028|NCT02364999|521714475|FG001|Overall Study|Randomized but did not receive treatment|3|||
144690029|NCT01566981|521714476|FG000|Overall Study|Lost to Follow-up|5|||
144690030|NCT01566981|521714477|FG001|Overall Study|Lost to Follow-up|8|||
144690031|NCT02177942|521714478|FG000|Overall Study|Adverse Event|1|||
144690032|NCT02177942|521714479|FG001|Overall Study|Adverse Event|0|||
144690033|NCT02177942|521714478|FG000|Overall Study|Lost to Follow-up|1|||
144690034|NCT02177942|521714479|FG001|Overall Study|Lost to Follow-up|1|||
144690035|NCT02177942|521714478|FG000|Overall Study|Protocol Violation|4|||
144690036|NCT02177942|521714479|FG001|Overall Study|Protocol Violation|6|||
144690037|NCT02177942|521714478|FG000|Overall Study|Withdrawal by Subject|71|||
144690038|NCT02177942|521714479|FG001|Overall Study|Withdrawal by Subject|81|||
144690039|NCT01351415|521714480|FG000|Overall Study|Withdrawal by Subject|15|||
144690040|NCT01351415|521714481|FG001|Overall Study|Withdrawal by Subject|17|||
144690041|NCT01351415|521714480|FG000|Overall Study|Trial termination by the Sponsor|28|||
144690042|NCT01351415|521714481|FG001|Overall Study|Trial termination by the Sponsor|19|||
144690043|NCT01351415|521714480|FG000|Overall Study|Lost to Follow-up|5|||
144690044|NCT01351415|521714481|FG001|Overall Study|Lost to Follow-up|7|||
144690045|NCT01351415|521714480|FG000|Overall Study|Death|190|||
144690046|NCT01351415|521714481|FG001|Overall Study|Death|187|||
144690047|NCT01351415|521714480|FG000|Overall Study|Physician Decision|2|||
144690048|NCT01351415|521714481|FG001|Overall Study|Physician Decision|3|||
144690049|NCT01351415|521714480|FG000|Overall Study|Reason unknown|0|||
144690050|NCT01351415|521714481|FG001|Overall Study|Reason unknown|2|||
144690051|NCT01351415|521714480|FG000|Overall Study|Never Started|5|||
144690052|NCT01351415|521714481|FG001|Overall Study|Never Started|5|||
144690053|NCT03480360|521714483|FG000|Overall Study|Death|2|||
144690054|NCT03147495|521714487|FG000|Overall Study|Physician Decision|0|||
144690055|NCT03147495|521714488|FG001|Overall Study|Physician Decision|6|||
144690056|NCT01142791|521714489|FG000|Overall Study|Alternative Treatment|1|||
144690057|NCT01142791|521714490|FG001|Overall Study|Alternative Treatment|0|||
144690058|NCT01142791|521714489|FG000|Overall Study|Lost to Follow-up|1|||
144690059|NCT01142791|521714490|FG001|Overall Study|Lost to Follow-up|0|||
144690060|NCT01142791|521714489|FG000|Overall Study|Withdrawal by Subject|5|||
144690061|NCT01142791|521714490|FG001|Overall Study|Withdrawal by Subject|0|||
144690062|NCT01142791|521714489|FG000|Overall Study|Received only 1 sonication|0|||
144690063|NCT01142791|521714490|FG001|Overall Study|Received only 1 sonication|6|||
144690064|NCT05375838|521714493|FG000|Overall Study|Other|0|||
144690065|NCT05375838|521714494|FG001|Overall Study|Other|0|||
144690066|NCT05375838|521714495|FG002|Overall Study|Other|0|||
144219520|NCT02848001|519998537|FG004|Overall Study|Progressive Disease|3|||
144219521|NCT02848001|519998538|FG005|Overall Study|Progressive Disease|0|||
144219522|NCT02848001|519998539|FG006|Overall Study|Progressive Disease|4|||
144690067|NCT05375838|521714496|FG003|Overall Study|Other|1|||
144690068|NCT05375838|521714497|FG004|Overall Study|Other|1|||
144690069|NCT05375838|521714498|FG005|Overall Study|Other|0|||
144690070|NCT05375838|521714493|FG000|Overall Study|Withdrawal by Subject|2|||
144690071|NCT05375838|521714494|FG001|Overall Study|Withdrawal by Subject|1|||
144690072|NCT05375838|521714495|FG002|Overall Study|Withdrawal by Subject|3|||
144690073|NCT05375838|521714496|FG003|Overall Study|Withdrawal by Subject|2|||
144690074|NCT05375838|521714497|FG004|Overall Study|Withdrawal by Subject|2|||
144690075|NCT05375838|521714498|FG005|Overall Study|Withdrawal by Subject|0|||
144690076|NCT05375838|521714493|FG000|Overall Study|Protocol Violation|0|||
144219523|NCT02848001|519998540|FG007|Overall Study|Progressive Disease|1|||
144690077|NCT05375838|521714494|FG001|Overall Study|Protocol Violation|0|||
144690078|NCT05375838|521714495|FG002|Overall Study|Protocol Violation|0|||
144690079|NCT05375838|521714496|FG003|Overall Study|Protocol Violation|0|||
144690080|NCT05375838|521714497|FG004|Overall Study|Protocol Violation|1|||
144219524|NCT02848001|519998541|FG008|Overall Study|Progressive Disease|0|||
144690081|NCT05375838|521714498|FG005|Overall Study|Protocol Violation|0|||
144690082|NCT05375838|521714493|FG000|Overall Study|Physician Decision|0|||
144690083|NCT05375838|521714494|FG001|Overall Study|Physician Decision|1|||
144690084|NCT05375838|521714495|FG002|Overall Study|Physician Decision|0|||
144690085|NCT05375838|521714496|FG003|Overall Study|Physician Decision|0|||
144690086|NCT05375838|521714497|FG004|Overall Study|Physician Decision|0|||
144690087|NCT05375838|521714498|FG005|Overall Study|Physician Decision|1|||
144690088|NCT05375838|521714493|FG000|Overall Study|Lost to Follow-up|2|||
144690089|NCT05375838|521714494|FG001|Overall Study|Lost to Follow-up|7|||
144690090|NCT05375838|521714495|FG002|Overall Study|Lost to Follow-up|0|||
144690091|NCT05375838|521714496|FG003|Overall Study|Lost to Follow-up|4|||
144690092|NCT05375838|521714497|FG004|Overall Study|Lost to Follow-up|2|||
144690093|NCT05375838|521714498|FG005|Overall Study|Lost to Follow-up|3|||
144690094|NCT00877890|521714499|FG000|Overall Study|Adverse Event|6|||
144690095|NCT00877890|521714500|FG001|Overall Study|Adverse Event|6|||
144690096|NCT00877890|521714499|FG000|Overall Study|Lost to Follow-up|5|||
144690097|NCT00877890|521714500|FG001|Overall Study|Lost to Follow-up|5|||
144690098|NCT00877890|521714499|FG000|Overall Study|Protocol Violation|0|||
144690099|NCT00877890|521714500|FG001|Overall Study|Protocol Violation|1|||
144690100|NCT00877890|521714499|FG000|Overall Study|Withdrawal of Consent|6|||
144690101|NCT00877890|521714500|FG001|Overall Study|Withdrawal of Consent|12|||
144690102|NCT00877890|521714499|FG000|Overall Study|Investigator Decision|0|||
144690103|NCT00877890|521714500|FG001|Overall Study|Investigator Decision|2|||
144690104|NCT00877890|521714499|FG000|Overall Study|Loss of Glucose Control|3|||
144690105|NCT00877890|521714500|FG001|Overall Study|Loss of Glucose Control|4|||
144690106|NCT01277666|521714504|FG000|Overall Study|Adverse Event|26|||
144690107|NCT01277666|521714505|FG001|Overall Study|Adverse Event|25|||
144690108|NCT01277666|521714506|FG002|Overall Study|Adverse Event|20|||
144690109|NCT01277666|521714504|FG000|Overall Study|Lack of Efficacy|8|||
144690110|NCT01277666|521714505|FG001|Overall Study|Lack of Efficacy|20|||
144690111|NCT01277666|521714506|FG002|Overall Study|Lack of Efficacy|12|||
144690112|NCT01277666|521714504|FG000|Overall Study|Protocol Violation|2|||
144690113|NCT01277666|521714505|FG001|Overall Study|Protocol Violation|3|||
144690114|NCT01277666|521714506|FG002|Overall Study|Protocol Violation|2|||
144690115|NCT01277666|521714504|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
144690116|NCT01277666|521714505|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
144690117|NCT01277666|521714506|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
144690118|NCT01277666|521714504|FG000|Overall Study|Lost to Follow-up|1|||
144690119|NCT01277666|521714505|FG001|Overall Study|Lost to Follow-up|1|||
144690120|NCT01277666|521714506|FG002|Overall Study|Lost to Follow-up|2|||
144690121|NCT01277666|521714504|FG000|Overall Study|Withdrawal by Subject|7|||
144690122|NCT01277666|521714505|FG001|Overall Study|Withdrawal by Subject|8|||
144741959|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741960|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
144741961|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741962|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741963|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741964|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741965|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741966|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741967|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741968|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741969|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
144741970|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741971|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741972|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741973|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144690123|NCT01277666|521714506|FG002|Overall Study|Withdrawal by Subject|6|||
144690124|NCT01277666|521714504|FG000|Overall Study|Death|0|||
144690125|NCT01277666|521714505|FG001|Overall Study|Death|0|||
144690126|NCT01277666|521714506|FG002|Overall Study|Death|1|||
144741974|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741975|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741976|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741977|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144690127|NCT01385098|521714509|FG000|Overall Study|Adverse Event|10|||
144690128|NCT01385098|521714509|FG000|Overall Study|Lost to Follow-up|4|||
144690129|NCT01230827|521714510|FG000|Overall Study|Lost to Follow-up|0|||
144690130|NCT01230827|521714511|FG001|Overall Study|Lost to Follow-up|0|||
144690131|NCT01230827|521714512|FG002|Overall Study|Lost to Follow-up|1|||
144690132|NCT01230827|521714513|FG003|Overall Study|Lost to Follow-up|3|||
144690133|NCT01230827|521714510|FG000|Overall Study|Withdrawal by Subject|1|||
144690134|NCT01230827|521714511|FG001|Overall Study|Withdrawal by Subject|0|||
144690135|NCT01230827|521714512|FG002|Overall Study|Withdrawal by Subject|3|||
144690136|NCT01230827|521714513|FG003|Overall Study|Withdrawal by Subject|2|||
144690137|NCT01230827|521714510|FG000|Overall Study|Lack of Efficacy|14|||
144741978|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741979|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741980|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741981|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741982|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741983|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741984|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741985|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741986|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
144741987|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741988|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741989|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741990|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741991|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741992|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741993|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741994|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741995|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
144741996|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741997|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741998|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
144741999|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742000|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742001|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742002|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742003|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742004|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742005|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742006|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742007|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742008|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742009|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742010|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742011|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742012|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
144742013|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742014|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742015|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742016|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742017|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742018|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
144742019|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
144742020|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
144742021|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
144742022|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
144742023|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742024|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742025|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742026|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742027|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742028|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742029|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742030|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742031|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144690138|NCT01230827|521714511|FG001|Overall Study|Lack of Efficacy|1|||
144690139|NCT01230827|521714512|FG002|Overall Study|Lack of Efficacy|2|||
144690140|NCT01230827|521714513|FG003|Overall Study|Lack of Efficacy|3|||
144690141|NCT01230827|521714510|FG000|Overall Study|Adverse Event|4|||
144690142|NCT01230827|521714511|FG001|Overall Study|Adverse Event|2|||
144690143|NCT01230827|521714512|FG002|Overall Study|Adverse Event|3|||
144690144|NCT01230827|521714513|FG003|Overall Study|Adverse Event|7|||
144690145|NCT01230827|521714510|FG000|Overall Study|Recovery|0|||
144690146|NCT01230827|521714511|FG001|Overall Study|Recovery|6|||
144690147|NCT01230827|521714512|FG002|Overall Study|Recovery|0|||
144690148|NCT01230827|521714513|FG003|Overall Study|Recovery|0|||
144690149|NCT01230827|521714510|FG000|Overall Study|Study terminated by Sponsor|0|||
144690150|NCT01230827|521714511|FG001|Overall Study|Study terminated by Sponsor|2|||
144690151|NCT01230827|521714512|FG002|Overall Study|Study terminated by Sponsor|56|||
144690152|NCT01230827|521714513|FG003|Overall Study|Study terminated by Sponsor|63|||
144742032|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742033|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144690153|NCT01021293|521714516|FG000|Overall Study|Serious Adverse Event|2|||
144690154|NCT01021293|521714517|FG001|Overall Study|Serious Adverse Event|1|||
144742034|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742035|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742036|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144742037|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144219525|NCT02848001|519998542|FG009|Overall Study|Progressive Disease|2|||
144219526|NCT02848001|519998543|FG010|Overall Study|Progressive Disease|3|||
144690155|NCT01021293|521714516|FG000|Overall Study|Adverse Event|2|||
144690156|NCT01021293|521714517|FG001|Overall Study|Adverse Event|1|||
144690157|NCT01021293|521714516|FG000|Overall Study|Withdrawal by Subject|1|||
144690158|NCT01021293|521714517|FG001|Overall Study|Withdrawal by Subject|3|||
144690159|NCT01021293|521714516|FG000|Overall Study|Migrated/moved from study area|6|||
144690160|NCT01021293|521714517|FG001|Overall Study|Migrated/moved from study area|18|||
144690161|NCT01021293|521714516|FG000|Overall Study|Lost to Follow-up|1|||
144690162|NCT01021293|521714517|FG001|Overall Study|Lost to Follow-up|1|||
144690163|NCT01864746|521716554|FG000|Overall Study|Disease recurrence|25|||
144690164|NCT01864746|521716555|FG001|Overall Study|Disease recurrence|40|||
144690165|NCT01864746|521716554|FG000|Overall Study|Second primary invasive nonbreast|2|||
144690166|NCT01864746|521716555|FG001|Overall Study|Second primary invasive nonbreast|3|||
144690167|NCT01864746|521716554|FG000|Overall Study|Death|2|||
144690168|NCT01864746|521716555|FG001|Overall Study|Death|1|||
144690169|NCT01864746|521716554|FG000|Overall Study|Adverse Event|33|||
144690170|NCT01864746|521716555|FG001|Overall Study|Adverse Event|5|||
144690171|NCT01864746|521716554|FG000|Overall Study|Withdrawal by Subject|56|||
144690172|NCT01864746|521716555|FG001|Overall Study|Withdrawal by Subject|41|||
144690173|NCT01864746|521716554|FG000|Overall Study|Physician Decision|5|||
144690174|NCT01864746|521716555|FG001|Overall Study|Physician Decision|6|||
144690175|NCT00413231|521716566|FG000|0 to 30-day Post Treatment|Death|5|||
144690176|NCT00413231|521716566|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
144690177|NCT00413231|521716566|FG000|30-day to 365-day Post Treatment|Death|13|||
144690178|NCT00413231|521716566|FG000|365-day to 60-month Post Treatment|Death|36|||
144690179|NCT00413231|521716566|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
144690180|NCT00413231|521716566|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
144690181|NCT00413231|521716566|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
144690182|NCT04450394|521716571|FG000|Overall Study|Adverse Event|2|||
144690183|NCT04450394|521716572|FG001|Overall Study|Adverse Event|0|||
144690184|NCT04450394|521716573|FG002|Overall Study|Adverse Event|0|||
144690185|NCT04450394|521716571|FG000|Overall Study|Death|0|||
144690186|NCT04450394|521716572|FG001|Overall Study|Death|1|||
144690187|NCT04450394|521716573|FG002|Overall Study|Death|0|||
144690188|NCT04450394|521716571|FG000|Overall Study|Lost to Follow-up|0|||
144690189|NCT04450394|521716572|FG001|Overall Study|Lost to Follow-up|3|||
144690190|NCT04450394|521716573|FG002|Overall Study|Lost to Follow-up|0|||
144690191|NCT04450394|521716571|FG000|Overall Study|Physician Decision|0|||
144690192|NCT04450394|521716572|FG001|Overall Study|Physician Decision|1|||
144690193|NCT04450394|521716573|FG002|Overall Study|Physician Decision|0|||
144690194|NCT04450394|521716571|FG000|Overall Study|Protocol Violation|2|||
144690195|NCT04450394|521716572|FG001|Overall Study|Protocol Violation|0|||
144690196|NCT04450394|521716573|FG002|Overall Study|Protocol Violation|0|||
144690197|NCT04450394|521716571|FG000|Overall Study|Withdrawal by Subject|6|||
144690198|NCT04450394|521716572|FG001|Overall Study|Withdrawal by Subject|9|||
144690199|NCT04450394|521716573|FG002|Overall Study|Withdrawal by Subject|0|||
144690200|NCT02643420|521716575|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
144690201|NCT02643420|521716576|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
144690202|NCT02643420|521716575|FG000|Overall Study|Withdrawal by Subject|25|||
144690203|NCT02643420|521716576|FG001|Overall Study|Withdrawal by Subject|19|||
144690204|NCT02643420|521716575|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
144690205|NCT02643420|521716576|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
144690206|NCT02643420|521716575|FG000|Overall Study|Lost to Follow-up|6|||
144690207|NCT02643420|521716576|FG001|Overall Study|Lost to Follow-up|10|||
144690208|NCT02643420|521716575|FG000|Overall Study|Investigator Decision|2|||
144690209|NCT02643420|521716576|FG001|Overall Study|Investigator Decision|4|||
144690210|NCT02643420|521716575|FG000|Overall Study|Sponsor decision|1|||
144690211|NCT02643420|521716576|FG001|Overall Study|Sponsor decision|1|||
144690212|NCT02643420|521716575|FG000|Overall Study|Death|0|||
144690213|NCT02643420|521716576|FG001|Overall Study|Death|2|||
144690214|NCT02643420|521716575|FG000|Overall Study|Reason not Specified|8|||
144742038|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
144219527|NCT02848001|519998544|FG011|Overall Study|Progressive Disease|2|||
144219528|NCT02848001|519998545|FG012|Overall Study|Progressive Disease|1|||
144690215|NCT02643420|521716576|FG001|Overall Study|Reason not Specified|7|||
144690216|NCT02127970|521716577|FG000|Overall Study|Adverse Event|2|||
144690217|NCT02127970|521716578|FG001|Overall Study|Adverse Event|1|||
144690218|NCT02127970|521716577|FG000|Overall Study|Death|1|||
144690219|NCT02127970|521716578|FG001|Overall Study|Death|1|||
144690220|NCT02127970|521716577|FG000|Overall Study|Lost to Follow-up|14|||
144690221|NCT02127970|521716578|FG001|Overall Study|Lost to Follow-up|14|||
144690222|NCT02127970|521716577|FG000|Overall Study|Reason not Specified|4|||
144690223|NCT02127970|521716578|FG001|Overall Study|Reason not Specified|7|||
144690224|NCT02127970|521716577|FG000|Overall Study|Pregnancy|0|||
144690225|NCT02127970|521716578|FG001|Overall Study|Pregnancy|1|||
144690226|NCT02127970|521716577|FG000|Overall Study|Subject Withdrew Consent|5|||
144690227|NCT02127970|521716578|FG001|Overall Study|Subject Withdrew Consent|3|||
144690228|NCT00542321|521716580|FG000|Overall Study|Death|0|||
144690229|NCT00542321|521716581|FG001|Overall Study|Death|1|||
144690230|NCT02988115|521716586|FG000|Overall Study|Adverse Event|6|||
144690231|NCT02988115|521716587|FG001|Overall Study|Adverse Event|1|||
144690232|NCT02988115|521716586|FG000|Overall Study|Sponsor Decision|5|||
144690233|NCT02988115|521716587|FG001|Overall Study|Sponsor Decision|2|||
144690234|NCT02988115|521716586|FG000|Overall Study|Withdrawal by Subject|1|||
144690235|NCT02988115|521716587|FG001|Overall Study|Withdrawal by Subject|1|||
144690236|NCT02988115|521716586|FG000|Overall Study|Withdrawn by Mistake|1|||
144690237|NCT02988115|521716587|FG001|Overall Study|Withdrawn by Mistake|0|||
144690238|NCT02988115|521716586|FG000|Overall Study|Lost to Follow-up|1|||
144690239|NCT02988115|521716587|FG001|Overall Study|Lost to Follow-up|0|||
144690240|NCT00104299|521716588|FG000|Overall Study|Adverse Event|3|||
144690241|NCT00104299|521716589|FG001|Overall Study|Adverse Event|1|||
144690242|NCT00104299|521716588|FG000|Overall Study|Death|2|||
144690243|NCT00104299|521716589|FG001|Overall Study|Death|2|||
144690244|NCT00104299|521716588|FG000|Overall Study|Withdrawal by Subject|2|||
144690245|NCT00104299|521716589|FG001|Overall Study|Withdrawal by Subject|6|||
144690246|NCT00104299|521716588|FG000|Overall Study|Physician Decision|1|||
144690247|NCT00104299|521716589|FG001|Overall Study|Physician Decision|1|||
144690248|NCT00104299|521716588|FG000|Overall Study|To have renal transplant|1|||
144690249|NCT00104299|521716589|FG001|Overall Study|To have renal transplant|0|||
144690250|NCT02452034|521716590|FG000|Overall Study|Adverse Event|0|||
144690251|NCT02452034|521716591|FG001|Overall Study|Adverse Event|0|||
144690252|NCT02452034|521716592|FG002|Overall Study|Adverse Event|0|||
144690253|NCT02452034|521716593|FG003|Overall Study|Adverse Event|0|||
144690254|NCT02452034|521716594|FG004|Overall Study|Adverse Event|0|||
144690255|NCT02452034|521716595|FG005|Overall Study|Adverse Event|1|||
144690256|NCT02452034|521716590|FG000|Overall Study|Death|0|||
144690257|NCT02452034|521716591|FG001|Overall Study|Death|0|||
144690258|NCT02452034|521716592|FG002|Overall Study|Death|0|||
144690259|NCT02452034|521716593|FG003|Overall Study|Death|0|||
144690260|NCT02452034|521716594|FG004|Overall Study|Death|1|||
144690261|NCT02452034|521716595|FG005|Overall Study|Death|1|||
144690262|NCT02452034|521716590|FG000|Overall Study|Physician Decision|0|||
144690263|NCT02452034|521716591|FG001|Overall Study|Physician Decision|1|||
144690264|NCT02452034|521716592|FG002|Overall Study|Physician Decision|1|||
144690265|NCT02452034|521716593|FG003|Overall Study|Physician Decision|0|||
144690266|NCT02452034|521716594|FG004|Overall Study|Physician Decision|0|||
144690267|NCT02452034|521716595|FG005|Overall Study|Physician Decision|0|||
144690268|NCT02452034|521716590|FG000|Overall Study|Protocol Violation|0|||
144690269|NCT02452034|521716591|FG001|Overall Study|Protocol Violation|0|||
144690270|NCT02452034|521716592|FG002|Overall Study|Protocol Violation|0|||
144690271|NCT02452034|521716593|FG003|Overall Study|Protocol Violation|0|||
144690272|NCT02452034|521716594|FG004|Overall Study|Protocol Violation|0|||
144690273|NCT02452034|521716595|FG005|Overall Study|Protocol Violation|1|||
144690274|NCT02452034|521716590|FG000|Overall Study|Screen Failure|1|||
144690275|NCT02452034|521716591|FG001|Overall Study|Screen Failure|0|||
144690276|NCT02452034|521716592|FG002|Overall Study|Screen Failure|0|||
144690277|NCT02452034|521716593|FG003|Overall Study|Screen Failure|1|||
144690278|NCT02452034|521716594|FG004|Overall Study|Screen Failure|0|||
144690279|NCT02452034|521716595|FG005|Overall Study|Screen Failure|0|||
144690280|NCT02452034|521716590|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
144690281|NCT02452034|521716591|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
144690282|NCT02452034|521716592|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
144690283|NCT02452034|521716593|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
144690284|NCT02452034|521716594|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
144690285|NCT02452034|521716595|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
144690286|NCT00125138|521716599|FG000|Overall Study|Adverse Event|1|||
144690287|NCT00125138|521716600|FG001|Overall Study|Adverse Event|0|||
144690288|NCT00125138|521716601|FG002|Overall Study|Adverse Event|3|||
144690289|NCT00125138|521716602|FG003|Overall Study|Adverse Event|2|||
144690290|NCT00125138|521716599|FG000|Overall Study|Withdrawal by Subject|2|||
144690291|NCT00125138|521716600|FG001|Overall Study|Withdrawal by Subject|3|||
144690292|NCT00125138|521716601|FG002|Overall Study|Withdrawal by Subject|1|||
144690293|NCT00125138|521716602|FG003|Overall Study|Withdrawal by Subject|1|||
144690294|NCT00125138|521716599|FG000|Overall Study|Lack of Efficacy|0|||
144690295|NCT00125138|521716600|FG001|Overall Study|Lack of Efficacy|0|||
144690296|NCT00125138|521716601|FG002|Overall Study|Lack of Efficacy|0|||
144690297|NCT00125138|521716602|FG003|Overall Study|Lack of Efficacy|1|||
144690298|NCT00125138|521716599|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
144690299|NCT00125138|521716600|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
144690300|NCT00125138|521716601|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
144690301|NCT00125138|521716602|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
144690302|NCT01904760|521716607|FG000|Overall Study|Protocol Violation|1|||
144690303|NCT01904760|521716608|FG001|Overall Study|Protocol Violation|0|||
144690304|NCT00783263|521716618|FG000|Overall Study|Adverse Event|3|||
144690305|NCT00783263|521716619|FG001|Overall Study|Adverse Event|0|||
144690306|NCT00783263|521716620|FG002|Overall Study|Adverse Event|2|||
144690307|NCT00783263|521716621|FG003|Overall Study|Adverse Event|1|||
144690308|NCT00783263|521716618|FG000|Overall Study|Lost to Follow-up|1|||
144690309|NCT00783263|521716619|FG001|Overall Study|Lost to Follow-up|1|||
144690310|NCT00783263|521716620|FG002|Overall Study|Lost to Follow-up|0|||
144690311|NCT00783263|521716621|FG003|Overall Study|Lost to Follow-up|0|||
144690312|NCT00783263|521716618|FG000|Overall Study|Withdrawal by Subject|0|||
144690313|NCT00783263|521716619|FG001|Overall Study|Withdrawal by Subject|1|||
144690314|NCT00783263|521716620|FG002|Overall Study|Withdrawal by Subject|1|||
144690315|NCT00783263|521716621|FG003|Overall Study|Withdrawal by Subject|2|||
144690316|NCT00405756|521716626|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
144690317|NCT00405756|521716627|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
144690318|NCT00405756|521716628|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
144690319|NCT00405756|521716626|FG000|Double-blind Treatment|Adverse Event|31|||
144690320|NCT00405756|521716627|FG001|Double-blind Treatment|Adverse Event|27|||
144690321|NCT00405756|521716628|FG002|Double-blind Treatment|Adverse Event|12|||
144690322|NCT00405756|521716626|FG000|Double-blind Treatment|Disease Progression|47|||
144690323|NCT00405756|521716627|FG001|Double-blind Treatment|Disease Progression|81|||
144690324|NCT00405756|521716628|FG002|Double-blind Treatment|Disease Progression|102|||
144690325|NCT00405756|521716626|FG000|Double-blind Treatment|Lack of Efficacy|1|||
144690326|NCT00405756|521716627|FG001|Double-blind Treatment|Lack of Efficacy|4|||
144690327|NCT00405756|521716628|FG002|Double-blind Treatment|Lack of Efficacy|2|||
144690328|NCT00405756|521716626|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
144690329|NCT00405756|521716627|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
144690330|NCT00405756|521716628|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
144690331|NCT00405756|521716626|FG000|Double-blind Treatment|Lost to Follow-up|1|||
144690332|NCT00405756|521716627|FG001|Double-blind Treatment|Lost to Follow-up|0|||
144690333|NCT00405756|521716628|FG002|Double-blind Treatment|Lost to Follow-up|0|||
144690334|NCT00405756|521716626|FG000|Double-blind Treatment|Death|4|||
144690335|NCT00405756|521716627|FG001|Double-blind Treatment|Death|4|||
144690336|NCT00405756|521716628|FG002|Double-blind Treatment|Death|4|||
144690337|NCT00405756|521716626|FG000|Double-blind Treatment|Protocol Violation|1|||
144690338|NCT00405756|521716627|FG001|Double-blind Treatment|Protocol Violation|0|||
144690339|NCT00405756|521716628|FG002|Double-blind Treatment|Protocol Violation|2|||
144690340|NCT00405756|521716626|FG000|Double-blind Treatment|Other|7|||
144690341|NCT00405756|521716627|FG001|Double-blind Treatment|Other|4|||
144690342|NCT00405756|521716628|FG002|Double-blind Treatment|Other|4|||
144690343|NCT00405756|521716626|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
144690344|NCT00405756|521716627|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
144690345|NCT00405756|521716628|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
144690346|NCT00405756|521716626|FG000|Open-label Extension|Adverse Event|1|||
144690347|NCT00405756|521716627|FG001|Open-label Extension|Adverse Event|3|||
144690348|NCT00405756|521716628|FG002|Open-label Extension|Adverse Event|7|||
144690349|NCT00405756|521716626|FG000|Open-label Extension|Disease Progression|8|||
144690350|NCT00405756|521716627|FG001|Open-label Extension|Disease Progression|23|||
144690351|NCT00405756|521716628|FG002|Open-label Extension|Disease Progression|26|||
144690352|NCT00405756|521716626|FG000|Open-label Extension|Withdrawal by Subject|2|||
144690353|NCT00405756|521716627|FG001|Open-label Extension|Withdrawal by Subject|3|||
144690354|NCT00405756|521716628|FG002|Open-label Extension|Withdrawal by Subject|3|||
144690355|NCT00405756|521716626|FG000|Open-label Extension|Death|1|||
144690356|NCT00405756|521716627|FG001|Open-label Extension|Death|2|||
144690357|NCT00405756|521716628|FG002|Open-label Extension|Death|4|||
144690358|NCT00405756|521716626|FG000|Open-label Extension|Other|0|||
144690359|NCT00405756|521716627|FG001|Open-label Extension|Other|1|||
144690360|NCT00405756|521716628|FG002|Open-label Extension|Other|7|||
144690361|NCT00405756|521716626|FG000|Follow-up|Ongoing in Follow-up Period|52|||
144690362|NCT00405756|521716627|FG001|Follow-up|Ongoing in Follow-up Period|51|||
144690363|NCT00405756|521716628|FG002|Follow-up|Ongoing in Follow-up Period|60|||
144690364|NCT00405756|521716626|FG000|Follow-up|Death|21|||
144690365|NCT00405756|521716627|FG001|Follow-up|Death|31|||
144690366|NCT00405756|521716628|FG002|Follow-up|Death|24|||
144690367|NCT00405756|521716626|FG000|Follow-up|Lost to Follow-up|2|||
144219529|NCT02848001|519998546|FG013|Overall Study|Progressive Disease|0|||
144690368|NCT00405756|521716627|FG001|Follow-up|Lost to Follow-up|8|||
144690369|NCT00405756|521716628|FG002|Follow-up|Lost to Follow-up|4|||
144690370|NCT01117428|521716630|FG000|Overall Study|Lack of Efficacy|1|||
144690371|NCT01117428|521716631|FG001|Overall Study|Lack of Efficacy|0|||
144690372|NCT01117428|521716632|FG002|Overall Study|Lack of Efficacy|0|||
144690373|NCT01117428|521716633|FG003|Overall Study|Lack of Efficacy|0|||
144690374|NCT01117428|521716634|FG004|Overall Study|Lack of Efficacy|0|||
144690375|NCT01117428|521716635|FG005|Overall Study|Lack of Efficacy|0|||
144690376|NCT01117428|521716630|FG000|Overall Study|Adverse Event|4|||
144690377|NCT01117428|521716631|FG001|Overall Study|Adverse Event|0|||
144690378|NCT01117428|521716632|FG002|Overall Study|Adverse Event|0|||
144690379|NCT01117428|521716633|FG003|Overall Study|Adverse Event|0|||
144690380|NCT01117428|521716634|FG004|Overall Study|Adverse Event|1|||
144690381|NCT01117428|521716635|FG005|Overall Study|Adverse Event|2|||
144690382|NCT01117428|521716630|FG000|Overall Study|Death|0|||
144690383|NCT01117428|521716631|FG001|Overall Study|Death|1|||
144690384|NCT01117428|521716632|FG002|Overall Study|Death|2|||
144690385|NCT01117428|521716633|FG003|Overall Study|Death|0|||
144690386|NCT01117428|521716634|FG004|Overall Study|Death|0|||
144690387|NCT01117428|521716635|FG005|Overall Study|Death|1|||
144690388|NCT01117428|521716630|FG000|Overall Study|Physician Decision|0|||
144690389|NCT01117428|521716631|FG001|Overall Study|Physician Decision|1|||
144690390|NCT01117428|521716632|FG002|Overall Study|Physician Decision|0|||
144690391|NCT01117428|521716633|FG003|Overall Study|Physician Decision|0|||
144690392|NCT01117428|521716634|FG004|Overall Study|Physician Decision|0|||
144690393|NCT01117428|521716635|FG005|Overall Study|Physician Decision|0|||
144690394|NCT01117428|521716630|FG000|Overall Study|Withdrawal by Subject|0|||
144690395|NCT01117428|521716631|FG001|Overall Study|Withdrawal by Subject|0|||
144690396|NCT01117428|521716632|FG002|Overall Study|Withdrawal by Subject|1|||
144690397|NCT01117428|521716633|FG003|Overall Study|Withdrawal by Subject|0|||
144690398|NCT01117428|521716634|FG004|Overall Study|Withdrawal by Subject|0|||
144690399|NCT01117428|521716635|FG005|Overall Study|Withdrawal by Subject|0|||
144690400|NCT01117428|521716630|FG000|Overall Study|Progressive disease|15|||
144690401|NCT01117428|521716631|FG001|Overall Study|Progressive disease|27|||
144690402|NCT01117428|521716632|FG002|Overall Study|Progressive disease|10|||
144690403|NCT01117428|521716633|FG003|Overall Study|Progressive disease|12|||
144690404|NCT01117428|521716634|FG004|Overall Study|Progressive disease|16|||
144690405|NCT01117428|521716635|FG005|Overall Study|Progressive disease|17|||
144690406|NCT02519777|521716636|FG000|Overall Study|Death|1|||
144690407|NCT02519777|521716637|FG001|Overall Study|Death|0|||
144690408|NCT02519777|521716638|FG002|Overall Study|Death|0|||
144690409|NCT02519777|521716636|FG000|Overall Study|Lost to Follow-up|0|||
144690410|NCT02519777|521716637|FG001|Overall Study|Lost to Follow-up|4|||
144690411|NCT02519777|521716638|FG002|Overall Study|Lost to Follow-up|2|||
144690412|NCT02519777|521716636|FG000|Overall Study|Withdrawal by Subject|3|||
144690413|NCT02519777|521716637|FG001|Overall Study|Withdrawal by Subject|1|||
144690414|NCT02519777|521716638|FG002|Overall Study|Withdrawal by Subject|0|||
144690415|NCT02519777|521716636|FG000|Overall Study|Severe Debilitation|1|||
144690416|NCT02519777|521716637|FG001|Overall Study|Severe Debilitation|1|||
144690417|NCT02519777|521716638|FG002|Overall Study|Severe Debilitation|1|||
144690418|NCT02519777|521716636|FG000|Overall Study|Not able to get to clinic|1|||
144690419|NCT02519777|521716637|FG001|Overall Study|Not able to get to clinic|2|||
144690420|NCT02519777|521716638|FG002|Overall Study|Not able to get to clinic|1|||
144690421|NCT02195531|521716639|FG000|Overall Study|Withdrawal by Subject|1|||
144690422|NCT02195531|521716640|FG001|Overall Study|Withdrawal by Subject|1|||
144690423|NCT02195531|521716641|FG002|Overall Study|Withdrawal by Subject|1|||
144690424|NCT01284127|521716645|FG000|Overall Study|Adverse Event|2|||
144690425|NCT01284127|521716645|FG000|Overall Study|Withdrawal by Subject|4|||
144690426|NCT01284127|521716645|FG000|Overall Study|Physician Decision|1|||
144690427|NCT01683058|521716649|FG000|Overall Study|Lost to Follow-up|9|||
144690428|NCT01683058|521716649|FG000|Overall Study|Adverse Event|6|||
144690429|NCT01683058|521716649|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
144690430|NCT01683058|521716649|FG000|Overall Study|Withdrawal by Subject|7|||
144690431|NCT01683058|521716649|FG000|Overall Study|Lack of Efficacy|2|||
144690432|NCT04062240|521716653|FG000|Overall Study|equipment malfunction|1|||
144690433|NCT01957111|521716654|FG000|Overall Study|Withdrawal by Subject|1|||
144690434|NCT01957111|521716655|FG001|Overall Study|Withdrawal by Subject|1|||
144690435|NCT01057394|521716656|FG000|Overall Study|Not eligible|0|||
144690436|NCT01057394|521716657|FG001|Overall Study|Not eligible|2|||
144690437|NCT01195636|521716658|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
144690438|NCT01195636|521716659|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
144690439|NCT01195636|521716658|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
144690440|NCT01195636|521716659|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
144690441|NCT01195636|521716658|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144690442|NCT01195636|521716659|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
144690443|NCT01195636|521716658|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
144690444|NCT01195636|521716659|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
144690445|NCT01195636|521716658|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
144690446|NCT01195636|521716659|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
144690447|NCT01195636|521716658|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
144690448|NCT01195636|521716659|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
144690449|NCT01195636|521716658|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
144690450|NCT01195636|521716659|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
144690451|NCT01195636|521716658|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
144690452|NCT01195636|521716659|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
144690453|NCT03961529|521716660|FG000|Overall Study|Adverse Event|13|||
144690454|NCT03961529|521716661|FG001|Overall Study|Adverse Event|5|||
144690455|NCT03961529|521716662|FG002|Overall Study|Adverse Event|2|||
144690456|NCT03961529|521716660|FG000|Overall Study|Withdrawal by Subject|17|||
144690457|NCT03961529|521716661|FG001|Overall Study|Withdrawal by Subject|2|||
144690458|NCT03961529|521716662|FG002|Overall Study|Withdrawal by Subject|1|||
144690459|NCT03961529|521716660|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144690460|NCT03961529|521716661|FG001|Overall Study|Withdrawal by parent/guardian|7|||
144690461|NCT03961529|521716662|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144690462|NCT03961529|521716660|FG000|Overall Study|Physician Decision|2|||
144690463|NCT03961529|521716661|FG001|Overall Study|Physician Decision|1|||
144690464|NCT03961529|521716662|FG002|Overall Study|Physician Decision|1|||
144690465|NCT03961529|521716660|FG000|Overall Study|Lost to Follow-up|2|||
144690466|NCT03961529|521716661|FG001|Overall Study|Lost to Follow-up|1|||
144690467|NCT03961529|521716662|FG002|Overall Study|Lost to Follow-up|0|||
144690468|NCT03961529|521716660|FG000|Overall Study|Lack of Efficacy|2|||
144690469|NCT03961529|521716661|FG001|Overall Study|Lack of Efficacy|0|||
144690470|NCT03961529|521716662|FG002|Overall Study|Lack of Efficacy|1|||
144690471|NCT03961529|521716660|FG000|Overall Study|Other|6|||
144690472|NCT03961529|521716661|FG001|Overall Study|Other|1|||
144690473|NCT03961529|521716662|FG002|Overall Study|Other|0|||
144690474|NCT03644173|521716663|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
144690475|NCT03644173|521716663|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
144690476|NCT03644173|521716663|FG000|Participants at the 1-month Follow up|Death|2|||
144690477|NCT03644173|521716663|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
144690478|NCT03500419|521716666|FG000|Overall Study|Withdrawal by Subject|2|||
144690479|NCT03500419|521716667|FG001|Overall Study|Withdrawal by Subject|25|||
144690480|NCT00256204|521716681|FG000|Overall Study|Adverse Event|10|||
144690481|NCT00256204|521716682|FG001|Overall Study|Adverse Event|14|||
144690482|NCT00256204|521716683|FG002|Overall Study|Adverse Event|16|||
144690483|NCT00256204|521716684|FG003|Overall Study|Adverse Event|14|||
144690484|NCT00256204|521716681|FG000|Overall Study|Death|0|||
144690485|NCT00256204|521716682|FG001|Overall Study|Death|1|||
144690486|NCT00256204|521716683|FG002|Overall Study|Death|0|||
144690487|NCT00256204|521716684|FG003|Overall Study|Death|0|||
144690488|NCT00256204|521716681|FG000|Overall Study|Lost to Follow-up|1|||
144690489|NCT00256204|521716682|FG001|Overall Study|Lost to Follow-up|1|||
144690490|NCT00256204|521716683|FG002|Overall Study|Lost to Follow-up|1|||
144690491|NCT00256204|521716684|FG003|Overall Study|Lost to Follow-up|2|||
144690492|NCT00256204|521716681|FG000|Overall Study|Protocol Violation|1|||
144690493|NCT00256204|521716682|FG001|Overall Study|Protocol Violation|0|||
144690494|NCT00256204|521716683|FG002|Overall Study|Protocol Violation|2|||
144690495|NCT00256204|521716684|FG003|Overall Study|Protocol Violation|1|||
144690496|NCT00256204|521716681|FG000|Overall Study|Physician Decision|0|||
144690497|NCT00256204|521716682|FG001|Overall Study|Physician Decision|0|||
144690498|NCT00256204|521716683|FG002|Overall Study|Physician Decision|1|||
144690499|NCT00256204|521716684|FG003|Overall Study|Physician Decision|2|||
144690500|NCT00256204|521716681|FG000|Overall Study|Withdrawal by Subject|17|||
144690501|NCT00256204|521716682|FG001|Overall Study|Withdrawal by Subject|6|||
144690502|NCT00256204|521716683|FG002|Overall Study|Withdrawal by Subject|7|||
144690503|NCT00256204|521716684|FG003|Overall Study|Withdrawal by Subject|5|||
144690504|NCT00256204|521716681|FG000|Overall Study|Need for additional prohibited treatment|38|||
144690505|NCT00256204|521716682|FG001|Overall Study|Need for additional prohibited treatment|28|||
144690506|NCT00256204|521716683|FG002|Overall Study|Need for additional prohibited treatment|27|||
144690507|NCT00256204|521716684|FG003|Overall Study|Need for additional prohibited treatment|25|||
144690508|NCT00082628|521716685|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
144690509|NCT00082628|521716686|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
144690510|NCT00082628|521716687|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
144690511|NCT00082628|521716688|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
144690512|NCT00082628|521716689|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
144690513|NCT00082628|521716685|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
144690514|NCT00082628|521716686|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
144690515|NCT00082628|521716687|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
144690516|NCT00082628|521716688|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
144690517|NCT00082628|521716689|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
144690518|NCT00082628|521716685|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
144690519|NCT00082628|521716686|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
144690520|NCT00082628|521716687|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
144690521|NCT00082628|521716688|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
144219530|NCT02848001|519998547|FG014|Overall Study|Progressive Disease|2|||
144690522|NCT00082628|521716689|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
144219531|NCT02848001|519998548|FG015|Overall Study|Progressive Disease|4|||
144690523|NCT00082628|521716685|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
144690524|NCT00082628|521716686|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
144690525|NCT00082628|521716687|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
144690526|NCT00082628|521716688|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
144690527|NCT00082628|521716689|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
144690528|NCT00082628|521716685|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
144690529|NCT00082628|521716686|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
144690530|NCT00082628|521716687|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
144690531|NCT00082628|521716688|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
144690532|NCT00082628|521716689|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
144690533|NCT00082628|521716685|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
144690534|NCT00082628|521716686|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
144690535|NCT00082628|521716687|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
144690536|NCT00082628|521716688|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
144690537|NCT00082628|521716689|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
144690538|NCT00082628|521716685|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
144690539|NCT00082628|521716686|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
144690540|NCT00082628|521716687|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
144690541|NCT00082628|521716688|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
144690542|NCT00082628|521716689|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
144690543|NCT01234337|521716697|FG000|Overall Study|Adverse Event|58|||
144690544|NCT01234337|521716698|FG001|Overall Study|Adverse Event|21|||
144690545|NCT01234337|521716697|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
144690546|NCT01234337|521716698|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
144690547|NCT01234337|521716697|FG000|Overall Study|Investi. decision not protocol driven|5|||
144690548|NCT01234337|521716698|FG001|Overall Study|Investi. decision not protocol driven|6|||
144690549|NCT01234337|521716697|FG000|Overall Study|Non-compliant with study medication|3|||
144690550|NCT01234337|521716698|FG001|Overall Study|Non-compliant with study medication|2|||
144690551|NCT01234337|521716697|FG000|Overall Study|Randomized but not treated|6|||
144690552|NCT01234337|521716698|FG001|Overall Study|Randomized but not treated|4|||
144690553|NCT01234337|521716697|FG000|Overall Study|Lost to Follow-up|0|||
144690554|NCT01234337|521716698|FG001|Overall Study|Lost to Follow-up|1|||
144690555|NCT01234337|521716697|FG000|Overall Study|Protocol Violation|2|||
144690556|NCT01234337|521716698|FG001|Overall Study|Protocol Violation|3|||
144690557|NCT01234337|521716697|FG000|Overall Study|Withdrawal by Subject|11|||
144690558|NCT01234337|521716698|FG001|Overall Study|Withdrawal by Subject|9|||
144690559|NCT01234337|521716697|FG000|Overall Study|Death|0|||
144690560|NCT01234337|521716698|FG001|Overall Study|Death|1|||
144690561|NCT01234337|521716697|FG000|Overall Study|Switch to commercial drug|0|||
144690562|NCT01234337|521716698|FG001|Overall Study|Switch to commercial drug|1|||
144690563|NCT03481634|521716703|FG000|Overall Study|Withdrawal by Subject|16|||
144690564|NCT03481634|521716704|FG001|Overall Study|Withdrawal by Subject|19|||
144690565|NCT03481634|521716705|FG002|Overall Study|Withdrawal by Subject|14|||
144690566|NCT03481634|521716703|FG000|Overall Study|Protocol Violation|1|||
144690567|NCT03481634|521716704|FG001|Overall Study|Protocol Violation|0|||
144690568|NCT03481634|521716705|FG002|Overall Study|Protocol Violation|1|||
144690569|NCT03481634|521716703|FG000|Overall Study|Progressive disease|0|||
144690570|NCT03481634|521716704|FG001|Overall Study|Progressive disease|1|||
144690571|NCT03481634|521716705|FG002|Overall Study|Progressive disease|0|||
144690572|NCT03481634|521716703|FG000|Overall Study|Physician Decision|3|||
144690573|NCT03481634|521716704|FG001|Overall Study|Physician Decision|0|||
144690574|NCT03481634|521716705|FG002|Overall Study|Physician Decision|1|||
144690575|NCT03481634|521716703|FG000|Overall Study|Lost to Follow-up|3|||
144690576|NCT03481634|521716704|FG001|Overall Study|Lost to Follow-up|4|||
144690577|NCT03481634|521716705|FG002|Overall Study|Lost to Follow-up|4|||
144690578|NCT03481634|521716703|FG000|Overall Study|Death|4|||
144690579|NCT03481634|521716704|FG001|Overall Study|Death|8|||
144690580|NCT03481634|521716705|FG002|Overall Study|Death|7|||
144690581|NCT03481634|521716703|FG000|Overall Study|Adverse Event|6|||
144690582|NCT03481634|521716704|FG001|Overall Study|Adverse Event|3|||
144690583|NCT03481634|521716705|FG002|Overall Study|Adverse Event|7|||
144690584|NCT03490734|521716706|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
144690585|NCT03490734|521716707|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
144690586|NCT03490734|521716708|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
144690587|NCT03490734|521716709|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
144690588|NCT03490734|521716706|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
144690589|NCT03490734|521716707|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
144690590|NCT03490734|521716708|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
144690591|NCT03490734|521716709|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
144690592|NCT03490734|521716706|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
144690593|NCT03490734|521716707|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
144690594|NCT03490734|521716708|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
144690595|NCT03490734|521716709|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
144690596|NCT03490734|521716706|FG000|Post-intervention Scan Visit|Adverse Event|2|||
144690597|NCT03490734|521716707|FG001|Post-intervention Scan Visit|Adverse Event|0|||
144690598|NCT03490734|521716708|FG002|Post-intervention Scan Visit|Adverse Event|0|||
144690599|NCT03490734|521716709|FG003|Post-intervention Scan Visit|Adverse Event|0|||
144690600|NCT03490734|521716706|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
144690601|NCT03490734|521716707|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
144690602|NCT03490734|521716708|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
144690603|NCT03490734|521716709|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
144690604|NCT03490734|521716706|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
144690605|NCT03490734|521716707|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
144690606|NCT03490734|521716708|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
144690607|NCT03490734|521716709|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
144690608|NCT00994890|521716715|FG000|Overall Study|Adverse Event|13|||
144690609|NCT00994890|521716716|FG001|Overall Study|Adverse Event|9|||
144690610|NCT00994890|521716717|FG002|Overall Study|Adverse Event|11|||
144690611|NCT00994890|521716715|FG000|Overall Study|Lack of Efficacy|0|||
144690612|NCT00994890|521716716|FG001|Overall Study|Lack of Efficacy|0|||
144690613|NCT00994890|521716717|FG002|Overall Study|Lack of Efficacy|1|||
144690614|NCT00994890|521716715|FG000|Overall Study|Lost to Follow-up|6|||
144690615|NCT00994890|521716716|FG001|Overall Study|Lost to Follow-up|1|||
144690616|NCT00994890|521716717|FG002|Overall Study|Lost to Follow-up|3|||
144690617|NCT00994890|521716715|FG000|Overall Study|No longer willing to participate|8|||
144690618|NCT00994890|521716716|FG001|Overall Study|No longer willing to participate|5|||
144690619|NCT00994890|521716717|FG002|Overall Study|No longer willing to participate|13|||
144690620|NCT00994890|521716715|FG000|Overall Study|Protocol Violation|2|||
144690621|NCT00994890|521716716|FG001|Overall Study|Protocol Violation|4|||
144690622|NCT00994890|521716717|FG002|Overall Study|Protocol Violation|0|||
144690623|NCT00994890|521716715|FG000|Overall Study|Study terminated by sponsor|199|||
144690624|NCT00994890|521716716|FG001|Overall Study|Study terminated by sponsor|201|||
144690625|NCT00994890|521716717|FG002|Overall Study|Study terminated by sponsor|197|||
144690626|NCT00994890|521716715|FG000|Overall Study|Randomized, but not treated|1|||
144690627|NCT00994890|521716716|FG001|Overall Study|Randomized, but not treated|0|||
144690628|NCT00994890|521716717|FG002|Overall Study|Randomized, but not treated|0|||
144690629|NCT00994890|521716715|FG000|Overall Study|Other|2|||
144690630|NCT00994890|521716716|FG001|Overall Study|Other|2|||
144690631|NCT00994890|521716717|FG002|Overall Study|Other|1|||
144690632|NCT03323385|521716724|FG000|Overall Study|Withdrawal by Subject|1|||
144690633|NCT03323385|521716725|FG001|Overall Study|Withdrawal by Subject|2|||
144690634|NCT03323385|521716724|FG000|Overall Study|Noncompliance|0|||
144690635|NCT03323385|521716725|FG001|Overall Study|Noncompliance|1|||
144690636|NCT01849289|521716726|FG000|Overall Study|Adverse Event|3|||
144690637|NCT01849289|521716727|FG001|Overall Study|Adverse Event|3|||
144690638|NCT01849289|521716726|FG000|Overall Study|Protocol Violation|3|||
144690639|NCT01849289|521716727|FG001|Overall Study|Protocol Violation|3|||
144690640|NCT01849289|521716726|FG000|Overall Study|Withdrawal criteria|1|||
144690641|NCT01849289|521716727|FG001|Overall Study|Withdrawal criteria|0|||
144690642|NCT01849289|521716726|FG000|Overall Study|Unclassified|25|||
144690643|NCT01849289|521716727|FG001|Overall Study|Unclassified|18|||
144690644|NCT00352027|521716728|FG000|Overall Study|Progressive disease|3|||
144690645|NCT04491591|521716729|FG000|Overall Study|Accidently randomized|3|||
144690646|NCT04491591|521716730|FG001|Overall Study|Accidently randomized|1|||
144690647|NCT04491591|521716731|FG002|Overall Study|Accidently randomized|0|||
144690648|NCT04491591|521716729|FG000|Overall Study|Did not complete survey|28|||
144690649|NCT04491591|521716730|FG001|Overall Study|Did not complete survey|20|||
144690650|NCT04491591|521716731|FG002|Overall Study|Did not complete survey|3|||
144690651|NCT00660816|521716732|FG000|Overall Study|Adverse Event|1|||
144690652|NCT00660816|521716733|FG001|Overall Study|Adverse Event|2|||
144690653|NCT00660816|521716732|FG000|Overall Study|Withdrawal by Subject|1|||
144690654|NCT00660816|521716733|FG001|Overall Study|Withdrawal by Subject|0|||
144690655|NCT00660816|521716732|FG000|Overall Study|Death|0|||
144690656|NCT00660816|521716733|FG001|Overall Study|Death|2|||
144742039|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742040|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742041|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144690657|NCT00660816|521716732|FG000|Overall Study|Lack of Efficacy|1|||
144690658|NCT00660816|521716733|FG001|Overall Study|Lack of Efficacy|0|||
144690659|NCT00660816|521716732|FG000|Overall Study|Physician Decision|0|||
144690660|NCT00660816|521716733|FG001|Overall Study|Physician Decision|2|||
144690661|NCT00660816|521716732|FG000|Overall Study|Protocol Violation|1|||
144690662|NCT00660816|521716733|FG001|Overall Study|Protocol Violation|0|||
144690663|NCT00660816|521716732|FG000|Overall Study|Disease Progression|16|||
144690664|NCT00660816|521716733|FG001|Overall Study|Disease Progression|12|||
144690665|NCT00660816|521716732|FG000|Overall Study|Complicating Disease|0|||
144690666|NCT00660816|521716733|FG001|Overall Study|Complicating Disease|1|||
144690667|NCT02607735|521716736|FG000|Primary Study|Randomized but Never Treated|1|||
144690668|NCT02607735|521716737|FG001|Primary Study|Randomized but Never Treated|0|||
144690669|NCT02607735|521716738|FG002|Primary Study|Randomized but Never Treated|0|||
144690670|NCT02607735|521716736|FG000|Primary Study|Lost to Follow-up|4|||
144690671|NCT02607735|521716737|FG001|Primary Study|Lost to Follow-up|0|||
144690672|NCT02607735|521716738|FG002|Primary Study|Lost to Follow-up|0|||
144690673|NCT02607735|521716736|FG000|Primary Study|Withdrew Consent|2|||
144690674|NCT02607735|521716737|FG001|Primary Study|Withdrew Consent|0|||
144690675|NCT02607735|521716738|FG002|Primary Study|Withdrew Consent|0|||
144690676|NCT02607735|521716736|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
144690677|NCT02607735|521716737|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
144690678|NCT02607735|521716738|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
144690679|NCT02607735|521716736|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
144690680|NCT02607735|521716737|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
144690681|NCT02607735|521716738|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
144690682|NCT01058356|521716741|FG000|Overall Study|Adverse Event|5|||
144690683|NCT01058356|521716741|FG000|Overall Study|Administration of contraindicated drugs|12|||
144690684|NCT01058356|521716741|FG000|Overall Study|Withdrawal by Subject|21|||
144690685|NCT01058356|521716741|FG000|Overall Study|Lost to Follow-up|4|||
144690686|NCT02993783|521716742|FG000|Overall Study|Reason not Specified|6|||
144690687|NCT02993783|521716743|FG001|Overall Study|Reason not Specified|9|||
144690688|NCT00606021|521716746|FG000|Induction Phase|Death|73|||
144690689|NCT00606021|521716747|FG001|Induction Phase|Death|0|||
144690690|NCT00606021|521716748|FG002|Induction Phase|Death|0|||
144690691|NCT00606021|521716746|FG000|Induction Phase|Physician Decision|2|||
144690692|NCT00606021|521716747|FG001|Induction Phase|Physician Decision|0|||
144690693|NCT00606021|521716748|FG002|Induction Phase|Physician Decision|0|||
144690694|NCT00606021|521716746|FG000|Induction Phase|Withdrawal by Subject|2|||
144690695|NCT00606021|521716747|FG001|Induction Phase|Withdrawal by Subject|0|||
144690696|NCT00606021|521716748|FG002|Induction Phase|Withdrawal by Subject|0|||
144690697|NCT00606021|521716746|FG000|Induction Phase|Lost to Follow-up|10|||
144690698|NCT00606021|521716747|FG001|Induction Phase|Lost to Follow-up|0|||
144690699|NCT00606021|521716748|FG002|Induction Phase|Lost to Follow-up|0|||
144690700|NCT00606021|521716746|FG000|Maintenance Phase|Death|0|||
144690701|NCT00606021|521716747|FG001|Maintenance Phase|Death|17|||
144690702|NCT00606021|521716748|FG002|Maintenance Phase|Death|15|||
144690703|NCT00606021|521716746|FG000|Maintenance Phase|Physician Decision|0|||
144690704|NCT00606021|521716747|FG001|Maintenance Phase|Physician Decision|1|||
144690705|NCT00606021|521716748|FG002|Maintenance Phase|Physician Decision|0|||
144690706|NCT00606021|521716746|FG000|Maintenance Phase|Lost to Follow-up|0|||
144690707|NCT00606021|521716747|FG001|Maintenance Phase|Lost to Follow-up|5|||
144690708|NCT00606021|521716748|FG002|Maintenance Phase|Lost to Follow-up|2|||
144690709|NCT01084096|521718962|FG000|Overall Study|Lost to Follow-up|1501|||
144690710|NCT01084096|521718963|FG001|Overall Study|Lost to Follow-up|1833|||
144690711|NCT01084096|521718962|FG000|Overall Study|Withdrawal by Subject|3|||
144690712|NCT01084096|521718963|FG001|Overall Study|Withdrawal by Subject|0|||
144690713|NCT01084096|521718962|FG000|Overall Study|Woman had a miscarriage|21|||
144690714|NCT01084096|521718963|FG001|Overall Study|Woman had a miscarriage|17|||
144690715|NCT02033369|521718964|FG000|Overall Study|Physician Decision|1|||
144690716|NCT02033369|521718965|FG001|Overall Study|Physician Decision|2|||
144690717|NCT02033369|521718964|FG000|Overall Study|Not a good demographic match|0|||
144690718|NCT02033369|521718965|FG001|Overall Study|Not a good demographic match|2|||
144690719|NCT02033369|521718964|FG000|Overall Study|Withdrawal by Subject|1|||
144690720|NCT02033369|521718965|FG001|Overall Study|Withdrawal by Subject|1|||
144690721|NCT02033369|521718964|FG000|Overall Study|Lost to Follow-up|1|||
144690722|NCT02033369|521718965|FG001|Overall Study|Lost to Follow-up|0|||
144690723|NCT02033369|521718964|FG000|Overall Study|Protocol Violation|2|||
144690724|NCT02033369|521718965|FG001|Overall Study|Protocol Violation|0|||
144690725|NCT01503229|521718966|FG000|Overall Study|Withdrew consent|1|||
144690726|NCT01354964|521718967|FG000|Overall Study|Lost to Follow-up|2|||
144690727|NCT01354964|521718968|FG001|Overall Study|Lost to Follow-up|0|||
144690728|NCT01354964|521718967|FG000|Overall Study|IV access issues|1|||
144690729|NCT01354964|521718968|FG001|Overall Study|IV access issues|1|||
144690730|NCT01354964|521718967|FG000|Overall Study|Physician Decision|1|||
144690731|NCT01354964|521718968|FG001|Overall Study|Physician Decision|0|||
144690732|NCT02534324|521718969|FG000|Overall Study|Protocol Violation|4|||
144690733|NCT02534324|521718970|FG001|Overall Study|Protocol Violation|1|||
144690734|NCT02534324|521718969|FG000|Overall Study|Lost to Follow-up|20|||
144690735|NCT02534324|521718970|FG001|Overall Study|Lost to Follow-up|7|||
144690736|NCT02534324|521718969|FG000|Overall Study|Adverse Event|1|||
144690737|NCT02534324|521718970|FG001|Overall Study|Adverse Event|0|||
144690738|NCT05604781|521718971|FG000|Overall Study|Lost to Follow-up|3|||
144690739|NCT05604781|521718971|FG000|Overall Study|Adverse Event|1|||
144690740|NCT04067310|521718975|FG000|Overall Study|Physician Decision|2|||
144690741|NCT04067310|521718976|FG001|Overall Study|Physician Decision|6|||
144690742|NCT04067310|521718975|FG000|Overall Study|Lost to Follow-up|0|||
144690743|NCT04067310|521718976|FG001|Overall Study|Lost to Follow-up|1|||
144690744|NCT04067310|521718975|FG000|Overall Study|Withdrawal by Subject|3|||
144690745|NCT04067310|521718976|FG001|Overall Study|Withdrawal by Subject|0|||
144690746|NCT01041027|521718977|FG000|Overall Study|Withdrawal by Subject|2|||
144690747|NCT01041027|521718977|FG000|Overall Study|Protocol Violation|1|||
144690748|NCT01041027|521718977|FG000|Overall Study|Delayed Radiation Therapy|1|||
144690749|NCT01041027|521718977|FG000|Overall Study|Adverse Event|4|||
144690750|NCT03890731|521718978|FG000|Overall Study|Progressive disease|1|||
144690751|NCT03890731|521718978|FG000|Overall Study|Patient's decision|1|||
144690752|NCT03890731|521718978|FG000|Overall Study|Adverse Event|4|||
144690753|NCT02528643|521718979|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
144690754|NCT02528643|521718980|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
144690755|NCT02528643|521718979|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
144690756|NCT02528643|521718980|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
144690757|NCT02528643|521718979|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
144690758|NCT02528643|521718980|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
144690759|NCT02528643|521718979|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
144690760|NCT02528643|521718980|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
144690761|NCT02528643|521718979|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
144690762|NCT02528643|521718980|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
144690763|NCT02528643|521718979|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
144690764|NCT02528643|521718980|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
144690765|NCT02528643|521718979|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
144690766|NCT02528643|521718980|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
144690767|NCT02058940|521718981|FG000|Overall Study|Discharged from Critical Care Unit|1|||
144690768|NCT01640353|521718993|FG000|Overall Study|Withdrew prior to treatment|10|||
144690769|NCT01640353|521718993|FG000|Overall Study|Withdrawn from analysis at term site|12|||
144690770|NCT01640353|521718993|FG000|Overall Study|Withdrawal by Subject|5|||
144690771|NCT01640353|521718993|FG000|Overall Study|Death|2|||
144690772|NCT01640353|521718993|FG000|Overall Study|Early site termination|3|||
144690773|NCT01640353|521718993|FG000|Overall Study|Lost to Follow-up|12|||
144690774|NCT01640353|521718993|FG000|Overall Study|Physician Decision|1|||
144690775|NCT01524900|521718994|FG000|Overall Study|Lost to Follow-up|3|||
144690776|NCT01524900|521718995|FG001|Overall Study|Lost to Follow-up|12|||
144690777|NCT01524900|521718996|FG002|Overall Study|Lost to Follow-up|1|||
144690778|NCT01524900|521718997|FG003|Overall Study|Lost to Follow-up|0|||
144690779|NCT01524900|521718998|FG004|Overall Study|Lost to Follow-up|0|||
144690780|NCT01524900|521718994|FG000|Overall Study|Other reason than stated above|1|||
144690781|NCT01524900|521718995|FG001|Overall Study|Other reason than stated above|1|||
144690782|NCT01524900|521718996|FG002|Overall Study|Other reason than stated above|0|||
144690783|NCT01524900|521718997|FG003|Overall Study|Other reason than stated above|0|||
144690784|NCT01524900|521718998|FG004|Overall Study|Other reason than stated above|0|||
144690785|NCT01524900|521718994|FG000|Overall Study|No reason documented|2|||
144690786|NCT01524900|521718995|FG001|Overall Study|No reason documented|1|||
144690787|NCT01524900|521718996|FG002|Overall Study|No reason documented|0|||
144690788|NCT01524900|521718997|FG003|Overall Study|No reason documented|1|||
144690789|NCT01524900|521718998|FG004|Overall Study|No reason documented|0|||
144690790|NCT03758612|521718999|FG000|Washout Period|Withdrawal by Subject|0|||
144690791|NCT03758612|521719000|FG001|Washout Period|Withdrawal by Subject|0|||
144690792|NCT03758612|521719001|FG002|Washout Period|Withdrawal by Subject|2|||
144690793|NCT03758612|521719002|FG003|Washout Period|Withdrawal by Subject|0|||
144690794|NCT03758612|521719003|FG004|Washout Period|Withdrawal by Subject|0|||
144690795|NCT03758612|521719004|FG005|Washout Period|Withdrawal by Subject|0|||
144690796|NCT03758612|521719005|FG006|Washout Period|Withdrawal by Subject|0|||
144690797|NCT03758612|521719006|FG007|Washout Period|Withdrawal by Subject|0|||
144690798|NCT03758612|521719007|FG008|Washout Period|Withdrawal by Subject|0|||
144690799|NCT03758612|521719008|FG009|Washout Period|Withdrawal by Subject|0|||
144690800|NCT03758612|521719009|FG010|Washout Period|Withdrawal by Subject|0|||
144690801|NCT03758612|521719010|FG011|Washout Period|Withdrawal by Subject|0|||
144690802|NCT03758612|521718999|FG000|Period 2|Protocol Violation|0|||
144690803|NCT03758612|521719000|FG001|Period 2|Protocol Violation|0|||
144690804|NCT03758612|521719001|FG002|Period 2|Protocol Violation|0|||
144690805|NCT03758612|521719002|FG003|Period 2|Protocol Violation|0|||
144690806|NCT03758612|521719003|FG004|Period 2|Protocol Violation|1|||
144690807|NCT03758612|521719004|FG005|Period 2|Protocol Violation|0|||
144690808|NCT03758612|521719005|FG006|Period 2|Protocol Violation|0|||
144690809|NCT03758612|521719006|FG007|Period 2|Protocol Violation|0|||
144690810|NCT03758612|521719007|FG008|Period 2|Protocol Violation|0|||
144690811|NCT03758612|521719008|FG009|Period 2|Protocol Violation|0|||
144690812|NCT03758612|521719009|FG010|Period 2|Protocol Violation|0|||
144690813|NCT03758612|521719010|FG011|Period 2|Protocol Violation|0|||
144690814|NCT03812224|521719017|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
144690815|NCT03812224|521719018|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
144690816|NCT03812224|521719017|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
144690817|NCT03812224|521719018|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
144690818|NCT03812224|521719017|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
144690819|NCT03812224|521719018|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
144690820|NCT03812224|521719017|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
144690821|NCT03812224|521719018|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
144690822|NCT00303719|521719019|FG000|Overall Study|Not evaluable, prior therapies|0|||
144690823|NCT00303719|521719020|FG001|Overall Study|Not evaluable, prior therapies|30|||
144690824|NCT00303719|521719019|FG000|Overall Study|Lost to Follow-up|0|||
144690825|NCT00303719|521719020|FG001|Overall Study|Lost to Follow-up|7|||
144690826|NCT01641952|521719021|FG000|Overall Study|Lost to Follow-up|28|||
144690827|NCT01641952|521719021|FG000|Overall Study|Adverse Event|6|||
144690828|NCT02500901|521719024|FG000|Overall Study|Disease ProgressionDD|2|||
144690829|NCT04249076|521719031|FG000|Overall Study|Adverse Event|1|||
144690830|NCT04249076|521719032|FG001|Overall Study|Adverse Event|1|||
144690831|NCT04249076|521719031|FG000|Overall Study|Protocol Violation|1|||
144690832|NCT04249076|521719032|FG001|Overall Study|Protocol Violation|2|||
144690833|NCT04249076|521719031|FG000|Overall Study|Lack of Efficacy|0|||
144690834|NCT04249076|521719032|FG001|Overall Study|Lack of Efficacy|1|||
144690835|NCT04249076|521719031|FG000|Overall Study|Withdrawal by Subject|0|||
144690836|NCT04249076|521719032|FG001|Overall Study|Withdrawal by Subject|1|||
144690837|NCT00106626|521719033|FG000|Overall Study|Adverse Event|5|||
144690838|NCT00106626|521719034|FG001|Overall Study|Adverse Event|4|||
144690839|NCT00106626|521719035|FG002|Overall Study|Adverse Event|3|||
144690840|NCT00106626|521719036|FG003|Overall Study|Adverse Event|3|||
144690841|NCT00106626|521719033|FG000|Overall Study|Progressive Disease|4|||
144690842|NCT00106626|521719034|FG001|Overall Study|Progressive Disease|1|||
144690843|NCT00106626|521719035|FG002|Overall Study|Progressive Disease|9|||
144690844|NCT00106626|521719036|FG003|Overall Study|Progressive Disease|10|||
144690845|NCT00106626|521719033|FG000|Overall Study|Received radiation on new therapy|1|||
144690846|NCT00106626|521719034|FG001|Overall Study|Received radiation on new therapy|0|||
144690847|NCT00106626|521719035|FG002|Overall Study|Received radiation on new therapy|0|||
144690848|NCT00106626|521719036|FG003|Overall Study|Received radiation on new therapy|0|||
144690849|NCT00106626|521719033|FG000|Overall Study|> 14 day delay in therapy start|0|||
144690850|NCT00106626|521719034|FG001|Overall Study|> 14 day delay in therapy start|1|||
144690851|NCT00106626|521719035|FG002|Overall Study|> 14 day delay in therapy start|0|||
144690852|NCT00106626|521719036|FG003|Overall Study|> 14 day delay in therapy start|0|||
144690853|NCT02242305|521719037|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
144690854|NCT02242305|521719038|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
144690855|NCT02242305|521719037|FG000|Overall Study|Adverse Event|1|||
144690856|NCT02242305|521719038|FG001|Overall Study|Adverse Event|0|||
144690857|NCT02242305|521719037|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
144690858|NCT02242305|521719038|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
144690859|NCT02242305|521719037|FG000|Overall Study|Subject withdraws inform consent|0|||
144690860|NCT02242305|521719038|FG001|Overall Study|Subject withdraws inform consent|4|||
144690861|NCT02242305|521719037|FG000|Overall Study|Lost to Follow-up|2|||
144690862|NCT02242305|521719038|FG001|Overall Study|Lost to Follow-up|0|||
144690863|NCT03018028|521719042|FG000|Overall Study|Withdrawal by Subject|3|||
144690864|NCT03018028|521719043|FG001|Overall Study|Withdrawal by Subject|0|||
144690865|NCT03018028|521719044|FG002|Overall Study|Withdrawal by Subject|1|||
144690866|NCT03018028|521719045|FG003|Overall Study|Withdrawal by Subject|2|||
144690867|NCT03018028|521719046|FG004|Overall Study|Withdrawal by Subject|0|||
144690868|NCT00699582|521719050|FG000|Overall Study|Adverse Event|4|||
144690869|NCT00699582|521719051|FG001|Overall Study|Adverse Event|11|||
144690870|NCT00699582|521719052|FG002|Overall Study|Adverse Event|23|||
144690871|NCT00699582|521719050|FG000|Overall Study|Withdrawal by Subject|6|||
144690872|NCT00699582|521719051|FG001|Overall Study|Withdrawal by Subject|7|||
144690873|NCT00699582|521719052|FG002|Overall Study|Withdrawal by Subject|4|||
144690874|NCT00699582|521719050|FG000|Overall Study|Lack of Efficacy|1|||
144690875|NCT00699582|521719051|FG001|Overall Study|Lack of Efficacy|0|||
144690876|NCT00699582|521719052|FG002|Overall Study|Lack of Efficacy|1|||
144690877|NCT00699582|521719050|FG000|Overall Study|Progressive Disease|1|||
144690878|NCT00699582|521719051|FG001|Overall Study|Progressive Disease|0|||
144690879|NCT00699582|521719052|FG002|Overall Study|Progressive Disease|0|||
144690880|NCT00699582|521719050|FG000|Overall Study|Administrative/Other|4|||
144690881|NCT00699582|521719051|FG001|Overall Study|Administrative/Other|3|||
144690882|NCT00699582|521719052|FG002|Overall Study|Administrative/Other|0|||
144690883|NCT00699582|521719050|FG000|Overall Study|Randomized, Not Treated|2|||
144690884|NCT00699582|521719051|FG001|Overall Study|Randomized, Not Treated|1|||
144690885|NCT00699582|521719052|FG002|Overall Study|Randomized, Not Treated|0|||
144690886|NCT03099304|521719058|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
144690887|NCT03099304|521719059|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
144690888|NCT03099304|521719060|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
144690889|NCT03099304|521719061|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
144690890|NCT03099304|521719062|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
144690891|NCT03099304|521719063|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
144690892|NCT03099304|521719058|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
144690893|NCT03099304|521719059|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
144690894|NCT03099304|521719060|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
144690895|NCT03099304|521719061|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
144690896|NCT03099304|521719062|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
144690897|NCT03099304|521719063|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
144690898|NCT03099304|521719058|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
144690899|NCT03099304|521719059|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
144690900|NCT03099304|521719060|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
144690901|NCT03099304|521719061|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
144690902|NCT03099304|521719062|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
144690903|NCT03099304|521719063|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
144690904|NCT03099304|521719058|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
144690905|NCT03099304|521719059|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
144690906|NCT03099304|521719060|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
144690907|NCT03099304|521719061|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
144690908|NCT03099304|521719062|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
144690909|NCT03099304|521719063|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
144690910|NCT03099304|521719058|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
144690911|NCT03099304|521719059|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
144690912|NCT03099304|521719060|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
144690913|NCT03099304|521719061|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
144690914|NCT03099304|521719062|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
144690915|NCT03099304|521719063|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
144690916|NCT03099304|521719058|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
144690917|NCT03099304|521719059|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
144690918|NCT03099304|521719060|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
144690919|NCT03099304|521719061|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
144690920|NCT03099304|521719062|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
144690921|NCT03099304|521719063|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
144690922|NCT03099304|521719058|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
144690923|NCT03099304|521719059|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
144690924|NCT03099304|521719060|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
144690925|NCT03099304|521719061|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
144690926|NCT03099304|521719062|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
144690927|NCT03099304|521719063|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
144690928|NCT03099304|521719058|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
144690929|NCT03099304|521719059|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
144690930|NCT03099304|521719060|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
144690931|NCT03099304|521719061|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
144690932|NCT03099304|521719062|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
144690933|NCT03099304|521719063|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
144690934|NCT03099304|521719058|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
144690935|NCT03099304|521719059|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
144690936|NCT03099304|521719060|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
144690937|NCT03099304|521719061|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
144690938|NCT03099304|521719062|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
144690939|NCT03099304|521719063|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
144690940|NCT03099304|521719058|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
144690941|NCT03099304|521719059|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
144690942|NCT03099304|521719060|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
144690943|NCT03099304|521719061|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
144690944|NCT03099304|521719062|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
144690945|NCT03099304|521719063|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
144690946|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
144690947|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
144690948|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
144690949|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
144690950|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
144690951|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
144690952|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
144690953|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
144690954|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
144690955|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
144690956|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
144690957|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
144690958|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
144690959|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
144690960|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
144690961|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
144690962|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
144690963|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
144742042|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742043|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742044|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742045|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742046|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742047|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742048|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
144742049|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742050|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742051|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742052|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742053|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742054|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742055|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742056|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742057|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742058|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742059|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742060|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144219532|NCT02848001|519998549|FG016|Overall Study|Progressive Disease|0|||
144219533|NCT02848001|519998533|FG000|Overall Study|Adverse Event|0|||
144219534|NCT02848001|519998534|FG001|Overall Study|Adverse Event|0|||
144219535|NCT02848001|519998535|FG002|Overall Study|Adverse Event|0|||
144219536|NCT02848001|519998536|FG003|Overall Study|Adverse Event|0|||
144219537|NCT02848001|519998537|FG004|Overall Study|Adverse Event|2|||
144219538|NCT02848001|519998538|FG005|Overall Study|Adverse Event|0|||
144219539|NCT02848001|519998539|FG006|Overall Study|Adverse Event|0|||
144219540|NCT02848001|519998540|FG007|Overall Study|Adverse Event|0|||
144219541|NCT02848001|519998541|FG008|Overall Study|Adverse Event|0|||
144219542|NCT02848001|519998542|FG009|Overall Study|Adverse Event|1|||
144219543|NCT02848001|519998543|FG010|Overall Study|Adverse Event|0|||
144219544|NCT02848001|519998544|FG011|Overall Study|Adverse Event|1|||
144219545|NCT02848001|519998545|FG012|Overall Study|Adverse Event|1|||
144219546|NCT02848001|519998546|FG013|Overall Study|Adverse Event|0|||
144219547|NCT02848001|519998547|FG014|Overall Study|Adverse Event|2|||
144219548|NCT02848001|519998548|FG015|Overall Study|Adverse Event|0|||
144219549|NCT02848001|519998549|FG016|Overall Study|Adverse Event|0|||
144219550|NCT02848001|519998533|FG000|Overall Study|Death|0|||
144219551|NCT02848001|519998534|FG001|Overall Study|Death|0|||
144219552|NCT02848001|519998535|FG002|Overall Study|Death|0|||
144219553|NCT02848001|519998536|FG003|Overall Study|Death|1|||
144219554|NCT02848001|519998537|FG004|Overall Study|Death|3|||
144219555|NCT02848001|519998538|FG005|Overall Study|Death|1|||
144219556|NCT02848001|519998539|FG006|Overall Study|Death|2|||
144219557|NCT02848001|519998540|FG007|Overall Study|Death|3|||
144219558|NCT02848001|519998541|FG008|Overall Study|Death|4|||
144219559|NCT02848001|519998542|FG009|Overall Study|Death|1|||
144219560|NCT02848001|519998543|FG010|Overall Study|Death|0|||
144219561|NCT02848001|519998544|FG011|Overall Study|Death|1|||
144219562|NCT02848001|519998545|FG012|Overall Study|Death|3|||
144219563|NCT02848001|519998546|FG013|Overall Study|Death|0|||
144219564|NCT02848001|519998547|FG014|Overall Study|Death|2|||
144219565|NCT02848001|519998548|FG015|Overall Study|Death|3|||
144219566|NCT02848001|519998549|FG016|Overall Study|Death|0|||
144219567|NCT02848001|519998533|FG000|Overall Study|Physician Decision|0|||
144219568|NCT02848001|519998534|FG001|Overall Study|Physician Decision|0|||
144219569|NCT02848001|519998535|FG002|Overall Study|Physician Decision|0|||
144219570|NCT02848001|519998536|FG003|Overall Study|Physician Decision|0|||
144219571|NCT02848001|519998537|FG004|Overall Study|Physician Decision|0|||
144219572|NCT02848001|519998538|FG005|Overall Study|Physician Decision|0|||
144219573|NCT02848001|519998539|FG006|Overall Study|Physician Decision|0|||
144219574|NCT02848001|519998540|FG007|Overall Study|Physician Decision|0|||
144219575|NCT02848001|519998541|FG008|Overall Study|Physician Decision|1|||
144742061|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742062|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144219576|NCT02848001|519998542|FG009|Overall Study|Physician Decision|1|||
144219577|NCT02848001|519998543|FG010|Overall Study|Physician Decision|0|||
144219578|NCT02848001|519998544|FG011|Overall Study|Physician Decision|0|||
144219579|NCT02848001|519998545|FG012|Overall Study|Physician Decision|2|||
144219580|NCT02848001|519998546|FG013|Overall Study|Physician Decision|0|||
144219581|NCT02848001|519998547|FG014|Overall Study|Physician Decision|0|||
144219582|NCT02848001|519998548|FG015|Overall Study|Physician Decision|0|||
144219583|NCT02848001|519998549|FG016|Overall Study|Physician Decision|0|||
144219584|NCT02848001|519998533|FG000|Overall Study|Withdrawal by Subject|0|||
144219585|NCT02848001|519998534|FG001|Overall Study|Withdrawal by Subject|0|||
144690964|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
144690965|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
144690966|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
144690967|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
144690968|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
144690969|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
144690970|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
144690971|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
144690972|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
144690973|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
144690974|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
144690975|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
144690976|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
144690977|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
144690978|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
144690979|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
144690980|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
144690981|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
144690982|NCT03099304|521719058|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
144690983|NCT03099304|521719059|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
144690984|NCT03099304|521719060|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
144690985|NCT03099304|521719061|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
144690986|NCT03099304|521719062|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
144690987|NCT03099304|521719063|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
144690988|NCT02692560|521719064|FG000|Overall Study|Withdrawal by Subject|0|||
144690989|NCT02692560|521719065|FG001|Overall Study|Withdrawal by Subject|6|||
144690990|NCT00715949|521719068|FG000|Overall Study|could not finish first test|4|||
144690991|NCT00420212|521719069|FG000|Overall Study|Adverse Event|22|||
144690992|NCT00420212|521719070|FG001|Overall Study|Adverse Event|40|||
144690993|NCT00420212|521719071|FG002|Overall Study|Adverse Event|36|||
144690994|NCT00420212|521719069|FG000|Overall Study|Lost to Follow-up|9|||
144690995|NCT00420212|521719070|FG001|Overall Study|Lost to Follow-up|11|||
144690996|NCT00420212|521719071|FG002|Overall Study|Lost to Follow-up|11|||
144690997|NCT00420212|521719069|FG000|Overall Study|Withdrawal by Subject|31|||
144690998|NCT00420212|521719070|FG001|Overall Study|Withdrawal by Subject|22|||
144690999|NCT00420212|521719071|FG002|Overall Study|Withdrawal by Subject|19|||
144691000|NCT00420212|521719069|FG000|Overall Study|Physician Decision|4|||
144691001|NCT00420212|521719070|FG001|Overall Study|Physician Decision|4|||
144691002|NCT00420212|521719071|FG002|Overall Study|Physician Decision|3|||
144691003|NCT00420212|521719069|FG000|Overall Study|Protocol Violation|4|||
144691004|NCT00420212|521719070|FG001|Overall Study|Protocol Violation|4|||
144691005|NCT00420212|521719071|FG002|Overall Study|Protocol Violation|8|||
144691006|NCT00420212|521719069|FG000|Overall Study|Death|0|||
144691007|NCT00420212|521719070|FG001|Overall Study|Death|0|||
144691008|NCT00420212|521719071|FG002|Overall Study|Death|1|||
144691009|NCT00420212|521719069|FG000|Overall Study|Other-Unspecified|21|||
144691010|NCT00420212|521719070|FG001|Overall Study|Other-Unspecified|14|||
144691011|NCT00420212|521719071|FG002|Overall Study|Other-Unspecified|18|||
144691012|NCT01326910|521719072|FG000|Overall Study|Withdrawal by Subject|3|||
144691013|NCT01326910|521719073|FG001|Overall Study|Withdrawal by Subject|2|||
144691014|NCT01326910|521719072|FG000|Overall Study|Protocol Violation|1|||
144691015|NCT01326910|521719073|FG001|Overall Study|Protocol Violation|1|||
144691016|NCT02274766|521719076|FG000|Overall Study|Withdrawal by Subject|3|||
144691017|NCT02274766|521719077|FG001|Overall Study|Withdrawal by Subject|6|||
144219586|NCT02848001|519998535|FG002|Overall Study|Withdrawal by Subject|0|||
144691018|NCT02274766|521719076|FG000|Overall Study|Did Not Receive Study Drug|1|||
144691019|NCT02274766|521719077|FG001|Overall Study|Did Not Receive Study Drug|1|||
144691020|NCT02274766|521719076|FG000|Overall Study|Subject Unwilling to Proceed|0|||
144691021|NCT02274766|521719077|FG001|Overall Study|Subject Unwilling to Proceed|1|||
144691022|NCT02274766|521719076|FG000|Overall Study|Adverse Event|0|||
144691023|NCT02274766|521719077|FG001|Overall Study|Adverse Event|1|||
144691024|NCT01681836|521719082|FG000|Second Intervention|Withdrawal by Subject|0|||
144691025|NCT01681836|521719083|FG001|Second Intervention|Withdrawal by Subject|1|||
144691026|NCT02394028|521719084|FG000|Induction Phase|Adverse Event|2|||
144691027|NCT02394028|521719085|FG001|Induction Phase|Adverse Event|4|||
144691028|NCT02394028|521719086|FG002|Induction Phase|Adverse Event|1|||
144691029|NCT02394028|521719087|FG003|Induction Phase|Adverse Event|2|||
144691030|NCT02394028|521719088|FG004|Induction Phase|Adverse Event|5|||
144691031|NCT02394028|521719089|FG005|Induction Phase|Adverse Event|2|||
144691032|NCT02394028|521719090|FG006|Induction Phase|Adverse Event|0|||
144691033|NCT02394028|521719091|FG007|Induction Phase|Adverse Event|0|||
144691034|NCT02394028|521719092|FG008|Induction Phase|Adverse Event|0|||
144691035|NCT02394028|521719093|FG009|Induction Phase|Adverse Event|0|||
144691036|NCT02394028|521719094|FG010|Induction Phase|Adverse Event|0|||
144742063|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742064|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
144742065|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742066|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742067|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742068|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742069|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742070|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742071|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742072|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742073|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742074|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
144742075|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742076|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742077|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742078|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742079|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742080|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742081|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742082|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742083|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742084|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742085|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742086|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742087|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742088|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742089|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742090|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
144742091|NCT00112437|521908528|FG000|Year 2 (12-Month Extension)|Moved|0|||
144742092|NCT00112437|521908529|FG001|Year 2 (12-Month Extension)|Moved|0|||
144742093|NCT00112437|521908530|FG002|Year 2 (12-Month Extension)|Moved|0|||
144742094|NCT00112437|521908531|FG003|Year 2 (12-Month Extension)|Moved|0|||
144742095|NCT00112437|521908532|FG004|Year 2 (12-Month Extension)|Moved|0|||
144742096|NCT00112437|521908533|FG005|Year 2 (12-Month Extension)|Moved|0|||
144742097|NCT00112437|521908534|FG006|Year 2 (12-Month Extension)|Moved|0|||
144742098|NCT00112437|521908535|FG007|Year 2 (12-Month Extension)|Moved|0|||
144742099|NCT00112437|521908536|FG008|Year 2 (12-Month Extension)|Moved|0|||
144742100|NCT00112437|521908537|FG009|Year 2 (12-Month Extension)|Moved|1|||
144742101|NCT00112437|521908538|FG010|Year 2 (12-Month Extension)|Moved|0|||
144742102|NCT00112437|521908539|FG011|Year 2 (12-Month Extension)|Moved|0|||
144742103|NCT00112437|521908540|FG012|Year 2 (12-Month Extension)|Moved|0|||
144742104|NCT00112437|521908541|FG013|Year 2 (12-Month Extension)|Moved|0|||
144742105|NCT00112437|521908542|FG014|Year 2 (12-Month Extension)|Moved|0|||
144742106|NCT00112437|521908543|FG015|Year 2 (12-Month Extension)|Moved|0|||
144742107|NCT00112437|521908544|FG016|Year 2 (12-Month Extension)|Moved|0|||
144742108|NCT00112437|521908545|FG017|Year 2 (12-Month Extension)|Moved|0|||
144742109|NCT00112437|521908546|FG018|Year 2 (12-Month Extension)|Moved|0|||
144742110|NCT00112437|521908547|FG019|Year 2 (12-Month Extension)|Moved|0|||
144742111|NCT00112437|521908548|FG020|Year 2 (12-Month Extension)|Moved|0|||
144742112|NCT00112437|521908549|FG021|Year 2 (12-Month Extension)|Moved|0|||
144742113|NCT00112437|521908550|FG022|Year 2 (12-Month Extension)|Moved|0|||
144742114|NCT00112437|521908551|FG023|Year 2 (12-Month Extension)|Moved|0|||
144742115|NCT00112437|521908552|FG024|Year 2 (12-Month Extension)|Moved|0|||
144742116|NCT00112437|521908553|FG025|Year 2 (12-Month Extension)|Moved|0|||
144742117|NCT00112437|521908528|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
144742118|NCT00112437|521908529|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
144742119|NCT00112437|521908530|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
144742120|NCT00112437|521908531|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
144742121|NCT00112437|521908532|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
144742122|NCT00112437|521908533|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
144742123|NCT00112437|521908534|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
144742124|NCT00112437|521908535|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
144742125|NCT00112437|521908536|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
144219587|NCT02848001|519998536|FG003|Overall Study|Withdrawal by Subject|0|||
144266121|NCT01064479|520176510|FG000|Overall Study|Other|1|||
144742126|NCT00112437|521908537|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
144742127|NCT00112437|521908538|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
144742128|NCT00112437|521908539|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
144742129|NCT00112437|521908540|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
144742130|NCT00112437|521908541|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
144742131|NCT00112437|521908542|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
144742132|NCT00112437|521908543|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
144742133|NCT00112437|521908544|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
144691037|NCT02394028|521719084|FG000|Induction Phase|Lack of Efficacy|3|||
144691038|NCT02394028|521719085|FG001|Induction Phase|Lack of Efficacy|6|||
144691039|NCT02394028|521719086|FG002|Induction Phase|Lack of Efficacy|2|||
144691040|NCT02394028|521719087|FG003|Induction Phase|Lack of Efficacy|17|||
144691041|NCT02394028|521719088|FG004|Induction Phase|Lack of Efficacy|14|||
144691042|NCT02394028|521719089|FG005|Induction Phase|Lack of Efficacy|8|||
144691043|NCT02394028|521719090|FG006|Induction Phase|Lack of Efficacy|17|||
144691044|NCT02394028|521719091|FG007|Induction Phase|Lack of Efficacy|23|||
144691045|NCT02394028|521719092|FG008|Induction Phase|Lack of Efficacy|0|||
144691046|NCT02394028|521719093|FG009|Induction Phase|Lack of Efficacy|0|||
144691047|NCT02394028|521719094|FG010|Induction Phase|Lack of Efficacy|0|||
144691048|NCT02394028|521719084|FG000|Induction Phase|Lost to Follow-up|1|||
144691049|NCT02394028|521719085|FG001|Induction Phase|Lost to Follow-up|0|||
144691050|NCT02394028|521719086|FG002|Induction Phase|Lost to Follow-up|0|||
144691051|NCT02394028|521719087|FG003|Induction Phase|Lost to Follow-up|1|||
144691052|NCT02394028|521719088|FG004|Induction Phase|Lost to Follow-up|0|||
144691053|NCT02394028|521719089|FG005|Induction Phase|Lost to Follow-up|0|||
144691054|NCT02394028|521719090|FG006|Induction Phase|Lost to Follow-up|1|||
144691055|NCT02394028|521719091|FG007|Induction Phase|Lost to Follow-up|0|||
144691056|NCT02394028|521719092|FG008|Induction Phase|Lost to Follow-up|0|||
144691057|NCT02394028|521719093|FG009|Induction Phase|Lost to Follow-up|0|||
144691058|NCT02394028|521719094|FG010|Induction Phase|Lost to Follow-up|0|||
144691059|NCT02394028|521719084|FG000|Induction Phase|Non-compliance|0|||
144691060|NCT02394028|521719085|FG001|Induction Phase|Non-compliance|1|||
144691061|NCT02394028|521719086|FG002|Induction Phase|Non-compliance|3|||
144691062|NCT02394028|521719087|FG003|Induction Phase|Non-compliance|1|||
144691063|NCT02394028|521719088|FG004|Induction Phase|Non-compliance|3|||
144691064|NCT02394028|521719089|FG005|Induction Phase|Non-compliance|0|||
144691065|NCT02394028|521719090|FG006|Induction Phase|Non-compliance|1|||
144691066|NCT02394028|521719091|FG007|Induction Phase|Non-compliance|1|||
144691067|NCT02394028|521719092|FG008|Induction Phase|Non-compliance|0|||
144691068|NCT02394028|521719093|FG009|Induction Phase|Non-compliance|0|||
144691069|NCT02394028|521719094|FG010|Induction Phase|Non-compliance|0|||
144691070|NCT02394028|521719084|FG000|Induction Phase|Physician Decision|0|||
144691071|NCT02394028|521719085|FG001|Induction Phase|Physician Decision|0|||
144691072|NCT02394028|521719086|FG002|Induction Phase|Physician Decision|1|||
144691073|NCT02394028|521719087|FG003|Induction Phase|Physician Decision|4|||
144691074|NCT02394028|521719088|FG004|Induction Phase|Physician Decision|0|||
144691075|NCT02394028|521719089|FG005|Induction Phase|Physician Decision|2|||
144691076|NCT02394028|521719090|FG006|Induction Phase|Physician Decision|1|||
144691077|NCT02394028|521719091|FG007|Induction Phase|Physician Decision|0|||
144691078|NCT02394028|521719092|FG008|Induction Phase|Physician Decision|0|||
144691079|NCT02394028|521719093|FG009|Induction Phase|Physician Decision|0|||
144691080|NCT02394028|521719094|FG010|Induction Phase|Physician Decision|0|||
144691081|NCT02394028|521719084|FG000|Induction Phase|Protocol Violation|0|||
144691082|NCT02394028|521719085|FG001|Induction Phase|Protocol Violation|2|||
144691083|NCT02394028|521719086|FG002|Induction Phase|Protocol Violation|0|||
144691084|NCT02394028|521719087|FG003|Induction Phase|Protocol Violation|3|||
144691085|NCT02394028|521719088|FG004|Induction Phase|Protocol Violation|0|||
144691086|NCT02394028|521719089|FG005|Induction Phase|Protocol Violation|1|||
144691087|NCT02394028|521719090|FG006|Induction Phase|Protocol Violation|1|||
144691088|NCT02394028|521719091|FG007|Induction Phase|Protocol Violation|0|||
144691089|NCT02394028|521719092|FG008|Induction Phase|Protocol Violation|0|||
144691090|NCT02394028|521719093|FG009|Induction Phase|Protocol Violation|0|||
144691091|NCT02394028|521719094|FG010|Induction Phase|Protocol Violation|0|||
144691092|NCT02394028|521719084|FG000|Induction Phase|Withdrawal by Subject|1|||
144691093|NCT02394028|521719085|FG001|Induction Phase|Withdrawal by Subject|2|||
144691094|NCT02394028|521719086|FG002|Induction Phase|Withdrawal by Subject|4|||
144691095|NCT02394028|521719087|FG003|Induction Phase|Withdrawal by Subject|6|||
144691096|NCT02394028|521719088|FG004|Induction Phase|Withdrawal by Subject|7|||
144691097|NCT02394028|521719089|FG005|Induction Phase|Withdrawal by Subject|4|||
144691098|NCT02394028|521719090|FG006|Induction Phase|Withdrawal by Subject|3|||
144742134|NCT00112437|521908545|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
144219588|NCT02848001|519998537|FG004|Overall Study|Withdrawal by Subject|0|||
144219589|NCT02848001|519998538|FG005|Overall Study|Withdrawal by Subject|1|||
144691099|NCT02394028|521719091|FG007|Induction Phase|Withdrawal by Subject|6|||
144691100|NCT02394028|521719092|FG008|Induction Phase|Withdrawal by Subject|0|||
144691101|NCT02394028|521719093|FG009|Induction Phase|Withdrawal by Subject|0|||
144691102|NCT02394028|521719094|FG010|Induction Phase|Withdrawal by Subject|0|||
144691103|NCT02394028|521719084|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691104|NCT02394028|521719085|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691105|NCT02394028|521719086|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691106|NCT02394028|521719087|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691107|NCT02394028|521719088|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691108|NCT02394028|521719089|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
144742135|NCT00112437|521908546|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
144691109|NCT02394028|521719090|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
144691110|NCT02394028|521719091|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691111|NCT02394028|521719092|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691112|NCT02394028|521719093|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691113|NCT02394028|521719094|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
144691114|NCT02394028|521719084|FG000|Induction Phase|Sponsor decision|0|||
144691115|NCT02394028|521719085|FG001|Induction Phase|Sponsor decision|1|||
144691116|NCT02394028|521719086|FG002|Induction Phase|Sponsor decision|2|||
144691117|NCT02394028|521719087|FG003|Induction Phase|Sponsor decision|0|||
144691118|NCT02394028|521719088|FG004|Induction Phase|Sponsor decision|0|||
144691119|NCT02394028|521719089|FG005|Induction Phase|Sponsor decision|0|||
144691120|NCT02394028|521719090|FG006|Induction Phase|Sponsor decision|0|||
144691121|NCT02394028|521719091|FG007|Induction Phase|Sponsor decision|0|||
144691122|NCT02394028|521719092|FG008|Induction Phase|Sponsor decision|0|||
144691123|NCT02394028|521719093|FG009|Induction Phase|Sponsor decision|0|||
144691124|NCT02394028|521719094|FG010|Induction Phase|Sponsor decision|0|||
144691125|NCT02394028|521719084|FG000|Induction Phase|Technical reason|0|||
144691126|NCT02394028|521719085|FG001|Induction Phase|Technical reason|0|||
144691127|NCT02394028|521719086|FG002|Induction Phase|Technical reason|0|||
144691128|NCT02394028|521719087|FG003|Induction Phase|Technical reason|1|||
144691129|NCT02394028|521719088|FG004|Induction Phase|Technical reason|0|||
144691130|NCT02394028|521719089|FG005|Induction Phase|Technical reason|0|||
144691131|NCT02394028|521719090|FG006|Induction Phase|Technical reason|0|||
144691132|NCT02394028|521719091|FG007|Induction Phase|Technical reason|0|||
144691133|NCT02394028|521719092|FG008|Induction Phase|Technical reason|0|||
144691134|NCT02394028|521719093|FG009|Induction Phase|Technical reason|0|||
144691135|NCT02394028|521719094|FG010|Induction Phase|Technical reason|0|||
144691136|NCT02394028|521719084|FG000|Induction Phase|:ack of calculation|0|||
144691137|NCT02394028|521719085|FG001|Induction Phase|:ack of calculation|0|||
144691138|NCT02394028|521719086|FG002|Induction Phase|:ack of calculation|0|||
144691139|NCT02394028|521719087|FG003|Induction Phase|:ack of calculation|0|||
144691140|NCT02394028|521719088|FG004|Induction Phase|:ack of calculation|0|||
144691141|NCT02394028|521719089|FG005|Induction Phase|:ack of calculation|0|||
144691142|NCT02394028|521719090|FG006|Induction Phase|:ack of calculation|0|||
144691143|NCT02394028|521719091|FG007|Induction Phase|:ack of calculation|1|||
144691144|NCT02394028|521719092|FG008|Induction Phase|:ack of calculation|0|||
144691145|NCT02394028|521719093|FG009|Induction Phase|:ack of calculation|0|||
144691146|NCT02394028|521719094|FG010|Induction Phase|:ack of calculation|0|||
144691147|NCT02394028|521719084|FG000|Maintenance Phase|Protocol Violation|0|||
144691148|NCT02394028|521719085|FG001|Maintenance Phase|Protocol Violation|0|||
144691149|NCT02394028|521719086|FG002|Maintenance Phase|Protocol Violation|0|||
144691150|NCT02394028|521719087|FG003|Maintenance Phase|Protocol Violation|0|||
144691151|NCT02394028|521719088|FG004|Maintenance Phase|Protocol Violation|0|||
144691152|NCT02394028|521719089|FG005|Maintenance Phase|Protocol Violation|0|||
144691153|NCT02394028|521719090|FG006|Maintenance Phase|Protocol Violation|0|||
144691154|NCT02394028|521719091|FG007|Maintenance Phase|Protocol Violation|0|||
144691155|NCT02394028|521719092|FG008|Maintenance Phase|Protocol Violation|0|||
144691156|NCT02394028|521719093|FG009|Maintenance Phase|Protocol Violation|0|||
144691157|NCT02394028|521719094|FG010|Maintenance Phase|Protocol Violation|1|||
144691158|NCT02394028|521719084|FG000|Maintenance Phase|Physician Decision|0|||
144691159|NCT02394028|521719085|FG001|Maintenance Phase|Physician Decision|0|||
144691160|NCT02394028|521719086|FG002|Maintenance Phase|Physician Decision|0|||
144691161|NCT02394028|521719087|FG003|Maintenance Phase|Physician Decision|0|||
144691162|NCT02394028|521719088|FG004|Maintenance Phase|Physician Decision|0|||
144691163|NCT02394028|521719089|FG005|Maintenance Phase|Physician Decision|0|||
144691164|NCT02394028|521719090|FG006|Maintenance Phase|Physician Decision|0|||
144691165|NCT02394028|521719091|FG007|Maintenance Phase|Physician Decision|0|||
144691166|NCT02394028|521719092|FG008|Maintenance Phase|Physician Decision|1|||
144691167|NCT02394028|521719093|FG009|Maintenance Phase|Physician Decision|3|||
144691168|NCT02394028|521719094|FG010|Maintenance Phase|Physician Decision|2|||
144691169|NCT02394028|521719084|FG000|Maintenance Phase|Lack of Efficacy|0|||
144691170|NCT02394028|521719085|FG001|Maintenance Phase|Lack of Efficacy|0|||
144691171|NCT02394028|521719086|FG002|Maintenance Phase|Lack of Efficacy|0|||
144691172|NCT02394028|521719087|FG003|Maintenance Phase|Lack of Efficacy|0|||
144691173|NCT02394028|521719088|FG004|Maintenance Phase|Lack of Efficacy|0|||
144691174|NCT02394028|521719089|FG005|Maintenance Phase|Lack of Efficacy|0|||
144691175|NCT02394028|521719090|FG006|Maintenance Phase|Lack of Efficacy|0|||
144691176|NCT02394028|521719091|FG007|Maintenance Phase|Lack of Efficacy|0|||
144691177|NCT02394028|521719092|FG008|Maintenance Phase|Lack of Efficacy|7|||
144691178|NCT02394028|521719093|FG009|Maintenance Phase|Lack of Efficacy|25|||
144691179|NCT02394028|521719094|FG010|Maintenance Phase|Lack of Efficacy|33|||
144691180|NCT02394028|521719084|FG000|Maintenance Phase|Death|0|||
144691181|NCT02394028|521719085|FG001|Maintenance Phase|Death|0|||
144691182|NCT02394028|521719086|FG002|Maintenance Phase|Death|0|||
144691183|NCT02394028|521719087|FG003|Maintenance Phase|Death|0|||
144691184|NCT02394028|521719088|FG004|Maintenance Phase|Death|0|||
144691185|NCT02394028|521719089|FG005|Maintenance Phase|Death|0|||
144691186|NCT02394028|521719090|FG006|Maintenance Phase|Death|0|||
144691187|NCT02394028|521719091|FG007|Maintenance Phase|Death|0|||
144691188|NCT02394028|521719092|FG008|Maintenance Phase|Death|0|||
144691189|NCT02394028|521719093|FG009|Maintenance Phase|Death|0|||
144691190|NCT02394028|521719094|FG010|Maintenance Phase|Death|1|||
144691191|NCT02394028|521719084|FG000|Maintenance Phase|Adverse Event|0|||
144691192|NCT02394028|521719085|FG001|Maintenance Phase|Adverse Event|0|||
144691193|NCT02394028|521719086|FG002|Maintenance Phase|Adverse Event|0|||
144691194|NCT02394028|521719087|FG003|Maintenance Phase|Adverse Event|0|||
144691195|NCT02394028|521719088|FG004|Maintenance Phase|Adverse Event|0|||
144691196|NCT02394028|521719089|FG005|Maintenance Phase|Adverse Event|0|||
144691197|NCT02394028|521719090|FG006|Maintenance Phase|Adverse Event|0|||
144691198|NCT02394028|521719091|FG007|Maintenance Phase|Adverse Event|0|||
144691199|NCT02394028|521719092|FG008|Maintenance Phase|Adverse Event|1|||
144691200|NCT02394028|521719093|FG009|Maintenance Phase|Adverse Event|1|||
144691201|NCT02394028|521719094|FG010|Maintenance Phase|Adverse Event|3|||
144691202|NCT02394028|521719084|FG000|Maintenance Phase|Site closure|0|||
144691203|NCT02394028|521719085|FG001|Maintenance Phase|Site closure|0|||
144691204|NCT02394028|521719086|FG002|Maintenance Phase|Site closure|0|||
144691205|NCT02394028|521719087|FG003|Maintenance Phase|Site closure|0|||
144691206|NCT02394028|521719088|FG004|Maintenance Phase|Site closure|0|||
144691207|NCT02394028|521719089|FG005|Maintenance Phase|Site closure|0|||
144691208|NCT02394028|521719090|FG006|Maintenance Phase|Site closure|0|||
144691209|NCT02394028|521719091|FG007|Maintenance Phase|Site closure|0|||
144691210|NCT02394028|521719092|FG008|Maintenance Phase|Site closure|0|||
144691211|NCT02394028|521719093|FG009|Maintenance Phase|Site closure|1|||
144691212|NCT02394028|521719094|FG010|Maintenance Phase|Site closure|0|||
144691213|NCT02394028|521719084|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144691214|NCT02394028|521719085|FG001|Maintenance Phase|Withdrawal by Subject|0|||
144691215|NCT02394028|521719086|FG002|Maintenance Phase|Withdrawal by Subject|0|||
144691216|NCT02394028|521719087|FG003|Maintenance Phase|Withdrawal by Subject|0|||
144691217|NCT02394028|521719088|FG004|Maintenance Phase|Withdrawal by Subject|0|||
144691218|NCT02394028|521719089|FG005|Maintenance Phase|Withdrawal by Subject|0|||
144691219|NCT02394028|521719090|FG006|Maintenance Phase|Withdrawal by Subject|0|||
144691220|NCT02394028|521719091|FG007|Maintenance Phase|Withdrawal by Subject|0|||
144691221|NCT02394028|521719092|FG008|Maintenance Phase|Withdrawal by Subject|3|||
144691222|NCT02394028|521719093|FG009|Maintenance Phase|Withdrawal by Subject|12|||
144691223|NCT02394028|521719094|FG010|Maintenance Phase|Withdrawal by Subject|12|||
144691224|NCT00742391|521719095|FG000|Overall Study|Adverse Event|2|||
144691225|NCT00742391|521719096|FG001|Overall Study|Adverse Event|1|||
144691226|NCT00742391|521719095|FG000|Overall Study|Lost to Follow-up|1|||
144691227|NCT00742391|521719096|FG001|Overall Study|Lost to Follow-up|0|||
144691228|NCT00742391|521719095|FG000|Overall Study|Protocol Violation|1|||
144691229|NCT00742391|521719096|FG001|Overall Study|Protocol Violation|0|||
144691230|NCT04815291|521719110|FG000|Overall Study|Lost to Follow-up|1|||
144691231|NCT04815291|521719110|FG000|Overall Study|Physician Decision|4|||
144691232|NCT04815291|521719110|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
144691233|NCT01899729|521719111|FG000|Overall Study|Adverse Event|1|||
144691234|NCT01899729|521719112|FG001|Overall Study|Adverse Event|0|||
144691235|NCT01899729|521719113|FG002|Overall Study|Adverse Event|0|||
144691236|NCT01899729|521719114|FG003|Overall Study|Adverse Event|0|||
144691237|NCT01899729|521719115|FG004|Overall Study|Adverse Event|1|||
144691238|NCT01899729|521719111|FG000|Overall Study|Withdrawal by Subject|1|||
144691239|NCT01899729|521719112|FG001|Overall Study|Withdrawal by Subject|2|||
144691240|NCT01899729|521719113|FG002|Overall Study|Withdrawal by Subject|0|||
144691241|NCT01899729|521719114|FG003|Overall Study|Withdrawal by Subject|0|||
144691242|NCT01899729|521719115|FG004|Overall Study|Withdrawal by Subject|0|||
144691243|NCT01899729|521719111|FG000|Overall Study|Lack of Efficacy|0|||
144691244|NCT01899729|521719112|FG001|Overall Study|Lack of Efficacy|0|||
144691245|NCT01899729|521719113|FG002|Overall Study|Lack of Efficacy|2|||
144691246|NCT01899729|521719114|FG003|Overall Study|Lack of Efficacy|0|||
144691247|NCT01899729|521719115|FG004|Overall Study|Lack of Efficacy|1|||
144691248|NCT01454531|521719118|FG000|Overall Study|Adverse Event|14|||
144691249|NCT01454531|521719118|FG000|Overall Study|Withdrawal by Subject|5|||
144691250|NCT01454531|521719118|FG000|Overall Study|Lost to Follow-up|1|||
144691251|NCT01454531|521719118|FG000|Overall Study|Physician Decision|1|||
144691252|NCT01454531|521719118|FG000|Overall Study|Delay in IMP administration|1|||
144691253|NCT01454531|521719118|FG000|Overall Study|Other|1|||
144691254|NCT00989664|521719119|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
144691255|NCT00989664|521719119|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
144691256|NCT00989664|521719119|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
144691257|NCT00989664|521719119|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
144691258|NCT00989664|521719119|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
144691259|NCT00989664|521719119|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
144691260|NCT00989664|521719119|FG000|Long-Term Follow-Up|Death|3|||
144691261|NCT00095836|521719120|FG000|Overall Study|Lost to Follow-up|1|||
144691262|NCT00095836|521719120|FG000|Overall Study|Adverse Event|1|||
144742136|NCT00112437|521908547|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
144742137|NCT00112437|521908548|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
144742138|NCT00112437|521908549|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
144742139|NCT00112437|521908550|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
144742140|NCT00112437|521908551|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
144742141|NCT00112437|521908552|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
144742142|NCT00112437|521908553|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
144742143|NCT00112437|521908528|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742144|NCT00112437|521908529|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742145|NCT00112437|521908530|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742146|NCT00112437|521908531|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742147|NCT00112437|521908532|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742148|NCT00112437|521908533|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742149|NCT00112437|521908534|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742150|NCT00112437|521908535|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742151|NCT00112437|521908536|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742152|NCT00112437|521908537|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742153|NCT00112437|521908538|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742154|NCT00112437|521908539|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
144742155|NCT00112437|521908540|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742156|NCT00112437|521908541|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
144742157|NCT00112437|521908542|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742158|NCT00112437|521908543|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
144742159|NCT00112437|521908544|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742160|NCT00112437|521908545|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742161|NCT00112437|521908546|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
144742162|NCT00112437|521908547|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742163|NCT00112437|521908548|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742164|NCT00112437|521908549|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742165|NCT00112437|521908550|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742166|NCT00112437|521908551|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742167|NCT00112437|521908552|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742168|NCT00112437|521908553|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
144742169|NCT00112437|521908528|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742170|NCT00112437|521908529|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742171|NCT00112437|521908530|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742172|NCT00112437|521908531|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742173|NCT00112437|521908532|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742174|NCT00112437|521908533|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742175|NCT00112437|521908534|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742176|NCT00112437|521908535|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742177|NCT00112437|521908536|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742178|NCT00112437|521908537|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742179|NCT00112437|521908538|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742180|NCT00112437|521908539|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742181|NCT00112437|521908540|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742182|NCT00112437|521908541|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742183|NCT00112437|521908542|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742184|NCT00112437|521908543|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
144742185|NCT00112437|521908544|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742186|NCT00112437|521908545|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742187|NCT00112437|521908546|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742188|NCT00112437|521908547|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742189|NCT00112437|521908548|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742190|NCT00112437|521908549|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742191|NCT00112437|521908550|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742192|NCT00112437|521908551|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742193|NCT00112437|521908552|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742194|NCT00112437|521908553|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
144742195|NCT00112437|521908528|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742196|NCT00112437|521908529|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742197|NCT00112437|521908530|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742198|NCT00112437|521908531|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742199|NCT00112437|521908532|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742200|NCT00112437|521908533|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742201|NCT00112437|521908534|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742202|NCT00112437|521908535|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742203|NCT00112437|521908536|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742204|NCT00112437|521908537|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742205|NCT00112437|521908538|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
144219590|NCT02848001|519998539|FG006|Overall Study|Withdrawal by Subject|1|||
144219591|NCT02848001|519998540|FG007|Overall Study|Withdrawal by Subject|1|||
144219592|NCT02848001|519998541|FG008|Overall Study|Withdrawal by Subject|0|||
144219593|NCT02848001|519998542|FG009|Overall Study|Withdrawal by Subject|0|||
144219594|NCT02848001|519998543|FG010|Overall Study|Withdrawal by Subject|0|||
144219595|NCT02848001|519998544|FG011|Overall Study|Withdrawal by Subject|0|||
144219596|NCT02848001|519998545|FG012|Overall Study|Withdrawal by Subject|0|||
144219597|NCT02848001|519998546|FG013|Overall Study|Withdrawal by Subject|0|||
144219598|NCT02848001|519998547|FG014|Overall Study|Withdrawal by Subject|0|||
144219599|NCT02848001|519998548|FG015|Overall Study|Withdrawal by Subject|0|||
144219600|NCT02848001|519998549|FG016|Overall Study|Withdrawal by Subject|0|||
144219601|NCT00118157|519998553|FG000|Overall Study|Adverse Event|2|||
144219602|NCT00118157|519998553|FG000|Overall Study|Death|8|||
144219603|NCT00118157|519998553|FG000|Overall Study|Withdrawal by Subject|2|||
144219604|NCT00711243|519998554|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
144219605|NCT00711243|519998555|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
144219606|NCT00711243|519998556|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
144219607|NCT00711243|519998557|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
144219608|NCT00711243|519998558|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
144219609|NCT00711243|519998559|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
144691263|NCT00095836|521719120|FG000|Overall Study|Death|2|||
144691264|NCT02363322|521719124|FG000|Overall Study|Lost to Follow-up|1|||
144691265|NCT02363322|521719125|FG001|Overall Study|Lost to Follow-up|0|||
144691266|NCT00983827|521719126|FG000|Overall Study|Withdrawal by Subject|1|||
144691267|NCT01854918|521719127|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
144691268|NCT01854918|521719128|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
144691269|NCT01854918|521719127|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
144691270|NCT01854918|521719128|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
144691271|NCT01854918|521719127|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
144691272|NCT01854918|521719128|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
144691273|NCT01854918|521719127|FG000|SOC-controlled Period (Year 1)|Death|5|||
144691274|NCT01854918|521719128|FG001|SOC-controlled Period (Year 1)|Death|5|||
144691275|NCT01854918|521719127|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
144691276|NCT01854918|521719128|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
144691277|NCT01854918|521719127|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
144691278|NCT01854918|521719128|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
144691279|NCT01854918|521719127|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
144691280|NCT01854918|521719128|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
144691281|NCT01854918|521719127|FG000|All-IP Period (Years 2 and 3)|Death|5|||
144691282|NCT01854918|521719128|FG001|All-IP Period (Years 2 and 3)|Death|16|||
144691283|NCT03091920|521719135|FG000|Overall Study|Adverse Event|0|||
144691284|NCT03091920|521719136|FG001|Overall Study|Adverse Event|1|||
144691285|NCT03091920|521719137|FG002|Overall Study|Adverse Event|0|||
144691286|NCT00711009|521721672|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
144691287|NCT00711009|521721673|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
144691288|NCT00711009|521721672|FG000|Overall Study|Withdrawal by Subject|4|||
144691289|NCT00711009|521721673|FG001|Overall Study|Withdrawal by Subject|2|||
144691290|NCT00711009|521721672|FG000|Overall Study|Lost to Follow-up|3|||
144691291|NCT00711009|521721673|FG001|Overall Study|Lost to Follow-up|9|||
144691292|NCT00711009|521721672|FG000|Overall Study|Participant Noncompliant|0|||
144691293|NCT00711009|521721673|FG001|Overall Study|Participant Noncompliant|1|||
144691294|NCT00711009|521721672|FG000|Overall Study|Virologic Failure|2|||
144691295|NCT00711009|521721673|FG001|Overall Study|Virologic Failure|1|||
144691296|NCT00711009|521721672|FG000|Overall Study|Pregnancy|1|||
144691297|NCT00711009|521721673|FG001|Overall Study|Pregnancy|0|||
144691298|NCT00711009|521721672|FG000|Overall Study|Site closing|0|||
144691299|NCT00711009|521721673|FG001|Overall Study|Site closing|1|||
144691300|NCT00711009|521721672|FG000|Overall Study|Dose adjustment|1|||
144691301|NCT00711009|521721673|FG001|Overall Study|Dose adjustment|0|||
144691302|NCT01459016|521721675|FG000|Overall Study|Withdrawal by Subject|11|||
144691303|NCT01459016|521721675|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
144691304|NCT00303602|521721679|FG000|Overall Study|Adverse Event|2|||
144691305|NCT00303602|521721680|FG001|Overall Study|Adverse Event|2|||
144691306|NCT00303602|521721679|FG000|Overall Study|Withdrawal by Subject|5|||
144691307|NCT00303602|521721680|FG001|Overall Study|Withdrawal by Subject|6|||
144691308|NCT00303602|521721679|FG000|Overall Study|Lost to Follow-up|5|||
144691309|NCT00303602|521721680|FG001|Overall Study|Lost to Follow-up|2|||
144691310|NCT00303602|521721679|FG000|Overall Study|Protocol entry criteria not met|2|||
144691311|NCT00303602|521721680|FG001|Overall Study|Protocol entry criteria not met|2|||
144691312|NCT00303602|521721679|FG000|Overall Study|Physician Decision|2|||
144691313|NCT00303602|521721680|FG001|Overall Study|Physician Decision|1|||
144691314|NCT00303602|521721679|FG000|Overall Study|Noncompliance|2|||
144691315|NCT00303602|521721680|FG001|Overall Study|Noncompliance|2|||
144691316|NCT00303602|521721679|FG000|Overall Study|Protocol Violation|1|||
144691317|NCT00303602|521721680|FG001|Overall Study|Protocol Violation|0|||
144691318|NCT02551874|521721687|FG000|Overall Study|Lost to Follow-up|0|||
144691319|NCT02551874|521721688|FG001|Overall Study|Lost to Follow-up|2|||
144691320|NCT02551874|521721687|FG000|Overall Study|Pregnancy|0|||
144691321|NCT02551874|521721688|FG001|Overall Study|Pregnancy|1|||
144691322|NCT02551874|521721687|FG000|Overall Study|Reason not reported|10|||
144691323|NCT02551874|521721688|FG001|Overall Study|Reason not reported|4|||
144691324|NCT02551874|521721687|FG000|Overall Study|Did not receive randomized treatment|0|||
144691325|NCT02551874|521721688|FG001|Overall Study|Did not receive randomized treatment|7|||
144691326|NCT02551874|521721687|FG000|Overall Study|Did not enter long-term study|18|||
144691327|NCT02551874|521721688|FG001|Overall Study|Did not enter long-term study|25|||
144691328|NCT00313716|521721689|FG000|Overall Study|Death|3|||
144691329|NCT00313716|521721690|FG001|Overall Study|Death|2|||
144691330|NCT00313716|521721691|FG002|Overall Study|Death|9|||
144691331|NCT00313716|521721692|FG003|Overall Study|Death|3|||
144691332|NCT00313716|521721693|FG004|Overall Study|Death|5|||
144691333|NCT00313716|521721694|FG005|Overall Study|Death|9|||
144691334|NCT00313716|521721689|FG000|Overall Study|Lost to Follow-up|2|||
144691335|NCT00313716|521721690|FG001|Overall Study|Lost to Follow-up|5|||
144691336|NCT00313716|521721691|FG002|Overall Study|Lost to Follow-up|2|||
144691337|NCT00313716|521721692|FG003|Overall Study|Lost to Follow-up|1|||
144691338|NCT00313716|521721693|FG004|Overall Study|Lost to Follow-up|0|||
144691339|NCT00313716|521721694|FG005|Overall Study|Lost to Follow-up|4|||
144219610|NCT00711243|519998554|FG000|Reached First Response/4 Cycles|Death|0|||
144219611|NCT00711243|519998555|FG001|Reached First Response/4 Cycles|Death|0|||
144219612|NCT00711243|519998556|FG002|Reached First Response/4 Cycles|Death|0|||
144219613|NCT00711243|519998557|FG003|Reached First Response/4 Cycles|Death|0|||
144219614|NCT00711243|519998558|FG004|Reached First Response/4 Cycles|Death|0|||
144219615|NCT00711243|519998559|FG005|Reached First Response/4 Cycles|Death|2|||
144219616|NCT00711243|519998554|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
144219617|NCT00711243|519998555|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
144219618|NCT00711243|519998556|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
144219619|NCT00711243|519998557|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
144219620|NCT00711243|519998558|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
144219621|NCT00711243|519998559|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
144219622|NCT00711243|519998554|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
144219623|NCT00711243|519998555|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
144219624|NCT00711243|519998556|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
144219625|NCT00711243|519998557|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
144219626|NCT00711243|519998558|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
144219627|NCT00711243|519998559|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
144219628|NCT00711243|519998554|FG000|Treated Cycle 5 After First Response|Death|0|||
144219629|NCT00711243|519998555|FG001|Treated Cycle 5 After First Response|Death|0|||
144219630|NCT00711243|519998556|FG002|Treated Cycle 5 After First Response|Death|0|||
144691340|NCT00313716|521721689|FG000|Overall Study|Withdrawal by Subject|0|||
144691341|NCT00313716|521721690|FG001|Overall Study|Withdrawal by Subject|1|||
144691342|NCT00313716|521721691|FG002|Overall Study|Withdrawal by Subject|1|||
144691343|NCT00313716|521721692|FG003|Overall Study|Withdrawal by Subject|0|||
144691344|NCT00313716|521721693|FG004|Overall Study|Withdrawal by Subject|1|||
144691345|NCT00313716|521721694|FG005|Overall Study|Withdrawal by Subject|0|||
144691346|NCT02491463|521721695|FG000|Overall Study|Withdrawal by Subject|1|||
144691347|NCT02491463|521721696|FG001|Overall Study|Withdrawal by Subject|2|||
144691348|NCT02491463|521721697|FG002|Overall Study|Withdrawal by Subject|0|||
144691349|NCT02491463|521721698|FG003|Overall Study|Withdrawal by Subject|0|||
144691350|NCT02491463|521721695|FG000|Overall Study|Migrated/moved from study area|1|||
144691351|NCT02491463|521721696|FG001|Overall Study|Migrated/moved from study area|5|||
144691352|NCT02491463|521721697|FG002|Overall Study|Migrated/moved from study area|1|||
144691353|NCT02491463|521721698|FG003|Overall Study|Migrated/moved from study area|1|||
144691354|NCT02491463|521721695|FG000|Overall Study|Lost to Follow-up|0|||
144219631|NCT00711243|519998557|FG003|Treated Cycle 5 After First Response|Death|0|||
144219632|NCT00711243|519998558|FG004|Treated Cycle 5 After First Response|Death|0|||
144219633|NCT00711243|519998559|FG005|Treated Cycle 5 After First Response|Death|2|||
144219634|NCT00711243|519998554|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
144266122|NCT01064479|520176511|FG001|Overall Study|Other|2|||
144266123|NCT03903172|520176516|FG000|Overall Study|screen fail|4|||
144266124|NCT03903172|520176517|FG001|Overall Study|screen fail|1|||
144266125|NCT02495389|520176518|FG000|Overall Study|Withdrawal by Subject|40|||
144266126|NCT01802385|520176522|FG000|Overall Study|Death|106|||
144266127|NCT01802385|520176523|FG001|Overall Study|Death|120|||
144266128|NCT05559905|520176524|FG000|Overall Study|Withdrawal by Subject|1|||
144266129|NCT05559905|520176525|FG001|Overall Study|Withdrawal by Subject|0|||
144691355|NCT02491463|521721696|FG001|Overall Study|Lost to Follow-up|3|||
144691356|NCT02491463|521721697|FG002|Overall Study|Lost to Follow-up|3|||
144691357|NCT02491463|521721698|FG003|Overall Study|Lost to Follow-up|0|||
144691358|NCT01491802|521721699|FG000|Overall Study|Adverse Event|1|||
144219635|NCT00711243|519998555|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
144219636|NCT00711243|519998556|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
144266130|NCT05559905|520176526|FG002|Overall Study|Withdrawal by Subject|0|||
144266131|NCT05559905|520176524|FG000|Overall Study|Not Reported|1|||
144266132|NCT05559905|520176525|FG001|Overall Study|Not Reported|0|||
144266133|NCT05559905|520176526|FG002|Overall Study|Not Reported|0|||
144266134|NCT04003103|520176527|FG000|Overall Study|Death|1|||
144266135|NCT04003103|520176528|FG001|Overall Study|Death|0|||
144266136|NCT04003103|520176529|FG002|Overall Study|Death|0|||
144266137|NCT04003103|520176527|FG000|Overall Study|Lost to Follow-up|4|||
144266138|NCT04003103|520176528|FG001|Overall Study|Lost to Follow-up|3|||
144266139|NCT04003103|520176529|FG002|Overall Study|Lost to Follow-up|2|||
144266140|NCT04003103|520176527|FG000|Overall Study|Withdrawal by Subject|10|||
144266141|NCT04003103|520176528|FG001|Overall Study|Withdrawal by Subject|1|||
144266142|NCT04003103|520176529|FG002|Overall Study|Withdrawal by Subject|1|||
144266143|NCT04003103|520176527|FG000|Overall Study|Status not recorded|0|||
144266144|NCT04003103|520176528|FG001|Overall Study|Status not recorded|2|||
144266145|NCT04003103|520176529|FG002|Overall Study|Status not recorded|0|||
144266146|NCT01747499|520176530|FG000|Overall Study|Steroid refractory aGvHD|1|||
144266147|NCT01747499|520176531|FG001|Overall Study|Steroid refractory aGvHD|0|||
144266148|NCT01747499|520176532|FG002|Overall Study|Steroid refractory aGvHD|0|||
144266149|NCT01747499|520176533|FG003|Overall Study|Steroid refractory aGvHD|1|||
144266150|NCT01747499|520176534|FG004|Overall Study|Steroid refractory aGvHD|4|||
144266151|NCT01747499|520176530|FG000|Overall Study|Physician Decision|0|||
144266152|NCT01747499|520176531|FG001|Overall Study|Physician Decision|1|||
144266153|NCT01747499|520176532|FG002|Overall Study|Physician Decision|0|||
144266154|NCT01747499|520176533|FG003|Overall Study|Physician Decision|0|||
144266155|NCT01747499|520176534|FG004|Overall Study|Physician Decision|2|||
144266156|NCT01747499|520176530|FG000|Overall Study|Death|0|||
144266157|NCT01747499|520176531|FG001|Overall Study|Death|0|||
144266158|NCT01747499|520176532|FG002|Overall Study|Death|0|||
144266159|NCT01747499|520176533|FG003|Overall Study|Death|1|||
144266160|NCT01747499|520176534|FG004|Overall Study|Death|1|||
144266161|NCT01747499|520176530|FG000|Overall Study|Withdrawal by Subject|0|||
144266162|NCT01747499|520176531|FG001|Overall Study|Withdrawal by Subject|0|||
144266163|NCT01747499|520176532|FG002|Overall Study|Withdrawal by Subject|0|||
144266164|NCT01747499|520176533|FG003|Overall Study|Withdrawal by Subject|0|||
144691359|NCT01491802|521721700|FG001|Overall Study|Adverse Event|1|||
144691360|NCT01491802|521721699|FG000|Overall Study|Withdrawal by Subject|0|||
144691361|NCT01491802|521721700|FG001|Overall Study|Withdrawal by Subject|1|||
144691362|NCT00663208|521721701|FG000|Treatment Period|Lost to Follow-up|0|||
144691363|NCT00663208|521721702|FG001|Treatment Period|Lost to Follow-up|1|||
144691364|NCT00663208|521721703|FG002|Treatment Period|Lost to Follow-up|0|||
144691365|NCT00663208|521721704|FG003|Treatment Period|Lost to Follow-up|0|||
144691366|NCT00663208|521721705|FG004|Treatment Period|Lost to Follow-up|0|||
144691367|NCT00663208|521721706|FG005|Treatment Period|Lost to Follow-up|0|||
144691368|NCT00663208|521721707|FG006|Treatment Period|Lost to Follow-up|0|||
144691369|NCT00663208|521721701|FG000|Follow-up Period|Lost to Follow-up|2|||
144691370|NCT00663208|521721702|FG001|Follow-up Period|Lost to Follow-up|0|||
144691371|NCT00663208|521721703|FG002|Follow-up Period|Lost to Follow-up|3|||
144691372|NCT00663208|521721704|FG003|Follow-up Period|Lost to Follow-up|2|||
144691373|NCT00663208|521721705|FG004|Follow-up Period|Lost to Follow-up|0|||
144691374|NCT00663208|521721706|FG005|Follow-up Period|Lost to Follow-up|0|||
144691375|NCT00663208|521721707|FG006|Follow-up Period|Lost to Follow-up|0|||
144691376|NCT00663208|521721701|FG000|Follow-up Period|Other reason|1|||
144691377|NCT00663208|521721702|FG001|Follow-up Period|Other reason|0|||
144691378|NCT00663208|521721703|FG002|Follow-up Period|Other reason|0|||
144691379|NCT00663208|521721704|FG003|Follow-up Period|Other reason|0|||
144691380|NCT00663208|521721705|FG004|Follow-up Period|Other reason|0|||
144691381|NCT00663208|521721706|FG005|Follow-up Period|Other reason|0|||
144691382|NCT00663208|521721707|FG006|Follow-up Period|Other reason|1|||
144691383|NCT00039377|521721709|FG000|Initial Registration|Adverse Event|2|||
144691384|NCT00039377|521721710|FG001|Initial Registration|Adverse Event|0|||
144691385|NCT00039377|521721711|FG002|Initial Registration|Adverse Event|0|||
144219637|NCT00711243|519998557|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
144691386|NCT00039377|521721712|FG003|Initial Registration|Adverse Event|0|||
144219638|NCT00711243|519998558|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
144219639|NCT00711243|519998559|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
144219640|NCT00711243|519998554|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
144266165|NCT01747499|520176534|FG004|Overall Study|Withdrawal by Subject|6|||
144266166|NCT01747499|520176530|FG000|Overall Study|Developed AML and death|0|||
144266167|NCT01747499|520176531|FG001|Overall Study|Developed AML and death|0|||
144266168|NCT01747499|520176532|FG002|Overall Study|Developed AML and death|0|||
144266169|NCT01747499|520176533|FG003|Overall Study|Developed AML and death|0|||
144266170|NCT01747499|520176534|FG004|Overall Study|Developed AML and death|1|||
144266171|NCT01747499|520176530|FG000|Overall Study|Determined not to be eligible|0|||
144691387|NCT00039377|521721709|FG000|Initial Registration|Relapsed|6|||
144691388|NCT00039377|521721710|FG001|Initial Registration|Relapsed|0|||
144691389|NCT00039377|521721711|FG002|Initial Registration|Relapsed|0|||
144691390|NCT00039377|521721712|FG003|Initial Registration|Relapsed|0|||
144691391|NCT00039377|521721709|FG000|Initial Registration|Received non-protocol therapy|11|||
144691392|NCT00039377|521721710|FG001|Initial Registration|Received non-protocol therapy|0|||
144691393|NCT00039377|521721711|FG002|Initial Registration|Received non-protocol therapy|0|||
144691394|NCT00039377|521721712|FG003|Initial Registration|Received non-protocol therapy|0|||
144691395|NCT00039377|521721709|FG000|Initial Registration|Withdrawal by Subject|3|||
144691396|NCT00039377|521721710|FG001|Initial Registration|Withdrawal by Subject|0|||
144691397|NCT00039377|521721711|FG002|Initial Registration|Withdrawal by Subject|0|||
144691398|NCT00039377|521721712|FG003|Initial Registration|Withdrawal by Subject|0|||
144691399|NCT01347931|521721716|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
144691400|NCT01249404|521721717|FG000|Overall Study|Study treatment not received|0|||
144691401|NCT01249404|521721718|FG001|Overall Study|Study treatment not received|1|||
144691402|NCT01249404|521721719|FG002|Overall Study|Study treatment not received|2|||
144691403|NCT01249404|521721717|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
144691404|NCT01249404|521721718|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
144691405|NCT01249404|521721719|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
144691406|NCT01249404|521721717|FG000|Overall Study|Adverse Event|2|||
144691407|NCT01249404|521721718|FG001|Overall Study|Adverse Event|2|||
144691408|NCT01249404|521721719|FG002|Overall Study|Adverse Event|2|||
144691409|NCT01249404|521721717|FG000|Overall Study|Withdrawal by Subject|2|||
144691410|NCT01249404|521721718|FG001|Overall Study|Withdrawal by Subject|2|||
144691411|NCT01249404|521721719|FG002|Overall Study|Withdrawal by Subject|0|||
144691412|NCT01249404|521721717|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
144691413|NCT01249404|521721718|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
144691414|NCT01249404|521721719|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
144691415|NCT01249404|521721717|FG000|Overall Study|Non compliance to visit schedule|0|||
144691416|NCT01249404|521721718|FG001|Overall Study|Non compliance to visit schedule|1|||
144691417|NCT01249404|521721719|FG002|Overall Study|Non compliance to visit schedule|0|||
144691418|NCT02493712|521721720|FG000|Overall Study|Withdrawal by Subject|1|||
144691419|NCT02493712|521721721|FG001|Overall Study|Withdrawal by Subject|0|||
144691420|NCT02493712|521721722|FG002|Overall Study|Withdrawal by Subject|2|||
144691421|NCT02493712|521721720|FG000|Overall Study|Protocol Violation|0|||
144691422|NCT02493712|521721721|FG001|Overall Study|Protocol Violation|0|||
144691423|NCT02493712|521721722|FG002|Overall Study|Protocol Violation|1|||
144691424|NCT02493712|521721720|FG000|Overall Study|Lost to Follow-up|1|||
144691425|NCT02493712|521721721|FG001|Overall Study|Lost to Follow-up|0|||
144691426|NCT02493712|521721722|FG002|Overall Study|Lost to Follow-up|0|||
144691427|NCT02493712|521721720|FG000|Overall Study|Physician Decision|0|||
144691428|NCT02493712|521721721|FG001|Overall Study|Physician Decision|1|||
144691429|NCT02493712|521721722|FG002|Overall Study|Physician Decision|0|||
144691430|NCT02493712|521721720|FG000|Overall Study|Lack of Efficacy|0|||
144691431|NCT02493712|521721721|FG001|Overall Study|Lack of Efficacy|5|||
144691432|NCT02493712|521721722|FG002|Overall Study|Lack of Efficacy|3|||
144691433|NCT03633461|521721730|FG000|Overall Study|Lost to Follow-up|0|||
144691434|NCT03633461|521721731|FG001|Overall Study|Lost to Follow-up|1|||
144691435|NCT03938857|521721738|FG000|Overall Study|Physician Decision|1|||
144691436|NCT03938857|521721739|FG001|Overall Study|Physician Decision|0|||
144691437|NCT03938857|521721740|FG002|Overall Study|Physician Decision|0|||
144691438|NCT03938857|521721741|FG003|Overall Study|Physician Decision|0|||
144691439|NCT01345162|521721742|FG000|Overall Study|Protocol Violation|2|||
144691440|NCT01345162|521721743|FG001|Overall Study|Protocol Violation|4|||
144691441|NCT01398176|521721744|FG000|Overall Study|Lost to Follow-up|1|||
144691442|NCT01398176|521721745|FG001|Overall Study|Lost to Follow-up|3|||
144691443|NCT01398176|521721744|FG000|Overall Study|Physician Decision|2|||
144691444|NCT01398176|521721745|FG001|Overall Study|Physician Decision|3|||
144691445|NCT01871870|521721746|FG000|Overall Study|Hardware issues|7|||
144691446|NCT01871870|521721746|FG000|Overall Study|hyperglycemia|2|||
144691447|NCT01977651|521721748|FG000|4 Month Treatment Period|Adverse Event|34|||
144691448|NCT01977651|521721748|FG000|4 Month Treatment Period|Death|3|||
144691449|NCT01977651|521721748|FG000|4 Month Treatment Period|Progressive Disease|43|||
144691450|NCT01977651|521721748|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
144691451|NCT01977651|521721748|FG000|4 Month Treatment Period|Physician Decision|4|||
144691452|NCT01977651|521721748|FG000|1 Year Extension Period|Adverse Event|14|||
144691453|NCT01977651|521721748|FG000|1 Year Extension Period|Death|10|||
144691454|NCT01977651|521721748|FG000|1 Year Extension Period|Lost to Follow-up|2|||
144691455|NCT01977651|521721748|FG000|1 Year Extension Period|Progressive Disease|86|||
144691456|NCT01977651|521721748|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
144691457|NCT01977651|521721748|FG000|1 Year Extension Period|Physician Decision|6|||
144691458|NCT01977651|521721748|FG000|1 Year Extension Period|Miscellaneous|1|||
144691459|NCT01977651|521721748|FG000|Post 1 Year Extension Period|Adverse Event|5|||
144691460|NCT01977651|521721748|FG000|Post 1 Year Extension Period|Death|13|||
144691461|NCT01977651|521721748|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
144219641|NCT00711243|519998555|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
144219642|NCT00711243|519998556|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
144219643|NCT00711243|519998557|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
144219644|NCT00711243|519998558|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
144219645|NCT00711243|519998559|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
144691462|NCT01977651|521721748|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
144691463|NCT01977651|521721748|FG000|Post 1 Year Extension Period|Physician Decision|4|||
144691464|NCT01977651|521721748|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
144691465|NCT03287089|521721749|FG000|Overall Study|Lost to Follow-up|0|||
144691466|NCT03287089|521721750|FG001|Overall Study|Lost to Follow-up|2|||
144691467|NCT03287089|521721749|FG000|Overall Study|Physician Decision|0|||
144691468|NCT03287089|521721750|FG001|Overall Study|Physician Decision|2|||
144691469|NCT03287089|521721749|FG000|Overall Study|Withdrawal by Subject|0|||
144691470|NCT03287089|521721750|FG001|Overall Study|Withdrawal by Subject|2|||
144691471|NCT02543801|521721753|FG000|Overall Study|Protocol Violation|1|||
144691472|NCT02543801|521721754|FG001|Overall Study|Protocol Violation|2|||
144691473|NCT02543801|521721755|FG002|Overall Study|Protocol Violation|0|||
144691474|NCT02543801|521721756|FG003|Overall Study|Protocol Violation|0|||
144691475|NCT04118127|521721763|FG000|Overall Study|Trial terminated by sponsor|0|||
144691476|NCT04118127|521721764|FG001|Overall Study|Trial terminated by sponsor|12|||
144691477|NCT04118127|521721763|FG000|Overall Study|Adverse Event|1|||
144691478|NCT04118127|521721764|FG001|Overall Study|Adverse Event|2|||
144691479|NCT04118127|521721763|FG000|Overall Study|Physician Decision|0|||
144691480|NCT04118127|521721764|FG001|Overall Study|Physician Decision|1|||
144691481|NCT04118127|521721763|FG000|Overall Study|Withdrawal by Subject|2|||
144691482|NCT04118127|521721764|FG001|Overall Study|Withdrawal by Subject|1|||
144691483|NCT01646255|521721765|FG000|Overall Study|Adverse Event|7|||
144691484|NCT01646255|521721766|FG001|Overall Study|Adverse Event|8|||
144691485|NCT01646255|521721765|FG000|Overall Study|Lack of Efficacy|2|||
144691486|NCT01646255|521721766|FG001|Overall Study|Lack of Efficacy|0|||
144691487|NCT01646255|521721765|FG000|Overall Study|Withdrawal by Subject|10|||
144691488|NCT01646255|521721766|FG001|Overall Study|Withdrawal by Subject|6|||
144691489|NCT01646255|521721765|FG000|Overall Study|Compliance is not well|1|||
144691490|NCT01646255|521721766|FG001|Overall Study|Compliance is not well|0|||
144691491|NCT01646255|521721765|FG000|Overall Study|Inclusion Criteria Deviation|1|||
144691492|NCT01646255|521721766|FG001|Overall Study|Inclusion Criteria Deviation|0|||
144691493|NCT01376908|521721767|FG000|Overall Study|Protocol Violation|1|||
144691494|NCT01376908|521721768|FG001|Overall Study|Protocol Violation|1|||
144691495|NCT01376908|521721767|FG000|Overall Study|Withdrawal by Subject|1|||
144691496|NCT01376908|521721768|FG001|Overall Study|Withdrawal by Subject|2|||
144691497|NCT02142712|521721769|FG000|Overall Study|Lost to Follow-up|1|||
144691498|NCT02142712|521721770|FG001|Overall Study|Lost to Follow-up|1|||
144691499|NCT02142712|521721771|FG002|Overall Study|Lost to Follow-up|1|||
144691500|NCT02142712|521721772|FG003|Overall Study|Lost to Follow-up|0|||
144691501|NCT01241318|521721773|FG000|Overall Study|Woman: false pregnancies|27|||
144691502|NCT01241318|521721774|FG001|Overall Study|Woman: false pregnancies|15|||
144691503|NCT01241318|521721773|FG000|Overall Study|Woman: miscarriage/abortion|46|||
144691504|NCT01241318|521721774|FG001|Overall Study|Woman: miscarriage/abortion|38|||
144691505|NCT01241318|521721773|FG000|Overall Study|Withdrawal by Subject|175|||
144691506|NCT01241318|521721774|FG001|Overall Study|Withdrawal by Subject|46|||
144691507|NCT01241318|521721773|FG000|Overall Study|Lost to Follow-up|740|||
144691508|NCT01241318|521721774|FG001|Overall Study|Lost to Follow-up|455|||
144691509|NCT01241318|521721773|FG000|Overall Study|Death|2|||
144691510|NCT01241318|521721774|FG001|Overall Study|Death|4|||
144691511|NCT01241318|521721773|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
144691512|NCT01241318|521721774|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
144691513|NCT01241318|521721773|FG000|Overall Study|Woman: Stillborn infant|129|||
144691514|NCT01241318|521721774|FG001|Overall Study|Woman: Stillborn infant|146|||
144691515|NCT02355665|521721775|FG000|Overall Study|Adverse Event|16|||
144691516|NCT02355665|521721776|FG001|Overall Study|Adverse Event|24|||
144691517|NCT02355665|521721775|FG000|Overall Study|Protocol Violation|2|||
144691518|NCT02355665|521721776|FG001|Overall Study|Protocol Violation|0|||
144691519|NCT02355665|521721775|FG000|Overall Study|Withdrawal by Subject|90|||
144691520|NCT02355665|521721776|FG001|Overall Study|Withdrawal by Subject|100|||
144691521|NCT02355665|521721775|FG000|Overall Study|Lost to Follow-up|131|||
144691522|NCT02355665|521721776|FG001|Overall Study|Lost to Follow-up|103|||
144691523|NCT02355665|521721775|FG000|Overall Study|Death|4|||
144691524|NCT02355665|521721776|FG001|Overall Study|Death|2|||
144691525|NCT02355665|521721775|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
144691526|NCT02355665|521721776|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
144691527|NCT04129242|521721777|FG000|Overall Study|Physician Decision|1|||
144691528|NCT04129242|521721778|FG001|Overall Study|Physician Decision|1|||
144219646|NCT05989672|519998560|FG000|Overall Study|Adverse Event|3|||
144691529|NCT04129242|521721777|FG000|Overall Study|Protocol Violation|0|||
144691530|NCT04129242|521721778|FG001|Overall Study|Protocol Violation|1|||
144691531|NCT03480841|521721779|FG000|Overall Study|Lost to Follow-up|2|||
144691532|NCT01362049|521721780|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
144691533|NCT01362049|521721781|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
144691534|NCT01362049|521721782|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
144691535|NCT01362049|521721783|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
144691536|NCT01362049|521721780|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
144691537|NCT01362049|521721781|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
144691538|NCT01362049|521721782|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
144691539|NCT01362049|521721783|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
144691540|NCT02417935|521721784|FG000|Treatment Period|Adverse Event|12|||
144691541|NCT02417935|521721785|FG001|Treatment Period|Adverse Event|10|||
144691542|NCT02417935|521721784|FG000|Treatment Period|Lost to Follow-up|1|||
144691543|NCT02417935|521721785|FG001|Treatment Period|Lost to Follow-up|0|||
144691544|NCT02417935|521721784|FG000|Treatment Period|Entry Criteria not met|0|||
144691545|NCT02417935|521721785|FG001|Treatment Period|Entry Criteria not met|1|||
144691546|NCT02417935|521721784|FG000|Treatment Period|Protocol Violation|2|||
144691547|NCT02417935|521721785|FG001|Treatment Period|Protocol Violation|1|||
144691548|NCT02417935|521721784|FG000|Treatment Period|Withdrawal by Subject|3|||
144691549|NCT02417935|521721785|FG001|Treatment Period|Withdrawal by Subject|3|||
144691550|NCT02417935|521721784|FG000|Treatment Period|Physician Decision|3|||
144691551|NCT02417935|521721785|FG001|Treatment Period|Physician Decision|1|||
144691552|NCT02850276|521721788|FG000|Overall Study|screen failure|43|||
144691553|NCT02850276|521721788|FG000|Overall Study|Withdrawal by Subject|14|||
144691554|NCT02850276|521721788|FG000|Overall Study|Physician Decision|2|||
144691555|NCT02850276|521721788|FG000|Overall Study|Lost to Follow-up|2|||
144691556|NCT00962780|521721790|FG000|Overall Study|Death|0|||
144691557|NCT00962780|521721791|FG001|Overall Study|Death|1|||
144691558|NCT00962780|521721790|FG000|Overall Study|Protocol Violation|9|||
144691559|NCT00962780|521721791|FG001|Overall Study|Protocol Violation|4|||
144691560|NCT00962780|521721790|FG000|Overall Study|Withdrawal by Subject|1|||
144691561|NCT00962780|521721791|FG001|Overall Study|Withdrawal by Subject|8|||
144691562|NCT00962780|521721790|FG000|Overall Study|Other|0|||
144691563|NCT00962780|521721791|FG001|Overall Study|Other|1|||
144691564|NCT02853318|521721792|FG000|Overall Study|Withdrawal by Subject|1|||
144691565|NCT02269709|521721795|FG000|Time of Enrollment|Withdrawal by Subject|3|||
144691566|NCT02269709|521721795|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
144691567|NCT02269709|521721795|FG000|Six Month Follow-up|Lost to Follow-up|12|||
144691568|NCT02055976|521721796|FG000|Overall Study|Other|0|||
144691569|NCT02055976|521721797|FG001|Overall Study|Other|0|||
144691570|NCT02055976|521721798|FG002|Overall Study|Other|1|||
144691571|NCT02055976|521721799|FG003|Overall Study|Other|0|||
144691572|NCT02055976|521721800|FG004|Overall Study|Other|0|||
144691573|NCT02055976|521721801|FG005|Overall Study|Other|0|||
144691574|NCT02055976|521721802|FG006|Overall Study|Other|0|||
144691575|NCT02055976|521721803|FG007|Overall Study|Other|0|||
144691576|NCT02055976|521721804|FG008|Overall Study|Other|0|||
144691577|NCT02055976|521721796|FG000|Overall Study|Adverse Event|0|||
144691578|NCT02055976|521721797|FG001|Overall Study|Adverse Event|0|||
144691579|NCT02055976|521721798|FG002|Overall Study|Adverse Event|0|||
144691580|NCT02055976|521721799|FG003|Overall Study|Adverse Event|0|||
144691581|NCT02055976|521721800|FG004|Overall Study|Adverse Event|0|||
144691582|NCT02055976|521721801|FG005|Overall Study|Adverse Event|1|||
144691583|NCT02055976|521721802|FG006|Overall Study|Adverse Event|1|||
144691584|NCT02055976|521721803|FG007|Overall Study|Adverse Event|0|||
144691585|NCT02055976|521721804|FG008|Overall Study|Adverse Event|0|||
144691586|NCT02055976|521721796|FG000|Overall Study|Does not meet entrance criteria|0|||
144691587|NCT02055976|521721797|FG001|Overall Study|Does not meet entrance criteria|0|||
144691588|NCT02055976|521721798|FG002|Overall Study|Does not meet entrance criteria|0|||
144691589|NCT02055976|521721799|FG003|Overall Study|Does not meet entrance criteria|0|||
144691590|NCT02055976|521721800|FG004|Overall Study|Does not meet entrance criteria|0|||
144691591|NCT02055976|521721801|FG005|Overall Study|Does not meet entrance criteria|0|||
144691592|NCT02055976|521721802|FG006|Overall Study|Does not meet entrance criteria|1|||
144691593|NCT02055976|521721803|FG007|Overall Study|Does not meet entrance criteria|0|||
144691594|NCT02055976|521721804|FG008|Overall Study|Does not meet entrance criteria|0|||
144691595|NCT02055976|521721796|FG000|Overall Study|Lost to Follow-up|0|||
144691596|NCT02055976|521721797|FG001|Overall Study|Lost to Follow-up|0|||
144691597|NCT02055976|521721798|FG002|Overall Study|Lost to Follow-up|0|||
144691598|NCT02055976|521721799|FG003|Overall Study|Lost to Follow-up|1|||
144691599|NCT02055976|521721800|FG004|Overall Study|Lost to Follow-up|0|||
144691600|NCT02055976|521721801|FG005|Overall Study|Lost to Follow-up|0|||
144691601|NCT02055976|521721802|FG006|Overall Study|Lost to Follow-up|0|||
144219647|NCT05989672|519998561|FG001|Overall Study|Adverse Event|0|||
144219648|NCT05989672|519998562|FG002|Overall Study|Adverse Event|0|||
144691602|NCT02055976|521721803|FG007|Overall Study|Lost to Follow-up|0|||
144691603|NCT02055976|521721804|FG008|Overall Study|Lost to Follow-up|0|||
144691604|NCT04411472|521721805|FG000|Overall Study|Adverse Event|5|||
144691605|NCT04411472|521721806|FG001|Overall Study|Adverse Event|10|||
144691606|NCT04411472|521721807|FG002|Overall Study|Adverse Event|1|||
144219649|NCT00696423|519998563|FG000|Overall Study|Lost to Follow-up|0|||
144691607|NCT04411472|521721808|FG003|Overall Study|Adverse Event|0|||
144691608|NCT04411472|521721809|FG004|Overall Study|Adverse Event|0|||
144691609|NCT04411472|521721810|FG005|Overall Study|Adverse Event|0|||
144691610|NCT04411472|521721805|FG000|Overall Study|Protocol Violation|1|||
144691611|NCT04411472|521721806|FG001|Overall Study|Protocol Violation|0|||
144691612|NCT04411472|521721807|FG002|Overall Study|Protocol Violation|0|||
144691613|NCT04411472|521721808|FG003|Overall Study|Protocol Violation|0|||
144691614|NCT04411472|521721809|FG004|Overall Study|Protocol Violation|0|||
144691615|NCT04411472|521721810|FG005|Overall Study|Protocol Violation|0|||
144691616|NCT04411472|521721805|FG000|Overall Study|Withdrawal by Subject|0|||
144691617|NCT04411472|521721806|FG001|Overall Study|Withdrawal by Subject|1|||
144691618|NCT04411472|521721807|FG002|Overall Study|Withdrawal by Subject|0|||
144691619|NCT04411472|521721808|FG003|Overall Study|Withdrawal by Subject|1|||
144691620|NCT04411472|521721809|FG004|Overall Study|Withdrawal by Subject|0|||
144691621|NCT04411472|521721810|FG005|Overall Study|Withdrawal by Subject|0|||
144691622|NCT04411472|521721805|FG000|Overall Study|Physician Decision|1|||
144691623|NCT04411472|521721806|FG001|Overall Study|Physician Decision|0|||
144691624|NCT04411472|521721807|FG002|Overall Study|Physician Decision|0|||
144691625|NCT04411472|521721808|FG003|Overall Study|Physician Decision|0|||
144691626|NCT04411472|521721809|FG004|Overall Study|Physician Decision|0|||
144691627|NCT04411472|521721810|FG005|Overall Study|Physician Decision|0|||
144691628|NCT04411472|521721805|FG000|Overall Study|Study terminated by sponsor|17|||
144691629|NCT04411472|521721806|FG001|Overall Study|Study terminated by sponsor|20|||
144691630|NCT04411472|521721807|FG002|Overall Study|Study terminated by sponsor|3|||
144691631|NCT04411472|521721808|FG003|Overall Study|Study terminated by sponsor|0|||
144691632|NCT04411472|521721809|FG004|Overall Study|Study terminated by sponsor|0|||
144691633|NCT04411472|521721810|FG005|Overall Study|Study terminated by sponsor|0|||
144691634|NCT00426842|521721811|FG000|Overall Study|Lost to Follow-up|1|||
144691635|NCT03769753|521721812|FG000|Overall Study|Not Treated|6|||
144691636|NCT03769753|521721812|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
144691637|NCT00684073|521721813|FG000|Selection|Selection/non-selection criteria|3|||
144691638|NCT00684073|521721813|FG000|Selection|Death|1|||
144691639|NCT00684073|521721813|FG000|Selection|noncompliance|1|||
144691640|NCT00684073|521721813|FG000|Selection|Lost to Follow-up|1|||
144691641|NCT00684073|521721813|FG000|Selection|request of the sponsor|1|||
144691642|NCT00684073|521721813|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
144691643|NCT03529162|521721816|FG000|Overall Study|Lost to Follow-up|2|||
144691644|NCT03529162|521721817|FG001|Overall Study|Lost to Follow-up|2|||
144691645|NCT02728804|521721823|FG000|Overall Study|Ineligible|3|||
144691646|NCT02728804|521721823|FG000|Overall Study|Did not complete baseline questionnaire|9|||
144691647|NCT02728804|521721823|FG000|Overall Study|Death|99|||
144691648|NCT02146352|521721824|FG000|Overall Study|Death|1|||
144691649|NCT02146352|521721824|FG000|Overall Study|Patient entered hospice care|1|||
144691650|NCT02918006|521721825|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
144691651|NCT02918006|521721826|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
144691652|NCT02918006|521721827|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
144691653|NCT02918006|521721825|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
144691654|NCT02918006|521721826|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
144691655|NCT02918006|521721827|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
144691656|NCT02918006|521721825|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
144691657|NCT02918006|521721826|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
144691658|NCT02918006|521721827|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
144691659|NCT02918006|521721825|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
144691660|NCT02918006|521721826|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
144691661|NCT02918006|521721827|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
144691662|NCT02918006|521721825|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
144691663|NCT02918006|521721826|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
144691664|NCT02918006|521721827|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
144691665|NCT02918006|521721825|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
144691666|NCT02918006|521721826|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
144691667|NCT02918006|521721827|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
144691668|NCT02918006|521721825|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
144691669|NCT02918006|521721826|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
144691670|NCT02918006|521721827|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
144691671|NCT02918006|521721825|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
144691672|NCT02918006|521721826|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
144691673|NCT02918006|521721827|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
144691674|NCT02918006|521721825|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
144691675|NCT02918006|521721826|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
144691676|NCT02918006|521721827|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
144691677|NCT00453349|521721830|FG000|Randomized|Adverse Event|12|||
144691678|NCT00453349|521721831|FG001|Randomized|Adverse Event|11|||
144691679|NCT00453349|521721830|FG000|Randomized|Lack of Efficacy|2|||
144691680|NCT00453349|521721831|FG001|Randomized|Lack of Efficacy|1|||
144691681|NCT00453349|521721830|FG000|Randomized|Lost to Follow-up|7|||
144691682|NCT00453349|521721831|FG001|Randomized|Lost to Follow-up|5|||
144219650|NCT00696423|519998564|FG001|Overall Study|Lost to Follow-up|5|||
144219651|NCT00818766|519998571|FG000|Overall Study|Could not be Contacted on Day 28|11|||
144219652|NCT00818766|519998572|FG001|Overall Study|Could not be Contacted on Day 28|10|||
144219653|NCT00818766|519998571|FG000|Overall Study|Death|1|||
144219654|NCT00818766|519998572|FG001|Overall Study|Death|0|||
144219655|NCT00818766|519998571|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
144219656|NCT00818766|519998572|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
144219657|NCT04515147|519998573|FG000|Overall Study|Withdrawal by Subject|1|||
144219658|NCT04515147|519998574|FG001|Overall Study|Withdrawal by Subject|0|||
144219659|NCT04515147|519998575|FG002|Overall Study|Withdrawal by Subject|10|||
144219660|NCT04515147|519998576|FG003|Overall Study|Withdrawal by Subject|18|||
144219661|NCT04515147|519998577|FG004|Overall Study|Withdrawal by Subject|1|||
144219662|NCT04515147|519998578|FG005|Overall Study|Withdrawal by Subject|8|||
144219663|NCT04515147|519998573|FG000|Overall Study|Lost to Follow-up|0|||
144219664|NCT04515147|519998574|FG001|Overall Study|Lost to Follow-up|1|||
144219665|NCT04515147|519998575|FG002|Overall Study|Lost to Follow-up|5|||
144219666|NCT04515147|519998576|FG003|Overall Study|Lost to Follow-up|6|||
144219667|NCT04515147|519998577|FG004|Overall Study|Lost to Follow-up|2|||
144219668|NCT04515147|519998578|FG005|Overall Study|Lost to Follow-up|1|||
144219669|NCT04515147|519998573|FG000|Overall Study|Adverse Event|0|||
144219670|NCT04515147|519998574|FG001|Overall Study|Adverse Event|0|||
144219671|NCT04515147|519998575|FG002|Overall Study|Adverse Event|0|||
144219672|NCT04515147|519998576|FG003|Overall Study|Adverse Event|2|||
144219673|NCT04515147|519998577|FG004|Overall Study|Adverse Event|0|||
144219674|NCT04515147|519998578|FG005|Overall Study|Adverse Event|0|||
144219675|NCT04515147|519998573|FG000|Overall Study|Miscellaneous|0|||
144691683|NCT00453349|521721830|FG000|Randomized|Protocol Violation|1|||
144691684|NCT00453349|521721831|FG001|Randomized|Protocol Violation|1|||
144691685|NCT00453349|521721830|FG000|Randomized|Withdrawal by Subject|3|||
144691686|NCT00453349|521721831|FG001|Randomized|Withdrawal by Subject|5|||
144691687|NCT00453349|521721830|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
144691688|NCT00453349|521721831|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
144691689|NCT00453349|521721830|FG000|Completed Study|Adverse Event|12|||
144691690|NCT00453349|521721831|FG001|Completed Study|Adverse Event|11|||
144691691|NCT00453349|521721830|FG000|Completed Study|Lack of Efficacy|2|||
144691692|NCT00453349|521721831|FG001|Completed Study|Lack of Efficacy|1|||
144691693|NCT00453349|521721830|FG000|Completed Study|Lost to Follow-up|7|||
144691694|NCT00453349|521721831|FG001|Completed Study|Lost to Follow-up|5|||
144691695|NCT00453349|521721830|FG000|Completed Study|Protocol Violation|1|||
144691696|NCT00453349|521721831|FG001|Completed Study|Protocol Violation|1|||
144691697|NCT00453349|521721830|FG000|Completed Study|Withdrawal by Subject|3|||
144691698|NCT00453349|521721831|FG001|Completed Study|Withdrawal by Subject|5|||
144691699|NCT00453349|521721830|FG000|Completed Study|Lost to follow up after study treatment|2|||
144691700|NCT00453349|521721831|FG001|Completed Study|Lost to follow up after study treatment|11|||
144691701|NCT01513460|521721836|FG000|Overall Study|Death|0|||
144691702|NCT01513460|521721837|FG001|Overall Study|Death|0|||
144691703|NCT01513460|521721838|FG002|Overall Study|Death|1|||
144691704|NCT01513460|521721836|FG000|Overall Study|Lost to Follow-up|0|||
144691705|NCT01513460|521721837|FG001|Overall Study|Lost to Follow-up|0|||
144691706|NCT01513460|521721838|FG002|Overall Study|Lost to Follow-up|2|||
144691707|NCT01513460|521721836|FG000|Overall Study|Abnormal laboratory value|1|||
144691708|NCT01513460|521721837|FG001|Overall Study|Abnormal laboratory value|0|||
144691709|NCT01513460|521721838|FG002|Overall Study|Abnormal laboratory value|1|||
144691710|NCT01513460|521721836|FG000|Overall Study|Lack of Efficacy|1|||
144219676|NCT04515147|519998574|FG001|Overall Study|Miscellaneous|0|||
144219677|NCT04515147|519998575|FG002|Overall Study|Miscellaneous|0|||
144219678|NCT04515147|519998576|FG003|Overall Study|Miscellaneous|1|||
144219679|NCT04515147|519998577|FG004|Overall Study|Miscellaneous|0|||
144691711|NCT01513460|521721837|FG001|Overall Study|Lack of Efficacy|2|||
144691712|NCT01513460|521721838|FG002|Overall Study|Lack of Efficacy|5|||
144691713|NCT01513460|521721836|FG000|Overall Study|Protocol deviations|3|||
144691714|NCT01513460|521721837|FG001|Overall Study|Protocol deviations|4|||
144691715|NCT01513460|521721838|FG002|Overall Study|Protocol deviations|3|||
144691716|NCT01513460|521721836|FG000|Overall Study|Withdrawal by Subject|7|||
144691717|NCT01513460|521721837|FG001|Overall Study|Withdrawal by Subject|8|||
144691718|NCT01513460|521721838|FG002|Overall Study|Withdrawal by Subject|21|||
144691719|NCT01513460|521721836|FG000|Overall Study|Adverse Event|16|||
144691720|NCT01513460|521721837|FG001|Overall Study|Adverse Event|18|||
144219680|NCT04515147|519998578|FG005|Overall Study|Miscellaneous|1|||
144219681|NCT02760004|519998582|FG000|Overall Study|Lost to Follow-up|13|||
144219682|NCT02760004|519998583|FG001|Overall Study|Lost to Follow-up|22|||
144219683|NCT02094300|519998590|FG000|Overall Study|Death|7|||
144691721|NCT01513460|521721838|FG002|Overall Study|Adverse Event|23|||
144219684|NCT02094300|519998590|FG000|Overall Study|Lost to Follow-up|10|||
144219685|NCT02094300|519998590|FG000|Overall Study|Still be eligible for follow-up|3|||
144219686|NCT00725491|519998593|FG000|Overall Study|Adverse Event|3|||
144691722|NCT01513460|521721836|FG000|Overall Study|Abnormal test procedure|1|||
144691723|NCT01513460|521721837|FG001|Overall Study|Abnormal test procedure|0|||
144742206|NCT00112437|521908539|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742207|NCT00112437|521908540|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742208|NCT00112437|521908541|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742209|NCT00112437|521908542|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742210|NCT00112437|521908543|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
144742211|NCT00112437|521908544|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742212|NCT00112437|521908545|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742213|NCT00112437|521908546|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742214|NCT00112437|521908547|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742215|NCT00112437|521908548|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742216|NCT00112437|521908549|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742217|NCT00112437|521908550|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742218|NCT00112437|521908551|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742219|NCT00112437|521908552|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742220|NCT00112437|521908553|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
144742221|NCT00112437|521908528|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742222|NCT00112437|521908529|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742223|NCT00112437|521908530|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742224|NCT00112437|521908531|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742225|NCT00112437|521908532|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742226|NCT00112437|521908533|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742227|NCT00112437|521908534|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742228|NCT00112437|521908535|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742229|NCT00112437|521908536|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742230|NCT00112437|521908537|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742231|NCT00112437|521908538|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742232|NCT00112437|521908539|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
144742233|NCT00112437|521908540|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742234|NCT00112437|521908541|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742235|NCT00112437|521908542|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
144742236|NCT00112437|521908543|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742237|NCT00112437|521908544|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742238|NCT00112437|521908545|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742239|NCT00112437|521908546|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742240|NCT00112437|521908547|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742241|NCT00112437|521908548|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742242|NCT00112437|521908549|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742243|NCT00112437|521908550|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742244|NCT00112437|521908551|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742245|NCT00112437|521908552|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742246|NCT00112437|521908553|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
144742247|NCT00112437|521908528|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742248|NCT00112437|521908529|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742249|NCT00112437|521908530|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742250|NCT00112437|521908531|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742251|NCT00112437|521908532|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742252|NCT00112437|521908533|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742253|NCT00112437|521908534|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742254|NCT00112437|521908535|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742255|NCT00112437|521908536|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742256|NCT00112437|521908537|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742257|NCT00112437|521908538|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
144742258|NCT00112437|521908539|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
144742259|NCT00112437|521908540|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742260|NCT00112437|521908541|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742261|NCT00112437|521908542|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742262|NCT00112437|521908543|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742263|NCT00112437|521908544|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742264|NCT00112437|521908545|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742265|NCT00112437|521908546|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742266|NCT00112437|521908547|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742267|NCT00112437|521908548|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742268|NCT00112437|521908549|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742269|NCT00112437|521908550|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742270|NCT00112437|521908551|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144266172|NCT01747499|520176531|FG001|Overall Study|Determined not to be eligible|0|||
144219687|NCT00725491|519998594|FG001|Overall Study|Adverse Event|2|||
144691724|NCT01513460|521721838|FG002|Overall Study|Abnormal test procedure|0|||
144691725|NCT00701064|521721839|FG000|Overall Study|Protocol Violation|1|||
144691726|NCT00701064|521721840|FG001|Overall Study|Protocol Violation|1|||
144691727|NCT00701064|521721839|FG000|Overall Study|Withdrawal by Subject|1|||
144691728|NCT00701064|521721840|FG001|Overall Study|Withdrawal by Subject|1|||
144691729|NCT00701064|521721839|FG000|Overall Study|initiated other PTSD treatment|2|||
144691730|NCT00701064|521721840|FG001|Overall Study|initiated other PTSD treatment|2|||
144691731|NCT03922945|521723391|FG000|Overall Study|Adverse Event|1|||
144691732|NCT03922945|521723392|FG001|Overall Study|Adverse Event|1|||
144691733|NCT03922945|521723393|FG002|Overall Study|Adverse Event|2|||
144691734|NCT03922945|521723391|FG000|Overall Study|Lost to Follow-up|13|||
144691735|NCT03922945|521723392|FG001|Overall Study|Lost to Follow-up|9|||
144691736|NCT03922945|521723393|FG002|Overall Study|Lost to Follow-up|20|||
144691737|NCT03922945|521723391|FG000|Overall Study|Lack of Efficacy|2|||
144691738|NCT03922945|521723392|FG001|Overall Study|Lack of Efficacy|0|||
144691739|NCT03922945|521723393|FG002|Overall Study|Lack of Efficacy|1|||
144691740|NCT03922945|521723391|FG000|Overall Study|Protocol Non-Compliance|0|||
144691741|NCT03922945|521723392|FG001|Overall Study|Protocol Non-Compliance|0|||
144691742|NCT03922945|521723393|FG002|Overall Study|Protocol Non-Compliance|1|||
144691743|NCT03922945|521723391|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
144691744|NCT03922945|521723392|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
144691745|NCT03922945|521723393|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
144691746|NCT03922945|521723391|FG000|Overall Study|All Other Personal Reasons|1|||
144691747|NCT03922945|521723392|FG001|Overall Study|All Other Personal Reasons|1|||
144691748|NCT03922945|521723393|FG002|Overall Study|All Other Personal Reasons|2|||
144691749|NCT01603615|521723404|FG000|Overall Study|Did not Receive Treatment|7|||
144691750|NCT01603615|521723404|FG000|Overall Study|Lost to Follow-up|9|||
144691751|NCT01603615|521723404|FG000|Overall Study|Personal Reasons|17|||
144691752|NCT01603615|521723404|FG000|Overall Study|Other Miscellaneous|1|||
144691753|NCT02719028|521723408|FG000|Overall Study|Adverse Event|2|||
144691754|NCT02719028|521723409|FG001|Overall Study|Adverse Event|1|||
144691755|NCT02719028|521723410|FG002|Overall Study|Adverse Event|4|||
144691756|NCT02719028|521723411|FG003|Overall Study|Adverse Event|8|||
144691757|NCT02719028|521723408|FG000|Overall Study|Physician Decision|0|||
144691758|NCT02719028|521723409|FG001|Overall Study|Physician Decision|1|||
144691759|NCT02719028|521723410|FG002|Overall Study|Physician Decision|1|||
144691760|NCT02719028|521723411|FG003|Overall Study|Physician Decision|1|||
144691761|NCT02719028|521723408|FG000|Overall Study|Use of prohibited medication|0|||
144691762|NCT02719028|521723409|FG001|Overall Study|Use of prohibited medication|0|||
144691763|NCT02719028|521723410|FG002|Overall Study|Use of prohibited medication|1|||
144691764|NCT02719028|521723411|FG003|Overall Study|Use of prohibited medication|0|||
144691765|NCT02719028|521723408|FG000|Overall Study|Protocol Violation|0|||
144691766|NCT02719028|521723409|FG001|Overall Study|Protocol Violation|0|||
144691767|NCT02719028|521723410|FG002|Overall Study|Protocol Violation|0|||
144691768|NCT02719028|521723411|FG003|Overall Study|Protocol Violation|1|||
144691769|NCT01539720|521723412|FG000|Overall Study|Screen Fail|15|||
144691770|NCT01539720|521723413|FG001|Overall Study|Screen Fail|3|||
144691771|NCT01539720|521723412|FG000|Overall Study|Lost to Follow-up|14|||
144691772|NCT01539720|521723413|FG001|Overall Study|Lost to Follow-up|7|||
144691773|NCT00298766|521723414|FG000|Overall Study|Adverse Event|18|||
144691774|NCT00298766|521723414|FG000|Overall Study|Death|2|||
144691775|NCT00298766|521723414|FG000|Overall Study|Withdrawal by Subject|9|||
144691776|NCT00298766|521723414|FG000|Overall Study|Treatment ongoing|4|||
144691777|NCT00298766|521723414|FG000|Overall Study|Progression of amyloid markers|4|||
144691778|NCT00298766|521723414|FG000|Overall Study|Deterioration in KPS and organ function|1|||
144691779|NCT00298766|521723414|FG000|Overall Study|Subjects overall condition deterioration|4|||
144691780|NCT00298766|521723414|FG000|Overall Study|Other|4|||
144691781|NCT03287960|521723415|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
144691782|NCT03287960|521723415|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
144691783|NCT00656136|521723418|FG000|Overall Study|Progressive disease|177|||
144691784|NCT00656136|521723419|FG001|Overall Study|Progressive disease|322|||
144219688|NCT00725491|519998593|FG000|Overall Study|Pregnancy|0|||
144691785|NCT00656136|521723418|FG000|Overall Study|Other Adverse Event|5|||
144691786|NCT00656136|521723419|FG001|Overall Study|Other Adverse Event|51|||
144691787|NCT00656136|521723418|FG000|Overall Study|Protocol Violation|2|||
144691788|NCT00656136|521723419|FG001|Overall Study|Protocol Violation|3|||
144691789|NCT00656136|521723418|FG000|Overall Study|Patient refused to take study medication|7|||
144691790|NCT00656136|521723419|FG001|Overall Study|Patient refused to take study medication|10|||
144691791|NCT00656136|521723418|FG000|Overall Study|Unknown and others|4|||
144691792|NCT00656136|521723419|FG001|Overall Study|Unknown and others|4|||
144691793|NCT01191190|521723421|FG000|Overall Study|Withdrawal by Subject|1|||
144691794|NCT03672006|521723428|FG000|Overall Study|exclusion criteria met|0|||
144219689|NCT00725491|519998594|FG001|Overall Study|Pregnancy|3|||
144691795|NCT03672006|521723429|FG001|Overall Study|exclusion criteria met|1|||
144691796|NCT00608426|521723430|FG000|Overall Study|Death|32|||
144219690|NCT00725491|519998593|FG000|Overall Study|Risk for hyperstimulation|2|||
144691797|NCT00608426|521723431|FG001|Overall Study|Death|36|||
144691798|NCT00608426|521723430|FG000|Overall Study|Lost to Follow-up|485|||
144691799|NCT00608426|521723431|FG001|Overall Study|Lost to Follow-up|521|||
144691800|NCT00608426|521723430|FG000|Overall Study|refused, health issues, wrong address|319|||
144691801|NCT00608426|521723431|FG001|Overall Study|refused, health issues, wrong address|348|||
144691802|NCT00761891|521723432|FG000|Overall Study|Withdrawal by Subject|10|||
144691803|NCT01707667|521723433|FG000|Period 1|expulsion of colonic sensor catheter|1|||
144691804|NCT01707667|521723434|FG001|Period 1|expulsion of colonic sensor catheter|0|||
144691805|NCT01453439|521723438|FG000|Treatment Phase|Withdrawal by Subject|13|||
144691806|NCT01453439|521723439|FG001|Treatment Phase|Withdrawal by Subject|10|||
144691807|NCT01453439|521723438|FG000|Treatment Phase|Suicidal Ideation|2|||
144691808|NCT01453439|521723439|FG001|Treatment Phase|Suicidal Ideation|0|||
144691809|NCT01453439|521723438|FG000|Treatment Phase|Need for higher level of care|1|||
144691810|NCT01453439|521723439|FG001|Treatment Phase|Need for higher level of care|1|||
144691811|NCT01453439|521723438|FG000|Treatment Phase|Therapist conflict of interest|1|||
144691812|NCT01453439|521723439|FG001|Treatment Phase|Therapist conflict of interest|0|||
144691813|NCT01453439|521723438|FG000|Follow-up|Withdrawal by Subject|0|||
144691814|NCT01453439|521723439|FG001|Follow-up|Withdrawal by Subject|1|||
144691815|NCT01453439|521723438|FG000|Follow-up|Lost to Follow-up|5|||
144691816|NCT01453439|521723439|FG001|Follow-up|Lost to Follow-up|10|||
144691817|NCT01014442|521723440|FG000|Overall Study|Adverse Event|0|||
144691818|NCT01014442|521723441|FG001|Overall Study|Adverse Event|8|||
144691819|NCT01014442|521723440|FG000|Overall Study|Withdrawal by Subject|4|||
144691820|NCT01014442|521723441|FG001|Overall Study|Withdrawal by Subject|4|||
144691821|NCT01014442|521723440|FG000|Overall Study|Protocol Violation|2|||
144691822|NCT01014442|521723441|FG001|Overall Study|Protocol Violation|5|||
144691823|NCT01014442|521723440|FG000|Overall Study|Lack of Compliance|0|||
144691824|NCT01014442|521723441|FG001|Overall Study|Lack of Compliance|1|||
144691825|NCT01014442|521723440|FG000|Overall Study|Unspecified Reason|1|||
144691826|NCT01014442|521723441|FG001|Overall Study|Unspecified Reason|1|||
144691827|NCT02074059|521723442|FG000|Overall Study|Death|0|||
144691828|NCT02074059|521723443|FG001|Overall Study|Death|0|||
144691829|NCT02074059|521723444|FG002|Overall Study|Death|0|||
144691830|NCT02074059|521723445|FG003|Overall Study|Death|0|||
144691831|NCT02074059|521723446|FG004|Overall Study|Death|1|||
144691832|NCT02074059|521723447|FG005|Overall Study|Death|1|||
144691833|NCT02764229|521723453|FG000|Overall Study|Withdrawal by Subject|15|||
144691834|NCT02764229|521723453|FG000|Overall Study|Adverse Event|9|||
144691835|NCT02764229|521723453|FG000|Overall Study|Physician Decision|5|||
144691836|NCT02764229|521723453|FG000|Overall Study|Lost to Follow-up|3|||
144691837|NCT02764229|521723453|FG000|Overall Study|Lack of Efficacy|1|||
144691838|NCT02764229|521723453|FG000|Overall Study|Study Stopped by Sponsor|69|||
144691839|NCT02135848|521723457|FG000|Overall Study|Adverse Event|2|||
144691840|NCT02135848|521723458|FG001|Overall Study|Adverse Event|0|||
144691841|NCT02135848|521723457|FG000|Overall Study|Withdrawal by Subject|1|||
144691842|NCT02135848|521723458|FG001|Overall Study|Withdrawal by Subject|1|||
144691843|NCT03258710|521723464|FG000|Overall Study|Adverse Event|1|||
144691844|NCT03258710|521723464|FG000|Overall Study|Protocol-defined stopping criteria|1|||
144691845|NCT03258710|521723464|FG000|Overall Study|Physician Decision|1|||
144691846|NCT03451630|521723465|FG000|Overall Study|Death|15|||
144219691|NCT00725491|519998594|FG001|Overall Study|Risk for hyperstimulation|9|||
144219692|NCT00725491|519998593|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
144691847|NCT03451630|521723466|FG001|Overall Study|Death|16|||
144691848|NCT03451630|521723467|FG002|Overall Study|Death|11|||
144691849|NCT03451630|521723465|FG000|Overall Study|Lost to Follow-up|9|||
144691850|NCT03451630|521723466|FG001|Overall Study|Lost to Follow-up|0|||
144691851|NCT03451630|521723467|FG002|Overall Study|Lost to Follow-up|4|||
144691852|NCT03451630|521723465|FG000|Overall Study|Withdrawal by Subject|0|||
144691853|NCT03451630|521723466|FG001|Overall Study|Withdrawal by Subject|3|||
144691854|NCT03451630|521723467|FG002|Overall Study|Withdrawal by Subject|0|||
144691855|NCT03451630|521723465|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
144700160|NCT00948896|521754508|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144700161|NCT00948896|521754509|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144700162|NCT00948896|521754510|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
144700163|NCT00948896|521754511|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144700164|NCT00948896|521754512|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144700165|NCT00948896|521754513|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144700166|NCT00948896|521754514|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
144700167|NCT01396434|521754515|FG000|Overall Study|Lost to Follow-up|1|||
144700168|NCT01396434|521754516|FG001|Overall Study|Lost to Follow-up|0|||
144700169|NCT01396434|521754517|FG002|Overall Study|Lost to Follow-up|0|||
144700170|NCT01396434|521754515|FG000|Overall Study|Other|10|||
144700171|NCT01396434|521754516|FG001|Overall Study|Other|0|||
144700172|NCT01396434|521754517|FG002|Overall Study|Other|0|||
144700173|NCT00157157|521754520|FG000|Overall Study|Withdrawal by Subject|6|||
144700174|NCT00157157|521754520|FG000|Overall Study|Physician Decision|1|||
144219693|NCT00725491|519998594|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
144219694|NCT00725491|519998593|FG000|Overall Study|Fertilization failure|0|||
144219695|NCT00725491|519998594|FG001|Overall Study|Fertilization failure|1|||
144219696|NCT00725491|519998593|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
144219697|NCT00725491|519998594|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
144219698|NCT01495000|519998597|FG000|Overall Study|Lost to Follow-up|2|||
144219699|NCT01495000|519998598|FG001|Overall Study|Lost to Follow-up|2|||
144219700|NCT01495000|519998597|FG000|Overall Study|Protocol Violation|1|||
144219701|NCT01495000|519998598|FG001|Overall Study|Protocol Violation|0|||
144219702|NCT01495000|519998597|FG000|Overall Study|Withdrawal by Subject|10|||
144219703|NCT01495000|519998598|FG001|Overall Study|Withdrawal by Subject|10|||
144219704|NCT02070965|519998599|FG000|Overall Study|Lost to Follow-up|0|||
144219705|NCT02070965|519998600|FG001|Overall Study|Lost to Follow-up|1|||
144219706|NCT02070965|519998601|FG002|Overall Study|Lost to Follow-up|0|||
144219707|NCT02070965|519998599|FG000|Overall Study|Withdrawal by Subject|1|||
144219708|NCT02070965|519998600|FG001|Overall Study|Withdrawal by Subject|1|||
144219709|NCT02070965|519998601|FG002|Overall Study|Withdrawal by Subject|1|||
144219710|NCT02070965|519998599|FG000|Overall Study|Subject moved|1|||
144219711|NCT02070965|519998600|FG001|Overall Study|Subject moved|0|||
144219712|NCT02070965|519998601|FG002|Overall Study|Subject moved|0|||
144219713|NCT00942357|519998604|FG000|Overall Study|Ineligible|37|||
144219714|NCT00942357|519998605|FG001|Overall Study|Ineligible|40|||
144219715|NCT03347110|519998608|FG000|Overall Study|Other (Participant is incarcerated)|1|||
144219716|NCT03347110|519998608|FG000|Overall Study|Withdrawal by Subject|9|||
144219717|NCT03347110|519998608|FG000|Overall Study|Lost to Follow-up|1|||
144219718|NCT03347110|519998608|FG000|Overall Study|Lack of Efficacy|2|||
144219719|NCT03347110|519998608|FG000|Overall Study|Adverse Event, non-fatal|9|||
144219720|NCT02676882|519998617|FG000|Overall Study|Adverse Event|1|||
144219721|NCT02676882|519998618|FG001|Overall Study|Adverse Event|0|||
144219722|NCT02676882|519998617|FG000|Overall Study|Lost to Follow-up|1|||
144219723|NCT02676882|519998618|FG001|Overall Study|Lost to Follow-up|0|||
144219724|NCT02676882|519998617|FG000|Overall Study|Withdrawal by Subject|1|||
144219725|NCT02676882|519998618|FG001|Overall Study|Withdrawal by Subject|2|||
144219726|NCT00958828|519998620|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
144219727|NCT00958828|519998621|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
144219728|NCT00958828|519998620|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
144219729|NCT00958828|519998621|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
144219730|NCT02687451|519998628|FG000|Overall Study|Withdrawal by Subject|1|||
144219731|NCT02687451|519998629|FG001|Overall Study|Withdrawal by Subject|0|||
144219732|NCT02687451|519998630|FG002|Overall Study|Withdrawal by Subject|0|||
144219733|NCT02687451|519998631|FG003|Overall Study|Withdrawal by Subject|0|||
144219734|NCT02687451|519998632|FG004|Overall Study|Withdrawal by Subject|0|||
144219735|NCT02687451|519998633|FG005|Overall Study|Withdrawal by Subject|1|||
144219736|NCT00707239|519998634|FG000|Overall Study|Adverse Event|5|||
144219737|NCT00707239|519998635|FG001|Overall Study|Adverse Event|3|||
144691856|NCT03451630|521723466|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
144691857|NCT03451630|521723467|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
144691858|NCT00089505|521723468|FG000|Overall Study|Death|4|||
144691859|NCT00089505|521723469|FG001|Overall Study|Death|1|||
144691860|NCT00089505|521723470|FG002|Overall Study|Death|5|||
144691861|NCT00089505|521723471|FG003|Overall Study|Death|8|||
144691862|NCT00089505|521723468|FG000|Overall Study|Withdrawal by Subject|3|||
144691863|NCT00089505|521723469|FG001|Overall Study|Withdrawal by Subject|0|||
144691864|NCT00089505|521723470|FG002|Overall Study|Withdrawal by Subject|6|||
144691865|NCT00089505|521723471|FG003|Overall Study|Withdrawal by Subject|6|||
144691866|NCT00089505|521723468|FG000|Overall Study|Lost to Follow-up|1|||
144691867|NCT00089505|521723469|FG001|Overall Study|Lost to Follow-up|1|||
144691868|NCT00089505|521723470|FG002|Overall Study|Lost to Follow-up|9|||
144691869|NCT00089505|521723471|FG003|Overall Study|Lost to Follow-up|7|||
144691870|NCT00089505|521723468|FG000|Overall Study|Physician Decision|1|||
144691871|NCT00089505|521723469|FG001|Overall Study|Physician Decision|0|||
144219738|NCT00707239|519998636|FG002|Overall Study|Adverse Event|2|||
144219739|NCT00707239|519998634|FG000|Overall Study|Death|3|||
144219740|NCT00707239|519998635|FG001|Overall Study|Death|1|||
144219741|NCT00707239|519998636|FG002|Overall Study|Death|3|||
144691872|NCT00089505|521723470|FG002|Overall Study|Physician Decision|0|||
144219742|NCT00707239|519998634|FG000|Overall Study|Physician Decision|1|||
144219743|NCT00707239|519998635|FG001|Overall Study|Physician Decision|1|||
144219744|NCT00707239|519998636|FG002|Overall Study|Physician Decision|2|||
144219745|NCT00707239|519998634|FG000|Overall Study|Protocol Violation|0|||
144219746|NCT00707239|519998635|FG001|Overall Study|Protocol Violation|0|||
144219747|NCT00707239|519998636|FG002|Overall Study|Protocol Violation|1|||
144219748|NCT00707239|519998634|FG000|Overall Study|Lack of Efficacy|1|||
144691873|NCT00089505|521723471|FG003|Overall Study|Physician Decision|0|||
144691874|NCT00089505|521723468|FG000|Overall Study|Protocol Violation|0|||
144691875|NCT00089505|521723469|FG001|Overall Study|Protocol Violation|0|||
144219749|NCT00707239|519998635|FG001|Overall Study|Lack of Efficacy|2|||
144691876|NCT00089505|521723470|FG002|Overall Study|Protocol Violation|1|||
144219750|NCT00707239|519998636|FG002|Overall Study|Lack of Efficacy|0|||
144219751|NCT00707239|519998634|FG000|Overall Study|Randomized, but not treated|1|||
144219752|NCT00707239|519998635|FG001|Overall Study|Randomized, but not treated|1|||
144219753|NCT00707239|519998636|FG002|Overall Study|Randomized, but not treated|1|||
144691877|NCT00089505|521723471|FG003|Overall Study|Protocol Violation|0|||
144691878|NCT02646332|521723474|FG000|Overall Study|Lost to Follow-up|0|||
144691879|NCT02646332|521723475|FG001|Overall Study|Lost to Follow-up|3|||
144691880|NCT01882439|521723481|FG000|Overall Study|Adverse event related to study drug|3|||
144691881|NCT01882439|521723482|FG001|Overall Study|Adverse event related to study drug|8|||
144691882|NCT01882439|521723483|FG002|Overall Study|Adverse event related to study drug|1|||
144691883|NCT01882439|521723484|FG003|Overall Study|Adverse event related to study drug|2|||
144691884|NCT01882439|521723481|FG000|Overall Study|Pregnancy|0|||
144691885|NCT01882439|521723482|FG001|Overall Study|Pregnancy|1|||
144691886|NCT01882439|521723483|FG002|Overall Study|Pregnancy|0|||
144691887|NCT01882439|521723484|FG003|Overall Study|Pregnancy|0|||
144691888|NCT01882439|521723481|FG000|Overall Study|Protocol Violation|2|||
144691889|NCT01882439|521723482|FG001|Overall Study|Protocol Violation|2|||
144691890|NCT01882439|521723483|FG002|Overall Study|Protocol Violation|0|||
144691891|NCT01882439|521723484|FG003|Overall Study|Protocol Violation|1|||
144691892|NCT01882439|521723481|FG000|Overall Study|No longer willing to participate|1|||
144691893|NCT01882439|521723482|FG001|Overall Study|No longer willing to participate|4|||
144691894|NCT01882439|521723483|FG002|Overall Study|No longer willing to participate|2|||
144691895|NCT01882439|521723484|FG003|Overall Study|No longer willing to participate|3|||
144691896|NCT01882439|521723481|FG000|Overall Study|Medication error with no associated AE|0|||
144691897|NCT01882439|521723482|FG001|Overall Study|Medication error with no associated AE|0|||
144691898|NCT01882439|521723483|FG002|Overall Study|Medication error with no associated AE|2|||
144691899|NCT01882439|521723484|FG003|Overall Study|Medication error with no associated AE|0|||
144691900|NCT01882439|521723481|FG000|Overall Study|Insufficient clinical response|1|||
144691901|NCT01882439|521723482|FG001|Overall Study|Insufficient clinical response|4|||
144691902|NCT01882439|521723483|FG002|Overall Study|Insufficient clinical response|4|||
144691903|NCT01882439|521723484|FG003|Overall Study|Insufficient clinical response|2|||
144691904|NCT01882439|521723481|FG000|Overall Study|Adverse event unrelated to study drug|2|||
144691905|NCT01882439|521723482|FG001|Overall Study|Adverse event unrelated to study drug|2|||
144691906|NCT01882439|521723483|FG002|Overall Study|Adverse event unrelated to study drug|1|||
144691907|NCT01882439|521723484|FG003|Overall Study|Adverse event unrelated to study drug|1|||
144691908|NCT03125902|521723487|FG000|Overall Study|Adverse Event|0|||
144691909|NCT03125902|521723488|FG001|Overall Study|Adverse Event|1|||
144691910|NCT03125902|521723487|FG000|Overall Study|Death|119|||
144691911|NCT03125902|521723488|FG001|Overall Study|Death|229|||
144691912|NCT03125902|521723487|FG000|Overall Study|Lost to Follow-up|4|||
144691913|NCT03125902|521723488|FG001|Overall Study|Lost to Follow-up|13|||
144691914|NCT03125902|521723487|FG000|Overall Study|Other|0|||
144691915|NCT03125902|521723488|FG001|Overall Study|Other|4|||
144691916|NCT03125902|521723487|FG000|Overall Study|Physician Decision|2|||
144691917|NCT03125902|521723488|FG001|Overall Study|Physician Decision|1|||
144691918|NCT03125902|521723487|FG000|Overall Study|Progressive Disease|0|||
144691919|NCT03125902|521723488|FG001|Overall Study|Progressive Disease|3|||
144691920|NCT03125902|521723487|FG000|Overall Study|Study Terminated By Sponsor|74|||
144691921|NCT03125902|521723488|FG001|Overall Study|Study Terminated By Sponsor|143|||
144691922|NCT03125902|521723487|FG000|Overall Study|Withdrawal by Subject|21|||
144691923|NCT03125902|521723488|FG001|Overall Study|Withdrawal by Subject|37|||
144691924|NCT01775995|521723489|FG000|Overall Study|Lost to Follow-up|1|||
144691925|NCT01775995|521723490|FG001|Overall Study|Lost to Follow-up|1|||
144691926|NCT01997333|521723491|FG000|Randomization and Treatment|Disease Progression|70|||
144691927|NCT01997333|521723492|FG001|Randomization and Treatment|Disease Progression|159|||
144691928|NCT01997333|521723491|FG000|Randomization and Treatment|Adverse Event|10|||
144691929|NCT01997333|521723492|FG001|Randomization and Treatment|Adverse Event|32|||
144691930|NCT01997333|521723491|FG000|Randomization and Treatment|Physician Decision|0|||
144691931|NCT01997333|521723492|FG001|Randomization and Treatment|Physician Decision|4|||
144691932|NCT01997333|521723491|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
144691933|NCT01997333|521723492|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
144691934|NCT01997333|521723491|FG000|Randomization and Treatment|Did not receive treatment|17|||
144691935|NCT01997333|521723492|FG001|Randomization and Treatment|Did not receive treatment|5|||
144691936|NCT01997333|521723491|FG000|Survival Follow up|Withdrawal by Subject|15|||
144691937|NCT01997333|521723492|FG001|Survival Follow up|Withdrawal by Subject|6|||
144691938|NCT01997333|521723491|FG000|Survival Follow up|Lost to Follow-up|0|||
144691939|NCT01997333|521723492|FG001|Survival Follow up|Lost to Follow-up|6|||
144691940|NCT01997333|521723491|FG000|Survival Follow up|Various|1|||
144691941|NCT01997333|521723492|FG001|Survival Follow up|Various|2|||
144219754|NCT00707239|519998634|FG000|Overall Study|Other|8|||
144691942|NCT02909504|521723493|FG000|Overall Study|Adverse Event|2|||
144691943|NCT02909504|521723493|FG000|Overall Study|Lack of Efficacy|3|||
144691944|NCT02909504|521723493|FG000|Overall Study|Withdrawal by Subject|4|||
144691945|NCT02909504|521723493|FG000|Overall Study|Pregnancy|1|||
144219755|NCT00707239|519998635|FG001|Overall Study|Other|3|||
144691946|NCT02909504|521723493|FG000|Overall Study|Subject moved|1|||
144691947|NCT02909504|521723493|FG000|Overall Study|Lost to Follow-up|1|||
144691948|NCT02504424|521723499|FG000|Overall Study|Withdrawal by Subject|2|||
144691949|NCT00440232|521723500|FG000|Overall Study|Lost to Follow-up|1|||
144691950|NCT00440232|521723501|FG001|Overall Study|Lost to Follow-up|1|||
144691951|NCT00440232|521723500|FG000|Overall Study|Unable to treat within allowed time|0|||
144691952|NCT00440232|521723501|FG001|Overall Study|Unable to treat within allowed time|1|||
144691953|NCT00440232|521723500|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
144691954|NCT00440232|521723501|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
144691955|NCT05060003|521723502|FG000|Overall Study|ctDNA negative|7|||
144691956|NCT00362297|521723503|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
144691957|NCT00362297|521723504|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
144691958|NCT01747655|521723509|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
144691959|NCT01747655|521723510|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
144691960|NCT01747655|521723509|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
144691961|NCT01747655|521723510|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
144691962|NCT01747655|521723509|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
144691963|NCT01747655|521723510|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
144691964|NCT00982111|521723513|FG000|Overall Study|Adverse Event|1|||
144691965|NCT00982111|521723514|FG001|Overall Study|Adverse Event|1|||
144691966|NCT00982111|521723513|FG000|Overall Study|Progressive Disease|46|||
144691967|NCT00982111|521723514|FG001|Overall Study|Progressive Disease|39|||
144691968|NCT00982111|521723513|FG000|Overall Study|Lost to Follow-up|9|||
144691969|NCT00982111|521723514|FG001|Overall Study|Lost to Follow-up|6|||
144691970|NCT00982111|521723513|FG000|Overall Study|New Anti-Cancer Therapy|5|||
144691971|NCT00982111|521723514|FG001|Overall Study|New Anti-Cancer Therapy|5|||
144691972|NCT00982111|521723513|FG000|Overall Study|Medical Decision|1|||
144691973|NCT00982111|521723514|FG001|Overall Study|Medical Decision|0|||
144691974|NCT00982111|521723513|FG000|Overall Study|Withdrawal by Subject|17|||
144691975|NCT00982111|521723514|FG001|Overall Study|Withdrawal by Subject|19|||
144691976|NCT00982111|521723513|FG000|Overall Study|Global Study End|0|||
144691977|NCT00982111|521723514|FG001|Overall Study|Global Study End|1|||
144691978|NCT00982111|521723513|FG000|Overall Study|Sponsor's Decision|0|||
144691979|NCT00982111|521723514|FG001|Overall Study|Sponsor's Decision|1|||
144691980|NCT01070381|521723515|FG000|Period 2, 1 Week of Wear|Handling|0|||
144691981|NCT01070381|521723516|FG001|Period 2, 1 Week of Wear|Handling|1|||
144691982|NCT01070381|521723515|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
144691983|NCT01070381|521723516|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
144691984|NCT01657903|521723517|FG000|Overall Study|Lost to Follow-up|1|||
144691985|NCT01657903|521723517|FG000|Overall Study|Withdrawal by Subject|1|||
144691986|NCT01259388|521723518|FG000|Overall Study|Adverse Event|3|||
144691987|NCT01259388|521723519|FG001|Overall Study|Adverse Event|0|||
144691988|NCT01259388|521723518|FG000|Overall Study|Withdrawal by Subject|1|||
144691989|NCT01259388|521723519|FG001|Overall Study|Withdrawal by Subject|1|||
144691990|NCT01259388|521723518|FG000|Overall Study|Physician Decision|1|||
144691991|NCT01259388|521723519|FG001|Overall Study|Physician Decision|0|||
144691992|NCT03512028|521723520|FG000|Overall Study|Withdrawal by Subject|2|||
144691993|NCT03512028|521723521|FG001|Overall Study|Withdrawal by Subject|0|||
144691994|NCT03512028|521723520|FG000|Overall Study|Protocol Violation|2|||
144691995|NCT03512028|521723521|FG001|Overall Study|Protocol Violation|0|||
144691996|NCT00489216|521723523|FG000|Overall Study|Adverse Event|1|||
144691997|NCT02828982|521723526|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144691998|NCT02828982|521723527|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144691999|NCT02312934|521723528|FG000|Overall Study|Lost to Follow-up|1|||
144692000|NCT02312934|521723529|FG001|Overall Study|Lost to Follow-up|0|||
144692001|NCT02312934|521723528|FG000|Overall Study|Physician Decision|1|||
144692002|NCT02312934|521723529|FG001|Overall Study|Physician Decision|0|||
144692003|NCT02098733|521723530|FG000|Overall Study|Data Not Available|5|||
144692004|NCT02098733|521723530|FG000|Overall Study|Lost to Follow-up|5|||
144692005|NCT03395704|521723531|FG000|Overall Study|Adverse Event|2|||
144692006|NCT03395704|521723532|FG001|Overall Study|Adverse Event|1|||
144692007|NCT03395704|521723531|FG000|Overall Study|Withdrawal by Subject|2|||
144692008|NCT03395704|521723532|FG001|Overall Study|Withdrawal by Subject|1|||
144692009|NCT03395704|521723531|FG000|Overall Study|Physician Decision|0|||
144692010|NCT03395704|521723532|FG001|Overall Study|Physician Decision|1|||
144692011|NCT02475564|521723533|FG000|Overall Study|Withdrawal by Subject|1|||
144692012|NCT02475564|521723534|FG001|Overall Study|Withdrawal by Subject|0|||
144692013|NCT02475564|521723533|FG000|Overall Study|Lost to Follow-up|2|||
144692014|NCT02475564|521723534|FG001|Overall Study|Lost to Follow-up|1|||
144692015|NCT02475564|521723533|FG000|Overall Study|Intense Menstrual bleeding|1|||
144692016|NCT02475564|521723534|FG001|Overall Study|Intense Menstrual bleeding|0|||
144692017|NCT01156012|521723535|FG000|Overall Study|Adverse Event|3|||
144692018|NCT01156012|521723536|FG001|Overall Study|Adverse Event|1|||
144692019|NCT01156012|521723535|FG000|Overall Study|Lost to Follow-up|1|||
144692020|NCT01156012|521723536|FG001|Overall Study|Lost to Follow-up|0|||
144692021|NCT01156012|521723535|FG000|Overall Study|Withdrawal by Subject|1|||
144219756|NCT00707239|519998636|FG002|Overall Study|Other|5|||
144692022|NCT01156012|521723536|FG001|Overall Study|Withdrawal by Subject|0|||
144692023|NCT01156012|521723535|FG000|Overall Study|use of commercial drug instead of study|0|||
144692024|NCT01156012|521723536|FG001|Overall Study|use of commercial drug instead of study|1|||
144692025|NCT01156012|521723535|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
144692026|NCT01156012|521723536|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
144692027|NCT01906489|521723537|FG000|Overall Study|Adverse Event|10|||
144692028|NCT01906489|521723538|FG001|Overall Study|Adverse Event|3|||
144692029|NCT01906489|521723537|FG000|Overall Study|Worsening of CKD|6|||
144692030|NCT01906489|521723538|FG001|Overall Study|Worsening of CKD|4|||
144692031|NCT01906489|521723537|FG000|Overall Study|Withdrawal by Subject|5|||
144692032|NCT01906489|521723538|FG001|Overall Study|Withdrawal by Subject|0|||
144692033|NCT01906489|521723537|FG000|Overall Study|Worsening of Anemia|1|||
144692034|NCT01906489|521723538|FG001|Overall Study|Worsening of Anemia|0|||
144692035|NCT01906489|521723537|FG000|Overall Study|Protocol Violation|0|||
144692036|NCT01906489|521723538|FG001|Overall Study|Protocol Violation|1|||
144692037|NCT01906489|521723537|FG000|Overall Study|Non- Compliance|1|||
144692038|NCT01906489|521723538|FG001|Overall Study|Non- Compliance|0|||
144692039|NCT01906489|521723537|FG000|Overall Study|Sponsor Decision|1|||
144692040|NCT01906489|521723538|FG001|Overall Study|Sponsor Decision|0|||
144692041|NCT01906489|521723537|FG000|Overall Study|Lost to Follow-up|1|||
144692042|NCT01906489|521723538|FG001|Overall Study|Lost to Follow-up|1|||
144692043|NCT01906489|521723537|FG000|Overall Study|Other|1|||
144692044|NCT01906489|521723538|FG001|Overall Study|Other|0|||
144692045|NCT01078389|521725479|FG000|Overall Study|Adverse Event|10|||
144692046|NCT01078389|521725480|FG001|Overall Study|Adverse Event|6|||
144692047|NCT01078389|521725479|FG000|Overall Study|Major Protocol Deviation|2|||
144692048|NCT01078389|521725480|FG001|Overall Study|Major Protocol Deviation|0|||
144692049|NCT01078389|521725479|FG000|Overall Study|Lost to Follow-up|23|||
144692050|NCT01078389|521725480|FG001|Overall Study|Lost to Follow-up|23|||
144692051|NCT01078389|521725479|FG000|Overall Study|Voluntary Withdrawal|20|||
144692052|NCT01078389|521725480|FG001|Overall Study|Voluntary Withdrawal|36|||
144692053|NCT01078389|521725479|FG000|Overall Study|Other|9|||
144692054|NCT01078389|521725480|FG001|Overall Study|Other|2|||
144692055|NCT02198040|521725481|FG000|Overall Study|Work reasons|0|||
144692056|NCT02198040|521725482|FG001|Overall Study|Work reasons|1|||
144692057|NCT02198040|521725483|FG002|Overall Study|Work reasons|0|||
144692058|NCT02198040|521725481|FG000|Overall Study|Withdrawal by Subject|0|||
144692059|NCT02198040|521725482|FG001|Overall Study|Withdrawal by Subject|0|||
144692060|NCT02198040|521725483|FG002|Overall Study|Withdrawal by Subject|1|||
144692061|NCT01884675|521725484|FG000|Overall Study|Study closed/terminated|3|||
144692062|NCT01884675|521725485|FG001|Overall Study|Study closed/terminated|2|||
144692063|NCT02361307|521725486|FG000|Overall Study|Unstable medical condition.|0|||
144692064|NCT02361307|521725487|FG001|Overall Study|Unstable medical condition.|1|||
144692065|NCT03359811|521725488|FG000|Overall Study|Protocol Violation|2|||
144692066|NCT03359811|521725489|FG001|Overall Study|Protocol Violation|0|||
144692067|NCT01189201|521725494|FG000|Overall Study|Adverse Event|1|||
144692068|NCT01682876|521725495|FG000|Overall Study|Administrative reason|4|||
144692069|NCT01682876|521725496|FG001|Overall Study|Administrative reason|4|||
144692070|NCT01682876|521725497|FG002|Overall Study|Administrative reason|0|||
144692071|NCT01682876|521725498|FG003|Overall Study|Administrative reason|3|||
144692072|NCT01682876|521725495|FG000|Overall Study|Adverse Event|0|||
144692073|NCT01682876|521725496|FG001|Overall Study|Adverse Event|0|||
144692074|NCT01682876|521725497|FG002|Overall Study|Adverse Event|0|||
144692075|NCT01682876|521725498|FG003|Overall Study|Adverse Event|1|||
144692076|NCT01682876|521725495|FG000|Overall Study|Lost to Follow-up|11|||
144692077|NCT01682876|521725496|FG001|Overall Study|Lost to Follow-up|15|||
144692078|NCT01682876|521725497|FG002|Overall Study|Lost to Follow-up|9|||
144692079|NCT01682876|521725498|FG003|Overall Study|Lost to Follow-up|11|||
144692080|NCT01682876|521725495|FG000|Overall Study|Protocol Violation|1|||
144692081|NCT01682876|521725496|FG001|Overall Study|Protocol Violation|1|||
144692082|NCT01682876|521725497|FG002|Overall Study|Protocol Violation|1|||
144692083|NCT01682876|521725498|FG003|Overall Study|Protocol Violation|1|||
144692084|NCT01682876|521725495|FG000|Overall Study|Withdrawal by Subject|4|||
144219757|NCT01778530|519998641|FG000|Overall Study|Progression on study|1|||
144692085|NCT01682876|521725496|FG001|Overall Study|Withdrawal by Subject|0|||
144692086|NCT01682876|521725497|FG002|Overall Study|Withdrawal by Subject|0|||
144692087|NCT01682876|521725498|FG003|Overall Study|Withdrawal by Subject|2|||
144692088|NCT01682876|521725495|FG000|Overall Study|Other|1|||
144692089|NCT01682876|521725496|FG001|Overall Study|Other|0|||
144692090|NCT01682876|521725497|FG002|Overall Study|Other|1|||
144692091|NCT01682876|521725498|FG003|Overall Study|Other|1|||
144219758|NCT01778530|519998641|FG000|Overall Study|Adverse event/side effect|1|||
144692092|NCT00911508|521725502|FG000|Overall Study|Lost to Follow-up|27|||
144692093|NCT00911508|521725503|FG001|Overall Study|Lost to Follow-up|18|||
144692094|NCT00911508|521725502|FG000|Overall Study|Withdrawal by Subject|79|||
144692095|NCT00911508|521725503|FG001|Overall Study|Withdrawal by Subject|112|||
144692096|NCT00240331|521725506|FG000|Overall Study|Withdrawal by Subject|125|||
144692097|NCT00240331|521725507|FG001|Overall Study|Withdrawal by Subject|132|||
144742271|NCT00112437|521908552|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742272|NCT00112437|521908553|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
144742273|NCT00112437|521908528|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742274|NCT00112437|521908529|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742275|NCT00112437|521908530|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742276|NCT00112437|521908531|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742277|NCT00112437|521908532|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742278|NCT00112437|521908533|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742279|NCT00112437|521908534|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742280|NCT00112437|521908535|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742281|NCT00112437|521908536|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742282|NCT00112437|521908537|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742283|NCT00112437|521908538|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742284|NCT00112437|521908539|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742285|NCT00112437|521908540|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742286|NCT00112437|521908541|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742287|NCT00112437|521908542|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742288|NCT00112437|521908543|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742289|NCT00112437|521908544|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742290|NCT00112437|521908545|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742291|NCT00112437|521908546|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742292|NCT00112437|521908547|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742293|NCT00112437|521908548|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
144742294|NCT00112437|521908549|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
144742295|NCT00112437|521908550|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742296|NCT00112437|521908551|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742297|NCT00112437|521908552|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742298|NCT00112437|521908553|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
144742299|NCT00112437|521908528|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742300|NCT00112437|521908529|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742301|NCT00112437|521908530|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742302|NCT00112437|521908531|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742303|NCT00112437|521908532|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742304|NCT00112437|521908533|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144692098|NCT00240331|521725506|FG000|Overall Study|Option selected by investigator|1|||
144692099|NCT00240331|521725507|FG001|Overall Study|Option selected by investigator|2|||
144692100|NCT01409382|521725508|FG000|Overall Study|Lost to Follow-up|1|||
144692101|NCT01409382|521725509|FG001|Overall Study|Lost to Follow-up|1|||
144692102|NCT01409382|521725508|FG000|Overall Study|Protocol Violation|0|||
144692103|NCT01409382|521725509|FG001|Overall Study|Protocol Violation|3|||
144692104|NCT01409382|521725508|FG000|Overall Study|Multiple pregnancy|2|||
144692105|NCT01409382|521725509|FG001|Overall Study|Multiple pregnancy|4|||
144692106|NCT01409382|521725508|FG000|Overall Study|Still pregnant when study ended|13|||
144219759|NCT03472014|519998642|FG000|Overall Study|Lost to Follow-up|4|||
144219760|NCT02635984|519998646|FG000|Overall Study|Lost to Follow-up|2|||
144692107|NCT01409382|521725509|FG001|Overall Study|Still pregnant when study ended|2|||
144692108|NCT01409382|521725508|FG000|Overall Study|Did not manage to get pregnant|64|||
144692109|NCT01409382|521725509|FG001|Overall Study|Did not manage to get pregnant|70|||
144692110|NCT01409382|521725508|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
144692111|NCT01409382|521725509|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
144692112|NCT01233076|521725510|FG000|Period 2, One Week|Lost to Follow-up|1|||
144692113|NCT01233076|521725511|FG001|Period 2, One Week|Lost to Follow-up|0|||
144692114|NCT04308668|521725512|FG000|Overall Study|Lost to Follow-up|32|||
144692115|NCT04308668|521725513|FG001|Overall Study|Lost to Follow-up|38|||
144692116|NCT04308668|521725512|FG000|Overall Study|Withdrawal by Subject|4|||
144742305|NCT00112437|521908534|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742306|NCT00112437|521908535|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742307|NCT00112437|521908536|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742308|NCT00112437|521908537|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742309|NCT00112437|521908538|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144219761|NCT02635984|519998647|FG001|Overall Study|Lost to Follow-up|4|||
144219762|NCT02635984|519998646|FG000|Overall Study|Study Arm Closed|1|||
144692117|NCT04308668|521725513|FG001|Overall Study|Withdrawal by Subject|4|||
144692118|NCT01266967|521725514|FG000|Overall Study|Death|69|||
144692119|NCT01266967|521725515|FG001|Overall Study|Death|61|||
144692120|NCT01266967|521725514|FG000|Overall Study|Study Closed/Terminated|15|||
144692121|NCT01266967|521725515|FG001|Overall Study|Study Closed/Terminated|17|||
144692122|NCT01266967|521725514|FG000|Overall Study|Lost to Follow-up|2|||
144692123|NCT01266967|521725515|FG001|Overall Study|Lost to Follow-up|1|||
144219763|NCT02635984|519998647|FG001|Overall Study|Study Arm Closed|0|||
144692124|NCT01266967|521725514|FG000|Overall Study|Physician Decision|0|||
144692125|NCT01266967|521725515|FG001|Overall Study|Physician Decision|1|||
144692126|NCT01266967|521725514|FG000|Overall Study|Withdrawal by Subject|3|||
144692127|NCT01266967|521725515|FG001|Overall Study|Withdrawal by Subject|3|||
144692128|NCT04563845|521725516|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692129|NCT04563845|521725517|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692130|NCT04563845|521725518|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692131|NCT04563845|521725519|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692132|NCT04563845|521725520|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692133|NCT04563845|521725521|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692134|NCT04563845|521725522|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692135|NCT04563845|521725523|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
144692136|NCT04563845|521725524|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692137|NCT04563845|521725525|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692138|NCT04563845|521725526|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692139|NCT04563845|521725527|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692140|NCT04563845|521725528|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692141|NCT04563845|521725529|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
144692142|NCT04563845|521725516|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692143|NCT04563845|521725517|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692144|NCT04563845|521725518|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692145|NCT04563845|521725519|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692146|NCT04563845|521725520|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
144692147|NCT04563845|521725521|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692148|NCT04563845|521725522|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692149|NCT04563845|521725523|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692150|NCT04563845|521725524|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692151|NCT04563845|521725525|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692152|NCT04563845|521725526|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692153|NCT04563845|521725527|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692154|NCT04563845|521725528|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692155|NCT04563845|521725529|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
144692156|NCT01020812|521725530|FG000|Overall Study|Physician Decision|1|||
144692157|NCT01020812|521725530|FG000|Overall Study|Withdrawal by Subject|1|||
144692158|NCT01020812|521725530|FG000|Overall Study|Protocol Violation|1|||
144692159|NCT01519700|521725531|FG000|Overall Study|Death|1|||
144692160|NCT01519700|521725532|FG001|Overall Study|Death|0|||
144692161|NCT01519700|521725533|FG002|Overall Study|Death|0|||
144692162|NCT01519700|521725534|FG003|Overall Study|Death|0|||
144692163|NCT01519700|521725531|FG000|Overall Study|Lost to Follow-up|0|||
144692164|NCT01519700|521725532|FG001|Overall Study|Lost to Follow-up|0|||
144692165|NCT01519700|521725533|FG002|Overall Study|Lost to Follow-up|1|||
144692166|NCT01519700|521725534|FG003|Overall Study|Lost to Follow-up|1|||
144692167|NCT01519700|521725531|FG000|Overall Study|Physician Decision|1|||
144692168|NCT01519700|521725532|FG001|Overall Study|Physician Decision|1|||
144692169|NCT01519700|521725533|FG002|Overall Study|Physician Decision|3|||
144692170|NCT01519700|521725534|FG003|Overall Study|Physician Decision|0|||
144692171|NCT01519700|521725531|FG000|Overall Study|Withdrawal by Subject|5|||
144692172|NCT01519700|521725532|FG001|Overall Study|Withdrawal by Subject|3|||
144692173|NCT01519700|521725533|FG002|Overall Study|Withdrawal by Subject|3|||
144692174|NCT01519700|521725534|FG003|Overall Study|Withdrawal by Subject|2|||
144692175|NCT01519700|521725531|FG000|Overall Study|Other Reason|2|||
144692176|NCT01519700|521725532|FG001|Overall Study|Other Reason|2|||
144692177|NCT01519700|521725533|FG002|Overall Study|Other Reason|0|||
144692178|NCT01519700|521725534|FG003|Overall Study|Other Reason|4|||
144692179|NCT02927990|521725535|FG000|Overall Study|Protocol Violation|4|||
144692180|NCT02927990|521725535|FG000|Overall Study|Physician Decision|9|||
144692181|NCT02927990|521725535|FG000|Overall Study|Room switched and therefore no study device available|15|||
144692182|NCT02927990|521725535|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
144692183|NCT00960323|521725536|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
144692184|NCT00772031|521725541|FG000|Overall Study|Early termination of trial|12|||
144692185|NCT00772031|521725542|FG001|Overall Study|Early termination of trial|10|||
144692186|NCT00772031|521725541|FG000|Overall Study|Lost to Follow-up|20|||
144692187|NCT00772031|521725542|FG001|Overall Study|Lost to Follow-up|33|||
144692188|NCT03419741|521725543|FG000|Overall Study|Adverse Event|1|||
144692189|NCT03419741|521725544|FG001|Overall Study|Adverse Event|0|||
144692190|NCT03419741|521725543|FG000|Overall Study|Withdrawal by Subject|1|||
144692191|NCT03419741|521725544|FG001|Overall Study|Withdrawal by Subject|2|||
144692192|NCT04354870|521725545|FG000|Overall Study|Lost to Follow-up|32|||
144692193|NCT04354870|521725546|FG001|Overall Study|Lost to Follow-up|12|||
144692194|NCT04354870|521725545|FG000|Overall Study|Withdrawal by Subject|10|||
144692195|NCT04354870|521725546|FG001|Overall Study|Withdrawal by Subject|16|||
144692196|NCT04354870|521725545|FG000|Overall Study|Did not complete all study visits|6|||
144219764|NCT00307086|519998648|FG000|Overall Study|ineligible|5|||
144219765|NCT00312338|519998649|FG000|Overall Study|Adverse Event|7|||
144219766|NCT00312338|519998650|FG001|Overall Study|Adverse Event|2|||
144219767|NCT00312338|519998649|FG000|Overall Study|Lost to Follow-up|9|||
144219768|NCT00312338|519998650|FG001|Overall Study|Lost to Follow-up|1|||
144219769|NCT00312338|519998649|FG000|Overall Study|Withdrawal by Subject|4|||
144219770|NCT00312338|519998650|FG001|Overall Study|Withdrawal by Subject|0|||
144219771|NCT00312338|519998649|FG000|Overall Study|Subsequent infection|2|||
144219772|NCT00312338|519998650|FG001|Overall Study|Subsequent infection|0|||
144692197|NCT04354870|521725546|FG001|Overall Study|Did not complete all study visits|5|||
144692198|NCT03384316|521725547|FG000|Overall Study|Screen failure|0|||
144692199|NCT03384316|521725548|FG001|Overall Study|Screen failure|1|||
144692200|NCT02194699|521725553|FG000|Randomised|Did not receive treatment|1|||
144692201|NCT02194699|521725554|FG001|Randomised|Did not receive treatment|5|||
144692202|NCT02194699|521725553|FG000|Randomised|Without potential for 52 weeks of IP|5|||
144692203|NCT02194699|521725554|FG001|Randomised|Without potential for 52 weeks of IP|5|||
144692204|NCT02194699|521725553|FG000|Randomised|Duplicate patient|2|||
144692205|NCT02194699|521725554|FG001|Randomised|Duplicate patient|1|||
144692206|NCT02194699|521725553|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
144692207|NCT02194699|521725554|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
144692208|NCT02194699|521725553|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
144692209|NCT02194699|521725554|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
144692210|NCT02194699|521725553|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
144692211|NCT02194699|521725554|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
144692212|NCT02194699|521725553|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
144692213|NCT02194699|521725554|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
144692214|NCT02194699|521725553|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
144692215|NCT02194699|521725554|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
144692216|NCT02194699|521725553|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
144692217|NCT02194699|521725554|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
144692218|NCT00561912|521725558|FG000|Overall Study|ineligible|1|||
144692219|NCT02577107|521725559|FG000|Overall Study|Protocol deviation|0|||
144692220|NCT02577107|521725560|FG001|Overall Study|Protocol deviation|1|||
144692221|NCT00577382|521725561|FG000|Overall Study|Adverse Event|0|||
144692222|NCT00577382|521725562|FG001|Overall Study|Adverse Event|6|||
144692223|NCT00577382|521725561|FG000|Overall Study|Withdrawal by Subject|0|||
144692224|NCT00577382|521725562|FG001|Overall Study|Withdrawal by Subject|1|||
144692225|NCT00577382|521725561|FG000|Overall Study|Progressive Disease|17|||
144692226|NCT00577382|521725562|FG001|Overall Study|Progressive Disease|19|||
144692227|NCT00577382|521725561|FG000|Overall Study|Intercurrent Illness|1|||
144692228|NCT00577382|521725562|FG001|Overall Study|Intercurrent Illness|2|||
144692229|NCT00577382|521725561|FG000|Overall Study|Death|1|||
144692230|NCT00577382|521725562|FG001|Overall Study|Death|1|||
144692231|NCT00577382|521725561|FG000|Overall Study|Lost to Follow-up|2|||
144692232|NCT00577382|521725562|FG001|Overall Study|Lost to Follow-up|2|||
144692233|NCT03007472|521725563|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
144692234|NCT03007472|521725563|FG000|Overall Study|Death|2|||
144692235|NCT03007472|521725563|FG000|Overall Study|Loss to Follow Up|1|||
144692236|NCT00649220|521725564|FG000|Overall Study|Adverse Event|2|||
144692237|NCT00649220|521725564|FG000|Overall Study|Withdrawal by Subject|1|||
144692238|NCT00525499|521725565|FG000|Overall Study|Lost to Follow-up|2|||
144692239|NCT00525499|521725566|FG001|Overall Study|Lost to Follow-up|4|||
144692240|NCT00525499|521725567|FG002|Overall Study|Lost to Follow-up|1|||
144692241|NCT00525499|521725568|FG003|Overall Study|Lost to Follow-up|4|||
144692242|NCT00525499|521725565|FG000|Overall Study|Adverse Event|0|||
144692243|NCT00525499|521725566|FG001|Overall Study|Adverse Event|1|||
144692244|NCT00525499|521725567|FG002|Overall Study|Adverse Event|0|||
144692245|NCT00525499|521725568|FG003|Overall Study|Adverse Event|1|||
144692246|NCT00525499|521725565|FG000|Overall Study|Withdrawal by Subject|5|||
144692247|NCT00525499|521725566|FG001|Overall Study|Withdrawal by Subject|1|||
144692248|NCT00525499|521725567|FG002|Overall Study|Withdrawal by Subject|5|||
144692249|NCT00525499|521725568|FG003|Overall Study|Withdrawal by Subject|2|||
144692250|NCT00525499|521725565|FG000|Overall Study|Protocol Violation|0|||
144692251|NCT00525499|521725566|FG001|Overall Study|Protocol Violation|1|||
144692252|NCT00525499|521725567|FG002|Overall Study|Protocol Violation|1|||
144692253|NCT00525499|521725568|FG003|Overall Study|Protocol Violation|0|||
144692254|NCT01729559|521725573|FG000|Overall Study|Protocol Violation|31|||
144692255|NCT01729559|521725574|FG001|Overall Study|Protocol Violation|28|||
144692256|NCT02906644|521725579|FG000|First 2 Weeks|Withdrawal by Subject|0|||
144692257|NCT02906644|521725580|FG001|First 2 Weeks|Withdrawal by Subject|2|||
144692258|NCT02906644|521725579|FG000|First 2 Weeks|Physician Decision|1|||
144692259|NCT02906644|521725580|FG001|First 2 Weeks|Physician Decision|1|||
144692260|NCT02906644|521725579|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
144692261|NCT02906644|521725580|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
144219773|NCT00262028|519998651|FG000|Overall Study|Withdrawal by Subject|6|||
144219774|NCT00262028|519998652|FG001|Overall Study|Withdrawal by Subject|3|||
144692262|NCT02906644|521725579|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
144692263|NCT02906644|521725580|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
144692264|NCT02030067|521725583|FG000|Overall Study|Disease Progression|1|||
144692265|NCT02030067|521725584|FG001|Overall Study|Disease Progression|1|||
144692266|NCT02030067|521725585|FG002|Overall Study|Disease Progression|2|||
144692267|NCT02030067|521725586|FG003|Overall Study|Disease Progression|2|||
144692268|NCT02030067|521725587|FG004|Overall Study|Disease Progression|3|||
144692269|NCT02030067|521725588|FG005|Overall Study|Disease Progression|2|||
144692270|NCT02030067|521725589|FG006|Overall Study|Disease Progression|3|||
144692271|NCT02030067|521725590|FG007|Overall Study|Disease Progression|3|||
144692272|NCT02030067|521725591|FG008|Overall Study|Disease Progression|4|||
144692273|NCT02030067|521725592|FG009|Overall Study|Disease Progression|3|||
144692274|NCT02030067|521725593|FG010|Overall Study|Disease Progression|7|||
144692275|NCT02030067|521725594|FG011|Overall Study|Disease Progression|2|||
144692276|NCT02030067|521725595|FG012|Overall Study|Disease Progression|59|||
144692277|NCT02030067|521725583|FG000|Overall Study|Withdrawal by Subject|0|||
144692278|NCT02030067|521725584|FG001|Overall Study|Withdrawal by Subject|0|||
144692279|NCT02030067|521725585|FG002|Overall Study|Withdrawal by Subject|0|||
144692280|NCT02030067|521725586|FG003|Overall Study|Withdrawal by Subject|1|||
144692281|NCT02030067|521725587|FG004|Overall Study|Withdrawal by Subject|0|||
144692282|NCT02030067|521725588|FG005|Overall Study|Withdrawal by Subject|0|||
144692283|NCT02030067|521725589|FG006|Overall Study|Withdrawal by Subject|0|||
144692284|NCT02030067|521725590|FG007|Overall Study|Withdrawal by Subject|1|||
144692285|NCT02030067|521725591|FG008|Overall Study|Withdrawal by Subject|0|||
144692286|NCT02030067|521725592|FG009|Overall Study|Withdrawal by Subject|0|||
144692287|NCT02030067|521725593|FG010|Overall Study|Withdrawal by Subject|3|||
144692288|NCT02030067|521725594|FG011|Overall Study|Withdrawal by Subject|0|||
144692289|NCT02030067|521725595|FG012|Overall Study|Withdrawal by Subject|6|||
144692290|NCT02030067|521725583|FG000|Overall Study|Physician Decision|0|||
144692291|NCT02030067|521725584|FG001|Overall Study|Physician Decision|0|||
144692292|NCT02030067|521725585|FG002|Overall Study|Physician Decision|0|||
144692293|NCT02030067|521725586|FG003|Overall Study|Physician Decision|0|||
144692294|NCT02030067|521725587|FG004|Overall Study|Physician Decision|0|||
144692295|NCT02030067|521725588|FG005|Overall Study|Physician Decision|0|||
144692296|NCT02030067|521725589|FG006|Overall Study|Physician Decision|0|||
144692297|NCT02030067|521725590|FG007|Overall Study|Physician Decision|0|||
144692298|NCT02030067|521725591|FG008|Overall Study|Physician Decision|0|||
144692299|NCT02030067|521725592|FG009|Overall Study|Physician Decision|0|||
144692300|NCT02030067|521725593|FG010|Overall Study|Physician Decision|1|||
144692301|NCT02030067|521725594|FG011|Overall Study|Physician Decision|0|||
144692302|NCT02030067|521725595|FG012|Overall Study|Physician Decision|3|||
144692303|NCT02030067|521725583|FG000|Overall Study|other reasons|0|||
144692304|NCT02030067|521725584|FG001|Overall Study|other reasons|0|||
144692305|NCT02030067|521725585|FG002|Overall Study|other reasons|0|||
144692306|NCT02030067|521725586|FG003|Overall Study|other reasons|0|||
144692307|NCT02030067|521725587|FG004|Overall Study|other reasons|0|||
144692308|NCT02030067|521725588|FG005|Overall Study|other reasons|1|||
144692309|NCT02030067|521725589|FG006|Overall Study|other reasons|0|||
144692310|NCT02030067|521725590|FG007|Overall Study|other reasons|0|||
144692311|NCT02030067|521725591|FG008|Overall Study|other reasons|2|||
144692312|NCT02030067|521725592|FG009|Overall Study|other reasons|0|||
144692313|NCT02030067|521725593|FG010|Overall Study|other reasons|0|||
144692314|NCT02030067|521725594|FG011|Overall Study|other reasons|0|||
144692315|NCT02030067|521725595|FG012|Overall Study|other reasons|4|||
144692316|NCT02030067|521725583|FG000|Overall Study|Adverse Event|0|||
144692317|NCT02030067|521725584|FG001|Overall Study|Adverse Event|0|||
144692318|NCT02030067|521725585|FG002|Overall Study|Adverse Event|0|||
144692319|NCT02030067|521725586|FG003|Overall Study|Adverse Event|0|||
144692320|NCT02030067|521725587|FG004|Overall Study|Adverse Event|0|||
144692321|NCT02030067|521725588|FG005|Overall Study|Adverse Event|0|||
144692322|NCT02030067|521725589|FG006|Overall Study|Adverse Event|0|||
144692323|NCT02030067|521725590|FG007|Overall Study|Adverse Event|0|||
144692324|NCT02030067|521725591|FG008|Overall Study|Adverse Event|0|||
144692325|NCT02030067|521725592|FG009|Overall Study|Adverse Event|0|||
144692326|NCT02030067|521725593|FG010|Overall Study|Adverse Event|0|||
144692327|NCT02030067|521725594|FG011|Overall Study|Adverse Event|1|||
144692328|NCT02030067|521725595|FG012|Overall Study|Adverse Event|8|||
144692329|NCT02041533|521725596|FG000|Pre-Treatment Period|Disease Progression|1|||
144742310|NCT00112437|521908539|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144692330|NCT02041533|521725597|FG001|Pre-Treatment Period|Disease Progression|1|||
144692331|NCT02041533|521725596|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
144692332|NCT02041533|521725597|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
144692333|NCT02041533|521725596|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
144692334|NCT02041533|521725597|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
144692335|NCT02041533|521725596|FG000|Treatment Period|Disease progression|189|||
144692336|NCT02041533|521725597|FG001|Treatment Period|Disease progression|146|||
144692337|NCT02041533|521725596|FG000|Treatment Period|Study drug toxicity|30|||
144692338|NCT02041533|521725597|FG001|Treatment Period|Study drug toxicity|34|||
144742311|NCT00112437|521908540|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742312|NCT00112437|521908541|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742313|NCT00112437|521908542|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742314|NCT00112437|521908543|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742315|NCT00112437|521908544|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742316|NCT00112437|521908545|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742317|NCT00112437|521908546|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742318|NCT00112437|521908547|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742319|NCT00112437|521908548|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
144742320|NCT00112437|521908549|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742321|NCT00112437|521908550|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742322|NCT00112437|521908551|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742323|NCT00112437|521908552|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742324|NCT00112437|521908553|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
144742325|NCT00112437|521908528|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742326|NCT00112437|521908529|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742327|NCT00112437|521908530|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742328|NCT00112437|521908531|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742329|NCT00112437|521908532|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742330|NCT00112437|521908533|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144219775|NCT00262028|519998653|FG002|Overall Study|Withdrawal by Subject|6|||
144219776|NCT00262028|519998654|FG003|Overall Study|Withdrawal by Subject|5|||
144219777|NCT00262028|519998655|FG004|Overall Study|Withdrawal by Subject|2|||
144219778|NCT00262028|519998656|FG005|Overall Study|Withdrawal by Subject|3|||
144219779|NCT00262028|519998657|FG006|Overall Study|Withdrawal by Subject|5|||
144219780|NCT00262028|519998658|FG007|Overall Study|Withdrawal by Subject|7|||
144219781|NCT00262028|519998659|FG008|Overall Study|Withdrawal by Subject|2|||
144742331|NCT00112437|521908534|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742332|NCT00112437|521908535|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742333|NCT00112437|521908536|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742334|NCT00112437|521908537|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742335|NCT00112437|521908538|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742336|NCT00112437|521908539|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742337|NCT00112437|521908540|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144219782|NCT00262028|519998651|FG000|Overall Study|Lost to Follow-up|7|||
144219783|NCT00262028|519998652|FG001|Overall Study|Lost to Follow-up|7|||
144219784|NCT00262028|519998653|FG002|Overall Study|Lost to Follow-up|5|||
144219785|NCT00262028|519998654|FG003|Overall Study|Lost to Follow-up|5|||
144219786|NCT00262028|519998655|FG004|Overall Study|Lost to Follow-up|4|||
144219787|NCT00262028|519998656|FG005|Overall Study|Lost to Follow-up|3|||
144219788|NCT00262028|519998657|FG006|Overall Study|Lost to Follow-up|3|||
144219789|NCT00262028|519998658|FG007|Overall Study|Lost to Follow-up|5|||
144219790|NCT00262028|519998659|FG008|Overall Study|Lost to Follow-up|6|||
144219791|NCT00262028|519998651|FG000|Overall Study|Administrative Reason|11|||
144219792|NCT00262028|519998652|FG001|Overall Study|Administrative Reason|14|||
144219793|NCT00262028|519998653|FG002|Overall Study|Administrative Reason|9|||
144219794|NCT00262028|519998654|FG003|Overall Study|Administrative Reason|12|||
144219795|NCT00262028|519998655|FG004|Overall Study|Administrative Reason|6|||
144219796|NCT00262028|519998656|FG005|Overall Study|Administrative Reason|7|||
144219797|NCT00262028|519998657|FG006|Overall Study|Administrative Reason|4|||
144219798|NCT00262028|519998658|FG007|Overall Study|Administrative Reason|6|||
144219799|NCT00262028|519998659|FG008|Overall Study|Administrative Reason|10|||
144219800|NCT00262028|519998651|FG000|Overall Study|Protocol Violation|0|||
144219801|NCT00262028|519998652|FG001|Overall Study|Protocol Violation|0|||
144219802|NCT00262028|519998653|FG002|Overall Study|Protocol Violation|0|||
144219803|NCT00262028|519998654|FG003|Overall Study|Protocol Violation|1|||
144219804|NCT00262028|519998655|FG004|Overall Study|Protocol Violation|0|||
144219805|NCT00262028|519998656|FG005|Overall Study|Protocol Violation|0|||
144219806|NCT00262028|519998657|FG006|Overall Study|Protocol Violation|0|||
144742338|NCT00112437|521908541|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742339|NCT00112437|521908542|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742340|NCT00112437|521908543|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742341|NCT00112437|521908544|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742342|NCT00112437|521908545|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742343|NCT00112437|521908546|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742344|NCT00112437|521908547|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742345|NCT00112437|521908548|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144219807|NCT00262028|519998658|FG007|Overall Study|Protocol Violation|0|||
144219808|NCT00262028|519998659|FG008|Overall Study|Protocol Violation|0|||
144219809|NCT00262028|519998651|FG000|Overall Study|Unable to classify|0|||
144219810|NCT00262028|519998652|FG001|Overall Study|Unable to classify|3|||
144219811|NCT00262028|519998653|FG002|Overall Study|Unable to classify|0|||
144692339|NCT02041533|521725596|FG000|Treatment Period|Death|1|||
144692340|NCT02041533|521725597|FG001|Treatment Period|Death|0|||
144692341|NCT02041533|521725596|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
144692342|NCT02041533|521725597|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
144692343|NCT02041533|521725596|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
144692344|NCT02041533|521725597|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
144692345|NCT02041533|521725596|FG000|Treatment Period|Participant withdrew consent|2|||
144692346|NCT02041533|521725597|FG001|Treatment Period|Participant withdrew consent|2|||
144692347|NCT02041533|521725596|FG000|Treatment Period|Maximum clinical benefit|0|||
144692348|NCT02041533|521725597|FG001|Treatment Period|Maximum clinical benefit|18|||
144692349|NCT02041533|521725596|FG000|Treatment Period|Poor/Non-compliance|1|||
144692350|NCT02041533|521725597|FG001|Treatment Period|Poor/Non-compliance|0|||
144692351|NCT02041533|521725596|FG000|Treatment Period|Administrative reason by sponsor|1|||
144692352|NCT02041533|521725597|FG001|Treatment Period|Administrative reason by sponsor|0|||
144692353|NCT02041533|521725596|FG000|Treatment Period|Other reasons|9|||
144692354|NCT02041533|521725597|FG001|Treatment Period|Other reasons|2|||
144692355|NCT02041533|521725596|FG000|Treatment Period|Not Reported|0|||
144692356|NCT02041533|521725597|FG001|Treatment Period|Not Reported|1|||
144692357|NCT01756846|521725598|FG000|Overall Study|Lost to Follow-up|5|||
144692358|NCT01756846|521725599|FG001|Overall Study|Lost to Follow-up|10|||
144692359|NCT01756846|521725598|FG000|Overall Study|Withdrawal by Subject|1|||
144692360|NCT01756846|521725599|FG001|Overall Study|Withdrawal by Subject|2|||
144692361|NCT00565721|521725604|FG000|Overall Study|Screen Failure|2|||
144692362|NCT00565721|521725604|FG000|Overall Study|Lost to Follow-up|6|||
144692363|NCT00565721|521725604|FG000|Overall Study|Technical Problems|1|||
144692364|NCT00565721|521725604|FG000|Overall Study|Physician Decision|2|||
144692365|NCT00565721|521725604|FG000|Overall Study|Other reasons|6|||
144692366|NCT00529152|521725605|FG000|Overall Study|Adverse Event|2|||
144692367|NCT00529152|521725605|FG000|Overall Study|Withdrawal by Subject|2|||
144692368|NCT00529152|521725605|FG000|Overall Study|Lost to Follow-up|1|||
144692369|NCT02500706|521725606|FG000|Overall Study|Adverse Event|0|||
144692370|NCT02500706|521725607|FG001|Overall Study|Adverse Event|0|||
144692371|NCT02500706|521725608|FG002|Overall Study|Adverse Event|1|||
144692372|NCT02500706|521725606|FG000|Overall Study|Lost to Follow-up|0|||
144692373|NCT02500706|521725607|FG001|Overall Study|Lost to Follow-up|1|||
144692374|NCT02500706|521725608|FG002|Overall Study|Lost to Follow-up|1|||
144692375|NCT02500706|521725606|FG000|Overall Study|Withdrawal by Subject|4|||
144692376|NCT02500706|521725607|FG001|Overall Study|Withdrawal by Subject|6|||
144692377|NCT02500706|521725608|FG002|Overall Study|Withdrawal by Subject|4|||
144692378|NCT02500706|521725606|FG000|Overall Study|Unclassified|0|||
144692379|NCT02500706|521725607|FG001|Overall Study|Unclassified|0|||
144692380|NCT02500706|521725608|FG002|Overall Study|Unclassified|1|||
144692381|NCT01497899|521725609|FG000|Double-Blind Phase|Randomized but not Treated|1|||
144700175|NCT00157157|521754520|FG000|Overall Study|Lost to Follow-up|1|||
144700176|NCT00157157|521754520|FG000|Overall Study|Enrolled in another study|1|||
144700177|NCT00157157|521754520|FG000|Overall Study|Met exclusion criteria|1|||
144700178|NCT00157157|521754520|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
144742346|NCT00112437|521908549|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
144742347|NCT00112437|521908550|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742348|NCT00112437|521908551|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742349|NCT00112437|521908552|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742350|NCT00112437|521908553|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
144742351|NCT00112437|521908528|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742352|NCT00112437|521908529|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742353|NCT00112437|521908530|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742354|NCT00112437|521908531|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742355|NCT00112437|521908532|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742356|NCT00112437|521908533|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742357|NCT00112437|521908534|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742358|NCT00112437|521908535|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742359|NCT00112437|521908536|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742360|NCT00112437|521908537|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742361|NCT00112437|521908538|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742362|NCT00112437|521908539|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742363|NCT00112437|521908540|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742364|NCT00112437|521908541|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742365|NCT00112437|521908542|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742366|NCT00112437|521908543|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742367|NCT00112437|521908544|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742368|NCT00112437|521908545|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742369|NCT00112437|521908546|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742370|NCT00112437|521908547|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742371|NCT00112437|521908548|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742372|NCT00112437|521908549|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
144692382|NCT01497899|521725610|FG001|Double-Blind Phase|Randomized but not Treated|0|||
144219812|NCT00262028|519998654|FG003|Overall Study|Unable to classify|0|||
144219813|NCT00262028|519998655|FG004|Overall Study|Unable to classify|0|||
144219814|NCT00262028|519998656|FG005|Overall Study|Unable to classify|0|||
144219815|NCT00262028|519998657|FG006|Overall Study|Unable to classify|0|||
144219816|NCT00262028|519998658|FG007|Overall Study|Unable to classify|0|||
144219817|NCT00262028|519998659|FG008|Overall Study|Unable to classify|1|||
144219818|NCT04583735|519998660|FG000|Double-masked Treatment Period|Adverse Event|0|||
144219819|NCT04583735|519998661|FG001|Double-masked Treatment Period|Adverse Event|1|||
144219820|NCT04583735|519998660|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
144219821|NCT04583735|519998661|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
144219822|NCT04583735|519998660|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
144219823|NCT04583735|519998661|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
144219824|NCT04583735|519998660|FG000|Open-label Treatment Period|Adverse Event|1|||
144219825|NCT04583735|519998661|FG001|Open-label Treatment Period|Adverse Event|1|||
144692383|NCT01497899|521725611|FG002|Double-Blind Phase|Randomized but not Treated|0|||
144692384|NCT01497899|521725612|FG003|Double-Blind Phase|Randomized but not Treated|0|||
144692385|NCT01497899|521725609|FG000|Double-Blind Phase|Adverse Event|1|||
144692386|NCT01497899|521725610|FG001|Double-Blind Phase|Adverse Event|0|||
144692387|NCT01497899|521725611|FG002|Double-Blind Phase|Adverse Event|0|||
144692388|NCT01497899|521725612|FG003|Double-Blind Phase|Adverse Event|0|||
144692389|NCT01497899|521725609|FG000|Double-Blind Phase|Lack of Efficacy|0|||
144692390|NCT01497899|521725610|FG001|Double-Blind Phase|Lack of Efficacy|1|||
144692391|NCT01497899|521725611|FG002|Double-Blind Phase|Lack of Efficacy|0|||
144692392|NCT01497899|521725612|FG003|Double-Blind Phase|Lack of Efficacy|0|||
144692393|NCT01497899|521725609|FG000|Double-Blind Phase|Investigator's Discretion|1|||
144692394|NCT01497899|521725610|FG001|Double-Blind Phase|Investigator's Discretion|0|||
144692395|NCT01497899|521725611|FG002|Double-Blind Phase|Investigator's Discretion|0|||
144692396|NCT01497899|521725612|FG003|Double-Blind Phase|Investigator's Discretion|0|||
144692397|NCT01497899|521725609|FG000|Double-Blind Phase|Withdrew Consent|0|||
144692398|NCT01497899|521725610|FG001|Double-Blind Phase|Withdrew Consent|1|||
144692399|NCT01497899|521725611|FG002|Double-Blind Phase|Withdrew Consent|0|||
144692400|NCT01497899|521725612|FG003|Double-Blind Phase|Withdrew Consent|0|||
144692401|NCT01497899|521725609|FG000|Double-Blind Phase|Lost to Follow-up|3|||
144692402|NCT01497899|521725610|FG001|Double-Blind Phase|Lost to Follow-up|2|||
144692403|NCT01497899|521725611|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144692404|NCT01497899|521725612|FG003|Double-Blind Phase|Lost to Follow-up|0|||
144692405|NCT01497899|521725609|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
144692406|NCT01497899|521725610|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
144692407|NCT01497899|521725611|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
144692408|NCT01497899|521725612|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
144692409|NCT01497899|521725609|FG000|Open-Label Extension Phase|Adverse Event|1|||
144692410|NCT01497899|521725610|FG001|Open-Label Extension Phase|Adverse Event|0|||
144692411|NCT01497899|521725611|FG002|Open-Label Extension Phase|Adverse Event|0|||
144692412|NCT01497899|521725612|FG003|Open-Label Extension Phase|Adverse Event|0|||
144692413|NCT01497899|521725609|FG000|Open-Label Extension Phase|Death|1|||
144692414|NCT01497899|521725610|FG001|Open-Label Extension Phase|Death|0|||
144692415|NCT01497899|521725611|FG002|Open-Label Extension Phase|Death|0|||
144692416|NCT01497899|521725612|FG003|Open-Label Extension Phase|Death|0|||
144692417|NCT01497899|521725609|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
144692418|NCT01497899|521725610|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
144692419|NCT01497899|521725611|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
144692420|NCT01497899|521725612|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
144692421|NCT01497899|521725609|FG000|Open-Label Extension Phase|Pregnancy|0|||
144692422|NCT01497899|521725610|FG001|Open-Label Extension Phase|Pregnancy|1|||
144692423|NCT01497899|521725611|FG002|Open-Label Extension Phase|Pregnancy|1|||
144692424|NCT01497899|521725612|FG003|Open-Label Extension Phase|Pregnancy|0|||
144692425|NCT01497899|521725609|FG000|Open-Label Extension Phase|Protocol Violation|0|||
144692426|NCT01497899|521725610|FG001|Open-Label Extension Phase|Protocol Violation|0|||
144692427|NCT01497899|521725611|FG002|Open-Label Extension Phase|Protocol Violation|1|||
144219826|NCT04583735|519998660|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
144219827|NCT04583735|519998661|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
144219828|NCT04583735|519998660|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
144692428|NCT01497899|521725612|FG003|Open-Label Extension Phase|Protocol Violation|0|||
144692429|NCT01497899|521725609|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
144692430|NCT01497899|521725610|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
144692431|NCT01497899|521725611|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
144692432|NCT01497899|521725612|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
144692433|NCT04212221|521725619|FG000|Overall Study|Remained on Treatment|0|||
144692434|NCT04212221|521725620|FG001|Overall Study|Remained on Treatment|0|||
144692435|NCT04212221|521725621|FG002|Overall Study|Remained on Treatment|0|||
144692436|NCT04212221|521725622|FG003|Overall Study|Remained on Treatment|1|||
144692437|NCT04212221|521725623|FG004|Overall Study|Remained on Treatment|0|||
144692438|NCT04212221|521725624|FG005|Overall Study|Remained on Treatment|0|||
144742373|NCT00112437|521908550|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742374|NCT00112437|521908551|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742375|NCT00112437|521908552|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742376|NCT00112437|521908553|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
144742377|NCT00112437|521908528|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742378|NCT00112437|521908529|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742379|NCT00112437|521908530|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742380|NCT00112437|521908531|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742381|NCT00112437|521908532|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742382|NCT00112437|521908533|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742383|NCT00112437|521908534|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742384|NCT00112437|521908535|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742385|NCT00112437|521908536|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742386|NCT00112437|521908537|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742387|NCT00112437|521908538|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742388|NCT00112437|521908539|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742389|NCT00112437|521908540|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742390|NCT00112437|521908541|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742391|NCT00112437|521908542|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742392|NCT00112437|521908543|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742393|NCT00112437|521908544|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742394|NCT00112437|521908545|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742395|NCT00112437|521908546|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742396|NCT00112437|521908547|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742397|NCT00112437|521908548|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
144742398|NCT00112437|521908549|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
144742399|NCT00112437|521908550|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742400|NCT00112437|521908551|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742401|NCT00112437|521908552|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742402|NCT00112437|521908553|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
144742403|NCT00112437|521908528|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742404|NCT00112437|521908529|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742405|NCT00112437|521908530|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742406|NCT00112437|521908531|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742407|NCT00112437|521908532|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742408|NCT00112437|521908533|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742409|NCT00112437|521908534|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742410|NCT00112437|521908535|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742411|NCT00112437|521908536|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742412|NCT00112437|521908537|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742413|NCT00112437|521908538|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742414|NCT00112437|521908539|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742415|NCT00112437|521908540|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742416|NCT00112437|521908541|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742417|NCT00112437|521908542|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742418|NCT00112437|521908543|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742419|NCT00112437|521908544|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144219829|NCT04583735|519998661|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
144219830|NCT00613171|519998662|FG000|Overall Study|Adverse Event|7|||
144219831|NCT00613171|519998662|FG000|Overall Study|Withdrawal by Subject|3|||
144219832|NCT00613171|519998662|FG000|Overall Study|Reason not Specified|4|||
144219833|NCT01197911|519998663|FG000|Overall Study|Adverse Event|0|||
144219834|NCT01197911|519998664|FG001|Overall Study|Adverse Event|0|||
144219835|NCT01197911|519998665|FG002|Overall Study|Adverse Event|1|||
144219836|NCT01526057|519998668|FG000|Overall Study|Withdrawal by Subject|3|||
144219837|NCT01526057|519998669|FG001|Overall Study|Withdrawal by Subject|2|||
144219838|NCT01526057|519998670|FG002|Overall Study|Withdrawal by Subject|2|||
144219839|NCT01526057|519998668|FG000|Overall Study|Adverse Event|3|||
144219840|NCT01526057|519998669|FG001|Overall Study|Adverse Event|1|||
144219841|NCT01526057|519998670|FG002|Overall Study|Adverse Event|1|||
144219842|NCT01526057|519998668|FG000|Overall Study|Death|1|||
144742420|NCT00112437|521908545|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742421|NCT00112437|521908546|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742422|NCT00112437|521908547|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742423|NCT00112437|521908548|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144219843|NCT01526057|519998669|FG001|Overall Study|Death|0|||
144219844|NCT01526057|519998670|FG002|Overall Study|Death|0|||
144219845|NCT01526057|519998668|FG000|Overall Study|Lost to Follow-up|1|||
144219846|NCT01526057|519998669|FG001|Overall Study|Lost to Follow-up|0|||
144219847|NCT01526057|519998670|FG002|Overall Study|Lost to Follow-up|1|||
144692439|NCT04212221|521725625|FG006|Overall Study|Remained on Treatment|3|||
144692440|NCT04212221|521725626|FG007|Overall Study|Remained on Treatment|9|||
144692441|NCT04212221|521725619|FG000|Overall Study|Adverse Event|0|||
144692442|NCT04212221|521725620|FG001|Overall Study|Adverse Event|0|||
144692443|NCT04212221|521725621|FG002|Overall Study|Adverse Event|0|||
144692444|NCT04212221|521725622|FG003|Overall Study|Adverse Event|0|||
144692445|NCT04212221|521725623|FG004|Overall Study|Adverse Event|0|||
144692446|NCT04212221|521725624|FG005|Overall Study|Adverse Event|0|||
144692447|NCT04212221|521725625|FG006|Overall Study|Adverse Event|2|||
144692448|NCT04212221|521725626|FG007|Overall Study|Adverse Event|3|||
144692449|NCT04212221|521725619|FG000|Overall Study|Death|0|||
144692450|NCT04212221|521725620|FG001|Overall Study|Death|0|||
144692451|NCT04212221|521725621|FG002|Overall Study|Death|0|||
144692452|NCT04212221|521725622|FG003|Overall Study|Death|0|||
144219848|NCT01526057|519998668|FG000|Overall Study|Other|1|||
144219849|NCT01526057|519998669|FG001|Overall Study|Other|0|||
144219850|NCT01526057|519998670|FG002|Overall Study|Other|1|||
144219851|NCT01526057|519998668|FG000|Overall Study|Protocol Violation|0|||
144219852|NCT01526057|519998669|FG001|Overall Study|Protocol Violation|0|||
144219853|NCT01526057|519998670|FG002|Overall Study|Protocol Violation|1|||
144219854|NCT01982955|519998671|FG000|Overall Study|Randomized but not treated|0|||
144219855|NCT01982955|519998672|FG001|Overall Study|Randomized but not treated|0|||
144219856|NCT01982955|519998673|FG002|Overall Study|Randomized but not treated|0|||
144219857|NCT01982955|519998674|FG003|Overall Study|Randomized but not treated|1|||
144219858|NCT01982955|519998675|FG004|Overall Study|Randomized but not treated|0|||
144219859|NCT05655546|520000270|FG000|Overall Study|Withdrawal by Subject|2|||
144219860|NCT05655546|520000271|FG001|Overall Study|Withdrawal by Subject|4|||
144219861|NCT04576507|520000278|FG000|Overall Study|Adverse Event|4|||
144219862|NCT04576507|520000278|FG000|Overall Study|Withdrawal by Subject|1|||
144219863|NCT05525520|520000279|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
144219864|NCT05525520|520000280|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
144219865|NCT05525520|520000279|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
144219866|NCT05525520|520000280|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
144219867|NCT02721732|520000281|FG000|Overall Study|Adverse Event|2|||
144219868|NCT02721732|520000282|FG001|Overall Study|Adverse Event|0|||
144219869|NCT02721732|520000283|FG002|Overall Study|Adverse Event|2|||
144219870|NCT02721732|520000284|FG003|Overall Study|Adverse Event|0|||
144219871|NCT02721732|520000285|FG004|Overall Study|Adverse Event|1|||
144219872|NCT02721732|520000286|FG005|Overall Study|Adverse Event|0|||
144219873|NCT02721732|520000287|FG006|Overall Study|Adverse Event|1|||
144219874|NCT02721732|520000288|FG007|Overall Study|Adverse Event|0|||
144219875|NCT02721732|520000289|FG008|Overall Study|Adverse Event|1|||
144219876|NCT02721732|520000290|FG009|Overall Study|Adverse Event|1|||
144219877|NCT02721732|520000281|FG000|Overall Study|Death|0|||
144219878|NCT02721732|520000282|FG001|Overall Study|Death|0|||
144219879|NCT02721732|520000283|FG002|Overall Study|Death|0|||
144219880|NCT02721732|520000284|FG003|Overall Study|Death|0|||
144219881|NCT02721732|520000285|FG004|Overall Study|Death|1|||
144219882|NCT02721732|520000286|FG005|Overall Study|Death|0|||
144692453|NCT04212221|521725623|FG004|Overall Study|Death|0|||
144692454|NCT04212221|521725624|FG005|Overall Study|Death|0|||
144692455|NCT04212221|521725625|FG006|Overall Study|Death|0|||
144692456|NCT04212221|521725626|FG007|Overall Study|Death|2|||
144692457|NCT04212221|521725619|FG000|Overall Study|Disease progression according to irRECIST|1|||
144692458|NCT04212221|521725620|FG001|Overall Study|Disease progression according to irRECIST|2|||
144692459|NCT04212221|521725621|FG002|Overall Study|Disease progression according to irRECIST|3|||
144692460|NCT04212221|521725622|FG003|Overall Study|Disease progression according to irRECIST|3|||
144692461|NCT04212221|521725623|FG004|Overall Study|Disease progression according to irRECIST|2|||
144692462|NCT04212221|521725624|FG005|Overall Study|Disease progression according to irRECIST|2|||
144692463|NCT04212221|521725625|FG006|Overall Study|Disease progression according to irRECIST|21|||
144692464|NCT04212221|521725626|FG007|Overall Study|Disease progression according to irRECIST|17|||
144692465|NCT04212221|521725619|FG000|Overall Study|Global Deterioration of Health Status|0|||
144219883|NCT02721732|520000287|FG006|Overall Study|Death|1|||
144219884|NCT02721732|520000288|FG007|Overall Study|Death|0|||
144219885|NCT02721732|520000289|FG008|Overall Study|Death|0|||
144219886|NCT02721732|520000290|FG009|Overall Study|Death|1|||
144219887|NCT02721732|520000281|FG000|Overall Study|Lack of Efficacy|12|||
144219888|NCT02721732|520000282|FG001|Overall Study|Lack of Efficacy|11|||
144219889|NCT02721732|520000283|FG002|Overall Study|Lack of Efficacy|18|||
144219890|NCT02721732|520000284|FG003|Overall Study|Lack of Efficacy|5|||
144219891|NCT02721732|520000285|FG004|Overall Study|Lack of Efficacy|21|||
144219892|NCT02721732|520000286|FG005|Overall Study|Lack of Efficacy|2|||
144219893|NCT02721732|520000287|FG006|Overall Study|Lack of Efficacy|8|||
144692466|NCT04212221|521725620|FG001|Overall Study|Global Deterioration of Health Status|0|||
144692467|NCT04212221|521725621|FG002|Overall Study|Global Deterioration of Health Status|0|||
144692468|NCT04212221|521725622|FG003|Overall Study|Global Deterioration of Health Status|0|||
144692469|NCT04212221|521725623|FG004|Overall Study|Global Deterioration of Health Status|0|||
144692470|NCT04212221|521725624|FG005|Overall Study|Global Deterioration of Health Status|0|||
144219894|NCT02721732|520000288|FG007|Overall Study|Lack of Efficacy|11|||
144219895|NCT02721732|520000289|FG008|Overall Study|Lack of Efficacy|10|||
144692471|NCT04212221|521725625|FG006|Overall Study|Global Deterioration of Health Status|0|||
144692472|NCT04212221|521725626|FG007|Overall Study|Global Deterioration of Health Status|2|||
144692473|NCT04212221|521725619|FG000|Overall Study|Investigator's Decision|0|||
144692474|NCT04212221|521725620|FG001|Overall Study|Investigator's Decision|0|||
144692475|NCT04212221|521725621|FG002|Overall Study|Investigator's Decision|0|||
144692476|NCT04212221|521725622|FG003|Overall Study|Investigator's Decision|1|||
144692477|NCT04212221|521725623|FG004|Overall Study|Investigator's Decision|0|||
144692478|NCT04212221|521725624|FG005|Overall Study|Investigator's Decision|0|||
144692479|NCT04212221|521725625|FG006|Overall Study|Investigator's Decision|3|||
144692480|NCT04212221|521725626|FG007|Overall Study|Investigator's Decision|0|||
144692481|NCT04212221|521725619|FG000|Overall Study|Participant refused to continue treatment|0|||
144692482|NCT04212221|521725620|FG001|Overall Study|Participant refused to continue treatment|1|||
144692483|NCT04212221|521725621|FG002|Overall Study|Participant refused to continue treatment|0|||
144692484|NCT04212221|521725622|FG003|Overall Study|Participant refused to continue treatment|1|||
144692485|NCT04212221|521725623|FG004|Overall Study|Participant refused to continue treatment|1|||
144692486|NCT04212221|521725624|FG005|Overall Study|Participant refused to continue treatment|2|||
144692487|NCT04212221|521725625|FG006|Overall Study|Participant refused to continue treatment|4|||
144692488|NCT04212221|521725626|FG007|Overall Study|Participant refused to continue treatment|2|||
144692489|NCT04212221|521725619|FG000|Overall Study|Protocol Violation|0|||
144692490|NCT04212221|521725620|FG001|Overall Study|Protocol Violation|0|||
144692491|NCT04212221|521725621|FG002|Overall Study|Protocol Violation|0|||
144692492|NCT04212221|521725622|FG003|Overall Study|Protocol Violation|0|||
144692493|NCT04212221|521725623|FG004|Overall Study|Protocol Violation|0|||
144692494|NCT04212221|521725624|FG005|Overall Study|Protocol Violation|0|||
144692495|NCT04212221|521725625|FG006|Overall Study|Protocol Violation|0|||
144219896|NCT02721732|520000290|FG009|Overall Study|Lack of Efficacy|20|||
144219897|NCT02721732|520000281|FG000|Overall Study|Physician Decision|0|||
144692496|NCT04212221|521725626|FG007|Overall Study|Protocol Violation|1|||
144692497|NCT00636506|521725631|FG000|Overall Study|Lost to Follow-up|8|||
144692498|NCT00636506|521725631|FG000|Overall Study|Explanted|1|||
144692499|NCT00636506|521725631|FG000|Overall Study|Withdrawal by Subject|6|||
144692500|NCT00636506|521725631|FG000|Overall Study|Procedure aborted|1|||
144692501|NCT01624974|521725632|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
144692502|NCT01624974|521725633|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
144692503|NCT01624974|521725632|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
144692504|NCT01624974|521725633|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
144692505|NCT01624974|521725632|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
144692506|NCT01624974|521725633|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
144692507|NCT01624974|521725632|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
144692508|NCT01624974|521725633|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
144692509|NCT01624974|521725632|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
144692510|NCT01624974|521725633|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
144692511|NCT01624974|521725632|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
144692512|NCT01624974|521725633|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
144692513|NCT01624974|521725632|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
144692514|NCT01624974|521725633|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
144692515|NCT01624974|521725632|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
144692516|NCT01624974|521725633|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
144692517|NCT01624974|521725632|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
144692518|NCT01624974|521725633|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
144692519|NCT01624974|521725632|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
144692520|NCT01624974|521725633|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
144692521|NCT01624974|521725632|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
144692522|NCT01624974|521725633|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
144692523|NCT01624974|521725632|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
144692524|NCT01624974|521725633|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
144692525|NCT00266695|521725634|FG000|Overall Study|Adverse Event|1|||
144692526|NCT00266695|521725634|FG000|Overall Study|Death|9|||
144692527|NCT00266695|521725634|FG000|Overall Study|Physician Decision|1|||
144692528|NCT00266695|521725634|FG000|Overall Study|Lost to Follow-up|3|||
144219898|NCT02721732|520000282|FG001|Overall Study|Physician Decision|0|||
144219899|NCT02721732|520000283|FG002|Overall Study|Physician Decision|1|||
144219900|NCT02721732|520000284|FG003|Overall Study|Physician Decision|0|||
144692529|NCT00266695|521725634|FG000|Overall Study|Withdrawal by Subject|15|||
144692530|NCT02380703|521725635|FG000|Overall Study|Withdrawal by Subject|12|||
144692531|NCT02380703|521725636|FG001|Overall Study|Withdrawal by Subject|9|||
144692532|NCT02380703|521725635|FG000|Overall Study|Lost to Follow-up|12|||
144692533|NCT02380703|521725636|FG001|Overall Study|Lost to Follow-up|12|||
144692534|NCT02380703|521725635|FG000|Overall Study|Caregiver death|1|||
144692535|NCT02380703|521725636|FG001|Overall Study|Caregiver death|0|||
144692536|NCT02380703|521725635|FG000|Overall Study|Person with dementia (PWD) death|7|||
144742424|NCT00112437|521908549|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144219901|NCT02721732|520000285|FG004|Overall Study|Physician Decision|0|||
144219902|NCT02721732|520000286|FG005|Overall Study|Physician Decision|0|||
144692537|NCT02380703|521725636|FG001|Overall Study|Person with dementia (PWD) death|8|||
144692538|NCT02380703|521725635|FG000|Overall Study|Entered Long-term Care|4|||
144692539|NCT02380703|521725636|FG001|Overall Study|Entered Long-term Care|7|||
144692540|NCT03607994|521725637|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
144692541|NCT03607994|521725638|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
144692542|NCT03969589|521725640|FG000|Overall Study|Lost to Follow-up|3|||
144692543|NCT03969589|521725641|FG001|Overall Study|Lost to Follow-up|2|||
144692544|NCT03969589|521725640|FG000|Overall Study|Declined Follow-Up|0|||
144692545|NCT03969589|521725641|FG001|Overall Study|Declined Follow-Up|1|||
144692546|NCT00517634|521725642|FG000|Second Treatment Period|Withdrawal by Subject|0|||
144692547|NCT00517634|521725643|FG001|Second Treatment Period|Withdrawal by Subject|0|||
144692548|NCT00517634|521725644|FG002|Second Treatment Period|Withdrawal by Subject|0|||
144692549|NCT00517634|521725645|FG003|Second Treatment Period|Withdrawal by Subject|0|||
144692550|NCT00517634|521725646|FG004|Second Treatment Period|Withdrawal by Subject|1|||
144692551|NCT00517634|521725647|FG005|Second Treatment Period|Withdrawal by Subject|0|||
144692552|NCT03417999|521725648|FG000|Overall Study|Withdrawal by Subject|1|||
144692553|NCT03417999|521725649|FG001|Overall Study|Withdrawal by Subject|0|||
144692554|NCT03417999|521725650|FG002|Overall Study|Withdrawal by Subject|0|||
144692555|NCT03417999|521725648|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
144692556|NCT03417999|521725649|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
144692557|NCT03417999|521725650|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
144692558|NCT03417999|521725648|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
144692559|NCT03417999|521725649|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
144692560|NCT03417999|521725650|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
144692561|NCT03417999|521725648|FG000|Overall Study|Inadequate study staff available to process samples|0|||
144692562|NCT03417999|521725649|FG001|Overall Study|Inadequate study staff available to process samples|0|||
144692563|NCT03417999|521725650|FG002|Overall Study|Inadequate study staff available to process samples|1|||
144692564|NCT00422942|521725655|FG000|Overall Study|Study terminated by Sponsor|3|||
144692565|NCT02539160|521725656|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
144692566|NCT02539160|521725657|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
144692567|NCT02539160|521725658|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
144692568|NCT02539160|521725659|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
144692569|NCT02539160|521725656|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
144692570|NCT02539160|521725657|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
144692571|NCT02539160|521725658|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
144692572|NCT02539160|521725659|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
144692573|NCT02539160|521725656|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
144692574|NCT02539160|521725657|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
144692575|NCT02539160|521725658|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
144692576|NCT02539160|521725659|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
144692577|NCT01681004|521725660|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
144692578|NCT01681004|521725661|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
144692579|NCT01681004|521725660|FG000|Study Completion|Lost to Follow-up|8|||
144692580|NCT01681004|521725661|FG001|Study Completion|Lost to Follow-up|3|||
144692581|NCT01681004|521725660|FG000|Study Completion|Physician Decision|1|||
144692582|NCT01681004|521725661|FG001|Study Completion|Physician Decision|3|||
144692583|NCT01681004|521725660|FG000|Study Completion|Site Termination|2|||
144692584|NCT01681004|521725661|FG001|Study Completion|Site Termination|1|||
144692585|NCT01681004|521725660|FG000|Study Completion|Death|1|||
144692586|NCT01681004|521725661|FG001|Study Completion|Death|1|||
144692587|NCT04823494|521727371|FG000|Overall Study|Programming software malfunction.|1|||
144692588|NCT04823494|521727372|FG001|Overall Study|Programming software malfunction.|0|||
144692589|NCT04823494|521727371|FG000|Overall Study|Withdrawal by Subject|1|||
144692590|NCT04823494|521727372|FG001|Overall Study|Withdrawal by Subject|0|||
144692591|NCT04823494|521727371|FG000|Overall Study|Devices lost|0|||
144692592|NCT04823494|521727372|FG001|Overall Study|Devices lost|1|||
144692593|NCT03691831|521727373|FG000|Overall Study|Lost to Follow-up|16|||
144692594|NCT03691831|521727374|FG001|Overall Study|Lost to Follow-up|12|||
144692595|NCT03691831|521727373|FG000|Overall Study|Withdrawal by Subject|9|||
144692596|NCT03691831|521727374|FG001|Overall Study|Withdrawal by Subject|17|||
144692597|NCT03691831|521727373|FG000|Overall Study|Investigator Decision|2|||
144692598|NCT03691831|521727374|FG001|Overall Study|Investigator Decision|2|||
144692599|NCT04524663|521727375|FG000|Overall Study|Withdrawal by Subject|0|||
144692600|NCT04524663|521727376|FG001|Overall Study|Withdrawal by Subject|2|||
144692601|NCT03824704|521727380|FG000|Overall Study|Study Terminated by Sponsor|1|||
144692602|NCT02155660|521727388|FG000|Overall Study|Other Reason|8|||
144692603|NCT02155660|521727389|FG001|Overall Study|Other Reason|6|||
144219903|NCT02721732|520000287|FG006|Overall Study|Physician Decision|0|||
144219904|NCT02721732|520000288|FG007|Overall Study|Physician Decision|0|||
144692604|NCT02155660|521727390|FG002|Overall Study|Other Reason|10|||
144692605|NCT02155660|521727391|FG003|Overall Study|Other Reason|10|||
144692606|NCT02155660|521727388|FG000|Overall Study|Study-specific withdrawal criteria|0|||
144219905|NCT02721732|520000289|FG008|Overall Study|Physician Decision|0|||
144219906|NCT02721732|520000290|FG009|Overall Study|Physician Decision|0|||
144219907|NCT02721732|520000281|FG000|Overall Study|Withdrawal by Subject|1|||
144219908|NCT02721732|520000282|FG001|Overall Study|Withdrawal by Subject|0|||
144219909|NCT02721732|520000283|FG002|Overall Study|Withdrawal by Subject|0|||
144692607|NCT02155660|521727389|FG001|Overall Study|Study-specific withdrawal criteria|1|||
144692608|NCT02155660|521727390|FG002|Overall Study|Study-specific withdrawal criteria|1|||
144692609|NCT02155660|521727391|FG003|Overall Study|Study-specific withdrawal criteria|1|||
144692610|NCT02155660|521727388|FG000|Overall Study|Severe non-compliance|0|||
144692611|NCT02155660|521727389|FG001|Overall Study|Severe non-compliance|4|||
144692612|NCT02155660|521727390|FG002|Overall Study|Severe non-compliance|0|||
144692613|NCT02155660|521727391|FG003|Overall Study|Severe non-compliance|1|||
144692614|NCT02155660|521727388|FG000|Overall Study|Adverse Event|2|||
144692615|NCT02155660|521727389|FG001|Overall Study|Adverse Event|6|||
144692616|NCT02155660|521727390|FG002|Overall Study|Adverse Event|3|||
144692617|NCT02155660|521727391|FG003|Overall Study|Adverse Event|1|||
144692618|NCT02155660|521727388|FG000|Overall Study|Lost to Follow-up|3|||
144692619|NCT02155660|521727389|FG001|Overall Study|Lost to Follow-up|6|||
144692620|NCT02155660|521727390|FG002|Overall Study|Lost to Follow-up|5|||
144692621|NCT02155660|521727391|FG003|Overall Study|Lost to Follow-up|8|||
144692622|NCT02155660|521727388|FG000|Overall Study|Death|17|||
144692623|NCT02155660|521727389|FG001|Overall Study|Death|19|||
144692624|NCT02155660|521727390|FG002|Overall Study|Death|17|||
144692625|NCT02155660|521727391|FG003|Overall Study|Death|19|||
144692626|NCT02155660|521727388|FG000|Overall Study|Withdrawal by Subject|28|||
144692627|NCT02155660|521727389|FG001|Overall Study|Withdrawal by Subject|31|||
144692628|NCT02155660|521727390|FG002|Overall Study|Withdrawal by Subject|24|||
144692629|NCT02155660|521727391|FG003|Overall Study|Withdrawal by Subject|21|||
144692630|NCT03730987|521727392|FG000|Overall Study|Lost to Follow-up|2|||
144692631|NCT03730987|521727393|FG001|Overall Study|Lost to Follow-up|0|||
144692632|NCT03730987|521727394|FG002|Overall Study|Lost to Follow-up|2|||
144692633|NCT03730987|521727395|FG003|Overall Study|Lost to Follow-up|0|||
144692634|NCT02505945|521727396|FG000|Overall Study|Withdrawal by Subject|13|||
144692635|NCT02505945|521727397|FG001|Overall Study|Withdrawal by Subject|2|||
144692636|NCT02505945|521727396|FG000|Overall Study|Adverse Event|1|||
144692637|NCT02505945|521727397|FG001|Overall Study|Adverse Event|0|||
144692638|NCT02505945|521727396|FG000|Overall Study|Physician Decision|2|||
144692639|NCT02505945|521727397|FG001|Overall Study|Physician Decision|1|||
144692640|NCT02505945|521727396|FG000|Overall Study|Lost to Follow-up|6|||
144692641|NCT02505945|521727397|FG001|Overall Study|Lost to Follow-up|1|||
144692642|NCT00386152|521727398|FG000|Overall Study|Adverse Event|6|||
144692643|NCT00386152|521727399|FG001|Overall Study|Adverse Event|5|||
144692644|NCT00386152|521727400|FG002|Overall Study|Adverse Event|4|||
144692645|NCT00386152|521727398|FG000|Overall Study|Chang from original chemo stratification|4|||
144692646|NCT00386152|521727399|FG001|Overall Study|Chang from original chemo stratification|5|||
144692647|NCT00386152|521727400|FG002|Overall Study|Chang from original chemo stratification|6|||
144692648|NCT00386152|521727398|FG000|Overall Study|Death|3|||
144692649|NCT00386152|521727399|FG001|Overall Study|Death|0|||
144692650|NCT00386152|521727400|FG002|Overall Study|Death|1|||
144692651|NCT00386152|521727398|FG000|Overall Study|Disease progression|7|||
144692652|NCT00386152|521727399|FG001|Overall Study|Disease progression|4|||
144692653|NCT00386152|521727400|FG002|Overall Study|Disease progression|5|||
144692654|NCT00386152|521727398|FG000|Overall Study|Physician Decision|13|||
144692655|NCT00386152|521727399|FG001|Overall Study|Physician Decision|10|||
144692656|NCT00386152|521727400|FG002|Overall Study|Physician Decision|4|||
144692657|NCT00386152|521727398|FG000|Overall Study|Lost to Follow-up|1|||
144692658|NCT00386152|521727399|FG001|Overall Study|Lost to Follow-up|0|||
144692659|NCT00386152|521727400|FG002|Overall Study|Lost to Follow-up|0|||
144692660|NCT00386152|521727398|FG000|Overall Study|Completed chemotherapy|4|||
144692661|NCT00386152|521727399|FG001|Overall Study|Completed chemotherapy|5|||
144692662|NCT00386152|521727400|FG002|Overall Study|Completed chemotherapy|1|||
144692663|NCT00386152|521727398|FG000|Overall Study|Protocol Violation|3|||
144692664|NCT00386152|521727399|FG001|Overall Study|Protocol Violation|5|||
144692665|NCT00386152|521727400|FG002|Overall Study|Protocol Violation|2|||
144219910|NCT02721732|520000284|FG003|Overall Study|Withdrawal by Subject|0|||
144692666|NCT00386152|521727398|FG000|Overall Study|Withdrawal by Subject|3|||
144692667|NCT00386152|521727399|FG001|Overall Study|Withdrawal by Subject|6|||
144692668|NCT00386152|521727400|FG002|Overall Study|Withdrawal by Subject|10|||
144692669|NCT01667731|521727402|FG000|Overall Study|Enrolled but not treated|0|||
144692670|NCT01667731|521727403|FG001|Overall Study|Enrolled but not treated|0|||
144692671|NCT01667731|521727404|FG002|Overall Study|Enrolled but not treated|0|||
144692672|NCT01667731|521727405|FG003|Overall Study|Enrolled but not treated|0|||
144692673|NCT01667731|521727406|FG004|Overall Study|Enrolled but not treated|1|||
144692674|NCT01667731|521727402|FG000|Overall Study|Efficacy Failure|1|||
144219911|NCT02721732|520000285|FG004|Overall Study|Withdrawal by Subject|3|||
144742425|NCT00112437|521908550|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
144742426|NCT00112437|521908551|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
144742427|NCT00112437|521908552|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
144742428|NCT00112437|521908553|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
144742429|NCT00112437|521908528|FG000|Years 6-10 (60-Month Extension)|Death|0|||
144742430|NCT00112437|521908529|FG001|Years 6-10 (60-Month Extension)|Death|0|||
144742431|NCT00112437|521908530|FG002|Years 6-10 (60-Month Extension)|Death|0|||
144742432|NCT00112437|521908531|FG003|Years 6-10 (60-Month Extension)|Death|0|||
144742433|NCT00112437|521908532|FG004|Years 6-10 (60-Month Extension)|Death|0|||
144742434|NCT00112437|521908533|FG005|Years 6-10 (60-Month Extension)|Death|0|||
144742435|NCT00112437|521908534|FG006|Years 6-10 (60-Month Extension)|Death|0|||
144742436|NCT00112437|521908535|FG007|Years 6-10 (60-Month Extension)|Death|0|||
144742437|NCT00112437|521908536|FG008|Years 6-10 (60-Month Extension)|Death|0|||
144742438|NCT00112437|521908537|FG009|Years 6-10 (60-Month Extension)|Death|0|||
144742439|NCT00112437|521908538|FG010|Years 6-10 (60-Month Extension)|Death|0|||
144742440|NCT00112437|521908539|FG011|Years 6-10 (60-Month Extension)|Death|0|||
144742441|NCT00112437|521908540|FG012|Years 6-10 (60-Month Extension)|Death|0|||
144742442|NCT00112437|521908541|FG013|Years 6-10 (60-Month Extension)|Death|0|||
144742443|NCT00112437|521908542|FG014|Years 6-10 (60-Month Extension)|Death|0|||
144742444|NCT00112437|521908543|FG015|Years 6-10 (60-Month Extension)|Death|0|||
144742445|NCT00112437|521908544|FG016|Years 6-10 (60-Month Extension)|Death|0|||
144742446|NCT00112437|521908545|FG017|Years 6-10 (60-Month Extension)|Death|0|||
144742447|NCT00112437|521908546|FG018|Years 6-10 (60-Month Extension)|Death|0|||
144742448|NCT00112437|521908547|FG019|Years 6-10 (60-Month Extension)|Death|0|||
144742449|NCT00112437|521908548|FG020|Years 6-10 (60-Month Extension)|Death|0|||
144742450|NCT00112437|521908549|FG021|Years 6-10 (60-Month Extension)|Death|0|||
144742451|NCT00112437|521908550|FG022|Years 6-10 (60-Month Extension)|Death|0|||
144742452|NCT00112437|521908551|FG023|Years 6-10 (60-Month Extension)|Death|2|||
144742453|NCT00112437|521908552|FG024|Years 6-10 (60-Month Extension)|Death|0|||
144742454|NCT00112437|521908553|FG025|Years 6-10 (60-Month Extension)|Death|0|||
144742455|NCT00112437|521908528|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742456|NCT00112437|521908529|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742457|NCT00112437|521908530|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742458|NCT00112437|521908531|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742459|NCT00112437|521908532|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742460|NCT00112437|521908533|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742461|NCT00112437|521908534|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742462|NCT00112437|521908535|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742463|NCT00112437|521908536|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742464|NCT00112437|521908537|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742465|NCT00112437|521908538|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742466|NCT00112437|521908539|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742467|NCT00112437|521908540|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742468|NCT00112437|521908541|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742469|NCT00112437|521908542|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742470|NCT00112437|521908543|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742471|NCT00112437|521908544|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742472|NCT00112437|521908545|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742473|NCT00112437|521908546|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742474|NCT00112437|521908547|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742475|NCT00112437|521908548|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742476|NCT00112437|521908549|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742477|NCT00112437|521908550|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144692675|NCT01667731|521727403|FG001|Overall Study|Efficacy Failure|12|||
144692676|NCT01667731|521727404|FG002|Overall Study|Efficacy Failure|0|||
144692677|NCT01667731|521727405|FG003|Overall Study|Efficacy Failure|1|||
144692678|NCT01667731|521727406|FG004|Overall Study|Efficacy Failure|24|||
144692679|NCT01667731|521727402|FG000|Overall Study|Lost to Follow-up|2|||
144692680|NCT01667731|521727403|FG001|Overall Study|Lost to Follow-up|3|||
144692681|NCT01667731|521727404|FG002|Overall Study|Lost to Follow-up|1|||
144692682|NCT01667731|521727405|FG003|Overall Study|Lost to Follow-up|1|||
144692683|NCT01667731|521727406|FG004|Overall Study|Lost to Follow-up|2|||
144692684|NCT01667731|521727402|FG000|Overall Study|Subject Withdrew Consent|2|||
144692685|NCT01667731|521727403|FG001|Overall Study|Subject Withdrew Consent|0|||
144692686|NCT01667731|521727404|FG002|Overall Study|Subject Withdrew Consent|1|||
144692687|NCT01667731|521727405|FG003|Overall Study|Subject Withdrew Consent|0|||
144692688|NCT01667731|521727406|FG004|Overall Study|Subject Withdrew Consent|1|||
144692689|NCT01667731|521727402|FG000|Overall Study|Death|0|||
144692690|NCT01667731|521727403|FG001|Overall Study|Death|1|||
144692691|NCT01667731|521727404|FG002|Overall Study|Death|0|||
144742478|NCT00112437|521908551|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144742479|NCT00112437|521908552|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
144692692|NCT01667731|521727405|FG003|Overall Study|Death|0|||
144692693|NCT01667731|521727406|FG004|Overall Study|Death|0|||
144742480|NCT00112437|521908553|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
144742481|NCT00112437|521908528|FG000|Years 6-10 (60-Month Extension)|Other|0|||
144742482|NCT00112437|521908529|FG001|Years 6-10 (60-Month Extension)|Other|0|||
144742483|NCT00112437|521908530|FG002|Years 6-10 (60-Month Extension)|Other|0|||
144742484|NCT00112437|521908531|FG003|Years 6-10 (60-Month Extension)|Other|0|||
144742485|NCT00112437|521908532|FG004|Years 6-10 (60-Month Extension)|Other|0|||
144742486|NCT00112437|521908533|FG005|Years 6-10 (60-Month Extension)|Other|0|||
144742487|NCT00112437|521908534|FG006|Years 6-10 (60-Month Extension)|Other|0|||
144742488|NCT00112437|521908535|FG007|Years 6-10 (60-Month Extension)|Other|0|||
144742489|NCT00112437|521908536|FG008|Years 6-10 (60-Month Extension)|Other|0|||
144742490|NCT00112437|521908537|FG009|Years 6-10 (60-Month Extension)|Other|0|||
144742491|NCT00112437|521908538|FG010|Years 6-10 (60-Month Extension)|Other|0|||
144742492|NCT00112437|521908539|FG011|Years 6-10 (60-Month Extension)|Other|0|||
144742493|NCT00112437|521908540|FG012|Years 6-10 (60-Month Extension)|Other|0|||
144742494|NCT00112437|521908541|FG013|Years 6-10 (60-Month Extension)|Other|0|||
144742495|NCT00112437|521908542|FG014|Years 6-10 (60-Month Extension)|Other|0|||
144742496|NCT00112437|521908543|FG015|Years 6-10 (60-Month Extension)|Other|0|||
144742497|NCT00112437|521908544|FG016|Years 6-10 (60-Month Extension)|Other|0|||
144742498|NCT00112437|521908545|FG017|Years 6-10 (60-Month Extension)|Other|0|||
144742499|NCT00112437|521908546|FG018|Years 6-10 (60-Month Extension)|Other|0|||
144742500|NCT00112437|521908547|FG019|Years 6-10 (60-Month Extension)|Other|0|||
144742501|NCT00112437|521908548|FG020|Years 6-10 (60-Month Extension)|Other|0|||
144742502|NCT00112437|521908549|FG021|Years 6-10 (60-Month Extension)|Other|0|||
144742503|NCT00112437|521908550|FG022|Years 6-10 (60-Month Extension)|Other|0|||
144742504|NCT00112437|521908551|FG023|Years 6-10 (60-Month Extension)|Other|0|||
144742505|NCT00112437|521908552|FG024|Years 6-10 (60-Month Extension)|Other|1|||
144742506|NCT00112437|521908553|FG025|Years 6-10 (60-Month Extension)|Other|0|||
144742507|NCT00112437|521908528|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742508|NCT00112437|521908529|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742509|NCT00112437|521908530|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742510|NCT00112437|521908531|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742511|NCT00112437|521908532|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742512|NCT00112437|521908533|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742513|NCT00112437|521908534|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742514|NCT00112437|521908535|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742515|NCT00112437|521908536|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742516|NCT00112437|521908537|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742517|NCT00112437|521908538|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742518|NCT00112437|521908539|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742519|NCT00112437|521908540|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742520|NCT00112437|521908541|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742521|NCT00112437|521908542|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742522|NCT00112437|521908543|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742523|NCT00112437|521908544|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742524|NCT00112437|521908545|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742525|NCT00112437|521908546|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742526|NCT00112437|521908547|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742527|NCT00112437|521908548|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742528|NCT00112437|521908549|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742529|NCT00112437|521908550|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742530|NCT00112437|521908551|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
144742531|NCT00112437|521908552|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144742532|NCT00112437|521908553|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
144219912|NCT02721732|520000286|FG005|Overall Study|Withdrawal by Subject|0|||
144219913|NCT02721732|520000287|FG006|Overall Study|Withdrawal by Subject|1|||
144219914|NCT02721732|520000288|FG007|Overall Study|Withdrawal by Subject|1|||
144219915|NCT02721732|520000289|FG008|Overall Study|Withdrawal by Subject|0|||
144219916|NCT02721732|520000290|FG009|Overall Study|Withdrawal by Subject|1|||
144219917|NCT02721732|520000281|FG000|Overall Study|Participant Choice|1|||
144219918|NCT02721732|520000282|FG001|Overall Study|Participant Choice|0|||
144219919|NCT02721732|520000283|FG002|Overall Study|Participant Choice|0|||
144219920|NCT02721732|520000284|FG003|Overall Study|Participant Choice|0|||
144742533|NCT00112437|521908528|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742534|NCT00112437|521908529|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742535|NCT00112437|521908530|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742536|NCT00112437|521908531|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742537|NCT00112437|521908532|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742538|NCT00112437|521908533|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144219921|NCT02721732|520000285|FG004|Overall Study|Participant Choice|0|||
144219922|NCT02721732|520000286|FG005|Overall Study|Participant Choice|0|||
144219923|NCT02721732|520000287|FG006|Overall Study|Participant Choice|0|||
144219924|NCT02721732|520000288|FG007|Overall Study|Participant Choice|0|||
144219925|NCT02721732|520000289|FG008|Overall Study|Participant Choice|0|||
144219926|NCT02721732|520000290|FG009|Overall Study|Participant Choice|1|||
144219927|NCT02721732|520000281|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144219928|NCT02721732|520000282|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144219929|NCT02721732|520000283|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
144219930|NCT02721732|520000284|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144219931|NCT02721732|520000285|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144219932|NCT02721732|520000286|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144219933|NCT02721732|520000287|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144692694|NCT02406586|521727407|FG000|Overall Study|Lost to Follow-up|0|||
144692695|NCT02406586|521727408|FG001|Overall Study|Lost to Follow-up|4|||
144692696|NCT02406586|521727409|FG002|Overall Study|Lost to Follow-up|2|||
144692697|NCT02406586|521727407|FG000|Overall Study|Withdrawal by Subject|1|||
144692698|NCT02406586|521727408|FG001|Overall Study|Withdrawal by Subject|0|||
144692699|NCT02406586|521727409|FG002|Overall Study|Withdrawal by Subject|0|||
144692700|NCT00883896|521727412|FG000|Overall Study|Lost to Follow-up|0|||
144692701|NCT00883896|521727413|FG001|Overall Study|Lost to Follow-up|0|||
144692702|NCT00883896|521727414|FG002|Overall Study|Lost to Follow-up|0|||
144692703|NCT00883896|521727415|FG003|Overall Study|Lost to Follow-up|2|||
144692704|NCT00883896|521727412|FG000|Overall Study|Withdrawal by Subject|5|||
144692705|NCT00883896|521727413|FG001|Overall Study|Withdrawal by Subject|0|||
144692706|NCT00883896|521727414|FG002|Overall Study|Withdrawal by Subject|1|||
144692707|NCT00883896|521727415|FG003|Overall Study|Withdrawal by Subject|3|||
144692708|NCT00883896|521727412|FG000|Overall Study|Lack of Efficacy|0|||
144692709|NCT00883896|521727413|FG001|Overall Study|Lack of Efficacy|0|||
144692710|NCT00883896|521727414|FG002|Overall Study|Lack of Efficacy|0|||
144692711|NCT00883896|521727415|FG003|Overall Study|Lack of Efficacy|2|||
144692712|NCT00883896|521727412|FG000|Overall Study|Other|1|||
144692713|NCT00883896|521727413|FG001|Overall Study|Other|0|||
144692714|NCT00883896|521727414|FG002|Overall Study|Other|0|||
144692715|NCT00883896|521727415|FG003|Overall Study|Other|0|||
144692716|NCT03380091|521727427|FG000|Overall Study|Withdrawal by Subject|2|||
144692717|NCT03380091|521727428|FG001|Overall Study|Withdrawal by Subject|1|||
144692718|NCT00661362|521727429|FG000|Overall Study|Adverse Event|5|||
144692719|NCT00661362|521727430|FG001|Overall Study|Adverse Event|4|||
144692720|NCT00661362|521727429|FG000|Overall Study|Incorrect enrollment|2|||
144692721|NCT00661362|521727430|FG001|Overall Study|Incorrect enrollment|0|||
144692722|NCT00661362|521727429|FG000|Overall Study|Study specific discontinuation criteria|4|||
144692723|NCT00661362|521727430|FG001|Overall Study|Study specific discontinuation criteria|11|||
144692724|NCT00661362|521727429|FG000|Overall Study|Withdrawal by Subject|13|||
144692725|NCT00661362|521727430|FG001|Overall Study|Withdrawal by Subject|23|||
144692726|NCT00661362|521727429|FG000|Overall Study|Lost to Follow-up|3|||
144692727|NCT00661362|521727430|FG001|Overall Study|Lost to Follow-up|1|||
144692728|NCT00661362|521727429|FG000|Overall Study|Severe non-compliance to protocol|0|||
144692729|NCT00661362|521727430|FG001|Overall Study|Severe non-compliance to protocol|1|||
144692730|NCT00661362|521727429|FG000|Overall Study|Safety reasons|1|||
144692731|NCT00661362|521727430|FG001|Overall Study|Safety reasons|0|||
144692732|NCT00661362|521727429|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
144692733|NCT00661362|521727430|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
144692734|NCT01220024|521727438|FG000|Overall Study|Lost to Follow-up|1|||
144692735|NCT01220024|521727439|FG001|Overall Study|Lost to Follow-up|1|||
144692736|NCT00174460|521727440|FG000|Overall Study|Withdrawal by Subject|0|||
144692737|NCT00174460|521727441|FG001|Overall Study|Withdrawal by Subject|1|||
144692738|NCT00579059|521727444|FG000|Overall Study|Study Canceled at 1 Year|21|||
144692739|NCT00579059|521727445|FG001|Overall Study|Study Canceled at 1 Year|10|||
144692740|NCT00265382|521727447|FG000|Overall Study|Adverse Event|21|||
144692741|NCT00265382|521727447|FG000|Overall Study|Laboratory Abnormality|1|||
144692742|NCT00265382|521727447|FG000|Overall Study|Lost to Follow-up|3|||
144692743|NCT00265382|521727447|FG000|Overall Study|Lack of Efficacy|6|||
144692744|NCT00265382|521727447|FG000|Overall Study|Miscellaneous|6|||
144692745|NCT00265382|521727447|FG000|Overall Study|Withdrawal by Subject|13|||
144692746|NCT00265382|521727447|FG000|Overall Study|Study terminated by sponsor|94|||
144692747|NCT00265382|521727447|FG000|Overall Study|Death|1|||
144692748|NCT01474993|521727450|FG000|Overall Study|Lost to Follow-up|1|||
144692749|NCT01474993|521727451|FG001|Overall Study|Lost to Follow-up|2|||
144692750|NCT01474993|521727450|FG000|Overall Study|Adverse Event|0|||
144692751|NCT01474993|521727451|FG001|Overall Study|Adverse Event|1|||
144692752|NCT01853397|521727452|FG000|Overall Study|Withdrawal by Subject|0|||
144692753|NCT01853397|521727453|FG001|Overall Study|Withdrawal by Subject|0|||
144692754|NCT01853397|521727454|FG002|Overall Study|Withdrawal by Subject|0|||
144692755|NCT01853397|521727455|FG003|Overall Study|Withdrawal by Subject|1|||
144692756|NCT01853397|521727452|FG000|Overall Study|Subject Noncompliance|0|||
144692757|NCT01853397|521727453|FG001|Overall Study|Subject Noncompliance|0|||
144692758|NCT01853397|521727454|FG002|Overall Study|Subject Noncompliance|0|||
144692759|NCT01853397|521727455|FG003|Overall Study|Subject Noncompliance|1|||
144692760|NCT02132312|521727456|FG000|Overall Study|Adverse Event|2|||
144692761|NCT02132312|521727457|FG001|Overall Study|Adverse Event|0|||
144692762|NCT02132312|521727456|FG000|Overall Study|Physician Decision|1|||
144692763|NCT02132312|521727457|FG001|Overall Study|Physician Decision|1|||
144692764|NCT02132312|521727456|FG000|Overall Study|Protocol Violation|0|||
144692765|NCT02132312|521727457|FG001|Overall Study|Protocol Violation|1|||
144692766|NCT02132312|521727456|FG000|Overall Study|Withdrawal by Subject|1|||
144692767|NCT02132312|521727457|FG001|Overall Study|Withdrawal by Subject|0|||
144692768|NCT02132312|521727456|FG000|Overall Study|Lost to Follow-up|2|||
144692769|NCT02132312|521727457|FG001|Overall Study|Lost to Follow-up|1|||
144692770|NCT01632345|521727458|FG000|Treatment: Part I|Adverse Event|1|||
144692771|NCT01632345|521727459|FG001|Treatment: Part I|Adverse Event|4|||
144692772|NCT01632345|521727460|FG002|Treatment: Part I|Adverse Event|2|||
144692773|NCT01632345|521727461|FG003|Treatment: Part I|Adverse Event|1|||
144692774|NCT01632345|521727462|FG004|Treatment: Part I|Adverse Event|3|||
144692775|NCT01632345|521727463|FG005|Treatment: Part I|Adverse Event|0|||
144692776|NCT01632345|521727464|FG006|Treatment: Part I|Adverse Event|0|||
144692777|NCT01632345|521727458|FG000|Treatment: Part I|Lack of Efficacy|0|||
144692778|NCT01632345|521727459|FG001|Treatment: Part I|Lack of Efficacy|1|||
144692779|NCT01632345|521727460|FG002|Treatment: Part I|Lack of Efficacy|0|||
144692780|NCT01632345|521727461|FG003|Treatment: Part I|Lack of Efficacy|1|||
144692781|NCT01632345|521727462|FG004|Treatment: Part I|Lack of Efficacy|1|||
144692782|NCT01632345|521727463|FG005|Treatment: Part I|Lack of Efficacy|0|||
144692783|NCT01632345|521727464|FG006|Treatment: Part I|Lack of Efficacy|0|||
144692784|NCT01632345|521727458|FG000|Treatment: Part I|Lost to Follow-up|3|||
144692785|NCT01632345|521727459|FG001|Treatment: Part I|Lost to Follow-up|2|||
144692786|NCT01632345|521727460|FG002|Treatment: Part I|Lost to Follow-up|1|||
144692787|NCT01632345|521727461|FG003|Treatment: Part I|Lost to Follow-up|3|||
144692788|NCT01632345|521727462|FG004|Treatment: Part I|Lost to Follow-up|4|||
144692789|NCT01632345|521727463|FG005|Treatment: Part I|Lost to Follow-up|0|||
144692790|NCT01632345|521727464|FG006|Treatment: Part I|Lost to Follow-up|0|||
144692791|NCT01632345|521727458|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
144692792|NCT01632345|521727459|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
144692793|NCT01632345|521727460|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
144692794|NCT01632345|521727461|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
144692795|NCT01632345|521727462|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
144692796|NCT01632345|521727463|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
144692797|NCT01632345|521727464|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
144692798|NCT01632345|521727458|FG000|Treatment: Part I|Physician Decision|2|||
144692799|NCT01632345|521727459|FG001|Treatment: Part I|Physician Decision|1|||
144692800|NCT01632345|521727460|FG002|Treatment: Part I|Physician Decision|0|||
144692801|NCT01632345|521727461|FG003|Treatment: Part I|Physician Decision|0|||
144692802|NCT01632345|521727462|FG004|Treatment: Part I|Physician Decision|1|||
144692803|NCT01632345|521727463|FG005|Treatment: Part I|Physician Decision|0|||
144692804|NCT01632345|521727464|FG006|Treatment: Part I|Physician Decision|0|||
144692805|NCT01632345|521727458|FG000|Treatment: Part I|Pregnancy|0|||
144692806|NCT01632345|521727459|FG001|Treatment: Part I|Pregnancy|1|||
144692807|NCT01632345|521727460|FG002|Treatment: Part I|Pregnancy|0|||
144692808|NCT01632345|521727461|FG003|Treatment: Part I|Pregnancy|0|||
144692809|NCT01632345|521727462|FG004|Treatment: Part I|Pregnancy|0|||
144692810|NCT01632345|521727463|FG005|Treatment: Part I|Pregnancy|0|||
144692811|NCT01632345|521727464|FG006|Treatment: Part I|Pregnancy|0|||
144692812|NCT01632345|521727458|FG000|Treatment: Part I|Protocol Deviation|0|||
144692813|NCT01632345|521727459|FG001|Treatment: Part I|Protocol Deviation|0|||
144692814|NCT01632345|521727460|FG002|Treatment: Part I|Protocol Deviation|1|||
144692815|NCT01632345|521727461|FG003|Treatment: Part I|Protocol Deviation|1|||
144692816|NCT01632345|521727462|FG004|Treatment: Part I|Protocol Deviation|0|||
144692817|NCT01632345|521727463|FG005|Treatment: Part I|Protocol Deviation|0|||
144692818|NCT01632345|521727464|FG006|Treatment: Part I|Protocol Deviation|0|||
144692819|NCT01632345|521727458|FG000|Treatment: Part I|Withdrawal by Subject|3|||
144692820|NCT01632345|521727459|FG001|Treatment: Part I|Withdrawal by Subject|4|||
144692821|NCT01632345|521727460|FG002|Treatment: Part I|Withdrawal by Subject|4|||
144692822|NCT01632345|521727461|FG003|Treatment: Part I|Withdrawal by Subject|1|||
144692823|NCT01632345|521727462|FG004|Treatment: Part I|Withdrawal by Subject|4|||
144692824|NCT01632345|521727463|FG005|Treatment: Part I|Withdrawal by Subject|0|||
144692825|NCT01632345|521727464|FG006|Treatment: Part I|Withdrawal by Subject|0|||
144692826|NCT01632345|521727458|FG000|Treatment: Part II|Adverse Event|0|||
144692827|NCT01632345|521727459|FG001|Treatment: Part II|Adverse Event|0|||
144692828|NCT01632345|521727460|FG002|Treatment: Part II|Adverse Event|0|||
144692829|NCT01632345|521727461|FG003|Treatment: Part II|Adverse Event|0|||
144692830|NCT01632345|521727462|FG004|Treatment: Part II|Adverse Event|0|||
144692831|NCT01632345|521727463|FG005|Treatment: Part II|Adverse Event|3|||
144692832|NCT01632345|521727464|FG006|Treatment: Part II|Adverse Event|8|||
144692833|NCT01632345|521727458|FG000|Treatment: Part II|Lost to Follow-up|0|||
144692834|NCT01632345|521727459|FG001|Treatment: Part II|Lost to Follow-up|0|||
144742539|NCT00112437|521908534|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742540|NCT00112437|521908535|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742541|NCT00112437|521908536|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742542|NCT00112437|521908537|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742543|NCT00112437|521908538|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742544|NCT00112437|521908539|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742545|NCT00112437|521908540|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742546|NCT00112437|521908541|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742547|NCT00112437|521908542|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742548|NCT00112437|521908543|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742549|NCT00112437|521908544|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742550|NCT00112437|521908545|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742551|NCT00112437|521908546|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742552|NCT00112437|521908547|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742553|NCT00112437|521908548|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742554|NCT00112437|521908549|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742555|NCT00112437|521908550|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
144742556|NCT00112437|521908551|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
144742557|NCT00112437|521908552|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
144742558|NCT00112437|521908553|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
144742559|NCT03500094|521908558|FG000|Overall Study|Withdrawal by Subject|1|||
144742560|NCT03500094|521908558|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
144742561|NCT03500094|521908558|FG000|Overall Study|Lost to Follow-up|1|||
144742562|NCT00640341|521910296|FG000|Overall Study|Adverse Event|0|||
144742563|NCT00640341|521910297|FG001|Overall Study|Adverse Event|0|||
144742564|NCT00640341|521910298|FG002|Overall Study|Adverse Event|1|||
144742565|NCT00640341|521910296|FG000|Overall Study|Positive Slit Lamp Findings|0|||
144742566|NCT00640341|521910297|FG001|Overall Study|Positive Slit Lamp Findings|0|||
144742567|NCT00640341|521910298|FG002|Overall Study|Positive Slit Lamp Findings|1|||
144742568|NCT00640341|521910296|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
144742569|NCT00640341|521910297|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
144742570|NCT00640341|521910298|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
144742571|NCT00640341|521910296|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
144742572|NCT00640341|521910297|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
144742573|NCT00640341|521910298|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
144742574|NCT00640341|521910296|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
144742575|NCT00640341|521910297|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
144742576|NCT00640341|521910298|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
144742577|NCT00640341|521910296|FG000|Overall Study|Lost to Follow-up|2|||
144742578|NCT00640341|521910297|FG001|Overall Study|Lost to Follow-up|0|||
144742579|NCT00640341|521910298|FG002|Overall Study|Lost to Follow-up|0|||
144742580|NCT00640341|521910296|FG000|Overall Study|Withdrawal by Subject|4|||
144742581|NCT00640341|521910297|FG001|Overall Study|Withdrawal by Subject|0|||
144742582|NCT00640341|521910298|FG002|Overall Study|Withdrawal by Subject|1|||
144742583|NCT00640341|521910296|FG000|Overall Study|Unacceptable Lens Movement|1|||
144742584|NCT00640341|521910297|FG001|Overall Study|Unacceptable Lens Movement|0|||
144742585|NCT00640341|521910298|FG002|Overall Study|Unacceptable Lens Movement|0|||
144742586|NCT00640341|521910296|FG000|Overall Study|Poor fit/Uncomfortable|4|||
144742587|NCT00640341|521910297|FG001|Overall Study|Poor fit/Uncomfortable|0|||
144742588|NCT00640341|521910298|FG002|Overall Study|Poor fit/Uncomfortable|0|||
144742589|NCT00640341|521910296|FG000|Overall Study|Ineligable at Baseline|5|||
144742590|NCT00640341|521910297|FG001|Overall Study|Ineligable at Baseline|3|||
144742591|NCT00640341|521910298|FG002|Overall Study|Ineligable at Baseline|2|||
144742592|NCT00640341|521910296|FG000|Overall Study|Adverse event and positive slit lamp|1|||
144742593|NCT00640341|521910297|FG001|Overall Study|Adverse event and positive slit lamp|0|||
144742594|NCT00640341|521910298|FG002|Overall Study|Adverse event and positive slit lamp|0|||
144742595|NCT00557245|521910302|FG000|Overall Study|Lost to Follow-up|7|||
144742596|NCT00557245|521910303|FG001|Overall Study|Lost to Follow-up|8|||
144742597|NCT00557245|521910304|FG002|Overall Study|Lost to Follow-up|10|||
144742598|NCT00557245|521910302|FG000|Overall Study|Ineligible|5|||
144219934|NCT02721732|520000288|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144742599|NCT00557245|521910303|FG001|Overall Study|Ineligible|4|||
144742600|NCT00557245|521910304|FG002|Overall Study|Ineligible|2|||
144742601|NCT02316223|521910308|FG000|Overall Study|Lack of Efficacy|0|||
144742602|NCT02316223|521910309|FG001|Overall Study|Lack of Efficacy|1|||
144742603|NCT02316223|521910310|FG002|Overall Study|Lack of Efficacy|1|||
144742604|NCT02316223|521910308|FG000|Overall Study|Lost to Follow-up|27|||
144742605|NCT02316223|521910309|FG001|Overall Study|Lost to Follow-up|34|||
144742606|NCT02316223|521910310|FG002|Overall Study|Lost to Follow-up|36|||
144742607|NCT02316223|521910308|FG000|Overall Study|COPD Diagnosis|3|||
144742608|NCT02316223|521910309|FG001|Overall Study|COPD Diagnosis|2|||
144742609|NCT02316223|521910310|FG002|Overall Study|COPD Diagnosis|3|||
144742610|NCT02316223|521910308|FG000|Overall Study|Reside outside study area|1|||
144742611|NCT02316223|521910309|FG001|Overall Study|Reside outside study area|1|||
144742612|NCT02316223|521910310|FG002|Overall Study|Reside outside study area|1|||
144742613|NCT02316223|521910308|FG000|Overall Study|No asthma|2|||
144742614|NCT02316223|521910309|FG001|Overall Study|No asthma|0|||
144742615|NCT02316223|521910310|FG002|Overall Study|No asthma|0|||
144742616|NCT02316223|521910308|FG000|Overall Study|Discontinued by PI|11|||
144742617|NCT02316223|521910309|FG001|Overall Study|Discontinued by PI|19|||
144742618|NCT02316223|521910310|FG002|Overall Study|Discontinued by PI|3|||
144742619|NCT03669250|521910312|FG000|Overall Study|Adverse Event|0|||
144742620|NCT03669250|521910313|FG001|Overall Study|Adverse Event|0|||
144742621|NCT03669250|521910314|FG002|Overall Study|Adverse Event|0|||
144742622|NCT03669250|521910315|FG003|Overall Study|Adverse Event|0|||
144742623|NCT03669250|521910316|FG004|Overall Study|Adverse Event|1|||
144742624|NCT03669250|521910317|FG005|Overall Study|Adverse Event|0|||
144742625|NCT03669250|521910312|FG000|Overall Study|Withdrawal by Subject|0|||
144742626|NCT03669250|521910313|FG001|Overall Study|Withdrawal by Subject|1|||
144742627|NCT03669250|521910314|FG002|Overall Study|Withdrawal by Subject|0|||
144742628|NCT03669250|521910315|FG003|Overall Study|Withdrawal by Subject|1|||
144742629|NCT03669250|521910316|FG004|Overall Study|Withdrawal by Subject|0|||
144742630|NCT03669250|521910317|FG005|Overall Study|Withdrawal by Subject|0|||
144742631|NCT04102345|521910318|FG000|Overall Study|Withdrawal by Subject|1|||
144742632|NCT04102345|521910319|FG001|Overall Study|Withdrawal by Subject|0|||
144742633|NCT00385736|521910322|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
144742634|NCT00385736|521910323|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
144742635|NCT00385736|521910324|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
144742636|NCT00385736|521910322|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
144742637|NCT00385736|521910323|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
144742638|NCT00385736|521910324|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
144742639|NCT00385736|521910322|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
144742640|NCT00385736|521910323|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
144742641|NCT00385736|521910324|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
144742642|NCT00385736|521910322|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
144742643|NCT00385736|521910323|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
144742644|NCT00385736|521910324|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
144742645|NCT00385736|521910322|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
144742646|NCT00385736|521910323|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
144742647|NCT00385736|521910324|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
144742648|NCT00385736|521910322|FG000|Efficacy Analysis Set - Induction|Other|0|||
144742649|NCT00385736|521910323|FG001|Efficacy Analysis Set - Induction|Other|0|||
144742650|NCT00385736|521910324|FG002|Efficacy Analysis Set - Induction|Other|1|||
144742651|NCT00385736|521910322|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
144742652|NCT00385736|521910323|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
144742653|NCT00385736|521910324|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
144742654|NCT00385736|521910322|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
144742655|NCT00385736|521910323|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
144742656|NCT00385736|521910324|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
144742657|NCT00385736|521910322|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
144742658|NCT00385736|521910323|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
144742659|NCT00385736|521910324|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
144742660|NCT00385736|521910322|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
144742661|NCT00385736|521910323|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
144742662|NCT00385736|521910324|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
144742663|NCT00385736|521910322|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
144742664|NCT00385736|521910323|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
144742665|NCT00385736|521910324|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
144742666|NCT00385736|521910322|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
144742667|NCT00385736|521910323|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
144742668|NCT00385736|521910324|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
144742669|NCT00385736|521910322|FG000|Safety Analysis Set|Adverse Event|23|||
144742670|NCT00385736|521910323|FG001|Safety Analysis Set|Adverse Event|15|||
144742671|NCT00385736|521910324|FG002|Safety Analysis Set|Adverse Event|23|||
144742672|NCT00385736|521910322|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
144742673|NCT00385736|521910323|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
144742674|NCT00385736|521910324|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
144742675|NCT00385736|521910322|FG000|Safety Analysis Set|Lost to Follow-up|0|||
144742676|NCT00385736|521910323|FG001|Safety Analysis Set|Lost to Follow-up|2|||
144742677|NCT00385736|521910324|FG002|Safety Analysis Set|Lost to Follow-up|2|||
144742678|NCT00385736|521910322|FG000|Safety Analysis Set|Lack of Efficacy|38|||
144742679|NCT00385736|521910323|FG001|Safety Analysis Set|Lack of Efficacy|16|||
144742680|NCT00385736|521910324|FG002|Safety Analysis Set|Lack of Efficacy|31|||
144742681|NCT00385736|521910322|FG000|Safety Analysis Set|Protocol Violation|2|||
144742682|NCT00385736|521910323|FG001|Safety Analysis Set|Protocol Violation|1|||
144742683|NCT00385736|521910324|FG002|Safety Analysis Set|Protocol Violation|6|||
144742684|NCT00385736|521910322|FG000|Safety Analysis Set|Other|1|||
144742685|NCT00385736|521910323|FG001|Safety Analysis Set|Other|4|||
144742686|NCT00385736|521910324|FG002|Safety Analysis Set|Other|4|||
144742687|NCT01380782|521910325|FG000|Overall Study|Adverse Event|0|||
144742688|NCT01380782|521910326|FG001|Overall Study|Adverse Event|1|||
144742689|NCT01380782|521910327|FG002|Overall Study|Adverse Event|0|||
144742690|NCT01380782|521910328|FG003|Overall Study|Adverse Event|0|||
144742691|NCT01380782|521910325|FG000|Overall Study|Death|1|||
144742692|NCT01380782|521910326|FG001|Overall Study|Death|0|||
144742693|NCT01380782|521910327|FG002|Overall Study|Death|0|||
144742694|NCT01380782|521910328|FG003|Overall Study|Death|0|||
144742695|NCT01380782|521910325|FG000|Overall Study|Lack of Efficacy|10|||
144742696|NCT01380782|521910326|FG001|Overall Study|Lack of Efficacy|9|||
144742697|NCT01380782|521910327|FG002|Overall Study|Lack of Efficacy|10|||
144742698|NCT01380782|521910328|FG003|Overall Study|Lack of Efficacy|3|||
144742699|NCT01380782|521910325|FG000|Overall Study|Physician Decision|1|||
144742700|NCT01380782|521910326|FG001|Overall Study|Physician Decision|0|||
144742701|NCT01380782|521910327|FG002|Overall Study|Physician Decision|0|||
144742702|NCT01380782|521910328|FG003|Overall Study|Physician Decision|0|||
144742703|NCT01380782|521910325|FG000|Overall Study|Withdrawal by Subject|0|||
144742704|NCT01380782|521910326|FG001|Overall Study|Withdrawal by Subject|0|||
144742705|NCT01380782|521910327|FG002|Overall Study|Withdrawal by Subject|1|||
144742706|NCT01380782|521910328|FG003|Overall Study|Withdrawal by Subject|1|||
144742707|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
144742708|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
144742709|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
144742710|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
144742711|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
144742712|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
144742713|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
144742714|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
144742715|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
144742716|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
144742717|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
144219935|NCT02721732|520000289|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144219936|NCT02721732|520000290|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
144692835|NCT01632345|521727460|FG002|Treatment: Part II|Lost to Follow-up|0|||
144692836|NCT01632345|521727461|FG003|Treatment: Part II|Lost to Follow-up|0|||
144692837|NCT01632345|521727462|FG004|Treatment: Part II|Lost to Follow-up|0|||
144692838|NCT01632345|521727463|FG005|Treatment: Part II|Lost to Follow-up|3|||
144692839|NCT01632345|521727464|FG006|Treatment: Part II|Lost to Follow-up|1|||
144692840|NCT01632345|521727458|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
144692841|NCT01632345|521727459|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
144692842|NCT01632345|521727460|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
144692843|NCT01632345|521727461|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
144692844|NCT01632345|521727462|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
144692845|NCT01632345|521727463|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
144692846|NCT01632345|521727464|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
144692847|NCT01632345|521727458|FG000|Treatment: Part II|Withdrawal by Subject|0|||
144692848|NCT01632345|521727459|FG001|Treatment: Part II|Withdrawal by Subject|0|||
144692849|NCT01632345|521727460|FG002|Treatment: Part II|Withdrawal by Subject|0|||
144692850|NCT01632345|521727461|FG003|Treatment: Part II|Withdrawal by Subject|0|||
144692851|NCT01632345|521727462|FG004|Treatment: Part II|Withdrawal by Subject|0|||
144692852|NCT01632345|521727463|FG005|Treatment: Part II|Withdrawal by Subject|2|||
144692853|NCT01632345|521727464|FG006|Treatment: Part II|Withdrawal by Subject|2|||
144692854|NCT01724021|521727465|FG000|Overall Study|Adverse Event|11|||
144692855|NCT01724021|521727466|FG001|Overall Study|Adverse Event|6|||
144692856|NCT01724021|521727465|FG000|Overall Study|Death|46|||
144692857|NCT01724021|521727466|FG001|Overall Study|Death|58|||
144692858|NCT01724021|521727465|FG000|Overall Study|Participant request/ Withdrew consent|18|||
144692859|NCT01724021|521727466|FG001|Overall Study|Participant request/ Withdrew consent|14|||
144692860|NCT01724021|521727465|FG000|Overall Study|Lost to Follow-up|15|||
144692861|NCT01724021|521727466|FG001|Overall Study|Lost to Follow-up|15|||
144692862|NCT01724021|521727465|FG000|Overall Study|Reason Not Specified|36|||
144692863|NCT01724021|521727466|FG001|Overall Study|Reason Not Specified|39|||
144692864|NCT01724021|521727465|FG000|Overall Study|Missing|1|||
144692865|NCT01724021|521727466|FG001|Overall Study|Missing|1|||
144692866|NCT02543918|521727467|FG000|Overall Study|Never treated|0|||
144692867|NCT02543918|521727468|FG001|Overall Study|Never treated|1|||
144692868|NCT02543918|521727467|FG000|Overall Study|Lost to Follow-up|1|||
144742718|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
144742719|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
144742720|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
144742721|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
144742722|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
144742723|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
144742724|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
144742725|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
144742726|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
144742727|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
144742728|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
144742729|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
144742730|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
144742731|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
144742732|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
144742733|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
144742734|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
144742735|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
144742736|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
144742737|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
144742738|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
144742739|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
144742740|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
144742741|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
144742742|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
144742743|NCT04194801|521910329|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
144742744|NCT04194801|521910330|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
144742745|NCT04194801|521910331|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
144742746|NCT04194801|521910329|FG000|Part Ib/II End of Study|Death|2|||
144742747|NCT04194801|521910330|FG001|Part Ib/II End of Study|Death|3|||
144742748|NCT04194801|521910331|FG002|Part Ib/II End of Study|Death|3|||
144742749|NCT04194801|521910329|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
144742750|NCT04194801|521910330|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
144742751|NCT04194801|521910331|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
144742752|NCT04194801|521910329|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
144742753|NCT04194801|521910330|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
144742754|NCT04194801|521910331|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
144742755|NCT04194801|521910329|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
144742756|NCT04194801|521910330|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
144742757|NCT04194801|521910331|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
144742758|NCT04194801|521910329|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
144742759|NCT04194801|521910330|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
144742760|NCT04194801|521910331|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
144742761|NCT03827395|521910332|FG000|Overall Study|Lost to Follow-up|1|||
144742762|NCT03827395|521910333|FG001|Overall Study|Lost to Follow-up|0|||
144742763|NCT03827395|521910332|FG000|Overall Study|Protocol Violation|1|||
144742764|NCT03827395|521910333|FG001|Overall Study|Protocol Violation|0|||
144742765|NCT03827395|521910332|FG000|Overall Study|Became ineligible after enrollment|1|||
144742766|NCT03827395|521910333|FG001|Overall Study|Became ineligible after enrollment|2|||
144742767|NCT04723693|521910334|FG000|Overall Study|Withdrawal by Subject|2|||
144742768|NCT00294047|521910335|FG000|Month 48|Adverse Event|28|||
144742769|NCT00294047|521910336|FG001|Month 48|Adverse Event|13|||
144742770|NCT00294047|521910335|FG000|Month 48|Protocol Violation|4|||
144742771|NCT00294047|521910336|FG001|Month 48|Protocol Violation|4|||
144742772|NCT00294047|521910335|FG000|Month 48|Withdrawal by Subject|111|||
144742773|NCT00294047|521910336|FG001|Month 48|Withdrawal by Subject|115|||
144742774|NCT00294047|521910335|FG000|Month 48|Lost to Follow-up|272|||
144742775|NCT00294047|521910336|FG001|Month 48|Lost to Follow-up|287|||
144742776|NCT00294047|521910335|FG000|Month 48|Other|10|||
144742777|NCT00294047|521910336|FG001|Month 48|Other|14|||
144742778|NCT00294047|521910335|FG000|Month 84|Adverse Event|4|||
144742779|NCT00294047|521910336|FG001|Month 84|Adverse Event|2|||
144742780|NCT00294047|521910335|FG000|Month 84|Protocol Violation|1|||
144742781|NCT00294047|521910336|FG001|Month 84|Protocol Violation|1|||
144742782|NCT00294047|521910335|FG000|Month 84|Withdrawal by Subject|33|||
144742783|NCT00294047|521910336|FG001|Month 84|Withdrawal by Subject|31|||
144742784|NCT00294047|521910335|FG000|Month 84|Lost to Follow-up|187|||
144742785|NCT00294047|521910336|FG001|Month 84|Lost to Follow-up|190|||
144742786|NCT00294047|521910335|FG000|Month 84|Absent Cervix|2|||
144742787|NCT00294047|521910336|FG001|Month 84|Absent Cervix|0|||
144742788|NCT00294047|521910335|FG000|Month 84|Work related reasons|4|||
144742789|NCT00294047|521910336|FG001|Month 84|Work related reasons|2|||
144742790|NCT00294047|521910335|FG000|Month 84|Center closed, subject did not transfer|1|||
144742791|NCT00294047|521910336|FG001|Month 84|Center closed, subject did not transfer|0|||
144742792|NCT00294047|521910335|FG000|Month 84|Family problems|2|||
144219937|NCT02721732|520000281|FG000|Overall Study|Progression and withdrew consent|1|||
144219938|NCT02721732|520000282|FG001|Overall Study|Progression and withdrew consent|1|||
144219939|NCT02721732|520000283|FG002|Overall Study|Progression and withdrew consent|0|||
144219940|NCT02721732|520000284|FG003|Overall Study|Progression and withdrew consent|0|||
144219941|NCT02721732|520000285|FG004|Overall Study|Progression and withdrew consent|0|||
144692869|NCT02543918|521727468|FG001|Overall Study|Lost to Follow-up|1|||
144692870|NCT02543918|521727467|FG000|Overall Study|Withdrawal by Subject|1|||
144692871|NCT02543918|521727468|FG001|Overall Study|Withdrawal by Subject|1|||
144692872|NCT02543918|521727467|FG000|Overall Study|Adverse Event|1|||
144692873|NCT02543918|521727468|FG001|Overall Study|Adverse Event|1|||
144692874|NCT02452892|521727469|FG000|Week 1 Initial Randommization|Adverse Event|1|||
144692875|NCT02452892|521727470|FG001|Week 1 Initial Randommization|Adverse Event|0|||
144692876|NCT02452892|521727471|FG002|Week 1 Initial Randommization|Adverse Event|0|||
144692877|NCT02452892|521727472|FG003|Week 1 Initial Randommization|Adverse Event|0|||
144692878|NCT02452892|521727469|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
144692879|NCT02452892|521727470|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
144692880|NCT02452892|521727471|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
144692881|NCT02452892|521727472|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
144692882|NCT02452892|521727469|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
144692883|NCT02452892|521727470|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
144692884|NCT02452892|521727471|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
144692885|NCT02452892|521727472|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
144692886|NCT02452892|521727469|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
144692887|NCT02452892|521727470|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
144692888|NCT02452892|521727471|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
144692889|NCT02452892|521727472|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
144692890|NCT02452892|521727469|FG000|Follow-up|Withdrawal by Subject|0|||
144692891|NCT02452892|521727470|FG001|Follow-up|Withdrawal by Subject|0|||
144692892|NCT02452892|521727471|FG002|Follow-up|Withdrawal by Subject|0|||
144692893|NCT02452892|521727472|FG003|Follow-up|Withdrawal by Subject|1|||
144692894|NCT02452892|521727469|FG000|Follow-up|Subject left town on Day 42|1|||
144692895|NCT02452892|521727470|FG001|Follow-up|Subject left town on Day 42|0|||
144692896|NCT02452892|521727471|FG002|Follow-up|Subject left town on Day 42|0|||
144692897|NCT02452892|521727472|FG003|Follow-up|Subject left town on Day 42|0|||
144692898|NCT00545740|521727474|FG000|Overall Study|Lack of Efficacy|34|||
144692899|NCT00545740|521727475|FG001|Overall Study|Lack of Efficacy|35|||
144692900|NCT00545740|521727476|FG002|Overall Study|Lack of Efficacy|47|||
144692901|NCT00545740|521727477|FG003|Overall Study|Lack of Efficacy|36|||
144692902|NCT00545740|521727474|FG000|Overall Study|Withdrawal by Subject|17|||
144692903|NCT00545740|521727475|FG001|Overall Study|Withdrawal by Subject|15|||
144692904|NCT00545740|521727476|FG002|Overall Study|Withdrawal by Subject|16|||
144692905|NCT00545740|521727477|FG003|Overall Study|Withdrawal by Subject|18|||
144692906|NCT00545740|521727474|FG000|Overall Study|Adverse Event|10|||
144692907|NCT00545740|521727475|FG001|Overall Study|Adverse Event|18|||
144692908|NCT00545740|521727476|FG002|Overall Study|Adverse Event|19|||
144692909|NCT00545740|521727477|FG003|Overall Study|Adverse Event|9|||
144692910|NCT00545740|521727474|FG000|Overall Study|Lost to Follow-up|7|||
144692911|NCT00545740|521727475|FG001|Overall Study|Lost to Follow-up|5|||
144692912|NCT00545740|521727476|FG002|Overall Study|Lost to Follow-up|5|||
144692913|NCT00545740|521727477|FG003|Overall Study|Lost to Follow-up|6|||
144692914|NCT00545740|521727474|FG000|Overall Study|Protocol Violation|1|||
144692915|NCT00545740|521727475|FG001|Overall Study|Protocol Violation|3|||
144692916|NCT00545740|521727476|FG002|Overall Study|Protocol Violation|1|||
144692917|NCT00545740|521727477|FG003|Overall Study|Protocol Violation|0|||
144692918|NCT00545740|521727474|FG000|Overall Study|Non-compliance|0|||
144692919|NCT00545740|521727475|FG001|Overall Study|Non-compliance|2|||
144692920|NCT00545740|521727476|FG002|Overall Study|Non-compliance|1|||
144692921|NCT00545740|521727477|FG003|Overall Study|Non-compliance|0|||
144692922|NCT00545740|521727474|FG000|Overall Study|Moved|2|||
144692923|NCT00545740|521727475|FG001|Overall Study|Moved|0|||
144692924|NCT00545740|521727476|FG002|Overall Study|Moved|1|||
144692925|NCT00545740|521727477|FG003|Overall Study|Moved|0|||
144692926|NCT00545740|521727474|FG000|Overall Study|Diverticulitis attack|0|||
144692927|NCT00545740|521727475|FG001|Overall Study|Diverticulitis attack|0|||
144692928|NCT00545740|521727476|FG002|Overall Study|Diverticulitis attack|1|||
144692929|NCT00545740|521727477|FG003|Overall Study|Diverticulitis attack|1|||
144692930|NCT00545740|521727474|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
144692931|NCT00545740|521727475|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
144692932|NCT00545740|521727476|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
144692933|NCT00545740|521727477|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
144692934|NCT00545740|521727474|FG000|Overall Study|Site closure|1|||
144692935|NCT00545740|521727475|FG001|Overall Study|Site closure|0|||
144692936|NCT00545740|521727476|FG002|Overall Study|Site closure|0|||
144692937|NCT00545740|521727477|FG003|Overall Study|Site closure|0|||
144219942|NCT02721732|520000286|FG005|Overall Study|Progression and withdrew consent|0|||
144219943|NCT02721732|520000287|FG006|Overall Study|Progression and withdrew consent|0|||
144219944|NCT02721732|520000288|FG007|Overall Study|Progression and withdrew consent|0|||
144219945|NCT02721732|520000289|FG008|Overall Study|Progression and withdrew consent|0|||
144219946|NCT02721732|520000290|FG009|Overall Study|Progression and withdrew consent|1|||
144219947|NCT02721732|520000281|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
144219948|NCT02721732|520000282|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
144219949|NCT02721732|520000283|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
144219950|NCT02721732|520000284|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
144219951|NCT02721732|520000285|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
144219952|NCT02721732|520000286|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
144266173|NCT01747499|520176532|FG002|Overall Study|Determined not to be eligible|0|||
144692938|NCT00545740|521727474|FG000|Overall Study|Missed visit|1|||
144692939|NCT00545740|521727475|FG001|Overall Study|Missed visit|0|||
144692940|NCT00545740|521727476|FG002|Overall Study|Missed visit|0|||
144692941|NCT00545740|521727477|FG003|Overall Study|Missed visit|0|||
144692942|NCT00545740|521727474|FG000|Overall Study|Physician Decision|0|||
144692943|NCT00545740|521727475|FG001|Overall Study|Physician Decision|0|||
144692944|NCT00545740|521727476|FG002|Overall Study|Physician Decision|3|||
144692945|NCT00545740|521727477|FG003|Overall Study|Physician Decision|0|||
144692946|NCT00545740|521727474|FG000|Overall Study|Accepted only monthly telephone calls|1|||
144692947|NCT00545740|521727475|FG001|Overall Study|Accepted only monthly telephone calls|0|||
144692948|NCT00545740|521727476|FG002|Overall Study|Accepted only monthly telephone calls|0|||
144692949|NCT00545740|521727477|FG003|Overall Study|Accepted only monthly telephone calls|0|||
144692950|NCT00545740|521727474|FG000|Overall Study|Sponsor decision|0|||
144692951|NCT00545740|521727475|FG001|Overall Study|Sponsor decision|1|||
144692952|NCT00545740|521727476|FG002|Overall Study|Sponsor decision|0|||
144692953|NCT00545740|521727477|FG003|Overall Study|Sponsor decision|0|||
144692954|NCT00545740|521727474|FG000|Overall Study|Lack of time|0|||
144692955|NCT00545740|521727475|FG001|Overall Study|Lack of time|1|||
144692956|NCT00545740|521727476|FG002|Overall Study|Lack of time|0|||
144692957|NCT00545740|521727477|FG003|Overall Study|Lack of time|0|||
144692958|NCT00545740|521727474|FG000|Overall Study|Non-adherence to visits|0|||
144692959|NCT00545740|521727475|FG001|Overall Study|Non-adherence to visits|1|||
144692960|NCT00545740|521727476|FG002|Overall Study|Non-adherence to visits|0|||
144692961|NCT00545740|521727477|FG003|Overall Study|Non-adherence to visits|0|||
144692962|NCT00545740|521727474|FG000|Overall Study|Patient difficulties|0|||
144692963|NCT00545740|521727475|FG001|Overall Study|Patient difficulties|1|||
144692964|NCT00545740|521727476|FG002|Overall Study|Patient difficulties|0|||
144692965|NCT00545740|521727477|FG003|Overall Study|Patient difficulties|0|||
144692966|NCT00545740|521727474|FG000|Overall Study|Husband against study|0|||
144692967|NCT00545740|521727475|FG001|Overall Study|Husband against study|0|||
144692968|NCT00545740|521727476|FG002|Overall Study|Husband against study|1|||
144692969|NCT00545740|521727477|FG003|Overall Study|Husband against study|0|||
144692970|NCT02117024|521727478|FG000|Overall Study|Progressive Disease|26|||
144692971|NCT02117024|521727479|FG001|Overall Study|Progressive Disease|9|||
144692972|NCT02117024|521727478|FG000|Overall Study|Significant Clinical Progression|7|||
144692973|NCT02117024|521727479|FG001|Overall Study|Significant Clinical Progression|4|||
144692974|NCT02117024|521727478|FG000|Overall Study|Death|5|||
144692975|NCT02117024|521727479|FG001|Overall Study|Death|0|||
144692976|NCT02117024|521727478|FG000|Overall Study|Withdrawal by Subject|3|||
144692977|NCT02117024|521727479|FG001|Overall Study|Withdrawal by Subject|1|||
144692978|NCT02117024|521727478|FG000|Overall Study|Protocol Violation|1|||
144692979|NCT02117024|521727479|FG001|Overall Study|Protocol Violation|0|||
144692980|NCT02117024|521727478|FG000|Overall Study|Adverse Event|1|||
144692981|NCT02117024|521727479|FG001|Overall Study|Adverse Event|2|||
144692982|NCT02117024|521727478|FG000|Overall Study|Randomized in Error|1|||
144692983|NCT02117024|521727479|FG001|Overall Study|Randomized in Error|0|||
144692984|NCT02117024|521727478|FG000|Overall Study|Patient returned to primary oncologist|0|||
144692985|NCT02117024|521727479|FG001|Overall Study|Patient returned to primary oncologist|1|||
144692986|NCT02117024|521727478|FG000|Overall Study|Patient took treatment break|0|||
144692987|NCT02117024|521727479|FG001|Overall Study|Patient took treatment break|1|||
144692988|NCT02117024|521727478|FG000|Overall Study|Physician Decision|0|||
144692989|NCT02117024|521727479|FG001|Overall Study|Physician Decision|2|||
144692990|NCT02813681|521727480|FG000|Overall Study|Physician Decision|5|||
144692991|NCT02813681|521727481|FG001|Overall Study|Physician Decision|5|||
144692992|NCT02813681|521727482|FG002|Overall Study|Physician Decision|0|||
144692993|NCT02813681|521727480|FG000|Overall Study|Lost to Follow-up|0|||
144692994|NCT02813681|521727481|FG001|Overall Study|Lost to Follow-up|1|||
144692995|NCT02813681|521727482|FG002|Overall Study|Lost to Follow-up|0|||
144692996|NCT01874288|521727485|FG000|Overall Study|Withdrawal by Subject|1|||
144692997|NCT01874288|521727486|FG001|Overall Study|Withdrawal by Subject|0|||
144692998|NCT01874288|521727487|FG002|Overall Study|Withdrawal by Subject|2|||
144692999|NCT01874288|521727488|FG003|Overall Study|Withdrawal by Subject|1|||
144742793|NCT00294047|521910336|FG001|Month 84|Family problems|2|||
144742794|NCT00294047|521910335|FG000|Month 84|Lack of time|3|||
144742795|NCT00294047|521910336|FG001|Month 84|Lack of time|1|||
144742796|NCT00294047|521910335|FG000|Month 84|Personal reason|2|||
144742797|NCT00294047|521910336|FG001|Month 84|Personal reason|4|||
144742798|NCT00294047|521910335|FG000|Month 84|Subject does not want male physician|1|||
144742799|NCT00294047|521910336|FG001|Month 84|Subject does not want male physician|0|||
144742800|NCT00294047|521910335|FG000|Month 84|Transport reimbursement delayed|0|||
144742801|NCT00294047|521910336|FG001|Month 84|Transport reimbursement delayed|1|||
144742802|NCT00294047|521910335|FG000|Month 84|Unable to reach study site|1|||
144742803|NCT00294047|521910336|FG001|Month 84|Unable to reach study site|0|||
144742804|NCT00294047|521910335|FG000|Month 84|Under investigation locally|1|||
144742805|NCT00294047|521910336|FG001|Month 84|Under investigation locally|0|||
144219953|NCT02721732|520000287|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
144219954|NCT02721732|520000288|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
144219955|NCT02721732|520000289|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
144219956|NCT02721732|520000290|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
144219957|NCT01962103|520000294|FG000|Phase 1|Adverse Event|4|||
144219958|NCT01962103|520000295|FG001|Phase 1|Adverse Event|0|||
144742806|NCT00294047|521910335|FG000|Month 84|Visit missed|0|||
144742807|NCT00294047|521910336|FG001|Month 84|Visit missed|1|||
144742808|NCT00294047|521910335|FG000|Month 84|No consent for Month 84 Follow-up|731|||
144742809|NCT00294047|521910336|FG001|Month 84|No consent for Month 84 Follow-up|754|||
144742810|NCT02157974|521910337|FG000|Overall Study|Withdrawal by Subject|0|||
144742811|NCT02157974|521910338|FG001|Overall Study|Withdrawal by Subject|1|||
144742812|NCT02157974|521910339|FG002|Overall Study|Withdrawal by Subject|0|||
144742813|NCT02157974|521910340|FG003|Overall Study|Withdrawal by Subject|0|||
144742814|NCT02157974|521910341|FG004|Overall Study|Withdrawal by Subject|0|||
144742815|NCT02157974|521910337|FG000|Overall Study|Screen Failure|0|||
144742816|NCT02157974|521910338|FG001|Overall Study|Screen Failure|1|||
144742817|NCT02157974|521910339|FG002|Overall Study|Screen Failure|0|||
144742818|NCT02157974|521910340|FG003|Overall Study|Screen Failure|0|||
144742819|NCT02157974|521910341|FG004|Overall Study|Screen Failure|0|||
144742820|NCT02157974|521910337|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
144742821|NCT02157974|521910338|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
144742822|NCT02157974|521910339|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
144742823|NCT02157974|521910340|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
144742824|NCT02157974|521910341|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
144742825|NCT00506831|521910344|FG000|Overall Study|Death|1|||
144742826|NCT00506831|521910344|FG000|Overall Study|Withdrawal by Subject|1|||
144742827|NCT01410227|521910348|FG000|Overall Study|Adverse Event|1|||
144742828|NCT01410227|521910349|FG001|Overall Study|Adverse Event|0|||
144742829|NCT01410227|521910350|FG002|Overall Study|Adverse Event|0|||
144742830|NCT01410227|521910351|FG003|Overall Study|Adverse Event|0|||
144742831|NCT01410227|521910348|FG000|Overall Study|Withdrawal by Subject|3|||
144742832|NCT01410227|521910349|FG001|Overall Study|Withdrawal by Subject|0|||
144742833|NCT01410227|521910350|FG002|Overall Study|Withdrawal by Subject|1|||
144742834|NCT01410227|521910351|FG003|Overall Study|Withdrawal by Subject|0|||
144742835|NCT01410227|521910348|FG000|Overall Study|Pregnancy|0|||
144742836|NCT01410227|521910349|FG001|Overall Study|Pregnancy|0|||
144742837|NCT01410227|521910350|FG002|Overall Study|Pregnancy|0|||
144742838|NCT01410227|521910351|FG003|Overall Study|Pregnancy|1|||
144742839|NCT01410227|521910348|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
144742840|NCT01410227|521910349|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
144742841|NCT01410227|521910350|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
144742842|NCT01410227|521910351|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
144742843|NCT00585286|521910353|FG000|Overall Study|Lost to Follow-up|1|||
144742844|NCT00608322|521910355|FG000|Overall Study|Death|2|||
144742845|NCT00608322|521910356|FG001|Overall Study|Death|1|||
144266174|NCT01747499|520176533|FG003|Overall Study|Determined not to be eligible|0|||
144742846|NCT03497130|521910357|FG000|Overall Study|Lost to Follow-up|1|||
144742847|NCT03497130|521910358|FG001|Overall Study|Lost to Follow-up|1|||
144742848|NCT04002648|521910359|FG000|Overall Study|Lost to Follow-up|2|||
144742849|NCT04002648|521910360|FG001|Overall Study|Lost to Follow-up|0|||
144742850|NCT03325881|521910364|FG000|Overall Study|Protocol Violation|0|||
144742851|NCT03325881|521910365|FG001|Overall Study|Protocol Violation|1|||
144742852|NCT03325881|521910364|FG000|Overall Study|Withdrawal by Subject|0|||
144742853|NCT03325881|521910365|FG001|Overall Study|Withdrawal by Subject|2|||
144742854|NCT03325881|521910364|FG000|Overall Study|Lack of Efficacy|2|||
144219959|NCT01962103|520000296|FG002|Phase 1|Adverse Event|2|||
144219960|NCT01962103|520000297|FG003|Phase 1|Adverse Event|1|||
144219961|NCT01962103|520000298|FG004|Phase 1|Adverse Event|2|||
144742855|NCT03325881|521910365|FG001|Overall Study|Lack of Efficacy|0|||
144742856|NCT03325881|521910364|FG000|Overall Study|Not treated|1|||
144742857|NCT03325881|521910365|FG001|Overall Study|Not treated|0|||
144742858|NCT03676634|521910367|FG000|Overall Study|Red blood cell loss|1|||
144742859|NCT03676634|521910367|FG000|Overall Study|Out-of-limit pulse|2|||
144742860|NCT00606281|521910371|FG000|Overall Study|Adverse Event|11|||
144742861|NCT00606281|521910372|FG001|Overall Study|Adverse Event|12|||
144742862|NCT00606281|521910371|FG000|Overall Study|Death|1|||
144742863|NCT00606281|521910372|FG001|Overall Study|Death|0|||
144742864|NCT00606281|521910371|FG000|Overall Study|Lack of Efficacy|28|||
144742865|NCT00606281|521910372|FG001|Overall Study|Lack of Efficacy|35|||
144742866|NCT00606281|521910371|FG000|Overall Study|Physician Decision|0|||
144742867|NCT00606281|521910372|FG001|Overall Study|Physician Decision|1|||
144742868|NCT00606281|521910371|FG000|Overall Study|Protocol Violation|3|||
144742869|NCT00606281|521910372|FG001|Overall Study|Protocol Violation|3|||
144742870|NCT00606281|521910371|FG000|Overall Study|Withdrawal by Subject|11|||
144742871|NCT00606281|521910372|FG001|Overall Study|Withdrawal by Subject|13|||
144742872|NCT00606281|521910371|FG000|Overall Study|Progression to depressive phase|1|||
144219962|NCT01962103|520000299|FG005|Phase 1|Adverse Event|2|||
144219963|NCT01962103|520000300|FG006|Phase 1|Adverse Event|0|||
144219964|NCT01962103|520000301|FG007|Phase 1|Adverse Event|0|||
144219965|NCT01962103|520000302|FG008|Phase 1|Adverse Event|0|||
144219966|NCT01962103|520000294|FG000|Phase 1|Progressive Disease|8|||
144219967|NCT01962103|520000295|FG001|Phase 1|Progressive Disease|6|||
144219968|NCT01962103|520000296|FG002|Phase 1|Progressive Disease|8|||
144742873|NCT00606281|521910372|FG001|Overall Study|Progression to depressive phase|1|||
144742874|NCT00606281|521910371|FG000|Overall Study|Change of residence or other commitments|1|||
144742875|NCT00606281|521910372|FG001|Overall Study|Change of residence or other commitments|1|||
144742876|NCT00829712|521910373|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
144742877|NCT00829712|521910374|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
144742878|NCT03131895|521910376|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
144742879|NCT03131895|521910377|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
144742880|NCT03131895|521910378|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
144742881|NCT03131895|521910379|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
144742882|NCT03131895|521910376|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
144742883|NCT03131895|521910377|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
144742884|NCT03131895|521910378|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
144742885|NCT03131895|521910379|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
144742886|NCT03131895|521910376|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144742887|NCT03131895|521910377|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
144742888|NCT03131895|521910378|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
144742889|NCT03131895|521910379|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
144742890|NCT03131895|521910376|FG000|Washout Period (at Least 5 Days)|Other|0|||
144742891|NCT03131895|521910377|FG001|Washout Period (at Least 5 Days)|Other|0|||
144742892|NCT03131895|521910378|FG002|Washout Period (at Least 5 Days)|Other|2|||
144742893|NCT03131895|521910379|FG003|Washout Period (at Least 5 Days)|Other|0|||
144742894|NCT03131895|521910376|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
144742895|NCT03131895|521910377|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
144742896|NCT03131895|521910378|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
144742897|NCT03131895|521910379|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
144742898|NCT03131895|521910376|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
144742899|NCT03131895|521910377|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
144742900|NCT03131895|521910378|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
144742901|NCT03131895|521910379|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
144742902|NCT00540423|521910380|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144742903|NCT00540423|521910381|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144742904|NCT00540423|521910382|FG002|Double-Blind Treatment Period|Adverse Event|0|||
144742905|NCT00540423|521910380|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
144742906|NCT00540423|521910381|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
144742907|NCT00540423|521910382|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
144742908|NCT02213263|521910390|FG000|Overall Study|Insufficient clinical response|4|||
144742909|NCT02213263|521910391|FG001|Overall Study|Insufficient clinical response|3|||
144742910|NCT02213263|521910390|FG000|Overall Study|Lost to Follow-up|0|||
144742911|NCT02213263|521910391|FG001|Overall Study|Lost to Follow-up|1|||
144742912|NCT02213263|521910390|FG000|Overall Study|No longer willing to participate|3|||
144742913|NCT02213263|521910391|FG001|Overall Study|No longer willing to participate|4|||
144742914|NCT02213263|521910390|FG000|Overall Study|Progressive disease|20|||
144742915|NCT02213263|521910391|FG001|Overall Study|Progressive disease|14|||
144742916|NCT02213263|521910390|FG000|Overall Study|Protocol Violation|0|||
144742917|NCT02213263|521910391|FG001|Overall Study|Protocol Violation|1|||
144742918|NCT02213263|521910390|FG000|Overall Study|Adverse Event|1|||
144742919|NCT02213263|521910391|FG001|Overall Study|Adverse Event|3|||
144219969|NCT01962103|520000297|FG003|Phase 1|Progressive Disease|4|||
144219970|NCT01962103|520000298|FG004|Phase 1|Progressive Disease|5|||
144219971|NCT01962103|520000299|FG005|Phase 1|Progressive Disease|4|||
144219972|NCT01962103|520000300|FG006|Phase 1|Progressive Disease|0|||
144219973|NCT01962103|520000301|FG007|Phase 1|Progressive Disease|0|||
144219974|NCT01962103|520000302|FG008|Phase 1|Progressive Disease|0|||
144742920|NCT01188681|521910392|FG000|Overall Study|bladder cancer|0|||
144742921|NCT01188681|521910393|FG001|Overall Study|bladder cancer|0|||
144742922|NCT01188681|521910394|FG002|Overall Study|bladder cancer|1|||
144742923|NCT01188681|521910395|FG003|Overall Study|bladder cancer|0|||
144742924|NCT01188681|521910392|FG000|Overall Study|Withdrawal by Subject|0|||
144742925|NCT01188681|521910393|FG001|Overall Study|Withdrawal by Subject|0|||
144742926|NCT01188681|521910394|FG002|Overall Study|Withdrawal by Subject|0|||
144742927|NCT01188681|521910395|FG003|Overall Study|Withdrawal by Subject|1|||
144742928|NCT05752721|521910396|FG000|Overall Study|Lost to Follow-up|22|||
144742929|NCT05752721|521910397|FG001|Overall Study|Lost to Follow-up|20|||
144742930|NCT05752721|521910396|FG000|Overall Study|Withdrawal by Subject|15|||
144742931|NCT05752721|521910397|FG001|Overall Study|Withdrawal by Subject|12|||
144742932|NCT02280863|521910398|FG000|Integrated Platform|Met stopping criteria|0|||
144742933|NCT02280863|521910399|FG001|Integrated Platform|Met stopping criteria|1|||
144742934|NCT00263588|521910400|FG000|Overall Study|Death|54|||
144742935|NCT00263588|521910401|FG001|Overall Study|Death|90|||
144742936|NCT00263588|521910400|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
144742937|NCT00263588|521910401|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
144742938|NCT00263588|521910400|FG000|Overall Study|Lost to Follow-up|7|||
144742939|NCT00263588|521910401|FG001|Overall Study|Lost to Follow-up|10|||
144742940|NCT00263588|521910400|FG000|Overall Study|Withdrawal by Subject|3|||
144742941|NCT00263588|521910401|FG001|Overall Study|Withdrawal by Subject|4|||
144742942|NCT00263588|521910400|FG000|Overall Study|Protocol Violation|0|||
144742943|NCT00263588|521910401|FG001|Overall Study|Protocol Violation|1|||
144742944|NCT00263588|521910400|FG000|Overall Study|Investigator decision|7|||
144742945|NCT00263588|521910401|FG001|Overall Study|Investigator decision|15|||
144742946|NCT00263588|521910400|FG000|Overall Study|Sponsor terminated study|0|||
144742947|NCT00263588|521910401|FG001|Overall Study|Sponsor terminated study|1|||
144742948|NCT03158727|521910411|FG000|Overall Study|Withdrawal by Subject|2|||
144742949|NCT03158727|521910412|FG001|Overall Study|Withdrawal by Subject|6|||
144742950|NCT03158727|521910411|FG000|Overall Study|Death|11|||
144742951|NCT03158727|521910412|FG001|Overall Study|Death|12|||
144742952|NCT03158727|521910411|FG000|Overall Study|Lost to Follow-up|1|||
144742953|NCT03158727|521910412|FG001|Overall Study|Lost to Follow-up|0|||
144742954|NCT03158727|521910411|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
144742955|NCT03158727|521910412|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
144742956|NCT03158727|521910411|FG000|Overall Study|Visit 11 not done by mistake|0|||
144742957|NCT03158727|521910412|FG001|Overall Study|Visit 11 not done by mistake|1|||
144742958|NCT03158727|521910411|FG000|Overall Study|Enrolled, not treated|1|||
144742959|NCT03158727|521910412|FG001|Overall Study|Enrolled, not treated|0|||
144742960|NCT00669162|521910413|FG000|Overall Study|Withdrawal by Subject|1|||
144742961|NCT00807495|521910414|FG000|Overall Study|Adverse Event|6|||
144742962|NCT00807495|521910415|FG001|Overall Study|Adverse Event|3|||
144742963|NCT00807495|521910416|FG002|Overall Study|Adverse Event|1|||
144742964|NCT00807495|521910417|FG003|Overall Study|Adverse Event|1|||
144742965|NCT00807495|521910418|FG004|Overall Study|Adverse Event|2|||
144742966|NCT00807495|521910414|FG000|Overall Study|Withdrawal by Patient|2|||
144742967|NCT00807495|521910415|FG001|Overall Study|Withdrawal by Patient|0|||
144742968|NCT00807495|521910416|FG002|Overall Study|Withdrawal by Patient|1|||
144742969|NCT00807495|521910417|FG003|Overall Study|Withdrawal by Patient|0|||
144742970|NCT00807495|521910418|FG004|Overall Study|Withdrawal by Patient|0|||
144742971|NCT00807495|521910414|FG000|Overall Study|Reason Not Specified|0|||
144742972|NCT00807495|521910415|FG001|Overall Study|Reason Not Specified|3|||
144742973|NCT00807495|521910416|FG002|Overall Study|Reason Not Specified|2|||
144742974|NCT00807495|521910417|FG003|Overall Study|Reason Not Specified|0|||
144742975|NCT00807495|521910418|FG004|Overall Study|Reason Not Specified|3|||
144742976|NCT02412852|521910419|FG000|Overall Study|Withdrawal by Subject|0|||
144742977|NCT02412852|521910420|FG001|Overall Study|Withdrawal by Subject|1|||
144742978|NCT02412852|521910421|FG002|Overall Study|Withdrawal by Subject|0|||
144742979|NCT02412852|521910422|FG003|Overall Study|Withdrawal by Subject|0|||
144219975|NCT01962103|520000294|FG000|Phase 1|Withdrawal by Subject|0|||
144219976|NCT01962103|520000295|FG001|Phase 1|Withdrawal by Subject|0|||
144742980|NCT02412852|521910419|FG000|Overall Study|Physician Decision|0|||
144742981|NCT02412852|521910420|FG001|Overall Study|Physician Decision|0|||
144742982|NCT02412852|521910421|FG002|Overall Study|Physician Decision|0|||
144742983|NCT02412852|521910422|FG003|Overall Study|Physician Decision|1|||
144742984|NCT00985439|521910423|FG000|Overall Study|Adverse Event|0|||
144742985|NCT00985439|521910424|FG001|Overall Study|Adverse Event|0|||
144742986|NCT00985439|521910425|FG002|Overall Study|Adverse Event|1|||
144742987|NCT00985439|521910426|FG003|Overall Study|Adverse Event|0|||
144742988|NCT01174186|521910427|FG000|Overall Study|Lost to Follow-up|0|||
144742989|NCT01174186|521910428|FG001|Overall Study|Lost to Follow-up|1|||
144742990|NCT01174186|521910427|FG000|Overall Study|Withdrawal by Subject|0|||
144742991|NCT01174186|521910428|FG001|Overall Study|Withdrawal by Subject|2|||
144742992|NCT05274763|521910429|FG000|Overall Study|Lost to Follow-up|1|||
144742993|NCT01906372|521910434|FG000|Overall Study|Withdrawal by Subject|2|||
144742994|NCT03629054|521910435|FG000|Period 2 (4 Days)|Not treated|0|||
144742995|NCT03629054|521910436|FG001|Period 2 (4 Days)|Not treated|1|||
144742996|NCT00924638|521910437|FG000|Overall Study|Death|3|||
144742997|NCT00924638|521910438|FG001|Overall Study|Death|2|||
144742998|NCT00924638|521910437|FG000|Overall Study|Lost to Follow-up|1|||
144742999|NCT00924638|521910438|FG001|Overall Study|Lost to Follow-up|1|||
144743000|NCT00924638|521910437|FG000|Overall Study|Withdrawal by Subject|5|||
144743001|NCT00924638|521910438|FG001|Overall Study|Withdrawal by Subject|7|||
144743002|NCT00924638|521910437|FG000|Overall Study|Physician Decision|3|||
144743003|NCT00924638|521910438|FG001|Overall Study|Physician Decision|3|||
144743004|NCT00367133|521910439|FG000|2 Years|Death|20|||
144743005|NCT00367133|521910440|FG001|2 Years|Death|12|||
144743006|NCT00367133|521910441|FG002|2 Years|Death|12|||
144743007|NCT00367133|521910439|FG000|2 Years|Dropped|34|||
144743008|NCT00367133|521910440|FG001|2 Years|Dropped|19|||
144743009|NCT00367133|521910441|FG002|2 Years|Dropped|33|||
144743010|NCT00367133|521910439|FG000|2 Years|Missed visit|4|||
144743011|NCT00367133|521910440|FG001|2 Years|Missed visit|5|||
144743012|NCT00367133|521910441|FG002|2 Years|Missed visit|4|||
144743013|NCT00847535|521910447|FG000|Overall Study|Withdrawal by Subject|2|||
144743014|NCT00847535|521910448|FG001|Overall Study|Withdrawal by Subject|1|||
144743015|NCT00847535|521910449|FG002|Overall Study|Withdrawal by Subject|1|||
144743016|NCT00847535|521910447|FG000|Overall Study|Lost to Follow-up|0|||
144743017|NCT00847535|521910448|FG001|Overall Study|Lost to Follow-up|1|||
144743018|NCT00847535|521910449|FG002|Overall Study|Lost to Follow-up|0|||
144743019|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Refused|1|||
144743020|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Refused|3|||
144743021|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Medical|0|||
144743022|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Medical|1|||
144743023|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
144743024|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
144743025|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
144743026|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
144743027|NCT02054715|521910452|FG000|Baseline/Follow-up 1|No Reason|0|||
144743028|NCT02054715|521910453|FG001|Baseline/Follow-up 1|No Reason|1|||
144743029|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
144743030|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
144743031|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Ineligible|3|||
144743032|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Ineligible|0|||
144743033|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Hospitalization|1|||
144743034|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Hospitalization|0|||
144743035|NCT02054715|521910452|FG000|Baseline/Follow-up 1|Changed Mind|1|||
144743036|NCT02054715|521910453|FG001|Baseline/Follow-up 1|Changed Mind|0|||
144743037|NCT02054715|521910452|FG000|Follow-up 2|Lost to Followup|3|||
144743038|NCT02054715|521910453|FG001|Follow-up 2|Lost to Followup|1|||
144743039|NCT02054715|521910452|FG000|Follow-up 2|Refused|3|||
144743040|NCT02054715|521910453|FG001|Follow-up 2|Refused|2|||
144743041|NCT02054715|521910452|FG000|Follow-up 2|Followup Not Completed|3|||
144743042|NCT02054715|521910453|FG001|Follow-up 2|Followup Not Completed|4|||
144743043|NCT02054715|521910452|FG000|Follow-up 2|Ineligible|4|||
144743044|NCT02054715|521910453|FG001|Follow-up 2|Ineligible|5|||
144743045|NCT02054715|521910452|FG000|Follow-up 2|Death|3|||
144743046|NCT02054715|521910453|FG001|Follow-up 2|Death|3|||
144743047|NCT02054715|521910452|FG000|Follow-up 2|Hospitalization|0|||
144743048|NCT02054715|521910453|FG001|Follow-up 2|Hospitalization|2|||
144743049|NCT02054715|521910452|FG000|Follow-up 2|Changed MD/Facility|0|||
144743050|NCT02054715|521910453|FG001|Follow-up 2|Changed MD/Facility|1|||
144743051|NCT02054715|521910452|FG000|Follow-up 2|Changed Mind|0|||
144743052|NCT02054715|521910453|FG001|Follow-up 2|Changed Mind|1|||
144743053|NCT02054715|521910452|FG000|Follow-up 2|No Reason|2|||
144743054|NCT02054715|521910453|FG001|Follow-up 2|No Reason|0|||
144743055|NCT02054715|521910452|FG000|Follow-up 2|Treatment Change or Delay|1|||
144743056|NCT02054715|521910453|FG001|Follow-up 2|Treatment Change or Delay|0|||
144219977|NCT01962103|520000296|FG002|Phase 1|Withdrawal by Subject|0|||
144743057|NCT00674128|521910456|FG000|Overall Study|Withdrawal by Subject|25|||
144743058|NCT00674128|521910457|FG001|Overall Study|Withdrawal by Subject|23|||
144743059|NCT04631562|521910458|FG000|Overall Study|Withdrawal by Subject|0|||
144743060|NCT04631562|521910459|FG001|Overall Study|Withdrawal by Subject|0|||
144743061|NCT04631562|521910460|FG002|Overall Study|Withdrawal by Subject|0|||
144743062|NCT04631562|521910461|FG003|Overall Study|Withdrawal by Subject|0|||
144743063|NCT04631562|521910462|FG004|Overall Study|Withdrawal by Subject|0|||
144743064|NCT04631562|521910463|FG005|Overall Study|Withdrawal by Subject|0|||
144743065|NCT04631562|521910464|FG006|Overall Study|Withdrawal by Subject|0|||
144743066|NCT04631562|521910465|FG007|Overall Study|Withdrawal by Subject|1|||
144743067|NCT04631562|521910466|FG008|Overall Study|Withdrawal by Subject|0|||
144743068|NCT04631562|521910458|FG000|Overall Study|Other|0|||
144743069|NCT04631562|521910459|FG001|Overall Study|Other|0|||
144743070|NCT04631562|521910460|FG002|Overall Study|Other|0|||
144743071|NCT04631562|521910461|FG003|Overall Study|Other|0|||
144743072|NCT04631562|521910462|FG004|Overall Study|Other|0|||
144743073|NCT04631562|521910463|FG005|Overall Study|Other|0|||
144743074|NCT04631562|521910464|FG006|Overall Study|Other|0|||
144743075|NCT04631562|521910465|FG007|Overall Study|Other|0|||
144743076|NCT04631562|521910466|FG008|Overall Study|Other|1|||
144743077|NCT04631562|521910458|FG000|Overall Study|Lost to Follow-up|0|||
144743078|NCT04631562|521910459|FG001|Overall Study|Lost to Follow-up|0|||
144743079|NCT04631562|521910460|FG002|Overall Study|Lost to Follow-up|0|||
144743080|NCT04631562|521910461|FG003|Overall Study|Lost to Follow-up|1|||
144743081|NCT04631562|521910462|FG004|Overall Study|Lost to Follow-up|0|||
144743082|NCT04631562|521910463|FG005|Overall Study|Lost to Follow-up|0|||
144743083|NCT04631562|521910464|FG006|Overall Study|Lost to Follow-up|0|||
144743084|NCT04631562|521910465|FG007|Overall Study|Lost to Follow-up|0|||
144743085|NCT04631562|521910466|FG008|Overall Study|Lost to Follow-up|0|||
144743086|NCT04631562|521910458|FG000|Overall Study|Adverse Event|0|||
144743087|NCT04631562|521910459|FG001|Overall Study|Adverse Event|0|||
144743088|NCT04631562|521910460|FG002|Overall Study|Adverse Event|0|||
144743089|NCT04631562|521910461|FG003|Overall Study|Adverse Event|0|||
144743090|NCT04631562|521910462|FG004|Overall Study|Adverse Event|0|||
144743091|NCT04631562|521910463|FG005|Overall Study|Adverse Event|0|||
144743092|NCT04631562|521910464|FG006|Overall Study|Adverse Event|1|||
144743093|NCT04631562|521910465|FG007|Overall Study|Adverse Event|0|||
144743094|NCT04631562|521910466|FG008|Overall Study|Adverse Event|0|||
144743095|NCT03498560|521910476|FG000|Overall Study|Found Ineligible|2|||
144743096|NCT03498560|521910476|FG000|Overall Study|Withdrawal by Subject|14|||
144743097|NCT03498560|521910476|FG000|Overall Study|Lost to Follow-up|4|||
144743098|NCT03498560|521910476|FG000|Overall Study|Death|1|||
144743099|NCT00867360|521910481|FG000|Overall Study|Withdrawal by Subject|1|||
144743100|NCT00867360|521910482|FG001|Overall Study|Withdrawal by Subject|0|||
144743101|NCT00867360|521910481|FG000|Overall Study|Physician Decision|0|||
144743102|NCT00867360|521910482|FG001|Overall Study|Physician Decision|1|||
144743103|NCT03531827|521910485|FG000|Overall Study|Adverse Event|2|||
144743104|NCT03531827|521910486|FG001|Overall Study|Adverse Event|0|||
144743105|NCT03531827|521910485|FG000|Overall Study|Progressive disease|1|||
144743106|NCT03531827|521910486|FG001|Overall Study|Progressive disease|0|||
144743107|NCT03506633|521912073|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
144743108|NCT03506633|521912074|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
144743109|NCT03247686|521912078|FG000|Overall Study|Withdrawal by Subject|1|||
144743110|NCT03247686|521912079|FG001|Overall Study|Withdrawal by Subject|2|||
144743111|NCT01541215|521912082|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
144743112|NCT01541215|521912083|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
144743113|NCT01541215|521912082|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
144743114|NCT01541215|521912083|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
144743115|NCT01541215|521912082|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
144743116|NCT01541215|521912083|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
144743117|NCT01541215|521912082|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
144743118|NCT01541215|521912083|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
144743119|NCT01541215|521912082|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
144743120|NCT01541215|521912083|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
144743121|NCT01541215|521912082|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
144743122|NCT01541215|521912083|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
144743123|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Subject request|8|||
144743124|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Subject request|11|||
144743125|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
144743126|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
144743127|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
144743128|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
144743129|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
144743130|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
144743131|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
144743132|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
144743133|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
144743134|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
144743135|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Death|1|||
144743136|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Death|0|||
144743137|NCT00521586|521912087|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
144743138|NCT00521586|521912088|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
144743139|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
144743140|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
144743141|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
144743142|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
144743143|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
144743144|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
144743145|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
144743146|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
144743147|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
144743148|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
144743149|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
144743150|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
144743151|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
144743152|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
144743153|NCT00521586|521912087|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
144743154|NCT00521586|521912088|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
144743155|NCT00521586|521912087|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
144743156|NCT00521586|521912088|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
144743157|NCT00521586|521912087|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
144743158|NCT00521586|521912088|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
144743159|NCT00521586|521912087|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
144743160|NCT00521586|521912088|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
144743161|NCT00828321|521912089|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
144743162|NCT00828321|521912090|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
144743163|NCT00828321|521912089|FG000|Second Intervention|Protocol Violation|0|||
144743164|NCT00828321|521912090|FG001|Second Intervention|Protocol Violation|1|||
144743165|NCT02997176|521912091|FG000|Overall Study|Adverse Event|0|||
144743166|NCT02997176|521912092|FG001|Overall Study|Adverse Event|0|||
144743167|NCT02997176|521912093|FG002|Overall Study|Adverse Event|0|||
144743168|NCT02997176|521912094|FG003|Overall Study|Adverse Event|8|||
144743169|NCT02997176|521912091|FG000|Overall Study|Progressive Disease|1|||
144743170|NCT02997176|521912092|FG001|Overall Study|Progressive Disease|0|||
144743171|NCT02997176|521912093|FG002|Overall Study|Progressive Disease|1|||
144743172|NCT02997176|521912094|FG003|Overall Study|Progressive Disease|1|||
144743173|NCT02997176|521912091|FG000|Overall Study|Death|0|||
144743174|NCT02997176|521912092|FG001|Overall Study|Death|0|||
144743175|NCT02997176|521912093|FG002|Overall Study|Death|1|||
144743176|NCT02997176|521912094|FG003|Overall Study|Death|1|||
144743177|NCT02997176|521912091|FG000|Overall Study|Withdrawal by Subject|0|||
144743178|NCT02997176|521912092|FG001|Overall Study|Withdrawal by Subject|2|||
144743179|NCT02997176|521912093|FG002|Overall Study|Withdrawal by Subject|0|||
144743180|NCT02997176|521912094|FG003|Overall Study|Withdrawal by Subject|1|||
144743181|NCT01630616|521912098|FG000|Overall Study|Adverse Event|0|||
144743182|NCT01630616|521912099|FG001|Overall Study|Adverse Event|0|||
144743183|NCT01630616|521912100|FG002|Overall Study|Adverse Event|0|||
144743184|NCT01630616|521912101|FG003|Overall Study|Adverse Event|1|||
144743185|NCT01630616|521912102|FG004|Overall Study|Adverse Event|0|||
144743186|NCT01630616|521912103|FG005|Overall Study|Adverse Event|0|||
144743187|NCT01630616|521912098|FG000|Overall Study|Withdrawal by Subject|0|||
144743188|NCT01630616|521912099|FG001|Overall Study|Withdrawal by Subject|0|||
144743189|NCT01630616|521912100|FG002|Overall Study|Withdrawal by Subject|0|||
144743190|NCT01630616|521912101|FG003|Overall Study|Withdrawal by Subject|2|||
144743191|NCT01630616|521912102|FG004|Overall Study|Withdrawal by Subject|0|||
144743192|NCT01630616|521912103|FG005|Overall Study|Withdrawal by Subject|0|||
144743193|NCT00691704|521912105|FG000|Induction Therapy|Disease Progression|1|||
144743194|NCT00691704|521912105|FG000|Induction Therapy|Active Hepatitis|1|||
144743195|NCT00691704|521912105|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
144743196|NCT00691704|521912105|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
144743197|NCT00691704|521912105|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
144743198|NCT04406194|521912106|FG000|Period 1|Withdrawal by Subject|0|||
144743199|NCT04406194|521912107|FG001|Period 1|Withdrawal by Subject|1|||
144743200|NCT05497557|521912111|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
144743201|NCT05497557|521912112|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
144743202|NCT05497557|521912113|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
144743203|NCT01701063|521912115|FG000|Overall Study|Lost to Follow-up|0|||
144743204|NCT01701063|521912116|FG001|Overall Study|Lost to Follow-up|1|||
144743205|NCT01701063|521912117|FG002|Overall Study|Lost to Follow-up|0|||
144743206|NCT01701063|521912115|FG000|Overall Study|Withdrawal by Subject|0|||
144743207|NCT01701063|521912116|FG001|Overall Study|Withdrawal by Subject|0|||
144743208|NCT01701063|521912117|FG002|Overall Study|Withdrawal by Subject|1|||
144743209|NCT01701063|521912115|FG000|Overall Study|Other|0|||
144743210|NCT01701063|521912116|FG001|Overall Study|Other|0|||
144743211|NCT01701063|521912117|FG002|Overall Study|Other|1|||
144743212|NCT02043132|521912118|FG000|Overall Study|Lost to Follow-up|1|||
144743213|NCT02043132|521912119|FG001|Overall Study|Lost to Follow-up|1|||
144743214|NCT02043132|521912118|FG000|Overall Study|screen failures|4|||
144743215|NCT02043132|521912119|FG001|Overall Study|screen failures|8|||
144743216|NCT00472212|521912120|FG000|Overall Study|Lost to Follow-up|6|||
144743217|NCT00472212|521912121|FG001|Overall Study|Lost to Follow-up|4|||
144743218|NCT01190865|521912131|FG000|Overall Study|Withdrawal by Subject|1|||
144743219|NCT01190865|521912131|FG000|Overall Study|Non-compliance|2|||
144219978|NCT01962103|520000297|FG003|Phase 1|Withdrawal by Subject|2|||
144743220|NCT00829452|521912132|FG000|First Intervention|Withdrawal by Subject|0|||
144743221|NCT00829452|521912133|FG001|First Intervention|Withdrawal by Subject|1|||
144743222|NCT00829452|521912132|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
144743223|NCT00829452|521912133|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
144219979|NCT01962103|520000298|FG004|Phase 1|Withdrawal by Subject|0|||
144743224|NCT00829452|521912132|FG000|Second Intervention|Physician Decision|0|||
144743225|NCT00829452|521912133|FG001|Second Intervention|Physician Decision|1|||
144743226|NCT00574847|521912136|FG000|Overall Study|Adverse Event|2|||
144743227|NCT00574847|521912137|FG001|Overall Study|Adverse Event|0|||
144743228|NCT00574847|521912136|FG000|Overall Study|Death|1|||
144743229|NCT00574847|521912137|FG001|Overall Study|Death|0|||
144743230|NCT00574847|521912136|FG000|Overall Study|Withdrawal by Subject|2|||
144743231|NCT00574847|521912137|FG001|Overall Study|Withdrawal by Subject|2|||
144743232|NCT00574847|521912136|FG000|Overall Study|Physician Decision|1|||
144743233|NCT00574847|521912137|FG001|Overall Study|Physician Decision|0|||
144743234|NCT00574847|521912136|FG000|Overall Study|Did not receive medication (declined)|2|||
144743235|NCT00574847|521912137|FG001|Overall Study|Did not receive medication (declined)|5|||
144743236|NCT02471807|521912142|FG000|Overall Study|Death|14|||
144743237|NCT02471807|521912142|FG000|Overall Study|Withdrawal by Subject|2|||
144743238|NCT02471807|521912142|FG000|Overall Study|Explant|5|||
144743239|NCT02471807|521912142|FG000|Overall Study|Lost to Follow-up|1|||
144743240|NCT01559363|521912143|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
144743241|NCT01559363|521912144|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
144743242|NCT01559363|521912145|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
144743243|NCT01559363|521912146|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
144743244|NCT01559363|521912147|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
144743245|NCT01559363|521912148|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
144743246|NCT01559363|521912143|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
144743247|NCT01559363|521912144|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
144743248|NCT01559363|521912145|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
144743249|NCT01559363|521912146|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
144743250|NCT01559363|521912147|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
144743251|NCT01559363|521912148|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
144743252|NCT01559363|521912143|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
144743253|NCT01559363|521912144|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
144743254|NCT01559363|521912145|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
144743255|NCT01559363|521912146|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
144743256|NCT01559363|521912147|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
144743257|NCT01559363|521912148|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
144743258|NCT01559363|521912143|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
144743259|NCT01559363|521912144|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
144743260|NCT01559363|521912145|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
144743261|NCT01559363|521912146|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
144743262|NCT01559363|521912147|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
144743263|NCT01559363|521912148|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
144743264|NCT01559363|521912143|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
144743265|NCT01559363|521912144|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
144743266|NCT01559363|521912145|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
144743267|NCT01559363|521912146|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
144743268|NCT01559363|521912147|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
144743269|NCT01559363|521912148|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
144743270|NCT01559363|521912143|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
144743271|NCT01559363|521912144|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
144743272|NCT01559363|521912145|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
144743273|NCT01559363|521912146|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
144743274|NCT01559363|521912147|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
144743275|NCT01559363|521912148|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
144743276|NCT01559363|521912143|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
144743277|NCT01559363|521912144|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
144743278|NCT01559363|521912145|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
144743279|NCT01559363|521912146|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
144743280|NCT01559363|521912147|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
144743281|NCT01559363|521912148|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
144743282|NCT01151618|521912163|FG000|Overall Study|Adverse Event|2|||
144743283|NCT01151618|521912163|FG000|Overall Study|Withdrawal by Subject|7|||
144743284|NCT00562718|521912164|FG000|Overall Study|Death|1|||
144743285|NCT00562718|521912164|FG000|Overall Study|Withdrawal by Subject|3|||
144743286|NCT00562718|521912164|FG000|Overall Study|Adverse Event|4|||
144743287|NCT00562718|521912164|FG000|Overall Study|Lack of Efficacy|2|||
144743288|NCT00562718|521912164|FG000|Overall Study|not stated|1|||
144743289|NCT04025021|521912165|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
144743290|NCT04025021|521912166|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
144743291|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
144743292|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
144743293|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
144743294|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
144743295|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
144743296|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
144743297|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
144743298|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
144743299|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
144743300|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
144743301|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
144743302|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
144743303|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
144743304|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
144743305|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
144743306|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
144743307|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
144743308|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
144743309|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
144743310|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
144743311|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
144743312|NCT02227238|521912167|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
144743313|NCT02227238|521912168|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
144743314|NCT02227238|521912169|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
144743315|NCT02227238|521912167|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
144743316|NCT02227238|521912168|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
144743317|NCT02227238|521912169|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
144743318|NCT02227238|521912167|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
144743319|NCT02227238|521912168|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
144743320|NCT02227238|521912169|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
144743321|NCT02227238|521912167|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
144743322|NCT02227238|521912168|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
144743323|NCT02227238|521912169|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
144743324|NCT02227238|521912167|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
144743325|NCT02227238|521912168|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
144743326|NCT02227238|521912169|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
144743327|NCT02227238|521912167|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
144743328|NCT02227238|521912168|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
144219980|NCT01962103|520000299|FG005|Phase 1|Withdrawal by Subject|0|||
144743329|NCT02227238|521912169|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
144743330|NCT02227238|521912167|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
144743331|NCT02227238|521912168|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
144743332|NCT02227238|521912169|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
144743333|NCT00868998|521912172|FG000|Overall Study|Screen Failure|1|||
144743334|NCT00868998|521912172|FG000|Overall Study|Withdrawal by Subject|1|||
144743335|NCT00868998|521912172|FG000|Overall Study|Progression of disease|2|||
144743336|NCT00868998|521912172|FG000|Overall Study|Death|1|||
144743337|NCT01483820|521912173|FG000|Overall Study|Lack of Efficacy|6|||
144743338|NCT01483820|521912173|FG000|Overall Study|Adverse Event|1|||
144743339|NCT01483820|521912173|FG000|Overall Study|Death|1|||
144743340|NCT01507662|521912174|FG000|Overall Study|Death|26|||
144743341|NCT01507662|521912175|FG001|Overall Study|Death|18|||
144743342|NCT01507662|521912174|FG000|Overall Study|Withdrawal by Subject|290|||
144743343|NCT01507662|521912175|FG001|Overall Study|Withdrawal by Subject|287|||
144743344|NCT01507662|521912174|FG000|Overall Study|Lost to Follow-up|498|||
144743345|NCT01507662|521912175|FG001|Overall Study|Lost to Follow-up|523|||
144743346|NCT01507662|521912174|FG000|Overall Study|Proxy interview done|2|||
144743347|NCT01507662|521912175|FG001|Overall Study|Proxy interview done|3|||
144743348|NCT01395017|521912178|FG000|Overall Study|Lost to Follow-up|1|||
144743349|NCT01395017|521912179|FG001|Overall Study|Lost to Follow-up|0|||
144743350|NCT01395017|521912178|FG000|Overall Study|Adverse Event|26|||
144743351|NCT01395017|521912179|FG001|Overall Study|Adverse Event|12|||
144743352|NCT01395017|521912178|FG000|Overall Study|Physician Decision|11|||
144743353|NCT01395017|521912179|FG001|Overall Study|Physician Decision|15|||
144743354|NCT01395017|521912178|FG000|Overall Study|Withdrawal by Subject|14|||
144743355|NCT01395017|521912179|FG001|Overall Study|Withdrawal by Subject|8|||
144219981|NCT01962103|520000300|FG006|Phase 1|Withdrawal by Subject|0|||
144743356|NCT01395017|521912178|FG000|Overall Study|Protocol deviation|1|||
144743357|NCT01395017|521912179|FG001|Overall Study|Protocol deviation|2|||
144743358|NCT01395017|521912178|FG000|Overall Study|Death|4|||
144743359|NCT01395017|521912179|FG001|Overall Study|Death|3|||
144219982|NCT01962103|520000301|FG007|Phase 1|Withdrawal by Subject|0|||
144219983|NCT01962103|520000302|FG008|Phase 1|Withdrawal by Subject|0|||
144743360|NCT01395017|521912178|FG000|Overall Study|Disease progression|42|||
144743361|NCT01395017|521912179|FG001|Overall Study|Disease progression|58|||
144743362|NCT01395017|521912178|FG000|Overall Study|Sponsor discontinued study|1|||
144743363|NCT01395017|521912179|FG001|Overall Study|Sponsor discontinued study|4|||
144743364|NCT01004510|521912184|FG000|Overall Study|Adverse Event|1|||
144743365|NCT01824576|521912185|FG000|Overall Study|Device deficiency|2|||
144743366|NCT03218787|521912186|FG000|Overall Study|Lost to Follow-up|12|||
144743367|NCT03218787|521912186|FG000|Overall Study|Withdrawal by Subject|72|||
144743368|NCT03218787|521912186|FG000|Overall Study|Physician Decision|11|||
144743369|NCT03218787|521912186|FG000|Overall Study|Death|111|||
144743370|NCT03961204|521912187|FG000|Overall Study|Withdrawal by Subject|2|||
144743371|NCT03961204|521912187|FG000|Overall Study|Lost to Follow-up|3|||
144743372|NCT03961204|521912187|FG000|Overall Study|Other|1|||
144743373|NCT03961204|521912187|FG000|Overall Study|Missing|1|||
144743374|NCT00147498|521912190|FG000|Overall Study|Adverse Event|1|||
144743375|NCT00147498|521912191|FG001|Overall Study|Adverse Event|6|||
144743376|NCT00147498|521912192|FG002|Overall Study|Adverse Event|7|||
144743377|NCT00147498|521912193|FG003|Overall Study|Adverse Event|3|||
144743378|NCT00147498|521912190|FG000|Overall Study|Lack of Efficacy|1|||
144743379|NCT00147498|521912191|FG001|Overall Study|Lack of Efficacy|1|||
144743380|NCT00147498|521912192|FG002|Overall Study|Lack of Efficacy|1|||
144743381|NCT00147498|521912193|FG003|Overall Study|Lack of Efficacy|8|||
144743382|NCT00147498|521912190|FG000|Overall Study|Laboratory abnormality|0|||
144743383|NCT00147498|521912191|FG001|Overall Study|Laboratory abnormality|0|||
144743384|NCT00147498|521912192|FG002|Overall Study|Laboratory abnormality|2|||
144743385|NCT00147498|521912193|FG003|Overall Study|Laboratory abnormality|0|||
144743386|NCT00147498|521912190|FG000|Overall Study|Participant defaulted|0|||
144743387|NCT00147498|521912191|FG001|Overall Study|Participant defaulted|1|||
144743388|NCT00147498|521912192|FG002|Overall Study|Participant defaulted|4|||
144743389|NCT00147498|521912193|FG003|Overall Study|Participant defaulted|3|||
144743390|NCT00147498|521912190|FG000|Overall Study|Other|1|||
144743391|NCT00147498|521912191|FG001|Overall Study|Other|1|||
144743392|NCT00147498|521912192|FG002|Overall Study|Other|3|||
144743393|NCT00147498|521912193|FG003|Overall Study|Other|3|||
144743394|NCT02452463|521912194|FG000|Overall Study|Death|1|||
144743395|NCT02452463|521912195|FG001|Overall Study|Death|0|||
144743396|NCT02452463|521912196|FG002|Overall Study|Death|0|||
144743397|NCT02452463|521912194|FG000|Overall Study|Study Suspended|1|||
144743398|NCT02452463|521912195|FG001|Overall Study|Study Suspended|0|||
144743399|NCT02452463|521912196|FG002|Overall Study|Study Suspended|0|||
144743400|NCT02452463|521912194|FG000|Overall Study|Recommended by DSMB|0|||
144743401|NCT02452463|521912195|FG001|Overall Study|Recommended by DSMB|1|||
144743402|NCT02452463|521912196|FG002|Overall Study|Recommended by DSMB|0|||
144743403|NCT02452463|521912194|FG000|Overall Study|Withdrawal by Subject|0|||
144743404|NCT02452463|521912195|FG001|Overall Study|Withdrawal by Subject|1|||
144743405|NCT02452463|521912196|FG002|Overall Study|Withdrawal by Subject|0|||
144743406|NCT01229150|521912197|FG000|Overall Study|Toxicity|2|||
144743407|NCT01229150|521912198|FG001|Overall Study|Toxicity|2|||
144743408|NCT01229150|521912199|FG002|Overall Study|Toxicity|0|||
144743409|NCT01229150|521912200|FG003|Overall Study|Toxicity|0|||
144743410|NCT01494532|521912201|FG000|Overall Study|Adverse Event|4|||
144743411|NCT01494532|521912202|FG001|Overall Study|Adverse Event|1|||
144743412|NCT01494532|521912203|FG002|Overall Study|Adverse Event|8|||
144743413|NCT01494532|521912204|FG003|Overall Study|Adverse Event|6|||
144743414|NCT01494532|521912205|FG004|Overall Study|Adverse Event|5|||
144743415|NCT01494532|521912206|FG005|Overall Study|Adverse Event|0|||
144743416|NCT01494532|521912201|FG000|Overall Study|Lack of Efficacy|0|||
144743417|NCT01494532|521912202|FG001|Overall Study|Lack of Efficacy|0|||
144743418|NCT01494532|521912203|FG002|Overall Study|Lack of Efficacy|0|||
144743419|NCT01494532|521912204|FG003|Overall Study|Lack of Efficacy|0|||
144743420|NCT01494532|521912205|FG004|Overall Study|Lack of Efficacy|2|||
144743421|NCT01494532|521912206|FG005|Overall Study|Lack of Efficacy|0|||
144743422|NCT01494532|521912201|FG000|Overall Study|Protocol deviation|2|||
144743423|NCT01494532|521912202|FG001|Overall Study|Protocol deviation|1|||
144743424|NCT01494532|521912203|FG002|Overall Study|Protocol deviation|3|||
144743425|NCT01494532|521912204|FG003|Overall Study|Protocol deviation|2|||
144743426|NCT01494532|521912205|FG004|Overall Study|Protocol deviation|3|||
144743427|NCT01494532|521912206|FG005|Overall Study|Protocol deviation|0|||
144743428|NCT01494532|521912201|FG000|Overall Study|Protocol-defined stopping criteria|0|||
144743429|NCT01494532|521912202|FG001|Overall Study|Protocol-defined stopping criteria|0|||
144743430|NCT01494532|521912203|FG002|Overall Study|Protocol-defined stopping criteria|1|||
144743431|NCT01494532|521912204|FG003|Overall Study|Protocol-defined stopping criteria|0|||
144743432|NCT01494532|521912205|FG004|Overall Study|Protocol-defined stopping criteria|0|||
144743433|NCT01494532|521912206|FG005|Overall Study|Protocol-defined stopping criteria|0|||
144743434|NCT01494532|521912201|FG000|Overall Study|Lost to Follow-up|1|||
144743435|NCT01494532|521912202|FG001|Overall Study|Lost to Follow-up|0|||
144743436|NCT01494532|521912203|FG002|Overall Study|Lost to Follow-up|0|||
144743437|NCT01494532|521912204|FG003|Overall Study|Lost to Follow-up|2|||
144743438|NCT01494532|521912205|FG004|Overall Study|Lost to Follow-up|0|||
144743439|NCT01494532|521912206|FG005|Overall Study|Lost to Follow-up|0|||
144743440|NCT01494532|521912201|FG000|Overall Study|Physician Decision|0|||
144743441|NCT01494532|521912202|FG001|Overall Study|Physician Decision|1|||
144743442|NCT01494532|521912203|FG002|Overall Study|Physician Decision|1|||
144743443|NCT01494532|521912204|FG003|Overall Study|Physician Decision|2|||
144743444|NCT01494532|521912205|FG004|Overall Study|Physician Decision|0|||
144743445|NCT01494532|521912206|FG005|Overall Study|Physician Decision|0|||
144743446|NCT01494532|521912201|FG000|Overall Study|Withdrawal by Subject|3|||
144743447|NCT01494532|521912202|FG001|Overall Study|Withdrawal by Subject|1|||
144743448|NCT01494532|521912203|FG002|Overall Study|Withdrawal by Subject|4|||
144743449|NCT01494532|521912204|FG003|Overall Study|Withdrawal by Subject|3|||
144743450|NCT01494532|521912205|FG004|Overall Study|Withdrawal by Subject|2|||
144743451|NCT01494532|521912206|FG005|Overall Study|Withdrawal by Subject|0|||
144743452|NCT00258856|521913979|FG000|Overall Study|Lost to Follow-up|1|||
144743453|NCT00258856|521913980|FG001|Overall Study|Lost to Follow-up|0|||
144743454|NCT00258856|521913981|FG002|Overall Study|Lost to Follow-up|2|||
144743455|NCT00258856|521913982|FG003|Overall Study|Lost to Follow-up|0|||
144743456|NCT00258856|521913979|FG000|Overall Study|Non-compliance|2|||
144743457|NCT00258856|521913980|FG001|Overall Study|Non-compliance|0|||
144743458|NCT00258856|521913981|FG002|Overall Study|Non-compliance|0|||
144743459|NCT00258856|521913982|FG003|Overall Study|Non-compliance|1|||
144743460|NCT01109849|521913983|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
144743461|NCT01109849|521913984|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
144743462|NCT01109849|521913985|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
144743463|NCT01109849|521913986|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
144743464|NCT01109849|521913987|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
144743465|NCT01109849|521913983|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
144743466|NCT01109849|521913984|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
144743467|NCT01109849|521913985|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
144743468|NCT01109849|521913986|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
144743469|NCT01109849|521913987|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
144743470|NCT01109849|521913983|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
144743471|NCT01109849|521913984|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
144743472|NCT01109849|521913985|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
144743473|NCT01109849|521913986|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
144743474|NCT01109849|521913987|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
144743475|NCT01109849|521913983|FG000|Initial Randomization: ADHD Treatment|move away|2|||
144743476|NCT01109849|521913984|FG001|Initial Randomization: ADHD Treatment|move away|7|||
144743477|NCT01109849|521913985|FG002|Initial Randomization: ADHD Treatment|move away|0|||
144743478|NCT01109849|521913986|FG003|Initial Randomization: ADHD Treatment|move away|0|||
144743479|NCT01109849|521913987|FG004|Initial Randomization: ADHD Treatment|move away|0|||
144743480|NCT01109849|521913983|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
144743481|NCT01109849|521913984|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
144743482|NCT01109849|521913985|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
144743483|NCT01109849|521913986|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
144743484|NCT01109849|521913987|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
144743485|NCT01109849|521913983|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
144743486|NCT01109849|521913984|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
144743487|NCT01109849|521913985|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
144743488|NCT01109849|521913986|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
144743489|NCT01109849|521913987|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
144743490|NCT03969641|521913995|FG000|Overall Study|Lost to Follow-up|5|||
144743491|NCT03969641|521913996|FG001|Overall Study|Lost to Follow-up|3|||
144743492|NCT03969641|521913995|FG000|Overall Study|Withdrawal by Subject|1|||
144743493|NCT03969641|521913996|FG001|Overall Study|Withdrawal by Subject|2|||
144743494|NCT03969641|521913995|FG000|Overall Study|Found to be ineligible|1|||
144743495|NCT03969641|521913996|FG001|Overall Study|Found to be ineligible|1|||
144743496|NCT03969641|521913995|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
144743497|NCT03969641|521913996|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
144743498|NCT03969641|521913995|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
144743499|NCT03969641|521913996|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
144743500|NCT03969641|521913995|FG000|Overall Study|Elective termination|0|||
144743501|NCT03969641|521913996|FG001|Overall Study|Elective termination|1|||
144743502|NCT00754052|521914004|FG000|Overall Study|Study terminated by Sponsor|5|||
144743503|NCT00754052|521914005|FG001|Overall Study|Study terminated by Sponsor|3|||
144743504|NCT02658019|521914007|FG000|Overall Study|Adverse Event|1|||
144743505|NCT00529763|521914008|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
144743506|NCT00529763|521914009|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
144743507|NCT00529763|521914010|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
144743508|NCT00529763|521914008|FG000|Overall Study|Death|1|||
144743509|NCT00529763|521914009|FG001|Overall Study|Death|1|||
144743510|NCT00529763|521914010|FG002|Overall Study|Death|1|||
144743511|NCT00529763|521914008|FG000|Overall Study|Disease Progression|10|||
144743512|NCT00529763|521914009|FG001|Overall Study|Disease Progression|16|||
144743513|NCT00529763|521914010|FG002|Overall Study|Disease Progression|11|||
144743514|NCT00529763|521914008|FG000|Overall Study|Lost to Follow-up|1|||
144743515|NCT00529763|521914009|FG001|Overall Study|Lost to Follow-up|2|||
144743516|NCT00529763|521914010|FG002|Overall Study|Lost to Follow-up|3|||
144743517|NCT00529763|521914008|FG000|Overall Study|Stem Cell Transplant|0|||
144743518|NCT00529763|521914009|FG001|Overall Study|Stem Cell Transplant|3|||
144743519|NCT00529763|521914010|FG002|Overall Study|Stem Cell Transplant|1|||
144743520|NCT00529763|521914008|FG000|Overall Study|Study Drug Toxicity|3|||
144743521|NCT00529763|521914009|FG001|Overall Study|Study Drug Toxicity|6|||
144743522|NCT00529763|521914010|FG002|Overall Study|Study Drug Toxicity|4|||
144743523|NCT00529763|521914008|FG000|Overall Study|Participant Withdrew Consent|2|||
144743524|NCT00529763|521914009|FG001|Overall Study|Participant Withdrew Consent|3|||
144743525|NCT00529763|521914010|FG002|Overall Study|Participant Withdrew Consent|4|||
144743526|NCT00529763|521914008|FG000|Overall Study|Other reasons|2|||
144743527|NCT00529763|521914009|FG001|Overall Study|Other reasons|0|||
144743528|NCT00529763|521914010|FG002|Overall Study|Other reasons|2|||
144743529|NCT00529763|521914008|FG000|Overall Study|Participant request to discontinue treatment|1|||
144743530|NCT00529763|521914009|FG001|Overall Study|Participant request to discontinue treatment|1|||
144743531|NCT00529763|521914010|FG002|Overall Study|Participant request to discontinue treatment|3|||
144743532|NCT03234907|521914011|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
144743533|NCT03234907|521914012|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
144743534|NCT03234907|521914013|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
144743535|NCT03234907|521914014|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
144743536|NCT03234907|521914015|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
144743537|NCT03234907|521914016|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
144743538|NCT03234907|521914011|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
144743539|NCT03234907|521914012|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
144743540|NCT03234907|521914013|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
144743541|NCT03234907|521914014|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
144743542|NCT03234907|521914015|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
144743543|NCT03234907|521914016|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
144743544|NCT03234907|521914011|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
144743545|NCT03234907|521914012|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
144743546|NCT03234907|521914013|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
144743547|NCT03234907|521914014|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
144743548|NCT03234907|521914015|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
144743549|NCT03234907|521914016|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
144743550|NCT03234907|521914011|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
144743551|NCT03234907|521914012|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
144743552|NCT03234907|521914013|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
144743553|NCT03234907|521914014|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
144743554|NCT03234907|521914015|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
144743555|NCT03234907|521914016|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
144743556|NCT03234907|521914011|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
144743557|NCT03234907|521914012|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
144743558|NCT03234907|521914013|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
144743559|NCT03234907|521914014|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
144743560|NCT03234907|521914015|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
144743561|NCT03234907|521914016|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
144743562|NCT03234907|521914011|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
144743563|NCT03234907|521914012|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
144743564|NCT03234907|521914013|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
144743565|NCT03234907|521914014|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
144743566|NCT03234907|521914015|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
144743567|NCT03234907|521914016|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
144743568|NCT03234907|521914011|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
144219984|NCT01962103|520000294|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
144219985|NCT01962103|520000295|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
144743569|NCT03234907|521914012|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
144743570|NCT03234907|521914013|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
144743571|NCT03234907|521914014|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
144743572|NCT03234907|521914015|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
144743573|NCT03234907|521914016|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
144743574|NCT02986139|521914017|FG000|Overall Study|Sponsor Decision|1|||
144219986|NCT01962103|520000296|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
144219987|NCT01962103|520000297|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
144743575|NCT02986139|521914018|FG001|Overall Study|Sponsor Decision|2|||
144743576|NCT02986139|521914017|FG000|Overall Study|Withdrawal by Subject|0|||
144743577|NCT02986139|521914018|FG001|Overall Study|Withdrawal by Subject|1|||
144743578|NCT02986139|521914017|FG000|Overall Study|Lost to Follow-up|0|||
144743579|NCT02986139|521914018|FG001|Overall Study|Lost to Follow-up|1|||
144743580|NCT00414726|521914020|FG000|Overall Study|Withdrawal by Subject|0|||
144743581|NCT00414726|521914021|FG001|Overall Study|Withdrawal by Subject|1|||
144743582|NCT02107196|521914022|FG000|12-week Treatment Period|Adverse Event|6|||
144743583|NCT02107196|521914023|FG001|12-week Treatment Period|Adverse Event|3|||
144743584|NCT02107196|521914022|FG000|12-week Treatment Period|Lack of Efficacy|2|||
144743585|NCT02107196|521914023|FG001|12-week Treatment Period|Lack of Efficacy|1|||
144743586|NCT02107196|521914022|FG000|12-week Treatment Period|Lost to Follow-up|3|||
144743587|NCT02107196|521914023|FG001|12-week Treatment Period|Lost to Follow-up|6|||
144743588|NCT02107196|521914022|FG000|12-week Treatment Period|Physician Decision|0|||
144743589|NCT02107196|521914023|FG001|12-week Treatment Period|Physician Decision|1|||
144743590|NCT02107196|521914022|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
144743591|NCT02107196|521914023|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
144743592|NCT02107196|521914022|FG000|12-week Treatment Period|Protocol Violation|7|||
144743593|NCT02107196|521914023|FG001|12-week Treatment Period|Protocol Violation|8|||
144743594|NCT02107196|521914022|FG000|12-week Treatment Period|Reason Missing|11|||
144743595|NCT02107196|521914023|FG001|12-week Treatment Period|Reason Missing|8|||
144743596|NCT02107196|521914022|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
144743597|NCT02107196|521914023|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
144743598|NCT02107196|521914022|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
144743599|NCT02107196|521914023|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
144743600|NCT02107196|521914022|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
144743601|NCT02107196|521914023|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
144743602|NCT02107196|521914022|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
144743603|NCT02107196|521914023|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
144743604|NCT01993186|521914024|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
144743605|NCT01993186|521914025|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
144743606|NCT01993186|521914024|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
144743607|NCT01993186|521914025|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
144743608|NCT01993186|521914024|FG000|Open-Label Extension Period|Other, Not Specified|0|||
144743609|NCT01993186|521914025|FG001|Open-Label Extension Period|Other, Not Specified|1|||
144743610|NCT01993186|521914024|FG000|Open-Label Extension Period|Adverse Event|1|||
144743611|NCT01993186|521914025|FG001|Open-Label Extension Period|Adverse Event|0|||
144743612|NCT01993186|521914024|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
144743613|NCT01993186|521914025|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
144743614|NCT01993186|521914024|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
144743615|NCT01993186|521914025|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
144743616|NCT01993186|521914024|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
144743617|NCT01993186|521914025|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
144743618|NCT04523480|521914026|FG000|Overall Study|Lost to Follow-up|30|||
144743619|NCT04523480|521914027|FG001|Overall Study|Lost to Follow-up|35|||
144743620|NCT04523480|521914028|FG002|Overall Study|Lost to Follow-up|0|||
144743621|NCT00835666|521914033|FG000|Washout|Protocol Violation|1|||
144743622|NCT00835666|521914034|FG001|Washout|Protocol Violation|0|||
144743623|NCT00835666|521914033|FG000|Washout|Withdrawal by Subject|1|||
144743624|NCT00835666|521914034|FG001|Washout|Withdrawal by Subject|0|||
144743625|NCT00635648|521914035|FG000|Overall Study|Adverse Event|12|||
144743626|NCT00635648|521914035|FG000|Overall Study|Withdrawal by Subject|9|||
144743627|NCT00635648|521914035|FG000|Overall Study|Physician Decision|4|||
144743628|NCT00635648|521914035|FG000|Overall Study|Rapid progression of baseline disease|4|||
144743629|NCT00635648|521914035|FG000|Overall Study|Use of other antifungal agent needed|1|||
144743630|NCT00635648|521914035|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
144743631|NCT00635648|521914035|FG000|Overall Study|Noncompliance with protocol|1|||
144743632|NCT00635648|521914035|FG000|Overall Study|Other reason|2|||
144743633|NCT01923740|521914036|FG000|Overall Study|Lost to Follow-up|4|||
144743634|NCT01923740|521914037|FG001|Overall Study|Lost to Follow-up|9|||
144743635|NCT01923740|521914036|FG000|Overall Study|Withdrawal by Subject|2|||
144743636|NCT01923740|521914037|FG001|Overall Study|Withdrawal by Subject|0|||
144743637|NCT01537887|521914038|FG000|Period 1|Physician Decision|0|||
144743638|NCT01537887|521914039|FG001|Period 1|Physician Decision|0|||
144743639|NCT01537887|521914040|FG002|Period 1|Physician Decision|0|||
144743640|NCT01537887|521914041|FG003|Period 1|Physician Decision|0|||
144743641|NCT01537887|521914042|FG004|Period 1|Physician Decision|1|||
144743642|NCT01537887|521914043|FG005|Period 1|Physician Decision|1|||
144743643|NCT01537887|521914038|FG000|Period 1|Did not receive treatment|0|||
144743644|NCT01537887|521914039|FG001|Period 1|Did not receive treatment|0|||
144743645|NCT01537887|521914040|FG002|Period 1|Did not receive treatment|1|||
144743646|NCT01537887|521914041|FG003|Period 1|Did not receive treatment|0|||
144743647|NCT01537887|521914042|FG004|Period 1|Did not receive treatment|0|||
144743648|NCT01537887|521914043|FG005|Period 1|Did not receive treatment|0|||
144743649|NCT01537887|521914038|FG000|Period 2|Withdrawal by Subject|0|||
144743650|NCT01537887|521914039|FG001|Period 2|Withdrawal by Subject|1|||
144743651|NCT01537887|521914040|FG002|Period 2|Withdrawal by Subject|0|||
144743652|NCT01537887|521914041|FG003|Period 2|Withdrawal by Subject|0|||
144743653|NCT01537887|521914042|FG004|Period 2|Withdrawal by Subject|0|||
144743654|NCT01537887|521914043|FG005|Period 2|Withdrawal by Subject|0|||
144743655|NCT01537887|521914038|FG000|Period 3|Adverse Event|0|||
144743656|NCT01537887|521914039|FG001|Period 3|Adverse Event|0|||
144743657|NCT01537887|521914040|FG002|Period 3|Adverse Event|1|||
144743658|NCT01537887|521914041|FG003|Period 3|Adverse Event|0|||
144743659|NCT01537887|521914042|FG004|Period 3|Adverse Event|0|||
144743660|NCT01537887|521914043|FG005|Period 3|Adverse Event|0|||
144743661|NCT01537887|521914038|FG000|Period 3|Withdrawal by Subject|0|||
144743662|NCT01537887|521914039|FG001|Period 3|Withdrawal by Subject|1|||
144743663|NCT01537887|521914040|FG002|Period 3|Withdrawal by Subject|0|||
144743664|NCT01537887|521914041|FG003|Period 3|Withdrawal by Subject|0|||
144743665|NCT01537887|521914042|FG004|Period 3|Withdrawal by Subject|0|||
144743666|NCT01537887|521914043|FG005|Period 3|Withdrawal by Subject|0|||
144743667|NCT02450539|521914044|FG000|Overall Study|Withdrawal by Subject|12|||
144743668|NCT02450539|521914045|FG001|Overall Study|Withdrawal by Subject|6|||
144743669|NCT02450539|521914044|FG000|Overall Study|Lost to Follow-up|4|||
144743670|NCT02450539|521914045|FG001|Overall Study|Lost to Follow-up|1|||
144743671|NCT01484912|521914048|FG000|Overall Study|Withdrawal by Subject|1|||
144743672|NCT01484912|521914049|FG001|Overall Study|Withdrawal by Subject|0|||
144743673|NCT01484912|521914048|FG000|Overall Study|Physician Decision|0|||
144743674|NCT01484912|521914049|FG001|Overall Study|Physician Decision|1|||
144743675|NCT00958724|521914058|FG000|Overall Study|Disease Progression|6|||
144743676|NCT05604014|521914059|FG000|Overall Study|Lost to Follow-up|13|||
144743677|NCT02121184|521914063|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
144743678|NCT02121184|521914064|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
144743679|NCT02121184|521914063|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
144743680|NCT02121184|521914064|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
144743681|NCT02121184|521914063|FG000|Overall Study|Emergency cesarean section required|0|||
144743682|NCT02121184|521914064|FG001|Overall Study|Emergency cesarean section required|2|||
144743683|NCT02121184|521914063|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
144743684|NCT02121184|521914064|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
144743685|NCT00840203|521914065|FG000|First Intervention|Protocol Violation|1|||
144743686|NCT00840203|521914066|FG001|First Intervention|Protocol Violation|1|||
144743687|NCT00840203|521914065|FG000|Washout|Protocol Violation|1|||
144743688|NCT00840203|521914066|FG001|Washout|Protocol Violation|0|||
144743689|NCT00989950|521914077|FG000|Randomized Phase|Protocol Violation|1|||
144743690|NCT00989950|521914078|FG001|Randomized Phase|Protocol Violation|0|||
144743691|NCT00989950|521914079|FG002|Randomized Phase|Protocol Violation|0|||
144743692|NCT00989950|521914080|FG003|Randomized Phase|Protocol Violation|0|||
144743693|NCT00989950|521914077|FG000|Randomized Phase|Adverse Event|0|||
144743694|NCT00989950|521914078|FG001|Randomized Phase|Adverse Event|1|||
144743695|NCT00989950|521914079|FG002|Randomized Phase|Adverse Event|0|||
144743696|NCT00989950|521914080|FG003|Randomized Phase|Adverse Event|0|||
144743697|NCT00101439|521914081|FG000|Period 2|Withdrawal by Subject|0|||
144743698|NCT00101439|521914082|FG001|Period 2|Withdrawal by Subject|2|||
144743699|NCT01867658|521914084|FG000|Overall Study|Withdrawal by Subject|6|||
144743700|NCT01867658|521914084|FG000|Overall Study|Death|2|||
144743701|NCT01867658|521914084|FG000|Overall Study|Subject could not be contacted|1|||
144743702|NCT03101358|521914087|FG000|Overall Study|Non-compliance with study schedule|1|||
144743703|NCT03101358|521914088|FG001|Overall Study|Non-compliance with study schedule|0|||
144743704|NCT03101358|521914089|FG002|Overall Study|Non-compliance with study schedule|0|||
144743705|NCT03101358|521914090|FG003|Overall Study|Non-compliance with study schedule|1|||
144743706|NCT03101358|521914087|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
144743707|NCT03101358|521914088|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
144743708|NCT03101358|521914089|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
144743709|NCT03101358|521914090|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
144219988|NCT01962103|520000298|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
144743710|NCT03101358|521914087|FG000|Overall Study|Physician Decision|1|||
144743711|NCT03101358|521914088|FG001|Overall Study|Physician Decision|0|||
144743712|NCT03101358|521914089|FG002|Overall Study|Physician Decision|0|||
144219989|NCT01962103|520000299|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
144743713|NCT03101358|521914090|FG003|Overall Study|Physician Decision|3|||
144743714|NCT03101358|521914087|FG000|Overall Study|Adverse Event|0|||
144743715|NCT03101358|521914088|FG001|Overall Study|Adverse Event|0|||
144743716|NCT03101358|521914089|FG002|Overall Study|Adverse Event|1|||
144743717|NCT03101358|521914090|FG003|Overall Study|Adverse Event|0|||
144743718|NCT03101358|521914087|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
144219990|NCT01962103|520000300|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
144219991|NCT01962103|520000301|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
144219992|NCT01962103|520000302|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
144219993|NCT01962103|520000294|FG000|Phase 1|Physician Decision|0|||
144219994|NCT01962103|520000295|FG001|Phase 1|Physician Decision|0|||
144219995|NCT01962103|520000296|FG002|Phase 1|Physician Decision|0|||
144219996|NCT01962103|520000297|FG003|Phase 1|Physician Decision|1|||
144219997|NCT01962103|520000298|FG004|Phase 1|Physician Decision|0|||
144219998|NCT01962103|520000299|FG005|Phase 1|Physician Decision|0|||
144219999|NCT01962103|520000300|FG006|Phase 1|Physician Decision|0|||
144220000|NCT01962103|520000301|FG007|Phase 1|Physician Decision|0|||
144220001|NCT01962103|520000302|FG008|Phase 1|Physician Decision|0|||
144693000|NCT01874288|521727489|FG004|Overall Study|Withdrawal by Subject|1|||
144693001|NCT01874288|521727485|FG000|Overall Study|Physician Decision|0|||
144743719|NCT03101358|521914088|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
144743720|NCT03101358|521914089|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
144743721|NCT03101358|521914090|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
144743722|NCT03101358|521914087|FG000|Overall Study|Lost to Follow-up|1|||
144743723|NCT03101358|521914088|FG001|Overall Study|Lost to Follow-up|0|||
144743724|NCT03101358|521914089|FG002|Overall Study|Lost to Follow-up|0|||
144743725|NCT03101358|521914090|FG003|Overall Study|Lost to Follow-up|1|||
144743726|NCT02426918|521914091|FG000|Overall Study|Adverse Event|2|||
144743727|NCT02426918|521914092|FG001|Overall Study|Adverse Event|2|||
144743728|NCT02426918|521914093|FG002|Overall Study|Adverse Event|0|||
144743729|NCT02426918|521914091|FG000|Overall Study|Physician Decision|1|||
144743730|NCT02426918|521914092|FG001|Overall Study|Physician Decision|1|||
144743731|NCT02426918|521914093|FG002|Overall Study|Physician Decision|1|||
144743732|NCT02426918|521914091|FG000|Overall Study|Withdrawal by Subject|5|||
144743733|NCT02426918|521914092|FG001|Overall Study|Withdrawal by Subject|5|||
144220002|NCT01962103|520000294|FG000|Phase 1|Symptomatic Deterioration|3|||
144220003|NCT01962103|520000295|FG001|Phase 1|Symptomatic Deterioration|2|||
144220004|NCT01962103|520000296|FG002|Phase 1|Symptomatic Deterioration|2|||
144693002|NCT01874288|521727486|FG001|Overall Study|Physician Decision|0|||
144693003|NCT01874288|521727487|FG002|Overall Study|Physician Decision|0|||
144693004|NCT01874288|521727488|FG003|Overall Study|Physician Decision|1|||
144693005|NCT01874288|521727489|FG004|Overall Study|Physician Decision|0|||
144693006|NCT01874288|521727485|FG000|Overall Study|Progressive disease|2|||
144693007|NCT01874288|521727486|FG001|Overall Study|Progressive disease|0|||
144693008|NCT01874288|521727487|FG002|Overall Study|Progressive disease|3|||
144693009|NCT01874288|521727488|FG003|Overall Study|Progressive disease|5|||
144693010|NCT01874288|521727489|FG004|Overall Study|Progressive disease|1|||
144693011|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
144693012|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
144693013|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
144693014|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
144693015|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
144693016|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
144693017|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Death|1|||
144693018|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Death|1|||
144693019|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Death|1|||
144693020|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Death|0|||
144693021|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Death|0|||
144693022|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Death|0|||
144693023|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
144693024|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
144693025|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
144693026|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
144693027|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
144693028|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
144693029|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
144693030|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
144693031|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
144693032|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
144693033|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
144693034|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
144693035|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
144693036|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
144743734|NCT02426918|521914093|FG002|Overall Study|Withdrawal by Subject|4|||
144743735|NCT02426918|521914091|FG000|Overall Study|Other|9|||
144220005|NCT01962103|520000297|FG003|Phase 1|Symptomatic Deterioration|2|||
144220006|NCT01962103|520000298|FG004|Phase 1|Symptomatic Deterioration|1|||
144693037|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
144693038|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
144693039|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
144743736|NCT02426918|521914092|FG001|Overall Study|Other|11|||
144743737|NCT02426918|521914093|FG002|Overall Study|Other|9|||
144743738|NCT01496118|521914094|FG000|Overall Study|Disease progression|3|||
144743739|NCT01496118|521914095|FG001|Overall Study|Disease progression|2|||
144743740|NCT01496118|521914096|FG002|Overall Study|Disease progression|3|||
144743741|NCT01496118|521914097|FG003|Overall Study|Disease progression|1|||
144743742|NCT01496118|521914098|FG004|Overall Study|Disease progression|2|||
144743743|NCT01496118|521914099|FG005|Overall Study|Disease progression|2|||
144743744|NCT01496118|521914100|FG006|Overall Study|Disease progression|14|||
144743745|NCT01496118|521914101|FG007|Overall Study|Disease progression|10|||
144743746|NCT01496118|521914094|FG000|Overall Study|Physician Decision|0|||
144743747|NCT01496118|521914095|FG001|Overall Study|Physician Decision|0|||
144743748|NCT01496118|521914096|FG002|Overall Study|Physician Decision|0|||
144743749|NCT01496118|521914097|FG003|Overall Study|Physician Decision|0|||
144220007|NCT01962103|520000299|FG005|Phase 1|Symptomatic Deterioration|1|||
144220008|NCT01962103|520000300|FG006|Phase 1|Symptomatic Deterioration|0|||
144220009|NCT01962103|520000301|FG007|Phase 1|Symptomatic Deterioration|0|||
144220010|NCT01962103|520000302|FG008|Phase 1|Symptomatic Deterioration|0|||
144220011|NCT01962103|520000294|FG000|Phase 1|Miscellaneous|1|||
144220012|NCT01962103|520000295|FG001|Phase 1|Miscellaneous|0|||
144220013|NCT01962103|520000296|FG002|Phase 1|Miscellaneous|0|||
144220014|NCT01962103|520000297|FG003|Phase 1|Miscellaneous|0|||
144220015|NCT01962103|520000298|FG004|Phase 1|Miscellaneous|0|||
144220016|NCT01962103|520000299|FG005|Phase 1|Miscellaneous|0|||
144220017|NCT01962103|520000300|FG006|Phase 1|Miscellaneous|0|||
144220018|NCT01962103|520000301|FG007|Phase 1|Miscellaneous|0|||
144220019|NCT01962103|520000302|FG008|Phase 1|Miscellaneous|0|||
144220020|NCT01962103|520000294|FG000|Phase 2|Adverse Event|0|||
144220021|NCT01962103|520000295|FG001|Phase 2|Adverse Event|0|||
144220022|NCT01962103|520000296|FG002|Phase 2|Adverse Event|0|||
144220023|NCT01962103|520000297|FG003|Phase 2|Adverse Event|0|||
144220024|NCT01962103|520000298|FG004|Phase 2|Adverse Event|0|||
144220025|NCT01962103|520000299|FG005|Phase 2|Adverse Event|0|||
144220026|NCT01962103|520000300|FG006|Phase 2|Adverse Event|1|||
144220027|NCT01962103|520000301|FG007|Phase 2|Adverse Event|0|||
144220028|NCT01962103|520000302|FG008|Phase 2|Adverse Event|3|||
144220029|NCT01962103|520000294|FG000|Phase 2|Progressive Disease|0|||
144220030|NCT01962103|520000295|FG001|Phase 2|Progressive Disease|0|||
144220031|NCT01962103|520000296|FG002|Phase 2|Progressive Disease|0|||
144220032|NCT01962103|520000297|FG003|Phase 2|Progressive Disease|0|||
144220033|NCT01962103|520000298|FG004|Phase 2|Progressive Disease|0|||
144220034|NCT01962103|520000299|FG005|Phase 2|Progressive Disease|0|||
144743750|NCT01496118|521914098|FG004|Overall Study|Physician Decision|1|||
144743751|NCT01496118|521914099|FG005|Overall Study|Physician Decision|0|||
144743752|NCT01496118|521914100|FG006|Overall Study|Physician Decision|3|||
144743753|NCT01496118|521914101|FG007|Overall Study|Physician Decision|6|||
144743754|NCT01496118|521914094|FG000|Overall Study|Adverse Event|1|||
144743755|NCT01496118|521914095|FG001|Overall Study|Adverse Event|1|||
144743756|NCT01496118|521914096|FG002|Overall Study|Adverse Event|0|||
144743757|NCT01496118|521914097|FG003|Overall Study|Adverse Event|0|||
144743758|NCT01496118|521914098|FG004|Overall Study|Adverse Event|0|||
144743759|NCT01496118|521914099|FG005|Overall Study|Adverse Event|0|||
144743760|NCT01496118|521914100|FG006|Overall Study|Adverse Event|6|||
144743761|NCT01496118|521914101|FG007|Overall Study|Adverse Event|10|||
144743762|NCT01496118|521914094|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743763|NCT01496118|521914095|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743764|NCT01496118|521914096|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743765|NCT01496118|521914097|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743766|NCT01496118|521914098|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743767|NCT01496118|521914099|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743768|NCT01496118|521914100|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
144220035|NCT01962103|520000300|FG006|Phase 2|Progressive Disease|11|||
144220036|NCT01962103|520000301|FG007|Phase 2|Progressive Disease|12|||
144220037|NCT01962103|520000302|FG008|Phase 2|Progressive Disease|11|||
144743769|NCT01496118|521914101|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
144743770|NCT01496118|521914094|FG000|Overall Study|Death|0|||
144743771|NCT01496118|521914095|FG001|Overall Study|Death|0|||
144743772|NCT01496118|521914096|FG002|Overall Study|Death|0|||
144743773|NCT01496118|521914097|FG003|Overall Study|Death|0|||
144743774|NCT01496118|521914098|FG004|Overall Study|Death|0|||
144743775|NCT01496118|521914099|FG005|Overall Study|Death|0|||
144220038|NCT01962103|520000294|FG000|Phase 2|Symptomatic Deterioration|0|||
144220039|NCT01962103|520000295|FG001|Phase 2|Symptomatic Deterioration|0|||
144220040|NCT01962103|520000296|FG002|Phase 2|Symptomatic Deterioration|0|||
144220041|NCT01962103|520000297|FG003|Phase 2|Symptomatic Deterioration|0|||
144220042|NCT01962103|520000298|FG004|Phase 2|Symptomatic Deterioration|0|||
144220043|NCT01962103|520000299|FG005|Phase 2|Symptomatic Deterioration|0|||
144220044|NCT01962103|520000300|FG006|Phase 2|Symptomatic Deterioration|2|||
144220045|NCT01962103|520000301|FG007|Phase 2|Symptomatic Deterioration|2|||
144220046|NCT01962103|520000302|FG008|Phase 2|Symptomatic Deterioration|0|||
144220047|NCT01321749|520000303|FG000|Overall Study|Lost to Follow-up|4|||
144220048|NCT01321749|520000304|FG001|Overall Study|Lost to Follow-up|11|||
144220049|NCT01321749|520000303|FG000|Overall Study|Protocol Violation|4|||
144220050|NCT01321749|520000304|FG001|Overall Study|Protocol Violation|7|||
144220051|NCT01321749|520000303|FG000|Overall Study|Withdrawal by Subject|5|||
144220052|NCT01321749|520000304|FG001|Overall Study|Withdrawal by Subject|4|||
144220053|NCT02763046|520000309|FG000|Overall Study|Adverse Event|5|||
144220054|NCT02763046|520000310|FG001|Overall Study|Adverse Event|4|||
144220055|NCT02763046|520000311|FG002|Overall Study|Adverse Event|0|||
144220056|NCT02763046|520000309|FG000|Overall Study|Lack of Efficacy|1|||
144220057|NCT02763046|520000310|FG001|Overall Study|Lack of Efficacy|1|||
144220058|NCT02763046|520000311|FG002|Overall Study|Lack of Efficacy|3|||
144220059|NCT02763046|520000309|FG000|Overall Study|Physician Decision|1|||
144220060|NCT02763046|520000310|FG001|Overall Study|Physician Decision|0|||
144693040|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
144693041|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
144693042|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
144693043|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
144693044|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
144693045|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
144220061|NCT02763046|520000311|FG002|Overall Study|Physician Decision|1|||
144220062|NCT02763046|520000309|FG000|Overall Study|Subject/guardian decision|2|||
144220063|NCT02763046|520000310|FG001|Overall Study|Subject/guardian decision|0|||
144220064|NCT02763046|520000311|FG002|Overall Study|Subject/guardian decision|4|||
144266175|NCT01747499|520176534|FG004|Overall Study|Determined not to be eligible|1|||
144266176|NCT00072410|520176535|FG000|Overall Study|Progressive disease|0|||
144693046|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
144220065|NCT01067105|520000316|FG000|Overall Study|Adverse Event|14|||
144220066|NCT01067105|520000316|FG000|Overall Study|Protocol Violation|48|||
144693047|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
144693048|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
144693049|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
144693050|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
144693051|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
144693052|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
144693053|NCT03370133|521727493|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
144693054|NCT03370133|521727494|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
144693055|NCT03370133|521727495|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
144693056|NCT03370133|521727496|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
144693057|NCT03370133|521727497|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
144693058|NCT03370133|521727498|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
144693059|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
144693060|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
144693061|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
144693062|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
144693063|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
144693064|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
144693065|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
144693066|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
144693067|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
144693068|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
144693069|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
144693070|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
144693071|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
144693072|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
144693073|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
144693074|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
144693075|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
144693076|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
144693077|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
144693078|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
144693079|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
144693080|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
144693081|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
144693082|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
144693083|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
144743776|NCT01496118|521914100|FG006|Overall Study|Death|1|||
144220067|NCT01067105|520000316|FG000|Overall Study|Withdrawal by Subject|36|||
144220068|NCT01067105|520000316|FG000|Overall Study|Lost to Follow-up|6|||
144266177|NCT00072410|520176536|FG001|Overall Study|Progressive disease|3|||
144220069|NCT01067105|520000316|FG000|Overall Study|Physician Decision|6|||
144220070|NCT01067105|520000316|FG000|Overall Study|Other|31|||
144220071|NCT02203357|520000319|FG000|Overall Study|Lost to Follow-up|58|||
144220072|NCT02203357|520000320|FG001|Overall Study|Lost to Follow-up|66|||
144220073|NCT02203357|520000321|FG002|Overall Study|Lost to Follow-up|70|||
144220074|NCT02439216|520000322|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
144220075|NCT02439216|520000323|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220076|NCT02439216|520000324|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220077|NCT02439216|520000325|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220078|NCT02439216|520000326|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220079|NCT02439216|520000327|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220080|NCT02439216|520000328|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220081|NCT02439216|520000329|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220082|NCT02439216|520000330|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
144220083|NCT02439216|520000322|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220084|NCT02439216|520000323|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220085|NCT02439216|520000324|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220086|NCT02439216|520000325|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220087|NCT02439216|520000326|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220088|NCT02439216|520000327|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220089|NCT02439216|520000328|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220090|NCT02439216|520000329|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
144220091|NCT02439216|520000330|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
144220092|NCT02439216|520000322|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220093|NCT02439216|520000323|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220094|NCT02439216|520000324|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220095|NCT02439216|520000325|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220096|NCT02439216|520000326|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220097|NCT02439216|520000327|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220098|NCT02439216|520000328|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
144220099|NCT02439216|520000329|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
144220100|NCT02439216|520000330|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
144220101|NCT02439216|520000322|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220102|NCT02439216|520000323|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220103|NCT02439216|520000324|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220104|NCT02439216|520000325|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220105|NCT02439216|520000326|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220106|NCT02439216|520000327|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220107|NCT02439216|520000328|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220108|NCT02439216|520000329|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
144220109|NCT02439216|520000330|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
144220110|NCT02439216|520000322|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144220111|NCT02439216|520000323|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144220112|NCT02439216|520000324|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144220113|NCT02439216|520000325|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144220114|NCT02439216|520000326|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144220115|NCT02439216|520000327|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144220116|NCT02439216|520000328|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
144743777|NCT01496118|521914101|FG007|Overall Study|Death|1|||
144743778|NCT01496118|521914094|FG000|Overall Study|Withdrawal by Subject|0|||
144743779|NCT01496118|521914095|FG001|Overall Study|Withdrawal by Subject|0|||
144743780|NCT01496118|521914096|FG002|Overall Study|Withdrawal by Subject|0|||
144743781|NCT01496118|521914097|FG003|Overall Study|Withdrawal by Subject|2|||
144743782|NCT01496118|521914098|FG004|Overall Study|Withdrawal by Subject|0|||
144743783|NCT01496118|521914099|FG005|Overall Study|Withdrawal by Subject|1|||
144743784|NCT01496118|521914100|FG006|Overall Study|Withdrawal by Subject|6|||
144743785|NCT01496118|521914101|FG007|Overall Study|Withdrawal by Subject|3|||
144743786|NCT02845336|521914102|FG000|Overall Study|Lost to Follow-up|3|||
144743787|NCT02845336|521914103|FG001|Overall Study|Lost to Follow-up|1|||
144220117|NCT02439216|520000329|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
144220118|NCT02439216|520000330|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
144220119|NCT02493660|520000335|FG000|Overall Study|Physician Decision|0|||
144220120|NCT02493660|520000336|FG001|Overall Study|Physician Decision|1|||
144220121|NCT02493660|520000335|FG000|Overall Study|Adverse Event|4|||
144220122|NCT02493660|520000336|FG001|Overall Study|Adverse Event|2|||
144743788|NCT02845336|521914102|FG000|Overall Study|Inability to get medication|2|||
144743789|NCT02845336|521914103|FG001|Overall Study|Inability to get medication|0|||
144743790|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
144743791|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
144743792|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
144743793|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
144743794|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
144743795|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
144743796|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
144743797|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
144743798|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
144743799|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
144743800|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
144743801|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
144743802|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
144743803|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
144743804|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
144743805|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
144743806|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
144743807|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
144743808|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
144743809|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
144743810|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
144743811|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
144743812|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
144743813|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
144743814|NCT00073307|521914109|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
144743815|NCT00073307|521914110|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
144743816|NCT00073307|521914111|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
144743817|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
144743818|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
144743819|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
144743820|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
144743821|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
144743822|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
144743823|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
144743824|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
144743825|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
144743826|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
144743827|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
144743828|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
144743829|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
144743830|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
144743831|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
144743832|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
144743833|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
144743834|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
144743835|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
144743836|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
144743837|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
144743838|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
144743839|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
144743840|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
144743841|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
144743842|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
144743843|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
144743844|NCT00073307|521914109|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
144743845|NCT00073307|521914110|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
144743846|NCT00073307|521914111|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
144743847|NCT03499873|521914112|FG000|Overall Study|Withdrawal by Subject|4|||
144266178|NCT05214118|520176552|FG000|Overall Study|Lost to Follow-up|0|||
144266179|NCT05214118|520176553|FG001|Overall Study|Lost to Follow-up|2|||
144266180|NCT05214118|520176552|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
144220123|NCT02493660|520000335|FG000|Overall Study|Withdrawal by Subject|2|||
144220124|NCT02493660|520000336|FG001|Overall Study|Withdrawal by Subject|3|||
144220125|NCT02493660|520000335|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
144220126|NCT02493660|520000336|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
144220127|NCT02493660|520000335|FG000|Overall Study|Protocol Violation|0|||
144220128|NCT02493660|520000336|FG001|Overall Study|Protocol Violation|1|||
144220129|NCT02493660|520000335|FG000|Overall Study|Death|0|||
144220130|NCT02493660|520000336|FG001|Overall Study|Death|1|||
144220131|NCT02493660|520000335|FG000|Overall Study|Lost to Follow-up|2|||
144220132|NCT02493660|520000336|FG001|Overall Study|Lost to Follow-up|4|||
144266181|NCT05214118|520176553|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
144693084|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
144693085|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
144693086|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
144693087|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
144693088|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
144693089|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
144693090|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
144693091|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
144693092|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
144693093|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
144693094|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
144693095|NCT03370133|521727493|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
144693096|NCT03370133|521727494|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
144693097|NCT03370133|521727495|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
144693098|NCT03370133|521727496|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
144693099|NCT03370133|521727497|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
144693100|NCT03370133|521727498|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
144693101|NCT03742271|521727499|FG000|Overall Study|Unsatisfactory Visual Response|1|||
144693102|NCT03742271|521727499|FG000|Overall Study|Withdrawal by Subject|3|||
144693103|NCT03742271|521727499|FG000|Overall Study|Lost to Follow-up|4|||
144693104|NCT03742271|521727499|FG000|Overall Study|Failed Insertion & removal|3|||
144693105|NCT03742271|521727499|FG000|Overall Study|Protocol Violation|1|||
144693106|NCT04490499|521727503|FG000|Overall Study|Withdrawal by Subject|2|||
144693107|NCT01843933|521727506|FG000|Overall Study|Data lost|6|||
144693108|NCT01843933|521727507|FG001|Overall Study|Data lost|4|||
144693109|NCT00620815|521727508|FG000|Overall Study|Adverse Event|1|||
144693110|NCT00620815|521727509|FG001|Overall Study|Adverse Event|1|||
144693111|NCT00620815|521727510|FG002|Overall Study|Adverse Event|2|||
144693112|NCT00620815|521727508|FG000|Overall Study|Withdrawal by Subject|1|||
144693113|NCT00620815|521727509|FG001|Overall Study|Withdrawal by Subject|2|||
144693114|NCT00620815|521727510|FG002|Overall Study|Withdrawal by Subject|0|||
144693115|NCT00620815|521727508|FG000|Overall Study|Lost to Follow-up|1|||
144693116|NCT00620815|521727509|FG001|Overall Study|Lost to Follow-up|6|||
144693117|NCT00620815|521727510|FG002|Overall Study|Lost to Follow-up|3|||
144693118|NCT00620815|521727508|FG000|Overall Study|Inappropriate enrolment|0|||
144693119|NCT00620815|521727509|FG001|Overall Study|Inappropriate enrolment|0|||
144693120|NCT00620815|521727510|FG002|Overall Study|Inappropriate enrolment|1|||
144693121|NCT00620815|521727508|FG000|Overall Study|Protocol Violation|1|||
144693122|NCT00620815|521727509|FG001|Overall Study|Protocol Violation|2|||
144693123|NCT00620815|521727510|FG002|Overall Study|Protocol Violation|1|||
144693124|NCT01888367|521727513|FG000|Overall Study|Physician Decision|3|||
144693125|NCT01888367|521727514|FG001|Overall Study|Physician Decision|4|||
144693126|NCT01888367|521727515|FG002|Overall Study|Physician Decision|2|||
144693127|NCT01888367|521727513|FG000|Overall Study|Death|2|||
144693128|NCT01888367|521727514|FG001|Overall Study|Death|0|||
144693129|NCT01888367|521727515|FG002|Overall Study|Death|1|||
144693130|NCT01888367|521727513|FG000|Overall Study|Withdrawal by Subject|1|||
144693131|NCT01888367|521727514|FG001|Overall Study|Withdrawal by Subject|0|||
144693132|NCT01888367|521727515|FG002|Overall Study|Withdrawal by Subject|1|||
144693133|NCT01888367|521727513|FG000|Overall Study|Lost to Follow-up|1|||
144693134|NCT01888367|521727514|FG001|Overall Study|Lost to Follow-up|1|||
144693135|NCT01888367|521727515|FG002|Overall Study|Lost to Follow-up|0|||
144693136|NCT01888367|521727513|FG000|Overall Study|Protocol Violation|0|||
144693137|NCT01888367|521727514|FG001|Overall Study|Protocol Violation|0|||
144693138|NCT01888367|521727515|FG002|Overall Study|Protocol Violation|1|||
144693139|NCT01888367|521727513|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
144693140|NCT01888367|521727514|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
144693141|NCT01888367|521727515|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
144693142|NCT00591786|521727516|FG000|Overall Study|Withdrawal of Informed Consent|0|||
144693143|NCT00591786|521727517|FG001|Overall Study|Withdrawal of Informed Consent|0|||
144693144|NCT00591786|521727518|FG002|Overall Study|Withdrawal of Informed Consent|1|||
144693145|NCT00591786|521727519|FG003|Overall Study|Withdrawal of Informed Consent|0|||
144220133|NCT02105467|520000340|FG000|Period 1|Lost to Follow-up|1|||
144220134|NCT02105467|520000341|FG001|Period 1|Lost to Follow-up|0|||
144220135|NCT02105467|520000340|FG000|Period 1|Death|1|||
144220136|NCT02105467|520000341|FG001|Period 1|Death|0|||
144220137|NCT02105467|520000340|FG000|Period 2|Lost to Follow-up|1|||
144220138|NCT02105467|520000341|FG001|Period 2|Lost to Follow-up|0|||
144220139|NCT02105467|520000340|FG000|Period 2|Death|1|||
144220140|NCT02105467|520000341|FG001|Period 2|Death|0|||
144220141|NCT02105467|520000340|FG000|Period 2|Withdrawal by Subject|0|||
144220142|NCT02105467|520000341|FG001|Period 2|Withdrawal by Subject|2|||
144220143|NCT02105467|520000340|FG000|Period 3|Lost to Follow-up|0|||
144220144|NCT02105467|520000341|FG001|Period 3|Lost to Follow-up|1|||
144266182|NCT05214118|520176552|FG000|Overall Study|moved|1|||
144743848|NCT03499873|521914113|FG001|Overall Study|Withdrawal by Subject|6|||
144743849|NCT03499873|521914114|FG002|Overall Study|Withdrawal by Subject|1|||
144743850|NCT03499873|521914112|FG000|Overall Study|Subjects condition worsened|0|||
144743851|NCT03499873|521914113|FG001|Overall Study|Subjects condition worsened|3|||
144743852|NCT03499873|521914114|FG002|Overall Study|Subjects condition worsened|11|||
144743853|NCT03499873|521914112|FG000|Overall Study|Adverse Event|8|||
144743854|NCT03499873|521914113|FG001|Overall Study|Adverse Event|3|||
144743855|NCT03499873|521914114|FG002|Overall Study|Adverse Event|6|||
144743856|NCT03499873|521914112|FG000|Overall Study|Physician Decision|1|||
144743857|NCT03499873|521914113|FG001|Overall Study|Physician Decision|0|||
144743858|NCT03499873|521914114|FG002|Overall Study|Physician Decision|0|||
144743859|NCT03499873|521914112|FG000|Overall Study|Administrative reasons|0|||
144220145|NCT00811733|520000342|FG000|Overall Study|Investigator Discretion|10|||
144220146|NCT00811733|520000343|FG001|Overall Study|Investigator Discretion|8|||
144220147|NCT00811733|520000342|FG000|Overall Study|Withdrawal by Subject|1|||
144220148|NCT00811733|520000343|FG001|Overall Study|Withdrawal by Subject|2|||
144693146|NCT00591786|521727520|FG004|Overall Study|Withdrawal of Informed Consent|0|||
144693147|NCT00591786|521727521|FG005|Overall Study|Withdrawal of Informed Consent|0|||
144693148|NCT00591786|521727522|FG006|Overall Study|Withdrawal of Informed Consent|0|||
144693149|NCT00591786|521727523|FG007|Overall Study|Withdrawal of Informed Consent|0|||
144693150|NCT00591786|521727524|FG008|Overall Study|Withdrawal of Informed Consent|0|||
144693151|NCT00591786|521727525|FG009|Overall Study|Withdrawal of Informed Consent|0|||
144693152|NCT03143855|521727527|FG000|Overall Study|Withdrawal by Subject|4|||
144693153|NCT03143855|521727528|FG001|Overall Study|Withdrawal by Subject|3|||
144693154|NCT03143855|521727527|FG000|Overall Study|Protocol Violation|1|||
144693155|NCT03143855|521727528|FG001|Overall Study|Protocol Violation|0|||
144693156|NCT03143855|521727527|FG000|Overall Study|Participant experienced withdrawal|0|||
144693157|NCT03143855|521727528|FG001|Overall Study|Participant experienced withdrawal|1|||
144693158|NCT02612194|521727529|FG000|Overall Study|Death|5|||
144693159|NCT02612194|521727530|FG001|Overall Study|Death|0|||
144693160|NCT02612194|521727531|FG002|Overall Study|Death|2|||
144693161|NCT02612194|521727529|FG000|Overall Study|Early Study Termination|1|||
144693162|NCT02612194|521727530|FG001|Overall Study|Early Study Termination|0|||
144693163|NCT02612194|521727531|FG002|Overall Study|Early Study Termination|0|||
144693164|NCT00372905|521727532|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
144693165|NCT00372905|521727533|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
144693166|NCT00372905|521727534|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
144693167|NCT00372905|521727535|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
144693168|NCT00372905|521727532|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
144693169|NCT00372905|521727533|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
144693170|NCT00372905|521727534|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
144693171|NCT00372905|521727535|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
144693172|NCT00372905|521727532|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
144693173|NCT00372905|521727533|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
144693174|NCT00372905|521727534|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
144693175|NCT00372905|521727535|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
144693176|NCT00372905|521727532|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
144693177|NCT00372905|521727533|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
144693178|NCT00372905|521727534|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
144693179|NCT00372905|521727535|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
144693180|NCT00372905|521727532|FG000|Follow up Until Relapse or Progression|Study closed|0|||
144693181|NCT00372905|521727533|FG001|Follow up Until Relapse or Progression|Study closed|0|||
144693182|NCT00372905|521727534|FG002|Follow up Until Relapse or Progression|Study closed|0|||
144693183|NCT00372905|521727535|FG003|Follow up Until Relapse or Progression|Study closed|3|||
144693184|NCT00372905|521727532|FG000|Follow up Until Relapse or Progression|Other|0|||
144693185|NCT00372905|521727533|FG001|Follow up Until Relapse or Progression|Other|1|||
144693186|NCT00372905|521727534|FG002|Follow up Until Relapse or Progression|Other|0|||
144693187|NCT00372905|521727535|FG003|Follow up Until Relapse or Progression|Other|0|||
144693188|NCT00695318|521727537|FG000|Overall Study|Lost to Follow-up|1|||
144693189|NCT00695318|521727538|FG001|Overall Study|Lost to Follow-up|0|||
144693190|NCT00695318|521727537|FG000|Overall Study|Withdrawal by Subject|2|||
144693191|NCT00695318|521727538|FG001|Overall Study|Withdrawal by Subject|0|||
144220149|NCT00793871|520000344|FG000|Overall Study|Death|50|||
144220150|NCT00793871|520000344|FG000|Overall Study|Lost to Follow-up|3|||
144220151|NCT00793871|520000344|FG000|Overall Study|Study terminated by the Sponsor|7|||
144220152|NCT02500589|520000345|FG000|Overall Study|Withdrawal by Subject|11|||
144743860|NCT03499873|521914113|FG001|Overall Study|Administrative reasons|1|||
144743861|NCT03499873|521914114|FG002|Overall Study|Administrative reasons|0|||
144743862|NCT03499873|521914112|FG000|Overall Study|Concomitant therapy|5|||
144743863|NCT03499873|521914113|FG001|Overall Study|Concomitant therapy|4|||
144743864|NCT03499873|521914114|FG002|Overall Study|Concomitant therapy|7|||
144743865|NCT03499873|521914112|FG000|Overall Study|Miscellaneous|1|||
144743866|NCT03499873|521914113|FG001|Overall Study|Miscellaneous|2|||
144743867|NCT03499873|521914114|FG002|Overall Study|Miscellaneous|2|||
144743868|NCT03499873|521914112|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
144743869|NCT03499873|521914113|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
144743870|NCT03499873|521914114|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
144743871|NCT00957021|521914120|FG000|Overall Study|Death|5|||
144743872|NCT00957021|521914120|FG000|Overall Study|Lost to Follow-up|8|||
144743873|NCT00957021|521914120|FG000|Overall Study|Withdrawal by Subject|34|||
144743874|NCT00957021|521914120|FG000|Overall Study|No 2 yr ROM data|35|||
144743875|NCT00957021|521914120|FG000|Overall Study|Revised study component by 2 yr visit|8|||
144743876|NCT00957021|521914120|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
144743877|NCT00957021|521914120|FG000|Overall Study|Surgery Cancelled|9|||
144743878|NCT00957021|521914120|FG000|Overall Study|Termination due to language issue|2|||
144743879|NCT00999687|521914123|FG000|First Intervention|Withdrawal by Subject|1|||
144743880|NCT00999687|521914123|FG000|Second Intervention|Withdrawal by Subject|2|||
144743881|NCT00999687|521914123|FG000|Second Intervention|Lack of Efficacy|1|||
144743882|NCT03541252|521914126|FG000|Overall Study|Withdrawal by Subject|1|||
144743883|NCT01960296|521914133|FG000|Overall Study|Postponed surgery|1|||
144743884|NCT01960296|521914134|FG001|Overall Study|Postponed surgery|0|||
144743885|NCT01960296|521914133|FG000|Overall Study|Received different procedure|1|||
144743886|NCT01960296|521914134|FG001|Overall Study|Received different procedure|3|||
144743887|NCT02003391|521914135|FG000|Overall Study|Withdrawal by Subject|2|||
144743888|NCT02003391|521914136|FG001|Overall Study|Withdrawal by Subject|1|||
144743889|NCT02003391|521914135|FG000|Overall Study|Protocol Violation|0|||
144743890|NCT02003391|521914136|FG001|Overall Study|Protocol Violation|1|||
144743891|NCT02003391|521914135|FG000|Overall Study|Adverse Event|1|||
144743892|NCT02003391|521914136|FG001|Overall Study|Adverse Event|0|||
144743893|NCT00858403|521914137|FG000|Overall Study|Withdrawal by Subject|1|||
144743894|NCT00858403|521914137|FG000|Overall Study|Death|3|||
144743895|NCT00858403|521914137|FG000|Overall Study|Disease Progression|1|||
144743896|NCT00243347|521914140|FG000|Overall Study|Lack of Efficacy|4|||
144743897|NCT00243347|521914140|FG000|Overall Study|Adverse Event|2|||
144743898|NCT00243347|521914140|FG000|Overall Study|Death|1|||
144743899|NCT00243347|521914140|FG000|Overall Study|Withdrawal by Subject|5|||
144743900|NCT00243347|521914140|FG000|Overall Study|Condition worsened|7|||
144743901|NCT02264977|521914142|FG000|Overall Study|Death|3|||
144743902|NCT02264977|521914142|FG000|Overall Study|Physician Decision|1|||
144743903|NCT02264977|521914142|FG000|Overall Study|Refuse to return|1|||
144743904|NCT03573544|521914143|FG000|Overall Study|Adverse Event|0|||
144743905|NCT03573544|521914144|FG001|Overall Study|Adverse Event|0|||
144743906|NCT03573544|521914145|FG002|Overall Study|Adverse Event|0|||
144743907|NCT03573544|521914146|FG003|Overall Study|Adverse Event|3|||
144743908|NCT03573544|521914147|FG004|Overall Study|Adverse Event|1|||
144743909|NCT03573544|521914148|FG005|Overall Study|Adverse Event|0|||
144743910|NCT03573544|521914149|FG006|Overall Study|Adverse Event|2|||
144743911|NCT03573544|521914150|FG007|Overall Study|Adverse Event|0|||
144743912|NCT03573544|521914143|FG000|Overall Study|Physician Decision|0|||
144743913|NCT03573544|521914144|FG001|Overall Study|Physician Decision|0|||
144743914|NCT03573544|521914145|FG002|Overall Study|Physician Decision|0|||
144220153|NCT02500589|520000346|FG001|Overall Study|Withdrawal by Subject|14|||
144220154|NCT02500589|520000345|FG000|Overall Study|Lost to Follow-up|10|||
144220155|NCT02500589|520000346|FG001|Overall Study|Lost to Follow-up|12|||
144743915|NCT03573544|521914146|FG003|Overall Study|Physician Decision|0|||
144220156|NCT02500589|520000345|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
144743916|NCT03573544|521914147|FG004|Overall Study|Physician Decision|0|||
144743917|NCT03573544|521914148|FG005|Overall Study|Physician Decision|0|||
144743918|NCT03573544|521914149|FG006|Overall Study|Physician Decision|1|||
144743919|NCT03573544|521914150|FG007|Overall Study|Physician Decision|0|||
144743920|NCT03573544|521914143|FG000|Overall Study|Withdrawal by Subject|2|||
144743921|NCT03573544|521914144|FG001|Overall Study|Withdrawal by Subject|0|||
144743922|NCT03573544|521914145|FG002|Overall Study|Withdrawal by Subject|0|||
144743923|NCT03573544|521914146|FG003|Overall Study|Withdrawal by Subject|1|||
144743924|NCT03573544|521914147|FG004|Overall Study|Withdrawal by Subject|1|||
144220157|NCT02500589|520000346|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
144743925|NCT03573544|521914148|FG005|Overall Study|Withdrawal by Subject|1|||
144743926|NCT03573544|521914149|FG006|Overall Study|Withdrawal by Subject|0|||
144743927|NCT03573544|521914150|FG007|Overall Study|Withdrawal by Subject|1|||
144220158|NCT02500589|520000345|FG000|Overall Study|Death|7|||
144220159|NCT02500589|520000346|FG001|Overall Study|Death|5|||
144220160|NCT01958437|520000347|FG000|Overall Study|Incidental MRI findings|0|||
144220161|NCT01958437|520000348|FG001|Overall Study|Incidental MRI findings|0|||
144220162|NCT01958437|520000349|FG002|Overall Study|Incidental MRI findings|1|||
144220163|NCT01958437|520000350|FG003|Overall Study|Incidental MRI findings|1|||
144220164|NCT03442751|520000351|FG000|Overall Study|Withdrawal by Subject|3|||
144220165|NCT03442751|520000352|FG001|Overall Study|Withdrawal by Subject|1|||
144220166|NCT03442751|520000351|FG000|Overall Study|Lost to Follow-up|3|||
144220167|NCT03442751|520000352|FG001|Overall Study|Lost to Follow-up|0|||
144220168|NCT01928472|520000354|FG000|Overall Study|Death|0|||
144220169|NCT01928472|520000355|FG001|Overall Study|Death|0|||
144220170|NCT01928472|520000356|FG002|Overall Study|Death|1|||
144220171|NCT01928472|520000357|FG003|Overall Study|Death|0|||
144220172|NCT01928472|520000354|FG000|Overall Study|Withdrawal by Subject|4|||
144220173|NCT01928472|520000355|FG001|Overall Study|Withdrawal by Subject|4|||
144220174|NCT01928472|520000356|FG002|Overall Study|Withdrawal by Subject|1|||
144220175|NCT01928472|520000357|FG003|Overall Study|Withdrawal by Subject|2|||
144220176|NCT01928472|520000354|FG000|Overall Study|Lost to Follow-up|2|||
144220177|NCT01928472|520000355|FG001|Overall Study|Lost to Follow-up|3|||
144220178|NCT01928472|520000356|FG002|Overall Study|Lost to Follow-up|4|||
144220179|NCT01928472|520000357|FG003|Overall Study|Lost to Follow-up|0|||
144220180|NCT01928472|520000354|FG000|Overall Study|Administrative Reason|2|||
144220181|NCT01928472|520000355|FG001|Overall Study|Administrative Reason|1|||
144220182|NCT01928472|520000356|FG002|Overall Study|Administrative Reason|0|||
144220183|NCT01928472|520000357|FG003|Overall Study|Administrative Reason|0|||
144220184|NCT01928472|520000354|FG000|Overall Study|Unclassified|0|||
144220185|NCT01928472|520000355|FG001|Overall Study|Unclassified|0|||
144220186|NCT01928472|520000356|FG002|Overall Study|Unclassified|1|||
144220187|NCT01928472|520000357|FG003|Overall Study|Unclassified|0|||
144220188|NCT01308424|520000359|FG000|Baseline Eligibility|Screen Failures|71|||
144220189|NCT01308424|520000360|FG001|Baseline Eligibility|Screen Failures|0|||
144220190|NCT01308424|520000361|FG002|Baseline Eligibility|Screen Failures|0|||
144220191|NCT01308424|520000359|FG000|Randomization|Adverse Event|0|||
144743928|NCT03573544|521914143|FG000|Overall Study|Disease progression|3|||
144743929|NCT03573544|521914144|FG001|Overall Study|Disease progression|3|||
144743930|NCT03573544|521914145|FG002|Overall Study|Disease progression|6|||
144743931|NCT03573544|521914146|FG003|Overall Study|Disease progression|4|||
144743932|NCT03573544|521914147|FG004|Overall Study|Disease progression|5|||
144743933|NCT03573544|521914148|FG005|Overall Study|Disease progression|7|||
144743934|NCT03573544|521914149|FG006|Overall Study|Disease progression|6|||
144743935|NCT03573544|521914150|FG007|Overall Study|Disease progression|7|||
144743936|NCT01899053|521914154|FG000|Overall Study|Progressive Disease|4|||
144743937|NCT01899053|521914155|FG001|Overall Study|Progressive Disease|0|||
144743938|NCT01899053|521914156|FG002|Overall Study|Progressive Disease|3|||
144743939|NCT01899053|521914157|FG003|Overall Study|Progressive Disease|0|||
144743940|NCT01899053|521914158|FG004|Overall Study|Progressive Disease|3|||
144743941|NCT01899053|521914159|FG005|Overall Study|Progressive Disease|1|||
144743942|NCT01899053|521914160|FG006|Overall Study|Progressive Disease|1|||
144743943|NCT01899053|521914161|FG007|Overall Study|Progressive Disease|1|||
144743944|NCT01899053|521914162|FG008|Overall Study|Progressive Disease|4|||
144743945|NCT01899053|521914163|FG009|Overall Study|Progressive Disease|3|||
144743946|NCT01899053|521914164|FG010|Overall Study|Progressive Disease|12|||
144743947|NCT01899053|521914165|FG011|Overall Study|Progressive Disease|5|||
144743948|NCT01899053|521914166|FG012|Overall Study|Progressive Disease|8|||
144743949|NCT01899053|521914167|FG013|Overall Study|Progressive Disease|17|||
144743950|NCT01899053|521914154|FG000|Overall Study|Adverse Event|1|||
144743951|NCT01899053|521914155|FG001|Overall Study|Adverse Event|1|||
144743952|NCT01899053|521914156|FG002|Overall Study|Adverse Event|1|||
144743953|NCT01899053|521914157|FG003|Overall Study|Adverse Event|3|||
144743954|NCT01899053|521914158|FG004|Overall Study|Adverse Event|1|||
144743955|NCT01899053|521914159|FG005|Overall Study|Adverse Event|1|||
144743956|NCT01899053|521914160|FG006|Overall Study|Adverse Event|1|||
144220192|NCT01308424|520000360|FG001|Randomization|Adverse Event|1|||
144220193|NCT01308424|520000361|FG002|Randomization|Adverse Event|1|||
144220194|NCT01308424|520000359|FG000|Randomization|Lost to Follow-up|0|||
144220195|NCT01308424|520000360|FG001|Randomization|Lost to Follow-up|1|||
144220196|NCT01308424|520000361|FG002|Randomization|Lost to Follow-up|0|||
144220197|NCT01308424|520000359|FG000|Randomization|Physician Decision|0|||
144743957|NCT01899053|521914161|FG007|Overall Study|Adverse Event|0|||
144743958|NCT01899053|521914162|FG008|Overall Study|Adverse Event|2|||
144743959|NCT01899053|521914163|FG009|Overall Study|Adverse Event|0|||
144743960|NCT01899053|521914164|FG010|Overall Study|Adverse Event|3|||
144743961|NCT01899053|521914165|FG011|Overall Study|Adverse Event|1|||
144743962|NCT01899053|521914166|FG012|Overall Study|Adverse Event|2|||
144743963|NCT01899053|521914167|FG013|Overall Study|Adverse Event|2|||
144220198|NCT01308424|520000360|FG001|Randomization|Physician Decision|1|||
144743964|NCT01899053|521914154|FG000|Overall Study|Reason Not Specified|0|||
144743965|NCT01899053|521914155|FG001|Overall Study|Reason Not Specified|0|||
144743966|NCT01899053|521914156|FG002|Overall Study|Reason Not Specified|0|||
144743967|NCT01899053|521914157|FG003|Overall Study|Reason Not Specified|0|||
144743968|NCT01899053|521914158|FG004|Overall Study|Reason Not Specified|0|||
144743969|NCT01899053|521914159|FG005|Overall Study|Reason Not Specified|0|||
144743970|NCT01899053|521914160|FG006|Overall Study|Reason Not Specified|1|||
144743971|NCT01899053|521914161|FG007|Overall Study|Reason Not Specified|0|||
144743972|NCT01899053|521914162|FG008|Overall Study|Reason Not Specified|0|||
144743973|NCT01899053|521914163|FG009|Overall Study|Reason Not Specified|0|||
144743974|NCT01899053|521914164|FG010|Overall Study|Reason Not Specified|0|||
144743975|NCT01899053|521914165|FG011|Overall Study|Reason Not Specified|0|||
144743976|NCT01899053|521914166|FG012|Overall Study|Reason Not Specified|1|||
144743977|NCT01899053|521914167|FG013|Overall Study|Reason Not Specified|0|||
144743978|NCT01899053|521914154|FG000|Overall Study|Withdrawal by Subject|1|||
144743979|NCT01899053|521914155|FG001|Overall Study|Withdrawal by Subject|1|||
144743980|NCT01899053|521914156|FG002|Overall Study|Withdrawal by Subject|2|||
144743981|NCT01899053|521914157|FG003|Overall Study|Withdrawal by Subject|0|||
144743982|NCT01899053|521914158|FG004|Overall Study|Withdrawal by Subject|2|||
144743983|NCT01899053|521914159|FG005|Overall Study|Withdrawal by Subject|0|||
144743984|NCT01899053|521914160|FG006|Overall Study|Withdrawal by Subject|0|||
144743985|NCT01899053|521914161|FG007|Overall Study|Withdrawal by Subject|1|||
144743986|NCT01899053|521914162|FG008|Overall Study|Withdrawal by Subject|0|||
144743987|NCT01899053|521914163|FG009|Overall Study|Withdrawal by Subject|0|||
144743988|NCT01899053|521914164|FG010|Overall Study|Withdrawal by Subject|0|||
144743989|NCT01899053|521914165|FG011|Overall Study|Withdrawal by Subject|0|||
144743990|NCT01899053|521914166|FG012|Overall Study|Withdrawal by Subject|1|||
144743991|NCT01899053|521914167|FG013|Overall Study|Withdrawal by Subject|1|||
144743992|NCT01899053|521914154|FG000|Overall Study|Protocol Violation|0|||
144743993|NCT01899053|521914155|FG001|Overall Study|Protocol Violation|0|||
144743994|NCT01899053|521914156|FG002|Overall Study|Protocol Violation|1|||
144743995|NCT01899053|521914157|FG003|Overall Study|Protocol Violation|0|||
144743996|NCT01899053|521914158|FG004|Overall Study|Protocol Violation|0|||
144743997|NCT01899053|521914159|FG005|Overall Study|Protocol Violation|0|||
144743998|NCT01899053|521914160|FG006|Overall Study|Protocol Violation|0|||
144743999|NCT01899053|521914161|FG007|Overall Study|Protocol Violation|0|||
144744000|NCT01899053|521914162|FG008|Overall Study|Protocol Violation|0|||
144744001|NCT01899053|521914163|FG009|Overall Study|Protocol Violation|0|||
144744002|NCT01899053|521914164|FG010|Overall Study|Protocol Violation|0|||
144744003|NCT01899053|521914165|FG011|Overall Study|Protocol Violation|0|||
144744004|NCT01899053|521914166|FG012|Overall Study|Protocol Violation|0|||
144744005|NCT01899053|521914167|FG013|Overall Study|Protocol Violation|0|||
144744006|NCT01899053|521914154|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
144744007|NCT01899053|521914155|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
144744008|NCT01899053|521914156|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744009|NCT01899053|521914157|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744010|NCT01899053|521914158|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744011|NCT01899053|521914159|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744012|NCT01899053|521914160|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744013|NCT01899053|521914161|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744014|NCT01899053|521914162|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744015|NCT01899053|521914163|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744016|NCT01899053|521914164|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
144744017|NCT01899053|521914165|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744018|NCT01899053|521914166|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744019|NCT01899053|521914167|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
144744020|NCT01899053|521914154|FG000|Overall Study|Symptomatic Deterioration|0|||
144744021|NCT01899053|521914155|FG001|Overall Study|Symptomatic Deterioration|0|||
144744022|NCT01899053|521914156|FG002|Overall Study|Symptomatic Deterioration|0|||
144744023|NCT01899053|521914157|FG003|Overall Study|Symptomatic Deterioration|0|||
144744024|NCT01899053|521914158|FG004|Overall Study|Symptomatic Deterioration|0|||
144744025|NCT01899053|521914159|FG005|Overall Study|Symptomatic Deterioration|1|||
144744026|NCT01899053|521914160|FG006|Overall Study|Symptomatic Deterioration|0|||
144744027|NCT01899053|521914161|FG007|Overall Study|Symptomatic Deterioration|1|||
144744028|NCT01899053|521914162|FG008|Overall Study|Symptomatic Deterioration|0|||
144744029|NCT01899053|521914163|FG009|Overall Study|Symptomatic Deterioration|0|||
144744030|NCT01899053|521914164|FG010|Overall Study|Symptomatic Deterioration|0|||
144744031|NCT01899053|521914165|FG011|Overall Study|Symptomatic Deterioration|1|||
144744032|NCT01899053|521914166|FG012|Overall Study|Symptomatic Deterioration|2|||
144744033|NCT01899053|521914167|FG013|Overall Study|Symptomatic Deterioration|0|||
144744034|NCT03105297|521914168|FG000|Baseline Phase (Day 1)|Other|21|||
144744035|NCT03105297|521914168|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
144744036|NCT03105297|521914168|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
144744037|NCT00227370|521914170|FG000|Overall Study|Withdrawal by Subject|1|||
144744038|NCT00227370|521914171|FG001|Overall Study|Withdrawal by Subject|2|||
144744039|NCT00227370|521914170|FG000|Overall Study|Death|3|||
144744040|NCT00227370|521914171|FG001|Overall Study|Death|4|||
144744041|NCT00227370|521914170|FG000|Overall Study|Adverse Event|6|||
144744042|NCT00227370|521914171|FG001|Overall Study|Adverse Event|11|||
144744043|NCT00227370|521914170|FG000|Overall Study|Physician Decision|9|||
144744044|NCT00227370|521914171|FG001|Overall Study|Physician Decision|6|||
144744045|NCT00227370|521914170|FG000|Overall Study|Other reasons|2|||
144744046|NCT00227370|521914171|FG001|Overall Study|Other reasons|1|||
144744047|NCT03846193|521914172|FG000|Overall Study|Physician Decision|0|||
144744048|NCT03846193|521914173|FG001|Overall Study|Physician Decision|0|||
144744049|NCT03846193|521914174|FG002|Overall Study|Physician Decision|1|||
144744050|NCT03846193|521914175|FG003|Overall Study|Physician Decision|0|||
144744051|NCT03846193|521914176|FG004|Overall Study|Physician Decision|0|||
144744052|NCT03846193|521914172|FG000|Overall Study|Lost to Follow-up|0|||
144744053|NCT03846193|521914173|FG001|Overall Study|Lost to Follow-up|0|||
144744054|NCT03846193|521914174|FG002|Overall Study|Lost to Follow-up|0|||
144744055|NCT03846193|521914175|FG003|Overall Study|Lost to Follow-up|0|||
144744056|NCT03846193|521914176|FG004|Overall Study|Lost to Follow-up|1|||
144744057|NCT03846193|521914172|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
144744058|NCT03846193|521914173|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
144744059|NCT03846193|521914174|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
144744060|NCT03846193|521914175|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
144744061|NCT03846193|521914176|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
144744062|NCT01401062|521914177|FG000|Overall Study|Death|9|||
144744063|NCT01401062|521914178|FG001|Overall Study|Death|7|||
144744064|NCT01401062|521914177|FG000|Overall Study|Physician Decision|1|||
144744065|NCT01401062|521914178|FG001|Overall Study|Physician Decision|0|||
144744066|NCT01401062|521914177|FG000|Overall Study|Withdrawal by Subject|1|||
144744067|NCT01401062|521914178|FG001|Overall Study|Withdrawal by Subject|1|||
144744068|NCT01968031|521914188|FG000|Overall Study|Adverse Event|13|||
144744069|NCT01968031|521914189|FG001|Overall Study|Adverse Event|10|||
144744070|NCT01968031|521914190|FG002|Overall Study|Adverse Event|22|||
144744071|NCT01968031|521914188|FG000|Overall Study|Withdrawal by Subject|3|||
144744072|NCT01968031|521914189|FG001|Overall Study|Withdrawal by Subject|7|||
144744073|NCT01968031|521914190|FG002|Overall Study|Withdrawal by Subject|3|||
144744074|NCT01968031|521914188|FG000|Overall Study|Did not meet entry criteria|1|||
144744075|NCT01968031|521914189|FG001|Overall Study|Did not meet entry criteria|1|||
144744076|NCT01968031|521914190|FG002|Overall Study|Did not meet entry criteria|1|||
144744077|NCT01968031|521914188|FG000|Overall Study|Noncompliance|0|||
144744078|NCT01968031|521914189|FG001|Overall Study|Noncompliance|0|||
144744079|NCT01968031|521914190|FG002|Overall Study|Noncompliance|2|||
144744080|NCT01968031|521914188|FG000|Overall Study|Failed inclusion criteria|0|||
144744081|NCT01968031|521914189|FG001|Overall Study|Failed inclusion criteria|2|||
144744082|NCT01968031|521914190|FG002|Overall Study|Failed inclusion criteria|0|||
144744083|NCT01968031|521914188|FG000|Overall Study|Death|0|||
144744084|NCT01968031|521914189|FG001|Overall Study|Death|0|||
144744085|NCT01968031|521914190|FG002|Overall Study|Death|1|||
144744086|NCT01968031|521914188|FG000|Overall Study|Prohibited concomitant medication|1|||
144744087|NCT01968031|521914189|FG001|Overall Study|Prohibited concomitant medication|0|||
144744088|NCT01968031|521914190|FG002|Overall Study|Prohibited concomitant medication|0|||
144744089|NCT00516295|521915904|FG000|Overall Study|Lack of Efficacy|2|||
144744090|NCT00516295|521915905|FG001|Overall Study|Lack of Efficacy|0|||
144744091|NCT00516295|521915906|FG002|Overall Study|Lack of Efficacy|0|||
144744092|NCT00516295|521915904|FG000|Overall Study|Ineligible|1|||
144744093|NCT00516295|521915905|FG001|Overall Study|Ineligible|0|||
144744094|NCT00516295|521915906|FG002|Overall Study|Ineligible|0|||
144744095|NCT02034513|521915907|FG000|Overall Study|Adverse Event|11|||
144744096|NCT02034513|521915908|FG001|Overall Study|Adverse Event|10|||
144744097|NCT02034513|521915907|FG000|Overall Study|Lack of Efficacy|0|||
144744098|NCT02034513|521915908|FG001|Overall Study|Lack of Efficacy|1|||
144744099|NCT02034513|521915907|FG000|Overall Study|Lost to Follow-up|6|||
144744100|NCT02034513|521915908|FG001|Overall Study|Lost to Follow-up|7|||
144744101|NCT02034513|521915907|FG000|Overall Study|Pregnancy|0|||
144744102|NCT02034513|521915908|FG001|Overall Study|Pregnancy|3|||
144744103|NCT02034513|521915907|FG000|Overall Study|Protocol Violation|7|||
144744104|NCT02034513|521915908|FG001|Overall Study|Protocol Violation|10|||
144744105|NCT02034513|521915907|FG000|Overall Study|Withdrawal by Subject|25|||
144744106|NCT02034513|521915908|FG001|Overall Study|Withdrawal by Subject|25|||
144744107|NCT02034513|521915907|FG000|Overall Study|Unclassified|0|||
144744108|NCT02034513|521915908|FG001|Overall Study|Unclassified|1|||
144744109|NCT02578641|521915909|FG000|Overall Study|Adverse Event|5|||
144744110|NCT02578641|521915910|FG001|Overall Study|Adverse Event|15|||
144744111|NCT02578641|521915909|FG000|Overall Study|Death|16|||
144744112|NCT02578641|521915910|FG001|Overall Study|Death|8|||
144744113|NCT02578641|521915909|FG000|Overall Study|Lost to Follow-up|0|||
144744114|NCT02578641|521915910|FG001|Overall Study|Lost to Follow-up|1|||
144744115|NCT02578641|521915909|FG000|Overall Study|Withdrawal by Subject|14|||
144744116|NCT02578641|521915910|FG001|Overall Study|Withdrawal by Subject|7|||
144744117|NCT02578641|521915909|FG000|Overall Study|Progressive Disease|69|||
144744118|NCT02578641|521915910|FG001|Overall Study|Progressive Disease|21|||
144744119|NCT02578641|521915909|FG000|Overall Study|No Study Drug|2|||
144744120|NCT02578641|521915910|FG001|Overall Study|No Study Drug|0|||
144744121|NCT02578641|521915909|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
144744122|NCT02578641|521915910|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
144744123|NCT02578641|521915909|FG000|Overall Study|Non-compliance with Study Schedule|1|||
144744124|NCT02578641|521915910|FG001|Overall Study|Non-compliance with Study Schedule|0|||
144744125|NCT02578641|521915909|FG000|Overall Study|Other|1|||
144744126|NCT02578641|521915910|FG001|Overall Study|Other|10|||
144744127|NCT02578641|521915909|FG000|Overall Study|Not treated|1|||
144744128|NCT02578641|521915910|FG001|Overall Study|Not treated|4|||
144744129|NCT02313558|521915914|FG000|Overall Study|Withdrawal by Subject|2|||
144744130|NCT02313558|521915915|FG001|Overall Study|Withdrawal by Subject|0|||
144744131|NCT02313558|521915914|FG000|Overall Study|Lost to Follow-up|4|||
144744132|NCT02313558|521915915|FG001|Overall Study|Lost to Follow-up|4|||
144744133|NCT04158687|521915916|FG000|Overall Study|Adverse Event|2|||
144744134|NCT04158687|521915917|FG001|Overall Study|Adverse Event|3|||
144744135|NCT04158687|521915918|FG002|Overall Study|Adverse Event|0|||
144744136|NCT04158687|521915919|FG003|Overall Study|Adverse Event|3|||
144744137|NCT04158687|521915916|FG000|Overall Study|Lost to Follow-up|5|||
144744138|NCT04158687|521915917|FG001|Overall Study|Lost to Follow-up|12|||
144744139|NCT04158687|521915918|FG002|Overall Study|Lost to Follow-up|4|||
144744140|NCT04158687|521915919|FG003|Overall Study|Lost to Follow-up|5|||
144744141|NCT04158687|521915916|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
144744142|NCT04158687|521915917|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
144744143|NCT04158687|521915918|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
144744144|NCT04158687|521915919|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
144744145|NCT04158687|521915916|FG000|Overall Study|Non-Compliance with Study Medication|2|||
144744146|NCT04158687|521915917|FG001|Overall Study|Non-Compliance with Study Medication|2|||
144744147|NCT04158687|521915918|FG002|Overall Study|Non-Compliance with Study Medication|3|||
144744148|NCT04158687|521915919|FG003|Overall Study|Non-Compliance with Study Medication|0|||
144744149|NCT04158687|521915916|FG000|Overall Study|Investigator Decision|0|||
144744150|NCT04158687|521915917|FG001|Overall Study|Investigator Decision|0|||
144744151|NCT04158687|521915918|FG002|Overall Study|Investigator Decision|2|||
144744152|NCT04158687|521915919|FG003|Overall Study|Investigator Decision|0|||
144744153|NCT04158687|521915916|FG000|Overall Study|Protocol Violation|0|||
144744154|NCT04158687|521915917|FG001|Overall Study|Protocol Violation|2|||
144744155|NCT04158687|521915918|FG002|Overall Study|Protocol Violation|1|||
144744156|NCT04158687|521915919|FG003|Overall Study|Protocol Violation|0|||
144744157|NCT04158687|521915916|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
144744158|NCT04158687|521915917|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
144744159|NCT04158687|521915918|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
144744160|NCT04158687|521915919|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
144744161|NCT04158687|521915916|FG000|Overall Study|Reason not Specified|3|||
144744162|NCT04158687|521915917|FG001|Overall Study|Reason not Specified|2|||
144744163|NCT04158687|521915918|FG002|Overall Study|Reason not Specified|4|||
144744164|NCT04158687|521915919|FG003|Overall Study|Reason not Specified|4|||
144744165|NCT00640393|521915920|FG000|Part 1|Lost to Follow-up|2|||
144744166|NCT00640393|521915921|FG001|Part 1|Lost to Follow-up|0|||
144744167|NCT00640393|521915922|FG002|Part 1|Lost to Follow-up|0|||
144744168|NCT00640393|521915920|FG000|Part 1|Withdrawal by Subject|3|||
144744169|NCT00640393|521915921|FG001|Part 1|Withdrawal by Subject|0|||
144744170|NCT00640393|521915922|FG002|Part 1|Withdrawal by Subject|0|||
144744171|NCT00640393|521915920|FG000|Randomization|Withdrawn per protocol|17|||
144744172|NCT00640393|521915921|FG001|Randomization|Withdrawn per protocol|0|||
144744173|NCT00640393|521915922|FG002|Randomization|Withdrawn per protocol|0|||
144744174|NCT00640393|521915920|FG000|Randomization|Never randomized by site|2|||
144744175|NCT00640393|521915921|FG001|Randomization|Never randomized by site|0|||
144744176|NCT00640393|521915922|FG002|Randomization|Never randomized by site|0|||
144744177|NCT00640393|521915920|FG000|Part 2|Lost to Follow-up|0|||
144744178|NCT00640393|521915921|FG001|Part 2|Lost to Follow-up|2|||
144744179|NCT00640393|521915922|FG002|Part 2|Lost to Follow-up|2|||
144744180|NCT00640393|521915920|FG000|Part 2|Withdrawal by Subject|0|||
144744181|NCT00640393|521915921|FG001|Part 2|Withdrawal by Subject|6|||
144744182|NCT00640393|521915922|FG002|Part 2|Withdrawal by Subject|1|||
144744183|NCT00640393|521915920|FG000|Part 2|Non-adherence|0|||
144744184|NCT00640393|521915921|FG001|Part 2|Non-adherence|1|||
144744185|NCT00640393|521915922|FG002|Part 2|Non-adherence|0|||
144744186|NCT00640393|521915920|FG000|Part 2|Adverse Event|0|||
144744187|NCT00640393|521915921|FG001|Part 2|Adverse Event|1|||
144220199|NCT01308424|520000361|FG002|Randomization|Physician Decision|1|||
144744188|NCT00640393|521915922|FG002|Part 2|Adverse Event|0|||
144744189|NCT00198133|521915924|FG000|Overall Study|Disease progression|2|||
144744190|NCT00198133|521915925|FG001|Overall Study|Disease progression|5|||
144744191|NCT00198133|521915924|FG000|Overall Study|Adverse Event|1|||
144744192|NCT00198133|521915925|FG001|Overall Study|Adverse Event|3|||
144744193|NCT00198133|521915924|FG000|Overall Study|Withdrawal by Subject|1|||
144744194|NCT00198133|521915925|FG001|Overall Study|Withdrawal by Subject|0|||
144744195|NCT00198133|521915924|FG000|Overall Study|Physician Decision|1|||
144744196|NCT00198133|521915925|FG001|Overall Study|Physician Decision|0|||
144744197|NCT03707587|521915931|FG000|Overall Study|Death|0|||
144744198|NCT03707587|521915932|FG001|Overall Study|Death|1|||
144744199|NCT00834444|521915933|FG000|First Intervention|Adverse Event|1|||
144744200|NCT00834444|521915934|FG001|First Intervention|Adverse Event|0|||
144744201|NCT00834444|521915933|FG000|First Intervention|Intolerance to Venopuncture|0|||
144744202|NCT00834444|521915934|FG001|First Intervention|Intolerance to Venopuncture|1|||
144744203|NCT00834444|521915933|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
144744204|NCT00834444|521915934|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
144744205|NCT00834444|521915933|FG000|Second Intervention|Adverse Event|1|||
144744206|NCT00834444|521915934|FG001|Second Intervention|Adverse Event|0|||
144744207|NCT00731939|521915938|FG000|Overall Study|Adverse Event|6|||
144744208|NCT00731939|521915938|FG000|Overall Study|Lost to Follow-up|15|||
144744209|NCT00731939|521915938|FG000|Overall Study|Not implanted with study device|9|||
144744210|NCT00731939|521915938|FG000|Overall Study|Withdrawal by Subject|2|||
144744211|NCT00731939|521915938|FG000|Overall Study|Did not meet enrollment criteria|2|||
144744212|NCT02420353|521915945|FG000|Overall Study|Withdrawal by Subject|0|||
144744213|NCT02420353|521915946|FG001|Overall Study|Withdrawal by Subject|1|||
144744214|NCT01438060|521915947|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
144744215|NCT01438060|521915948|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
144744216|NCT01438060|521915947|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
144744217|NCT01438060|521915948|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
144744218|NCT01438060|521915947|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
144744219|NCT01438060|521915948|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
144744220|NCT01438060|521915947|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
144744221|NCT01438060|521915948|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
144744222|NCT01438060|521915947|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
144744223|NCT01438060|521915948|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
144744224|NCT01438060|521915947|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
144744225|NCT01438060|521915948|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
144744226|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
144744227|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
144744228|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
144744229|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
144744230|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
144744231|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
144744232|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
144744233|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
144744234|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
144744235|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
144744236|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
144744237|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
144744238|NCT01438060|521915947|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
144744239|NCT01438060|521915948|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
144744240|NCT01438060|521915947|FG000|On Study Beyond Week 140|Adverse Event|0|||
144744241|NCT01438060|521915948|FG001|On Study Beyond Week 140|Adverse Event|2|||
144744242|NCT01438060|521915947|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
144744243|NCT01438060|521915948|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
144744244|NCT01438060|521915947|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
144744245|NCT01438060|521915948|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
144744246|NCT01438060|521915947|FG000|On Study Beyond Week 140|Death|0|||
144744247|NCT01438060|521915948|FG001|On Study Beyond Week 140|Death|1|||
144744248|NCT01438060|521915947|FG000|On Study Beyond Week 140|Other Reason|0|||
144744249|NCT01438060|521915948|FG001|On Study Beyond Week 140|Other Reason|3|||
144744250|NCT01964950|521915949|FG000|Overall Study|Protocol Violation|25|||
144744251|NCT01297504|521915950|FG000|Overall Study|Invalid Consent|1|||
144744252|NCT01297504|521915950|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
144744253|NCT01297504|521915950|FG000|Overall Study|No Study Visits|4|||
144744254|NCT01297504|521915950|FG000|Overall Study|Death|3|||
144744255|NCT01297504|521915950|FG000|Overall Study|Lost to Follow-up|43|||
144744256|NCT01297504|521915950|FG000|Overall Study|Withdrawal by Subject|9|||
144744257|NCT01297504|521915950|FG000|Overall Study|Site Closure|3|||
144744258|NCT01297504|521915950|FG000|Overall Study|Protocol Violation|3|||
144744259|NCT03602339|521915951|FG000|Overall Study|Withdrawal by Subject|9|||
144744260|NCT03602339|521915951|FG000|Overall Study|Physician Decision|2|||
144744261|NCT03602339|521915951|FG000|Overall Study|Other reason|4|||
144744262|NCT00654186|521915952|FG000|Overall Study|Withdrawal by Subject|5|||
144744263|NCT01024855|521915955|FG000|Overall Study|Inclusion/exclusion criteria|1|||
144744264|NCT03306277|521915957|FG000|Overall Study|Death|1|||
144744265|NCT03306277|521915957|FG000|Overall Study|Adverse Event|1|||
144744266|NCT03306277|521915957|FG000|Overall Study|Withdrawal by Subject|1|||
144744267|NCT00487435|521915958|FG000|Overall Study|Adverse Event|146|||
144744268|NCT00487435|521915958|FG000|Overall Study|Death|2|||
144744269|NCT00487435|521915958|FG000|Overall Study|Lack of Efficacy|33|||
144744270|NCT00487435|521915958|FG000|Overall Study|Lost to Follow-up|54|||
144744271|NCT00487435|521915958|FG000|Overall Study|Pregnancy|2|||
144744272|NCT00487435|521915958|FG000|Overall Study|Withdrawal by Subject|132|||
144744273|NCT00487435|521915958|FG000|Overall Study|Resolution Of Pain|1|||
144744274|NCT00487435|521915958|FG000|Overall Study|Study Medication Non-Compliant|32|||
144744275|NCT00487435|521915958|FG000|Overall Study|Other|83|||
144744276|NCT01155531|521915965|FG000|Overall Study|Adverse Event|0|||
144744277|NCT01155531|521915966|FG001|Overall Study|Adverse Event|0|||
144744278|NCT01155531|521915967|FG002|Overall Study|Adverse Event|1|||
144744279|NCT01155531|521915968|FG003|Overall Study|Adverse Event|0|||
144744280|NCT01155531|521915965|FG000|Overall Study|Lost to Follow-up|0|||
144744281|NCT01155531|521915966|FG001|Overall Study|Lost to Follow-up|0|||
144744282|NCT01155531|521915967|FG002|Overall Study|Lost to Follow-up|0|||
144744283|NCT01155531|521915968|FG003|Overall Study|Lost to Follow-up|1|||
144744284|NCT01155531|521915965|FG000|Overall Study|Withdrawal by Subject|1|||
144744285|NCT01155531|521915966|FG001|Overall Study|Withdrawal by Subject|0|||
144744286|NCT01155531|521915967|FG002|Overall Study|Withdrawal by Subject|1|||
144744287|NCT01155531|521915968|FG003|Overall Study|Withdrawal by Subject|0|||
144744288|NCT01087502|521915969|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
144744289|NCT01087502|521915970|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
144744290|NCT01087502|521915969|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
144744291|NCT01087502|521915970|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
144744292|NCT01087502|521915969|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
144744293|NCT01087502|521915970|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
144744294|NCT01087502|521915969|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
144744295|NCT01087502|521915970|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
144744296|NCT01087502|521915969|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
144744297|NCT01087502|521915970|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
144744298|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
144744299|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
144744300|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
144744301|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
144744302|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
144744303|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
144744304|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
144744305|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
144744306|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
144744307|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
144744308|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
144744309|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
144744310|NCT01087502|521915969|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
144744311|NCT01087502|521915970|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
144744312|NCT01653704|521915971|FG000|Overall Study|Technical failure during recording|1|||
144744313|NCT01653704|521915972|FG001|Overall Study|Technical failure during recording|1|||
144744314|NCT01653704|521915971|FG000|Overall Study|Performance not reflective of training|1|||
144744315|NCT01653704|521915972|FG001|Overall Study|Performance not reflective of training|0|||
144744316|NCT02705716|521915973|FG000|Overall Study|Adverse Event|0|||
144744317|NCT02705716|521915974|FG001|Overall Study|Adverse Event|1|||
144744318|NCT02705716|521915973|FG000|Overall Study|Protocol Violation|3|||
144744319|NCT02705716|521915974|FG001|Overall Study|Protocol Violation|0|||
144744320|NCT02705716|521915973|FG000|Overall Study|Withdrawal of Consent|1|||
144744321|NCT02705716|521915974|FG001|Overall Study|Withdrawal of Consent|1|||
144744322|NCT01632306|521915975|FG000|Overall Study|Protocol Violation|1|||
144744323|NCT01632306|521915976|FG001|Overall Study|Protocol Violation|0|||
144744324|NCT01632306|521915977|FG002|Overall Study|Protocol Violation|0|||
144744325|NCT03966911|521915980|FG000|Overall Study|Adverse Event|1|||
144744326|NCT03966911|521915981|FG001|Overall Study|Adverse Event|1|||
144744327|NCT03966911|521915980|FG000|Overall Study|Withdrawal by Subject|8|||
144220200|NCT05767905|520000362|FG000|Overall Study|Adverse Event|0|||
144220201|NCT05767905|520000363|FG001|Overall Study|Adverse Event|0|||
144220202|NCT05767905|520000364|FG002|Overall Study|Adverse Event|1|||
144744328|NCT03966911|521915981|FG001|Overall Study|Withdrawal by Subject|2|||
144744329|NCT03966911|521915980|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
144744330|NCT03966911|521915981|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
144744331|NCT00985751|521915982|FG000|Overall Study|Adverse Event|0|||
144744332|NCT00985751|521915983|FG001|Overall Study|Adverse Event|0|||
144744333|NCT00985751|521915984|FG002|Overall Study|Adverse Event|0|||
144744334|NCT00985751|521915985|FG003|Overall Study|Adverse Event|0|||
144744335|NCT00985751|521915986|FG004|Overall Study|Adverse Event|1|||
144744336|NCT00380588|521915987|FG000|Overall Study|Unequivocal Disease Progression|25|||
144744337|NCT00380588|521915988|FG001|Overall Study|Unequivocal Disease Progression|34|||
144744338|NCT00380588|521915987|FG000|Overall Study|Next Cycle Not Started|4|||
144220203|NCT03535740|520000365|FG000|Overall Study|Death|44|||
144693192|NCT00695318|521727537|FG000|Overall Study|Death|1|||
144693193|NCT00695318|521727538|FG001|Overall Study|Death|1|||
144693194|NCT00695318|521727537|FG000|Overall Study|Study Terminated|1|||
144693195|NCT00695318|521727538|FG001|Overall Study|Study Terminated|0|||
144693196|NCT02705755|521727539|FG000|Part A (6 Days)|Adverse Event|1|||
144693197|NCT02705755|521727540|FG001|Part A (6 Days)|Adverse Event|0|||
144693198|NCT02705755|521727541|FG002|Part A (6 Days)|Adverse Event|0|||
144693199|NCT02705755|521727542|FG003|Part A (6 Days)|Adverse Event|0|||
144693200|NCT02705755|521727539|FG000|Part A (6 Days)|Physician Decision|3|||
144693201|NCT02705755|521727540|FG001|Part A (6 Days)|Physician Decision|0|||
144693202|NCT02705755|521727541|FG002|Part A (6 Days)|Physician Decision|0|||
144693203|NCT02705755|521727542|FG003|Part A (6 Days)|Physician Decision|0|||
144693204|NCT02705755|521727539|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
144693205|NCT02705755|521727540|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
144693206|NCT02705755|521727541|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
144693207|NCT02705755|521727542|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
144693208|NCT02705755|521727539|FG000|Part C (20 Weeks)|Physician Decision|0|||
144693209|NCT02705755|521727540|FG001|Part C (20 Weeks)|Physician Decision|0|||
144693210|NCT02705755|521727541|FG002|Part C (20 Weeks)|Physician Decision|0|||
144693211|NCT02705755|521727542|FG003|Part C (20 Weeks)|Physician Decision|2|||
144693212|NCT02705755|521727539|FG000|Part C (20 Weeks)|Adverse Event|0|||
144693213|NCT02705755|521727540|FG001|Part C (20 Weeks)|Adverse Event|0|||
144693214|NCT02705755|521727541|FG002|Part C (20 Weeks)|Adverse Event|0|||
144693215|NCT02705755|521727542|FG003|Part C (20 Weeks)|Adverse Event|6|||
144693216|NCT02705755|521727539|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
144693217|NCT02705755|521727540|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
144693218|NCT02705755|521727541|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
144693219|NCT02705755|521727542|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
144693220|NCT00939094|521727543|FG000|Overall Study|Adverse Event|9|||
144693221|NCT00939094|521727544|FG001|Overall Study|Adverse Event|0|||
144693222|NCT00939094|521727543|FG000|Overall Study|Withdrawal by Subject|1|||
144693223|NCT00939094|521727544|FG001|Overall Study|Withdrawal by Subject|6|||
144693224|NCT00939094|521727543|FG000|Overall Study|Lost to Follow-up|1|||
144693225|NCT00939094|521727544|FG001|Overall Study|Lost to Follow-up|1|||
144693226|NCT00939094|521727543|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144693227|NCT00939094|521727544|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144693228|NCT00939094|521727543|FG000|Overall Study|Severe non-compliance to protocol|0|||
144693229|NCT00939094|521727544|FG001|Overall Study|Severe non-compliance to protocol|1|||
144693230|NCT00939094|521727543|FG000|Overall Study|Study stopped by sponsor|0|||
144693231|NCT00939094|521727544|FG001|Overall Study|Study stopped by sponsor|2|||
144693232|NCT00939094|521727543|FG000|Overall Study|Abnormal ECG findings|1|||
144693233|NCT00939094|521727544|FG001|Overall Study|Abnormal ECG findings|0|||
144693234|NCT03726320|521729593|FG000|Overall Study|Lost to Follow-up|2|||
144693235|NCT03726320|521729594|FG001|Overall Study|Lost to Follow-up|4|||
144693236|NCT03726320|521729595|FG002|Overall Study|Lost to Follow-up|0|||
144693237|NCT03726320|521729593|FG000|Overall Study|Time Constraints|4|||
144693238|NCT03726320|521729594|FG001|Overall Study|Time Constraints|1|||
144693239|NCT03726320|521729595|FG002|Overall Study|Time Constraints|0|||
144693240|NCT03726320|521729593|FG000|Overall Study|Ineligible after enrollment|3|||
144693241|NCT03726320|521729594|FG001|Overall Study|Ineligible after enrollment|3|||
144693242|NCT03726320|521729595|FG002|Overall Study|Ineligible after enrollment|0|||
144693243|NCT03726320|521729593|FG000|Overall Study|Clinic / insurance issue|2|||
144693244|NCT03726320|521729594|FG001|Overall Study|Clinic / insurance issue|0|||
144693245|NCT03726320|521729595|FG002|Overall Study|Clinic / insurance issue|0|||
144693246|NCT03726320|521729593|FG000|Overall Study|Language barrier|1|||
144693247|NCT03726320|521729594|FG001|Overall Study|Language barrier|0|||
144693248|NCT03726320|521729595|FG002|Overall Study|Language barrier|0|||
144693249|NCT03726320|521729593|FG000|Overall Study|Provider left the clinic|0|||
144693250|NCT03726320|521729594|FG001|Overall Study|Provider left the clinic|0|||
144693251|NCT03726320|521729595|FG002|Overall Study|Provider left the clinic|1|||
144693252|NCT02028182|521729598|FG000|Overall Study|Protocol Violation|2|||
144693253|NCT01684930|521729601|FG000|Overall Study|Withdrawal by Subject|3|||
144693254|NCT01684930|521729602|FG001|Overall Study|Withdrawal by Subject|1|||
144693255|NCT00965458|521729603|FG000|Overall Study|Adverse Event|1|||
144693256|NCT00965458|521729604|FG001|Overall Study|Adverse Event|0|||
144693257|NCT00965458|521729603|FG000|Overall Study|Lost to Follow-up|1|||
144693258|NCT00965458|521729604|FG001|Overall Study|Lost to Follow-up|3|||
144693259|NCT00965458|521729603|FG000|Overall Study|Withdrawal by Subject|0|||
144693260|NCT00965458|521729604|FG001|Overall Study|Withdrawal by Subject|1|||
144220204|NCT03535740|520000365|FG000|Overall Study|Lost to Follow-up|1|||
144220205|NCT03535740|520000365|FG000|Overall Study|Withdrawal by Subject|13|||
144693261|NCT00594958|521729605|FG000|Overall Study|Withdrawal by Subject|1|||
144693262|NCT00594958|521729606|FG001|Overall Study|Withdrawal by Subject|0|||
144693263|NCT00594958|521729607|FG002|Overall Study|Withdrawal by Subject|1|||
144693264|NCT00594958|521729605|FG000|Overall Study|Adverse Event|4|||
144693265|NCT00594958|521729606|FG001|Overall Study|Adverse Event|1|||
144693266|NCT00594958|521729607|FG002|Overall Study|Adverse Event|2|||
144744339|NCT00380588|521915988|FG001|Overall Study|Next Cycle Not Started|0|||
144744340|NCT00380588|521915987|FG000|Overall Study|Adverse Event|7|||
144744341|NCT00380588|521915988|FG001|Overall Study|Adverse Event|3|||
144744342|NCT00380588|521915987|FG000|Overall Study|Withdrawal by Subject|1|||
144744343|NCT00380588|521915988|FG001|Overall Study|Withdrawal by Subject|3|||
144744344|NCT00380588|521915987|FG000|Overall Study|Physician Decision|2|||
144744345|NCT00380588|521915988|FG001|Overall Study|Physician Decision|0|||
144744346|NCT01986647|521915989|FG000|Overall Study|Lost to Follow-up|4|||
144744347|NCT01986647|521915990|FG001|Overall Study|Lost to Follow-up|1|||
144744348|NCT01986647|521915991|FG002|Overall Study|Lost to Follow-up|4|||
144744349|NCT01986647|521915992|FG003|Overall Study|Lost to Follow-up|4|||
144744350|NCT01986647|521915989|FG000|Overall Study|Withdrawal by Subject|1|||
144744351|NCT01986647|521915990|FG001|Overall Study|Withdrawal by Subject|3|||
144744352|NCT01986647|521915991|FG002|Overall Study|Withdrawal by Subject|2|||
144744353|NCT01986647|521915992|FG003|Overall Study|Withdrawal by Subject|3|||
144744354|NCT01986647|521915989|FG000|Overall Study|Health|5|||
144744355|NCT01986647|521915990|FG001|Overall Study|Health|3|||
144744356|NCT01986647|521915991|FG002|Overall Study|Health|6|||
144744357|NCT01986647|521915992|FG003|Overall Study|Health|4|||
144744358|NCT02905435|521915993|FG000|Overall Study|Death|2|||
144744359|NCT02905435|521915993|FG000|Overall Study|Physician Decision|1|||
144744360|NCT02905435|521915993|FG000|Overall Study|Lost to Follow-up|4|||
144693267|NCT00594958|521729605|FG000|Overall Study|Pregnancy|0|||
144693268|NCT00594958|521729606|FG001|Overall Study|Pregnancy|2|||
144693269|NCT00594958|521729607|FG002|Overall Study|Pregnancy|0|||
144693270|NCT00594958|521729605|FG000|Overall Study|Protocol Violation|1|||
144693271|NCT00594958|521729606|FG001|Overall Study|Protocol Violation|0|||
144693272|NCT00594958|521729607|FG002|Overall Study|Protocol Violation|2|||
144693273|NCT00594958|521729605|FG000|Overall Study|Lost to Follow-up|5|||
144693274|NCT00594958|521729606|FG001|Overall Study|Lost to Follow-up|0|||
144744361|NCT01663896|521915997|FG000|Overall Study|Various reasons|43|||
144744362|NCT01046084|521916001|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
144744363|NCT01046084|521916002|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
144744364|NCT00474188|521916003|FG000|Overall Study|Withdrawal by Subject|1|||
144744365|NCT00474188|521916003|FG000|Overall Study|Study discontinued by sponsor|5|||
144744366|NCT03614728|521916004|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
144744367|NCT03614728|521916005|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
144744368|NCT03614728|521916006|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
144744369|NCT03614728|521916007|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
144744370|NCT03614728|521916004|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
144744371|NCT03614728|521916005|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
144744372|NCT03614728|521916006|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
144744373|NCT03614728|521916007|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
144744374|NCT00842309|521916012|FG000|Overall Study|Withdrawal by Subject|3|||
144744375|NCT00842309|521916013|FG001|Overall Study|Withdrawal by Subject|1|||
144744376|NCT01962298|521916014|FG000|Overall Study|Protocol Violation|1|||
144744377|NCT01962298|521916015|FG001|Overall Study|Protocol Violation|0|||
144744378|NCT01962298|521916016|FG002|Overall Study|Protocol Violation|1|||
144744379|NCT01962298|521916017|FG003|Overall Study|Protocol Violation|1|||
144744380|NCT01962298|521916018|FG004|Overall Study|Protocol Violation|0|||
144744381|NCT01962298|521916014|FG000|Overall Study|Data quality insufficient|2|||
144744382|NCT01962298|521916015|FG001|Overall Study|Data quality insufficient|0|||
144744383|NCT01962298|521916016|FG002|Overall Study|Data quality insufficient|3|||
144744384|NCT01962298|521916017|FG003|Overall Study|Data quality insufficient|1|||
144744385|NCT01962298|521916018|FG004|Overall Study|Data quality insufficient|4|||
144744386|NCT01962298|521916014|FG000|Overall Study|Insufficient data|0|||
144744387|NCT01962298|521916015|FG001|Overall Study|Insufficient data|2|||
144744388|NCT01962298|521916016|FG002|Overall Study|Insufficient data|1|||
144744389|NCT01962298|521916017|FG003|Overall Study|Insufficient data|0|||
144744390|NCT01962298|521916018|FG004|Overall Study|Insufficient data|1|||
144693275|NCT00594958|521729607|FG002|Overall Study|Lost to Follow-up|3|||
144693276|NCT00594958|521729605|FG000|Overall Study|administrative|3|||
144693277|NCT00594958|521729606|FG001|Overall Study|administrative|0|||
144744391|NCT01962298|521916014|FG000|Overall Study|Incorrect data recorded|0|||
144744392|NCT01962298|521916015|FG001|Overall Study|Incorrect data recorded|1|||
144744393|NCT01962298|521916016|FG002|Overall Study|Incorrect data recorded|0|||
144744394|NCT01962298|521916017|FG003|Overall Study|Incorrect data recorded|0|||
144744395|NCT01962298|521916018|FG004|Overall Study|Incorrect data recorded|0|||
144744396|NCT01962298|521916014|FG000|Overall Study|Physician Decision|0|||
144744397|NCT01962298|521916015|FG001|Overall Study|Physician Decision|1|||
144744398|NCT01962298|521916016|FG002|Overall Study|Physician Decision|0|||
144744399|NCT01962298|521916017|FG003|Overall Study|Physician Decision|0|||
144744400|NCT01962298|521916018|FG004|Overall Study|Physician Decision|1|||
144744401|NCT04476277|521916019|FG000|Overall Study|Withdrawal by Subject|0|||
144744402|NCT04476277|521916020|FG001|Overall Study|Withdrawal by Subject|0|||
144693278|NCT00594958|521729607|FG002|Overall Study|administrative|2|||
144693279|NCT03233009|521729608|FG000|Overall Study|Lost to Follow-up|1|||
144693280|NCT01425268|521729609|FG000|Overall Study|Withdrawal by Subject|2|||
144744403|NCT04476277|521916021|FG002|Overall Study|Withdrawal by Subject|1|||
144744404|NCT04476277|521916022|FG003|Overall Study|Withdrawal by Subject|0|||
144744405|NCT01576705|521916023|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
144744406|NCT01576705|521916024|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
144744407|NCT01576705|521916025|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
144744408|NCT01576705|521916026|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
144744409|NCT01576705|521916023|FG000|Overall Study|invalid ICF|0|||
144744410|NCT01576705|521916024|FG001|Overall Study|invalid ICF|1|||
144744411|NCT01576705|521916025|FG002|Overall Study|invalid ICF|0|||
144744412|NCT01576705|521916026|FG003|Overall Study|invalid ICF|0|||
144744413|NCT03727139|521916027|FG000|Overall Study|Protocol Violation|60|||
144744414|NCT02896296|521916028|FG000|Overall Study|Adverse Event|1|||
144744415|NCT02896296|521916028|FG000|Overall Study|Lost to Follow-up|19|||
144744416|NCT02896296|521916028|FG000|Overall Study|Pregnancy|1|||
144744417|NCT02896296|521916028|FG000|Overall Study|Physician Decision|2|||
144744418|NCT02896296|521916028|FG000|Overall Study|Withdrawal by Subject|10|||
144744419|NCT02896296|521916028|FG000|Overall Study|Site closing|7|||
144744420|NCT02896296|521916028|FG000|Overall Study|Incarceration|1|||
144744421|NCT02896296|521916028|FG000|Overall Study|Relocation|1|||
144744422|NCT02272803|521916029|FG000|Overall Study|Disease progression|16|||
144744423|NCT02272803|521916030|FG001|Overall Study|Disease progression|8|||
144744424|NCT02272803|521916029|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
144744425|NCT02272803|521916030|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
144744426|NCT02272803|521916029|FG000|Overall Study|Study drug toxicity|4|||
144744427|NCT02272803|521916030|FG001|Overall Study|Study drug toxicity|9|||
144744428|NCT02272803|521916029|FG000|Overall Study|Participant request to discontinue study treatment|3|||
144744429|NCT02272803|521916030|FG001|Overall Study|Participant request to discontinue study treatment|7|||
144744430|NCT02272803|521916029|FG000|Overall Study|Maximum clinical benefit|4|||
144744431|NCT02272803|521916030|FG001|Overall Study|Maximum clinical benefit|2|||
144744432|NCT02272803|521916029|FG000|Overall Study|Poor/non-compliance|2|||
144744433|NCT02272803|521916030|FG001|Overall Study|Poor/non-compliance|2|||
144744434|NCT02272803|521916029|FG000|Overall Study|Withdrawal by Subject|2|||
144744435|NCT02272803|521916030|FG001|Overall Study|Withdrawal by Subject|1|||
144744436|NCT02272803|521916029|FG000|Overall Study|Death|0|||
144744437|NCT02272803|521916030|FG001|Overall Study|Death|1|||
144744438|NCT02272803|521916029|FG000|Overall Study|Other reasons|1|||
144744439|NCT02272803|521916030|FG001|Overall Study|Other reasons|3|||
144744440|NCT02272803|521916029|FG000|Overall Study|Administrative reason by sponsor|5|||
144744441|NCT02272803|521916030|FG001|Overall Study|Administrative reason by sponsor|4|||
144744442|NCT02611323|521916031|FG000|Overall Study|Death|3|||
144744443|NCT02611323|521916032|FG001|Overall Study|Death|1|||
144744444|NCT02611323|521916033|FG002|Overall Study|Death|0|||
144744445|NCT02611323|521916034|FG003|Overall Study|Death|0|||
144744446|NCT02611323|521916035|FG004|Overall Study|Death|1|||
144744447|NCT02611323|521916036|FG005|Overall Study|Death|1|||
144744448|NCT02611323|521916037|FG006|Overall Study|Death|8|||
144744449|NCT02611323|521916038|FG007|Overall Study|Death|0|||
144744450|NCT02611323|521916039|FG008|Overall Study|Death|4|||
144266183|NCT05214118|520176553|FG001|Overall Study|moved|0|||
144266184|NCT03217591|520176554|FG000|Overall Study|Adverse Event|1|||
144266185|NCT03217591|520176555|FG001|Overall Study|Adverse Event|2|||
144266186|NCT03217591|520176556|FG002|Overall Study|Adverse Event|6|||
144266187|NCT03217591|520176554|FG000|Overall Study|Withdrawal by Subject|0|||
144266188|NCT03217591|520176555|FG001|Overall Study|Withdrawal by Subject|1|||
144266189|NCT03217591|520176556|FG002|Overall Study|Withdrawal by Subject|3|||
144266190|NCT03217591|520176554|FG000|Overall Study|Lost to Follow-up|1|||
144266191|NCT03217591|520176555|FG001|Overall Study|Lost to Follow-up|0|||
144266192|NCT03217591|520176556|FG002|Overall Study|Lost to Follow-up|0|||
144266193|NCT03217591|520176554|FG000|Overall Study|Protocol Violation|1|||
144266194|NCT03217591|520176555|FG001|Overall Study|Protocol Violation|0|||
144266195|NCT03217591|520176556|FG002|Overall Study|Protocol Violation|1|||
144266196|NCT03014206|520176559|FG000|Overall Study|Registration Violation|12|||
144266197|NCT01091246|520176560|FG000|Overall Study|Lost to Follow-up|23|||
144266198|NCT01091246|520176561|FG001|Overall Study|Lost to Follow-up|11|||
144266199|NCT01091246|520176562|FG002|Overall Study|Lost to Follow-up|7|||
144266200|NCT01091246|520176560|FG000|Overall Study|Adverse Event|1|||
144266201|NCT01091246|520176561|FG001|Overall Study|Adverse Event|0|||
144266202|NCT01091246|520176562|FG002|Overall Study|Adverse Event|1|||
144266203|NCT01091246|520176560|FG000|Overall Study|Withdrawal by Subject|9|||
144266204|NCT01091246|520176561|FG001|Overall Study|Withdrawal by Subject|5|||
144266205|NCT01091246|520176562|FG002|Overall Study|Withdrawal by Subject|4|||
144744451|NCT02611323|521916040|FG009|Overall Study|Death|6|||
144266206|NCT01091246|520176560|FG000|Overall Study|Subject not dosed|2|||
144266207|NCT01091246|520176561|FG001|Overall Study|Subject not dosed|0|||
144266208|NCT01091246|520176562|FG002|Overall Study|Subject not dosed|1|||
144266209|NCT04577794|520176563|FG000|Overall Study|Adverse Event|1|||
144266210|NCT04577794|520176564|FG001|Overall Study|Adverse Event|1|||
144266211|NCT01676012|520176565|FG000|Overall Study|Adverse Event|2|||
144744452|NCT02611323|521916041|FG010|Overall Study|Death|26|||
144744453|NCT02611323|521916031|FG000|Overall Study|Lost to Follow-up|1|||
144744454|NCT02611323|521916032|FG001|Overall Study|Lost to Follow-up|0|||
144744455|NCT02611323|521916033|FG002|Overall Study|Lost to Follow-up|0|||
144744456|NCT02611323|521916034|FG003|Overall Study|Lost to Follow-up|0|||
144744457|NCT02611323|521916035|FG004|Overall Study|Lost to Follow-up|0|||
144744458|NCT02611323|521916036|FG005|Overall Study|Lost to Follow-up|0|||
144744459|NCT02611323|521916037|FG006|Overall Study|Lost to Follow-up|3|||
144744460|NCT02611323|521916038|FG007|Overall Study|Lost to Follow-up|0|||
144744461|NCT02611323|521916039|FG008|Overall Study|Lost to Follow-up|0|||
144744462|NCT02611323|521916040|FG009|Overall Study|Lost to Follow-up|0|||
144744463|NCT02611323|521916041|FG010|Overall Study|Lost to Follow-up|2|||
144744464|NCT02611323|521916031|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744465|NCT02611323|521916032|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744466|NCT02611323|521916033|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744467|NCT02611323|521916034|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744468|NCT02611323|521916035|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744469|NCT02611323|521916036|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744470|NCT02611323|521916037|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744471|NCT02611323|521916038|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744472|NCT02611323|521916039|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744473|NCT02611323|521916040|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
144744474|NCT02611323|521916041|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
144744475|NCT02611323|521916031|FG000|Overall Study|Progressive Disease|0|||
144744476|NCT02611323|521916032|FG001|Overall Study|Progressive Disease|0|||
144744477|NCT02611323|521916033|FG002|Overall Study|Progressive Disease|0|||
144744478|NCT02611323|521916034|FG003|Overall Study|Progressive Disease|0|||
144744479|NCT02611323|521916035|FG004|Overall Study|Progressive Disease|0|||
144744480|NCT02611323|521916036|FG005|Overall Study|Progressive Disease|0|||
144744481|NCT02611323|521916037|FG006|Overall Study|Progressive Disease|0|||
144744482|NCT02611323|521916038|FG007|Overall Study|Progressive Disease|0|||
144744483|NCT02611323|521916039|FG008|Overall Study|Progressive Disease|0|||
144744484|NCT02611323|521916040|FG009|Overall Study|Progressive Disease|0|||
144744485|NCT02611323|521916041|FG010|Overall Study|Progressive Disease|1|||
144744486|NCT02611323|521916031|FG000|Overall Study|Withdrawal by Subject|1|||
144744487|NCT02611323|521916032|FG001|Overall Study|Withdrawal by Subject|0|||
144744488|NCT02611323|521916033|FG002|Overall Study|Withdrawal by Subject|0|||
144744489|NCT02611323|521916034|FG003|Overall Study|Withdrawal by Subject|0|||
144744490|NCT02611323|521916035|FG004|Overall Study|Withdrawal by Subject|0|||
144744491|NCT02611323|521916036|FG005|Overall Study|Withdrawal by Subject|0|||
144744492|NCT02611323|521916037|FG006|Overall Study|Withdrawal by Subject|0|||
144744493|NCT02611323|521916038|FG007|Overall Study|Withdrawal by Subject|1|||
144744494|NCT02611323|521916039|FG008|Overall Study|Withdrawal by Subject|0|||
144744495|NCT02611323|521916040|FG009|Overall Study|Withdrawal by Subject|1|||
144744496|NCT02611323|521916041|FG010|Overall Study|Withdrawal by Subject|0|||
144744497|NCT02597049|521916042|FG000|Overall Study|Lost to Follow-up|0|||
144744498|NCT02597049|521916043|FG001|Overall Study|Lost to Follow-up|3|||
144744499|NCT02597049|521916044|FG002|Overall Study|Lost to Follow-up|2|||
144744500|NCT02597049|521916042|FG000|Overall Study|Withdrawal by Subject|2|||
144744501|NCT02597049|521916043|FG001|Overall Study|Withdrawal by Subject|2|||
144744502|NCT02597049|521916044|FG002|Overall Study|Withdrawal by Subject|1|||
144744503|NCT02597049|521916042|FG000|Overall Study|Adverse Event|2|||
144744504|NCT02597049|521916043|FG001|Overall Study|Adverse Event|0|||
144744505|NCT02597049|521916044|FG002|Overall Study|Adverse Event|0|||
144744506|NCT02597049|521916042|FG000|Overall Study|Death|2|||
144744507|NCT02597049|521916043|FG001|Overall Study|Death|0|||
144744508|NCT02597049|521916044|FG002|Overall Study|Death|0|||
144744509|NCT02597049|521916042|FG000|Overall Study|Noncompliant with Study Visits|1|||
144744510|NCT02597049|521916043|FG001|Overall Study|Noncompliant with Study Visits|0|||
144744511|NCT02597049|521916044|FG002|Overall Study|Noncompliant with Study Visits|0|||
144744512|NCT01131260|521916046|FG000|Overall Study|Randomization error|5|||
144744513|NCT01131260|521916047|FG001|Overall Study|Randomization error|1|||
144744514|NCT01131260|521916046|FG000|Overall Study|Declined to continue participation|8|||
144744515|NCT01131260|521916047|FG001|Overall Study|Declined to continue participation|13|||
144744516|NCT01131260|521916046|FG000|Overall Study|Physician Decision|22|||
144744517|NCT01131260|521916047|FG001|Overall Study|Physician Decision|24|||
144744518|NCT01131260|521916046|FG000|Overall Study|Technical problems|7|||
144744519|NCT01131260|521916047|FG001|Overall Study|Technical problems|6|||
144744520|NCT01131260|521916046|FG000|Overall Study|Staff error|2|||
144744521|NCT01131260|521916047|FG001|Overall Study|Staff error|1|||
144744522|NCT01131260|521916046|FG000|Overall Study|Ineligible|0|||
144744523|NCT01131260|521916047|FG001|Overall Study|Ineligible|2|||
144744524|NCT03684928|521916048|FG000|First Intervention|Lost to Follow-up|0|||
144744525|NCT03684928|521916049|FG001|First Intervention|Lost to Follow-up|1|||
144744526|NCT03684928|521916048|FG000|First Intervention|Withdrawal by Subject|0|||
144744527|NCT03684928|521916049|FG001|First Intervention|Withdrawal by Subject|2|||
144744528|NCT03684928|521916048|FG000|Second Intervention|Soft Tissue Injury|1|||
144744529|NCT03684928|521916049|FG001|Second Intervention|Soft Tissue Injury|0|||
144744530|NCT01018862|521916058|FG000|Overall Study|Adverse Event|2|||
144744531|NCT01018862|521916059|FG001|Overall Study|Adverse Event|0|||
144744532|NCT01018862|521916060|FG002|Overall Study|Adverse Event|6|||
144744533|NCT01018862|521916058|FG000|Overall Study|Lack of Efficacy|1|||
144744534|NCT01018862|521916059|FG001|Overall Study|Lack of Efficacy|0|||
144744535|NCT01018862|521916060|FG002|Overall Study|Lack of Efficacy|2|||
144744536|NCT01018862|521916058|FG000|Overall Study|Lost to Follow-up|3|||
144744537|NCT01018862|521916059|FG001|Overall Study|Lost to Follow-up|1|||
144744538|NCT01018862|521916060|FG002|Overall Study|Lost to Follow-up|0|||
144744539|NCT01018862|521916058|FG000|Overall Study|Protocol Violation|1|||
144744540|NCT01018862|521916059|FG001|Overall Study|Protocol Violation|3|||
144744541|NCT01018862|521916060|FG002|Overall Study|Protocol Violation|3|||
144744542|NCT01018862|521916058|FG000|Overall Study|Withdrawal by Subject|1|||
144744543|NCT01018862|521916059|FG001|Overall Study|Withdrawal by Subject|2|||
144744544|NCT01018862|521916060|FG002|Overall Study|Withdrawal by Subject|1|||
144744545|NCT01018862|521916058|FG000|Overall Study|administrative problems|5|||
144744546|NCT01018862|521916059|FG001|Overall Study|administrative problems|4|||
144744547|NCT01018862|521916060|FG002|Overall Study|administrative problems|4|||
144744548|NCT01891357|521916061|FG000|Overall Study|Protocol Violation|3|||
144744549|NCT00840879|521916062|FG000|Second Intervention|Withdrawal by Subject|1|||
144744550|NCT00840879|521916063|FG001|Second Intervention|Withdrawal by Subject|0|||
144744551|NCT00874276|521916064|FG000|Overall Study|Withdrawal by Subject|1|||
144744552|NCT00874276|521916065|FG001|Overall Study|Withdrawal by Subject|1|||
144744553|NCT03733145|521916066|FG000|Overall Study|screenfail|3|||
144744554|NCT03733145|521916067|FG001|Overall Study|screenfail|3|||
144744555|NCT03733145|521916068|FG002|Overall Study|screenfail|2|||
144744556|NCT01142388|521918869|FG000|Overall Study|Lack of Efficacy|21|||
144744557|NCT01142388|521918870|FG001|Overall Study|Lack of Efficacy|31|||
144744558|NCT01142388|521918869|FG000|Overall Study|Adverse Event|9|||
144744559|NCT01142388|521918870|FG001|Overall Study|Adverse Event|5|||
144744560|NCT01142388|521918869|FG000|Overall Study|Death|3|||
144744561|NCT01142388|521918870|FG001|Overall Study|Death|2|||
144744562|NCT01142388|521918869|FG000|Overall Study|Withdrawal by Subject|5|||
144744563|NCT01142388|521918870|FG001|Overall Study|Withdrawal by Subject|3|||
144744564|NCT01142388|521918869|FG000|Overall Study|Alternative therapy|1|||
144744565|NCT01142388|521918870|FG001|Overall Study|Alternative therapy|0|||
144744566|NCT01142388|521918869|FG000|Overall Study|Other complications|0|||
144744567|NCT01142388|521918870|FG001|Overall Study|Other complications|2|||
144744568|NCT01142388|521918869|FG000|Overall Study|Other|1|||
144744569|NCT01142388|521918870|FG001|Overall Study|Other|1|||
144744570|NCT01142388|521918869|FG000|Overall Study|Never started therapy|7|||
144744571|NCT01142388|521918870|FG001|Overall Study|Never started therapy|3|||
144744572|NCT01274338|521918871|FG000|Overall Study|Lack of Efficacy|72|||
144744573|NCT01274338|521918872|FG001|Overall Study|Lack of Efficacy|108|||
144744574|NCT01274338|521918873|FG002|Overall Study|Lack of Efficacy|116|||
144744575|NCT01274338|521918874|FG003|Overall Study|Lack of Efficacy|0|||
144744576|NCT01274338|521918875|FG004|Overall Study|Lack of Efficacy|0|||
144744577|NCT01274338|521918876|FG005|Overall Study|Lack of Efficacy|0|||
144744578|NCT01274338|521918871|FG000|Overall Study|Adverse Event|272|||
144744579|NCT01274338|521918872|FG001|Overall Study|Adverse Event|105|||
144744580|NCT01274338|521918873|FG002|Overall Study|Adverse Event|180|||
144744581|NCT01274338|521918874|FG003|Overall Study|Adverse Event|1|||
144744582|NCT01274338|521918875|FG004|Overall Study|Adverse Event|0|||
144220206|NCT03535740|520000365|FG000|Overall Study|Site terminated by Sponsor|45|||
144220207|NCT05198518|520000371|FG000|Screening Visit|Deemed unable to participate|58|||
144220208|NCT05198518|520000372|FG001|Screening Visit|Deemed unable to participate|0|||
144220209|NCT05198518|520000373|FG002|Screening Visit|Deemed unable to participate|0|||
144220210|NCT02766335|520000374|FG000|Initial Registration|Adverse Event|6|||
144744583|NCT01274338|521918876|FG005|Overall Study|Adverse Event|0|||
144744584|NCT01274338|521918871|FG000|Overall Study|Death|8|||
144744585|NCT01274338|521918872|FG001|Overall Study|Death|1|||
144744586|NCT01274338|521918873|FG002|Overall Study|Death|0|||
144744587|NCT01274338|521918874|FG003|Overall Study|Death|0|||
144744588|NCT01274338|521918875|FG004|Overall Study|Death|0|||
144744589|NCT01274338|521918876|FG005|Overall Study|Death|0|||
144744590|NCT01274338|521918871|FG000|Overall Study|Withdrawal by Subject|27|||
144744591|NCT01274338|521918872|FG001|Overall Study|Withdrawal by Subject|99|||
144744592|NCT01274338|521918873|FG002|Overall Study|Withdrawal by Subject|17|||
144744593|NCT01274338|521918874|FG003|Overall Study|Withdrawal by Subject|0|||
144744594|NCT01274338|521918875|FG004|Overall Study|Withdrawal by Subject|0|||
144744595|NCT01274338|521918876|FG005|Overall Study|Withdrawal by Subject|0|||
144744596|NCT01274338|521918871|FG000|Overall Study|Did not start treatment|8|||
144744597|NCT01274338|521918872|FG001|Overall Study|Did not start treatment|116|||
144744598|NCT01274338|521918873|FG002|Overall Study|Did not start treatment|7|||
144744599|NCT01274338|521918874|FG003|Overall Study|Did not start treatment|0|||
144744600|NCT01274338|521918875|FG004|Overall Study|Did not start treatment|0|||
144744601|NCT01274338|521918876|FG005|Overall Study|Did not start treatment|0|||
144744602|NCT01274338|521918871|FG000|Overall Study|Alternative therapy|0|||
144744603|NCT01274338|521918872|FG001|Overall Study|Alternative therapy|1|||
144744604|NCT01274338|521918873|FG002|Overall Study|Alternative therapy|0|||
144220211|NCT02766335|520000375|FG001|Initial Registration|Adverse Event|3|||
144220212|NCT02766335|520000376|FG002|Initial Registration|Adverse Event|0|||
144220213|NCT02766335|520000374|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
144220214|NCT02766335|520000375|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
144220215|NCT02766335|520000376|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
144220216|NCT02766335|520000374|FG000|Initial Registration|Progression/relapse|49|||
144220217|NCT02766335|520000375|FG001|Initial Registration|Progression/relapse|15|||
144220218|NCT02766335|520000376|FG002|Initial Registration|Progression/relapse|0|||
144220219|NCT02766335|520000374|FG000|Initial Registration|Death|1|||
144220220|NCT02766335|520000375|FG001|Initial Registration|Death|3|||
144220221|NCT02766335|520000376|FG002|Initial Registration|Death|0|||
144220222|NCT02766335|520000374|FG000|Initial Registration|not protocol specified|1|||
144220223|NCT02766335|520000375|FG001|Initial Registration|not protocol specified|9|||
144220224|NCT02766335|520000376|FG002|Initial Registration|not protocol specified|0|||
144220225|NCT02766335|520000374|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
144220226|NCT02766335|520000375|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
144220227|NCT02766335|520000376|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
144220228|NCT02766335|520000374|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
144220229|NCT02766335|520000375|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
144220230|NCT02766335|520000376|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
144220231|NCT03645863|520000378|FG000|Overall Study|Withdrawal by Subject|1|||
144220232|NCT03645863|520000379|FG001|Overall Study|Withdrawal by Subject|0|||
144220233|NCT03645863|520000380|FG002|Overall Study|Withdrawal by Subject|0|||
144220234|NCT03624192|520000386|FG000|Overall Study|Lost to Follow-up|1|||
144220235|NCT03624192|520000387|FG001|Overall Study|Lost to Follow-up|1|||
144220236|NCT01841593|520000388|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
144220237|NCT01841593|520000389|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
144220238|NCT01841593|520000388|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
144220239|NCT01841593|520000389|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
144220240|NCT03125798|520000390|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
144220241|NCT03125798|520000391|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
144220242|NCT03125798|520000390|FG000|Overall Study|Conversion to thoracotomy|7|||
144220243|NCT03125798|520000391|FG001|Overall Study|Conversion to thoracotomy|7|||
144220244|NCT01169350|520000397|FG000|Overall Study|Physician Decision|3|||
144220245|NCT01169350|520000397|FG000|Overall Study|Lost to Follow-up|2|||
144220246|NCT04870710|520000402|FG000|Overall Study|Lost to Follow-up|3|||
144220247|NCT00786409|520000404|FG000|Overall Study|Withdrawal by Subject|2|||
144220248|NCT00786409|520000404|FG000|Overall Study|Adverse Event|2|||
144220249|NCT00786409|520000404|FG000|Overall Study|Pregnancy|2|||
144220250|NCT00786409|520000404|FG000|Overall Study|Lost to Follow-up|1|||
144220251|NCT03200717|520000415|FG000|Overall Study|Progressive disease|24|||
144220252|NCT03200717|520000416|FG001|Overall Study|Progressive disease|5|||
144220253|NCT03200717|520000415|FG000|Overall Study|Adverse Event|11|||
144220254|NCT03200717|520000416|FG001|Overall Study|Adverse Event|8|||
144220255|NCT03200717|520000415|FG000|Overall Study|Physician Decision|3|||
144220256|NCT03200717|520000416|FG001|Overall Study|Physician Decision|2|||
144220257|NCT03200717|520000415|FG000|Overall Study|Death|2|||
144220258|NCT03200717|520000416|FG001|Overall Study|Death|0|||
144220259|NCT03200717|520000415|FG000|Overall Study|Subject/Guardian Decision|1|||
144220260|NCT03200717|520000416|FG001|Overall Study|Subject/Guardian Decision|0|||
144220261|NCT03629184|520000417|FG000|Overall Study|Withdrawal by Subject|2|||
144220262|NCT03629184|520000418|FG001|Overall Study|Withdrawal by Subject|1|||
144220263|NCT03629184|520000417|FG000|Overall Study|Physician Decision|1|||
144220264|NCT03629184|520000418|FG001|Overall Study|Physician Decision|0|||
144220265|NCT01461538|520000419|FG000|Overall Study|Death|15|||
144220266|NCT01461538|520000420|FG001|Overall Study|Death|6|||
144220267|NCT01461538|520000421|FG002|Overall Study|Death|2|||
144220268|NCT01461538|520000419|FG000|Overall Study|Study Stopped by Sponsor|2|||
144220269|NCT01461538|520000420|FG001|Overall Study|Study Stopped by Sponsor|1|||
144220270|NCT01461538|520000421|FG002|Overall Study|Study Stopped by Sponsor|0|||
144220271|NCT01461538|520000419|FG000|Overall Study|Withdrawal by Subject|1|||
144220272|NCT01461538|520000420|FG001|Overall Study|Withdrawal by Subject|1|||
144220273|NCT01461538|520000421|FG002|Overall Study|Withdrawal by Subject|0|||
144220274|NCT02046603|520000422|FG000|Overall Study|Other|11|||
144744605|NCT01274338|521918874|FG003|Overall Study|Alternative therapy|0|||
144220275|NCT02046603|520000423|FG001|Overall Study|Other|66|||
144220276|NCT02046603|520000422|FG000|Overall Study|Protocol Violation|0|||
144220277|NCT02046603|520000423|FG001|Overall Study|Protocol Violation|1|||
144220278|NCT02046603|520000422|FG000|Overall Study|Participant/legal guardian decision|1|||
144220279|NCT02046603|520000423|FG001|Overall Study|Participant/legal guardian decision|3|||
144266212|NCT01676012|520176565|FG000|Overall Study|incomplete set of videos|1|||
144744606|NCT01274338|521918875|FG004|Overall Study|Alternative therapy|0|||
144744607|NCT01274338|521918876|FG005|Overall Study|Alternative therapy|0|||
144220280|NCT02046603|520000422|FG000|Overall Study|Physician Decision|2|||
144220281|NCT02046603|520000423|FG001|Overall Study|Physician Decision|1|||
144220282|NCT02046603|520000422|FG000|Overall Study|Lost to Follow-up|1|||
144220283|NCT02046603|520000423|FG001|Overall Study|Lost to Follow-up|2|||
144220284|NCT02046603|520000422|FG000|Overall Study|Death|0|||
144220285|NCT02046603|520000423|FG001|Overall Study|Death|1|||
144220286|NCT02046603|520000422|FG000|Overall Study|Adverse Event|0|||
144220287|NCT02046603|520000423|FG001|Overall Study|Adverse Event|1|||
144220288|NCT03447743|520000424|FG000|Overall Study|Withdrawal by Subject|2|||
144220289|NCT03447743|520000424|FG000|Overall Study|Lost to Follow-up|3|||
144220290|NCT03447743|520000424|FG000|Overall Study|Adverse Event|1|||
144220291|NCT03447743|520000424|FG000|Overall Study|Did not meet criteria to continue|1|||
144220292|NCT04179838|520002122|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
144220293|NCT04179838|520002123|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
144220294|NCT04179838|520002122|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
144220295|NCT04179838|520002123|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
144220296|NCT00086684|520002124|FG000|Overall Study|Adverse Event|12|||
144220297|NCT00086684|520002125|FG001|Overall Study|Adverse Event|17|||
144220298|NCT00086684|520002126|FG002|Overall Study|Adverse Event|14|||
144220299|NCT00086684|520002124|FG000|Overall Study|Lack of Efficacy|6|||
144744608|NCT01274338|521918871|FG000|Overall Study|Other complicating diseases|0|||
144744609|NCT01274338|521918872|FG001|Overall Study|Other complicating diseases|3|||
144744610|NCT01274338|521918873|FG002|Overall Study|Other complicating diseases|1|||
144744611|NCT01274338|521918874|FG003|Overall Study|Other complicating diseases|0|||
144744612|NCT01274338|521918875|FG004|Overall Study|Other complicating diseases|0|||
144744613|NCT01274338|521918876|FG005|Overall Study|Other complicating diseases|0|||
144744614|NCT01274338|521918871|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
144744615|NCT01274338|521918872|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
144744616|NCT01274338|521918873|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
144220300|NCT00086684|520002125|FG001|Overall Study|Lack of Efficacy|6|||
144220301|NCT00086684|520002126|FG002|Overall Study|Lack of Efficacy|5|||
144220302|NCT00086684|520002124|FG000|Overall Study|Lost to Follow-up|15|||
144220303|NCT00086684|520002125|FG001|Overall Study|Lost to Follow-up|8|||
144220304|NCT00086684|520002126|FG002|Overall Study|Lost to Follow-up|10|||
144744617|NCT01274338|521918874|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
144744618|NCT01274338|521918875|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
144744619|NCT01274338|521918876|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
144744620|NCT01274338|521918871|FG000|Overall Study|Pregnancy|0|||
144744621|NCT01274338|521918872|FG001|Overall Study|Pregnancy|0|||
144744622|NCT01274338|521918873|FG002|Overall Study|Pregnancy|1|||
144744623|NCT01274338|521918874|FG003|Overall Study|Pregnancy|0|||
144744624|NCT01274338|521918875|FG004|Overall Study|Pregnancy|0|||
144744625|NCT01274338|521918876|FG005|Overall Study|Pregnancy|0|||
144744626|NCT01274338|521918871|FG000|Overall Study|Reason not reported|12|||
144744627|NCT01274338|521918872|FG001|Overall Study|Reason not reported|21|||
144744628|NCT01274338|521918873|FG002|Overall Study|Reason not reported|3|||
144744629|NCT01274338|521918874|FG003|Overall Study|Reason not reported|0|||
144744630|NCT01274338|521918875|FG004|Overall Study|Reason not reported|1|||
144744631|NCT01274338|521918876|FG005|Overall Study|Reason not reported|0|||
144220305|NCT00086684|520002124|FG000|Overall Study|Protocol Violation|8|||
144220306|NCT00086684|520002125|FG001|Overall Study|Protocol Violation|3|||
144220307|NCT00086684|520002126|FG002|Overall Study|Protocol Violation|0|||
144220308|NCT00086684|520002124|FG000|Overall Study|Withdrawal by Subject|0|||
144220309|NCT00086684|520002125|FG001|Overall Study|Withdrawal by Subject|4|||
144220310|NCT00086684|520002126|FG002|Overall Study|Withdrawal by Subject|10|||
144220311|NCT00086684|520002124|FG000|Overall Study|NONCOMPLIANCE|5|||
144220312|NCT00086684|520002125|FG001|Overall Study|NONCOMPLIANCE|7|||
144220313|NCT00086684|520002126|FG002|Overall Study|NONCOMPLIANCE|6|||
144693281|NCT01425268|521729610|FG001|Overall Study|Withdrawal by Subject|0|||
144693282|NCT01425268|521729609|FG000|Overall Study|Sponsor Decision|5|||
144693283|NCT01425268|521729610|FG001|Overall Study|Sponsor Decision|0|||
144693284|NCT01425268|521729609|FG000|Overall Study|Physician Decision|1|||
144693285|NCT01425268|521729610|FG001|Overall Study|Physician Decision|0|||
144693286|NCT00134563|521729611|FG000|Overall Study|Not treated due to protocol violation|0|||
144693287|NCT00134563|521729612|FG001|Overall Study|Not treated due to protocol violation|1|||
144693288|NCT00134563|521729613|FG002|Overall Study|Not treated due to protocol violation|1|||
144693289|NCT00134563|521729611|FG000|Overall Study|Adverse Event|29|||
144693290|NCT00134563|521729612|FG001|Overall Study|Adverse Event|37|||
144693291|NCT00134563|521729613|FG002|Overall Study|Adverse Event|38|||
144693292|NCT00134563|521729611|FG000|Overall Study|Lack of Efficacy|24|||
144693293|NCT00134563|521729612|FG001|Overall Study|Lack of Efficacy|14|||
144693294|NCT00134563|521729613|FG002|Overall Study|Lack of Efficacy|17|||
144693295|NCT00134563|521729611|FG000|Overall Study|Protocol Violation|3|||
144693296|NCT00134563|521729612|FG001|Overall Study|Protocol Violation|2|||
144693297|NCT00134563|521729613|FG002|Overall Study|Protocol Violation|5|||
144693298|NCT00134563|521729611|FG000|Overall Study|Lost to Follow-up|4|||
144693299|NCT00134563|521729612|FG001|Overall Study|Lost to Follow-up|0|||
144693300|NCT00134563|521729613|FG002|Overall Study|Lost to Follow-up|2|||
144693301|NCT00134563|521729611|FG000|Overall Study|progressive disease|11|||
144693302|NCT00134563|521729612|FG001|Overall Study|progressive disease|4|||
144693303|NCT00134563|521729613|FG002|Overall Study|progressive disease|2|||
144744632|NCT05730725|521918879|FG000|Overall Study|Withdrawal by Subject|3|||
144744633|NCT05730725|521918880|FG001|Overall Study|Withdrawal by Subject|0|||
144744634|NCT05730725|521918881|FG002|Overall Study|Withdrawal by Subject|0|||
144744635|NCT05730725|521918882|FG003|Overall Study|Withdrawal by Subject|1|||
144744636|NCT05730725|521918879|FG000|Overall Study|Not Reported|1|||
144744637|NCT05730725|521918880|FG001|Overall Study|Not Reported|1|||
144744638|NCT05730725|521918881|FG002|Overall Study|Not Reported|1|||
144744639|NCT05730725|521918882|FG003|Overall Study|Not Reported|1|||
144744640|NCT05265728|521918883|FG000|Overall Study|Adverse Event|1|||
144744641|NCT05265728|521918883|FG000|Overall Study|Study Terminated by Sponsor|5|||
144744642|NCT05265728|521918883|FG000|Overall Study|Withdrawal by Subject|2|||
144744643|NCT05084053|521918884|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
144744644|NCT05084053|521918885|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
144744645|NCT05084053|521918886|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
144744646|NCT05084053|521918887|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
144744647|NCT05084053|521918884|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
144744648|NCT05084053|521918885|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
144744649|NCT05084053|521918886|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
144744650|NCT05084053|521918887|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
144744651|NCT05084053|521918884|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
144744652|NCT05084053|521918885|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
144744653|NCT05084053|521918886|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
144744654|NCT05084053|521918887|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
144744655|NCT03687957|521918888|FG000|Overall Study|Withdrawal by Subject|0|||
144744656|NCT03687957|521918889|FG001|Overall Study|Withdrawal by Subject|0|||
144744657|NCT03687957|521918890|FG002|Overall Study|Withdrawal by Subject|0|||
144744658|NCT03687957|521918891|FG003|Overall Study|Withdrawal by Subject|2|||
144744659|NCT03687957|521918892|FG004|Overall Study|Withdrawal by Subject|0|||
144744660|NCT03687957|521918893|FG005|Overall Study|Withdrawal by Subject|0|||
144744661|NCT03687957|521918894|FG006|Overall Study|Withdrawal by Subject|3|||
144744662|NCT03687957|521918895|FG007|Overall Study|Withdrawal by Subject|1|||
144744663|NCT03687957|521918896|FG008|Overall Study|Withdrawal by Subject|1|||
144744664|NCT03687957|521918897|FG009|Overall Study|Withdrawal by Subject|0|||
144744665|NCT03687957|521918888|FG000|Overall Study|Disease progression|0|||
144744666|NCT03687957|521918889|FG001|Overall Study|Disease progression|1|||
144744667|NCT03687957|521918890|FG002|Overall Study|Disease progression|1|||
144744668|NCT03687957|521918891|FG003|Overall Study|Disease progression|2|||
144744669|NCT03687957|521918892|FG004|Overall Study|Disease progression|2|||
144744670|NCT03687957|521918893|FG005|Overall Study|Disease progression|0|||
144744671|NCT03687957|521918894|FG006|Overall Study|Disease progression|2|||
144744672|NCT03687957|521918895|FG007|Overall Study|Disease progression|1|||
144744673|NCT03687957|521918896|FG008|Overall Study|Disease progression|0|||
144744674|NCT03687957|521918897|FG009|Overall Study|Disease progression|0|||
144744675|NCT03687957|521918888|FG000|Overall Study|Physician Decision|0|||
144744676|NCT03687957|521918889|FG001|Overall Study|Physician Decision|0|||
144744677|NCT03687957|521918890|FG002|Overall Study|Physician Decision|0|||
144744678|NCT03687957|521918891|FG003|Overall Study|Physician Decision|2|||
144744679|NCT03687957|521918892|FG004|Overall Study|Physician Decision|1|||
144744680|NCT03687957|521918893|FG005|Overall Study|Physician Decision|0|||
144744681|NCT03687957|521918894|FG006|Overall Study|Physician Decision|1|||
144744682|NCT03687957|521918895|FG007|Overall Study|Physician Decision|0|||
144744683|NCT03687957|521918896|FG008|Overall Study|Physician Decision|0|||
144744684|NCT03687957|521918897|FG009|Overall Study|Physician Decision|0|||
144744685|NCT03687957|521918888|FG000|Overall Study|New malignancy|0|||
144744686|NCT03687957|521918889|FG001|Overall Study|New malignancy|0|||
144744687|NCT03687957|521918890|FG002|Overall Study|New malignancy|0|||
144744688|NCT03687957|521918891|FG003|Overall Study|New malignancy|0|||
144744689|NCT03687957|521918892|FG004|Overall Study|New malignancy|1|||
144744690|NCT03687957|521918893|FG005|Overall Study|New malignancy|0|||
144744691|NCT03687957|521918894|FG006|Overall Study|New malignancy|0|||
144744692|NCT03687957|521918895|FG007|Overall Study|New malignancy|0|||
144744693|NCT03687957|521918896|FG008|Overall Study|New malignancy|0|||
144744694|NCT03687957|521918897|FG009|Overall Study|New malignancy|0|||
144744695|NCT03687957|521918888|FG000|Overall Study|Adverse Event|0|||
144744696|NCT03687957|521918889|FG001|Overall Study|Adverse Event|0|||
144744697|NCT03687957|521918890|FG002|Overall Study|Adverse Event|0|||
144744698|NCT03687957|521918891|FG003|Overall Study|Adverse Event|0|||
144744699|NCT03687957|521918892|FG004|Overall Study|Adverse Event|0|||
144744700|NCT03687957|521918893|FG005|Overall Study|Adverse Event|2|||
144744701|NCT03687957|521918894|FG006|Overall Study|Adverse Event|0|||
144744702|NCT03687957|521918895|FG007|Overall Study|Adverse Event|3|||
144744703|NCT03687957|521918896|FG008|Overall Study|Adverse Event|0|||
144744704|NCT03687957|521918897|FG009|Overall Study|Adverse Event|0|||
144744705|NCT03687957|521918888|FG000|Overall Study|Patient went on hospice|0|||
144744706|NCT03687957|521918889|FG001|Overall Study|Patient went on hospice|0|||
144744707|NCT03687957|521918890|FG002|Overall Study|Patient went on hospice|0|||
144744708|NCT03687957|521918891|FG003|Overall Study|Patient went on hospice|0|||
144744709|NCT03687957|521918892|FG004|Overall Study|Patient went on hospice|0|||
144266213|NCT02849080|520176568|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
144693304|NCT00134563|521729611|FG000|Overall Study|did not wish to continue|33|||
144693305|NCT00134563|521729612|FG001|Overall Study|did not wish to continue|32|||
144693306|NCT00134563|521729613|FG002|Overall Study|did not wish to continue|26|||
144693307|NCT00134563|521729611|FG000|Overall Study|Reason other than above|0|||
144693308|NCT00134563|521729612|FG001|Overall Study|Reason other than above|2|||
144693309|NCT00134563|521729613|FG002|Overall Study|Reason other than above|5|||
144693310|NCT02839330|521729614|FG000|Overall Study|Adverse Event|0|||
144693311|NCT02839330|521729615|FG001|Overall Study|Adverse Event|1|||
144693312|NCT02839330|521729616|FG002|Overall Study|Adverse Event|2|||
144693313|NCT02839330|521729617|FG003|Overall Study|Adverse Event|2|||
144693314|NCT02839330|521729614|FG000|Overall Study|Death|4|||
144693315|NCT02839330|521729615|FG001|Overall Study|Death|6|||
144693316|NCT02839330|521729616|FG002|Overall Study|Death|1|||
144693317|NCT02839330|521729617|FG003|Overall Study|Death|1|||
144693318|NCT02839330|521729614|FG000|Overall Study|Withdrawal by Subject|27|||
144693319|NCT02839330|521729615|FG001|Overall Study|Withdrawal by Subject|19|||
144693320|NCT02839330|521729616|FG002|Overall Study|Withdrawal by Subject|11|||
144693321|NCT02839330|521729617|FG003|Overall Study|Withdrawal by Subject|13|||
144693322|NCT02839330|521729614|FG000|Overall Study|Lost to Follow-up|22|||
144693323|NCT02839330|521729615|FG001|Overall Study|Lost to Follow-up|27|||
144693324|NCT02839330|521729616|FG002|Overall Study|Lost to Follow-up|29|||
144693325|NCT02839330|521729617|FG003|Overall Study|Lost to Follow-up|25|||
144693326|NCT02839330|521729614|FG000|Overall Study|Administrative Reason|0|||
144693327|NCT02839330|521729615|FG001|Overall Study|Administrative Reason|0|||
144693328|NCT02839330|521729616|FG002|Overall Study|Administrative Reason|0|||
144693329|NCT02839330|521729617|FG003|Overall Study|Administrative Reason|1|||
144693330|NCT02839330|521729614|FG000|Overall Study|Protocol Violation|1|||
144693331|NCT02839330|521729615|FG001|Overall Study|Protocol Violation|2|||
144693332|NCT02839330|521729616|FG002|Overall Study|Protocol Violation|2|||
144693333|NCT02839330|521729617|FG003|Overall Study|Protocol Violation|3|||
144693334|NCT02839330|521729614|FG000|Overall Study|Other reason, not specified|4|||
144693335|NCT02839330|521729615|FG001|Overall Study|Other reason, not specified|3|||
144693336|NCT02839330|521729616|FG002|Overall Study|Other reason, not specified|3|||
144693337|NCT02839330|521729617|FG003|Overall Study|Other reason, not specified|6|||
144693338|NCT00682539|521729618|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
144693339|NCT00682539|521729619|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
144693340|NCT00682539|521729620|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
144693341|NCT00682539|521729618|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
144693342|NCT00682539|521729619|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
144693343|NCT00682539|521729620|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
144693344|NCT01856920|521729627|FG000|Overall Study|Disease Progression On Study|3|||
144693345|NCT01856920|521729628|FG001|Overall Study|Disease Progression On Study|4|||
144693346|NCT01856920|521729627|FG000|Overall Study|Disease Progression before Treatment|1|||
144693347|NCT01856920|521729628|FG001|Overall Study|Disease Progression before Treatment|0|||
144693348|NCT01856920|521729627|FG000|Overall Study|Ineligible|0|||
144693349|NCT01856920|521729628|FG001|Overall Study|Ineligible|1|||
144693350|NCT01856920|521729627|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
144693351|NCT01856920|521729628|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
144693352|NCT01856920|521729627|FG000|Overall Study|Refused further Treatment|5|||
144693353|NCT01856920|521729628|FG001|Overall Study|Refused further Treatment|1|||
144693354|NCT01856920|521729627|FG000|Overall Study|Other Reasons|0|||
144693355|NCT01856920|521729628|FG001|Overall Study|Other Reasons|1|||
144693356|NCT01856920|521729627|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
144693357|NCT01856920|521729628|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
144693358|NCT04594213|521729629|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
144693359|NCT04594213|521729630|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
144693360|NCT04594213|521729631|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
144693361|NCT04594213|521729632|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
144693362|NCT04594213|521729633|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
144693363|NCT04594213|521729634|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
144693364|NCT04594213|521729629|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
144693365|NCT04594213|521729630|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
144693366|NCT04594213|521729631|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
144693367|NCT04594213|521729632|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
144693368|NCT04594213|521729633|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
144693369|NCT04594213|521729634|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
144693370|NCT04594213|521729629|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
144693371|NCT04594213|521729630|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144693372|NCT04594213|521729631|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
144693373|NCT04594213|521729632|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144693374|NCT04594213|521729633|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144693375|NCT04594213|521729634|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
144744710|NCT03687957|521918893|FG005|Overall Study|Patient went on hospice|0|||
144744711|NCT03687957|521918894|FG006|Overall Study|Patient went on hospice|1|||
144744712|NCT03687957|521918895|FG007|Overall Study|Patient went on hospice|0|||
144744713|NCT03687957|521918896|FG008|Overall Study|Patient went on hospice|0|||
144744714|NCT03687957|521918897|FG009|Overall Study|Patient went on hospice|0|||
144744715|NCT03687957|521918888|FG000|Overall Study|Death|0|||
144744716|NCT03687957|521918889|FG001|Overall Study|Death|0|||
144744717|NCT03687957|521918890|FG002|Overall Study|Death|0|||
144744718|NCT03687957|521918891|FG003|Overall Study|Death|0|||
144744719|NCT03687957|521918892|FG004|Overall Study|Death|0|||
144744720|NCT03687957|521918893|FG005|Overall Study|Death|0|||
144744721|NCT03687957|521918894|FG006|Overall Study|Death|0|||
144744722|NCT03687957|521918895|FG007|Overall Study|Death|1|||
144744723|NCT03687957|521918896|FG008|Overall Study|Death|0|||
144744724|NCT03687957|521918897|FG009|Overall Study|Death|0|||
144744725|NCT02180724|521918898|FG000|Overall Study|Death|26|||
144744726|NCT02180724|521918899|FG001|Overall Study|Death|1|||
144744727|NCT02180724|521918898|FG000|Overall Study|Lost to Follow-up|3|||
144744728|NCT02180724|521918899|FG001|Overall Study|Lost to Follow-up|1|||
144744729|NCT02180724|521918898|FG000|Overall Study|Withdrawal by Subject|4|||
144744730|NCT02180724|521918899|FG001|Overall Study|Withdrawal by Subject|2|||
144744731|NCT02180724|521918898|FG000|Overall Study|PI Decision|5|||
144744732|NCT02180724|521918899|FG001|Overall Study|PI Decision|2|||
144744733|NCT02180724|521918898|FG000|Overall Study|Study terminated by sponsor|54|||
144744734|NCT02180724|521918899|FG001|Overall Study|Study terminated by sponsor|8|||
144744735|NCT03284957|521918902|FG000|Overall Study|Adverse Event|0|||
144744736|NCT03284957|521918903|FG001|Overall Study|Adverse Event|0|||
144744737|NCT03284957|521918904|FG002|Overall Study|Adverse Event|0|||
144744738|NCT03284957|521918905|FG003|Overall Study|Adverse Event|0|||
144744739|NCT03284957|521918906|FG004|Overall Study|Adverse Event|0|||
144744740|NCT03284957|521918907|FG005|Overall Study|Adverse Event|1|||
144744741|NCT03284957|521918908|FG006|Overall Study|Adverse Event|1|||
144744742|NCT03284957|521918909|FG007|Overall Study|Adverse Event|1|||
144744743|NCT03284957|521918910|FG008|Overall Study|Adverse Event|0|||
144744744|NCT03284957|521918911|FG009|Overall Study|Adverse Event|4|||
144744745|NCT03284957|521918912|FG010|Overall Study|Adverse Event|1|||
144744746|NCT03284957|521918913|FG011|Overall Study|Adverse Event|1|||
144744747|NCT03284957|521918914|FG012|Overall Study|Adverse Event|0|||
144744748|NCT03284957|521918915|FG013|Overall Study|Adverse Event|0|||
144744749|NCT03284957|521918916|FG014|Overall Study|Adverse Event|0|||
144744750|NCT03284957|521918917|FG015|Overall Study|Adverse Event|0|||
144744751|NCT03284957|521918902|FG000|Overall Study|Progressive Disease|3|||
144744752|NCT03284957|521918903|FG001|Overall Study|Progressive Disease|3|||
144744753|NCT03284957|521918904|FG002|Overall Study|Progressive Disease|4|||
144744754|NCT03284957|521918905|FG003|Overall Study|Progressive Disease|3|||
144744755|NCT03284957|521918906|FG004|Overall Study|Progressive Disease|3|||
144744756|NCT03284957|521918907|FG005|Overall Study|Progressive Disease|5|||
144744757|NCT03284957|521918908|FG006|Overall Study|Progressive Disease|45|||
144744758|NCT03284957|521918909|FG007|Overall Study|Progressive Disease|8|||
144744759|NCT03284957|521918910|FG008|Overall Study|Progressive Disease|5|||
144744760|NCT03284957|521918911|FG009|Overall Study|Progressive Disease|18|||
144744761|NCT03284957|521918912|FG010|Overall Study|Progressive Disease|7|||
144744762|NCT03284957|521918913|FG011|Overall Study|Progressive Disease|2|||
144744763|NCT03284957|521918914|FG012|Overall Study|Progressive Disease|3|||
144744764|NCT03284957|521918915|FG013|Overall Study|Progressive Disease|1|||
144220314|NCT00086684|520002124|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144220315|NCT00086684|520002125|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
144744765|NCT03284957|521918916|FG014|Overall Study|Progressive Disease|1|||
144744766|NCT03284957|521918917|FG015|Overall Study|Progressive Disease|2|||
144744767|NCT03284957|521918902|FG000|Overall Study|Withdrawal by Subject|0|||
144744768|NCT03284957|521918903|FG001|Overall Study|Withdrawal by Subject|0|||
144220316|NCT00086684|520002126|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
144220317|NCT00086684|520002124|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
144220318|NCT00086684|520002125|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
144220319|NCT00086684|520002126|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
144220320|NCT00086684|520002124|FG000|Overall Study|Other|4|||
144220321|NCT00086684|520002125|FG001|Overall Study|Other|2|||
144744769|NCT03284957|521918904|FG002|Overall Study|Withdrawal by Subject|0|||
144744770|NCT03284957|521918905|FG003|Overall Study|Withdrawal by Subject|0|||
144744771|NCT03284957|521918906|FG004|Overall Study|Withdrawal by Subject|0|||
144744772|NCT03284957|521918907|FG005|Overall Study|Withdrawal by Subject|0|||
144744773|NCT03284957|521918908|FG006|Overall Study|Withdrawal by Subject|0|||
144744774|NCT03284957|521918909|FG007|Overall Study|Withdrawal by Subject|0|||
144744775|NCT03284957|521918910|FG008|Overall Study|Withdrawal by Subject|0|||
144744776|NCT03284957|521918911|FG009|Overall Study|Withdrawal by Subject|2|||
144220322|NCT00086684|520002126|FG002|Overall Study|Other|3|||
144744777|NCT03284957|521918912|FG010|Overall Study|Withdrawal by Subject|0|||
144744778|NCT03284957|521918913|FG011|Overall Study|Withdrawal by Subject|0|||
144744779|NCT03284957|521918914|FG012|Overall Study|Withdrawal by Subject|0|||
144744780|NCT03284957|521918915|FG013|Overall Study|Withdrawal by Subject|0|||
144744781|NCT03284957|521918916|FG014|Overall Study|Withdrawal by Subject|0|||
144744782|NCT03284957|521918917|FG015|Overall Study|Withdrawal by Subject|0|||
144744783|NCT03284957|521918902|FG000|Overall Study|Other|0|||
144744784|NCT03284957|521918903|FG001|Overall Study|Other|0|||
144744785|NCT03284957|521918904|FG002|Overall Study|Other|0|||
144744786|NCT03284957|521918905|FG003|Overall Study|Other|0|||
144744787|NCT03284957|521918906|FG004|Overall Study|Other|0|||
144744788|NCT03284957|521918907|FG005|Overall Study|Other|0|||
144744789|NCT03284957|521918908|FG006|Overall Study|Other|3|||
144744790|NCT03284957|521918909|FG007|Overall Study|Other|0|||
144744791|NCT03284957|521918910|FG008|Overall Study|Other|1|||
144744792|NCT03284957|521918911|FG009|Overall Study|Other|6|||
144744793|NCT03284957|521918912|FG010|Overall Study|Other|0|||
144744794|NCT03284957|521918913|FG011|Overall Study|Other|0|||
144744795|NCT03284957|521918914|FG012|Overall Study|Other|0|||
144744796|NCT03284957|521918915|FG013|Overall Study|Other|0|||
144744797|NCT03284957|521918916|FG014|Overall Study|Other|2|||
144744798|NCT03284957|521918917|FG015|Overall Study|Other|0|||
144744799|NCT04609553|521918918|FG000|Overall Study|Lost to Follow-up|27|||
144744800|NCT04609553|521918919|FG001|Overall Study|Lost to Follow-up|31|||
144744801|NCT04609553|521918920|FG002|Overall Study|Lost to Follow-up|24|||
144744802|NCT04609553|521918918|FG000|Overall Study|Discontinued|12|||
144744803|NCT04609553|521918919|FG001|Overall Study|Discontinued|10|||
144744804|NCT04609553|521918920|FG002|Overall Study|Discontinued|9|||
144744805|NCT01927744|521918921|FG000|Overall Study|Death|2|||
144744806|NCT01927744|521918922|FG001|Overall Study|Death|9|||
144744807|NCT01286272|521918928|FG000|Overall Study|Ineligible after beginning treatment|1|||
144744808|NCT01286272|521918929|FG001|Overall Study|Ineligible after beginning treatment|3|||
144744809|NCT05195359|521918934|FG000|Overall Study|Lost to Follow-up|124|||
144744810|NCT05195359|521918935|FG001|Overall Study|Lost to Follow-up|34|||
144744811|NCT04001829|521918936|FG000|Overall Study|Never start protocol therapy|5|||
144744812|NCT04001829|521918937|FG001|Overall Study|Never start protocol therapy|5|||
144744813|NCT04001829|521918936|FG000|Overall Study|Adverse Event|11|||
144744814|NCT04001829|521918937|FG001|Overall Study|Adverse Event|7|||
144744815|NCT04001829|521918936|FG000|Overall Study|Alternative therapy|1|||
144744816|NCT04001829|521918937|FG001|Overall Study|Alternative therapy|2|||
144744817|NCT04001829|521918936|FG000|Overall Study|Disease progression/relapse|2|||
144744818|NCT04001829|521918937|FG001|Overall Study|Disease progression/relapse|1|||
144744819|NCT04001829|521918936|FG000|Overall Study|Other complicating disease|1|||
144744820|NCT04001829|521918937|FG001|Overall Study|Other complicating disease|0|||
144744821|NCT04001829|521918936|FG000|Overall Study|Withdrawal by Subject|1|||
144744822|NCT04001829|521918937|FG001|Overall Study|Withdrawal by Subject|4|||
144744823|NCT04001829|521918936|FG000|Overall Study|Ineligible|2|||
144744824|NCT04001829|521918937|FG001|Overall Study|Ineligible|2|||
144744825|NCT04001829|521918936|FG000|Overall Study|Reason missing due to delinquent data|1|||
144744826|NCT04001829|521918937|FG001|Overall Study|Reason missing due to delinquent data|0|||
144744827|NCT03584152|521918938|FG000|Overall Study|Discontinued intervention|7|||
144744828|NCT03584152|521918939|FG001|Overall Study|Discontinued intervention|4|||
144744829|NCT05011396|521918941|FG000|Overall Study|Lost to Follow-up|3|||
144744830|NCT05011396|521918942|FG001|Overall Study|Lost to Follow-up|1|||
144744831|NCT05011396|521918941|FG000|Overall Study|Withdrawal by Subject|0|||
144744832|NCT05011396|521918942|FG001|Overall Study|Withdrawal by Subject|1|||
144744833|NCT05011396|521918941|FG000|Overall Study|Positive Drug Screen|0|||
144744834|NCT05011396|521918942|FG001|Overall Study|Positive Drug Screen|1|||
144744835|NCT03052608|521918943|FG000|Treatment Phase|Adverse Event|10|||
144744836|NCT03052608|521918944|FG001|Treatment Phase|Adverse Event|12|||
144744837|NCT03052608|521918943|FG000|Treatment Phase|Death|6|||
144744838|NCT03052608|521918944|FG001|Treatment Phase|Death|4|||
144744839|NCT03052608|521918943|FG000|Treatment Phase|Withdrawal by Subject|4|||
144744840|NCT03052608|521918944|FG001|Treatment Phase|Withdrawal by Subject|12|||
144744841|NCT03052608|521918943|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
144744842|NCT03052608|521918944|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
144744843|NCT03052608|521918943|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
144744844|NCT03052608|521918944|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
144744845|NCT03052608|521918943|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
144744846|NCT03052608|521918944|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
144744847|NCT03052608|521918943|FG000|Treatment Phase|Ongoing|103|||
144744848|NCT03052608|521918944|FG001|Treatment Phase|Ongoing|31|||
144744849|NCT03052608|521918943|FG000|Long-Term Follow-up Phase|Death|23|||
144744850|NCT03052608|521918944|FG001|Long-Term Follow-up Phase|Death|28|||
144744851|NCT03052608|521918943|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
144744852|NCT03052608|521918944|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
144744853|NCT03052608|521918943|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
144744854|NCT03052608|521918944|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
144744855|NCT03052608|521918943|FG000|Long-Term Follow-up Phase|Ongoing|122|||
144744856|NCT03052608|521918944|FG001|Long-Term Follow-up Phase|Ongoing|99|||
144744857|NCT05458011|521918947|FG000|DB Period (12 Weeks)|Adverse Event|2|||
144220323|NCT01050530|520002130|FG000|Overall Study|Adverse Event|6|||
144220324|NCT01050530|520002131|FG001|Overall Study|Adverse Event|3|||
144220325|NCT01050530|520002130|FG000|Overall Study|Lack of Efficacy|1|||
144220326|NCT01050530|520002131|FG001|Overall Study|Lack of Efficacy|4|||
144220327|NCT01050530|520002130|FG000|Overall Study|Withdrawal by Subject|0|||
144220328|NCT01050530|520002131|FG001|Overall Study|Withdrawal by Subject|3|||
144220329|NCT01050530|520002130|FG000|Overall Study|Protocol Violation|1|||
144220330|NCT01050530|520002131|FG001|Overall Study|Protocol Violation|0|||
144220331|NCT02288312|520002132|FG000|Overall Study|Pregnancy|1|||
144220332|NCT02288312|520002133|FG001|Overall Study|Pregnancy|0|||
144220333|NCT02288312|520002134|FG002|Overall Study|Pregnancy|0|||
144220334|NCT01276041|520002135|FG000|Overall Study|Adverse Event|2|||
144220335|NCT01276041|520002135|FG000|Overall Study|Protocol Violation|1|||
144220336|NCT00840749|520002139|FG000|Overall Study|Death|1|||
144220337|NCT00840749|520002140|FG001|Overall Study|Death|2|||
144220338|NCT00840749|520002139|FG000|Overall Study|not treated on study arm|11|||
144220339|NCT00840749|520002140|FG001|Overall Study|not treated on study arm|11|||
144220340|NCT00840749|520002139|FG000|Overall Study|study closed|19|||
144220341|NCT00840749|520002140|FG001|Overall Study|study closed|14|||
144220342|NCT01113892|520002143|FG000|Overall Study|Lost to Follow-up|2|||
144220343|NCT01113892|520002144|FG001|Overall Study|Lost to Follow-up|2|||
144744858|NCT05458011|521918948|FG001|DB Period (12 Weeks)|Adverse Event|1|||
144744859|NCT05458011|521918949|FG002|DB Period (12 Weeks)|Adverse Event|1|||
144744860|NCT05458011|521918947|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
144744861|NCT05458011|521918948|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
144744862|NCT05458011|521918949|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
144744863|NCT05458011|521918947|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
144744864|NCT05458011|521918948|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
144744865|NCT05458011|521918949|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
144744866|NCT05458011|521918947|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
144744867|NCT05458011|521918948|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
144744868|NCT05458011|521918949|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
144744869|NCT05458011|521918947|FG000|OL Period (12 Weeks)|Adverse Event|1|||
144744870|NCT05458011|521918948|FG001|OL Period (12 Weeks)|Adverse Event|2|||
144744871|NCT05458011|521918949|FG002|OL Period (12 Weeks)|Adverse Event|1|||
144744872|NCT05458011|521918947|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
144744873|NCT05458011|521918948|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
144744874|NCT05458011|521918949|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
144744875|NCT03253848|521918951|FG000|Overall Study|Adverse Event|7|||
144744876|NCT03253848|521918951|FG000|Overall Study|Death|5|||
144744877|NCT03253848|521918951|FG000|Overall Study|initiation of other treatments|3|||
144744878|NCT03253848|521918951|FG000|Overall Study|Other complicating disease|1|||
144744879|NCT03253848|521918951|FG000|Overall Study|Withdrawal by Subject|1|||
144744880|NCT03253848|521918951|FG000|Overall Study|Declining health|1|||
144744881|NCT01147965|521918952|FG000|Overall Study|Progressive Disease|3|||
144744882|NCT01147965|521918953|FG001|Overall Study|Progressive Disease|3|||
144744883|NCT01147965|521918954|FG002|Overall Study|Progressive Disease|5|||
144744884|NCT01147965|521918955|FG003|Overall Study|Progressive Disease|9|||
144744885|NCT01147965|521918956|FG004|Overall Study|Progressive Disease|5|||
144744886|NCT01147965|521918957|FG005|Overall Study|Progressive Disease|5|||
144744887|NCT01147965|521918952|FG000|Overall Study|Death|0|||
144744888|NCT01147965|521918953|FG001|Overall Study|Death|0|||
144744889|NCT01147965|521918954|FG002|Overall Study|Death|1|||
144744890|NCT01147965|521918955|FG003|Overall Study|Death|1|||
144744891|NCT01147965|521918956|FG004|Overall Study|Death|0|||
144744892|NCT01147965|521918957|FG005|Overall Study|Death|2|||
144744893|NCT01147965|521918952|FG000|Overall Study|Withdrawal by Subject|0|||
144744894|NCT01147965|521918953|FG001|Overall Study|Withdrawal by Subject|0|||
144220344|NCT01113892|520002143|FG000|Overall Study|Withdrawal by Subject|1|||
144220345|NCT01113892|520002144|FG001|Overall Study|Withdrawal by Subject|1|||
144220346|NCT01113892|520002143|FG000|Overall Study|Death|2|||
144220347|NCT01113892|520002144|FG001|Overall Study|Death|4|||
144220348|NCT01113892|520002143|FG000|Overall Study|Graft no longer evaluable|9|||
144220349|NCT01113892|520002144|FG001|Overall Study|Graft no longer evaluable|9|||
144744895|NCT01147965|521918954|FG002|Overall Study|Withdrawal by Subject|1|||
144744896|NCT01147965|521918955|FG003|Overall Study|Withdrawal by Subject|1|||
144744897|NCT01147965|521918956|FG004|Overall Study|Withdrawal by Subject|0|||
144744898|NCT01147965|521918957|FG005|Overall Study|Withdrawal by Subject|0|||
144744899|NCT01147965|521918952|FG000|Overall Study|Administration Of Alternative Therapy|0|||
144744900|NCT01147965|521918953|FG001|Overall Study|Administration Of Alternative Therapy|0|||
144744901|NCT01147965|521918954|FG002|Overall Study|Administration Of Alternative Therapy|0|||
144744902|NCT01147965|521918955|FG003|Overall Study|Administration Of Alternative Therapy|0|||
144744903|NCT01147965|521918956|FG004|Overall Study|Administration Of Alternative Therapy|0|||
144220350|NCT02569801|520002149|FG000|Overall Study|Withdrawal by Subject|9|||
144220351|NCT02569801|520002150|FG001|Overall Study|Withdrawal by Subject|9|||
144220352|NCT02569801|520002149|FG000|Overall Study|Sponsor Decision|13|||
144220353|NCT02569801|520002150|FG001|Overall Study|Sponsor Decision|14|||
144744904|NCT01147965|521918957|FG005|Overall Study|Administration Of Alternative Therapy|1|||
144744905|NCT01147965|521918952|FG000|Overall Study|Other|0|||
144744906|NCT01147965|521918953|FG001|Overall Study|Other|0|||
144744907|NCT01147965|521918954|FG002|Overall Study|Other|0|||
144744908|NCT01147965|521918955|FG003|Overall Study|Other|3|||
144744909|NCT01147965|521918956|FG004|Overall Study|Other|1|||
144744910|NCT01147965|521918957|FG005|Overall Study|Other|0|||
144744911|NCT03569449|521918962|FG000|Overall Study|Lost to Follow-up|0|||
144744912|NCT03569449|521918963|FG001|Overall Study|Lost to Follow-up|1|||
144744913|NCT03569449|521918964|FG002|Overall Study|Lost to Follow-up|0|||
144744914|NCT03569449|521918965|FG003|Overall Study|Lost to Follow-up|2|||
144744915|NCT03569449|521918966|FG004|Overall Study|Lost to Follow-up|0|||
144744916|NCT03569449|521918967|FG005|Overall Study|Lost to Follow-up|0|||
144744917|NCT03569449|521918968|FG006|Overall Study|Lost to Follow-up|0|||
144744918|NCT03569449|521918969|FG007|Overall Study|Lost to Follow-up|0|||
144744919|NCT03569449|521918970|FG008|Overall Study|Lost to Follow-up|0|||
144744920|NCT03569449|521918971|FG009|Overall Study|Lost to Follow-up|0|||
144744921|NCT03569449|521918972|FG010|Overall Study|Lost to Follow-up|0|||
144744922|NCT03569449|521918973|FG011|Overall Study|Lost to Follow-up|0|||
144744923|NCT03569449|521918974|FG012|Overall Study|Lost to Follow-up|0|||
144744924|NCT03569449|521918975|FG013|Overall Study|Lost to Follow-up|0|||
144744925|NCT03569449|521918976|FG014|Overall Study|Lost to Follow-up|1|||
144744926|NCT03569449|521918977|FG015|Overall Study|Lost to Follow-up|0|||
144744927|NCT03569449|521918962|FG000|Overall Study|Withdrawal by Subject|0|||
144744928|NCT03569449|521918963|FG001|Overall Study|Withdrawal by Subject|1|||
144744929|NCT03569449|521918964|FG002|Overall Study|Withdrawal by Subject|0|||
144744930|NCT03569449|521918965|FG003|Overall Study|Withdrawal by Subject|0|||
144744931|NCT03569449|521918966|FG004|Overall Study|Withdrawal by Subject|1|||
144744932|NCT03569449|521918967|FG005|Overall Study|Withdrawal by Subject|0|||
144744933|NCT03569449|521918968|FG006|Overall Study|Withdrawal by Subject|0|||
144744934|NCT03569449|521918969|FG007|Overall Study|Withdrawal by Subject|0|||
144744935|NCT03569449|521918970|FG008|Overall Study|Withdrawal by Subject|0|||
144744936|NCT03569449|521918971|FG009|Overall Study|Withdrawal by Subject|0|||
144744937|NCT03569449|521918972|FG010|Overall Study|Withdrawal by Subject|0|||
144744938|NCT03569449|521918973|FG011|Overall Study|Withdrawal by Subject|0|||
144744939|NCT03569449|521918974|FG012|Overall Study|Withdrawal by Subject|0|||
144744940|NCT03569449|521918975|FG013|Overall Study|Withdrawal by Subject|0|||
144744941|NCT03569449|521918976|FG014|Overall Study|Withdrawal by Subject|0|||
144744942|NCT03569449|521918977|FG015|Overall Study|Withdrawal by Subject|0|||
144744943|NCT04667949|521918978|FG000|Overall Study|Adverse Event|0|||
144744944|NCT04667949|521918979|FG001|Overall Study|Adverse Event|2|||
144744945|NCT04667949|521918978|FG000|Overall Study|Lost to Follow-up|0|||
144744946|NCT04667949|521918979|FG001|Overall Study|Lost to Follow-up|1|||
144744947|NCT04667949|521918978|FG000|Overall Study|Physician Decision|0|||
144744948|NCT04667949|521918979|FG001|Overall Study|Physician Decision|2|||
144744949|NCT04667949|521918978|FG000|Overall Study|Subject decision|1|||
144744950|NCT04667949|521918979|FG001|Overall Study|Subject decision|7|||
144744951|NCT02213926|521918980|FG000|Overall Study|Death|59|||
144744952|NCT02213926|521918980|FG000|Overall Study|Withdrawal by Subject|10|||
144744953|NCT02213926|521918980|FG000|Overall Study|study terminated by sponsor|51|||
144744954|NCT02213926|521918980|FG000|Overall Study|Lost to Follow-up|3|||
144744955|NCT02213926|521918980|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
144744956|NCT05887908|521918981|FG000|Overall Study|Adverse Event|6|||
144744957|NCT05887908|521918982|FG001|Overall Study|Adverse Event|1|||
144744958|NCT05887908|521918983|FG002|Overall Study|Adverse Event|1|||
144744959|NCT05887908|521918981|FG000|Overall Study|Physician Decision|4|||
144744960|NCT05887908|521918982|FG001|Overall Study|Physician Decision|1|||
144744961|NCT05887908|521918983|FG002|Overall Study|Physician Decision|0|||
144744962|NCT05887908|521918981|FG000|Overall Study|Withdrawal by Subject|3|||
144744963|NCT05887908|521918982|FG001|Overall Study|Withdrawal by Subject|2|||
144744964|NCT05887908|521918983|FG002|Overall Study|Withdrawal by Subject|3|||
144744965|NCT05887908|521918981|FG000|Overall Study|Ineligibility after the start of the study|4|||
144744966|NCT05887908|521918982|FG001|Overall Study|Ineligibility after the start of the study|1|||
144744967|NCT05887908|521918983|FG002|Overall Study|Ineligibility after the start of the study|0|||
144744968|NCT05887908|521918981|FG000|Overall Study|Subject non-compliance|4|||
144744969|NCT05887908|521918982|FG001|Overall Study|Subject non-compliance|0|||
144744970|NCT05887908|521918983|FG002|Overall Study|Subject non-compliance|4|||
144744971|NCT05887908|521918981|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
144744972|NCT05887908|521918982|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
144744973|NCT05887908|521918983|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
144744974|NCT05887908|521918981|FG000|Overall Study|Pregnancy|0|||
144744975|NCT05887908|521918982|FG001|Overall Study|Pregnancy|1|||
144744976|NCT05887908|521918983|FG002|Overall Study|Pregnancy|0|||
144744977|NCT05887908|521918981|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
144744978|NCT05887908|521918982|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
144744979|NCT05887908|521918983|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
144744980|NCT05887908|521918981|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
144744981|NCT05887908|521918982|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
144744982|NCT05887908|521918983|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
144744983|NCT05887908|521918981|FG000|Overall Study|Other Reason|3|||
144744984|NCT05887908|521918982|FG001|Overall Study|Other Reason|3|||
144744985|NCT05887908|521918983|FG002|Overall Study|Other Reason|3|||
144744986|NCT05855655|521918986|FG000|Overall Study|Withdrawal by Subject|0|||
144744987|NCT05855655|521918987|FG001|Overall Study|Withdrawal by Subject|1|||
144744988|NCT05855655|521918986|FG000|Overall Study|Lost to Follow-up|4|||
144744989|NCT05855655|521918987|FG001|Overall Study|Lost to Follow-up|0|||
144744990|NCT05279898|521918988|FG000|Overall Study|Withdrawal by Subject|1|||
144744991|NCT05279898|521918989|FG001|Overall Study|Withdrawal by Subject|0|||
144744992|NCT05279898|521918988|FG000|Overall Study|Physician Decision|1|||
144744993|NCT05279898|521918989|FG001|Overall Study|Physician Decision|1|||
144744994|NCT05136170|521918990|FG000|Overall Study|Withdrawal by Subject|2|||
144744995|NCT05136170|521918991|FG001|Overall Study|Withdrawal by Subject|2|||
144744996|NCT05136170|521918990|FG000|Overall Study|Can no longer make office visits|1|||
144744997|NCT05136170|521918991|FG001|Overall Study|Can no longer make office visits|0|||
144744998|NCT04393038|521918992|FG000|Overall Study|Adverse Event|11|||
144744999|NCT04393038|521918993|FG001|Overall Study|Adverse Event|2|||
144745000|NCT04393038|521918992|FG000|Overall Study|Protocol Violation|1|||
144745001|NCT04393038|521918993|FG001|Overall Study|Protocol Violation|0|||
144745002|NCT04393038|521918992|FG000|Overall Study|Death|6|||
144745003|NCT04393038|521918993|FG001|Overall Study|Death|4|||
144745004|NCT04393038|521918992|FG000|Overall Study|Withdrawal by Subject|24|||
144745005|NCT04393038|521918993|FG001|Overall Study|Withdrawal by Subject|8|||
144745006|NCT04393038|521918992|FG000|Overall Study|Lost to Follow-up|5|||
144745007|NCT04393038|521918993|FG001|Overall Study|Lost to Follow-up|4|||
144745008|NCT04393038|521918992|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
144745009|NCT04393038|521918993|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
144745010|NCT04393038|521918992|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
144745011|NCT04393038|521918993|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
144745012|NCT05168813|521918994|FG000|Part A (Open-label)|Lost to Follow-up|21|||
144745013|NCT05168813|521918995|FG001|Part A (Open-label)|Lost to Follow-up|39|||
144745014|NCT05168813|521918996|FG002|Part A (Open-label)|Lost to Follow-up|8|||
144745015|NCT05168813|521918997|FG003|Part A (Open-label)|Lost to Follow-up|26|||
144745016|NCT05168813|521918998|FG004|Part A (Open-label)|Lost to Follow-up|0|||
144745017|NCT05168813|521918999|FG005|Part A (Open-label)|Lost to Follow-up|0|||
144745018|NCT05168813|521918994|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
144745019|NCT05168813|521918995|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
144745020|NCT05168813|521918996|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
144745021|NCT05168813|521918997|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
144745022|NCT05168813|521918998|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
144745023|NCT05168813|521918999|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
144745024|NCT05168813|521918994|FG000|Part A (Open-label)|Death|23|||
144745025|NCT05168813|521918995|FG001|Part A (Open-label)|Death|28|||
144745026|NCT05168813|521918996|FG002|Part A (Open-label)|Death|1|||
144745027|NCT05168813|521918997|FG003|Part A (Open-label)|Death|9|||
144745028|NCT05168813|521918998|FG004|Part A (Open-label)|Death|0|||
144745029|NCT05168813|521918999|FG005|Part A (Open-label)|Death|0|||
144745030|NCT05168813|521918994|FG000|Part A (Open-label)|Physician Decision|0|||
144745031|NCT05168813|521918995|FG001|Part A (Open-label)|Physician Decision|1|||
144745032|NCT05168813|521918996|FG002|Part A (Open-label)|Physician Decision|0|||
144745033|NCT05168813|521918997|FG003|Part A (Open-label)|Physician Decision|2|||
144745034|NCT05168813|521918998|FG004|Part A (Open-label)|Physician Decision|0|||
144745035|NCT05168813|521918999|FG005|Part A (Open-label)|Physician Decision|0|||
144745036|NCT05168813|521918994|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
144745037|NCT05168813|521918995|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
144745038|NCT05168813|521918996|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
144745039|NCT05168813|521918997|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
144220354|NCT02569801|520002149|FG000|Overall Study|Progressive Disease|2|||
144220355|NCT02569801|520002150|FG001|Overall Study|Progressive Disease|7|||
144220356|NCT02569801|520002149|FG000|Overall Study|Lost to Follow-up|0|||
144745040|NCT05168813|521918998|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
144745041|NCT05168813|521918999|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
144745042|NCT05168813|521918994|FG000|Part A (Open-label)|Protocol Violation|0|||
144745043|NCT05168813|521918995|FG001|Part A (Open-label)|Protocol Violation|1|||
144745044|NCT05168813|521918996|FG002|Part A (Open-label)|Protocol Violation|0|||
144220357|NCT02569801|520002150|FG001|Overall Study|Lost to Follow-up|1|||
144220358|NCT02569801|520002149|FG000|Overall Study|Death|12|||
144220359|NCT02569801|520002150|FG001|Overall Study|Death|4|||
144745045|NCT05168813|521918997|FG003|Part A (Open-label)|Protocol Violation|0|||
144745046|NCT05168813|521918998|FG004|Part A (Open-label)|Protocol Violation|0|||
144220360|NCT01960413|520002151|FG000|Overall Study|Withdrawal by Subject|1|||
144220361|NCT01960413|520002152|FG001|Overall Study|Withdrawal by Subject|1|||
144220362|NCT01960413|520002151|FG000|Overall Study|Physician Decision|1|||
144220363|NCT01960413|520002152|FG001|Overall Study|Physician Decision|0|||
144220364|NCT01960413|520002151|FG000|Overall Study|Lost to Follow-up|2|||
144220365|NCT01960413|520002152|FG001|Overall Study|Lost to Follow-up|0|||
144220366|NCT04886596|520002153|FG000|Overall Study|Adverse Event|442|||
144220367|NCT04886596|520002154|FG001|Overall Study|Adverse Event|441|||
144220368|NCT04886596|520002153|FG000|Overall Study|Lost to Follow-up|448|||
144220369|NCT04886596|520002154|FG001|Overall Study|Lost to Follow-up|465|||
144220370|NCT04886596|520002153|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
144220371|NCT04886596|520002154|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
144220372|NCT04886596|520002153|FG000|Overall Study|Migrated/moved from the study area|201|||
144220373|NCT04886596|520002154|FG001|Overall Study|Migrated/moved from the study area|184|||
144220374|NCT04886596|520002153|FG000|Overall Study|Other|298|||
144220375|NCT04886596|520002154|FG001|Overall Study|Other|326|||
144220376|NCT02603887|520002155|FG000|Stage 1|Adverse Event|4|||
144220377|NCT02603887|520002155|FG000|Stage 1|Disease progression|1|||
144220378|NCT02603887|520002155|FG000|Stage 2|FDA guidance|1|||
144220379|NCT00948155|520002158|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
144220380|NCT00948155|520002159|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
144220381|NCT00948155|520002158|FG000|Washout 14 Days|Lost to Follow-up|1|||
144220382|NCT00948155|520002159|FG001|Washout 14 Days|Lost to Follow-up|2|||
144220383|NCT00476190|520002161|FG000|Overall Study|Ineligible|1|||
144220384|NCT00476190|520002162|FG001|Overall Study|Ineligible|1|||
144220385|NCT00476190|520002161|FG000|Overall Study|Induction Death|2|||
144220386|NCT00476190|520002162|FG001|Overall Study|Induction Death|0|||
144220387|NCT00476190|520002161|FG000|Overall Study|Induction Failure|2|||
144220388|NCT00476190|520002162|FG001|Overall Study|Induction Failure|4|||
144220389|NCT00476190|520002161|FG000|Overall Study|Lost to Follow-up|1|||
144220390|NCT00476190|520002162|FG001|Overall Study|Lost to Follow-up|0|||
144220391|NCT00476190|520002161|FG000|Overall Study|Relapse/Progression|5|||
144220392|NCT00476190|520002162|FG001|Overall Study|Relapse/Progression|2|||
144220393|NCT00476190|520002161|FG000|Overall Study|Remission Death|0|||
144220394|NCT00476190|520002162|FG001|Overall Study|Remission Death|1|||
144220395|NCT00476190|520002161|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
144220396|NCT00476190|520002162|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
144220397|NCT00476190|520002161|FG000|Overall Study|Withdrawal by Subject|6|||
144220398|NCT00476190|520002162|FG001|Overall Study|Withdrawal by Subject|2|||
144220399|NCT00476190|520002161|FG000|Overall Study|Other|9|||
144220400|NCT00476190|520002162|FG001|Overall Study|Other|10|||
144220401|NCT02189837|520002163|FG000|Overall Study|Withdrawal by Subject|2|||
144220402|NCT02189837|520002164|FG001|Overall Study|Withdrawal by Subject|1|||
144220403|NCT02189837|520002165|FG002|Overall Study|Withdrawal by Subject|3|||
144220404|NCT02189837|520002166|FG003|Overall Study|Withdrawal by Subject|1|||
144220405|NCT02189837|520002163|FG000|Overall Study|Sponsor Decision|0|||
144220406|NCT02189837|520002164|FG001|Overall Study|Sponsor Decision|0|||
144220407|NCT02189837|520002165|FG002|Overall Study|Sponsor Decision|0|||
144220408|NCT02189837|520002166|FG003|Overall Study|Sponsor Decision|1|||
144220409|NCT02198963|520002170|FG000|Overall Study|Adverse Event|1|||
144220410|NCT02198963|520002170|FG000|Overall Study|Withdrawal by Subject|6|||
144220411|NCT00243412|520002171|FG000|Overall Study|Death|0|||
144220412|NCT00243412|520002172|FG001|Overall Study|Death|1|||
144220413|NCT00243412|520002171|FG000|Overall Study|Adverse Event|4|||
144220414|NCT00243412|520002172|FG001|Overall Study|Adverse Event|2|||
144220415|NCT00243412|520002171|FG000|Overall Study|Lost to Follow-up|0|||
144745047|NCT05168813|521918999|FG005|Part A (Open-label)|Protocol Violation|0|||
144745048|NCT05168813|521918994|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
144745049|NCT05168813|521918995|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
144745050|NCT05168813|521918996|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
144220416|NCT00243412|520002172|FG001|Overall Study|Lost to Follow-up|1|||
144220417|NCT00243412|520002171|FG000|Overall Study|Physician Decision|1|||
144220418|NCT00243412|520002172|FG001|Overall Study|Physician Decision|1|||
144220419|NCT00243412|520002171|FG000|Overall Study|Withdrawal by Subject|4|||
144220420|NCT00243412|520002172|FG001|Overall Study|Withdrawal by Subject|5|||
144220421|NCT00243412|520002171|FG000|Overall Study|Other|1|||
144220422|NCT00243412|520002172|FG001|Overall Study|Other|1|||
144220423|NCT00281957|520002174|FG000|Overall Study|Adverse Event|7|||
144220424|NCT00281957|520002175|FG001|Overall Study|Adverse Event|2|||
144220425|NCT00281957|520002174|FG000|Overall Study|Death|1|||
144220426|NCT00281957|520002175|FG001|Overall Study|Death|0|||
144220427|NCT00281957|520002174|FG000|Overall Study|Progression/relapse|47|||
144220428|NCT00281957|520002175|FG001|Overall Study|Progression/relapse|35|||
144745051|NCT05168813|521918997|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
144220429|NCT00281957|520002174|FG000|Overall Study|Not protocol specified|8|||
144220430|NCT00281957|520002175|FG001|Overall Study|Not protocol specified|1|||
144220431|NCT00281957|520002174|FG000|Overall Study|Not eligible|1|||
144220432|NCT00281957|520002175|FG001|Overall Study|Not eligible|2|||
144220433|NCT00281957|520002174|FG000|Overall Study|Did not start treatment|3|||
144220434|NCT00281957|520002175|FG001|Overall Study|Did not start treatment|1|||
144266214|NCT02849080|520176569|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
144266215|NCT02849080|520176570|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
144693376|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144693377|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144693378|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144693379|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144693380|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
144693381|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
144693382|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144693383|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144693384|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
144693385|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
144693386|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
144693387|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
144693388|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144693389|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144693390|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144693391|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144693392|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
144693393|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
144693394|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144693395|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144693396|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144693397|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
144693398|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144693399|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
144693400|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
144693401|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
144693402|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
144693403|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
144693404|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
144693405|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
144693406|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
144693407|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
144693408|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
144693409|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
144693410|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
144693411|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
144693412|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
144693413|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
144693414|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
144693415|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
144693416|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
144693417|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
144693418|NCT04594213|521729629|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
144693419|NCT04594213|521729630|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
144693420|NCT04594213|521729631|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
144693421|NCT04594213|521729632|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
144693422|NCT04594213|521729633|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
144693423|NCT04594213|521729634|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
144693424|NCT01980056|521729636|FG000|Overall Study|Death|1|||
144693425|NCT01980056|521729637|FG001|Overall Study|Death|1|||
144693426|NCT01980056|521729638|FG002|Overall Study|Death|0|||
144693427|NCT03764813|521729639|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
144693428|NCT03764813|521729640|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
144693429|NCT03764813|521729641|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
144693430|NCT03764813|521729642|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
144693431|NCT01654666|521729645|FG000|Overall Study|Protocol Violation|7|||
144693432|NCT01654666|521729646|FG001|Overall Study|Protocol Violation|4|||
144693433|NCT01654666|521729647|FG002|Overall Study|Protocol Violation|8|||
144693434|NCT01654666|521729645|FG000|Overall Study|Lost to Follow-up|4|||
144693435|NCT01654666|521729646|FG001|Overall Study|Lost to Follow-up|5|||
144693436|NCT01654666|521729647|FG002|Overall Study|Lost to Follow-up|5|||
144693437|NCT01654666|521729645|FG000|Overall Study|Withdrawal by Subject|4|||
144693438|NCT01654666|521729646|FG001|Overall Study|Withdrawal by Subject|4|||
144693439|NCT01654666|521729647|FG002|Overall Study|Withdrawal by Subject|1|||
144693440|NCT00535262|521729648|FG000|Overall Study|No funding|3|||
144266216|NCT02849080|520176571|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
144266217|NCT02849080|520176568|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
144220435|NCT00281957|520002174|FG000|Overall Study|Refusal unrelated to adverse events|0|||
144220436|NCT00281957|520002175|FG001|Overall Study|Refusal unrelated to adverse events|1|||
144220437|NCT01876446|520002176|FG000|Overall Study|Death|0|||
144220438|NCT01876446|520002177|FG001|Overall Study|Death|1|||
144220439|NCT01876446|520002176|FG000|Overall Study|Withdrawal by Subject|1|||
144220440|NCT01876446|520002177|FG001|Overall Study|Withdrawal by Subject|2|||
144220441|NCT01876446|520002176|FG000|Overall Study|Physician Decision|1|||
144745052|NCT05168813|521918998|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
144745053|NCT05168813|521918999|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
144745054|NCT05168813|521918994|FG000|Part A (Open-label)|Other|0|||
144745055|NCT05168813|521918995|FG001|Part A (Open-label)|Other|1|||
144745056|NCT05168813|521918996|FG002|Part A (Open-label)|Other|0|||
144745057|NCT05168813|521918997|FG003|Part A (Open-label)|Other|0|||
144745058|NCT05168813|521918998|FG004|Part A (Open-label)|Other|0|||
144745059|NCT05168813|521918999|FG005|Part A (Open-label)|Other|0|||
144745060|NCT05168813|521918994|FG000|Part B (Blinded)|Lost to Follow-up|0|||
144745061|NCT05168813|521918995|FG001|Part B (Blinded)|Lost to Follow-up|0|||
144745062|NCT05168813|521918996|FG002|Part B (Blinded)|Lost to Follow-up|0|||
144220442|NCT01876446|520002177|FG001|Overall Study|Physician Decision|3|||
144220443|NCT00822692|520002187|FG000|Overall Study|Lost to Follow-up|17|||
144745063|NCT05168813|521918997|FG003|Part B (Blinded)|Lost to Follow-up|0|||
144745064|NCT05168813|521918998|FG004|Part B (Blinded)|Lost to Follow-up|219|||
144745065|NCT05168813|521918999|FG005|Part B (Blinded)|Lost to Follow-up|88|||
144745066|NCT05168813|521918994|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
144745067|NCT05168813|521918995|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
144745068|NCT05168813|521918996|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
144745069|NCT05168813|521918997|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
144745070|NCT05168813|521918998|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
144745071|NCT05168813|521918999|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
144745072|NCT05168813|521918994|FG000|Part B (Blinded)|Death|0|||
144745073|NCT05168813|521918995|FG001|Part B (Blinded)|Death|0|||
144745074|NCT05168813|521918996|FG002|Part B (Blinded)|Death|0|||
144745075|NCT05168813|521918997|FG003|Part B (Blinded)|Death|0|||
144745076|NCT05168813|521918998|FG004|Part B (Blinded)|Death|63|||
144745077|NCT05168813|521918999|FG005|Part B (Blinded)|Death|19|||
144745078|NCT05168813|521918994|FG000|Part B (Blinded)|Physician Decision|0|||
144745079|NCT05168813|521918995|FG001|Part B (Blinded)|Physician Decision|0|||
144745080|NCT05168813|521918996|FG002|Part B (Blinded)|Physician Decision|0|||
144745081|NCT05168813|521918997|FG003|Part B (Blinded)|Physician Decision|0|||
144745082|NCT05168813|521918998|FG004|Part B (Blinded)|Physician Decision|6|||
144745083|NCT05168813|521918999|FG005|Part B (Blinded)|Physician Decision|1|||
144745084|NCT05168813|521918994|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
144745085|NCT05168813|521918995|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
144745086|NCT05168813|521918996|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
144745087|NCT05168813|521918997|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
144745088|NCT05168813|521918998|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
144745089|NCT05168813|521918999|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
144745090|NCT05168813|521918994|FG000|Part B (Blinded)|Pregnancy|0|||
144745091|NCT05168813|521918995|FG001|Part B (Blinded)|Pregnancy|0|||
144745092|NCT05168813|521918996|FG002|Part B (Blinded)|Pregnancy|0|||
144745093|NCT05168813|521918997|FG003|Part B (Blinded)|Pregnancy|0|||
144745094|NCT05168813|521918998|FG004|Part B (Blinded)|Pregnancy|1|||
144745095|NCT05168813|521918999|FG005|Part B (Blinded)|Pregnancy|0|||
144745096|NCT05168813|521918994|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
144745097|NCT05168813|521918995|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
144745098|NCT05168813|521918996|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
144745099|NCT05168813|521918997|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
144745100|NCT05168813|521918998|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
144745101|NCT05168813|521918999|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
144745102|NCT05168813|521918994|FG000|Part B (Blinded)|Other|0|||
144745103|NCT05168813|521918995|FG001|Part B (Blinded)|Other|0|||
144745104|NCT05168813|521918996|FG002|Part B (Blinded)|Other|0|||
144220444|NCT00822692|520002188|FG001|Overall Study|Lost to Follow-up|25|||
144220445|NCT03281876|520002190|FG000|Overall Study|Adverse Event|4|||
144745105|NCT05168813|521918997|FG003|Part B (Blinded)|Other|0|||
144745106|NCT05168813|521918998|FG004|Part B (Blinded)|Other|41|||
144220446|NCT03281876|520002191|FG001|Overall Study|Adverse Event|15|||
144220447|NCT03281876|520002190|FG000|Overall Study|Lost to Follow-up|1|||
144266218|NCT02849080|520176569|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
144745107|NCT05168813|521918999|FG005|Part B (Blinded)|Other|27|||
144745108|NCT02630693|521919000|FG000|Overall Study|No receive treatment|0|||
144745109|NCT02630693|521919001|FG001|Overall Study|No receive treatment|1|||
144745110|NCT04423939|521919003|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
144745111|NCT04423939|521919004|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
144745112|NCT04423939|521919003|FG000|Overall Study|Death|3|||
144745113|NCT04423939|521919004|FG001|Overall Study|Death|0|||
144745114|NCT04423939|521919003|FG000|Overall Study|Withdrawal by Subject|3|||
144745115|NCT04423939|521919004|FG001|Overall Study|Withdrawal by Subject|0|||
144745116|NCT04423939|521919003|FG000|Overall Study|Caregiver to patient who died|0|||
144745117|NCT04423939|521919004|FG001|Overall Study|Caregiver to patient who died|3|||
144745118|NCT04423939|521919003|FG000|Overall Study|Caregiver to patient who withdrew|0|||
144745119|NCT04423939|521919004|FG001|Overall Study|Caregiver to patient who withdrew|3|||
144745120|NCT01169337|521919010|FG000|Overall Study|Lack of Efficacy|5|||
144745121|NCT01169337|521919011|FG001|Overall Study|Lack of Efficacy|7|||
144745122|NCT01169337|521919012|FG002|Overall Study|Lack of Efficacy|0|||
144745123|NCT01169337|521919010|FG000|Overall Study|Adverse Event|12|||
144745124|NCT01169337|521919011|FG001|Overall Study|Adverse Event|18|||
144745125|NCT01169337|521919012|FG002|Overall Study|Adverse Event|0|||
144745126|NCT01169337|521919010|FG000|Overall Study|Death|2|||
144745127|NCT01169337|521919011|FG001|Overall Study|Death|0|||
144745128|NCT01169337|521919012|FG002|Overall Study|Death|0|||
144745129|NCT01169337|521919010|FG000|Overall Study|Withdrawal by Subject|11|||
144745130|NCT01169337|521919011|FG001|Overall Study|Withdrawal by Subject|11|||
144745131|NCT01169337|521919012|FG002|Overall Study|Withdrawal by Subject|6|||
144745132|NCT01169337|521919010|FG000|Overall Study|Noncompliance|2|||
144745133|NCT01169337|521919011|FG001|Overall Study|Noncompliance|0|||
144745134|NCT01169337|521919012|FG002|Overall Study|Noncompliance|0|||
144745135|NCT01169337|521919010|FG000|Overall Study|Other complicating disease|1|||
144745136|NCT01169337|521919011|FG001|Overall Study|Other complicating disease|1|||
144745137|NCT01169337|521919012|FG002|Overall Study|Other complicating disease|0|||
144745138|NCT01169337|521919010|FG000|Overall Study|Physician Decision|1|||
144745139|NCT01169337|521919011|FG001|Overall Study|Physician Decision|5|||
144745140|NCT01169337|521919012|FG002|Overall Study|Physician Decision|0|||
144745141|NCT01169337|521919010|FG000|Overall Study|Alternative therapy|0|||
144745142|NCT01169337|521919011|FG001|Overall Study|Alternative therapy|2|||
144745143|NCT01169337|521919012|FG002|Overall Study|Alternative therapy|0|||
144745144|NCT01169337|521919010|FG000|Overall Study|Changed hospital|0|||
144745145|NCT01169337|521919011|FG001|Overall Study|Changed hospital|1|||
144745146|NCT01169337|521919012|FG002|Overall Study|Changed hospital|0|||
144745147|NCT01169337|521919010|FG000|Overall Study|Never started treatment|0|||
144745148|NCT01169337|521919011|FG001|Overall Study|Never started treatment|2|||
144745149|NCT01169337|521919012|FG002|Overall Study|Never started treatment|0|||
144745150|NCT01169337|521919010|FG000|Overall Study|Reason not reported|1|||
144745151|NCT01169337|521919011|FG001|Overall Study|Reason not reported|0|||
144745152|NCT01169337|521919012|FG002|Overall Study|Reason not reported|0|||
144745153|NCT01169337|521919010|FG000|Overall Study|Continuing lenalidomide|9|||
144745154|NCT01169337|521919011|FG001|Overall Study|Continuing lenalidomide|43|||
144745155|NCT01169337|521919012|FG002|Overall Study|Continuing lenalidomide|0|||
144745156|NCT01134614|521919013|FG000|Overall Study|Still on treatment as of March 2013|21|||
144745157|NCT01134614|521919014|FG001|Overall Study|Still on treatment as of March 2013|13|||
144745158|NCT01134614|521919013|FG000|Overall Study|Progressive disease|60|||
144745159|NCT01134614|521919014|FG001|Overall Study|Progressive disease|54|||
144745160|NCT01134614|521919013|FG000|Overall Study|Adverse Event|26|||
144745161|NCT01134614|521919014|FG001|Overall Study|Adverse Event|39|||
144745162|NCT01134614|521919013|FG000|Overall Study|Death|5|||
144745163|NCT01134614|521919014|FG001|Overall Study|Death|8|||
144745164|NCT01134614|521919013|FG000|Overall Study|Withdrawal by Subject|3|||
144745165|NCT01134614|521919014|FG001|Overall Study|Withdrawal by Subject|2|||
144745166|NCT01134614|521919013|FG000|Overall Study|Alternative therapy|2|||
144745167|NCT01134614|521919014|FG001|Overall Study|Alternative therapy|0|||
144745168|NCT01134614|521919013|FG000|Overall Study|Complicating disease|2|||
144745169|NCT01134614|521919014|FG001|Overall Study|Complicating disease|1|||
144745170|NCT01134614|521919013|FG000|Overall Study|Physician's decision|0|||
144745171|NCT01134614|521919014|FG001|Overall Study|Physician's decision|1|||
144745172|NCT01134614|521919013|FG000|Overall Study|Never started treatment|4|||
144745173|NCT01134614|521919014|FG001|Overall Study|Never started treatment|1|||
144745174|NCT01134614|521919013|FG000|Overall Study|Pt received tx not allowed on study|0|||
144745175|NCT01134614|521919014|FG001|Overall Study|Pt received tx not allowed on study|1|||
144745176|NCT01134614|521919013|FG000|Overall Study|Symptomatic deterioration|0|||
144220448|NCT03281876|520002191|FG001|Overall Study|Lost to Follow-up|4|||
144745177|NCT01134614|521919014|FG001|Overall Study|Symptomatic deterioration|1|||
144745178|NCT01134614|521919013|FG000|Overall Study|Patient in hospice care|0|||
144745179|NCT01134614|521919014|FG001|Overall Study|Patient in hospice care|1|||
144745180|NCT04527549|521919016|FG000|Overall Study|Withdrawal by Subject|1|||
144745181|NCT04527549|521919017|FG001|Overall Study|Withdrawal by Subject|1|||
144745182|NCT05764161|521919020|FG000|12-week DBVC Period|Lack of Efficacy|2|||
144745183|NCT05764161|521919021|FG001|12-week DBVC Period|Lack of Efficacy|1|||
144745184|NCT05764161|521919020|FG000|12-week DBVC Period|Lost to Follow-up|0|||
144745185|NCT05764161|521919021|FG001|12-week DBVC Period|Lost to Follow-up|2|||
144745186|NCT05764161|521919020|FG000|12-week DBVC Period|Protocol Violation|2|||
144745187|NCT05764161|521919021|FG001|12-week DBVC Period|Protocol Violation|4|||
144745188|NCT05764161|521919020|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
144745189|NCT05764161|521919021|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
144745190|NCT05764161|521919020|FG000|40-week OLE Period|Lack of Efficacy|0|||
144745191|NCT05764161|521919021|FG001|40-week OLE Period|Lack of Efficacy|1|||
144745192|NCT05764161|521919020|FG000|40-week OLE Period|Lost to Follow-up|1|||
144745193|NCT05764161|521919021|FG001|40-week OLE Period|Lost to Follow-up|4|||
144745194|NCT05764161|521919020|FG000|40-week OLE Period|Withdrawal by Subject|2|||
144745195|NCT05764161|521919021|FG001|40-week OLE Period|Withdrawal by Subject|7|||
144745196|NCT05764161|521919020|FG000|40-week OLE Period|Extended Travel|0|||
144745197|NCT05764161|521919021|FG001|40-week OLE Period|Extended Travel|1|||
144745198|NCT05764161|521919020|FG000|40-week OLE Period|Ongoing|66|||
144745199|NCT05764161|521919021|FG001|40-week OLE Period|Ongoing|59|||
144745200|NCT03718767|521919022|FG000|Overall Study|Declined to participate (before treatment started)|0|||
144745201|NCT03718767|521919023|FG001|Overall Study|Declined to participate (before treatment started)|0|||
144745202|NCT03718767|521919024|FG002|Overall Study|Declined to participate (before treatment started)|7|||
144745203|NCT03718767|521919022|FG000|Overall Study|Ineligible|0|||
144745204|NCT03718767|521919023|FG001|Overall Study|Ineligible|0|||
144745205|NCT03718767|521919024|FG002|Overall Study|Ineligible|17|||
144745206|NCT05694065|521919025|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
144745207|NCT05694065|521919025|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
144745208|NCT05694065|521919025|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
144745209|NCT05338710|521919026|FG000|Overall Study|Withdrawal by Subject|3|||
144745210|NCT04503551|521919027|FG000|Overall Study|Withdrawal by Subject|5|||
144745211|NCT04503551|521919028|FG001|Overall Study|Withdrawal by Subject|3|||
144745212|NCT04503551|521919027|FG000|Overall Study|Physician Decision|1|||
144745213|NCT04503551|521919028|FG001|Overall Study|Physician Decision|0|||
144745214|NCT04503551|521919027|FG000|Overall Study|Death|0|||
144745215|NCT04503551|521919028|FG001|Overall Study|Death|1|||
144745216|NCT04503551|521919027|FG000|Overall Study|Lost to Follow-up|1|||
144745217|NCT04503551|521919028|FG001|Overall Study|Lost to Follow-up|2|||
144745218|NCT04503551|521919027|FG000|Overall Study|Ongoing at Week 52|99|||
144745219|NCT04503551|521919028|FG001|Overall Study|Ongoing at Week 52|62|||
144745220|NCT05299606|521919029|FG000|Overall Study|Death|1|||
144745221|NCT01708941|521919030|FG000|Overall Study|Adverse Event|4|||
144745222|NCT01708941|521919031|FG001|Overall Study|Adverse Event|6|||
144745223|NCT01708941|521919032|FG002|Overall Study|Adverse Event|1|||
144745224|NCT01708941|521919033|FG003|Overall Study|Adverse Event|0|||
144745225|NCT01708941|521919030|FG000|Overall Study|Death|1|||
144745226|NCT01708941|521919031|FG001|Overall Study|Death|1|||
144745227|NCT01708941|521919032|FG002|Overall Study|Death|2|||
144745228|NCT01708941|521919033|FG003|Overall Study|Death|14|||
144745229|NCT01708941|521919030|FG000|Overall Study|Withdrawal by Subject|1|||
144745230|NCT01708941|521919031|FG001|Overall Study|Withdrawal by Subject|0|||
144745231|NCT01708941|521919032|FG002|Overall Study|Withdrawal by Subject|3|||
144745232|NCT01708941|521919033|FG003|Overall Study|Withdrawal by Subject|4|||
144745233|NCT01708941|521919030|FG000|Overall Study|Disease progression|9|||
144745234|NCT01708941|521919031|FG001|Overall Study|Disease progression|10|||
144745235|NCT01708941|521919032|FG002|Overall Study|Disease progression|8|||
144745236|NCT01708941|521919033|FG003|Overall Study|Disease progression|0|||
144745237|NCT01708941|521919030|FG000|Overall Study|Alternative therapy|0|||
144745238|NCT01708941|521919031|FG001|Overall Study|Alternative therapy|0|||
144745239|NCT01708941|521919032|FG002|Overall Study|Alternative therapy|2|||
144745240|NCT01708941|521919033|FG003|Overall Study|Alternative therapy|0|||
144745241|NCT01708941|521919030|FG000|Overall Study|Ineligible and never started treatment|1|||
144745242|NCT01708941|521919031|FG001|Overall Study|Ineligible and never started treatment|0|||
144745243|NCT01708941|521919032|FG002|Overall Study|Ineligible and never started treatment|1|||
144745244|NCT01708941|521919033|FG003|Overall Study|Ineligible and never started treatment|0|||
144745245|NCT01708941|521919030|FG000|Overall Study|Never started treatment|2|||
144745246|NCT01708941|521919031|FG001|Overall Study|Never started treatment|1|||
144745247|NCT01708941|521919032|FG002|Overall Study|Never started treatment|0|||
144745248|NCT01708941|521919033|FG003|Overall Study|Never started treatment|0|||
144745249|NCT01708941|521919030|FG000|Overall Study|Ineligible|0|||
144745250|NCT01708941|521919031|FG001|Overall Study|Ineligible|0|||
144745251|NCT01708941|521919032|FG002|Overall Study|Ineligible|2|||
144745252|NCT01708941|521919033|FG003|Overall Study|Ineligible|0|||
144745253|NCT03515304|521919036|FG000|Overall Study|Lost to Follow-up|0|||
144220449|NCT03281876|520002190|FG000|Overall Study|Withdrawal by Subject|11|||
144220450|NCT03281876|520002191|FG001|Overall Study|Withdrawal by Subject|15|||
144745254|NCT03515304|521919037|FG001|Overall Study|Lost to Follow-up|3|||
144745255|NCT03946670|521919038|FG000|Overall Study|Progressive Disease|34|||
144745256|NCT03946670|521919039|FG001|Overall Study|Progressive Disease|27|||
144745257|NCT03946670|521919038|FG000|Overall Study|Adverse Event|7|||
144745258|NCT03946670|521919039|FG001|Overall Study|Adverse Event|10|||
144745259|NCT03946670|521919038|FG000|Overall Study|Physician Decision|6|||
144745260|NCT03946670|521919039|FG001|Overall Study|Physician Decision|5|||
144745261|NCT03946670|521919038|FG000|Overall Study|Death|5|||
144745262|NCT03946670|521919039|FG001|Overall Study|Death|8|||
144745263|NCT03946670|521919038|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
144745264|NCT03946670|521919039|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
144745265|NCT03946670|521919038|FG000|Overall Study|Subject Decision|4|||
144220451|NCT03281876|520002190|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
144220452|NCT03281876|520002191|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144220453|NCT03281876|520002190|FG000|Overall Study|OTHER|5|||
144220454|NCT03281876|520002191|FG001|Overall Study|OTHER|5|||
144220455|NCT02208089|520002192|FG000|Overall Study|Withdrawal by Subject|1|||
144220456|NCT02208089|520002193|FG001|Overall Study|Withdrawal by Subject|0|||
144220457|NCT02208089|520002192|FG000|Overall Study|Lost to Follow-up|6|||
144220458|NCT02208089|520002193|FG001|Overall Study|Lost to Follow-up|0|||
144220459|NCT02443740|520002194|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
144693441|NCT03802331|521729649|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
144693442|NCT03802331|521729650|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
144693443|NCT00368069|521729651|FG000|Overall Study|Adverse Event|5|||
144693444|NCT00368069|521729652|FG001|Overall Study|Adverse Event|2|||
144693445|NCT00368069|521729651|FG000|Overall Study|Lack of Efficacy|0|||
144693446|NCT00368069|521729652|FG001|Overall Study|Lack of Efficacy|1|||
144693447|NCT00368069|521729651|FG000|Overall Study|Lost to Follow-up|1|||
144693448|NCT00368069|521729652|FG001|Overall Study|Lost to Follow-up|0|||
144693449|NCT00368069|521729651|FG000|Overall Study|Protocol Violation|0|||
144693450|NCT00368069|521729652|FG001|Overall Study|Protocol Violation|2|||
144693451|NCT00368069|521729651|FG000|Overall Study|Withdrawal of Consent|2|||
144693452|NCT00368069|521729652|FG001|Overall Study|Withdrawal of Consent|1|||
144693453|NCT00368069|521729651|FG000|Overall Study|no blood sampling possible|0|||
144693454|NCT00368069|521729652|FG001|Overall Study|no blood sampling possible|1|||
144693455|NCT00779506|521729653|FG000|Overall Study|Screening Failed|2|||
144693456|NCT00779506|521729653|FG000|Overall Study|Adverse Event|4|||
144693457|NCT00779506|521729653|FG000|Overall Study|Lack of Efficacy|11|||
144693458|NCT00779506|521729653|FG000|Overall Study|Protocol Violation|5|||
144693459|NCT00779506|521729653|FG000|Overall Study|Withdrawal by Subject|6|||
144693460|NCT00779506|521729653|FG000|Overall Study|Lost to Follow-up|1|||
144693461|NCT04047472|521729654|FG000|Overall Study|Adverse Event|3|||
144693462|NCT04047472|521729655|FG001|Overall Study|Adverse Event|3|||
144693463|NCT04047472|521729654|FG000|Overall Study|Death|0|||
144693464|NCT04047472|521729655|FG001|Overall Study|Death|1|||
144693465|NCT04047472|521729654|FG000|Overall Study|Lost to Follow-up|1|||
144693466|NCT04047472|521729655|FG001|Overall Study|Lost to Follow-up|0|||
144693467|NCT04047472|521729654|FG000|Overall Study|Physician Decision|1|||
144693468|NCT04047472|521729655|FG001|Overall Study|Physician Decision|2|||
144693469|NCT04047472|521729654|FG000|Overall Study|Protocol Violation|1|||
144693470|NCT04047472|521729655|FG001|Overall Study|Protocol Violation|0|||
144693471|NCT04047472|521729654|FG000|Overall Study|Withdrawal by Subject|10|||
144693472|NCT04047472|521729655|FG001|Overall Study|Withdrawal by Subject|10|||
144693473|NCT03982069|521729656|FG000|Overall Study|Lost to Follow-up|5|||
144693474|NCT03982069|521729657|FG001|Overall Study|Lost to Follow-up|5|||
144693475|NCT03982069|521729658|FG002|Overall Study|Lost to Follow-up|3|||
144693476|NCT03982069|521729659|FG003|Overall Study|Lost to Follow-up|5|||
144693477|NCT03982069|521729656|FG000|Overall Study|Physician Decision|0|||
144693478|NCT03982069|521729657|FG001|Overall Study|Physician Decision|1|||
144693479|NCT03982069|521729658|FG002|Overall Study|Physician Decision|0|||
144693480|NCT03982069|521729659|FG003|Overall Study|Physician Decision|0|||
144693481|NCT03982069|521729656|FG000|Overall Study|Withdrawal by Subject|2|||
144693482|NCT03982069|521729657|FG001|Overall Study|Withdrawal by Subject|1|||
144693483|NCT03982069|521729658|FG002|Overall Study|Withdrawal by Subject|5|||
144693484|NCT03982069|521729659|FG003|Overall Study|Withdrawal by Subject|2|||
144693485|NCT03982069|521729656|FG000|Overall Study|Specimen loss|3|||
144693486|NCT03982069|521729657|FG001|Overall Study|Specimen loss|3|||
144693487|NCT03982069|521729658|FG002|Overall Study|Specimen loss|1|||
144693488|NCT03982069|521729659|FG003|Overall Study|Specimen loss|1|||
144693489|NCT01218477|521729660|FG000|Overall Study|Disease progression|2|||
144693490|NCT01218477|521729661|FG001|Overall Study|Disease progression|3|||
144693491|NCT01218477|521729662|FG002|Overall Study|Disease progression|6|||
144693492|NCT01218477|521729663|FG003|Overall Study|Disease progression|2|||
144693493|NCT01218477|521729660|FG000|Overall Study|Study drug toxicity|0|||
144693494|NCT01218477|521729661|FG001|Overall Study|Study drug toxicity|2|||
144220460|NCT02443740|520002195|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
144220461|NCT02443740|520002196|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
144220462|NCT02443740|520002197|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
144693495|NCT01218477|521729662|FG002|Overall Study|Study drug toxicity|5|||
144693496|NCT01218477|521729663|FG003|Overall Study|Study drug toxicity|0|||
144693497|NCT01218477|521729660|FG000|Overall Study|No longer meets study criteria|1|||
144693498|NCT01218477|521729661|FG001|Overall Study|No longer meets study criteria|0|||
144693499|NCT01218477|521729662|FG002|Overall Study|No longer meets study criteria|0|||
144693500|NCT01218477|521729663|FG003|Overall Study|No longer meets study criteria|0|||
144693501|NCT01218477|521729660|FG000|Overall Study|Withdrawal by Subject|0|||
144693502|NCT01218477|521729661|FG001|Overall Study|Withdrawal by Subject|0|||
144693503|NCT01218477|521729662|FG002|Overall Study|Withdrawal by Subject|1|||
144693504|NCT01218477|521729663|FG003|Overall Study|Withdrawal by Subject|0|||
144693505|NCT01218477|521729660|FG000|Overall Study|Prepared for cell transplantation|0|||
144693506|NCT01218477|521729661|FG001|Overall Study|Prepared for cell transplantation|1|||
144220463|NCT02443740|520002198|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
144745266|NCT03946670|521919039|FG001|Overall Study|Subject Decision|5|||
144745267|NCT03946670|521919038|FG000|Overall Study|Study Terminated By Sponsor|2|||
144745268|NCT03946670|521919039|FG001|Overall Study|Study Terminated By Sponsor|0|||
144745269|NCT03946670|521919038|FG000|Overall Study|New Therapy For Study Indication|1|||
144745270|NCT03946670|521919039|FG001|Overall Study|New Therapy For Study Indication|0|||
144745271|NCT03946670|521919038|FG000|Overall Study|Not Treated|1|||
144745272|NCT03946670|521919039|FG001|Overall Study|Not Treated|1|||
144745273|NCT02226146|521919047|FG000|Overall Study|Received rescue therapy|1|||
144745274|NCT02226146|521919047|FG000|Overall Study|Withdrawal by Subject|2|||
144745275|NCT05464836|521919050|FG000|Overall Study|Progression of Disease|1|||
144745276|NCT05464836|521919050|FG000|Overall Study|Physician Decision|1|||
144745277|NCT01522976|521919051|FG000|Overall Study|Ineligible|4|||
144745278|NCT01522976|521919052|FG001|Overall Study|Ineligible|0|||
144745279|NCT01522976|521919053|FG002|Overall Study|Ineligible|1|||
144745280|NCT01522976|521919051|FG000|Overall Study|Death|7|||
144745281|NCT01522976|521919052|FG001|Overall Study|Death|6|||
144745282|NCT01522976|521919053|FG002|Overall Study|Death|2|||
144745283|NCT01522976|521919051|FG000|Overall Study|Still on treatment|9|||
144745284|NCT01522976|521919052|FG001|Overall Study|Still on treatment|9|||
144745285|NCT01522976|521919053|FG002|Overall Study|Still on treatment|6|||
144745286|NCT01522976|521919051|FG000|Overall Study|Disease progression|28|||
144745287|NCT01522976|521919052|FG001|Overall Study|Disease progression|30|||
144745288|NCT01522976|521919053|FG002|Overall Study|Disease progression|25|||
144745289|NCT01522976|521919051|FG000|Overall Study|Adverse Event|17|||
144745290|NCT01522976|521919052|FG001|Overall Study|Adverse Event|7|||
144745291|NCT01522976|521919053|FG002|Overall Study|Adverse Event|18|||
144745292|NCT01522976|521919051|FG000|Overall Study|Refusal unrelated to adverse event|10|||
144745293|NCT01522976|521919052|FG001|Overall Study|Refusal unrelated to adverse event|13|||
144745294|NCT01522976|521919053|FG002|Overall Study|Refusal unrelated to adverse event|14|||
144745295|NCT01522976|521919051|FG000|Overall Study|Not protocol specified|22|||
144745296|NCT01522976|521919052|FG001|Overall Study|Not protocol specified|27|||
144745297|NCT01522976|521919053|FG002|Overall Study|Not protocol specified|27|||
144745298|NCT05710640|521919056|FG000|Overall Study|Physician Decision|0|||
144745299|NCT05710640|521919057|FG001|Overall Study|Physician Decision|1|||
144745300|NCT05710640|521919056|FG000|Overall Study|Withdrawal by Subject|1|||
144745301|NCT05710640|521919057|FG001|Overall Study|Withdrawal by Subject|0|||
144745302|NCT05710640|521919056|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
144745303|NCT05710640|521919057|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
144745304|NCT02883049|521919058|FG000|Induction|Adverse Event|52|||
144745305|NCT02883049|521919059|FG001|Induction|Adverse Event|2|||
144745306|NCT02883049|521919060|FG002|Induction|Adverse Event|0|||
144745307|NCT02883049|521919061|FG003|Induction|Adverse Event|0|||
144745308|NCT02883049|521919062|FG004|Induction|Adverse Event|0|||
144745309|NCT02883049|521919063|FG005|Induction|Adverse Event|0|||
144745310|NCT02883049|521919064|FG006|Induction|Adverse Event|0|||
144745311|NCT02883049|521919065|FG007|Induction|Adverse Event|0|||
144745312|NCT02883049|521919066|FG008|Induction|Adverse Event|0|||
144745313|NCT02883049|521919067|FG009|Induction|Adverse Event|0|||
144745314|NCT02883049|521919068|FG010|Induction|Adverse Event|0|||
144745315|NCT02883049|521919069|FG011|Induction|Adverse Event|0|||
144745316|NCT02883049|521919070|FG012|Induction|Adverse Event|0|||
144745317|NCT02883049|521919071|FG013|Induction|Adverse Event|0|||
144745318|NCT02883049|521919072|FG014|Induction|Adverse Event|0|||
144745319|NCT02883049|521919073|FG015|Induction|Adverse Event|0|||
144220464|NCT02443740|520002199|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
144220465|NCT02443740|520002200|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
144745320|NCT02883049|521919058|FG000|Induction|Death|76|||
144745321|NCT02883049|521919059|FG001|Induction|Death|8|||
144745322|NCT02883049|521919060|FG002|Induction|Death|0|||
144745323|NCT02883049|521919061|FG003|Induction|Death|0|||
144745324|NCT02883049|521919062|FG004|Induction|Death|0|||
144220466|NCT02443740|520002201|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
144220467|NCT02443740|520002202|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
144745325|NCT02883049|521919063|FG005|Induction|Death|0|||
144745326|NCT02883049|521919064|FG006|Induction|Death|0|||
144745327|NCT02883049|521919065|FG007|Induction|Death|0|||
144745328|NCT02883049|521919066|FG008|Induction|Death|0|||
144745329|NCT02883049|521919067|FG009|Induction|Death|0|||
144745330|NCT02883049|521919068|FG010|Induction|Death|0|||
144745331|NCT02883049|521919069|FG011|Induction|Death|0|||
144745332|NCT02883049|521919070|FG012|Induction|Death|0|||
144745333|NCT02883049|521919071|FG013|Induction|Death|0|||
144745334|NCT02883049|521919072|FG014|Induction|Death|0|||
144745335|NCT02883049|521919073|FG015|Induction|Death|0|||
144745336|NCT02883049|521919058|FG000|Induction|Lost to Follow-up|2|||
144745337|NCT02883049|521919059|FG001|Induction|Lost to Follow-up|0|||
144745338|NCT02883049|521919060|FG002|Induction|Lost to Follow-up|0|||
144745339|NCT02883049|521919061|FG003|Induction|Lost to Follow-up|0|||
144745340|NCT02883049|521919062|FG004|Induction|Lost to Follow-up|0|||
144745341|NCT02883049|521919063|FG005|Induction|Lost to Follow-up|0|||
144745342|NCT02883049|521919064|FG006|Induction|Lost to Follow-up|0|||
144745343|NCT02883049|521919065|FG007|Induction|Lost to Follow-up|0|||
144220468|NCT02443740|520002203|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
144220469|NCT02443740|520002204|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
144220470|NCT02443740|520002194|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
144220471|NCT02443740|520002195|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220472|NCT02443740|520002196|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220473|NCT02443740|520002197|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220474|NCT02443740|520002198|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220475|NCT02443740|520002199|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220476|NCT02443740|520002200|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
144266219|NCT02849080|520176570|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
144266220|NCT02849080|520176571|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
144266221|NCT02849080|520176568|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
144266222|NCT02849080|520176569|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
144266223|NCT02849080|520176570|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
144266224|NCT02849080|520176571|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
144266225|NCT02849080|520176568|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
144266226|NCT02849080|520176569|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
144266227|NCT02849080|520176570|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
144266228|NCT02849080|520176571|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
144266229|NCT02849080|520176568|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
144266230|NCT02849080|520176569|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
144266231|NCT02849080|520176570|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
144266232|NCT02849080|520176571|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
144266233|NCT02849080|520176568|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
144266234|NCT02849080|520176569|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
144266235|NCT02849080|520176570|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
144266236|NCT02849080|520176571|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
144266237|NCT01819727|520176572|FG000|Overall Study|Adverse Event|8|||
144266238|NCT01819727|520176573|FG001|Overall Study|Adverse Event|9|||
144266239|NCT01819727|520176572|FG000|Overall Study|Death|1|||
144266240|NCT01819727|520176573|FG001|Overall Study|Death|0|||
144266241|NCT01819727|520176572|FG000|Overall Study|Lost to Follow-up|1|||
144266242|NCT01819727|520176573|FG001|Overall Study|Lost to Follow-up|1|||
144266243|NCT01819727|520176572|FG000|Overall Study|Physician Decision|3|||
144266244|NCT01819727|520176573|FG001|Overall Study|Physician Decision|2|||
144266245|NCT01819727|520176572|FG000|Overall Study|Pregnancy|1|||
144266246|NCT01819727|520176573|FG001|Overall Study|Pregnancy|0|||
144266247|NCT01819727|520176572|FG000|Overall Study|Protocol Violation|0|||
144266248|NCT01819727|520176573|FG001|Overall Study|Protocol Violation|2|||
144266249|NCT01819727|520176572|FG000|Overall Study|Study Terminated by Sponsor|0|||
144266250|NCT01819727|520176573|FG001|Overall Study|Study Terminated by Sponsor|1|||
144266251|NCT01819727|520176572|FG000|Overall Study|Withdrawal by Subject|6|||
144266252|NCT01819727|520176573|FG001|Overall Study|Withdrawal by Subject|11|||
144266253|NCT01819727|520176572|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
144266254|NCT01819727|520176573|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
144266255|NCT01819727|520176572|FG000|Overall Study|Quit due to lack of health benifits|0|||
144266256|NCT01819727|520176573|FG001|Overall Study|Quit due to lack of health benifits|1|||
144266257|NCT01628848|520176574|FG000|Overall Study|Adverse Event|9|||
144266258|NCT01628848|520176575|FG001|Overall Study|Adverse Event|7|||
144266259|NCT01628848|520176574|FG000|Overall Study|Lack of Efficacy|0|||
144266260|NCT01628848|520176575|FG001|Overall Study|Lack of Efficacy|4|||
144266261|NCT01628848|520176574|FG000|Overall Study|Withdrawal by Subject|0|||
144266262|NCT01628848|520176575|FG001|Overall Study|Withdrawal by Subject|2|||
144266263|NCT01628848|520176574|FG000|Overall Study|Physician Decision|3|||
144266264|NCT01628848|520176575|FG001|Overall Study|Physician Decision|1|||
144266265|NCT03644017|520176578|FG000|Overall Study|Access Abandonment|5|||
144266266|NCT03644017|520176578|FG000|Overall Study|Kidney Transplant|2|||
144266267|NCT02340000|520176579|FG000|Time Period 1|Withdrawal by Subject|6|||
144266268|NCT02340000|520176580|FG001|Time Period 1|Withdrawal by Subject|8|||
144266269|NCT02340000|520176579|FG000|Time Period 1|Lost to Follow-up|6|||
144266270|NCT02340000|520176580|FG001|Time Period 1|Lost to Follow-up|7|||
144266271|NCT02340000|520176579|FG000|Time Period 2|Withdrawal by Subject|9|||
144266272|NCT02340000|520176580|FG001|Time Period 2|Withdrawal by Subject|7|||
144266273|NCT02340000|520176579|FG000|Time Period 2|Lost to Follow-up|10|||
144266274|NCT02340000|520176580|FG001|Time Period 2|Lost to Follow-up|8|||
144266275|NCT01949142|520176581|FG000|Overall Study|Withdrawal of consent|1|||
144266276|NCT01949142|520176582|FG001|Overall Study|Withdrawal of consent|0|||
144745344|NCT02883049|521919066|FG008|Induction|Lost to Follow-up|0|||
144220477|NCT02443740|520002201|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144266277|NCT01949142|520176581|FG000|Overall Study|Lost to Follow-up|1|||
144266278|NCT01949142|520176582|FG001|Overall Study|Lost to Follow-up|1|||
144266279|NCT01949142|520176581|FG000|Overall Study|Parent changed their mind|1|||
144266280|NCT01949142|520176582|FG001|Overall Study|Parent changed their mind|0|||
144266281|NCT01548599|520178293|FG000|Overall Study|Lost to Follow-up|0|||
144266282|NCT01548599|520178294|FG001|Overall Study|Lost to Follow-up|1|||
144745345|NCT02883049|521919067|FG009|Induction|Lost to Follow-up|0|||
144745346|NCT02883049|521919068|FG010|Induction|Lost to Follow-up|0|||
144745347|NCT02883049|521919069|FG011|Induction|Lost to Follow-up|0|||
144745348|NCT02883049|521919070|FG012|Induction|Lost to Follow-up|0|||
144745349|NCT02883049|521919071|FG013|Induction|Lost to Follow-up|0|||
144745350|NCT02883049|521919072|FG014|Induction|Lost to Follow-up|0|||
144745351|NCT02883049|521919073|FG015|Induction|Lost to Follow-up|0|||
144745352|NCT02883049|521919058|FG000|Induction|Physician Decision|1407|||
144745353|NCT02883049|521919059|FG001|Induction|Physician Decision|8|||
144745354|NCT02883049|521919060|FG002|Induction|Physician Decision|0|||
144745355|NCT02883049|521919061|FG003|Induction|Physician Decision|0|||
144745356|NCT02883049|521919062|FG004|Induction|Physician Decision|0|||
144745357|NCT02883049|521919063|FG005|Induction|Physician Decision|0|||
144745358|NCT02883049|521919064|FG006|Induction|Physician Decision|0|||
144745359|NCT02883049|521919065|FG007|Induction|Physician Decision|0|||
144745360|NCT02883049|521919066|FG008|Induction|Physician Decision|0|||
144745361|NCT02883049|521919067|FG009|Induction|Physician Decision|0|||
144745362|NCT02883049|521919068|FG010|Induction|Physician Decision|0|||
144745363|NCT02883049|521919069|FG011|Induction|Physician Decision|0|||
144745364|NCT02883049|521919070|FG012|Induction|Physician Decision|0|||
144745365|NCT02883049|521919071|FG013|Induction|Physician Decision|0|||
144745366|NCT02883049|521919072|FG014|Induction|Physician Decision|0|||
144745367|NCT02883049|521919073|FG015|Induction|Physician Decision|0|||
144745368|NCT02883049|521919058|FG000|Induction|Protocol Violation|6|||
144745369|NCT02883049|521919059|FG001|Induction|Protocol Violation|0|||
144745370|NCT02883049|521919060|FG002|Induction|Protocol Violation|0|||
144745371|NCT02883049|521919061|FG003|Induction|Protocol Violation|0|||
144745372|NCT02883049|521919062|FG004|Induction|Protocol Violation|0|||
144745373|NCT02883049|521919063|FG005|Induction|Protocol Violation|0|||
144745374|NCT02883049|521919064|FG006|Induction|Protocol Violation|0|||
144745375|NCT02883049|521919065|FG007|Induction|Protocol Violation|0|||
144745376|NCT02883049|521919066|FG008|Induction|Protocol Violation|0|||
144745377|NCT02883049|521919067|FG009|Induction|Protocol Violation|0|||
144745378|NCT02883049|521919068|FG010|Induction|Protocol Violation|0|||
144745379|NCT02883049|521919069|FG011|Induction|Protocol Violation|0|||
144745380|NCT02883049|521919070|FG012|Induction|Protocol Violation|0|||
144745381|NCT02883049|521919071|FG013|Induction|Protocol Violation|0|||
144745382|NCT02883049|521919072|FG014|Induction|Protocol Violation|0|||
144745383|NCT02883049|521919073|FG015|Induction|Protocol Violation|0|||
144745384|NCT02883049|521919058|FG000|Induction|Withdrawal by Subject|6|||
144745385|NCT02883049|521919059|FG001|Induction|Withdrawal by Subject|0|||
144745386|NCT02883049|521919060|FG002|Induction|Withdrawal by Subject|0|||
144745387|NCT02883049|521919061|FG003|Induction|Withdrawal by Subject|0|||
144745388|NCT02883049|521919062|FG004|Induction|Withdrawal by Subject|0|||
144745389|NCT02883049|521919063|FG005|Induction|Withdrawal by Subject|0|||
144745390|NCT02883049|521919064|FG006|Induction|Withdrawal by Subject|0|||
144745391|NCT02883049|521919065|FG007|Induction|Withdrawal by Subject|0|||
144745392|NCT02883049|521919066|FG008|Induction|Withdrawal by Subject|0|||
144745393|NCT02883049|521919067|FG009|Induction|Withdrawal by Subject|0|||
144745394|NCT02883049|521919068|FG010|Induction|Withdrawal by Subject|0|||
144745395|NCT02883049|521919069|FG011|Induction|Withdrawal by Subject|0|||
144745396|NCT02883049|521919070|FG012|Induction|Withdrawal by Subject|0|||
144745397|NCT02883049|521919071|FG013|Induction|Withdrawal by Subject|0|||
144745398|NCT02883049|521919072|FG014|Induction|Withdrawal by Subject|0|||
144745399|NCT02883049|521919073|FG015|Induction|Withdrawal by Subject|0|||
144745400|NCT02883049|521919058|FG000|Induction|Ineligible|35|||
144745401|NCT02883049|521919059|FG001|Induction|Ineligible|1|||
144745402|NCT02883049|521919060|FG002|Induction|Ineligible|0|||
144745403|NCT02883049|521919061|FG003|Induction|Ineligible|0|||
144745404|NCT02883049|521919062|FG004|Induction|Ineligible|0|||
144745405|NCT02883049|521919063|FG005|Induction|Ineligible|0|||
144745406|NCT02883049|521919064|FG006|Induction|Ineligible|0|||
144745407|NCT02883049|521919065|FG007|Induction|Ineligible|0|||
144745408|NCT02883049|521919066|FG008|Induction|Ineligible|0|||
144745409|NCT02883049|521919067|FG009|Induction|Ineligible|0|||
144745410|NCT02883049|521919068|FG010|Induction|Ineligible|0|||
144745411|NCT02883049|521919069|FG011|Induction|Ineligible|0|||
144745412|NCT02883049|521919070|FG012|Induction|Ineligible|0|||
144745413|NCT02883049|521919071|FG013|Induction|Ineligible|0|||
144745414|NCT02883049|521919072|FG014|Induction|Ineligible|0|||
144745415|NCT02883049|521919073|FG015|Induction|Ineligible|0|||
144745416|NCT02883049|521919058|FG000|Induction|Refusal of further protocol therapy|466|||
144745417|NCT02883049|521919059|FG001|Induction|Refusal of further protocol therapy|2|||
144745418|NCT02883049|521919060|FG002|Induction|Refusal of further protocol therapy|0|||
144745419|NCT02883049|521919061|FG003|Induction|Refusal of further protocol therapy|0|||
144745420|NCT02883049|521919062|FG004|Induction|Refusal of further protocol therapy|0|||
144745421|NCT02883049|521919063|FG005|Induction|Refusal of further protocol therapy|0|||
144745422|NCT02883049|521919064|FG006|Induction|Refusal of further protocol therapy|0|||
144745423|NCT02883049|521919065|FG007|Induction|Refusal of further protocol therapy|0|||
144745424|NCT02883049|521919066|FG008|Induction|Refusal of further protocol therapy|0|||
144745425|NCT02883049|521919067|FG009|Induction|Refusal of further protocol therapy|0|||
144745426|NCT02883049|521919068|FG010|Induction|Refusal of further protocol therapy|0|||
144220478|NCT02443740|520002202|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220479|NCT02443740|520002203|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220480|NCT02443740|520002204|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
144220481|NCT02443740|520002194|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220482|NCT02443740|520002195|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220483|NCT02443740|520002196|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220484|NCT02443740|520002197|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220485|NCT02443740|520002198|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220486|NCT02443740|520002199|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
144220487|NCT02443740|520002200|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220488|NCT02443740|520002201|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220489|NCT02443740|520002202|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220490|NCT02443740|520002203|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220491|NCT02443740|520002204|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
144220492|NCT00456300|520002205|FG000|Overall Study|Adverse Event|1|||
144220493|NCT00456300|520002206|FG001|Overall Study|Adverse Event|0|||
144220494|NCT02452476|520002208|FG000|Overall Study|Death|4|||
144220495|NCT02452476|520002209|FG001|Overall Study|Death|7|||
144220496|NCT02452476|520002208|FG000|Overall Study|Lost to Follow-up|1|||
144220497|NCT02452476|520002209|FG001|Overall Study|Lost to Follow-up|1|||
144220498|NCT02452476|520002208|FG000|Overall Study|Physician Decision|1|||
144220499|NCT02452476|520002209|FG001|Overall Study|Physician Decision|1|||
144220500|NCT02452476|520002208|FG000|Overall Study|Not treated|5|||
144220501|NCT02452476|520002209|FG001|Overall Study|Not treated|1|||
144220502|NCT00683657|520002211|FG000|Overall Study|Adverse Event|0|||
144220503|NCT00683657|520002212|FG001|Overall Study|Adverse Event|1|||
144220504|NCT00683657|520002211|FG000|Overall Study|Subject Withdrew Consent|1|||
144220505|NCT00683657|520002212|FG001|Overall Study|Subject Withdrew Consent|0|||
144220506|NCT02461160|520002221|FG000|Overall Study|Lost to Follow-up|0|||
144220507|NCT02461160|520002222|FG001|Overall Study|Lost to Follow-up|0|||
144220508|NCT02461160|520002223|FG002|Overall Study|Lost to Follow-up|0|||
144220509|NCT02461160|520002224|FG003|Overall Study|Lost to Follow-up|0|||
144220510|NCT02461160|520002225|FG004|Overall Study|Lost to Follow-up|0|||
144220511|NCT02461160|520002226|FG005|Overall Study|Lost to Follow-up|0|||
144220512|NCT02461160|520002227|FG006|Overall Study|Lost to Follow-up|0|||
144220513|NCT02461160|520002228|FG007|Overall Study|Lost to Follow-up|1|||
144220514|NCT02461160|520002229|FG008|Overall Study|Lost to Follow-up|0|||
144220515|NCT02461160|520002230|FG009|Overall Study|Lost to Follow-up|0|||
144220516|NCT02461160|520002231|FG010|Overall Study|Lost to Follow-up|0|||
144220517|NCT02461160|520002232|FG011|Overall Study|Lost to Follow-up|0|||
144220518|NCT02461160|520002233|FG012|Overall Study|Lost to Follow-up|0|||
144220519|NCT00193050|520002234|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
144220520|NCT00193050|520002234|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
144220521|NCT00193050|520002234|FG000|Neoadjuvant Treatment|Physician Decision|2|||
144220522|NCT00193050|520002234|FG000|Neoadjuvant Treatment|Adverse Event|2|||
144220523|NCT00193050|520002234|FG000|Adjuvant|Physician Decision|5|||
144220524|NCT00193050|520002234|FG000|Adjuvant|Intercurrent Hospitalization|3|||
144220525|NCT00193050|520002234|FG000|Adjuvant|Lack of Efficacy|2|||
144220526|NCT00061932|520002235|FG000|Overall Study|Withdrawal by Subject|13|||
144220527|NCT00061932|520002236|FG001|Overall Study|Withdrawal by Subject|4|||
144220528|NCT02899962|520002237|FG000|Open-label Phase|Adverse Event|2|||
144220529|NCT02899962|520002238|FG001|Open-label Phase|Adverse Event|0|||
144220530|NCT02899962|520002239|FG002|Open-label Phase|Adverse Event|0|||
144220531|NCT02899962|520002237|FG000|Open-label Phase|Lost to Follow-up|9|||
144220532|NCT02899962|520002238|FG001|Open-label Phase|Lost to Follow-up|0|||
144220533|NCT02899962|520002239|FG002|Open-label Phase|Lost to Follow-up|0|||
144220534|NCT02899962|520002237|FG000|Open-label Phase|Other reasons|9|||
144220535|NCT02899962|520002238|FG001|Open-label Phase|Other reasons|0|||
144220536|NCT02899962|520002239|FG002|Open-label Phase|Other reasons|0|||
144220537|NCT02899962|520002237|FG000|Open-label Phase|Withdrawal by Subject|7|||
144220538|NCT02899962|520002238|FG001|Open-label Phase|Withdrawal by Subject|0|||
144220539|NCT02899962|520002239|FG002|Open-label Phase|Withdrawal by Subject|0|||
144220540|NCT02899962|520002237|FG000|Maintenance Phase|Adverse Event|0|||
144220541|NCT02899962|520002238|FG001|Maintenance Phase|Adverse Event|2|||
144693507|NCT01218477|521729662|FG002|Overall Study|Prepared for cell transplantation|1|||
144220542|NCT02899962|520002239|FG002|Maintenance Phase|Adverse Event|1|||
144220543|NCT02899962|520002237|FG000|Maintenance Phase|Death|0|||
144220544|NCT02899962|520002238|FG001|Maintenance Phase|Death|0|||
144220545|NCT02899962|520002239|FG002|Maintenance Phase|Death|1|||
144220546|NCT02899962|520002237|FG000|Maintenance Phase|Lack of Efficacy|0|||
144693508|NCT01218477|521729663|FG003|Overall Study|Prepared for cell transplantation|0|||
144220547|NCT02899962|520002238|FG001|Maintenance Phase|Lack of Efficacy|20|||
144220548|NCT02899962|520002239|FG002|Maintenance Phase|Lack of Efficacy|16|||
144220549|NCT02899962|520002237|FG000|Maintenance Phase|Lost to Follow-up|0|||
144220550|NCT02899962|520002238|FG001|Maintenance Phase|Lost to Follow-up|12|||
144220551|NCT02899962|520002239|FG002|Maintenance Phase|Lost to Follow-up|14|||
144220552|NCT02899962|520002237|FG000|Maintenance Phase|Other reasons|0|||
144220553|NCT02899962|520002238|FG001|Maintenance Phase|Other reasons|9|||
144220554|NCT02899962|520002239|FG002|Maintenance Phase|Other reasons|13|||
144220555|NCT02899962|520002237|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
144220556|NCT02899962|520002238|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
144220557|NCT02899962|520002239|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
144220558|NCT02899962|520002237|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
144220559|NCT02899962|520002238|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
144220560|NCT02899962|520002239|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
144220561|NCT02899962|520002237|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144220562|NCT02899962|520002238|FG001|Maintenance Phase|Withdrawal by Subject|30|||
144220563|NCT02899962|520002239|FG002|Maintenance Phase|Withdrawal by Subject|36|||
144220564|NCT01245283|520002240|FG000|Overall Study|Lost to Follow-up|14|||
144220565|NCT01245283|520002241|FG001|Overall Study|Lost to Follow-up|11|||
144220566|NCT01245283|520002242|FG002|Overall Study|Lost to Follow-up|11|||
144220567|NCT03567980|520002245|FG000|Overall Study|Adverse Event|1|||
144220568|NCT01610492|520002246|FG000|Overall Study|Adverse Event|1|||
144220569|NCT01610492|520002246|FG000|Overall Study|Lack of Efficacy|3|||
144745427|NCT02883049|521919069|FG011|Induction|Refusal of further protocol therapy|0|||
144745428|NCT02883049|521919070|FG012|Induction|Refusal of further protocol therapy|0|||
144745429|NCT02883049|521919071|FG013|Induction|Refusal of further protocol therapy|0|||
144745430|NCT02883049|521919072|FG014|Induction|Refusal of further protocol therapy|0|||
144745431|NCT02883049|521919073|FG015|Induction|Refusal of further protocol therapy|0|||
144745432|NCT02883049|521919058|FG000|Induction|Identified as Ph+ patients|279|||
144745433|NCT02883049|521919059|FG001|Induction|Identified as Ph+ patients|1|||
144745434|NCT02883049|521919060|FG002|Induction|Identified as Ph+ patients|0|||
144745435|NCT02883049|521919061|FG003|Induction|Identified as Ph+ patients|0|||
144745436|NCT02883049|521919062|FG004|Induction|Identified as Ph+ patients|0|||
144745437|NCT02883049|521919063|FG005|Induction|Identified as Ph+ patients|0|||
144745438|NCT02883049|521919064|FG006|Induction|Identified as Ph+ patients|0|||
144745439|NCT02883049|521919065|FG007|Induction|Identified as Ph+ patients|0|||
144745440|NCT02883049|521919066|FG008|Induction|Identified as Ph+ patients|0|||
144745441|NCT02883049|521919067|FG009|Induction|Identified as Ph+ patients|0|||
144745442|NCT02883049|521919068|FG010|Induction|Identified as Ph+ patients|0|||
144745443|NCT02883049|521919069|FG011|Induction|Identified as Ph+ patients|0|||
144745444|NCT02883049|521919070|FG012|Induction|Identified as Ph+ patients|0|||
144745445|NCT02883049|521919071|FG013|Induction|Identified as Ph+ patients|0|||
144745446|NCT02883049|521919072|FG014|Induction|Identified as Ph+ patients|0|||
144745447|NCT02883049|521919073|FG015|Induction|Identified as Ph+ patients|0|||
144745448|NCT02883049|521919058|FG000|Induction|M3 Marrow at Day29|8|||
144745449|NCT02883049|521919059|FG001|Induction|M3 Marrow at Day29|1|||
144745450|NCT02883049|521919060|FG002|Induction|M3 Marrow at Day29|0|||
144745451|NCT02883049|521919061|FG003|Induction|M3 Marrow at Day29|0|||
144745452|NCT02883049|521919062|FG004|Induction|M3 Marrow at Day29|0|||
144745453|NCT02883049|521919063|FG005|Induction|M3 Marrow at Day29|0|||
144745454|NCT02883049|521919064|FG006|Induction|M3 Marrow at Day29|0|||
144745455|NCT02883049|521919065|FG007|Induction|M3 Marrow at Day29|0|||
144745456|NCT02883049|521919066|FG008|Induction|M3 Marrow at Day29|0|||
144745457|NCT02883049|521919067|FG009|Induction|M3 Marrow at Day29|0|||
144745458|NCT02883049|521919068|FG010|Induction|M3 Marrow at Day29|0|||
144745459|NCT02883049|521919069|FG011|Induction|M3 Marrow at Day29|0|||
144745460|NCT02883049|521919070|FG012|Induction|M3 Marrow at Day29|0|||
144745461|NCT02883049|521919071|FG013|Induction|M3 Marrow at Day29|0|||
144745462|NCT02883049|521919072|FG014|Induction|M3 Marrow at Day29|0|||
144745463|NCT02883049|521919073|FG015|Induction|M3 Marrow at Day29|0|||
144745464|NCT02883049|521919058|FG000|Induction|Inevaluable|33|||
144745465|NCT02883049|521919059|FG001|Induction|Inevaluable|1|||
144745466|NCT02883049|521919060|FG002|Induction|Inevaluable|0|||
144745467|NCT02883049|521919061|FG003|Induction|Inevaluable|0|||
144745468|NCT02883049|521919062|FG004|Induction|Inevaluable|0|||
144745469|NCT02883049|521919063|FG005|Induction|Inevaluable|0|||
144220570|NCT01610492|520002246|FG000|Overall Study|Other: Reached stopping criteria|1|||
144220571|NCT01610492|520002246|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
144220572|NCT02633787|520002247|FG000|Overall Study|Withdrawal by Subject|1|||
144220573|NCT01459783|520002248|FG000|Baseline to 6 Months|Death|1|||
144220574|NCT01459783|520002249|FG001|Baseline to 6 Months|Death|0|||
144745470|NCT02883049|521919064|FG006|Induction|Inevaluable|0|||
144745471|NCT02883049|521919065|FG007|Induction|Inevaluable|0|||
144745472|NCT02883049|521919066|FG008|Induction|Inevaluable|0|||
144745473|NCT02883049|521919067|FG009|Induction|Inevaluable|0|||
144745474|NCT02883049|521919068|FG010|Induction|Inevaluable|0|||
144745475|NCT02883049|521919069|FG011|Induction|Inevaluable|0|||
144745476|NCT02883049|521919070|FG012|Induction|Inevaluable|0|||
144745477|NCT02883049|521919071|FG013|Induction|Inevaluable|0|||
144745478|NCT02883049|521919072|FG014|Induction|Inevaluable|0|||
144745479|NCT02883049|521919073|FG015|Induction|Inevaluable|0|||
144745480|NCT02883049|521919058|FG000|Induction|Identified as VHR at end of Induction|244|||
144745481|NCT02883049|521919059|FG001|Induction|Identified as VHR at end of Induction|0|||
144745482|NCT02883049|521919060|FG002|Induction|Identified as VHR at end of Induction|0|||
144220575|NCT01459783|520002248|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
144220576|NCT01459783|520002249|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
144220577|NCT01459783|520002248|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
144220578|NCT01459783|520002249|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
144220579|NCT01459783|520002248|FG000|6 Months to 12 Months|Death|0|||
144220580|NCT01459783|520002249|FG001|6 Months to 12 Months|Death|1|||
144220581|NCT01459783|520002248|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
144220582|NCT01459783|520002249|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
144220583|NCT01459783|520002248|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
144220584|NCT01459783|520002249|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
144220585|NCT01459783|520002248|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
144220586|NCT01459783|520002249|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
144220587|NCT04211831|520002250|FG000|Overall Study|Withdrawal by Subject|4|||
144220588|NCT04211831|520002251|FG001|Overall Study|Withdrawal by Subject|1|||
144220589|NCT04211831|520002252|FG002|Overall Study|Withdrawal by Subject|1|||
144220590|NCT04211831|520002250|FG000|Overall Study|Protocol Violation|0|||
144220591|NCT04211831|520002251|FG001|Overall Study|Protocol Violation|0|||
144220592|NCT04211831|520002252|FG002|Overall Study|Protocol Violation|1|||
144220593|NCT04211831|520002250|FG000|Overall Study|Adverse Event|0|||
144220594|NCT04211831|520002251|FG001|Overall Study|Adverse Event|1|||
144693509|NCT01218477|521729660|FG000|Overall Study|Administrative reason by sponsor|0|||
144693510|NCT01218477|521729661|FG001|Overall Study|Administrative reason by sponsor|0|||
144693511|NCT01218477|521729662|FG002|Overall Study|Administrative reason by sponsor|1|||
144693512|NCT01218477|521729663|FG003|Overall Study|Administrative reason by sponsor|0|||
144693513|NCT01218477|521729660|FG000|Overall Study|Maximum clinical benefit|0|||
144693514|NCT01218477|521729661|FG001|Overall Study|Maximum clinical benefit|2|||
144693515|NCT01218477|521729662|FG002|Overall Study|Maximum clinical benefit|0|||
144693516|NCT01218477|521729663|FG003|Overall Study|Maximum clinical benefit|0|||
144693517|NCT00787527|521729666|FG000|Overall Study|Toxicity|3|||
144693518|NCT03137433|521729667|FG000|Overall Study|Withdrawal by Subject|11|||
144693519|NCT03137433|521729668|FG001|Overall Study|Withdrawal by Subject|11|||
144693520|NCT03137433|521729667|FG000|Overall Study|Lost to Follow-up|5|||
144693521|NCT03137433|521729668|FG001|Overall Study|Lost to Follow-up|6|||
144693522|NCT03137433|521729667|FG000|Overall Study|Physician Decision|2|||
144693523|NCT03137433|521729668|FG001|Overall Study|Physician Decision|0|||
144693524|NCT03137433|521729667|FG000|Overall Study|Moved out of study area|1|||
144693525|NCT03137433|521729668|FG001|Overall Study|Moved out of study area|0|||
144693526|NCT03137433|521729667|FG000|Overall Study|Too far out of window due to COVID|0|||
144693527|NCT03137433|521729668|FG001|Overall Study|Too far out of window due to COVID|1|||
144693528|NCT00083616|521729669|FG000|Overall Study|Disease Progression|16|||
144693529|NCT00083616|521729669|FG000|Overall Study|Lost to Follow-up|1|||
144693530|NCT00083616|521729669|FG000|Overall Study|Physician Decision|2|||
144693531|NCT00083616|521729669|FG000|Overall Study|Withdrawal by Subject|3|||
144693532|NCT00083616|521729669|FG000|Overall Study|Ineligibility determined|2|||
144693533|NCT00083616|521729669|FG000|Overall Study|Non-compliance|1|||
144693534|NCT00083616|521729669|FG000|Overall Study|Other|6|||
144693535|NCT01000311|521729676|FG000|Overall Study|Adverse Event|2|||
144693536|NCT01000311|521729677|FG001|Overall Study|Adverse Event|5|||
144693537|NCT01000311|521729676|FG000|Overall Study|Withdrawal by Subject|16|||
144693538|NCT01000311|521729677|FG001|Overall Study|Withdrawal by Subject|24|||
144693539|NCT01000311|521729676|FG000|Overall Study|Lost to Follow-up|15|||
144693540|NCT01000311|521729677|FG001|Overall Study|Lost to Follow-up|24|||
144693541|NCT01000311|521729676|FG000|Overall Study|Protocol Violation|1|||
144693542|NCT01000311|521729677|FG001|Overall Study|Protocol Violation|2|||
144693543|NCT01000311|521729676|FG000|Overall Study|Inappropriate enrollment|2|||
144693544|NCT01000311|521729677|FG001|Overall Study|Inappropriate enrollment|0|||
144693545|NCT01000311|521729676|FG000|Overall Study|Administrative reason|9|||
144693546|NCT01000311|521729677|FG001|Overall Study|Administrative reason|15|||
144693547|NCT01468844|521729678|FG000|Overall Study|Adverse Event|1|||
144693548|NCT01468844|521729679|FG001|Overall Study|Adverse Event|0|||
144693549|NCT01468844|521729678|FG000|Overall Study|Withdrawal by Subject|1|||
144693550|NCT01468844|521729679|FG001|Overall Study|Withdrawal by Subject|0|||
144693551|NCT00819052|521729680|FG000|Overall Study|Adverse Event|0|||
144693552|NCT00819052|521729681|FG001|Overall Study|Adverse Event|5|||
144693553|NCT00819052|521729680|FG000|Overall Study|Protocol Violation|1|||
144693554|NCT00819052|521729681|FG001|Overall Study|Protocol Violation|2|||
144693555|NCT00819052|521729680|FG000|Overall Study|Lost to Follow-up|1|||
144693556|NCT00819052|521729681|FG001|Overall Study|Lost to Follow-up|2|||
144693557|NCT00819052|521729680|FG000|Overall Study|Withdrawal by Subject|1|||
144693558|NCT00819052|521729681|FG001|Overall Study|Withdrawal by Subject|2|||
144693559|NCT00819052|521729680|FG000|Overall Study|Lack of Efficacy|1|||
144693560|NCT00819052|521729681|FG001|Overall Study|Lack of Efficacy|1|||
144693561|NCT00819052|521729680|FG000|Overall Study|Pregnancy|1|||
144693562|NCT00819052|521729681|FG001|Overall Study|Pregnancy|2|||
144693563|NCT00819052|521729680|FG000|Overall Study|Death or events leading to death|1|||
144693564|NCT00819052|521729681|FG001|Overall Study|Death or events leading to death|0|||
144693565|NCT03524664|521729682|FG000|Overall Study|Withdrawal by Subject|1|||
144220595|NCT04211831|520002252|FG002|Overall Study|Adverse Event|0|||
144220596|NCT04211831|520002250|FG000|Overall Study|Lack of Efficacy|0|||
144220597|NCT04211831|520002251|FG001|Overall Study|Lack of Efficacy|0|||
144220598|NCT04211831|520002252|FG002|Overall Study|Lack of Efficacy|1|||
144220599|NCT04211831|520002250|FG000|Overall Study|Lost to Follow-up|0|||
144220600|NCT04211831|520002251|FG001|Overall Study|Lost to Follow-up|0|||
144220601|NCT04211831|520002252|FG002|Overall Study|Lost to Follow-up|2|||
144220602|NCT04211831|520002250|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
144220603|NCT04211831|520002251|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
144220604|NCT04211831|520002252|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
144220605|NCT04211831|520002250|FG000|Overall Study|Other|0|||
144220606|NCT04211831|520002251|FG001|Overall Study|Other|1|||
144220607|NCT04211831|520002252|FG002|Overall Study|Other|0|||
144220608|NCT04871776|520002253|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
144220609|NCT04871776|520002254|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
144220610|NCT04871776|520002255|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
144220611|NCT04871776|520002253|FG000|Overall Study|Did not meet eligibility criteria|1|||
144220612|NCT04871776|520002254|FG001|Overall Study|Did not meet eligibility criteria|1|||
144220613|NCT04871776|520002255|FG002|Overall Study|Did not meet eligibility criteria|1|||
144220614|NCT06389487|520002261|FG000|Overall Study|Lost to Follow-up|9|||
144220615|NCT06389487|520002262|FG001|Overall Study|Lost to Follow-up|5|||
144220616|NCT06389487|520002263|FG002|Overall Study|Lost to Follow-up|13|||
144220617|NCT06389487|520002261|FG000|Overall Study|Protocol Violation|0|||
144220618|NCT06389487|520002262|FG001|Overall Study|Protocol Violation|0|||
144220619|NCT06389487|520002263|FG002|Overall Study|Protocol Violation|2|||
144220620|NCT06389487|520002261|FG000|Overall Study|Withdrawal by Subject|2|||
144220621|NCT06389487|520002262|FG001|Overall Study|Withdrawal by Subject|2|||
144220622|NCT06389487|520002263|FG002|Overall Study|Withdrawal by Subject|1|||
144220623|NCT06389487|520002261|FG000|Overall Study|Other|1|||
144220624|NCT06389487|520002262|FG001|Overall Study|Other|0|||
144220625|NCT06389487|520002263|FG002|Overall Study|Other|1|||
144220626|NCT05620082|520002268|FG000|Overall Study|Discharged before study end|1|||
144220627|NCT05620082|520002269|FG001|Overall Study|Discharged before study end|4|||
144220628|NCT05620082|520002270|FG002|Overall Study|Discharged before study end|0|||
144220629|NCT05620082|520002268|FG000|Overall Study|Moved to a different ward|1|||
144220630|NCT05620082|520002269|FG001|Overall Study|Moved to a different ward|0|||
144220631|NCT05620082|520002270|FG002|Overall Study|Moved to a different ward|0|||
144220632|NCT05620082|520002268|FG000|Overall Study|Feeling too unwell|1|||
144220633|NCT05620082|520002269|FG001|Overall Study|Feeling too unwell|0|||
144220634|NCT05620082|520002270|FG002|Overall Study|Feeling too unwell|0|||
144220635|NCT02394600|520003649|FG000|Overall Study|Adverse Event|3|||
144220636|NCT02394600|520003650|FG001|Overall Study|Adverse Event|0|||
144220637|NCT02394600|520003649|FG000|Overall Study|Lost to Follow-up|0|||
144220638|NCT02394600|520003650|FG001|Overall Study|Lost to Follow-up|1|||
144220639|NCT02394600|520003649|FG000|Overall Study|Withdrawal by Subject|0|||
144220640|NCT02394600|520003650|FG001|Overall Study|Withdrawal by Subject|1|||
144220641|NCT02394600|520003649|FG000|Overall Study|Protocol Violation|1|||
144220642|NCT02394600|520003650|FG001|Overall Study|Protocol Violation|0|||
144745483|NCT02883049|521919061|FG003|Induction|Identified as VHR at end of Induction|0|||
144745484|NCT02883049|521919062|FG004|Induction|Identified as VHR at end of Induction|0|||
144745485|NCT02883049|521919063|FG005|Induction|Identified as VHR at end of Induction|0|||
144745486|NCT02883049|521919064|FG006|Induction|Identified as VHR at end of Induction|0|||
144745487|NCT02883049|521919065|FG007|Induction|Identified as VHR at end of Induction|0|||
144745488|NCT02883049|521919066|FG008|Induction|Identified as VHR at end of Induction|0|||
144745489|NCT02883049|521919067|FG009|Induction|Identified as VHR at end of Induction|0|||
144745490|NCT02883049|521919068|FG010|Induction|Identified as VHR at end of Induction|0|||
144745491|NCT02883049|521919069|FG011|Induction|Identified as VHR at end of Induction|0|||
144220643|NCT00428246|520003651|FG000|Overall Study|Withdrawal by Subject|0|||
144220644|NCT00428246|520003652|FG001|Overall Study|Withdrawal by Subject|0|||
144220645|NCT00428246|520003653|FG002|Overall Study|Withdrawal by Subject|1|||
144220646|NCT00428246|520003651|FG000|Overall Study|Adverse Event|1|||
144220647|NCT00428246|520003652|FG001|Overall Study|Adverse Event|0|||
144220648|NCT00428246|520003653|FG002|Overall Study|Adverse Event|0|||
144220649|NCT00791778|520003657|FG000|Double-blind Treatment|Adverse Event|49|||
144220650|NCT00791778|520003658|FG001|Double-blind Treatment|Adverse Event|9|||
144220651|NCT00791778|520003657|FG000|Double-blind Treatment|Physician Decision|6|||
144745492|NCT02883049|521919070|FG012|Induction|Identified as VHR at end of Induction|0|||
144220652|NCT00791778|520003658|FG001|Double-blind Treatment|Physician Decision|26|||
144220653|NCT00791778|520003657|FG000|Double-blind Treatment|Protocol Violation|0|||
144745493|NCT02883049|521919071|FG013|Induction|Identified as VHR at end of Induction|0|||
144220654|NCT00791778|520003658|FG001|Double-blind Treatment|Protocol Violation|4|||
144220655|NCT00791778|520003657|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
144220656|NCT00791778|520003658|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
144220657|NCT00791778|520003657|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
144220658|NCT00791778|520003658|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
144220659|NCT00791778|520003657|FG000|Follow-up|Withdrawal by Subject|3|||
144220660|NCT00791778|520003658|FG001|Follow-up|Withdrawal by Subject|0|||
144220661|NCT00791778|520003657|FG000|Follow-up|Lost to Follow-up|2|||
144220662|NCT00791778|520003658|FG001|Follow-up|Lost to Follow-up|1|||
144220663|NCT04620746|520003661|FG000|Overall Study|Adverse Event|2|||
144220664|NCT04620746|520003662|FG001|Overall Study|Adverse Event|0|||
144220665|NCT04620746|520003661|FG000|Overall Study|Uniterpretable skin test|1|||
144220666|NCT04620746|520003662|FG001|Overall Study|Uniterpretable skin test|0|||
144220667|NCT04620746|520003661|FG000|Overall Study|Withdrawal by Subject|0|||
144220668|NCT04620746|520003662|FG001|Overall Study|Withdrawal by Subject|1|||
144220669|NCT03473925|520003663|FG000|Overall Study|Death|48|||
144220670|NCT03473925|520003664|FG001|Overall Study|Death|44|||
144693566|NCT03524664|521729683|FG001|Overall Study|Withdrawal by Subject|2|||
144693567|NCT03524664|521729682|FG000|Overall Study|Lost to Follow-up|4|||
144693568|NCT03524664|521729683|FG001|Overall Study|Lost to Follow-up|13|||
144693569|NCT01373294|521729684|FG000|Overall Study|Adverse Event|1|||
144693570|NCT01373294|521729685|FG001|Overall Study|Adverse Event|0|||
144693571|NCT02694562|521729686|FG000|Overall Study|Death|8|||
144693572|NCT02694562|521729686|FG000|Overall Study|Protocol Violation|4|||
144693573|NCT02694562|521729686|FG000|Overall Study|Lost to Follow-up|3|||
144693574|NCT02694562|521729686|FG000|Overall Study|Screen Failure|2|||
144693575|NCT02694562|521729686|FG000|Overall Study|Physician Decision|1|||
144693576|NCT03702166|521729687|FG000|Overall Study|Lost to Follow-up|1|||
144693577|NCT03702166|521729687|FG000|Overall Study|Withdrawal by Subject|1|||
144693578|NCT01333865|521729688|FG000|Overall Study|Adverse Event|2|||
144693579|NCT01521494|521729693|FG000|Overall Study|Adverse Event|1|||
144693580|NCT01521494|521729694|FG001|Overall Study|Adverse Event|2|||
144693581|NCT01521494|521729695|FG002|Overall Study|Adverse Event|9|||
144693582|NCT01521494|521729696|FG003|Overall Study|Adverse Event|6|||
144693583|NCT01521494|521729697|FG004|Overall Study|Adverse Event|2|||
144693584|NCT01521494|521729693|FG000|Overall Study|Lack of Efficacy|0|||
144693585|NCT01521494|521729694|FG001|Overall Study|Lack of Efficacy|0|||
144693586|NCT01521494|521729695|FG002|Overall Study|Lack of Efficacy|0|||
144693587|NCT01521494|521729696|FG003|Overall Study|Lack of Efficacy|0|||
144693588|NCT01521494|521729697|FG004|Overall Study|Lack of Efficacy|2|||
144693589|NCT01521494|521729693|FG000|Overall Study|Withdrawal by Subject|1|||
144693590|NCT01521494|521729694|FG001|Overall Study|Withdrawal by Subject|1|||
144693591|NCT01521494|521729695|FG002|Overall Study|Withdrawal by Subject|0|||
144693592|NCT01521494|521729696|FG003|Overall Study|Withdrawal by Subject|2|||
144693593|NCT01521494|521729697|FG004|Overall Study|Withdrawal by Subject|0|||
144693594|NCT01521494|521729693|FG000|Overall Study|Decrease in serum phosphate|0|||
144693595|NCT01521494|521729694|FG001|Overall Study|Decrease in serum phosphate|2|||
144693596|NCT01521494|521729695|FG002|Overall Study|Decrease in serum phosphate|3|||
144693597|NCT01521494|521729696|FG003|Overall Study|Decrease in serum phosphate|12|||
144693598|NCT01521494|521729697|FG004|Overall Study|Decrease in serum phosphate|0|||
144693599|NCT01521494|521729693|FG000|Overall Study|Decrease in serum calcium|0|||
144693600|NCT01521494|521729694|FG001|Overall Study|Decrease in serum calcium|0|||
144693601|NCT01521494|521729695|FG002|Overall Study|Decrease in serum calcium|0|||
144693602|NCT01521494|521729696|FG003|Overall Study|Decrease in serum calcium|1|||
144693603|NCT01521494|521729697|FG004|Overall Study|Decrease in serum calcium|1|||
144693604|NCT01521494|521729693|FG000|Overall Study|Physician Decision|0|||
144693605|NCT01521494|521729694|FG001|Overall Study|Physician Decision|0|||
144693606|NCT01521494|521729695|FG002|Overall Study|Physician Decision|0|||
144693607|NCT01521494|521729696|FG003|Overall Study|Physician Decision|0|||
144693608|NCT01521494|521729697|FG004|Overall Study|Physician Decision|2|||
144693609|NCT01920061|521729700|FG000|Overall Study|Death|1|||
144693610|NCT01920061|521729701|FG001|Overall Study|Death|1|||
144693611|NCT01920061|521729702|FG002|Overall Study|Death|0|||
144693612|NCT01920061|521729703|FG003|Overall Study|Death|1|||
144693613|NCT01920061|521729704|FG004|Overall Study|Death|1|||
144693614|NCT01920061|521729705|FG005|Overall Study|Death|0|||
144693615|NCT01920061|521729706|FG006|Overall Study|Death|0|||
144693616|NCT01920061|521729707|FG007|Overall Study|Death|1|||
144693617|NCT01920061|521729708|FG008|Overall Study|Death|0|||
144693618|NCT01920061|521729709|FG009|Overall Study|Death|1|||
144693619|NCT01920061|521729710|FG010|Overall Study|Death|0|||
144693620|NCT01920061|521729711|FG011|Overall Study|Death|1|||
144693621|NCT01920061|521729712|FG012|Overall Study|Death|0|||
144693622|NCT01920061|521729713|FG013|Overall Study|Death|2|||
144693623|NCT01920061|521729714|FG014|Overall Study|Death|0|||
144693624|NCT01920061|521729715|FG015|Overall Study|Death|0|||
144693625|NCT01920061|521729716|FG016|Overall Study|Death|0|||
144693626|NCT01920061|521729717|FG017|Overall Study|Death|0|||
144693627|NCT01920061|521729718|FG018|Overall Study|Death|1|||
144693628|NCT01920061|521729719|FG019|Overall Study|Death|0|||
144693629|NCT01920061|521729700|FG000|Overall Study|Lost to Follow-up|0|||
144693630|NCT01920061|521729701|FG001|Overall Study|Lost to Follow-up|2|||
144693631|NCT01920061|521729702|FG002|Overall Study|Lost to Follow-up|0|||
144693632|NCT01920061|521729703|FG003|Overall Study|Lost to Follow-up|0|||
144693633|NCT01920061|521729704|FG004|Overall Study|Lost to Follow-up|0|||
144220671|NCT03473925|520003663|FG000|Overall Study|Sponsor Decision|2|||
144220672|NCT03473925|520003664|FG001|Overall Study|Sponsor Decision|7|||
144220673|NCT03473925|520003663|FG000|Overall Study|Withdrawal by Subject|1|||
144220674|NCT03473925|520003664|FG001|Overall Study|Withdrawal by Subject|3|||
144220675|NCT03473925|520003663|FG000|Overall Study|Not Treated|1|||
144220676|NCT03473925|520003664|FG001|Overall Study|Not Treated|1|||
144220677|NCT03411863|520003665|FG000|Overall Study|Withdrawal by Subject|3|||
144220678|NCT03411863|520003666|FG001|Overall Study|Withdrawal by Subject|1|||
144220679|NCT03411863|520003665|FG000|Overall Study|Physician Decision|0|||
144220680|NCT03411863|520003666|FG001|Overall Study|Physician Decision|1|||
144220681|NCT02756611|520003669|FG000|Overall Study|Death|70|||
144220682|NCT02756611|520003669|FG000|Overall Study|Withdrawal by Subject|2|||
144220683|NCT02756611|520003669|FG000|Overall Study|Lost to Follow-up|3|||
144220684|NCT02756611|520003669|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
144220685|NCT02756611|520003669|FG000|Overall Study|Other|10|||
144220686|NCT00124917|520003677|FG000|Overall Study|Physician Decision|3|||
144220687|NCT03518008|520003678|FG000|Period 2, Second Week of Wear|Family emergency|0|||
144693634|NCT01920061|521729705|FG005|Overall Study|Lost to Follow-up|0|||
144693635|NCT01920061|521729706|FG006|Overall Study|Lost to Follow-up|1|||
144693636|NCT01920061|521729707|FG007|Overall Study|Lost to Follow-up|0|||
144693637|NCT01920061|521729708|FG008|Overall Study|Lost to Follow-up|0|||
144693638|NCT01920061|521729709|FG009|Overall Study|Lost to Follow-up|0|||
144693639|NCT01920061|521729710|FG010|Overall Study|Lost to Follow-up|3|||
144693640|NCT01920061|521729711|FG011|Overall Study|Lost to Follow-up|0|||
144693641|NCT01920061|521729712|FG012|Overall Study|Lost to Follow-up|0|||
144693642|NCT01920061|521729713|FG013|Overall Study|Lost to Follow-up|0|||
144693643|NCT01920061|521729714|FG014|Overall Study|Lost to Follow-up|0|||
144693644|NCT01920061|521729715|FG015|Overall Study|Lost to Follow-up|0|||
144693645|NCT01920061|521729716|FG016|Overall Study|Lost to Follow-up|0|||
144693646|NCT01920061|521729717|FG017|Overall Study|Lost to Follow-up|1|||
144693647|NCT01920061|521729718|FG018|Overall Study|Lost to Follow-up|4|||
144693648|NCT01920061|521729719|FG019|Overall Study|Lost to Follow-up|3|||
144693649|NCT01920061|521729700|FG000|Overall Study|Other|1|||
144693650|NCT01920061|521729701|FG001|Overall Study|Other|1|||
144693651|NCT01920061|521729702|FG002|Overall Study|Other|2|||
144693652|NCT01920061|521729703|FG003|Overall Study|Other|1|||
144693653|NCT01920061|521729704|FG004|Overall Study|Other|0|||
144693654|NCT01920061|521729705|FG005|Overall Study|Other|1|||
144693655|NCT01920061|521729706|FG006|Overall Study|Other|0|||
144693656|NCT01920061|521729707|FG007|Overall Study|Other|0|||
144693657|NCT01920061|521729708|FG008|Overall Study|Other|0|||
144693658|NCT01920061|521729709|FG009|Overall Study|Other|1|||
144693659|NCT01920061|521729710|FG010|Overall Study|Other|1|||
144693660|NCT01920061|521729711|FG011|Overall Study|Other|2|||
144693661|NCT01920061|521729712|FG012|Overall Study|Other|1|||
144693662|NCT01920061|521729713|FG013|Overall Study|Other|4|||
144693663|NCT01920061|521729714|FG014|Overall Study|Other|0|||
144693664|NCT01920061|521729715|FG015|Overall Study|Other|1|||
144693665|NCT01920061|521729716|FG016|Overall Study|Other|1|||
144693666|NCT01920061|521729717|FG017|Overall Study|Other|0|||
144693667|NCT01920061|521729718|FG018|Overall Study|Other|1|||
144693668|NCT01920061|521729719|FG019|Overall Study|Other|1|||
144693669|NCT01920061|521729700|FG000|Overall Study|Participant refused further follow-up|0|||
144693670|NCT01920061|521729701|FG001|Overall Study|Participant refused further follow-up|0|||
144693671|NCT01920061|521729702|FG002|Overall Study|Participant refused further follow-up|0|||
144693672|NCT01920061|521729703|FG003|Overall Study|Participant refused further follow-up|0|||
144693673|NCT01920061|521729704|FG004|Overall Study|Participant refused further follow-up|1|||
144693674|NCT01920061|521729705|FG005|Overall Study|Participant refused further follow-up|1|||
144693675|NCT01920061|521729706|FG006|Overall Study|Participant refused further follow-up|0|||
144693676|NCT01920061|521729707|FG007|Overall Study|Participant refused further follow-up|0|||
144693677|NCT01920061|521729708|FG008|Overall Study|Participant refused further follow-up|1|||
144693678|NCT01920061|521729709|FG009|Overall Study|Participant refused further follow-up|0|||
144693679|NCT01920061|521729710|FG010|Overall Study|Participant refused further follow-up|1|||
144693680|NCT01920061|521729711|FG011|Overall Study|Participant refused further follow-up|0|||
144693681|NCT01920061|521729712|FG012|Overall Study|Participant refused further follow-up|1|||
144693682|NCT01920061|521729713|FG013|Overall Study|Participant refused further follow-up|0|||
144693683|NCT01920061|521729714|FG014|Overall Study|Participant refused further follow-up|1|||
144220688|NCT03518008|520003679|FG001|Period 2, Second Week of Wear|Family emergency|1|||
144693684|NCT01920061|521729715|FG015|Overall Study|Participant refused further follow-up|2|||
144693685|NCT01920061|521729716|FG016|Overall Study|Participant refused further follow-up|1|||
144693686|NCT01920061|521729717|FG017|Overall Study|Participant refused further follow-up|1|||
144693687|NCT01920061|521729718|FG018|Overall Study|Participant refused further follow-up|0|||
144693688|NCT01920061|521729719|FG019|Overall Study|Participant refused further follow-up|0|||
144220689|NCT01515423|520003680|FG000|Open Label Phase|Adverse Event|57|||
144220690|NCT01515423|520003681|FG001|Open Label Phase|Adverse Event|0|||
144220691|NCT01515423|520003682|FG002|Open Label Phase|Adverse Event|0|||
144220692|NCT01515423|520003680|FG000|Open Label Phase|Death|2|||
144693689|NCT00877929|521729720|FG000|Overall Study|Adverse Event|11|||
144693690|NCT00877929|521729721|FG001|Overall Study|Adverse Event|20|||
144693691|NCT00877929|521729720|FG000|Overall Study|Protocol Violation|3|||
144693692|NCT00877929|521729721|FG001|Overall Study|Protocol Violation|3|||
144693693|NCT00877929|521729720|FG000|Overall Study|Lost to Follow-up|0|||
144693694|NCT00877929|521729721|FG001|Overall Study|Lost to Follow-up|1|||
144693695|NCT00877929|521729720|FG000|Overall Study|Withdrawal by Subject|4|||
144693696|NCT00877929|521729721|FG001|Overall Study|Withdrawal by Subject|4|||
144693697|NCT00877929|521729720|FG000|Overall Study|Lack of Efficacy|0|||
144693698|NCT00877929|521729721|FG001|Overall Study|Lack of Efficacy|1|||
144693699|NCT00877929|521729720|FG000|Overall Study|Other reason (not specified)|2|||
144693700|NCT00877929|521729721|FG001|Overall Study|Other reason (not specified)|6|||
144693701|NCT00554229|521729722|FG000|Overall Study|Lost to Follow-up|3|||
144693702|NCT00554229|521729723|FG001|Overall Study|Lost to Follow-up|6|||
144693703|NCT00554229|521729722|FG000|Overall Study|Withdrawal by Subject|29|||
144693704|NCT00554229|521729723|FG001|Overall Study|Withdrawal by Subject|37|||
144693705|NCT00554229|521729722|FG000|Overall Study|Adverse Event|71|||
144693706|NCT00554229|521729723|FG001|Overall Study|Adverse Event|39|||
144693707|NCT00554229|521729722|FG000|Overall Study|Protocol Violation|3|||
144693708|NCT00554229|521729723|FG001|Overall Study|Protocol Violation|3|||
144693709|NCT00554229|521729722|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
144693710|NCT00554229|521729723|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
144693711|NCT00554229|521729722|FG000|Overall Study|Randomised but no treatment received|1|||
144693712|NCT00554229|521729723|FG001|Overall Study|Randomised but no treatment received|0|||
144693713|NCT01140646|521729724|FG000|Overall Study|Adverse Event|4|||
144693714|NCT01140646|521729724|FG000|Overall Study|Refused Further Treatment|5|||
144693715|NCT00784836|521729732|FG000|Overall Study|Early Study Termination|3|||
144693716|NCT00689299|521729736|FG000|Overall Study|Adverse Event|2|||
144745494|NCT02883049|521919072|FG014|Induction|Identified as VHR at end of Induction|0|||
144745495|NCT02883049|521919073|FG015|Induction|Identified as VHR at end of Induction|0|||
144745496|NCT02883049|521919058|FG000|Induction|Moved to another non-COG institution|3|||
144745497|NCT02883049|521919059|FG001|Induction|Moved to another non-COG institution|0|||
144745498|NCT02883049|521919060|FG002|Induction|Moved to another non-COG institution|0|||
144745499|NCT02883049|521919061|FG003|Induction|Moved to another non-COG institution|0|||
144745500|NCT02883049|521919062|FG004|Induction|Moved to another non-COG institution|0|||
144745501|NCT02883049|521919063|FG005|Induction|Moved to another non-COG institution|0|||
144745502|NCT02883049|521919064|FG006|Induction|Moved to another non-COG institution|0|||
144745503|NCT02883049|521919065|FG007|Induction|Moved to another non-COG institution|0|||
144745504|NCT02883049|521919066|FG008|Induction|Moved to another non-COG institution|0|||
144745505|NCT02883049|521919067|FG009|Induction|Moved to another non-COG institution|0|||
144745506|NCT02883049|521919068|FG010|Induction|Moved to another non-COG institution|0|||
144745507|NCT02883049|521919069|FG011|Induction|Moved to another non-COG institution|0|||
144745508|NCT02883049|521919070|FG012|Induction|Moved to another non-COG institution|0|||
144745509|NCT02883049|521919071|FG013|Induction|Moved to another non-COG institution|0|||
144745510|NCT02883049|521919072|FG014|Induction|Moved to another non-COG institution|0|||
144745511|NCT02883049|521919073|FG015|Induction|Moved to another non-COG institution|0|||
144745512|NCT02883049|521919058|FG000|Induction|Randomization closed|41|||
144745513|NCT02883049|521919059|FG001|Induction|Randomization closed|0|||
144745514|NCT02883049|521919060|FG002|Induction|Randomization closed|0|||
144745515|NCT02883049|521919061|FG003|Induction|Randomization closed|0|||
144745516|NCT02883049|521919062|FG004|Induction|Randomization closed|0|||
144745517|NCT02883049|521919063|FG005|Induction|Randomization closed|0|||
144745518|NCT02883049|521919064|FG006|Induction|Randomization closed|0|||
144745519|NCT02883049|521919065|FG007|Induction|Randomization closed|0|||
144745520|NCT02883049|521919066|FG008|Induction|Randomization closed|0|||
144745521|NCT02883049|521919067|FG009|Induction|Randomization closed|0|||
144745522|NCT02883049|521919068|FG010|Induction|Randomization closed|0|||
144745523|NCT02883049|521919069|FG011|Induction|Randomization closed|0|||
144745524|NCT02883049|521919070|FG012|Induction|Randomization closed|0|||
144745525|NCT02883049|521919071|FG013|Induction|Randomization closed|0|||
144745526|NCT02883049|521919072|FG014|Induction|Randomization closed|0|||
144745527|NCT02883049|521919073|FG015|Induction|Randomization closed|0|||
144745528|NCT02883049|521919058|FG000|Induction|MRD negative|36|||
144745529|NCT02883049|521919059|FG001|Induction|MRD negative|0|||
144745530|NCT02883049|521919060|FG002|Induction|MRD negative|0|||
144693717|NCT00689299|521729737|FG001|Overall Study|Adverse Event|1|||
144693718|NCT00689299|521729738|FG002|Overall Study|Adverse Event|1|||
144745531|NCT02883049|521919061|FG003|Induction|MRD negative|0|||
144745532|NCT02883049|521919062|FG004|Induction|MRD negative|0|||
144745533|NCT02883049|521919063|FG005|Induction|MRD negative|0|||
144745534|NCT02883049|521919064|FG006|Induction|MRD negative|0|||
144745535|NCT02883049|521919065|FG007|Induction|MRD negative|0|||
144745536|NCT02883049|521919066|FG008|Induction|MRD negative|0|||
144745537|NCT02883049|521919067|FG009|Induction|MRD negative|0|||
144745538|NCT02883049|521919068|FG010|Induction|MRD negative|0|||
144745539|NCT02883049|521919069|FG011|Induction|MRD negative|0|||
144745540|NCT02883049|521919070|FG012|Induction|MRD negative|0|||
144745541|NCT02883049|521919071|FG013|Induction|MRD negative|0|||
144220693|NCT01515423|520003681|FG001|Open Label Phase|Death|0|||
144220694|NCT01515423|520003682|FG002|Open Label Phase|Death|0|||
144220695|NCT01515423|520003680|FG000|Open Label Phase|Lack of Efficacy|117|||
144220696|NCT01515423|520003681|FG001|Open Label Phase|Lack of Efficacy|0|||
144220697|NCT01515423|520003682|FG002|Open Label Phase|Lack of Efficacy|0|||
144220698|NCT01515423|520003680|FG000|Open Label Phase|Lost to Follow-up|21|||
144745542|NCT02883049|521919072|FG014|Induction|MRD negative|0|||
144745543|NCT02883049|521919073|FG015|Induction|MRD negative|0|||
144745544|NCT02883049|521919058|FG000|Induction|Identified as HR patients|165|||
144745545|NCT02883049|521919059|FG001|Induction|Identified as HR patients|0|||
144745546|NCT02883049|521919060|FG002|Induction|Identified as HR patients|0|||
144745547|NCT02883049|521919061|FG003|Induction|Identified as HR patients|0|||
144745548|NCT02883049|521919062|FG004|Induction|Identified as HR patients|0|||
144220699|NCT01515423|520003681|FG001|Open Label Phase|Lost to Follow-up|0|||
144220700|NCT01515423|520003682|FG002|Open Label Phase|Lost to Follow-up|0|||
144220701|NCT01515423|520003680|FG000|Open Label Phase|Withdrawal by Subject|118|||
144220702|NCT01515423|520003681|FG001|Open Label Phase|Withdrawal by Subject|0|||
144220703|NCT01515423|520003682|FG002|Open Label Phase|Withdrawal by Subject|0|||
144220704|NCT01515423|520003680|FG000|Open Label Phase|excluded from DB Phase|70|||
144220705|NCT01515423|520003681|FG001|Open Label Phase|excluded from DB Phase|0|||
144220706|NCT01515423|520003682|FG002|Open Label Phase|excluded from DB Phase|0|||
144220707|NCT01515423|520003680|FG000|Open Label Phase|Other|28|||
144220708|NCT01515423|520003681|FG001|Open Label Phase|Other|0|||
144220709|NCT01515423|520003682|FG002|Open Label Phase|Other|0|||
144220710|NCT01515423|520003680|FG000|DOUBLE BLIND|Adverse Event|0|||
144693719|NCT00689299|521729736|FG000|Overall Study|Lost to Follow-up|0|||
144693720|NCT00689299|521729737|FG001|Overall Study|Lost to Follow-up|1|||
144693721|NCT00689299|521729738|FG002|Overall Study|Lost to Follow-up|1|||
144693722|NCT00689299|521729736|FG000|Overall Study|Withdrawal by Subject|4|||
144693723|NCT00689299|521729737|FG001|Overall Study|Withdrawal by Subject|1|||
144693724|NCT00689299|521729738|FG002|Overall Study|Withdrawal by Subject|3|||
144693725|NCT00689299|521729736|FG000|Overall Study|Protocol Violation|1|||
144693726|NCT00689299|521729737|FG001|Overall Study|Protocol Violation|0|||
144693727|NCT00689299|521729738|FG002|Overall Study|Protocol Violation|0|||
144693728|NCT02613910|521729741|FG000|Overall Study|Termination of study|1|||
144693729|NCT00434876|521729746|FG000|Overall Study|Lost to Follow-up|1|||
144693730|NCT00434876|521729747|FG001|Overall Study|Lost to Follow-up|1|||
144693731|NCT00758394|521729748|FG000|2nd Intervention Order|Lost to Follow-up|0|||
144693732|NCT00758394|521729749|FG001|2nd Intervention Order|Lost to Follow-up|1|||
144693733|NCT00758394|521729750|FG002|2nd Intervention Order|Lost to Follow-up|0|||
144693734|NCT00758394|521729751|FG003|2nd Intervention Order|Lost to Follow-up|0|||
144693735|NCT00758394|521729748|FG000|3rd Intervention|Lost to Follow-up|1|||
144693736|NCT00758394|521729749|FG001|3rd Intervention|Lost to Follow-up|0|||
144693737|NCT00758394|521729750|FG002|3rd Intervention|Lost to Follow-up|0|||
144693738|NCT00758394|521729751|FG003|3rd Intervention|Lost to Follow-up|1|||
144693739|NCT00337935|521731124|FG000|Overall Study|Adverse Event|2|||
144693740|NCT00337935|521731125|FG001|Overall Study|Adverse Event|5|||
144693741|NCT00337935|521731124|FG000|Overall Study|Death|2|||
144693742|NCT00337935|521731125|FG001|Overall Study|Death|8|||
144693743|NCT00337935|521731124|FG000|Overall Study|Physician Decision|1|||
144693744|NCT00337935|521731125|FG001|Overall Study|Physician Decision|1|||
144693745|NCT00337935|521731124|FG000|Overall Study|Lost to Follow-up|0|||
144693746|NCT00337935|521731125|FG001|Overall Study|Lost to Follow-up|1|||
144693747|NCT00337935|521731124|FG000|Overall Study|Protocol Violation|4|||
144693748|NCT00337935|521731125|FG001|Overall Study|Protocol Violation|3|||
144693749|NCT00337935|521731124|FG000|Overall Study|Withdrawal by Subject|1|||
144693750|NCT00337935|521731125|FG001|Overall Study|Withdrawal by Subject|7|||
144693751|NCT00337935|521731124|FG000|Overall Study|Other|0|||
144693752|NCT00337935|521731125|FG001|Overall Study|Other|1|||
144693753|NCT00337935|521731124|FG000|Overall Study|Lack of Efficacy|0|||
144693754|NCT00337935|521731125|FG001|Overall Study|Lack of Efficacy|1|||
144693755|NCT01336647|521731128|FG000|Overall Study|Lost to Follow-up|4|||
144693756|NCT01336647|521731129|FG001|Overall Study|Lost to Follow-up|1|||
144693757|NCT01336647|521731130|FG002|Overall Study|Lost to Follow-up|3|||
144693758|NCT01858701|521731131|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
144693759|NCT01858701|521731132|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
144693760|NCT01858701|521731131|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
144693761|NCT01858701|521731132|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
144220711|NCT01515423|520003681|FG001|DOUBLE BLIND|Adverse Event|15|||
144220712|NCT01515423|520003682|FG002|DOUBLE BLIND|Adverse Event|13|||
144693762|NCT01858701|521731131|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
144693763|NCT01858701|521731132|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
144693764|NCT01858701|521731131|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
144220713|NCT01515423|520003680|FG000|DOUBLE BLIND|Death|0|||
144220714|NCT01515423|520003681|FG001|DOUBLE BLIND|Death|1|||
144220715|NCT01515423|520003682|FG002|DOUBLE BLIND|Death|2|||
144693765|NCT01858701|521731132|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
144745549|NCT02883049|521919063|FG005|Induction|Identified as HR patients|0|||
144220716|NCT01515423|520003680|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
144745550|NCT02883049|521919064|FG006|Induction|Identified as HR patients|0|||
144745551|NCT02883049|521919065|FG007|Induction|Identified as HR patients|0|||
144745552|NCT02883049|521919066|FG008|Induction|Identified as HR patients|0|||
144745553|NCT02883049|521919067|FG009|Induction|Identified as HR patients|0|||
144745554|NCT02883049|521919068|FG010|Induction|Identified as HR patients|0|||
144745555|NCT02883049|521919069|FG011|Induction|Identified as HR patients|0|||
144745556|NCT02883049|521919070|FG012|Induction|Identified as HR patients|0|||
144745557|NCT02883049|521919071|FG013|Induction|Identified as HR patients|0|||
144745558|NCT02883049|521919072|FG014|Induction|Identified as HR patients|0|||
144745559|NCT02883049|521919073|FG015|Induction|Identified as HR patients|0|||
144745560|NCT02883049|521919058|FG000|Induction|Developed SMN|0|||
144745561|NCT02883049|521919059|FG001|Induction|Developed SMN|1|||
144745562|NCT02883049|521919060|FG002|Induction|Developed SMN|0|||
144745563|NCT02883049|521919061|FG003|Induction|Developed SMN|0|||
144745564|NCT02883049|521919062|FG004|Induction|Developed SMN|0|||
144745565|NCT02883049|521919063|FG005|Induction|Developed SMN|0|||
144745566|NCT02883049|521919064|FG006|Induction|Developed SMN|0|||
144745567|NCT02883049|521919065|FG007|Induction|Developed SMN|0|||
144745568|NCT02883049|521919066|FG008|Induction|Developed SMN|0|||
144745569|NCT02883049|521919067|FG009|Induction|Developed SMN|0|||
144745570|NCT02883049|521919068|FG010|Induction|Developed SMN|0|||
144745571|NCT02883049|521919069|FG011|Induction|Developed SMN|0|||
144745572|NCT02883049|521919070|FG012|Induction|Developed SMN|0|||
144745573|NCT02883049|521919071|FG013|Induction|Developed SMN|0|||
144745574|NCT02883049|521919072|FG014|Induction|Developed SMN|0|||
144745575|NCT02883049|521919073|FG015|Induction|Developed SMN|0|||
144745576|NCT02883049|521919058|FG000|Induction|Enrolled onto another COG study|72|||
144745577|NCT02883049|521919059|FG001|Induction|Enrolled onto another COG study|0|||
144745578|NCT02883049|521919060|FG002|Induction|Enrolled onto another COG study|0|||
144745579|NCT02883049|521919061|FG003|Induction|Enrolled onto another COG study|0|||
144745580|NCT02883049|521919062|FG004|Induction|Enrolled onto another COG study|0|||
144745581|NCT02883049|521919063|FG005|Induction|Enrolled onto another COG study|0|||
144745582|NCT02883049|521919064|FG006|Induction|Enrolled onto another COG study|0|||
144745583|NCT02883049|521919065|FG007|Induction|Enrolled onto another COG study|0|||
144745584|NCT02883049|521919066|FG008|Induction|Enrolled onto another COG study|0|||
144745585|NCT02883049|521919067|FG009|Induction|Enrolled onto another COG study|0|||
144745586|NCT02883049|521919068|FG010|Induction|Enrolled onto another COG study|0|||
144745587|NCT02883049|521919069|FG011|Induction|Enrolled onto another COG study|0|||
144745588|NCT02883049|521919070|FG012|Induction|Enrolled onto another COG study|0|||
144745589|NCT02883049|521919071|FG013|Induction|Enrolled onto another COG study|0|||
144745590|NCT02883049|521919072|FG014|Induction|Enrolled onto another COG study|0|||
144745591|NCT02883049|521919073|FG015|Induction|Enrolled onto another COG study|0|||
144745592|NCT02883049|521919058|FG000|Induction|Incomplete induction data|17|||
144745593|NCT02883049|521919059|FG001|Induction|Incomplete induction data|0|||
144745594|NCT02883049|521919060|FG002|Induction|Incomplete induction data|0|||
144745595|NCT02883049|521919061|FG003|Induction|Incomplete induction data|0|||
144745596|NCT02883049|521919062|FG004|Induction|Incomplete induction data|0|||
144745597|NCT02883049|521919063|FG005|Induction|Incomplete induction data|0|||
144745598|NCT02883049|521919064|FG006|Induction|Incomplete induction data|0|||
144745599|NCT02883049|521919065|FG007|Induction|Incomplete induction data|0|||
144745600|NCT02883049|521919066|FG008|Induction|Incomplete induction data|0|||
144745601|NCT02883049|521919067|FG009|Induction|Incomplete induction data|0|||
144745602|NCT02883049|521919068|FG010|Induction|Incomplete induction data|0|||
144745603|NCT02883049|521919069|FG011|Induction|Incomplete induction data|0|||
144745604|NCT02883049|521919070|FG012|Induction|Incomplete induction data|0|||
144745605|NCT02883049|521919071|FG013|Induction|Incomplete induction data|0|||
144745606|NCT02883049|521919072|FG014|Induction|Incomplete induction data|0|||
144745607|NCT02883049|521919073|FG015|Induction|Incomplete induction data|0|||
144745608|NCT02883049|521919058|FG000|Post Induction|Adverse Event|0|||
144745609|NCT02883049|521919059|FG001|Post Induction|Adverse Event|0|||
144220717|NCT01515423|520003681|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
144745610|NCT02883049|521919060|FG002|Post Induction|Adverse Event|0|||
144745611|NCT02883049|521919061|FG003|Post Induction|Adverse Event|7|||
144220718|NCT01515423|520003682|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
144220719|NCT01515423|520003680|FG000|DOUBLE BLIND|Pregnancy|0|||
144745612|NCT02883049|521919062|FG004|Post Induction|Adverse Event|8|||
144745613|NCT02883049|521919063|FG005|Post Induction|Adverse Event|3|||
144745614|NCT02883049|521919064|FG006|Post Induction|Adverse Event|4|||
144745615|NCT02883049|521919065|FG007|Post Induction|Adverse Event|5|||
144745616|NCT02883049|521919066|FG008|Post Induction|Adverse Event|6|||
144745617|NCT02883049|521919067|FG009|Post Induction|Adverse Event|7|||
144745618|NCT02883049|521919068|FG010|Post Induction|Adverse Event|2|||
144745619|NCT02883049|521919069|FG011|Post Induction|Adverse Event|2|||
144745620|NCT02883049|521919070|FG012|Post Induction|Adverse Event|0|||
144745621|NCT02883049|521919071|FG013|Post Induction|Adverse Event|0|||
144745622|NCT02883049|521919072|FG014|Post Induction|Adverse Event|5|||
144745623|NCT02883049|521919073|FG015|Post Induction|Adverse Event|2|||
144745624|NCT02883049|521919058|FG000|Post Induction|Death|0|||
144745625|NCT02883049|521919059|FG001|Post Induction|Death|0|||
144745626|NCT02883049|521919060|FG002|Post Induction|Death|0|||
144220720|NCT01515423|520003681|FG001|DOUBLE BLIND|Pregnancy|2|||
144220721|NCT01515423|520003682|FG002|DOUBLE BLIND|Pregnancy|0|||
144220722|NCT01515423|520003680|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
144220723|NCT01515423|520003681|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
144220724|NCT01515423|520003682|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
144220725|NCT01515423|520003680|FG000|DOUBLE BLIND|Other|0|||
144220726|NCT01515423|520003681|FG001|DOUBLE BLIND|Other|6|||
144220727|NCT01515423|520003682|FG002|DOUBLE BLIND|Other|12|||
144220728|NCT01515423|520003680|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
144220729|NCT01515423|520003681|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
144220730|NCT01515423|520003682|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
144220731|NCT01125917|520003691|FG000|Overall Study|Adverse Event|43|||
144220732|NCT01125917|520003691|FG000|Overall Study|Lost to Follow-up|23|||
144266283|NCT01548599|520178293|FG000|Overall Study|Withdrawal by Subject|4|||
144266284|NCT01548599|520178294|FG001|Overall Study|Withdrawal by Subject|0|||
144266285|NCT01548599|520178293|FG000|Overall Study|Death|2|||
144266286|NCT01548599|520178294|FG001|Overall Study|Death|1|||
144266287|NCT02486692|520178297|FG000|Overall Study|did not login for randomization|4|||
144266288|NCT02486692|520178298|FG001|Overall Study|did not login for randomization|7|||
144266289|NCT01573000|520178299|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
144266290|NCT01573000|520178300|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
144266291|NCT01573000|520178299|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
144266292|NCT01573000|520178300|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
144266293|NCT01573000|520178299|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
144266294|NCT01573000|520178300|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
144266295|NCT01573000|520178299|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
144266296|NCT01573000|520178300|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
144266297|NCT01573000|520178299|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
144266298|NCT01573000|520178300|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
144266299|NCT01573000|520178299|FG000|Crossover Phase|Lack of Efficacy|0|||
144266300|NCT01573000|520178300|FG001|Crossover Phase|Lack of Efficacy|13|||
144266301|NCT01573000|520178299|FG000|Crossover Phase|Lost to Follow-up|0|||
144266302|NCT01573000|520178300|FG001|Crossover Phase|Lost to Follow-up|2|||
144745627|NCT02883049|521919061|FG003|Post Induction|Death|9|||
144745628|NCT02883049|521919062|FG004|Post Induction|Death|9|||
144745629|NCT02883049|521919063|FG005|Post Induction|Death|0|||
144745630|NCT02883049|521919064|FG006|Post Induction|Death|1|||
144745631|NCT02883049|521919065|FG007|Post Induction|Death|6|||
144745632|NCT02883049|521919066|FG008|Post Induction|Death|5|||
144745633|NCT02883049|521919067|FG009|Post Induction|Death|3|||
144745634|NCT02883049|521919068|FG010|Post Induction|Death|1|||
144745635|NCT02883049|521919069|FG011|Post Induction|Death|0|||
144745636|NCT02883049|521919070|FG012|Post Induction|Death|1|||
144745637|NCT02883049|521919071|FG013|Post Induction|Death|1|||
144745638|NCT02883049|521919072|FG014|Post Induction|Death|10|||
144745639|NCT02883049|521919073|FG015|Post Induction|Death|2|||
144745640|NCT02883049|521919058|FG000|Post Induction|Lost to Follow-up|0|||
144745641|NCT02883049|521919059|FG001|Post Induction|Lost to Follow-up|0|||
144745642|NCT02883049|521919060|FG002|Post Induction|Lost to Follow-up|0|||
144745643|NCT02883049|521919061|FG003|Post Induction|Lost to Follow-up|0|||
144745644|NCT02883049|521919062|FG004|Post Induction|Lost to Follow-up|1|||
144745645|NCT02883049|521919063|FG005|Post Induction|Lost to Follow-up|1|||
144745646|NCT02883049|521919064|FG006|Post Induction|Lost to Follow-up|0|||
144745647|NCT02883049|521919065|FG007|Post Induction|Lost to Follow-up|0|||
144745648|NCT02883049|521919066|FG008|Post Induction|Lost to Follow-up|3|||
144745649|NCT02883049|521919067|FG009|Post Induction|Lost to Follow-up|0|||
144745650|NCT02883049|521919068|FG010|Post Induction|Lost to Follow-up|1|||
144745651|NCT02883049|521919069|FG011|Post Induction|Lost to Follow-up|0|||
144745652|NCT02883049|521919070|FG012|Post Induction|Lost to Follow-up|0|||
144220733|NCT01125917|520003691|FG000|Overall Study|Withdrawal by Subject|31|||
144220734|NCT01125917|520003691|FG000|Overall Study|Administrative|223|||
144220735|NCT01125917|520003691|FG000|Overall Study|Lack of Efficacy|19|||
144220736|NCT04421131|520003693|FG000|Overall Study|Lost to Follow-up|1|||
144220737|NCT04421131|520003693|FG000|Overall Study|Protocol Violation|2|||
144220738|NCT04421131|520003693|FG000|Overall Study|App crashed|5|||
144220739|NCT00951496|520003701|FG000|Overall Study|Did not initiate study treatment|10|||
144220740|NCT00951496|520003702|FG001|Overall Study|Did not initiate study treatment|8|||
144266303|NCT01573000|520178299|FG000|Crossover Phase|Death|0|||
144266304|NCT01573000|520178300|FG001|Crossover Phase|Death|3|||
144220741|NCT00951496|520003703|FG002|Overall Study|Did not initiate study treatment|13|||
144266305|NCT01573000|520178299|FG000|Long-Term Follow-Up|Death|3|||
144745653|NCT02883049|521919071|FG013|Post Induction|Lost to Follow-up|0|||
144745654|NCT02883049|521919072|FG014|Post Induction|Lost to Follow-up|0|||
144745655|NCT02883049|521919073|FG015|Post Induction|Lost to Follow-up|0|||
144745656|NCT02883049|521919058|FG000|Post Induction|Physician Decision|0|||
144745657|NCT02883049|521919059|FG001|Post Induction|Physician Decision|0|||
144745658|NCT02883049|521919060|FG002|Post Induction|Physician Decision|0|||
144745659|NCT02883049|521919061|FG003|Post Induction|Physician Decision|27|||
144745660|NCT02883049|521919062|FG004|Post Induction|Physician Decision|27|||
144745661|NCT02883049|521919063|FG005|Post Induction|Physician Decision|23|||
144745662|NCT02883049|521919064|FG006|Post Induction|Physician Decision|30|||
144745663|NCT02883049|521919065|FG007|Post Induction|Physician Decision|56|||
144745664|NCT02883049|521919066|FG008|Post Induction|Physician Decision|85|||
144745665|NCT02883049|521919067|FG009|Post Induction|Physician Decision|12|||
144745666|NCT02883049|521919068|FG010|Post Induction|Physician Decision|5|||
144745667|NCT02883049|521919069|FG011|Post Induction|Physician Decision|14|||
144745668|NCT02883049|521919070|FG012|Post Induction|Physician Decision|1|||
144745669|NCT02883049|521919071|FG013|Post Induction|Physician Decision|11|||
144745670|NCT02883049|521919072|FG014|Post Induction|Physician Decision|19|||
144745671|NCT02883049|521919073|FG015|Post Induction|Physician Decision|5|||
144745672|NCT02883049|521919058|FG000|Post Induction|Protocol Violation|0|||
144745673|NCT02883049|521919059|FG001|Post Induction|Protocol Violation|0|||
144745674|NCT02883049|521919060|FG002|Post Induction|Protocol Violation|0|||
144745675|NCT02883049|521919061|FG003|Post Induction|Protocol Violation|0|||
144745676|NCT02883049|521919062|FG004|Post Induction|Protocol Violation|0|||
144745677|NCT02883049|521919063|FG005|Post Induction|Protocol Violation|0|||
144745678|NCT02883049|521919064|FG006|Post Induction|Protocol Violation|0|||
144745679|NCT02883049|521919065|FG007|Post Induction|Protocol Violation|1|||
144745680|NCT02883049|521919066|FG008|Post Induction|Protocol Violation|0|||
144745681|NCT02883049|521919067|FG009|Post Induction|Protocol Violation|0|||
144745682|NCT02883049|521919068|FG010|Post Induction|Protocol Violation|0|||
144745683|NCT02883049|521919069|FG011|Post Induction|Protocol Violation|0|||
144745684|NCT02883049|521919070|FG012|Post Induction|Protocol Violation|0|||
144745685|NCT02883049|521919071|FG013|Post Induction|Protocol Violation|0|||
144745686|NCT02883049|521919072|FG014|Post Induction|Protocol Violation|0|||
144745687|NCT02883049|521919073|FG015|Post Induction|Protocol Violation|0|||
144745688|NCT02883049|521919058|FG000|Post Induction|Withdrawal by Subject|0|||
144745689|NCT02883049|521919059|FG001|Post Induction|Withdrawal by Subject|0|||
144745690|NCT02883049|521919060|FG002|Post Induction|Withdrawal by Subject|0|||
144745691|NCT02883049|521919061|FG003|Post Induction|Withdrawal by Subject|5|||
144745692|NCT02883049|521919062|FG004|Post Induction|Withdrawal by Subject|2|||
144745693|NCT02883049|521919063|FG005|Post Induction|Withdrawal by Subject|1|||
144745694|NCT02883049|521919064|FG006|Post Induction|Withdrawal by Subject|0|||
144745695|NCT02883049|521919065|FG007|Post Induction|Withdrawal by Subject|0|||
144745696|NCT02883049|521919066|FG008|Post Induction|Withdrawal by Subject|2|||
144745697|NCT02883049|521919067|FG009|Post Induction|Withdrawal by Subject|0|||
144745698|NCT02883049|521919068|FG010|Post Induction|Withdrawal by Subject|1|||
144745699|NCT02883049|521919069|FG011|Post Induction|Withdrawal by Subject|1|||
144745700|NCT02883049|521919070|FG012|Post Induction|Withdrawal by Subject|0|||
144745701|NCT02883049|521919071|FG013|Post Induction|Withdrawal by Subject|0|||
144745702|NCT02883049|521919072|FG014|Post Induction|Withdrawal by Subject|1|||
144745703|NCT02883049|521919073|FG015|Post Induction|Withdrawal by Subject|0|||
144745704|NCT02883049|521919058|FG000|Post Induction|Ineligible|0|||
144745705|NCT02883049|521919059|FG001|Post Induction|Ineligible|0|||
144745706|NCT02883049|521919060|FG002|Post Induction|Ineligible|2|||
144745707|NCT02883049|521919061|FG003|Post Induction|Ineligible|0|||
144745708|NCT02883049|521919062|FG004|Post Induction|Ineligible|0|||
144745709|NCT02883049|521919063|FG005|Post Induction|Ineligible|0|||
144745710|NCT02883049|521919064|FG006|Post Induction|Ineligible|1|||
144745711|NCT02883049|521919065|FG007|Post Induction|Ineligible|0|||
144745712|NCT02883049|521919066|FG008|Post Induction|Ineligible|0|||
144745713|NCT02883049|521919067|FG009|Post Induction|Ineligible|0|||
144745714|NCT02883049|521919068|FG010|Post Induction|Ineligible|1|||
144745715|NCT02883049|521919069|FG011|Post Induction|Ineligible|0|||
144745716|NCT02883049|521919070|FG012|Post Induction|Ineligible|0|||
144745717|NCT02883049|521919071|FG013|Post Induction|Ineligible|0|||
144745718|NCT02883049|521919072|FG014|Post Induction|Ineligible|0|||
144745719|NCT02883049|521919073|FG015|Post Induction|Ineligible|1|||
144745720|NCT02883049|521919058|FG000|Post Induction|Refusal of further protocol therapy|0|||
144745721|NCT02883049|521919059|FG001|Post Induction|Refusal of further protocol therapy|0|||
144745722|NCT02883049|521919060|FG002|Post Induction|Refusal of further protocol therapy|0|||
144745723|NCT02883049|521919061|FG003|Post Induction|Refusal of further protocol therapy|11|||
144745724|NCT02883049|521919062|FG004|Post Induction|Refusal of further protocol therapy|15|||
144745725|NCT02883049|521919063|FG005|Post Induction|Refusal of further protocol therapy|9|||
144745726|NCT02883049|521919064|FG006|Post Induction|Refusal of further protocol therapy|13|||
144745727|NCT02883049|521919065|FG007|Post Induction|Refusal of further protocol therapy|5|||
144745728|NCT02883049|521919066|FG008|Post Induction|Refusal of further protocol therapy|21|||
144745729|NCT02883049|521919067|FG009|Post Induction|Refusal of further protocol therapy|7|||
144745730|NCT02883049|521919068|FG010|Post Induction|Refusal of further protocol therapy|0|||
144745731|NCT02883049|521919069|FG011|Post Induction|Refusal of further protocol therapy|7|||
144745732|NCT02883049|521919070|FG012|Post Induction|Refusal of further protocol therapy|3|||
144745733|NCT02883049|521919071|FG013|Post Induction|Refusal of further protocol therapy|0|||
144745734|NCT02883049|521919072|FG014|Post Induction|Refusal of further protocol therapy|4|||
144745735|NCT02883049|521919073|FG015|Post Induction|Refusal of further protocol therapy|1|||
144220742|NCT00838526|520003704|FG000|Overall Study|Adverse Event|3|||
144220743|NCT00838526|520003705|FG001|Overall Study|Adverse Event|12|||
144220744|NCT00838526|520003704|FG000|Overall Study|Lost to Follow-up|4|||
144220745|NCT00838526|520003705|FG001|Overall Study|Lost to Follow-up|12|||
144220746|NCT00838526|520003704|FG000|Overall Study|Withdrawal by Subject|4|||
144220747|NCT00838526|520003705|FG001|Overall Study|Withdrawal by Subject|5|||
144220748|NCT00838526|520003704|FG000|Overall Study|Lack of Efficacy|2|||
144220749|NCT00838526|520003705|FG001|Overall Study|Lack of Efficacy|3|||
144220750|NCT00838526|520003704|FG000|Overall Study|Other|11|||
144220751|NCT00838526|520003705|FG001|Overall Study|Other|7|||
144220752|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
144220753|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
144220754|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
144220755|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
144220756|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
144220757|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
144220758|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
144220759|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
144220760|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
144693766|NCT01801475|521731137|FG000|Overall Study|Withdrawal by Subject|0|||
144693767|NCT01801475|521731138|FG001|Overall Study|Withdrawal by Subject|0|||
144693768|NCT01801475|521731139|FG002|Overall Study|Withdrawal by Subject|0|||
144693769|NCT01801475|521731140|FG003|Overall Study|Withdrawal by Subject|0|||
144745736|NCT02883049|521919058|FG000|Post Induction|Inevaluable|0|||
144745737|NCT02883049|521919059|FG001|Post Induction|Inevaluable|0|||
144745738|NCT02883049|521919060|FG002|Post Induction|Inevaluable|0|||
144745739|NCT02883049|521919061|FG003|Post Induction|Inevaluable|1|||
144745740|NCT02883049|521919062|FG004|Post Induction|Inevaluable|1|||
144745741|NCT02883049|521919063|FG005|Post Induction|Inevaluable|2|||
144745742|NCT02883049|521919064|FG006|Post Induction|Inevaluable|7|||
144745743|NCT02883049|521919065|FG007|Post Induction|Inevaluable|6|||
144745744|NCT02883049|521919066|FG008|Post Induction|Inevaluable|4|||
144745745|NCT02883049|521919067|FG009|Post Induction|Inevaluable|4|||
144745746|NCT02883049|521919068|FG010|Post Induction|Inevaluable|1|||
144745747|NCT02883049|521919069|FG011|Post Induction|Inevaluable|1|||
144745748|NCT02883049|521919070|FG012|Post Induction|Inevaluable|2|||
144745749|NCT02883049|521919071|FG013|Post Induction|Inevaluable|0|||
144745750|NCT02883049|521919072|FG014|Post Induction|Inevaluable|0|||
144745751|NCT02883049|521919073|FG015|Post Induction|Inevaluable|1|||
144745752|NCT02883049|521919058|FG000|Post Induction|Moved to another non-COG institution|0|||
144745753|NCT02883049|521919059|FG001|Post Induction|Moved to another non-COG institution|0|||
144745754|NCT02883049|521919060|FG002|Post Induction|Moved to another non-COG institution|0|||
144745755|NCT02883049|521919061|FG003|Post Induction|Moved to another non-COG institution|0|||
144745756|NCT02883049|521919062|FG004|Post Induction|Moved to another non-COG institution|0|||
144745757|NCT02883049|521919063|FG005|Post Induction|Moved to another non-COG institution|0|||
144745758|NCT02883049|521919064|FG006|Post Induction|Moved to another non-COG institution|0|||
144745759|NCT02883049|521919065|FG007|Post Induction|Moved to another non-COG institution|2|||
144745760|NCT02883049|521919066|FG008|Post Induction|Moved to another non-COG institution|2|||
144745761|NCT02883049|521919067|FG009|Post Induction|Moved to another non-COG institution|0|||
144745762|NCT02883049|521919068|FG010|Post Induction|Moved to another non-COG institution|0|||
144693770|NCT01801475|521731141|FG004|Overall Study|Withdrawal by Subject|1|||
144693771|NCT01786707|521731142|FG000|Overall Study|Lost to Follow-up|1|||
144693772|NCT01786707|521731143|FG001|Overall Study|Lost to Follow-up|1|||
144693773|NCT05111548|521731155|FG000|Overall Study|Withdrawal by Subject|2|||
144693774|NCT05111548|521731156|FG001|Overall Study|Withdrawal by Subject|1|||
144693775|NCT05111548|521731155|FG000|Overall Study|Adverse Event|1|||
144693776|NCT05111548|521731156|FG001|Overall Study|Adverse Event|0|||
144693777|NCT02079077|521731157|FG000|Overall Study|Lost to Follow-up|5|||
144693778|NCT02079077|521731158|FG001|Overall Study|Lost to Follow-up|7|||
144693779|NCT02079077|521731157|FG000|Overall Study|Became STIs Positive|1|||
144693780|NCT02079077|521731158|FG001|Overall Study|Became STIs Positive|2|||
144693781|NCT02087085|521731159|FG000|Overall Study|Adverse Event|10|||
144693782|NCT02087085|521731160|FG001|Overall Study|Adverse Event|14|||
144693783|NCT02087085|521731159|FG000|Overall Study|Lack of Efficacy|4|||
144745763|NCT02883049|521919069|FG011|Post Induction|Moved to another non-COG institution|1|||
144745764|NCT02883049|521919070|FG012|Post Induction|Moved to another non-COG institution|0|||
144745765|NCT02883049|521919071|FG013|Post Induction|Moved to another non-COG institution|0|||
144745766|NCT02883049|521919072|FG014|Post Induction|Moved to another non-COG institution|0|||
144220761|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
144220762|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
144220763|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
144693784|NCT02087085|521731160|FG001|Overall Study|Lack of Efficacy|3|||
144693785|NCT02087085|521731159|FG000|Overall Study|Lost to Follow-up|6|||
144693786|NCT02087085|521731160|FG001|Overall Study|Lost to Follow-up|4|||
144693787|NCT02087085|521731159|FG000|Overall Study|Withdrawal by Subject|9|||
144693788|NCT02087085|521731160|FG001|Overall Study|Withdrawal by Subject|11|||
144693789|NCT02087085|521731159|FG000|Overall Study|Protocol Violation|1|||
144693790|NCT02087085|521731160|FG001|Overall Study|Protocol Violation|0|||
144693791|NCT02087085|521731159|FG000|Overall Study|Study Terminated by Sponsor|87|||
144693792|NCT02087085|521731160|FG001|Overall Study|Study Terminated by Sponsor|80|||
144693793|NCT02087085|521731159|FG000|Overall Study|Other Miscellaneous Reasons|3|||
144693794|NCT02087085|521731160|FG001|Overall Study|Other Miscellaneous Reasons|4|||
144693795|NCT01101321|521731161|FG000|Period 1|Withdrawal by Subject|1|||
144693796|NCT01101321|521731162|FG001|Period 1|Withdrawal by Subject|1|||
144693797|NCT01101321|521731161|FG000|Period 1|Adverse Event|3|||
144693798|NCT01101321|521731162|FG001|Period 1|Adverse Event|3|||
144693799|NCT00719706|521731163|FG000|Overall Study|Adverse Event|5|||
144693800|NCT00719706|521731164|FG001|Overall Study|Adverse Event|4|||
144693801|NCT00719706|521731163|FG000|Overall Study|Withdrawal by Subject|1|||
144693802|NCT00719706|521731164|FG001|Overall Study|Withdrawal by Subject|2|||
144693803|NCT00719706|521731163|FG000|Overall Study|Protocol Violation|3|||
144693804|NCT00719706|521731164|FG001|Overall Study|Protocol Violation|0|||
144693805|NCT01270139|521731165|FG000|Overall Study|Adverse Event|8|||
144693806|NCT01270139|521731166|FG001|Overall Study|Adverse Event|17|||
144693807|NCT01270139|521731167|FG002|Overall Study|Adverse Event|18|||
144693808|NCT01270139|521731165|FG000|Overall Study|Lost to Follow-up|10|||
144693809|NCT01270139|521731166|FG001|Overall Study|Lost to Follow-up|9|||
144693810|NCT01270139|521731167|FG002|Overall Study|Lost to Follow-up|2|||
144693811|NCT00508872|521731172|FG000|Overall Study|Lost to Follow-up|1|||
144693812|NCT00508872|521731172|FG000|Overall Study|Physician Decision|1|||
144693813|NCT03339999|521731179|FG000|Overall Study|Adverse Event|1|||
144693814|NCT03339999|521731180|FG001|Overall Study|Adverse Event|2|||
144693815|NCT03339999|521731181|FG002|Overall Study|Adverse Event|2|||
144693816|NCT03339999|521731182|FG003|Overall Study|Adverse Event|1|||
144693817|NCT03339999|521731179|FG000|Overall Study|Lack of Efficacy|0|||
144693818|NCT03339999|521731180|FG001|Overall Study|Lack of Efficacy|1|||
144693819|NCT03339999|521731181|FG002|Overall Study|Lack of Efficacy|0|||
144693820|NCT03339999|521731182|FG003|Overall Study|Lack of Efficacy|0|||
144693821|NCT03339999|521731179|FG000|Overall Study|Lost to Follow-up|0|||
144693822|NCT03339999|521731180|FG001|Overall Study|Lost to Follow-up|0|||
144693823|NCT03339999|521731181|FG002|Overall Study|Lost to Follow-up|0|||
144693824|NCT03339999|521731182|FG003|Overall Study|Lost to Follow-up|1|||
144693825|NCT03339999|521731179|FG000|Overall Study|Study Terminated by Sponsor|6|||
144693826|NCT03339999|521731180|FG001|Overall Study|Study Terminated by Sponsor|3|||
144693827|NCT03339999|521731181|FG002|Overall Study|Study Terminated by Sponsor|4|||
144693828|NCT03339999|521731182|FG003|Overall Study|Study Terminated by Sponsor|3|||
144693829|NCT02545270|521731184|FG000|Overall Study|technical difficulties|0|||
144693830|NCT02545270|521731185|FG001|Overall Study|technical difficulties|1|||
144693831|NCT02545270|521731186|FG002|Overall Study|technical difficulties|0|||
144693832|NCT02545270|521731184|FG000|Overall Study|Videos being too similar to other|0|||
144693833|NCT02545270|521731185|FG001|Overall Study|Videos being too similar to other|0|||
144693834|NCT02545270|521731186|FG002|Overall Study|Videos being too similar to other|2|||
144693835|NCT02898662|521731192|FG000|Overall Study|Adverse Event|1|||
144693836|NCT02898662|521731193|FG001|Overall Study|Adverse Event|0|||
144693837|NCT02898662|521731192|FG000|Overall Study|Loss of asthma control|23|||
144693838|NCT02898662|521731193|FG001|Overall Study|Loss of asthma control|24|||
144693839|NCT02898662|521731192|FG000|Overall Study|Withdrawal by Subject|4|||
144693840|NCT02898662|521731193|FG001|Overall Study|Withdrawal by Subject|1|||
144693841|NCT02898662|521731192|FG000|Overall Study|Technical issue|0|||
144693842|NCT02898662|521731193|FG001|Overall Study|Technical issue|1|||
144693843|NCT02898662|521731192|FG000|Overall Study|Randomized in error|0|||
144693844|NCT02898662|521731193|FG001|Overall Study|Randomized in error|1|||
144693845|NCT02898662|521731192|FG000|Overall Study|Subject decision|1|||
144693846|NCT02898662|521731193|FG001|Overall Study|Subject decision|0|||
144693847|NCT02898662|521731192|FG000|Overall Study|Other|0|||
144220764|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
144220765|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
144220766|NCT04338022|520003714|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
144220767|NCT04338022|520003715|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
144266306|NCT01573000|520178300|FG001|Long-Term Follow-Up|Death|0|||
144693848|NCT02898662|521731193|FG001|Overall Study|Other|1|||
144693849|NCT00917553|521731194|FG000|Overall Study|Lost to Follow-up|2|||
144693850|NCT00917553|521731195|FG001|Overall Study|Lost to Follow-up|1|||
144693851|NCT01616173|521731196|FG000|Overall Study|Lost to Follow-up|0|||
144693852|NCT01616173|521731197|FG001|Overall Study|Lost to Follow-up|2|||
144693853|NCT01616173|521731198|FG002|Overall Study|Lost to Follow-up|0|||
144693854|NCT03432819|521731201|FG000|Overall Study|Lost to Follow-up|2|||
144693855|NCT03432819|521731202|FG001|Overall Study|Lost to Follow-up|2|||
144693856|NCT03432819|521731201|FG000|Overall Study|Withdrawal by Subject|5|||
144693857|NCT03432819|521731202|FG001|Overall Study|Withdrawal by Subject|3|||
144693858|NCT04382066|521731204|FG000|Overall Study|Adverse Event|1|||
144220768|NCT04338022|520003714|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
144220769|NCT04338022|520003715|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
144220770|NCT04338022|520003714|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
144220771|NCT04338022|520003715|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
144220772|NCT04338022|520003714|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
144220773|NCT04338022|520003715|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
144693859|NCT04382066|521731205|FG001|Overall Study|Adverse Event|0|||
144693860|NCT04382066|521731206|FG002|Overall Study|Adverse Event|0|||
144693861|NCT04382066|521731204|FG000|Overall Study|Death|1|||
144693862|NCT04382066|521731205|FG001|Overall Study|Death|0|||
144693863|NCT04382066|521731206|FG002|Overall Study|Death|1|||
144693864|NCT01430559|521731208|FG000|Overall Study|Adverse Event|7|||
144693865|NCT01430559|521731209|FG001|Overall Study|Adverse Event|3|||
144693866|NCT01430559|521731208|FG000|Overall Study|Entry criteria not met|1|||
144693867|NCT01430559|521731209|FG001|Overall Study|Entry criteria not met|1|||
144693868|NCT01430559|521731208|FG000|Overall Study|Lost to Follow-up|1|||
144693869|NCT01430559|521731209|FG001|Overall Study|Lost to Follow-up|0|||
144693870|NCT01430559|521731208|FG000|Overall Study|Medication error|1|||
144693871|NCT01430559|521731209|FG001|Overall Study|Medication error|0|||
144693872|NCT01430559|521731208|FG000|Overall Study|Withdrawal by Subject|3|||
144693873|NCT01430559|521731209|FG001|Overall Study|Withdrawal by Subject|2|||
144693874|NCT01430559|521731208|FG000|Overall Study|Protocol Violation|1|||
144693875|NCT01430559|521731209|FG001|Overall Study|Protocol Violation|0|||
144693876|NCT01430559|521731208|FG000|Overall Study|Other|3|||
144693877|NCT01430559|521731209|FG001|Overall Study|Other|3|||
144693878|NCT01430559|521731208|FG000|Overall Study|Randomized, Not Treated|3|||
144693879|NCT01430559|521731209|FG001|Overall Study|Randomized, Not Treated|3|||
144693880|NCT01177943|521731210|FG000|First Intervention|Withdrawal by Subject|2|||
144693881|NCT01177943|521731211|FG001|First Intervention|Withdrawal by Subject|0|||
144693882|NCT04225026|521731213|FG000|Overall Study|Withdrawal by Subject|4|||
144693883|NCT04225026|521731213|FG000|Overall Study|Adverse Event|1|||
144693884|NCT04225026|521731213|FG000|Overall Study|Other|1|||
144693885|NCT04225026|521731213|FG000|Overall Study|Death|11|||
144693886|NCT04225026|521731213|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
144693887|NCT00779142|521731216|FG000|Overall Study|Screen Failures|3|||
144693888|NCT00672490|521731217|FG000|Overall Study|Withdrawal by Subject|8|||
144693889|NCT00672490|521731218|FG001|Overall Study|Withdrawal by Subject|8|||
144693890|NCT00672490|521731217|FG000|Overall Study|Lack of Compliance|2|||
144693891|NCT00672490|521731218|FG001|Overall Study|Lack of Compliance|7|||
144693892|NCT00672490|521731217|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
144693893|NCT00672490|521731218|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
144693894|NCT00672490|521731217|FG000|Overall Study|Adverse Event|5|||
144693895|NCT00672490|521731218|FG001|Overall Study|Adverse Event|8|||
144693896|NCT00672490|521731217|FG000|Overall Study|Violation of Concomitant Medicine|1|||
144693897|NCT00672490|521731218|FG001|Overall Study|Violation of Concomitant Medicine|0|||
144693898|NCT00672490|521731217|FG000|Overall Study|Intolerance|0|||
144693899|NCT00672490|521731218|FG001|Overall Study|Intolerance|2|||
144693900|NCT00672490|521731217|FG000|Overall Study|Lost to Follow-up|1|||
144693901|NCT00672490|521731218|FG001|Overall Study|Lost to Follow-up|5|||
144693902|NCT00672490|521731217|FG000|Overall Study|No reason was provided|6|||
144693903|NCT00672490|521731218|FG001|Overall Study|No reason was provided|2|||
144693904|NCT04738123|521731222|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
144693905|NCT04738123|521731223|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
144693906|NCT04738123|521731222|FG000|Overall Study|Progressive Disease|0|||
144693907|NCT04738123|521731223|FG001|Overall Study|Progressive Disease|4|||
144693908|NCT04738123|521731222|FG000|Overall Study|Adverse Event|8|||
144693909|NCT04738123|521731223|FG001|Overall Study|Adverse Event|7|||
144693910|NCT04738123|521731222|FG000|Overall Study|Other Reasons|0|||
144693911|NCT04738123|521731223|FG001|Overall Study|Other Reasons|1|||
144693912|NCT04738123|521731222|FG000|Overall Study|Suicidal or assaultive behavior|0|||
144693913|NCT04738123|521731223|FG001|Overall Study|Suicidal or assaultive behavior|2|||
144693914|NCT04738123|521731222|FG000|Overall Study|Protocol Violation|2|||
144693915|NCT04738123|521731223|FG001|Overall Study|Protocol Violation|2|||
144693916|NCT04738123|521731222|FG000|Overall Study|Consent Withdrawn|35|||
144693917|NCT04738123|521731223|FG001|Overall Study|Consent Withdrawn|22|||
144693918|NCT01288911|521731224|FG000|Double-blind Period|Death|11|||
144693919|NCT01288911|521731225|FG001|Double-blind Period|Death|7|||
144220774|NCT04338022|520003714|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
144693920|NCT01288911|521731224|FG000|Double-blind Period|Lost to Follow-up|0|||
144693921|NCT01288911|521731225|FG001|Double-blind Period|Lost to Follow-up|2|||
144693922|NCT01288911|521731224|FG000|Double-blind Period|Progressive Disease|75|||
144220775|NCT04338022|520003715|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
144693923|NCT01288911|521731225|FG001|Double-blind Period|Progressive Disease|103|||
144693924|NCT01288911|521731224|FG000|Double-blind Period|Protocol Violation|1|||
144693925|NCT01288911|521731225|FG001|Double-blind Period|Protocol Violation|0|||
144693926|NCT01288911|521731224|FG000|Double-blind Period|Withdrawal by Subject|25|||
144693927|NCT01288911|521731225|FG001|Double-blind Period|Withdrawal by Subject|26|||
144745767|NCT02883049|521919073|FG015|Post Induction|Moved to another non-COG institution|0|||
144745768|NCT02883049|521919058|FG000|Post Induction|Randomization closed|0|||
144745769|NCT02883049|521919059|FG001|Post Induction|Randomization closed|0|||
144745770|NCT02883049|521919060|FG002|Post Induction|Randomization closed|0|||
144745771|NCT02883049|521919061|FG003|Post Induction|Randomization closed|0|||
144745772|NCT02883049|521919062|FG004|Post Induction|Randomization closed|0|||
144745773|NCT02883049|521919063|FG005|Post Induction|Randomization closed|0|||
144745774|NCT02883049|521919064|FG006|Post Induction|Randomization closed|0|||
144745775|NCT02883049|521919065|FG007|Post Induction|Randomization closed|20|||
144745776|NCT02883049|521919066|FG008|Post Induction|Randomization closed|0|||
144745777|NCT02883049|521919067|FG009|Post Induction|Randomization closed|0|||
144745778|NCT02883049|521919068|FG010|Post Induction|Randomization closed|0|||
144745779|NCT02883049|521919069|FG011|Post Induction|Randomization closed|0|||
144745780|NCT02883049|521919070|FG012|Post Induction|Randomization closed|0|||
144220776|NCT04338022|520003714|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
144745781|NCT02883049|521919071|FG013|Post Induction|Randomization closed|0|||
144745782|NCT02883049|521919072|FG014|Post Induction|Randomization closed|0|||
144745783|NCT02883049|521919073|FG015|Post Induction|Randomization closed|0|||
144745784|NCT02883049|521919058|FG000|Post Induction|MRD negative|0|||
144745785|NCT02883049|521919059|FG001|Post Induction|MRD negative|0|||
144745786|NCT02883049|521919060|FG002|Post Induction|MRD negative|0|||
144745787|NCT02883049|521919061|FG003|Post Induction|MRD negative|0|||
144745788|NCT02883049|521919062|FG004|Post Induction|MRD negative|0|||
144745789|NCT02883049|521919063|FG005|Post Induction|MRD negative|0|||
144745790|NCT02883049|521919064|FG006|Post Induction|MRD negative|0|||
144745791|NCT02883049|521919065|FG007|Post Induction|MRD negative|11|||
144745792|NCT02883049|521919066|FG008|Post Induction|MRD negative|0|||
144745793|NCT02883049|521919067|FG009|Post Induction|MRD negative|0|||
144745794|NCT02883049|521919068|FG010|Post Induction|MRD negative|0|||
144220777|NCT04338022|520003715|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
144220778|NCT04338022|520003714|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
144220779|NCT04338022|520003715|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
144220780|NCT04782076|520003722|FG000|Overall Study|Family Emergency|1|||
144220781|NCT02860546|520003723|FG000|Overall Study|Clinical Progression|6|||
144220782|NCT02860546|520003723|FG000|Overall Study|Radiological Progression|12|||
144220783|NCT02466321|520003724|FG000|Overall Study|Death|26|||
144220784|NCT02466321|520003724|FG000|Overall Study|Revision|6|||
144220785|NCT02466321|520003724|FG000|Overall Study|Lost to Follow-up|60|||
144220786|NCT02466321|520003724|FG000|Overall Study|Did not receive study device|1|||
144220787|NCT01074944|520003725|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
144220788|NCT01074944|520003726|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
144220789|NCT01074944|520003727|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
144220790|NCT01074944|520003728|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
144220791|NCT01074944|520003729|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
144220792|NCT01074944|520003725|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
144220793|NCT01074944|520003726|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
144220794|NCT01074944|520003727|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
144220795|NCT01074944|520003728|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
144220796|NCT01074944|520003729|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
144220797|NCT01074944|520003725|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
144220798|NCT01074944|520003726|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
144220799|NCT01074944|520003727|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
144220800|NCT01074944|520003728|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
144220801|NCT01074944|520003729|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
144220802|NCT01074944|520003725|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
144220803|NCT01074944|520003726|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
144745795|NCT02883049|521919069|FG011|Post Induction|MRD negative|0|||
144745796|NCT02883049|521919070|FG012|Post Induction|MRD negative|0|||
144745797|NCT02883049|521919071|FG013|Post Induction|MRD negative|0|||
144745798|NCT02883049|521919072|FG014|Post Induction|MRD negative|0|||
144220804|NCT01074944|520003727|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
144266307|NCT01573000|520178299|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
144220805|NCT01074944|520003728|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
144266308|NCT01573000|520178300|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
144266309|NCT01100853|520178304|FG000|Overall Study|Lost to Follow-up|11|||
144220806|NCT01074944|520003729|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
144266310|NCT01100853|520178305|FG001|Overall Study|Lost to Follow-up|6|||
144745799|NCT02883049|521919073|FG015|Post Induction|MRD negative|0|||
144745800|NCT02883049|521919058|FG000|Post Induction|Developed SMN|0|||
144745801|NCT02883049|521919059|FG001|Post Induction|Developed SMN|0|||
144745802|NCT02883049|521919060|FG002|Post Induction|Developed SMN|0|||
144745803|NCT02883049|521919061|FG003|Post Induction|Developed SMN|0|||
144745804|NCT02883049|521919062|FG004|Post Induction|Developed SMN|1|||
144745805|NCT02883049|521919063|FG005|Post Induction|Developed SMN|0|||
144745806|NCT02883049|521919064|FG006|Post Induction|Developed SMN|1|||
144745807|NCT02883049|521919065|FG007|Post Induction|Developed SMN|0|||
144745808|NCT02883049|521919066|FG008|Post Induction|Developed SMN|0|||
144745809|NCT02883049|521919067|FG009|Post Induction|Developed SMN|0|||
144745810|NCT02883049|521919068|FG010|Post Induction|Developed SMN|1|||
144745811|NCT02883049|521919069|FG011|Post Induction|Developed SMN|1|||
144745812|NCT02883049|521919070|FG012|Post Induction|Developed SMN|0|||
144745813|NCT02883049|521919071|FG013|Post Induction|Developed SMN|0|||
144745814|NCT02883049|521919072|FG014|Post Induction|Developed SMN|1|||
144745815|NCT02883049|521919073|FG015|Post Induction|Developed SMN|0|||
144745816|NCT02883049|521919058|FG000|Post Induction|Enrolled onto another COG study|0|||
144745817|NCT02883049|521919059|FG001|Post Induction|Enrolled onto another COG study|0|||
144745818|NCT02883049|521919060|FG002|Post Induction|Enrolled onto another COG study|0|||
144745819|NCT02883049|521919061|FG003|Post Induction|Enrolled onto another COG study|1|||
144745820|NCT02883049|521919062|FG004|Post Induction|Enrolled onto another COG study|1|||
144745821|NCT02883049|521919063|FG005|Post Induction|Enrolled onto another COG study|0|||
144745822|NCT02883049|521919064|FG006|Post Induction|Enrolled onto another COG study|0|||
144745823|NCT02883049|521919065|FG007|Post Induction|Enrolled onto another COG study|4|||
144745824|NCT02883049|521919066|FG008|Post Induction|Enrolled onto another COG study|0|||
144745825|NCT02883049|521919067|FG009|Post Induction|Enrolled onto another COG study|0|||
144745826|NCT02883049|521919068|FG010|Post Induction|Enrolled onto another COG study|0|||
144745827|NCT02883049|521919069|FG011|Post Induction|Enrolled onto another COG study|2|||
144745828|NCT02883049|521919070|FG012|Post Induction|Enrolled onto another COG study|0|||
144745829|NCT02883049|521919071|FG013|Post Induction|Enrolled onto another COG study|1|||
144745830|NCT02883049|521919072|FG014|Post Induction|Enrolled onto another COG study|0|||
144745831|NCT02883049|521919073|FG015|Post Induction|Enrolled onto another COG study|0|||
144745832|NCT02883049|521919058|FG000|Post Induction|Recurrent leukemia|0|||
144745833|NCT02883049|521919059|FG001|Post Induction|Recurrent leukemia|0|||
144745834|NCT02883049|521919060|FG002|Post Induction|Recurrent leukemia|0|||
144745835|NCT02883049|521919061|FG003|Post Induction|Recurrent leukemia|17|||
144745836|NCT02883049|521919062|FG004|Post Induction|Recurrent leukemia|12|||
144745837|NCT02883049|521919063|FG005|Post Induction|Recurrent leukemia|4|||
144745838|NCT02883049|521919064|FG006|Post Induction|Recurrent leukemia|1|||
144745839|NCT02883049|521919065|FG007|Post Induction|Recurrent leukemia|13|||
144745840|NCT02883049|521919066|FG008|Post Induction|Recurrent leukemia|27|||
144745841|NCT02883049|521919067|FG009|Post Induction|Recurrent leukemia|5|||
144745842|NCT02883049|521919068|FG010|Post Induction|Recurrent leukemia|3|||
144745843|NCT02883049|521919069|FG011|Post Induction|Recurrent leukemia|12|||
144745844|NCT02883049|521919070|FG012|Post Induction|Recurrent leukemia|1|||
144745845|NCT02883049|521919071|FG013|Post Induction|Recurrent leukemia|1|||
144745846|NCT02883049|521919072|FG014|Post Induction|Recurrent leukemia|9|||
144745847|NCT02883049|521919073|FG015|Post Induction|Recurrent leukemia|3|||
144745848|NCT02883049|521919058|FG000|Post Induction|Induction Failure|0|||
144745849|NCT02883049|521919059|FG001|Post Induction|Induction Failure|0|||
144745850|NCT02883049|521919060|FG002|Post Induction|Induction Failure|0|||
144745851|NCT02883049|521919061|FG003|Post Induction|Induction Failure|0|||
144745852|NCT02883049|521919062|FG004|Post Induction|Induction Failure|0|||
144745853|NCT02883049|521919063|FG005|Post Induction|Induction Failure|0|||
144745854|NCT02883049|521919064|FG006|Post Induction|Induction Failure|0|||
144745855|NCT02883049|521919065|FG007|Post Induction|Induction Failure|2|||
144745856|NCT02883049|521919066|FG008|Post Induction|Induction Failure|2|||
144745857|NCT02883049|521919067|FG009|Post Induction|Induction Failure|0|||
144745858|NCT02883049|521919068|FG010|Post Induction|Induction Failure|0|||
144745859|NCT02883049|521919069|FG011|Post Induction|Induction Failure|0|||
144745860|NCT02883049|521919070|FG012|Post Induction|Induction Failure|0|||
144745861|NCT02883049|521919071|FG013|Post Induction|Induction Failure|2|||
144745862|NCT02883049|521919072|FG014|Post Induction|Induction Failure|0|||
144745863|NCT02883049|521919073|FG015|Post Induction|Induction Failure|0|||
144745864|NCT01048853|521919074|FG000|Overall Study|Death|1|||
144745865|NCT01048853|521919075|FG001|Overall Study|Death|0|||
144745866|NCT01048853|521919076|FG002|Overall Study|Death|0|||
144745867|NCT01048853|521919074|FG000|Overall Study|Lost to Follow-up|1|||
144745868|NCT01048853|521919075|FG001|Overall Study|Lost to Follow-up|4|||
144745869|NCT01048853|521919076|FG002|Overall Study|Lost to Follow-up|0|||
144745870|NCT04158375|521919077|FG000|Overall Study|Withdrawal by Subject|0|||
144745871|NCT04158375|521919078|FG001|Overall Study|Withdrawal by Subject|3|||
144745872|NCT04158375|521919079|FG002|Overall Study|Withdrawal by Subject|0|||
144745873|NCT04847843|521919080|FG000|Overall Study|Scheduling Conflicts|6|||
144745874|NCT04847843|521919081|FG001|Overall Study|Scheduling Conflicts|9|||
144745875|NCT04847843|521919080|FG000|Overall Study|Withdrawal by Subject|1|||
144745876|NCT04847843|521919081|FG001|Overall Study|Withdrawal by Subject|0|||
144745877|NCT04847843|521919080|FG000|Overall Study|Lost to Follow-up|1|||
144745878|NCT04847843|521919081|FG001|Overall Study|Lost to Follow-up|1|||
144745879|NCT04847843|521919080|FG000|Overall Study|Pregnancy|0|||
144745880|NCT04847843|521919081|FG001|Overall Study|Pregnancy|2|||
144745881|NCT04847843|521919080|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
144745882|NCT04847843|521919081|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
144745883|NCT02734004|521919082|FG000|Overall Study|Death|36|||
144745884|NCT02734004|521919083|FG001|Overall Study|Death|24|||
144220807|NCT01074944|520003725|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
144220808|NCT01074944|520003726|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
144220809|NCT01074944|520003727|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
144220810|NCT01074944|520003728|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
144220811|NCT01074944|520003729|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
144220812|NCT01074944|520003725|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
144220813|NCT01074944|520003726|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
144220814|NCT01074944|520003727|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
144220815|NCT01074944|520003728|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
144220816|NCT01074944|520003729|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
144220817|NCT01074944|520003725|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
144220818|NCT01074944|520003726|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
144220819|NCT01074944|520003727|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
144220820|NCT01074944|520003728|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
144220821|NCT01074944|520003729|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
144220822|NCT01074944|520003725|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
144220823|NCT01074944|520003726|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
144220824|NCT01074944|520003727|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
144220825|NCT01074944|520003728|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
144220826|NCT01074944|520003729|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
144220827|NCT01074944|520003725|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
144220828|NCT01074944|520003726|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
144220829|NCT01074944|520003727|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
144220830|NCT01074944|520003728|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
144220831|NCT01074944|520003729|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
144220832|NCT01074944|520003725|FG000|Long Term Treatment|Adverse Event|0|||
144220833|NCT01074944|520003726|FG001|Long Term Treatment|Adverse Event|0|||
144220834|NCT01074944|520003727|FG002|Long Term Treatment|Adverse Event|0|||
144220835|NCT01074944|520003728|FG003|Long Term Treatment|Adverse Event|3|||
144220836|NCT01074944|520003729|FG004|Long Term Treatment|Adverse Event|0|||
144745885|NCT02734004|521919084|FG002|Overall Study|Death|26|||
144745886|NCT02734004|521919085|FG003|Overall Study|Death|35|||
144220837|NCT01074944|520003725|FG000|Long Term Treatment|Lost to Follow-up|0|||
144220838|NCT01074944|520003726|FG001|Long Term Treatment|Lost to Follow-up|0|||
144220839|NCT01074944|520003727|FG002|Long Term Treatment|Lost to Follow-up|0|||
144220840|NCT01074944|520003728|FG003|Long Term Treatment|Lost to Follow-up|2|||
144220841|NCT01074944|520003729|FG004|Long Term Treatment|Lost to Follow-up|0|||
144220842|NCT01074944|520003725|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
144220843|NCT01074944|520003726|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
144220844|NCT01074944|520003727|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
144220845|NCT01074944|520003728|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
144220846|NCT01074944|520003729|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
144220847|NCT01074944|520003725|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
144220848|NCT01074944|520003726|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
144220849|NCT01074944|520003727|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
144220850|NCT01074944|520003728|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
144220851|NCT01074944|520003729|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
144220852|NCT01074944|520003725|FG000|Long Term Treatment|Withdrawal by Subject|0|||
144220853|NCT01074944|520003726|FG001|Long Term Treatment|Withdrawal by Subject|0|||
144220854|NCT01074944|520003727|FG002|Long Term Treatment|Withdrawal by Subject|0|||
144220855|NCT01074944|520003728|FG003|Long Term Treatment|Withdrawal by Subject|2|||
144220856|NCT01074944|520003729|FG004|Long Term Treatment|Withdrawal by Subject|0|||
144220857|NCT01074944|520003725|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
144220858|NCT01074944|520003726|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
144220859|NCT01074944|520003727|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
144745887|NCT02734004|521919086|FG004|Overall Study|Death|13|||
144745888|NCT02734004|521919087|FG005|Overall Study|Death|17|||
144745889|NCT02734004|521919088|FG006|Overall Study|Death|20|||
144745890|NCT02734004|521919082|FG000|Overall Study|Lost to Follow-up|1|||
144745891|NCT02734004|521919083|FG001|Overall Study|Lost to Follow-up|1|||
144745892|NCT02734004|521919084|FG002|Overall Study|Lost to Follow-up|0|||
144745893|NCT02734004|521919085|FG003|Overall Study|Lost to Follow-up|0|||
144745894|NCT02734004|521919086|FG004|Overall Study|Lost to Follow-up|1|||
144220860|NCT01074944|520003728|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
144745895|NCT02734004|521919087|FG005|Overall Study|Lost to Follow-up|0|||
144745896|NCT02734004|521919088|FG006|Overall Study|Lost to Follow-up|0|||
144745897|NCT02734004|521919082|FG000|Overall Study|Withdrawal by Subject|3|||
144745898|NCT02734004|521919083|FG001|Overall Study|Withdrawal by Subject|1|||
144745899|NCT02734004|521919084|FG002|Overall Study|Withdrawal by Subject|1|||
144745900|NCT02734004|521919085|FG003|Overall Study|Withdrawal by Subject|1|||
144220861|NCT01074944|520003729|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
144220862|NCT01074944|520003725|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
144220863|NCT01074944|520003726|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
144220864|NCT01074944|520003727|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
144220865|NCT01074944|520003728|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
144220866|NCT01074944|520003729|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
144220867|NCT02348112|520003732|FG000|Overall Study|Withdrawal by Subject|32|||
144220868|NCT02348112|520003733|FG001|Overall Study|Withdrawal by Subject|29|||
144220869|NCT02348112|520003732|FG000|Overall Study|Lost to Follow-up|24|||
144220870|NCT02348112|520003733|FG001|Overall Study|Lost to Follow-up|20|||
144220871|NCT02348112|520003732|FG000|Overall Study|Physician Decision|17|||
144220872|NCT02348112|520003733|FG001|Overall Study|Physician Decision|15|||
144220873|NCT02348112|520003732|FG000|Overall Study|Site closed due to PI leaving|0|||
144220874|NCT02348112|520003733|FG001|Overall Study|Site closed due to PI leaving|30|||
144220875|NCT02348112|520003732|FG000|Overall Study|Sponsor withdrawal|0|||
144220876|NCT02348112|520003733|FG001|Overall Study|Sponsor withdrawal|7|||
144220877|NCT02348112|520003732|FG000|Overall Study|Death|0|||
144220878|NCT02348112|520003733|FG001|Overall Study|Death|1|||
144220879|NCT01408043|520003734|FG000|Overall Study|unable to collect cells|1|||
144220880|NCT03552380|520003737|FG000|Study Treatment|Disease Progression|3|||
144220881|NCT03552380|520003738|FG001|Study Treatment|Disease Progression|4|||
144220882|NCT03552380|520003737|FG000|Study Treatment|Adverse Event|2|||
144220883|NCT03552380|520003738|FG001|Study Treatment|Adverse Event|2|||
144220884|NCT03552380|520003737|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
144220885|NCT03552380|520003738|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
144220886|NCT03552380|520003737|FG000|Follow up|Death|3|||
144220887|NCT03552380|520003738|FG001|Follow up|Death|4|||
144220888|NCT03552380|520003737|FG000|Follow up|Site IRB terminated|0|||
144220889|NCT03552380|520003738|FG001|Follow up|Site IRB terminated|1|||
144220890|NCT02431364|520003739|FG000|Overall Study|Adverse Event|0|||
144220891|NCT02431364|520003740|FG001|Overall Study|Adverse Event|1|||
144220892|NCT02431364|520003741|FG002|Overall Study|Adverse Event|0|||
144220893|NCT02431364|520003742|FG003|Overall Study|Adverse Event|0|||
144220894|NCT02431364|520003743|FG004|Overall Study|Adverse Event|0|||
144220895|NCT02431364|520003739|FG000|Overall Study|Randomized but never treated|0|||
144220896|NCT02431364|520003740|FG001|Overall Study|Randomized but never treated|0|||
144220897|NCT02431364|520003741|FG002|Overall Study|Randomized but never treated|0|||
144220898|NCT02431364|520003742|FG003|Overall Study|Randomized but never treated|1|||
144220899|NCT02431364|520003743|FG004|Overall Study|Randomized but never treated|0|||
144220900|NCT00916383|520003744|FG000|Overall Study|Adverse Event|1|||
144220901|NCT00916383|520003744|FG000|Overall Study|Death|1|||
144220902|NCT00916383|520003744|FG000|Overall Study|Protocol Violation|1|||
144220903|NCT03093259|520003756|FG000|Overall Study|Adverse Event|1|||
144220904|NCT03093259|520003757|FG001|Overall Study|Adverse Event|0|||
144220905|NCT03093259|520003756|FG000|Overall Study|Withdrawal by Subject|1|||
144220906|NCT03093259|520003757|FG001|Overall Study|Withdrawal by Subject|0|||
144220907|NCT01757275|520003758|FG000|Overall Study|Lost to Follow-up|1|||
144745901|NCT02734004|521919086|FG004|Overall Study|Withdrawal by Subject|3|||
144745902|NCT02734004|521919087|FG005|Overall Study|Withdrawal by Subject|0|||
144745903|NCT02734004|521919088|FG006|Overall Study|Withdrawal by Subject|2|||
144745904|NCT02734004|521919082|FG000|Overall Study|Other|0|||
144745905|NCT02734004|521919083|FG001|Overall Study|Other|8|||
144745906|NCT02734004|521919084|FG002|Overall Study|Other|7|||
144745907|NCT02734004|521919085|FG003|Overall Study|Other|4|||
144745908|NCT02734004|521919086|FG004|Overall Study|Other|34|||
144745909|NCT02734004|521919087|FG005|Overall Study|Other|14|||
144745910|NCT02734004|521919088|FG006|Overall Study|Other|10|||
144220908|NCT01757275|520003759|FG001|Overall Study|Lost to Follow-up|2|||
144220909|NCT01757275|520003758|FG000|Overall Study|Adverse Event|3|||
144745911|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
144745912|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
144745913|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
144745914|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
144220910|NCT01757275|520003759|FG001|Overall Study|Adverse Event|3|||
144220911|NCT01757275|520003758|FG000|Overall Study|Withdrawal by Subject|2|||
144220912|NCT01757275|520003759|FG001|Overall Study|Withdrawal by Subject|4|||
144220913|NCT01757275|520003758|FG000|Overall Study|Not treated|3|||
144220914|NCT01757275|520003759|FG001|Overall Study|Not treated|4|||
144220915|NCT01821807|520003762|FG000|Overall Study|Lost to Follow-up|3|||
144220916|NCT01821807|520003763|FG001|Overall Study|Lost to Follow-up|1|||
144220917|NCT01401452|520003764|FG000|Overall Study|Adverse reaction|9|||
144220918|NCT01401452|520003764|FG000|Overall Study|Lost to Follow-up|12|||
144745915|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
144745916|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
144745917|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
144745918|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
144745919|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
144745920|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
144745921|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
144745922|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
144745923|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
144745924|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
144745925|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
144745926|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
144745927|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
144745928|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
144745929|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
144745930|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
144745931|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
144745932|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
144745933|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
144745934|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
144745935|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Other|6|||
144745936|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Other|0|||
144745937|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Other|0|||
144745938|NCT05615220|521919089|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
144745939|NCT05615220|521919090|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
144745940|NCT05615220|521919091|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
144745941|NCT05615220|521919089|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
144745942|NCT05615220|521919090|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
144745943|NCT05615220|521919091|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
144745944|NCT05615220|521919089|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
144745945|NCT05615220|521919090|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
144745946|NCT05615220|521919091|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
144745947|NCT05615220|521919089|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
144745948|NCT05615220|521919090|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
144745949|NCT05615220|521919091|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
144745950|NCT05615220|521919089|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
144745951|NCT05615220|521919090|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
144745952|NCT05615220|521919091|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
144745953|NCT05615220|521919089|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
144745954|NCT05615220|521919090|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
144745955|NCT05615220|521919091|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
144745956|NCT04999969|521919097|FG000|Overall Study|Death|76|||
144745957|NCT04999969|521919097|FG000|Overall Study|Progressive Disease|1|||
144745958|NCT04999969|521919097|FG000|Overall Study|Withdrawal by Subject|8|||
144745959|NCT01272037|521919101|FG000|Overall Study|Death|25|||
144745960|NCT01272037|521919102|FG001|Overall Study|Death|28|||
144745961|NCT01272037|521919101|FG000|Overall Study|Adverse Event|12|||
144745962|NCT01272037|521919102|FG001|Overall Study|Adverse Event|7|||
144745963|NCT01272037|521919101|FG000|Overall Study|Withdrawal by Subject|175|||
144745964|NCT01272037|521919102|FG001|Overall Study|Withdrawal by Subject|93|||
144745965|NCT01272037|521919101|FG000|Overall Study|Disease progression|70|||
144745966|NCT01272037|521919102|FG001|Overall Study|Disease progression|111|||
144745967|NCT01272037|521919101|FG000|Overall Study|Other reason|42|||
144745968|NCT01272037|521919102|FG001|Overall Study|Other reason|41|||
144745969|NCT01272037|521919101|FG000|Overall Study|Delinquent data|24|||
144745970|NCT01272037|521919102|FG001|Overall Study|Delinquent data|19|||
144745971|NCT01272037|521919101|FG000|Overall Study|Reason under review|33|||
144745972|NCT01272037|521919102|FG001|Overall Study|Reason under review|29|||
144745973|NCT01272037|521919101|FG000|Overall Study|On treatment|626|||
144745974|NCT01272037|521919102|FG001|Overall Study|On treatment|632|||
144745975|NCT04221438|521919103|FG000|Overall Study|Adverse Event|1|||
144745976|NCT04221438|521919103|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
144220919|NCT01401452|520003764|FG000|Overall Study|Lack of Efficacy|30|||
144220920|NCT01401452|520003764|FG000|Overall Study|Participant developed breast cancer|1|||
144745977|NCT03779334|521919107|FG000|Overall Study|Withdrawal by Subject|3|||
144745978|NCT03779334|521919108|FG001|Overall Study|Withdrawal by Subject|0|||
144745979|NCT03779334|521919109|FG002|Overall Study|Withdrawal by Subject|0|||
144745980|NCT03779334|521919107|FG000|Overall Study|Ongoing in Study|5|||
144745981|NCT03779334|521919108|FG001|Overall Study|Ongoing in Study|13|||
144745982|NCT03779334|521919109|FG002|Overall Study|Ongoing in Study|5|||
144220921|NCT01401452|520003764|FG000|Overall Study|Tx stopped due to financial reasons|1|||
144220922|NCT01401452|520003764|FG000|Overall Study|Tx stopped by psychiatrist|1|||
144220923|NCT01401452|520003764|FG000|Overall Study|No more visits within the 36 wk followup|4|||
144220924|NCT01401452|520003764|FG000|Overall Study|Subject did not come to follow up visits|2|||
144220925|NCT01401452|520003764|FG000|Overall Study|Subject didn't return for routine visits|1|||
144220926|NCT01401452|520003764|FG000|Overall Study|Subject moved to another city|1|||
144220927|NCT01401452|520003764|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
144220928|NCT01401452|520003764|FG000|Overall Study|Psoriatic arthritis|1|||
144220929|NCT01401452|520003764|FG000|Overall Study|Participant stopped Tx|2|||
144220930|NCT01401452|520003764|FG000|Overall Study|Discontinuation for personal reasons|1|||
144220931|NCT01401452|520003764|FG000|Overall Study|Treatment failure|1|||
144220932|NCT01401452|520003764|FG000|Overall Study|Unsatisfactory output|1|||
144220933|NCT01401452|520003764|FG000|Overall Study|Subject withdrew because of Tx success|1|||
144220934|NCT01401452|520003764|FG000|Overall Study|Subject chose to discontinue treatment|1|||
144220935|NCT01401452|520003764|FG000|Overall Study|Participant withdrew consent|1|||
144220936|NCT02404805|520003765|FG000|Overall Study|Withdrawal by Subject|1|||
144220937|NCT02404805|520003766|FG001|Overall Study|Withdrawal by Subject|0|||
144220938|NCT02404805|520003767|FG002|Overall Study|Withdrawal by Subject|0|||
144220939|NCT02404805|520003768|FG003|Overall Study|Withdrawal by Subject|0|||
144220940|NCT02404805|520003769|FG004|Overall Study|Withdrawal by Subject|0|||
144220941|NCT02404805|520003770|FG005|Overall Study|Withdrawal by Subject|0|||
144220942|NCT00967330|520003774|FG000|Overall Study|Protocol Violation|3|||
144220943|NCT00967330|520003775|FG001|Overall Study|Protocol Violation|4|||
144220944|NCT00967330|520003774|FG000|Overall Study|Regular|10|||
144220945|NCT00967330|520003775|FG001|Overall Study|Regular|3|||
144220946|NCT00967330|520003774|FG000|Overall Study|Withdrawal by Subject|6|||
144220947|NCT00967330|520003775|FG001|Overall Study|Withdrawal by Subject|0|||
144220948|NCT00967330|520003774|FG000|Overall Study|Lost to Follow-up|1|||
144220949|NCT00967330|520003775|FG001|Overall Study|Lost to Follow-up|1|||
144220950|NCT00967330|520003774|FG000|Overall Study|Death|102|||
144220951|NCT00967330|520003775|FG001|Overall Study|Death|51|||
144220952|NCT00967330|520003774|FG000|Overall Study|Severe protocol deviation|0|||
144220953|NCT00967330|520003775|FG001|Overall Study|Severe protocol deviation|1|||
144220954|NCT04720105|520003778|FG000|Overall Study|Lack of Efficacy|1|||
144220955|NCT04720105|520003778|FG000|Overall Study|Lost to Follow-up|1|||
144220956|NCT04720105|520003778|FG000|Overall Study|Withdrawal by Subject|3|||
144220957|NCT02698163|520003779|FG000|Overall Study|Lost to Follow-up|0|||
144220958|NCT02698163|520003780|FG001|Overall Study|Lost to Follow-up|1|||
144220959|NCT05373108|520003781|FG000|Overall Study|Withdrawal by Subject|2|||
144220960|NCT02892331|520003782|FG000|Overall Study|Withdrawal by Subject|0|||
144220961|NCT02892331|520003783|FG001|Overall Study|Withdrawal by Subject|1|||
144220962|NCT02892331|520003784|FG002|Overall Study|Withdrawal by Subject|1|||
144220963|NCT02892331|520003782|FG000|Overall Study|Sick family member|0|||
144220964|NCT02892331|520003783|FG001|Overall Study|Sick family member|0|||
144220965|NCT02892331|520003784|FG002|Overall Study|Sick family member|1|||
144220966|NCT02892331|520003782|FG000|Overall Study|Corona virus pandemic|1|||
144220967|NCT02892331|520003783|FG001|Overall Study|Corona virus pandemic|0|||
144220968|NCT02892331|520003784|FG002|Overall Study|Corona virus pandemic|1|||
144220969|NCT02892331|520003782|FG000|Overall Study|Lost to Follow-up|1|||
144220970|NCT02892331|520003783|FG001|Overall Study|Lost to Follow-up|0|||
144220971|NCT02892331|520003784|FG002|Overall Study|Lost to Follow-up|1|||
144220972|NCT02892331|520003782|FG000|Overall Study|Blood pressure was too elevated|0|||
144220973|NCT02892331|520003783|FG001|Overall Study|Blood pressure was too elevated|1|||
144220974|NCT02892331|520003784|FG002|Overall Study|Blood pressure was too elevated|0|||
144220975|NCT02892331|520003782|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
144220976|NCT02892331|520003783|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
144220977|NCT02892331|520003784|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
144220978|NCT01133067|520003785|FG000|Overall Study|Death|136|||
144220979|NCT01133067|520003785|FG000|Overall Study|Lost to Follow-up|3|||
144220980|NCT00349973|520003789|FG000|Overall Study|Adverse Event|3|||
144220981|NCT00349973|520003790|FG001|Overall Study|Adverse Event|3|||
144220982|NCT00349973|520003789|FG000|Overall Study|Withdrawal by Subject|1|||
144220983|NCT00349973|520003790|FG001|Overall Study|Withdrawal by Subject|0|||
144220984|NCT04135937|520003792|FG000|Overall Study|Lost to Follow-up|2|||
144220985|NCT04135937|520003792|FG000|Overall Study|Withdrawal by Subject|1|||
144220986|NCT02548143|520003793|FG000|Overall Study|Adverse Event|1|||
144220987|NCT02548143|520003794|FG001|Overall Study|Adverse Event|0|||
144220988|NCT02548143|520003793|FG000|Overall Study|Withdrawal by Subject|0|||
144220989|NCT02548143|520003794|FG001|Overall Study|Withdrawal by Subject|1|||
144220990|NCT06018129|520003796|FG000|Overall Study|Death|1|||
144220991|NCT06018129|520003797|FG001|Overall Study|Death|1|||
144220992|NCT06018129|520003798|FG002|Overall Study|Death|2|||
144220993|NCT06018129|520003796|FG000|Overall Study|Sponsor Decision|2|||
144220994|NCT06018129|520003797|FG001|Overall Study|Sponsor Decision|2|||
144220995|NCT06018129|520003798|FG002|Overall Study|Sponsor Decision|1|||
144220996|NCT00858273|520003799|FG000|Overall Study|Protocol Violation|3|||
144220997|NCT00858273|520003800|FG001|Overall Study|Protocol Violation|5|||
144266311|NCT01100853|520178304|FG000|Overall Study|Received <4 study injections|10|||
144693928|NCT01288911|521731224|FG000|Double-blind Period|Miscellaneous Reason|29|||
144693929|NCT01288911|521731225|FG001|Double-blind Period|Miscellaneous Reason|42|||
144693930|NCT01288911|521731224|FG000|Double-blind Period|Randomized but never received study drug|1|||
144693931|NCT01288911|521731225|FG001|Double-blind Period|Randomized but never received study drug|2|||
144693932|NCT01288911|521731224|FG000|Open-label Period (All Enzalutamide)|Death|0|||
144693933|NCT01288911|521731225|FG001|Open-label Period (All Enzalutamide)|Death|1|||
144266312|NCT01100853|520178305|FG001|Overall Study|Received <4 study injections|13|||
144266313|NCT01100853|520178304|FG000|Overall Study|Withdrawal by Subject|6|||
144266314|NCT01100853|520178305|FG001|Overall Study|Withdrawal by Subject|4|||
144266315|NCT01384877|520178306|FG000|Treatment 2|Lost to Follow-up|2|||
144266316|NCT01384877|520178307|FG001|Treatment 2|Lost to Follow-up|2|||
144266317|NCT04161391|520178310|FG000|Overall Study|Adverse Event|0|||
144266318|NCT04161391|520178311|FG001|Overall Study|Adverse Event|1|||
144266319|NCT04161391|520178312|FG002|Overall Study|Adverse Event|0|||
144266320|NCT04161391|520178313|FG003|Overall Study|Adverse Event|1|||
144266321|NCT04161391|520178314|FG004|Overall Study|Adverse Event|0|||
144266322|NCT04161391|520178315|FG005|Overall Study|Adverse Event|0|||
144266323|NCT04161391|520178316|FG006|Overall Study|Adverse Event|0|||
144266324|NCT04161391|520178317|FG007|Overall Study|Adverse Event|3|||
144266325|NCT04161391|520178318|FG008|Overall Study|Adverse Event|0|||
144266326|NCT04161391|520178310|FG000|Overall Study|Death|0|||
144266327|NCT04161391|520178311|FG001|Overall Study|Death|0|||
144266328|NCT04161391|520178312|FG002|Overall Study|Death|0|||
144266329|NCT04161391|520178313|FG003|Overall Study|Death|0|||
144266330|NCT04161391|520178314|FG004|Overall Study|Death|0|||
144266331|NCT04161391|520178315|FG005|Overall Study|Death|0|||
144266332|NCT04161391|520178316|FG006|Overall Study|Death|0|||
144266333|NCT04161391|520178317|FG007|Overall Study|Death|1|||
144266334|NCT04161391|520178318|FG008|Overall Study|Death|0|||
144266335|NCT04161391|520178310|FG000|Overall Study|Physician Decision|0|||
144266336|NCT04161391|520178311|FG001|Overall Study|Physician Decision|0|||
144266337|NCT04161391|520178312|FG002|Overall Study|Physician Decision|1|||
144266338|NCT04161391|520178313|FG003|Overall Study|Physician Decision|2|||
144266339|NCT04161391|520178314|FG004|Overall Study|Physician Decision|0|||
144266340|NCT04161391|520178315|FG005|Overall Study|Physician Decision|0|||
144266341|NCT04161391|520178316|FG006|Overall Study|Physician Decision|2|||
144266342|NCT04161391|520178317|FG007|Overall Study|Physician Decision|0|||
144266343|NCT04161391|520178318|FG008|Overall Study|Physician Decision|0|||
144266344|NCT04161391|520178310|FG000|Overall Study|Progressive Disease|4|||
144266345|NCT04161391|520178311|FG001|Overall Study|Progressive Disease|3|||
144266346|NCT04161391|520178312|FG002|Overall Study|Progressive Disease|3|||
144266347|NCT04161391|520178313|FG003|Overall Study|Progressive Disease|5|||
144266348|NCT04161391|520178314|FG004|Overall Study|Progressive Disease|3|||
144266349|NCT04161391|520178315|FG005|Overall Study|Progressive Disease|3|||
144266350|NCT04161391|520178316|FG006|Overall Study|Progressive Disease|5|||
144266351|NCT04161391|520178317|FG007|Overall Study|Progressive Disease|2|||
144266352|NCT04161391|520178318|FG008|Overall Study|Progressive Disease|2|||
144266353|NCT01162343|520178319|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
144266354|NCT01162343|520178319|FG000|Overall Study|Refused psychiatrist assessment|12|||
144266355|NCT00641056|520178320|FG000|Overall Study|Adverse Event|12|||
144266356|NCT00641056|520178321|FG001|Overall Study|Adverse Event|2|||
144266357|NCT00641056|520178320|FG000|Overall Study|Lost to Follow-up|2|||
144266358|NCT00641056|520178321|FG001|Overall Study|Lost to Follow-up|1|||
144266359|NCT00641056|520178320|FG000|Overall Study|Physician Decision|3|||
144266360|NCT00641056|520178321|FG001|Overall Study|Physician Decision|1|||
144266361|NCT00641056|520178320|FG000|Overall Study|Protocol Violation|2|||
144266362|NCT00641056|520178321|FG001|Overall Study|Protocol Violation|0|||
144266363|NCT00641056|520178320|FG000|Overall Study|Entry Criteria Not Met|3|||
144266364|NCT00641056|520178321|FG001|Overall Study|Entry Criteria Not Met|0|||
144266365|NCT00641056|520178320|FG000|Overall Study|Subject Decision|6|||
144266366|NCT00641056|520178321|FG001|Overall Study|Subject Decision|19|||
144266367|NCT00641056|520178320|FG000|Overall Study|Sponsor Decision|1|||
144266368|NCT00641056|520178321|FG001|Overall Study|Sponsor Decision|2|||
144266369|NCT00896493|520178324|FG000|Overall Study|Early disease relapse|3|||
144266370|NCT02026141|520178327|FG000|Overall Study|Protocol Violation|0|||
144266371|NCT02026141|520178328|FG001|Overall Study|Protocol Violation|1|||
144266372|NCT03102762|520178331|FG000|Overall Study|Lost to Follow-up|1|||
144266373|NCT03102762|520178332|FG001|Overall Study|Lost to Follow-up|0|||
144266374|NCT01232790|520178333|FG000|Randomization|Withdrawal by Subject|2|||
144266375|NCT01232790|520178334|FG001|Randomization|Withdrawal by Subject|0|||
144266376|NCT01232790|520178333|FG000|Randomization|Protocol Violation|0|||
144266377|NCT01232790|520178334|FG001|Randomization|Protocol Violation|1|||
144266378|NCT01232790|520178333|FG000|Randomization|Physician Decision|0|||
144266379|NCT01232790|520178334|FG001|Randomization|Physician Decision|1|||
144266380|NCT01232790|520178333|FG000|Initial Assessment|Withdrawal by Subject|0|||
144266381|NCT01232790|520178334|FG001|Initial Assessment|Withdrawal by Subject|1|||
144266382|NCT01232790|520178333|FG000|First Crossover|Withdrawal by Subject|1|||
144220998|NCT04075487|520005689|FG000|Overall Study|Withdrawal by Subject|1|||
144220999|NCT05016960|520005692|FG000|Overall Study|Withdrawal by Subject|1|||
144221000|NCT05016960|520005693|FG001|Overall Study|Withdrawal by Subject|9|||
144221001|NCT01168232|520005696|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
144221002|NCT01168232|520005696|FG000|Overall Study|Ineligible- Wrong cell type|6|||
144221003|NCT01168232|520005696|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
144221004|NCT01730053|520005697|FG000|Overall Study|Participant moved|0|||
144221005|NCT01730053|520005698|FG001|Overall Study|Participant moved|0|||
144221006|NCT01730053|520005699|FG002|Overall Study|Participant moved|1|||
144221007|NCT01730053|520005700|FG003|Overall Study|Participant moved|0|||
144221008|NCT01730053|520005701|FG004|Overall Study|Participant moved|0|||
144221009|NCT01730053|520005702|FG005|Overall Study|Participant moved|0|||
144221010|NCT01730053|520005697|FG000|Overall Study|Physician Decision|0|||
144221011|NCT01730053|520005698|FG001|Overall Study|Physician Decision|0|||
144221012|NCT01730053|520005699|FG002|Overall Study|Physician Decision|0|||
144221013|NCT01730053|520005700|FG003|Overall Study|Physician Decision|1|||
144221014|NCT01730053|520005701|FG004|Overall Study|Physician Decision|0|||
144221015|NCT01730053|520005702|FG005|Overall Study|Physician Decision|0|||
144221016|NCT01730053|520005697|FG000|Overall Study|Adverse Event|2|||
144745983|NCT00588770|521919116|FG000|Overall Study|Disease progression|85|||
144745984|NCT00588770|521919117|FG001|Overall Study|Disease progression|68|||
144745985|NCT00588770|521919116|FG000|Overall Study|Adverse Event|29|||
144221017|NCT01730053|520005698|FG001|Overall Study|Adverse Event|6|||
144221018|NCT01730053|520005699|FG002|Overall Study|Adverse Event|3|||
144221019|NCT01730053|520005700|FG003|Overall Study|Adverse Event|3|||
144221020|NCT01730053|520005701|FG004|Overall Study|Adverse Event|2|||
144693934|NCT01288911|521731224|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
144693935|NCT01288911|521731225|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
144693936|NCT01288911|521731224|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
144693937|NCT01288911|521731225|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
144693938|NCT01288911|521731224|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
144693939|NCT01288911|521731225|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
144693940|NCT01288911|521731224|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
144693941|NCT01288911|521731225|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
144693942|NCT01288911|521731224|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
144693943|NCT01288911|521731225|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
144693944|NCT00486720|521731226|FG000|Overall Study|Adverse Event|1|||
144693945|NCT00486720|521731227|FG001|Overall Study|Adverse Event|2|||
144693946|NCT00486720|521731226|FG000|Overall Study|Lack of Efficacy|4|||
144693947|NCT00486720|521731227|FG001|Overall Study|Lack of Efficacy|6|||
144693948|NCT00486720|521731226|FG000|Overall Study|Physician Decision|1|||
144693949|NCT00486720|521731227|FG001|Overall Study|Physician Decision|2|||
144693950|NCT00486720|521731226|FG000|Overall Study|Protocol Violation|1|||
144693951|NCT00486720|521731227|FG001|Overall Study|Protocol Violation|0|||
144693952|NCT00486720|521731226|FG000|Overall Study|Withdrawal by Subject|3|||
144693953|NCT00486720|521731227|FG001|Overall Study|Withdrawal by Subject|1|||
144693954|NCT00486720|521731226|FG000|Overall Study|Progressive Disease|0|||
144693955|NCT00486720|521731227|FG001|Overall Study|Progressive Disease|1|||
144693956|NCT01005875|521731228|FG000|Overall Study|Death|3|||
144693957|NCT00606931|521731231|FG000|Overall Study|Withdrawal by Subject|3|||
144693958|NCT05047601|521731233|FG000|Overall Study|Lost to Follow-up|9|||
144693959|NCT05047601|521731234|FG001|Overall Study|Lost to Follow-up|11|||
144693960|NCT05047601|521731235|FG002|Overall Study|Lost to Follow-up|7|||
144693961|NCT05047601|521731233|FG000|Overall Study|Withdrawal by Subject|25|||
144693962|NCT05047601|521731234|FG001|Overall Study|Withdrawal by Subject|36|||
144693963|NCT05047601|521731235|FG002|Overall Study|Withdrawal by Subject|23|||
144693964|NCT05047601|521731233|FG000|Overall Study|Other|10|||
144693965|NCT05047601|521731234|FG001|Overall Study|Other|6|||
144693966|NCT05047601|521731235|FG002|Overall Study|Other|5|||
144693967|NCT00286234|521731236|FG000|Overall Study|Protocol Violation|1|||
144693968|NCT00286234|521731237|FG001|Overall Study|Protocol Violation|2|||
144693969|NCT00286234|521731238|FG002|Overall Study|Protocol Violation|0|||
144693970|NCT00286234|521731239|FG003|Overall Study|Protocol Violation|1|||
144693971|NCT00286234|521731236|FG000|Overall Study|Physician Decision|1|||
144693972|NCT00286234|521731237|FG001|Overall Study|Physician Decision|0|||
144693973|NCT00286234|521731238|FG002|Overall Study|Physician Decision|0|||
144693974|NCT00286234|521731239|FG003|Overall Study|Physician Decision|1|||
144693975|NCT00286234|521731236|FG000|Overall Study|Adverse Event|0|||
144693976|NCT00286234|521731237|FG001|Overall Study|Adverse Event|0|||
144693977|NCT00286234|521731238|FG002|Overall Study|Adverse Event|0|||
144221021|NCT01730053|520005702|FG005|Overall Study|Adverse Event|2|||
144221022|NCT01730053|520005697|FG000|Overall Study|Poor compliance to protocol|1|||
144221023|NCT01730053|520005698|FG001|Overall Study|Poor compliance to protocol|2|||
144221024|NCT01730053|520005699|FG002|Overall Study|Poor compliance to protocol|2|||
144221025|NCT01730053|520005700|FG003|Overall Study|Poor compliance to protocol|0|||
144693978|NCT00286234|521731239|FG003|Overall Study|Adverse Event|1|||
144693979|NCT00286234|521731236|FG000|Overall Study|Adverse Event|0|||
144745986|NCT00588770|521919117|FG001|Overall Study|Adverse Event|58|||
144745987|NCT00588770|521919116|FG000|Overall Study|Death|13|||
144745988|NCT00588770|521919117|FG001|Overall Study|Death|22|||
144745989|NCT00588770|521919116|FG000|Overall Study|Withdrawal by Subject|15|||
144745990|NCT00588770|521919117|FG001|Overall Study|Withdrawal by Subject|25|||
144745991|NCT00588770|521919116|FG000|Overall Study|Alternative therapy|2|||
144745992|NCT00588770|521919117|FG001|Overall Study|Alternative therapy|4|||
144745993|NCT00588770|521919116|FG000|Overall Study|Other complicating disease|3|||
144745994|NCT00588770|521919117|FG001|Overall Study|Other complicating disease|2|||
144745995|NCT00588770|521919116|FG000|Overall Study|Not start protocol therapy|0|||
144745996|NCT00588770|521919117|FG001|Overall Study|Not start protocol therapy|9|||
144745997|NCT00588770|521919116|FG000|Overall Study|Lack of Efficacy|8|||
144745998|NCT00588770|521919117|FG001|Overall Study|Lack of Efficacy|10|||
144745999|NCT00588770|521919116|FG000|Overall Study|Physician discretion|2|||
144746000|NCT00588770|521919117|FG001|Overall Study|Physician discretion|0|||
144746001|NCT00588770|521919116|FG000|Overall Study|Patient non-compliance|2|||
144746002|NCT00588770|521919117|FG001|Overall Study|Patient non-compliance|2|||
144746003|NCT04585269|521919118|FG000|Intervention|Withdrawal by Subject|9|||
144746004|NCT04585269|521919119|FG001|Intervention|Withdrawal by Subject|0|||
144746005|NCT04585269|521919118|FG000|Intervention|Unable to schedule|15|||
144746006|NCT04585269|521919119|FG001|Intervention|Unable to schedule|0|||
144746007|NCT04585269|521919118|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
144746008|NCT04585269|521919119|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
144746009|NCT04585269|521919118|FG000|FU Time 2 (3 months)|Death|2|||
144746010|NCT04585269|521919119|FG001|FU Time 2 (3 months)|Death|2|||
144746011|NCT04585269|521919118|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
144746012|NCT04585269|521919119|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
144746013|NCT04585269|521919118|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
144746014|NCT04585269|521919119|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
144746015|NCT04585269|521919118|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
144746016|NCT04585269|521919119|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
144746017|NCT04585269|521919118|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
144746018|NCT04585269|521919119|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
144746019|NCT04585269|521919118|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
144746020|NCT04585269|521919119|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
144746021|NCT06964165|521919121|FG000|Overall Study|Death|4|||
144746022|NCT06964165|521919122|FG001|Overall Study|Death|4|||
144746023|NCT06964165|521919121|FG000|Overall Study|Physician Decision|1|||
144746024|NCT06964165|521919122|FG001|Overall Study|Physician Decision|1|||
144746025|NCT06964165|521919121|FG000|Overall Study|Withdrawal by Subject|0|||
144746026|NCT06964165|521919122|FG001|Overall Study|Withdrawal by Subject|2|||
144746027|NCT06964165|521919121|FG000|Overall Study|Study terminated by sponsor|12|||
144746028|NCT06964165|521919122|FG001|Overall Study|Study terminated by sponsor|10|||
144746029|NCT06964165|521919121|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
144746030|NCT06964165|521919122|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
144746031|NCT06964165|521919121|FG000|Overall Study|Participant removed due to non-compliance|0|||
144746032|NCT06964165|521919122|FG001|Overall Study|Participant removed due to non-compliance|1|||
144746033|NCT06245044|521919123|FG000|No MI help|Technical issues|18|||
144746034|NCT04271540|521919127|FG000|Overall Study|Lost to Follow-up|1|||
144746035|NCT04271540|521919127|FG000|Overall Study|Screen Fail|5|||
144746036|NCT03307785|521919128|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
144746037|NCT03307785|521919129|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746038|NCT03307785|521919130|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746039|NCT03307785|521919131|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746040|NCT03307785|521919132|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746041|NCT03307785|521919133|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746042|NCT03307785|521919134|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746043|NCT03307785|521919135|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746044|NCT03307785|521919136|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746045|NCT03307785|521919137|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746046|NCT03307785|521919138|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746047|NCT03307785|521919139|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746048|NCT03307785|521919140|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
144746049|NCT03307785|521919128|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
144746050|NCT03307785|521919129|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
144746051|NCT03307785|521919130|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746052|NCT03307785|521919131|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746053|NCT03307785|521919132|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746054|NCT03307785|521919133|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746055|NCT03307785|521919134|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746056|NCT03307785|521919135|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746057|NCT03307785|521919136|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746058|NCT03307785|521919137|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746059|NCT03307785|521919138|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746060|NCT03307785|521919139|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746061|NCT03307785|521919140|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
144746062|NCT03307785|521919128|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
144746063|NCT03307785|521919129|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
144746064|NCT03307785|521919130|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746065|NCT03307785|521919131|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746066|NCT03307785|521919132|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746067|NCT03307785|521919133|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746068|NCT03307785|521919134|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746069|NCT03307785|521919135|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746070|NCT03307785|521919136|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746071|NCT03307785|521919137|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746072|NCT03307785|521919138|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746073|NCT03307785|521919139|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746074|NCT03307785|521919140|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
144746075|NCT03307785|521919128|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
144746076|NCT03307785|521919129|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
144746077|NCT03307785|521919130|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746078|NCT03307785|521919131|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746079|NCT03307785|521919132|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746080|NCT03307785|521919133|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746081|NCT03307785|521919134|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746082|NCT03307785|521919135|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746083|NCT03307785|521919136|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746084|NCT03307785|521919137|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746085|NCT03307785|521919138|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746086|NCT03307785|521919139|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746087|NCT03307785|521919140|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
144746088|NCT03307785|521919128|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746089|NCT03307785|521919129|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746090|NCT03307785|521919130|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
144693980|NCT00286234|521731237|FG001|Overall Study|Adverse Event|0|||
144693981|NCT00286234|521731238|FG002|Overall Study|Adverse Event|0|||
144693982|NCT00286234|521731239|FG003|Overall Study|Adverse Event|1|||
144693983|NCT00283062|521731258|FG000|Overall Study|Did not receive any study medication|5|||
144693984|NCT00283062|521731259|FG001|Overall Study|Did not receive any study medication|4|||
144693985|NCT00283062|521731260|FG002|Overall Study|Did not receive any study medication|36|||
144693986|NCT00283062|521731261|FG003|Overall Study|Did not receive any study medication|45|||
144693987|NCT00283062|521731258|FG000|Overall Study|Adverse Event|2|||
144693988|NCT00283062|521731259|FG001|Overall Study|Adverse Event|0|||
144693989|NCT00283062|521731260|FG002|Overall Study|Adverse Event|1|||
144693990|NCT00283062|521731261|FG003|Overall Study|Adverse Event|0|||
144693991|NCT00283062|521731258|FG000|Overall Study|Lost to Follow-up|1|||
144693992|NCT00283062|521731259|FG001|Overall Study|Lost to Follow-up|0|||
144693993|NCT00283062|521731260|FG002|Overall Study|Lost to Follow-up|1|||
144693994|NCT00283062|521731261|FG003|Overall Study|Lost to Follow-up|0|||
144693995|NCT00283062|521731258|FG000|Overall Study|Progressive disease|0|||
144693996|NCT00283062|521731259|FG001|Overall Study|Progressive disease|0|||
144693997|NCT00283062|521731260|FG002|Overall Study|Progressive disease|1|||
144693998|NCT00283062|521731261|FG003|Overall Study|Progressive disease|0|||
144693999|NCT00283062|521731258|FG000|Overall Study|Participant did not wish to continue|3|||
144694000|NCT00283062|521731259|FG001|Overall Study|Participant did not wish to continue|2|||
144221026|NCT01730053|520005701|FG004|Overall Study|Poor compliance to protocol|0|||
144221027|NCT01730053|520005702|FG005|Overall Study|Poor compliance to protocol|2|||
144221028|NCT01730053|520005697|FG000|Overall Study|Other than specified|2|||
144221029|NCT01730053|520005698|FG001|Overall Study|Other than specified|6|||
144221030|NCT01730053|520005699|FG002|Overall Study|Other than specified|5|||
144221031|NCT01730053|520005700|FG003|Overall Study|Other than specified|4|||
144221032|NCT01730053|520005701|FG004|Overall Study|Other than specified|7|||
144221033|NCT01730053|520005702|FG005|Overall Study|Other than specified|9|||
144221034|NCT03657797|520005707|FG000|Overall Study|Lost to Follow-up|0|||
144221035|NCT03657797|520005708|FG001|Overall Study|Lost to Follow-up|1|||
144694001|NCT00283062|521731260|FG002|Overall Study|Participant did not wish to continue|1|||
144694002|NCT00283062|521731261|FG003|Overall Study|Participant did not wish to continue|0|||
144694003|NCT00283062|521731258|FG000|Overall Study|Undefined|0|||
144694004|NCT00283062|521731259|FG001|Overall Study|Undefined|1|||
144694005|NCT00283062|521731260|FG002|Overall Study|Undefined|1|||
144221036|NCT03657797|520005709|FG002|Overall Study|Lost to Follow-up|1|||
144746091|NCT03307785|521919131|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746092|NCT03307785|521919132|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746093|NCT03307785|521919133|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746094|NCT03307785|521919134|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746095|NCT03307785|521919135|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746096|NCT03307785|521919136|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746097|NCT03307785|521919137|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746098|NCT03307785|521919138|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746099|NCT03307785|521919139|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746100|NCT03307785|521919140|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
144746101|NCT03307785|521919128|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746102|NCT03307785|521919129|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746103|NCT03307785|521919130|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
144746104|NCT03307785|521919131|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746105|NCT03307785|521919132|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746106|NCT03307785|521919133|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746107|NCT03307785|521919134|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746108|NCT03307785|521919135|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746109|NCT03307785|521919136|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746110|NCT03307785|521919137|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746111|NCT03307785|521919138|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746112|NCT03307785|521919139|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746113|NCT03307785|521919140|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
144746114|NCT03307785|521919128|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746115|NCT03307785|521919129|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746116|NCT03307785|521919130|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
144746117|NCT03307785|521919131|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746118|NCT03307785|521919132|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746119|NCT03307785|521919133|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746120|NCT03307785|521919134|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746121|NCT03307785|521919135|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746122|NCT03307785|521919136|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746123|NCT03307785|521919137|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746124|NCT03307785|521919138|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144221037|NCT03657797|520005710|FG003|Overall Study|Lost to Follow-up|0|||
144221038|NCT03657797|520005707|FG000|Overall Study|Physician Decision|0|||
144221039|NCT03657797|520005708|FG001|Overall Study|Physician Decision|1|||
144221040|NCT03657797|520005709|FG002|Overall Study|Physician Decision|0|||
144221041|NCT03657797|520005710|FG003|Overall Study|Physician Decision|0|||
144221042|NCT03657797|520005707|FG000|Overall Study|Withdrawal by Subject|0|||
144221043|NCT03657797|520005708|FG001|Overall Study|Withdrawal by Subject|1|||
144221044|NCT03657797|520005709|FG002|Overall Study|Withdrawal by Subject|2|||
144221045|NCT03657797|520005710|FG003|Overall Study|Withdrawal by Subject|0|||
144221046|NCT03657797|520005707|FG000|Overall Study|Adverse Event|0|||
144221047|NCT03657797|520005708|FG001|Overall Study|Adverse Event|0|||
144221048|NCT03657797|520005709|FG002|Overall Study|Adverse Event|2|||
144221049|NCT03657797|520005710|FG003|Overall Study|Adverse Event|0|||
144221050|NCT02115269|520005711|FG000|Overall Study|Lost to Follow-up|43|||
144221051|NCT02115269|520005711|FG000|Overall Study|Did not complete patient diary|3|||
144221052|NCT02115269|520005711|FG000|Overall Study|Moved to another city|7|||
144221053|NCT02115269|520005711|FG000|Overall Study|Withdrawal by Subject|2|||
144221054|NCT02115269|520005711|FG000|Overall Study|Didn't take study drug|2|||
144221055|NCT01402570|520005714|FG000|Overall Study|Adverse Event|1|||
144746125|NCT03307785|521919139|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746126|NCT03307785|521919140|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
144746127|NCT03307785|521919128|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746128|NCT03307785|521919129|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746129|NCT03307785|521919130|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
144746130|NCT03307785|521919131|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746131|NCT03307785|521919132|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144221056|NCT02572570|520005715|FG000|Overall Study|Study Terminated|27|||
144221057|NCT01417156|520005716|FG000|Overall Study|Adverse Event|12|||
144221058|NCT01417156|520005716|FG000|Overall Study|Protocol Violation|2|||
144221059|NCT01103180|520005723|FG000|Overall Study|Withdrawal by Subject|8|||
144221060|NCT01103180|520005724|FG001|Overall Study|Withdrawal by Subject|13|||
144221061|NCT01103180|520005723|FG000|Overall Study|Lost to Follow-up|13|||
144221062|NCT01103180|520005724|FG001|Overall Study|Lost to Follow-up|7|||
144221063|NCT01103180|520005723|FG000|Overall Study|Physician Decision|1|||
144746132|NCT03307785|521919133|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746133|NCT03307785|521919134|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746134|NCT03307785|521919135|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746135|NCT03307785|521919136|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746136|NCT03307785|521919137|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746137|NCT03307785|521919138|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746138|NCT03307785|521919139|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746139|NCT03307785|521919140|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
144746140|NCT03307785|521919128|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746141|NCT03307785|521919129|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746142|NCT03307785|521919130|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
144746143|NCT03307785|521919131|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746144|NCT03307785|521919132|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746145|NCT03307785|521919133|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746146|NCT03307785|521919134|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746147|NCT03307785|521919135|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746148|NCT03307785|521919136|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746149|NCT03307785|521919137|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746150|NCT03307785|521919138|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746151|NCT03307785|521919139|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746152|NCT03307785|521919140|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
144746153|NCT03307785|521919128|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746154|NCT03307785|521919129|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746155|NCT03307785|521919130|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746156|NCT03307785|521919131|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
144746157|NCT03307785|521919132|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
144746158|NCT03307785|521919133|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746159|NCT03307785|521919134|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746160|NCT03307785|521919135|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746161|NCT03307785|521919136|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746162|NCT03307785|521919137|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746163|NCT03307785|521919138|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746164|NCT03307785|521919139|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746165|NCT03307785|521919140|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
144746166|NCT03307785|521919128|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746167|NCT03307785|521919129|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746168|NCT03307785|521919130|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746169|NCT03307785|521919131|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
144746170|NCT03307785|521919132|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
144746171|NCT03307785|521919133|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746172|NCT03307785|521919134|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746173|NCT03307785|521919135|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746174|NCT03307785|521919136|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746175|NCT03307785|521919137|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746176|NCT03307785|521919138|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746177|NCT03307785|521919139|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746178|NCT03307785|521919140|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
144746179|NCT03307785|521919128|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746180|NCT03307785|521919129|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746181|NCT03307785|521919130|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746182|NCT03307785|521919131|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
144746183|NCT03307785|521919132|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746184|NCT03307785|521919133|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746185|NCT03307785|521919134|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746186|NCT03307785|521919135|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746187|NCT03307785|521919136|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746188|NCT03307785|521919137|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746189|NCT03307785|521919138|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746190|NCT03307785|521919139|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746191|NCT03307785|521919140|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
144746192|NCT03307785|521919128|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746193|NCT03307785|521919129|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144221064|NCT01103180|520005724|FG001|Overall Study|Physician Decision|0|||
144746194|NCT03307785|521919130|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746195|NCT03307785|521919131|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746196|NCT03307785|521919132|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
144746197|NCT03307785|521919133|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746198|NCT03307785|521919134|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746199|NCT03307785|521919135|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746200|NCT03307785|521919136|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746201|NCT03307785|521919137|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746202|NCT03307785|521919138|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746203|NCT03307785|521919139|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746204|NCT03307785|521919140|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
144746205|NCT03307785|521919128|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144694006|NCT00283062|521731261|FG003|Overall Study|Undefined|4|||
144694007|NCT00283062|521731258|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
144694008|NCT00283062|521731259|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
144694009|NCT00283062|521731260|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
144694010|NCT00283062|521731261|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
144694011|NCT00252499|521731262|FG000|Overall Study|Lost to Follow-up|1|||
144694012|NCT00252499|521731263|FG001|Overall Study|Lost to Follow-up|0|||
144694013|NCT00252499|521731264|FG002|Overall Study|Lost to Follow-up|0|||
144694014|NCT03137173|521731265|FG000|Overall Study|Withdrawal by Subject|8|||
144694015|NCT03137173|521731266|FG001|Overall Study|Withdrawal by Subject|13|||
144694016|NCT03137173|521731265|FG000|Overall Study|Death|1|||
144694017|NCT03137173|521731266|FG001|Overall Study|Death|3|||
144694018|NCT03137173|521731265|FG000|Overall Study|Physician Decision|1|||
144694019|NCT03137173|521731266|FG001|Overall Study|Physician Decision|0|||
144694020|NCT03137173|521731265|FG000|Overall Study|Lost to Follow-up|13|||
144694021|NCT03137173|521731266|FG001|Overall Study|Lost to Follow-up|18|||
144694022|NCT03137173|521731265|FG000|Overall Study|Other reasons|3|||
144694023|NCT03137173|521731266|FG001|Overall Study|Other reasons|2|||
144694024|NCT01535638|521731267|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
144694025|NCT01535638|521731268|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
144694026|NCT01535638|521731269|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
144694027|NCT01535638|521731270|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
144694028|NCT01535638|521731271|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
144694029|NCT01535638|521731272|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
144694030|NCT01535638|521731267|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
144694031|NCT01535638|521731268|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
144694032|NCT01535638|521731269|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
144694033|NCT01535638|521731270|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
144694034|NCT01535638|521731271|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
144694035|NCT01535638|521731272|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
144694036|NCT01365468|521731273|FG000|Overall Study|Physician Decision|1|||
144694037|NCT01365468|521731274|FG001|Overall Study|Physician Decision|0|||
144694038|NCT01365468|521731273|FG000|Overall Study|Disease progression|1|||
144694039|NCT01365468|521731274|FG001|Overall Study|Disease progression|0|||
144694040|NCT01365468|521731273|FG000|Overall Study|Lost to Follow-up|2|||
144694041|NCT01365468|521731274|FG001|Overall Study|Lost to Follow-up|0|||
144694042|NCT01482598|521731275|FG000|Overall Study|Death|7|||
144694043|NCT01482598|521731276|FG001|Overall Study|Death|10|||
144694044|NCT01482598|521731275|FG000|Overall Study|Physician Decision|0|||
144694045|NCT01482598|521731276|FG001|Overall Study|Physician Decision|3|||
144694046|NCT01482598|521731275|FG000|Overall Study|Withdrawal by Subject|4|||
144694047|NCT01482598|521731276|FG001|Overall Study|Withdrawal by Subject|5|||
144694048|NCT01482598|521731275|FG000|Overall Study|Lost to Follow-up|5|||
144694049|NCT01482598|521731276|FG001|Overall Study|Lost to Follow-up|4|||
144694050|NCT00423267|521731277|FG000|Period A|Withdrawal by Subject|0|||
144694051|NCT00423267|521731278|FG001|Period A|Withdrawal by Subject|1|||
144694052|NCT00423267|521731277|FG000|Period A|Non-compliance with protocol|1|||
144694053|NCT00423267|521731278|FG001|Period A|Non-compliance with protocol|0|||
144694054|NCT00423267|521731277|FG000|Period A|Administrative|1|||
144694055|NCT00423267|521731278|FG001|Period A|Administrative|0|||
144694056|NCT00827112|521731279|FG000|Overall Study|Adverse Event|2|||
144694057|NCT00827112|521731280|FG001|Overall Study|Adverse Event|0|||
144694058|NCT00827112|521731279|FG000|Overall Study|Lack of Efficacy|2|||
144694059|NCT00827112|521731280|FG001|Overall Study|Lack of Efficacy|0|||
144694060|NCT00827112|521731279|FG000|Overall Study|Lost to Follow-up|3|||
144694061|NCT00827112|521731280|FG001|Overall Study|Lost to Follow-up|2|||
144694062|NCT00827112|521731279|FG000|Overall Study|Pregnancy|0|||
144221065|NCT01103180|520005723|FG000|Overall Study|Protocol Violation|0|||
144694063|NCT00827112|521731280|FG001|Overall Study|Pregnancy|1|||
144694064|NCT00827112|521731279|FG000|Overall Study|Protocol Violation|0|||
144221066|NCT01103180|520005724|FG001|Overall Study|Protocol Violation|1|||
144694065|NCT00827112|521731280|FG001|Overall Study|Protocol Violation|2|||
144746206|NCT03307785|521919129|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746207|NCT03307785|521919130|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746208|NCT03307785|521919131|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746209|NCT03307785|521919132|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746210|NCT03307785|521919133|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
144746211|NCT03307785|521919134|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746212|NCT03307785|521919135|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746213|NCT03307785|521919136|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746214|NCT03307785|521919137|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746215|NCT03307785|521919138|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746216|NCT03307785|521919139|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746217|NCT03307785|521919140|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
144746218|NCT03307785|521919128|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746219|NCT03307785|521919129|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746220|NCT03307785|521919130|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746221|NCT03307785|521919131|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746222|NCT03307785|521919132|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746223|NCT03307785|521919133|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
144746224|NCT03307785|521919134|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746225|NCT03307785|521919135|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746226|NCT03307785|521919136|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746227|NCT03307785|521919137|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746228|NCT03307785|521919138|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746229|NCT03307785|521919139|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746230|NCT03307785|521919140|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
144746231|NCT03307785|521919128|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746232|NCT03307785|521919129|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746233|NCT03307785|521919130|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746234|NCT03307785|521919131|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746235|NCT03307785|521919132|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746236|NCT03307785|521919133|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
144746237|NCT03307785|521919134|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746238|NCT03307785|521919135|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746239|NCT03307785|521919136|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746240|NCT03307785|521919137|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746241|NCT03307785|521919138|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746242|NCT03307785|521919139|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746243|NCT03307785|521919140|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
144746244|NCT03307785|521919128|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746245|NCT03307785|521919129|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746246|NCT03307785|521919130|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746247|NCT03307785|521919131|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746248|NCT03307785|521919132|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746249|NCT03307785|521919133|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
144746250|NCT03307785|521919134|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746251|NCT03307785|521919135|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746252|NCT03307785|521919136|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746253|NCT03307785|521919137|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746254|NCT03307785|521919138|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746255|NCT03307785|521919139|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746256|NCT03307785|521919140|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
144746257|NCT03307785|521919128|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746258|NCT03307785|521919129|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746259|NCT03307785|521919130|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746260|NCT03307785|521919131|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746261|NCT03307785|521919132|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746262|NCT03307785|521919133|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
144746263|NCT03307785|521919134|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144221067|NCT01173523|520005725|FG000|Overall Study|Clinical Progression|1|||
144221068|NCT01173523|520005726|FG001|Overall Study|Clinical Progression|1|||
144221069|NCT01173523|520005725|FG000|Overall Study|Progressive Disease|10|||
144746264|NCT03307785|521919135|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746265|NCT03307785|521919136|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746266|NCT03307785|521919137|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144221070|NCT01173523|520005726|FG001|Overall Study|Progressive Disease|8|||
144221071|NCT01173523|520005725|FG000|Overall Study|Other|2|||
144221072|NCT01173523|520005726|FG001|Overall Study|Other|3|||
144221073|NCT02302833|520005731|FG000|Overall Study|Lost to Follow-up|3|||
144221074|NCT05017246|520005732|FG000|Overall Study|Withdrawal by Subject|5|||
144221075|NCT05017246|520005733|FG001|Overall Study|Withdrawal by Subject|3|||
144221076|NCT05017246|520005732|FG000|Overall Study|Determined to be ineligible|0|||
144221077|NCT05017246|520005733|FG001|Overall Study|Determined to be ineligible|1|||
144221078|NCT05017246|520005732|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
144221079|NCT05017246|520005733|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
144221080|NCT05017246|520005732|FG000|Overall Study|Technical failure|1|||
144221081|NCT05017246|520005733|FG001|Overall Study|Technical failure|3|||
144221082|NCT01866826|520005734|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
144221083|NCT01866826|520005735|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
144221084|NCT01866826|520005734|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
144221085|NCT01866826|520005735|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
144221086|NCT01866826|520005734|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
144221087|NCT01866826|520005735|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
144266383|NCT01232790|520178334|FG001|First Crossover|Withdrawal by Subject|0|||
144266384|NCT01232790|520178333|FG000|Second Crossover|Withdrawal by Subject|1|||
144694066|NCT00827112|521731279|FG000|Overall Study|Withdrawal by Subject|2|||
144694067|NCT00827112|521731280|FG001|Overall Study|Withdrawal by Subject|1|||
144694068|NCT00827112|521731279|FG000|Overall Study|Randomized but not treated|5|||
144694069|NCT00827112|521731280|FG001|Overall Study|Randomized but not treated|3|||
144694070|NCT00827112|521731279|FG000|Overall Study|Other|1|||
144694071|NCT00827112|521731280|FG001|Overall Study|Other|3|||
144694072|NCT00689728|521731283|FG000|Double-Blind Treatment|Adverse Event|1|||
144694073|NCT00689728|521731284|FG001|Double-Blind Treatment|Adverse Event|0|||
144694074|NCT00689728|521731285|FG002|Double-Blind Treatment|Adverse Event|0|||
144694075|NCT00689728|521731283|FG000|Double-Blind Treatment|Protocol Violation|0|||
144694076|NCT00689728|521731284|FG001|Double-Blind Treatment|Protocol Violation|0|||
144694077|NCT00689728|521731285|FG002|Double-Blind Treatment|Protocol Violation|1|||
144694078|NCT00689728|521731283|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
144694079|NCT00689728|521731284|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
144694080|NCT00689728|521731285|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
144694081|NCT00689728|521731283|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
144694082|NCT00689728|521731284|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
144694083|NCT00689728|521731285|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
144694084|NCT00689728|521731283|FG000|Rescue|Adverse Event|0|||
144694085|NCT00689728|521731284|FG001|Rescue|Adverse Event|1|||
144694086|NCT00689728|521731285|FG002|Rescue|Adverse Event|0|||
144694087|NCT00689728|521731283|FG000|Rescue|Withdrawal by Subject|1|||
144694088|NCT00689728|521731284|FG001|Rescue|Withdrawal by Subject|1|||
144694089|NCT00689728|521731285|FG002|Rescue|Withdrawal by Subject|1|||
144694090|NCT00689728|521731283|FG000|Optional Follow-Up|Adverse Event|1|||
144694091|NCT00689728|521731284|FG001|Optional Follow-Up|Adverse Event|0|||
144694092|NCT00689728|521731285|FG002|Optional Follow-Up|Adverse Event|0|||
144694093|NCT00689728|521731283|FG000|Optional Follow-Up|Lack of Efficacy|0|||
144694094|NCT00689728|521731284|FG001|Optional Follow-Up|Lack of Efficacy|1|||
144694095|NCT00689728|521731285|FG002|Optional Follow-Up|Lack of Efficacy|1|||
144694096|NCT00689728|521731283|FG000|Optional Follow-Up|Lost to Follow-up|0|||
144694097|NCT00689728|521731284|FG001|Optional Follow-Up|Lost to Follow-up|1|||
144694098|NCT00689728|521731285|FG002|Optional Follow-Up|Lost to Follow-up|1|||
144694099|NCT00689728|521731283|FG000|Optional Follow-Up|Protocol Violation|0|||
144694100|NCT00689728|521731284|FG001|Optional Follow-Up|Protocol Violation|0|||
144694101|NCT00689728|521731285|FG002|Optional Follow-Up|Protocol Violation|1|||
144694102|NCT00689728|521731283|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
144694103|NCT00689728|521731284|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
144694104|NCT00689728|521731285|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
144694105|NCT01277757|521733028|FG000|Overall Study|Disease Progression|1|||
144694106|NCT01277757|521733028|FG000|Overall Study|Withdrawal by Subject|1|||
144694107|NCT03808298|521733029|FG000|Overall Study|Adverse Event|3|||
144694108|NCT03808298|521733029|FG000|Overall Study|Physician Decision|1|||
144694109|NCT03808298|521733029|FG000|Overall Study|Withdrawal by Subject|1|||
144694110|NCT03808298|521733029|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
144694111|NCT01004822|521733030|FG000|Overall Study|Objective progression or relapse|3|||
144694112|NCT01004822|521733031|FG001|Overall Study|Objective progression or relapse|3|||
144694113|NCT01004822|521733032|FG002|Overall Study|Objective progression or relapse|0|||
144694114|NCT01004822|521733033|FG003|Overall Study|Objective progression or relapse|1|||
144694115|NCT01004822|521733034|FG004|Overall Study|Objective progression or relapse|2|||
144694116|NCT01004822|521733035|FG005|Overall Study|Objective progression or relapse|2|||
144746267|NCT03307785|521919138|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746268|NCT03307785|521919139|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746269|NCT03307785|521919140|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
144746270|NCT03307785|521919128|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746271|NCT03307785|521919129|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746272|NCT03307785|521919130|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746273|NCT03307785|521919131|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746274|NCT03307785|521919132|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746275|NCT03307785|521919133|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746276|NCT03307785|521919134|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
144746277|NCT03307785|521919135|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746278|NCT03307785|521919136|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746279|NCT03307785|521919137|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746280|NCT03307785|521919138|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746281|NCT03307785|521919139|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746282|NCT03307785|521919140|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
144746283|NCT03307785|521919128|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746284|NCT03307785|521919129|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746285|NCT03307785|521919130|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746286|NCT03307785|521919131|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746287|NCT03307785|521919132|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746288|NCT03307785|521919133|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746289|NCT03307785|521919134|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
144746290|NCT03307785|521919135|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746291|NCT03307785|521919136|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746292|NCT03307785|521919137|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746293|NCT03307785|521919138|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746294|NCT03307785|521919139|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746295|NCT03307785|521919140|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
144746296|NCT03307785|521919128|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746297|NCT03307785|521919129|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746298|NCT03307785|521919130|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746299|NCT03307785|521919131|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746300|NCT03307785|521919132|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746301|NCT03307785|521919133|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746302|NCT03307785|521919134|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746303|NCT03307785|521919135|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
144746304|NCT03307785|521919136|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746305|NCT03307785|521919137|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746306|NCT03307785|521919138|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746307|NCT03307785|521919139|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746308|NCT03307785|521919140|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
144746309|NCT03307785|521919128|FG000|PACT Phase: Up to 19 Months|Death|0|||
144746310|NCT03307785|521919129|FG001|PACT Phase: Up to 19 Months|Death|0|||
144746311|NCT03307785|521919130|FG002|PACT Phase: Up to 19 Months|Death|0|||
144746312|NCT03307785|521919131|FG003|PACT Phase: Up to 19 Months|Death|0|||
144746313|NCT03307785|521919132|FG004|PACT Phase: Up to 19 Months|Death|0|||
144746314|NCT03307785|521919133|FG005|PACT Phase: Up to 19 Months|Death|0|||
144746315|NCT03307785|521919134|FG006|PACT Phase: Up to 19 Months|Death|0|||
144746316|NCT03307785|521919135|FG007|PACT Phase: Up to 19 Months|Death|0|||
144746317|NCT03307785|521919136|FG008|PACT Phase: Up to 19 Months|Death|0|||
144746318|NCT03307785|521919137|FG009|PACT Phase: Up to 19 Months|Death|0|||
144746319|NCT03307785|521919138|FG010|PACT Phase: Up to 19 Months|Death|0|||
144746320|NCT03307785|521919139|FG011|PACT Phase: Up to 19 Months|Death|0|||
144746321|NCT03307785|521919140|FG012|PACT Phase: Up to 19 Months|Death|1|||
144746322|NCT04735393|521919141|FG000|Overall Study|Lost to Follow-up|46|||
144746323|NCT04735393|521919142|FG001|Overall Study|Lost to Follow-up|24|||
144746324|NCT04735393|521919141|FG000|Overall Study|Physician Decision|2|||
144746325|NCT04735393|521919142|FG001|Overall Study|Physician Decision|1|||
144221088|NCT00742209|520005737|FG000|Overall Study|Adverse Event|11|||
144746326|NCT04735393|521919141|FG000|Overall Study|Not Detailed|1|||
144746327|NCT04735393|521919142|FG001|Overall Study|Not Detailed|2|||
144746328|NCT04735393|521919141|FG000|Overall Study|Withdrawal by Subject|71|||
144746329|NCT04735393|521919142|FG001|Overall Study|Withdrawal by Subject|28|||
144746330|NCT04735393|521919141|FG000|Overall Study|Adverse Event|56|||
144746331|NCT04735393|521919142|FG001|Overall Study|Adverse Event|7|||
144746332|NCT04735393|521919141|FG000|Overall Study|Protocol Violation|6|||
144746333|NCT04735393|521919142|FG001|Overall Study|Protocol Violation|1|||
144221089|NCT00742209|520005738|FG001|Overall Study|Adverse Event|4|||
144221090|NCT00742209|520005739|FG002|Overall Study|Adverse Event|17|||
144221091|NCT00742209|520005740|FG003|Overall Study|Adverse Event|16|||
144746334|NCT04735393|521919141|FG000|Overall Study|Trial terminated by Sponsor|49|||
144746335|NCT04735393|521919142|FG001|Overall Study|Trial terminated by Sponsor|29|||
144746336|NCT00843882|521919143|FG000|Step 1|Lack of Efficacy|14|||
144746337|NCT00843882|521919144|FG001|Step 1|Lack of Efficacy|10|||
144746338|NCT00843882|521919145|FG002|Step 1|Lack of Efficacy|21|||
144746339|NCT00843882|521919143|FG000|Step 1|Adverse Event|8|||
144746340|NCT00843882|521919144|FG001|Step 1|Adverse Event|17|||
144746341|NCT00843882|521919145|FG002|Step 1|Adverse Event|20|||
144746342|NCT00843882|521919143|FG000|Step 1|Death|1|||
144746343|NCT00843882|521919144|FG001|Step 1|Death|2|||
144746344|NCT00843882|521919145|FG002|Step 1|Death|4|||
144746345|NCT00843882|521919143|FG000|Step 1|Withdrawal by Subject|6|||
144746346|NCT00843882|521919144|FG001|Step 1|Withdrawal by Subject|12|||
144746347|NCT00843882|521919145|FG002|Step 1|Withdrawal by Subject|9|||
144746348|NCT00843882|521919143|FG000|Step 1|Physician Decision|0|||
144746349|NCT00843882|521919144|FG001|Step 1|Physician Decision|5|||
144746350|NCT00843882|521919145|FG002|Step 1|Physician Decision|1|||
144746351|NCT00843882|521919143|FG000|Step 1|Patient and physician's decision|0|||
144746352|NCT00843882|521919144|FG001|Step 1|Patient and physician's decision|0|||
144746353|NCT00843882|521919145|FG002|Step 1|Patient and physician's decision|1|||
144746354|NCT00843882|521919143|FG000|Step 1|Other complicating disease|1|||
144746355|NCT00843882|521919144|FG001|Step 1|Other complicating disease|3|||
144746356|NCT00843882|521919145|FG002|Step 1|Other complicating disease|4|||
144746357|NCT00843882|521919143|FG000|Step 1|Alternative therapy|0|||
144746358|NCT00843882|521919144|FG001|Step 1|Alternative therapy|1|||
144746359|NCT00843882|521919145|FG002|Step 1|Alternative therapy|1|||
144746360|NCT00843882|521919143|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
144746361|NCT00843882|521919144|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
144746362|NCT00843882|521919145|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
144746363|NCT00843882|521919143|FG000|Step 1|Off treatment reason unknown|0|||
144746364|NCT00843882|521919144|FG001|Step 1|Off treatment reason unknown|1|||
144746365|NCT00843882|521919145|FG002|Step 1|Off treatment reason unknown|4|||
144746366|NCT00843882|521919143|FG000|Step 1|Never started treatment|2|||
144746367|NCT00843882|521919144|FG001|Step 1|Never started treatment|0|||
144746368|NCT00843882|521919145|FG002|Step 1|Never started treatment|0|||
144746369|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
144746370|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
144746371|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
144746372|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
144746373|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
144746374|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
144746375|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
144746376|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
144746377|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
144746378|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
144746379|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
144746380|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
144746381|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
144746382|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
144746383|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
144746384|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
144746385|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
144746386|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
144746387|NCT00843882|521919143|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
144746388|NCT00843882|521919144|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
144746389|NCT00843882|521919145|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
144746390|NCT03224104|521920305|FG000|Overall Study|Lack of Efficacy|2|||
144746391|NCT03224104|521920306|FG001|Overall Study|Lack of Efficacy|6|||
144746392|NCT03224104|521920307|FG002|Overall Study|Lack of Efficacy|3|||
144746393|NCT03224104|521920308|FG003|Overall Study|Lack of Efficacy|4|||
144746394|NCT03224104|521920309|FG004|Overall Study|Lack of Efficacy|42|||
144746395|NCT03224104|521920305|FG000|Overall Study|Withdrawal by Subject|0|||
144746396|NCT03224104|521920306|FG001|Overall Study|Withdrawal by Subject|2|||
144746397|NCT03224104|521920307|FG002|Overall Study|Withdrawal by Subject|0|||
144746398|NCT03224104|521920308|FG003|Overall Study|Withdrawal by Subject|1|||
144746399|NCT03224104|521920309|FG004|Overall Study|Withdrawal by Subject|3|||
144746400|NCT03224104|521920305|FG000|Overall Study|Death|0|||
144746401|NCT03224104|521920306|FG001|Overall Study|Death|1|||
144746402|NCT03224104|521920307|FG002|Overall Study|Death|0|||
144746403|NCT03224104|521920308|FG003|Overall Study|Death|0|||
144746404|NCT03224104|521920309|FG004|Overall Study|Death|0|||
144746405|NCT03224104|521920305|FG000|Overall Study|Adverse Event|1|||
144746406|NCT03224104|521920306|FG001|Overall Study|Adverse Event|0|||
144746407|NCT03224104|521920307|FG002|Overall Study|Adverse Event|0|||
144746408|NCT03224104|521920308|FG003|Overall Study|Adverse Event|1|||
144746409|NCT03224104|521920309|FG004|Overall Study|Adverse Event|3|||
144221092|NCT00742209|520005741|FG004|Overall Study|Adverse Event|13|||
144694117|NCT01004822|521733036|FG006|Overall Study|Objective progression or relapse|1|||
144694118|NCT01004822|521733037|FG007|Overall Study|Objective progression or relapse|4|||
144694119|NCT01004822|521733030|FG000|Overall Study|Global deterioration of health status|0|||
144694120|NCT01004822|521733031|FG001|Overall Study|Global deterioration of health status|0|||
144694121|NCT01004822|521733032|FG002|Overall Study|Global deterioration of health status|0|||
144694122|NCT01004822|521733033|FG003|Overall Study|Global deterioration of health status|1|||
144694123|NCT01004822|521733034|FG004|Overall Study|Global deterioration of health status|0|||
144694124|NCT01004822|521733035|FG005|Overall Study|Global deterioration of health status|0|||
144694125|NCT01004822|521733036|FG006|Overall Study|Global deterioration of health status|1|||
144694126|NCT01004822|521733037|FG007|Overall Study|Global deterioration of health status|0|||
144694127|NCT01004822|521733030|FG000|Overall Study|No longer willing to continue|0|||
144694128|NCT01004822|521733031|FG001|Overall Study|No longer willing to continue|0|||
144694129|NCT01004822|521733032|FG002|Overall Study|No longer willing to continue|0|||
144694130|NCT01004822|521733033|FG003|Overall Study|No longer willing to continue|1|||
144694131|NCT01004822|521733034|FG004|Overall Study|No longer willing to continue|2|||
144694132|NCT01004822|521733035|FG005|Overall Study|No longer willing to continue|1|||
144694133|NCT01004822|521733036|FG006|Overall Study|No longer willing to continue|1|||
144694134|NCT01004822|521733037|FG007|Overall Study|No longer willing to continue|0|||
144694135|NCT01004822|521733030|FG000|Overall Study|Adverse Event|0|||
144694136|NCT01004822|521733031|FG001|Overall Study|Adverse Event|0|||
144694137|NCT01004822|521733032|FG002|Overall Study|Adverse Event|0|||
144694138|NCT01004822|521733033|FG003|Overall Study|Adverse Event|0|||
144694139|NCT01004822|521733034|FG004|Overall Study|Adverse Event|0|||
144694140|NCT01004822|521733035|FG005|Overall Study|Adverse Event|0|||
144694141|NCT01004822|521733036|FG006|Overall Study|Adverse Event|1|||
144694142|NCT01004822|521733037|FG007|Overall Study|Adverse Event|1|||
144694143|NCT01004822|521733030|FG000|Overall Study|Other|0|||
144694144|NCT01004822|521733031|FG001|Overall Study|Other|0|||
144694145|NCT01004822|521733032|FG002|Overall Study|Other|4|||
144694146|NCT01004822|521733033|FG003|Overall Study|Other|1|||
144694147|NCT01004822|521733034|FG004|Overall Study|Other|0|||
144694148|NCT01004822|521733035|FG005|Overall Study|Other|1|||
144694149|NCT01004822|521733036|FG006|Overall Study|Other|0|||
144694150|NCT01004822|521733037|FG007|Overall Study|Other|0|||
144694151|NCT00421928|521733040|FG000|Overall Study|Adverse Event|61|||
144694152|NCT00421928|521733041|FG001|Overall Study|Adverse Event|140|||
144694153|NCT00421928|521733042|FG002|Overall Study|Adverse Event|22|||
144694154|NCT00421928|521733040|FG000|Overall Study|Lost to Follow-up|5|||
144694155|NCT00421928|521733041|FG001|Overall Study|Lost to Follow-up|0|||
144694156|NCT00421928|521733042|FG002|Overall Study|Lost to Follow-up|3|||
144694157|NCT00421928|521733040|FG000|Overall Study|Withdrawal by Subject|50|||
144694158|NCT00421928|521733041|FG001|Overall Study|Withdrawal by Subject|48|||
144694159|NCT00421928|521733042|FG002|Overall Study|Withdrawal by Subject|43|||
144694160|NCT00421928|521733040|FG000|Overall Study|Lack of Efficacy|15|||
144694161|NCT00421928|521733041|FG001|Overall Study|Lack of Efficacy|7|||
144694162|NCT00421928|521733042|FG002|Overall Study|Lack of Efficacy|35|||
144694163|NCT00421928|521733040|FG000|Overall Study|Study drug non-compliant|6|||
144694164|NCT00421928|521733041|FG001|Overall Study|Study drug non-compliant|7|||
144694165|NCT00421928|521733042|FG002|Overall Study|Study drug non-compliant|4|||
144694166|NCT00421928|521733040|FG000|Overall Study|All other|26|||
144694167|NCT00421928|521733041|FG001|Overall Study|All other|21|||
144694168|NCT00421928|521733042|FG002|Overall Study|All other|27|||
144694169|NCT00421928|521733040|FG000|Overall Study|Death|0|||
144694170|NCT00421928|521733041|FG001|Overall Study|Death|1|||
144694171|NCT00421928|521733042|FG002|Overall Study|Death|0|||
144694172|NCT04120116|521733052|FG000|Overall Study|Lost to Follow-up|0|||
144694173|NCT04120116|521733053|FG001|Overall Study|Lost to Follow-up|1|||
144694174|NCT04120116|521733054|FG002|Overall Study|Lost to Follow-up|0|||
144694175|NCT04120116|521733055|FG003|Overall Study|Lost to Follow-up|2|||
144694176|NCT04120116|521733052|FG000|Overall Study|Withdrawal by Subject|1|||
144694177|NCT04120116|521733053|FG001|Overall Study|Withdrawal by Subject|0|||
144694178|NCT04120116|521733054|FG002|Overall Study|Withdrawal by Subject|1|||
144694179|NCT04120116|521733055|FG003|Overall Study|Withdrawal by Subject|1|||
144694180|NCT04120116|521733052|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
144694181|NCT04120116|521733053|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
144694182|NCT04120116|521733054|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
144694183|NCT04120116|521733055|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
144694184|NCT02181634|521733066|FG000|Overall Study|Lack of Efficacy|33|||
144694185|NCT02181634|521733066|FG000|Overall Study|Adverse Event|17|||
144694186|NCT02181634|521733066|FG000|Overall Study|Physician Decision|8|||
144694187|NCT02181634|521733066|FG000|Overall Study|Withdrawal by Subject|5|||
144694188|NCT02181634|521733066|FG000|Overall Study|Death|2|||
144694189|NCT02181634|521733066|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
144694190|NCT02181634|521733066|FG000|Overall Study|Ineligible|1|||
144694191|NCT02181634|521733066|FG000|Overall Study|Max number of dose reduction|1|||
144746410|NCT03224104|521920305|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
144746411|NCT03224104|521920306|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
144746412|NCT03224104|521920307|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
144746413|NCT03224104|521920308|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
144746414|NCT03224104|521920309|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
144746415|NCT03224104|521920305|FG000|Overall Study|Treatment ongoing|0|||
144746416|NCT03224104|521920306|FG001|Overall Study|Treatment ongoing|0|||
144746417|NCT03224104|521920307|FG002|Overall Study|Treatment ongoing|0|||
144746418|NCT03224104|521920308|FG003|Overall Study|Treatment ongoing|0|||
144746419|NCT03224104|521920309|FG004|Overall Study|Treatment ongoing|1|||
144746420|NCT04795752|521920311|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
144746421|NCT04795752|521920312|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
144746422|NCT04795752|521920311|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
144746423|NCT04795752|521920312|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
144746424|NCT04795752|521920311|FG000|Primary Endpoint Phase|Physician Decision|2|||
144746425|NCT04795752|521920312|FG001|Primary Endpoint Phase|Physician Decision|0|||
144746426|NCT04795752|521920311|FG000|Primary Endpoint Phase|Other|4|||
144746427|NCT04795752|521920312|FG001|Primary Endpoint Phase|Other|1|||
144746428|NCT04795752|521920311|FG000|Primary Endpoint Phase|Protocol Violation|1|||
144746429|NCT04795752|521920312|FG001|Primary Endpoint Phase|Protocol Violation|0|||
144746430|NCT04795752|521920311|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
144746431|NCT04795752|521920312|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
144746432|NCT04795752|521920311|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
144746433|NCT04795752|521920312|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
144746434|NCT04795752|521920311|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
144746435|NCT04795752|521920312|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
144746436|NCT04795752|521920311|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
144746437|NCT04795752|521920312|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
144746438|NCT04795752|521920311|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
144746439|NCT04795752|521920312|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
144746440|NCT00792948|521920313|FG000|Overall Study|Adverse Event|6|||
144746441|NCT00792948|521920313|FG000|Overall Study|Death|4|||
144746442|NCT00792948|521920313|FG000|Overall Study|Withdrawal by Subject|3|||
144746443|NCT00792948|521920313|FG000|Overall Study|Ineligible|2|||
144746444|NCT00792948|521920313|FG000|Overall Study|Insurance denial - not treated|1|||
144746445|NCT00792948|521920313|FG000|Overall Study|Physician Decision|11|||
144746446|NCT00792948|521920313|FG000|Overall Study|Protocol Violation|1|||
144746447|NCT05025787|521920314|FG000|Overall Study|Lack of Efficacy|0|||
144746448|NCT05025787|521920315|FG001|Overall Study|Lack of Efficacy|1|||
144746449|NCT05025787|521920314|FG000|Overall Study|Adverse Event|2|||
144746450|NCT05025787|521920315|FG001|Overall Study|Adverse Event|4|||
144746451|NCT05025787|521920314|FG000|Overall Study|Non compliance|0|||
144746452|NCT05025787|521920315|FG001|Overall Study|Non compliance|1|||
144221093|NCT00742209|520005737|FG000|Overall Study|Participant Withdrew Consent|8|||
144221094|NCT00742209|520005738|FG001|Overall Study|Participant Withdrew Consent|4|||
144221095|NCT00742209|520005739|FG002|Overall Study|Participant Withdrew Consent|14|||
144746453|NCT05025787|521920314|FG000|Overall Study|Protocol Violation|3|||
144746454|NCT05025787|521920315|FG001|Overall Study|Protocol Violation|1|||
144746455|NCT05025787|521920314|FG000|Overall Study|Stopping criteria met|1|||
144746456|NCT05025787|521920315|FG001|Overall Study|Stopping criteria met|1|||
144746457|NCT05025787|521920314|FG000|Overall Study|Withdrawal by Subject|3|||
144746458|NCT05025787|521920315|FG001|Overall Study|Withdrawal by Subject|1|||
144746459|NCT06129045|521920316|FG000|Overall Study|Lost to Follow-up|1|||
144746460|NCT06129045|521920317|FG001|Overall Study|Lost to Follow-up|1|||
144746461|NCT06129045|521920318|FG002|Overall Study|Lost to Follow-up|4|||
144746462|NCT01582269|521920321|FG000|Overall Study|Withdrawal by Subject|1|||
144746463|NCT01582269|521920322|FG001|Overall Study|Withdrawal by Subject|0|||
144746464|NCT01582269|521920323|FG002|Overall Study|Withdrawal by Subject|0|||
144746465|NCT05600309|521920326|FG000|Overall Study|Death|41|||
144746466|NCT05600309|521920327|FG001|Overall Study|Death|38|||
144746467|NCT05600309|521920326|FG000|Overall Study|Sponsor Decision|9|||
144221096|NCT00742209|520005740|FG003|Overall Study|Participant Withdrew Consent|7|||
144221097|NCT00742209|520005741|FG004|Overall Study|Participant Withdrew Consent|4|||
144221098|NCT00742209|520005737|FG000|Overall Study|Protocol Violation|6|||
144221099|NCT00742209|520005738|FG001|Overall Study|Protocol Violation|5|||
144221100|NCT00742209|520005739|FG002|Overall Study|Protocol Violation|4|||
144746468|NCT05600309|521920327|FG001|Overall Study|Sponsor Decision|6|||
144746469|NCT06218251|521920328|FG000|Overall Study|Lost to Follow-up|4|||
144746470|NCT06087328|521920329|FG000|28-Day Treatment|Lost to Follow-up|7|||
144746471|NCT06087328|521920330|FG001|28-Day Treatment|Lost to Follow-up|3|||
144746472|NCT06087328|521920331|FG002|28-Day Treatment|Lost to Follow-up|4|||
144746473|NCT06087328|521920329|FG000|1-month Follow-up|Lost to Follow-up|0|||
144746474|NCT06087328|521920330|FG001|1-month Follow-up|Lost to Follow-up|1|||
144746475|NCT06087328|521920331|FG002|1-month Follow-up|Lost to Follow-up|1|||
144746476|NCT05076266|521920332|FG000|Overall Study|Survey not complete - Participant refusal|2|||
144266385|NCT01232790|520178334|FG001|Second Crossover|Withdrawal by Subject|2|||
144266386|NCT02000921|520178335|FG000|Overall Study|Withdrawal by Subject|3|||
144266387|NCT02000921|520178336|FG001|Overall Study|Withdrawal by Subject|10|||
144266388|NCT02000921|520178337|FG002|Overall Study|Withdrawal by Subject|5|||
144266389|NCT02000921|520178335|FG000|Overall Study|Lost to Follow-up|2|||
144266390|NCT02000921|520178336|FG001|Overall Study|Lost to Follow-up|4|||
144266391|NCT02000921|520178337|FG002|Overall Study|Lost to Follow-up|5|||
144266392|NCT02000921|520178335|FG000|Overall Study|Physician Decision|0|||
144266393|NCT02000921|520178336|FG001|Overall Study|Physician Decision|2|||
144266394|NCT02000921|520178337|FG002|Overall Study|Physician Decision|0|||
144266395|NCT02631941|520178342|FG000|Overall Study|Physician Decision|0|||
144266396|NCT02631941|520178343|FG001|Overall Study|Physician Decision|1|||
144266397|NCT02631941|520178344|FG002|Overall Study|Physician Decision|0|||
144266398|NCT02631941|520178345|FG003|Overall Study|Physician Decision|0|||
144266399|NCT02631941|520178346|FG004|Overall Study|Physician Decision|0|||
144266400|NCT02631941|520178347|FG005|Overall Study|Physician Decision|0|||
144266401|NCT02631941|520178348|FG006|Overall Study|Physician Decision|0|||
144221101|NCT00742209|520005740|FG003|Overall Study|Protocol Violation|5|||
144221102|NCT00742209|520005741|FG004|Overall Study|Protocol Violation|3|||
144221103|NCT00742209|520005737|FG000|Overall Study|Lost to Follow-up|3|||
144221104|NCT00742209|520005738|FG001|Overall Study|Lost to Follow-up|4|||
144221105|NCT00742209|520005739|FG002|Overall Study|Lost to Follow-up|5|||
144221106|NCT00742209|520005740|FG003|Overall Study|Lost to Follow-up|5|||
144221107|NCT00742209|520005741|FG004|Overall Study|Lost to Follow-up|3|||
144221108|NCT00742209|520005737|FG000|Overall Study|Lack of Efficacy|6|||
144221109|NCT00742209|520005738|FG001|Overall Study|Lack of Efficacy|1|||
144221110|NCT00742209|520005739|FG002|Overall Study|Lack of Efficacy|1|||
144221111|NCT00742209|520005740|FG003|Overall Study|Lack of Efficacy|3|||
144221112|NCT00742209|520005741|FG004|Overall Study|Lack of Efficacy|1|||
144221113|NCT00742209|520005737|FG000|Overall Study|Investigator Discretion|0|||
144221114|NCT00742209|520005738|FG001|Overall Study|Investigator Discretion|0|||
144221115|NCT00742209|520005739|FG002|Overall Study|Investigator Discretion|5|||
144221116|NCT00742209|520005740|FG003|Overall Study|Investigator Discretion|1|||
144221117|NCT00742209|520005741|FG004|Overall Study|Investigator Discretion|1|||
144221118|NCT00485264|520005744|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
144221119|NCT00485264|520005745|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
144221120|NCT00485264|520005746|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
144746477|NCT05076266|521920333|FG001|Overall Study|Survey not complete - Participant refusal|0|||
144746478|NCT05822830|521920334|FG000|Overall Study|Adverse Event|6|||
144746479|NCT05822830|521920335|FG001|Overall Study|Adverse Event|6|||
144746480|NCT05822830|521920334|FG000|Overall Study|Assigned Treatment by Mistake|5|||
144746481|NCT05822830|521920335|FG001|Overall Study|Assigned Treatment by Mistake|3|||
144746482|NCT05822830|521920334|FG000|Overall Study|Lost to Follow-up|16|||
144746483|NCT05822830|521920335|FG001|Overall Study|Lost to Follow-up|18|||
144746484|NCT05822830|521920334|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144746485|NCT05822830|521920335|FG001|Overall Study|Non-Compliance With Study Drug|1|||
144746486|NCT05822830|521920334|FG000|Overall Study|Participant was Out of the Country|0|||
144746487|NCT05822830|521920335|FG001|Overall Study|Participant was Out of the Country|1|||
144746488|NCT05822830|521920334|FG000|Overall Study|Pregnancy|1|||
144746489|NCT05822830|521920335|FG001|Overall Study|Pregnancy|2|||
144221121|NCT00485264|520005747|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
144221122|NCT00485264|520005748|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
144221123|NCT00485264|520005749|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
144221124|NCT00485264|520005744|FG000|Overall Study|Death|1|||
144221125|NCT00485264|520005745|FG001|Overall Study|Death|0|||
144221126|NCT00485264|520005746|FG002|Overall Study|Death|0|||
144221127|NCT00485264|520005747|FG003|Overall Study|Death|0|||
144221128|NCT00485264|520005748|FG004|Overall Study|Death|1|||
144221129|NCT00485264|520005749|FG005|Overall Study|Death|0|||
144266402|NCT02631941|520178349|FG007|Overall Study|Physician Decision|0|||
144266403|NCT02631941|520178350|FG008|Overall Study|Physician Decision|0|||
144266404|NCT02631941|520178351|FG009|Overall Study|Physician Decision|0|||
144221130|NCT00485264|520005744|FG000|Overall Study|Adverse Event|1|||
144221131|NCT00485264|520005745|FG001|Overall Study|Adverse Event|0|||
144221132|NCT00485264|520005746|FG002|Overall Study|Adverse Event|2|||
144266405|NCT02631941|520178342|FG000|Overall Study|Adverse Event|0|||
144266406|NCT02631941|520178343|FG001|Overall Study|Adverse Event|1|||
144266407|NCT02631941|520178344|FG002|Overall Study|Adverse Event|0|||
144746490|NCT05822830|521920334|FG000|Overall Study|Withdrawal by Subject|27|||
144266408|NCT02631941|520178345|FG003|Overall Study|Adverse Event|0|||
144266409|NCT02631941|520178346|FG004|Overall Study|Adverse Event|0|||
144746491|NCT05822830|521920335|FG001|Overall Study|Withdrawal by Subject|26|||
144221133|NCT00485264|520005747|FG003|Overall Study|Adverse Event|3|||
144221134|NCT00485264|520005748|FG004|Overall Study|Adverse Event|1|||
144221135|NCT00485264|520005749|FG005|Overall Study|Adverse Event|3|||
144221136|NCT00485264|520005744|FG000|Overall Study|Pregnancy|4|||
144221137|NCT00485264|520005745|FG001|Overall Study|Pregnancy|0|||
144746492|NCT05797155|521920336|FG000|Overall Study|Lost to Follow-up|33|||
144746493|NCT05797155|521920337|FG001|Overall Study|Lost to Follow-up|12|||
144221138|NCT00485264|520005746|FG002|Overall Study|Pregnancy|0|||
144221139|NCT00485264|520005747|FG003|Overall Study|Pregnancy|0|||
144221140|NCT00485264|520005748|FG004|Overall Study|Pregnancy|0|||
144221141|NCT00485264|520005749|FG005|Overall Study|Pregnancy|0|||
144221142|NCT00485264|520005744|FG000|Overall Study|Disallowed Medication|0|||
144221143|NCT00485264|520005745|FG001|Overall Study|Disallowed Medication|0|||
144746494|NCT05526521|521920339|FG000|Overall Study|Withdrawal by Subject|0|||
144746495|NCT05526521|521920340|FG001|Overall Study|Withdrawal by Subject|1|||
144746496|NCT05526521|521920341|FG002|Overall Study|Withdrawal by Subject|0|||
144746497|NCT05526521|521920342|FG003|Overall Study|Withdrawal by Subject|0|||
144746498|NCT03201965|521920345|FG000|Overall Study|Death|5|||
144746499|NCT03201965|521920346|FG001|Overall Study|Death|65|||
144746500|NCT03201965|521920347|FG002|Overall Study|Death|47|||
144746501|NCT03201965|521920345|FG000|Overall Study|Lost to Follow-up|0|||
144746502|NCT03201965|521920346|FG001|Overall Study|Lost to Follow-up|6|||
144746503|NCT03201965|521920347|FG002|Overall Study|Lost to Follow-up|0|||
144746504|NCT03201965|521920345|FG000|Overall Study|Withdrawal by Subject|3|||
144746505|NCT03201965|521920346|FG001|Overall Study|Withdrawal by Subject|23|||
144746506|NCT03201965|521920347|FG002|Overall Study|Withdrawal by Subject|8|||
144746507|NCT03201965|521920345|FG000|Overall Study|Sponsor's Decision|20|||
144746508|NCT03201965|521920346|FG001|Overall Study|Sponsor's Decision|99|||
144746509|NCT03201965|521920347|FG002|Overall Study|Sponsor's Decision|140|||
144746510|NCT03368664|521920348|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
144746511|NCT03368664|521920348|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
144746512|NCT03368664|521920348|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
144746513|NCT03368664|521920348|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
144746514|NCT03919929|521920349|FG000|Overall Study|Withdrawal by Subject|0|||
144746515|NCT03919929|521920350|FG001|Overall Study|Withdrawal by Subject|4|||
144746516|NCT03919929|521920349|FG000|Overall Study|Screen Failure|0|||
144746517|NCT03919929|521920350|FG001|Overall Study|Screen Failure|5|||
144746518|NCT03589326|521920358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
144746519|NCT03589326|521920359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
144746520|NCT03589326|521920358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
144746521|NCT03589326|521920359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
144746522|NCT03589326|521920358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
144746523|NCT03589326|521920359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
144746524|NCT03589326|521920358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
144746525|NCT03589326|521920359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
144746526|NCT03589326|521920358|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
144746527|NCT03589326|521920359|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
144746528|NCT05441592|521920360|FG000|Overall Study|Lost to Follow-up|1|||
144746529|NCT05441592|521920361|FG001|Overall Study|Lost to Follow-up|5|||
144746530|NCT01371981|521920362|FG000|Overall Study|Adverse Event|12|||
144746531|NCT01371981|521920363|FG001|Overall Study|Adverse Event|17|||
144746532|NCT01371981|521920364|FG002|Overall Study|Adverse Event|0|||
144746533|NCT01371981|521920365|FG003|Overall Study|Adverse Event|4|||
144746534|NCT01371981|521920366|FG004|Overall Study|Adverse Event|1|||
144746535|NCT01371981|521920367|FG005|Overall Study|Adverse Event|0|||
144746536|NCT01371981|521920362|FG000|Overall Study|Death|22|||
144746537|NCT01371981|521920363|FG001|Overall Study|Death|16|||
144746538|NCT01371981|521920364|FG002|Overall Study|Death|0|||
144746539|NCT01371981|521920365|FG003|Overall Study|Death|0|||
144746540|NCT01371981|521920366|FG004|Overall Study|Death|2|||
144746541|NCT01371981|521920367|FG005|Overall Study|Death|2|||
144746542|NCT01371981|521920362|FG000|Overall Study|Lack of Efficacy|69|||
144746543|NCT01371981|521920363|FG001|Overall Study|Lack of Efficacy|61|||
144746544|NCT01371981|521920364|FG002|Overall Study|Lack of Efficacy|4|||
144746545|NCT01371981|521920365|FG003|Overall Study|Lack of Efficacy|8|||
144221144|NCT00485264|520005746|FG002|Overall Study|Disallowed Medication|0|||
144221145|NCT00485264|520005747|FG003|Overall Study|Disallowed Medication|0|||
144221146|NCT00485264|520005748|FG004|Overall Study|Disallowed Medication|0|||
144746546|NCT01371981|521920366|FG004|Overall Study|Lack of Efficacy|5|||
144746547|NCT01371981|521920367|FG005|Overall Study|Lack of Efficacy|0|||
144746548|NCT01371981|521920362|FG000|Overall Study|Physician Decision|48|||
144746549|NCT01371981|521920363|FG001|Overall Study|Physician Decision|63|||
144746550|NCT01371981|521920364|FG002|Overall Study|Physician Decision|1|||
144746551|NCT01371981|521920365|FG003|Overall Study|Physician Decision|7|||
144746552|NCT01371981|521920366|FG004|Overall Study|Physician Decision|14|||
144746553|NCT01371981|521920367|FG005|Overall Study|Physician Decision|3|||
144746554|NCT01371981|521920362|FG000|Overall Study|Withdrawal by Subject|12|||
144746555|NCT01371981|521920363|FG001|Overall Study|Withdrawal by Subject|19|||
144746556|NCT01371981|521920364|FG002|Overall Study|Withdrawal by Subject|1|||
144746557|NCT01371981|521920365|FG003|Overall Study|Withdrawal by Subject|2|||
144746558|NCT01371981|521920366|FG004|Overall Study|Withdrawal by Subject|10|||
144746559|NCT01371981|521920367|FG005|Overall Study|Withdrawal by Subject|3|||
144746560|NCT01371981|521920362|FG000|Overall Study|Ineligible|19|||
144221147|NCT00485264|520005749|FG005|Overall Study|Disallowed Medication|1|||
144221148|NCT00485264|520005744|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
144221149|NCT00485264|520005745|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
144221150|NCT00485264|520005746|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
144221151|NCT00485264|520005747|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
144221152|NCT00485264|520005748|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
144221153|NCT00485264|520005749|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
144221154|NCT00485264|520005744|FG000|Overall Study|Lack of Efficacy|0|||
144221155|NCT00485264|520005745|FG001|Overall Study|Lack of Efficacy|1|||
144221156|NCT00485264|520005746|FG002|Overall Study|Lack of Efficacy|0|||
144221157|NCT00485264|520005747|FG003|Overall Study|Lack of Efficacy|0|||
144221158|NCT00485264|520005748|FG004|Overall Study|Lack of Efficacy|0|||
144221159|NCT00485264|520005749|FG005|Overall Study|Lack of Efficacy|0|||
144221160|NCT00485264|520005744|FG000|Overall Study|Guardian Consent Withdrawn|1|||
144221161|NCT00485264|520005745|FG001|Overall Study|Guardian Consent Withdrawn|0|||
144221162|NCT00485264|520005746|FG002|Overall Study|Guardian Consent Withdrawn|0|||
144221163|NCT00485264|520005747|FG003|Overall Study|Guardian Consent Withdrawn|0|||
144221164|NCT00485264|520005748|FG004|Overall Study|Guardian Consent Withdrawn|1|||
144221165|NCT00485264|520005749|FG005|Overall Study|Guardian Consent Withdrawn|0|||
144221166|NCT00485264|520005744|FG000|Overall Study|Physician Decision|0|||
144221167|NCT00485264|520005745|FG001|Overall Study|Physician Decision|2|||
144221168|NCT00485264|520005746|FG002|Overall Study|Physician Decision|0|||
144694192|NCT02181634|521733066|FG000|Overall Study|Symptomatic progression|1|||
144694193|NCT02181634|521733066|FG000|Overall Study|Patient opted to proceed to surgery|1|||
144694194|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
144694195|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
144694196|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
144694197|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
144694198|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
144694199|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
144694200|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
144694201|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
144694202|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
144694203|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
144694204|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
144694205|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
144694206|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
144694207|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
144694208|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
144694209|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|Other|6|||
144694210|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|Other|6|||
144694211|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|Other|7|||
144694212|NCT02681094|521733067|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
144694213|NCT02681094|521733068|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
144694214|NCT02681094|521733069|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
144694215|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|Participant decision|7|||
144694216|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|Participant decision|10|||
144694217|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|Participant decision|9|||
144694218|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
144694219|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
144694220|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
144694221|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
144694222|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
144694223|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
144694224|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
144694225|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
144694226|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
144694227|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
144694228|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
144694229|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
144694230|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|Other|6|||
144694231|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|Other|6|||
144694232|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|Other|7|||
144694233|NCT02681094|521733067|FG000|2 - Enrolled Participants Set|No treatment given|0|||
144694234|NCT02681094|521733068|FG001|2 - Enrolled Participants Set|No treatment given|1|||
144746561|NCT01371981|521920363|FG001|Overall Study|Ineligible|13|||
144221169|NCT00485264|520005747|FG003|Overall Study|Physician Decision|0|||
144221170|NCT00485264|520005748|FG004|Overall Study|Physician Decision|0|||
144746562|NCT01371981|521920364|FG002|Overall Study|Ineligible|0|||
144746563|NCT01371981|521920365|FG003|Overall Study|Ineligible|0|||
144746564|NCT01371981|521920366|FG004|Overall Study|Ineligible|0|||
144746565|NCT01371981|521920367|FG005|Overall Study|Ineligible|4|||
144746566|NCT01371981|521920362|FG000|Overall Study|Did not start treatment|2|||
144746567|NCT01371981|521920363|FG001|Overall Study|Did not start treatment|3|||
144746568|NCT01371981|521920364|FG002|Overall Study|Did not start treatment|0|||
144746569|NCT01371981|521920365|FG003|Overall Study|Did not start treatment|0|||
144746570|NCT01371981|521920366|FG004|Overall Study|Did not start treatment|0|||
144746571|NCT01371981|521920367|FG005|Overall Study|Did not start treatment|2|||
144746572|NCT00026312|521920369|FG000|Overall Study|Adverse Event|0|||
144746573|NCT00026312|521920370|FG001|Overall Study|Adverse Event|32|||
144746574|NCT00026312|521920369|FG000|Overall Study|Death|1|||
144746575|NCT00026312|521920370|FG001|Overall Study|Death|7|||
144746576|NCT00026312|521920369|FG000|Overall Study|Lack of Efficacy|19|||
144746577|NCT00026312|521920370|FG001|Overall Study|Lack of Efficacy|114|||
144746578|NCT00026312|521920369|FG000|Overall Study|Lost to Follow-up|0|||
144746579|NCT00026312|521920370|FG001|Overall Study|Lost to Follow-up|5|||
144746580|NCT00026312|521920369|FG000|Overall Study|Physician Decision|1|||
144746581|NCT00026312|521920370|FG001|Overall Study|Physician Decision|37|||
144746582|NCT00026312|521920369|FG000|Overall Study|Protocol Violation|0|||
144746583|NCT00026312|521920370|FG001|Overall Study|Protocol Violation|3|||
144746584|NCT00026312|521920369|FG000|Overall Study|Withdrawal by Subject|1|||
144746585|NCT00026312|521920370|FG001|Overall Study|Withdrawal by Subject|6|||
144746586|NCT00026312|521920369|FG000|Overall Study|Ineligible|4|||
144746587|NCT00026312|521920370|FG001|Overall Study|Ineligible|5|||
144746588|NCT00026312|521920369|FG000|Overall Study|Entry onto another COG study|0|||
144746589|NCT00026312|521920370|FG001|Overall Study|Entry onto another COG study|1|||
144746590|NCT00026312|521920369|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
144746591|NCT00026312|521920370|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
144746592|NCT02445391|521920372|FG000|Overall Study|No active protocol treatment|3|||
144746593|NCT02445391|521920373|FG001|Overall Study|No active protocol treatment|0|||
144746594|NCT02445391|521920374|FG002|Overall Study|No active protocol treatment|0|||
144746595|NCT02445391|521920372|FG000|Overall Study|Adverse Event|0|||
144746596|NCT02445391|521920373|FG001|Overall Study|Adverse Event|21|||
144746597|NCT02445391|521920374|FG002|Overall Study|Adverse Event|12|||
144746598|NCT02445391|521920372|FG000|Overall Study|Alternative therapy|0|||
144746599|NCT02445391|521920373|FG001|Overall Study|Alternative therapy|0|||
144746600|NCT02445391|521920374|FG002|Overall Study|Alternative therapy|1|||
144746601|NCT02445391|521920372|FG000|Overall Study|Disease progression|0|||
144746602|NCT02445391|521920373|FG001|Overall Study|Disease progression|7|||
144746603|NCT02445391|521920374|FG002|Overall Study|Disease progression|22|||
144746604|NCT02445391|521920372|FG000|Overall Study|Complicating disease|0|||
144746605|NCT02445391|521920373|FG001|Overall Study|Complicating disease|2|||
144746606|NCT02445391|521920374|FG002|Overall Study|Complicating disease|1|||
144746607|NCT02445391|521920372|FG000|Overall Study|Withdrawal by Subject|0|||
144746608|NCT02445391|521920373|FG001|Overall Study|Withdrawal by Subject|4|||
144746609|NCT02445391|521920374|FG002|Overall Study|Withdrawal by Subject|9|||
144746610|NCT02445391|521920372|FG000|Overall Study|Financial issue|0|||
144746611|NCT02445391|521920373|FG001|Overall Study|Financial issue|0|||
144746612|NCT02445391|521920374|FG002|Overall Study|Financial issue|2|||
144746613|NCT02445391|521920372|FG000|Overall Study|Still on treatment|0|||
144746614|NCT02445391|521920373|FG001|Overall Study|Still on treatment|7|||
144746615|NCT02445391|521920374|FG002|Overall Study|Still on treatment|16|||
144746616|NCT02445391|521920372|FG000|Overall Study|Not start protocol therapy|0|||
144746617|NCT02445391|521920373|FG001|Overall Study|Not start protocol therapy|12|||
144746618|NCT02445391|521920374|FG002|Overall Study|Not start protocol therapy|9|||
144746619|NCT01671956|521920376|FG000|Overall Study|Disease progression|0|||
144746620|NCT01671956|521920377|FG001|Overall Study|Disease progression|1|||
144746621|NCT01671956|521920376|FG000|Overall Study|Withdrawal by Subject|1|||
144746622|NCT01671956|521920377|FG001|Overall Study|Withdrawal by Subject|1|||
144746623|NCT01671956|521920376|FG000|Overall Study|Adverse Event|1|||
144221171|NCT00485264|520005749|FG005|Overall Study|Physician Decision|0|||
144221172|NCT00485264|520005744|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
144221173|NCT00485264|520005745|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
144221174|NCT00485264|520005746|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
144746624|NCT01671956|521920377|FG001|Overall Study|Adverse Event|0|||
144746625|NCT05584202|521920381|FG000|Overall Study|Withdrawal of Consent|3|||
144746626|NCT05584202|521920382|FG001|Overall Study|Withdrawal of Consent|2|||
144746627|NCT05584202|521920381|FG000|Overall Study|Lost to Follow-up|2|||
144746628|NCT05584202|521920382|FG001|Overall Study|Lost to Follow-up|1|||
144746629|NCT05584202|521920381|FG000|Overall Study|Death|0|||
144746630|NCT05584202|521920382|FG001|Overall Study|Death|1|||
144746631|NCT04266912|521920398|FG000|Overall Study|Withdrawal by Subject|1|||
144746632|NCT04266912|521920399|FG001|Overall Study|Withdrawal by Subject|0|||
144746633|NCT04266912|521920400|FG002|Overall Study|Withdrawal by Subject|0|||
144746634|NCT04266912|521920401|FG003|Overall Study|Withdrawal by Subject|0|||
144746635|NCT04266912|521920398|FG000|Overall Study|Progression|6|||
144746636|NCT04266912|521920399|FG001|Overall Study|Progression|6|||
144221175|NCT00485264|520005747|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
144221176|NCT00485264|520005748|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
144221177|NCT00485264|520005749|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
144694235|NCT02681094|521733069|FG002|2 - Enrolled Participants Set|No treatment given|1|||
144694236|NCT02452320|521733072|FG000|Overall Study|Adverse Event|0|||
144694237|NCT02452320|521733073|FG001|Overall Study|Adverse Event|1|||
144694238|NCT03382639|521733074|FG000|Overall Study|Adverse Event|2|||
144694239|NCT03382639|521733075|FG001|Overall Study|Adverse Event|0|||
144694240|NCT03382639|521733076|FG002|Overall Study|Adverse Event|1|||
144694241|NCT03382639|521733077|FG003|Overall Study|Adverse Event|1|||
144694242|NCT03382639|521733074|FG000|Overall Study|Lost to Follow-up|1|||
144694243|NCT03382639|521733075|FG001|Overall Study|Lost to Follow-up|0|||
144694244|NCT03382639|521733076|FG002|Overall Study|Lost to Follow-up|0|||
144694245|NCT03382639|521733077|FG003|Overall Study|Lost to Follow-up|0|||
144694246|NCT03382639|521733074|FG000|Overall Study|Withdrawal by Subject|4|||
144694247|NCT03382639|521733075|FG001|Overall Study|Withdrawal by Subject|3|||
144694248|NCT03382639|521733076|FG002|Overall Study|Withdrawal by Subject|2|||
144694249|NCT03382639|521733077|FG003|Overall Study|Withdrawal by Subject|3|||
144694250|NCT03382639|521733074|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
144694251|NCT03382639|521733075|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
144694252|NCT03382639|521733076|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
144694253|NCT03382639|521733077|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
144694254|NCT03382639|521733074|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
144694255|NCT03382639|521733075|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
144694256|NCT03382639|521733076|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
144694257|NCT03382639|521733077|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
144694258|NCT03382639|521733074|FG000|Overall Study|Other|2|||
144694259|NCT03382639|521733075|FG001|Overall Study|Other|0|||
144694260|NCT03382639|521733076|FG002|Overall Study|Other|0|||
144694261|NCT03382639|521733077|FG003|Overall Study|Other|3|||
144694262|NCT01072175|521733080|FG000|Part A (Drug-Drug Interaction)|Death|1|||
144694263|NCT01072175|521733081|FG001|Part A (Drug-Drug Interaction)|Death|0|||
144694264|NCT01072175|521733082|FG002|Part A (Drug-Drug Interaction)|Death|0|||
144694265|NCT01072175|521733083|FG003|Part A (Drug-Drug Interaction)|Death|0|||
144694266|NCT01072175|521733084|FG004|Part A (Drug-Drug Interaction)|Death|0|||
144694267|NCT01072175|521733085|FG005|Part A (Drug-Drug Interaction)|Death|0|||
144694268|NCT01072175|521733086|FG006|Part A (Drug-Drug Interaction)|Death|0|||
144694269|NCT01072175|521733087|FG007|Part A (Drug-Drug Interaction)|Death|0|||
144694270|NCT01072175|521733088|FG008|Part A (Drug-Drug Interaction)|Death|0|||
144694271|NCT01072175|521733089|FG009|Part A (Drug-Drug Interaction)|Death|0|||
144694272|NCT01072175|521733090|FG010|Part A (Drug-Drug Interaction)|Death|0|||
144694273|NCT01072175|521733091|FG011|Part A (Drug-Drug Interaction)|Death|0|||
144694274|NCT01072175|521733092|FG012|Part A (Drug-Drug Interaction)|Death|0|||
144694275|NCT01072175|521733080|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
144694276|NCT01072175|521733081|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694277|NCT01072175|521733082|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694278|NCT01072175|521733083|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694279|NCT01072175|521733084|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694280|NCT01072175|521733085|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694281|NCT01072175|521733086|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694282|NCT01072175|521733087|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694283|NCT01072175|521733088|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694284|NCT01072175|521733089|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694285|NCT01072175|521733090|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694286|NCT01072175|521733091|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694287|NCT01072175|521733092|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
144694288|NCT01072175|521733080|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
144694289|NCT01072175|521733081|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694290|NCT01072175|521733082|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694291|NCT01072175|521733083|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694292|NCT01072175|521733084|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694293|NCT01072175|521733085|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694294|NCT01072175|521733086|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694295|NCT01072175|521733087|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694296|NCT01072175|521733088|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694297|NCT01072175|521733089|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694298|NCT01072175|521733090|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694299|NCT01072175|521733091|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694300|NCT01072175|521733092|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
144694301|NCT01072175|521733080|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
144694302|NCT01072175|521733081|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
144221178|NCT00485264|520005744|FG000|Overall Study|Not Able to Attend Clinic|5|||
144694303|NCT01072175|521733082|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
144694304|NCT01072175|521733083|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
144694305|NCT01072175|521733084|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
144694306|NCT01072175|521733085|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
144694307|NCT01072175|521733086|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
144694308|NCT01072175|521733087|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
144694309|NCT01072175|521733088|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
144694310|NCT01072175|521733089|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
144694311|NCT01072175|521733090|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
144694312|NCT01072175|521733091|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
144694313|NCT01072175|521733092|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
144694314|NCT01072175|521733080|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694315|NCT01072175|521733081|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694316|NCT01072175|521733082|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
144694317|NCT01072175|521733083|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694318|NCT01072175|521733084|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
144694319|NCT01072175|521733085|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694320|NCT01072175|521733086|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694321|NCT01072175|521733087|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694322|NCT01072175|521733088|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694323|NCT01072175|521733089|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694324|NCT01072175|521733090|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694325|NCT01072175|521733091|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694326|NCT01072175|521733092|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
144694327|NCT01072175|521733080|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694328|NCT01072175|521733081|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
144694329|NCT01072175|521733082|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694330|NCT01072175|521733083|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
144694331|NCT01072175|521733084|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
144694332|NCT01072175|521733085|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694333|NCT01072175|521733086|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694334|NCT01072175|521733087|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694335|NCT01072175|521733088|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694336|NCT01072175|521733089|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694337|NCT01072175|521733090|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694338|NCT01072175|521733091|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694339|NCT01072175|521733092|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
144694340|NCT01072175|521733080|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694341|NCT01072175|521733081|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694342|NCT01072175|521733082|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
144694343|NCT01072175|521733083|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
144694344|NCT01072175|521733084|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
144694345|NCT01072175|521733085|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694346|NCT01072175|521733086|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694347|NCT01072175|521733087|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694348|NCT01072175|521733088|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694349|NCT01072175|521733089|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694350|NCT01072175|521733090|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694351|NCT01072175|521733091|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694352|NCT01072175|521733092|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
144694353|NCT01072175|521733080|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694354|NCT01072175|521733081|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
144694355|NCT01072175|521733082|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694356|NCT01072175|521733083|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
144694357|NCT01072175|521733084|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
144694358|NCT01072175|521733085|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694359|NCT01072175|521733086|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694360|NCT01072175|521733087|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694361|NCT01072175|521733088|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694362|NCT01072175|521733089|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694363|NCT01072175|521733090|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694364|NCT01072175|521733091|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694365|NCT01072175|521733092|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
144694366|NCT01072175|521733080|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
144694367|NCT01072175|521733081|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
144746637|NCT04266912|521920400|FG002|Overall Study|Progression|0|||
144746638|NCT04266912|521920401|FG003|Overall Study|Progression|10|||
144746639|NCT05757427|521920402|FG000|Overall Study|Adverse Event|1|||
144746640|NCT05757427|521920402|FG000|Overall Study|Device deficiency|1|||
144746641|NCT05757427|521920402|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
144221179|NCT00485264|520005745|FG001|Overall Study|Not Able to Attend Clinic|0|||
144221180|NCT00485264|520005746|FG002|Overall Study|Not Able to Attend Clinic|0|||
144221181|NCT00485264|520005747|FG003|Overall Study|Not Able to Attend Clinic|1|||
144221182|NCT00485264|520005748|FG004|Overall Study|Not Able to Attend Clinic|1|||
144221183|NCT00485264|520005749|FG005|Overall Study|Not Able to Attend Clinic|2|||
144221184|NCT00485264|520005744|FG000|Overall Study|Non-Compliant|17|||
144221185|NCT00485264|520005745|FG001|Overall Study|Non-Compliant|2|||
144221186|NCT00485264|520005746|FG002|Overall Study|Non-Compliant|1|||
144221187|NCT00485264|520005747|FG003|Overall Study|Non-Compliant|0|||
144221188|NCT00485264|520005748|FG004|Overall Study|Non-Compliant|1|||
144221189|NCT00485264|520005749|FG005|Overall Study|Non-Compliant|0|||
144221190|NCT00485264|520005744|FG000|Overall Study|Lost to Follow-up|2|||
144221191|NCT00485264|520005745|FG001|Overall Study|Lost to Follow-up|1|||
144221192|NCT00485264|520005746|FG002|Overall Study|Lost to Follow-up|1|||
144221193|NCT00485264|520005747|FG003|Overall Study|Lost to Follow-up|0|||
144221194|NCT00485264|520005748|FG004|Overall Study|Lost to Follow-up|0|||
144221195|NCT00485264|520005749|FG005|Overall Study|Lost to Follow-up|1|||
144221196|NCT00485264|520005744|FG000|Overall Study|Other Reason|3|||
144221197|NCT00485264|520005745|FG001|Overall Study|Other Reason|0|||
144221198|NCT00485264|520005746|FG002|Overall Study|Other Reason|0|||
144221199|NCT00485264|520005747|FG003|Overall Study|Other Reason|0|||
144221200|NCT00485264|520005748|FG004|Overall Study|Other Reason|0|||
144221201|NCT00485264|520005749|FG005|Overall Study|Other Reason|0|||
144221202|NCT01514461|520005750|FG000|Overall Study|Adverse Event|2|||
144221203|NCT01514461|520005751|FG001|Overall Study|Adverse Event|1|||
144221204|NCT01514461|520005752|FG002|Overall Study|Adverse Event|3|||
144746642|NCT05757427|521920402|FG000|Overall Study|MWBI scan of only 1 breast|3|||
144746643|NCT05757427|521920402|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
144746644|NCT03423979|521920403|FG000|Overall Study|Death|5|||
144746645|NCT03423979|521920403|FG000|Overall Study|Adverse Event|4|||
144746646|NCT03423979|521920403|FG000|Overall Study|Withdrawal by Subject|3|||
144746647|NCT03423979|521920403|FG000|Overall Study|Lost to Follow-up|16|||
144746648|NCT04971785|521920404|FG000|Overall Study|Withdrew Consent|5|||
144746649|NCT04971785|521920405|FG001|Overall Study|Withdrew Consent|5|||
144746650|NCT04971785|521920406|FG002|Overall Study|Withdrew Consent|17|||
144746651|NCT04971785|521920407|FG003|Overall Study|Withdrew Consent|7|||
144746652|NCT04971785|521920404|FG000|Overall Study|Adverse Event|7|||
144746653|NCT04971785|521920405|FG001|Overall Study|Adverse Event|8|||
144746654|NCT04971785|521920406|FG002|Overall Study|Adverse Event|6|||
144746655|NCT04971785|521920407|FG003|Overall Study|Adverse Event|3|||
144746656|NCT04971785|521920404|FG000|Overall Study|Lost to Follow-up|2|||
144746657|NCT04971785|521920405|FG001|Overall Study|Lost to Follow-up|1|||
144746658|NCT04971785|521920406|FG002|Overall Study|Lost to Follow-up|6|||
144746659|NCT04971785|521920407|FG003|Overall Study|Lost to Follow-up|7|||
144746660|NCT04971785|521920404|FG000|Overall Study|Protocol Violation|3|||
144746661|NCT04971785|521920405|FG001|Overall Study|Protocol Violation|1|||
144746662|NCT04971785|521920406|FG002|Overall Study|Protocol Violation|1|||
144746663|NCT04971785|521920407|FG003|Overall Study|Protocol Violation|2|||
144746664|NCT04971785|521920404|FG000|Overall Study|Investigator's Discretion|3|||
144746665|NCT04971785|521920405|FG001|Overall Study|Investigator's Discretion|1|||
144746666|NCT04971785|521920406|FG002|Overall Study|Investigator's Discretion|1|||
144746667|NCT04971785|521920407|FG003|Overall Study|Investigator's Discretion|0|||
144746668|NCT04971785|521920404|FG000|Overall Study|Randomized but Never Treated|1|||
144746669|NCT04971785|521920405|FG001|Overall Study|Randomized but Never Treated|2|||
144746670|NCT04971785|521920406|FG002|Overall Study|Randomized but Never Treated|0|||
144746671|NCT04971785|521920407|FG003|Overall Study|Randomized but Never Treated|1|||
144746672|NCT04971785|521920404|FG000|Overall Study|Death|0|||
144746673|NCT04971785|521920405|FG001|Overall Study|Death|1|||
144221205|NCT01514461|520005750|FG000|Overall Study|Physician Decision|1|||
144221206|NCT01514461|520005751|FG001|Overall Study|Physician Decision|1|||
144221207|NCT01514461|520005752|FG002|Overall Study|Physician Decision|0|||
144221208|NCT01514461|520005750|FG000|Overall Study|Patient/guardian decision|1|||
144221209|NCT01514461|520005751|FG001|Overall Study|Patient/guardian decision|1|||
144221210|NCT01514461|520005752|FG002|Overall Study|Patient/guardian decision|1|||
144221211|NCT01514461|520005750|FG000|Overall Study|Death|1|||
144746674|NCT04971785|521920406|FG002|Overall Study|Death|1|||
144746675|NCT04971785|521920407|FG003|Overall Study|Death|0|||
144221212|NCT01514461|520005751|FG001|Overall Study|Death|0|||
144746676|NCT04971785|521920404|FG000|Overall Study|Site Terminated by Sponsor|1|||
144746677|NCT04971785|521920405|FG001|Overall Study|Site Terminated by Sponsor|1|||
144746678|NCT04971785|521920406|FG002|Overall Study|Site Terminated by Sponsor|0|||
144746679|NCT04971785|521920407|FG003|Overall Study|Site Terminated by Sponsor|0|||
144221213|NCT01514461|520005752|FG002|Overall Study|Death|0|||
144221214|NCT03499067|520005753|FG000|First Intervention|Physician Decision|2|||
144221215|NCT03499067|520005754|FG001|First Intervention|Physician Decision|1|||
144221216|NCT03499067|520005753|FG000|First Intervention|Withdrawal by Subject|3|||
144221217|NCT03499067|520005754|FG001|First Intervention|Withdrawal by Subject|6|||
144221218|NCT00654095|520005755|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
144221219|NCT00654095|520005755|FG000|Overall Study|Elevated triglyceride level (2)|1|||
144221220|NCT00654095|520005755|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
144221221|NCT00654095|520005755|FG000|Overall Study|Adverse Event|11|||
144221222|NCT00654095|520005755|FG000|Overall Study|Withdrawal by Subject|5|||
144221223|NCT00654095|520005755|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
144221224|NCT00654095|520005755|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
144221225|NCT00654095|520005755|FG000|Overall Study|Did not meet inclusion criteria|1|||
144221226|NCT02440464|520005756|FG000|Overall Study|Withdrawal by Subject|3|||
144221227|NCT02440464|520005757|FG001|Overall Study|Withdrawal by Subject|2|||
144221228|NCT02392481|520005758|FG000|Overall Study|Adverse Event|0|||
144221229|NCT02392481|520005759|FG001|Overall Study|Adverse Event|0|||
144221230|NCT02392481|520005760|FG002|Overall Study|Adverse Event|1|||
144221231|NCT02392481|520005761|FG003|Overall Study|Adverse Event|2|||
144221232|NCT02392481|520005758|FG000|Overall Study|Withdrawal by Subject|0|||
144221233|NCT02392481|520005759|FG001|Overall Study|Withdrawal by Subject|0|||
144221234|NCT02392481|520005760|FG002|Overall Study|Withdrawal by Subject|1|||
144221235|NCT02392481|520005761|FG003|Overall Study|Withdrawal by Subject|0|||
144221236|NCT02548832|520005763|FG000|Overall Study|Lost to Follow-up|2|||
144221237|NCT02548832|520005764|FG001|Overall Study|Lost to Follow-up|2|||
144221238|NCT02548832|520005765|FG002|Overall Study|Lost to Follow-up|2|||
144221239|NCT03565900|520005766|FG000|Overall Study|Disposition Unknown|4|||
144221240|NCT03565900|520005767|FG001|Overall Study|Disposition Unknown|1|||
144221241|NCT03565900|520005766|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
144221242|NCT03565900|520005767|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
144221243|NCT03565900|520005766|FG000|Overall Study|Withdrawal by Subject|4|||
144221244|NCT03565900|520005767|FG001|Overall Study|Withdrawal by Subject|5|||
144221245|NCT03565900|520005766|FG000|Overall Study|Randomized By Mistake|0|||
144221246|NCT03565900|520005767|FG001|Overall Study|Randomized By Mistake|2|||
144221247|NCT03565900|520005766|FG000|Overall Study|Physician Decision|7|||
144221248|NCT03565900|520005767|FG001|Overall Study|Physician Decision|11|||
144221249|NCT03565900|520005766|FG000|Overall Study|Death|9|||
144221250|NCT03565900|520005767|FG001|Overall Study|Death|7|||
144221251|NCT02058069|520005770|FG000|Overall Study|Exclusion due to implant size|5|||
144221252|NCT02058069|520005770|FG000|Overall Study|Withdrawal by Subject|6|||
144221253|NCT03359850|520005774|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
144221254|NCT03359850|520005775|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
144221255|NCT03359850|520005774|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
144221256|NCT03359850|520005775|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
144221257|NCT03359850|520005774|FG000|Extension Phase (Up to 28 Months)|Death|2|||
144221258|NCT03359850|520005775|FG001|Extension Phase (Up to 28 Months)|Death|4|||
144221259|NCT03359850|520005774|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
144221260|NCT03359850|520005775|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
144221261|NCT03359850|520005774|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
144221262|NCT03359850|520005775|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
144221263|NCT00116779|520005793|FG000|Overall Study|Adverse Event|4|||
144221264|NCT00116779|520005794|FG001|Overall Study|Adverse Event|2|||
144221265|NCT00116779|520005793|FG000|Overall Study|Protocol Violation|1|||
144266410|NCT02631941|520178347|FG005|Overall Study|Adverse Event|0|||
144746680|NCT00980460|521920408|FG000|Overall Study|Death|0|||
144746681|NCT00980460|521920409|FG001|Overall Study|Death|0|||
144746682|NCT00980460|521920410|FG002|Overall Study|Death|1|||
144746683|NCT00980460|521920411|FG003|Overall Study|Death|2|||
144746684|NCT00980460|521920412|FG004|Overall Study|Death|1|||
144746685|NCT00980460|521920408|FG000|Overall Study|Lack of Efficacy|0|||
144746686|NCT00980460|521920409|FG001|Overall Study|Lack of Efficacy|0|||
144746687|NCT00980460|521920410|FG002|Overall Study|Lack of Efficacy|10|||
144746688|NCT00980460|521920411|FG003|Overall Study|Lack of Efficacy|6|||
144746689|NCT00980460|521920412|FG004|Overall Study|Lack of Efficacy|8|||
144746690|NCT00980460|521920408|FG000|Overall Study|Lost to Follow-up|0|||
144746691|NCT00980460|521920409|FG001|Overall Study|Lost to Follow-up|0|||
144746692|NCT00980460|521920410|FG002|Overall Study|Lost to Follow-up|0|||
144221266|NCT00116779|520005794|FG001|Overall Study|Protocol Violation|4|||
144221267|NCT00116779|520005793|FG000|Overall Study|Withdrawal by Subject|4|||
144221268|NCT00116779|520005794|FG001|Overall Study|Withdrawal by Subject|1|||
144221269|NCT00116779|520005793|FG000|Overall Study|Inadequate testosterone suppression|7|||
144221270|NCT00116779|520005794|FG001|Overall Study|Inadequate testosterone suppression|9|||
144221271|NCT00116779|520005793|FG000|Overall Study|Physician Decision|3|||
144221272|NCT00116779|520005794|FG001|Overall Study|Physician Decision|1|||
144221273|NCT00116779|520005793|FG000|Overall Study|Elevated PSA levels|2|||
144266411|NCT02631941|520178348|FG006|Overall Study|Adverse Event|0|||
144266412|NCT02631941|520178349|FG007|Overall Study|Adverse Event|0|||
144746693|NCT00980460|521920411|FG003|Overall Study|Lost to Follow-up|1|||
144746694|NCT00980460|521920412|FG004|Overall Study|Lost to Follow-up|0|||
144746695|NCT00980460|521920408|FG000|Overall Study|Physician Decision|0|||
144746696|NCT00980460|521920409|FG001|Overall Study|Physician Decision|0|||
144746697|NCT00980460|521920410|FG002|Overall Study|Physician Decision|11|||
144746698|NCT00980460|521920411|FG003|Overall Study|Physician Decision|5|||
144746699|NCT00980460|521920412|FG004|Overall Study|Physician Decision|3|||
144746700|NCT00980460|521920408|FG000|Overall Study|Withdrawal by Subject|0|||
144746701|NCT00980460|521920409|FG001|Overall Study|Withdrawal by Subject|0|||
144746702|NCT00980460|521920410|FG002|Overall Study|Withdrawal by Subject|1|||
144746703|NCT00980460|521920411|FG003|Overall Study|Withdrawal by Subject|0|||
144746704|NCT00980460|521920412|FG004|Overall Study|Withdrawal by Subject|0|||
144746705|NCT00980460|521920408|FG000|Overall Study|Ineligible|0|||
144746706|NCT00980460|521920409|FG001|Overall Study|Ineligible|2|||
144746707|NCT00980460|521920410|FG002|Overall Study|Ineligible|3|||
144746708|NCT00980460|521920411|FG003|Overall Study|Ineligible|1|||
144746709|NCT00980460|521920412|FG004|Overall Study|Ineligible|4|||
144746710|NCT00980460|521920408|FG000|Overall Study|Refusal of further therapy|0|||
144746711|NCT00980460|521920409|FG001|Overall Study|Refusal of further therapy|2|||
144746712|NCT00980460|521920410|FG002|Overall Study|Refusal of further therapy|3|||
144746713|NCT00980460|521920411|FG003|Overall Study|Refusal of further therapy|2|||
144746714|NCT00980460|521920412|FG004|Overall Study|Refusal of further therapy|0|||
144746715|NCT00980460|521920408|FG000|Overall Study|No therapy within 42 days of resection|0|||
144746716|NCT00980460|521920409|FG001|Overall Study|No therapy within 42 days of resection|0|||
144746717|NCT00980460|521920410|FG002|Overall Study|No therapy within 42 days of resection|3|||
144746718|NCT00980460|521920411|FG003|Overall Study|No therapy within 42 days of resection|1|||
144746719|NCT00980460|521920412|FG004|Overall Study|No therapy within 42 days of resection|0|||
144746720|NCT00980460|521920408|FG000|Overall Study|No transplant by protocol timepoints|0|||
144746721|NCT00980460|521920409|FG001|Overall Study|No transplant by protocol timepoints|0|||
144746722|NCT00980460|521920410|FG002|Overall Study|No transplant by protocol timepoints|3|||
144746723|NCT00980460|521920411|FG003|Overall Study|No transplant by protocol timepoints|0|||
144746724|NCT00980460|521920412|FG004|Overall Study|No transplant by protocol timepoints|0|||
144746725|NCT01251861|521920413|FG000|Overall Study|Disease progression|6|||
144746726|NCT01251861|521920414|FG001|Overall Study|Disease progression|6|||
144746727|NCT01251861|521920413|FG000|Overall Study|Adverse Event|2|||
144746728|NCT01251861|521920414|FG001|Overall Study|Adverse Event|17|||
144746729|NCT01251861|521920413|FG000|Overall Study|Withdrawal by Subject|2|||
144746730|NCT01251861|521920414|FG001|Overall Study|Withdrawal by Subject|2|||
144746731|NCT01251861|521920413|FG000|Overall Study|Alternative therapy|1|||
144746732|NCT01251861|521920414|FG001|Overall Study|Alternative therapy|0|||
144746733|NCT01251861|521920413|FG000|Overall Study|Other complicating disease|0|||
144746734|NCT01251861|521920414|FG001|Overall Study|Other complicating disease|1|||
144746735|NCT01251861|521920413|FG000|Overall Study|Physician Decision|1|||
144746736|NCT01251861|521920414|FG001|Overall Study|Physician Decision|0|||
144746737|NCT01251861|521920413|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
144746738|NCT01251861|521920414|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
144746739|NCT01251861|521920413|FG000|Overall Study|Other|1|||
144746740|NCT01251861|521920414|FG001|Overall Study|Other|0|||
144746741|NCT01251861|521920413|FG000|Overall Study|Never started therapy|4|||
144746742|NCT01251861|521920414|FG001|Overall Study|Never started therapy|1|||
144746743|NCT01251861|521920413|FG000|Overall Study|Potential interaction of drugs|0|||
144746744|NCT01251861|521920414|FG001|Overall Study|Potential interaction of drugs|1|||
144746745|NCT03516942|521920415|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
144746746|NCT03516942|521920415|FG000|Registration through baseline survey com|Death|8|||
144746747|NCT03516942|521920415|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
144746748|NCT03516942|521920415|FG000|T0: Baseline|LOST|13|||
144746749|NCT03516942|521920415|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
144746750|NCT03516942|521920415|FG000|T1: 3 Months Survey|Death|10|||
144746751|NCT03516942|521920415|FG000|T1: 3 Months Survey|Lost|163|||
144746752|NCT03516942|521920415|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
144746753|NCT03516942|521920415|FG000|T2: 6 Month Survey|Death|14|||
144746754|NCT03516942|521920415|FG000|T2: 6 Month Survey|Lost|180|||
144221274|NCT00116779|520005794|FG001|Overall Study|Elevated PSA levels|2|||
144221275|NCT01321879|520005795|FG000|Overall Study|Lack of Efficacy|5|||
144221276|NCT01321879|520005795|FG000|Overall Study|Adverse Event|5|||
144746755|NCT03516942|521920415|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
144746756|NCT03516942|521920415|FG000|T3: 12 Month Survey|Death|19|||
144746757|NCT03516942|521920415|FG000|T3: 12 Month Survey|Lost|209|||
144746758|NCT05696444|521920728|FG000|Treatment|Physician Decision|0|||
144746759|NCT05696444|521920729|FG001|Treatment|Physician Decision|1|||
144746760|NCT05696444|521920730|FG002|Treatment|Physician Decision|0|||
144746761|NCT05696444|521920728|FG000|30 Days|Death|1|||
144746762|NCT05696444|521920729|FG001|30 Days|Death|1|||
144746763|NCT05696444|521920730|FG002|30 Days|Death|0|||
144746764|NCT05696444|521920728|FG000|30 Days|Missed Visit|1|||
144746765|NCT05696444|521920729|FG001|30 Days|Missed Visit|1|||
144746766|NCT05696444|521920730|FG002|30 Days|Missed Visit|1|||
144221277|NCT01321879|520005795|FG000|Overall Study|Death|3|||
144746767|NCT05200572|521920731|FG000|Overall Study|Withdrawal by Subject|14|||
144746768|NCT05371912|521920732|FG000|Overall Study|Lost to Follow-up|3|||
144746769|NCT05371912|521920733|FG001|Overall Study|Lost to Follow-up|2|||
144746770|NCT02598661|521920736|FG000|Overall Study|Death|27|||
144746771|NCT02598661|521920737|FG001|Overall Study|Death|34|||
144746772|NCT02598661|521920738|FG002|Overall Study|Death|14|||
144746773|NCT02598661|521920739|FG003|Overall Study|Death|1|||
144746774|NCT02598661|521920740|FG004|Overall Study|Death|0|||
144746775|NCT02598661|521920736|FG000|Overall Study|Lost to Follow-up|2|||
144746776|NCT02598661|521920737|FG001|Overall Study|Lost to Follow-up|3|||
144746777|NCT02598661|521920738|FG002|Overall Study|Lost to Follow-up|2|||
144746778|NCT02598661|521920739|FG003|Overall Study|Lost to Follow-up|0|||
144746779|NCT02598661|521920740|FG004|Overall Study|Lost to Follow-up|0|||
144746780|NCT02598661|521920736|FG000|Overall Study|Withdrawal by Subject|13|||
144746781|NCT02598661|521920737|FG001|Overall Study|Withdrawal by Subject|24|||
144746782|NCT02598661|521920738|FG002|Overall Study|Withdrawal by Subject|14|||
144746783|NCT02598661|521920739|FG003|Overall Study|Withdrawal by Subject|1|||
144746784|NCT02598661|521920740|FG004|Overall Study|Withdrawal by Subject|1|||
144746785|NCT02598661|521920736|FG000|Overall Study|Adverse Event|0|||
144746786|NCT02598661|521920737|FG001|Overall Study|Adverse Event|0|||
144746787|NCT02598661|521920738|FG002|Overall Study|Adverse Event|1|||
144746788|NCT02598661|521920739|FG003|Overall Study|Adverse Event|0|||
144746789|NCT02598661|521920740|FG004|Overall Study|Adverse Event|0|||
144746790|NCT02598661|521920736|FG000|Overall Study|Randomized, Never Treated|0|||
144746791|NCT02598661|521920737|FG001|Overall Study|Randomized, Never Treated|0|||
144746792|NCT02598661|521920738|FG002|Overall Study|Randomized, Never Treated|0|||
144746793|NCT02598661|521920739|FG003|Overall Study|Randomized, Never Treated|0|||
144746794|NCT02598661|521920740|FG004|Overall Study|Randomized, Never Treated|1|||
144221278|NCT01321879|520005795|FG000|Overall Study|Withdrawal by Subject|1|||
144221279|NCT03743051|520005796|FG000|Overall Study|Adverse Event|5|||
144221280|NCT03743051|520005797|FG001|Overall Study|Adverse Event|9|||
144221281|NCT03743051|520005796|FG000|Overall Study|Death|27|||
144221282|NCT03743051|520005797|FG001|Overall Study|Death|26|||
144221283|NCT03743051|520005796|FG000|Overall Study|Lost to Follow-up|4|||
144221284|NCT03743051|520005797|FG001|Overall Study|Lost to Follow-up|8|||
144221285|NCT03743051|520005796|FG000|Overall Study|Withdrawal by Subject|32|||
144221286|NCT03743051|520005797|FG001|Overall Study|Withdrawal by Subject|19|||
144221287|NCT03743051|520005796|FG000|Overall Study|Physician Decision|10|||
144221288|NCT03743051|520005797|FG001|Overall Study|Physician Decision|15|||
144221289|NCT03743051|520005796|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
144221290|NCT03743051|520005797|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
144221291|NCT00711087|520005800|FG000|Overall Study|Lost to Follow-up|1|||
144221292|NCT00711087|520005801|FG001|Overall Study|Lost to Follow-up|0|||
144221293|NCT03652051|520005802|FG000|Stage 1|Adverse Event|0|||
144221294|NCT03652051|520005803|FG001|Stage 1|Adverse Event|5|||
144221295|NCT03652051|520005804|FG002|Stage 1|Adverse Event|7|||
144221296|NCT03652051|520005805|FG003|Stage 1|Adverse Event|1|||
144221297|NCT03652051|520005802|FG000|Stage 1|Withdrawal by Subject|0|||
144266413|NCT02631941|520178350|FG008|Overall Study|Adverse Event|0|||
144221298|NCT03652051|520005803|FG001|Stage 1|Withdrawal by Subject|0|||
144221299|NCT03652051|520005804|FG002|Stage 1|Withdrawal by Subject|1|||
144221300|NCT03652051|520005805|FG003|Stage 1|Withdrawal by Subject|0|||
144221301|NCT03652051|520005802|FG000|Stage 2|Adverse Event|0|||
144266414|NCT02631941|520178351|FG009|Overall Study|Adverse Event|0|||
144266415|NCT02631941|520178342|FG000|Overall Study|Withdrawal by Subject|0|||
144221302|NCT03652051|520005803|FG001|Stage 2|Adverse Event|2|||
144221303|NCT03652051|520005804|FG002|Stage 2|Adverse Event|1|||
144221304|NCT03652051|520005805|FG003|Stage 2|Adverse Event|0|||
144221305|NCT03652051|520005802|FG000|Stage 2|Protocol Violation|0|||
144221306|NCT03652051|520005803|FG001|Stage 2|Protocol Violation|1|||
144221307|NCT03652051|520005804|FG002|Stage 2|Protocol Violation|6|||
144221308|NCT03652051|520005805|FG003|Stage 2|Protocol Violation|0|||
144221309|NCT03652051|520005802|FG000|Stage 2|Lost to Follow-up|0|||
144221310|NCT03652051|520005803|FG001|Stage 2|Lost to Follow-up|2|||
144266416|NCT02631941|520178343|FG001|Overall Study|Withdrawal by Subject|0|||
144266417|NCT02631941|520178344|FG002|Overall Study|Withdrawal by Subject|0|||
144266418|NCT02631941|520178345|FG003|Overall Study|Withdrawal by Subject|0|||
144266419|NCT02631941|520178346|FG004|Overall Study|Withdrawal by Subject|1|||
144266420|NCT02631941|520178347|FG005|Overall Study|Withdrawal by Subject|0|||
144266421|NCT02631941|520178348|FG006|Overall Study|Withdrawal by Subject|0|||
144266422|NCT02631941|520178349|FG007|Overall Study|Withdrawal by Subject|1|||
144266423|NCT02631941|520178350|FG008|Overall Study|Withdrawal by Subject|0|||
144266424|NCT02631941|520178351|FG009|Overall Study|Withdrawal by Subject|0|||
144266425|NCT02631941|520178342|FG000|Overall Study|Lost to Follow-up|0|||
144266426|NCT02631941|520178343|FG001|Overall Study|Lost to Follow-up|0|||
144266427|NCT02631941|520178344|FG002|Overall Study|Lost to Follow-up|0|||
144266428|NCT02631941|520178345|FG003|Overall Study|Lost to Follow-up|0|||
144266429|NCT02631941|520178346|FG004|Overall Study|Lost to Follow-up|0|||
144266430|NCT02631941|520178347|FG005|Overall Study|Lost to Follow-up|0|||
144266431|NCT02631941|520178348|FG006|Overall Study|Lost to Follow-up|0|||
144266432|NCT02631941|520178349|FG007|Overall Study|Lost to Follow-up|0|||
144266433|NCT02631941|520178350|FG008|Overall Study|Lost to Follow-up|1|||
144266434|NCT02631941|520178351|FG009|Overall Study|Lost to Follow-up|0|||
144266435|NCT03722576|520178357|FG000|Overall Study|Withdrawal by Subject|3|||
144266436|NCT03722576|520178357|FG000|Overall Study|Adverse Event|2|||
144266437|NCT03722576|520178357|FG000|Overall Study|Physician Decision|1|||
144266438|NCT03722576|520178357|FG000|Overall Study|Lost to Follow-up|1|||
144266439|NCT01240382|520178358|FG000|Overall Study|Adverse Event|2|||
144266440|NCT01240382|520178359|FG001|Overall Study|Adverse Event|1|||
144266441|NCT01240382|520178358|FG000|Overall Study|Lack of Efficacy|0|||
144266442|NCT01240382|520178359|FG001|Overall Study|Lack of Efficacy|2|||
144266443|NCT01240382|520178358|FG000|Overall Study|Fear of adverse events|0|||
144266444|NCT01240382|520178359|FG001|Overall Study|Fear of adverse events|1|||
144266445|NCT01663402|520178363|FG000|Overall Study|Randomized but not treated|19|||
144266446|NCT01663402|520178364|FG001|Overall Study|Randomized but not treated|11|||
144266447|NCT01663402|520178363|FG000|Overall Study|Adverse Event|347|||
144266448|NCT01663402|520178364|FG001|Overall Study|Adverse Event|362|||
144266449|NCT01663402|520178363|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
144266450|NCT01663402|520178364|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
144266451|NCT01663402|520178363|FG000|Overall Study|Poor compliance to protocol|529|||
144266452|NCT01663402|520178364|FG001|Overall Study|Poor compliance to protocol|454|||
144266453|NCT01663402|520178363|FG000|Overall Study|Physician Decision|77|||
144266454|NCT01663402|520178364|FG001|Overall Study|Physician Decision|62|||
144266455|NCT01663402|520178363|FG000|Overall Study|Site terminated by sponsor|1|||
144266456|NCT01663402|520178364|FG001|Overall Study|Site terminated by sponsor|3|||
144266457|NCT01663402|520178363|FG000|Overall Study|Participant moved|139|||
144266458|NCT01663402|520178364|FG001|Overall Study|Participant moved|104|||
144266459|NCT01663402|520178363|FG000|Overall Study|Withdrawal by Subject|118|||
144266460|NCT01663402|520178364|FG001|Overall Study|Withdrawal by Subject|91|||
144266461|NCT01663402|520178363|FG000|Overall Study|Related to study drug administration|96|||
144266462|NCT01663402|520178364|FG001|Overall Study|Related to study drug administration|105|||
144266463|NCT01663402|520178363|FG000|Overall Study|Lost to Follow-up|17|||
144266464|NCT01663402|520178364|FG001|Overall Study|Lost to Follow-up|15|||
144266465|NCT01663402|520178363|FG000|Overall Study|Other than specified above|172|||
144694368|NCT01072175|521733082|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
144266466|NCT01663402|520178364|FG001|Overall Study|Other than specified above|147|||
144266467|NCT03585270|520178369|FG000|Overall Study|Withdrawal by Subject|2|||
144266468|NCT03585270|520178370|FG001|Overall Study|Withdrawal by Subject|6|||
144266469|NCT03585270|520178369|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
144266470|NCT03585270|520178370|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
144266471|NCT03585270|520178369|FG000|Overall Study|Adverse Event|5|||
144266472|NCT03585270|520178370|FG001|Overall Study|Adverse Event|2|||
144694369|NCT01072175|521733083|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
144694370|NCT01072175|521733084|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
144221311|NCT03652051|520005804|FG002|Stage 2|Lost to Follow-up|0|||
144221312|NCT03652051|520005805|FG003|Stage 2|Lost to Follow-up|3|||
144266473|NCT03585270|520178369|FG000|Overall Study|Lost to Follow-up|1|||
144266474|NCT03585270|520178370|FG001|Overall Study|Lost to Follow-up|4|||
144266475|NCT03585270|520178369|FG000|Overall Study|Death|5|||
144266476|NCT03585270|520178370|FG001|Overall Study|Death|3|||
144266477|NCT03585270|520178369|FG000|Overall Study|Other reasons|2|||
144221313|NCT03652051|520005802|FG000|Stage 2|Withdrawal by Subject|0|||
144221314|NCT03652051|520005803|FG001|Stage 2|Withdrawal by Subject|11|||
144221315|NCT03652051|520005804|FG002|Stage 2|Withdrawal by Subject|9|||
144221316|NCT03652051|520005805|FG003|Stage 2|Withdrawal by Subject|3|||
144221317|NCT03164551|520005806|FG000|Overall Study|Imaging discontinued prior completion|8|||
144221318|NCT03164551|520005807|FG001|Overall Study|Imaging discontinued prior completion|0|||
144221319|NCT03164551|520005806|FG000|Overall Study|Participant was non-compliant|1|||
144221320|NCT03164551|520005807|FG001|Overall Study|Participant was non-compliant|0|||
144221321|NCT03164551|520005806|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
144221322|NCT03164551|520005807|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
144221323|NCT03164551|520005806|FG000|Overall Study|Other|8|||
144221324|NCT03164551|520005807|FG001|Overall Study|Other|2|||
144221325|NCT02501928|520005808|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
144221326|NCT02501928|520005809|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
144221327|NCT02501928|520005810|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
144221328|NCT02501928|520005811|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
144221329|NCT02501928|520005812|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
144694371|NCT01072175|521733085|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
144694372|NCT01072175|521733086|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
144694373|NCT01072175|521733087|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
144694374|NCT01072175|521733088|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
144694375|NCT01072175|521733089|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
144694376|NCT01072175|521733090|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
144694377|NCT01072175|521733091|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
144694378|NCT01072175|521733092|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
144694379|NCT01072175|521733080|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694380|NCT01072175|521733081|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694381|NCT01072175|521733082|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694382|NCT01072175|521733083|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694383|NCT01072175|521733084|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694384|NCT01072175|521733085|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
144694385|NCT01072175|521733086|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
144694386|NCT01072175|521733087|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
144694387|NCT01072175|521733088|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694388|NCT01072175|521733089|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694389|NCT01072175|521733090|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694390|NCT01072175|521733091|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694391|NCT01072175|521733092|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
144694392|NCT01072175|521733080|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694393|NCT01072175|521733081|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694394|NCT01072175|521733082|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694395|NCT01072175|521733083|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694396|NCT01072175|521733084|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694397|NCT01072175|521733085|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694398|NCT01072175|521733086|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
144694399|NCT01072175|521733087|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
144694400|NCT01072175|521733088|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694401|NCT01072175|521733089|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694402|NCT01072175|521733090|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694403|NCT01072175|521733091|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694404|NCT01072175|521733092|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
144694405|NCT01072175|521733080|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694406|NCT01072175|521733081|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694407|NCT01072175|521733082|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694408|NCT01072175|521733083|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694409|NCT01072175|521733084|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694410|NCT01072175|521733085|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
144694411|NCT01072175|521733086|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
144694412|NCT01072175|521733087|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
144694413|NCT01072175|521733088|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694414|NCT01072175|521733089|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694415|NCT01072175|521733090|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694416|NCT01072175|521733091|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694417|NCT01072175|521733092|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
144694418|NCT01072175|521733080|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694419|NCT01072175|521733081|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694420|NCT01072175|521733082|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694421|NCT01072175|521733083|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694422|NCT01072175|521733084|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694423|NCT01072175|521733085|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
144694424|NCT01072175|521733086|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
144694425|NCT01072175|521733087|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694426|NCT01072175|521733088|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694427|NCT01072175|521733089|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694428|NCT01072175|521733090|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694429|NCT01072175|521733091|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694430|NCT01072175|521733092|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
144694431|NCT01072175|521733080|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694432|NCT01072175|521733081|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694433|NCT01072175|521733082|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694434|NCT01072175|521733083|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694435|NCT01072175|521733084|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694436|NCT01072175|521733085|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144266478|NCT03585270|520178370|FG001|Overall Study|Other reasons|2|||
144266479|NCT05518539|520178371|FG000|Overall Study|Lost to Follow-up|6|||
144221330|NCT02501928|520005813|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
144221331|NCT02586155|520005819|FG000|Overall Study|Adverse Event|2|||
144221332|NCT02586155|520005820|FG001|Overall Study|Adverse Event|3|||
144221333|NCT02586155|520005819|FG000|Overall Study|Withdrawal by Subject|31|||
144221334|NCT02586155|520005820|FG001|Overall Study|Withdrawal by Subject|24|||
144221335|NCT02586155|520005819|FG000|Overall Study|Lost to Follow-up|7|||
144221336|NCT02586155|520005820|FG001|Overall Study|Lost to Follow-up|13|||
144221337|NCT02586155|520005819|FG000|Overall Study|Death|61|||
144221338|NCT02586155|520005820|FG001|Overall Study|Death|72|||
144221339|NCT02586155|520005819|FG000|Overall Study|Other reasons|26|||
144221340|NCT02586155|520005820|FG001|Overall Study|Other reasons|15|||
144221341|NCT02072980|520005822|FG000|Period 2, Second Wear|Adverse Event|0|||
144221342|NCT02072980|520005823|FG001|Period 2, Second Wear|Adverse Event|1|||
144221343|NCT00473590|520005824|FG000|Overall Study|Adverse Event|3|||
144221344|NCT00473590|520005825|FG001|Overall Study|Adverse Event|3|||
144221345|NCT00473590|520005824|FG000|Overall Study|Death|4|||
144221346|NCT00473590|520005825|FG001|Overall Study|Death|2|||
144221347|NCT00473590|520005824|FG000|Overall Study|Progression not resulting in death|24|||
144221348|NCT00473590|520005825|FG001|Overall Study|Progression not resulting in death|20|||
144221349|NCT00473590|520005824|FG000|Overall Study|Non-protocol-specified therapy|7|||
144221350|NCT00473590|520005825|FG001|Overall Study|Non-protocol-specified therapy|5|||
144221351|NCT00473590|520005824|FG000|Overall Study|Physician Decision|2|||
144221352|NCT00473590|520005825|FG001|Overall Study|Physician Decision|4|||
144221353|NCT00473590|520005824|FG000|Overall Study|Withdrawal by Subject|5|||
144221354|NCT00473590|520005825|FG001|Overall Study|Withdrawal by Subject|3|||
144221355|NCT00473590|520005824|FG000|Overall Study|Other|0|||
144221356|NCT00473590|520005825|FG001|Overall Study|Other|1|||
144221357|NCT01112059|520005826|FG000|Overall Study|Withdrawal by Subject|1|||
144266480|NCT04613518|520178374|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
144266481|NCT04613518|520178375|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
144266482|NCT04613518|520178376|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
144221358|NCT01112059|520005827|FG001|Overall Study|Withdrawal by Subject|0|||
144221359|NCT02575833|520005828|FG000|Overall Study|Withdrawal by Subject|0|||
144221360|NCT02575833|520005829|FG001|Overall Study|Withdrawal by Subject|1|||
144221361|NCT02575833|520005828|FG000|Overall Study|Lost to Follow-up|1|||
144221362|NCT02575833|520005829|FG001|Overall Study|Lost to Follow-up|0|||
144221363|NCT03367819|520005831|FG000|Overall Study|Adverse Event|4|||
144221364|NCT03367819|520005832|FG001|Overall Study|Adverse Event|4|||
144221365|NCT03367819|520005831|FG000|Overall Study|Progressive Disease|15|||
144221366|NCT03367819|520005832|FG001|Overall Study|Progressive Disease|13|||
144221367|NCT03367819|520005831|FG000|Overall Study|Withdrawal by Subject|1|||
144221368|NCT03367819|520005832|FG001|Overall Study|Withdrawal by Subject|0|||
144221369|NCT03367819|520005831|FG000|Overall Study|Other|4|||
144221370|NCT03367819|520005832|FG001|Overall Study|Other|2|||
144221371|NCT02601014|520005833|FG000|Overall Study|Adverse Event|3|||
144221372|NCT02601014|520005834|FG001|Overall Study|Adverse Event|3|||
144221373|NCT02601014|520005833|FG000|Overall Study|Death|3|||
144221374|NCT02601014|520005834|FG001|Overall Study|Death|1|||
144221375|NCT02601014|520005833|FG000|Overall Study|Disease progression|4|||
144221376|NCT02601014|520005834|FG001|Overall Study|Disease progression|8|||
144221377|NCT01168427|520005835|FG000|Overall Study|Patient exited prior to implant|1|||
144221378|NCT00640315|520005838|FG000|Overall Study|Withdrawal by Subject|0|||
144221379|NCT00640315|520005839|FG001|Overall Study|Withdrawal by Subject|1|||
144221380|NCT00397514|520005840|FG000|Overall Study|Withdrawal by Subject|1|||
144221381|NCT00397514|520005840|FG000|Overall Study|Pacing wire malfunction|1|||
144221382|NCT00397514|520005840|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
144221383|NCT00397514|520005840|FG000|Overall Study|early extubation|2|||
144221384|NCT00397514|520005840|FG000|Overall Study|poor echocardiographic windows|1|||
144694437|NCT01072175|521733086|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694438|NCT01072175|521733087|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694439|NCT01072175|521733088|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
144694440|NCT01072175|521733089|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694441|NCT01072175|521733090|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694442|NCT01072175|521733091|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694443|NCT01072175|521733092|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
144694444|NCT01072175|521733080|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694445|NCT01072175|521733081|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694446|NCT01072175|521733082|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694447|NCT01072175|521733083|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694448|NCT01072175|521733084|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694449|NCT01072175|521733085|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694450|NCT01072175|521733086|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694451|NCT01072175|521733087|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694452|NCT01072175|521733088|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
144694453|NCT01072175|521733089|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694454|NCT01072175|521733090|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694455|NCT01072175|521733091|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694456|NCT01072175|521733092|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
144694457|NCT01072175|521733080|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694458|NCT01072175|521733081|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694459|NCT01072175|521733082|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694460|NCT01072175|521733083|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694461|NCT01072175|521733084|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694462|NCT01072175|521733085|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694463|NCT01072175|521733086|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694464|NCT01072175|521733087|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694465|NCT01072175|521733088|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
144694466|NCT01072175|521733089|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694467|NCT01072175|521733090|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694468|NCT01072175|521733091|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694469|NCT01072175|521733092|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
144694470|NCT01072175|521733080|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694471|NCT01072175|521733081|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694472|NCT01072175|521733082|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694473|NCT01072175|521733083|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694474|NCT01072175|521733084|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694475|NCT01072175|521733085|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694476|NCT01072175|521733086|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694477|NCT01072175|521733087|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694478|NCT01072175|521733088|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
144694479|NCT01072175|521733089|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694480|NCT01072175|521733090|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694481|NCT01072175|521733091|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694482|NCT01072175|521733092|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
144694483|NCT01072175|521733080|FG000|Part D (HPMC Capsules)|Death|0|||
144694484|NCT01072175|521733081|FG001|Part D (HPMC Capsules)|Death|0|||
144694485|NCT01072175|521733082|FG002|Part D (HPMC Capsules)|Death|0|||
144694486|NCT01072175|521733083|FG003|Part D (HPMC Capsules)|Death|0|||
144694487|NCT01072175|521733084|FG004|Part D (HPMC Capsules)|Death|0|||
144694488|NCT01072175|521733085|FG005|Part D (HPMC Capsules)|Death|0|||
144694489|NCT01072175|521733086|FG006|Part D (HPMC Capsules)|Death|0|||
144694490|NCT01072175|521733087|FG007|Part D (HPMC Capsules)|Death|0|||
144694491|NCT01072175|521733088|FG008|Part D (HPMC Capsules)|Death|0|||
144694492|NCT01072175|521733089|FG009|Part D (HPMC Capsules)|Death|10|||
144694493|NCT01072175|521733090|FG010|Part D (HPMC Capsules)|Death|12|||
144694494|NCT01072175|521733091|FG011|Part D (HPMC Capsules)|Death|28|||
144694495|NCT01072175|521733092|FG012|Part D (HPMC Capsules)|Death|26|||
144694496|NCT01072175|521733080|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
144694497|NCT01072175|521733081|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
144694498|NCT01072175|521733082|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
144694499|NCT01072175|521733083|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
144694500|NCT01072175|521733084|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
144694501|NCT01072175|521733085|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
144694502|NCT01072175|521733086|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
144694503|NCT01072175|521733087|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
144221385|NCT01256879|520005841|FG000|Overall Study|Withdrawal by Subject|1|||
144221386|NCT00625820|520005843|FG000|Overall Study|Withdrawal by Subject|1|||
144221387|NCT00982657|520005844|FG000|Overall Study|Death|1|||
144221388|NCT00982657|520005845|FG001|Overall Study|Death|0|||
144221389|NCT00982657|520005846|FG002|Overall Study|Death|1|||
144221390|NCT00982657|520005847|FG003|Overall Study|Death|1|||
144221391|NCT00982657|520005844|FG000|Overall Study|Withdrawal by Subject|0|||
144221392|NCT00982657|520005845|FG001|Overall Study|Withdrawal by Subject|0|||
144221393|NCT00982657|520005846|FG002|Overall Study|Withdrawal by Subject|1|||
144221394|NCT00982657|520005847|FG003|Overall Study|Withdrawal by Subject|3|||
144221395|NCT00982657|520005844|FG000|Overall Study|Other|0|||
144221396|NCT00982657|520005845|FG001|Overall Study|Other|0|||
144221397|NCT00982657|520005846|FG002|Overall Study|Other|0|||
144221398|NCT00982657|520005847|FG003|Overall Study|Other|4|||
144221399|NCT00982657|520005844|FG000|Overall Study|On going at date of cut-off|0|||
144221400|NCT00982657|520005845|FG001|Overall Study|On going at date of cut-off|0|||
144221401|NCT00982657|520005846|FG002|Overall Study|On going at date of cut-off|0|||
144221402|NCT00982657|520005847|FG003|Overall Study|On going at date of cut-off|1|||
144221403|NCT00070564|520008070|FG000|Overall Study|Progression|2|||
144221404|NCT00070564|520008071|FG001|Overall Study|Progression|4|||
144221405|NCT00070564|520008072|FG002|Overall Study|Progression|7|||
144221406|NCT00070564|520008073|FG003|Overall Study|Progression|7|||
144221407|NCT00070564|520008074|FG004|Overall Study|Progression|1|||
144221408|NCT00070564|520008075|FG005|Overall Study|Progression|0|||
144221409|NCT00070564|520008070|FG000|Overall Study|Delinquent|1|||
144221410|NCT00070564|520008071|FG001|Overall Study|Delinquent|4|||
144221411|NCT00070564|520008072|FG002|Overall Study|Delinquent|2|||
144221412|NCT00070564|520008073|FG003|Overall Study|Delinquent|0|||
144221413|NCT00070564|520008074|FG004|Overall Study|Delinquent|0|||
144221414|NCT00070564|520008075|FG005|Overall Study|Delinquent|0|||
144221415|NCT00070564|520008070|FG000|Overall Study|Adverse Event|150|||
144221416|NCT00070564|520008071|FG001|Overall Study|Adverse Event|142|||
144221417|NCT00070564|520008072|FG002|Overall Study|Adverse Event|120|||
144221418|NCT00070564|520008073|FG003|Overall Study|Adverse Event|108|||
144221419|NCT00070564|520008074|FG004|Overall Study|Adverse Event|63|||
144221420|NCT00070564|520008075|FG005|Overall Study|Adverse Event|36|||
144221421|NCT00070564|520008070|FG000|Overall Study|Death|4|||
144221422|NCT00070564|520008071|FG001|Overall Study|Death|1|||
144221423|NCT00070564|520008072|FG002|Overall Study|Death|5|||
144221424|NCT00070564|520008073|FG003|Overall Study|Death|3|||
144221425|NCT00070564|520008074|FG004|Overall Study|Death|0|||
144221426|NCT00070564|520008075|FG005|Overall Study|Death|1|||
144221427|NCT00070564|520008070|FG000|Overall Study|Other, not protocol specified|17|||
144221428|NCT00070564|520008071|FG001|Overall Study|Other, not protocol specified|15|||
144221429|NCT00070564|520008072|FG002|Overall Study|Other, not protocol specified|14|||
144221430|NCT00070564|520008073|FG003|Overall Study|Other, not protocol specified|19|||
144221431|NCT00070564|520008074|FG004|Overall Study|Other, not protocol specified|6|||
144221432|NCT00070564|520008075|FG005|Overall Study|Other, not protocol specified|7|||
144221433|NCT00070564|520008070|FG000|Overall Study|Withdrawal by Subject|26|||
144221434|NCT00070564|520008071|FG001|Overall Study|Withdrawal by Subject|37|||
144221435|NCT00070564|520008072|FG002|Overall Study|Withdrawal by Subject|23|||
144221436|NCT00070564|520008073|FG003|Overall Study|Withdrawal by Subject|30|||
144221437|NCT00070564|520008074|FG004|Overall Study|Withdrawal by Subject|8|||
144221438|NCT00070564|520008075|FG005|Overall Study|Withdrawal by Subject|8|||
144221439|NCT00070564|520008070|FG000|Overall Study|Not reported|0|||
144221440|NCT00070564|520008071|FG001|Overall Study|Not reported|0|||
144221441|NCT00070564|520008072|FG002|Overall Study|Not reported|0|||
144221442|NCT00070564|520008073|FG003|Overall Study|Not reported|0|||
144221443|NCT00070564|520008074|FG004|Overall Study|Not reported|1|||
144221444|NCT00070564|520008075|FG005|Overall Study|Not reported|0|||
144221445|NCT04510090|520008081|FG000|FE-HS|Withdrawal by Subject|0|||
144221446|NCT04510090|520008082|FG001|FE-HS|Withdrawal by Subject|0|||
144221447|NCT04510090|520008083|FG002|FE-HS|Withdrawal by Subject|0|||
144221448|NCT04510090|520008084|FG003|FE-HS|Withdrawal by Subject|0|||
144221449|NCT04510090|520008085|FG004|FE-HS|Withdrawal by Subject|1|||
144694504|NCT01072175|521733088|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
144694505|NCT01072175|521733089|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
144694506|NCT01072175|521733090|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
144694507|NCT01072175|521733091|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
144694508|NCT01072175|521733092|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
144221450|NCT04510090|520008086|FG005|FE-HS|Withdrawal by Subject|0|||
144221451|NCT04510090|520008087|FG006|FE-HS|Withdrawal by Subject|0|||
144221452|NCT04510090|520008088|FG007|FE-HS|Withdrawal by Subject|0|||
144221453|NCT05825404|520008089|FG000|First Intervention (Weeks 2-5)|Death|0|||
144221454|NCT05825404|520008090|FG001|First Intervention (Weeks 2-5)|Death|1|||
144221455|NCT05825404|520008089|FG000|Second Intervention (Weeks 8-11)|Death|0|||
144221456|NCT05825404|520008090|FG001|Second Intervention (Weeks 8-11)|Death|1|||
144221457|NCT01127256|520008091|FG000|Overall Study|Adverse Event|13|||
144221458|NCT01127256|520008092|FG001|Overall Study|Adverse Event|13|||
144221459|NCT01127256|520008091|FG000|Overall Study|Lack of Efficacy|4|||
144221460|NCT01127256|520008092|FG001|Overall Study|Lack of Efficacy|0|||
144221461|NCT01127256|520008091|FG000|Overall Study|Lost to Follow-up|16|||
144221462|NCT01127256|520008092|FG001|Overall Study|Lost to Follow-up|17|||
144221463|NCT01127256|520008091|FG000|Overall Study|Withdrawal by Subject|5|||
144221464|NCT01127256|520008092|FG001|Overall Study|Withdrawal by Subject|9|||
144221465|NCT01127256|520008091|FG000|Overall Study|Protocol Violation|1|||
144221466|NCT01127256|520008092|FG001|Overall Study|Protocol Violation|0|||
144221467|NCT01749826|520008093|FG000|Overall Study|Study Terminated|20|||
144221468|NCT01749826|520008094|FG001|Overall Study|Study Terminated|0|||
144221469|NCT00931528|520008095|FG000|Overall Study|Protocol Violation|9|||
144221470|NCT00931528|520008096|FG001|Overall Study|Protocol Violation|12|||
144221471|NCT00931528|520008095|FG000|Overall Study|Withdrawal by Subject|4|||
144221472|NCT00931528|520008096|FG001|Overall Study|Withdrawal by Subject|12|||
144221473|NCT00931528|520008095|FG000|Overall Study|Lost to Follow-up|6|||
144221474|NCT00931528|520008096|FG001|Overall Study|Lost to Follow-up|13|||
144221475|NCT00931528|520008095|FG000|Overall Study|Assessment outside of Time Frame|22|||
144221476|NCT00931528|520008096|FG001|Overall Study|Assessment outside of Time Frame|23|||
144221477|NCT01470248|520008097|FG000|Overall Study|Withdrawal by Subject|1|||
144221478|NCT05085834|520008098|FG000|Overall Study|Lost to Follow-up|9|||
144221479|NCT05085834|520008099|FG001|Overall Study|Lost to Follow-up|2|||
144221480|NCT05085834|520008098|FG000|Overall Study|Adverse Event|6|||
144221481|NCT05085834|520008099|FG001|Overall Study|Adverse Event|0|||
144221482|NCT05085834|520008098|FG000|Overall Study|Death|1|||
144221483|NCT05085834|520008099|FG001|Overall Study|Death|0|||
144221484|NCT05085834|520008098|FG000|Overall Study|Inability to swallow the pill|0|||
144221485|NCT05085834|520008099|FG001|Overall Study|Inability to swallow the pill|1|||
144221486|NCT05364931|520008100|FG000|Overall Study|Adverse Event|0|||
144221487|NCT05364931|520008101|FG001|Overall Study|Adverse Event|2|||
144221488|NCT05364931|520008102|FG002|Overall Study|Adverse Event|1|||
144221489|NCT05364931|520008103|FG003|Overall Study|Adverse Event|0|||
144221490|NCT05364931|520008100|FG000|Overall Study|Lost to Follow-up|1|||
144221491|NCT05364931|520008101|FG001|Overall Study|Lost to Follow-up|0|||
144221492|NCT05364931|520008102|FG002|Overall Study|Lost to Follow-up|0|||
144221493|NCT05364931|520008103|FG003|Overall Study|Lost to Follow-up|0|||
144221494|NCT05364931|520008100|FG000|Overall Study|Withdrawal by Subject|1|||
144221495|NCT05364931|520008101|FG001|Overall Study|Withdrawal by Subject|1|||
144221496|NCT05364931|520008102|FG002|Overall Study|Withdrawal by Subject|3|||
144221497|NCT05364931|520008103|FG003|Overall Study|Withdrawal by Subject|2|||
144221498|NCT05364931|520008100|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
144221499|NCT05364931|520008101|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
144221500|NCT05364931|520008102|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
144221501|NCT05364931|520008103|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
144221502|NCT05364931|520008100|FG000|Overall Study|Discontinued|1|||
144221503|NCT05364931|520008101|FG001|Overall Study|Discontinued|0|||
144221504|NCT05364931|520008102|FG002|Overall Study|Discontinued|0|||
144221505|NCT05364931|520008103|FG003|Overall Study|Discontinued|0|||
144221506|NCT05842967|520008104|FG000|Period 1: SSA|Adverse Event|1|||
144221507|NCT05842967|520008105|FG001|Period 1: SSA|Adverse Event|1|||
144221508|NCT05842967|520008106|FG002|Period 1: SSA|Adverse Event|0|||
144221509|NCT05842967|520008107|FG003|Period 1: SSA|Adverse Event|0|||
144221510|NCT05842967|520008104|FG000|Period 1: SSA|Death|1|||
144221511|NCT05842967|520008105|FG001|Period 1: SSA|Death|0|||
144221512|NCT05842967|520008106|FG002|Period 1: SSA|Death|0|||
144221513|NCT05842967|520008107|FG003|Period 1: SSA|Death|0|||
144221514|NCT05842967|520008104|FG000|Period 1: SSA|Lost to Follow-up|16|||
144221515|NCT05842967|520008105|FG001|Period 1: SSA|Lost to Follow-up|4|||
144221516|NCT05842967|520008106|FG002|Period 1: SSA|Lost to Follow-up|0|||
144221517|NCT05842967|520008107|FG003|Period 1: SSA|Lost to Follow-up|0|||
144221518|NCT05842967|520008104|FG000|Period 1: SSA|Physician Decision|1|||
144221519|NCT05842967|520008105|FG001|Period 1: SSA|Physician Decision|0|||
144694509|NCT01072175|521733080|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694510|NCT01072175|521733081|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694511|NCT01072175|521733082|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694512|NCT01072175|521733083|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694513|NCT01072175|521733084|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694514|NCT01072175|521733085|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694515|NCT01072175|521733086|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694516|NCT01072175|521733087|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694517|NCT01072175|521733088|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694518|NCT01072175|521733089|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
144694519|NCT01072175|521733090|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
144694520|NCT01072175|521733091|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
144694521|NCT01072175|521733092|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
144694522|NCT01072175|521733080|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694523|NCT01072175|521733081|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694524|NCT01072175|521733082|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694525|NCT01072175|521733083|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694526|NCT01072175|521733084|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694527|NCT01072175|521733085|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694528|NCT01072175|521733086|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694529|NCT01072175|521733087|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694530|NCT01072175|521733088|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
144694531|NCT01072175|521733089|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
144694532|NCT01072175|521733090|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
144694533|NCT01072175|521733091|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
144694534|NCT01072175|521733092|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
144694535|NCT01072175|521733080|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694536|NCT01072175|521733081|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694537|NCT01072175|521733082|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694538|NCT01072175|521733083|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694539|NCT01072175|521733084|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694540|NCT01072175|521733085|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694541|NCT01072175|521733086|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694542|NCT01072175|521733087|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694543|NCT01072175|521733088|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694544|NCT01072175|521733089|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694545|NCT01072175|521733090|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
144694546|NCT01072175|521733091|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
144694547|NCT01072175|521733092|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
144694548|NCT02477215|521733093|FG000|Dose Escalation Phase|Physician Decision|1|||
144694549|NCT02477215|521733094|FG001|Dose Escalation Phase|Physician Decision|2|||
144694550|NCT02477215|521733095|FG002|Dose Escalation Phase|Physician Decision|0|||
144694551|NCT02477215|521733093|FG000|Fixed Dose Phase|Physician Decision|0|||
144694552|NCT02477215|521733094|FG001|Fixed Dose Phase|Physician Decision|7|||
144694553|NCT02477215|521733095|FG002|Fixed Dose Phase|Physician Decision|0|||
144694554|NCT02210559|521733096|FG000|Overall Study|Progressive Disease|3|||
144694555|NCT02210559|521733097|FG001|Overall Study|Progressive Disease|2|||
144694556|NCT02210559|521733096|FG000|Overall Study|Adverse Event|2|||
144694557|NCT02210559|521733097|FG001|Overall Study|Adverse Event|2|||
144694558|NCT02210559|521733096|FG000|Overall Study|Physician Decision|1|||
144694559|NCT02210559|521733097|FG001|Overall Study|Physician Decision|0|||
144694560|NCT02210559|521733096|FG000|Overall Study|Withdrawal by Subject|0|||
144694561|NCT02210559|521733097|FG001|Overall Study|Withdrawal by Subject|1|||
144694562|NCT02210559|521733096|FG000|Overall Study|Other than specified|0|||
144694563|NCT02210559|521733097|FG001|Overall Study|Other than specified|1|||
144694564|NCT02546193|521733098|FG000|Overall Study|Withdrawal by Subject|2|||
144694565|NCT02546193|521733099|FG001|Overall Study|Withdrawal by Subject|0|||
144694566|NCT02546193|521733100|FG002|Overall Study|Withdrawal by Subject|1|||
144694567|NCT02546193|521733101|FG003|Overall Study|Withdrawal by Subject|0|||
144694568|NCT02546193|521733098|FG000|Overall Study|Not eligible at time of induction|4|||
144694569|NCT02546193|521733099|FG001|Overall Study|Not eligible at time of induction|6|||
144694570|NCT02546193|521733100|FG002|Overall Study|Not eligible at time of induction|1|||
144694571|NCT02546193|521733101|FG003|Overall Study|Not eligible at time of induction|0|||
144694572|NCT00310440|521733102|FG000|Overall Study|Lost to Follow-up|17|||
144694573|NCT00310440|521733103|FG001|Overall Study|Lost to Follow-up|8|||
144694574|NCT00310440|521733102|FG000|Overall Study|Withdrawal by Subject|2|||
144694575|NCT00310440|521733103|FG001|Overall Study|Withdrawal by Subject|1|||
144221520|NCT05842967|520008106|FG002|Period 1: SSA|Physician Decision|0|||
144221521|NCT05842967|520008107|FG003|Period 1: SSA|Physician Decision|0|||
144221522|NCT05842967|520008104|FG000|Period 1: SSA|Withdrawal by Subject|2|||
144221523|NCT05842967|520008105|FG001|Period 1: SSA|Withdrawal by Subject|2|||
144221524|NCT05842967|520008106|FG002|Period 1: SSA|Withdrawal by Subject|0|||
144221525|NCT05842967|520008107|FG003|Period 1: SSA|Withdrawal by Subject|0|||
144221526|NCT05842967|520008104|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
144221527|NCT05842967|520008105|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
144221528|NCT05842967|520008106|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
144221529|NCT05842967|520008107|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
144221530|NCT05842967|520008104|FG000|Period 2: SSB|Adverse Event|0|||
144221531|NCT05842967|520008105|FG001|Period 2: SSB|Adverse Event|0|||
144221532|NCT05842967|520008106|FG002|Period 2: SSB|Adverse Event|2|||
144221533|NCT05842967|520008107|FG003|Period 2: SSB|Adverse Event|0|||
144221534|NCT05842967|520008104|FG000|Period 2: SSB|Lost to Follow-up|0|||
144221535|NCT05842967|520008105|FG001|Period 2: SSB|Lost to Follow-up|0|||
144221536|NCT05842967|520008106|FG002|Period 2: SSB|Lost to Follow-up|4|||
144221537|NCT05842967|520008107|FG003|Period 2: SSB|Lost to Follow-up|3|||
144221538|NCT05842967|520008104|FG000|Period 2: SSB|Withdrawal by Subject|0|||
144221539|NCT05842967|520008105|FG001|Period 2: SSB|Withdrawal by Subject|0|||
144221540|NCT05842967|520008106|FG002|Period 2: SSB|Withdrawal by Subject|1|||
144221541|NCT05842967|520008107|FG003|Period 2: SSB|Withdrawal by Subject|0|||
144221542|NCT05842967|520008104|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
144221543|NCT05842967|520008105|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
144221544|NCT05842967|520008106|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
144221545|NCT05842967|520008107|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
144221546|NCT05842967|520008104|FG000|Period 2: SSB|Protocol Violation|0|||
144221547|NCT05842967|520008105|FG001|Period 2: SSB|Protocol Violation|0|||
144221548|NCT05842967|520008106|FG002|Period 2: SSB|Protocol Violation|0|||
144221549|NCT05842967|520008107|FG003|Period 2: SSB|Protocol Violation|1|||
144221550|NCT00725283|520008115|FG000|Overall Study|Missing Code|3|||
144221551|NCT00725283|520008115|FG000|Overall Study|Death|5|||
144221552|NCT00725283|520008115|FG000|Overall Study|Other|6|||
144221553|NCT00725283|520008115|FG000|Overall Study|Withdrawal by Subject|10|||
144221554|NCT01823328|520008117|FG000|Overall Study|Withdrawal by Subject|8|||
144221555|NCT01823328|520008118|FG001|Overall Study|Withdrawal by Subject|6|||
144221556|NCT03642262|520008119|FG000|Period 1|Withdrawal by Subject|1|||
144221557|NCT03642262|520008120|FG001|Period 1|Withdrawal by Subject|1|||
144221558|NCT03642262|520008119|FG000|Period 1|Adverse Event|0|||
144221559|NCT03642262|520008120|FG001|Period 1|Adverse Event|1|||
144221560|NCT01557504|520008121|FG000|Overall Study|Physician Decision|1|||
144221561|NCT01557504|520008122|FG001|Overall Study|Physician Decision|0|||
144221562|NCT02750618|520008125|FG000|Overall Study|Withdrawal by Subject|1|||
144221563|NCT00513695|520008128|FG000|Overall Study|Discontinued therapy|2|||
144221564|NCT00513695|520008128|FG000|Overall Study|Progression prior to surgery|3|||
144221565|NCT02157935|520008129|FG000|Overall Study|Withdrawal by Subject|25|||
144221566|NCT02157935|520008130|FG001|Overall Study|Withdrawal by Subject|39|||
144221567|NCT02157935|520008129|FG000|Overall Study|Screen failure|1|||
144221568|NCT02157935|520008130|FG001|Overall Study|Screen failure|2|||
144221569|NCT02157935|520008129|FG000|Overall Study|Protocol Violation|1|||
144221570|NCT02157935|520008130|FG001|Overall Study|Protocol Violation|0|||
144221571|NCT02157935|520008129|FG000|Overall Study|Progressive disease|0|||
144221572|NCT02157935|520008130|FG001|Overall Study|Progressive disease|2|||
144221573|NCT02157935|520008129|FG000|Overall Study|Other|5|||
144221574|NCT02157935|520008130|FG001|Overall Study|Other|12|||
144221575|NCT02157935|520008129|FG000|Overall Study|Lack of Efficacy|0|||
144221576|NCT02157935|520008130|FG001|Overall Study|Lack of Efficacy|1|||
144221577|NCT02157935|520008129|FG000|Overall Study|Death|4|||
144221578|NCT02157935|520008130|FG001|Overall Study|Death|4|||
144221579|NCT02157935|520008129|FG000|Overall Study|Adverse Event|3|||
144221580|NCT02157935|520008130|FG001|Overall Study|Adverse Event|5|||
144221581|NCT02222922|520008137|FG000|Overall Study|Death|0|||
144221582|NCT02222922|520008138|FG001|Overall Study|Death|0|||
144221583|NCT02222922|520008139|FG002|Overall Study|Death|0|||
144221584|NCT02222922|520008140|FG003|Overall Study|Death|0|||
144694576|NCT00310440|521733102|FG000|Overall Study|Missed 12 Month Visit|7|||
144694577|NCT00310440|521733103|FG001|Overall Study|Missed 12 Month Visit|4|||
144221585|NCT02222922|520008141|FG004|Overall Study|Death|13|||
144694578|NCT01287403|521733104|FG000|1st Intervention (1 Day)|Adverse Event|1|||
144221586|NCT02222922|520008142|FG005|Overall Study|Death|0|||
144221587|NCT02222922|520008143|FG006|Overall Study|Death|0|||
144221588|NCT02222922|520008144|FG007|Overall Study|Death|0|||
144221589|NCT02222922|520008145|FG008|Overall Study|Death|2|||
144221590|NCT02222922|520008137|FG000|Overall Study|Lost to Follow-up|0|||
144221591|NCT02222922|520008138|FG001|Overall Study|Lost to Follow-up|0|||
144221592|NCT02222922|520008139|FG002|Overall Study|Lost to Follow-up|1|||
144221593|NCT02222922|520008140|FG003|Overall Study|Lost to Follow-up|0|||
144221594|NCT02222922|520008141|FG004|Overall Study|Lost to Follow-up|9|||
144221595|NCT02222922|520008142|FG005|Overall Study|Lost to Follow-up|1|||
144221596|NCT02222922|520008143|FG006|Overall Study|Lost to Follow-up|0|||
144694579|NCT00148109|521733105|FG000|Overall Study|Lack of Efficacy|10|||
144694580|NCT00148109|521733106|FG001|Overall Study|Lack of Efficacy|18|||
144694581|NCT00148109|521733105|FG000|Overall Study|Adverse Event|0|||
144694582|NCT00148109|521733106|FG001|Overall Study|Adverse Event|2|||
144694583|NCT00148109|521733105|FG000|Overall Study|Withdrawal by Subject|2|||
144694584|NCT00148109|521733106|FG001|Overall Study|Withdrawal by Subject|0|||
144694585|NCT01098266|521733107|FG000|Overall Study|Physician Decision|1|||
144694586|NCT01098266|521733108|FG001|Overall Study|Physician Decision|0|||
144694587|NCT01098266|521733107|FG000|Overall Study|Death|3|||
144694588|NCT01098266|521733108|FG001|Overall Study|Death|2|||
144694589|NCT01098266|521733107|FG000|Overall Study|Withdrawal by Subject|3|||
144221597|NCT02222922|520008144|FG007|Overall Study|Lost to Follow-up|0|||
144221598|NCT02222922|520008145|FG008|Overall Study|Lost to Follow-up|0|||
144221599|NCT02222922|520008137|FG000|Overall Study|Other|0|||
144221600|NCT02222922|520008138|FG001|Overall Study|Other|0|||
144221601|NCT02222922|520008139|FG002|Overall Study|Other|0|||
144221602|NCT02222922|520008140|FG003|Overall Study|Other|2|||
144221603|NCT02222922|520008141|FG004|Overall Study|Other|10|||
144221604|NCT02222922|520008142|FG005|Overall Study|Other|2|||
144221605|NCT02222922|520008143|FG006|Overall Study|Other|2|||
144221606|NCT02222922|520008144|FG007|Overall Study|Other|4|||
144221607|NCT02222922|520008145|FG008|Overall Study|Other|1|||
144221608|NCT02222922|520008137|FG000|Overall Study|Participant refused further follow-up|1|||
144221609|NCT02222922|520008138|FG001|Overall Study|Participant refused further follow-up|0|||
144221610|NCT02222922|520008139|FG002|Overall Study|Participant refused further follow-up|0|||
144221611|NCT02222922|520008140|FG003|Overall Study|Participant refused further follow-up|1|||
144221612|NCT02222922|520008141|FG004|Overall Study|Participant refused further follow-up|6|||
144694590|NCT01098266|521733108|FG001|Overall Study|Withdrawal by Subject|5|||
144694591|NCT00438815|521733109|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
144221613|NCT02222922|520008142|FG005|Overall Study|Participant refused further follow-up|0|||
144221614|NCT02222922|520008143|FG006|Overall Study|Participant refused further follow-up|0|||
144266483|NCT04613518|520178374|FG000|Double-Blind Treatment Period|Adverse Event|2|||
144694592|NCT00438815|521733109|FG000|Overall Study|3-month follow-up no longer required|12|||
144266484|NCT04613518|520178375|FG001|Double-Blind Treatment Period|Adverse Event|0|||
144694593|NCT00438815|521733109|FG000|Overall Study|Noncompliance with protocol requirements|9|||
144694594|NCT00438815|521733109|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
144694595|NCT00438815|521733109|FG000|Overall Study|Lost to Follow-up|6|||
144694596|NCT00438815|521733109|FG000|Overall Study|Withdrawal by Subject|6|||
144694597|NCT00438815|521733109|FG000|Overall Study|Death|1|||
144694598|NCT01733758|521733110|FG000|Overall Study|Adverse Event|5|||
144694599|NCT01733758|521733111|FG001|Overall Study|Adverse Event|7|||
144694600|NCT01733758|521733112|FG002|Overall Study|Adverse Event|8|||
144694601|NCT01733758|521733113|FG003|Overall Study|Adverse Event|1|||
144694602|NCT01733758|521733110|FG000|Overall Study|Withdrawal by Subject|1|||
144694603|NCT01733758|521733111|FG001|Overall Study|Withdrawal by Subject|1|||
144694604|NCT01733758|521733112|FG002|Overall Study|Withdrawal by Subject|5|||
144694605|NCT01733758|521733113|FG003|Overall Study|Withdrawal by Subject|3|||
144694606|NCT01733758|521733110|FG000|Overall Study|Persistent Hyperglycemia|3|||
144694607|NCT01733758|521733111|FG001|Overall Study|Persistent Hyperglycemia|2|||
144694608|NCT01733758|521733112|FG002|Overall Study|Persistent Hyperglycemia|0|||
144694609|NCT01733758|521733113|FG003|Overall Study|Persistent Hyperglycemia|0|||
144694610|NCT01733758|521733110|FG000|Overall Study|Protocol Violation|0|||
144694611|NCT01733758|521733111|FG001|Overall Study|Protocol Violation|1|||
144694612|NCT01733758|521733112|FG002|Overall Study|Protocol Violation|2|||
144694613|NCT01733758|521733113|FG003|Overall Study|Protocol Violation|2|||
144694614|NCT01733758|521733110|FG000|Overall Study|Non-compliance|1|||
144694615|NCT01733758|521733111|FG001|Overall Study|Non-compliance|0|||
144694616|NCT01733758|521733112|FG002|Overall Study|Non-compliance|0|||
144694617|NCT01733758|521733113|FG003|Overall Study|Non-compliance|0|||
144694618|NCT01733758|521733110|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
144694619|NCT01733758|521733111|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
144694620|NCT01733758|521733112|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
144694621|NCT01733758|521733113|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
144694622|NCT01733758|521733110|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
144694623|NCT01733758|521733111|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
144694624|NCT01733758|521733112|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
144694625|NCT01733758|521733113|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
144694626|NCT02557308|521733116|FG000|Overall Study|Withdrawal by Subject|11|||
144694627|NCT02557308|521733117|FG001|Overall Study|Withdrawal by Subject|3|||
144694628|NCT02557308|521733118|FG002|Overall Study|Withdrawal by Subject|2|||
144694629|NCT02557308|521733119|FG003|Overall Study|Withdrawal by Subject|0|||
144694630|NCT02557308|521733120|FG004|Overall Study|Withdrawal by Subject|1|||
144694631|NCT02557308|521733121|FG005|Overall Study|Withdrawal by Subject|0|||
144694632|NCT02557308|521733122|FG006|Overall Study|Withdrawal by Subject|10|||
144694633|NCT02557308|521733123|FG007|Overall Study|Withdrawal by Subject|1|||
144694634|NCT02557308|521733116|FG000|Overall Study|Disease Progression|0|||
144694635|NCT02557308|521733117|FG001|Overall Study|Disease Progression|1|||
144694636|NCT02557308|521733118|FG002|Overall Study|Disease Progression|0|||
144694637|NCT02557308|521733119|FG003|Overall Study|Disease Progression|0|||
144694638|NCT02557308|521733120|FG004|Overall Study|Disease Progression|0|||
144694639|NCT02557308|521733121|FG005|Overall Study|Disease Progression|0|||
144694640|NCT02557308|521733122|FG006|Overall Study|Disease Progression|0|||
144694641|NCT02557308|521733123|FG007|Overall Study|Disease Progression|0|||
144694642|NCT02557308|521733116|FG000|Overall Study|Lack of Efficacy|3|||
144694643|NCT02557308|521733117|FG001|Overall Study|Lack of Efficacy|0|||
144694644|NCT02557308|521733118|FG002|Overall Study|Lack of Efficacy|0|||
144694645|NCT02557308|521733119|FG003|Overall Study|Lack of Efficacy|0|||
144694646|NCT02557308|521733120|FG004|Overall Study|Lack of Efficacy|0|||
144694647|NCT02557308|521733121|FG005|Overall Study|Lack of Efficacy|0|||
144694648|NCT02557308|521733122|FG006|Overall Study|Lack of Efficacy|1|||
144694649|NCT02557308|521733123|FG007|Overall Study|Lack of Efficacy|0|||
144694650|NCT02557308|521733116|FG000|Overall Study|Adverse Event|4|||
144694651|NCT02557308|521733117|FG001|Overall Study|Adverse Event|1|||
144694652|NCT02557308|521733118|FG002|Overall Study|Adverse Event|2|||
144694653|NCT02557308|521733119|FG003|Overall Study|Adverse Event|0|||
144694654|NCT02557308|521733120|FG004|Overall Study|Adverse Event|0|||
144694655|NCT02557308|521733121|FG005|Overall Study|Adverse Event|0|||
144694656|NCT02557308|521733122|FG006|Overall Study|Adverse Event|4|||
144694657|NCT02557308|521733123|FG007|Overall Study|Adverse Event|1|||
144694658|NCT02557308|521733116|FG000|Overall Study|Lost to Follow-up|2|||
144694659|NCT02557308|521733117|FG001|Overall Study|Lost to Follow-up|0|||
144694660|NCT02557308|521733118|FG002|Overall Study|Lost to Follow-up|1|||
144694661|NCT02557308|521733119|FG003|Overall Study|Lost to Follow-up|0|||
144694662|NCT02557308|521733120|FG004|Overall Study|Lost to Follow-up|0|||
144694663|NCT02557308|521733121|FG005|Overall Study|Lost to Follow-up|0|||
144694664|NCT02557308|521733122|FG006|Overall Study|Lost to Follow-up|2|||
144694665|NCT02557308|521733123|FG007|Overall Study|Lost to Follow-up|0|||
144694666|NCT02557308|521733116|FG000|Overall Study|Death|1|||
144694667|NCT02557308|521733117|FG001|Overall Study|Death|0|||
144694668|NCT02557308|521733118|FG002|Overall Study|Death|0|||
144694669|NCT02557308|521733119|FG003|Overall Study|Death|0|||
144694670|NCT02557308|521733120|FG004|Overall Study|Death|0|||
144694671|NCT02557308|521733121|FG005|Overall Study|Death|0|||
144694672|NCT02557308|521733122|FG006|Overall Study|Death|0|||
144694673|NCT02557308|521733123|FG007|Overall Study|Death|0|||
144694674|NCT02557308|521733116|FG000|Overall Study|Study Close|98|||
144694675|NCT02557308|521733117|FG001|Overall Study|Study Close|18|||
144694676|NCT02557308|521733118|FG002|Overall Study|Study Close|5|||
144694677|NCT02557308|521733119|FG003|Overall Study|Study Close|3|||
144694678|NCT02557308|521733120|FG004|Overall Study|Study Close|1|||
144694679|NCT02557308|521733121|FG005|Overall Study|Study Close|0|||
144694680|NCT02557308|521733122|FG006|Overall Study|Study Close|123|||
144694681|NCT02557308|521733123|FG007|Overall Study|Study Close|5|||
144694682|NCT02557308|521733116|FG000|Overall Study|Except for study close|5|||
144694683|NCT02557308|521733117|FG001|Overall Study|Except for study close|0|||
144694684|NCT02557308|521733118|FG002|Overall Study|Except for study close|0|||
144694685|NCT02557308|521733119|FG003|Overall Study|Except for study close|0|||
144694686|NCT02557308|521733120|FG004|Overall Study|Except for study close|3|||
144694687|NCT02557308|521733121|FG005|Overall Study|Except for study close|0|||
144694688|NCT02557308|521733122|FG006|Overall Study|Except for study close|6|||
144694689|NCT02557308|521733123|FG007|Overall Study|Except for study close|10|||
144694690|NCT03911401|521733128|FG000|Overall Study|Adverse Event|1|||
144694691|NCT03911401|521733129|FG001|Overall Study|Adverse Event|2|||
144694692|NCT03911401|521733130|FG002|Overall Study|Adverse Event|5|||
144694693|NCT03911401|521733128|FG000|Overall Study|Lack of Efficacy|1|||
144694694|NCT03911401|521733129|FG001|Overall Study|Lack of Efficacy|1|||
144694695|NCT03911401|521733130|FG002|Overall Study|Lack of Efficacy|8|||
144694696|NCT03911401|521733128|FG000|Overall Study|Physician Decision|0|||
144694697|NCT03911401|521733129|FG001|Overall Study|Physician Decision|0|||
144694698|NCT03911401|521733130|FG002|Overall Study|Physician Decision|1|||
144694699|NCT03911401|521733128|FG000|Overall Study|Withdrawal by Subject|1|||
144694700|NCT03911401|521733129|FG001|Overall Study|Withdrawal by Subject|2|||
144694701|NCT03911401|521733130|FG002|Overall Study|Withdrawal by Subject|0|||
144694702|NCT03911401|521733128|FG000|Overall Study|Withdrawal by parent/guardian|4|||
144694703|NCT03911401|521733129|FG001|Overall Study|Withdrawal by parent/guardian|4|||
144694704|NCT03911401|521733130|FG002|Overall Study|Withdrawal by parent/guardian|11|||
144694705|NCT06104423|521733131|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
144694706|NCT06104423|521733132|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
144694707|NCT06104423|521733133|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
144694708|NCT06104423|521733131|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
144694709|NCT06104423|521733132|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
144694710|NCT06104423|521733133|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
144694711|NCT02918968|521733134|FG000|1st Line AAT|Progressive disease|9|||
144694712|NCT02918968|521733135|FG001|1st Line AAT|Progressive disease|4|||
144694713|NCT02918968|521733134|FG000|1st Line AAT|Adverse Event|12|||
144694714|NCT02918968|521733135|FG001|1st Line AAT|Adverse Event|3|||
144694715|NCT02918968|521733134|FG000|1st Line AAT|Physician Decision|4|||
144694716|NCT02918968|521733135|FG001|1st Line AAT|Physician Decision|2|||
144694717|NCT02918968|521733134|FG000|1st Line AAT|Withdrawal by Subject|2|||
144694718|NCT02918968|521733135|FG001|1st Line AAT|Withdrawal by Subject|1|||
144694719|NCT02918968|521733134|FG000|1st Line AAT|Lost to Follow-up|0|||
144694720|NCT02918968|521733135|FG001|1st Line AAT|Lost to Follow-up|1|||
144694721|NCT02918968|521733134|FG000|1st Line AAT|Death|1|||
144694722|NCT02918968|521733135|FG001|1st Line AAT|Death|0|||
144694723|NCT02918968|521733134|FG000|1st Line AAT|Miscellaneous|1|||
144694724|NCT02918968|521733135|FG001|1st Line AAT|Miscellaneous|0|||
144694725|NCT02918968|521733134|FG000|2nd Line AAT|Progressive disease|21|||
144694726|NCT02918968|521733135|FG001|2nd Line AAT|Progressive disease|3|||
144694727|NCT02918968|521733134|FG000|2nd Line AAT|Adverse Event|2|||
144694728|NCT02918968|521733135|FG001|2nd Line AAT|Adverse Event|5|||
144694729|NCT02918968|521733134|FG000|2nd Line AAT|Physician Decision|0|||
144694730|NCT02918968|521733135|FG001|2nd Line AAT|Physician Decision|1|||
144694731|NCT02918968|521733134|FG000|2nd Line AAT|Withdrawal by Subject|2|||
144694732|NCT02918968|521733135|FG001|2nd Line AAT|Withdrawal by Subject|2|||
144694733|NCT02918968|521733134|FG000|2nd Line AAT|Death|0|||
144694734|NCT02918968|521733135|FG001|2nd Line AAT|Death|1|||
144694735|NCT00496782|521733141|FG000|Overall Study|Protocol Violation|1|||
144694736|NCT00496782|521733142|FG001|Overall Study|Protocol Violation|2|||
144694737|NCT00760994|521733143|FG000|Overall Study|Lost to Follow-up|4|||
144694738|NCT00760994|521733144|FG001|Overall Study|Lost to Follow-up|4|||
144694739|NCT00760994|521733145|FG002|Overall Study|Lost to Follow-up|3|||
144694740|NCT02431559|521733146|FG000|Overall Study|Adverse Event|0|||
144694741|NCT02431559|521733147|FG001|Overall Study|Adverse Event|1|||
144694742|NCT02431559|521733148|FG002|Overall Study|Adverse Event|0|||
144694743|NCT02431559|521733149|FG003|Overall Study|Adverse Event|4|||
144694744|NCT02431559|521733146|FG000|Overall Study|Progressive disease|2|||
144694745|NCT02431559|521733147|FG001|Overall Study|Progressive disease|1|||
144221615|NCT02222922|520008144|FG007|Overall Study|Participant refused further follow-up|0|||
144221616|NCT02222922|520008145|FG008|Overall Study|Participant refused further follow-up|3|||
144221617|NCT01254643|520008146|FG000|Overall Study|Withdrawal by Subject|1|||
144221618|NCT03817125|520008148|FG000|Overall Study|Adverse Event|1|||
144221619|NCT03817125|520008149|FG001|Overall Study|Adverse Event|0|||
144221620|NCT03817125|520008148|FG000|Overall Study|Physician Decision|0|||
144221621|NCT03817125|520008149|FG001|Overall Study|Physician Decision|1|||
144221622|NCT03817125|520008148|FG000|Overall Study|Lack of Efficacy|1|||
144221623|NCT03817125|520008149|FG001|Overall Study|Lack of Efficacy|5|||
144221624|NCT02002221|520008150|FG000|Overall Study|Adverse Event|2|||
144221625|NCT02002221|520008151|FG001|Overall Study|Adverse Event|1|||
144221626|NCT02002221|520008150|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144221627|NCT02002221|520008151|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144694746|NCT02431559|521733148|FG002|Overall Study|Progressive disease|4|||
144694747|NCT02431559|521733149|FG003|Overall Study|Progressive disease|22|||
144694748|NCT02431559|521733146|FG000|Overall Study|Withdrawal by Subject|0|||
144694749|NCT02431559|521733147|FG001|Overall Study|Withdrawal by Subject|1|||
144694750|NCT02431559|521733148|FG002|Overall Study|Withdrawal by Subject|0|||
144694751|NCT02431559|521733149|FG003|Overall Study|Withdrawal by Subject|4|||
144694752|NCT02431559|521733146|FG000|Overall Study|Physician Decision|0|||
144694753|NCT02431559|521733147|FG001|Overall Study|Physician Decision|0|||
144694754|NCT02431559|521733148|FG002|Overall Study|Physician Decision|0|||
144694755|NCT02431559|521733149|FG003|Overall Study|Physician Decision|1|||
144694756|NCT00955682|521733152|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
144694757|NCT00955682|521733153|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
144694758|NCT02924129|521733156|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
144694759|NCT02924129|521733157|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
144694760|NCT02924129|521733156|FG000|Overall Study|Withdrawal by Subject|2|||
144694761|NCT02924129|521733157|FG001|Overall Study|Withdrawal by Subject|2|||
144694762|NCT02924129|521733156|FG000|Overall Study|Physician Decision|1|||
144694763|NCT02924129|521733157|FG001|Overall Study|Physician Decision|0|||
144694764|NCT02924129|521733156|FG000|Overall Study|Missed Visit|0|||
144694765|NCT02924129|521733157|FG001|Overall Study|Missed Visit|1|||
144694766|NCT01348828|521733164|FG000|Overall Study|Death|20|||
144694767|NCT01348828|521733164|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
144694768|NCT01348828|521733164|FG000|Overall Study|Conversion|2|||
144694769|NCT01348828|521733164|FG000|Overall Study|missed visit|1|||
144694770|NCT00302731|521733167|FG000|Overall Study|Lost to Follow-up|1|||
144694771|NCT00302731|521733168|FG001|Overall Study|Lost to Follow-up|2|||
144694772|NCT00302731|521733169|FG002|Overall Study|Lost to Follow-up|0|||
144694773|NCT00302731|521733170|FG003|Overall Study|Lost to Follow-up|0|||
144694774|NCT00302731|521733167|FG000|Overall Study|Adverse Event|0|||
144694775|NCT00302731|521733168|FG001|Overall Study|Adverse Event|2|||
144694776|NCT00302731|521733169|FG002|Overall Study|Adverse Event|2|||
144694777|NCT00302731|521733170|FG003|Overall Study|Adverse Event|0|||
144694778|NCT00302731|521733167|FG000|Overall Study|Withdrawal by Subject|1|||
144694779|NCT00302731|521733168|FG001|Overall Study|Withdrawal by Subject|1|||
144694780|NCT00302731|521733169|FG002|Overall Study|Withdrawal by Subject|0|||
144694781|NCT00302731|521733170|FG003|Overall Study|Withdrawal by Subject|0|||
144694782|NCT00302731|521733167|FG000|Overall Study|Protocol Violation|1|||
144694783|NCT00302731|521733168|FG001|Overall Study|Protocol Violation|0|||
144694784|NCT00302731|521733169|FG002|Overall Study|Protocol Violation|0|||
144694785|NCT00302731|521733170|FG003|Overall Study|Protocol Violation|0|||
144694786|NCT00302731|521733167|FG000|Overall Study|cancer unrelated to study discovered|1|||
144694787|NCT00302731|521733168|FG001|Overall Study|cancer unrelated to study discovered|0|||
144694788|NCT00302731|521733169|FG002|Overall Study|cancer unrelated to study discovered|1|||
144694789|NCT00302731|521733170|FG003|Overall Study|cancer unrelated to study discovered|0|||
144694790|NCT01610752|521733171|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
144694791|NCT01610752|521733172|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
144694792|NCT01610752|521733173|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
144694793|NCT02815670|521733174|FG000|Overall Study|Prematurely discontinued of the trial|1|||
144694794|NCT01002573|521735000|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
144694795|NCT01002573|521735001|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
144694796|NCT00690612|521735007|FG000|Overall Study|Adverse Event|1|||
144694797|NCT00690612|521735007|FG000|Overall Study|Withdrawal by Subject|2|||
144694798|NCT02926833|521735008|FG000|Overall Study|Death|1|||
144694799|NCT02926833|521735009|FG001|Overall Study|Death|1|||
144694800|NCT02926833|521735010|FG002|Overall Study|Death|2|||
144694801|NCT02926833|521735011|FG003|Overall Study|Death|13|||
144694802|NCT02926833|521735008|FG000|Overall Study|Lost to Follow-up|1|||
144694803|NCT02926833|521735009|FG001|Overall Study|Lost to Follow-up|2|||
144694804|NCT02926833|521735010|FG002|Overall Study|Lost to Follow-up|0|||
144694805|NCT02926833|521735011|FG003|Overall Study|Lost to Follow-up|3|||
144694806|NCT02926833|521735008|FG000|Overall Study|Full Consent Withdrawal|0|||
144694807|NCT02926833|521735009|FG001|Overall Study|Full Consent Withdrawal|0|||
144694808|NCT02926833|521735010|FG002|Overall Study|Full Consent Withdrawal|0|||
144694809|NCT02926833|521735011|FG003|Overall Study|Full Consent Withdrawal|2|||
144694810|NCT02926833|521735008|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
144694811|NCT02926833|521735009|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
144694812|NCT02926833|521735010|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
144694813|NCT02926833|521735011|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
144694814|NCT02926833|521735008|FG000|Overall Study|Investigator Decision|0|||
144694815|NCT02926833|521735009|FG001|Overall Study|Investigator Decision|1|||
144694816|NCT02926833|521735010|FG002|Overall Study|Investigator Decision|0|||
144694817|NCT02926833|521735011|FG003|Overall Study|Investigator Decision|0|||
144694818|NCT02926833|521735008|FG000|Overall Study|Adverse Event|0|||
144694819|NCT02926833|521735009|FG001|Overall Study|Adverse Event|0|||
144694820|NCT02926833|521735010|FG002|Overall Study|Adverse Event|1|||
144694821|NCT02926833|521735011|FG003|Overall Study|Adverse Event|0|||
144694822|NCT02926833|521735008|FG000|Overall Study|Partial Withdrawal of Consent|0|||
144694823|NCT02926833|521735009|FG001|Overall Study|Partial Withdrawal of Consent|0|||
144694824|NCT02926833|521735010|FG002|Overall Study|Partial Withdrawal of Consent|0|||
144694825|NCT02926833|521735011|FG003|Overall Study|Partial Withdrawal of Consent|1|||
144694826|NCT01945866|521735012|FG000|Overall Study|Eyes did not complete or were dropped|2|||
144694827|NCT01945866|521735013|FG001|Overall Study|Eyes did not complete or were dropped|0|||
144694828|NCT01846039|521735016|FG000|Overall Study|Protocol Violation|1|||
144694829|NCT01846039|521735016|FG000|Overall Study|Subject Withdrew Consent|1|||
144694830|NCT03039686|521735018|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
144694831|NCT03039686|521735019|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
144694832|NCT03039686|521735020|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
144694833|NCT03039686|521735018|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
144694834|NCT03039686|521735019|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
144694835|NCT03039686|521735020|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
144694836|NCT03039686|521735018|FG000|Double-blind Period|Withdrawal by Subject|2|||
144694837|NCT03039686|521735019|FG001|Double-blind Period|Withdrawal by Subject|2|||
144694838|NCT03039686|521735020|FG002|Double-blind Period|Withdrawal by Subject|1|||
144694839|NCT03039686|521735018|FG000|Double-blind Period|Death|0|||
144694840|NCT03039686|521735019|FG001|Double-blind Period|Death|0|||
144694841|NCT03039686|521735020|FG002|Double-blind Period|Death|1|||
144694842|NCT03039686|521735018|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
144694843|NCT03039686|521735019|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
144694844|NCT03039686|521735020|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
144694845|NCT03039686|521735018|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
144694846|NCT03039686|521735019|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
144694847|NCT03039686|521735020|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
144694848|NCT03039686|521735018|FG000|Open Label Period|Withdrawal by Subject|0|||
144694849|NCT03039686|521735019|FG001|Open Label Period|Withdrawal by Subject|3|||
144694850|NCT03039686|521735020|FG002|Open Label Period|Withdrawal by Subject|1|||
144694851|NCT01855607|521735021|FG000|Overall Study|Withdrawal by Subject|1|||
144694852|NCT01855607|521735021|FG000|Overall Study|Study was terminated|11|||
144694853|NCT02528331|521735022|FG000|Overall Study|Withdrawal by Subject|2|||
144694854|NCT02392078|521735023|FG000|Overall Study|Did not have procedure|32|||
144694855|NCT02392078|521735024|FG001|Overall Study|Did not have procedure|43|||
144694856|NCT02392078|521735025|FG002|Overall Study|Did not have procedure|20|||
144694857|NCT02392078|521735026|FG003|Overall Study|Did not have procedure|1|||
144694858|NCT00635804|521735033|FG000|Overall Study|Adverse Event|0|||
144694859|NCT00635804|521735034|FG001|Overall Study|Adverse Event|0|||
144694860|NCT00635804|521735035|FG002|Overall Study|Adverse Event|0|||
144694861|NCT00635804|521735036|FG003|Overall Study|Adverse Event|0|||
144694862|NCT00635804|521735037|FG004|Overall Study|Adverse Event|0|||
144694863|NCT00635804|521735038|FG005|Overall Study|Adverse Event|1|||
144694864|NCT00635804|521735039|FG006|Overall Study|Adverse Event|0|||
144694865|NCT00635804|521735040|FG007|Overall Study|Adverse Event|0|||
144694866|NCT00635804|521735033|FG000|Overall Study|Withdrawal by Subject|1|||
144694867|NCT00635804|521735034|FG001|Overall Study|Withdrawal by Subject|0|||
144694868|NCT00635804|521735035|FG002|Overall Study|Withdrawal by Subject|0|||
144694869|NCT00635804|521735036|FG003|Overall Study|Withdrawal by Subject|0|||
144694870|NCT00635804|521735037|FG004|Overall Study|Withdrawal by Subject|0|||
144694871|NCT00635804|521735038|FG005|Overall Study|Withdrawal by Subject|0|||
144694872|NCT00635804|521735039|FG006|Overall Study|Withdrawal by Subject|0|||
144694873|NCT00635804|521735040|FG007|Overall Study|Withdrawal by Subject|0|||
144694874|NCT00285857|521735051|FG000|Overall Study|Withdrawal by Subject|2|||
144694875|NCT00285857|521735051|FG000|Overall Study|Inadequate initial breast cytology|1|||
144694876|NCT00285857|521735051|FG000|Overall Study|Adverse Event|1|||
144694877|NCT05602818|521735052|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
144694878|NCT05602818|521735053|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
144694879|NCT05602818|521735054|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
144694880|NCT05602818|521735055|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
144694881|NCT05602818|521735056|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
144694882|NCT05602818|521735057|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
144694883|NCT05602818|521735058|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
144694884|NCT05602818|521735059|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
144694885|NCT05602818|521735060|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
144694886|NCT05602818|521735061|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
144694887|NCT05602818|521735062|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
144694888|NCT05602818|521735063|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
144694889|NCT05602818|521735052|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
144694890|NCT05602818|521735053|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
144694891|NCT05602818|521735054|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694892|NCT05602818|521735055|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144221628|NCT02002221|520008150|FG000|Overall Study|Patient withdrew consent|0|||
144221629|NCT02002221|520008151|FG001|Overall Study|Patient withdrew consent|1|||
144221630|NCT00942084|520008152|FG000|Overall Study|Death|2|||
144221631|NCT01998919|520008153|FG000|Overall Study|Death|2|||
144221632|NCT01998919|520008154|FG001|Overall Study|Death|2|||
144221633|NCT01998919|520008153|FG000|Overall Study|Adverse Event|0|||
144221634|NCT01998919|520008154|FG001|Overall Study|Adverse Event|5|||
144221635|NCT01998919|520008153|FG000|Overall Study|Disease progression|31|||
144694893|NCT05602818|521735056|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694894|NCT05602818|521735057|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694895|NCT05602818|521735058|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694896|NCT05602818|521735059|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694897|NCT05602818|521735060|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694898|NCT05602818|521735061|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694899|NCT05602818|521735062|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694900|NCT05602818|521735063|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
144694901|NCT05602818|521735052|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
144694902|NCT05602818|521735053|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694903|NCT05602818|521735054|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694904|NCT05602818|521735055|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694905|NCT05602818|521735056|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694906|NCT05602818|521735057|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694907|NCT05602818|521735058|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694908|NCT05602818|521735059|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694909|NCT05602818|521735060|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694910|NCT05602818|521735061|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694911|NCT05602818|521735062|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694912|NCT05602818|521735063|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
144694913|NCT05602818|521735052|FG000|Qualification Phase (3 Days)|Other|1|||
144694914|NCT05602818|521735053|FG001|Qualification Phase (3 Days)|Other|0|||
144694915|NCT05602818|521735054|FG002|Qualification Phase (3 Days)|Other|0|||
144694916|NCT05602818|521735055|FG003|Qualification Phase (3 Days)|Other|0|||
144694917|NCT05602818|521735056|FG004|Qualification Phase (3 Days)|Other|0|||
144694918|NCT05602818|521735057|FG005|Qualification Phase (3 Days)|Other|0|||
144694919|NCT05602818|521735058|FG006|Qualification Phase (3 Days)|Other|0|||
144694920|NCT05602818|521735059|FG007|Qualification Phase (3 Days)|Other|0|||
144694921|NCT05602818|521735060|FG008|Qualification Phase (3 Days)|Other|0|||
144694922|NCT05602818|521735061|FG009|Qualification Phase (3 Days)|Other|0|||
144694923|NCT05602818|521735062|FG010|Qualification Phase (3 Days)|Other|0|||
144694924|NCT05602818|521735063|FG011|Qualification Phase (3 Days)|Other|0|||
144694925|NCT05602818|521735052|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694926|NCT05602818|521735053|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
144694927|NCT05602818|521735054|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694928|NCT05602818|521735055|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694929|NCT05602818|521735056|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694930|NCT05602818|521735057|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694931|NCT05602818|521735058|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694932|NCT05602818|521735059|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694933|NCT05602818|521735060|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694934|NCT05602818|521735061|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694935|NCT05602818|521735062|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694936|NCT05602818|521735063|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
144694937|NCT05602818|521735052|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
144694938|NCT05602818|521735053|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
144694939|NCT05602818|521735054|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
144694940|NCT05602818|521735055|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
144694941|NCT05602818|521735056|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
144694942|NCT05602818|521735057|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
144694943|NCT05602818|521735058|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
144694944|NCT05602818|521735059|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
144694945|NCT05602818|521735060|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
144694946|NCT05602818|521735061|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
144694947|NCT05602818|521735062|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
144694948|NCT05602818|521735063|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
144221636|NCT01998919|520008154|FG001|Overall Study|Disease progression|22|||
144221637|NCT01998919|520008153|FG000|Overall Study|Withdrawal by Subject|2|||
144221638|NCT01998919|520008154|FG001|Overall Study|Withdrawal by Subject|4|||
144221639|NCT01998919|520008153|FG000|Overall Study|Lost to Follow-up|2|||
144221640|NCT01998919|520008154|FG001|Overall Study|Lost to Follow-up|0|||
144221641|NCT01998919|520008153|FG000|Overall Study|Other|5|||
144221642|NCT01998919|520008154|FG001|Overall Study|Other|2|||
144221643|NCT01037218|520008157|FG000|Overall Study|Adverse Event|4|||
144221644|NCT01037218|520008158|FG001|Overall Study|Adverse Event|2|||
144221645|NCT01037218|520008159|FG002|Overall Study|Adverse Event|2|||
144221646|NCT01037218|520008160|FG003|Overall Study|Adverse Event|1|||
144221647|NCT01037218|520008157|FG000|Overall Study|Lack of Efficacy|0|||
144221648|NCT01037218|520008158|FG001|Overall Study|Lack of Efficacy|2|||
144221649|NCT01037218|520008159|FG002|Overall Study|Lack of Efficacy|1|||
144221650|NCT01037218|520008160|FG003|Overall Study|Lack of Efficacy|5|||
144221651|NCT01037218|520008157|FG000|Overall Study|Lost to Follow-up|3|||
144221652|NCT01037218|520008158|FG001|Overall Study|Lost to Follow-up|5|||
144221653|NCT01037218|520008159|FG002|Overall Study|Lost to Follow-up|4|||
144221654|NCT01037218|520008160|FG003|Overall Study|Lost to Follow-up|2|||
144221655|NCT01037218|520008157|FG000|Overall Study|Withdrawal by Subject|6|||
144221656|NCT01037218|520008158|FG001|Overall Study|Withdrawal by Subject|7|||
144221657|NCT01037218|520008159|FG002|Overall Study|Withdrawal by Subject|7|||
144221658|NCT01037218|520008160|FG003|Overall Study|Withdrawal by Subject|4|||
144221659|NCT01037218|520008157|FG000|Overall Study|Partner Withdrew Consent|0|||
144221660|NCT01037218|520008158|FG001|Overall Study|Partner Withdrew Consent|3|||
144221661|NCT01037218|520008159|FG002|Overall Study|Partner Withdrew Consent|2|||
144221662|NCT01037218|520008160|FG003|Overall Study|Partner Withdrew Consent|1|||
144221663|NCT01037218|520008157|FG000|Overall Study|Protocol Violation|0|||
144221664|NCT01037218|520008158|FG001|Overall Study|Protocol Violation|0|||
144221665|NCT01037218|520008159|FG002|Overall Study|Protocol Violation|2|||
144221666|NCT01037218|520008160|FG003|Overall Study|Protocol Violation|2|||
144221667|NCT01037218|520008157|FG000|Overall Study|Various|3|||
144221668|NCT01037218|520008158|FG001|Overall Study|Various|2|||
144221669|NCT01037218|520008159|FG002|Overall Study|Various|3|||
144221670|NCT01037218|520008160|FG003|Overall Study|Various|1|||
144221671|NCT00897715|520008164|FG000|Overall Study|Lost to Follow-up|0|||
144221672|NCT00897715|520008165|FG001|Overall Study|Lost to Follow-up|1|||
144221673|NCT00897715|520008164|FG000|Overall Study|Physician Decision|1|||
144221674|NCT00897715|520008165|FG001|Overall Study|Physician Decision|0|||
144221675|NCT00897715|520008164|FG000|Overall Study|increased risk of infection|1|||
144221676|NCT00897715|520008165|FG001|Overall Study|increased risk of infection|0|||
144221677|NCT02714218|520008167|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144221678|NCT02714218|520008168|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144221679|NCT02714218|520008169|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144221680|NCT02714218|520008167|FG000|Pre-Treatment Period|Other reasons|0|||
144221681|NCT02714218|520008168|FG001|Pre-Treatment Period|Other reasons|1|||
144221682|NCT02714218|520008169|FG002|Pre-Treatment Period|Other reasons|0|||
144221683|NCT02714218|520008167|FG000|Treatment Period|Disease Progression|55|||
144221684|NCT02714218|520008168|FG001|Treatment Period|Disease Progression|52|||
144221685|NCT02714218|520008169|FG002|Treatment Period|Disease Progression|14|||
144221686|NCT02714218|520008167|FG000|Treatment Period|Study drug toxicity|46|||
144221687|NCT02714218|520008168|FG001|Treatment Period|Study drug toxicity|70|||
144221688|NCT02714218|520008169|FG002|Treatment Period|Study drug toxicity|6|||
144221689|NCT02714218|520008167|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
144221690|NCT02714218|520008168|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
144221691|NCT02714218|520008169|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
144221692|NCT02714218|520008167|FG000|Treatment Period|Request to discontinue treatment|1|||
144221693|NCT02714218|520008168|FG001|Treatment Period|Request to discontinue treatment|4|||
144221694|NCT02714218|520008169|FG002|Treatment Period|Request to discontinue treatment|1|||
144221695|NCT02714218|520008167|FG000|Treatment Period|Participant withdrew consent|2|||
144221696|NCT02714218|520008168|FG001|Treatment Period|Participant withdrew consent|2|||
144221697|NCT02714218|520008169|FG002|Treatment Period|Participant withdrew consent|0|||
144221698|NCT02714218|520008167|FG000|Treatment Period|Maximum clinical benefit|4|||
144221699|NCT02714218|520008168|FG001|Treatment Period|Maximum clinical benefit|2|||
144221700|NCT02714218|520008169|FG002|Treatment Period|Maximum clinical benefit|0|||
144221701|NCT02714218|520008167|FG000|Treatment Period|Administrative reason by sponsor|2|||
144221702|NCT02714218|520008168|FG001|Treatment Period|Administrative reason by sponsor|1|||
144221703|NCT02714218|520008169|FG002|Treatment Period|Administrative reason by sponsor|0|||
144694949|NCT05602818|521735052|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144221704|NCT02714218|520008167|FG000|Treatment Period|Other reasons|6|||
144221705|NCT02714218|520008168|FG001|Treatment Period|Other reasons|6|||
144221706|NCT02714218|520008169|FG002|Treatment Period|Other reasons|0|||
144221707|NCT02714218|520008167|FG000|Treatment Period|Completed treatment as per protocol|36|||
144221708|NCT02714218|520008168|FG001|Treatment Period|Completed treatment as per protocol|27|||
144221709|NCT02714218|520008169|FG002|Treatment Period|Completed treatment as per protocol|3|||
144221710|NCT02714218|520008167|FG000|Treatment Period|Not reported|9|||
144221711|NCT02714218|520008168|FG001|Treatment Period|Not reported|6|||
144221712|NCT02714218|520008169|FG002|Treatment Period|Not reported|0|||
144221713|NCT01199939|520008170|FG000|Overall Study|Adverse Event|4|||
144221714|NCT01199939|520008170|FG000|Overall Study|Protocol Violation|3|||
144221715|NCT01199939|520008170|FG000|Overall Study|Lost to Follow-up|2|||
144221716|NCT01199939|520008170|FG000|Overall Study|Reached a virologic endpoint|4|||
144221717|NCT03875508|520008173|FG000|Overall Study|Adverse Event|1|||
144221718|NCT03875508|520008173|FG000|Overall Study|Lost to Follow-up|8|||
144266485|NCT04613518|520178376|FG002|Double-Blind Treatment Period|Adverse Event|1|||
144266486|NCT04613518|520178374|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
144266487|NCT04613518|520178375|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
144266488|NCT04613518|520178376|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
144221719|NCT03875508|520008173|FG000|Overall Study|Lack of Efficacy|1|||
144221720|NCT03875508|520008173|FG000|Overall Study|Other, not specified|2|||
144221721|NCT02857816|520008175|FG000|Overall Study|Screen Failure|33|||
144221722|NCT02857816|520008175|FG000|Overall Study|Withdrawal by Subject|4|||
144221723|NCT02857816|520008175|FG000|Overall Study|Lost to Follow-up|1|||
144221724|NCT02289729|520008177|FG000|Overall Study|Lack of Efficacy|3|||
144221725|NCT02289729|520008177|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
144221726|NCT02289729|520008177|FG000|Overall Study|Withdrawal by Subject|1|||
144221727|NCT02289729|520008177|FG000|Overall Study|Death|1|||
144221728|NCT01320293|520008178|FG000|Overall Study|Lack of Efficacy|1|||
144221729|NCT01320293|520008178|FG000|Overall Study|Adverse Event|1|||
144221730|NCT00931411|520008179|FG000|First Intervention - 42 Days|Adverse Event|2|||
144221731|NCT00931411|520008180|FG001|First Intervention - 42 Days|Adverse Event|3|||
144221732|NCT00931411|520008179|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
144221733|NCT00931411|520008180|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
144221734|NCT00931411|520008179|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
144221735|NCT00931411|520008180|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
144221736|NCT00470470|520008181|FG000|Overall Study|Adverse Event|2|||
144221737|NCT00470470|520008181|FG000|Overall Study|Death|2|||
144221738|NCT00470470|520008181|FG000|Overall Study|Not treated|1|||
144221739|NCT03483012|520008182|FG000|Overall Study|Lack of Efficacy|6|||
144221740|NCT01949662|520008194|FG000|Overall Study|Death|9|||
144221741|NCT01949662|520008195|FG001|Overall Study|Death|7|||
144221742|NCT01949662|520008194|FG000|Overall Study|Discharged before an agitation event|8|||
144221743|NCT01949662|520008195|FG001|Overall Study|Discharged before an agitation event|3|||
144221744|NCT01949662|520008194|FG000|Overall Study|Dropped out|1|||
144221745|NCT01949662|520008195|FG001|Overall Study|Dropped out|3|||
144266489|NCT04613518|520178374|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
144266490|NCT04613518|520178375|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
144221746|NCT01949662|520008194|FG000|Overall Study|Ineligible|0|||
144221747|NCT01949662|520008195|FG001|Overall Study|Ineligible|1|||
144221748|NCT02291237|520008196|FG000|Overall Study|Study Terminated by Sponsor|72|||
144221749|NCT02291237|520008197|FG001|Overall Study|Study Terminated by Sponsor|67|||
144221750|NCT02291237|520008196|FG000|Overall Study|Adverse Event|1|||
144221751|NCT02291237|520008197|FG001|Overall Study|Adverse Event|3|||
144221752|NCT02291237|520008196|FG000|Overall Study|Investigator's Discretion|0|||
144221753|NCT02291237|520008197|FG001|Overall Study|Investigator's Discretion|3|||
144221754|NCT02291237|520008196|FG000|Overall Study|Withdrew Consent|11|||
144221755|NCT02291237|520008197|FG001|Overall Study|Withdrew Consent|11|||
144221756|NCT02291237|520008196|FG000|Overall Study|Lost to Follow-up|0|||
144221757|NCT02291237|520008197|FG001|Overall Study|Lost to Follow-up|2|||
144221758|NCT02291237|520008196|FG000|Overall Study|Subject Required Prohibited Medication|2|||
144221759|NCT02291237|520008197|FG001|Overall Study|Subject Required Prohibited Medication|0|||
144221760|NCT00729937|520008200|FG000|Overall Study|Lost to Follow-up|49|||
144221761|NCT00729937|520008201|FG001|Overall Study|Lost to Follow-up|58|||
144221762|NCT00729937|520008202|FG002|Overall Study|Lost to Follow-up|18|||
144221763|NCT00729937|520008203|FG003|Overall Study|Lost to Follow-up|33|||
144221764|NCT00729937|520008204|FG004|Overall Study|Lost to Follow-up|18|||
144221765|NCT00729937|520008205|FG005|Overall Study|Lost to Follow-up|23|||
144221766|NCT00729937|520008200|FG000|Overall Study|Physician Decision|7|||
144221767|NCT00729937|520008201|FG001|Overall Study|Physician Decision|16|||
144221768|NCT00729937|520008202|FG002|Overall Study|Physician Decision|2|||
144221769|NCT00729937|520008203|FG003|Overall Study|Physician Decision|0|||
144221770|NCT00729937|520008204|FG004|Overall Study|Physician Decision|5|||
144221771|NCT00729937|520008205|FG005|Overall Study|Physician Decision|8|||
144221772|NCT00729937|520008200|FG000|Overall Study|Death|1|||
144221773|NCT00729937|520008201|FG001|Overall Study|Death|0|||
144221774|NCT00729937|520008202|FG002|Overall Study|Death|1|||
144221775|NCT00729937|520008203|FG003|Overall Study|Death|0|||
144221776|NCT00729937|520008204|FG004|Overall Study|Death|0|||
144266491|NCT04613518|520178376|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
144694950|NCT05602818|521735053|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694951|NCT05602818|521735054|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694952|NCT05602818|521735055|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144221777|NCT00729937|520008205|FG005|Overall Study|Death|1|||
144221778|NCT00729937|520008200|FG000|Overall Study|Withdrawal by Subject|3|||
144221779|NCT00729937|520008201|FG001|Overall Study|Withdrawal by Subject|5|||
144221780|NCT00729937|520008202|FG002|Overall Study|Withdrawal by Subject|6|||
144221781|NCT00729937|520008203|FG003|Overall Study|Withdrawal by Subject|0|||
144221782|NCT00729937|520008204|FG004|Overall Study|Withdrawal by Subject|4|||
144221783|NCT00729937|520008205|FG005|Overall Study|Withdrawal by Subject|2|||
144221784|NCT00729937|520008200|FG000|Overall Study|Randomized but not treated|12|||
144221785|NCT00729937|520008201|FG001|Overall Study|Randomized but not treated|6|||
144221786|NCT00729937|520008202|FG002|Overall Study|Randomized but not treated|1|||
144221787|NCT00729937|520008203|FG003|Overall Study|Randomized but not treated|0|||
144221788|NCT00729937|520008204|FG004|Overall Study|Randomized but not treated|1|||
144221789|NCT00729937|520008205|FG005|Overall Study|Randomized but not treated|3|||
144221790|NCT00729937|520008200|FG000|Overall Study|Did not meet eligibility criteria|2|||
144221791|NCT00729937|520008201|FG001|Overall Study|Did not meet eligibility criteria|1|||
144221792|NCT00729937|520008202|FG002|Overall Study|Did not meet eligibility criteria|0|||
144221793|NCT00729937|520008203|FG003|Overall Study|Did not meet eligibility criteria|0|||
144221794|NCT00729937|520008204|FG004|Overall Study|Did not meet eligibility criteria|0|||
144221795|NCT00729937|520008205|FG005|Overall Study|Did not meet eligibility criteria|0|||
144221796|NCT00729937|520008200|FG000|Overall Study|Incarcerated|0|||
144221797|NCT00729937|520008201|FG001|Overall Study|Incarcerated|2|||
144221798|NCT00729937|520008202|FG002|Overall Study|Incarcerated|1|||
144221799|NCT00729937|520008203|FG003|Overall Study|Incarcerated|1|||
144221800|NCT00729937|520008204|FG004|Overall Study|Incarcerated|0|||
144221801|NCT00729937|520008205|FG005|Overall Study|Incarcerated|0|||
144221802|NCT01478373|520008207|FG000|Treatment Phase|Protocol Violation|1|||
144221803|NCT01478373|520008207|FG000|Survival Phase|Adverse Event|8|||
144221804|NCT01478373|520008207|FG000|Survival Phase|Protocol Violation|1|||
144221805|NCT01478373|520008207|FG000|Survival Phase|crossover to another study|2|||
144221806|NCT01478373|520008207|FG000|Survival Phase|Progressive Disease|27|||
144221807|NCT01998841|520008213|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
144221808|NCT01998841|520008214|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
144221809|NCT01998841|520008215|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
144221810|NCT01998841|520008216|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
144221811|NCT01998841|520008217|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
144221812|NCT01998841|520008213|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
144221813|NCT01998841|520008214|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
144221814|NCT01998841|520008215|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
144221815|NCT01998841|520008216|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
144221816|NCT01998841|520008217|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
144221817|NCT00972595|520008218|FG000|Period 1|Adverse Event|1|||
144221818|NCT00972595|520008219|FG001|Period 1|Adverse Event|0|||
144221819|NCT02552121|520008220|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
144221820|NCT02552121|520008221|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221821|NCT02552121|520008222|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221822|NCT02552121|520008223|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221823|NCT02552121|520008224|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221824|NCT02552121|520008225|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221825|NCT02552121|520008226|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221826|NCT02552121|520008227|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
144221827|NCT02552121|520008220|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
144221828|NCT02552121|520008221|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221829|NCT02552121|520008222|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221830|NCT02552121|520008223|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221831|NCT02552121|520008224|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221832|NCT02552121|520008225|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221833|NCT02552121|520008226|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221834|NCT02552121|520008227|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
144221835|NCT02552121|520008220|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221836|NCT02552121|520008221|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
144221837|NCT02552121|520008222|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221838|NCT02552121|520008223|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221839|NCT02552121|520008224|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221840|NCT02552121|520008225|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221841|NCT02552121|520008226|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221842|NCT02552121|520008227|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
144221843|NCT02552121|520008220|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221844|NCT02552121|520008221|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
144221845|NCT02552121|520008222|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221846|NCT02552121|520008223|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221847|NCT02552121|520008224|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221848|NCT02552121|520008225|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221849|NCT02552121|520008226|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221850|NCT02552121|520008227|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
144221851|NCT02552121|520008220|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221852|NCT02552121|520008221|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
144221853|NCT02552121|520008222|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221854|NCT02552121|520008223|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221855|NCT02552121|520008224|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221856|NCT02552121|520008225|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221857|NCT02552121|520008226|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221858|NCT02552121|520008227|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
144221859|NCT02552121|520008220|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221860|NCT02552121|520008221|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
144221861|NCT02552121|520008222|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221862|NCT02552121|520008223|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221863|NCT02552121|520008224|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221864|NCT02552121|520008225|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221865|NCT02552121|520008226|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221866|NCT02552121|520008227|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
144221867|NCT02552121|520008220|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
144221868|NCT02552121|520008221|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
144221869|NCT02552121|520008222|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
144221870|NCT02552121|520008223|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
144221871|NCT02552121|520008224|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
144221872|NCT02552121|520008225|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
144221873|NCT02552121|520008226|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
144221874|NCT02552121|520008227|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
144221875|NCT02552121|520008220|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
144221876|NCT02552121|520008221|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
144221877|NCT02552121|520008222|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
144221878|NCT02552121|520008223|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
144221879|NCT02552121|520008224|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
144221880|NCT02552121|520008225|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
144221881|NCT02552121|520008226|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
144221882|NCT02552121|520008227|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
144221883|NCT02552121|520008220|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
144221884|NCT02552121|520008221|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
144221885|NCT02552121|520008222|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
144221886|NCT02552121|520008223|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
144221887|NCT02552121|520008224|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
144221888|NCT02552121|520008225|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
144221889|NCT02552121|520008226|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
144221890|NCT02552121|520008227|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
144221891|NCT02552121|520008220|FG000|Part 2: Cohort Expansion|Death|0|||
144221892|NCT02552121|520008221|FG001|Part 2: Cohort Expansion|Death|0|||
144221893|NCT02552121|520008222|FG002|Part 2: Cohort Expansion|Death|1|||
144221894|NCT02552121|520008223|FG003|Part 2: Cohort Expansion|Death|0|||
144221895|NCT02552121|520008224|FG004|Part 2: Cohort Expansion|Death|0|||
144221896|NCT02552121|520008225|FG005|Part 2: Cohort Expansion|Death|0|||
144221897|NCT02552121|520008226|FG006|Part 2: Cohort Expansion|Death|0|||
144221898|NCT02552121|520008227|FG007|Part 2: Cohort Expansion|Death|0|||
144221899|NCT01522456|520008228|FG000|Overall Study|Adverse Event|2|||
144221900|NCT01522456|520008228|FG000|Overall Study|Lost to Follow-up|2|||
144221901|NCT01522456|520008228|FG000|Overall Study|Withdrawal by Subject|2|||
144221902|NCT01522456|520008228|FG000|Overall Study|Pregnancy|1|||
144221903|NCT01522456|520008228|FG000|Overall Study|Tolerability Assessment|1|||
144221904|NCT04052620|520008229|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
144221905|NCT04052620|520008230|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
144221906|NCT04052620|520008229|FG000|Overall Study|Withdrawal by Subject|1|||
144221907|NCT04052620|520008230|FG001|Overall Study|Withdrawal by Subject|0|||
144221908|NCT04052620|520008229|FG000|Overall Study|Lost to Follow-up|1|||
144221909|NCT04052620|520008230|FG001|Overall Study|Lost to Follow-up|1|||
144221910|NCT04052620|520008229|FG000|Overall Study|Adverse Event|1|||
144694953|NCT05602818|521735056|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694954|NCT05602818|521735057|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694955|NCT05602818|521735058|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694956|NCT05602818|521735059|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694957|NCT05602818|521735060|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694958|NCT05602818|521735061|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
144694959|NCT05602818|521735062|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
144694960|NCT05602818|521735063|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
144694961|NCT05602818|521735052|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
144694962|NCT05602818|521735053|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
144694963|NCT05602818|521735054|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
144694964|NCT05602818|521735055|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
144694965|NCT05602818|521735056|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
144694966|NCT05602818|521735057|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
144694967|NCT05602818|521735058|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
144694968|NCT05602818|521735059|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
144694969|NCT05602818|521735060|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
144694970|NCT05602818|521735061|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
144694971|NCT05602818|521735062|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
144694972|NCT05602818|521735063|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
144694973|NCT00727246|521735064|FG000|Overall Study|could not complete MRI|0|||
144694974|NCT00727246|521735065|FG001|Overall Study|could not complete MRI|1|||
144694975|NCT00727246|521735066|FG002|Overall Study|could not complete MRI|0|||
144694976|NCT00727246|521735067|FG003|Overall Study|could not complete MRI|1|||
144694977|NCT00727246|521735064|FG000|Overall Study|incidental finding|0|||
144694978|NCT00727246|521735065|FG001|Overall Study|incidental finding|0|||
144694979|NCT00727246|521735066|FG002|Overall Study|incidental finding|0|||
144694980|NCT00727246|521735067|FG003|Overall Study|incidental finding|1|||
144694981|NCT00727246|521735064|FG000|Overall Study|withdrawn|0|||
144694982|NCT00727246|521735065|FG001|Overall Study|withdrawn|0|||
144694983|NCT00727246|521735066|FG002|Overall Study|withdrawn|1|||
144694984|NCT00727246|521735067|FG003|Overall Study|withdrawn|0|||
144694985|NCT03814499|521735068|FG000|Overall Study|Lost to Follow-up|3|||
144694986|NCT00351611|521735069|FG000|Overall Study|Adverse Event|11|||
144694987|NCT00351611|521735070|FG001|Overall Study|Adverse Event|3|||
144694988|NCT00351611|521735069|FG000|Overall Study|Death|1|||
144694989|NCT00351611|521735070|FG001|Overall Study|Death|0|||
144694990|NCT00351611|521735069|FG000|Overall Study|Lost to Follow-up|1|||
144694991|NCT00351611|521735070|FG001|Overall Study|Lost to Follow-up|0|||
144694992|NCT00351611|521735069|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
144694993|NCT00351611|521735070|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
144694994|NCT00351611|521735069|FG000|Overall Study|Other|1|||
144694995|NCT00351611|521735070|FG001|Overall Study|Other|0|||
144694996|NCT00351611|521735069|FG000|Overall Study|Protocol Violation|0|||
144694997|NCT00351611|521735070|FG001|Overall Study|Protocol Violation|2|||
144694998|NCT02046993|521735071|FG000|Overall Study|Withdrawal by Subject|2|||
144694999|NCT02046993|521735072|FG001|Overall Study|Withdrawal by Subject|10|||
144695000|NCT02046993|521735071|FG000|Overall Study|Lost to Follow-up|1|||
144695001|NCT02046993|521735072|FG001|Overall Study|Lost to Follow-up|1|||
144695002|NCT01589185|521735073|FG000|Overall Study|Death|1|||
144695003|NCT01589185|521735074|FG001|Overall Study|Death|2|||
144695004|NCT01589185|521735075|FG002|Overall Study|Death|2|||
144695005|NCT01589185|521735076|FG003|Overall Study|Death|0|||
144695006|NCT01589185|521735077|FG004|Overall Study|Death|1|||
144695007|NCT01589185|521735073|FG000|Overall Study|Lost to Follow-up|1|||
144695008|NCT01589185|521735074|FG001|Overall Study|Lost to Follow-up|0|||
144695009|NCT01589185|521735075|FG002|Overall Study|Lost to Follow-up|2|||
144695010|NCT01589185|521735076|FG003|Overall Study|Lost to Follow-up|3|||
144221911|NCT04052620|520008230|FG001|Overall Study|Adverse Event|0|||
144695011|NCT01589185|521735077|FG004|Overall Study|Lost to Follow-up|0|||
144695012|NCT00598442|521735078|FG000|Overall Study|Adverse Event|3|||
144695013|NCT00598442|521735079|FG001|Overall Study|Adverse Event|0|||
144695014|NCT00598442|521735080|FG002|Overall Study|Adverse Event|0|||
144695015|NCT00598442|521735078|FG000|Overall Study|Death|19|||
144695016|NCT00598442|521735079|FG001|Overall Study|Death|11|||
144695017|NCT00598442|521735080|FG002|Overall Study|Death|11|||
144695018|NCT00598442|521735078|FG000|Overall Study|Lost to Follow-up|4|||
144695019|NCT00598442|521735079|FG001|Overall Study|Lost to Follow-up|3|||
144695020|NCT00598442|521735080|FG002|Overall Study|Lost to Follow-up|3|||
144695021|NCT00598442|521735078|FG000|Overall Study|Physician Decision|2|||
144695022|NCT00598442|521735079|FG001|Overall Study|Physician Decision|1|||
144695023|NCT00598442|521735080|FG002|Overall Study|Physician Decision|1|||
144695024|NCT00598442|521735078|FG000|Overall Study|Withdrawal by Subject|8|||
144695025|NCT00598442|521735079|FG001|Overall Study|Withdrawal by Subject|16|||
144695026|NCT00598442|521735080|FG002|Overall Study|Withdrawal by Subject|6|||
144695027|NCT00598442|521735078|FG000|Overall Study|Noncompliance|0|||
144695028|NCT00598442|521735079|FG001|Overall Study|Noncompliance|2|||
144695029|NCT00598442|521735080|FG002|Overall Study|Noncompliance|1|||
144695030|NCT00598442|521735078|FG000|Overall Study|Relocation|1|||
144695031|NCT00598442|521735079|FG001|Overall Study|Relocation|4|||
144695032|NCT00598442|521735080|FG002|Overall Study|Relocation|0|||
144695033|NCT00598442|521735078|FG000|Overall Study|Renal transplant|0|||
144695034|NCT00598442|521735079|FG001|Overall Study|Renal transplant|0|||
144695035|NCT00598442|521735080|FG002|Overall Study|Renal transplant|1|||
144695036|NCT00598442|521735078|FG000|Overall Study|Site closed by sponsor|5|||
144695037|NCT00598442|521735079|FG001|Overall Study|Site closed by sponsor|2|||
144695038|NCT00598442|521735080|FG002|Overall Study|Site closed by sponsor|1|||
144695039|NCT00598442|521735078|FG000|Overall Study|Started dialysis|1|||
144695040|NCT00598442|521735079|FG001|Overall Study|Started dialysis|0|||
144695041|NCT00598442|521735080|FG002|Overall Study|Started dialysis|0|||
144695042|NCT00462501|521735091|FG000|Overall Study|Not treated|3|||
144695043|NCT00462501|521735091|FG000|Overall Study|Adverse Event|2|||
144695044|NCT00408408|521735093|FG000|Overall Study|No follow up data|2|||
144695045|NCT00408408|521735094|FG001|Overall Study|No follow up data|3|||
144695046|NCT00408408|521735095|FG002|Overall Study|No follow up data|0|||
144695047|NCT00408408|521735096|FG003|Overall Study|No follow up data|7|||
144695048|NCT00408408|521735097|FG004|Overall Study|No follow up data|5|||
144695049|NCT00408408|521735098|FG005|Overall Study|No follow up data|3|||
144695050|NCT00267202|521735107|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
144695051|NCT00267202|521735108|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
144695052|NCT00267202|521735107|FG000|Overall Study|Withdrawal by Subject|12|||
144695053|NCT00267202|521735108|FG001|Overall Study|Withdrawal by Subject|15|||
144695054|NCT00267202|521735107|FG000|Overall Study|Adverse Event|13|||
144695055|NCT00267202|521735108|FG001|Overall Study|Adverse Event|7|||
144695056|NCT00267202|521735107|FG000|Overall Study|Protocol Violation|2|||
144695057|NCT00267202|521735108|FG001|Overall Study|Protocol Violation|3|||
144695058|NCT00267202|521735107|FG000|Overall Study|Administrative problems|2|||
144695059|NCT00267202|521735108|FG001|Overall Study|Administrative problems|1|||
144695060|NCT00267202|521735107|FG000|Overall Study|Lost to Follow-up|3|||
144695061|NCT00267202|521735108|FG001|Overall Study|Lost to Follow-up|0|||
144695062|NCT00399542|521735109|FG000|Overall Study|Adverse Event|18|||
144695063|NCT00399542|521735110|FG001|Overall Study|Adverse Event|15|||
144695064|NCT00399542|521735109|FG000|Overall Study|Protocol Violation|13|||
144695065|NCT00399542|521735110|FG001|Overall Study|Protocol Violation|3|||
144695066|NCT00399542|521735109|FG000|Overall Study|Withdrawal by Subject|28|||
144695067|NCT00399542|521735110|FG001|Overall Study|Withdrawal by Subject|10|||
144695068|NCT00399542|521735109|FG000|Overall Study|Lack of Efficacy|18|||
144695069|NCT00399542|521735110|FG001|Overall Study|Lack of Efficacy|8|||
144695070|NCT00399542|521735109|FG000|Overall Study|Lost to Follow-up|6|||
144695071|NCT00399542|521735110|FG001|Overall Study|Lost to Follow-up|6|||
144695072|NCT00399542|521735109|FG000|Overall Study|Other|1|||
144695073|NCT00399542|521735110|FG001|Overall Study|Other|0|||
144695074|NCT00399542|521735109|FG000|Overall Study|Physician Decision|0|||
144695075|NCT00399542|521735110|FG001|Overall Study|Physician Decision|1|||
144695076|NCT03172026|521735111|FG000|Overall Study|Withdrawal by Subject|1|||
144695077|NCT03172026|521735112|FG001|Overall Study|Withdrawal by Subject|0|||
144695078|NCT03172026|521735111|FG000|Overall Study|COVID restrictions|1|||
144695079|NCT03172026|521735112|FG001|Overall Study|COVID restrictions|0|||
144695080|NCT00612456|521735113|FG000|Overall Study|Adverse Event|1|||
144695081|NCT00612456|521735114|FG001|Overall Study|Adverse Event|0|||
144695082|NCT00612456|521735115|FG002|Overall Study|Adverse Event|0|||
144695083|NCT00612456|521735113|FG000|Overall Study|Lack of Efficacy|1|||
144695084|NCT00612456|521735114|FG001|Overall Study|Lack of Efficacy|1|||
144695085|NCT00612456|521735115|FG002|Overall Study|Lack of Efficacy|0|||
144695086|NCT00612456|521735113|FG000|Overall Study|Withdrawal by Subject|0|||
144695087|NCT00612456|521735114|FG001|Overall Study|Withdrawal by Subject|1|||
144695088|NCT00612456|521735115|FG002|Overall Study|Withdrawal by Subject|0|||
144695089|NCT00504595|521735116|FG000|Overall Study|Lack of Efficacy|1|||
144695090|NCT00504595|521735117|FG001|Overall Study|Lack of Efficacy|0|||
144695091|NCT00504595|521735118|FG002|Overall Study|Lack of Efficacy|0|||
144695092|NCT00504595|521735119|FG003|Overall Study|Lack of Efficacy|0|||
144695093|NCT00504595|521735116|FG000|Overall Study|Other|0|||
144695094|NCT00504595|521735117|FG001|Overall Study|Other|0|||
144695095|NCT00504595|521735118|FG002|Overall Study|Other|2|||
144695096|NCT00504595|521735119|FG003|Overall Study|Other|0|||
144695097|NCT04652245|521735124|FG000|Wash-Out Period|Adverse Event|0|||
144695098|NCT04652245|521735125|FG001|Wash-Out Period|Adverse Event|2|||
144266492|NCT04613518|520178374|FG000|Double-Blind Treatment Period|Other Reasons|2|||
144266493|NCT04613518|520178375|FG001|Double-Blind Treatment Period|Other Reasons|0|||
144266494|NCT04613518|520178376|FG002|Double-Blind Treatment Period|Other Reasons|0|||
144266495|NCT04613518|520178374|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
144266496|NCT04613518|520178375|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
144266497|NCT04613518|520178376|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
144266498|NCT04613518|520178374|FG000|Open-Label Treatment Period|Adverse Event|1|||
144266499|NCT04613518|520178375|FG001|Open-Label Treatment Period|Adverse Event|0|||
144266500|NCT04613518|520178376|FG002|Open-Label Treatment Period|Adverse Event|3|||
144266501|NCT04613518|520178374|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
144266502|NCT04613518|520178375|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
144266503|NCT04613518|520178376|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
144266504|NCT04613518|520178374|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
144266505|NCT04613518|520178375|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
144266506|NCT04613518|520178376|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
144266507|NCT04613518|520178374|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
144266508|NCT04613518|520178375|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
144266509|NCT04613518|520178376|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
144266510|NCT04613518|520178374|FG000|Open-Label Treatment Period|Other reasons|1|||
144266511|NCT04613518|520178375|FG001|Open-Label Treatment Period|Other reasons|0|||
144266512|NCT04613518|520178376|FG002|Open-Label Treatment Period|Other reasons|0|||
144266513|NCT01076543|520178377|FG000|Overall Study|Withdrawal by Subject|2|||
144266514|NCT01076543|520178378|FG001|Overall Study|Withdrawal by Subject|0|||
144266515|NCT01076543|520178379|FG002|Overall Study|Withdrawal by Subject|0|||
144266516|NCT01076543|520178380|FG003|Overall Study|Withdrawal by Subject|0|||
144266517|NCT01076543|520178381|FG004|Overall Study|Withdrawal by Subject|0|||
144266518|NCT01076543|520178382|FG005|Overall Study|Withdrawal by Subject|0|||
144266519|NCT00338741|520178383|FG000|Overall Study|Lost to Follow-up|2|||
144266520|NCT00338741|520178384|FG001|Overall Study|Lost to Follow-up|0|||
144266521|NCT01077323|520178385|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
144266522|NCT01077323|520178386|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
144266523|NCT01077323|520178387|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
144266524|NCT01077323|520178385|FG000|Overall Study|Dispensing of drug in baseline period|0|||
144266525|NCT01077323|520178386|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
144266526|NCT01077323|520178387|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
144266527|NCT01077323|520178385|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
144266528|NCT01077323|520178386|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
144266529|NCT01077323|520178387|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
144266530|NCT00617357|520178388|FG000|Overall Study|Lost to Follow-up|7|||
144266531|NCT00617357|520178388|FG000|Overall Study|Death|5|||
144266532|NCT00617357|520178388|FG000|Overall Study|insurance concerns|2|||
144266533|NCT00617357|520178388|FG000|Overall Study|Withdrawal by Subject|1|||
144266534|NCT00617357|520178388|FG000|Overall Study|Physician Decision|1|||
144266535|NCT02616783|520178389|FG000|Overall Study|Randomized but Not Treated|1|||
144695099|NCT04652245|521735124|FG000|Wash-Out Period|Withdrawal by Subject|0|||
144695100|NCT04652245|521735125|FG001|Wash-Out Period|Withdrawal by Subject|2|||
144695101|NCT00851721|521735126|FG000|Overall Study|planned surgery|1|||
144695102|NCT00851721|521735127|FG001|Overall Study|planned surgery|0|||
144695103|NCT00851721|521735126|FG000|Overall Study|Death|1|||
144695104|NCT00851721|521735127|FG001|Overall Study|Death|0|||
144695105|NCT00851721|521735126|FG000|Overall Study|Adverse Event|0|||
144695106|NCT00851721|521735127|FG001|Overall Study|Adverse Event|1|||
144695107|NCT03604159|521735130|FG000|Overall Study|Lost to Follow-up|6|||
144695108|NCT03604159|521735131|FG001|Overall Study|Lost to Follow-up|7|||
144695109|NCT04533204|521735135|FG000|Overall Study|Unable to understand training instructions|1|||
144695110|NCT04533204|521735136|FG001|Overall Study|Unable to understand training instructions|1|||
144695111|NCT00383292|521735137|FG000|Overall Study|Adverse Event|4|||
144695112|NCT00383292|521735138|FG001|Overall Study|Adverse Event|1|||
144695113|NCT00383292|521735139|FG002|Overall Study|Adverse Event|2|||
144695114|NCT00383292|521735137|FG000|Overall Study|Death|3|||
144695115|NCT00383292|521735138|FG001|Overall Study|Death|3|||
144695116|NCT00383292|521735139|FG002|Overall Study|Death|3|||
144695117|NCT00383292|521735137|FG000|Overall Study|Physician Decision|4|||
144695118|NCT00383292|521735138|FG001|Overall Study|Physician Decision|0|||
144695119|NCT00383292|521735139|FG002|Overall Study|Physician Decision|1|||
144695120|NCT00383292|521735137|FG000|Overall Study|Withdrawal by Subject|3|||
144695121|NCT00383292|521735138|FG001|Overall Study|Withdrawal by Subject|2|||
144695122|NCT00383292|521735139|FG002|Overall Study|Withdrawal by Subject|2|||
144695123|NCT00383292|521735137|FG000|Overall Study|Other|1|||
144695124|NCT00383292|521735138|FG001|Overall Study|Other|0|||
144695125|NCT00383292|521735139|FG002|Overall Study|Other|0|||
144221912|NCT04052620|520008229|FG000|Overall Study|Subject did not meet study Criteria|0|||
144221913|NCT04052620|520008230|FG001|Overall Study|Subject did not meet study Criteria|1|||
144221914|NCT04052620|520008229|FG000|Overall Study|Screened failure, randomized by mistake|0|||
144221915|NCT04052620|520008230|FG001|Overall Study|Screened failure, randomized by mistake|1|||
144221916|NCT04052620|520008229|FG000|Overall Study|Personal reasons|2|||
144221917|NCT04052620|520008230|FG001|Overall Study|Personal reasons|4|||
144221918|NCT04052620|520008229|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
144221919|NCT04052620|520008230|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
144221920|NCT02201784|520008231|FG000|Overall Study|Failure to achieve adequate block|2|||
144221921|NCT02201784|520008232|FG001|Overall Study|Failure to achieve adequate block|0|||
144221922|NCT00258960|520008233|FG000|Overall Study|Death|2|||
144221923|NCT00258960|520008233|FG000|Overall Study|Disease Progression|7|||
144221924|NCT00258960|520008233|FG000|Overall Study|Adverse Event|4|||
144221925|NCT00258960|520008233|FG000|Overall Study|Physician Decision|1|||
144221926|NCT00258960|520008233|FG000|Overall Study|Withdrawal by Subject|1|||
144221927|NCT00258960|520008233|FG000|Overall Study|Mistake|2|||
144221928|NCT00550459|520008234|FG000|Overall Study|Adverse Event|0|||
144221929|NCT00550459|520008235|FG001|Overall Study|Adverse Event|2|||
144221930|NCT00550459|520008234|FG000|Overall Study|Withdrawal by Subject|1|||
144221931|NCT00550459|520008235|FG001|Overall Study|Withdrawal by Subject|1|||
144221932|NCT00584454|520008236|FG000|Overall Study|Adverse Event|1|||
144221933|NCT00584454|520008236|FG000|Overall Study|Relocation|1|||
144221934|NCT00584454|520008236|FG000|Overall Study|Clinical Hold|2|||
144221935|NCT01742897|520008237|FG000|Overall Study|Adverse Event|3|||
144221936|NCT01742897|520008237|FG000|Overall Study|Withdrawal by Subject|1|||
144221937|NCT01742897|520008237|FG000|Overall Study|Other|1|||
144221938|NCT00445146|520008240|FG000|Overall Study|Withdrew Consent|29|||
144221939|NCT00445146|520008240|FG000|Overall Study|Lack of Efficacy|28|||
144221940|NCT00445146|520008240|FG000|Overall Study|Investigator's Discretion|22|||
144221941|NCT00445146|520008240|FG000|Overall Study|Adverse Event|13|||
144221942|NCT00445146|520008240|FG000|Overall Study|Lost to Follow-up|13|||
144221943|NCT00445146|520008240|FG000|Overall Study|Death|9|||
144221944|NCT00445146|520008240|FG000|Overall Study|Protocol Violation|4|||
144221945|NCT00445146|520008240|FG000|Overall Study|Pregnancy|1|||
144221946|NCT00725920|520008241|FG000|Overall Study|Lack of Efficacy|3|||
144221947|NCT00725920|520008242|FG001|Overall Study|Lack of Efficacy|6|||
144221948|NCT02623725|520008243|FG000|Overall Study|Non compliance with protocol|9|||
144221949|NCT02623725|520008244|FG001|Overall Study|Non compliance with protocol|3|||
144221950|NCT02623725|520008243|FG000|Overall Study|Serious adverse event|0|||
144221951|NCT02623725|520008244|FG001|Overall Study|Serious adverse event|2|||
144221952|NCT02623725|520008243|FG000|Overall Study|Withdrawal by Subject|7|||
144221953|NCT02623725|520008244|FG001|Overall Study|Withdrawal by Subject|1|||
144221954|NCT02456740|520008245|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
144221955|NCT02456740|520008246|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
144221956|NCT02456740|520008247|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
144221957|NCT02456740|520008248|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
144221958|NCT02456740|520008249|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
144221959|NCT02456740|520008250|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
144221960|NCT02456740|520008251|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
144221961|NCT02456740|520008252|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
144221962|NCT02456740|520008253|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
144221963|NCT02456740|520008245|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
144221964|NCT02456740|520008246|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
144221965|NCT02456740|520008247|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
144221966|NCT02456740|520008248|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
144221967|NCT02456740|520008249|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
144221968|NCT02456740|520008250|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
144221969|NCT02456740|520008251|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
144221970|NCT02456740|520008252|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
144221971|NCT02456740|520008253|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
144221972|NCT02456740|520008245|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
144221973|NCT02456740|520008246|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
144221974|NCT02456740|520008247|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
144221975|NCT02456740|520008248|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
144221976|NCT02456740|520008249|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
144695126|NCT01303159|521735146|FG000|Overall Study|Death|16|||
144695127|NCT01303159|521735146|FG000|Overall Study|Study Termination|7|||
144695128|NCT02442284|521735158|FG000|Overall Study|Adverse Event|1|||
144695129|NCT02442284|521735158|FG000|Overall Study|Withdrew Consent|2|||
144695130|NCT02442284|521735158|FG000|Overall Study|Lost to Follow-up|3|||
144695131|NCT02442284|521735158|FG000|Overall Study|Other|1|||
144695132|NCT00842829|521735159|FG000|Dose Titration Period|Adverse Event|11|||
144695133|NCT00842829|521735160|FG001|Dose Titration Period|Adverse Event|10|||
144695134|NCT00842829|521735161|FG002|Dose Titration Period|Adverse Event|0|||
144695135|NCT00842829|521735159|FG000|Dose Titration Period|Lack of Efficacy|4|||
144695136|NCT00842829|521735160|FG001|Dose Titration Period|Lack of Efficacy|1|||
144695137|NCT00842829|521735161|FG002|Dose Titration Period|Lack of Efficacy|0|||
144695138|NCT00842829|521735159|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
144695139|NCT00842829|521735160|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
144695140|NCT00842829|521735161|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
144695141|NCT00842829|521735159|FG000|Dose Titration Period|Withdrawal by Subject|2|||
144695142|NCT00842829|521735160|FG001|Dose Titration Period|Withdrawal by Subject|6|||
144695143|NCT00842829|521735161|FG002|Dose Titration Period|Withdrawal by Subject|0|||
144695144|NCT00842829|521735159|FG000|Dose Titration Period|Other|5|||
144695145|NCT00842829|521735160|FG001|Dose Titration Period|Other|4|||
144695146|NCT00842829|521735161|FG002|Dose Titration Period|Other|0|||
144695147|NCT00842829|521735159|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
144695148|NCT00842829|521735160|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
144695149|NCT00842829|521735161|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
144695150|NCT00842829|521735159|FG000|Dose Titration Period|Non-compliance to study drug|2|||
144695151|NCT00842829|521735160|FG001|Dose Titration Period|Non-compliance to study drug|1|||
144695152|NCT00842829|521735161|FG002|Dose Titration Period|Non-compliance to study drug|0|||
144695153|NCT00842829|521735159|FG000|Treatment Period|Adverse Event|0|||
144695154|NCT00842829|521735160|FG001|Treatment Period|Adverse Event|0|||
144695155|NCT00842829|521735161|FG002|Treatment Period|Adverse Event|15|||
144695156|NCT00842829|521735159|FG000|Treatment Period|Lack of Efficacy|0|||
144695157|NCT00842829|521735160|FG001|Treatment Period|Lack of Efficacy|0|||
144695158|NCT00842829|521735161|FG002|Treatment Period|Lack of Efficacy|6|||
144695159|NCT00842829|521735159|FG000|Treatment Period|Unstable persistent cancer pain|0|||
144695160|NCT00842829|521735160|FG001|Treatment Period|Unstable persistent cancer pain|0|||
144695161|NCT00842829|521735161|FG002|Treatment Period|Unstable persistent cancer pain|5|||
144695162|NCT00842829|521735159|FG000|Treatment Period|Withdrawal by Subject|0|||
144695163|NCT00842829|521735160|FG001|Treatment Period|Withdrawal by Subject|0|||
144695164|NCT00842829|521735161|FG002|Treatment Period|Withdrawal by Subject|11|||
144695165|NCT00842829|521735159|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
144695166|NCT00842829|521735160|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
144695167|NCT00842829|521735161|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
144695168|NCT00842829|521735159|FG000|Treatment Period|Protocol Violation|0|||
144695169|NCT00842829|521735160|FG001|Treatment Period|Protocol Violation|0|||
144695170|NCT00842829|521735161|FG002|Treatment Period|Protocol Violation|2|||
144695171|NCT00842829|521735159|FG000|Treatment Period|Other|0|||
144695172|NCT00842829|521735160|FG001|Treatment Period|Other|0|||
144695173|NCT00842829|521735161|FG002|Treatment Period|Other|18|||
144695174|NCT00842829|521735159|FG000|Treatment Period|Non-compliance to study procedures|0|||
144695175|NCT00842829|521735160|FG001|Treatment Period|Non-compliance to study procedures|0|||
144695176|NCT00842829|521735161|FG002|Treatment Period|Non-compliance to study procedures|4|||
144695177|NCT00842829|521735159|FG000|Treatment Period|Unclear completion status|0|||
144695178|NCT00842829|521735160|FG001|Treatment Period|Unclear completion status|0|||
144695179|NCT00842829|521735161|FG002|Treatment Period|Unclear completion status|1|||
144695180|NCT00842829|521735159|FG000|Continuation Period|Adverse Event|0|||
144695181|NCT00842829|521735160|FG001|Continuation Period|Adverse Event|0|||
144695182|NCT00842829|521735161|FG002|Continuation Period|Adverse Event|32|||
144695183|NCT00842829|521735159|FG000|Continuation Period|Lack of Efficacy|0|||
144695184|NCT00842829|521735160|FG001|Continuation Period|Lack of Efficacy|0|||
144695185|NCT00842829|521735161|FG002|Continuation Period|Lack of Efficacy|6|||
144695186|NCT00842829|521735159|FG000|Continuation Period|Unstable persistent cancer pain|0|||
144695187|NCT00842829|521735160|FG001|Continuation Period|Unstable persistent cancer pain|0|||
144695188|NCT00842829|521735161|FG002|Continuation Period|Unstable persistent cancer pain|3|||
144695189|NCT00842829|521735159|FG000|Continuation Period|Withdrawal by Subject|0|||
144695190|NCT00842829|521735160|FG001|Continuation Period|Withdrawal by Subject|0|||
144695191|NCT00842829|521735161|FG002|Continuation Period|Withdrawal by Subject|10|||
144695192|NCT00842829|521735159|FG000|Continuation Period|Other|0|||
144695193|NCT00842829|521735160|FG001|Continuation Period|Other|0|||
144695194|NCT00842829|521735161|FG002|Continuation Period|Other|7|||
144221977|NCT02456740|520008250|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
144221978|NCT02456740|520008251|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
144221979|NCT02456740|520008252|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
144221980|NCT02456740|520008253|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
144221981|NCT02456740|520008245|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
144221982|NCT02456740|520008246|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
144221983|NCT02456740|520008247|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
144221984|NCT02456740|520008248|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
144221985|NCT02456740|520008249|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
144221986|NCT02456740|520008250|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
144221987|NCT02456740|520008251|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
144221988|NCT02456740|520008252|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
144221989|NCT02456740|520008253|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
144221990|NCT02456740|520008245|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144221991|NCT02456740|520008246|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144221992|NCT02456740|520008247|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
144221993|NCT02456740|520008248|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
144695195|NCT00842829|521735159|FG000|Continuation Period|Non-compliance to study procedures|0|||
144695196|NCT00842829|521735160|FG001|Continuation Period|Non-compliance to study procedures|0|||
144695197|NCT00842829|521735161|FG002|Continuation Period|Non-compliance to study procedures|2|||
144695198|NCT00842829|521735159|FG000|Continuation Period|Non-compliance to study drug|0|||
144695199|NCT00842829|521735160|FG001|Continuation Period|Non-compliance to study drug|0|||
144695200|NCT00842829|521735161|FG002|Continuation Period|Non-compliance to study drug|1|||
144695201|NCT00660829|521735164|FG000|Overall Study|Adverse Event|3|||
144695202|NCT00660829|521735165|FG001|Overall Study|Adverse Event|4|||
144695203|NCT00660829|521735164|FG000|Overall Study|Lack of Efficacy|2|||
144695204|NCT00660829|521735165|FG001|Overall Study|Lack of Efficacy|3|||
144695205|NCT00660829|521735164|FG000|Overall Study|Non-Compliance|0|||
144695206|NCT00660829|521735165|FG001|Overall Study|Non-Compliance|4|||
144695207|NCT00660829|521735164|FG000|Overall Study|Withdrawal by Subject|1|||
144695208|NCT00660829|521735165|FG001|Overall Study|Withdrawal by Subject|2|||
144695209|NCT00660829|521735164|FG000|Overall Study|Lost to Follow-up|3|||
144695210|NCT00660829|521735165|FG001|Overall Study|Lost to Follow-up|2|||
144695211|NCT00660829|521735164|FG000|Overall Study|Other|9|||
144695212|NCT00660829|521735165|FG001|Overall Study|Other|4|||
144695213|NCT03590613|521735166|FG000|Period 2, 4 Days|Physician Decision|0|||
144695214|NCT03590613|521735167|FG001|Period 2, 4 Days|Physician Decision|0|||
144695215|NCT03590613|521735168|FG002|Period 2, 4 Days|Physician Decision|0|||
144695216|NCT03590613|521735169|FG003|Period 2, 4 Days|Physician Decision|1|||
144695217|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Death|2|||
144695218|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Death|0|||
144695219|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Adverse Event|33|||
144695220|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Adverse Event|31|||
144695221|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
144695222|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
144695223|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
144695224|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
144695225|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
144695226|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
144695227|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Other|7|||
144695228|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Other|8|||
144695229|NCT00280059|521735170|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
144695230|NCT00280059|521735171|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
144695231|NCT04369742|521735172|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
144695232|NCT04369742|521735173|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
144695233|NCT04369742|521735172|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
144695234|NCT04369742|521735173|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
144695235|NCT02127931|521735174|FG000|Overall Study|Glitch in Game|1|||
144695236|NCT01130831|521735175|FG000|Overall Study|Withdrawal by Subject|7|||
144695237|NCT01130831|521735175|FG000|Overall Study|Death|4|||
144695238|NCT01130831|521735175|FG000|Overall Study|Information was missing|3|||
144695239|NCT00951912|521735176|FG000|Overall Study|Lack of Efficacy|1|||
144695240|NCT00951912|521735177|FG001|Overall Study|Lack of Efficacy|0|||
144695241|NCT00951912|521735178|FG002|Overall Study|Lack of Efficacy|0|||
144695242|NCT00951912|521735176|FG000|Overall Study|Adverse Event|0|||
144695243|NCT00951912|521735177|FG001|Overall Study|Adverse Event|1|||
144695244|NCT00951912|521735178|FG002|Overall Study|Adverse Event|1|||
144695245|NCT00951912|521735176|FG000|Overall Study|Lost to Follow-up|2|||
144695246|NCT00951912|521735177|FG001|Overall Study|Lost to Follow-up|2|||
144695247|NCT00951912|521735178|FG002|Overall Study|Lost to Follow-up|0|||
144695248|NCT00951912|521735176|FG000|Overall Study|Physician Decision|1|||
144695249|NCT00951912|521735177|FG001|Overall Study|Physician Decision|0|||
144695250|NCT00951912|521735178|FG002|Overall Study|Physician Decision|1|||
144695251|NCT00951912|521735176|FG000|Overall Study|Withdrawal by Subject|1|||
144695252|NCT00951912|521735177|FG001|Overall Study|Withdrawal by Subject|1|||
144695253|NCT00951912|521735178|FG002|Overall Study|Withdrawal by Subject|0|||
144695254|NCT00951912|521735176|FG000|Overall Study|Other:Depression|1|||
144695255|NCT00951912|521735177|FG001|Overall Study|Other:Depression|0|||
144266536|NCT02616783|520178390|FG001|Overall Study|Randomized but Not Treated|0|||
144695256|NCT00951912|521735178|FG002|Overall Study|Other:Depression|0|||
144695257|NCT00951912|521735176|FG000|Overall Study|Other: Colon cancer|1|||
144695258|NCT00951912|521735177|FG001|Overall Study|Other: Colon cancer|0|||
144695259|NCT00951912|521735178|FG002|Overall Study|Other: Colon cancer|0|||
144695260|NCT00951912|521735176|FG000|Overall Study|Other: Stroke|0|||
144695261|NCT00951912|521735177|FG001|Overall Study|Other: Stroke|1|||
144695262|NCT00951912|521735178|FG002|Overall Study|Other: Stroke|0|||
144695263|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
144695264|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
144266537|NCT02616783|520178389|FG000|Overall Study|Adverse Event|1|||
144221994|NCT02456740|520008249|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
144221995|NCT02456740|520008250|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
144221996|NCT02456740|520008251|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
144221997|NCT02456740|520008252|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
144221998|NCT02456740|520008253|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
144221999|NCT02456740|520008245|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222000|NCT02456740|520008246|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222001|NCT02456740|520008247|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222002|NCT02456740|520008248|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222003|NCT02456740|520008249|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144695265|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
144695266|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
144695267|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
144695268|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
144695269|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
144695270|NCT00950755|521735180|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
144695271|NCT00950755|521735180|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
144695272|NCT00950755|521735180|FG000|Long-Term Follow-Up|Death|8|||
144695273|NCT02946515|521737634|FG000|Overall Study|Lost to Follow-up|2|||
144695274|NCT02946515|521737635|FG001|Overall Study|Lost to Follow-up|1|||
144695275|NCT03410693|521737636|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
144695276|NCT03410693|521737637|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
144695277|NCT03410693|521737636|FG000|Overall Study|Disc trt: Lost to follow up|0|||
144695278|NCT03410693|521737637|FG001|Overall Study|Disc trt: Lost to follow up|1|||
144695279|NCT03410693|521737636|FG000|Overall Study|Disc trt: radiological progression|58|||
144695280|NCT03410693|521737637|FG001|Overall Study|Disc trt: radiological progression|50|||
144695281|NCT03410693|521737636|FG000|Overall Study|Disc trt: Other|1|||
144695282|NCT03410693|521737637|FG001|Overall Study|Disc trt: Other|0|||
144695283|NCT03410693|521737636|FG000|Overall Study|Study drug never administered|1|||
144695284|NCT03410693|521737637|FG001|Overall Study|Study drug never administered|6|||
144695285|NCT03410693|521737636|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
144695286|NCT03410693|521737637|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
144695287|NCT03410693|521737636|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
144695288|NCT03410693|521737637|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
144695289|NCT03410693|521737636|FG000|Overall Study|Disc trt: Physician decision|0|||
144695290|NCT03410693|521737637|FG001|Overall Study|Disc trt: Physician decision|5|||
144695291|NCT03410693|521737636|FG000|Overall Study|Disc trt: clinical progression|1|||
144695292|NCT03410693|521737637|FG001|Overall Study|Disc trt: clinical progression|5|||
144695293|NCT03410693|521737636|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
144695294|NCT03410693|521737637|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
144695295|NCT01789476|521737638|FG000|Overall Study|Lack of Efficacy|6|||
144695296|NCT01789476|521737639|FG001|Overall Study|Lack of Efficacy|2|||
144695297|NCT01789476|521737638|FG000|Overall Study|Adverse Event|1|||
144695298|NCT01789476|521737639|FG001|Overall Study|Adverse Event|0|||
144695299|NCT01789476|521737638|FG000|Overall Study|Unable to get IV access|1|||
144695300|NCT01789476|521737639|FG001|Overall Study|Unable to get IV access|0|||
144695301|NCT00953576|521737640|FG000|Overall Study|Adverse Event|0|||
144695302|NCT00953576|521737641|FG001|Overall Study|Adverse Event|1|||
144695303|NCT00953576|521737640|FG000|Overall Study|Ineligible after Consent|2|||
144695304|NCT00953576|521737641|FG001|Overall Study|Ineligible after Consent|0|||
144695305|NCT00501969|521737642|FG000|Overall Study|Major Protocol Violation|4|||
144695306|NCT00501969|521737642|FG000|Overall Study|Lack of Efficacy|29|||
144695307|NCT00501969|521737642|FG000|Overall Study|Adverse Event|76|||
144695308|NCT00501969|521737642|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
144695309|NCT00501969|521737642|FG000|Overall Study|Subject withdrew consent|51|||
144695310|NCT00501969|521737642|FG000|Overall Study|Lost to Follow-up|4|||
144695311|NCT00501969|521737642|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
144695312|NCT00501969|521737642|FG000|Overall Study|Other: Sponsors Request|10|||
144695313|NCT00501969|521737642|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
144695314|NCT00501969|521737642|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
144695315|NCT00501969|521737642|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
144695316|NCT00501969|521737642|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
144695317|NCT00501969|521737642|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
144695318|NCT00501969|521737642|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
144695319|NCT00501969|521737642|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
144695320|NCT00501969|521737642|FG000|Overall Study|Other: As Required by Local EC|2|||
144695321|NCT00501969|521737642|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
144695322|NCT00501969|521737642|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
144695323|NCT00665366|521737645|FG000|Overall Study|Lack of Efficacy|11|||
144695324|NCT00665366|521737646|FG001|Overall Study|Lack of Efficacy|10|||
144222004|NCT02456740|520008250|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222005|NCT02456740|520008251|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222006|NCT02456740|520008252|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
144222007|NCT02456740|520008253|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
144222008|NCT02456740|520008245|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144222009|NCT02456740|520008246|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144222010|NCT02456740|520008247|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
144222011|NCT02456740|520008248|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
144222012|NCT02456740|520008249|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
144222013|NCT02456740|520008250|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
144222014|NCT02456740|520008251|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
144222015|NCT02456740|520008252|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
144222016|NCT02456740|520008253|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
144222017|NCT02654054|520008254|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
144222018|NCT02654054|520008255|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
144222019|NCT02654054|520008256|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
144222020|NCT02654054|520008254|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
144222021|NCT02654054|520008255|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
144222022|NCT02654054|520008256|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
144222023|NCT02654054|520008254|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
144222024|NCT02654054|520008255|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
144222025|NCT02654054|520008256|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
144222026|NCT02654054|520008254|FG000|Post-Treatment Follow-Up Period|Other|1|||
144222027|NCT02654054|520008255|FG001|Post-Treatment Follow-Up Period|Other|0|||
144222028|NCT02654054|520008256|FG002|Post-Treatment Follow-Up Period|Other|4|||
144222029|NCT02654054|520008254|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
144222030|NCT02654054|520008255|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
144222031|NCT02654054|520008256|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
144222032|NCT04199104|520010276|FG000|Overall Study|Death|148|||
144222033|NCT04199104|520010277|FG001|Overall Study|Death|134|||
144222034|NCT04199104|520010276|FG000|Overall Study|Lost to Follow-up|1|||
144222035|NCT04199104|520010277|FG001|Overall Study|Lost to Follow-up|1|||
144222036|NCT04199104|520010276|FG000|Overall Study|Withdrawal by Subject|4|||
144222037|NCT04199104|520010277|FG001|Overall Study|Withdrawal by Subject|4|||
144222038|NCT04199104|520010276|FG000|Overall Study|Participants Ongoing|103|||
144222039|NCT04199104|520010277|FG001|Overall Study|Participants Ongoing|116|||
144222040|NCT04796961|520010281|FG000|Overall Study|Lost to Follow-up|10|||
144222041|NCT04796961|520010281|FG000|Overall Study|Withdrawal by Subject|3|||
144222042|NCT04796961|520010281|FG000|Overall Study|Left Organization|10|||
144222043|NCT02325973|520010282|FG000|Overall Study|Death|5|||
144222044|NCT02325973|520010282|FG000|Overall Study|Withdrawal by subject or investigator|16|||
144222045|NCT03428958|520010286|FG000|Overall Study|Adverse Event|0|||
144222046|NCT03428958|520010287|FG001|Overall Study|Adverse Event|0|||
144222047|NCT03428958|520010288|FG002|Overall Study|Adverse Event|0|||
144695325|NCT00665366|521737645|FG000|Overall Study|Adverse Event|25|||
144695326|NCT00665366|521737646|FG001|Overall Study|Adverse Event|23|||
144695327|NCT00665366|521737645|FG000|Overall Study|Withdrawal by Subject|11|||
144695328|NCT00665366|521737646|FG001|Overall Study|Withdrawal by Subject|14|||
144695329|NCT00665366|521737645|FG000|Overall Study|Lost to Follow-up|3|||
144695330|NCT00665366|521737646|FG001|Overall Study|Lost to Follow-up|5|||
144695331|NCT00665366|521737645|FG000|Overall Study|Poor compliance/noncompliance|3|||
144695332|NCT00665366|521737646|FG001|Overall Study|Poor compliance/noncompliance|5|||
144695333|NCT00665366|521737645|FG000|Overall Study|Pregnancy|1|||
144695334|NCT00665366|521737646|FG001|Overall Study|Pregnancy|0|||
144695335|NCT00665366|521737645|FG000|Overall Study|No longer meets study criteria|0|||
144695336|NCT00665366|521737646|FG001|Overall Study|No longer meets study criteria|1|||
144695337|NCT00665366|521737645|FG000|Overall Study|Other reasons|4|||
144695338|NCT00665366|521737646|FG001|Overall Study|Other reasons|1|||
144695339|NCT03778021|521737654|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
144695340|NCT03778021|521737655|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
144695341|NCT01545375|521737656|FG000|Overall Study|Adverse Event|2|||
144695342|NCT01545375|521737657|FG001|Overall Study|Adverse Event|1|||
144695343|NCT01545375|521737656|FG000|Overall Study|Lost to Follow-up|34|||
144695344|NCT01545375|521737657|FG001|Overall Study|Lost to Follow-up|31|||
144695345|NCT01545375|521737656|FG000|Overall Study|Protocol Violation|3|||
144695346|NCT01545375|521737657|FG001|Overall Study|Protocol Violation|3|||
144695347|NCT01545375|521737656|FG000|Overall Study|Withdrawal by Subject|58|||
144695348|NCT01545375|521737657|FG001|Overall Study|Withdrawal by Subject|55|||
144695349|NCT00679042|521737658|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
144695350|NCT00679042|521737658|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
144222048|NCT03428958|520010289|FG003|Overall Study|Adverse Event|1|||
144695351|NCT00679042|521737658|FG000|5-Year Follow Up|Death|1|||
144695352|NCT00679042|521737658|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
144222049|NCT03428958|520010290|FG004|Overall Study|Adverse Event|0|||
144222050|NCT03428958|520010291|FG005|Overall Study|Adverse Event|2|||
144222051|NCT03428958|520010292|FG006|Overall Study|Adverse Event|1|||
144222052|NCT03428958|520010293|FG007|Overall Study|Adverse Event|0|||
144222053|NCT03428958|520010294|FG008|Overall Study|Adverse Event|0|||
144222054|NCT03428958|520010295|FG009|Overall Study|Adverse Event|0|||
144222055|NCT03428958|520010296|FG010|Overall Study|Adverse Event|0|||
144222056|NCT03428958|520010297|FG011|Overall Study|Adverse Event|0|||
144222057|NCT03428958|520010298|FG012|Overall Study|Adverse Event|0|||
144222058|NCT03428958|520010299|FG013|Overall Study|Adverse Event|0|||
144222059|NCT03428958|520010300|FG014|Overall Study|Adverse Event|0|||
144222060|NCT03428958|520010301|FG015|Overall Study|Adverse Event|0|||
144222061|NCT03428958|520010302|FG016|Overall Study|Adverse Event|0|||
144222062|NCT03428958|520010286|FG000|Overall Study|Clinical Progression|2|||
144222063|NCT03428958|520010287|FG001|Overall Study|Clinical Progression|3|||
144222064|NCT03428958|520010288|FG002|Overall Study|Clinical Progression|2|||
144222065|NCT03428958|520010289|FG003|Overall Study|Clinical Progression|1|||
144222066|NCT03428958|520010290|FG004|Overall Study|Clinical Progression|0|||
144222067|NCT03428958|520010291|FG005|Overall Study|Clinical Progression|2|||
144222068|NCT03428958|520010292|FG006|Overall Study|Clinical Progression|0|||
144222069|NCT03428958|520010293|FG007|Overall Study|Clinical Progression|0|||
144222070|NCT03428958|520010294|FG008|Overall Study|Clinical Progression|0|||
144222071|NCT03428958|520010295|FG009|Overall Study|Clinical Progression|0|||
144222072|NCT03428958|520010296|FG010|Overall Study|Clinical Progression|0|||
144222073|NCT03428958|520010297|FG011|Overall Study|Clinical Progression|0|||
144222074|NCT03428958|520010298|FG012|Overall Study|Clinical Progression|0|||
144222075|NCT03428958|520010299|FG013|Overall Study|Clinical Progression|0|||
144222076|NCT03428958|520010300|FG014|Overall Study|Clinical Progression|0|||
144222077|NCT03428958|520010301|FG015|Overall Study|Clinical Progression|0|||
144222078|NCT03428958|520010302|FG016|Overall Study|Clinical Progression|0|||
144222079|NCT03428958|520010286|FG000|Overall Study|Progression per RECIST|6|||
144222080|NCT03428958|520010287|FG001|Overall Study|Progression per RECIST|6|||
144222081|NCT03428958|520010288|FG002|Overall Study|Progression per RECIST|7|||
144222082|NCT03428958|520010289|FG003|Overall Study|Progression per RECIST|4|||
144222083|NCT03428958|520010290|FG004|Overall Study|Progression per RECIST|0|||
144222084|NCT03428958|520010291|FG005|Overall Study|Progression per RECIST|7|||
144222085|NCT03428958|520010292|FG006|Overall Study|Progression per RECIST|8|||
144222086|NCT03428958|520010293|FG007|Overall Study|Progression per RECIST|0|||
144222087|NCT03428958|520010294|FG008|Overall Study|Progression per RECIST|0|||
144222088|NCT03428958|520010295|FG009|Overall Study|Progression per RECIST|0|||
144222089|NCT03428958|520010296|FG010|Overall Study|Progression per RECIST|0|||
144222090|NCT03428958|520010297|FG011|Overall Study|Progression per RECIST|0|||
144222091|NCT03428958|520010298|FG012|Overall Study|Progression per RECIST|1|||
144222092|NCT03428958|520010299|FG013|Overall Study|Progression per RECIST|0|||
144222093|NCT03428958|520010300|FG014|Overall Study|Progression per RECIST|0|||
144222094|NCT03428958|520010301|FG015|Overall Study|Progression per RECIST|0|||
144222095|NCT03428958|520010302|FG016|Overall Study|Progression per RECIST|0|||
144222096|NCT03428958|520010286|FG000|Overall Study|Death|2|||
144222097|NCT03428958|520010287|FG001|Overall Study|Death|2|||
144222098|NCT03428958|520010288|FG002|Overall Study|Death|0|||
144222099|NCT03428958|520010289|FG003|Overall Study|Death|0|||
144695353|NCT00679042|521737658|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
144695354|NCT02687815|521737659|FG000|Overall Study|Lost to Follow-up|2|||
144695355|NCT02687815|521737660|FG001|Overall Study|Lost to Follow-up|4|||
144695356|NCT02687815|521737659|FG000|Overall Study|Withdrawal by Subject|2|||
144695357|NCT02687815|521737660|FG001|Overall Study|Withdrawal by Subject|4|||
144695358|NCT04177862|521737661|FG000|Overall Study|Protocol Violation|2|||
144695359|NCT04177862|521737662|FG001|Overall Study|Protocol Violation|7|||
144695360|NCT05637515|521737665|FG000|Overall Study|Withdrawal by Subject|17|||
144695361|NCT05637515|521737666|FG001|Overall Study|Withdrawal by Subject|17|||
144695362|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
144695363|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
144695364|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695365|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695366|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695367|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695368|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695369|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695370|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695371|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695372|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695373|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
144695374|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
144695375|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695376|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695377|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695378|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695379|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695380|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
144695381|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695382|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695383|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695384|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
144695385|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
144695386|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695387|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
144695388|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695389|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695390|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695391|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695392|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695393|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695394|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695395|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695396|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695397|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
144695398|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
144695399|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
144695400|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
144695401|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
144695402|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
144695403|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
144695404|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
144695405|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
144695406|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
144695407|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
144695408|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
144695409|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
144695410|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695411|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695412|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695413|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695414|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695415|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
144695416|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695417|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695418|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695419|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695420|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144266538|NCT02616783|520178390|FG001|Overall Study|Adverse Event|0|||
144266539|NCT02616783|520178389|FG000|Overall Study|Death|1|||
144266540|NCT02616783|520178390|FG001|Overall Study|Death|0|||
144266541|NCT02616783|520178389|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144266542|NCT02616783|520178390|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144266543|NCT02616783|520178389|FG000|Overall Study|Protocol Violation|1|||
144266544|NCT02616783|520178390|FG001|Overall Study|Protocol Violation|1|||
144266545|NCT02616783|520178389|FG000|Overall Study|Withdrew Consent|1|||
144266546|NCT02616783|520178390|FG001|Overall Study|Withdrew Consent|1|||
144266547|NCT01791985|520178391|FG000|Overall Study|Adverse Event|7|||
144266548|NCT01791985|520178391|FG000|Overall Study|Withdrawal by Subject|1|||
144266549|NCT00372424|520178392|FG000|Overall Study|Adverse Event|2|||
144266550|NCT00372424|520178392|FG000|Overall Study|Withdrawal by Subject|1|||
144266551|NCT00372424|520178392|FG000|Overall Study|Death|1|||
144266552|NCT00372424|520178392|FG000|Overall Study|Objective Progression or Relapse|14|||
144266553|NCT00372424|520178392|FG000|Overall Study|Other|7|||
144266554|NCT00372424|520178392|FG000|Overall Study|Enrolled, Not Treated|1|||
144266555|NCT03797898|520178396|FG000|Overall Study|Lost to Follow-up|60|||
144266556|NCT03797898|520178397|FG001|Overall Study|Lost to Follow-up|69|||
144266557|NCT03797898|520178396|FG000|Overall Study|Withdrawal by Subject|9|||
144266558|NCT03797898|520178397|FG001|Overall Study|Withdrawal by Subject|7|||
144266559|NCT03797898|520178396|FG000|Overall Study|Became ineligible|5|||
144266560|NCT03797898|520178397|FG001|Overall Study|Became ineligible|2|||
144266561|NCT01614470|520178398|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
144266562|NCT01614470|520178399|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144266563|NCT01614470|520178400|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
144266564|NCT01614470|520178398|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
144266565|NCT01614470|520178399|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
144695421|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
144695422|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695423|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695424|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695425|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144222100|NCT03428958|520010290|FG004|Overall Study|Death|0|||
144222101|NCT03428958|520010291|FG005|Overall Study|Death|7|||
144222102|NCT03428958|520010292|FG006|Overall Study|Death|9|||
144222103|NCT03428958|520010293|FG007|Overall Study|Death|6|||
144222104|NCT03428958|520010294|FG008|Overall Study|Death|0|||
144222105|NCT03428958|520010295|FG009|Overall Study|Death|0|||
144222106|NCT03428958|520010296|FG010|Overall Study|Death|3|||
144222107|NCT03428958|520010297|FG011|Overall Study|Death|0|||
144222108|NCT03428958|520010298|FG012|Overall Study|Death|4|||
144222109|NCT03428958|520010299|FG013|Overall Study|Death|0|||
144222110|NCT03428958|520010300|FG014|Overall Study|Death|0|||
144222111|NCT03428958|520010301|FG015|Overall Study|Death|0|||
144222112|NCT03428958|520010302|FG016|Overall Study|Death|0|||
144222113|NCT03428958|520010286|FG000|Overall Study|Lost to Follow-up|0|||
144222114|NCT03428958|520010287|FG001|Overall Study|Lost to Follow-up|0|||
144222115|NCT03428958|520010288|FG002|Overall Study|Lost to Follow-up|0|||
144222116|NCT03428958|520010289|FG003|Overall Study|Lost to Follow-up|0|||
144222117|NCT03428958|520010290|FG004|Overall Study|Lost to Follow-up|0|||
144222118|NCT03428958|520010291|FG005|Overall Study|Lost to Follow-up|1|||
144222119|NCT03428958|520010292|FG006|Overall Study|Lost to Follow-up|1|||
144222120|NCT03428958|520010293|FG007|Overall Study|Lost to Follow-up|0|||
144222121|NCT03428958|520010294|FG008|Overall Study|Lost to Follow-up|0|||
144222122|NCT03428958|520010295|FG009|Overall Study|Lost to Follow-up|0|||
144222123|NCT03428958|520010296|FG010|Overall Study|Lost to Follow-up|0|||
144222124|NCT03428958|520010297|FG011|Overall Study|Lost to Follow-up|0|||
144222125|NCT03428958|520010298|FG012|Overall Study|Lost to Follow-up|0|||
144222126|NCT03428958|520010299|FG013|Overall Study|Lost to Follow-up|0|||
144222127|NCT03428958|520010300|FG014|Overall Study|Lost to Follow-up|0|||
144222128|NCT03428958|520010301|FG015|Overall Study|Lost to Follow-up|0|||
144222129|NCT03428958|520010302|FG016|Overall Study|Lost to Follow-up|0|||
144222130|NCT03428958|520010286|FG000|Overall Study|Physician/Sponsor Decision|1|||
144222131|NCT03428958|520010287|FG001|Overall Study|Physician/Sponsor Decision|0|||
144222132|NCT03428958|520010288|FG002|Overall Study|Physician/Sponsor Decision|1|||
144222133|NCT03428958|520010289|FG003|Overall Study|Physician/Sponsor Decision|0|||
144222134|NCT03428958|520010290|FG004|Overall Study|Physician/Sponsor Decision|0|||
144222135|NCT03428958|520010291|FG005|Overall Study|Physician/Sponsor Decision|2|||
144222136|NCT03428958|520010292|FG006|Overall Study|Physician/Sponsor Decision|2|||
144266566|NCT01614470|520178400|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
144222137|NCT03428958|520010293|FG007|Overall Study|Physician/Sponsor Decision|2|||
144222138|NCT03428958|520010294|FG008|Overall Study|Physician/Sponsor Decision|0|||
144222139|NCT03428958|520010295|FG009|Overall Study|Physician/Sponsor Decision|0|||
144222140|NCT03428958|520010296|FG010|Overall Study|Physician/Sponsor Decision|2|||
144222141|NCT03428958|520010297|FG011|Overall Study|Physician/Sponsor Decision|0|||
144222142|NCT03428958|520010298|FG012|Overall Study|Physician/Sponsor Decision|4|||
144222143|NCT03428958|520010299|FG013|Overall Study|Physician/Sponsor Decision|0|||
144222144|NCT03428958|520010300|FG014|Overall Study|Physician/Sponsor Decision|0|||
144222145|NCT03428958|520010301|FG015|Overall Study|Physician/Sponsor Decision|0|||
144222146|NCT03428958|520010302|FG016|Overall Study|Physician/Sponsor Decision|0|||
144222147|NCT03428958|520010286|FG000|Overall Study|Withdrawal by Subject|0|||
144222148|NCT03428958|520010287|FG001|Overall Study|Withdrawal by Subject|0|||
144222149|NCT03428958|520010288|FG002|Overall Study|Withdrawal by Subject|2|||
144222150|NCT03428958|520010289|FG003|Overall Study|Withdrawal by Subject|0|||
144222151|NCT03428958|520010290|FG004|Overall Study|Withdrawal by Subject|0|||
144222152|NCT03428958|520010291|FG005|Overall Study|Withdrawal by Subject|2|||
144222153|NCT03428958|520010292|FG006|Overall Study|Withdrawal by Subject|4|||
144222154|NCT03428958|520010293|FG007|Overall Study|Withdrawal by Subject|1|||
144222155|NCT03428958|520010294|FG008|Overall Study|Withdrawal by Subject|0|||
144222156|NCT03428958|520010295|FG009|Overall Study|Withdrawal by Subject|0|||
144222157|NCT03428958|520010296|FG010|Overall Study|Withdrawal by Subject|0|||
144222158|NCT03428958|520010297|FG011|Overall Study|Withdrawal by Subject|0|||
144222159|NCT03428958|520010298|FG012|Overall Study|Withdrawal by Subject|0|||
144222160|NCT03428958|520010299|FG013|Overall Study|Withdrawal by Subject|0|||
144222161|NCT03428958|520010300|FG014|Overall Study|Withdrawal by Subject|0|||
144222162|NCT03428958|520010301|FG015|Overall Study|Withdrawal by Subject|0|||
144222163|NCT03428958|520010302|FG016|Overall Study|Withdrawal by Subject|0|||
144222164|NCT03874117|520010303|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
144222165|NCT03874117|520010304|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
144222166|NCT03874117|520010303|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
144222167|NCT03874117|520010304|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
144222168|NCT03874117|520010303|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
144222169|NCT03874117|520010304|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144222170|NCT03874117|520010303|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
144222171|NCT03874117|520010304|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
144222172|NCT03874117|520010303|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144222173|NCT03874117|520010304|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
144222174|NCT05012098|520010305|FG000|Overall Study|Disease progression|5|||
144222175|NCT05012098|520010306|FG001|Overall Study|Disease progression|2|||
144222176|NCT05012098|520010305|FG000|Overall Study|Adverse Event|1|||
144222177|NCT05012098|520010306|FG001|Overall Study|Adverse Event|0|||
144222178|NCT05012098|520010305|FG000|Overall Study|Withdrawal by Subject|1|||
144222179|NCT05012098|520010306|FG001|Overall Study|Withdrawal by Subject|0|||
144222180|NCT05012098|520010305|FG000|Overall Study|Discontinuation per protocol|1|||
144222181|NCT05012098|520010306|FG001|Overall Study|Discontinuation per protocol|0|||
144222182|NCT05258773|520010307|FG000|Overall Study|Screen Failure|1|||
144222183|NCT05258773|520010308|FG001|Overall Study|Screen Failure|1|||
144222184|NCT05258773|520010307|FG000|Overall Study|Adverse Event|1|||
144222185|NCT05258773|520010308|FG001|Overall Study|Adverse Event|0|||
144222186|NCT05258773|520010307|FG000|Overall Study|Withdrawal by Subject|0|||
144222187|NCT05258773|520010308|FG001|Overall Study|Withdrawal by Subject|1|||
144222188|NCT03018288|520010309|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
144222189|NCT03018288|520010310|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
144222190|NCT03018288|520010311|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
144222191|NCT03018288|520010312|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
144222192|NCT03018288|520010309|FG000|Overall Study|Participant withdrew consent.|0|||
144222193|NCT03018288|520010310|FG001|Overall Study|Participant withdrew consent.|0|||
144222194|NCT03018288|520010311|FG002|Overall Study|Participant withdrew consent.|1|||
144222195|NCT03018288|520010312|FG003|Overall Study|Participant withdrew consent.|0|||
144222196|NCT03018288|520010309|FG000|Overall Study|Switched to alternative treatment.|0|||
144222197|NCT03018288|520010310|FG001|Overall Study|Switched to alternative treatment.|0|||
144222198|NCT03018288|520010311|FG002|Overall Study|Switched to alternative treatment.|1|||
144222199|NCT03018288|520010312|FG003|Overall Study|Switched to alternative treatment.|0|||
144222200|NCT03018288|520010309|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
144222201|NCT03018288|520010310|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
144222202|NCT03018288|520010311|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
144222203|NCT03018288|520010312|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
144222204|NCT03018288|520010309|FG000|Overall Study|Screen failures|0|||
144222205|NCT03018288|520010310|FG001|Overall Study|Screen failures|0|||
144222206|NCT03018288|520010311|FG002|Overall Study|Screen failures|0|||
144222207|NCT03018288|520010312|FG003|Overall Study|Screen failures|51|||
144222208|NCT03018288|520010309|FG000|Overall Study|Chose treatment outside of UNC|0|||
144222209|NCT03018288|520010310|FG001|Overall Study|Chose treatment outside of UNC|0|||
144222210|NCT03018288|520010311|FG002|Overall Study|Chose treatment outside of UNC|0|||
144222211|NCT03018288|520010312|FG003|Overall Study|Chose treatment outside of UNC|1|||
144222212|NCT03018288|520010309|FG000|Overall Study|Unable to comply with protocol requirements|1|||
144222213|NCT03018288|520010310|FG001|Overall Study|Unable to comply with protocol requirements|1|||
144222214|NCT03018288|520010311|FG002|Overall Study|Unable to comply with protocol requirements|0|||
144222215|NCT03018288|520010312|FG003|Overall Study|Unable to comply with protocol requirements|1|||
144222216|NCT03018288|520010309|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
144222217|NCT03018288|520010310|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
144222218|NCT03018288|520010311|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
144222219|NCT03018288|520010312|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
144222220|NCT03018288|520010309|FG000|Overall Study|Physician Decision|0|||
144222221|NCT03018288|520010310|FG001|Overall Study|Physician Decision|0|||
144222222|NCT03018288|520010311|FG002|Overall Study|Physician Decision|0|||
144222223|NCT03018288|520010312|FG003|Overall Study|Physician Decision|1|||
144222224|NCT01490086|520010316|FG000|Overall Study|Consent withdrawn|4|||
144222225|NCT01490086|520010317|FG001|Overall Study|Consent withdrawn|4|||
144222226|NCT01490086|520010318|FG002|Overall Study|Consent withdrawn|3|||
144222227|NCT01490086|520010319|FG003|Overall Study|Consent withdrawn|0|||
144222228|NCT01490086|520010320|FG004|Overall Study|Consent withdrawn|1|||
144222229|NCT01490086|520010316|FG000|Overall Study|Non-compliance|0|||
144222230|NCT01490086|520010317|FG001|Overall Study|Non-compliance|1|||
144222231|NCT01490086|520010318|FG002|Overall Study|Non-compliance|0|||
144222232|NCT01490086|520010319|FG003|Overall Study|Non-compliance|0|||
144222233|NCT01490086|520010320|FG004|Overall Study|Non-compliance|0|||
144222234|NCT01490086|520010316|FG000|Overall Study|Abnormal laboratory findings|1|||
144222235|NCT01490086|520010317|FG001|Overall Study|Abnormal laboratory findings|0|||
144222236|NCT01490086|520010318|FG002|Overall Study|Abnormal laboratory findings|0|||
144222237|NCT01490086|520010319|FG003|Overall Study|Abnormal laboratory findings|0|||
144222238|NCT01490086|520010320|FG004|Overall Study|Abnormal laboratory findings|0|||
144222239|NCT01490086|520010316|FG000|Overall Study|Lost to Follow-up|0|||
144222240|NCT01490086|520010317|FG001|Overall Study|Lost to Follow-up|0|||
144222241|NCT01490086|520010318|FG002|Overall Study|Lost to Follow-up|0|||
144222242|NCT01490086|520010319|FG003|Overall Study|Lost to Follow-up|0|||
144222243|NCT01490086|520010320|FG004|Overall Study|Lost to Follow-up|1|||
144222244|NCT01490086|520010316|FG000|Overall Study|Physician Decision|3|||
144222245|NCT01490086|520010317|FG001|Overall Study|Physician Decision|4|||
144222246|NCT01490086|520010318|FG002|Overall Study|Physician Decision|2|||
144222247|NCT01490086|520010319|FG003|Overall Study|Physician Decision|3|||
144222248|NCT01490086|520010320|FG004|Overall Study|Physician Decision|1|||
144222249|NCT01490086|520010316|FG000|Overall Study|Adverse Event|0|||
144222250|NCT01490086|520010317|FG001|Overall Study|Adverse Event|0|||
144222251|NCT01490086|520010318|FG002|Overall Study|Adverse Event|1|||
144222252|NCT01490086|520010319|FG003|Overall Study|Adverse Event|2|||
144222253|NCT01490086|520010320|FG004|Overall Study|Adverse Event|0|||
144222254|NCT01490086|520010316|FG000|Overall Study|Lack of Efficacy|0|||
144222255|NCT01490086|520010317|FG001|Overall Study|Lack of Efficacy|3|||
144222256|NCT01490086|520010318|FG002|Overall Study|Lack of Efficacy|1|||
144222257|NCT01490086|520010319|FG003|Overall Study|Lack of Efficacy|0|||
144222258|NCT01490086|520010320|FG004|Overall Study|Lack of Efficacy|8|||
144222259|NCT01490086|520010316|FG000|Overall Study|Worsening of symptoms|0|||
144222260|NCT01490086|520010317|FG001|Overall Study|Worsening of symptoms|1|||
144222261|NCT01490086|520010318|FG002|Overall Study|Worsening of symptoms|0|||
144222262|NCT01490086|520010319|FG003|Overall Study|Worsening of symptoms|1|||
144222263|NCT01490086|520010320|FG004|Overall Study|Worsening of symptoms|0|||
144222264|NCT01490086|520010316|FG000|Overall Study|Subject uncontrollable and abusive|0|||
144222265|NCT01490086|520010317|FG001|Overall Study|Subject uncontrollable and abusive|1|||
144222266|NCT01490086|520010318|FG002|Overall Study|Subject uncontrollable and abusive|0|||
144222267|NCT01490086|520010319|FG003|Overall Study|Subject uncontrollable and abusive|0|||
144222268|NCT01490086|520010320|FG004|Overall Study|Subject uncontrollable and abusive|0|||
144222269|NCT01490086|520010316|FG000|Overall Study|Subject left hospital|0|||
144222270|NCT01490086|520010317|FG001|Overall Study|Subject left hospital|1|||
144222271|NCT01490086|520010318|FG002|Overall Study|Subject left hospital|0|||
144222272|NCT01490086|520010319|FG003|Overall Study|Subject left hospital|1|||
144222273|NCT01490086|520010320|FG004|Overall Study|Subject left hospital|0|||
144222274|NCT00679211|520010321|FG000|Overall Study|Progressive disease|82|||
144222275|NCT00679211|520010321|FG000|Overall Study|Adverse Event|7|||
144222276|NCT00679211|520010321|FG000|Overall Study|Withdrawal by Subject|2|||
144222277|NCT00679211|520010321|FG000|Overall Study|Physician Decision|5|||
144222278|NCT00679211|520010321|FG000|Overall Study|Refused to undergo protocol procedures|1|||
144222279|NCT00679211|520010321|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
144222280|NCT00679211|520010321|FG000|Overall Study|Other|1|||
144222281|NCT01922037|520010322|FG000|Overall Study|Withdrawal by Subject|2|||
144222282|NCT01922037|520010323|FG001|Overall Study|Withdrawal by Subject|44|||
144222283|NCT01922037|520010322|FG000|Overall Study|Adverse Event|1|||
144222284|NCT01922037|520010323|FG001|Overall Study|Adverse Event|7|||
144222285|NCT01922037|520010322|FG000|Overall Study|Death|0|||
144222286|NCT01922037|520010323|FG001|Overall Study|Death|5|||
144222287|NCT01922037|520010322|FG000|Overall Study|Pregnancy|0|||
144222288|NCT01922037|520010323|FG001|Overall Study|Pregnancy|2|||
144222289|NCT01922037|520010322|FG000|Overall Study|Participant non-compliance|4|||
144222290|NCT01922037|520010323|FG001|Overall Study|Participant non-compliance|46|||
144222291|NCT01922037|520010322|FG000|Overall Study|Investigator/Sponsor decision|1|||
144222292|NCT01922037|520010323|FG001|Overall Study|Investigator/Sponsor decision|4|||
144222293|NCT01922037|520010322|FG000|Overall Study|Other unspecified|2|||
144222294|NCT01922037|520010323|FG001|Overall Study|Other unspecified|66|||
144222295|NCT00413699|520010324|FG000|Initial Period|Death|25|||
144222296|NCT00413699|520010325|FG001|Initial Period|Death|30|||
144222297|NCT00413699|520010326|FG002|Initial Period|Death|0|||
144222298|NCT00413699|520010324|FG000|Initial Period|Lack of Efficacy|59|||
144222299|NCT00413699|520010325|FG001|Initial Period|Lack of Efficacy|115|||
144266567|NCT00086190|520178401|FG000|Overall Study|Adverse Event|6|||
144222300|NCT00413699|520010326|FG002|Initial Period|Lack of Efficacy|0|||
144222301|NCT00413699|520010324|FG000|Initial Period|Lost to Follow-up|31|||
144222302|NCT00413699|520010325|FG001|Initial Period|Lost to Follow-up|101|||
144222303|NCT00413699|520010326|FG002|Initial Period|Lost to Follow-up|0|||
144222304|NCT00413699|520010324|FG000|Initial Period|Protocol Violation|38|||
144222305|NCT00413699|520010325|FG001|Initial Period|Protocol Violation|89|||
144222306|NCT00413699|520010326|FG002|Initial Period|Protocol Violation|0|||
144222307|NCT00413699|520010324|FG000|Initial Period|Pregnancy|10|||
144222308|NCT00413699|520010325|FG001|Initial Period|Pregnancy|8|||
144222309|NCT00413699|520010326|FG002|Initial Period|Pregnancy|0|||
144222310|NCT00413699|520010324|FG000|Initial Period|Did not meet entrance criteria|2|||
144222311|NCT00413699|520010325|FG001|Initial Period|Did not meet entrance criteria|2|||
144222312|NCT00413699|520010326|FG002|Initial Period|Did not meet entrance criteria|0|||
144222313|NCT00413699|520010324|FG000|Initial Period|Medication error without adverse event|0|||
144222314|NCT00413699|520010325|FG001|Initial Period|Medication error without adverse event|1|||
144222315|NCT00413699|520010326|FG002|Initial Period|Medication error without adverse event|0|||
144222316|NCT00413699|520010324|FG000|Initial Period|Study terminated by Sponsor|0|||
144222317|NCT00413699|520010325|FG001|Initial Period|Study terminated by Sponsor|1|||
144222318|NCT00413699|520010326|FG002|Initial Period|Study terminated by Sponsor|0|||
144222319|NCT00413699|520010324|FG000|Initial Period|Other|67|||
144222320|NCT00413699|520010325|FG001|Initial Period|Other|211|||
144222321|NCT00413699|520010326|FG002|Initial Period|Other|0|||
144222322|NCT00413699|520010324|FG000|Initial Period|Adverse event related to study drug|178|||
144222323|NCT00413699|520010325|FG001|Initial Period|Adverse event related to study drug|527|||
144222324|NCT00413699|520010326|FG002|Initial Period|Adverse event related to study drug|0|||
144222325|NCT00413699|520010324|FG000|Initial Period|Adverse event not related to study drug|113|||
144222326|NCT00413699|520010325|FG001|Initial Period|Adverse event not related to study drug|248|||
144222327|NCT00413699|520010326|FG002|Initial Period|Adverse event not related to study drug|0|||
144222328|NCT00413699|520010324|FG000|Initial Period|Missing end of study page|0|||
144222329|NCT00413699|520010325|FG001|Initial Period|Missing end of study page|4|||
144222330|NCT00413699|520010326|FG002|Initial Period|Missing end of study page|0|||
144222331|NCT00413699|520010324|FG000|Initial Period|No longer willing to participate|116|||
144222332|NCT00413699|520010325|FG001|Initial Period|No longer willing to participate|368|||
144222333|NCT00413699|520010326|FG002|Initial Period|No longer willing to participate|0|||
144222334|NCT00413699|520010324|FG000|Extension Period|No Longer Willing to Participate|0|||
144222335|NCT00413699|520010325|FG001|Extension Period|No Longer Willing to Participate|0|||
144222336|NCT00413699|520010326|FG002|Extension Period|No Longer Willing to Participate|2|||
144222337|NCT00413699|520010324|FG000|Extension Period|Protocol Violation|0|||
144222338|NCT00413699|520010325|FG001|Extension Period|Protocol Violation|0|||
144222339|NCT00413699|520010326|FG002|Extension Period|Protocol Violation|1|||
144222340|NCT00413699|520010324|FG000|Extension Period|Adverse Event|0|||
144222341|NCT00413699|520010325|FG001|Extension Period|Adverse Event|0|||
144222342|NCT00413699|520010326|FG002|Extension Period|Adverse Event|2|||
144222343|NCT00075816|520010327|FG000|Overall Study|Did not undergo transplantation|14|||
144222344|NCT00075816|520010328|FG001|Overall Study|Did not undergo transplantation|11|||
144222345|NCT03511105|520010329|FG000|Overall Study|Adverse Event|1|||
144222346|NCT03511105|520010330|FG001|Overall Study|Adverse Event|0|||
144222347|NCT03511105|520010329|FG000|Overall Study|Withdrew consent|1|||
144222348|NCT03511105|520010330|FG001|Overall Study|Withdrew consent|0|||
144222349|NCT02810457|520010331|FG000|Overall Study|Randomised but no treatment received|2|||
144222350|NCT02810457|520010332|FG001|Overall Study|Randomised but no treatment received|1|||
144222351|NCT02810457|520010331|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
144222352|NCT02810457|520010332|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
144222353|NCT02810457|520010331|FG000|Overall Study|Adverse Event|37|||
144222354|NCT02810457|520010332|FG001|Overall Study|Adverse Event|43|||
144222355|NCT02810457|520010331|FG000|Overall Study|Patient decision|31|||
144222356|NCT02810457|520010332|FG001|Overall Study|Patient decision|35|||
144222357|NCT02810457|520010331|FG000|Overall Study|Patient lost to follow-up|2|||
144222358|NCT02810457|520010332|FG001|Overall Study|Patient lost to follow-up|2|||
144266568|NCT00086190|520178402|FG001|Overall Study|Adverse Event|2|||
144222359|NCT02810457|520010331|FG000|Overall Study|Death|39|||
144222360|NCT02810457|520010332|FG001|Overall Study|Death|28|||
144222361|NCT02810457|520010331|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
144222362|NCT02810457|520010332|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
144222363|NCT02810457|520010331|FG000|Overall Study|Clinical progression|15|||
144222364|NCT02810457|520010332|FG001|Overall Study|Clinical progression|16|||
144222365|NCT02810457|520010331|FG000|Overall Study|Investigator decision|3|||
144222366|NCT02810457|520010332|FG001|Overall Study|Investigator decision|2|||
144222367|NCT02810457|520010331|FG000|Overall Study|Patient ineligibility|3|||
144266569|NCT00086190|520178403|FG002|Overall Study|Adverse Event|2|||
144266570|NCT00086190|520178401|FG000|Overall Study|Withdrawal by Subject|0|||
144266571|NCT00086190|520178402|FG001|Overall Study|Withdrawal by Subject|2|||
144266572|NCT00086190|520178403|FG002|Overall Study|Withdrawal by Subject|2|||
144695426|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695427|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
144695428|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695429|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695430|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695431|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695432|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695433|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
144695434|NCT00151775|521737667|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695435|NCT00151775|521737668|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695436|NCT00151775|521737669|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695437|NCT00151775|521737670|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695438|NCT00151775|521737671|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695439|NCT00151775|521737672|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695440|NCT00151775|521737673|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
144695441|NCT00151775|521737674|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695442|NCT00151775|521737675|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695443|NCT00151775|521737676|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695444|NCT00151775|521737677|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695445|NCT00151775|521737678|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
144695446|NCT00151775|521737667|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695447|NCT00151775|521737668|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695448|NCT00151775|521737669|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695449|NCT00151775|521737670|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695450|NCT00151775|521737671|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695451|NCT00151775|521737672|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
144695452|NCT00151775|521737673|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695453|NCT00151775|521737674|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695454|NCT00151775|521737675|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695455|NCT00151775|521737676|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695456|NCT00151775|521737677|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695457|NCT00151775|521737678|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
144695458|NCT00151775|521737667|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
144695459|NCT00151775|521737668|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
144695460|NCT00151775|521737669|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
144695461|NCT00151775|521737670|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
144695462|NCT00151775|521737671|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
144695463|NCT00151775|521737672|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
144695464|NCT00151775|521737673|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
144695465|NCT00151775|521737674|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
144695466|NCT00151775|521737675|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
144695467|NCT00151775|521737676|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
144695468|NCT00151775|521737677|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
144695469|NCT00151775|521737678|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
144695470|NCT00151775|521737667|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695471|NCT00151775|521737668|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695472|NCT00151775|521737669|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695473|NCT00151775|521737670|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695474|NCT00151775|521737671|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695475|NCT00151775|521737672|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695476|NCT00151775|521737673|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
144695477|NCT00151775|521737674|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695478|NCT00151775|521737675|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695479|NCT00151775|521737676|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695480|NCT00151775|521737677|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695481|NCT00151775|521737678|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
144695482|NCT00151775|521737667|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695483|NCT00151775|521737668|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695484|NCT00151775|521737669|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
144695485|NCT00151775|521737670|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144222368|NCT02810457|520010332|FG001|Overall Study|Patient ineligibility|0|||
144222369|NCT02810457|520010331|FG000|Overall Study|Miscalculated PD|1|||
144222370|NCT02810457|520010332|FG001|Overall Study|Miscalculated PD|0|||
144222371|NCT02810457|520010331|FG000|Overall Study|Physician Decision|0|||
144222372|NCT02810457|520010332|FG001|Overall Study|Physician Decision|1|||
144222373|NCT02019472|520010333|FG000|Overall Study|Adverse Event|14|||
144222374|NCT02019472|520010334|FG001|Overall Study|Adverse Event|23|||
144222375|NCT02019472|520010335|FG002|Overall Study|Adverse Event|17|||
144222376|NCT02019472|520010333|FG000|Overall Study|Death|0|||
144222377|NCT02019472|520010334|FG001|Overall Study|Death|1|||
144222378|NCT02019472|520010335|FG002|Overall Study|Death|1|||
144222379|NCT02019472|520010333|FG000|Overall Study|Lack of Efficacy|7|||
144222380|NCT02019472|520010334|FG001|Overall Study|Lack of Efficacy|4|||
144222381|NCT02019472|520010335|FG002|Overall Study|Lack of Efficacy|4|||
144222382|NCT02019472|520010333|FG000|Overall Study|Lost to Follow-up|0|||
144222383|NCT02019472|520010334|FG001|Overall Study|Lost to Follow-up|2|||
144222384|NCT02019472|520010335|FG002|Overall Study|Lost to Follow-up|1|||
144222385|NCT02019472|520010333|FG000|Overall Study|Physician Decision|1|||
144222386|NCT02019472|520010334|FG001|Overall Study|Physician Decision|2|||
144222387|NCT02019472|520010335|FG002|Overall Study|Physician Decision|0|||
144222388|NCT02019472|520010333|FG000|Overall Study|Pregnancy|1|||
144222389|NCT02019472|520010334|FG001|Overall Study|Pregnancy|2|||
144222390|NCT02019472|520010335|FG002|Overall Study|Pregnancy|2|||
144222391|NCT02019472|520010333|FG000|Overall Study|Withdrawal by Subject|11|||
144222392|NCT02019472|520010334|FG001|Overall Study|Withdrawal by Subject|10|||
144222393|NCT02019472|520010335|FG002|Overall Study|Withdrawal by Subject|11|||
144222394|NCT02019472|520010333|FG000|Overall Study|Other|3|||
144222395|NCT02019472|520010334|FG001|Overall Study|Other|8|||
144222396|NCT02019472|520010335|FG002|Overall Study|Other|6|||
144222397|NCT03192488|520010336|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
144222398|NCT03192488|520010337|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
144222399|NCT03192488|520010338|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
144222400|NCT03192488|520010339|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
144222401|NCT03192488|520010340|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
144222402|NCT03192488|520010341|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
144222403|NCT03192488|520010336|FG000|Third Intervention (d1)|Adverse Event|0|||
144222404|NCT03192488|520010337|FG001|Third Intervention (d1)|Adverse Event|0|||
144222405|NCT03192488|520010338|FG002|Third Intervention (d1)|Adverse Event|0|||
144222406|NCT03192488|520010339|FG003|Third Intervention (d1)|Adverse Event|0|||
144222407|NCT03192488|520010340|FG004|Third Intervention (d1)|Adverse Event|1|||
144222408|NCT03192488|520010341|FG005|Third Intervention (d1)|Adverse Event|0|||
144222409|NCT03588910|520010343|FG000|Overall Study|Withdrawal by Subject|1|||
144222410|NCT03588910|520010344|FG001|Overall Study|Withdrawal by Subject|0|||
144222411|NCT03588910|520010343|FG000|Overall Study|Allergy|2|||
144222412|NCT03588910|520010344|FG001|Overall Study|Allergy|0|||
144222413|NCT03588910|520010343|FG000|Overall Study|Protocol Violation|0|||
144222414|NCT03588910|520010344|FG001|Overall Study|Protocol Violation|3|||
144222415|NCT03588910|520010343|FG000|Overall Study|Did not complete Day 1 Survey|5|||
144222416|NCT03588910|520010344|FG001|Overall Study|Did not complete Day 1 Survey|10|||
144222417|NCT03588910|520010343|FG000|Overall Study|Did not complete Day 7 Survey|5|||
144222418|NCT03588910|520010344|FG001|Overall Study|Did not complete Day 7 Survey|2|||
144222419|NCT02547428|520010345|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
144222420|NCT02547428|520010346|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
144222421|NCT02547428|520010345|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
144222422|NCT02547428|520010346|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
144222423|NCT02547428|520010345|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
144222424|NCT02547428|520010346|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
144222425|NCT02547428|520010345|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
144222426|NCT02547428|520010346|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
144222427|NCT02547428|520010345|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
144222428|NCT02547428|520010346|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
144222429|NCT02547428|520010345|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
144222430|NCT02547428|520010346|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
144222431|NCT02547428|520010345|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
144222432|NCT02547428|520010346|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
144222433|NCT02547428|520010345|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
144222434|NCT02547428|520010346|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
144222435|NCT04429503|520010349|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
144222436|NCT04429503|520010350|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
144222437|NCT04429503|520010351|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
144266573|NCT00086190|520178401|FG000|Overall Study|Protocol Violation|1|||
144266574|NCT00086190|520178402|FG001|Overall Study|Protocol Violation|0|||
144266575|NCT00086190|520178403|FG002|Overall Study|Protocol Violation|0|||
144222438|NCT04429503|520010352|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
144222439|NCT04429503|520010353|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
144222440|NCT04429503|520010354|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
144222441|NCT04429503|520010349|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
144222442|NCT04429503|520010350|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
144222443|NCT04429503|520010351|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
144222444|NCT04429503|520010352|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
144222445|NCT04429503|520010353|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
144222446|NCT04429503|520010354|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
144222447|NCT04429503|520010349|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
144222448|NCT04429503|520010350|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
144222449|NCT04429503|520010351|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
144222450|NCT04429503|520010352|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
144222451|NCT04429503|520010353|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
144222452|NCT04429503|520010354|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
144222453|NCT04429503|520010349|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
144222454|NCT04429503|520010350|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
144222455|NCT04429503|520010351|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
144222456|NCT04429503|520010352|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
144222457|NCT04429503|520010353|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
144222458|NCT04429503|520010354|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
144222459|NCT04429503|520010349|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
144222460|NCT04429503|520010350|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
144222461|NCT04429503|520010351|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
144266576|NCT00086190|520178401|FG000|Overall Study|Moved|1|||
144695486|NCT00151775|521737671|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695487|NCT00151775|521737672|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695488|NCT00151775|521737673|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695489|NCT00151775|521737674|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695490|NCT00151775|521737675|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695491|NCT00151775|521737676|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695492|NCT00151775|521737677|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695493|NCT00151775|521737678|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
144695494|NCT00151775|521737667|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695495|NCT00151775|521737668|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695496|NCT00151775|521737669|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
144695497|NCT00151775|521737670|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695498|NCT00151775|521737671|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695499|NCT00151775|521737672|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695500|NCT00151775|521737673|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695501|NCT00151775|521737674|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695502|NCT00151775|521737675|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695503|NCT00151775|521737676|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695504|NCT00151775|521737677|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695505|NCT00151775|521737678|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
144695506|NCT00151775|521737667|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695507|NCT00151775|521737668|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695508|NCT00151775|521737669|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695509|NCT00151775|521737670|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695510|NCT00151775|521737671|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695511|NCT00151775|521737672|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695512|NCT00151775|521737673|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695513|NCT00151775|521737674|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695514|NCT00151775|521737675|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695515|NCT00151775|521737676|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695516|NCT00151775|521737677|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
144695517|NCT00151775|521737678|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
144695518|NCT00151775|521737667|FG000|Period 4: Open Label|Increased blood pressure|0|||
144695519|NCT00151775|521737668|FG001|Period 4: Open Label|Increased blood pressure|0|||
144695520|NCT00151775|521737669|FG002|Period 4: Open Label|Increased blood pressure|0|||
144695521|NCT00151775|521737670|FG003|Period 4: Open Label|Increased blood pressure|0|||
144695522|NCT00151775|521737671|FG004|Period 4: Open Label|Increased blood pressure|1|||
144695523|NCT00151775|521737672|FG005|Period 4: Open Label|Increased blood pressure|0|||
144695524|NCT00151775|521737673|FG006|Period 4: Open Label|Increased blood pressure|0|||
144695525|NCT00151775|521737674|FG007|Period 4: Open Label|Increased blood pressure|0|||
144695526|NCT00151775|521737675|FG008|Period 4: Open Label|Increased blood pressure|0|||
144695527|NCT00151775|521737676|FG009|Period 4: Open Label|Increased blood pressure|1|||
144695528|NCT00151775|521737677|FG010|Period 4: Open Label|Increased blood pressure|0|||
144695529|NCT00151775|521737678|FG011|Period 4: Open Label|Increased blood pressure|0|||
144695530|NCT00151775|521737667|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
144695531|NCT00151775|521737668|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
144695532|NCT00151775|521737669|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
144695533|NCT00151775|521737670|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
144695534|NCT00151775|521737671|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
144695535|NCT00151775|521737672|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
144695536|NCT00151775|521737673|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
144695537|NCT00151775|521737674|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
144695538|NCT00151775|521737675|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
144695539|NCT00151775|521737676|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
144695540|NCT00151775|521737677|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
144695541|NCT00151775|521737678|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
144695542|NCT00151775|521737667|FG000|Period 4: Open Label|Adverse Event|0|||
144695543|NCT00151775|521737668|FG001|Period 4: Open Label|Adverse Event|0|||
144695544|NCT00151775|521737669|FG002|Period 4: Open Label|Adverse Event|0|||
144695545|NCT00151775|521737670|FG003|Period 4: Open Label|Adverse Event|0|||
144695546|NCT00151775|521737671|FG004|Period 4: Open Label|Adverse Event|1|||
144695547|NCT00151775|521737672|FG005|Period 4: Open Label|Adverse Event|0|||
144695548|NCT00151775|521737673|FG006|Period 4: Open Label|Adverse Event|0|||
144695549|NCT00151775|521737674|FG007|Period 4: Open Label|Adverse Event|0|||
144695550|NCT00151775|521737675|FG008|Period 4: Open Label|Adverse Event|0|||
144695551|NCT00151775|521737676|FG009|Period 4: Open Label|Adverse Event|2|||
144695552|NCT00151775|521737677|FG010|Period 4: Open Label|Adverse Event|0|||
144695553|NCT00151775|521737678|FG011|Period 4: Open Label|Adverse Event|0|||
144266577|NCT00086190|520178402|FG001|Overall Study|Moved|0|||
144266578|NCT00086190|520178403|FG002|Overall Study|Moved|0|||
144266579|NCT00086190|520178401|FG000|Overall Study|Worsening depression|0|||
144266580|NCT00086190|520178402|FG001|Overall Study|Worsening depression|0|||
144695554|NCT00151775|521737667|FG000|Period 4: Open Label|Lost to Follow-up|0|||
144695555|NCT00151775|521737668|FG001|Period 4: Open Label|Lost to Follow-up|0|||
144695556|NCT00151775|521737669|FG002|Period 4: Open Label|Lost to Follow-up|0|||
144695557|NCT00151775|521737670|FG003|Period 4: Open Label|Lost to Follow-up|0|||
144695558|NCT00151775|521737671|FG004|Period 4: Open Label|Lost to Follow-up|17|||
144695559|NCT00151775|521737672|FG005|Period 4: Open Label|Lost to Follow-up|0|||
144695560|NCT00151775|521737673|FG006|Period 4: Open Label|Lost to Follow-up|0|||
144695561|NCT00151775|521737674|FG007|Period 4: Open Label|Lost to Follow-up|0|||
144695562|NCT00151775|521737675|FG008|Period 4: Open Label|Lost to Follow-up|0|||
144695563|NCT00151775|521737676|FG009|Period 4: Open Label|Lost to Follow-up|7|||
144695564|NCT00151775|521737677|FG010|Period 4: Open Label|Lost to Follow-up|0|||
144695565|NCT00151775|521737678|FG011|Period 4: Open Label|Lost to Follow-up|0|||
144695566|NCT00151775|521737667|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
144695567|NCT00151775|521737668|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
144695568|NCT00151775|521737669|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
144695569|NCT00151775|521737670|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
144695570|NCT00151775|521737671|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
144695571|NCT00151775|521737672|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
144695572|NCT00151775|521737673|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
144695573|NCT00151775|521737674|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
144695574|NCT00151775|521737675|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
144695575|NCT00151775|521737676|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
144695576|NCT00151775|521737677|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
144695577|NCT00151775|521737678|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
144695578|NCT00151775|521737667|FG000|Period 4: Open Label|Other|0|||
144695579|NCT00151775|521737668|FG001|Period 4: Open Label|Other|0|||
144695580|NCT00151775|521737669|FG002|Period 4: Open Label|Other|0|||
144695581|NCT00151775|521737670|FG003|Period 4: Open Label|Other|0|||
144695582|NCT00151775|521737671|FG004|Period 4: Open Label|Other|1|||
144695583|NCT00151775|521737672|FG005|Period 4: Open Label|Other|0|||
144695584|NCT00151775|521737673|FG006|Period 4: Open Label|Other|0|||
144695585|NCT00151775|521737674|FG007|Period 4: Open Label|Other|0|||
144695586|NCT00151775|521737675|FG008|Period 4: Open Label|Other|0|||
144695587|NCT00151775|521737676|FG009|Period 4: Open Label|Other|3|||
144695588|NCT00151775|521737677|FG010|Period 4: Open Label|Other|0|||
144695589|NCT00151775|521737678|FG011|Period 4: Open Label|Other|0|||
144695590|NCT00151775|521737667|FG000|Period 4: Open Label|Physician Decision|0|||
144695591|NCT00151775|521737668|FG001|Period 4: Open Label|Physician Decision|0|||
144695592|NCT00151775|521737669|FG002|Period 4: Open Label|Physician Decision|0|||
144695593|NCT00151775|521737670|FG003|Period 4: Open Label|Physician Decision|0|||
144695594|NCT00151775|521737671|FG004|Period 4: Open Label|Physician Decision|0|||
144695595|NCT00151775|521737672|FG005|Period 4: Open Label|Physician Decision|0|||
144695596|NCT00151775|521737673|FG006|Period 4: Open Label|Physician Decision|0|||
144695597|NCT00151775|521737674|FG007|Period 4: Open Label|Physician Decision|0|||
144695598|NCT00151775|521737675|FG008|Period 4: Open Label|Physician Decision|0|||
144695599|NCT00151775|521737676|FG009|Period 4: Open Label|Physician Decision|2|||
144695600|NCT00151775|521737677|FG010|Period 4: Open Label|Physician Decision|0|||
144695601|NCT00151775|521737678|FG011|Period 4: Open Label|Physician Decision|0|||
144695602|NCT00151775|521737667|FG000|Period 4: Open Label|Protocol Violation|0|||
144695603|NCT00151775|521737668|FG001|Period 4: Open Label|Protocol Violation|0|||
144695604|NCT00151775|521737669|FG002|Period 4: Open Label|Protocol Violation|0|||
144695605|NCT00151775|521737670|FG003|Period 4: Open Label|Protocol Violation|0|||
144695606|NCT00151775|521737671|FG004|Period 4: Open Label|Protocol Violation|1|||
144695607|NCT00151775|521737672|FG005|Period 4: Open Label|Protocol Violation|0|||
144695608|NCT00151775|521737673|FG006|Period 4: Open Label|Protocol Violation|0|||
144695609|NCT00151775|521737674|FG007|Period 4: Open Label|Protocol Violation|0|||
144695610|NCT00151775|521737675|FG008|Period 4: Open Label|Protocol Violation|0|||
144695611|NCT00151775|521737676|FG009|Period 4: Open Label|Protocol Violation|0|||
144695612|NCT00151775|521737677|FG010|Period 4: Open Label|Protocol Violation|0|||
144695613|NCT00151775|521737678|FG011|Period 4: Open Label|Protocol Violation|0|||
144695614|NCT04516291|521737679|FG000|Treatment Period (24 Weeks)|Other|1|||
144695615|NCT04516291|521737680|FG001|Treatment Period (24 Weeks)|Other|0|||
144695616|NCT04516291|521737681|FG002|Treatment Period (24 Weeks)|Other|0|||
144695617|NCT04516291|521737682|FG003|Treatment Period (24 Weeks)|Other|2|||
144266581|NCT00086190|520178403|FG002|Overall Study|Worsening depression|2|||
144695618|NCT04516291|521737683|FG004|Treatment Period (24 Weeks)|Other|2|||
144695619|NCT04516291|521737684|FG005|Treatment Period (24 Weeks)|Other|4|||
144695620|NCT04516291|521737685|FG006|Treatment Period (24 Weeks)|Other|2|||
144695621|NCT04516291|521737686|FG007|Treatment Period (24 Weeks)|Other|0|||
144695622|NCT04516291|521737679|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144695623|NCT04516291|521737680|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
144695624|NCT04516291|521737681|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
144266582|NCT04467515|520178404|FG000|Overall Study|Lost to Follow-up|1|||
144266583|NCT04467515|520178405|FG001|Overall Study|Lost to Follow-up|0|||
144266584|NCT04467515|520178406|FG002|Overall Study|Lost to Follow-up|0|||
144266585|NCT04467515|520178404|FG000|Overall Study|Withdrawal by Subject|1|||
144266586|NCT04467515|520178405|FG001|Overall Study|Withdrawal by Subject|0|||
144266587|NCT04467515|520178406|FG002|Overall Study|Withdrawal by Subject|1|||
144266588|NCT04467515|520178404|FG000|Overall Study|Progressive Disease|0|||
144266589|NCT04467515|520178405|FG001|Overall Study|Progressive Disease|1|||
144266590|NCT04467515|520178406|FG002|Overall Study|Progressive Disease|3|||
144266591|NCT04467515|520178404|FG000|Overall Study|Death|0|||
144266592|NCT04467515|520178405|FG001|Overall Study|Death|1|||
144266593|NCT04467515|520178406|FG002|Overall Study|Death|0|||
144266594|NCT03834506|520178409|FG000|Overall Study|Death|336|||
144266595|NCT03834506|520178410|FG001|Overall Study|Death|326|||
144266596|NCT03834506|520178409|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
144266597|NCT03834506|520178410|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144266598|NCT03834506|520178409|FG000|Overall Study|Withdrawal by Subject|10|||
144266599|NCT03834506|520178410|FG001|Overall Study|Withdrawal by Subject|8|||
144266600|NCT03834506|520178409|FG000|Overall Study|Sponsor decision|165|||
144266601|NCT03834506|520178410|FG001|Overall Study|Sponsor decision|178|||
144266602|NCT03834506|520178409|FG000|Overall Study|Physician Decision|3|||
144266603|NCT03834506|520178410|FG001|Overall Study|Physician Decision|1|||
144266604|NCT03834506|520178409|FG000|Overall Study|Lost to Follow-up|0|||
144266605|NCT03834506|520178410|FG001|Overall Study|Lost to Follow-up|1|||
144266606|NCT04460326|520178422|FG000|Completed at Least 4 Meals|Early discharge|5|||
144266607|NCT04460326|520178423|FG001|Completed at Least 4 Meals|Early discharge|5|||
144266608|NCT04460326|520178422|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
144695625|NCT04516291|521737682|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144695626|NCT04516291|521737683|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
144695627|NCT04516291|521737684|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144695628|NCT04516291|521737685|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144695629|NCT04516291|521737686|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144695630|NCT04516291|521737679|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695631|NCT04516291|521737680|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695632|NCT04516291|521737681|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695633|NCT04516291|521737682|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
144695634|NCT04516291|521737683|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695635|NCT04516291|521737684|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695636|NCT04516291|521737685|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695637|NCT04516291|521737686|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
144695638|NCT04516291|521737679|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695639|NCT04516291|521737680|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
144695640|NCT04516291|521737681|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695641|NCT04516291|521737682|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695642|NCT04516291|521737683|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695643|NCT04516291|521737684|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695644|NCT04516291|521737685|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695645|NCT04516291|521737686|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
144695646|NCT04516291|521737679|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
144695647|NCT04516291|521737680|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
144695648|NCT04516291|521737681|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
144695649|NCT04516291|521737682|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
144695650|NCT04516291|521737683|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
144695651|NCT04516291|521737684|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
144695652|NCT04516291|521737685|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
144222462|NCT04429503|520010352|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
144222463|NCT04429503|520010353|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
144222464|NCT04429503|520010354|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
144222465|NCT04429503|520010349|FG000|Main Study (Up to Wk 96)|Death|9|||
144222466|NCT04429503|520010350|FG001|Main Study (Up to Wk 96)|Death|18|||
144222467|NCT04429503|520010351|FG002|Main Study (Up to Wk 96)|Death|5|||
144222468|NCT04429503|520010352|FG003|Main Study (Up to Wk 96)|Death|0|||
144222469|NCT04429503|520010353|FG004|Main Study (Up to Wk 96)|Death|0|||
144222470|NCT04429503|520010354|FG005|Main Study (Up to Wk 96)|Death|0|||
144222471|NCT04429503|520010349|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
144222472|NCT04429503|520010350|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
144222473|NCT04429503|520010351|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
144222474|NCT04429503|520010352|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
144222475|NCT04429503|520010353|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
144222476|NCT04429503|520010354|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
144222477|NCT04429503|520010349|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
144222478|NCT04429503|520010350|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
144222479|NCT04429503|520010351|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
144222480|NCT04429503|520010352|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
144222481|NCT04429503|520010353|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
144222482|NCT04429503|520010354|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
144222483|NCT04429503|520010349|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
144222484|NCT04429503|520010350|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
144222485|NCT04429503|520010351|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
144222486|NCT04429503|520010352|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
144222487|NCT04429503|520010353|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
144222488|NCT04429503|520010354|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
144222489|NCT04429503|520010349|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
144222490|NCT04429503|520010350|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
144222491|NCT04429503|520010351|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
144222492|NCT04429503|520010352|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
144222493|NCT04429503|520010353|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
144222494|NCT04429503|520010354|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
144222495|NCT04429503|520010349|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
144222496|NCT04429503|520010350|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
144222497|NCT04429503|520010351|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
144222498|NCT04429503|520010352|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
144222499|NCT04429503|520010353|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
144222500|NCT04429503|520010354|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
144222501|NCT04429503|520010349|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
144222502|NCT04429503|520010350|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
144222503|NCT04429503|520010351|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
144222504|NCT04429503|520010352|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
144222505|NCT04429503|520010353|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
144222506|NCT04429503|520010354|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
144222507|NCT05516108|520010355|FG000|Overall Study|Time Commitment|3|||
144222508|NCT05516108|520010356|FG001|Overall Study|Time Commitment|1|||
144222509|NCT05516108|520010355|FG000|Overall Study|Reason Unknown|2|||
144222510|NCT05516108|520010356|FG001|Overall Study|Reason Unknown|4|||
144266609|NCT04460326|520178423|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
144266610|NCT04460326|520178422|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
144266611|NCT04460326|520178423|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
144222511|NCT03664232|520010361|FG000|Overall Study|Withdrawal by Subject|0|||
144222512|NCT03664232|520010362|FG001|Overall Study|Withdrawal by Subject|1|||
144222513|NCT03664232|520010363|FG002|Overall Study|Withdrawal by Subject|0|||
144222514|NCT03664232|520010364|FG003|Overall Study|Withdrawal by Subject|1|||
144222515|NCT03664232|520010361|FG000|Overall Study|Adverse Event|0|||
144222516|NCT03664232|520010362|FG001|Overall Study|Adverse Event|0|||
144222517|NCT03664232|520010363|FG002|Overall Study|Adverse Event|1|||
144222518|NCT03664232|520010364|FG003|Overall Study|Adverse Event|0|||
144222519|NCT03664232|520010361|FG000|Overall Study|Other-Non-compliance with study drug|0|||
144222520|NCT03664232|520010362|FG001|Overall Study|Other-Non-compliance with study drug|1|||
144222521|NCT03664232|520010363|FG002|Overall Study|Other-Non-compliance with study drug|0|||
144222522|NCT03664232|520010364|FG003|Overall Study|Other-Non-compliance with study drug|2|||
144222523|NCT03664232|520010361|FG000|Overall Study|Other-Unspecified|0|||
144222524|NCT03664232|520010362|FG001|Overall Study|Other-Unspecified|3|||
144222525|NCT03664232|520010363|FG002|Overall Study|Other-Unspecified|0|||
144222526|NCT03664232|520010364|FG003|Overall Study|Other-Unspecified|1|||
144222527|NCT03664232|520010361|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
144222528|NCT03664232|520010362|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
144222529|NCT03664232|520010363|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
144222530|NCT03664232|520010364|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
144222531|NCT02717507|520010365|FG000|Overall Study|Lost to Follow-up|5|||
144222532|NCT02717507|520010366|FG001|Overall Study|Lost to Follow-up|8|||
144222533|NCT02717507|520010365|FG000|Overall Study|Pregnancy|1|||
144222534|NCT02717507|520010366|FG001|Overall Study|Pregnancy|1|||
144222535|NCT02717507|520010365|FG000|Overall Study|Protocol Violation|2|||
144222536|NCT02717507|520010366|FG001|Overall Study|Protocol Violation|2|||
144222537|NCT02717507|520010365|FG000|Overall Study|Withdrawal by Subject|20|||
144222538|NCT02717507|520010366|FG001|Overall Study|Withdrawal by Subject|20|||
144222539|NCT02717507|520010365|FG000|Overall Study|Relapse|1|||
144222540|NCT02717507|520010366|FG001|Overall Study|Relapse|1|||
144222541|NCT02717507|520010365|FG000|Overall Study|Cardiac Event|2|||
144222542|NCT02717507|520010366|FG001|Overall Study|Cardiac Event|6|||
144222543|NCT00709995|520010367|FG000|Overall Study|Adverse Event|4|||
144222544|NCT00709995|520010368|FG001|Overall Study|Adverse Event|2|||
144222545|NCT00709995|520010367|FG000|Overall Study|Withdrawal by Subject|1|||
144222546|NCT00709995|520010368|FG001|Overall Study|Withdrawal by Subject|3|||
144222547|NCT02003209|520010373|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
144222548|NCT02003209|520010374|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
144222549|NCT00638508|520010375|FG000|Overall Study|Physician Decision|5|||
144222550|NCT00638508|520010376|FG001|Overall Study|Physician Decision|2|||
144266612|NCT04460326|520178422|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
144266613|NCT04460326|520178423|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
144266614|NCT04460326|520178422|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
144266615|NCT04460326|520178423|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
144266616|NCT04460326|520178422|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
144266617|NCT04460326|520178423|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
144266618|NCT03160716|520178424|FG000|Overall Study|Lost to Follow-up|1|||
144266619|NCT04794751|520178426|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
144266620|NCT04794751|520178427|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
144266621|NCT04794751|520178426|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
144266622|NCT04794751|520178427|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
144266623|NCT04794751|520178426|FG000|Period 1|Protocol Violation|0|||
144266624|NCT04794751|520178427|FG001|Period 1|Protocol Violation|2|||
144266625|NCT04794751|520178426|FG000|Period 1|Withdrawal by Subject|0|||
144266626|NCT04794751|520178427|FG001|Period 1|Withdrawal by Subject|1|||
144266627|NCT04794751|520178426|FG000|Period 2|Withdrawal by Subject|0|||
144266628|NCT04794751|520178427|FG001|Period 2|Withdrawal by Subject|1|||
144266629|NCT04794751|520178426|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
144266630|NCT04794751|520178427|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
144266631|NCT04794751|520178426|FG000|Period 2|Protocol Violation|1|||
144266632|NCT04794751|520178427|FG001|Period 2|Protocol Violation|0|||
144266633|NCT02283658|520178428|FG000|Overall Study|Withdrawal by Subject|1|||
144266634|NCT03528551|520178430|FG000|Overall Study|Lost to Follow-up|0|||
144266635|NCT03528551|520178431|FG001|Overall Study|Lost to Follow-up|1|||
144266636|NCT03528551|520178432|FG002|Overall Study|Lost to Follow-up|0|||
144266637|NCT03528551|520178430|FG000|Overall Study|Transferred to other arm/group|2|||
144266638|NCT03528551|520178431|FG001|Overall Study|Transferred to other arm/group|3|||
144266639|NCT03528551|520178432|FG002|Overall Study|Transferred to other arm/group|0|||
144266640|NCT03528551|520178430|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144266641|NCT03528551|520178431|FG001|Overall Study|Withdrawal by parent/guardian|5|||
144266642|NCT03528551|520178432|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144266643|NCT03528551|520178430|FG000|Overall Study|Protocol Violation|0|||
144266644|NCT03528551|520178431|FG001|Overall Study|Protocol Violation|3|||
144266645|NCT03528551|520178432|FG002|Overall Study|Protocol Violation|0|||
144266646|NCT03528551|520178430|FG000|Overall Study|Withdrawal by Subject|0|||
144266647|NCT03528551|520178431|FG001|Overall Study|Withdrawal by Subject|7|||
144266648|NCT03528551|520178432|FG002|Overall Study|Withdrawal by Subject|0|||
144266649|NCT01939314|520178435|FG000|Overall Study|Withdrawal by Subject|3|||
144266650|NCT01939314|520178436|FG001|Overall Study|Withdrawal by Subject|1|||
144266651|NCT01939314|520178435|FG000|Overall Study|Protocol Violation|1|||
144266652|NCT01939314|520178436|FG001|Overall Study|Protocol Violation|0|||
144266653|NCT01939314|520178435|FG000|Overall Study|Pregnancy|0|||
144266654|NCT01939314|520178436|FG001|Overall Study|Pregnancy|1|||
144266655|NCT01939314|520178435|FG000|Overall Study|Lost to Follow-up|5|||
144266656|NCT01939314|520178436|FG001|Overall Study|Lost to Follow-up|6|||
144266657|NCT02700048|520178437|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
144266658|NCT02700048|520178438|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
144266659|NCT02175225|520178439|FG000|Overall Study|Withdrawal by Subject|1|||
144266660|NCT02175225|520178440|FG001|Overall Study|Withdrawal by Subject|2|||
144266661|NCT02175225|520178439|FG000|Overall Study|Lost to Follow-up|6|||
144266662|NCT02175225|520178440|FG001|Overall Study|Lost to Follow-up|7|||
144266663|NCT02175225|520178439|FG000|Overall Study|Study drug not administered|1|||
144266664|NCT02175225|520178440|FG001|Overall Study|Study drug not administered|2|||
144266665|NCT00969228|520178445|FG000|Overall Study|Adverse Event|1|||
144266666|NCT00969228|520178446|FG001|Overall Study|Adverse Event|0|||
144266667|NCT00969228|520178445|FG000|Overall Study|Withdrawal by Subject|4|||
144266668|NCT00969228|520178446|FG001|Overall Study|Withdrawal by Subject|0|||
144266669|NCT00969228|520178445|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
144266670|NCT00969228|520178446|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
144266671|NCT01107925|520178448|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
144266672|NCT01107925|520178449|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
144266673|NCT01107925|520178450|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
144266674|NCT01107925|520178451|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
144266675|NCT01107925|520178452|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
144266676|NCT01107925|520178453|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
144266677|NCT01107925|520178448|FG000|Period 2|Withdrawal by Subject|0|||
144266678|NCT01107925|520178449|FG001|Period 2|Withdrawal by Subject|1|||
144266679|NCT01107925|520178450|FG002|Period 2|Withdrawal by Subject|0|||
144266680|NCT01107925|520178451|FG003|Period 2|Withdrawal by Subject|0|||
144266681|NCT01107925|520178452|FG004|Period 2|Withdrawal by Subject|0|||
144266682|NCT01107925|520178453|FG005|Period 2|Withdrawal by Subject|1|||
144266683|NCT03311945|520178454|FG000|Overall Study|Adverse Event|2|||
144266684|NCT03311945|520178454|FG000|Overall Study|Lack of Efficacy|1|||
144266685|NCT04877990|520178455|FG000|Treatment|Other reasons|3|||
144266686|NCT04877990|520178456|FG001|Treatment|Other reasons|1|||
144222551|NCT03500198|520010377|FG000|Overall Study|Lost to Follow-up|0|||
144222552|NCT03500198|520010378|FG001|Overall Study|Lost to Follow-up|1|||
144222553|NCT00324987|520010384|FG000|Overall Study|Adverse Event|2|||
144222554|NCT00324987|520010385|FG001|Overall Study|Adverse Event|1|||
144222555|NCT00324987|520010384|FG000|Overall Study|Withdrawal by Subject|1|||
144222556|NCT00324987|520010385|FG001|Overall Study|Withdrawal by Subject|1|||
144222557|NCT00324987|520010384|FG000|Overall Study|Progression|1|||
144222558|NCT00324987|520010385|FG001|Overall Study|Progression|1|||
144222559|NCT00324987|520010384|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
144222560|NCT00324987|520010385|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
144222561|NCT01068860|520010386|FG000|Overall Study|Withdrawal by Subject|0|||
144222562|NCT01068860|520010387|FG001|Overall Study|Withdrawal by Subject|0|||
144222563|NCT01068860|520010388|FG002|Overall Study|Withdrawal by Subject|0|||
144695653|NCT04516291|521737686|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
144695654|NCT04516291|521737679|FG000|Follow-up Period (12 Weeks)|Other|0|||
144695655|NCT04516291|521737680|FG001|Follow-up Period (12 Weeks)|Other|1|||
144695656|NCT04516291|521737681|FG002|Follow-up Period (12 Weeks)|Other|0|||
144695657|NCT04516291|521737682|FG003|Follow-up Period (12 Weeks)|Other|2|||
144695658|NCT04516291|521737683|FG004|Follow-up Period (12 Weeks)|Other|0|||
144222564|NCT01068860|520010389|FG003|Overall Study|Withdrawal by Subject|0|||
144222565|NCT01068860|520010390|FG004|Overall Study|Withdrawal by Subject|0|||
144695659|NCT04516291|521737684|FG005|Follow-up Period (12 Weeks)|Other|0|||
144695660|NCT04516291|521737685|FG006|Follow-up Period (12 Weeks)|Other|0|||
144695661|NCT04516291|521737686|FG007|Follow-up Period (12 Weeks)|Other|0|||
144695662|NCT04516291|521737679|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695663|NCT04516291|521737680|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695664|NCT04516291|521737681|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695665|NCT04516291|521737682|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695666|NCT04516291|521737683|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
144695667|NCT04516291|521737684|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695668|NCT04516291|521737685|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695669|NCT04516291|521737686|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
144695670|NCT04516291|521737679|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
144695671|NCT04516291|521737680|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
144695672|NCT04516291|521737681|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
144695673|NCT04516291|521737682|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
144695674|NCT04516291|521737683|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
144695675|NCT04516291|521737684|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
144695676|NCT04516291|521737685|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
144695677|NCT04516291|521737686|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
144695678|NCT02158949|521737687|FG000|Overall Study|Withdrawal by Subject|1|||
144695679|NCT02158949|521737688|FG001|Overall Study|Withdrawal by Subject|0|||
144695680|NCT02158949|521737687|FG000|Overall Study|Lost to Follow-up|5|||
144695681|NCT02158949|521737688|FG001|Overall Study|Lost to Follow-up|11|||
144695682|NCT01161173|521737701|FG000|Overall Study|Protocol Violation|13|||
144695683|NCT01161173|521737701|FG000|Overall Study|Lost to Follow-up|7|||
144695684|NCT01161173|521737701|FG000|Overall Study|Progressive Disease|82|||
144695685|NCT01161173|521737701|FG000|Overall Study|Withdrawal of Consent|5|||
144695686|NCT01161173|521737701|FG000|Overall Study|Unacceptable Toxicity|21|||
144695687|NCT01161173|521737701|FG000|Overall Study|Death|194|||
144695688|NCT01161173|521737701|FG000|Overall Study|End of Study|2|||
144695689|NCT01161173|521737701|FG000|Overall Study|Reasons Not Specified|23|||
144695690|NCT00792467|521737702|FG000|Overall Study|progression of disease|17|||
144695691|NCT00792467|521737702|FG000|Overall Study|Adverse Event|1|||
144695692|NCT00792467|521737702|FG000|Overall Study|patient request|1|||
144695693|NCT00792467|521737702|FG000|Overall Study|Lost to Follow-up|1|||
144695694|NCT00792467|521737702|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
144695695|NCT00792467|521737702|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
144695696|NCT03781167|521737704|FG000|Overall Study|Adverse Event|23|||
144695697|NCT03781167|521737705|FG001|Overall Study|Adverse Event|25|||
144695698|NCT03781167|521737704|FG000|Overall Study|Withdrew consent|16|||
144695699|NCT03781167|521737705|FG001|Overall Study|Withdrew consent|12|||
144695700|NCT03781167|521737704|FG000|Overall Study|Lost to Follow-up|0|||
144695701|NCT03781167|521737705|FG001|Overall Study|Lost to Follow-up|1|||
144695702|NCT03781167|521737704|FG000|Overall Study|Lack of Efficacy|4|||
144695703|NCT03781167|521737705|FG001|Overall Study|Lack of Efficacy|5|||
144695704|NCT03781167|521737704|FG000|Overall Study|Difficulty with drug delivery system|2|||
144695705|NCT03781167|521737705|FG001|Overall Study|Difficulty with drug delivery system|3|||
144695706|NCT03781167|521737704|FG000|Overall Study|Other, not specified|2|||
144695707|NCT03781167|521737705|FG001|Overall Study|Other, not specified|2|||
144695708|NCT00679354|521737707|FG000|Overall Study|Death|3|||
144695709|NCT00679354|521737707|FG000|Overall Study|Lack of Efficacy|22|||
144695710|NCT00679354|521737707|FG000|Overall Study|Physician Decision|4|||
144695711|NCT00679354|521737707|FG000|Overall Study|Ineligible|1|||
144695712|NCT01590628|521737708|FG000|Overall Study|Death|2|||
144222566|NCT01068860|520010391|FG005|Overall Study|Withdrawal by Subject|2|||
144222567|NCT01068860|520010392|FG006|Overall Study|Withdrawal by Subject|0|||
144695713|NCT01590628|521737709|FG001|Overall Study|Death|0|||
144695714|NCT00808665|521737710|FG000|Overall Study|Withdrawal by Subject|1|||
144222568|NCT01068860|520010393|FG007|Overall Study|Withdrawal by Subject|0|||
144695715|NCT00808665|521737711|FG001|Overall Study|Withdrawal by Subject|0|||
144695716|NCT00808665|521737710|FG000|Overall Study|only required minimally invasive surgery|1|||
144695717|NCT00808665|521737711|FG001|Overall Study|only required minimally invasive surgery|0|||
144695718|NCT00808665|521737710|FG000|Overall Study|surgery cancelled|1|||
144695719|NCT00808665|521737711|FG001|Overall Study|surgery cancelled|0|||
144695720|NCT00808665|521737710|FG000|Overall Study|required an additional procedure|0|||
144695721|NCT00808665|521737711|FG001|Overall Study|required an additional procedure|1|||
144695722|NCT00808665|521737710|FG000|Overall Study|Physician Decision|3|||
144695723|NCT00808665|521737711|FG001|Overall Study|Physician Decision|1|||
144695724|NCT00808665|521737710|FG000|Overall Study|Medication stopped by resident|0|||
144695725|NCT00808665|521737711|FG001|Overall Study|Medication stopped by resident|1|||
144695726|NCT03326323|521737712|FG000|Overall Study|Unable to receive ANH protocol|3|||
144695727|NCT01757821|521737713|FG000|Overall Study|Adverse Event|1|||
144695728|NCT03831282|521737714|FG000|Overall Study|Could not place sensor|1|||
144695729|NCT00334893|521737715|FG000|Overall Study|Not Treated|1|||
144695730|NCT00334893|521737716|FG001|Overall Study|Not Treated|0|||
144695731|NCT01258803|521737717|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
144695732|NCT01258803|521737718|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
144695733|NCT01258803|521737719|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
144695734|NCT01258803|521737720|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
144695735|NCT01258803|521737721|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
144695736|NCT01258803|521737722|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
144695737|NCT01258803|521737717|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
144695738|NCT01258803|521737718|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
144695739|NCT01258803|521737719|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
144695740|NCT01258803|521737720|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
144695741|NCT01258803|521737721|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
144695742|NCT01258803|521737722|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
144695743|NCT01258803|521737717|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
144695744|NCT01258803|521737718|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
144695745|NCT01258803|521737719|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
144695746|NCT01258803|521737720|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
144695747|NCT01258803|521737721|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
144695748|NCT01258803|521737722|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
144695749|NCT00920582|521737723|FG000|Overall Study|Lost to Follow-up|5|||
144695750|NCT00920582|521737724|FG001|Overall Study|Lost to Follow-up|1|||
144695751|NCT00920582|521737725|FG002|Overall Study|Lost to Follow-up|2|||
144695752|NCT00920582|521737726|FG003|Overall Study|Lost to Follow-up|0|||
144695753|NCT00920582|521737723|FG000|Overall Study|Withdrawal by Subject|5|||
144695754|NCT00920582|521737724|FG001|Overall Study|Withdrawal by Subject|4|||
144695755|NCT00920582|521737725|FG002|Overall Study|Withdrawal by Subject|6|||
144695756|NCT00920582|521737726|FG003|Overall Study|Withdrawal by Subject|3|||
144695757|NCT00920582|521737723|FG000|Overall Study|Protocol Violation|1|||
144695758|NCT00920582|521737724|FG001|Overall Study|Protocol Violation|0|||
144695759|NCT00920582|521737725|FG002|Overall Study|Protocol Violation|0|||
144695760|NCT00920582|521737726|FG003|Overall Study|Protocol Violation|0|||
144695761|NCT00920582|521737723|FG000|Overall Study|Other|2|||
144695762|NCT00920582|521737724|FG001|Overall Study|Other|1|||
144695763|NCT00920582|521737725|FG002|Overall Study|Other|3|||
144695764|NCT00920582|521737726|FG003|Overall Study|Other|2|||
144695765|NCT01552408|521737729|FG000|Overall Study|Lost to Follow-up|2|||
144222569|NCT01068860|520010394|FG008|Overall Study|Withdrawal by Subject|0|||
144222570|NCT01068860|520010395|FG009|Overall Study|Withdrawal by Subject|3|||
144222571|NCT01068860|520010386|FG000|Overall Study|Administrative problems; misrandomized|0|||
144222572|NCT01068860|520010387|FG001|Overall Study|Administrative problems; misrandomized|0|||
144222573|NCT01068860|520010388|FG002|Overall Study|Administrative problems; misrandomized|0|||
144222574|NCT01068860|520010389|FG003|Overall Study|Administrative problems; misrandomized|1|||
144222575|NCT01068860|520010390|FG004|Overall Study|Administrative problems; misrandomized|0|||
144222576|NCT01068860|520010391|FG005|Overall Study|Administrative problems; misrandomized|0|||
144222577|NCT01068860|520010392|FG006|Overall Study|Administrative problems; misrandomized|0|||
144222578|NCT01068860|520010393|FG007|Overall Study|Administrative problems; misrandomized|0|||
144222579|NCT01068860|520010394|FG008|Overall Study|Administrative problems; misrandomized|0|||
144222580|NCT01068860|520010395|FG009|Overall Study|Administrative problems; misrandomized|1|||
144222581|NCT01068860|520010386|FG000|Overall Study|Lost to Follow-up|0|||
144222582|NCT01068860|520010387|FG001|Overall Study|Lost to Follow-up|1|||
144222583|NCT01068860|520010388|FG002|Overall Study|Lost to Follow-up|0|||
144222584|NCT01068860|520010389|FG003|Overall Study|Lost to Follow-up|0|||
144222585|NCT01068860|520010390|FG004|Overall Study|Lost to Follow-up|0|||
144222586|NCT01068860|520010391|FG005|Overall Study|Lost to Follow-up|0|||
144222587|NCT01068860|520010392|FG006|Overall Study|Lost to Follow-up|0|||
144222588|NCT01068860|520010393|FG007|Overall Study|Lost to Follow-up|0|||
144222589|NCT01068860|520010394|FG008|Overall Study|Lost to Follow-up|0|||
144222590|NCT01068860|520010395|FG009|Overall Study|Lost to Follow-up|0|||
144222591|NCT02568072|520010396|FG000|Overall Study|Unavailable for appointment|23|||
144222592|NCT02568072|520010396|FG000|Overall Study|Unable to contact|3|||
144222593|NCT02568072|520010396|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
144695766|NCT01552408|521737730|FG001|Overall Study|Lost to Follow-up|0|||
144695767|NCT01552408|521737729|FG000|Overall Study|Relocation|0|||
144695768|NCT01552408|521737730|FG001|Overall Study|Relocation|1|||
144695769|NCT01552408|521737729|FG000|Overall Study|Withdrawal by Subject|2|||
144222594|NCT02568072|520010396|FG000|Overall Study|Withdrawal by Subject|1|||
144222595|NCT02568072|520010396|FG000|Overall Study|Sustained injury, marathon not run|24|||
144222596|NCT03335475|520010397|FG000|Overall Study|Did not wear accelerometer|4|||
144222597|NCT03335475|520010398|FG001|Overall Study|Did not wear accelerometer|0|||
144222598|NCT03335475|520010397|FG000|Overall Study|Withdrawal by Subject|0|||
144222599|NCT03335475|520010398|FG001|Overall Study|Withdrawal by Subject|1|||
144222600|NCT06481709|520010399|FG000|Overall Study|Withdrawal by Subject|0|||
144222601|NCT06481709|520010400|FG001|Overall Study|Withdrawal by Subject|0|||
144222602|NCT06481709|520010401|FG002|Overall Study|Withdrawal by Subject|2|||
144222603|NCT06481709|520010402|FG003|Overall Study|Withdrawal by Subject|0|||
144222604|NCT00789854|520010403|FG000|Overall Study|Adverse Event|28|||
144222605|NCT00789854|520010404|FG001|Overall Study|Adverse Event|23|||
144222606|NCT00789854|520010405|FG002|Overall Study|Adverse Event|18|||
144222607|NCT00789854|520010403|FG000|Overall Study|Lost to Follow-up|1|||
144222608|NCT00789854|520010404|FG001|Overall Study|Lost to Follow-up|1|||
144222609|NCT00789854|520010405|FG002|Overall Study|Lost to Follow-up|4|||
144222610|NCT00789854|520010403|FG000|Overall Study|Withdrawal by Subject|9|||
144222611|NCT00789854|520010404|FG001|Overall Study|Withdrawal by Subject|6|||
144222612|NCT00789854|520010405|FG002|Overall Study|Withdrawal by Subject|17|||
144222613|NCT00789854|520010403|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144222614|NCT00789854|520010404|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
144222615|NCT00789854|520010405|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
144222616|NCT00789854|520010403|FG000|Overall Study|Severe non-compliance to the protocol|3|||
144222617|NCT00789854|520010404|FG001|Overall Study|Severe non-compliance to the protocol|0|||
144222618|NCT00789854|520010405|FG002|Overall Study|Severe non-compliance to the protocol|0|||
144222619|NCT00789854|520010403|FG000|Overall Study|Safety reasons|0|||
144222620|NCT00789854|520010404|FG001|Overall Study|Safety reasons|0|||
144222621|NCT00789854|520010405|FG002|Overall Study|Safety reasons|2|||
144222622|NCT00789854|520010403|FG000|Overall Study|Other|6|||
144222623|NCT00789854|520010404|FG001|Overall Study|Other|0|||
144222624|NCT00789854|520010405|FG002|Overall Study|Other|5|||
144222625|NCT03918629|520010406|FG000|Overall Study|Adverse Event|19|||
144222626|NCT03918629|520010407|FG001|Overall Study|Adverse Event|20|||
144222627|NCT03918629|520010406|FG000|Overall Study|Death|14|||
144222628|NCT03918629|520010407|FG001|Overall Study|Death|7|||
144222629|NCT03918629|520010406|FG000|Overall Study|Lost to Follow-up|36|||
144222630|NCT03918629|520010407|FG001|Overall Study|Lost to Follow-up|28|||
144222631|NCT03918629|520010406|FG000|Overall Study|Physician Decision|1|||
144222632|NCT03918629|520010407|FG001|Overall Study|Physician Decision|0|||
144222633|NCT03918629|520010406|FG000|Overall Study|Protocol Violation|7|||
144222634|NCT03918629|520010407|FG001|Overall Study|Protocol Violation|4|||
144222635|NCT03918629|520010406|FG000|Overall Study|Withdrawal by Subject|47|||
144222636|NCT03918629|520010407|FG001|Overall Study|Withdrawal by Subject|47|||
144222637|NCT03918629|520010406|FG000|Overall Study|Other|7|||
144222638|NCT03918629|520010407|FG001|Overall Study|Other|11|||
144222639|NCT03918629|520010406|FG000|Overall Study|Randomized but not vaccinated|2|||
144222640|NCT03918629|520010407|FG001|Overall Study|Randomized but not vaccinated|1|||
144222641|NCT01891864|520010411|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
144222642|NCT01891864|520010412|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
144222643|NCT01891864|520010413|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
144222644|NCT01891864|520010414|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
144222645|NCT01891864|520010415|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
144222646|NCT01891864|520010416|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
144222647|NCT01891864|520010411|FG000|Treatment Period 1|Physician Decision|0|||
144222648|NCT01891864|520010412|FG001|Treatment Period 1|Physician Decision|1|||
144222649|NCT01891864|520010413|FG002|Treatment Period 1|Physician Decision|0|||
144222650|NCT01891864|520010414|FG003|Treatment Period 1|Physician Decision|0|||
144222651|NCT01891864|520010415|FG004|Treatment Period 1|Physician Decision|0|||
144222652|NCT01891864|520010416|FG005|Treatment Period 1|Physician Decision|0|||
144222653|NCT01891864|520010411|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
144222654|NCT01891864|520010412|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
144222655|NCT01891864|520010413|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
144222656|NCT01891864|520010414|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
144222657|NCT01891864|520010415|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
144222658|NCT01891864|520010416|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
144222659|NCT01891864|520010411|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
144222660|NCT01891864|520010412|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
144222661|NCT01891864|520010413|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
144222662|NCT01891864|520010414|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
144222663|NCT01891864|520010415|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
144222664|NCT01891864|520010416|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
144222665|NCT01891864|520010411|FG000|Treatment Period 1|Withdrawal by Subject|2|||
144222666|NCT01891864|520010412|FG001|Treatment Period 1|Withdrawal by Subject|5|||
144222667|NCT01891864|520010413|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144222668|NCT01891864|520010414|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144222669|NCT01891864|520010415|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144222670|NCT01891864|520010416|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144222671|NCT01891864|520010411|FG000|Treatment Period 1|Lost to Follow-up|1|||
144222672|NCT01891864|520010412|FG001|Treatment Period 1|Lost to Follow-up|0|||
144222673|NCT01891864|520010413|FG002|Treatment Period 1|Lost to Follow-up|0|||
144222674|NCT01891864|520010414|FG003|Treatment Period 1|Lost to Follow-up|0|||
144222675|NCT01891864|520010415|FG004|Treatment Period 1|Lost to Follow-up|0|||
144222676|NCT01891864|520010416|FG005|Treatment Period 1|Lost to Follow-up|0|||
144222677|NCT01891864|520010411|FG000|Treatment Period 2|Protocol Violation|0|||
144222678|NCT01891864|520010412|FG001|Treatment Period 2|Protocol Violation|0|||
144222679|NCT01891864|520010413|FG002|Treatment Period 2|Protocol Violation|0|||
144222680|NCT01891864|520010414|FG003|Treatment Period 2|Protocol Violation|1|||
144222681|NCT01891864|520010415|FG004|Treatment Period 2|Protocol Violation|0|||
144222682|NCT01891864|520010416|FG005|Treatment Period 2|Protocol Violation|0|||
144222683|NCT01891864|520010411|FG000|Treatment Period 2|Physician Decision|0|||
144222684|NCT01891864|520010412|FG001|Treatment Period 2|Physician Decision|0|||
144222685|NCT01891864|520010413|FG002|Treatment Period 2|Physician Decision|1|||
144222686|NCT01891864|520010414|FG003|Treatment Period 2|Physician Decision|0|||
144695770|NCT01552408|521737730|FG001|Overall Study|Withdrawal by Subject|1|||
144695771|NCT03319160|521737731|FG000|Overall Study|Data not available.|7|||
144695772|NCT02243306|521737732|FG000|Overall Study|Adverse Event|0|||
144695773|NCT02243306|521737733|FG001|Overall Study|Adverse Event|1|||
144695774|NCT02243306|521737732|FG000|Overall Study|Other: Reached stopping criteria|0|||
144695775|NCT02243306|521737733|FG001|Overall Study|Other: Reached stopping criteria|1|||
144695776|NCT02243306|521737732|FG000|Overall Study|Physician Decision|0|||
144695777|NCT02243306|521737733|FG001|Overall Study|Physician Decision|1|||
144695778|NCT01016912|521737734|FG000|End of Treatment Period|Lack of Efficacy|0|||
144695779|NCT01016912|521737735|FG001|End of Treatment Period|Lack of Efficacy|1|||
144695780|NCT01016912|521737736|FG002|End of Treatment Period|Lack of Efficacy|0|||
144695781|NCT01016912|521737737|FG003|End of Treatment Period|Lack of Efficacy|4|||
144695782|NCT01016912|521737738|FG004|End of Treatment Period|Lack of Efficacy|4|||
144222687|NCT01891864|520010415|FG004|Treatment Period 2|Physician Decision|0|||
144222688|NCT01891864|520010416|FG005|Treatment Period 2|Physician Decision|0|||
144222689|NCT01891864|520010411|FG000|Treatment Period 2|Site Termination|0|||
144222690|NCT01891864|520010412|FG001|Treatment Period 2|Site Termination|0|||
144222691|NCT01891864|520010413|FG002|Treatment Period 2|Site Termination|1|||
144222692|NCT01891864|520010414|FG003|Treatment Period 2|Site Termination|2|||
144222693|NCT01891864|520010415|FG004|Treatment Period 2|Site Termination|0|||
144222694|NCT01891864|520010416|FG005|Treatment Period 2|Site Termination|0|||
144222695|NCT01891864|520010411|FG000|Treatment Period 2|Lack of Efficacy|0|||
144222696|NCT01891864|520010412|FG001|Treatment Period 2|Lack of Efficacy|0|||
144222697|NCT01891864|520010413|FG002|Treatment Period 2|Lack of Efficacy|1|||
144222698|NCT01891864|520010414|FG003|Treatment Period 2|Lack of Efficacy|0|||
144222699|NCT01891864|520010415|FG004|Treatment Period 2|Lack of Efficacy|1|||
144222700|NCT01891864|520010416|FG005|Treatment Period 2|Lack of Efficacy|0|||
144222701|NCT01891864|520010411|FG000|Treatment Period 2|Adverse Event|0|||
144222702|NCT01891864|520010412|FG001|Treatment Period 2|Adverse Event|0|||
144222703|NCT01891864|520010413|FG002|Treatment Period 2|Adverse Event|1|||
144222704|NCT01891864|520010414|FG003|Treatment Period 2|Adverse Event|2|||
144222705|NCT01891864|520010415|FG004|Treatment Period 2|Adverse Event|0|||
144222706|NCT01891864|520010416|FG005|Treatment Period 2|Adverse Event|4|||
144222707|NCT01891864|520010411|FG000|Treatment Period 2|Termination of Site|0|||
144222708|NCT01891864|520010412|FG001|Treatment Period 2|Termination of Site|0|||
144222709|NCT01891864|520010413|FG002|Treatment Period 2|Termination of Site|0|||
144222710|NCT01891864|520010414|FG003|Treatment Period 2|Termination of Site|0|||
144222711|NCT01891864|520010415|FG004|Treatment Period 2|Termination of Site|2|||
144222712|NCT01891864|520010416|FG005|Treatment Period 2|Termination of Site|0|||
144222713|NCT01891864|520010411|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144222714|NCT01891864|520010412|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144222715|NCT01891864|520010413|FG002|Treatment Period 2|Withdrawal by Subject|3|||
144222716|NCT01891864|520010414|FG003|Treatment Period 2|Withdrawal by Subject|4|||
144222717|NCT01891864|520010415|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144222718|NCT01891864|520010416|FG005|Treatment Period 2|Withdrawal by Subject|1|||
144222719|NCT01891864|520010411|FG000|Extension Period|Lack of Efficacy|0|||
144222720|NCT01891864|520010412|FG001|Extension Period|Lack of Efficacy|0|||
144222721|NCT01891864|520010413|FG002|Extension Period|Lack of Efficacy|0|||
144222722|NCT01891864|520010414|FG003|Extension Period|Lack of Efficacy|1|||
144222723|NCT01891864|520010415|FG004|Extension Period|Lack of Efficacy|1|||
144222724|NCT01891864|520010416|FG005|Extension Period|Lack of Efficacy|0|||
144222725|NCT01891864|520010411|FG000|Extension Period|Pregnancy|0|||
144222726|NCT01891864|520010412|FG001|Extension Period|Pregnancy|0|||
144222727|NCT01891864|520010413|FG002|Extension Period|Pregnancy|1|||
144222728|NCT01891864|520010414|FG003|Extension Period|Pregnancy|0|||
144222729|NCT01891864|520010415|FG004|Extension Period|Pregnancy|0|||
144222730|NCT01891864|520010416|FG005|Extension Period|Pregnancy|0|||
144222731|NCT01891864|520010411|FG000|Extension Period|Adverse Event|0|||
144222732|NCT01891864|520010412|FG001|Extension Period|Adverse Event|0|||
144222733|NCT01891864|520010413|FG002|Extension Period|Adverse Event|4|||
144222734|NCT01891864|520010414|FG003|Extension Period|Adverse Event|2|||
144222735|NCT01891864|520010415|FG004|Extension Period|Adverse Event|2|||
144222736|NCT01891864|520010416|FG005|Extension Period|Adverse Event|0|||
144222737|NCT01891864|520010411|FG000|Extension Period|Withdrawal by Subject|0|||
144222738|NCT01891864|520010412|FG001|Extension Period|Withdrawal by Subject|0|||
144222739|NCT01891864|520010413|FG002|Extension Period|Withdrawal by Subject|1|||
144222740|NCT01891864|520010414|FG003|Extension Period|Withdrawal by Subject|2|||
144222741|NCT01891864|520010415|FG004|Extension Period|Withdrawal by Subject|4|||
144222742|NCT01891864|520010416|FG005|Extension Period|Withdrawal by Subject|0|||
144222743|NCT01891864|520010411|FG000|Extension Period|Lost to Follow-up|0|||
144222744|NCT01891864|520010412|FG001|Extension Period|Lost to Follow-up|0|||
144222745|NCT01891864|520010413|FG002|Extension Period|Lost to Follow-up|2|||
144222746|NCT01891864|520010414|FG003|Extension Period|Lost to Follow-up|0|||
144222747|NCT01891864|520010415|FG004|Extension Period|Lost to Follow-up|0|||
144222748|NCT01891864|520010416|FG005|Extension Period|Lost to Follow-up|0|||
144222749|NCT00752128|520010417|FG000|Overall Study|Withdrawal by Subject|4|||
144222750|NCT02286713|520010423|FG000|One Week Follow-Up|Death|1|||
144222751|NCT02286713|520010424|FG001|One Week Follow-Up|Death|0|||
144222752|NCT02286713|520010423|FG000|One Week Follow-Up|Lost to Follow-up|17|||
144222753|NCT02286713|520010424|FG001|One Week Follow-Up|Lost to Follow-up|21|||
144222754|NCT02286713|520010423|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
144222755|NCT02286713|520010424|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
144222756|NCT02286713|520010423|FG000|Three Month Follow-Up|Death|1|||
144222757|NCT02286713|520010424|FG001|Three Month Follow-Up|Death|1|||
144222758|NCT02286713|520010423|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
144222759|NCT02286713|520010424|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
144222760|NCT02286713|520010423|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
144222761|NCT02286713|520010424|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
144222762|NCT02286713|520010423|FG000|Six Month Follow-Up|Death|2|||
144222763|NCT02286713|520010424|FG001|Six Month Follow-Up|Death|0|||
144222764|NCT02286713|520010423|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
144222765|NCT02286713|520010424|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
144222766|NCT04314037|520010425|FG000|Treatment Period 2|Adverse Event|1|||
144222767|NCT04314037|520010426|FG001|Treatment Period 2|Adverse Event|0|||
144222768|NCT04314037|520010425|FG000|Treatment Period 3|Protocol Violation|1|||
144222769|NCT04314037|520010426|FG001|Treatment Period 3|Protocol Violation|0|||
144266687|NCT04877990|520178455|FG000|Treatment|Administrative reasons by sponsor|17|||
144222770|NCT04314037|520010425|FG000|Treatment Period 3|Adverse Event|0|||
144266688|NCT04877990|520178456|FG001|Treatment|Administrative reasons by sponsor|33|||
144695783|NCT01016912|521737734|FG000|End of Treatment Period|Adverse Event|0|||
144695784|NCT01016912|521737735|FG001|End of Treatment Period|Adverse Event|1|||
144695785|NCT01016912|521737736|FG002|End of Treatment Period|Adverse Event|1|||
144695786|NCT01016912|521737737|FG003|End of Treatment Period|Adverse Event|0|||
144695787|NCT01016912|521737738|FG004|End of Treatment Period|Adverse Event|0|||
144695788|NCT01016912|521737734|FG000|End of Treatment Period|Completed double-blind period only|0|||
144695789|NCT01016912|521737735|FG001|End of Treatment Period|Completed double-blind period only|1|||
144695790|NCT01016912|521737736|FG002|End of Treatment Period|Completed double-blind period only|0|||
144695791|NCT01016912|521737737|FG003|End of Treatment Period|Completed double-blind period only|0|||
144695792|NCT01016912|521737738|FG004|End of Treatment Period|Completed double-blind period only|0|||
144695793|NCT01016912|521737734|FG000|Follow-up Period|Other reason|0|||
144695794|NCT01016912|521737735|FG001|Follow-up Period|Other reason|0|||
144695795|NCT01016912|521737736|FG002|Follow-up Period|Other reason|1|||
144695796|NCT01016912|521737737|FG003|Follow-up Period|Other reason|1|||
144695797|NCT01016912|521737738|FG004|Follow-up Period|Other reason|0|||
144695798|NCT00914940|521737739|FG000|D0 to D100 Post-transplant|Death|2|||
144695799|NCT00914940|521737739|FG000|D101 to 2 Years Post-transplant|Death|8|||
144695800|NCT00914940|521737739|FG000|2 Years to 5 Years Post-transplant|Death|3|||
144695801|NCT02260791|521737743|FG000|Overall Study|Lost to Follow-up|4|||
144695802|NCT02260791|521737744|FG001|Overall Study|Lost to Follow-up|4|||
144695803|NCT02260791|521737743|FG000|Overall Study|Lack of Efficacy|2|||
144695804|NCT02260791|521737744|FG001|Overall Study|Lack of Efficacy|1|||
144695805|NCT02260791|521737743|FG000|Overall Study|Adverse Event|13|||
144695806|NCT02260791|521737744|FG001|Overall Study|Adverse Event|9|||
144695807|NCT02260791|521737743|FG000|Overall Study|Death|1|||
144695808|NCT02260791|521737744|FG001|Overall Study|Death|0|||
144695809|NCT02260791|521737743|FG000|Overall Study|Withdrawal by Subject|11|||
144695810|NCT02260791|521737744|FG001|Overall Study|Withdrawal by Subject|16|||
144695811|NCT02260791|521737743|FG000|Overall Study|Screen failure|0|||
144695812|NCT02260791|521737744|FG001|Overall Study|Screen failure|1|||
144695813|NCT02260791|521737743|FG000|Overall Study|Protocol deviation|2|||
144695814|NCT02260791|521737744|FG001|Overall Study|Protocol deviation|3|||
144695815|NCT01815099|521737745|FG000|Overall Study|Lack of Efficacy|1|||
144695816|NCT01815099|521737745|FG000|Overall Study|unable to attend study visits|1|||
144695817|NCT01475214|521737746|FG000|Overall Study|Lost to Follow-up|1|||
144695818|NCT01475214|521737747|FG001|Overall Study|Lost to Follow-up|0|||
144695819|NCT01475214|521737748|FG002|Overall Study|Lost to Follow-up|1|||
144695820|NCT01475214|521737746|FG000|Overall Study|Physician Decision|2|||
144695821|NCT01475214|521737747|FG001|Overall Study|Physician Decision|0|||
144695822|NCT01475214|521737748|FG002|Overall Study|Physician Decision|0|||
144695823|NCT01475214|521737746|FG000|Overall Study|Withdrawal by Subject|2|||
144695824|NCT01475214|521737747|FG001|Overall Study|Withdrawal by Subject|4|||
144695825|NCT01475214|521737748|FG002|Overall Study|Withdrawal by Subject|1|||
144695826|NCT00643851|521737749|FG000|Overall Study|Death|0|||
144695827|NCT00643851|521737750|FG001|Overall Study|Death|1|||
144695828|NCT00643851|521737751|FG002|Overall Study|Death|0|||
144695829|NCT00643851|521737749|FG000|Overall Study|Lack of Efficacy|0|||
144695830|NCT00643851|521737750|FG001|Overall Study|Lack of Efficacy|1|||
144695831|NCT00643851|521737751|FG002|Overall Study|Lack of Efficacy|0|||
144695832|NCT00643851|521737749|FG000|Overall Study|Adverse Event|2|||
144695833|NCT00643851|521737750|FG001|Overall Study|Adverse Event|6|||
144695834|NCT00643851|521737751|FG002|Overall Study|Adverse Event|6|||
144695835|NCT00643851|521737749|FG000|Overall Study|Lost to Follow-up|4|||
144695836|NCT00643851|521737750|FG001|Overall Study|Lost to Follow-up|6|||
144695837|NCT00643851|521737751|FG002|Overall Study|Lost to Follow-up|9|||
144695838|NCT00643851|521737749|FG000|Overall Study|Withdrawal by Subject|8|||
144695839|NCT00643851|521737750|FG001|Overall Study|Withdrawal by Subject|15|||
144695840|NCT00643851|521737751|FG002|Overall Study|Withdrawal by Subject|9|||
144695841|NCT00643851|521737749|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
144695842|NCT00643851|521737750|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
144695843|NCT00643851|521737751|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
144695844|NCT02354599|521737754|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
144695845|NCT02354599|521737755|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
144695846|NCT02354599|521737756|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
144695847|NCT02354599|521737757|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
144266689|NCT04877990|520178455|FG000|Treatment|Withdrawal by Subject|2|||
144222771|NCT04314037|520010426|FG001|Treatment Period 3|Adverse Event|1|||
144222772|NCT00273182|520010428|FG000|Overall Study|Death|450|||
144695848|NCT02354599|521737758|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
144695849|NCT02354599|521737759|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
144695850|NCT02354599|521737754|FG000|Overall Study|Withdrawal by Subject|1|||
144695851|NCT02354599|521737755|FG001|Overall Study|Withdrawal by Subject|1|||
144695852|NCT02354599|521737756|FG002|Overall Study|Withdrawal by Subject|0|||
144695853|NCT02354599|521737757|FG003|Overall Study|Withdrawal by Subject|0|||
144695854|NCT02354599|521737758|FG004|Overall Study|Withdrawal by Subject|0|||
144695855|NCT02354599|521737759|FG005|Overall Study|Withdrawal by Subject|0|||
144695856|NCT00495794|521737762|FG000|Overall Study|Pharmacist did not activate patient|522|||
144695857|NCT00495794|521737763|FG001|Overall Study|Pharmacist did not activate patient|0|||
144695858|NCT02173158|521737764|FG000|Efficacy Phase|Adverse Event|1|||
144695859|NCT01377194|521737765|FG000|Overall Study|Adverse Event|3|||
144695860|NCT01377194|521737766|FG001|Overall Study|Adverse Event|12|||
144695861|NCT01377194|521737767|FG002|Overall Study|Adverse Event|19|||
144695862|NCT01377194|521737765|FG000|Overall Study|Lack of Efficacy|3|||
144695863|NCT01377194|521737766|FG001|Overall Study|Lack of Efficacy|3|||
144695864|NCT01377194|521737767|FG002|Overall Study|Lack of Efficacy|3|||
144695865|NCT01377194|521737765|FG000|Overall Study|Protocol Violation|4|||
144695866|NCT01377194|521737766|FG001|Overall Study|Protocol Violation|10|||
144695867|NCT01377194|521737767|FG002|Overall Study|Protocol Violation|6|||
144695868|NCT01377194|521737765|FG000|Overall Study|Withdrawal by Subject|8|||
144695869|NCT01377194|521737766|FG001|Overall Study|Withdrawal by Subject|10|||
144695870|NCT01377194|521737767|FG002|Overall Study|Withdrawal by Subject|7|||
144695871|NCT01377194|521737765|FG000|Overall Study|Lost to Follow-up|14|||
144695872|NCT01377194|521737766|FG001|Overall Study|Lost to Follow-up|8|||
144695873|NCT01377194|521737767|FG002|Overall Study|Lost to Follow-up|11|||
144695874|NCT01728454|521737768|FG000|Stage 1 and 2|Pregnancy|1|||
144695875|NCT01728454|521737769|FG001|Stage 1 and 2|Pregnancy|0|||
144695876|NCT01728454|521737770|FG002|Stage 1 and 2|Pregnancy|0|||
144695877|NCT01728454|521737768|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
144695878|NCT01728454|521737769|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
144695879|NCT01728454|521737770|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
144695880|NCT01728454|521737768|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
144695881|NCT01728454|521737769|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
144695882|NCT01728454|521737770|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
144695883|NCT01728454|521737768|FG000|Stage 1 and 2|Lost to Follow-up|1|||
144695884|NCT01728454|521737769|FG001|Stage 1 and 2|Lost to Follow-up|1|||
144695885|NCT01728454|521737770|FG002|Stage 1 and 2|Lost to Follow-up|0|||
144695886|NCT01728454|521737768|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
144695887|NCT01728454|521737769|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
144695888|NCT01728454|521737770|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
144695889|NCT01728454|521737768|FG000|Stage 3|Reason Missing|0|||
144695890|NCT01728454|521737769|FG001|Stage 3|Reason Missing|0|||
144695891|NCT01728454|521737770|FG002|Stage 3|Reason Missing|1|||
144695892|NCT01728454|521737768|FG000|Stage 3|Subject Required Other Treatment|0|||
144695893|NCT01728454|521737769|FG001|Stage 3|Subject Required Other Treatment|1|||
144695894|NCT01728454|521737770|FG002|Stage 3|Subject Required Other Treatment|0|||
144695895|NCT01728454|521737768|FG000|Stage 3|Pregnancy|1|||
144695896|NCT01728454|521737769|FG001|Stage 3|Pregnancy|0|||
144695897|NCT01728454|521737770|FG002|Stage 3|Pregnancy|0|||
144695898|NCT01728454|521737768|FG000|Stage 3|Withdrew Consent|1|||
144695899|NCT01728454|521737769|FG001|Stage 3|Withdrew Consent|0|||
144695900|NCT01728454|521737770|FG002|Stage 3|Withdrew Consent|1|||
144695901|NCT01728454|521737768|FG000|Stage 3|Non-compliance with Protocol|0|||
144695902|NCT01728454|521737769|FG001|Stage 3|Non-compliance with Protocol|0|||
144695903|NCT01728454|521737770|FG002|Stage 3|Non-compliance with Protocol|1|||
144695904|NCT01728454|521737768|FG000|Stage 3|Lost to Follow-up|0|||
144695905|NCT01728454|521737769|FG001|Stage 3|Lost to Follow-up|3|||
144695906|NCT01728454|521737770|FG002|Stage 3|Lost to Follow-up|1|||
144695907|NCT01728454|521737768|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
144695908|NCT01728454|521737769|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
144695909|NCT01728454|521737770|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
144695910|NCT01190839|521737773|FG000|Overall Study|Adverse Event|32|||
144695911|NCT01190839|521737774|FG001|Overall Study|Adverse Event|41|||
144695912|NCT01190839|521737773|FG000|Overall Study|Protocol Violation|2|||
144695913|NCT01190839|521737774|FG001|Overall Study|Protocol Violation|2|||
144695914|NCT01190839|521737773|FG000|Overall Study|Lost to Follow-up|7|||
144695915|NCT01190839|521737774|FG001|Overall Study|Lost to Follow-up|1|||
144695916|NCT01190839|521737773|FG000|Overall Study|Death|1|||
144695917|NCT01190839|521737774|FG001|Overall Study|Death|0|||
144695918|NCT01190839|521737773|FG000|Overall Study|Trial stopped by Sponsor|71|||
144695919|NCT01190839|521737774|FG001|Overall Study|Trial stopped by Sponsor|68|||
144695920|NCT01190839|521737773|FG000|Overall Study|Undefined|35|||
144695921|NCT01190839|521737774|FG001|Overall Study|Undefined|31|||
144695922|NCT01190839|521737773|FG000|Overall Study|Randomized but not treated|2|||
144695923|NCT01190839|521737774|FG001|Overall Study|Randomized but not treated|4|||
144695924|NCT03077646|521737779|FG000|Overall Study|Lost to Follow-up|29|||
144695925|NCT03077646|521737780|FG001|Overall Study|Lost to Follow-up|30|||
144695926|NCT03077646|521737781|FG002|Overall Study|Lost to Follow-up|31|||
144695927|NCT02058966|521737782|FG000|Open-Label Methamphetamine|Adverse Event|1|||
144695928|NCT02058966|521737782|FG000|First Intervention|Withdrawal by Subject|1|||
144695929|NCT00765726|521737783|FG000|Overall Study|Withdrawal by Subject|1|||
144695930|NCT00765726|521737783|FG000|Overall Study|Discontinuation of study by sponsor|8|||
144266690|NCT04877990|520178456|FG001|Treatment|Withdrawal by Subject|6|||
144266691|NCT04877990|520178455|FG000|Treatment|Adverse Event|2|||
144695931|NCT02993731|521737784|FG000|Overall Study|Study Termination|101|||
144695932|NCT02993731|521737785|FG001|Overall Study|Study Termination|105|||
144695933|NCT01265511|521737786|FG000|Overall Study|Lack of Efficacy|2|||
144222773|NCT00273182|520010428|FG000|Overall Study|Lost to Follow-up|88|||
144222774|NCT00273182|520010428|FG000|Overall Study|Withdrawal by Subject|257|||
144695934|NCT01265511|521737787|FG001|Overall Study|Lack of Efficacy|1|||
144695935|NCT01265511|521737786|FG000|Overall Study|Met stopping rules|0|||
144695936|NCT01265511|521737787|FG001|Overall Study|Met stopping rules|2|||
144695937|NCT00323479|521737790|FG000|Overall Study|Adverse Event|2|||
144695938|NCT00323479|521737790|FG000|Overall Study|Withdrawal by Subject|2|||
144695939|NCT00323479|521737790|FG000|Overall Study|Protocol Violation|3|||
144695940|NCT00323479|521737790|FG000|Overall Study|house moving|1|||
144695941|NCT01362062|521737791|FG000|Overall Study|Adverse Event|1|||
144695942|NCT01362062|521737792|FG001|Overall Study|Adverse Event|0|||
144695943|NCT01362062|521737791|FG000|Overall Study|Lost to Follow-up|11|||
144695944|NCT01362062|521737792|FG001|Overall Study|Lost to Follow-up|0|||
144695945|NCT01362062|521737791|FG000|Overall Study|Withdrawal by Subject|2|||
144695946|NCT01362062|521737792|FG001|Overall Study|Withdrawal by Subject|0|||
144695947|NCT01362062|521737791|FG000|Overall Study|Non-compliant participant|2|||
144695948|NCT01362062|521737792|FG001|Overall Study|Non-compliant participant|0|||
144695949|NCT01362062|521737791|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
144695950|NCT01362062|521737792|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
144695951|NCT01362062|521737791|FG000|Overall Study|Had significant improvement|9|||
144695952|NCT01362062|521737792|FG001|Overall Study|Had significant improvement|0|||
144695953|NCT02545504|521737795|FG000|Overall Study|Death|174|||
144695954|NCT02545504|521737796|FG001|Overall Study|Death|168|||
144695955|NCT02545504|521737795|FG000|Overall Study|Unknown reason|30|||
144695956|NCT02545504|521737796|FG001|Overall Study|Unknown reason|32|||
144695957|NCT02545504|521737795|FG000|Overall Study|Withdrew consent|9|||
144695958|NCT02545504|521737796|FG001|Overall Study|Withdrew consent|11|||
144695959|NCT02545504|521737795|FG000|Overall Study|Investigator's discretion|3|||
144695960|NCT02545504|521737796|FG001|Overall Study|Investigator's discretion|1|||
144695961|NCT02545504|521737795|FG000|Overall Study|Lost to Follow-up|2|||
144695962|NCT02545504|521737796|FG001|Overall Study|Lost to Follow-up|2|||
144695963|NCT00967343|521737797|FG000|Overall Study|Study termination by sponsor|12|||
144695964|NCT00967343|521737797|FG000|Overall Study|Death|24|||
144695965|NCT00967343|521737797|FG000|Overall Study|Relapse|1|||
144695966|NCT00967343|521737797|FG000|Overall Study|Lost to Follow-up|1|||
144695967|NCT03044730|521737799|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
144695968|NCT03044730|521737799|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
144695969|NCT03044730|521737799|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
144695970|NCT03044730|521737799|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
144695971|NCT03044730|521737799|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
144695972|NCT03044730|521737799|FG000|Cycles 4 and Beyond|Adverse Event|1|||
144695973|NCT03044730|521737799|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
144695974|NCT03044730|521737799|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
144695975|NCT03044730|521737799|FG000|On Follow-up for 2 Years|Death|17|||
144695976|NCT00508820|521737800|FG000|Overall Study|Adverse Event|6|||
144695977|NCT00508820|521737801|FG001|Overall Study|Adverse Event|10|||
144695978|NCT00508820|521737800|FG000|Overall Study|Death|6|||
144695979|NCT00508820|521737801|FG001|Overall Study|Death|8|||
144695980|NCT00508820|521737800|FG000|Overall Study|Lost to Follow-up|1|||
144695981|NCT00508820|521737801|FG001|Overall Study|Lost to Follow-up|1|||
144695982|NCT00508820|521737800|FG000|Overall Study|Physician Decision|8|||
144695983|NCT00508820|521737801|FG001|Overall Study|Physician Decision|2|||
144695984|NCT00508820|521737800|FG000|Overall Study|Pregnancy|0|||
144695985|NCT00508820|521737801|FG001|Overall Study|Pregnancy|2|||
144695986|NCT00508820|521737800|FG000|Overall Study|Protocol Violation|2|||
144695987|NCT00508820|521737801|FG001|Overall Study|Protocol Violation|0|||
144695988|NCT00508820|521737800|FG000|Overall Study|Withdrawal by Subject|10|||
144695989|NCT00508820|521737801|FG001|Overall Study|Withdrawal by Subject|12|||
144695990|NCT00508820|521737800|FG000|Overall Study|Other|11|||
144695991|NCT00508820|521737801|FG001|Overall Study|Other|2|||
144695992|NCT00508820|521737800|FG000|Overall Study|Noncompliance|1|||
144695993|NCT00508820|521737801|FG001|Overall Study|Noncompliance|0|||
144695994|NCT00508820|521737800|FG000|Overall Study|Requirement for alternative therapy|7|||
144695995|NCT00508820|521737801|FG001|Overall Study|Requirement for alternative therapy|15|||
144695996|NCT00508820|521737800|FG000|Overall Study|Protocol-specified Criteria|3|||
144695997|NCT00508820|521737801|FG001|Overall Study|Protocol-specified Criteria|12|||
144222775|NCT00273182|520010428|FG000|Overall Study|Device/System Explant|154|||
144695998|NCT02930889|521739262|FG000|Overall Study|Lost to Follow-up|2|||
144695999|NCT02930889|521739262|FG000|Overall Study|Withdrawal by Subject|6|||
144696000|NCT02930889|521739262|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
144696001|NCT04398030|521739263|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
144696002|NCT04398030|521739264|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
144696003|NCT04398030|521739263|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
144696004|NCT04398030|521739264|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
144696005|NCT02713490|521739268|FG000|Overall Study|Withdrawal by Subject|2|||
144696006|NCT02713490|521739269|FG001|Overall Study|Withdrawal by Subject|1|||
144696007|NCT02713490|521739268|FG000|Overall Study|Did not receive study drug|1|||
144696008|NCT02713490|521739269|FG001|Overall Study|Did not receive study drug|0|||
144696009|NCT02713490|521739268|FG000|Overall Study|Met exclusion criteria|0|||
144696010|NCT02713490|521739269|FG001|Overall Study|Met exclusion criteria|1|||
144696011|NCT00346775|521739270|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
144696012|NCT00346775|521739271|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
144696013|NCT00346775|521739270|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
144696014|NCT00346775|521739271|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
144696015|NCT00346775|521739270|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
144696016|NCT00346775|521739271|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
144696017|NCT00960869|521739272|FG000|Overall Study|Adverse Event|17|||
144696018|NCT00960869|521739273|FG001|Overall Study|Adverse Event|26|||
144696019|NCT00960869|521739272|FG000|Overall Study|Withdrawal by Subject|16|||
144696020|NCT00960869|521739273|FG001|Overall Study|Withdrawal by Subject|14|||
144696021|NCT00960869|521739272|FG000|Overall Study|Lost to Follow-up|1|||
144696022|NCT00960869|521739273|FG001|Overall Study|Lost to Follow-up|4|||
144696023|NCT00960869|521739272|FG000|Overall Study|Misc|19|||
144696024|NCT00960869|521739273|FG001|Overall Study|Misc|18|||
144696025|NCT00548340|521739278|FG000|Overall Study|Protocol Violation|2|||
144696026|NCT00548340|521739279|FG001|Overall Study|Protocol Violation|3|||
144696027|NCT00548340|521739280|FG002|Overall Study|Protocol Violation|3|||
144696028|NCT00548340|521739278|FG000|Overall Study|Adverse Event|2|||
144696029|NCT00548340|521739279|FG001|Overall Study|Adverse Event|2|||
144696030|NCT00548340|521739280|FG002|Overall Study|Adverse Event|2|||
144696031|NCT00548340|521739278|FG000|Overall Study|Lost to Follow-up|1|||
144696032|NCT00548340|521739279|FG001|Overall Study|Lost to Follow-up|1|||
144696033|NCT00548340|521739280|FG002|Overall Study|Lost to Follow-up|0|||
144696034|NCT00548340|521739278|FG000|Overall Study|Withdrawal by Subject|2|||
144696035|NCT00548340|521739279|FG001|Overall Study|Withdrawal by Subject|4|||
144696036|NCT00548340|521739280|FG002|Overall Study|Withdrawal by Subject|3|||
144696037|NCT00548340|521739278|FG000|Overall Study|Other|1|||
144696038|NCT00548340|521739279|FG001|Overall Study|Other|1|||
144696039|NCT00548340|521739280|FG002|Overall Study|Other|1|||
144696040|NCT01096017|521739281|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
144696041|NCT01096017|521739282|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
144696042|NCT01846442|521739286|FG000|Overall Study|Adverse Event|2|||
144696043|NCT01846442|521739287|FG001|Overall Study|Adverse Event|4|||
144696044|NCT01846442|521739288|FG002|Overall Study|Adverse Event|2|||
144696045|NCT01846442|521739289|FG003|Overall Study|Adverse Event|1|||
144696046|NCT01846442|521739286|FG000|Overall Study|Lost to Follow-up|0|||
144696047|NCT01846442|521739287|FG001|Overall Study|Lost to Follow-up|0|||
144696048|NCT01846442|521739288|FG002|Overall Study|Lost to Follow-up|1|||
144696049|NCT01846442|521739289|FG003|Overall Study|Lost to Follow-up|0|||
144696050|NCT01846442|521739286|FG000|Overall Study|Withdrawal by Subject|3|||
144696051|NCT01846442|521739287|FG001|Overall Study|Withdrawal by Subject|2|||
144696052|NCT01846442|521739288|FG002|Overall Study|Withdrawal by Subject|0|||
144696053|NCT01846442|521739289|FG003|Overall Study|Withdrawal by Subject|1|||
144696054|NCT01846442|521739286|FG000|Overall Study|Left the city/Lost medication|1|||
144696055|NCT01846442|521739287|FG001|Overall Study|Left the city/Lost medication|0|||
144696056|NCT01846442|521739288|FG002|Overall Study|Left the city/Lost medication|1|||
144696057|NCT01846442|521739289|FG003|Overall Study|Left the city/Lost medication|1|||
144696058|NCT02600559|521739290|FG000|Overall Study|Withdrawal by Subject|3|||
144696059|NCT02600559|521739290|FG000|Overall Study|Lost to Follow-up|20|||
144696060|NCT00379639|521739293|FG000|Overall Study|Disease Progression|3|||
144696061|NCT00379639|521739294|FG001|Overall Study|Disease Progression|3|||
144696062|NCT00379639|521739295|FG002|Overall Study|Disease Progression|3|||
144696063|NCT00379639|521739296|FG003|Overall Study|Disease Progression|4|||
144696064|NCT00379639|521739297|FG004|Overall Study|Disease Progression|4|||
144696065|NCT00379639|521739293|FG000|Overall Study|Physician Decision|0|||
144696066|NCT00379639|521739294|FG001|Overall Study|Physician Decision|2|||
144696067|NCT00379639|521739295|FG002|Overall Study|Physician Decision|1|||
144696068|NCT00379639|521739296|FG003|Overall Study|Physician Decision|1|||
144696069|NCT00379639|521739297|FG004|Overall Study|Physician Decision|0|||
144696070|NCT00379639|521739293|FG000|Overall Study|Symptomatic Deterioration|0|||
144696071|NCT00379639|521739294|FG001|Overall Study|Symptomatic Deterioration|0|||
144696072|NCT00379639|521739295|FG002|Overall Study|Symptomatic Deterioration|1|||
144696073|NCT00379639|521739296|FG003|Overall Study|Symptomatic Deterioration|0|||
144696074|NCT00379639|521739297|FG004|Overall Study|Symptomatic Deterioration|1|||
144222776|NCT00273182|520010428|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
144696075|NCT00379639|521739293|FG000|Overall Study|Adverse Event|0|||
144696076|NCT00379639|521739294|FG001|Overall Study|Adverse Event|0|||
144696077|NCT00379639|521739295|FG002|Overall Study|Adverse Event|1|||
144696078|NCT00379639|521739296|FG003|Overall Study|Adverse Event|0|||
144696079|NCT00379639|521739297|FG004|Overall Study|Adverse Event|1|||
144696080|NCT00379639|521739293|FG000|Overall Study|Lost to Follow-up|0|||
144696081|NCT00379639|521739294|FG001|Overall Study|Lost to Follow-up|0|||
144696082|NCT00379639|521739295|FG002|Overall Study|Lost to Follow-up|0|||
144222777|NCT00856492|520010431|FG000|Overall Study|Ineligible or withdrew consent|1|||
144696083|NCT00379639|521739296|FG003|Overall Study|Lost to Follow-up|1|||
144696084|NCT00379639|521739297|FG004|Overall Study|Lost to Follow-up|0|||
144696085|NCT00379639|521739293|FG000|Overall Study|Other|0|||
144696086|NCT00379639|521739294|FG001|Overall Study|Other|0|||
144696087|NCT00379639|521739295|FG002|Overall Study|Other|3|||
144696088|NCT00379639|521739296|FG003|Overall Study|Other|0|||
144696089|NCT00379639|521739297|FG004|Overall Study|Other|0|||
144696090|NCT04963231|521739299|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
144696091|NCT04963231|521739300|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
144696092|NCT04963231|521739301|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
144696093|NCT04963231|521739299|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
144696094|NCT04963231|521739300|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
144696095|NCT04963231|521739301|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
144696096|NCT04963231|521739299|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
144696097|NCT04963231|521739300|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
144696098|NCT04963231|521739301|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
144696099|NCT04963231|521739299|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
144696100|NCT04963231|521739300|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
144696101|NCT04963231|521739301|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
144696102|NCT04963231|521739299|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
144696103|NCT04963231|521739300|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
144696104|NCT04963231|521739301|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
144696105|NCT04963231|521739299|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
144696106|NCT04963231|521739300|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
144696107|NCT04963231|521739301|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
144696108|NCT04963231|521739299|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
144696109|NCT04963231|521739300|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
144696110|NCT04963231|521739301|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
144696111|NCT01928758|521739307|FG000|Overall Study|Lost to Follow-up|14|||
144696112|NCT01928758|521739308|FG001|Overall Study|Lost to Follow-up|9|||
144696113|NCT01928758|521739307|FG000|Overall Study|Withdrawal by Subject|5|||
144696114|NCT01928758|521739308|FG001|Overall Study|Withdrawal by Subject|2|||
144696115|NCT01928758|521739307|FG000|Overall Study|Adverse Event|3|||
144696116|NCT01928758|521739308|FG001|Overall Study|Adverse Event|5|||
144696117|NCT01928758|521739307|FG000|Overall Study|Protocol Violation|3|||
144696118|NCT01928758|521739308|FG001|Overall Study|Protocol Violation|4|||
144696119|NCT02718131|521739309|FG000|Overall Study|Withdrawal by Subject|1|||
144696120|NCT02718131|521739310|FG001|Overall Study|Withdrawal by Subject|0|||
144696121|NCT02718131|521739309|FG000|Overall Study|Adverse Event|1|||
144696122|NCT02718131|521739310|FG001|Overall Study|Adverse Event|0|||
144696123|NCT02718131|521739309|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
144696124|NCT02718131|521739310|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
144696125|NCT01097057|521739311|FG000|Overall Study|Physician Decision|3|||
144696126|NCT03198559|521739312|FG000|Overall Study|Adverse Event|2|||
144696127|NCT03737812|521739313|FG000|Overall Study|Withdrawal by Subject|1|||
144696128|NCT03737812|521739314|FG001|Overall Study|Withdrawal by Subject|2|||
144696129|NCT03737812|521739315|FG002|Overall Study|Withdrawal by Subject|1|||
144696130|NCT03737812|521739313|FG000|Overall Study|Sponsor Discontinued the Study|4|||
144696131|NCT03737812|521739314|FG001|Overall Study|Sponsor Discontinued the Study|3|||
144696132|NCT03737812|521739315|FG002|Overall Study|Sponsor Discontinued the Study|2|||
144696133|NCT03737812|521739313|FG000|Overall Study|Adverse Event|0|||
144696134|NCT03737812|521739314|FG001|Overall Study|Adverse Event|1|||
144696135|NCT03737812|521739315|FG002|Overall Study|Adverse Event|0|||
144696136|NCT03737812|521739313|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
144696137|NCT03737812|521739314|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
144696138|NCT03737812|521739315|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
144696139|NCT02624713|521739316|FG000|Overall Study|Lost to Follow-up|14|||
144696140|NCT02624713|521739317|FG001|Overall Study|Lost to Follow-up|0|||
144696141|NCT01911546|521739321|FG000|Overall Study|Lost to Follow-up|1|||
144696142|NCT01911546|521739321|FG000|Overall Study|Everolimus was discontinued|5|||
144696143|NCT01474291|521739324|FG000|Overall Study|Not Evaluable for Efficacy|26|||
144696144|NCT01474291|521739324|FG000|Overall Study|Lack of Treatment Efficacy|88|||
144696145|NCT01474291|521739324|FG000|Overall Study|Adverse Event|53|||
144696146|NCT01474291|521739324|FG000|Overall Study|Lost to Follow-up|29|||
144696147|NCT01474291|521739324|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
144696148|NCT01474291|521739324|FG000|Overall Study|No Reason Reported|10|||
144696149|NCT01474291|521739324|FG000|Overall Study|Death|2|||
144696150|NCT02213666|521739325|FG000|Overall Study|Withdrawal by Subject|1|||
144696151|NCT01399619|521739326|FG000|Overall Study|Adverse Event|10|||
144696152|NCT01399619|521739327|FG001|Overall Study|Adverse Event|0|||
144696153|NCT01399619|521739328|FG002|Overall Study|Adverse Event|4|||
144696154|NCT01399619|521739329|FG003|Overall Study|Adverse Event|10|||
144696155|NCT01399619|521739326|FG000|Overall Study|Lack of Efficacy|9|||
144696156|NCT01399619|521739327|FG001|Overall Study|Lack of Efficacy|0|||
144696157|NCT01399619|521739328|FG002|Overall Study|Lack of Efficacy|5|||
144696158|NCT01399619|521739329|FG003|Overall Study|Lack of Efficacy|0|||
144696159|NCT01399619|521739326|FG000|Overall Study|Withdrawal by Subject|6|||
144696160|NCT01399619|521739327|FG001|Overall Study|Withdrawal by Subject|0|||
144696161|NCT01399619|521739328|FG002|Overall Study|Withdrawal by Subject|3|||
144222778|NCT00856492|520010432|FG001|Overall Study|Ineligible or withdrew consent|1|||
144222779|NCT00856492|520010433|FG002|Overall Study|Ineligible or withdrew consent|2|||
144222780|NCT03832686|520010434|FG000|Overall Study|Lost to Follow-up|6|||
144696162|NCT01399619|521739329|FG003|Overall Study|Withdrawal by Subject|4|||
144696163|NCT01399619|521739326|FG000|Overall Study|Protocol Violation|0|||
144696164|NCT01399619|521739327|FG001|Overall Study|Protocol Violation|0|||
144696165|NCT01399619|521739328|FG002|Overall Study|Protocol Violation|0|||
144696166|NCT01399619|521739329|FG003|Overall Study|Protocol Violation|1|||
144696167|NCT01399619|521739326|FG000|Overall Study|Not treated|0|||
144696168|NCT01399619|521739327|FG001|Overall Study|Not treated|0|||
144696169|NCT01399619|521739328|FG002|Overall Study|Not treated|0|||
144696170|NCT01399619|521739329|FG003|Overall Study|Not treated|2|||
144696171|NCT00229931|521739352|FG000|Overall Study|Death|1|||
144696172|NCT00229931|521739353|FG001|Overall Study|Death|0|||
144696173|NCT00229931|521739352|FG000|Overall Study|Lost to Follow-up|3|||
144696174|NCT00229931|521739353|FG001|Overall Study|Lost to Follow-up|2|||
144696175|NCT00475657|521739354|FG000|Overall Study|Death|1|||
144696176|NCT00475657|521739354|FG000|Overall Study|Sponsor's Decision|3|||
144696177|NCT02992743|521739355|FG000|Overall Study|Withdrawal by Subject|1|||
144696178|NCT02992743|521739356|FG001|Overall Study|Withdrawal by Subject|1|||
144696179|NCT02992743|521739355|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
144696180|NCT02992743|521739356|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
144696181|NCT02992743|521739355|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
144696182|NCT02992743|521739356|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
144696183|NCT02992743|521739355|FG000|Overall Study|No measurable disease|1|||
144696184|NCT02992743|521739356|FG001|Overall Study|No measurable disease|0|||
144696185|NCT02992743|521739355|FG000|Overall Study|Lost to Follow-up|0|||
144696186|NCT02992743|521739356|FG001|Overall Study|Lost to Follow-up|1|||
144696187|NCT00998166|521739359|FG000|Overall Study|Early Study Termination|8|||
144696188|NCT04585906|521739372|FG000|Overall Study|Lost to Follow-up|8|||
144696189|NCT04585906|521739373|FG001|Overall Study|Lost to Follow-up|5|||
144696190|NCT03907072|521739376|FG000|Overall Study|Study Terminated by Sponsor|2|||
144696191|NCT03907072|521739377|FG001|Overall Study|Study Terminated by Sponsor|2|||
144696192|NCT03907072|521739378|FG002|Overall Study|Study Terminated by Sponsor|2|||
144696193|NCT02463097|521739381|FG000|Overall Study|Withdrawal by Subject|1|||
144696194|NCT05146999|521739383|FG000|Overall Study|Withdrew consent|6|||
144696195|NCT05146999|521739384|FG001|Overall Study|Withdrew consent|1|||
144696196|NCT05146999|521739383|FG000|Overall Study|Lost to Follow-up|3|||
144696197|NCT05146999|521739384|FG001|Overall Study|Lost to Follow-up|2|||
144696198|NCT05146999|521739383|FG000|Overall Study|Other|1|||
144696199|NCT05146999|521739384|FG001|Overall Study|Other|3|||
144696200|NCT00665002|521739385|FG000|Overall Study|Progression/relapse during treatment|11|||
144696201|NCT00665002|521739385|FG000|Overall Study|Cytogenetic resistance|1|||
144696202|NCT00697255|521739386|FG000|Stage 1a|Insufficient ovarian response|1|||
144696203|NCT00697255|521739387|FG001|Stage 1a|Insufficient ovarian response|0|||
144696204|NCT00697255|521739386|FG000|Stage 1a|Multifollicular growth|1|||
144696205|NCT00697255|521739387|FG001|Stage 1a|Multifollicular growth|0|||
144696206|NCT00697255|521739386|FG000|Stage 1a|Not growing of dominant follicle|1|||
144696207|NCT00697255|521739387|FG001|Stage 1a|Not growing of dominant follicle|0|||
144696208|NCT00697255|521739386|FG000|Stage 1b|Not growing of dominant follicle|0|||
144696209|NCT00697255|521739387|FG001|Stage 1b|Not growing of dominant follicle|1|||
144696210|NCT00697255|521739386|FG000|Stage 1b|Insufficient ovarian response|0|||
144696211|NCT00697255|521739387|FG001|Stage 1b|Insufficient ovarian response|1|||
144696212|NCT01333501|521739392|FG000|Overall Study|Adverse Event|3|||
144696213|NCT01333501|521739393|FG001|Overall Study|Adverse Event|1|||
144696214|NCT01333501|521739392|FG000|Overall Study|Abnormal laboratory value|2|||
144696215|NCT01333501|521739393|FG001|Overall Study|Abnormal laboratory value|1|||
144696216|NCT01333501|521739392|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144696217|NCT01333501|521739393|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
144696218|NCT01333501|521739392|FG000|Overall Study|Withdrawn consent|3|||
144696219|NCT01333501|521739393|FG001|Overall Study|Withdrawn consent|12|||
144696220|NCT02221882|521739394|FG000|Overall Study|Withdrawal by Subject|0|||
144696221|NCT02221882|521739395|FG001|Overall Study|Withdrawal by Subject|0|||
144696222|NCT02221882|521739396|FG002|Overall Study|Withdrawal by Subject|4|||
144696223|NCT02221882|521739397|FG003|Overall Study|Withdrawal by Subject|2|||
144696224|NCT02221882|521739398|FG004|Overall Study|Withdrawal by Subject|2|||
144222781|NCT03832686|520010435|FG001|Overall Study|Lost to Follow-up|9|||
144696225|NCT02221882|521739399|FG005|Overall Study|Withdrawal by Subject|2|||
144696226|NCT02221882|521739394|FG000|Overall Study|Death|0|||
144696227|NCT02221882|521739395|FG001|Overall Study|Death|1|||
144696228|NCT02221882|521739396|FG002|Overall Study|Death|0|||
144696229|NCT02221882|521739397|FG003|Overall Study|Death|0|||
144696230|NCT02221882|521739398|FG004|Overall Study|Death|0|||
144696231|NCT02221882|521739399|FG005|Overall Study|Death|0|||
144696232|NCT00796367|521739400|FG000|Overall Study|Adverse Event|6|||
144696233|NCT00796367|521739401|FG001|Overall Study|Adverse Event|4|||
144696234|NCT00796367|521739402|FG002|Overall Study|Adverse Event|7|||
144696235|NCT00796367|521739400|FG000|Overall Study|Lost to Follow-up|5|||
144696236|NCT00796367|521739401|FG001|Overall Study|Lost to Follow-up|4|||
144696237|NCT00796367|521739402|FG002|Overall Study|Lost to Follow-up|21|||
144696238|NCT00796367|521739400|FG000|Overall Study|Withdrawal by Subject|9|||
144696239|NCT00796367|521739401|FG001|Overall Study|Withdrawal by Subject|11|||
144696240|NCT00796367|521739402|FG002|Overall Study|Withdrawal by Subject|12|||
144696241|NCT00796367|521739400|FG000|Overall Study|Lack of Efficacy|2|||
144696242|NCT00796367|521739401|FG001|Overall Study|Lack of Efficacy|1|||
144696243|NCT00796367|521739402|FG002|Overall Study|Lack of Efficacy|0|||
144696244|NCT00796367|521739400|FG000|Overall Study|non compliance|3|||
144696245|NCT00796367|521739401|FG001|Overall Study|non compliance|1|||
144696246|NCT00796367|521739402|FG002|Overall Study|non compliance|1|||
144696247|NCT00796367|521739400|FG000|Overall Study|Pregnancy|1|||
144696248|NCT00796367|521739401|FG001|Overall Study|Pregnancy|0|||
144696249|NCT00796367|521739402|FG002|Overall Study|Pregnancy|1|||
144696250|NCT00796367|521739400|FG000|Overall Study|Requirement for restricted medication|2|||
144696251|NCT00796367|521739401|FG001|Overall Study|Requirement for restricted medication|0|||
144696252|NCT00796367|521739402|FG002|Overall Study|Requirement for restricted medication|2|||
144696253|NCT00796367|521739400|FG000|Overall Study|other|2|||
144696254|NCT00796367|521739401|FG001|Overall Study|other|4|||
144696255|NCT00796367|521739402|FG002|Overall Study|other|3|||
144696256|NCT04246996|521739403|FG000|Overall Study|Physician Decision|1|||
144696257|NCT04246996|521739404|FG001|Overall Study|Physician Decision|1|||
144696258|NCT04246996|521739403|FG000|Overall Study|Did not meet eligibility criteria|1|||
144696259|NCT04246996|521739404|FG001|Overall Study|Did not meet eligibility criteria|4|||
144696260|NCT04806334|521739405|FG000|Overall Study|Withdrawal by Subject|1|||
144696261|NCT00465894|521739406|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
144696262|NCT00465894|521739407|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
144696263|NCT00465894|521739406|FG000|Treatment For 12 Weeks|Family Issues|1|||
144696264|NCT00465894|521739407|FG001|Treatment For 12 Weeks|Family Issues|1|||
144696265|NCT00465894|521739406|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
144696266|NCT00465894|521739407|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
144696267|NCT01636076|521739408|FG000|Overall Study|Terminated by sponsor|1|||
144696268|NCT01636076|521739409|FG001|Overall Study|Terminated by sponsor|1|||
144696269|NCT01636076|521739408|FG000|Overall Study|Lack of Efficacy|0|||
144696270|NCT01636076|521739409|FG001|Overall Study|Lack of Efficacy|1|||
144696271|NCT01636076|521739408|FG000|Overall Study|Lost to Follow-up|1|||
144696272|NCT01636076|521739409|FG001|Overall Study|Lost to Follow-up|0|||
144696273|NCT01636076|521739408|FG000|Overall Study|Physician Decision|1|||
144696274|NCT01636076|521739409|FG001|Overall Study|Physician Decision|1|||
144696275|NCT01636076|521739408|FG000|Overall Study|Non-compliance with study treatment|1|||
144696276|NCT01636076|521739409|FG001|Overall Study|Non-compliance with study treatment|1|||
144696277|NCT01636076|521739408|FG000|Overall Study|Adverse Event|6|||
144696278|NCT01636076|521739409|FG001|Overall Study|Adverse Event|11|||
144696279|NCT01636076|521739408|FG000|Overall Study|Withdrawal by Subject|7|||
144696280|NCT01636076|521739409|FG001|Overall Study|Withdrawal by Subject|10|||
144696281|NCT01159665|521739410|FG000|Overall Study|Withdrawal by Subject|0|||
144696282|NCT01159665|521739411|FG001|Overall Study|Withdrawal by Subject|1|||
144696283|NCT01159665|521739412|FG002|Overall Study|Withdrawal by Subject|0|||
144696284|NCT01159665|521739413|FG003|Overall Study|Withdrawal by Subject|0|||
144696285|NCT01159665|521739414|FG004|Overall Study|Withdrawal by Subject|0|||
144696286|NCT01159665|521739415|FG005|Overall Study|Withdrawal by Subject|0|||
144696287|NCT01018680|521741285|FG000|Overall Study|Adverse Event|23|||
144696288|NCT01018680|521741286|FG001|Overall Study|Adverse Event|40|||
144696289|NCT01018680|521741285|FG000|Overall Study|Withdrawal by Subject|10|||
144696290|NCT01018680|521741286|FG001|Overall Study|Withdrawal by Subject|10|||
144696291|NCT01018680|521741285|FG000|Overall Study|Protocol Violation|5|||
144696292|NCT01018680|521741286|FG001|Overall Study|Protocol Violation|8|||
144696293|NCT01018680|521741285|FG000|Overall Study|Sponsor Decision|6|||
144696294|NCT01018680|521741286|FG001|Overall Study|Sponsor Decision|7|||
144696295|NCT01018680|521741285|FG000|Overall Study|Lack of Efficacy|8|||
144696296|NCT01018680|521741286|FG001|Overall Study|Lack of Efficacy|2|||
144696297|NCT01018680|521741285|FG000|Overall Study|Lost to Follow-up|5|||
144696298|NCT01018680|521741286|FG001|Overall Study|Lost to Follow-up|3|||
144696299|NCT01018680|521741285|FG000|Overall Study|Entry Criteria Not Met|1|||
144696300|NCT01018680|521741286|FG001|Overall Study|Entry Criteria Not Met|4|||
144696301|NCT01018680|521741285|FG000|Overall Study|Physician Decision|3|||
144696302|NCT01018680|521741286|FG001|Overall Study|Physician Decision|1|||
144696303|NCT01674010|521741287|FG000|Open Treatment Phase 1|Adverse Event|10|||
144696304|NCT01674010|521741288|FG001|Open Treatment Phase 1|Adverse Event|0|||
144696305|NCT01674010|521741289|FG002|Open Treatment Phase 1|Adverse Event|0|||
144696306|NCT01674010|521741287|FG000|Open Treatment Phase 1|Death|1|||
144696307|NCT01674010|521741288|FG001|Open Treatment Phase 1|Death|0|||
144696308|NCT01674010|521741289|FG002|Open Treatment Phase 1|Death|0|||
144696309|NCT01674010|521741287|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
144696310|NCT01674010|521741288|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
144696311|NCT01674010|521741289|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
144696312|NCT01674010|521741287|FG000|Open Treatment Phase 1|Physician Decision|9|||
144696313|NCT01674010|521741288|FG001|Open Treatment Phase 1|Physician Decision|0|||
144696314|NCT01674010|521741289|FG002|Open Treatment Phase 1|Physician Decision|0|||
144266692|NCT04877990|520178456|FG001|Treatment|Adverse Event|1|||
144696315|NCT01674010|521741287|FG000|Open Treatment Phase 1|Protocol Violation|7|||
144696316|NCT01674010|521741288|FG001|Open Treatment Phase 1|Protocol Violation|0|||
144696317|NCT01674010|521741289|FG002|Open Treatment Phase 1|Protocol Violation|0|||
144696318|NCT01674010|521741287|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
144696319|NCT01674010|521741288|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
144222782|NCT03832686|520010434|FG000|Overall Study|Discontinued Intervention|5|||
144222783|NCT03832686|520010435|FG001|Overall Study|Discontinued Intervention|4|||
144222784|NCT03323398|520010438|FG000|Overall Study|Other than Specified|0|||
144222785|NCT03323398|520010439|FG001|Overall Study|Other than Specified|1|||
144222786|NCT03323398|520010440|FG002|Overall Study|Other than Specified|2|||
144222787|NCT03323398|520010441|FG003|Overall Study|Other than Specified|0|||
144222788|NCT03323398|520010442|FG004|Overall Study|Other than Specified|0|||
144222789|NCT03323398|520010443|FG005|Overall Study|Other than Specified|0|||
144222790|NCT03323398|520010444|FG006|Overall Study|Other than Specified|1|||
144222791|NCT03323398|520010445|FG007|Overall Study|Other than Specified|0|||
144222792|NCT03323398|520010446|FG008|Overall Study|Other than Specified|2|||
144696320|NCT01674010|521741289|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
144696321|NCT01674010|521741287|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
144696322|NCT01674010|521741288|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
144696323|NCT01674010|521741289|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
144696324|NCT01674010|521741287|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
144696325|NCT01674010|521741288|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
144696326|NCT01674010|521741289|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
144696327|NCT01674010|521741287|FG000|Randomization Phase 2|Adverse Event|0|||
144696328|NCT01674010|521741288|FG001|Randomization Phase 2|Adverse Event|1|||
144696329|NCT01674010|521741289|FG002|Randomization Phase 2|Adverse Event|1|||
144696330|NCT01674010|521741287|FG000|Randomization Phase 2|Lost to Follow-up|0|||
144696331|NCT01674010|521741288|FG001|Randomization Phase 2|Lost to Follow-up|1|||
144696332|NCT01674010|521741289|FG002|Randomization Phase 2|Lost to Follow-up|2|||
144696333|NCT01674010|521741287|FG000|Randomization Phase 2|Mood episode recurrence|0|||
144696334|NCT01674010|521741288|FG001|Randomization Phase 2|Mood episode recurrence|8|||
144696335|NCT01674010|521741289|FG002|Randomization Phase 2|Mood episode recurrence|2|||
144696336|NCT01674010|521741287|FG000|Randomization Phase 2|Physician Decision|0|||
144696337|NCT01674010|521741288|FG001|Randomization Phase 2|Physician Decision|0|||
144696338|NCT01674010|521741289|FG002|Randomization Phase 2|Physician Decision|2|||
144696339|NCT01674010|521741287|FG000|Randomization Phase 2|Pregnancy|0|||
144266693|NCT01619878|520178457|FG000|6 Week Follow-up Phase|Adverse Event|1|||
144696340|NCT01674010|521741288|FG001|Randomization Phase 2|Pregnancy|1|||
144696341|NCT01674010|521741289|FG002|Randomization Phase 2|Pregnancy|1|||
144266694|NCT01619878|520178457|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
144266695|NCT01619878|520178457|FG000|Follow-up at 12 Months of Age|Death|2|||
144266696|NCT01305564|520178458|FG000|Overall Study|Death|21|||
144266697|NCT01305564|520178458|FG000|Overall Study|Lost to Follow-up|12|||
144266698|NCT01305564|520178458|FG000|Overall Study|Withdrawal by Subject|1|||
144266699|NCT01305564|520178458|FG000|Overall Study|Physician Decision|3|||
144266700|NCT00960804|520178471|FG000|Overall Study|Adverse Event|1|||
144266701|NCT00960804|520178472|FG001|Overall Study|Adverse Event|0|||
144266702|NCT00960804|520178473|FG002|Overall Study|Adverse Event|0|||
144266703|NCT00960804|520178471|FG000|Overall Study|Withdrawal by Subject|1|||
144266704|NCT00960804|520178472|FG001|Overall Study|Withdrawal by Subject|0|||
144266705|NCT00960804|520178473|FG002|Overall Study|Withdrawal by Subject|0|||
144266706|NCT00960804|520178471|FG000|Overall Study|Study terminated by the sponsor|5|||
144266707|NCT00960804|520178472|FG001|Overall Study|Study terminated by the sponsor|4|||
144266708|NCT00960804|520178473|FG002|Overall Study|Study terminated by the sponsor|10|||
144266709|NCT02007720|520178474|FG000|Overall Study|Withdrawal by Subject|9|||
144266710|NCT02007720|520178475|FG001|Overall Study|Withdrawal by Subject|11|||
144266711|NCT02007720|520178474|FG000|Overall Study|study terminated by sponsor|58|||
144266712|NCT02007720|520178475|FG001|Overall Study|study terminated by sponsor|54|||
144266713|NCT02007720|520178474|FG000|Overall Study|technical problem|4|||
144266714|NCT02007720|520178475|FG001|Overall Study|technical problem|2|||
144266715|NCT02007720|520178474|FG000|Overall Study|patient followd less than 165 days|11|||
144266716|NCT02007720|520178475|FG001|Overall Study|patient followd less than 165 days|5|||
144266717|NCT00870727|520179722|FG000|Overall Study|Lost to Follow-up|0|||
144696342|NCT01674010|521741287|FG000|Randomization Phase 2|Protocol Violation|0|||
144696343|NCT01674010|521741288|FG001|Randomization Phase 2|Protocol Violation|1|||
144696344|NCT01674010|521741289|FG002|Randomization Phase 2|Protocol Violation|1|||
144696345|NCT01674010|521741287|FG000|Randomization Phase 2|Sponsor Decision|0|||
144696346|NCT01674010|521741288|FG001|Randomization Phase 2|Sponsor Decision|42|||
144696347|NCT01674010|521741289|FG002|Randomization Phase 2|Sponsor Decision|45|||
144696348|NCT01674010|521741287|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
144696349|NCT01674010|521741288|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
144696350|NCT01674010|521741289|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
144696351|NCT03159455|521741290|FG000|Overall Study|Adverse Event|0|||
144696352|NCT03159455|521741291|FG001|Overall Study|Adverse Event|0|||
144696353|NCT03159455|521741292|FG002|Overall Study|Adverse Event|0|||
144696354|NCT03159455|521741293|FG003|Overall Study|Adverse Event|0|||
144696355|NCT03159455|521741294|FG004|Overall Study|Adverse Event|0|||
144696356|NCT03159455|521741295|FG005|Overall Study|Adverse Event|1|||
144696357|NCT05056311|521741296|FG000|Overall Study|Lost to Follow-up|14|||
144696358|NCT05056311|521741296|FG000|Overall Study|Withdrawal by Subject|1|||
144696359|NCT05056311|521741296|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
144696360|NCT03799198|521741299|FG000|Overall Study|Lost to Follow-up|4|||
144696361|NCT03799198|521741300|FG001|Overall Study|Lost to Follow-up|8|||
144696362|NCT03799198|521741299|FG000|Overall Study|Death|0|||
144696363|NCT03799198|521741300|FG001|Overall Study|Death|1|||
144696364|NCT01714726|521741301|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
144696365|NCT01714726|521741302|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
144696366|NCT01714726|521741303|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
144696367|NCT01714726|521741304|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
144696368|NCT01714726|521741301|FG000|Double-Blinded Induction Period|Adverse Event|0|||
144696369|NCT01714726|521741302|FG001|Double-Blinded Induction Period|Adverse Event|1|||
144696370|NCT01714726|521741303|FG002|Double-Blinded Induction Period|Adverse Event|0|||
144696371|NCT01714726|521741304|FG003|Double-Blinded Induction Period|Adverse Event|0|||
144696372|NCT01714726|521741301|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
144696373|NCT01714726|521741302|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
144696374|NCT01714726|521741303|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
144696375|NCT01714726|521741304|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
144696376|NCT01714726|521741301|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
144696377|NCT01714726|521741302|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
144696378|NCT01714726|521741303|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
144696379|NCT01714726|521741304|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
144696380|NCT01714726|521741301|FG000|Open-Label Period|Other|0|||
144696381|NCT01714726|521741302|FG001|Open-Label Period|Other|0|||
144696382|NCT01714726|521741303|FG002|Open-Label Period|Other|1|||
144696383|NCT01714726|521741304|FG003|Open-Label Period|Other|3|||
144696384|NCT01714726|521741301|FG000|Open-Label Period|Adverse Event|0|||
144696385|NCT01714726|521741302|FG001|Open-Label Period|Adverse Event|0|||
144696386|NCT01714726|521741303|FG002|Open-Label Period|Adverse Event|1|||
144696387|NCT01714726|521741304|FG003|Open-Label Period|Adverse Event|0|||
144696388|NCT01714726|521741301|FG000|Open-Label Period|Withdrawal by Subject|0|||
144266718|NCT00870727|520179723|FG001|Overall Study|Lost to Follow-up|1|||
144266719|NCT00870727|520179722|FG000|Overall Study|Lack of Efficacy|1|||
144266720|NCT00870727|520179723|FG001|Overall Study|Lack of Efficacy|3|||
144696389|NCT01714726|521741302|FG001|Open-Label Period|Withdrawal by Subject|0|||
144696390|NCT01714726|521741303|FG002|Open-Label Period|Withdrawal by Subject|9|||
144696391|NCT01714726|521741304|FG003|Open-Label Period|Withdrawal by Subject|19|||
144696392|NCT01714726|521741301|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
144696393|NCT01714726|521741302|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
144696394|NCT01714726|521741303|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
144696395|NCT01714726|521741304|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
144696396|NCT01714726|521741301|FG000|Open-Label Period|Lost to Follow-up|0|||
144696397|NCT01714726|521741302|FG001|Open-Label Period|Lost to Follow-up|0|||
144696398|NCT01714726|521741303|FG002|Open-Label Period|Lost to Follow-up|3|||
144696399|NCT01714726|521741304|FG003|Open-Label Period|Lost to Follow-up|4|||
144696400|NCT02501642|521741305|FG000|Overall Study|Lost to Follow-up|7|||
144696401|NCT02501642|521741306|FG001|Overall Study|Lost to Follow-up|11|||
144696402|NCT01153971|521741313|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
144696403|NCT01153971|521741313|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
144696404|NCT01153971|521741313|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
144696405|NCT01153971|521741313|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
144696406|NCT01153971|521741313|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
144696407|NCT01153971|521741313|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
144696408|NCT01153971|521741313|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
144696409|NCT03628781|521741314|FG000|Overall Study|Lost to Follow-up|16|||
144696410|NCT03628781|521741315|FG001|Overall Study|Lost to Follow-up|8|||
144696411|NCT03628781|521741314|FG000|Overall Study|Withdrawal by Subject|16|||
144696412|NCT03628781|521741315|FG001|Overall Study|Withdrawal by Subject|1|||
144696413|NCT03053102|521741318|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
144696414|NCT03053102|521741318|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
144696415|NCT01798056|521741319|FG000|Overall Study|Serious Adverse Event|13|||
144696416|NCT01798056|521741320|FG001|Overall Study|Serious Adverse Event|12|||
144696417|NCT01798056|521741319|FG000|Overall Study|Withdrawal by Subject|12|||
144696418|NCT01798056|521741320|FG001|Overall Study|Withdrawal by Subject|9|||
144696419|NCT01798056|521741319|FG000|Overall Study|Migrated/moved from study area|1|||
144696420|NCT01798056|521741320|FG001|Overall Study|Migrated/moved from study area|1|||
144696421|NCT01798056|521741319|FG000|Overall Study|Lost to Follow-up|1|||
144696422|NCT01798056|521741320|FG001|Overall Study|Lost to Follow-up|1|||
144696423|NCT01798056|521741319|FG000|Overall Study|Other|0|||
144222793|NCT03323398|520010438|FG000|Overall Study|Lost to Follow-up|1|||
144222794|NCT03323398|520010439|FG001|Overall Study|Lost to Follow-up|2|||
144222795|NCT03323398|520010440|FG002|Overall Study|Lost to Follow-up|1|||
144222796|NCT03323398|520010441|FG003|Overall Study|Lost to Follow-up|0|||
144222797|NCT03323398|520010442|FG004|Overall Study|Lost to Follow-up|0|||
144222798|NCT03323398|520010443|FG005|Overall Study|Lost to Follow-up|0|||
144222799|NCT03323398|520010444|FG006|Overall Study|Lost to Follow-up|0|||
144222800|NCT03323398|520010445|FG007|Overall Study|Lost to Follow-up|0|||
144222801|NCT03323398|520010446|FG008|Overall Study|Lost to Follow-up|0|||
144222802|NCT03323398|520010438|FG000|Overall Study|Death|4|||
144222803|NCT03323398|520010439|FG001|Overall Study|Death|6|||
144222804|NCT03323398|520010440|FG002|Overall Study|Death|2|||
144222805|NCT03323398|520010441|FG003|Overall Study|Death|2|||
144222806|NCT03323398|520010442|FG004|Overall Study|Death|1|||
144222807|NCT03323398|520010443|FG005|Overall Study|Death|2|||
144222808|NCT03323398|520010444|FG006|Overall Study|Death|0|||
144222809|NCT03323398|520010445|FG007|Overall Study|Death|0|||
144696424|NCT01798056|521741320|FG001|Overall Study|Other|2|||
144696425|NCT01238861|521741323|FG000|Overall Study|Lost to Follow-up|4|||
144696426|NCT01238861|521741324|FG001|Overall Study|Lost to Follow-up|2|||
144696427|NCT01238861|521741325|FG002|Overall Study|Lost to Follow-up|3|||
144222810|NCT03323398|520010446|FG008|Overall Study|Death|6|||
144696428|NCT01238861|521741326|FG003|Overall Study|Lost to Follow-up|1|||
144222811|NCT03323398|520010438|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
144266721|NCT00870727|520179722|FG000|Overall Study|Adverse Event|0|||
144266722|NCT00870727|520179723|FG001|Overall Study|Adverse Event|1|||
144696429|NCT01238861|521741327|FG004|Overall Study|Lost to Follow-up|1|||
144696430|NCT01238861|521741328|FG005|Overall Study|Lost to Follow-up|2|||
144696431|NCT01238861|521741323|FG000|Overall Study|Unplanned surgery|1|||
144696432|NCT01238861|521741324|FG001|Overall Study|Unplanned surgery|0|||
144696433|NCT01238861|521741325|FG002|Overall Study|Unplanned surgery|0|||
144696434|NCT01238861|521741326|FG003|Overall Study|Unplanned surgery|0|||
144696435|NCT01238861|521741327|FG004|Overall Study|Unplanned surgery|0|||
144696436|NCT01238861|521741328|FG005|Overall Study|Unplanned surgery|0|||
144696437|NCT01238861|521741323|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
144696438|NCT01238861|521741324|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
144696439|NCT01238861|521741325|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
144696440|NCT01238861|521741326|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
144222812|NCT03323398|520010439|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
144222813|NCT03323398|520010440|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
144222814|NCT03323398|520010441|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
144222815|NCT03323398|520010442|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
144222816|NCT03323398|520010443|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
144222817|NCT03323398|520010444|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
144222818|NCT03323398|520010445|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
144222819|NCT03323398|520010446|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
144222820|NCT03323398|520010438|FG000|Overall Study|Withdrawal by Subject|2|||
144222821|NCT03323398|520010439|FG001|Overall Study|Withdrawal by Subject|1|||
144222822|NCT03323398|520010440|FG002|Overall Study|Withdrawal by Subject|3|||
144222823|NCT03323398|520010441|FG003|Overall Study|Withdrawal by Subject|0|||
144222824|NCT03323398|520010442|FG004|Overall Study|Withdrawal by Subject|0|||
144222825|NCT03323398|520010443|FG005|Overall Study|Withdrawal by Subject|1|||
144222826|NCT03323398|520010444|FG006|Overall Study|Withdrawal by Subject|0|||
144222827|NCT03323398|520010445|FG007|Overall Study|Withdrawal by Subject|0|||
144222828|NCT03323398|520010446|FG008|Overall Study|Withdrawal by Subject|0|||
144222829|NCT03323398|520010438|FG000|Overall Study|Participant was Put on Hospice|0|||
144222830|NCT03323398|520010439|FG001|Overall Study|Participant was Put on Hospice|0|||
144222831|NCT03323398|520010440|FG002|Overall Study|Participant was Put on Hospice|0|||
144222832|NCT03323398|520010441|FG003|Overall Study|Participant was Put on Hospice|0|||
144222833|NCT03323398|520010442|FG004|Overall Study|Participant was Put on Hospice|0|||
144222834|NCT03323398|520010443|FG005|Overall Study|Participant was Put on Hospice|0|||
144222835|NCT03323398|520010444|FG006|Overall Study|Participant was Put on Hospice|1|||
144222836|NCT03323398|520010445|FG007|Overall Study|Participant was Put on Hospice|0|||
144222837|NCT03323398|520010446|FG008|Overall Study|Participant was Put on Hospice|0|||
144222838|NCT03323398|520010438|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
144222839|NCT03323398|520010439|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
144222840|NCT03323398|520010440|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
144696441|NCT01238861|521741327|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
144696442|NCT01238861|521741328|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
144222841|NCT03323398|520010441|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
144222842|NCT03323398|520010442|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
144222843|NCT03323398|520010443|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
144222844|NCT03323398|520010444|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
144266723|NCT00557466|520179724|FG000|Overall Study|Adverse Event|3|||
144266724|NCT00557466|520179725|FG001|Overall Study|Adverse Event|1|||
144696443|NCT01238861|521741323|FG000|Overall Study|Incorrect enrollment/randomization|0|||
144222845|NCT03323398|520010445|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
144222846|NCT03323398|520010446|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
144696444|NCT01238861|521741324|FG001|Overall Study|Incorrect enrollment/randomization|0|||
144696445|NCT01238861|521741325|FG002|Overall Study|Incorrect enrollment/randomization|1|||
144696446|NCT01238861|521741326|FG003|Overall Study|Incorrect enrollment/randomization|0|||
144696447|NCT01238861|521741327|FG004|Overall Study|Incorrect enrollment/randomization|1|||
144696448|NCT01238861|521741328|FG005|Overall Study|Incorrect enrollment/randomization|0|||
144696449|NCT01238861|521741323|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
144696450|NCT01238861|521741324|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
144696451|NCT01238861|521741325|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
144696452|NCT01238861|521741326|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
144696453|NCT01238861|521741327|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
144696454|NCT01238861|521741328|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
144696455|NCT01238861|521741323|FG000|Overall Study|Subject moved out of state/area|0|||
144696456|NCT01238861|521741324|FG001|Overall Study|Subject moved out of state/area|0|||
144696457|NCT01238861|521741325|FG002|Overall Study|Subject moved out of state/area|1|||
144696458|NCT01238861|521741326|FG003|Overall Study|Subject moved out of state/area|1|||
144696459|NCT01238861|521741327|FG004|Overall Study|Subject moved out of state/area|0|||
144266725|NCT00557466|520179726|FG002|Overall Study|Adverse Event|4|||
144266726|NCT00557466|520179727|FG003|Overall Study|Adverse Event|1|||
144266727|NCT00557466|520179728|FG004|Overall Study|Adverse Event|2|||
144266728|NCT00557466|520179729|FG005|Overall Study|Adverse Event|4|||
144266729|NCT00557466|520179724|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144266730|NCT00557466|520179725|FG001|Overall Study|Abnormal laboratory value(s)|2|||
144266731|NCT00557466|520179726|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144266732|NCT00557466|520179727|FG003|Overall Study|Abnormal laboratory value(s)|0|||
144266733|NCT00557466|520179728|FG004|Overall Study|Abnormal laboratory value(s)|0|||
144266734|NCT00557466|520179729|FG005|Overall Study|Abnormal laboratory value(s)|0|||
144266735|NCT00557466|520179724|FG000|Overall Study|Protocol deviation|0|||
144266736|NCT00557466|520179725|FG001|Overall Study|Protocol deviation|1|||
144266737|NCT00557466|520179726|FG002|Overall Study|Protocol deviation|0|||
144266738|NCT00557466|520179727|FG003|Overall Study|Protocol deviation|2|||
144266739|NCT00557466|520179728|FG004|Overall Study|Protocol deviation|0|||
144266740|NCT00557466|520179729|FG005|Overall Study|Protocol deviation|0|||
144266741|NCT00557466|520179724|FG000|Overall Study|Subject withdrew consent|0|||
144266742|NCT00557466|520179725|FG001|Overall Study|Subject withdrew consent|0|||
144266743|NCT00557466|520179726|FG002|Overall Study|Subject withdrew consent|0|||
144266744|NCT00557466|520179727|FG003|Overall Study|Subject withdrew consent|0|||
144266745|NCT00557466|520179728|FG004|Overall Study|Subject withdrew consent|1|||
144266746|NCT00557466|520179729|FG005|Overall Study|Subject withdrew consent|2|||
144266747|NCT00557466|520179724|FG000|Overall Study|Administrative problems|0|||
144266748|NCT00557466|520179725|FG001|Overall Study|Administrative problems|1|||
144266749|NCT00557466|520179726|FG002|Overall Study|Administrative problems|1|||
144266750|NCT00557466|520179727|FG003|Overall Study|Administrative problems|0|||
144266751|NCT00557466|520179728|FG004|Overall Study|Administrative problems|0|||
144266752|NCT00557466|520179729|FG005|Overall Study|Administrative problems|0|||
144266753|NCT00557466|520179724|FG000|Overall Study|Abnormal test procedure results|0|||
144266754|NCT00557466|520179725|FG001|Overall Study|Abnormal test procedure results|0|||
144266755|NCT00557466|520179726|FG002|Overall Study|Abnormal test procedure results|1|||
144266756|NCT00557466|520179727|FG003|Overall Study|Abnormal test procedure results|0|||
144266757|NCT00557466|520179728|FG004|Overall Study|Abnormal test procedure results|0|||
144266758|NCT00557466|520179729|FG005|Overall Study|Abnormal test procedure results|0|||
144696460|NCT01238861|521741328|FG005|Overall Study|Subject moved out of state/area|0|||
144696461|NCT01238861|521741323|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
144696462|NCT01238861|521741324|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
144696463|NCT01238861|521741325|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
144696464|NCT01238861|521741326|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
144222847|NCT02235454|520010447|FG000|Overall Study|Withdrawal by Subject|2|||
144696465|NCT01238861|521741327|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
144696466|NCT01238861|521741328|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
144696467|NCT01238861|521741323|FG000|Overall Study|Personal problems|0|||
144696468|NCT01238861|521741324|FG001|Overall Study|Personal problems|0|||
144696469|NCT01238861|521741325|FG002|Overall Study|Personal problems|0|||
144696470|NCT01238861|521741326|FG003|Overall Study|Personal problems|1|||
144696471|NCT01238861|521741327|FG004|Overall Study|Personal problems|0|||
144696472|NCT01238861|521741328|FG005|Overall Study|Personal problems|0|||
144696473|NCT01238861|521741323|FG000|Overall Study|Unable to continue visits|0|||
144696474|NCT01238861|521741324|FG001|Overall Study|Unable to continue visits|0|||
144696475|NCT01238861|521741325|FG002|Overall Study|Unable to continue visits|0|||
144696476|NCT01238861|521741326|FG003|Overall Study|Unable to continue visits|1|||
144696477|NCT01238861|521741327|FG004|Overall Study|Unable to continue visits|0|||
144696478|NCT01238861|521741328|FG005|Overall Study|Unable to continue visits|1|||
144696479|NCT01238861|521741323|FG000|Overall Study|Serious adverse event|0|||
144696480|NCT01238861|521741324|FG001|Overall Study|Serious adverse event|0|||
144696481|NCT01238861|521741325|FG002|Overall Study|Serious adverse event|0|||
144696482|NCT01238861|521741326|FG003|Overall Study|Serious adverse event|0|||
144696483|NCT01238861|521741327|FG004|Overall Study|Serious adverse event|0|||
144222848|NCT03641469|520010448|FG000|Overall Study|Ineligible|2|||
144222849|NCT03641469|520010448|FG000|Overall Study|Withdrawal by Subject|5|||
144222850|NCT03641469|520010448|FG000|Overall Study|Physician Decision|1|||
144222851|NCT03641469|520010448|FG000|Overall Study|Protocol Violation|1|||
144222852|NCT03641469|520010448|FG000|Overall Study|Lost to Follow-up|2|||
144222853|NCT04023396|520012320|FG000|Overall Study|Adverse Event|16|||
144222854|NCT04023396|520012320|FG000|Overall Study|Death|1|||
144222855|NCT04023396|520012320|FG000|Overall Study|Lost to Follow-up|1|||
144222856|NCT04023396|520012320|FG000|Overall Study|Withdrawal by Subject|14|||
144222857|NCT04023396|520012320|FG000|Overall Study|Pregnancy|4|||
144222858|NCT04023396|520012320|FG000|Overall Study|Lack of Efficacy|3|||
144222859|NCT04023396|520012320|FG000|Overall Study|Physician Decision|4|||
144222860|NCT04023396|520012320|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
144222861|NCT04075825|520012323|FG000|Overall Study|Withdrawal by Subject|6|||
144222862|NCT04075825|520012324|FG001|Overall Study|Withdrawal by Subject|8|||
144222863|NCT04075825|520012323|FG000|Overall Study|Physician Decision|3|||
144222864|NCT04075825|520012324|FG001|Overall Study|Physician Decision|1|||
144222865|NCT04075825|520012323|FG000|Overall Study|Lost to Follow-up|5|||
144696484|NCT01238861|521741328|FG005|Overall Study|Serious adverse event|1|||
144696485|NCT01238861|521741323|FG000|Overall Study|Lack of compliance|0|||
144696486|NCT01238861|521741324|FG001|Overall Study|Lack of compliance|0|||
144222866|NCT04075825|520012324|FG001|Overall Study|Lost to Follow-up|1|||
144222867|NCT04075825|520012323|FG000|Overall Study|Participation in New Clinical Trial|1|||
144696487|NCT01238861|521741325|FG002|Overall Study|Lack of compliance|0|||
144222868|NCT04075825|520012324|FG001|Overall Study|Participation in New Clinical Trial|1|||
144222869|NCT04075825|520012323|FG000|Overall Study|Reason Not Specified|2|||
144222870|NCT04075825|520012324|FG001|Overall Study|Reason Not Specified|2|||
144696488|NCT01238861|521741326|FG003|Overall Study|Lack of compliance|0|||
144266759|NCT00557466|520179724|FG000|Overall Study|Lost to Follow-up|0|||
144266760|NCT00557466|520179725|FG001|Overall Study|Lost to Follow-up|0|||
144222871|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
144222872|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
144696489|NCT01238861|521741327|FG004|Overall Study|Lack of compliance|0|||
144696490|NCT01238861|521741328|FG005|Overall Study|Lack of compliance|1|||
144696491|NCT01238861|521741323|FG000|Overall Study|Adverse Event|0|||
144696492|NCT01238861|521741324|FG001|Overall Study|Adverse Event|1|||
144696493|NCT01238861|521741325|FG002|Overall Study|Adverse Event|0|||
144696494|NCT01238861|521741326|FG003|Overall Study|Adverse Event|0|||
144696495|NCT01238861|521741327|FG004|Overall Study|Adverse Event|0|||
144696496|NCT01238861|521741328|FG005|Overall Study|Adverse Event|0|||
144696497|NCT01238861|521741323|FG000|Overall Study|Withdrawal by Subject|6|||
144696498|NCT01238861|521741324|FG001|Overall Study|Withdrawal by Subject|5|||
144696499|NCT01238861|521741325|FG002|Overall Study|Withdrawal by Subject|4|||
144696500|NCT01238861|521741326|FG003|Overall Study|Withdrawal by Subject|8|||
144696501|NCT01238861|521741327|FG004|Overall Study|Withdrawal by Subject|10|||
144696502|NCT01238861|521741328|FG005|Overall Study|Withdrawal by Subject|9|||
144696503|NCT01269346|521741329|FG000|Treatment Phase|Disease progression|3|||
144696504|NCT01269346|521741329|FG000|Treatment Phase|Adverse Event|3|||
144696505|NCT01269346|521741329|FG000|Treatment Phase|Withdrawal by Subject|1|||
144696506|NCT01269346|521741329|FG000|Treatment Phase|Other|2|||
144696507|NCT01269346|521741329|FG000|Extension Phase|Adverse Event|6|||
144696508|NCT01269346|521741329|FG000|Extension Phase|Withdrawal by Subject|4|||
144696509|NCT01269346|521741329|FG000|Extension Phase|Disease progression|22|||
144696510|NCT01269346|521741329|FG000|Extension Phase|Physician decision or participant choice|9|||
144696511|NCT01269346|521741329|FG000|Extension Phase|Clinical progression|1|||
144696512|NCT01269346|521741329|FG000|Extension Phase|Started a prohibited con med|1|||
144696513|NCT00247416|521741330|FG000|Overall Study|3 patients were found to be ineligible|1|||
144696514|NCT00247416|521741331|FG001|Overall Study|3 patients were found to be ineligible|2|||
144696515|NCT00474994|521741340|FG000|Overall Study|Patient Not treated|1|||
144696516|NCT00474994|521741340|FG000|Overall Study|Patient evaluable for toxicity only|3|||
144696517|NCT00474994|521741340|FG000|Overall Study|Patient found to be ineligible|1|||
144696518|NCT00278473|521741341|FG000|Overall Study|drop out|4|||
144696519|NCT00278473|521741342|FG001|Overall Study|drop out|3|||
144696520|NCT00761761|521741344|FG000|Overall Study|Lost to Follow-up|3|||
144696521|NCT00761761|521741345|FG001|Overall Study|Lost to Follow-up|1|||
144696522|NCT00761761|521741344|FG000|Overall Study|Withdrawal by Subject|3|||
144696523|NCT00761761|521741345|FG001|Overall Study|Withdrawal by Subject|0|||
144696524|NCT06045026|521741349|FG000|Overall Study|Lost to Follow-up|60|||
144696525|NCT06045026|521741349|FG000|Overall Study|Adverse Event|12|||
144696526|NCT06045026|521741349|FG000|Overall Study|Withdrawal by Subject|3|||
144696527|NCT06045026|521741349|FG000|Overall Study|Enrollment closed|1|||
144696528|NCT04511533|521741350|FG000|Treatment|Other|2|||
144696529|NCT04511533|521741350|FG000|Treatment|Withdrawal by Subject|11|||
144696530|NCT04511533|521741350|FG000|Treatment|Death|5|||
144696531|NCT04511533|521741350|FG000|Treatment|Physician Decision|1|||
144696532|NCT04511533|521741350|FG000|Treatment|Progressive Disease|61|||
144696533|NCT04511533|521741350|FG000|Follow-Up|Other|7|||
144696534|NCT04511533|521741350|FG000|Follow-Up|Withdrawal by Subject|5|||
144696535|NCT04511533|521741350|FG000|Follow-Up|Lost to Follow-up|2|||
144696536|NCT04511533|521741350|FG000|Follow-Up|Death|4|||
144696537|NCT01224171|521741351|FG000|Overall Study|Adverse Event|8|||
144696538|NCT01224171|521741352|FG001|Overall Study|Adverse Event|4|||
144696539|NCT01224171|521741351|FG000|Overall Study|Protocol Violation|0|||
144696540|NCT01224171|521741352|FG001|Overall Study|Protocol Violation|1|||
144696541|NCT01224171|521741351|FG000|Overall Study|Lack of Efficacy|5|||
144696542|NCT01224171|521741352|FG001|Overall Study|Lack of Efficacy|1|||
144696543|NCT01224171|521741351|FG000|Overall Study|Withdrawal of Consent|2|||
144696544|NCT01224171|521741352|FG001|Overall Study|Withdrawal of Consent|4|||
144696545|NCT01224171|521741351|FG000|Overall Study|Lost to Follow-up|0|||
144696546|NCT01224171|521741352|FG001|Overall Study|Lost to Follow-up|3|||
144696547|NCT00750061|521741356|FG000|Overall Study|Adverse Event|2|||
144696548|NCT00750061|521741357|FG001|Overall Study|Adverse Event|0|||
144696549|NCT00750061|521741356|FG000|Overall Study|Withdrawal by Subject|0|||
144696550|NCT00750061|521741357|FG001|Overall Study|Withdrawal by Subject|1|||
144696551|NCT00750061|521741356|FG000|Overall Study|Physician Decision|0|||
144696552|NCT00750061|521741357|FG001|Overall Study|Physician Decision|1|||
144696553|NCT02708524|521741358|FG000|Overall Study|Adverse Event|0|||
144696554|NCT02708524|521741359|FG001|Overall Study|Adverse Event|1|||
144696555|NCT02708524|521741360|FG002|Overall Study|Adverse Event|0|||
144696556|NCT02708524|521741361|FG003|Overall Study|Adverse Event|0|||
144696557|NCT02708524|521741358|FG000|Overall Study|Lens Discomfort|1|||
144696558|NCT02708524|521741359|FG001|Overall Study|Lens Discomfort|0|||
144696559|NCT02708524|521741360|FG002|Overall Study|Lens Discomfort|1|||
144696560|NCT02708524|521741361|FG003|Overall Study|Lens Discomfort|0|||
144696561|NCT02708524|521741358|FG000|Overall Study|Lost to Follow-up|1|||
144696562|NCT02708524|521741359|FG001|Overall Study|Lost to Follow-up|1|||
144696563|NCT02708524|521741360|FG002|Overall Study|Lost to Follow-up|1|||
144696564|NCT02708524|521741361|FG003|Overall Study|Lost to Follow-up|0|||
144696565|NCT02708524|521741358|FG000|Overall Study|Protocol Violation|0|||
144696566|NCT02708524|521741359|FG001|Overall Study|Protocol Violation|1|||
144696567|NCT02708524|521741360|FG002|Overall Study|Protocol Violation|0|||
144696568|NCT02708524|521741361|FG003|Overall Study|Protocol Violation|0|||
144696569|NCT02708524|521741358|FG000|Overall Study|Withdrawal by Subject|1|||
144696570|NCT02708524|521741359|FG001|Overall Study|Withdrawal by Subject|1|||
144696571|NCT02708524|521741360|FG002|Overall Study|Withdrawal by Subject|0|||
144696572|NCT02708524|521741361|FG003|Overall Study|Withdrawal by Subject|0|||
144696573|NCT02708524|521741358|FG000|Overall Study|Dispensed incorrect study lens|0|||
144696574|NCT02708524|521741359|FG001|Overall Study|Dispensed incorrect study lens|1|||
144696575|NCT02708524|521741360|FG002|Overall Study|Dispensed incorrect study lens|1|||
144696576|NCT02708524|521741361|FG003|Overall Study|Dispensed incorrect study lens|0|||
144696577|NCT02708524|521741358|FG000|Overall Study|Did not wear lens at final visit|0|||
144696578|NCT02708524|521741359|FG001|Overall Study|Did not wear lens at final visit|1|||
144696579|NCT02708524|521741360|FG002|Overall Study|Did not wear lens at final visit|0|||
144696580|NCT02708524|521741361|FG003|Overall Study|Did not wear lens at final visit|0|||
144696581|NCT02708524|521741358|FG000|Overall Study|Subject lost study lens|1|||
144696582|NCT02708524|521741359|FG001|Overall Study|Subject lost study lens|0|||
144696583|NCT02708524|521741360|FG002|Overall Study|Subject lost study lens|0|||
144696584|NCT02708524|521741361|FG003|Overall Study|Subject lost study lens|0|||
144696585|NCT00381680|521741362|FG000|Overall Study|Adverse Event|9|||
144696586|NCT00381680|521741363|FG001|Overall Study|Adverse Event|3|||
144696587|NCT00381680|521741362|FG000|Overall Study|Death|10|||
144696588|NCT00381680|521741363|FG001|Overall Study|Death|7|||
144696589|NCT00381680|521741362|FG000|Overall Study|Lost to Follow-up|3|||
144696590|NCT00381680|521741363|FG001|Overall Study|Lost to Follow-up|2|||
144696591|NCT00381680|521741362|FG000|Overall Study|Physician Decision|25|||
144696592|NCT00381680|521741363|FG001|Overall Study|Physician Decision|6|||
144696593|NCT00381680|521741362|FG000|Overall Study|Withdrawal by Subject|3|||
144696594|NCT00381680|521741363|FG001|Overall Study|Withdrawal by Subject|1|||
144696595|NCT00381680|521741362|FG000|Overall Study|Entry onto another COG Trial|1|||
144696596|NCT00381680|521741363|FG001|Overall Study|Entry onto another COG Trial|2|||
144696597|NCT00381680|521741362|FG000|Overall Study|Alternative Therapy|11|||
144696598|NCT00381680|521741363|FG001|Overall Study|Alternative Therapy|5|||
144696599|NCT00381680|521741362|FG000|Overall Study|Secondary Malignancy|3|||
144696600|NCT00381680|521741363|FG001|Overall Study|Secondary Malignancy|0|||
144696601|NCT00381680|521741362|FG000|Overall Study|Delay initiation|1|||
144696602|NCT00381680|521741363|FG001|Overall Study|Delay initiation|0|||
144696603|NCT00381680|521741362|FG000|Overall Study|Stem Cell Transplant|26|||
144696604|NCT00381680|521741363|FG001|Overall Study|Stem Cell Transplant|10|||
144696605|NCT00381680|521741362|FG000|Overall Study|Relapse|18|||
144696606|NCT00381680|521741363|FG001|Overall Study|Relapse|9|||
144696607|NCT00381680|521741362|FG000|Overall Study|Induction Failure|4|||
144696608|NCT00381680|521741363|FG001|Overall Study|Induction Failure|1|||
144696609|NCT00381680|521741362|FG000|Overall Study|Progression|1|||
144696610|NCT00381680|521741363|FG001|Overall Study|Progression|1|||
144696611|NCT00381680|521741362|FG000|Overall Study|Other not otherwise specified|7|||
144696612|NCT00381680|521741363|FG001|Overall Study|Other not otherwise specified|2|||
144696613|NCT00381680|521741362|FG000|Overall Study|Ineligible|3|||
144696614|NCT00381680|521741363|FG001|Overall Study|Ineligible|1|||
144696615|NCT00361504|521741366|FG000|Overall Study|Withdrawal by Subject|94|||
144696616|NCT00361504|521741367|FG001|Overall Study|Withdrawal by Subject|31|||
144696617|NCT00361504|521741366|FG000|Overall Study|Lost to Follow-up|40|||
144696618|NCT00361504|521741367|FG001|Overall Study|Lost to Follow-up|7|||
144696619|NCT00361504|521741366|FG000|Overall Study|Adverse Event|203|||
144696620|NCT00361504|521741367|FG001|Overall Study|Adverse Event|82|||
144696621|NCT00361504|521741366|FG000|Overall Study|Lack of Efficacy|72|||
144696622|NCT00361504|521741367|FG001|Overall Study|Lack of Efficacy|7|||
144696623|NCT00361504|521741366|FG000|Overall Study|Resolution of Pain|2|||
144696624|NCT00361504|521741367|FG001|Overall Study|Resolution of Pain|0|||
144696625|NCT00361504|521741366|FG000|Overall Study|Study medication non compliant|42|||
144696626|NCT00361504|521741367|FG001|Overall Study|Study medication non compliant|15|||
144696627|NCT00361504|521741366|FG000|Overall Study|All other|28|||
144696628|NCT00361504|521741367|FG001|Overall Study|All other|3|||
144696629|NCT01374516|521741374|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
144696630|NCT01374516|521741375|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
144696631|NCT01374516|521741374|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
144696632|NCT01374516|521741375|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
144696633|NCT01374516|521741374|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
144696634|NCT01374516|521741375|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
144696635|NCT01374516|521741374|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
144696636|NCT01374516|521741375|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
144696637|NCT01374516|521741374|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
144696638|NCT01374516|521741375|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
144696639|NCT01374516|521741374|FG000|Surveillance Expansion Period|Protocol Violation|386|||
144696640|NCT01374516|521741375|FG001|Surveillance Expansion Period|Protocol Violation|217|||
144696641|NCT01374516|521741374|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
144696642|NCT01374516|521741375|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
144696643|NCT01374516|521741374|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
144696644|NCT01374516|521741375|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
144696645|NCT01374516|521741374|FG000|Surveillance Expansion Period|Serious adverse event|20|||
144696646|NCT01374516|521741375|FG001|Surveillance Expansion Period|Serious adverse event|5|||
144222873|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
144696647|NCT00450814|521741376|FG000|Overall Study|Failed to complete the initial therapy|0|||
144696648|NCT00450814|521741377|FG001|Overall Study|Failed to complete the initial therapy|0|||
144696649|NCT00450814|521741378|FG002|Overall Study|Failed to complete the initial therapy|0|||
144696650|NCT00450814|521741379|FG003|Overall Study|Failed to complete the initial therapy|1|||
144696651|NCT00450814|521741380|FG004|Overall Study|Failed to complete the initial therapy|1|||
144696652|NCT00450814|521741381|FG005|Overall Study|Failed to complete the initial therapy|1|||
144696653|NCT00450814|521741382|FG006|Overall Study|Failed to complete the initial therapy|0|||
144696654|NCT00450814|521741383|FG007|Overall Study|Failed to complete the initial therapy|0|||
144696655|NCT00450814|521741384|FG008|Overall Study|Failed to complete the initial therapy|0|||
144696656|NCT00450814|521741385|FG009|Overall Study|Failed to complete the initial therapy|0|||
144696657|NCT00450814|521741386|FG010|Overall Study|Failed to complete the initial therapy|0|||
144222874|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
144696658|NCT00450814|521741376|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
144696659|NCT00450814|521741377|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
144696660|NCT00450814|521741378|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
144696661|NCT00450814|521741379|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
144696662|NCT00450814|521741380|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
144696663|NCT00450814|521741381|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
144696664|NCT00450814|521741382|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
144696665|NCT00450814|521741383|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
144696666|NCT00450814|521741384|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
144696667|NCT00450814|521741385|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
144696668|NCT00450814|521741386|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
144696669|NCT04145531|521741387|FG000|Part A|Adverse Event|2|||
144696670|NCT04145531|521741388|FG001|Part A|Adverse Event|12|||
144696671|NCT04145531|521741389|FG002|Part A|Adverse Event|6|||
144696672|NCT04145531|521741390|FG003|Part A|Adverse Event|0|||
144696673|NCT04145531|521741387|FG000|Part A|Death|1|||
144696674|NCT04145531|521741388|FG001|Part A|Death|2|||
144696675|NCT04145531|521741389|FG002|Part A|Death|0|||
144696676|NCT04145531|521741390|FG003|Part A|Death|0|||
144696677|NCT04145531|521741387|FG000|Part A|Physician Decision|2|||
144696678|NCT04145531|521741388|FG001|Part A|Physician Decision|5|||
144696679|NCT04145531|521741389|FG002|Part A|Physician Decision|2|||
144696680|NCT04145531|521741390|FG003|Part A|Physician Decision|0|||
144696681|NCT04145531|521741387|FG000|Part A|Progressive disease|0|||
144696682|NCT04145531|521741388|FG001|Part A|Progressive disease|2|||
144696683|NCT04145531|521741389|FG002|Part A|Progressive disease|1|||
144696684|NCT04145531|521741390|FG003|Part A|Progressive disease|0|||
144696685|NCT04145531|521741387|FG000|Part A|Protocol deviation|0|||
144696686|NCT04145531|521741388|FG001|Part A|Protocol deviation|0|||
144696687|NCT04145531|521741389|FG002|Part A|Protocol deviation|1|||
144696688|NCT04145531|521741390|FG003|Part A|Protocol deviation|0|||
144696689|NCT04145531|521741387|FG000|Part A|Withdrawal by parent or guardian|1|||
144696690|NCT04145531|521741388|FG001|Part A|Withdrawal by parent or guardian|0|||
144696691|NCT04145531|521741389|FG002|Part A|Withdrawal by parent or guardian|0|||
144696692|NCT04145531|521741390|FG003|Part A|Withdrawal by parent or guardian|0|||
144696693|NCT04145531|521741387|FG000|Part A|Withdrawal by participant|0|||
144696694|NCT04145531|521741388|FG001|Part A|Withdrawal by participant|0|||
144696695|NCT04145531|521741389|FG002|Part A|Withdrawal by participant|1|||
144696696|NCT04145531|521741390|FG003|Part A|Withdrawal by participant|0|||
144696697|NCT04145531|521741387|FG000|Part A|Other|0|||
144696698|NCT04145531|521741388|FG001|Part A|Other|0|||
144696699|NCT04145531|521741389|FG002|Part A|Other|1|||
144696700|NCT04145531|521741390|FG003|Part A|Other|0|||
144696701|NCT04145531|521741387|FG000|Part B|Adverse Event|0|||
144696702|NCT04145531|521741388|FG001|Part B|Adverse Event|0|||
144696703|NCT04145531|521741389|FG002|Part B|Adverse Event|0|||
144696704|NCT04145531|521741390|FG003|Part B|Adverse Event|21|||
144696705|NCT04145531|521741387|FG000|Part B|Physician Decision|0|||
144696706|NCT04145531|521741388|FG001|Part B|Physician Decision|0|||
144696707|NCT04145531|521741389|FG002|Part B|Physician Decision|0|||
144696708|NCT04145531|521741390|FG003|Part B|Physician Decision|7|||
144696709|NCT04145531|521741387|FG000|Part B|Progressive disease|0|||
144696710|NCT04145531|521741388|FG001|Part B|Progressive disease|0|||
144696711|NCT04145531|521741389|FG002|Part B|Progressive disease|0|||
144696712|NCT04145531|521741390|FG003|Part B|Progressive disease|1|||
144696713|NCT04145531|521741387|FG000|Part B|Recurrent disease|0|||
144696714|NCT04145531|521741388|FG001|Part B|Recurrent disease|0|||
144696715|NCT04145531|521741389|FG002|Part B|Recurrent disease|0|||
144696716|NCT04145531|521741390|FG003|Part B|Recurrent disease|1|||
144696717|NCT04145531|521741387|FG000|Part B|Withdrawal by parent or guardian|0|||
144696718|NCT04145531|521741388|FG001|Part B|Withdrawal by parent or guardian|0|||
144696719|NCT04145531|521741389|FG002|Part B|Withdrawal by parent or guardian|0|||
144696720|NCT04145531|521741390|FG003|Part B|Withdrawal by parent or guardian|3|||
144696721|NCT04145531|521741387|FG000|Part B|Withdrawal by participant|0|||
144696722|NCT04145531|521741388|FG001|Part B|Withdrawal by participant|0|||
144696723|NCT04145531|521741389|FG002|Part B|Withdrawal by participant|0|||
144696724|NCT04145531|521741390|FG003|Part B|Withdrawal by participant|1|||
144696725|NCT04145531|521741387|FG000|Part B|Other|0|||
144696726|NCT04145531|521741388|FG001|Part B|Other|0|||
144696727|NCT04145531|521741389|FG002|Part B|Other|0|||
144696728|NCT04145531|521741390|FG003|Part B|Other|1|||
144696729|NCT04988035|521741391|FG000|Overall Study|Death|19|||
144696730|NCT04988035|521741392|FG001|Overall Study|Death|13|||
144696731|NCT04988035|521741391|FG000|Overall Study|Lost to Follow-up|12|||
144696732|NCT04988035|521741392|FG001|Overall Study|Lost to Follow-up|6|||
144696733|NCT04988035|521741391|FG000|Overall Study|Protocol Violation|0|||
144696734|NCT04988035|521741392|FG001|Overall Study|Protocol Violation|1|||
144696735|NCT04988035|521741391|FG000|Overall Study|Withdrawal by Subject|2|||
144696736|NCT04988035|521741392|FG001|Overall Study|Withdrawal by Subject|4|||
144696737|NCT04988035|521741391|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
144696738|NCT04988035|521741392|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
144696739|NCT03602976|521741393|FG000|Overall Study|Withdrawal by Subject|1|||
144696740|NCT03732534|521741394|FG000|Overall Study|Study terminated by Sponsor|6|||
144696741|NCT02190604|521741395|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696742|NCT02190604|521741396|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696743|NCT02190604|521741397|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696744|NCT02190604|521741398|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696745|NCT02190604|521741399|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696746|NCT02190604|521741400|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696747|NCT02190604|521741401|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696748|NCT02190604|521741402|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696749|NCT02190604|521741403|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696750|NCT02190604|521741404|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696751|NCT02190604|521741405|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696752|NCT02190604|521741406|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696753|NCT02190604|521741407|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696754|NCT02190604|521741408|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696755|NCT02190604|521741409|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
144696756|NCT02190604|521741410|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696757|NCT02190604|521741411|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696758|NCT02190604|521741412|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696759|NCT02190604|521741413|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
144696760|NCT02190604|521741395|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696761|NCT02190604|521741396|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696762|NCT02190604|521741397|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696763|NCT02190604|521741398|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696764|NCT02190604|521741399|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696765|NCT02190604|521741400|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696766|NCT02190604|521741401|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696767|NCT02190604|521741402|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696768|NCT02190604|521741403|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696769|NCT02190604|521741404|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696770|NCT02190604|521741405|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696771|NCT02190604|521741406|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696772|NCT02190604|521741407|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696773|NCT02190604|521741408|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
144696774|NCT02190604|521741409|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696775|NCT02190604|521741410|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696776|NCT02190604|521741411|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696777|NCT02190604|521741412|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696778|NCT02190604|521741413|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
144696779|NCT02797951|521741414|FG000|Overall Study|Adverse Event|4|||
144696780|NCT02797951|521741414|FG000|Overall Study|Death|1|||
144696781|NCT02797951|521741414|FG000|Overall Study|Lack of Efficacy|19|||
144696782|NCT02797951|521741414|FG000|Overall Study|Lost to Follow-up|4|||
144696783|NCT02797951|521741414|FG000|Overall Study|Physician Decision|6|||
144696784|NCT02797951|521741414|FG000|Overall Study|Withdrawal by Subject|15|||
144696785|NCT03735849|521741415|FG000|Overall Study|Lost to Follow-up|1|||
144696786|NCT03735849|521741416|FG001|Overall Study|Lost to Follow-up|0|||
144696787|NCT03735849|521741417|FG002|Overall Study|Lost to Follow-up|0|||
144696788|NCT03735849|521741415|FG000|Overall Study|Participant unable to adhere to visit|1|||
144696789|NCT03735849|521741416|FG001|Overall Study|Participant unable to adhere to visit|0|||
144266761|NCT00557466|520179726|FG002|Overall Study|Lost to Follow-up|0|||
144696790|NCT03735849|521741417|FG002|Overall Study|Participant unable to adhere to visit|0|||
144696791|NCT03735849|521741415|FG000|Overall Study|Not Randomized|0|||
144696792|NCT03735849|521741416|FG001|Overall Study|Not Randomized|0|||
144696793|NCT03735849|521741417|FG002|Overall Study|Not Randomized|4|||
144696794|NCT04626947|521741420|FG000|Overall Study|Study terminated|14|||
144696795|NCT00265109|521741425|FG000|Overall Study|Withdrawal by Subject|5|||
144696796|NCT00265109|521741425|FG000|Overall Study|Adverse Event|1|||
144696797|NCT03556202|521741428|FG000|Extension Treatment Period|Adverse Event|18|||
144696798|NCT03556202|521741429|FG001|Extension Treatment Period|Adverse Event|14|||
144696799|NCT03556202|521741430|FG002|Extension Treatment Period|Adverse Event|9|||
144696800|NCT03556202|521741428|FG000|Extension Treatment Period|Death|2|||
144266762|NCT00557466|520179727|FG003|Overall Study|Lost to Follow-up|1|||
144696801|NCT03556202|521741429|FG001|Extension Treatment Period|Death|6|||
144696802|NCT03556202|521741430|FG002|Extension Treatment Period|Death|0|||
144696803|NCT03556202|521741428|FG000|Extension Treatment Period|Lack of Efficacy|5|||
144696804|NCT03556202|521741429|FG001|Extension Treatment Period|Lack of Efficacy|12|||
144696805|NCT03556202|521741430|FG002|Extension Treatment Period|Lack of Efficacy|18|||
144696806|NCT03556202|521741428|FG000|Extension Treatment Period|Lost to Follow-up|9|||
144696807|NCT03556202|521741429|FG001|Extension Treatment Period|Lost to Follow-up|20|||
144696808|NCT03556202|521741430|FG002|Extension Treatment Period|Lost to Follow-up|2|||
144696809|NCT03556202|521741428|FG000|Extension Treatment Period|Pregnancy|2|||
144696810|NCT03556202|521741429|FG001|Extension Treatment Period|Pregnancy|4|||
144696811|NCT03556202|521741430|FG002|Extension Treatment Period|Pregnancy|3|||
144696812|NCT03556202|521741428|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
144696813|NCT03556202|521741429|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
144696814|NCT03556202|521741430|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
144696815|NCT03556202|521741428|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
144696816|NCT03556202|521741429|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
144696817|NCT03556202|521741430|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
144696818|NCT03556202|521741428|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
144696819|NCT03556202|521741429|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
144696820|NCT03556202|521741430|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
144696821|NCT03556202|521741428|FG000|Extension Treatment Period|Physician Decision|0|||
144696822|NCT03556202|521741429|FG001|Extension Treatment Period|Physician Decision|8|||
144696823|NCT03556202|521741430|FG002|Extension Treatment Period|Physician Decision|2|||
144696824|NCT03556202|521741428|FG000|Extension Treatment Period|Protocol Violation|0|||
144696825|NCT03556202|521741429|FG001|Extension Treatment Period|Protocol Violation|1|||
144696826|NCT03556202|521741430|FG002|Extension Treatment Period|Protocol Violation|1|||
144696827|NCT03556202|521741428|FG000|Extension Treatment Period|Sponsor Decision|0|||
144696828|NCT03556202|521741429|FG001|Extension Treatment Period|Sponsor Decision|1|||
144696829|NCT03556202|521741430|FG002|Extension Treatment Period|Sponsor Decision|0|||
144696830|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
144696831|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
144696832|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
144696833|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Death|1|||
144696834|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Death|0|||
144696835|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Death|0|||
144696836|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
144696837|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
144696838|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
144696839|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
144696840|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
144696841|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
144696842|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
144696843|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
144696844|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
144696845|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
144696846|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
144696847|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
144696848|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
144696849|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
144696850|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
144696851|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
144696852|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
144696853|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
144696854|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
144696855|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
144696856|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
144696857|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
144696858|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
144696859|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
144696860|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
144696861|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
144696862|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
144696863|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
144696864|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
144696865|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
144696866|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
144696867|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
144696868|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
144696869|NCT03556202|521741428|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
144696870|NCT03556202|521741429|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
144696871|NCT03556202|521741430|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
144696872|NCT04604015|521741439|FG000|Overall Study|Incomplete Data Collection|33|||
144696873|NCT03289676|521741442|FG000|Overall Study|Withdrawal by Subject|2|||
144696874|NCT03289676|521741443|FG001|Overall Study|Withdrawal by Subject|0|||
144696875|NCT03289676|521741442|FG000|Overall Study|Protocol Violation|2|||
144696876|NCT03289676|521741443|FG001|Overall Study|Protocol Violation|0|||
144696877|NCT03289676|521741442|FG000|Overall Study|Lost to Follow-up|0|||
144696878|NCT03289676|521741443|FG001|Overall Study|Lost to Follow-up|1|||
144696879|NCT02576652|521741444|FG000|Overall Study|Withdrawal by Subject|2|||
144696880|NCT04557189|521741453|FG000|Overall Study|Adverse Event|0|||
144696881|NCT04557189|521741454|FG001|Overall Study|Adverse Event|1|||
144696882|NCT04557189|521741453|FG000|Overall Study|Lost to Follow-up|1|||
144696883|NCT04557189|521741454|FG001|Overall Study|Lost to Follow-up|1|||
144696884|NCT04557189|521741453|FG000|Overall Study|Withdrawal by Subject|2|||
144696885|NCT04557189|521741454|FG001|Overall Study|Withdrawal by Subject|1|||
144696886|NCT04557189|521741453|FG000|Overall Study|Reason not Specified|3|||
144696887|NCT04557189|521741454|FG001|Overall Study|Reason not Specified|6|||
144266763|NCT00557466|520179728|FG004|Overall Study|Lost to Follow-up|0|||
144696888|NCT01087944|521741470|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
144696889|NCT01087944|521741471|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
144696890|NCT01087944|521741470|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
144696891|NCT01087944|521741471|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
144696892|NCT00540228|521741472|FG000|Overall Study|Adverse Event|2|||
144696893|NCT00540228|521741473|FG001|Overall Study|Adverse Event|0|||
144696894|NCT00540228|521741474|FG002|Overall Study|Adverse Event|0|||
144696895|NCT00540228|521741475|FG003|Overall Study|Adverse Event|0|||
144696896|NCT00540228|521741476|FG004|Overall Study|Adverse Event|0|||
144696897|NCT00540228|521741472|FG000|Overall Study|Lost to Follow-up|1|||
144696898|NCT00540228|521741473|FG001|Overall Study|Lost to Follow-up|1|||
144696899|NCT00540228|521741474|FG002|Overall Study|Lost to Follow-up|0|||
144696900|NCT00540228|521741475|FG003|Overall Study|Lost to Follow-up|0|||
144696901|NCT00540228|521741476|FG004|Overall Study|Lost to Follow-up|0|||
144696902|NCT02451137|521741477|FG000|Overall Study|Randomized but not treated|19|||
144696903|NCT02451137|521741478|FG001|Overall Study|Randomized but not treated|27|||
144696904|NCT02451137|521741477|FG000|Overall Study|Adverse Event|43|||
144696905|NCT02451137|521741478|FG001|Overall Study|Adverse Event|42|||
144696906|NCT02451137|521741477|FG000|Overall Study|Lack of Efficacy|4|||
144696907|NCT02451137|521741478|FG001|Overall Study|Lack of Efficacy|9|||
144696908|NCT02451137|521741477|FG000|Overall Study|Participant decision:discontinue insulin|41|||
144696909|NCT02451137|521741478|FG001|Overall Study|Participant decision:discontinue insulin|43|||
144696910|NCT02451137|521741477|FG000|Overall Study|Hypoglycemia|2|||
144696911|NCT02451137|521741478|FG001|Overall Study|Hypoglycemia|1|||
144696912|NCT02451137|521741477|FG000|Overall Study|Investigator's decision|23|||
144696913|NCT02451137|521741478|FG001|Overall Study|Investigator's decision|19|||
144696914|NCT02451137|521741477|FG000|Overall Study|Lost to Follow-up|53|||
144696915|NCT02451137|521741478|FG001|Overall Study|Lost to Follow-up|61|||
144696916|NCT02451137|521741477|FG000|Overall Study|Physician Decision|6|||
144696917|NCT02451137|521741478|FG001|Overall Study|Physician Decision|5|||
144696918|NCT02451137|521741477|FG000|Overall Study|Sponsor decision|13|||
144696919|NCT02451137|521741478|FG001|Overall Study|Sponsor decision|25|||
144696920|NCT02451137|521741477|FG000|Overall Study|Withdrawal by Subject|40|||
144696921|NCT02451137|521741478|FG001|Overall Study|Withdrawal by Subject|63|||
144696922|NCT02451137|521741477|FG000|Overall Study|Other than specified above|2|||
144696923|NCT02451137|521741478|FG001|Overall Study|Other than specified above|3|||
144696924|NCT01977573|521741479|FG000|Overall Study|Adverse Event|7|||
144696925|NCT01977573|521741480|FG001|Overall Study|Adverse Event|0|||
144696926|NCT01977573|521741481|FG002|Overall Study|Adverse Event|2|||
144696927|NCT01977573|521741482|FG003|Overall Study|Adverse Event|1|||
144696928|NCT01977573|521741479|FG000|Overall Study|Lost to Follow-up|1|||
144696929|NCT01977573|521741480|FG001|Overall Study|Lost to Follow-up|0|||
144696930|NCT01977573|521741481|FG002|Overall Study|Lost to Follow-up|0|||
144696931|NCT01977573|521741482|FG003|Overall Study|Lost to Follow-up|1|||
144696932|NCT01977573|521741479|FG000|Overall Study|Physician Decision|1|||
144696933|NCT01977573|521741480|FG001|Overall Study|Physician Decision|0|||
144696934|NCT01977573|521741481|FG002|Overall Study|Physician Decision|0|||
144696935|NCT01977573|521741482|FG003|Overall Study|Physician Decision|0|||
144696936|NCT01977573|521741479|FG000|Overall Study|Protocol Violation|3|||
144696937|NCT01977573|521741480|FG001|Overall Study|Protocol Violation|1|||
144696938|NCT01977573|521741481|FG002|Overall Study|Protocol Violation|0|||
144696939|NCT01977573|521741482|FG003|Overall Study|Protocol Violation|0|||
144696940|NCT01977573|521741479|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
144696941|NCT01977573|521741480|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
144696942|NCT01977573|521741481|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
144696943|NCT01977573|521741482|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
144696944|NCT01977573|521741479|FG000|Overall Study|Withdrawal by Subject|6|||
144696945|NCT01977573|521741480|FG001|Overall Study|Withdrawal by Subject|1|||
144696946|NCT01977573|521741481|FG002|Overall Study|Withdrawal by Subject|1|||
144696947|NCT01977573|521741482|FG003|Overall Study|Withdrawal by Subject|1|||
144696948|NCT00198107|521742772|FG000|Double-Blind Period|Adverse Event|1|||
144696949|NCT00198107|521742773|FG001|Double-Blind Period|Adverse Event|1|||
144696950|NCT00198107|521742774|FG002|Double-Blind Period|Adverse Event|0|||
144696951|NCT00198107|521742772|FG000|Double-Blind Period|Lack of Efficacy|2|||
144696952|NCT00198107|521742773|FG001|Double-Blind Period|Lack of Efficacy|0|||
144696953|NCT00198107|521742774|FG002|Double-Blind Period|Lack of Efficacy|0|||
144696954|NCT00198107|521742772|FG000|Double-Blind Period|Lost to Follow-up|2|||
144696955|NCT00198107|521742773|FG001|Double-Blind Period|Lost to Follow-up|1|||
144696956|NCT00198107|521742774|FG002|Double-Blind Period|Lost to Follow-up|0|||
144696957|NCT00198107|521742772|FG000|Double-Blind Period|Physician Decision|1|||
144696958|NCT00198107|521742773|FG001|Double-Blind Period|Physician Decision|0|||
144696959|NCT00198107|521742774|FG002|Double-Blind Period|Physician Decision|0|||
144696960|NCT00198107|521742772|FG000|Double-Blind Period|Withdrawal by Subject|0|||
144696961|NCT00198107|521742773|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144696962|NCT00198107|521742774|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144696963|NCT00198107|521742772|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
144696964|NCT00198107|521742773|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
144696965|NCT00198107|521742774|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
144696966|NCT02513732|521742775|FG000|Overall Study|Lost to Follow-up|11|||
144696967|NCT02513732|521742775|FG000|Overall Study|Death|9|||
144696968|NCT02513732|521742775|FG000|Overall Study|Changing hospital|2|||
144696969|NCT00934661|521742776|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
144696970|NCT00934661|521742777|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
144696971|NCT03472586|521742783|FG000|Overall Study|Physician Decision|6|||
144696972|NCT03472586|521742783|FG000|Overall Study|Death|6|||
144696973|NCT03472586|521742783|FG000|Overall Study|Adverse Event|1|||
144696974|NCT02706327|521742785|FG000|Overall Study|Lost to Follow-up|1|||
144696975|NCT02706327|521742786|FG001|Overall Study|Lost to Follow-up|1|||
144696976|NCT02706327|521742787|FG002|Overall Study|Lost to Follow-up|2|||
144696977|NCT02652793|521742790|FG000|Overall Study|Adverse Event|1|||
144696978|NCT02652793|521742790|FG000|Overall Study|Lost to Follow-up|2|||
144696979|NCT02652793|521742790|FG000|Overall Study|Withdrawal by Subject|1|||
144696980|NCT03868410|521742793|FG000|Overall Study|Physician Decision|0|||
144696981|NCT03868410|521742794|FG001|Overall Study|Physician Decision|1|||
144696982|NCT01059175|521742795|FG000|Overall Study|Death|17|||
144696983|NCT01059175|521742796|FG001|Overall Study|Death|17|||
144696984|NCT01059175|521742795|FG000|Overall Study|Adverse Event|4|||
144696985|NCT01059175|521742796|FG001|Overall Study|Adverse Event|2|||
144696986|NCT01059175|521742795|FG000|Overall Study|Lost to Follow-up|0|||
144696987|NCT01059175|521742796|FG001|Overall Study|Lost to Follow-up|1|||
144696988|NCT02957149|521742797|FG000|Overall Study|Withdrawal by Subject|5|||
144696989|NCT03471507|521742800|FG000|Overall Study|Lost to Follow-up|1|||
144696990|NCT03471507|521742801|FG001|Overall Study|Lost to Follow-up|3|||
144696991|NCT03471507|521742800|FG000|Overall Study|Physician Decision|0|||
144696992|NCT03471507|521742801|FG001|Overall Study|Physician Decision|1|||
144696993|NCT03471507|521742800|FG000|Overall Study|Withdrawal by Subject|2|||
144696994|NCT03471507|521742801|FG001|Overall Study|Withdrawal by Subject|1|||
144696995|NCT03417245|521742803|FG000|Overall Study|Adverse Event|1|||
144696996|NCT03417245|521742804|FG001|Overall Study|Adverse Event|0|||
144696997|NCT03417245|521742803|FG000|Overall Study|Protocol Violation|1|||
144696998|NCT03417245|521742804|FG001|Overall Study|Protocol Violation|0|||
144696999|NCT03417245|521742803|FG000|Overall Study|Withdrawal by Subject|1|||
144697000|NCT03417245|521742804|FG001|Overall Study|Withdrawal by Subject|1|||
144697001|NCT00761735|521742809|FG000|Overall Study|Lost to Follow-up|6|||
144697002|NCT00761735|521742809|FG000|Overall Study|Withdrawal by Subject|6|||
144697003|NCT00761735|521742809|FG000|Overall Study|Non-compliance with protocol|1|||
144697004|NCT00761735|521742809|FG000|Overall Study|Administrative|1|||
144697005|NCT03290131|521742810|FG000|Overall Study|Adverse Event|22|||
144697006|NCT03290131|521742811|FG001|Overall Study|Adverse Event|57|||
144697007|NCT03290131|521742812|FG002|Overall Study|Adverse Event|11|||
144697008|NCT03290131|521742810|FG000|Overall Study|Withdrawal by Subject|18|||
144697009|NCT03290131|521742811|FG001|Overall Study|Withdrawal by Subject|13|||
144697010|NCT03290131|521742812|FG002|Overall Study|Withdrawal by Subject|8|||
144697011|NCT03290131|521742810|FG000|Overall Study|MS Relapse|2|||
144697012|NCT03290131|521742811|FG001|Overall Study|MS Relapse|1|||
144697013|NCT03290131|521742812|FG002|Overall Study|MS Relapse|0|||
144697014|NCT03290131|521742810|FG000|Overall Study|Unknown reason|0|||
144697015|NCT03290131|521742811|FG001|Overall Study|Unknown reason|1|||
144697016|NCT03290131|521742812|FG002|Overall Study|Unknown reason|0|||
144697017|NCT00933543|521742814|FG000|Overall Study|Adverse Event|2|||
144697018|NCT00933543|521742815|FG001|Overall Study|Adverse Event|1|||
144697019|NCT00933543|521742814|FG000|Overall Study|Lost to Follow-up|0|||
144697020|NCT00933543|521742815|FG001|Overall Study|Lost to Follow-up|1|||
144697021|NCT00933543|521742814|FG000|Overall Study|Withdrawal by Subject|0|||
144697022|NCT00933543|521742815|FG001|Overall Study|Withdrawal by Subject|1|||
144697023|NCT00933543|521742814|FG000|Overall Study|Lack of Efficacy|0|||
144697024|NCT00933543|521742815|FG001|Overall Study|Lack of Efficacy|3|||
144697025|NCT00933543|521742814|FG000|Overall Study|Other|1|||
144697026|NCT00933543|521742815|FG001|Overall Study|Other|1|||
144697027|NCT04629534|521742818|FG000|Overall Study|Physician Decision|1|||
144697028|NCT04629534|521742819|FG001|Overall Study|Physician Decision|0|||
144697029|NCT04629534|521742818|FG000|Overall Study|Protocol Violation|0|||
144266764|NCT00557466|520179729|FG005|Overall Study|Lost to Follow-up|0|||
144697030|NCT04629534|521742819|FG001|Overall Study|Protocol Violation|2|||
144697031|NCT01049360|521742822|FG000|Period 1|Adverse Event|0|||
144697032|NCT01049360|521742823|FG001|Period 1|Adverse Event|1|||
144697033|NCT01049360|521742824|FG002|Period 1|Adverse Event|0|||
144697034|NCT01049360|521742825|FG003|Period 1|Adverse Event|1|||
144697035|NCT01049360|521742826|FG004|Period 1|Adverse Event|0|||
144697036|NCT01049360|521742827|FG005|Period 1|Adverse Event|0|||
144697037|NCT01049360|521742828|FG006|Period 1|Adverse Event|0|||
144697038|NCT01049360|521742829|FG007|Period 1|Adverse Event|1|||
144697039|NCT01049360|521742830|FG008|Period 1|Adverse Event|0|||
144697040|NCT01049360|521742831|FG009|Period 1|Adverse Event|0|||
144697041|NCT01049360|521742832|FG010|Period 1|Adverse Event|0|||
144697042|NCT01049360|521742833|FG011|Period 1|Adverse Event|0|||
144697043|NCT01049360|521742834|FG012|Period 1|Adverse Event|1|||
144697044|NCT01049360|521742835|FG013|Period 1|Adverse Event|1|||
144697045|NCT01049360|521742836|FG014|Period 1|Adverse Event|0|||
144697046|NCT01049360|521742837|FG015|Period 1|Adverse Event|0|||
144697047|NCT01049360|521742838|FG016|Period 1|Adverse Event|1|||
144697048|NCT01049360|521742839|FG017|Period 1|Adverse Event|0|||
144697049|NCT01049360|521742840|FG018|Period 1|Adverse Event|1|||
144697050|NCT01049360|521742841|FG019|Period 1|Adverse Event|0|||
144697051|NCT01049360|521742822|FG000|Period 1|Did not meet inc/exc criteria|0|||
144697052|NCT01049360|521742823|FG001|Period 1|Did not meet inc/exc criteria|0|||
144697053|NCT01049360|521742824|FG002|Period 1|Did not meet inc/exc criteria|0|||
144697054|NCT01049360|521742825|FG003|Period 1|Did not meet inc/exc criteria|0|||
144697055|NCT01049360|521742826|FG004|Period 1|Did not meet inc/exc criteria|0|||
144697056|NCT01049360|521742827|FG005|Period 1|Did not meet inc/exc criteria|0|||
144697057|NCT01049360|521742828|FG006|Period 1|Did not meet inc/exc criteria|0|||
144697058|NCT01049360|521742829|FG007|Period 1|Did not meet inc/exc criteria|1|||
144697059|NCT01049360|521742830|FG008|Period 1|Did not meet inc/exc criteria|1|||
144697060|NCT01049360|521742831|FG009|Period 1|Did not meet inc/exc criteria|0|||
144697061|NCT01049360|521742832|FG010|Period 1|Did not meet inc/exc criteria|0|||
144697062|NCT01049360|521742833|FG011|Period 1|Did not meet inc/exc criteria|0|||
144697063|NCT01049360|521742834|FG012|Period 1|Did not meet inc/exc criteria|0|||
144697064|NCT01049360|521742835|FG013|Period 1|Did not meet inc/exc criteria|0|||
144697065|NCT01049360|521742836|FG014|Period 1|Did not meet inc/exc criteria|0|||
144697066|NCT01049360|521742837|FG015|Period 1|Did not meet inc/exc criteria|0|||
144697067|NCT01049360|521742838|FG016|Period 1|Did not meet inc/exc criteria|0|||
144697068|NCT01049360|521742839|FG017|Period 1|Did not meet inc/exc criteria|0|||
144697069|NCT01049360|521742840|FG018|Period 1|Did not meet inc/exc criteria|0|||
144697070|NCT01049360|521742841|FG019|Period 1|Did not meet inc/exc criteria|0|||
144697071|NCT01049360|521742822|FG000|Period 1|Withdrawal by Subject|0|||
144697072|NCT01049360|521742823|FG001|Period 1|Withdrawal by Subject|0|||
144697073|NCT01049360|521742824|FG002|Period 1|Withdrawal by Subject|0|||
144697074|NCT01049360|521742825|FG003|Period 1|Withdrawal by Subject|0|||
144697075|NCT01049360|521742826|FG004|Period 1|Withdrawal by Subject|0|||
144697076|NCT01049360|521742827|FG005|Period 1|Withdrawal by Subject|0|||
144697077|NCT01049360|521742828|FG006|Period 1|Withdrawal by Subject|0|||
144697078|NCT01049360|521742829|FG007|Period 1|Withdrawal by Subject|0|||
144222875|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
144697079|NCT01049360|521742830|FG008|Period 1|Withdrawal by Subject|1|||
144697080|NCT01049360|521742831|FG009|Period 1|Withdrawal by Subject|0|||
144697081|NCT01049360|521742832|FG010|Period 1|Withdrawal by Subject|1|||
144222876|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
144697082|NCT01049360|521742833|FG011|Period 1|Withdrawal by Subject|0|||
144697083|NCT01049360|521742834|FG012|Period 1|Withdrawal by Subject|1|||
144697084|NCT01049360|521742835|FG013|Period 1|Withdrawal by Subject|0|||
144697085|NCT01049360|521742836|FG014|Period 1|Withdrawal by Subject|0|||
144697086|NCT01049360|521742837|FG015|Period 1|Withdrawal by Subject|0|||
144697087|NCT01049360|521742838|FG016|Period 1|Withdrawal by Subject|0|||
144697088|NCT01049360|521742839|FG017|Period 1|Withdrawal by Subject|0|||
144697089|NCT01049360|521742840|FG018|Period 1|Withdrawal by Subject|0|||
144697090|NCT01049360|521742841|FG019|Period 1|Withdrawal by Subject|0|||
144697091|NCT01049360|521742822|FG000|Period 2|Protocol Violation|0|||
144697092|NCT01049360|521742823|FG001|Period 2|Protocol Violation|0|||
144697093|NCT01049360|521742824|FG002|Period 2|Protocol Violation|0|||
144697094|NCT01049360|521742825|FG003|Period 2|Protocol Violation|1|||
144697095|NCT01049360|521742826|FG004|Period 2|Protocol Violation|0|||
144697096|NCT01049360|521742827|FG005|Period 2|Protocol Violation|0|||
144697097|NCT01049360|521742828|FG006|Period 2|Protocol Violation|0|||
144697098|NCT01049360|521742829|FG007|Period 2|Protocol Violation|0|||
144697099|NCT01049360|521742830|FG008|Period 2|Protocol Violation|0|||
144697100|NCT01049360|521742831|FG009|Period 2|Protocol Violation|0|||
144697101|NCT01049360|521742832|FG010|Period 2|Protocol Violation|0|||
144697102|NCT01049360|521742833|FG011|Period 2|Protocol Violation|0|||
144697103|NCT01049360|521742834|FG012|Period 2|Protocol Violation|0|||
144697104|NCT01049360|521742835|FG013|Period 2|Protocol Violation|0|||
144697105|NCT01049360|521742836|FG014|Period 2|Protocol Violation|1|||
144697106|NCT01049360|521742837|FG015|Period 2|Protocol Violation|1|||
144697107|NCT01049360|521742838|FG016|Period 2|Protocol Violation|0|||
144697108|NCT01049360|521742839|FG017|Period 2|Protocol Violation|0|||
144697109|NCT01049360|521742840|FG018|Period 2|Protocol Violation|0|||
144697110|NCT01049360|521742841|FG019|Period 2|Protocol Violation|0|||
144697111|NCT01049360|521742822|FG000|Period 2|Adverse Event|0|||
144697112|NCT01049360|521742823|FG001|Period 2|Adverse Event|1|||
144697113|NCT01049360|521742824|FG002|Period 2|Adverse Event|0|||
144697114|NCT01049360|521742825|FG003|Period 2|Adverse Event|0|||
144697115|NCT01049360|521742826|FG004|Period 2|Adverse Event|0|||
144697116|NCT01049360|521742827|FG005|Period 2|Adverse Event|0|||
144697117|NCT01049360|521742828|FG006|Period 2|Adverse Event|0|||
144697118|NCT01049360|521742829|FG007|Period 2|Adverse Event|0|||
144697119|NCT01049360|521742830|FG008|Period 2|Adverse Event|1|||
144697120|NCT01049360|521742831|FG009|Period 2|Adverse Event|0|||
144697121|NCT01049360|521742832|FG010|Period 2|Adverse Event|0|||
144697122|NCT01049360|521742833|FG011|Period 2|Adverse Event|0|||
144697123|NCT01049360|521742834|FG012|Period 2|Adverse Event|0|||
144697124|NCT01049360|521742835|FG013|Period 2|Adverse Event|0|||
144697125|NCT01049360|521742836|FG014|Period 2|Adverse Event|0|||
144697126|NCT01049360|521742837|FG015|Period 2|Adverse Event|0|||
144697127|NCT01049360|521742838|FG016|Period 2|Adverse Event|0|||
144697128|NCT01049360|521742839|FG017|Period 2|Adverse Event|0|||
144697129|NCT01049360|521742840|FG018|Period 2|Adverse Event|0|||
144697130|NCT01049360|521742841|FG019|Period 2|Adverse Event|1|||
144697131|NCT01049360|521742822|FG000|Period 2|Withdrawal by Subject|0|||
144697132|NCT01049360|521742823|FG001|Period 2|Withdrawal by Subject|0|||
144697133|NCT01049360|521742824|FG002|Period 2|Withdrawal by Subject|0|||
144697134|NCT01049360|521742825|FG003|Period 2|Withdrawal by Subject|1|||
144697135|NCT01049360|521742826|FG004|Period 2|Withdrawal by Subject|0|||
144697136|NCT01049360|521742827|FG005|Period 2|Withdrawal by Subject|0|||
144697137|NCT01049360|521742828|FG006|Period 2|Withdrawal by Subject|0|||
144697138|NCT01049360|521742829|FG007|Period 2|Withdrawal by Subject|0|||
144697139|NCT01049360|521742830|FG008|Period 2|Withdrawal by Subject|0|||
144697140|NCT01049360|521742831|FG009|Period 2|Withdrawal by Subject|0|||
144697141|NCT01049360|521742832|FG010|Period 2|Withdrawal by Subject|0|||
144697142|NCT01049360|521742833|FG011|Period 2|Withdrawal by Subject|0|||
144697143|NCT01049360|521742834|FG012|Period 2|Withdrawal by Subject|0|||
144697144|NCT01049360|521742835|FG013|Period 2|Withdrawal by Subject|0|||
144697145|NCT01049360|521742836|FG014|Period 2|Withdrawal by Subject|1|||
144697146|NCT01049360|521742837|FG015|Period 2|Withdrawal by Subject|0|||
144697147|NCT01049360|521742838|FG016|Period 2|Withdrawal by Subject|0|||
144697148|NCT01049360|521742839|FG017|Period 2|Withdrawal by Subject|0|||
144697149|NCT01049360|521742840|FG018|Period 2|Withdrawal by Subject|0|||
144697150|NCT01049360|521742841|FG019|Period 2|Withdrawal by Subject|1|||
144697151|NCT01049360|521742822|FG000|Period 2|Lack of Efficacy|0|||
144697152|NCT01049360|521742823|FG001|Period 2|Lack of Efficacy|0|||
144697153|NCT01049360|521742824|FG002|Period 2|Lack of Efficacy|0|||
144697154|NCT01049360|521742825|FG003|Period 2|Lack of Efficacy|0|||
144697155|NCT01049360|521742826|FG004|Period 2|Lack of Efficacy|0|||
144697156|NCT01049360|521742827|FG005|Period 2|Lack of Efficacy|1|||
144697157|NCT01049360|521742828|FG006|Period 2|Lack of Efficacy|0|||
144697158|NCT01049360|521742829|FG007|Period 2|Lack of Efficacy|0|||
144697159|NCT01049360|521742830|FG008|Period 2|Lack of Efficacy|0|||
144697160|NCT01049360|521742831|FG009|Period 2|Lack of Efficacy|0|||
144697161|NCT01049360|521742832|FG010|Period 2|Lack of Efficacy|0|||
144697162|NCT01049360|521742833|FG011|Period 2|Lack of Efficacy|0|||
144697163|NCT01049360|521742834|FG012|Period 2|Lack of Efficacy|0|||
144697164|NCT01049360|521742835|FG013|Period 2|Lack of Efficacy|0|||
144697165|NCT01049360|521742836|FG014|Period 2|Lack of Efficacy|0|||
144697166|NCT01049360|521742837|FG015|Period 2|Lack of Efficacy|0|||
144697167|NCT01049360|521742838|FG016|Period 2|Lack of Efficacy|0|||
144697168|NCT01049360|521742839|FG017|Period 2|Lack of Efficacy|0|||
144697169|NCT01049360|521742840|FG018|Period 2|Lack of Efficacy|0|||
144697170|NCT01049360|521742841|FG019|Period 2|Lack of Efficacy|0|||
144697171|NCT01049360|521742822|FG000|Period 4|Protocol Violation|0|||
144697172|NCT01049360|521742823|FG001|Period 4|Protocol Violation|0|||
144697173|NCT01049360|521742824|FG002|Period 4|Protocol Violation|0|||
144697174|NCT01049360|521742825|FG003|Period 4|Protocol Violation|0|||
144697175|NCT01049360|521742826|FG004|Period 4|Protocol Violation|0|||
144697176|NCT01049360|521742827|FG005|Period 4|Protocol Violation|0|||
144697177|NCT01049360|521742828|FG006|Period 4|Protocol Violation|0|||
144697178|NCT01049360|521742829|FG007|Period 4|Protocol Violation|0|||
144697179|NCT01049360|521742830|FG008|Period 4|Protocol Violation|0|||
144697180|NCT01049360|521742831|FG009|Period 4|Protocol Violation|0|||
144697181|NCT01049360|521742832|FG010|Period 4|Protocol Violation|0|||
144697182|NCT01049360|521742833|FG011|Period 4|Protocol Violation|0|||
144697183|NCT01049360|521742834|FG012|Period 4|Protocol Violation|0|||
144697184|NCT01049360|521742835|FG013|Period 4|Protocol Violation|0|||
144697185|NCT01049360|521742836|FG014|Period 4|Protocol Violation|0|||
144697186|NCT01049360|521742837|FG015|Period 4|Protocol Violation|0|||
144697187|NCT01049360|521742838|FG016|Period 4|Protocol Violation|0|||
144697188|NCT01049360|521742839|FG017|Period 4|Protocol Violation|1|||
144697189|NCT01049360|521742840|FG018|Period 4|Protocol Violation|0|||
144697190|NCT01049360|521742841|FG019|Period 4|Protocol Violation|0|||
144697191|NCT01049360|521742822|FG000|Period 4|Withdrawal by Subject|0|||
144697192|NCT01049360|521742823|FG001|Period 4|Withdrawal by Subject|0|||
144697193|NCT01049360|521742824|FG002|Period 4|Withdrawal by Subject|0|||
144697194|NCT01049360|521742825|FG003|Period 4|Withdrawal by Subject|1|||
144697195|NCT01049360|521742826|FG004|Period 4|Withdrawal by Subject|0|||
144697196|NCT01049360|521742827|FG005|Period 4|Withdrawal by Subject|0|||
144697197|NCT01049360|521742828|FG006|Period 4|Withdrawal by Subject|0|||
144697198|NCT01049360|521742829|FG007|Period 4|Withdrawal by Subject|0|||
144697199|NCT01049360|521742830|FG008|Period 4|Withdrawal by Subject|0|||
144697200|NCT01049360|521742831|FG009|Period 4|Withdrawal by Subject|0|||
144697201|NCT01049360|521742832|FG010|Period 4|Withdrawal by Subject|0|||
144697202|NCT01049360|521742833|FG011|Period 4|Withdrawal by Subject|0|||
144697203|NCT01049360|521742834|FG012|Period 4|Withdrawal by Subject|0|||
144697204|NCT01049360|521742835|FG013|Period 4|Withdrawal by Subject|0|||
144697205|NCT01049360|521742836|FG014|Period 4|Withdrawal by Subject|0|||
144697206|NCT01049360|521742837|FG015|Period 4|Withdrawal by Subject|0|||
144697207|NCT01049360|521742838|FG016|Period 4|Withdrawal by Subject|0|||
144697208|NCT01049360|521742839|FG017|Period 4|Withdrawal by Subject|0|||
144697209|NCT01049360|521742840|FG018|Period 4|Withdrawal by Subject|0|||
144697210|NCT01049360|521742841|FG019|Period 4|Withdrawal by Subject|0|||
144697211|NCT00429026|521742842|FG000|Overall Study|Inevaluable for response.|40|||
144697212|NCT01012765|521742843|FG000|Treatment Period 1|Adverse Event|1|||
144697213|NCT01012765|521742844|FG001|Treatment Period 1|Adverse Event|0|||
144697214|NCT01012765|521742845|FG002|Treatment Period 1|Adverse Event|1|||
144697215|NCT01012765|521742846|FG003|Treatment Period 1|Adverse Event|0|||
144697216|NCT01012765|521742847|FG004|Treatment Period 1|Adverse Event|0|||
144697217|NCT01012765|521742848|FG005|Treatment Period 1|Adverse Event|0|||
144697218|NCT01012765|521742843|FG000|Treatment Period 1|Withdrawal by Subject|2|||
144697219|NCT01012765|521742844|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144697220|NCT01012765|521742845|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144697221|NCT01012765|521742846|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144697222|NCT01012765|521742847|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144697223|NCT01012765|521742848|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144697224|NCT01012765|521742843|FG000|Treatment Period 1|Administrative problems|0|||
144697225|NCT01012765|521742844|FG001|Treatment Period 1|Administrative problems|0|||
144697226|NCT01012765|521742845|FG002|Treatment Period 1|Administrative problems|1|||
144697227|NCT01012765|521742846|FG003|Treatment Period 1|Administrative problems|1|||
144697228|NCT01012765|521742847|FG004|Treatment Period 1|Administrative problems|1|||
144697229|NCT01012765|521742848|FG005|Treatment Period 1|Administrative problems|0|||
144697230|NCT01012765|521742843|FG000|Treatment Period 1|Protocol Violation|0|||
144697231|NCT01012765|521742844|FG001|Treatment Period 1|Protocol Violation|0|||
144697232|NCT01012765|521742845|FG002|Treatment Period 1|Protocol Violation|0|||
144697233|NCT01012765|521742846|FG003|Treatment Period 1|Protocol Violation|2|||
144697234|NCT01012765|521742847|FG004|Treatment Period 1|Protocol Violation|1|||
144697235|NCT01012765|521742848|FG005|Treatment Period 1|Protocol Violation|0|||
144697236|NCT01012765|521742843|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
144697237|NCT01012765|521742844|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
144697238|NCT01012765|521742845|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
144697239|NCT01012765|521742846|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
144697240|NCT01012765|521742847|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
144697241|NCT01012765|521742848|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
144697242|NCT01012765|521742843|FG000|Treatment Period 2|Withdrawal by Subject|1|||
144697243|NCT01012765|521742844|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144697244|NCT01012765|521742845|FG002|Treatment Period 2|Withdrawal by Subject|1|||
144697245|NCT01012765|521742846|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144697246|NCT01012765|521742847|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144697247|NCT01012765|521742848|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144697248|NCT01012765|521742843|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
144697249|NCT01012765|521742844|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
144697250|NCT01012765|521742845|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
144697251|NCT01012765|521742846|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
144697252|NCT01012765|521742847|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
144697253|NCT01012765|521742848|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
144697254|NCT01012765|521742843|FG000|Treatment Period 2|Adverse Event|0|||
144697255|NCT01012765|521742844|FG001|Treatment Period 2|Adverse Event|1|||
144697256|NCT01012765|521742845|FG002|Treatment Period 2|Adverse Event|1|||
144697257|NCT01012765|521742846|FG003|Treatment Period 2|Adverse Event|0|||
144697258|NCT01012765|521742847|FG004|Treatment Period 2|Adverse Event|0|||
144697259|NCT01012765|521742848|FG005|Treatment Period 2|Adverse Event|0|||
144697260|NCT01012765|521742843|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
144697261|NCT01012765|521742844|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
144697262|NCT01012765|521742845|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
144697263|NCT01012765|521742846|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
144697264|NCT01012765|521742847|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
144697265|NCT01012765|521742848|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
144697266|NCT00499694|521742857|FG000|Overall Study|Patient never received treatment.|1|||
144697267|NCT03457701|521742858|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
144697268|NCT03457701|521742859|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
144697269|NCT03457701|521742858|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
144697270|NCT03457701|521742859|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
144697271|NCT02370173|521742864|FG000|Overall Study|Protocol Violation|1|||
144697272|NCT02370173|521742865|FG001|Overall Study|Protocol Violation|1|||
144697273|NCT02370173|521742864|FG000|Overall Study|Withdrawal by Subject|2|||
144697274|NCT02370173|521742865|FG001|Overall Study|Withdrawal by Subject|2|||
144697275|NCT04034225|521742866|FG000|Overall Study|Death|3|||
144697276|NCT04034225|521742866|FG000|Overall Study|Withdrawal by Subject|2|||
144697277|NCT04034225|521742866|FG000|Overall Study|Study termination by Sponsor|18|||
144697278|NCT04034225|521742866|FG000|Overall Study|Physician Decision|1|||
144697279|NCT04034225|521742866|FG000|Overall Study|Lack of Efficacy|1|||
144697280|NCT00307736|521742870|FG000|Overall Study|Adverse Event|0|||
144697281|NCT00307736|521742871|FG001|Overall Study|Adverse Event|0|||
144697282|NCT00307736|521742872|FG002|Overall Study|Adverse Event|1|||
144697283|NCT00307736|521742873|FG003|Overall Study|Adverse Event|3|||
144697284|NCT00307736|521742870|FG000|Overall Study|Withdrawal by Subject|0|||
144697285|NCT00307736|521742871|FG001|Overall Study|Withdrawal by Subject|0|||
144697286|NCT00307736|521742872|FG002|Overall Study|Withdrawal by Subject|2|||
144697287|NCT00307736|521742873|FG003|Overall Study|Withdrawal by Subject|0|||
144697288|NCT01365182|521742875|FG000|Overall Study|Withdrawal by Subject|10|||
144697289|NCT01365182|521742876|FG001|Overall Study|Withdrawal by Subject|13|||
144697290|NCT01365182|521742877|FG002|Overall Study|Withdrawal by Subject|12|||
144697291|NCT00736840|521742878|FG000|Overall Study|Lost to Follow-up|13|||
144697292|NCT01411917|521742879|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
144697293|NCT01411917|521742880|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
144697294|NCT01728194|521742887|FG000|Overall Study|Lost to Follow-up|4|||
144697295|NCT01728194|521742888|FG001|Overall Study|Lost to Follow-up|3|||
144697296|NCT01728194|521742887|FG000|Overall Study|Physician Decision|4|||
144697297|NCT01728194|521742888|FG001|Overall Study|Physician Decision|0|||
144697298|NCT01728194|521742887|FG000|Overall Study|Withdrawal by Subject|7|||
144697299|NCT01728194|521742888|FG001|Overall Study|Withdrawal by Subject|3|||
144697300|NCT01728194|521742887|FG000|Overall Study|Perceived Medication Side Effects|4|||
144697301|NCT01728194|521742888|FG001|Overall Study|Perceived Medication Side Effects|0|||
144697302|NCT01728194|521742887|FG000|Overall Study|Family Member Request|1|||
144697303|NCT01728194|521742888|FG001|Overall Study|Family Member Request|0|||
144697304|NCT02309372|521742889|FG000|Overall Study|Lost to Follow-up|3|||
144697305|NCT02309372|521742890|FG001|Overall Study|Lost to Follow-up|2|||
144697306|NCT00242658|521742892|FG000|Overall Study|Lost to Follow-up|22|||
144697307|NCT00242658|521742893|FG001|Overall Study|Lost to Follow-up|19|||
144697308|NCT02811640|521742895|FG000|Overall Study|Technology malfunction|2|||
144697309|NCT00553319|521742899|FG000|Overall Study|Lost to Follow-up|10|||
144697310|NCT00553319|521742900|FG001|Overall Study|Lost to Follow-up|9|||
144697311|NCT00553319|521742901|FG002|Overall Study|Lost to Follow-up|5|||
144697312|NCT00553319|521742899|FG000|Overall Study|wanted treatment elsewhere|2|||
144697313|NCT00553319|521742900|FG001|Overall Study|wanted treatment elsewhere|1|||
144697314|NCT00553319|521742901|FG002|Overall Study|wanted treatment elsewhere|1|||
144697315|NCT00553319|521742899|FG000|Overall Study|non-compliance|0|||
144697316|NCT00553319|521742900|FG001|Overall Study|non-compliance|0|||
144697317|NCT00553319|521742901|FG002|Overall Study|non-compliance|2|||
144697318|NCT00553319|521742899|FG000|Overall Study|incarceration|1|||
144697319|NCT00553319|521742900|FG001|Overall Study|incarceration|0|||
144697320|NCT00553319|521742901|FG002|Overall Study|incarceration|0|||
144697321|NCT00553319|521742899|FG000|Overall Study|moved|1|||
144697322|NCT00553319|521742900|FG001|Overall Study|moved|0|||
144697323|NCT00553319|521742901|FG002|Overall Study|moved|1|||
144697324|NCT01731600|521742907|FG000|Overall Study|Adverse Event|2|||
144697325|NCT01731600|521742908|FG001|Overall Study|Adverse Event|0|||
144697326|NCT01731600|521742907|FG000|Overall Study|Withdrawal criteria|1|||
144697327|NCT01731600|521742908|FG001|Overall Study|Withdrawal criteria|0|||
144697328|NCT01731600|521742907|FG000|Overall Study|Other reasons|3|||
144697329|NCT01731600|521742908|FG001|Overall Study|Other reasons|0|||
144697330|NCT03575975|521742909|FG000|Overall Study|Lost to Follow-up|1|||
144697331|NCT03575975|521742910|FG001|Overall Study|Lost to Follow-up|0|||
144697332|NCT03575975|521742911|FG002|Overall Study|Lost to Follow-up|0|||
144697333|NCT00129220|521742914|FG000|Study Period II|Adverse Event|9|||
144697334|NCT00129220|521742915|FG001|Study Period II|Adverse Event|5|||
144697335|NCT00129220|521742916|FG002|Study Period II|Adverse Event|7|||
144697336|NCT00129220|521742914|FG000|Study Period II|Lack of Efficacy|15|||
144697337|NCT00129220|521742915|FG001|Study Period II|Lack of Efficacy|1|||
144697338|NCT00129220|521742916|FG002|Study Period II|Lack of Efficacy|28|||
144697339|NCT00129220|521742914|FG000|Study Period II|Entry Criteria Not Met|2|||
144697340|NCT00129220|521742915|FG001|Study Period II|Entry Criteria Not Met|0|||
144697341|NCT00129220|521742916|FG002|Study Period II|Entry Criteria Not Met|2|||
144697342|NCT00129220|521742914|FG000|Study Period II|Protocol Violation|4|||
144697343|NCT00129220|521742915|FG001|Study Period II|Protocol Violation|2|||
144697344|NCT00129220|521742916|FG002|Study Period II|Protocol Violation|1|||
144697345|NCT00129220|521742914|FG000|Study Period II|Physician Decision|0|||
144697346|NCT00129220|521742915|FG001|Study Period II|Physician Decision|1|||
144697347|NCT00129220|521742916|FG002|Study Period II|Physician Decision|0|||
144697348|NCT00129220|521742914|FG000|Study Period II|Withdrawal by Subject|1|||
144697349|NCT00129220|521742915|FG001|Study Period II|Withdrawal by Subject|3|||
144697350|NCT00129220|521742916|FG002|Study Period II|Withdrawal by Subject|4|||
144697351|NCT00129220|521742914|FG000|Study Period II|Reason Not Specified|2|||
144697352|NCT00129220|521742915|FG001|Study Period II|Reason Not Specified|0|||
144697353|NCT00129220|521742916|FG002|Study Period II|Reason Not Specified|5|||
144697354|NCT00129220|521742914|FG000|Study Period III|Adverse Event|1|||
144697355|NCT00129220|521742915|FG001|Study Period III|Adverse Event|0|||
144697356|NCT00129220|521742916|FG002|Study Period III|Adverse Event|3|||
144697357|NCT00129220|521742914|FG000|Study Period III|Protocol Violation|1|||
144697358|NCT00129220|521742915|FG001|Study Period III|Protocol Violation|1|||
144697359|NCT00129220|521742916|FG002|Study Period III|Protocol Violation|2|||
144697360|NCT00129220|521742914|FG000|Study Period III|Withdrawal by Subject|1|||
144697361|NCT00129220|521742915|FG001|Study Period III|Withdrawal by Subject|0|||
144697362|NCT00129220|521742916|FG002|Study Period III|Withdrawal by Subject|3|||
144697363|NCT00129220|521742914|FG000|Study Period III|Sponsor Decision|1|||
144697364|NCT00129220|521742915|FG001|Study Period III|Sponsor Decision|0|||
144697365|NCT00129220|521742916|FG002|Study Period III|Sponsor Decision|0|||
144697366|NCT00129220|521742914|FG000|Study Period III|Reason Not Specified|9|||
144697367|NCT00129220|521742915|FG001|Study Period III|Reason Not Specified|0|||
144697368|NCT00129220|521742916|FG002|Study Period III|Reason Not Specified|2|||
144697369|NCT01883362|521742917|FG000|Treatment|Adverse Event|1|||
144697370|NCT01883362|521742918|FG001|Treatment|Adverse Event|8|||
144697371|NCT01883362|521742917|FG000|Treatment|Withdrawal by Subject|6|||
144697372|NCT01883362|521742918|FG001|Treatment|Withdrawal by Subject|2|||
144697373|NCT01883362|521742917|FG000|Treatment|Administrative problems|4|||
144697374|NCT01883362|521742918|FG001|Treatment|Administrative problems|1|||
144697375|NCT01883362|521742917|FG000|Treatment|Relapse|4|||
144697376|NCT01883362|521742918|FG001|Treatment|Relapse|2|||
144697377|NCT01883362|521742917|FG000|Treatment|Randomized, not treated|1|||
144697378|NCT01883362|521742918|FG001|Treatment|Randomized, not treated|1|||
144697379|NCT01883362|521742917|FG000|Post Treatment Follow-up|Protocol Violation|0|||
144697380|NCT01883362|521742918|FG001|Post Treatment Follow-up|Protocol Violation|1|||
144697381|NCT01883362|521742917|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
144697382|NCT01883362|521742918|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
144697383|NCT01883362|521742917|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
144697384|NCT01883362|521742918|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
144697385|NCT01883362|521742917|FG000|Post Treatment Follow-up|Administrative problems|2|||
144697386|NCT01883362|521742918|FG001|Post Treatment Follow-up|Administrative problems|0|||
144697387|NCT01883362|521742917|FG000|Post Treatment Follow-up|Death|8|||
144697388|NCT01883362|521742918|FG001|Post Treatment Follow-up|Death|4|||
144697389|NCT01883362|521742917|FG000|Post Treatment Follow-up|Relapse|1|||
144697390|NCT01883362|521742918|FG001|Post Treatment Follow-up|Relapse|2|||
144697391|NCT01230489|521742920|FG000|Overall Study|Death|2|||
144697392|NCT01230489|521742920|FG000|Overall Study|Adverse Event|2|||
144697393|NCT01230489|521742920|FG000|Overall Study|Treatment modality changed|1|||
144697394|NCT03996694|521744392|FG000|First Washout (7 Days)|positive urine drug screen|0|||
144697395|NCT03996694|521744393|FG001|First Washout (7 Days)|positive urine drug screen|0|||
144697396|NCT03996694|521744394|FG002|First Washout (7 Days)|positive urine drug screen|1|||
144697397|NCT03996694|521744395|FG003|First Washout (7 Days)|positive urine drug screen|0|||
144697398|NCT03996694|521744396|FG004|First Washout (7 Days)|positive urine drug screen|0|||
144697399|NCT03996694|521744397|FG005|First Washout (7 Days)|positive urine drug screen|0|||
144697400|NCT03996694|521744392|FG000|First Washout (7 Days)|Adverse Event|0|||
144697401|NCT03996694|521744393|FG001|First Washout (7 Days)|Adverse Event|1|||
144697402|NCT03996694|521744394|FG002|First Washout (7 Days)|Adverse Event|0|||
144697403|NCT03996694|521744395|FG003|First Washout (7 Days)|Adverse Event|0|||
144697404|NCT03996694|521744396|FG004|First Washout (7 Days)|Adverse Event|0|||
144697405|NCT03996694|521744397|FG005|First Washout (7 Days)|Adverse Event|0|||
144697406|NCT03996694|521744392|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
144697407|NCT03996694|521744393|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
144697408|NCT03996694|521744394|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
144697409|NCT03996694|521744395|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
144697410|NCT03996694|521744396|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
144697411|NCT03996694|521744397|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
144697412|NCT03996694|521744392|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
144697413|NCT03996694|521744393|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
144697414|NCT03996694|521744394|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
144697415|NCT03996694|521744395|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
144697416|NCT03996694|521744396|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
144697417|NCT03996694|521744397|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
144697418|NCT00656669|521744404|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
144697419|NCT00656669|521744404|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
144697420|NCT00656669|521744404|FG000|AC (Cycles 6-9)|Adverse Event|1|||
144697421|NCT00656669|521744404|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
144697422|NCT02777554|521744407|FG000|Overall Study|Adverse Event|4|||
144697423|NCT02777554|521744408|FG001|Overall Study|Adverse Event|4|||
144697424|NCT02777554|521744409|FG002|Overall Study|Adverse Event|0|||
144697425|NCT02777554|521744410|FG003|Overall Study|Adverse Event|1|||
144697426|NCT02777554|521744411|FG004|Overall Study|Adverse Event|0|||
144697427|NCT02777554|521744412|FG005|Overall Study|Adverse Event|0|||
144697428|NCT02777554|521744407|FG000|Overall Study|Withdrawal by Subject|3|||
144697429|NCT02777554|521744408|FG001|Overall Study|Withdrawal by Subject|1|||
144697430|NCT02777554|521744409|FG002|Overall Study|Withdrawal by Subject|1|||
144697431|NCT02777554|521744410|FG003|Overall Study|Withdrawal by Subject|0|||
144697432|NCT02777554|521744411|FG004|Overall Study|Withdrawal by Subject|0|||
144697433|NCT02777554|521744412|FG005|Overall Study|Withdrawal by Subject|0|||
144697434|NCT02777554|521744407|FG000|Overall Study|Discharged early due to hurricane|22|||
144697435|NCT02777554|521744408|FG001|Overall Study|Discharged early due to hurricane|20|||
144697436|NCT02777554|521744409|FG002|Overall Study|Discharged early due to hurricane|0|||
144697437|NCT02777554|521744410|FG003|Overall Study|Discharged early due to hurricane|0|||
144697438|NCT02777554|521744411|FG004|Overall Study|Discharged early due to hurricane|0|||
144697439|NCT02777554|521744412|FG005|Overall Study|Discharged early due to hurricane|0|||
144697440|NCT02777554|521744407|FG000|Overall Study|Other - Miscellaneous|1|||
144697441|NCT02777554|521744408|FG001|Overall Study|Other - Miscellaneous|0|||
144697442|NCT02777554|521744409|FG002|Overall Study|Other - Miscellaneous|0|||
144697443|NCT02777554|521744410|FG003|Overall Study|Other - Miscellaneous|0|||
144697444|NCT02777554|521744411|FG004|Overall Study|Other - Miscellaneous|0|||
144697445|NCT02777554|521744412|FG005|Overall Study|Other - Miscellaneous|0|||
144697446|NCT00066573|521744413|FG000|Overall Study|Did not received protocol treatment|28|||
144697447|NCT00066573|521744414|FG001|Overall Study|Did not received protocol treatment|28|||
144697448|NCT02147132|521744415|FG000|Overall Study|Lost to Follow-up|1|||
144697449|NCT02147132|521744416|FG001|Overall Study|Lost to Follow-up|0|||
144697450|NCT02147132|521744417|FG002|Overall Study|Lost to Follow-up|0|||
144697451|NCT02147132|521744418|FG003|Overall Study|Lost to Follow-up|0|||
144697452|NCT01013207|521744419|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
144697453|NCT01541644|521744424|FG000|Overall Study|Withdrawal by Subject|3|||
144697454|NCT01458535|521744427|FG000|Overall Study|Other|0|||
144697455|NCT01458535|521744428|FG001|Overall Study|Other|0|||
144697456|NCT01458535|521744429|FG002|Overall Study|Other|0|||
144697457|NCT01458535|521744430|FG003|Overall Study|Other|0|||
144697458|NCT01458535|521744431|FG004|Overall Study|Other|1|||
144697459|NCT01458535|521744432|FG005|Overall Study|Other|1|||
144697460|NCT01458535|521744427|FG000|Overall Study|Withdrawal by Subject|0|||
144697461|NCT01458535|521744428|FG001|Overall Study|Withdrawal by Subject|0|||
144697462|NCT01458535|521744429|FG002|Overall Study|Withdrawal by Subject|2|||
144697463|NCT01458535|521744430|FG003|Overall Study|Withdrawal by Subject|0|||
144697464|NCT01458535|521744431|FG004|Overall Study|Withdrawal by Subject|1|||
144697465|NCT01458535|521744432|FG005|Overall Study|Withdrawal by Subject|1|||
144697466|NCT01458535|521744427|FG000|Overall Study|Lost to Follow-up|0|||
144697467|NCT01458535|521744428|FG001|Overall Study|Lost to Follow-up|2|||
144697468|NCT01458535|521744429|FG002|Overall Study|Lost to Follow-up|0|||
144697469|NCT01458535|521744430|FG003|Overall Study|Lost to Follow-up|3|||
144697470|NCT01458535|521744431|FG004|Overall Study|Lost to Follow-up|2|||
144697471|NCT01458535|521744432|FG005|Overall Study|Lost to Follow-up|2|||
144697472|NCT01458535|521744427|FG000|Overall Study|Adverse Event|0|||
144697473|NCT01458535|521744428|FG001|Overall Study|Adverse Event|0|||
144697474|NCT01458535|521744429|FG002|Overall Study|Adverse Event|0|||
144697475|NCT01458535|521744430|FG003|Overall Study|Adverse Event|1|||
144697476|NCT01458535|521744431|FG004|Overall Study|Adverse Event|0|||
144266765|NCT01712516|520179730|FG000|Overall Study|Technical problems|0|||
144266766|NCT01712516|520179731|FG001|Overall Study|Technical problems|0|||
144266767|NCT01712516|520179732|FG002|Overall Study|Technical problems|0|||
144266768|NCT01712516|520179733|FG003|Overall Study|Technical problems|2|||
144266769|NCT01712516|520179730|FG000|Overall Study|Lost to Follow-up|0|||
144266770|NCT01712516|520179731|FG001|Overall Study|Lost to Follow-up|0|||
144266771|NCT01712516|520179732|FG002|Overall Study|Lost to Follow-up|2|||
144697477|NCT01458535|521744432|FG005|Overall Study|Adverse Event|0|||
144697478|NCT02842736|521744433|FG000|Overall Study|Lost to Follow-up|13|||
144697479|NCT02842736|521744433|FG000|Overall Study|Intervention for menstrual bleeding|17|||
144697480|NCT02842736|521744433|FG000|Overall Study|Withdrawal by Subject|4|||
144697481|NCT02842736|521744433|FG000|Overall Study|Pregnancy|3|||
144697482|NCT02842736|521744433|FG000|Overall Study|Hysterectomy for fibroids|2|||
144697483|NCT02842736|521744433|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
144697484|NCT02842736|521744433|FG000|Overall Study|IUD: Mirena|1|||
144697485|NCT02660489|521744437|FG000|Overall Study|Lost to Follow-up|1|||
144697486|NCT02660489|521744438|FG001|Overall Study|Lost to Follow-up|1|||
144697487|NCT02660489|521744437|FG000|Overall Study|Adverse Event|1|||
144697488|NCT02660489|521744438|FG001|Overall Study|Adverse Event|3|||
144697489|NCT02660489|521744437|FG000|Overall Study|no rhinovirus infection|4|||
144697490|NCT02660489|521744438|FG001|Overall Study|no rhinovirus infection|4|||
144697491|NCT04854421|521744439|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
144697492|NCT04854421|521744440|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
144697493|NCT02322866|521744441|FG000|Overall Study|Adverse Event|6|||
144697494|NCT02322866|521744442|FG001|Overall Study|Adverse Event|11|||
144697495|NCT02322866|521744441|FG000|Overall Study|Withdrawal of Consent|16|||
144697496|NCT02322866|521744442|FG001|Overall Study|Withdrawal of Consent|25|||
144697497|NCT02322866|521744441|FG000|Overall Study|Lost to Follow-up|36|||
144697498|NCT02322866|521744442|FG001|Overall Study|Lost to Follow-up|39|||
144697499|NCT02322866|521744441|FG000|Overall Study|Protocol Violation|1|||
144697500|NCT02322866|521744442|FG001|Overall Study|Protocol Violation|0|||
144697501|NCT02322866|521744441|FG000|Overall Study|Noncompliance with Treatment|3|||
144697502|NCT02322866|521744442|FG001|Overall Study|Noncompliance with Treatment|4|||
144697503|NCT02322866|521744441|FG000|Overall Study|Lack of Efficacy|3|||
144697504|NCT02322866|521744442|FG001|Overall Study|Lack of Efficacy|1|||
144697505|NCT02322866|521744441|FG000|Overall Study|Other Miscellaneous Reasons|6|||
144697506|NCT02322866|521744442|FG001|Overall Study|Other Miscellaneous Reasons|6|||
144697507|NCT00798161|521744443|FG000|Overall Study|Adverse Event|3|||
144697508|NCT00798161|521744444|FG001|Overall Study|Adverse Event|4|||
144697509|NCT00798161|521744445|FG002|Overall Study|Adverse Event|6|||
144697510|NCT00798161|521744446|FG003|Overall Study|Adverse Event|6|||
144266772|NCT01712516|520179733|FG003|Overall Study|Lost to Follow-up|1|||
144697511|NCT00798161|521744447|FG004|Overall Study|Adverse Event|5|||
144697512|NCT00798161|521744448|FG005|Overall Study|Adverse Event|2|||
144697513|NCT00798161|521744449|FG006|Overall Study|Adverse Event|4|||
144697514|NCT00798161|521744443|FG000|Overall Study|Protocol Violation|2|||
144697515|NCT00798161|521744444|FG001|Overall Study|Protocol Violation|1|||
144697516|NCT00798161|521744445|FG002|Overall Study|Protocol Violation|3|||
144697517|NCT00798161|521744446|FG003|Overall Study|Protocol Violation|3|||
144697518|NCT00798161|521744447|FG004|Overall Study|Protocol Violation|3|||
144697519|NCT00798161|521744448|FG005|Overall Study|Protocol Violation|2|||
144266773|NCT01712516|520179730|FG000|Overall Study|Death|0|||
144697520|NCT00798161|521744449|FG006|Overall Study|Protocol Violation|0|||
144697521|NCT00798161|521744443|FG000|Overall Study|Lost to Follow-up|1|||
144266774|NCT01712516|520179731|FG001|Overall Study|Death|1|||
144266775|NCT01712516|520179732|FG002|Overall Study|Death|0|||
144697522|NCT00798161|521744444|FG001|Overall Study|Lost to Follow-up|3|||
144697523|NCT00798161|521744445|FG002|Overall Study|Lost to Follow-up|4|||
144697524|NCT00798161|521744446|FG003|Overall Study|Lost to Follow-up|3|||
144697525|NCT00798161|521744447|FG004|Overall Study|Lost to Follow-up|4|||
144697526|NCT00798161|521744448|FG005|Overall Study|Lost to Follow-up|0|||
144697527|NCT00798161|521744449|FG006|Overall Study|Lost to Follow-up|0|||
144697528|NCT00798161|521744443|FG000|Overall Study|Withdrawal by Subject|5|||
144697529|NCT00798161|521744444|FG001|Overall Study|Withdrawal by Subject|4|||
144697530|NCT00798161|521744445|FG002|Overall Study|Withdrawal by Subject|5|||
144697531|NCT00798161|521744446|FG003|Overall Study|Withdrawal by Subject|4|||
144697532|NCT00798161|521744447|FG004|Overall Study|Withdrawal by Subject|2|||
144697533|NCT00798161|521744448|FG005|Overall Study|Withdrawal by Subject|3|||
144697534|NCT00798161|521744449|FG006|Overall Study|Withdrawal by Subject|1|||
144697535|NCT00798161|521744443|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
144697536|NCT00798161|521744444|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
144697537|NCT00798161|521744445|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
144697538|NCT00798161|521744446|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
144697539|NCT00798161|521744447|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
144697540|NCT00798161|521744448|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
144697541|NCT00798161|521744449|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
144697542|NCT04001790|521744459|FG000|Overall Study|Withdrawal by Subject|1|||
144697543|NCT04001790|521744460|FG001|Overall Study|Withdrawal by Subject|2|||
144697544|NCT05028816|521744461|FG000|Overall Study|Lost to Follow-up|5|||
144697545|NCT05028816|521744462|FG001|Overall Study|Lost to Follow-up|3|||
144697546|NCT05028816|521744461|FG000|Overall Study|Withdrawal by Subject|4|||
144697547|NCT05028816|521744462|FG001|Overall Study|Withdrawal by Subject|1|||
144697548|NCT05028816|521744461|FG000|Overall Study|Physician Decision|1|||
144697549|NCT05028816|521744462|FG001|Overall Study|Physician Decision|0|||
144697550|NCT00401726|521744463|FG000|Overall Study|Adverse Event|34|||
144697551|NCT00401726|521744464|FG001|Overall Study|Adverse Event|45|||
144697552|NCT00401726|521744463|FG000|Overall Study|Death|0|||
144697553|NCT00401726|521744464|FG001|Overall Study|Death|3|||
144697554|NCT00401726|521744463|FG000|Overall Study|Sponsor Request|0|||
144697555|NCT00401726|521744464|FG001|Overall Study|Sponsor Request|1|||
144697556|NCT00401726|521744463|FG000|Overall Study|Physician Decision|3|||
144697557|NCT00401726|521744464|FG001|Overall Study|Physician Decision|6|||
144697558|NCT00401726|521744463|FG000|Overall Study|Lost to Follow-up|23|||
144697559|NCT00401726|521744464|FG001|Overall Study|Lost to Follow-up|20|||
144697560|NCT00401726|521744463|FG000|Overall Study|Protocol Violation|6|||
144697561|NCT00401726|521744464|FG001|Overall Study|Protocol Violation|3|||
144697562|NCT00401726|521744463|FG000|Overall Study|Withdrawal by Subject|18|||
144697563|NCT00401726|521744464|FG001|Overall Study|Withdrawal by Subject|24|||
144697564|NCT00401726|521744463|FG000|Overall Study|Lack of Efficacy|4|||
144697565|NCT00401726|521744464|FG001|Overall Study|Lack of Efficacy|6|||
144697566|NCT00401726|521744463|FG000|Overall Study|Protocol Deviation|9|||
144697567|NCT00401726|521744464|FG001|Overall Study|Protocol Deviation|4|||
144697568|NCT02067728|521744465|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
144697569|NCT02067728|521744466|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
144697570|NCT02067728|521744465|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
144697571|NCT02067728|521744466|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
144697572|NCT02067728|521744465|FG000|6 Month Measurements|Unable to attend|114|||
144697573|NCT02067728|521744466|FG001|6 Month Measurements|Unable to attend|97|||
144697574|NCT04837807|521744467|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
144697575|NCT04837807|521744468|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
144697576|NCT00308555|521744469|FG000|Overall Study|Withdrawal by Subject|1|||
144697577|NCT00308555|521744470|FG001|Overall Study|Withdrawal by Subject|0|||
144697578|NCT00308555|521744469|FG000|Overall Study|Physician Decision|2|||
144697579|NCT00308555|521744470|FG001|Overall Study|Physician Decision|0|||
144697580|NCT00814502|521744471|FG000|Overall Study|Adverse Event|1|||
144697581|NCT00814502|521744472|FG001|Overall Study|Adverse Event|0|||
144697582|NCT00814502|521744471|FG000|Overall Study|Withdrawal by Subject|0|||
144697583|NCT00814502|521744472|FG001|Overall Study|Withdrawal by Subject|2|||
144697584|NCT01901393|521744473|FG000|Overall Study|Adverse Event|1|||
144697585|NCT01901393|521744474|FG001|Overall Study|Adverse Event|0|||
144697586|NCT04246593|521744482|FG000|Overall Study|Withdrawal by Subject|14|||
144697587|NCT04246593|521744483|FG001|Overall Study|Withdrawal by Subject|13|||
144697588|NCT04246593|521744482|FG000|Overall Study|Lost to Follow-up|124|||
144697589|NCT04246593|521744483|FG001|Overall Study|Lost to Follow-up|71|||
144697590|NCT04246593|521744482|FG000|Overall Study|Moved out of area/became ineligible|3|||
144266776|NCT01712516|520179733|FG003|Overall Study|Death|0|||
144222877|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
144266777|NCT01712516|520179730|FG000|Overall Study|Protocol deviation|1|||
144697591|NCT04246593|521744483|FG001|Overall Study|Moved out of area/became ineligible|1|||
144697592|NCT04246593|521744482|FG000|Overall Study|Reason unknown|4|||
144697593|NCT04246593|521744483|FG001|Overall Study|Reason unknown|2|||
144697594|NCT01326312|521744488|FG000|Overall Study|Adverse Event|11|||
144697595|NCT01326312|521744489|FG001|Overall Study|Adverse Event|11|||
144697596|NCT01326312|521744490|FG002|Overall Study|Adverse Event|1|||
144697597|NCT01326312|521744488|FG000|Overall Study|Withdrawal by Subject|1|||
144697598|NCT01326312|521744489|FG001|Overall Study|Withdrawal by Subject|2|||
144697599|NCT01326312|521744490|FG002|Overall Study|Withdrawal by Subject|1|||
144697600|NCT01326312|521744488|FG000|Overall Study|Protocol Violation|0|||
144697601|NCT01326312|521744489|FG001|Overall Study|Protocol Violation|1|||
144697602|NCT01326312|521744490|FG002|Overall Study|Protocol Violation|0|||
144697603|NCT01326312|521744488|FG000|Overall Study|Lack of Efficacy|13|||
144697604|NCT01326312|521744489|FG001|Overall Study|Lack of Efficacy|7|||
144697605|NCT01326312|521744490|FG002|Overall Study|Lack of Efficacy|1|||
144697606|NCT01326312|521744488|FG000|Overall Study|Death|1|||
144697607|NCT01326312|521744489|FG001|Overall Study|Death|0|||
144697608|NCT01326312|521744490|FG002|Overall Study|Death|1|||
144697609|NCT01326312|521744488|FG000|Overall Study|progressive disease|0|||
144697610|NCT01326312|521744489|FG001|Overall Study|progressive disease|1|||
144697611|NCT01326312|521744490|FG002|Overall Study|progressive disease|1|||
144697612|NCT01326312|521744488|FG000|Overall Study|Study terminated by Sponsor|8|||
144697613|NCT01326312|521744489|FG001|Overall Study|Study terminated by Sponsor|32|||
144697614|NCT01326312|521744490|FG002|Overall Study|Study terminated by Sponsor|46|||
144697615|NCT01326312|521744488|FG000|Overall Study|Treatment arm terminated|19|||
144697616|NCT01326312|521744489|FG001|Overall Study|Treatment arm terminated|0|||
144697617|NCT01326312|521744490|FG002|Overall Study|Treatment arm terminated|0|||
144697618|NCT01326312|521744488|FG000|Overall Study|QTc > 500|0|||
144697619|NCT01326312|521744489|FG001|Overall Study|QTc > 500|1|||
144697620|NCT01326312|521744490|FG002|Overall Study|QTc > 500|0|||
144697621|NCT00234533|521744497|FG000|Overall Study|Withdrawal by Subject|6|||
144697622|NCT00234533|521744497|FG000|Overall Study|Adverse Event|2|||
144697623|NCT00234533|521744497|FG000|Overall Study|Enrolled but not treated|3|||
144697624|NCT04338685|521744498|FG000|Overall Study|Death|3|||
144697625|NCT04338685|521744499|FG001|Overall Study|Death|4|||
144697626|NCT04338685|521744500|FG002|Overall Study|Death|2|||
144697627|NCT04338685|521744501|FG003|Overall Study|Death|4|||
144697628|NCT04338685|521744502|FG004|Overall Study|Death|4|||
144697629|NCT04338685|521744503|FG005|Overall Study|Death|8|||
144697630|NCT04338685|521744504|FG006|Overall Study|Death|1|||
144697631|NCT04338685|521744505|FG007|Overall Study|Death|0|||
144697632|NCT04338685|521744506|FG008|Overall Study|Death|0|||
144697633|NCT04338685|521744498|FG000|Overall Study|Study terminated by Sponsor|0|||
144697634|NCT04338685|521744499|FG001|Overall Study|Study terminated by Sponsor|0|||
144697635|NCT04338685|521744500|FG002|Overall Study|Study terminated by Sponsor|1|||
144697636|NCT04338685|521744501|FG003|Overall Study|Study terminated by Sponsor|4|||
144697637|NCT04338685|521744502|FG004|Overall Study|Study terminated by Sponsor|0|||
144697638|NCT04338685|521744503|FG005|Overall Study|Study terminated by Sponsor|5|||
144697639|NCT04338685|521744504|FG006|Overall Study|Study terminated by Sponsor|2|||
144697640|NCT04338685|521744505|FG007|Overall Study|Study terminated by Sponsor|4|||
144697641|NCT04338685|521744506|FG008|Overall Study|Study terminated by Sponsor|1|||
144697642|NCT04338685|521744498|FG000|Overall Study|Withdrawal by Subject|1|||
144697643|NCT04338685|521744499|FG001|Overall Study|Withdrawal by Subject|2|||
144697644|NCT04338685|521744500|FG002|Overall Study|Withdrawal by Subject|0|||
144697645|NCT04338685|521744501|FG003|Overall Study|Withdrawal by Subject|2|||
144697646|NCT04338685|521744502|FG004|Overall Study|Withdrawal by Subject|0|||
144697647|NCT04338685|521744503|FG005|Overall Study|Withdrawal by Subject|5|||
144697648|NCT04338685|521744504|FG006|Overall Study|Withdrawal by Subject|1|||
144697649|NCT04338685|521744505|FG007|Overall Study|Withdrawal by Subject|1|||
144697650|NCT04338685|521744506|FG008|Overall Study|Withdrawal by Subject|0|||
144697651|NCT02967055|521744507|FG000|Overall Study|Excluded|40|||
144697652|NCT02967055|521744507|FG000|Overall Study|Screen fail|3|||
144697653|NCT02967055|521744507|FG000|Overall Study|Lost to Follow-up|2|||
144697654|NCT02967055|521744507|FG000|Overall Study|Stopped due to side effects|3|||
144697655|NCT02967055|521744507|FG000|Overall Study|Stopped due to drug cost|1|||
144697656|NCT00976989|521744508|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
144697657|NCT00976989|521744509|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
144697658|NCT00976989|521744510|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
144697659|NCT00976989|521744508|FG000|Overall Study|Death|5|||
144697660|NCT00976989|521744509|FG001|Overall Study|Death|7|||
144697661|NCT00976989|521744510|FG002|Overall Study|Death|10|||
144697662|NCT00976989|521744508|FG000|Overall Study|Refused Treatment|4|||
144697663|NCT00976989|521744509|FG001|Overall Study|Refused Treatment|3|||
144697664|NCT00976989|521744510|FG002|Overall Study|Refused Treatment|5|||
144697665|NCT00976989|521744508|FG000|Overall Study|Failure to Return|2|||
144697666|NCT00976989|521744509|FG001|Overall Study|Failure to Return|1|||
144697667|NCT00976989|521744510|FG002|Overall Study|Failure to Return|0|||
144697668|NCT00976989|521744508|FG000|Overall Study|Recurrence of Disease|0|||
144697669|NCT00976989|521744509|FG001|Overall Study|Recurrence of Disease|1|||
144697670|NCT00976989|521744510|FG002|Overall Study|Recurrence of Disease|0|||
144697671|NCT00976989|521744508|FG000|Overall Study|Other|1|||
144697672|NCT00976989|521744509|FG001|Overall Study|Other|0|||
144697673|NCT00976989|521744510|FG002|Overall Study|Other|1|||
144697674|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
144697675|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
144697676|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
144697677|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
144697678|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
144697679|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
144697680|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
144697681|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
144697682|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
144697683|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
144697684|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
144697685|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
144697686|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
144697687|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
144697688|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
144697689|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
144697690|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
144697691|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
144697692|NCT00570492|521744511|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
144697693|NCT00570492|521744512|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
144697694|NCT00570492|521744513|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
144697695|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144697696|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
144697697|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
144697698|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
144697699|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
144697700|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
144697701|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
144697702|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
144697703|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
144697704|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
144697705|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
144697706|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
144697707|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
144697708|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
144697709|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
144697710|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
144697711|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
144697712|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
144697713|NCT00570492|521744511|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
144697714|NCT00570492|521744512|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
144697715|NCT00570492|521744513|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
144697716|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Adverse Event|6|||
144697717|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Adverse Event|6|||
144697718|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Death|14|||
144697719|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Death|11|||
144697720|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
144697721|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
144697722|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
144697723|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
144697724|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
144697725|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
144697726|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Disease Progression|1|||
144697727|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Disease Progression|0|||
144222878|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
144222879|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
144222880|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
144222881|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
144697728|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
144697729|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
144697730|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
144697731|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
144697732|NCT04419558|521744514|FG000|DB Period (48 Weeks)|Participant Decision|4|||
144697733|NCT04419558|521744515|FG001|DB Period (48 Weeks)|Participant Decision|3|||
144697734|NCT04419558|521744514|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
144697735|NCT04419558|521744515|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
144697736|NCT04419558|521744514|FG000|OLE Period (48 Weeks)|Death|4|||
144697737|NCT04419558|521744515|FG001|OLE Period (48 Weeks)|Death|6|||
144697738|NCT04419558|521744514|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
144697739|NCT04419558|521744515|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
144697740|NCT04419558|521744514|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
144697741|NCT04419558|521744515|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
144697742|NCT00908375|521744516|FG000|Overall Study|Withdrawal by Subject|2|||
144697743|NCT00908375|521744517|FG001|Overall Study|Withdrawal by Subject|4|||
144697744|NCT00908375|521744516|FG000|Overall Study|Lost to Follow-up|8|||
144697745|NCT00908375|521744517|FG001|Overall Study|Lost to Follow-up|6|||
144697746|NCT00903357|521744518|FG000|First Intervention|Withdrawal by Subject|5|||
144697747|NCT00903357|521744519|FG001|First Intervention|Withdrawal by Subject|3|||
144697748|NCT00903357|521744518|FG000|First Intervention|Flu|0|||
144697749|NCT00903357|521744519|FG001|First Intervention|Flu|1|||
144697750|NCT00903357|521744518|FG000|Wash Out Period of 2 Weeks|Flu|0|||
144697751|NCT00903357|521744519|FG001|Wash Out Period of 2 Weeks|Flu|1|||
144697752|NCT00903357|521744518|FG000|Second Intervention|Lost to Follow-up|1|||
144697753|NCT00903357|521744519|FG001|Second Intervention|Lost to Follow-up|0|||
144697754|NCT00678652|521744522|FG000|Overall Study|Protocol Violation|2|||
144697755|NCT00678652|521744523|FG001|Overall Study|Protocol Violation|0|||
144222882|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
144222883|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
144222884|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
144697756|NCT00678652|521744524|FG002|Overall Study|Protocol Violation|0|||
144697757|NCT00678652|521744525|FG003|Overall Study|Protocol Violation|0|||
144697758|NCT00678652|521744522|FG000|Overall Study|Pregnancy|0|||
144697759|NCT00678652|521744523|FG001|Overall Study|Pregnancy|0|||
144697760|NCT00678652|521744524|FG002|Overall Study|Pregnancy|1|||
144697761|NCT00678652|521744525|FG003|Overall Study|Pregnancy|0|||
144222885|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
144222886|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
144222887|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
144222888|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
144222889|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
144697762|NCT00678652|521744522|FG000|Overall Study|Relocation|1|||
144697763|NCT00678652|521744523|FG001|Overall Study|Relocation|0|||
144697764|NCT00678652|521744524|FG002|Overall Study|Relocation|0|||
144697765|NCT00678652|521744525|FG003|Overall Study|Relocation|0|||
144697766|NCT03958045|521744528|FG000|Overall Study|Withdrawal by Subject|1|||
144697767|NCT00674440|521744529|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
144697768|NCT00674440|521744529|FG000|Overall Study|did not have surgery, so unevaluable|7|||
144697769|NCT00674440|521744529|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
144697770|NCT03329404|521744530|FG000|Overall Study|The study was suspended.|1|||
144697771|NCT03329404|521744531|FG001|Overall Study|The study was suspended.|4|||
144697772|NCT04095039|521744532|FG000|Overall Study|Withdrawal by Subject|2|||
144697773|NCT04095039|521744533|FG001|Overall Study|Withdrawal by Subject|16|||
144697774|NCT04095039|521744532|FG000|Overall Study|Transplanted|21|||
144697775|NCT04095039|521744533|FG001|Overall Study|Transplanted|24|||
144697776|NCT04095039|521744532|FG000|Overall Study|Transferred to Non-study Facility|47|||
144697777|NCT04095039|521744533|FG001|Overall Study|Transferred to Non-study Facility|44|||
144697778|NCT04095039|521744532|FG000|Overall Study|Withdrawal from internvention target|0|||
144697779|NCT04095039|521744533|FG001|Overall Study|Withdrawal from internvention target|2|||
144697780|NCT04095039|521744532|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
144697781|NCT04095039|521744533|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
144697782|NCT04095039|521744532|FG000|Overall Study|Cacliphylaxis|0|||
144697783|NCT04095039|521744533|FG001|Overall Study|Cacliphylaxis|1|||
144697784|NCT04095039|521744532|FG000|Overall Study|Pregnancy|1|||
144697785|NCT04095039|521744533|FG001|Overall Study|Pregnancy|0|||
144697786|NCT01326481|521744536|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
144697787|NCT02441517|521744544|FG000|Overall Study|Lost to Follow-up|1|||
144697788|NCT02441517|521744544|FG000|Overall Study|Withdrawal by Subject|2|||
144697789|NCT02441517|521744544|FG000|Overall Study|Study Terminated by Sponsor|1|||
144697790|NCT01393444|521744545|FG000|Overall Study|Withdrawal by Subject|1|||
144697791|NCT01393444|521744545|FG000|Overall Study|Determined ineligible during screening.|2|||
144697792|NCT03039699|521744546|FG000|Overall Study|Incorrect inclusion|5|||
144697793|NCT03039699|521744547|FG001|Overall Study|Incorrect inclusion|4|||
144697794|NCT03039699|521744546|FG000|Overall Study|Lack of data to assess study endpoint|5|||
144697795|NCT03039699|521744547|FG001|Overall Study|Lack of data to assess study endpoint|3|||
144697796|NCT03039699|521744546|FG000|Overall Study|Bacterial infection|12|||
144697797|NCT03039699|521744547|FG001|Overall Study|Bacterial infection|28|||
144697798|NCT00761462|521747054|FG000|Treatment|Subjects never received study medication|23|||
144697799|NCT00761462|521747055|FG001|Treatment|Subjects never received study medication|12|||
144697800|NCT00761462|521747054|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
144697801|NCT00761462|521747055|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
144697802|NCT00761462|521747054|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
144697803|NCT00761462|521747055|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
144697804|NCT00761462|521747054|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
144697805|NCT00761462|521747055|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
144697806|NCT02383966|521747056|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
144697807|NCT02383966|521747057|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
144697808|NCT02383966|521747056|FG000|Overall Study|Randomized, but not treated|1|||
144697809|NCT02383966|521747057|FG001|Overall Study|Randomized, but not treated|3|||
144697810|NCT02163759|521747058|FG000|Overall Study|Withdrawal by Subject|1|||
144697811|NCT02163759|521747059|FG001|Overall Study|Withdrawal by Subject|5|||
144697812|NCT02163759|521747060|FG002|Overall Study|Withdrawal by Subject|1|||
144697813|NCT02163759|521747058|FG000|Overall Study|Adverse Event|0|||
144697814|NCT02163759|521747059|FG001|Overall Study|Adverse Event|0|||
144697815|NCT02163759|521747060|FG002|Overall Study|Adverse Event|1|||
144697816|NCT02163759|521747058|FG000|Overall Study|Death|0|||
144697817|NCT02163759|521747059|FG001|Overall Study|Death|0|||
144697818|NCT02163759|521747060|FG002|Overall Study|Death|1|||
144697819|NCT03575806|521747067|FG000|Overall Study|Withdrawal by Subject|0|||
144697820|NCT03575806|521747068|FG001|Overall Study|Withdrawal by Subject|2|||
144697821|NCT03575806|521747067|FG000|Overall Study|Protocol Violation|0|||
144697822|NCT03575806|521747068|FG001|Overall Study|Protocol Violation|2|||
144697823|NCT00219349|521747069|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
144697824|NCT00219349|521747069|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
144697825|NCT00219349|521747069|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
144697826|NCT00219349|521747069|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
144697827|NCT00270205|521747071|FG000|Overall Study|Lost to Follow-up|1|||
144697828|NCT00270205|521747072|FG001|Overall Study|Lost to Follow-up|0|||
144697829|NCT00270205|521747073|FG002|Overall Study|Lost to Follow-up|0|||
144697830|NCT00270205|521747074|FG003|Overall Study|Lost to Follow-up|1|||
144697831|NCT00869362|521747078|FG000|Overall Study|Death|0|||
144697832|NCT00869362|521747079|FG001|Overall Study|Death|2|||
144697833|NCT00869362|521747078|FG000|Overall Study|Lost to Follow-up|1|||
144697834|NCT00869362|521747079|FG001|Overall Study|Lost to Follow-up|3|||
144697835|NCT02646566|521747080|FG000|Overall Study|Lost to Follow-up|5|||
144697836|NCT02646566|521747081|FG001|Overall Study|Lost to Follow-up|4|||
144697837|NCT02646566|521747082|FG002|Overall Study|Lost to Follow-up|5|||
144697838|NCT02646566|521747080|FG000|Overall Study|Treatment failure|1|||
144697839|NCT02646566|521747081|FG001|Overall Study|Treatment failure|0|||
144697840|NCT02646566|521747082|FG002|Overall Study|Treatment failure|0|||
144697841|NCT02064231|521747087|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
144697842|NCT02064231|521747088|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
144697843|NCT02064231|521747089|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
144697844|NCT02064231|521747090|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
144697845|NCT02064231|521747087|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
144697846|NCT02064231|521747088|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
144697847|NCT02064231|521747089|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
144697848|NCT02064231|521747090|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
144697849|NCT02064231|521747087|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
144697850|NCT02064231|521747088|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
144697851|NCT02064231|521747089|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
144697852|NCT02064231|521747090|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
144697853|NCT02064231|521747087|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
144697854|NCT02064231|521747088|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
144697855|NCT02064231|521747089|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
144697856|NCT02064231|521747090|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
144697857|NCT00718809|521747092|FG000|Overall Study|Disease progression|9|||
144697858|NCT00718809|521747093|FG001|Overall Study|Disease progression|7|||
144697859|NCT00718809|521747092|FG000|Overall Study|Adverse Event|1|||
144697860|NCT00718809|521747093|FG001|Overall Study|Adverse Event|1|||
144697861|NCT00718809|521747092|FG000|Overall Study|Withdrawal by Subject|0|||
144697862|NCT00718809|521747093|FG001|Overall Study|Withdrawal by Subject|1|||
144697863|NCT00718809|521747092|FG000|Overall Study|Lost to Follow-up|1|||
144697864|NCT00718809|521747093|FG001|Overall Study|Lost to Follow-up|0|||
144697865|NCT00718809|521747092|FG000|Overall Study|Noncompliance|1|||
144697866|NCT00718809|521747093|FG001|Overall Study|Noncompliance|0|||
144697867|NCT00463385|521747094|FG000|Overall Study|Other|4|||
144697868|NCT00463385|521747095|FG001|Overall Study|Other|3|||
144697869|NCT00463385|521747096|FG002|Overall Study|Other|6|||
144697870|NCT00463385|521747097|FG003|Overall Study|Other|4|||
144697871|NCT00463385|521747094|FG000|Overall Study|Adverse Event|5|||
144697872|NCT00463385|521747095|FG001|Overall Study|Adverse Event|8|||
144697873|NCT00463385|521747096|FG002|Overall Study|Adverse Event|4|||
144697874|NCT00463385|521747097|FG003|Overall Study|Adverse Event|2|||
144697875|NCT00463385|521747094|FG000|Overall Study|Lack of Efficacy|6|||
144697876|NCT00463385|521747095|FG001|Overall Study|Lack of Efficacy|6|||
144697877|NCT00463385|521747096|FG002|Overall Study|Lack of Efficacy|7|||
144697878|NCT00463385|521747097|FG003|Overall Study|Lack of Efficacy|9|||
144697879|NCT00463385|521747094|FG000|Overall Study|Withdrawal by Subject|3|||
144697880|NCT00463385|521747095|FG001|Overall Study|Withdrawal by Subject|3|||
144697881|NCT00463385|521747096|FG002|Overall Study|Withdrawal by Subject|3|||
144697882|NCT00463385|521747097|FG003|Overall Study|Withdrawal by Subject|4|||
144697883|NCT00463385|521747094|FG000|Overall Study|Lost to Follow-up|0|||
144697884|NCT00463385|521747095|FG001|Overall Study|Lost to Follow-up|0|||
144697885|NCT00463385|521747096|FG002|Overall Study|Lost to Follow-up|0|||
144697886|NCT00463385|521747097|FG003|Overall Study|Lost to Follow-up|1|||
144697887|NCT00463385|521747094|FG000|Overall Study|Death|2|||
144697888|NCT00463385|521747095|FG001|Overall Study|Death|1|||
144697889|NCT00463385|521747096|FG002|Overall Study|Death|2|||
144697890|NCT00463385|521747097|FG003|Overall Study|Death|0|||
144697891|NCT00463385|521747094|FG000|Overall Study|Missing|2|||
144697892|NCT00463385|521747095|FG001|Overall Study|Missing|0|||
144697893|NCT00463385|521747096|FG002|Overall Study|Missing|0|||
144697894|NCT00463385|521747097|FG003|Overall Study|Missing|2|||
144697895|NCT00463385|521747094|FG000|Overall Study|1 participant received commercial drug|0|||
144697896|NCT00463385|521747095|FG001|Overall Study|1 participant received commercial drug|1|||
144697897|NCT00463385|521747096|FG002|Overall Study|1 participant received commercial drug|0|||
144697898|NCT00463385|521747097|FG003|Overall Study|1 participant received commercial drug|0|||
144697899|NCT00344968|521747098|FG000|Overall Study|Adverse Event|5|||
144697900|NCT00344968|521747099|FG001|Overall Study|Adverse Event|4|||
144697901|NCT00344968|521747100|FG002|Overall Study|Adverse Event|15|||
144697902|NCT00344968|521747098|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144697903|NCT00344968|521747099|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
144697904|NCT00344968|521747100|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
144697905|NCT00344968|521747098|FG000|Overall Study|Protocol Violation|2|||
144697906|NCT00344968|521747099|FG001|Overall Study|Protocol Violation|2|||
144697907|NCT00344968|521747100|FG002|Overall Study|Protocol Violation|5|||
144697908|NCT00344968|521747098|FG000|Overall Study|Withdrawal by Subject|14|||
144697909|NCT00344968|521747099|FG001|Overall Study|Withdrawal by Subject|31|||
144697910|NCT00344968|521747100|FG002|Overall Study|Withdrawal by Subject|27|||
144697911|NCT00344968|521747098|FG000|Overall Study|Lost to Follow-up|24|||
144697912|NCT00344968|521747099|FG001|Overall Study|Lost to Follow-up|37|||
144697913|NCT00344968|521747100|FG002|Overall Study|Lost to Follow-up|37|||
144697914|NCT00344968|521747098|FG000|Overall Study|Death|11|||
144697915|NCT00344968|521747099|FG001|Overall Study|Death|27|||
144697916|NCT00344968|521747100|FG002|Overall Study|Death|31|||
144222890|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
144697917|NCT00344968|521747098|FG000|Overall Study|Other|0|||
144697918|NCT00344968|521747099|FG001|Overall Study|Other|1|||
144697919|NCT00344968|521747100|FG002|Overall Study|Other|0|||
144697920|NCT03735680|521747101|FG000|Overall Study|Withdrawal by Subject|0|||
144697921|NCT03735680|521747102|FG001|Overall Study|Withdrawal by Subject|1|||
144697922|NCT03735680|521747103|FG002|Overall Study|Withdrawal by Subject|0|||
144697923|NCT03735680|521747104|FG003|Overall Study|Withdrawal by Subject|0|||
144697924|NCT03735680|521747105|FG004|Overall Study|Withdrawal by Subject|0|||
144697925|NCT03735680|521747106|FG005|Overall Study|Withdrawal by Subject|1|||
144697926|NCT03735680|521747101|FG000|Overall Study|Patient unable or unwilling to continue|0|||
144697927|NCT03735680|521747102|FG001|Overall Study|Patient unable or unwilling to continue|0|||
144697928|NCT03735680|521747103|FG002|Overall Study|Patient unable or unwilling to continue|1|||
144697929|NCT03735680|521747104|FG003|Overall Study|Patient unable or unwilling to continue|0|||
144697930|NCT03735680|521747105|FG004|Overall Study|Patient unable or unwilling to continue|0|||
144697931|NCT03735680|521747106|FG005|Overall Study|Patient unable or unwilling to continue|0|||
144697932|NCT00503035|521747111|FG000|Overall Study|Lost to Follow-up|2|||
144697933|NCT00503035|521747111|FG000|Overall Study|Physician Decision|3|||
144697934|NCT00503035|521747111|FG000|Overall Study|Ineligible|15|||
144697935|NCT05064436|521747112|FG000|Overall Study|Other Reasons|1|||
144697936|NCT05064436|521747113|FG001|Overall Study|Other Reasons|0|||
144697937|NCT01711736|521747115|FG000|Overall Study|Lost to Follow-up|4|||
144697938|NCT01711736|521747116|FG001|Overall Study|Lost to Follow-up|1|||
144697939|NCT01711736|521747115|FG000|Overall Study|Withdrawal by Subject|6|||
144697940|NCT01711736|521747116|FG001|Overall Study|Withdrawal by Subject|6|||
144697941|NCT01711736|521747115|FG000|Overall Study|Migrated/moved from study area|2|||
144697942|NCT01711736|521747116|FG001|Overall Study|Migrated/moved from study area|1|||
144697943|NCT01342445|521747117|FG000|Overall Study|Experienced side effects|0|||
144697944|NCT01342445|521747118|FG001|Overall Study|Experienced side effects|2|||
144697945|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Adverse Event|4|||
144697946|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Adverse Event|3|||
144697947|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Adverse Event|0|||
144697948|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Adverse Event|0|||
144697949|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Death|24|||
144697950|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Death|9|||
144697951|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Death|0|||
144697952|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Death|0|||
144697953|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
144697954|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
144697955|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
144697956|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
144697957|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Physician Decision|4|||
144697958|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Physician Decision|1|||
144697959|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Physician Decision|0|||
144697960|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Physician Decision|0|||
144697961|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Progressive disease|1|||
144697962|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Progressive disease|0|||
144697963|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Progressive disease|0|||
144697964|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Progressive disease|0|||
144697965|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
144697966|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
144697967|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
144697968|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
144697969|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
144697970|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
144697971|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
144697972|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
144697973|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
144697974|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
144697975|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
144697976|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
144697977|NCT04579666|521747124|FG000|RTP (Up to Week 52)|Other|2|||
144697978|NCT04579666|521747125|FG001|RTP (Up to Week 52)|Other|0|||
144697979|NCT04579666|521747126|FG002|RTP (Up to Week 52)|Other|0|||
144697980|NCT04579666|521747127|FG003|RTP (Up to Week 52)|Other|0|||
144697981|NCT04579666|521747124|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
144697982|NCT04579666|521747125|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
144697983|NCT04579666|521747126|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
144697984|NCT04579666|521747127|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
144697985|NCT04579666|521747124|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
144697986|NCT04579666|521747125|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
144697987|NCT04579666|521747126|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
144697988|NCT04579666|521747127|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
144697989|NCT04579666|521747124|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
144697990|NCT04579666|521747125|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
144697991|NCT04579666|521747126|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
144697992|NCT04579666|521747127|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
144697993|NCT04579666|521747124|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
144697994|NCT04579666|521747125|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
144697995|NCT04579666|521747126|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
144697996|NCT04579666|521747127|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
144697997|NCT04579666|521747124|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
144697998|NCT04579666|521747125|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
144697999|NCT04579666|521747126|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
144698000|NCT04579666|521747127|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
144698001|NCT05450198|521747128|FG000|Overall Study|Withdrawal by Subject|1|||
144698002|NCT05450198|521747129|FG001|Overall Study|Withdrawal by Subject|1|||
144698003|NCT05450198|521747130|FG002|Overall Study|Withdrawal by Subject|2|||
144698004|NCT05450198|521747131|FG003|Overall Study|Withdrawal by Subject|0|||
144698005|NCT05450198|521747128|FG000|Overall Study|Lost to Follow-up|1|||
144698006|NCT05450198|521747129|FG001|Overall Study|Lost to Follow-up|0|||
144698007|NCT05450198|521747130|FG002|Overall Study|Lost to Follow-up|2|||
144698008|NCT05450198|521747131|FG003|Overall Study|Lost to Follow-up|1|||
144698009|NCT01982942|521747132|FG000|Overall Study|Adverse Event|10|||
144698010|NCT01982942|521747133|FG001|Overall Study|Adverse Event|5|||
144698011|NCT01982942|521747132|FG000|Overall Study|Lost to Follow-up|4|||
144698012|NCT01982942|521747133|FG001|Overall Study|Lost to Follow-up|3|||
144698013|NCT01982942|521747132|FG000|Overall Study|Multiple sclerosis progression|3|||
144698014|NCT01982942|521747133|FG001|Overall Study|Multiple sclerosis progression|2|||
144698015|NCT01982942|521747132|FG000|Overall Study|Wanted to try therapy not permitted|1|||
144698016|NCT01982942|521747133|FG001|Overall Study|Wanted to try therapy not permitted|0|||
144698017|NCT01982942|521747132|FG000|Overall Study|Subject declined future visits|0|||
144698018|NCT01982942|521747133|FG001|Overall Study|Subject declined future visits|1|||
144698019|NCT01982942|521747132|FG000|Overall Study|Left geographical area|2|||
144698020|NCT01982942|521747133|FG001|Overall Study|Left geographical area|0|||
144698021|NCT01982942|521747132|FG000|Overall Study|Too many pills|1|||
144698022|NCT01982942|521747133|FG001|Overall Study|Too many pills|0|||
144698023|NCT01982942|521747132|FG000|Overall Study|MS Relapse|0|||
144698024|NCT01982942|521747133|FG001|Overall Study|MS Relapse|1|||
144698025|NCT01982942|521747132|FG000|Overall Study|Chose to join a stem cell trial|0|||
144698026|NCT01982942|521747133|FG001|Overall Study|Chose to join a stem cell trial|1|||
144698027|NCT01982942|521747132|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
144698028|NCT01982942|521747133|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
144698029|NCT04576702|521747134|FG000|Overall Study|Death|1|||
144698030|NCT04576702|521747135|FG001|Overall Study|Death|0|||
144698031|NCT04576702|521747136|FG002|Overall Study|Death|0|||
144698032|NCT04576702|521747137|FG003|Overall Study|Death|0|||
144698033|NCT04576702|521747134|FG000|Overall Study|Withdrawal by Subject|0|||
144698034|NCT04576702|521747135|FG001|Overall Study|Withdrawal by Subject|2|||
144698035|NCT04576702|521747136|FG002|Overall Study|Withdrawal by Subject|1|||
144698036|NCT04576702|521747137|FG003|Overall Study|Withdrawal by Subject|0|||
144698037|NCT04576702|521747134|FG000|Overall Study|Lost to Follow-up|3|||
144698038|NCT04576702|521747135|FG001|Overall Study|Lost to Follow-up|3|||
144698039|NCT04576702|521747136|FG002|Overall Study|Lost to Follow-up|3|||
144698040|NCT04576702|521747137|FG003|Overall Study|Lost to Follow-up|4|||
144698041|NCT01319422|521747138|FG000|Overall Study|Withdrawal by Subject|1|||
144698042|NCT01319422|521747139|FG001|Overall Study|Withdrawal by Subject|0|||
144698043|NCT00465101|521747142|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
144698044|NCT00465101|521747142|FG000|Overall Study|Change in health precluded follow up|4|||
144698045|NCT00465101|521747142|FG000|Overall Study|Did not meet study criteria|4|||
144698046|NCT00465101|521747142|FG000|Overall Study|Lost to Follow-up|5|||
144698047|NCT00465101|521747142|FG000|Overall Study|Other|6|||
144698048|NCT00465101|521747142|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
144698049|NCT00465101|521747142|FG000|Overall Study|Patient postponed procedure|1|||
144698050|NCT00465101|521747142|FG000|Overall Study|Site closed due to IRB expiration|1|||
144698051|NCT00465101|521747142|FG000|Overall Study|Unable to obtain IRB approval|1|||
144698052|NCT00465101|521747142|FG000|Overall Study|Death|3|||
144698053|NCT00465101|521747142|FG000|Overall Study|Withdrawal by Subject|25|||
144698054|NCT00465101|521747142|FG000|Overall Study|Physician Decision|1|||
144698055|NCT00465101|521747142|FG000|Overall Study|Withdrew consent prior to procedure|3|||
144698056|NCT03099096|521747143|FG000|Overall Study|Adverse Event|1|||
144698057|NCT03099096|521747143|FG000|Overall Study|Physician Decision|1|||
144698058|NCT02985996|521747149|FG000|Overall Study|Withdrawal by Subject|0|||
144698059|NCT02985996|521747150|FG001|Overall Study|Withdrawal by Subject|0|||
144698060|NCT02985996|521747151|FG002|Overall Study|Withdrawal by Subject|1|||
144698061|NCT02985996|521747152|FG003|Overall Study|Withdrawal by Subject|0|||
144698062|NCT02985996|521747153|FG004|Overall Study|Withdrawal by Subject|0|||
144698063|NCT02985996|521747149|FG000|Overall Study|Protocol Violation|0|||
144698064|NCT02985996|521747150|FG001|Overall Study|Protocol Violation|1|||
144698065|NCT02985996|521747151|FG002|Overall Study|Protocol Violation|0|||
144698066|NCT02985996|521747152|FG003|Overall Study|Protocol Violation|0|||
144698067|NCT02985996|521747153|FG004|Overall Study|Protocol Violation|0|||
144698068|NCT03532048|521747155|FG000|Overall Study|Lost to Follow-up|12|||
144698069|NCT03532048|521747156|FG001|Overall Study|Lost to Follow-up|17|||
144698070|NCT03532048|521747155|FG000|Overall Study|Withdrawal by Subject|7|||
144698071|NCT03532048|521747156|FG001|Overall Study|Withdrawal by Subject|0|||
144698072|NCT04113746|521747161|FG000|Overall Study|Lost to Follow-up|4|||
144698073|NCT04113746|521747162|FG001|Overall Study|Lost to Follow-up|4|||
144698074|NCT03125382|521747163|FG000|Randomization|screening failure|1|||
144698075|NCT03125382|521747164|FG001|Randomization|screening failure|4|||
144698076|NCT03125382|521747165|FG002|Randomization|screening failure|2|||
144698077|NCT03125382|521747166|FG003|Randomization|screening failure|0|||
144698078|NCT03125382|521747163|FG000|Follow-up|Death|1|||
144698079|NCT03125382|521747164|FG001|Follow-up|Death|2|||
144698080|NCT03125382|521747165|FG002|Follow-up|Death|1|||
144698081|NCT03125382|521747166|FG003|Follow-up|Death|2|||
144698082|NCT03125382|521747163|FG000|Follow-up|Lost to Follow-up|1|||
144698083|NCT03125382|521747164|FG001|Follow-up|Lost to Follow-up|4|||
144698084|NCT03125382|521747165|FG002|Follow-up|Lost to Follow-up|3|||
144698085|NCT03125382|521747166|FG003|Follow-up|Lost to Follow-up|1|||
144698086|NCT01050998|521747167|FG000|Overall Study|Adverse Event|1|||
144698087|NCT01050998|521747168|FG001|Overall Study|Adverse Event|0|||
144698088|NCT01050998|521747169|FG002|Overall Study|Adverse Event|1|||
144698089|NCT01050998|521747170|FG003|Overall Study|Adverse Event|0|||
144698090|NCT01050998|521747171|FG004|Overall Study|Adverse Event|2|||
144698091|NCT01050998|521747167|FG000|Overall Study|Withdrawal by Subject|0|||
144698092|NCT01050998|521747168|FG001|Overall Study|Withdrawal by Subject|0|||
144698093|NCT01050998|521747169|FG002|Overall Study|Withdrawal by Subject|0|||
144698094|NCT01050998|521747170|FG003|Overall Study|Withdrawal by Subject|1|||
144698095|NCT01050998|521747171|FG004|Overall Study|Withdrawal by Subject|3|||
144698096|NCT01050998|521747167|FG000|Overall Study|Other|3|||
144698097|NCT01050998|521747168|FG001|Overall Study|Other|2|||
144698098|NCT01050998|521747169|FG002|Overall Study|Other|1|||
144698099|NCT01050998|521747170|FG003|Overall Study|Other|1|||
144698100|NCT01050998|521747171|FG004|Overall Study|Other|5|||
144698101|NCT01050998|521747167|FG000|Overall Study|Data integrity issues|0|||
144698102|NCT01050998|521747168|FG001|Overall Study|Data integrity issues|0|||
144698103|NCT01050998|521747169|FG002|Overall Study|Data integrity issues|1|||
144698104|NCT01050998|521747170|FG003|Overall Study|Data integrity issues|1|||
144698105|NCT01050998|521747171|FG004|Overall Study|Data integrity issues|4|||
144698106|NCT01484691|521747172|FG000|Overall Study|Withdrawal by Subject|1|||
144698107|NCT01484691|521747173|FG001|Overall Study|Withdrawal by Subject|1|||
144698108|NCT01484691|521747174|FG002|Overall Study|Withdrawal by Subject|1|||
144698109|NCT01484691|521747172|FG000|Overall Study|Physician Decision|0|||
144222891|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
144222892|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
144222893|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
144222894|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
144222895|NCT02513160|520012325|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
144222896|NCT02513160|520012326|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
144222897|NCT02513160|520012327|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
144222898|NCT02513160|520012328|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
144222899|NCT02513160|520012325|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
144222900|NCT02513160|520012326|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
144222901|NCT02513160|520012327|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
144222902|NCT02513160|520012328|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
144222903|NCT02513160|520012325|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
144222904|NCT02513160|520012326|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
144222905|NCT02513160|520012327|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
144222906|NCT02513160|520012328|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
144222907|NCT02513160|520012325|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
144222908|NCT02513160|520012326|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
144222909|NCT02513160|520012327|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
144222910|NCT02513160|520012328|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
144222911|NCT02513160|520012325|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
144222912|NCT02513160|520012326|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
144222913|NCT02513160|520012327|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
144222914|NCT02513160|520012328|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
144222915|NCT02513160|520012325|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
144222916|NCT02513160|520012326|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
144222917|NCT02513160|520012327|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
144222918|NCT02513160|520012328|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
144222919|NCT02861586|520012329|FG000|Overall Study|Withdrawal by Subject|1|||
144222920|NCT02861586|520012330|FG001|Overall Study|Withdrawal by Subject|2|||
144222921|NCT02861586|520012331|FG002|Overall Study|Withdrawal by Subject|0|||
144222922|NCT02861586|520012332|FG003|Overall Study|Withdrawal by Subject|0|||
144222923|NCT02861586|520012333|FG004|Overall Study|Withdrawal by Subject|0|||
144222924|NCT02861586|520012334|FG005|Overall Study|Withdrawal by Subject|1|||
144222925|NCT02861586|520012335|FG006|Overall Study|Withdrawal by Subject|1|||
144222926|NCT02861586|520012336|FG007|Overall Study|Withdrawal by Subject|0|||
144222927|NCT02861586|520012329|FG000|Overall Study|Lost to Follow-up|3|||
144222928|NCT02861586|520012330|FG001|Overall Study|Lost to Follow-up|1|||
144222929|NCT02861586|520012331|FG002|Overall Study|Lost to Follow-up|1|||
144222930|NCT02861586|520012332|FG003|Overall Study|Lost to Follow-up|0|||
144222931|NCT02861586|520012333|FG004|Overall Study|Lost to Follow-up|0|||
144222932|NCT02861586|520012334|FG005|Overall Study|Lost to Follow-up|3|||
144222933|NCT02861586|520012335|FG006|Overall Study|Lost to Follow-up|0|||
144222934|NCT02861586|520012336|FG007|Overall Study|Lost to Follow-up|0|||
144222935|NCT02861586|520012329|FG000|Overall Study|Adverse Event|0|||
144222936|NCT02861586|520012330|FG001|Overall Study|Adverse Event|0|||
144222937|NCT02861586|520012331|FG002|Overall Study|Adverse Event|0|||
144222938|NCT02861586|520012332|FG003|Overall Study|Adverse Event|0|||
144222939|NCT02861586|520012333|FG004|Overall Study|Adverse Event|0|||
144222940|NCT02861586|520012334|FG005|Overall Study|Adverse Event|1|||
144222941|NCT02861586|520012335|FG006|Overall Study|Adverse Event|0|||
144222942|NCT02861586|520012336|FG007|Overall Study|Adverse Event|0|||
144222943|NCT03103087|520012339|FG000|Overall Study|Did not receive any study drug|1|||
144222944|NCT03103087|520012340|FG001|Overall Study|Did not receive any study drug|0|||
144222945|NCT03103087|520012341|FG002|Overall Study|Did not receive any study drug|0|||
144222946|NCT03103087|520012339|FG000|Overall Study|Protocol Violation|1|||
144222947|NCT03103087|520012340|FG001|Overall Study|Protocol Violation|2|||
144222948|NCT03103087|520012341|FG002|Overall Study|Protocol Violation|1|||
144222949|NCT03103087|520012339|FG000|Overall Study|Lack of Efficacy|2|||
144222950|NCT03103087|520012340|FG001|Overall Study|Lack of Efficacy|1|||
144222951|NCT03103087|520012341|FG002|Overall Study|Lack of Efficacy|1|||
144222952|NCT03103087|520012339|FG000|Overall Study|Pregnancy|0|||
144222953|NCT03103087|520012340|FG001|Overall Study|Pregnancy|0|||
144222954|NCT03103087|520012341|FG002|Overall Study|Pregnancy|1|||
144222955|NCT03103087|520012339|FG000|Overall Study|Adverse Event|2|||
144222956|NCT03103087|520012340|FG001|Overall Study|Adverse Event|15|||
144222957|NCT03103087|520012341|FG002|Overall Study|Adverse Event|6|||
144222958|NCT03103087|520012339|FG000|Overall Study|Withdrawal by Subject|13|||
144222959|NCT03103087|520012340|FG001|Overall Study|Withdrawal by Subject|6|||
144222960|NCT03103087|520012341|FG002|Overall Study|Withdrawal by Subject|6|||
144266778|NCT01712516|520179731|FG001|Overall Study|Protocol deviation|0|||
144698110|NCT01484691|521747173|FG001|Overall Study|Physician Decision|2|||
144698111|NCT01484691|521747174|FG002|Overall Study|Physician Decision|1|||
144698112|NCT04668157|521747177|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
144698113|NCT04668157|521747178|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
144698114|NCT04668157|521747177|FG000|Treatment Period (52 Weeks)|Other|0|||
144698115|NCT04668157|521747178|FG001|Treatment Period (52 Weeks)|Other|2|||
144698116|NCT05664672|521747183|FG000|Overall Study|Adverse Event|0|||
144698117|NCT05664672|521747184|FG001|Overall Study|Adverse Event|0|||
144698118|NCT05664672|521747185|FG002|Overall Study|Adverse Event|0|||
144698119|NCT05664672|521747186|FG003|Overall Study|Adverse Event|0|||
144698120|NCT05664672|521747187|FG004|Overall Study|Adverse Event|0|||
144698121|NCT05664672|521747188|FG005|Overall Study|Adverse Event|1|||
144698122|NCT05664672|521747183|FG000|Overall Study|Withdrawal by Subject|0|||
144698123|NCT05664672|521747184|FG001|Overall Study|Withdrawal by Subject|1|||
144698124|NCT05664672|521747185|FG002|Overall Study|Withdrawal by Subject|3|||
144698125|NCT05664672|521747186|FG003|Overall Study|Withdrawal by Subject|0|||
144698126|NCT05664672|521747187|FG004|Overall Study|Withdrawal by Subject|5|||
144698127|NCT05664672|521747188|FG005|Overall Study|Withdrawal by Subject|6|||
144698128|NCT05664672|521747183|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
144698129|NCT05664672|521747184|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
144698130|NCT05664672|521747185|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
144698131|NCT05664672|521747186|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
144698132|NCT05664672|521747187|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
144698133|NCT05664672|521747188|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
144698134|NCT05664672|521747183|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
144698135|NCT05664672|521747184|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
144698136|NCT05664672|521747185|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
144698137|NCT05664672|521747186|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
144698138|NCT05664672|521747187|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
144698139|NCT05664672|521747188|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
144698140|NCT01590810|521747191|FG000|Overall Study|Physician Decision|0|||
144698141|NCT01590810|521747192|FG001|Overall Study|Physician Decision|1|||
144698142|NCT01590810|521747193|FG002|Overall Study|Physician Decision|1|||
144698143|NCT01590810|521747194|FG003|Overall Study|Physician Decision|0|||
144698144|NCT01590810|521747195|FG004|Overall Study|Physician Decision|0|||
144698145|NCT01314261|521747196|FG000|Overall Study|Adverse Event|1|||
144698146|NCT01314261|521747197|FG001|Overall Study|Adverse Event|0|||
144698147|NCT01314261|521747198|FG002|Overall Study|Adverse Event|0|||
144698148|NCT01314261|521747199|FG003|Overall Study|Adverse Event|0|||
144698149|NCT01314261|521747196|FG000|Overall Study|Withdrawal by Subject|0|||
144698150|NCT01314261|521747197|FG001|Overall Study|Withdrawal by Subject|3|||
144698151|NCT01314261|521747198|FG002|Overall Study|Withdrawal by Subject|1|||
144698152|NCT01314261|521747199|FG003|Overall Study|Withdrawal by Subject|0|||
144698153|NCT01314261|521747196|FG000|Overall Study|Lost to Follow-up|1|||
144698154|NCT01314261|521747197|FG001|Overall Study|Lost to Follow-up|0|||
144698155|NCT01314261|521747198|FG002|Overall Study|Lost to Follow-up|2|||
144698156|NCT01314261|521747199|FG003|Overall Study|Lost to Follow-up|2|||
144698157|NCT01314261|521747196|FG000|Overall Study|Virologic Failure|0|||
144698158|NCT01314261|521747197|FG001|Overall Study|Virologic Failure|1|||
144698159|NCT01314261|521747198|FG002|Overall Study|Virologic Failure|0|||
144698160|NCT01314261|521747199|FG003|Overall Study|Virologic Failure|1|||
144698161|NCT02129192|521747200|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
144698162|NCT02129192|521747201|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
144222961|NCT03103087|520012339|FG000|Overall Study|Lost to Follow-up|4|||
144698163|NCT01231620|521747202|FG000|Overall Study|Physician Decision|3|||
144698164|NCT01231620|521747203|FG001|Overall Study|Physician Decision|5|||
144698165|NCT01231620|521747204|FG002|Overall Study|Physician Decision|10|||
144222962|NCT03103087|520012340|FG001|Overall Study|Lost to Follow-up|2|||
144698166|NCT01231620|521747202|FG000|Overall Study|Death|12|||
144698167|NCT01231620|521747203|FG001|Overall Study|Death|14|||
144698168|NCT01231620|521747204|FG002|Overall Study|Death|11|||
144698169|NCT01231620|521747202|FG000|Overall Study|Adverse Event|2|||
144698170|NCT01231620|521747203|FG001|Overall Study|Adverse Event|2|||
144698171|NCT01231620|521747204|FG002|Overall Study|Adverse Event|1|||
144698172|NCT01231620|521747202|FG000|Overall Study|Withdrawal by Subject|6|||
144698173|NCT01231620|521747203|FG001|Overall Study|Withdrawal by Subject|6|||
144698174|NCT01231620|521747204|FG002|Overall Study|Withdrawal by Subject|8|||
144698175|NCT01231620|521747202|FG000|Overall Study|Lost to Follow-up|3|||
144698176|NCT01231620|521747203|FG001|Overall Study|Lost to Follow-up|4|||
144698177|NCT01231620|521747204|FG002|Overall Study|Lost to Follow-up|9|||
144698178|NCT02400281|521747206|FG000|Overall Study|Adverse Event|0|||
144698179|NCT02400281|521747207|FG001|Overall Study|Adverse Event|0|||
144698180|NCT02400281|521747208|FG002|Overall Study|Adverse Event|1|||
144698181|NCT02400281|521747209|FG003|Overall Study|Adverse Event|0|||
144698182|NCT02400281|521747210|FG004|Overall Study|Adverse Event|1|||
144698183|NCT02400281|521747211|FG005|Overall Study|Adverse Event|0|||
144698184|NCT02400281|521747206|FG000|Overall Study|Physician Decision|0|||
144698185|NCT02400281|521747207|FG001|Overall Study|Physician Decision|0|||
144698186|NCT02400281|521747208|FG002|Overall Study|Physician Decision|1|||
144698187|NCT02400281|521747209|FG003|Overall Study|Physician Decision|0|||
144698188|NCT02400281|521747210|FG004|Overall Study|Physician Decision|0|||
144698189|NCT02400281|521747211|FG005|Overall Study|Physician Decision|0|||
144698190|NCT04524507|521747212|FG000|Overall Study|Lost to Follow-up|2|||
144698191|NCT04524507|521747213|FG001|Overall Study|Lost to Follow-up|4|||
144266779|NCT01712516|520179732|FG002|Overall Study|Protocol deviation|1|||
144698192|NCT04524507|521747212|FG000|Overall Study|Withdrawal by Subject|2|||
144266780|NCT01712516|520179733|FG003|Overall Study|Protocol deviation|0|||
144266781|NCT01712516|520179730|FG000|Overall Study|Physician Decision|2|||
144266782|NCT01712516|520179731|FG001|Overall Study|Physician Decision|0|||
144266783|NCT01712516|520179732|FG002|Overall Study|Physician Decision|0|||
144266784|NCT01712516|520179733|FG003|Overall Study|Physician Decision|1|||
144266785|NCT01712516|520179730|FG000|Overall Study|Withdrawal by Subject|3|||
144266786|NCT01712516|520179731|FG001|Overall Study|Withdrawal by Subject|9|||
144266787|NCT01712516|520179732|FG002|Overall Study|Withdrawal by Subject|3|||
144266788|NCT01712516|520179733|FG003|Overall Study|Withdrawal by Subject|9|||
144266789|NCT00496769|520179734|FG000|Double Blind|>=1 reason assigned per patient|558|||
144266790|NCT00496769|520179735|FG001|Double Blind|>=1 reason assigned per patient|649|||
144266791|NCT00496769|520179736|FG002|Double Blind|>=1 reason assigned per patient|0|||
144266792|NCT00496769|520179734|FG000|Open Label|>=1 reason assigned per patient|0|||
144266793|NCT00496769|520179735|FG001|Open Label|>=1 reason assigned per patient|0|||
144266794|NCT00496769|520179736|FG002|Open Label|>=1 reason assigned per patient|1011|||
144266795|NCT02810418|520179742|FG000|Arm A Dose Escalation|Adverse Event|2|||
144266796|NCT02810418|520179743|FG001|Arm A Dose Escalation|Adverse Event|1|||
144266797|NCT02810418|520179744|FG002|Arm A Dose Escalation|Adverse Event|0|||
144266798|NCT02810418|520179745|FG003|Arm A Dose Escalation|Adverse Event|0|||
144266799|NCT02810418|520179746|FG004|Arm A Dose Escalation|Adverse Event|0|||
144266800|NCT02810418|520179747|FG005|Arm A Dose Escalation|Adverse Event|0|||
144266801|NCT02810418|520179748|FG006|Arm A Dose Escalation|Adverse Event|0|||
144266802|NCT02810418|520179742|FG000|Dose Expansion|Adverse Event|0|||
144266803|NCT02810418|520179743|FG001|Dose Expansion|Adverse Event|1|||
144266804|NCT02810418|520179744|FG002|Dose Expansion|Adverse Event|1|||
144266805|NCT02810418|520179745|FG003|Dose Expansion|Adverse Event|0|||
144266806|NCT02810418|520179746|FG004|Dose Expansion|Adverse Event|0|||
144266807|NCT02810418|520179747|FG005|Dose Expansion|Adverse Event|0|||
144266808|NCT02810418|520179748|FG006|Dose Expansion|Adverse Event|0|||
144266809|NCT02810418|520179742|FG000|Dose Expansion|Physician Decision|0|||
144266810|NCT02810418|520179743|FG001|Dose Expansion|Physician Decision|0|||
144266811|NCT02810418|520179744|FG002|Dose Expansion|Physician Decision|2|||
144266812|NCT02810418|520179745|FG003|Dose Expansion|Physician Decision|0|||
144266813|NCT02810418|520179746|FG004|Dose Expansion|Physician Decision|0|||
144266814|NCT02810418|520179747|FG005|Dose Expansion|Physician Decision|0|||
144266815|NCT02810418|520179748|FG006|Dose Expansion|Physician Decision|0|||
144266816|NCT02810418|520179742|FG000|Arm B Dose Escalation|Adverse Event|0|||
144266817|NCT02810418|520179743|FG001|Arm B Dose Escalation|Adverse Event|0|||
144266818|NCT02810418|520179744|FG002|Arm B Dose Escalation|Adverse Event|0|||
144266819|NCT02810418|520179745|FG003|Arm B Dose Escalation|Adverse Event|0|||
144266820|NCT02810418|520179746|FG004|Arm B Dose Escalation|Adverse Event|1|||
144266821|NCT02810418|520179747|FG005|Arm B Dose Escalation|Adverse Event|2|||
144266822|NCT02810418|520179748|FG006|Arm B Dose Escalation|Adverse Event|0|||
144266823|NCT02224625|520179749|FG000|Irritation|Adverse Event|6|||
144266824|NCT02224625|520179749|FG000|Sensitization|Adverse Event|55|||
144266825|NCT02579629|520179762|FG000|Overall Study|Withdrawal by Subject|0|||
144222963|NCT03103087|520012341|FG002|Overall Study|Lost to Follow-up|7|||
144222964|NCT03103087|520012339|FG000|Overall Study|Other reason not reported|1|||
144222965|NCT03103087|520012340|FG001|Overall Study|Other reason not reported|3|||
144222966|NCT03103087|520012341|FG002|Overall Study|Other reason not reported|5|||
144222967|NCT01439802|520012342|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
144222968|NCT01439802|520012342|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
144222969|NCT00595621|520012343|FG000|Open Label Run in|Adverse Event|1|||
144222970|NCT00595621|520012344|FG001|Open Label Run in|Adverse Event|0|||
144222971|NCT00595621|520012343|FG000|Open Label Run in|Physician Decision|1|||
144222972|NCT00595621|520012344|FG001|Open Label Run in|Physician Decision|0|||
144222973|NCT00595621|520012343|FG000|Open Label Run in|Withdrawal by Subject|1|||
144222974|NCT00595621|520012344|FG001|Open Label Run in|Withdrawal by Subject|0|||
144222975|NCT00595621|520012343|FG000|Randomization and Study|Adverse Event|2|||
144222976|NCT00595621|520012344|FG001|Randomization and Study|Adverse Event|0|||
144222977|NCT00595621|520012343|FG000|Randomization and Study|Withdrawal by Subject|0|||
144222978|NCT00595621|520012344|FG001|Randomization and Study|Withdrawal by Subject|1|||
144222979|NCT02502149|520012345|FG000|Intermediate|Discontinued prematurely|1|||
144266826|NCT02579629|520179763|FG001|Overall Study|Withdrawal by Subject|1|||
144266827|NCT02579629|520179764|FG002|Overall Study|Withdrawal by Subject|0|||
144266828|NCT02579629|520179762|FG000|Overall Study|Screen Failure|2|||
144266829|NCT02579629|520179763|FG001|Overall Study|Screen Failure|0|||
144266830|NCT02579629|520179764|FG002|Overall Study|Screen Failure|2|||
144266831|NCT01930539|520179765|FG000|Overall Study|Withdrawal by Subject|2|||
144222980|NCT02502149|520012346|FG001|Intermediate|Discontinued prematurely|0|||
144222981|NCT02502149|520012347|FG002|Intermediate|Discontinued prematurely|0|||
144222982|NCT02502149|520012348|FG003|Intermediate|Discontinued prematurely|0|||
144266832|NCT01930539|520179766|FG001|Overall Study|Withdrawal by Subject|2|||
144266833|NCT01548404|520179767|FG000|Overall Study|Adverse Event|3|||
144266834|NCT01548404|520179768|FG001|Overall Study|Adverse Event|1|||
144698193|NCT04524507|521747213|FG001|Overall Study|Withdrawal by Subject|9|||
144698194|NCT04524507|521747212|FG000|Overall Study|Death|2|||
144698195|NCT04524507|521747213|FG001|Overall Study|Death|10|||
144698196|NCT00412360|521747214|FG000|Overall Study|Lost to Follow-up|0|||
144698197|NCT00412360|521747215|FG001|Overall Study|Lost to Follow-up|1|||
144698198|NCT00412360|521747214|FG000|Overall Study|Not Transplanted|1|||
144698199|NCT00412360|521747215|FG001|Overall Study|Not Transplanted|2|||
144698200|NCT03655951|521747219|FG000|Overall Study|Lost to Follow-up|39|||
144698201|NCT03655951|521747220|FG001|Overall Study|Lost to Follow-up|20|||
144698202|NCT03655951|521747219|FG000|Overall Study|Withdrawal by Subject|0|||
144698203|NCT03655951|521747220|FG001|Overall Study|Withdrawal by Subject|1|||
144266835|NCT01548404|520179767|FG000|Overall Study|Physician Decision|2|||
144266836|NCT01548404|520179768|FG001|Overall Study|Physician Decision|1|||
144222983|NCT02502149|520012349|FG004|Intermediate|Discontinued prematurely|0|||
144222984|NCT02968576|520012350|FG000|Overall Study|Pregnancy|0|||
144266837|NCT01548404|520179767|FG000|Overall Study|Inadequate response to study treatment|23|||
144266838|NCT01548404|520179768|FG001|Overall Study|Inadequate response to study treatment|7|||
144266839|NCT01548404|520179767|FG000|Overall Study|Lost to Follow-up|2|||
144698204|NCT01349816|521747221|FG000|Overall Study|Withdrawal by Subject|4|||
144698205|NCT01349816|521747221|FG000|Overall Study|Physician Decision|1|||
144698206|NCT01349816|521747221|FG000|Overall Study|Adverse Event|14|||
144698207|NCT01349816|521747221|FG000|Overall Study|Lost to Follow-up|2|||
144698208|NCT01349816|521747221|FG000|Overall Study|Protocol Violation|1|||
144698209|NCT01349816|521747221|FG000|Overall Study|Protocol-specified criteria|8|||
144698210|NCT02569996|521747222|FG000|Overall Study|Adverse Event|6|||
144698211|NCT02569996|521747222|FG000|Overall Study|Physician Decision|3|||
144698212|NCT02569996|521747222|FG000|Overall Study|Progression of the disease|18|||
144698213|NCT02569996|521747222|FG000|Overall Study|New anti-lymphoma treatment|1|||
144698214|NCT02569996|521747222|FG000|Overall Study|Non-compliance|9|||
144698215|NCT02569996|521747222|FG000|Overall Study|Withdrawal by Subject|5|||
144698216|NCT02569996|521747222|FG000|Overall Study|Lost to Follow-up|5|||
144698217|NCT02569996|521747222|FG000|Overall Study|Complete remission|7|||
144698218|NCT02569996|521747222|FG000|Overall Study|Unknown reason|1|||
144698219|NCT02911285|521747223|FG000|Overall Study|Lost to Follow-up|8|||
144698220|NCT02911285|521747224|FG001|Overall Study|Lost to Follow-up|5|||
144698221|NCT02911285|521747223|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
144698222|NCT02911285|521747224|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
144698223|NCT01397409|521747225|FG000|Stage 2|Adverse Event|0|||
144698224|NCT01397409|521747226|FG001|Stage 2|Adverse Event|0|||
144698225|NCT01397409|521747227|FG002|Stage 2|Adverse Event|0|||
144698226|NCT01397409|521747228|FG003|Stage 2|Adverse Event|0|||
144698227|NCT01397409|521747229|FG004|Stage 2|Adverse Event|6|||
144698228|NCT01397409|521747230|FG005|Stage 2|Adverse Event|3|||
144698229|NCT01397409|521747231|FG006|Stage 2|Adverse Event|0|||
144698230|NCT01397409|521747232|FG007|Stage 2|Adverse Event|0|||
144698231|NCT01397409|521747233|FG008|Stage 2|Adverse Event|0|||
144698232|NCT01397409|521747234|FG009|Stage 2|Adverse Event|0|||
144698233|NCT01397409|521747225|FG000|Stage 2|Personal Reasons|0|||
144698234|NCT01397409|521747226|FG001|Stage 2|Personal Reasons|0|||
144698235|NCT01397409|521747227|FG002|Stage 2|Personal Reasons|0|||
144698236|NCT01397409|521747228|FG003|Stage 2|Personal Reasons|0|||
144698237|NCT01397409|521747229|FG004|Stage 2|Personal Reasons|1|||
144698238|NCT01397409|521747230|FG005|Stage 2|Personal Reasons|0|||
144698239|NCT01397409|521747231|FG006|Stage 2|Personal Reasons|0|||
144698240|NCT01397409|521747232|FG007|Stage 2|Personal Reasons|0|||
144698241|NCT01397409|521747233|FG008|Stage 2|Personal Reasons|0|||
144698242|NCT01397409|521747234|FG009|Stage 2|Personal Reasons|0|||
144698243|NCT01397409|521747225|FG000|Stage 2|Other Miscellaneous Reasons|0|||
144698244|NCT01397409|521747226|FG001|Stage 2|Other Miscellaneous Reasons|0|||
144698245|NCT01397409|521747227|FG002|Stage 2|Other Miscellaneous Reasons|0|||
144698246|NCT01397409|521747228|FG003|Stage 2|Other Miscellaneous Reasons|0|||
144698247|NCT01397409|521747229|FG004|Stage 2|Other Miscellaneous Reasons|1|||
144698248|NCT01397409|521747230|FG005|Stage 2|Other Miscellaneous Reasons|1|||
144698249|NCT01397409|521747231|FG006|Stage 2|Other Miscellaneous Reasons|0|||
144698250|NCT01397409|521747232|FG007|Stage 2|Other Miscellaneous Reasons|0|||
144698251|NCT01397409|521747233|FG008|Stage 2|Other Miscellaneous Reasons|0|||
144698252|NCT01397409|521747234|FG009|Stage 2|Other Miscellaneous Reasons|0|||
144698253|NCT01397409|521747225|FG000|Stage 3|Adverse Event|0|||
144698254|NCT01397409|521747226|FG001|Stage 3|Adverse Event|0|||
144698255|NCT01397409|521747227|FG002|Stage 3|Adverse Event|0|||
144698256|NCT01397409|521747228|FG003|Stage 3|Adverse Event|0|||
144698257|NCT01397409|521747229|FG004|Stage 3|Adverse Event|0|||
144698258|NCT01397409|521747230|FG005|Stage 3|Adverse Event|0|||
144698259|NCT01397409|521747231|FG006|Stage 3|Adverse Event|0|||
144698260|NCT01397409|521747232|FG007|Stage 3|Adverse Event|1|||
144698261|NCT01397409|521747233|FG008|Stage 3|Adverse Event|0|||
144698262|NCT01397409|521747234|FG009|Stage 3|Adverse Event|0|||
144698263|NCT01397409|521747225|FG000|Stage 3|Other Miscellaneous Reasons|0|||
144698264|NCT01397409|521747226|FG001|Stage 3|Other Miscellaneous Reasons|0|||
144698265|NCT01397409|521747227|FG002|Stage 3|Other Miscellaneous Reasons|0|||
144698266|NCT01397409|521747228|FG003|Stage 3|Other Miscellaneous Reasons|0|||
144698267|NCT01397409|521747229|FG004|Stage 3|Other Miscellaneous Reasons|0|||
144698268|NCT01397409|521747230|FG005|Stage 3|Other Miscellaneous Reasons|0|||
144698269|NCT01397409|521747231|FG006|Stage 3|Other Miscellaneous Reasons|0|||
144698270|NCT01397409|521747232|FG007|Stage 3|Other Miscellaneous Reasons|1|||
144698271|NCT01397409|521747233|FG008|Stage 3|Other Miscellaneous Reasons|0|||
144698272|NCT01397409|521747234|FG009|Stage 3|Other Miscellaneous Reasons|0|||
144698273|NCT01207427|521747235|FG000|Double-blind Treatment Period|Adverse Event|0|||
144698274|NCT01207427|521747236|FG001|Double-blind Treatment Period|Adverse Event|1|||
144698275|NCT01207427|521747237|FG002|Double-blind Treatment Period|Adverse Event|0|||
144698276|NCT01207427|521747235|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144698277|NCT01207427|521747236|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
144698278|NCT01207427|521747237|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
144698279|NCT01207427|521747235|FG000|Double-blind Treatment Period|Protocol Violation|2|||
144266840|NCT01548404|520179768|FG001|Overall Study|Lost to Follow-up|0|||
144266841|NCT01548404|520179767|FG000|Overall Study|Withdrawal by Subject|0|||
144266842|NCT01548404|520179768|FG001|Overall Study|Withdrawal by Subject|3|||
144266843|NCT01548404|520179767|FG000|Overall Study|Other than specified above|0|||
144266844|NCT01548404|520179768|FG001|Overall Study|Other than specified above|2|||
144266845|NCT00737048|520179769|FG000|Overall Study|Physician Decision|0|||
144698280|NCT01207427|521747236|FG001|Double-blind Treatment Period|Protocol Violation|1|||
144698281|NCT01207427|521747237|FG002|Double-blind Treatment Period|Protocol Violation|1|||
144698282|NCT01207427|521747235|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
144698283|NCT01207427|521747236|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
144698284|NCT01207427|521747237|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144698285|NCT01791543|521747238|FG000|Overall Study|Lost to Follow-up|1|||
144698286|NCT01791543|521747238|FG000|Overall Study|Adverse Event|1|||
144698287|NCT01790633|521747243|FG000|Overall Study|Protocol Violation|1|||
144698288|NCT01790633|521747244|FG001|Overall Study|Protocol Violation|2|||
144698289|NCT01790633|521747243|FG000|Overall Study|Did not have serology performed|47|||
144698290|NCT01790633|521747244|FG001|Overall Study|Did not have serology performed|0|||
144698291|NCT01790633|521747243|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
144698292|NCT01790633|521747244|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
144698293|NCT01302366|521748131|FG000|Overall Study|patient choice or noncompliance|5|||
144698294|NCT00467051|521748132|FG000|Overall Study|Adverse Event|2|||
144698295|NCT01740297|521748133|FG000|Overall Study|Withdrawal by Subject|4|||
144698296|NCT01740297|521748134|FG001|Overall Study|Withdrawal by Subject|16|||
144698297|NCT01740297|521748135|FG002|Overall Study|Withdrawal by Subject|17|||
144698298|NCT01740297|521748133|FG000|Overall Study|Death|8|||
144698299|NCT01740297|521748134|FG001|Overall Study|Death|46|||
144698300|NCT01740297|521748135|FG002|Overall Study|Death|40|||
144698301|NCT01740297|521748133|FG000|Overall Study|Lost to Follow-up|1|||
144698302|NCT01740297|521748134|FG001|Overall Study|Lost to Follow-up|2|||
144698303|NCT01740297|521748135|FG002|Overall Study|Lost to Follow-up|4|||
144698304|NCT02985541|521748139|FG000|Overall Study|Withdrawal by Subject|33|||
144698305|NCT02985541|521748139|FG000|Overall Study|Lost to Follow-up|26|||
144698306|NCT02985541|521748139|FG000|Overall Study|Adverse Event|27|||
144698307|NCT02985541|521748139|FG000|Overall Study|Physician Decision|2|||
144698308|NCT02985541|521748139|FG000|Overall Study|Pregnancy|2|||
144698309|NCT02985541|521748139|FG000|Overall Study|Wish for pregnancy|44|||
144698310|NCT02985541|521748139|FG000|Overall Study|Other reason|5|||
144698311|NCT02985541|521748139|FG000|Overall Study|Not valid for analysis|2|||
144698312|NCT00451191|521748143|FG000|Overall Study|withdrawal or received alternate tx|15|||
144698313|NCT00451191|521748144|FG001|Overall Study|withdrawal or received alternate tx|11|||
144698314|NCT02815540|521748152|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
144698315|NCT02222246|521748153|FG000|Overall Study|No Emergency Department Visits|27|||
144698316|NCT02222246|521748154|FG001|Overall Study|No Emergency Department Visits|26|||
144698317|NCT02222246|521748153|FG000|Overall Study|Physician Decision|0|||
144698318|NCT02222246|521748154|FG001|Overall Study|Physician Decision|1|||
144698319|NCT04887922|521748162|FG000|1st Randomization|Decided not to have surgery|0|||
144698320|NCT04887922|521748163|FG001|1st Randomization|Decided not to have surgery|1|||
144698321|NCT04887922|521748164|FG002|1st Randomization|Decided not to have surgery|0|||
144698322|NCT04887922|521748165|FG003|1st Randomization|Decided not to have surgery|0|||
144698323|NCT04887922|521748166|FG004|1st Randomization|Decided not to have surgery|0|||
144698324|NCT00953017|521748167|FG000|Overall Study|DId not show up for colonoscopy|4|||
144698325|NCT00953017|521748168|FG001|Overall Study|DId not show up for colonoscopy|4|||
144698326|NCT00953017|521748169|FG002|Overall Study|DId not show up for colonoscopy|5|||
144698327|NCT00953017|521748170|FG003|Overall Study|DId not show up for colonoscopy|4|||
144698328|NCT00953017|521748167|FG000|Overall Study|Incomplete data|1|||
144698329|NCT00953017|521748168|FG001|Overall Study|Incomplete data|1|||
144698330|NCT00953017|521748169|FG002|Overall Study|Incomplete data|0|||
144698331|NCT00953017|521748170|FG003|Overall Study|Incomplete data|0|||
144698332|NCT00953017|521748167|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
144698333|NCT00953017|521748168|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
144698334|NCT00953017|521748169|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
144698335|NCT00953017|521748170|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
144698336|NCT00953017|521748167|FG000|Overall Study|Brown stool prior to procedure|0|||
144698337|NCT00953017|521748168|FG001|Overall Study|Brown stool prior to procedure|0|||
144698338|NCT00953017|521748169|FG002|Overall Study|Brown stool prior to procedure|1|||
144698339|NCT00953017|521748170|FG003|Overall Study|Brown stool prior to procedure|0|||
144698340|NCT00558831|521748173|FG000|Overall Study|Lost to Follow-up|1|||
144698341|NCT04311411|521748176|FG000|Overall Study|Adverse Event|2|||
144698342|NCT04311411|521748177|FG001|Overall Study|Adverse Event|3|||
144698343|NCT04311411|521748178|FG002|Overall Study|Adverse Event|2|||
144698344|NCT04311411|521748176|FG000|Overall Study|Withdrawal by Subject|3|||
144698345|NCT04311411|521748177|FG001|Overall Study|Withdrawal by Subject|3|||
144698346|NCT04311411|521748178|FG002|Overall Study|Withdrawal by Subject|0|||
144698347|NCT00489411|521748179|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
144698348|NCT00489411|521748180|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
144698349|NCT00489411|521748179|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
144698350|NCT00489411|521748180|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
144698351|NCT00489411|521748179|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
144698352|NCT00489411|521748180|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
144698353|NCT00489411|521748179|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
144698354|NCT00489411|521748180|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
144698355|NCT00489411|521748179|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
144698356|NCT00489411|521748180|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
144698357|NCT03219372|521748181|FG000|Overall Study|Withdrawal by Subject|1|||
144698358|NCT03219372|521748182|FG001|Overall Study|Withdrawal by Subject|0|||
144698359|NCT01428882|521748183|FG000|Overall Study|Lack of Efficacy|2|||
144698360|NCT01428882|521748184|FG001|Overall Study|Lack of Efficacy|7|||
144698361|NCT01428882|521748183|FG000|Overall Study|Protocol Violation|4|||
144698362|NCT01428882|521748184|FG001|Overall Study|Protocol Violation|3|||
144698363|NCT02219477|521748185|FG000|Overall Study|Adverse Event|0|||
144698364|NCT02219477|521748186|FG001|Overall Study|Adverse Event|1|||
144698365|NCT02219477|521748187|FG002|Overall Study|Adverse Event|1|||
144698366|NCT02219477|521748185|FG000|Overall Study|Withdrawal by Subject|0|||
144266846|NCT00737048|520179770|FG001|Overall Study|Physician Decision|0|||
144698367|NCT02219477|521748186|FG001|Overall Study|Withdrawal by Subject|1|||
144698368|NCT02219477|521748187|FG002|Overall Study|Withdrawal by Subject|0|||
144698369|NCT02304484|521748188|FG000|Overall Study|Death|9|||
144698370|NCT02304484|521748188|FG000|Overall Study|Withdrawal by Subject|14|||
144698371|NCT02304484|521748188|FG000|Overall Study|Lost to Follow-up|2|||
144698372|NCT01539512|521748189|FG000|Overall Study|Adverse Event|9|||
144698373|NCT01539512|521748190|FG001|Overall Study|Adverse Event|7|||
144698374|NCT01539512|521748189|FG000|Overall Study|Physician Decision|1|||
144698375|NCT01539512|521748190|FG001|Overall Study|Physician Decision|1|||
144698376|NCT01539512|521748189|FG000|Overall Study|Withdrawal by Subject|12|||
144698377|NCT01539512|521748190|FG001|Overall Study|Withdrawal by Subject|5|||
144698378|NCT01539512|521748189|FG000|Overall Study|Richter's Transformation|1|||
144698379|NCT01539512|521748190|FG001|Overall Study|Richter's Transformation|0|||
144698380|NCT04479358|521748191|FG000|Overall Study|Withdrawal by Subject|0|||
144698381|NCT04479358|521748192|FG001|Overall Study|Withdrawal by Subject|0|||
144698382|NCT04479358|521748193|FG002|Overall Study|Withdrawal by Subject|1|||
144698383|NCT04479358|521748194|FG003|Overall Study|Withdrawal by Subject|0|||
144698384|NCT04479358|521748195|FG004|Overall Study|Withdrawal by Subject|0|||
144698385|NCT04479358|521748196|FG005|Overall Study|Withdrawal by Subject|1|||
144698386|NCT03282123|521748198|FG000|Overall Study|Withdrawal by Subject|5|||
144698387|NCT00764465|521748199|FG000|Overall Study|Adverse Event|2|||
144698388|NCT00764465|521748200|FG001|Overall Study|Adverse Event|0|||
144698389|NCT00764465|521748201|FG002|Overall Study|Adverse Event|0|||
144698390|NCT00764465|521748202|FG003|Overall Study|Adverse Event|1|||
144698391|NCT00764465|521748203|FG004|Overall Study|Adverse Event|1|||
144698392|NCT00764465|521748204|FG005|Overall Study|Adverse Event|1|||
144698393|NCT00764465|521748199|FG000|Overall Study|Withdrawal by Subject|0|||
144698394|NCT00764465|521748200|FG001|Overall Study|Withdrawal by Subject|1|||
144698395|NCT00764465|521748201|FG002|Overall Study|Withdrawal by Subject|1|||
144698396|NCT00764465|521748202|FG003|Overall Study|Withdrawal by Subject|0|||
144698397|NCT00764465|521748203|FG004|Overall Study|Withdrawal by Subject|0|||
144698398|NCT00764465|521748204|FG005|Overall Study|Withdrawal by Subject|0|||
144698399|NCT01195662|521748206|FG000|Double Blind Treatment Period|Adverse Event|4|||
144698400|NCT01195662|521748207|FG001|Double Blind Treatment Period|Adverse Event|1|||
144698401|NCT01195662|521748208|FG002|Double Blind Treatment Period|Adverse Event|2|||
144698402|NCT01195662|521748206|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
144698403|NCT01195662|521748207|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
144698404|NCT01195662|521748208|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
144698405|NCT01195662|521748206|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
144698406|NCT01195662|521748207|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
144698407|NCT01195662|521748208|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
144698408|NCT01195662|521748206|FG000|Double Blind Treatment Period|Administrative reason|2|||
144698409|NCT01195662|521748207|FG001|Double Blind Treatment Period|Administrative reason|1|||
144698410|NCT01195662|521748208|FG002|Double Blind Treatment Period|Administrative reason|1|||
144698411|NCT01195662|521748206|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
144698412|NCT01195662|521748207|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
144698413|NCT01195662|521748208|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
144698414|NCT01195662|521748206|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
144698415|NCT01195662|521748207|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
144698416|NCT01195662|521748208|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
144698417|NCT01195662|521748206|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
144698418|NCT01195662|521748207|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
144698419|NCT01195662|521748208|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
144698420|NCT01195662|521748206|FG000|Double Blind Treatment Period|Non-specified|3|||
144698421|NCT01195662|521748207|FG001|Double Blind Treatment Period|Non-specified|0|||
144698422|NCT01195662|521748208|FG002|Double Blind Treatment Period|Non-specified|0|||
144698423|NCT01195662|521748206|FG000|Double Blind Treatment Period|Missing disposition information|0|||
144698424|NCT01195662|521748207|FG001|Double Blind Treatment Period|Missing disposition information|1|||
144698425|NCT01195662|521748208|FG002|Double Blind Treatment Period|Missing disposition information|1|||
144698426|NCT01195662|521748206|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
144698427|NCT01195662|521748207|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
144698428|NCT01195662|521748208|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
144698429|NCT01195662|521748206|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
144698430|NCT01195662|521748207|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
144698431|NCT01195662|521748208|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
144698432|NCT01463631|521748209|FG000|Overall Study|Withdrawal by Subject|0|||
144698433|NCT01463631|521748210|FG001|Overall Study|Withdrawal by Subject|0|||
144698434|NCT01463631|521748211|FG002|Overall Study|Withdrawal by Subject|0|||
144698435|NCT01463631|521748212|FG003|Overall Study|Withdrawal by Subject|1|||
144698436|NCT01463631|521748209|FG000|Overall Study|Death|0|||
144698437|NCT01463631|521748210|FG001|Overall Study|Death|0|||
144698438|NCT01463631|521748211|FG002|Overall Study|Death|1|||
144698439|NCT01463631|521748212|FG003|Overall Study|Death|0|||
144698440|NCT01463631|521748209|FG000|Overall Study|Progressive Disease|0|||
144698441|NCT01463631|521748210|FG001|Overall Study|Progressive Disease|0|||
144698442|NCT01463631|521748211|FG002|Overall Study|Progressive Disease|0|||
144698443|NCT01463631|521748212|FG003|Overall Study|Progressive Disease|5|||
144698444|NCT01298323|521748214|FG000|Overall Study|Adverse Event|2|||
144698445|NCT01298323|521748215|FG001|Overall Study|Adverse Event|4|||
144698446|NCT01298323|521748214|FG000|Overall Study|Death|11|||
144698447|NCT01298323|521748215|FG001|Overall Study|Death|16|||
144698448|NCT01298323|521748214|FG000|Overall Study|Lost to Follow-up|1|||
144698449|NCT01298323|521748215|FG001|Overall Study|Lost to Follow-up|0|||
144698450|NCT01298323|521748214|FG000|Overall Study|Withdrawal by Subject|6|||
144698451|NCT01298323|521748215|FG001|Overall Study|Withdrawal by Subject|3|||
144698452|NCT01298323|521748214|FG000|Overall Study|Protocol Violation|1|||
144698453|NCT01298323|521748215|FG001|Overall Study|Protocol Violation|0|||
144698454|NCT01298323|521748214|FG000|Overall Study|Other|10|||
144698455|NCT01298323|521748215|FG001|Overall Study|Other|9|||
144698456|NCT01298323|521748214|FG000|Overall Study|Ongoing|55|||
144698457|NCT01298323|521748215|FG001|Overall Study|Ongoing|55|||
144698458|NCT01298323|521748214|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144698459|NCT01298323|521748215|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144698460|NCT04768881|521748218|FG000|Overall Study|Completed Study Follow-up|0|||
144698461|NCT04768881|521748219|FG001|Overall Study|Completed Study Follow-up|2|||
144698462|NCT04768881|521748218|FG000|Overall Study|Death|3|||
144698463|NCT04768881|521748219|FG001|Overall Study|Death|2|||
144698464|NCT04768881|521748218|FG000|Overall Study|Study Terminated by Sponsor|2|||
144698465|NCT04768881|521748219|FG001|Overall Study|Study Terminated by Sponsor|2|||
144698466|NCT04768881|521748218|FG000|Overall Study|Withdrawal by Subject|2|||
144698467|NCT04768881|521748219|FG001|Overall Study|Withdrawal by Subject|0|||
144698468|NCT04768881|521748218|FG000|Overall Study|Other|2|||
144698469|NCT04768881|521748219|FG001|Overall Study|Other|0|||
144698470|NCT04236986|521748220|FG000|Overall Study|Withdrawal by Subject|3|||
144698471|NCT04236986|521748221|FG001|Overall Study|Withdrawal by Subject|1|||
144698472|NCT00945815|521748227|FG000|Overall Study|Death|3|||
144698473|NCT00945815|521748227|FG000|Overall Study|Not protocol specified|1|||
144698474|NCT00945815|521748227|FG000|Overall Study|Ineligible|3|||
144698475|NCT00945815|521748227|FG000|Overall Study|Did not begin protocol therapy|1|||
144698476|NCT01990339|521748232|FG000|Overall Study|Data Not Available|49|||
144698477|NCT01990339|521748232|FG000|Overall Study|Voluntary Withdrawal|1402|||
144698478|NCT01990339|521748232|FG000|Overall Study|Lost to Follow-up|861|||
144698479|NCT01038609|521748233|FG000|Overall Study|Adverse Event|0|||
144698480|NCT01038609|521748234|FG001|Overall Study|Adverse Event|0|||
144698481|NCT01038609|521748235|FG002|Overall Study|Adverse Event|1|||
144698482|NCT01038609|521748236|FG003|Overall Study|Adverse Event|0|||
144698483|NCT01038609|521748237|FG004|Overall Study|Adverse Event|0|||
144698484|NCT01038609|521748233|FG000|Overall Study|Dosing Error|0|||
144698485|NCT01038609|521748234|FG001|Overall Study|Dosing Error|0|||
144698486|NCT01038609|521748235|FG002|Overall Study|Dosing Error|0|||
144698487|NCT01038609|521748236|FG003|Overall Study|Dosing Error|1|||
144698488|NCT01038609|521748237|FG004|Overall Study|Dosing Error|1|||
144698489|NCT01038609|521748233|FG000|Overall Study|Death in the Family|1|||
144698490|NCT01038609|521748234|FG001|Overall Study|Death in the Family|0|||
144698491|NCT01038609|521748235|FG002|Overall Study|Death in the Family|0|||
144698492|NCT01038609|521748236|FG003|Overall Study|Death in the Family|0|||
144698493|NCT01038609|521748237|FG004|Overall Study|Death in the Family|0|||
144698494|NCT01038609|521748233|FG000|Overall Study|Refusal of Blood Draws|0|||
144698495|NCT01038609|521748234|FG001|Overall Study|Refusal of Blood Draws|1|||
144698496|NCT01038609|521748235|FG002|Overall Study|Refusal of Blood Draws|0|||
144698497|NCT01038609|521748236|FG003|Overall Study|Refusal of Blood Draws|0|||
144698498|NCT01038609|521748237|FG004|Overall Study|Refusal of Blood Draws|0|||
144698499|NCT01078974|521748240|FG000|Overall Study|Adverse Event|3|||
144698500|NCT01383317|521748242|FG000|Overall Study|Lost to Follow-up|2|||
144698501|NCT01383317|521748243|FG001|Overall Study|Lost to Follow-up|1|||
144698502|NCT01383317|521748242|FG000|Overall Study|Death|1|||
144698503|NCT01383317|521748243|FG001|Overall Study|Death|0|||
144698504|NCT01383317|521748242|FG000|Overall Study|Adverse Event|0|||
144698505|NCT01383317|521748243|FG001|Overall Study|Adverse Event|1|||
144698506|NCT00422227|521748245|FG000|Overall Study|Adverse Event|3|||
144698507|NCT00422227|521748246|FG001|Overall Study|Adverse Event|8|||
144698508|NCT00422227|521748245|FG000|Overall Study|Lost to Follow-up|1|||
144698509|NCT00422227|521748246|FG001|Overall Study|Lost to Follow-up|3|||
144698510|NCT00422227|521748245|FG000|Overall Study|Withdrawal by Subject|0|||
144698511|NCT00422227|521748246|FG001|Overall Study|Withdrawal by Subject|4|||
144698512|NCT03418727|521748247|FG000|Overall Study|Adverse Event|1|||
144698513|NCT03418727|521748248|FG001|Overall Study|Adverse Event|2|||
144698514|NCT03418727|521748249|FG002|Overall Study|Adverse Event|0|||
144698515|NCT03418727|521748247|FG000|Overall Study|Withdrawal by Subject|0|||
144698516|NCT03418727|521748248|FG001|Overall Study|Withdrawal by Subject|0|||
144698517|NCT03418727|521748249|FG002|Overall Study|Withdrawal by Subject|2|||
144698518|NCT00686894|521748251|FG000|Overall Study|Relapse|2|||
144698519|NCT00686894|521748251|FG000|Overall Study|Protocol Violation|4|||
144698520|NCT01479777|521750325|FG000|Overall Study|Physician Decision|2|||
144698521|NCT01241591|521750329|FG000|Overall Study|Lack of Efficacy|5|||
144698522|NCT01241591|521750330|FG001|Overall Study|Lack of Efficacy|2|||
144698523|NCT01241591|521750331|FG002|Overall Study|Lack of Efficacy|2|||
144698524|NCT01241591|521750332|FG003|Overall Study|Lack of Efficacy|3|||
144698525|NCT01241591|521750329|FG000|Overall Study|Protocol Violation|5|||
144698526|NCT01241591|521750330|FG001|Overall Study|Protocol Violation|2|||
144698527|NCT01241591|521750331|FG002|Overall Study|Protocol Violation|3|||
144698528|NCT01241591|521750332|FG003|Overall Study|Protocol Violation|0|||
144698529|NCT01241591|521750329|FG000|Overall Study|Lost to Follow-up|1|||
144698530|NCT01241591|521750330|FG001|Overall Study|Lost to Follow-up|2|||
144698531|NCT01241591|521750331|FG002|Overall Study|Lost to Follow-up|2|||
144698532|NCT01241591|521750332|FG003|Overall Study|Lost to Follow-up|2|||
144698533|NCT01241591|521750329|FG000|Overall Study|Screen Failure|3|||
144698534|NCT01241591|521750330|FG001|Overall Study|Screen Failure|2|||
144698535|NCT01241591|521750331|FG002|Overall Study|Screen Failure|1|||
144698536|NCT01241591|521750332|FG003|Overall Study|Screen Failure|0|||
144698537|NCT01241591|521750329|FG000|Overall Study|Withdrawal by Subject|6|||
144698538|NCT01241591|521750330|FG001|Overall Study|Withdrawal by Subject|4|||
144698539|NCT01241591|521750331|FG002|Overall Study|Withdrawal by Subject|2|||
144698540|NCT01241591|521750332|FG003|Overall Study|Withdrawal by Subject|2|||
144698541|NCT01241591|521750329|FG000|Overall Study|Other|0|||
144698542|NCT01241591|521750330|FG001|Overall Study|Other|1|||
144698543|NCT01241591|521750331|FG002|Overall Study|Other|0|||
144698544|NCT01241591|521750332|FG003|Overall Study|Other|1|||
144698545|NCT01241591|521750329|FG000|Overall Study|Adverse Event|3|||
144698546|NCT01241591|521750330|FG001|Overall Study|Adverse Event|11|||
144698547|NCT01241591|521750331|FG002|Overall Study|Adverse Event|12|||
144698548|NCT01241591|521750332|FG003|Overall Study|Adverse Event|4|||
144698549|NCT01945034|521750333|FG000|Overall Study|Medication Error|0|||
144698550|NCT01945034|521750334|FG001|Overall Study|Medication Error|1|||
144698551|NCT01945034|521750335|FG002|Overall Study|Medication Error|0|||
144698552|NCT01945034|521750333|FG000|Overall Study|Withdrawal by Subject|0|||
144698553|NCT01945034|521750334|FG001|Overall Study|Withdrawal by Subject|3|||
144698554|NCT01945034|521750335|FG002|Overall Study|Withdrawal by Subject|1|||
144698555|NCT01945034|521750333|FG000|Overall Study|Other|0|||
144698556|NCT01945034|521750334|FG001|Overall Study|Other|1|||
144698557|NCT01945034|521750335|FG002|Overall Study|Other|3|||
144698558|NCT01945034|521750333|FG000|Overall Study|Lost to Follow-up|0|||
144698559|NCT01945034|521750334|FG001|Overall Study|Lost to Follow-up|0|||
144698560|NCT01945034|521750335|FG002|Overall Study|Lost to Follow-up|2|||
144698561|NCT01945034|521750333|FG000|Overall Study|Protocol Violation|1|||
144698562|NCT01945034|521750334|FG001|Overall Study|Protocol Violation|0|||
144698563|NCT01945034|521750335|FG002|Overall Study|Protocol Violation|1|||
144698564|NCT02389621|521750338|FG000|Treatment Period|Withdrawal by Subject|1|||
144698565|NCT02389621|521750339|FG001|Treatment Period|Withdrawal by Subject|1|||
144698566|NCT02389621|521750338|FG000|Posttreatment Period|Adverse Event|3|||
144698567|NCT02389621|521750339|FG001|Posttreatment Period|Adverse Event|1|||
144698568|NCT02389621|521750338|FG000|Posttreatment Period|Withdrawal by Subject|3|||
144698569|NCT02389621|521750339|FG001|Posttreatment Period|Withdrawal by Subject|2|||
144698570|NCT02389621|521750338|FG000|Posttreatment Period|Lost to Follow-up|1|||
144698571|NCT02389621|521750339|FG001|Posttreatment Period|Lost to Follow-up|1|||
144698572|NCT02389621|521750338|FG000|Posttreatment Period|Other - Miscellaneous|2|||
144698573|NCT02389621|521750339|FG001|Posttreatment Period|Other - Miscellaneous|0|||
144698574|NCT03323034|521750342|FG000|Overall Study|Lack of Efficacy|5|||
144698575|NCT03323034|521750343|FG001|Overall Study|Lack of Efficacy|5|||
144698576|NCT03323034|521750344|FG002|Overall Study|Lack of Efficacy|6|||
144698577|NCT03323034|521750345|FG003|Overall Study|Lack of Efficacy|5|||
144698578|NCT03323034|521750346|FG004|Overall Study|Lack of Efficacy|5|||
144698579|NCT03323034|521750342|FG000|Overall Study|Physician Decision|0|||
144698580|NCT03323034|521750343|FG001|Overall Study|Physician Decision|0|||
144698581|NCT03323034|521750344|FG002|Overall Study|Physician Decision|0|||
144698582|NCT03323034|521750345|FG003|Overall Study|Physician Decision|0|||
144698583|NCT03323034|521750346|FG004|Overall Study|Physician Decision|1|||
144698584|NCT03323034|521750342|FG000|Overall Study|Withdrawal by Subject|1|||
144698585|NCT03323034|521750343|FG001|Overall Study|Withdrawal by Subject|1|||
144698586|NCT03323034|521750344|FG002|Overall Study|Withdrawal by Subject|0|||
144698587|NCT03323034|521750345|FG003|Overall Study|Withdrawal by Subject|1|||
144698588|NCT03323034|521750346|FG004|Overall Study|Withdrawal by Subject|0|||
144698589|NCT01300741|521750350|FG000|Overall Study|Lens deposits|1|||
144698590|NCT01300741|521750350|FG000|Overall Study|Lost to Follow-up|1|||
144698591|NCT01300741|521750350|FG000|Overall Study|Discomfort|1|||
144698592|NCT01548573|521750353|FG000|Overall Study|Death|3|||
144698593|NCT01548573|521750353|FG000|Overall Study|Withdrawal by Subject|2|||
144698594|NCT01366846|521750354|FG000|Overall Study|Withdrawal by Subject|2|||
144698595|NCT01366846|521750355|FG001|Overall Study|Withdrawal by Subject|0|||
144266847|NCT00737048|520179771|FG002|Overall Study|Physician Decision|1|||
144266848|NCT00737048|520179769|FG000|Overall Study|Adverse Event|0|||
144266849|NCT00737048|520179770|FG001|Overall Study|Adverse Event|1|||
144266850|NCT00737048|520179771|FG002|Overall Study|Adverse Event|0|||
144222985|NCT02968576|520012351|FG001|Overall Study|Pregnancy|1|||
144222986|NCT00927589|520012354|FG000|Overall Study|Death|1|||
144222987|NCT00927589|520012354|FG000|Overall Study|Physician Decision|1|||
144222988|NCT00927589|520012354|FG000|Overall Study|Withdrawal by Subject|3|||
144222989|NCT00927589|520012354|FG000|Overall Study|Adverse Event|2|||
144698596|NCT01366846|521750356|FG002|Overall Study|Withdrawal by Subject|0|||
144698597|NCT01366846|521750357|FG003|Overall Study|Withdrawal by Subject|0|||
144698598|NCT01366846|521750354|FG000|Overall Study|Communication Difficulties|1|||
144698599|NCT01366846|521750355|FG001|Overall Study|Communication Difficulties|4|||
144698600|NCT01366846|521750356|FG002|Overall Study|Communication Difficulties|0|||
144698601|NCT01366846|521750357|FG003|Overall Study|Communication Difficulties|1|||
144698602|NCT01366846|521750354|FG000|Overall Study|Scheduling Conflicts|0|||
144698603|NCT01366846|521750355|FG001|Overall Study|Scheduling Conflicts|0|||
144698604|NCT01366846|521750356|FG002|Overall Study|Scheduling Conflicts|1|||
144698605|NCT01366846|521750357|FG003|Overall Study|Scheduling Conflicts|0|||
144698606|NCT00290511|521750363|FG000|Overall Study|Adverse Event|1|||
144698607|NCT00290511|521750363|FG000|Overall Study|Death|1|||
144698608|NCT00290511|521750363|FG000|Overall Study|Physician Decision|1|||
144698609|NCT00290511|521750363|FG000|Overall Study|Withdrawal by Subject|1|||
144698610|NCT00447265|521750364|FG000|Overall Study|Physician Decision|1|||
144698611|NCT00447265|521750365|FG001|Overall Study|Physician Decision|0|||
144698612|NCT02204449|521750368|FG000|Overall Study|Lost to Follow-up|7|||
144698613|NCT02204449|521750369|FG001|Overall Study|Lost to Follow-up|9|||
144698614|NCT02204449|521750368|FG000|Overall Study|Death|0|||
144698615|NCT02204449|521750369|FG001|Overall Study|Death|1|||
144698616|NCT02204449|521750368|FG000|Overall Study|Withdrawal by Subject|0|||
144698617|NCT02204449|521750369|FG001|Overall Study|Withdrawal by Subject|1|||
144698618|NCT05299359|521750370|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
144698619|NCT05299359|521750371|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
144698620|NCT05299359|521750370|FG000|Main Part: Day 1 up to Day 366|Other|2|||
144698621|NCT05299359|521750371|FG001|Main Part: Day 1 up to Day 366|Other|0|||
144698622|NCT05299359|521750370|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
144698623|NCT05299359|521750371|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
144698624|NCT05299359|521750370|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
144698625|NCT05299359|521750371|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
144698626|NCT05299359|521750370|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
144698627|NCT05299359|521750371|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
144698628|NCT05299359|521750370|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
144698629|NCT05299359|521750371|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
144698630|NCT05299359|521750370|FG000|Extension Part: Day 1 to Day 366|Other|0|||
144698631|NCT05299359|521750371|FG001|Extension Part: Day 1 to Day 366|Other|1|||
144698632|NCT04780776|521750376|FG000|Titration Week 1-5|Lost to Follow-up|2|||
144698633|NCT04780776|521750377|FG001|Titration Week 1-5|Lost to Follow-up|8|||
144698634|NCT04780776|521750376|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
144698635|NCT04780776|521750377|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
144698636|NCT04780776|521750376|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
144698637|NCT04780776|521750377|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
144698638|NCT03113760|521750378|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
144698639|NCT03113760|521750379|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
144698640|NCT03113760|521750380|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
144698641|NCT03113760|521750381|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
144698642|NCT03113760|521750378|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
144698643|NCT03113760|521750379|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
144698644|NCT03113760|521750380|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
144698645|NCT03113760|521750381|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
144698646|NCT03113760|521750378|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
144698647|NCT03113760|521750379|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
144698648|NCT03113760|521750380|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
144698649|NCT03113760|521750381|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
144698650|NCT02506101|521750384|FG000|Overall Study|Transportation issues|1|||
144698651|NCT02506101|521750385|FG001|Overall Study|Transportation issues|0|||
144698652|NCT02506101|521750384|FG000|Overall Study|No enrollment and staff unavailability|1|||
144698653|NCT02506101|521750385|FG001|Overall Study|No enrollment and staff unavailability|0|||
144698654|NCT01151085|521750386|FG000|Overall Study|Lost to Follow-up|31|||
144698655|NCT01151085|521750386|FG000|Overall Study|Protocol Violation|25|||
144698656|NCT01308476|521750387|FG000|Overall Study|Lost to Follow-up|2|||
144698657|NCT01308476|521750388|FG001|Overall Study|Lost to Follow-up|2|||
144698658|NCT01308476|521750387|FG000|Overall Study|Other|1|||
144698659|NCT01308476|521750388|FG001|Overall Study|Other|0|||
144698660|NCT02696382|521750389|FG000|Overall Study|Death|7|||
144698661|NCT02696382|521750390|FG001|Overall Study|Death|2|||
144698662|NCT02696382|521750389|FG000|Overall Study|Withdrawal by Subject|5|||
144222990|NCT00927589|520012354|FG000|Overall Study|Disease Progression|8|||
144222991|NCT00927589|520012354|FG000|Overall Study|Non-compliance|1|||
144266851|NCT00737048|520179769|FG000|Overall Study|Worsening of the symptoms|3|||
144266852|NCT00737048|520179770|FG001|Overall Study|Worsening of the symptoms|5|||
144266853|NCT00737048|520179771|FG002|Overall Study|Worsening of the symptoms|3|||
144266854|NCT00301834|520179772|FG000|Overall Study|Death|1|||
144266855|NCT02870868|520179773|FG000|Overall Study|Withdrawal by Subject|2|||
144266856|NCT02870868|520179774|FG001|Overall Study|Withdrawal by Subject|1|||
144266857|NCT01309386|520179775|FG000|Overall Study|Other|2|||
144266858|NCT01309386|520179776|FG001|Overall Study|Other|0|||
144266859|NCT01309386|520179775|FG000|Overall Study|Withdrawal by Subject|2|||
144266860|NCT01309386|520179776|FG001|Overall Study|Withdrawal by Subject|0|||
144266861|NCT01309386|520179775|FG000|Overall Study|Progressive disease|9|||
144266862|NCT01309386|520179776|FG001|Overall Study|Progressive disease|11|||
144266863|NCT01309386|520179775|FG000|Overall Study|Physician Decision|1|||
144266864|NCT01309386|520179776|FG001|Overall Study|Physician Decision|1|||
144266865|NCT01309386|520179775|FG000|Overall Study|Lack of Efficacy|3|||
144266866|NCT01309386|520179776|FG001|Overall Study|Lack of Efficacy|1|||
144266867|NCT01309386|520179775|FG000|Overall Study|Adverse Event|5|||
144266868|NCT01309386|520179776|FG001|Overall Study|Adverse Event|8|||
144266869|NCT02062437|520179777|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
144266870|NCT02062437|520179777|FG000|Overall Study|Patient not available for the 2y visit|18|||
144266871|NCT02062437|520179777|FG000|Overall Study|Death|2|||
144266872|NCT02062437|520179777|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
144266873|NCT00723229|520179778|FG000|First Intervention|Lost to Follow-up|7|||
144266874|NCT00723229|520179779|FG001|First Intervention|Lost to Follow-up|3|||
144266875|NCT02900352|520179780|FG000|Overall Study|Lost to Follow-up|28|||
144266876|NCT02900352|520179781|FG001|Overall Study|Lost to Follow-up|17|||
144266877|NCT03074695|520179782|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
144266878|NCT03074695|520179783|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
144266879|NCT03074695|520179782|FG000|Overall Study|Research staff not available|1|||
144266880|NCT03074695|520179783|FG001|Overall Study|Research staff not available|2|||
144266881|NCT03074695|520179782|FG000|Overall Study|Did not receive neuraxial block|2|||
144266882|NCT03074695|520179783|FG001|Overall Study|Did not receive neuraxial block|2|||
144266883|NCT01774981|520179784|FG000|Overall Study|Adverse Event|0|||
144266884|NCT01774981|520179785|FG001|Overall Study|Adverse Event|0|||
144266885|NCT01774981|520179786|FG002|Overall Study|Adverse Event|0|||
144266886|NCT01774981|520179787|FG003|Overall Study|Adverse Event|0|||
144266887|NCT01774981|520179788|FG004|Overall Study|Adverse Event|0|||
144266888|NCT01774981|520179789|FG005|Overall Study|Adverse Event|1|||
144266889|NCT01774981|520179790|FG006|Overall Study|Adverse Event|0|||
144222992|NCT00513240|520012356|FG000|Overall Study|Did not have intended surgery|3|||
144222993|NCT00513240|520012357|FG001|Overall Study|Did not have intended surgery|0|||
144222994|NCT00513240|520012356|FG000|Overall Study|Death|3|||
144222995|NCT00513240|520012357|FG001|Overall Study|Death|3|||
144222996|NCT00513240|520012356|FG000|Overall Study|Withdrawal by Subject|7|||
144222997|NCT00513240|520012357|FG001|Overall Study|Withdrawal by Subject|4|||
144222998|NCT05263908|520012358|FG000|Overall Study|No informed consent for publication of study results|397|||
144222999|NCT05263908|520012358|FG000|Overall Study|CRF not collected|1|||
144223000|NCT01641640|520012366|FG000|Overall Study|Enrolled but not treated|1|||
144223001|NCT01641640|520012366|FG000|Overall Study|Efficacy failure|29|||
144266890|NCT01774981|520179791|FG007|Overall Study|Adverse Event|0|||
144266891|NCT01774981|520179784|FG000|Overall Study|Withdrawal by Subject|0|||
144266892|NCT01774981|520179785|FG001|Overall Study|Withdrawal by Subject|0|||
144266893|NCT01774981|520179786|FG002|Overall Study|Withdrawal by Subject|0|||
144266894|NCT01774981|520179787|FG003|Overall Study|Withdrawal by Subject|0|||
144266895|NCT01774981|520179788|FG004|Overall Study|Withdrawal by Subject|0|||
144266896|NCT01774981|520179789|FG005|Overall Study|Withdrawal by Subject|0|||
144266897|NCT01774981|520179790|FG006|Overall Study|Withdrawal by Subject|0|||
144266898|NCT01774981|520179791|FG007|Overall Study|Withdrawal by Subject|1|||
144266899|NCT01774981|520179784|FG000|Overall Study|Death|0|||
144266900|NCT01774981|520179785|FG001|Overall Study|Death|0|||
144266901|NCT01774981|520179786|FG002|Overall Study|Death|0|||
144266902|NCT01774981|520179787|FG003|Overall Study|Death|0|||
144266903|NCT01774981|520179788|FG004|Overall Study|Death|1|||
144266904|NCT01774981|520179789|FG005|Overall Study|Death|0|||
144266905|NCT01774981|520179790|FG006|Overall Study|Death|0|||
144266906|NCT01774981|520179791|FG007|Overall Study|Death|0|||
144266907|NCT00902577|520179796|FG000|Overall Study|Withdrawal by Subject|6|||
144266908|NCT00902577|520179796|FG000|Overall Study|FMISO production failure|2|||
144266909|NCT03322293|520179799|FG000|Overall Study|Lost to Follow-up|0|||
144266910|NCT03322293|520179800|FG001|Overall Study|Lost to Follow-up|0|||
144266911|NCT03322293|520179801|FG002|Overall Study|Lost to Follow-up|1|||
144266912|NCT00083915|520179802|FG000|Overall Study|Death|6|||
144266913|NCT00083915|520179803|FG001|Overall Study|Death|3|||
144223002|NCT01641640|520012366|FG000|Overall Study|Lost to Follow-up|3|||
144223003|NCT01641640|520012366|FG000|Overall Study|Withdrawal by Subject|2|||
144266914|NCT00083915|520179802|FG000|Overall Study|Physician Decision|11|||
144266915|NCT00083915|520179803|FG001|Overall Study|Physician Decision|6|||
144698663|NCT02696382|521750390|FG001|Overall Study|Withdrawal by Subject|12|||
144698664|NCT02696382|521750389|FG000|Overall Study|Lost to Follow-up|4|||
144698665|NCT02696382|521750390|FG001|Overall Study|Lost to Follow-up|7|||
144698666|NCT03246152|521750394|FG000|Overall Study|Lost to Follow-up|2|||
144698667|NCT03246152|521750394|FG000|Overall Study|Protocol Violation|1|||
144698668|NCT01243762|521750395|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
144698669|NCT01243762|521750396|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
144698670|NCT01243762|521750397|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
144698671|NCT01243762|521750398|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
144698672|NCT01243762|521750399|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
144698673|NCT01243762|521750400|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
144698674|NCT01243762|521750401|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
144698675|NCT01243762|521750395|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
144698676|NCT01243762|521750396|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
144698677|NCT01243762|521750397|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
144698678|NCT01243762|521750398|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
144698679|NCT01243762|521750399|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
144698680|NCT01243762|521750400|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
144698681|NCT01243762|521750401|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
144698682|NCT01243762|521750395|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
144698683|NCT01243762|521750396|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
144698684|NCT01243762|521750397|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
144698685|NCT01243762|521750398|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
144698686|NCT01243762|521750399|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
144698687|NCT01243762|521750400|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
144698688|NCT01243762|521750401|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
144698689|NCT01243762|521750395|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
144698690|NCT01243762|521750396|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
144698691|NCT01243762|521750397|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
144698692|NCT01243762|521750398|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
144698693|NCT01243762|521750399|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
144698694|NCT01243762|521750400|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
144698695|NCT01243762|521750401|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
144698696|NCT01243762|521750395|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
144698697|NCT01243762|521750396|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
144698698|NCT01243762|521750397|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
144698699|NCT01243762|521750398|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
144698700|NCT01243762|521750399|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
144223004|NCT01641640|520012366|FG000|Overall Study|Adverse Event|1|||
144223005|NCT00882518|520012369|FG000|Overall Study|Adverse Event|9|||
144223006|NCT00882518|520012370|FG001|Overall Study|Adverse Event|18|||
144223007|NCT00882518|520012369|FG000|Overall Study|Withdrawal by Subject|9|||
144266916|NCT00083915|520179802|FG000|Overall Study|Withdrawal by Subject|8|||
144266917|NCT00083915|520179803|FG001|Overall Study|Withdrawal by Subject|3|||
144266918|NCT00083915|520179802|FG000|Overall Study|disease progression|18|||
144266919|NCT00083915|520179803|FG001|Overall Study|disease progression|23|||
144266920|NCT00083915|520179802|FG000|Overall Study|Failure to collect|3|||
144266921|NCT00083915|520179803|FG001|Overall Study|Failure to collect|0|||
144266922|NCT00083915|520179802|FG000|Overall Study|No response|3|||
144266923|NCT00083915|520179803|FG001|Overall Study|No response|1|||
144266924|NCT00083915|520179802|FG000|Overall Study|Insurance issues|1|||
144266925|NCT00083915|520179803|FG001|Overall Study|Insurance issues|1|||
144266926|NCT01239797|520179804|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
144266927|NCT01239797|520179805|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
144266928|NCT01239797|520179804|FG000|Randomized Participants|Participant withdrew consent|1|||
144266929|NCT01239797|520179805|FG001|Randomized Participants|Participant withdrew consent|7|||
144266930|NCT01239797|520179804|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
144266931|NCT01239797|520179805|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
144266932|NCT01239797|520179804|FG000|Treated Participants|Disease progression|185|||
144266933|NCT01239797|520179805|FG001|Treated Participants|Disease progression|185|||
144266934|NCT01239797|520179804|FG000|Treated Participants|Study drug toxicity|39|||
144266935|NCT01239797|520179805|FG001|Treated Participants|Study drug toxicity|45|||
144266936|NCT01239797|520179804|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
144266937|NCT01239797|520179805|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
144266938|NCT01239797|520179804|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
144266939|NCT01239797|520179805|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
144266940|NCT01239797|520179804|FG000|Treated Participants|Administrative reason by sponsor|13|||
144266941|NCT01239797|520179805|FG001|Treated Participants|Administrative reason by sponsor|4|||
144266942|NCT01239797|520179804|FG000|Treated Participants|Other reasons|14|||
144266943|NCT01239797|520179805|FG001|Treated Participants|Other reasons|14|||
144266944|NCT01239797|520179804|FG000|Treated Participants|Participant withdrew consent|6|||
144266945|NCT01239797|520179805|FG001|Treated Participants|Participant withdrew consent|11|||
144266946|NCT01239797|520179804|FG000|Treated Participants|Death|1|||
144266947|NCT01239797|520179805|FG001|Treated Participants|Death|1|||
144266948|NCT01239797|520179804|FG000|Treated Participants|Participant no longer meets study criteria|1|||
144266949|NCT01239797|520179805|FG001|Treated Participants|Participant no longer meets study criteria|1|||
144266950|NCT01239797|520179804|FG000|Treated Participants|Poor/non-compliance|0|||
144266951|NCT01239797|520179805|FG001|Treated Participants|Poor/non-compliance|1|||
144266952|NCT02914834|520179806|FG000|Overall Study|Study halted due to COVID|1|||
144266953|NCT02914834|520179807|FG001|Overall Study|Study halted due to COVID|1|||
144266954|NCT02914834|520179806|FG000|Overall Study|1 subject withdrew|0|||
144266955|NCT02914834|520179807|FG001|Overall Study|1 subject withdrew|1|||
144266956|NCT03885908|520179812|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
144266957|NCT03885908|520179813|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
144266958|NCT03885908|520179812|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
144266959|NCT03885908|520179813|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
144266960|NCT03885908|520179812|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
144266961|NCT03885908|520179813|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
144266962|NCT03885908|520179812|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
144266963|NCT03885908|520179813|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
144266964|NCT03669549|520179814|FG000|Overall Study|Adverse Event|4|||
144266965|NCT03669549|520179814|FG000|Overall Study|Withdrawal by Subject|1|||
144266966|NCT03669549|520179814|FG000|Overall Study|Study terminated by the Sponsor|1|||
144266967|NCT05002972|520179819|FG000|Overall Study|Withdrawal by Subject|2|||
144266968|NCT01664091|520179820|FG000|Overall Study|Death|1|||
144266969|NCT01664091|520179820|FG000|Overall Study|Disease Progression|2|||
144266970|NCT01664091|520179820|FG000|Overall Study|Lost to Follow-up|2|||
144266971|NCT01664091|520179820|FG000|Overall Study|Withdrawal by Subject|1|||
144266972|NCT01172873|520179821|FG000|Overall Study|Withdrawal by Subject|3|||
144266973|NCT01172873|520179822|FG001|Overall Study|Withdrawal by Subject|2|||
144266974|NCT02053493|520179825|FG000|Overall Study|Withdrawal by Subject|1|||
144266975|NCT02053493|520179826|FG001|Overall Study|Withdrawal by Subject|1|||
144266976|NCT03902613|520179830|FG000|Overall Study|Physician Decision|1|||
144266977|NCT01789047|520179832|FG000|Overall Study|Adverse Event|3|||
144266978|NCT01789047|520179833|FG001|Overall Study|Adverse Event|2|||
144266979|NCT01789047|520179832|FG000|Overall Study|Withdrawal by Subject|1|||
144266980|NCT01789047|520179833|FG001|Overall Study|Withdrawal by Subject|2|||
144266981|NCT02668640|520179834|FG000|Overall Study|Lost to Follow-up|13|||
144266982|NCT02668640|520179834|FG000|Overall Study|Other, not specified|1|||
144266983|NCT02322749|520179837|FG000|Period 2|Adverse Event|0|||
144266984|NCT02322749|520179838|FG001|Period 2|Adverse Event|0|||
144266985|NCT02322749|520179839|FG002|Period 2|Adverse Event|0|||
144266986|NCT02322749|520179840|FG003|Period 2|Adverse Event|1|||
144223008|NCT00882518|520012370|FG001|Overall Study|Withdrawal by Subject|13|||
144223009|NCT00882518|520012369|FG000|Overall Study|Lack of Efficacy|12|||
144698701|NCT01243762|521750400|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
144698702|NCT01243762|521750401|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
144698703|NCT01243762|521750395|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
144698704|NCT01243762|521750396|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
144698705|NCT01243762|521750397|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
144698706|NCT01243762|521750398|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
144698707|NCT01243762|521750399|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
144698708|NCT01243762|521750400|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
144698709|NCT01243762|521750401|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
144698710|NCT01243762|521750395|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
144698711|NCT01243762|521750396|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
144698712|NCT01243762|521750397|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
144698713|NCT01243762|521750398|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
144698714|NCT01243762|521750399|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
144698715|NCT01243762|521750400|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
144698716|NCT01243762|521750401|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
144698717|NCT01243762|521750395|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
144698718|NCT01243762|521750396|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
144698719|NCT01243762|521750397|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
144698720|NCT01243762|521750398|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
144698721|NCT01243762|521750399|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
144698722|NCT01243762|521750400|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
144698723|NCT01243762|521750401|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
144698724|NCT00003526|521750402|FG000|Overall Study|Not evaluable|6|||
144698725|NCT02059265|521750403|FG000|Overall Study|Ineligible|4|||
144698726|NCT04196023|521750404|FG000|Overall Study|Withdrawal by Subject|0|||
144698727|NCT04196023|521750405|FG001|Overall Study|Withdrawal by Subject|1|||
144698728|NCT04196023|521750404|FG000|Overall Study|Adverse Event|3|||
144698729|NCT04196023|521750405|FG001|Overall Study|Adverse Event|1|||
144698730|NCT04196023|521750404|FG000|Overall Study|Lost to Follow-up|0|||
144698731|NCT04196023|521750405|FG001|Overall Study|Lost to Follow-up|1|||
144698732|NCT03358407|521750407|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698733|NCT03358407|521750408|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698734|NCT03358407|521750409|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
144698735|NCT03358407|521750410|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698736|NCT03358407|521750411|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698737|NCT03358407|521750412|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698738|NCT03358407|521750413|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698739|NCT03358407|521750414|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698740|NCT03358407|521750415|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698741|NCT03358407|521750416|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
144698742|NCT03358407|521750407|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698743|NCT03358407|521750408|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698744|NCT03358407|521750409|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698745|NCT03358407|521750410|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698746|NCT03358407|521750411|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
144698747|NCT03358407|521750412|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698748|NCT03358407|521750413|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698749|NCT03358407|521750414|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698750|NCT03358407|521750415|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698751|NCT03358407|521750416|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698752|NCT03358407|521750407|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698753|NCT03358407|521750408|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698754|NCT03358407|521750409|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698755|NCT03358407|521750410|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698756|NCT03358407|521750411|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698757|NCT03358407|521750412|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
144698758|NCT03358407|521750413|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698759|NCT03358407|521750414|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
144698760|NCT03358407|521750415|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144698761|NCT03358407|521750416|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
144223010|NCT00882518|520012370|FG001|Overall Study|Lack of Efficacy|9|||
144223011|NCT00882518|520012369|FG000|Overall Study|Severe non-compliance to protocol|3|||
144223012|NCT00882518|520012370|FG001|Overall Study|Severe non-compliance to protocol|1|||
144223013|NCT00882518|520012369|FG000|Overall Study|Incorrect enrolment|4|||
144223014|NCT00882518|520012370|FG001|Overall Study|Incorrect enrolment|2|||
144223015|NCT00882518|520012369|FG000|Overall Study|Central lab closure for National day|1|||
144223016|NCT00882518|520012370|FG001|Overall Study|Central lab closure for National day|0|||
144223017|NCT00882518|520012369|FG000|Overall Study|Allocating random number by mistake|0|||
144223018|NCT00882518|520012370|FG001|Overall Study|Allocating random number by mistake|1|||
144223019|NCT03711188|520012371|FG000|Overall Study|Disease progression|11|||
144223020|NCT03711188|520012371|FG000|Overall Study|Adverse Event|1|||
144223021|NCT01433471|520012372|FG000|Overall Study|Withdrawal by Subject|0|||
144223022|NCT01433471|520012373|FG001|Overall Study|Withdrawal by Subject|1|||
144223023|NCT03238651|520012374|FG000|Overall Study|Other|0|||
144223024|NCT03238651|520012375|FG001|Overall Study|Other|0|||
144223025|NCT03238651|520012376|FG002|Overall Study|Other|0|||
144223026|NCT03238651|520012377|FG003|Overall Study|Other|0|||
144223027|NCT03238651|520012378|FG004|Overall Study|Other|1|||
144223028|NCT03238651|520012374|FG000|Overall Study|Progressive Disease|2|||
144223029|NCT03238651|520012375|FG001|Overall Study|Progressive Disease|2|||
144223030|NCT03238651|520012376|FG002|Overall Study|Progressive Disease|2|||
144223031|NCT03238651|520012377|FG003|Overall Study|Progressive Disease|2|||
144223032|NCT03238651|520012378|FG004|Overall Study|Progressive Disease|0|||
144223033|NCT03238651|520012374|FG000|Overall Study|Withdrawal by Subject|0|||
144223034|NCT03238651|520012375|FG001|Overall Study|Withdrawal by Subject|1|||
144223035|NCT03238651|520012376|FG002|Overall Study|Withdrawal by Subject|0|||
144223036|NCT03238651|520012377|FG003|Overall Study|Withdrawal by Subject|1|||
144223037|NCT03238651|520012378|FG004|Overall Study|Withdrawal by Subject|0|||
144223038|NCT03238651|520012374|FG000|Overall Study|Adverse Event|1|||
144223039|NCT03238651|520012375|FG001|Overall Study|Adverse Event|3|||
144223040|NCT03238651|520012376|FG002|Overall Study|Adverse Event|2|||
144223041|NCT03238651|520012377|FG003|Overall Study|Adverse Event|0|||
144223042|NCT03238651|520012378|FG004|Overall Study|Adverse Event|0|||
144223043|NCT02137252|520012379|FG000|Overall Study|trial terminated early|2|||
144223044|NCT02137252|520012380|FG001|Overall Study|trial terminated early|1|||
144223045|NCT00063934|520012381|FG000|Overall Study|Ineligible|1|||
144223046|NCT04341363|520012382|FG000|Overall Study|Adverse Event|1|||
144223047|NCT04341363|520012382|FG000|Overall Study|Withdrawal by Subject|1|||
144223048|NCT01930162|520012383|FG000|Overall Study|Abnormal test procedure result(s)|4|||
144223049|NCT01930162|520012383|FG000|Overall Study|Death|1|||
144223050|NCT02550561|520012384|FG000|Overall Study|Lost to Follow-up|5|||
144223051|NCT02550561|520012384|FG000|Overall Study|Withdrawal by Subject|1|||
144223052|NCT02570308|520012390|FG000|Overall Study|Death|1|||
144223053|NCT02570308|520012391|FG001|Overall Study|Death|5|||
144223054|NCT02570308|520012392|FG002|Overall Study|Death|4|||
144223055|NCT02570308|520012393|FG003|Overall Study|Death|4|||
144223056|NCT02570308|520012394|FG004|Overall Study|Death|69|||
144223057|NCT02570308|520012390|FG000|Overall Study|Lost to Follow-up|0|||
144223058|NCT02570308|520012391|FG001|Overall Study|Lost to Follow-up|0|||
144223059|NCT02570308|520012392|FG002|Overall Study|Lost to Follow-up|0|||
144223060|NCT02570308|520012393|FG003|Overall Study|Lost to Follow-up|0|||
144223061|NCT02570308|520012394|FG004|Overall Study|Lost to Follow-up|2|||
144223062|NCT02570308|520012390|FG000|Overall Study|Withdrawal by Subject|0|||
144223063|NCT02570308|520012391|FG001|Overall Study|Withdrawal by Subject|0|||
144223064|NCT02570308|520012392|FG002|Overall Study|Withdrawal by Subject|0|||
144223065|NCT02570308|520012393|FG003|Overall Study|Withdrawal by Subject|0|||
144223066|NCT02570308|520012394|FG004|Overall Study|Withdrawal by Subject|1|||
144223067|NCT02570308|520012390|FG000|Overall Study|Other|0|||
144223068|NCT02570308|520012391|FG001|Overall Study|Other|0|||
144223069|NCT02570308|520012392|FG002|Overall Study|Other|0|||
144223070|NCT02570308|520012393|FG003|Overall Study|Other|0|||
144223071|NCT02570308|520012394|FG004|Overall Study|Other|2|||
144223072|NCT02069015|520012396|FG000|Overall Study|Lost to Follow-up|39|||
144223073|NCT02069015|520012397|FG001|Overall Study|Lost to Follow-up|32|||
144223074|NCT02069015|520012396|FG000|Overall Study|Withdrawal by Subject|1|||
144223075|NCT02069015|520012397|FG001|Overall Study|Withdrawal by Subject|1|||
144223076|NCT02285361|520012398|FG000|Overall Study|Protocol Violation|43|||
144223077|NCT02285361|520012398|FG000|Overall Study|Lost to Follow-up|5|||
144223078|NCT02285361|520012398|FG000|Overall Study|Not taken GIOTRIF|2|||
144223079|NCT02285361|520012398|FG000|Overall Study|Consented prior to the contract date|1|||
144223080|NCT05506046|520012399|FG000|Overall Study|Lost to Follow-up|89|||
144223081|NCT05506046|520012400|FG001|Overall Study|Lost to Follow-up|101|||
144223082|NCT05506046|520012401|FG002|Overall Study|Lost to Follow-up|102|||
144223083|NCT05506046|520012402|FG003|Overall Study|Lost to Follow-up|99|||
144223084|NCT01283464|520012403|FG000|Overall Study|Lost to Follow-up|0|||
144223085|NCT01283464|520012404|FG001|Overall Study|Lost to Follow-up|1|||
144223086|NCT01283464|520012403|FG000|Overall Study|Withdrawal by Subject|1|||
144266987|NCT02322749|520179841|FG004|Period 2|Adverse Event|0|||
144698762|NCT03358407|521750407|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698763|NCT03358407|521750408|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698764|NCT03358407|521750409|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698765|NCT03358407|521750410|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698766|NCT03358407|521750411|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698767|NCT03358407|521750412|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
144698768|NCT03358407|521750413|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698769|NCT03358407|521750414|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
144698770|NCT03358407|521750415|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698771|NCT03358407|521750416|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
144698772|NCT03358407|521750407|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698773|NCT03358407|521750408|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698774|NCT03358407|521750409|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698775|NCT03358407|521750410|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698776|NCT03358407|521750411|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698777|NCT03358407|521750412|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
144698778|NCT03358407|521750413|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
144698779|NCT03358407|521750414|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698780|NCT03358407|521750415|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698781|NCT03358407|521750416|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
144698782|NCT03358407|521750407|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698783|NCT03358407|521750408|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698784|NCT03358407|521750409|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698785|NCT03358407|521750410|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698786|NCT03358407|521750411|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698787|NCT03358407|521750412|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
144698788|NCT03358407|521750413|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
144698789|NCT03358407|521750414|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
144698790|NCT03358407|521750415|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698791|NCT03358407|521750416|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
144698792|NCT03605758|521750417|FG000|Overall Study|Lost to Follow-up|2|||
144698793|NCT03605758|521750418|FG001|Overall Study|Lost to Follow-up|1|||
144698794|NCT03605758|521750417|FG000|Overall Study|Illness|0|||
144698795|NCT03605758|521750418|FG001|Overall Study|Illness|1|||
144698796|NCT03605758|521750417|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
144698797|NCT03605758|521750418|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
144698798|NCT01748162|521750421|FG000|Overall Study|no additional croup episodes to evaluate|2|||
144698799|NCT01748162|521750422|FG001|Overall Study|no additional croup episodes to evaluate|2|||
144698800|NCT01748162|521750421|FG000|Overall Study|participant consented but did not begin|0|||
144698801|NCT01748162|521750422|FG001|Overall Study|participant consented but did not begin|1|||
144698802|NCT01748162|521750421|FG000|Overall Study|reasons not available|3|||
144698803|NCT01748162|521750422|FG001|Overall Study|reasons not available|2|||
144698804|NCT00779857|521750423|FG000|Overall Study|Death|1|||
144698805|NCT00779857|521750423|FG000|Overall Study|Withdrawal by Subject|3|||
144698806|NCT00779857|521750423|FG000|Overall Study|Missed Visit|2|||
144698807|NCT00276458|521750424|FG000|Overall Study|Adverse Event|0|||
144698808|NCT00276458|521750425|FG001|Overall Study|Adverse Event|2|||
144698809|NCT00276458|521750424|FG000|Overall Study|Lost to Follow-up|2|||
144698810|NCT00276458|521750425|FG001|Overall Study|Lost to Follow-up|2|||
144698811|NCT00276458|521750424|FG000|Overall Study|Protocol Violation|4|||
144698812|NCT00276458|521750425|FG001|Overall Study|Protocol Violation|3|||
144698813|NCT02940392|521750426|FG000|Overall Study|Lost to Follow-up|3|||
144698814|NCT02940392|521750426|FG000|Overall Study|Retreatment|3|||
144698815|NCT02940392|521750426|FG000|Overall Study|Death|2|||
144223087|NCT01283464|520012404|FG001|Overall Study|Withdrawal by Subject|0|||
144223088|NCT01283464|520012403|FG000|Overall Study|Physician Decision|1|||
144266988|NCT02322749|520179842|FG005|Period 2|Adverse Event|0|||
144266989|NCT02322749|520179837|FG000|Period 2|Withdrawal by Subject|0|||
144266990|NCT02322749|520179838|FG001|Period 2|Withdrawal by Subject|0|||
144266991|NCT02322749|520179839|FG002|Period 2|Withdrawal by Subject|0|||
144266992|NCT02322749|520179840|FG003|Period 2|Withdrawal by Subject|1|||
144266993|NCT02322749|520179841|FG004|Period 2|Withdrawal by Subject|0|||
144266994|NCT02322749|520179842|FG005|Period 2|Withdrawal by Subject|0|||
144266995|NCT02322749|520179837|FG000|Period 3|Withdrawal by Subject|0|||
144266996|NCT02322749|520179838|FG001|Period 3|Withdrawal by Subject|0|||
144266997|NCT02322749|520179839|FG002|Period 3|Withdrawal by Subject|1|||
144266998|NCT02322749|520179840|FG003|Period 3|Withdrawal by Subject|0|||
144266999|NCT02322749|520179841|FG004|Period 3|Withdrawal by Subject|0|||
144267000|NCT02322749|520179842|FG005|Period 3|Withdrawal by Subject|0|||
144267001|NCT00073918|520179843|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
144267002|NCT00073918|520179843|FG000|Overall Study|Rapid disease progression|2|||
144267003|NCT00073918|520179843|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
144267004|NCT01190813|520179844|FG000|Overall Study|Lost to Follow-up|1|||
144267005|NCT01190813|520179845|FG001|Overall Study|Lost to Follow-up|2|||
144267006|NCT01190813|520179844|FG000|Overall Study|Withdrawal by Subject|2|||
144267007|NCT01190813|520179845|FG001|Overall Study|Withdrawal by Subject|1|||
144267008|NCT01190813|520179844|FG000|Overall Study|Refused study treatment after randomized|1|||
144267009|NCT01190813|520179845|FG001|Overall Study|Refused study treatment after randomized|0|||
144267010|NCT01190813|520179844|FG000|Overall Study|Adverse Event|0|||
144267011|NCT01190813|520179845|FG001|Overall Study|Adverse Event|1|||
144267012|NCT04821830|520179848|FG000|Overall Study|Withdrawal by Subject|1|||
144267013|NCT04821830|520179849|FG001|Overall Study|Withdrawal by Subject|0|||
144267014|NCT00919633|520179850|FG000|Overall Study|Adverse Event|1|||
144267015|NCT00919633|520179851|FG001|Overall Study|Adverse Event|9|||
144267016|NCT00919633|520179852|FG002|Overall Study|Adverse Event|12|||
144267017|NCT00919633|520179853|FG003|Overall Study|Adverse Event|10|||
144267018|NCT00919633|520179850|FG000|Overall Study|Death|0|||
144267019|NCT00919633|520179851|FG001|Overall Study|Death|0|||
144267020|NCT00919633|520179852|FG002|Overall Study|Death|2|||
144267021|NCT00919633|520179853|FG003|Overall Study|Death|0|||
144267022|NCT00919633|520179850|FG000|Overall Study|Lack of Efficacy|17|||
144267023|NCT00919633|520179851|FG001|Overall Study|Lack of Efficacy|3|||
144267024|NCT00919633|520179852|FG002|Overall Study|Lack of Efficacy|2|||
144267025|NCT00919633|520179853|FG003|Overall Study|Lack of Efficacy|3|||
144223089|NCT01283464|520012404|FG001|Overall Study|Physician Decision|0|||
144267026|NCT00919633|520179850|FG000|Overall Study|Withdrawal by Subject|1|||
144267027|NCT00919633|520179851|FG001|Overall Study|Withdrawal by Subject|2|||
144267028|NCT00919633|520179852|FG002|Overall Study|Withdrawal by Subject|4|||
144267029|NCT00919633|520179853|FG003|Overall Study|Withdrawal by Subject|3|||
144267030|NCT00919633|520179850|FG000|Overall Study|Lost to Follow-up|3|||
144267031|NCT00919633|520179851|FG001|Overall Study|Lost to Follow-up|1|||
144267032|NCT00919633|520179852|FG002|Overall Study|Lost to Follow-up|0|||
144267033|NCT00919633|520179853|FG003|Overall Study|Lost to Follow-up|2|||
144267034|NCT00919633|520179850|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
144267035|NCT00919633|520179851|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
144267036|NCT00919633|520179852|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
144267037|NCT00919633|520179853|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
144267038|NCT00919633|520179850|FG000|Overall Study|Protocol Violation|0|||
144267039|NCT00919633|520179851|FG001|Overall Study|Protocol Violation|0|||
144267040|NCT00919633|520179852|FG002|Overall Study|Protocol Violation|0|||
144267041|NCT00919633|520179853|FG003|Overall Study|Protocol Violation|1|||
144267042|NCT00919633|520179850|FG000|Overall Study|Physician Decision|0|||
144267043|NCT00919633|520179851|FG001|Overall Study|Physician Decision|0|||
144267044|NCT00919633|520179852|FG002|Overall Study|Physician Decision|0|||
144267045|NCT00919633|520179853|FG003|Overall Study|Physician Decision|1|||
144267046|NCT00919633|520179850|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
144267047|NCT00919633|520179851|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
144267048|NCT00919633|520179852|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
144267049|NCT00919633|520179853|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
144267050|NCT00919633|520179850|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
144267051|NCT00919633|520179851|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
144267052|NCT00919633|520179852|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
144267053|NCT00919633|520179853|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
144267054|NCT01526785|520179854|FG000|Overall Study|Study Terminated by Sponsor|8|||
144267055|NCT01526785|520179854|FG000|Overall Study|Death|2|||
144267056|NCT01526785|520179854|FG000|Overall Study|Physician Decision|1|||
144267057|NCT01526785|520179854|FG000|Overall Study|Withdrawal by Subject|2|||
144267058|NCT04265261|520179858|FG000|Overall Study|Adverse Event|2|||
144267059|NCT04265261|520179859|FG001|Overall Study|Adverse Event|0|||
144267060|NCT04265261|520179860|FG002|Overall Study|Adverse Event|0|||
144267061|NCT04265261|520179858|FG000|Overall Study|Death|1|||
144267062|NCT04265261|520179859|FG001|Overall Study|Death|0|||
144267063|NCT04265261|520179860|FG002|Overall Study|Death|0|||
144267064|NCT04265261|520179858|FG000|Overall Study|Lost to Follow-up|4|||
144267065|NCT04265261|520179859|FG001|Overall Study|Lost to Follow-up|1|||
144267066|NCT04265261|520179860|FG002|Overall Study|Lost to Follow-up|3|||
144267067|NCT04265261|520179858|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144267068|NCT04265261|520179859|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144267069|NCT04265261|520179860|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144267070|NCT04265261|520179858|FG000|Overall Study|Physician Decision|0|||
144267071|NCT04265261|520179859|FG001|Overall Study|Physician Decision|0|||
144267072|NCT04265261|520179860|FG002|Overall Study|Physician Decision|1|||
144267073|NCT04265261|520179858|FG000|Overall Study|Protocol Deviation|0|||
144267074|NCT04265261|520179859|FG001|Overall Study|Protocol Deviation|2|||
144267075|NCT04265261|520179860|FG002|Overall Study|Protocol Deviation|0|||
144267076|NCT04265261|520179858|FG000|Overall Study|Withdrawal by Subject|2|||
144267077|NCT04265261|520179859|FG001|Overall Study|Withdrawal by Subject|1|||
144267078|NCT04265261|520179860|FG002|Overall Study|Withdrawal by Subject|4|||
144267079|NCT05630196|520181310|FG000|Overall Study|Adverse Event|2|||
144267080|NCT05630196|520181311|FG001|Overall Study|Adverse Event|1|||
144267081|NCT05630196|520181310|FG000|Overall Study|Lost to Follow-up|1|||
144267082|NCT05630196|520181311|FG001|Overall Study|Lost to Follow-up|1|||
144267083|NCT05630196|520181310|FG000|Overall Study|Protocol Violation|2|||
144267084|NCT05630196|520181311|FG001|Overall Study|Protocol Violation|3|||
144267085|NCT05630196|520181310|FG000|Overall Study|Physician Decision|1|||
144267086|NCT05630196|520181311|FG001|Overall Study|Physician Decision|0|||
144267087|NCT05630196|520181310|FG000|Overall Study|Withdrawal by Subject|3|||
144267088|NCT05630196|520181311|FG001|Overall Study|Withdrawal by Subject|4|||
144267089|NCT01655901|520181313|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
144267090|NCT01655901|520181314|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
144267091|NCT01655901|520181315|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
144267092|NCT01655901|520181316|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
144267093|NCT01655901|520181317|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
144223090|NCT03051100|520012405|FG000|Overall Study|Withdrawal by Subject|1|||
144698816|NCT03205046|521750428|FG000|Overall Study|Death|10|||
144698817|NCT03205046|521750429|FG001|Overall Study|Death|6|||
144698818|NCT03205046|521750428|FG000|Overall Study|Withdrawal by Subject|1|||
144698819|NCT03205046|521750429|FG001|Overall Study|Withdrawal by Subject|2|||
144698820|NCT03205046|521750428|FG000|Overall Study|Lost to Follow-up|0|||
144698821|NCT03205046|521750429|FG001|Overall Study|Lost to Follow-up|1|||
144698822|NCT03205046|521750428|FG000|Overall Study|Study terminated by sponsor|2|||
144698823|NCT03205046|521750429|FG001|Overall Study|Study terminated by sponsor|1|||
144698824|NCT01023815|521750430|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
144698825|NCT01023815|521750431|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
144698826|NCT01023815|521750432|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
144698827|NCT01023815|521750433|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
144698828|NCT01023815|521750430|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
144698829|NCT01023815|521750431|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
144698830|NCT01023815|521750432|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
144698831|NCT01023815|521750433|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
144698832|NCT01023815|521750430|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
144698833|NCT01023815|521750431|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
144698834|NCT01023815|521750432|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
144698835|NCT01023815|521750433|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
144698836|NCT01023815|521750430|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
144698837|NCT01023815|521750431|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
144698838|NCT01023815|521750432|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
144698839|NCT01023815|521750433|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
144698840|NCT01023815|521750430|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
144698841|NCT01023815|521750431|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
144698842|NCT01023815|521750432|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
144698843|NCT01023815|521750433|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
144698844|NCT03253809|521750436|FG000|Overall Study|Unable to obtain study related data|14|||
144698845|NCT00752206|521750440|FG000|Overall Study|Disease progression|8|||
144698846|NCT00752206|521750441|FG001|Overall Study|Disease progression|11|||
144698847|NCT00752206|521750440|FG000|Overall Study|Pregnancy|1|||
144698848|NCT00752206|521750441|FG001|Overall Study|Pregnancy|0|||
144698849|NCT02283411|521750448|FG000|Overall Study|Withdrawal by Subject|3|||
144698850|NCT02283411|521750448|FG000|Overall Study|Screen Failed|28|||
144698851|NCT01683565|521750449|FG000|Overall Study|Lost to Follow-up|2|||
144698852|NCT01683565|521750450|FG001|Overall Study|Lost to Follow-up|0|||
144698853|NCT01683565|521750449|FG000|Overall Study|Discontinued Intervention|1|||
144698854|NCT01683565|521750450|FG001|Overall Study|Discontinued Intervention|1|||
144698855|NCT05437211|521750459|FG000|Overall Study|Patient's decision|1|||
144698856|NCT05437211|521750460|FG001|Overall Study|Patient's decision|1|||
144698857|NCT04410991|521750461|FG000|Overall Study|Poor compliance to protocol|5|||
144698858|NCT04410991|521750462|FG001|Overall Study|Poor compliance to protocol|4|||
144698859|NCT04410991|521750461|FG000|Overall Study|Withdrawal by Subject|59|||
144698860|NCT04410991|521750462|FG001|Overall Study|Withdrawal by Subject|55|||
144698861|NCT04410991|521750461|FG000|Overall Study|Other|10|||
144698862|NCT04410991|521750462|FG001|Overall Study|Other|4|||
144698863|NCT01250418|521750467|FG000|Overall Study|monitor data failure|1|||
144698864|NCT01250418|521750468|FG001|Overall Study|monitor data failure|1|||
144698865|NCT01761565|521750469|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
144698866|NCT05966129|521750472|FG000|Overall Study|Death|1|||
144698867|NCT05966129|521750473|FG001|Overall Study|Death|2|||
144698868|NCT05966129|521750472|FG000|Overall Study|Lost to Follow-up|63|||
144698869|NCT05966129|521750473|FG001|Overall Study|Lost to Follow-up|66|||
144698870|NCT05966129|521750472|FG000|Overall Study|Protocol Violation|1|||
144698871|NCT05966129|521750473|FG001|Overall Study|Protocol Violation|0|||
144698872|NCT05966129|521750472|FG000|Overall Study|Withdrawal by Subject|26|||
144698873|NCT05966129|521750473|FG001|Overall Study|Withdrawal by Subject|25|||
144698874|NCT05966129|521750472|FG000|Overall Study|Surgery not completed|63|||
144698875|NCT05966129|521750473|FG001|Overall Study|Surgery not completed|69|||
144698876|NCT05966129|521750472|FG000|Overall Study|Surgery logistics issue|2|||
144698877|NCT05966129|521750473|FG001|Overall Study|Surgery logistics issue|1|||
144698878|NCT02500732|521750482|FG000|Overall Study|Physician Decision|0|||
144698879|NCT02500732|521750483|FG001|Overall Study|Physician Decision|1|||
144698880|NCT04409262|521750484|FG000|Overall Study|Adverse Event|0|||
144698881|NCT04409262|521750485|FG001|Overall Study|Adverse Event|2|||
144698882|NCT04409262|521750484|FG000|Overall Study|Death|55|||
144698883|NCT04409262|521750485|FG001|Overall Study|Death|97|||
144698884|NCT04409262|521750484|FG000|Overall Study|Lost to Follow-up|12|||
144698885|NCT04409262|521750485|FG001|Overall Study|Lost to Follow-up|23|||
144698886|NCT04409262|521750484|FG000|Overall Study|Lack of Staff|0|||
144698887|NCT04409262|521750485|FG001|Overall Study|Lack of Staff|1|||
144698888|NCT04409262|521750484|FG000|Overall Study|Protocol Violation|3|||
144267094|NCT01655901|520181318|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
144267095|NCT00352118|520181319|FG000|Overall Study|Physician Decision|4|||
144267096|NCT02990000|520181320|FG000|Overall Study|Failed to provide data beyond baseline|36|||
144223091|NCT03051100|520012406|FG001|Overall Study|Withdrawal by Subject|0|||
144223092|NCT01778855|520012407|FG000|Overall Study|Death|0|||
144223093|NCT01778855|520012408|FG001|Overall Study|Death|1|||
144223094|NCT02059135|520012409|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
144223095|NCT02059135|520012410|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
144223096|NCT02059135|520012409|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
144223097|NCT02059135|520012410|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
144223098|NCT02059135|520012409|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
144223099|NCT02059135|520012410|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
144223100|NCT02059135|520012409|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
144223101|NCT02059135|520012410|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
144223102|NCT02059135|520012409|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
144223103|NCT02059135|520012410|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
144223104|NCT02059135|520012409|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
144223105|NCT02059135|520012410|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
144223106|NCT02059135|520012409|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
144223107|NCT02059135|520012410|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
144223108|NCT02059135|520012409|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
144223109|NCT02059135|520012410|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
144223110|NCT00191477|520012412|FG000|Overall Study|Tumor Recurrence|49|||
144223111|NCT00191477|520012413|FG001|Overall Study|Tumor Recurrence|48|||
144223112|NCT00191477|520012412|FG000|Overall Study|Death, Study Disease|1|||
144223113|NCT00191477|520012413|FG001|Overall Study|Death, Study Disease|1|||
144223114|NCT00191477|520012412|FG000|Overall Study|Death, Other Cause|3|||
144223115|NCT00191477|520012413|FG001|Overall Study|Death, Other Cause|6|||
144223116|NCT00191477|520012412|FG000|Overall Study|Lost to Follow-up|23|||
144223117|NCT00191477|520012413|FG001|Overall Study|Lost to Follow-up|21|||
144223118|NCT00191477|520012412|FG000|Overall Study|Protocol Violation|1|||
144223119|NCT00191477|520012413|FG001|Overall Study|Protocol Violation|1|||
144223120|NCT00191477|520012412|FG000|Overall Study|Treatment Change|2|||
144223121|NCT00191477|520012413|FG001|Overall Study|Treatment Change|0|||
144223122|NCT00191477|520012412|FG000|Overall Study|Withdrawal by Subject|2|||
144223123|NCT00191477|520012413|FG001|Overall Study|Withdrawal by Subject|0|||
144223124|NCT00191477|520012412|FG000|Overall Study|Other|2|||
144223125|NCT00191477|520012413|FG001|Overall Study|Other|0|||
144223126|NCT00191477|520012412|FG000|Overall Study|Not Eligible|41|||
144223127|NCT00191477|520012413|FG001|Overall Study|Not Eligible|38|||
144223128|NCT00191477|520012412|FG000|Overall Study|Pathological Specimen Lost|1|||
144223129|NCT00191477|520012413|FG001|Overall Study|Pathological Specimen Lost|0|||
144223130|NCT00191477|520012412|FG000|Overall Study|Discontinued Prior to Instillation|13|||
144223131|NCT00191477|520012413|FG001|Overall Study|Discontinued Prior to Instillation|14|||
144223132|NCT03776357|520012416|FG000|Overall Study|Lost to Follow-up|3|||
144223133|NCT05921903|520012422|FG000|Overall Study|Unsolicited non-SAE|0|||
144223134|NCT05921903|520012423|FG001|Overall Study|Unsolicited non-SAE|1|||
144223135|NCT05921903|520012424|FG002|Overall Study|Unsolicited non-SAE|0|||
144223136|NCT05921903|520012422|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
144223137|NCT05921903|520012423|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
144223138|NCT05921903|520012424|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
144223139|NCT05921903|520012422|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
144223140|NCT05921903|520012423|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
144223141|NCT05921903|520012424|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
144223142|NCT00923013|520012427|FG000|Overall Study|Refused further treatment|0|||
144223143|NCT00923013|520012428|FG001|Overall Study|Refused further treatment|1|||
144223144|NCT00923013|520012429|FG002|Overall Study|Refused further treatment|2|||
144267097|NCT02990000|520181321|FG001|Overall Study|Failed to provide data beyond baseline|34|||
144267098|NCT00922636|520181322|FG000|Overall Study|Adverse Event|3|||
144223145|NCT00923013|520012430|FG003|Overall Study|Refused further treatment|0|||
144223146|NCT00923013|520012431|FG004|Overall Study|Refused further treatment|0|||
144223147|NCT00923013|520012432|FG005|Overall Study|Refused further treatment|0|||
144223148|NCT00923013|520012427|FG000|Overall Study|Switched to alternative treatment|0|||
144698889|NCT04409262|521750485|FG001|Overall Study|Protocol Violation|1|||
144698890|NCT04409262|521750484|FG000|Overall Study|Withdrawal by Subject|5|||
144698891|NCT04409262|521750485|FG001|Overall Study|Withdrawal by Subject|10|||
144698892|NCT03205605|521750486|FG000|Overall Study|Withdrawal by Subject|1|||
144698893|NCT02396849|521750487|FG000|Overall Study|Lost to Follow-up|1|||
144698894|NCT02396849|521750488|FG001|Overall Study|Lost to Follow-up|1|||
144698895|NCT02396849|521750487|FG000|Overall Study|Did not tolerate intervention|1|||
144698896|NCT02396849|521750488|FG001|Overall Study|Did not tolerate intervention|1|||
144698897|NCT03328325|521750491|FG000|Overall Study|Lost to Follow-up|4|||
144698898|NCT03328325|521750491|FG000|Overall Study|Physician Decision|1|||
144698899|NCT03328325|521750491|FG000|Overall Study|Withdrawal by Subject|3|||
144698900|NCT03328325|521750491|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
144698901|NCT01869959|521750494|FG000|Randomization Period|Physician Decision|0|||
144698902|NCT01869959|521750495|FG001|Randomization Period|Physician Decision|0|||
144223149|NCT00923013|520012428|FG001|Overall Study|Switched to alternative treatment|1|||
144698903|NCT01869959|521750496|FG002|Randomization Period|Physician Decision|0|||
144698904|NCT01869959|521750497|FG003|Randomization Period|Physician Decision|0|||
144698905|NCT01869959|521750498|FG004|Randomization Period|Physician Decision|1|||
144698906|NCT01869959|521750494|FG000|Treatment Period|Adverse Event|1|||
144698907|NCT01869959|521750495|FG001|Treatment Period|Adverse Event|0|||
144698908|NCT01869959|521750496|FG002|Treatment Period|Adverse Event|3|||
144698909|NCT01869959|521750497|FG003|Treatment Period|Adverse Event|1|||
144698910|NCT01869959|521750498|FG004|Treatment Period|Adverse Event|0|||
144698911|NCT01869959|521750494|FG000|Treatment Period|Sponsor decision|0|||
144698912|NCT01869959|521750495|FG001|Treatment Period|Sponsor decision|1|||
144698913|NCT01869959|521750496|FG002|Treatment Period|Sponsor decision|0|||
144698914|NCT01869959|521750497|FG003|Treatment Period|Sponsor decision|1|||
144698915|NCT01869959|521750498|FG004|Treatment Period|Sponsor decision|0|||
144698916|NCT01869959|521750494|FG000|Treatment Period|Withdrawal by Subject|0|||
144698917|NCT01869959|521750495|FG001|Treatment Period|Withdrawal by Subject|1|||
144698918|NCT01869959|521750496|FG002|Treatment Period|Withdrawal by Subject|0|||
144698919|NCT01869959|521750497|FG003|Treatment Period|Withdrawal by Subject|0|||
144698920|NCT01869959|521750498|FG004|Treatment Period|Withdrawal by Subject|0|||
144698921|NCT01965600|521750499|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
144698922|NCT01965600|521750500|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
144698923|NCT01965600|521750501|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
144698924|NCT01965600|521750502|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
144698925|NCT01965600|521750499|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
144698926|NCT01965600|521750500|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
144698927|NCT01965600|521750501|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
144698928|NCT01965600|521750502|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
144698929|NCT01965600|521750499|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
144698930|NCT01965600|521750500|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
144698931|NCT01965600|521750501|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
144698932|NCT01965600|521750502|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
144698933|NCT01965600|521750499|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
144698934|NCT01965600|521750500|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
144698935|NCT01965600|521750501|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
144698936|NCT01965600|521750502|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
144698937|NCT01965600|521750499|FG000|Second Intervention|Study terminated by Sponsor|0|||
144698938|NCT01965600|521750500|FG001|Second Intervention|Study terminated by Sponsor|0|||
144698939|NCT01965600|521750501|FG002|Second Intervention|Study terminated by Sponsor|2|||
144698940|NCT01965600|521750502|FG003|Second Intervention|Study terminated by Sponsor|2|||
144698941|NCT01473602|521752510|FG000|Overall Study|Adverse Event|1|||
144698942|NCT01473602|521752511|FG001|Overall Study|Adverse Event|2|||
144698943|NCT01473602|521752510|FG000|Overall Study|Death|0|||
144698944|NCT01473602|521752511|FG001|Overall Study|Death|1|||
144698945|NCT01473602|521752510|FG000|Overall Study|Lost to Follow-up|1|||
144698946|NCT01473602|521752511|FG001|Overall Study|Lost to Follow-up|1|||
144698947|NCT01473602|521752510|FG000|Overall Study|Withdrawal by Subject|5|||
144698948|NCT01473602|521752511|FG001|Overall Study|Withdrawal by Subject|4|||
144698949|NCT01473602|521752510|FG000|Overall Study|Physician Decision|1|||
144698950|NCT01473602|521752511|FG001|Overall Study|Physician Decision|0|||
144698951|NCT00449761|521752512|FG000|Overall Study|Disease progression|12|||
144698952|NCT00449761|521752512|FG000|Overall Study|Death|5|||
144698953|NCT00449761|521752512|FG000|Overall Study|New cancer therapy|1|||
144698954|NCT00726882|521752513|FG000|Overall Study|Withdrawal by Subject|5|||
144698955|NCT00726882|521752513|FG000|Overall Study|Lost to Follow-up|7|||
144698956|NCT00726882|521752513|FG000|Overall Study|Other|10|||
144698957|NCT00594568|521752514|FG000|Initial Treatment|Adverse Event|51|||
144698958|NCT00594568|521752515|FG001|Initial Treatment|Adverse Event|121|||
144698959|NCT00594568|521752516|FG002|Initial Treatment|Adverse Event|144|||
144698960|NCT00594568|521752514|FG000|Initial Treatment|Death|6|||
144698961|NCT00594568|521752515|FG001|Initial Treatment|Death|11|||
144223150|NCT00923013|520012429|FG002|Overall Study|Switched to alternative treatment|0|||
144223151|NCT00923013|520012430|FG003|Overall Study|Switched to alternative treatment|0|||
144698962|NCT00594568|521752516|FG002|Initial Treatment|Death|15|||
144698963|NCT00594568|521752514|FG000|Initial Treatment|Lost to Follow-up|4|||
144698964|NCT00594568|521752515|FG001|Initial Treatment|Lost to Follow-up|1|||
144698965|NCT00594568|521752516|FG002|Initial Treatment|Lost to Follow-up|4|||
144698966|NCT00594568|521752514|FG000|Initial Treatment|Physician Decision|3|||
144698967|NCT00594568|521752515|FG001|Initial Treatment|Physician Decision|2|||
144698968|NCT00594568|521752516|FG002|Initial Treatment|Physician Decision|4|||
144698969|NCT00594568|521752514|FG000|Initial Treatment|Protocol Violation|2|||
144698970|NCT00594568|521752515|FG001|Initial Treatment|Protocol Violation|2|||
144698971|NCT00594568|521752516|FG002|Initial Treatment|Protocol Violation|5|||
144698972|NCT00594568|521752514|FG000|Initial Treatment|Withdrawal by Subject|25|||
144698973|NCT00594568|521752515|FG001|Initial Treatment|Withdrawal by Subject|31|||
144698974|NCT00594568|521752516|FG002|Initial Treatment|Withdrawal by Subject|46|||
144698975|NCT00594568|521752514|FG000|Initial Treatment|Sponsor decision|193|||
144698976|NCT00594568|521752515|FG001|Initial Treatment|Sponsor decision|142|||
144698977|NCT00594568|521752516|FG002|Initial Treatment|Sponsor decision|147|||
144698978|NCT00594568|521752514|FG000|Initial Treatment|Caregiver decision|21|||
144698979|NCT00594568|521752515|FG001|Initial Treatment|Caregiver decision|36|||
144698980|NCT00594568|521752516|FG002|Initial Treatment|Caregiver decision|36|||
144698981|NCT00594568|521752514|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
144698982|NCT00594568|521752515|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
144698983|NCT00594568|521752516|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
144698984|NCT00594568|521752514|FG000|Initial Treatment|Entry criteria exclusion|0|||
144698985|NCT00594568|521752515|FG001|Initial Treatment|Entry criteria exclusion|1|||
144698986|NCT00594568|521752516|FG002|Initial Treatment|Entry criteria exclusion|1|||
144698987|NCT00594568|521752514|FG000|Delayed Start|Death|0|||
144698988|NCT00594568|521752515|FG001|Delayed Start|Death|0|||
144223152|NCT00923013|520012431|FG004|Overall Study|Switched to alternative treatment|0|||
144223153|NCT00923013|520012432|FG005|Overall Study|Switched to alternative treatment|0|||
144223154|NCT00923013|520012427|FG000|Overall Study|Death on study|2|||
144223155|NCT00923013|520012428|FG001|Overall Study|Death on study|2|||
144223156|NCT00923013|520012429|FG002|Overall Study|Death on study|0|||
144223157|NCT00923013|520012430|FG003|Overall Study|Death on study|1|||
144223158|NCT00923013|520012431|FG004|Overall Study|Death on study|0|||
144223159|NCT00923013|520012432|FG005|Overall Study|Death on study|0|||
144223160|NCT05366010|520012434|FG000|Overall Study|Withdrawal by Subject|1|||
144223161|NCT05366010|520012434|FG000|Overall Study|Protocol Violation|1|||
144223162|NCT05366010|520012434|FG000|Overall Study|Lost to Follow-up|2|||
144223163|NCT05366010|520012434|FG000|Overall Study|Screen Failure|2|||
144223164|NCT05906628|520012435|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
144223165|NCT05906628|520012436|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
144223166|NCT05906628|520012435|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
144223167|NCT05906628|520012436|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
144223168|NCT05906628|520012435|FG000|16-Week DBVC Period|Protocol Violation|4|||
144223169|NCT05906628|520012436|FG001|16-Week DBVC Period|Protocol Violation|2|||
144223170|NCT05906628|520012435|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
144223171|NCT05906628|520012436|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
144223172|NCT05906628|520012435|FG000|16-Week OLE Period|Death|1|||
144223173|NCT05906628|520012436|FG001|16-Week OLE Period|Death|0|||
144223174|NCT05906628|520012435|FG000|16-Week OLE Period|Lost to Follow-up|1|||
144223175|NCT05906628|520012436|FG001|16-Week OLE Period|Lost to Follow-up|1|||
144223176|NCT05906628|520012435|FG000|16-Week OLE Period|Protocol Violation|0|||
144223177|NCT05906628|520012436|FG001|16-Week OLE Period|Protocol Violation|1|||
144223178|NCT05906628|520012435|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
144223179|NCT05906628|520012436|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
144223180|NCT01108718|520012437|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
144223181|NCT01108718|520012438|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
144223182|NCT05317312|520012439|FG000|Overall Study|Withdrawal by Subject|0|||
144223183|NCT05317312|520012440|FG001|Overall Study|Withdrawal by Subject|1|||
144223184|NCT05317312|520012441|FG002|Overall Study|Withdrawal by Subject|0|||
144223185|NCT05317312|520012442|FG003|Overall Study|Withdrawal by Subject|0|||
144223186|NCT05317312|520012439|FG000|Overall Study|Lost to Follow-up|0|||
144223187|NCT05317312|520012440|FG001|Overall Study|Lost to Follow-up|0|||
144223188|NCT05317312|520012441|FG002|Overall Study|Lost to Follow-up|0|||
144223189|NCT05317312|520012442|FG003|Overall Study|Lost to Follow-up|1|||
144223190|NCT05317312|520012439|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
144223191|NCT05317312|520012440|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
144223192|NCT05317312|520012441|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
144223193|NCT05317312|520012442|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
144223194|NCT01060072|520012443|FG000|Overall Study|Adverse Event|1|||
144223195|NCT01060072|520012444|FG001|Overall Study|Adverse Event|1|||
144223196|NCT01060072|520012443|FG000|Overall Study|Physician Decision|0|||
144223197|NCT01060072|520012444|FG001|Overall Study|Physician Decision|2|||
144223198|NCT01060072|520012443|FG000|Overall Study|Protocol Violation|0|||
144223199|NCT01060072|520012444|FG001|Overall Study|Protocol Violation|1|||
144223200|NCT01060072|520012443|FG000|Overall Study|Acute cholecystitis|1|||
144223201|NCT01060072|520012444|FG001|Overall Study|Acute cholecystitis|0|||
144698989|NCT00594568|521752516|FG002|Delayed Start|Death|1|||
144698990|NCT00594568|521752514|FG000|Delayed Start|Adverse Event|12|||
144223202|NCT01060072|520012443|FG000|Overall Study|Excluded Medications|0|||
144223203|NCT01060072|520012444|FG001|Overall Study|Excluded Medications|1|||
144223204|NCT00235755|520012445|FG000|4-Week Titration Phase|Adverse Event|6|||
144223205|NCT00235755|520012446|FG001|4-Week Titration Phase|Adverse Event|14|||
144223206|NCT00235755|520012447|FG002|4-Week Titration Phase|Adverse Event|20|||
144223207|NCT00235755|520012445|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
144223208|NCT00235755|520012446|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
144698991|NCT00594568|521752515|FG001|Delayed Start|Adverse Event|2|||
144698992|NCT00594568|521752516|FG002|Delayed Start|Adverse Event|2|||
144698993|NCT00594568|521752514|FG000|Delayed Start|Withdrawal by Subject|4|||
144698994|NCT00594568|521752515|FG001|Delayed Start|Withdrawal by Subject|3|||
144698995|NCT00594568|521752516|FG002|Delayed Start|Withdrawal by Subject|0|||
144698996|NCT00594568|521752514|FG000|Delayed Start|Physician Decision|0|||
144698997|NCT00594568|521752515|FG001|Delayed Start|Physician Decision|0|||
144698998|NCT00594568|521752516|FG002|Delayed Start|Physician Decision|1|||
144698999|NCT00594568|521752514|FG000|Delayed Start|Lost to Follow-up|0|||
144699000|NCT00594568|521752515|FG001|Delayed Start|Lost to Follow-up|0|||
144699001|NCT00594568|521752516|FG002|Delayed Start|Lost to Follow-up|1|||
144699002|NCT00594568|521752514|FG000|Delayed Start|Caregiver Decision|5|||
144699003|NCT00594568|521752515|FG001|Delayed Start|Caregiver Decision|6|||
144699004|NCT00594568|521752516|FG002|Delayed Start|Caregiver Decision|2|||
144699005|NCT00594568|521752514|FG000|Delayed Start|Sponsor Decision|77|||
144699006|NCT00594568|521752515|FG001|Delayed Start|Sponsor Decision|66|||
144699007|NCT00594568|521752516|FG002|Delayed Start|Sponsor Decision|59|||
144699008|NCT00594568|521752514|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
144699009|NCT00594568|521752515|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
144699010|NCT00594568|521752516|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
144699011|NCT00594568|521752514|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
144699012|NCT00594568|521752515|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
144699013|NCT00594568|521752516|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
144699014|NCT00594568|521752514|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
144699015|NCT00594568|521752515|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
144699016|NCT00594568|521752516|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
144699017|NCT00594568|521752514|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
144699018|NCT00594568|521752515|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
144699019|NCT00594568|521752516|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
144699020|NCT00594568|521752514|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
144699021|NCT00594568|521752515|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
144699022|NCT00594568|521752516|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
144699023|NCT00594568|521752514|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
144699024|NCT00594568|521752515|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
144699025|NCT00594568|521752516|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
144699026|NCT01422876|521752518|FG000|Week 24|Lost to Follow-up|1|||
144699027|NCT01422876|521752519|FG001|Week 24|Lost to Follow-up|1|||
144699028|NCT01422876|521752520|FG002|Week 24|Lost to Follow-up|2|||
144699029|NCT01422876|521752521|FG003|Week 24|Lost to Follow-up|4|||
144699030|NCT01422876|521752522|FG004|Week 24|Lost to Follow-up|2|||
144699031|NCT01422876|521752523|FG005|Week 24|Lost to Follow-up|0|||
144699032|NCT01422876|521752524|FG006|Week 24|Lost to Follow-up|1|||
144699033|NCT01422876|521752525|FG007|Week 24|Lost to Follow-up|3|||
144699034|NCT01422876|521752526|FG008|Week 24|Lost to Follow-up|3|||
144223209|NCT00235755|520012447|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
144223210|NCT00235755|520012445|FG000|4-Week Titration Phase|Protocol Violation|2|||
144223211|NCT00235755|520012446|FG001|4-Week Titration Phase|Protocol Violation|2|||
144223212|NCT00235755|520012447|FG002|4-Week Titration Phase|Protocol Violation|1|||
144223213|NCT00235755|520012445|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
144223214|NCT00235755|520012446|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
144223215|NCT00235755|520012447|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
144223216|NCT00235755|520012445|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
144223217|NCT00235755|520012446|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
144223218|NCT00235755|520012447|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
144223219|NCT00235755|520012445|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
144223220|NCT00235755|520012446|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
144223221|NCT00235755|520012447|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
144699035|NCT01422876|521752527|FG009|Week 24|Lost to Follow-up|4|||
144699036|NCT01422876|521752518|FG000|Week 24|Consent withdrawn|5|||
144699037|NCT01422876|521752519|FG001|Week 24|Consent withdrawn|1|||
144699038|NCT01422876|521752520|FG002|Week 24|Consent withdrawn|3|||
144699039|NCT01422876|521752521|FG003|Week 24|Consent withdrawn|4|||
144699040|NCT01422876|521752522|FG004|Week 24|Consent withdrawn|5|||
144699041|NCT01422876|521752523|FG005|Week 24|Consent withdrawn|6|||
144699042|NCT01422876|521752524|FG006|Week 24|Consent withdrawn|5|||
144699043|NCT01422876|521752525|FG007|Week 24|Consent withdrawn|4|||
144699044|NCT01422876|521752526|FG008|Week 24|Consent withdrawn|3|||
144699045|NCT01422876|521752527|FG009|Week 24|Consent withdrawn|6|||
144699046|NCT01422876|521752518|FG000|Week 24|Death|0|||
144699047|NCT01422876|521752519|FG001|Week 24|Death|1|||
144699048|NCT01422876|521752520|FG002|Week 24|Death|0|||
144699049|NCT01422876|521752521|FG003|Week 24|Death|0|||
144223222|NCT00235755|520012445|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
144223223|NCT00235755|520012446|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
144699050|NCT01422876|521752522|FG004|Week 24|Death|0|||
144699051|NCT01422876|521752523|FG005|Week 24|Death|0|||
144699052|NCT01422876|521752524|FG006|Week 24|Death|0|||
144699053|NCT01422876|521752525|FG007|Week 24|Death|0|||
144699054|NCT01422876|521752526|FG008|Week 24|Death|0|||
144699055|NCT01422876|521752527|FG009|Week 24|Death|0|||
144699056|NCT01422876|521752518|FG000|Week 52|Lost to Follow-up|3|||
144699057|NCT01422876|521752519|FG001|Week 52|Lost to Follow-up|5|||
144699058|NCT01422876|521752520|FG002|Week 52|Lost to Follow-up|7|||
144699059|NCT01422876|521752521|FG003|Week 52|Lost to Follow-up|5|||
144699060|NCT01422876|521752522|FG004|Week 52|Lost to Follow-up|8|||
144699061|NCT01422876|521752523|FG005|Week 52|Lost to Follow-up|5|||
144699062|NCT01422876|521752524|FG006|Week 52|Lost to Follow-up|5|||
144699063|NCT01422876|521752525|FG007|Week 52|Lost to Follow-up|8|||
144699064|NCT01422876|521752526|FG008|Week 52|Lost to Follow-up|7|||
144699065|NCT01422876|521752527|FG009|Week 52|Lost to Follow-up|8|||
144699066|NCT01422876|521752518|FG000|Week 52|Consent withdrawn|9|||
144699067|NCT01422876|521752519|FG001|Week 52|Consent withdrawn|4|||
144699068|NCT01422876|521752520|FG002|Week 52|Consent withdrawn|6|||
144699069|NCT01422876|521752521|FG003|Week 52|Consent withdrawn|12|||
144699070|NCT01422876|521752522|FG004|Week 52|Consent withdrawn|7|||
144699071|NCT01422876|521752523|FG005|Week 52|Consent withdrawn|12|||
144699072|NCT01422876|521752524|FG006|Week 52|Consent withdrawn|10|||
144699073|NCT01422876|521752525|FG007|Week 52|Consent withdrawn|12|||
144699074|NCT01422876|521752526|FG008|Week 52|Consent withdrawn|13|||
144699075|NCT01422876|521752527|FG009|Week 52|Consent withdrawn|9|||
144699076|NCT01422876|521752518|FG000|Week 52|Death|0|||
144699077|NCT01422876|521752519|FG001|Week 52|Death|1|||
144699078|NCT01422876|521752520|FG002|Week 52|Death|0|||
144699079|NCT01422876|521752521|FG003|Week 52|Death|1|||
144699080|NCT01422876|521752522|FG004|Week 52|Death|0|||
144699081|NCT01422876|521752523|FG005|Week 52|Death|0|||
144699082|NCT01422876|521752524|FG006|Week 52|Death|1|||
144699083|NCT01422876|521752525|FG007|Week 52|Death|3|||
144699084|NCT01422876|521752526|FG008|Week 52|Death|1|||
144699085|NCT01422876|521752527|FG009|Week 52|Death|0|||
144699086|NCT02526017|521752528|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699087|NCT02526017|521752529|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699088|NCT02526017|521752530|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699089|NCT02526017|521752531|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699090|NCT02526017|521752532|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
144699091|NCT02526017|521752533|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699092|NCT02526017|521752534|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699093|NCT02526017|521752535|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699094|NCT02526017|521752536|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
144699095|NCT00536991|521752538|FG000|Overall Study|Withdrawal by Subject|10|||
144699096|NCT00536991|521752538|FG000|Overall Study|Physician Decision|1|||
144699097|NCT00536991|521752538|FG000|Overall Study|patient ineligible|2|||
144699098|NCT00518531|521752539|FG000|Treatment Period 1|Adverse Event|5|||
144699099|NCT00518531|521752540|FG001|Treatment Period 1|Adverse Event|0|||
144699100|NCT00518531|521752539|FG000|Treatment Period 1|Lost to Follow-up|5|||
144699101|NCT00518531|521752540|FG001|Treatment Period 1|Lost to Follow-up|3|||
144699102|NCT00518531|521752539|FG000|Treatment Period 1|Physician Decision|1|||
144699103|NCT00518531|521752540|FG001|Treatment Period 1|Physician Decision|0|||
144699104|NCT00518531|521752539|FG000|Treatment Period 1|Protocol Violation|2|||
144699105|NCT00518531|521752540|FG001|Treatment Period 1|Protocol Violation|0|||
144699106|NCT00518531|521752539|FG000|Treatment Period 1|Withdrawal by Subject|4|||
144699107|NCT00518531|521752540|FG001|Treatment Period 1|Withdrawal by Subject|6|||
144699108|NCT00518531|521752539|FG000|Treatment Period 1|Early crossover|1|||
144699109|NCT00518531|521752540|FG001|Treatment Period 1|Early crossover|3|||
144699110|NCT00518531|521752539|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144699111|NCT00518531|521752540|FG001|Treatment Period 2|Withdrawal by Subject|8|||
144699112|NCT00518531|521752539|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
144699113|NCT00518531|521752540|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
144699114|NCT00518531|521752539|FG000|Treatment Period 2|Adverse Event|1|||
144699115|NCT00518531|521752540|FG001|Treatment Period 2|Adverse Event|7|||
144699116|NCT00518531|521752539|FG000|Treatment Period 2|Protocol-specified criteria|0|||
144699117|NCT00518531|521752540|FG001|Treatment Period 2|Protocol-specified criteria|1|||
144699118|NCT00518531|521752539|FG000|Treatment Period 2|Non-compliance|1|||
144699119|NCT00518531|521752540|FG001|Treatment Period 2|Non-compliance|2|||
144699120|NCT00054639|521752541|FG000|Overall Study|Lack of Efficacy|1|||
144699121|NCT00054639|521752541|FG000|Overall Study|Physician Decision|1|||
144699122|NCT01600755|521752542|FG000|Overall Study|Withdrawal by Subject|6|||
144699123|NCT04621227|521752549|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
144699124|NCT04621227|521752549|FG000|Period 3 (29 Days)|Adverse Event|1|||
144267099|NCT00922636|520181323|FG001|Overall Study|Adverse Event|3|||
144699125|NCT04621227|521752549|FG000|Period 8 (2 Days)|Adverse Event|1|||
144699126|NCT01728376|521752550|FG000|Overall Study|Adverse Event|1|||
144699127|NCT01728376|521752551|FG001|Overall Study|Adverse Event|1|||
144699128|NCT01728376|521752552|FG002|Overall Study|Adverse Event|1|||
144699129|NCT01728376|521752553|FG003|Overall Study|Adverse Event|1|||
144699130|NCT01728376|521752554|FG004|Overall Study|Adverse Event|1|||
144699131|NCT01728376|521752555|FG005|Overall Study|Adverse Event|0|||
144699132|NCT01728376|521752550|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
144699133|NCT01728376|521752551|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
144699134|NCT01728376|521752552|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
144699135|NCT01728376|521752553|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
144699136|NCT01728376|521752554|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
144699137|NCT01728376|521752555|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
144699138|NCT01728376|521752550|FG000|Overall Study|No relevant bacteria|2|||
144699139|NCT01728376|521752551|FG001|Overall Study|No relevant bacteria|0|||
144699140|NCT01728376|521752552|FG002|Overall Study|No relevant bacteria|0|||
144699141|NCT01728376|521752553|FG003|Overall Study|No relevant bacteria|0|||
144699142|NCT01728376|521752554|FG004|Overall Study|No relevant bacteria|1|||
144699143|NCT01728376|521752555|FG005|Overall Study|No relevant bacteria|1|||
144699144|NCT01728376|521752550|FG000|Overall Study|Did not receive treatment|0|||
144699145|NCT01728376|521752551|FG001|Overall Study|Did not receive treatment|1|||
144699146|NCT01728376|521752552|FG002|Overall Study|Did not receive treatment|0|||
144699147|NCT01728376|521752553|FG003|Overall Study|Did not receive treatment|0|||
144699148|NCT01728376|521752554|FG004|Overall Study|Did not receive treatment|0|||
144699149|NCT01728376|521752555|FG005|Overall Study|Did not receive treatment|0|||
144699150|NCT01728376|521752550|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
144699151|NCT01728376|521752551|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
144699152|NCT01728376|521752552|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
144699153|NCT01728376|521752553|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
144699154|NCT01728376|521752554|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
144699155|NCT01728376|521752555|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
144699156|NCT02856282|521752561|FG000|Overall Study|Withdrawal by Subject|1|||
144699157|NCT00057330|521752562|FG000|Overall Study|Adverse Event|9|||
144699158|NCT00057330|521752563|FG001|Overall Study|Adverse Event|12|||
144699159|NCT00057330|521752562|FG000|Overall Study|Death|1|||
144699160|NCT00057330|521752563|FG001|Overall Study|Death|0|||
144699161|NCT00057330|521752562|FG000|Overall Study|Protocol Violation|1|||
144699162|NCT00057330|521752563|FG001|Overall Study|Protocol Violation|1|||
144699163|NCT00057330|521752562|FG000|Overall Study|Withdrawal by Subject|115|||
144699164|NCT00057330|521752563|FG001|Overall Study|Withdrawal by Subject|84|||
144699165|NCT00057330|521752562|FG000|Overall Study|Lost to Follow-up|745|||
144699166|NCT00057330|521752563|FG001|Overall Study|Lost to Follow-up|617|||
144699167|NCT00057330|521752562|FG000|Overall Study|Physician Decision|1|||
144699168|NCT00057330|521752563|FG001|Overall Study|Physician Decision|0|||
144699169|NCT00057330|521752562|FG000|Overall Study|Other|260|||
144699170|NCT00057330|521752563|FG001|Overall Study|Other|206|||
144699171|NCT01976663|521752572|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
144699172|NCT01976663|521752572|FG000|Overall Study|Personal Reasons|6|||
144699173|NCT01976663|521752572|FG000|Overall Study|Withdrawal by Subject|4|||
144699174|NCT01976663|521752572|FG000|Overall Study|Screen Failure|3|||
144699175|NCT01976663|521752572|FG000|Overall Study|Adverse Event|2|||
144699176|NCT01976663|521752572|FG000|Overall Study|Lost to Follow-up|3|||
144699177|NCT00423137|521752573|FG000|Overall Study|Lost to Follow-up|0|||
144699178|NCT00423137|521752574|FG001|Overall Study|Lost to Follow-up|0|||
144699179|NCT00423137|521752575|FG002|Overall Study|Lost to Follow-up|1|||
144699180|NCT00423137|521752576|FG003|Overall Study|Lost to Follow-up|0|||
144699181|NCT00423137|521752573|FG000|Overall Study|Protocol Violation|0|||
144699182|NCT00423137|521752574|FG001|Overall Study|Protocol Violation|0|||
144699183|NCT00423137|521752575|FG002|Overall Study|Protocol Violation|0|||
144699184|NCT00423137|521752576|FG003|Overall Study|Protocol Violation|1|||
144699185|NCT00423137|521752573|FG000|Overall Study|Adverse Event Study disease worse|1|||
144699186|NCT00423137|521752574|FG001|Overall Study|Adverse Event Study disease worse|0|||
144699187|NCT00423137|521752575|FG002|Overall Study|Adverse Event Study disease worse|3|||
144699188|NCT00423137|521752576|FG003|Overall Study|Adverse Event Study disease worse|1|||
144699189|NCT00423137|521752573|FG000|Overall Study|Adverse Event Other|0|||
144699190|NCT00423137|521752574|FG001|Overall Study|Adverse Event Other|0|||
144699191|NCT00423137|521752575|FG002|Overall Study|Adverse Event Other|2|||
144699192|NCT00423137|521752576|FG003|Overall Study|Adverse Event Other|0|||
144699193|NCT00483574|521752587|FG000|Overall Study|Adverse Event|6|||
144699194|NCT00483574|521752588|FG001|Overall Study|Adverse Event|0|||
144699195|NCT00483574|521752587|FG000|Overall Study|Protocol Violation|28|||
144699196|NCT00483574|521752588|FG001|Overall Study|Protocol Violation|9|||
144699197|NCT00483574|521752587|FG000|Overall Study|Lost to Follow-up|16|||
144699198|NCT00483574|521752588|FG001|Overall Study|Lost to Follow-up|4|||
144699199|NCT00483574|521752587|FG000|Overall Study|Withdrawal by Subject|52|||
144699200|NCT00483574|521752588|FG001|Overall Study|Withdrawal by Subject|0|||
144699201|NCT04753606|521752589|FG000|Overall Study|Adverse Event|1|||
144699202|NCT04753606|521752590|FG001|Overall Study|Adverse Event|0|||
144699203|NCT04753606|521752591|FG002|Overall Study|Adverse Event|0|||
144699204|NCT03841331|521752592|FG000|Overall Study|Withdrawal by Subject|4|||
144699205|NCT03841331|521752593|FG001|Overall Study|Withdrawal by Subject|9|||
144699206|NCT03841331|521752592|FG000|Overall Study|Lost to Follow-up|5|||
144699207|NCT03841331|521752593|FG001|Overall Study|Lost to Follow-up|1|||
144699208|NCT04640168|521752594|FG000|Overall Study|Withdrawal by Subject|8|||
144699209|NCT04640168|521752595|FG001|Overall Study|Withdrawal by Subject|7|||
144699210|NCT04640168|521752594|FG000|Overall Study|Lost to Follow-up|1|||
144699211|NCT04640168|521752595|FG001|Overall Study|Lost to Follow-up|0|||
144699212|NCT04640168|521752594|FG000|Overall Study|Enrolled but not treated|12|||
144699213|NCT04640168|521752595|FG001|Overall Study|Enrolled but not treated|12|||
144699214|NCT00442572|521752603|FG000|Overall Study|Relapse|8|||
144699215|NCT00442572|521752604|FG001|Overall Study|Relapse|1|||
144699216|NCT00442572|521752603|FG000|Overall Study|Lost to Follow-up|0|||
144699217|NCT00442572|521752604|FG001|Overall Study|Lost to Follow-up|1|||
144699218|NCT00442572|521752603|FG000|Overall Study|Withdrawal by Subject|0|||
144699219|NCT00442572|521752604|FG001|Overall Study|Withdrawal by Subject|1|||
144699220|NCT04366258|521752605|FG000|Baseline Assessments|Screen Failure|21|||
144699221|NCT04366258|521752605|FG000|Baseline Assessments|Early Termination|3|||
144699222|NCT03557775|521752606|FG000|Overall Study|Withdrawal by Subject|1|||
144699223|NCT03557775|521752607|FG001|Overall Study|Withdrawal by Subject|2|||
144699224|NCT03557775|521752608|FG002|Overall Study|Withdrawal by Subject|4|||
144699225|NCT03557775|521752606|FG000|Overall Study|Physician Decision|0|||
144699226|NCT03557775|521752607|FG001|Overall Study|Physician Decision|1|||
144699227|NCT03557775|521752608|FG002|Overall Study|Physician Decision|0|||
144699228|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
144699229|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
144699230|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
144699231|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
144699232|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
144699233|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Death|1|||
144699234|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Death|0|||
144699235|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Death|0|||
144699236|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Death|0|||
144699237|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Death|0|||
144699238|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
144699239|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
144699240|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
144699241|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
144699242|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
144699243|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
144699244|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
144699245|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
144699246|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
144699247|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
144699248|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
144699249|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
144699250|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
144699251|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
144699252|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
144699253|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
144699254|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
144699255|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
144699256|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
144699257|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
144699258|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
144699259|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
144699260|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
144699261|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
144699262|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
144699263|NCT00634933|521752624|FG000|Part A: Baseline to Week 24|Other|1|||
144699264|NCT00634933|521752625|FG001|Part A: Baseline to Week 24|Other|8|||
144699265|NCT00634933|521752626|FG002|Part A: Baseline to Week 24|Other|5|||
144699266|NCT00634933|521752627|FG003|Part A: Baseline to Week 24|Other|0|||
144699267|NCT00634933|521752628|FG004|Part A: Baseline to Week 24|Other|0|||
144699268|NCT00634933|521752624|FG000|Between Part A and Part B|Physician Decision|0|||
144699269|NCT00634933|521752625|FG001|Between Part A and Part B|Physician Decision|1|||
144699270|NCT00634933|521752626|FG002|Between Part A and Part B|Physician Decision|0|||
144699271|NCT00634933|521752627|FG003|Between Part A and Part B|Physician Decision|0|||
144699272|NCT00634933|521752628|FG004|Between Part A and Part B|Physician Decision|0|||
144699273|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
144699274|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
144699275|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
144699276|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
144699277|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
144699278|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
144699279|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
144699280|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
144699281|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
144699282|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
144699283|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
144699284|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
144699285|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
144699286|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
144699287|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
144699288|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
144699289|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
144699290|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
144699291|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
144699292|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
144699293|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
144699294|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
144699295|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
144699296|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
144699297|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
144699298|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
144699299|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
144699300|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
144699301|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
144699302|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
144699303|NCT00634933|521752624|FG000|Part B: Week 24 to Week 52|Other|0|||
144699304|NCT00634933|521752625|FG001|Part B: Week 24 to Week 52|Other|0|||
144699305|NCT00634933|521752626|FG002|Part B: Week 24 to Week 52|Other|5|||
144699306|NCT00634933|521752627|FG003|Part B: Week 24 to Week 52|Other|0|||
144699307|NCT00634933|521752628|FG004|Part B: Week 24 to Week 52|Other|1|||
144699308|NCT02058849|521752629|FG000|Overall Study|Hospitalization|1|||
144699309|NCT02058849|521752630|FG001|Overall Study|Hospitalization|1|||
144699310|NCT02058849|521752629|FG000|Overall Study|Death|1|||
144699311|NCT02058849|521752630|FG001|Overall Study|Death|0|||
144699312|NCT02058849|521752629|FG000|Overall Study|Lost to Follow-up|1|||
144699313|NCT02058849|521752630|FG001|Overall Study|Lost to Follow-up|0|||
144699314|NCT02058849|521752629|FG000|Overall Study|Withdrawal by Subject|4|||
144699315|NCT02058849|521752630|FG001|Overall Study|Withdrawal by Subject|0|||
144699316|NCT01694849|521752631|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
144699317|NCT01694849|521752632|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
144699318|NCT01694849|521752633|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
144699319|NCT01694849|521752631|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
144699320|NCT01694849|521752632|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
144699321|NCT01694849|521752633|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
144699322|NCT01694849|521752631|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
144699323|NCT01694849|521752632|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
144699324|NCT01694849|521752633|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
144699325|NCT01694849|521752631|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
144699326|NCT01694849|521752632|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
144699327|NCT01694849|521752633|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
144699328|NCT01694849|521752631|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
144699329|NCT01694849|521752632|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
144699330|NCT01694849|521752633|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
144699331|NCT01694849|521752631|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
144699332|NCT01694849|521752632|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
144699333|NCT01694849|521752633|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
144699334|NCT01694849|521752631|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
144699335|NCT01694849|521752632|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
144699336|NCT01694849|521752633|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
144699337|NCT01694849|521752631|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
144699338|NCT01694849|521752632|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
144699339|NCT01694849|521752633|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
144699340|NCT05147311|521752636|FG000|Overall Study|Did not complete survey|2|||
144699341|NCT05147311|521752637|FG001|Overall Study|Did not complete survey|1|||
144699342|NCT05147311|521752636|FG000|Overall Study|Patient too sick|1|||
144699343|NCT05147311|521752637|FG001|Overall Study|Patient too sick|2|||
144699344|NCT05147311|521752636|FG000|Overall Study|Death|0|||
144699345|NCT05147311|521752637|FG001|Overall Study|Death|1|||
144699346|NCT05147311|521752636|FG000|Overall Study|Declined survey|1|||
144699347|NCT05147311|521752637|FG001|Overall Study|Declined survey|0|||
144699348|NCT02279888|521752639|FG000|Overall Study|Death|326|||
144699349|NCT02279888|521752639|FG000|Overall Study|Withdrawal by Subject|38|||
144699350|NCT02279888|521752639|FG000|Overall Study|Lost to Follow-up|21|||
144699351|NCT02279888|521752639|FG000|Overall Study|Physician Decision|62|||
144699352|NCT02279888|521752639|FG000|Overall Study|Subject Non-compliance|43|||
144699353|NCT02279888|521752639|FG000|Overall Study|Not implanted|14|||
144267100|NCT00922636|520181324|FG002|Overall Study|Adverse Event|2|||
144267101|NCT00922636|520181325|FG003|Overall Study|Adverse Event|3|||
144267102|NCT00922636|520181326|FG004|Overall Study|Adverse Event|2|||
144699354|NCT02279888|521752639|FG000|Overall Study|Visit not performed|26|||
144699355|NCT04505592|521752640|FG000|Overall Study|Death|2|||
144699356|NCT04505592|521752641|FG001|Overall Study|Death|1|||
144699357|NCT04678557|521752653|FG000|Overall Study|Withdrawal by Subject|1|||
144699358|NCT04678557|521752654|FG001|Overall Study|Withdrawal by Subject|0|||
144699359|NCT04678557|521752653|FG000|Overall Study|Lack of Efficacy|0|||
144699360|NCT04678557|521752654|FG001|Overall Study|Lack of Efficacy|13|||
144699361|NCT04678557|521752653|FG000|Overall Study|Safety Evaluation|0|||
144699362|NCT04678557|521752654|FG001|Overall Study|Safety Evaluation|1|||
144699363|NCT02260804|521752659|FG000|Induction Study Period|Protocol Violation|2|||
144699364|NCT02260804|521752660|FG001|Induction Study Period|Protocol Violation|0|||
144699365|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
144699366|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
144699367|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
144699368|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
144699369|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
144699370|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
144699371|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
144699372|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
144699373|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
144699374|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
144699375|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
144699376|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
144699377|NCT02260804|521752659|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
144699378|NCT02260804|521752660|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
144699379|NCT02260804|521752659|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
144699380|NCT02260804|521752660|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
144699381|NCT02260804|521752659|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
144699382|NCT02260804|521752660|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
144699383|NCT02260804|521752659|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
144699384|NCT02260804|521752660|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
144699385|NCT00509223|521754347|FG000|Overall Study|Lost to Follow-up|1|||
144699386|NCT00509223|521754348|FG001|Overall Study|Lost to Follow-up|1|||
144699387|NCT00509223|521754347|FG000|Overall Study|Adverse Event|1|||
144699388|NCT00509223|521754348|FG001|Overall Study|Adverse Event|1|||
144699389|NCT00509223|521754347|FG000|Overall Study|Withdrawal by Subject|25|||
144699390|NCT00509223|521754348|FG001|Overall Study|Withdrawal by Subject|6|||
144699391|NCT00509223|521754347|FG000|Overall Study|Including: subject change of address|5|||
144699392|NCT00509223|521754348|FG001|Overall Study|Including: subject change of address|2|||
144699393|NCT00509223|521754347|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
144699394|NCT00509223|521754348|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
144699395|NCT00437294|521754356|FG000|Overall Study|Adverse Event|5|||
144699396|NCT00437294|521754357|FG001|Overall Study|Adverse Event|4|||
144699397|NCT00437294|521754356|FG000|Overall Study|Death|5|||
144699398|NCT00437294|521754357|FG001|Overall Study|Death|2|||
144699399|NCT00437294|521754356|FG000|Overall Study|Physician Decision|0|||
144699400|NCT00437294|521754357|FG001|Overall Study|Physician Decision|3|||
144699401|NCT00437294|521754356|FG000|Overall Study|Withdrawal by Subject|5|||
144699402|NCT00437294|521754357|FG001|Overall Study|Withdrawal by Subject|0|||
144699403|NCT00437294|521754356|FG000|Overall Study|Progressive Disease|19|||
144699404|NCT00437294|521754357|FG001|Overall Study|Progressive Disease|23|||
144699405|NCT00437294|521754356|FG000|Overall Study|Sponsor Decision|8|||
144699406|NCT00437294|521754357|FG001|Overall Study|Sponsor Decision|9|||
144223224|NCT00235755|520012447|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
144223225|NCT00235755|520012445|FG000|12-Week Maintenance Phase|Adverse Event|8|||
144223226|NCT00235755|520012446|FG001|12-Week Maintenance Phase|Adverse Event|12|||
144223227|NCT00235755|520012447|FG002|12-Week Maintenance Phase|Adverse Event|26|||
144223228|NCT00235755|520012445|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
144223229|NCT00235755|520012446|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
144223230|NCT00235755|520012447|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
144267103|NCT00922636|520181322|FG000|Overall Study|Lack of Efficacy|1|||
144267104|NCT00922636|520181323|FG001|Overall Study|Lack of Efficacy|7|||
144699407|NCT00437294|521754356|FG000|Overall Study|Protocol Violation|0|||
144223231|NCT00235755|520012445|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
144267105|NCT00922636|520181324|FG002|Overall Study|Lack of Efficacy|3|||
144699408|NCT00437294|521754357|FG001|Overall Study|Protocol Violation|1|||
144699409|NCT00437294|521754356|FG000|Overall Study|Entry criteria not met|1|||
144699410|NCT00437294|521754357|FG001|Overall Study|Entry criteria not met|1|||
144699411|NCT00560573|521754365|FG000|Overall Study|Death|4|||
144267106|NCT00922636|520181325|FG003|Overall Study|Lack of Efficacy|2|||
144699412|NCT00560573|521754366|FG001|Overall Study|Death|1|||
144699413|NCT00560573|521754367|FG002|Overall Study|Death|4|||
144699414|NCT00560573|521754368|FG003|Overall Study|Death|5|||
144699415|NCT00560573|521754369|FG004|Overall Study|Death|1|||
144699416|NCT00560573|521754370|FG005|Overall Study|Death|10|||
144699417|NCT00560573|521754365|FG000|Overall Study|Lost to Follow-up|0|||
144699418|NCT00560573|521754366|FG001|Overall Study|Lost to Follow-up|0|||
144699419|NCT00560573|521754367|FG002|Overall Study|Lost to Follow-up|0|||
144699420|NCT00560573|521754368|FG003|Overall Study|Lost to Follow-up|1|||
144699421|NCT00560573|521754369|FG004|Overall Study|Lost to Follow-up|1|||
144699422|NCT00560573|521754370|FG005|Overall Study|Lost to Follow-up|0|||
144699423|NCT00560573|521754365|FG000|Overall Study|Withdrawal by Subject|0|||
144699424|NCT00560573|521754366|FG001|Overall Study|Withdrawal by Subject|0|||
144699425|NCT00560573|521754367|FG002|Overall Study|Withdrawal by Subject|0|||
144699426|NCT00560573|521754368|FG003|Overall Study|Withdrawal by Subject|1|||
144699427|NCT00560573|521754369|FG004|Overall Study|Withdrawal by Subject|1|||
144699428|NCT00560573|521754370|FG005|Overall Study|Withdrawal by Subject|0|||
144699429|NCT00560573|521754365|FG000|Overall Study|Other|2|||
144699430|NCT00560573|521754366|FG001|Overall Study|Other|2|||
144699431|NCT00560573|521754367|FG002|Overall Study|Other|2|||
144699432|NCT00560573|521754368|FG003|Overall Study|Other|3|||
144699433|NCT00560573|521754369|FG004|Overall Study|Other|3|||
144699434|NCT00560573|521754370|FG005|Overall Study|Other|3|||
144699435|NCT00560573|521754365|FG000|Overall Study|Enrolled, not treated|0|||
144699436|NCT00560573|521754366|FG001|Overall Study|Enrolled, not treated|0|||
144699437|NCT00560573|521754367|FG002|Overall Study|Enrolled, not treated|0|||
144699438|NCT00560573|521754368|FG003|Overall Study|Enrolled, not treated|0|||
144699439|NCT00560573|521754369|FG004|Overall Study|Enrolled, not treated|1|||
144699440|NCT00560573|521754370|FG005|Overall Study|Enrolled, not treated|0|||
144699441|NCT01339273|521754371|FG000|Overall Study|Lost to Follow-up|8|||
144699442|NCT01339273|521754372|FG001|Overall Study|Lost to Follow-up|8|||
144699443|NCT04888377|521754375|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
144699444|NCT04888377|521754376|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
144699445|NCT04888377|521754375|FG000|Overall Study|Physician Decision|6|||
144699446|NCT04888377|521754376|FG001|Overall Study|Physician Decision|6|||
144699447|NCT04888377|521754375|FG000|Overall Study|Withdrawal by Subject|7|||
144699448|NCT04888377|521754376|FG001|Overall Study|Withdrawal by Subject|3|||
144699449|NCT04359758|521754377|FG000|Overall Study|Protocol Violation|3|||
144699450|NCT04359758|521754378|FG001|Overall Study|Protocol Violation|2|||
144699451|NCT01207219|521754381|FG000|Overall Study|changed diagnosis during study period|5|||
144699452|NCT01207219|521754382|FG001|Overall Study|changed diagnosis during study period|3|||
144699453|NCT01207219|521754383|FG002|Overall Study|changed diagnosis during study period|1|||
144699454|NCT01207219|521754381|FG000|Overall Study|Lost to Follow-up|6|||
144699455|NCT01207219|521754382|FG001|Overall Study|Lost to Follow-up|8|||
144223232|NCT00235755|520012446|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
144223233|NCT00235755|520012447|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
144223234|NCT00235755|520012445|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
144223235|NCT00235755|520012446|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
144223236|NCT00235755|520012447|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
144223237|NCT00235755|520012445|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
144223238|NCT00235755|520012446|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
144699456|NCT01207219|521754383|FG002|Overall Study|Lost to Follow-up|6|||
144699457|NCT01012609|521754384|FG000|Overall Study|Withdrawal by Subject|1|||
144699458|NCT01012609|521754385|FG001|Overall Study|Withdrawal by Subject|1|||
144267107|NCT00922636|520181326|FG004|Overall Study|Lack of Efficacy|4|||
144267108|NCT00922636|520181322|FG000|Overall Study|Sponsor Decision|0|||
144267109|NCT00922636|520181323|FG001|Overall Study|Sponsor Decision|0|||
144267110|NCT00922636|520181324|FG002|Overall Study|Sponsor Decision|2|||
144267111|NCT00922636|520181325|FG003|Overall Study|Sponsor Decision|0|||
144267112|NCT00922636|520181326|FG004|Overall Study|Sponsor Decision|0|||
144267113|NCT00922636|520181322|FG000|Overall Study|Withdrawal by Subject|0|||
144267114|NCT00922636|520181323|FG001|Overall Study|Withdrawal by Subject|0|||
144267115|NCT00922636|520181324|FG002|Overall Study|Withdrawal by Subject|5|||
144267116|NCT00922636|520181325|FG003|Overall Study|Withdrawal by Subject|2|||
144267117|NCT00922636|520181326|FG004|Overall Study|Withdrawal by Subject|4|||
144267118|NCT00922636|520181322|FG000|Overall Study|Protocol Violation|0|||
144267119|NCT00922636|520181323|FG001|Overall Study|Protocol Violation|0|||
144267120|NCT00922636|520181324|FG002|Overall Study|Protocol Violation|2|||
144267121|NCT00922636|520181325|FG003|Overall Study|Protocol Violation|2|||
144267122|NCT00922636|520181326|FG004|Overall Study|Protocol Violation|0|||
144267123|NCT00922636|520181322|FG000|Overall Study|Entry Criteria Not Met|0|||
144267124|NCT00922636|520181323|FG001|Overall Study|Entry Criteria Not Met|0|||
144267125|NCT00922636|520181324|FG002|Overall Study|Entry Criteria Not Met|1|||
144267126|NCT00922636|520181325|FG003|Overall Study|Entry Criteria Not Met|1|||
144267127|NCT00922636|520181326|FG004|Overall Study|Entry Criteria Not Met|0|||
144267128|NCT00922636|520181322|FG000|Overall Study|Parent/Caregiver Decision|2|||
144267129|NCT00922636|520181323|FG001|Overall Study|Parent/Caregiver Decision|4|||
144267130|NCT00922636|520181324|FG002|Overall Study|Parent/Caregiver Decision|3|||
144267131|NCT00922636|520181325|FG003|Overall Study|Parent/Caregiver Decision|5|||
144267132|NCT00922636|520181326|FG004|Overall Study|Parent/Caregiver Decision|2|||
144267133|NCT00922636|520181322|FG000|Overall Study|Lost to Follow-up|1|||
144267134|NCT00922636|520181323|FG001|Overall Study|Lost to Follow-up|2|||
144267135|NCT00922636|520181324|FG002|Overall Study|Lost to Follow-up|2|||
144267136|NCT00922636|520181325|FG003|Overall Study|Lost to Follow-up|2|||
144267137|NCT00922636|520181326|FG004|Overall Study|Lost to Follow-up|4|||
144267138|NCT01251952|520181329|FG000|Overall Study|Adverse Event|1|||
144267139|NCT02308046|520181330|FG000|Overall Study|Negative yeast culture at Baseline|32|||
144267140|NCT02308046|520181331|FG001|Overall Study|Negative yeast culture at Baseline|33|||
144267141|NCT02308046|520181330|FG000|Overall Study|Positive for STD at Baseline|1|||
144267142|NCT02308046|520181331|FG001|Overall Study|Positive for STD at Baseline|2|||
144267143|NCT02308046|520181330|FG000|Overall Study|Lost to Follow-up|1|||
144267144|NCT02308046|520181331|FG001|Overall Study|Lost to Follow-up|3|||
144267145|NCT01181167|520181332|FG000|Overall Study|Adverse Event|11|||
144267146|NCT01181167|520181333|FG001|Overall Study|Adverse Event|21|||
144267147|NCT01181167|520181332|FG000|Overall Study|Lost to Follow-up|1|||
144267148|NCT01181167|520181333|FG001|Overall Study|Lost to Follow-up|0|||
144267149|NCT01181167|520181332|FG000|Overall Study|Physician Decision|2|||
144267150|NCT01181167|520181333|FG001|Overall Study|Physician Decision|3|||
144267151|NCT01181167|520181332|FG000|Overall Study|Protocol Violation|3|||
144267152|NCT01181167|520181333|FG001|Overall Study|Protocol Violation|0|||
144267153|NCT01181167|520181332|FG000|Overall Study|Withdrawal by Subject|6|||
144267154|NCT01181167|520181333|FG001|Overall Study|Withdrawal by Subject|8|||
144267155|NCT00161213|520181334|FG000|Overall Study|Withdrawal by Subject|1|||
144223239|NCT00235755|520012447|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
144223240|NCT00235755|520012445|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
144223241|NCT00235755|520012446|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
144223242|NCT00235755|520012447|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
144223243|NCT00837148|520012448|FG000|Overall Study|Adverse Event|1|||
144223244|NCT00837148|520012448|FG000|Overall Study|Death|1|||
144223245|NCT01422213|520012451|FG000|Overall Study|Adverse Event|8|||
144223246|NCT01422213|520012452|FG001|Overall Study|Adverse Event|7|||
144223247|NCT01422213|520012453|FG002|Overall Study|Adverse Event|11|||
144223248|NCT01422213|520012451|FG000|Overall Study|Lack of Efficacy|10|||
144223249|NCT01422213|520012452|FG001|Overall Study|Lack of Efficacy|2|||
144223250|NCT01422213|520012453|FG002|Overall Study|Lack of Efficacy|2|||
144223251|NCT01422213|520012451|FG000|Overall Study|Non-compliance with study drug|0|||
144223252|NCT01422213|520012452|FG001|Overall Study|Non-compliance with study drug|1|||
144223253|NCT01422213|520012453|FG002|Overall Study|Non-compliance with study drug|0|||
144267156|NCT00161213|520181334|FG000|Overall Study|Evaluable for toxicity but not response|1|||
144267157|NCT01433159|520181337|FG000|Overall Study|Adverse Event|1|||
144267158|NCT01433159|520181338|FG001|Overall Study|Adverse Event|0|||
144267159|NCT01433159|520181337|FG000|Overall Study|Physician Decision|1|||
144267160|NCT01433159|520181338|FG001|Overall Study|Physician Decision|0|||
144223254|NCT01422213|520012451|FG000|Overall Study|Protocol Violation|0|||
144223255|NCT01422213|520012452|FG001|Overall Study|Protocol Violation|2|||
144223256|NCT01422213|520012453|FG002|Overall Study|Protocol Violation|4|||
144223257|NCT01422213|520012451|FG000|Overall Study|Withdrawal of Consent|7|||
144223258|NCT01422213|520012452|FG001|Overall Study|Withdrawal of Consent|3|||
144223259|NCT01422213|520012453|FG002|Overall Study|Withdrawal of Consent|5|||
144223260|NCT01422213|520012451|FG000|Overall Study|Lost to Follow-up|3|||
144223261|NCT01422213|520012452|FG001|Overall Study|Lost to Follow-up|3|||
144223262|NCT01422213|520012453|FG002|Overall Study|Lost to Follow-up|5|||
144223263|NCT01422213|520012451|FG000|Overall Study|Administrative or Other Reason(s)|5|||
144223264|NCT01422213|520012452|FG001|Overall Study|Administrative or Other Reason(s)|4|||
144223265|NCT01422213|520012453|FG002|Overall Study|Administrative or Other Reason(s)|2|||
144223266|NCT03762265|520012454|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
144223267|NCT03762265|520012455|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
144223268|NCT03762265|520012454|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
144223269|NCT03762265|520012455|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
144223270|NCT03762265|520012454|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
144223271|NCT03762265|520012455|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
144223272|NCT03762265|520012454|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
144223273|NCT03762265|520012455|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
144223274|NCT03762265|520012454|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
144223275|NCT03762265|520012455|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
144223276|NCT03762265|520012454|FG000|BT Period: Weeks 1 to 37|Other|0|||
144223277|NCT03762265|520012455|FG001|BT Period: Weeks 1 to 37|Other|1|||
144699459|NCT00620776|521754386|FG000|Overall Study|Did not receive treatment|3|||
144699460|NCT00620776|521754387|FG001|Overall Study|Did not receive treatment|5|||
144699461|NCT00620776|521754386|FG000|Overall Study|Adverse Event|2|||
144699462|NCT00620776|521754387|FG001|Overall Study|Adverse Event|3|||
144699463|NCT00620776|521754386|FG000|Overall Study|Lack of Efficacy|2|||
144699464|NCT00620776|521754387|FG001|Overall Study|Lack of Efficacy|1|||
144699465|NCT00620776|521754386|FG000|Overall Study|Lost to Follow-up|2|||
144699466|NCT00620776|521754387|FG001|Overall Study|Lost to Follow-up|5|||
144699467|NCT00620776|521754386|FG000|Overall Study|Withdrawal by Subject|3|||
144699468|NCT00620776|521754387|FG001|Overall Study|Withdrawal by Subject|2|||
144699469|NCT01725217|521754390|FG000|Overall Study|Withdrawal by Subject|1|||
144699470|NCT01725217|521754391|FG001|Overall Study|Withdrawal by Subject|0|||
144699471|NCT01725217|521754392|FG002|Overall Study|Withdrawal by Subject|0|||
144699472|NCT03992456|521754393|FG000|Overall Study|Withdrawal by Subject|1|||
144699473|NCT03992456|521754394|FG001|Overall Study|Withdrawal by Subject|0|||
144699474|NCT03992456|521754393|FG000|Overall Study|Disease progression|4|||
144699475|NCT03992456|521754394|FG001|Overall Study|Disease progression|5|||
144699476|NCT03992456|521754393|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
144699477|NCT03992456|521754394|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
144699478|NCT00910000|521754395|FG000|Overall Study|Adverse Event|0|||
144699479|NCT00910000|521754396|FG001|Overall Study|Adverse Event|3|||
144699480|NCT00910000|521754397|FG002|Overall Study|Adverse Event|2|||
144699481|NCT00910000|521754398|FG003|Overall Study|Adverse Event|2|||
144699482|NCT00910000|521754399|FG004|Overall Study|Adverse Event|0|||
144699483|NCT00910000|521754400|FG005|Overall Study|Adverse Event|1|||
144699484|NCT00910000|521754395|FG000|Overall Study|Withdrawal by Subject|0|||
144699485|NCT00910000|521754396|FG001|Overall Study|Withdrawal by Subject|0|||
144699486|NCT00910000|521754397|FG002|Overall Study|Withdrawal by Subject|1|||
144699487|NCT00910000|521754398|FG003|Overall Study|Withdrawal by Subject|0|||
144699488|NCT00910000|521754399|FG004|Overall Study|Withdrawal by Subject|1|||
144699489|NCT00910000|521754400|FG005|Overall Study|Withdrawal by Subject|0|||
144699490|NCT04637815|521754401|FG000|Overall Study|Death|1|||
144699491|NCT04637815|521754402|FG001|Overall Study|Death|0|||
144699492|NCT04637815|521754401|FG000|Overall Study|Lost to Follow-up|5|||
144699493|NCT04637815|521754402|FG001|Overall Study|Lost to Follow-up|2|||
144699494|NCT01977625|521754403|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
144699495|NCT01977625|521754404|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
144699496|NCT01977625|521754403|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144223278|NCT03762265|520012454|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
144223279|NCT03762265|520012455|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
144223280|NCT03762265|520012454|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
144699497|NCT01977625|521754404|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
144699498|NCT02594384|521754405|FG000|Overall Study|Disease Progression|3|||
144699499|NCT02594384|521754406|FG001|Overall Study|Disease Progression|7|||
144699500|NCT02594384|521754407|FG002|Overall Study|Disease Progression|0|||
144699501|NCT02594384|521754408|FG003|Overall Study|Disease Progression|2|||
144699502|NCT02594384|521754409|FG004|Overall Study|Disease Progression|2|||
144699503|NCT02594384|521754410|FG005|Overall Study|Disease Progression|12|||
144699504|NCT02594384|521754411|FG006|Overall Study|Disease Progression|5|||
144223281|NCT03762265|520012455|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
144223282|NCT03762265|520012454|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
144223283|NCT03762265|520012455|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
144223284|NCT03762265|520012454|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
144223285|NCT03762265|520012455|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
144223286|NCT03762265|520012454|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
144223287|NCT03762265|520012455|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
144223288|NCT03762265|520012454|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
144223289|NCT03762265|520012455|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
144223290|NCT03762265|520012454|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
144223291|NCT03762265|520012455|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
144223292|NCT03762265|520012454|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
144223293|NCT03762265|520012455|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
144223294|NCT03762265|520012454|FG000|LTE Period: Weeks 61 to 109|Other|1|||
144223295|NCT03762265|520012455|FG001|LTE Period: Weeks 61 to 109|Other|0|||
144223296|NCT01532934|520012458|FG000|Overall Study|Lost to Follow-up|11|||
144223297|NCT01532934|520012459|FG001|Overall Study|Lost to Follow-up|11|||
144223298|NCT01532934|520012458|FG000|Overall Study|In controlled environment|3|||
144223299|NCT01532934|520012459|FG001|Overall Study|In controlled environment|2|||
144223300|NCT01597778|520012460|FG000|Overall Study|Death|7|||
144223301|NCT01597778|520012461|FG001|Overall Study|Death|10|||
144223302|NCT01597778|520012460|FG000|Overall Study|Withdrawal by Subject|3|||
144223303|NCT01597778|520012461|FG001|Overall Study|Withdrawal by Subject|4|||
144223304|NCT01597778|520012460|FG000|Overall Study|Adverse Event|1|||
144223305|NCT01597778|520012461|FG001|Overall Study|Adverse Event|1|||
144223306|NCT01597778|520012460|FG000|Overall Study|Protocol Violation|1|||
144223307|NCT01597778|520012461|FG001|Overall Study|Protocol Violation|11|||
144223308|NCT01597778|520012460|FG000|Overall Study|Transplanted off protocol|2|||
144223309|NCT01597778|520012461|FG001|Overall Study|Transplanted off protocol|3|||
144223310|NCT01149863|520012462|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
144223311|NCT03326193|520012463|FG000|Overall Study|Sponsor decision|35|||
144223312|NCT01406574|520012466|FG000|Overall Study|Adverse Event|0|||
144223313|NCT01406574|520012467|FG001|Overall Study|Adverse Event|0|||
144223314|NCT01406574|520012468|FG002|Overall Study|Adverse Event|1|||
144223315|NCT01406574|520012469|FG003|Overall Study|Adverse Event|3|||
144223316|NCT01406574|520012466|FG000|Overall Study|Physician Decision|0|||
144223317|NCT01406574|520012467|FG001|Overall Study|Physician Decision|0|||
144223318|NCT01406574|520012468|FG002|Overall Study|Physician Decision|0|||
144223319|NCT01406574|520012469|FG003|Overall Study|Physician Decision|1|||
144223320|NCT01406574|520012466|FG000|Overall Study|Withdrawal by Subject|0|||
144223321|NCT01406574|520012467|FG001|Overall Study|Withdrawal by Subject|1|||
144223322|NCT01406574|520012468|FG002|Overall Study|Withdrawal by Subject|0|||
144223323|NCT01406574|520012469|FG003|Overall Study|Withdrawal by Subject|0|||
144223324|NCT01406574|520012466|FG000|Overall Study|Definite progression of primary disease|1|||
144223325|NCT01406574|520012467|FG001|Overall Study|Definite progression of primary disease|0|||
144223326|NCT01406574|520012468|FG002|Overall Study|Definite progression of primary disease|0|||
144223327|NCT01406574|520012469|FG003|Overall Study|Definite progression of primary disease|0|||
144223328|NCT03759392|520012475|FG000|Overall Study|Adverse Event|12|||
144223329|NCT03759392|520012476|FG001|Overall Study|Adverse Event|4|||
144223330|NCT03759392|520012475|FG000|Overall Study|Death|2|||
144223331|NCT03759392|520012476|FG001|Overall Study|Death|1|||
144223332|NCT03759392|520012475|FG000|Overall Study|Withdrawal by Subject|2|||
144223333|NCT03759392|520012476|FG001|Overall Study|Withdrawal by Subject|0|||
144223334|NCT03759392|520012475|FG000|Overall Study|Protocol Violation|2|||
144223335|NCT03759392|520012476|FG001|Overall Study|Protocol Violation|0|||
144223336|NCT03759392|520012475|FG000|Overall Study|Physician Decision|0|||
144223337|NCT03759392|520012476|FG001|Overall Study|Physician Decision|1|||
144223338|NCT03759392|520012475|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
144223339|NCT03759392|520012476|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
144223340|NCT03759392|520012475|FG000|Overall Study|No longer able to take medicines|1|||
144223341|NCT03759392|520012476|FG001|Overall Study|No longer able to take medicines|0|||
144223342|NCT03759392|520012475|FG000|Overall Study|Stopped taking study drug|1|||
144223343|NCT03759392|520012476|FG001|Overall Study|Stopped taking study drug|0|||
144699505|NCT02594384|521754412|FG007|Overall Study|Disease Progression|5|||
144699506|NCT02594384|521754405|FG000|Overall Study|Adverse Event|0|||
144699507|NCT02594384|521754406|FG001|Overall Study|Adverse Event|1|||
144699508|NCT02594384|521754407|FG002|Overall Study|Adverse Event|4|||
144699509|NCT02594384|521754408|FG003|Overall Study|Adverse Event|1|||
144699510|NCT02594384|521754409|FG004|Overall Study|Adverse Event|0|||
144699511|NCT02594384|521754410|FG005|Overall Study|Adverse Event|6|||
144699512|NCT02594384|521754411|FG006|Overall Study|Adverse Event|1|||
144699513|NCT02594384|521754412|FG007|Overall Study|Adverse Event|1|||
144699514|NCT02594384|521754405|FG000|Overall Study|Withdrawal by Subject|0|||
144699515|NCT02594384|521754406|FG001|Overall Study|Withdrawal by Subject|0|||
144699516|NCT02594384|521754407|FG002|Overall Study|Withdrawal by Subject|0|||
144223344|NCT01709500|520012477|FG000|Overall Study|Randomized but not treated|0|||
144223345|NCT01709500|520012478|FG001|Overall Study|Randomized but not treated|1|||
144699517|NCT02594384|521754408|FG003|Overall Study|Withdrawal by Subject|1|||
144267161|NCT01433159|520181337|FG000|Overall Study|Protocol Violation|0|||
144267162|NCT01433159|520181338|FG001|Overall Study|Protocol Violation|1|||
144267163|NCT01190891|520181341|FG000|Overall Study|Protocol Violation|1|||
144267164|NCT01190891|520181342|FG001|Overall Study|Protocol Violation|0|||
144267165|NCT01190891|520181341|FG000|Overall Study|Withdrawal by Subject|5|||
144267166|NCT01190891|520181342|FG001|Overall Study|Withdrawal by Subject|0|||
144267167|NCT01926028|520181343|FG000|Overall Study|Lost to Follow-up|7|||
144267168|NCT01926028|520181344|FG001|Overall Study|Lost to Follow-up|6|||
144267169|NCT01926028|520181345|FG002|Overall Study|Lost to Follow-up|0|||
144267170|NCT01926028|520181343|FG000|Overall Study|Physician Decision|1|||
144267171|NCT01926028|520181344|FG001|Overall Study|Physician Decision|5|||
144267172|NCT01926028|520181345|FG002|Overall Study|Physician Decision|0|||
144267173|NCT01926028|520181343|FG000|Overall Study|Withdrawal by Subject|9|||
144267174|NCT01926028|520181344|FG001|Overall Study|Withdrawal by Subject|9|||
144267175|NCT01926028|520181345|FG002|Overall Study|Withdrawal by Subject|2|||
144267176|NCT01926028|520181343|FG000|Overall Study|Non compliance or other reasons|4|||
144267177|NCT01926028|520181344|FG001|Overall Study|Non compliance or other reasons|2|||
144267178|NCT01926028|520181345|FG002|Overall Study|Non compliance or other reasons|0|||
144267179|NCT01130272|520181346|FG000|Overall Study|Adverse Event|2|||
144267180|NCT01130272|520181347|FG001|Overall Study|Adverse Event|5|||
144267181|NCT01130272|520181348|FG002|Overall Study|Adverse Event|6|||
144267182|NCT01130272|520181349|FG003|Overall Study|Adverse Event|22|||
144267183|NCT01130272|520181350|FG004|Overall Study|Adverse Event|7|||
144267184|NCT01130272|520181346|FG000|Overall Study|IVRS-confirmed constipation|0|||
144267185|NCT01130272|520181347|FG001|Overall Study|IVRS-confirmed constipation|1|||
144267186|NCT01130272|520181348|FG002|Overall Study|IVRS-confirmed constipation|1|||
144267187|NCT01130272|520181349|FG003|Overall Study|IVRS-confirmed constipation|2|||
144267188|NCT01130272|520181350|FG004|Overall Study|IVRS-confirmed constipation|0|||
144267189|NCT01130272|520181346|FG000|Overall Study|Rescue medications due to diarrhea|3|||
144267190|NCT01130272|520181347|FG001|Overall Study|Rescue medications due to diarrhea|5|||
144267191|NCT01130272|520181348|FG002|Overall Study|Rescue medications due to diarrhea|8|||
144267192|NCT01130272|520181349|FG003|Overall Study|Rescue medications due to diarrhea|8|||
144267193|NCT01130272|520181350|FG004|Overall Study|Rescue medications due to diarrhea|6|||
144267194|NCT01130272|520181346|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
144267195|NCT01130272|520181347|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
144267196|NCT01130272|520181348|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
144267197|NCT01130272|520181349|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
144267198|NCT01130272|520181350|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
144267199|NCT01130272|520181346|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
144267200|NCT01130272|520181347|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
144267201|NCT01130272|520181348|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
144267202|NCT01130272|520181349|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
144267203|NCT01130272|520181350|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
144267204|NCT01130272|520181346|FG000|Overall Study|Protocol Violation|0|||
144267205|NCT01130272|520181347|FG001|Overall Study|Protocol Violation|0|||
144267206|NCT01130272|520181348|FG002|Overall Study|Protocol Violation|3|||
144267207|NCT01130272|520181349|FG003|Overall Study|Protocol Violation|5|||
144267208|NCT01130272|520181350|FG004|Overall Study|Protocol Violation|5|||
144267209|NCT01130272|520181346|FG000|Overall Study|Lost to Follow-up|4|||
144267210|NCT01130272|520181347|FG001|Overall Study|Lost to Follow-up|3|||
144267211|NCT01130272|520181348|FG002|Overall Study|Lost to Follow-up|4|||
144267212|NCT01130272|520181349|FG003|Overall Study|Lost to Follow-up|7|||
144267213|NCT01130272|520181350|FG004|Overall Study|Lost to Follow-up|6|||
144267214|NCT01130272|520181346|FG000|Overall Study|Withdrawal by Subject|4|||
144267215|NCT01130272|520181347|FG001|Overall Study|Withdrawal by Subject|11|||
144267216|NCT01130272|520181348|FG002|Overall Study|Withdrawal by Subject|10|||
144267217|NCT01130272|520181349|FG003|Overall Study|Withdrawal by Subject|9|||
144267218|NCT01130272|520181350|FG004|Overall Study|Withdrawal by Subject|8|||
144267219|NCT01130272|520181346|FG000|Overall Study|Physician Decision|1|||
144267220|NCT01130272|520181347|FG001|Overall Study|Physician Decision|1|||
144267221|NCT01130272|520181348|FG002|Overall Study|Physician Decision|0|||
144267222|NCT01130272|520181349|FG003|Overall Study|Physician Decision|1|||
144267223|NCT01130272|520181350|FG004|Overall Study|Physician Decision|2|||
144267224|NCT01130272|520181346|FG000|Overall Study|Sponsor decision|6|||
144267225|NCT01130272|520181347|FG001|Overall Study|Sponsor decision|15|||
144267226|NCT01130272|520181348|FG002|Overall Study|Sponsor decision|16|||
144267227|NCT01130272|520181349|FG003|Overall Study|Sponsor decision|13|||
144267228|NCT01130272|520181350|FG004|Overall Study|Sponsor decision|16|||
144267229|NCT01130272|520181346|FG000|Overall Study|Study arm discontinued|38|||
144267230|NCT01130272|520181347|FG001|Overall Study|Study arm discontinued|0|||
144267231|NCT01130272|520181348|FG002|Overall Study|Study arm discontinued|0|||
144267232|NCT01130272|520181349|FG003|Overall Study|Study arm discontinued|0|||
144223346|NCT01709500|520012477|FG000|Overall Study|Adverse Event|5|||
144223347|NCT01709500|520012478|FG001|Overall Study|Adverse Event|1|||
144223348|NCT01709500|520012477|FG000|Overall Study|Poor compliance to protocol|2|||
144223349|NCT01709500|520012478|FG001|Overall Study|Poor compliance to protocol|1|||
144223350|NCT01709500|520012477|FG000|Overall Study|Other|3|||
144223351|NCT01709500|520012478|FG001|Overall Study|Other|1|||
144699518|NCT02594384|521754409|FG004|Overall Study|Withdrawal by Subject|0|||
144699519|NCT02594384|521754410|FG005|Overall Study|Withdrawal by Subject|0|||
144699520|NCT02594384|521754411|FG006|Overall Study|Withdrawal by Subject|0|||
144699521|NCT02594384|521754412|FG007|Overall Study|Withdrawal by Subject|1|||
144699522|NCT02594384|521754405|FG000|Overall Study|Physician Decision|0|||
144699523|NCT02594384|521754406|FG001|Overall Study|Physician Decision|0|||
144699524|NCT02594384|521754407|FG002|Overall Study|Physician Decision|0|||
144699525|NCT02594384|521754408|FG003|Overall Study|Physician Decision|0|||
144699526|NCT02594384|521754409|FG004|Overall Study|Physician Decision|0|||
144699527|NCT02594384|521754410|FG005|Overall Study|Physician Decision|1|||
144699528|NCT02594384|521754411|FG006|Overall Study|Physician Decision|2|||
144699529|NCT02594384|521754412|FG007|Overall Study|Physician Decision|0|||
144699530|NCT02594384|521754405|FG000|Overall Study|Progressive Leukocytosis|0|||
144699531|NCT02594384|521754406|FG001|Overall Study|Progressive Leukocytosis|0|||
144699532|NCT02594384|521754407|FG002|Overall Study|Progressive Leukocytosis|1|||
144699533|NCT02594384|521754408|FG003|Overall Study|Progressive Leukocytosis|0|||
144699534|NCT02594384|521754409|FG004|Overall Study|Progressive Leukocytosis|0|||
144699535|NCT02594384|521754410|FG005|Overall Study|Progressive Leukocytosis|0|||
144699536|NCT02594384|521754411|FG006|Overall Study|Progressive Leukocytosis|0|||
144699537|NCT02594384|521754412|FG007|Overall Study|Progressive Leukocytosis|0|||
144699538|NCT02594384|521754405|FG000|Overall Study|Lack of Efficacy|0|||
144699539|NCT02594384|521754406|FG001|Overall Study|Lack of Efficacy|0|||
144699540|NCT02594384|521754407|FG002|Overall Study|Lack of Efficacy|0|||
144223352|NCT01709500|520012477|FG000|Overall Study|Related to IMP administration|1|||
144699541|NCT02594384|521754408|FG003|Overall Study|Lack of Efficacy|0|||
144699542|NCT02594384|521754409|FG004|Overall Study|Lack of Efficacy|1|||
144699543|NCT02594384|521754410|FG005|Overall Study|Lack of Efficacy|0|||
144699544|NCT02594384|521754411|FG006|Overall Study|Lack of Efficacy|0|||
144223353|NCT01709500|520012478|FG001|Overall Study|Related to IMP administration|0|||
144223354|NCT01709500|520012477|FG000|Overall Study|Treatment ongoing|156|||
144223355|NCT01709500|520012478|FG001|Overall Study|Treatment ongoing|78|||
144223356|NCT00420420|520012480|FG000|Overall Study|Adverse Event|5|||
144223357|NCT00420420|520012481|FG001|Overall Study|Adverse Event|3|||
144223358|NCT00420420|520012480|FG000|Overall Study|Protocol Violation|1|||
144223359|NCT00420420|520012481|FG001|Overall Study|Protocol Violation|1|||
144223360|NCT00420420|520012480|FG000|Overall Study|Withdrawal by Subject|1|||
144223361|NCT00420420|520012481|FG001|Overall Study|Withdrawal by Subject|0|||
144223362|NCT00420420|520012480|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
144223363|NCT00420420|520012481|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
144223364|NCT05479435|520012482|FG000|Overall Study|Withdrawal by Subject|1|||
144223365|NCT05479435|520012483|FG001|Overall Study|Withdrawal by Subject|0|||
144223366|NCT05479435|520012484|FG002|Overall Study|Withdrawal by Subject|0|||
144223367|NCT05479435|520012482|FG000|Overall Study|Covid 19|0|||
144223368|NCT05479435|520012483|FG001|Overall Study|Covid 19|0|||
144223369|NCT05479435|520012484|FG002|Overall Study|Covid 19|2|||
144223370|NCT00955617|520012487|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
144223371|NCT00955617|520012488|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
144223372|NCT00955617|520012487|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
144223373|NCT00955617|520012488|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
144223374|NCT00955617|520012487|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
144223375|NCT00955617|520012488|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
144223376|NCT00955617|520012487|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
144223377|NCT00955617|520012488|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
144223378|NCT00868530|520012489|FG000|Overall Study|Adverse Event|3|||
144223379|NCT00868530|520012489|FG000|Overall Study|Lost to Follow-up|1|||
144223380|NCT06025721|520013970|FG000|Overall Study|Physician Decision|1|||
144223381|NCT06025721|520013970|FG000|Overall Study|Protocol Violation|1|||
144223382|NCT06025721|520013970|FG000|Overall Study|Incarceration|1|||
144223383|NCT02832687|520013972|FG000|Overall Study|Adverse Event|0|||
144223384|NCT02832687|520013973|FG001|Overall Study|Adverse Event|2|||
144223385|NCT02764762|520013974|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
144223386|NCT02764762|520013974|FG000|Overall Study|Lost to Follow-up|4|||
144223387|NCT02764762|520013974|FG000|Overall Study|Voluntary Withdrawal|8|||
144223388|NCT02764762|520013974|FG000|Overall Study|Site Termination|1|||
144223389|NCT02764762|520013974|FG000|Overall Study|Lack of Efficacy|16|||
144223390|NCT02764762|520013974|FG000|Overall Study|Reason not Specified|1|||
144223391|NCT01062425|520013975|FG000|Overall Study|Protocol Violation|3|||
144223392|NCT01062425|520013976|FG001|Overall Study|Protocol Violation|6|||
144223393|NCT01651117|520013977|FG000|Overall Study|Death|2|||
144223394|NCT01651117|520013978|FG001|Overall Study|Death|3|||
144223395|NCT01651117|520013979|FG002|Overall Study|Death|2|||
144223396|NCT01651117|520013980|FG003|Overall Study|Death|2|||
144223397|NCT02088177|520013981|FG000|Overall Study|Lost to Follow-up|3|||
144223398|NCT00289848|520013982|FG000|Overall Study|Adverse Event|6|||
144223399|NCT00289848|520013983|FG001|Overall Study|Adverse Event|4|||
144223400|NCT00289848|520013982|FG000|Overall Study|Death|1|||
144223401|NCT00289848|520013983|FG001|Overall Study|Death|0|||
144223402|NCT00289848|520013982|FG000|Overall Study|Lack of Efficacy|20|||
144223403|NCT00289848|520013983|FG001|Overall Study|Lack of Efficacy|24|||
144223404|NCT00289848|520013982|FG000|Overall Study|Lost to Follow-up|3|||
144223405|NCT00289848|520013983|FG001|Overall Study|Lost to Follow-up|1|||
144223406|NCT00289848|520013982|FG000|Overall Study|Protocol Violation|5|||
144223407|NCT00289848|520013983|FG001|Overall Study|Protocol Violation|2|||
144223408|NCT00289848|520013982|FG000|Overall Study|Withdrawal by Subject|5|||
144223409|NCT00289848|520013983|FG001|Overall Study|Withdrawal by Subject|11|||
144223410|NCT00289848|520013982|FG000|Overall Study|Patient Moved|6|||
144223411|NCT00289848|520013983|FG001|Overall Study|Patient Moved|2|||
144223412|NCT00289848|520013982|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
144223413|NCT00289848|520013983|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
144223414|NCT01234350|520013985|FG000|Overall Study|Adverse Event|277|||
144223415|NCT01234350|520013986|FG001|Overall Study|Adverse Event|92|||
144223416|NCT01234350|520013985|FG000|Overall Study|Withdrawal by Subject|61|||
144223417|NCT01234350|520013986|FG001|Overall Study|Withdrawal by Subject|36|||
144267233|NCT01130272|520181350|FG004|Overall Study|Study arm discontinued|0|||
144267234|NCT00744939|520181351|FG000|Overall Study|Withdrawal by Subject|9|||
144223418|NCT01234350|520013985|FG000|Overall Study|Lost to Follow-up|115|||
144223419|NCT01234350|520013986|FG001|Overall Study|Lost to Follow-up|47|||
144223420|NCT01234350|520013985|FG000|Overall Study|Covers a diverse set of reasons|234|||
144223421|NCT01234350|520013986|FG001|Overall Study|Covers a diverse set of reasons|92|||
144223422|NCT02792517|520013994|FG000|Overall Study|Withdrawal by Subject|10|||
144223423|NCT02792517|520013994|FG000|Overall Study|Decision by Sponsor|7|||
144223424|NCT02792517|520013994|FG000|Overall Study|Lost to Follow-up|3|||
144223425|NCT01894919|520013995|FG000|Overall Study|Withdrawal by Subject|1|||
144223426|NCT01894919|520013996|FG001|Overall Study|Withdrawal by Subject|0|||
144223427|NCT01894919|520013997|FG002|Overall Study|Withdrawal by Subject|0|||
144223428|NCT01894919|520013998|FG003|Overall Study|Withdrawal by Subject|0|||
144267235|NCT00744939|520181351|FG000|Overall Study|Protocol Violation|13|||
144267236|NCT00744939|520181351|FG000|Overall Study|Death|24|||
144267237|NCT00744939|520181351|FG000|Overall Study|distance|4|||
144267238|NCT00744939|520181351|FG000|Overall Study|Lost to Follow-up|12|||
144267239|NCT00744939|520181351|FG000|Overall Study|Medical history exclusionary|1|||
144699545|NCT02594384|521754412|FG007|Overall Study|Lack of Efficacy|0|||
144699546|NCT02594384|521754405|FG000|Overall Study|Substantial noncompliance|0|||
144699547|NCT02594384|521754406|FG001|Overall Study|Substantial noncompliance|0|||
144699548|NCT02594384|521754407|FG002|Overall Study|Substantial noncompliance|0|||
144699549|NCT02594384|521754408|FG003|Overall Study|Substantial noncompliance|0|||
144699550|NCT02594384|521754409|FG004|Overall Study|Substantial noncompliance|0|||
144699551|NCT02594384|521754410|FG005|Overall Study|Substantial noncompliance|0|||
144699552|NCT02594384|521754411|FG006|Overall Study|Substantial noncompliance|1|||
144699553|NCT02594384|521754412|FG007|Overall Study|Substantial noncompliance|0|||
144699554|NCT03919669|521754416|FG000|Overall Study|Withdrawal by Subject|1|||
144699555|NCT03919669|521754417|FG001|Overall Study|Withdrawal by Subject|0|||
144699556|NCT03919669|521754418|FG002|Overall Study|Withdrawal by Subject|0|||
144699557|NCT02319642|521754419|FG000|Overall Study|Adverse Event|2|||
144699558|NCT02319642|521754420|FG001|Overall Study|Adverse Event|4|||
144223429|NCT01894919|520013999|FG004|Overall Study|Withdrawal by Subject|1|||
144223430|NCT01894919|520014000|FG005|Overall Study|Withdrawal by Subject|0|||
144223431|NCT01894919|520014001|FG006|Overall Study|Withdrawal by Subject|0|||
144699559|NCT02319642|521754419|FG000|Overall Study|Lack of Efficacy|1|||
144223432|NCT01894919|520014002|FG007|Overall Study|Withdrawal by Subject|0|||
144223433|NCT01894919|520014003|FG008|Overall Study|Withdrawal by Subject|0|||
144223434|NCT01894919|520014004|FG009|Overall Study|Withdrawal by Subject|1|||
144223435|NCT01894919|520014005|FG010|Overall Study|Withdrawal by Subject|1|||
144223436|NCT01894919|520014006|FG011|Overall Study|Withdrawal by Subject|0|||
144223437|NCT01894919|520014007|FG012|Overall Study|Withdrawal by Subject|0|||
144223438|NCT01894919|520013995|FG000|Overall Study|Adverse Event|0|||
144223439|NCT01894919|520013996|FG001|Overall Study|Adverse Event|0|||
144267240|NCT00744939|520181351|FG000|Overall Study|Did not receive Magnevist|7|||
144267241|NCT00744939|520181351|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
144223440|NCT01894919|520013997|FG002|Overall Study|Adverse Event|0|||
144223441|NCT01894919|520013998|FG003|Overall Study|Adverse Event|0|||
144223442|NCT01894919|520013999|FG004|Overall Study|Adverse Event|0|||
144223443|NCT01894919|520014000|FG005|Overall Study|Adverse Event|0|||
144223444|NCT01894919|520014001|FG006|Overall Study|Adverse Event|0|||
144223445|NCT01894919|520014002|FG007|Overall Study|Adverse Event|0|||
144223446|NCT01894919|520014003|FG008|Overall Study|Adverse Event|0|||
144223447|NCT01894919|520014004|FG009|Overall Study|Adverse Event|0|||
144223448|NCT01894919|520014005|FG010|Overall Study|Adverse Event|1|||
144223449|NCT01894919|520014006|FG011|Overall Study|Adverse Event|0|||
144699560|NCT02319642|521754420|FG001|Overall Study|Lack of Efficacy|1|||
144699561|NCT02319642|521754419|FG000|Overall Study|Withdrawal by Subject|1|||
144699562|NCT02319642|521754420|FG001|Overall Study|Withdrawal by Subject|1|||
144699563|NCT01265875|521754421|FG000|Overall Study|Uncooperative/unreliable|1|||
144699564|NCT00483119|521754422|FG000|Overall Study|Adverse Event|0|||
144699565|NCT00483119|521754423|FG001|Overall Study|Adverse Event|1|||
144699566|NCT00483119|521754422|FG000|Overall Study|Physician Decision|1|||
144699567|NCT00483119|521754423|FG001|Overall Study|Physician Decision|0|||
144699568|NCT04409509|521754424|FG000|Overall Study|Failure to meet randomization requirement|1|||
144699569|NCT04409509|521754425|FG001|Overall Study|Failure to meet randomization requirement|0|||
144699570|NCT04409509|521754424|FG000|Overall Study|Adverse Event|0|||
144699571|NCT04409509|521754425|FG001|Overall Study|Adverse Event|1|||
144699572|NCT04409509|521754424|FG000|Overall Study|Death|11|||
144699573|NCT04409509|521754425|FG001|Overall Study|Death|10|||
144699574|NCT04409509|521754424|FG000|Overall Study|Non-compliance with study drug|0|||
144699575|NCT04409509|521754425|FG001|Overall Study|Non-compliance with study drug|1|||
144699576|NCT04409509|521754424|FG000|Overall Study|Lost to Follow-up|0|||
144699577|NCT04409509|521754425|FG001|Overall Study|Lost to Follow-up|3|||
144699578|NCT04409509|521754424|FG000|Overall Study|Withdrawal by Subject|0|||
144699579|NCT04409509|521754425|FG001|Overall Study|Withdrawal by Subject|3|||
144699580|NCT04409509|521754424|FG000|Overall Study|Randomized by mistake|0|||
144699581|NCT04409509|521754425|FG001|Overall Study|Randomized by mistake|1|||
144699582|NCT04409509|521754424|FG000|Overall Study|Other|1|||
144699583|NCT04409509|521754425|FG001|Overall Study|Other|1|||
144699584|NCT04668066|521754428|FG000|Part 1: Treatment Phase|Adverse Event|0|||
144699585|NCT04668066|521754429|FG001|Part 1: Treatment Phase|Adverse Event|0|||
144699586|NCT04668066|521754430|FG002|Part 1: Treatment Phase|Adverse Event|0|||
144699587|NCT04668066|521754431|FG003|Part 1: Treatment Phase|Adverse Event|0|||
144699588|NCT04668066|521754432|FG004|Part 1: Treatment Phase|Adverse Event|0|||
144699589|NCT04668066|521754433|FG005|Part 1: Treatment Phase|Adverse Event|0|||
144699590|NCT04668066|521754434|FG006|Part 1: Treatment Phase|Adverse Event|0|||
144699591|NCT04668066|521754435|FG007|Part 1: Treatment Phase|Adverse Event|0|||
144699592|NCT04668066|521754436|FG008|Part 1: Treatment Phase|Adverse Event|0|||
144699593|NCT04668066|521754437|FG009|Part 1: Treatment Phase|Adverse Event|0|||
144699594|NCT04668066|521754438|FG010|Part 1: Treatment Phase|Adverse Event|0|||
144699595|NCT04668066|521754439|FG011|Part 1: Treatment Phase|Adverse Event|1|||
144699596|NCT04668066|521754440|FG012|Part 1: Treatment Phase|Adverse Event|1|||
144699597|NCT04668066|521754441|FG013|Part 1: Treatment Phase|Adverse Event|0|||
144699598|NCT04668066|521754442|FG014|Part 1: Treatment Phase|Adverse Event|0|||
144699599|NCT04668066|521754443|FG015|Part 1: Treatment Phase|Adverse Event|0|||
144699600|NCT04668066|521754444|FG016|Part 1: Treatment Phase|Adverse Event|0|||
144699601|NCT04668066|521754445|FG017|Part 1: Treatment Phase|Adverse Event|0|||
144699602|NCT04668066|521754446|FG018|Part 1: Treatment Phase|Adverse Event|0|||
144699603|NCT04668066|521754428|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699604|NCT04668066|521754429|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699605|NCT04668066|521754430|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
144699606|NCT04668066|521754431|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699607|NCT04668066|521754432|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699608|NCT04668066|521754433|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699609|NCT04668066|521754434|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699610|NCT04668066|521754435|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699611|NCT04668066|521754436|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699612|NCT04668066|521754437|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699613|NCT04668066|521754438|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699614|NCT04668066|521754439|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699615|NCT04668066|521754440|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699616|NCT04668066|521754441|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699617|NCT04668066|521754442|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699618|NCT04668066|521754443|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699619|NCT04668066|521754444|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699620|NCT04668066|521754445|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699621|NCT04668066|521754446|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
144699622|NCT04668066|521754428|FG000|Part 1: Treatment Phase|Other|0|||
144699623|NCT04668066|521754429|FG001|Part 1: Treatment Phase|Other|0|||
144699624|NCT04668066|521754430|FG002|Part 1: Treatment Phase|Other|0|||
144699625|NCT04668066|521754431|FG003|Part 1: Treatment Phase|Other|0|||
144699626|NCT04668066|521754432|FG004|Part 1: Treatment Phase|Other|0|||
144699627|NCT04668066|521754433|FG005|Part 1: Treatment Phase|Other|0|||
144699628|NCT04668066|521754434|FG006|Part 1: Treatment Phase|Other|0|||
144699629|NCT04668066|521754435|FG007|Part 1: Treatment Phase|Other|0|||
144699630|NCT04668066|521754436|FG008|Part 1: Treatment Phase|Other|0|||
144699631|NCT04668066|521754437|FG009|Part 1: Treatment Phase|Other|0|||
144699632|NCT04668066|521754438|FG010|Part 1: Treatment Phase|Other|0|||
144699633|NCT04668066|521754439|FG011|Part 1: Treatment Phase|Other|1|||
144699634|NCT04668066|521754440|FG012|Part 1: Treatment Phase|Other|0|||
144699635|NCT04668066|521754441|FG013|Part 1: Treatment Phase|Other|0|||
144699636|NCT04668066|521754442|FG014|Part 1: Treatment Phase|Other|0|||
144267242|NCT00744939|520181351|FG000|Overall Study|coma|1|||
144699637|NCT04668066|521754443|FG015|Part 1: Treatment Phase|Other|0|||
144699638|NCT04668066|521754444|FG016|Part 1: Treatment Phase|Other|0|||
144699639|NCT04668066|521754445|FG017|Part 1: Treatment Phase|Other|0|||
144699640|NCT04668066|521754446|FG018|Part 1: Treatment Phase|Other|0|||
144699641|NCT04668066|521754428|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699642|NCT04668066|521754429|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699643|NCT04668066|521754430|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699644|NCT04668066|521754431|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699645|NCT04668066|521754432|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699646|NCT04668066|521754433|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699647|NCT04668066|521754434|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699648|NCT04668066|521754435|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699649|NCT04668066|521754436|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699650|NCT04668066|521754437|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699651|NCT04668066|521754438|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699652|NCT04668066|521754439|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699653|NCT04668066|521754440|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
144699654|NCT04668066|521754441|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699655|NCT04668066|521754442|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699656|NCT04668066|521754443|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
144699657|NCT04668066|521754444|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699658|NCT04668066|521754445|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699659|NCT04668066|521754446|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
144699660|NCT04668066|521754428|FG000|Part 1: Follow-Up|Adverse Event|0|||
144699661|NCT04668066|521754429|FG001|Part 1: Follow-Up|Adverse Event|0|||
144699662|NCT04668066|521754430|FG002|Part 1: Follow-Up|Adverse Event|0|||
144699663|NCT04668066|521754431|FG003|Part 1: Follow-Up|Adverse Event|0|||
144699664|NCT04668066|521754432|FG004|Part 1: Follow-Up|Adverse Event|0|||
144699665|NCT04668066|521754433|FG005|Part 1: Follow-Up|Adverse Event|0|||
144699666|NCT04668066|521754434|FG006|Part 1: Follow-Up|Adverse Event|0|||
144699667|NCT04668066|521754435|FG007|Part 1: Follow-Up|Adverse Event|0|||
144699668|NCT04668066|521754436|FG008|Part 1: Follow-Up|Adverse Event|0|||
144699669|NCT04668066|521754437|FG009|Part 1: Follow-Up|Adverse Event|0|||
144699670|NCT04668066|521754438|FG010|Part 1: Follow-Up|Adverse Event|0|||
144699671|NCT04668066|521754439|FG011|Part 1: Follow-Up|Adverse Event|1|||
144699672|NCT04668066|521754440|FG012|Part 1: Follow-Up|Adverse Event|0|||
144699673|NCT04668066|521754441|FG013|Part 1: Follow-Up|Adverse Event|0|||
144699674|NCT04668066|521754442|FG014|Part 1: Follow-Up|Adverse Event|0|||
144699675|NCT04668066|521754443|FG015|Part 1: Follow-Up|Adverse Event|0|||
144699676|NCT04668066|521754444|FG016|Part 1: Follow-Up|Adverse Event|0|||
144699677|NCT04668066|521754445|FG017|Part 1: Follow-Up|Adverse Event|0|||
144699678|NCT04668066|521754446|FG018|Part 1: Follow-Up|Adverse Event|0|||
144699679|NCT04668066|521754428|FG000|Part 1: Follow-Up|Other|0|||
144699680|NCT04668066|521754429|FG001|Part 1: Follow-Up|Other|0|||
144699681|NCT04668066|521754430|FG002|Part 1: Follow-Up|Other|0|||
144699682|NCT04668066|521754431|FG003|Part 1: Follow-Up|Other|0|||
144699683|NCT04668066|521754432|FG004|Part 1: Follow-Up|Other|0|||
144699684|NCT04668066|521754433|FG005|Part 1: Follow-Up|Other|0|||
144699685|NCT04668066|521754434|FG006|Part 1: Follow-Up|Other|0|||
144699686|NCT04668066|521754435|FG007|Part 1: Follow-Up|Other|0|||
144699687|NCT04668066|521754436|FG008|Part 1: Follow-Up|Other|0|||
144699688|NCT04668066|521754437|FG009|Part 1: Follow-Up|Other|0|||
144699689|NCT04668066|521754438|FG010|Part 1: Follow-Up|Other|0|||
144699690|NCT04668066|521754439|FG011|Part 1: Follow-Up|Other|1|||
144699691|NCT04668066|521754440|FG012|Part 1: Follow-Up|Other|1|||
144699692|NCT04668066|521754441|FG013|Part 1: Follow-Up|Other|0|||
144699693|NCT04668066|521754442|FG014|Part 1: Follow-Up|Other|0|||
144699694|NCT04668066|521754443|FG015|Part 1: Follow-Up|Other|0|||
144699695|NCT04668066|521754444|FG016|Part 1: Follow-Up|Other|0|||
144699696|NCT04668066|521754445|FG017|Part 1: Follow-Up|Other|0|||
144699697|NCT04668066|521754446|FG018|Part 1: Follow-Up|Other|0|||
144699698|NCT04668066|521754428|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699699|NCT04668066|521754429|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699700|NCT04668066|521754430|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699701|NCT04668066|521754431|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699702|NCT04668066|521754432|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699703|NCT04668066|521754433|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699704|NCT04668066|521754434|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699705|NCT04668066|521754435|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699706|NCT04668066|521754436|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699707|NCT04668066|521754437|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699708|NCT04668066|521754438|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699709|NCT04668066|521754439|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699710|NCT04668066|521754440|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
144699711|NCT04668066|521754441|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699712|NCT04668066|521754442|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699713|NCT04668066|521754443|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
144267243|NCT00744939|520181351|FG000|Overall Study|incorrect race|1|||
144267244|NCT04040439|520181352|FG000|Overall Study|Invalid registration|11|||
144223450|NCT01894919|520014007|FG012|Overall Study|Adverse Event|0|||
144223451|NCT01894919|520013995|FG000|Overall Study|Other-Unspecified|1|||
144223452|NCT01894919|520013996|FG001|Overall Study|Other-Unspecified|0|||
144223453|NCT01894919|520013997|FG002|Overall Study|Other-Unspecified|0|||
144223454|NCT01894919|520013998|FG003|Overall Study|Other-Unspecified|0|||
144223455|NCT01894919|520013999|FG004|Overall Study|Other-Unspecified|0|||
144223456|NCT01894919|520014000|FG005|Overall Study|Other-Unspecified|0|||
144223457|NCT01894919|520014001|FG006|Overall Study|Other-Unspecified|0|||
144223458|NCT01894919|520014002|FG007|Overall Study|Other-Unspecified|0|||
144223459|NCT01894919|520014003|FG008|Overall Study|Other-Unspecified|0|||
144223460|NCT01894919|520014004|FG009|Overall Study|Other-Unspecified|0|||
144223461|NCT01894919|520014005|FG010|Overall Study|Other-Unspecified|0|||
144223462|NCT01894919|520014006|FG011|Overall Study|Other-Unspecified|0|||
144223463|NCT01894919|520014007|FG012|Overall Study|Other-Unspecified|0|||
144223464|NCT01894919|520013995|FG000|Overall Study|Lost to Follow-up|0|||
144223465|NCT01894919|520013996|FG001|Overall Study|Lost to Follow-up|0|||
144223466|NCT01894919|520013997|FG002|Overall Study|Lost to Follow-up|0|||
144223467|NCT01894919|520013998|FG003|Overall Study|Lost to Follow-up|0|||
144223468|NCT01894919|520013999|FG004|Overall Study|Lost to Follow-up|2|||
144223469|NCT01894919|520014000|FG005|Overall Study|Lost to Follow-up|0|||
144223470|NCT01894919|520014001|FG006|Overall Study|Lost to Follow-up|0|||
144223471|NCT01894919|520014002|FG007|Overall Study|Lost to Follow-up|0|||
144223472|NCT01894919|520014003|FG008|Overall Study|Lost to Follow-up|0|||
144223473|NCT01894919|520014004|FG009|Overall Study|Lost to Follow-up|0|||
144223474|NCT01894919|520014005|FG010|Overall Study|Lost to Follow-up|0|||
144223475|NCT01894919|520014006|FG011|Overall Study|Lost to Follow-up|0|||
144223476|NCT01894919|520014007|FG012|Overall Study|Lost to Follow-up|0|||
144223477|NCT03534687|520014013|FG000|Overall Study|Lost to Follow-up|7|||
144223478|NCT03534687|520014014|FG001|Overall Study|Lost to Follow-up|2|||
144223479|NCT03428152|520014015|FG000|Overall Study|Physician Decision|4|||
144223480|NCT03428152|520014016|FG001|Overall Study|Physician Decision|2|||
144223481|NCT03428152|520014015|FG000|Overall Study|Protocol Violation|3|||
144223482|NCT03428152|520014016|FG001|Overall Study|Protocol Violation|5|||
144223483|NCT03428152|520014015|FG000|Overall Study|Lack of Efficacy|0|||
144223484|NCT03428152|520014016|FG001|Overall Study|Lack of Efficacy|4|||
144223485|NCT00395629|520014017|FG000|Core Study|Adverse Event|0|||
144223486|NCT00395629|520014018|FG001|Core Study|Adverse Event|3|||
144223487|NCT00395629|520014019|FG002|Core Study|Adverse Event|4|||
144223488|NCT00395629|520014017|FG000|Core Study|Abnormal laboratory value(s)|0|||
144223489|NCT00395629|520014018|FG001|Core Study|Abnormal laboratory value(s)|0|||
144223490|NCT00395629|520014019|FG002|Core Study|Abnormal laboratory value(s)|1|||
144223491|NCT00395629|520014017|FG000|Core Study|Protocol Violation|1|||
144223492|NCT00395629|520014018|FG001|Core Study|Protocol Violation|0|||
144223493|NCT00395629|520014019|FG002|Core Study|Protocol Violation|0|||
144223494|NCT00395629|520014017|FG000|Core Study|Withdrawal by Subject|0|||
144223495|NCT00395629|520014018|FG001|Core Study|Withdrawal by Subject|1|||
144223496|NCT00395629|520014019|FG002|Core Study|Withdrawal by Subject|1|||
144223497|NCT00395629|520014017|FG000|Core Study|Lost to Follow-up|0|||
144223498|NCT00395629|520014018|FG001|Core Study|Lost to Follow-up|0|||
144223499|NCT00395629|520014019|FG002|Core Study|Lost to Follow-up|1|||
144223500|NCT00395629|520014017|FG000|Extension Study|Adverse Event|0|||
144223501|NCT00395629|520014018|FG001|Extension Study|Adverse Event|0|||
144223502|NCT00395629|520014019|FG002|Extension Study|Adverse Event|2|||
144223503|NCT00395629|520014017|FG000|Extension Study|Administrative problems|0|||
144223504|NCT00395629|520014018|FG001|Extension Study|Administrative problems|0|||
144223505|NCT00395629|520014019|FG002|Extension Study|Administrative problems|1|||
144223506|NCT01686373|520014020|FG000|Overall Study|Lost to Follow-up|3|||
144223507|NCT01686373|520014021|FG001|Overall Study|Lost to Follow-up|0|||
144223508|NCT01686373|520014020|FG000|Overall Study|Withdrawal by Subject|0|||
144223509|NCT01686373|520014021|FG001|Overall Study|Withdrawal by Subject|1|||
144223510|NCT01686373|520014020|FG000|Overall Study|Adverse Event|0|||
144223511|NCT01686373|520014021|FG001|Overall Study|Adverse Event|1|||
144223512|NCT01836471|520014028|FG000|Overall Study|Pregnancy|1|||
144223513|NCT01836471|520014029|FG001|Overall Study|Pregnancy|0|||
144223514|NCT01836471|520014030|FG002|Overall Study|Pregnancy|0|||
144223515|NCT01836471|520014031|FG003|Overall Study|Pregnancy|0|||
144223516|NCT01836471|520014032|FG004|Overall Study|Pregnancy|0|||
144223517|NCT01836471|520014028|FG000|Overall Study|Withdrawal by Subject|3|||
144223518|NCT01836471|520014029|FG001|Overall Study|Withdrawal by Subject|4|||
144223519|NCT01836471|520014030|FG002|Overall Study|Withdrawal by Subject|1|||
144223520|NCT01836471|520014031|FG003|Overall Study|Withdrawal by Subject|0|||
144223521|NCT01836471|520014032|FG004|Overall Study|Withdrawal by Subject|2|||
144223522|NCT01836471|520014028|FG000|Overall Study|Physician Decision|0|||
144223523|NCT01836471|520014029|FG001|Overall Study|Physician Decision|1|||
144223524|NCT01836471|520014030|FG002|Overall Study|Physician Decision|0|||
144223525|NCT01836471|520014031|FG003|Overall Study|Physician Decision|0|||
144223526|NCT01836471|520014032|FG004|Overall Study|Physician Decision|0|||
144223527|NCT01836471|520014028|FG000|Overall Study|Lost to Follow-up|0|||
144223528|NCT01836471|520014029|FG001|Overall Study|Lost to Follow-up|0|||
144223529|NCT01836471|520014030|FG002|Overall Study|Lost to Follow-up|0|||
144223530|NCT01836471|520014031|FG003|Overall Study|Lost to Follow-up|1|||
144223531|NCT01836471|520014032|FG004|Overall Study|Lost to Follow-up|1|||
144223532|NCT01836471|520014028|FG000|Overall Study|Adverse Event|6|||
144223533|NCT01836471|520014029|FG001|Overall Study|Adverse Event|3|||
144223534|NCT01836471|520014030|FG002|Overall Study|Adverse Event|1|||
144223535|NCT01836471|520014031|FG003|Overall Study|Adverse Event|1|||
144223536|NCT01836471|520014032|FG004|Overall Study|Adverse Event|2|||
144223537|NCT01836471|520014028|FG000|Overall Study|Non compliance with tx|1|||
144223538|NCT01836471|520014029|FG001|Overall Study|Non compliance with tx|1|||
144223539|NCT01836471|520014030|FG002|Overall Study|Non compliance with tx|0|||
144223540|NCT01836471|520014031|FG003|Overall Study|Non compliance with tx|0|||
144223541|NCT01836471|520014032|FG004|Overall Study|Non compliance with tx|0|||
144223542|NCT01286467|520014038|FG000|Overall Study|Death|1|||
144223543|NCT01286467|520014039|FG001|Overall Study|Death|1|||
144223544|NCT01286467|520014040|FG002|Overall Study|Death|1|||
144223545|NCT01286467|520014041|FG003|Overall Study|Death|0|||
144223546|NCT01286467|520014038|FG000|Overall Study|Lost to Follow-up|0|||
144223547|NCT01286467|520014039|FG001|Overall Study|Lost to Follow-up|0|||
144223548|NCT01286467|520014040|FG002|Overall Study|Lost to Follow-up|0|||
144223549|NCT01286467|520014041|FG003|Overall Study|Lost to Follow-up|1|||
144223550|NCT01286467|520014038|FG000|Overall Study|Withdrawal by Subject|0|||
144223551|NCT01286467|520014039|FG001|Overall Study|Withdrawal by Subject|0|||
144223552|NCT01286467|520014040|FG002|Overall Study|Withdrawal by Subject|1|||
144223553|NCT01286467|520014041|FG003|Overall Study|Withdrawal by Subject|0|||
144223554|NCT01286467|520014038|FG000|Overall Study|Physician Decision|0|||
144223555|NCT01286467|520014039|FG001|Overall Study|Physician Decision|0|||
144223556|NCT01286467|520014040|FG002|Overall Study|Physician Decision|0|||
144223557|NCT01286467|520014041|FG003|Overall Study|Physician Decision|1|||
144223558|NCT01286467|520014038|FG000|Overall Study|Disease progression|3|||
144267245|NCT04040439|520181352|FG000|Overall Study|No IC* on publication of study results|2|||
144267246|NCT01674725|520181359|FG000|Overall Study|Adverse Event|1|||
144267247|NCT01674725|520181360|FG001|Overall Study|Adverse Event|0|||
144267248|NCT01674725|520181359|FG000|Overall Study|Did not receive study drug|1|||
144267249|NCT01674725|520181360|FG001|Overall Study|Did not receive study drug|0|||
144267250|NCT01674725|520181359|FG000|Overall Study|Withdrawal by Subject|1|||
144267251|NCT01674725|520181360|FG001|Overall Study|Withdrawal by Subject|0|||
144267252|NCT01674725|520181359|FG000|Overall Study|Lost to Follow-up|0|||
144267253|NCT01674725|520181360|FG001|Overall Study|Lost to Follow-up|1|||
144267254|NCT00960193|520181365|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
144267255|NCT01324102|520181366|FG000|Overall Study|illness|1|||
144267256|NCT01324102|520181367|FG001|Overall Study|illness|6|||
144267257|NCT03238417|520181368|FG000|Overall|non-response|955|||
144223559|NCT01286467|520014039|FG001|Overall Study|Disease progression|2|||
144223560|NCT01286467|520014040|FG002|Overall Study|Disease progression|2|||
144223561|NCT01286467|520014041|FG003|Overall Study|Disease progression|3|||
144223562|NCT01286467|520014038|FG000|Overall Study|Adverse Event|0|||
144223563|NCT01286467|520014039|FG001|Overall Study|Adverse Event|1|||
144223564|NCT01286467|520014040|FG002|Overall Study|Adverse Event|2|||
144223565|NCT01286467|520014041|FG003|Overall Study|Adverse Event|3|||
144223566|NCT01286467|520014038|FG000|Overall Study|Study drug stop longer than 14 days|0|||
144223567|NCT01286467|520014039|FG001|Overall Study|Study drug stop longer than 14 days|0|||
144223568|NCT01286467|520014040|FG002|Overall Study|Study drug stop longer than 14 days|1|||
144223569|NCT01286467|520014041|FG003|Overall Study|Study drug stop longer than 14 days|0|||
144223570|NCT01058642|520014042|FG000|Treatment Period 1|Adverse Event|0|||
144223571|NCT01058642|520014043|FG001|Treatment Period 1|Adverse Event|1|||
144223572|NCT01058642|520014044|FG002|Treatment Period 1|Adverse Event|1|||
144223573|NCT01058642|520014045|FG003|Treatment Period 1|Adverse Event|0|||
144223574|NCT01058642|520014042|FG000|Treatment Period 1|Physician Decision|0|||
144223575|NCT01058642|520014043|FG001|Treatment Period 1|Physician Decision|0|||
144223576|NCT01058642|520014044|FG002|Treatment Period 1|Physician Decision|1|||
144223577|NCT01058642|520014045|FG003|Treatment Period 1|Physician Decision|0|||
144223578|NCT01058642|520014042|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144223579|NCT01058642|520014043|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144223580|NCT01058642|520014044|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144223581|NCT01058642|520014045|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144223582|NCT01058642|520014042|FG000|Treatment Period 1|Lack of Efficacy|0|||
144223583|NCT01058642|520014043|FG001|Treatment Period 1|Lack of Efficacy|0|||
144223584|NCT01058642|520014044|FG002|Treatment Period 1|Lack of Efficacy|0|||
144223585|NCT01058642|520014045|FG003|Treatment Period 1|Lack of Efficacy|1|||
144223586|NCT01058642|520014042|FG000|Treatment Period 1|Protocol Violation|0|||
144223587|NCT01058642|520014043|FG001|Treatment Period 1|Protocol Violation|0|||
144223588|NCT01058642|520014044|FG002|Treatment Period 1|Protocol Violation|0|||
144223589|NCT01058642|520014045|FG003|Treatment Period 1|Protocol Violation|1|||
144223590|NCT01058642|520014042|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
144223591|NCT01058642|520014043|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
144223592|NCT01058642|520014044|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
144223593|NCT01058642|520014045|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
144223594|NCT02411656|520014046|FG000|Overall Study|Adverse Event|4|||
144223595|NCT02411656|520014046|FG000|Overall Study|Clinical Progression|33|||
144223596|NCT03305848|520014047|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
144223597|NCT03305848|520014047|FG000|Overall Study|Physician Decision|2|||
144223598|NCT02224157|520014049|FG000|Overall Study|Severe non-compliance to protocol|2|||
144223599|NCT02224157|520014050|FG001|Overall Study|Severe non-compliance to protocol|2|||
144223600|NCT02224157|520014049|FG000|Overall Study|Other|13|||
144223601|NCT02224157|520014050|FG001|Overall Study|Other|10|||
144267258|NCT03238417|520181369|FG001|Overall|non-response|1920|||
144267259|NCT03238417|520181368|FG000|Overall|partial completion|48|||
144267260|NCT03238417|520181369|FG001|Overall|partial completion|68|||
144267261|NCT03238417|520181368|FG000|Baseline|Partial completion|17|||
144267262|NCT03238417|520181369|FG001|Baseline|Partial completion|48|||
144267263|NCT03238417|520181368|FG000|Baseline|non-response|372|||
144223602|NCT02224157|520014049|FG000|Overall Study|Subject decision|58|||
144223603|NCT02224157|520014050|FG001|Overall Study|Subject decision|50|||
144223604|NCT02224157|520014049|FG000|Overall Study|Prematurely closed site|4|||
144223605|NCT02224157|520014050|FG001|Overall Study|Prematurely closed site|2|||
144223606|NCT02224157|520014049|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
144223607|NCT02224157|520014050|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
144223608|NCT02224157|520014049|FG000|Overall Study|Lost to Follow-up|27|||
144223609|NCT02224157|520014050|FG001|Overall Study|Lost to Follow-up|35|||
144267264|NCT03238417|520181369|FG001|Baseline|non-response|669|||
144223610|NCT02224157|520014049|FG000|Overall Study|Death|1|||
144223611|NCT02224157|520014050|FG001|Overall Study|Death|1|||
144223612|NCT02224157|520014049|FG000|Overall Study|Adverse Event|1|||
144223613|NCT02224157|520014050|FG001|Overall Study|Adverse Event|3|||
144267265|NCT03238417|520181368|FG000|12-month|non-response|296|||
144267266|NCT03238417|520181369|FG001|12-month|non-response|669|||
144267267|NCT03238417|520181368|FG000|12-month|partial completion|23|||
144267268|NCT03238417|520181369|FG001|12-month|partial completion|37|||
144267269|NCT03238417|520181368|FG000|24-month|non-response|287|||
144267270|NCT03238417|520181369|FG001|24-month|non-response|594|||
144267271|NCT03238417|520181368|FG000|24-month|partial completion|8|||
144267272|NCT03238417|520181369|FG001|24-month|partial completion|31|||
144267273|NCT02089347|520181370|FG000|Overall Study|Protocol Violation|1|||
144267274|NCT02089347|520181371|FG001|Overall Study|Protocol Violation|0|||
144267275|NCT00001566|520181372|FG000|Overall Study|patients' choice to discontinue protocol|3|||
144267276|NCT00001566|520181372|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
144267277|NCT00001566|520181372|FG000|Overall Study|Death|13|||
144267278|NCT00001566|520181372|FG000|Overall Study|Lost to Follow-up|1|||
144267279|NCT00001566|520181372|FG000|Overall Study|unable to complete initial apheresis|1|||
144699714|NCT04668066|521754444|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
144267280|NCT03439137|520181380|FG000|Overall Study|Adverse Event|16|||
144267281|NCT03439137|520181381|FG001|Overall Study|Adverse Event|12|||
144267282|NCT03439137|520181380|FG000|Overall Study|Physician Decision|0|||
144267283|NCT03439137|520181381|FG001|Overall Study|Physician Decision|5|||
144267284|NCT03439137|520181380|FG000|Overall Study|Withdrawal by Subject|14|||
144267285|NCT03439137|520181381|FG001|Overall Study|Withdrawal by Subject|4|||
144267286|NCT03439137|520181380|FG000|Overall Study|Conducting rescue therapy|2|||
144267287|NCT03439137|520181381|FG001|Overall Study|Conducting rescue therapy|1|||
144267288|NCT03439137|520181380|FG000|Overall Study|Difficult to control Hb|10|||
144267289|NCT03439137|520181381|FG001|Overall Study|Difficult to control Hb|2|||
144267290|NCT03439137|520181380|FG000|Overall Study|Initiation of a renal transplant|0|||
144267291|NCT03439137|520181381|FG001|Overall Study|Initiation of a renal transplant|2|||
144267292|NCT01249131|520181386|FG000|Washout Period of 10 Days|Adverse Event|0|||
144267293|NCT01249131|520181387|FG001|Washout Period of 10 Days|Adverse Event|0|||
144267294|NCT01249131|520181388|FG002|Washout Period of 10 Days|Adverse Event|0|||
144267295|NCT01249131|520181389|FG003|Washout Period of 10 Days|Adverse Event|0|||
144267296|NCT01249131|520181390|FG004|Washout Period of 10 Days|Adverse Event|1|||
144267297|NCT01249131|520181391|FG005|Washout Period of 10 Days|Adverse Event|0|||
144267298|NCT00719901|520181392|FG000|Overall Study|Adverse Event|5|||
144267299|NCT00719901|520181392|FG000|Overall Study|Withdrawal by Subject|1|||
144267300|NCT00719901|520181392|FG000|Overall Study|Alternate Treatment|1|||
144267301|NCT00719901|520181392|FG000|Overall Study|Disease Progression|3|||
144267302|NCT00719901|520181392|FG000|Overall Study|Availability of Study Drug|1|||
144267303|NCT00473083|520181395|FG000|Overall Study|Adverse Event|1|||
144267304|NCT00473083|520181396|FG001|Overall Study|Adverse Event|0|||
144267305|NCT00473083|520181397|FG002|Overall Study|Adverse Event|0|||
144267306|NCT02915835|520181398|FG000|Overall Study|Physician Decision|1|||
144267307|NCT02915835|520181399|FG001|Overall Study|Physician Decision|0|||
144267308|NCT02915835|520181398|FG000|Overall Study|Withdrawal by Subject|0|||
144267309|NCT02915835|520181399|FG001|Overall Study|Withdrawal by Subject|1|||
144267310|NCT03426345|520181400|FG000|Overall Study|Adverse Event|4|||
144267311|NCT03426345|520181401|FG001|Overall Study|Adverse Event|4|||
144267312|NCT03426345|520181400|FG000|Overall Study|Lack of Efficacy|1|||
144267313|NCT03426345|520181401|FG001|Overall Study|Lack of Efficacy|0|||
144267314|NCT03426345|520181400|FG000|Overall Study|Withdrawal by Subject|5|||
144267315|NCT03426345|520181401|FG001|Overall Study|Withdrawal by Subject|6|||
144267316|NCT03426345|520181400|FG000|Overall Study|Lost to Follow-up|3|||
144267317|NCT03426345|520181401|FG001|Overall Study|Lost to Follow-up|1|||
144267318|NCT03426345|520181400|FG000|Overall Study|Protocol Deviation|3|||
144267319|NCT03426345|520181401|FG001|Overall Study|Protocol Deviation|4|||
144267320|NCT03426345|520181400|FG000|Overall Study|Reason Not Specified|1|||
144267321|NCT03426345|520181401|FG001|Overall Study|Reason Not Specified|2|||
144267322|NCT03426345|520181400|FG000|Overall Study|Missing Completion Status|1|||
144267323|NCT03426345|520181401|FG001|Overall Study|Missing Completion Status|0|||
144267324|NCT02446691|520181402|FG000|Overall Study|Withdrawal by Subject|2|||
144267325|NCT02446691|520181402|FG000|Overall Study|Lost to Follow-up|8|||
144267326|NCT02446691|520181402|FG000|Overall Study|Protocol Violation|1|||
144699715|NCT04668066|521754445|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699716|NCT04668066|521754446|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
144699717|NCT04668066|521754428|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699718|NCT04668066|521754429|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699719|NCT04668066|521754430|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699720|NCT04668066|521754431|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144267327|NCT00192114|520181403|FG000|Overall Study|Objective Tumor Progression|19|||
144267328|NCT00192114|520181403|FG000|Overall Study|Adverse Event|2|||
144267329|NCT00192114|520181403|FG000|Overall Study|Clinical Progression|2|||
144699721|NCT04668066|521754432|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699722|NCT04668066|521754433|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699723|NCT04668066|521754434|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699724|NCT04668066|521754435|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699725|NCT04668066|521754436|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144223614|NCT04578535|520014053|FG000|Overall Study|Lost to Follow-up|1|||
144223615|NCT04578535|520014054|FG001|Overall Study|Lost to Follow-up|0|||
144223616|NCT04578535|520014055|FG002|Overall Study|Lost to Follow-up|0|||
144223617|NCT04578535|520014056|FG003|Overall Study|Lost to Follow-up|1|||
144223618|NCT04578535|520014057|FG004|Overall Study|Lost to Follow-up|0|||
144223619|NCT04578535|520014058|FG005|Overall Study|Lost to Follow-up|2|||
144223620|NCT04578535|520014053|FG000|Overall Study|Pregnancy|1|||
144223621|NCT04578535|520014054|FG001|Overall Study|Pregnancy|0|||
144223622|NCT04578535|520014055|FG002|Overall Study|Pregnancy|0|||
144223623|NCT04578535|520014056|FG003|Overall Study|Pregnancy|0|||
144223624|NCT04578535|520014057|FG004|Overall Study|Pregnancy|0|||
144223625|NCT04578535|520014058|FG005|Overall Study|Pregnancy|0|||
144223626|NCT04578535|520014053|FG000|Overall Study|Withdrawal by Subject|0|||
144223627|NCT04578535|520014054|FG001|Overall Study|Withdrawal by Subject|0|||
144223628|NCT04578535|520014055|FG002|Overall Study|Withdrawal by Subject|0|||
144223629|NCT04578535|520014056|FG003|Overall Study|Withdrawal by Subject|1|||
144223630|NCT04578535|520014057|FG004|Overall Study|Withdrawal by Subject|1|||
144223631|NCT04578535|520014058|FG005|Overall Study|Withdrawal by Subject|5|||
144223632|NCT04578535|520014053|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
144223633|NCT04578535|520014054|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
144223634|NCT04578535|520014055|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
144223635|NCT04578535|520014056|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
144267330|NCT00192114|520181403|FG000|Overall Study|Death|1|||
144223636|NCT04578535|520014057|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
144223637|NCT04578535|520014058|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
144223638|NCT02301169|520014063|FG000|Overall Study|Adverse Event|1|||
144223639|NCT02301169|520014064|FG001|Overall Study|Adverse Event|0|||
144223640|NCT03839628|520014065|FG000|Overall Study|Withdrawal by Subject|1|||
144223641|NCT00586703|520014070|FG000|Overall Study|Death|12|||
144223642|NCT00806403|520014071|FG000|Overall Study|Death|4|||
144223643|NCT00806403|520014072|FG001|Overall Study|Death|3|||
144223644|NCT00765102|520014073|FG000|Overall Study|Progressive disease|18|||
144223645|NCT00765102|520014073|FG000|Overall Study|Adverse Event|6|||
144223646|NCT00765102|520014073|FG000|Overall Study|Physician Decision|4|||
144223647|NCT00765102|520014073|FG000|Overall Study|Withdrawal by Subject|2|||
144223648|NCT00765102|520014073|FG000|Overall Study|Protocol Violation|1|||
144223649|NCT01147068|520014086|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
144223650|NCT01147068|520014087|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
144223651|NCT01147068|520014088|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
144223652|NCT01147068|520014089|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
144223653|NCT01147068|520014090|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
144223654|NCT01147068|520014091|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
144223655|NCT01147068|520014092|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
144223656|NCT01147068|520014086|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
144223657|NCT01147068|520014087|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
144223658|NCT01147068|520014088|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
144223659|NCT01147068|520014089|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
144699726|NCT04668066|521754437|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699727|NCT04668066|521754438|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699728|NCT04668066|521754439|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699729|NCT04668066|521754440|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699730|NCT04668066|521754441|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699731|NCT04668066|521754442|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699732|NCT04668066|521754443|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699733|NCT04668066|521754444|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699734|NCT04668066|521754445|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
144699735|NCT04668066|521754446|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
144699736|NCT04668066|521754428|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699737|NCT04668066|521754429|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699738|NCT04668066|521754430|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699739|NCT04668066|521754431|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699740|NCT04668066|521754432|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699741|NCT04668066|521754433|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699742|NCT04668066|521754434|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699743|NCT04668066|521754435|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699744|NCT04668066|521754436|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699745|NCT04668066|521754437|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699746|NCT04668066|521754438|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699747|NCT04668066|521754439|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699748|NCT04668066|521754440|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699749|NCT04668066|521754441|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699750|NCT04668066|521754442|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699751|NCT04668066|521754443|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699752|NCT04668066|521754444|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699753|NCT04668066|521754445|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
144699754|NCT04668066|521754446|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
144699755|NCT04668066|521754428|FG000|Part 2: Treatment Phase|Other|0|||
144699756|NCT04668066|521754429|FG001|Part 2: Treatment Phase|Other|0|||
144699757|NCT04668066|521754430|FG002|Part 2: Treatment Phase|Other|0|||
144699758|NCT04668066|521754431|FG003|Part 2: Treatment Phase|Other|0|||
144699759|NCT04668066|521754432|FG004|Part 2: Treatment Phase|Other|0|||
144699760|NCT04668066|521754433|FG005|Part 2: Treatment Phase|Other|0|||
144699761|NCT04668066|521754434|FG006|Part 2: Treatment Phase|Other|0|||
144699762|NCT04668066|521754435|FG007|Part 2: Treatment Phase|Other|0|||
144699763|NCT04668066|521754436|FG008|Part 2: Treatment Phase|Other|0|||
144699764|NCT04668066|521754437|FG009|Part 2: Treatment Phase|Other|0|||
144699765|NCT04668066|521754438|FG010|Part 2: Treatment Phase|Other|0|||
144699766|NCT04668066|521754439|FG011|Part 2: Treatment Phase|Other|0|||
144699767|NCT04668066|521754440|FG012|Part 2: Treatment Phase|Other|0|||
144699768|NCT04668066|521754441|FG013|Part 2: Treatment Phase|Other|0|||
144699769|NCT04668066|521754442|FG014|Part 2: Treatment Phase|Other|0|||
144699770|NCT04668066|521754443|FG015|Part 2: Treatment Phase|Other|0|||
144699771|NCT04668066|521754444|FG016|Part 2: Treatment Phase|Other|0|||
144699772|NCT04668066|521754445|FG017|Part 2: Treatment Phase|Other|0|||
144699773|NCT04668066|521754446|FG018|Part 2: Treatment Phase|Other|1|||
144699774|NCT04668066|521754428|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699775|NCT04668066|521754429|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699776|NCT04668066|521754430|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699777|NCT04668066|521754431|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699778|NCT04668066|521754432|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699779|NCT04668066|521754433|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699780|NCT04668066|521754434|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699781|NCT04668066|521754435|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699782|NCT04668066|521754436|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699783|NCT04668066|521754437|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
144267331|NCT02643693|520181404|FG000|Overall Study|Physician Decision|0|||
144267332|NCT02643693|520181405|FG001|Overall Study|Physician Decision|1|||
144267333|NCT02643693|520181406|FG002|Overall Study|Physician Decision|0|||
144267334|NCT02643693|520181407|FG003|Overall Study|Physician Decision|0|||
144267335|NCT02643693|520181408|FG004|Overall Study|Physician Decision|0|||
144267336|NCT02643693|520181409|FG005|Overall Study|Physician Decision|0|||
144267337|NCT02643693|520181404|FG000|Overall Study|Withdrawal by Subject|0|||
144267338|NCT02643693|520181405|FG001|Overall Study|Withdrawal by Subject|1|||
144267339|NCT02643693|520181406|FG002|Overall Study|Withdrawal by Subject|0|||
144267340|NCT02643693|520181407|FG003|Overall Study|Withdrawal by Subject|0|||
144267341|NCT02643693|520181408|FG004|Overall Study|Withdrawal by Subject|0|||
144267342|NCT02643693|520181409|FG005|Overall Study|Withdrawal by Subject|0|||
144267343|NCT02643693|520181404|FG000|Overall Study|Protocol Adherence Issues|2|||
144267344|NCT02643693|520181405|FG001|Overall Study|Protocol Adherence Issues|0|||
144267345|NCT02643693|520181406|FG002|Overall Study|Protocol Adherence Issues|1|||
144267346|NCT02643693|520181407|FG003|Overall Study|Protocol Adherence Issues|0|||
144267347|NCT02643693|520181408|FG004|Overall Study|Protocol Adherence Issues|0|||
144267348|NCT02643693|520181409|FG005|Overall Study|Protocol Adherence Issues|1|||
144267349|NCT00492297|520181410|FG000|Treatment|Death|2|||
144267350|NCT00492297|520181410|FG000|Treatment|Study terminated by sponsor|3|||
144267351|NCT00492297|520181410|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
144267352|NCT00492297|520181410|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
144267353|NCT00492297|520181410|FG000|Survival Only Follow-up|Death|46|||
144267354|NCT00492297|520181410|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
144267355|NCT00492297|520181410|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
144267356|NCT00113607|520181411|FG000|Overall Study|Adverse Event|40|||
144267357|NCT00113607|520181412|FG001|Overall Study|Adverse Event|71|||
144267358|NCT00113607|520181411|FG000|Overall Study|Death|8|||
144267359|NCT00113607|520181412|FG001|Overall Study|Death|8|||
144223660|NCT01147068|520014090|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
144223661|NCT01147068|520014091|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
144223662|NCT01147068|520014092|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
144223663|NCT01147068|520014086|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
144223664|NCT01147068|520014087|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
144223665|NCT01147068|520014088|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
144223666|NCT01147068|520014089|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
144223667|NCT01147068|520014090|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
144223668|NCT01147068|520014091|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
144223669|NCT01147068|520014092|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
144223670|NCT01147068|520014086|FG000|Subjects That Received 2nd Dose|Other|0|||
144223671|NCT01147068|520014087|FG001|Subjects That Received 2nd Dose|Other|3|||
144223672|NCT01147068|520014088|FG002|Subjects That Received 2nd Dose|Other|3|||
144223673|NCT01147068|520014089|FG003|Subjects That Received 2nd Dose|Other|0|||
144223674|NCT01147068|520014090|FG004|Subjects That Received 2nd Dose|Other|1|||
144699784|NCT04668066|521754438|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699785|NCT04668066|521754439|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699786|NCT04668066|521754440|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699787|NCT04668066|521754441|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699788|NCT04668066|521754442|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699789|NCT04668066|521754443|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699790|NCT04668066|521754444|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699791|NCT04668066|521754445|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
144699792|NCT04668066|521754446|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
144699793|NCT02369874|521754447|FG000|Overall Study|Lost to Follow-up|2|||
144699794|NCT02369874|521754448|FG001|Overall Study|Lost to Follow-up|2|||
144699795|NCT02369874|521754449|FG002|Overall Study|Lost to Follow-up|2|||
144699796|NCT02369874|521754447|FG000|Overall Study|Withdrawal by Subject|7|||
144699797|NCT02369874|521754448|FG001|Overall Study|Withdrawal by Subject|9|||
144699798|NCT02369874|521754449|FG002|Overall Study|Withdrawal by Subject|27|||
144699799|NCT02369874|521754447|FG000|Overall Study|Miscellaneous|1|||
144699800|NCT02369874|521754448|FG001|Overall Study|Miscellaneous|1|||
144699801|NCT02369874|521754449|FG002|Overall Study|Miscellaneous|0|||
144699802|NCT02369874|521754447|FG000|Overall Study|On Treatment/Off Study|34|||
144699803|NCT02369874|521754448|FG001|Overall Study|On Treatment/Off Study|45|||
144699804|NCT02369874|521754449|FG002|Overall Study|On Treatment/Off Study|32|||
144699805|NCT02331680|521754450|FG000|Overall Study|Adverse Event|3|||
144699806|NCT02331680|521754451|FG001|Overall Study|Adverse Event|0|||
144699807|NCT02331680|521754452|FG002|Overall Study|Adverse Event|2|||
144699808|NCT02331680|521754450|FG000|Overall Study|Physician Decision|1|||
144699809|NCT02331680|521754451|FG001|Overall Study|Physician Decision|1|||
144699810|NCT02331680|521754452|FG002|Overall Study|Physician Decision|2|||
144699811|NCT02331680|521754450|FG000|Overall Study|Withdrawal by Subject|0|||
144699812|NCT02331680|521754451|FG001|Overall Study|Withdrawal by Subject|1|||
144699813|NCT02331680|521754452|FG002|Overall Study|Withdrawal by Subject|2|||
144699814|NCT02331680|521754450|FG000|Overall Study|Met withdrawal criteria|2|||
144699815|NCT02331680|521754451|FG001|Overall Study|Met withdrawal criteria|2|||
144699816|NCT02331680|521754452|FG002|Overall Study|Met withdrawal criteria|5|||
144699817|NCT02331680|521754450|FG000|Overall Study|Non-compliance with study drug|0|||
144699818|NCT02331680|521754451|FG001|Overall Study|Non-compliance with study drug|0|||
144699819|NCT02331680|521754452|FG002|Overall Study|Non-compliance with study drug|1|||
144699820|NCT02331680|521754450|FG000|Overall Study|Protocol Violation|0|||
144699821|NCT02331680|521754451|FG001|Overall Study|Protocol Violation|0|||
144699822|NCT02331680|521754452|FG002|Overall Study|Protocol Violation|3|||
144699823|NCT00596466|521754453|FG000|Overall Study|Lack of Efficacy|5|||
144699824|NCT00596466|521754453|FG000|Overall Study|Adverse Event|4|||
144699825|NCT00596466|521754453|FG000|Overall Study|Withdrawal by Subject|2|||
144699826|NCT00596466|521754453|FG000|Overall Study|Protocol Violation|2|||
144699827|NCT00596466|521754453|FG000|Overall Study|Unpecified|2|||
144699828|NCT00596466|521754453|FG000|Overall Study|Enrolled, not treated|2|||
144699829|NCT00145795|521754454|FG000|Overall Study|Adverse Event|1|||
144699830|NCT00145795|521754455|FG001|Overall Study|Adverse Event|0|||
144699831|NCT01891669|521754456|FG000|Overall Study|Death|0|||
144699832|NCT01891669|521754457|FG001|Overall Study|Death|0|||
144699833|NCT01891669|521754458|FG002|Overall Study|Death|0|||
144699834|NCT01891669|521754459|FG003|Overall Study|Death|0|||
144699835|NCT01891669|521754460|FG004|Overall Study|Death|0|||
144699836|NCT01891669|521754461|FG005|Overall Study|Death|0|||
144699837|NCT01891669|521754462|FG006|Overall Study|Death|0|||
144699838|NCT01891669|521754463|FG007|Overall Study|Death|1|||
144699839|NCT01891669|521754464|FG008|Overall Study|Death|0|||
144699840|NCT01891669|521754465|FG009|Overall Study|Death|1|||
144699841|NCT01891669|521754456|FG000|Overall Study|Withdrawal by Subject|1|||
144699842|NCT01891669|521754457|FG001|Overall Study|Withdrawal by Subject|1|||
144699843|NCT01891669|521754458|FG002|Overall Study|Withdrawal by Subject|0|||
144223675|NCT01147068|520014091|FG005|Subjects That Received 2nd Dose|Other|0|||
144223676|NCT01147068|520014092|FG006|Subjects That Received 2nd Dose|Other|0|||
144223677|NCT01147068|520014086|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
144223678|NCT01147068|520014087|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
144223679|NCT01147068|520014088|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
144223680|NCT01147068|520014089|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
144223681|NCT01147068|520014090|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
144223682|NCT01147068|520014091|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
144223683|NCT01147068|520014092|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
144223684|NCT01147068|520014086|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
144223685|NCT01147068|520014087|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
144223686|NCT01147068|520014088|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
144223687|NCT01147068|520014089|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
144223688|NCT01147068|520014090|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
144223689|NCT01147068|520014091|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
144223690|NCT01147068|520014092|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
144223691|NCT01147068|520014086|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
144223692|NCT01147068|520014087|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
144223693|NCT01147068|520014088|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
144223694|NCT01147068|520014089|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
144223695|NCT01147068|520014090|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
144223696|NCT01147068|520014091|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
144223697|NCT01147068|520014092|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
144223698|NCT03181633|520014094|FG000|Overall Study|Withdrawal by Subject|1|||
144223699|NCT03181633|520014094|FG000|Overall Study|Missing follow-up visit|1|||
144223700|NCT01964976|520014097|FG000|Overall Study|Protocol Violation|31|||
144223701|NCT00699998|520014098|FG000|Overall Study|Withdrawal by Subject|194|||
144223702|NCT00699998|520014099|FG001|Overall Study|Withdrawal by Subject|83|||
144223703|NCT00699998|520014100|FG002|Overall Study|Withdrawal by Subject|202|||
144223704|NCT00699998|520014101|FG003|Overall Study|Withdrawal by Subject|80|||
144223705|NCT00699998|520014098|FG000|Overall Study|Physician Decision|3|||
144223706|NCT00699998|520014099|FG001|Overall Study|Physician Decision|2|||
144223707|NCT00699998|520014100|FG002|Overall Study|Physician Decision|1|||
144223708|NCT00699998|520014101|FG003|Overall Study|Physician Decision|1|||
144223709|NCT00699998|520014098|FG000|Overall Study|Lost to Follow-up|2|||
144223710|NCT00699998|520014099|FG001|Overall Study|Lost to Follow-up|1|||
144223711|NCT00699998|520014100|FG002|Overall Study|Lost to Follow-up|3|||
144223712|NCT00699998|520014101|FG003|Overall Study|Lost to Follow-up|1|||
144223713|NCT04616612|520014104|FG000|Overall Study|Lost to Follow-up|6|||
144223714|NCT04616612|520014105|FG001|Overall Study|Lost to Follow-up|3|||
144223715|NCT04740918|520014106|FG000|Overall Study|Study Terminated by Sponsor|41|||
144223716|NCT04740918|520014107|FG001|Overall Study|Study Terminated by Sponsor|32|||
144223717|NCT04740918|520014106|FG000|Overall Study|Death|3|||
144223718|NCT04740918|520014107|FG001|Overall Study|Death|6|||
144223719|NCT04740918|520014106|FG000|Overall Study|Withdrawal by Subject|5|||
144223720|NCT04740918|520014107|FG001|Overall Study|Withdrawal by Subject|4|||
144223721|NCT04740918|520014106|FG000|Overall Study|Lost to Follow-up|1|||
144223722|NCT04740918|520014107|FG001|Overall Study|Lost to Follow-up|3|||
144223723|NCT04740918|520014106|FG000|Overall Study|Progressive disease|0|||
144223724|NCT04740918|520014107|FG001|Overall Study|Progressive disease|1|||
144223725|NCT03170544|520014109|FG000|Part 1|Lost to Follow-up|1|||
144223726|NCT03170544|520014110|FG001|Part 1|Lost to Follow-up|0|||
144223727|NCT03170544|520014111|FG002|Part 1|Lost to Follow-up|0|||
144223728|NCT03170544|520014112|FG003|Part 1|Lost to Follow-up|0|||
144223729|NCT03170544|520014113|FG004|Part 1|Lost to Follow-up|0|||
144223730|NCT03170544|520014114|FG005|Part 1|Lost to Follow-up|0|||
144223731|NCT03170544|520014115|FG006|Part 1|Lost to Follow-up|0|||
144223732|NCT03170544|520014116|FG007|Part 1|Lost to Follow-up|0|||
144223733|NCT03170544|520014117|FG008|Part 1|Lost to Follow-up|0|||
144223734|NCT03170544|520014118|FG009|Part 1|Lost to Follow-up|0|||
144223735|NCT03170544|520014119|FG010|Part 1|Lost to Follow-up|0|||
144223736|NCT03170544|520014120|FG011|Part 1|Lost to Follow-up|0|||
144223737|NCT03170544|520014109|FG000|Part 1|Not treated|0|||
144223738|NCT03170544|520014110|FG001|Part 1|Not treated|0|||
144223739|NCT03170544|520014111|FG002|Part 1|Not treated|0|||
144223740|NCT03170544|520014112|FG003|Part 1|Not treated|1|||
144223741|NCT03170544|520014113|FG004|Part 1|Not treated|0|||
144223742|NCT03170544|520014114|FG005|Part 1|Not treated|0|||
144223743|NCT03170544|520014115|FG006|Part 1|Not treated|0|||
144223744|NCT03170544|520014116|FG007|Part 1|Not treated|0|||
144223745|NCT03170544|520014117|FG008|Part 1|Not treated|0|||
144223746|NCT03170544|520014118|FG009|Part 1|Not treated|0|||
144223747|NCT03170544|520014119|FG010|Part 1|Not treated|0|||
144223748|NCT03170544|520014120|FG011|Part 1|Not treated|0|||
144223749|NCT01609790|520014122|FG000|Overall Study|Protocol Violation|1|||
144223750|NCT01609790|520014123|FG001|Overall Study|Protocol Violation|7|||
144223751|NCT01609790|520014124|FG002|Overall Study|Protocol Violation|8|||
144223752|NCT04563754|520015721|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
144223753|NCT04563754|520015722|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
144223754|NCT04563754|520015723|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
144223755|NCT04563754|520015721|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
144223756|NCT04563754|520015722|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
144223757|NCT04563754|520015723|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
144223758|NCT04563754|520015721|FG000|Follow up|Lost to Follow-up|61|||
144223759|NCT04563754|520015722|FG001|Follow up|Lost to Follow-up|23|||
144223760|NCT04563754|520015723|FG002|Follow up|Lost to Follow-up|5|||
144223761|NCT04563754|520015721|FG000|Follow up|Death|0|||
144223762|NCT04563754|520015722|FG001|Follow up|Death|2|||
144223763|NCT04563754|520015723|FG002|Follow up|Death|0|||
144223764|NCT04563754|520015721|FG000|Follow up|Ongoing|0|||
144223765|NCT04563754|520015722|FG001|Follow up|Ongoing|28|||
144223766|NCT04563754|520015723|FG002|Follow up|Ongoing|0|||
144223767|NCT04581824|520015725|FG000|Overall Study|Lost to Follow-up|1|||
144223768|NCT04581824|520015726|FG001|Overall Study|Lost to Follow-up|0|||
144223769|NCT04581824|520015725|FG000|Overall Study|Withdrawal by Subject|2|||
144223770|NCT04581824|520015726|FG001|Overall Study|Withdrawal by Subject|7|||
144223771|NCT04581824|520015725|FG000|Overall Study|Study terminated by sponsor|37|||
144223772|NCT04581824|520015726|FG001|Overall Study|Study terminated by sponsor|23|||
144223773|NCT04796909|520015727|FG000|Overall Study|Withdrawal by Subject|1|||
144223774|NCT04796909|520015728|FG001|Overall Study|Withdrawal by Subject|1|||
144223775|NCT03879135|520015729|FG000|Overall Study|Physician Decision|0|||
144223776|NCT03879135|520015730|FG001|Overall Study|Physician Decision|0|||
144223777|NCT03879135|520015731|FG002|Overall Study|Physician Decision|0|||
144223778|NCT03879135|520015732|FG003|Overall Study|Physician Decision|1|||
144223779|NCT03879135|520015733|FG004|Overall Study|Physician Decision|0|||
144223780|NCT03879135|520015734|FG005|Overall Study|Physician Decision|0|||
144223781|NCT03879135|520015729|FG000|Overall Study|Withdrawal by Subject|0|||
144223782|NCT03879135|520015730|FG001|Overall Study|Withdrawal by Subject|0|||
144223783|NCT03879135|520015731|FG002|Overall Study|Withdrawal by Subject|0|||
144223784|NCT03879135|520015732|FG003|Overall Study|Withdrawal by Subject|0|||
144223785|NCT03879135|520015733|FG004|Overall Study|Withdrawal by Subject|0|||
144223786|NCT03879135|520015734|FG005|Overall Study|Withdrawal by Subject|1|||
144223787|NCT03879135|520015729|FG000|Overall Study|Site Closed by Sponsor|0|||
144223788|NCT03879135|520015730|FG001|Overall Study|Site Closed by Sponsor|0|||
144223789|NCT03879135|520015731|FG002|Overall Study|Site Closed by Sponsor|0|||
144223790|NCT03879135|520015732|FG003|Overall Study|Site Closed by Sponsor|1|||
144223791|NCT03879135|520015733|FG004|Overall Study|Site Closed by Sponsor|1|||
144223792|NCT03879135|520015734|FG005|Overall Study|Site Closed by Sponsor|0|||
144223793|NCT04162847|520015735|FG000|Overall Study|Withdrawal by Subject|7|||
144223794|NCT04162847|520015736|FG001|Overall Study|Withdrawal by Subject|1|||
144223795|NCT04815083|520015737|FG000|Overall Study|Physician Decision|1|||
144223796|NCT04815083|520015737|FG000|Overall Study|Study pause|2|||
144223797|NCT04815083|520015737|FG000|Overall Study|Screening failure|4|||
144223798|NCT02068508|520015740|FG000|Overall Study|Case report forms uncollected|27|||
144223799|NCT02068508|520015740|FG000|Overall Study|Patient did not visit the study site|1|||
144223800|NCT02068508|520015740|FG000|Overall Study|Protocol Violation|4|||
144223801|NCT00813150|520015741|FG000|Treatment Period|Adverse Event|16|||
144223802|NCT00813150|520015742|FG001|Treatment Period|Adverse Event|15|||
144223803|NCT00813150|520015741|FG000|Treatment Period|Death|2|||
144223804|NCT00813150|520015742|FG001|Treatment Period|Death|0|||
144223805|NCT00813150|520015741|FG000|Treatment Period|Progressive disease|1|||
144223806|NCT00813150|520015742|FG001|Treatment Period|Progressive disease|0|||
144223807|NCT00813150|520015741|FG000|Treatment Period|Complete response|0|||
144223808|NCT00813150|520015742|FG001|Treatment Period|Complete response|1|||
144223809|NCT00813150|520015741|FG000|Treatment Period|Stable disease|1|||
144223810|NCT00813150|520015742|FG001|Treatment Period|Stable disease|2|||
144223811|NCT00813150|520015741|FG000|Treatment Period|Protocol Violation|3|||
144223812|NCT00813150|520015742|FG001|Treatment Period|Protocol Violation|4|||
144223813|NCT00813150|520015741|FG000|Treatment Period|Withdrawal by Subject|5|||
144223814|NCT00813150|520015742|FG001|Treatment Period|Withdrawal by Subject|3|||
144223815|NCT00813150|520015741|FG000|Treatment Period|Non compliance|0|||
144223816|NCT00813150|520015742|FG001|Treatment Period|Non compliance|1|||
144223817|NCT00813150|520015741|FG000|Treatment Period|Reason not specified|3|||
144223818|NCT00813150|520015742|FG001|Treatment Period|Reason not specified|4|||
144223819|NCT00813150|520015741|FG000|Treatment Period|Data not available|1|||
144223820|NCT00813150|520015742|FG001|Treatment Period|Data not available|2|||
144267360|NCT00113607|520181411|FG000|Overall Study|Withdrawal by Subject|50|||
144223821|NCT00813150|520015741|FG000|Long Term Follow-up|Death|0|||
144223822|NCT00813150|520015742|FG001|Long Term Follow-up|Death|4|||
144223823|NCT00813150|520015741|FG000|Long Term Follow-up|Other|0|||
144223824|NCT00813150|520015742|FG001|Long Term Follow-up|Other|3|||
144223825|NCT00813150|520015741|FG000|Long Term Follow-up|Lost to Follow-up|2|||
144223826|NCT00813150|520015742|FG001|Long Term Follow-up|Lost to Follow-up|0|||
144223827|NCT00813150|520015741|FG000|Long Term Follow-up|Progression/Relapse|22|||
144267361|NCT00113607|520181412|FG001|Overall Study|Withdrawal by Subject|58|||
144267362|NCT00113607|520181411|FG000|Overall Study|Lost to Follow-up|0|||
144267363|NCT00113607|520181412|FG001|Overall Study|Lost to Follow-up|2|||
144267364|NCT00113607|520181411|FG000|Overall Study|Disease Progression|180|||
144267365|NCT00113607|520181412|FG001|Overall Study|Disease Progression|142|||
144267366|NCT00113607|520181411|FG000|Overall Study|Complete Response (Confirmed)|14|||
144267367|NCT00113607|520181412|FG001|Overall Study|Complete Response (Confirmed)|24|||
144267368|NCT00113607|520181411|FG000|Overall Study|Other|43|||
144267369|NCT00113607|520181412|FG001|Overall Study|Other|32|||
144267370|NCT00749398|520181413|FG000|Overall Study|Lack of Efficacy|7|||
144267371|NCT00749398|520181413|FG000|Overall Study|Adverse Event|4|||
144267372|NCT00749398|520181413|FG000|Overall Study|Serious adverse event|11|||
144267373|NCT00749398|520181413|FG000|Overall Study|Withdrawal by Subject|17|||
144267374|NCT00749398|520181413|FG000|Overall Study|Lost to Follow-up|11|||
144267375|NCT00749398|520181413|FG000|Overall Study|Reason not specified|2|||
144267376|NCT00749398|520181413|FG000|Overall Study|Unknown reason|1|||
144267377|NCT02984982|520181416|FG000|Overall Study|Adverse Event|2|||
144267378|NCT02984982|520181417|FG001|Overall Study|Adverse Event|5|||
144267379|NCT02984982|520181416|FG000|Overall Study|Poor Compliance to Protocol|4|||
144267380|NCT02984982|520181417|FG001|Overall Study|Poor Compliance to Protocol|4|||
144267381|NCT02984982|520181416|FG000|Overall Study|Withdrawal by Subject|2|||
144267382|NCT02984982|520181417|FG001|Overall Study|Withdrawal by Subject|0|||
144267383|NCT02984982|520181416|FG000|Overall Study|Randomized but not treated|0|||
144267384|NCT02984982|520181417|FG001|Overall Study|Randomized but not treated|1|||
144267385|NCT02153918|520181418|FG000|Overall Study|Refused further treatment|1|||
144267386|NCT01103323|520181419|FG000|Without/Before Drug Switch|Adverse Event|50|||
144267387|NCT01103323|520181420|FG001|Without/Before Drug Switch|Adverse Event|7|||
144267388|NCT01103323|520181419|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
144267389|NCT01103323|520181420|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
144267390|NCT01103323|520181419|FG000|Without/Before Drug Switch|Protocol Violation|2|||
144267391|NCT01103323|520181420|FG001|Without/Before Drug Switch|Protocol Violation|0|||
144267392|NCT01103323|520181419|FG000|Without/Before Drug Switch|Physician Decision|2|||
144267393|NCT01103323|520181420|FG001|Without/Before Drug Switch|Physician Decision|0|||
144267394|NCT01103323|520181419|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
144267395|NCT01103323|520181420|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
144267396|NCT01103323|520181419|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
144267397|NCT01103323|520181420|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
144267398|NCT01103323|520181419|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
144267399|NCT01103323|520181420|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
144267400|NCT00577317|520181426|FG000|Overall Study|Study Terminated|0|||
144267401|NCT00577317|520181427|FG001|Overall Study|Study Terminated|2|||
144267402|NCT00846586|520181430|FG000|Overall Study|Adverse Event|20|||
144267403|NCT00846586|520181431|FG001|Overall Study|Adverse Event|10|||
144267404|NCT00846586|520181430|FG000|Overall Study|Subject withdrew consent|8|||
144267405|NCT00846586|520181431|FG001|Overall Study|Subject withdrew consent|10|||
144267406|NCT00846586|520181430|FG000|Overall Study|Administrative problems|5|||
144267407|NCT00846586|520181431|FG001|Overall Study|Administrative problems|4|||
144267408|NCT00846586|520181430|FG000|Overall Study|Death|2|||
144267409|NCT00846586|520181431|FG001|Overall Study|Death|0|||
144267410|NCT00846586|520181430|FG000|Overall Study|Protocol deviation|2|||
144267411|NCT00846586|520181431|FG001|Overall Study|Protocol deviation|6|||
144267412|NCT00846586|520181430|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144267413|NCT00846586|520181431|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144267414|NCT00846586|520181430|FG000|Overall Study|Lost to Follow-up|1|||
144267415|NCT00846586|520181431|FG001|Overall Study|Lost to Follow-up|4|||
144267416|NCT00846586|520181430|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144267417|NCT00846586|520181431|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144267418|NCT00780975|520181432|FG000|Overall Study|Progressive disease|3|||
144267419|NCT00780975|520181432|FG000|Overall Study|Toxicity|5|||
144267420|NCT01061606|520181433|FG000|Overall Study|Adverse Event|1|||
144267421|NCT01061606|520181433|FG000|Overall Study|Death|1|||
144267422|NCT01061606|520181433|FG000|Overall Study|Disease Progression|4|||
144267423|NCT01061606|520181433|FG000|Overall Study|alternative therapy|2|||
144267424|NCT01204671|520181434|FG000|Overall Study|Adverse Event|4|||
144267425|NCT01204671|520181435|FG001|Overall Study|Adverse Event|3|||
144267426|NCT01204671|520181436|FG002|Overall Study|Adverse Event|3|||
144267427|NCT01204671|520181437|FG003|Overall Study|Adverse Event|3|||
144267428|NCT01204671|520181438|FG004|Overall Study|Adverse Event|1|||
144267429|NCT01204671|520181434|FG000|Overall Study|Withdrawal by Subject|2|||
144267430|NCT01204671|520181435|FG001|Overall Study|Withdrawal by Subject|3|||
144267431|NCT01204671|520181436|FG002|Overall Study|Withdrawal by Subject|4|||
144267432|NCT01204671|520181437|FG003|Overall Study|Withdrawal by Subject|5|||
144267433|NCT01204671|520181438|FG004|Overall Study|Withdrawal by Subject|3|||
144267434|NCT01204671|520181434|FG000|Overall Study|Lost to Follow-up|7|||
144267435|NCT01204671|520181435|FG001|Overall Study|Lost to Follow-up|8|||
144267436|NCT01204671|520181436|FG002|Overall Study|Lost to Follow-up|6|||
144267437|NCT01204671|520181437|FG003|Overall Study|Lost to Follow-up|4|||
144267438|NCT01204671|520181438|FG004|Overall Study|Lost to Follow-up|0|||
144267439|NCT01204671|520181434|FG000|Overall Study|Unknown Completion Status|1|||
144267440|NCT01204671|520181435|FG001|Overall Study|Unknown Completion Status|1|||
144267441|NCT01204671|520181436|FG002|Overall Study|Unknown Completion Status|0|||
144267442|NCT01204671|520181437|FG003|Overall Study|Unknown Completion Status|0|||
144267443|NCT01204671|520181438|FG004|Overall Study|Unknown Completion Status|0|||
144267444|NCT01204671|520181434|FG000|Overall Study|Physician Decision|0|||
144267445|NCT01204671|520181435|FG001|Overall Study|Physician Decision|0|||
144267446|NCT01204671|520181436|FG002|Overall Study|Physician Decision|0|||
144267447|NCT01204671|520181437|FG003|Overall Study|Physician Decision|1|||
144267448|NCT01204671|520181438|FG004|Overall Study|Physician Decision|0|||
144267449|NCT00492726|520181439|FG000|Overall Study|Adverse Event|10|||
144267450|NCT00492726|520181440|FG001|Overall Study|Adverse Event|6|||
144267451|NCT00492726|520181439|FG000|Overall Study|Death|7|||
144267452|NCT00492726|520181440|FG001|Overall Study|Death|2|||
144267453|NCT00492726|520181439|FG000|Overall Study|Lack of Efficacy|0|||
144267454|NCT00492726|520181440|FG001|Overall Study|Lack of Efficacy|2|||
144267455|NCT00492726|520181439|FG000|Overall Study|Lost to Follow-up|27|||
144267456|NCT00492726|520181440|FG001|Overall Study|Lost to Follow-up|19|||
144267457|NCT00492726|520181439|FG000|Overall Study|Physician Decision|0|||
144267458|NCT00492726|520181440|FG001|Overall Study|Physician Decision|1|||
144267459|NCT00492726|520181439|FG000|Overall Study|Withdrawal by Subject|6|||
144267460|NCT00492726|520181440|FG001|Overall Study|Withdrawal by Subject|3|||
144267461|NCT00492726|520181439|FG000|Overall Study|Non compliant with study medication|0|||
144267462|NCT00492726|520181440|FG001|Overall Study|Non compliant with study medication|3|||
144267463|NCT04386902|520181441|FG000|Overall Study|Withdrawal by Subject|5|||
144267464|NCT04386902|520181441|FG000|Overall Study|Technical problems in the recording|5|||
144267465|NCT01100502|520181442|FG000|Overall Study|Withdrawal by Subject|18|||
144267466|NCT01100502|520181443|FG001|Overall Study|Withdrawal by Subject|25|||
144223828|NCT00813150|520015742|FG001|Long Term Follow-up|Progression/Relapse|24|||
144223829|NCT05423093|520015750|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
144223830|NCT05423093|520015750|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
144223831|NCT05423093|520015750|FG000|Attended Intervention Session|Lost to Follow-up|3|||
144223832|NCT05423093|520015750|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
144223833|NCT05423093|520015750|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
144223834|NCT02243605|520015751|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
144223835|NCT02243605|520015752|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
144223836|NCT02243605|520015751|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
144223837|NCT02243605|520015752|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
144223838|NCT02243605|520015751|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
144223839|NCT02243605|520015752|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
144223840|NCT02243605|520015751|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
144223841|NCT02243605|520015752|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
144223842|NCT02243605|520015751|FG000|Stage 2 - Final Analysis Population|Progression|0|||
144223843|NCT02243605|520015752|FG001|Stage 2 - Final Analysis Population|Progression|1|||
144223844|NCT03593525|520015753|FG000|Overall Study|Withdrawal by Subject|1|||
144223845|NCT03593525|520015754|FG001|Overall Study|Withdrawal by Subject|0|||
144223846|NCT03593525|520015753|FG000|Overall Study|Lost to Follow-up|7|||
144223847|NCT03593525|520015754|FG001|Overall Study|Lost to Follow-up|5|||
144223848|NCT04173507|520015761|FG000|Overall Study|On Treatment|3|||
144223849|NCT04173507|520015761|FG000|Overall Study|Adverse Event|3|||
144223850|NCT04173507|520015761|FG000|Overall Study|Progression/Relapse|34|||
144223851|NCT04173507|520015761|FG000|Overall Study|Death|2|||
144223852|NCT00210210|520015762|FG000|Overall Study|Withdrawal by Subject|3|||
144223853|NCT00210210|520015763|FG001|Overall Study|Withdrawal by Subject|2|||
144223854|NCT00210210|520015762|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
144223855|NCT00210210|520015763|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
144223856|NCT04231825|520015764|FG000|Overall Study|Protocol Violation|3|||
144223857|NCT04231825|520015765|FG001|Overall Study|Protocol Violation|3|||
144223858|NCT04231825|520015764|FG000|Overall Study|Lost to Follow-up|0|||
144223859|NCT04231825|520015765|FG001|Overall Study|Lost to Follow-up|1|||
144223860|NCT02596971|520015766|FG000|Overall Study|Death|5|||
144223861|NCT02596971|520015767|FG001|Overall Study|Death|1|||
144267467|NCT01100502|520181442|FG000|Overall Study|Lost to Follow-up|13|||
144267468|NCT01100502|520181443|FG001|Overall Study|Lost to Follow-up|28|||
144267469|NCT01100502|520181442|FG000|Overall Study|Site request to end participation in study|0|||
144267470|NCT01100502|520181443|FG001|Overall Study|Site request to end participation in study|1|||
144267471|NCT01100502|520181442|FG000|Overall Study|Death|45|||
144267472|NCT01100502|520181443|FG001|Overall Study|Death|40|||
144223862|NCT02596971|520015768|FG002|Overall Study|Death|5|||
144223863|NCT02596971|520015766|FG000|Overall Study|Withdrawal by Subject|5|||
144223864|NCT02596971|520015767|FG001|Overall Study|Withdrawal by Subject|1|||
144223865|NCT02596971|520015768|FG002|Overall Study|Withdrawal by Subject|4|||
144223866|NCT00595920|520015769|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
144267473|NCT00721799|520181444|FG000|Overall Study|Withdrawal by Subject|7|||
144267474|NCT00721799|520181444|FG000|Overall Study|withdraw by subject after scan 1|1|||
144267475|NCT05158140|520181446|FG000|Overall Study|Death|0|||
144267476|NCT05158140|520181447|FG001|Overall Study|Death|0|||
144267477|NCT05158140|520181448|FG002|Overall Study|Death|0|||
144267478|NCT05158140|520181449|FG003|Overall Study|Death|1|||
144267479|NCT05158140|520181446|FG000|Overall Study|Lost to Follow-up|3|||
144267480|NCT05158140|520181447|FG001|Overall Study|Lost to Follow-up|6|||
144267481|NCT05158140|520181448|FG002|Overall Study|Lost to Follow-up|4|||
144267482|NCT05158140|520181449|FG003|Overall Study|Lost to Follow-up|3|||
144267483|NCT05158140|520181446|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144267484|NCT05158140|520181447|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144267485|NCT05158140|520181448|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
144267486|NCT05158140|520181449|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144267487|NCT05158140|520181446|FG000|Overall Study|Withdrawal by Subject|3|||
144267488|NCT05158140|520181447|FG001|Overall Study|Withdrawal by Subject|7|||
144267489|NCT05158140|520181448|FG002|Overall Study|Withdrawal by Subject|3|||
144267490|NCT05158140|520181449|FG003|Overall Study|Withdrawal by Subject|7|||
144267491|NCT00807365|520181453|FG000|Overall Study|Study Terminated|5|||
144267492|NCT01121263|520181455|FG000|Overall Study|Death|3|||
144267493|NCT01121263|520181456|FG001|Overall Study|Death|2|||
144267494|NCT01121263|520181455|FG000|Overall Study|Lost to Follow-up|22|||
144267495|NCT01121263|520181456|FG001|Overall Study|Lost to Follow-up|12|||
144267496|NCT01121263|520181455|FG000|Overall Study|Withdrawal by Subject|0|||
144267497|NCT01121263|520181456|FG001|Overall Study|Withdrawal by Subject|1|||
144267498|NCT03810456|520181457|FG000|Treatment|Urgent Family Matters|3|||
144267499|NCT03810456|520181458|FG001|Treatment|Urgent Family Matters|0|||
144267500|NCT03810456|520181459|FG002|Treatment|Urgent Family Matters|0|||
144267501|NCT03810456|520181457|FG000|Treatment|Scheduling Conflicts|0|||
144267502|NCT03810456|520181458|FG001|Treatment|Scheduling Conflicts|11|||
144267503|NCT03810456|520181459|FG002|Treatment|Scheduling Conflicts|0|||
144267504|NCT03810456|520181457|FG000|Treatment|No Longer Interested|0|||
144267505|NCT03810456|520181458|FG001|Treatment|No Longer Interested|12|||
144267506|NCT03810456|520181459|FG002|Treatment|No Longer Interested|0|||
144267507|NCT03810456|520181457|FG000|Treatment|Transportation Issues|0|||
144267508|NCT03810456|520181458|FG001|Treatment|Transportation Issues|1|||
144267509|NCT03810456|520181459|FG002|Treatment|Transportation Issues|0|||
144267510|NCT03810456|520181457|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
144267511|NCT03810456|520181458|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
144267512|NCT03810456|520181459|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
144267513|NCT03810456|520181457|FG000|1 Month Follow-Up|Relocated to Different State|1|||
144267514|NCT03810456|520181458|FG001|1 Month Follow-Up|Relocated to Different State|0|||
144267515|NCT03810456|520181459|FG002|1 Month Follow-Up|Relocated to Different State|1|||
144267516|NCT03810456|520181457|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
144267517|NCT03810456|520181458|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
144267518|NCT03810456|520181459|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
144267519|NCT03810456|520181457|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
144267520|NCT03810456|520181458|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
144267521|NCT03810456|520181459|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
144267522|NCT03810456|520181457|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
144267523|NCT03810456|520181458|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
144267524|NCT03810456|520181459|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
144267525|NCT03810456|520181457|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
144267526|NCT03810456|520181458|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
144267527|NCT03810456|520181459|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
144267528|NCT03810456|520181457|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
144267529|NCT03810456|520181458|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
144267530|NCT03810456|520181459|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
144267531|NCT02100124|520181464|FG000|Overall Study|Lost to Follow-up|5|||
144267532|NCT02100124|520181465|FG001|Overall Study|Lost to Follow-up|11|||
144267533|NCT02100124|520181466|FG002|Overall Study|Lost to Follow-up|3|||
144267534|NCT02100124|520181464|FG000|Overall Study|Withdrawal by Subject|1|||
144267535|NCT02100124|520181465|FG001|Overall Study|Withdrawal by Subject|0|||
144267536|NCT02100124|520181466|FG002|Overall Study|Withdrawal by Subject|0|||
144267537|NCT04350827|520181467|FG000|Overall Study|Lost to Follow-up|1|||
144267538|NCT04350827|520181468|FG001|Overall Study|Lost to Follow-up|2|||
144267539|NCT02812186|520183228|FG000|Period 1|Post randomization screen failure|5|||
144267540|NCT02812186|520183229|FG001|Period 1|Post randomization screen failure|9|||
144267541|NCT02812186|520183228|FG000|Period 1|nonevaluable data sets|6|||
144267542|NCT02812186|520183229|FG001|Period 1|nonevaluable data sets|6|||
144267543|NCT03103503|520183230|FG000|Overall Study|Death|64|||
144267544|NCT03103503|520183230|FG000|Overall Study|Physician Decision|57|||
144267545|NCT03103503|520183230|FG000|Overall Study|Withdrawal by Subject|10|||
144267546|NCT03103503|520183230|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
144267547|NCT03103503|520183230|FG000|Overall Study|Lost to Follow-up|3|||
144267548|NCT03103503|520183230|FG000|Overall Study|Study Closure|757|||
144267549|NCT03342001|520183234|FG000|Overall Study|Adverse Event|1|||
144267550|NCT03342001|520183234|FG000|Overall Study|Lost to Follow-up|1|||
144267551|NCT04635839|520183237|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
144267552|NCT04635839|520183238|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
144267553|NCT02737358|520183239|FG000|Overall Study|Withdrawal by Subject|7|||
144267554|NCT02737358|520183240|FG001|Overall Study|Withdrawal by Subject|12|||
144267555|NCT02737358|520183239|FG000|Overall Study|Lost to Follow-up|2|||
144223867|NCT00611923|520015770|FG000|Overall Study|Withdrawal by Subject|2|||
144223868|NCT00611923|520015771|FG001|Overall Study|Withdrawal by Subject|2|||
144223869|NCT04565145|520015772|FG000|Overall Study|Withdrawal by Subject|1|||
144223870|NCT04565145|520015773|FG001|Overall Study|Withdrawal by Subject|1|||
144223871|NCT03096314|520015774|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
144223872|NCT03096314|520015775|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
144223873|NCT01479465|520015776|FG000|Overall Study|Disease Progression|9|||
144223874|NCT01479465|520015777|FG001|Overall Study|Disease Progression|61|||
144223875|NCT01479465|520015778|FG002|Overall Study|Disease Progression|65|||
144223876|NCT01479465|520015779|FG003|Overall Study|Disease Progression|70|||
144223877|NCT01479465|520015776|FG000|Overall Study|Study Discontinued by Sponsor|0|||
144223878|NCT01479465|520015777|FG001|Overall Study|Study Discontinued by Sponsor|7|||
144223879|NCT01479465|520015778|FG002|Overall Study|Study Discontinued by Sponsor|5|||
144223880|NCT01479465|520015779|FG003|Overall Study|Study Discontinued by Sponsor|3|||
144223881|NCT01479465|520015776|FG000|Overall Study|Adverse Event|0|||
144223882|NCT01479465|520015777|FG001|Overall Study|Adverse Event|3|||
144223883|NCT01479465|520015778|FG002|Overall Study|Adverse Event|6|||
144223884|NCT01479465|520015779|FG003|Overall Study|Adverse Event|4|||
144223885|NCT01479465|520015776|FG000|Overall Study|Investigator Discretion|1|||
144223886|NCT01479465|520015777|FG001|Overall Study|Investigator Discretion|4|||
144223887|NCT01479465|520015778|FG002|Overall Study|Investigator Discretion|2|||
144223888|NCT01479465|520015779|FG003|Overall Study|Investigator Discretion|4|||
144223889|NCT01479465|520015776|FG000|Overall Study|Subject Request|1|||
144223890|NCT01479465|520015777|FG001|Overall Study|Subject Request|3|||
144223891|NCT01479465|520015778|FG002|Overall Study|Subject Request|4|||
144223892|NCT01479465|520015779|FG003|Overall Study|Subject Request|2|||
144223893|NCT01479465|520015776|FG000|Overall Study|Subject Withdrew Consent|0|||
144223894|NCT01479465|520015777|FG001|Overall Study|Subject Withdrew Consent|5|||
144223895|NCT01479465|520015778|FG002|Overall Study|Subject Withdrew Consent|2|||
144223896|NCT01479465|520015779|FG003|Overall Study|Subject Withdrew Consent|1|||
144223897|NCT01479465|520015776|FG000|Overall Study|Protocol Violation|0|||
144223898|NCT01479465|520015777|FG001|Overall Study|Protocol Violation|1|||
144223899|NCT01479465|520015778|FG002|Overall Study|Protocol Violation|1|||
144223900|NCT01479465|520015779|FG003|Overall Study|Protocol Violation|0|||
144223901|NCT01479465|520015776|FG000|Overall Study|Death|0|||
144223902|NCT01479465|520015777|FG001|Overall Study|Death|0|||
144223903|NCT01479465|520015778|FG002|Overall Study|Death|0|||
144223904|NCT01479465|520015779|FG003|Overall Study|Death|1|||
144223905|NCT01479465|520015776|FG000|Overall Study|Lost to Follow-up|0|||
144223906|NCT01479465|520015777|FG001|Overall Study|Lost to Follow-up|0|||
144223907|NCT01479465|520015778|FG002|Overall Study|Lost to Follow-up|1|||
144223908|NCT01479465|520015779|FG003|Overall Study|Lost to Follow-up|0|||
144223909|NCT00370552|520015780|FG000|Overall Study|Adverse Event|2|||
144223910|NCT00370552|520015781|FG001|Overall Study|Adverse Event|2|||
144223911|NCT00370552|520015782|FG002|Overall Study|Adverse Event|2|||
144223912|NCT00370552|520015780|FG000|Overall Study|Disease progression|23|||
144223913|NCT00370552|520015781|FG001|Overall Study|Disease progression|23|||
144223914|NCT00370552|520015782|FG002|Overall Study|Disease progression|15|||
144223915|NCT00370552|520015780|FG000|Overall Study|Maximum clinical benefit|3|||
144223916|NCT00370552|520015781|FG001|Overall Study|Maximum clinical benefit|5|||
144223917|NCT00370552|520015782|FG002|Overall Study|Maximum clinical benefit|5|||
144223918|NCT00370552|520015780|FG000|Overall Study|Poor or noncompliance|0|||
144223919|NCT00370552|520015781|FG001|Overall Study|Poor or noncompliance|0|||
144223920|NCT00370552|520015782|FG002|Overall Study|Poor or noncompliance|1|||
144223921|NCT00370552|520015780|FG000|Overall Study|Study drug toxicity|11|||
144223922|NCT00370552|520015781|FG001|Overall Study|Study drug toxicity|8|||
144223923|NCT00370552|520015782|FG002|Overall Study|Study drug toxicity|6|||
144223924|NCT00370552|520015780|FG000|Overall Study|Withdrawal by Subject|2|||
144223925|NCT00370552|520015781|FG001|Overall Study|Withdrawal by Subject|0|||
144223926|NCT00370552|520015782|FG002|Overall Study|Withdrawal by Subject|1|||
144223927|NCT00370552|520015780|FG000|Overall Study|Still on treatment|1|||
144223928|NCT00370552|520015781|FG001|Overall Study|Still on treatment|3|||
144223929|NCT00370552|520015782|FG002|Overall Study|Still on treatment|2|||
144223930|NCT00370552|520015780|FG000|Overall Study|Never treated|1|||
144223931|NCT00370552|520015781|FG001|Overall Study|Never treated|0|||
144223932|NCT00370552|520015782|FG002|Overall Study|Never treated|0|||
144223933|NCT00370552|520015780|FG000|Overall Study|Physician Decision|1|||
144223934|NCT00370552|520015781|FG001|Overall Study|Physician Decision|1|||
144223935|NCT00370552|520015782|FG002|Overall Study|Physician Decision|0|||
144223936|NCT00370552|520015780|FG000|Overall Study|Investigator decision|2|||
144223937|NCT00370552|520015781|FG001|Overall Study|Investigator decision|1|||
144223938|NCT00370552|520015782|FG002|Overall Study|Investigator decision|0|||
144223939|NCT00370552|520015780|FG000|Overall Study|High risk of allergic reaction|0|||
144223940|NCT00370552|520015781|FG001|Overall Study|High risk of allergic reaction|1|||
144223941|NCT00370552|520015782|FG002|Overall Study|High risk of allergic reaction|0|||
144223942|NCT00370552|520015780|FG000|Overall Study|Planned radiation for palliation|0|||
144223943|NCT00370552|520015781|FG001|Overall Study|Planned radiation for palliation|1|||
144223944|NCT00370552|520015782|FG002|Overall Study|Planned radiation for palliation|0|||
144223945|NCT02342678|520015791|FG000|Overall Study|Lost to Follow-up|0|||
144223946|NCT02342678|520015792|FG001|Overall Study|Lost to Follow-up|1|||
144223947|NCT02342678|520015791|FG000|Overall Study|Too busy to complete study|0|||
144223948|NCT02342678|520015792|FG001|Overall Study|Too busy to complete study|2|||
144223949|NCT02342678|520015791|FG000|Overall Study|Family illness/emergency|0|||
144223950|NCT02342678|520015792|FG001|Overall Study|Family illness/emergency|1|||
144223951|NCT02342678|520015791|FG000|Overall Study|Illness/medical reason|1|||
144223952|NCT02342678|520015792|FG001|Overall Study|Illness/medical reason|1|||
144223953|NCT02383017|520015793|FG000|Overall Study|Injury Sustained Outside Study|1|||
144223954|NCT02383017|520015794|FG001|Overall Study|Injury Sustained Outside Study|0|||
144223955|NCT02383017|520015793|FG000|Overall Study|Compliance|3|||
144223956|NCT02383017|520015794|FG001|Overall Study|Compliance|2|||
144223957|NCT02383017|520015793|FG000|Overall Study|Found to be Hypogonadal|1|||
144223958|NCT02383017|520015794|FG001|Overall Study|Found to be Hypogonadal|0|||
144223959|NCT01198470|520015795|FG000|Overall Study|Adverse Event|2|||
144223960|NCT04383327|520015796|FG000|Overall Study|Lost to Follow-up|112|||
144223961|NCT04383327|520015797|FG001|Overall Study|Lost to Follow-up|14|||
144223962|NCT04383327|520015798|FG002|Overall Study|Lost to Follow-up|78|||
144223963|NCT04383327|520015799|FG003|Overall Study|Lost to Follow-up|13|||
144223964|NCT04383327|520015800|FG004|Overall Study|Lost to Follow-up|110|||
144223965|NCT04383327|520015801|FG005|Overall Study|Lost to Follow-up|13|||
144223966|NCT04383327|520015802|FG006|Overall Study|Lost to Follow-up|74|||
144223967|NCT04383327|520015803|FG007|Overall Study|Lost to Follow-up|13|||
144223968|NCT04383327|520015804|FG008|Overall Study|Lost to Follow-up|78|||
144223969|NCT04383327|520015805|FG009|Overall Study|Lost to Follow-up|10|||
144223970|NCT04383327|520015806|FG010|Overall Study|Lost to Follow-up|160|||
144223971|NCT04383327|520015807|FG011|Overall Study|Lost to Follow-up|13|||
144223972|NCT05271175|520015817|FG000|One Week Follow up|Lost to Follow-up|10|||
144223973|NCT05271175|520015818|FG001|One Week Follow up|Lost to Follow-up|7|||
144223974|NCT05271175|520015819|FG002|One Week Follow up|Lost to Follow-up|5|||
144223975|NCT05271175|520015817|FG000|One Month Follow up|Lost to Follow-up|12|||
144223976|NCT05271175|520015818|FG001|One Month Follow up|Lost to Follow-up|7|||
144223977|NCT05271175|520015819|FG002|One Month Follow up|Lost to Follow-up|9|||
144223978|NCT05271175|520015817|FG000|Six Months Follow up|Lost to Follow-up|8|||
144223979|NCT05271175|520015818|FG001|Six Months Follow up|Lost to Follow-up|2|||
144223980|NCT05271175|520015819|FG002|Six Months Follow up|Lost to Follow-up|2|||
144223981|NCT00991887|520015820|FG000|Overall Study|Lost to Follow-up|2|||
144223982|NCT00991887|520015821|FG001|Overall Study|Lost to Follow-up|1|||
144223983|NCT00226499|520015822|FG000|Overall Study|Adverse Event|10|||
144223984|NCT00226499|520015823|FG001|Overall Study|Adverse Event|6|||
144223985|NCT00226499|520015824|FG002|Overall Study|Adverse Event|3|||
144223986|NCT00226499|520015822|FG000|Overall Study|Others|1064|||
144223987|NCT00226499|520015823|FG001|Overall Study|Others|1066|||
144223988|NCT00226499|520015824|FG002|Overall Study|Others|356|||
144223989|NCT01306305|520015825|FG000|Overall Study|Lost to Follow-up|1|||
144223990|NCT01306305|520015826|FG001|Overall Study|Lost to Follow-up|0|||
144223991|NCT01306305|520015825|FG000|Overall Study|Withdrew consent|1|||
144223992|NCT01306305|520015826|FG001|Overall Study|Withdrew consent|0|||
144223993|NCT04030299|520015827|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
144223994|NCT04030299|520015827|FG000|Overall Study|Withdrawal by Subject|3|||
144223995|NCT00946920|520015828|FG000|Overall Study|Withdrawal by Subject|28|||
144223996|NCT00946920|520015829|FG001|Overall Study|Withdrawal by Subject|15|||
144223997|NCT00946920|520015828|FG000|Overall Study|Lost to Follow-up|2|||
144223998|NCT00946920|520015829|FG001|Overall Study|Lost to Follow-up|2|||
144223999|NCT00946920|520015828|FG000|Overall Study|Physician Decision|5|||
144224000|NCT00946920|520015829|FG001|Overall Study|Physician Decision|2|||
144224001|NCT00946920|520015828|FG000|Overall Study|Adverse Event|41|||
144224002|NCT00946920|520015829|FG001|Overall Study|Adverse Event|14|||
144224003|NCT00946920|520015828|FG000|Overall Study|Protocol Violation|16|||
144224004|NCT00946920|520015829|FG001|Overall Study|Protocol Violation|8|||
144224005|NCT00946920|520015828|FG000|Overall Study|Miscellaneous reasons|18|||
144224006|NCT00946920|520015829|FG001|Overall Study|Miscellaneous reasons|3|||
144224007|NCT02964247|520015830|FG000|Overall Study|Lost to Follow-up|2|||
144224008|NCT02964247|520015831|FG001|Overall Study|Lost to Follow-up|0|||
144224009|NCT02964247|520015830|FG000|Overall Study|Withdrawal by Subject|1|||
144224010|NCT02964247|520015831|FG001|Overall Study|Withdrawal by Subject|2|||
144224011|NCT01288079|520015832|FG000|Overall Study|Withdrawal by Subject|2|||
144224012|NCT01288079|520015833|FG001|Overall Study|Withdrawal by Subject|4|||
144224013|NCT01288079|520015834|FG002|Overall Study|Withdrawal by Subject|1|||
144224014|NCT01288079|520015835|FG003|Overall Study|Withdrawal by Subject|0|||
144224015|NCT01288079|520015832|FG000|Overall Study|Adverse Event|2|||
144224016|NCT01288079|520015833|FG001|Overall Study|Adverse Event|1|||
144224017|NCT01288079|520015834|FG002|Overall Study|Adverse Event|2|||
144224018|NCT01288079|520015835|FG003|Overall Study|Adverse Event|3|||
144224019|NCT01288079|520015832|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
144224020|NCT01288079|520015833|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
144224021|NCT01288079|520015834|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
144224022|NCT01288079|520015835|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
144224023|NCT01288079|520015832|FG000|Overall Study|Condition under Investigation Worsened|0|||
144224024|NCT01288079|520015833|FG001|Overall Study|Condition under Investigation Worsened|0|||
144224025|NCT01288079|520015834|FG002|Overall Study|Condition under Investigation Worsened|0|||
144224026|NCT01288079|520015835|FG003|Overall Study|Condition under Investigation Worsened|1|||
144224027|NCT01288079|520015832|FG000|Overall Study|Lack of Efficacy|2|||
144224028|NCT01288079|520015833|FG001|Overall Study|Lack of Efficacy|2|||
144224029|NCT01288079|520015834|FG002|Overall Study|Lack of Efficacy|0|||
144224030|NCT01288079|520015835|FG003|Overall Study|Lack of Efficacy|2|||
144224031|NCT01288079|520015832|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
144267556|NCT02737358|520183240|FG001|Overall Study|Lost to Follow-up|3|||
144267557|NCT01739335|520183242|FG000|Overall Study|Lost to Follow-up|7|||
144267558|NCT01739335|520183243|FG001|Overall Study|Lost to Follow-up|4|||
144267559|NCT01739335|520183242|FG000|Overall Study|Ineligible patient randomized|0|||
144267560|NCT01739335|520183243|FG001|Overall Study|Ineligible patient randomized|1|||
144267561|NCT00288912|520183244|FG000|Overall Study|Developed exclusion criterion|4|||
144267562|NCT00288912|520183245|FG001|Overall Study|Developed exclusion criterion|6|||
144267563|NCT00288912|520183246|FG002|Overall Study|Developed exclusion criterion|7|||
144267564|NCT00288912|520183244|FG000|Overall Study|Lost to Follow-up|9|||
144267565|NCT00288912|520183245|FG001|Overall Study|Lost to Follow-up|6|||
144267566|NCT00288912|520183246|FG002|Overall Study|Lost to Follow-up|9|||
144267567|NCT00288912|520183244|FG000|Overall Study|Withdrawal by Subject|4|||
144267568|NCT00288912|520183245|FG001|Overall Study|Withdrawal by Subject|5|||
144267569|NCT00288912|520183246|FG002|Overall Study|Withdrawal by Subject|12|||
144267570|NCT00183430|520183249|FG000|Overall Study|Adverse Event|1|||
144267571|NCT00183430|520183250|FG001|Overall Study|Adverse Event|0|||
144267572|NCT00183430|520183249|FG000|Overall Study|Lost to Follow-up|3|||
144267573|NCT00183430|520183250|FG001|Overall Study|Lost to Follow-up|0|||
144267574|NCT00183430|520183249|FG000|Overall Study|did not meet inclusion criteria|1|||
144267575|NCT00183430|520183250|FG001|Overall Study|did not meet inclusion criteria|0|||
144267576|NCT00183430|520183249|FG000|Overall Study|Withdrawal by Subject|1|||
144267577|NCT00183430|520183250|FG001|Overall Study|Withdrawal by Subject|0|||
144267578|NCT00883181|520183253|FG000|Overall Study|Hematological Adverse Event|26|||
144267579|NCT00883181|520183253|FG000|Overall Study|Non-hematological Adverse Event|55|||
144267580|NCT00883181|520183253|FG000|Overall Study|Disease Progression|94|||
144267581|NCT00883181|520183253|FG000|Overall Study|Administrative Reason|24|||
144267582|NCT00883181|520183253|FG000|Overall Study|Withdrawal by Subject|4|||
144267583|NCT00883181|520183253|FG000|Overall Study|Death|31|||
144267584|NCT00883181|520183253|FG000|Overall Study|Other|38|||
144267585|NCT00883181|520183253|FG000|Overall Study|Protocol Deviation|3|||
144267586|NCT00883181|520183253|FG000|Overall Study|Noncompliance|3|||
144267587|NCT01248455|520183254|FG000|Overall Study|switched to alternate treatment|1|||
144267588|NCT00426270|520183255|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
144267589|NCT00426270|520183255|FG000|Overall Study|Adverse Event|5|||
144267590|NCT01587885|520183256|FG000|Treatment Period 1|Failure to Return|0|||
144267591|NCT01587885|520183257|FG001|Treatment Period 1|Failure to Return|1|||
144267592|NCT01587885|520183256|FG000|Treatment Period 1|Protocol Violation|0|||
144267593|NCT01587885|520183257|FG001|Treatment Period 1|Protocol Violation|2|||
144267594|NCT01117870|520183259|FG000|Overall Study|Inability to place needle|1|||
144267595|NCT01117870|520183260|FG001|Overall Study|Inability to place needle|0|||
144267596|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
144267597|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
144267598|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
144267599|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
144267600|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
144267601|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
144267602|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
144267603|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
144267604|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
144267605|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
144267606|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
144267607|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
144267608|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
144267609|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
144267610|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
144267611|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
144267612|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
144267613|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
144267614|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
144267615|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
144267616|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
144267617|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
144267618|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
144267619|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
144267620|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
144267621|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
144267622|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
144267623|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
144267624|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
144267625|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
144267626|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
144224032|NCT01288079|520015833|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
144224033|NCT01288079|520015834|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
144224034|NCT01288079|520015835|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
144224035|NCT01288079|520015832|FG000|Overall Study|Lost to Follow-up|1|||
144224036|NCT01288079|520015833|FG001|Overall Study|Lost to Follow-up|1|||
144224037|NCT01288079|520015834|FG002|Overall Study|Lost to Follow-up|1|||
144224038|NCT01288079|520015835|FG003|Overall Study|Lost to Follow-up|0|||
144224039|NCT01288079|520015832|FG000|Overall Study|Other or Study Termination|11|||
144224040|NCT01288079|520015833|FG001|Overall Study|Other or Study Termination|15|||
144224041|NCT01288079|520015834|FG002|Overall Study|Other or Study Termination|14|||
144267627|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
144267628|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
144267629|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
144267630|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
144267631|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
144267632|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
144267633|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
144267634|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
144267635|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
144267636|NCT02709746|520183261|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
144267637|NCT02709746|520183262|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
144267638|NCT02709746|520183263|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
144267639|NCT02709746|520183264|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
144267640|NCT02709746|520183265|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
144267641|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
144267642|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
144267643|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
144267644|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
144267645|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
144267646|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
144267647|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
144267648|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
144267649|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
144267650|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
144267651|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
144267652|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
144267653|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
144267654|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
144267655|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
144267656|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
144267657|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
144267658|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
144267659|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
144267660|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
144267661|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
144267662|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
144267663|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
144267664|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
144267665|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
144267666|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
144267667|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
144267668|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
144267669|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
144267670|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
144267671|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
144267672|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
144267673|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
144267674|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
144267675|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
144224042|NCT01288079|520015835|FG003|Overall Study|Other or Study Termination|8|||
144224043|NCT01530464|520015836|FG000|Washout (24h)|Withdrawal by Subject|1|||
144224044|NCT01530464|520015837|FG001|Washout (24h)|Withdrawal by Subject|0|||
144224045|NCT01530464|520015836|FG000|Washout (24h)|Withdrawal by Subject|0|||
144224046|NCT01530464|520015837|FG001|Washout (24h)|Withdrawal by Subject|1|||
144224047|NCT02387840|520015838|FG000|Overall Study|Death|0|||
144224048|NCT02387840|520015839|FG001|Overall Study|Death|0|||
144224049|NCT02387840|520015840|FG002|Overall Study|Death|0|||
144224050|NCT02387840|520015841|FG003|Overall Study|Death|0|||
144224051|NCT02387840|520015842|FG004|Overall Study|Death|0|||
144224052|NCT02387840|520015843|FG005|Overall Study|Death|1|||
144224053|NCT03539302|520015848|FG000|Overall Study|Spontaneous cardio version|0|||
144224054|NCT03539302|520015849|FG001|Overall Study|Spontaneous cardio version|0|||
144224055|NCT03539302|520015850|FG002|Overall Study|Spontaneous cardio version|0|||
144224056|NCT03539302|520015851|FG003|Overall Study|Spontaneous cardio version|0|||
144224057|NCT03539302|520015852|FG004|Overall Study|Spontaneous cardio version|0|||
144224058|NCT03539302|520015853|FG005|Overall Study|Spontaneous cardio version|1|||
144224059|NCT03539302|520015854|FG006|Overall Study|Spontaneous cardio version|1|||
144224060|NCT02107131|520015859|FG000|Overall Study|Lost to Follow-up|4|||
144224061|NCT02107131|520015860|FG001|Overall Study|Lost to Follow-up|4|||
144267676|NCT02709746|520183261|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
144267677|NCT02709746|520183262|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
144267678|NCT02709746|520183263|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
144267679|NCT02709746|520183264|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
144267680|NCT02709746|520183265|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
144267681|NCT00752089|520183266|FG000|Overall Study|Adverse Event|1|||
144267682|NCT00752089|520183266|FG000|Overall Study|Protocol Deviation|2|||
144267683|NCT00752089|520183266|FG000|Overall Study|Could not attend visit 9|1|||
144267684|NCT00752089|520183266|FG000|Overall Study|Not capable of wearing partial denture|1|||
144267685|NCT00752089|520183266|FG000|Overall Study|Cannot continue the study|1|||
144267686|NCT00386334|520183267|FG000|Double Blind Period|Adverse Event|9|||
144267687|NCT00386334|520183268|FG001|Double Blind Period|Adverse Event|14|||
144267688|NCT00386334|520183267|FG000|Double Blind Period|Protocol Violation|1|||
144267689|NCT00386334|520183268|FG001|Double Blind Period|Protocol Violation|1|||
144267690|NCT00386334|520183267|FG000|Double Blind Period|Withdrawal by Subject|9|||
144267691|NCT00386334|520183268|FG001|Double Blind Period|Withdrawal by Subject|13|||
144267692|NCT00386334|520183267|FG000|Double Blind Period|Lack of Efficacy|20|||
144267693|NCT00386334|520183268|FG001|Double Blind Period|Lack of Efficacy|11|||
144267694|NCT00386334|520183267|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
144267695|NCT00386334|520183268|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
144267696|NCT00386334|520183267|FG000|Double Blind Period|Other|3|||
144267697|NCT00386334|520183268|FG001|Double Blind Period|Other|3|||
144267698|NCT00386334|520183267|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
144267699|NCT00386334|520183268|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
144267700|NCT01245101|520183269|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
144267701|NCT01245101|520183270|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
144267702|NCT01245101|520183269|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
144267703|NCT01245101|520183270|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
144267704|NCT01245101|520183269|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
144267705|NCT01245101|520183270|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
144267706|NCT01225549|520183271|FG000|Period 4 - Washout|Disallowed medication|0|||
144267707|NCT01225549|520183272|FG001|Period 4 - Washout|Disallowed medication|1|||
144267708|NCT01225549|520183273|FG002|Period 4 - Washout|Disallowed medication|0|||
144267709|NCT01225549|520183274|FG003|Period 4 - Washout|Disallowed medication|0|||
144267710|NCT01225549|520183275|FG004|Period 4 - Washout|Disallowed medication|0|||
144267711|NCT01225549|520183276|FG005|Period 4 - Washout|Disallowed medication|0|||
144267712|NCT01225549|520183277|FG006|Period 4 - Washout|Disallowed medication|0|||
144267713|NCT01225549|520183278|FG007|Period 4 - Washout|Disallowed medication|0|||
144267714|NCT01225549|520183279|FG008|Period 4 - Washout|Disallowed medication|0|||
144267715|NCT01225549|520183280|FG009|Period 4 - Washout|Disallowed medication|0|||
144267716|NCT01225549|520183271|FG000|Period 6 - Washout|Disallowed medication|0|||
144267717|NCT01225549|520183272|FG001|Period 6 - Washout|Disallowed medication|0|||
144267718|NCT01225549|520183273|FG002|Period 6 - Washout|Disallowed medication|0|||
144267719|NCT01225549|520183274|FG003|Period 6 - Washout|Disallowed medication|1|||
144267720|NCT01225549|520183275|FG004|Period 6 - Washout|Disallowed medication|0|||
144267721|NCT01225549|520183276|FG005|Period 6 - Washout|Disallowed medication|0|||
144267722|NCT01225549|520183277|FG006|Period 6 - Washout|Disallowed medication|0|||
144267723|NCT01225549|520183278|FG007|Period 6 - Washout|Disallowed medication|0|||
144267724|NCT01225549|520183279|FG008|Period 6 - Washout|Disallowed medication|0|||
144267725|NCT01225549|520183280|FG009|Period 6 - Washout|Disallowed medication|0|||
144267726|NCT01122173|520183281|FG000|Overall Study|Lost to Follow-up|3|||
144267727|NCT01122173|520183281|FG000|Overall Study|Withdrawal by Subject|3|||
144267728|NCT01122173|520183281|FG000|Overall Study|Left study for other reasons|3|||
144267729|NCT01184872|520183282|FG000|Overall Study|Adverse Event|3|||
144267730|NCT01184872|520183283|FG001|Overall Study|Adverse Event|4|||
144267731|NCT01184872|520183282|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
144267732|NCT01184872|520183283|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144267733|NCT01184872|520183282|FG000|Overall Study|Withdrawal by Subject|2|||
144267734|NCT01184872|520183283|FG001|Overall Study|Withdrawal by Subject|0|||
144267735|NCT01184872|520183282|FG000|Overall Study|Lost to Follow-up|0|||
144267736|NCT01184872|520183283|FG001|Overall Study|Lost to Follow-up|1|||
144224062|NCT02107131|520015859|FG000|Overall Study|Physician Decision|1|||
144224063|NCT02107131|520015860|FG001|Overall Study|Physician Decision|0|||
144224064|NCT02107131|520015859|FG000|Overall Study|Withdrawal by Subject|2|||
144224065|NCT02107131|520015860|FG001|Overall Study|Withdrawal by Subject|0|||
144224066|NCT02107131|520015859|FG000|Overall Study|mental instability|1|||
144224067|NCT02107131|520015860|FG001|Overall Study|mental instability|0|||
144224068|NCT02107131|520015859|FG000|Overall Study|Death|0|||
144224069|NCT02107131|520015860|FG001|Overall Study|Death|1|||
144224070|NCT02107131|520015859|FG000|Overall Study|Protocol Violation|0|||
144224071|NCT02107131|520015860|FG001|Overall Study|Protocol Violation|4|||
144224072|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Adverse Event|7|||
144224073|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
144224074|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Non-compliance|3|||
144224075|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Other|17|||
144224076|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Physician Decision|2|||
144224077|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Pregnancy|1|||
144224078|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
144224079|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
144224080|NCT05207865|520017475|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
144224081|NCT05207865|520017475|FG000|Follow-up Phase|Lost to Follow-up|1|||
144224082|NCT05207865|520017475|FG000|Follow-up Phase|Non-compliance|1|||
144224083|NCT05207865|520017475|FG000|Follow-up Phase|Not reported|2|||
144224084|NCT05207865|520017475|FG000|Follow-up Phase|Not collected|11|||
144224085|NCT02546986|520017476|FG000|Treatment Period|Progressive Disease|20|||
144224086|NCT02546986|520017477|FG001|Treatment Period|Progressive Disease|22|||
144224087|NCT02546986|520017476|FG000|Treatment Period|Adverse Event|14|||
144224088|NCT02546986|520017477|FG001|Treatment Period|Adverse Event|6|||
144224089|NCT02546986|520017476|FG000|Treatment Period|Symptomatic Deterioration|4|||
144224090|NCT02546986|520017477|FG001|Treatment Period|Symptomatic Deterioration|3|||
144224091|NCT02546986|520017476|FG000|Treatment Period|Death|3|||
144224092|NCT02546986|520017477|FG001|Treatment Period|Death|4|||
144224093|NCT02546986|520017476|FG000|Treatment Period|Physician Decision|1|||
144224094|NCT02546986|520017477|FG001|Treatment Period|Physician Decision|2|||
144224095|NCT02546986|520017476|FG000|Treatment Period|Protocol Violation|1|||
144224096|NCT02546986|520017477|FG001|Treatment Period|Protocol Violation|0|||
144224097|NCT02546986|520017476|FG000|Treatment Period|Withdrawal by Subject|1|||
144224098|NCT02546986|520017477|FG001|Treatment Period|Withdrawal by Subject|1|||
144224099|NCT02546986|520017476|FG000|Treatment Period|Non-compliance with Study Drug|0|||
144224100|NCT02546986|520017477|FG001|Treatment Period|Non-compliance with Study Drug|1|||
144224101|NCT02546986|520017476|FG000|Treatment Period|Study Terminated by Sponsor|0|||
144224102|NCT02546986|520017477|FG001|Treatment Period|Study Terminated by Sponsor|1|||
144224103|NCT02546986|520017476|FG000|Treatment Period|Miscellaneous|7|||
144224104|NCT02546986|520017477|FG001|Treatment Period|Miscellaneous|9|||
144224105|NCT02546986|520017476|FG000|Survival Follow-Up Phase|Missing Status|3|||
144224106|NCT02546986|520017477|FG001|Survival Follow-Up Phase|Missing Status|5|||
144224107|NCT02546986|520017476|FG000|Survival Follow-Up Phase|Death|18|||
144224108|NCT02546986|520017477|FG001|Survival Follow-Up Phase|Death|12|||
144224109|NCT02546986|520017476|FG000|Survival Follow-Up Phase|Alive|13|||
144224110|NCT02546986|520017477|FG001|Survival Follow-Up Phase|Alive|16|||
144224111|NCT02546986|520017476|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
144224112|NCT02546986|520017477|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
144224113|NCT04021914|520017478|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
144224114|NCT03985800|520017479|FG000|Overall Study|Death|1|||
144224115|NCT03985800|520017480|FG001|Overall Study|Death|2|||
144224116|NCT03985800|520017479|FG000|Overall Study|Withdrawal by Subject|3|||
144224117|NCT03985800|520017480|FG001|Overall Study|Withdrawal by Subject|6|||
144224118|NCT03985800|520017479|FG000|Overall Study|Protocol Violation|2|||
144224119|NCT03985800|520017480|FG001|Overall Study|Protocol Violation|0|||
144224120|NCT01415518|520017485|FG000|Overall Study|Withdrawal by Subject|2|||
144224121|NCT01415518|520017486|FG001|Overall Study|Withdrawal by Subject|12|||
144224122|NCT01415518|520017485|FG000|Overall Study|Protocol Violation|6|||
144224123|NCT01415518|520017486|FG001|Overall Study|Protocol Violation|8|||
144224124|NCT01415518|520017485|FG000|Overall Study|Lost to Follow-up|3|||
144224125|NCT01415518|520017486|FG001|Overall Study|Lost to Follow-up|5|||
144224126|NCT01415518|520017485|FG000|Overall Study|Adverse Event|3|||
144224127|NCT01415518|520017486|FG001|Overall Study|Adverse Event|4|||
144224128|NCT01415518|520017485|FG000|Overall Study|Death|1|||
144224129|NCT01415518|520017486|FG001|Overall Study|Death|1|||
144224130|NCT01415518|520017485|FG000|Overall Study|Condition under Investigation Worsened|1|||
144224131|NCT01415518|520017486|FG001|Overall Study|Condition under Investigation Worsened|1|||
144224132|NCT01662635|520017488|FG000|Overall Study|scarce samples for evaluation|30|||
144224133|NCT02445248|520017491|FG000|Overall Study|Death|45|||
144224134|NCT02445248|520017492|FG001|Overall Study|Death|12|||
144224135|NCT02445248|520017491|FG000|Overall Study|Progressive disease|13|||
144224136|NCT02445248|520017492|FG001|Overall Study|Progressive disease|1|||
144224137|NCT02445248|520017491|FG000|Overall Study|Subject decision|8|||
144224138|NCT02445248|520017492|FG001|Overall Study|Subject decision|0|||
144267737|NCT01184872|520183282|FG000|Overall Study|Administrative problems|1|||
144224139|NCT02445248|520017491|FG000|Overall Study|Physician Decision|5|||
144224140|NCT02445248|520017492|FG001|Overall Study|Physician Decision|0|||
144224141|NCT02445248|520017491|FG000|Overall Study|Adverse Event|1|||
144224142|NCT02445248|520017492|FG001|Overall Study|Adverse Event|0|||
144224143|NCT02445248|520017491|FG000|Overall Study|Lost to Follow-up|1|||
144224144|NCT02445248|520017492|FG001|Overall Study|Lost to Follow-up|0|||
144224145|NCT01217112|520017493|FG000|Overall Study|Adverse Event|0|||
144224146|NCT01217112|520017494|FG001|Overall Study|Adverse Event|2|||
144224147|NCT01217112|520017495|FG002|Overall Study|Adverse Event|0|||
144224148|NCT01217112|520017496|FG003|Overall Study|Adverse Event|2|||
144224149|NCT01217112|520017497|FG004|Overall Study|Adverse Event|0|||
144224150|NCT01217112|520017493|FG000|Overall Study|Withdrawal by Subject|0|||
144224151|NCT01217112|520017494|FG001|Overall Study|Withdrawal by Subject|0|||
144224152|NCT01217112|520017495|FG002|Overall Study|Withdrawal by Subject|1|||
144224153|NCT01217112|520017496|FG003|Overall Study|Withdrawal by Subject|0|||
144224154|NCT01217112|520017497|FG004|Overall Study|Withdrawal by Subject|0|||
144224155|NCT01217112|520017493|FG000|Overall Study|Physician Decision|0|||
144224156|NCT01217112|520017494|FG001|Overall Study|Physician Decision|0|||
144224157|NCT01217112|520017495|FG002|Overall Study|Physician Decision|0|||
144224158|NCT01217112|520017496|FG003|Overall Study|Physician Decision|0|||
144267738|NCT01184872|520183283|FG001|Overall Study|Administrative problems|1|||
144224159|NCT01217112|520017497|FG004|Overall Study|Physician Decision|1|||
144224160|NCT01401361|520017500|FG000|Overall Study|Withdrawal by Subject|16|||
144224161|NCT01401361|520017500|FG000|Overall Study|Lack of Efficacy|6|||
144224162|NCT01401361|520017500|FG000|Overall Study|Physician Decision|1|||
144224163|NCT01401361|520017500|FG000|Overall Study|Lost to Follow-up|3|||
144224164|NCT01401361|520017500|FG000|Overall Study|Subject/family decision post procedure|2|||
144224165|NCT00351468|520017501|FG000|Overall Study|Adverse Event|42|||
144224166|NCT00351468|520017501|FG000|Overall Study|Withdrawal by Subject|39|||
144224167|NCT00351468|520017501|FG000|Overall Study|Various -follow up w clinical team|39|||
144224168|NCT00351468|520017501|FG000|Overall Study|Lack of Efficacy|32|||
144224169|NCT00351468|520017501|FG000|Overall Study|Non-compliance|8|||
144224170|NCT00351468|520017501|FG000|Overall Study|Lost to Follow-up|4|||
144224171|NCT00351468|520017501|FG000|Overall Study|Protocol Violation|3|||
144224172|NCT04225715|520017502|FG000|Overall Study|Reason not Specified|1|||
144224173|NCT04225715|520017503|FG001|Overall Study|Reason not Specified|0|||
144224174|NCT04225715|520017504|FG002|Overall Study|Reason not Specified|0|||
144224175|NCT04225715|520017505|FG003|Overall Study|Reason not Specified|0|||
144224176|NCT04225715|520017506|FG004|Overall Study|Reason not Specified|0|||
144224177|NCT04225715|520017507|FG005|Overall Study|Reason not Specified|0|||
144224178|NCT04225715|520017508|FG006|Overall Study|Reason not Specified|0|||
144224179|NCT04225715|520017509|FG007|Overall Study|Reason not Specified|0|||
144224180|NCT04225715|520017510|FG008|Overall Study|Reason not Specified|0|||
144224181|NCT04225715|520017502|FG000|Overall Study|Protocol Violation|1|||
144224182|NCT04225715|520017503|FG001|Overall Study|Protocol Violation|0|||
144224183|NCT04225715|520017504|FG002|Overall Study|Protocol Violation|0|||
144224184|NCT04225715|520017505|FG003|Overall Study|Protocol Violation|0|||
144224185|NCT04225715|520017506|FG004|Overall Study|Protocol Violation|0|||
144224186|NCT04225715|520017507|FG005|Overall Study|Protocol Violation|9|||
144224187|NCT04225715|520017508|FG006|Overall Study|Protocol Violation|0|||
144224188|NCT04225715|520017509|FG007|Overall Study|Protocol Violation|0|||
144224189|NCT04225715|520017510|FG008|Overall Study|Protocol Violation|0|||
144224190|NCT04225715|520017502|FG000|Overall Study|Withdrawal by Subject|4|||
144224191|NCT04225715|520017503|FG001|Overall Study|Withdrawal by Subject|1|||
144224192|NCT04225715|520017504|FG002|Overall Study|Withdrawal by Subject|1|||
144224193|NCT04225715|520017505|FG003|Overall Study|Withdrawal by Subject|0|||
144224194|NCT04225715|520017506|FG004|Overall Study|Withdrawal by Subject|3|||
144224195|NCT04225715|520017507|FG005|Overall Study|Withdrawal by Subject|1|||
144224196|NCT04225715|520017508|FG006|Overall Study|Withdrawal by Subject|1|||
144224197|NCT04225715|520017509|FG007|Overall Study|Withdrawal by Subject|1|||
144224198|NCT04225715|520017510|FG008|Overall Study|Withdrawal by Subject|0|||
144224199|NCT04225715|520017502|FG000|Overall Study|Adverse Event|0|||
144224200|NCT04225715|520017503|FG001|Overall Study|Adverse Event|0|||
144224201|NCT04225715|520017504|FG002|Overall Study|Adverse Event|0|||
144224202|NCT04225715|520017505|FG003|Overall Study|Adverse Event|0|||
144224203|NCT04225715|520017506|FG004|Overall Study|Adverse Event|0|||
144224204|NCT04225715|520017507|FG005|Overall Study|Adverse Event|0|||
144224205|NCT04225715|520017508|FG006|Overall Study|Adverse Event|0|||
144224206|NCT04225715|520017509|FG007|Overall Study|Adverse Event|0|||
144224207|NCT04225715|520017510|FG008|Overall Study|Adverse Event|1|||
144224208|NCT04225715|520017502|FG000|Overall Study|Arm Terminated By Sponsor|0|||
144224209|NCT04225715|520017503|FG001|Overall Study|Arm Terminated By Sponsor|0|||
144224210|NCT04225715|520017504|FG002|Overall Study|Arm Terminated By Sponsor|0|||
144224211|NCT04225715|520017505|FG003|Overall Study|Arm Terminated By Sponsor|0|||
144224212|NCT04225715|520017506|FG004|Overall Study|Arm Terminated By Sponsor|0|||
144224213|NCT04225715|520017507|FG005|Overall Study|Arm Terminated By Sponsor|0|||
144224214|NCT04225715|520017508|FG006|Overall Study|Arm Terminated By Sponsor|0|||
144224215|NCT04225715|520017509|FG007|Overall Study|Arm Terminated By Sponsor|17|||
144224216|NCT04225715|520017510|FG008|Overall Study|Arm Terminated By Sponsor|18|||
144224217|NCT02512302|520017511|FG000|Period 1|Adverse Event|0|||
144224218|NCT02512302|520017512|FG001|Period 1|Adverse Event|1|||
144224219|NCT02512302|520017513|FG002|Period 1|Adverse Event|0|||
144224220|NCT02512302|520017514|FG003|Period 1|Adverse Event|0|||
144224221|NCT02512302|520017515|FG004|Period 1|Adverse Event|0|||
144224222|NCT02512302|520017516|FG005|Period 1|Adverse Event|0|||
144224223|NCT02512302|520017517|FG006|Period 1|Adverse Event|0|||
144224224|NCT02512302|520017518|FG007|Period 1|Adverse Event|0|||
144224225|NCT02512302|520017519|FG008|Period 1|Adverse Event|0|||
144224226|NCT02512302|520017520|FG009|Period 1|Adverse Event|0|||
144224227|NCT02512302|520017511|FG000|Period 2|Adverse Event|0|||
144224228|NCT02512302|520017512|FG001|Period 2|Adverse Event|0|||
144224229|NCT02512302|520017513|FG002|Period 2|Adverse Event|0|||
144224230|NCT02512302|520017514|FG003|Period 2|Adverse Event|0|||
144224231|NCT02512302|520017515|FG004|Period 2|Adverse Event|0|||
144224232|NCT02512302|520017516|FG005|Period 2|Adverse Event|0|||
144224233|NCT02512302|520017517|FG006|Period 2|Adverse Event|0|||
144224234|NCT02512302|520017518|FG007|Period 2|Adverse Event|0|||
144224235|NCT02512302|520017519|FG008|Period 2|Adverse Event|0|||
144224236|NCT02512302|520017520|FG009|Period 2|Adverse Event|1|||
144224237|NCT02512302|520017511|FG000|Period 3|Lost to Follow-up|0|||
144224238|NCT02512302|520017512|FG001|Period 3|Lost to Follow-up|0|||
144224239|NCT02512302|520017513|FG002|Period 3|Lost to Follow-up|1|||
144224240|NCT02512302|520017514|FG003|Period 3|Lost to Follow-up|0|||
144224241|NCT02512302|520017515|FG004|Period 3|Lost to Follow-up|0|||
144224242|NCT02512302|520017516|FG005|Period 3|Lost to Follow-up|0|||
144224243|NCT02512302|520017517|FG006|Period 3|Lost to Follow-up|0|||
144224244|NCT02512302|520017518|FG007|Period 3|Lost to Follow-up|0|||
144224245|NCT02512302|520017519|FG008|Period 3|Lost to Follow-up|0|||
144224246|NCT02512302|520017520|FG009|Period 3|Lost to Follow-up|0|||
144224247|NCT02512302|520017511|FG000|Period 4|Adverse Event|0|||
144224248|NCT02512302|520017512|FG001|Period 4|Adverse Event|0|||
144267739|NCT01184872|520183282|FG000|Overall Study|Protocol deviation|1|||
144267740|NCT01184872|520183283|FG001|Overall Study|Protocol deviation|0|||
144267741|NCT00433836|520183284|FG000|Overall Study|Adverse Event|7|||
144267742|NCT00433836|520183285|FG001|Overall Study|Adverse Event|0|||
144267743|NCT00433836|520183284|FG000|Overall Study|Lost to Follow-up|3|||
144267744|NCT00433836|520183285|FG001|Overall Study|Lost to Follow-up|0|||
144267745|NCT00433836|520183284|FG000|Overall Study|Withdrawal by Subject|2|||
144267746|NCT00433836|520183285|FG001|Overall Study|Withdrawal by Subject|1|||
144267747|NCT00433836|520183284|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144267748|NCT00433836|520183285|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144267749|NCT00433836|520183284|FG000|Overall Study|Protocol Violation|0|||
144267750|NCT00433836|520183285|FG001|Overall Study|Protocol Violation|2|||
144267751|NCT00433836|520183284|FG000|Overall Study|Condition no longer requires study drug|0|||
144267752|NCT00433836|520183285|FG001|Overall Study|Condition no longer requires study drug|1|||
144267753|NCT00433836|520183284|FG000|Overall Study|Abnormal laboratory values|0|||
144267754|NCT00433836|520183285|FG001|Overall Study|Abnormal laboratory values|1|||
144267755|NCT03093181|520183286|FG000|Overall Study|Withdrawal by Subject|2|||
144267756|NCT03093181|520183287|FG001|Overall Study|Withdrawal by Subject|1|||
144267757|NCT03093181|520183288|FG002|Overall Study|Withdrawal by Subject|2|||
144267758|NCT03093181|520183286|FG000|Overall Study|Other (Not specified)|1|||
144267759|NCT03093181|520183287|FG001|Overall Study|Other (Not specified)|0|||
144267760|NCT03093181|520183288|FG002|Overall Study|Other (Not specified)|0|||
144267761|NCT03093181|520183286|FG000|Overall Study|Adverse Event|0|||
144267762|NCT03093181|520183287|FG001|Overall Study|Adverse Event|1|||
144267763|NCT03093181|520183288|FG002|Overall Study|Adverse Event|0|||
144267764|NCT03093181|520183286|FG000|Overall Study|Other (Protocol violation)|0|||
144267765|NCT03093181|520183287|FG001|Overall Study|Other (Protocol violation)|0|||
144267766|NCT03093181|520183288|FG002|Overall Study|Other (Protocol violation)|1|||
144267767|NCT03555149|520183289|FG000|Overall Study|Death|18|||
144267768|NCT03555149|520183290|FG001|Overall Study|Death|15|||
144267769|NCT03555149|520183291|FG002|Overall Study|Death|15|||
144267770|NCT03555149|520183292|FG003|Overall Study|Death|4|||
144267771|NCT03555149|520183293|FG004|Overall Study|Death|4|||
144267772|NCT03555149|520183294|FG005|Overall Study|Death|11|||
144267773|NCT03555149|520183295|FG006|Overall Study|Death|12|||
144267774|NCT03555149|520183296|FG007|Overall Study|Death|1|||
144267775|NCT03555149|520183289|FG000|Overall Study|Lost to Follow-up|1|||
144267776|NCT03555149|520183290|FG001|Overall Study|Lost to Follow-up|0|||
144267777|NCT03555149|520183291|FG002|Overall Study|Lost to Follow-up|0|||
144224249|NCT02512302|520017513|FG002|Period 4|Adverse Event|0|||
144224250|NCT02512302|520017514|FG003|Period 4|Adverse Event|0|||
144224251|NCT02512302|520017515|FG004|Period 4|Adverse Event|0|||
144224252|NCT02512302|520017516|FG005|Period 4|Adverse Event|0|||
144224253|NCT02512302|520017517|FG006|Period 4|Adverse Event|1|||
144224254|NCT02512302|520017518|FG007|Period 4|Adverse Event|0|||
144267778|NCT03555149|520183292|FG003|Overall Study|Lost to Follow-up|0|||
144267779|NCT03555149|520183293|FG004|Overall Study|Lost to Follow-up|0|||
144267780|NCT03555149|520183294|FG005|Overall Study|Lost to Follow-up|1|||
144267781|NCT03555149|520183295|FG006|Overall Study|Lost to Follow-up|0|||
144267782|NCT03555149|520183296|FG007|Overall Study|Lost to Follow-up|0|||
144267783|NCT03555149|520183289|FG000|Overall Study|Physician Decision|1|||
144267784|NCT03555149|520183290|FG001|Overall Study|Physician Decision|0|||
144267785|NCT03555149|520183291|FG002|Overall Study|Physician Decision|0|||
144267786|NCT03555149|520183292|FG003|Overall Study|Physician Decision|0|||
144267787|NCT03555149|520183293|FG004|Overall Study|Physician Decision|0|||
144267788|NCT03555149|520183294|FG005|Overall Study|Physician Decision|0|||
144267789|NCT03555149|520183295|FG006|Overall Study|Physician Decision|0|||
144267790|NCT03555149|520183296|FG007|Overall Study|Physician Decision|0|||
144267791|NCT03555149|520183289|FG000|Overall Study|Study Terminated By Sponsor|1|||
144267792|NCT03555149|520183290|FG001|Overall Study|Study Terminated By Sponsor|0|||
144267793|NCT03555149|520183291|FG002|Overall Study|Study Terminated By Sponsor|0|||
144267794|NCT03555149|520183292|FG003|Overall Study|Study Terminated By Sponsor|0|||
144267795|NCT03555149|520183293|FG004|Overall Study|Study Terminated By Sponsor|0|||
144267796|NCT03555149|520183294|FG005|Overall Study|Study Terminated By Sponsor|2|||
144267797|NCT03555149|520183295|FG006|Overall Study|Study Terminated By Sponsor|3|||
144267798|NCT03555149|520183296|FG007|Overall Study|Study Terminated By Sponsor|1|||
144267799|NCT03555149|520183289|FG000|Overall Study|Withdrawal by Subject|3|||
144267800|NCT03555149|520183290|FG001|Overall Study|Withdrawal by Subject|0|||
144267801|NCT03555149|520183291|FG002|Overall Study|Withdrawal by Subject|0|||
144267802|NCT03555149|520183292|FG003|Overall Study|Withdrawal by Subject|2|||
144267803|NCT03555149|520183293|FG004|Overall Study|Withdrawal by Subject|0|||
144267804|NCT03555149|520183294|FG005|Overall Study|Withdrawal by Subject|1|||
144267805|NCT03555149|520183295|FG006|Overall Study|Withdrawal by Subject|0|||
144267806|NCT03555149|520183296|FG007|Overall Study|Withdrawal by Subject|0|||
144267807|NCT03055936|520183301|FG000|Overall Study|Adverse Event|0|||
144267808|NCT03055936|520183302|FG001|Overall Study|Adverse Event|1|||
144267809|NCT03055936|520183303|FG002|Overall Study|Adverse Event|1|||
144267810|NCT03055936|520183304|FG003|Overall Study|Adverse Event|1|||
144267811|NCT03055936|520183301|FG000|Overall Study|Personal reason|2|||
144267812|NCT03055936|520183302|FG001|Overall Study|Personal reason|0|||
144267813|NCT03055936|520183303|FG002|Overall Study|Personal reason|1|||
144267814|NCT03055936|520183304|FG003|Overall Study|Personal reason|0|||
144267815|NCT01038687|520183308|FG000|Overall Study|Adverse Event|0|||
144267816|NCT01038687|520183309|FG001|Overall Study|Adverse Event|2|||
144267817|NCT01038687|520183310|FG002|Overall Study|Adverse Event|1|||
144267818|NCT02144701|520183315|FG000|Overall Study|development of relapse, GVHD or death|9|||
144267819|NCT02144701|520183316|FG001|Overall Study|development of relapse, GVHD or death|3|||
144267820|NCT03327324|520183317|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267821|NCT03327324|520183318|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
144267822|NCT03327324|520183319|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267823|NCT03327324|520183320|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
144267824|NCT03327324|520183321|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267825|NCT03327324|520183322|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
144267826|NCT03327324|520183317|FG000|Baseline (Month 0-Month 3)|Refused|0|||
144267827|NCT03327324|520183318|FG001|Baseline (Month 0-Month 3)|Refused|0|||
144267828|NCT03327324|520183319|FG002|Baseline (Month 0-Month 3)|Refused|0|||
144267829|NCT03327324|520183320|FG003|Baseline (Month 0-Month 3)|Refused|0|||
144267830|NCT03327324|520183321|FG004|Baseline (Month 0-Month 3)|Refused|1|||
144267831|NCT03327324|520183322|FG005|Baseline (Month 0-Month 3)|Refused|0|||
144267832|NCT03327324|520183317|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
144267833|NCT03327324|520183318|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
144267834|NCT03327324|520183319|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
144267835|NCT03327324|520183320|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
144267836|NCT03327324|520183321|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
144267837|NCT03327324|520183322|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
144267838|NCT03327324|520183317|FG000|Baseline (Month 0-Month 3)|Death|0|||
144267839|NCT03327324|520183318|FG001|Baseline (Month 0-Month 3)|Death|0|||
144267840|NCT03327324|520183319|FG002|Baseline (Month 0-Month 3)|Death|0|||
144267841|NCT03327324|520183320|FG003|Baseline (Month 0-Month 3)|Death|0|||
144267842|NCT03327324|520183321|FG004|Baseline (Month 0-Month 3)|Death|1|||
144267843|NCT03327324|520183322|FG005|Baseline (Month 0-Month 3)|Death|0|||
144267844|NCT03327324|520183317|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267845|NCT03327324|520183318|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267846|NCT03327324|520183319|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267847|NCT03327324|520183320|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267848|NCT03327324|520183321|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267849|NCT03327324|520183322|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
144267850|NCT03327324|520183317|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267851|NCT03327324|520183318|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267852|NCT03327324|520183319|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
144267853|NCT03327324|520183320|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267854|NCT03327324|520183321|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267855|NCT03327324|520183322|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267856|NCT03327324|520183317|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
144267857|NCT03327324|520183318|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
144267858|NCT03327324|520183319|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
144267859|NCT03327324|520183320|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
144267860|NCT03327324|520183321|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
144267861|NCT03327324|520183322|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
144267862|NCT03327324|520183317|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
144267863|NCT03327324|520183318|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
144267864|NCT03327324|520183319|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
144267865|NCT03327324|520183320|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
144267866|NCT03327324|520183321|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
144267867|NCT03327324|520183322|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
144267868|NCT03327324|520183317|FG000|Intervention (Month 3-Month 6)|Death|1|||
144267869|NCT03327324|520183318|FG001|Intervention (Month 3-Month 6)|Death|0|||
144267870|NCT03327324|520183319|FG002|Intervention (Month 3-Month 6)|Death|1|||
144267871|NCT03327324|520183320|FG003|Intervention (Month 3-Month 6)|Death|1|||
144267872|NCT03327324|520183321|FG004|Intervention (Month 3-Month 6)|Death|1|||
144267873|NCT03327324|520183322|FG005|Intervention (Month 3-Month 6)|Death|0|||
144267874|NCT03327324|520183317|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267875|NCT03327324|520183318|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267876|NCT03327324|520183319|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267877|NCT03327324|520183320|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267878|NCT03327324|520183321|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267879|NCT03327324|520183322|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
144267880|NCT03327324|520183317|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
144267881|NCT03327324|520183318|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267882|NCT03327324|520183319|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267883|NCT03327324|520183320|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267884|NCT03327324|520183321|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267885|NCT03327324|520183322|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
144267886|NCT03327324|520183317|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
144267887|NCT03327324|520183318|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
144267888|NCT03327324|520183319|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
144267889|NCT03327324|520183320|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
144267890|NCT03327324|520183321|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
144267891|NCT03327324|520183322|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
144267892|NCT03327324|520183317|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
144267893|NCT03327324|520183318|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
144267894|NCT03327324|520183319|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
144267895|NCT03327324|520183320|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
144267896|NCT03327324|520183321|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
144267897|NCT03327324|520183322|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
144267898|NCT03327324|520183317|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267899|NCT03327324|520183318|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267900|NCT03327324|520183319|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267901|NCT03327324|520183320|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
144267902|NCT03327324|520183321|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
144267903|NCT03327324|520183322|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
144267904|NCT03327324|520183317|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
144267905|NCT03327324|520183318|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
144267906|NCT03327324|520183319|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
144267907|NCT03327324|520183320|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
144267908|NCT03327324|520183321|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
144267909|NCT03327324|520183322|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
144267910|NCT03327324|520183317|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
144267911|NCT03327324|520183318|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
144267912|NCT03327324|520183319|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
144267913|NCT03327324|520183320|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
144267914|NCT03327324|520183321|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
144267915|NCT03327324|520183322|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
144267916|NCT02314728|520183328|FG000|Overall Study|Protocol Violation|1|||
144267917|NCT02314728|520183329|FG001|Overall Study|Protocol Violation|0|||
144267918|NCT02314728|520183328|FG000|Overall Study|Lost to Follow-up|0|||
144267919|NCT02314728|520183329|FG001|Overall Study|Lost to Follow-up|1|||
144267920|NCT00249834|520183340|FG000|Overall Study|Ovarian stimulation failed|1|||
144267921|NCT00249834|520183341|FG001|Overall Study|Ovarian stimulation failed|0|||
144267922|NCT00249834|520183342|FG002|Overall Study|Ovarian stimulation failed|0|||
144267923|NCT00249834|520183343|FG003|Overall Study|Ovarian stimulation failed|0|||
144267924|NCT00249834|520183344|FG004|Overall Study|Ovarian stimulation failed|0|||
144267925|NCT00249834|520183345|FG005|Overall Study|Ovarian stimulation failed|0|||
144267926|NCT00249834|520183346|FG006|Overall Study|Ovarian stimulation failed|0|||
144267927|NCT00249834|520183347|FG007|Overall Study|Ovarian stimulation failed|0|||
144267928|NCT00249834|520183340|FG000|Overall Study|Failure of down-regulation|0|||
144267929|NCT00249834|520183341|FG001|Overall Study|Failure of down-regulation|0|||
144267930|NCT00249834|520183342|FG002|Overall Study|Failure of down-regulation|0|||
144267931|NCT00249834|520183343|FG003|Overall Study|Failure of down-regulation|0|||
144267932|NCT00249834|520183344|FG004|Overall Study|Failure of down-regulation|0|||
144267933|NCT00249834|520183345|FG005|Overall Study|Failure of down-regulation|0|||
144267934|NCT00249834|520183346|FG006|Overall Study|Failure of down-regulation|1|||
144267935|NCT00249834|520183347|FG007|Overall Study|Failure of down-regulation|0|||
144267936|NCT00249834|520183340|FG000|Overall Study|Protocol Violation|0|||
144267937|NCT00249834|520183341|FG001|Overall Study|Protocol Violation|19|||
144267938|NCT00249834|520183342|FG002|Overall Study|Protocol Violation|14|||
144267939|NCT00249834|520183343|FG003|Overall Study|Protocol Violation|8|||
144267940|NCT00249834|520183344|FG004|Overall Study|Protocol Violation|5|||
144267941|NCT00249834|520183345|FG005|Overall Study|Protocol Violation|2|||
144267942|NCT00249834|520183346|FG006|Overall Study|Protocol Violation|0|||
144267943|NCT00249834|520183347|FG007|Overall Study|Protocol Violation|0|||
144267944|NCT00069264|520183349|FG000|Overall Study|Adverse Event|3|||
144224255|NCT02512302|520017519|FG008|Period 4|Adverse Event|0|||
144224256|NCT02512302|520017520|FG009|Period 4|Adverse Event|0|||
144224257|NCT00471822|520017521|FG000|Overall Study|Protocol Violation|2|||
144224258|NCT00683618|520017522|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
144224259|NCT00683618|520017523|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
144224260|NCT00683618|520017524|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
144224261|NCT00683618|520017522|FG000|Randomised Treatment Period|Protocol Violation|0|||
144224262|NCT00683618|520017523|FG001|Randomised Treatment Period|Protocol Violation|1|||
144224263|NCT00683618|520017524|FG002|Randomised Treatment Period|Protocol Violation|0|||
144224264|NCT00683618|520017522|FG000|Randomised Treatment Period|Adverse Event|2|||
144224265|NCT00683618|520017523|FG001|Randomised Treatment Period|Adverse Event|0|||
144267945|NCT00069264|520183349|FG000|Overall Study|Progressive Disease|23|||
144267946|NCT00069264|520183349|FG000|Overall Study|Withdrawal by Subject|3|||
144267947|NCT00069264|520183349|FG000|Overall Study|Discon Therapy|3|||
144267948|NCT03177148|520183350|FG000|Overall Study|Lost to Follow-up|50|||
144267949|NCT03177148|520183351|FG001|Overall Study|Lost to Follow-up|1|||
144267950|NCT03177148|520183350|FG000|Overall Study|Death|1|||
144267951|NCT03177148|520183351|FG001|Overall Study|Death|0|||
144267952|NCT02848664|520183352|FG000|Overall Study|Withdrawal by Subject|2|||
144267953|NCT02848664|520183352|FG000|Overall Study|Adverse Event|1|||
144267954|NCT02848664|520183352|FG000|Overall Study|no assistance for device training|1|||
144267955|NCT00732069|520183353|FG000|Washout After First Study Drug|Adverse Event|1|||
144267956|NCT00732069|520183354|FG001|Washout After First Study Drug|Adverse Event|0|||
144224266|NCT00683618|520017524|FG002|Randomised Treatment Period|Adverse Event|2|||
144224267|NCT00683618|520017522|FG000|Randomised Treatment Period|Reason not provided|0|||
144224268|NCT00683618|520017523|FG001|Randomised Treatment Period|Reason not provided|0|||
144224269|NCT00683618|520017524|FG002|Randomised Treatment Period|Reason not provided|2|||
144224270|NCT00683618|520017522|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
144224271|NCT00683618|520017523|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
144224272|NCT00683618|520017524|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
144224273|NCT00683618|520017522|FG000|Extension Treatment Period|Adverse Event|1|||
144224274|NCT00683618|520017523|FG001|Extension Treatment Period|Adverse Event|0|||
144224275|NCT00683618|520017524|FG002|Extension Treatment Period|Adverse Event|0|||
144224276|NCT00683618|520017522|FG000|Extension Treatment Period|Protocol Violation|1|||
144224277|NCT00683618|520017523|FG001|Extension Treatment Period|Protocol Violation|0|||
144224278|NCT00683618|520017524|FG002|Extension Treatment Period|Protocol Violation|0|||
144224279|NCT04570670|520017525|FG000|Overall Study|Withdrawal by Subject|1|||
144224280|NCT04570670|520017526|FG001|Overall Study|Withdrawal by Subject|0|||
144224281|NCT01002989|520017527|FG000|Overall Study|exclusion criteria, no consent|5|||
144267957|NCT00732069|520183355|FG002|Washout After First Study Drug|Adverse Event|0|||
144224282|NCT03318861|520017531|FG000|Overall Study|Death|2|||
144224283|NCT03318861|520017532|FG001|Overall Study|Death|3|||
144224284|NCT03318861|520017533|FG002|Overall Study|Death|3|||
144224285|NCT03318861|520017534|FG003|Overall Study|Death|2|||
144224286|NCT03318861|520017535|FG004|Overall Study|Death|2|||
144224287|NCT03318861|520017531|FG000|Overall Study|Enrolled But Never Treated|0|||
144267958|NCT00732069|520183356|FG003|Washout After First Study Drug|Adverse Event|0|||
144267959|NCT00732069|520183357|FG004|Washout After First Study Drug|Adverse Event|0|||
144267960|NCT00732069|520183358|FG005|Washout After First Study Drug|Adverse Event|0|||
144224288|NCT03318861|520017532|FG001|Overall Study|Enrolled But Never Treated|1|||
144224289|NCT03318861|520017533|FG002|Overall Study|Enrolled But Never Treated|0|||
144224290|NCT03318861|520017534|FG003|Overall Study|Enrolled But Never Treated|1|||
144224291|NCT03318861|520017535|FG004|Overall Study|Enrolled But Never Treated|1|||
144224292|NCT03318861|520017531|FG000|Overall Study|Informed Consent Withdraw|0|||
144224293|NCT03318861|520017532|FG001|Overall Study|Informed Consent Withdraw|0|||
144224294|NCT03318861|520017533|FG002|Overall Study|Informed Consent Withdraw|0|||
144224295|NCT03318861|520017534|FG003|Overall Study|Informed Consent Withdraw|1|||
144224296|NCT03318861|520017535|FG004|Overall Study|Informed Consent Withdraw|0|||
144267961|NCT01405898|520183360|FG000|Overall Study|Withdrawal by Subject|2|||
144224297|NCT03318861|520017531|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
144224298|NCT03318861|520017532|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
144224299|NCT03318861|520017533|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
144224300|NCT03318861|520017534|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
144224301|NCT03318861|520017535|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
144224302|NCT00917852|520017536|FG000|Overall Study|Death|6|||
144224303|NCT00471081|520017537|FG000|Active Phase|Protocol Violation|1|||
144224304|NCT00471081|520017538|FG001|Active Phase|Protocol Violation|1|||
144224305|NCT00471081|520017537|FG000|Active Phase|Withdrawal by Subject|0|||
144224306|NCT00471081|520017538|FG001|Active Phase|Withdrawal by Subject|3|||
144224307|NCT00471081|520017537|FG000|Active Phase|Lost to Follow-up|0|||
144224308|NCT00471081|520017538|FG001|Active Phase|Lost to Follow-up|1|||
144224309|NCT00471081|520017537|FG000|Active Phase|Lost health plan/insurance|1|||
144224310|NCT00471081|520017538|FG001|Active Phase|Lost health plan/insurance|8|||
144224311|NCT00471081|520017537|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
144224312|NCT00471081|520017538|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
144267962|NCT01405898|520183361|FG001|Overall Study|Withdrawal by Subject|2|||
144267963|NCT01687218|520183363|FG000|Overall Study|Withdrawal by Subject|2|||
144267964|NCT01687218|520183364|FG001|Overall Study|Withdrawal by Subject|3|||
144224313|NCT00471081|520017537|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
144224314|NCT00471081|520017538|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
144224315|NCT00471081|520017537|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
144224316|NCT00471081|520017538|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
144224317|NCT02844933|520017539|FG000|Overall Study|Discontinued due to premature termination of study|3|||
144224318|NCT02844933|520017540|FG001|Overall Study|Discontinued due to premature termination of study|2|||
144224319|NCT01892501|520017541|FG000|Overall Study|Protocol Violation|2|||
144224320|NCT01892501|520017541|FG000|Overall Study|Puncture not carried out|9|||
144224321|NCT01892501|520017541|FG000|Overall Study|Radiological monitoring not carried out|5|||
144224322|NCT01892501|520017541|FG000|Overall Study|Non-contributory histological result|12|||
144224323|NCT02393950|520017546|FG000|Overall Study|Adverse Event|1|||
144224324|NCT02393950|520017547|FG001|Overall Study|Adverse Event|0|||
144224325|NCT02393950|520017546|FG000|Overall Study|Withdrawal by Subject|0|||
144224326|NCT02393950|520017547|FG001|Overall Study|Withdrawal by Subject|1|||
144224327|NCT04335123|520017549|FG000|Overall Study|Withdrawal by Subject|2|||
144224328|NCT04335123|520017550|FG001|Overall Study|Withdrawal by Subject|0|||
144224329|NCT04335123|520017549|FG000|Overall Study|Physician Decision|2|||
144224330|NCT04335123|520017550|FG001|Overall Study|Physician Decision|0|||
144224331|NCT05486091|520017551|FG000|Overall Study|Withdrawal by Subject|1|||
144224332|NCT05486091|520017551|FG000|Overall Study|Lost to Follow-up|2|||
144224333|NCT01082328|520017554|FG000|Overall Study|Adverse Event|1|||
144224334|NCT00031590|520017555|FG000|Overall Study|Adverse Event|1|||
144224335|NCT00031590|520017555|FG000|Overall Study|Withdrawal by parents|2|||
144224336|NCT00957801|520017556|FG000|Overall Study|Withdrawal by Subject|0|||
144224337|NCT00957801|520017557|FG001|Overall Study|Withdrawal by Subject|0|||
144224338|NCT00957801|520017558|FG002|Overall Study|Withdrawal by Subject|0|||
144224339|NCT00957801|520017559|FG003|Overall Study|Withdrawal by Subject|1|||
144224340|NCT02755103|520017569|FG000|Overall Study|Lost to Follow-up|17|||
144224341|NCT02755103|520017570|FG001|Overall Study|Lost to Follow-up|15|||
144224342|NCT02755103|520017569|FG000|Overall Study|Death|0|||
144224343|NCT02755103|520017570|FG001|Overall Study|Death|1|||
144224344|NCT02755103|520017569|FG000|Overall Study|Physician Decision|0|||
144224345|NCT02755103|520017570|FG001|Overall Study|Physician Decision|1|||
144224346|NCT02755103|520017569|FG000|Overall Study|Pregnancy|0|||
144224347|NCT02755103|520017570|FG001|Overall Study|Pregnancy|1|||
144224348|NCT02755103|520017569|FG000|Overall Study|Withdrawal by Subject|3|||
144224349|NCT02755103|520017570|FG001|Overall Study|Withdrawal by Subject|0|||
144224350|NCT00658723|520017571|FG000|Overall Study|Lost to Follow-up|0|||
144224351|NCT00658723|520017572|FG001|Overall Study|Lost to Follow-up|2|||
144224352|NCT00658723|520017573|FG002|Overall Study|Lost to Follow-up|2|||
144224353|NCT00658723|520017571|FG000|Overall Study|Death|2|||
144224354|NCT00658723|520017572|FG001|Overall Study|Death|1|||
144224355|NCT00658723|520017573|FG002|Overall Study|Death|4|||
144224356|NCT00658723|520017571|FG000|Overall Study|Scheduling Issue|1|||
144224357|NCT00658723|520017572|FG001|Overall Study|Scheduling Issue|1|||
144224358|NCT00658723|520017573|FG002|Overall Study|Scheduling Issue|0|||
144224359|NCT00658723|520017571|FG000|Overall Study|Withdrawal by Subject|1|||
144224360|NCT00658723|520017572|FG001|Overall Study|Withdrawal by Subject|0|||
144224361|NCT00658723|520017573|FG002|Overall Study|Withdrawal by Subject|1|||
144224362|NCT00380874|520017576|FG000|Overall Study|Adverse Event|7|||
144224363|NCT00380874|520017577|FG001|Overall Study|Adverse Event|7|||
144224364|NCT00380874|520017576|FG000|Overall Study|Death|1|||
144224365|NCT00380874|520017577|FG001|Overall Study|Death|0|||
144224366|NCT00380874|520017576|FG000|Overall Study|Withdrawal by Subject|2|||
144224367|NCT00380874|520017577|FG001|Overall Study|Withdrawal by Subject|1|||
144224368|NCT00380874|520017576|FG000|Overall Study|Not related to study drug|3|||
144224369|NCT00380874|520017577|FG001|Overall Study|Not related to study drug|2|||
144224370|NCT01707290|520017578|FG000|Overall Study|Adverse event (AE)|1|||
144224371|NCT01707290|520017579|FG001|Overall Study|Adverse event (AE)|0|||
144224372|NCT01707290|520017578|FG000|Overall Study|Physician Decision|1|||
144224373|NCT01707290|520017579|FG001|Overall Study|Physician Decision|0|||
144224374|NCT01707290|520017578|FG000|Overall Study|Lost to Follow-up|3|||
144224375|NCT01707290|520017579|FG001|Overall Study|Lost to Follow-up|0|||
144224376|NCT01707290|520017578|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
144224377|NCT01707290|520017579|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
144224378|NCT01707290|520017578|FG000|Overall Study|Commercial drug available|60|||
144224379|NCT01707290|520017579|FG001|Overall Study|Commercial drug available|1|||
144224380|NCT01707290|520017578|FG000|Overall Study|Other unspecified|17|||
144224381|NCT01707290|520017579|FG001|Overall Study|Other unspecified|0|||
144224382|NCT02208362|520017583|FG000|Overall Study|Participant did not complete treatment|0|||
144224383|NCT02208362|520017584|FG001|Overall Study|Participant did not complete treatment|1|||
144224384|NCT02208362|520017585|FG002|Overall Study|Participant did not complete treatment|0|||
144224385|NCT02208362|520017586|FG003|Overall Study|Participant did not complete treatment|0|||
144224386|NCT02208362|520017587|FG004|Overall Study|Participant did not complete treatment|0|||
144224387|NCT02208362|520017588|FG005|Overall Study|Participant did not complete treatment|0|||
144224388|NCT02208362|520017589|FG006|Overall Study|Participant did not complete treatment|1|||
144224389|NCT02208362|520017590|FG007|Overall Study|Participant did not complete treatment|1|||
144224390|NCT02208362|520017591|FG008|Overall Study|Participant did not complete treatment|2|||
144224391|NCT02208362|520017592|FG009|Overall Study|Participant did not complete treatment|0|||
144224392|NCT02208362|520017593|FG010|Overall Study|Participant did not complete treatment|1|||
144224393|NCT02208362|520017594|FG011|Overall Study|Participant did not complete treatment|0|||
144224394|NCT02208362|520017583|FG000|Overall Study|Participant received disallowed treatment|0|||
144224395|NCT02208362|520017584|FG001|Overall Study|Participant received disallowed treatment|0|||
144224396|NCT02208362|520017585|FG002|Overall Study|Participant received disallowed treatment|0|||
144224397|NCT02208362|520017586|FG003|Overall Study|Participant received disallowed treatment|0|||
144224398|NCT02208362|520017587|FG004|Overall Study|Participant received disallowed treatment|0|||
144224399|NCT02208362|520017588|FG005|Overall Study|Participant received disallowed treatment|0|||
144224400|NCT02208362|520017589|FG006|Overall Study|Participant received disallowed treatment|0|||
144224401|NCT02208362|520017590|FG007|Overall Study|Participant received disallowed treatment|0|||
144224402|NCT02208362|520017591|FG008|Overall Study|Participant received disallowed treatment|1|||
144224403|NCT02208362|520017592|FG009|Overall Study|Participant received disallowed treatment|0|||
144224404|NCT02208362|520017593|FG010|Overall Study|Participant received disallowed treatment|0|||
144224405|NCT02208362|520017594|FG011|Overall Study|Participant received disallowed treatment|0|||
144224406|NCT00739882|520019058|FG000|Double-blind Period|Adverse Event|1|||
144224407|NCT00739882|520019059|FG001|Double-blind Period|Adverse Event|2|||
144224408|NCT00739882|520019058|FG000|Double-blind Period|Protocol Violation|1|||
144224409|NCT00739882|520019059|FG001|Double-blind Period|Protocol Violation|0|||
144224410|NCT00739882|520019058|FG000|Double-blind Period|Lack of Efficacy|1|||
144224411|NCT00739882|520019059|FG001|Double-blind Period|Lack of Efficacy|1|||
144224412|NCT00739882|520019058|FG000|Double-blind Period|Other|16|||
144224413|NCT00739882|520019059|FG001|Double-blind Period|Other|8|||
144224414|NCT00739882|520019058|FG000|Open-label Period|Adverse Event|1|||
144224415|NCT00739882|520019059|FG001|Open-label Period|Adverse Event|0|||
144224416|NCT00739882|520019058|FG000|Open-label Period|Other|9|||
144224417|NCT00739882|520019059|FG001|Open-label Period|Other|5|||
144224418|NCT02844543|520019060|FG000|Overall Study|Withdrawal by Subject|4|||
144224419|NCT02844543|520019060|FG000|Overall Study|Did not meet eligibility criteria|1|||
144224420|NCT03349060|520019061|FG000|Overall Study|Adverse Event|9|||
144224421|NCT03349060|520019062|FG001|Overall Study|Adverse Event|9|||
144224422|NCT03349060|520019063|FG002|Overall Study|Adverse Event|7|||
144224423|NCT03349060|520019061|FG000|Overall Study|Lack of Efficacy|1|||
144224424|NCT03349060|520019062|FG001|Overall Study|Lack of Efficacy|0|||
144224425|NCT03349060|520019063|FG002|Overall Study|Lack of Efficacy|2|||
144224426|NCT03349060|520019061|FG000|Overall Study|Lost to Follow-up|2|||
144224427|NCT03349060|520019062|FG001|Overall Study|Lost to Follow-up|1|||
144224428|NCT03349060|520019063|FG002|Overall Study|Lost to Follow-up|1|||
144224429|NCT03349060|520019061|FG000|Overall Study|Protocol Violation|2|||
144224430|NCT03349060|520019062|FG001|Overall Study|Protocol Violation|2|||
144224431|NCT03349060|520019063|FG002|Overall Study|Protocol Violation|1|||
144224432|NCT03349060|520019061|FG000|Overall Study|Withdrawal by Subject|5|||
144224433|NCT03349060|520019062|FG001|Overall Study|Withdrawal by Subject|3|||
144224434|NCT03349060|520019063|FG002|Overall Study|Withdrawal by Subject|4|||
144224435|NCT03349060|520019061|FG000|Overall Study|Medication error,no linked adverse event|0|||
144224436|NCT03349060|520019062|FG001|Overall Study|Medication error,no linked adverse event|0|||
144224437|NCT03349060|520019063|FG002|Overall Study|Medication error,no linked adverse event|1|||
144224438|NCT03349060|520019061|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
144224439|NCT03349060|520019062|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
144224440|NCT03349060|520019063|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
144224441|NCT03349060|520019061|FG000|Overall Study|Other|2|||
144224442|NCT03349060|520019062|FG001|Overall Study|Other|1|||
144224443|NCT03349060|520019063|FG002|Overall Study|Other|0|||
144224444|NCT00955409|520019064|FG000|Overall Study|Lack of Efficacy|1|||
144224445|NCT00955409|520019065|FG001|Overall Study|Lack of Efficacy|0|||
144224446|NCT00955409|520019066|FG002|Overall Study|Lack of Efficacy|0|||
144224447|NCT00955409|520019067|FG003|Overall Study|Lack of Efficacy|0|||
144224448|NCT00955409|520019068|FG004|Overall Study|Lack of Efficacy|0|||
144224449|NCT00955409|520019069|FG005|Overall Study|Lack of Efficacy|0|||
144224450|NCT00955409|520019070|FG006|Overall Study|Lack of Efficacy|0|||
144224451|NCT00955409|520019071|FG007|Overall Study|Lack of Efficacy|0|||
144224452|NCT00955409|520019072|FG008|Overall Study|Lack of Efficacy|0|||
144224453|NCT00955409|520019073|FG009|Overall Study|Lack of Efficacy|0|||
144224454|NCT00955409|520019064|FG000|Overall Study|Withdrawal by Subject|1|||
144224455|NCT00955409|520019065|FG001|Overall Study|Withdrawal by Subject|0|||
144224456|NCT00955409|520019066|FG002|Overall Study|Withdrawal by Subject|5|||
144224457|NCT00955409|520019067|FG003|Overall Study|Withdrawal by Subject|2|||
144224458|NCT00955409|520019068|FG004|Overall Study|Withdrawal by Subject|0|||
144224459|NCT00955409|520019069|FG005|Overall Study|Withdrawal by Subject|0|||
144224460|NCT00955409|520019070|FG006|Overall Study|Withdrawal by Subject|2|||
144224461|NCT00955409|520019071|FG007|Overall Study|Withdrawal by Subject|0|||
144224462|NCT00955409|520019072|FG008|Overall Study|Withdrawal by Subject|1|||
144224463|NCT00955409|520019073|FG009|Overall Study|Withdrawal by Subject|0|||
144224464|NCT00955409|520019064|FG000|Overall Study|Caregiver Request|2|||
144224465|NCT00955409|520019065|FG001|Overall Study|Caregiver Request|0|||
144224466|NCT00955409|520019066|FG002|Overall Study|Caregiver Request|6|||
144224467|NCT00955409|520019067|FG003|Overall Study|Caregiver Request|5|||
144224468|NCT00955409|520019068|FG004|Overall Study|Caregiver Request|0|||
144224469|NCT00955409|520019069|FG005|Overall Study|Caregiver Request|2|||
144224470|NCT00955409|520019070|FG006|Overall Study|Caregiver Request|3|||
144224471|NCT00955409|520019071|FG007|Overall Study|Caregiver Request|1|||
144224472|NCT00955409|520019072|FG008|Overall Study|Caregiver Request|3|||
144224473|NCT00955409|520019073|FG009|Overall Study|Caregiver Request|0|||
144224474|NCT00955409|520019064|FG000|Overall Study|Investigator Request|0|||
144224475|NCT00955409|520019065|FG001|Overall Study|Investigator Request|0|||
144224476|NCT00955409|520019066|FG002|Overall Study|Investigator Request|1|||
144224477|NCT00955409|520019067|FG003|Overall Study|Investigator Request|0|||
144224478|NCT00955409|520019068|FG004|Overall Study|Investigator Request|0|||
144224479|NCT00955409|520019069|FG005|Overall Study|Investigator Request|0|||
144224480|NCT00955409|520019070|FG006|Overall Study|Investigator Request|0|||
144224481|NCT00955409|520019071|FG007|Overall Study|Investigator Request|0|||
144224482|NCT00955409|520019072|FG008|Overall Study|Investigator Request|0|||
144224483|NCT00955409|520019073|FG009|Overall Study|Investigator Request|0|||
144224484|NCT00955409|520019064|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
144224485|NCT00955409|520019065|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
144224486|NCT00955409|520019066|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
144224487|NCT00955409|520019067|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
144224488|NCT00955409|520019068|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
144224489|NCT00955409|520019069|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
144224490|NCT00955409|520019070|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
144224491|NCT00955409|520019071|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
144224492|NCT00955409|520019072|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
144224493|NCT00955409|520019073|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
144224494|NCT00955409|520019064|FG000|Overall Study|Lost to Follow-up|0|||
144224495|NCT00955409|520019065|FG001|Overall Study|Lost to Follow-up|0|||
144224496|NCT00955409|520019066|FG002|Overall Study|Lost to Follow-up|1|||
144224497|NCT00955409|520019067|FG003|Overall Study|Lost to Follow-up|0|||
144224498|NCT00955409|520019068|FG004|Overall Study|Lost to Follow-up|0|||
144224499|NCT00955409|520019069|FG005|Overall Study|Lost to Follow-up|0|||
144224500|NCT00955409|520019070|FG006|Overall Study|Lost to Follow-up|1|||
144224501|NCT00955409|520019071|FG007|Overall Study|Lost to Follow-up|0|||
144224502|NCT00955409|520019072|FG008|Overall Study|Lost to Follow-up|0|||
144224503|NCT00955409|520019073|FG009|Overall Study|Lost to Follow-up|0|||
144224504|NCT00955409|520019064|FG000|Overall Study|Failed to Return|2|||
144224505|NCT00955409|520019065|FG001|Overall Study|Failed to Return|0|||
144224506|NCT00955409|520019066|FG002|Overall Study|Failed to Return|0|||
144224507|NCT00955409|520019067|FG003|Overall Study|Failed to Return|0|||
144224508|NCT00955409|520019068|FG004|Overall Study|Failed to Return|0|||
144224509|NCT00955409|520019069|FG005|Overall Study|Failed to Return|0|||
144224510|NCT00955409|520019070|FG006|Overall Study|Failed to Return|0|||
144224511|NCT00955409|520019071|FG007|Overall Study|Failed to Return|2|||
144224512|NCT00955409|520019072|FG008|Overall Study|Failed to Return|0|||
144224513|NCT00955409|520019073|FG009|Overall Study|Failed to Return|0|||
144224514|NCT00955409|520019064|FG000|Overall Study|Adverse Event (AE)|2|||
144224515|NCT00955409|520019065|FG001|Overall Study|Adverse Event (AE)|0|||
144224516|NCT00955409|520019066|FG002|Overall Study|Adverse Event (AE)|0|||
144224517|NCT00955409|520019067|FG003|Overall Study|Adverse Event (AE)|0|||
144224518|NCT00955409|520019068|FG004|Overall Study|Adverse Event (AE)|0|||
144224519|NCT00955409|520019069|FG005|Overall Study|Adverse Event (AE)|1|||
144224520|NCT00955409|520019070|FG006|Overall Study|Adverse Event (AE)|2|||
144224521|NCT00955409|520019071|FG007|Overall Study|Adverse Event (AE)|0|||
144224522|NCT00955409|520019072|FG008|Overall Study|Adverse Event (AE)|2|||
144224523|NCT00955409|520019073|FG009|Overall Study|Adverse Event (AE)|0|||
144224524|NCT00955409|520019064|FG000|Overall Study|Reason not Specified|2|||
144224525|NCT00955409|520019065|FG001|Overall Study|Reason not Specified|1|||
144224526|NCT00955409|520019066|FG002|Overall Study|Reason not Specified|13|||
144224527|NCT00955409|520019067|FG003|Overall Study|Reason not Specified|1|||
144224528|NCT00955409|520019068|FG004|Overall Study|Reason not Specified|2|||
144224529|NCT00955409|520019069|FG005|Overall Study|Reason not Specified|0|||
144224530|NCT00955409|520019070|FG006|Overall Study|Reason not Specified|16|||
144224531|NCT00955409|520019071|FG007|Overall Study|Reason not Specified|0|||
144224532|NCT00955409|520019072|FG008|Overall Study|Reason not Specified|8|||
144224533|NCT00955409|520019073|FG009|Overall Study|Reason not Specified|1|||
144224534|NCT00485732|520019074|FG000|Overall Study|Protocol Violation|1|||
144224535|NCT00485732|520019075|FG001|Overall Study|Protocol Violation|3|||
144224536|NCT00485732|520019074|FG000|Overall Study|Withdrawal by Subject|5|||
144224537|NCT00485732|520019075|FG001|Overall Study|Withdrawal by Subject|4|||
144224538|NCT00485732|520019074|FG000|Overall Study|Lost to Follow-up|2|||
144224539|NCT00485732|520019075|FG001|Overall Study|Lost to Follow-up|2|||
144224540|NCT00803790|520019076|FG000|Period 1|Adverse Event|0|||
144224541|NCT00803790|520019077|FG001|Period 1|Adverse Event|1|||
144224542|NCT00803790|520019078|FG002|Period 1|Adverse Event|0|||
144224543|NCT00803790|520019079|FG003|Period 1|Adverse Event|0|||
144224544|NCT00803790|520019076|FG000|Period 1|Lost to Follow-up|1|||
144224545|NCT00803790|520019077|FG001|Period 1|Lost to Follow-up|2|||
144224546|NCT00803790|520019078|FG002|Period 1|Lost to Follow-up|0|||
144224547|NCT00803790|520019079|FG003|Period 1|Lost to Follow-up|0|||
144224548|NCT00803790|520019076|FG000|Period 1|Withdrawal by Subject|8|||
144224549|NCT00803790|520019077|FG001|Period 1|Withdrawal by Subject|6|||
144224550|NCT00803790|520019078|FG002|Period 1|Withdrawal by Subject|0|||
144224551|NCT00803790|520019079|FG003|Period 1|Withdrawal by Subject|0|||
144224552|NCT00803790|520019076|FG000|Period 1|positive drug screen or personal reasons|0|||
144224553|NCT00803790|520019077|FG001|Period 1|positive drug screen or personal reasons|3|||
144224554|NCT00803790|520019078|FG002|Period 1|positive drug screen or personal reasons|0|||
144224555|NCT00803790|520019079|FG003|Period 1|positive drug screen or personal reasons|4|||
144224556|NCT00803790|520019076|FG000|Period 1|Protocol Violation|0|||
144224557|NCT00803790|520019077|FG001|Period 1|Protocol Violation|0|||
144224558|NCT00803790|520019078|FG002|Period 1|Protocol Violation|1|||
144224559|NCT00803790|520019079|FG003|Period 1|Protocol Violation|0|||
144224560|NCT00803790|520019076|FG000|Period 2|Adverse Event|0|||
144224561|NCT00803790|520019077|FG001|Period 2|Adverse Event|0|||
144224562|NCT00803790|520019078|FG002|Period 2|Adverse Event|1|||
144224563|NCT00803790|520019079|FG003|Period 2|Adverse Event|1|||
144224564|NCT00803790|520019076|FG000|Period 2|Withdrawal by Subject|1|||
144224565|NCT00803790|520019077|FG001|Period 2|Withdrawal by Subject|0|||
144224566|NCT00803790|520019078|FG002|Period 2|Withdrawal by Subject|0|||
144224567|NCT00803790|520019079|FG003|Period 2|Withdrawal by Subject|0|||
144224568|NCT00803790|520019076|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
144224569|NCT00803790|520019077|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
144224570|NCT00803790|520019078|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
144224571|NCT00803790|520019079|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
144224572|NCT04710576|520019080|FG000|Overall Study|Participants still in the study|73|||
144224573|NCT04710576|520019081|FG001|Overall Study|Participants still in the study|70|||
144224574|NCT04710576|520019082|FG002|Overall Study|Participants still in the study|60|||
144224575|NCT04710576|520019080|FG000|Overall Study|Death|2|||
144224576|NCT04710576|520019081|FG001|Overall Study|Death|7|||
144224577|NCT04710576|520019082|FG002|Overall Study|Death|12|||
144224578|NCT04710576|520019080|FG000|Overall Study|Withdrawal by Subject|4|||
144224579|NCT04710576|520019081|FG001|Overall Study|Withdrawal by Subject|3|||
144224580|NCT04710576|520019082|FG002|Overall Study|Withdrawal by Subject|7|||
144224581|NCT04710576|520019080|FG000|Overall Study|Sponsor decision|1|||
144224582|NCT04710576|520019081|FG001|Overall Study|Sponsor decision|0|||
144224583|NCT04710576|520019082|FG002|Overall Study|Sponsor decision|0|||
144224584|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
144224585|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
144224586|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
144224587|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
144224588|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
144224589|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
144224590|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
144224591|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
144224592|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
144224593|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
144224594|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
144224595|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
144224596|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
144224597|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
144224598|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
144224599|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
144224600|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
144224601|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
144224602|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
144224603|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
144224604|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
144224605|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
144224606|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
144224607|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
144224608|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
144224609|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
144224610|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
144224611|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
144224612|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
144224613|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
144224614|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
144224615|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
144224616|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
144224617|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
144224618|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
144224619|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
144224620|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
144224621|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
144224622|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
144224623|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
144224624|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
144224625|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
144224626|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
144224627|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
144224628|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
144224629|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
144224630|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
144224631|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
144224632|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
144224633|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
144224634|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
144224635|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
144224636|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Site closed|0|||
144224637|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Site closed|0|||
144224638|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Site closed|1|||
144224639|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Site closed|0|||
144224640|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
144224641|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
144224642|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
144224643|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
144224644|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
144224645|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
144224646|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
144224647|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
144224648|NCT00838903|520019085|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
144224649|NCT00838903|520019086|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
144224650|NCT00838903|520019087|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
144224651|NCT00838903|520019088|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
144224652|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
144224653|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
144224654|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
144224655|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
144224656|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
144224657|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
144224658|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
144224659|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
144224660|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
144224661|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
144224662|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
144224663|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
144224664|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
144224665|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
144224666|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
144224667|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
144224668|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
144224669|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
144224670|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
144224671|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
144224672|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
144224673|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
144224674|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
144224675|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
144224676|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
144224677|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
144224678|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
144224679|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
144224680|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
144224681|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
144224682|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
144224683|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
144224684|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
144224685|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
144224686|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
144224687|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
144224688|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
144224689|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
144224690|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
144224691|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
144224692|NCT00838903|520019085|FG000|Follow-up Period (8 Weeks)|Missing|1|||
144224693|NCT00838903|520019086|FG001|Follow-up Period (8 Weeks)|Missing|2|||
144224694|NCT00838903|520019087|FG002|Follow-up Period (8 Weeks)|Missing|1|||
144224695|NCT00838903|520019088|FG003|Follow-up Period (8 Weeks)|Missing|1|||
144224696|NCT01611935|520019089|FG000|Overall Study|Family Declined Participation|1|||
144224697|NCT01611935|520019090|FG001|Overall Study|Family Declined Participation|0|||
144224698|NCT05177484|520019091|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
144224699|NCT05177484|520019092|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
144224700|NCT05177484|520019091|FG000|Overall Study|Inadvertently withdrawn|3|||
144224701|NCT05177484|520019092|FG001|Overall Study|Inadvertently withdrawn|1|||
144224702|NCT05177484|520019091|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
144224703|NCT05177484|520019092|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
144224704|NCT00729612|520019095|FG000|Overall Study|Non evaluable for response|10|||
144224705|NCT00460603|520019103|FG000|Phase 1|Death|1|||
144224706|NCT00460603|520019104|FG001|Phase 1|Death|0|||
144224707|NCT00460603|520019105|FG002|Phase 1|Death|0|||
144224708|NCT00460603|520019106|FG003|Phase 1|Death|2|||
144224709|NCT00460603|520019107|FG004|Phase 1|Death|0|||
144224710|NCT00460603|520019108|FG005|Phase 1|Death|0|||
144224711|NCT00460603|520019109|FG006|Phase 1|Death|0|||
144224712|NCT00460603|520019110|FG007|Phase 1|Death|0|||
144224713|NCT00460603|520019111|FG008|Phase 1|Death|1|||
144224714|NCT00460603|520019112|FG009|Phase 1|Death|0|||
144224715|NCT00460603|520019113|FG010|Phase 1|Death|0|||
144224716|NCT00460603|520019114|FG011|Phase 1|Death|0|||
144224717|NCT00460603|520019103|FG000|Phase 1|Adverse Event|3|||
144224718|NCT00460603|520019104|FG001|Phase 1|Adverse Event|1|||
144224719|NCT00460603|520019105|FG002|Phase 1|Adverse Event|1|||
144224720|NCT00460603|520019106|FG003|Phase 1|Adverse Event|2|||
144224721|NCT00460603|520019107|FG004|Phase 1|Adverse Event|0|||
144224722|NCT00460603|520019108|FG005|Phase 1|Adverse Event|0|||
144224723|NCT00460603|520019109|FG006|Phase 1|Adverse Event|3|||
144224724|NCT00460603|520019110|FG007|Phase 1|Adverse Event|0|||
144224725|NCT00460603|520019111|FG008|Phase 1|Adverse Event|4|||
144224726|NCT00460603|520019112|FG009|Phase 1|Adverse Event|0|||
144224727|NCT00460603|520019113|FG010|Phase 1|Adverse Event|0|||
144224728|NCT00460603|520019114|FG011|Phase 1|Adverse Event|0|||
144224729|NCT00460603|520019103|FG000|Phase 1|Lack of Efficacy|1|||
144224730|NCT00460603|520019104|FG001|Phase 1|Lack of Efficacy|0|||
144224731|NCT00460603|520019105|FG002|Phase 1|Lack of Efficacy|1|||
144224732|NCT00460603|520019106|FG003|Phase 1|Lack of Efficacy|2|||
144224733|NCT00460603|520019107|FG004|Phase 1|Lack of Efficacy|2|||
144224734|NCT00460603|520019108|FG005|Phase 1|Lack of Efficacy|2|||
144224735|NCT00460603|520019109|FG006|Phase 1|Lack of Efficacy|2|||
144224736|NCT00460603|520019110|FG007|Phase 1|Lack of Efficacy|2|||
144224737|NCT00460603|520019111|FG008|Phase 1|Lack of Efficacy|11|||
144224738|NCT00460603|520019112|FG009|Phase 1|Lack of Efficacy|0|||
144224739|NCT00460603|520019113|FG010|Phase 1|Lack of Efficacy|0|||
144224740|NCT00460603|520019114|FG011|Phase 1|Lack of Efficacy|0|||
144224741|NCT00460603|520019103|FG000|Phase 1|Withdrawal by Subject|1|||
144224742|NCT00460603|520019104|FG001|Phase 1|Withdrawal by Subject|2|||
144224743|NCT00460603|520019105|FG002|Phase 1|Withdrawal by Subject|1|||
144224744|NCT00460603|520019106|FG003|Phase 1|Withdrawal by Subject|1|||
144224745|NCT00460603|520019107|FG004|Phase 1|Withdrawal by Subject|3|||
144224746|NCT00460603|520019108|FG005|Phase 1|Withdrawal by Subject|0|||
144224747|NCT00460603|520019109|FG006|Phase 1|Withdrawal by Subject|1|||
144224748|NCT00460603|520019110|FG007|Phase 1|Withdrawal by Subject|0|||
144224749|NCT00460603|520019111|FG008|Phase 1|Withdrawal by Subject|2|||
144224750|NCT00460603|520019112|FG009|Phase 1|Withdrawal by Subject|0|||
144224751|NCT00460603|520019113|FG010|Phase 1|Withdrawal by Subject|0|||
144224752|NCT00460603|520019114|FG011|Phase 1|Withdrawal by Subject|0|||
144224753|NCT00460603|520019103|FG000|Phase 1|Other|0|||
144224754|NCT00460603|520019104|FG001|Phase 1|Other|3|||
144224755|NCT00460603|520019105|FG002|Phase 1|Other|1|||
144224756|NCT00460603|520019106|FG003|Phase 1|Other|1|||
144224757|NCT00460603|520019107|FG004|Phase 1|Other|1|||
144224758|NCT00460603|520019108|FG005|Phase 1|Other|2|||
144224759|NCT00460603|520019109|FG006|Phase 1|Other|0|||
144224760|NCT00460603|520019110|FG007|Phase 1|Other|1|||
144224761|NCT00460603|520019111|FG008|Phase 1|Other|0|||
144224762|NCT00460603|520019112|FG009|Phase 1|Other|0|||
144224763|NCT00460603|520019113|FG010|Phase 1|Other|0|||
144267965|NCT01687218|520183365|FG002|Overall Study|Withdrawal by Subject|0|||
144267966|NCT01687218|520183366|FG003|Overall Study|Withdrawal by Subject|1|||
144267967|NCT01687218|520183367|FG004|Overall Study|Withdrawal by Subject|1|||
144267968|NCT01687218|520183368|FG005|Overall Study|Withdrawal by Subject|0|||
144267969|NCT01687218|520183363|FG000|Overall Study|Relocated, no follow-up planned|1|||
144267970|NCT01687218|520183364|FG001|Overall Study|Relocated, no follow-up planned|0|||
144267971|NCT01687218|520183365|FG002|Overall Study|Relocated, no follow-up planned|1|||
144267972|NCT01687218|520183366|FG003|Overall Study|Relocated, no follow-up planned|1|||
144267973|NCT01687218|520183367|FG004|Overall Study|Relocated, no follow-up planned|0|||
144267974|NCT01687218|520183368|FG005|Overall Study|Relocated, no follow-up planned|0|||
144267975|NCT00875810|520183375|FG000|Overall Study|Withdrawal by Subject|1|||
144267976|NCT00875810|520183375|FG000|Overall Study|Physician Decision|3|||
144267977|NCT00875810|520183375|FG000|Overall Study|Lost to Follow-up|39|||
144267978|NCT00875810|520183375|FG000|Overall Study|Patient enroled but not implanted|2|||
144267979|NCT00875810|520183375|FG000|Overall Study|Device explanted|1|||
144267980|NCT03106077|520183378|FG000|Overall Study|Screen Failure|94|||
144267981|NCT03106077|520183379|FG001|Overall Study|Screen Failure|0|||
144267982|NCT01274533|520183380|FG000|Overall Study|Withdrawal by Subject|1|||
144267983|NCT01274533|520183380|FG000|Overall Study|Non-compliance|1|||
144267984|NCT01274533|520183380|FG000|Overall Study|Disease progression|2|||
144267985|NCT02563899|520183381|FG000|Overall Study|Protocol Violation|1|||
144267986|NCT02563899|520183382|FG001|Overall Study|Protocol Violation|0|||
144267987|NCT02563899|520183383|FG002|Overall Study|Protocol Violation|0|||
144267988|NCT02563899|520183384|FG003|Overall Study|Protocol Violation|0|||
144267989|NCT02563899|520183381|FG000|Overall Study|Withdrawal by Subject|0|||
144267990|NCT02563899|520183382|FG001|Overall Study|Withdrawal by Subject|0|||
144267991|NCT02563899|520183383|FG002|Overall Study|Withdrawal by Subject|1|||
144267992|NCT02563899|520183384|FG003|Overall Study|Withdrawal by Subject|0|||
144267993|NCT03669588|520183385|FG000|Overall Study|Adverse Event|1|||
144267994|NCT03669588|520183386|FG001|Overall Study|Adverse Event|0|||
144267995|NCT03669588|520183385|FG000|Overall Study|Physician Decision|0|||
144267996|NCT03669588|520183386|FG001|Overall Study|Physician Decision|1|||
144267997|NCT03669588|520183385|FG000|Overall Study|Protocol Violation|1|||
144267998|NCT03669588|520183386|FG001|Overall Study|Protocol Violation|0|||
144267999|NCT03669588|520183385|FG000|Overall Study|Sponsor Decision|1|||
144268000|NCT03669588|520183386|FG001|Overall Study|Sponsor Decision|1|||
144268001|NCT03669588|520183385|FG000|Overall Study|Withdrawal by Subject|1|||
144224764|NCT00460603|520019114|FG011|Phase 1|Other|0|||
144224765|NCT00460603|520019103|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224766|NCT00460603|520019104|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224767|NCT00460603|520019105|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224768|NCT00460603|520019106|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224769|NCT00460603|520019107|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224770|NCT00460603|520019108|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224771|NCT00460603|520019109|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224772|NCT00460603|520019110|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224773|NCT00460603|520019111|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224774|NCT00460603|520019112|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
144224775|NCT00460603|520019113|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224776|NCT00460603|520019114|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
144224777|NCT00460603|520019103|FG000|Phase 2|Adverse Event|0|||
144224778|NCT00460603|520019104|FG001|Phase 2|Adverse Event|0|||
144224779|NCT00460603|520019105|FG002|Phase 2|Adverse Event|0|||
144224780|NCT00460603|520019106|FG003|Phase 2|Adverse Event|0|||
144224781|NCT00460603|520019107|FG004|Phase 2|Adverse Event|0|||
144224782|NCT00460603|520019108|FG005|Phase 2|Adverse Event|0|||
144224783|NCT00460603|520019109|FG006|Phase 2|Adverse Event|0|||
144224784|NCT00460603|520019110|FG007|Phase 2|Adverse Event|0|||
144224785|NCT00460603|520019111|FG008|Phase 2|Adverse Event|0|||
144224786|NCT00460603|520019112|FG009|Phase 2|Adverse Event|12|||
144224787|NCT00460603|520019113|FG010|Phase 2|Adverse Event|9|||
144224788|NCT00460603|520019114|FG011|Phase 2|Adverse Event|10|||
144224789|NCT00460603|520019103|FG000|Phase 2|Death|0|||
144224790|NCT00460603|520019104|FG001|Phase 2|Death|0|||
144224791|NCT00460603|520019105|FG002|Phase 2|Death|0|||
144224792|NCT00460603|520019106|FG003|Phase 2|Death|0|||
144224793|NCT00460603|520019107|FG004|Phase 2|Death|0|||
144224794|NCT00460603|520019108|FG005|Phase 2|Death|0|||
144224795|NCT00460603|520019109|FG006|Phase 2|Death|0|||
144224796|NCT00460603|520019110|FG007|Phase 2|Death|0|||
144224797|NCT00460603|520019111|FG008|Phase 2|Death|0|||
144224798|NCT00460603|520019112|FG009|Phase 2|Death|4|||
144224799|NCT00460603|520019113|FG010|Phase 2|Death|2|||
144224800|NCT00460603|520019114|FG011|Phase 2|Death|2|||
144224801|NCT00460603|520019103|FG000|Phase 2|Protocol Violation|0|||
144224802|NCT00460603|520019104|FG001|Phase 2|Protocol Violation|0|||
144224803|NCT00460603|520019105|FG002|Phase 2|Protocol Violation|0|||
144224804|NCT00460603|520019106|FG003|Phase 2|Protocol Violation|0|||
144224805|NCT00460603|520019107|FG004|Phase 2|Protocol Violation|0|||
144224806|NCT00460603|520019108|FG005|Phase 2|Protocol Violation|0|||
144224807|NCT00460603|520019109|FG006|Phase 2|Protocol Violation|0|||
144224808|NCT00460603|520019110|FG007|Phase 2|Protocol Violation|0|||
144224809|NCT00460603|520019111|FG008|Phase 2|Protocol Violation|0|||
144224810|NCT00460603|520019112|FG009|Phase 2|Protocol Violation|1|||
144224811|NCT00460603|520019113|FG010|Phase 2|Protocol Violation|1|||
144224812|NCT00460603|520019114|FG011|Phase 2|Protocol Violation|0|||
144224813|NCT00460603|520019103|FG000|Phase 2|Lost to Follow-up|0|||
144224814|NCT00460603|520019104|FG001|Phase 2|Lost to Follow-up|0|||
144224815|NCT00460603|520019105|FG002|Phase 2|Lost to Follow-up|0|||
144224816|NCT00460603|520019106|FG003|Phase 2|Lost to Follow-up|0|||
144224817|NCT00460603|520019107|FG004|Phase 2|Lost to Follow-up|0|||
144224818|NCT00460603|520019108|FG005|Phase 2|Lost to Follow-up|0|||
144224819|NCT00460603|520019109|FG006|Phase 2|Lost to Follow-up|0|||
144224820|NCT00460603|520019110|FG007|Phase 2|Lost to Follow-up|0|||
144224821|NCT00460603|520019111|FG008|Phase 2|Lost to Follow-up|0|||
144224822|NCT00460603|520019112|FG009|Phase 2|Lost to Follow-up|1|||
144224823|NCT00460603|520019113|FG010|Phase 2|Lost to Follow-up|0|||
144224824|NCT00460603|520019114|FG011|Phase 2|Lost to Follow-up|0|||
144224825|NCT00460603|520019103|FG000|Phase 2|Other|0|||
144224826|NCT00460603|520019104|FG001|Phase 2|Other|0|||
144224827|NCT00460603|520019105|FG002|Phase 2|Other|0|||
144224828|NCT00460603|520019106|FG003|Phase 2|Other|0|||
144224829|NCT00460603|520019107|FG004|Phase 2|Other|0|||
144224830|NCT00460603|520019108|FG005|Phase 2|Other|0|||
144268002|NCT03669588|520183386|FG001|Overall Study|Withdrawal by Subject|4|||
144268003|NCT03669588|520183385|FG000|Overall Study|Rescue Therapy Needed|0|||
144268004|NCT03669588|520183386|FG001|Overall Study|Rescue Therapy Needed|1|||
144268005|NCT02008526|520183387|FG000|Overall Study|Death|0|||
144268006|NCT02008526|520183388|FG001|Overall Study|Death|2|||
144268007|NCT02008526|520183389|FG002|Overall Study|Death|1|||
144268008|NCT02008526|520183387|FG000|Overall Study|Withdrawal by Subject|3|||
144268009|NCT02008526|520183388|FG001|Overall Study|Withdrawal by Subject|3|||
144268010|NCT02008526|520183389|FG002|Overall Study|Withdrawal by Subject|2|||
144268011|NCT02008526|520183387|FG000|Overall Study|Lost to Follow-up|5|||
144268012|NCT02008526|520183388|FG001|Overall Study|Lost to Follow-up|9|||
144268013|NCT02008526|520183389|FG002|Overall Study|Lost to Follow-up|6|||
144268014|NCT02033759|520183398|FG000|Overall Study|Withdrawal by Subject|2|||
144268015|NCT02033759|520183399|FG001|Overall Study|Withdrawal by Subject|1|||
144268016|NCT02033759|520183398|FG000|Overall Study|Protocol Violation|1|||
144268017|NCT02033759|520183399|FG001|Overall Study|Protocol Violation|1|||
144268018|NCT04194814|520183404|FG000|Overall Study|Physician Decision|3|||
144268019|NCT04194814|520183405|FG001|Overall Study|Physician Decision|0|||
144268020|NCT04194814|520183404|FG000|Overall Study|Withdrawal by Subject|0|||
144268021|NCT04194814|520183405|FG001|Overall Study|Withdrawal by Subject|2|||
144268022|NCT02133508|520185109|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
144268023|NCT02133508|520185109|FG000|Overall Study|Death|12|||
144268024|NCT02133508|520185109|FG000|Overall Study|Lost to Follow-up|2|||
144268025|NCT04210986|520185114|FG000|Overall Study|Lost to Follow-up|5|||
144268026|NCT04210986|520185115|FG001|Overall Study|Lost to Follow-up|2|||
144268027|NCT04210986|520185114|FG000|Overall Study|Withdrawal by Subject|3|||
144268028|NCT04210986|520185115|FG001|Overall Study|Withdrawal by Subject|1|||
144268029|NCT04210986|520185114|FG000|Overall Study|Protocol Violation|1|||
144268030|NCT04210986|520185115|FG001|Overall Study|Protocol Violation|1|||
144268031|NCT04210986|520185114|FG000|Overall Study|Physician Decision|0|||
144268032|NCT04210986|520185115|FG001|Overall Study|Physician Decision|1|||
144268033|NCT02378662|520185116|FG000|Overall Study|Early Discontinuation|2|||
144268034|NCT02378662|520185117|FG001|Overall Study|Early Discontinuation|0|||
144268035|NCT01159574|520185118|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
144268036|NCT01159574|520185118|FG000|Treatment Phase|Adverse Event|3|||
144268037|NCT01159574|520185118|FG000|Treatment Phase|Death|6|||
144268038|NCT01159574|520185118|FG000|Treatment Phase|Physician Decision|2|||
144268039|NCT01159574|520185118|FG000|Treatment Phase|Withdrawal by Subject|7|||
144268040|NCT01159574|520185118|FG000|Treatment Phase|still on treatment|2|||
144268041|NCT01159574|520185118|FG000|Follow Up Phase|Lost to Follow-up|2|||
144268042|NCT01159574|520185118|FG000|Follow Up Phase|still being followed for overall surviva|18|||
144268043|NCT02666222|520185119|FG000|Overall Study|Death|2|||
144268044|NCT01474486|520185128|FG000|Overall Study|Death|2|||
144268045|NCT01474486|520185128|FG000|Overall Study|Withdrawal by Subject|4|||
144268046|NCT01474486|520185128|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
144268047|NCT03863353|520185132|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
144268048|NCT03863353|520185133|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
144268049|NCT01299584|520185134|FG000|Overall Study|Protocol Violation|9|||
144268050|NCT00572832|520185135|FG000|Overall Study|Lost to Follow-up|0|||
144268051|NCT00572832|520185136|FG001|Overall Study|Lost to Follow-up|11|||
144268052|NCT00572832|520185135|FG000|Overall Study|Pregnancy|0|||
144268053|NCT00572832|520185136|FG001|Overall Study|Pregnancy|1|||
144268054|NCT04079790|520185140|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
144268055|NCT04079790|520185141|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
144268056|NCT04079790|520185142|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
144268057|NCT04079790|520185143|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
144268058|NCT04079790|520185140|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
144268059|NCT04079790|520185141|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
144268060|NCT04079790|520185142|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
144268061|NCT04079790|520185143|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
144268062|NCT04079790|520185140|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
144268063|NCT04079790|520185141|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
144268064|NCT04079790|520185142|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
144268065|NCT04079790|520185143|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
144268066|NCT00390689|520185144|FG000|Overall Study|Adverse Event|2|||
144224831|NCT00460603|520019109|FG006|Phase 2|Other|0|||
144224832|NCT00460603|520019110|FG007|Phase 2|Other|0|||
144224833|NCT00460603|520019111|FG008|Phase 2|Other|0|||
144224834|NCT00460603|520019112|FG009|Phase 2|Other|6|||
144224835|NCT00460603|520019113|FG010|Phase 2|Other|16|||
144268067|NCT00390689|520185145|FG001|Overall Study|Adverse Event|5|||
144268068|NCT00390689|520185146|FG002|Overall Study|Adverse Event|2|||
144268069|NCT00390689|520185144|FG000|Overall Study|Lack of Efficacy|0|||
144268070|NCT00390689|520185145|FG001|Overall Study|Lack of Efficacy|0|||
144268071|NCT00390689|520185146|FG002|Overall Study|Lack of Efficacy|1|||
144268072|NCT00390689|520185144|FG000|Overall Study|Protocol Violation|1|||
144268073|NCT00390689|520185145|FG001|Overall Study|Protocol Violation|0|||
144268074|NCT00390689|520185146|FG002|Overall Study|Protocol Violation|0|||
144224836|NCT00460603|520019114|FG011|Phase 2|Other|7|||
144224837|NCT00460603|520019103|FG000|Phase 2|Objective Progression or Relapse|0|||
144224838|NCT00460603|520019104|FG001|Phase 2|Objective Progression or Relapse|0|||
144224839|NCT00460603|520019105|FG002|Phase 2|Objective Progression or Relapse|0|||
144224840|NCT00460603|520019106|FG003|Phase 2|Objective Progression or Relapse|0|||
144224841|NCT00460603|520019107|FG004|Phase 2|Objective Progression or Relapse|0|||
144224842|NCT00460603|520019108|FG005|Phase 2|Objective Progression or Relapse|0|||
144224843|NCT00460603|520019109|FG006|Phase 2|Objective Progression or Relapse|0|||
144224844|NCT00460603|520019110|FG007|Phase 2|Objective Progression or Relapse|0|||
144224845|NCT00460603|520019111|FG008|Phase 2|Objective Progression or Relapse|0|||
144224846|NCT00460603|520019112|FG009|Phase 2|Objective Progression or Relapse|9|||
144224847|NCT00460603|520019113|FG010|Phase 2|Objective Progression or Relapse|10|||
144224848|NCT00460603|520019114|FG011|Phase 2|Objective Progression or Relapse|17|||
144224849|NCT00460603|520019103|FG000|Phase 2|Global Deterioration of Health Status|0|||
144224850|NCT00460603|520019104|FG001|Phase 2|Global Deterioration of Health Status|0|||
144224851|NCT00460603|520019105|FG002|Phase 2|Global Deterioration of Health Status|0|||
144224852|NCT00460603|520019106|FG003|Phase 2|Global Deterioration of Health Status|0|||
144224853|NCT00460603|520019107|FG004|Phase 2|Global Deterioration of Health Status|0|||
144224854|NCT00460603|520019108|FG005|Phase 2|Global Deterioration of Health Status|0|||
144224855|NCT00460603|520019109|FG006|Phase 2|Global Deterioration of Health Status|0|||
144224856|NCT00460603|520019110|FG007|Phase 2|Global Deterioration of Health Status|0|||
144224857|NCT00460603|520019111|FG008|Phase 2|Global Deterioration of Health Status|0|||
144224858|NCT00460603|520019112|FG009|Phase 2|Global Deterioration of Health Status|0|||
144224859|NCT00460603|520019113|FG010|Phase 2|Global Deterioration of Health Status|1|||
144224860|NCT00460603|520019114|FG011|Phase 2|Global Deterioration of Health Status|0|||
144224861|NCT00460603|520019103|FG000|Phase 2|Withdrawal by Subject|0|||
144224862|NCT00460603|520019104|FG001|Phase 2|Withdrawal by Subject|0|||
144224863|NCT00460603|520019105|FG002|Phase 2|Withdrawal by Subject|0|||
144224864|NCT00460603|520019106|FG003|Phase 2|Withdrawal by Subject|0|||
144224865|NCT00460603|520019107|FG004|Phase 2|Withdrawal by Subject|0|||
144224866|NCT00460603|520019108|FG005|Phase 2|Withdrawal by Subject|0|||
144224867|NCT00460603|520019109|FG006|Phase 2|Withdrawal by Subject|0|||
144224868|NCT00460603|520019110|FG007|Phase 2|Withdrawal by Subject|0|||
144224869|NCT00460603|520019111|FG008|Phase 2|Withdrawal by Subject|0|||
144224870|NCT00460603|520019112|FG009|Phase 2|Withdrawal by Subject|5|||
144224871|NCT00460603|520019113|FG010|Phase 2|Withdrawal by Subject|4|||
144224872|NCT00460603|520019114|FG011|Phase 2|Withdrawal by Subject|5|||
144224873|NCT00460603|520019103|FG000|Phase 2|Randomized, but not treated|0|||
144224874|NCT00460603|520019104|FG001|Phase 2|Randomized, but not treated|0|||
144224875|NCT00460603|520019105|FG002|Phase 2|Randomized, but not treated|0|||
144224876|NCT00460603|520019106|FG003|Phase 2|Randomized, but not treated|0|||
144224877|NCT00460603|520019107|FG004|Phase 2|Randomized, but not treated|0|||
144224878|NCT00460603|520019108|FG005|Phase 2|Randomized, but not treated|0|||
144224879|NCT00460603|520019109|FG006|Phase 2|Randomized, but not treated|0|||
144268075|NCT00390689|520185144|FG000|Overall Study|Investigator's judgement|2|||
144224880|NCT00460603|520019110|FG007|Phase 2|Randomized, but not treated|0|||
144224881|NCT00460603|520019111|FG008|Phase 2|Randomized, but not treated|0|||
144224882|NCT00460603|520019112|FG009|Phase 2|Randomized, but not treated|3|||
144224883|NCT00460603|520019113|FG010|Phase 2|Randomized, but not treated|0|||
144224884|NCT00460603|520019114|FG011|Phase 2|Randomized, but not treated|0|||
144224885|NCT03802825|520019117|FG000|Overall Study|Lost to follow-up for intervention|12|||
144224886|NCT03802825|520019118|FG001|Overall Study|Lost to follow-up for intervention|3|||
144268076|NCT00390689|520185145|FG001|Overall Study|Investigator's judgement|0|||
144268077|NCT00390689|520185146|FG002|Overall Study|Investigator's judgement|0|||
144268078|NCT01924533|520185147|FG000|Overall Study|Death|181|||
144268079|NCT01924533|520185148|FG001|Overall Study|Death|200|||
144268080|NCT01924533|520185147|FG000|Overall Study|Lost to Follow-up|0|||
144268081|NCT01924533|520185148|FG001|Overall Study|Lost to Follow-up|1|||
144268082|NCT01924533|520185147|FG000|Overall Study|Withdrawal by Subject|7|||
144268083|NCT01924533|520185148|FG001|Overall Study|Withdrawal by Subject|3|||
144268084|NCT01924533|520185147|FG000|Overall Study|Other Eligibility criteria|1|||
144268085|NCT01924533|520185148|FG001|Overall Study|Other Eligibility criteria|1|||
144268086|NCT05817669|520185149|FG000|Overall Study|Prohibited medication used|1|||
144268087|NCT05817669|520185150|FG001|Overall Study|Prohibited medication used|2|||
144268088|NCT05817669|520185149|FG000|Overall Study|Adverse Event|1|||
144268089|NCT05817669|520185150|FG001|Overall Study|Adverse Event|0|||
144268090|NCT05817669|520185149|FG000|Overall Study|Withdrawal by Subject|1|||
144268091|NCT05817669|520185150|FG001|Overall Study|Withdrawal by Subject|2|||
144268092|NCT04233879|520185151|FG000|Overall Study|Death|2|||
144268093|NCT04233879|520185152|FG001|Overall Study|Death|0|||
144268094|NCT04233879|520185151|FG000|Overall Study|Lost to Follow-up|3|||
144268095|NCT04233879|520185152|FG001|Overall Study|Lost to Follow-up|8|||
144268096|NCT04233879|520185151|FG000|Overall Study|Physician Decision|4|||
144268097|NCT04233879|520185152|FG001|Overall Study|Physician Decision|4|||
144268098|NCT04233879|520185151|FG000|Overall Study|Withdrawal by Subject|7|||
144268099|NCT04233879|520185152|FG001|Overall Study|Withdrawal by Subject|10|||
144268100|NCT04233879|520185151|FG000|Overall Study|Other|281|||
144268101|NCT04233879|520185152|FG001|Overall Study|Other|279|||
144268102|NCT03810183|520185153|FG000|Overall Study|Study terminated by Sponsor|2|||
144268103|NCT03810183|520185154|FG001|Overall Study|Study terminated by Sponsor|1|||
144268104|NCT00323063|520185156|FG000|Overall Study|Adverse Event|1|||
144268105|NCT00323063|520185157|FG001|Overall Study|Adverse Event|0|||
144268106|NCT00323063|520185156|FG000|Overall Study|brain mets discovered prior to treatment|1|||
144268107|NCT00323063|520185157|FG001|Overall Study|brain mets discovered prior to treatment|0|||
144268108|NCT04275336|520185158|FG000|Overall Study|First venipuncture failed|4|||
144268109|NCT04275336|520185159|FG001|Overall Study|First venipuncture failed|6|||
144268110|NCT04275336|520185160|FG002|Overall Study|First venipuncture failed|5|||
144268111|NCT04275336|520185158|FG000|Overall Study|Unscheduled venipuncture|9|||
144268112|NCT04275336|520185159|FG001|Overall Study|Unscheduled venipuncture|13|||
144268113|NCT04275336|520185160|FG002|Overall Study|Unscheduled venipuncture|7|||
144268114|NCT04275336|520185158|FG000|Overall Study|Failed specimen of saliva|4|||
144268115|NCT04275336|520185159|FG001|Overall Study|Failed specimen of saliva|3|||
144268116|NCT04275336|520185160|FG002|Overall Study|Failed specimen of saliva|4|||
144268117|NCT03167242|520185161|FG000|Overall Study|Patient/Guardian Decision|0|||
144268118|NCT03167242|520185162|FG001|Overall Study|Patient/Guardian Decision|1|||
144268119|NCT03167242|520185163|FG002|Overall Study|Patient/Guardian Decision|2|||
144268120|NCT03167242|520185164|FG003|Overall Study|Patient/Guardian Decision|1|||
144224887|NCT03802825|520019117|FG000|Overall Study|Received only 1 component of intervention|0|||
144224888|NCT03802825|520019118|FG001|Overall Study|Received only 1 component of intervention|13|||
144224889|NCT01051960|520019122|FG000|Overall Study|Adverse Event|1|||
144224890|NCT00360282|520019123|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
144224891|NCT00360282|520019124|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
144224892|NCT00360282|520019125|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
144224893|NCT00360282|520019126|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
144224894|NCT00360282|520019123|FG000|Second Intervention|Adverse Event|0|||
144224895|NCT00360282|520019124|FG001|Second Intervention|Adverse Event|1|||
144224896|NCT00360282|520019125|FG002|Second Intervention|Adverse Event|0|||
144224897|NCT00360282|520019126|FG003|Second Intervention|Adverse Event|0|||
144224898|NCT04537078|520019129|FG000|Overall Study|Protocol Violation|3|||
144224899|NCT04537078|520019130|FG001|Overall Study|Protocol Violation|2|||
144224900|NCT04537078|520019129|FG000|Overall Study|Lost to Follow-up|1|||
144224901|NCT04537078|520019130|FG001|Overall Study|Lost to Follow-up|0|||
144224902|NCT04537078|520019129|FG000|Overall Study|Withdrawal by Subject|0|||
144224903|NCT04537078|520019130|FG001|Overall Study|Withdrawal by Subject|1|||
144224904|NCT01293695|520019134|FG000|Overall Study|Withdrawal by Subject|7|||
144224905|NCT01293695|520019135|FG001|Overall Study|Withdrawal by Subject|1|||
144224906|NCT01293695|520019134|FG000|Overall Study|Lost to Follow-up|8|||
144224907|NCT01293695|520019135|FG001|Overall Study|Lost to Follow-up|6|||
144224908|NCT00314340|520019136|FG000|Overall Study|lost interest|1|||
144224909|NCT04177095|520019140|FG000|Overall Study|Withdrawal by Subject|3|||
144224910|NCT04177095|520019140|FG000|Overall Study|Screen Failure|3|||
144224911|NCT04177095|520019140|FG000|Overall Study|Problems with the Trugraf assay|1|||
144224912|NCT00777296|520019141|FG000|Overall Study|Adverse Event|0|||
144224913|NCT00777296|520019142|FG001|Overall Study|Adverse Event|1|||
144224914|NCT00777296|520019143|FG002|Overall Study|Adverse Event|0|||
144224915|NCT00777296|520019144|FG003|Overall Study|Adverse Event|1|||
144224916|NCT00777296|520019141|FG000|Overall Study|Withdrawal by Subject|1|||
144224917|NCT00777296|520019142|FG001|Overall Study|Withdrawal by Subject|0|||
144224918|NCT00777296|520019143|FG002|Overall Study|Withdrawal by Subject|0|||
144224919|NCT00777296|520019144|FG003|Overall Study|Withdrawal by Subject|0|||
144224920|NCT00777296|520019141|FG000|Overall Study|CRF form not completed|0|||
144224921|NCT00777296|520019142|FG001|Overall Study|CRF form not completed|0|||
144224922|NCT00777296|520019143|FG002|Overall Study|CRF form not completed|2|||
144224923|NCT00777296|520019144|FG003|Overall Study|CRF form not completed|0|||
144224924|NCT01139125|520019148|FG000|Overall Study|Withdrawal by Subject|1|||
144224925|NCT03751098|520019149|FG000|Overall Study|Withdrawal by Subject|0|||
144224926|NCT03751098|520019150|FG001|Overall Study|Withdrawal by Subject|1|||
144224927|NCT01592786|520019151|FG000|Overall Study|Adverse Event|60|||
144224928|NCT01592786|520019151|FG000|Overall Study|Lack of Efficacy|19|||
144224929|NCT01592786|520019151|FG000|Overall Study|Protocol Violation|14|||
144224930|NCT01592786|520019151|FG000|Overall Study|Withdrawal by Subject|23|||
144224931|NCT01592786|520019151|FG000|Overall Study|Lost to Follow-up|19|||
144224932|NCT01592786|520019151|FG000|Overall Study|Other|3|||
144224933|NCT02172664|520019159|FG000|Overall Study|Lost to Follow-up|4|||
144224934|NCT02172664|520019160|FG001|Overall Study|Lost to Follow-up|4|||
144224935|NCT02172664|520019159|FG000|Overall Study|Death|1|||
144224936|NCT02172664|520019160|FG001|Overall Study|Death|1|||
144224937|NCT02172664|520019159|FG000|Overall Study|Moved out of area|1|||
144224938|NCT02172664|520019160|FG001|Overall Study|Moved out of area|1|||
144224939|NCT01909934|520019161|FG000|Overall Study|Withdrawal by Subject|3|||
144224940|NCT01909934|520019161|FG000|Overall Study|Lost to Follow-up|1|||
144224941|NCT01909934|520019161|FG000|Overall Study|Death|25|||
144224942|NCT01909934|520019161|FG000|Overall Study|Withdrawal of Informed Consent|1|||
144224943|NCT01909934|520019161|FG000|Overall Study|Reason Not Specified|1|||
144224944|NCT03810092|520019162|FG000|Overall Study|no ground support|17|||
144224945|NCT03810092|520019162|FG000|Overall Study|ADL not done at J0|16|||
144224946|NCT03810092|520019162|FG000|Overall Study|No hemoglobin measure at J5|27|||
144224947|NCT03380429|520019166|FG000|Overall Study|Physician Decision|0|||
144224948|NCT03380429|520019167|FG001|Overall Study|Physician Decision|1|||
144224949|NCT03380429|520019168|FG002|Overall Study|Physician Decision|0|||
144224950|NCT03380429|520019169|FG003|Overall Study|Physician Decision|1|||
144224951|NCT03380429|520019170|FG004|Overall Study|Physician Decision|1|||
144224952|NCT03380429|520019166|FG000|Overall Study|Withdrawal by Subject|3|||
144224953|NCT03380429|520019167|FG001|Overall Study|Withdrawal by Subject|3|||
144224954|NCT03380429|520019168|FG002|Overall Study|Withdrawal by Subject|5|||
144224955|NCT03380429|520019169|FG003|Overall Study|Withdrawal by Subject|2|||
144224956|NCT03380429|520019170|FG004|Overall Study|Withdrawal by Subject|1|||
144224957|NCT03380429|520019166|FG000|Overall Study|Lost to Follow-up|0|||
144224958|NCT03380429|520019167|FG001|Overall Study|Lost to Follow-up|2|||
144224959|NCT03380429|520019168|FG002|Overall Study|Lost to Follow-up|4|||
144224960|NCT03380429|520019169|FG003|Overall Study|Lost to Follow-up|3|||
144224961|NCT03380429|520019170|FG004|Overall Study|Lost to Follow-up|1|||
144224962|NCT03380429|520019166|FG000|Overall Study|Protocol Violation|1|||
144224963|NCT03380429|520019167|FG001|Overall Study|Protocol Violation|0|||
144224964|NCT03380429|520019168|FG002|Overall Study|Protocol Violation|1|||
144224965|NCT03380429|520019169|FG003|Overall Study|Protocol Violation|0|||
144224966|NCT03380429|520019170|FG004|Overall Study|Protocol Violation|1|||
144224967|NCT03380429|520019166|FG000|Overall Study|Lack of Efficacy|0|||
144224968|NCT03380429|520019167|FG001|Overall Study|Lack of Efficacy|0|||
144224969|NCT03380429|520019168|FG002|Overall Study|Lack of Efficacy|0|||
144224970|NCT03380429|520019169|FG003|Overall Study|Lack of Efficacy|2|||
144224971|NCT03380429|520019170|FG004|Overall Study|Lack of Efficacy|1|||
144224972|NCT03380429|520019166|FG000|Overall Study|Adverse Event|1|||
144224973|NCT03380429|520019167|FG001|Overall Study|Adverse Event|1|||
144224974|NCT03380429|520019168|FG002|Overall Study|Adverse Event|1|||
144224975|NCT03380429|520019169|FG003|Overall Study|Adverse Event|2|||
144224976|NCT03380429|520019170|FG004|Overall Study|Adverse Event|0|||
144224977|NCT02314026|520019171|FG000|Overall Study|Protocol Violation|28|||
144224978|NCT02949973|520019172|FG000|Overall Study|Physician Decision|1|||
144224979|NCT04760626|520019173|FG000|Overall Study|Withdrawal by Subject|24|||
144224980|NCT04760626|520019174|FG001|Overall Study|Withdrawal by Subject|20|||
144224981|NCT04760626|520019173|FG000|Overall Study|Lost to Follow-up|14|||
144224982|NCT04760626|520019174|FG001|Overall Study|Lost to Follow-up|19|||
144224983|NCT04760626|520019173|FG000|Overall Study|Physician Decision|3|||
144224984|NCT04760626|520019174|FG001|Overall Study|Physician Decision|5|||
144224985|NCT04760626|520019173|FG000|Overall Study|Death|3|||
144224986|NCT04760626|520019174|FG001|Overall Study|Death|6|||
144224987|NCT04760626|520019173|FG000|Overall Study|Site closure|1|||
144224988|NCT04760626|520019174|FG001|Overall Study|Site closure|0|||
144224989|NCT01882985|520019177|FG000|Overall Study|Lost to Follow-up|1|||
144224990|NCT01882985|520019177|FG000|Overall Study|Withdrawal by Subject|1|||
144224991|NCT03193853|520019178|FG000|Overall Study|Death|6|||
144224992|NCT04129125|520019179|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
144224993|NCT04129125|520019179|FG000|Overall Study|Study device was not used|3|||
144224994|NCT01827111|520019182|FG000|Overall Study|Disease Progression|1|||
144224995|NCT02962648|520019183|FG000|Overall Study|Withdrawal by Subject|3|||
144224996|NCT02962648|520019183|FG000|Overall Study|Lost to Follow-up|3|||
144224997|NCT02962648|520019183|FG000|Overall Study|Physician Decision|1|||
144224998|NCT02962648|520019183|FG000|Overall Study|Subject had problems with transportation|2|||
144224999|NCT03267212|520019184|FG000|First Intervention|Lost to Follow-up|0|||
144225000|NCT03267212|520019185|FG001|First Intervention|Lost to Follow-up|2|||
144225001|NCT03267212|520019184|FG000|First Intervention|Withdrawal by Subject|1|||
144225002|NCT03267212|520019185|FG001|First Intervention|Withdrawal by Subject|1|||
144225003|NCT03267212|520019184|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
144225004|NCT03267212|520019185|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
144225005|NCT05303194|520019188|FG000|Overall Study|Lost to Follow-up|1|||
144225006|NCT05303194|520019189|FG001|Overall Study|Lost to Follow-up|1|||
144225007|NCT05303194|520019188|FG000|Overall Study|Withdrawal by Subject|0|||
144225008|NCT05303194|520019189|FG001|Overall Study|Withdrawal by Subject|1|||
144225009|NCT04837196|520019190|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
144225010|NCT04837196|520019191|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
144225011|NCT04837196|520019192|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
144225012|NCT04837196|520019193|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
144225013|NCT04837196|520019194|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
144225014|NCT04837196|520019190|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
144225015|NCT04837196|520019191|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
144225016|NCT04837196|520019192|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
144225017|NCT04837196|520019193|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
144225018|NCT04837196|520019194|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
144225019|NCT04837196|520019190|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
144225020|NCT04837196|520019191|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
144225021|NCT04837196|520019192|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
144225022|NCT04837196|520019193|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
144225023|NCT04837196|520019194|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
144225024|NCT04837196|520019190|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
144225025|NCT04837196|520019191|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
144225026|NCT04837196|520019192|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
144225027|NCT04837196|520019193|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
144225028|NCT04837196|520019194|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
144225029|NCT04837196|520019190|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
144225030|NCT04837196|520019191|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
144225031|NCT04837196|520019192|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
144225032|NCT04837196|520019193|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
144225033|NCT04837196|520019194|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
144225034|NCT00740636|520019201|FG000|Overall Study|Adverse Event|0|||
144225035|NCT00740636|520019202|FG001|Overall Study|Adverse Event|2|||
144225036|NCT00740636|520019201|FG000|Overall Study|Patient Ineligible|0|||
144225037|NCT00740636|520019202|FG001|Overall Study|Patient Ineligible|1|||
144225038|NCT00740636|520019201|FG000|Overall Study|Patient Not Treated|0|||
144225039|NCT00740636|520019202|FG001|Overall Study|Patient Not Treated|1|||
144225040|NCT00740636|520019201|FG000|Overall Study|Progressive Disease|1|||
144268121|NCT03167242|520185165|FG004|Overall Study|Patient/Guardian Decision|1|||
144268122|NCT03167242|520185166|FG005|Overall Study|Patient/Guardian Decision|1|||
144268123|NCT03167242|520185167|FG006|Overall Study|Patient/Guardian Decision|0|||
144268124|NCT03167242|520185168|FG007|Overall Study|Patient/Guardian Decision|0|||
144268125|NCT03167242|520185169|FG008|Overall Study|Patient/Guardian Decision|0|||
144268126|NCT03167242|520185170|FG009|Overall Study|Patient/Guardian Decision|0|||
144268127|NCT03167242|520185171|FG010|Overall Study|Patient/Guardian Decision|1|||
144268128|NCT03167242|520185172|FG011|Overall Study|Patient/Guardian Decision|0|||
144268129|NCT03167242|520185161|FG000|Overall Study|Lost to Follow-up|0|||
144268130|NCT03167242|520185162|FG001|Overall Study|Lost to Follow-up|0|||
144268131|NCT03167242|520185163|FG002|Overall Study|Lost to Follow-up|1|||
144268132|NCT03167242|520185164|FG003|Overall Study|Lost to Follow-up|0|||
144268133|NCT03167242|520185165|FG004|Overall Study|Lost to Follow-up|0|||
144268134|NCT03167242|520185166|FG005|Overall Study|Lost to Follow-up|1|||
144268135|NCT03167242|520185167|FG006|Overall Study|Lost to Follow-up|2|||
144268136|NCT03167242|520185168|FG007|Overall Study|Lost to Follow-up|1|||
144268137|NCT03167242|520185169|FG008|Overall Study|Lost to Follow-up|0|||
144268138|NCT03167242|520185170|FG009|Overall Study|Lost to Follow-up|0|||
144225041|NCT00740636|520019202|FG001|Overall Study|Progressive Disease|0|||
144225042|NCT00740636|520019201|FG000|Overall Study|Death|1|||
144225043|NCT00740636|520019202|FG001|Overall Study|Death|0|||
144225044|NCT02174627|520019204|FG000|Overall Study|Missing|0|||
144225045|NCT02174627|520019205|FG001|Overall Study|Missing|1|||
144225046|NCT02174627|520019204|FG000|Overall Study|Incorrect enrolment before randomization|0|||
144225047|NCT02174627|520019205|FG001|Overall Study|Incorrect enrolment before randomization|1|||
144225048|NCT02174627|520019204|FG000|Overall Study|Participant decision|84|||
144225049|NCT02174627|520019205|FG001|Overall Study|Participant decision|128|||
144225050|NCT04564092|520019206|FG000|Overall Study|Withdrawal by Subject|1|||
144225051|NCT01831635|520019207|FG000|Overall Study|Withdrawal by Subject|0|||
144225052|NCT01831635|520019208|FG001|Overall Study|Withdrawal by Subject|2|||
144225053|NCT01831635|520019209|FG002|Overall Study|Withdrawal by Subject|0|||
144225054|NCT02362360|520019215|FG000|Period 1|Lack of Efficacy|1|||
144225055|NCT02362360|520019216|FG001|Period 1|Lack of Efficacy|0|||
144225056|NCT02362360|520019215|FG000|Period 1|Withdrawal by Subject|2|||
144225057|NCT02362360|520019216|FG001|Period 1|Withdrawal by Subject|1|||
144225058|NCT01880554|520020634|FG000|Overall Study|Protocol Violation|14|||
144225059|NCT01880554|520020634|FG000|Overall Study|Simon's design requirements|2|||
144225060|NCT05734157|520020635|FG000|Overall Study|Death|3|||
144225061|NCT05734157|520020635|FG000|Overall Study|Withdrawal by Subject|2|||
144225062|NCT05734157|520020635|FG000|Overall Study|Lost to Follow-up|1|||
144225063|NCT05734157|520020635|FG000|Overall Study|Telephone call|3|||
144225064|NCT02549859|520020637|FG000|Long-term 60 Hz DBS|Study Closed|1|||
144225065|NCT04067050|520020640|FG000|One Month|Lost to Follow-up|4|||
144225066|NCT04067050|520020641|FG001|One Month|Lost to Follow-up|0|||
144225067|NCT04067050|520020640|FG000|Two Month|Lost to Follow-up|1|||
144225068|NCT04067050|520020641|FG001|Two Month|Lost to Follow-up|0|||
144225069|NCT04067050|520020640|FG000|Two Month|Adverse Event|1|||
144225070|NCT04067050|520020641|FG001|Two Month|Adverse Event|0|||
144225071|NCT03003962|520020644|FG000|Overall Study|Withdrawal by Subject|5|||
144225072|NCT03003962|520020645|FG001|Overall Study|Withdrawal by Subject|17|||
144225073|NCT03003962|520020644|FG000|Overall Study|Death|274|||
144225074|NCT03003962|520020645|FG001|Overall Study|Death|277|||
144225075|NCT03003962|520020644|FG000|Overall Study|Participants ongoing at DCO|55|||
144225076|NCT03003962|520020645|FG001|Overall Study|Participants ongoing at DCO|40|||
144225077|NCT03871543|520020646|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
144225078|NCT03871543|520020646|FG000|Period 1|Investigator Error|1|||
144225079|NCT03871543|520020646|FG000|Period 1|Protocol Violation|2|||
144225080|NCT03871543|520020646|FG000|Period 1|COVID-19 Related|1|||
144225081|NCT03871543|520020646|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
144225082|NCT03871543|520020646|FG000|Period 1|Withdrawal by Subject|10|||
144225083|NCT03871543|520020646|FG000|Period 2|Adverse Event|1|||
144225084|NCT03871543|520020646|FG000|Period 2|Withdrawal by Subject|1|||
144225085|NCT02626026|520020648|FG000|Overall Study|Randomized but Never Treated|0|||
144225086|NCT02626026|520020649|FG001|Overall Study|Randomized but Never Treated|0|||
144225087|NCT02626026|520020650|FG002|Overall Study|Randomized but Never Treated|0|||
144225088|NCT02626026|520020651|FG003|Overall Study|Randomized but Never Treated|0|||
144225089|NCT02626026|520020652|FG004|Overall Study|Randomized but Never Treated|1|||
144225090|NCT02626026|520020653|FG005|Overall Study|Randomized but Never Treated|0|||
144225091|NCT01568892|520020654|FG000|Open-label Phase|Adverse Event|2|||
144225092|NCT01568892|520020655|FG001|Open-label Phase|Adverse Event|0|||
144225093|NCT01568892|520020654|FG000|Open-label Phase|Lack of Efficacy|4|||
144225094|NCT01568892|520020655|FG001|Open-label Phase|Lack of Efficacy|2|||
144225095|NCT01568892|520020654|FG000|Open-label Phase|Lost to Follow-up|0|||
144225096|NCT01568892|520020655|FG001|Open-label Phase|Lost to Follow-up|1|||
144225097|NCT03922308|520020656|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
144225098|NCT03922308|520020657|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
144225099|NCT03922308|520020658|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
144225100|NCT03922308|520020656|FG000|Overall Study|Lost to Follow-up|1|||
144225101|NCT03922308|520020657|FG001|Overall Study|Lost to Follow-up|0|||
144225102|NCT03922308|520020658|FG002|Overall Study|Lost to Follow-up|0|||
144225103|NCT03922308|520020656|FG000|Overall Study|Reason not Specified|0|||
144225104|NCT03922308|520020657|FG001|Overall Study|Reason not Specified|2|||
144225105|NCT03922308|520020658|FG002|Overall Study|Reason not Specified|1|||
144225106|NCT01704495|520020659|FG000|Subjects Randomized|Other Reason|3|||
144225107|NCT01704495|520020660|FG001|Subjects Randomized|Other Reason|2|||
144225108|NCT01704495|520020661|FG002|Subjects Randomized|Other Reason|3|||
144225109|NCT01704495|520020662|FG003|Subjects Randomized|Other Reason|2|||
144225110|NCT01704495|520020659|FG000|Subjects Randomized|Discontinuation criteria met|4|||
144225111|NCT01704495|520020660|FG001|Subjects Randomized|Discontinuation criteria met|2|||
144225112|NCT01704495|520020661|FG002|Subjects Randomized|Discontinuation criteria met|2|||
144225113|NCT01704495|520020662|FG003|Subjects Randomized|Discontinuation criteria met|0|||
144225114|NCT01704495|520020659|FG000|Subjects Randomized|Adverse Event|8|||
144225115|NCT01704495|520020660|FG001|Subjects Randomized|Adverse Event|2|||
144225116|NCT01704495|520020661|FG002|Subjects Randomized|Adverse Event|0|||
144225117|NCT01704495|520020662|FG003|Subjects Randomized|Adverse Event|7|||
144225118|NCT01704495|520020659|FG000|Subjects Randomized|Withdrawal by Subject|5|||
144225119|NCT01704495|520020660|FG001|Subjects Randomized|Withdrawal by Subject|5|||
144225120|NCT01704495|520020661|FG002|Subjects Randomized|Withdrawal by Subject|5|||
144225121|NCT01704495|520020662|FG003|Subjects Randomized|Withdrawal by Subject|5|||
144225122|NCT01704495|520020659|FG000|Subjects Randomized|Protocol Violation|1|||
144225123|NCT01704495|520020660|FG001|Subjects Randomized|Protocol Violation|1|||
144225124|NCT01704495|520020661|FG002|Subjects Randomized|Protocol Violation|2|||
144225125|NCT01704495|520020662|FG003|Subjects Randomized|Protocol Violation|0|||
144268139|NCT03167242|520185171|FG010|Overall Study|Lost to Follow-up|1|||
144268140|NCT03167242|520185172|FG011|Overall Study|Lost to Follow-up|1|||
144268141|NCT03167242|520185161|FG000|Overall Study|Reason not provided|0|||
144268142|NCT03167242|520185162|FG001|Overall Study|Reason not provided|0|||
144268143|NCT03167242|520185163|FG002|Overall Study|Reason not provided|0|||
144268144|NCT03167242|520185164|FG003|Overall Study|Reason not provided|0|||
144268145|NCT03167242|520185165|FG004|Overall Study|Reason not provided|0|||
144268146|NCT03167242|520185166|FG005|Overall Study|Reason not provided|0|||
144268147|NCT03167242|520185167|FG006|Overall Study|Reason not provided|0|||
144268148|NCT03167242|520185168|FG007|Overall Study|Reason not provided|0|||
144268149|NCT03167242|520185169|FG008|Overall Study|Reason not provided|1|||
144268150|NCT03167242|520185170|FG009|Overall Study|Reason not provided|0|||
144268151|NCT03167242|520185171|FG010|Overall Study|Reason not provided|0|||
144268152|NCT03167242|520185172|FG011|Overall Study|Reason not provided|0|||
144268153|NCT05222880|520185178|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
144268154|NCT05222880|520185178|FG000|Overall Study|Withdrew Consent during Study|1|||
144268155|NCT05222880|520185178|FG000|Overall Study|COVID-19 Related|1|||
144268156|NCT05401565|520185179|FG000|Overall Study|Lost to Follow-up|1|||
144268157|NCT05401565|520185180|FG001|Overall Study|Lost to Follow-up|0|||
144268158|NCT05401565|520185179|FG000|Overall Study|Adverse Event|2|||
144268159|NCT05401565|520185180|FG001|Overall Study|Adverse Event|0|||
144268160|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
144268161|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
144268162|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
144268163|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
144268164|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
144268165|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
144268166|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
144268167|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
144268168|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
144268169|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
144268170|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
144268171|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
144268172|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
144268173|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
144268174|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
144268175|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
144268176|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
144268177|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
144268178|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
144268179|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
144268180|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
144268181|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
144268182|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
144268183|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
144268184|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
144268185|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
144268186|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
144268187|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
144268188|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
144268189|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
144268190|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
144268191|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
144268192|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
144268193|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
144268194|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
144268195|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
144268196|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
144268197|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
144268198|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
144268199|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
144268200|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
144268201|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
144268202|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
144268203|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
144268204|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
144268205|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
144268206|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
144268207|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
144225126|NCT01704495|520020659|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
144225127|NCT01704495|520020660|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
144225128|NCT01704495|520020661|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
144225129|NCT01704495|520020662|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
144225130|NCT01704495|520020659|FG000|Optional Safety Extension|Adverse Event|0|||
144225131|NCT01704495|520020660|FG001|Optional Safety Extension|Adverse Event|4|||
144225132|NCT01704495|520020661|FG002|Optional Safety Extension|Adverse Event|0|||
144225133|NCT01704495|520020662|FG003|Optional Safety Extension|Adverse Event|1|||
144225134|NCT01704495|520020659|FG000|Optional Safety Extension|Other reason|27|||
144225135|NCT01704495|520020660|FG001|Optional Safety Extension|Other reason|29|||
144225136|NCT01704495|520020661|FG002|Optional Safety Extension|Other reason|30|||
144225137|NCT01704495|520020662|FG003|Optional Safety Extension|Other reason|28|||
144225138|NCT01704495|520020659|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
144225139|NCT01704495|520020660|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
144225140|NCT01704495|520020661|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
144225141|NCT01704495|520020662|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
144225142|NCT02375971|520020663|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
144225143|NCT02375971|520020664|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
144225144|NCT02375971|520020665|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
144225145|NCT02375971|520020663|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
144225146|NCT02375971|520020664|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
144225147|NCT02375971|520020665|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
144225148|NCT02375971|520020663|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
144225149|NCT02375971|520020664|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
144225150|NCT02375971|520020665|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
144225151|NCT02375971|520020663|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
144225152|NCT02375971|520020664|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
144225153|NCT02375971|520020665|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
144225154|NCT02375971|520020663|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
144225155|NCT02375971|520020664|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
144225156|NCT02375971|520020665|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
144225157|NCT02375971|520020663|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
144225158|NCT02375971|520020664|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
144225159|NCT02375971|520020665|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
144225160|NCT02375971|520020663|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
144225161|NCT02375971|520020664|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
144225162|NCT02375971|520020665|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
144225163|NCT02375971|520020663|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
144225164|NCT02375971|520020664|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
144225165|NCT02375971|520020665|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
144225166|NCT03866512|520020666|FG000|Overall Study|Lost to Follow-up|1|||
144225167|NCT03866512|520020667|FG001|Overall Study|Lost to Follow-up|2|||
144225168|NCT03866512|520020668|FG002|Overall Study|Lost to Follow-up|1|||
144225169|NCT03866512|520020666|FG000|Overall Study|Cannulation issues|0|||
144225170|NCT03866512|520020667|FG001|Overall Study|Cannulation issues|1|||
144225171|NCT03866512|520020668|FG002|Overall Study|Cannulation issues|2|||
144225172|NCT03876743|520020680|FG000|Overall Study|Lost to Follow-up|6|||
144225173|NCT03876743|520020681|FG001|Overall Study|Lost to Follow-up|4|||
144225174|NCT03876743|520020682|FG002|Overall Study|Lost to Follow-up|4|||
144225175|NCT03876743|520020683|FG003|Overall Study|Lost to Follow-up|7|||
144225176|NCT03889418|520020684|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
144225177|NCT03889418|520020685|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225178|NCT03889418|520020686|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225179|NCT03889418|520020687|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225180|NCT03889418|520020688|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225181|NCT03889418|520020689|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225182|NCT03889418|520020690|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225183|NCT03889418|520020691|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225184|NCT03889418|520020692|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225185|NCT03889418|520020693|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
144225186|NCT03889418|520020684|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225187|NCT03889418|520020685|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
144225188|NCT03889418|520020686|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
144225189|NCT03889418|520020687|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225190|NCT03889418|520020688|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225191|NCT03889418|520020689|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225192|NCT03889418|520020690|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225193|NCT03889418|520020691|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225194|NCT03889418|520020692|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144268208|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
144268209|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
144268210|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
144268211|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
144268212|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
144268213|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
144268214|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
144268215|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
144268216|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
144268217|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
144268218|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
144268219|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
144268220|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
144268221|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
144268222|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
144268223|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
144268224|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
144268225|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
144268226|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
144268227|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
144268228|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
144268229|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
144268230|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
144268231|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
144268232|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
144268233|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
144268234|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
144268235|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
144268236|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
144268237|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
144268238|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
144268239|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
144268240|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
144268241|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
144268242|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
144268243|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
144268244|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
144268245|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
144268246|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
144268247|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
144268248|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
144268249|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
144268250|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
144268251|NCT01791595|520185183|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
144268252|NCT01791595|520185184|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
144268253|NCT01791595|520185185|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
144268254|NCT01791595|520185186|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
144268255|NCT01791595|520185187|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
144268256|NCT01791595|520185188|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
144268257|NCT01791595|520185189|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
144268258|NCT01791595|520185183|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
144268259|NCT01791595|520185184|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
144225195|NCT03889418|520020693|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
144225196|NCT03889418|520020684|FG000|October-December 2019 (Month 7-9)|Death|0|||
144268260|NCT01791595|520185185|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
144268261|NCT01791595|520185186|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
144268262|NCT01791595|520185187|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
144268263|NCT01791595|520185188|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
144225197|NCT03889418|520020685|FG001|October-December 2019 (Month 7-9)|Death|0|||
144225198|NCT03889418|520020686|FG002|October-December 2019 (Month 7-9)|Death|0|||
144225199|NCT03889418|520020687|FG003|October-December 2019 (Month 7-9)|Death|0|||
144225200|NCT03889418|520020688|FG004|October-December 2019 (Month 7-9)|Death|0|||
144225201|NCT03889418|520020689|FG005|October-December 2019 (Month 7-9)|Death|0|||
144225202|NCT03889418|520020690|FG006|October-December 2019 (Month 7-9)|Death|0|||
144225203|NCT03889418|520020691|FG007|October-December 2019 (Month 7-9)|Death|0|||
144225204|NCT03889418|520020692|FG008|October-December 2019 (Month 7-9)|Death|1|||
144225205|NCT03889418|520020693|FG009|October-December 2019 (Month 7-9)|Death|0|||
144225206|NCT03889418|520020684|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225207|NCT03889418|520020685|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225208|NCT03889418|520020686|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225209|NCT03889418|520020687|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
144225210|NCT03889418|520020688|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225211|NCT03889418|520020689|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225212|NCT03889418|520020690|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225213|NCT03889418|520020691|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
144225214|NCT03889418|520020692|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225215|NCT03889418|520020693|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
144225216|NCT03889418|520020684|FG000|April - June 2020 (Month 13-15)|Death|0|||
144225217|NCT03889418|520020685|FG001|April - June 2020 (Month 13-15)|Death|1|||
144225218|NCT03889418|520020686|FG002|April - June 2020 (Month 13-15)|Death|0|||
144225219|NCT03889418|520020687|FG003|April - June 2020 (Month 13-15)|Death|0|||
144225220|NCT03889418|520020688|FG004|April - June 2020 (Month 13-15)|Death|0|||
144225221|NCT03889418|520020689|FG005|April - June 2020 (Month 13-15)|Death|0|||
144225222|NCT03889418|520020690|FG006|April - June 2020 (Month 13-15)|Death|0|||
144225223|NCT03889418|520020691|FG007|April - June 2020 (Month 13-15)|Death|0|||
144225224|NCT03889418|520020692|FG008|April - June 2020 (Month 13-15)|Death|0|||
144225225|NCT03889418|520020693|FG009|April - June 2020 (Month 13-15)|Death|0|||
144225226|NCT03889418|520020684|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225227|NCT03889418|520020685|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225228|NCT03889418|520020686|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225229|NCT03889418|520020687|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
144225230|NCT03889418|520020688|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225231|NCT03889418|520020689|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225232|NCT03889418|520020690|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225233|NCT03889418|520020691|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225234|NCT03889418|520020692|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225235|NCT03889418|520020693|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
144225236|NCT03889418|520020684|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
144225237|NCT03889418|520020685|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
144225238|NCT03889418|520020686|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
144225239|NCT03889418|520020687|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
144225240|NCT03889418|520020688|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
144225241|NCT03889418|520020689|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
144225242|NCT03889418|520020690|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
144225243|NCT03889418|520020691|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
144225244|NCT03889418|520020692|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
144225245|NCT03889418|520020693|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
144225246|NCT03889418|520020684|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
144225247|NCT03889418|520020685|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
144225248|NCT03889418|520020686|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
144225249|NCT03889418|520020687|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
144225250|NCT03889418|520020688|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
144225251|NCT03889418|520020689|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
144225252|NCT03889418|520020690|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
144225253|NCT03889418|520020691|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
144225254|NCT03889418|520020692|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
144268264|NCT01791595|520185189|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
144225255|NCT03889418|520020693|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
144225256|NCT00092118|520020695|FG000|Overall Study|Adverse Event|35|||
144225257|NCT00092118|520020696|FG001|Overall Study|Adverse Event|32|||
144225258|NCT00092118|520020695|FG000|Overall Study|Lack of Efficacy|12|||
144225259|NCT00092118|520020696|FG001|Overall Study|Lack of Efficacy|14|||
144225260|NCT00092118|520020695|FG000|Overall Study|Lost to Follow-up|4|||
144225261|NCT00092118|520020696|FG001|Overall Study|Lost to Follow-up|3|||
144225262|NCT00092118|520020695|FG000|Overall Study|Protocol Violation|23|||
144225263|NCT00092118|520020696|FG001|Overall Study|Protocol Violation|25|||
144225264|NCT00092118|520020695|FG000|Overall Study|Withdrawal by Subject|4|||
144225265|NCT00092118|520020696|FG001|Overall Study|Withdrawal by Subject|10|||
144225266|NCT00092118|520020695|FG000|Overall Study|Other|6|||
144225267|NCT00092118|520020696|FG001|Overall Study|Other|5|||
144225268|NCT01139775|520020699|FG000|Overall Study|Adverse Event|0|||
144225269|NCT01139775|520020700|FG001|Overall Study|Adverse Event|6|||
144225270|NCT01139775|520020701|FG002|Overall Study|Adverse Event|2|||
144225271|NCT01139775|520020699|FG000|Overall Study|Protocol Violation|0|||
144225272|NCT01139775|520020700|FG001|Overall Study|Protocol Violation|5|||
144225273|NCT01139775|520020701|FG002|Overall Study|Protocol Violation|0|||
144225274|NCT01139775|520020699|FG000|Overall Study|Withdrawal by Subject|1|||
144225275|NCT01139775|520020700|FG001|Overall Study|Withdrawal by Subject|0|||
144225276|NCT01139775|520020701|FG002|Overall Study|Withdrawal by Subject|2|||
144225277|NCT01139775|520020699|FG000|Overall Study|Physician Decision|0|||
144225278|NCT01139775|520020700|FG001|Overall Study|Physician Decision|2|||
144225279|NCT01139775|520020701|FG002|Overall Study|Physician Decision|2|||
144225280|NCT01924689|520020702|FG000|Overall Study|Death|0|||
144225281|NCT01924689|520020703|FG001|Overall Study|Death|1|||
144225282|NCT01924689|520020704|FG002|Overall Study|Death|0|||
144225283|NCT01924689|520020705|FG003|Overall Study|Death|1|||
144225284|NCT01924689|520020706|FG004|Overall Study|Death|0|||
144225285|NCT01924689|520020707|FG005|Overall Study|Death|0|||
144225286|NCT01924689|520020702|FG000|Overall Study|Disease progression|0|||
144225287|NCT01924689|520020703|FG001|Overall Study|Disease progression|0|||
144225288|NCT01924689|520020704|FG002|Overall Study|Disease progression|2|||
144225289|NCT01924689|520020705|FG003|Overall Study|Disease progression|0|||
144225290|NCT01924689|520020706|FG004|Overall Study|Disease progression|3|||
144225291|NCT01924689|520020707|FG005|Overall Study|Disease progression|2|||
144225292|NCT01924689|520020702|FG000|Overall Study|New therapy or study|3|||
144225293|NCT01924689|520020703|FG001|Overall Study|New therapy or study|2|||
144225294|NCT01924689|520020704|FG002|Overall Study|New therapy or study|1|||
144225295|NCT01924689|520020705|FG003|Overall Study|New therapy or study|4|||
144225296|NCT01924689|520020706|FG004|Overall Study|New therapy or study|2|||
144225297|NCT01924689|520020707|FG005|Overall Study|New therapy or study|0|||
144225298|NCT01924689|520020702|FG000|Overall Study|Withdrawal of consent|0|||
144225299|NCT01924689|520020703|FG001|Overall Study|Withdrawal of consent|0|||
144225300|NCT01924689|520020704|FG002|Overall Study|Withdrawal of consent|1|||
144225301|NCT01924689|520020705|FG003|Overall Study|Withdrawal of consent|1|||
144225302|NCT01924689|520020706|FG004|Overall Study|Withdrawal of consent|0|||
144225303|NCT01924689|520020707|FG005|Overall Study|Withdrawal of consent|0|||
144225304|NCT01924689|520020702|FG000|Overall Study|Other|0|||
144225305|NCT01924689|520020703|FG001|Overall Study|Other|0|||
144225306|NCT01924689|520020704|FG002|Overall Study|Other|0|||
144225307|NCT01924689|520020705|FG003|Overall Study|Other|0|||
144225308|NCT01924689|520020706|FG004|Overall Study|Other|1|||
144225309|NCT01924689|520020707|FG005|Overall Study|Other|0|||
144225310|NCT01289678|520020708|FG000|Overall Study|Physician Decision|6|||
144268265|NCT01791595|520185183|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
144225311|NCT01597973|520020709|FG000|Overall Study|Found ineligible before study medication started|4|||
144268266|NCT01791595|520185184|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
144225312|NCT01597973|520020710|FG001|Overall Study|Found ineligible before study medication started|2|||
144225313|NCT01597973|520020709|FG000|Overall Study|Eligible pathogen not confirmed|14|||
144225314|NCT01597973|520020710|FG001|Overall Study|Eligible pathogen not confirmed|15|||
144225315|NCT01597973|520020709|FG000|Overall Study|LAR not authorized to consent|0|||
144225316|NCT01597973|520020710|FG001|Overall Study|LAR not authorized to consent|1|||
144225317|NCT01597973|520020709|FG000|Overall Study|Ineligible due to early seizures|1|||
144225318|NCT01597973|520020710|FG001|Overall Study|Ineligible due to early seizures|0|||
144225319|NCT01597973|520020709|FG000|Overall Study|Ineligible due to non-target infection|1|||
144225320|NCT01597973|520020710|FG001|Overall Study|Ineligible due to non-target infection|1|||
144225321|NCT02723344|520020711|FG000|Overall Study|Lost to Follow-up|0|||
144225322|NCT02723344|520020712|FG001|Overall Study|Lost to Follow-up|4|||
144225323|NCT00908544|520020713|FG000|Overall Study|Withdrawal by Subject|2|||
144225324|NCT00908544|520020714|FG001|Overall Study|Withdrawal by Subject|4|||
144268267|NCT01791595|520185185|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
144268268|NCT01791595|520185186|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
144268269|NCT01791595|520185187|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
144268270|NCT01791595|520185188|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
144268271|NCT01791595|520185189|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
144268272|NCT01791595|520185183|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
144268273|NCT01791595|520185184|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
144268274|NCT01791595|520185185|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
144268275|NCT01791595|520185186|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
144268276|NCT01791595|520185187|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
144268277|NCT01791595|520185188|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
144268278|NCT01791595|520185189|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
144268279|NCT01791595|520185183|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
144268280|NCT01791595|520185184|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
144268281|NCT01791595|520185185|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
144268282|NCT01791595|520185186|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
144268283|NCT01791595|520185187|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
144268284|NCT01791595|520185188|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
144268285|NCT01791595|520185189|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
144268286|NCT03118934|520185190|FG000|Overall Study|Adverse Event|0|||
144268287|NCT03118934|520185191|FG001|Overall Study|Adverse Event|0|||
144268288|NCT03118934|520185192|FG002|Overall Study|Adverse Event|0|||
144268289|NCT03118934|520185193|FG003|Overall Study|Adverse Event|0|||
144268290|NCT03118934|520185194|FG004|Overall Study|Adverse Event|0|||
144268291|NCT03118934|520185195|FG005|Overall Study|Adverse Event|1|||
144268292|NCT03118934|520185190|FG000|Overall Study|Physician Decision|0|||
144268293|NCT03118934|520185191|FG001|Overall Study|Physician Decision|0|||
144268294|NCT03118934|520185192|FG002|Overall Study|Physician Decision|0|||
144268295|NCT03118934|520185193|FG003|Overall Study|Physician Decision|0|||
144268296|NCT03118934|520185194|FG004|Overall Study|Physician Decision|0|||
144268297|NCT03118934|520185195|FG005|Overall Study|Physician Decision|1|||
144268298|NCT03118934|520185190|FG000|Overall Study|Discontinued prior to exposure|0|||
144268299|NCT03118934|520185191|FG001|Overall Study|Discontinued prior to exposure|1|||
144268300|NCT03118934|520185192|FG002|Overall Study|Discontinued prior to exposure|1|||
144268301|NCT03118934|520185193|FG003|Overall Study|Discontinued prior to exposure|1|||
144268302|NCT03118934|520185194|FG004|Overall Study|Discontinued prior to exposure|2|||
144268303|NCT03118934|520185195|FG005|Overall Study|Discontinued prior to exposure|0|||
144268304|NCT03080935|520185196|FG000|Overall Study|Death|34|||
144268305|NCT03080935|520185197|FG001|Overall Study|Death|50|||
144268306|NCT03080935|520185196|FG000|Overall Study|Lost to Follow-up|5|||
144268307|NCT03080935|520185197|FG001|Overall Study|Lost to Follow-up|4|||
144268308|NCT03080935|520185196|FG000|Overall Study|Withdrawal by Subject|11|||
144268309|NCT03080935|520185197|FG001|Overall Study|Withdrawal by Subject|15|||
144268310|NCT02175121|520185198|FG000|Overall Study|Lack of Efficacy|1|||
144268311|NCT02175121|520185199|FG001|Overall Study|Lack of Efficacy|0|||
144268312|NCT02175121|520185200|FG002|Overall Study|Lack of Efficacy|0|||
144268313|NCT02175121|520185201|FG003|Overall Study|Lack of Efficacy|0|||
144268314|NCT02175121|520185202|FG004|Overall Study|Lack of Efficacy|0|||
144268315|NCT02175121|520185198|FG000|Overall Study|Lost to Follow-up|0|||
144268316|NCT02175121|520185199|FG001|Overall Study|Lost to Follow-up|1|||
144268317|NCT02175121|520185200|FG002|Overall Study|Lost to Follow-up|0|||
144268318|NCT02175121|520185201|FG003|Overall Study|Lost to Follow-up|1|||
144268319|NCT02175121|520185202|FG004|Overall Study|Lost to Follow-up|0|||
144268320|NCT02175121|520185198|FG000|Overall Study|Personal emergency|0|||
144268321|NCT02175121|520185199|FG001|Overall Study|Personal emergency|0|||
144268322|NCT02175121|520185200|FG002|Overall Study|Personal emergency|0|||
144268323|NCT02175121|520185201|FG003|Overall Study|Personal emergency|0|||
144268324|NCT02175121|520185202|FG004|Overall Study|Personal emergency|1|||
144268325|NCT02175121|520185198|FG000|Overall Study|Schedule conflict|0|||
144268326|NCT02175121|520185199|FG001|Overall Study|Schedule conflict|0|||
144268327|NCT02175121|520185200|FG002|Overall Study|Schedule conflict|1|||
144268328|NCT02175121|520185201|FG003|Overall Study|Schedule conflict|0|||
144268329|NCT02175121|520185202|FG004|Overall Study|Schedule conflict|0|||
144268330|NCT02175121|520185198|FG000|Overall Study|Time issues|0|||
144268331|NCT02175121|520185199|FG001|Overall Study|Time issues|0|||
144268332|NCT02175121|520185200|FG002|Overall Study|Time issues|1|||
144268333|NCT02175121|520185201|FG003|Overall Study|Time issues|0|||
144268334|NCT02175121|520185202|FG004|Overall Study|Time issues|0|||
144268335|NCT02027025|520185207|FG000|Overall Study|Adverse Event|0|||
144268336|NCT02027025|520185208|FG001|Overall Study|Adverse Event|1|||
144268337|NCT02027025|520185209|FG002|Overall Study|Adverse Event|1|||
144268338|NCT02027025|520185207|FG000|Overall Study|Protocol Violation|1|||
144268339|NCT02027025|520185208|FG001|Overall Study|Protocol Violation|0|||
144268340|NCT02027025|520185209|FG002|Overall Study|Protocol Violation|0|||
144268341|NCT02027025|520185207|FG000|Overall Study|Lost to Follow-up|0|||
144268342|NCT02027025|520185208|FG001|Overall Study|Lost to Follow-up|2|||
144268343|NCT02027025|520185209|FG002|Overall Study|Lost to Follow-up|0|||
144268344|NCT02027025|520185207|FG000|Overall Study|Withdrawal by Subject|0|||
144268345|NCT02027025|520185208|FG001|Overall Study|Withdrawal by Subject|1|||
144268346|NCT02027025|520185209|FG002|Overall Study|Withdrawal by Subject|0|||
144268347|NCT02027025|520185207|FG000|Overall Study|Sponsor's decision|0|||
144268348|NCT02027025|520185208|FG001|Overall Study|Sponsor's decision|1|||
144268349|NCT02027025|520185209|FG002|Overall Study|Sponsor's decision|0|||
144268350|NCT03886272|520185212|FG000|Period 1|Withdrawal by Subject|0|||
144268351|NCT03886272|520185213|FG001|Period 1|Withdrawal by Subject|0|||
144268352|NCT03886272|520185214|FG002|Period 1|Withdrawal by Subject|0|||
144268353|NCT03886272|520185215|FG003|Period 1|Withdrawal by Subject|0|||
144268354|NCT03886272|520185216|FG004|Period 1|Withdrawal by Subject|0|||
144268355|NCT03886272|520185217|FG005|Period 1|Withdrawal by Subject|1|||
144268356|NCT03886272|520185218|FG006|Period 1|Withdrawal by Subject|0|||
144268357|NCT02895347|520185221|FG000|Overall Study|Withdrawal by Subject|3|||
144268358|NCT02895347|520185222|FG001|Overall Study|Withdrawal by Subject|1|||
144268359|NCT00402727|520185226|FG000|Overall Study|Adverse Event|10|||
144268360|NCT00402727|520185227|FG001|Overall Study|Adverse Event|6|||
144268361|NCT00402727|520185226|FG000|Overall Study|Death|1|||
144268362|NCT00402727|520185227|FG001|Overall Study|Death|0|||
144268363|NCT00402727|520185226|FG000|Overall Study|Lack of Efficacy|1|||
144268364|NCT00402727|520185227|FG001|Overall Study|Lack of Efficacy|3|||
144268365|NCT00402727|520185226|FG000|Overall Study|Lost to Follow-up|24|||
144268366|NCT00402727|520185227|FG001|Overall Study|Lost to Follow-up|11|||
144268367|NCT00402727|520185226|FG000|Overall Study|Physician Decision|1|||
144268368|NCT00402727|520185227|FG001|Overall Study|Physician Decision|1|||
144268369|NCT00402727|520185226|FG000|Overall Study|Protocol Violation|0|||
144268370|NCT00402727|520185227|FG001|Overall Study|Protocol Violation|4|||
144268371|NCT00402727|520185226|FG000|Overall Study|Withdrawal by Subject|3|||
144268372|NCT00402727|520185227|FG001|Overall Study|Withdrawal by Subject|7|||
144268373|NCT00402727|520185226|FG000|Overall Study|supply problems|2|||
144268374|NCT00402727|520185227|FG001|Overall Study|supply problems|1|||
144268375|NCT00402727|520185226|FG000|Overall Study|non-compliance|0|||
144268376|NCT00402727|520185227|FG001|Overall Study|non-compliance|1|||
144268377|NCT03139552|520185239|FG000|Overall Study|unable to attend tasting due to schedule|3|||
144268378|NCT00264147|520185257|FG000|Treatment I Period|Adverse Event|3|||
144268379|NCT00264147|520185258|FG001|Treatment I Period|Adverse Event|6|||
144268380|NCT00264147|520185259|FG002|Treatment I Period|Adverse Event|3|||
144268381|NCT00264147|520185260|FG003|Treatment I Period|Adverse Event|5|||
144268382|NCT00264147|520185261|FG004|Treatment I Period|Adverse Event|7|||
144268383|NCT00264147|520185262|FG005|Treatment I Period|Adverse Event|0|||
144268384|NCT00264147|520185257|FG000|Treatment I Period|Laboratory Adverse Event|0|||
144268385|NCT00264147|520185258|FG001|Treatment I Period|Laboratory Adverse Event|0|||
144268386|NCT00264147|520185259|FG002|Treatment I Period|Laboratory Adverse Event|0|||
144268387|NCT00264147|520185260|FG003|Treatment I Period|Laboratory Adverse Event|1|||
144268388|NCT00264147|520185261|FG004|Treatment I Period|Laboratory Adverse Event|0|||
144268389|NCT00264147|520185262|FG005|Treatment I Period|Laboratory Adverse Event|0|||
144268390|NCT00264147|520185257|FG000|Treatment I Period|Lack of Efficacy|6|||
144268391|NCT00264147|520185258|FG001|Treatment I Period|Lack of Efficacy|2|||
144268392|NCT00264147|520185259|FG002|Treatment I Period|Lack of Efficacy|8|||
144268393|NCT00264147|520185260|FG003|Treatment I Period|Lack of Efficacy|0|||
144268394|NCT00264147|520185261|FG004|Treatment I Period|Lack of Efficacy|1|||
144268395|NCT00264147|520185262|FG005|Treatment I Period|Lack of Efficacy|0|||
144268396|NCT00264147|520185257|FG000|Treatment I Period|Lost to Follow-up|1|||
144268397|NCT00264147|520185258|FG001|Treatment I Period|Lost to Follow-up|0|||
144268398|NCT00264147|520185259|FG002|Treatment I Period|Lost to Follow-up|0|||
144268399|NCT00264147|520185260|FG003|Treatment I Period|Lost to Follow-up|1|||
144268400|NCT00264147|520185261|FG004|Treatment I Period|Lost to Follow-up|1|||
144268401|NCT00264147|520185262|FG005|Treatment I Period|Lost to Follow-up|0|||
144268402|NCT00264147|520185257|FG000|Treatment I Period|Protocol Violation|2|||
144268403|NCT00264147|520185258|FG001|Treatment I Period|Protocol Violation|2|||
144268404|NCT00264147|520185259|FG002|Treatment I Period|Protocol Violation|0|||
144268405|NCT00264147|520185260|FG003|Treatment I Period|Protocol Violation|0|||
144268406|NCT00264147|520185261|FG004|Treatment I Period|Protocol Violation|0|||
144268407|NCT00264147|520185262|FG005|Treatment I Period|Protocol Violation|0|||
144268408|NCT00264147|520185257|FG000|Treatment I Period|Withdrawal by Subject|2|||
144268409|NCT00264147|520185258|FG001|Treatment I Period|Withdrawal by Subject|0|||
144268410|NCT00264147|520185259|FG002|Treatment I Period|Withdrawal by Subject|0|||
144268411|NCT00264147|520185260|FG003|Treatment I Period|Withdrawal by Subject|2|||
144268412|NCT00264147|520185261|FG004|Treatment I Period|Withdrawal by Subject|2|||
144268413|NCT00264147|520185262|FG005|Treatment I Period|Withdrawal by Subject|0|||
144268414|NCT00264147|520185257|FG000|Treatment I Period|Patient out of town for an extended time|0|||
144268415|NCT00264147|520185258|FG001|Treatment I Period|Patient out of town for an extended time|1|||
144268416|NCT00264147|520185259|FG002|Treatment I Period|Patient out of town for an extended time|0|||
144268417|NCT00264147|520185260|FG003|Treatment I Period|Patient out of town for an extended time|0|||
144268418|NCT00264147|520185261|FG004|Treatment I Period|Patient out of town for an extended time|0|||
144268419|NCT00264147|520185262|FG005|Treatment I Period|Patient out of town for an extended time|0|||
144268420|NCT00264147|520185257|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
144268421|NCT00264147|520185258|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
144268422|NCT00264147|520185259|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
144268423|NCT00264147|520185260|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
144268424|NCT00264147|520185261|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
144268425|NCT00264147|520185262|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
144268426|NCT00264147|520185257|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
144268427|NCT00264147|520185258|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
144268428|NCT00264147|520185259|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
144268429|NCT00264147|520185260|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
144268430|NCT00264147|520185261|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
144268431|NCT00264147|520185262|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
144268432|NCT00264147|520185257|FG000|Treatment II Period|Adverse Event|0|||
144268433|NCT00264147|520185258|FG001|Treatment II Period|Adverse Event|0|||
144268434|NCT00264147|520185259|FG002|Treatment II Period|Adverse Event|0|||
144268435|NCT00264147|520185260|FG003|Treatment II Period|Adverse Event|0|||
144268436|NCT00264147|520185261|FG004|Treatment II Period|Adverse Event|9|||
144268437|NCT00264147|520185262|FG005|Treatment II Period|Adverse Event|9|||
144268438|NCT00264147|520185257|FG000|Treatment II Period|Laboratory Adverse Event|0|||
144268439|NCT00264147|520185258|FG001|Treatment II Period|Laboratory Adverse Event|0|||
144268440|NCT00264147|520185259|FG002|Treatment II Period|Laboratory Adverse Event|0|||
144268441|NCT00264147|520185260|FG003|Treatment II Period|Laboratory Adverse Event|0|||
144268442|NCT00264147|520185261|FG004|Treatment II Period|Laboratory Adverse Event|0|||
144268443|NCT00264147|520185262|FG005|Treatment II Period|Laboratory Adverse Event|1|||
144268444|NCT00264147|520185257|FG000|Treatment II Period|Lack of Efficacy|0|||
144268445|NCT00264147|520185258|FG001|Treatment II Period|Lack of Efficacy|0|||
144268446|NCT00264147|520185259|FG002|Treatment II Period|Lack of Efficacy|0|||
144268447|NCT00264147|520185260|FG003|Treatment II Period|Lack of Efficacy|0|||
144268448|NCT00264147|520185261|FG004|Treatment II Period|Lack of Efficacy|20|||
144268449|NCT00264147|520185262|FG005|Treatment II Period|Lack of Efficacy|19|||
144268450|NCT00264147|520185257|FG000|Treatment II Period|Lost to Follow-up|0|||
144268451|NCT00264147|520185258|FG001|Treatment II Period|Lost to Follow-up|0|||
144268452|NCT00264147|520185259|FG002|Treatment II Period|Lost to Follow-up|0|||
144268453|NCT00264147|520185260|FG003|Treatment II Period|Lost to Follow-up|0|||
144268454|NCT00264147|520185261|FG004|Treatment II Period|Lost to Follow-up|1|||
144225325|NCT00908544|520020713|FG000|Overall Study|Lack of Efficacy|0|||
144225326|NCT00908544|520020714|FG001|Overall Study|Lack of Efficacy|1|||
144225327|NCT00908544|520020713|FG000|Overall Study|Pregnancy|1|||
144225328|NCT00908544|520020714|FG001|Overall Study|Pregnancy|0|||
144225329|NCT00908544|520020713|FG000|Overall Study|Relocation abroad|1|||
144225330|NCT00908544|520020714|FG001|Overall Study|Relocation abroad|1|||
144225331|NCT00908544|520020713|FG000|Overall Study|Unable to visit sutdy center|1|||
144225332|NCT00908544|520020714|FG001|Overall Study|Unable to visit sutdy center|0|||
144225333|NCT04762160|520020715|FG000|Overall Study|Study terminated early due to business reasons|5|||
144225334|NCT01591096|520020717|FG000|Overall Study|Adverse Event|1|||
144225335|NCT04146012|520020720|FG000|Overall Study|Study Terminated|30|||
144225336|NCT04146012|520020721|FG001|Overall Study|Study Terminated|15|||
144225337|NCT01546025|520020722|FG000|Overall Study|Lost to Follow-up|0|||
144225338|NCT01546025|520020723|FG001|Overall Study|Lost to Follow-up|1|||
144225339|NCT02729025|520020724|FG000|Overall Study|Sponsor Decision|0|||
144225340|NCT02729025|520020725|FG001|Overall Study|Sponsor Decision|1|||
144225341|NCT05142722|520021848|FG000|Overall Study|Lost to Follow-up|16|||
144225342|NCT05142722|520021849|FG001|Overall Study|Lost to Follow-up|38|||
144225343|NCT05142722|520021848|FG000|Overall Study|Withdrawal by Subject|20|||
144268455|NCT00264147|520185262|FG005|Treatment II Period|Lost to Follow-up|1|||
144268456|NCT00264147|520185257|FG000|Treatment II Period|Withdrawal by Subject|0|||
144268457|NCT00264147|520185258|FG001|Treatment II Period|Withdrawal by Subject|0|||
144268458|NCT00264147|520185259|FG002|Treatment II Period|Withdrawal by Subject|0|||
144268459|NCT00264147|520185260|FG003|Treatment II Period|Withdrawal by Subject|0|||
144268460|NCT00264147|520185261|FG004|Treatment II Period|Withdrawal by Subject|3|||
144268461|NCT00264147|520185262|FG005|Treatment II Period|Withdrawal by Subject|2|||
144268462|NCT00264147|520185257|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
144268463|NCT00264147|520185258|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
144268464|NCT00264147|520185259|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
144268465|NCT00264147|520185260|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
144268466|NCT00264147|520185261|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
144268467|NCT00264147|520185262|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
144268468|NCT01316224|520185263|FG000|Overall Study|Protocol Violation|3|||
144268469|NCT01316224|520185263|FG000|Overall Study|Adverse Event|3|||
144268470|NCT01316224|520185263|FG000|Overall Study|Lack of Efficacy|1|||
144268471|NCT01316224|520185263|FG000|Overall Study|Withdrawal by Subject|1|||
144268472|NCT01316224|520185263|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
144268473|NCT01316224|520185263|FG000|Overall Study|Other|1|||
144268474|NCT00449163|520185264|FG000|Overall Study|Physician Decision|3|||
144268475|NCT02949947|520185274|FG000|Overall Study|Non Compliance|0|||
144268476|NCT02949947|520185275|FG001|Overall Study|Non Compliance|1|||
144268477|NCT02949947|520185274|FG000|Overall Study|Insurance change|1|||
144268478|NCT02949947|520185275|FG001|Overall Study|Insurance change|0|||
144268479|NCT02230891|520185279|FG000|Baseline|Did not meet inclusion|0|||
144268480|NCT02230891|520185280|FG001|Baseline|Did not meet inclusion|1|||
144268481|NCT02230891|520185281|FG002|Baseline|Did not meet inclusion|1|||
144268482|NCT02230891|520185279|FG000|2 Week|Withdrawal by Subject|2|||
144268483|NCT02230891|520185280|FG001|2 Week|Withdrawal by Subject|2|||
144268484|NCT02230891|520185281|FG002|2 Week|Withdrawal by Subject|0|||
144268485|NCT02230891|520185279|FG000|2 Week|Consent withdrawn|1|||
144268486|NCT02230891|520185280|FG001|2 Week|Consent withdrawn|0|||
144268487|NCT02230891|520185281|FG002|2 Week|Consent withdrawn|0|||
144268488|NCT02230891|520185279|FG000|6 Month|Withdrawal by Subject|1|||
144268489|NCT02230891|520185280|FG001|6 Month|Withdrawal by Subject|1|||
144268490|NCT02230891|520185281|FG002|6 Month|Withdrawal by Subject|1|||
144268491|NCT02230891|520185279|FG000|6 Month|Physician Decision|0|||
144268492|NCT02230891|520185280|FG001|6 Month|Physician Decision|2|||
144268493|NCT02230891|520185281|FG002|6 Month|Physician Decision|0|||
144268494|NCT02230891|520185279|FG000|12 Month|Death|1|||
144268495|NCT02230891|520185280|FG001|12 Month|Death|0|||
144268496|NCT02230891|520185281|FG002|12 Month|Death|0|||
144268497|NCT02230891|520185279|FG000|12 Month|Lost to Follow-up|0|||
144268498|NCT02230891|520185280|FG001|12 Month|Lost to Follow-up|1|||
144268499|NCT02230891|520185281|FG002|12 Month|Lost to Follow-up|0|||
144268500|NCT02230891|520185279|FG000|12 Month|Withdrawal by Subject|0|||
144268501|NCT02230891|520185280|FG001|12 Month|Withdrawal by Subject|2|||
144268502|NCT02230891|520185281|FG002|12 Month|Withdrawal by Subject|0|||
144268503|NCT02230891|520185279|FG000|18 Month End of Study|Death|0|||
144268504|NCT02230891|520185280|FG001|18 Month End of Study|Death|0|||
144268505|NCT02230891|520185281|FG002|18 Month End of Study|Death|1|||
144268506|NCT02230891|520185279|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
144268507|NCT02230891|520185280|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
144268508|NCT02230891|520185281|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
144268509|NCT04158219|520185282|FG000|Overall Study|Lost to Follow-up|1|||
144268510|NCT01814007|520185283|FG000|Overall Study|Withdrawal by Subject|1|||
144268511|NCT02997163|520187673|FG000|Overall Study|Adverse Event|1|||
144268512|NCT02997163|520187674|FG001|Overall Study|Adverse Event|0|||
144268513|NCT02997163|520187675|FG002|Overall Study|Adverse Event|0|||
144268514|NCT02997163|520187676|FG003|Overall Study|Adverse Event|1|||
144268515|NCT02337764|520187677|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
144268516|NCT02337764|520187677|FG000|Overall Study|Voluntary Withdrawal|12|||
144268517|NCT02337764|520187677|FG000|Overall Study|Lack of Efficacy|2|||
144268518|NCT03630393|520187689|FG000|Overall Study|Death|1|||
144268519|NCT03630393|520187690|FG001|Overall Study|Death|0|||
144268520|NCT00408499|520187691|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
144268521|NCT00408499|520187692|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
144225344|NCT05142722|520021849|FG001|Overall Study|Withdrawal by Subject|27|||
144225345|NCT05142722|520021848|FG000|Overall Study|Death|11|||
144225346|NCT05142722|520021849|FG001|Overall Study|Death|17|||
144225347|NCT05142722|520021848|FG000|Overall Study|Physician Decision|0|||
144225348|NCT05142722|520021849|FG001|Overall Study|Physician Decision|1|||
144225349|NCT05142722|520021848|FG000|Overall Study|Participant Moved Away|0|||
144225350|NCT05142722|520021849|FG001|Overall Study|Participant Moved Away|2|||
144225351|NCT05142722|520021848|FG000|Overall Study|Adverse Event|2|||
144225352|NCT05142722|520021849|FG001|Overall Study|Adverse Event|1|||
144225353|NCT02141438|520021850|FG000|Overall Study|Death|1308|||
144225354|NCT02141438|520021850|FG000|Overall Study|Lost to Follow-up|84|||
144225355|NCT02141438|520021850|FG000|Overall Study|Withdrawal by Subject|52|||
144225356|NCT02141438|520021850|FG000|Overall Study|Physician Decision|1|||
144225357|NCT02141438|520021850|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
144225358|NCT05573464|520021853|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
144225359|NCT05573464|520021854|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
144225360|NCT05573464|520021853|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
144225361|NCT05573464|520021854|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
144225362|NCT05573464|520021853|FG000|12-week Treatment Period|Protocol Violation|3|||
144225363|NCT05573464|520021854|FG001|12-week Treatment Period|Protocol Violation|1|||
144225364|NCT05573464|520021853|FG000|12-week Treatment Period|Physician Decision|1|||
144225365|NCT05573464|520021854|FG001|12-week Treatment Period|Physician Decision|2|||
144225366|NCT05573464|520021853|FG000|12-week Treatment Period|Lost to Follow-up|2|||
144225367|NCT05573464|520021854|FG001|12-week Treatment Period|Lost to Follow-up|0|||
144225368|NCT05573464|520021853|FG000|12-week Treatment Period|Adverse Event|20|||
144225369|NCT05573464|520021854|FG001|12-week Treatment Period|Adverse Event|9|||
144225370|NCT05573464|520021853|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
144225371|NCT05573464|520021854|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
144225372|NCT05573464|520021853|FG000|12-week Treatment Period|Randomised, not treated|0|||
144225373|NCT05573464|520021854|FG001|12-week Treatment Period|Randomised, not treated|1|||
144225374|NCT05573464|520021853|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
144225375|NCT05573464|520021854|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
144225376|NCT05573464|520021853|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
144225377|NCT05573464|520021854|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
144225378|NCT05573464|520021853|FG000|52-week Treatment Period|Protocol Violation|1|||
144225379|NCT05573464|520021854|FG001|52-week Treatment Period|Protocol Violation|1|||
144225380|NCT05573464|520021853|FG000|52-week Treatment Period|Physician Decision|2|||
144225381|NCT05573464|520021854|FG001|52-week Treatment Period|Physician Decision|2|||
144225382|NCT05573464|520021853|FG000|52-week Treatment Period|Lost to Follow-up|1|||
144225383|NCT05573464|520021854|FG001|52-week Treatment Period|Lost to Follow-up|1|||
144225384|NCT05573464|520021853|FG000|52-week Treatment Period|Adverse Event|11|||
144225385|NCT05573464|520021854|FG001|52-week Treatment Period|Adverse Event|8|||
144225386|NCT05573464|520021853|FG000|52-week Treatment Period|Death|1|||
144225387|NCT05573464|520021854|FG001|52-week Treatment Period|Death|1|||
144225388|NCT04632927|520021855|FG000|Overall Study|Adverse Event|0|||
144225389|NCT04632927|520021856|FG001|Overall Study|Adverse Event|1|||
144225390|NCT04632927|520021855|FG000|Overall Study|Lack of Efficacy|0|||
144225391|NCT04632927|520021856|FG001|Overall Study|Lack of Efficacy|4|||
144225392|NCT04632927|520021855|FG000|Overall Study|Loss of efficacy|0|||
144225393|NCT04632927|520021856|FG001|Overall Study|Loss of efficacy|1|||
144225394|NCT04632927|520021855|FG000|Overall Study|Non-compliance with study drug|0|||
144225395|NCT04632927|520021856|FG001|Overall Study|Non-compliance with study drug|1|||
144225396|NCT04632927|520021855|FG000|Overall Study|Physician Decision|0|||
144225397|NCT04632927|520021856|FG001|Overall Study|Physician Decision|1|||
144225398|NCT04632927|520021855|FG000|Overall Study|Subject decision|0|||
144225399|NCT04632927|520021856|FG001|Overall Study|Subject decision|1|||
144225400|NCT04632927|520021855|FG000|Overall Study|Withdrawal by Subject|0|||
144225401|NCT04632927|520021856|FG001|Overall Study|Withdrawal by Subject|1|||
144225402|NCT03313180|520021857|FG000|Overall Study|Adverse Event|120|||
144225403|NCT03313180|520021857|FG000|Overall Study|Lost to Follow-up|3|||
144225404|NCT03313180|520021857|FG000|Overall Study|Withdrawal by Subject|39|||
144225405|NCT03313180|520021857|FG000|Overall Study|Other than listed above|15|||
144225406|NCT03313180|520021857|FG000|Overall Study|Covid-19 related|2|||
144225407|NCT01697748|520021859|FG000|Overall Study|ineligible skin incision|1|||
144225408|NCT01697748|520021860|FG001|Overall Study|ineligible skin incision|2|||
144225409|NCT01697748|520021859|FG000|Overall Study|ineligible uterine incision|4|||
144225410|NCT01697748|520021860|FG001|Overall Study|ineligible uterine incision|1|||
144225411|NCT01697748|520021859|FG000|Overall Study|Lost to Follow-up|53|||
144225412|NCT01697748|520021860|FG001|Overall Study|Lost to Follow-up|65|||
144225413|NCT01256450|520021861|FG000|Open-label Titration|Adverse Event|39|||
144225414|NCT01256450|520021862|FG001|Open-label Titration|Adverse Event|0|||
144225415|NCT01256450|520021863|FG002|Open-label Titration|Adverse Event|0|||
144225416|NCT01256450|520021861|FG000|Open-label Titration|Lost to Follow-up|7|||
144225417|NCT01256450|520021862|FG001|Open-label Titration|Lost to Follow-up|0|||
144225418|NCT01256450|520021863|FG002|Open-label Titration|Lost to Follow-up|0|||
144225419|NCT01256450|520021861|FG000|Open-label Titration|Lack of analgesic effect|30|||
144225420|NCT01256450|520021862|FG001|Open-label Titration|Lack of analgesic effect|0|||
144225421|NCT01256450|520021863|FG002|Open-label Titration|Lack of analgesic effect|0|||
144225422|NCT01256450|520021861|FG000|Open-label Titration|Non-compliance|9|||
144225423|NCT01256450|520021862|FG001|Open-label Titration|Non-compliance|0|||
144225424|NCT01256450|520021863|FG002|Open-label Titration|Non-compliance|0|||
144225425|NCT01256450|520021861|FG000|Open-label Titration|Screen failure|1|||
144225426|NCT01256450|520021862|FG001|Open-label Titration|Screen failure|0|||
144225427|NCT01256450|520021863|FG002|Open-label Titration|Screen failure|0|||
144225428|NCT01256450|520021861|FG000|Open-label Titration|Other|13|||
144225429|NCT01256450|520021862|FG001|Open-label Titration|Other|0|||
144225430|NCT01256450|520021863|FG002|Open-label Titration|Other|0|||
144225431|NCT01256450|520021861|FG000|Double-blind Treatment|Adverse Event|0|||
144225432|NCT01256450|520021862|FG001|Double-blind Treatment|Adverse Event|8|||
144225433|NCT01256450|520021863|FG002|Double-blind Treatment|Adverse Event|6|||
144225434|NCT01256450|520021861|FG000|Double-blind Treatment|Lost to Follow-up|0|||
144268522|NCT00408499|520187693|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
144268523|NCT00408499|520187694|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
144268524|NCT00408499|520187695|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
144268525|NCT00408499|520187691|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
144268526|NCT00408499|520187692|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
144268527|NCT00408499|520187693|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
144225435|NCT01256450|520021862|FG001|Double-blind Treatment|Lost to Follow-up|1|||
144225436|NCT01256450|520021863|FG002|Double-blind Treatment|Lost to Follow-up|7|||
144225437|NCT01256450|520021861|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
144225438|NCT01256450|520021862|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
144225439|NCT01256450|520021863|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
144225440|NCT01256450|520021861|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
144225441|NCT01256450|520021862|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
144225442|NCT01256450|520021863|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
144225443|NCT01256450|520021861|FG000|Double-blind Treatment|Non-compliance|0|||
144225444|NCT01256450|520021862|FG001|Double-blind Treatment|Non-compliance|5|||
144225445|NCT01256450|520021863|FG002|Double-blind Treatment|Non-compliance|4|||
144225446|NCT01256450|520021861|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
144225447|NCT01256450|520021862|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
144225448|NCT01256450|520021863|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
144225449|NCT01256450|520021861|FG000|Double-blind Treatment|Other|0|||
144225450|NCT01256450|520021862|FG001|Double-blind Treatment|Other|9|||
144225451|NCT01256450|520021863|FG002|Double-blind Treatment|Other|12|||
144225452|NCT00832455|520021864|FG000|Overall Study|Adverse Event|13|||
144225453|NCT00832455|520021864|FG000|Overall Study|Lost to Follow-up|26|||
144225454|NCT00832455|520021864|FG000|Overall Study|Protocol Violation|4|||
144225455|NCT00832455|520021864|FG000|Overall Study|Withdrawal by Subject|17|||
144225456|NCT00832455|520021864|FG000|Overall Study|Screening Failure|2|||
144225457|NCT00832455|520021864|FG000|Overall Study|Stopped Medication|4|||
144225458|NCT00832455|520021864|FG000|Overall Study|Parent misunderstood study|1|||
144225459|NCT00832455|520021864|FG000|Overall Study|Parent dissatisfied|1|||
144225460|NCT00832455|520021864|FG000|Overall Study|No improvement|3|||
144225461|NCT00832455|520021864|FG000|Overall Study|Patient moved|1|||
144225462|NCT03376789|520021866|FG000|Overall Study|Withdrawal by Subject|3|||
144225463|NCT03376789|520021867|FG001|Overall Study|Withdrawal by Subject|5|||
144225464|NCT03376789|520021866|FG000|Overall Study|Protocol Violation|0|||
144225465|NCT03376789|520021867|FG001|Overall Study|Protocol Violation|1|||
144225466|NCT03376789|520021866|FG000|Overall Study|Adverse Event|0|||
144225467|NCT03376789|520021867|FG001|Overall Study|Adverse Event|1|||
144225468|NCT03376789|520021866|FG000|Overall Study|Lost to Follow-up|1|||
144225469|NCT03376789|520021867|FG001|Overall Study|Lost to Follow-up|1|||
144225470|NCT03376789|520021866|FG000|Overall Study|Per sponsor due to noncompliance|1|||
144225471|NCT03376789|520021867|FG001|Overall Study|Per sponsor due to noncompliance|0|||
144225472|NCT03376789|520021866|FG000|Overall Study|Subject off study medication|0|||
144225473|NCT03376789|520021867|FG001|Overall Study|Subject off study medication|1|||
144225474|NCT02556775|520021870|FG000|Overall Study|Withdrawal by Subject|1|||
144225475|NCT02556775|520021871|FG001|Overall Study|Withdrawal by Subject|0|||
144225476|NCT02556775|520021872|FG002|Overall Study|Withdrawal by Subject|1|||
144225477|NCT02556775|520021873|FG003|Overall Study|Withdrawal by Subject|0|||
144225478|NCT02556775|520021870|FG000|Overall Study|Lost to Follow-up|1|||
144225479|NCT02556775|520021871|FG001|Overall Study|Lost to Follow-up|0|||
144225480|NCT02556775|520021872|FG002|Overall Study|Lost to Follow-up|0|||
144225481|NCT02556775|520021873|FG003|Overall Study|Lost to Follow-up|0|||
144225482|NCT02025725|520021876|FG000|Overall Study|Adverse Event|5|||
144225483|NCT02025725|520021877|FG001|Overall Study|Adverse Event|0|||
144225484|NCT02025725|520021876|FG000|Overall Study|Lost to Follow-up|2|||
144225485|NCT02025725|520021877|FG001|Overall Study|Lost to Follow-up|0|||
144225486|NCT02025725|520021876|FG000|Overall Study|Protocol Violation|1|||
144225487|NCT02025725|520021877|FG001|Overall Study|Protocol Violation|1|||
144225488|NCT02025725|520021876|FG000|Overall Study|Withdrawal by Subject|3|||
144225489|NCT02025725|520021877|FG001|Overall Study|Withdrawal by Subject|2|||
144225490|NCT02025725|520021876|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
144225491|NCT02025725|520021877|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
144225492|NCT02946463|520021878|FG000|Primary Evaluation Period|Physician Decision|0|||
144225493|NCT02946463|520021879|FG001|Primary Evaluation Period|Physician Decision|1|||
144225494|NCT02946463|520021880|FG002|Primary Evaluation Period|Physician Decision|0|||
144225495|NCT02946463|520021881|FG003|Primary Evaluation Period|Physician Decision|0|||
144225496|NCT02946463|520021878|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
144225497|NCT02946463|520021879|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
144225498|NCT02946463|520021880|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
144225499|NCT02946463|520021881|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
144225500|NCT02946463|520021878|FG000|Extension Period|Death|4|||
144225501|NCT02946463|520021879|FG001|Extension Period|Death|4|||
144225502|NCT02946463|520021880|FG002|Extension Period|Death|0|||
144225503|NCT02946463|520021881|FG003|Extension Period|Death|0|||
144225504|NCT02946463|520021878|FG000|Extension Period|Withdrawal by Subject|4|||
144225505|NCT02946463|520021879|FG001|Extension Period|Withdrawal by Subject|3|||
144225506|NCT02946463|520021880|FG002|Extension Period|Withdrawal by Subject|0|||
144225507|NCT02946463|520021881|FG003|Extension Period|Withdrawal by Subject|0|||
144225508|NCT02946463|520021878|FG000|Extension Period|Other than specified|2|||
144268528|NCT00408499|520187694|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
144268529|NCT00408499|520187695|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
144268530|NCT00408499|520187691|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
144225509|NCT02946463|520021879|FG001|Extension Period|Other than specified|3|||
144225510|NCT02946463|520021880|FG002|Extension Period|Other than specified|2|||
144225511|NCT02946463|520021881|FG003|Extension Period|Other than specified|0|||
144225512|NCT02946463|520021878|FG000|Extension Period|Physician Decision|1|||
144225513|NCT02946463|520021879|FG001|Extension Period|Physician Decision|4|||
144225514|NCT02946463|520021880|FG002|Extension Period|Physician Decision|0|||
144225515|NCT02946463|520021881|FG003|Extension Period|Physician Decision|0|||
144268531|NCT00408499|520187692|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
144225516|NCT02946463|520021878|FG000|Extension Period|Pregnancy|3|||
144268532|NCT00408499|520187693|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
144225517|NCT02946463|520021879|FG001|Extension Period|Pregnancy|1|||
144225518|NCT02946463|520021880|FG002|Extension Period|Pregnancy|0|||
144225519|NCT02946463|520021881|FG003|Extension Period|Pregnancy|0|||
144225520|NCT02946463|520021878|FG000|Extension Period|Adverse Event|1|||
144225521|NCT02946463|520021879|FG001|Extension Period|Adverse Event|2|||
144225522|NCT02946463|520021880|FG002|Extension Period|Adverse Event|0|||
144225523|NCT02946463|520021881|FG003|Extension Period|Adverse Event|0|||
144225524|NCT02946463|520021878|FG000|Extension Period|Lost to Follow-up|1|||
144225525|NCT02946463|520021879|FG001|Extension Period|Lost to Follow-up|0|||
144225526|NCT02946463|520021880|FG002|Extension Period|Lost to Follow-up|0|||
144225527|NCT02946463|520021881|FG003|Extension Period|Lost to Follow-up|0|||
144225528|NCT01787292|520021885|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
144225529|NCT01787292|520021886|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
144225530|NCT01787292|520021885|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
144225531|NCT01787292|520021886|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
144225532|NCT05691712|520021887|FG000|Overall Study|Adverse Event|0|||
144225533|NCT05691712|520021888|FG001|Overall Study|Adverse Event|1|||
144225534|NCT05691712|520021889|FG002|Overall Study|Adverse Event|2|||
144225535|NCT05691712|520021890|FG003|Overall Study|Adverse Event|1|||
144225536|NCT05691712|520021887|FG000|Overall Study|Withdrawal by Subject|2|||
144225537|NCT05691712|520021888|FG001|Overall Study|Withdrawal by Subject|3|||
144225538|NCT05691712|520021889|FG002|Overall Study|Withdrawal by Subject|3|||
144225539|NCT05691712|520021890|FG003|Overall Study|Withdrawal by Subject|1|||
144225540|NCT05691712|520021887|FG000|Overall Study|Death|1|||
144225541|NCT05691712|520021888|FG001|Overall Study|Death|0|||
144225542|NCT05691712|520021889|FG002|Overall Study|Death|0|||
144225543|NCT05691712|520021890|FG003|Overall Study|Death|0|||
144225544|NCT05691712|520021887|FG000|Overall Study|Pregnancy|0|||
144225545|NCT05691712|520021888|FG001|Overall Study|Pregnancy|1|||
144225546|NCT05691712|520021889|FG002|Overall Study|Pregnancy|0|||
144225547|NCT05691712|520021890|FG003|Overall Study|Pregnancy|0|||
144225548|NCT05691712|520021887|FG000|Overall Study|Assigned Treatment by Mistake|1|||
144225549|NCT05691712|520021888|FG001|Overall Study|Assigned Treatment by Mistake|0|||
144225550|NCT05691712|520021889|FG002|Overall Study|Assigned Treatment by Mistake|0|||
144225551|NCT05691712|520021890|FG003|Overall Study|Assigned Treatment by Mistake|1|||
144225552|NCT00468819|520021891|FG000|Overall Study|Withdrawal by Subject|4|||
144225553|NCT00468819|520021892|FG001|Overall Study|Withdrawal by Subject|0|||
144225554|NCT00468819|520021893|FG002|Overall Study|Withdrawal by Subject|1|||
144225555|NCT00468819|520021891|FG000|Overall Study|Lost to Follow-up|0|||
144225556|NCT00468819|520021892|FG001|Overall Study|Lost to Follow-up|0|||
144225557|NCT00468819|520021893|FG002|Overall Study|Lost to Follow-up|1|||
144225558|NCT00468819|520021891|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
144225559|NCT00468819|520021892|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
144225560|NCT00468819|520021893|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
144225561|NCT02492867|520021894|FG000|Overall Study|Alternate therapy|1|||
144225562|NCT02492867|520021894|FG000|Overall Study|Withdrawal by Subject|2|||
144225563|NCT02492867|520021894|FG000|Overall Study|Disease progression after treatment started|1|||
144225564|NCT02492867|520021894|FG000|Overall Study|Death|1|||
144225565|NCT03296527|520021895|FG000|Overall Study|Adverse Event|15|||
144225566|NCT03296527|520021896|FG001|Overall Study|Adverse Event|33|||
144225567|NCT03296527|520021895|FG000|Overall Study|Protocol Deviation|4|||
144225568|NCT03296527|520021896|FG001|Overall Study|Protocol Deviation|0|||
144225569|NCT03296527|520021895|FG000|Overall Study|Participant withdrew consent|3|||
144225570|NCT03296527|520021896|FG001|Overall Study|Participant withdrew consent|1|||
144225571|NCT03296527|520021895|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
144225572|NCT03296527|520021896|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
144225573|NCT03296527|520021895|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
144225574|NCT03296527|520021896|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
144225575|NCT03296527|520021895|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
144225576|NCT03296527|520021896|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
144268533|NCT00408499|520187694|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
144268534|NCT00408499|520187695|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
144268535|NCT00408499|520187691|FG000|Phase II- MTD Expansion|Adverse Event|0|||
144268536|NCT00408499|520187692|FG001|Phase II- MTD Expansion|Adverse Event|0|||
144268537|NCT00408499|520187693|FG002|Phase II- MTD Expansion|Adverse Event|0|||
144268538|NCT00408499|520187694|FG003|Phase II- MTD Expansion|Adverse Event|0|||
144268539|NCT00408499|520187695|FG004|Phase II- MTD Expansion|Adverse Event|9|||
144268540|NCT00408499|520187691|FG000|Phase II- MTD Expansion|Death|0|||
144268541|NCT00408499|520187692|FG001|Phase II- MTD Expansion|Death|0|||
144268542|NCT00408499|520187693|FG002|Phase II- MTD Expansion|Death|0|||
144268543|NCT00408499|520187694|FG003|Phase II- MTD Expansion|Death|0|||
144268544|NCT00408499|520187695|FG004|Phase II- MTD Expansion|Death|2|||
144268545|NCT00408499|520187691|FG000|Phase II- MTD Expansion|Physician Decision|0|||
144268546|NCT00408499|520187692|FG001|Phase II- MTD Expansion|Physician Decision|0|||
144268547|NCT00408499|520187693|FG002|Phase II- MTD Expansion|Physician Decision|0|||
144268548|NCT00408499|520187694|FG003|Phase II- MTD Expansion|Physician Decision|0|||
144268549|NCT00408499|520187695|FG004|Phase II- MTD Expansion|Physician Decision|1|||
144268550|NCT00408499|520187691|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
144268551|NCT00408499|520187692|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
144268552|NCT00408499|520187693|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
144268553|NCT00408499|520187694|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
144268554|NCT00408499|520187695|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
144268555|NCT00408499|520187691|FG000|Phase II- MTD Expansion|treatment delay|0|||
144268556|NCT00408499|520187692|FG001|Phase II- MTD Expansion|treatment delay|0|||
144268557|NCT00408499|520187693|FG002|Phase II- MTD Expansion|treatment delay|0|||
144268558|NCT00408499|520187694|FG003|Phase II- MTD Expansion|treatment delay|0|||
144268559|NCT00408499|520187695|FG004|Phase II- MTD Expansion|treatment delay|3|||
144268560|NCT01586195|520187697|FG000|Overall Study|Death|11|||
144268561|NCT01586195|520187697|FG000|Overall Study|Withdrawal of Consent|5|||
144268562|NCT01586195|520187697|FG000|Overall Study|Started new anti-melanoma therapy|1|||
144225577|NCT03296527|520021895|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
144225578|NCT03296527|520021896|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
144225579|NCT03296527|520021895|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
144225580|NCT03296527|520021896|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
144225581|NCT01565889|520021897|FG000|Part A|Withdrawal by Subject|1|||
144225582|NCT01565889|520021898|FG001|Part A|Withdrawal by Subject|0|||
144225583|NCT01565889|520021899|FG002|Part A|Withdrawal by Subject|0|||
144225584|NCT01565889|520021900|FG003|Part A|Withdrawal by Subject|0|||
144225585|NCT01565889|520021901|FG004|Part A|Withdrawal by Subject|0|||
144225586|NCT01565889|520021902|FG005|Part A|Withdrawal by Subject|0|||
144225587|NCT01565889|520021897|FG000|Part B|Withdrawal by Subject|0|||
144225588|NCT01565889|520021898|FG001|Part B|Withdrawal by Subject|0|||
144225589|NCT01565889|520021899|FG002|Part B|Withdrawal by Subject|0|||
144225590|NCT01565889|520021900|FG003|Part B|Withdrawal by Subject|0|||
144225591|NCT01565889|520021901|FG004|Part B|Withdrawal by Subject|0|||
144225592|NCT01565889|520021902|FG005|Part B|Withdrawal by Subject|1|||
144225593|NCT01565889|520021897|FG000|Part B|Lack of Efficacy|0|||
144225594|NCT01565889|520021898|FG001|Part B|Lack of Efficacy|0|||
144225595|NCT01565889|520021899|FG002|Part B|Lack of Efficacy|0|||
144225596|NCT01565889|520021900|FG003|Part B|Lack of Efficacy|0|||
144225597|NCT01565889|520021901|FG004|Part B|Lack of Efficacy|0|||
144225598|NCT01565889|520021902|FG005|Part B|Lack of Efficacy|2|||
144225599|NCT01565889|520021897|FG000|Part B|Lost to Follow-up|0|||
144225600|NCT01565889|520021898|FG001|Part B|Lost to Follow-up|0|||
144225601|NCT01565889|520021899|FG002|Part B|Lost to Follow-up|0|||
144225602|NCT01565889|520021900|FG003|Part B|Lost to Follow-up|0|||
144225603|NCT01565889|520021901|FG004|Part B|Lost to Follow-up|0|||
144225604|NCT01565889|520021902|FG005|Part B|Lost to Follow-up|1|||
144225605|NCT02524847|520021904|FG000|Overall Study|Adverse Event|4|||
144225606|NCT02524847|520021904|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
144225607|NCT02524847|520021904|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
144225608|NCT02524847|520021904|FG000|Overall Study|Death|1|||
144225609|NCT02524847|520021904|FG000|Overall Study|Reason not Specified|1|||
144268563|NCT01586195|520187697|FG000|Overall Study|Reason not specified|9|||
144268564|NCT01373164|520187702|FG000|Overall Study|Lost to Follow-up|0|||
144225610|NCT01326845|520021905|FG000|Overall Study|Administrative Problems|5|||
144225611|NCT01326845|520021906|FG001|Overall Study|Administrative Problems|2|||
144225612|NCT01326845|520021905|FG000|Overall Study|Adverse Event|1|||
144225613|NCT01326845|520021906|FG001|Overall Study|Adverse Event|0|||
144268565|NCT01373164|520187703|FG001|Overall Study|Lost to Follow-up|0|||
144225614|NCT01326845|520021905|FG000|Overall Study|Misisng|1|||
144225615|NCT01326845|520021906|FG001|Overall Study|Misisng|3|||
144225616|NCT04352101|520021907|FG000|Overall Study|Physician Decision|2|||
144225617|NCT04352101|520021908|FG001|Overall Study|Physician Decision|1|||
144225618|NCT00122382|520021914|FG000|Double-Blind Study|Adverse Event|9|||
144225619|NCT00122382|520021915|FG001|Double-Blind Study|Adverse Event|11|||
144225620|NCT00122382|520021916|FG002|Double-Blind Study|Adverse Event|0|||
144225621|NCT00122382|520021914|FG000|Double-Blind Study|Death|2|||
144225622|NCT00122382|520021915|FG001|Double-Blind Study|Death|2|||
144225623|NCT00122382|520021916|FG002|Double-Blind Study|Death|0|||
144225624|NCT00122382|520021914|FG000|Double-Blind Study|Lack of Efficacy|0|||
144225625|NCT00122382|520021915|FG001|Double-Blind Study|Lack of Efficacy|8|||
144225626|NCT00122382|520021916|FG002|Double-Blind Study|Lack of Efficacy|0|||
144225627|NCT00122382|520021914|FG000|Double-Blind Study|Lost to Follow-up|2|||
144225628|NCT00122382|520021915|FG001|Double-Blind Study|Lost to Follow-up|1|||
144225629|NCT00122382|520021916|FG002|Double-Blind Study|Lost to Follow-up|0|||
144225630|NCT00122382|520021914|FG000|Double-Blind Study|Pregnancy|2|||
144225631|NCT00122382|520021915|FG001|Double-Blind Study|Pregnancy|0|||
144225632|NCT00122382|520021916|FG002|Double-Blind Study|Pregnancy|0|||
144225633|NCT00122382|520021914|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
144225634|NCT00122382|520021915|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
144225635|NCT00122382|520021916|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
144225636|NCT00122382|520021914|FG000|Double-Blind Study|Withdrawal of Consent|7|||
144225637|NCT00122382|520021915|FG001|Double-Blind Study|Withdrawal of Consent|3|||
144225638|NCT00122382|520021916|FG002|Double-Blind Study|Withdrawal of Consent|0|||
144225639|NCT00122382|520021914|FG000|Double-Blind Study|Protocol Violation|1|||
144225640|NCT00122382|520021915|FG001|Double-Blind Study|Protocol Violation|0|||
144225641|NCT00122382|520021916|FG002|Double-Blind Study|Protocol Violation|0|||
144225642|NCT00122382|520021914|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
144225643|NCT00122382|520021915|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
144225644|NCT00122382|520021916|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
144225645|NCT00122382|520021914|FG000|Double-Blind Study|Randomized but not treated|0|||
144225646|NCT00122382|520021915|FG001|Double-Blind Study|Randomized but not treated|2|||
144225647|NCT00122382|520021916|FG002|Double-Blind Study|Randomized but not treated|0|||
144225648|NCT00122382|520021914|FG000|Open-Label Study|Adverse Event|0|||
144225649|NCT00122382|520021915|FG001|Open-Label Study|Adverse Event|0|||
144225650|NCT00122382|520021916|FG002|Open-Label Study|Adverse Event|11|||
144225651|NCT00122382|520021914|FG000|Open-Label Study|Death|0|||
144225652|NCT00122382|520021915|FG001|Open-Label Study|Death|0|||
144225653|NCT00122382|520021916|FG002|Open-Label Study|Death|2|||
144225654|NCT00122382|520021914|FG000|Open-Label Study|Lack of Efficacy|0|||
144225655|NCT00122382|520021915|FG001|Open-Label Study|Lack of Efficacy|0|||
144225656|NCT00122382|520021916|FG002|Open-Label Study|Lack of Efficacy|3|||
144225657|NCT00122382|520021914|FG000|Open-Label Study|Lost to Follow-up|0|||
144225658|NCT00122382|520021915|FG001|Open-Label Study|Lost to Follow-up|0|||
144225659|NCT00122382|520021916|FG002|Open-Label Study|Lost to Follow-up|3|||
144225660|NCT00122382|520021914|FG000|Open-Label Study|Pregnancy|0|||
144225661|NCT00122382|520021915|FG001|Open-Label Study|Pregnancy|0|||
144225662|NCT00122382|520021916|FG002|Open-Label Study|Pregnancy|2|||
144225663|NCT00122382|520021914|FG000|Open-Label Study|Poor/Non-Compliance|0|||
144225664|NCT00122382|520021915|FG001|Open-Label Study|Poor/Non-Compliance|0|||
144225665|NCT00122382|520021916|FG002|Open-Label Study|Poor/Non-Compliance|1|||
144225666|NCT00122382|520021914|FG000|Open-Label Study|Withdrawal of Consent|0|||
144225667|NCT00122382|520021915|FG001|Open-Label Study|Withdrawal of Consent|0|||
144225668|NCT00122382|520021916|FG002|Open-Label Study|Withdrawal of Consent|4|||
144225669|NCT02859337|520021920|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
144225670|NCT02859337|520021921|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
144225671|NCT02859337|520021922|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
144225672|NCT02859337|520021920|FG000|Overall Study|Withdrawal by Subject|3|||
144225673|NCT02859337|520021921|FG001|Overall Study|Withdrawal by Subject|1|||
144225674|NCT02859337|520021922|FG002|Overall Study|Withdrawal by Subject|0|||
144225675|NCT02859337|520021920|FG000|Overall Study|Lost to Follow-up|1|||
144225676|NCT02859337|520021921|FG001|Overall Study|Lost to Follow-up|0|||
144225677|NCT02859337|520021922|FG002|Overall Study|Lost to Follow-up|0|||
144225678|NCT05514873|520021925|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
144225679|NCT05514873|520021925|FG000|Main Treatment Period|Adverse Event|2|||
144225680|NCT05514873|520021925|FG000|Extension Treatment Period|Lost to Follow-up|3|||
144225681|NCT03525678|520021928|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
144225682|NCT03525678|520021929|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
144268566|NCT01373164|520187704|FG002|Overall Study|Lost to Follow-up|1|||
144225683|NCT03525678|520021930|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
144225684|NCT03525678|520021931|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
144225685|NCT03525678|520021932|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
144225686|NCT03525678|520021928|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
144225687|NCT03525678|520021929|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
144225688|NCT03525678|520021930|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
144225689|NCT03525678|520021931|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
144268567|NCT01373164|520187705|FG003|Overall Study|Lost to Follow-up|2|||
144225690|NCT03525678|520021932|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
144225691|NCT03525678|520021928|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
144268568|NCT01373164|520187706|FG004|Overall Study|Lost to Follow-up|0|||
144268569|NCT01373164|520187702|FG000|Overall Study|Withdrawal by Subject|0|||
144268570|NCT01373164|520187703|FG001|Overall Study|Withdrawal by Subject|1|||
144268571|NCT01373164|520187704|FG002|Overall Study|Withdrawal by Subject|0|||
144268572|NCT01373164|520187705|FG003|Overall Study|Withdrawal by Subject|10|||
144268573|NCT01373164|520187706|FG004|Overall Study|Withdrawal by Subject|2|||
144225692|NCT03525678|520021929|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
144225693|NCT03525678|520021930|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
144225694|NCT03525678|520021931|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
144225695|NCT03525678|520021932|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
144225696|NCT03525678|520021928|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
144225697|NCT03525678|520021929|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
144225698|NCT03525678|520021930|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
144268574|NCT02669849|520187711|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
144268575|NCT02669849|520187712|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
144268576|NCT02669849|520187713|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
144268577|NCT02669849|520187711|FG000|Overall Study|Lost to Follow-up|1|||
144268578|NCT02669849|520187712|FG001|Overall Study|Lost to Follow-up|0|||
144268579|NCT02669849|520187713|FG002|Overall Study|Lost to Follow-up|3|||
144268580|NCT02669849|520187711|FG000|Overall Study|Death|1|||
144268581|NCT02669849|520187712|FG001|Overall Study|Death|1|||
144268582|NCT02669849|520187713|FG002|Overall Study|Death|2|||
144225699|NCT03525678|520021931|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
144225700|NCT03525678|520021932|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
144225701|NCT03525678|520021928|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
144225702|NCT03525678|520021929|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
144268583|NCT02669849|520187711|FG000|Overall Study|Study terminated by sponsor|16|||
144225703|NCT03525678|520021930|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
144225704|NCT03525678|520021931|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
144225705|NCT03525678|520021932|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
144225706|NCT03525678|520021928|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
144225707|NCT03525678|520021929|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
144225708|NCT03525678|520021930|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
144268584|NCT02669849|520187712|FG001|Overall Study|Study terminated by sponsor|1|||
144268585|NCT02669849|520187713|FG002|Overall Study|Study terminated by sponsor|14|||
144268586|NCT02669849|520187711|FG000|Overall Study|Other|0|||
144268587|NCT02669849|520187712|FG001|Overall Study|Other|0|||
144268588|NCT02669849|520187713|FG002|Overall Study|Other|2|||
144268589|NCT04745351|520187716|FG000|Overall Study|Death|51|||
144268590|NCT04745351|520187717|FG001|Overall Study|Death|25|||
144268591|NCT04745351|520187716|FG000|Overall Study|Lost to Follow-up|9|||
144268592|NCT04745351|520187717|FG001|Overall Study|Lost to Follow-up|3|||
144268593|NCT04745351|520187716|FG000|Overall Study|Randomized but Never Treated|3|||
144268594|NCT04745351|520187717|FG001|Overall Study|Randomized but Never Treated|3|||
144268595|NCT04745351|520187716|FG000|Overall Study|Adverse Event|4|||
144225709|NCT03525678|520021931|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
144225710|NCT03525678|520021932|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
144225711|NCT05966584|520021933|FG000|Overall Study|Lost to Follow-up|1|||
144225712|NCT05086744|520023530|FG000|Part A|Adverse Event|0|||
144225713|NCT05086744|520023531|FG001|Part A|Adverse Event|1|||
144225714|NCT05086744|520023530|FG000|Part A|Lack of Efficacy|3|||
144225715|NCT05086744|520023531|FG001|Part A|Lack of Efficacy|0|||
144225716|NCT05086744|520023530|FG000|Part A|Protocol deviation|1|||
144225717|NCT05086744|520023531|FG001|Part A|Protocol deviation|0|||
144225718|NCT05086744|520023530|FG000|Part A|Subject decision|1|||
144225719|NCT05086744|520023531|FG001|Part A|Subject decision|0|||
144225720|NCT05086744|520023530|FG000|Part B|Adverse Event|0|||
144225721|NCT05086744|520023531|FG001|Part B|Adverse Event|1|||
144225722|NCT05086744|520023530|FG000|Part B|Lack of Efficacy|0|||
144225723|NCT05086744|520023531|FG001|Part B|Lack of Efficacy|1|||
144225724|NCT05086744|520023530|FG000|Part B|Study terminated by sponsor|1|||
144225725|NCT05086744|520023531|FG001|Part B|Study terminated by sponsor|6|||
144225726|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
144225727|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
144225728|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
144225729|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
144225730|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
144225731|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
144225732|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
144225733|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
144225734|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
144225735|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
144225736|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
144225737|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
144225738|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
144225739|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
144225740|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
144225741|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
144268596|NCT04745351|520187717|FG001|Overall Study|Adverse Event|0|||
144268597|NCT04745351|520187716|FG000|Overall Study|Withdrew Consent|1|||
144268598|NCT04745351|520187717|FG001|Overall Study|Withdrew Consent|2|||
144225742|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
144268599|NCT04745351|520187716|FG000|Overall Study|Investigator's Discretion|2|||
144225743|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
144225744|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
144268600|NCT04745351|520187717|FG001|Overall Study|Investigator's Discretion|0|||
144268601|NCT04745351|520187716|FG000|Overall Study|Protocol Violation|1|||
144268602|NCT04745351|520187717|FG001|Overall Study|Protocol Violation|0|||
144225745|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
144225746|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
144225747|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
144225748|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
144225749|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
144225750|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
144225751|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
144225752|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
144225753|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
144225754|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
144225755|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
144225756|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
144225757|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
144225758|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225759|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225760|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
144225761|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225762|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225763|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225764|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
144225765|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225766|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
144225767|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
144225768|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
144225769|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
144225770|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
144225771|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
144268603|NCT01863771|520187718|FG000|Induction Phase|Adverse Event|9|||
144268604|NCT01863771|520187719|FG001|Induction Phase|Adverse Event|0|||
144268605|NCT01863771|520187720|FG002|Induction Phase|Adverse Event|0|||
144268606|NCT01863771|520187721|FG003|Induction Phase|Adverse Event|0|||
144268607|NCT01863771|520187718|FG000|Induction Phase|Lack of Efficacy|10|||
144268608|NCT01863771|520187719|FG001|Induction Phase|Lack of Efficacy|0|||
144268609|NCT01863771|520187720|FG002|Induction Phase|Lack of Efficacy|0|||
144268610|NCT01863771|520187721|FG003|Induction Phase|Lack of Efficacy|0|||
144268611|NCT01863771|520187718|FG000|Induction Phase|Withdrawal by Subject|2|||
144268612|NCT01863771|520187719|FG001|Induction Phase|Withdrawal by Subject|0|||
144268613|NCT01863771|520187720|FG002|Induction Phase|Withdrawal by Subject|0|||
144268614|NCT01863771|520187721|FG003|Induction Phase|Withdrawal by Subject|0|||
144268615|NCT01863771|520187718|FG000|Maintenance Phase|Adverse Event|0|||
144268616|NCT01863771|520187719|FG001|Maintenance Phase|Adverse Event|0|||
144268617|NCT01863771|520187720|FG002|Maintenance Phase|Adverse Event|1|||
144268618|NCT01863771|520187721|FG003|Maintenance Phase|Adverse Event|1|||
144268619|NCT01863771|520187718|FG000|Maintenance Phase|Lack of Efficacy|0|||
144268620|NCT01863771|520187719|FG001|Maintenance Phase|Lack of Efficacy|3|||
144268621|NCT01863771|520187720|FG002|Maintenance Phase|Lack of Efficacy|7|||
144268622|NCT01863771|520187721|FG003|Maintenance Phase|Lack of Efficacy|38|||
144268623|NCT01863771|520187718|FG000|Maintenance Phase|Physician Decision|0|||
144268624|NCT01863771|520187719|FG001|Maintenance Phase|Physician Decision|0|||
144268625|NCT01863771|520187720|FG002|Maintenance Phase|Physician Decision|2|||
144268626|NCT01863771|520187721|FG003|Maintenance Phase|Physician Decision|1|||
144268627|NCT01863771|520187718|FG000|Maintenance Phase|Pregnancy|0|||
144268628|NCT01863771|520187719|FG001|Maintenance Phase|Pregnancy|1|||
144268629|NCT01863771|520187720|FG002|Maintenance Phase|Pregnancy|0|||
144268630|NCT01863771|520187721|FG003|Maintenance Phase|Pregnancy|0|||
144268631|NCT01863771|520187718|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144268632|NCT01863771|520187719|FG001|Maintenance Phase|Withdrawal by Subject|1|||
144268633|NCT01863771|520187720|FG002|Maintenance Phase|Withdrawal by Subject|2|||
144268634|NCT01863771|520187721|FG003|Maintenance Phase|Withdrawal by Subject|3|||
144268635|NCT03499795|520187722|FG000|Overall Study|Adverse Event|1|||
144268636|NCT03499795|520187722|FG000|Overall Study|Lost to Follow-up|1|||
144268637|NCT03636256|520187723|FG000|Overall Study|Lost to Follow-up|3|||
144268638|NCT03636256|520187724|FG001|Overall Study|Lost to Follow-up|0|||
144268639|NCT03636256|520187725|FG002|Overall Study|Lost to Follow-up|2|||
144268640|NCT03636256|520187726|FG003|Overall Study|Lost to Follow-up|1|||
144268641|NCT03636256|520187727|FG004|Overall Study|Lost to Follow-up|0|||
144268642|NCT03636256|520187728|FG005|Overall Study|Lost to Follow-up|4|||
144268643|NCT03636256|520187729|FG006|Overall Study|Lost to Follow-up|2|||
144268644|NCT03636256|520187730|FG007|Overall Study|Lost to Follow-up|0|||
144268645|NCT03636256|520187731|FG008|Overall Study|Lost to Follow-up|4|||
144268646|NCT03636256|520187723|FG000|Overall Study|Withdrawal by Subject|0|||
144268647|NCT03636256|520187724|FG001|Overall Study|Withdrawal by Subject|0|||
144268648|NCT03636256|520187725|FG002|Overall Study|Withdrawal by Subject|0|||
144268649|NCT03636256|520187726|FG003|Overall Study|Withdrawal by Subject|0|||
144268650|NCT03636256|520187727|FG004|Overall Study|Withdrawal by Subject|0|||
144268651|NCT03636256|520187728|FG005|Overall Study|Withdrawal by Subject|0|||
144268652|NCT03636256|520187729|FG006|Overall Study|Withdrawal by Subject|0|||
144268653|NCT03636256|520187730|FG007|Overall Study|Withdrawal by Subject|0|||
144268654|NCT03636256|520187731|FG008|Overall Study|Withdrawal by Subject|1|||
144268655|NCT01218308|520187732|FG000|Overall Study|Adverse Event|1|||
144268656|NCT01218308|520187733|FG001|Overall Study|Adverse Event|2|||
144268657|NCT01218308|520187732|FG000|Overall Study|Protocol Violation|0|||
144268658|NCT01218308|520187733|FG001|Overall Study|Protocol Violation|2|||
144268659|NCT01218308|520187732|FG000|Overall Study|Withdrawal by Subject|61|||
144268660|NCT01218308|520187733|FG001|Overall Study|Withdrawal by Subject|64|||
144268661|NCT01218308|520187732|FG000|Overall Study|Lost to Follow-up|27|||
144268662|NCT01218308|520187733|FG001|Overall Study|Lost to Follow-up|31|||
144268663|NCT01218308|520187732|FG000|Overall Study|Other|14|||
144268664|NCT01218308|520187733|FG001|Overall Study|Other|21|||
144268665|NCT01450813|520187734|FG000|Overall Study|Physician Decision|1|||
144268666|NCT01450813|520187735|FG001|Overall Study|Physician Decision|1|||
144268667|NCT01450813|520187736|FG002|Overall Study|Physician Decision|0|||
144268668|NCT01450813|520187737|FG003|Overall Study|Physician Decision|3|||
144268669|NCT02932943|520187738|FG000|Overall Study|Lost to Follow-up|0|||
144268670|NCT02932943|520187739|FG001|Overall Study|Lost to Follow-up|2|||
144268671|NCT02932943|520187738|FG000|Overall Study|Adverse Event|2|||
144268672|NCT02932943|520187739|FG001|Overall Study|Adverse Event|2|||
144268673|NCT02932943|520187738|FG000|Overall Study|Withdrawal by Subject|3|||
144268674|NCT02932943|520187739|FG001|Overall Study|Withdrawal by Subject|3|||
144268675|NCT01483118|520187740|FG000|Overall Study|Lost to Follow-up|12|||
144268676|NCT01483118|520187741|FG001|Overall Study|Lost to Follow-up|16|||
144268677|NCT00785356|520187742|FG000|Overall Study|Study prematurely terminated|8|||
144268678|NCT01079780|520187744|FG000|Overall Study|Disease progression|43|||
144268679|NCT01079780|520187745|FG001|Overall Study|Disease progression|7|||
144268680|NCT01079780|520187746|FG002|Overall Study|Disease progression|31|||
144268681|NCT01079780|520187744|FG000|Overall Study|Adverse Event|13|||
144268682|NCT01079780|520187745|FG001|Overall Study|Adverse Event|5|||
144268683|NCT01079780|520187746|FG002|Overall Study|Adverse Event|7|||
144268684|NCT01079780|520187744|FG000|Overall Study|Death|2|||
144268685|NCT01079780|520187745|FG001|Overall Study|Death|0|||
144268686|NCT01079780|520187746|FG002|Overall Study|Death|2|||
144268687|NCT01079780|520187744|FG000|Overall Study|Withdrawal by Subject|6|||
144268688|NCT01079780|520187745|FG001|Overall Study|Withdrawal by Subject|4|||
144268689|NCT01079780|520187746|FG002|Overall Study|Withdrawal by Subject|4|||
144268690|NCT01079780|520187744|FG000|Overall Study|Alternative therapy|2|||
144268691|NCT01079780|520187745|FG001|Overall Study|Alternative therapy|0|||
144268692|NCT01079780|520187746|FG002|Overall Study|Alternative therapy|2|||
144268693|NCT01079780|520187744|FG000|Overall Study|Physician Decision|1|||
144268694|NCT01079780|520187745|FG001|Overall Study|Physician Decision|0|||
144268695|NCT01079780|520187746|FG002|Overall Study|Physician Decision|1|||
144268696|NCT01079780|520187744|FG000|Overall Study|Error made in lesion measurement|1|||
144268697|NCT01079780|520187745|FG001|Overall Study|Error made in lesion measurement|0|||
144268698|NCT01079780|520187746|FG002|Overall Study|Error made in lesion measurement|0|||
144268699|NCT01079780|520187744|FG000|Overall Study|Patient had surgery|1|||
144268700|NCT01079780|520187745|FG001|Overall Study|Patient had surgery|0|||
144268701|NCT01079780|520187746|FG002|Overall Study|Patient had surgery|0|||
144268702|NCT01079780|520187744|FG000|Overall Study|Treatment cycle delay|0|||
144268703|NCT01079780|520187745|FG001|Overall Study|Treatment cycle delay|0|||
144268704|NCT01079780|520187746|FG002|Overall Study|Treatment cycle delay|1|||
144268705|NCT01079780|520187744|FG000|Overall Study|Never started treatment|1|||
144268706|NCT01079780|520187745|FG001|Overall Study|Never started treatment|0|||
144268707|NCT01079780|520187746|FG002|Overall Study|Never started treatment|2|||
144268708|NCT01178294|520187747|FG000|Overall Study|Adverse Event|4|||
144268709|NCT01178294|520187747|FG000|Overall Study|Lost to Follow-up|2|||
144268710|NCT01178294|520187747|FG000|Overall Study|Lack of Efficacy|1|||
144268711|NCT01178294|520187747|FG000|Overall Study|Death|1|||
144268712|NCT01178294|520187747|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
144268713|NCT01178294|520187747|FG000|Overall Study|Subject status is terminal|1|||
144268714|NCT01178294|520187747|FG000|Overall Study|Completion status could not be verified|1|||
144268715|NCT02051296|520187748|FG000|Overall Study|Lost to Follow-up|1|||
144268716|NCT02051296|520187749|FG001|Overall Study|Lost to Follow-up|2|||
144268717|NCT02051296|520187748|FG000|Overall Study|withdraw prior to treatment|7|||
144268718|NCT02051296|520187749|FG001|Overall Study|withdraw prior to treatment|7|||
144268719|NCT00975416|520187750|FG000|Overall Study|early discharge from tx|3|||
144268720|NCT00975416|520187751|FG001|Overall Study|early discharge from tx|5|||
144268721|NCT05379920|520187752|FG000|Overall Study|Lost to Follow-up|0|||
144268722|NCT05379920|520187753|FG001|Overall Study|Lost to Follow-up|5|||
144268723|NCT05379920|520187754|FG002|Overall Study|Lost to Follow-up|0|||
144268724|NCT05379920|520187755|FG003|Overall Study|Lost to Follow-up|0|||
144268725|NCT00106002|520187758|FG000|Overall Study|Did not take any study drug|1|||
144268726|NCT00106002|520187758|FG000|Overall Study|Ineligible after Registration|1|||
144268727|NCT02265510|520187762|FG000|Overall Study|Withdrawal by Subject|1|||
144268728|NCT02265510|520187763|FG001|Overall Study|Withdrawal by Subject|1|||
144268729|NCT02265510|520187764|FG002|Overall Study|Withdrawal by Subject|2|||
144268730|NCT02265510|520187765|FG003|Overall Study|Withdrawal by Subject|1|||
144268731|NCT02265510|520187766|FG004|Overall Study|Withdrawal by Subject|0|||
144268732|NCT02265510|520187767|FG005|Overall Study|Withdrawal by Subject|2|||
144268733|NCT02265510|520187768|FG006|Overall Study|Withdrawal by Subject|0|||
144268734|NCT02265510|520187769|FG007|Overall Study|Withdrawal by Subject|2|||
144268735|NCT02265510|520187770|FG008|Overall Study|Withdrawal by Subject|0|||
144268736|NCT02265510|520187771|FG009|Overall Study|Withdrawal by Subject|0|||
144268737|NCT02265510|520187772|FG010|Overall Study|Withdrawal by Subject|0|||
144268738|NCT02265510|520187773|FG011|Overall Study|Withdrawal by Subject|0|||
144268739|NCT02265510|520187774|FG012|Overall Study|Withdrawal by Subject|1|||
144268740|NCT02265510|520187775|FG013|Overall Study|Withdrawal by Subject|0|||
144268741|NCT02265510|520187762|FG000|Overall Study|Disease Progression|0|||
144268742|NCT02265510|520187763|FG001|Overall Study|Disease Progression|1|||
144268743|NCT02265510|520187764|FG002|Overall Study|Disease Progression|2|||
144268744|NCT02265510|520187765|FG003|Overall Study|Disease Progression|1|||
144268745|NCT02265510|520187766|FG004|Overall Study|Disease Progression|1|||
144268746|NCT02265510|520187767|FG005|Overall Study|Disease Progression|0|||
144268747|NCT02265510|520187768|FG006|Overall Study|Disease Progression|0|||
144268748|NCT02265510|520187769|FG007|Overall Study|Disease Progression|0|||
144268749|NCT02265510|520187770|FG008|Overall Study|Disease Progression|0|||
144268750|NCT02265510|520187771|FG009|Overall Study|Disease Progression|0|||
144268751|NCT02265510|520187772|FG010|Overall Study|Disease Progression|0|||
144225772|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
144225773|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
144225774|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
144225775|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
144225776|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
144225777|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
144268752|NCT02265510|520187773|FG011|Overall Study|Disease Progression|0|||
144268753|NCT02265510|520187774|FG012|Overall Study|Disease Progression|0|||
144268754|NCT02265510|520187775|FG013|Overall Study|Disease Progression|0|||
144268755|NCT02265510|520187762|FG000|Overall Study|Death|2|||
144268756|NCT02265510|520187763|FG001|Overall Study|Death|0|||
144268757|NCT02265510|520187764|FG002|Overall Study|Death|2|||
144268758|NCT02265510|520187765|FG003|Overall Study|Death|2|||
144268759|NCT02265510|520187766|FG004|Overall Study|Death|1|||
144268760|NCT02265510|520187767|FG005|Overall Study|Death|3|||
144268761|NCT02265510|520187768|FG006|Overall Study|Death|2|||
144268762|NCT02265510|520187769|FG007|Overall Study|Death|1|||
144268763|NCT02265510|520187770|FG008|Overall Study|Death|3|||
144268764|NCT02265510|520187771|FG009|Overall Study|Death|3|||
144268765|NCT02265510|520187772|FG010|Overall Study|Death|4|||
144268766|NCT02265510|520187773|FG011|Overall Study|Death|12|||
144268767|NCT02265510|520187774|FG012|Overall Study|Death|7|||
144268768|NCT02265510|520187775|FG013|Overall Study|Death|6|||
144268769|NCT02265510|520187762|FG000|Overall Study|Lost to Follow-up|0|||
144268770|NCT02265510|520187763|FG001|Overall Study|Lost to Follow-up|0|||
144268771|NCT02265510|520187764|FG002|Overall Study|Lost to Follow-up|0|||
144268772|NCT02265510|520187765|FG003|Overall Study|Lost to Follow-up|0|||
144268773|NCT02265510|520187766|FG004|Overall Study|Lost to Follow-up|1|||
144268774|NCT02265510|520187767|FG005|Overall Study|Lost to Follow-up|0|||
144268775|NCT02265510|520187768|FG006|Overall Study|Lost to Follow-up|0|||
144268776|NCT02265510|520187769|FG007|Overall Study|Lost to Follow-up|0|||
144225778|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
144225779|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
144699844|NCT01891669|521754459|FG003|Overall Study|Withdrawal by Subject|0|||
144699845|NCT01891669|521754460|FG004|Overall Study|Withdrawal by Subject|0|||
144699846|NCT01891669|521754461|FG005|Overall Study|Withdrawal by Subject|0|||
144699847|NCT01891669|521754462|FG006|Overall Study|Withdrawal by Subject|1|||
144699848|NCT01891669|521754463|FG007|Overall Study|Withdrawal by Subject|2|||
144699849|NCT01891669|521754464|FG008|Overall Study|Withdrawal by Subject|1|||
144225780|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
144225781|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
144225782|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225783|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
144268777|NCT02265510|520187770|FG008|Overall Study|Lost to Follow-up|0|||
144699850|NCT01891669|521754465|FG009|Overall Study|Withdrawal by Subject|1|||
144699851|NCT01891669|521754456|FG000|Overall Study|Other|1|||
144699852|NCT01891669|521754457|FG001|Overall Study|Other|0|||
144699853|NCT01891669|521754458|FG002|Overall Study|Other|0|||
144225784|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225785|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225786|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225787|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225788|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225789|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
144225790|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144268778|NCT02265510|520187771|FG009|Overall Study|Lost to Follow-up|2|||
144268779|NCT02265510|520187772|FG010|Overall Study|Lost to Follow-up|0|||
144268780|NCT02265510|520187773|FG011|Overall Study|Lost to Follow-up|0|||
144268781|NCT02265510|520187774|FG012|Overall Study|Lost to Follow-up|0|||
144268782|NCT02265510|520187775|FG013|Overall Study|Lost to Follow-up|2|||
144268783|NCT02265510|520187762|FG000|Overall Study|Other|0|||
144268784|NCT02265510|520187763|FG001|Overall Study|Other|1|||
144268785|NCT02265510|520187764|FG002|Overall Study|Other|0|||
144268786|NCT02265510|520187765|FG003|Overall Study|Other|0|||
144268787|NCT02265510|520187766|FG004|Overall Study|Other|0|||
144268788|NCT02265510|520187767|FG005|Overall Study|Other|0|||
144268789|NCT02265510|520187768|FG006|Overall Study|Other|0|||
144268790|NCT02265510|520187769|FG007|Overall Study|Other|0|||
144268791|NCT02265510|520187770|FG008|Overall Study|Other|0|||
144268792|NCT02265510|520187771|FG009|Overall Study|Other|0|||
144268793|NCT02265510|520187772|FG010|Overall Study|Other|0|||
144268794|NCT02265510|520187773|FG011|Overall Study|Other|0|||
144268795|NCT02265510|520187774|FG012|Overall Study|Other|0|||
144268796|NCT02265510|520187775|FG013|Overall Study|Other|0|||
144268797|NCT02265510|520187762|FG000|Overall Study|Study Terminated by Sponsor|0|||
144268798|NCT02265510|520187763|FG001|Overall Study|Study Terminated by Sponsor|0|||
144268799|NCT02265510|520187764|FG002|Overall Study|Study Terminated by Sponsor|0|||
144268800|NCT02265510|520187765|FG003|Overall Study|Study Terminated by Sponsor|0|||
144225791|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144225792|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144225793|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144699854|NCT01891669|521754459|FG003|Overall Study|Other|0|||
144699855|NCT01891669|521754460|FG004|Overall Study|Other|0|||
144699856|NCT01891669|521754461|FG005|Overall Study|Other|0|||
144699857|NCT01891669|521754462|FG006|Overall Study|Other|0|||
144699858|NCT01891669|521754463|FG007|Overall Study|Other|1|||
144699859|NCT01891669|521754464|FG008|Overall Study|Other|0|||
144699860|NCT01891669|521754465|FG009|Overall Study|Other|0|||
144699861|NCT01015118|521754466|FG000|Overall Study|Protocol Violation|5|||
144699862|NCT01015118|521754467|FG001|Overall Study|Protocol Violation|6|||
144699863|NCT01015118|521754466|FG000|Overall Study|Withdrawal by Subject|103|||
144699864|NCT01015118|521754467|FG001|Overall Study|Withdrawal by Subject|27|||
144699865|NCT01015118|521754466|FG000|Overall Study|Other Adverse Event (AE)|141|||
144699866|NCT01015118|521754467|FG001|Overall Study|Other Adverse Event (AE)|33|||
144699867|NCT01015118|521754466|FG000|Overall Study|Worsening or AE of underlying disease|5|||
144699868|NCT01015118|521754467|FG001|Overall Study|Worsening or AE of underlying disease|4|||
144699869|NCT01015118|521754466|FG000|Overall Study|Progressive disease|364|||
144699870|NCT01015118|521754467|FG001|Overall Study|Progressive disease|229|||
144699871|NCT01015118|521754466|FG000|Overall Study|Not treated|9|||
144699872|NCT01015118|521754467|FG001|Overall Study|Not treated|5|||
144699873|NCT01015118|521754466|FG000|Overall Study|Other than stated above|42|||
144699874|NCT01015118|521754467|FG001|Overall Study|Other than stated above|23|||
144699875|NCT03522506|521754468|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144699876|NCT03522506|521754469|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144699877|NCT03522506|521754470|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144699878|NCT03522506|521754471|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
144699879|NCT03522506|521754468|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144699880|NCT03522506|521754469|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144699881|NCT03522506|521754470|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
144699882|NCT03522506|521754471|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
144699883|NCT03480243|521754472|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
144699884|NCT03480243|521754472|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
144699885|NCT02388906|521754481|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
144699886|NCT02388906|521754482|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
144699887|NCT02388906|521754481|FG000|Treatment Period|Disease progression|121|||
144699888|NCT02388906|521754482|FG001|Treatment Period|Disease progression|100|||
144699889|NCT02388906|521754481|FG000|Treatment Period|Study drug toxicity|41|||
144699890|NCT02388906|521754482|FG001|Treatment Period|Study drug toxicity|208|||
144699891|NCT02388906|521754481|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
144699892|NCT02388906|521754482|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
144699893|NCT02388906|521754481|FG000|Treatment Period|Participant request to stop treatment|5|||
144699894|NCT02388906|521754482|FG001|Treatment Period|Participant request to stop treatment|9|||
144699895|NCT02388906|521754481|FG000|Treatment Period|Participant withdrew consent|2|||
144699896|NCT02388906|521754482|FG001|Treatment Period|Participant withdrew consent|3|||
144225794|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
144225795|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144225796|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144225797|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
144225798|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225799|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225800|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225801|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225802|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225803|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
144225804|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144225805|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
144268801|NCT02265510|520187766|FG004|Overall Study|Study Terminated by Sponsor|0|||
144225806|NCT03896503|520023532|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
144225807|NCT03896503|520023533|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
144225808|NCT03896503|520023534|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
144225809|NCT03896503|520023535|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
144225810|NCT03896503|520023536|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
144225811|NCT03896503|520023537|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
144225812|NCT03896503|520023538|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
144225813|NCT03896503|520023539|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
144225814|NCT00437021|520023542|FG000|Overall Study|Adverse Event|0|||
144225815|NCT00437021|520023543|FG001|Overall Study|Adverse Event|0|||
144225816|NCT00437021|520023544|FG002|Overall Study|Adverse Event|0|||
144225817|NCT00437021|520023545|FG003|Overall Study|Adverse Event|0|||
144225818|NCT00437021|520023546|FG004|Overall Study|Adverse Event|0|||
144225819|NCT00437021|520023547|FG005|Overall Study|Adverse Event|0|||
144225820|NCT00437021|520023548|FG006|Overall Study|Adverse Event|1|||
144225821|NCT00437021|520023549|FG007|Overall Study|Adverse Event|0|||
144225822|NCT00437021|520023550|FG008|Overall Study|Adverse Event|0|||
144225823|NCT00437021|520023551|FG009|Overall Study|Adverse Event|0|||
144225824|NCT00437021|520023552|FG010|Overall Study|Adverse Event|0|||
144225825|NCT00437021|520023553|FG011|Overall Study|Adverse Event|0|||
144225826|NCT00437021|520023542|FG000|Overall Study|Lost to Follow-up|0|||
144225827|NCT00437021|520023543|FG001|Overall Study|Lost to Follow-up|3|||
144225828|NCT00437021|520023544|FG002|Overall Study|Lost to Follow-up|0|||
144225829|NCT00437021|520023545|FG003|Overall Study|Lost to Follow-up|0|||
144225830|NCT00437021|520023546|FG004|Overall Study|Lost to Follow-up|0|||
144225831|NCT00437021|520023547|FG005|Overall Study|Lost to Follow-up|2|||
144225832|NCT00437021|520023548|FG006|Overall Study|Lost to Follow-up|0|||
144225833|NCT00437021|520023549|FG007|Overall Study|Lost to Follow-up|1|||
144225834|NCT00437021|520023550|FG008|Overall Study|Lost to Follow-up|0|||
144225835|NCT00437021|520023551|FG009|Overall Study|Lost to Follow-up|0|||
144225836|NCT00437021|520023552|FG010|Overall Study|Lost to Follow-up|0|||
144225837|NCT00437021|520023553|FG011|Overall Study|Lost to Follow-up|0|||
144225838|NCT00437021|520023542|FG000|Overall Study|Withdrawal by Subject|2|||
144225839|NCT00437021|520023543|FG001|Overall Study|Withdrawal by Subject|1|||
144225840|NCT00437021|520023544|FG002|Overall Study|Withdrawal by Subject|0|||
144225841|NCT00437021|520023545|FG003|Overall Study|Withdrawal by Subject|0|||
144225842|NCT00437021|520023546|FG004|Overall Study|Withdrawal by Subject|0|||
144225843|NCT00437021|520023547|FG005|Overall Study|Withdrawal by Subject|0|||
144225844|NCT00437021|520023548|FG006|Overall Study|Withdrawal by Subject|0|||
144225845|NCT00437021|520023549|FG007|Overall Study|Withdrawal by Subject|0|||
144225846|NCT00437021|520023550|FG008|Overall Study|Withdrawal by Subject|0|||
144225847|NCT00437021|520023551|FG009|Overall Study|Withdrawal by Subject|0|||
144225848|NCT00437021|520023552|FG010|Overall Study|Withdrawal by Subject|0|||
144225849|NCT00437021|520023553|FG011|Overall Study|Withdrawal by Subject|0|||
144225850|NCT05161481|520023554|FG000|Overall Study|Withdrawal of consent|0|||
144225851|NCT05161481|520023555|FG001|Overall Study|Withdrawal of consent|1|||
144225852|NCT05161481|520023556|FG002|Overall Study|Withdrawal of consent|1|||
144225853|NCT05161481|520023554|FG000|Overall Study|Study terminated by sponsor|3|||
144225854|NCT05161481|520023555|FG001|Overall Study|Study terminated by sponsor|3|||
144225855|NCT05161481|520023556|FG002|Overall Study|Study terminated by sponsor|2|||
144225856|NCT05161481|520023554|FG000|Overall Study|Adverse Event|3|||
144225857|NCT05161481|520023555|FG001|Overall Study|Adverse Event|0|||
144225858|NCT05161481|520023556|FG002|Overall Study|Adverse Event|6|||
144225859|NCT05161481|520023554|FG000|Overall Study|Randomised in error and was not treated|1|||
144225860|NCT05161481|520023555|FG001|Overall Study|Randomised in error and was not treated|0|||
144225861|NCT05161481|520023556|FG002|Overall Study|Randomised in error and was not treated|0|||
144225862|NCT05161481|520023554|FG000|Overall Study|Subject decision|0|||
144225863|NCT05161481|520023555|FG001|Overall Study|Subject decision|0|||
144225864|NCT05161481|520023556|FG002|Overall Study|Subject decision|1|||
144225865|NCT04846569|520023561|FG000|Overall Study|Withdrawal by Subject|3|||
144225866|NCT04846569|520023562|FG001|Overall Study|Withdrawal by Subject|1|||
144225867|NCT01894841|520023568|FG000|Overall Study|Withdrawal by Subject|9|||
144225868|NCT01894841|520023569|FG001|Overall Study|Withdrawal by Subject|4|||
144225869|NCT01894841|520023568|FG000|Overall Study|Withdrawn by investigator|2|||
144225870|NCT01894841|520023569|FG001|Overall Study|Withdrawn by investigator|2|||
144225871|NCT01894841|520023568|FG000|Overall Study|Lost to Follow-up|7|||
144225872|NCT01894841|520023569|FG001|Overall Study|Lost to Follow-up|3|||
144225873|NCT04227197|520023592|FG000|Randomization|Protocol Violation|1|||
144225874|NCT04227197|520023593|FG001|Randomization|Protocol Violation|0|||
144225875|NCT04227197|520023592|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
144225876|NCT04227197|520023593|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
144225877|NCT04227197|520023592|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
144225878|NCT04227197|520023593|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
144225879|NCT04227197|520023592|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
144225880|NCT04227197|520023593|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
144268802|NCT02265510|520187767|FG005|Overall Study|Study Terminated by Sponsor|1|||
144268803|NCT02265510|520187768|FG006|Overall Study|Study Terminated by Sponsor|1|||
144225881|NCT04227197|520023592|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
144268804|NCT02265510|520187769|FG007|Overall Study|Study Terminated by Sponsor|1|||
144225882|NCT04227197|520023593|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
144268805|NCT02265510|520187770|FG008|Overall Study|Study Terminated by Sponsor|1|||
144268806|NCT02265510|520187771|FG009|Overall Study|Study Terminated by Sponsor|2|||
144225883|NCT04227197|520023592|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
144225884|NCT04227197|520023593|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
144225885|NCT04227197|520023592|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
144225886|NCT04227197|520023593|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
144225887|NCT01209949|520023603|FG000|Overall Study|Lost to Follow-up|3|||
144225888|NCT00708552|520023608|FG000|Overall Study|Adverse Event|10|||
144225889|NCT00708552|520023609|FG001|Overall Study|Adverse Event|3|||
144225890|NCT00708552|520023610|FG002|Overall Study|Adverse Event|4|||
144225891|NCT00708552|520023611|FG003|Overall Study|Adverse Event|6|||
144225892|NCT00708552|520023608|FG000|Overall Study|Lack of Efficacy|0|||
144225893|NCT00708552|520023609|FG001|Overall Study|Lack of Efficacy|4|||
144225894|NCT00708552|520023610|FG002|Overall Study|Lack of Efficacy|1|||
144225895|NCT00708552|520023611|FG003|Overall Study|Lack of Efficacy|0|||
144225896|NCT00708552|520023608|FG000|Overall Study|Protocol Violation|0|||
144225897|NCT00708552|520023609|FG001|Overall Study|Protocol Violation|0|||
144225898|NCT00708552|520023610|FG002|Overall Study|Protocol Violation|2|||
144225899|NCT00708552|520023611|FG003|Overall Study|Protocol Violation|4|||
144225900|NCT00708552|520023608|FG000|Overall Study|Lost to Follow-up|4|||
144225901|NCT00708552|520023609|FG001|Overall Study|Lost to Follow-up|2|||
144225902|NCT00708552|520023610|FG002|Overall Study|Lost to Follow-up|0|||
144225903|NCT00708552|520023611|FG003|Overall Study|Lost to Follow-up|1|||
144225904|NCT00708552|520023608|FG000|Overall Study|Physician Decision|1|||
144225905|NCT00708552|520023609|FG001|Overall Study|Physician Decision|2|||
144225906|NCT00708552|520023610|FG002|Overall Study|Physician Decision|0|||
144225907|NCT00708552|520023611|FG003|Overall Study|Physician Decision|0|||
144225908|NCT00708552|520023608|FG000|Overall Study|Withdrawal by Subject|12|||
144225909|NCT00708552|520023609|FG001|Overall Study|Withdrawal by Subject|7|||
144225910|NCT00708552|520023610|FG002|Overall Study|Withdrawal by Subject|8|||
144225911|NCT00708552|520023611|FG003|Overall Study|Withdrawal by Subject|10|||
144225912|NCT04878432|520023613|FG000|Overall Study|Adverse Event|1|||
144225913|NCT04878432|520023613|FG000|Overall Study|Death|2|||
144225914|NCT04878432|520023613|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144225915|NCT04878432|520023613|FG000|Overall Study|Withdrawal by Subject|6|||
144225916|NCT04878432|520023613|FG000|Overall Study|Progressive Disease|7|||
144225917|NCT04878432|520023613|FG000|Overall Study|New Therapy for Study Indication|7|||
144225918|NCT04878432|520023613|FG000|Overall Study|Physician Decision|11|||
144225919|NCT03971071|520023614|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
144225920|NCT03971071|520023615|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
144225921|NCT03971071|520023616|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
144225922|NCT03971071|520023617|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
144225923|NCT03971071|520023618|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
144225924|NCT03971071|520023614|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
144225925|NCT03971071|520023615|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
144225926|NCT03971071|520023616|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
144225927|NCT03971071|520023617|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144268807|NCT02265510|520187772|FG010|Overall Study|Study Terminated by Sponsor|1|||
144268808|NCT02265510|520187773|FG011|Overall Study|Study Terminated by Sponsor|4|||
144268809|NCT02265510|520187774|FG012|Overall Study|Study Terminated by Sponsor|1|||
144225928|NCT03971071|520023618|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
144225929|NCT03971071|520023614|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
144225930|NCT03971071|520023615|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
144225931|NCT03971071|520023616|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
144268810|NCT02265510|520187775|FG013|Overall Study|Study Terminated by Sponsor|2|||
144268811|NCT00116142|520187776|FG000|Overall Study|Adverse Event|8|||
144225932|NCT03971071|520023617|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
144268812|NCT00116142|520187777|FG001|Overall Study|Adverse Event|7|||
144225933|NCT03971071|520023618|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
144225934|NCT03971071|520023614|FG000|Open-label Treatment Period|Sponsor decision|0|||
144225935|NCT03971071|520023615|FG001|Open-label Treatment Period|Sponsor decision|0|||
144225936|NCT03971071|520023616|FG002|Open-label Treatment Period|Sponsor decision|0|||
144268813|NCT00116142|520187776|FG000|Overall Study|Protocol Violation|2|||
144268814|NCT00116142|520187777|FG001|Overall Study|Protocol Violation|1|||
144268815|NCT00116142|520187776|FG000|Overall Study|Withdrawal by Subject|5|||
144268816|NCT00116142|520187777|FG001|Overall Study|Withdrawal by Subject|5|||
144268817|NCT00116142|520187776|FG000|Overall Study|Physician Decision|3|||
144268818|NCT00116142|520187777|FG001|Overall Study|Physician Decision|1|||
144268819|NCT00116142|520187776|FG000|Overall Study|Delayed Radiation Therapy|1|||
144268820|NCT00116142|520187777|FG001|Overall Study|Delayed Radiation Therapy|0|||
144268821|NCT00116142|520187776|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
144268822|NCT00116142|520187777|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
144225937|NCT03971071|520023617|FG003|Open-label Treatment Period|Sponsor decision|0|||
144225938|NCT03971071|520023618|FG004|Open-label Treatment Period|Sponsor decision|1|||
144225939|NCT03971071|520023614|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
144225940|NCT03971071|520023615|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
144225941|NCT03971071|520023616|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
144225942|NCT03971071|520023617|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
144225943|NCT03971071|520023618|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
144225944|NCT03971071|520023614|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
144225945|NCT03971071|520023615|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
144225946|NCT03971071|520023616|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
144225947|NCT03971071|520023617|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
144225948|NCT03971071|520023618|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
144225949|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
144225950|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
144225951|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
144225952|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
144225953|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
144225954|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225955|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225956|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225957|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225958|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225959|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225960|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225961|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225962|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225963|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
144225964|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
144225965|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
144225966|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
144225967|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
144225968|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
144225969|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225970|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225971|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225972|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225973|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225974|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225975|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225976|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225977|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225978|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
144225979|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
144225980|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
144225981|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
144225982|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
144225983|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
144225984|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225985|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144268823|NCT00116142|520187776|FG000|Overall Study|Patient stopped due to depression|0|||
144225986|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225987|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225988|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225989|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225990|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225991|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225992|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144225993|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
144268824|NCT00116142|520187777|FG001|Overall Study|Patient stopped due to depression|1|||
144225994|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
144225995|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
144225996|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
144225997|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
144225998|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
144225999|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226000|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226001|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226002|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226003|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226004|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226005|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226006|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226007|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226008|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
144226009|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
144226010|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144268825|NCT00116142|520187776|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
144268826|NCT00116142|520187777|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
144268827|NCT00116142|520187776|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
144268828|NCT00116142|520187777|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
144268829|NCT00116142|520187776|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
144268830|NCT00116142|520187777|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
144268831|NCT00644059|520187778|FG000|Overall Study|Lost to Follow-up|37|||
144268832|NCT00644059|520187779|FG001|Overall Study|Lost to Follow-up|34|||
144268833|NCT00644059|520187780|FG002|Overall Study|Lost to Follow-up|16|||
144268834|NCT00644059|520187778|FG000|Overall Study|Withdrawal by Subject|52|||
144268835|NCT00644059|520187779|FG001|Overall Study|Withdrawal by Subject|60|||
144268836|NCT00644059|520187780|FG002|Overall Study|Withdrawal by Subject|30|||
144268837|NCT00644059|520187778|FG000|Overall Study|Adverse Event|8|||
144268838|NCT00644059|520187779|FG001|Overall Study|Adverse Event|5|||
144268839|NCT00644059|520187780|FG002|Overall Study|Adverse Event|1|||
144268840|NCT00644059|520187778|FG000|Overall Study|Inappropriate Enrollment|1|||
144268841|NCT00644059|520187779|FG001|Overall Study|Inappropriate Enrollment|3|||
144226011|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
144226012|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
144226013|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
144268842|NCT00644059|520187780|FG002|Overall Study|Inappropriate Enrollment|0|||
144226014|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226015|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226016|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226017|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226018|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226019|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226020|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226021|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226022|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226023|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
144226024|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226025|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226026|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226027|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
144226028|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226029|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226030|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226031|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226032|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226033|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226034|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226035|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226036|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226037|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226038|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
144226039|NCT03334435|520023623|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226040|NCT03334435|520023624|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
144226041|NCT03334435|520023625|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
144268843|NCT00644059|520187778|FG000|Overall Study|Protocol Deviation/violation|20|||
144268844|NCT00644059|520187779|FG001|Overall Study|Protocol Deviation/violation|19|||
144226042|NCT03334435|520023626|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
144226043|NCT03334435|520023627|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
144226044|NCT03334435|520023628|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226045|NCT03334435|520023629|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226046|NCT03334435|520023630|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226047|NCT03334435|520023631|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226048|NCT03334435|520023632|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226049|NCT03334435|520023633|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226050|NCT03334435|520023634|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226051|NCT03334435|520023635|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226052|NCT03334435|520023636|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
144226053|NCT03334435|520023637|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
144699897|NCT02388906|521754481|FG000|Treatment Period|Poor/non-compliance|0|||
144699898|NCT02388906|521754482|FG001|Treatment Period|Poor/non-compliance|1|||
144699899|NCT02388906|521754481|FG000|Treatment Period|Participant no longer meets study criteria|0|||
144699900|NCT02388906|521754482|FG001|Treatment Period|Participant no longer meets study criteria|1|||
144699901|NCT02388906|521754481|FG000|Treatment Period|Other reasons|3|||
144699902|NCT02388906|521754482|FG001|Treatment Period|Other reasons|3|||
144699903|NCT04527380|521754483|FG000|Overall Study|Lack of Efficacy|0|||
144699904|NCT04527380|521754484|FG001|Overall Study|Lack of Efficacy|1|||
144699905|NCT04527380|521754483|FG000|Overall Study|Withdrawal by Subject|1|||
144699906|NCT04527380|521754484|FG001|Overall Study|Withdrawal by Subject|0|||
144699907|NCT05643573|521754485|FG000|Overall Study|Adverse Event|117|||
144699908|NCT05643573|521754486|FG001|Overall Study|Adverse Event|90|||
144699909|NCT05643573|521754485|FG000|Overall Study|Death|53|||
144699910|NCT05643573|521754486|FG001|Overall Study|Death|57|||
144699911|NCT05643573|521754485|FG000|Overall Study|Lost to Follow-up|6|||
144699912|NCT05643573|521754486|FG001|Overall Study|Lost to Follow-up|3|||
144699913|NCT05643573|521754485|FG000|Overall Study|Other|18|||
144699914|NCT05643573|521754486|FG001|Overall Study|Other|15|||
144699915|NCT05643573|521754485|FG000|Overall Study|Outcome event|64|||
144699916|NCT05643573|521754486|FG001|Overall Study|Outcome event|36|||
144226054|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
144226055|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
144226056|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
144226057|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
144226058|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
144226059|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
144226060|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
144226061|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
144226062|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
144226063|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
144226064|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
144226065|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
144226066|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
144226067|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
144226068|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
144226069|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
144226070|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
144226071|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
144226072|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
144226073|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
144226074|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
144226075|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
144226076|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
144226077|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
144226078|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
144226079|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
144226080|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
144226081|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
144226082|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
144226083|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
144226084|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
144226085|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
144226086|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
144226087|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
144226088|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
144226089|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
144226090|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
144226091|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
144226092|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
144226093|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
144226094|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
144226095|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
144226096|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
144226097|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
144226098|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
144226099|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
144268845|NCT00644059|520187780|FG002|Overall Study|Protocol Deviation/violation|15|||
144268846|NCT00644059|520187778|FG000|Overall Study|Unable to classify|6|||
144268847|NCT00644059|520187779|FG001|Overall Study|Unable to classify|2|||
144226100|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
144226101|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
144268848|NCT00644059|520187780|FG002|Overall Study|Unable to classify|3|||
144226102|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
144226103|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
144226104|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
144226105|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
144226106|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
144226107|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
144226108|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
144226109|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
144226110|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
144226111|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
144226112|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
144226113|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
144226114|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226115|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226116|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226117|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226118|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226119|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226120|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
144226121|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
144226122|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
144226123|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
144226124|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
144226125|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
144226126|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
144226127|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
144226128|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
144226129|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226130|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226131|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226132|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226133|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226134|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226135|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226136|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226137|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226138|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226139|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226140|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
144226141|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226142|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
144226143|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
144226144|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226145|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226146|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
144268849|NCT02497469|520187791|FG000|Overall Study|Randomized but not Treated|0|||
144268850|NCT02497469|520187792|FG001|Overall Study|Randomized but not Treated|2|||
144268851|NCT02497469|520187791|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
144268852|NCT02497469|520187792|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
144268853|NCT02497469|520187791|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
144268854|NCT02497469|520187792|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
144699917|NCT05643573|521754485|FG000|Overall Study|Physician Decision|33|||
144699918|NCT05643573|521754486|FG001|Overall Study|Physician Decision|19|||
144699919|NCT05643573|521754485|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
144699920|NCT05643573|521754486|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
144699921|NCT05643573|521754485|FG000|Overall Study|Site terminated by sponsor|10|||
144699922|NCT05643573|521754486|FG001|Overall Study|Site terminated by sponsor|10|||
144699923|NCT05643573|521754485|FG000|Overall Study|Study terminated by sponsor|1|||
144699924|NCT05643573|521754486|FG001|Overall Study|Study terminated by sponsor|0|||
144699925|NCT05643573|521754485|FG000|Overall Study|Withdrawal by Subject|178|||
144699926|NCT05643573|521754486|FG001|Overall Study|Withdrawal by Subject|130|||
144699927|NCT05182840|521754487|FG000|Run-in Period|Not treated|0|||
144699928|NCT05182840|521754488|FG001|Run-in Period|Not treated|1|||
144699929|NCT05182840|521754489|FG002|Run-in Period|Not treated|0|||
144699930|NCT05182840|521754490|FG003|Run-in Period|Not treated|0|||
144699931|NCT05182840|521754491|FG004|Run-in Period|Not treated|0|||
144699932|NCT05182840|521754492|FG005|Run-in Period|Not treated|0|||
144699933|NCT05182840|521754493|FG006|Run-in Period|Not treated|0|||
144699934|NCT05182840|521754494|FG007|Run-in Period|Not treated|0|||
144699935|NCT05182840|521754495|FG008|Run-in Period|Not treated|0|||
144699936|NCT05182840|521754496|FG009|Run-in Period|Not treated|0|||
144699937|NCT05182840|521754487|FG000|Run-in Period|Other reason but not sponsor termination|14|||
144699938|NCT05182840|521754488|FG001|Run-in Period|Other reason but not sponsor termination|18|||
144699939|NCT05182840|521754489|FG002|Run-in Period|Other reason but not sponsor termination|0|||
144699940|NCT05182840|521754490|FG003|Run-in Period|Other reason but not sponsor termination|0|||
144699941|NCT05182840|521754491|FG004|Run-in Period|Other reason but not sponsor termination|0|||
144699942|NCT05182840|521754492|FG005|Run-in Period|Other reason but not sponsor termination|0|||
144699943|NCT05182840|521754493|FG006|Run-in Period|Other reason but not sponsor termination|0|||
144699944|NCT05182840|521754494|FG007|Run-in Period|Other reason but not sponsor termination|0|||
144699945|NCT05182840|521754495|FG008|Run-in Period|Other reason but not sponsor termination|0|||
144699946|NCT05182840|521754496|FG009|Run-in Period|Other reason but not sponsor termination|0|||
144699947|NCT05182840|521754487|FG000|Run-in Period|No reason available|2|||
144699948|NCT05182840|521754488|FG001|Run-in Period|No reason available|2|||
144699949|NCT05182840|521754489|FG002|Run-in Period|No reason available|0|||
144699950|NCT05182840|521754490|FG003|Run-in Period|No reason available|0|||
144699951|NCT05182840|521754491|FG004|Run-in Period|No reason available|0|||
144699952|NCT05182840|521754492|FG005|Run-in Period|No reason available|0|||
144699953|NCT05182840|521754493|FG006|Run-in Period|No reason available|0|||
144699954|NCT05182840|521754494|FG007|Run-in Period|No reason available|0|||
144699955|NCT05182840|521754495|FG008|Run-in Period|No reason available|0|||
144699956|NCT05182840|521754496|FG009|Run-in Period|No reason available|0|||
144699957|NCT05182840|521754487|FG000|Run-in Period|Burden of study procedures|2|||
144699958|NCT05182840|521754488|FG001|Run-in Period|Burden of study procedures|2|||
144699959|NCT05182840|521754489|FG002|Run-in Period|Burden of study procedures|0|||
144699960|NCT05182840|521754490|FG003|Run-in Period|Burden of study procedures|0|||
144699961|NCT05182840|521754491|FG004|Run-in Period|Burden of study procedures|0|||
144699962|NCT05182840|521754492|FG005|Run-in Period|Burden of study procedures|0|||
144699963|NCT05182840|521754493|FG006|Run-in Period|Burden of study procedures|0|||
144699964|NCT05182840|521754494|FG007|Run-in Period|Burden of study procedures|0|||
144699965|NCT05182840|521754495|FG008|Run-in Period|Burden of study procedures|0|||
144699966|NCT05182840|521754496|FG009|Run-in Period|Burden of study procedures|0|||
144699967|NCT05182840|521754487|FG000|Run-in Period|Change of residence|1|||
144699968|NCT05182840|521754488|FG001|Run-in Period|Change of residence|0|||
144699969|NCT05182840|521754489|FG002|Run-in Period|Change of residence|0|||
144699970|NCT05182840|521754490|FG003|Run-in Period|Change of residence|0|||
144699971|NCT05182840|521754491|FG004|Run-in Period|Change of residence|0|||
144699972|NCT05182840|521754492|FG005|Run-in Period|Change of residence|0|||
144699973|NCT05182840|521754493|FG006|Run-in Period|Change of residence|0|||
144699974|NCT05182840|521754494|FG007|Run-in Period|Change of residence|0|||
144699975|NCT05182840|521754495|FG008|Run-in Period|Change of residence|0|||
144699976|NCT05182840|521754496|FG009|Run-in Period|Change of residence|0|||
144699977|NCT05182840|521754487|FG000|Run-in Period|Adverse Event|5|||
144699978|NCT05182840|521754488|FG001|Run-in Period|Adverse Event|5|||
144699979|NCT05182840|521754489|FG002|Run-in Period|Adverse Event|0|||
144699980|NCT05182840|521754490|FG003|Run-in Period|Adverse Event|0|||
144699981|NCT05182840|521754491|FG004|Run-in Period|Adverse Event|0|||
144699982|NCT05182840|521754492|FG005|Run-in Period|Adverse Event|0|||
144699983|NCT05182840|521754493|FG006|Run-in Period|Adverse Event|0|||
144699984|NCT05182840|521754494|FG007|Run-in Period|Adverse Event|0|||
144699985|NCT05182840|521754495|FG008|Run-in Period|Adverse Event|0|||
144226147|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226148|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226149|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
144226150|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226151|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226152|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226153|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226154|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226155|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226156|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226157|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
144226158|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
144226159|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226160|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226161|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226162|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226163|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226164|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
144226165|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
144226166|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
144226167|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
144226168|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
144226169|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
144226170|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
144226171|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226172|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226173|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
144226174|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226175|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226176|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226177|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226178|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226179|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
144226180|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
144226181|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226182|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226183|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226184|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
144226185|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
144226186|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
144226187|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
144226188|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
144226189|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226190|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226191|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226192|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226193|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144268855|NCT02497469|520187791|FG000|Overall Study|Significant Protocol Deviation|4|||
144268856|NCT02497469|520187792|FG001|Overall Study|Significant Protocol Deviation|5|||
144268857|NCT02497469|520187791|FG000|Overall Study|Lost to Follow-up|14|||
144268858|NCT02497469|520187792|FG001|Overall Study|Lost to Follow-up|4|||
144268859|NCT02497469|520187791|FG000|Overall Study|Voluntary Withdrawal|39|||
144268860|NCT02497469|520187792|FG001|Overall Study|Voluntary Withdrawal|41|||
144268861|NCT02497469|520187791|FG000|Overall Study|Pregnancy|1|||
144268862|NCT02497469|520187792|FG001|Overall Study|Pregnancy|1|||
144268863|NCT02497469|520187791|FG000|Overall Study|Lack of Efficacy|86|||
144268864|NCT02497469|520187792|FG001|Overall Study|Lack of Efficacy|40|||
144268865|NCT02497469|520187791|FG000|Overall Study|Reason not Specified|6|||
144268866|NCT02497469|520187792|FG001|Overall Study|Reason not Specified|6|||
144226194|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
144268867|NCT03558516|520187793|FG000|Overall Study|Protocol Violation|2|||
144268868|NCT03558516|520187794|FG001|Overall Study|Protocol Violation|2|||
144268869|NCT00472420|520187795|FG000|Induction Treatment Period|Physician Decision|9|||
144268870|NCT00472420|520187795|FG000|Induction Treatment Period|Adverse Event|3|||
144226195|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226196|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226197|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226198|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226199|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
144226200|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226201|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226202|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
144226203|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
144226204|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226205|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226206|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226207|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226208|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226209|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226210|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226211|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
144226212|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
144226213|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226214|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
144226215|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
144268871|NCT00472420|520187795|FG000|Induction Treatment Period|Non-compliance|1|||
144268872|NCT00472420|520187795|FG000|Induction Treatment Period|Death|3|||
144268873|NCT00472420|520187795|FG000|Follow-up Period|Death|5|||
144268874|NCT00472420|520187795|FG000|Follow-up Period|Physician Decision|9|||
144268875|NCT00472420|520187795|FG000|Follow-up Period|Lost to Follow-up|2|||
144268876|NCT00472420|520187795|FG000|Follow-up Period|Protocol Violation|1|||
144226216|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
144226217|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226218|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
144226219|NCT03334435|520023623|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226220|NCT03334435|520023624|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226221|NCT03334435|520023625|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144268877|NCT01026493|520187798|FG000|Overall Study|Protocol Violation|0|||
144268878|NCT01026493|520187799|FG001|Overall Study|Protocol Violation|1|||
144268879|NCT01026493|520187800|FG002|Overall Study|Protocol Violation|0|||
144268880|NCT01026493|520187801|FG003|Overall Study|Protocol Violation|0|||
144268881|NCT01026493|520187802|FG004|Overall Study|Protocol Violation|2|||
144268882|NCT01026493|520187803|FG005|Overall Study|Protocol Violation|3|||
144268883|NCT01026493|520187804|FG006|Overall Study|Protocol Violation|4|||
144268884|NCT01026493|520187805|FG007|Overall Study|Protocol Violation|1|||
144268885|NCT03154086|520187809|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268886|NCT03154086|520187810|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268887|NCT03154086|520187811|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144699986|NCT05182840|521754496|FG009|Run-in Period|Adverse Event|0|||
144699987|NCT05182840|521754487|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
144699988|NCT05182840|521754488|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
144699989|NCT05182840|521754489|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699990|NCT05182840|521754490|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699991|NCT05182840|521754491|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699992|NCT05182840|521754492|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144268888|NCT03154086|520187812|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
144226222|NCT03334435|520023626|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226223|NCT03334435|520023627|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226224|NCT03334435|520023628|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226225|NCT03334435|520023629|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226226|NCT03334435|520023630|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226227|NCT03334435|520023631|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226228|NCT03334435|520023632|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226229|NCT03334435|520023633|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226230|NCT03334435|520023634|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
144226231|NCT03334435|520023635|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
144226232|NCT03334435|520023636|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
144226233|NCT03334435|520023637|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
144226234|NCT03922321|520023638|FG000|Overall Study|Participant Moved|1|||
144226235|NCT03922321|520023638|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
144226236|NCT03214224|520023639|FG000|Overall Study|Protocol Violation|1|||
144226237|NCT03214224|520023639|FG000|Overall Study|Withdrawal by Subject|2|||
144226238|NCT03214224|520023639|FG000|Overall Study|Practice controls or therapists|6|||
144268889|NCT03154086|520187813|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268890|NCT03154086|520187814|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268891|NCT03154086|520187815|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268892|NCT03154086|520187816|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268893|NCT03154086|520187817|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268894|NCT03154086|520187818|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268895|NCT03154086|520187819|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268896|NCT03154086|520187820|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268897|NCT03154086|520187821|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268898|NCT03154086|520187822|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268899|NCT03154086|520187823|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
144268900|NCT03154086|520187809|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268901|NCT03154086|520187810|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
144268902|NCT03154086|520187811|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144226239|NCT02712320|520023640|FG000|Overall Study|Lost to Follow-up|1|||
144226240|NCT02712320|520023640|FG000|Overall Study|Withdrawal by Subject|1|||
144226241|NCT02712320|520023640|FG000|Overall Study|Transferred to another facility|1|||
144226242|NCT02712320|520023640|FG000|Overall Study|Treating with the prohibited medications|2|||
144226243|NCT00444535|520023641|FG000|Overall Study|Withdrawal by Subject|5|||
144226244|NCT00444535|520023641|FG000|Overall Study|Physician Decision|5|||
144226245|NCT00444535|520023641|FG000|Overall Study|progressive disease|1|||
144226246|NCT00444535|520023641|FG000|Overall Study|Adverse Event|2|||
144226247|NCT05005507|520023642|FG000|Overall Study|Premature termination of study|1|||
144226248|NCT05581641|520023646|FG000|Overall Study|Withdrawal by Subject|0|||
144226249|NCT05581641|520023647|FG001|Overall Study|Withdrawal by Subject|1|||
144226250|NCT05581641|520023648|FG002|Overall Study|Withdrawal by Subject|3|||
144226251|NCT05581641|520023649|FG003|Overall Study|Withdrawal by Subject|1|||
144226252|NCT05581641|520023646|FG000|Overall Study|Lost to Follow-up|0|||
144226253|NCT05581641|520023647|FG001|Overall Study|Lost to Follow-up|1|||
144226254|NCT05581641|520023648|FG002|Overall Study|Lost to Follow-up|0|||
144226255|NCT05581641|520023649|FG003|Overall Study|Lost to Follow-up|1|||
144226256|NCT05581641|520023646|FG000|Overall Study|Protocol Violation|1|||
144226257|NCT05581641|520023647|FG001|Overall Study|Protocol Violation|0|||
144226258|NCT05581641|520023648|FG002|Overall Study|Protocol Violation|0|||
144226259|NCT05581641|520023649|FG003|Overall Study|Protocol Violation|0|||
144226260|NCT05581641|520023646|FG000|Overall Study|Other|1|||
144226261|NCT05581641|520023647|FG001|Overall Study|Other|0|||
144226262|NCT05581641|520023648|FG002|Overall Study|Other|2|||
144226263|NCT05581641|520023649|FG003|Overall Study|Other|1|||
144226264|NCT02040805|520023650|FG000|Overall Study|Lost to Follow-up|14|||
144226265|NCT02040805|520023651|FG001|Overall Study|Lost to Follow-up|9|||
144226266|NCT02040805|520023650|FG000|Overall Study|Withdrawal by Subject|28|||
144268903|NCT03154086|520187812|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268904|NCT03154086|520187813|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268905|NCT03154086|520187814|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268906|NCT03154086|520187815|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268907|NCT03154086|520187816|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268908|NCT03154086|520187817|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268909|NCT03154086|520187818|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268910|NCT03154086|520187819|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268911|NCT03154086|520187820|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268912|NCT03154086|520187821|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268913|NCT03154086|520187822|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268914|NCT03154086|520187823|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
144268915|NCT03154086|520187809|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268916|NCT03154086|520187810|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268917|NCT03154086|520187811|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
144268918|NCT03154086|520187812|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268919|NCT03154086|520187813|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268920|NCT03154086|520187814|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268921|NCT03154086|520187815|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268922|NCT03154086|520187816|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268923|NCT03154086|520187817|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268924|NCT03154086|520187818|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268925|NCT03154086|520187819|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268926|NCT03154086|520187820|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268927|NCT03154086|520187821|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268928|NCT03154086|520187822|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268929|NCT03154086|520187823|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
144268930|NCT03154086|520187809|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
144268931|NCT03154086|520187810|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268932|NCT03154086|520187811|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268933|NCT03154086|520187812|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268934|NCT03154086|520187813|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268935|NCT03154086|520187814|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268936|NCT03154086|520187815|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268937|NCT03154086|520187816|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268938|NCT03154086|520187817|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268939|NCT03154086|520187818|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268940|NCT03154086|520187819|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268941|NCT03154086|520187820|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268942|NCT03154086|520187821|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268943|NCT03154086|520187822|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268944|NCT03154086|520187823|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
144268945|NCT03154086|520187809|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268946|NCT03154086|520187810|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268947|NCT03154086|520187811|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268948|NCT03154086|520187812|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268949|NCT03154086|520187813|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268950|NCT03154086|520187814|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268951|NCT03154086|520187815|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268952|NCT03154086|520187816|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268953|NCT03154086|520187817|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
144268954|NCT03154086|520187818|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268955|NCT03154086|520187819|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268956|NCT03154086|520187820|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268957|NCT03154086|520187821|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268958|NCT03154086|520187822|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268959|NCT03154086|520187823|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
144268960|NCT03154086|520187809|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268961|NCT03154086|520187810|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268962|NCT03154086|520187811|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268963|NCT03154086|520187812|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268964|NCT03154086|520187813|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268965|NCT03154086|520187814|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268966|NCT03154086|520187815|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144226267|NCT02040805|520023651|FG001|Overall Study|Withdrawal by Subject|41|||
144226268|NCT01213966|520023652|FG000|Overall Study|Protocol Violation|1|||
144226269|NCT01213966|520023653|FG001|Overall Study|Protocol Violation|0|||
144226270|NCT01213966|520023654|FG002|Overall Study|Protocol Violation|3|||
144226271|NCT01213966|520023655|FG003|Overall Study|Protocol Violation|1|||
144226272|NCT00071110|520023660|FG000|Overall Study|Protocol Violation|0|||
144226273|NCT00071110|520023661|FG001|Overall Study|Protocol Violation|4|||
144226274|NCT02166333|520023663|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
144226275|NCT02166333|520023664|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
144226276|NCT02166333|520023665|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
144226277|NCT02166333|520023666|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
144226278|NCT02166333|520023667|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
144226279|NCT02166333|520023668|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
144226280|NCT02166333|520023663|FG000|Stage 1|Death|4|||
144226281|NCT02166333|520023664|FG001|Stage 1|Death|0|||
144226282|NCT02166333|520023665|FG002|Stage 1|Death|2|||
144226283|NCT02166333|520023666|FG003|Stage 1|Death|0|||
144226284|NCT02166333|520023667|FG004|Stage 1|Death|3|||
144226285|NCT02166333|520023668|FG005|Stage 1|Death|2|||
144226286|NCT02166333|520023663|FG000|Stage 1|Lost to Follow-up|12|||
144226287|NCT02166333|520023664|FG001|Stage 1|Lost to Follow-up|0|||
144226288|NCT02166333|520023665|FG002|Stage 1|Lost to Follow-up|6|||
144226289|NCT02166333|520023666|FG003|Stage 1|Lost to Follow-up|0|||
144226290|NCT02166333|520023667|FG004|Stage 1|Lost to Follow-up|3|||
144226291|NCT02166333|520023668|FG005|Stage 1|Lost to Follow-up|3|||
144226292|NCT02166333|520023663|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
144226293|NCT02166333|520023664|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
144226294|NCT02166333|520023665|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
144226295|NCT02166333|520023666|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
144226296|NCT02166333|520023667|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
144226297|NCT02166333|520023668|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
144226298|NCT02166333|520023663|FG000|Stage 2|Death|4|||
144226299|NCT02166333|520023664|FG001|Stage 2|Death|2|||
144226300|NCT02166333|520023665|FG002|Stage 2|Death|1|||
144226301|NCT02166333|520023666|FG003|Stage 2|Death|0|||
144226302|NCT02166333|520023667|FG004|Stage 2|Death|0|||
144226303|NCT02166333|520023668|FG005|Stage 2|Death|1|||
144226304|NCT02166333|520023663|FG000|Stage 2|Lost to Follow-up|23|||
144226305|NCT02166333|520023664|FG001|Stage 2|Lost to Follow-up|4|||
144226306|NCT02166333|520023665|FG002|Stage 2|Lost to Follow-up|11|||
144226307|NCT02166333|520023666|FG003|Stage 2|Lost to Follow-up|9|||
144226308|NCT02166333|520023667|FG004|Stage 2|Lost to Follow-up|3|||
144226309|NCT02166333|520023668|FG005|Stage 2|Lost to Follow-up|6|||
144226310|NCT02269098|520023669|FG000|Overall Study|Lost to Follow-up|14|||
144226311|NCT02269098|520023670|FG001|Overall Study|Lost to Follow-up|9|||
144226312|NCT00503698|520023671|FG000|Overall Study|Protocol Violation|5|||
144226313|NCT00503698|520023672|FG001|Overall Study|Protocol Violation|6|||
144226314|NCT00503698|520023671|FG000|Overall Study|Adverse Event|52|||
144226315|NCT00503698|520023672|FG001|Overall Study|Adverse Event|41|||
144226316|NCT00503698|520023671|FG000|Overall Study|Death|1|||
144226317|NCT00503698|520023672|FG001|Overall Study|Death|0|||
144226318|NCT00503698|520023671|FG000|Overall Study|Lack of Efficacy|3|||
144226319|NCT00503698|520023672|FG001|Overall Study|Lack of Efficacy|4|||
144226320|NCT00503698|520023671|FG000|Overall Study|Trial terminated|216|||
144226321|NCT00503698|520023672|FG001|Overall Study|Trial terminated|253|||
144226322|NCT00503698|520023671|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
144226323|NCT00503698|520023672|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
144226324|NCT00503698|520023671|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
144226325|NCT00503698|520023672|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
144226326|NCT00503698|520023671|FG000|Overall Study|Any condition in exclusion criteria|4|||
144226327|NCT00503698|520023672|FG001|Overall Study|Any condition in exclusion criteria|6|||
144226328|NCT00503698|520023671|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
144226329|NCT00503698|520023672|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
144226330|NCT00503698|520023671|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
144226331|NCT00503698|520023672|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
144226332|NCT00503698|520023671|FG000|Overall Study|Critically ill|2|||
144226333|NCT00503698|520023672|FG001|Overall Study|Critically ill|0|||
144226334|NCT00503698|520023671|FG000|Overall Study|Unclassified|48|||
144226335|NCT00503698|520023672|FG001|Overall Study|Unclassified|32|||
144226336|NCT00503698|520023671|FG000|Overall Study|Not exposed to trial drug|11|||
144226337|NCT00503698|520023672|FG001|Overall Study|Not exposed to trial drug|6|||
144226338|NCT00682786|520023680|FG000|Overall Study|Withdrawal by Subject|2|||
144226339|NCT00682786|520023681|FG001|Overall Study|Withdrawal by Subject|2|||
144226340|NCT00682786|520023680|FG000|Overall Study|Did not receive irinotecan|0|||
144268967|NCT03154086|520187816|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
144268968|NCT03154086|520187817|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268969|NCT03154086|520187818|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268970|NCT03154086|520187819|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268971|NCT03154086|520187820|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268972|NCT03154086|520187821|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268973|NCT03154086|520187822|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268974|NCT03154086|520187823|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
144268975|NCT03154086|520187809|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
144268976|NCT03154086|520187810|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
144268977|NCT03154086|520187811|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
144268978|NCT03154086|520187812|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
144268979|NCT03154086|520187813|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
144268980|NCT03154086|520187814|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
144268981|NCT03154086|520187815|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
144268982|NCT03154086|520187816|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
144268983|NCT03154086|520187817|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
144226341|NCT00682786|520023681|FG001|Overall Study|Did not receive irinotecan|1|||
144226342|NCT00359424|520023684|FG000|Overall Study|Death|99|||
144226343|NCT00359424|520023685|FG001|Overall Study|Death|58|||
144226344|NCT00359424|520023684|FG000|Overall Study|Lost to Follow-up|19|||
144226345|NCT00359424|520023685|FG001|Overall Study|Lost to Follow-up|7|||
144226346|NCT00359424|520023684|FG000|Overall Study|Withdrawal by Subject|10|||
144226347|NCT00359424|520023685|FG001|Overall Study|Withdrawal by Subject|2|||
144226348|NCT00359424|520023684|FG000|Overall Study|follow up not conducted|2|||
144226349|NCT00359424|520023685|FG001|Overall Study|follow up not conducted|0|||
144226350|NCT02259010|520023688|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
144226351|NCT03655405|520023689|FG000|Overall Study|Death after initial data collection|4|||
144226352|NCT03655405|520023690|FG001|Overall Study|Death after initial data collection|2|||
144226353|NCT03655405|520023689|FG000|Overall Study|Died before initial data collection|1|||
144226354|NCT03655405|520023690|FG001|Overall Study|Died before initial data collection|2|||
144226355|NCT03655405|520023689|FG000|Overall Study|Protocol Violation|0|||
144226356|NCT03655405|520023690|FG001|Overall Study|Protocol Violation|1|||
144226357|NCT01445730|520023693|FG000|Overall Study|Adverse Event|1|||
144226358|NCT01445730|520023693|FG000|Overall Study|For the advice of a dentist|1|||
144226359|NCT01445730|520023693|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
144226360|NCT01167140|520023696|FG000|Overall Study|Withdrawal by Subject|1|||
144226361|NCT03805412|520023697|FG000|Overall Study|Lost to Follow-up|0|||
144226362|NCT03805412|520023698|FG001|Overall Study|Lost to Follow-up|1|||
144226363|NCT02389829|520023704|FG000|Overall Study|Lost to Follow-up|0|||
144226364|NCT02389829|520023705|FG001|Overall Study|Lost to Follow-up|1|||
144226365|NCT03817190|520023706|FG000|Overall Study|Early Termination|13|||
144226366|NCT03817190|520023707|FG001|Overall Study|Early Termination|20|||
144268984|NCT03154086|520187818|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
144268985|NCT03154086|520187819|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
144268986|NCT03154086|520187820|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
144268987|NCT03154086|520187821|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
144268988|NCT03154086|520187822|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
144268989|NCT03154086|520187823|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
144226367|NCT03817190|520023706|FG000|Overall Study|Adverse Event|10|||
144226368|NCT03817190|520023707|FG001|Overall Study|Adverse Event|17|||
144226369|NCT03817190|520023706|FG000|Overall Study|Withdrawal by Subject|12|||
144226370|NCT03817190|520023707|FG001|Overall Study|Withdrawal by Subject|8|||
144226371|NCT03817190|520023706|FG000|Overall Study|Lost to Follow-up|11|||
144226372|NCT03817190|520023707|FG001|Overall Study|Lost to Follow-up|7|||
144226373|NCT03817190|520023706|FG000|Overall Study|Lack of Efficacy|7|||
144226374|NCT03817190|520023707|FG001|Overall Study|Lack of Efficacy|5|||
144226375|NCT03817190|520023706|FG000|Overall Study|Investigator Decision|5|||
144226376|NCT03817190|520023707|FG001|Overall Study|Investigator Decision|1|||
144226377|NCT03817190|520023706|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
144226378|NCT03817190|520023707|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
144226379|NCT03817190|520023706|FG000|Overall Study|Lack of Contact|1|||
144226380|NCT03817190|520023707|FG001|Overall Study|Lack of Contact|0|||
144226381|NCT03817190|520023706|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
144226382|NCT03817190|520023707|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
144226383|NCT04767282|520025751|FG000|Overall Study|Refused or did not begin surveys|6|||
144226384|NCT04767282|520025752|FG001|Overall Study|Refused or did not begin surveys|2|||
144226385|NCT04767282|520025753|FG002|Overall Study|Refused or did not begin surveys|2|||
144226386|NCT04767282|520025751|FG000|Overall Study|Duplicate household previously enrolled|2|||
144226387|NCT04767282|520025752|FG001|Overall Study|Duplicate household previously enrolled|0|||
144226388|NCT04767282|520025753|FG002|Overall Study|Duplicate household previously enrolled|8|||
144226389|NCT04767282|520025751|FG000|Overall Study|Unable to confirm legal guardian|0|||
144226390|NCT04767282|520025752|FG001|Overall Study|Unable to confirm legal guardian|2|||
144226391|NCT04767282|520025753|FG002|Overall Study|Unable to confirm legal guardian|8|||
144226392|NCT04767282|520025751|FG000|Overall Study|Withdrawal by Subject|0|||
144226393|NCT04767282|520025752|FG001|Overall Study|Withdrawal by Subject|0|||
144226394|NCT04767282|520025753|FG002|Overall Study|Withdrawal by Subject|6|||
144226395|NCT04767282|520025751|FG000|Overall Study|Survey comprehension challenges|4|||
144226396|NCT04767282|520025752|FG001|Overall Study|Survey comprehension challenges|0|||
144226397|NCT04767282|520025753|FG002|Overall Study|Survey comprehension challenges|0|||
144268990|NCT04076917|520187824|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
144268991|NCT04076917|520187824|FG000|Overall Study|Study closure|13|||
144268992|NCT04076917|520187824|FG000|Overall Study|Physician Decision|3|||
144226398|NCT00824772|520025754|FG000|Overall Study|Withdrawal by Subject|8|||
144226399|NCT00536939|520025755|FG000|Overall Study|Withdrawal by Subject|1|||
144226400|NCT00536939|520025756|FG001|Overall Study|Withdrawal by Subject|0|||
144226401|NCT00536939|520025755|FG000|Overall Study|Other Complicating Disease|1|||
144226402|NCT00536939|520025756|FG001|Overall Study|Other Complicating Disease|0|||
144226403|NCT00529087|520025766|FG000|Overall Study|Adverse Event|10|||
144226404|NCT00529087|520025767|FG001|Overall Study|Adverse Event|13|||
144226405|NCT00529087|520025768|FG002|Overall Study|Adverse Event|4|||
144226406|NCT00529087|520025766|FG000|Overall Study|Lost to Follow-up|6|||
144226407|NCT00529087|520025767|FG001|Overall Study|Lost to Follow-up|4|||
144226408|NCT00529087|520025768|FG002|Overall Study|Lost to Follow-up|1|||
144268993|NCT04076917|520187824|FG000|Overall Study|Death|1|||
144268994|NCT04076917|520187824|FG000|Overall Study|Lost to Follow-up|1|||
144268995|NCT04076917|520187824|FG000|Overall Study|Withdrawal by Subject|1|||
144226409|NCT00529087|520025766|FG000|Overall Study|Protocol Violation|8|||
144226410|NCT00529087|520025767|FG001|Overall Study|Protocol Violation|7|||
144226411|NCT00529087|520025768|FG002|Overall Study|Protocol Violation|6|||
144226412|NCT00529087|520025766|FG000|Overall Study|Withdrawal by Subject|3|||
144226413|NCT00529087|520025767|FG001|Overall Study|Withdrawal by Subject|3|||
144226414|NCT00529087|520025768|FG002|Overall Study|Withdrawal by Subject|3|||
144226415|NCT00529087|520025766|FG000|Overall Study|Protocol deviation|1|||
144226416|NCT00529087|520025767|FG001|Overall Study|Protocol deviation|1|||
144226417|NCT00529087|520025768|FG002|Overall Study|Protocol deviation|2|||
144226418|NCT02954601|520025769|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
144226419|NCT02954601|520025770|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
144226420|NCT02954601|520025771|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
144226421|NCT02954601|520025772|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
144226422|NCT00318474|520025773|FG000|Overall Study|Adverse Event|1|||
144226423|NCT00318474|520025774|FG001|Overall Study|Adverse Event|1|||
144226424|NCT00318474|520025773|FG000|Overall Study|Lost to Follow-up|0|||
144226425|NCT00318474|520025774|FG001|Overall Study|Lost to Follow-up|1|||
144226426|NCT00318474|520025773|FG000|Overall Study|Pregnancy|0|||
144226427|NCT00318474|520025774|FG001|Overall Study|Pregnancy|2|||
144226428|NCT00318474|520025773|FG000|Overall Study|Protocol Violation|1|||
144226429|NCT00318474|520025774|FG001|Overall Study|Protocol Violation|0|||
144226430|NCT00318474|520025773|FG000|Overall Study|Withdrawal by Subject|3|||
144226431|NCT00318474|520025774|FG001|Overall Study|Withdrawal by Subject|2|||
144226432|NCT00318474|520025773|FG000|Overall Study|Fall in GFR|3|||
144226433|NCT00318474|520025774|FG001|Overall Study|Fall in GFR|3|||
144226434|NCT00318474|520025773|FG000|Overall Study|Post-therapy hyperflycemia|0|||
144226435|NCT00318474|520025774|FG001|Overall Study|Post-therapy hyperflycemia|1|||
144226436|NCT00318474|520025773|FG000|Overall Study|Trial terminated|10|||
144226437|NCT00318474|520025774|FG001|Overall Study|Trial terminated|7|||
144226438|NCT01735916|520025783|FG000|Overall Study|Subject not eligible to be randomized|11|||
144226439|NCT01735916|520025784|FG001|Overall Study|Subject not eligible to be randomized|0|||
144226440|NCT01735916|520025785|FG002|Overall Study|Subject not eligible to be randomized|0|||
144226441|NCT01735916|520025783|FG000|Overall Study|Early termination of study by sponsor|4|||
144226442|NCT01735916|520025784|FG001|Overall Study|Early termination of study by sponsor|19|||
144226443|NCT01735916|520025785|FG002|Overall Study|Early termination of study by sponsor|7|||
144226444|NCT01735916|520025783|FG000|Overall Study|Withdrawal by Subject|3|||
144226445|NCT01735916|520025784|FG001|Overall Study|Withdrawal by Subject|0|||
144226446|NCT01735916|520025785|FG002|Overall Study|Withdrawal by Subject|0|||
144226447|NCT02275546|520025791|FG000|Treatment Period 2|Withdrawal by Subject|2|||
144226448|NCT02275546|520025792|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144226449|NCT02275546|520025791|FG000|Treatment Period 2|Protocol Violation|0|||
144226450|NCT02275546|520025792|FG001|Treatment Period 2|Protocol Violation|1|||
144226451|NCT02955355|520025798|FG000|Overall Study|Adverse Event|4|||
144226452|NCT02955355|520025798|FG000|Overall Study|Death|1|||
144226453|NCT02955355|520025798|FG000|Overall Study|Physician Decision|21|||
144226454|NCT02955355|520025798|FG000|Overall Study|Site Terminated by Sponsor|35|||
144226455|NCT02955355|520025798|FG000|Overall Study|Withdrawal by Subject|19|||
144226456|NCT02955355|520025798|FG000|Overall Study|Reason Not Specified|5|||
144226457|NCT00333983|520025799|FG000|Overall Study|Lost to Follow-up|2|||
144226458|NCT00333983|520025800|FG001|Overall Study|Lost to Follow-up|1|||
144226459|NCT00333983|520025801|FG002|Overall Study|Lost to Follow-up|0|||
144226460|NCT00333983|520025799|FG000|Overall Study|Adverse Event|1|||
144226461|NCT00333983|520025800|FG001|Overall Study|Adverse Event|1|||
144226462|NCT00333983|520025801|FG002|Overall Study|Adverse Event|1|||
144226463|NCT00333983|520025799|FG000|Overall Study|Withdrawal by Subject|0|||
144226464|NCT00333983|520025800|FG001|Overall Study|Withdrawal by Subject|3|||
144226465|NCT00333983|520025801|FG002|Overall Study|Withdrawal by Subject|1|||
144226466|NCT01379768|520025808|FG000|Overall Study|Adverse Event|1|||
144226467|NCT01379768|520025809|FG001|Overall Study|Adverse Event|1|||
144268996|NCT04076917|520187824|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
144268997|NCT01701245|520187827|FG000|Overall Study|Protocol Violation|1|||
144268998|NCT01701245|520187828|FG001|Overall Study|Protocol Violation|3|||
144268999|NCT01701245|520187827|FG000|Overall Study|Did not complete the open label period|11|||
144269000|NCT01701245|520187828|FG001|Overall Study|Did not complete the open label period|12|||
144226468|NCT01379768|520025810|FG002|Overall Study|Adverse Event|0|||
144226469|NCT01379768|520025808|FG000|Overall Study|Lost to Follow-up|2|||
144226470|NCT01379768|520025809|FG001|Overall Study|Lost to Follow-up|0|||
144226471|NCT01379768|520025810|FG002|Overall Study|Lost to Follow-up|0|||
144226472|NCT02075203|520025815|FG000|Overall Study|Withdrawal by Subject|1|||
144226473|NCT02075203|520025816|FG001|Overall Study|Withdrawal by Subject|0|||
144226474|NCT02075203|520025817|FG002|Overall Study|Withdrawal by Subject|1|||
144226475|NCT02075203|520025815|FG000|Overall Study|Adverse Event|1|||
144226476|NCT02075203|520025816|FG001|Overall Study|Adverse Event|0|||
144226477|NCT02075203|520025817|FG002|Overall Study|Adverse Event|0|||
144226478|NCT02075203|520025815|FG000|Overall Study|participant refused to use contraception|1|||
144226479|NCT02075203|520025816|FG001|Overall Study|participant refused to use contraception|0|||
144226480|NCT02075203|520025817|FG002|Overall Study|participant refused to use contraception|0|||
144226481|NCT00350207|520025818|FG000|Overall Study|Adverse Event|5|||
144226482|NCT00350207|520025819|FG001|Overall Study|Adverse Event|2|||
144226483|NCT00350207|520025820|FG002|Overall Study|Adverse Event|2|||
144226484|NCT00350207|520025818|FG000|Overall Study|Lack of Efficacy|1|||
144226485|NCT00350207|520025819|FG001|Overall Study|Lack of Efficacy|0|||
144226486|NCT00350207|520025820|FG002|Overall Study|Lack of Efficacy|2|||
144226487|NCT00350207|520025818|FG000|Overall Study|Lost to Follow-up|1|||
144226488|NCT00350207|520025819|FG001|Overall Study|Lost to Follow-up|0|||
144226489|NCT00350207|520025820|FG002|Overall Study|Lost to Follow-up|1|||
144226490|NCT00350207|520025818|FG000|Overall Study|Withdrawal by Subject|0|||
144226491|NCT00350207|520025819|FG001|Overall Study|Withdrawal by Subject|1|||
144226492|NCT00350207|520025820|FG002|Overall Study|Withdrawal by Subject|1|||
144226493|NCT00350207|520025818|FG000|Overall Study|Other|1|||
144226494|NCT00350207|520025819|FG001|Overall Study|Other|3|||
144226495|NCT00350207|520025820|FG002|Overall Study|Other|1|||
144226496|NCT00495391|520025821|FG000|Overall Study|Lack of Efficacy|34|||
144226497|NCT00495391|520025822|FG001|Overall Study|Lack of Efficacy|18|||
144226498|NCT00495391|520025821|FG000|Overall Study|Withdrawal by Subject|2|||
144226499|NCT00495391|520025822|FG001|Overall Study|Withdrawal by Subject|3|||
144226500|NCT00568451|520025831|FG000|Overall Study|Disease Progression|0|||
144226501|NCT00568451|520025832|FG001|Overall Study|Disease Progression|0|||
144226502|NCT00568451|520025833|FG002|Overall Study|Disease Progression|2|||
144226503|NCT00568451|520025834|FG003|Overall Study|Disease Progression|7|||
144226504|NCT05266053|520025837|FG000|Overall Study|Withdrawal by Subject|8|||
144226505|NCT05266053|520025838|FG001|Overall Study|Withdrawal by Subject|4|||
144226506|NCT05344560|520025839|FG000|Period 1|Subject out of visit window|1|||
144226507|NCT05344560|520025840|FG001|Period 1|Subject out of visit window|1|||
144226508|NCT05344560|520025839|FG000|Period 2|Covid-19 Related|1|||
144226509|NCT05344560|520025840|FG001|Period 2|Covid-19 Related|0|||
144226510|NCT05344560|520025839|FG000|Period 2|Adverse Event|1|||
144226511|NCT05344560|520025840|FG001|Period 2|Adverse Event|0|||
144226512|NCT05344560|520025839|FG000|Period 2|Subject out of visit window|1|||
144269001|NCT01774591|520187829|FG000|Overall Study|Physician Decision|1|||
144269002|NCT01774591|520187830|FG001|Overall Study|Physician Decision|1|||
144269003|NCT01774591|520187829|FG000|Overall Study|Withdrawal by Subject|0|||
144226513|NCT05344560|520025840|FG001|Period 2|Subject out of visit window|1|||
144226514|NCT05344560|520025839|FG000|Period 3|Subject out of visit window|1|||
144226515|NCT05344560|520025840|FG001|Period 3|Subject out of visit window|0|||
144226516|NCT02996968|520025841|FG000|Overall Study|Withdrawal by Subject|1|||
144226517|NCT02996968|520025842|FG001|Overall Study|Withdrawal by Subject|0|||
144226518|NCT03817853|520025843|FG000|Induction Phase|Adverse Event|5|||
144226519|NCT03817853|520025844|FG001|Induction Phase|Adverse Event|0|||
144226520|NCT03817853|520025845|FG002|Induction Phase|Adverse Event|0|||
144226521|NCT03817853|520025843|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
144226522|NCT03817853|520025844|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
144226523|NCT03817853|520025845|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
144226524|NCT03817853|520025843|FG000|Induction Phase|Physician Decision|2|||
144226525|NCT03817853|520025844|FG001|Induction Phase|Physician Decision|0|||
144226526|NCT03817853|520025845|FG002|Induction Phase|Physician Decision|0|||
144226527|NCT03817853|520025843|FG000|Induction Phase|Progressive Disease|6|||
144226528|NCT03817853|520025844|FG001|Induction Phase|Progressive Disease|0|||
144226529|NCT03817853|520025845|FG002|Induction Phase|Progressive Disease|0|||
144226530|NCT03817853|520025843|FG000|Induction Phase|Withdrawal by Subject|4|||
144226531|NCT03817853|520025844|FG001|Induction Phase|Withdrawal by Subject|0|||
144226532|NCT03817853|520025845|FG002|Induction Phase|Withdrawal by Subject|0|||
144226533|NCT03817853|520025843|FG000|Maintenance Phase|Adverse Event|0|||
144226534|NCT03817853|520025844|FG001|Maintenance Phase|Adverse Event|8|||
144226535|NCT03817853|520025845|FG002|Maintenance Phase|Adverse Event|0|||
144226536|NCT03817853|520025843|FG000|Maintenance Phase|Death|0|||
144226537|NCT03817853|520025844|FG001|Maintenance Phase|Death|5|||
144226538|NCT03817853|520025845|FG002|Maintenance Phase|Death|0|||
144226539|NCT03817853|520025843|FG000|Maintenance Phase|Progressive Disease|0|||
144226540|NCT03817853|520025844|FG001|Maintenance Phase|Progressive Disease|7|||
144226541|NCT03817853|520025845|FG002|Maintenance Phase|Progressive Disease|0|||
144226542|NCT03817853|520025843|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144226543|NCT03817853|520025844|FG001|Maintenance Phase|Withdrawal by Subject|2|||
144226544|NCT03817853|520025845|FG002|Maintenance Phase|Withdrawal by Subject|0|||
144226545|NCT03817853|520025843|FG000|Maintenance Phase|Physician Decision|0|||
144226546|NCT03817853|520025844|FG001|Maintenance Phase|Physician Decision|1|||
144226547|NCT03817853|520025845|FG002|Maintenance Phase|Physician Decision|0|||
144226548|NCT03817853|520025843|FG000|Maintenance Phase|Various reasons|0|||
144226549|NCT03817853|520025844|FG001|Maintenance Phase|Various reasons|4|||
144226550|NCT03817853|520025845|FG002|Maintenance Phase|Various reasons|0|||
144226551|NCT03817853|520025843|FG000|Maintenance Phase|Protocol Deviation|0|||
144226552|NCT03817853|520025844|FG001|Maintenance Phase|Protocol Deviation|1|||
144226553|NCT03817853|520025845|FG002|Maintenance Phase|Protocol Deviation|0|||
144226554|NCT03817853|520025843|FG000|Follow-up Phase|Adverse Event|0|||
144226555|NCT03817853|520025844|FG001|Follow-up Phase|Adverse Event|0|||
144226556|NCT03817853|520025845|FG002|Follow-up Phase|Adverse Event|2|||
144226557|NCT03817853|520025843|FG000|Follow-up Phase|Death|0|||
144226558|NCT03817853|520025844|FG001|Follow-up Phase|Death|0|||
144226559|NCT03817853|520025845|FG002|Follow-up Phase|Death|1|||
144226560|NCT03817853|520025843|FG000|Follow-up Phase|Progressive Disease|0|||
144226561|NCT03817853|520025844|FG001|Follow-up Phase|Progressive Disease|0|||
144226562|NCT03817853|520025845|FG002|Follow-up Phase|Progressive Disease|3|||
144226563|NCT03817853|520025843|FG000|Follow-up Phase|Withdrawal by Subject|0|||
144226564|NCT03817853|520025844|FG001|Follow-up Phase|Withdrawal by Subject|0|||
144226565|NCT03817853|520025845|FG002|Follow-up Phase|Withdrawal by Subject|1|||
144226566|NCT00391768|520025846|FG000|Overall Study|Withdrawal by Subject|0|||
144226567|NCT00391768|520025847|FG001|Overall Study|Withdrawal by Subject|0|||
144226568|NCT00391768|520025848|FG002|Overall Study|Withdrawal by Subject|1|||
144226569|NCT00391768|520025849|FG003|Overall Study|Withdrawal by Subject|0|||
144226570|NCT00391768|520025850|FG004|Overall Study|Withdrawal by Subject|0|||
144226571|NCT00391768|520025851|FG005|Overall Study|Withdrawal by Subject|1|||
144226572|NCT00391768|520025852|FG006|Overall Study|Withdrawal by Subject|1|||
144226573|NCT00391768|520025846|FG000|Overall Study|Lost to Follow-up|0|||
144226574|NCT00391768|520025847|FG001|Overall Study|Lost to Follow-up|0|||
144226575|NCT00391768|520025848|FG002|Overall Study|Lost to Follow-up|0|||
144226576|NCT00391768|520025849|FG003|Overall Study|Lost to Follow-up|1|||
144226577|NCT00391768|520025850|FG004|Overall Study|Lost to Follow-up|2|||
144226578|NCT00391768|520025851|FG005|Overall Study|Lost to Follow-up|2|||
144226579|NCT00391768|520025852|FG006|Overall Study|Lost to Follow-up|3|||
144226580|NCT01620138|520025853|FG000|Overall Study|Withdrawal by Subject|3|||
144226581|NCT01620138|520025854|FG001|Overall Study|Withdrawal by Subject|0|||
144226582|NCT01620138|520025853|FG000|Overall Study|Lack of Efficacy|1|||
144226583|NCT01620138|520025854|FG001|Overall Study|Lack of Efficacy|0|||
144226584|NCT01620138|520025853|FG000|Overall Study|Adverse Event|2|||
144226585|NCT01620138|520025854|FG001|Overall Study|Adverse Event|0|||
144226586|NCT00449865|520025857|FG000|Overall Study|Withdrawal by Subject|110|||
144269004|NCT01774591|520187830|FG001|Overall Study|Withdrawal by Subject|1|||
144269005|NCT01774591|520187829|FG000|Overall Study|Adverse Event|0|||
144269006|NCT01774591|520187830|FG001|Overall Study|Adverse Event|2|||
144269007|NCT00630916|520187833|FG000|Overall Study|Death|110|||
144269008|NCT00630916|520187833|FG000|Overall Study|Explant|8|||
144269009|NCT00630916|520187833|FG000|Overall Study|Lost to Follow-up|5|||
144269010|NCT00630916|520187833|FG000|Overall Study|Withdrawal by Subject|30|||
144269011|NCT00630916|520187833|FG000|Overall Study|Protocol Violation|7|||
144269012|NCT00630916|520187833|FG000|Overall Study|Physician Decision|47|||
144269013|NCT00630916|520187833|FG000|Overall Study|Lack of Efficacy|3|||
144269014|NCT02295644|520187835|FG000|Overall Study|Did not meet inclusion criterion|0|||
144269015|NCT02295644|520187836|FG001|Overall Study|Did not meet inclusion criterion|0|||
144269016|NCT02295644|520187837|FG002|Overall Study|Did not meet inclusion criterion|1|||
144269017|NCT02295644|520187838|FG003|Overall Study|Did not meet inclusion criterion|2|||
144269018|NCT02147626|520187839|FG000|Overall Study|Lost to Follow-up|4|||
144269019|NCT02147626|520187840|FG001|Overall Study|Lost to Follow-up|4|||
144269020|NCT02147626|520187839|FG000|Overall Study|Pregnancy|1|||
144269021|NCT02147626|520187840|FG001|Overall Study|Pregnancy|2|||
144269022|NCT02147626|520187839|FG000|Overall Study|Withdrawal by Subject|0|||
144269023|NCT02147626|520187840|FG001|Overall Study|Withdrawal by Subject|1|||
144269024|NCT03504917|520187841|FG000|Blinded Treatment Period|Protocol Violation|1|||
144269025|NCT03504917|520187842|FG001|Blinded Treatment Period|Protocol Violation|0|||
144269026|NCT03504917|520187841|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
144269027|NCT03504917|520187842|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
144269028|NCT03504917|520187841|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
144269029|NCT03504917|520187842|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
144269030|NCT03504917|520187841|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
144269031|NCT03504917|520187842|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
144269032|NCT03504917|520187841|FG000|Blinded Treatment Period|Adverse Event|4|||
144269033|NCT03504917|520187842|FG001|Blinded Treatment Period|Adverse Event|4|||
144269034|NCT03504917|520187841|FG000|Blinded Treatment Period|Physician Decision|1|||
144226587|NCT00449865|520025858|FG001|Overall Study|Withdrawal by Subject|110|||
144269035|NCT03504917|520187842|FG001|Blinded Treatment Period|Physician Decision|0|||
144226588|NCT00449865|520025857|FG000|Overall Study|Lost to Follow-up|36|||
144226589|NCT00449865|520025858|FG001|Overall Study|Lost to Follow-up|37|||
144226590|NCT00449865|520025857|FG000|Overall Study|Physician Decision|13|||
144226591|NCT00449865|520025858|FG001|Overall Study|Physician Decision|12|||
144226592|NCT00449865|520025857|FG000|Overall Study|Death|31|||
144226593|NCT00449865|520025858|FG001|Overall Study|Death|40|||
144226594|NCT00449865|520025857|FG000|Overall Study|Protocol Violation|8|||
144226595|NCT00449865|520025858|FG001|Overall Study|Protocol Violation|7|||
144226596|NCT00449865|520025857|FG000|Overall Study|Study was stopped|324|||
144226597|NCT00449865|520025858|FG001|Overall Study|Study was stopped|328|||
144226598|NCT00406367|520025859|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
144226599|NCT00406367|520025860|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
144226600|NCT00406367|520025859|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
144226601|NCT00406367|520025860|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
144226602|NCT00406367|520025859|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
144226603|NCT00406367|520025860|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
144226604|NCT00406367|520025859|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
144226605|NCT00406367|520025860|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
144226606|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
144226607|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
144226608|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
144226609|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
144226610|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
144226611|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
144226612|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
144226613|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
144226614|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
144226615|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
144226616|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
144226617|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
144226618|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
144226619|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
144226620|NCT00406367|520025859|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
144226621|NCT00406367|520025860|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
144226622|NCT00171210|520025861|FG000|Overall Study|Adverse Event|16|||
144226623|NCT00171210|520025862|FG001|Overall Study|Adverse Event|27|||
144226624|NCT00171210|520025861|FG000|Overall Study|Abnormal laboratory value(s)|6|||
144226625|NCT00171210|520025862|FG001|Overall Study|Abnormal laboratory value(s)|3|||
144226626|NCT00171210|520025861|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144226627|NCT00171210|520025862|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144226628|NCT00171210|520025861|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
144226629|NCT00171210|520025862|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
144226630|NCT00171210|520025861|FG000|Overall Study|Protocol Violation|0|||
144226631|NCT00171210|520025862|FG001|Overall Study|Protocol Violation|2|||
144226632|NCT00171210|520025861|FG000|Overall Study|Withdrawal by Subject|32|||
144226633|NCT00171210|520025862|FG001|Overall Study|Withdrawal by Subject|30|||
144226634|NCT00171210|520025861|FG000|Overall Study|Lost to Follow-up|1|||
144226635|NCT00171210|520025862|FG001|Overall Study|Lost to Follow-up|0|||
144226636|NCT00171210|520025861|FG000|Overall Study|Administrative problems|1|||
144226637|NCT00171210|520025862|FG001|Overall Study|Administrative problems|1|||
144226638|NCT00171210|520025861|FG000|Overall Study|Death|2|||
144226639|NCT00171210|520025862|FG001|Overall Study|Death|3|||
144226640|NCT00171210|520025861|FG000|Overall Study|Stopped at end of core|0|||
144226641|NCT00171210|520025862|FG001|Overall Study|Stopped at end of core|32|||
144226642|NCT00171210|520025861|FG000|Overall Study|Stopped at end of extension 1|0|||
144226643|NCT00171210|520025862|FG001|Overall Study|Stopped at end of extension 1|1|||
144226644|NCT03187301|520025865|FG000|Titration Period|Adverse Event|0|||
144226645|NCT03187301|520025866|FG001|Titration Period|Adverse Event|0|||
144226646|NCT03187301|520025867|FG002|Titration Period|Adverse Event|0|||
144226647|NCT03187301|520025868|FG003|Titration Period|Adverse Event|0|||
144226648|NCT03187301|520025869|FG004|Titration Period|Adverse Event|0|||
144226649|NCT03187301|520025870|FG005|Titration Period|Adverse Event|0|||
144226650|NCT03187301|520025871|FG006|Titration Period|Adverse Event|5|||
144226651|NCT03187301|520025865|FG000|Titration Period|Withdrawal by Subject|0|||
144226652|NCT03187301|520025866|FG001|Titration Period|Withdrawal by Subject|0|||
144226653|NCT03187301|520025867|FG002|Titration Period|Withdrawal by Subject|0|||
144226654|NCT03187301|520025868|FG003|Titration Period|Withdrawal by Subject|0|||
144226655|NCT03187301|520025869|FG004|Titration Period|Withdrawal by Subject|0|||
144226656|NCT03187301|520025870|FG005|Titration Period|Withdrawal by Subject|0|||
144226657|NCT03187301|520025871|FG006|Titration Period|Withdrawal by Subject|1|||
144226658|NCT03187301|520025865|FG000|Titration Period|Exclusion Criteria Met|0|||
144226659|NCT03187301|520025866|FG001|Titration Period|Exclusion Criteria Met|0|||
144226660|NCT03187301|520025867|FG002|Titration Period|Exclusion Criteria Met|0|||
144226661|NCT03187301|520025868|FG003|Titration Period|Exclusion Criteria Met|0|||
144226662|NCT03187301|520025869|FG004|Titration Period|Exclusion Criteria Met|0|||
144226663|NCT03187301|520025870|FG005|Titration Period|Exclusion Criteria Met|0|||
144226664|NCT03187301|520025871|FG006|Titration Period|Exclusion Criteria Met|1|||
144226665|NCT03187301|520025865|FG000|Pre-Intervention|Withdrawal by Subject|1|||
144226666|NCT03187301|520025866|FG001|Pre-Intervention|Withdrawal by Subject|0|||
144226667|NCT03187301|520025867|FG002|Pre-Intervention|Withdrawal by Subject|0|||
144226668|NCT03187301|520025868|FG003|Pre-Intervention|Withdrawal by Subject|0|||
144226669|NCT03187301|520025869|FG004|Pre-Intervention|Withdrawal by Subject|0|||
144226670|NCT03187301|520025870|FG005|Pre-Intervention|Withdrawal by Subject|0|||
144226671|NCT03187301|520025871|FG006|Pre-Intervention|Withdrawal by Subject|0|||
144226672|NCT03252535|520025873|FG000|Overall Study|Withdrawal by Subject|1|||
144226673|NCT03252535|520025874|FG001|Overall Study|Withdrawal by Subject|0|||
144226674|NCT03252535|520025875|FG002|Overall Study|Withdrawal by Subject|0|||
144226675|NCT03252535|520025873|FG000|Overall Study|Physician Decision|0|||
144226676|NCT03252535|520025874|FG001|Overall Study|Physician Decision|1|||
144226677|NCT03252535|520025875|FG002|Overall Study|Physician Decision|0|||
144226678|NCT03252535|520025873|FG000|Overall Study|Met discontinuation criteria|0|||
144226679|NCT03252535|520025874|FG001|Overall Study|Met discontinuation criteria|1|||
144226680|NCT03252535|520025875|FG002|Overall Study|Met discontinuation criteria|0|||
144226681|NCT00461630|520025880|FG000|Overall Study|Death|798|||
144226682|NCT00461630|520025881|FG001|Overall Study|Death|732|||
144226683|NCT00461630|520025880|FG000|Overall Study|Lost to Follow-up|108|||
144226684|NCT00461630|520025881|FG001|Overall Study|Lost to Follow-up|95|||
144226685|NCT00442897|520025885|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
144226686|NCT00442897|520025886|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
144226687|NCT00442897|520025885|FG000|Base Study (12 Week Follow-up)|Death|0|||
144226688|NCT00442897|520025886|FG001|Base Study (12 Week Follow-up)|Death|1|||
144226689|NCT00442897|520025885|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
144226690|NCT00442897|520025886|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
144226691|NCT00442897|520025885|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
144226692|NCT00442897|520025886|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
144226693|NCT00442897|520025885|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
144226694|NCT00442897|520025886|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
144226695|NCT00442897|520025885|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
144226696|NCT00442897|520025886|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
144226697|NCT00442897|520025885|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
144226698|NCT00442897|520025886|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
144226699|NCT00442897|520025885|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
144226700|NCT00442897|520025886|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
144226701|NCT04498182|520025887|FG000|Overall Study|Adverse Event|2|||
144226702|NCT04498182|520025888|FG001|Overall Study|Adverse Event|3|||
144226703|NCT04498182|520025889|FG002|Overall Study|Adverse Event|2|||
144226704|NCT04498182|520025887|FG000|Overall Study|Withdrawal of Consent|3|||
144226705|NCT04498182|520025888|FG001|Overall Study|Withdrawal of Consent|4|||
144226706|NCT04498182|520025889|FG002|Overall Study|Withdrawal of Consent|3|||
144226707|NCT04498182|520025887|FG000|Overall Study|Non-Compliant|1|||
144226708|NCT04498182|520025888|FG001|Overall Study|Non-Compliant|0|||
144226709|NCT04498182|520025889|FG002|Overall Study|Non-Compliant|1|||
144226710|NCT04498182|520025887|FG000|Overall Study|Lost to Follow-up|0|||
144226711|NCT04498182|520025888|FG001|Overall Study|Lost to Follow-up|0|||
144226712|NCT04498182|520025889|FG002|Overall Study|Lost to Follow-up|1|||
144226713|NCT04498182|520025887|FG000|Overall Study|Investigator Decision|0|||
144226714|NCT04498182|520025888|FG001|Overall Study|Investigator Decision|0|||
144226715|NCT04498182|520025889|FG002|Overall Study|Investigator Decision|1|||
144226716|NCT04498182|520025887|FG000|Overall Study|Protocol Violation|1|||
144226717|NCT04498182|520025888|FG001|Overall Study|Protocol Violation|0|||
144226718|NCT04498182|520025889|FG002|Overall Study|Protocol Violation|2|||
144226719|NCT00997373|520025891|FG000|Overall Study|Withdrawal by Subject|5|||
144226720|NCT00997373|520025892|FG001|Overall Study|Withdrawal by Subject|0|||
144226721|NCT00997373|520025891|FG000|Overall Study|wrong tumor type|4|||
144226722|NCT00997373|520025892|FG001|Overall Study|wrong tumor type|0|||
144226723|NCT00997373|520025891|FG000|Overall Study|could not have hysterectomy|6|||
144226724|NCT00997373|520025892|FG001|Overall Study|could not have hysterectomy|0|||
144226725|NCT02022202|520025893|FG000|Overall Study|Withdrawal by Subject|2|||
144226726|NCT02022202|520025893|FG000|Overall Study|Disease Progression|3|||
144226727|NCT02022202|520025893|FG000|Overall Study|Desire go to immediately to surgery|3|||
144226728|NCT04390763|520025894|FG000|Safety run-in Part|Adverse Event|4|||
144226729|NCT04390763|520025895|FG001|Safety run-in Part|Adverse Event|0|||
144226730|NCT04390763|520025896|FG002|Safety run-in Part|Adverse Event|0|||
144226731|NCT04390763|520025897|FG003|Safety run-in Part|Adverse Event|0|||
144226732|NCT04390763|520025894|FG000|Safety run-in Part|Physician Decision|1|||
144226733|NCT04390763|520025895|FG001|Safety run-in Part|Physician Decision|0|||
144226734|NCT04390763|520025896|FG002|Safety run-in Part|Physician Decision|0|||
144226735|NCT04390763|520025897|FG003|Safety run-in Part|Physician Decision|0|||
144226736|NCT04390763|520025894|FG000|Safety run-in Part|Progressive Disease|6|||
144226737|NCT04390763|520025895|FG001|Safety run-in Part|Progressive Disease|0|||
144226738|NCT04390763|520025896|FG002|Safety run-in Part|Progressive Disease|0|||
144226739|NCT04390763|520025897|FG003|Safety run-in Part|Progressive Disease|0|||
144226740|NCT04390763|520025894|FG000|Randomized Part|Adverse Event|0|||
144226741|NCT04390763|520025895|FG001|Randomized Part|Adverse Event|11|||
144226742|NCT04390763|520025896|FG002|Randomized Part|Adverse Event|5|||
144226743|NCT04390763|520025897|FG003|Randomized Part|Adverse Event|5|||
144226744|NCT04390763|520025894|FG000|Randomized Part|Death|0|||
144226745|NCT04390763|520025895|FG001|Randomized Part|Death|3|||
144226746|NCT04390763|520025896|FG002|Randomized Part|Death|4|||
144226747|NCT04390763|520025897|FG003|Randomized Part|Death|2|||
144226748|NCT04390763|520025894|FG000|Randomized Part|Physician Decision|0|||
144226749|NCT04390763|520025895|FG001|Randomized Part|Physician Decision|2|||
144226750|NCT04390763|520025896|FG002|Randomized Part|Physician Decision|2|||
144226751|NCT04390763|520025897|FG003|Randomized Part|Physician Decision|9|||
144226752|NCT04390763|520025894|FG000|Randomized Part|Progressive Disease|0|||
144226753|NCT04390763|520025895|FG001|Randomized Part|Progressive Disease|24|||
144226754|NCT04390763|520025896|FG002|Randomized Part|Progressive Disease|31|||
144226755|NCT04390763|520025897|FG003|Randomized Part|Progressive Disease|23|||
144226756|NCT04390763|520025894|FG000|Randomized Part|Study terminated by sponsor|0|||
144226757|NCT04390763|520025895|FG001|Randomized Part|Study terminated by sponsor|1|||
144226758|NCT04390763|520025896|FG002|Randomized Part|Study terminated by sponsor|0|||
144226759|NCT04390763|520025897|FG003|Randomized Part|Study terminated by sponsor|0|||
144226760|NCT04390763|520025894|FG000|Randomized Part|Participant Decision|0|||
144226761|NCT04390763|520025895|FG001|Randomized Part|Participant Decision|5|||
144226762|NCT04390763|520025896|FG002|Randomized Part|Participant Decision|7|||
144226763|NCT04390763|520025897|FG003|Randomized Part|Participant Decision|6|||
144226764|NCT04390763|520025894|FG000|Randomized Part|Not treated|0|||
144226765|NCT04390763|520025895|FG001|Randomized Part|Not treated|4|||
144226766|NCT04390763|520025896|FG002|Randomized Part|Not treated|2|||
144226767|NCT04390763|520025897|FG003|Randomized Part|Not treated|7|||
144226768|NCT04340843|520025898|FG000|Overall Study|Adverse Event|0|||
144226769|NCT04340843|520025899|FG001|Overall Study|Adverse Event|2|||
144226770|NCT04340843|520025898|FG000|Overall Study|Withdrawal by Subject|0|||
144226771|NCT04340843|520025899|FG001|Overall Study|Withdrawal by Subject|2|||
144226772|NCT01956773|520025904|FG000|Overall Study|Lost to Follow-up|628|||
144226773|NCT01956773|520025905|FG001|Overall Study|Lost to Follow-up|1|||
144226774|NCT01383174|520025908|FG000|3 Month Assessment|Death|0|||
144226775|NCT01383174|520025909|FG001|3 Month Assessment|Death|1|||
144226776|NCT01383174|520025908|FG000|3 Month Assessment|Lost to Follow-up|2|||
144226777|NCT01383174|520025909|FG001|3 Month Assessment|Lost to Follow-up|0|||
144226778|NCT01383174|520025908|FG000|3 Month Assessment|Refused to complete|4|||
144226779|NCT01383174|520025909|FG001|3 Month Assessment|Refused to complete|0|||
144226780|NCT01383174|520025908|FG000|6 Month Assessment|Lost to Follow-up|1|||
144226781|NCT01383174|520025909|FG001|6 Month Assessment|Lost to Follow-up|1|||
144226782|NCT01383174|520025908|FG000|6 Month Assessment|Refused to complete|4|||
144226783|NCT01383174|520025909|FG001|6 Month Assessment|Refused to complete|0|||
144226784|NCT01153815|520025912|FG000|Overall Study|Adverse Event|3|||
144226785|NCT01153815|520025913|FG001|Overall Study|Adverse Event|1|||
144226786|NCT01153815|520025912|FG000|Overall Study|Withdrawal by Subject|6|||
144226787|NCT01153815|520025913|FG001|Overall Study|Withdrawal by Subject|4|||
144226788|NCT01786993|520025914|FG000|Overall Study|Death|6|||
144226789|NCT01786993|520025915|FG001|Overall Study|Death|7|||
144226790|NCT01786993|520025914|FG000|Overall Study|Withdrawal by Subject|3|||
144226791|NCT01786993|520025915|FG001|Overall Study|Withdrawal by Subject|2|||
144226792|NCT01786993|520025914|FG000|Overall Study|Lost to Follow-up|0|||
144226793|NCT01786993|520025915|FG001|Overall Study|Lost to Follow-up|1|||
144226794|NCT01786993|520025914|FG000|Overall Study|Subject Non-Compliance|1|||
144226795|NCT01786993|520025915|FG001|Overall Study|Subject Non-Compliance|0|||
144226796|NCT01786993|520025914|FG000|Overall Study|System Explant|1|||
144226797|NCT01786993|520025915|FG001|Overall Study|System Explant|0|||
144226798|NCT01786993|520025914|FG000|Overall Study|Hospice Admission|1|||
144226799|NCT01786993|520025915|FG001|Overall Study|Hospice Admission|0|||
144226800|NCT00450437|520025916|FG000|Overall Study|Withdrawal by Subject|10|||
144269036|NCT03504917|520187841|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
144269037|NCT03504917|520187842|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
144269038|NCT03504917|520187841|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
144269039|NCT03504917|520187842|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
144269040|NCT03504917|520187841|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
144269041|NCT03504917|520187842|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
144269042|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
144226801|NCT00450437|520025917|FG001|Overall Study|Withdrawal by Subject|2|||
144226802|NCT00450437|520025918|FG002|Overall Study|Withdrawal by Subject|0|||
144226803|NCT00450437|520025919|FG003|Overall Study|Withdrawal by Subject|1|||
144226804|NCT00450437|520025916|FG000|Overall Study|Lost to Follow-up|31|||
144226805|NCT00450437|520025917|FG001|Overall Study|Lost to Follow-up|12|||
144226806|NCT00450437|520025918|FG002|Overall Study|Lost to Follow-up|19|||
144226807|NCT00450437|520025919|FG003|Overall Study|Lost to Follow-up|9|||
144226808|NCT00450437|520025916|FG000|Overall Study|Protocol Violation|0|||
144226809|NCT00450437|520025917|FG001|Overall Study|Protocol Violation|1|||
144226810|NCT00450437|520025918|FG002|Overall Study|Protocol Violation|0|||
144226811|NCT00450437|520025919|FG003|Overall Study|Protocol Violation|1|||
144226812|NCT00450437|520025916|FG000|Overall Study|Inappropriate enrollment|4|||
144226813|NCT00450437|520025917|FG001|Overall Study|Inappropriate enrollment|1|||
144226814|NCT00450437|520025918|FG002|Overall Study|Inappropriate enrollment|3|||
144226815|NCT00450437|520025919|FG003|Overall Study|Inappropriate enrollment|0|||
144226816|NCT00450437|520025916|FG000|Overall Study|Administrative reason|0|||
144226817|NCT00450437|520025917|FG001|Overall Study|Administrative reason|0|||
144226818|NCT00450437|520025918|FG002|Overall Study|Administrative reason|1|||
144226819|NCT00450437|520025919|FG003|Overall Study|Administrative reason|0|||
144226820|NCT00450437|520025916|FG000|Overall Study|Unable to Classify|1|||
144226821|NCT00450437|520025917|FG001|Overall Study|Unable to Classify|0|||
144226822|NCT00450437|520025918|FG002|Overall Study|Unable to Classify|1|||
144226823|NCT00450437|520025919|FG003|Overall Study|Unable to Classify|0|||
144226824|NCT01890122|520025920|FG000|Overall Study|Adverse Event|1|||
144226825|NCT01890122|520025921|FG001|Overall Study|Adverse Event|1|||
144226826|NCT01890122|520025922|FG002|Overall Study|Adverse Event|1|||
144226827|NCT01890122|520025923|FG003|Overall Study|Adverse Event|2|||
144226828|NCT01890122|520025920|FG000|Overall Study|Major Protocol Deviation|3|||
144226829|NCT01890122|520025921|FG001|Overall Study|Major Protocol Deviation|1|||
144226830|NCT01890122|520025922|FG002|Overall Study|Major Protocol Deviation|0|||
144226831|NCT01890122|520025923|FG003|Overall Study|Major Protocol Deviation|1|||
144226832|NCT01890122|520025920|FG000|Overall Study|Lost to Follow-up|0|||
144226833|NCT01890122|520025921|FG001|Overall Study|Lost to Follow-up|1|||
144226834|NCT01890122|520025922|FG002|Overall Study|Lost to Follow-up|2|||
144226835|NCT01890122|520025923|FG003|Overall Study|Lost to Follow-up|2|||
144226836|NCT01890122|520025920|FG000|Overall Study|Voluntary Withdrawal|8|||
144226837|NCT01890122|520025921|FG001|Overall Study|Voluntary Withdrawal|8|||
144226838|NCT01890122|520025922|FG002|Overall Study|Voluntary Withdrawal|2|||
144226839|NCT01890122|520025923|FG003|Overall Study|Voluntary Withdrawal|11|||
144226840|NCT01890122|520025920|FG000|Overall Study|Lack of Efficacy|14|||
144226841|NCT01890122|520025921|FG001|Overall Study|Lack of Efficacy|24|||
144226842|NCT01890122|520025922|FG002|Overall Study|Lack of Efficacy|7|||
144226843|NCT01890122|520025923|FG003|Overall Study|Lack of Efficacy|41|||
144226844|NCT01890122|520025920|FG000|Overall Study|Reason not Specified|0|||
144226845|NCT01890122|520025921|FG001|Overall Study|Reason not Specified|1|||
144226846|NCT01890122|520025922|FG002|Overall Study|Reason not Specified|1|||
144226847|NCT01890122|520025923|FG003|Overall Study|Reason not Specified|2|||
144226848|NCT01890122|520025920|FG000|Overall Study|Randomized but not Treated|1|||
144226849|NCT01890122|520025921|FG001|Overall Study|Randomized but not Treated|1|||
144226850|NCT01890122|520025922|FG002|Overall Study|Randomized but not Treated|0|||
144226851|NCT01890122|520025923|FG003|Overall Study|Randomized but not Treated|0|||
144226852|NCT03591874|520025924|FG000|Overall Study|Adverse Event|4|||
144226853|NCT03591874|520025925|FG001|Overall Study|Adverse Event|0|||
144226854|NCT03591874|520025924|FG000|Overall Study|Withdrawal by Subject|2|||
144226855|NCT03591874|520025925|FG001|Overall Study|Withdrawal by Subject|1|||
144226856|NCT03591874|520025924|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
144226857|NCT03591874|520025925|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
144226858|NCT03591874|520025924|FG000|Overall Study|On Study at Time of Study Termination|12|||
144226859|NCT03591874|520025925|FG001|Overall Study|On Study at Time of Study Termination|6|||
144226860|NCT00848718|520025927|FG000|Overall Study|Adverse Event|2|||
144226861|NCT00848718|520025928|FG001|Overall Study|Adverse Event|2|||
144226862|NCT00848718|520025929|FG002|Overall Study|Adverse Event|1|||
144226863|NCT00848718|520025930|FG003|Overall Study|Adverse Event|1|||
144226864|NCT00848718|520025931|FG004|Overall Study|Adverse Event|1|||
144226865|NCT00848718|520025932|FG005|Overall Study|Adverse Event|0|||
144226866|NCT00848718|520025933|FG006|Overall Study|Adverse Event|0|||
144226867|NCT00848718|520025934|FG007|Overall Study|Adverse Event|1|||
144226868|NCT00848718|520025935|FG008|Overall Study|Adverse Event|1|||
144226869|NCT00848718|520025936|FG009|Overall Study|Adverse Event|0|||
144226870|NCT00848718|520025937|FG010|Overall Study|Adverse Event|0|||
144226871|NCT00848718|520025938|FG011|Overall Study|Adverse Event|0|||
144226872|NCT00848718|520025939|FG012|Overall Study|Adverse Event|2|||
144226873|NCT00848718|520025927|FG000|Overall Study|Lack of Efficacy|0|||
144226874|NCT00848718|520025928|FG001|Overall Study|Lack of Efficacy|0|||
144226875|NCT00848718|520025929|FG002|Overall Study|Lack of Efficacy|1|||
144226876|NCT00848718|520025930|FG003|Overall Study|Lack of Efficacy|0|||
144226877|NCT00848718|520025931|FG004|Overall Study|Lack of Efficacy|0|||
144226878|NCT00848718|520025932|FG005|Overall Study|Lack of Efficacy|0|||
144226879|NCT00848718|520025933|FG006|Overall Study|Lack of Efficacy|1|||
144226880|NCT00848718|520025934|FG007|Overall Study|Lack of Efficacy|0|||
144226881|NCT00848718|520025935|FG008|Overall Study|Lack of Efficacy|0|||
144226882|NCT00848718|520025936|FG009|Overall Study|Lack of Efficacy|0|||
144226883|NCT00848718|520025937|FG010|Overall Study|Lack of Efficacy|0|||
144226884|NCT00848718|520025938|FG011|Overall Study|Lack of Efficacy|0|||
144226885|NCT00848718|520025939|FG012|Overall Study|Lack of Efficacy|0|||
144226886|NCT00848718|520025927|FG000|Overall Study|Physician Decision|0|||
144226887|NCT00848718|520025928|FG001|Overall Study|Physician Decision|1|||
144226888|NCT00848718|520025929|FG002|Overall Study|Physician Decision|0|||
144226889|NCT00848718|520025930|FG003|Overall Study|Physician Decision|0|||
144226890|NCT00848718|520025931|FG004|Overall Study|Physician Decision|1|||
144226891|NCT00848718|520025932|FG005|Overall Study|Physician Decision|1|||
144226892|NCT00848718|520025933|FG006|Overall Study|Physician Decision|0|||
144226893|NCT00848718|520025934|FG007|Overall Study|Physician Decision|0|||
144226894|NCT00848718|520025935|FG008|Overall Study|Physician Decision|1|||
144226895|NCT00848718|520025936|FG009|Overall Study|Physician Decision|2|||
144226896|NCT00848718|520025937|FG010|Overall Study|Physician Decision|0|||
144226897|NCT00848718|520025938|FG011|Overall Study|Physician Decision|0|||
144226898|NCT00848718|520025939|FG012|Overall Study|Physician Decision|1|||
144226899|NCT00848718|520025927|FG000|Overall Study|Progressive disease before treatment|1|||
144226900|NCT00848718|520025928|FG001|Overall Study|Progressive disease before treatment|5|||
144226901|NCT00848718|520025929|FG002|Overall Study|Progressive disease before treatment|1|||
144226902|NCT00848718|520025930|FG003|Overall Study|Progressive disease before treatment|3|||
144226903|NCT00848718|520025931|FG004|Overall Study|Progressive disease before treatment|4|||
144226904|NCT00848718|520025932|FG005|Overall Study|Progressive disease before treatment|4|||
144226905|NCT00848718|520025933|FG006|Overall Study|Progressive disease before treatment|2|||
144226906|NCT00848718|520025934|FG007|Overall Study|Progressive disease before treatment|1|||
144226907|NCT00848718|520025935|FG008|Overall Study|Progressive disease before treatment|2|||
144226908|NCT00848718|520025936|FG009|Overall Study|Progressive disease before treatment|7|||
144226909|NCT00848718|520025937|FG010|Overall Study|Progressive disease before treatment|3|||
144226910|NCT00848718|520025938|FG011|Overall Study|Progressive disease before treatment|6|||
144226911|NCT00848718|520025939|FG012|Overall Study|Progressive disease before treatment|2|||
144226912|NCT00848718|520025927|FG000|Overall Study|Protocol Violation|0|||
144226913|NCT00848718|520025928|FG001|Overall Study|Protocol Violation|1|||
144226914|NCT00848718|520025929|FG002|Overall Study|Protocol Violation|0|||
144226915|NCT00848718|520025930|FG003|Overall Study|Protocol Violation|0|||
144226916|NCT00848718|520025931|FG004|Overall Study|Protocol Violation|0|||
144226917|NCT00848718|520025932|FG005|Overall Study|Protocol Violation|0|||
144226918|NCT00848718|520025933|FG006|Overall Study|Protocol Violation|0|||
144226919|NCT00848718|520025934|FG007|Overall Study|Protocol Violation|1|||
144226920|NCT00848718|520025935|FG008|Overall Study|Protocol Violation|0|||
144226921|NCT00848718|520025936|FG009|Overall Study|Protocol Violation|0|||
144226922|NCT00848718|520025937|FG010|Overall Study|Protocol Violation|0|||
144226923|NCT00848718|520025938|FG011|Overall Study|Protocol Violation|0|||
144226924|NCT00848718|520025939|FG012|Overall Study|Protocol Violation|1|||
144226925|NCT00848718|520025927|FG000|Overall Study|Withdrawal by Subject|1|||
144226926|NCT00848718|520025928|FG001|Overall Study|Withdrawal by Subject|0|||
144226927|NCT00848718|520025929|FG002|Overall Study|Withdrawal by Subject|0|||
144226928|NCT00848718|520025930|FG003|Overall Study|Withdrawal by Subject|1|||
144226929|NCT00848718|520025931|FG004|Overall Study|Withdrawal by Subject|0|||
144226930|NCT00848718|520025932|FG005|Overall Study|Withdrawal by Subject|0|||
144226931|NCT00848718|520025933|FG006|Overall Study|Withdrawal by Subject|0|||
144226932|NCT00848718|520025934|FG007|Overall Study|Withdrawal by Subject|0|||
144226933|NCT00848718|520025935|FG008|Overall Study|Withdrawal by Subject|0|||
144226934|NCT00848718|520025936|FG009|Overall Study|Withdrawal by Subject|0|||
144226935|NCT00848718|520025937|FG010|Overall Study|Withdrawal by Subject|1|||
144226936|NCT00848718|520025938|FG011|Overall Study|Withdrawal by Subject|0|||
144226937|NCT00848718|520025939|FG012|Overall Study|Withdrawal by Subject|0|||
144226938|NCT00848718|520025927|FG000|Overall Study|Progressive disease during treatment|3|||
144226939|NCT00848718|520025928|FG001|Overall Study|Progressive disease during treatment|0|||
144226940|NCT00848718|520025929|FG002|Overall Study|Progressive disease during treatment|3|||
144226941|NCT00848718|520025930|FG003|Overall Study|Progressive disease during treatment|0|||
144226942|NCT00848718|520025931|FG004|Overall Study|Progressive disease during treatment|0|||
144226943|NCT00848718|520025932|FG005|Overall Study|Progressive disease during treatment|0|||
144226944|NCT00848718|520025933|FG006|Overall Study|Progressive disease during treatment|0|||
144226945|NCT00848718|520025934|FG007|Overall Study|Progressive disease during treatment|2|||
144226946|NCT00848718|520025935|FG008|Overall Study|Progressive disease during treatment|0|||
144226947|NCT00848718|520025936|FG009|Overall Study|Progressive disease during treatment|0|||
144226948|NCT00848718|520025937|FG010|Overall Study|Progressive disease during treatment|0|||
144226949|NCT00848718|520025938|FG011|Overall Study|Progressive disease during treatment|0|||
144226950|NCT00848718|520025939|FG012|Overall Study|Progressive disease during treatment|2|||
144226951|NCT01120184|520027377|FG000|Overall Study|Adverse Event|0|||
144226952|NCT01120184|520027378|FG001|Overall Study|Adverse Event|1|||
144226953|NCT01120184|520027379|FG002|Overall Study|Adverse Event|0|||
144226954|NCT01120184|520027377|FG000|Overall Study|Lost to Follow-up|13|||
144226955|NCT01120184|520027378|FG001|Overall Study|Lost to Follow-up|13|||
144226956|NCT01120184|520027379|FG002|Overall Study|Lost to Follow-up|11|||
144226957|NCT01120184|520027377|FG000|Overall Study|Physician Decision|9|||
144226958|NCT01120184|520027378|FG001|Overall Study|Physician Decision|1|||
144226959|NCT01120184|520027379|FG002|Overall Study|Physician Decision|3|||
144226960|NCT01120184|520027377|FG000|Overall Study|Reason not Specified|8|||
144226961|NCT01120184|520027378|FG001|Overall Study|Reason not Specified|3|||
144226962|NCT01120184|520027379|FG002|Overall Study|Reason not Specified|12|||
144226963|NCT01120184|520027377|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
144226964|NCT01120184|520027378|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
144226965|NCT01120184|520027379|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
144226966|NCT01120184|520027377|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
144226967|NCT01120184|520027378|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
144226968|NCT01120184|520027379|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
144226969|NCT01120184|520027377|FG000|Overall Study|Death|170|||
144226970|NCT01120184|520027378|FG001|Overall Study|Death|176|||
144226971|NCT01120184|520027379|FG002|Overall Study|Death|169|||
144226972|NCT02612623|520027380|FG000|Overall Study|Withdrawal by Subject|0|||
144226973|NCT02612623|520027381|FG001|Overall Study|Withdrawal by Subject|1|||
144226974|NCT02612623|520027382|FG002|Overall Study|Withdrawal by Subject|0|||
144226975|NCT02612623|520027383|FG003|Overall Study|Withdrawal by Subject|0|||
144226976|NCT02612623|520027380|FG000|Overall Study|Adverse Event|1|||
144226977|NCT02612623|520027381|FG001|Overall Study|Adverse Event|0|||
144226978|NCT02612623|520027382|FG002|Overall Study|Adverse Event|1|||
144226979|NCT02612623|520027383|FG003|Overall Study|Adverse Event|0|||
144226980|NCT02182843|520027385|FG000|Overall Study|Withdrawal by Subject|7|||
144226981|NCT02182843|520027385|FG000|Overall Study|Lost to Follow-up|2|||
144226982|NCT02182843|520027385|FG000|Overall Study|Adverse Event|1|||
144226983|NCT00891020|520027391|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
144226984|NCT00891020|520027392|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
144226985|NCT00891020|520027393|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
144226986|NCT00891020|520027391|FG000|24 Week Treatment Period|Death|0|||
144226987|NCT00891020|520027392|FG001|24 Week Treatment Period|Death|2|||
144226988|NCT00891020|520027393|FG002|24 Week Treatment Period|Death|0|||
144226989|NCT00891020|520027391|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
144226990|NCT00891020|520027392|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
144226991|NCT00891020|520027393|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
144226992|NCT00891020|520027391|FG000|24 Week Treatment Period|Failure to return|4|||
144226993|NCT00891020|520027392|FG001|24 Week Treatment Period|Failure to return|5|||
144226994|NCT00891020|520027393|FG002|24 Week Treatment Period|Failure to return|5|||
144226995|NCT00891020|520027391|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
144226996|NCT00891020|520027392|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
144226997|NCT00891020|520027393|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
144226998|NCT00891020|520027391|FG000|24 Week Treatment Period|Other protocol violation|1|||
144226999|NCT00891020|520027392|FG001|24 Week Treatment Period|Other protocol violation|1|||
144227000|NCT00891020|520027393|FG002|24 Week Treatment Period|Other protocol violation|2|||
144227001|NCT00891020|520027391|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
144227002|NCT00891020|520027392|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
144227003|NCT00891020|520027393|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
144227004|NCT00891020|520027391|FG000|24 Week Treatment Period|Withdrew consent|6|||
144227005|NCT00891020|520027392|FG001|24 Week Treatment Period|Withdrew consent|3|||
144227006|NCT00891020|520027393|FG002|24 Week Treatment Period|Withdrew consent|15|||
144227007|NCT00891020|520027391|FG000|24 Week Treatment Period|Administrative/Other|5|||
144227008|NCT00891020|520027392|FG001|24 Week Treatment Period|Administrative/Other|6|||
144227009|NCT00891020|520027393|FG002|24 Week Treatment Period|Administrative/Other|1|||
144227010|NCT00891020|520027391|FG000|Long-term Extension Period|Adverse Event|1|||
144227011|NCT00891020|520027392|FG001|Long-term Extension Period|Adverse Event|11|||
144227012|NCT00891020|520027393|FG002|Long-term Extension Period|Adverse Event|10|||
144227013|NCT00891020|520027391|FG000|Long-term Extension Period|Death|0|||
144227014|NCT00891020|520027392|FG001|Long-term Extension Period|Death|0|||
144227015|NCT00891020|520027393|FG002|Long-term Extension Period|Death|1|||
144227016|NCT00891020|520027391|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
144227017|NCT00891020|520027392|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
144227018|NCT00891020|520027393|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
144227019|NCT00891020|520027391|FG000|Long-term Extension Period|Protocol Violation|0|||
144227020|NCT00891020|520027392|FG001|Long-term Extension Period|Protocol Violation|1|||
144227021|NCT00891020|520027393|FG002|Long-term Extension Period|Protocol Violation|1|||
144227022|NCT00891020|520027391|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
144227023|NCT00891020|520027392|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
144227024|NCT00891020|520027393|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
144227025|NCT00891020|520027391|FG000|Long-term Extension Period|Failure to return|0|||
144227026|NCT00891020|520027392|FG001|Long-term Extension Period|Failure to return|2|||
144227027|NCT00891020|520027393|FG002|Long-term Extension Period|Failure to return|3|||
144227028|NCT00891020|520027391|FG000|Long-term Extension Period|Administrative|1|||
144227029|NCT00891020|520027392|FG001|Long-term Extension Period|Administrative|2|||
144227030|NCT00891020|520027393|FG002|Long-term Extension Period|Administrative|2|||
144227031|NCT00320710|520027401|FG000|Overall Study|Disease progression|24|||
144227032|NCT00320710|520027402|FG001|Overall Study|Disease progression|19|||
144227033|NCT00320710|520027403|FG002|Overall Study|Disease progression|2|||
144227034|NCT00320710|520027401|FG000|Overall Study|Death|10|||
144227035|NCT00320710|520027402|FG001|Overall Study|Death|7|||
144227036|NCT00320710|520027403|FG002|Overall Study|Death|1|||
144227037|NCT00320710|520027401|FG000|Overall Study|Administrative problems|1|||
144227038|NCT00320710|520027402|FG001|Overall Study|Administrative problems|2|||
144227039|NCT00320710|520027403|FG002|Overall Study|Administrative problems|0|||
144227040|NCT00320710|520027401|FG000|Overall Study|Withdrawal by Subject|20|||
144227041|NCT00320710|520027402|FG001|Overall Study|Withdrawal by Subject|26|||
144227042|NCT00320710|520027403|FG002|Overall Study|Withdrawal by Subject|1|||
144227043|NCT00320710|520027401|FG000|Overall Study|Protocol Violation|6|||
144227044|NCT00320710|520027402|FG001|Overall Study|Protocol Violation|5|||
144227045|NCT00320710|520027403|FG002|Overall Study|Protocol Violation|0|||
144227046|NCT00320710|520027401|FG000|Overall Study|Abnormal test procedure result(s)|2|||
144227047|NCT00320710|520027402|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144227048|NCT00320710|520027403|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144227049|NCT00320710|520027401|FG000|Overall Study|Abnormal laboratory value(s)|12|||
144227050|NCT00320710|520027402|FG001|Overall Study|Abnormal laboratory value(s)|3|||
144227051|NCT00320710|520027403|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144227052|NCT00320710|520027401|FG000|Overall Study|Adverse Event|18|||
144227053|NCT00320710|520027402|FG001|Overall Study|Adverse Event|14|||
144227054|NCT00320710|520027403|FG002|Overall Study|Adverse Event|1|||
144227055|NCT00320710|520027401|FG000|Overall Study|Lost to Follow-up|1|||
144227056|NCT00320710|520027402|FG001|Overall Study|Lost to Follow-up|0|||
144227057|NCT00320710|520027403|FG002|Overall Study|Lost to Follow-up|0|||
144227058|NCT02588612|520027404|FG000|Overall Study|Physician Decision|1|||
144227059|NCT02588612|520027404|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
144227060|NCT02588612|520027404|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
144227061|NCT02588612|520027404|FG000|Overall Study|Death prior to T-cell infusion|1|||
144227062|NCT03448419|520027414|FG000|Overall Study|Adverse Event|10|||
144227063|NCT03448419|520027415|FG001|Overall Study|Adverse Event|9|||
144227064|NCT03448419|520027414|FG000|Overall Study|Lost to Follow-up|0|||
144227065|NCT03448419|520027415|FG001|Overall Study|Lost to Follow-up|2|||
144227066|NCT03448419|520027414|FG000|Overall Study|Withdrawal by Subject|3|||
144227067|NCT03448419|520027415|FG001|Overall Study|Withdrawal by Subject|1|||
144227068|NCT03448419|520027414|FG000|Overall Study|Not treated|0|||
144227069|NCT03448419|520027415|FG001|Overall Study|Not treated|1|||
144227070|NCT03448419|520027414|FG000|Overall Study|Patient did not attend all visits|0|||
144227071|NCT03448419|520027415|FG001|Overall Study|Patient did not attend all visits|2|||
144227072|NCT03448419|520027414|FG000|Overall Study|Withdrawn by Sponsor|0|||
144227073|NCT03448419|520027415|FG001|Overall Study|Withdrawn by Sponsor|1|||
144227074|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
144227075|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
144227076|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
144269043|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
144227077|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
144227078|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
144227079|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
144269044|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
144227080|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
144227081|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
144227082|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
144227083|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
144227084|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
144227085|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
144227086|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
144227087|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
144227088|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
144227089|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
144227090|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
144227091|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
144227092|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
144227093|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
144227094|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
144227095|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
144227096|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
144227097|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
144227098|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
144227099|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
144227100|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
144227101|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
144227102|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
144227103|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
144227104|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
144227105|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
144227106|NCT00506415|520027417|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
144227107|NCT00506415|520027418|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
144227108|NCT00506415|520027419|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
144227109|NCT00506415|520027420|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
144227110|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
144227111|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
144227112|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
144227113|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
144227114|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
144227115|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
144227116|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
144227117|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
144227118|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
144227119|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
144227120|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
144227121|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
144227122|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
144227123|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
144227124|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
144227125|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
144227126|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
144227127|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
144227128|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
144227129|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
144227130|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
144227131|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
144227132|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
144227133|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
144227134|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
144269045|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
144269046|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
144269047|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
144269048|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
144269049|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
144227135|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
144227136|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
144227137|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
144269050|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
144269051|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
144227138|NCT00506415|520027417|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
144227139|NCT00506415|520027418|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
144227140|NCT00506415|520027419|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
144227141|NCT00506415|520027420|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
144227142|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
144227143|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
144227144|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
144227145|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
144227146|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
144227147|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
144227148|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
144227149|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
144227150|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
144227151|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
144227152|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
144227153|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
144227154|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
144227155|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
144227156|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
144227157|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
144227158|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
144227159|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
144227160|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
144227161|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
144227162|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
144227163|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
144227164|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
144227165|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
144227166|NCT00506415|520027417|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
144227167|NCT00506415|520027418|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
144227168|NCT00506415|520027419|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
144227169|NCT00506415|520027420|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
144227170|NCT04578457|520027421|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
144227171|NCT04578457|520027421|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
144227172|NCT04578457|520027421|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
144227173|NCT04578457|520027421|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
144227174|NCT02841995|520027422|FG000|Overall Study|Disease progression|5|||
144227175|NCT02841995|520027423|FG001|Overall Study|Disease progression|11|||
144227176|NCT02841995|520027424|FG002|Overall Study|Disease progression|8|||
144227177|NCT02841995|520027422|FG000|Overall Study|Withdrawal by Subject|2|||
144227178|NCT02841995|520027423|FG001|Overall Study|Withdrawal by Subject|4|||
144227179|NCT02841995|520027424|FG002|Overall Study|Withdrawal by Subject|4|||
144227180|NCT02841995|520027422|FG000|Overall Study|Adverse Event|2|||
144227181|NCT02841995|520027423|FG001|Overall Study|Adverse Event|0|||
144227182|NCT02841995|520027424|FG002|Overall Study|Adverse Event|1|||
144227183|NCT02841995|520027422|FG000|Overall Study|Investigator decision|2|||
144227184|NCT02841995|520027423|FG001|Overall Study|Investigator decision|0|||
144227185|NCT02841995|520027424|FG002|Overall Study|Investigator decision|1|||
144227186|NCT02841995|520027422|FG000|Overall Study|Death|0|||
144227187|NCT02841995|520027423|FG001|Overall Study|Death|0|||
144227188|NCT02841995|520027424|FG002|Overall Study|Death|2|||
144227189|NCT02841995|520027422|FG000|Overall Study|Noncompliance to protocol|1|||
144227190|NCT02841995|520027423|FG001|Overall Study|Noncompliance to protocol|0|||
144227191|NCT02841995|520027424|FG002|Overall Study|Noncompliance to protocol|0|||
144227192|NCT02841995|520027422|FG000|Overall Study|Sponsor decision|1|||
144227193|NCT02841995|520027423|FG001|Overall Study|Sponsor decision|0|||
144227194|NCT02841995|520027424|FG002|Overall Study|Sponsor decision|0|||
144227195|NCT02841995|520027422|FG000|Overall Study|Other|4|||
144227196|NCT02841995|520027423|FG001|Overall Study|Other|1|||
144227197|NCT02841995|520027424|FG002|Overall Study|Other|5|||
144227198|NCT03809663|520027432|FG000|Overall Study|Decision by sponsor|24|||
144227199|NCT03809663|520027433|FG001|Overall Study|Decision by sponsor|18|||
144227200|NCT03809663|520027434|FG002|Overall Study|Decision by sponsor|20|||
144227201|NCT03809663|520027435|FG003|Overall Study|Decision by sponsor|20|||
144227202|NCT03809663|520027436|FG004|Overall Study|Decision by sponsor|0|||
144227203|NCT03809663|520027437|FG005|Overall Study|Decision by sponsor|0|||
144227204|NCT03809663|520027432|FG000|Overall Study|Withdrawal by Subject|26|||
144227205|NCT03809663|520027433|FG001|Overall Study|Withdrawal by Subject|22|||
144227206|NCT03809663|520027434|FG002|Overall Study|Withdrawal by Subject|27|||
144227207|NCT03809663|520027435|FG003|Overall Study|Withdrawal by Subject|26|||
144227208|NCT03809663|520027436|FG004|Overall Study|Withdrawal by Subject|0|||
144227209|NCT03809663|520027437|FG005|Overall Study|Withdrawal by Subject|0|||
144227210|NCT03809663|520027432|FG000|Overall Study|Lost to Follow-up|1|||
144227211|NCT03809663|520027433|FG001|Overall Study|Lost to Follow-up|4|||
144227212|NCT03809663|520027434|FG002|Overall Study|Lost to Follow-up|1|||
144227213|NCT03809663|520027435|FG003|Overall Study|Lost to Follow-up|1|||
144227214|NCT03809663|520027436|FG004|Overall Study|Lost to Follow-up|0|||
144227215|NCT03809663|520027437|FG005|Overall Study|Lost to Follow-up|0|||
144227216|NCT01703260|520027438|FG000|Overall Study|Adverse Event|1|||
144227217|NCT01703260|520027439|FG001|Overall Study|Adverse Event|2|||
144227218|NCT01703260|520027440|FG002|Overall Study|Adverse Event|2|||
144227219|NCT01703260|520027438|FG000|Overall Study|Lost to Follow-up|1|||
144227220|NCT01703260|520027439|FG001|Overall Study|Lost to Follow-up|0|||
144227221|NCT01703260|520027440|FG002|Overall Study|Lost to Follow-up|0|||
144227222|NCT01703260|520027438|FG000|Overall Study|Withdrawal by Subject|0|||
144227223|NCT01703260|520027439|FG001|Overall Study|Withdrawal by Subject|0|||
144227224|NCT01703260|520027440|FG002|Overall Study|Withdrawal by Subject|1|||
144227225|NCT01703260|520027438|FG000|Overall Study|Study Termination|1|||
144227226|NCT01703260|520027439|FG001|Overall Study|Study Termination|2|||
144227227|NCT01703260|520027440|FG002|Overall Study|Study Termination|0|||
144227228|NCT02275819|520027442|FG000|Overall Study|Adverse Event|0|||
144227229|NCT02275819|520027443|FG001|Overall Study|Adverse Event|1|||
144227230|NCT01346059|520027444|FG000|Overall Study|Withdrawal by Subject|1|||
144227231|NCT01346059|520027445|FG001|Overall Study|Withdrawal by Subject|0|||
144227232|NCT02792062|520027452|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
144227233|NCT02792062|520027453|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
144227234|NCT02792062|520027454|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
144227235|NCT02792062|520027455|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
144227236|NCT02792062|520027456|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
144227237|NCT02792062|520027457|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
144227238|NCT02230904|520027458|FG000|Overall Study|Safety follow up could not take place|0|||
144227239|NCT02230904|520027459|FG001|Overall Study|Safety follow up could not take place|1|||
144227240|NCT01464424|520027460|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
144227241|NCT01464424|520027461|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
144227242|NCT01464333|520027465|FG000|Overall Study|Adverse Event|34|||
144227243|NCT01464333|520027465|FG000|Overall Study|Lack of Efficacy|72|||
144227244|NCT01464333|520027465|FG000|Overall Study|Withdrawal by Subject|11|||
144227245|NCT01464333|520027465|FG000|Overall Study|Other|4|||
144227246|NCT01464333|520027465|FG000|Overall Study|No Hospital Visit|42|||
144227247|NCT05047211|520027467|FG000|Overall Study|Lost to Follow-up|8|||
144227248|NCT05047211|520027468|FG001|Overall Study|Lost to Follow-up|5|||
144227249|NCT02187198|520027469|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
144227250|NCT02187198|520027470|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
144227251|NCT02187198|520027469|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
144227252|NCT02187198|520027470|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
144227253|NCT00561392|520027471|FG000|Overall Study|Adverse Event|38|||
144227254|NCT00561392|520027471|FG000|Overall Study|Lack of Efficacy|2|||
144227255|NCT00561392|520027471|FG000|Overall Study|Protocol Violation|1|||
144227256|NCT00561392|520027471|FG000|Overall Study|Withdrawal by Subject|8|||
144227257|NCT00561392|520027471|FG000|Overall Study|Administrative problems|4|||
144227258|NCT02632409|520027475|FG000|Randomized|AE unrelated to study Drug|0|||
144227259|NCT02632409|520027476|FG001|Randomized|AE unrelated to study Drug|1|||
144227260|NCT02632409|520027475|FG000|Randomized|Participant withdrew consent|2|||
144227261|NCT02632409|520027476|FG001|Randomized|Participant withdrew consent|1|||
144227262|NCT02632409|520027475|FG000|Randomized|No Longer meets study criteria|5|||
144227263|NCT02632409|520027476|FG001|Randomized|No Longer meets study criteria|0|||
144227264|NCT02632409|520027475|FG000|Randomized|other reasons|1|||
144227265|NCT02632409|520027476|FG001|Randomized|other reasons|0|||
144227266|NCT02632409|520027475|FG000|Treatment Period|Ongoing Treatment|20|||
144227267|NCT02632409|520027476|FG001|Treatment Period|Ongoing Treatment|21|||
144227268|NCT02632409|520027475|FG000|Treatment Period|Disease Recurrence|147|||
144227269|NCT02632409|520027476|FG001|Treatment Period|Disease Recurrence|90|||
144227270|NCT02632409|520027475|FG000|Treatment Period|Study Drug Toxicity|8|||
144227271|NCT02632409|520027476|FG001|Treatment Period|Study Drug Toxicity|49|||
144227272|NCT02632409|520027475|FG000|Treatment Period|Death|1|||
144227273|NCT02632409|520027476|FG001|Treatment Period|Death|0|||
144227274|NCT02632409|520027475|FG000|Treatment Period|AE unrelated to study drug|15|||
144227275|NCT02632409|520027476|FG001|Treatment Period|AE unrelated to study drug|16|||
144227276|NCT02632409|520027475|FG000|Treatment Period|Request to discontinue treatment|4|||
144227277|NCT02632409|520027476|FG001|Treatment Period|Request to discontinue treatment|19|||
144227278|NCT02632409|520027475|FG000|Treatment Period|Participant withdrew consent|7|||
144227279|NCT02632409|520027476|FG001|Treatment Period|Participant withdrew consent|5|||
144227280|NCT02632409|520027475|FG000|Treatment Period|Lost to Follow-up|0|||
144227281|NCT02632409|520027476|FG001|Treatment Period|Lost to Follow-up|1|||
144269052|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
144227282|NCT02632409|520027475|FG000|Treatment Period|Maximum clinical benefit|1|||
144227283|NCT02632409|520027476|FG001|Treatment Period|Maximum clinical benefit|0|||
144227284|NCT02632409|520027475|FG000|Treatment Period|No longer meets study criteria|3|||
144227285|NCT02632409|520027476|FG001|Treatment Period|No longer meets study criteria|0|||
144227286|NCT02632409|520027475|FG000|Treatment Period|Administrative Reason by sponsor|0|||
144227287|NCT02632409|520027476|FG001|Treatment Period|Administrative Reason by sponsor|1|||
144227288|NCT02632409|520027475|FG000|Treatment Period|Other Reasons|10|||
144227289|NCT02632409|520027476|FG001|Treatment Period|Other Reasons|6|||
144227290|NCT05600283|520027477|FG000|Overall Study|Withdrawal by Subject|3|||
144227291|NCT05600283|520027478|FG001|Overall Study|Withdrawal by Subject|8|||
144227292|NCT05600283|520027477|FG000|Overall Study|invalid individual swab|1|||
144227293|NCT05600283|520027478|FG001|Overall Study|invalid individual swab|0|||
144227294|NCT05600283|520027477|FG000|Overall Study|missing clinician collection|3|||
144227295|NCT05600283|520027478|FG001|Overall Study|missing clinician collection|0|||
144227296|NCT05600283|520027477|FG000|Overall Study|screening failure|0|||
144227297|NCT05600283|520027478|FG001|Overall Study|screening failure|2|||
144227298|NCT04426006|520027479|FG000|Inclusion|Protocol Violation|1|||
144227299|NCT04426006|520027479|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
144227300|NCT04426006|520027479|FG000|Inclusion|Blood sample at inclusion not done|1|||
144227301|NCT04426006|520027479|FG000|3 Months|Lost to Follow-up|17|||
144227302|NCT04426006|520027479|FG000|12 Months|Lost to Follow-up|38|||
144227303|NCT00720213|520027482|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
144227304|NCT00720213|520027483|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
144227305|NCT00720213|520027484|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
144227306|NCT01808066|520027487|FG000|Overall Study|Withdrawal by Subject|15|||
144227307|NCT01252095|520027488|FG000|Overall Study|Disease progression|1|||
144227308|NCT01252095|520027489|FG001|Overall Study|Disease progression|0|||
144227309|NCT01420068|520027490|FG000|Overall Study|Administrative problems|1|||
144227310|NCT01420068|520027491|FG001|Overall Study|Administrative problems|3|||
144227311|NCT01420068|520027490|FG000|Overall Study|Withdrawal by Subject|1|||
144227312|NCT01420068|520027491|FG001|Overall Study|Withdrawal by Subject|2|||
144227313|NCT00745901|520027492|FG000|Overall Study|Adverse Event|3|||
144227314|NCT00745901|520027493|FG001|Overall Study|Adverse Event|4|||
144227315|NCT00745901|520027492|FG000|Overall Study|Protocol Violation|0|||
144227316|NCT00745901|520027493|FG001|Overall Study|Protocol Violation|1|||
144227317|NCT00745901|520027492|FG000|Overall Study|Withdrawal by Subject|1|||
144227318|NCT00745901|520027493|FG001|Overall Study|Withdrawal by Subject|0|||
144227319|NCT00745901|520027492|FG000|Overall Study|Lost to Follow-up|7|||
144227320|NCT00745901|520027493|FG001|Overall Study|Lost to Follow-up|4|||
144227321|NCT00745901|520027492|FG000|Overall Study|Pregnancy|2|||
144227322|NCT00745901|520027493|FG001|Overall Study|Pregnancy|4|||
144227323|NCT00745901|520027492|FG000|Overall Study|Lack of compliance|2|||
144227324|NCT00745901|520027493|FG001|Overall Study|Lack of compliance|2|||
144227325|NCT00745901|520027492|FG000|Overall Study|Patient's next menses did not start with|1|||
144227326|NCT00745901|520027493|FG001|Overall Study|Patient's next menses did not start with|0|||
144227327|NCT00745901|520027492|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
144227328|NCT00745901|520027493|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
144227329|NCT00745901|520027492|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
144227330|NCT00745901|520027493|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
144227331|NCT00745901|520027492|FG000|Overall Study|Patient didn't take any study medication|7|||
144227332|NCT00745901|520027493|FG001|Overall Study|Patient didn't take any study medication|3|||
144227333|NCT00884117|520027496|FG000|Overall Study|Adverse Event|2|||
144227334|NCT00884117|520027496|FG000|Overall Study|Withdrawal by Subject|89|||
144227335|NCT00884117|520027496|FG000|Overall Study|Death|3|||
144227336|NCT00884117|520027496|FG000|Overall Study|Lost to Follow-up|143|||
144227337|NCT00884117|520027496|FG000|Overall Study|Other|12|||
144227338|NCT01753310|520027497|FG000|Overall Study|Entered into open label extension study|25|||
144227339|NCT01753310|520027498|FG001|Overall Study|Entered into open label extension study|22|||
144227340|NCT01753310|520027497|FG000|Overall Study|Adverse Event|1|||
144227341|NCT01753310|520027498|FG001|Overall Study|Adverse Event|0|||
144227342|NCT01753310|520027497|FG000|Overall Study|Lost to Follow-up|2|||
144227343|NCT01753310|520027498|FG001|Overall Study|Lost to Follow-up|0|||
144227344|NCT01753310|520027497|FG000|Overall Study|Subject decision|2|||
144227345|NCT01753310|520027498|FG001|Overall Study|Subject decision|2|||
144227346|NCT01753310|520027497|FG000|Overall Study|Sponsor decision|1|||
144227347|NCT01753310|520027498|FG001|Overall Study|Sponsor decision|0|||
144227348|NCT01753310|520027497|FG000|Overall Study|Withdrawal by Subject|1|||
144227349|NCT01753310|520027498|FG001|Overall Study|Withdrawal by Subject|0|||
144227350|NCT00952068|520027500|FG000|Overall Study|Adverse Event|3|||
144227351|NCT00952068|520027500|FG000|Overall Study|Withdrawal by Subject|4|||
144227352|NCT02462603|520027502|FG000|Overall Study|Investigator Decision|1|||
144227353|NCT02462603|520027502|FG000|Overall Study|Non-Compliance|1|||
144227354|NCT02462603|520027502|FG000|Overall Study|Withdrawal by Subject|2|||
144227355|NCT03194542|520027503|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
144227356|NCT03194542|520027504|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
144227357|NCT03194542|520027505|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
144227358|NCT03194542|520027506|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
144227359|NCT03194542|520027503|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
144227360|NCT03194542|520027504|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
144227361|NCT03194542|520027505|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
144227362|NCT03194542|520027506|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
144227363|NCT03194542|520027503|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
144227364|NCT03194542|520027504|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
144227365|NCT03194542|520027505|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
144227366|NCT03194542|520027506|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
144227367|NCT03194542|520027503|FG000|Overall Study|Loss of Response|4|||
144227368|NCT03194542|520027504|FG001|Overall Study|Loss of Response|2|||
144227369|NCT03194542|520027505|FG002|Overall Study|Loss of Response|3|||
144227370|NCT03194542|520027506|FG003|Overall Study|Loss of Response|4|||
144227371|NCT03194542|520027503|FG000|Overall Study|Physician Decision|0|||
144227372|NCT03194542|520027504|FG001|Overall Study|Physician Decision|1|||
144227373|NCT03194542|520027505|FG002|Overall Study|Physician Decision|0|||
144227374|NCT03194542|520027506|FG003|Overall Study|Physician Decision|0|||
144227375|NCT03194542|520027503|FG000|Overall Study|Lack of Efficacy|2|||
144227376|NCT03194542|520027504|FG001|Overall Study|Lack of Efficacy|2|||
144227377|NCT03194542|520027505|FG002|Overall Study|Lack of Efficacy|2|||
144227378|NCT03194542|520027506|FG003|Overall Study|Lack of Efficacy|6|||
144227379|NCT03194542|520027503|FG000|Overall Study|Withdrawal by Subject|2|||
144227380|NCT03194542|520027504|FG001|Overall Study|Withdrawal by Subject|1|||
144227381|NCT03194542|520027505|FG002|Overall Study|Withdrawal by Subject|5|||
144227382|NCT03194542|520027506|FG003|Overall Study|Withdrawal by Subject|4|||
144227383|NCT03194542|520027503|FG000|Overall Study|Progressive Disease|1|||
144227384|NCT03194542|520027504|FG001|Overall Study|Progressive Disease|0|||
144227385|NCT03194542|520027505|FG002|Overall Study|Progressive Disease|1|||
144227386|NCT03194542|520027506|FG003|Overall Study|Progressive Disease|1|||
144227387|NCT03194542|520027503|FG000|Overall Study|Adverse Event|1|||
144227388|NCT03194542|520027504|FG001|Overall Study|Adverse Event|2|||
144227389|NCT03194542|520027505|FG002|Overall Study|Adverse Event|0|||
144227390|NCT03194542|520027506|FG003|Overall Study|Adverse Event|5|||
144227391|NCT03194542|520027503|FG000|Overall Study|Death|1|||
144227392|NCT03194542|520027504|FG001|Overall Study|Death|2|||
144227393|NCT03194542|520027505|FG002|Overall Study|Death|0|||
144227394|NCT03194542|520027506|FG003|Overall Study|Death|5|||
144227395|NCT03194542|520027503|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
144227396|NCT03194542|520027504|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
144227397|NCT03194542|520027505|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
144227398|NCT03194542|520027506|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
144227399|NCT01991743|520027507|FG000|Overall Study|external cephalic version not performed|0|||
144227400|NCT01991743|520027508|FG001|Overall Study|external cephalic version not performed|0|||
144227401|NCT01991743|520027509|FG002|Overall Study|external cephalic version not performed|1|||
144227402|NCT01991743|520027510|FG003|Overall Study|external cephalic version not performed|0|||
144227403|NCT01611883|520027512|FG000|Overall Study|Adverse Event|1|||
144227404|NCT01611883|520027513|FG001|Overall Study|Adverse Event|1|||
144227405|NCT01806051|520027514|FG000|Overall Study|Withdrawal by Subject|6|||
144227406|NCT00734994|520027517|FG000|Overall Study|Withdrawal by Subject|1|||
144227407|NCT00571727|520027518|FG000|Overall Study|Did not enter in this study|1|||
144227408|NCT00571727|520027518|FG000|Overall Study|Non-compliance|4|||
144227409|NCT00571727|520027518|FG000|Overall Study|Lost to Follow-up|30|||
144227410|NCT00571727|520027518|FG000|Overall Study|Poor growth|1|||
144227411|NCT00571727|520027518|FG000|Overall Study|Parent/patient decision|2|||
144227412|NCT00571727|520027518|FG000|Overall Study|Participant transferred to commercial drug|14|||
144227413|NCT00571727|520027518|FG000|Overall Study|Unable to provide study drug|6|||
144227414|NCT00571727|520027518|FG000|Overall Study|On-treatment at end of study|8|||
144227415|NCT02747108|520027521|FG000|Overall Study|Death|2|||
144227416|NCT02747108|520027522|FG001|Overall Study|Death|2|||
144227417|NCT02747108|520027521|FG000|Overall Study|Withdrawal by Subject|1|||
144227418|NCT02747108|520027522|FG001|Overall Study|Withdrawal by Subject|0|||
144227419|NCT02747108|520027521|FG000|Overall Study|Protocol Violation|2|||
144227420|NCT02747108|520027522|FG001|Overall Study|Protocol Violation|0|||
144227421|NCT04955691|520029210|FG000|Period 2|Discontinued intervention|1|||
144227422|NCT04955691|520029211|FG001|Period 2|Discontinued intervention|2|||
144227423|NCT05795153|520029212|FG000|Overall Study|Adverse Event|2|||
144227424|NCT05795153|520029212|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144227425|NCT05795153|520029212|FG000|Overall Study|Lost to Follow-up|1|||
144227426|NCT05795153|520029212|FG000|Overall Study|Subject decision|2|||
144227427|NCT03760744|520029213|FG000|Overall Study|Lost to Follow-up|3|||
144227428|NCT03760744|520029214|FG001|Overall Study|Lost to Follow-up|0|||
144227429|NCT04050462|520029215|FG000|Overall Study|Withdrawal by Subject|1|||
144227430|NCT04050462|520029216|FG001|Overall Study|Withdrawal by Subject|0|||
144227431|NCT04050462|520029217|FG002|Overall Study|Withdrawal by Subject|0|||
144227432|NCT05151744|520029218|FG000|Overall Study|Adverse Event|6|||
144227433|NCT05151744|520029219|FG001|Overall Study|Adverse Event|2|||
144227434|NCT05151744|520029218|FG000|Overall Study|Death|1|||
144227435|NCT05151744|520029219|FG001|Overall Study|Death|2|||
144227436|NCT05151744|520029218|FG000|Overall Study|Lack of Efficacy|1|||
144227437|NCT05151744|520029219|FG001|Overall Study|Lack of Efficacy|1|||
144227438|NCT05151744|520029218|FG000|Overall Study|Lost to Follow-up|2|||
144227439|NCT05151744|520029219|FG001|Overall Study|Lost to Follow-up|2|||
144227440|NCT05151744|520029218|FG000|Overall Study|Need for Rescue Treatment|0|||
144227441|NCT05151744|520029219|FG001|Overall Study|Need for Rescue Treatment|1|||
144227442|NCT05151744|520029218|FG000|Overall Study|Non-compliance with Study Drug|0|||
144227443|NCT05151744|520029219|FG001|Overall Study|Non-compliance with Study Drug|1|||
144227444|NCT05151744|520029218|FG000|Overall Study|Reason not Specified|10|||
144227445|NCT05151744|520029219|FG001|Overall Study|Reason not Specified|0|||
144227446|NCT05151744|520029218|FG000|Overall Study|Physician Decision|2|||
144227447|NCT05151744|520029219|FG001|Overall Study|Physician Decision|1|||
144227448|NCT05151744|520029218|FG000|Overall Study|Protocol Violation|1|||
144227449|NCT05151744|520029219|FG001|Overall Study|Protocol Violation|0|||
144227450|NCT05151744|520029218|FG000|Overall Study|Withdrawal by Subject|6|||
144227451|NCT05151744|520029219|FG001|Overall Study|Withdrawal by Subject|3|||
144227452|NCT05228470|520029220|FG000|Overall Study|Death|6|||
144227453|NCT05228470|520029221|FG001|Overall Study|Death|11|||
144227454|NCT05228470|520029220|FG000|Overall Study|Withdrawal by Subject|1|||
144269053|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
144269054|NCT03504917|520187841|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
144227455|NCT05228470|520029221|FG001|Overall Study|Withdrawal by Subject|8|||
144227456|NCT05228470|520029220|FG000|Overall Study|Ongoing|1|||
144227457|NCT05228470|520029221|FG001|Overall Study|Ongoing|11|||
144227458|NCT04053868|520029222|FG000|Overall Study|Withdrawal by Subject|1|||
144227459|NCT04053868|520029223|FG001|Overall Study|Withdrawal by Subject|0|||
144227460|NCT05731700|520029224|FG000|Overall Study|Death|1|||
144227461|NCT04010240|520029227|FG000|Overall Study|IHC not performed|2299|||
144227462|NCT01068678|520029236|FG000|Overall Study|Lack of Efficacy|3|||
144227463|NCT01068678|520029237|FG001|Overall Study|Lack of Efficacy|2|||
144227464|NCT01068678|520029236|FG000|Overall Study|Protocol Violation|5|||
144227465|NCT01068678|520029237|FG001|Overall Study|Protocol Violation|1|||
144227466|NCT01068678|520029236|FG000|Overall Study|Withdrawal criteria|12|||
144227467|NCT01068678|520029237|FG001|Overall Study|Withdrawal criteria|6|||
144227468|NCT01068678|520029236|FG000|Overall Study|Unclassified|18|||
144227469|NCT01068678|520029237|FG001|Overall Study|Unclassified|15|||
144227470|NCT00570687|520029240|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227471|NCT00570687|520029241|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227472|NCT00570687|520029242|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227473|NCT00570687|520029243|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227474|NCT00570687|520029244|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
144227475|NCT00570687|520029245|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
144227476|NCT00570687|520029246|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
144227477|NCT00570687|520029247|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
144227478|NCT00570687|520029248|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
144227479|NCT00570687|520029249|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
144227480|NCT00570687|520029240|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227481|NCT00570687|520029241|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227482|NCT00570687|520029242|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227483|NCT00570687|520029243|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227484|NCT00570687|520029244|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227485|NCT00570687|520029245|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227486|NCT00570687|520029246|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227487|NCT00570687|520029247|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227488|NCT00570687|520029248|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
144227489|NCT00570687|520029249|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227490|NCT00570687|520029240|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227491|NCT00570687|520029241|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227492|NCT00570687|520029242|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227493|NCT00570687|520029243|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227494|NCT00570687|520029244|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227495|NCT00570687|520029245|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227496|NCT00570687|520029246|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
144227497|NCT00570687|520029247|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227498|NCT00570687|520029248|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227499|NCT00570687|520029249|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
144227500|NCT03055338|520029250|FG000|Overall Study|Lost to Follow-up|9|||
144227501|NCT03055338|520029251|FG001|Overall Study|Lost to Follow-up|2|||
144227502|NCT03055338|520029252|FG002|Overall Study|Lost to Follow-up|3|||
144227503|NCT03055338|520029250|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
144227504|NCT03055338|520029251|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
144227505|NCT03055338|520029252|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
144227506|NCT03055338|520029250|FG000|Overall Study|Physician Decision|0|||
144227507|NCT03055338|520029251|FG001|Overall Study|Physician Decision|0|||
144227508|NCT03055338|520029252|FG002|Overall Study|Physician Decision|2|||
144227509|NCT03055338|520029250|FG000|Overall Study|Withdrawal by Subject|9|||
144227510|NCT03055338|520029251|FG001|Overall Study|Withdrawal by Subject|8|||
144227511|NCT03055338|520029252|FG002|Overall Study|Withdrawal by Subject|7|||
144227512|NCT00975611|520029253|FG000|Overall Study|Screen Fail|16|||
144227513|NCT00975611|520029253|FG000|Overall Study|Physician Decision|1|||
144227514|NCT03058705|520029254|FG000|Overall Study|Withdrawal by Subject|2|||
144227515|NCT03058705|520029254|FG000|Overall Study|Physician Decision|2|||
144227516|NCT01102257|520029255|FG000|Overall Study|Adverse Event|1|||
144227517|NCT01102257|520029256|FG001|Overall Study|Adverse Event|0|||
144227518|NCT01102257|520029255|FG000|Overall Study|Adverse Event|1|||
144227519|NCT01102257|520029256|FG001|Overall Study|Adverse Event|0|||
144227520|NCT03752970|520029257|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
144227521|NCT03752970|520029258|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
144227522|NCT03752970|520029259|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
144227523|NCT03752970|520029257|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
144227524|NCT03752970|520029258|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
144227525|NCT03752970|520029259|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
144227526|NCT03752970|520029257|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
144227527|NCT03752970|520029258|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
144227528|NCT03752970|520029259|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
144227529|NCT03752970|520029257|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
144227530|NCT03752970|520029258|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
144227531|NCT03752970|520029259|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
144227532|NCT03752970|520029257|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
144227533|NCT03752970|520029258|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
144227534|NCT03752970|520029259|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
144227535|NCT03976362|520029260|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
144227536|NCT03976362|520029261|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
144227537|NCT03976362|520029262|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
144227538|NCT03976362|520029260|FG000|Induction Phase|Death|62|||
144227539|NCT03976362|520029261|FG001|Induction Phase|Death|0|||
144227540|NCT03976362|520029262|FG002|Induction Phase|Death|0|||
144227541|NCT03976362|520029260|FG000|Maintenance Phase|Participants Ongoing|0|||
144227542|NCT03976362|520029261|FG001|Maintenance Phase|Participants Ongoing|106|||
144227543|NCT03976362|520029262|FG002|Maintenance Phase|Participants Ongoing|103|||
144227544|NCT03976362|520029260|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144227545|NCT03976362|520029261|FG001|Maintenance Phase|Withdrawal by Subject|4|||
144227546|NCT03976362|520029262|FG002|Maintenance Phase|Withdrawal by Subject|4|||
144227547|NCT03976362|520029260|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
144227548|NCT03976362|520029261|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
144227549|NCT03976362|520029262|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
144227550|NCT03976362|520029260|FG000|Maintenance Phase|Death|0|||
144227551|NCT03976362|520029261|FG001|Maintenance Phase|Death|186|||
144227552|NCT03976362|520029262|FG002|Maintenance Phase|Death|187|||
144227553|NCT01467713|520029264|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
144227554|NCT01467713|520029265|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
144227555|NCT01467713|520029266|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
144227556|NCT01467713|520029267|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
144227557|NCT01467713|520029264|FG000|Overall Study|Major Protocol Deviation|2|||
144227558|NCT01467713|520029265|FG001|Overall Study|Major Protocol Deviation|4|||
144227559|NCT01467713|520029266|FG002|Overall Study|Major Protocol Deviation|4|||
144227560|NCT01467713|520029267|FG003|Overall Study|Major Protocol Deviation|1|||
144227561|NCT01467713|520029264|FG000|Overall Study|Lost to Follow-up|9|||
144227562|NCT01467713|520029265|FG001|Overall Study|Lost to Follow-up|12|||
144227563|NCT01467713|520029266|FG002|Overall Study|Lost to Follow-up|6|||
144227564|NCT01467713|520029267|FG003|Overall Study|Lost to Follow-up|9|||
144227565|NCT01467713|520029264|FG000|Overall Study|Voluntary Withdrawal|18|||
144227566|NCT01467713|520029265|FG001|Overall Study|Voluntary Withdrawal|14|||
144227567|NCT01467713|520029266|FG002|Overall Study|Voluntary Withdrawal|21|||
144227568|NCT01467713|520029267|FG003|Overall Study|Voluntary Withdrawal|20|||
144227569|NCT01467713|520029264|FG000|Overall Study|Study Termination|23|||
144227570|NCT01467713|520029265|FG001|Overall Study|Study Termination|33|||
144227571|NCT01467713|520029266|FG002|Overall Study|Study Termination|28|||
144227572|NCT01467713|520029267|FG003|Overall Study|Study Termination|29|||
144227573|NCT01467713|520029264|FG000|Overall Study|Pregnancy|0|||
144227574|NCT01467713|520029265|FG001|Overall Study|Pregnancy|1|||
144227575|NCT01467713|520029266|FG002|Overall Study|Pregnancy|1|||
144227576|NCT01467713|520029267|FG003|Overall Study|Pregnancy|3|||
144227577|NCT01467713|520029264|FG000|Overall Study|Relapse|35|||
144227578|NCT01467713|520029265|FG001|Overall Study|Relapse|25|||
144227579|NCT01467713|520029266|FG002|Overall Study|Relapse|28|||
144227580|NCT01467713|520029267|FG003|Overall Study|Relapse|35|||
144227581|NCT01467713|520029264|FG000|Overall Study|Reason not Specified|6|||
144227582|NCT01467713|520029265|FG001|Overall Study|Reason not Specified|11|||
144227583|NCT01467713|520029266|FG002|Overall Study|Reason not Specified|8|||
144227584|NCT01467713|520029267|FG003|Overall Study|Reason not Specified|7|||
144227585|NCT02525783|520029268|FG000|Overall Study|Lost to Follow-up|10|||
144227586|NCT00866281|520029269|FG000|Overall Study|Adverse Event|1|||
144227587|NCT00866281|520029270|FG001|Overall Study|Adverse Event|0|||
144227588|NCT00866281|520029269|FG000|Overall Study|Withdrawal by participants|3|||
144227589|NCT00866281|520029270|FG001|Overall Study|Withdrawal by participants|0|||
144227590|NCT00866281|520029269|FG000|Overall Study|Disease progression|3|||
144227591|NCT00866281|520029270|FG001|Overall Study|Disease progression|11|||
144269055|NCT03504917|520187842|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
144269056|NCT04219189|520187843|FG000|Overall Study|Withdrawal by Subject|1|||
144227592|NCT00866281|520029269|FG000|Overall Study|New cancer therapy|0|||
144227593|NCT00866281|520029270|FG001|Overall Study|New cancer therapy|4|||
144227594|NCT01100086|520029271|FG000|Period 1|Withdrawal by Subject|1|||
144227595|NCT01100086|520029272|FG001|Period 1|Withdrawal by Subject|0|||
144227596|NCT00570141|520029273|FG000|Overall Study|Adverse Event|1|||
144227597|NCT00570141|520029273|FG000|Overall Study|Missed visits|1|||
144227598|NCT00570141|520029273|FG000|Overall Study|Lost to Follow-up|1|||
144227599|NCT03270657|520029278|FG000|Overall Study|Withdrawal by Subject|1|||
144227600|NCT00455403|520029279|FG000|Overall Study|Lost to Follow-up|2|||
144227601|NCT00455403|520029280|FG001|Overall Study|Lost to Follow-up|1|||
144227602|NCT00455403|520029279|FG000|Overall Study|Withdrawal by Subject|1|||
144227603|NCT00455403|520029280|FG001|Overall Study|Withdrawal by Subject|3|||
144227604|NCT00455403|520029279|FG000|Overall Study|Protocol Violation|0|||
144227605|NCT00455403|520029280|FG001|Overall Study|Protocol Violation|2|||
144227606|NCT04509076|520029281|FG000|Overall Study|Withdrawal by Subject|1|||
144227607|NCT04509076|520029282|FG001|Overall Study|Withdrawal by Subject|2|||
144227608|NCT04509076|520029281|FG000|Overall Study|Lost to Follow-up|1|||
144227609|NCT04509076|520029282|FG001|Overall Study|Lost to Follow-up|2|||
144227610|NCT01343043|520029285|FG000|Overall Study|Disease progression before treatment|1|||
144227611|NCT01343043|520029286|FG001|Overall Study|Disease progression before treatment|0|||
144227612|NCT01343043|520029287|FG002|Overall Study|Disease progression before treatment|0|||
144227613|NCT01343043|520029288|FG003|Overall Study|Disease progression before treatment|0|||
144227614|NCT01343043|520029285|FG000|Overall Study|Withdrawal by Subject|1|||
144227615|NCT01343043|520029286|FG001|Overall Study|Withdrawal by Subject|0|||
144227616|NCT01343043|520029287|FG002|Overall Study|Withdrawal by Subject|0|||
144227617|NCT01343043|520029288|FG003|Overall Study|Withdrawal by Subject|0|||
144227618|NCT01343043|520029285|FG000|Overall Study|Death|1|||
144227619|NCT01343043|520029286|FG001|Overall Study|Death|1|||
144227620|NCT01343043|520029287|FG002|Overall Study|Death|0|||
144227621|NCT01343043|520029288|FG003|Overall Study|Death|1|||
144227622|NCT00925704|520029289|FG000|First Intervention|Withdrew consent|0|||
144227623|NCT00925704|520029290|FG001|First Intervention|Withdrew consent|0|||
144227624|NCT00925704|520029291|FG002|First Intervention|Withdrew consent|0|||
144227625|NCT00925704|520029292|FG003|First Intervention|Withdrew consent|1|||
144227626|NCT00925704|520029293|FG004|First Intervention|Withdrew consent|1|||
144227627|NCT00925704|520029294|FG005|First Intervention|Withdrew consent|0|||
144227628|NCT00925704|520029289|FG000|Second Intervention|Withdrawal by Subject|1|||
144227629|NCT00925704|520029290|FG001|Second Intervention|Withdrawal by Subject|0|||
144227630|NCT00925704|520029291|FG002|Second Intervention|Withdrawal by Subject|0|||
144227631|NCT00925704|520029292|FG003|Second Intervention|Withdrawal by Subject|0|||
144227632|NCT00925704|520029293|FG004|Second Intervention|Withdrawal by Subject|1|||
144227633|NCT00925704|520029294|FG005|Second Intervention|Withdrawal by Subject|0|||
144227634|NCT00925704|520029289|FG000|Third Intervention|Withdrew consent|0|||
144227635|NCT00925704|520029290|FG001|Third Intervention|Withdrew consent|0|||
144227636|NCT00925704|520029291|FG002|Third Intervention|Withdrew consent|0|||
144227637|NCT00925704|520029292|FG003|Third Intervention|Withdrew consent|0|||
144227638|NCT00925704|520029293|FG004|Third Intervention|Withdrew consent|0|||
144227639|NCT00925704|520029294|FG005|Third Intervention|Withdrew consent|1|||
144227640|NCT00502242|520029302|FG000|Overall Study|Lack of Efficacy|1|||
144227641|NCT00502242|520029303|FG001|Overall Study|Lack of Efficacy|11|||
144227642|NCT00502242|520029302|FG000|Overall Study|Adverse Event|31|||
144227643|NCT00502242|520029303|FG001|Overall Study|Adverse Event|20|||
144227644|NCT00502242|520029302|FG000|Overall Study|Physician Decision|2|||
144227645|NCT00502242|520029303|FG001|Overall Study|Physician Decision|3|||
144227646|NCT00502242|520029302|FG000|Overall Study|Other - Unspecified|8|||
144227647|NCT00502242|520029303|FG001|Overall Study|Other - Unspecified|14|||
144227648|NCT00502242|520029302|FG000|Overall Study|Protocol Violation|3|||
144227649|NCT00502242|520029303|FG001|Overall Study|Protocol Violation|1|||
144227650|NCT00502242|520029302|FG000|Overall Study|Withdrawal by Subject|6|||
144227651|NCT00502242|520029303|FG001|Overall Study|Withdrawal by Subject|7|||
144227652|NCT03207815|520029304|FG000|Overall Study|Protocol Violation|3|||
144227653|NCT03207815|520029305|FG001|Overall Study|Protocol Violation|1|||
144227654|NCT03207815|520029304|FG000|Overall Study|Adverse Event|1|||
144227655|NCT03207815|520029305|FG001|Overall Study|Adverse Event|2|||
144227656|NCT03207815|520029304|FG000|Overall Study|Lost to Follow-up|1|||
144227657|NCT03207815|520029305|FG001|Overall Study|Lost to Follow-up|2|||
144227658|NCT03207815|520029304|FG000|Overall Study|Investigator's Discretion|1|||
144227659|NCT03207815|520029305|FG001|Overall Study|Investigator's Discretion|1|||
144227660|NCT03207815|520029304|FG000|Overall Study|Lack of Efficacy|0|||
144227661|NCT03207815|520029305|FG001|Overall Study|Lack of Efficacy|1|||
144227662|NCT03207815|520029304|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
144227663|NCT03207815|520029305|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
144227664|NCT03207815|520029304|FG000|Overall Study|Withdrew Consent|1|||
144227665|NCT03207815|520029305|FG001|Overall Study|Withdrew Consent|0|||
144227666|NCT01671007|520029306|FG000|Overall Study|Other reasons than listed|166|||
144227667|NCT01671007|520029307|FG001|Overall Study|Other reasons than listed|373|||
144269057|NCT04219189|520187844|FG001|Overall Study|Withdrawal by Subject|2|||
144269058|NCT04219189|520187843|FG000|Overall Study|Protocol Violation|0|||
144269059|NCT04219189|520187844|FG001|Overall Study|Protocol Violation|1|||
144227668|NCT01671007|520029308|FG002|Overall Study|Other reasons than listed|197|||
144227669|NCT01671007|520029309|FG003|Overall Study|Other reasons than listed|228|||
144227670|NCT01671007|520029310|FG004|Overall Study|Other reasons than listed|14|||
144269060|NCT04219189|520187843|FG000|Overall Study|Lost to Follow-up|0|||
144227671|NCT01671007|520029311|FG005|Overall Study|Other reasons than listed|71|||
144227672|NCT01671007|520029312|FG006|Overall Study|Other reasons than listed|17|||
144227673|NCT01671007|520029313|FG007|Overall Study|Other reasons than listed|66|||
144269061|NCT04219189|520187844|FG001|Overall Study|Lost to Follow-up|1|||
144269062|NCT04219189|520187843|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
144269063|NCT04219189|520187844|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
144227674|NCT01671007|520029314|FG008|Overall Study|Other reasons than listed|0|||
144227675|NCT01671007|520029306|FG000|Overall Study|Withdrawal by Subject|36|||
144227676|NCT01671007|520029307|FG001|Overall Study|Withdrawal by Subject|59|||
144269064|NCT00324155|520187845|FG000|Enrolled and Randomized|No longer met study criteria|3|||
144227677|NCT01671007|520029308|FG002|Overall Study|Withdrawal by Subject|53|||
144227678|NCT01671007|520029309|FG003|Overall Study|Withdrawal by Subject|58|||
144227679|NCT01671007|520029310|FG004|Overall Study|Withdrawal by Subject|4|||
144227680|NCT01671007|520029311|FG005|Overall Study|Withdrawal by Subject|15|||
144227681|NCT01671007|520029312|FG006|Overall Study|Withdrawal by Subject|1|||
144227682|NCT01671007|520029313|FG007|Overall Study|Withdrawal by Subject|19|||
144227683|NCT01671007|520029314|FG008|Overall Study|Withdrawal by Subject|0|||
144227684|NCT01671007|520029306|FG000|Overall Study|Lost to Follow-up|93|||
144227685|NCT01671007|520029307|FG001|Overall Study|Lost to Follow-up|142|||
144227686|NCT01671007|520029308|FG002|Overall Study|Lost to Follow-up|91|||
144227687|NCT01671007|520029309|FG003|Overall Study|Lost to Follow-up|63|||
144227688|NCT01671007|520029310|FG004|Overall Study|Lost to Follow-up|7|||
144227689|NCT01671007|520029311|FG005|Overall Study|Lost to Follow-up|20|||
144227690|NCT01671007|520029312|FG006|Overall Study|Lost to Follow-up|2|||
144227691|NCT01671007|520029313|FG007|Overall Study|Lost to Follow-up|28|||
144227692|NCT01671007|520029314|FG008|Overall Study|Lost to Follow-up|0|||
144227693|NCT01671007|520029306|FG000|Overall Study|No end of study case report form|3|||
144227694|NCT01671007|520029307|FG001|Overall Study|No end of study case report form|1|||
144227695|NCT01671007|520029308|FG002|Overall Study|No end of study case report form|0|||
144227696|NCT01671007|520029309|FG003|Overall Study|No end of study case report form|2|||
144227697|NCT01671007|520029310|FG004|Overall Study|No end of study case report form|0|||
144227698|NCT01671007|520029311|FG005|Overall Study|No end of study case report form|0|||
144227699|NCT01671007|520029312|FG006|Overall Study|No end of study case report form|0|||
144227700|NCT01671007|520029313|FG007|Overall Study|No end of study case report form|0|||
144227701|NCT01671007|520029314|FG008|Overall Study|No end of study case report form|0|||
144227702|NCT01671007|520029306|FG000|Overall Study|Not eligible|23|||
144227703|NCT01671007|520029307|FG001|Overall Study|Not eligible|76|||
144227704|NCT01671007|520029308|FG002|Overall Study|Not eligible|25|||
144227705|NCT01671007|520029309|FG003|Overall Study|Not eligible|17|||
144227706|NCT01671007|520029310|FG004|Overall Study|Not eligible|0|||
144227707|NCT01671007|520029311|FG005|Overall Study|Not eligible|6|||
144227708|NCT01671007|520029312|FG006|Overall Study|Not eligible|1|||
144227709|NCT01671007|520029313|FG007|Overall Study|Not eligible|19|||
144227710|NCT01671007|520029314|FG008|Overall Study|Not eligible|0|||
144227711|NCT01812109|520029315|FG000|Overall Study|research personnel delay|16|||
144227712|NCT01812109|520029315|FG000|Overall Study|NIRS Unattainable|17|||
144227713|NCT01966120|520029316|FG000|Overall Study|Withdrawal by Subject|0|||
144227714|NCT01966120|520029317|FG001|Overall Study|Withdrawal by Subject|5|||
144227715|NCT01966120|520029316|FG000|Overall Study|Lost to Follow-up|1|||
144227716|NCT01966120|520029317|FG001|Overall Study|Lost to Follow-up|1|||
144227717|NCT04630002|520029318|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
144227718|NCT04630002|520029319|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
144227719|NCT04630002|520029320|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
144227720|NCT04630002|520029318|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
144227721|NCT04630002|520029319|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
144227722|NCT04630002|520029320|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
144227723|NCT04630002|520029318|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
144227724|NCT04630002|520029319|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
144227725|NCT04630002|520029320|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
144227726|NCT04630002|520029318|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
144227727|NCT04630002|520029319|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
144227728|NCT04630002|520029320|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
144227729|NCT04630002|520029318|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
144227730|NCT04630002|520029319|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
144227731|NCT04630002|520029320|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
144227732|NCT04630002|520029318|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
144227733|NCT04630002|520029319|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
144227734|NCT04630002|520029320|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
144227735|NCT04630002|520029318|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
144227736|NCT04630002|520029319|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
144227737|NCT04630002|520029320|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
144227738|NCT04630002|520029318|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
144227739|NCT04630002|520029319|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
144227740|NCT04630002|520029320|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
144227741|NCT01681212|520029323|FG000|Overall Study|No longer met study criteria|5|||
144227742|NCT01681212|520029323|FG000|Overall Study|Administrative reason by sponsor|1|||
144227743|NCT01575834|520029324|FG000|Overall Study|Withdrawal by Subject|352|||
144227744|NCT01575834|520029325|FG001|Overall Study|Withdrawal by Subject|390|||
144227745|NCT01575834|520029324|FG000|Overall Study|Death|81|||
144227746|NCT01575834|520029325|FG001|Overall Study|Death|74|||
144227747|NCT01575834|520029324|FG000|Overall Study|Other|70|||
144227748|NCT01575834|520029325|FG001|Overall Study|Other|70|||
144227749|NCT01575834|520029324|FG000|Overall Study|Adverse Event|63|||
144227750|NCT01575834|520029325|FG001|Overall Study|Adverse Event|61|||
144227751|NCT01575834|520029324|FG000|Overall Study|Lost to Follow-up|55|||
144227752|NCT01575834|520029325|FG001|Overall Study|Lost to Follow-up|68|||
144227753|NCT01575834|520029324|FG000|Overall Study|Noncompliance|52|||
144227754|NCT01575834|520029325|FG001|Overall Study|Noncompliance|27|||
144227755|NCT01575834|520029324|FG000|Overall Study|Administrative decision|15|||
144227756|NCT01575834|520029325|FG001|Overall Study|Administrative decision|33|||
144227757|NCT01575834|520029324|FG000|Overall Study|Ineligibility Determined|5|||
144227758|NCT01575834|520029325|FG001|Overall Study|Ineligibility Determined|8|||
144227759|NCT01575834|520029324|FG000|Overall Study|Protocol Deviation|4|||
144227760|NCT01575834|520029325|FG001|Overall Study|Protocol Deviation|3|||
144227761|NCT01575834|520029324|FG000|Overall Study|Requirement for Alternative Therapy|2|||
144227762|NCT01575834|520029325|FG001|Overall Study|Requirement for Alternative Therapy|4|||
144227763|NCT02282813|520029328|FG000|Overall Study|Withdrawal by Subject|4|||
144227764|NCT02282813|520029329|FG001|Overall Study|Withdrawal by Subject|5|||
144227765|NCT02282813|520029330|FG002|Overall Study|Withdrawal by Subject|0|||
144227766|NCT02282813|520029328|FG000|Overall Study|Adverse Event|3|||
144227767|NCT02282813|520029329|FG001|Overall Study|Adverse Event|10|||
144227768|NCT02282813|520029330|FG002|Overall Study|Adverse Event|1|||
144227769|NCT02282813|520029328|FG000|Overall Study|Subject non-compliance|1|||
144227770|NCT02282813|520029329|FG001|Overall Study|Subject non-compliance|4|||
144227771|NCT02282813|520029330|FG002|Overall Study|Subject non-compliance|0|||
144227772|NCT02282813|520029328|FG000|Overall Study|Physician Decision|0|||
144227773|NCT02282813|520029329|FG001|Overall Study|Physician Decision|3|||
144227774|NCT02282813|520029330|FG002|Overall Study|Physician Decision|1|||
144227775|NCT02282813|520029328|FG000|Overall Study|Lost to Follow-up|2|||
144227776|NCT02282813|520029329|FG001|Overall Study|Lost to Follow-up|0|||
144227777|NCT02282813|520029330|FG002|Overall Study|Lost to Follow-up|1|||
144227778|NCT02282813|520029328|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
144227779|NCT02282813|520029329|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
144227780|NCT02282813|520029330|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
144227781|NCT02282813|520029328|FG000|Overall Study|Lack of Efficacy|1|||
144227782|NCT02282813|520029329|FG001|Overall Study|Lack of Efficacy|0|||
144227783|NCT02282813|520029330|FG002|Overall Study|Lack of Efficacy|0|||
144227784|NCT02282813|520029328|FG000|Overall Study|Administrative reasons|0|||
144227785|NCT02282813|520029329|FG001|Overall Study|Administrative reasons|1|||
144227786|NCT02282813|520029330|FG002|Overall Study|Administrative reasons|0|||
144227787|NCT00463047|520029331|FG000|Titration Period 1|Adverse Event|10|||
144227788|NCT00463047|520029332|FG001|Titration Period 1|Adverse Event|8|||
144227789|NCT00463047|520029331|FG000|Titration Period 1|Lack of Efficacy|10|||
144227790|NCT00463047|520029332|FG001|Titration Period 1|Lack of Efficacy|4|||
144227791|NCT00463047|520029331|FG000|Titration Period 1|Lost to Follow-up|2|||
144227792|NCT00463047|520029332|FG001|Titration Period 1|Lost to Follow-up|0|||
144227793|NCT00463047|520029331|FG000|Titration Period 1|Non-compliance with study medication|3|||
144227794|NCT00463047|520029332|FG001|Titration Period 1|Non-compliance with study medication|5|||
144227795|NCT00463047|520029331|FG000|Titration Period 1|Protocol Violation|5|||
144227796|NCT00463047|520029332|FG001|Titration Period 1|Protocol Violation|5|||
144227797|NCT00463047|520029331|FG000|Titration Period 1|Withdrawal by Subject|3|||
144227798|NCT00463047|520029332|FG001|Titration Period 1|Withdrawal by Subject|5|||
144227799|NCT00463047|520029331|FG000|Titration Period 1|Non-compliance procedures|4|||
144227800|NCT00463047|520029332|FG001|Titration Period 1|Non-compliance procedures|10|||
144227801|NCT00463047|520029331|FG000|Titration Period 1|Other|0|||
144227802|NCT00463047|520029332|FG001|Titration Period 1|Other|2|||
144227803|NCT00463047|520029331|FG000|Titration Period 2|Adverse Event|9|||
144227804|NCT00463047|520029332|FG001|Titration Period 2|Adverse Event|9|||
144227805|NCT00463047|520029331|FG000|Titration Period 2|Lack of Efficacy|6|||
144227806|NCT00463047|520029332|FG001|Titration Period 2|Lack of Efficacy|4|||
144227807|NCT00463047|520029331|FG000|Titration Period 2|Withdrawal by Subject|1|||
144227808|NCT00463047|520029332|FG001|Titration Period 2|Withdrawal by Subject|0|||
144227809|NCT00463047|520029331|FG000|Titration Period 2|Protocol Violation|2|||
144227810|NCT00463047|520029332|FG001|Titration Period 2|Protocol Violation|3|||
144227811|NCT00463047|520029331|FG000|Titration Period 2|Lost to Follow-up|1|||
144227812|NCT00463047|520029332|FG001|Titration Period 2|Lost to Follow-up|2|||
144227813|NCT00463047|520029331|FG000|Titration Period 2|Non-compliance study medication|4|||
144227814|NCT00463047|520029332|FG001|Titration Period 2|Non-compliance study medication|2|||
144227815|NCT00463047|520029331|FG000|Titration Period 2|Non-compliance procedures|4|||
144227816|NCT00463047|520029332|FG001|Titration Period 2|Non-compliance procedures|1|||
144227817|NCT00463047|520029331|FG000|Titration Period 2|Other|3|||
144227818|NCT00463047|520029332|FG001|Titration Period 2|Other|2|||
144227819|NCT00463047|520029331|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
144227820|NCT00463047|520029332|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
144227821|NCT00463047|520029331|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
144227822|NCT00463047|520029332|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
144227823|NCT00463047|520029331|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
144227824|NCT00463047|520029332|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
144227825|NCT00463047|520029331|FG000|Double-Blind Treatment Period 1|Other|1|||
144227826|NCT00463047|520029332|FG001|Double-Blind Treatment Period 1|Other|0|||
144227827|NCT00463047|520029331|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
144227828|NCT00463047|520029332|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
144227829|NCT00463047|520029331|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
144227830|NCT00463047|520029332|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
144227831|NCT00463047|520029331|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
144227832|NCT00463047|520029332|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
144227833|NCT02867592|520029333|FG000|Overall Study|Adverse Event|3|||
144227834|NCT02867592|520029334|FG001|Overall Study|Adverse Event|0|||
144227835|NCT02867592|520029335|FG002|Overall Study|Adverse Event|2|||
144227836|NCT02867592|520029336|FG003|Overall Study|Adverse Event|1|||
144227837|NCT02867592|520029337|FG004|Overall Study|Adverse Event|1|||
144227838|NCT02867592|520029338|FG005|Overall Study|Adverse Event|5|||
144227839|NCT02867592|520029333|FG000|Overall Study|Death|0|||
144227840|NCT02867592|520029334|FG001|Overall Study|Death|0|||
144227841|NCT02867592|520029335|FG002|Overall Study|Death|0|||
144227842|NCT02867592|520029336|FG003|Overall Study|Death|1|||
144227843|NCT02867592|520029337|FG004|Overall Study|Death|0|||
144227844|NCT02867592|520029338|FG005|Overall Study|Death|1|||
144227845|NCT02867592|520029333|FG000|Overall Study|Lack of Efficacy|8|||
144227846|NCT02867592|520029334|FG001|Overall Study|Lack of Efficacy|10|||
144227847|NCT02867592|520029335|FG002|Overall Study|Lack of Efficacy|8|||
144227848|NCT02867592|520029336|FG003|Overall Study|Lack of Efficacy|8|||
144227849|NCT02867592|520029337|FG004|Overall Study|Lack of Efficacy|12|||
144227850|NCT02867592|520029338|FG005|Overall Study|Lack of Efficacy|17|||
144227851|NCT02867592|520029333|FG000|Overall Study|Physician Decision|1|||
144227852|NCT02867592|520029334|FG001|Overall Study|Physician Decision|2|||
144227853|NCT02867592|520029335|FG002|Overall Study|Physician Decision|2|||
144227854|NCT02867592|520029336|FG003|Overall Study|Physician Decision|0|||
144227855|NCT02867592|520029337|FG004|Overall Study|Physician Decision|5|||
144227856|NCT02867592|520029338|FG005|Overall Study|Physician Decision|1|||
144227857|NCT02867592|520029333|FG000|Overall Study|Protocol Violation|0|||
144227858|NCT02867592|520029334|FG001|Overall Study|Protocol Violation|0|||
144227859|NCT02867592|520029335|FG002|Overall Study|Protocol Violation|0|||
144227860|NCT02867592|520029336|FG003|Overall Study|Protocol Violation|0|||
144227861|NCT02867592|520029337|FG004|Overall Study|Protocol Violation|1|||
144227862|NCT02867592|520029338|FG005|Overall Study|Protocol Violation|1|||
144227863|NCT02867592|520029333|FG000|Overall Study|Withdrawal by Subject|0|||
144227864|NCT02867592|520029334|FG001|Overall Study|Withdrawal by Subject|1|||
144227865|NCT02867592|520029335|FG002|Overall Study|Withdrawal by Subject|0|||
144227866|NCT02867592|520029336|FG003|Overall Study|Withdrawal by Subject|1|||
144227867|NCT02867592|520029337|FG004|Overall Study|Withdrawal by Subject|3|||
144227868|NCT02867592|520029338|FG005|Overall Study|Withdrawal by Subject|3|||
144227869|NCT02867592|520029333|FG000|Overall Study|Ineligible|1|||
144227870|NCT02867592|520029334|FG001|Overall Study|Ineligible|1|||
144227871|NCT02867592|520029335|FG002|Overall Study|Ineligible|0|||
144227872|NCT02867592|520029336|FG003|Overall Study|Ineligible|0|||
144227873|NCT02867592|520029337|FG004|Overall Study|Ineligible|2|||
144227874|NCT02867592|520029338|FG005|Overall Study|Ineligible|0|||
144227875|NCT02867592|520029333|FG000|Overall Study|No Treatment|1|||
144227876|NCT02867592|520029334|FG001|Overall Study|No Treatment|0|||
144227877|NCT02867592|520029335|FG002|Overall Study|No Treatment|0|||
144227878|NCT02867592|520029336|FG003|Overall Study|No Treatment|0|||
144227879|NCT02867592|520029337|FG004|Overall Study|No Treatment|0|||
144227880|NCT02867592|520029338|FG005|Overall Study|No Treatment|0|||
144227881|NCT02867592|520029333|FG000|Overall Study|Still on Therapy|0|||
144227882|NCT02867592|520029334|FG001|Overall Study|Still on Therapy|0|||
144227883|NCT02867592|520029335|FG002|Overall Study|Still on Therapy|0|||
144227884|NCT02867592|520029336|FG003|Overall Study|Still on Therapy|0|||
144227885|NCT02867592|520029337|FG004|Overall Study|Still on Therapy|1|||
144227886|NCT02867592|520029338|FG005|Overall Study|Still on Therapy|0|||
144227887|NCT02867592|520029333|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
144227888|NCT02867592|520029334|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
144227889|NCT02867592|520029335|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
144227890|NCT02867592|520029336|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
144227891|NCT02867592|520029337|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
144227892|NCT02867592|520029338|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
144227893|NCT02867592|520029333|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
144227894|NCT02867592|520029334|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
144227895|NCT02867592|520029335|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
144227896|NCT02867592|520029336|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
144227897|NCT02867592|520029337|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
144227898|NCT02867592|520029338|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
144227899|NCT02883062|520029339|FG000|Overall Study|Withdrawal by Subject|6|||
144227900|NCT02883062|520029340|FG001|Overall Study|Withdrawal by Subject|0|||
144227901|NCT00365794|520029344|FG000|Overall Study|Withdrawal by Subject|2|||
144227902|NCT02554682|520029345|FG000|Overall Study|Lost to Follow-up|11|||
144227903|NCT02554682|520029346|FG001|Overall Study|Lost to Follow-up|9|||
144227904|NCT02554682|520029347|FG002|Overall Study|Lost to Follow-up|4|||
144227905|NCT02554682|520029348|FG003|Overall Study|Lost to Follow-up|3|||
144227906|NCT02554682|520029349|FG004|Overall Study|Lost to Follow-up|2|||
144227907|NCT02554682|520029350|FG005|Overall Study|Lost to Follow-up|1|||
144227908|NCT02554682|520029351|FG006|Overall Study|Lost to Follow-up|6|||
144227909|NCT02554682|520029352|FG007|Overall Study|Lost to Follow-up|6|||
144227910|NCT02554682|520029353|FG008|Overall Study|Lost to Follow-up|2|||
144227911|NCT02554682|520029354|FG009|Overall Study|Lost to Follow-up|2|||
144227912|NCT02554682|520029345|FG000|Overall Study|Withdrawal by Subject|2|||
144227913|NCT02554682|520029346|FG001|Overall Study|Withdrawal by Subject|1|||
144227914|NCT02554682|520029347|FG002|Overall Study|Withdrawal by Subject|0|||
144227915|NCT02554682|520029348|FG003|Overall Study|Withdrawal by Subject|0|||
144227916|NCT02554682|520029349|FG004|Overall Study|Withdrawal by Subject|0|||
144227917|NCT02554682|520029350|FG005|Overall Study|Withdrawal by Subject|0|||
144227918|NCT02554682|520029351|FG006|Overall Study|Withdrawal by Subject|0|||
144227919|NCT02554682|520029352|FG007|Overall Study|Withdrawal by Subject|0|||
144227920|NCT02554682|520029353|FG008|Overall Study|Withdrawal by Subject|0|||
144227921|NCT02554682|520029354|FG009|Overall Study|Withdrawal by Subject|0|||
144227922|NCT02554682|520029345|FG000|Overall Study|Physician Decision|2|||
144227923|NCT02554682|520029346|FG001|Overall Study|Physician Decision|2|||
144227924|NCT02554682|520029347|FG002|Overall Study|Physician Decision|0|||
144227925|NCT02554682|520029348|FG003|Overall Study|Physician Decision|0|||
144227926|NCT02554682|520029349|FG004|Overall Study|Physician Decision|0|||
144227927|NCT02554682|520029350|FG005|Overall Study|Physician Decision|0|||
144227928|NCT02554682|520029351|FG006|Overall Study|Physician Decision|0|||
144227929|NCT02554682|520029352|FG007|Overall Study|Physician Decision|0|||
144227930|NCT02554682|520029353|FG008|Overall Study|Physician Decision|0|||
144227931|NCT02554682|520029354|FG009|Overall Study|Physician Decision|0|||
144227932|NCT04526288|520029355|FG000|Overall Study|Disease Progression|1|||
144227933|NCT04526288|520029356|FG001|Overall Study|Disease Progression|0|||
144227934|NCT00594165|520029357|FG000|Overall Study|Major protocol violation|1|||
144227935|NCT00594165|520029357|FG000|Overall Study|Lack of Efficacy|12|||
144227936|NCT00594165|520029357|FG000|Overall Study|Adverse Event|52|||
144227937|NCT00594165|520029357|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
144227938|NCT00594165|520029357|FG000|Overall Study|Subject withdrew consent|27|||
144227939|NCT00594165|520029357|FG000|Overall Study|Study ended per sponsor|102|||
144227940|NCT00594165|520029357|FG000|Overall Study|Lost to Follow-up|4|||
144227941|NCT00594165|520029357|FG000|Overall Study|Other: PI discretion|5|||
144227942|NCT00594165|520029357|FG000|Overall Study|Other: Subject moving|3|||
144227943|NCT00594165|520029357|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
144227944|NCT00594165|520029357|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
144227945|NCT00594165|520029357|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
144227946|NCT00594165|520029357|FG000|Overall Study|Other: Site terminated participation|2|||
144227947|NCT02169271|520029358|FG000|Overall Study|Protocol Violation|1|||
144227948|NCT02169271|520029359|FG001|Overall Study|Protocol Violation|2|||
144269065|NCT00324155|520187846|FG001|Enrolled and Randomized|No longer met study criteria|0|||
144269066|NCT00324155|520187845|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
144227949|NCT04495829|520029367|FG000|Overall Study|Lost to Follow-up|2|||
144227950|NCT04495829|520029367|FG000|Overall Study|Inclusion criterion not met|3|||
144227951|NCT03644342|520029368|FG000|Overall Study|Adverse Event|2|||
144227952|NCT03644342|520029369|FG001|Overall Study|Adverse Event|0|||
144227953|NCT03644342|520029368|FG000|Overall Study|Protocol Violation|0|||
144227954|NCT03644342|520029369|FG001|Overall Study|Protocol Violation|1|||
144227955|NCT02503540|520029370|FG000|Overall Study|Death|2|||
144227956|NCT02503540|520029370|FG000|Overall Study|Withdrawal by Subject|1|||
144227957|NCT03830333|520029371|FG000|Overall Study|Death|0|||
144227958|NCT03830333|520029372|FG001|Overall Study|Death|1|||
144269067|NCT00324155|520187846|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
144269068|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
144227959|NCT03830333|520029371|FG000|Overall Study|Withdrawal by Subject|5|||
144227960|NCT03830333|520029372|FG001|Overall Study|Withdrawal by Subject|1|||
144227961|NCT03830333|520029371|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
144227962|NCT03830333|520029372|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
144227963|NCT00722137|520029373|FG000|Overall Study|Overt Disease Progression|5|||
144227964|NCT00722137|520029374|FG001|Overall Study|Overt Disease Progression|4|||
144227965|NCT00722137|520029373|FG000|Overall Study|Adverse Event|17|||
144227966|NCT00722137|520029374|FG001|Overall Study|Adverse Event|21|||
144227967|NCT00722137|520029373|FG000|Overall Study|Death|12|||
144227968|NCT00722137|520029374|FG001|Overall Study|Death|7|||
144227969|NCT00722137|520029373|FG000|Overall Study|Withdrawal by Subject|6|||
144227970|NCT00722137|520029374|FG001|Overall Study|Withdrawal by Subject|9|||
144227971|NCT00722137|520029373|FG000|Overall Study|Other Reason Unknown|3|||
144227972|NCT00722137|520029374|FG001|Overall Study|Other Reason Unknown|4|||
144227973|NCT00722137|520029373|FG000|Overall Study|Randomized But Not Treated|2|||
144227974|NCT00722137|520029374|FG001|Overall Study|Randomized But Not Treated|3|||
144227975|NCT04390113|520029383|FG000|Overall Study|Not Treated|0|||
144227976|NCT04390113|520029384|FG001|Overall Study|Not Treated|1|||
144227977|NCT04390113|520029383|FG000|Overall Study|Adverse Event|1|||
144227978|NCT04390113|520029384|FG001|Overall Study|Adverse Event|0|||
144227979|NCT04390113|520029383|FG000|Overall Study|Death|2|||
144227980|NCT04390113|520029384|FG001|Overall Study|Death|1|||
144227981|NCT04390113|520029383|FG000|Overall Study|Physician Decision|1|||
144227982|NCT04390113|520029384|FG001|Overall Study|Physician Decision|3|||
144227983|NCT04390113|520029383|FG000|Overall Study|Study Terminated by Sponsor|5|||
144227984|NCT04390113|520029384|FG001|Overall Study|Study Terminated by Sponsor|3|||
144227985|NCT04390113|520029383|FG000|Overall Study|Withdrawal by Subject|10|||
144227986|NCT04390113|520029384|FG001|Overall Study|Withdrawal by Subject|5|||
144227987|NCT04390113|520029383|FG000|Overall Study|Other|1|||
144227988|NCT04390113|520029384|FG001|Overall Study|Other|0|||
144227989|NCT04390113|520029383|FG000|Overall Study|Missing|0|||
144227990|NCT04390113|520029384|FG001|Overall Study|Missing|1|||
144227991|NCT00030901|520029386|FG000|Initial Registration|Ineligible|167|||
144227992|NCT00030901|520029387|FG001|Initial Registration|Ineligible|0|||
144227993|NCT00030901|520029388|FG002|Initial Registration|Ineligible|0|||
144227994|NCT00030901|520029386|FG000|Randomization|Adverse Event|0|||
144227995|NCT00030901|520029387|FG001|Randomization|Adverse Event|11|||
144227996|NCT00030901|520029388|FG002|Randomization|Adverse Event|7|||
144227997|NCT00030901|520029386|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
144227998|NCT00030901|520029387|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
144227999|NCT00030901|520029388|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
144228000|NCT00030901|520029386|FG000|Randomization|Progression/Relapse|0|||
144228001|NCT00030901|520029387|FG001|Randomization|Progression/Relapse|22|||
144228002|NCT00030901|520029388|FG002|Randomization|Progression/Relapse|21|||
144228003|NCT00030901|520029386|FG000|Randomization|Death|0|||
144228004|NCT00030901|520029387|FG001|Randomization|Death|1|||
144228005|NCT00030901|520029388|FG002|Randomization|Death|3|||
144228006|NCT00030901|520029386|FG000|Randomization|Other|0|||
144228007|NCT00030901|520029387|FG001|Randomization|Other|36|||
144228008|NCT00030901|520029388|FG002|Randomization|Other|33|||
144228009|NCT00030901|520029386|FG000|Randomization|Ineligible|0|||
144228010|NCT00030901|520029387|FG001|Randomization|Ineligible|15|||
144228011|NCT00030901|520029388|FG002|Randomization|Ineligible|14|||
144228012|NCT02576847|520029391|FG000|Overall Study|Adverse Event|27|||
144228013|NCT02576847|520029391|FG000|Overall Study|Lost to Follow-up|22|||
144228014|NCT02576847|520029391|FG000|Overall Study|Physician Decision|1|||
144228015|NCT02576847|520029391|FG000|Overall Study|Pregnancy|1|||
144228016|NCT02576847|520029391|FG000|Overall Study|Protocol Violation|3|||
144228017|NCT02576847|520029391|FG000|Overall Study|Withdrawal by Subject|78|||
144228018|NCT02576847|520029391|FG000|Overall Study|Other|5|||
144228019|NCT01622673|520029392|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144228020|NCT01622673|520029393|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144228021|NCT01622673|520029394|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144228022|NCT01622673|520029395|FG003|Treatment Period 1|Withdrawal by Subject|1|||
144228023|NCT01622673|520029396|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144228024|NCT01622673|520029397|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144228025|NCT01622673|520029392|FG000|Treatment Period 1|Protocol Violation|0|||
144228026|NCT01622673|520029393|FG001|Treatment Period 1|Protocol Violation|1|||
144228027|NCT01622673|520029394|FG002|Treatment Period 1|Protocol Violation|0|||
144228028|NCT01622673|520029395|FG003|Treatment Period 1|Protocol Violation|0|||
144228029|NCT01622673|520029396|FG004|Treatment Period 1|Protocol Violation|0|||
144228030|NCT01622673|520029397|FG005|Treatment Period 1|Protocol Violation|0|||
144228031|NCT01622673|520029392|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144228032|NCT01622673|520029393|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144228033|NCT01622673|520029394|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144228034|NCT01622673|520029395|FG003|Treatment Period 2|Withdrawal by Subject|1|||
144228035|NCT01622673|520029396|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144228036|NCT01622673|520029397|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144228037|NCT01622673|520029392|FG000|Treatment Period 3|Protocol Violation|0|||
144228038|NCT01622673|520029393|FG001|Treatment Period 3|Protocol Violation|1|||
144228039|NCT01622673|520029394|FG002|Treatment Period 3|Protocol Violation|0|||
144228040|NCT01622673|520029395|FG003|Treatment Period 3|Protocol Violation|0|||
144228041|NCT01622673|520029396|FG004|Treatment Period 3|Protocol Violation|0|||
144228042|NCT01622673|520029397|FG005|Treatment Period 3|Protocol Violation|0|||
144228043|NCT03668119|520031773|FG000|Pre-treatment|Disease Progression|1|||
144228044|NCT03668119|520031774|FG001|Pre-treatment|Disease Progression|0|||
144228045|NCT03668119|520031773|FG000|Treatment|Disease Progression|76|||
144228046|NCT03668119|520031774|FG001|Treatment|Disease Progression|57|||
144228047|NCT03668119|520031773|FG000|Treatment|Study drug toxicity|19|||
144228048|NCT03668119|520031774|FG001|Treatment|Study drug toxicity|1|||
144228049|NCT03668119|520031773|FG000|Treatment|Death|3|||
144228050|NCT03668119|520031774|FG001|Treatment|Death|0|||
144228051|NCT03668119|520031773|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
144228052|NCT03668119|520031774|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
144228053|NCT03668119|520031773|FG000|Treatment|Withdrawal by Subject|1|||
144228054|NCT03668119|520031774|FG001|Treatment|Withdrawal by Subject|1|||
144228055|NCT03668119|520031773|FG000|Treatment|Participant request to discontinue study treatment|3|||
144228056|NCT03668119|520031774|FG001|Treatment|Participant request to discontinue study treatment|1|||
144228057|NCT03668119|520031773|FG000|Treatment|Maximum Clinical Benefit|0|||
144228058|NCT03668119|520031774|FG001|Treatment|Maximum Clinical Benefit|1|||
144228059|NCT03668119|520031773|FG000|Treatment|Participants completed treatment|27|||
144228060|NCT03668119|520031774|FG001|Treatment|Participants completed treatment|11|||
144228061|NCT03668119|520031773|FG000|Treatment|Other reasons|2|||
144228062|NCT03668119|520031774|FG001|Treatment|Other reasons|1|||
144228063|NCT03769168|520031775|FG000|Overall Study|Adverse Event|0|||
144228064|NCT03769168|520031776|FG001|Overall Study|Adverse Event|1|||
144228065|NCT03769168|520031775|FG000|Overall Study|Lack of Efficacy|2|||
144228066|NCT03769168|520031776|FG001|Overall Study|Lack of Efficacy|4|||
144228067|NCT03769168|520031775|FG000|Overall Study|Post study access to treatment|3|||
144228068|NCT03769168|520031776|FG001|Overall Study|Post study access to treatment|11|||
144228069|NCT03769168|520031775|FG000|Overall Study|Physician Decision|1|||
144228070|NCT03769168|520031776|FG001|Overall Study|Physician Decision|4|||
144228071|NCT03769168|520031775|FG000|Overall Study|Subject Decision|2|||
144228072|NCT03769168|520031776|FG001|Overall Study|Subject Decision|4|||
144228073|NCT03769168|520031775|FG000|Overall Study|Guardian decision|1|||
144228074|NCT03769168|520031776|FG001|Overall Study|Guardian decision|0|||
144228075|NCT05336227|520031777|FG000|Overall Study|Adverse Event|1|||
144228076|NCT05336227|520031778|FG001|Overall Study|Adverse Event|0|||
144228077|NCT05336227|520031777|FG000|Overall Study|Lost to Follow-up|2|||
144228078|NCT05336227|520031778|FG001|Overall Study|Lost to Follow-up|0|||
144228079|NCT05336227|520031777|FG000|Overall Study|Withdrawal by Subject|1|||
144228080|NCT05336227|520031778|FG001|Overall Study|Withdrawal by Subject|0|||
144228081|NCT03771898|520031781|FG000|Overall Study|Adverse Event|1|||
144228082|NCT03771898|520031782|FG001|Overall Study|Adverse Event|0|||
144228083|NCT03771898|520031783|FG002|Overall Study|Adverse Event|0|||
144228084|NCT03771898|520031784|FG003|Overall Study|Adverse Event|0|||
144228085|NCT03771898|520031785|FG004|Overall Study|Adverse Event|0|||
144228086|NCT03771898|520031781|FG000|Overall Study|Lost to Follow-up|1|||
144228087|NCT03771898|520031782|FG001|Overall Study|Lost to Follow-up|1|||
144228088|NCT03771898|520031783|FG002|Overall Study|Lost to Follow-up|1|||
144228089|NCT03771898|520031784|FG003|Overall Study|Lost to Follow-up|0|||
144228090|NCT03771898|520031785|FG004|Overall Study|Lost to Follow-up|0|||
144228091|NCT03771898|520031781|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144228092|NCT03771898|520031782|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144228093|NCT03771898|520031783|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144228094|NCT03771898|520031784|FG003|Overall Study|Withdrawal by parent/guardian|0|||
144228095|NCT03771898|520031785|FG004|Overall Study|Withdrawal by parent/guardian|0|||
144228096|NCT03771898|520031781|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
144228097|NCT03771898|520031782|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
144228098|NCT03771898|520031783|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
144228099|NCT03771898|520031784|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
144228100|NCT03771898|520031785|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
144228101|NCT05343000|520031786|FG000|Overall Study|Physician Decision|2|||
144228102|NCT02632175|520031790|FG000|Overall Study|Withdrawal by Subject|6|||
144228103|NCT02632175|520031790|FG000|Overall Study|Lost to Follow-up|1|||
144228104|NCT02632175|520031790|FG000|Overall Study|Lack of Efficacy|18|||
144228105|NCT02632175|520031790|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
144228106|NCT02632175|520031790|FG000|Overall Study|Subject noncompliance|3|||
144228107|NCT02632175|520031790|FG000|Overall Study|other|2|||
144228108|NCT04623216|520031791|FG000|Overall Study|Death|5|||
144228109|NCT04623216|520031792|FG001|Overall Study|Death|2|||
144228110|NCT04623216|520031793|FG002|Overall Study|Death|0|||
144228111|NCT04623216|520031794|FG003|Overall Study|Death|0|||
144228112|NCT04623216|520031791|FG000|Overall Study|Terminated by Sponsor|3|||
144228113|NCT04623216|520031792|FG001|Overall Study|Terminated by Sponsor|2|||
144228114|NCT04623216|520031793|FG002|Overall Study|Terminated by Sponsor|2|||
144228115|NCT04623216|520031794|FG003|Overall Study|Terminated by Sponsor|0|||
144228116|NCT04623216|520031791|FG000|Overall Study|Physician Decision|1|||
144228117|NCT04623216|520031792|FG001|Overall Study|Physician Decision|0|||
144228118|NCT04623216|520031793|FG002|Overall Study|Physician Decision|0|||
144228119|NCT04623216|520031794|FG003|Overall Study|Physician Decision|0|||
144228120|NCT03521154|520031797|FG000|Overall Study|Ongoing study at data cut-off|111|||
144228121|NCT03521154|520031798|FG001|Overall Study|Ongoing study at data cut-off|52|||
144228122|NCT05468164|520031799|FG000|Treatment Period 4|Adverse Event|0|||
144228123|NCT05468164|520031800|FG001|Treatment Period 4|Adverse Event|0|||
144228124|NCT05468164|520031801|FG002|Treatment Period 4|Adverse Event|0|||
144228125|NCT05468164|520031802|FG003|Treatment Period 4|Adverse Event|1|||
144228126|NCT05386680|520031803|FG000|Overall Study|Guardian decision|2|||
144228127|NCT03827291|520031804|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
144228128|NCT03827291|520031805|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
144228129|NCT04795466|520031806|FG000|Overall Study|Adverse Event|3|||
144228130|NCT04795466|520031807|FG001|Overall Study|Adverse Event|1|||
144228131|NCT04795466|520031806|FG000|Overall Study|Physician Decision|1|||
144228132|NCT04795466|520031807|FG001|Overall Study|Physician Decision|0|||
144228133|NCT04795466|520031806|FG000|Overall Study|Withdrawal by Subject|2|||
144228134|NCT04795466|520031807|FG001|Overall Study|Withdrawal by Subject|1|||
144228135|NCT04652726|520031808|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
144228136|NCT04652726|520031809|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
144228137|NCT04652726|520031810|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
144228138|NCT04652726|520031808|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
144228139|NCT04652726|520031809|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
144228140|NCT04652726|520031810|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
144228141|NCT04066244|520031823|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
144228142|NCT04066244|520031824|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
144228143|NCT04066244|520031825|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
144228144|NCT04066244|520031826|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
144228145|NCT04066244|520031827|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
144228146|NCT04066244|520031828|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
144228147|NCT04066244|520031823|FG000|Part 2 (Cohort 5)|Death|0|||
144228148|NCT04066244|520031824|FG001|Part 2 (Cohort 5)|Death|0|||
144228149|NCT04066244|520031825|FG002|Part 2 (Cohort 5)|Death|0|||
144228150|NCT04066244|520031826|FG003|Part 2 (Cohort 5)|Death|0|||
144228151|NCT04066244|520031827|FG004|Part 2 (Cohort 5)|Death|0|||
144228152|NCT04066244|520031828|FG005|Part 2 (Cohort 5)|Death|2|||
144228153|NCT04066244|520031823|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
144228154|NCT04066244|520031824|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
144228155|NCT04066244|520031825|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
144228156|NCT04066244|520031826|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
144228157|NCT04066244|520031827|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
144228158|NCT04066244|520031828|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
144228159|NCT04066244|520031823|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
144228160|NCT04066244|520031824|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
144228161|NCT04066244|520031825|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
144228162|NCT04066244|520031826|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
144228163|NCT04066244|520031827|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
144228164|NCT04066244|520031828|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
144228165|NCT03877068|520031829|FG000|Overall Study|Physician Decision|9|||
144228166|NCT03877068|520031830|FG001|Overall Study|Physician Decision|3|||
144228167|NCT01346696|520031831|FG000|Overall Study|Death|1|||
144228168|NCT00630825|520031833|FG000|Overall Study|Adverse Event|4|||
144228169|NCT00630825|520031834|FG001|Overall Study|Adverse Event|4|||
144228170|NCT00630825|520031835|FG002|Overall Study|Adverse Event|3|||
144228171|NCT00630825|520031836|FG003|Overall Study|Adverse Event|1|||
144228172|NCT00630825|520031833|FG000|Overall Study|Entry Criteria Not Met|1|||
144228173|NCT00630825|520031834|FG001|Overall Study|Entry Criteria Not Met|0|||
144228174|NCT00630825|520031835|FG002|Overall Study|Entry Criteria Not Met|2|||
144228175|NCT00630825|520031836|FG003|Overall Study|Entry Criteria Not Met|1|||
144228176|NCT00630825|520031833|FG000|Overall Study|Lost to Follow-up|1|||
144228177|NCT00630825|520031834|FG001|Overall Study|Lost to Follow-up|1|||
144228178|NCT00630825|520031835|FG002|Overall Study|Lost to Follow-up|1|||
144228179|NCT00630825|520031836|FG003|Overall Study|Lost to Follow-up|1|||
144228180|NCT00630825|520031833|FG000|Overall Study|Physician Decision|1|||
144228181|NCT00630825|520031834|FG001|Overall Study|Physician Decision|0|||
144228182|NCT00630825|520031835|FG002|Overall Study|Physician Decision|0|||
144228183|NCT00630825|520031836|FG003|Overall Study|Physician Decision|0|||
144228184|NCT00630825|520031833|FG000|Overall Study|Withdrawal by Subject|2|||
144228185|NCT00630825|520031834|FG001|Overall Study|Withdrawal by Subject|2|||
144228186|NCT00630825|520031835|FG002|Overall Study|Withdrawal by Subject|2|||
144228187|NCT00630825|520031836|FG003|Overall Study|Withdrawal by Subject|3|||
144228188|NCT02211209|520031839|FG000|Overall Study|Investigator judgment|0|||
144228189|NCT02211209|520031840|FG001|Overall Study|Investigator judgment|1|||
144228190|NCT02211209|520031839|FG000|Overall Study|Voluntary withdrawal|1|||
144228191|NCT02211209|520031840|FG001|Overall Study|Voluntary withdrawal|4|||
144228192|NCT02211209|520031839|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
144228193|NCT02211209|520031840|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
144228194|NCT02211209|520031839|FG000|Overall Study|Reason Not Specified|1|||
144228195|NCT02211209|520031840|FG001|Overall Study|Reason Not Specified|0|||
144228196|NCT03321968|520031845|FG000|Overall Study|Withdrawal by Subject|1|||
144228197|NCT03321968|520031846|FG001|Overall Study|Withdrawal by Subject|2|||
144228198|NCT03321968|520031847|FG002|Overall Study|Withdrawal by Subject|1|||
144228199|NCT03321968|520031845|FG000|Overall Study|Lost to Follow-up|2|||
144228200|NCT03321968|520031846|FG001|Overall Study|Lost to Follow-up|0|||
144228201|NCT03321968|520031847|FG002|Overall Study|Lost to Follow-up|1|||
144228202|NCT03321968|520031845|FG000|Overall Study|Other than specified|0|||
144228203|NCT03321968|520031846|FG001|Overall Study|Other than specified|0|||
144228204|NCT03321968|520031847|FG002|Overall Study|Other than specified|1|||
144228205|NCT03822468|520031848|FG000|Treatment Period|Progressive disease|98|||
144228206|NCT03822468|520031849|FG001|Treatment Period|Progressive disease|94|||
144269069|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
144269070|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
144269071|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
144228207|NCT03822468|520031848|FG000|Treatment Period|Adverse Event|21|||
144228208|NCT03822468|520031849|FG001|Treatment Period|Adverse Event|24|||
144228209|NCT03822468|520031848|FG000|Treatment Period|Withdrawal by Subject|9|||
144228210|NCT03822468|520031849|FG001|Treatment Period|Withdrawal by Subject|5|||
144228211|NCT03822468|520031848|FG000|Treatment Period|Physician Decision|9|||
144228212|NCT03822468|520031849|FG001|Treatment Period|Physician Decision|7|||
144228213|NCT03822468|520031848|FG000|Treatment Period|Protocol Violation|2|||
144228214|NCT03822468|520031849|FG001|Treatment Period|Protocol Violation|1|||
144228215|NCT03822468|520031848|FG000|Treatment Period|Death|2|||
144228216|NCT03822468|520031849|FG001|Treatment Period|Death|3|||
144228217|NCT03822468|520031848|FG000|Treatment Period|Lost to Follow-up|1|||
144228218|NCT03822468|520031849|FG001|Treatment Period|Lost to Follow-up|1|||
144228219|NCT03822468|520031848|FG000|Treatment Period|Sponsor decision|46|||
144228220|NCT03822468|520031849|FG001|Treatment Period|Sponsor decision|53|||
144228221|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
144228222|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
144228223|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
144228224|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
144228225|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Death|1|||
144228226|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Death|0|||
144228227|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144228228|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
144228229|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
144228230|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
144228231|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
144228232|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
144228233|NCT03822468|520031848|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
144228234|NCT03822468|520031849|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
144228235|NCT01532518|520031850|FG000|Overall Study|Withdrawal by Subject|0|||
144228236|NCT01532518|520031851|FG001|Overall Study|Withdrawal by Subject|0|||
144228237|NCT01532518|520031852|FG002|Overall Study|Withdrawal by Subject|1|||
144228238|NCT02155283|520031853|FG000|Overall Study|Lost to Follow-up|3|||
144228239|NCT02155283|520031853|FG000|Overall Study|Withdrawal by Subject|1|||
144228240|NCT02155283|520031853|FG000|Overall Study|Protocol Violation|3|||
144228241|NCT01741688|520031855|FG000|Overall Study|Lack of insurance coverage|2|||
144228242|NCT01741688|520031855|FG000|Overall Study|Withdrawal by Subject|1|||
144228243|NCT02220764|520031862|FG000|Overall Study|Lost to Follow-up|3|||
144228244|NCT02220764|520031863|FG001|Overall Study|Lost to Follow-up|1|||
144228245|NCT02220764|520031862|FG000|Overall Study|Death|1|||
144228246|NCT02220764|520031863|FG001|Overall Study|Death|0|||
144228247|NCT02861807|520031864|FG000|Overall Study|Lost to Follow-up|7|||
144228248|NCT02861807|520031865|FG001|Overall Study|Lost to Follow-up|6|||
144228249|NCT02861807|520031864|FG000|Overall Study|Withdrawal by Subject|5|||
144228250|NCT02861807|520031865|FG001|Overall Study|Withdrawal by Subject|8|||
144228251|NCT03020992|520031866|FG000|Overall Study|Adverse Event|5|||
144228252|NCT03020992|520031866|FG000|Overall Study|Withdrawal by Subject|1|||
144228253|NCT05000164|520031867|FG000|Overall Study|Adverse Event|1|||
144228254|NCT05000164|520031867|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
144228255|NCT05000164|520031867|FG000|Overall Study|Lens Discomfort|3|||
144228256|NCT05000164|520031867|FG000|Overall Study|Withdrew Consent during Study|2|||
144228257|NCT05000164|520031867|FG000|Overall Study|Subject Withdrawn by PI|2|||
144228258|NCT05000164|520031867|FG000|Overall Study|Other Fractured Test Article|1|||
144228259|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
144228260|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
144228261|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
144228262|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
144228263|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Pregnancy|0|||
144228264|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Pregnancy|1|||
144228265|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
144228266|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
144228267|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
144228268|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
144228269|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
144228270|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
144228271|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Other|3|||
144228272|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Other|0|||
144228273|NCT01006122|520031868|FG000|First Double-blind Intervention Period|Adverse Event|0|||
144228274|NCT01006122|520031869|FG001|First Double-blind Intervention Period|Adverse Event|4|||
144228275|NCT01006122|520031868|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
144228276|NCT01006122|520031869|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
144228277|NCT01006122|520031868|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
144228278|NCT01006122|520031869|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
144228279|NCT01006122|520031868|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
144228280|NCT01006122|520031869|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
144228281|NCT01006122|520031868|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
144228282|NCT01006122|520031869|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
144228283|NCT01006122|520031868|FG000|Second Double-blind Intervention Period|Death|0|||
144228284|NCT01006122|520031869|FG001|Second Double-blind Intervention Period|Death|1|||
144228285|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
144228286|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
144228287|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
144228288|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
144228289|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
144228290|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
144228291|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
144228292|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
144228293|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
144228294|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
144228295|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
144228296|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
144228297|NCT03493854|520031870|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
144228298|NCT03493854|520031871|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
144228299|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
144228300|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
144228301|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
144228302|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
144228303|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
144228304|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
144228305|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
144228306|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
144228307|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
144228308|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
144228309|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
144228310|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
144228311|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
144269072|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Death|8|||
144228312|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
144228313|NCT03493854|520031870|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
144269073|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Death|15|||
144269074|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
144269075|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
144269076|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
144269077|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
144269078|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
144269079|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
144269080|NCT00324155|520187845|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
144269081|NCT00324155|520187846|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
144269082|NCT00324155|520187845|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
144269083|NCT00324155|520187846|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
144269084|NCT00324155|520187845|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
144269085|NCT00324155|520187846|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
144269086|NCT00324155|520187845|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
144269087|NCT00324155|520187846|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
144269088|NCT00324155|520187845|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
144269089|NCT00324155|520187846|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
144269090|NCT00324155|520187845|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
144269091|NCT00324155|520187846|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
144269092|NCT00324155|520187845|FG000|Follow-up Phase|On-going participants still on drug|11|||
144269093|NCT00324155|520187846|FG001|Follow-up Phase|On-going participants still on drug|6|||
144269094|NCT01253161|520187847|FG000|Overall Study|Adverse Event|1|||
144269095|NCT03101020|520187849|FG000|Overall Study|Lack of time to participate|1|||
144269096|NCT03101020|520187850|FG001|Overall Study|Lack of time to participate|0|||
144269097|NCT03101020|520187849|FG000|Overall Study|Ran over by a car|0|||
144269098|NCT03101020|520187850|FG001|Overall Study|Ran over by a car|1|||
144269099|NCT03101020|520187849|FG000|Overall Study|Withdrawal by Subject|0|||
144269100|NCT03101020|520187850|FG001|Overall Study|Withdrawal by Subject|2|||
144269101|NCT03292016|520187851|FG000|Second Washout|Adverse Event|0|||
144269102|NCT03292016|520187852|FG001|Second Washout|Adverse Event|1|||
144269103|NCT03292016|520187853|FG002|Second Washout|Adverse Event|0|||
144269104|NCT03292016|520187854|FG003|Second Washout|Adverse Event|0|||
144269105|NCT03292016|520187855|FG004|Second Washout|Adverse Event|0|||
144269106|NCT03292016|520187856|FG005|Second Washout|Adverse Event|0|||
144269107|NCT03786380|520187857|FG000|Overall Study|Adverse Event|1|||
144269108|NCT03786380|520187858|FG001|Overall Study|Adverse Event|0|||
144269109|NCT03786380|520187859|FG002|Overall Study|Adverse Event|0|||
144269110|NCT03786380|520187860|FG003|Overall Study|Adverse Event|3|||
144269111|NCT03786380|520187861|FG004|Overall Study|Adverse Event|1|||
144269112|NCT03786380|520187857|FG000|Overall Study|Lack of Efficacy|0|||
144269113|NCT03786380|520187858|FG001|Overall Study|Lack of Efficacy|0|||
144269114|NCT03786380|520187859|FG002|Overall Study|Lack of Efficacy|0|||
144269115|NCT03786380|520187860|FG003|Overall Study|Lack of Efficacy|0|||
144269116|NCT03786380|520187861|FG004|Overall Study|Lack of Efficacy|1|||
144269117|NCT03786380|520187857|FG000|Overall Study|Withdrawal by Subject|1|||
144269118|NCT03786380|520187858|FG001|Overall Study|Withdrawal by Subject|2|||
144269119|NCT03786380|520187859|FG002|Overall Study|Withdrawal by Subject|2|||
144269120|NCT03786380|520187860|FG003|Overall Study|Withdrawal by Subject|1|||
144269121|NCT03786380|520187861|FG004|Overall Study|Withdrawal by Subject|2|||
144269122|NCT03786380|520187857|FG000|Overall Study|Lost to Follow-up|3|||
144228314|NCT03493854|520031871|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
144228315|NCT03493854|520031870|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
144269123|NCT03786380|520187858|FG001|Overall Study|Lost to Follow-up|0|||
144269124|NCT03786380|520187859|FG002|Overall Study|Lost to Follow-up|1|||
144269125|NCT03786380|520187860|FG003|Overall Study|Lost to Follow-up|2|||
144269126|NCT03786380|520187861|FG004|Overall Study|Lost to Follow-up|0|||
144269127|NCT03786380|520187857|FG000|Overall Study|Physician Decision|0|||
144228316|NCT03493854|520031871|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
144228317|NCT03493854|520031870|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
144228318|NCT03493854|520031871|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
144228319|NCT03493854|520031870|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
144228320|NCT03493854|520031871|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
144228321|NCT00739661|520031876|FG000|Overall Study|Adverse Event|2|||
144228322|NCT00739661|520031877|FG001|Overall Study|Adverse Event|0|||
144228323|NCT00739661|520031876|FG000|Overall Study|Physician decision to withdraw patient|1|||
144228324|NCT00739661|520031877|FG001|Overall Study|Physician decision to withdraw patient|0|||
144228325|NCT00739661|520031876|FG000|Overall Study|Patient decision to withdraw|9|||
144228326|NCT00739661|520031877|FG001|Overall Study|Patient decision to withdraw|4|||
144228327|NCT00739661|520031876|FG000|Overall Study|Disease progression, radiographic|33|||
144228328|NCT00739661|520031877|FG001|Overall Study|Disease progression, radiographic|37|||
144228329|NCT00739661|520031876|FG000|Overall Study|Reason for discontinuation not available|1|||
144228330|NCT00739661|520031877|FG001|Overall Study|Reason for discontinuation not available|1|||
144228331|NCT00410813|520031878|FG000|Overall Study|Adverse Event|6|||
144228332|NCT00410813|520031879|FG001|Overall Study|Adverse Event|11|||
144228333|NCT00410813|520031878|FG000|Overall Study|Progression|32|||
144228334|NCT00410813|520031879|FG001|Overall Study|Progression|21|||
144228335|NCT00410813|520031878|FG000|Overall Study|Not protocol specified|3|||
144228336|NCT00410813|520031879|FG001|Overall Study|Not protocol specified|4|||
144269128|NCT03786380|520187858|FG001|Overall Study|Physician Decision|0|||
144269129|NCT03786380|520187859|FG002|Overall Study|Physician Decision|1|||
144269130|NCT03786380|520187860|FG003|Overall Study|Physician Decision|0|||
144269131|NCT03786380|520187861|FG004|Overall Study|Physician Decision|0|||
144269132|NCT03786380|520187857|FG000|Overall Study|Study Terminated by the Sponsor|30|||
144269133|NCT03786380|520187858|FG001|Overall Study|Study Terminated by the Sponsor|20|||
144228337|NCT00410813|520031878|FG000|Overall Study|Ineligible|2|||
144228338|NCT00410813|520031879|FG001|Overall Study|Ineligible|4|||
144228339|NCT00410813|520031878|FG000|Overall Study|Death|0|||
144269134|NCT03786380|520187859|FG002|Overall Study|Study Terminated by the Sponsor|50|||
144269135|NCT03786380|520187860|FG003|Overall Study|Study Terminated by the Sponsor|57|||
144269136|NCT03786380|520187861|FG004|Overall Study|Study Terminated by the Sponsor|23|||
144228340|NCT00410813|520031879|FG001|Overall Study|Death|2|||
144228341|NCT02198664|520031880|FG000|Overall Study|Adverse Event|2|||
144228342|NCT02198664|520031881|FG001|Overall Study|Adverse Event|0|||
144228343|NCT02198664|520031880|FG000|Overall Study|Withdrawal by Subject|11|||
144228344|NCT02198664|520031881|FG001|Overall Study|Withdrawal by Subject|8|||
144228345|NCT02198664|520031880|FG000|Overall Study|Failure to tolerate|2|||
144228346|NCT02198664|520031881|FG001|Overall Study|Failure to tolerate|0|||
144228347|NCT02198664|520031880|FG000|Overall Study|Not stated|1|||
144228348|NCT02198664|520031881|FG001|Overall Study|Not stated|0|||
144228349|NCT04278417|520031892|FG000|Overall Study|Withdrawal by Subject|20|||
144228350|NCT04278417|520031893|FG001|Overall Study|Withdrawal by Subject|20|||
144228351|NCT04278417|520031892|FG000|Overall Study|Progressive disease|0|||
144228352|NCT04278417|520031893|FG001|Overall Study|Progressive disease|2|||
144228353|NCT04278417|520031892|FG000|Overall Study|Physician Decision|4|||
144269137|NCT03786380|520187857|FG000|Overall Study|Reason Not Specified|0|||
144269138|NCT03786380|520187858|FG001|Overall Study|Reason Not Specified|0|||
144228354|NCT04278417|520031893|FG001|Overall Study|Physician Decision|6|||
144228355|NCT04278417|520031892|FG000|Overall Study|Lost to Follow-up|11|||
144228356|NCT04278417|520031893|FG001|Overall Study|Lost to Follow-up|13|||
144228357|NCT04278417|520031892|FG000|Overall Study|Death|8|||
144228358|NCT04278417|520031893|FG001|Overall Study|Death|9|||
144228359|NCT04278417|520031892|FG000|Overall Study|Adverse Event|3|||
144228360|NCT04278417|520031893|FG001|Overall Study|Adverse Event|5|||
144228361|NCT06509438|520031894|FG000|Overall Study|Adverse Event|1|||
144228362|NCT06509438|520031894|FG000|Overall Study|Lost to Follow-up|3|||
144228363|NCT01262872|520031896|FG000|Step 2|Death|0|||
144228364|NCT01262872|520031897|FG001|Step 2|Death|0|||
144228365|NCT01262872|520031898|FG002|Step 2|Death|0|||
144228366|NCT01262872|520031899|FG003|Step 2|Death|1|||
144228367|NCT01262872|520031900|FG004|Step 2|Death|0|||
144228368|NCT01262872|520031901|FG005|Step 2|Death|2|||
144228369|NCT01262872|520031902|FG006|Step 2|Death|2|||
144228370|NCT01262872|520031903|FG007|Step 2|Death|1|||
144228371|NCT01262872|520031896|FG000|Step 2|Protocol Violation|0|||
144228372|NCT01262872|520031897|FG001|Step 2|Protocol Violation|0|||
144228373|NCT01262872|520031898|FG002|Step 2|Protocol Violation|1|||
144228374|NCT01262872|520031899|FG003|Step 2|Protocol Violation|0|||
144228375|NCT01262872|520031900|FG004|Step 2|Protocol Violation|0|||
144228376|NCT01262872|520031901|FG005|Step 2|Protocol Violation|0|||
144228377|NCT01262872|520031902|FG006|Step 2|Protocol Violation|3|||
144269139|NCT03786380|520187859|FG002|Overall Study|Reason Not Specified|0|||
144269140|NCT03786380|520187860|FG003|Overall Study|Reason Not Specified|0|||
144269141|NCT03786380|520187861|FG004|Overall Study|Reason Not Specified|1|||
144269142|NCT01909804|520187866|FG000|Overall Study|Randomized but Never Treated|0|||
144269143|NCT01909804|520187867|FG001|Overall Study|Randomized but Never Treated|0|||
144269144|NCT01909804|520187868|FG002|Overall Study|Randomized but Never Treated|0|||
144269145|NCT01909804|520187869|FG003|Overall Study|Randomized but Never Treated|0|||
144269146|NCT01909804|520187870|FG004|Overall Study|Randomized but Never Treated|0|||
144269147|NCT01909804|520187871|FG005|Overall Study|Randomized but Never Treated|0|||
144269148|NCT01909804|520187872|FG006|Overall Study|Randomized but Never Treated|1|||
144269149|NCT01909804|520187873|FG007|Overall Study|Randomized but Never Treated|0|||
144269150|NCT01909804|520187874|FG008|Overall Study|Randomized but Never Treated|0|||
144269151|NCT01909804|520187875|FG009|Overall Study|Randomized but Never Treated|0|||
144269152|NCT01909804|520187876|FG010|Overall Study|Randomized but Never Treated|0|||
144269153|NCT01909804|520187877|FG011|Overall Study|Randomized but Never Treated|1|||
144269154|NCT01909804|520187866|FG000|Overall Study|Death|0|||
144269155|NCT01909804|520187867|FG001|Overall Study|Death|0|||
144269156|NCT01909804|520187868|FG002|Overall Study|Death|0|||
144269157|NCT01909804|520187869|FG003|Overall Study|Death|0|||
144269158|NCT01909804|520187870|FG004|Overall Study|Death|0|||
144269159|NCT01909804|520187871|FG005|Overall Study|Death|0|||
144269160|NCT01909804|520187872|FG006|Overall Study|Death|0|||
144269161|NCT01909804|520187873|FG007|Overall Study|Death|0|||
144269162|NCT01909804|520187874|FG008|Overall Study|Death|0|||
144269163|NCT01909804|520187875|FG009|Overall Study|Death|0|||
144228378|NCT01262872|520031903|FG007|Step 2|Protocol Violation|1|||
144228379|NCT01262872|520031896|FG000|Step 2|Withdrawal by Subject|0|||
144228380|NCT01262872|520031897|FG001|Step 2|Withdrawal by Subject|0|||
144228381|NCT01262872|520031898|FG002|Step 2|Withdrawal by Subject|4|||
144228382|NCT01262872|520031899|FG003|Step 2|Withdrawal by Subject|6|||
144228383|NCT01262872|520031900|FG004|Step 2|Withdrawal by Subject|3|||
144228384|NCT01262872|520031901|FG005|Step 2|Withdrawal by Subject|1|||
144228385|NCT01262872|520031902|FG006|Step 2|Withdrawal by Subject|2|||
144228386|NCT01262872|520031903|FG007|Step 2|Withdrawal by Subject|1|||
144228387|NCT01262872|520031896|FG000|Step 2|Migrated/moved from study area|0|||
144228388|NCT01262872|520031897|FG001|Step 2|Migrated/moved from study area|0|||
144228389|NCT01262872|520031898|FG002|Step 2|Migrated/moved from study area|4|||
144228390|NCT01262872|520031899|FG003|Step 2|Migrated/moved from study area|3|||
144228391|NCT01262872|520031900|FG004|Step 2|Migrated/moved from study area|2|||
144228392|NCT01262872|520031901|FG005|Step 2|Migrated/moved from study area|6|||
144269164|NCT01909804|520187876|FG010|Overall Study|Death|1|||
144269165|NCT01909804|520187877|FG011|Overall Study|Death|0|||
144269166|NCT01909804|520187866|FG000|Overall Study|Lack of Efficacy|4|||
144269167|NCT01909804|520187867|FG001|Overall Study|Lack of Efficacy|1|||
144269168|NCT01909804|520187868|FG002|Overall Study|Lack of Efficacy|0|||
144269169|NCT01909804|520187869|FG003|Overall Study|Lack of Efficacy|0|||
144269170|NCT01909804|520187870|FG004|Overall Study|Lack of Efficacy|7|||
144269171|NCT01909804|520187871|FG005|Overall Study|Lack of Efficacy|3|||
144269172|NCT01909804|520187872|FG006|Overall Study|Lack of Efficacy|1|||
144269173|NCT01909804|520187873|FG007|Overall Study|Lack of Efficacy|1|||
144269174|NCT01909804|520187874|FG008|Overall Study|Lack of Efficacy|0|||
144269175|NCT01909804|520187875|FG009|Overall Study|Lack of Efficacy|1|||
144269176|NCT01909804|520187876|FG010|Overall Study|Lack of Efficacy|0|||
144269177|NCT01909804|520187877|FG011|Overall Study|Lack of Efficacy|1|||
144269178|NCT01909804|520187866|FG000|Overall Study|Withdrew Consent|0|||
144269179|NCT01909804|520187867|FG001|Overall Study|Withdrew Consent|0|||
144228393|NCT01262872|520031902|FG006|Step 2|Migrated/moved from study area|2|||
144228394|NCT01262872|520031903|FG007|Step 2|Migrated/moved from study area|3|||
144228395|NCT01000155|520031904|FG000|Overall Study|Withdrawal by Subject|1|||
144228396|NCT01000155|520031904|FG000|Overall Study|Adverse Event|1|||
144228397|NCT04926831|520031905|FG000|Overall Study|Withdrawal by Subject|2|||
144228398|NCT04926831|520031905|FG000|Overall Study|Adverse Event|2|||
144228399|NCT04025879|520031906|FG000|Randomization|Participant withdrew consent|0|||
144228400|NCT04025879|520031907|FG001|Randomization|Participant withdrew consent|1|||
144228401|NCT04025879|520031906|FG000|Randomization|Participant no longer met study criteria|1|||
144228402|NCT04025879|520031907|FG001|Randomization|Participant no longer met study criteria|1|||
144228403|NCT04025879|520031906|FG000|Treatment|Ongoing treatment|10|||
144228404|NCT04025879|520031907|FG001|Treatment|Ongoing treatment|8|||
144228405|NCT04025879|520031906|FG000|Treatment|Disease progression/recurrence|36|||
144228406|NCT04025879|520031907|FG001|Treatment|Disease progression/recurrence|72|||
144228407|NCT04025879|520031906|FG000|Treatment|Study drug toxicity|36|||
144228408|NCT04025879|520031907|FG001|Treatment|Study drug toxicity|13|||
144228409|NCT04025879|520031906|FG000|Treatment|Death|2|||
144228410|NCT04025879|520031907|FG001|Treatment|Death|0|||
144228411|NCT04025879|520031906|FG000|Treatment|Adverse event unrelated to study drug|21|||
144228412|NCT04025879|520031907|FG001|Treatment|Adverse event unrelated to study drug|14|||
144228413|NCT04025879|520031906|FG000|Treatment|Participant request to discontinue study treatment|16|||
144228414|NCT04025879|520031907|FG001|Treatment|Participant request to discontinue study treatment|8|||
144228415|NCT04025879|520031906|FG000|Treatment|Participant withdrew consent|1|||
144228416|NCT04025879|520031907|FG001|Treatment|Participant withdrew consent|3|||
144228417|NCT04025879|520031906|FG000|Treatment|Participant no longer meets study criteria|3|||
144228418|NCT04025879|520031907|FG001|Treatment|Participant no longer meets study criteria|2|||
144228419|NCT04025879|520031906|FG000|Treatment|Lost to Follow-up|1|||
144228420|NCT04025879|520031907|FG001|Treatment|Lost to Follow-up|0|||
144228421|NCT04025879|520031906|FG000|Treatment|Other reasons|15|||
144228422|NCT04025879|520031907|FG001|Treatment|Other reasons|17|||
144228423|NCT04025879|520031906|FG000|Treatment|Administrative reason by sponsor|0|||
144228424|NCT04025879|520031907|FG001|Treatment|Administrative reason by sponsor|1|||
144228425|NCT04025879|520031906|FG000|Treatment|Not reported|2|||
144228426|NCT04025879|520031907|FG001|Treatment|Not reported|0|||
144228427|NCT03482635|520031908|FG000|Overall Study|Lack of Efficacy|0|||
144228428|NCT03482635|520031909|FG001|Overall Study|Lack of Efficacy|0|||
144228429|NCT03482635|520031910|FG002|Overall Study|Lack of Efficacy|1|||
144228430|NCT03482635|520031911|FG003|Overall Study|Lack of Efficacy|3|||
144228431|NCT03482635|520031908|FG000|Overall Study|Adverse Event|2|||
144228432|NCT03482635|520031909|FG001|Overall Study|Adverse Event|2|||
144228433|NCT03482635|520031910|FG002|Overall Study|Adverse Event|0|||
144269180|NCT01909804|520187868|FG002|Overall Study|Withdrew Consent|0|||
144269181|NCT01909804|520187869|FG003|Overall Study|Withdrew Consent|0|||
144269182|NCT01909804|520187870|FG004|Overall Study|Withdrew Consent|1|||
144228434|NCT03482635|520031911|FG003|Overall Study|Adverse Event|3|||
144228435|NCT03482635|520031908|FG000|Overall Study|Withdrawal by Subject|2|||
144228436|NCT03482635|520031909|FG001|Overall Study|Withdrawal by Subject|1|||
144228437|NCT03482635|520031910|FG002|Overall Study|Withdrawal by Subject|0|||
144228438|NCT03482635|520031911|FG003|Overall Study|Withdrawal by Subject|1|||
144228439|NCT03482635|520031908|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
144228440|NCT03482635|520031909|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
144228441|NCT03482635|520031910|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
144228442|NCT03482635|520031911|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
144228443|NCT03482635|520031908|FG000|Overall Study|Not treated|0|||
144228444|NCT03482635|520031909|FG001|Overall Study|Not treated|0|||
144228445|NCT03482635|520031910|FG002|Overall Study|Not treated|0|||
144269183|NCT01909804|520187871|FG005|Overall Study|Withdrew Consent|1|||
144269184|NCT01909804|520187872|FG006|Overall Study|Withdrew Consent|0|||
144269185|NCT01909804|520187873|FG007|Overall Study|Withdrew Consent|0|||
144228446|NCT03482635|520031911|FG003|Overall Study|Not treated|1|||
144228447|NCT02712554|520031919|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
144269186|NCT01909804|520187874|FG008|Overall Study|Withdrew Consent|0|||
144228448|NCT02712554|520031920|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
144228449|NCT02712554|520031919|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
144228450|NCT02712554|520031920|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
144228451|NCT02712554|520031919|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
144228452|NCT02712554|520031920|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
144228453|NCT02712554|520031919|FG000|Part B: Qualification Phase|Adverse Event|0|||
144228454|NCT02712554|520031920|FG001|Part B: Qualification Phase|Adverse Event|1|||
144228455|NCT02712554|520031919|FG000|Part B: Treatment Phase|Adverse Event|0|||
144228456|NCT02712554|520031920|FG001|Part B: Treatment Phase|Adverse Event|1|||
144228457|NCT02712554|520031919|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
144228458|NCT02712554|520031920|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
144228459|NCT02712554|520031919|FG000|Part B: Treatment Phase|Other|0|||
144228460|NCT02712554|520031920|FG001|Part B: Treatment Phase|Other|1|||
144228461|NCT01662492|520031922|FG000|Overall Study|Other miscellaneous reasons.|1|||
144228462|NCT01662492|520031923|FG001|Overall Study|Other miscellaneous reasons.|0|||
144228463|NCT01662492|520031924|FG002|Overall Study|Other miscellaneous reasons.|1|||
144228464|NCT01662492|520031922|FG000|Overall Study|Withdrawal by Subject|0|||
144228465|NCT01662492|520031923|FG001|Overall Study|Withdrawal by Subject|0|||
144228466|NCT01662492|520031924|FG002|Overall Study|Withdrawal by Subject|1|||
144228467|NCT01662492|520031922|FG000|Overall Study|Protocol Violation|1|||
144228468|NCT01662492|520031923|FG001|Overall Study|Protocol Violation|0|||
144228469|NCT01662492|520031924|FG002|Overall Study|Protocol Violation|0|||
144228470|NCT01662492|520031922|FG000|Overall Study|Lost to Follow-up|0|||
144228471|NCT01662492|520031923|FG001|Overall Study|Lost to Follow-up|0|||
144228472|NCT01662492|520031924|FG002|Overall Study|Lost to Follow-up|2|||
144228473|NCT01662492|520031922|FG000|Overall Study|Lack of Efficacy|1|||
144228474|NCT01662492|520031923|FG001|Overall Study|Lack of Efficacy|1|||
144228475|NCT01662492|520031924|FG002|Overall Study|Lack of Efficacy|2|||
144228476|NCT03103152|520031926|FG000|Overall Study|Physician Decision|5|||
144228477|NCT03103152|520031927|FG001|Overall Study|Physician Decision|2|||
144228478|NCT03103152|520031928|FG002|Overall Study|Physician Decision|6|||
144228479|NCT03103152|520031929|FG003|Overall Study|Physician Decision|3|||
144228480|NCT03103152|520031930|FG004|Overall Study|Physician Decision|3|||
144228481|NCT03103152|520031931|FG005|Overall Study|Physician Decision|1|||
144228482|NCT03103152|520031926|FG000|Overall Study|Protocol Violation|2|||
144228483|NCT03103152|520031927|FG001|Overall Study|Protocol Violation|2|||
144228484|NCT03103152|520031928|FG002|Overall Study|Protocol Violation|1|||
144228485|NCT03103152|520031929|FG003|Overall Study|Protocol Violation|2|||
144228486|NCT03103152|520031930|FG004|Overall Study|Protocol Violation|1|||
144228487|NCT03103152|520031931|FG005|Overall Study|Protocol Violation|1|||
144228488|NCT03103152|520031926|FG000|Overall Study|Inter-current illness|0|||
144228489|NCT03103152|520031927|FG001|Overall Study|Inter-current illness|0|||
144228490|NCT03103152|520031928|FG002|Overall Study|Inter-current illness|1|||
144228491|NCT03103152|520031929|FG003|Overall Study|Inter-current illness|0|||
144228492|NCT03103152|520031930|FG004|Overall Study|Inter-current illness|0|||
144228493|NCT03103152|520031931|FG005|Overall Study|Inter-current illness|0|||
144228494|NCT03103152|520031926|FG000|Overall Study|Death|0|||
144228495|NCT03103152|520031927|FG001|Overall Study|Death|1|||
144228496|NCT03103152|520031928|FG002|Overall Study|Death|0|||
144228497|NCT03103152|520031929|FG003|Overall Study|Death|0|||
144228498|NCT03103152|520031930|FG004|Overall Study|Death|0|||
144228499|NCT03103152|520031931|FG005|Overall Study|Death|0|||
144228500|NCT03103152|520031926|FG000|Overall Study|Adverse Event|0|||
144228501|NCT03103152|520031927|FG001|Overall Study|Adverse Event|0|||
144228502|NCT03103152|520031928|FG002|Overall Study|Adverse Event|1|||
144228503|NCT03103152|520031929|FG003|Overall Study|Adverse Event|0|||
144228504|NCT03103152|520031930|FG004|Overall Study|Adverse Event|0|||
144228505|NCT03103152|520031931|FG005|Overall Study|Adverse Event|1|||
144228506|NCT03103152|520031926|FG000|Overall Study|Withdrawal by Subject|1|||
144228507|NCT03103152|520031927|FG001|Overall Study|Withdrawal by Subject|0|||
144228508|NCT03103152|520031928|FG002|Overall Study|Withdrawal by Subject|1|||
144228509|NCT03103152|520031929|FG003|Overall Study|Withdrawal by Subject|1|||
144228510|NCT03103152|520031930|FG004|Overall Study|Withdrawal by Subject|1|||
144228511|NCT03103152|520031931|FG005|Overall Study|Withdrawal by Subject|1|||
144228512|NCT03103152|520031926|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
144269187|NCT01909804|520187875|FG009|Overall Study|Withdrew Consent|0|||
144228513|NCT03103152|520031927|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
144228514|NCT03103152|520031928|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
144228515|NCT03103152|520031929|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
144228516|NCT03103152|520031930|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
144228517|NCT03103152|520031931|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
144269188|NCT01909804|520187876|FG010|Overall Study|Withdrew Consent|0|||
144228518|NCT03103152|520031926|FG000|Overall Study|Unacceptable side effects|0|||
144228519|NCT03103152|520031927|FG001|Overall Study|Unacceptable side effects|0|||
144228520|NCT03103152|520031928|FG002|Overall Study|Unacceptable side effects|0|||
144228521|NCT03103152|520031929|FG003|Overall Study|Unacceptable side effects|0|||
144269189|NCT01909804|520187877|FG011|Overall Study|Withdrew Consent|0|||
144269190|NCT01909804|520187866|FG000|Overall Study|Protocol Violation|0|||
144269191|NCT01909804|520187867|FG001|Overall Study|Protocol Violation|0|||
144269192|NCT01909804|520187868|FG002|Overall Study|Protocol Violation|0|||
144269193|NCT01909804|520187869|FG003|Overall Study|Protocol Violation|0|||
144269194|NCT01909804|520187870|FG004|Overall Study|Protocol Violation|0|||
144269195|NCT01909804|520187871|FG005|Overall Study|Protocol Violation|0|||
144269196|NCT01909804|520187872|FG006|Overall Study|Protocol Violation|0|||
144269197|NCT01909804|520187873|FG007|Overall Study|Protocol Violation|0|||
144269198|NCT01909804|520187874|FG008|Overall Study|Protocol Violation|0|||
144269199|NCT01909804|520187875|FG009|Overall Study|Protocol Violation|0|||
144269200|NCT01909804|520187876|FG010|Overall Study|Protocol Violation|0|||
144269201|NCT01909804|520187877|FG011|Overall Study|Protocol Violation|1|||
144269202|NCT01673178|520187878|FG000|Overall Study|Lost to Follow-up|0|||
144269203|NCT01673178|520187879|FG001|Overall Study|Lost to Follow-up|1|||
144269204|NCT01673178|520187880|FG002|Overall Study|Lost to Follow-up|0|||
144269205|NCT01673178|520187881|FG003|Overall Study|Lost to Follow-up|0|||
144269206|NCT01673178|520187882|FG004|Overall Study|Lost to Follow-up|0|||
144269207|NCT01673178|520187878|FG000|Overall Study|Withdrawal by Subject|0|||
144269208|NCT01673178|520187879|FG001|Overall Study|Withdrawal by Subject|0|||
144269209|NCT01673178|520187880|FG002|Overall Study|Withdrawal by Subject|1|||
144269210|NCT01673178|520187881|FG003|Overall Study|Withdrawal by Subject|4|||
144269211|NCT01673178|520187882|FG004|Overall Study|Withdrawal by Subject|2|||
144269212|NCT01673178|520187878|FG000|Overall Study|Protocol Violation|1|||
144269213|NCT01673178|520187879|FG001|Overall Study|Protocol Violation|1|||
144269214|NCT01673178|520187880|FG002|Overall Study|Protocol Violation|0|||
144269215|NCT01673178|520187881|FG003|Overall Study|Protocol Violation|1|||
144269216|NCT01673178|520187882|FG004|Overall Study|Protocol Violation|0|||
144269217|NCT01673178|520187878|FG000|Overall Study|Adverse Event|1|||
144269218|NCT01673178|520187879|FG001|Overall Study|Adverse Event|0|||
144269219|NCT01673178|520187880|FG002|Overall Study|Adverse Event|0|||
144269220|NCT01673178|520187881|FG003|Overall Study|Adverse Event|2|||
144269221|NCT01673178|520187882|FG004|Overall Study|Adverse Event|0|||
144269222|NCT01673178|520187878|FG000|Overall Study|Other|1|||
144269223|NCT01673178|520187879|FG001|Overall Study|Other|0|||
144269224|NCT01673178|520187880|FG002|Overall Study|Other|2|||
144269225|NCT01673178|520187881|FG003|Overall Study|Other|1|||
144269226|NCT01673178|520187882|FG004|Overall Study|Other|0|||
144269227|NCT00931632|520187884|FG000|Overall Study|Withdrawal by Subject|2|||
144269228|NCT00931632|520187885|FG001|Overall Study|Withdrawal by Subject|3|||
144269229|NCT00931632|520187884|FG000|Overall Study|Adverse Event|19|||
144269230|NCT00931632|520187885|FG001|Overall Study|Adverse Event|15|||
144269231|NCT01419314|520187886|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
144269232|NCT01419314|520187887|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
144269233|NCT01419314|520187886|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
144269234|NCT01419314|520187887|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
144269235|NCT01419314|520187886|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
144269236|NCT01419314|520187887|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
144269237|NCT03372798|520187891|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
144269238|NCT03372798|520187892|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
144269239|NCT03372798|520187891|FG000|Overall Study|Failure of imaging probe|0|||
144269240|NCT03372798|520187892|FG001|Overall Study|Failure of imaging probe|1|||
144269241|NCT00887484|520187893|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
144269242|NCT00887484|520187893|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
144269243|NCT00887484|520187893|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
144269244|NCT03044314|520187899|FG000|Overall Study|Physician Decision|2|||
144269245|NCT03044314|520187899|FG000|Overall Study|Withdrawal by Subject|1|||
144269246|NCT03044314|520187899|FG000|Overall Study|Connector tubing not available|1|||
144269247|NCT03122171|520187900|FG000|Overall Study|Withdrawal by Subject|1|||
144269248|NCT03234465|520187901|FG000|Overall Study|Adverse Event|4|||
144269249|NCT03234465|520187902|FG001|Overall Study|Adverse Event|2|||
144269250|NCT03234465|520187901|FG000|Overall Study|Death|0|||
144269251|NCT03234465|520187902|FG001|Overall Study|Death|1|||
144269252|NCT03234465|520187901|FG000|Overall Study|Lost to Follow-up|1|||
144269253|NCT03234465|520187902|FG001|Overall Study|Lost to Follow-up|1|||
144269254|NCT03234465|520187901|FG000|Overall Study|Withdrawal by Subject|12|||
144269255|NCT03234465|520187902|FG001|Overall Study|Withdrawal by Subject|27|||
144269256|NCT03234465|520187901|FG000|Overall Study|Symptomatic deterioration|0|||
144269257|NCT03234465|520187902|FG001|Overall Study|Symptomatic deterioration|1|||
144269258|NCT03234465|520187901|FG000|Overall Study|Non-compliance|2|||
144269259|NCT03234465|520187902|FG001|Overall Study|Non-compliance|0|||
144269260|NCT03234465|520187901|FG000|Overall Study|Other|14|||
144269261|NCT03234465|520187902|FG001|Overall Study|Other|8|||
144269262|NCT02873689|520189422|FG000|Overall Study|Lack of Efficacy|1|||
144269263|NCT02873689|520189423|FG001|Overall Study|Lack of Efficacy|0|||
144269264|NCT02873689|520189422|FG000|Overall Study|Withdrawal by Subject|2|||
144269265|NCT02873689|520189423|FG001|Overall Study|Withdrawal by Subject|2|||
144269266|NCT02873689|520189422|FG000|Overall Study|Protocol Violation|1|||
144269267|NCT02873689|520189423|FG001|Overall Study|Protocol Violation|0|||
144269268|NCT02873689|520189422|FG000|Overall Study|Adverse Event|2|||
144269269|NCT02873689|520189423|FG001|Overall Study|Adverse Event|2|||
144269270|NCT02873689|520189422|FG000|Overall Study|Randomized but not Treated|1|||
144269271|NCT02873689|520189423|FG001|Overall Study|Randomized but not Treated|1|||
144269272|NCT00350545|520189424|FG000|Overall Study|Withdrawal by Subject|2|||
144269273|NCT00434252|520189428|FG000|Overall Study|Lack of Efficacy|50|||
144269274|NCT00434252|520189429|FG001|Overall Study|Lack of Efficacy|100|||
144269275|NCT00434252|520189428|FG000|Overall Study|Adverse Event|6|||
144269276|NCT00434252|520189429|FG001|Overall Study|Adverse Event|13|||
144269277|NCT00434252|520189428|FG000|Overall Study|Death|1|||
144269278|NCT00434252|520189429|FG001|Overall Study|Death|2|||
144269279|NCT00434252|520189428|FG000|Overall Study|Lost to Follow-up|0|||
144269280|NCT00434252|520189429|FG001|Overall Study|Lost to Follow-up|1|||
144269281|NCT00434252|520189428|FG000|Overall Study|Physician Decision|4|||
144269282|NCT00434252|520189429|FG001|Overall Study|Physician Decision|8|||
144269283|NCT00434252|520189428|FG000|Overall Study|Withdrawal by Subject|3|||
144269284|NCT00434252|520189429|FG001|Overall Study|Withdrawal by Subject|7|||
144269285|NCT00720278|520189451|FG000|Overall Study|Adverse Event|5|||
144269286|NCT00720278|520189452|FG001|Overall Study|Adverse Event|3|||
144269287|NCT00720278|520189453|FG002|Overall Study|Adverse Event|4|||
144269288|NCT00720278|520189451|FG000|Overall Study|Withdrawal by Subject|0|||
144269289|NCT00720278|520189452|FG001|Overall Study|Withdrawal by Subject|1|||
144269290|NCT00720278|520189453|FG002|Overall Study|Withdrawal by Subject|0|||
144269291|NCT00720278|520189451|FG000|Overall Study|Lost to Follow-up|0|||
144269292|NCT00720278|520189452|FG001|Overall Study|Lost to Follow-up|0|||
144269293|NCT00720278|520189453|FG002|Overall Study|Lost to Follow-up|1|||
144269294|NCT00720278|520189451|FG000|Overall Study|Non-compliance|1|||
144269295|NCT00720278|520189452|FG001|Overall Study|Non-compliance|0|||
144269296|NCT00720278|520189453|FG002|Overall Study|Non-compliance|0|||
144269297|NCT00720278|520189451|FG000|Overall Study|eligibility criteria violation|1|||
144269298|NCT00720278|520189452|FG001|Overall Study|eligibility criteria violation|0|||
144269299|NCT00720278|520189453|FG002|Overall Study|eligibility criteria violation|1|||
144269300|NCT00997334|520189456|FG000|Overall Study|still on therapy|12|||
144269301|NCT00997334|520189456|FG000|Overall Study|Adverse Event|3|||
144269302|NCT00997334|520189456|FG000|Overall Study|Patient non-compliance|1|||
144269303|NCT00997334|520189456|FG000|Overall Study|Withdrawal by Subject|3|||
144269304|NCT00997334|520189456|FG000|Overall Study|Death|2|||
144269305|NCT00997334|520189456|FG000|Overall Study|Urgent Palliative Care|2|||
144269306|NCT00997334|520189456|FG000|Overall Study|No lesion amenable|1|||
144228522|NCT03103152|520031930|FG004|Overall Study|Unacceptable side effects|0|||
144228523|NCT03103152|520031931|FG005|Overall Study|Unacceptable side effects|1|||
144228524|NCT03103152|520031926|FG000|Overall Study|Lost to Follow-up|0|||
144228525|NCT03103152|520031927|FG001|Overall Study|Lost to Follow-up|1|||
144228526|NCT03103152|520031928|FG002|Overall Study|Lost to Follow-up|0|||
144228527|NCT03103152|520031929|FG003|Overall Study|Lost to Follow-up|1|||
144228528|NCT03103152|520031930|FG004|Overall Study|Lost to Follow-up|0|||
144228529|NCT03103152|520031931|FG005|Overall Study|Lost to Follow-up|1|||
144228530|NCT03103152|520031926|FG000|Overall Study|Testicular pain|0|||
144228531|NCT03103152|520031927|FG001|Overall Study|Testicular pain|0|||
144228532|NCT03103152|520031928|FG002|Overall Study|Testicular pain|0|||
144228533|NCT03103152|520031929|FG003|Overall Study|Testicular pain|1|||
144228534|NCT03103152|520031930|FG004|Overall Study|Testicular pain|0|||
144228535|NCT03103152|520031931|FG005|Overall Study|Testicular pain|0|||
144269307|NCT00997334|520189456|FG000|Overall Study|Ineligible|1|||
144269308|NCT00266708|520189460|FG000|Overall Study|No renal function|1|||
144269309|NCT00266708|520189461|FG001|Overall Study|No renal function|1|||
144269310|NCT00266708|520189460|FG000|Overall Study|Refused biopsy|3|||
144269311|NCT00266708|520189461|FG001|Overall Study|Refused biopsy|6|||
144269312|NCT00266708|520189460|FG000|Overall Study|Asthma|0|||
144269313|NCT00266708|520189461|FG001|Overall Study|Asthma|2|||
144269314|NCT02791269|520189462|FG000|Overall Study|Lost to Follow-up|0|||
144269315|NCT02791269|520189463|FG001|Overall Study|Lost to Follow-up|1|||
144269316|NCT02351934|520189464|FG000|Allocation|POD weight<pre-op weight|3|||
144228536|NCT03474965|520031932|FG000|Overall Study|Pregnancy|1|||
144269317|NCT02351934|520189465|FG001|Allocation|POD weight<pre-op weight|0|||
144269318|NCT02351934|520189464|FG000|Allocation|Hypotension preventing administration|2|||
144269319|NCT02351934|520189465|FG001|Allocation|Hypotension preventing administration|0|||
144269320|NCT02351934|520189464|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
144269321|NCT02351934|520189465|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
144228537|NCT03474965|520031933|FG001|Overall Study|Pregnancy|0|||
144228538|NCT03474965|520031934|FG002|Overall Study|Pregnancy|0|||
144228539|NCT03474965|520031935|FG003|Overall Study|Pregnancy|0|||
144228540|NCT03474965|520031932|FG000|Overall Study|Lost to Follow-up|0|||
144228541|NCT03474965|520031933|FG001|Overall Study|Lost to Follow-up|0|||
144228542|NCT03474965|520031934|FG002|Overall Study|Lost to Follow-up|1|||
144228543|NCT03474965|520031935|FG003|Overall Study|Lost to Follow-up|0|||
144228544|NCT03474965|520031932|FG000|Overall Study|Death|1|||
144228545|NCT03474965|520031933|FG001|Overall Study|Death|0|||
144228546|NCT03474965|520031934|FG002|Overall Study|Death|0|||
144228547|NCT03474965|520031935|FG003|Overall Study|Death|0|||
144228548|NCT03474965|520031932|FG000|Overall Study|Adverse Event|1|||
144228549|NCT03474965|520031933|FG001|Overall Study|Adverse Event|0|||
144228550|NCT03474965|520031934|FG002|Overall Study|Adverse Event|0|||
144228551|NCT03474965|520031935|FG003|Overall Study|Adverse Event|1|||
144228552|NCT03474965|520031932|FG000|Overall Study|Physician Decision|3|||
144228553|NCT03474965|520031933|FG001|Overall Study|Physician Decision|1|||
144228554|NCT03474965|520031934|FG002|Overall Study|Physician Decision|2|||
144228555|NCT03474965|520031935|FG003|Overall Study|Physician Decision|0|||
144228556|NCT03474965|520031932|FG000|Overall Study|Participant Decision|7|||
144228557|NCT03474965|520031933|FG001|Overall Study|Participant Decision|0|||
144228558|NCT03474965|520031934|FG002|Overall Study|Participant Decision|1|||
144228559|NCT03474965|520031935|FG003|Overall Study|Participant Decision|0|||
144228560|NCT03474965|520031932|FG000|Overall Study|Guardian Decision|4|||
144228561|NCT03474965|520031933|FG001|Overall Study|Guardian Decision|2|||
144228562|NCT03474965|520031934|FG002|Overall Study|Guardian Decision|7|||
144228563|NCT03474965|520031935|FG003|Overall Study|Guardian Decision|2|||
144228564|NCT03100903|520033608|FG000|Overall Study|Withdrawal by Subject|0|||
144228565|NCT03100903|520033609|FG001|Overall Study|Withdrawal by Subject|0|||
144228566|NCT03100903|520033610|FG002|Overall Study|Withdrawal by Subject|1|||
144228567|NCT04659993|520033611|FG000|Overall Study|Withdrawal by Subject|2|||
144228568|NCT04659993|520033611|FG000|Overall Study|Lost to Follow-up|2|||
144269322|NCT02351934|520189464|FG000|Follow-Up|POD weight<pre-op weight|3|||
144269323|NCT02351934|520189465|FG001|Follow-Up|POD weight<pre-op weight|0|||
144269324|NCT02351934|520189464|FG000|Follow-Up|Acute Kidney Injury|1|||
144269325|NCT02351934|520189465|FG001|Follow-Up|Acute Kidney Injury|0|||
144269326|NCT02351934|520189464|FG000|Follow-Up|Early dismissal|3|||
144269327|NCT02351934|520189465|FG001|Follow-Up|Early dismissal|0|||
144269328|NCT02351934|520189464|FG000|Follow-Up|Hypotension|3|||
144269329|NCT02351934|520189465|FG001|Follow-Up|Hypotension|0|||
144269330|NCT02351934|520189464|FG000|Follow-Up|No documentation|2|||
144269331|NCT02351934|520189465|FG001|Follow-Up|No documentation|0|||
144269332|NCT02351934|520189464|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
144269333|NCT02351934|520189465|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
144269334|NCT02351934|520189464|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
144269335|NCT02351934|520189465|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
144269336|NCT02683109|520189466|FG000|Overall Study|Adverse Event|1|||
144269337|NCT02683109|520189467|FG001|Overall Study|Adverse Event|0|||
144269338|NCT00368251|520189468|FG000|Overall Study|SAE, non-fatal|1|||
144269339|NCT00368251|520189469|FG001|Overall Study|SAE, non-fatal|0|||
144269340|NCT00368251|520189470|FG002|Overall Study|SAE, non-fatal|0|||
144269341|NCT00368251|520189468|FG000|Overall Study|AE, non-serious non-fatal|0|||
144269342|NCT00368251|520189469|FG001|Overall Study|AE, non-serious non-fatal|0|||
144269343|NCT00368251|520189470|FG002|Overall Study|AE, non-serious non-fatal|1|||
144269344|NCT02466399|520189475|FG000|Overall Study|Adverse Event|1|||
144269345|NCT02466399|520189476|FG001|Overall Study|Adverse Event|0|||
144269346|NCT02466399|520189475|FG000|Overall Study|Early exit due to family emergency|1|||
144269347|NCT02466399|520189476|FG001|Overall Study|Early exit due to family emergency|0|||
144269348|NCT03408899|520189481|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
144269349|NCT04748718|520189484|FG000|Overall Study|Lost to Follow-up|50|||
144269350|NCT01935089|520189486|FG000|Overall Study|Adverse Event|2|||
144269351|NCT01935089|520189486|FG000|Overall Study|Withdrawal by Subject|1|||
144269352|NCT02783066|520189494|FG000|Overall Study|Withdrawal by Subject|13|||
144269353|NCT03176771|520189495|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
144269354|NCT03176771|520189496|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
144269355|NCT03176771|520189497|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
144269356|NCT03176771|520189498|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
144269357|NCT03176771|520189499|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
144269358|NCT03176771|520189495|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
144269359|NCT03176771|520189496|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
144269360|NCT03176771|520189497|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
144269361|NCT03176771|520189498|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
144269362|NCT03176771|520189499|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
144228569|NCT05400655|520033612|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
144228570|NCT05400655|520033613|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
144269363|NCT03176771|520189495|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
144228571|NCT05400655|520033614|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
144228572|NCT05400655|520033615|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
144228573|NCT05400655|520033616|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
144228574|NCT05400655|520033617|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
144228575|NCT05400655|520033618|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
144228576|NCT05400655|520033619|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
144228577|NCT05400655|520033620|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
144228578|NCT05400655|520033621|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
144228579|NCT05400655|520033622|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
144228580|NCT05400655|520033623|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
144228581|NCT05400655|520033624|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
144228582|NCT05400655|520033625|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
144228583|NCT05400655|520033626|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
144228584|NCT05400655|520033627|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
144228585|NCT05400655|520033628|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
144228586|NCT05400655|520033629|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
144228587|NCT05400655|520033630|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
144228588|NCT05400655|520033631|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
144228589|NCT05400655|520033632|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
144228590|NCT05400655|520033633|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
144228591|NCT05400655|520033612|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228592|NCT05400655|520033613|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228593|NCT05400655|520033614|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228594|NCT05400655|520033615|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228595|NCT05400655|520033616|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228596|NCT05400655|520033617|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228597|NCT05400655|520033618|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228598|NCT05400655|520033619|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228599|NCT05400655|520033620|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228600|NCT05400655|520033621|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228601|NCT05400655|520033622|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228602|NCT05400655|520033623|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228603|NCT05400655|520033624|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
144228604|NCT05400655|520033625|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228605|NCT05400655|520033626|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228606|NCT05400655|520033627|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228607|NCT05400655|520033628|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
144228608|NCT05400655|520033629|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228609|NCT05400655|520033630|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
144228610|NCT05400655|520033631|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
144228611|NCT05400655|520033632|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228612|NCT05400655|520033633|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
144228613|NCT05400655|520033612|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228614|NCT05400655|520033613|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228615|NCT05400655|520033614|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228616|NCT05400655|520033615|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228617|NCT05400655|520033616|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228618|NCT05400655|520033617|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228619|NCT05400655|520033618|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228620|NCT05400655|520033619|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228621|NCT05400655|520033620|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228622|NCT05400655|520033621|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228623|NCT05400655|520033622|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228624|NCT05400655|520033623|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228625|NCT05400655|520033624|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228626|NCT05400655|520033625|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
144228627|NCT05400655|520033626|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228628|NCT05400655|520033627|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228629|NCT05400655|520033628|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
144228630|NCT05400655|520033629|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228631|NCT05400655|520033630|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
144228632|NCT05400655|520033631|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228633|NCT05400655|520033632|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228634|NCT05400655|520033633|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
144228635|NCT05400655|520033612|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228636|NCT05400655|520033613|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228637|NCT05400655|520033614|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228638|NCT05400655|520033615|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228639|NCT05400655|520033616|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228640|NCT05400655|520033617|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228641|NCT05400655|520033618|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228642|NCT05400655|520033619|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228643|NCT05400655|520033620|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228644|NCT05400655|520033621|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228645|NCT05400655|520033622|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228646|NCT05400655|520033623|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228647|NCT05400655|520033624|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228648|NCT05400655|520033625|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228649|NCT05400655|520033626|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228650|NCT05400655|520033627|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228651|NCT05400655|520033628|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
144228652|NCT05400655|520033629|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
144228653|NCT05400655|520033630|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
144228654|NCT05400655|520033631|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
144228655|NCT05400655|520033632|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
144228656|NCT05400655|520033633|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
144228657|NCT05400655|520033612|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228658|NCT05400655|520033613|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228659|NCT05400655|520033614|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228660|NCT05400655|520033615|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228661|NCT05400655|520033616|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228662|NCT05400655|520033617|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228663|NCT05400655|520033618|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228664|NCT05400655|520033619|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228665|NCT05400655|520033620|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228666|NCT05400655|520033621|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228667|NCT05400655|520033622|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228668|NCT05400655|520033623|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228669|NCT05400655|520033624|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228670|NCT05400655|520033625|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228671|NCT05400655|520033626|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228672|NCT05400655|520033627|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228673|NCT05400655|520033628|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228674|NCT05400655|520033629|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
144228675|NCT05400655|520033630|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
144228676|NCT05400655|520033631|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228677|NCT05400655|520033632|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228678|NCT05400655|520033633|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
144228679|NCT05400655|520033612|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228680|NCT05400655|520033613|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228681|NCT05400655|520033614|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228682|NCT05400655|520033615|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228683|NCT05400655|520033616|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228684|NCT05400655|520033617|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228685|NCT05400655|520033618|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228686|NCT05400655|520033619|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228687|NCT05400655|520033620|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228688|NCT05400655|520033621|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228689|NCT05400655|520033622|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228690|NCT05400655|520033623|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228691|NCT05400655|520033624|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228692|NCT05400655|520033625|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228693|NCT05400655|520033626|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228694|NCT05400655|520033627|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228695|NCT05400655|520033628|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
144228696|NCT05400655|520033629|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
144228697|NCT05400655|520033630|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
144228698|NCT05400655|520033631|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
144228699|NCT05400655|520033632|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
144228700|NCT05400655|520033633|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
144228701|NCT01682226|520033634|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
144228702|NCT01682226|520033634|FG000|Overall Study|Participants did not receive treatment|2|||
144228703|NCT01682226|520033634|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
144228704|NCT03263936|520033635|FG000|Overall Study|Adverse Event|0|||
144228705|NCT03263936|520033636|FG001|Overall Study|Adverse Event|1|||
144228706|NCT03263936|520033637|FG002|Overall Study|Adverse Event|0|||
144228707|NCT03263936|520033635|FG000|Overall Study|Death|0|||
144228708|NCT03263936|520033636|FG001|Overall Study|Death|1|||
144228709|NCT03263936|520033637|FG002|Overall Study|Death|0|||
144228710|NCT03123120|520033638|FG000|Overall Study|Lost to Follow-up|0|||
144228711|NCT03123120|520033639|FG001|Overall Study|Lost to Follow-up|1|||
144228712|NCT03123120|520033638|FG000|Overall Study|Withdrawal by Subject|0|||
144228713|NCT03123120|520033639|FG001|Overall Study|Withdrawal by Subject|1|||
144228714|NCT03135548|520033640|FG000|Overall Study|Lost to Follow-up|3|||
144228715|NCT03135548|520033641|FG001|Overall Study|Lost to Follow-up|0|||
144228716|NCT03135548|520033642|FG002|Overall Study|Lost to Follow-up|0|||
144228717|NCT03135548|520033640|FG000|Overall Study|Withdrawal by Subject|2|||
144228718|NCT03135548|520033641|FG001|Overall Study|Withdrawal by Subject|2|||
144228719|NCT03135548|520033642|FG002|Overall Study|Withdrawal by Subject|1|||
144228720|NCT03135548|520033640|FG000|Overall Study|Other than listed|0|||
144228721|NCT03135548|520033641|FG001|Overall Study|Other than listed|2|||
144228722|NCT03135548|520033642|FG002|Overall Study|Other than listed|2|||
144228723|NCT02088554|520033643|FG000|Overall Study|Exited before procedure|130|||
144228724|NCT02088554|520033643|FG000|Overall Study|Attempted but not implanted|31|||
144228725|NCT02088554|520033643|FG000|Overall Study|Implant not attempted|19|||
144228726|NCT02088554|520033643|FG000|Overall Study|Pending next visit|532|||
144228727|NCT02088554|520033643|FG000|Overall Study|Death|170|||
144228728|NCT02088554|520033643|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
144228729|NCT02088554|520033643|FG000|Overall Study|Lost to Follow-up|23|||
144228730|NCT02088554|520033643|FG000|Overall Study|Explanted|32|||
144228731|NCT02088554|520033643|FG000|Overall Study|Any other reason not covered by previous categories|11|||
144228732|NCT05326529|520033659|FG000|Overall Study|Lack of Efficacy|0|||
144228733|NCT05326529|520033660|FG001|Overall Study|Lack of Efficacy|1|||
144228734|NCT05326529|520033661|FG002|Overall Study|Lack of Efficacy|0|||
144228735|NCT05326529|520033659|FG000|Overall Study|Physician Decision|0|||
144228736|NCT05326529|520033660|FG001|Overall Study|Physician Decision|0|||
144228737|NCT05326529|520033661|FG002|Overall Study|Physician Decision|2|||
144228738|NCT02126579|520033662|FG000|Overall Study|disease progression|0|||
144228739|NCT02126579|520033663|FG001|Overall Study|disease progression|0|||
144228740|NCT02126579|520033664|FG002|Overall Study|disease progression|0|||
144228741|NCT02126579|520033665|FG003|Overall Study|disease progression|1|||
144228742|NCT02126579|520033666|FG004|Overall Study|disease progression|0|||
144228743|NCT02126579|520033667|FG005|Overall Study|disease progression|0|||
144228744|NCT02126579|520033668|FG006|Overall Study|disease progression|1|||
144228745|NCT01780038|520033670|FG000|Overall Study|Lost to Follow-up|4|||
144228746|NCT01780038|520033671|FG001|Overall Study|Lost to Follow-up|1|||
144228747|NCT03168711|520033677|FG000|Overall Study|Adverse Event|2|||
144228748|NCT03168711|520033678|FG001|Overall Study|Adverse Event|0|||
144228749|NCT03168711|520033677|FG000|Overall Study|Withdrawal by Subject|0|||
144228750|NCT03168711|520033678|FG001|Overall Study|Withdrawal by Subject|1|||
144228751|NCT03168711|520033677|FG000|Overall Study|Death|0|||
144228752|NCT03168711|520033678|FG001|Overall Study|Death|1|||
144228753|NCT01609010|520033679|FG000|Overall Study|Stable disease (SD)|22|||
144228754|NCT01609010|520033680|FG001|Overall Study|Stable disease (SD)|16|||
144228755|NCT01609010|520033679|FG000|Overall Study|Progressive disease (PD)|8|||
144228756|NCT01609010|520033680|FG001|Overall Study|Progressive disease (PD)|10|||
144228757|NCT01609010|520033679|FG000|Overall Study|Adverse Event|3|||
144228758|NCT01609010|520033680|FG001|Overall Study|Adverse Event|6|||
144228759|NCT01609010|520033679|FG000|Overall Study|Withdrawal by Subject|2|||
144228760|NCT01609010|520033680|FG001|Overall Study|Withdrawal by Subject|2|||
144228761|NCT01609010|520033679|FG000|Overall Study|Other|2|||
144228762|NCT01609010|520033680|FG001|Overall Study|Other|0|||
144228763|NCT01609010|520033679|FG000|Overall Study|Other malignancy|1|||
144228764|NCT01609010|520033680|FG001|Overall Study|Other malignancy|0|||
144228765|NCT01609010|520033679|FG000|Overall Study|Pathology review|2|||
144228766|NCT01609010|520033680|FG001|Overall Study|Pathology review|1|||
144228767|NCT01609010|520033679|FG000|Overall Study|Protocol Violation|1|||
144228768|NCT01609010|520033680|FG001|Overall Study|Protocol Violation|1|||
144228769|NCT01609010|520033679|FG000|Overall Study|New cancer|1|||
144228770|NCT01609010|520033680|FG001|Overall Study|New cancer|0|||
144228771|NCT01609010|520033679|FG000|Overall Study|Lost to Follow-up|1|||
144228772|NCT01609010|520033680|FG001|Overall Study|Lost to Follow-up|1|||
144228773|NCT03581123|520033683|FG000|2-month Follow-up|Withdrawal by Subject|5|||
144228774|NCT03581123|520033684|FG001|2-month Follow-up|Withdrawal by Subject|4|||
144228775|NCT03581123|520033685|FG002|2-month Follow-up|Withdrawal by Subject|6|||
144228776|NCT03581123|520033686|FG003|2-month Follow-up|Withdrawal by Subject|4|||
144228777|NCT03581123|520033683|FG000|2-month Follow-up|Lost to Follow-up|8|||
144228778|NCT03581123|520033684|FG001|2-month Follow-up|Lost to Follow-up|1|||
144228779|NCT03581123|520033685|FG002|2-month Follow-up|Lost to Follow-up|2|||
144228780|NCT03581123|520033686|FG003|2-month Follow-up|Lost to Follow-up|2|||
144228781|NCT03581123|520033683|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
144228782|NCT03581123|520033684|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
144228783|NCT03581123|520033685|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
144228784|NCT03581123|520033686|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
144228785|NCT03581123|520033683|FG000|6-Month Follow-up|Lost to Follow-up|3|||
144228786|NCT03581123|520033684|FG001|6-Month Follow-up|Lost to Follow-up|3|||
144228787|NCT03581123|520033685|FG002|6-Month Follow-up|Lost to Follow-up|1|||
144228788|NCT03581123|520033686|FG003|6-Month Follow-up|Lost to Follow-up|1|||
144228789|NCT03581123|520033683|FG000|12-Month Follow-up|Lost to Follow-up|4|||
144228790|NCT03581123|520033684|FG001|12-Month Follow-up|Lost to Follow-up|3|||
144228791|NCT03581123|520033685|FG002|12-Month Follow-up|Lost to Follow-up|4|||
144228792|NCT03581123|520033686|FG003|12-Month Follow-up|Lost to Follow-up|5|||
144228793|NCT02044302|520033693|FG000|Overall Study|study terminated|2|||
144228794|NCT02044302|520033694|FG001|Overall Study|study terminated|0|||
144228795|NCT04548193|520033697|FG000|Overall Study|Lost to Follow-up|0|||
144228796|NCT04548193|520033698|FG001|Overall Study|Lost to Follow-up|1|||
144228797|NCT04548193|520033697|FG000|Overall Study|Death|0|||
144228798|NCT04548193|520033698|FG001|Overall Study|Death|1|||
144228799|NCT04548193|520033697|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
144228800|NCT04548193|520033698|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
144228801|NCT04548193|520033697|FG000|Overall Study|Withdrawal by Subject|2|||
144228802|NCT04548193|520033698|FG001|Overall Study|Withdrawal by Subject|2|||
144228803|NCT02042014|520033699|FG000|Overall Study|Adverse Event|1|||
144269364|NCT03176771|520189496|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
144269365|NCT03176771|520189497|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
144269366|NCT03176771|520189498|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
144269367|NCT03176771|520189499|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
144269368|NCT03176771|520189495|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
144269369|NCT03176771|520189496|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
144269370|NCT03176771|520189497|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
144269371|NCT03176771|520189498|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
144269372|NCT03176771|520189499|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
144269373|NCT03176771|520189495|FG000|Double-Blind Extension Period|Adverse Event|0|||
144269374|NCT03176771|520189496|FG001|Double-Blind Extension Period|Adverse Event|0|||
144269375|NCT03176771|520189497|FG002|Double-Blind Extension Period|Adverse Event|0|||
144269376|NCT03176771|520189498|FG003|Double-Blind Extension Period|Adverse Event|15|||
144269377|NCT03176771|520189499|FG004|Double-Blind Extension Period|Adverse Event|18|||
144269378|NCT03176771|520189495|FG000|Double-Blind Extension Period|Death|0|||
144269379|NCT03176771|520189496|FG001|Double-Blind Extension Period|Death|0|||
144269380|NCT03176771|520189497|FG002|Double-Blind Extension Period|Death|0|||
144269381|NCT03176771|520189498|FG003|Double-Blind Extension Period|Death|3|||
144269382|NCT03176771|520189499|FG004|Double-Blind Extension Period|Death|4|||
144269383|NCT03176771|520189495|FG000|Double-Blind Extension Period|Physician Decision|0|||
144269384|NCT03176771|520189496|FG001|Double-Blind Extension Period|Physician Decision|0|||
144269385|NCT03176771|520189497|FG002|Double-Blind Extension Period|Physician Decision|0|||
144228804|NCT02042014|520033699|FG000|Overall Study|Physician Decision|7|||
144228805|NCT04610346|520033701|FG000|Overall Study|Withdrawal by Subject|1|||
144228806|NCT04610346|520033702|FG001|Overall Study|Withdrawal by Subject|1|||
144228807|NCT04610346|520033701|FG000|Overall Study|did not complete shelter onboarding|2|||
144228808|NCT04610346|520033702|FG001|Overall Study|did not complete shelter onboarding|1|||
144228809|NCT00558467|520033703|FG000|Overall Study|Adverse Event|1|||
144228810|NCT00558467|520033704|FG001|Overall Study|Adverse Event|2|||
144228811|NCT00558467|520033703|FG000|Overall Study|Lack of Efficacy|0|||
144228812|NCT00558467|520033704|FG001|Overall Study|Lack of Efficacy|1|||
144228813|NCT00558467|520033703|FG000|Overall Study|Patient moving out of state|0|||
144228814|NCT00558467|520033704|FG001|Overall Study|Patient moving out of state|1|||
144228815|NCT00931255|520033707|FG000|Overall Study|Follow up biopsy not done|2|||
144228816|NCT00931255|520033708|FG001|Overall Study|Follow up biopsy not done|3|||
144228817|NCT01372995|520033709|FG000|Overall Study|Spouse withdrew participant from study|0|||
144228818|NCT01372995|520033710|FG001|Overall Study|Spouse withdrew participant from study|1|||
144228819|NCT01372995|520033711|FG002|Overall Study|Spouse withdrew participant from study|0|||
144228820|NCT01372995|520033709|FG000|Overall Study|Physician Decision|0|||
144228821|NCT01372995|520033710|FG001|Overall Study|Physician Decision|0|||
144228822|NCT01372995|520033711|FG002|Overall Study|Physician Decision|1|||
144228823|NCT02019264|520033720|FG000|Overall Study|Not treated|6|||
144228824|NCT02019264|520033721|FG001|Overall Study|Not treated|4|||
144228825|NCT02019264|520033720|FG000|Overall Study|Lost to Follow-up|50|||
144228826|NCT02019264|520033721|FG001|Overall Study|Lost to Follow-up|47|||
144228827|NCT02019264|520033720|FG000|Overall Study|Withdrawal by Subject|142|||
144228828|NCT02019264|520033721|FG001|Overall Study|Withdrawal by Subject|117|||
144228829|NCT02019264|520033720|FG000|Overall Study|Administrative reason|36|||
144228830|NCT02019264|520033721|FG001|Overall Study|Administrative reason|28|||
144228831|NCT02019264|520033720|FG000|Overall Study|Missing|14|||
144228832|NCT02019264|520033721|FG001|Overall Study|Missing|11|||
144228833|NCT03123393|520033727|FG000|Overall Study|Study Terminated by Sponsor|6|||
144228834|NCT03123393|520033728|FG001|Overall Study|Study Terminated by Sponsor|9|||
144228835|NCT03123393|520033727|FG000|Overall Study|Withdrawal by Subject|2|||
144228836|NCT03123393|520033728|FG001|Overall Study|Withdrawal by Subject|1|||
144228837|NCT03123393|520033727|FG000|Overall Study|Reason not Specified|13|||
144228838|NCT03123393|520033728|FG001|Overall Study|Reason not Specified|13|||
144228839|NCT00558701|520033730|FG000|Overall Study|Protocol Deviations|1|||
144228840|NCT00558701|520033731|FG001|Overall Study|Protocol Deviations|4|||
144228841|NCT00427648|520033732|FG000|Overall Study|Protocol Violation|1|||
144228842|NCT00427648|520033733|FG001|Overall Study|Protocol Violation|2|||
144228843|NCT00427648|520033732|FG000|Overall Study|Adverse Event|0|||
144228844|NCT00427648|520033733|FG001|Overall Study|Adverse Event|1|||
144228845|NCT01297517|520033736|FG000|Overall Study|Adverse Event|21|||
144228846|NCT01297517|520033737|FG001|Overall Study|Adverse Event|7|||
144228847|NCT01297517|520033738|FG002|Overall Study|Adverse Event|16|||
144228848|NCT01297517|520033736|FG000|Overall Study|Lost to Follow-up|1|||
144228849|NCT01297517|520033737|FG001|Overall Study|Lost to Follow-up|0|||
144228850|NCT01297517|520033738|FG002|Overall Study|Lost to Follow-up|1|||
144228851|NCT01297517|520033736|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
144228852|NCT01297517|520033737|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
144228853|NCT01297517|520033738|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
144228854|NCT01297517|520033736|FG000|Overall Study|Noncompliance|1|||
144228855|NCT01297517|520033737|FG001|Overall Study|Noncompliance|0|||
144228856|NCT01297517|520033738|FG002|Overall Study|Noncompliance|0|||
144228857|NCT01297517|520033736|FG000|Overall Study|Protocol Violation|1|||
144228858|NCT01297517|520033737|FG001|Overall Study|Protocol Violation|1|||
144228859|NCT01297517|520033738|FG002|Overall Study|Protocol Violation|1|||
144228860|NCT01297517|520033736|FG000|Overall Study|Inadequate Control of IOP|1|||
144228861|NCT01297517|520033737|FG001|Overall Study|Inadequate Control of IOP|1|||
144228862|NCT01297517|520033738|FG002|Overall Study|Inadequate Control of IOP|2|||
144228863|NCT01609296|520033739|FG000|Overall Study|Death|253|||
144228864|NCT01609296|520033739|FG000|Overall Study|Withdrawal by Subject|151|||
144228865|NCT01609296|520033739|FG000|Overall Study|Lost to Follow-up|21|||
144228866|NCT01609296|520033739|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
144228867|NCT01609296|520033739|FG000|Overall Study|missed visit but known to be alive|28|||
144228868|NCT00386360|520033740|FG000|Overall Study|Adverse Event|4|||
144228869|NCT00386360|520033741|FG001|Overall Study|Adverse Event|2|||
144228870|NCT00386360|520033740|FG000|Overall Study|Physician Decision|2|||
144228871|NCT00386360|520033741|FG001|Overall Study|Physician Decision|2|||
144228872|NCT00386360|520033740|FG000|Overall Study|Lost to Follow-up|0|||
144228873|NCT00386360|520033741|FG001|Overall Study|Lost to Follow-up|2|||
144228874|NCT00386360|520033740|FG000|Overall Study|Protocol Violation|0|||
144228875|NCT00386360|520033741|FG001|Overall Study|Protocol Violation|3|||
144228876|NCT00386360|520033740|FG000|Overall Study|Withdrawal by Subject|3|||
144228877|NCT00386360|520033741|FG001|Overall Study|Withdrawal by Subject|6|||
144228878|NCT00386360|520033740|FG000|Overall Study|Did not take any study medication|0|||
144228879|NCT00386360|520033741|FG001|Overall Study|Did not take any study medication|2|||
144228880|NCT00628212|520033742|FG000|Overall Study|Adverse Event|2|||
144228881|NCT00628212|520033743|FG001|Overall Study|Adverse Event|0|||
144228882|NCT00628212|520033744|FG002|Overall Study|Adverse Event|1|||
144228883|NCT00628212|520033745|FG003|Overall Study|Adverse Event|2|||
144228884|NCT00628212|520033742|FG000|Overall Study|Physician Decision|1|||
144228885|NCT00628212|520033743|FG001|Overall Study|Physician Decision|1|||
144228886|NCT00628212|520033744|FG002|Overall Study|Physician Decision|2|||
144228887|NCT00628212|520033745|FG003|Overall Study|Physician Decision|3|||
144228888|NCT00546377|520033746|FG000|Overall Study|Deemed ineligible|1|||
144228889|NCT00546377|520033746|FG000|Overall Study|Adverse Event|6|||
144228890|NCT01684423|520033750|FG000|Overall Study|Withdrawal by Subject|0|||
144228891|NCT01684423|520033751|FG001|Overall Study|Withdrawal by Subject|0|||
144228892|NCT01684423|520033752|FG002|Overall Study|Withdrawal by Subject|1|||
144228893|NCT01684423|520033753|FG003|Overall Study|Withdrawal by Subject|0|||
144228894|NCT01684423|520033754|FG004|Overall Study|Withdrawal by Subject|0|||
144228895|NCT02062450|520033758|FG000|Overall Study|No follow-up visit|124|||
144228896|NCT04745689|520033759|FG000|Overall Study|Death|9|||
144228897|NCT04745689|520033760|FG001|Overall Study|Death|6|||
144228898|NCT04745689|520033759|FG000|Overall Study|Lost to Follow-up|1|||
144228899|NCT04745689|520033760|FG001|Overall Study|Lost to Follow-up|0|||
144228900|NCT04745689|520033759|FG000|Overall Study|Withdrawal by Subject|2|||
144228901|NCT04745689|520033760|FG001|Overall Study|Withdrawal by Subject|0|||
144228902|NCT04745689|520033759|FG000|Overall Study|Study terminated by sponsor|10|||
144228903|NCT04745689|520033760|FG001|Overall Study|Study terminated by sponsor|3|||
144228904|NCT03859427|520033761|FG000|Overall Study|Withdrawal by Subject|4|||
144228905|NCT03859427|520033762|FG001|Overall Study|Withdrawal by Subject|7|||
144228906|NCT03859427|520033761|FG000|Overall Study|Decision by sponsor|0|||
144228907|NCT03859427|520033762|FG001|Overall Study|Decision by sponsor|3|||
144228908|NCT03859427|520033761|FG000|Overall Study|Lost to Follow-up|3|||
144228909|NCT03859427|520033762|FG001|Overall Study|Lost to Follow-up|2|||
144228910|NCT03859427|520033761|FG000|Overall Study|Death|22|||
144228911|NCT03859427|520033762|FG001|Overall Study|Death|25|||
144228912|NCT00979654|520033766|FG000|Overall Study|Lost to Follow-up|1|||
144228913|NCT00979654|520033766|FG000|Overall Study|Withdrawal by Subject|22|||
144228914|NCT00979654|520033766|FG000|Overall Study|Death|1|||
144228915|NCT00979654|520033766|FG000|Overall Study|Lack of Efficacy|6|||
144228916|NCT00979654|520033766|FG000|Overall Study|Adverse Event|1|||
144228917|NCT00979654|520033766|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
144228918|NCT00979654|520033766|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
144228919|NCT00979654|520033766|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
144228920|NCT00979654|520033766|FG000|Overall Study|Serious Adverse Event|1|||
144228921|NCT00979654|520033766|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
144228922|NCT01804946|520033769|FG000|Overall Study|Protocol Violation|1|||
144228923|NCT01804946|520033770|FG001|Overall Study|Protocol Violation|0|||
144228924|NCT01804946|520033769|FG000|Overall Study|Adverse Event|0|||
144228925|NCT01804946|520033770|FG001|Overall Study|Adverse Event|1|||
144228926|NCT01804946|520033769|FG000|Overall Study|Insufficient data available|0|||
144228927|NCT01804946|520033770|FG001|Overall Study|Insufficient data available|1|||
144228928|NCT01804946|520033769|FG000|Overall Study|Do not meet inclusion criteria|1|||
144228929|NCT01804946|520033770|FG001|Overall Study|Do not meet inclusion criteria|2|||
144228930|NCT01129557|520033771|FG000|Overall Study|Adverse Event|1|||
144228931|NCT01129557|520033772|FG001|Overall Study|Adverse Event|2|||
144228932|NCT01129557|520033773|FG002|Overall Study|Adverse Event|2|||
144228933|NCT01129557|520033771|FG000|Overall Study|Novartis terminated study early|3|||
144228934|NCT01129557|520033772|FG001|Overall Study|Novartis terminated study early|3|||
144228935|NCT01129557|520033773|FG002|Overall Study|Novartis terminated study early|2|||
144228936|NCT01486446|520033774|FG000|Overall Study|Adverse Event|1|||
144228937|NCT01486446|520033775|FG001|Overall Study|Adverse Event|0|||
144228938|NCT00985504|520033776|FG000|Acute Treatment Period|Adverse Event|3|||
144228939|NCT00985504|520033777|FG001|Acute Treatment Period|Adverse Event|4|||
144228940|NCT00985504|520033776|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
144228941|NCT00985504|520033777|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
144228942|NCT00985504|520033776|FG000|Acute Treatment Period|Protocol Violation|2|||
144228943|NCT00985504|520033777|FG001|Acute Treatment Period|Protocol Violation|0|||
144228944|NCT00985504|520033776|FG000|Acute Treatment Period|Sponsor Decision|0|||
144228945|NCT00985504|520033777|FG001|Acute Treatment Period|Sponsor Decision|1|||
144228946|NCT00985504|520033776|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
144228947|NCT00985504|520033777|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
144228948|NCT00985504|520033776|FG000|Optimization Period|Adverse Event|7|||
144228949|NCT00985504|520033777|FG001|Optimization Period|Adverse Event|9|||
144228950|NCT00985504|520033776|FG000|Optimization Period|Death|0|||
144228951|NCT00985504|520033777|FG001|Optimization Period|Death|1|||
144228952|NCT00985504|520033776|FG000|Optimization Period|Lack of Efficacy|5|||
144228953|NCT00985504|520033777|FG001|Optimization Period|Lack of Efficacy|3|||
144228954|NCT00985504|520033776|FG000|Optimization Period|Lost to Follow-up|0|||
144228955|NCT00985504|520033777|FG001|Optimization Period|Lost to Follow-up|1|||
144228956|NCT00985504|520033776|FG000|Optimization Period|Physician Decision|1|||
144228957|NCT00985504|520033777|FG001|Optimization Period|Physician Decision|0|||
144228958|NCT00985504|520033776|FG000|Optimization Period|Protocol Violation|3|||
144228959|NCT00985504|520033777|FG001|Optimization Period|Protocol Violation|1|||
144228960|NCT00985504|520033776|FG000|Optimization Period|Withdrawal by Subject|10|||
144228961|NCT00985504|520033777|FG001|Optimization Period|Withdrawal by Subject|8|||
144228962|NCT00298272|520035761|FG000|Double-blind Phase|Adverse Event|2|||
144228963|NCT00298272|520035762|FG001|Double-blind Phase|Adverse Event|0|||
144228964|NCT00298272|520035761|FG000|Double-blind Phase|Failure to Return|2|||
144228965|NCT00298272|520035762|FG001|Double-blind Phase|Failure to Return|0|||
144228966|NCT00298272|520035761|FG000|Double-blind Phase|Protocol Violation|2|||
144228967|NCT00298272|520035762|FG001|Double-blind Phase|Protocol Violation|0|||
144228968|NCT00298272|520035761|FG000|Double-blind Phase|Withdrawal by Subject|2|||
144228969|NCT00298272|520035762|FG001|Double-blind Phase|Withdrawal by Subject|0|||
144228970|NCT00298272|520035761|FG000|Open Label Retreatment Phase|Adverse Event|1|||
144228971|NCT00298272|520035762|FG001|Open Label Retreatment Phase|Adverse Event|2|||
144228972|NCT00298272|520035761|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
144228973|NCT00298272|520035762|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
144228974|NCT00298272|520035761|FG000|Open Label Retreatment Phase|Failure to Return|1|||
144228975|NCT00298272|520035762|FG001|Open Label Retreatment Phase|Failure to Return|0|||
144228976|NCT00298272|520035761|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
144228977|NCT00298272|520035762|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
144228978|NCT00298272|520035761|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
144228979|NCT00298272|520035762|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
144228980|NCT00298272|520035761|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
144228981|NCT00298272|520035762|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
144228982|NCT00298272|520035761|FG000|Safety Follow-up Phase|Failure to Return|1|||
144228983|NCT00298272|520035762|FG001|Safety Follow-up Phase|Failure to Return|1|||
144228984|NCT00298272|520035761|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
144228985|NCT00298272|520035762|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
144228986|NCT00298272|520035761|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
144228987|NCT00298272|520035762|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
144228988|NCT00457002|520035763|FG000|Overall Study|Death|40|||
144228989|NCT00457002|520035764|FG001|Overall Study|Death|47|||
144228990|NCT00457002|520035763|FG000|Overall Study|Adverse Event|284|||
144228991|NCT00457002|520035764|FG001|Overall Study|Adverse Event|260|||
144228992|NCT00457002|520035763|FG000|Overall Study|Withdrawal by Subject|299|||
144228993|NCT00457002|520035764|FG001|Overall Study|Withdrawal by Subject|271|||
144228994|NCT00457002|520035763|FG000|Overall Study|Lost to Follow-up|72|||
144228995|NCT00457002|520035764|FG001|Overall Study|Lost to Follow-up|71|||
144228996|NCT00457002|520035763|FG000|Overall Study|Poor/Non-compliance|46|||
144228997|NCT00457002|520035764|FG001|Overall Study|Poor/Non-compliance|33|||
144228998|NCT00457002|520035763|FG000|Overall Study|No longer met criteria|41|||
144228999|NCT00457002|520035764|FG001|Overall Study|No longer met criteria|37|||
144229000|NCT00457002|520035763|FG000|Overall Study|Administrative reason by Sponsor|1|||
144229001|NCT00457002|520035764|FG001|Overall Study|Administrative reason by Sponsor|0|||
144229002|NCT00457002|520035763|FG000|Overall Study|non-specified|29|||
144229003|NCT00457002|520035764|FG001|Overall Study|non-specified|38|||
144229004|NCT00457002|520035763|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
144229005|NCT00457002|520035764|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
144229006|NCT00454246|520035765|FG000|Overall Study|Adverse Event|2|||
144229007|NCT00454246|520035766|FG001|Overall Study|Adverse Event|2|||
144229008|NCT00454246|520035767|FG002|Overall Study|Adverse Event|0|||
144229009|NCT00454246|520035765|FG000|Overall Study|Violation of selection criteria at entry|6|||
144229010|NCT00454246|520035766|FG001|Overall Study|Violation of selection criteria at entry|0|||
144229011|NCT00454246|520035767|FG002|Overall Study|Violation of selection criteria at entry|0|||
144229012|NCT00454246|520035765|FG000|Overall Study|Protocol Violation|1|||
144229013|NCT00454246|520035766|FG001|Overall Study|Protocol Violation|0|||
144229014|NCT00454246|520035767|FG002|Overall Study|Protocol Violation|0|||
144229015|NCT00454246|520035765|FG000|Overall Study|Refused Treatment|1|||
144229016|NCT00454246|520035766|FG001|Overall Study|Refused Treatment|1|||
144229017|NCT00454246|520035767|FG002|Overall Study|Refused Treatment|0|||
144229018|NCT00454246|520035765|FG000|Overall Study|Failure to return|1|||
144229019|NCT00454246|520035766|FG001|Overall Study|Failure to return|0|||
144229020|NCT00454246|520035767|FG002|Overall Study|Failure to return|0|||
144229021|NCT00454246|520035765|FG000|Overall Study|Early termination of study|62|||
144229022|NCT00454246|520035766|FG001|Overall Study|Early termination of study|26|||
144229023|NCT00454246|520035767|FG002|Overall Study|Early termination of study|9|||
144229024|NCT02283268|520035768|FG000|Overall Study|Withdrawal by Subject|1|||
144229025|NCT00833105|520035769|FG000|Overall Study|Withdrawal by Subject|1|||
144229026|NCT00833105|520035769|FG000|Overall Study|Adverse Event|2|||
144229027|NCT02898597|520035770|FG000|Overall Study|Protocol Violation|4|||
144229028|NCT02898597|520035771|FG001|Overall Study|Protocol Violation|2|||
144229029|NCT02898597|520035770|FG000|Overall Study|Lost to Follow-up|0|||
144229030|NCT02898597|520035771|FG001|Overall Study|Lost to Follow-up|9|||
144229031|NCT02898597|520035770|FG000|Overall Study|Death|0|||
144229032|NCT02898597|520035771|FG001|Overall Study|Death|1|||
144229033|NCT03656068|520035772|FG000|Overall Study|Withdrawal by Subject|4|||
144229034|NCT03656068|520035772|FG000|Overall Study|Adverse Event|1|||
144229035|NCT00154284|520035773|FG000|Overall Study|Adverse Event|6|||
144229036|NCT00154284|520035774|FG001|Overall Study|Adverse Event|9|||
144229037|NCT00154284|520035773|FG000|Overall Study|Abnormal laboratory value(s)|0|||
144229038|NCT00154284|520035774|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144229039|NCT00154284|520035773|FG000|Overall Study|Lack of Efficacy|1|||
144229040|NCT00154284|520035774|FG001|Overall Study|Lack of Efficacy|2|||
144229041|NCT00154284|520035773|FG000|Overall Study|Protocol Violation|0|||
144229042|NCT00154284|520035774|FG001|Overall Study|Protocol Violation|1|||
144229043|NCT00326716|520035775|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
144229044|NCT00326716|520035776|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
144229045|NCT00326716|520035777|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
144229046|NCT00326716|520035778|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
144229047|NCT05253573|520035779|FG000|Overall Study|Death|1|||
144229048|NCT05253573|520035780|FG001|Overall Study|Death|0|||
144229049|NCT01344824|520035781|FG000|Overall Study|Adverse Event|15|||
144229050|NCT01344824|520035781|FG000|Overall Study|Withdrawal by Subject|6|||
144229051|NCT01344824|520035781|FG000|Overall Study|Other complicating disease|1|||
144229052|NCT01344824|520035781|FG000|Overall Study|Progression|15|||
144229053|NCT01295671|520035786|FG000|Overall Study|Lost to Follow-up|4|||
144229054|NCT01295671|520035787|FG001|Overall Study|Lost to Follow-up|6|||
144229055|NCT01295671|520035788|FG002|Overall Study|Lost to Follow-up|3|||
144229056|NCT01295671|520035786|FG000|Overall Study|Withdrawal by Subject|3|||
144229057|NCT01295671|520035787|FG001|Overall Study|Withdrawal by Subject|1|||
144229058|NCT01295671|520035788|FG002|Overall Study|Withdrawal by Subject|0|||
144229059|NCT01436370|520035789|FG000|Overall Study|Lost to Follow-up|0|||
144229060|NCT01436370|520035790|FG001|Overall Study|Lost to Follow-up|0|||
144229061|NCT01436370|520035791|FG002|Overall Study|Lost to Follow-up|0|||
144229062|NCT01436370|520035792|FG003|Overall Study|Lost to Follow-up|0|||
144229063|NCT01436370|520035793|FG004|Overall Study|Lost to Follow-up|1|||
144229064|NCT01436370|520035794|FG005|Overall Study|Lost to Follow-up|0|||
144229065|NCT01436370|520035795|FG006|Overall Study|Lost to Follow-up|0|||
144229066|NCT01436370|520035796|FG007|Overall Study|Lost to Follow-up|0|||
144229067|NCT02395848|520035797|FG000|Overall Study|Lost to Follow-up|2|||
144229068|NCT02276560|520035798|FG000|Overall Study|Adverse Event|1|||
144229069|NCT02276560|520035799|FG001|Overall Study|Adverse Event|0|||
144229070|NCT02276560|520035800|FG002|Overall Study|Adverse Event|0|||
144229071|NCT01754129|520035801|FG000|Overall Study|Death|13|||
144229072|NCT01754129|520035801|FG000|Overall Study|Duodopa discontinuation|9|||
144229073|NCT01754129|520035801|FG000|Overall Study|Lost to Follow-up|7|||
144229074|NCT01754129|520035801|FG000|Overall Study|Withdrew consent|1|||
144229075|NCT01754129|520035801|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
144229076|NCT01085630|520035805|FG000|Overall Study|Insufficient data|1|||
144229077|NCT01085630|520035806|FG001|Overall Study|Insufficient data|0|||
144229078|NCT01085630|520035805|FG000|Overall Study|Ineligible|3|||
144229079|NCT01085630|520035806|FG001|Overall Study|Ineligible|0|||
144229080|NCT02366637|520035807|FG000|First Intervention Period|Adverse Event|0|||
144229081|NCT02366637|520035808|FG001|First Intervention Period|Adverse Event|1|||
144229082|NCT02366637|520035807|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
144229083|NCT02366637|520035808|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
144229084|NCT02366637|520035807|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
144229085|NCT02366637|520035808|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
144229086|NCT02609607|520035814|FG000|Overall Study|Lost to Follow-up|0|||
144229087|NCT02609607|520035815|FG001|Overall Study|Lost to Follow-up|1|||
144229088|NCT02309411|520035816|FG000|Overall Study|Physician Decision|1|||
144229089|NCT02309411|520035817|FG001|Overall Study|Physician Decision|0|||
144229090|NCT02309411|520035818|FG002|Overall Study|Physician Decision|0|||
144229091|NCT02309411|520035816|FG000|Overall Study|Withdrawal by Subject|1|||
144229092|NCT02309411|520035817|FG001|Overall Study|Withdrawal by Subject|1|||
144229093|NCT02309411|520035818|FG002|Overall Study|Withdrawal by Subject|0|||
144229094|NCT04541589|520035824|FG000|Treatment Period|Adverse Event|8|||
144229095|NCT04541589|520035825|FG001|Treatment Period|Adverse Event|2|||
144229096|NCT04541589|520035824|FG000|Treatment Period|Physician Decision|3|||
144229097|NCT04541589|520035825|FG001|Treatment Period|Physician Decision|1|||
144229098|NCT04541589|520035824|FG000|Treatment Period|Subject decision|7|||
144229099|NCT04541589|520035825|FG001|Treatment Period|Subject decision|4|||
144229100|NCT04541589|520035824|FG000|Treatment Period|Withdrawal by Subject|1|||
144229101|NCT04541589|520035825|FG001|Treatment Period|Withdrawal by Subject|0|||
144229102|NCT04541589|520035824|FG000|Safety Follow-up Period|Adverse Event|2|||
144229103|NCT04541589|520035825|FG001|Safety Follow-up Period|Adverse Event|1|||
144229104|NCT04541589|520035824|FG000|Safety Follow-up Period|Physician Decision|1|||
144229105|NCT04541589|520035825|FG001|Safety Follow-up Period|Physician Decision|0|||
144229106|NCT04541589|520035824|FG000|Safety Follow-up Period|Subject decision|5|||
144229107|NCT04541589|520035825|FG001|Safety Follow-up Period|Subject decision|3|||
144229108|NCT04541589|520035824|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
144229109|NCT04541589|520035825|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
144229110|NCT02770170|520035826|FG000|Overall Study|Withdrawal by Subject|0|||
144229111|NCT02770170|520035827|FG001|Overall Study|Withdrawal by Subject|0|||
144229112|NCT02770170|520035828|FG002|Overall Study|Withdrawal by Subject|0|||
144229113|NCT02770170|520035829|FG003|Overall Study|Withdrawal by Subject|2|||
144229114|NCT02770170|520035826|FG000|Overall Study|due to pregnancy|1|||
144229115|NCT02770170|520035827|FG001|Overall Study|due to pregnancy|0|||
144229116|NCT02770170|520035828|FG002|Overall Study|due to pregnancy|0|||
144229117|NCT02770170|520035829|FG003|Overall Study|due to pregnancy|0|||
144229118|NCT02770170|520035826|FG000|Overall Study|Lack of Efficacy|2|||
144229119|NCT02770170|520035827|FG001|Overall Study|Lack of Efficacy|0|||
144229120|NCT02770170|520035828|FG002|Overall Study|Lack of Efficacy|0|||
144229121|NCT02770170|520035829|FG003|Overall Study|Lack of Efficacy|1|||
144229122|NCT02770170|520035826|FG000|Overall Study|Adverse Event|4|||
144229123|NCT02770170|520035827|FG001|Overall Study|Adverse Event|3|||
144229124|NCT02770170|520035828|FG002|Overall Study|Adverse Event|5|||
144229125|NCT02770170|520035829|FG003|Overall Study|Adverse Event|3|||
144229126|NCT02770170|520035826|FG000|Overall Study|due to disease worsening|0|||
144229127|NCT02770170|520035827|FG001|Overall Study|due to disease worsening|0|||
144229128|NCT02770170|520035828|FG002|Overall Study|due to disease worsening|0|||
144229129|NCT02770170|520035829|FG003|Overall Study|due to disease worsening|1|||
144229130|NCT00162981|520035830|FG000|Overall Study|Adverse Event|2|||
144229131|NCT00162981|520035831|FG001|Overall Study|Adverse Event|5|||
144229132|NCT00162981|520035830|FG000|Overall Study|Withdrawal by Subject|1|||
144229133|NCT00162981|520035831|FG001|Overall Study|Withdrawal by Subject|1|||
144229134|NCT00162981|520035830|FG000|Overall Study|Physician Decision|1|||
144229135|NCT00162981|520035831|FG001|Overall Study|Physician Decision|0|||
144229136|NCT04195685|520035832|FG000|Overall Study|Withdrawal by Subject|6|||
144229137|NCT04195685|520035833|FG001|Overall Study|Withdrawal by Subject|2|||
144229138|NCT04195685|520035832|FG000|Overall Study|Lost to Follow-up|1|||
144229139|NCT04195685|520035833|FG001|Overall Study|Lost to Follow-up|4|||
144229140|NCT03351608|520035834|FG000|Overall Study|Lost to Follow-up|0|||
144229141|NCT03351608|520035835|FG001|Overall Study|Lost to Follow-up|1|||
144229142|NCT03351608|520035836|FG002|Overall Study|Lost to Follow-up|1|||
144229143|NCT03351608|520035837|FG003|Overall Study|Lost to Follow-up|1|||
144229144|NCT03351608|520035838|FG004|Overall Study|Lost to Follow-up|1|||
144229145|NCT03351608|520035834|FG000|Overall Study|Physician Decision|1|||
144229146|NCT03351608|520035835|FG001|Overall Study|Physician Decision|0|||
144229147|NCT03351608|520035836|FG002|Overall Study|Physician Decision|0|||
144229148|NCT03351608|520035837|FG003|Overall Study|Physician Decision|2|||
144229149|NCT03351608|520035838|FG004|Overall Study|Physician Decision|1|||
144229150|NCT03351608|520035834|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
144229151|NCT03351608|520035835|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
144229152|NCT03351608|520035836|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
144229153|NCT03351608|520035837|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
144229154|NCT03351608|520035838|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
144229155|NCT03351608|520035834|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144229156|NCT03351608|520035835|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144229157|NCT03351608|520035836|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144229158|NCT03351608|520035837|FG003|Overall Study|Withdrawal by parent/guardian|1|||
144229159|NCT03351608|520035838|FG004|Overall Study|Withdrawal by parent/guardian|0|||
144229160|NCT03351608|520035834|FG000|Overall Study|Other|0|||
144229161|NCT03351608|520035835|FG001|Overall Study|Other|1|||
144229162|NCT03351608|520035836|FG002|Overall Study|Other|1|||
144229163|NCT03351608|520035837|FG003|Overall Study|Other|3|||
144229164|NCT03351608|520035838|FG004|Overall Study|Other|0|||
144229165|NCT02877004|520035839|FG000|Overall Study|Pregnancy|0|||
144229166|NCT02877004|520035840|FG001|Overall Study|Pregnancy|0|||
144229167|NCT02877004|520035841|FG002|Overall Study|Pregnancy|1|||
144229168|NCT02727478|520035843|FG000|Overall Study|Withdrawal by Subject|8|||
144229169|NCT02727478|520035844|FG001|Overall Study|Withdrawal by Subject|10|||
144229170|NCT02633293|520035845|FG000|Overall Study|Death|56|||
144229171|NCT02633293|520035845|FG000|Overall Study|Progressive Disease|12|||
144229172|NCT02633293|520035845|FG000|Overall Study|Adverse Event|29|||
144229173|NCT02633293|520035845|FG000|Overall Study|Withdrawal by Subject|41|||
144229174|NCT02633293|520035845|FG000|Overall Study|Protocol Violation|1|||
144229175|NCT02633293|520035845|FG000|Overall Study|Lost to Follow-up|1|||
144229176|NCT02633293|520035845|FG000|Overall Study|Study Terminated by Sponsor|24|||
144229177|NCT02633293|520035845|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
144229178|NCT02633293|520035845|FG000|Overall Study|Lung Transplant|5|||
144229179|NCT02633293|520035845|FG000|Overall Study|Lack of Efficacy|2|||
144229180|NCT02633293|520035845|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
144229181|NCT01017874|520035846|FG000|Overall Study|Withdrawal by Subject|23|||
144229182|NCT01017874|520035847|FG001|Overall Study|Withdrawal by Subject|20|||
144229183|NCT01017874|520035846|FG000|Overall Study|Sponsor decision|3|||
144229184|NCT01017874|520035847|FG001|Overall Study|Sponsor decision|1|||
144229185|NCT01017874|520035846|FG000|Overall Study|Lost to Follow-up|3|||
144229186|NCT01017874|520035847|FG001|Overall Study|Lost to Follow-up|2|||
144229187|NCT01017874|520035846|FG000|Overall Study|Physician Decision|1|||
144229188|NCT01017874|520035847|FG001|Overall Study|Physician Decision|3|||
144229189|NCT00808210|520035848|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
144229190|NCT00808210|520035849|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
144229191|NCT00808210|520035848|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
144229192|NCT00808210|520035849|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
144229193|NCT00808210|520035848|FG000|Double-Blind TX Period|Adverse Event|0|||
144229194|NCT00808210|520035849|FG001|Double-Blind TX Period|Adverse Event|1|||
144229195|NCT00808210|520035848|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
144229196|NCT00808210|520035849|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
144229197|NCT00808210|520035848|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
144229198|NCT00808210|520035849|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
144269386|NCT03176771|520189498|FG003|Double-Blind Extension Period|Physician Decision|3|||
144269387|NCT03176771|520189499|FG004|Double-Blind Extension Period|Physician Decision|1|||
144269388|NCT03176771|520189495|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
144269389|NCT03176771|520189496|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
144269390|NCT03176771|520189497|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
144269391|NCT03176771|520189498|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
144269392|NCT03176771|520189499|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
144269393|NCT01004614|520189501|FG000|Washout|Withdrawal by Subject|0|||
144269394|NCT01004614|520189502|FG001|Washout|Withdrawal by Subject|1|||
144269395|NCT01004614|520189503|FG002|Washout|Withdrawal by Subject|0|||
144269396|NCT01004614|520189504|FG003|Washout|Withdrawal by Subject|0|||
144269397|NCT02530385|520189505|FG000|Overall Study|Withdrawal by Subject|0|||
144269398|NCT02530385|520189506|FG001|Overall Study|Withdrawal by Subject|1|||
144269399|NCT01569022|520189508|FG000|First Intervention|Lost to Follow-up|2|||
144269400|NCT01569022|520189509|FG001|First Intervention|Lost to Follow-up|1|||
144269401|NCT01569022|520189508|FG000|Second Intervention|Lost to Follow-up|2|||
144269402|NCT01569022|520189509|FG001|Second Intervention|Lost to Follow-up|2|||
144269403|NCT02111083|520189514|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
144269404|NCT02111083|520189515|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
144269405|NCT01302899|520189516|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
144269406|NCT01302899|520189517|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
144269407|NCT01302899|520189516|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
144269408|NCT01302899|520189517|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
144269409|NCT01462942|520189520|FG000|Overall Study|Adverse Event|7|||
144269410|NCT01462942|520189521|FG001|Overall Study|Adverse Event|12|||
144269411|NCT01462942|520189522|FG002|Overall Study|Adverse Event|10|||
144269412|NCT01462942|520189523|FG003|Overall Study|Adverse Event|11|||
144269413|NCT01462942|520189524|FG004|Overall Study|Adverse Event|11|||
144269414|NCT01462942|520189520|FG000|Overall Study|Other, including COPD exacerbation|3|||
144269415|NCT01462942|520189521|FG001|Overall Study|Other, including COPD exacerbation|5|||
144269416|NCT01462942|520189522|FG002|Overall Study|Other, including COPD exacerbation|2|||
144269417|NCT01462942|520189523|FG003|Overall Study|Other, including COPD exacerbation|8|||
144269418|NCT01462942|520189524|FG004|Overall Study|Other, including COPD exacerbation|5|||
144229199|NCT00808210|520035848|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
144229200|NCT00808210|520035849|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
144229201|NCT00778817|520035854|FG000|Overall Study|Adverse Event|2|||
144269419|NCT01462942|520189520|FG000|Overall Study|Withdrawal by Subject|14|||
144269420|NCT01462942|520189521|FG001|Overall Study|Withdrawal by Subject|10|||
144269421|NCT01462942|520189522|FG002|Overall Study|Withdrawal by Subject|14|||
144269422|NCT01462942|520189523|FG003|Overall Study|Withdrawal by Subject|16|||
144269423|NCT01462942|520189524|FG004|Overall Study|Withdrawal by Subject|19|||
144229202|NCT00778817|520035854|FG000|Overall Study|Withdrawal by Subject|2|||
144229203|NCT02356588|520035855|FG000|Overall Study|Lack of Efficacy|4|||
144229204|NCT02356588|520035856|FG001|Overall Study|Lack of Efficacy|10|||
144229205|NCT02356588|520035855|FG000|Overall Study|Adverse Event|0|||
144229206|NCT02356588|520035856|FG001|Overall Study|Adverse Event|2|||
144229207|NCT02356588|520035855|FG000|Overall Study|Withdrawal by Subject|1|||
144229208|NCT02356588|520035856|FG001|Overall Study|Withdrawal by Subject|0|||
144229209|NCT02356588|520035855|FG000|Overall Study|Protocol Violation|0|||
144229210|NCT02356588|520035856|FG001|Overall Study|Protocol Violation|1|||
144229211|NCT01418378|520035857|FG000|Overall Study|Death|1|||
144229212|NCT01418378|520035858|FG001|Overall Study|Death|2|||
144229213|NCT01418378|520035857|FG000|Overall Study|Physician Decision|0|||
144229214|NCT01418378|520035858|FG001|Overall Study|Physician Decision|1|||
144229215|NCT01418378|520035857|FG000|Overall Study|ligament imbalance|0|||
144229216|NCT01418378|520035858|FG001|Overall Study|ligament imbalance|1|||
144229217|NCT01418378|520035857|FG000|Overall Study|developed chronic myopathy|0|||
144229218|NCT01418378|520035858|FG001|Overall Study|developed chronic myopathy|1|||
144229219|NCT03150719|520035861|FG000|Overall Study|Adverse Event|0|||
144229220|NCT03150719|520035862|FG001|Overall Study|Adverse Event|1|||
144229221|NCT03150719|520035861|FG000|Overall Study|Death|0|||
144229222|NCT03150719|520035862|FG001|Overall Study|Death|1|||
144229223|NCT03150719|520035861|FG000|Overall Study|Other|1|||
144229224|NCT03150719|520035862|FG001|Overall Study|Other|0|||
144229225|NCT01790984|520035863|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
144229226|NCT01790984|520035864|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
144229227|NCT01790984|520035865|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
144229228|NCT01790984|520035866|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
144229229|NCT01051791|520035874|FG000|Overall Study|Failed screening|3|||
144229230|NCT01051791|520035874|FG000|Overall Study|Withdrawal by Subject|1|||
144229231|NCT01372618|520035875|FG000|Overall Study|PI Died. Study Terminated|9|||
144229232|NCT04157348|520035878|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
144229233|NCT04157348|520035879|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
144229234|NCT04157348|520035878|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
144229235|NCT04157348|520035879|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
144229236|NCT04157348|520035878|FG000|Double-blind Treatment Period|Adverse Event|0|||
144229237|NCT04157348|520035879|FG001|Double-blind Treatment Period|Adverse Event|1|||
144229238|NCT04157348|520035878|FG000|Open-label Extension Period|Adverse Event|1|||
144229239|NCT04157348|520035879|FG001|Open-label Extension Period|Adverse Event|1|||
144229240|NCT04157348|520035878|FG000|Open-label Extension Period|Death|0|||
144229241|NCT04157348|520035879|FG001|Open-label Extension Period|Death|1|||
144229242|NCT04157348|520035878|FG000|Open-label Extension Period|Lack of Efficacy|2|||
144229243|NCT04157348|520035879|FG001|Open-label Extension Period|Lack of Efficacy|2|||
144229244|NCT04157348|520035878|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
144229245|NCT04157348|520035879|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
144229246|NCT04157348|520035878|FG000|Open-label Extension Period|Ongoing|60|||
144229247|NCT04157348|520035879|FG001|Open-label Extension Period|Ongoing|57|||
144229248|NCT04157348|520035878|FG000|Open-label Extension Period|other reasons|1|||
144229249|NCT04157348|520035879|FG001|Open-label Extension Period|other reasons|1|||
144269424|NCT01462942|520189520|FG000|Overall Study|Lack of Efficacy|6|||
144229250|NCT00529308|520035880|FG000|Overall Study|Withdrawal by Subject|1|||
144229251|NCT00529308|520035881|FG001|Overall Study|Withdrawal by Subject|1|||
144229252|NCT00812981|520035884|FG000|Overall Study|Other|0|||
144229253|NCT00812981|520035885|FG001|Overall Study|Other|1|||
144229254|NCT04666259|520035886|FG000|Treatment Phase|Physician Decision|9|||
144229255|NCT04666259|520035887|FG001|Treatment Phase|Physician Decision|3|||
144229256|NCT04666259|520035888|FG002|Treatment Phase|Physician Decision|3|||
144229257|NCT04666259|520035886|FG000|Treatment Phase|Adverse Event|3|||
144229258|NCT04666259|520035887|FG001|Treatment Phase|Adverse Event|1|||
144229259|NCT04666259|520035888|FG002|Treatment Phase|Adverse Event|0|||
144229260|NCT04666259|520035886|FG000|Treatment Phase|Subject decision|1|||
144229261|NCT04666259|520035887|FG001|Treatment Phase|Subject decision|2|||
144229262|NCT04666259|520035888|FG002|Treatment Phase|Subject decision|0|||
144229263|NCT04666259|520035886|FG000|Treatment Phase|Progressive disease|0|||
144229264|NCT04666259|520035887|FG001|Treatment Phase|Progressive disease|1|||
144229265|NCT04666259|520035888|FG002|Treatment Phase|Progressive disease|0|||
144229266|NCT04666259|520035886|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
144229267|NCT04666259|520035887|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
144229268|NCT04666259|520035888|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
144229269|NCT04666259|520035886|FG000|Safety Follow-up Phase|Physician Decision|2|||
144229270|NCT04666259|520035887|FG001|Safety Follow-up Phase|Physician Decision|0|||
144229271|NCT04666259|520035888|FG002|Safety Follow-up Phase|Physician Decision|0|||
144229272|NCT04666259|520035886|FG000|Safety Follow-up Phase|Subject decision|1|||
144229273|NCT04666259|520035887|FG001|Safety Follow-up Phase|Subject decision|0|||
144229274|NCT04666259|520035888|FG002|Safety Follow-up Phase|Subject decision|0|||
144229275|NCT04666259|520035886|FG000|Safety Follow-up Phase|Death|0|||
144229276|NCT04666259|520035887|FG001|Safety Follow-up Phase|Death|1|||
144229277|NCT04666259|520035888|FG002|Safety Follow-up Phase|Death|0|||
144229278|NCT02677922|520035889|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
144229279|NCT02677922|520035890|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
144229280|NCT02677922|520035891|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
144229281|NCT02677922|520035892|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
144229282|NCT02677922|520035893|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
144229283|NCT02677922|520035894|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
144229284|NCT02677922|520035889|FG000|Treatment Period|Adverse Event|0|||
144229285|NCT02677922|520035890|FG001|Treatment Period|Adverse Event|0|||
144229286|NCT02677922|520035891|FG002|Treatment Period|Adverse Event|1|||
144229287|NCT02677922|520035892|FG003|Treatment Period|Adverse Event|3|||
144229288|NCT02677922|520035893|FG004|Treatment Period|Adverse Event|5|||
144229289|NCT02677922|520035894|FG005|Treatment Period|Adverse Event|2|||
144229290|NCT02677922|520035889|FG000|Treatment Period|Progressive Disease|1|||
144229291|NCT02677922|520035890|FG001|Treatment Period|Progressive Disease|1|||
144229292|NCT02677922|520035891|FG002|Treatment Period|Progressive Disease|0|||
144229293|NCT02677922|520035892|FG003|Treatment Period|Progressive Disease|0|||
144229294|NCT02677922|520035893|FG004|Treatment Period|Progressive Disease|8|||
144229295|NCT02677922|520035894|FG005|Treatment Period|Progressive Disease|7|||
144229296|NCT02677922|520035889|FG000|Treatment Period|Lack of Efficacy|0|||
144229297|NCT02677922|520035890|FG001|Treatment Period|Lack of Efficacy|0|||
144229298|NCT02677922|520035891|FG002|Treatment Period|Lack of Efficacy|0|||
144229299|NCT02677922|520035892|FG003|Treatment Period|Lack of Efficacy|1|||
144229300|NCT02677922|520035893|FG004|Treatment Period|Lack of Efficacy|1|||
144229301|NCT02677922|520035894|FG005|Treatment Period|Lack of Efficacy|6|||
144229302|NCT02677922|520035889|FG000|Treatment Period|Withdrawal by Subject|0|||
144229303|NCT02677922|520035890|FG001|Treatment Period|Withdrawal by Subject|0|||
144229304|NCT02677922|520035891|FG002|Treatment Period|Withdrawal by Subject|1|||
144229305|NCT02677922|520035892|FG003|Treatment Period|Withdrawal by Subject|3|||
144229306|NCT02677922|520035893|FG004|Treatment Period|Withdrawal by Subject|5|||
144229307|NCT02677922|520035894|FG005|Treatment Period|Withdrawal by Subject|5|||
144229308|NCT02677922|520035889|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
144229309|NCT02677922|520035890|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
144229310|NCT02677922|520035891|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
144229311|NCT02677922|520035892|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
144229312|NCT02677922|520035893|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
144229313|NCT02677922|520035894|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
144229314|NCT02677922|520035889|FG000|Treatment Period|Disease Relapse|0|||
144229315|NCT02677922|520035890|FG001|Treatment Period|Disease Relapse|0|||
144269425|NCT01462942|520189521|FG001|Overall Study|Lack of Efficacy|0|||
144269426|NCT01462942|520189522|FG002|Overall Study|Lack of Efficacy|4|||
144229316|NCT02677922|520035891|FG002|Treatment Period|Disease Relapse|0|||
144229317|NCT02677922|520035892|FG003|Treatment Period|Disease Relapse|3|||
144229318|NCT02677922|520035893|FG004|Treatment Period|Disease Relapse|6|||
144229319|NCT02677922|520035894|FG005|Treatment Period|Disease Relapse|1|||
144229320|NCT02677922|520035889|FG000|Treatment Period|Allogeneic HSCT|1|||
144229321|NCT02677922|520035890|FG001|Treatment Period|Allogeneic HSCT|0|||
144229322|NCT02677922|520035891|FG002|Treatment Period|Allogeneic HSCT|0|||
144229323|NCT02677922|520035892|FG003|Treatment Period|Allogeneic HSCT|1|||
144229324|NCT02677922|520035893|FG004|Treatment Period|Allogeneic HSCT|4|||
144229325|NCT02677922|520035894|FG005|Treatment Period|Allogeneic HSCT|1|||
144229326|NCT02677922|520035889|FG000|Treatment Period|Other Reasons|0|||
144229327|NCT02677922|520035890|FG001|Treatment Period|Other Reasons|0|||
144229328|NCT02677922|520035891|FG002|Treatment Period|Other Reasons|0|||
144269427|NCT01462942|520189523|FG003|Overall Study|Lack of Efficacy|5|||
144229329|NCT02677922|520035892|FG003|Treatment Period|Other Reasons|1|||
144229330|NCT02677922|520035893|FG004|Treatment Period|Other Reasons|3|||
144229331|NCT02677922|520035894|FG005|Treatment Period|Other Reasons|5|||
144229332|NCT02677922|520035889|FG000|Treatment Period|Death|0|||
144229333|NCT02677922|520035890|FG001|Treatment Period|Death|0|||
144229334|NCT02677922|520035891|FG002|Treatment Period|Death|0|||
144229335|NCT02677922|520035892|FG003|Treatment Period|Death|0|||
144229336|NCT02677922|520035893|FG004|Treatment Period|Death|12|||
144229337|NCT02677922|520035894|FG005|Treatment Period|Death|1|||
144229338|NCT02677922|520035889|FG000|Treatment Period|Non-compliance with Study Drug|0|||
144229339|NCT02677922|520035890|FG001|Treatment Period|Non-compliance with Study Drug|0|||
144229340|NCT02677922|520035891|FG002|Treatment Period|Non-compliance with Study Drug|0|||
144229341|NCT02677922|520035892|FG003|Treatment Period|Non-compliance with Study Drug|0|||
144229342|NCT02677922|520035893|FG004|Treatment Period|Non-compliance with Study Drug|1|||
144229343|NCT02677922|520035894|FG005|Treatment Period|Non-compliance with Study Drug|0|||
144229344|NCT02677922|520035889|FG000|Treatment Period|Physician Decision|0|||
144229345|NCT02677922|520035890|FG001|Treatment Period|Physician Decision|0|||
144229346|NCT02677922|520035891|FG002|Treatment Period|Physician Decision|0|||
144229347|NCT02677922|520035892|FG003|Treatment Period|Physician Decision|0|||
144229348|NCT02677922|520035893|FG004|Treatment Period|Physician Decision|0|||
144229349|NCT02677922|520035894|FG005|Treatment Period|Physician Decision|1|||
144229350|NCT02677922|520035889|FG000|Treatment Period|Symptomatic Deterioration|0|||
144229351|NCT02677922|520035890|FG001|Treatment Period|Symptomatic Deterioration|0|||
144229352|NCT02677922|520035891|FG002|Treatment Period|Symptomatic Deterioration|0|||
144229353|NCT02677922|520035892|FG003|Treatment Period|Symptomatic Deterioration|0|||
144229354|NCT02677922|520035893|FG004|Treatment Period|Symptomatic Deterioration|1|||
144229355|NCT02677922|520035894|FG005|Treatment Period|Symptomatic Deterioration|0|||
144229356|NCT05343364|520035895|FG000|Overall Study|Miscellaneous|0|||
144229357|NCT05343364|520035896|FG001|Overall Study|Miscellaneous|1|||
144229358|NCT03331796|520035897|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
144229359|NCT03331796|520035898|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
144229360|NCT03331796|520035899|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
144229361|NCT03331796|520035897|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
144229362|NCT03331796|520035898|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
144229363|NCT03331796|520035899|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
144229364|NCT03331796|520035897|FG000|Extended Follow-up|Adverse Event|1|||
144229365|NCT03331796|520035898|FG001|Extended Follow-up|Adverse Event|0|||
144229366|NCT03331796|520035899|FG002|Extended Follow-up|Adverse Event|1|||
144229367|NCT03331796|520035897|FG000|Extended Follow-up|Lost to Follow-up|0|||
144229368|NCT03331796|520035898|FG001|Extended Follow-up|Lost to Follow-up|0|||
144229369|NCT03331796|520035899|FG002|Extended Follow-up|Lost to Follow-up|1|||
144229370|NCT03331796|520035897|FG000|Extended Follow-up|Withdrawal by Subject|1|||
144229371|NCT03331796|520035898|FG001|Extended Follow-up|Withdrawal by Subject|0|||
144229372|NCT03331796|520035899|FG002|Extended Follow-up|Withdrawal by Subject|0|||
144229373|NCT03331796|520035897|FG000|Extended Follow-up|Termination of Funding|0|||
144229374|NCT03331796|520035898|FG001|Extended Follow-up|Termination of Funding|1|||
144229375|NCT03331796|520035899|FG002|Extended Follow-up|Termination of Funding|0|||
144229376|NCT01422889|520035907|FG000|Overall Study|No Data Entered for Study Stent|9|||
144229377|NCT01580670|520035908|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
144229378|NCT01580670|520035908|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
144229379|NCT02748356|520035909|FG000|Overall Study|Withdrawal by Subject|1|||
144269428|NCT01462942|520189524|FG004|Overall Study|Lack of Efficacy|3|||
144269429|NCT01462942|520189520|FG000|Overall Study|Lost to Follow-up|0|||
144269430|NCT01462942|520189521|FG001|Overall Study|Lost to Follow-up|1|||
144229380|NCT00996125|520035910|FG000|Overall Study|Adverse Event|0|||
144229381|NCT00996125|520035911|FG001|Overall Study|Adverse Event|2|||
144229382|NCT00996125|520035910|FG000|Overall Study|Lost to Follow-up|1|||
144229383|NCT00996125|520035911|FG001|Overall Study|Lost to Follow-up|6|||
144229384|NCT00996125|520035910|FG000|Overall Study|Withdrawal by Subject|4|||
144229385|NCT00996125|520035911|FG001|Overall Study|Withdrawal by Subject|3|||
144229386|NCT00488644|520035913|FG000|Overall Study|Not Eligible|1|||
144229387|NCT00488644|520035913|FG000|Overall Study|Not Evaluable|1|||
144229388|NCT04331067|520035914|FG000|Overall Study|Adverse Event|1|||
144229389|NCT04331067|520035915|FG001|Overall Study|Adverse Event|3|||
144229390|NCT04331067|520035916|FG002|Overall Study|Adverse Event|1|||
144269431|NCT01462942|520189522|FG002|Overall Study|Lost to Follow-up|1|||
144229391|NCT04331067|520035914|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
144229392|NCT04331067|520035915|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
144229393|NCT04331067|520035916|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
144229394|NCT01367886|520035919|FG000|Overall Study|Lost to Follow-up|4|||
144229395|NCT01367886|520035919|FG000|Overall Study|Lack of Efficacy|2|||
144229396|NCT01367886|520035919|FG000|Overall Study|Death|1|||
144229397|NCT03711786|520035922|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
144229398|NCT03711786|520035923|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
144269432|NCT01462942|520189523|FG003|Overall Study|Lost to Follow-up|1|||
144229399|NCT03711786|520035922|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
144229400|NCT03711786|520035923|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
144229401|NCT03711786|520035922|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
144229402|NCT03711786|520035923|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
144229403|NCT03711786|520035922|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
144229404|NCT03711786|520035923|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
144229405|NCT03711786|520035922|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
144229406|NCT03711786|520035923|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
144229407|NCT03711786|520035922|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
144229408|NCT03711786|520035923|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
144229409|NCT00669669|520035924|FG000|Overall Study|To late to start treatment|1|||
144229410|NCT03379727|520035925|FG000|Overall Study|Lack of Efficacy|73|||
144229411|NCT03379727|520035925|FG000|Overall Study|Adverse Event|32|||
144229412|NCT03379727|520035925|FG000|Overall Study|Death|18|||
144229413|NCT03379727|520035925|FG000|Overall Study|Patient/guardian decision|17|||
144229414|NCT03379727|520035925|FG000|Overall Study|Physician Decision|104|||
144229415|NCT03379727|520035925|FG000|Overall Study|Protocol Violation|4|||
144229416|NCT03379727|520035925|FG000|Overall Study|Lost to Follow-up|1|||
144229417|NCT02418182|520035931|FG000|Overall Study|Unable to re-consent|18|||
144229418|NCT02418182|520035932|FG001|Overall Study|Unable to re-consent|15|||
144229419|NCT02418182|520035931|FG000|Overall Study|Lost to Follow-up|0|||
144229420|NCT02418182|520035932|FG001|Overall Study|Lost to Follow-up|2|||
144229421|NCT01205776|520035933|FG000|Overall Study|Lost to Follow-up|53|||
144229422|NCT01205776|520035934|FG001|Overall Study|Lost to Follow-up|61|||
144229423|NCT01205776|520035933|FG000|Overall Study|Withdrawal by Subject|11|||
144229424|NCT01205776|520035934|FG001|Overall Study|Withdrawal by Subject|34|||
144229425|NCT02431676|520035935|FG000|Overall Study|no lab obtained|0|||
144229426|NCT02431676|520035936|FG001|Overall Study|no lab obtained|1|||
144229427|NCT02431676|520035937|FG002|Overall Study|no lab obtained|2|||
144229428|NCT03782792|520037671|FG000|Overall Study|Patient left the country|0|||
144229429|NCT03782792|520037672|FG001|Overall Study|Patient left the country|1|||
144229430|NCT03782792|520037671|FG000|Overall Study|Withdrawal by Subject|1|||
144229431|NCT03782792|520037672|FG001|Overall Study|Withdrawal by Subject|2|||
144229432|NCT05271370|520037673|FG000|Overall Study|Study early termination|8|||
144229433|NCT05271370|520037674|FG001|Overall Study|Study early termination|16|||
144229434|NCT05271370|520037675|FG002|Overall Study|Study early termination|29|||
144229435|NCT02151851|520037676|FG000|Overall Study|Lack of Efficacy|67|||
144229436|NCT02151851|520037677|FG001|Overall Study|Lack of Efficacy|94|||
144229437|NCT02151851|520037676|FG000|Overall Study|Protocol Violation|0|||
144229438|NCT02151851|520037677|FG001|Overall Study|Protocol Violation|1|||
144229439|NCT02151851|520037676|FG000|Overall Study|Withdrawal by Subject|2|||
144229440|NCT02151851|520037677|FG001|Overall Study|Withdrawal by Subject|5|||
144229441|NCT02151851|520037676|FG000|Overall Study|Medical impairment|1|||
144229442|NCT02151851|520037677|FG001|Overall Study|Medical impairment|0|||
144229443|NCT02151851|520037676|FG000|Overall Study|Low compliance to study visits|0|||
144229444|NCT02151851|520037677|FG001|Overall Study|Low compliance to study visits|1|||
144229445|NCT02151851|520037676|FG000|Overall Study|Subject entered into study in error|0|||
144229446|NCT02151851|520037677|FG001|Overall Study|Subject entered into study in error|1|||
144229447|NCT02151851|520037676|FG000|Overall Study|Adverse Event|6|||
144229448|NCT02151851|520037677|FG001|Overall Study|Adverse Event|28|||
144229449|NCT02159053|520037678|FG000|Overall Study|Death|2|||
144229450|NCT02159053|520037679|FG001|Overall Study|Death|0|||
144229451|NCT02159053|520037680|FG002|Overall Study|Death|1|||
144229452|NCT02159053|520037678|FG000|Overall Study|Physician Decision|0|||
144229453|NCT02159053|520037679|FG001|Overall Study|Physician Decision|1|||
144229454|NCT02159053|520037680|FG002|Overall Study|Physician Decision|1|||
144229455|NCT02159053|520037678|FG000|Overall Study|Lack of Efficacy|3|||
144229456|NCT02159053|520037679|FG001|Overall Study|Lack of Efficacy|4|||
144229457|NCT02159053|520037680|FG002|Overall Study|Lack of Efficacy|7|||
144229458|NCT02159053|520037678|FG000|Overall Study|Adverse Event|7|||
144229459|NCT02159053|520037679|FG001|Overall Study|Adverse Event|6|||
144229460|NCT02159053|520037680|FG002|Overall Study|Adverse Event|5|||
144229461|NCT02159053|520037678|FG000|Overall Study|Participants/guardian decision|8|||
144229462|NCT02159053|520037679|FG001|Overall Study|Participants/guardian decision|10|||
144229463|NCT02159053|520037680|FG002|Overall Study|Participants/guardian decision|6|||
144229464|NCT01540487|520037681|FG000|Overall Study|Protocol Violation|1|||
144229465|NCT01540487|520037682|FG001|Overall Study|Protocol Violation|0|||
144229466|NCT00617890|520037683|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
144229467|NCT00617890|520037684|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
144229468|NCT00617890|520037685|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
144229469|NCT00617890|520037686|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
144229470|NCT00617890|520037683|FG000|Overall Study|Lack of Efficacy|23|||
144229471|NCT00617890|520037684|FG001|Overall Study|Lack of Efficacy|26|||
144229472|NCT00617890|520037685|FG002|Overall Study|Lack of Efficacy|30|||
144229473|NCT00617890|520037686|FG003|Overall Study|Lack of Efficacy|97|||
144229474|NCT00617890|520037683|FG000|Overall Study|Lost to Follow-up|0|||
144229475|NCT00617890|520037684|FG001|Overall Study|Lost to Follow-up|0|||
144229476|NCT00617890|520037685|FG002|Overall Study|Lost to Follow-up|1|||
144229477|NCT00617890|520037686|FG003|Overall Study|Lost to Follow-up|2|||
144229478|NCT00617890|520037683|FG000|Overall Study|Withdrawal by Subject|4|||
144229479|NCT00617890|520037684|FG001|Overall Study|Withdrawal by Subject|1|||
144229480|NCT00617890|520037685|FG002|Overall Study|Withdrawal by Subject|0|||
144229481|NCT00617890|520037686|FG003|Overall Study|Withdrawal by Subject|2|||
144229482|NCT00617890|520037683|FG000|Overall Study|Protocol Violation|2|||
144229483|NCT00617890|520037684|FG001|Overall Study|Protocol Violation|1|||
144229484|NCT00617890|520037685|FG002|Overall Study|Protocol Violation|0|||
144229485|NCT00617890|520037686|FG003|Overall Study|Protocol Violation|0|||
144229486|NCT00617890|520037683|FG000|Overall Study|Adverse Event|1|||
144229487|NCT00617890|520037684|FG001|Overall Study|Adverse Event|0|||
144229488|NCT00617890|520037685|FG002|Overall Study|Adverse Event|3|||
144229489|NCT00617890|520037686|FG003|Overall Study|Adverse Event|8|||
144229490|NCT00617890|520037683|FG000|Overall Study|Not treated|1|||
144229491|NCT00617890|520037684|FG001|Overall Study|Not treated|0|||
144229492|NCT00617890|520037685|FG002|Overall Study|Not treated|1|||
144229493|NCT00617890|520037686|FG003|Overall Study|Not treated|1|||
144229494|NCT03503370|520037687|FG000|Overall Study|Death|3|||
144229495|NCT03503370|520037688|FG001|Overall Study|Death|1|||
144229496|NCT03483961|520037689|FG000|Overall Study|Lost to Follow-up|7|||
144229497|NCT03483961|520037690|FG001|Overall Study|Lost to Follow-up|6|||
144229498|NCT03483961|520037691|FG002|Overall Study|Lost to Follow-up|6|||
144229499|NCT03483961|520037692|FG003|Overall Study|Lost to Follow-up|6|||
144229500|NCT03483961|520037693|FG004|Overall Study|Lost to Follow-up|6|||
144229501|NCT03483961|520037694|FG005|Overall Study|Lost to Follow-up|4|||
144229502|NCT03483961|520037695|FG006|Overall Study|Lost to Follow-up|4|||
144229503|NCT03483961|520037696|FG007|Overall Study|Lost to Follow-up|11|||
144229504|NCT03483961|520037697|FG008|Overall Study|Lost to Follow-up|1|||
144229505|NCT03483961|520037698|FG009|Overall Study|Lost to Follow-up|0|||
144229506|NCT03483961|520037689|FG000|Overall Study|Withdrawal by Subject|3|||
144229507|NCT03483961|520037690|FG001|Overall Study|Withdrawal by Subject|4|||
144229508|NCT03483961|520037691|FG002|Overall Study|Withdrawal by Subject|5|||
144229509|NCT03483961|520037692|FG003|Overall Study|Withdrawal by Subject|3|||
144229510|NCT03483961|520037693|FG004|Overall Study|Withdrawal by Subject|4|||
144229511|NCT03483961|520037694|FG005|Overall Study|Withdrawal by Subject|2|||
144229512|NCT03483961|520037695|FG006|Overall Study|Withdrawal by Subject|1|||
144229513|NCT03483961|520037696|FG007|Overall Study|Withdrawal by Subject|2|||
144229514|NCT03483961|520037697|FG008|Overall Study|Withdrawal by Subject|1|||
144229515|NCT03483961|520037698|FG009|Overall Study|Withdrawal by Subject|0|||
144229516|NCT03483961|520037689|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
144229517|NCT03483961|520037690|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229518|NCT03483961|520037691|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229519|NCT03483961|520037692|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229520|NCT03483961|520037693|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229521|NCT03483961|520037694|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229522|NCT03483961|520037695|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229523|NCT03483961|520037696|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229524|NCT03483961|520037697|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229525|NCT03483961|520037698|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
144229526|NCT03483961|520037689|FG000|Overall Study|Adverse Event|0|||
144229527|NCT03483961|520037690|FG001|Overall Study|Adverse Event|0|||
144229528|NCT03483961|520037691|FG002|Overall Study|Adverse Event|1|||
144229529|NCT03483961|520037692|FG003|Overall Study|Adverse Event|0|||
144229530|NCT03483961|520037693|FG004|Overall Study|Adverse Event|0|||
144229531|NCT03483961|520037694|FG005|Overall Study|Adverse Event|0|||
144229532|NCT03483961|520037695|FG006|Overall Study|Adverse Event|0|||
144229533|NCT03483961|520037696|FG007|Overall Study|Adverse Event|0|||
144229534|NCT03483961|520037697|FG008|Overall Study|Adverse Event|0|||
144229535|NCT03483961|520037698|FG009|Overall Study|Adverse Event|0|||
144229536|NCT04003636|520037700|FG000|Overall Study|Death|409|||
144229537|NCT04003636|520037701|FG001|Overall Study|Death|443|||
144229538|NCT04003636|520037700|FG000|Overall Study|Lost to Follow-up|0|||
144229539|NCT04003636|520037701|FG001|Overall Study|Lost to Follow-up|1|||
144229540|NCT04003636|520037700|FG000|Overall Study|Withdrawal by Subject|5|||
144229541|NCT04003636|520037701|FG001|Overall Study|Withdrawal by Subject|2|||
144229542|NCT04003636|520037700|FG000|Overall Study|Participant On-going|119|||
144229543|NCT04003636|520037701|FG001|Overall Study|Participant On-going|90|||
144269433|NCT01462942|520189524|FG004|Overall Study|Lost to Follow-up|1|||
144229544|NCT03048747|520037702|FG000|Overall Study|Adverse Event|2|||
144229545|NCT03048747|520037702|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
144229546|NCT03048747|520037702|FG000|Overall Study|Physician Decision|1|||
144229547|NCT00915018|520037703|FG000|Overall Study|Death|75|||
144229548|NCT00915018|520037704|FG001|Overall Study|Death|70|||
144229549|NCT00915018|520037703|FG000|Overall Study|Lost to Follow-up|10|||
144229550|NCT00915018|520037704|FG001|Overall Study|Lost to Follow-up|5|||
144229551|NCT00915018|520037703|FG000|Overall Study|Withdrawal by Subject|38|||
144229552|NCT00915018|520037704|FG001|Overall Study|Withdrawal by Subject|27|||
144229553|NCT00915018|520037703|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
144229554|NCT00915018|520037704|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
144229555|NCT04168112|520037705|FG000|Overall Study|Lost to Follow-up|1|||
144229556|NCT04168112|520037706|FG001|Overall Study|Lost to Follow-up|0|||
144229557|NCT04168112|520037705|FG000|Overall Study|Withdrawal by Subject|1|||
144229558|NCT04168112|520037706|FG001|Overall Study|Withdrawal by Subject|0|||
144229559|NCT00684411|520037707|FG000|Overall Study|New Primary Cancer|1|||
144229560|NCT00684411|520037707|FG000|Overall Study|Disease Progression|10|||
144229561|NCT00684411|520037707|FG000|Overall Study|Adverse Event|1|||
144229562|NCT00651261|520037714|FG000|Overall Study|Adverse Event|32|||
144229563|NCT00651261|520037715|FG001|Overall Study|Adverse Event|22|||
144229564|NCT00651261|520037714|FG000|Overall Study|Death|18|||
144229565|NCT00651261|520037715|FG001|Overall Study|Death|18|||
144229566|NCT00651261|520037714|FG000|Overall Study|Withdrawal by Subject|22|||
144229567|NCT00651261|520037715|FG001|Overall Study|Withdrawal by Subject|40|||
144229568|NCT00651261|520037714|FG000|Overall Study|Induction failure|24|||
144229569|NCT00651261|520037715|FG001|Overall Study|Induction failure|35|||
144229570|NCT00651261|520037714|FG000|Overall Study|Disease progression|58|||
144229571|NCT00651261|520037715|FG001|Overall Study|Disease progression|58|||
144229572|NCT00651261|520037714|FG000|Overall Study|Alternative therapy|109|||
144229573|NCT00651261|520037715|FG001|Overall Study|Alternative therapy|107|||
144229574|NCT00651261|520037714|FG000|Overall Study|Other disease or participant decisions|23|||
144229575|NCT00651261|520037715|FG001|Overall Study|Other disease or participant decisions|23|||
144229576|NCT00651261|520037714|FG000|Overall Study|Never treated|5|||
144229577|NCT00651261|520037715|FG001|Overall Study|Never treated|3|||
144229578|NCT00687271|520037716|FG000|Overall Study|Adverse Event|1|||
144229579|NCT00687271|520037717|FG001|Overall Study|Adverse Event|3|||
144229580|NCT00687271|520037718|FG002|Overall Study|Adverse Event|1|||
144229581|NCT00687271|520037719|FG003|Overall Study|Adverse Event|0|||
144229582|NCT00687271|520037716|FG000|Overall Study|Lost to Follow-up|0|||
144229583|NCT00687271|520037717|FG001|Overall Study|Lost to Follow-up|1|||
144229584|NCT00687271|520037718|FG002|Overall Study|Lost to Follow-up|0|||
144229585|NCT00687271|520037719|FG003|Overall Study|Lost to Follow-up|0|||
144229586|NCT00687271|520037716|FG000|Overall Study|Protocol Violation|2|||
144229587|NCT00687271|520037717|FG001|Overall Study|Protocol Violation|1|||
144229588|NCT00687271|520037718|FG002|Overall Study|Protocol Violation|1|||
144229589|NCT00687271|520037719|FG003|Overall Study|Protocol Violation|0|||
144229590|NCT00687271|520037716|FG000|Overall Study|Withdrawal by Subject|0|||
144229591|NCT00687271|520037717|FG001|Overall Study|Withdrawal by Subject|1|||
144229592|NCT00687271|520037718|FG002|Overall Study|Withdrawal by Subject|3|||
144229593|NCT00687271|520037719|FG003|Overall Study|Withdrawal by Subject|0|||
144229594|NCT01134107|520037720|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
144229595|NCT01134107|520037721|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
144229596|NCT01134107|520037720|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
144229597|NCT01134107|520037721|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
144229598|NCT01134107|520037720|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
144229599|NCT01134107|520037721|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
144229600|NCT01134107|520037720|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
144229601|NCT01134107|520037721|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
144229602|NCT01134107|520037720|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
144229603|NCT01134107|520037721|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
144229604|NCT01134107|520037720|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
144229605|NCT01134107|520037721|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
144229606|NCT01134107|520037720|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
144229607|NCT01134107|520037721|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
144229608|NCT02027545|520037723|FG000|Overall Study|Failed to sign HIPAA|0|||
144229609|NCT02027545|520037724|FG001|Overall Study|Failed to sign HIPAA|2|||
144229610|NCT02027545|520037723|FG000|Overall Study|Failed to attend study visit|2|||
144229611|NCT02027545|520037724|FG001|Overall Study|Failed to attend study visit|0|||
144229612|NCT02027545|520037723|FG000|Overall Study|Protocol Violation|1|||
144229613|NCT02027545|520037724|FG001|Overall Study|Protocol Violation|0|||
144229614|NCT05483686|520037733|FG000|Overall Study|Lost to Follow-up|5|||
144229615|NCT05483686|520037734|FG001|Overall Study|Lost to Follow-up|7|||
144229616|NCT02693106|520037735|FG000|Overall Study|No time|3|||
144229617|NCT05780983|520037741|FG000|Overall Study|Withdrawal by Subject|1|||
144229618|NCT06028438|520037745|FG000|Overall Study|Adverse Event|3|||
144229619|NCT06028438|520037746|FG001|Overall Study|Adverse Event|9|||
144229620|NCT06028438|520037745|FG000|Overall Study|Lack of Efficacy|1|||
144229621|NCT06028438|520037746|FG001|Overall Study|Lack of Efficacy|1|||
144229622|NCT06028438|520037745|FG000|Overall Study|Lost to Follow-up|1|||
144229623|NCT06028438|520037746|FG001|Overall Study|Lost to Follow-up|0|||
144229624|NCT06028438|520037745|FG000|Overall Study|Withdrawal by Subject|1|||
144229625|NCT06028438|520037746|FG001|Overall Study|Withdrawal by Subject|0|||
144229626|NCT06028438|520037745|FG000|Overall Study|Other|3|||
144229627|NCT06028438|520037746|FG001|Overall Study|Other|3|||
144229628|NCT05625802|520037747|FG000|Overall Study|Lost to Follow-up|1|||
144229629|NCT05625802|520037748|FG001|Overall Study|Lost to Follow-up|0|||
144229630|NCT00288626|520037751|FG000|Overall Study|Death|3|||
144229631|NCT00288626|520037751|FG000|Overall Study|Withdrawal by Subject|4|||
144229632|NCT03309943|520037753|FG000|Overall Study|Withdrawal by Subject|0|||
144229633|NCT03309943|520037754|FG001|Overall Study|Withdrawal by Subject|1|||
144229634|NCT03309943|520037753|FG000|Overall Study|Inappropriate behavior towards staff|0|||
144229635|NCT03309943|520037754|FG001|Overall Study|Inappropriate behavior towards staff|1|||
144229636|NCT00507455|520037755|FG000|Overall Study|Adverse Event|3|||
144229637|NCT00507455|520037756|FG001|Overall Study|Adverse Event|3|||
144229638|NCT00507455|520037757|FG002|Overall Study|Adverse Event|6|||
144229639|NCT00507455|520037755|FG000|Overall Study|Withdrawal by Subject|2|||
144229640|NCT00507455|520037756|FG001|Overall Study|Withdrawal by Subject|1|||
144229641|NCT00507455|520037757|FG002|Overall Study|Withdrawal by Subject|2|||
144229642|NCT00507455|520037755|FG000|Overall Study|Protocol Violation|4|||
144229643|NCT00507455|520037756|FG001|Overall Study|Protocol Violation|1|||
144229644|NCT00507455|520037757|FG002|Overall Study|Protocol Violation|1|||
144229645|NCT00507455|520037755|FG000|Overall Study|Lost to Follow-up|2|||
144229646|NCT00507455|520037756|FG001|Overall Study|Lost to Follow-up|0|||
144229647|NCT00507455|520037757|FG002|Overall Study|Lost to Follow-up|2|||
144229648|NCT00507455|520037755|FG000|Overall Study|Lack of Efficacy|0|||
144229649|NCT00507455|520037756|FG001|Overall Study|Lack of Efficacy|1|||
144229650|NCT00507455|520037757|FG002|Overall Study|Lack of Efficacy|0|||
144229651|NCT00507455|520037755|FG000|Overall Study|Other - miscellaneous reason|1|||
144229652|NCT00507455|520037756|FG001|Overall Study|Other - miscellaneous reason|0|||
144229653|NCT00507455|520037757|FG002|Overall Study|Other - miscellaneous reason|1|||
144229654|NCT02914613|520037762|FG000|Overall Study|Withdrawal by Subject|1|||
144229655|NCT02914613|520037763|FG001|Overall Study|Withdrawal by Subject|2|||
144229656|NCT02914613|520037762|FG000|Overall Study|Adverse Event|1|||
144229657|NCT02914613|520037763|FG001|Overall Study|Adverse Event|0|||
144229658|NCT00789373|520037764|FG000|Induction|Adverse Event|64|||
144229659|NCT00789373|520037765|FG001|Induction|Adverse Event|0|||
144229660|NCT00789373|520037766|FG002|Induction|Adverse Event|0|||
144269434|NCT01462942|520189520|FG000|Overall Study|Protocol Violation|4|||
144269435|NCT01462942|520189521|FG001|Overall Study|Protocol Violation|6|||
144229661|NCT00789373|520037764|FG000|Induction|Death Due to study disease|24|||
144229662|NCT00789373|520037765|FG001|Induction|Death Due to study disease|0|||
144229663|NCT00789373|520037766|FG002|Induction|Death Due to study disease|0|||
144229664|NCT00789373|520037764|FG000|Induction|Death due to adverse event|19|||
144229665|NCT00789373|520037765|FG001|Induction|Death due to adverse event|0|||
144229666|NCT00789373|520037766|FG002|Induction|Death due to adverse event|0|||
144229667|NCT00789373|520037764|FG000|Induction|Death due to toxicity|11|||
144229668|NCT00789373|520037765|FG001|Induction|Death due to toxicity|0|||
144229669|NCT00789373|520037766|FG002|Induction|Death due to toxicity|0|||
144229670|NCT00789373|520037764|FG000|Induction|Death due to procedure|1|||
144229671|NCT00789373|520037765|FG001|Induction|Death due to procedure|0|||
144269436|NCT01462942|520189522|FG002|Overall Study|Protocol Violation|9|||
144229672|NCT00789373|520037766|FG002|Induction|Death due to procedure|0|||
144229673|NCT00789373|520037764|FG000|Induction|Investigator decision|7|||
144229674|NCT00789373|520037765|FG001|Induction|Investigator decision|0|||
144229675|NCT00789373|520037766|FG002|Induction|Investigator decision|0|||
144229676|NCT00789373|520037764|FG000|Induction|Protocol entry criteria not met|9|||
144229677|NCT00789373|520037765|FG001|Induction|Protocol entry criteria not met|0|||
144229678|NCT00789373|520037766|FG002|Induction|Protocol entry criteria not met|0|||
144229679|NCT00789373|520037764|FG000|Induction|Lost to Follow-up|6|||
144229680|NCT00789373|520037765|FG001|Induction|Lost to Follow-up|0|||
144229681|NCT00789373|520037766|FG002|Induction|Lost to Follow-up|0|||
144229682|NCT00789373|520037764|FG000|Induction|Protocol Violation|1|||
144229683|NCT00789373|520037765|FG001|Induction|Protocol Violation|0|||
144229684|NCT00789373|520037766|FG002|Induction|Protocol Violation|0|||
144269437|NCT01462942|520189523|FG003|Overall Study|Protocol Violation|9|||
144269438|NCT01462942|520189524|FG004|Overall Study|Protocol Violation|6|||
144229685|NCT00789373|520037764|FG000|Induction|Progressive Disease|220|||
144229686|NCT00789373|520037765|FG001|Induction|Progressive Disease|0|||
144229687|NCT00789373|520037766|FG002|Induction|Progressive Disease|0|||
144229688|NCT00789373|520037764|FG000|Induction|Withdrawal by Subject|37|||
144229689|NCT00789373|520037765|FG001|Induction|Withdrawal by Subject|0|||
144229690|NCT00789373|520037766|FG002|Induction|Withdrawal by Subject|0|||
144229691|NCT00789373|520037764|FG000|Maintenance|Adverse Event|0|||
144229692|NCT00789373|520037765|FG001|Maintenance|Adverse Event|65|||
144229693|NCT00789373|520037766|FG002|Maintenance|Adverse Event|12|||
144229694|NCT00789373|520037764|FG000|Maintenance|Death due to study disease|0|||
144229695|NCT00789373|520037765|FG001|Maintenance|Death due to study disease|3|||
144229696|NCT00789373|520037766|FG002|Maintenance|Death due to study disease|1|||
144229697|NCT00789373|520037764|FG000|Maintenance|Death due to adverse event|0|||
144229698|NCT00789373|520037765|FG001|Maintenance|Death due to adverse event|4|||
144229699|NCT00789373|520037766|FG002|Maintenance|Death due to adverse event|1|||
144229700|NCT00789373|520037764|FG000|Maintenance|Death due to toxicity|0|||
144229701|NCT00789373|520037765|FG001|Maintenance|Death due to toxicity|1|||
144229702|NCT00789373|520037766|FG002|Maintenance|Death due to toxicity|2|||
144229703|NCT00789373|520037764|FG000|Maintenance|Investigator Decision|0|||
144229704|NCT00789373|520037765|FG001|Maintenance|Investigator Decision|4|||
144229705|NCT00789373|520037766|FG002|Maintenance|Investigator Decision|2|||
144229706|NCT00789373|520037764|FG000|Maintenance|Protocol entry criteria not met|0|||
144229707|NCT00789373|520037765|FG001|Maintenance|Protocol entry criteria not met|2|||
144229708|NCT00789373|520037766|FG002|Maintenance|Protocol entry criteria not met|0|||
144229709|NCT00789373|520037764|FG000|Maintenance|Lost to Follow-up|0|||
144229710|NCT00789373|520037765|FG001|Maintenance|Lost to Follow-up|2|||
144229711|NCT00789373|520037766|FG002|Maintenance|Lost to Follow-up|0|||
144229712|NCT00789373|520037764|FG000|Maintenance|Progressive Disease|0|||
144229713|NCT00789373|520037765|FG001|Maintenance|Progressive Disease|253|||
144229714|NCT00789373|520037766|FG002|Maintenance|Progressive Disease|152|||
144229715|NCT00789373|520037764|FG000|Maintenance|Withdrawal by Subject|0|||
144229716|NCT00789373|520037765|FG001|Maintenance|Withdrawal by Subject|21|||
144229717|NCT00789373|520037766|FG002|Maintenance|Withdrawal by Subject|8|||
144229718|NCT00789373|520037764|FG000|Maintenance|Sponsor Decision|0|||
144229719|NCT00789373|520037765|FG001|Maintenance|Sponsor Decision|0|||
144229720|NCT00789373|520037766|FG002|Maintenance|Sponsor Decision|2|||
144229721|NCT00789373|520037764|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
144229722|NCT00789373|520037765|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
144229723|NCT00789373|520037766|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
144229724|NCT00656292|520037770|FG000|Overall Study|Withdrawal by Subject|2|||
144229725|NCT00656292|520037771|FG001|Overall Study|Withdrawal by Subject|3|||
144229726|NCT00656292|520037770|FG000|Overall Study|Screen failure|1|||
144229727|NCT00656292|520037771|FG001|Overall Study|Screen failure|2|||
144229728|NCT03674112|520037772|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
144229729|NCT03674112|520037773|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
144229730|NCT03674112|520037772|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
144229731|NCT03674112|520037773|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
144229732|NCT03674112|520037772|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
144229733|NCT03674112|520037773|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
144229734|NCT03674112|520037772|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
144229735|NCT03674112|520037773|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
144229736|NCT03674112|520037772|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
144229737|NCT03674112|520037773|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
144229738|NCT03674112|520037772|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
144229739|NCT03674112|520037773|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
144229740|NCT03674112|520037772|FG000|Follow-Up Period (≥3 Years)|Death|2|||
144229741|NCT03674112|520037773|FG001|Follow-Up Period (≥3 Years)|Death|0|||
144229742|NCT03674112|520037772|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
144229743|NCT03674112|520037773|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
144229744|NCT00568061|520037778|FG000|Overall Study|Inclusion / exclusion criteria|5|||
144229745|NCT00568061|520037779|FG001|Overall Study|Inclusion / exclusion criteria|1|||
144229746|NCT00568061|520037778|FG000|Overall Study|Adverse Event|0|||
144229747|NCT00568061|520037779|FG001|Overall Study|Adverse Event|1|||
144229748|NCT05027451|520037780|FG000|Overall Study|Lost to Follow-up|1|||
144229749|NCT05027451|520037781|FG001|Overall Study|Lost to Follow-up|1|||
144229750|NCT02693002|520037783|FG000|Overall Study|Withdrawal by Subject|1|||
144229751|NCT02693002|520037784|FG001|Overall Study|Withdrawal by Subject|0|||
144229752|NCT01791894|520037786|FG000|Overall Study|Adverse Event|1|||
144229753|NCT04830969|520037789|FG000|Overall Study|Withdrawal by Subject|6|||
144229754|NCT04830969|520037790|FG001|Overall Study|Withdrawal by Subject|2|||
144229755|NCT04830969|520037789|FG000|Overall Study|Protocol Violation|3|||
144229756|NCT04830969|520037790|FG001|Overall Study|Protocol Violation|9|||
144229757|NCT04830969|520037789|FG000|Overall Study|Lost to Follow-up|4|||
144229758|NCT04830969|520037790|FG001|Overall Study|Lost to Follow-up|4|||
144229759|NCT05870371|520037791|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
144229760|NCT05870371|520037792|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
144229761|NCT02203721|520037796|FG000|Overall Study|Lost to Follow-up|1|||
144229762|NCT02203721|520037797|FG001|Overall Study|Lost to Follow-up|0|||
144229763|NCT02203721|520037796|FG000|Overall Study|Death|0|||
144229764|NCT02203721|520037797|FG001|Overall Study|Death|2|||
144229765|NCT02203721|520037796|FG000|Overall Study|Illness|0|||
144229766|NCT02203721|520037797|FG001|Overall Study|Illness|1|||
144229767|NCT04495751|520037800|FG000|Overall Study|Withdrawal by Subject|1|||
144229768|NCT04495751|520037801|FG001|Overall Study|Withdrawal by Subject|0|||
144229769|NCT04495751|520037800|FG000|Overall Study|Lost to Follow-up|1|||
144229770|NCT04495751|520037801|FG001|Overall Study|Lost to Follow-up|0|||
144229771|NCT03289754|520037802|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
144229772|NCT03584854|520037803|FG000|Overall Study|Primary outcome not measured|1|||
144229773|NCT03584854|520037804|FG001|Overall Study|Primary outcome not measured|2|||
144229774|NCT00153179|520037805|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
144229775|NCT00153179|520037806|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
144229776|NCT00153179|520037807|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
144229777|NCT00153179|520037808|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
144229778|NCT00314327|520037809|FG000|Overall Study|Withdrawal by Subject|1|||
144229779|NCT01205269|520037810|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
144229780|NCT01205269|520037811|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
144229781|NCT01205269|520037812|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
144229782|NCT01205269|520037813|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
144229783|NCT01205269|520037814|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
144229784|NCT01205269|520037815|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
144229785|NCT01408303|520037816|FG000|Overall Study|Adverse Event|3|||
144269439|NCT02737722|520189527|FG000|Overall Study|Physician Decision|0|||
144229786|NCT01408303|520037817|FG001|Overall Study|Adverse Event|7|||
144229787|NCT01408303|520037818|FG002|Overall Study|Adverse Event|2|||
144229788|NCT01408303|520037816|FG000|Overall Study|Lost to Follow-up|0|||
144229789|NCT01408303|520037817|FG001|Overall Study|Lost to Follow-up|1|||
144229790|NCT01408303|520037818|FG002|Overall Study|Lost to Follow-up|2|||
144229791|NCT01408303|520037816|FG000|Overall Study|Withdrawal by Subject|2|||
144229792|NCT01408303|520037817|FG001|Overall Study|Withdrawal by Subject|3|||
144229793|NCT01408303|520037818|FG002|Overall Study|Withdrawal by Subject|1|||
144229794|NCT01408303|520037816|FG000|Overall Study|Protocol Violation|0|||
144229795|NCT01408303|520037817|FG001|Overall Study|Protocol Violation|1|||
144229796|NCT01408303|520037818|FG002|Overall Study|Protocol Violation|0|||
144229797|NCT01408303|520037816|FG000|Overall Study|Noncompliance|1|||
144229798|NCT01408303|520037817|FG001|Overall Study|Noncompliance|0|||
144229799|NCT01408303|520037818|FG002|Overall Study|Noncompliance|1|||
144229800|NCT00987337|520037819|FG000|Overall Study|Adverse Event|10|||
144229801|NCT00987337|520037820|FG001|Overall Study|Adverse Event|9|||
144229802|NCT00987337|520037821|FG002|Overall Study|Adverse Event|8|||
144229803|NCT00987337|520037819|FG000|Overall Study|Insufficient Virologic Response|10|||
144229804|NCT00987337|520037820|FG001|Overall Study|Insufficient Virologic Response|7|||
144229805|NCT00987337|520037821|FG002|Overall Study|Insufficient Virologic Response|12|||
144229806|NCT00987337|520037819|FG000|Overall Study|Virologic Breakthrough|2|||
144229807|NCT00987337|520037820|FG001|Overall Study|Virologic Breakthrough|2|||
144229808|NCT00987337|520037821|FG002|Overall Study|Virologic Breakthrough|8|||
144229809|NCT00987337|520037819|FG000|Overall Study|Lost to Follow-up|10|||
144269440|NCT02737722|520189528|FG001|Overall Study|Physician Decision|0|||
144229810|NCT00987337|520037820|FG001|Overall Study|Lost to Follow-up|6|||
144269441|NCT02737722|520189529|FG002|Overall Study|Physician Decision|1|||
144269442|NCT02737722|520189530|FG003|Overall Study|Physician Decision|0|||
144229811|NCT00987337|520037821|FG002|Overall Study|Lost to Follow-up|2|||
144229812|NCT00987337|520037819|FG000|Overall Study|Withdrawal by Subject|6|||
144229813|NCT00987337|520037820|FG001|Overall Study|Withdrawal by Subject|9|||
144229814|NCT00987337|520037821|FG002|Overall Study|Withdrawal by Subject|9|||
144229815|NCT00987337|520037819|FG000|Overall Study|Other|0|||
144229816|NCT00987337|520037820|FG001|Overall Study|Other|2|||
144229817|NCT00987337|520037821|FG002|Overall Study|Other|5|||
144229818|NCT00987337|520037819|FG000|Overall Study|Protocol Violation|1|||
144229819|NCT00987337|520037820|FG001|Overall Study|Protocol Violation|0|||
144229820|NCT00987337|520037821|FG002|Overall Study|Protocol Violation|2|||
144229821|NCT00987337|520037819|FG000|Overall Study|Participant Relapsed|18|||
144229822|NCT00987337|520037820|FG001|Overall Study|Participant Relapsed|20|||
144229823|NCT00987337|520037821|FG002|Overall Study|Participant Relapsed|5|||
144229824|NCT04031846|520037825|FG000|Overall Study|Lost to Follow-up|4|||
144229825|NCT04031846|520037826|FG001|Overall Study|Lost to Follow-up|4|||
144229826|NCT04031846|520037825|FG000|Overall Study|Physician Decision|0|||
144229827|NCT04031846|520037826|FG001|Overall Study|Physician Decision|1|||
144229828|NCT04031846|520037825|FG000|Overall Study|Protocol Violation|1|||
144229829|NCT04031846|520037826|FG001|Overall Study|Protocol Violation|1|||
144229830|NCT04031846|520037825|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
144229831|NCT04031846|520037826|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
144229832|NCT06152224|520039560|FG000|Overall Study|Withdrawal by Subject|1|||
144229833|NCT06152224|520039561|FG001|Overall Study|Withdrawal by Subject|0|||
144229834|NCT06152224|520039560|FG000|Overall Study|Lost to Follow-up|0|||
144229835|NCT06152224|520039561|FG001|Overall Study|Lost to Follow-up|1|||
144229836|NCT06152224|520039560|FG000|Overall Study|On Follow Up|18|||
144229837|NCT06152224|520039561|FG001|Overall Study|On Follow Up|18|||
144229838|NCT01954056|520039563|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
144229839|NCT01954056|520039564|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
144229840|NCT03337113|520039571|FG000|Overall Study|Adverse Event|1|||
144229841|NCT03337113|520039572|FG001|Overall Study|Adverse Event|1|||
144229842|NCT03337113|520039573|FG002|Overall Study|Adverse Event|0|||
144229843|NCT03337113|520039574|FG003|Overall Study|Adverse Event|1|||
144229844|NCT03337113|520039571|FG000|Overall Study|Physician Decision|0|||
144229845|NCT03337113|520039572|FG001|Overall Study|Physician Decision|2|||
144229846|NCT03337113|520039573|FG002|Overall Study|Physician Decision|0|||
144229847|NCT03337113|520039574|FG003|Overall Study|Physician Decision|1|||
144229848|NCT03337113|520039571|FG000|Overall Study|Withdrawal by Subject|0|||
144229849|NCT03337113|520039572|FG001|Overall Study|Withdrawal by Subject|0|||
144229850|NCT03337113|520039573|FG002|Overall Study|Withdrawal by Subject|1|||
144229851|NCT03337113|520039574|FG003|Overall Study|Withdrawal by Subject|0|||
144229852|NCT01081769|520039577|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
144229853|NCT01081769|520039578|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
144229854|NCT01081769|520039577|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
144229855|NCT01081769|520039578|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
144229856|NCT01081769|520039577|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
144229857|NCT01081769|520039578|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
144229858|NCT01081769|520039577|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
144229859|NCT01081769|520039578|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
144229860|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Adverse Event|14|||
144229861|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Adverse Event|11|||
144229862|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Death|1|||
144229863|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Death|1|||
144229864|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
144229865|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
144229866|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
144229867|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
144229868|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Pregnancy|1|||
144229869|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Pregnancy|0|||
144229870|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
144229871|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
144229872|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
144229873|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
144229874|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Other|0|||
144229875|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Other|1|||
144229876|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Ineligibility|3|||
144229877|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Ineligibility|4|||
144229878|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
144229879|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
144229880|NCT01081769|520039577|FG000|CORE Intent-To-Treat|Patient Moved|2|||
144229881|NCT01081769|520039578|FG001|CORE Intent-To-Treat|Patient Moved|2|||
144229882|NCT00105079|520039582|FG000|Overall Study|Adverse Event|5|||
144229883|NCT00105079|520039583|FG001|Overall Study|Adverse Event|12|||
144229884|NCT00105079|520039582|FG000|Overall Study|Death|3|||
144229885|NCT00105079|520039583|FG001|Overall Study|Death|1|||
144229886|NCT00105079|520039582|FG000|Overall Study|Lost to Follow-up|12|||
144229887|NCT00105079|520039583|FG001|Overall Study|Lost to Follow-up|12|||
144229888|NCT00105079|520039582|FG000|Overall Study|Lack of Efficacy|9|||
144229889|NCT00105079|520039583|FG001|Overall Study|Lack of Efficacy|3|||
144229890|NCT00105079|520039582|FG000|Overall Study|Refused treatment|6|||
144229891|NCT00105079|520039583|FG001|Overall Study|Refused treatment|4|||
144229892|NCT00105079|520039582|FG000|Overall Study|Violation of selection criteria at entry|0|||
144229893|NCT00105079|520039583|FG001|Overall Study|Violation of selection criteria at entry|2|||
144229894|NCT00105079|520039582|FG000|Overall Study|Protocol Violation|1|||
144229895|NCT00105079|520039583|FG001|Overall Study|Protocol Violation|0|||
144229896|NCT00105079|520039582|FG000|Overall Study|Other|3|||
144229897|NCT00105079|520039583|FG001|Overall Study|Other|1|||
144229898|NCT01464593|520039586|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
144229899|NCT03777436|520039601|FG000|Placebo-controlled Phase|Adverse Event|8|||
144229900|NCT03777436|520039602|FG001|Placebo-controlled Phase|Adverse Event|10|||
144229901|NCT03777436|520039603|FG002|Placebo-controlled Phase|Adverse Event|0|||
144229902|NCT03777436|520039601|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
144229903|NCT03777436|520039602|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
144229904|NCT03777436|520039603|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
144229905|NCT03777436|520039601|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
144229906|NCT03777436|520039602|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
144229907|NCT03777436|520039603|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
144229908|NCT03777436|520039601|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
144229909|NCT03777436|520039602|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
144229910|NCT03777436|520039603|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
144229911|NCT03777436|520039601|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
144229912|NCT03777436|520039602|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
144229913|NCT03777436|520039603|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
144229914|NCT03777436|520039601|FG000|Placebo-controlled Phase|Physician Decision|0|||
144229915|NCT03777436|520039602|FG001|Placebo-controlled Phase|Physician Decision|1|||
144229916|NCT03777436|520039603|FG002|Placebo-controlled Phase|Physician Decision|0|||
144229917|NCT03777436|520039601|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
144229918|NCT03777436|520039602|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
144229919|NCT03777436|520039603|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
144229920|NCT03777436|520039601|FG000|Apremilast Extension Phase|Adverse Event|0|||
144229921|NCT03777436|520039602|FG001|Apremilast Extension Phase|Adverse Event|0|||
144229922|NCT03777436|520039603|FG002|Apremilast Extension Phase|Adverse Event|6|||
144229923|NCT03777436|520039601|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
144229924|NCT03777436|520039602|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
144229925|NCT03777436|520039603|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
144229926|NCT03777436|520039601|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
144229927|NCT03777436|520039602|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
144229928|NCT03777436|520039603|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
144229929|NCT03777436|520039601|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
144229930|NCT03777436|520039602|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
144229931|NCT03777436|520039603|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
144229932|NCT03777436|520039601|FG000|Apremilast Extension Phase|Miscellaneous|0|||
144229933|NCT03777436|520039602|FG001|Apremilast Extension Phase|Miscellaneous|0|||
144229934|NCT03777436|520039603|FG002|Apremilast Extension Phase|Miscellaneous|1|||
144229935|NCT03363776|520039606|FG000|Overall Study|Progressive disease|2|||
144229936|NCT03363776|520039607|FG001|Overall Study|Progressive disease|3|||
144229937|NCT03363776|520039608|FG002|Overall Study|Progressive disease|1|||
144229938|NCT03363776|520039606|FG000|Overall Study|Study drug toxicity|0|||
144229939|NCT03363776|520039607|FG001|Overall Study|Study drug toxicity|0|||
144229940|NCT03363776|520039608|FG002|Overall Study|Study drug toxicity|1|||
144229941|NCT03363776|520039606|FG000|Overall Study|Death|1|||
144229942|NCT03363776|520039607|FG001|Overall Study|Death|0|||
144229943|NCT03363776|520039608|FG002|Overall Study|Death|0|||
144229944|NCT02527434|520039609|FG000|Overall Study|Lost to Follow-up|2|||
144229945|NCT02527434|520039610|FG001|Overall Study|Lost to Follow-up|2|||
144229946|NCT02527434|520039611|FG002|Overall Study|Lost to Follow-up|0|||
144229947|NCT02527434|520039609|FG000|Overall Study|Death|19|||
144229948|NCT02527434|520039610|FG001|Overall Study|Death|6|||
144229949|NCT02527434|520039611|FG002|Overall Study|Death|17|||
144229950|NCT02527434|520039609|FG000|Overall Study|Withdrawal by Subject|5|||
144229951|NCT02527434|520039610|FG001|Overall Study|Withdrawal by Subject|3|||
144229952|NCT02527434|520039611|FG002|Overall Study|Withdrawal by Subject|3|||
144229953|NCT02527434|520039609|FG000|Overall Study|Reason Not Specified|1|||
144229954|NCT02527434|520039610|FG001|Overall Study|Reason Not Specified|0|||
144229955|NCT02527434|520039611|FG002|Overall Study|Reason Not Specified|0|||
144229956|NCT02527434|520039609|FG000|Overall Study|Site closure|1|||
144229957|NCT02527434|520039610|FG001|Overall Study|Site closure|0|||
144229958|NCT02527434|520039611|FG002|Overall Study|Site closure|0|||
144229959|NCT04178122|520039616|FG000|Overall Study|Withdrawal by Subject|1|||
144229960|NCT04178122|520039617|FG001|Overall Study|Withdrawal by Subject|1|||
144229961|NCT04178122|520039616|FG000|Overall Study|Death|2|||
144229962|NCT04178122|520039617|FG001|Overall Study|Death|0|||
144229963|NCT04178122|520039616|FG000|Overall Study|Did not complete testing|3|||
144229964|NCT04178122|520039617|FG001|Overall Study|Did not complete testing|13|||
144229965|NCT02105987|520039624|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
144229966|NCT02105987|520039625|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
144229967|NCT02105987|520039626|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
144229968|NCT02105987|520039627|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
144229969|NCT02105987|520039628|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
144229970|NCT02105987|520039629|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
144229971|NCT02105987|520039624|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
144229972|NCT02105987|520039625|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
144229973|NCT02105987|520039626|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
144229974|NCT02105987|520039627|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
144229975|NCT02105987|520039628|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
144229976|NCT02105987|520039629|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
144229977|NCT02105987|520039624|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
144229978|NCT02105987|520039625|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
144229979|NCT02105987|520039626|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144229980|NCT02105987|520039627|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144229981|NCT02105987|520039628|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144229982|NCT02105987|520039629|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144229983|NCT02105987|520039624|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
144229984|NCT02105987|520039625|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
144229985|NCT02105987|520039626|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144229986|NCT02105987|520039627|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144229987|NCT02105987|520039628|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144229988|NCT02105987|520039629|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144229989|NCT02105987|520039624|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
144229990|NCT02105987|520039625|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
144229991|NCT02105987|520039626|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
144229992|NCT02105987|520039627|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
144229993|NCT02105987|520039628|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
144229994|NCT02105987|520039629|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
144229995|NCT02105987|520039624|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
144229996|NCT02105987|520039625|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
144229997|NCT02105987|520039626|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
144229998|NCT02105987|520039627|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
144229999|NCT02105987|520039628|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
144230000|NCT02105987|520039629|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
144230001|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
144230002|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
144230003|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
144230004|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
144230005|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
144230006|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
144230007|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
144230008|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
144230009|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
144230010|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
144230011|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
144230012|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
144230013|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144230014|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144230015|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
144230016|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
144230017|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144230018|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
144230019|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144230020|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144230021|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
144230022|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
144230023|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144230024|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
144230025|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
144230026|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
144230027|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
144230028|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
144269443|NCT02662569|520189531|FG000|Overall Study|Withdrawal by Subject|6|||
144269444|NCT02662569|520189532|FG001|Overall Study|Withdrawal by Subject|1|||
144230029|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
144230030|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
144230031|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
144230032|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
144230033|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
144230034|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
144230035|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
144230036|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
144230037|NCT02105987|520039624|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
144230038|NCT02105987|520039625|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
144230039|NCT02105987|520039626|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
144230040|NCT02105987|520039627|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
144230041|NCT02105987|520039628|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
144230042|NCT02105987|520039629|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
144230043|NCT02105987|520039624|FG000|Continuation Phase|Protocol Violation|0|||
144230044|NCT02105987|520039625|FG001|Continuation Phase|Protocol Violation|0|||
144230045|NCT02105987|520039626|FG002|Continuation Phase|Protocol Violation|0|||
144230046|NCT02105987|520039627|FG003|Continuation Phase|Protocol Violation|0|||
144230047|NCT02105987|520039628|FG004|Continuation Phase|Protocol Violation|1|||
144230048|NCT02105987|520039629|FG005|Continuation Phase|Protocol Violation|0|||
144230049|NCT01753570|520039630|FG000|Overall Study|Adverse Event|1|||
144230050|NCT01753570|520039631|FG001|Overall Study|Adverse Event|0|||
144230051|NCT01753570|520039632|FG002|Overall Study|Adverse Event|1|||
144230052|NCT01753570|520039630|FG000|Overall Study|Physician Decision|0|||
144230053|NCT01753570|520039631|FG001|Overall Study|Physician Decision|1|||
144230054|NCT01753570|520039632|FG002|Overall Study|Physician Decision|0|||
144230055|NCT01753570|520039630|FG000|Overall Study|Withdrawal by Subject|1|||
144230056|NCT01753570|520039631|FG001|Overall Study|Withdrawal by Subject|4|||
144230057|NCT01753570|520039632|FG002|Overall Study|Withdrawal by Subject|0|||
144230058|NCT02268916|520039637|FG000|Overall Study|Lost to Follow-up|1|||
144230059|NCT02268916|520039638|FG001|Overall Study|Lost to Follow-up|1|||
144230060|NCT02268916|520039637|FG000|Overall Study|Withdrawal by Subject|6|||
144230061|NCT02268916|520039638|FG001|Overall Study|Withdrawal by Subject|5|||
144230062|NCT02268916|520039637|FG000|Overall Study|Participant did not have diabetes|1|||
144230063|NCT02268916|520039638|FG001|Overall Study|Participant did not have diabetes|0|||
144230064|NCT02268916|520039637|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
144230065|NCT02268916|520039638|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
144230066|NCT03926117|520039648|FG000|Overall Study|Unclassified|1|||
144230067|NCT03926117|520039649|FG001|Overall Study|Unclassified|4|||
144230068|NCT03926117|520039650|FG002|Overall Study|Unclassified|1|||
144230069|NCT03926117|520039651|FG003|Overall Study|Unclassified|4|||
144230070|NCT03926117|520039648|FG000|Overall Study|Withdrawal by Subject|3|||
144230071|NCT03926117|520039649|FG001|Overall Study|Withdrawal by Subject|0|||
144230072|NCT03926117|520039650|FG002|Overall Study|Withdrawal by Subject|1|||
144230073|NCT03926117|520039651|FG003|Overall Study|Withdrawal by Subject|1|||
144230074|NCT03926117|520039648|FG000|Overall Study|Lost to Follow-up|0|||
144230075|NCT03926117|520039649|FG001|Overall Study|Lost to Follow-up|2|||
144230076|NCT03926117|520039650|FG002|Overall Study|Lost to Follow-up|1|||
144230077|NCT03926117|520039651|FG003|Overall Study|Lost to Follow-up|0|||
144230078|NCT03926117|520039648|FG000|Overall Study|Adverse Event|1|||
144230079|NCT03926117|520039649|FG001|Overall Study|Adverse Event|2|||
144230080|NCT03926117|520039650|FG002|Overall Study|Adverse Event|3|||
144230081|NCT03926117|520039651|FG003|Overall Study|Adverse Event|1|||
144230082|NCT03926117|520039648|FG000|Overall Study|Randomized but not treated|1|||
144230083|NCT03926117|520039649|FG001|Overall Study|Randomized but not treated|1|||
144230084|NCT03926117|520039650|FG002|Overall Study|Randomized but not treated|0|||
144230085|NCT03926117|520039651|FG003|Overall Study|Randomized but not treated|1|||
144230086|NCT05107492|520039655|FG000|Overall Study|Lost to Follow-up|1|||
144230087|NCT05107492|520039656|FG001|Overall Study|Lost to Follow-up|0|||
144230088|NCT04873934|520039659|FG000|Overall Study|Adverse Event|0|||
144230089|NCT04873934|520039660|FG001|Overall Study|Adverse Event|1|||
144230090|NCT04873934|520039659|FG000|Overall Study|Death|0|||
144230091|NCT04873934|520039660|FG001|Overall Study|Death|2|||
144230092|NCT04873934|520039659|FG000|Overall Study|Lost to Follow-up|13|||
144230093|NCT04873934|520039660|FG001|Overall Study|Lost to Follow-up|9|||
144230094|NCT04873934|520039659|FG000|Overall Study|Physician Decision|1|||
144230095|NCT04873934|520039660|FG001|Overall Study|Physician Decision|1|||
144230096|NCT04873934|520039659|FG000|Overall Study|Protocol deviation|2|||
144230097|NCT04873934|520039660|FG001|Overall Study|Protocol deviation|1|||
144230098|NCT04873934|520039659|FG000|Overall Study|Subject decision|1|||
144230099|NCT04873934|520039660|FG001|Overall Study|Subject decision|8|||
144230100|NCT04873934|520039659|FG000|Overall Study|Withdrew consent|0|||
144230101|NCT04873934|520039660|FG001|Overall Study|Withdrew consent|4|||
144230102|NCT04873934|520039659|FG000|Overall Study|Missing|1|||
144230103|NCT04873934|520039660|FG001|Overall Study|Missing|0|||
144230104|NCT00708461|520039661|FG000|Overall Study|Lost to Follow-up|18|||
144230105|NCT00708461|520039662|FG001|Overall Study|Lost to Follow-up|11|||
144230106|NCT00708461|520039661|FG000|Overall Study|Withdrawal by Subject|8|||
144230107|NCT00708461|520039662|FG001|Overall Study|Withdrawal by Subject|9|||
144230108|NCT00708461|520039661|FG000|Overall Study|left workforce|115|||
144230109|NCT00708461|520039662|FG001|Overall Study|left workforce|180|||
144230110|NCT02907177|520039666|FG000|Overall Study|Death|0|||
144230111|NCT02907177|520039667|FG001|Overall Study|Death|1|||
144230112|NCT02907177|520039666|FG000|Overall Study|Physician Decision|3|||
144230113|NCT02907177|520039667|FG001|Overall Study|Physician Decision|3|||
144230114|NCT02907177|520039666|FG000|Overall Study|Withdrawal by Subject|15|||
144230115|NCT02907177|520039667|FG001|Overall Study|Withdrawal by Subject|7|||
144230116|NCT02907177|520039666|FG000|Overall Study|Sponsor's Decision|50|||
144230117|NCT02907177|520039667|FG001|Overall Study|Sponsor's Decision|57|||
144230118|NCT02670525|520039668|FG000|Overall Study|Death|94|||
144230119|NCT02670525|520039669|FG001|Overall Study|Death|14|||
144230120|NCT02670525|520039668|FG000|Overall Study|Lost to Follow-up|4|||
144230121|NCT02670525|520039669|FG001|Overall Study|Lost to Follow-up|1|||
144230122|NCT02670525|520039668|FG000|Overall Study|Subject withdrew consent|1|||
144230123|NCT02670525|520039669|FG001|Overall Study|Subject withdrew consent|0|||
144230124|NCT02670525|520039668|FG000|Overall Study|Unknown, data entry delayed|123|||
144230125|NCT02670525|520039669|FG001|Overall Study|Unknown, data entry delayed|78|||
144230126|NCT01796392|520039670|FG000|Overall Study|Withdrawal by Subject|2|||
144230127|NCT01796392|520039671|FG001|Overall Study|Withdrawal by Subject|0|||
144230128|NCT01796392|520039670|FG000|Overall Study|Death|5|||
144230129|NCT01796392|520039671|FG001|Overall Study|Death|1|||
144230130|NCT01796392|520039670|FG000|Overall Study|Excluded for medical reasons|1|||
144230131|NCT01796392|520039671|FG001|Overall Study|Excluded for medical reasons|2|||
144230132|NCT01796392|520039670|FG000|Overall Study|Lost to Follow-up|1|||
144230133|NCT01796392|520039671|FG001|Overall Study|Lost to Follow-up|0|||
144230134|NCT02505217|520039672|FG000|Overall Study|Withdrawal by Subject|1|||
144230135|NCT02505217|520039673|FG001|Overall Study|Withdrawal by Subject|2|||
144230136|NCT04639219|520039674|FG000|Overall Study|Withdrawal by Subject|8|||
144230137|NCT04639219|520039674|FG000|Overall Study|Lost to Follow-up|6|||
144230138|NCT04639219|520039674|FG000|Overall Study|Death|55|||
144230139|NCT04681066|520039675|FG000|Overall Study|Lost to Follow-up|3|||
144230140|NCT04681066|520039676|FG001|Overall Study|Lost to Follow-up|1|||
144230141|NCT04681066|520039677|FG002|Overall Study|Lost to Follow-up|2|||
144230142|NCT04681066|520039678|FG003|Overall Study|Lost to Follow-up|1|||
144230143|NCT04681066|520039675|FG000|Overall Study|Withdrawal by Subject|2|||
144230144|NCT04681066|520039676|FG001|Overall Study|Withdrawal by Subject|1|||
144230145|NCT04681066|520039677|FG002|Overall Study|Withdrawal by Subject|0|||
144230146|NCT04681066|520039678|FG003|Overall Study|Withdrawal by Subject|3|||
144230147|NCT04681066|520039675|FG000|Overall Study|Death|0|||
144230148|NCT04681066|520039676|FG001|Overall Study|Death|1|||
144230149|NCT04681066|520039677|FG002|Overall Study|Death|0|||
144230150|NCT04681066|520039678|FG003|Overall Study|Death|0|||
144230151|NCT00564850|520039686|FG000|Overall Study|Protocol Violation|2|||
144230152|NCT01207687|520039687|FG000|Overall Study|Adverse Event|1|||
144230153|NCT01207687|520039687|FG000|Overall Study|Withdrawal by Subject|1|||
144230154|NCT06868654|520039690|FG000|Overall Study|Death|4|||
144230155|NCT06868654|520039691|FG001|Overall Study|Death|14|||
144230156|NCT06868654|520039690|FG000|Overall Study|Lost to Follow-up|0|||
144230157|NCT06868654|520039691|FG001|Overall Study|Lost to Follow-up|1|||
144230158|NCT06868654|520039690|FG000|Overall Study|Withdrawal by Subject|5|||
144230159|NCT06868654|520039691|FG001|Overall Study|Withdrawal by Subject|3|||
144230160|NCT06868654|520039690|FG000|Overall Study|Physician Decision|0|||
144230161|NCT06868654|520039691|FG001|Overall Study|Physician Decision|1|||
144230162|NCT06868654|520039690|FG000|Overall Study|Ongoing|23|||
144230163|NCT06868654|520039691|FG001|Overall Study|Ongoing|21|||
144230164|NCT02134015|520039694|FG000|Overall Study|Protocol Violation|0|||
144230165|NCT02134015|520039695|FG001|Overall Study|Protocol Violation|1|||
144230166|NCT02134015|520039694|FG000|Overall Study|Death|2|||
144230167|NCT02134015|520039695|FG001|Overall Study|Death|1|||
144230168|NCT02134015|520039694|FG000|Overall Study|Reason not provided|1|||
144230169|NCT02134015|520039695|FG001|Overall Study|Reason not provided|2|||
144230170|NCT02134015|520039694|FG000|Overall Study|Clinical progression|14|||
144230171|NCT02134015|520039695|FG001|Overall Study|Clinical progression|7|||
144230172|NCT02134015|520039694|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
144269445|NCT02662569|520189533|FG002|Overall Study|Withdrawal by Subject|6|||
144269446|NCT02662569|520189534|FG003|Overall Study|Withdrawal by Subject|4|||
144230173|NCT02134015|520039695|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
144230174|NCT02134015|520039694|FG000|Overall Study|Study terminated by sponsor|2|||
144230175|NCT02134015|520039695|FG001|Overall Study|Study terminated by sponsor|3|||
144230176|NCT02134015|520039694|FG000|Overall Study|Adverse Event|9|||
144230177|NCT02134015|520039695|FG001|Overall Study|Adverse Event|10|||
144230178|NCT02134015|520039694|FG000|Overall Study|Withdrawal by Subject|3|||
144230179|NCT02134015|520039695|FG001|Overall Study|Withdrawal by Subject|7|||
144230180|NCT03867201|520039696|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
144230181|NCT03867201|520039697|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
144230182|NCT03867201|520039696|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
144269447|NCT02662569|520189531|FG000|Overall Study|Lost to Follow-up|1|||
144230183|NCT03867201|520039697|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
144230184|NCT03867201|520039696|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
144230185|NCT03867201|520039697|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
144230186|NCT03867201|520039696|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
144230187|NCT03867201|520039697|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
144230188|NCT03867201|520039696|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
144230189|NCT03867201|520039697|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
144230190|NCT03867201|520039696|FG000|Open-Label Period From Week 12|Adverse Event|5|||
144230191|NCT03867201|520039697|FG001|Open-Label Period From Week 12|Adverse Event|11|||
144230192|NCT03867201|520039696|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
144230193|NCT03867201|520039697|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
144230194|NCT03867201|520039696|FG000|Open-Label Period From Week 12|Physician Decision|6|||
144230195|NCT03867201|520039697|FG001|Open-Label Period From Week 12|Physician Decision|3|||
144230196|NCT03867201|520039696|FG000|Open-Label Period From Week 12|Pregnancy|2|||
144230197|NCT03867201|520039697|FG001|Open-Label Period From Week 12|Pregnancy|2|||
144230198|NCT03867201|520039696|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
144230199|NCT03867201|520039697|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
144230200|NCT03867201|520039696|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
144230201|NCT03867201|520039697|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
144230202|NCT03867201|520039696|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
144230203|NCT03867201|520039697|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
144230204|NCT03867201|520039696|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
144230205|NCT03867201|520039697|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
144230206|NCT05763875|520039698|FG000|Overall Study|Subject decision|5|||
144230207|NCT05763875|520039699|FG001|Overall Study|Subject decision|2|||
144230208|NCT05763875|520039700|FG002|Overall Study|Subject decision|1|||
144230209|NCT05763875|520039698|FG000|Overall Study|Lost to Follow-up|4|||
144230210|NCT05763875|520039699|FG001|Overall Study|Lost to Follow-up|1|||
144230211|NCT05763875|520039700|FG002|Overall Study|Lost to Follow-up|2|||
144230212|NCT05763875|520039698|FG000|Overall Study|Adverse Event|1|||
144230213|NCT05763875|520039699|FG001|Overall Study|Adverse Event|0|||
144230214|NCT05763875|520039700|FG002|Overall Study|Adverse Event|0|||
144230215|NCT01777282|520039701|FG000|Overall Study|Persistent Hyperglycemia|0|||
144230216|NCT01777282|520039702|FG001|Overall Study|Persistent Hyperglycemia|0|||
144230217|NCT01777282|520039703|FG002|Overall Study|Persistent Hyperglycemia|1|||
144230218|NCT01777282|520039704|FG003|Overall Study|Persistent Hyperglycemia|0|||
144230219|NCT01777282|520039705|FG004|Overall Study|Persistent Hyperglycemia|0|||
144230220|NCT01777282|520039701|FG000|Overall Study|New Antidiabetic Medication|0|||
144230221|NCT01777282|520039702|FG001|Overall Study|New Antidiabetic Medication|0|||
144230222|NCT01777282|520039703|FG002|Overall Study|New Antidiabetic Medication|1|||
144230223|NCT01777282|520039704|FG003|Overall Study|New Antidiabetic Medication|0|||
144230224|NCT01777282|520039705|FG004|Overall Study|New Antidiabetic Medication|0|||
144230225|NCT01777282|520039701|FG000|Overall Study|Adverse Event|4|||
144230226|NCT01777282|520039702|FG001|Overall Study|Adverse Event|4|||
144230227|NCT01777282|520039703|FG002|Overall Study|Adverse Event|2|||
144230228|NCT01777282|520039704|FG003|Overall Study|Adverse Event|1|||
144230229|NCT01777282|520039705|FG004|Overall Study|Adverse Event|3|||
144230230|NCT01777282|520039701|FG000|Overall Study|Withdrawal by Subject|4|||
144230231|NCT01777282|520039702|FG001|Overall Study|Withdrawal by Subject|0|||
144230232|NCT01777282|520039703|FG002|Overall Study|Withdrawal by Subject|0|||
144230233|NCT01777282|520039704|FG003|Overall Study|Withdrawal by Subject|1|||
144230234|NCT01777282|520039705|FG004|Overall Study|Withdrawal by Subject|2|||
144230235|NCT01777282|520039701|FG000|Overall Study|Protocol Violation|2|||
144230236|NCT01777282|520039702|FG001|Overall Study|Protocol Violation|0|||
144230237|NCT01777282|520039703|FG002|Overall Study|Protocol Violation|1|||
144230238|NCT01777282|520039704|FG003|Overall Study|Protocol Violation|0|||
144230239|NCT01777282|520039705|FG004|Overall Study|Protocol Violation|2|||
144230240|NCT01777282|520039701|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
144230241|NCT01777282|520039702|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
144230242|NCT01777282|520039703|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
144230243|NCT01777282|520039704|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
144230244|NCT01777282|520039705|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
144230245|NCT04015518|520039706|FG000|Overall Study|Adverse Event|6|||
144230246|NCT04015518|520039707|FG001|Overall Study|Adverse Event|1|||
144230247|NCT04015518|520039708|FG002|Overall Study|Adverse Event|1|||
144230248|NCT04015518|520039709|FG003|Overall Study|Adverse Event|3|||
144230249|NCT04015518|520039710|FG004|Overall Study|Adverse Event|3|||
144230250|NCT04015518|520039706|FG000|Overall Study|Lack of Efficacy|1|||
144230251|NCT04015518|520039707|FG001|Overall Study|Lack of Efficacy|0|||
144230252|NCT04015518|520039708|FG002|Overall Study|Lack of Efficacy|1|||
144230253|NCT04015518|520039709|FG003|Overall Study|Lack of Efficacy|0|||
144230254|NCT04015518|520039710|FG004|Overall Study|Lack of Efficacy|4|||
144230255|NCT04015518|520039706|FG000|Overall Study|Lost to Follow-up|0|||
144230256|NCT04015518|520039707|FG001|Overall Study|Lost to Follow-up|0|||
144230257|NCT04015518|520039708|FG002|Overall Study|Lost to Follow-up|0|||
144230258|NCT04015518|520039709|FG003|Overall Study|Lost to Follow-up|0|||
144230259|NCT04015518|520039710|FG004|Overall Study|Lost to Follow-up|1|||
144230260|NCT04015518|520039706|FG000|Overall Study|Withdrawal by Subject|0|||
144230261|NCT04015518|520039707|FG001|Overall Study|Withdrawal by Subject|1|||
144230262|NCT04015518|520039708|FG002|Overall Study|Withdrawal by Subject|0|||
144230263|NCT04015518|520039709|FG003|Overall Study|Withdrawal by Subject|1|||
144230264|NCT04015518|520039710|FG004|Overall Study|Withdrawal by Subject|1|||
144230265|NCT04015518|520039706|FG000|Overall Study|Patient did not come for consecutive visits|0|||
144230266|NCT04015518|520039707|FG001|Overall Study|Patient did not come for consecutive visits|1|||
144230267|NCT04015518|520039708|FG002|Overall Study|Patient did not come for consecutive visits|0|||
144230268|NCT04015518|520039709|FG003|Overall Study|Patient did not come for consecutive visits|0|||
144230269|NCT04015518|520039710|FG004|Overall Study|Patient did not come for consecutive visits|0|||
144230270|NCT04015518|520039706|FG000|Overall Study|not willing to travel due to Covid-19|0|||
144230271|NCT04015518|520039707|FG001|Overall Study|not willing to travel due to Covid-19|0|||
144230272|NCT04015518|520039708|FG002|Overall Study|not willing to travel due to Covid-19|1|||
144230273|NCT04015518|520039709|FG003|Overall Study|not willing to travel due to Covid-19|0|||
144230274|NCT04015518|520039710|FG004|Overall Study|not willing to travel due to Covid-19|0|||
144230275|NCT04015518|520039706|FG000|Overall Study|Patient wants to discontinue treatment|0|||
144230276|NCT04015518|520039707|FG001|Overall Study|Patient wants to discontinue treatment|0|||
144230277|NCT04015518|520039708|FG002|Overall Study|Patient wants to discontinue treatment|0|||
144230278|NCT04015518|520039709|FG003|Overall Study|Patient wants to discontinue treatment|1|||
144230279|NCT04015518|520039710|FG004|Overall Study|Patient wants to discontinue treatment|0|||
144230280|NCT04015518|520039706|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
144230281|NCT04015518|520039707|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
144230282|NCT04015518|520039708|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
144230283|NCT04015518|520039709|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
144230284|NCT04015518|520039710|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
144230285|NCT04015518|520039706|FG000|Overall Study|Pregnancy|0|||
144230286|NCT04015518|520039707|FG001|Overall Study|Pregnancy|0|||
144230287|NCT04015518|520039708|FG002|Overall Study|Pregnancy|0|||
144230288|NCT04015518|520039709|FG003|Overall Study|Pregnancy|0|||
144230289|NCT04015518|520039710|FG004|Overall Study|Pregnancy|1|||
144230290|NCT04015518|520039706|FG000|Overall Study|Personal reasons|1|||
144230291|NCT04015518|520039707|FG001|Overall Study|Personal reasons|0|||
144230292|NCT04015518|520039708|FG002|Overall Study|Personal reasons|0|||
144230293|NCT04015518|520039709|FG003|Overall Study|Personal reasons|0|||
144230294|NCT04015518|520039710|FG004|Overall Study|Personal reasons|1|||
144230295|NCT04015518|520039706|FG000|Overall Study|Withdrew consent|1|||
144230296|NCT04015518|520039707|FG001|Overall Study|Withdrew consent|0|||
144230297|NCT04015518|520039708|FG002|Overall Study|Withdrew consent|0|||
144230298|NCT04015518|520039709|FG003|Overall Study|Withdrew consent|0|||
144230299|NCT04015518|520039710|FG004|Overall Study|Withdrew consent|0|||
144230300|NCT04015518|520039706|FG000|Overall Study|Prostate carcinoma|1|||
144230301|NCT04015518|520039707|FG001|Overall Study|Prostate carcinoma|0|||
144230302|NCT04015518|520039708|FG002|Overall Study|Prostate carcinoma|0|||
144230303|NCT04015518|520039709|FG003|Overall Study|Prostate carcinoma|0|||
144230304|NCT04015518|520039710|FG004|Overall Study|Prostate carcinoma|0|||
144230305|NCT04015518|520039706|FG000|Overall Study|Could not keep appointments due to work|1|||
144230306|NCT04015518|520039707|FG001|Overall Study|Could not keep appointments due to work|0|||
144230307|NCT04015518|520039708|FG002|Overall Study|Could not keep appointments due to work|0|||
144230308|NCT04015518|520039709|FG003|Overall Study|Could not keep appointments due to work|0|||
144230309|NCT04015518|520039710|FG004|Overall Study|Could not keep appointments due to work|0|||
144269448|NCT02662569|520189532|FG001|Overall Study|Lost to Follow-up|0|||
144230310|NCT00433511|520041214|FG000|Step 1|Adverse Event|50|||
144230311|NCT00433511|520041215|FG001|Step 1|Adverse Event|157|||
144230312|NCT00433511|520041216|FG002|Step 1|Adverse Event|153|||
144230313|NCT00433511|520041214|FG000|Step 1|Withdrawal by Subject|45|||
144230314|NCT00433511|520041215|FG001|Step 1|Withdrawal by Subject|143|||
144230315|NCT00433511|520041216|FG002|Step 1|Withdrawal by Subject|154|||
144230316|NCT00433511|520041214|FG000|Step 1|Death|3|||
144230317|NCT00433511|520041215|FG001|Step 1|Death|1|||
144230318|NCT00433511|520041216|FG002|Step 1|Death|1|||
144230319|NCT00433511|520041214|FG000|Step 1|Physician Decision|1|||
144230320|NCT00433511|520041215|FG001|Step 1|Physician Decision|4|||
144230321|NCT00433511|520041216|FG002|Step 1|Physician Decision|3|||
144230322|NCT00433511|520041214|FG000|Step 1|Never started protocol therapy|28|||
144230323|NCT00433511|520041215|FG001|Step 1|Never started protocol therapy|64|||
144230324|NCT00433511|520041216|FG002|Step 1|Never started protocol therapy|66|||
144230325|NCT00433511|520041214|FG000|Step 1|Alternative therapy|2|||
144230326|NCT00433511|520041215|FG001|Step 1|Alternative therapy|1|||
144230327|NCT00433511|520041216|FG002|Step 1|Alternative therapy|3|||
144230328|NCT00433511|520041214|FG000|Step 1|Disease progression, relapse|5|||
144230329|NCT00433511|520041215|FG001|Step 1|Disease progression, relapse|3|||
144230330|NCT00433511|520041216|FG002|Step 1|Disease progression, relapse|3|||
144230331|NCT00433511|520041214|FG000|Step 1|Other complicating disease|2|||
144230332|NCT00433511|520041215|FG001|Step 1|Other complicating disease|6|||
144230333|NCT00433511|520041216|FG002|Step 1|Other complicating disease|3|||
144230334|NCT00433511|520041214|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
144230335|NCT00433511|520041215|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
144230336|NCT00433511|520041216|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
144230337|NCT00433511|520041214|FG000|Step 1|Suspected recurrence|0|||
144230338|NCT00433511|520041215|FG001|Step 1|Suspected recurrence|1|||
144230339|NCT00433511|520041216|FG002|Step 1|Suspected recurrence|0|||
144230340|NCT00433511|520041214|FG000|Step 1|Insurance/drug distribution issues|0|||
144230341|NCT00433511|520041215|FG001|Step 1|Insurance/drug distribution issues|1|||
144230342|NCT00433511|520041216|FG002|Step 1|Insurance/drug distribution issues|2|||
144230343|NCT00433511|520041214|FG000|Step 1|Patient moved|0|||
144230344|NCT00433511|520041215|FG001|Step 1|Patient moved|0|||
144230345|NCT00433511|520041216|FG002|Step 1|Patient moved|1|||
144230346|NCT00433511|520041214|FG000|Step 2 (Arm D)|Adverse Event|0|||
144230347|NCT00433511|520041215|FG001|Step 2 (Arm D)|Adverse Event|0|||
144230348|NCT00433511|520041216|FG002|Step 2 (Arm D)|Adverse Event|135|||
144230349|NCT00433511|520041214|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
144230350|NCT00433511|520041215|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
144230351|NCT00433511|520041216|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
144230352|NCT00433511|520041214|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
144230353|NCT00433511|520041215|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
144230354|NCT00433511|520041216|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
144230355|NCT00433511|520041214|FG000|Step 2 (Arm D)|Physician Decision|0|||
144230356|NCT00433511|520041215|FG001|Step 2 (Arm D)|Physician Decision|0|||
144230357|NCT00433511|520041216|FG002|Step 2 (Arm D)|Physician Decision|9|||
144230358|NCT00433511|520041214|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
144230359|NCT00433511|520041215|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
144230360|NCT00433511|520041216|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
144230361|NCT00433511|520041214|FG000|Step 2 (Arm D)|Other complicating disease|0|||
144230362|NCT00433511|520041215|FG001|Step 2 (Arm D)|Other complicating disease|0|||
144230363|NCT00433511|520041216|FG002|Step 2 (Arm D)|Other complicating disease|3|||
144230364|NCT00433511|520041214|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
144230365|NCT00433511|520041215|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
144230366|NCT00433511|520041216|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
144230367|NCT00433511|520041214|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
144230368|NCT00433511|520041215|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
144230369|NCT00433511|520041216|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
144230370|NCT00433511|520041214|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
144230371|NCT00433511|520041215|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
144230372|NCT00433511|520041216|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
144230373|NCT00433511|520041214|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
144230374|NCT00433511|520041215|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
144230375|NCT00433511|520041216|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
144230376|NCT02640950|520041219|FG000|Overall Study|Adverse Event|1|||
144230377|NCT02640950|520041219|FG000|Overall Study|Withdrawal by Subject|1|||
144230378|NCT04545489|520041220|FG000|Overall Study|Withdrawal by Subject|12|||
144230379|NCT04545489|520041221|FG001|Overall Study|Withdrawal by Subject|4|||
144230380|NCT04545489|520041220|FG000|Overall Study|Lost to Follow-up|17|||
144230381|NCT04545489|520041221|FG001|Overall Study|Lost to Follow-up|18|||
144230382|NCT04545489|520041220|FG000|Overall Study|12month BP not collected|4|||
144230383|NCT04545489|520041221|FG001|Overall Study|12month BP not collected|4|||
144230384|NCT00652626|520041222|FG000|Initial Treatment Phase|Adverse Event|0|||
144230385|NCT00652626|520041223|FG001|Initial Treatment Phase|Adverse Event|0|||
144230386|NCT00652626|520041224|FG002|Initial Treatment Phase|Adverse Event|0|||
144230387|NCT00652626|520041225|FG003|Initial Treatment Phase|Adverse Event|0|||
144230388|NCT00652626|520041226|FG004|Initial Treatment Phase|Adverse Event|1|||
144230389|NCT00652626|520041227|FG005|Initial Treatment Phase|Adverse Event|0|||
144230390|NCT00652626|520041228|FG006|Initial Treatment Phase|Adverse Event|0|||
144230391|NCT00652626|520041222|FG000|Initial Treatment Phase|Protocol Violation|0|||
144230392|NCT00652626|520041223|FG001|Initial Treatment Phase|Protocol Violation|0|||
144230393|NCT00652626|520041224|FG002|Initial Treatment Phase|Protocol Violation|0|||
144230394|NCT00652626|520041225|FG003|Initial Treatment Phase|Protocol Violation|1|||
144230395|NCT00652626|520041226|FG004|Initial Treatment Phase|Protocol Violation|0|||
144230396|NCT00652626|520041227|FG005|Initial Treatment Phase|Protocol Violation|0|||
144230397|NCT00652626|520041228|FG006|Initial Treatment Phase|Protocol Violation|0|||
144230398|NCT00652626|520041222|FG000|Initial Treatment Phase|Physician Decision|0|||
144230399|NCT00652626|520041223|FG001|Initial Treatment Phase|Physician Decision|0|||
144230400|NCT00652626|520041224|FG002|Initial Treatment Phase|Physician Decision|0|||
144230401|NCT00652626|520041225|FG003|Initial Treatment Phase|Physician Decision|0|||
144230402|NCT00652626|520041226|FG004|Initial Treatment Phase|Physician Decision|1|||
144230403|NCT00652626|520041227|FG005|Initial Treatment Phase|Physician Decision|0|||
144230404|NCT00652626|520041228|FG006|Initial Treatment Phase|Physician Decision|0|||
144230405|NCT00652626|520041222|FG000|Initial Treatment Phase|Sponsor Request|0|||
144230406|NCT00652626|520041223|FG001|Initial Treatment Phase|Sponsor Request|0|||
144230407|NCT00652626|520041224|FG002|Initial Treatment Phase|Sponsor Request|1|||
144230408|NCT00652626|520041225|FG003|Initial Treatment Phase|Sponsor Request|0|||
144230409|NCT00652626|520041226|FG004|Initial Treatment Phase|Sponsor Request|0|||
144230410|NCT00652626|520041227|FG005|Initial Treatment Phase|Sponsor Request|0|||
144230411|NCT00652626|520041228|FG006|Initial Treatment Phase|Sponsor Request|0|||
144230412|NCT00652626|520041222|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
144230413|NCT00652626|520041223|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
144230414|NCT00652626|520041224|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
144230415|NCT00652626|520041225|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
144230416|NCT00652626|520041226|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
144230417|NCT00652626|520041227|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
144230418|NCT00652626|520041228|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
144230419|NCT00652626|520041222|FG000|Extension Phase|Withdrawal by Subject|0|||
144230420|NCT00652626|520041223|FG001|Extension Phase|Withdrawal by Subject|0|||
144230421|NCT00652626|520041224|FG002|Extension Phase|Withdrawal by Subject|0|||
144230422|NCT00652626|520041225|FG003|Extension Phase|Withdrawal by Subject|0|||
144230423|NCT00652626|520041226|FG004|Extension Phase|Withdrawal by Subject|0|||
144230424|NCT00652626|520041227|FG005|Extension Phase|Withdrawal by Subject|2|||
144230425|NCT00652626|520041228|FG006|Extension Phase|Withdrawal by Subject|0|||
144230426|NCT00652626|520041222|FG000|Extension Phase|Adverse Event|0|||
144230427|NCT00652626|520041223|FG001|Extension Phase|Adverse Event|0|||
144230428|NCT00652626|520041224|FG002|Extension Phase|Adverse Event|0|||
144230429|NCT00652626|520041225|FG003|Extension Phase|Adverse Event|0|||
144230430|NCT00652626|520041226|FG004|Extension Phase|Adverse Event|0|||
144230431|NCT00652626|520041227|FG005|Extension Phase|Adverse Event|2|||
144230432|NCT00652626|520041228|FG006|Extension Phase|Adverse Event|1|||
144230433|NCT00652626|520041222|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
144230434|NCT00652626|520041223|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
144230435|NCT00652626|520041224|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
144230436|NCT00652626|520041225|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
144230437|NCT00652626|520041226|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
144230438|NCT00652626|520041227|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
144230439|NCT00652626|520041228|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
144230440|NCT00652626|520041222|FG000|Extension Phase|Physician Decision|0|||
144230441|NCT00652626|520041223|FG001|Extension Phase|Physician Decision|0|||
144230442|NCT00652626|520041224|FG002|Extension Phase|Physician Decision|0|||
144230443|NCT00652626|520041225|FG003|Extension Phase|Physician Decision|0|||
144230444|NCT00652626|520041226|FG004|Extension Phase|Physician Decision|0|||
144230445|NCT00652626|520041227|FG005|Extension Phase|Physician Decision|1|||
144230446|NCT00652626|520041228|FG006|Extension Phase|Physician Decision|1|||
144230447|NCT00652626|520041222|FG000|Extension Phase|Death|0|||
144230448|NCT00652626|520041223|FG001|Extension Phase|Death|0|||
144230449|NCT00652626|520041224|FG002|Extension Phase|Death|0|||
144230450|NCT00652626|520041225|FG003|Extension Phase|Death|0|||
144230451|NCT00652626|520041226|FG004|Extension Phase|Death|0|||
144230452|NCT00652626|520041227|FG005|Extension Phase|Death|1|||
144230453|NCT00652626|520041228|FG006|Extension Phase|Death|1|||
144230454|NCT01623310|520041231|FG000|Overall Study|Adverse Event|21|||
144230455|NCT01623310|520041231|FG000|Overall Study|Lost to Follow-up|18|||
144230456|NCT01623310|520041231|FG000|Overall Study|Lack of Efficacy|6|||
144269449|NCT02662569|520189533|FG002|Overall Study|Lost to Follow-up|0|||
144269450|NCT02662569|520189534|FG003|Overall Study|Lost to Follow-up|0|||
144230457|NCT01623310|520041231|FG000|Overall Study|Protocol Violation|6|||
144230458|NCT01623310|520041231|FG000|Overall Study|Withdrawal by Subject|25|||
144269451|NCT02785939|520189545|FG000|Overall Study|Progression|25|||
144269452|NCT02785939|520189546|FG001|Overall Study|Progression|8|||
144230459|NCT01623310|520041231|FG000|Overall Study|Became potentially child-bearing|1|||
144230460|NCT01623310|520041231|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
144230461|NCT01623310|520041231|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
144230462|NCT00566020|520041232|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
144230463|NCT00566020|520041233|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
144230464|NCT00566020|520041232|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
144230465|NCT00566020|520041233|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
144269453|NCT02785939|520189545|FG000|Overall Study|Adverse Event|3|||
144230466|NCT00566020|520041232|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
144230467|NCT00566020|520041233|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
144230468|NCT00566020|520041232|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
144230469|NCT00566020|520041233|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
144230470|NCT00566020|520041232|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
144230471|NCT00566020|520041233|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
144230472|NCT00566020|520041232|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
144230473|NCT00566020|520041233|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
144230474|NCT02582242|520041234|FG000|Overall Study|Adverse Event|4|||
144230475|NCT02582242|520041235|FG001|Overall Study|Adverse Event|3|||
144230476|NCT02582242|520041234|FG000|Overall Study|Protocol Violation|3|||
144230477|NCT02582242|520041235|FG001|Overall Study|Protocol Violation|1|||
144230478|NCT02582242|520041234|FG000|Overall Study|Lost to Follow-up|0|||
144230479|NCT02582242|520041235|FG001|Overall Study|Lost to Follow-up|1|||
144230480|NCT02582242|520041234|FG000|Overall Study|Withdrawal by Subject|11|||
144230481|NCT02582242|520041235|FG001|Overall Study|Withdrawal by Subject|11|||
144230482|NCT02582242|520041234|FG000|Overall Study|Unclassified|2|||
144230483|NCT02582242|520041235|FG001|Overall Study|Unclassified|1|||
144230484|NCT02058537|520041236|FG000|Overall Study|Withdrawal by Subject|1|||
144230485|NCT00300885|520041237|FG000|Treatment|Adverse Event|134|||
144230486|NCT00300885|520041238|FG001|Treatment|Adverse Event|82|||
144230487|NCT00300885|520041237|FG000|Treatment|Death|20|||
144230488|NCT00300885|520041238|FG001|Treatment|Death|7|||
144230489|NCT00300885|520041237|FG000|Treatment|Lack of Efficacy|1|||
144230490|NCT00300885|520041238|FG001|Treatment|Lack of Efficacy|1|||
144230491|NCT00300885|520041237|FG000|Treatment|Lost to Follow-up|3|||
144230492|NCT00300885|520041238|FG001|Treatment|Lost to Follow-up|2|||
144230493|NCT00300885|520041237|FG000|Treatment|Physician Decision|4|||
144230494|NCT00300885|520041238|FG001|Treatment|Physician Decision|5|||
144230495|NCT00300885|520041237|FG000|Treatment|Protocol Violation|11|||
144230496|NCT00300885|520041238|FG001|Treatment|Protocol Violation|11|||
144230497|NCT00300885|520041237|FG000|Treatment|Withdrawal by Subject|26|||
144230498|NCT00300885|520041238|FG001|Treatment|Withdrawal by Subject|23|||
144230499|NCT00300885|520041237|FG000|Treatment|Disease progression|171|||
144230500|NCT00300885|520041238|FG001|Treatment|Disease progression|238|||
144230501|NCT00300885|520041237|FG000|Treatment|Random code broken (subject died)|0|||
144230502|NCT00300885|520041238|FG001|Treatment|Random code broken (subject died)|1|||
144230503|NCT00300885|520041237|FG000|Treatment|Non-compliant with study medication|3|||
144230504|NCT00300885|520041238|FG001|Treatment|Non-compliant with study medication|4|||
144230505|NCT00300885|520041237|FG000|Follow-up|Death|141|||
144230506|NCT00300885|520041238|FG001|Follow-up|Death|163|||
144230507|NCT00300885|520041237|FG000|Follow-up|Lost to Follow-up|11|||
144230508|NCT00300885|520041238|FG001|Follow-up|Lost to Follow-up|7|||
144230509|NCT00300885|520041237|FG000|Follow-up|Withdrawal by Subject|26|||
144230510|NCT00300885|520041238|FG001|Follow-up|Withdrawal by Subject|25|||
144230511|NCT00459290|520041239|FG000|Overall Study|Adverse Event|3|||
144230512|NCT00459290|520041239|FG000|Overall Study|Ineligible|2|||
144230513|NCT02476578|520041246|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
144230514|NCT02476578|520041247|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
144230515|NCT02476578|520041246|FG000|Overall Study|Lost to Follow-up|6|||
144230516|NCT02476578|520041247|FG001|Overall Study|Lost to Follow-up|13|||
144230517|NCT01964222|520041248|FG000|Overall Study|Lost to Follow-up|7|||
144230518|NCT01964222|520041249|FG001|Overall Study|Lost to Follow-up|5|||
144230519|NCT01964222|520041248|FG000|Overall Study|Withdrawal by Subject|6|||
144230520|NCT01964222|520041249|FG001|Overall Study|Withdrawal by Subject|6|||
144230521|NCT01964222|520041248|FG000|Overall Study|Screening Failure|2|||
144230522|NCT01964222|520041249|FG001|Overall Study|Screening Failure|0|||
144230523|NCT00026494|520041256|FG000|Overall Study|Withdrawal by Subject|1|||
144230524|NCT00026494|520041257|FG001|Overall Study|Withdrawal by Subject|0|||
144230525|NCT00026494|520041258|FG002|Overall Study|Withdrawal by Subject|1|||
144230526|NCT00026494|520041259|FG003|Overall Study|Withdrawal by Subject|0|||
144230527|NCT00026494|520041256|FG000|Overall Study|Patient non-compliance|1|||
144230528|NCT00026494|520041257|FG001|Overall Study|Patient non-compliance|0|||
144230529|NCT00026494|520041258|FG002|Overall Study|Patient non-compliance|0|||
144230530|NCT00026494|520041259|FG003|Overall Study|Patient non-compliance|0|||
144230531|NCT00026494|520041256|FG000|Overall Study|Patient not treated|0|||
144230532|NCT00026494|520041257|FG001|Overall Study|Patient not treated|0|||
144230533|NCT00026494|520041258|FG002|Overall Study|Patient not treated|2|||
144230534|NCT00026494|520041259|FG003|Overall Study|Patient not treated|0|||
144230535|NCT00026494|520041256|FG000|Overall Study|Clinical progression|0|||
144230536|NCT00026494|520041257|FG001|Overall Study|Clinical progression|0|||
144230537|NCT00026494|520041258|FG002|Overall Study|Clinical progression|3|||
144230538|NCT00026494|520041259|FG003|Overall Study|Clinical progression|0|||
144230539|NCT01455597|520041260|FG000|Overall Study|Adverse Event|7|||
144269454|NCT02785939|520189546|FG001|Overall Study|Adverse Event|1|||
144269455|NCT02785939|520189545|FG000|Overall Study|Death|1|||
144269456|NCT02785939|520189546|FG001|Overall Study|Death|0|||
144269457|NCT02785939|520189545|FG000|Overall Study|Refusal|1|||
144269458|NCT02785939|520189546|FG001|Overall Study|Refusal|0|||
144269459|NCT02785939|520189545|FG000|Overall Study|Deteriorating health|1|||
144269460|NCT02785939|520189546|FG001|Overall Study|Deteriorating health|0|||
144269461|NCT02785939|520189545|FG000|Overall Study|Not protocol specified|0|||
144269462|NCT02785939|520189546|FG001|Overall Study|Not protocol specified|1|||
144269463|NCT01787552|520189549|FG000|Overall Study|Withdrawal by Subject|2|||
144269464|NCT01787552|520189550|FG001|Overall Study|Withdrawal by Subject|0|||
144269465|NCT01787552|520189551|FG002|Overall Study|Withdrawal by Subject|0|||
144269466|NCT01787552|520189552|FG003|Overall Study|Withdrawal by Subject|4|||
144269467|NCT01787552|520189549|FG000|Overall Study|Physician Decision|2|||
144269468|NCT01787552|520189550|FG001|Overall Study|Physician Decision|2|||
144269469|NCT01787552|520189551|FG002|Overall Study|Physician Decision|1|||
144269470|NCT01787552|520189552|FG003|Overall Study|Physician Decision|2|||
144269471|NCT01787552|520189549|FG000|Overall Study|Death|0|||
144269472|NCT01787552|520189550|FG001|Overall Study|Death|0|||
144269473|NCT01787552|520189551|FG002|Overall Study|Death|0|||
144230540|NCT01455597|520041261|FG001|Overall Study|Adverse Event|0|||
144230541|NCT01455597|520041262|FG002|Overall Study|Adverse Event|5|||
144230542|NCT01455597|520041263|FG003|Overall Study|Adverse Event|1|||
144230543|NCT01455597|520041260|FG000|Overall Study|Lack of Efficacy|0|||
144230544|NCT01455597|520041261|FG001|Overall Study|Lack of Efficacy|1|||
144230545|NCT01455597|520041262|FG002|Overall Study|Lack of Efficacy|2|||
144230546|NCT01455597|520041263|FG003|Overall Study|Lack of Efficacy|0|||
144230547|NCT01455597|520041260|FG000|Overall Study|Lost to Follow-up|3|||
144230548|NCT01455597|520041261|FG001|Overall Study|Lost to Follow-up|0|||
144230549|NCT01455597|520041262|FG002|Overall Study|Lost to Follow-up|2|||
144230550|NCT01455597|520041263|FG003|Overall Study|Lost to Follow-up|1|||
144230551|NCT01455597|520041260|FG000|Overall Study|Withdrew Consent|6|||
144230552|NCT01455597|520041261|FG001|Overall Study|Withdrew Consent|5|||
144230553|NCT01455597|520041262|FG002|Overall Study|Withdrew Consent|8|||
144230554|NCT01455597|520041263|FG003|Overall Study|Withdrew Consent|5|||
144230555|NCT01455597|520041260|FG000|Overall Study|Reason not Specified|1|||
144230556|NCT01455597|520041261|FG001|Overall Study|Reason not Specified|2|||
144230557|NCT01455597|520041262|FG002|Overall Study|Reason not Specified|3|||
144230558|NCT01455597|520041263|FG003|Overall Study|Reason not Specified|3|||
144230559|NCT00441129|520041264|FG000|Overall Study|Withdrawal by Subject|6|||
144230560|NCT00441129|520041265|FG001|Overall Study|Withdrawal by Subject|14|||
144230561|NCT01737710|520041266|FG000|Overall Study|Lost to Follow-up|0|||
144230562|NCT01737710|520041267|FG001|Overall Study|Lost to Follow-up|2|||
144230563|NCT01737710|520041268|FG002|Overall Study|Lost to Follow-up|2|||
144230564|NCT01737710|520041269|FG003|Overall Study|Lost to Follow-up|0|||
144230565|NCT01737710|520041270|FG004|Overall Study|Lost to Follow-up|0|||
144230566|NCT01737710|520041266|FG000|Overall Study|Withdrawal by Subject|1|||
144230567|NCT01737710|520041267|FG001|Overall Study|Withdrawal by Subject|1|||
144230568|NCT01737710|520041268|FG002|Overall Study|Withdrawal by Subject|1|||
144230569|NCT01737710|520041269|FG003|Overall Study|Withdrawal by Subject|0|||
144230570|NCT01737710|520041270|FG004|Overall Study|Withdrawal by Subject|0|||
144230571|NCT01737710|520041266|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
144230572|NCT01737710|520041267|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
144230573|NCT01737710|520041268|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
144230574|NCT01737710|520041269|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
144230575|NCT01737710|520041270|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
144230576|NCT03412734|520041271|FG000|Overall Study|Incorrect labeling of samples|2|||
144230577|NCT03412734|520041272|FG001|Overall Study|Incorrect labeling of samples|0|||
144230578|NCT03412734|520041271|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
144230579|NCT03412734|520041272|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
144230580|NCT04747886|520041273|FG000|Overall Study|Withdrawal by Subject|1|||
144230581|NCT04747886|520041274|FG001|Overall Study|Withdrawal by Subject|4|||
144230582|NCT03850496|520041277|FG000|Overall Study|Withdrawal by Subject|1|||
144230583|NCT03850496|520041278|FG001|Overall Study|Withdrawal by Subject|0|||
144230584|NCT03850496|520041279|FG002|Overall Study|Withdrawal by Subject|0|||
144230585|NCT03850496|520041277|FG000|Overall Study|Lost to Follow-up|0|||
144230586|NCT03850496|520041278|FG001|Overall Study|Lost to Follow-up|1|||
144230587|NCT03850496|520041279|FG002|Overall Study|Lost to Follow-up|4|||
144230588|NCT02418949|520041295|FG000|Overall Study|Withdrawal by Subject|1|||
144230589|NCT02418949|520041296|FG001|Overall Study|Withdrawal by Subject|0|||
144230590|NCT02418949|520041297|FG002|Overall Study|Withdrawal by Subject|1|||
144230591|NCT02418949|520041298|FG003|Overall Study|Withdrawal by Subject|1|||
144230592|NCT02418949|520041295|FG000|Overall Study|Lost to Follow-up|1|||
144230593|NCT02418949|520041296|FG001|Overall Study|Lost to Follow-up|0|||
144230594|NCT02418949|520041297|FG002|Overall Study|Lost to Follow-up|1|||
144230595|NCT02418949|520041298|FG003|Overall Study|Lost to Follow-up|0|||
144230596|NCT02418949|520041295|FG000|Overall Study|Physician Decision|1|||
144230597|NCT02418949|520041296|FG001|Overall Study|Physician Decision|1|||
144230598|NCT02418949|520041297|FG002|Overall Study|Physician Decision|1|||
144230599|NCT02418949|520041298|FG003|Overall Study|Physician Decision|0|||
144230600|NCT00984542|520041303|FG000|Overall Study|disease progression|19|||
144230601|NCT00984542|520041303|FG000|Overall Study|toxicity|7|||
144230602|NCT00984542|520041303|FG000|Overall Study|Death|7|||
144230603|NCT00984542|520041303|FG000|Overall Study|complicating disease|3|||
144230604|NCT00984542|520041303|FG000|Overall Study|Withdrawal by Subject|3|||
144230605|NCT00984542|520041303|FG000|Overall Study|clinical deterioration|2|||
144230606|NCT02343939|520041304|FG000|Overall Study|Death|0|||
144230607|NCT02343939|520041305|FG001|Overall Study|Death|15|||
144230608|NCT02343939|520041306|FG002|Overall Study|Death|4|||
144230609|NCT02343939|520041307|FG003|Overall Study|Death|2|||
144230610|NCT02343939|520041308|FG004|Overall Study|Death|5|||
144230611|NCT02343939|520041309|FG005|Overall Study|Death|11|||
144269474|NCT01787552|520189552|FG003|Overall Study|Death|1|||
144269475|NCT01787552|520189549|FG000|Overall Study|Adverse Event|2|||
144269476|NCT01787552|520189550|FG001|Overall Study|Adverse Event|5|||
144269477|NCT01787552|520189551|FG002|Overall Study|Adverse Event|2|||
144269478|NCT01787552|520189552|FG003|Overall Study|Adverse Event|16|||
144269479|NCT01787552|520189549|FG000|Overall Study|Study terminated by Sponsor|0|||
144269480|NCT01787552|520189550|FG001|Overall Study|Study terminated by Sponsor|0|||
144269481|NCT01787552|520189551|FG002|Overall Study|Study terminated by Sponsor|1|||
144269482|NCT01787552|520189552|FG003|Overall Study|Study terminated by Sponsor|3|||
144269483|NCT01787552|520189549|FG000|Overall Study|Progressive Disease|2|||
144269484|NCT01787552|520189550|FG001|Overall Study|Progressive Disease|2|||
144230612|NCT02343939|520041310|FG006|Overall Study|Death|8|||
144230613|NCT02343939|520041311|FG007|Overall Study|Death|22|||
144230614|NCT02343939|520041312|FG008|Overall Study|Death|1|||
144230615|NCT02343939|520041304|FG000|Overall Study|Study terminated by sponsor|0|||
144230616|NCT02343939|520041305|FG001|Overall Study|Study terminated by sponsor|27|||
144230617|NCT02343939|520041306|FG002|Overall Study|Study terminated by sponsor|0|||
144230618|NCT02343939|520041307|FG003|Overall Study|Study terminated by sponsor|1|||
144230619|NCT02343939|520041308|FG004|Overall Study|Study terminated by sponsor|1|||
144230620|NCT02343939|520041309|FG005|Overall Study|Study terminated by sponsor|5|||
144230621|NCT02343939|520041310|FG006|Overall Study|Study terminated by sponsor|3|||
144230622|NCT02343939|520041311|FG007|Overall Study|Study terminated by sponsor|4|||
144230623|NCT02343939|520041312|FG008|Overall Study|Study terminated by sponsor|0|||
144230624|NCT02343939|520041304|FG000|Overall Study|Withdrew consent|3|||
144230625|NCT02343939|520041305|FG001|Overall Study|Withdrew consent|6|||
144230626|NCT02343939|520041306|FG002|Overall Study|Withdrew consent|1|||
144230627|NCT02343939|520041307|FG003|Overall Study|Withdrew consent|2|||
144230628|NCT02343939|520041308|FG004|Overall Study|Withdrew consent|2|||
144230629|NCT02343939|520041309|FG005|Overall Study|Withdrew consent|0|||
144230630|NCT02343939|520041310|FG006|Overall Study|Withdrew consent|0|||
144230631|NCT02343939|520041311|FG007|Overall Study|Withdrew consent|8|||
144230632|NCT02343939|520041312|FG008|Overall Study|Withdrew consent|6|||
144230633|NCT02343939|520041304|FG000|Overall Study|Treatment failure|0|||
144230634|NCT02343939|520041305|FG001|Overall Study|Treatment failure|0|||
144230635|NCT02343939|520041306|FG002|Overall Study|Treatment failure|0|||
144230636|NCT02343939|520041307|FG003|Overall Study|Treatment failure|0|||
144230637|NCT02343939|520041308|FG004|Overall Study|Treatment failure|0|||
144230638|NCT02343939|520041309|FG005|Overall Study|Treatment failure|0|||
144230639|NCT02343939|520041310|FG006|Overall Study|Treatment failure|2|||
144230640|NCT02343939|520041311|FG007|Overall Study|Treatment failure|1|||
144230641|NCT02343939|520041312|FG008|Overall Study|Treatment failure|0|||
144230642|NCT02343939|520041304|FG000|Overall Study|Investigator's discretion|0|||
144230643|NCT02343939|520041305|FG001|Overall Study|Investigator's discretion|0|||
144230644|NCT02343939|520041306|FG002|Overall Study|Investigator's discretion|0|||
144230645|NCT02343939|520041307|FG003|Overall Study|Investigator's discretion|1|||
144230646|NCT02343939|520041308|FG004|Overall Study|Investigator's discretion|0|||
144230647|NCT02343939|520041309|FG005|Overall Study|Investigator's discretion|0|||
144230648|NCT02343939|520041310|FG006|Overall Study|Investigator's discretion|1|||
144230649|NCT02343939|520041311|FG007|Overall Study|Investigator's discretion|0|||
144230650|NCT02343939|520041312|FG008|Overall Study|Investigator's discretion|0|||
144230651|NCT02343939|520041304|FG000|Overall Study|Adverse Event|0|||
144230652|NCT02343939|520041305|FG001|Overall Study|Adverse Event|0|||
144230653|NCT02343939|520041306|FG002|Overall Study|Adverse Event|0|||
144230654|NCT02343939|520041307|FG003|Overall Study|Adverse Event|0|||
144230655|NCT02343939|520041308|FG004|Overall Study|Adverse Event|0|||
144230656|NCT02343939|520041309|FG005|Overall Study|Adverse Event|1|||
144230657|NCT02343939|520041310|FG006|Overall Study|Adverse Event|0|||
144230658|NCT02343939|520041311|FG007|Overall Study|Adverse Event|0|||
144230659|NCT02343939|520041312|FG008|Overall Study|Adverse Event|0|||
144230660|NCT02343939|520041304|FG000|Overall Study|Never Treated With ENTO|0|||
144230661|NCT02343939|520041305|FG001|Overall Study|Never Treated With ENTO|0|||
144230662|NCT02343939|520041306|FG002|Overall Study|Never Treated With ENTO|0|||
144230663|NCT02343939|520041307|FG003|Overall Study|Never Treated With ENTO|0|||
144230664|NCT02343939|520041308|FG004|Overall Study|Never Treated With ENTO|0|||
144230665|NCT02343939|520041309|FG005|Overall Study|Never Treated With ENTO|0|||
144230666|NCT02343939|520041310|FG006|Overall Study|Never Treated With ENTO|1|||
144230667|NCT02343939|520041311|FG007|Overall Study|Never Treated With ENTO|2|||
144230668|NCT02343939|520041312|FG008|Overall Study|Never Treated With ENTO|0|||
144269485|NCT01787552|520189551|FG002|Overall Study|Progressive Disease|1|||
144269486|NCT01787552|520189552|FG003|Overall Study|Progressive Disease|1|||
144269487|NCT02557399|520189557|FG000|Overall Study|Adverse Event|6|||
144269488|NCT02557399|520189558|FG001|Overall Study|Adverse Event|5|||
144269489|NCT02557399|520189557|FG000|Overall Study|Protocol Violation|0|||
144269490|NCT02557399|520189558|FG001|Overall Study|Protocol Violation|1|||
144269491|NCT02557399|520189557|FG000|Overall Study|Protocol-defined stopping criteria|0|||
144269492|NCT02557399|520189558|FG001|Overall Study|Protocol-defined stopping criteria|1|||
144269493|NCT02557399|520189557|FG000|Overall Study|Withdrawal by Subject|1|||
144269494|NCT02557399|520189558|FG001|Overall Study|Withdrawal by Subject|1|||
144269495|NCT00606307|520189561|FG000|Overall Study|Adverse Event|2|||
144269496|NCT00606307|520189561|FG000|Overall Study|Withdrawal by Subject|2|||
144269497|NCT00606307|520189561|FG000|Overall Study|Disease progression|6|||
144269498|NCT00606307|520189561|FG000|Overall Study|QTc prolongation|1|||
144230669|NCT02684097|520041315|FG000|Overall Study|Lack of Efficacy|13|||
144230670|NCT02684097|520041316|FG001|Overall Study|Lack of Efficacy|6|||
144230671|NCT00460811|520041317|FG000|Overall Study|Adverse Event|4|||
144230672|NCT00460811|520041318|FG001|Overall Study|Adverse Event|6|||
144230673|NCT00460811|520041319|FG002|Overall Study|Adverse Event|3|||
144230674|NCT00460811|520041320|FG003|Overall Study|Adverse Event|10|||
144230675|NCT00460811|520041321|FG004|Overall Study|Adverse Event|2|||
144230676|NCT00460811|520041317|FG000|Overall Study|Noncompliance|1|||
144230677|NCT00460811|520041318|FG001|Overall Study|Noncompliance|0|||
144230678|NCT00460811|520041319|FG002|Overall Study|Noncompliance|0|||
144230679|NCT00460811|520041320|FG003|Overall Study|Noncompliance|2|||
144230680|NCT00460811|520041321|FG004|Overall Study|Noncompliance|1|||
144230681|NCT00460811|520041317|FG000|Overall Study|Withdrawal by Subject|7|||
144230682|NCT00460811|520041318|FG001|Overall Study|Withdrawal by Subject|7|||
144230683|NCT00460811|520041319|FG002|Overall Study|Withdrawal by Subject|6|||
144230684|NCT00460811|520041320|FG003|Overall Study|Withdrawal by Subject|3|||
144230685|NCT00460811|520041321|FG004|Overall Study|Withdrawal by Subject|11|||
144230686|NCT00460811|520041317|FG000|Overall Study|Physician Decision|1|||
144230687|NCT00460811|520041318|FG001|Overall Study|Physician Decision|0|||
144230688|NCT00460811|520041319|FG002|Overall Study|Physician Decision|0|||
144230689|NCT00460811|520041320|FG003|Overall Study|Physician Decision|0|||
144230690|NCT00460811|520041321|FG004|Overall Study|Physician Decision|0|||
144230691|NCT00460811|520041317|FG000|Overall Study|Lost to Follow-up|3|||
144230692|NCT00460811|520041318|FG001|Overall Study|Lost to Follow-up|2|||
144230693|NCT00460811|520041319|FG002|Overall Study|Lost to Follow-up|5|||
144230694|NCT00460811|520041320|FG003|Overall Study|Lost to Follow-up|3|||
144230695|NCT00460811|520041321|FG004|Overall Study|Lost to Follow-up|6|||
144230696|NCT00462709|520041322|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
144230697|NCT00462709|520041322|FG000|Overall Study|Lost to Follow-up|10|||
144230698|NCT00462709|520041322|FG000|Overall Study|Withdrawal by Subject|8|||
144230699|NCT00462709|520041322|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
144230700|NCT00462709|520041322|FG000|Overall Study|Death|2|||
144230701|NCT00462709|520041322|FG000|Overall Study|Logistical reasons|2|||
144230702|NCT00462709|520041322|FG000|Overall Study|Physician Decision|1|||
144230703|NCT00462709|520041322|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
144230704|NCT00425750|520041326|FG000|Overall Study|Death|1|||
144230705|NCT00425750|520041326|FG000|Overall Study|Withdrawal by Subject|3|||
144230706|NCT00425750|520041326|FG000|Overall Study|Adverse Event|3|||
144230707|NCT00425750|520041326|FG000|Overall Study|Progression of disease|18|||
144230708|NCT02064816|520041327|FG000|Overall Study|Adverse Event|3|||
144230709|NCT02064816|520041328|FG001|Overall Study|Adverse Event|2|||
144230710|NCT02064816|520041327|FG000|Overall Study|Withdrawal by Subject|2|||
144230711|NCT02064816|520041328|FG001|Overall Study|Withdrawal by Subject|1|||
144230712|NCT02064816|520041327|FG000|Overall Study|Lost to Follow-up|2|||
144230713|NCT02064816|520041328|FG001|Overall Study|Lost to Follow-up|1|||
144230714|NCT02064816|520041327|FG000|Overall Study|Therapeutic failure|0|||
144230715|NCT02064816|520041328|FG001|Overall Study|Therapeutic failure|1|||
144230716|NCT02064816|520041327|FG000|Overall Study|Other|1|||
144230717|NCT02064816|520041328|FG001|Overall Study|Other|3|||
144230718|NCT04468347|520041335|FG000|Overall Study|Withdrawal by Subject|0|||
144230719|NCT04468347|520041336|FG001|Overall Study|Withdrawal by Subject|1|||
144230720|NCT04468347|520041337|FG002|Overall Study|Withdrawal by Subject|3|||
144230721|NCT04468347|520041338|FG003|Overall Study|Withdrawal by Subject|3|||
144230722|NCT04468347|520041335|FG000|Overall Study|Lost to Follow-up|0|||
144230723|NCT04468347|520041336|FG001|Overall Study|Lost to Follow-up|0|||
144230724|NCT04468347|520041337|FG002|Overall Study|Lost to Follow-up|1|||
144230725|NCT04468347|520041338|FG003|Overall Study|Lost to Follow-up|1|||
144230726|NCT04468347|520041335|FG000|Overall Study|Physician Decision|1|||
144230727|NCT04468347|520041336|FG001|Overall Study|Physician Decision|0|||
144230728|NCT04468347|520041337|FG002|Overall Study|Physician Decision|2|||
144230729|NCT04468347|520041338|FG003|Overall Study|Physician Decision|0|||
144230730|NCT04468347|520041335|FG000|Overall Study|Protocol Violation|1|||
144230731|NCT04468347|520041336|FG001|Overall Study|Protocol Violation|0|||
144230732|NCT04468347|520041337|FG002|Overall Study|Protocol Violation|0|||
144230733|NCT04468347|520041338|FG003|Overall Study|Protocol Violation|0|||
144230734|NCT01732458|520041339|FG000|Overall Study|Lost to Follow-up|0|||
144230735|NCT01732458|520041340|FG001|Overall Study|Lost to Follow-up|2|||
144230736|NCT01732458|520041341|FG002|Overall Study|Lost to Follow-up|0|||
144230737|NCT01732458|520041342|FG003|Overall Study|Lost to Follow-up|0|||
144230738|NCT01732458|520041339|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144230739|NCT01732458|520041340|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144230740|NCT01732458|520041341|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144230741|NCT01732458|520041342|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144230742|NCT01732458|520041339|FG000|Overall Study|Physician Decision|1|||
144230743|NCT01732458|520041340|FG001|Overall Study|Physician Decision|2|||
144230744|NCT01732458|520041341|FG002|Overall Study|Physician Decision|2|||
144230745|NCT01732458|520041342|FG003|Overall Study|Physician Decision|0|||
144230746|NCT01732458|520041339|FG000|Overall Study|Protocol Violation|2|||
144230747|NCT01732458|520041340|FG001|Overall Study|Protocol Violation|0|||
144230748|NCT01732458|520041341|FG002|Overall Study|Protocol Violation|0|||
144230749|NCT01732458|520041342|FG003|Overall Study|Protocol Violation|2|||
144230750|NCT01732458|520041339|FG000|Overall Study|Screen Failure|0|||
144230751|NCT01732458|520041340|FG001|Overall Study|Screen Failure|1|||
144230752|NCT01732458|520041341|FG002|Overall Study|Screen Failure|0|||
144230753|NCT01732458|520041342|FG003|Overall Study|Screen Failure|0|||
144230754|NCT00237458|520041343|FG000|Overall Study|Lack of Efficacy|1|||
144230755|NCT00237458|520041343|FG000|Overall Study|Adverse Event|1|||
144230756|NCT00237458|520041343|FG000|Overall Study|Withdrawal by Subject|1|||
144230757|NCT02977572|520041344|FG000|Overall Study|Exclusion criterion|2|||
144230758|NCT02977572|520041345|FG001|Overall Study|Exclusion criterion|2|||
144230759|NCT05236764|520041346|FG000|Overall Study|In follow up (ongoing)|1|||
144230760|NCT05236764|520041346|FG000|Overall Study|Taken off study - secondary graft failure|1|||
144230761|NCT05236764|520041346|FG000|Overall Study|Death|1|||
144230762|NCT04339062|520041347|FG000|Overall Study|Death|0|||
144230763|NCT04339062|520041348|FG001|Overall Study|Death|1|||
144230764|NCT03218826|520041349|FG000|Overall Study|Non-compliance with protocol|1|||
144230765|NCT03218826|520041350|FG001|Overall Study|Non-compliance with protocol|0|||
144230766|NCT03218826|520041351|FG002|Overall Study|Non-compliance with protocol|2|||
144230767|NCT03218826|520041352|FG003|Overall Study|Non-compliance with protocol|1|||
144230768|NCT03218826|520041353|FG004|Overall Study|Non-compliance with protocol|1|||
144230769|NCT01197534|520041354|FG000|Overall Study|Not reported|16|||
144230770|NCT01197534|520041355|FG001|Overall Study|Not reported|10|||
144230771|NCT01197534|520041356|FG002|Overall Study|Not reported|16|||
144230772|NCT01197534|520041354|FG000|Overall Study|Enrolment in long term extension|57|||
144230773|NCT01197534|520041355|FG001|Overall Study|Enrolment in long term extension|66|||
144230774|NCT01197534|520041356|FG002|Overall Study|Enrolment in long term extension|119|||
144230775|NCT01197534|520041354|FG000|Overall Study|Severe non-compliance to protocol|3|||
144230776|NCT01197534|520041355|FG001|Overall Study|Severe non-compliance to protocol|4|||
144230777|NCT01197534|520041356|FG002|Overall Study|Severe non-compliance to protocol|1|||
144230778|NCT01197534|520041354|FG000|Overall Study|Lack of therapeutic response|9|||
144230779|NCT01197534|520041355|FG001|Overall Study|Lack of therapeutic response|4|||
144230780|NCT01197534|520041356|FG002|Overall Study|Lack of therapeutic response|9|||
144230781|NCT01197534|520041354|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
144230782|NCT01197534|520041355|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
144230783|NCT01197534|520041356|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
144230784|NCT01197534|520041354|FG000|Overall Study|Lost to Follow-up|1|||
144230785|NCT01197534|520041355|FG001|Overall Study|Lost to Follow-up|4|||
144230786|NCT01197534|520041356|FG002|Overall Study|Lost to Follow-up|2|||
144230787|NCT01197534|520041354|FG000|Overall Study|Adverse Event|35|||
144230788|NCT01197534|520041355|FG001|Overall Study|Adverse Event|36|||
144230789|NCT01197534|520041356|FG002|Overall Study|Adverse Event|24|||
144230790|NCT00703157|520041359|FG000|Overall Study|Lost to Follow-up|0|||
144230791|NCT00703157|520041360|FG001|Overall Study|Lost to Follow-up|1|||
144230792|NCT00703157|520041359|FG000|Overall Study|source data permanently lost/ other|4|||
144230793|NCT00703157|520041360|FG001|Overall Study|source data permanently lost/ other|1|||
144230794|NCT03517540|520041368|FG000|Overall Study|Protocol Violation|2|||
144230795|NCT03517540|520041369|FG001|Overall Study|Protocol Violation|0|||
144230796|NCT03517540|520041370|FG002|Overall Study|Protocol Violation|0|||
144230797|NCT03517540|520041371|FG003|Overall Study|Protocol Violation|1|||
144230798|NCT03517540|520041368|FG000|Overall Study|Adverse Event|9|||
144230799|NCT03517540|520041369|FG001|Overall Study|Adverse Event|3|||
144230800|NCT03517540|520041370|FG002|Overall Study|Adverse Event|8|||
144230801|NCT03517540|520041371|FG003|Overall Study|Adverse Event|1|||
144230802|NCT03517540|520041368|FG000|Overall Study|Withdrawal by Subject|3|||
144230803|NCT03517540|520041369|FG001|Overall Study|Withdrawal by Subject|4|||
144230804|NCT03517540|520041370|FG002|Overall Study|Withdrawal by Subject|1|||
144230805|NCT03517540|520041371|FG003|Overall Study|Withdrawal by Subject|3|||
144230806|NCT02640664|520041372|FG000|Epoch 1|Withdrawal of informed consent|1|||
144230807|NCT02640664|520041373|FG001|Epoch 1|Withdrawal of informed consent|0|||
144230808|NCT02640664|520041374|FG002|Epoch 1|Withdrawal of informed consent|0|||
144230809|NCT02640664|520041372|FG000|Epoch 1|Death|0|||
144230810|NCT02640664|520041373|FG001|Epoch 1|Death|0|||
144230811|NCT02640664|520041374|FG002|Epoch 1|Death|1|||
144230812|NCT02640664|520041372|FG000|Epoch 2|Withdrawal of informed consent|3|||
144230813|NCT02640664|520041373|FG001|Epoch 2|Withdrawal of informed consent|4|||
144230814|NCT02640664|520041374|FG002|Epoch 2|Withdrawal of informed consent|2|||
144230815|NCT02640664|520041372|FG000|Epoch 2|Subject/guardian decision|0|||
144230816|NCT02640664|520041373|FG001|Epoch 2|Subject/guardian decision|2|||
144230817|NCT02640664|520041374|FG002|Epoch 2|Subject/guardian decision|2|||
144230818|NCT02640664|520041372|FG000|Epoch 2|Lost to Follow-up|3|||
144230819|NCT02640664|520041373|FG001|Epoch 2|Lost to Follow-up|4|||
144230820|NCT02640664|520041374|FG002|Epoch 2|Lost to Follow-up|1|||
144230821|NCT02640664|520041372|FG000|Epoch 2|Death|0|||
144230822|NCT02640664|520041373|FG001|Epoch 2|Death|0|||
144230823|NCT02640664|520041374|FG002|Epoch 2|Death|1|||
144230824|NCT01801865|520041375|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
144230825|NCT01801865|520041375|FG000|Overall Study|Physician Decision|7|||
144230826|NCT00550745|520041376|FG000|Overall Study|Death|20|||
144230827|NCT00550745|520041377|FG001|Overall Study|Death|16|||
144230828|NCT00550745|520041376|FG000|Overall Study|Lost to Follow-up|45|||
144230829|NCT00550745|520041377|FG001|Overall Study|Lost to Follow-up|30|||
144230830|NCT00550745|520041376|FG000|Overall Study|Physician Decision|0|||
144230831|NCT00550745|520041377|FG001|Overall Study|Physician Decision|2|||
144230832|NCT00550745|520041376|FG000|Overall Study|Protocol Violation|4|||
144230833|NCT00550745|520041377|FG001|Overall Study|Protocol Violation|2|||
144230834|NCT00550745|520041376|FG000|Overall Study|Withdrawal by Subject|17|||
144230835|NCT00550745|520041377|FG001|Overall Study|Withdrawal by Subject|10|||
144230836|NCT00550745|520041376|FG000|Overall Study|Screen failure|1|||
144230837|NCT00550745|520041377|FG001|Overall Study|Screen failure|0|||
144230838|NCT00347958|520043169|FG000|Overall Study|Adverse Event|1|||
144230839|NCT00347958|520043169|FG000|Overall Study|Protocol Violation|2|||
144230840|NCT00347958|520043169|FG000|Overall Study|Withdrawal by Subject|1|||
144230841|NCT00734162|520043173|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
144230842|NCT00734162|520043174|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
144230843|NCT00734162|520043175|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
144230844|NCT00734162|520043176|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
144230845|NCT00734162|520043173|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
144230846|NCT00734162|520043174|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
144230847|NCT00734162|520043175|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
144230848|NCT00734162|520043176|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
144230849|NCT00734162|520043173|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
144230850|NCT00734162|520043174|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
144230851|NCT00734162|520043175|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
144230852|NCT00734162|520043176|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
144230853|NCT00734162|520043173|FG000|Open-Label Phase|Withdrew Consent|1|||
144230854|NCT00734162|520043174|FG001|Open-Label Phase|Withdrew Consent|0|||
144230855|NCT00734162|520043175|FG002|Open-Label Phase|Withdrew Consent|1|||
144230856|NCT00734162|520043176|FG003|Open-Label Phase|Withdrew Consent|1|||
144230857|NCT00734162|520043173|FG000|Open-Label Phase|Lost to Follow-up|1|||
144230858|NCT00734162|520043174|FG001|Open-Label Phase|Lost to Follow-up|2|||
144230859|NCT00734162|520043175|FG002|Open-Label Phase|Lost to Follow-up|0|||
144230860|NCT00734162|520043176|FG003|Open-Label Phase|Lost to Follow-up|1|||
144230861|NCT00734162|520043173|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
144230862|NCT00734162|520043174|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
144230863|NCT00734162|520043175|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
144230864|NCT00734162|520043176|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
144230865|NCT00932373|520043177|FG000|Overall Study|Progressive disease|3|||
144230866|NCT00932373|520043178|FG001|Overall Study|Progressive disease|1|||
144230867|NCT00932373|520043179|FG002|Overall Study|Progressive disease|0|||
144230868|NCT00932373|520043180|FG003|Overall Study|Progressive disease|0|||
144230869|NCT00932373|520043181|FG004|Overall Study|Progressive disease|10|||
144230870|NCT00932373|520043182|FG005|Overall Study|Progressive disease|1|||
144230871|NCT00932373|520043183|FG006|Overall Study|Progressive disease|0|||
144230872|NCT00932373|520043184|FG007|Overall Study|Progressive disease|2|||
144230873|NCT00932373|520043185|FG008|Overall Study|Progressive disease|1|||
144230874|NCT00932373|520043186|FG009|Overall Study|Progressive disease|9|||
144230875|NCT00932373|520043187|FG010|Overall Study|Progressive disease|2|||
144230876|NCT00932373|520043177|FG000|Overall Study|Adverse Event|0|||
144230877|NCT00932373|520043178|FG001|Overall Study|Adverse Event|0|||
144230878|NCT00932373|520043179|FG002|Overall Study|Adverse Event|0|||
144230879|NCT00932373|520043180|FG003|Overall Study|Adverse Event|0|||
144230880|NCT00932373|520043181|FG004|Overall Study|Adverse Event|2|||
144230881|NCT00932373|520043182|FG005|Overall Study|Adverse Event|1|||
144230882|NCT00932373|520043183|FG006|Overall Study|Adverse Event|0|||
144230883|NCT00932373|520043184|FG007|Overall Study|Adverse Event|1|||
144230884|NCT00932373|520043185|FG008|Overall Study|Adverse Event|0|||
144230885|NCT00932373|520043186|FG009|Overall Study|Adverse Event|2|||
144230886|NCT00932373|520043187|FG010|Overall Study|Adverse Event|1|||
144230887|NCT00932373|520043177|FG000|Overall Study|Physician Decision|0|||
144230888|NCT00932373|520043178|FG001|Overall Study|Physician Decision|0|||
144230889|NCT00932373|520043179|FG002|Overall Study|Physician Decision|1|||
144230890|NCT00932373|520043180|FG003|Overall Study|Physician Decision|0|||
144230891|NCT00932373|520043181|FG004|Overall Study|Physician Decision|2|||
144230892|NCT00932373|520043182|FG005|Overall Study|Physician Decision|0|||
144230893|NCT00932373|520043183|FG006|Overall Study|Physician Decision|0|||
144230894|NCT00932373|520043184|FG007|Overall Study|Physician Decision|0|||
144230895|NCT00932373|520043185|FG008|Overall Study|Physician Decision|0|||
144230896|NCT00932373|520043186|FG009|Overall Study|Physician Decision|1|||
144230897|NCT00932373|520043187|FG010|Overall Study|Physician Decision|0|||
144230898|NCT00932373|520043177|FG000|Overall Study|Dose limiting toxicity|0|||
144230899|NCT00932373|520043178|FG001|Overall Study|Dose limiting toxicity|0|||
144230900|NCT00932373|520043179|FG002|Overall Study|Dose limiting toxicity|0|||
144230901|NCT00932373|520043180|FG003|Overall Study|Dose limiting toxicity|0|||
144230902|NCT00932373|520043181|FG004|Overall Study|Dose limiting toxicity|0|||
144230903|NCT00932373|520043182|FG005|Overall Study|Dose limiting toxicity|1|||
144230904|NCT00932373|520043183|FG006|Overall Study|Dose limiting toxicity|0|||
144230905|NCT00932373|520043184|FG007|Overall Study|Dose limiting toxicity|0|||
144230906|NCT00932373|520043185|FG008|Overall Study|Dose limiting toxicity|0|||
144230907|NCT00932373|520043186|FG009|Overall Study|Dose limiting toxicity|0|||
144230908|NCT00932373|520043187|FG010|Overall Study|Dose limiting toxicity|0|||
144230909|NCT00932373|520043177|FG000|Overall Study|Withdrawal by Subject|0|||
144230910|NCT00932373|520043178|FG001|Overall Study|Withdrawal by Subject|0|||
144230911|NCT00932373|520043179|FG002|Overall Study|Withdrawal by Subject|0|||
144230912|NCT00932373|520043180|FG003|Overall Study|Withdrawal by Subject|0|||
144230913|NCT00932373|520043181|FG004|Overall Study|Withdrawal by Subject|0|||
144230914|NCT00932373|520043182|FG005|Overall Study|Withdrawal by Subject|0|||
144230915|NCT00932373|520043183|FG006|Overall Study|Withdrawal by Subject|0|||
144230916|NCT00932373|520043184|FG007|Overall Study|Withdrawal by Subject|0|||
144230917|NCT00932373|520043185|FG008|Overall Study|Withdrawal by Subject|1|||
144230918|NCT00932373|520043186|FG009|Overall Study|Withdrawal by Subject|0|||
144230919|NCT00932373|520043187|FG010|Overall Study|Withdrawal by Subject|0|||
144230920|NCT00932373|520043177|FG000|Overall Study|Clinical progression|0|||
144230921|NCT00932373|520043178|FG001|Overall Study|Clinical progression|0|||
144230922|NCT00932373|520043179|FG002|Overall Study|Clinical progression|0|||
144230923|NCT00932373|520043180|FG003|Overall Study|Clinical progression|0|||
144230924|NCT00932373|520043181|FG004|Overall Study|Clinical progression|0|||
144230925|NCT00932373|520043182|FG005|Overall Study|Clinical progression|0|||
144230926|NCT00932373|520043183|FG006|Overall Study|Clinical progression|1|||
144230927|NCT00932373|520043184|FG007|Overall Study|Clinical progression|0|||
144230928|NCT00932373|520043185|FG008|Overall Study|Clinical progression|0|||
144230929|NCT00932373|520043186|FG009|Overall Study|Clinical progression|0|||
144230930|NCT00932373|520043187|FG010|Overall Study|Clinical progression|0|||
144230931|NCT00932373|520043177|FG000|Overall Study|Lack of Efficacy|0|||
144230932|NCT00932373|520043178|FG001|Overall Study|Lack of Efficacy|0|||
144230933|NCT00932373|520043179|FG002|Overall Study|Lack of Efficacy|0|||
144230934|NCT00932373|520043180|FG003|Overall Study|Lack of Efficacy|0|||
144230935|NCT00932373|520043181|FG004|Overall Study|Lack of Efficacy|0|||
144230936|NCT00932373|520043182|FG005|Overall Study|Lack of Efficacy|0|||
144230937|NCT00932373|520043183|FG006|Overall Study|Lack of Efficacy|0|||
144230938|NCT00932373|520043184|FG007|Overall Study|Lack of Efficacy|0|||
144230939|NCT00932373|520043185|FG008|Overall Study|Lack of Efficacy|0|||
144230940|NCT00932373|520043186|FG009|Overall Study|Lack of Efficacy|1|||
144230941|NCT00932373|520043187|FG010|Overall Study|Lack of Efficacy|0|||
144230942|NCT06098339|520043188|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
144230943|NCT06098339|520043189|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
144230944|NCT06098339|520043188|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
144230945|NCT06098339|520043189|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
144230946|NCT03831113|520043192|FG000|Overall Study|Withdrawal by Subject|0|||
144230947|NCT03831113|520043193|FG001|Overall Study|Withdrawal by Subject|2|||
144230948|NCT03831113|520043192|FG000|Overall Study|Protocol Violation|0|||
144230949|NCT03831113|520043193|FG001|Overall Study|Protocol Violation|9|||
144230950|NCT04938180|520043196|FG000|Overall Study|Adverse Event|1|||
144230951|NCT03491462|520043197|FG000|Overall Study|Lost to Follow-up|2|||
144230952|NCT03491462|520043198|FG001|Overall Study|Lost to Follow-up|0|||
144230953|NCT03491462|520043197|FG000|Overall Study|Adverse Event|11|||
144230954|NCT03491462|520043198|FG001|Overall Study|Adverse Event|1|||
144230955|NCT03491462|520043197|FG000|Overall Study|Physician Decision|3|||
144230956|NCT03491462|520043198|FG001|Overall Study|Physician Decision|0|||
144230957|NCT03491462|520043197|FG000|Overall Study|Withdrawal by Subject|22|||
144230958|NCT03491462|520043198|FG001|Overall Study|Withdrawal by Subject|15|||
144230959|NCT01019694|520043201|FG000|Overall Study|Adverse Event|12|||
144230960|NCT01019694|520043202|FG001|Overall Study|Adverse Event|16|||
144230961|NCT01019694|520043203|FG002|Overall Study|Adverse Event|19|||
144230962|NCT01019694|520043201|FG000|Overall Study|Protocol Violation|2|||
144230963|NCT01019694|520043202|FG001|Overall Study|Protocol Violation|6|||
144230964|NCT01019694|520043203|FG002|Overall Study|Protocol Violation|4|||
144230965|NCT01019694|520043201|FG000|Overall Study|Lost to Follow-up|5|||
144230966|NCT01019694|520043202|FG001|Overall Study|Lost to Follow-up|3|||
144230967|NCT01019694|520043203|FG002|Overall Study|Lost to Follow-up|3|||
144230968|NCT01019694|520043201|FG000|Overall Study|Withdrawal by Subject|4|||
144230969|NCT01019694|520043202|FG001|Overall Study|Withdrawal by Subject|6|||
144230970|NCT01019694|520043203|FG002|Overall Study|Withdrawal by Subject|12|||
144230971|NCT01019694|520043201|FG000|Overall Study|Not treated|0|||
144230972|NCT01019694|520043202|FG001|Overall Study|Not treated|2|||
144230973|NCT01019694|520043203|FG002|Overall Study|Not treated|3|||
144230974|NCT01019694|520043201|FG000|Overall Study|Other reason (not specified)|1|||
144230975|NCT01019694|520043202|FG001|Overall Study|Other reason (not specified)|5|||
144230976|NCT01019694|520043203|FG002|Overall Study|Other reason (not specified)|6|||
144230977|NCT00423332|520043211|FG000|Overall Study|Adverse Event|6|||
144230978|NCT00423332|520043212|FG001|Overall Study|Adverse Event|2|||
144230979|NCT00423332|520043211|FG000|Overall Study|Withdrawal by Subject|1|||
144230980|NCT00423332|520043212|FG001|Overall Study|Withdrawal by Subject|0|||
144230981|NCT00423332|520043211|FG000|Overall Study|Condition under investigation worsened|1|||
144230982|NCT00423332|520043212|FG001|Overall Study|Condition under investigation worsened|1|||
144230983|NCT00423332|520043211|FG000|Overall Study|Progressive at Week 6|0|||
144230984|NCT00423332|520043212|FG001|Overall Study|Progressive at Week 6|1|||
144230985|NCT00423332|520043211|FG000|Overall Study|Unblinded before 12 weeks|1|||
144230986|NCT00423332|520043212|FG001|Overall Study|Unblinded before 12 weeks|3|||
144230987|NCT02035202|520043213|FG000|Overall Study|Lost to Follow-up|8|||
144230988|NCT02035202|520043214|FG001|Overall Study|Lost to Follow-up|16|||
144230989|NCT02035202|520043215|FG002|Overall Study|Lost to Follow-up|2|||
144230990|NCT00685399|520043217|FG000|Treatment Period 1|Withdrawal by Subject|2|||
144230991|NCT00685399|520043218|FG001|Treatment Period 1|Withdrawal by Subject|0|||
144230992|NCT00685399|520043219|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144230993|NCT00685399|520043220|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144230994|NCT00685399|520043221|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144230995|NCT00685399|520043222|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144230996|NCT00685399|520043223|FG006|Treatment Period 1|Withdrawal by Subject|0|||
144230997|NCT00685399|520043224|FG007|Treatment Period 1|Withdrawal by Subject|0|||
144230998|NCT00685399|520043217|FG000|Treatment Period 1|Protocol Violation|1|||
144230999|NCT00685399|520043218|FG001|Treatment Period 1|Protocol Violation|0|||
144231000|NCT00685399|520043219|FG002|Treatment Period 1|Protocol Violation|0|||
144231001|NCT00685399|520043220|FG003|Treatment Period 1|Protocol Violation|0|||
144231002|NCT00685399|520043221|FG004|Treatment Period 1|Protocol Violation|0|||
144231003|NCT00685399|520043222|FG005|Treatment Period 1|Protocol Violation|0|||
144231004|NCT00685399|520043223|FG006|Treatment Period 1|Protocol Violation|0|||
144231005|NCT00685399|520043224|FG007|Treatment Period 1|Protocol Violation|0|||
144231006|NCT00685399|520043217|FG000|Treatment Period 1|Administrative|2|||
144231007|NCT00685399|520043218|FG001|Treatment Period 1|Administrative|0|||
144231008|NCT00685399|520043219|FG002|Treatment Period 1|Administrative|0|||
144231009|NCT00685399|520043220|FG003|Treatment Period 1|Administrative|0|||
144231010|NCT00685399|520043221|FG004|Treatment Period 1|Administrative|0|||
144231011|NCT00685399|520043222|FG005|Treatment Period 1|Administrative|0|||
144231012|NCT00685399|520043223|FG006|Treatment Period 1|Administrative|0|||
144231013|NCT00685399|520043224|FG007|Treatment Period 1|Administrative|0|||
144231014|NCT00685399|520043217|FG000|Treatment Period 1|Lack of Efficacy|1|||
144231015|NCT00685399|520043218|FG001|Treatment Period 1|Lack of Efficacy|0|||
144231016|NCT00685399|520043219|FG002|Treatment Period 1|Lack of Efficacy|0|||
144231017|NCT00685399|520043220|FG003|Treatment Period 1|Lack of Efficacy|0|||
144231018|NCT00685399|520043221|FG004|Treatment Period 1|Lack of Efficacy|0|||
144231019|NCT00685399|520043222|FG005|Treatment Period 1|Lack of Efficacy|0|||
144231020|NCT00685399|520043223|FG006|Treatment Period 1|Lack of Efficacy|0|||
144231021|NCT00685399|520043224|FG007|Treatment Period 1|Lack of Efficacy|0|||
144231022|NCT00685399|520043217|FG000|Treatment Period 2|Administrative Problems|0|||
144231023|NCT00685399|520043218|FG001|Treatment Period 2|Administrative Problems|2|||
144231024|NCT00685399|520043219|FG002|Treatment Period 2|Administrative Problems|1|||
144231025|NCT00685399|520043220|FG003|Treatment Period 2|Administrative Problems|0|||
144231026|NCT00685399|520043221|FG004|Treatment Period 2|Administrative Problems|0|||
144231027|NCT00685399|520043222|FG005|Treatment Period 2|Administrative Problems|0|||
144231028|NCT00685399|520043223|FG006|Treatment Period 2|Administrative Problems|0|||
144231029|NCT00685399|520043224|FG007|Treatment Period 2|Administrative Problems|0|||
144231030|NCT00685399|520043217|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144231031|NCT00685399|520043218|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144231032|NCT00685399|520043219|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144231033|NCT00685399|520043220|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144231034|NCT00685399|520043221|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144231035|NCT00685399|520043222|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144231036|NCT00685399|520043223|FG006|Treatment Period 2|Withdrawal by Subject|0|||
144231037|NCT00685399|520043224|FG007|Treatment Period 2|Withdrawal by Subject|2|||
144231038|NCT00685399|520043217|FG000|Treatment Period 2|Adverse Event|0|||
144231039|NCT00685399|520043218|FG001|Treatment Period 2|Adverse Event|0|||
144231040|NCT00685399|520043219|FG002|Treatment Period 2|Adverse Event|0|||
144231041|NCT00685399|520043220|FG003|Treatment Period 2|Adverse Event|0|||
144231042|NCT00685399|520043221|FG004|Treatment Period 2|Adverse Event|0|||
144231043|NCT00685399|520043222|FG005|Treatment Period 2|Adverse Event|1|||
144231044|NCT00685399|520043223|FG006|Treatment Period 2|Adverse Event|0|||
144231045|NCT00685399|520043224|FG007|Treatment Period 2|Adverse Event|0|||
144231046|NCT00685399|520043217|FG000|Treatment Period 2|Lack of Efficacy|0|||
144231047|NCT00685399|520043218|FG001|Treatment Period 2|Lack of Efficacy|10|||
144231048|NCT00685399|520043219|FG002|Treatment Period 2|Lack of Efficacy|2|||
144231049|NCT00685399|520043220|FG003|Treatment Period 2|Lack of Efficacy|0|||
144231050|NCT00685399|520043221|FG004|Treatment Period 2|Lack of Efficacy|0|||
144231051|NCT00685399|520043222|FG005|Treatment Period 2|Lack of Efficacy|1|||
144231052|NCT00685399|520043223|FG006|Treatment Period 2|Lack of Efficacy|0|||
144231053|NCT00685399|520043224|FG007|Treatment Period 2|Lack of Efficacy|0|||
144231054|NCT00685399|520043217|FG000|Extension|Administrative Issues|0|||
144231055|NCT00685399|520043218|FG001|Extension|Administrative Issues|0|||
144231056|NCT00685399|520043219|FG002|Extension|Administrative Issues|0|||
144231057|NCT00685399|520043220|FG003|Extension|Administrative Issues|1|||
144231058|NCT00685399|520043221|FG004|Extension|Administrative Issues|0|||
144231059|NCT00685399|520043222|FG005|Extension|Administrative Issues|0|||
144231060|NCT00685399|520043223|FG006|Extension|Administrative Issues|0|||
144231061|NCT00685399|520043224|FG007|Extension|Administrative Issues|0|||
144231062|NCT00685399|520043217|FG000|Extension|Withdrawal by Subject|0|||
144231063|NCT00685399|520043218|FG001|Extension|Withdrawal by Subject|0|||
144231064|NCT00685399|520043219|FG002|Extension|Withdrawal by Subject|0|||
144231065|NCT00685399|520043220|FG003|Extension|Withdrawal by Subject|1|||
144231066|NCT00685399|520043221|FG004|Extension|Withdrawal by Subject|0|||
144231067|NCT00685399|520043222|FG005|Extension|Withdrawal by Subject|0|||
144231068|NCT00685399|520043223|FG006|Extension|Withdrawal by Subject|0|||
144231069|NCT00685399|520043224|FG007|Extension|Withdrawal by Subject|0|||
144231070|NCT00685399|520043217|FG000|Extension|Protocol Violation|0|||
144231071|NCT00685399|520043218|FG001|Extension|Protocol Violation|0|||
144231072|NCT00685399|520043219|FG002|Extension|Protocol Violation|0|||
144231073|NCT00685399|520043220|FG003|Extension|Protocol Violation|1|||
144231074|NCT00685399|520043221|FG004|Extension|Protocol Violation|0|||
144231075|NCT00685399|520043222|FG005|Extension|Protocol Violation|0|||
144231076|NCT00685399|520043223|FG006|Extension|Protocol Violation|0|||
144231077|NCT00685399|520043224|FG007|Extension|Protocol Violation|0|||
144231078|NCT00685399|520043217|FG000|Extension|Lack of Efficacy|0|||
144231079|NCT00685399|520043218|FG001|Extension|Lack of Efficacy|0|||
144231080|NCT00685399|520043219|FG002|Extension|Lack of Efficacy|0|||
144231081|NCT00685399|520043220|FG003|Extension|Lack of Efficacy|2|||
144231082|NCT00685399|520043221|FG004|Extension|Lack of Efficacy|0|||
144231083|NCT00685399|520043222|FG005|Extension|Lack of Efficacy|0|||
144231084|NCT00685399|520043223|FG006|Extension|Lack of Efficacy|0|||
144231085|NCT00685399|520043224|FG007|Extension|Lack of Efficacy|0|||
144231086|NCT00685399|520043217|FG000|Extension|Adverse Event|0|||
144231087|NCT00685399|520043218|FG001|Extension|Adverse Event|0|||
144231088|NCT00685399|520043219|FG002|Extension|Adverse Event|0|||
144231089|NCT00685399|520043220|FG003|Extension|Adverse Event|2|||
144231090|NCT00685399|520043221|FG004|Extension|Adverse Event|0|||
144231091|NCT00685399|520043222|FG005|Extension|Adverse Event|0|||
144231092|NCT00685399|520043223|FG006|Extension|Adverse Event|0|||
144231093|NCT00685399|520043224|FG007|Extension|Adverse Event|0|||
144231094|NCT00869999|520043225|FG000|Overall Study|Withdrawal by Subject|1|||
144231095|NCT00869999|520043225|FG000|Overall Study|removed prior to starting therapy|1|||
144231096|NCT00644917|520043227|FG000|Overall Study|Withdrawal by Subject|2|||
144231097|NCT00758485|520043228|FG000|Overall Study|Lost to Follow-up|0|||
144231098|NCT00758485|520043229|FG001|Overall Study|Lost to Follow-up|1|||
144231099|NCT00758485|520043228|FG000|Overall Study|Not Treated|1|||
144231100|NCT00758485|520043229|FG001|Overall Study|Not Treated|2|||
144231101|NCT00921557|520043230|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
144231102|NCT00921557|520043231|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
144231103|NCT00921557|520043232|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
144231104|NCT00921557|520043230|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
144231105|NCT00921557|520043231|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
144231106|NCT00921557|520043232|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
144231107|NCT00921557|520043230|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
144231108|NCT00921557|520043231|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
144231109|NCT00921557|520043232|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
144231110|NCT00921557|520043230|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
144231111|NCT00921557|520043231|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
144231112|NCT00921557|520043232|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
144231113|NCT00921557|520043230|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
144231114|NCT00921557|520043231|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
144231115|NCT00921557|520043232|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
144231116|NCT03259425|520043242|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
144231117|NCT02097238|520043252|FG000|Overall Study|Death|1|||
144231118|NCT02097238|520043252|FG000|Overall Study|Physician Decision|1|||
144231119|NCT02097238|520043252|FG000|Overall Study|Progressive Disease|17|||
144231120|NCT01106911|520043253|FG000|Overall Study|Physician Decision|2|||
144231121|NCT01106911|520043253|FG000|Overall Study|deemed ineligible after screening|3|||
144231122|NCT01282372|520043255|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
144231123|NCT01282372|520043255|FG000|Overall Study|Lost to Follow-up|23|||
144231124|NCT01282372|520043255|FG000|Overall Study|Withdrawal by Subject|11|||
144231125|NCT01282372|520043255|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
144231126|NCT01282372|520043255|FG000|Overall Study|Death|1|||
144231127|NCT01282372|520043255|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
144231128|NCT01282372|520043255|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
144231129|NCT01282372|520043255|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
144231130|NCT01282372|520043255|FG000|Overall Study|Adverse Event|12|||
144231131|NCT01814696|520043256|FG000|Overall Study|Withdrawal by Subject|1|||
144231132|NCT01814696|520043257|FG001|Overall Study|Withdrawal by Subject|0|||
144231133|NCT01814696|520043256|FG000|Overall Study|Randomized to wrong group|1|||
144231134|NCT01814696|520043257|FG001|Overall Study|Randomized to wrong group|0|||
144231135|NCT00713258|520043258|FG000|Overall Study|Adverse Event|2|||
144231136|NCT00713258|520043259|FG001|Overall Study|Adverse Event|4|||
144231137|NCT00713258|520043258|FG000|Overall Study|Non-Compliance|2|||
144231138|NCT00713258|520043259|FG001|Overall Study|Non-Compliance|1|||
144231139|NCT00713258|520043258|FG000|Overall Study|Other|1|||
144231140|NCT00713258|520043259|FG001|Overall Study|Other|1|||
144231141|NCT01322490|520043260|FG000|Treatment Period|Adverse Event|12|||
144231142|NCT01322490|520043261|FG001|Treatment Period|Adverse Event|18|||
144231143|NCT01322490|520043262|FG002|Treatment Period|Adverse Event|15|||
144231144|NCT01322490|520043260|FG000|Treatment Period|Death|5|||
144231145|NCT01322490|520043261|FG001|Treatment Period|Death|7|||
144231146|NCT01322490|520043262|FG002|Treatment Period|Death|3|||
144231147|NCT01322490|520043260|FG000|Treatment Period|Lack of Efficacy|89|||
144231148|NCT01322490|520043261|FG001|Treatment Period|Lack of Efficacy|100|||
144231149|NCT01322490|520043262|FG002|Treatment Period|Lack of Efficacy|112|||
144231150|NCT01322490|520043260|FG000|Treatment Period|Physician Decision|0|||
144231151|NCT01322490|520043261|FG001|Treatment Period|Physician Decision|2|||
144269499|NCT03368807|520189562|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
144269500|NCT03368807|520189562|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
144231152|NCT01322490|520043262|FG002|Treatment Period|Physician Decision|1|||
144231153|NCT01322490|520043260|FG000|Treatment Period|Protocol Violation|7|||
144231154|NCT01322490|520043261|FG001|Treatment Period|Protocol Violation|5|||
144231155|NCT01322490|520043262|FG002|Treatment Period|Protocol Violation|4|||
144231156|NCT01322490|520043260|FG000|Treatment Period|Withdrawal by Subject|14|||
144231157|NCT01322490|520043261|FG001|Treatment Period|Withdrawal by Subject|16|||
144231158|NCT01322490|520043262|FG002|Treatment Period|Withdrawal by Subject|11|||
144231159|NCT01322490|520043260|FG000|Treatment Period|Non-compliance with study drug|0|||
144231160|NCT01322490|520043261|FG001|Treatment Period|Non-compliance with study drug|0|||
144231161|NCT01322490|520043262|FG002|Treatment Period|Non-compliance with study drug|1|||
144231162|NCT01322490|520043260|FG000|Treatment Period|Other per report|2|||
144231163|NCT01322490|520043261|FG001|Treatment Period|Other per report|2|||
144231164|NCT01322490|520043262|FG002|Treatment Period|Other per report|1|||
144231165|NCT01322490|520043260|FG000|Treatment Period|Randomized but Not Treated|3|||
144231166|NCT01322490|520043261|FG001|Treatment Period|Randomized but Not Treated|3|||
144231167|NCT01322490|520043262|FG002|Treatment Period|Randomized but Not Treated|5|||
144231168|NCT01322490|520043260|FG000|Long Term Follow-up Period|Death|235|||
144231169|NCT01322490|520043261|FG001|Long Term Follow-up Period|Death|239|||
144231170|NCT01322490|520043262|FG002|Long Term Follow-up Period|Death|236|||
144231171|NCT01322490|520043260|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
144231172|NCT01322490|520043261|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
144231173|NCT01322490|520043262|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
144231174|NCT01322490|520043260|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
144231175|NCT01322490|520043261|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
144231176|NCT01322490|520043262|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
144231177|NCT01322490|520043260|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
144231178|NCT01322490|520043261|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
144231179|NCT01322490|520043262|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
144231180|NCT01322490|520043260|FG000|Long Term Follow-up Period|Other per report|3|||
144231181|NCT01322490|520043261|FG001|Long Term Follow-up Period|Other per report|2|||
144231182|NCT01322490|520043262|FG002|Long Term Follow-up Period|Other per report|2|||
144231183|NCT01322490|520043260|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
144231184|NCT01322490|520043261|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
144231185|NCT01322490|520043262|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
144231186|NCT02199795|520043264|FG000|Overall Study|no longer met inclusion criteria|1|||
144231187|NCT02199795|520043265|FG001|Overall Study|no longer met inclusion criteria|0|||
144231188|NCT02199795|520043264|FG000|Overall Study|withdrew due to shoulder pain|1|||
144231189|NCT02199795|520043265|FG001|Overall Study|withdrew due to shoulder pain|0|||
144231190|NCT05310071|520043269|FG000|Overall Study|Death|0|||
144231191|NCT05310071|520043270|FG001|Overall Study|Death|3|||
144231192|NCT05310071|520043269|FG000|Overall Study|Adverse Event|4|||
144231193|NCT05310071|520043270|FG001|Overall Study|Adverse Event|31|||
144231194|NCT05310071|520043269|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
144231195|NCT05310071|520043270|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
144231196|NCT05310071|520043269|FG000|Overall Study|Protocol Deviation|2|||
144231197|NCT05310071|520043270|FG001|Overall Study|Protocol Deviation|0|||
144231198|NCT05310071|520043269|FG000|Overall Study|Randomized by Mistake|0|||
144231199|NCT05310071|520043270|FG001|Overall Study|Randomized by Mistake|1|||
144231200|NCT05310071|520043269|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
144231201|NCT05310071|520043270|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
144231202|NCT05310071|520043269|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
144231203|NCT05310071|520043270|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
144231204|NCT05310071|520043269|FG000|Overall Study|Site Terminated by Sponsor|0|||
144231205|NCT05310071|520043270|FG001|Overall Study|Site Terminated by Sponsor|2|||
144231206|NCT05310071|520043269|FG000|Overall Study|Study Terminated by Sponsor|282|||
144231207|NCT05310071|520043270|FG001|Overall Study|Study Terminated by Sponsor|559|||
144231208|NCT05310071|520043269|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
144231209|NCT05310071|520043270|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
144231210|NCT05310071|520043269|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
144231211|NCT05310071|520043270|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
144231212|NCT05310071|520043269|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
144231213|NCT05310071|520043270|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
144231214|NCT05310071|520043269|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
144231215|NCT05310071|520043270|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
144231216|NCT05310071|520043269|FG000|Overall Study|Withdrawal by Participant - Other|25|||
144231217|NCT05310071|520043270|FG001|Overall Study|Withdrawal by Participant - Other|30|||
144231218|NCT05310071|520043269|FG000|Overall Study|Lost to Follow-up|2|||
144231219|NCT05310071|520043270|FG001|Overall Study|Lost to Follow-up|4|||
144231220|NCT05310071|520043269|FG000|Overall Study|Reason Not Specified|1|||
144231221|NCT05310071|520043270|FG001|Overall Study|Reason Not Specified|3|||
144231222|NCT02097745|520043271|FG000|Overall Study|Adverse Event|25|||
144231223|NCT02097745|520043271|FG000|Overall Study|Death|16|||
144231224|NCT02097745|520043271|FG000|Overall Study|Failure to Return|14|||
144231225|NCT02097745|520043271|FG000|Overall Study|Administrative/Other|27|||
144231226|NCT02097745|520043271|FG000|Overall Study|Reason Not Specified|96|||
144231227|NCT02099110|520043274|FG000|Overall Study|Protocol Violation|2|||
144231228|NCT02099110|520043275|FG001|Overall Study|Protocol Violation|1|||
144231229|NCT02099110|520043276|FG002|Overall Study|Protocol Violation|0|||
144231230|NCT02099110|520043277|FG003|Overall Study|Protocol Violation|3|||
144231231|NCT02099110|520043278|FG004|Overall Study|Protocol Violation|1|||
144231232|NCT02099110|520043274|FG000|Overall Study|Participant moved|1|||
144231233|NCT02099110|520043275|FG001|Overall Study|Participant moved|1|||
144231234|NCT02099110|520043276|FG002|Overall Study|Participant moved|1|||
144231235|NCT02099110|520043277|FG003|Overall Study|Participant moved|0|||
144231236|NCT02099110|520043278|FG004|Overall Study|Participant moved|2|||
144231237|NCT02099110|520043274|FG000|Overall Study|Withdrawal by Subject|7|||
144231238|NCT02099110|520043275|FG001|Overall Study|Withdrawal by Subject|11|||
144231239|NCT02099110|520043276|FG002|Overall Study|Withdrawal by Subject|13|||
144231240|NCT02099110|520043277|FG003|Overall Study|Withdrawal by Subject|9|||
144231241|NCT02099110|520043278|FG004|Overall Study|Withdrawal by Subject|13|||
144231242|NCT02099110|520043274|FG000|Overall Study|Adverse Event|3|||
144269501|NCT03368807|520189562|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
144269502|NCT03368807|520189562|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
144269503|NCT01973218|520189583|FG000|Overall Study|Adverse Event|1|||
144231243|NCT02099110|520043275|FG001|Overall Study|Adverse Event|5|||
144231244|NCT02099110|520043276|FG002|Overall Study|Adverse Event|2|||
144231245|NCT02099110|520043277|FG003|Overall Study|Adverse Event|3|||
144231246|NCT02099110|520043278|FG004|Overall Study|Adverse Event|2|||
144231247|NCT02099110|520043274|FG000|Overall Study|Lost to Follow-up|6|||
144231248|NCT02099110|520043275|FG001|Overall Study|Lost to Follow-up|12|||
144231249|NCT02099110|520043276|FG002|Overall Study|Lost to Follow-up|11|||
144231250|NCT02099110|520043277|FG003|Overall Study|Lost to Follow-up|5|||
144231251|NCT02099110|520043278|FG004|Overall Study|Lost to Follow-up|6|||
144231252|NCT02099110|520043274|FG000|Overall Study|Death|0|||
144231253|NCT02099110|520043275|FG001|Overall Study|Death|1|||
144231254|NCT02099110|520043276|FG002|Overall Study|Death|0|||
144231255|NCT02099110|520043277|FG003|Overall Study|Death|0|||
144231256|NCT02099110|520043278|FG004|Overall Study|Death|0|||
144231257|NCT02099110|520043274|FG000|Overall Study|Screen failure|0|||
144231258|NCT02099110|520043275|FG001|Overall Study|Screen failure|0|||
144231259|NCT02099110|520043276|FG002|Overall Study|Screen failure|0|||
144231260|NCT02099110|520043277|FG003|Overall Study|Screen failure|0|||
144231261|NCT02099110|520043278|FG004|Overall Study|Screen failure|1|||
144231262|NCT02099110|520043274|FG000|Overall Study|Non-compliance with study drug|2|||
144231263|NCT02099110|520043275|FG001|Overall Study|Non-compliance with study drug|0|||
144231264|NCT02099110|520043276|FG002|Overall Study|Non-compliance with study drug|0|||
144231265|NCT02099110|520043277|FG003|Overall Study|Non-compliance with study drug|0|||
144231266|NCT02099110|520043278|FG004|Overall Study|Non-compliance with study drug|1|||
144231267|NCT02099110|520043274|FG000|Overall Study|Physician Decision|3|||
144231268|NCT02099110|520043275|FG001|Overall Study|Physician Decision|0|||
144231269|NCT02099110|520043276|FG002|Overall Study|Physician Decision|1|||
144231270|NCT02099110|520043277|FG003|Overall Study|Physician Decision|2|||
144231271|NCT02099110|520043278|FG004|Overall Study|Physician Decision|1|||
144231272|NCT01757184|520043281|FG000|Double-blind Period|Adverse Event|1|||
144231273|NCT01757184|520043282|FG001|Double-blind Period|Adverse Event|0|||
144231274|NCT01757184|520043283|FG002|Double-blind Period|Adverse Event|0|||
144231275|NCT01757184|520043284|FG003|Double-blind Period|Adverse Event|0|||
144231276|NCT01757184|520043281|FG000|Open-label Period|Lost to Follow-up|0|||
144231277|NCT01757184|520043282|FG001|Open-label Period|Lost to Follow-up|0|||
144231278|NCT01757184|520043283|FG002|Open-label Period|Lost to Follow-up|2|||
144231279|NCT01757184|520043284|FG003|Open-label Period|Lost to Follow-up|0|||
144231280|NCT01757184|520043281|FG000|Open-label Period|Withdrawal by Subject|0|||
144231281|NCT01757184|520043282|FG001|Open-label Period|Withdrawal by Subject|0|||
144231282|NCT01757184|520043283|FG002|Open-label Period|Withdrawal by Subject|1|||
144231283|NCT01757184|520043284|FG003|Open-label Period|Withdrawal by Subject|1|||
144231284|NCT01757184|520043281|FG000|Open-label Period|Discontinued by Sponsor|0|||
144231285|NCT01757184|520043282|FG001|Open-label Period|Discontinued by Sponsor|0|||
144231286|NCT01757184|520043283|FG002|Open-label Period|Discontinued by Sponsor|1|||
144231287|NCT01757184|520043284|FG003|Open-label Period|Discontinued by Sponsor|2|||
144231288|NCT03515811|520043285|FG000|Overall Study|Lost to Follow-up|2|||
144231289|NCT03515811|520043286|FG001|Overall Study|Lost to Follow-up|1|||
144231290|NCT03515811|520043285|FG000|Overall Study|Protocol Violation|1|||
144231291|NCT03515811|520043286|FG001|Overall Study|Protocol Violation|1|||
144231292|NCT03515811|520043285|FG000|Overall Study|Death|1|||
144231293|NCT03515811|520043286|FG001|Overall Study|Death|1|||
144231294|NCT03515811|520043285|FG000|Overall Study|Withdrawal by Subject|0|||
144231295|NCT03515811|520043286|FG001|Overall Study|Withdrawal by Subject|2|||
144231296|NCT03515811|520043285|FG000|Overall Study|Technical Problems|1|||
144231297|NCT03515811|520043286|FG001|Overall Study|Technical Problems|0|||
144231298|NCT03515811|520043285|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
144231299|NCT03515811|520043286|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
144231300|NCT03515811|520043285|FG000|Overall Study|COVID-19|0|||
144231301|NCT03515811|520043286|FG001|Overall Study|COVID-19|1|||
144231302|NCT02589639|520043296|FG000|Overall Study|Lost to Follow-up|1|||
144231303|NCT02589639|520043297|FG001|Overall Study|Lost to Follow-up|0|||
144231304|NCT02589639|520043298|FG002|Overall Study|Lost to Follow-up|0|||
144231305|NCT02589639|520043296|FG000|Overall Study|Protocol Violation|1|||
144231306|NCT02589639|520043297|FG001|Overall Study|Protocol Violation|0|||
144231307|NCT02589639|520043298|FG002|Overall Study|Protocol Violation|0|||
144231308|NCT02589639|520043296|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
144231309|NCT02589639|520043297|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
144231310|NCT02589639|520043298|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
144231311|NCT02589639|520043296|FG000|Overall Study|Adverse Event|4|||
144231312|NCT02589639|520043297|FG001|Overall Study|Adverse Event|5|||
144231313|NCT02589639|520043298|FG002|Overall Study|Adverse Event|3|||
144231314|NCT02589639|520043296|FG000|Overall Study|Other reason than specified above|1|||
144231315|NCT02589639|520043297|FG001|Overall Study|Other reason than specified above|2|||
144231316|NCT02589639|520043298|FG002|Overall Study|Other reason than specified above|1|||
144269504|NCT01973218|520189584|FG001|Overall Study|Adverse Event|0|||
144269505|NCT01973218|520189583|FG000|Overall Study|Withdrawal by Subject|1|||
144269506|NCT01973218|520189584|FG001|Overall Study|Withdrawal by Subject|0|||
144269507|NCT02247466|520189585|FG000|Overall Study|Procedure changed to open surgery|0|||
144269508|NCT02247466|520189586|FG001|Overall Study|Procedure changed to open surgery|3|||
144269509|NCT02404545|520189589|FG000|Overall Study|Sponsor Termination|6|||
144231317|NCT02589639|520043296|FG000|Overall Study|Not Treated|0|||
144231318|NCT02589639|520043297|FG001|Overall Study|Not Treated|3|||
144231319|NCT02589639|520043298|FG002|Overall Study|Not Treated|0|||
144231320|NCT01276756|520043299|FG000|Overall Study|Lost to Follow-up|2|||
144231321|NCT01276756|520043300|FG001|Overall Study|Lost to Follow-up|0|||
144231322|NCT01276756|520043299|FG000|Overall Study|Adverse Event|3|||
144231323|NCT01276756|520043300|FG001|Overall Study|Adverse Event|2|||
144231324|NCT00347009|520043303|FG000|Overall Study|Death|1|||
144231325|NCT00347009|520043303|FG000|Overall Study|Adverse Event|6|||
144231326|NCT00347009|520043303|FG000|Overall Study|Withdrawal by Subject|3|||
144231327|NCT00347009|520043303|FG000|Overall Study|Physician Decision|5|||
144231328|NCT00347009|520043303|FG000|Overall Study|Lost to Follow-up|4|||
144231329|NCT00347009|520043303|FG000|Overall Study|Protocol Violation|2|||
144231330|NCT00347009|520043303|FG000|Overall Study|Adverse Laboratory Experience|1|||
144231331|NCT00347009|520043303|FG000|Overall Study|Insufficient Viral Suppression|3|||
144231332|NCT00347009|520043303|FG000|Overall Study|Increased ALT/HBV DNA|1|||
144231333|NCT00347009|520043303|FG000|Overall Study|Serious Adverse Event|1|||
144231334|NCT05868577|520043304|FG000|Overall Study|Lost to Follow-up|5|||
144231335|NCT05868577|520043305|FG001|Overall Study|Lost to Follow-up|5|||
144231336|NCT02522884|520043306|FG000|Overall Study|Withdrawal by Subject|6|||
144231337|NCT02522884|520043306|FG000|Overall Study|Death|3|||
144231338|NCT02522884|520043306|FG000|Overall Study|Missed 12-month Follow-up|9|||
144231339|NCT02630251|520043307|FG000|Overall Study|Physician Decision|0|||
144231340|NCT02630251|520043308|FG001|Overall Study|Physician Decision|0|||
144231341|NCT02630251|520043309|FG002|Overall Study|Physician Decision|1|||
144231342|NCT02630251|520043310|FG003|Overall Study|Physician Decision|0|||
144231343|NCT02968173|520043313|FG000|Overall Study|Withdrawal by Subject|1|||
144231344|NCT04586244|520043314|FG000|Overall Study|Lost to Follow-up|1|||
144231345|NCT04586244|520043315|FG001|Overall Study|Lost to Follow-up|0|||
144231346|NCT04586244|520043316|FG002|Overall Study|Lost to Follow-up|0|||
144231347|NCT04586244|520043317|FG003|Overall Study|Lost to Follow-up|1|||
144231348|NCT04586244|520043318|FG004|Overall Study|Lost to Follow-up|0|||
144231349|NCT04586244|520043314|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
144231350|NCT04586244|520043315|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
144231351|NCT04586244|520043316|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
144231352|NCT04586244|520043317|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
144231353|NCT04586244|520043318|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
144231354|NCT00591565|520043319|FG000|Overall Study|lost follow up, withdrawn|5|||
144231355|NCT03564119|520043322|FG000|Overall Study|Adverse Event|4|||
144231356|NCT03564119|520043323|FG001|Overall Study|Adverse Event|0|||
144231357|NCT03564119|520043322|FG000|Overall Study|Lost to Follow-up|1|||
144231358|NCT03564119|520043323|FG001|Overall Study|Lost to Follow-up|4|||
144231359|NCT03564119|520043322|FG000|Overall Study|Protocol Violation|1|||
144231360|NCT03564119|520043323|FG001|Overall Study|Protocol Violation|0|||
144231361|NCT03564119|520043322|FG000|Overall Study|Withdrawal by Subject|9|||
144231362|NCT03564119|520043323|FG001|Overall Study|Withdrawal by Subject|4|||
144231363|NCT03564119|520043322|FG000|Overall Study|Other Than Specified|0|||
144231364|NCT03564119|520043323|FG001|Overall Study|Other Than Specified|1|||
144231365|NCT00634036|520043324|FG000|Overall Study|Lost to Follow-up|1|||
144231366|NCT00634036|520043325|FG001|Overall Study|Lost to Follow-up|1|||
144231367|NCT00634036|520043324|FG000|Overall Study|Withdrawal by Subject|1|||
144231368|NCT00634036|520043325|FG001|Overall Study|Withdrawal by Subject|1|||
144231369|NCT03896022|520043326|FG000|Overall Study|Withdrawal by Subject|1|||
144231370|NCT03896022|520043327|FG001|Overall Study|Withdrawal by Subject|0|||
144231371|NCT03896022|520043328|FG002|Overall Study|Withdrawal by Subject|0|||
144231372|NCT03896022|520043326|FG000|Overall Study|Did not have procedure|3|||
144231373|NCT03896022|520043327|FG001|Overall Study|Did not have procedure|0|||
144231374|NCT03896022|520043328|FG002|Overall Study|Did not have procedure|0|||
144231375|NCT01131455|520043334|FG000|Overall Study|Death of PI|6|||
144231376|NCT01131455|520043335|FG001|Overall Study|Death of PI|4|||
144231377|NCT01131455|520043336|FG002|Overall Study|Death of PI|0|||
144231378|NCT00764660|520043337|FG000|Overall Study|Adverse Event|6|||
144231379|NCT00764660|520043338|FG001|Overall Study|Adverse Event|3|||
144231380|NCT00764660|520043337|FG000|Overall Study|Lost to Follow-up|3|||
144231381|NCT00764660|520043338|FG001|Overall Study|Lost to Follow-up|4|||
144231382|NCT00764660|520043337|FG000|Overall Study|Withdrawal by Subject|7|||
144231383|NCT00764660|520043338|FG001|Overall Study|Withdrawal by Subject|3|||
144231384|NCT00764660|520043337|FG000|Overall Study|Noncompliance With Protocol|5|||
144231385|NCT00764660|520043338|FG001|Overall Study|Noncompliance With Protocol|1|||
144231386|NCT00764660|520043337|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
144231387|NCT00764660|520043338|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
144231388|NCT02186873|520044789|FG000|Overall Study|Adverse Event|1|||
144231389|NCT02186873|520044790|FG001|Overall Study|Adverse Event|3|||
144231390|NCT02186873|520044789|FG000|Overall Study|Lack of Efficacy|0|||
144231391|NCT02186873|520044790|FG001|Overall Study|Lack of Efficacy|1|||
144231392|NCT02186873|520044789|FG000|Overall Study|Lost to Follow-up|1|||
144231393|NCT02186873|520044790|FG001|Overall Study|Lost to Follow-up|2|||
144231394|NCT02186873|520044789|FG000|Overall Study|Withdrawal by Subject|7|||
144231395|NCT02186873|520044790|FG001|Overall Study|Withdrawal by Subject|2|||
144231396|NCT03694002|520044791|FG000|Overall Study|Progression|4|||
144231397|NCT03694002|520044792|FG001|Overall Study|Progression|2|||
144231398|NCT03694002|520044791|FG000|Overall Study|Adverse Event|2|||
144231399|NCT03694002|520044792|FG001|Overall Study|Adverse Event|0|||
144231400|NCT03694002|520044791|FG000|Overall Study|Other not protocol specified|1|||
144231401|NCT03694002|520044792|FG001|Overall Study|Other not protocol specified|0|||
144231402|NCT03694002|520044791|FG000|Overall Study|Ineligible|0|||
144231403|NCT03694002|520044792|FG001|Overall Study|Ineligible|1|||
144231404|NCT03694002|520044791|FG000|Overall Study|Withdrew consent before starting treatment|0|||
144231405|NCT03694002|520044792|FG001|Overall Study|Withdrew consent before starting treatment|3|||
144231406|NCT05678959|520044793|FG000|Overall Study|Study Terminated by Sponsor|76|||
144231407|NCT05678959|520044794|FG001|Overall Study|Study Terminated by Sponsor|76|||
144231408|NCT05678959|520044793|FG000|Overall Study|Physician Decision|2|||
144231409|NCT05678959|520044794|FG001|Overall Study|Physician Decision|3|||
144231410|NCT05678959|520044793|FG000|Overall Study|Adverse Event|1|||
144231411|NCT05678959|520044794|FG001|Overall Study|Adverse Event|1|||
144231412|NCT05678959|520044793|FG000|Overall Study|Guardian Decision|1|||
144231413|NCT05678959|520044794|FG001|Overall Study|Guardian Decision|0|||
144231414|NCT05678959|520044793|FG000|Overall Study|Protocol Deviation|0|||
144231415|NCT05678959|520044794|FG001|Overall Study|Protocol Deviation|1|||
144231416|NCT05678959|520044793|FG000|Overall Study|Subject Decision|1|||
144231417|NCT05678959|520044794|FG001|Overall Study|Subject Decision|0|||
144231418|NCT05678959|520044793|FG000|Overall Study|Technical Problem|0|||
144231419|NCT05678959|520044794|FG001|Overall Study|Technical Problem|1|||
144231420|NCT06360588|520044795|FG000|Overall Study|Adverse Event|3|||
144231421|NCT06360588|520044795|FG000|Overall Study|Death|2|||
144231422|NCT06360588|520044795|FG000|Overall Study|Disease Progression|14|||
144231423|NCT06360588|520044795|FG000|Overall Study|Withdrawal by Subject|1|||
144231424|NCT06360588|520044795|FG000|Overall Study|Lack of Efficacy|1|||
144231425|NCT06360588|520044795|FG000|Overall Study|Ineligible|1|||
144231426|NCT01481766|520044796|FG000|4 months|Lost to Follow-up|3|||
144231427|NCT01481766|520044797|FG001|4 months|Lost to Follow-up|2|||
144231428|NCT01481766|520044798|FG002|4 months|Lost to Follow-up|1|||
144231429|NCT01481766|520044799|FG003|4 months|Lost to Follow-up|5|||
144231430|NCT01481766|520044796|FG000|12 months|Lost to Follow-up|7|||
144231431|NCT01481766|520044797|FG001|12 months|Lost to Follow-up|8|||
144231432|NCT01481766|520044798|FG002|12 months|Lost to Follow-up|5|||
144231433|NCT01481766|520044799|FG003|12 months|Lost to Follow-up|3|||
144231434|NCT00754234|520044800|FG000|Overall Study|Withdrawal by Subject|3|||
144231435|NCT03868930|520044801|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
144231436|NCT03868930|520044802|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
144231437|NCT03868930|520044801|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
144231438|NCT03868930|520044802|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
144231439|NCT03868930|520044801|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
144231440|NCT03868930|520044802|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
144231441|NCT03868930|520044801|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
144231442|NCT03868930|520044802|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
144231443|NCT03868930|520044801|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
144231444|NCT03868930|520044802|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
144231445|NCT04432831|520044803|FG000|Overall Study|Withdrawal by Subject|24|||
144231446|NCT04432831|520044804|FG001|Overall Study|Withdrawal by Subject|28|||
144231447|NCT04432831|520044805|FG002|Overall Study|Withdrawal by Subject|21|||
144231448|NCT04432831|520044803|FG000|Overall Study|Death|23|||
144231449|NCT04432831|520044804|FG001|Overall Study|Death|23|||
144231450|NCT04432831|520044805|FG002|Overall Study|Death|17|||
144231451|NCT04432831|520044803|FG000|Overall Study|Lost to Follow-up|15|||
144231452|NCT04432831|520044804|FG001|Overall Study|Lost to Follow-up|15|||
144231453|NCT04432831|520044805|FG002|Overall Study|Lost to Follow-up|12|||
144231454|NCT04432831|520044803|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
144231455|NCT04432831|520044804|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
144231456|NCT04432831|520044805|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
144231457|NCT04432831|520044803|FG000|Overall Study|Reason Not Specified|7|||
144231458|NCT04432831|520044804|FG001|Overall Study|Reason Not Specified|11|||
144231459|NCT04432831|520044805|FG002|Overall Study|Reason Not Specified|9|||
144231460|NCT04432831|520044803|FG000|Overall Study|Adverse Event|7|||
144231461|NCT04432831|520044804|FG001|Overall Study|Adverse Event|7|||
144231462|NCT04432831|520044805|FG002|Overall Study|Adverse Event|7|||
144231463|NCT04432831|520044803|FG000|Overall Study|Physician Decision|1|||
144231464|NCT04432831|520044804|FG001|Overall Study|Physician Decision|3|||
144231465|NCT04432831|520044805|FG002|Overall Study|Physician Decision|6|||
144231466|NCT04432831|520044803|FG000|Overall Study|Protocol Violation|1|||
144231467|NCT04432831|520044804|FG001|Overall Study|Protocol Violation|0|||
144231468|NCT04432831|520044805|FG002|Overall Study|Protocol Violation|2|||
144231469|NCT04432831|520044803|FG000|Overall Study|Pregnancy|0|||
144231470|NCT04432831|520044804|FG001|Overall Study|Pregnancy|1|||
144231471|NCT04432831|520044805|FG002|Overall Study|Pregnancy|0|||
144231472|NCT04432831|520044803|FG000|Overall Study|Lack of Efficacy|0|||
144231473|NCT04432831|520044804|FG001|Overall Study|Lack of Efficacy|0|||
144231474|NCT04432831|520044805|FG002|Overall Study|Lack of Efficacy|2|||
144231475|NCT03056638|520044820|FG000|Overall Study|Death|1|||
144231476|NCT03056638|520044821|FG001|Overall Study|Death|0|||
144231477|NCT02530125|520044822|FG000|Completed Treatment|Early termination of study|1|||
144231478|NCT02530125|520044822|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
144231479|NCT00356603|520044823|FG000|Overall Study|Other|6|||
144231480|NCT00356603|520044824|FG001|Overall Study|Other|3|||
144231481|NCT00468481|520044825|FG000|Overall Study|Adverse Event|13|||
144231482|NCT00468481|520044826|FG001|Overall Study|Adverse Event|3|||
144231483|NCT00468481|520044825|FG000|Overall Study|Lost to Follow-up|25|||
144231484|NCT00468481|520044826|FG001|Overall Study|Lost to Follow-up|8|||
144231485|NCT00468481|520044825|FG000|Overall Study|Pregnancy|2|||
144231486|NCT00468481|520044826|FG001|Overall Study|Pregnancy|0|||
144231487|NCT00468481|520044825|FG000|Overall Study|Protocol Violation|18|||
144231488|NCT00468481|520044826|FG001|Overall Study|Protocol Violation|8|||
144231489|NCT00468481|520044825|FG000|Overall Study|Withdrawal by Subject|12|||
144231490|NCT00468481|520044826|FG001|Overall Study|Withdrawal by Subject|3|||
144231491|NCT00468481|520044825|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
144231492|NCT00468481|520044826|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
144231493|NCT00468481|520044825|FG000|Overall Study|Prohibited Medication|1|||
144231494|NCT00468481|520044826|FG001|Overall Study|Prohibited Medication|1|||
144231495|NCT00468481|520044825|FG000|Overall Study|Egg Donor|1|||
144231496|NCT00468481|520044826|FG001|Overall Study|Egg Donor|0|||
144231497|NCT00468481|520044825|FG000|Overall Study|Moved out of area|4|||
144231498|NCT00468481|520044826|FG001|Overall Study|Moved out of area|1|||
144231499|NCT00468481|520044825|FG000|Overall Study|Non-Compliance|5|||
144231500|NCT00468481|520044826|FG001|Overall Study|Non-Compliance|0|||
144231501|NCT00468481|520044825|FG000|Overall Study|Other|6|||
144231502|NCT00468481|520044826|FG001|Overall Study|Other|0|||
144231503|NCT01568034|520044827|FG000|Overall Study|Withdrawal by Subject|1|||
144231504|NCT01568034|520044828|FG001|Overall Study|Withdrawal by Subject|0|||
144231505|NCT01568034|520044829|FG002|Overall Study|Withdrawal by Subject|0|||
144231506|NCT01568034|520044830|FG003|Overall Study|Withdrawal by Subject|0|||
144231507|NCT00728468|520044831|FG000|Overall Study|Enrolled but not treated|1|||
144231508|NCT00728468|520044831|FG000|Overall Study|Death|1|||
144231509|NCT00728468|520044831|FG000|Overall Study|Protocol Violation|4|||
144231510|NCT00728468|520044831|FG000|Overall Study|Objective progression or relapse|9|||
144231511|NCT00728468|520044831|FG000|Overall Study|Study terminated by sponsor|1|||
144231512|NCT01262287|520044832|FG000|Overall Study|Lost to Follow-up|2|||
144231513|NCT01262287|520044833|FG001|Overall Study|Lost to Follow-up|1|||
144269510|NCT02404545|520189590|FG001|Overall Study|Sponsor Termination|6|||
144269511|NCT01324947|520189598|FG000|Overall Study|Adverse Event|7|||
144269512|NCT01324947|520189598|FG000|Overall Study|Death|10|||
144269513|NCT01324947|520189598|FG000|Overall Study|Other|3|||
144269514|NCT01324947|520189598|FG000|Overall Study|Progressive Disease|50|||
144269515|NCT01324947|520189598|FG000|Overall Study|Withdrawal by Subject|3|||
144269516|NCT01324947|520189598|FG000|Overall Study|1 discontinued before starting drug|1|||
144269517|NCT00499122|520191322|FG000|Overall Study|Withdrawal by Subject|2|||
144269518|NCT03312738|520191323|FG000|Overall Study|Progressive disease|58|||
144269519|NCT03312738|520191324|FG001|Overall Study|Progressive disease|67|||
144269520|NCT03312738|520191323|FG000|Overall Study|Patient/guardian decision|13|||
144269521|NCT03312738|520191324|FG001|Overall Study|Patient/guardian decision|5|||
144269522|NCT03312738|520191323|FG000|Overall Study|Adverse Event|5|||
144269523|NCT03312738|520191324|FG001|Overall Study|Adverse Event|3|||
144269524|NCT03312738|520191323|FG000|Overall Study|Protocol deviation|2|||
144269525|NCT03312738|520191324|FG001|Overall Study|Protocol deviation|0|||
144269526|NCT03312738|520191323|FG000|Overall Study|Technical problems|0|||
144269527|NCT03312738|520191324|FG001|Overall Study|Technical problems|1|||
144269528|NCT03312738|520191323|FG000|Overall Study|Physician Decision|2|||
144269529|NCT03312738|520191324|FG001|Overall Study|Physician Decision|3|||
144269530|NCT00607893|520191328|FG000|Overall Study|Lost to Follow-up|4|||
144231514|NCT00596687|520044834|FG000|Overall Study|< 24 hours of insulin treatment|8|||
144231515|NCT00596687|520044835|FG001|Overall Study|< 24 hours of insulin treatment|6|||
144231516|NCT00596687|520044834|FG000|Overall Study|continuous insulin infusion during TPN|2|||
144231517|NCT00596687|520044835|FG001|Overall Study|continuous insulin infusion during TPN|1|||
144231518|NCT00596687|520044834|FG000|Overall Study|Withdrawal by Subject|3|||
144231519|NCT00596687|520044835|FG001|Overall Study|Withdrawal by Subject|1|||
144231520|NCT00596687|520044834|FG000|Overall Study|cancelled surgery|1|||
144231521|NCT00596687|520044835|FG001|Overall Study|cancelled surgery|1|||
144231522|NCT04134767|520044836|FG000|Overall Study|Death|0|||
144231523|NCT04134767|520044837|FG001|Overall Study|Death|1|||
144231524|NCT04134767|520044836|FG000|Overall Study|Removed for harassing staff|0|||
144231525|NCT04134767|520044837|FG001|Overall Study|Removed for harassing staff|1|||
144231526|NCT04134767|520044836|FG000|Overall Study|Lost to Follow-up|44|||
144231527|NCT04134767|520044837|FG001|Overall Study|Lost to Follow-up|40|||
144231528|NCT00638404|520044838|FG000|Overall Study|Physician Decision|8|||
144231529|NCT00638404|520044839|FG001|Overall Study|Physician Decision|0|||
144231530|NCT02492984|520044840|FG000|Overall Study|Adverse Event|1|||
144231531|NCT02492984|520044841|FG001|Overall Study|Adverse Event|0|||
144231532|NCT02492984|520044840|FG000|Overall Study|Protocol Violation|1|||
144231533|NCT02492984|520044841|FG001|Overall Study|Protocol Violation|0|||
144231534|NCT02492984|520044840|FG000|Overall Study|Withdrawal by Subject|1|||
144231535|NCT02492984|520044841|FG001|Overall Study|Withdrawal by Subject|0|||
144231536|NCT02101736|520044842|FG000|Overall Study|Protocol Violation|3|||
144231537|NCT02101736|520044843|FG001|Overall Study|Protocol Violation|0|||
144231538|NCT02101736|520044842|FG000|Overall Study|Withdrawal by Subject|1|||
144231539|NCT02101736|520044843|FG001|Overall Study|Withdrawal by Subject|1|||
144231540|NCT02282631|520044845|FG000|Overall Study|Lost to Follow-up|2|||
144231541|NCT02282631|520044846|FG001|Overall Study|Lost to Follow-up|0|||
144231542|NCT01515865|520044847|FG000|Part A (Open-label)|Other|3|||
144231543|NCT01515865|520044848|FG001|Part A (Open-label)|Other|0|||
144231544|NCT01515865|520044849|FG002|Part A (Open-label)|Other|0|||
144231545|NCT01515865|520044847|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
144231546|NCT01515865|520044848|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
144269531|NCT00607893|520191329|FG001|Overall Study|Lost to Follow-up|0|||
144269532|NCT00607893|520191328|FG000|Overall Study|withdrew due to loss of interest|0|||
144269533|NCT00607893|520191329|FG001|Overall Study|withdrew due to loss of interest|1|||
144269534|NCT00607893|520191328|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
144269535|NCT00607893|520191329|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
144231547|NCT01515865|520044849|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
144231548|NCT01515865|520044847|FG000|Part B (Open-label)|Other|1|||
144269536|NCT00607893|520191328|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
144231549|NCT01515865|520044848|FG001|Part B (Open-label)|Other|0|||
144231550|NCT01515865|520044849|FG002|Part B (Open-label)|Other|0|||
144231551|NCT03691207|520044850|FG000|Overall Study|Death|41|||
144231552|NCT03691207|520044851|FG001|Overall Study|Death|26|||
144269537|NCT00607893|520191329|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
144269538|NCT00607893|520191328|FG000|Overall Study|Declined to be treated|1|||
144269539|NCT00607893|520191329|FG001|Overall Study|Declined to be treated|0|||
144231553|NCT03691207|520044850|FG000|Overall Study|Lost to Follow-up|1|||
144231554|NCT03691207|520044851|FG001|Overall Study|Lost to Follow-up|1|||
144231555|NCT03691207|520044850|FG000|Overall Study|Withdrawal by Subject|2|||
144231556|NCT03691207|520044851|FG001|Overall Study|Withdrawal by Subject|8|||
144231557|NCT03691207|520044850|FG000|Overall Study|Sponsor decision|1|||
144231558|NCT03691207|520044851|FG001|Overall Study|Sponsor decision|7|||
144231559|NCT02453334|520044852|FG000|Overall Study|Death|15|||
144231560|NCT02453334|520044853|FG001|Overall Study|Death|13|||
144231561|NCT02453334|520044852|FG000|Overall Study|Adverse Event|2|||
144231562|NCT02453334|520044853|FG001|Overall Study|Adverse Event|1|||
144231563|NCT02453334|520044852|FG000|Overall Study|Lost to Follow-up|5|||
144231564|NCT02453334|520044853|FG001|Overall Study|Lost to Follow-up|9|||
144231565|NCT02453334|520044852|FG000|Overall Study|Physician Decision|1|||
144231566|NCT02453334|520044853|FG001|Overall Study|Physician Decision|0|||
144231567|NCT02453334|520044852|FG000|Overall Study|Withdrawal by Subject|17|||
144231568|NCT02453334|520044853|FG001|Overall Study|Withdrawal by Subject|13|||
144231569|NCT02453334|520044852|FG000|Overall Study|Other reason|1|||
144231570|NCT02453334|520044853|FG001|Overall Study|Other reason|4|||
144231571|NCT02510664|520044857|FG000|Overall Study|Transferred Care|9|||
144231572|NCT02510664|520044858|FG001|Overall Study|Transferred Care|9|||
144231573|NCT02510664|520044859|FG002|Overall Study|Transferred Care|0|||
144231574|NCT02510664|520044857|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
144231575|NCT02510664|520044858|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
144231576|NCT02510664|520044859|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
144231577|NCT02510664|520044857|FG000|Overall Study|Time Constraints|1|||
144231578|NCT02510664|520044858|FG001|Overall Study|Time Constraints|1|||
144231579|NCT02510664|520044859|FG002|Overall Study|Time Constraints|0|||
144231580|NCT04090060|520044866|FG000|Overall Study|Lost to Follow-up|76|||
144231581|NCT04090060|520044867|FG001|Overall Study|Lost to Follow-up|77|||
144231582|NCT01303172|520044909|FG000|Overall Study|Physician Decision|9|||
144231583|NCT01303172|520044910|FG001|Overall Study|Physician Decision|6|||
144231584|NCT01303172|520044909|FG000|Overall Study|Adverse Event|5|||
144231585|NCT01303172|520044910|FG001|Overall Study|Adverse Event|2|||
144231586|NCT01303172|520044909|FG000|Overall Study|Withdrawal by Subject|4|||
144231587|NCT01303172|520044910|FG001|Overall Study|Withdrawal by Subject|2|||
144231588|NCT01303172|520044909|FG000|Overall Study|Death|20|||
144231589|NCT01303172|520044910|FG001|Overall Study|Death|7|||
144231590|NCT01303172|520044909|FG000|Overall Study|Lack of Efficacy|25|||
144231591|NCT01303172|520044910|FG001|Overall Study|Lack of Efficacy|17|||
144231592|NCT01863667|520044915|FG000|Overall Study|Adverse Event|1|||
144231593|NCT01863667|520044916|FG001|Overall Study|Adverse Event|0|||
144231594|NCT01863667|520044915|FG000|Overall Study|Study terminated by Sponsor|30|||
144231595|NCT01863667|520044916|FG001|Overall Study|Study terminated by Sponsor|30|||
144231596|NCT01863667|520044915|FG000|Overall Study|Withdrawal by Subject|2|||
144231597|NCT01863667|520044916|FG001|Overall Study|Withdrawal by Subject|2|||
144231598|NCT03627546|520044917|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
144231599|NCT03627546|520044918|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
144231600|NCT03627546|520044919|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
144231601|NCT03627546|520044917|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
144231602|NCT03627546|520044918|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
144231603|NCT03627546|520044919|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
144231604|NCT00615550|520044922|FG000|Overall Study|Lost to Follow-up|6|||
144231605|NCT00615550|520044923|FG001|Overall Study|Lost to Follow-up|1|||
144231606|NCT01537042|520044924|FG000|Overall Study|Adverse Event|0|||
144231607|NCT01537042|520044925|FG001|Overall Study|Adverse Event|2|||
144231608|NCT01537042|520044924|FG000|Overall Study|Lack of Efficacy|0|||
144231609|NCT01537042|520044925|FG001|Overall Study|Lack of Efficacy|1|||
144231610|NCT01537042|520044924|FG000|Overall Study|Protocol Violation|0|||
144231611|NCT01537042|520044925|FG001|Overall Study|Protocol Violation|1|||
144231612|NCT01537042|520044924|FG000|Overall Study|Other|0|||
144231613|NCT01537042|520044925|FG001|Overall Study|Other|1|||
144231614|NCT02741076|520044926|FG000|Overall Study|Adverse Event|0|||
144231615|NCT02741076|520044927|FG001|Overall Study|Adverse Event|1|||
144231616|NCT02741076|520044928|FG002|Overall Study|Adverse Event|1|||
144231617|NCT02741076|520044929|FG003|Overall Study|Adverse Event|0|||
144231618|NCT02741076|520044926|FG000|Overall Study|Lack of Efficacy|1|||
144231619|NCT02741076|520044927|FG001|Overall Study|Lack of Efficacy|0|||
144231620|NCT02741076|520044928|FG002|Overall Study|Lack of Efficacy|0|||
144231621|NCT02741076|520044929|FG003|Overall Study|Lack of Efficacy|0|||
144269540|NCT00607893|520191328|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
144231622|NCT02741076|520044926|FG000|Overall Study|Withdrawal by Subject|0|||
144231623|NCT02741076|520044927|FG001|Overall Study|Withdrawal by Subject|1|||
144231624|NCT02741076|520044928|FG002|Overall Study|Withdrawal by Subject|0|||
144231625|NCT02741076|520044929|FG003|Overall Study|Withdrawal by Subject|0|||
144231626|NCT02741076|520044926|FG000|Overall Study|Sponsor Request|2|||
144231627|NCT02741076|520044927|FG001|Overall Study|Sponsor Request|3|||
144231628|NCT02741076|520044928|FG002|Overall Study|Sponsor Request|0|||
144269541|NCT00607893|520191329|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
144231629|NCT02741076|520044929|FG003|Overall Study|Sponsor Request|1|||
144231630|NCT02741076|520044926|FG000|Overall Study|No additional information available|0|||
144231631|NCT02741076|520044927|FG001|Overall Study|No additional information available|0|||
144231632|NCT02741076|520044928|FG002|Overall Study|No additional information available|1|||
144231633|NCT02741076|520044929|FG003|Overall Study|No additional information available|1|||
144231634|NCT02965573|520044932|FG000|Overall Study|Lack of Efficacy|1|||
144231635|NCT02965573|520044933|FG001|Overall Study|Lack of Efficacy|0|||
144231636|NCT01779440|520044935|FG000|Overall Study|Withdrawal by Subject|3|||
144231637|NCT01779440|520044936|FG001|Overall Study|Withdrawal by Subject|5|||
144231638|NCT00315458|520044937|FG000|Overall Study|Administrative|0|||
144231639|NCT00315458|520044938|FG001|Overall Study|Administrative|3|||
144231640|NCT00315458|520044939|FG002|Overall Study|Administrative|8|||
144231641|NCT00315458|520044940|FG003|Overall Study|Administrative|21|||
144231642|NCT00315458|520044937|FG000|Overall Study|Adverse Event|2|||
144231643|NCT00315458|520044938|FG001|Overall Study|Adverse Event|4|||
144231644|NCT00315458|520044939|FG002|Overall Study|Adverse Event|23|||
144231645|NCT00315458|520044940|FG003|Overall Study|Adverse Event|3|||
144231646|NCT00315458|520044937|FG000|Overall Study|Lost to Follow-up|1|||
144231647|NCT00315458|520044938|FG001|Overall Study|Lost to Follow-up|2|||
144231648|NCT00315458|520044939|FG002|Overall Study|Lost to Follow-up|0|||
144231649|NCT00315458|520044940|FG003|Overall Study|Lost to Follow-up|2|||
144231650|NCT00315458|520044937|FG000|Overall Study|Withdrawal by Subject|0|||
144231651|NCT00315458|520044938|FG001|Overall Study|Withdrawal by Subject|3|||
144231652|NCT00315458|520044939|FG002|Overall Study|Withdrawal by Subject|0|||
144231653|NCT00315458|520044940|FG003|Overall Study|Withdrawal by Subject|2|||
144231654|NCT00315458|520044937|FG000|Overall Study|Lack of Efficacy|0|||
144231655|NCT00315458|520044938|FG001|Overall Study|Lack of Efficacy|0|||
144231656|NCT00315458|520044939|FG002|Overall Study|Lack of Efficacy|20|||
144231657|NCT00315458|520044940|FG003|Overall Study|Lack of Efficacy|1|||
144231658|NCT00315458|520044937|FG000|Overall Study|Did not qualify|0|||
144231659|NCT00315458|520044938|FG001|Overall Study|Did not qualify|0|||
144231660|NCT00315458|520044939|FG002|Overall Study|Did not qualify|1|||
144231661|NCT00315458|520044940|FG003|Overall Study|Did not qualify|0|||
144231662|NCT00523848|520044941|FG000|Overall Study|Adverse Event|11|||
144231663|NCT00523848|520044941|FG000|Overall Study|Withdrawal by Subject|2|||
144231664|NCT00523848|520044941|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
144231665|NCT00523848|520044941|FG000|Overall Study|Disease Progression|5|||
144231666|NCT00523848|520044941|FG000|Overall Study|Other, unspecified|4|||
144231667|NCT00086619|520044942|FG000|Overall Study|Withdrawal by Subject|6|||
144231668|NCT00086619|520044943|FG001|Overall Study|Withdrawal by Subject|6|||
144231669|NCT00086619|520044942|FG000|Overall Study|Adverse Event|8|||
144231670|NCT00086619|520044943|FG001|Overall Study|Adverse Event|10|||
144231671|NCT00086619|520044942|FG000|Overall Study|Protocol Violation|1|||
144231672|NCT00086619|520044943|FG001|Overall Study|Protocol Violation|1|||
144231673|NCT00489918|520044944|FG000|Overall Study|Withdrawal by Subject|2|||
144231674|NCT00489918|520044945|FG001|Overall Study|Withdrawal by Subject|1|||
144231675|NCT00489918|520044946|FG002|Overall Study|Withdrawal by Subject|1|||
144231676|NCT00489918|520044947|FG003|Overall Study|Withdrawal by Subject|0|||
144231677|NCT00489918|520044948|FG004|Overall Study|Withdrawal by Subject|1|||
144231678|NCT00489918|520044944|FG000|Overall Study|Adverse Event|0|||
144231679|NCT00489918|520044945|FG001|Overall Study|Adverse Event|1|||
144231680|NCT00489918|520044946|FG002|Overall Study|Adverse Event|1|||
144231681|NCT00489918|520044947|FG003|Overall Study|Adverse Event|0|||
144231682|NCT00489918|520044948|FG004|Overall Study|Adverse Event|0|||
144231683|NCT00489918|520044944|FG000|Overall Study|Lost to Follow-up|0|||
144231684|NCT00489918|520044945|FG001|Overall Study|Lost to Follow-up|0|||
144231685|NCT00489918|520044946|FG002|Overall Study|Lost to Follow-up|1|||
144231686|NCT00489918|520044947|FG003|Overall Study|Lost to Follow-up|1|||
144231687|NCT00489918|520044948|FG004|Overall Study|Lost to Follow-up|0|||
144231688|NCT00489918|520044944|FG000|Overall Study|Physician Decision|0|||
144231689|NCT00489918|520044945|FG001|Overall Study|Physician Decision|0|||
144231690|NCT00489918|520044946|FG002|Overall Study|Physician Decision|1|||
144231691|NCT00489918|520044947|FG003|Overall Study|Physician Decision|0|||
144231692|NCT00489918|520044948|FG004|Overall Study|Physician Decision|0|||
144231693|NCT02748213|520044949|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
144231694|NCT02748213|520044950|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
144231695|NCT02748213|520044949|FG000|Overall Study|Abnormal Laboratory Test|1|||
144231696|NCT02748213|520044950|FG001|Overall Study|Abnormal Laboratory Test|0|||
144231697|NCT02748213|520044949|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
144231698|NCT02748213|520044950|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
144231699|NCT02748213|520044949|FG000|Overall Study|Death|5|||
144231700|NCT02748213|520044950|FG001|Overall Study|Death|3|||
144231701|NCT02748213|520044949|FG000|Overall Study|Insufficient Therapeutic Response|56|||
144231702|NCT02748213|520044950|FG001|Overall Study|Insufficient Therapeutic Response|57|||
144231703|NCT02748213|520044949|FG000|Overall Study|Violation of Selection Criteria|2|||
144231704|NCT02748213|520044950|FG001|Overall Study|Violation of Selection Criteria|0|||
144231705|NCT02748213|520044949|FG000|Overall Study|Protocol Violation|6|||
144231706|NCT02748213|520044950|FG001|Overall Study|Protocol Violation|4|||
144231707|NCT02748213|520044949|FG000|Overall Study|Refused Treatment*|6|||
144231708|NCT02748213|520044950|FG001|Overall Study|Refused Treatment*|6|||
144231709|NCT02748213|520044949|FG000|Overall Study|Failure to Return|1|||
144231710|NCT02748213|520044950|FG001|Overall Study|Failure to Return|0|||
144231711|NCT02748213|520044949|FG000|Overall Study|Other|30|||
144231712|NCT02748213|520044950|FG001|Overall Study|Other|29|||
144231713|NCT00961350|520044952|FG000|Overall Study|Adverse Event|18|||
144231714|NCT00961350|520044953|FG001|Overall Study|Adverse Event|33|||
144231715|NCT00961350|520044952|FG000|Overall Study|Withdrawal by Subject|10|||
144231716|NCT00961350|520044953|FG001|Overall Study|Withdrawal by Subject|10|||
144231717|NCT00961350|520044952|FG000|Overall Study|Lost to Follow-up|3|||
144231718|NCT00961350|520044953|FG001|Overall Study|Lost to Follow-up|3|||
144231719|NCT00961350|520044952|FG000|Overall Study|Misc|16|||
144231720|NCT00961350|520044953|FG001|Overall Study|Misc|21|||
144231721|NCT01500382|520044954|FG000|Washout Period|Study site went out of business|0|||
144231722|NCT01500382|520044955|FG001|Washout Period|Study site went out of business|0|||
144231723|NCT01500382|520044956|FG002|Washout Period|Study site went out of business|1|||
144231724|NCT01500382|520044957|FG003|Washout Period|Study site went out of business|0|||
144231725|NCT04284774|520044964|FG000|Overall Study|Progressive disease|5|||
144231726|NCT01760655|520046498|FG000|Overall Study|Death|18|||
144231727|NCT01760655|520046498|FG000|Overall Study|Physician Decision|1|||
144231728|NCT02498444|520046502|FG000|Overall Study|Withdrawal by Subject|3|||
144231729|NCT02498444|520046503|FG001|Overall Study|Withdrawal by Subject|0|||
144231730|NCT02498444|520046502|FG000|Overall Study|Physician Decision|1|||
144231731|NCT02498444|520046503|FG001|Overall Study|Physician Decision|0|||
144231732|NCT03656692|520046504|FG000|Overall Study|Worsening of disease activity|2|||
144231733|NCT03656692|520046504|FG000|Overall Study|Physician Decision|1|||
144231734|NCT01270464|520046505|FG000|Overall Study|Protocol Violation|4|||
144231735|NCT01270464|520046506|FG001|Overall Study|Protocol Violation|3|||
144231736|NCT01270464|520046507|FG002|Overall Study|Protocol Violation|2|||
144231737|NCT01270464|520046505|FG000|Overall Study|Lack of Efficacy|2|||
144231738|NCT01270464|520046506|FG001|Overall Study|Lack of Efficacy|3|||
144231739|NCT01270464|520046507|FG002|Overall Study|Lack of Efficacy|1|||
144231740|NCT01270464|520046505|FG000|Overall Study|Adverse Event|9|||
144231741|NCT01270464|520046506|FG001|Overall Study|Adverse Event|1|||
144231742|NCT01270464|520046507|FG002|Overall Study|Adverse Event|7|||
144231743|NCT01270464|520046505|FG000|Overall Study|Withdrawal by Subject|2|||
144231744|NCT01270464|520046506|FG001|Overall Study|Withdrawal by Subject|1|||
144231745|NCT01270464|520046507|FG002|Overall Study|Withdrawal by Subject|4|||
144231746|NCT01270464|520046505|FG000|Overall Study|Lost to Follow-up|2|||
144231747|NCT01270464|520046506|FG001|Overall Study|Lost to Follow-up|3|||
144231748|NCT01270464|520046507|FG002|Overall Study|Lost to Follow-up|1|||
144231749|NCT01270464|520046505|FG000|Overall Study|Other|1|||
144231750|NCT01270464|520046506|FG001|Overall Study|Other|1|||
144231751|NCT01270464|520046507|FG002|Overall Study|Other|3|||
144231752|NCT03981900|520046509|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
144231753|NCT03981900|520046509|FG000|Overall Study|Adverse Event|5|||
144231754|NCT03981900|520046509|FG000|Overall Study|Protocol Violation|1|||
144231755|NCT03981900|520046509|FG000|Overall Study|Withdrawal by Subject|7|||
144231756|NCT03981900|520046509|FG000|Overall Study|Lost to Follow-up|46|||
144231757|NCT03981900|520046509|FG000|Overall Study|Decision of the researcher|3|||
144231758|NCT03981900|520046509|FG000|Overall Study|Death|3|||
144231759|NCT03981900|520046509|FG000|Overall Study|Other|5|||
144231760|NCT05656534|520046514|FG000|Overall Study|Withdrawal by Subject|1|||
144231761|NCT05656534|520046515|FG001|Overall Study|Withdrawal by Subject|1|||
144231762|NCT05656534|520046516|FG002|Overall Study|Withdrawal by Subject|0|||
144231763|NCT05656534|520046517|FG003|Overall Study|Withdrawal by Subject|0|||
144231764|NCT05656534|520046514|FG000|Overall Study|Physician Decision|1|||
144231765|NCT05656534|520046515|FG001|Overall Study|Physician Decision|1|||
144231766|NCT05656534|520046516|FG002|Overall Study|Physician Decision|0|||
144231767|NCT05656534|520046517|FG003|Overall Study|Physician Decision|0|||
144231768|NCT02509507|520046521|FG000|Overall Study|Death|21|||
144231769|NCT02509507|520046522|FG001|Overall Study|Death|3|||
144231770|NCT02509507|520046523|FG002|Overall Study|Death|22|||
144231771|NCT02509507|520046524|FG003|Overall Study|Death|14|||
144231772|NCT02509507|520046525|FG004|Overall Study|Death|8|||
144231773|NCT02509507|520046526|FG005|Overall Study|Death|12|||
144231774|NCT02509507|520046527|FG006|Overall Study|Death|5|||
144231775|NCT02509507|520046528|FG007|Overall Study|Death|4|||
144231776|NCT02509507|520046529|FG008|Overall Study|Death|8|||
144231777|NCT02509507|520046521|FG000|Overall Study|Lost to Follow-up|0|||
144231778|NCT02509507|520046522|FG001|Overall Study|Lost to Follow-up|1|||
144231779|NCT02509507|520046523|FG002|Overall Study|Lost to Follow-up|0|||
144231780|NCT02509507|520046524|FG003|Overall Study|Lost to Follow-up|0|||
144231781|NCT02509507|520046525|FG004|Overall Study|Lost to Follow-up|0|||
144231782|NCT02509507|520046526|FG005|Overall Study|Lost to Follow-up|2|||
144231783|NCT02509507|520046527|FG006|Overall Study|Lost to Follow-up|0|||
144231784|NCT02509507|520046528|FG007|Overall Study|Lost to Follow-up|0|||
144231785|NCT02509507|520046529|FG008|Overall Study|Lost to Follow-up|0|||
144231786|NCT02509507|520046521|FG000|Overall Study|Withdrawal by Subject|2|||
144231787|NCT02509507|520046522|FG001|Overall Study|Withdrawal by Subject|0|||
144231788|NCT02509507|520046523|FG002|Overall Study|Withdrawal by Subject|1|||
144231789|NCT02509507|520046524|FG003|Overall Study|Withdrawal by Subject|4|||
144231790|NCT02509507|520046525|FG004|Overall Study|Withdrawal by Subject|1|||
144231791|NCT02509507|520046526|FG005|Overall Study|Withdrawal by Subject|3|||
144231792|NCT02509507|520046527|FG006|Overall Study|Withdrawal by Subject|4|||
144231793|NCT02509507|520046528|FG007|Overall Study|Withdrawal by Subject|0|||
144231794|NCT02509507|520046529|FG008|Overall Study|Withdrawal by Subject|1|||
144231795|NCT00839800|520046532|FG000|Overall Study|Adverse Event|8|||
144231796|NCT00839800|520046533|FG001|Overall Study|Adverse Event|12|||
144231797|NCT00839800|520046532|FG000|Overall Study|Lost to Follow-up|31|||
144231798|NCT00839800|520046533|FG001|Overall Study|Lost to Follow-up|26|||
144231799|NCT00839800|520046532|FG000|Overall Study|Withdrawal by Subject|28|||
144231800|NCT00839800|520046533|FG001|Overall Study|Withdrawal by Subject|34|||
144231801|NCT00839800|520046532|FG000|Overall Study|Incorrect Enrolment|3|||
144231802|NCT00839800|520046533|FG001|Overall Study|Incorrect Enrolment|3|||
144231803|NCT00839800|520046532|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
144231804|NCT00839800|520046533|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
144231805|NCT00839800|520046532|FG000|Overall Study|Safety Reasons|2|||
144231806|NCT00839800|520046533|FG001|Overall Study|Safety Reasons|1|||
144231807|NCT00839800|520046532|FG000|Overall Study|Other|8|||
144231808|NCT00839800|520046533|FG001|Overall Study|Other|14|||
144231809|NCT00839800|520046532|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
144231810|NCT00839800|520046533|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
144231811|NCT02801617|520046536|FG000|Overall Study|Protocol Violation|2|||
144231812|NCT02801617|520046537|FG001|Overall Study|Protocol Violation|6|||
144231813|NCT01164579|520046538|FG000|Overall Study|Lack of Efficacy|0|||
144231814|NCT01164579|520046539|FG001|Overall Study|Lack of Efficacy|0|||
144231815|NCT01164579|520046540|FG002|Overall Study|Lack of Efficacy|6|||
144231816|NCT01164579|520046538|FG000|Overall Study|Lost to Follow-up|1|||
144231817|NCT01164579|520046539|FG001|Overall Study|Lost to Follow-up|1|||
144231818|NCT01164579|520046540|FG002|Overall Study|Lost to Follow-up|0|||
144231819|NCT01164579|520046538|FG000|Overall Study|Withdrawal by Subject|2|||
144231820|NCT01164579|520046539|FG001|Overall Study|Withdrawal by Subject|5|||
144231821|NCT01164579|520046540|FG002|Overall Study|Withdrawal by Subject|3|||
144231822|NCT01164579|520046538|FG000|Overall Study|Protocol Violation|0|||
144231823|NCT01164579|520046539|FG001|Overall Study|Protocol Violation|1|||
144231824|NCT01164579|520046540|FG002|Overall Study|Protocol Violation|2|||
144231825|NCT01164579|520046538|FG000|Overall Study|Adverse Event|4|||
144231826|NCT01164579|520046539|FG001|Overall Study|Adverse Event|2|||
144231827|NCT01164579|520046540|FG002|Overall Study|Adverse Event|5|||
144231828|NCT01164579|520046538|FG000|Overall Study|Reason not specified|1|||
144231829|NCT01164579|520046539|FG001|Overall Study|Reason not specified|0|||
144231830|NCT01164579|520046540|FG002|Overall Study|Reason not specified|0|||
144231831|NCT02176655|520046544|FG000|Overall Study|Subjects did not treat|6|||
144231832|NCT06110494|520046545|FG000|Overall Study|Protocol Violation|2|||
144231833|NCT06110494|520046546|FG001|Overall Study|Protocol Violation|0|||
144231834|NCT06110494|520046547|FG002|Overall Study|Protocol Violation|1|||
144231835|NCT06110494|520046545|FG000|Overall Study|Dixon's test for outlier analysis|1|||
144231836|NCT06110494|520046546|FG001|Overall Study|Dixon's test for outlier analysis|1|||
144231837|NCT06110494|520046547|FG002|Overall Study|Dixon's test for outlier analysis|0|||
144231838|NCT00302328|520046548|FG000|Overall Study|Physician Decision|0|||
144231839|NCT00302328|520046549|FG001|Overall Study|Physician Decision|1|||
144231840|NCT00302328|520046550|FG002|Overall Study|Physician Decision|0|||
144231841|NCT01288937|520046553|FG000|Overall Study|Adverse Event|1|||
144231842|NCT01288937|520046554|FG001|Overall Study|Adverse Event|0|||
144231843|NCT02490371|520046555|FG000|Overall Study|Lost to Follow-up|1|||
144231844|NCT02490371|520046556|FG001|Overall Study|Lost to Follow-up|1|||
144231845|NCT01718535|520046557|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
144231846|NCT01718535|520046558|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
144231847|NCT01718535|520046559|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
144231848|NCT01718535|520046560|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
144231849|NCT01718535|520046561|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
144231850|NCT01718535|520046562|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
144231851|NCT01718535|520046563|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
144231852|NCT01718535|520046564|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
144231853|NCT01718535|520046565|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
144231854|NCT01718535|520046566|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
144231855|NCT01163851|520046569|FG000|Overall Study|Site Closure|0|||
144231856|NCT01163851|520046570|FG001|Overall Study|Site Closure|1|||
144231857|NCT01163851|520046569|FG000|Overall Study|Enrolled but not treated|1|||
144231858|NCT01163851|520046570|FG001|Overall Study|Enrolled but not treated|0|||
144231859|NCT01073605|520046574|FG000|Overall Study|Ongoing at Cutoff Date|1|||
144231860|NCT01073605|520046575|FG001|Overall Study|Ongoing at Cutoff Date|1|||
144231861|NCT01073605|520046576|FG002|Overall Study|Ongoing at Cutoff Date|0|||
144231862|NCT01073605|520046574|FG000|Overall Study|Adverse Event|2|||
144231863|NCT01073605|520046575|FG001|Overall Study|Adverse Event|1|||
144231864|NCT01073605|520046576|FG002|Overall Study|Adverse Event|0|||
144231865|NCT01073605|520046574|FG000|Overall Study|Lost to Follow-up|3|||
144231866|NCT01073605|520046575|FG001|Overall Study|Lost to Follow-up|4|||
144231867|NCT01073605|520046576|FG002|Overall Study|Lost to Follow-up|9|||
144231868|NCT01073605|520046574|FG000|Overall Study|Other|25|||
144231869|NCT01073605|520046575|FG001|Overall Study|Other|21|||
144231870|NCT01073605|520046576|FG002|Overall Study|Other|29|||
144231871|NCT01073605|520046574|FG000|Overall Study|Withdrawal by Subject|31|||
144231872|NCT01073605|520046575|FG001|Overall Study|Withdrawal by Subject|39|||
144231873|NCT01073605|520046576|FG002|Overall Study|Withdrawal by Subject|22|||
144231874|NCT01073605|520046574|FG000|Overall Study|Randomized But Not Treated|0|||
144231875|NCT01073605|520046575|FG001|Overall Study|Randomized But Not Treated|1|||
144231876|NCT01073605|520046576|FG002|Overall Study|Randomized But Not Treated|1|||
144231877|NCT03018080|520046577|FG000|Overall Study|Death|12|||
144231878|NCT03018080|520046578|FG001|Overall Study|Death|19|||
144231879|NCT00740792|520046579|FG000|Overall Study|Adverse Event|3|||
144231880|NCT00740792|520046580|FG001|Overall Study|Adverse Event|1|||
144231881|NCT00740792|520046581|FG002|Overall Study|Adverse Event|1|||
144231882|NCT00740792|520046582|FG003|Overall Study|Adverse Event|3|||
144231883|NCT00740792|520046579|FG000|Overall Study|Lack of Efficacy|1|||
144231884|NCT00740792|520046580|FG001|Overall Study|Lack of Efficacy|1|||
144231885|NCT00740792|520046581|FG002|Overall Study|Lack of Efficacy|0|||
144231886|NCT00740792|520046582|FG003|Overall Study|Lack of Efficacy|3|||
144231887|NCT00740792|520046579|FG000|Overall Study|Lost to Follow-up|2|||
144231888|NCT00740792|520046580|FG001|Overall Study|Lost to Follow-up|1|||
144231889|NCT00740792|520046581|FG002|Overall Study|Lost to Follow-up|0|||
144231890|NCT00740792|520046582|FG003|Overall Study|Lost to Follow-up|0|||
144231891|NCT00740792|520046579|FG000|Overall Study|Protocol Violation|0|||
144231892|NCT00740792|520046580|FG001|Overall Study|Protocol Violation|1|||
144231893|NCT00740792|520046581|FG002|Overall Study|Protocol Violation|0|||
144231894|NCT00740792|520046582|FG003|Overall Study|Protocol Violation|2|||
144231895|NCT00740792|520046579|FG000|Overall Study|Withdrawal by Subject|1|||
144231896|NCT00740792|520046580|FG001|Overall Study|Withdrawal by Subject|1|||
144231897|NCT00740792|520046581|FG002|Overall Study|Withdrawal by Subject|0|||
144231898|NCT00740792|520046582|FG003|Overall Study|Withdrawal by Subject|0|||
144231899|NCT00740792|520046579|FG000|Overall Study|administrative|3|||
144231900|NCT00740792|520046580|FG001|Overall Study|administrative|3|||
144231901|NCT00740792|520046581|FG002|Overall Study|administrative|8|||
144231902|NCT00740792|520046582|FG003|Overall Study|administrative|2|||
144231903|NCT00912743|520046587|FG000|Overall Study|Adverse Event|3|||
144231904|NCT00912743|520046588|FG001|Overall Study|Adverse Event|1|||
144231905|NCT00912743|520046587|FG000|Overall Study|Lack of Efficacy|9|||
144231906|NCT00912743|520046588|FG001|Overall Study|Lack of Efficacy|18|||
144231907|NCT00912743|520046587|FG000|Overall Study|Toxicity|0|||
144231908|NCT00912743|520046588|FG001|Overall Study|Toxicity|1|||
144231909|NCT00912743|520046587|FG000|Overall Study|End of treatment form was not collected|1|||
144231910|NCT00912743|520046588|FG001|Overall Study|End of treatment form was not collected|0|||
144231911|NCT00179660|520046598|FG000|Overall Study|Adverse Event|7|||
144269542|NCT01799941|520191330|FG000|Overall Study|Adverse Event|34|||
144231912|NCT00179660|520046598|FG000|Overall Study|Lack of therapeutic effect|28|||
144231913|NCT00179660|520046598|FG000|Overall Study|Withdrawal by Subject|2|||
144231914|NCT00179660|520046598|FG000|Overall Study|Lost to Follow-up|1|||
144231915|NCT00179660|520046598|FG000|Overall Study|Death|3|||
144231916|NCT00179660|520046598|FG000|Overall Study|Other - Unspecified|9|||
144231917|NCT04478695|520046601|FG000|Overall Study|Death|1|||
144231918|NCT04478695|520046602|FG001|Overall Study|Death|0|||
144231919|NCT00402688|520046603|FG000|Overall Study|Adverse Event|12|||
144231920|NCT00402688|520046604|FG001|Overall Study|Adverse Event|9|||
144231921|NCT00402688|520046605|FG002|Overall Study|Adverse Event|3|||
144231922|NCT00402688|520046603|FG000|Overall Study|Withdrawal by Subject|3|||
144231923|NCT00402688|520046604|FG001|Overall Study|Withdrawal by Subject|1|||
144231924|NCT00402688|520046605|FG002|Overall Study|Withdrawal by Subject|1|||
144231925|NCT00402688|520046603|FG000|Overall Study|Physician Decision|0|||
144231926|NCT00402688|520046604|FG001|Overall Study|Physician Decision|0|||
144231927|NCT00402688|520046605|FG002|Overall Study|Physician Decision|1|||
144231928|NCT00402688|520046603|FG000|Overall Study|Lack of Efficacy|4|||
144231929|NCT00402688|520046604|FG001|Overall Study|Lack of Efficacy|4|||
144231930|NCT00402688|520046605|FG002|Overall Study|Lack of Efficacy|5|||
144231931|NCT00402688|520046603|FG000|Overall Study|Protocol Violation|1|||
144231932|NCT00402688|520046604|FG001|Overall Study|Protocol Violation|1|||
144231933|NCT00402688|520046605|FG002|Overall Study|Protocol Violation|1|||
144231934|NCT00402688|520046603|FG000|Overall Study|Lost to Follow-up|1|||
144231935|NCT00402688|520046604|FG001|Overall Study|Lost to Follow-up|0|||
144231936|NCT00402688|520046605|FG002|Overall Study|Lost to Follow-up|2|||
144231937|NCT00402688|520046603|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
144231938|NCT00402688|520046604|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
144231939|NCT00402688|520046605|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
144269543|NCT01799941|520191330|FG000|Overall Study|Withdrawal by Subject|21|||
144269544|NCT01799941|520191330|FG000|Overall Study|Death|2|||
144231940|NCT00402688|520046603|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
144231941|NCT00402688|520046604|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
144231942|NCT00402688|520046605|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
144269545|NCT01799941|520191330|FG000|Overall Study|Investigator Decision|4|||
144231943|NCT00402688|520046603|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
144231944|NCT00402688|520046604|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
144231945|NCT00402688|520046605|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
144231946|NCT02347774|520046606|FG000|Study Participation|Lost to Follow-up|3|||
144231947|NCT02347774|520046607|FG001|Study Participation|Lost to Follow-up|6|||
144231948|NCT02347774|520046608|FG002|Study Participation|Lost to Follow-up|2|||
144231949|NCT02347774|520046606|FG000|Study Participation|Withdrawal by Subject|8|||
144231950|NCT02347774|520046607|FG001|Study Participation|Withdrawal by Subject|9|||
144231951|NCT02347774|520046608|FG002|Study Participation|Withdrawal by Subject|15|||
144231952|NCT02347774|520046606|FG000|Study Participation|Adverse Event|1|||
144231953|NCT02347774|520046607|FG001|Study Participation|Adverse Event|4|||
144231954|NCT02347774|520046608|FG002|Study Participation|Adverse Event|6|||
144231955|NCT02347774|520046606|FG000|Study Participation|withdrew consent|1|||
144231956|NCT02347774|520046607|FG001|Study Participation|withdrew consent|1|||
144231957|NCT02347774|520046608|FG002|Study Participation|withdrew consent|1|||
144231958|NCT02347774|520046606|FG000|Study Participation|Met Prolonged QT criteria|1|||
144231959|NCT02347774|520046607|FG001|Study Participation|Met Prolonged QT criteria|0|||
144231960|NCT02347774|520046608|FG002|Study Participation|Met Prolonged QT criteria|0|||
144231961|NCT02347774|520046606|FG000|Study Participation|non-compliance with study drug|0|||
144231962|NCT02347774|520046607|FG001|Study Participation|non-compliance with study drug|1|||
144231963|NCT02347774|520046608|FG002|Study Participation|non-compliance with study drug|0|||
144231964|NCT02347774|520046606|FG000|Study Participation|incarceration|1|||
144231965|NCT02347774|520046607|FG001|Study Participation|incarceration|0|||
144231966|NCT02347774|520046608|FG002|Study Participation|incarceration|0|||
144231967|NCT02347774|520046606|FG000|Study Participation|randomized in error|0|||
144231968|NCT02347774|520046607|FG001|Study Participation|randomized in error|0|||
144231969|NCT02347774|520046608|FG002|Study Participation|randomized in error|1|||
144231970|NCT02347774|520046606|FG000|On Study Treatment|Adverse Event|9|||
144231971|NCT02347774|520046607|FG001|On Study Treatment|Adverse Event|15|||
144231972|NCT02347774|520046608|FG002|On Study Treatment|Adverse Event|19|||
144231973|NCT02347774|520046606|FG000|On Study Treatment|Lack of Efficacy|3|||
144231974|NCT02347774|520046607|FG001|On Study Treatment|Lack of Efficacy|0|||
144231975|NCT02347774|520046608|FG002|On Study Treatment|Lack of Efficacy|2|||
144231976|NCT02347774|520046606|FG000|On Study Treatment|non-complicance with study medication|0|||
144231977|NCT02347774|520046607|FG001|On Study Treatment|non-complicance with study medication|2|||
144231978|NCT02347774|520046608|FG002|On Study Treatment|non-complicance with study medication|0|||
144231979|NCT02347774|520046606|FG000|On Study Treatment|Protocol Violation|0|||
144231980|NCT02347774|520046607|FG001|On Study Treatment|Protocol Violation|0|||
144231981|NCT02347774|520046608|FG002|On Study Treatment|Protocol Violation|1|||
144231982|NCT02347774|520046606|FG000|On Study Treatment|withdrew consent|9|||
144231983|NCT02347774|520046607|FG001|On Study Treatment|withdrew consent|8|||
144231984|NCT02347774|520046608|FG002|On Study Treatment|withdrew consent|12|||
144231985|NCT02347774|520046606|FG000|On Study Treatment|Lost to Follow-up|2|||
144231986|NCT02347774|520046607|FG001|On Study Treatment|Lost to Follow-up|6|||
144231987|NCT02347774|520046608|FG002|On Study Treatment|Lost to Follow-up|1|||
144231988|NCT02347774|520046606|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
144231989|NCT02347774|520046607|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
144231990|NCT02347774|520046608|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
144231991|NCT02347774|520046606|FG000|On Study Treatment|ranomized in error|0|||
144231992|NCT02347774|520046607|FG001|On Study Treatment|ranomized in error|0|||
144231993|NCT02347774|520046608|FG002|On Study Treatment|ranomized in error|1|||
144231994|NCT00927862|520046609|FG000|Overall Study|Missing data needed for endpt analyses|27|||
144231995|NCT00927862|520046610|FG001|Overall Study|Missing data needed for endpt analyses|45|||
144231996|NCT00820248|520046612|FG000|Overall Study|No treated|4|||
144231997|NCT00820248|520046613|FG001|Overall Study|No treated|1|||
144231998|NCT02237196|520046614|FG000|Overall Study|Adverse Event|0|||
144231999|NCT02237196|520046615|FG001|Overall Study|Adverse Event|1|||
144232000|NCT02237196|520046616|FG002|Overall Study|Adverse Event|1|||
144232001|NCT02237196|520046617|FG003|Overall Study|Adverse Event|0|||
144232002|NCT02237196|520046614|FG000|Overall Study|Lost to Follow-up|4|||
144232003|NCT02237196|520046615|FG001|Overall Study|Lost to Follow-up|2|||
144232004|NCT02237196|520046616|FG002|Overall Study|Lost to Follow-up|4|||
144232005|NCT02237196|520046617|FG003|Overall Study|Lost to Follow-up|6|||
144232006|NCT02237196|520046614|FG000|Overall Study|Physician Decision|2|||
144232007|NCT02237196|520046615|FG001|Overall Study|Physician Decision|0|||
144232008|NCT02237196|520046616|FG002|Overall Study|Physician Decision|0|||
144232009|NCT02237196|520046617|FG003|Overall Study|Physician Decision|1|||
144232010|NCT02237196|520046614|FG000|Overall Study|Pregnancy|0|||
144232011|NCT02237196|520046615|FG001|Overall Study|Pregnancy|0|||
144232012|NCT02237196|520046616|FG002|Overall Study|Pregnancy|1|||
144232013|NCT02237196|520046617|FG003|Overall Study|Pregnancy|1|||
144232014|NCT02237196|520046614|FG000|Overall Study|Withdrawal by Subject|1|||
144232015|NCT02237196|520046615|FG001|Overall Study|Withdrawal by Subject|1|||
144232016|NCT02237196|520046616|FG002|Overall Study|Withdrawal by Subject|4|||
144232017|NCT02237196|520046617|FG003|Overall Study|Withdrawal by Subject|1|||
144232018|NCT02237196|520046614|FG000|Overall Study|Site Error|1|||
144232019|NCT02237196|520046615|FG001|Overall Study|Site Error|2|||
144232020|NCT02237196|520046616|FG002|Overall Study|Site Error|0|||
144232021|NCT02237196|520046617|FG003|Overall Study|Site Error|2|||
144269546|NCT01799941|520191330|FG000|Overall Study|Lack of Efficacy|3|||
144232022|NCT04157296|520046618|FG000|Overall Study|Withdrawal by Subject|0|||
144232023|NCT04157296|520046619|FG001|Overall Study|Withdrawal by Subject|1|||
144232024|NCT04157296|520046618|FG000|Overall Study|Did not obtain second fMRI.|0|||
144232025|NCT04157296|520046619|FG001|Overall Study|Did not obtain second fMRI.|1|||
144232026|NCT04157296|520046618|FG000|Overall Study|MRI failed/no second fMRI|0|||
144232027|NCT04157296|520046619|FG001|Overall Study|MRI failed/no second fMRI|1|||
144232028|NCT01431716|520046633|FG000|Overall Study|Withdrawal of consent|1|||
144232029|NCT05708976|520046637|FG000|Overall Study|Withdrawal by Subject|0|||
144232030|NCT05708976|520046638|FG001|Overall Study|Withdrawal by Subject|1|||
144232031|NCT00183885|520046641|FG000|Overall Study|Adverse Event|11|||
144232032|NCT00183885|520046641|FG000|Overall Study|Death|1|||
144232033|NCT00183885|520046641|FG000|Overall Study|Lost to Follow-up|3|||
144232034|NCT00183885|520046641|FG000|Overall Study|Physician Decision|6|||
144232035|NCT00183885|520046641|FG000|Overall Study|Withdrawal by Subject|5|||
144232036|NCT00183885|520046641|FG000|Overall Study|Switched to alternative treatment|8|||
144232037|NCT00183885|520046641|FG000|Overall Study|Treatment delayed too long|4|||
144232038|NCT00183885|520046641|FG000|Overall Study|Developed second malignancy|1|||
144232039|NCT00014495|520046642|FG000|Overall Study|Death|0|||
144232040|NCT00014495|520046643|FG001|Overall Study|Death|0|||
144232041|NCT00014495|520046644|FG002|Overall Study|Death|1|||
144232042|NCT00014495|520046645|FG003|Overall Study|Death|0|||
144232043|NCT00014495|520046642|FG000|Overall Study|Clinical deterioration|0|||
144232044|NCT00014495|520046643|FG001|Overall Study|Clinical deterioration|0|||
144232045|NCT00014495|520046644|FG002|Overall Study|Clinical deterioration|0|||
144232046|NCT00014495|520046645|FG003|Overall Study|Clinical deterioration|1|||
144232047|NCT02091089|520046647|FG000|Overall Study|Lost to Follow-up|2|||
144232048|NCT02929589|520046648|FG000|Overall Study|Withdrawal by Subject|1|||
144232049|NCT02929589|520046649|FG001|Overall Study|Withdrawal by Subject|0|||
144232050|NCT02929589|520046650|FG002|Overall Study|Withdrawal by Subject|0|||
144232051|NCT02929589|520046651|FG003|Overall Study|Withdrawal by Subject|0|||
144232052|NCT02929589|520046648|FG000|Overall Study|Physician Decision|2|||
144232053|NCT02929589|520046649|FG001|Overall Study|Physician Decision|0|||
144232054|NCT02929589|520046650|FG002|Overall Study|Physician Decision|0|||
144232055|NCT02929589|520046651|FG003|Overall Study|Physician Decision|0|||
144232056|NCT00994461|520046660|FG000|Overall Study|Adverse Event|2|||
144232057|NCT00994461|520046661|FG001|Overall Study|Adverse Event|1|||
144232058|NCT00994461|520046662|FG002|Overall Study|Adverse Event|0|||
144232059|NCT01637922|520048696|FG000|Overall Study|Adverse Event|0|||
144232060|NCT01637922|520048697|FG001|Overall Study|Adverse Event|1|||
144232061|NCT01637922|520048696|FG000|Overall Study|Protocol Violation|0|||
144232062|NCT01637922|520048697|FG001|Overall Study|Protocol Violation|1|||
144232063|NCT01637922|520048696|FG000|Overall Study|Withdrawal by Subject|0|||
144232064|NCT01637922|520048697|FG001|Overall Study|Withdrawal by Subject|3|||
144232065|NCT01637922|520048696|FG000|Overall Study|Lost to Follow-up|2|||
144232066|NCT01637922|520048697|FG001|Overall Study|Lost to Follow-up|0|||
144232067|NCT01136356|520048698|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
144232068|NCT01136356|520048699|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
144232069|NCT01136356|520048698|FG000|First 18-day Withdrawal|Physician Decision|1|||
144232070|NCT01136356|520048699|FG001|First 18-day Withdrawal|Physician Decision|0|||
144232071|NCT01136356|520048698|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
144232072|NCT01136356|520048699|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
144232073|NCT00267969|520048700|FG000|Controlled Period|Adverse Event|6|||
144232074|NCT00267969|520048701|FG001|Controlled Period|Adverse Event|0|||
144232075|NCT00267969|520048702|FG002|Controlled Period|Adverse Event|2|||
144232076|NCT00267969|520048703|FG003|Controlled Period|Adverse Event|0|||
144232077|NCT00267969|520048704|FG004|Controlled Period|Adverse Event|0|||
144232078|NCT00267969|520048705|FG005|Controlled Period|Adverse Event|0|||
144232079|NCT00267969|520048706|FG006|Controlled Period|Adverse Event|0|||
144232080|NCT00267969|520048700|FG000|Controlled Period|Lack of Efficacy|3|||
144232081|NCT00267969|520048701|FG001|Controlled Period|Lack of Efficacy|0|||
144232082|NCT00267969|520048702|FG002|Controlled Period|Lack of Efficacy|1|||
144232083|NCT00267969|520048703|FG003|Controlled Period|Lack of Efficacy|0|||
144232084|NCT00267969|520048704|FG004|Controlled Period|Lack of Efficacy|0|||
144232085|NCT00267969|520048705|FG005|Controlled Period|Lack of Efficacy|0|||
144232086|NCT00267969|520048706|FG006|Controlled Period|Lack of Efficacy|0|||
144232087|NCT00267969|520048700|FG000|Controlled Period|Lost to Follow-up|1|||
144232088|NCT00267969|520048701|FG001|Controlled Period|Lost to Follow-up|0|||
144232089|NCT00267969|520048702|FG002|Controlled Period|Lost to Follow-up|1|||
144232090|NCT00267969|520048703|FG003|Controlled Period|Lost to Follow-up|0|||
144232091|NCT00267969|520048704|FG004|Controlled Period|Lost to Follow-up|0|||
144232092|NCT00267969|520048705|FG005|Controlled Period|Lost to Follow-up|0|||
144232093|NCT00267969|520048706|FG006|Controlled Period|Lost to Follow-up|0|||
144232094|NCT00267969|520048700|FG000|Controlled Period|Randomized but not treated|0|||
144232095|NCT00267969|520048701|FG001|Controlled Period|Randomized but not treated|0|||
144232096|NCT00267969|520048702|FG002|Controlled Period|Randomized but not treated|1|||
144232097|NCT00267969|520048703|FG003|Controlled Period|Randomized but not treated|0|||
144232098|NCT00267969|520048704|FG004|Controlled Period|Randomized but not treated|0|||
144232099|NCT00267969|520048705|FG005|Controlled Period|Randomized but not treated|0|||
144232100|NCT00267969|520048706|FG006|Controlled Period|Randomized but not treated|0|||
144232101|NCT00267969|520048700|FG000|Controlled Period|Other|2|||
144232102|NCT00267969|520048701|FG001|Controlled Period|Other|1|||
144232103|NCT00267969|520048702|FG002|Controlled Period|Other|6|||
144232104|NCT00267969|520048703|FG003|Controlled Period|Other|0|||
144232105|NCT00267969|520048704|FG004|Controlled Period|Other|0|||
144232106|NCT00267969|520048705|FG005|Controlled Period|Other|0|||
144232107|NCT00267969|520048706|FG006|Controlled Period|Other|0|||
144232108|NCT00267969|520048700|FG000|After Controlled Period|Adverse Event|0|||
144232109|NCT00267969|520048701|FG001|After Controlled Period|Adverse Event|0|||
144232110|NCT00267969|520048702|FG002|After Controlled Period|Adverse Event|0|||
144232111|NCT00267969|520048703|FG003|After Controlled Period|Adverse Event|7|||
144232112|NCT00267969|520048704|FG004|After Controlled Period|Adverse Event|8|||
144232113|NCT00267969|520048705|FG005|After Controlled Period|Adverse Event|23|||
144232114|NCT00267969|520048706|FG006|After Controlled Period|Adverse Event|21|||
144232115|NCT00267969|520048700|FG000|After Controlled Period|Death|0|||
144232116|NCT00267969|520048701|FG001|After Controlled Period|Death|0|||
144232117|NCT00267969|520048702|FG002|After Controlled Period|Death|0|||
144232118|NCT00267969|520048703|FG003|After Controlled Period|Death|1|||
144232119|NCT00267969|520048704|FG004|After Controlled Period|Death|2|||
144232120|NCT00267969|520048705|FG005|After Controlled Period|Death|0|||
144232121|NCT00267969|520048706|FG006|After Controlled Period|Death|1|||
144232122|NCT00267969|520048700|FG000|After Controlled Period|Lack of Efficacy|0|||
144232123|NCT00267969|520048701|FG001|After Controlled Period|Lack of Efficacy|0|||
144232124|NCT00267969|520048702|FG002|After Controlled Period|Lack of Efficacy|0|||
144232125|NCT00267969|520048703|FG003|After Controlled Period|Lack of Efficacy|10|||
144232126|NCT00267969|520048704|FG004|After Controlled Period|Lack of Efficacy|6|||
144232127|NCT00267969|520048705|FG005|After Controlled Period|Lack of Efficacy|28|||
144232128|NCT00267969|520048706|FG006|After Controlled Period|Lack of Efficacy|15|||
144232129|NCT00267969|520048700|FG000|After Controlled Period|Lost to Follow-up|0|||
144232130|NCT00267969|520048701|FG001|After Controlled Period|Lost to Follow-up|0|||
144232131|NCT00267969|520048702|FG002|After Controlled Period|Lost to Follow-up|0|||
144232132|NCT00267969|520048703|FG003|After Controlled Period|Lost to Follow-up|5|||
144232133|NCT00267969|520048704|FG004|After Controlled Period|Lost to Follow-up|8|||
144232134|NCT00267969|520048705|FG005|After Controlled Period|Lost to Follow-up|9|||
144232135|NCT00267969|520048706|FG006|After Controlled Period|Lost to Follow-up|10|||
144232136|NCT00267969|520048700|FG000|After Controlled Period|Other|0|||
144232137|NCT00267969|520048701|FG001|After Controlled Period|Other|0|||
144232138|NCT00267969|520048702|FG002|After Controlled Period|Other|0|||
144232139|NCT00267969|520048703|FG003|After Controlled Period|Other|13|||
144232140|NCT00267969|520048704|FG004|After Controlled Period|Other|11|||
144232141|NCT00267969|520048705|FG005|After Controlled Period|Other|22|||
144232142|NCT00267969|520048706|FG006|After Controlled Period|Other|25|||
144232143|NCT00862823|520048709|FG000|First Intervention|Withdrawal by Subject|1|||
144232144|NCT00862823|520048710|FG001|First Intervention|Withdrawal by Subject|1|||
144232145|NCT00887315|520048711|FG000|Overall Study|Study termination|7|||
144232146|NCT00887315|520048712|FG001|Overall Study|Study termination|4|||
144232147|NCT02308540|520048715|FG000|Overall Study|Lost to Follow-up|0|||
144232148|NCT02308540|520048716|FG001|Overall Study|Lost to Follow-up|0|||
144232149|NCT02308540|520048717|FG002|Overall Study|Lost to Follow-up|0|||
144232150|NCT02308540|520048718|FG003|Overall Study|Lost to Follow-up|0|||
144232151|NCT02308540|520048719|FG004|Overall Study|Lost to Follow-up|0|||
144232152|NCT02308540|520048720|FG005|Overall Study|Lost to Follow-up|1|||
144232153|NCT02049814|520048727|FG000|Overall Study|Reason not Specified|4|||
144232154|NCT02049814|520048728|FG001|Overall Study|Reason not Specified|3|||
144232155|NCT02049814|520048727|FG000|Overall Study|Pregnancy|1|||
144232156|NCT02049814|520048728|FG001|Overall Study|Pregnancy|0|||
144232157|NCT02049814|520048727|FG000|Overall Study|Lost to Follow-up|2|||
144232158|NCT02049814|520048728|FG001|Overall Study|Lost to Follow-up|3|||
144232159|NCT02049814|520048727|FG000|Overall Study|Serious Protocol Violation|5|||
144232160|NCT02049814|520048728|FG001|Overall Study|Serious Protocol Violation|7|||
144232161|NCT02049814|520048727|FG000|Overall Study|Study Termination|0|||
144232162|NCT02049814|520048728|FG001|Overall Study|Study Termination|1|||
144232163|NCT02049814|520048727|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
144232164|NCT02049814|520048728|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
144232165|NCT02049814|520048727|FG000|Overall Study|Voluntary withdrawal|9|||
144232166|NCT02049814|520048728|FG001|Overall Study|Voluntary withdrawal|8|||
144232167|NCT00954941|520048729|FG000|Overall Study|Received treatment at home|1|||
144232168|NCT00954941|520048730|FG001|Overall Study|Received treatment at home|0|||
144232169|NCT00954941|520048729|FG000|Overall Study|Withdrawal by Subject|1|||
144269547|NCT01799941|520191330|FG000|Overall Study|Lost to Follow-up|17|||
144269548|NCT01799941|520191330|FG000|Overall Study|Other|15|||
144232170|NCT00954941|520048730|FG001|Overall Study|Withdrawal by Subject|0|||
144232171|NCT00954941|520048729|FG000|Overall Study|Insurance Denial|2|||
144232172|NCT00954941|520048730|FG001|Overall Study|Insurance Denial|2|||
144232173|NCT00954941|520048729|FG000|Overall Study|Physician Decision|2|||
144232174|NCT00954941|520048730|FG001|Overall Study|Physician Decision|2|||
144232175|NCT00954941|520048729|FG000|Overall Study|Ineligible|2|||
144232176|NCT00954941|520048730|FG001|Overall Study|Ineligible|2|||
144232177|NCT00954941|520048729|FG000|Overall Study|Adverse Event|0|||
144232178|NCT00954941|520048730|FG001|Overall Study|Adverse Event|1|||
144232179|NCT00356148|520048733|FG000|Overall Study|Reoperation within 30 days|2|||
144232180|NCT00356148|520048734|FG001|Overall Study|Reoperation within 30 days|1|||
144232181|NCT02484456|520048735|FG000|Washout Period|Withdrawal by Subject|0|||
144232182|NCT02484456|520048736|FG001|Washout Period|Withdrawal by Subject|1|||
144232183|NCT02484456|520048735|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
144232184|NCT02484456|520048736|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
144232185|NCT02484456|520048735|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
144232186|NCT02484456|520048736|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
144232187|NCT02484456|520048735|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
144232188|NCT02484456|520048736|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
144232189|NCT01996254|520048737|FG000|Overall Study|Change in Eligibility|0|||
144232190|NCT01996254|520048738|FG001|Overall Study|Change in Eligibility|2|||
144232191|NCT01996254|520048739|FG002|Overall Study|Change in Eligibility|0|||
144232192|NCT01996254|520048737|FG000|Overall Study|Withdrawal by Subject|0|||
144232193|NCT01996254|520048738|FG001|Overall Study|Withdrawal by Subject|3|||
144232194|NCT01996254|520048739|FG002|Overall Study|Withdrawal by Subject|4|||
144232195|NCT01996254|520048737|FG000|Overall Study|Lost to Follow-up|1|||
144232196|NCT01996254|520048738|FG001|Overall Study|Lost to Follow-up|0|||
144232197|NCT01996254|520048739|FG002|Overall Study|Lost to Follow-up|4|||
144232198|NCT03423173|520048742|FG000|Overall Study|Randomized but not vaccinated|1|||
144232199|NCT03423173|520048743|FG001|Overall Study|Randomized but not vaccinated|0|||
144232200|NCT03423173|520048744|FG002|Overall Study|Randomized but not vaccinated|2|||
144232201|NCT03423173|520048745|FG003|Overall Study|Randomized but not vaccinated|1|||
144232202|NCT03423173|520048742|FG000|Overall Study|Adverse Event|1|||
144232203|NCT03423173|520048743|FG001|Overall Study|Adverse Event|1|||
144232204|NCT03423173|520048744|FG002|Overall Study|Adverse Event|1|||
144232205|NCT03423173|520048745|FG003|Overall Study|Adverse Event|1|||
144232206|NCT03423173|520048742|FG000|Overall Study|Lost to Follow-up|10|||
144232207|NCT03423173|520048743|FG001|Overall Study|Lost to Follow-up|19|||
144232208|NCT03423173|520048744|FG002|Overall Study|Lost to Follow-up|17|||
144232209|NCT03423173|520048745|FG003|Overall Study|Lost to Follow-up|22|||
144232210|NCT03423173|520048742|FG000|Overall Study|Withdrawal of consent|4|||
144232211|NCT03423173|520048743|FG001|Overall Study|Withdrawal of consent|10|||
144232212|NCT03423173|520048744|FG002|Overall Study|Withdrawal of consent|4|||
144232213|NCT03423173|520048745|FG003|Overall Study|Withdrawal of consent|5|||
144232214|NCT03423173|520048742|FG000|Overall Study|Death|1|||
144232215|NCT03423173|520048743|FG001|Overall Study|Death|0|||
144232216|NCT03423173|520048744|FG002|Overall Study|Death|0|||
144232217|NCT03423173|520048745|FG003|Overall Study|Death|0|||
144232218|NCT03423173|520048742|FG000|Overall Study|Reason not Specified|2|||
144232219|NCT03423173|520048743|FG001|Overall Study|Reason not Specified|5|||
144232220|NCT03423173|520048744|FG002|Overall Study|Reason not Specified|3|||
144232221|NCT03423173|520048745|FG003|Overall Study|Reason not Specified|1|||
144232222|NCT03348930|520048746|FG000|Washout (1 Week)|Lost to Follow-up|1|||
144232223|NCT03348930|520048747|FG001|Washout (1 Week)|Lost to Follow-up|1|||
144232224|NCT01053663|520048748|FG000|Overall Study|Death|2|||
144232225|NCT01053663|520048748|FG000|Overall Study|Lost to Follow-up|1|||
144232226|NCT01053663|520048748|FG000|Overall Study|Poor IV Access|1|||
144232227|NCT01053663|520048748|FG000|Overall Study|Transferred to Another Hospital|1|||
144232228|NCT01053663|520048748|FG000|Overall Study|Negative Influenza Diagnosis|1|||
144232229|NCT02737930|520048751|FG000|Overall Study|Withdrawal by Subject|0|||
144232230|NCT02737930|520048752|FG001|Overall Study|Withdrawal by Subject|1|||
144232231|NCT00708214|520048753|FG000|Overall Study|Other Adverse Event|3|||
144232232|NCT00708214|520048754|FG001|Overall Study|Other Adverse Event|6|||
144232233|NCT00708214|520048755|FG002|Overall Study|Other Adverse Event|2|||
144232234|NCT00708214|520048753|FG000|Overall Study|Other|0|||
144232235|NCT00708214|520048754|FG001|Overall Study|Other|1|||
144232236|NCT00708214|520048755|FG002|Overall Study|Other|1|||
144232237|NCT00708214|520048753|FG000|Overall Study|Progressive Disease|4|||
144232238|NCT00708214|520048754|FG001|Overall Study|Progressive Disease|6|||
144232239|NCT00708214|520048755|FG002|Overall Study|Progressive Disease|5|||
144232240|NCT03533114|520048756|FG000|Overall|Adverse Event|16|||
144232241|NCT03533114|520048757|FG001|Overall|Adverse Event|11|||
144232242|NCT03533114|520048756|FG000|Overall|Consent Withdrawal by Participant|7|||
144232243|NCT03533114|520048757|FG001|Overall|Consent Withdrawal by Participant|6|||
144232244|NCT03533114|520048756|FG000|Overall|Lack of Efficacy|5|||
144232245|NCT03533114|520048757|FG001|Overall|Lack of Efficacy|3|||
144232246|NCT03533114|520048756|FG000|Overall|Lost to Follow-up|1|||
144232247|NCT03533114|520048757|FG001|Overall|Lost to Follow-up|1|||
144232248|NCT03533114|520048756|FG000|Overall|Physician Decision|0|||
144232249|NCT03533114|520048757|FG001|Overall|Physician Decision|2|||
144232250|NCT03533114|520048756|FG000|Overall|Protocol deviation|1|||
144232251|NCT03533114|520048757|FG001|Overall|Protocol deviation|1|||
144232252|NCT03533114|520048756|FG000|Overall|Failure to meet randomization criteria|1|||
144232253|NCT03533114|520048757|FG001|Overall|Failure to meet randomization criteria|2|||
144232254|NCT03533114|520048756|FG000|Overall|Non-Compliance with study drug|0|||
144232255|NCT03533114|520048757|FG001|Overall|Non-Compliance with study drug|1|||
144232256|NCT03533114|520048756|FG000|Overall|Other|0|||
144232257|NCT03533114|520048757|FG001|Overall|Other|1|||
144232258|NCT03533114|520048756|FG000|Open Label Titration and Optimization|Adverse Event|11|||
144232259|NCT03533114|520048757|FG001|Open Label Titration and Optimization|Adverse Event|8|||
144232260|NCT03533114|520048756|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
144232261|NCT03533114|520048757|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
144232262|NCT03533114|520048756|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
144232263|NCT03533114|520048757|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
144232264|NCT03533114|520048756|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
144232265|NCT03533114|520048757|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
144232266|NCT03533114|520048756|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
144232267|NCT03533114|520048757|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
144232268|NCT03533114|520048756|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
144232269|NCT03533114|520048757|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
144232270|NCT03533114|520048756|FG000|Stable Dose|Adverse Event|0|||
144232271|NCT03533114|520048757|FG001|Stable Dose|Adverse Event|2|||
144232272|NCT03533114|520048756|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
144232273|NCT03533114|520048757|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
144232274|NCT03533114|520048756|FG000|Stable Dose|Lack of Efficacy|1|||
144232275|NCT03533114|520048757|FG001|Stable Dose|Lack of Efficacy|0|||
144232276|NCT03533114|520048756|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
144232277|NCT03533114|520048757|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
144232278|NCT03533114|520048756|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
144232279|NCT03533114|520048757|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
144232280|NCT03533114|520048756|FG000|Open-Label Safety Extension|Adverse Event|3|||
144232281|NCT03533114|520048757|FG001|Open-Label Safety Extension|Adverse Event|0|||
144232282|NCT03533114|520048756|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
144232283|NCT03533114|520048757|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
144232284|NCT03533114|520048756|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
144232285|NCT03533114|520048757|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
144232286|NCT03533114|520048756|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
144232287|NCT03533114|520048757|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
144232288|NCT03533114|520048756|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
144232289|NCT03533114|520048757|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
144232290|NCT03852264|520048758|FG000|Third Research Visit|Lost to Follow-up|1|||
144232291|NCT03852264|520048759|FG001|Third Research Visit|Lost to Follow-up|0|||
144232292|NCT02411396|520048762|FG000|Overall Study|Lost to Follow-up|31|||
144232293|NCT02411396|520048762|FG000|Overall Study|Death|10|||
144232294|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
144232295|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
144232296|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
144232297|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
144232298|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
144232299|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
144232300|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
144232301|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
144232302|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
144232303|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
144232304|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
144232305|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
144232306|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
144232307|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
144232308|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
144232309|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
144232310|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
144232311|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
144232312|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
144232313|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
144232314|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
144232315|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
144232316|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
144232317|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
144232318|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
144232319|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
144232320|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
144232321|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
144232322|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
144232323|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
144232324|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
144232325|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
144232326|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
144232327|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
144232328|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
144232329|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
144232330|NCT02016105|520048769|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
144232331|NCT02016105|520048770|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
144232332|NCT02016105|520048771|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
144232333|NCT02016105|520048772|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
144232334|NCT02016105|520048773|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
144232335|NCT02016105|520048774|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
144232336|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
144232337|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
144232338|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
144232339|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
144232340|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
144232341|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
144232342|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
144232343|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
144232344|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
144232345|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
144232346|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
144232347|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
144232348|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
144232349|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
144232350|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
144232351|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
144232352|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
144232353|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
144232354|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Death|0|||
144232355|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Death|0|||
144232356|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Death|0|||
144232357|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Death|0|||
144232358|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Death|0|||
144232359|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Death|1|||
144232360|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
144232361|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
144232362|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
144232363|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
144232364|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
144232365|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
144232366|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
144232367|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
144232368|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
144232369|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
144232370|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
144232371|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
144232372|NCT02016105|520048769|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
144232373|NCT02016105|520048770|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
144232374|NCT02016105|520048771|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
144232375|NCT02016105|520048772|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
144232376|NCT02016105|520048773|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
144232377|NCT02016105|520048774|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
144232378|NCT02016105|520048769|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
144232379|NCT02016105|520048770|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
144232380|NCT02016105|520048771|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
144232381|NCT02016105|520048772|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
144232382|NCT02016105|520048773|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
144232383|NCT02016105|520048774|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
144232384|NCT02016105|520048769|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
144232385|NCT02016105|520048770|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
144232386|NCT02016105|520048771|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
144232387|NCT02016105|520048772|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
144232388|NCT02016105|520048773|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
144232389|NCT02016105|520048774|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
144232390|NCT02016105|520048769|FG000|EXTENSION PERIOD|Adverse Event|0|||
144232391|NCT02016105|520048770|FG001|EXTENSION PERIOD|Adverse Event|0|||
144232392|NCT02016105|520048771|FG002|EXTENSION PERIOD|Adverse Event|2|||
144232393|NCT02016105|520048772|FG003|EXTENSION PERIOD|Adverse Event|0|||
144232394|NCT02016105|520048773|FG004|EXTENSION PERIOD|Adverse Event|1|||
144232395|NCT02016105|520048774|FG005|EXTENSION PERIOD|Adverse Event|0|||
144232396|NCT02016105|520048769|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
144232397|NCT02016105|520048770|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
144232398|NCT02016105|520048771|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
144232399|NCT02016105|520048772|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
144232400|NCT02016105|520048773|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
144232401|NCT02016105|520048774|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
144232402|NCT02016105|520048769|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
144232403|NCT02016105|520048770|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
144232404|NCT02016105|520048771|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
144232405|NCT02016105|520048772|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
144232406|NCT02016105|520048773|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
144232407|NCT02016105|520048774|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
144232408|NCT02016105|520048769|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
144232409|NCT02016105|520048770|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
144232410|NCT02016105|520048771|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
144232411|NCT02016105|520048772|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
144232412|NCT02016105|520048773|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
144232413|NCT02016105|520048774|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
144232414|NCT02865499|520048775|FG000|Baseline|Adverse Event|1|||
144232415|NCT02865499|520048775|FG000|Baseline|Withdrawal by Subject|1|||
144232416|NCT02792192|520048776|FG000|Overall Study|Death|1|||
144232417|NCT02792192|520048777|FG001|Overall Study|Death|0|||
144232418|NCT02792192|520048778|FG002|Overall Study|Death|0|||
144232419|NCT02792192|520048779|FG003|Overall Study|Death|0|||
144232420|NCT02792192|520048776|FG000|Overall Study|Informed Consent Withdrawn|4|||
144232421|NCT02792192|520048777|FG001|Overall Study|Informed Consent Withdrawn|0|||
144232422|NCT02792192|520048778|FG002|Overall Study|Informed Consent Withdrawn|0|||
144232423|NCT02792192|520048779|FG003|Overall Study|Informed Consent Withdrawn|0|||
144232424|NCT02792192|520048776|FG000|Overall Study|Physician Decision|1|||
144232425|NCT02792192|520048777|FG001|Overall Study|Physician Decision|0|||
144232426|NCT02792192|520048778|FG002|Overall Study|Physician Decision|0|||
144232427|NCT02792192|520048779|FG003|Overall Study|Physician Decision|0|||
144232428|NCT02792192|520048776|FG000|Overall Study|Progressive Disease|0|||
144232429|NCT02792192|520048777|FG001|Overall Study|Progressive Disease|1|||
144232430|NCT02792192|520048778|FG002|Overall Study|Progressive Disease|0|||
144232431|NCT02792192|520048779|FG003|Overall Study|Progressive Disease|0|||
144232432|NCT02792192|520048776|FG000|Overall Study|Study Terminated By Sponsor|6|||
144232433|NCT02792192|520048777|FG001|Overall Study|Study Terminated By Sponsor|10|||
144232434|NCT02792192|520048778|FG002|Overall Study|Study Terminated By Sponsor|0|||
144232435|NCT02792192|520048779|FG003|Overall Study|Study Terminated By Sponsor|0|||
144232436|NCT01430403|520048780|FG000|Overall Study|Lost to Follow-up|5|||
144232437|NCT01430403|520048781|FG001|Overall Study|Lost to Follow-up|5|||
144232438|NCT01430403|520048782|FG002|Overall Study|Lost to Follow-up|3|||
144232439|NCT01430403|520048780|FG000|Overall Study|Physician Decision|1|||
144232440|NCT01430403|520048781|FG001|Overall Study|Physician Decision|0|||
144232441|NCT01430403|520048782|FG002|Overall Study|Physician Decision|0|||
144232442|NCT01430403|520048780|FG000|Overall Study|Protocol Violation|2|||
144232443|NCT01430403|520048781|FG001|Overall Study|Protocol Violation|3|||
144232444|NCT01430403|520048782|FG002|Overall Study|Protocol Violation|2|||
144232445|NCT01430403|520048780|FG000|Overall Study|Withdrawal by Subject|9|||
144232446|NCT01430403|520048781|FG001|Overall Study|Withdrawal by Subject|1|||
144232447|NCT01430403|520048782|FG002|Overall Study|Withdrawal by Subject|3|||
144232448|NCT04481789|520048783|FG000|Period 1|Withdrawal by Subject|1|||
144232449|NCT04481789|520048784|FG001|Period 1|Withdrawal by Subject|0|||
144232450|NCT04481789|520048785|FG002|Period 1|Withdrawal by Subject|0|||
144232451|NCT04481789|520048786|FG003|Period 1|Withdrawal by Subject|0|||
144232452|NCT04481789|520048787|FG004|Period 1|Withdrawal by Subject|0|||
144232453|NCT04481789|520048788|FG005|Period 1|Withdrawal by Subject|0|||
144232454|NCT03124407|520048791|FG000|Overall Study|Lost to Follow-up|1|||
144232455|NCT03124407|520048792|FG001|Overall Study|Lost to Follow-up|0|||
144232456|NCT03124407|520048793|FG002|Overall Study|Lost to Follow-up|0|||
144232457|NCT03124407|520048794|FG003|Overall Study|Lost to Follow-up|0|||
144232458|NCT03124407|520048791|FG000|Overall Study|Adverse Event|0|||
144232459|NCT03124407|520048792|FG001|Overall Study|Adverse Event|0|||
144232460|NCT03124407|520048793|FG002|Overall Study|Adverse Event|1|||
144232461|NCT03124407|520048794|FG003|Overall Study|Adverse Event|0|||
144232462|NCT01860040|520048797|FG000|Overall Study|Withdrawal by Subject|1|||
144232463|NCT01860040|520048798|FG001|Overall Study|Withdrawal by Subject|0|||
144232464|NCT01931995|520048799|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
144232465|NCT01931995|520048800|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
144232466|NCT01931995|520048799|FG000|First Intervention (1 Day)|Physician Decision|1|||
144232467|NCT01931995|520048800|FG001|First Intervention (1 Day)|Physician Decision|1|||
144232468|NCT01931995|520048799|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
144232469|NCT01931995|520048800|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
144232470|NCT02477826|520048819|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
144232471|NCT02477826|520048820|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
144232472|NCT02477826|520048821|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
144232473|NCT02477826|520048822|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
144232474|NCT02477826|520048823|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
144232475|NCT02477826|520048824|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
144232476|NCT02477826|520048825|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
144232477|NCT02477826|520048826|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
144232478|NCT02477826|520048827|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
144232479|NCT02477826|520048828|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
144232480|NCT02477826|520048819|FG000|Pre-Treatment|Other reasons|4|||
144232481|NCT02477826|520048820|FG001|Pre-Treatment|Other reasons|1|||
144232482|NCT02477826|520048821|FG002|Pre-Treatment|Other reasons|4|||
144232483|NCT02477826|520048822|FG003|Pre-Treatment|Other reasons|1|||
144232484|NCT02477826|520048823|FG004|Pre-Treatment|Other reasons|4|||
144232485|NCT02477826|520048824|FG005|Pre-Treatment|Other reasons|2|||
144232486|NCT02477826|520048825|FG006|Pre-Treatment|Other reasons|0|||
144232487|NCT02477826|520048826|FG007|Pre-Treatment|Other reasons|0|||
144232488|NCT02477826|520048827|FG008|Pre-Treatment|Other reasons|0|||
144232489|NCT02477826|520048828|FG009|Pre-Treatment|Other reasons|0|||
144232490|NCT02477826|520048819|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
144232491|NCT02477826|520048820|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
144232492|NCT02477826|520048821|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
144232493|NCT02477826|520048822|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
144232494|NCT02477826|520048823|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
144232495|NCT02477826|520048824|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
144232496|NCT02477826|520048825|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
144232497|NCT02477826|520048826|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
144232498|NCT02477826|520048827|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
144232499|NCT02477826|520048828|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
144232500|NCT02477826|520048819|FG000|Pre-Treatment|Subject withdrew consent|0|||
144232501|NCT02477826|520048820|FG001|Pre-Treatment|Subject withdrew consent|0|||
144232502|NCT02477826|520048821|FG002|Pre-Treatment|Subject withdrew consent|3|||
144232503|NCT02477826|520048822|FG003|Pre-Treatment|Subject withdrew consent|0|||
144232504|NCT02477826|520048823|FG004|Pre-Treatment|Subject withdrew consent|0|||
144232505|NCT02477826|520048824|FG005|Pre-Treatment|Subject withdrew consent|1|||
144232506|NCT02477826|520048825|FG006|Pre-Treatment|Subject withdrew consent|0|||
144232507|NCT02477826|520048826|FG007|Pre-Treatment|Subject withdrew consent|1|||
144232508|NCT02477826|520048827|FG008|Pre-Treatment|Subject withdrew consent|0|||
144232509|NCT02477826|520048828|FG009|Pre-Treatment|Subject withdrew consent|3|||
144232510|NCT02477826|520048819|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232511|NCT02477826|520048820|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
144232512|NCT02477826|520048821|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232513|NCT02477826|520048822|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232514|NCT02477826|520048823|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232515|NCT02477826|520048824|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232516|NCT02477826|520048825|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232517|NCT02477826|520048826|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232518|NCT02477826|520048827|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
144232519|NCT02477826|520048828|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
144232520|NCT02477826|520048819|FG000|Pre-Treatment|Death|0|||
144232521|NCT02477826|520048820|FG001|Pre-Treatment|Death|0|||
144232522|NCT02477826|520048821|FG002|Pre-Treatment|Death|0|||
144232523|NCT02477826|520048822|FG003|Pre-Treatment|Death|0|||
144232524|NCT02477826|520048823|FG004|Pre-Treatment|Death|0|||
144232525|NCT02477826|520048824|FG005|Pre-Treatment|Death|0|||
144232526|NCT02477826|520048825|FG006|Pre-Treatment|Death|1|||
144232527|NCT02477826|520048826|FG007|Pre-Treatment|Death|0|||
144232528|NCT02477826|520048827|FG008|Pre-Treatment|Death|0|||
144232529|NCT02477826|520048828|FG009|Pre-Treatment|Death|0|||
144232530|NCT02477826|520048819|FG000|Treatment Period|Not reported|8|||
144232531|NCT02477826|520048820|FG001|Treatment Period|Not reported|6|||
144232532|NCT02477826|520048821|FG002|Treatment Period|Not reported|4|||
144232533|NCT02477826|520048822|FG003|Treatment Period|Not reported|4|||
144232534|NCT02477826|520048823|FG004|Treatment Period|Not reported|2|||
144232535|NCT02477826|520048824|FG005|Treatment Period|Not reported|1|||
144232536|NCT02477826|520048825|FG006|Treatment Period|Not reported|14|||
144232537|NCT02477826|520048826|FG007|Treatment Period|Not reported|8|||
144232538|NCT02477826|520048827|FG008|Treatment Period|Not reported|5|||
144232539|NCT02477826|520048828|FG009|Treatment Period|Not reported|2|||
144232540|NCT02477826|520048819|FG000|Treatment Period|Other reasons|5|||
144232541|NCT02477826|520048820|FG001|Treatment Period|Other reasons|6|||
144232542|NCT02477826|520048821|FG002|Treatment Period|Other reasons|12|||
144232543|NCT02477826|520048822|FG003|Treatment Period|Other reasons|7|||
144232544|NCT02477826|520048823|FG004|Treatment Period|Other reasons|5|||
144232545|NCT02477826|520048824|FG005|Treatment Period|Other reasons|1|||
144232546|NCT02477826|520048825|FG006|Treatment Period|Other reasons|8|||
144232547|NCT02477826|520048826|FG007|Treatment Period|Other reasons|8|||
144232548|NCT02477826|520048827|FG008|Treatment Period|Other reasons|21|||
144232549|NCT02477826|520048828|FG009|Treatment Period|Other reasons|1|||
144232550|NCT02477826|520048819|FG000|Treatment Period|Administrative reason by sponsor|0|||
144232551|NCT02477826|520048820|FG001|Treatment Period|Administrative reason by sponsor|3|||
144232552|NCT02477826|520048821|FG002|Treatment Period|Administrative reason by sponsor|0|||
144232553|NCT02477826|520048822|FG003|Treatment Period|Administrative reason by sponsor|0|||
144232554|NCT02477826|520048823|FG004|Treatment Period|Administrative reason by sponsor|0|||
144232555|NCT02477826|520048824|FG005|Treatment Period|Administrative reason by sponsor|0|||
144232556|NCT02477826|520048825|FG006|Treatment Period|Administrative reason by sponsor|0|||
144232557|NCT02477826|520048826|FG007|Treatment Period|Administrative reason by sponsor|0|||
144232558|NCT02477826|520048827|FG008|Treatment Period|Administrative reason by sponsor|0|||
144232559|NCT02477826|520048828|FG009|Treatment Period|Administrative reason by sponsor|0|||
144232560|NCT02477826|520048819|FG000|Treatment Period|Participant meet no longer study criteria|1|||
144232561|NCT02477826|520048820|FG001|Treatment Period|Participant meet no longer study criteria|1|||
144232562|NCT02477826|520048821|FG002|Treatment Period|Participant meet no longer study criteria|0|||
144232563|NCT02477826|520048822|FG003|Treatment Period|Participant meet no longer study criteria|0|||
144232564|NCT02477826|520048823|FG004|Treatment Period|Participant meet no longer study criteria|1|||
144232565|NCT02477826|520048824|FG005|Treatment Period|Participant meet no longer study criteria|1|||
144232566|NCT02477826|520048825|FG006|Treatment Period|Participant meet no longer study criteria|0|||
144232567|NCT02477826|520048826|FG007|Treatment Period|Participant meet no longer study criteria|1|||
144232568|NCT02477826|520048827|FG008|Treatment Period|Participant meet no longer study criteria|0|||
144232569|NCT02477826|520048828|FG009|Treatment Period|Participant meet no longer study criteria|0|||
144232570|NCT02477826|520048819|FG000|Treatment Period|Poor/Non Compliance|1|||
144232571|NCT02477826|520048820|FG001|Treatment Period|Poor/Non Compliance|0|||
144232572|NCT02477826|520048821|FG002|Treatment Period|Poor/Non Compliance|2|||
144232573|NCT02477826|520048822|FG003|Treatment Period|Poor/Non Compliance|0|||
144232574|NCT02477826|520048823|FG004|Treatment Period|Poor/Non Compliance|0|||
144232575|NCT02477826|520048824|FG005|Treatment Period|Poor/Non Compliance|1|||
144232576|NCT02477826|520048825|FG006|Treatment Period|Poor/Non Compliance|1|||
144232577|NCT02477826|520048826|FG007|Treatment Period|Poor/Non Compliance|0|||
144232578|NCT02477826|520048827|FG008|Treatment Period|Poor/Non Compliance|0|||
144269549|NCT00606008|520191331|FG000|Overall Study|Adverse Event|1|||
144269550|NCT00606008|520191331|FG000|Overall Study|Withdrawal by Subject|4|||
144269551|NCT02014272|520191344|FG000|Intervention Period 1|Withdrawal by Subject|1|||
144269552|NCT02014272|520191345|FG001|Intervention Period 1|Withdrawal by Subject|0|||
144269553|NCT02014272|520191344|FG000|Intervention Period 1|Adverse Event|0|||
144232579|NCT02477826|520048828|FG009|Treatment Period|Poor/Non Compliance|1|||
144232580|NCT02477826|520048819|FG000|Treatment Period|Maximum Clinical Benefit|3|||
144232581|NCT02477826|520048820|FG001|Treatment Period|Maximum Clinical Benefit|3|||
144232582|NCT02477826|520048821|FG002|Treatment Period|Maximum Clinical Benefit|1|||
144232583|NCT02477826|520048822|FG003|Treatment Period|Maximum Clinical Benefit|1|||
144232584|NCT02477826|520048823|FG004|Treatment Period|Maximum Clinical Benefit|3|||
144232585|NCT02477826|520048824|FG005|Treatment Period|Maximum Clinical Benefit|0|||
144232586|NCT02477826|520048825|FG006|Treatment Period|Maximum Clinical Benefit|3|||
144232587|NCT02477826|520048826|FG007|Treatment Period|Maximum Clinical Benefit|2|||
144232588|NCT02477826|520048827|FG008|Treatment Period|Maximum Clinical Benefit|2|||
144232589|NCT02477826|520048828|FG009|Treatment Period|Maximum Clinical Benefit|2|||
144232590|NCT02477826|520048819|FG000|Treatment Period|Lost to Follow-up|0|||
144232591|NCT02477826|520048820|FG001|Treatment Period|Lost to Follow-up|0|||
144232592|NCT02477826|520048821|FG002|Treatment Period|Lost to Follow-up|1|||
144232593|NCT02477826|520048822|FG003|Treatment Period|Lost to Follow-up|1|||
144232594|NCT02477826|520048823|FG004|Treatment Period|Lost to Follow-up|0|||
144232595|NCT02477826|520048824|FG005|Treatment Period|Lost to Follow-up|0|||
144232596|NCT02477826|520048825|FG006|Treatment Period|Lost to Follow-up|2|||
144232597|NCT02477826|520048826|FG007|Treatment Period|Lost to Follow-up|2|||
144232598|NCT02477826|520048827|FG008|Treatment Period|Lost to Follow-up|0|||
144232599|NCT02477826|520048828|FG009|Treatment Period|Lost to Follow-up|0|||
144232600|NCT02477826|520048819|FG000|Treatment Period|Participant withdrew Consent|5|||
144232601|NCT02477826|520048820|FG001|Treatment Period|Participant withdrew Consent|5|||
144232602|NCT02477826|520048821|FG002|Treatment Period|Participant withdrew Consent|3|||
144269554|NCT02014272|520191345|FG001|Intervention Period 1|Adverse Event|1|||
144232603|NCT02477826|520048822|FG003|Treatment Period|Participant withdrew Consent|3|||
144232604|NCT02477826|520048823|FG004|Treatment Period|Participant withdrew Consent|1|||
144232605|NCT02477826|520048824|FG005|Treatment Period|Participant withdrew Consent|3|||
144232606|NCT02477826|520048825|FG006|Treatment Period|Participant withdrew Consent|3|||
144232607|NCT02477826|520048826|FG007|Treatment Period|Participant withdrew Consent|3|||
144232608|NCT02477826|520048827|FG008|Treatment Period|Participant withdrew Consent|2|||
144232609|NCT02477826|520048828|FG009|Treatment Period|Participant withdrew Consent|3|||
144232610|NCT02477826|520048819|FG000|Treatment Period|Participant request to discontinue treatment|5|||
144232611|NCT02477826|520048820|FG001|Treatment Period|Participant request to discontinue treatment|3|||
144232612|NCT02477826|520048821|FG002|Treatment Period|Participant request to discontinue treatment|15|||
144232613|NCT02477826|520048822|FG003|Treatment Period|Participant request to discontinue treatment|5|||
144269555|NCT02426684|520191346|FG000|Overall Study|Physician Decision|1|||
144232614|NCT02477826|520048823|FG004|Treatment Period|Participant request to discontinue treatment|3|||
144232615|NCT02477826|520048824|FG005|Treatment Period|Participant request to discontinue treatment|6|||
144232616|NCT02477826|520048825|FG006|Treatment Period|Participant request to discontinue treatment|13|||
144232617|NCT02477826|520048826|FG007|Treatment Period|Participant request to discontinue treatment|15|||
144232618|NCT02477826|520048827|FG008|Treatment Period|Participant request to discontinue treatment|4|||
144232619|NCT02477826|520048828|FG009|Treatment Period|Participant request to discontinue treatment|18|||
144232620|NCT02477826|520048819|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
144232621|NCT02477826|520048820|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
144232622|NCT02477826|520048821|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
144232623|NCT02477826|520048822|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
144232624|NCT02477826|520048823|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
144232625|NCT02477826|520048824|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
144232626|NCT02477826|520048825|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
144232627|NCT02477826|520048826|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
144232628|NCT02477826|520048827|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
144232629|NCT02477826|520048828|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
144232630|NCT02477826|520048819|FG000|Treatment Period|Death|4|||
144232631|NCT02477826|520048820|FG001|Treatment Period|Death|7|||
144232632|NCT02477826|520048821|FG002|Treatment Period|Death|0|||
144232633|NCT02477826|520048822|FG003|Treatment Period|Death|0|||
144232634|NCT02477826|520048823|FG004|Treatment Period|Death|1|||
144232635|NCT02477826|520048824|FG005|Treatment Period|Death|2|||
144232636|NCT02477826|520048825|FG006|Treatment Period|Death|6|||
144232637|NCT02477826|520048826|FG007|Treatment Period|Death|5|||
144232638|NCT02477826|520048827|FG008|Treatment Period|Death|9|||
144232639|NCT02477826|520048828|FG009|Treatment Period|Death|0|||
144232640|NCT02477826|520048819|FG000|Treatment Period|Study Drug Toxicity|79|||
144232641|NCT02477826|520048820|FG001|Treatment Period|Study Drug Toxicity|51|||
144232642|NCT02477826|520048821|FG002|Treatment Period|Study Drug Toxicity|31|||
144232643|NCT02477826|520048822|FG003|Treatment Period|Study Drug Toxicity|39|||
144232644|NCT02477826|520048823|FG004|Treatment Period|Study Drug Toxicity|12|||
144232645|NCT02477826|520048824|FG005|Treatment Period|Study Drug Toxicity|25|||
144232646|NCT02477826|520048825|FG006|Treatment Period|Study Drug Toxicity|52|||
144232647|NCT02477826|520048826|FG007|Treatment Period|Study Drug Toxicity|30|||
144232648|NCT02477826|520048827|FG008|Treatment Period|Study Drug Toxicity|20|||
144232649|NCT02477826|520048828|FG009|Treatment Period|Study Drug Toxicity|9|||
144232650|NCT02477826|520048819|FG000|Treatment Period|Disease progression|212|||
144232651|NCT02477826|520048820|FG001|Treatment Period|Disease progression|240|||
144232652|NCT02477826|520048821|FG002|Treatment Period|Disease progression|202|||
144232653|NCT02477826|520048822|FG003|Treatment Period|Disease progression|93|||
144232654|NCT02477826|520048823|FG004|Treatment Period|Disease progression|113|||
144232655|NCT02477826|520048824|FG005|Treatment Period|Disease progression|96|||
144232656|NCT02477826|520048825|FG006|Treatment Period|Disease progression|208|||
144232657|NCT02477826|520048826|FG007|Treatment Period|Disease progression|195|||
144232658|NCT02477826|520048827|FG008|Treatment Period|Disease progression|59|||
144232659|NCT02477826|520048828|FG009|Treatment Period|Disease progression|46|||
144232660|NCT02477826|520048819|FG000|Treatment Period|Pregnancy|0|||
144232661|NCT02477826|520048820|FG001|Treatment Period|Pregnancy|0|||
144232662|NCT02477826|520048821|FG002|Treatment Period|Pregnancy|0|||
144232663|NCT02477826|520048822|FG003|Treatment Period|Pregnancy|0|||
144232664|NCT02477826|520048823|FG004|Treatment Period|Pregnancy|0|||
144232665|NCT02477826|520048824|FG005|Treatment Period|Pregnancy|0|||
144232666|NCT02477826|520048825|FG006|Treatment Period|Pregnancy|0|||
144232667|NCT02477826|520048826|FG007|Treatment Period|Pregnancy|0|||
144232668|NCT02477826|520048827|FG008|Treatment Period|Pregnancy|0|||
144232669|NCT02477826|520048828|FG009|Treatment Period|Pregnancy|1|||
144232670|NCT02477826|520048819|FG000|Treatment Period|Other|0|||
144232671|NCT02477826|520048820|FG001|Treatment Period|Other|0|||
144232672|NCT02477826|520048821|FG002|Treatment Period|Other|0|||
144232673|NCT02477826|520048822|FG003|Treatment Period|Other|0|||
144232674|NCT02477826|520048823|FG004|Treatment Period|Other|0|||
144232675|NCT02477826|520048824|FG005|Treatment Period|Other|0|||
144232676|NCT02477826|520048825|FG006|Treatment Period|Other|0|||
144232677|NCT02477826|520048826|FG007|Treatment Period|Other|0|||
144232678|NCT02477826|520048827|FG008|Treatment Period|Other|0|||
144232679|NCT02477826|520048828|FG009|Treatment Period|Other|1|||
144232680|NCT00554515|520048831|FG000|Overall Study|Withdrawal by Subject|3|||
144232681|NCT00554515|520048831|FG000|Overall Study|Disease progression|52|||
144232682|NCT00554515|520048831|FG000|Overall Study|Physician Decision|18|||
144232683|NCT00554515|520048831|FG000|Overall Study|Withdrawal by Subject|11|||
144232684|NCT00554515|520048831|FG000|Overall Study|Adverse Event|9|||
144232685|NCT00554515|520048831|FG000|Overall Study|Death|2|||
144232686|NCT00554515|520048831|FG000|Overall Study|Achieved Stable Disease|7|||
144232687|NCT00554515|520048831|FG000|Overall Study|Other|1|||
144232688|NCT00554515|520048831|FG000|Overall Study|Misc|15|||
144232689|NCT02593097|520048839|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
144232690|NCT02593097|520048840|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
144232691|NCT02593097|520048839|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
144232692|NCT02593097|520048840|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
144232693|NCT02593097|520048839|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
144232694|NCT02593097|520048840|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
144232695|NCT02593097|520048839|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
144232696|NCT02593097|520048840|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
144232697|NCT02593097|520048839|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
144232698|NCT02593097|520048840|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
144232699|NCT03759587|520048841|FG000|Overall Study|Adverse Event|5|||
144232700|NCT03759587|520048841|FG000|Overall Study|Progressive Disease|10|||
144232701|NCT03759587|520048841|FG000|Overall Study|Site Terminated by Sponsor|3|||
144232702|NCT03759587|520048841|FG000|Overall Study|Withdrawal by Subject|1|||
144232703|NCT00665431|520048843|FG000|Overall Study|Adverse Event|16|||
144232704|NCT00665431|520048844|FG001|Overall Study|Adverse Event|22|||
144232705|NCT00665431|520048845|FG002|Overall Study|Adverse Event|6|||
144232706|NCT00665431|520048843|FG000|Overall Study|Withdrawal by Subject|17|||
144232707|NCT00665431|520048844|FG001|Overall Study|Withdrawal by Subject|25|||
144232708|NCT00665431|520048845|FG002|Overall Study|Withdrawal by Subject|15|||
144232709|NCT00665431|520048843|FG000|Overall Study|Lost to Follow-up|3|||
144232710|NCT00665431|520048844|FG001|Overall Study|Lost to Follow-up|3|||
144232711|NCT00665431|520048845|FG002|Overall Study|Lost to Follow-up|1|||
144232712|NCT00665431|520048843|FG000|Overall Study|Other|4|||
144232713|NCT00665431|520048844|FG001|Overall Study|Other|7|||
144232714|NCT00665431|520048845|FG002|Overall Study|Other|2|||
144232715|NCT03340454|520048848|FG000|Overall Study|Lost to Follow-up|0|||
144232716|NCT03340454|520048849|FG001|Overall Study|Lost to Follow-up|4|||
144232717|NCT03682848|520048850|FG000|Overall Study|Withdrawal by Subject|2|||
144232718|NCT03682848|520048850|FG000|Overall Study|Site closed|5|||
144232719|NCT03682848|520048850|FG000|Overall Study|Protocol Deviation|1|||
144232720|NCT03682848|520048850|FG000|Overall Study|Adverse Event|1|||
144232721|NCT01464164|520048851|FG000|Overall Study|Screen failure|0|||
144232722|NCT01464164|520048852|FG001|Overall Study|Screen failure|1|||
144232723|NCT01464164|520048853|FG002|Overall Study|Screen failure|2|||
144232724|NCT01464164|520048854|FG003|Overall Study|Screen failure|0|||
144232725|NCT01464164|520048855|FG004|Overall Study|Screen failure|0|||
144232726|NCT01464164|520048856|FG005|Overall Study|Screen failure|0|||
144232727|NCT01464164|520048857|FG006|Overall Study|Screen failure|0|||
144232728|NCT01464164|520048851|FG000|Overall Study|Physician Decision|0|||
144232729|NCT01464164|520048852|FG001|Overall Study|Physician Decision|1|||
144232730|NCT01464164|520048853|FG002|Overall Study|Physician Decision|0|||
144232731|NCT01464164|520048854|FG003|Overall Study|Physician Decision|0|||
144232732|NCT01464164|520048855|FG004|Overall Study|Physician Decision|0|||
144232733|NCT01464164|520048856|FG005|Overall Study|Physician Decision|0|||
144232734|NCT01464164|520048857|FG006|Overall Study|Physician Decision|2|||
144232735|NCT00454363|520048858|FG000|Overall Study|Adverse Event|1|||
144232736|NCT00454363|520048859|FG001|Overall Study|Adverse Event|2|||
144232737|NCT00454363|520048858|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
144232738|NCT00454363|520048859|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
144232739|NCT01578239|520048860|FG000|Treatment Period|Progressive Disease|19|||
144232740|NCT01578239|520048861|FG001|Treatment Period|Progressive Disease|64|||
144232741|NCT01578239|520048860|FG000|Treatment Period|Physician Decision|17|||
144232742|NCT01578239|520048861|FG001|Treatment Period|Physician Decision|17|||
144232743|NCT01578239|520048860|FG000|Treatment Period|Adverse Event|13|||
144232744|NCT01578239|520048861|FG001|Treatment Period|Adverse Event|10|||
144232745|NCT01578239|520048860|FG000|Treatment Period|Non-compliance|2|||
144232746|NCT01578239|520048861|FG001|Treatment Period|Non-compliance|0|||
144232747|NCT01578239|520048860|FG000|Treatment Period|Withdrawal by Subject|10|||
144232748|NCT01578239|520048861|FG001|Treatment Period|Withdrawal by Subject|9|||
144232749|NCT01578239|520048860|FG000|Treatment Period|Other|6|||
144232750|NCT01578239|520048861|FG001|Treatment Period|Other|1|||
144232751|NCT01578239|520048860|FG000|Long-term Follow-Up Period|Death|69|||
144232752|NCT01578239|520048861|FG001|Long-term Follow-Up Period|Death|64|||
144232753|NCT01578239|520048860|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
144232754|NCT01578239|520048861|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
144232755|NCT01578239|520048860|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
144232756|NCT01578239|520048861|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
144232757|NCT01578239|520048860|FG000|Long-term Follow-Up Period|Other|2|||
144232758|NCT01578239|520048861|FG001|Long-term Follow-Up Period|Other|2|||
144232759|NCT02347813|520048863|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
144232760|NCT02347813|520048864|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
144232761|NCT02347813|520048863|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
144232762|NCT02347813|520048864|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
144232763|NCT02837731|520048865|FG000|Allocation|Admitted to General Floor|3|||
144232764|NCT02837731|520048866|FG001|Allocation|Admitted to General Floor|4|||
144232765|NCT02837731|520048865|FG000|Allocation|Immediate surgery/withdrew|2|||
144232766|NCT02837731|520048866|FG001|Allocation|Immediate surgery/withdrew|0|||
144232767|NCT02837731|520048865|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
144232768|NCT02837731|520048866|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
144232769|NCT02837731|520048865|FG000|Allocation|Withdrawal by Subject|2|||
144232770|NCT02837731|520048866|FG001|Allocation|Withdrawal by Subject|0|||
144232771|NCT02837731|520048865|FG000|Allocation|Device not available|1|||
144232772|NCT02837731|520048866|FG001|Allocation|Device not available|0|||
144232773|NCT02837731|520048865|FG000|Allocation|Protocol not implemented|7|||
144232774|NCT02837731|520048866|FG001|Allocation|Protocol not implemented|0|||
144232775|NCT02837731|520048865|FG000|Allocation|Moribund/Do not resuscitate|2|||
144232776|NCT02837731|520048866|FG001|Allocation|Moribund/Do not resuscitate|0|||
144232777|NCT02837731|520048865|FG000|Allocation|Did not meet sepsis criteria|1|||
144232778|NCT02837731|520048866|FG001|Allocation|Did not meet sepsis criteria|2|||
144232779|NCT02837731|520048865|FG000|Allocation|Known aortic abnormalities|0|||
144232780|NCT02837731|520048866|FG001|Allocation|Known aortic abnormalities|1|||
144232781|NCT01119859|520048867|FG000|Overall Study|Adverse Event|9|||
144232782|NCT01119859|520048868|FG001|Overall Study|Adverse Event|10|||
144232783|NCT01119859|520048867|FG000|Overall Study|Death|2|||
144232784|NCT01119859|520048868|FG001|Overall Study|Death|0|||
144232785|NCT01119859|520048867|FG000|Overall Study|Insufficient therapeutic response|7|||
144232786|NCT01119859|520048868|FG001|Overall Study|Insufficient therapeutic response|14|||
144232787|NCT01119859|520048867|FG000|Overall Study|Refused treatment|3|||
144232788|NCT01119859|520048868|FG001|Overall Study|Refused treatment|6|||
144232789|NCT01119859|520048867|FG000|Overall Study|Failure to return|3|||
144232790|NCT01119859|520048868|FG001|Overall Study|Failure to return|0|||
144232791|NCT02644668|520048870|FG000|Overall Study|Adverse Event|2|||
144232792|NCT02644668|520048871|FG001|Overall Study|Adverse Event|0|||
144232793|NCT02644668|520048872|FG002|Overall Study|Adverse Event|1|||
144232794|NCT02644668|520048870|FG000|Overall Study|Protocol Violation|0|||
144232795|NCT02644668|520048871|FG001|Overall Study|Protocol Violation|0|||
144232796|NCT02644668|520048872|FG002|Overall Study|Protocol Violation|1|||
144232797|NCT02644668|520048870|FG000|Overall Study|Withdrawal by Subject|0|||
144232798|NCT02644668|520048871|FG001|Overall Study|Withdrawal by Subject|0|||
144232799|NCT02644668|520048872|FG002|Overall Study|Withdrawal by Subject|1|||
144232800|NCT03817229|520048873|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
144232801|NCT03817229|520048874|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
144232802|NCT03817229|520048875|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
144232803|NCT03817229|520048876|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
144232804|NCT03817229|520048873|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
144232805|NCT03817229|520048874|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
144269556|NCT01458587|520191347|FG000|Overall Study|Withdrawal by Subject|1|||
144232806|NCT03817229|520048875|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
144232807|NCT03817229|520048876|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
144232808|NCT03817229|520048873|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
144232809|NCT03817229|520048874|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
144232810|NCT03817229|520048875|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
144269557|NCT01458587|520191348|FG001|Overall Study|Withdrawal by Subject|0|||
144269558|NCT01603602|520191349|FG000|Overall Study|Adverse Event|1|||
144232811|NCT03817229|520048876|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
144232812|NCT03817229|520048873|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
144232813|NCT03817229|520048874|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
144232814|NCT03817229|520048875|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
144232815|NCT03817229|520048876|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
144232816|NCT03817229|520048873|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
144232817|NCT03817229|520048874|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
144232818|NCT03817229|520048875|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
144232819|NCT03817229|520048876|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
144232820|NCT03817229|520048873|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
144232821|NCT03817229|520048874|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
144269559|NCT01603602|520191350|FG001|Overall Study|Adverse Event|0|||
144232822|NCT03817229|520048875|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
144232823|NCT03817229|520048876|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
144232824|NCT03817229|520048873|FG000|Post-Intervention|Withdrawal by Subject|6|||
144232825|NCT03817229|520048874|FG001|Post-Intervention|Withdrawal by Subject|0|||
144232826|NCT03817229|520048875|FG002|Post-Intervention|Withdrawal by Subject|2|||
144232827|NCT03817229|520048876|FG003|Post-Intervention|Withdrawal by Subject|2|||
144232828|NCT03817229|520048873|FG000|Post-Intervention|Withdrawal by Study Team|3|||
144232829|NCT03817229|520048874|FG001|Post-Intervention|Withdrawal by Study Team|1|||
144232830|NCT03817229|520048875|FG002|Post-Intervention|Withdrawal by Study Team|1|||
144232831|NCT03817229|520048876|FG003|Post-Intervention|Withdrawal by Study Team|4|||
144232832|NCT03817229|520048873|FG000|Post-Intervention|Weaned from medication|3|||
144232833|NCT03817229|520048874|FG001|Post-Intervention|Weaned from medication|0|||
144232834|NCT03817229|520048875|FG002|Post-Intervention|Weaned from medication|2|||
144232835|NCT03817229|520048876|FG003|Post-Intervention|Weaned from medication|1|||
144232836|NCT03817229|520048873|FG000|Post-Intervention|Transferred care to another institution|1|||
144232837|NCT03817229|520048874|FG001|Post-Intervention|Transferred care to another institution|0|||
144232838|NCT03817229|520048875|FG002|Post-Intervention|Transferred care to another institution|0|||
144232839|NCT03817229|520048876|FG003|Post-Intervention|Transferred care to another institution|0|||
144232840|NCT03817229|520048873|FG000|Post-Intervention|Change in parental guardianship|0|||
144232841|NCT03817229|520048874|FG001|Post-Intervention|Change in parental guardianship|0|||
144232842|NCT03817229|520048875|FG002|Post-Intervention|Change in parental guardianship|1|||
144232843|NCT03817229|520048876|FG003|Post-Intervention|Change in parental guardianship|0|||
144232844|NCT03817229|520048873|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
144232845|NCT03817229|520048874|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
144232846|NCT03817229|520048875|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
144232847|NCT03817229|520048876|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
144232848|NCT03817229|520048873|FG000|Follow-up 1|Withdrawal by Subject|1|||
144232849|NCT03817229|520048874|FG001|Follow-up 1|Withdrawal by Subject|2|||
144232850|NCT03817229|520048875|FG002|Follow-up 1|Withdrawal by Subject|0|||
144232851|NCT03817229|520048876|FG003|Follow-up 1|Withdrawal by Subject|0|||
144232852|NCT03817229|520048873|FG000|Follow-up 1|Withdrawal by Study Team|3|||
144232853|NCT03817229|520048874|FG001|Follow-up 1|Withdrawal by Study Team|1|||
144232854|NCT03817229|520048875|FG002|Follow-up 1|Withdrawal by Study Team|0|||
144232855|NCT03817229|520048876|FG003|Follow-up 1|Withdrawal by Study Team|0|||
144232856|NCT03817229|520048873|FG000|Follow-up 1|Wean from medication|3|||
144232857|NCT03817229|520048874|FG001|Follow-up 1|Wean from medication|4|||
144232858|NCT03817229|520048875|FG002|Follow-up 1|Wean from medication|0|||
144232859|NCT03817229|520048876|FG003|Follow-up 1|Wean from medication|1|||
144232860|NCT03817229|520048873|FG000|Follow-up 1|Transferred care to another hospital|1|||
144232861|NCT03817229|520048874|FG001|Follow-up 1|Transferred care to another hospital|0|||
144232862|NCT03817229|520048875|FG002|Follow-up 1|Transferred care to another hospital|0|||
144232863|NCT03817229|520048876|FG003|Follow-up 1|Transferred care to another hospital|0|||
144232864|NCT03817229|520048873|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
144232865|NCT03817229|520048874|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
144232866|NCT03817229|520048875|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
144232867|NCT03817229|520048876|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
144232868|NCT03817229|520048873|FG000|Follow-up 2|Withdrawal by Subject|2|||
144232869|NCT03817229|520048874|FG001|Follow-up 2|Withdrawal by Subject|0|||
144232870|NCT03817229|520048875|FG002|Follow-up 2|Withdrawal by Subject|1|||
144232871|NCT03817229|520048876|FG003|Follow-up 2|Withdrawal by Subject|1|||
144232872|NCT03817229|520048873|FG000|Follow-up 2|Withdrawal by Study Team|2|||
144232873|NCT03817229|520048874|FG001|Follow-up 2|Withdrawal by Study Team|0|||
144232874|NCT03817229|520048875|FG002|Follow-up 2|Withdrawal by Study Team|1|||
144232875|NCT03817229|520048876|FG003|Follow-up 2|Withdrawal by Study Team|0|||
144232876|NCT03817229|520048873|FG000|Follow-up 2|Wean from medication|1|||
144232877|NCT03817229|520048874|FG001|Follow-up 2|Wean from medication|0|||
144232878|NCT03817229|520048875|FG002|Follow-up 2|Wean from medication|0|||
144232879|NCT03817229|520048876|FG003|Follow-up 2|Wean from medication|0|||
144232880|NCT03817229|520048873|FG000|Follow-up 2|Transferred care|0|||
144232881|NCT03817229|520048874|FG001|Follow-up 2|Transferred care|0|||
144232882|NCT03817229|520048875|FG002|Follow-up 2|Transferred care|1|||
144232883|NCT03817229|520048876|FG003|Follow-up 2|Transferred care|0|||
144232884|NCT01209520|520048877|FG000|Overall Study|Withdrawal by Subject|3|||
144232885|NCT00757042|520048881|FG000|Overall Study|Lost to Follow-up|0|||
144232886|NCT00757042|520048882|FG001|Overall Study|Lost to Follow-up|0|||
144232887|NCT00757042|520048883|FG002|Overall Study|Lost to Follow-up|0|||
144232888|NCT00757042|520048884|FG003|Overall Study|Lost to Follow-up|0|||
144232889|NCT00757042|520048885|FG004|Overall Study|Lost to Follow-up|0|||
144232890|NCT00757042|520048886|FG005|Overall Study|Lost to Follow-up|0|||
144232891|NCT00757042|520048887|FG006|Overall Study|Lost to Follow-up|0|||
144232892|NCT00757042|520048888|FG007|Overall Study|Lost to Follow-up|0|||
144232893|NCT00757042|520048889|FG008|Overall Study|Lost to Follow-up|1|||
144232894|NCT00757042|520048890|FG009|Overall Study|Lost to Follow-up|0|||
144232895|NCT00757042|520048891|FG010|Overall Study|Lost to Follow-up|0|||
144232896|NCT00757042|520048881|FG000|Overall Study|Ineligibility Determined|0|||
144232897|NCT00757042|520048882|FG001|Overall Study|Ineligibility Determined|0|||
144232898|NCT00757042|520048883|FG002|Overall Study|Ineligibility Determined|0|||
144232899|NCT00757042|520048884|FG003|Overall Study|Ineligibility Determined|0|||
144232900|NCT00757042|520048885|FG004|Overall Study|Ineligibility Determined|0|||
144232901|NCT00757042|520048886|FG005|Overall Study|Ineligibility Determined|0|||
144232902|NCT00757042|520048887|FG006|Overall Study|Ineligibility Determined|0|||
144232903|NCT00757042|520048888|FG007|Overall Study|Ineligibility Determined|0|||
144232904|NCT00757042|520048889|FG008|Overall Study|Ineligibility Determined|0|||
144232905|NCT00757042|520048890|FG009|Overall Study|Ineligibility Determined|0|||
144232906|NCT00757042|520048891|FG010|Overall Study|Ineligibility Determined|1|||
144232907|NCT00757042|520048881|FG000|Overall Study|Withdrawal by Subject|0|||
144232908|NCT00757042|520048882|FG001|Overall Study|Withdrawal by Subject|0|||
144232909|NCT00757042|520048883|FG002|Overall Study|Withdrawal by Subject|0|||
144232910|NCT00757042|520048884|FG003|Overall Study|Withdrawal by Subject|0|||
144232911|NCT00757042|520048885|FG004|Overall Study|Withdrawal by Subject|0|||
144232912|NCT00757042|520048886|FG005|Overall Study|Withdrawal by Subject|0|||
144232913|NCT00757042|520048887|FG006|Overall Study|Withdrawal by Subject|0|||
144232914|NCT00757042|520048888|FG007|Overall Study|Withdrawal by Subject|0|||
144232915|NCT00757042|520048889|FG008|Overall Study|Withdrawal by Subject|0|||
144232916|NCT00757042|520048890|FG009|Overall Study|Withdrawal by Subject|1|||
144232917|NCT00757042|520048891|FG010|Overall Study|Withdrawal by Subject|0|||
144232918|NCT01921101|520048894|FG000|Overall Study|Death|16|||
144232919|NCT01921101|520048895|FG001|Overall Study|Death|6|||
144232920|NCT01266291|520048896|FG000|Overall Study|Adverse Event|1|||
144232921|NCT03291431|520048897|FG000|Overall Study|Protocol Violation|2|||
144232922|NCT03291431|520048898|FG001|Overall Study|Protocol Violation|1|||
144232923|NCT03291431|520048897|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
144232924|NCT03291431|520048898|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
144232925|NCT03291431|520048897|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
144232926|NCT03291431|520048898|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
144232927|NCT03850483|520048904|FG000|Treatment for Stage 1|Adverse Event|1|||
144232928|NCT03850483|520048905|FG001|Treatment for Stage 1|Adverse Event|1|||
144232929|NCT03850483|520048906|FG002|Treatment for Stage 1|Adverse Event|3|||
144232930|NCT03850483|520048907|FG003|Treatment for Stage 1|Adverse Event|0|||
144232931|NCT03850483|520048908|FG004|Treatment for Stage 1|Adverse Event|2|||
144232932|NCT03850483|520048909|FG005|Treatment for Stage 1|Adverse Event|0|||
144232933|NCT03850483|520048910|FG006|Treatment for Stage 1|Adverse Event|2|||
144232934|NCT03850483|520048911|FG007|Treatment for Stage 1|Adverse Event|2|||
144232935|NCT03850483|520048912|FG008|Treatment for Stage 1|Adverse Event|0|||
144232936|NCT03850483|520048913|FG009|Treatment for Stage 1|Adverse Event|0|||
144232937|NCT03850483|520048904|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
144232938|NCT03850483|520048905|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
144232939|NCT03850483|520048906|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
144232940|NCT03850483|520048907|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
144232941|NCT03850483|520048908|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
144232942|NCT03850483|520048909|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
144232943|NCT03850483|520048910|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
144232944|NCT03850483|520048911|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
144232945|NCT03850483|520048912|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
144232946|NCT03850483|520048913|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
144232947|NCT03850483|520048904|FG000|Treatment for Stage 1|Protocol Violation|1|||
144232948|NCT03850483|520048905|FG001|Treatment for Stage 1|Protocol Violation|0|||
144232949|NCT03850483|520048906|FG002|Treatment for Stage 1|Protocol Violation|0|||
144232950|NCT03850483|520048907|FG003|Treatment for Stage 1|Protocol Violation|0|||
144232951|NCT03850483|520048908|FG004|Treatment for Stage 1|Protocol Violation|0|||
144232952|NCT03850483|520048909|FG005|Treatment for Stage 1|Protocol Violation|0|||
144232953|NCT03850483|520048910|FG006|Treatment for Stage 1|Protocol Violation|1|||
144232954|NCT03850483|520048911|FG007|Treatment for Stage 1|Protocol Violation|0|||
144232955|NCT03850483|520048912|FG008|Treatment for Stage 1|Protocol Violation|0|||
144232956|NCT03850483|520048913|FG009|Treatment for Stage 1|Protocol Violation|0|||
144232957|NCT03850483|520048904|FG000|Treatment for Stage 1|Physician Decision|0|||
144232958|NCT03850483|520048905|FG001|Treatment for Stage 1|Physician Decision|0|||
144232959|NCT03850483|520048906|FG002|Treatment for Stage 1|Physician Decision|0|||
144232960|NCT03850483|520048907|FG003|Treatment for Stage 1|Physician Decision|0|||
144232961|NCT03850483|520048908|FG004|Treatment for Stage 1|Physician Decision|0|||
144232962|NCT03850483|520048909|FG005|Treatment for Stage 1|Physician Decision|1|||
144232963|NCT03850483|520048910|FG006|Treatment for Stage 1|Physician Decision|0|||
144232964|NCT03850483|520048911|FG007|Treatment for Stage 1|Physician Decision|0|||
144232965|NCT03850483|520048912|FG008|Treatment for Stage 1|Physician Decision|0|||
144232966|NCT03850483|520048913|FG009|Treatment for Stage 1|Physician Decision|0|||
144232967|NCT03850483|520048904|FG000|Treatment for Stage 1|Other|0|||
144232968|NCT03850483|520048905|FG001|Treatment for Stage 1|Other|0|||
144232969|NCT03850483|520048906|FG002|Treatment for Stage 1|Other|0|||
144232970|NCT03850483|520048907|FG003|Treatment for Stage 1|Other|0|||
144232971|NCT03850483|520048908|FG004|Treatment for Stage 1|Other|2|||
144232972|NCT03850483|520048909|FG005|Treatment for Stage 1|Other|1|||
144232973|NCT03850483|520048910|FG006|Treatment for Stage 1|Other|0|||
144232974|NCT03850483|520048911|FG007|Treatment for Stage 1|Other|0|||
144232975|NCT03850483|520048912|FG008|Treatment for Stage 1|Other|0|||
144232976|NCT03850483|520048913|FG009|Treatment for Stage 1|Other|0|||
144232977|NCT03850483|520048904|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232978|NCT03850483|520048905|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232979|NCT03850483|520048906|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
144232980|NCT03850483|520048907|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232981|NCT03850483|520048908|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232982|NCT03850483|520048909|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232983|NCT03850483|520048910|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232984|NCT03850483|520048911|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232985|NCT03850483|520048912|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232986|NCT03850483|520048913|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
144232987|NCT03850483|520048904|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232988|NCT03850483|520048905|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232989|NCT03850483|520048906|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232990|NCT03850483|520048907|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232991|NCT03850483|520048908|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232992|NCT03850483|520048909|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
144232993|NCT03850483|520048910|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232994|NCT03850483|520048911|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232995|NCT03850483|520048912|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232996|NCT03850483|520048913|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
144232997|NCT03850483|520048904|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
144232998|NCT03850483|520048905|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
144232999|NCT03850483|520048906|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
144233000|NCT03850483|520048907|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
144233001|NCT03850483|520048908|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
144233002|NCT03850483|520048909|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
144233003|NCT03850483|520048910|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
144233004|NCT03850483|520048911|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
144233005|NCT03850483|520048912|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
144233006|NCT03850483|520048913|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
144233007|NCT03850483|520048904|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
144233008|NCT03850483|520048905|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
144233009|NCT03850483|520048906|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
144233010|NCT03850483|520048907|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
144233011|NCT03850483|520048908|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
144233012|NCT03850483|520048909|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
144233013|NCT03850483|520048910|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
144233014|NCT03850483|520048911|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
144233015|NCT03850483|520048912|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
144233016|NCT03850483|520048913|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
144233017|NCT03850483|520048904|FG000|Treatment for Stage 1|Death|0|||
144233018|NCT03850483|520048905|FG001|Treatment for Stage 1|Death|0|||
144233019|NCT03850483|520048906|FG002|Treatment for Stage 1|Death|0|||
144233020|NCT03850483|520048907|FG003|Treatment for Stage 1|Death|0|||
144233021|NCT03850483|520048908|FG004|Treatment for Stage 1|Death|0|||
144233022|NCT03850483|520048909|FG005|Treatment for Stage 1|Death|1|||
144233023|NCT03850483|520048910|FG006|Treatment for Stage 1|Death|0|||
144233024|NCT03850483|520048911|FG007|Treatment for Stage 1|Death|0|||
144233025|NCT03850483|520048912|FG008|Treatment for Stage 1|Death|0|||
144233026|NCT03850483|520048913|FG009|Treatment for Stage 1|Death|0|||
144233027|NCT03850483|520048904|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
144233028|NCT03850483|520048905|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
144233029|NCT03850483|520048906|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
144233030|NCT03850483|520048907|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
144233031|NCT03850483|520048908|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
144233032|NCT03850483|520048909|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
144233033|NCT03850483|520048910|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
144233034|NCT03850483|520048911|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
144269560|NCT01603602|520191351|FG002|Overall Study|Adverse Event|0|||
144269561|NCT01603602|520191349|FG000|Overall Study|Personal Reasons|1|||
144233035|NCT03850483|520048912|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
144233036|NCT03850483|520048913|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
144233037|NCT03850483|520048904|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
144233038|NCT03850483|520048905|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
144233039|NCT03850483|520048906|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
144233040|NCT03850483|520048907|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
144233041|NCT03850483|520048908|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
144233042|NCT03850483|520048909|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
144233043|NCT03850483|520048910|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
144233044|NCT03850483|520048911|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
144233045|NCT03850483|520048912|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
144233046|NCT03850483|520048913|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
144233047|NCT03850483|520048904|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233048|NCT03850483|520048905|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233049|NCT03850483|520048906|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233050|NCT03850483|520048907|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233051|NCT03850483|520048908|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233052|NCT03850483|520048909|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233053|NCT03850483|520048910|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
144233054|NCT03850483|520048911|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
144233055|NCT03850483|520048912|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233056|NCT03850483|520048913|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
144233057|NCT03850483|520048904|FG000|Follow-up for Stage 1|Physician Decision|0|||
144233058|NCT03850483|520048905|FG001|Follow-up for Stage 1|Physician Decision|0|||
144233059|NCT03850483|520048906|FG002|Follow-up for Stage 1|Physician Decision|0|||
144233060|NCT03850483|520048907|FG003|Follow-up for Stage 1|Physician Decision|0|||
144233061|NCT03850483|520048908|FG004|Follow-up for Stage 1|Physician Decision|1|||
144233062|NCT03850483|520048909|FG005|Follow-up for Stage 1|Physician Decision|0|||
144233063|NCT03850483|520048910|FG006|Follow-up for Stage 1|Physician Decision|1|||
144233064|NCT03850483|520048911|FG007|Follow-up for Stage 1|Physician Decision|0|||
144233065|NCT03850483|520048912|FG008|Follow-up for Stage 1|Physician Decision|0|||
144233066|NCT03850483|520048913|FG009|Follow-up for Stage 1|Physician Decision|0|||
144233067|NCT03850483|520048904|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
144233068|NCT03850483|520048905|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
144233069|NCT03850483|520048906|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
144233070|NCT03850483|520048907|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
144233071|NCT03850483|520048908|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
144233072|NCT03850483|520048909|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
144233073|NCT03850483|520048910|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
144233074|NCT03850483|520048911|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
144233075|NCT03850483|520048912|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
144233076|NCT03850483|520048913|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
144233077|NCT03850483|520048904|FG000|Follow-up for Stage 1|Adverse Event|0|||
144233078|NCT03850483|520048905|FG001|Follow-up for Stage 1|Adverse Event|0|||
144233079|NCT03850483|520048906|FG002|Follow-up for Stage 1|Adverse Event|1|||
144233080|NCT03850483|520048907|FG003|Follow-up for Stage 1|Adverse Event|0|||
144233081|NCT03850483|520048908|FG004|Follow-up for Stage 1|Adverse Event|0|||
144233082|NCT03850483|520048909|FG005|Follow-up for Stage 1|Adverse Event|1|||
144233083|NCT03850483|520048910|FG006|Follow-up for Stage 1|Adverse Event|0|||
144233084|NCT03850483|520048911|FG007|Follow-up for Stage 1|Adverse Event|0|||
144233085|NCT03850483|520048912|FG008|Follow-up for Stage 1|Adverse Event|0|||
144233086|NCT03850483|520048913|FG009|Follow-up for Stage 1|Adverse Event|0|||
144233087|NCT03850483|520048904|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233088|NCT03850483|520048905|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
144233089|NCT03850483|520048906|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233090|NCT03850483|520048907|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233091|NCT03850483|520048908|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
144233092|NCT03850483|520048909|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
144233093|NCT03850483|520048910|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233094|NCT03850483|520048911|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233095|NCT03850483|520048912|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233096|NCT03850483|520048913|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
144233097|NCT03850483|520048904|FG000|Follow-up for Stage 1|Other|0|||
144233098|NCT03850483|520048905|FG001|Follow-up for Stage 1|Other|2|||
144233099|NCT03850483|520048906|FG002|Follow-up for Stage 1|Other|0|||
144233100|NCT03850483|520048907|FG003|Follow-up for Stage 1|Other|2|||
144233101|NCT03850483|520048908|FG004|Follow-up for Stage 1|Other|0|||
144233102|NCT03850483|520048909|FG005|Follow-up for Stage 1|Other|1|||
144233103|NCT03850483|520048910|FG006|Follow-up for Stage 1|Other|0|||
144233104|NCT03850483|520048911|FG007|Follow-up for Stage 1|Other|0|||
144233105|NCT03850483|520048912|FG008|Follow-up for Stage 1|Other|0|||
144233106|NCT03850483|520048913|FG009|Follow-up for Stage 1|Other|0|||
144233107|NCT03850483|520048904|FG000|Treatment for Stage 2|Adverse Event|0|||
144233108|NCT03850483|520048905|FG001|Treatment for Stage 2|Adverse Event|0|||
144233109|NCT03850483|520048906|FG002|Treatment for Stage 2|Adverse Event|0|||
144233110|NCT03850483|520048907|FG003|Treatment for Stage 2|Adverse Event|0|||
144233111|NCT03850483|520048908|FG004|Treatment for Stage 2|Adverse Event|0|||
144233112|NCT03850483|520048909|FG005|Treatment for Stage 2|Adverse Event|0|||
144233113|NCT03850483|520048910|FG006|Treatment for Stage 2|Adverse Event|0|||
144233114|NCT03850483|520048911|FG007|Treatment for Stage 2|Adverse Event|0|||
144233115|NCT03850483|520048912|FG008|Treatment for Stage 2|Adverse Event|0|||
144233116|NCT03850483|520048913|FG009|Treatment for Stage 2|Adverse Event|1|||
144233117|NCT03850483|520048904|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
144233118|NCT03850483|520048905|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
144233119|NCT03850483|520048906|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
144233120|NCT03850483|520048907|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
144233121|NCT03850483|520048908|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
144233122|NCT03850483|520048909|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
144233123|NCT03850483|520048910|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
144233124|NCT03850483|520048911|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
144233125|NCT03850483|520048912|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
144233126|NCT03850483|520048913|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
144233127|NCT03850483|520048904|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
144233128|NCT03850483|520048905|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
144233129|NCT03850483|520048906|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
144233130|NCT03850483|520048907|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
144233131|NCT03850483|520048908|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
144233132|NCT03850483|520048909|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
144233133|NCT03850483|520048910|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
144233134|NCT03850483|520048911|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
144233135|NCT03850483|520048912|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
144233136|NCT03850483|520048913|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
144233137|NCT03850483|520048904|FG000|Treatment for Stage 2|Physician Decision|0|||
144233138|NCT03850483|520048905|FG001|Treatment for Stage 2|Physician Decision|0|||
144233139|NCT03850483|520048906|FG002|Treatment for Stage 2|Physician Decision|0|||
144233140|NCT03850483|520048907|FG003|Treatment for Stage 2|Physician Decision|0|||
144233141|NCT03850483|520048908|FG004|Treatment for Stage 2|Physician Decision|0|||
144233142|NCT03850483|520048909|FG005|Treatment for Stage 2|Physician Decision|0|||
144233143|NCT03850483|520048910|FG006|Treatment for Stage 2|Physician Decision|0|||
144233144|NCT03850483|520048911|FG007|Treatment for Stage 2|Physician Decision|0|||
144233145|NCT03850483|520048912|FG008|Treatment for Stage 2|Physician Decision|0|||
144233146|NCT03850483|520048913|FG009|Treatment for Stage 2|Physician Decision|1|||
144233147|NCT03850483|520048904|FG000|Treatment for Stage 2|Protocol Violation|0|||
144233148|NCT03850483|520048905|FG001|Treatment for Stage 2|Protocol Violation|0|||
144233149|NCT03850483|520048906|FG002|Treatment for Stage 2|Protocol Violation|0|||
144233150|NCT03850483|520048907|FG003|Treatment for Stage 2|Protocol Violation|0|||
144233151|NCT03850483|520048908|FG004|Treatment for Stage 2|Protocol Violation|0|||
144233152|NCT03850483|520048909|FG005|Treatment for Stage 2|Protocol Violation|0|||
144233153|NCT03850483|520048910|FG006|Treatment for Stage 2|Protocol Violation|0|||
144233154|NCT03850483|520048911|FG007|Treatment for Stage 2|Protocol Violation|0|||
144233155|NCT03850483|520048912|FG008|Treatment for Stage 2|Protocol Violation|1|||
144233156|NCT03850483|520048913|FG009|Treatment for Stage 2|Protocol Violation|0|||
144233157|NCT03850483|520048904|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
144233158|NCT03850483|520048905|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
144233159|NCT03850483|520048906|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
144233160|NCT03850483|520048907|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
144233161|NCT03850483|520048908|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
144233162|NCT03850483|520048909|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
144233163|NCT03850483|520048910|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
144233164|NCT03850483|520048911|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
144233165|NCT03850483|520048912|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
144233166|NCT03850483|520048913|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
144233167|NCT03850483|520048904|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233168|NCT03850483|520048905|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233169|NCT03850483|520048906|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233170|NCT03850483|520048907|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233171|NCT03850483|520048908|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233172|NCT03850483|520048909|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233173|NCT03850483|520048910|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233174|NCT03850483|520048911|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233175|NCT03850483|520048912|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
144233176|NCT03850483|520048913|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
144233177|NCT03850483|520048904|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
144233178|NCT03850483|520048905|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
144233179|NCT03850483|520048906|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
144233180|NCT03850483|520048907|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
144233181|NCT03850483|520048908|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
144233182|NCT03850483|520048909|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
144233183|NCT03850483|520048910|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
144233184|NCT03850483|520048911|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
144233185|NCT03850483|520048912|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
144233186|NCT03850483|520048913|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
144233187|NCT03850483|520048904|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
144233188|NCT03850483|520048905|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
144233189|NCT03850483|520048906|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
144233190|NCT03850483|520048907|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
144233191|NCT03850483|520048908|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
144233192|NCT03850483|520048909|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
144233193|NCT03850483|520048910|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
144233194|NCT03850483|520048911|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
144233195|NCT03850483|520048912|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
144233196|NCT03850483|520048913|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
144233197|NCT03850483|520048904|FG000|Follow-up For Stage 2|Other|0|||
144233198|NCT03850483|520048905|FG001|Follow-up For Stage 2|Other|0|||
144233199|NCT03850483|520048906|FG002|Follow-up For Stage 2|Other|0|||
144233200|NCT03850483|520048907|FG003|Follow-up For Stage 2|Other|0|||
144233201|NCT03850483|520048908|FG004|Follow-up For Stage 2|Other|0|||
144233202|NCT03850483|520048909|FG005|Follow-up For Stage 2|Other|0|||
144233203|NCT03850483|520048910|FG006|Follow-up For Stage 2|Other|0|||
144233204|NCT03850483|520048911|FG007|Follow-up For Stage 2|Other|0|||
144233205|NCT03850483|520048912|FG008|Follow-up For Stage 2|Other|0|||
144233206|NCT03850483|520048913|FG009|Follow-up For Stage 2|Other|1|||
144233207|NCT01108341|520049958|FG000|Overall Study|Death|2|||
144233208|NCT01108341|520049958|FG000|Overall Study|Withdrawal by Subject|1|||
144233209|NCT01108341|520049958|FG000|Overall Study|Lost to Follow-up|1|||
144233210|NCT01108341|520049958|FG000|Overall Study|Other|1|||
144233211|NCT04402138|520049959|FG000|Overall Study|Progressive Disease|2|||
144233212|NCT04402138|520049959|FG000|Overall Study|Adverse Event|1|||
144233213|NCT04390503|520049961|FG000|Overall Study|Physician Decision|2|||
144233214|NCT04390503|520049962|FG001|Overall Study|Physician Decision|1|||
144233215|NCT04390503|520049961|FG000|Overall Study|Adverse Event|1|||
144233216|NCT04390503|520049962|FG001|Overall Study|Adverse Event|0|||
144233217|NCT03508726|520049963|FG000|Overall Study|Withdrawal by Subject|0|||
144233218|NCT03508726|520049964|FG001|Overall Study|Withdrawal by Subject|1|||
144233219|NCT01841762|520049965|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
144233220|NCT01841762|520049965|FG000|Treatment Period|Adverse Event|16|||
144233221|NCT01841762|520049965|FG000|Treatment Period|Death|1|||
144233222|NCT01841762|520049965|FG000|Treatment Period|Withdrawal by Subject|7|||
144233223|NCT01841762|520049965|FG000|Treatment Period|Lost to Follow-up|1|||
144233224|NCT01841762|520049965|FG000|Treatment Period|Physician Decision|2|||
144233225|NCT01841762|520049965|FG000|Treatment Period|Other, including non-compliance|5|||
144233226|NCT01841762|520049965|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
144233227|NCT01841762|520049965|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
144233228|NCT01841762|520049965|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
144233229|NCT01841762|520049965|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
144233230|NCT02448537|520049966|FG000|Overall Study|Withdrawal by Subject|1|||
144233231|NCT02448537|520049967|FG001|Overall Study|Withdrawal by Subject|1|||
144233232|NCT02448537|520049968|FG002|Overall Study|Withdrawal by Subject|1|||
144233233|NCT04725812|520049969|FG000|Overall Study|Withdrawal by Subject|1|||
144269562|NCT01603602|520191350|FG001|Overall Study|Personal Reasons|0|||
144269563|NCT01603602|520191351|FG002|Overall Study|Personal Reasons|1|||
144269564|NCT01118299|520191352|FG000|Overall Study|Death|7|||
144269565|NCT01118299|520191353|FG001|Overall Study|Death|5|||
144269566|NCT01118299|520191352|FG000|Overall Study|Withdrawal by Subject|8|||
144269567|NCT01118299|520191353|FG001|Overall Study|Withdrawal by Subject|8|||
144233234|NCT02875613|520049977|FG000|Overall Study|Withdrawal by Subject|1|||
144233235|NCT02875613|520049977|FG000|Overall Study|Screen Failure|1|||
144269568|NCT01118299|520191352|FG000|Overall Study|Lost to Follow-up|2|||
144269569|NCT01118299|520191353|FG001|Overall Study|Lost to Follow-up|1|||
144269570|NCT01118299|520191352|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
144233236|NCT00178685|520049978|FG000|Overall Study|Death|3|||
144233237|NCT00178685|520049979|FG001|Overall Study|Death|3|||
144233238|NCT00178685|520049980|FG002|Overall Study|Death|6|||
144233239|NCT00178685|520049978|FG000|Overall Study|Lost to Follow-up|100|||
144233240|NCT00178685|520049979|FG001|Overall Study|Lost to Follow-up|187|||
144233241|NCT00178685|520049980|FG002|Overall Study|Lost to Follow-up|183|||
144233242|NCT00178685|520049978|FG000|Overall Study|Withdrawal by Subject|8|||
144233243|NCT00178685|520049979|FG001|Overall Study|Withdrawal by Subject|14|||
144233244|NCT00178685|520049980|FG002|Overall Study|Withdrawal by Subject|7|||
144233245|NCT04112043|520049981|FG000|Overall Study|Withdrawal by Subject|1|||
144233246|NCT04112043|520049982|FG001|Overall Study|Withdrawal by Subject|1|||
144233247|NCT04112043|520049983|FG002|Overall Study|Withdrawal by Subject|1|||
144233248|NCT04112043|520049981|FG000|Overall Study|Taking NR supplement|1|||
144233249|NCT04112043|520049982|FG001|Overall Study|Taking NR supplement|0|||
144233250|NCT04112043|520049983|FG002|Overall Study|Taking NR supplement|0|||
144233251|NCT04112043|520049981|FG000|Overall Study|Adverse Event|0|||
144233252|NCT04112043|520049982|FG001|Overall Study|Adverse Event|1|||
144233253|NCT04112043|520049983|FG002|Overall Study|Adverse Event|0|||
144233254|NCT01750697|520049986|FG000|Overall Study|Transferred Back to Local Hospital|1|||
144233255|NCT01750697|520049986|FG000|Overall Study|Physician and Family Decision|1|||
144233256|NCT01750697|520049986|FG000|Overall Study|Transferred to Adult Services|5|||
144233257|NCT01750697|520049986|FG000|Overall Study|Physician Decision|1|||
144233258|NCT01750697|520049986|FG000|Overall Study|Withdrawal by Subject|1|||
144233259|NCT01057810|520049987|FG000|Overall Study|Disease progression|156|||
144233260|NCT01057810|520049988|FG001|Overall Study|Disease progression|197|||
144233261|NCT01057810|520049987|FG000|Overall Study|Study drug toxicity|5|||
144233262|NCT01057810|520049988|FG001|Overall Study|Study drug toxicity|114|||
144233263|NCT01057810|520049987|FG000|Overall Study|Adverse event unrelated to study drug|13|||
144233264|NCT01057810|520049988|FG001|Overall Study|Adverse event unrelated to study drug|29|||
144233265|NCT01057810|520049987|FG000|Overall Study|Withdrawal by Subject|10|||
144233266|NCT01057810|520049988|FG001|Overall Study|Withdrawal by Subject|25|||
144233267|NCT01057810|520049987|FG000|Overall Study|Death|2|||
144233268|NCT01057810|520049988|FG001|Overall Study|Death|12|||
144233269|NCT01057810|520049987|FG000|Overall Study|Maximum clinical benefit|5|||
144233270|NCT01057810|520049988|FG001|Overall Study|Maximum clinical benefit|5|||
144233271|NCT01057810|520049987|FG000|Overall Study|Poor/non-compliance|0|||
144233272|NCT01057810|520049988|FG001|Overall Study|Poor/non-compliance|1|||
144233273|NCT01057810|520049987|FG000|Overall Study|No longer met study criteria|0|||
144233274|NCT01057810|520049988|FG001|Overall Study|No longer met study criteria|1|||
144233275|NCT01057810|520049987|FG000|Overall Study|Other|7|||
144233276|NCT01057810|520049988|FG001|Overall Study|Other|14|||
144233277|NCT02088905|520049989|FG000|Overall Study|Withdrawal by Subject|5|||
144233278|NCT02088905|520049990|FG001|Overall Study|Withdrawal by Subject|1|||
144233279|NCT04075682|520049991|FG000|Overall Study|Lost to Follow-up|5|||
144233280|NCT04075682|520049992|FG001|Overall Study|Lost to Follow-up|5|||
144233281|NCT04075682|520049993|FG002|Overall Study|Lost to Follow-up|2|||
144233282|NCT04075682|520049994|FG003|Overall Study|Lost to Follow-up|2|||
144233283|NCT04075682|520049991|FG000|Overall Study|Withdrawal by Subject|1|||
144233284|NCT04075682|520049992|FG001|Overall Study|Withdrawal by Subject|0|||
144233285|NCT04075682|520049993|FG002|Overall Study|Withdrawal by Subject|1|||
144233286|NCT04075682|520049994|FG003|Overall Study|Withdrawal by Subject|0|||
144233287|NCT04075682|520049991|FG000|Overall Study|Protocol Violation|0|||
144233288|NCT04075682|520049992|FG001|Overall Study|Protocol Violation|1|||
144233289|NCT04075682|520049993|FG002|Overall Study|Protocol Violation|1|||
144233290|NCT04075682|520049994|FG003|Overall Study|Protocol Violation|0|||
144233291|NCT04075682|520049991|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
144233292|NCT04075682|520049992|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
144233293|NCT04075682|520049993|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
144233294|NCT04075682|520049994|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
144233295|NCT04075682|520049991|FG000|Overall Study|Lost study phone the first day of study participation|0|||
144233296|NCT04075682|520049992|FG001|Overall Study|Lost study phone the first day of study participation|1|||
144233297|NCT04075682|520049993|FG002|Overall Study|Lost study phone the first day of study participation|0|||
144233298|NCT04075682|520049994|FG003|Overall Study|Lost study phone the first day of study participation|0|||
144233299|NCT00619892|520049996|FG000|Overall Study|Adverse Event|3|||
144233300|NCT00619892|520049997|FG001|Overall Study|Adverse Event|0|||
144233301|NCT00619892|520049996|FG000|Overall Study|Lost to Follow-up|0|||
144233302|NCT00619892|520049997|FG001|Overall Study|Lost to Follow-up|1|||
144233303|NCT00619892|520049996|FG000|Overall Study|Intercurrent illness|0|||
144233304|NCT00619892|520049997|FG001|Overall Study|Intercurrent illness|1|||
144233305|NCT01562782|520050003|FG000|Overall Study|Withdrawal by Subject|3|||
144233306|NCT01562782|520050004|FG001|Overall Study|Withdrawal by Subject|3|||
144233307|NCT01562782|520050003|FG000|Overall Study|screen failure|1|||
144233308|NCT01562782|520050004|FG001|Overall Study|screen failure|2|||
144233309|NCT00857896|520050007|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
144233310|NCT01091662|520050008|FG000|Overall Study|Adverse Event|1|||
144233311|NCT01091662|520050009|FG001|Overall Study|Adverse Event|9|||
144233312|NCT01091662|520050008|FG000|Overall Study|Physician Decision|1|||
144233313|NCT01091662|520050009|FG001|Overall Study|Physician Decision|1|||
144233314|NCT01091662|520050008|FG000|Overall Study|Withdrawal by Subject|7|||
144233315|NCT01091662|520050009|FG001|Overall Study|Withdrawal by Subject|6|||
144233316|NCT01091662|520050008|FG000|Overall Study|met exit criteria|7|||
144233317|NCT01091662|520050009|FG001|Overall Study|met exit criteria|13|||
144233318|NCT01091662|520050008|FG000|Overall Study|met exclusion criteria|1|||
144233319|NCT01091662|520050009|FG001|Overall Study|met exclusion criteria|0|||
144233320|NCT01091662|520050008|FG000|Overall Study|Lost to Follow-up|0|||
144233321|NCT01091662|520050009|FG001|Overall Study|Lost to Follow-up|1|||
144233322|NCT01091662|520050008|FG000|Overall Study|Pregnancy|0|||
144233323|NCT01091662|520050009|FG001|Overall Study|Pregnancy|1|||
144233324|NCT01091662|520050008|FG000|Overall Study|Protocol Violation|0|||
144233325|NCT01091662|520050009|FG001|Overall Study|Protocol Violation|2|||
144233326|NCT01091662|520050008|FG000|Overall Study|unable to swallow capsule|0|||
144233327|NCT01091662|520050009|FG001|Overall Study|unable to swallow capsule|1|||
144233328|NCT04109391|520050010|FG000|Overall Study|Adverse Event|2|||
144233329|NCT04109391|520050011|FG001|Overall Study|Adverse Event|2|||
144233330|NCT04109391|520050012|FG002|Overall Study|Adverse Event|0|||
144233331|NCT04109391|520050010|FG000|Overall Study|Withdrawal by Subject|2|||
144233332|NCT04109391|520050011|FG001|Overall Study|Withdrawal by Subject|0|||
144233333|NCT04109391|520050012|FG002|Overall Study|Withdrawal by Subject|0|||
144233334|NCT04109391|520050010|FG000|Overall Study|Pregnancy|1|||
144233335|NCT04109391|520050011|FG001|Overall Study|Pregnancy|0|||
144233336|NCT04109391|520050012|FG002|Overall Study|Pregnancy|0|||
144233337|NCT04109391|520050010|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
144233338|NCT04109391|520050011|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
144233339|NCT04109391|520050012|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
144233340|NCT04109391|520050010|FG000|Overall Study|Lost to Follow-up|0|||
144233341|NCT04109391|520050011|FG001|Overall Study|Lost to Follow-up|0|||
144233342|NCT04109391|520050012|FG002|Overall Study|Lost to Follow-up|1|||
144233343|NCT04109391|520050010|FG000|Overall Study|Lack of Efficacy|2|||
144233344|NCT04109391|520050011|FG001|Overall Study|Lack of Efficacy|2|||
144233345|NCT04109391|520050012|FG002|Overall Study|Lack of Efficacy|3|||
144233346|NCT00443079|520050015|FG000|Overall Study|Lost to Follow-up|0|||
144233347|NCT00443079|520050016|FG001|Overall Study|Lost to Follow-up|1|||
144233348|NCT02993250|520050017|FG000|Overall Study|Lost to Follow-up|0|||
144233349|NCT02993250|520050018|FG001|Overall Study|Lost to Follow-up|1|||
144233350|NCT04606394|520050022|FG000|Overall Study|Withdrawal by Subject|3|||
144233351|NCT04606394|520050022|FG000|Overall Study|Exclusion criteria screen failure|12|||
144233352|NCT01896128|520050023|FG000|Overall Study|Withdrawal by Subject|3|||
144233353|NCT01896128|520050024|FG001|Overall Study|Withdrawal by Subject|3|||
144233354|NCT00955955|520050025|FG000|Overall Study|Lost to Follow-up|2|||
144233355|NCT00955955|520050026|FG001|Overall Study|Lost to Follow-up|0|||
144233356|NCT00955955|520050027|FG002|Overall Study|Lost to Follow-up|0|||
144233357|NCT02071706|520050029|FG000|Overall Study|Adverse Event|1|||
144233358|NCT02071706|520050029|FG000|Overall Study|Withdrawal by Subject|2|||
144233359|NCT01908829|520050033|FG000|Overall Study|Adverse Event|13|||
144233360|NCT01908829|520050034|FG001|Overall Study|Adverse Event|11|||
144233361|NCT01908829|520050035|FG002|Overall Study|Adverse Event|13|||
144233362|NCT01908829|520050033|FG000|Overall Study|Lost to Follow-up|4|||
144233363|NCT01908829|520050034|FG001|Overall Study|Lost to Follow-up|2|||
144233364|NCT01908829|520050035|FG002|Overall Study|Lost to Follow-up|1|||
144233365|NCT01908829|520050033|FG000|Overall Study|Randomized no double-blind drug received|1|||
144233366|NCT01908829|520050034|FG001|Overall Study|Randomized no double-blind drug received|0|||
144233367|NCT01908829|520050035|FG002|Overall Study|Randomized no double-blind drug received|1|||
144233368|NCT01908829|520050033|FG000|Overall Study|Discontinued (no EoT page)|2|||
144233369|NCT01908829|520050034|FG001|Overall Study|Discontinued (no EoT page)|0|||
144233370|NCT01908829|520050035|FG002|Overall Study|Discontinued (no EoT page)|0|||
144233371|NCT01908829|520050033|FG000|Overall Study|Miscellaneous|0|||
144233372|NCT01908829|520050034|FG001|Overall Study|Miscellaneous|2|||
144233373|NCT01908829|520050035|FG002|Overall Study|Miscellaneous|0|||
144233374|NCT01908829|520050033|FG000|Overall Study|Protocol Violation|2|||
144233375|NCT01908829|520050034|FG001|Overall Study|Protocol Violation|2|||
144233376|NCT01908829|520050035|FG002|Overall Study|Protocol Violation|0|||
144233377|NCT01908829|520050033|FG000|Overall Study|Lack of Efficacy|1|||
144233378|NCT01908829|520050034|FG001|Overall Study|Lack of Efficacy|3|||
144233379|NCT01908829|520050035|FG002|Overall Study|Lack of Efficacy|2|||
144233380|NCT01908829|520050033|FG000|Overall Study|Withdrawal by Subject|26|||
144233381|NCT01908829|520050034|FG001|Overall Study|Withdrawal by Subject|29|||
144233382|NCT01908829|520050035|FG002|Overall Study|Withdrawal by Subject|22|||
144233383|NCT02247440|520050036|FG000|Overall Study|Withdrawal by Subject|1|||
144233384|NCT02247440|520050036|FG000|Overall Study|Lack of Efficacy|3|||
144233385|NCT01339923|520050037|FG000|Overall Study|Adverse Event|1|||
144233386|NCT01339923|520050038|FG001|Overall Study|Adverse Event|1|||
144233387|NCT01339923|520050039|FG002|Overall Study|Adverse Event|1|||
144233388|NCT01339923|520050040|FG003|Overall Study|Adverse Event|0|||
144233389|NCT01339923|520050041|FG004|Overall Study|Adverse Event|0|||
144233390|NCT01339923|520050042|FG005|Overall Study|Adverse Event|0|||
144233391|NCT01339923|520050043|FG006|Overall Study|Adverse Event|1|||
144233392|NCT01339923|520050037|FG000|Overall Study|Inappropriate Enrollment|1|||
144233393|NCT01339923|520050038|FG001|Overall Study|Inappropriate Enrollment|0|||
144233394|NCT01339923|520050039|FG002|Overall Study|Inappropriate Enrollment|0|||
144233395|NCT01339923|520050040|FG003|Overall Study|Inappropriate Enrollment|0|||
144233396|NCT01339923|520050041|FG004|Overall Study|Inappropriate Enrollment|0|||
144233397|NCT01339923|520050042|FG005|Overall Study|Inappropriate Enrollment|1|||
144233398|NCT01339923|520050043|FG006|Overall Study|Inappropriate Enrollment|0|||
144233399|NCT01339923|520050037|FG000|Overall Study|Lost to Follow-up|4|||
144233400|NCT01339923|520050038|FG001|Overall Study|Lost to Follow-up|4|||
144233401|NCT01339923|520050039|FG002|Overall Study|Lost to Follow-up|0|||
144233402|NCT01339923|520050040|FG003|Overall Study|Lost to Follow-up|3|||
144233403|NCT01339923|520050041|FG004|Overall Study|Lost to Follow-up|1|||
144233404|NCT01339923|520050042|FG005|Overall Study|Lost to Follow-up|1|||
144233405|NCT01339923|520050043|FG006|Overall Study|Lost to Follow-up|5|||
144233406|NCT01339923|520050037|FG000|Overall Study|Protocol Violation|0|||
144233407|NCT01339923|520050038|FG001|Overall Study|Protocol Violation|0|||
144233408|NCT01339923|520050039|FG002|Overall Study|Protocol Violation|0|||
144233409|NCT01339923|520050040|FG003|Overall Study|Protocol Violation|0|||
144233410|NCT01339923|520050041|FG004|Overall Study|Protocol Violation|0|||
144233411|NCT01339923|520050042|FG005|Overall Study|Protocol Violation|3|||
144233412|NCT01339923|520050043|FG006|Overall Study|Protocol Violation|1|||
144233413|NCT01339923|520050037|FG000|Overall Study|Unable to Classify|1|||
144233414|NCT01339923|520050038|FG001|Overall Study|Unable to Classify|0|||
144233415|NCT01339923|520050039|FG002|Overall Study|Unable to Classify|1|||
144233416|NCT01339923|520050040|FG003|Overall Study|Unable to Classify|0|||
144233417|NCT01339923|520050041|FG004|Overall Study|Unable to Classify|0|||
144269571|NCT01118299|520191353|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
144233418|NCT01339923|520050042|FG005|Overall Study|Unable to Classify|1|||
144233419|NCT01339923|520050043|FG006|Overall Study|Unable to Classify|5|||
144233420|NCT01339923|520050037|FG000|Overall Study|Withdrawal by Subject|7|||
144233421|NCT01339923|520050038|FG001|Overall Study|Withdrawal by Subject|11|||
144233422|NCT01339923|520050039|FG002|Overall Study|Withdrawal by Subject|6|||
144233423|NCT01339923|520050040|FG003|Overall Study|Withdrawal by Subject|1|||
144269572|NCT02337491|520191355|FG000|Overall Study|Death|1|||
144269573|NCT02337491|520191356|FG001|Overall Study|Death|1|||
144233424|NCT01339923|520050041|FG004|Overall Study|Withdrawal by Subject|4|||
144233425|NCT01339923|520050042|FG005|Overall Study|Withdrawal by Subject|3|||
144233426|NCT01339923|520050043|FG006|Overall Study|Withdrawal by Subject|2|||
144233427|NCT00661609|520050044|FG000|Overall Study|Adverse Event|4|||
144233428|NCT00661609|520050044|FG000|Overall Study|Death|20|||
144233429|NCT00661609|520050044|FG000|Overall Study|Withdrawal by Subject|2|||
144233430|NCT00661609|520050044|FG000|Overall Study|PI Decision|1|||
144233431|NCT00661609|520050044|FG000|Overall Study|Survival follow up stage discontinued|11|||
144233432|NCT00661609|520050044|FG000|Overall Study|Disease progression|3|||
144233433|NCT01855243|520050047|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
144233434|NCT01855243|520050048|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
144233435|NCT01855243|520050049|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
144233436|NCT00403481|520050051|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
144233437|NCT00403481|520050051|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
144233438|NCT00403481|520050051|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
144233439|NCT00403481|520050051|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
144233440|NCT00403481|520050051|FG000|Olm 40 mg|Adverse Event|2|||
144233441|NCT00403481|520050051|FG000|Olm 40 mg|Protocol Violation|1|||
144233442|NCT00403481|520050051|FG000|Olm 40 mg|Withdrawal by Subject|1|||
144269574|NCT02337491|520191355|FG000|Overall Study|Adverse Event|0|||
144233443|NCT00403481|520050051|FG000|Olm 40 mg|Other|1|||
144233444|NCT00403481|520050051|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
144269575|NCT02337491|520191356|FG001|Overall Study|Adverse Event|1|||
144269576|NCT02337491|520191355|FG000|Overall Study|Withdrawal by Subject|3|||
144269577|NCT02337491|520191356|FG001|Overall Study|Withdrawal by Subject|0|||
144233445|NCT00403481|520050051|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
144269578|NCT02337491|520191355|FG000|Overall Study|Progressive Disease|44|||
144233446|NCT00403481|520050051|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
144233447|NCT00403481|520050051|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
144233448|NCT00403481|520050051|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
144233449|NCT00403481|520050051|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
144233450|NCT00396656|520050052|FG000|First Treatment Period|Withdrawal by Subject|0|||
144233451|NCT00396656|520050053|FG001|First Treatment Period|Withdrawal by Subject|2|||
144233452|NCT00396656|520050052|FG000|Second Treatment Period|Adverse Event|0|||
144233453|NCT00396656|520050053|FG001|Second Treatment Period|Adverse Event|1|||
144233454|NCT00766636|520050059|FG000|Overall Study|Withdrawal by Subject|1|||
144233455|NCT00766636|520050060|FG001|Overall Study|Withdrawal by Subject|1|||
144233456|NCT00766636|520050059|FG000|Overall Study|Incomplete Treatment|0|||
144233457|NCT00766636|520050060|FG001|Overall Study|Incomplete Treatment|1|||
144233458|NCT00766636|520050059|FG000|Overall Study|Adverse Event|1|||
144233459|NCT00766636|520050060|FG001|Overall Study|Adverse Event|0|||
144233460|NCT00766636|520050059|FG000|Overall Study|Disease Progression|1|||
144233461|NCT00766636|520050060|FG001|Overall Study|Disease Progression|0|||
144233462|NCT04925557|520051939|FG000|Overall Study|Study closed|5|||
144233463|NCT04925557|520051940|FG001|Overall Study|Study closed|3|||
144233464|NCT05488470|520051941|FG000|Overall Study|Physician Decision|2|||
144233465|NCT05488470|520051941|FG000|Overall Study|Withdrawal by Subject|1|||
144233466|NCT05488470|520051941|FG000|Overall Study|Death|1|||
144233467|NCT00068393|520051946|FG000|Overall Study|Adverse Event|2|||
144233468|NCT00068393|520051946|FG000|Overall Study|Death|3|||
144233469|NCT00068393|520051946|FG000|Overall Study|Withdrawal by Subject|3|||
144233470|NCT00068393|520051946|FG000|Overall Study|Alternative treatment|1|||
144233471|NCT00068393|520051946|FG000|Overall Study|Quality of life worsening|1|||
144233472|NCT01068730|520051950|FG000|Period 3|Personal reason|1|||
144233473|NCT01068730|520051951|FG001|Period 3|Personal reason|0|||
144233474|NCT01068730|520051952|FG002|Period 3|Personal reason|0|||
144233475|NCT01068730|520051953|FG003|Period 3|Personal reason|0|||
144233476|NCT01068730|520051950|FG000|Period 4|Family emergency|0|||
144233477|NCT01068730|520051951|FG001|Period 4|Family emergency|1|||
144233478|NCT01068730|520051952|FG002|Period 4|Family emergency|0|||
144233479|NCT01068730|520051953|FG003|Period 4|Family emergency|0|||
144233480|NCT03260244|520051955|FG000|Overall Study|Death|19|||
144233481|NCT03260244|520051955|FG000|Overall Study|Lost to Follow-up|60|||
144233482|NCT03260244|520051955|FG000|Overall Study|Withdrawal by Subject|48|||
144233483|NCT03260244|520051955|FG000|Overall Study|Procedure Not Performed|21|||
144233484|NCT03260244|520051955|FG000|Overall Study|Enrollment Criteria Not Met|31|||
144233485|NCT03260244|520051955|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
144233486|NCT03260244|520051955|FG000|Overall Study|Subject Noncompliance|6|||
144233487|NCT03260244|520051955|FG000|Overall Study|No inducible Arrhythmia|2|||
144233488|NCT03260244|520051955|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
144233489|NCT03260244|520051955|FG000|Overall Study|Screen Failure|2|||
144233490|NCT03260244|520051955|FG000|Overall Study|Treated Off Label|69|||
144233491|NCT03260244|520051955|FG000|Overall Study|No Radiofrequency Ablation|14|||
144233492|NCT00610155|520051960|FG000|Period 1|Withdrawal by Subject|0|||
144233493|NCT00610155|520051961|FG001|Period 1|Withdrawal by Subject|0|||
144233494|NCT00610155|520051962|FG002|Period 1|Withdrawal by Subject|1|||
144233495|NCT00610155|520051963|FG003|Period 1|Withdrawal by Subject|0|||
144233496|NCT00610155|520051964|FG004|Period 1|Withdrawal by Subject|0|||
144233497|NCT00610155|520051965|FG005|Period 1|Withdrawal by Subject|0|||
144233498|NCT00610155|520051960|FG000|Period 3|Adverse Event|1|||
144233499|NCT00610155|520051961|FG001|Period 3|Adverse Event|0|||
144233500|NCT00610155|520051962|FG002|Period 3|Adverse Event|0|||
144233501|NCT00610155|520051963|FG003|Period 3|Adverse Event|0|||
144233502|NCT00610155|520051964|FG004|Period 3|Adverse Event|0|||
144233503|NCT00610155|520051965|FG005|Period 3|Adverse Event|0|||
144233504|NCT00384839|520051968|FG000|Overall Study|Adverse Event|4|||
144233505|NCT00384839|520051968|FG000|Overall Study|Investigator Request|1|||
144233506|NCT00384839|520051968|FG000|Overall Study|Patient Request|1|||
144233507|NCT00384839|520051968|FG000|Overall Study|Ineligible|2|||
144233508|NCT02714595|520051969|FG000|Overall Study|Lost to Follow-up|1|||
144233509|NCT02714595|520051970|FG001|Overall Study|Lost to Follow-up|0|||
144233510|NCT02714595|520051969|FG000|Overall Study|Withdrawal by Subject|1|||
144233511|NCT02714595|520051970|FG001|Overall Study|Withdrawal by Subject|2|||
144233512|NCT02714595|520051969|FG000|Overall Study|Lack of Efficacy|0|||
144233513|NCT02714595|520051970|FG001|Overall Study|Lack of Efficacy|1|||
144233514|NCT02714595|520051969|FG000|Overall Study|Death|30|||
144233515|NCT02714595|520051970|FG001|Overall Study|Death|9|||
144233516|NCT02714595|520051969|FG000|Overall Study|Other-Miscellaneous|0|||
144233517|NCT02714595|520051970|FG001|Overall Study|Other-Miscellaneous|1|||
144233518|NCT02320058|520051971|FG000|Overall Study|Death|25|||
144233519|NCT02320058|520051972|FG001|Overall Study|Death|10|||
144233520|NCT02320058|520051971|FG000|Overall Study|Lost to Follow-up|4|||
144233521|NCT02320058|520051972|FG001|Overall Study|Lost to Follow-up|0|||
144233522|NCT02320058|520051971|FG000|Overall Study|Other reasons|4|||
144233523|NCT02320058|520051972|FG001|Overall Study|Other reasons|1|||
144233524|NCT02320058|520051971|FG000|Overall Study|Withdrawal by Subject|8|||
144233525|NCT02320058|520051972|FG001|Overall Study|Withdrawal by Subject|2|||
144233526|NCT02320058|520051971|FG000|Overall Study|Not reported|1|||
144233527|NCT02320058|520051972|FG001|Overall Study|Not reported|0|||
144233528|NCT00828568|520051973|FG000|Randomized|Withdrawal by Subject|1|||
144233529|NCT00828568|520051974|FG001|Randomized|Withdrawal by Subject|0|||
144233530|NCT00828568|520051975|FG002|Randomized|Withdrawal by Subject|2|||
144233531|NCT00828568|520051973|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
144233532|NCT00828568|520051974|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
144233533|NCT00828568|520051975|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
144233534|NCT00828568|520051973|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
144233535|NCT00828568|520051974|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
144233536|NCT00828568|520051975|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
144233537|NCT00828568|520051973|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
144233538|NCT00828568|520051974|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
144233539|NCT00828568|520051975|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
144233540|NCT00828568|520051973|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
144233541|NCT00828568|520051974|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
144233542|NCT00828568|520051975|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
144233543|NCT02821754|520051976|FG000|Overall Study|Procedure not required prior to amendment change|13|||
144233544|NCT02821754|520051977|FG001|Overall Study|Procedure not required prior to amendment change|11|||
144233545|NCT02821754|520051978|FG002|Overall Study|Procedure not required prior to amendment change|0|||
144233546|NCT02821754|520051976|FG000|Overall Study|Participant's Clinical status|2|||
144233547|NCT02821754|520051977|FG001|Overall Study|Participant's Clinical status|0|||
144233548|NCT02821754|520051978|FG002|Overall Study|Participant's Clinical status|0|||
144233549|NCT02821754|520051976|FG000|Overall Study|Participant removed for noncompliance|1|||
144233550|NCT02821754|520051977|FG001|Overall Study|Participant removed for noncompliance|0|||
144233551|NCT02821754|520051978|FG002|Overall Study|Participant removed for noncompliance|0|||
144233552|NCT02821754|520051976|FG000|Overall Study|Drug not available.|0|||
144233553|NCT02821754|520051977|FG001|Overall Study|Drug not available.|0|||
144233554|NCT02821754|520051978|FG002|Overall Study|Drug not available.|1|||
144233555|NCT02821754|520051976|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
144233556|NCT02821754|520051977|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
144233557|NCT02821754|520051978|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
144233558|NCT02477332|520051980|FG000|Overall Study|Adverse Event|0|||
144233559|NCT02477332|520051981|FG001|Overall Study|Adverse Event|1|||
144233560|NCT02477332|520051982|FG002|Overall Study|Adverse Event|1|||
144233561|NCT02477332|520051983|FG003|Overall Study|Adverse Event|2|||
144233562|NCT02477332|520051984|FG004|Overall Study|Adverse Event|1|||
144233563|NCT02477332|520051985|FG005|Overall Study|Adverse Event|2|||
144233564|NCT02477332|520051980|FG000|Overall Study|Lack of Efficacy|1|||
144233565|NCT02477332|520051981|FG001|Overall Study|Lack of Efficacy|2|||
144233566|NCT02477332|520051982|FG002|Overall Study|Lack of Efficacy|1|||
144233567|NCT02477332|520051983|FG003|Overall Study|Lack of Efficacy|2|||
144233568|NCT02477332|520051984|FG004|Overall Study|Lack of Efficacy|1|||
144233569|NCT02477332|520051985|FG005|Overall Study|Lack of Efficacy|1|||
144233570|NCT02477332|520051980|FG000|Overall Study|Non-compliance with study treatment|0|||
144233571|NCT02477332|520051981|FG001|Overall Study|Non-compliance with study treatment|1|||
144233572|NCT02477332|520051982|FG002|Overall Study|Non-compliance with study treatment|2|||
144233573|NCT02477332|520051983|FG003|Overall Study|Non-compliance with study treatment|0|||
144233574|NCT02477332|520051984|FG004|Overall Study|Non-compliance with study treatment|0|||
144233575|NCT02477332|520051985|FG005|Overall Study|Non-compliance with study treatment|0|||
144233576|NCT02477332|520051980|FG000|Overall Study|Pregnancy|0|||
144233577|NCT02477332|520051981|FG001|Overall Study|Pregnancy|0|||
144233578|NCT02477332|520051982|FG002|Overall Study|Pregnancy|0|||
144233579|NCT02477332|520051983|FG003|Overall Study|Pregnancy|1|||
144233580|NCT02477332|520051984|FG004|Overall Study|Pregnancy|0|||
144233581|NCT02477332|520051985|FG005|Overall Study|Pregnancy|0|||
144233582|NCT02477332|520051980|FG000|Overall Study|Protocol Violation|2|||
144233583|NCT02477332|520051981|FG001|Overall Study|Protocol Violation|0|||
144233584|NCT02477332|520051982|FG002|Overall Study|Protocol Violation|3|||
144233585|NCT02477332|520051983|FG003|Overall Study|Protocol Violation|3|||
144233586|NCT02477332|520051984|FG004|Overall Study|Protocol Violation|1|||
144233587|NCT02477332|520051985|FG005|Overall Study|Protocol Violation|1|||
144233588|NCT02477332|520051980|FG000|Overall Study|Technical problems|0|||
144233589|NCT02477332|520051981|FG001|Overall Study|Technical problems|0|||
144233590|NCT02477332|520051982|FG002|Overall Study|Technical problems|1|||
144233591|NCT02477332|520051983|FG003|Overall Study|Technical problems|0|||
144233592|NCT02477332|520051984|FG004|Overall Study|Technical problems|0|||
144233593|NCT02477332|520051985|FG005|Overall Study|Technical problems|0|||
144233594|NCT02477332|520051980|FG000|Overall Study|Lost to Follow-up|0|||
144233595|NCT02477332|520051981|FG001|Overall Study|Lost to Follow-up|0|||
144233596|NCT02477332|520051982|FG002|Overall Study|Lost to Follow-up|2|||
144233597|NCT02477332|520051983|FG003|Overall Study|Lost to Follow-up|0|||
144233598|NCT02477332|520051984|FG004|Overall Study|Lost to Follow-up|0|||
144233599|NCT02477332|520051985|FG005|Overall Study|Lost to Follow-up|0|||
144233600|NCT02477332|520051980|FG000|Overall Study|Physician Decision|0|||
144233601|NCT02477332|520051981|FG001|Overall Study|Physician Decision|0|||
144233602|NCT02477332|520051982|FG002|Overall Study|Physician Decision|1|||
144233603|NCT02477332|520051983|FG003|Overall Study|Physician Decision|3|||
144233604|NCT02477332|520051984|FG004|Overall Study|Physician Decision|0|||
144233605|NCT02477332|520051985|FG005|Overall Study|Physician Decision|1|||
144233606|NCT02477332|520051980|FG000|Overall Study|Withdrawal by Subject|0|||
144233607|NCT02477332|520051981|FG001|Overall Study|Withdrawal by Subject|3|||
144233608|NCT02477332|520051982|FG002|Overall Study|Withdrawal by Subject|1|||
144233609|NCT02477332|520051983|FG003|Overall Study|Withdrawal by Subject|2|||
144233610|NCT02477332|520051984|FG004|Overall Study|Withdrawal by Subject|1|||
144233611|NCT02477332|520051985|FG005|Overall Study|Withdrawal by Subject|0|||
144233612|NCT04657198|520051986|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
144233613|NCT04657198|520051987|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
144233614|NCT04657198|520051988|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
144233615|NCT03793842|520051989|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
144233616|NCT03793842|520051990|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
144233617|NCT03793842|520051989|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
144233618|NCT03793842|520051990|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
144233619|NCT04087720|520051991|FG000|Overall Study|Withdrawal by Subject|2|||
144233620|NCT04087720|520051991|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
144233621|NCT00520533|520051996|FG000|Overall Study|Death|1|||
144233622|NCT00520533|520051996|FG000|Overall Study|Suspension of the study for safety reasons|1|||
144233623|NCT00520533|520051996|FG000|Overall Study|Withdrawal by Subject|1|||
144233624|NCT00520533|520051996|FG000|Overall Study|Physician Decision|1|||
144233625|NCT00900159|520051997|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
144233626|NCT00900159|520051998|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
144233627|NCT01166438|520051999|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
144233628|NCT01166438|520052000|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
144233629|NCT01166438|520051999|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
144233630|NCT01166438|520052000|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
144233631|NCT01166438|520051999|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
144233632|NCT01166438|520052000|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
144233633|NCT01166438|520051999|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
144233634|NCT01166438|520052000|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
144233635|NCT01166438|520051999|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
144233636|NCT01166438|520052000|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
144233637|NCT01166438|520051999|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
144233638|NCT01166438|520052000|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
144233639|NCT01075256|520052001|FG000|Overall Study|Withdrawal by Subject|1|||
144233640|NCT01075256|520052002|FG001|Overall Study|Withdrawal by Subject|0|||
144233641|NCT01075256|520052003|FG002|Overall Study|Withdrawal by Subject|0|||
144233642|NCT01377922|520052010|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
144233643|NCT01377922|520052011|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
144233644|NCT02157376|520052012|FG000|Overall Study|Death|10|||
144233645|NCT02157376|520052013|FG001|Overall Study|Death|4|||
144233646|NCT02157376|520052012|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144233647|NCT02157376|520052013|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144233648|NCT02157376|520052012|FG000|Overall Study|Withdrawal by Subject|3|||
144233649|NCT02157376|520052013|FG001|Overall Study|Withdrawal by Subject|8|||
144233650|NCT02157376|520052012|FG000|Overall Study|Not treated|8|||
144233651|NCT02157376|520052013|FG001|Overall Study|Not treated|3|||
144233652|NCT02157376|520052012|FG000|Overall Study|Investigator's misjudgement|1|||
144233653|NCT02157376|520052013|FG001|Overall Study|Investigator's misjudgement|2|||
144233654|NCT00529373|520052014|FG000|Base Study|Adverse Event|525|||
144233655|NCT00529373|520052015|FG001|Base Study|Adverse Event|470|||
144233656|NCT00529373|520052014|FG000|Base Study|Lack of Efficacy|16|||
144233657|NCT00529373|520052015|FG001|Base Study|Lack of Efficacy|75|||
144233658|NCT00529373|520052014|FG000|Base Study|Lost to Follow-up|221|||
144233659|NCT00529373|520052015|FG001|Base Study|Lost to Follow-up|208|||
144233660|NCT00529373|520052014|FG000|Base Study|Other Protocol Specified Criteria|19|||
144233661|NCT00529373|520052015|FG001|Base Study|Other Protocol Specified Criteria|20|||
144233662|NCT00529373|520052014|FG000|Base Study|Physician Decision|60|||
144233663|NCT00529373|520052015|FG001|Base Study|Physician Decision|52|||
144233664|NCT00529373|520052014|FG000|Base Study|Protocol Violation|48|||
144233665|NCT00529373|520052015|FG001|Base Study|Protocol Violation|38|||
144233666|NCT00529373|520052014|FG000|Base Study|Withdrawal by Subject|1062|||
144233667|NCT00529373|520052015|FG001|Base Study|Withdrawal by Subject|967|||
144233668|NCT00529373|520052014|FG000|Base Study|Did not continue into Extension|1795|||
144233669|NCT00529373|520052015|FG001|Base Study|Did not continue into Extension|2238|||
144233670|NCT00529373|520052014|FG000|First Extension Study|Adverse Event|162|||
144233671|NCT00529373|520052015|FG001|First Extension Study|Adverse Event|142|||
144233672|NCT00529373|520052014|FG000|First Extension Study|Lack of Efficacy|65|||
144233673|NCT00529373|520052015|FG001|First Extension Study|Lack of Efficacy|427|||
144233674|NCT00529373|520052014|FG000|First Extension Study|Lost to Follow-up|41|||
144233675|NCT00529373|520052015|FG001|First Extension Study|Lost to Follow-up|37|||
144233676|NCT00529373|520052014|FG000|First Extension Study|Other|27|||
144233677|NCT00529373|520052015|FG001|First Extension Study|Other|47|||
144233678|NCT00529373|520052014|FG000|First Extension Study|Physician Decision|50|||
144233679|NCT00529373|520052015|FG001|First Extension Study|Physician Decision|45|||
144233680|NCT00529373|520052014|FG000|First Extension Study|Protocol Violation|16|||
144233681|NCT00529373|520052015|FG001|First Extension Study|Protocol Violation|13|||
144233682|NCT00529373|520052014|FG000|First Extension Study|Withdrawal by Subject|296|||
144233683|NCT00529373|520052015|FG001|First Extension Study|Withdrawal by Subject|287|||
144233684|NCT00529373|520052014|FG000|First Extension Study|Disposition record non-existing|0|||
144233685|NCT00529373|520052015|FG001|First Extension Study|Disposition record non-existing|1|||
144233686|NCT00529373|520052014|FG000|First Extension Study|Discontinued after 5 years completion|208|||
144233687|NCT00529373|520052015|FG001|First Extension Study|Discontinued after 5 years completion|346|||
144233688|NCT00529373|520052014|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
144233689|NCT00529373|520052015|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
144233690|NCT00529373|520052014|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
144233691|NCT00529373|520052015|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
144233692|NCT00529373|520052014|FG000|Second Extension Study|Adverse Event|101|||
144233693|NCT00529373|520052015|FG001|Second Extension Study|Adverse Event|51|||
144233694|NCT00529373|520052014|FG000|Second Extension Study|Lack of Efficacy|7|||
144233695|NCT00529373|520052015|FG001|Second Extension Study|Lack of Efficacy|15|||
144233696|NCT00529373|520052014|FG000|Second Extension Study|Lost to Follow-up|18|||
144233697|NCT00529373|520052015|FG001|Second Extension Study|Lost to Follow-up|12|||
144233698|NCT00529373|520052014|FG000|Second Extension Study|Other|7|||
144233699|NCT00529373|520052015|FG001|Second Extension Study|Other|12|||
144233700|NCT00529373|520052014|FG000|Second Extension Study|Physician Decision|63|||
144233701|NCT00529373|520052015|FG001|Second Extension Study|Physician Decision|26|||
144233702|NCT00529373|520052014|FG000|Second Extension Study|Protocol Violation|2|||
144233703|NCT00529373|520052015|FG001|Second Extension Study|Protocol Violation|1|||
144233704|NCT00529373|520052014|FG000|Second Extension Study|Withdrawal by Subject|97|||
144233705|NCT00529373|520052015|FG001|Second Extension Study|Withdrawal by Subject|75|||
144233706|NCT00529373|520052014|FG000|Second Extension Study|Status Missing|5|||
144233707|NCT00529373|520052015|FG001|Second Extension Study|Status Missing|5|||
144233708|NCT01074268|520052024|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
144233709|NCT01074268|520052025|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
144233710|NCT01074268|520052024|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
144233711|NCT01074268|520052025|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
144233712|NCT01074268|520052024|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
144233713|NCT01074268|520052025|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
144233714|NCT01074268|520052024|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
144233715|NCT01074268|520052025|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
144233716|NCT01074268|520052024|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
144233717|NCT01074268|520052025|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
144233718|NCT01074268|520052024|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
144233719|NCT01074268|520052025|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
144233720|NCT01074268|520052024|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
144233721|NCT01074268|520052025|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
144233722|NCT01074268|520052024|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
144233723|NCT01074268|520052025|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
144233724|NCT01074268|520052024|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
144233725|NCT01074268|520052025|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
144233726|NCT04200651|520052028|FG000|Overall Study|Moved to another country during follow-up|2|||
144233727|NCT04200651|520052029|FG001|Overall Study|Moved to another country during follow-up|2|||
144233728|NCT04200651|520052028|FG000|Overall Study|Lost to Follow-up|1|||
144233729|NCT04200651|520052029|FG001|Overall Study|Lost to Follow-up|3|||
144233730|NCT01134939|520052033|FG000|Overall Study|Adverse Event|9|||
144233731|NCT01134939|520052034|FG001|Overall Study|Adverse Event|3|||
144233732|NCT01134939|520052035|FG002|Overall Study|Adverse Event|4|||
144233733|NCT01134939|520052036|FG003|Overall Study|Adverse Event|5|||
144233734|NCT01134939|520052037|FG004|Overall Study|Adverse Event|5|||
144233735|NCT01134939|520052038|FG005|Overall Study|Adverse Event|5|||
144233736|NCT01134939|520052039|FG006|Overall Study|Adverse Event|1|||
144233737|NCT01134939|520052040|FG007|Overall Study|Adverse Event|0|||
144233738|NCT01134939|520052033|FG000|Overall Study|Lack of Efficacy|2|||
144233739|NCT01134939|520052034|FG001|Overall Study|Lack of Efficacy|5|||
144233740|NCT01134939|520052035|FG002|Overall Study|Lack of Efficacy|1|||
144233741|NCT01134939|520052036|FG003|Overall Study|Lack of Efficacy|0|||
144233742|NCT01134939|520052037|FG004|Overall Study|Lack of Efficacy|3|||
144233743|NCT01134939|520052038|FG005|Overall Study|Lack of Efficacy|0|||
144233744|NCT01134939|520052039|FG006|Overall Study|Lack of Efficacy|1|||
144233745|NCT01134939|520052040|FG007|Overall Study|Lack of Efficacy|0|||
144233746|NCT01134939|520052033|FG000|Overall Study|Lost to Follow-up|2|||
144233747|NCT01134939|520052034|FG001|Overall Study|Lost to Follow-up|3|||
144233748|NCT01134939|520052035|FG002|Overall Study|Lost to Follow-up|0|||
144233749|NCT01134939|520052036|FG003|Overall Study|Lost to Follow-up|1|||
144233750|NCT01134939|520052037|FG004|Overall Study|Lost to Follow-up|2|||
144233751|NCT01134939|520052038|FG005|Overall Study|Lost to Follow-up|1|||
144233752|NCT01134939|520052039|FG006|Overall Study|Lost to Follow-up|0|||
144233753|NCT01134939|520052040|FG007|Overall Study|Lost to Follow-up|0|||
144233754|NCT01134939|520052033|FG000|Overall Study|Death|0|||
144233755|NCT01134939|520052034|FG001|Overall Study|Death|1|||
144233756|NCT01134939|520052035|FG002|Overall Study|Death|0|||
144233757|NCT01134939|520052036|FG003|Overall Study|Death|0|||
144233758|NCT01134939|520052037|FG004|Overall Study|Death|0|||
144233759|NCT01134939|520052038|FG005|Overall Study|Death|0|||
144233760|NCT01134939|520052039|FG006|Overall Study|Death|0|||
144233761|NCT01134939|520052040|FG007|Overall Study|Death|0|||
144233762|NCT01134939|520052033|FG000|Overall Study|Termination page not available|4|||
144233763|NCT01134939|520052034|FG001|Overall Study|Termination page not available|6|||
144233764|NCT01134939|520052035|FG002|Overall Study|Termination page not available|5|||
144233765|NCT01134939|520052036|FG003|Overall Study|Termination page not available|8|||
144233766|NCT01134939|520052037|FG004|Overall Study|Termination page not available|0|||
144233767|NCT01134939|520052038|FG005|Overall Study|Termination page not available|3|||
144233768|NCT01134939|520052039|FG006|Overall Study|Termination page not available|7|||
144233769|NCT01134939|520052040|FG007|Overall Study|Termination page not available|0|||
144233770|NCT00733421|520052041|FG000|Overall Study|Withdrawal by Subject|1|||
144233771|NCT00733421|520052042|FG001|Overall Study|Withdrawal by Subject|1|||
144233772|NCT02547220|520052045|FG000|Overall Study|Withdrawal by Subject|1|||
144233773|NCT02547220|520052046|FG001|Overall Study|Withdrawal by Subject|0|||
144233774|NCT02547220|520052045|FG000|Overall Study|Study terminated by sponsor|18|||
144233775|NCT02547220|520052046|FG001|Overall Study|Study terminated by sponsor|20|||
144233776|NCT04185220|520052050|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
144233777|NCT04185220|520052051|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
144233778|NCT04185220|520052050|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
144233779|NCT04185220|520052051|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
144233780|NCT01031680|520052056|FG000|Overall Study|Adverse Event|8|||
144233781|NCT01031680|520052057|FG001|Overall Study|Adverse Event|3|||
144233782|NCT01031680|520052056|FG000|Overall Study|Lost to Follow-up|2|||
144233783|NCT01031680|520052057|FG001|Overall Study|Lost to Follow-up|10|||
144233784|NCT01031680|520052056|FG000|Overall Study|Withdrawal by Subject|12|||
144233785|NCT01031680|520052057|FG001|Overall Study|Withdrawal by Subject|16|||
144233786|NCT01031680|520052056|FG000|Overall Study|Death|2|||
144233787|NCT01031680|520052057|FG001|Overall Study|Death|1|||
144233788|NCT01031680|520052056|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
144233789|NCT01031680|520052057|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
144233790|NCT01031680|520052056|FG000|Overall Study|Poor/Non-compliance|5|||
144233791|NCT01031680|520052057|FG001|Overall Study|Poor/Non-compliance|6|||
144233792|NCT01031680|520052056|FG000|Overall Study|Safety|1|||
144233793|NCT01031680|520052057|FG001|Overall Study|Safety|0|||
144233794|NCT01031680|520052056|FG000|Overall Study|Incorrect Enrolment|1|||
144233795|NCT01031680|520052057|FG001|Overall Study|Incorrect Enrolment|2|||
144233796|NCT01031680|520052056|FG000|Overall Study|Administrative Reason by Sponsor|0|||
144233797|NCT01031680|520052057|FG001|Overall Study|Administrative Reason by Sponsor|1|||
144233798|NCT01031680|520052056|FG000|Overall Study|Various|0|||
144233799|NCT01031680|520052057|FG001|Overall Study|Various|2|||
144233800|NCT01029782|520052060|FG000|Overall Study|Lost to Follow-up|2|||
144233801|NCT01029782|520052061|FG001|Overall Study|Lost to Follow-up|2|||
144233802|NCT01029782|520052060|FG000|Overall Study|Diagnosis changed|1|||
144233803|NCT01029782|520052061|FG001|Overall Study|Diagnosis changed|1|||
144233804|NCT01029782|520052060|FG000|Overall Study|Adverse Event|0|||
144233805|NCT01029782|520052061|FG001|Overall Study|Adverse Event|1|||
144233806|NCT01029782|520052060|FG000|Overall Study|Physician Decision|0|||
144233807|NCT01029782|520052061|FG001|Overall Study|Physician Decision|1|||
144233808|NCT01029782|520052060|FG000|Overall Study|Protocol Violation|0|||
144233809|NCT01029782|520052061|FG001|Overall Study|Protocol Violation|2|||
144233810|NCT01029782|520052060|FG000|Overall Study|Withdrawal by Subject|0|||
144233811|NCT01029782|520052061|FG001|Overall Study|Withdrawal by Subject|1|||
144233812|NCT01186692|520052066|FG000|Overall Study|Not Catheterized|11|||
144233813|NCT01186692|520052066|FG000|Overall Study|Futher testing contraindicated implant|19|||
144233814|NCT01186692|520052066|FG000|Overall Study|Adverse Event|2|||
144233815|NCT02195869|520052067|FG000|Overall Study|cGVHD Progression|5|||
144233816|NCT02195869|520052067|FG000|Overall Study|Malignancy Progression/relapse|2|||
144233817|NCT02195869|520052067|FG000|Overall Study|Adverse Event|15|||
144233818|NCT02195869|520052067|FG000|Overall Study|Withdrawal by Subject|7|||
144233819|NCT02195869|520052067|FG000|Overall Study|Physician Decision|4|||
144233820|NCT02195869|520052067|FG000|Overall Study|Study Terminated by Sponsor|7|||
144233821|NCT02195869|520052067|FG000|Overall Study|Noncompliance with study drug|2|||
144233822|NCT03319732|520052071|FG000|Overall Study|Adverse Event|40|||
144233823|NCT03319732|520052071|FG000|Overall Study|Withdrawal by Subject|50|||
144233824|NCT03319732|520052071|FG000|Overall Study|MS relapse|10|||
144233825|NCT03319732|520052071|FG000|Overall Study|reason not specified|5|||
144233826|NCT02654977|520052072|FG000|Overall Study|Death|1|||
144233827|NCT02654977|520052072|FG000|Overall Study|Lost to Follow-up|1|||
144233828|NCT02654977|520052072|FG000|Overall Study|Adverse Event|1|||
144233829|NCT02654977|520052072|FG000|Overall Study|Withdrawal by Subject|1|||
144233830|NCT02654977|520052072|FG000|Overall Study|Lack of Efficacy|3|||
144233831|NCT00767455|520052073|FG000|Overall Study|Investigator error|19|||
144233832|NCT01870973|520052074|FG000|Overall Study|Lost to Follow-up|10|||
144233833|NCT01870973|520052075|FG001|Overall Study|Lost to Follow-up|3|||
144233834|NCT03225105|520052082|FG000|Overall Study|Withdrawal by Subject|1|||
144233835|NCT03225105|520052083|FG001|Overall Study|Withdrawal by Subject|0|||
144233836|NCT03225105|520052084|FG002|Overall Study|Withdrawal by Subject|0|||
144233837|NCT03225105|520052085|FG003|Overall Study|Withdrawal by Subject|0|||
144233838|NCT03225105|520052082|FG000|Overall Study|Death|0|||
144233839|NCT03225105|520052083|FG001|Overall Study|Death|4|||
144233840|NCT03225105|520052084|FG002|Overall Study|Death|2|||
144233841|NCT03225105|520052085|FG003|Overall Study|Death|0|||
144233842|NCT03225105|520052082|FG000|Overall Study|Study termination per Sponsor Decision|2|||
144233843|NCT03225105|520052083|FG001|Overall Study|Study termination per Sponsor Decision|0|||
144233844|NCT03225105|520052084|FG002|Overall Study|Study termination per Sponsor Decision|3|||
144233845|NCT03225105|520052085|FG003|Overall Study|Study termination per Sponsor Decision|3|||
144233846|NCT03232931|520053645|FG000|Overall Study|Physician Decision|1|||
144233847|NCT03232931|520053646|FG001|Overall Study|Physician Decision|1|||
144233848|NCT03232931|520053645|FG000|Overall Study|Withdrawal by Subject|6|||
144233849|NCT03232931|520053646|FG001|Overall Study|Withdrawal by Subject|0|||
144233850|NCT03232931|520053645|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
144233851|NCT03232931|520053646|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
144233852|NCT03232931|520053645|FG000|Overall Study|Parent did not record voice|1|||
144233853|NCT03232931|520053646|FG001|Overall Study|Parent did not record voice|2|||
144233854|NCT03232931|520053645|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
144233855|NCT03232931|520053646|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
144233856|NCT05088603|520053647|FG000|Overall Study|Protocol Violation|6|||
144233857|NCT05088603|520053648|FG001|Overall Study|Protocol Violation|1|||
144233858|NCT03233529|520053654|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
144233859|NCT03233529|520053654|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
144233860|NCT00594100|520053657|FG000|Procedure|Technical Failure|9|||
144233861|NCT00594100|520053657|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
144233862|NCT00594100|520053657|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
144233863|NCT00594100|520053657|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
144233864|NCT04696055|520053663|FG000|Overall Study|Adverse Event|10|||
144233865|NCT04696055|520053664|FG001|Overall Study|Adverse Event|2|||
144233866|NCT04696055|520053663|FG000|Overall Study|Death|4|||
144233867|NCT04696055|520053664|FG001|Overall Study|Death|0|||
144233868|NCT04696055|520053663|FG000|Overall Study|Other|7|||
144233869|NCT04696055|520053664|FG001|Overall Study|Other|2|||
144233870|NCT04696055|520053663|FG000|Overall Study|Physician Decision|3|||
144233871|NCT04696055|520053664|FG001|Overall Study|Physician Decision|0|||
144233872|NCT04696055|520053663|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
144233873|NCT04696055|520053664|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
144233874|NCT04696055|520053663|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
144233875|NCT04696055|520053664|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
144233876|NCT04696055|520053663|FG000|Overall Study|Subject Decision|1|||
144233877|NCT04696055|520053664|FG001|Overall Study|Subject Decision|2|||
144233878|NCT03969901|520053665|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144233879|NCT03969901|520053666|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144233880|NCT03969901|520053667|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144233881|NCT03969901|520053668|FG003|Overall Study|Withdrawal by parent/guardian|0|||
144233882|NCT03969901|520053669|FG004|Overall Study|Withdrawal by parent/guardian|1|||
144233883|NCT03969901|520053670|FG005|Overall Study|Withdrawal by parent/guardian|0|||
144233884|NCT03969901|520053671|FG006|Overall Study|Withdrawal by parent/guardian|0|||
144233885|NCT03969901|520053672|FG007|Overall Study|Withdrawal by parent/guardian|1|||
144233886|NCT03969901|520053673|FG008|Overall Study|Withdrawal by parent/guardian|1|||
144233887|NCT03969901|520053674|FG009|Overall Study|Withdrawal by parent/guardian|0|||
144233888|NCT01284348|520053677|FG000|Overall Study|Death|1|||
144233889|NCT01284348|520053678|FG001|Overall Study|Death|1|||
144233890|NCT01284348|520053677|FG000|Overall Study|Withdrew consent|0|||
144233891|NCT01284348|520053678|FG001|Overall Study|Withdrew consent|1|||
144233892|NCT01284348|520053677|FG000|Overall Study|Status not recorded|9|||
144233893|NCT01284348|520053678|FG001|Overall Study|Status not recorded|10|||
144233894|NCT00083759|520053685|FG000|Overall Study|Adverse Event|5|||
144233895|NCT00083759|520053686|FG001|Overall Study|Adverse Event|3|||
144233896|NCT00083759|520053685|FG000|Overall Study|Lost to Follow-up|1|||
144233897|NCT00083759|520053686|FG001|Overall Study|Lost to Follow-up|0|||
144233898|NCT00083759|520053685|FG000|Overall Study|Death|1|||
144233899|NCT00083759|520053686|FG001|Overall Study|Death|1|||
144233900|NCT00083759|520053685|FG000|Overall Study|Inadequate Therapeutic Response|32|||
144233901|NCT00083759|520053686|FG001|Overall Study|Inadequate Therapeutic Response|35|||
144233902|NCT00083759|520053685|FG000|Overall Study|Subject Withdrew Consent|2|||
144233903|NCT00083759|520053686|FG001|Overall Study|Subject Withdrew Consent|2|||
144233904|NCT00083759|520053685|FG000|Overall Study|Non-Compliance|1|||
144233905|NCT00083759|520053686|FG001|Overall Study|Non-Compliance|0|||
144233906|NCT00083759|520053685|FG000|Overall Study|Sponsor's Discretion|28|||
144233907|NCT00083759|520053686|FG001|Overall Study|Sponsor's Discretion|29|||
144233908|NCT00083759|520053685|FG000|Overall Study|Other|14|||
144233909|NCT00083759|520053686|FG001|Overall Study|Other|13|||
144233910|NCT03645395|520053687|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
144233911|NCT03645395|520053688|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
144233912|NCT03645395|520053689|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
144233913|NCT03645395|520053690|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
144233914|NCT03645395|520053687|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
144233915|NCT03645395|520053688|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
144233916|NCT03645395|520053689|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
144233917|NCT03645395|520053690|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
144233918|NCT03645395|520053687|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
144233919|NCT03645395|520053688|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
144233920|NCT03645395|520053689|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
144233921|NCT03645395|520053690|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
144233922|NCT03645395|520053687|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
144233923|NCT03645395|520053688|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
144233924|NCT03645395|520053689|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
144233925|NCT03645395|520053690|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
144233926|NCT02564900|520053691|FG000|Dose Escalation|Progressive disease per RECIST|2|||
144233927|NCT02564900|520053692|FG001|Dose Escalation|Progressive disease per RECIST|3|||
144233928|NCT02564900|520053693|FG002|Dose Escalation|Progressive disease per RECIST|3|||
144233929|NCT02564900|520053694|FG003|Dose Escalation|Progressive disease per RECIST|3|||
144233930|NCT02564900|520053695|FG004|Dose Escalation|Progressive disease per RECIST|3|||
144233931|NCT02564900|520053696|FG005|Dose Escalation|Progressive disease per RECIST|1|||
144233932|NCT02564900|520053697|FG006|Dose Escalation|Progressive disease per RECIST|0|||
144233933|NCT02564900|520053698|FG007|Dose Escalation|Progressive disease per RECIST|0|||
144233934|NCT02564900|520053699|FG008|Dose Escalation|Progressive disease per RECIST|0|||
144233935|NCT02564900|520053700|FG009|Dose Escalation|Progressive disease per RECIST|0|||
144233936|NCT02564900|520053701|FG010|Dose Escalation|Progressive disease per RECIST|0|||
144233937|NCT02564900|520053702|FG011|Dose Escalation|Progressive disease per RECIST|0|||
144233938|NCT02564900|520053703|FG012|Dose Escalation|Progressive disease per RECIST|0|||
144233939|NCT02564900|520053704|FG013|Dose Escalation|Progressive disease per RECIST|0|||
144269579|NCT02337491|520191356|FG001|Overall Study|Progressive Disease|28|||
144269580|NCT02337491|520191355|FG000|Overall Study|On Treatment|2|||
144233940|NCT02564900|520053705|FG014|Dose Escalation|Progressive disease per RECIST|0|||
144233941|NCT02564900|520053691|FG000|Dose Escalation|Ongoing|1|||
144233942|NCT02564900|520053692|FG001|Dose Escalation|Ongoing|0|||
144233943|NCT02564900|520053693|FG002|Dose Escalation|Ongoing|0|||
144233944|NCT02564900|520053694|FG003|Dose Escalation|Ongoing|2|||
144233945|NCT02564900|520053695|FG004|Dose Escalation|Ongoing|2|||
144233946|NCT02564900|520053696|FG005|Dose Escalation|Ongoing|2|||
144233947|NCT02564900|520053697|FG006|Dose Escalation|Ongoing|0|||
144233948|NCT02564900|520053698|FG007|Dose Escalation|Ongoing|0|||
144233949|NCT02564900|520053699|FG008|Dose Escalation|Ongoing|0|||
144233950|NCT02564900|520053700|FG009|Dose Escalation|Ongoing|0|||
144233951|NCT02564900|520053701|FG010|Dose Escalation|Ongoing|0|||
144233952|NCT02564900|520053702|FG011|Dose Escalation|Ongoing|0|||
144233953|NCT02564900|520053703|FG012|Dose Escalation|Ongoing|0|||
144233954|NCT02564900|520053704|FG013|Dose Escalation|Ongoing|0|||
144233955|NCT02564900|520053705|FG014|Dose Escalation|Ongoing|0|||
144233956|NCT02564900|520053691|FG000|Dose Escalation|Adverse Event|0|||
144233957|NCT02564900|520053692|FG001|Dose Escalation|Adverse Event|0|||
144233958|NCT02564900|520053693|FG002|Dose Escalation|Adverse Event|0|||
144233959|NCT02564900|520053694|FG003|Dose Escalation|Adverse Event|1|||
144233960|NCT02564900|520053695|FG004|Dose Escalation|Adverse Event|1|||
144233961|NCT02564900|520053696|FG005|Dose Escalation|Adverse Event|3|||
144233962|NCT02564900|520053697|FG006|Dose Escalation|Adverse Event|0|||
144233963|NCT02564900|520053698|FG007|Dose Escalation|Adverse Event|0|||
144233964|NCT02564900|520053699|FG008|Dose Escalation|Adverse Event|0|||
144233965|NCT02564900|520053700|FG009|Dose Escalation|Adverse Event|0|||
144233966|NCT02564900|520053701|FG010|Dose Escalation|Adverse Event|0|||
144233967|NCT02564900|520053702|FG011|Dose Escalation|Adverse Event|0|||
144233968|NCT02564900|520053703|FG012|Dose Escalation|Adverse Event|0|||
144233969|NCT02564900|520053704|FG013|Dose Escalation|Adverse Event|0|||
144233970|NCT02564900|520053705|FG014|Dose Escalation|Adverse Event|0|||
144233971|NCT02564900|520053691|FG000|Dose Expansion|Progressive disease per RECIST|0|||
144233972|NCT02564900|520053692|FG001|Dose Expansion|Progressive disease per RECIST|0|||
144233973|NCT02564900|520053693|FG002|Dose Expansion|Progressive disease per RECIST|0|||
144233974|NCT02564900|520053694|FG003|Dose Expansion|Progressive disease per RECIST|0|||
144233975|NCT02564900|520053695|FG004|Dose Expansion|Progressive disease per RECIST|0|||
144233976|NCT02564900|520053696|FG005|Dose Expansion|Progressive disease per RECIST|0|||
144233977|NCT02564900|520053697|FG006|Dose Expansion|Progressive disease per RECIST|19|||
144233978|NCT02564900|520053698|FG007|Dose Expansion|Progressive disease per RECIST|17|||
144233979|NCT02564900|520053699|FG008|Dose Expansion|Progressive disease per RECIST|8|||
144233980|NCT02564900|520053700|FG009|Dose Expansion|Progressive disease per RECIST|16|||
144233981|NCT02564900|520053701|FG010|Dose Expansion|Progressive disease per RECIST|13|||
144233982|NCT02564900|520053702|FG011|Dose Expansion|Progressive disease per RECIST|19|||
144233983|NCT02564900|520053703|FG012|Dose Expansion|Progressive disease per RECIST|10|||
144233984|NCT02564900|520053704|FG013|Dose Expansion|Progressive disease per RECIST|13|||
144233985|NCT02564900|520053705|FG014|Dose Expansion|Progressive disease per RECIST|11|||
144233986|NCT02564900|520053691|FG000|Dose Expansion|Clinical progression|0|||
144233987|NCT02564900|520053692|FG001|Dose Expansion|Clinical progression|0|||
144233988|NCT02564900|520053693|FG002|Dose Expansion|Clinical progression|0|||
144233989|NCT02564900|520053694|FG003|Dose Expansion|Clinical progression|0|||
144233990|NCT02564900|520053695|FG004|Dose Expansion|Clinical progression|0|||
144233991|NCT02564900|520053696|FG005|Dose Expansion|Clinical progression|0|||
144233992|NCT02564900|520053697|FG006|Dose Expansion|Clinical progression|5|||
144233993|NCT02564900|520053698|FG007|Dose Expansion|Clinical progression|12|||
144233994|NCT02564900|520053699|FG008|Dose Expansion|Clinical progression|0|||
144233995|NCT02564900|520053700|FG009|Dose Expansion|Clinical progression|3|||
144233996|NCT02564900|520053701|FG010|Dose Expansion|Clinical progression|2|||
144233997|NCT02564900|520053702|FG011|Dose Expansion|Clinical progression|0|||
144233998|NCT02564900|520053703|FG012|Dose Expansion|Clinical progression|1|||
144233999|NCT02564900|520053704|FG013|Dose Expansion|Clinical progression|3|||
144234000|NCT02564900|520053705|FG014|Dose Expansion|Clinical progression|1|||
144234001|NCT02564900|520053691|FG000|Dose Expansion|Adverse Event|0|||
144234002|NCT02564900|520053692|FG001|Dose Expansion|Adverse Event|0|||
144234003|NCT02564900|520053693|FG002|Dose Expansion|Adverse Event|0|||
144234004|NCT02564900|520053694|FG003|Dose Expansion|Adverse Event|0|||
144234005|NCT02564900|520053695|FG004|Dose Expansion|Adverse Event|0|||
144234006|NCT02564900|520053696|FG005|Dose Expansion|Adverse Event|0|||
144234007|NCT02564900|520053697|FG006|Dose Expansion|Adverse Event|9|||
144234008|NCT02564900|520053698|FG007|Dose Expansion|Adverse Event|22|||
144234009|NCT02564900|520053699|FG008|Dose Expansion|Adverse Event|0|||
144234010|NCT02564900|520053700|FG009|Dose Expansion|Adverse Event|11|||
144234011|NCT02564900|520053701|FG010|Dose Expansion|Adverse Event|0|||
144234012|NCT02564900|520053702|FG011|Dose Expansion|Adverse Event|5|||
144234013|NCT02564900|520053703|FG012|Dose Expansion|Adverse Event|2|||
144234014|NCT02564900|520053704|FG013|Dose Expansion|Adverse Event|2|||
144234015|NCT02564900|520053705|FG014|Dose Expansion|Adverse Event|1|||
144234016|NCT02564900|520053691|FG000|Dose Expansion|Ongoing|0|||
144234017|NCT02564900|520053692|FG001|Dose Expansion|Ongoing|0|||
144234018|NCT02564900|520053693|FG002|Dose Expansion|Ongoing|0|||
144234019|NCT02564900|520053694|FG003|Dose Expansion|Ongoing|0|||
144234020|NCT02564900|520053695|FG004|Dose Expansion|Ongoing|0|||
144234021|NCT02564900|520053696|FG005|Dose Expansion|Ongoing|0|||
144234022|NCT02564900|520053697|FG006|Dose Expansion|Ongoing|9|||
144234023|NCT02564900|520053698|FG007|Dose Expansion|Ongoing|10|||
144234024|NCT02564900|520053699|FG008|Dose Expansion|Ongoing|11|||
144234025|NCT02564900|520053700|FG009|Dose Expansion|Ongoing|3|||
144234026|NCT02564900|520053701|FG010|Dose Expansion|Ongoing|0|||
144234027|NCT02564900|520053702|FG011|Dose Expansion|Ongoing|0|||
144234028|NCT02564900|520053703|FG012|Dose Expansion|Ongoing|4|||
144234029|NCT02564900|520053704|FG013|Dose Expansion|Ongoing|0|||
144234030|NCT02564900|520053705|FG014|Dose Expansion|Ongoing|6|||
144234031|NCT02564900|520053691|FG000|Dose Expansion|Death|0|||
144234032|NCT02564900|520053692|FG001|Dose Expansion|Death|0|||
144234033|NCT02564900|520053693|FG002|Dose Expansion|Death|0|||
144234034|NCT02564900|520053694|FG003|Dose Expansion|Death|0|||
144234035|NCT02564900|520053695|FG004|Dose Expansion|Death|0|||
144234036|NCT02564900|520053696|FG005|Dose Expansion|Death|0|||
144234037|NCT02564900|520053697|FG006|Dose Expansion|Death|1|||
144234038|NCT02564900|520053698|FG007|Dose Expansion|Death|0|||
144234039|NCT02564900|520053699|FG008|Dose Expansion|Death|0|||
144234040|NCT02564900|520053700|FG009|Dose Expansion|Death|0|||
144234041|NCT02564900|520053701|FG010|Dose Expansion|Death|1|||
144234042|NCT02564900|520053702|FG011|Dose Expansion|Death|0|||
144234043|NCT02564900|520053703|FG012|Dose Expansion|Death|1|||
144234044|NCT02564900|520053704|FG013|Dose Expansion|Death|1|||
144234045|NCT02564900|520053705|FG014|Dose Expansion|Death|0|||
144234046|NCT02564900|520053691|FG000|Dose Expansion|Withdrawal by Subject|0|||
144234047|NCT02564900|520053692|FG001|Dose Expansion|Withdrawal by Subject|0|||
144234048|NCT02564900|520053693|FG002|Dose Expansion|Withdrawal by Subject|0|||
144234049|NCT02564900|520053694|FG003|Dose Expansion|Withdrawal by Subject|0|||
144234050|NCT02564900|520053695|FG004|Dose Expansion|Withdrawal by Subject|0|||
144234051|NCT02564900|520053696|FG005|Dose Expansion|Withdrawal by Subject|0|||
144234052|NCT02564900|520053697|FG006|Dose Expansion|Withdrawal by Subject|4|||
144234053|NCT02564900|520053698|FG007|Dose Expansion|Withdrawal by Subject|0|||
144234054|NCT02564900|520053699|FG008|Dose Expansion|Withdrawal by Subject|0|||
144234055|NCT02564900|520053700|FG009|Dose Expansion|Withdrawal by Subject|0|||
144234056|NCT02564900|520053701|FG010|Dose Expansion|Withdrawal by Subject|1|||
144234057|NCT02564900|520053702|FG011|Dose Expansion|Withdrawal by Subject|0|||
144234058|NCT02564900|520053703|FG012|Dose Expansion|Withdrawal by Subject|0|||
144234059|NCT02564900|520053704|FG013|Dose Expansion|Withdrawal by Subject|1|||
144234060|NCT02564900|520053705|FG014|Dose Expansion|Withdrawal by Subject|1|||
144234061|NCT02564900|520053691|FG000|Dose Expansion|Other|0|||
144234062|NCT02564900|520053692|FG001|Dose Expansion|Other|0|||
144234063|NCT02564900|520053693|FG002|Dose Expansion|Other|0|||
144234064|NCT02564900|520053694|FG003|Dose Expansion|Other|0|||
144234065|NCT02564900|520053695|FG004|Dose Expansion|Other|0|||
144234066|NCT02564900|520053696|FG005|Dose Expansion|Other|0|||
144234067|NCT02564900|520053697|FG006|Dose Expansion|Other|1|||
144234068|NCT02564900|520053698|FG007|Dose Expansion|Other|0|||
144234069|NCT02564900|520053699|FG008|Dose Expansion|Other|1|||
144269581|NCT02337491|520191356|FG001|Overall Study|On Treatment|0|||
144269582|NCT00958074|520191357|FG000|Overall Study|Withdrawal by Subject|0|||
144269583|NCT00958074|520191358|FG001|Overall Study|Withdrawal by Subject|1|||
144269584|NCT00095979|520191361|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
144234070|NCT02564900|520053700|FG009|Dose Expansion|Other|0|||
144234071|NCT02564900|520053701|FG010|Dose Expansion|Other|0|||
144234072|NCT02564900|520053702|FG011|Dose Expansion|Other|0|||
144234073|NCT02564900|520053703|FG012|Dose Expansion|Other|0|||
144234074|NCT02564900|520053704|FG013|Dose Expansion|Other|0|||
144234075|NCT02564900|520053705|FG014|Dose Expansion|Other|1|||
144234076|NCT02564900|520053691|FG000|Dose Expansion|Did not receive treatment|0|||
144234077|NCT02564900|520053692|FG001|Dose Expansion|Did not receive treatment|0|||
144234078|NCT02564900|520053693|FG002|Dose Expansion|Did not receive treatment|0|||
144234079|NCT02564900|520053694|FG003|Dose Expansion|Did not receive treatment|0|||
144234080|NCT02564900|520053695|FG004|Dose Expansion|Did not receive treatment|0|||
144234081|NCT02564900|520053696|FG005|Dose Expansion|Did not receive treatment|0|||
144234082|NCT02564900|520053697|FG006|Dose Expansion|Did not receive treatment|1|||
144234083|NCT02564900|520053698|FG007|Dose Expansion|Did not receive treatment|1|||
144234084|NCT02564900|520053699|FG008|Dose Expansion|Did not receive treatment|0|||
144234085|NCT02564900|520053700|FG009|Dose Expansion|Did not receive treatment|0|||
144234086|NCT02564900|520053701|FG010|Dose Expansion|Did not receive treatment|0|||
144234087|NCT02564900|520053702|FG011|Dose Expansion|Did not receive treatment|0|||
144234088|NCT02564900|520053703|FG012|Dose Expansion|Did not receive treatment|0|||
144234089|NCT02564900|520053704|FG013|Dose Expansion|Did not receive treatment|0|||
144234090|NCT02564900|520053705|FG014|Dose Expansion|Did not receive treatment|1|||
144234091|NCT00892151|520053706|FG000|Overall Study|Protocol Violation|1|||
144234092|NCT00379080|520053709|FG000|Overall Study|Withdrawal by Subject|0|||
144234093|NCT00379080|520053710|FG001|Overall Study|Withdrawal by Subject|4|||
144234094|NCT00379080|520053711|FG002|Overall Study|Withdrawal by Subject|0|||
144234095|NCT01222520|520053712|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
144234096|NCT01222520|520053713|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
144234097|NCT01222520|520053712|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
144234098|NCT01222520|520053713|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
144234099|NCT01222520|520053712|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
144234100|NCT01222520|520053713|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
144234101|NCT01222520|520053712|FG000|Double-blind Period|Adverse Event|0|||
144234102|NCT01222520|520053713|FG001|Double-blind Period|Adverse Event|1|||
144234103|NCT01222520|520053712|FG000|Double-blind Period|Lack of Efficacy|0|||
144234104|NCT01222520|520053713|FG001|Double-blind Period|Lack of Efficacy|1|||
144234105|NCT01222520|520053712|FG000|Double-blind Period|Study medication stolen|1|||
144234106|NCT01222520|520053713|FG001|Double-blind Period|Study medication stolen|0|||
144234107|NCT02285166|520053714|FG000|Overall Study|Case Report Forms Uncollected|564|||
144234108|NCT02285166|520053714|FG000|Overall Study|Protocol Deviation|402|||
144234109|NCT01089608|520053715|FG000|Overall Study|Adverse Event|0|||
144234110|NCT01089608|520053716|FG001|Overall Study|Adverse Event|4|||
144234111|NCT01089608|520053715|FG000|Overall Study|Lost to Follow-up|0|||
144234112|NCT01089608|520053716|FG001|Overall Study|Lost to Follow-up|2|||
144234113|NCT01421225|520053717|FG000|Overall Study|Withdrawal by Subject|0|||
144234114|NCT01421225|520053718|FG001|Overall Study|Withdrawal by Subject|1|||
144234115|NCT02649439|520053719|FG000|Overall Study|Switched to alternative treatment|6|||
144234116|NCT02649439|520053720|FG001|Overall Study|Switched to alternative treatment|4|||
144234117|NCT02649439|520053719|FG000|Overall Study|Patient decision|1|||
144234118|NCT02649439|520053720|FG001|Overall Study|Patient decision|0|||
144234119|NCT02649439|520053719|FG000|Overall Study|Patient going out of country|1|||
144234120|NCT02649439|520053720|FG001|Overall Study|Patient going out of country|0|||
144234121|NCT02649439|520053719|FG000|Overall Study|To start finasteride|1|||
144234122|NCT02649439|520053720|FG001|Overall Study|To start finasteride|0|||
144234123|NCT02649439|520053719|FG000|Overall Study|Physician Decision|1|||
144234124|NCT02649439|520053720|FG001|Overall Study|Physician Decision|0|||
144234125|NCT02649439|520053719|FG000|Overall Study|Disease progression on study|12|||
144234126|NCT02649439|520053720|FG001|Overall Study|Disease progression on study|13|||
144234127|NCT02649439|520053719|FG000|Overall Study|Refused further treatment|1|||
144269585|NCT03712280|520191363|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
144269586|NCT03712280|520191364|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
144269587|NCT03712280|520191365|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
144269588|NCT03712280|520191366|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
144269589|NCT03712280|520191363|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
144234128|NCT02649439|520053720|FG001|Overall Study|Refused further treatment|0|||
144234129|NCT02649439|520053719|FG000|Overall Study|Refused further follow up|2|||
144234130|NCT02649439|520053720|FG001|Overall Study|Refused further follow up|7|||
144234131|NCT02649439|520053719|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
144234132|NCT02649439|520053720|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
144234133|NCT02649439|520053719|FG000|Overall Study|No treatment, per protocol|1|||
144234134|NCT02649439|520053720|FG001|Overall Study|No treatment, per protocol|0|||
144234135|NCT02649439|520053719|FG000|Overall Study|PSA DT makes ineligible|0|||
144234136|NCT02649439|520053720|FG001|Overall Study|PSA DT makes ineligible|1|||
144234137|NCT02649439|520053719|FG000|Overall Study|Rising PSA No Mets|0|||
144234138|NCT02649439|520053720|FG001|Overall Study|Rising PSA No Mets|1|||
144234139|NCT02649439|520053719|FG000|Overall Study|Rising PSA|0|||
144234140|NCT02649439|520053720|FG001|Overall Study|Rising PSA|1|||
144234141|NCT02649439|520053719|FG000|Overall Study|Signed follow up protocol|0|||
144234142|NCT02649439|520053720|FG001|Overall Study|Signed follow up protocol|1|||
144234143|NCT02257489|520053725|FG000|Overall Study|Withdrawal by Subject|0|||
144234144|NCT02257489|520053726|FG001|Overall Study|Withdrawal by Subject|0|||
144234145|NCT02257489|520053727|FG002|Overall Study|Withdrawal by Subject|0|||
144234146|NCT02257489|520053728|FG003|Overall Study|Withdrawal by Subject|1|||
144234147|NCT02257489|520053729|FG004|Overall Study|Withdrawal by Subject|0|||
144234148|NCT02257489|520053730|FG005|Overall Study|Withdrawal by Subject|0|||
144234149|NCT02257489|520053731|FG006|Overall Study|Withdrawal by Subject|0|||
144234150|NCT02257489|520053732|FG007|Overall Study|Withdrawal by Subject|0|||
144234151|NCT02257489|520053733|FG008|Overall Study|Withdrawal by Subject|0|||
144234152|NCT01028014|520053735|FG000|Overall Study|Lost to Follow-up|1|||
144234153|NCT01028014|520053736|FG001|Overall Study|Lost to Follow-up|2|||
144234154|NCT01028014|520053737|FG002|Overall Study|Lost to Follow-up|0|||
144234155|NCT01028014|520053738|FG003|Overall Study|Lost to Follow-up|1|||
144234156|NCT01028014|520053739|FG004|Overall Study|Lost to Follow-up|1|||
144234157|NCT01028014|520053740|FG005|Overall Study|Lost to Follow-up|2|||
144234158|NCT01127451|520053741|FG000|Overall Study|Other|2|||
144234159|NCT01127451|520053742|FG001|Overall Study|Other|1|||
144234160|NCT01127451|520053741|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
144234161|NCT01127451|520053742|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
144234162|NCT01127451|520053741|FG000|Overall Study|Death|22|||
144234163|NCT01127451|520053742|FG001|Overall Study|Death|17|||
144234164|NCT01127451|520053741|FG000|Overall Study|Lost to Follow-up|3|||
144234165|NCT01127451|520053742|FG001|Overall Study|Lost to Follow-up|0|||
144234166|NCT01127451|520053741|FG000|Overall Study|Administrative Reason by Sponsor|2|||
144234167|NCT01127451|520053742|FG001|Overall Study|Administrative Reason by Sponsor|2|||
144234168|NCT00090493|520053743|FG000|Overall Study|Physician Decision|2|||
144234169|NCT02111577|520053746|FG000|Overall Study|Protocol Violation|2|||
144234170|NCT02111577|520053747|FG001|Overall Study|Protocol Violation|0|||
144234171|NCT02111577|520053746|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
144234172|NCT02111577|520053747|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
144234173|NCT02111577|520053746|FG000|Overall Study|Failure to produce study treatment|6|||
144234174|NCT02111577|520053747|FG001|Overall Study|Failure to produce study treatment|0|||
144234175|NCT02111577|520053746|FG000|Overall Study|Death|518|||
144234176|NCT02111577|520053747|FG001|Overall Study|Death|254|||
144234177|NCT02111577|520053746|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
144234178|NCT02111577|520053747|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
144234179|NCT02111577|520053746|FG000|Overall Study|Adverse Event|1|||
144234180|NCT02111577|520053747|FG001|Overall Study|Adverse Event|1|||
144234181|NCT02111577|520053746|FG000|Overall Study|Withdrawal by Subject|51|||
144234182|NCT02111577|520053747|FG001|Overall Study|Withdrawal by Subject|23|||
144234183|NCT02111577|520053746|FG000|Overall Study|Disease progression|0|||
144234184|NCT02111577|520053747|FG001|Overall Study|Disease progression|1|||
144234185|NCT02111577|520053746|FG000|Overall Study|Lost to Follow-up|19|||
144234186|NCT02111577|520053747|FG001|Overall Study|Lost to Follow-up|10|||
144234187|NCT00886743|520053748|FG000|Overall Study|Adverse Event|3|||
144234188|NCT00886743|520053748|FG000|Overall Study|Other|1|||
144234189|NCT02549287|520053749|FG000|Overall Study|Lost to Follow-up|65|||
144234190|NCT02549287|520053750|FG001|Overall Study|Lost to Follow-up|26|||
144234191|NCT02549287|520053749|FG000|Overall Study|Withdrawal by Subject|15|||
144269590|NCT03712280|520191364|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
144269591|NCT03712280|520191365|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
144269592|NCT03712280|520191366|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
144234192|NCT02549287|520053750|FG001|Overall Study|Withdrawal by Subject|6|||
144234193|NCT00427921|520053754|FG000|Overall Study|Adverse Event|26|||
144234194|NCT00427921|520053754|FG000|Overall Study|Withdrawal by Subject|4|||
144234195|NCT00427921|520053754|FG000|Overall Study|Lost to Follow-up|2|||
144234196|NCT00427921|520053754|FG000|Overall Study|Other reason not specified|10|||
144234197|NCT00427921|520053754|FG000|Overall Study|Adverse Event + Hospitalization|1|||
144234198|NCT00427921|520053754|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
144234199|NCT00427921|520053754|FG000|Overall Study|Adverse Event + No Response|1|||
144234200|NCT00427921|520053754|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
144234201|NCT00427921|520053754|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
144234202|NCT00427921|520053754|FG000|Overall Study|Adverse Event + Lost Response|1|||
144234203|NCT00427921|520053754|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
144234204|NCT00427921|520053754|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
144234205|NCT02887248|520053755|FG000|Overall Study|Withdrawal by Subject|1|||
144234206|NCT02887248|520053755|FG000|Overall Study|Adverse Event|1|||
144234207|NCT02887248|520053755|FG000|Overall Study|Progressive Disease|1|||
144234208|NCT03170362|520053756|FG000|Overall Study|Death|2|||
144234209|NCT03170362|520053757|FG001|Overall Study|Death|2|||
144234210|NCT03170362|520053756|FG000|Overall Study|Withdrawal by Subject|23|||
144234211|NCT03170362|520053757|FG001|Overall Study|Withdrawal by Subject|22|||
144234212|NCT03170362|520053756|FG000|Overall Study|Lost to Follow-up|187|||
144234213|NCT03170362|520053757|FG001|Overall Study|Lost to Follow-up|167|||
144234214|NCT04615403|520053758|FG000|Overall Study|Death|1|||
144234215|NCT01972438|520053761|FG000|Baseline-Month 3 Crossover Period|Death|1|||
144234216|NCT01972438|520053762|FG001|Baseline-Month 3 Crossover Period|Death|0|||
144234217|NCT01972438|520053761|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
144234218|NCT01972438|520053762|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
144234219|NCT01972438|520053761|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
144234220|NCT01972438|520053762|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
144234221|NCT01972438|520053761|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
144234222|NCT01972438|520053762|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
144234223|NCT01972438|520053761|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
144234224|NCT01972438|520053762|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
144234225|NCT01972438|520053761|FG000|Months 6-12 Study Period|Death|1|||
144234226|NCT01972438|520053762|FG001|Months 6-12 Study Period|Death|0|||
144234227|NCT01972438|520053761|FG000|Months 6-12 Study Period|Early Study Closure|2|||
144234228|NCT01972438|520053762|FG001|Months 6-12 Study Period|Early Study Closure|2|||
144234229|NCT01972438|520053761|FG000|Post Month 12 Study Period|Early Study Closure|3|||
144234230|NCT01972438|520053762|FG001|Post Month 12 Study Period|Early Study Closure|4|||
144234231|NCT00570063|520053765|FG000|Overall Study|Adverse Event|4|||
144234232|NCT00570063|520053766|FG001|Overall Study|Adverse Event|1|||
144234233|NCT00570063|520053765|FG000|Overall Study|Lack of Efficacy|0|||
144234234|NCT00570063|520053766|FG001|Overall Study|Lack of Efficacy|1|||
144234235|NCT00570063|520053765|FG000|Overall Study|Withdrawal by Subject|4|||
144234236|NCT00570063|520053766|FG001|Overall Study|Withdrawal by Subject|3|||
144234237|NCT00570063|520053765|FG000|Overall Study|Sponsor's Decision|7|||
144234238|NCT00570063|520053766|FG001|Overall Study|Sponsor's Decision|3|||
144234239|NCT00697463|520053767|FG000|Overall Study|Withdrawal by Subject|1|||
144234240|NCT03307252|520053768|FG000|Part 2, Period 1|Treatment not received|0|||
144234241|NCT03307252|520053769|FG001|Part 2, Period 1|Treatment not received|0|||
144234242|NCT03307252|520053770|FG002|Part 2, Period 1|Treatment not received|0|||
144234243|NCT03307252|520053771|FG003|Part 2, Period 1|Treatment not received|0|||
144234244|NCT03307252|520053772|FG004|Part 2, Period 1|Treatment not received|0|||
144234245|NCT03307252|520053773|FG005|Part 2, Period 1|Treatment not received|1|||
144234246|NCT03307252|520053774|FG006|Part 2, Period 1|Treatment not received|0|||
144234247|NCT03307252|520053775|FG007|Part 2, Period 1|Treatment not received|0|||
144234248|NCT03307252|520053776|FG008|Part 2, Period 1|Treatment not received|0|||
144234249|NCT03307252|520053777|FG009|Part 2, Period 1|Treatment not received|0|||
144234250|NCT03307252|520053778|FG010|Part 2, Period 1|Treatment not received|0|||
144234251|NCT03307252|520053768|FG000|Part 2, Period 3|Other than listed|0|||
144234252|NCT03307252|520053769|FG001|Part 2, Period 3|Other than listed|0|||
144234253|NCT03307252|520053770|FG002|Part 2, Period 3|Other than listed|0|||
144234254|NCT03307252|520053771|FG003|Part 2, Period 3|Other than listed|0|||
144234255|NCT03307252|520053772|FG004|Part 2, Period 3|Other than listed|1|||
144234256|NCT03307252|520053773|FG005|Part 2, Period 3|Other than listed|0|||
144234257|NCT03307252|520053774|FG006|Part 2, Period 3|Other than listed|0|||
144234258|NCT03307252|520053775|FG007|Part 2, Period 3|Other than listed|0|||
144234259|NCT03307252|520053776|FG008|Part 2, Period 3|Other than listed|0|||
144234260|NCT03307252|520053777|FG009|Part 2, Period 3|Other than listed|0|||
144234261|NCT03307252|520053778|FG010|Part 2, Period 3|Other than listed|0|||
144234262|NCT03307252|520053768|FG000|Part 2, Period 4|Other than listed|0|||
144234263|NCT03307252|520053769|FG001|Part 2, Period 4|Other than listed|0|||
144234264|NCT03307252|520053770|FG002|Part 2, Period 4|Other than listed|0|||
144234265|NCT03307252|520053771|FG003|Part 2, Period 4|Other than listed|0|||
144234266|NCT03307252|520053772|FG004|Part 2, Period 4|Other than listed|0|||
144234267|NCT03307252|520053773|FG005|Part 2, Period 4|Other than listed|0|||
144234268|NCT03307252|520053774|FG006|Part 2, Period 4|Other than listed|1|||
144234269|NCT03307252|520053775|FG007|Part 2, Period 4|Other than listed|0|||
144269593|NCT03712280|520191363|FG000|Overall Study|Adverse Event|0|||
144234270|NCT03307252|520053776|FG008|Part 2, Period 4|Other than listed|0|||
144234271|NCT03307252|520053777|FG009|Part 2, Period 4|Other than listed|0|||
144234272|NCT03307252|520053778|FG010|Part 2, Period 4|Other than listed|0|||
144234273|NCT03307252|520053768|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234274|NCT03307252|520053769|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234275|NCT03307252|520053770|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234276|NCT03307252|520053771|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234277|NCT03307252|520053772|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234278|NCT03307252|520053773|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234279|NCT03307252|520053774|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234280|NCT03307252|520053775|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234281|NCT03307252|520053776|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234282|NCT03307252|520053777|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
144234283|NCT03307252|520053778|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
144234284|NCT03482453|520053779|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234285|NCT03482453|520053780|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234286|NCT03482453|520053781|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234287|NCT03482453|520053782|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234288|NCT03482453|520053783|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234289|NCT03482453|520053784|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234290|NCT03482453|520053785|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234291|NCT03482453|520053786|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234292|NCT03482453|520053787|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234293|NCT03482453|520053788|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234294|NCT03482453|520053789|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
144234295|NCT03482453|520053790|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
144234296|NCT02568189|520053791|FG000|Overall Study|Protocol Violation|0|||
144234297|NCT02568189|520053792|FG001|Overall Study|Protocol Violation|0|||
144234298|NCT02568189|520053793|FG002|Overall Study|Protocol Violation|19|||
144234299|NCT02568189|520053794|FG003|Overall Study|Protocol Violation|18|||
144234300|NCT01554527|520053795|FG000|Overall Study|Withdrawal by Subject|1|||
144234301|NCT01554527|520053796|FG001|Overall Study|Withdrawal by Subject|0|||
144234302|NCT01554527|520053797|FG002|Overall Study|Withdrawal by Subject|3|||
144234303|NCT01554527|520053795|FG000|Overall Study|Lost to Follow-up|0|||
144234304|NCT01554527|520053796|FG001|Overall Study|Lost to Follow-up|0|||
144234305|NCT01554527|520053797|FG002|Overall Study|Lost to Follow-up|4|||
144234306|NCT01554527|520053795|FG000|Overall Study|Physician Decision|0|||
144234307|NCT01554527|520053796|FG001|Overall Study|Physician Decision|0|||
144234308|NCT01554527|520053797|FG002|Overall Study|Physician Decision|1|||
144234309|NCT01052480|520053798|FG000|Overall Study|Lost to Follow-up|3|||
144234310|NCT01052480|520053799|FG001|Overall Study|Lost to Follow-up|3|||
144234311|NCT01052480|520053798|FG000|Overall Study|Protocol Violation|1|||
144234312|NCT01052480|520053799|FG001|Overall Study|Protocol Violation|0|||
144234313|NCT01052480|520053798|FG000|Overall Study|Withdrawal by Subject|3|||
144234314|NCT01052480|520053799|FG001|Overall Study|Withdrawal by Subject|7|||
144234315|NCT01052480|520053798|FG000|Overall Study|Physician Decision|0|||
144234316|NCT01052480|520053799|FG001|Overall Study|Physician Decision|2|||
144234317|NCT01052480|520053798|FG000|Overall Study|Death|1|||
144234318|NCT01052480|520053799|FG001|Overall Study|Death|5|||
144234319|NCT02887183|520053800|FG000|Overall Study|Adverse Event|44|||
144234320|NCT02887183|520053800|FG000|Overall Study|Death|30|||
144234321|NCT02887183|520053800|FG000|Overall Study|Pregnancy|1|||
144234322|NCT02887183|520053800|FG000|Overall Study|Protocol Violation|6|||
144234323|NCT02887183|520053800|FG000|Overall Study|Technical Problems|2|||
144234324|NCT02887183|520053800|FG000|Overall Study|Lost to Follow-up|13|||
144234325|NCT02887183|520053800|FG000|Overall Study|Physician Decision|10|||
144234326|NCT02887183|520053800|FG000|Overall Study|Withdrawal by Subject|35|||
144234327|NCT00789698|520053803|FG000|Overall Study|Lack of Efficacy|10|||
144234328|NCT00789698|520053804|FG001|Overall Study|Lack of Efficacy|4|||
144234329|NCT00789698|520053805|FG002|Overall Study|Lack of Efficacy|5|||
144234330|NCT00789698|520053806|FG003|Overall Study|Lack of Efficacy|18|||
144234331|NCT00789698|520053803|FG000|Overall Study|Adverse Event|5|||
144234332|NCT00789698|520053804|FG001|Overall Study|Adverse Event|5|||
144234333|NCT00789698|520053805|FG002|Overall Study|Adverse Event|3|||
144234334|NCT00789698|520053806|FG003|Overall Study|Adverse Event|4|||
144234335|NCT00789698|520053803|FG000|Overall Study|Lost to Follow-up|5|||
144234336|NCT00789698|520053804|FG001|Overall Study|Lost to Follow-up|5|||
144234337|NCT00789698|520053805|FG002|Overall Study|Lost to Follow-up|2|||
144234338|NCT00789698|520053806|FG003|Overall Study|Lost to Follow-up|9|||
144234339|NCT00789698|520053803|FG000|Overall Study|Protocol Violation|6|||
144234340|NCT00789698|520053804|FG001|Overall Study|Protocol Violation|1|||
144234341|NCT00789698|520053805|FG002|Overall Study|Protocol Violation|2|||
144234342|NCT00789698|520053806|FG003|Overall Study|Protocol Violation|1|||
144234343|NCT00789698|520053803|FG000|Overall Study|Withdrawal by Subject|14|||
144234344|NCT00789698|520053804|FG001|Overall Study|Withdrawal by Subject|15|||
144234345|NCT00789698|520053805|FG002|Overall Study|Withdrawal by Subject|12|||
144269594|NCT03712280|520191364|FG001|Overall Study|Adverse Event|0|||
144234346|NCT00789698|520053806|FG003|Overall Study|Withdrawal by Subject|19|||
144234347|NCT00789698|520053803|FG000|Overall Study|Administrative|0|||
144234348|NCT00789698|520053804|FG001|Overall Study|Administrative|3|||
144234349|NCT00789698|520053805|FG002|Overall Study|Administrative|3|||
144234350|NCT00789698|520053806|FG003|Overall Study|Administrative|1|||
144234351|NCT02702388|520053809|FG000|Overall Study|Disease Progression|18|||
144234352|NCT02702388|520053810|FG001|Overall Study|Disease Progression|25|||
144234353|NCT02702388|520053809|FG000|Overall Study|Withdrawal by Subject|9|||
144234354|NCT02702388|520053810|FG001|Overall Study|Withdrawal by Subject|7|||
144234355|NCT02702388|520053809|FG000|Overall Study|Adverse Event|11|||
144234356|NCT02702388|520053810|FG001|Overall Study|Adverse Event|15|||
144234357|NCT02702388|520053809|FG000|Overall Study|Other|2|||
144234358|NCT02702388|520053810|FG001|Overall Study|Other|4|||
144234359|NCT02729051|520053811|FG000|Overall Study|Adverse Event|21|||
144234360|NCT02729051|520053812|FG001|Overall Study|Adverse Event|11|||
144234361|NCT02729051|520053811|FG000|Overall Study|Lack of Efficacy|1|||
144234362|NCT02729051|520053812|FG001|Overall Study|Lack of Efficacy|1|||
144234363|NCT02729051|520053811|FG000|Overall Study|Lost to Follow-up|1|||
144234364|NCT02729051|520053812|FG001|Overall Study|Lost to Follow-up|2|||
144234365|NCT02729051|520053811|FG000|Overall Study|Physician Decision|1|||
144234366|NCT02729051|520053812|FG001|Overall Study|Physician Decision|1|||
144234367|NCT02729051|520053811|FG000|Overall Study|Withdrawal by Subject|6|||
144234368|NCT02729051|520053812|FG001|Overall Study|Withdrawal by Subject|17|||
144234369|NCT01190410|520055055|FG000|Overall Study|Adverse Event|0|||
144234370|NCT01190410|520055056|FG001|Overall Study|Adverse Event|3|||
144234371|NCT01190410|520055055|FG000|Overall Study|Lack of Efficacy|0|||
144234372|NCT01190410|520055056|FG001|Overall Study|Lack of Efficacy|2|||
144234373|NCT01190410|520055055|FG000|Overall Study|Withdrawal by Subject|0|||
144234374|NCT01190410|520055056|FG001|Overall Study|Withdrawal by Subject|2|||
144234375|NCT01190410|520055055|FG000|Overall Study|Administrative decision|1|||
144234376|NCT01190410|520055056|FG001|Overall Study|Administrative decision|0|||
144234377|NCT01190410|520055055|FG000|Overall Study|PI discretion|0|||
144234378|NCT01190410|520055056|FG001|Overall Study|PI discretion|2|||
144234379|NCT01399047|520055057|FG000|Overall Study|Withdrawal by Subject|0|||
144234380|NCT01399047|520055058|FG001|Overall Study|Withdrawal by Subject|1|||
144234381|NCT03652636|520055066|FG000|Overall Study|Withdrawal by Subject|7|||
144234382|NCT03300505|520055071|FG000|Overall Study|Death|0|||
144234383|NCT03300505|520055072|FG001|Overall Study|Death|1|||
144234384|NCT03300505|520055073|FG002|Overall Study|Death|0|||
144234385|NCT03300505|520055071|FG000|Overall Study|Withdrawal by Subject|0|||
144234386|NCT03300505|520055072|FG001|Overall Study|Withdrawal by Subject|1|||
144234387|NCT03300505|520055073|FG002|Overall Study|Withdrawal by Subject|1|||
144234388|NCT03300505|520055071|FG000|Overall Study|Sponsor Termination|0|||
144234389|NCT03300505|520055072|FG001|Overall Study|Sponsor Termination|1|||
144234390|NCT03300505|520055073|FG002|Overall Study|Sponsor Termination|0|||
144234391|NCT03300505|520055071|FG000|Overall Study|Adverse Event|0|||
144234392|NCT03300505|520055072|FG001|Overall Study|Adverse Event|0|||
144234393|NCT03300505|520055073|FG002|Overall Study|Adverse Event|2|||
144234394|NCT05119595|520055074|FG000|Overall Study|Death|1|||
144234395|NCT05119595|520055074|FG000|Overall Study|Lost to Follow-up|7|||
144234396|NCT03467217|520055078|FG000|Overall Study|Trial stopped early|5|||
144234397|NCT03467217|520055079|FG001|Overall Study|Trial stopped early|2|||
144234398|NCT03467217|520055078|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
144234399|NCT03467217|520055079|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
144234400|NCT03467217|520055078|FG000|Overall Study|Lost to Follow-up|0|||
144234401|NCT03467217|520055079|FG001|Overall Study|Lost to Follow-up|2|||
144234402|NCT04981470|520055080|FG000|Overall Study|Device failure in all 4 patients|4|||
144234403|NCT00956592|520055083|FG000|Overall Study|Protocol Violation|1|||
144234404|NCT00956592|520055084|FG001|Overall Study|Protocol Violation|3|||
144234405|NCT03528369|520055085|FG000|Overall Study|Withdrawal by Subject|2|||
144234406|NCT03528369|520055086|FG001|Overall Study|Withdrawal by Subject|0|||
144234407|NCT03528369|520055087|FG002|Overall Study|Withdrawal by Subject|0|||
144234408|NCT03528369|520055085|FG000|Overall Study|Lost to Follow-up|1|||
144234409|NCT03528369|520055086|FG001|Overall Study|Lost to Follow-up|0|||
144234410|NCT03528369|520055087|FG002|Overall Study|Lost to Follow-up|0|||
144234411|NCT03528369|520055085|FG000|Overall Study|Adverse Event|0|||
144234412|NCT03528369|520055086|FG001|Overall Study|Adverse Event|1|||
144234413|NCT03528369|520055087|FG002|Overall Study|Adverse Event|0|||
144234414|NCT00076752|520055088|FG000|Overall Study|Death|2|||
144234415|NCT00076752|520055088|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
144234416|NCT02589626|520055093|FG000|Overall Study|Other than the reason specified|1|||
144234417|NCT02589626|520055094|FG001|Overall Study|Other than the reason specified|0|||
144234418|NCT02589626|520055093|FG000|Overall Study|Withdrawal by Subject|1|||
144234419|NCT02589626|520055094|FG001|Overall Study|Withdrawal by Subject|1|||
144234420|NCT02589626|520055093|FG000|Overall Study|Adverse Event|1|||
144234421|NCT02589626|520055094|FG001|Overall Study|Adverse Event|1|||
144234422|NCT04292912|520055095|FG000|Overall Study|Physician Decision|1|||
144234423|NCT04292912|520055095|FG000|Overall Study|Protocol Violation|6|||
144234424|NCT02920008|520055096|FG000|Overall Study|Death|117|||
144234425|NCT02920008|520055097|FG001|Overall Study|Death|127|||
144234426|NCT02920008|520055096|FG000|Overall Study|Withdrawal by Subject|3|||
144234427|NCT02920008|520055097|FG001|Overall Study|Withdrawal by Subject|6|||
144234428|NCT02920008|520055096|FG000|Overall Study|Lost to Follow-up|0|||
144234429|NCT02920008|520055097|FG001|Overall Study|Lost to Follow-up|1|||
144234430|NCT01862250|520055098|FG000|Overall Study|Adverse Event|4|||
144234431|NCT02423343|520055099|FG000|Overall Study|Withdrawal by Subject|0|||
144234432|NCT02423343|520055100|FG001|Overall Study|Withdrawal by Subject|1|||
144234433|NCT02423343|520055101|FG002|Overall Study|Withdrawal by Subject|0|||
144234434|NCT02423343|520055102|FG003|Overall Study|Withdrawal by Subject|0|||
144234435|NCT02423343|520055103|FG004|Overall Study|Withdrawal by Subject|0|||
144234436|NCT02423343|520055104|FG005|Overall Study|Withdrawal by Subject|0|||
144234437|NCT02423343|520055099|FG000|Overall Study|Progressive Disease|0|||
144234438|NCT02423343|520055100|FG001|Overall Study|Progressive Disease|0|||
144234439|NCT02423343|520055101|FG002|Overall Study|Progressive Disease|0|||
144234440|NCT02423343|520055102|FG003|Overall Study|Progressive Disease|0|||
144234441|NCT02423343|520055103|FG004|Overall Study|Progressive Disease|2|||
144234442|NCT02423343|520055104|FG005|Overall Study|Progressive Disease|0|||
144234443|NCT02423343|520055099|FG000|Overall Study|Adverse Event|0|||
144234444|NCT02423343|520055100|FG001|Overall Study|Adverse Event|0|||
144234445|NCT02423343|520055101|FG002|Overall Study|Adverse Event|0|||
144234446|NCT02423343|520055102|FG003|Overall Study|Adverse Event|0|||
144234447|NCT02423343|520055103|FG004|Overall Study|Adverse Event|2|||
144234448|NCT02423343|520055104|FG005|Overall Study|Adverse Event|0|||
144234449|NCT02423343|520055099|FG000|Overall Study|Death|0|||
144234450|NCT02423343|520055100|FG001|Overall Study|Death|0|||
144234451|NCT02423343|520055101|FG002|Overall Study|Death|0|||
144234452|NCT02423343|520055102|FG003|Overall Study|Death|0|||
144234453|NCT02423343|520055103|FG004|Overall Study|Death|1|||
144234454|NCT02423343|520055104|FG005|Overall Study|Death|0|||
144234455|NCT00729157|520055105|FG000|Overall Study|Withdrawal by Subject|1|||
144234456|NCT02217410|520055106|FG000|Overall Study|Graft Loss|0|||
144234457|NCT02217410|520055107|FG001|Overall Study|Graft Loss|0|||
144234458|NCT02217410|520055108|FG002|Overall Study|Graft Loss|2|||
144234459|NCT02217410|520055106|FG000|Overall Study|Withdrawal by Subject|0|||
144234460|NCT02217410|520055107|FG001|Overall Study|Withdrawal by Subject|0|||
144234461|NCT02217410|520055108|FG002|Overall Study|Withdrawal by Subject|2|||
144234462|NCT02217410|520055106|FG000|Overall Study|Lost to Follow-up|0|||
144234463|NCT02217410|520055107|FG001|Overall Study|Lost to Follow-up|0|||
144234464|NCT02217410|520055108|FG002|Overall Study|Lost to Follow-up|1|||
144234465|NCT02217410|520055106|FG000|Overall Study|Lack of Efficacy|0|||
144234466|NCT02217410|520055107|FG001|Overall Study|Lack of Efficacy|1|||
144234467|NCT02217410|520055108|FG002|Overall Study|Lack of Efficacy|0|||
144234468|NCT02217410|520055106|FG000|Overall Study|Physician Decision|1|||
144234469|NCT02217410|520055107|FG001|Overall Study|Physician Decision|3|||
144234470|NCT02217410|520055108|FG002|Overall Study|Physician Decision|0|||
144234471|NCT02429778|520055110|FG000|Overall Study|Lost to Follow-up|2|||
144234472|NCT02429778|520055111|FG001|Overall Study|Lost to Follow-up|0|||
144234473|NCT02429778|520055110|FG000|Overall Study|Withdrawal by Subject|5|||
144234474|NCT02429778|520055111|FG001|Overall Study|Withdrawal by Subject|0|||
144234475|NCT02475265|520055112|FG000|Overall Study|Physician Decision|1|||
144234476|NCT02475265|520055112|FG000|Overall Study|Withdrawal by Subject|2|||
144234477|NCT00637000|520055113|FG000|Overall Study|Withdrawal by Subject|4|||
144234478|NCT00637000|520055114|FG001|Overall Study|Withdrawal by Subject|3|||
144234479|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
144234480|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
144234481|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
144234482|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
144234483|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
144234484|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
144234485|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
144234486|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
144234487|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
144234488|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
144234489|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
144269595|NCT03712280|520191365|FG002|Overall Study|Adverse Event|1|||
144269596|NCT03712280|520191366|FG003|Overall Study|Adverse Event|0|||
144234490|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
144234491|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
144234492|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
144234493|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
144234494|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
144234495|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
144234496|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
144234497|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
144234498|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
144234499|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
144234500|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
144234501|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
144234502|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
144234503|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
144234504|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
144234505|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
144234506|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
144234507|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
144234508|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
144234509|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
144234510|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
144234511|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
144234512|NCT00839527|520055117|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
144234513|NCT00839527|520055118|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
144234514|NCT00839527|520055119|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
144234515|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
144234516|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
144234517|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
144234518|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
144234519|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
144234520|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
144234521|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
144234522|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
144234523|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
144234524|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
144234525|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
144234526|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
144234527|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
144234528|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
144234529|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
144234530|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
144234531|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
144234532|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
144234533|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
144234534|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
144234535|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
144234536|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
144234537|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
144234538|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
144234539|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
144234540|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
144234541|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
144234542|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
144234543|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
144234544|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
144234545|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
144234546|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
144234547|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
144234548|NCT00839527|520055117|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
144234549|NCT00839527|520055118|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
144234550|NCT00839527|520055119|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
144234551|NCT02751450|520055120|FG000|Overall Study|Adverse Event|1|||
144234552|NCT02751450|520055121|FG001|Overall Study|Adverse Event|0|||
144234553|NCT01598090|520055122|FG000|Treatment Period|Poor/non-compliance|0|||
144234554|NCT01598090|520055123|FG001|Treatment Period|Poor/non-compliance|2|||
144269597|NCT00551369|520191367|FG000|Overall Study|Protocol Violation|5|||
144269598|NCT00551369|520191367|FG000|Overall Study|Withdrawal by Subject|1|||
144269599|NCT00551369|520191367|FG000|Overall Study|Not treated per protocol and re|1|||
144234555|NCT01598090|520055124|FG002|Treatment Period|Poor/non-compliance|0|||
144269600|NCT03530293|520191371|FG000|Pre-randomization|Adverse Event|12|||
144234556|NCT01598090|520055122|FG000|Treatment Period|No longer meet study criteria|0|||
144234557|NCT01598090|520055123|FG001|Treatment Period|No longer meet study criteria|1|||
144234558|NCT01598090|520055124|FG002|Treatment Period|No longer meet study criteria|0|||
144234559|NCT01598090|520055122|FG000|Treatment Period|Lack of Efficacy|5|||
144234560|NCT01598090|520055123|FG001|Treatment Period|Lack of Efficacy|14|||
144234561|NCT01598090|520055124|FG002|Treatment Period|Lack of Efficacy|6|||
144234562|NCT01598090|520055122|FG000|Treatment Period|Adverse Event|2|||
144234563|NCT01598090|520055123|FG001|Treatment Period|Adverse Event|33|||
144234564|NCT01598090|520055124|FG002|Treatment Period|Adverse Event|17|||
144234565|NCT01598090|520055122|FG000|Treatment Period|Other reasons|0|||
144234566|NCT01598090|520055123|FG001|Treatment Period|Other reasons|4|||
144234567|NCT01598090|520055124|FG002|Treatment Period|Other reasons|1|||
144234568|NCT01598090|520055122|FG000|Treatment Period|Withdrawal by Subject|3|||
144234569|NCT01598090|520055123|FG001|Treatment Period|Withdrawal by Subject|13|||
144234570|NCT01598090|520055124|FG002|Treatment Period|Withdrawal by Subject|10|||
144234571|NCT01598090|520055122|FG000|Treatment Period|Lost to Follow-up|1|||
144234572|NCT01598090|520055123|FG001|Treatment Period|Lost to Follow-up|5|||
144234573|NCT01598090|520055124|FG002|Treatment Period|Lost to Follow-up|1|||
144234574|NCT01598090|520055122|FG000|Follow-up Period|Death|0|||
144234575|NCT01598090|520055123|FG001|Follow-up Period|Death|1|||
144234576|NCT01598090|520055124|FG002|Follow-up Period|Death|0|||
144234577|NCT01598090|520055122|FG000|Follow-up Period|No longer required per protocol|1|||
144234578|NCT01598090|520055123|FG001|Follow-up Period|No longer required per protocol|3|||
144234579|NCT01598090|520055124|FG002|Follow-up Period|No longer required per protocol|2|||
144234580|NCT01598090|520055122|FG000|Follow-up Period|Not reported|0|||
144234581|NCT01598090|520055123|FG001|Follow-up Period|Not reported|10|||
144234582|NCT01598090|520055124|FG002|Follow-up Period|Not reported|4|||
144234583|NCT01598090|520055122|FG000|Follow-up Period|Withdrawal by Subject|0|||
144234584|NCT01598090|520055123|FG001|Follow-up Period|Withdrawal by Subject|3|||
144234585|NCT01598090|520055124|FG002|Follow-up Period|Withdrawal by Subject|2|||
144234586|NCT01598090|520055122|FG000|Follow-up Period|Other reasons|2|||
144234587|NCT01598090|520055123|FG001|Follow-up Period|Other reasons|8|||
144234588|NCT01598090|520055124|FG002|Follow-up Period|Other reasons|8|||
144234589|NCT01598090|520055122|FG000|Follow-up Period|Lost to Follow-up|2|||
144234590|NCT01598090|520055123|FG001|Follow-up Period|Lost to Follow-up|10|||
144234591|NCT01598090|520055124|FG002|Follow-up Period|Lost to Follow-up|12|||
144234592|NCT02587598|520055125|FG000|Overall Study|Death|4|||
144234593|NCT02587598|520055126|FG001|Overall Study|Death|8|||
144234594|NCT02587598|520055127|FG002|Overall Study|Death|4|||
144234595|NCT02587598|520055128|FG003|Overall Study|Death|16|||
144234596|NCT02587598|520055129|FG004|Overall Study|Death|9|||
144234597|NCT02587598|520055130|FG005|Overall Study|Death|4|||
144234598|NCT02587598|520055131|FG006|Overall Study|Death|6|||
144234599|NCT02587598|520055132|FG007|Overall Study|Death|7|||
144234600|NCT02587598|520055133|FG008|Overall Study|Death|9|||
144234601|NCT02587598|520055134|FG009|Overall Study|Death|1|||
144234602|NCT02587598|520055135|FG010|Overall Study|Death|3|||
144234603|NCT02587598|520055125|FG000|Overall Study|Study Terminated by the Sponsor|0|||
144234604|NCT02587598|520055126|FG001|Overall Study|Study Terminated by the Sponsor|1|||
144234605|NCT02587598|520055127|FG002|Overall Study|Study Terminated by the Sponsor|0|||
144234606|NCT02587598|520055128|FG003|Overall Study|Study Terminated by the Sponsor|3|||
144234607|NCT02587598|520055129|FG004|Overall Study|Study Terminated by the Sponsor|0|||
144234608|NCT02587598|520055130|FG005|Overall Study|Study Terminated by the Sponsor|1|||
144234609|NCT02587598|520055131|FG006|Overall Study|Study Terminated by the Sponsor|0|||
144234610|NCT02587598|520055132|FG007|Overall Study|Study Terminated by the Sponsor|0|||
144234611|NCT02587598|520055133|FG008|Overall Study|Study Terminated by the Sponsor|0|||
144234612|NCT02587598|520055134|FG009|Overall Study|Study Terminated by the Sponsor|1|||
144234613|NCT02587598|520055135|FG010|Overall Study|Study Terminated by the Sponsor|6|||
144234614|NCT02587598|520055125|FG000|Overall Study|Reason for study withdrawal not specified|0|||
144234615|NCT02587598|520055126|FG001|Overall Study|Reason for study withdrawal not specified|1|||
144234616|NCT02587598|520055127|FG002|Overall Study|Reason for study withdrawal not specified|0|||
144234617|NCT02587598|520055128|FG003|Overall Study|Reason for study withdrawal not specified|0|||
144234618|NCT02587598|520055129|FG004|Overall Study|Reason for study withdrawal not specified|0|||
144234619|NCT02587598|520055130|FG005|Overall Study|Reason for study withdrawal not specified|0|||
144234620|NCT02587598|520055131|FG006|Overall Study|Reason for study withdrawal not specified|0|||
144234621|NCT02587598|520055132|FG007|Overall Study|Reason for study withdrawal not specified|0|||
144234622|NCT02587598|520055133|FG008|Overall Study|Reason for study withdrawal not specified|0|||
144234623|NCT02587598|520055134|FG009|Overall Study|Reason for study withdrawal not specified|0|||
144234624|NCT02587598|520055135|FG010|Overall Study|Reason for study withdrawal not specified|0|||
144234625|NCT02587598|520055125|FG000|Overall Study|Withdrawal by Subject|0|||
144234626|NCT02587598|520055126|FG001|Overall Study|Withdrawal by Subject|1|||
144234627|NCT02587598|520055127|FG002|Overall Study|Withdrawal by Subject|0|||
144234628|NCT02587598|520055128|FG003|Overall Study|Withdrawal by Subject|2|||
144234629|NCT02587598|520055129|FG004|Overall Study|Withdrawal by Subject|3|||
144234630|NCT02587598|520055130|FG005|Overall Study|Withdrawal by Subject|1|||
144269601|NCT03530293|520191372|FG001|Pre-randomization|Adverse Event|0|||
144234631|NCT02587598|520055131|FG006|Overall Study|Withdrawal by Subject|0|||
144234632|NCT02587598|520055132|FG007|Overall Study|Withdrawal by Subject|0|||
144234633|NCT02587598|520055133|FG008|Overall Study|Withdrawal by Subject|0|||
144234634|NCT02587598|520055134|FG009|Overall Study|Withdrawal by Subject|1|||
144234635|NCT02587598|520055135|FG010|Overall Study|Withdrawal by Subject|2|||
144234636|NCT02587598|520055125|FG000|Overall Study|Physician Decision|0|||
144234637|NCT02587598|520055126|FG001|Overall Study|Physician Decision|0|||
144234638|NCT02587598|520055127|FG002|Overall Study|Physician Decision|0|||
144234639|NCT02587598|520055128|FG003|Overall Study|Physician Decision|0|||
144234640|NCT02587598|520055129|FG004|Overall Study|Physician Decision|0|||
144234641|NCT02587598|520055130|FG005|Overall Study|Physician Decision|0|||
144234642|NCT02587598|520055131|FG006|Overall Study|Physician Decision|0|||
144234643|NCT02587598|520055132|FG007|Overall Study|Physician Decision|0|||
144234644|NCT02587598|520055133|FG008|Overall Study|Physician Decision|0|||
144234645|NCT02587598|520055134|FG009|Overall Study|Physician Decision|0|||
144234646|NCT02587598|520055135|FG010|Overall Study|Physician Decision|3|||
144234647|NCT01704651|520055142|FG000|Overall Study|Pre-op withdrawal by subject|1|||
144234648|NCT01704651|520055143|FG001|Overall Study|Pre-op withdrawal by subject|1|||
144234649|NCT01704651|520055142|FG000|Overall Study|Pre-op change in treatment plan|1|||
144234650|NCT01704651|520055143|FG001|Overall Study|Pre-op change in treatment plan|4|||
144234651|NCT01704651|520055142|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
144234652|NCT01704651|520055143|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
144234653|NCT01704651|520055142|FG000|Overall Study|Post-op did not have laparotomy|2|||
144234654|NCT01704651|520055143|FG001|Overall Study|Post-op did not have laparotomy|1|||
144234655|NCT03474731|520055146|FG000|Overall Study|Withdrawal by Subject|36|||
144234656|NCT03474731|520055147|FG001|Overall Study|Withdrawal by Subject|29|||
144234657|NCT03474731|520055148|FG002|Overall Study|Withdrawal by Subject|11|||
144234658|NCT03474731|520055149|FG003|Overall Study|Withdrawal by Subject|27|||
144234659|NCT03474731|520055146|FG000|Overall Study|COVID|0|||
144234660|NCT03474731|520055147|FG001|Overall Study|COVID|23|||
144234661|NCT03474731|520055148|FG002|Overall Study|COVID|0|||
144234662|NCT03474731|520055149|FG003|Overall Study|COVID|0|||
144234663|NCT03474731|520055146|FG000|Overall Study|Participant moved from area|1|||
144234664|NCT03474731|520055147|FG001|Overall Study|Participant moved from area|0|||
144234665|NCT03474731|520055148|FG002|Overall Study|Participant moved from area|0|||
144234666|NCT03474731|520055149|FG003|Overall Study|Participant moved from area|0|||
144234667|NCT03474731|520055146|FG000|Overall Study|Lost to Follow-up|11|||
144234668|NCT03474731|520055147|FG001|Overall Study|Lost to Follow-up|3|||
144234669|NCT03474731|520055148|FG002|Overall Study|Lost to Follow-up|18|||
144234670|NCT03474731|520055149|FG003|Overall Study|Lost to Follow-up|17|||
144234671|NCT03474731|520055146|FG000|Overall Study|Death|0|||
144234672|NCT03474731|520055147|FG001|Overall Study|Death|1|||
144234673|NCT03474731|520055148|FG002|Overall Study|Death|0|||
144234674|NCT03474731|520055149|FG003|Overall Study|Death|0|||
144234675|NCT03474731|520055146|FG000|Overall Study|Participant Removed|0|||
144234676|NCT03474731|520055147|FG001|Overall Study|Participant Removed|0|||
144234677|NCT03474731|520055148|FG002|Overall Study|Participant Removed|0|||
144234678|NCT03474731|520055149|FG003|Overall Study|Participant Removed|1|||
144234679|NCT03502070|520055153|FG000|Overall Study|Withdrawal by Subject|1|||
144234680|NCT03502070|520055153|FG000|Overall Study|Screen Failure|1|||
144234681|NCT00765336|520055154|FG000|Overall Study|Protocol Violation|4|||
144234682|NCT00765336|520055155|FG001|Overall Study|Protocol Violation|2|||
144234683|NCT00765336|520055154|FG000|Overall Study|Withdrawal by Subject|6|||
144234684|NCT00765336|520055155|FG001|Overall Study|Withdrawal by Subject|4|||
144234685|NCT00765336|520055154|FG000|Overall Study|Lost to Follow-up|7|||
144269602|NCT03530293|520191373|FG002|Pre-randomization|Adverse Event|0|||
144234686|NCT00765336|520055155|FG001|Overall Study|Lost to Follow-up|9|||
144234687|NCT00765336|520055154|FG000|Overall Study|Adverse Event|2|||
144234688|NCT00765336|520055155|FG001|Overall Study|Adverse Event|1|||
144234689|NCT00478777|520055156|FG000|Overall Study|Adverse Event|29|||
144234690|NCT00478777|520055156|FG000|Overall Study|Lack of Efficacy|23|||
144234691|NCT00478777|520055156|FG000|Overall Study|Withdrawal by Subject|4|||
144234692|NCT00478777|520055156|FG000|Overall Study|Death|3|||
144269603|NCT03530293|520191371|FG000|Pre-randomization|Protocol Violation|2|||
144234693|NCT00478777|520055156|FG000|Overall Study|Protocol Violation|3|||
144234694|NCT00478777|520055156|FG000|Overall Study|Lost to Follow-up|3|||
144234695|NCT00478777|520055156|FG000|Overall Study|Physician Decision|1|||
144234696|NCT00478777|520055156|FG000|Overall Study|Intolerance of therapy|1|||
144234697|NCT00478777|520055156|FG000|Overall Study|Lack of compliance|1|||
144234698|NCT00478777|520055156|FG000|Overall Study|Lymphocytes infusion|1|||
144234699|NCT00478777|520055156|FG000|Overall Study|End of therapy|2|||
144234700|NCT00478777|520055156|FG000|Overall Study|Not treated with lenalidomide|6|||
144234701|NCT04105218|520055162|FG000|Overall Study|Withdrawal by Subject|3|||
144234702|NCT04105218|520055163|FG001|Overall Study|Withdrawal by Subject|2|||
144234703|NCT04105218|520055162|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
144234704|NCT04105218|520055163|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
144234705|NCT04105218|520055162|FG000|Overall Study|Failed screening tests|2|||
144234706|NCT04105218|520055163|FG001|Overall Study|Failed screening tests|1|||
144234707|NCT02858583|520055166|FG000|Overall Study|Declined consent|1|||
144234708|NCT02858583|520055167|FG001|Overall Study|Declined consent|1|||
144234709|NCT01218087|520055169|FG000|Overall Study|Death|2|||
144234710|NCT01218087|520055170|FG001|Overall Study|Death|1|||
144234711|NCT01218087|520055169|FG000|Overall Study|Withdrawal by Subject|5|||
144234712|NCT01218087|520055170|FG001|Overall Study|Withdrawal by Subject|0|||
144234713|NCT01218087|520055169|FG000|Overall Study|Transferred|8|||
144234714|NCT01218087|520055170|FG001|Overall Study|Transferred|5|||
144234715|NCT01323387|520055176|FG000|Overall Study|Withdrawal by Subject|41|||
144234716|NCT01323387|520055176|FG000|Overall Study|Radiographic Data Unavailable|1|||
144234717|NCT01323387|520055176|FG000|Overall Study|Revision|14|||
144234718|NCT01323387|520055176|FG000|Overall Study|Protocol Violation|12|||
144234719|NCT01323387|520055176|FG000|Overall Study|Randomized but Never Treated|16|||
144234720|NCT00603473|520055182|FG000|Overall Study|Adverse Event|4|||
144234721|NCT00603473|520055182|FG000|Overall Study|Lack of Efficacy|4|||
144234722|NCT00603473|520055182|FG000|Overall Study|Protocol Violation|1|||
144234723|NCT00596817|520055185|FG000|Open-label Period|Adverse Event|0|||
144234724|NCT00596817|520055186|FG001|Open-label Period|Adverse Event|49|||
144234725|NCT00596817|520055185|FG000|Open-label Period|Lack of Efficacy|0|||
144234726|NCT00596817|520055186|FG001|Open-label Period|Lack of Efficacy|33|||
144234727|NCT00596817|520055185|FG000|Open-label Period|Other Reasons|0|||
144234728|NCT00596817|520055186|FG001|Open-label Period|Other Reasons|65|||
144234729|NCT00596817|520055185|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
144234730|NCT00596817|520055186|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
144234731|NCT00596817|520055185|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
144234732|NCT00596817|520055186|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
144234733|NCT00596817|520055185|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
144234734|NCT00596817|520055186|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
144234735|NCT00596817|520055185|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
144234736|NCT00596817|520055186|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
144234737|NCT00596817|520055185|FG000|Double-blind Period|Adverse Event|5|||
144234738|NCT00596817|520055186|FG001|Double-blind Period|Adverse Event|16|||
144234739|NCT00596817|520055185|FG000|Double-blind Period|Lack of Efficacy|52|||
144234740|NCT00596817|520055186|FG001|Double-blind Period|Lack of Efficacy|28|||
144234741|NCT00596817|520055185|FG000|Double-blind Period|Non-compliance With Study Product|3|||
144234742|NCT00596817|520055186|FG001|Double-blind Period|Non-compliance With Study Product|4|||
144234743|NCT00596817|520055185|FG000|Double-blind Period|Protocol Violation|11|||
144234744|NCT00596817|520055186|FG001|Double-blind Period|Protocol Violation|8|||
144234745|NCT00596817|520055185|FG000|Double-blind Period|Withdrawal of Consent|7|||
144234746|NCT00596817|520055186|FG001|Double-blind Period|Withdrawal of Consent|3|||
144234747|NCT00596817|520055185|FG000|Double-blind Period|Lost to Follow-up|0|||
144234748|NCT00596817|520055186|FG001|Double-blind Period|Lost to Follow-up|2|||
144234749|NCT00596817|520055185|FG000|Double-blind Period|Other Reasons|10|||
144234750|NCT00596817|520055186|FG001|Double-blind Period|Other Reasons|18|||
144234751|NCT00679029|520056774|FG000|Overall Study|Adverse Event|3|||
144234752|NCT00679029|520056774|FG000|Overall Study|Withdrawal by Subject|1|||
144234753|NCT00679029|520056774|FG000|Overall Study|Lost to Follow-up|1|||
144234754|NCT01283334|520056779|FG000|Overall Study|Withdrawal by Subject|1|||
144234755|NCT01283334|520056779|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
144234756|NCT01283334|520056779|FG000|Overall Study|Adverse Event|4|||
144234757|NCT01283334|520056779|FG000|Overall Study|Physician Decision|1|||
144234758|NCT00784238|520056780|FG000|Overall Study|Adverse Event|14|||
144234759|NCT00784238|520056780|FG000|Overall Study|Death|2|||
144234760|NCT00784238|520056780|FG000|Overall Study|Lack of Efficacy|33|||
144234761|NCT00784238|520056780|FG000|Overall Study|Lost to Follow-up|29|||
144234762|NCT00784238|520056780|FG000|Overall Study|Pregnancy|1|||
144234763|NCT00784238|520056780|FG000|Overall Study|Withdrawal by Subject|26|||
144234764|NCT00784238|520056780|FG000|Overall Study|Other|14|||
144234765|NCT03806933|520056781|FG000|Main Period|Physician Decision|0|||
144234766|NCT03806933|520056782|FG001|Main Period|Physician Decision|0|||
144234767|NCT03806933|520056783|FG002|Main Period|Physician Decision|0|||
144234768|NCT03806933|520056784|FG003|Main Period|Physician Decision|1|||
144234769|NCT03806933|520056781|FG000|Main Period|Pregnancy|0|||
144234770|NCT03806933|520056782|FG001|Main Period|Pregnancy|0|||
144234771|NCT03806933|520056783|FG002|Main Period|Pregnancy|1|||
144234772|NCT03806933|520056784|FG003|Main Period|Pregnancy|0|||
144234773|NCT03806933|520056781|FG000|Main Period|Withdrawal by Subject|2|||
144234774|NCT03806933|520056782|FG001|Main Period|Withdrawal by Subject|1|||
144234775|NCT03806933|520056783|FG002|Main Period|Withdrawal by Subject|1|||
144234776|NCT03806933|520056784|FG003|Main Period|Withdrawal by Subject|2|||
144234777|NCT03806933|520056781|FG000|Main Period|Lost to Follow-up|2|||
144234778|NCT03806933|520056782|FG001|Main Period|Lost to Follow-up|2|||
144234779|NCT03806933|520056783|FG002|Main Period|Lost to Follow-up|0|||
144234780|NCT03806933|520056784|FG003|Main Period|Lost to Follow-up|0|||
144269604|NCT03530293|520191372|FG001|Pre-randomization|Protocol Violation|0|||
144269605|NCT03530293|520191373|FG002|Pre-randomization|Protocol Violation|0|||
144234781|NCT03806933|520056781|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
144234782|NCT03806933|520056782|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
144234783|NCT03806933|520056783|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
144234784|NCT03806933|520056784|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
144234785|NCT00078767|520056785|FG000|Overall Study|Withdrawal by Subject|1|||
144234786|NCT00078767|520056786|FG001|Overall Study|Withdrawal by Subject|1|||
144234787|NCT00809471|520056787|FG000|Overall Study|Protocol non-compliance|15|||
144234788|NCT00809471|520056788|FG001|Overall Study|Protocol non-compliance|15|||
144234789|NCT00809471|520056789|FG002|Overall Study|Protocol non-compliance|6|||
144234790|NCT00809471|520056787|FG000|Overall Study|Lost to Follow-up|4|||
144234791|NCT00809471|520056788|FG001|Overall Study|Lost to Follow-up|2|||
144234792|NCT00809471|520056789|FG002|Overall Study|Lost to Follow-up|9|||
144234793|NCT00809471|520056787|FG000|Overall Study|Adverse Event|0|||
144234794|NCT00809471|520056788|FG001|Overall Study|Adverse Event|2|||
144234795|NCT00809471|520056789|FG002|Overall Study|Adverse Event|2|||
144234796|NCT00809471|520056787|FG000|Overall Study|Requirement for restricted medication|1|||
144234797|NCT00809471|520056788|FG001|Overall Study|Requirement for restricted medication|1|||
144234798|NCT00809471|520056789|FG002|Overall Study|Requirement for restricted medication|0|||
144234799|NCT01736397|520056791|FG000|Overall Study|Lack of Efficacy|1|||
144234800|NCT01736397|520056792|FG001|Overall Study|Lack of Efficacy|11|||
144234801|NCT01736397|520056791|FG000|Overall Study|Withdrawal by Subject|6|||
144234802|NCT01736397|520056792|FG001|Overall Study|Withdrawal by Subject|5|||
144234803|NCT01736397|520056791|FG000|Overall Study|Lost to Follow-up|0|||
144234804|NCT01736397|520056792|FG001|Overall Study|Lost to Follow-up|1|||
144234805|NCT01736397|520056791|FG000|Overall Study|Adverse Event|6|||
144234806|NCT01736397|520056792|FG001|Overall Study|Adverse Event|3|||
144234807|NCT01736397|520056791|FG000|Overall Study|Not stated|1|||
144234808|NCT01736397|520056792|FG001|Overall Study|Not stated|4|||
144234809|NCT01868438|520056793|FG000|First Intervention|Withdrawal by Subject|5|||
144234810|NCT01868438|520056794|FG001|First Intervention|Withdrawal by Subject|1|||
144234811|NCT01868438|520056793|FG000|First Intervention|Lost to Follow-up|2|||
144234812|NCT01868438|520056794|FG001|First Intervention|Lost to Follow-up|3|||
144234813|NCT01868438|520056793|FG000|First Intervention|Meeting the non-redosing criteria|0|||
144234814|NCT01868438|520056794|FG001|First Intervention|Meeting the non-redosing criteria|1|||
144234815|NCT01868438|520056793|FG000|Second Intervention|Adverse Event|3|||
144234816|NCT01868438|520056794|FG001|Second Intervention|Adverse Event|3|||
144234817|NCT01177293|520056795|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
144234818|NCT01177293|520056796|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
144234819|NCT02162719|520056797|FG000|Overall Study|Death|41|||
144234820|NCT02162719|520056798|FG001|Overall Study|Death|46|||
144234821|NCT02162719|520056797|FG000|Overall Study|Lost to Follow-up|1|||
144234822|NCT02162719|520056798|FG001|Overall Study|Lost to Follow-up|3|||
144234823|NCT02162719|520056797|FG000|Overall Study|Disease Progression|2|||
144234824|NCT02162719|520056798|FG001|Overall Study|Disease Progression|1|||
144234825|NCT02162719|520056797|FG000|Overall Study|Withdrawal by Subject|8|||
144234826|NCT02162719|520056798|FG001|Overall Study|Withdrawal by Subject|2|||
144234827|NCT02162719|520056797|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
144234828|NCT02162719|520056798|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
144234829|NCT03555565|520056799|FG000|Overall Study|Case Report Forms Uncollected|2|||
144234830|NCT03555565|520056799|FG000|Overall Study|Protocol Deviation|13|||
144234831|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
144234832|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
144234833|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
144234834|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
144234835|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
144234836|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
144234837|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
144234838|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
144234839|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Death|0|||
144234840|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Death|1|||
144234841|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
144234842|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
144234843|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
144234844|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
144234845|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
144234846|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
144234847|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
144234848|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
144234849|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
144234850|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
144234851|NCT00394836|520056803|FG000|Teatment or Follow-up Phase|Non compliance|0|||
144234852|NCT00394836|520056804|FG001|Teatment or Follow-up Phase|Non compliance|1|||
144234853|NCT00394836|520056803|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
144234854|NCT00394836|520056804|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
144234855|NCT00394836|520056803|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
144234856|NCT00394836|520056804|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
144234857|NCT00394836|520056803|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
144234858|NCT00394836|520056804|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
144234859|NCT00394836|520056803|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
144234860|NCT00394836|520056804|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
144234861|NCT04411810|520056806|FG000|Overall Study|Screen failure|1|||
144234862|NCT04411810|520056806|FG000|Overall Study|Withdrawal by Subject|1|||
144234863|NCT01920958|520056807|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
144234864|NCT02028767|520056808|FG000|Treatment Period 2|Non compliant with protocol|1|||
144234865|NCT02028767|520056809|FG001|Treatment Period 2|Non compliant with protocol|0|||
144234866|NCT02028767|520056808|FG000|Treatment Period 2|Reason other than those specified above|1|||
144234867|NCT02028767|520056809|FG001|Treatment Period 2|Reason other than those specified above|0|||
144234868|NCT03192306|520056812|FG000|Overall Study|Did not treat cold sore during study|149|||
144234869|NCT03192306|520056813|FG001|Overall Study|Did not treat cold sore during study|143|||
144234870|NCT03192306|520056812|FG000|Overall Study|Withdrawal by Subject|1|||
144234871|NCT03192306|520056813|FG001|Overall Study|Withdrawal by Subject|1|||
144234872|NCT03192306|520056812|FG000|Overall Study|Lost to Follow-up|1|||
144234873|NCT03192306|520056813|FG001|Overall Study|Lost to Follow-up|0|||
144234874|NCT03192306|520056812|FG000|Overall Study|Protocol Violation|1|||
144234875|NCT03192306|520056813|FG001|Overall Study|Protocol Violation|1|||
144234876|NCT00280397|520056821|FG000|Overall Study|Adverse Event|1|||
144234877|NCT00654875|520056831|FG000|Overall Study|Adverse Event|5|||
144234878|NCT00654875|520056832|FG001|Overall Study|Adverse Event|5|||
144234879|NCT00654875|520056831|FG000|Overall Study|Withdrawal by Subject|4|||
144234880|NCT00654875|520056832|FG001|Overall Study|Withdrawal by Subject|4|||
144234881|NCT00654875|520056831|FG000|Overall Study|Protocol Violation|3|||
144234882|NCT00654875|520056832|FG001|Overall Study|Protocol Violation|3|||
144234883|NCT00654875|520056831|FG000|Overall Study|Lack of Efficacy|2|||
144234884|NCT00654875|520056832|FG001|Overall Study|Lack of Efficacy|2|||
144234885|NCT00654875|520056831|FG000|Overall Study|Lost to Follow-up|1|||
144234886|NCT00654875|520056832|FG001|Overall Study|Lost to Follow-up|3|||
144234887|NCT00654875|520056831|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
144234888|NCT00654875|520056832|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
144234889|NCT00654875|520056831|FG000|Overall Study|Administrative Problems|1|||
144234890|NCT00654875|520056832|FG001|Overall Study|Administrative Problems|0|||
144234891|NCT01014988|520056835|FG000|Overall Study|Adverse Event|20|||
144234892|NCT01014988|520056836|FG001|Overall Study|Adverse Event|0|||
144234893|NCT01014988|520056837|FG002|Overall Study|Adverse Event|1|||
144234894|NCT01014988|520056838|FG003|Overall Study|Adverse Event|0|||
144234895|NCT01014988|520056839|FG004|Overall Study|Adverse Event|1|||
144234896|NCT01014988|520056840|FG005|Overall Study|Adverse Event|3|||
144234897|NCT01014988|520056835|FG000|Overall Study|Lost to Follow-up|1|||
144234898|NCT01014988|520056836|FG001|Overall Study|Lost to Follow-up|0|||
144234899|NCT01014988|520056837|FG002|Overall Study|Lost to Follow-up|1|||
144234900|NCT01014988|520056838|FG003|Overall Study|Lost to Follow-up|0|||
144234901|NCT01014988|520056839|FG004|Overall Study|Lost to Follow-up|0|||
144234902|NCT01014988|520056840|FG005|Overall Study|Lost to Follow-up|0|||
144234903|NCT01014988|520056835|FG000|Overall Study|Physician Decision|1|||
144234904|NCT01014988|520056836|FG001|Overall Study|Physician Decision|0|||
144234905|NCT01014988|520056837|FG002|Overall Study|Physician Decision|0|||
144234906|NCT01014988|520056838|FG003|Overall Study|Physician Decision|0|||
144234907|NCT01014988|520056839|FG004|Overall Study|Physician Decision|0|||
144234908|NCT01014988|520056840|FG005|Overall Study|Physician Decision|0|||
144234909|NCT01014988|520056835|FG000|Overall Study|Withdrawal by Subject|1|||
144234910|NCT01014988|520056836|FG001|Overall Study|Withdrawal by Subject|0|||
144234911|NCT01014988|520056837|FG002|Overall Study|Withdrawal by Subject|0|||
144234912|NCT01014988|520056838|FG003|Overall Study|Withdrawal by Subject|0|||
144269606|NCT03530293|520191371|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
144269607|NCT03530293|520191372|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
144234913|NCT01014988|520056839|FG004|Overall Study|Withdrawal by Subject|0|||
144234914|NCT01014988|520056840|FG005|Overall Study|Withdrawal by Subject|0|||
144234915|NCT00626821|520056844|FG000|Overall Study|Adverse Event|44|||
144234916|NCT00626821|520056844|FG000|Overall Study|Protocol Violation|33|||
144234917|NCT00626821|520056844|FG000|Overall Study|Withdrawal by Subject|10|||
144269608|NCT03530293|520191373|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
144234918|NCT00626821|520056844|FG000|Overall Study|Physician Decision|9|||
144234919|NCT00626821|520056844|FG000|Overall Study|Product dysfunction|21|||
144234920|NCT00626821|520056844|FG000|Overall Study|other/unknown reason|104|||
144269609|NCT03530293|520191371|FG000|Pre-randomization|Withdrawal by Subject|5|||
144269610|NCT03530293|520191372|FG001|Pre-randomization|Withdrawal by Subject|0|||
144269611|NCT03530293|520191373|FG002|Pre-randomization|Withdrawal by Subject|0|||
144269612|NCT03530293|520191371|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
144269613|NCT03530293|520191372|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
144269614|NCT03530293|520191373|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
144269615|NCT03530293|520191371|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
144269616|NCT03530293|520191372|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
144234921|NCT01940887|520056848|FG000|Year 1|Protocol Violation|0|||
144234922|NCT01940887|520056849|FG001|Year 1|Protocol Violation|1|||
144234923|NCT01940887|520056848|FG000|Year 1|Physician Decision|7|||
144234924|NCT01940887|520056849|FG001|Year 1|Physician Decision|3|||
144234925|NCT01940887|520056848|FG000|Year 1|Death|5|||
144234926|NCT01940887|520056849|FG001|Year 1|Death|3|||
144234927|NCT01940887|520056848|FG000|Year 1|Adverse Event|7|||
144234928|NCT01940887|520056849|FG001|Year 1|Adverse Event|6|||
144234929|NCT01940887|520056848|FG000|Year 1|Withdrawal by Subject|18|||
144234930|NCT01940887|520056849|FG001|Year 1|Withdrawal by Subject|9|||
144234931|NCT01940887|520056848|FG000|Year 1|Lost to Follow-up|2|||
144234932|NCT01940887|520056849|FG001|Year 1|Lost to Follow-up|1|||
144234933|NCT01940887|520056848|FG000|Year 2|Physician Decision|8|||
144269617|NCT03530293|520191373|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
144234934|NCT01940887|520056849|FG001|Year 2|Physician Decision|1|||
144234935|NCT01940887|520056848|FG000|Year 2|Death|0|||
144234936|NCT01940887|520056849|FG001|Year 2|Death|2|||
144234937|NCT01940887|520056848|FG000|Year 2|Sponsor Decision, early termination|192|||
144234938|NCT01940887|520056849|FG001|Year 2|Sponsor Decision, early termination|203|||
144234939|NCT01940887|520056848|FG000|Year 2|Adverse Event|8|||
144234940|NCT01940887|520056849|FG001|Year 2|Adverse Event|2|||
144234941|NCT01940887|520056848|FG000|Year 2|Withdrawal by Subject|8|||
144234942|NCT01940887|520056849|FG001|Year 2|Withdrawal by Subject|8|||
144234943|NCT01940887|520056848|FG000|Year 2|Lost to Follow-up|1|||
144234944|NCT01940887|520056849|FG001|Year 2|Lost to Follow-up|6|||
144234945|NCT03521115|520056851|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
144234946|NCT03521115|520056852|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
144234947|NCT03521115|520056851|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
144234948|NCT03521115|520056852|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
144234949|NCT03063086|520056855|FG000|Overall Study|technical problems|1|||
144234950|NCT03063086|520056856|FG001|Overall Study|technical problems|0|||
144234951|NCT03063086|520056857|FG002|Overall Study|technical problems|0|||
144234952|NCT03063086|520056858|FG003|Overall Study|technical problems|0|||
144234953|NCT03063086|520056859|FG004|Overall Study|technical problems|0|||
144234954|NCT03063086|520056860|FG005|Overall Study|technical problems|0|||
144234955|NCT03063086|520056855|FG000|Overall Study|Adverse Event|1|||
144234956|NCT03063086|520056856|FG001|Overall Study|Adverse Event|1|||
144234957|NCT03063086|520056857|FG002|Overall Study|Adverse Event|1|||
144234958|NCT03063086|520056858|FG003|Overall Study|Adverse Event|1|||
144234959|NCT03063086|520056859|FG004|Overall Study|Adverse Event|0|||
144234960|NCT03063086|520056860|FG005|Overall Study|Adverse Event|0|||
144234961|NCT03063086|520056855|FG000|Overall Study|subject/guardian decision|1|||
144234962|NCT03063086|520056856|FG001|Overall Study|subject/guardian decision|0|||
144234963|NCT03063086|520056857|FG002|Overall Study|subject/guardian decision|0|||
144234964|NCT03063086|520056858|FG003|Overall Study|subject/guardian decision|0|||
144234965|NCT03063086|520056859|FG004|Overall Study|subject/guardian decision|0|||
144234966|NCT03063086|520056860|FG005|Overall Study|subject/guardian decision|0|||
144234967|NCT03063086|520056855|FG000|Overall Study|Non-compliance with study treatment|0|||
144234968|NCT03063086|520056856|FG001|Overall Study|Non-compliance with study treatment|0|||
144234969|NCT03063086|520056857|FG002|Overall Study|Non-compliance with study treatment|0|||
144234970|NCT03063086|520056858|FG003|Overall Study|Non-compliance with study treatment|1|||
144234971|NCT03063086|520056859|FG004|Overall Study|Non-compliance with study treatment|0|||
144234972|NCT03063086|520056860|FG005|Overall Study|Non-compliance with study treatment|1|||
144234973|NCT03063086|520056855|FG000|Overall Study|Physician Decision|0|||
144234974|NCT03063086|520056856|FG001|Overall Study|Physician Decision|0|||
144234975|NCT03063086|520056857|FG002|Overall Study|Physician Decision|0|||
144234976|NCT03063086|520056858|FG003|Overall Study|Physician Decision|1|||
144234977|NCT03063086|520056859|FG004|Overall Study|Physician Decision|0|||
144234978|NCT03063086|520056860|FG005|Overall Study|Physician Decision|0|||
144234979|NCT04590586|520056861|FG000|Overall Study|Death|7|||
144269618|NCT03530293|520191371|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
144234980|NCT04590586|520056862|FG001|Overall Study|Death|1|||
144234981|NCT04590586|520056863|FG002|Overall Study|Death|37|||
144234982|NCT04590586|520056864|FG003|Overall Study|Death|34|||
144234983|NCT04590586|520056865|FG004|Overall Study|Death|19|||
144269619|NCT03530293|520191372|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
144269620|NCT03530293|520191373|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
144269621|NCT03530293|520191371|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
144269622|NCT03530293|520191372|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
144269623|NCT03530293|520191373|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
144269624|NCT03530293|520191371|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
144269625|NCT03530293|520191372|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
144269626|NCT03530293|520191373|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
144269627|NCT01663623|520191374|FG000|Overall Study|Adverse Event|3|||
144269628|NCT01663623|520191375|FG001|Overall Study|Adverse Event|7|||
144269629|NCT01663623|520191374|FG000|Overall Study|Lack of Efficacy|5|||
144269630|NCT01663623|520191375|FG001|Overall Study|Lack of Efficacy|6|||
144269631|NCT01663623|520191374|FG000|Overall Study|Protocol Violation|0|||
144234984|NCT04590586|520056866|FG005|Overall Study|Death|3|||
144234985|NCT04590586|520056861|FG000|Overall Study|Lost to Follow-up|3|||
144234986|NCT04590586|520056862|FG001|Overall Study|Lost to Follow-up|0|||
144234987|NCT04590586|520056863|FG002|Overall Study|Lost to Follow-up|11|||
144234988|NCT04590586|520056864|FG003|Overall Study|Lost to Follow-up|11|||
144234989|NCT04590586|520056865|FG004|Overall Study|Lost to Follow-up|6|||
144234990|NCT04590586|520056866|FG005|Overall Study|Lost to Follow-up|0|||
144234991|NCT04590586|520056861|FG000|Overall Study|Withdrawal by Subject|0|||
144234992|NCT04590586|520056862|FG001|Overall Study|Withdrawal by Subject|0|||
144234993|NCT04590586|520056863|FG002|Overall Study|Withdrawal by Subject|6|||
144234994|NCT04590586|520056864|FG003|Overall Study|Withdrawal by Subject|0|||
144234995|NCT04590586|520056865|FG004|Overall Study|Withdrawal by Subject|3|||
144234996|NCT04590586|520056866|FG005|Overall Study|Withdrawal by Subject|0|||
144234997|NCT04590586|520056861|FG000|Overall Study|Other|3|||
144234998|NCT04590586|520056862|FG001|Overall Study|Other|0|||
144234999|NCT04590586|520056863|FG002|Overall Study|Other|1|||
144235000|NCT04590586|520056864|FG003|Overall Study|Other|1|||
144235001|NCT04590586|520056865|FG004|Overall Study|Other|2|||
144235002|NCT04590586|520056866|FG005|Overall Study|Other|1|||
144235003|NCT01290679|520056867|FG000|Overall Study|Adverse Event|2|||
144235004|NCT01290679|520056868|FG001|Overall Study|Adverse Event|0|||
144235005|NCT01290679|520056867|FG000|Overall Study|Lost to Follow-up|8|||
144235006|NCT01290679|520056868|FG001|Overall Study|Lost to Follow-up|10|||
144235007|NCT01290679|520056867|FG000|Overall Study|Protocol Violation|0|||
144235008|NCT01290679|520056868|FG001|Overall Study|Protocol Violation|1|||
144235009|NCT01290679|520056867|FG000|Overall Study|Withdrawal by Subject|6|||
144235010|NCT01290679|520056868|FG001|Overall Study|Withdrawal by Subject|5|||
144235011|NCT01290679|520056867|FG000|Overall Study|Subject Entered Another Trial|0|||
144235012|NCT01290679|520056868|FG001|Overall Study|Subject Entered Another Trial|5|||
144235013|NCT00562302|520056869|FG000|Overall Study|Lost to Follow-up|3|||
144235014|NCT00562302|520056870|FG001|Overall Study|Lost to Follow-up|3|||
144235015|NCT00562302|520056869|FG000|Overall Study|Adverse Event|0|||
144235016|NCT00562302|520056870|FG001|Overall Study|Adverse Event|6|||
144235017|NCT00562302|520056869|FG000|Overall Study|Non-compliance|1|||
144235018|NCT00562302|520056870|FG001|Overall Study|Non-compliance|2|||
144235019|NCT00562302|520056869|FG000|Overall Study|Withdrawal by Subject|7|||
144235020|NCT00562302|520056870|FG001|Overall Study|Withdrawal by Subject|8|||
144235021|NCT00562302|520056869|FG000|Overall Study|Death|1|||
144235022|NCT00562302|520056870|FG001|Overall Study|Death|2|||
144235023|NCT00562302|520056869|FG000|Overall Study|Lung resection prior to study completion|7|||
144235024|NCT00562302|520056870|FG001|Overall Study|Lung resection prior to study completion|7|||
144235025|NCT00562302|520056869|FG000|Overall Study|Not stated|1|||
144235026|NCT00562302|520056870|FG001|Overall Study|Not stated|4|||
144235027|NCT04791319|520056871|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
144235028|NCT04791319|520056872|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
144235029|NCT04791319|520056873|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
144235030|NCT04791319|520056874|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
144235031|NCT04791319|520056875|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235032|NCT04791319|520056876|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235033|NCT04791319|520056877|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235034|NCT04791319|520056878|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235035|NCT04791319|520056879|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235036|NCT04791319|520056880|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235037|NCT04791319|520056881|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
144235038|NCT04791319|520056871|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
144235039|NCT04791319|520056872|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235040|NCT04791319|520056873|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
144235041|NCT04791319|520056874|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
144235042|NCT04791319|520056875|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235043|NCT04791319|520056876|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235044|NCT04791319|520056877|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235045|NCT04791319|520056878|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235046|NCT04791319|520056879|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235047|NCT04791319|520056880|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235048|NCT04791319|520056881|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
144235049|NCT04791319|520056871|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
144235050|NCT04791319|520056872|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
144235051|NCT04791319|520056873|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
144235052|NCT04791319|520056874|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
144235053|NCT04791319|520056875|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235054|NCT04791319|520056876|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235055|NCT04791319|520056877|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235056|NCT04791319|520056878|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235057|NCT04791319|520056879|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235058|NCT04791319|520056880|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235059|NCT04791319|520056881|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
144235060|NCT04791319|520056871|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
144235061|NCT04791319|520056872|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
144269632|NCT01663623|520191375|FG001|Overall Study|Protocol Violation|1|||
144269633|NCT01663623|520191374|FG000|Overall Study|Other-Study closed/terminated|1|||
144269634|NCT01663623|520191375|FG001|Overall Study|Other-Study closed/terminated|1|||
144269635|NCT01663623|520191374|FG000|Overall Study|Physician Decision|1|||
144269636|NCT01663623|520191375|FG001|Overall Study|Physician Decision|4|||
144269637|NCT01663623|520191374|FG000|Overall Study|Withdrawal by Subject|2|||
144269638|NCT01663623|520191375|FG001|Overall Study|Withdrawal by Subject|1|||
144235062|NCT04791319|520056873|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
144235063|NCT04791319|520056874|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
144235064|NCT04791319|520056875|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144235065|NCT04791319|520056876|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144235066|NCT04791319|520056877|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144269639|NCT02251275|520191376|FG000|Overall Study|Adverse Event|23|||
144269640|NCT02251275|520191377|FG001|Overall Study|Adverse Event|60|||
144269641|NCT02251275|520191378|FG002|Overall Study|Adverse Event|28|||
144269642|NCT02251275|520191379|FG003|Overall Study|Adverse Event|0|||
144269643|NCT02251275|520191380|FG004|Overall Study|Adverse Event|0|||
144269644|NCT02251275|520191376|FG000|Overall Study|Lost to Follow-up|5|||
144269645|NCT02251275|520191377|FG001|Overall Study|Lost to Follow-up|6|||
144269646|NCT02251275|520191378|FG002|Overall Study|Lost to Follow-up|4|||
144269647|NCT02251275|520191379|FG003|Overall Study|Lost to Follow-up|0|||
144269648|NCT02251275|520191380|FG004|Overall Study|Lost to Follow-up|0|||
144269649|NCT02251275|520191376|FG000|Overall Study|Physician Decision|19|||
144269650|NCT02251275|520191377|FG001|Overall Study|Physician Decision|30|||
144235067|NCT04791319|520056878|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144235068|NCT04791319|520056879|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144235069|NCT04791319|520056880|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144235070|NCT04791319|520056881|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
144235071|NCT04791319|520056871|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235072|NCT04791319|520056872|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235073|NCT04791319|520056873|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235074|NCT04791319|520056874|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
144235075|NCT04791319|520056875|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235076|NCT04791319|520056876|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235077|NCT04791319|520056877|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235078|NCT04791319|520056878|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235079|NCT04791319|520056879|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235080|NCT04791319|520056880|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235081|NCT04791319|520056881|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
144235082|NCT04791319|520056871|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144269651|NCT02251275|520191378|FG002|Overall Study|Physician Decision|26|||
144269652|NCT02251275|520191379|FG003|Overall Study|Physician Decision|0|||
144235083|NCT04791319|520056872|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144235084|NCT04791319|520056873|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144235085|NCT04791319|520056874|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144235086|NCT04791319|520056875|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
144235087|NCT04791319|520056876|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
144235088|NCT04791319|520056877|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
144235089|NCT04791319|520056878|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144235090|NCT04791319|520056879|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144235091|NCT04791319|520056880|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
144235092|NCT04791319|520056881|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
144269653|NCT02251275|520191380|FG004|Overall Study|Physician Decision|1|||
144269654|NCT02251275|520191376|FG000|Overall Study|Protocol Deviation|0|||
144269655|NCT02251275|520191377|FG001|Overall Study|Protocol Deviation|0|||
144269656|NCT02251275|520191378|FG002|Overall Study|Protocol Deviation|1|||
144269657|NCT02251275|520191379|FG003|Overall Study|Protocol Deviation|0|||
144269658|NCT02251275|520191380|FG004|Overall Study|Protocol Deviation|0|||
144269659|NCT02251275|520191376|FG000|Overall Study|Withdrawal by Subject|25|||
144269660|NCT02251275|520191377|FG001|Overall Study|Withdrawal by Subject|51|||
144269661|NCT02251275|520191378|FG002|Overall Study|Withdrawal by Subject|35|||
144235093|NCT04791319|520056871|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235094|NCT04791319|520056872|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235095|NCT04791319|520056873|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235096|NCT04791319|520056874|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235097|NCT04791319|520056875|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235098|NCT04791319|520056876|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235099|NCT04791319|520056877|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235100|NCT04791319|520056878|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235101|NCT04791319|520056879|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235102|NCT04791319|520056880|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
144235103|NCT04791319|520056881|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
144235104|NCT04791319|520056871|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
144269662|NCT02251275|520191379|FG003|Overall Study|Withdrawal by Subject|1|||
144269663|NCT02251275|520191380|FG004|Overall Study|Withdrawal by Subject|0|||
144235105|NCT04791319|520056872|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
144269664|NCT02152007|520191381|FG000|Overall Study|Withdrawal by Subject|1|||
144269665|NCT05412134|520191382|FG000|Overall Study|Lost to Follow-up|2|||
144235106|NCT04791319|520056873|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
144235107|NCT04791319|520056874|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
144269666|NCT05412134|520191383|FG001|Overall Study|Lost to Follow-up|0|||
144269667|NCT01704261|520191384|FG000|Overall Study|Withdrawal by Subject|12|||
144269668|NCT01704261|520191385|FG001|Overall Study|Withdrawal by Subject|15|||
144269669|NCT01704261|520191384|FG000|Overall Study|Lost to Follow-up|1|||
144269670|NCT01704261|520191385|FG001|Overall Study|Lost to Follow-up|0|||
144269671|NCT02783911|520191388|FG000|Overall Study|Lost to Follow-up|3|||
144269672|NCT02783911|520191389|FG001|Overall Study|Lost to Follow-up|32|||
144269673|NCT01041859|520191396|FG000|Open-Label Titration|Adverse Event|69|||
144269674|NCT01041859|520191397|FG001|Open-Label Titration|Adverse Event|0|||
144269675|NCT01041859|520191398|FG002|Open-Label Titration|Adverse Event|0|||
144269676|NCT01041859|520191396|FG000|Open-Label Titration|Lack of Efficacy|3|||
144269677|NCT01041859|520191397|FG001|Open-Label Titration|Lack of Efficacy|0|||
144269678|NCT01041859|520191398|FG002|Open-Label Titration|Lack of Efficacy|0|||
144269679|NCT01041859|520191396|FG000|Open-Label Titration|Lost to Follow-up|1|||
144269680|NCT01041859|520191397|FG001|Open-Label Titration|Lost to Follow-up|0|||
144269681|NCT01041859|520191398|FG002|Open-Label Titration|Lost to Follow-up|0|||
144269682|NCT01041859|520191396|FG000|Open-Label Titration|Physician Decision|1|||
144269683|NCT01041859|520191397|FG001|Open-Label Titration|Physician Decision|0|||
144269684|NCT01041859|520191398|FG002|Open-Label Titration|Physician Decision|0|||
144269685|NCT01041859|520191396|FG000|Open-Label Titration|Protocol Violation|1|||
144269686|NCT01041859|520191397|FG001|Open-Label Titration|Protocol Violation|0|||
144269687|NCT01041859|520191398|FG002|Open-Label Titration|Protocol Violation|0|||
144269688|NCT01041859|520191396|FG000|Open-Label Titration|Other|7|||
144269689|NCT01041859|520191397|FG001|Open-Label Titration|Other|0|||
144269690|NCT01041859|520191398|FG002|Open-Label Titration|Other|0|||
144269691|NCT01041859|520191396|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
144269692|NCT01041859|520191397|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
144269693|NCT01041859|520191398|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
144269694|NCT01041859|520191396|FG000|Open-Label Titration|Withdrawal by Subject|11|||
144269695|NCT01041859|520191397|FG001|Open-Label Titration|Withdrawal by Subject|0|||
144269696|NCT01041859|520191398|FG002|Open-Label Titration|Withdrawal by Subject|0|||
144269697|NCT01041859|520191396|FG000|Double-Blind Maintenance|Adverse Event|0|||
144269698|NCT01041859|520191397|FG001|Double-Blind Maintenance|Adverse Event|23|||
144269699|NCT01041859|520191398|FG002|Double-Blind Maintenance|Adverse Event|13|||
144269700|NCT01041859|520191396|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
144269701|NCT01041859|520191397|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
144269702|NCT01041859|520191398|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
144269703|NCT01041859|520191396|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
144269704|NCT01041859|520191397|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
144269705|NCT01041859|520191398|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
144269706|NCT01041859|520191396|FG000|Double-Blind Maintenance|Physician Decision|0|||
144269707|NCT01041859|520191397|FG001|Double-Blind Maintenance|Physician Decision|2|||
144269708|NCT01041859|520191398|FG002|Double-Blind Maintenance|Physician Decision|1|||
144269709|NCT01041859|520191396|FG000|Double-Blind Maintenance|Protocol Violation|0|||
144269710|NCT01041859|520191397|FG001|Double-Blind Maintenance|Protocol Violation|1|||
144269711|NCT01041859|520191398|FG002|Double-Blind Maintenance|Protocol Violation|3|||
144269712|NCT01041859|520191396|FG000|Double-Blind Maintenance|Other|0|||
144269713|NCT01041859|520191397|FG001|Double-Blind Maintenance|Other|6|||
144269714|NCT01041859|520191398|FG002|Double-Blind Maintenance|Other|2|||
144269715|NCT01041859|520191396|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
144269716|NCT01041859|520191397|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
144269717|NCT01041859|520191398|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
144269718|NCT01041859|520191396|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
144269719|NCT01041859|520191397|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
144269720|NCT01041859|520191398|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
144269721|NCT03329885|520191401|FG000|Overall Study|Sponsor discontinued the study early|0|||
144269722|NCT03329885|520191402|FG001|Overall Study|Sponsor discontinued the study early|0|||
144269723|NCT03329885|520191403|FG002|Overall Study|Sponsor discontinued the study early|0|||
144269724|NCT03329885|520191404|FG003|Overall Study|Sponsor discontinued the study early|0|||
144269725|NCT03329885|520191405|FG004|Overall Study|Sponsor discontinued the study early|0|||
144269726|NCT03329885|520191406|FG005|Overall Study|Sponsor discontinued the study early|0|||
144269727|NCT03329885|520191407|FG006|Overall Study|Sponsor discontinued the study early|1|||
144269728|NCT03329885|520191408|FG007|Overall Study|Sponsor discontinued the study early|1|||
144269729|NCT03329885|520191409|FG008|Overall Study|Sponsor discontinued the study early|0|||
144269730|NCT04249427|520191412|FG000|Overall Study|Adverse Event|3|||
144269731|NCT04249427|520191413|FG001|Overall Study|Adverse Event|1|||
144269732|NCT04249427|520191412|FG000|Overall Study|Lack of Efficacy|0|||
144269733|NCT04249427|520191413|FG001|Overall Study|Lack of Efficacy|1|||
144269734|NCT04249427|520191412|FG000|Overall Study|Withdrawal by Subject|1|||
144269735|NCT04249427|520191413|FG001|Overall Study|Withdrawal by Subject|2|||
144269736|NCT03608826|520191414|FG000|Overall Study|Death|3|||
144269737|NCT03608826|520191414|FG000|Overall Study|Heart Transplant|3|||
144235108|NCT04791319|520056875|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
144235109|NCT04791319|520056876|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
144235110|NCT04791319|520056877|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
144235111|NCT04791319|520056878|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
144235112|NCT04791319|520056879|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
144235113|NCT04791319|520056880|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
144235114|NCT04791319|520056881|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
144235115|NCT04791319|520056871|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
144235116|NCT04791319|520056872|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
144235117|NCT04791319|520056873|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
144235118|NCT04791319|520056874|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
144235119|NCT04791319|520056875|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
144235120|NCT04791319|520056876|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
144235121|NCT04791319|520056877|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
144235122|NCT04791319|520056878|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
144235123|NCT04791319|520056879|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
144235124|NCT04791319|520056880|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
144235125|NCT04791319|520056881|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
144235126|NCT00791661|520056882|FG000|7 Day Wash-out|Adverse Event|0|||
144235127|NCT00791661|520056883|FG001|7 Day Wash-out|Adverse Event|0|||
144235128|NCT00791661|520056884|FG002|7 Day Wash-out|Adverse Event|1|||
144235129|NCT00791661|520056882|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
144235130|NCT00791661|520056883|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
144235131|NCT00791661|520056884|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
144235132|NCT03605862|520056885|FG000|Overall Study|Withdrawal by Subject|12|||
144235133|NCT03605862|520056886|FG001|Overall Study|Withdrawal by Subject|9|||
144235134|NCT03605862|520056885|FG000|Overall Study|Adverse Event|2|||
144235135|NCT03605862|520056886|FG001|Overall Study|Adverse Event|1|||
144235136|NCT03605862|520056885|FG000|Overall Study|Physician Decision|3|||
144235137|NCT03605862|520056886|FG001|Overall Study|Physician Decision|1|||
144235138|NCT03605862|520056885|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
144235139|NCT03605862|520056886|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
144235140|NCT00679289|520056887|FG000|Overall Study|Progressive disease|4|||
144235141|NCT00679289|520056888|FG001|Overall Study|Progressive disease|5|||
144269738|NCT03608826|520191414|FG000|Overall Study|Physician Decision|4|||
144235142|NCT00679289|520056889|FG002|Overall Study|Progressive disease|18|||
144235143|NCT00679289|520056887|FG000|Overall Study|Withdrawal by Subject|0|||
144235144|NCT00679289|520056888|FG001|Overall Study|Withdrawal by Subject|1|||
144235145|NCT00679289|520056889|FG002|Overall Study|Withdrawal by Subject|1|||
144235146|NCT00679289|520056887|FG000|Overall Study|Adverse Event|0|||
144235147|NCT00679289|520056888|FG001|Overall Study|Adverse Event|0|||
144235148|NCT00679289|520056889|FG002|Overall Study|Adverse Event|3|||
144235149|NCT00679289|520056887|FG000|Overall Study|Physician Decision|1|||
144235150|NCT00679289|520056888|FG001|Overall Study|Physician Decision|0|||
144235151|NCT00679289|520056889|FG002|Overall Study|Physician Decision|1|||
144235152|NCT00937040|520056890|FG000|Overall Study|Adverse Event|5|||
144235153|NCT00937040|520056891|FG001|Overall Study|Adverse Event|8|||
144235154|NCT00937040|520056890|FG000|Overall Study|Lost to Follow-up|12|||
144235155|NCT00937040|520056891|FG001|Overall Study|Lost to Follow-up|12|||
144235156|NCT00937040|520056890|FG000|Overall Study|Protocol Violation|3|||
144235157|NCT00937040|520056891|FG001|Overall Study|Protocol Violation|0|||
144235158|NCT00937040|520056890|FG000|Overall Study|Withdrawal by Subject|13|||
144235159|NCT00937040|520056891|FG001|Overall Study|Withdrawal by Subject|7|||
144235160|NCT00937040|520056890|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
144235161|NCT00937040|520056891|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
144235162|NCT00937040|520056890|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
144235163|NCT00937040|520056891|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
144235164|NCT00634803|520056894|FG000|Overall Study|Lost to Follow-up|6|||
144235165|NCT00634803|520056895|FG001|Overall Study|Lost to Follow-up|7|||
144235166|NCT00634803|520056896|FG002|Overall Study|Lost to Follow-up|7|||
144235167|NCT00364923|520056897|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
144235168|NCT00364923|520056897|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
144235169|NCT00550043|520056902|FG000|Overall Study|Adverse Event|0|||
144235170|NCT00550043|520056903|FG001|Overall Study|Adverse Event|0|||
144235171|NCT00550043|520056904|FG002|Overall Study|Adverse Event|0|||
144235172|NCT00550043|520056905|FG003|Overall Study|Adverse Event|1|||
144235173|NCT00550043|520056906|FG004|Overall Study|Adverse Event|1|||
144235174|NCT00550043|520056902|FG000|Overall Study|Subject Withdrew Consent|0|||
144235175|NCT00550043|520056903|FG001|Overall Study|Subject Withdrew Consent|2|||
144235176|NCT00550043|520056904|FG002|Overall Study|Subject Withdrew Consent|1|||
144235177|NCT00550043|520056905|FG003|Overall Study|Subject Withdrew Consent|0|||
144235178|NCT00550043|520056906|FG004|Overall Study|Subject Withdrew Consent|0|||
144235179|NCT00550043|520056902|FG000|Overall Study|Other Reasons- Unspecified|0|||
144235180|NCT00550043|520056903|FG001|Overall Study|Other Reasons- Unspecified|1|||
144235181|NCT00550043|520056904|FG002|Overall Study|Other Reasons- Unspecified|0|||
144235182|NCT00550043|520056905|FG003|Overall Study|Other Reasons- Unspecified|1|||
144235183|NCT00550043|520056906|FG004|Overall Study|Other Reasons- Unspecified|0|||
144235184|NCT03478644|520056907|FG000|Phase 2|Withdrawal by Subject|2|||
144235185|NCT03478644|520056908|FG001|Phase 2|Withdrawal by Subject|1|||
144235186|NCT03478644|520056907|FG000|Phase 2|Lost to Follow-up|1|||
144235187|NCT03478644|520056908|FG001|Phase 2|Lost to Follow-up|0|||
144235188|NCT02073929|520056909|FG000|Overall Study|Lost to Follow-up|2|||
144235189|NCT02073929|520056910|FG001|Overall Study|Lost to Follow-up|1|||
144235190|NCT02073929|520056909|FG000|Overall Study|Adverse Event|2|||
144235191|NCT02073929|520056910|FG001|Overall Study|Adverse Event|1|||
144235192|NCT02073929|520056909|FG000|Overall Study|Withdrawal by Subject|0|||
144235193|NCT02073929|520056910|FG001|Overall Study|Withdrawal by Subject|1|||
144235194|NCT01483027|520056911|FG000|Overall Study|Administrative Reasons|2|||
144235195|NCT01483027|520056912|FG001|Overall Study|Administrative Reasons|1|||
144235196|NCT01483027|520056911|FG000|Overall Study|Withdrawal by Subject|21|||
144235197|NCT01483027|520056912|FG001|Overall Study|Withdrawal by Subject|32|||
144235198|NCT01483027|520056911|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
144235199|NCT01483027|520056912|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
144235200|NCT01483027|520056911|FG000|Overall Study|Lost to Follow-up|1|||
144235201|NCT01483027|520056912|FG001|Overall Study|Lost to Follow-up|1|||
144235202|NCT01483027|520056911|FG000|Overall Study|Adverse Event|0|||
144235203|NCT01483027|520056912|FG001|Overall Study|Adverse Event|1|||
144235204|NCT01483027|520056911|FG000|Overall Study|Withdrawal by Subject|0|||
144235205|NCT01483027|520056912|FG001|Overall Study|Withdrawal by Subject|1|||
144235206|NCT01314872|520056917|FG000|Treatment Period 1|Protocol Violation|2|||
144235207|NCT01314872|520056918|FG001|Treatment Period 1|Protocol Violation|1|||
144235208|NCT01314872|520056919|FG002|Treatment Period 1|Protocol Violation|1|||
144235209|NCT01314872|520056920|FG003|Treatment Period 1|Protocol Violation|0|||
144235210|NCT01314872|520056921|FG004|Treatment Period 1|Protocol Violation|1|||
144235211|NCT01314872|520056922|FG005|Treatment Period 1|Protocol Violation|0|||
144235212|NCT01314872|520056923|FG006|Treatment Period 1|Protocol Violation|0|||
144269739|NCT01118052|520191415|FG000|Overall Study|Never treated|2|||
144235213|NCT01314872|520056924|FG007|Treatment Period 1|Protocol Violation|0|||
144235214|NCT01314872|520056925|FG008|Treatment Period 1|Protocol Violation|0|||
144269740|NCT00843492|520191418|FG000|Overall Study|Adverse Event|0|||
144269741|NCT00843492|520191419|FG001|Overall Study|Adverse Event|3|||
144235215|NCT01314872|520056926|FG009|Treatment Period 1|Protocol Violation|1|||
144235216|NCT01314872|520056927|FG010|Treatment Period 1|Protocol Violation|1|||
144235217|NCT01314872|520056928|FG011|Treatment Period 1|Protocol Violation|0|||
144235218|NCT01314872|520056929|FG012|Treatment Period 1|Protocol Violation|0|||
144235219|NCT01314872|520056930|FG013|Treatment Period 1|Protocol Violation|0|||
144235220|NCT01314872|520056931|FG014|Treatment Period 1|Protocol Violation|0|||
144235221|NCT01314872|520056917|FG000|Treatment Period 1|Physician Decision|0|||
144235222|NCT01314872|520056918|FG001|Treatment Period 1|Physician Decision|1|||
144235223|NCT01314872|520056919|FG002|Treatment Period 1|Physician Decision|0|||
144235224|NCT01314872|520056920|FG003|Treatment Period 1|Physician Decision|1|||
144269742|NCT00843492|520191418|FG000|Overall Study|Lost to Follow-up|4|||
144269743|NCT00843492|520191419|FG001|Overall Study|Lost to Follow-up|4|||
144269744|NCT00843492|520191418|FG000|Overall Study|Withdrawal by Subject|0|||
144269745|NCT00843492|520191419|FG001|Overall Study|Withdrawal by Subject|4|||
144269746|NCT00843492|520191418|FG000|Overall Study|Immobilization Stopped|1|||
144269747|NCT00843492|520191419|FG001|Overall Study|Immobilization Stopped|0|||
144235225|NCT01314872|520056921|FG004|Treatment Period 1|Physician Decision|0|||
144235226|NCT01314872|520056922|FG005|Treatment Period 1|Physician Decision|0|||
144235227|NCT01314872|520056923|FG006|Treatment Period 1|Physician Decision|0|||
144235228|NCT01314872|520056924|FG007|Treatment Period 1|Physician Decision|0|||
144235229|NCT01314872|520056925|FG008|Treatment Period 1|Physician Decision|0|||
144235230|NCT01314872|520056926|FG009|Treatment Period 1|Physician Decision|1|||
144235231|NCT01314872|520056927|FG010|Treatment Period 1|Physician Decision|0|||
144235232|NCT01314872|520056928|FG011|Treatment Period 1|Physician Decision|0|||
144235233|NCT01314872|520056929|FG012|Treatment Period 1|Physician Decision|0|||
144269748|NCT00843492|520191418|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
144269749|NCT00843492|520191419|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
144269750|NCT00843492|520191418|FG000|Overall Study|Orthopedic Surgery|0|||
144269751|NCT00843492|520191419|FG001|Overall Study|Orthopedic Surgery|2|||
144269752|NCT00843492|520191418|FG000|Overall Study|Visit Not Performed|1|||
144235234|NCT01314872|520056930|FG013|Treatment Period 1|Physician Decision|0|||
144235235|NCT01314872|520056931|FG014|Treatment Period 1|Physician Decision|0|||
144235236|NCT01314872|520056917|FG000|Treatment Period 1|Lack of Efficacy|1|||
144235237|NCT01314872|520056918|FG001|Treatment Period 1|Lack of Efficacy|0|||
144235238|NCT01314872|520056919|FG002|Treatment Period 1|Lack of Efficacy|0|||
144235239|NCT01314872|520056920|FG003|Treatment Period 1|Lack of Efficacy|0|||
144235240|NCT01314872|520056921|FG004|Treatment Period 1|Lack of Efficacy|0|||
144235241|NCT01314872|520056922|FG005|Treatment Period 1|Lack of Efficacy|1|||
144235242|NCT01314872|520056923|FG006|Treatment Period 1|Lack of Efficacy|0|||
144235243|NCT01314872|520056924|FG007|Treatment Period 1|Lack of Efficacy|2|||
144235244|NCT01314872|520056925|FG008|Treatment Period 1|Lack of Efficacy|0|||
144269753|NCT00843492|520191419|FG001|Overall Study|Visit Not Performed|0|||
144235245|NCT01314872|520056926|FG009|Treatment Period 1|Lack of Efficacy|0|||
144235246|NCT01314872|520056927|FG010|Treatment Period 1|Lack of Efficacy|0|||
144235247|NCT01314872|520056928|FG011|Treatment Period 1|Lack of Efficacy|0|||
144235248|NCT01314872|520056929|FG012|Treatment Period 1|Lack of Efficacy|0|||
144269754|NCT00843492|520191418|FG000|Overall Study|Deep-vein Thrombosis|1|||
144269755|NCT00843492|520191419|FG001|Overall Study|Deep-vein Thrombosis|0|||
144269756|NCT00369343|520191420|FG000|Double-blind Phase|Adverse Event|19|||
144269757|NCT00369343|520191421|FG001|Double-blind Phase|Adverse Event|4|||
144269758|NCT00369343|520191420|FG000|Double-blind Phase|Failed to return|2|||
144269759|NCT00369343|520191421|FG001|Double-blind Phase|Failed to return|0|||
144269760|NCT00369343|520191420|FG000|Double-blind Phase|Lost to Follow-up|9|||
144269761|NCT00369343|520191421|FG001|Double-blind Phase|Lost to Follow-up|2|||
144269762|NCT00369343|520191420|FG000|Double-blind Phase|Protocol Violation|2|||
144269763|NCT00369343|520191421|FG001|Double-blind Phase|Protocol Violation|0|||
144269764|NCT00369343|520191420|FG000|Double-blind Phase|Withdrawal by Subject|8|||
144269765|NCT00369343|520191421|FG001|Double-blind Phase|Withdrawal by Subject|6|||
144269766|NCT00369343|520191420|FG000|Double-blind Phase|Lack of Efficacy|0|||
144269767|NCT00369343|520191421|FG001|Double-blind Phase|Lack of Efficacy|4|||
144269768|NCT00369343|520191420|FG000|Double-blind Phase|Protocol deviation|4|||
144269769|NCT00369343|520191421|FG001|Double-blind Phase|Protocol deviation|0|||
144269770|NCT00369343|520191420|FG000|Open-label Phase|Adverse Event|19|||
144269771|NCT00369343|520191421|FG001|Open-label Phase|Adverse Event|7|||
144269772|NCT00369343|520191420|FG000|Open-label Phase|Failed to return|4|||
144269773|NCT00369343|520191421|FG001|Open-label Phase|Failed to return|0|||
144269774|NCT00369343|520191420|FG000|Open-label Phase|Physician Decision|2|||
144269775|NCT00369343|520191421|FG001|Open-label Phase|Physician Decision|0|||
144269776|NCT00369343|520191420|FG000|Open-label Phase|Lost to Follow-up|5|||
144269777|NCT00369343|520191421|FG001|Open-label Phase|Lost to Follow-up|3|||
144269778|NCT00369343|520191420|FG000|Open-label Phase|inadvertently reported study completers|3|||
144269779|NCT00369343|520191421|FG001|Open-label Phase|inadvertently reported study completers|2|||
144269780|NCT00369343|520191420|FG000|Open-label Phase|Protocol Violation|1|||
144269781|NCT00369343|520191421|FG001|Open-label Phase|Protocol Violation|3|||
144269782|NCT00369343|520191420|FG000|Open-label Phase|Withdrawal by Subject|15|||
144269783|NCT00369343|520191421|FG001|Open-label Phase|Withdrawal by Subject|6|||
144269784|NCT00369343|520191420|FG000|Open-label Phase|Lack of Efficacy|4|||
144269785|NCT00369343|520191421|FG001|Open-label Phase|Lack of Efficacy|3|||
144235249|NCT01314872|520056930|FG013|Treatment Period 1|Lack of Efficacy|0|||
144235250|NCT01314872|520056931|FG014|Treatment Period 1|Lack of Efficacy|0|||
144235251|NCT01314872|520056917|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
144235252|NCT01314872|520056918|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
144235253|NCT01314872|520056919|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
144235254|NCT01314872|520056920|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
144235255|NCT01314872|520056921|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
144235256|NCT01314872|520056922|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
144235257|NCT01314872|520056923|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
144235258|NCT01314872|520056924|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
144235259|NCT01314872|520056925|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
144235260|NCT01314872|520056926|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
144235261|NCT01314872|520056927|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
144235262|NCT01314872|520056928|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
144235263|NCT01314872|520056929|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
144235264|NCT01314872|520056930|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
144235265|NCT01314872|520056931|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
144235266|NCT01314872|520056917|FG000|Treatment Period 1|Withdrawal by Subject|3|||
144235267|NCT01314872|520056918|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144235268|NCT01314872|520056919|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144235269|NCT01314872|520056920|FG003|Treatment Period 1|Withdrawal by Subject|2|||
144235270|NCT01314872|520056921|FG004|Treatment Period 1|Withdrawal by Subject|3|||
144235271|NCT01314872|520056922|FG005|Treatment Period 1|Withdrawal by Subject|1|||
144235272|NCT01314872|520056923|FG006|Treatment Period 1|Withdrawal by Subject|3|||
144235273|NCT01314872|520056924|FG007|Treatment Period 1|Withdrawal by Subject|2|||
144235274|NCT01314872|520056925|FG008|Treatment Period 1|Withdrawal by Subject|2|||
144235275|NCT01314872|520056926|FG009|Treatment Period 1|Withdrawal by Subject|2|||
144235276|NCT01314872|520056927|FG010|Treatment Period 1|Withdrawal by Subject|1|||
144235277|NCT01314872|520056928|FG011|Treatment Period 1|Withdrawal by Subject|0|||
144235278|NCT01314872|520056929|FG012|Treatment Period 1|Withdrawal by Subject|0|||
144235279|NCT01314872|520056930|FG013|Treatment Period 1|Withdrawal by Subject|0|||
144235280|NCT01314872|520056931|FG014|Treatment Period 1|Withdrawal by Subject|0|||
144235281|NCT01314872|520056917|FG000|Treatment Period 1|Lost to Follow-up|0|||
144235282|NCT01314872|520056918|FG001|Treatment Period 1|Lost to Follow-up|1|||
144269786|NCT00369343|520191420|FG000|Open-label Phase|Lack of continuance tolerability|3|||
144269787|NCT00369343|520191421|FG001|Open-label Phase|Lack of continuance tolerability|4|||
144269788|NCT00369343|520191420|FG000|Open-label Phase|did not take study drug|1|||
144269789|NCT00369343|520191421|FG001|Open-label Phase|did not take study drug|2|||
144235283|NCT01314872|520056919|FG002|Treatment Period 1|Lost to Follow-up|2|||
144269790|NCT00794664|520191422|FG000|Treatment Period|Withdrawal by Subject|0|||
144235284|NCT01314872|520056920|FG003|Treatment Period 1|Lost to Follow-up|2|||
144235285|NCT01314872|520056921|FG004|Treatment Period 1|Lost to Follow-up|1|||
144235286|NCT01314872|520056922|FG005|Treatment Period 1|Lost to Follow-up|1|||
144235287|NCT01314872|520056923|FG006|Treatment Period 1|Lost to Follow-up|1|||
144235288|NCT01314872|520056924|FG007|Treatment Period 1|Lost to Follow-up|1|||
144269791|NCT00794664|520191423|FG001|Treatment Period|Withdrawal by Subject|2|||
144269792|NCT00794664|520191422|FG000|Treatment Period|Protocol non-compliance|0|||
144269793|NCT00794664|520191423|FG001|Treatment Period|Protocol non-compliance|1|||
144269794|NCT00794664|520191422|FG000|Treatment Period|Other|0|||
144269795|NCT00794664|520191423|FG001|Treatment Period|Other|1|||
144235289|NCT01314872|520056925|FG008|Treatment Period 1|Lost to Follow-up|1|||
144235290|NCT01314872|520056926|FG009|Treatment Period 1|Lost to Follow-up|0|||
144235291|NCT01314872|520056927|FG010|Treatment Period 1|Lost to Follow-up|0|||
144235292|NCT01314872|520056928|FG011|Treatment Period 1|Lost to Follow-up|0|||
144235293|NCT01314872|520056929|FG012|Treatment Period 1|Lost to Follow-up|0|||
144235294|NCT01314872|520056930|FG013|Treatment Period 1|Lost to Follow-up|0|||
144235295|NCT01314872|520056931|FG014|Treatment Period 1|Lost to Follow-up|0|||
144235296|NCT01314872|520056917|FG000|Period 2|Protocol Violation|0|||
144235297|NCT01314872|520056918|FG001|Period 2|Protocol Violation|0|||
144235298|NCT01314872|520056919|FG002|Period 2|Protocol Violation|0|||
144235299|NCT01314872|520056920|FG003|Period 2|Protocol Violation|0|||
144235300|NCT01314872|520056921|FG004|Period 2|Protocol Violation|0|||
144235301|NCT01314872|520056922|FG005|Period 2|Protocol Violation|0|||
144235302|NCT01314872|520056923|FG006|Period 2|Protocol Violation|0|||
144235303|NCT01314872|520056924|FG007|Period 2|Protocol Violation|0|||
144235304|NCT01314872|520056925|FG008|Period 2|Protocol Violation|0|||
144235305|NCT01314872|520056926|FG009|Period 2|Protocol Violation|0|||
144235306|NCT01314872|520056927|FG010|Period 2|Protocol Violation|0|||
144235307|NCT01314872|520056928|FG011|Period 2|Protocol Violation|3|||
144235308|NCT01314872|520056929|FG012|Period 2|Protocol Violation|3|||
144235309|NCT01314872|520056930|FG013|Period 2|Protocol Violation|2|||
144235310|NCT01314872|520056931|FG014|Period 2|Protocol Violation|0|||
144235311|NCT01314872|520056917|FG000|Period 2|Non-compliance with study drug|0|||
144235312|NCT01314872|520056918|FG001|Period 2|Non-compliance with study drug|0|||
144235313|NCT01314872|520056919|FG002|Period 2|Non-compliance with study drug|0|||
144235314|NCT01314872|520056920|FG003|Period 2|Non-compliance with study drug|0|||
144235315|NCT01314872|520056921|FG004|Period 2|Non-compliance with study drug|0|||
144235316|NCT01314872|520056922|FG005|Period 2|Non-compliance with study drug|0|||
144235317|NCT01314872|520056923|FG006|Period 2|Non-compliance with study drug|0|||
144235318|NCT01314872|520056924|FG007|Period 2|Non-compliance with study drug|0|||
144235319|NCT01314872|520056925|FG008|Period 2|Non-compliance with study drug|0|||
144235320|NCT01314872|520056926|FG009|Period 2|Non-compliance with study drug|0|||
144235321|NCT01314872|520056927|FG010|Period 2|Non-compliance with study drug|0|||
144235322|NCT01314872|520056928|FG011|Period 2|Non-compliance with study drug|3|||
144235323|NCT01314872|520056929|FG012|Period 2|Non-compliance with study drug|3|||
144235324|NCT01314872|520056930|FG013|Period 2|Non-compliance with study drug|1|||
144235325|NCT01314872|520056931|FG014|Period 2|Non-compliance with study drug|2|||
144235326|NCT01314872|520056917|FG000|Period 2|Lack of Efficacy|0|||
144235327|NCT01314872|520056918|FG001|Period 2|Lack of Efficacy|0|||
144235328|NCT01314872|520056919|FG002|Period 2|Lack of Efficacy|0|||
144235329|NCT01314872|520056920|FG003|Period 2|Lack of Efficacy|0|||
144235330|NCT01314872|520056921|FG004|Period 2|Lack of Efficacy|0|||
144235331|NCT01314872|520056922|FG005|Period 2|Lack of Efficacy|0|||
144235332|NCT01314872|520056923|FG006|Period 2|Lack of Efficacy|0|||
144235333|NCT01314872|520056924|FG007|Period 2|Lack of Efficacy|0|||
144235334|NCT01314872|520056925|FG008|Period 2|Lack of Efficacy|0|||
144235335|NCT01314872|520056926|FG009|Period 2|Lack of Efficacy|0|||
144235336|NCT01314872|520056927|FG010|Period 2|Lack of Efficacy|0|||
144235337|NCT01314872|520056928|FG011|Period 2|Lack of Efficacy|7|||
144235338|NCT01314872|520056929|FG012|Period 2|Lack of Efficacy|12|||
144235339|NCT01314872|520056930|FG013|Period 2|Lack of Efficacy|9|||
144235340|NCT01314872|520056931|FG014|Period 2|Lack of Efficacy|2|||
144235341|NCT01314872|520056917|FG000|Period 2|Pregnancy|0|||
144235342|NCT01314872|520056918|FG001|Period 2|Pregnancy|0|||
144235343|NCT01314872|520056919|FG002|Period 2|Pregnancy|0|||
144235344|NCT01314872|520056920|FG003|Period 2|Pregnancy|0|||
144235345|NCT01314872|520056921|FG004|Period 2|Pregnancy|0|||
144235346|NCT01314872|520056922|FG005|Period 2|Pregnancy|0|||
144235347|NCT01314872|520056923|FG006|Period 2|Pregnancy|0|||
144235348|NCT01314872|520056924|FG007|Period 2|Pregnancy|0|||
144235349|NCT01314872|520056925|FG008|Period 2|Pregnancy|0|||
144235350|NCT01314872|520056926|FG009|Period 2|Pregnancy|0|||
144235351|NCT01314872|520056927|FG010|Period 2|Pregnancy|0|||
144235352|NCT01314872|520056928|FG011|Period 2|Pregnancy|0|||
144235353|NCT01314872|520056929|FG012|Period 2|Pregnancy|0|||
144235354|NCT01314872|520056930|FG013|Period 2|Pregnancy|0|||
144235355|NCT01314872|520056931|FG014|Period 2|Pregnancy|1|||
144235356|NCT01314872|520056917|FG000|Period 2|Study terminated by Sponsor|0|||
144235357|NCT01314872|520056918|FG001|Period 2|Study terminated by Sponsor|0|||
144235358|NCT01314872|520056919|FG002|Period 2|Study terminated by Sponsor|0|||
144235359|NCT01314872|520056920|FG003|Period 2|Study terminated by Sponsor|0|||
144235360|NCT01314872|520056921|FG004|Period 2|Study terminated by Sponsor|0|||
144235361|NCT01314872|520056922|FG005|Period 2|Study terminated by Sponsor|0|||
144235362|NCT01314872|520056923|FG006|Period 2|Study terminated by Sponsor|0|||
144235363|NCT01314872|520056924|FG007|Period 2|Study terminated by Sponsor|0|||
144235364|NCT01314872|520056925|FG008|Period 2|Study terminated by Sponsor|0|||
144235365|NCT01314872|520056926|FG009|Period 2|Study terminated by Sponsor|0|||
144235366|NCT01314872|520056927|FG010|Period 2|Study terminated by Sponsor|0|||
144235367|NCT01314872|520056928|FG011|Period 2|Study terminated by Sponsor|2|||
144235368|NCT01314872|520056929|FG012|Period 2|Study terminated by Sponsor|2|||
144235369|NCT01314872|520056930|FG013|Period 2|Study terminated by Sponsor|3|||
144235370|NCT01314872|520056931|FG014|Period 2|Study terminated by Sponsor|0|||
144235371|NCT01314872|520056917|FG000|Period 2|Adverse event, non-fatal|0|||
144235372|NCT01314872|520056918|FG001|Period 2|Adverse event, non-fatal|0|||
144235373|NCT01314872|520056919|FG002|Period 2|Adverse event, non-fatal|0|||
144235374|NCT01314872|520056920|FG003|Period 2|Adverse event, non-fatal|0|||
144235375|NCT01314872|520056921|FG004|Period 2|Adverse event, non-fatal|0|||
144235376|NCT01314872|520056922|FG005|Period 2|Adverse event, non-fatal|0|||
144235377|NCT01314872|520056923|FG006|Period 2|Adverse event, non-fatal|0|||
144235378|NCT01314872|520056924|FG007|Period 2|Adverse event, non-fatal|0|||
144235379|NCT01314872|520056925|FG008|Period 2|Adverse event, non-fatal|0|||
144235380|NCT01314872|520056926|FG009|Period 2|Adverse event, non-fatal|0|||
144235381|NCT01314872|520056927|FG010|Period 2|Adverse event, non-fatal|0|||
144235382|NCT01314872|520056928|FG011|Period 2|Adverse event, non-fatal|13|||
144235383|NCT01314872|520056929|FG012|Period 2|Adverse event, non-fatal|16|||
144235384|NCT01314872|520056930|FG013|Period 2|Adverse event, non-fatal|24|||
144235385|NCT01314872|520056931|FG014|Period 2|Adverse event, non-fatal|9|||
144235386|NCT01314872|520056917|FG000|Period 2|Withdrawal by Subject|0|||
144235387|NCT01314872|520056918|FG001|Period 2|Withdrawal by Subject|0|||
144235388|NCT01314872|520056919|FG002|Period 2|Withdrawal by Subject|0|||
144235389|NCT01314872|520056920|FG003|Period 2|Withdrawal by Subject|0|||
144235390|NCT01314872|520056921|FG004|Period 2|Withdrawal by Subject|0|||
144235391|NCT01314872|520056922|FG005|Period 2|Withdrawal by Subject|0|||
144235392|NCT01314872|520056923|FG006|Period 2|Withdrawal by Subject|0|||
144235393|NCT01314872|520056924|FG007|Period 2|Withdrawal by Subject|0|||
144235394|NCT01314872|520056925|FG008|Period 2|Withdrawal by Subject|0|||
144235395|NCT01314872|520056926|FG009|Period 2|Withdrawal by Subject|0|||
144235396|NCT01314872|520056927|FG010|Period 2|Withdrawal by Subject|0|||
144235397|NCT01314872|520056928|FG011|Period 2|Withdrawal by Subject|14|||
144235398|NCT01314872|520056929|FG012|Period 2|Withdrawal by Subject|17|||
144235399|NCT01314872|520056930|FG013|Period 2|Withdrawal by Subject|12|||
144235400|NCT01314872|520056931|FG014|Period 2|Withdrawal by Subject|4|||
144235401|NCT01314872|520056917|FG000|Period 2|Lost to Follow-up|0|||
144235402|NCT01314872|520056918|FG001|Period 2|Lost to Follow-up|0|||
144235403|NCT01314872|520056919|FG002|Period 2|Lost to Follow-up|0|||
144235404|NCT01314872|520056920|FG003|Period 2|Lost to Follow-up|0|||
144235405|NCT01314872|520056921|FG004|Period 2|Lost to Follow-up|0|||
144235406|NCT01314872|520056922|FG005|Period 2|Lost to Follow-up|0|||
144235407|NCT01314872|520056923|FG006|Period 2|Lost to Follow-up|0|||
144235408|NCT01314872|520056924|FG007|Period 2|Lost to Follow-up|0|||
144235409|NCT01314872|520056925|FG008|Period 2|Lost to Follow-up|0|||
144235410|NCT01314872|520056926|FG009|Period 2|Lost to Follow-up|0|||
144235411|NCT01314872|520056927|FG010|Period 2|Lost to Follow-up|0|||
144235412|NCT01314872|520056928|FG011|Period 2|Lost to Follow-up|6|||
144235413|NCT01314872|520056929|FG012|Period 2|Lost to Follow-up|7|||
144235414|NCT01314872|520056930|FG013|Period 2|Lost to Follow-up|2|||
144235415|NCT01314872|520056931|FG014|Period 2|Lost to Follow-up|6|||
144235416|NCT00748189|520058564|FG000|Overall Study|Death|99|||
144235417|NCT00748189|520058565|FG001|Overall Study|Death|84|||
144235418|NCT00748189|520058564|FG000|Overall Study|Withdrawal by Subject|23|||
144235419|NCT00748189|520058565|FG001|Overall Study|Withdrawal by Subject|29|||
144235420|NCT00748189|520058564|FG000|Overall Study|Physician Decision|16|||
144235421|NCT00748189|520058565|FG001|Overall Study|Physician Decision|5|||
144235422|NCT00748189|520058564|FG000|Overall Study|Lost to Follow-up|8|||
144235423|NCT00748189|520058565|FG001|Overall Study|Lost to Follow-up|15|||
144235424|NCT00748189|520058564|FG000|Overall Study|Study terminated by Sponsor|70|||
144235425|NCT00748189|520058565|FG001|Overall Study|Study terminated by Sponsor|79|||
144235426|NCT04481191|520058566|FG000|Overall Study|Withdrawn by parent/guardian|15|||
144235427|NCT04481191|520058567|FG001|Overall Study|Withdrawn by parent/guardian|10|||
144235428|NCT05338502|520058570|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
144235429|NCT05338502|520058571|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
144235430|NCT05338502|520058572|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
144235431|NCT05338502|520058570|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
144235432|NCT05338502|520058571|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
144235433|NCT05338502|520058572|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
144235434|NCT03575793|520058573|FG000|Overall Study|Withdrawal by Subject|0|||
144235435|NCT03575793|520058574|FG001|Overall Study|Withdrawal by Subject|1|||
144235436|NCT03575793|520058573|FG000|Overall Study|Never Treated|0|||
144235437|NCT03575793|520058574|FG001|Overall Study|Never Treated|2|||
144269796|NCT00794664|520191422|FG000|Treatment Period|Adverse Event|1|||
144235438|NCT01250873|520058575|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
144235439|NCT01250873|520058575|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
144235440|NCT02278939|520058576|FG000|Overall Study|lack of time|1|||
144235441|NCT02278939|520058577|FG001|Overall Study|lack of time|0|||
144235442|NCT02278939|520058576|FG000|Overall Study|Lost to Follow-up|1|||
144235443|NCT02278939|520058577|FG001|Overall Study|Lost to Follow-up|1|||
144235444|NCT02278939|520058576|FG000|Overall Study|death in family|1|||
144235445|NCT02278939|520058577|FG001|Overall Study|death in family|0|||
144235446|NCT02278939|520058576|FG000|Overall Study|family emergency unable to commit|2|||
144235447|NCT02278939|520058577|FG001|Overall Study|family emergency unable to commit|0|||
144235448|NCT00930774|520058583|FG000|Overall Study|Withdrawal by Subject|1|||
144235449|NCT00930774|520058584|FG001|Overall Study|Withdrawal by Subject|9|||
144235450|NCT00930774|520058585|FG002|Overall Study|Withdrawal by Subject|2|||
144235451|NCT00930774|520058586|FG003|Overall Study|Withdrawal by Subject|0|||
144235452|NCT03200704|520058587|FG000|Overall Study|Withdrawal by Subject|1|||
144235453|NCT02042950|520058588|FG000|Overall Study|Progressive Disease|4|||
144235454|NCT01683266|520058592|FG000|Overall Study|Adverse Event|5|||
144235455|NCT01683266|520058593|FG001|Overall Study|Adverse Event|4|||
144235456|NCT01683266|520058592|FG000|Overall Study|Lack of Efficacy|5|||
144235457|NCT01683266|520058593|FG001|Overall Study|Lack of Efficacy|2|||
144235458|NCT01683266|520058592|FG000|Overall Study|Protocol Violation|13|||
144235459|NCT01683266|520058593|FG001|Overall Study|Protocol Violation|6|||
144235460|NCT01683266|520058592|FG000|Overall Study|Personal Reason|17|||
144235461|NCT01683266|520058593|FG001|Overall Study|Personal Reason|25|||
144235462|NCT01683266|520058592|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
144235463|NCT01683266|520058593|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
144235464|NCT01683266|520058592|FG000|Overall Study|Lost to Follow-up|5|||
144235465|NCT01683266|520058593|FG001|Overall Study|Lost to Follow-up|0|||
144235466|NCT01683266|520058592|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
144235467|NCT01683266|520058593|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
144235468|NCT01683266|520058592|FG000|Overall Study|Nonserious Hypoglycemia|0|||
144235469|NCT01683266|520058593|FG001|Overall Study|Nonserious Hypoglycemia|3|||
144235470|NCT01683266|520058592|FG000|Overall Study|Perceived Lack of Efficacy|1|||
144235471|NCT01683266|520058593|FG001|Overall Study|Perceived Lack of Efficacy|1|||
144235472|NCT01683266|520058592|FG000|Overall Study|Possibly Hypoglycemia|1|||
144235473|NCT01683266|520058593|FG001|Overall Study|Possibly Hypoglycemia|0|||
144235474|NCT01683266|520058592|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
144235475|NCT01683266|520058593|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
144235476|NCT01062113|520058598|FG000|Overall Study|Adverse Event|1|||
144235477|NCT01062113|520058599|FG001|Overall Study|Adverse Event|0|||
144235478|NCT01062113|520058600|FG002|Overall Study|Adverse Event|0|||
144235479|NCT01062113|520058598|FG000|Overall Study|Lack of Efficacy|38|||
144235480|NCT01062113|520058599|FG001|Overall Study|Lack of Efficacy|22|||
144235481|NCT01062113|520058600|FG002|Overall Study|Lack of Efficacy|31|||
144235482|NCT01062113|520058598|FG000|Overall Study|Withdrawal by Subject|1|||
144235483|NCT01062113|520058599|FG001|Overall Study|Withdrawal by Subject|0|||
144235484|NCT01062113|520058600|FG002|Overall Study|Withdrawal by Subject|0|||
144235485|NCT00526669|520058601|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
144235486|NCT00526669|520058602|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
144235487|NCT00526669|520058601|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
144235488|NCT00526669|520058602|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
144235489|NCT00526669|520058601|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
144235490|NCT00526669|520058602|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
144235491|NCT00526669|520058601|FG000|Combined Treatment Phase|Death|0|||
144235492|NCT00526669|520058602|FG001|Combined Treatment Phase|Death|2|||
144235493|NCT01981954|520058608|FG000|Titration Period|Protocol Deviation|1|||
144235494|NCT01981954|520058608|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
144235495|NCT03655470|520058611|FG000|Overall Study|Lost to Follow-up|6|||
144235496|NCT03655470|520058612|FG001|Overall Study|Lost to Follow-up|7|||
144235497|NCT01893281|520058620|FG000|Overall Study|Adverse Event|1|||
144235498|NCT01893281|520058620|FG000|Overall Study|Protocol Violation|1|||
144235499|NCT01893281|520058620|FG000|Overall Study|Withdrawal by Subject|1|||
144235500|NCT05481125|520058623|FG000|Overall Study|Adverse Event|1|||
144235501|NCT05481125|520058624|FG001|Overall Study|Adverse Event|0|||
144235502|NCT05481125|520058623|FG000|Overall Study|Lost to Follow-up|0|||
144235503|NCT05481125|520058624|FG001|Overall Study|Lost to Follow-up|1|||
144235504|NCT05481125|520058623|FG000|Overall Study|Withdrawal by Subject|0|||
144235505|NCT05481125|520058624|FG001|Overall Study|Withdrawal by Subject|1|||
144235506|NCT02244463|520058625|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
144235507|NCT02244463|520058626|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
144235508|NCT02244463|520058627|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
144235509|NCT02244463|520058628|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
144235510|NCT02244463|520058629|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
144235511|NCT02244463|520058630|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
144235512|NCT02244463|520058625|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
144235513|NCT02244463|520058626|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
144235514|NCT02244463|520058627|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
144235515|NCT02244463|520058628|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
144235516|NCT02244463|520058629|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
144235517|NCT02244463|520058630|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
144235518|NCT02244463|520058625|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
144235519|NCT02244463|520058626|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
144235520|NCT02244463|520058627|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
144269797|NCT00794664|520191423|FG001|Treatment Period|Adverse Event|8|||
144269798|NCT00794664|520191422|FG000|Follow-up Period|Other|1|||
144269799|NCT00794664|520191423|FG001|Follow-up Period|Other|2|||
144269800|NCT00794664|520191422|FG000|Follow-up Period|Withdrawal by Subject|0|||
144269801|NCT00794664|520191423|FG001|Follow-up Period|Withdrawal by Subject|2|||
144269802|NCT00794664|520191422|FG000|Follow-up Period|Protocol non-compliance|0|||
144235521|NCT02244463|520058628|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
144235522|NCT02244463|520058629|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
144235523|NCT02244463|520058630|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
144235524|NCT02244463|520058625|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
144235525|NCT02244463|520058626|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
144235526|NCT02244463|520058627|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
144235527|NCT02244463|520058628|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
144235528|NCT02244463|520058629|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
144235529|NCT02244463|520058630|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
144235530|NCT02244463|520058625|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
144235531|NCT02244463|520058626|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
144235532|NCT02244463|520058627|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
144235533|NCT02244463|520058628|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
144235534|NCT02244463|520058629|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
144235535|NCT02244463|520058630|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
144235536|NCT02244463|520058625|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
144235537|NCT02244463|520058626|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
144235538|NCT02244463|520058627|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
144235539|NCT02244463|520058628|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
144235540|NCT02244463|520058629|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
144235541|NCT02244463|520058630|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
144235542|NCT02244463|520058625|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
144235543|NCT02244463|520058626|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
144235544|NCT02244463|520058627|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
144235545|NCT02244463|520058628|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
144235546|NCT02244463|520058629|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
144235547|NCT02244463|520058630|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
144235548|NCT02244463|520058625|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
144235549|NCT02244463|520058626|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
144235550|NCT02244463|520058627|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
144235551|NCT02244463|520058628|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
144235552|NCT02244463|520058629|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
144235553|NCT02244463|520058630|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
144235554|NCT02244463|520058625|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
144235555|NCT02244463|520058626|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
144235556|NCT02244463|520058627|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
144235557|NCT02244463|520058628|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
144235558|NCT02244463|520058629|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
144235559|NCT02244463|520058630|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
144235560|NCT02244463|520058625|FG000|Period 5: Phase II|Disease Progression|0|||
144235561|NCT02244463|520058626|FG001|Period 5: Phase II|Disease Progression|0|||
144235562|NCT02244463|520058627|FG002|Period 5: Phase II|Disease Progression|0|||
144235563|NCT02244463|520058628|FG003|Period 5: Phase II|Disease Progression|0|||
144235564|NCT02244463|520058629|FG004|Period 5: Phase II|Disease Progression|10|||
144235565|NCT02244463|520058630|FG005|Period 5: Phase II|Disease Progression|11|||
144235566|NCT02244463|520058625|FG000|Period 5: Phase II|Physician Decision|0|||
144235567|NCT02244463|520058626|FG001|Period 5: Phase II|Physician Decision|0|||
144235568|NCT02244463|520058627|FG002|Period 5: Phase II|Physician Decision|0|||
144235569|NCT02244463|520058628|FG003|Period 5: Phase II|Physician Decision|0|||
144235570|NCT02244463|520058629|FG004|Period 5: Phase II|Physician Decision|3|||
144235571|NCT02244463|520058630|FG005|Period 5: Phase II|Physician Decision|2|||
144235572|NCT02244463|520058625|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
144235573|NCT02244463|520058626|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
144235574|NCT02244463|520058627|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
144235575|NCT02244463|520058628|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
144235576|NCT02244463|520058629|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
144235577|NCT02244463|520058630|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
144235578|NCT02244463|520058625|FG000|Period 5: Phase II|Intercurrent Illness|0|||
144235579|NCT02244463|520058626|FG001|Period 5: Phase II|Intercurrent Illness|0|||
144235580|NCT02244463|520058627|FG002|Period 5: Phase II|Intercurrent Illness|0|||
144235581|NCT02244463|520058628|FG003|Period 5: Phase II|Intercurrent Illness|0|||
144235582|NCT02244463|520058629|FG004|Period 5: Phase II|Intercurrent Illness|2|||
144235583|NCT02244463|520058630|FG005|Period 5: Phase II|Intercurrent Illness|0|||
144235584|NCT02244463|520058625|FG000|Period 5: Phase II|Adverse Event|0|||
144235585|NCT02244463|520058626|FG001|Period 5: Phase II|Adverse Event|0|||
144235586|NCT02244463|520058627|FG002|Period 5: Phase II|Adverse Event|0|||
144235587|NCT02244463|520058628|FG003|Period 5: Phase II|Adverse Event|0|||
144235588|NCT02244463|520058629|FG004|Period 5: Phase II|Adverse Event|0|||
144235589|NCT02244463|520058630|FG005|Period 5: Phase II|Adverse Event|2|||
144235590|NCT02244463|520058625|FG000|Period 5: Phase II|Still On treatment|0|||
144235591|NCT02244463|520058626|FG001|Period 5: Phase II|Still On treatment|0|||
144235592|NCT02244463|520058627|FG002|Period 5: Phase II|Still On treatment|0|||
144235593|NCT02244463|520058628|FG003|Period 5: Phase II|Still On treatment|0|||
144235594|NCT02244463|520058629|FG004|Period 5: Phase II|Still On treatment|0|||
144235595|NCT02244463|520058630|FG005|Period 5: Phase II|Still On treatment|3|||
144235596|NCT01769508|520058631|FG000|Overall Study|Death|3|||
144235597|NCT01769508|520058631|FG000|Overall Study|Withdrawal by Subject|1|||
144235598|NCT01769508|520058631|FG000|Overall Study|Adverse Event|1|||
144235599|NCT01769508|520058631|FG000|Overall Study|Lost to Follow-up|1|||
144235600|NCT03615144|520058635|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
144235601|NCT03615144|520058636|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
144235602|NCT01355575|520058640|FG000|Overall Study|Withdrawal by Subject|2|||
144235603|NCT00552396|520058648|FG000|Overall Study|protocol withdrawal criteria|3|||
144235604|NCT00552396|520058649|FG001|Overall Study|protocol withdrawal criteria|3|||
144235605|NCT00552396|520058650|FG002|Overall Study|protocol withdrawal criteria|3|||
144235606|NCT00552396|520058651|FG003|Overall Study|protocol withdrawal criteria|6|||
144235607|NCT00552396|520058652|FG004|Overall Study|protocol withdrawal criteria|3|||
144235608|NCT00552396|520058653|FG005|Overall Study|protocol withdrawal criteria|3|||
144235609|NCT00552396|520058654|FG006|Overall Study|protocol withdrawal criteria|9|||
144235610|NCT02553499|520058657|FG000|Overall Study|Adverse Event|0|||
144235611|NCT02553499|520058658|FG001|Overall Study|Adverse Event|0|||
144235612|NCT02553499|520058659|FG002|Overall Study|Adverse Event|0|||
144235613|NCT02553499|520058660|FG003|Overall Study|Adverse Event|0|||
144235614|NCT02553499|520058661|FG004|Overall Study|Adverse Event|0|||
144235615|NCT02553499|520058662|FG005|Overall Study|Adverse Event|0|||
144235616|NCT02553499|520058663|FG006|Overall Study|Adverse Event|1|||
144235617|NCT02553499|520058664|FG007|Overall Study|Adverse Event|1|||
144235618|NCT02553499|520058665|FG008|Overall Study|Adverse Event|0|||
144235619|NCT02553499|520058666|FG009|Overall Study|Adverse Event|0|||
144235620|NCT02553499|520058667|FG010|Overall Study|Adverse Event|0|||
144235621|NCT02553499|520058668|FG011|Overall Study|Adverse Event|0|||
144235622|NCT02553499|520058669|FG012|Overall Study|Adverse Event|0|||
144235623|NCT02553499|520058670|FG013|Overall Study|Adverse Event|1|||
144235624|NCT02553499|520058657|FG000|Overall Study|Death|0|||
144235625|NCT02553499|520058658|FG001|Overall Study|Death|1|||
144235626|NCT02553499|520058659|FG002|Overall Study|Death|1|||
144235627|NCT02553499|520058660|FG003|Overall Study|Death|0|||
144235628|NCT02553499|520058661|FG004|Overall Study|Death|1|||
144235629|NCT02553499|520058662|FG005|Overall Study|Death|2|||
144235630|NCT02553499|520058663|FG006|Overall Study|Death|0|||
144235631|NCT02553499|520058664|FG007|Overall Study|Death|0|||
144235632|NCT02553499|520058665|FG008|Overall Study|Death|0|||
144235633|NCT02553499|520058666|FG009|Overall Study|Death|0|||
144235634|NCT02553499|520058667|FG010|Overall Study|Death|1|||
144235635|NCT02553499|520058668|FG011|Overall Study|Death|0|||
144235636|NCT02553499|520058669|FG012|Overall Study|Death|0|||
144235637|NCT02553499|520058670|FG013|Overall Study|Death|0|||
144235638|NCT02553499|520058657|FG000|Overall Study|Lost to Follow-up|0|||
144235639|NCT02553499|520058658|FG001|Overall Study|Lost to Follow-up|0|||
144235640|NCT02553499|520058659|FG002|Overall Study|Lost to Follow-up|0|||
144235641|NCT02553499|520058660|FG003|Overall Study|Lost to Follow-up|0|||
144235642|NCT02553499|520058661|FG004|Overall Study|Lost to Follow-up|0|||
144235643|NCT02553499|520058662|FG005|Overall Study|Lost to Follow-up|0|||
144235644|NCT02553499|520058663|FG006|Overall Study|Lost to Follow-up|1|||
144235645|NCT02553499|520058664|FG007|Overall Study|Lost to Follow-up|0|||
144235646|NCT02553499|520058665|FG008|Overall Study|Lost to Follow-up|0|||
144235647|NCT02553499|520058666|FG009|Overall Study|Lost to Follow-up|0|||
144235648|NCT02553499|520058667|FG010|Overall Study|Lost to Follow-up|0|||
144235649|NCT02553499|520058668|FG011|Overall Study|Lost to Follow-up|0|||
144235650|NCT02553499|520058669|FG012|Overall Study|Lost to Follow-up|0|||
144269803|NCT00794664|520191423|FG001|Follow-up Period|Protocol non-compliance|1|||
144235651|NCT02553499|520058670|FG013|Overall Study|Lost to Follow-up|0|||
144235652|NCT02553499|520058657|FG000|Overall Study|Physician Decision|0|||
144235653|NCT02553499|520058658|FG001|Overall Study|Physician Decision|1|||
144235654|NCT02553499|520058659|FG002|Overall Study|Physician Decision|1|||
144235655|NCT02553499|520058660|FG003|Overall Study|Physician Decision|0|||
144235656|NCT02553499|520058661|FG004|Overall Study|Physician Decision|1|||
144235657|NCT02553499|520058662|FG005|Overall Study|Physician Decision|0|||
144235658|NCT02553499|520058663|FG006|Overall Study|Physician Decision|0|||
144235659|NCT02553499|520058664|FG007|Overall Study|Physician Decision|1|||
144235660|NCT02553499|520058665|FG008|Overall Study|Physician Decision|1|||
144235661|NCT02553499|520058666|FG009|Overall Study|Physician Decision|2|||
144235662|NCT02553499|520058667|FG010|Overall Study|Physician Decision|1|||
144235663|NCT02553499|520058668|FG011|Overall Study|Physician Decision|3|||
144235664|NCT02553499|520058669|FG012|Overall Study|Physician Decision|1|||
144235665|NCT02553499|520058670|FG013|Overall Study|Physician Decision|0|||
144235666|NCT02553499|520058657|FG000|Overall Study|Progressive Disease|0|||
144235667|NCT02553499|520058658|FG001|Overall Study|Progressive Disease|0|||
144235668|NCT02553499|520058659|FG002|Overall Study|Progressive Disease|0|||
144235669|NCT02553499|520058660|FG003|Overall Study|Progressive Disease|2|||
144235670|NCT02553499|520058661|FG004|Overall Study|Progressive Disease|1|||
144235671|NCT02553499|520058662|FG005|Overall Study|Progressive Disease|1|||
144235672|NCT02553499|520058663|FG006|Overall Study|Progressive Disease|1|||
144235673|NCT02553499|520058664|FG007|Overall Study|Progressive Disease|0|||
144235674|NCT02553499|520058665|FG008|Overall Study|Progressive Disease|0|||
144235675|NCT02553499|520058666|FG009|Overall Study|Progressive Disease|1|||
144235676|NCT02553499|520058667|FG010|Overall Study|Progressive Disease|0|||
144235677|NCT02553499|520058668|FG011|Overall Study|Progressive Disease|0|||
144235678|NCT02553499|520058669|FG012|Overall Study|Progressive Disease|2|||
144235679|NCT02553499|520058670|FG013|Overall Study|Progressive Disease|1|||
144235680|NCT02553499|520058657|FG000|Overall Study|Study Terminated by Sponsor|0|||
144235681|NCT02553499|520058658|FG001|Overall Study|Study Terminated by Sponsor|0|||
144235682|NCT02553499|520058659|FG002|Overall Study|Study Terminated by Sponsor|0|||
144235683|NCT02553499|520058660|FG003|Overall Study|Study Terminated by Sponsor|0|||
144235684|NCT02553499|520058661|FG004|Overall Study|Study Terminated by Sponsor|0|||
144235685|NCT02553499|520058662|FG005|Overall Study|Study Terminated by Sponsor|0|||
144235686|NCT02553499|520058663|FG006|Overall Study|Study Terminated by Sponsor|0|||
144235687|NCT02553499|520058664|FG007|Overall Study|Study Terminated by Sponsor|0|||
144235688|NCT02553499|520058665|FG008|Overall Study|Study Terminated by Sponsor|1|||
144235689|NCT02553499|520058666|FG009|Overall Study|Study Terminated by Sponsor|0|||
144235690|NCT02553499|520058667|FG010|Overall Study|Study Terminated by Sponsor|0|||
144235691|NCT02553499|520058668|FG011|Overall Study|Study Terminated by Sponsor|0|||
144235692|NCT02553499|520058669|FG012|Overall Study|Study Terminated by Sponsor|0|||
144235693|NCT02553499|520058670|FG013|Overall Study|Study Terminated by Sponsor|0|||
144235694|NCT02553499|520058657|FG000|Overall Study|Withdrawal by Subject|2|||
144235695|NCT02553499|520058658|FG001|Overall Study|Withdrawal by Subject|0|||
144235696|NCT02553499|520058659|FG002|Overall Study|Withdrawal by Subject|0|||
144235697|NCT02553499|520058660|FG003|Overall Study|Withdrawal by Subject|0|||
144235698|NCT02553499|520058661|FG004|Overall Study|Withdrawal by Subject|0|||
144235699|NCT02553499|520058662|FG005|Overall Study|Withdrawal by Subject|0|||
144235700|NCT02553499|520058663|FG006|Overall Study|Withdrawal by Subject|0|||
144235701|NCT02553499|520058664|FG007|Overall Study|Withdrawal by Subject|1|||
144235702|NCT02553499|520058665|FG008|Overall Study|Withdrawal by Subject|1|||
144235703|NCT02553499|520058666|FG009|Overall Study|Withdrawal by Subject|0|||
144235704|NCT02553499|520058667|FG010|Overall Study|Withdrawal by Subject|1|||
144235705|NCT02553499|520058668|FG011|Overall Study|Withdrawal by Subject|0|||
144235706|NCT02553499|520058669|FG012|Overall Study|Withdrawal by Subject|0|||
144235707|NCT02553499|520058670|FG013|Overall Study|Withdrawal by Subject|0|||
144235708|NCT01726270|520058671|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
144235709|NCT01726270|520058671|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
144235710|NCT01726270|520058671|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
144235711|NCT01726270|520058671|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
144235712|NCT01726270|520058671|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
144235713|NCT01726270|520058671|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
144235714|NCT00582608|520058673|FG000|Overall Study|Not Treated|7|||
144235715|NCT00582608|520058673|FG000|Overall Study|Patient Ineligible|1|||
144235716|NCT00582608|520058673|FG000|Overall Study|Lack of accrual|4|||
144235717|NCT04152837|520058676|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
144269804|NCT01677741|520191424|FG000|Overall Study|Death|0|||
144235718|NCT04152837|520058676|FG000|Maintenance Period|Adverse Event|1|||
144235719|NCT04152837|520058676|FG000|Maintenance Period|Withdrawal by Subject|1|||
144235720|NCT04152837|520058676|FG000|Maintenance Period|Sponsor Termination of Study|2|||
144235721|NCT00586820|520058677|FG000|Overall Study|Unsuccessful PCI|1|||
144235722|NCT00586820|520058678|FG001|Overall Study|Unsuccessful PCI|0|||
144235723|NCT00101166|520058679|FG000|Overall Study|progressive disease|10|||
144235724|NCT00686829|520058680|FG000|Overall Study|Adverse Event|5|||
144235725|NCT00686829|520058680|FG000|Overall Study|Lack of Efficacy|6|||
144235726|NCT00686829|520058680|FG000|Overall Study|Lost to Follow-up|4|||
144235727|NCT00686829|520058680|FG000|Overall Study|Withdrawal by Subject|14|||
144235728|NCT00686829|520058680|FG000|Overall Study|Protocol Violation|3|||
144235729|NCT00686829|520058680|FG000|Overall Study|Sponsor discontinued VCV|47|||
144269805|NCT01677741|520191425|FG001|Overall Study|Death|0|||
144235730|NCT01827267|520058681|FG000|Overall Study|Did not receive study drug|1|||
144235731|NCT01827267|520058682|FG001|Overall Study|Did not receive study drug|1|||
144235732|NCT01827267|520058681|FG000|Overall Study|Physician Decision|1|||
144235733|NCT01827267|520058682|FG001|Overall Study|Physician Decision|0|||
144235734|NCT01827267|520058681|FG000|Overall Study|Disease Progression|1|||
144235735|NCT01827267|520058682|FG001|Overall Study|Disease Progression|1|||
144235736|NCT01827267|520058681|FG000|Overall Study|Sponsor Discontinued Study|2|||
144235737|NCT01827267|520058682|FG001|Overall Study|Sponsor Discontinued Study|8|||
144235738|NCT01827267|520058681|FG000|Overall Study|Still on study|0|||
144235739|NCT01827267|520058682|FG001|Overall Study|Still on study|2|||
144235740|NCT01732640|520058683|FG000|Overall Study|Adverse Event|0|||
144235741|NCT01732640|520058684|FG001|Overall Study|Adverse Event|1|||
144235742|NCT01732640|520058683|FG000|Overall Study|Death|0|||
144235743|NCT01732640|520058684|FG001|Overall Study|Death|1|||
144235744|NCT03070002|520058687|FG000|Follow up for 2 Years|Death|1|||
144235745|NCT00712543|520058690|FG000|Day 8-14|Lost to Follow-up|0|||
144235746|NCT00712543|520058691|FG001|Day 8-14|Lost to Follow-up|2|||
144235747|NCT04740827|520058701|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
144235748|NCT04740827|520058702|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
144235749|NCT04740827|520058701|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
144235750|NCT04740827|520058702|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
144235751|NCT04740827|520058701|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
144235752|NCT04740827|520058702|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
144235753|NCT04740827|520058701|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
144235754|NCT04740827|520058702|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
144235755|NCT04740827|520058701|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
144235756|NCT04740827|520058702|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
144235757|NCT04740827|520058701|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
144235758|NCT04740827|520058702|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
144235759|NCT02147158|520058703|FG000|Treatment Course 1|Adverse Event|1|||
144235760|NCT02147158|520058704|FG001|Treatment Course 1|Adverse Event|4|||
144235761|NCT02147158|520058705|FG002|Treatment Course 1|Adverse Event|3|||
144235762|NCT02147158|520058706|FG003|Treatment Course 1|Adverse Event|4|||
144235763|NCT02147158|520058707|FG004|Treatment Course 1|Adverse Event|1|||
144235764|NCT02147158|520058708|FG005|Treatment Course 1|Adverse Event|2|||
144235765|NCT02147158|520058703|FG000|Treatment Course 1|Lost to Follow-up|2|||
144235766|NCT02147158|520058704|FG001|Treatment Course 1|Lost to Follow-up|4|||
144235767|NCT02147158|520058705|FG002|Treatment Course 1|Lost to Follow-up|3|||
144235768|NCT02147158|520058706|FG003|Treatment Course 1|Lost to Follow-up|3|||
144235769|NCT02147158|520058707|FG004|Treatment Course 1|Lost to Follow-up|2|||
144235770|NCT02147158|520058708|FG005|Treatment Course 1|Lost to Follow-up|4|||
144235771|NCT02147158|520058703|FG000|Treatment Course 1|Protocol Violation|0|||
144235772|NCT02147158|520058704|FG001|Treatment Course 1|Protocol Violation|0|||
144235773|NCT02147158|520058705|FG002|Treatment Course 1|Protocol Violation|1|||
144235774|NCT02147158|520058706|FG003|Treatment Course 1|Protocol Violation|1|||
144235775|NCT02147158|520058707|FG004|Treatment Course 1|Protocol Violation|0|||
144235776|NCT02147158|520058708|FG005|Treatment Course 1|Protocol Violation|0|||
144235777|NCT02147158|520058703|FG000|Treatment Course 1|Withdrawal of Consent|1|||
144235778|NCT02147158|520058704|FG001|Treatment Course 1|Withdrawal of Consent|1|||
144235779|NCT02147158|520058705|FG002|Treatment Course 1|Withdrawal of Consent|1|||
144235780|NCT02147158|520058706|FG003|Treatment Course 1|Withdrawal of Consent|5|||
144235781|NCT02147158|520058707|FG004|Treatment Course 1|Withdrawal of Consent|3|||
144235782|NCT02147158|520058708|FG005|Treatment Course 1|Withdrawal of Consent|2|||
144235783|NCT02147158|520058703|FG000|Off-Treatment Interval 1|Adverse Event|1|||
144235784|NCT02147158|520058704|FG001|Off-Treatment Interval 1|Adverse Event|0|||
144235785|NCT02147158|520058705|FG002|Off-Treatment Interval 1|Adverse Event|0|||
144235786|NCT02147158|520058706|FG003|Off-Treatment Interval 1|Adverse Event|1|||
144235787|NCT02147158|520058707|FG004|Off-Treatment Interval 1|Adverse Event|0|||
144235788|NCT02147158|520058708|FG005|Off-Treatment Interval 1|Adverse Event|0|||
144235789|NCT02147158|520058703|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
144235790|NCT02147158|520058704|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
144235791|NCT02147158|520058705|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
144235792|NCT02147158|520058706|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
144235793|NCT02147158|520058707|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
144235794|NCT02147158|520058708|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
144235795|NCT02147158|520058703|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
144235796|NCT02147158|520058704|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
144235797|NCT02147158|520058705|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
144235798|NCT02147158|520058706|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
144235799|NCT02147158|520058707|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
144235800|NCT02147158|520058708|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
144235801|NCT02147158|520058703|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
144235802|NCT02147158|520058704|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
144235803|NCT02147158|520058705|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
144235804|NCT02147158|520058706|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
144235805|NCT02147158|520058707|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
144235806|NCT02147158|520058708|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
144235807|NCT02147158|520058703|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
144235808|NCT02147158|520058704|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
144235809|NCT02147158|520058705|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
144235810|NCT02147158|520058706|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
144235811|NCT02147158|520058707|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
144235812|NCT02147158|520058708|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
144235813|NCT02147158|520058703|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
144235814|NCT02147158|520058704|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
144235815|NCT02147158|520058705|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
144235816|NCT02147158|520058706|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
144235817|NCT02147158|520058707|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
144235818|NCT02147158|520058708|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
144235819|NCT02147158|520058703|FG000|Treatment Course 2|Adverse Event|0|||
144235820|NCT02147158|520058704|FG001|Treatment Course 2|Adverse Event|4|||
144235821|NCT02147158|520058705|FG002|Treatment Course 2|Adverse Event|2|||
144235822|NCT02147158|520058706|FG003|Treatment Course 2|Adverse Event|1|||
144235823|NCT02147158|520058707|FG004|Treatment Course 2|Adverse Event|0|||
144235824|NCT02147158|520058708|FG005|Treatment Course 2|Adverse Event|1|||
144235825|NCT02147158|520058703|FG000|Treatment Course 2|Withdrawal of Consent|0|||
144235826|NCT02147158|520058704|FG001|Treatment Course 2|Withdrawal of Consent|1|||
144235827|NCT02147158|520058705|FG002|Treatment Course 2|Withdrawal of Consent|2|||
144235828|NCT02147158|520058706|FG003|Treatment Course 2|Withdrawal of Consent|3|||
144235829|NCT02147158|520058707|FG004|Treatment Course 2|Withdrawal of Consent|0|||
144235830|NCT02147158|520058708|FG005|Treatment Course 2|Withdrawal of Consent|0|||
144235831|NCT02147158|520058703|FG000|Treatment Course 2|Lost to Follow-up|1|||
144235832|NCT02147158|520058704|FG001|Treatment Course 2|Lost to Follow-up|0|||
144235833|NCT02147158|520058705|FG002|Treatment Course 2|Lost to Follow-up|1|||
144235834|NCT02147158|520058706|FG003|Treatment Course 2|Lost to Follow-up|1|||
144235835|NCT02147158|520058707|FG004|Treatment Course 2|Lost to Follow-up|0|||
144235836|NCT02147158|520058708|FG005|Treatment Course 2|Lost to Follow-up|1|||
144235837|NCT02147158|520058703|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
144235838|NCT02147158|520058704|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
144235839|NCT02147158|520058705|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
144235840|NCT02147158|520058706|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
144235841|NCT02147158|520058707|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
144235842|NCT02147158|520058708|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
144235843|NCT02147158|520058703|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
144235844|NCT02147158|520058704|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
144235845|NCT02147158|520058705|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
144235846|NCT02147158|520058706|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
144235847|NCT02147158|520058707|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
144235848|NCT02147158|520058708|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
144235849|NCT02147158|520058703|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
144235850|NCT02147158|520058704|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
144235851|NCT02147158|520058705|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
144235852|NCT02147158|520058706|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
144235853|NCT02147158|520058707|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
144235854|NCT02147158|520058708|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
144235855|NCT02147158|520058703|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
144235856|NCT02147158|520058704|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
144235857|NCT02147158|520058705|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
144235858|NCT02147158|520058706|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
144235859|NCT02147158|520058707|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
144235860|NCT02147158|520058708|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
144235861|NCT02147158|520058703|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
144235862|NCT02147158|520058704|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
144235863|NCT02147158|520058705|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
144235864|NCT02147158|520058706|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
144235865|NCT02147158|520058707|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
144235866|NCT02147158|520058708|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
144235867|NCT04520997|520058710|FG000|Overall Study|Lost to Follow-up|1|||
144235868|NCT04520997|520058711|FG001|Overall Study|Lost to Follow-up|1|||
144235869|NCT04520997|520058710|FG000|Overall Study|Withdrawal by Subject|1|||
144235870|NCT04520997|520058711|FG001|Overall Study|Withdrawal by Subject|0|||
144235871|NCT04520997|520058710|FG000|Overall Study|Not Treated|0|||
144235872|NCT04520997|520058711|FG001|Overall Study|Not Treated|1|||
144235873|NCT02981082|520058714|FG000|Overall Study|Withdrawal by Subject|2|||
144235874|NCT02981082|520058715|FG001|Overall Study|Withdrawal by Subject|0|||
144235875|NCT02981082|520058714|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
144235876|NCT02981082|520058715|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
144235877|NCT02981082|520058714|FG000|Overall Study|Adverse Event|0|||
144235878|NCT02981082|520058715|FG001|Overall Study|Adverse Event|1|||
144235879|NCT03689374|520058716|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
144235880|NCT03689374|520058717|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
144235881|NCT03689374|520058718|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
144235882|NCT03689374|520058716|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
144235883|NCT03689374|520058717|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
144235884|NCT03689374|520058718|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
144235885|NCT03689374|520058716|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
144235886|NCT03689374|520058717|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
144235887|NCT03689374|520058718|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
144235888|NCT03689374|520058716|FG000|Treatment Period (Week 0 to 52)|Death|0|||
144235889|NCT03689374|520058717|FG001|Treatment Period (Week 0 to 52)|Death|11|||
144235890|NCT03689374|520058718|FG002|Treatment Period (Week 0 to 52)|Death|1|||
144235891|NCT05367973|520058719|FG000|Overall Study|Adverse Event|0|||
144235892|NCT05367973|520058720|FG001|Overall Study|Adverse Event|2|||
144235893|NCT01082211|520058721|FG000|Overall Study|Protocol Violation|4|||
144235894|NCT01082211|520058721|FG000|Overall Study|No protocol treatment received|3|||
144235895|NCT01806961|520060207|FG000|Overall Study|sponsor decision|16|||
144235896|NCT00769067|520060208|FG000|Overall Study|Death|89|||
144235897|NCT00769067|520060209|FG001|Overall Study|Death|86|||
144235898|NCT00769067|520060208|FG000|Overall Study|Lost to Follow-up|3|||
144235899|NCT00769067|520060209|FG001|Overall Study|Lost to Follow-up|1|||
144235900|NCT00769067|520060208|FG000|Overall Study|Study terminated by sponsor|1|||
144235901|NCT00769067|520060209|FG001|Overall Study|Study terminated by sponsor|3|||
144235902|NCT00769067|520060208|FG000|Overall Study|Other|1|||
144235903|NCT00769067|520060209|FG001|Overall Study|Other|3|||
144235904|NCT00769067|520060208|FG000|Overall Study|Withdrawal by Subject|0|||
144235905|NCT00769067|520060209|FG001|Overall Study|Withdrawal by Subject|1|||
144235906|NCT00972816|520060212|FG000|Overall Study|Adverse Event|0|||
144235907|NCT00972816|520060213|FG001|Overall Study|Adverse Event|0|||
144235908|NCT00972816|520060214|FG002|Overall Study|Adverse Event|1|||
144235909|NCT00972816|520060215|FG003|Overall Study|Adverse Event|0|||
144235910|NCT00972816|520060216|FG004|Overall Study|Adverse Event|0|||
144235911|NCT00972816|520060217|FG005|Overall Study|Adverse Event|0|||
144235912|NCT00972816|520060218|FG006|Overall Study|Adverse Event|0|||
144235913|NCT00972816|520060219|FG007|Overall Study|Adverse Event|0|||
144235914|NCT00972816|520060212|FG000|Overall Study|Withdrawal by Subject|4|||
144235915|NCT00972816|520060213|FG001|Overall Study|Withdrawal by Subject|2|||
144235916|NCT00972816|520060214|FG002|Overall Study|Withdrawal by Subject|1|||
144235917|NCT00972816|520060215|FG003|Overall Study|Withdrawal by Subject|3|||
144235918|NCT00972816|520060216|FG004|Overall Study|Withdrawal by Subject|0|||
144235919|NCT00972816|520060217|FG005|Overall Study|Withdrawal by Subject|1|||
144235920|NCT00972816|520060218|FG006|Overall Study|Withdrawal by Subject|1|||
144235921|NCT00972816|520060219|FG007|Overall Study|Withdrawal by Subject|2|||
144235922|NCT00972816|520060212|FG000|Overall Study|Lost to Follow-up|11|||
144235923|NCT00972816|520060213|FG001|Overall Study|Lost to Follow-up|9|||
144235924|NCT00972816|520060214|FG002|Overall Study|Lost to Follow-up|7|||
144235925|NCT00972816|520060215|FG003|Overall Study|Lost to Follow-up|5|||
144235926|NCT00972816|520060216|FG004|Overall Study|Lost to Follow-up|11|||
144235927|NCT00972816|520060217|FG005|Overall Study|Lost to Follow-up|10|||
144235928|NCT00972816|520060218|FG006|Overall Study|Lost to Follow-up|7|||
144235929|NCT00972816|520060219|FG007|Overall Study|Lost to Follow-up|7|||
144235930|NCT00972816|520060212|FG000|Overall Study|Inappropriate enrolment|0|||
144235931|NCT00972816|520060213|FG001|Overall Study|Inappropriate enrolment|0|||
144235932|NCT00972816|520060214|FG002|Overall Study|Inappropriate enrolment|0|||
144235933|NCT00972816|520060215|FG003|Overall Study|Inappropriate enrolment|0|||
144235934|NCT00972816|520060216|FG004|Overall Study|Inappropriate enrolment|0|||
144235935|NCT00972816|520060217|FG005|Overall Study|Inappropriate enrolment|0|||
144235936|NCT00972816|520060218|FG006|Overall Study|Inappropriate enrolment|2|||
144235937|NCT00972816|520060219|FG007|Overall Study|Inappropriate enrolment|0|||
144235938|NCT00972816|520060212|FG000|Overall Study|Unable to classify|2|||
144235939|NCT00972816|520060213|FG001|Overall Study|Unable to classify|0|||
144235940|NCT00972816|520060214|FG002|Overall Study|Unable to classify|0|||
144235941|NCT00972816|520060215|FG003|Overall Study|Unable to classify|0|||
144235942|NCT00972816|520060216|FG004|Overall Study|Unable to classify|1|||
144235943|NCT00972816|520060217|FG005|Overall Study|Unable to classify|0|||
144235944|NCT00972816|520060218|FG006|Overall Study|Unable to classify|0|||
144235945|NCT00972816|520060219|FG007|Overall Study|Unable to classify|0|||
144235946|NCT00593684|520060222|FG000|Overall Study|Death|2|||
144235947|NCT00593684|520060223|FG001|Overall Study|Death|1|||
144235948|NCT03625466|520060224|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
144235949|NCT03625466|520060225|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
144269806|NCT01677741|520191426|FG002|Overall Study|Death|0|||
144235950|NCT03625466|520060226|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
144235951|NCT03625466|520060224|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
144235952|NCT03625466|520060225|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
144235953|NCT03625466|520060226|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
144235954|NCT03625466|520060224|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
144235955|NCT03625466|520060225|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
144235956|NCT03625466|520060226|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
144235957|NCT00831311|520060228|FG000|Overall Study|Definitive Contraindication|3|||
144235958|NCT00831311|520060229|FG001|Overall Study|Definitive Contraindication|3|||
144235959|NCT00831311|520060228|FG000|Overall Study|Lost to Follow-up|3|||
144235960|NCT00831311|520060229|FG001|Overall Study|Lost to Follow-up|0|||
144235961|NCT00831311|520060228|FG000|Overall Study|Physician Decision|0|||
144235962|NCT00831311|520060229|FG001|Overall Study|Physician Decision|1|||
144235963|NCT00831311|520060228|FG000|Overall Study|Withdrawal by Subject|6|||
144235964|NCT00831311|520060229|FG001|Overall Study|Withdrawal by Subject|4|||
144235965|NCT00160706|520060235|FG000|Overall Study|Adverse Event|53|||
144235966|NCT00160706|520060235|FG000|Overall Study|Adverse Event and Other Reason|105|||
144235967|NCT00160706|520060235|FG000|Overall Study|Protocol Violation|3|||
144235968|NCT00160706|520060235|FG000|Overall Study|Withdrawal by Subject|41|||
144235969|NCT00160706|520060235|FG000|Overall Study|Withdrawal by Subject and Other|12|||
144235970|NCT00160706|520060235|FG000|Overall Study|Physician Decision|10|||
144235971|NCT00160706|520060235|FG000|Overall Study|Physician Decision and Other|3|||
144235972|NCT00160706|520060235|FG000|Overall Study|Lost to Follow-up|4|||
144235973|NCT00160706|520060235|FG000|Overall Study|Lost to Follow-up and Other|1|||
144235974|NCT00160706|520060235|FG000|Overall Study|Lack of Efficacy|42|||
144235975|NCT00160706|520060235|FG000|Overall Study|Lack of Efficacy and Other|1|||
144235976|NCT00160706|520060235|FG000|Overall Study|Other Reason|11|||
144235977|NCT03214380|520060236|FG000|Lead-in|Adverse Event|3|||
144235978|NCT03214380|520060237|FG001|Lead-in|Adverse Event|0|||
144235979|NCT03214380|520060238|FG002|Lead-in|Adverse Event|0|||
144235980|NCT03214380|520060239|FG003|Lead-in|Adverse Event|1|||
144235981|NCT03214380|520060240|FG004|Lead-in|Adverse Event|0|||
144235982|NCT03214380|520060241|FG005|Lead-in|Adverse Event|0|||
144235983|NCT03214380|520060236|FG000|Lead-in|Lost to Follow-up|4|||
144235984|NCT03214380|520060237|FG001|Lead-in|Lost to Follow-up|0|||
144235985|NCT03214380|520060238|FG002|Lead-in|Lost to Follow-up|0|||
144235986|NCT03214380|520060239|FG003|Lead-in|Lost to Follow-up|1|||
144235987|NCT03214380|520060240|FG004|Lead-in|Lost to Follow-up|0|||
144235988|NCT03214380|520060241|FG005|Lead-in|Lost to Follow-up|0|||
144235989|NCT03214380|520060236|FG000|Lead-in|Eligibility Criteria|3|||
144235990|NCT03214380|520060237|FG001|Lead-in|Eligibility Criteria|0|||
144235991|NCT03214380|520060238|FG002|Lead-in|Eligibility Criteria|0|||
144235992|NCT03214380|520060239|FG003|Lead-in|Eligibility Criteria|0|||
144235993|NCT03214380|520060240|FG004|Lead-in|Eligibility Criteria|0|||
144235994|NCT03214380|520060241|FG005|Lead-in|Eligibility Criteria|0|||
144235995|NCT03214380|520060236|FG000|Lead-in|Physician Decision|6|||
144235996|NCT03214380|520060237|FG001|Lead-in|Physician Decision|0|||
144235997|NCT03214380|520060238|FG002|Lead-in|Physician Decision|0|||
144235998|NCT03214380|520060239|FG003|Lead-in|Physician Decision|0|||
144235999|NCT03214380|520060240|FG004|Lead-in|Physician Decision|0|||
144236000|NCT03214380|520060241|FG005|Lead-in|Physician Decision|0|||
144236001|NCT03214380|520060236|FG000|Lead-in|Protocol Deviation|7|||
144236002|NCT03214380|520060237|FG001|Lead-in|Protocol Deviation|0|||
144236003|NCT03214380|520060238|FG002|Lead-in|Protocol Deviation|0|||
144236004|NCT03214380|520060239|FG003|Lead-in|Protocol Deviation|3|||
144236005|NCT03214380|520060240|FG004|Lead-in|Protocol Deviation|0|||
144236006|NCT03214380|520060241|FG005|Lead-in|Protocol Deviation|0|||
144236007|NCT03214380|520060236|FG000|Lead-in|Withdrawal by Subject|41|||
144236008|NCT03214380|520060237|FG001|Lead-in|Withdrawal by Subject|0|||
144236009|NCT03214380|520060238|FG002|Lead-in|Withdrawal by Subject|0|||
144236010|NCT03214380|520060239|FG003|Lead-in|Withdrawal by Subject|14|||
144236011|NCT03214380|520060240|FG004|Lead-in|Withdrawal by Subject|0|||
144236012|NCT03214380|520060241|FG005|Lead-in|Withdrawal by Subject|0|||
144236013|NCT03214380|520060236|FG000|Lead-in|Family Emergency|1|||
144236014|NCT03214380|520060237|FG001|Lead-in|Family Emergency|0|||
144269807|NCT01677741|520191427|FG003|Overall Study|Death|1|||
144269808|NCT01677741|520191428|FG004|Overall Study|Death|0|||
144269809|NCT01677741|520191429|FG005|Overall Study|Death|1|||
144236015|NCT03214380|520060238|FG002|Lead-in|Family Emergency|0|||
144236016|NCT03214380|520060239|FG003|Lead-in|Family Emergency|0|||
144236017|NCT03214380|520060240|FG004|Lead-in|Family Emergency|0|||
144236018|NCT03214380|520060241|FG005|Lead-in|Family Emergency|0|||
144236019|NCT03214380|520060236|FG000|Lead-in|Natural Disaster|9|||
144236020|NCT03214380|520060237|FG001|Lead-in|Natural Disaster|0|||
144236021|NCT03214380|520060238|FG002|Lead-in|Natural Disaster|0|||
144236022|NCT03214380|520060239|FG003|Lead-in|Natural Disaster|0|||
144236023|NCT03214380|520060240|FG004|Lead-in|Natural Disaster|0|||
144236024|NCT03214380|520060241|FG005|Lead-in|Natural Disaster|0|||
144269810|NCT01677741|520191430|FG006|Overall Study|Death|0|||
144269811|NCT01677741|520191431|FG007|Overall Study|Death|0|||
144236025|NCT03214380|520060236|FG000|Lead-in|Non Compliance|1|||
144236026|NCT03214380|520060237|FG001|Lead-in|Non Compliance|0|||
144236027|NCT03214380|520060238|FG002|Lead-in|Non Compliance|0|||
144236028|NCT03214380|520060239|FG003|Lead-in|Non Compliance|0|||
144236029|NCT03214380|520060240|FG004|Lead-in|Non Compliance|0|||
144236030|NCT03214380|520060241|FG005|Lead-in|Non Compliance|0|||
144236031|NCT03214380|520060236|FG000|Lead-in|Participant Schedule|2|||
144236032|NCT03214380|520060237|FG001|Lead-in|Participant Schedule|0|||
144236033|NCT03214380|520060238|FG002|Lead-in|Participant Schedule|0|||
144236034|NCT03214380|520060239|FG003|Lead-in|Participant Schedule|0|||
144236035|NCT03214380|520060240|FG004|Lead-in|Participant Schedule|0|||
144236036|NCT03214380|520060241|FG005|Lead-in|Participant Schedule|0|||
144236037|NCT03214380|520060236|FG000|Treatment Period|Adverse Event|0|||
144236038|NCT03214380|520060237|FG001|Treatment Period|Adverse Event|1|||
144236039|NCT03214380|520060238|FG002|Treatment Period|Adverse Event|1|||
144236040|NCT03214380|520060239|FG003|Treatment Period|Adverse Event|0|||
144236041|NCT03214380|520060240|FG004|Treatment Period|Adverse Event|1|||
144236042|NCT03214380|520060241|FG005|Treatment Period|Adverse Event|0|||
144236043|NCT03214380|520060236|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
144236044|NCT03214380|520060237|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
144236045|NCT03214380|520060238|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
144236046|NCT03214380|520060239|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
144236047|NCT03214380|520060240|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
144236048|NCT03214380|520060241|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
144236049|NCT03214380|520060236|FG000|Treatment Period|Withdrawal by Subject|0|||
144236050|NCT03214380|520060237|FG001|Treatment Period|Withdrawal by Subject|10|||
144236051|NCT03214380|520060238|FG002|Treatment Period|Withdrawal by Subject|8|||
144236052|NCT03214380|520060239|FG003|Treatment Period|Withdrawal by Subject|0|||
144236053|NCT03214380|520060240|FG004|Treatment Period|Withdrawal by Subject|7|||
144236054|NCT03214380|520060241|FG005|Treatment Period|Withdrawal by Subject|11|||
144236055|NCT03214380|520060236|FG000|Treatment Period|Death|0|||
144236056|NCT03214380|520060237|FG001|Treatment Period|Death|1|||
144236057|NCT03214380|520060238|FG002|Treatment Period|Death|2|||
144236058|NCT03214380|520060239|FG003|Treatment Period|Death|0|||
144236059|NCT03214380|520060240|FG004|Treatment Period|Death|0|||
144236060|NCT03214380|520060241|FG005|Treatment Period|Death|0|||
144236061|NCT03214380|520060236|FG000|Treatment Period|Lost to Follow-up|0|||
144236062|NCT03214380|520060237|FG001|Treatment Period|Lost to Follow-up|6|||
144236063|NCT03214380|520060238|FG002|Treatment Period|Lost to Follow-up|3|||
144236064|NCT03214380|520060239|FG003|Treatment Period|Lost to Follow-up|0|||
144236065|NCT03214380|520060240|FG004|Treatment Period|Lost to Follow-up|0|||
144236066|NCT03214380|520060241|FG005|Treatment Period|Lost to Follow-up|0|||
144236067|NCT03214380|520060236|FG000|Treatment Period|Participant schedule|0|||
144236068|NCT03214380|520060237|FG001|Treatment Period|Participant schedule|0|||
144236069|NCT03214380|520060238|FG002|Treatment Period|Participant schedule|1|||
144236070|NCT03214380|520060239|FG003|Treatment Period|Participant schedule|0|||
144236071|NCT03214380|520060240|FG004|Treatment Period|Participant schedule|0|||
144236072|NCT03214380|520060241|FG005|Treatment Period|Participant schedule|0|||
144236073|NCT03214380|520060236|FG000|Treatment Period|Treatment Interruption|0|||
144236074|NCT03214380|520060237|FG001|Treatment Period|Treatment Interruption|0|||
144236075|NCT03214380|520060238|FG002|Treatment Period|Treatment Interruption|1|||
144236076|NCT03214380|520060239|FG003|Treatment Period|Treatment Interruption|0|||
144236077|NCT03214380|520060240|FG004|Treatment Period|Treatment Interruption|0|||
144236078|NCT03214380|520060241|FG005|Treatment Period|Treatment Interruption|0|||
144236079|NCT03692325|520060245|FG000|Overall Study|Adverse Event|2|||
144236080|NCT03692325|520060245|FG000|Overall Study|Progression/Recurrence|2|||
144236081|NCT00546117|520060246|FG000|Overall Study|Withdrawal by Subject|3|||
144236082|NCT00546117|520060247|FG001|Overall Study|Withdrawal by Subject|0|||
144236083|NCT00546117|520060246|FG000|Overall Study|Inability to schedule follow-up visit|1|||
144236084|NCT00546117|520060247|FG001|Overall Study|Inability to schedule follow-up visit|0|||
144236085|NCT01560234|520060250|FG000|Overall Study|Lost to Follow-up|3|||
144236086|NCT01560234|520060251|FG001|Overall Study|Lost to Follow-up|0|||
144236087|NCT01560234|520060252|FG002|Overall Study|Lost to Follow-up|1|||
144236088|NCT01560234|520060253|FG003|Overall Study|Lost to Follow-up|0|||
144236089|NCT01560234|520060254|FG004|Overall Study|Lost to Follow-up|0|||
144236090|NCT01560234|520060255|FG005|Overall Study|Lost to Follow-up|2|||
144236091|NCT01560234|520060256|FG006|Overall Study|Lost to Follow-up|0|||
144236092|NCT01560234|520060257|FG007|Overall Study|Lost to Follow-up|2|||
144236093|NCT01289639|520060258|FG000|Overall Study|Lost to Follow-up|1|||
144236094|NCT01289639|520060259|FG001|Overall Study|Lost to Follow-up|0|||
144236095|NCT01289639|520060260|FG002|Overall Study|Lost to Follow-up|0|||
144236096|NCT02780713|520060261|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
144236097|NCT02780713|520060262|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
144236098|NCT02780713|520060263|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
144236099|NCT02780713|520060264|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
144236100|NCT02780713|520060265|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
144236101|NCT01931475|520060266|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
144236102|NCT01931475|520060267|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
144236103|NCT01931475|520060266|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
144236104|NCT01931475|520060267|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
144236105|NCT01931475|520060266|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
144236106|NCT01931475|520060267|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
144236107|NCT01931475|520060266|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
144236108|NCT01931475|520060267|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
144236109|NCT01931475|520060266|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
144236110|NCT01931475|520060267|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
144236111|NCT01931475|520060266|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
144236112|NCT01931475|520060267|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
144236113|NCT01931475|520060266|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
144236114|NCT01931475|520060267|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
144236115|NCT01931475|520060266|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
144236116|NCT01931475|520060267|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
144236117|NCT01931475|520060266|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
144236118|NCT01931475|520060267|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
144236119|NCT01931475|520060266|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
144236120|NCT01931475|520060267|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
144236121|NCT01931475|520060266|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
144236122|NCT01931475|520060267|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
144236123|NCT00425061|520060271|FG000|Overall Study|Adverse Event|1|||
144236124|NCT00425061|520060272|FG001|Overall Study|Adverse Event|0|||
144236125|NCT00425061|520060273|FG002|Overall Study|Adverse Event|0|||
144236126|NCT00425061|520060274|FG003|Overall Study|Adverse Event|2|||
144236127|NCT00425061|520060275|FG004|Overall Study|Adverse Event|2|||
144236128|NCT00425061|520060276|FG005|Overall Study|Adverse Event|0|||
144236129|NCT00425061|520060277|FG006|Overall Study|Adverse Event|0|||
144236130|NCT00425061|520060271|FG000|Overall Study|Lost to Follow-up|0|||
144236131|NCT00425061|520060272|FG001|Overall Study|Lost to Follow-up|1|||
144236132|NCT00425061|520060273|FG002|Overall Study|Lost to Follow-up|0|||
144236133|NCT00425061|520060274|FG003|Overall Study|Lost to Follow-up|0|||
144236134|NCT00425061|520060275|FG004|Overall Study|Lost to Follow-up|0|||
144236135|NCT00425061|520060276|FG005|Overall Study|Lost to Follow-up|0|||
144236136|NCT00425061|520060277|FG006|Overall Study|Lost to Follow-up|0|||
144236137|NCT00425061|520060271|FG000|Overall Study|Protocol Violation|1|||
144236138|NCT00425061|520060272|FG001|Overall Study|Protocol Violation|0|||
144236139|NCT00425061|520060273|FG002|Overall Study|Protocol Violation|0|||
144236140|NCT00425061|520060274|FG003|Overall Study|Protocol Violation|0|||
144236141|NCT00425061|520060275|FG004|Overall Study|Protocol Violation|0|||
144236142|NCT00425061|520060276|FG005|Overall Study|Protocol Violation|0|||
144236143|NCT00425061|520060277|FG006|Overall Study|Protocol Violation|0|||
144236144|NCT00425061|520060271|FG000|Overall Study|Withdrawal by Subject|0|||
144236145|NCT00425061|520060272|FG001|Overall Study|Withdrawal by Subject|1|||
144236146|NCT00425061|520060273|FG002|Overall Study|Withdrawal by Subject|0|||
144236147|NCT00425061|520060274|FG003|Overall Study|Withdrawal by Subject|0|||
144236148|NCT00425061|520060275|FG004|Overall Study|Withdrawal by Subject|1|||
144236149|NCT00425061|520060276|FG005|Overall Study|Withdrawal by Subject|0|||
144236150|NCT00425061|520060277|FG006|Overall Study|Withdrawal by Subject|3|||
144236151|NCT00425061|520060271|FG000|Overall Study|Sponsor's request|0|||
144236152|NCT00425061|520060272|FG001|Overall Study|Sponsor's request|0|||
144236153|NCT00425061|520060273|FG002|Overall Study|Sponsor's request|0|||
144236154|NCT00425061|520060274|FG003|Overall Study|Sponsor's request|0|||
144236155|NCT00425061|520060275|FG004|Overall Study|Sponsor's request|19|||
144236156|NCT00425061|520060276|FG005|Overall Study|Sponsor's request|4|||
144236157|NCT00425061|520060277|FG006|Overall Study|Sponsor's request|15|||
144269812|NCT01677741|520191424|FG000|Overall Study|Withdrawal by Subject|2|||
144236158|NCT00425061|520060271|FG000|Overall Study|Physician Decision|0|||
144236159|NCT00425061|520060272|FG001|Overall Study|Physician Decision|0|||
144269813|NCT01677741|520191425|FG001|Overall Study|Withdrawal by Subject|7|||
144236160|NCT00425061|520060273|FG002|Overall Study|Physician Decision|0|||
144236161|NCT00425061|520060274|FG003|Overall Study|Physician Decision|0|||
144236162|NCT00425061|520060275|FG004|Overall Study|Physician Decision|1|||
144236163|NCT00425061|520060276|FG005|Overall Study|Physician Decision|0|||
144236164|NCT00425061|520060277|FG006|Overall Study|Physician Decision|0|||
144236165|NCT00425061|520060271|FG000|Overall Study|Other|0|||
144236166|NCT00425061|520060272|FG001|Overall Study|Other|0|||
144236167|NCT00425061|520060273|FG002|Overall Study|Other|0|||
144236168|NCT00425061|520060274|FG003|Overall Study|Other|0|||
144236169|NCT00425061|520060275|FG004|Overall Study|Other|3|||
144236170|NCT00425061|520060276|FG005|Overall Study|Other|0|||
144236171|NCT00425061|520060277|FG006|Overall Study|Other|1|||
144236172|NCT03436693|520060278|FG000|Overall Study|Adverse Event|22|||
144236173|NCT03436693|520060279|FG001|Overall Study|Adverse Event|10|||
144236174|NCT03436693|520060278|FG000|Overall Study|Physician Decision|3|||
144236175|NCT03436693|520060279|FG001|Overall Study|Physician Decision|3|||
144236176|NCT03436693|520060278|FG000|Overall Study|Withdrawal by Subject|4|||
144236177|NCT03436693|520060279|FG001|Overall Study|Withdrawal by Subject|13|||
144236178|NCT03436693|520060278|FG000|Overall Study|Progressive Disease|1|||
144236179|NCT03436693|520060279|FG001|Overall Study|Progressive Disease|1|||
144236180|NCT01680861|520060280|FG000|Early Post-transplant Period|Protocol Violation|1|||
144236181|NCT01680861|520060281|FG001|Early Post-transplant Period|Protocol Violation|1|||
144236182|NCT04967885|520060284|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
144236183|NCT04967885|520060285|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
144236184|NCT04967885|520060284|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
144236185|NCT04967885|520060285|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
144236186|NCT04967885|520060284|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
144236187|NCT04967885|520060285|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
144236188|NCT04967885|520060284|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
144236189|NCT04967885|520060285|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
144236190|NCT04967885|520060284|FG000|EMI-II Intervention|Lost to Follow-up|14|||
144236191|NCT04967885|520060285|FG001|EMI-II Intervention|Lost to Follow-up|10|||
144236192|NCT01011465|520060286|FG000|Overall Study|Withdrawal by Subject|2|||
144236193|NCT01011465|520060287|FG001|Overall Study|Withdrawal by Subject|1|||
144236194|NCT01011465|520060288|FG002|Overall Study|Withdrawal by Subject|0|||
144236195|NCT01011465|520060289|FG003|Overall Study|Withdrawal by Subject|0|||
144236196|NCT01011465|520060290|FG004|Overall Study|Withdrawal by Subject|1|||
144236197|NCT01011465|520060291|FG005|Overall Study|Withdrawal by Subject|0|||
144236198|NCT01011465|520060292|FG006|Overall Study|Withdrawal by Subject|1|||
144236199|NCT01011465|520060293|FG007|Overall Study|Withdrawal by Subject|0|||
144236200|NCT00723008|520060294|FG000|Enrollment|Lost to Follow-up|1|||
144236201|NCT00723008|520060295|FG001|Enrollment|Lost to Follow-up|0|||
144236202|NCT00723008|520060294|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
144236203|NCT00723008|520060295|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
144236204|NCT00723008|520060294|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
144236205|NCT00723008|520060295|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
144236206|NCT00723008|520060294|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
144236207|NCT00723008|520060295|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
144236208|NCT00723008|520060294|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
144236209|NCT00723008|520060295|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
144236210|NCT00723008|520060294|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
144236211|NCT00723008|520060295|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
144236212|NCT05835011|520060296|FG000|Overall Study|Study Terminated by the Sponsor|1|||
144236213|NCT05835011|520060296|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
144236214|NCT04720911|520060299|FG000|Overall Study|Withdrawal by Subject|0|||
144236215|NCT04720911|520060300|FG001|Overall Study|Withdrawal by Subject|1|||
144236216|NCT04720911|520060301|FG002|Overall Study|Withdrawal by Subject|0|||
144236217|NCT00090220|520060302|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
144236218|NCT00090220|520060303|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
144236219|NCT00090220|520060304|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144236220|NCT00090220|520060305|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144236221|NCT00090220|520060306|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144236222|NCT00090220|520060307|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
144236223|NCT00090220|520060302|FG000|Base Study Vaccination Period|Adverse Event|6|||
144236224|NCT00090220|520060303|FG001|Base Study Vaccination Period|Adverse Event|1|||
144236225|NCT00090220|520060304|FG002|Base Study Vaccination Period|Adverse Event|0|||
144236226|NCT00090220|520060305|FG003|Base Study Vaccination Period|Adverse Event|0|||
144236227|NCT00090220|520060306|FG004|Base Study Vaccination Period|Adverse Event|0|||
144236228|NCT00090220|520060307|FG005|Base Study Vaccination Period|Adverse Event|0|||
144236229|NCT00090220|520060302|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
144236230|NCT00090220|520060303|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
144236231|NCT00090220|520060304|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
144236232|NCT00090220|520060305|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
144236233|NCT00090220|520060306|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
144236234|NCT00090220|520060307|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
144236235|NCT00090220|520060302|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
144236236|NCT00090220|520060303|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
144236237|NCT00090220|520060304|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
144236238|NCT00090220|520060305|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
144236239|NCT00090220|520060306|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
144236240|NCT00090220|520060307|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
144236241|NCT00090220|520060302|FG000|Base Study Vaccination Period|Patient Moved|6|||
144236242|NCT00090220|520060303|FG001|Base Study Vaccination Period|Patient Moved|2|||
144236243|NCT00090220|520060304|FG002|Base Study Vaccination Period|Patient Moved|0|||
144236244|NCT00090220|520060305|FG003|Base Study Vaccination Period|Patient Moved|0|||
144236245|NCT00090220|520060306|FG004|Base Study Vaccination Period|Patient Moved|0|||
144236246|NCT00090220|520060307|FG005|Base Study Vaccination Period|Patient Moved|0|||
144236247|NCT00090220|520060302|FG000|Base Study Vaccination Period|Other|4|||
144236248|NCT00090220|520060303|FG001|Base Study Vaccination Period|Other|4|||
144236249|NCT00090220|520060304|FG002|Base Study Vaccination Period|Other|0|||
144236250|NCT00090220|520060305|FG003|Base Study Vaccination Period|Other|0|||
144236251|NCT00090220|520060306|FG004|Base Study Vaccination Period|Other|0|||
144236252|NCT00090220|520060307|FG005|Base Study Vaccination Period|Other|0|||
144236253|NCT00090220|520060302|FG000|Base Study Follow-up Period|Adverse Event|6|||
144236254|NCT00090220|520060303|FG001|Base Study Follow-up Period|Adverse Event|1|||
144236255|NCT00090220|520060304|FG002|Base Study Follow-up Period|Adverse Event|0|||
144236256|NCT00090220|520060305|FG003|Base Study Follow-up Period|Adverse Event|0|||
144236257|NCT00090220|520060306|FG004|Base Study Follow-up Period|Adverse Event|0|||
144236258|NCT00090220|520060307|FG005|Base Study Follow-up Period|Adverse Event|0|||
144236259|NCT00090220|520060302|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
144236260|NCT00090220|520060303|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
144236261|NCT00090220|520060304|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
144236262|NCT00090220|520060305|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
144236263|NCT00090220|520060306|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
144236264|NCT00090220|520060307|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
144236265|NCT00090220|520060302|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
144236266|NCT00090220|520060303|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
144236267|NCT00090220|520060304|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
144236268|NCT00090220|520060305|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
144236269|NCT00090220|520060306|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
144236270|NCT00090220|520060307|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
144236271|NCT00090220|520060302|FG000|Base Study Follow-up Period|Patient Moved|20|||
144236272|NCT00090220|520060303|FG001|Base Study Follow-up Period|Patient Moved|28|||
144236273|NCT00090220|520060304|FG002|Base Study Follow-up Period|Patient Moved|0|||
144236274|NCT00090220|520060305|FG003|Base Study Follow-up Period|Patient Moved|0|||
144236275|NCT00090220|520060306|FG004|Base Study Follow-up Period|Patient Moved|0|||
144236276|NCT00090220|520060307|FG005|Base Study Follow-up Period|Patient Moved|0|||
144236277|NCT00090220|520060302|FG000|Base Study Follow-up Period|Other|19|||
144236278|NCT00090220|520060303|FG001|Base Study Follow-up Period|Other|21|||
144236279|NCT00090220|520060304|FG002|Base Study Follow-up Period|Other|0|||
144236280|NCT00090220|520060305|FG003|Base Study Follow-up Period|Other|0|||
144236281|NCT00090220|520060306|FG004|Base Study Follow-up Period|Other|0|||
144236282|NCT00090220|520060307|FG005|Base Study Follow-up Period|Other|0|||
144236283|NCT00090220|520060302|FG000|Extension 1 (EXT1)|Adverse Event|0|||
144236284|NCT00090220|520060303|FG001|Extension 1 (EXT1)|Adverse Event|0|||
144236285|NCT00090220|520060304|FG002|Extension 1 (EXT1)|Adverse Event|4|||
144236286|NCT00090220|520060305|FG003|Extension 1 (EXT1)|Adverse Event|0|||
144236287|NCT00090220|520060306|FG004|Extension 1 (EXT1)|Adverse Event|0|||
144236288|NCT00090220|520060307|FG005|Extension 1 (EXT1)|Adverse Event|0|||
144269814|NCT01677741|520191426|FG002|Overall Study|Withdrawal by Subject|5|||
144236289|NCT00090220|520060302|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
144236290|NCT00090220|520060303|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
144236291|NCT00090220|520060304|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
144236292|NCT00090220|520060305|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
144236293|NCT00090220|520060306|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
144236294|NCT00090220|520060307|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
144236295|NCT00090220|520060302|FG000|Extension 1 (EXT1)|Moved|0|||
144236296|NCT00090220|520060303|FG001|Extension 1 (EXT1)|Moved|0|||
144236297|NCT00090220|520060304|FG002|Extension 1 (EXT1)|Moved|2|||
144236298|NCT00090220|520060305|FG003|Extension 1 (EXT1)|Moved|1|||
144236299|NCT00090220|520060306|FG004|Extension 1 (EXT1)|Moved|0|||
144236300|NCT00090220|520060307|FG005|Extension 1 (EXT1)|Moved|0|||
144236301|NCT00090220|520060302|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
144236302|NCT00090220|520060303|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
144236303|NCT00090220|520060304|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
144236304|NCT00090220|520060305|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
144236305|NCT00090220|520060306|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
144236306|NCT00090220|520060307|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
144236307|NCT00090220|520060302|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
144236308|NCT00090220|520060303|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
144236309|NCT00090220|520060304|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
144236310|NCT00090220|520060305|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
144236311|NCT00090220|520060306|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
144236312|NCT00090220|520060307|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
144236313|NCT00090220|520060302|FG000|Extension 1 (EXT1)|Other reason|0|||
144236314|NCT00090220|520060303|FG001|Extension 1 (EXT1)|Other reason|0|||
144236315|NCT00090220|520060304|FG002|Extension 1 (EXT1)|Other reason|2|||
144236316|NCT00090220|520060305|FG003|Extension 1 (EXT1)|Other reason|0|||
144236317|NCT00090220|520060306|FG004|Extension 1 (EXT1)|Other reason|0|||
144236318|NCT00090220|520060307|FG005|Extension 1 (EXT1)|Other reason|0|||
144236319|NCT00090220|520060302|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144236320|NCT00090220|520060303|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144236321|NCT00090220|520060304|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144236322|NCT00090220|520060305|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
144236323|NCT00090220|520060306|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
144236324|NCT00090220|520060307|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
144236325|NCT00090220|520060302|FG000|Long-term Follow-up (EXT2)|Death|0|||
144236326|NCT00090220|520060303|FG001|Long-term Follow-up (EXT2)|Death|0|||
144236327|NCT00090220|520060304|FG002|Long-term Follow-up (EXT2)|Death|0|||
144236328|NCT00090220|520060305|FG003|Long-term Follow-up (EXT2)|Death|0|||
144236329|NCT00090220|520060306|FG004|Long-term Follow-up (EXT2)|Death|1|||
144236330|NCT00090220|520060307|FG005|Long-term Follow-up (EXT2)|Death|1|||
144236331|NCT00090220|520060302|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144236332|NCT00090220|520060303|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144236333|NCT00090220|520060304|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144236334|NCT00090220|520060305|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
144236335|NCT00090220|520060306|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
144236336|NCT00090220|520060307|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
144236337|NCT00090220|520060302|FG000|Long-term Follow-up (EXT2)|Other|0|||
144236338|NCT00090220|520060303|FG001|Long-term Follow-up (EXT2)|Other|0|||
144236339|NCT00090220|520060304|FG002|Long-term Follow-up (EXT2)|Other|0|||
144236340|NCT00090220|520060305|FG003|Long-term Follow-up (EXT2)|Other|0|||
144236341|NCT00090220|520060306|FG004|Long-term Follow-up (EXT2)|Other|1|||
144236342|NCT00090220|520060307|FG005|Long-term Follow-up (EXT2)|Other|0|||
144236343|NCT00941863|520060308|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
144236344|NCT00941863|520060309|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
144236345|NCT00941863|520060310|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
144236346|NCT00941863|520060311|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
144236347|NCT00941863|520060312|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
144236348|NCT00941863|520060308|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
144236349|NCT00941863|520060309|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
144236350|NCT00941863|520060310|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
144236351|NCT00941863|520060311|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
144236352|NCT00941863|520060312|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
144236353|NCT00941863|520060308|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
144269815|NCT01677741|520191427|FG003|Overall Study|Withdrawal by Subject|4|||
144236354|NCT00941863|520060309|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
144236355|NCT00941863|520060310|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
144236356|NCT00941863|520060311|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
144236357|NCT00941863|520060312|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
144236358|NCT00941863|520060308|FG000|Until Primary Completion Date (PCD)|Death|0|||
144236359|NCT00941863|520060309|FG001|Until Primary Completion Date (PCD)|Death|0|||
144236360|NCT00941863|520060310|FG002|Until Primary Completion Date (PCD)|Death|1|||
144236361|NCT00941863|520060311|FG003|Until Primary Completion Date (PCD)|Death|2|||
144236362|NCT00941863|520060312|FG004|Until Primary Completion Date (PCD)|Death|7|||
144236363|NCT00941863|520060308|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
144236364|NCT00941863|520060309|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
144236365|NCT00941863|520060310|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
144236366|NCT00941863|520060311|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
144236367|NCT00941863|520060312|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
144236368|NCT00941863|520060308|FG000|Continued After PCD|Withdrawal by Subject|0|||
144236369|NCT00941863|520060309|FG001|Continued After PCD|Withdrawal by Subject|0|||
144236370|NCT00941863|520060310|FG002|Continued After PCD|Withdrawal by Subject|0|||
144236371|NCT00941863|520060311|FG003|Continued After PCD|Withdrawal by Subject|0|||
144236372|NCT00941863|520060312|FG004|Continued After PCD|Withdrawal by Subject|1|||
144236373|NCT00941863|520060308|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
144236374|NCT00941863|520060309|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
144236375|NCT00941863|520060310|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
144236376|NCT00941863|520060311|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
144236377|NCT00941863|520060312|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
144236378|NCT01867710|520060315|FG000|Overall Study|Death|25|||
144236379|NCT01867710|520060316|FG001|Overall Study|Death|15|||
144236380|NCT01867710|520060317|FG002|Overall Study|Death|27|||
144236381|NCT01867710|520060318|FG003|Overall Study|Death|20|||
144236382|NCT01867710|520060315|FG000|Overall Study|Lost to Follow-up|3|||
144236383|NCT01867710|520060316|FG001|Overall Study|Lost to Follow-up|4|||
144236384|NCT01867710|520060317|FG002|Overall Study|Lost to Follow-up|3|||
144236385|NCT01867710|520060318|FG003|Overall Study|Lost to Follow-up|2|||
144236386|NCT01867710|520060315|FG000|Overall Study|Withdrawal of consent|2|||
144236387|NCT01867710|520060316|FG001|Overall Study|Withdrawal of consent|5|||
144236388|NCT01867710|520060317|FG002|Overall Study|Withdrawal of consent|1|||
144236389|NCT01867710|520060318|FG003|Overall Study|Withdrawal of consent|2|||
144236390|NCT01867710|520060315|FG000|Overall Study|Study Terminated by Sponsor|9|||
144236391|NCT01867710|520060316|FG001|Overall Study|Study Terminated by Sponsor|13|||
144236392|NCT01867710|520060317|FG002|Overall Study|Study Terminated by Sponsor|8|||
144236393|NCT01867710|520060318|FG003|Overall Study|Study Terminated by Sponsor|16|||
144236394|NCT01867710|520060315|FG000|Overall Study|Biochemical progression|0|||
144236395|NCT01867710|520060316|FG001|Overall Study|Biochemical progression|1|||
144236396|NCT01867710|520060317|FG002|Overall Study|Biochemical progression|0|||
144236397|NCT01867710|520060318|FG003|Overall Study|Biochemical progression|0|||
144236398|NCT01867710|520060315|FG000|Overall Study|Clinical progression|0|||
144236399|NCT01867710|520060316|FG001|Overall Study|Clinical progression|0|||
144236400|NCT01867710|520060317|FG002|Overall Study|Clinical progression|1|||
144236401|NCT01867710|520060318|FG003|Overall Study|Clinical progression|0|||
144236402|NCT01867710|520060315|FG000|Overall Study|Disease progression|1|||
144236403|NCT01867710|520060316|FG001|Overall Study|Disease progression|0|||
144236404|NCT01867710|520060317|FG002|Overall Study|Disease progression|0|||
144236405|NCT01867710|520060318|FG003|Overall Study|Disease progression|0|||
144236406|NCT01867710|520060315|FG000|Overall Study|Patient decision|0|||
144236407|NCT01867710|520060316|FG001|Overall Study|Patient decision|0|||
144236408|NCT01867710|520060317|FG002|Overall Study|Patient decision|0|||
144236409|NCT01867710|520060318|FG003|Overall Study|Patient decision|1|||
144236410|NCT01867710|520060315|FG000|Overall Study|Patient to follow subsequent treatment|0|||
144236411|NCT01867710|520060316|FG001|Overall Study|Patient to follow subsequent treatment|1|||
144236412|NCT01867710|520060317|FG002|Overall Study|Patient to follow subsequent treatment|0|||
144236413|NCT01867710|520060318|FG003|Overall Study|Patient to follow subsequent treatment|0|||
144236414|NCT01867710|520060315|FG000|Overall Study|Progressive disease|1|||
144236415|NCT01867710|520060316|FG001|Overall Study|Progressive disease|0|||
144236416|NCT01867710|520060317|FG002|Overall Study|Progressive disease|0|||
144236417|NCT01867710|520060318|FG003|Overall Study|Progressive disease|0|||
144236418|NCT01867710|520060315|FG000|Overall Study|Protocol Violation|0|||
144236419|NCT01867710|520060316|FG001|Overall Study|Protocol Violation|0|||
144236420|NCT01867710|520060317|FG002|Overall Study|Protocol Violation|0|||
144236421|NCT01867710|520060318|FG003|Overall Study|Protocol Violation|1|||
144236422|NCT01867710|520060315|FG000|Overall Study|PSA-progression|0|||
144236423|NCT01867710|520060316|FG001|Overall Study|PSA-progression|1|||
144236424|NCT01867710|520060317|FG002|Overall Study|PSA-progression|0|||
144236425|NCT01867710|520060318|FG003|Overall Study|PSA-progression|0|||
144236426|NCT01867710|520060315|FG000|Overall Study|Study medication no longer effective|0|||
144236427|NCT01867710|520060316|FG001|Overall Study|Study medication no longer effective|1|||
144236428|NCT01867710|520060317|FG002|Overall Study|Study medication no longer effective|0|||
144236429|NCT01867710|520060318|FG003|Overall Study|Study medication no longer effective|0|||
144236430|NCT01471340|520060322|FG000|Overall Study|Death|5|||
144236431|NCT01471340|520060323|FG001|Overall Study|Death|4|||
144236432|NCT01471340|520060322|FG000|Overall Study|Lost to Follow-up|0|||
144236433|NCT01471340|520060323|FG001|Overall Study|Lost to Follow-up|1|||
144236434|NCT01471340|520060322|FG000|Overall Study|Investigational site closure|0|||
144236435|NCT01471340|520060323|FG001|Overall Study|Investigational site closure|1|||
144236436|NCT01471340|520060322|FG000|Overall Study|Invalid informed consent|1|||
144236437|NCT01471340|520060323|FG001|Overall Study|Invalid informed consent|0|||
144236438|NCT00355147|520060326|FG000|Overall Study|Lost to Follow-up|10|||
144236439|NCT00355147|520060327|FG001|Overall Study|Lost to Follow-up|8|||
144236440|NCT00355147|520060326|FG000|Overall Study|Withdrawal by Subject|8|||
144236441|NCT00355147|520060327|FG001|Overall Study|Withdrawal by Subject|12|||
144236442|NCT03557931|520060332|FG000|Overall Study|Adverse Event|4|||
144236443|NCT03557931|520060333|FG001|Overall Study|Adverse Event|6|||
144236444|NCT03557931|520060334|FG002|Overall Study|Adverse Event|1|||
144236445|NCT03557931|520060332|FG000|Overall Study|Lost to Follow-up|4|||
144236446|NCT03557931|520060333|FG001|Overall Study|Lost to Follow-up|4|||
144236447|NCT03557931|520060334|FG002|Overall Study|Lost to Follow-up|1|||
144236448|NCT03557931|520060332|FG000|Overall Study|Protocol Violation|1|||
144236449|NCT03557931|520060333|FG001|Overall Study|Protocol Violation|4|||
144236450|NCT03557931|520060334|FG002|Overall Study|Protocol Violation|1|||
144236451|NCT03557931|520060332|FG000|Overall Study|Withdrawal by Subject|14|||
144236452|NCT03557931|520060333|FG001|Overall Study|Withdrawal by Subject|0|||
144236453|NCT03557931|520060334|FG002|Overall Study|Withdrawal by Subject|7|||
144236454|NCT03557931|520060332|FG000|Overall Study|Miscellaneous|8|||
144236455|NCT03557931|520060333|FG001|Overall Study|Miscellaneous|5|||
144236456|NCT03557931|520060334|FG002|Overall Study|Miscellaneous|3|||
144236457|NCT03315286|520060335|FG000|Overall Study|Lost to Follow-up|0|||
144236458|NCT03315286|520060336|FG001|Overall Study|Lost to Follow-up|3|||
144236459|NCT03315286|520060335|FG000|Overall Study|Withdrawal by Subject|1|||
144236460|NCT03315286|520060336|FG001|Overall Study|Withdrawal by Subject|0|||
144236461|NCT03315286|520060335|FG000|Overall Study|Protocol Violation|0|||
144236462|NCT03315286|520060336|FG001|Overall Study|Protocol Violation|1|||
144236463|NCT03075891|520060338|FG000|Overall Study|Withdrawal by Subject|3|||
144236464|NCT03075891|520060339|FG001|Overall Study|Withdrawal by Subject|6|||
144236465|NCT03075891|520060338|FG000|Overall Study|Lost to Follow-up|1|||
144236466|NCT03075891|520060339|FG001|Overall Study|Lost to Follow-up|0|||
144236467|NCT03075891|520060338|FG000|Overall Study|Pregnancy|3|||
144236468|NCT03075891|520060339|FG001|Overall Study|Pregnancy|1|||
144236469|NCT03075891|520060338|FG000|Overall Study|visits not performed (no time)|1|||
144236470|NCT03075891|520060339|FG001|Overall Study|visits not performed (no time)|0|||
144236471|NCT03075891|520060338|FG000|Overall Study|Drug abuse relapse issue|0|||
144236472|NCT03075891|520060339|FG001|Overall Study|Drug abuse relapse issue|1|||
144236473|NCT03075891|520060338|FG000|Overall Study|Participant requiring study withdrawal|0|||
144236474|NCT03075891|520060339|FG001|Overall Study|Participant requiring study withdrawal|1|||
144236475|NCT03075891|520060338|FG000|Overall Study|Adverse event, non-fatal|1|||
144236476|NCT03075891|520060339|FG001|Overall Study|Adverse event, non-fatal|4|||
144236477|NCT00638443|520060340|FG000|First Intervention|Adverse Event|2|||
144236478|NCT00638443|520060341|FG001|First Intervention|Adverse Event|1|||
144236479|NCT01435460|520060342|FG000|Overall Study|Adverse Event|2|||
144236480|NCT01435460|520060343|FG001|Overall Study|Adverse Event|1|||
144236481|NCT01435460|520060342|FG000|Overall Study|Lost to Follow-up|6|||
144236482|NCT01435460|520060343|FG001|Overall Study|Lost to Follow-up|1|||
144236483|NCT01435460|520060342|FG000|Overall Study|Withdrawal by Subject|1|||
144236484|NCT01435460|520060343|FG001|Overall Study|Withdrawal by Subject|3|||
144236485|NCT01435460|520060342|FG000|Overall Study|Protocol Violation|0|||
144236486|NCT01435460|520060343|FG001|Overall Study|Protocol Violation|1|||
144236487|NCT01435460|520060342|FG000|Overall Study|Did not meet eligibility criteria|2|||
144236488|NCT01435460|520060343|FG001|Overall Study|Did not meet eligibility criteria|0|||
144236489|NCT01706939|520060344|FG000|Pre Randomization|Screen Failure|1|||
144236490|NCT01706939|520060345|FG001|Pre Randomization|Screen Failure|0|||
144236491|NCT01706939|520060346|FG002|Pre Randomization|Screen Failure|0|||
144236492|NCT01706939|520060344|FG000|Pre Randomization|Ineligible for Randomization|1|||
144236493|NCT01706939|520060345|FG001|Pre Randomization|Ineligible for Randomization|0|||
144236494|NCT01706939|520060346|FG002|Pre Randomization|Ineligible for Randomization|0|||
144236495|NCT01706939|520060344|FG000|Pre Randomization|Withdrawal by Subject|1|||
144236496|NCT01706939|520060345|FG001|Pre Randomization|Withdrawal by Subject|0|||
144236497|NCT01706939|520060346|FG002|Pre Randomization|Withdrawal by Subject|0|||
144236498|NCT01706939|520060344|FG000|Randomization|Insufficient QoL survey compliance|0|||
144236499|NCT01706939|520060345|FG001|Randomization|Insufficient QoL survey compliance|1|||
144236500|NCT01706939|520060346|FG002|Randomization|Insufficient QoL survey compliance|1|||
144236501|NCT01706939|520060344|FG000|Randomization|Progression of disease|0|||
144236502|NCT01706939|520060345|FG001|Randomization|Progression of disease|2|||
144236503|NCT01706939|520060346|FG002|Randomization|Progression of disease|1|||
144236504|NCT01046903|520060347|FG000|Overall Study|Lost to Follow-up|16|||
144236505|NCT01046903|520060347|FG000|Overall Study|Adverse Event|4|||
144236506|NCT01046903|520060347|FG000|Overall Study|Withdrawal by Subject|3|||
144236507|NCT01046903|520060347|FG000|Overall Study|Other|5|||
144236508|NCT01894100|520060348|FG000|Overall Study|Lost to Follow-up|0|||
144236509|NCT01894100|520060349|FG001|Overall Study|Lost to Follow-up|1|||
144236510|NCT01894100|520060348|FG000|Overall Study|Withdrawal by Subject|3|||
144236511|NCT01894100|520060349|FG001|Overall Study|Withdrawal by Subject|0|||
144236512|NCT01582178|520060354|FG000|Overall Study|Physician Decision|6|||
144236513|NCT01582178|520060355|FG001|Overall Study|Physician Decision|5|||
144236514|NCT04463251|520060359|FG000|Overall Study|Death|1|||
144236515|NCT04463251|520060360|FG001|Overall Study|Death|0|||
144236516|NCT04463251|520060361|FG002|Overall Study|Death|1|||
144236517|NCT04463251|520060359|FG000|Overall Study|Adverse Event|0|||
144236518|NCT04463251|520060360|FG001|Overall Study|Adverse Event|1|||
144236519|NCT04463251|520060361|FG002|Overall Study|Adverse Event|0|||
144236520|NCT04463251|520060359|FG000|Overall Study|Lost to Follow-up|0|||
144236521|NCT04463251|520060360|FG001|Overall Study|Lost to Follow-up|1|||
144236522|NCT04463251|520060361|FG002|Overall Study|Lost to Follow-up|0|||
144236523|NCT04463251|520060359|FG000|Overall Study|Withdrawal by Subject|0|||
144236524|NCT04463251|520060360|FG001|Overall Study|Withdrawal by Subject|2|||
144236525|NCT04463251|520060361|FG002|Overall Study|Withdrawal by Subject|2|||
144236526|NCT00504725|520062885|FG000|Overall Study|Protocol Violation|1|||
144236527|NCT00504725|520062886|FG001|Overall Study|Protocol Violation|0|||
144236528|NCT01435018|520062887|FG000|Overall Study|Death|37|||
144236529|NCT01435018|520062888|FG001|Overall Study|Death|18|||
144236530|NCT01435018|520062889|FG002|Overall Study|Death|25|||
144236531|NCT01435018|520062887|FG000|Overall Study|Site is closing|4|||
144236532|NCT01435018|520062888|FG001|Overall Study|Site is closing|9|||
144236533|NCT01435018|520062889|FG002|Overall Study|Site is closing|7|||
144236534|NCT01435018|520062887|FG000|Overall Study|Withdrew consent|0|||
144236535|NCT01435018|520062888|FG001|Overall Study|Withdrew consent|3|||
144236536|NCT01435018|520062889|FG002|Overall Study|Withdrew consent|1|||
144236537|NCT01435018|520062887|FG000|Overall Study|Not willing to adhere to requirements|0|||
144236538|NCT01435018|520062888|FG001|Overall Study|Not willing to adhere to requirements|2|||
144236539|NCT01435018|520062889|FG002|Overall Study|Not willing to adhere to requirements|3|||
144236540|NCT01435018|520062887|FG000|Overall Study|Not able to get to clinic|2|||
144236541|NCT01435018|520062888|FG001|Overall Study|Not able to get to clinic|0|||
144236542|NCT01435018|520062889|FG002|Overall Study|Not able to get to clinic|2|||
144236543|NCT01435018|520062887|FG000|Overall Study|Severe debilitation, unable to continue|0|||
144236544|NCT01435018|520062888|FG001|Overall Study|Severe debilitation, unable to continue|0|||
144236545|NCT01435018|520062889|FG002|Overall Study|Severe debilitation, unable to continue|1|||
144236546|NCT01435018|520062887|FG000|Overall Study|Unable to contact participant/parent|1|||
144236547|NCT01435018|520062888|FG001|Overall Study|Unable to contact participant/parent|1|||
144236548|NCT01435018|520062889|FG002|Overall Study|Unable to contact participant/parent|1|||
144236549|NCT01435018|520062887|FG000|Overall Study|Enrollment Violation|0|||
144236550|NCT01435018|520062888|FG001|Overall Study|Enrollment Violation|1|||
144236551|NCT01435018|520062889|FG002|Overall Study|Enrollment Violation|0|||
144236552|NCT01435018|520062887|FG000|Overall Study|Never started chemotherapy|3|||
144236553|NCT01435018|520062888|FG001|Overall Study|Never started chemotherapy|0|||
144236554|NCT01435018|520062889|FG002|Overall Study|Never started chemotherapy|1|||
144236555|NCT00378508|520062890|FG000|Overall Study|Withdrawal by Subject|1|||
144236556|NCT00378508|520062891|FG001|Overall Study|Withdrawal by Subject|3|||
144236557|NCT00378508|520062890|FG000|Overall Study|Lost to Follow-up|1|||
144236558|NCT00378508|520062891|FG001|Overall Study|Lost to Follow-up|0|||
144236559|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
144236560|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
144236561|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
144236562|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
144236563|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Death|0|||
144236564|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Death|0|||
144236565|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Death|1|||
144236566|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Death|0|||
144236567|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
144236568|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
144236569|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
144236570|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
144236571|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
144236572|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
144236573|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
144236574|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
144236575|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
144236576|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
144236577|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
144236578|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
144236579|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
144236580|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
144236581|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
144236582|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
144236583|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
144236584|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
144236585|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
144236586|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
144236587|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
144236588|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
144236589|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
144236590|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
144236591|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
144236592|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
144236593|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144236594|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
144236595|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
144236596|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
144236597|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
144236598|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
144236599|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
144236600|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
144236601|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
144236602|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
144236603|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Other|8|||
144236604|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Other|14|||
144236605|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Other|8|||
144236606|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Other|23|||
144236607|NCT01106677|520062892|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
144236608|NCT01106677|520062893|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
144236609|NCT01106677|520062894|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
144236610|NCT01106677|520062895|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
144236611|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
144236612|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
144236613|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
144236614|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
144236615|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Death|0|||
144236616|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Death|0|||
144236617|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Death|0|||
144236618|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Death|1|||
144236619|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
144236620|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
144236621|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
144236622|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
144236623|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
144236624|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
144236625|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
144236626|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
144236627|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
144236628|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
144236629|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
144269816|NCT01677741|520191428|FG004|Overall Study|Withdrawal by Subject|11|||
144236630|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
144236631|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
144236632|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144236633|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144236634|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
144236635|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144236636|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
144236637|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
144236638|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
144236639|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
144236640|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
144236641|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
144236642|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
144236643|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144236644|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144236645|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
144236646|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
144236647|NCT01106677|520062892|FG000|Extension Period: Week 26 to Week 52|Other|6|||
144236648|NCT01106677|520062893|FG001|Extension Period: Week 26 to Week 52|Other|5|||
144236649|NCT01106677|520062894|FG002|Extension Period: Week 26 to Week 52|Other|8|||
144236650|NCT01106677|520062895|FG003|Extension Period: Week 26 to Week 52|Other|5|||
144236651|NCT01905553|520062902|FG000|Period 2|Adverse Event|1|||
144236652|NCT01905553|520062903|FG001|Period 2|Adverse Event|0|||
144236653|NCT02656290|520062913|FG000|Overall Study|Lost to Follow-up|1|||
144236654|NCT02656290|520062913|FG000|Overall Study|Reintervention|3|||
144236655|NCT01608087|520062914|FG000|Overall Study|Lost to Follow-up|0|||
144236656|NCT01608087|520062915|FG001|Overall Study|Lost to Follow-up|1|||
144236657|NCT01608087|520062916|FG002|Overall Study|Lost to Follow-up|0|||
144236658|NCT01608087|520062914|FG000|Overall Study|Other Reason|0|||
144236659|NCT01608087|520062915|FG001|Overall Study|Other Reason|1|||
144236660|NCT01608087|520062916|FG002|Overall Study|Other Reason|0|||
144236661|NCT00664859|520062917|FG000|Overall Study|Adverse Event|2|||
144236662|NCT00664859|520062918|FG001|Overall Study|Adverse Event|1|||
144236663|NCT00664859|520062919|FG002|Overall Study|Adverse Event|3|||
144236664|NCT00664859|520062917|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
144236665|NCT00664859|520062918|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
144236666|NCT00664859|520062919|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
144236667|NCT00664859|520062917|FG000|Overall Study|Noncompliance with protocol|1|||
144236668|NCT00664859|520062918|FG001|Overall Study|Noncompliance with protocol|0|||
144236669|NCT00664859|520062919|FG002|Overall Study|Noncompliance with protocol|4|||
144236670|NCT00664859|520062917|FG000|Overall Study|Laboratory abnormality|2|||
144236671|NCT00664859|520062918|FG001|Overall Study|Laboratory abnormality|1|||
144236672|NCT00664859|520062919|FG002|Overall Study|Laboratory abnormality|4|||
144236673|NCT00664859|520062917|FG000|Overall Study|Withdrawal by Subject|4|||
144236674|NCT00664859|520062918|FG001|Overall Study|Withdrawal by Subject|1|||
144236675|NCT00664859|520062919|FG002|Overall Study|Withdrawal by Subject|3|||
144236676|NCT00664859|520062917|FG000|Overall Study|Lost to Follow-up|2|||
144236677|NCT00664859|520062918|FG001|Overall Study|Lost to Follow-up|2|||
144236678|NCT00664859|520062919|FG002|Overall Study|Lost to Follow-up|1|||
144236679|NCT00664859|520062917|FG000|Overall Study|Other|0|||
144236680|NCT00664859|520062918|FG001|Overall Study|Other|1|||
144236681|NCT00664859|520062919|FG002|Overall Study|Other|2|||
144236682|NCT01943851|520062920|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236683|NCT01943851|520062921|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236684|NCT01943851|520062922|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236685|NCT01943851|520062923|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
144236686|NCT01943851|520062924|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236687|NCT01943851|520062925|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236688|NCT01943851|520062926|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
144236689|NCT01943851|520062927|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
144236690|NCT01943851|520062928|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
144236691|NCT01943851|520062929|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236692|NCT01943851|520062930|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236693|NCT01943851|520062931|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236694|NCT01943851|520062932|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236695|NCT01943851|520062933|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236696|NCT01943851|520062934|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236697|NCT01943851|520062935|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236698|NCT01943851|520062936|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236699|NCT01943851|520062937|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
144236700|NCT01943851|520062920|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236701|NCT01943851|520062921|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236702|NCT01943851|520062922|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236703|NCT01943851|520062923|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236704|NCT01943851|520062924|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
144236705|NCT01943851|520062925|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236706|NCT01943851|520062926|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236707|NCT01943851|520062927|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
144236708|NCT01943851|520062928|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236709|NCT01943851|520062929|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236710|NCT01943851|520062930|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236711|NCT01943851|520062931|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236712|NCT01943851|520062932|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236713|NCT01943851|520062933|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236714|NCT01943851|520062934|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236715|NCT01943851|520062935|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236716|NCT01943851|520062936|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236717|NCT01943851|520062937|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
144236718|NCT01943851|520062920|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236719|NCT01943851|520062921|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236720|NCT01943851|520062922|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236721|NCT01943851|520062923|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236722|NCT01943851|520062924|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236723|NCT01943851|520062925|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236724|NCT01943851|520062926|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236725|NCT01943851|520062927|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236726|NCT01943851|520062928|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236727|NCT01943851|520062929|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236728|NCT01943851|520062930|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236729|NCT01943851|520062931|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236730|NCT01943851|520062932|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236731|NCT01943851|520062933|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
144236732|NCT01943851|520062934|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236733|NCT01943851|520062935|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236734|NCT01943851|520062936|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236735|NCT01943851|520062937|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
144236736|NCT01943851|520062920|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236737|NCT01943851|520062921|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236738|NCT01943851|520062922|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236739|NCT01943851|520062923|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236740|NCT01943851|520062924|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236741|NCT01943851|520062925|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236742|NCT01943851|520062926|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236743|NCT01943851|520062927|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236744|NCT01943851|520062928|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236745|NCT01943851|520062929|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236746|NCT01943851|520062930|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236747|NCT01943851|520062931|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236748|NCT01943851|520062932|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236749|NCT01943851|520062933|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236750|NCT01943851|520062934|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236751|NCT01943851|520062935|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
144236752|NCT01943851|520062936|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236753|NCT01943851|520062937|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
144236754|NCT01943851|520062920|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236755|NCT01943851|520062921|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236756|NCT01943851|520062922|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236757|NCT01943851|520062923|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236758|NCT01943851|520062924|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236759|NCT01943851|520062925|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236760|NCT01943851|520062926|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236761|NCT01943851|520062927|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236762|NCT01943851|520062928|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236763|NCT01943851|520062929|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236764|NCT01943851|520062930|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236765|NCT01943851|520062931|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236766|NCT01943851|520062932|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236767|NCT01943851|520062933|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236768|NCT01943851|520062934|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
144236769|NCT01943851|520062935|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
144236770|NCT01943851|520062936|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
144236771|NCT01943851|520062937|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
144236772|NCT04470544|520062953|FG000|Overall Study|Withdrawal by Subject|4|||
144236773|NCT04470544|520062954|FG001|Overall Study|Withdrawal by Subject|6|||
144236774|NCT00712881|520062956|FG000|Overall Study|Adverse Event|3|||
144236775|NCT00712881|520062957|FG001|Overall Study|Adverse Event|3|||
144236776|NCT00712881|520062956|FG000|Overall Study|Withdrawal by Subject|1|||
144236777|NCT00712881|520062957|FG001|Overall Study|Withdrawal by Subject|1|||
144236778|NCT00712881|520062956|FG000|Overall Study|Disease Progression|2|||
144236779|NCT00712881|520062957|FG001|Overall Study|Disease Progression|1|||
144236780|NCT00712881|520062956|FG000|Overall Study|Lost to Follow-up|1|||
144236781|NCT00712881|520062957|FG001|Overall Study|Lost to Follow-up|1|||
144236782|NCT00712881|520062956|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
144236783|NCT00712881|520062957|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
144236784|NCT00712881|520062956|FG000|Overall Study|Protocol Violation|1|||
144236785|NCT00712881|520062957|FG001|Overall Study|Protocol Violation|1|||
144236786|NCT00712881|520062956|FG000|Overall Study|Randomized but not treated|1|||
144236787|NCT00712881|520062957|FG001|Overall Study|Randomized but not treated|0|||
144236788|NCT00968981|520062960|FG000|Overall Study|Adverse Event|2|||
144236789|NCT00968981|520062961|FG001|Overall Study|Adverse Event|0|||
144236790|NCT00968981|520062962|FG002|Overall Study|Adverse Event|0|||
144236791|NCT00968981|520062960|FG000|Overall Study|Disease Progression|14|||
144236792|NCT00968981|520062961|FG001|Overall Study|Disease Progression|16|||
144236793|NCT00968981|520062962|FG002|Overall Study|Disease Progression|13|||
144236794|NCT00968981|520062960|FG000|Overall Study|Lost to Follow-up|0|||
144236795|NCT00968981|520062961|FG001|Overall Study|Lost to Follow-up|0|||
144236796|NCT00968981|520062962|FG002|Overall Study|Lost to Follow-up|1|||
144236797|NCT00968981|520062960|FG000|Overall Study|Physician Decision|5|||
144236798|NCT00968981|520062961|FG001|Overall Study|Physician Decision|3|||
144236799|NCT00968981|520062962|FG002|Overall Study|Physician Decision|5|||
144236800|NCT00968981|520062960|FG000|Overall Study|Withdrawal by Subject|1|||
144236801|NCT00968981|520062961|FG001|Overall Study|Withdrawal by Subject|3|||
144236802|NCT00968981|520062962|FG002|Overall Study|Withdrawal by Subject|3|||
144236803|NCT03499899|520062966|FG000|Overall Study|Adverse Event|2|||
144236804|NCT03499899|520062967|FG001|Overall Study|Adverse Event|3|||
144236805|NCT03499899|520062968|FG002|Overall Study|Adverse Event|3|||
144236806|NCT03499899|520062966|FG000|Overall Study|Death|0|||
144236807|NCT03499899|520062967|FG001|Overall Study|Death|0|||
144236808|NCT03499899|520062968|FG002|Overall Study|Death|1|||
144236809|NCT03499899|520062966|FG000|Overall Study|Physician Decision|3|||
144236810|NCT03499899|520062967|FG001|Overall Study|Physician Decision|6|||
144236811|NCT03499899|520062968|FG002|Overall Study|Physician Decision|6|||
144236812|NCT03499899|520062966|FG000|Overall Study|Progressive disease|15|||
144236813|NCT03499899|520062967|FG001|Overall Study|Progressive disease|23|||
144236814|NCT03499899|520062968|FG002|Overall Study|Progressive disease|23|||
144236815|NCT03499899|520062966|FG000|Overall Study|Patient decision|0|||
144236816|NCT03499899|520062967|FG001|Overall Study|Patient decision|1|||
144236817|NCT03499899|520062968|FG002|Overall Study|Patient decision|1|||
144236818|NCT03499899|520062966|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
144236819|NCT03499899|520062967|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
144236820|NCT03499899|520062968|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
144236821|NCT01609543|520062969|FG000|Overall Study|Disease Progression|28|||
144236822|NCT01609543|520062969|FG000|Overall Study|Adverse Event|5|||
144236823|NCT01609543|520062969|FG000|Overall Study|Withdrawal by Subject|1|||
144236824|NCT01609543|520062969|FG000|Overall Study|Protocol Violation|1|||
144236825|NCT01609543|520062969|FG000|Overall Study|Death|7|||
144236826|NCT02218736|520062970|FG000|Overall Study|Withdrawal by Subject|10|||
144236827|NCT02218736|520062971|FG001|Overall Study|Withdrawal by Subject|9|||
144236828|NCT02218736|520062970|FG000|Overall Study|Protocol Violation|2|||
144236829|NCT02218736|520062971|FG001|Overall Study|Protocol Violation|0|||
144236830|NCT03702010|520062976|FG000|Follow-up (30days)|Lack of Efficacy|2|||
144236831|NCT03702010|520062977|FG001|Follow-up (30days)|Lack of Efficacy|2|||
144236832|NCT01254318|520062978|FG000|Overall Study|Lost to Follow-up|5|||
144236833|NCT01254318|520062978|FG000|Overall Study|Death|47|||
144236834|NCT04016779|520062989|FG000|Overall Study|Adverse Event|9|||
144236835|NCT04016779|520062990|FG001|Overall Study|Adverse Event|17|||
144236836|NCT04016779|520062989|FG000|Overall Study|Lack of Efficacy|4|||
144236837|NCT04016779|520062990|FG001|Overall Study|Lack of Efficacy|1|||
144236838|NCT04016779|520062989|FG000|Overall Study|Lost to Follow-up|5|||
144236839|NCT04016779|520062990|FG001|Overall Study|Lost to Follow-up|14|||
144236840|NCT04016779|520062989|FG000|Overall Study|Physician Decision|1|||
144236841|NCT04016779|520062990|FG001|Overall Study|Physician Decision|3|||
144236842|NCT04016779|520062989|FG000|Overall Study|Withdrawal by Subject|6|||
144236843|NCT04016779|520062990|FG001|Overall Study|Withdrawal by Subject|8|||
144236844|NCT04016779|520062989|FG000|Overall Study|Non-compliance with Study Drug|2|||
144236845|NCT04016779|520062990|FG001|Overall Study|Non-compliance with Study Drug|3|||
144236846|NCT04016779|520062989|FG000|Overall Study|Other, Multiple categories|17|||
144236847|NCT04016779|520062990|FG001|Overall Study|Other, Multiple categories|17|||
144236848|NCT02295020|520062993|FG000|Overall Study|Adverse Event|0|||
144236849|NCT02295020|520062994|FG001|Overall Study|Adverse Event|1|||
144236850|NCT02295020|520062993|FG000|Overall Study|Withdrawal by Subject|3|||
144236851|NCT02295020|520062994|FG001|Overall Study|Withdrawal by Subject|2|||
144236852|NCT01137110|520062995|FG000|Overall Study|Protocol Violation|1|||
144236853|NCT01137110|520062996|FG001|Overall Study|Protocol Violation|0|||
144236854|NCT03514485|520063002|FG000|Overall Study|Lost to Follow-up|5|||
144236855|NCT03514485|520063003|FG001|Overall Study|Lost to Follow-up|3|||
144236856|NCT03514485|520063004|FG002|Overall Study|Lost to Follow-up|2|||
144236857|NCT03514485|520063005|FG003|Overall Study|Lost to Follow-up|0|||
144236858|NCT03514485|520063006|FG004|Overall Study|Lost to Follow-up|1|||
144236859|NCT03514485|520063007|FG005|Overall Study|Lost to Follow-up|4|||
144236860|NCT03514485|520063002|FG000|Overall Study|Withdrawal by Subject|0|||
144236861|NCT03514485|520063003|FG001|Overall Study|Withdrawal by Subject|1|||
144236862|NCT03514485|520063004|FG002|Overall Study|Withdrawal by Subject|3|||
144236863|NCT03514485|520063005|FG003|Overall Study|Withdrawal by Subject|1|||
144236864|NCT03514485|520063006|FG004|Overall Study|Withdrawal by Subject|2|||
144236865|NCT03514485|520063007|FG005|Overall Study|Withdrawal by Subject|1|||
144236866|NCT02438826|520063010|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
144236867|NCT02438826|520063011|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
144236868|NCT02438826|520063012|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
144236869|NCT02438826|520063013|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
144236870|NCT02438826|520063010|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
144236871|NCT02438826|520063011|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144236872|NCT02438826|520063012|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144236873|NCT02438826|520063013|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144236874|NCT02438826|520063010|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
144236875|NCT02438826|520063011|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
144236876|NCT02438826|520063012|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144236877|NCT02438826|520063013|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144236878|NCT02438826|520063010|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
144236879|NCT02438826|520063011|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
144236880|NCT02438826|520063012|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
144236881|NCT02438826|520063013|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
144236882|NCT02438826|520063010|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
144236883|NCT02438826|520063011|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
144236884|NCT02438826|520063012|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
144236885|NCT02438826|520063013|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
144236886|NCT02438826|520063010|FG000|Open-Label Treatment Phase|Adverse Event|11|||
144236887|NCT02438826|520063011|FG001|Open-Label Treatment Phase|Adverse Event|6|||
144236888|NCT02438826|520063012|FG002|Open-Label Treatment Phase|Adverse Event|0|||
144236889|NCT02438826|520063013|FG003|Open-Label Treatment Phase|Adverse Event|0|||
144236890|NCT02438826|520063010|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
144236891|NCT02438826|520063011|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
144236892|NCT02438826|520063012|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
144236893|NCT02438826|520063013|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
144236894|NCT02438826|520063010|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
144236895|NCT02438826|520063011|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
144236896|NCT02438826|520063012|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
144236897|NCT02438826|520063013|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
144236898|NCT02438826|520063010|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
144236899|NCT02438826|520063011|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
144236900|NCT02438826|520063012|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
144236901|NCT02438826|520063013|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
144236902|NCT02438826|520063010|FG000|Post-Treatment Phase|Adverse Event|3|||
144236903|NCT02438826|520063011|FG001|Post-Treatment Phase|Adverse Event|0|||
144236904|NCT02438826|520063012|FG002|Post-Treatment Phase|Adverse Event|0|||
144236905|NCT02438826|520063013|FG003|Post-Treatment Phase|Adverse Event|0|||
144236906|NCT02438826|520063010|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
144236907|NCT02438826|520063011|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
144236908|NCT02438826|520063012|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
144236909|NCT02438826|520063013|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
144236910|NCT02438826|520063010|FG000|Post-Treatment Phase|Physician Decision|1|||
144236911|NCT02438826|520063011|FG001|Post-Treatment Phase|Physician Decision|0|||
144236912|NCT02438826|520063012|FG002|Post-Treatment Phase|Physician Decision|0|||
144236913|NCT02438826|520063013|FG003|Post-Treatment Phase|Physician Decision|0|||
144236914|NCT02438826|520063010|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
144236915|NCT02438826|520063011|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
144236916|NCT02438826|520063012|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
144236917|NCT02438826|520063013|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
144236918|NCT00675428|520063018|FG000|Overall Study|Disease Progression|2|||
144236919|NCT00675428|520063019|FG001|Overall Study|Disease Progression|2|||
144236920|NCT00675428|520063018|FG000|Overall Study|No Disease Response After Cycle 6|0|||
144269817|NCT01677741|520191429|FG005|Overall Study|Withdrawal by Subject|20|||
144269818|NCT01677741|520191430|FG006|Overall Study|Withdrawal by Subject|4|||
144236921|NCT00675428|520063019|FG001|Overall Study|No Disease Response After Cycle 6|1|||
144236922|NCT00675428|520063018|FG000|Overall Study|Physician Decision|1|||
144236923|NCT00675428|520063019|FG001|Overall Study|Physician Decision|0|||
144236924|NCT01500187|520063022|FG000|Overall Study|Lost to Follow-up|6|||
144236925|NCT01500187|520063023|FG001|Overall Study|Lost to Follow-up|0|||
144236926|NCT01343277|520063038|FG000|Overall Study|Other|3|||
144236927|NCT01343277|520063039|FG001|Overall Study|Other|3|||
144236928|NCT01343277|520063038|FG000|Overall Study|Withdrawal by Subject|18|||
144236929|NCT01343277|520063039|FG001|Overall Study|Withdrawal by Subject|13|||
144236930|NCT01343277|520063038|FG000|Overall Study|Physician Decision|1|||
144236931|NCT01343277|520063039|FG001|Overall Study|Physician Decision|2|||
144236932|NCT01343277|520063038|FG000|Overall Study|Death|10|||
144236933|NCT01343277|520063039|FG001|Overall Study|Death|1|||
144236934|NCT01343277|520063038|FG000|Overall Study|Adverse Event|67|||
144236935|NCT01343277|520063039|FG001|Overall Study|Adverse Event|13|||
144236936|NCT01343277|520063038|FG000|Overall Study|Disease progression|270|||
144236937|NCT01343277|520063039|FG001|Overall Study|Disease progression|138|||
144236938|NCT01343277|520063038|FG000|Overall Study|Randomized not treated|6|||
144236939|NCT01343277|520063039|FG001|Overall Study|Randomized not treated|21|||
144236940|NCT01343277|520063038|FG000|Overall Study|Treatment ongoing|8|||
144236941|NCT01343277|520063039|FG001|Overall Study|Treatment ongoing|2|||
144236942|NCT01343277|520063038|FG000|Overall Study|Subsequent anticancer therapy|1|||
144236943|NCT01343277|520063039|FG001|Overall Study|Subsequent anticancer therapy|0|||
144236944|NCT01094301|520063040|FG000|Trial Stage|Withdrawal by Subject|1|||
144236945|NCT01094301|520063040|FG000|Implant Stage|Adverse Event|1|||
144236946|NCT01094301|520063040|FG000|Implant Stage|Protocol Violation|1|||
144236947|NCT01094301|520063040|FG000|Implant Stage|Withdrawal by Subject|2|||
144236948|NCT01094301|520063040|FG000|Implant Stage|No return of pain|4|||
144236949|NCT00135512|520063041|FG000|Overall Study|Adverse Event|56|||
144236950|NCT00135512|520063041|FG000|Overall Study|Lack of Efficacy|25|||
144236951|NCT00135512|520063041|FG000|Overall Study|Other|42|||
144236952|NCT04013672|520063043|FG000|Overall Study|Withdrawal by Subject|3|||
144236953|NCT04013672|520063044|FG001|Overall Study|Withdrawal by Subject|0|||
144236954|NCT04013672|520063043|FG000|Overall Study|Death|1|||
144236955|NCT04013672|520063044|FG001|Overall Study|Death|0|||
144236956|NCT04013672|520063043|FG000|Overall Study|Physician Decision|5|||
144236957|NCT04013672|520063044|FG001|Overall Study|Physician Decision|0|||
144236958|NCT00430573|520063047|FG000|Overall Study|Withdrawal by Subject|5|||
144236959|NCT05020665|520063050|FG000|Overall Study|Study terminated by Sponsor|5|||
144236960|NCT05020665|520063051|FG001|Overall Study|Study terminated by Sponsor|4|||
144236961|NCT05020665|520063050|FG000|Overall Study|Death|2|||
144236962|NCT05020665|520063051|FG001|Overall Study|Death|1|||
144236963|NCT05020665|520063050|FG000|Overall Study|Physician Decision|0|||
144236964|NCT05020665|520063051|FG001|Overall Study|Physician Decision|1|||
144236965|NCT05020665|520063050|FG000|Overall Study|Withdrawal by Subject|0|||
144236966|NCT05020665|520063051|FG001|Overall Study|Withdrawal by Subject|1|||
144236967|NCT05020665|520063050|FG000|Overall Study|Reason not specified|1|||
144236968|NCT05020665|520063051|FG001|Overall Study|Reason not specified|0|||
144236969|NCT01868022|520063052|FG000|Overall Study|Withdrawal by Subject|0|||
144236970|NCT01868022|520063053|FG001|Overall Study|Withdrawal by Subject|0|||
144236971|NCT01868022|520063054|FG002|Overall Study|Withdrawal by Subject|1|||
144236972|NCT01868022|520063055|FG003|Overall Study|Withdrawal by Subject|1|||
144236973|NCT01868022|520063056|FG004|Overall Study|Withdrawal by Subject|0|||
144236974|NCT01868022|520063057|FG005|Overall Study|Withdrawal by Subject|0|||
144236975|NCT01868022|520063058|FG006|Overall Study|Withdrawal by Subject|0|||
144236976|NCT01868022|520063059|FG007|Overall Study|Withdrawal by Subject|1|||
144236977|NCT01868022|520063060|FG008|Overall Study|Withdrawal by Subject|0|||
144236978|NCT01868022|520063052|FG000|Overall Study|Adverse Event|0|||
144236979|NCT01868022|520063053|FG001|Overall Study|Adverse Event|0|||
144236980|NCT01868022|520063054|FG002|Overall Study|Adverse Event|0|||
144236981|NCT01868022|520063055|FG003|Overall Study|Adverse Event|0|||
144236982|NCT01868022|520063056|FG004|Overall Study|Adverse Event|2|||
144236983|NCT01868022|520063057|FG005|Overall Study|Adverse Event|0|||
144236984|NCT01868022|520063058|FG006|Overall Study|Adverse Event|0|||
144236985|NCT01868022|520063059|FG007|Overall Study|Adverse Event|2|||
144236986|NCT01868022|520063060|FG008|Overall Study|Adverse Event|2|||
144236987|NCT01868022|520063052|FG000|Overall Study|Physician Decision|0|||
144236988|NCT01868022|520063053|FG001|Overall Study|Physician Decision|0|||
144236989|NCT01868022|520063054|FG002|Overall Study|Physician Decision|0|||
144236990|NCT01868022|520063055|FG003|Overall Study|Physician Decision|0|||
144236991|NCT01868022|520063056|FG004|Overall Study|Physician Decision|0|||
144236992|NCT01868022|520063057|FG005|Overall Study|Physician Decision|1|||
144269819|NCT01677741|520191431|FG007|Overall Study|Withdrawal by Subject|2|||
144236993|NCT01868022|520063058|FG006|Overall Study|Physician Decision|0|||
144236994|NCT01868022|520063059|FG007|Overall Study|Physician Decision|2|||
144236995|NCT01868022|520063060|FG008|Overall Study|Physician Decision|0|||
144236996|NCT01868022|520063052|FG000|Overall Study|Study closed/terminated|0|||
144269820|NCT01677741|520191424|FG000|Overall Study|Enrolled in a rollover study|0|||
144236997|NCT01868022|520063053|FG001|Overall Study|Study closed/terminated|0|||
144236998|NCT01868022|520063054|FG002|Overall Study|Study closed/terminated|0|||
144236999|NCT01868022|520063055|FG003|Overall Study|Study closed/terminated|0|||
144237000|NCT01868022|520063056|FG004|Overall Study|Study closed/terminated|0|||
144237001|NCT01868022|520063057|FG005|Overall Study|Study closed/terminated|0|||
144237002|NCT01868022|520063058|FG006|Overall Study|Study closed/terminated|0|||
144237003|NCT01868022|520063059|FG007|Overall Study|Study closed/terminated|1|||
144237004|NCT01868022|520063060|FG008|Overall Study|Study closed/terminated|0|||
144237005|NCT01868022|520063052|FG000|Overall Study|Ongoing|0|||
144237006|NCT01868022|520063053|FG001|Overall Study|Ongoing|0|||
144237007|NCT01868022|520063054|FG002|Overall Study|Ongoing|0|||
144237008|NCT01868022|520063055|FG003|Overall Study|Ongoing|0|||
144237009|NCT01868022|520063056|FG004|Overall Study|Ongoing|0|||
144237010|NCT01868022|520063057|FG005|Overall Study|Ongoing|0|||
144237011|NCT01868022|520063058|FG006|Overall Study|Ongoing|0|||
144237012|NCT01868022|520063059|FG007|Overall Study|Ongoing|3|||
144237013|NCT01868022|520063060|FG008|Overall Study|Ongoing|0|||
144237014|NCT04999163|520063071|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
144237015|NCT04999163|520063072|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
144237016|NCT04999163|520063071|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
144237017|NCT04999163|520063072|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
144237018|NCT04999163|520063071|FG000|Overall Study|Withdrawal by Subject|1|||
144237019|NCT04999163|520063072|FG001|Overall Study|Withdrawal by Subject|0|||
144237020|NCT02817516|520065854|FG000|Overall Study|Other|0|||
144237021|NCT02817516|520065855|FG001|Overall Study|Other|0|||
144237022|NCT02817516|520065856|FG002|Overall Study|Other|1|||
144237023|NCT02817516|520065857|FG003|Overall Study|Other|0|||
144237024|NCT00348595|520065858|FG000|Overall Study|Adverse Event|5|||
144237025|NCT00348595|520065859|FG001|Overall Study|Adverse Event|8|||
144237026|NCT04429555|520065860|FG000|Overall Study|Death|0|||
144237027|NCT04429555|520065861|FG001|Overall Study|Death|2|||
144237028|NCT04429555|520065860|FG000|Overall Study|Other|2|||
144237029|NCT04429555|520065861|FG001|Overall Study|Other|0|||
144237030|NCT05113979|520065862|FG000|Overall Study|Death|2|||
144237031|NCT05113979|520065862|FG000|Overall Study|Lost to Follow-up|1|||
144237032|NCT02394340|520065871|FG000|Overall Study|Failed drug screen test|1|||
144237033|NCT02394340|520065871|FG000|Overall Study|Adverse Event|1|||
144237034|NCT02828124|520065874|FG000|Overall Study|Disease Progression|1|||
144237035|NCT02828124|520065875|FG001|Overall Study|Disease Progression|2|||
144237036|NCT02828124|520065876|FG002|Overall Study|Disease Progression|1|||
144237037|NCT02828124|520065877|FG003|Overall Study|Disease Progression|4|||
144237038|NCT02828124|520065874|FG000|Overall Study|AE Unrelated to Study Drug|0|||
144237039|NCT02828124|520065875|FG001|Overall Study|AE Unrelated to Study Drug|0|||
144237040|NCT02828124|520065876|FG002|Overall Study|AE Unrelated to Study Drug|0|||
144237041|NCT02828124|520065877|FG003|Overall Study|AE Unrelated to Study Drug|1|||
144237042|NCT02828124|520065874|FG000|Overall Study|Subject Withdrew Consent|0|||
144237043|NCT02828124|520065875|FG001|Overall Study|Subject Withdrew Consent|0|||
144237044|NCT02828124|520065876|FG002|Overall Study|Subject Withdrew Consent|0|||
144237045|NCT02828124|520065877|FG003|Overall Study|Subject Withdrew Consent|1|||
144237046|NCT00747474|520065879|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237047|NCT00747474|520065880|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237048|NCT00747474|520065881|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237049|NCT00747474|520065882|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237050|NCT00747474|520065883|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237051|NCT00747474|520065884|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237052|NCT00747474|520065885|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237053|NCT00747474|520065886|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
144237054|NCT00747474|520065887|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237055|NCT00747474|520065888|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237056|NCT00747474|520065889|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237057|NCT00747474|520065890|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
144237058|NCT02829723|520065891|FG000|Overall Study|Adverse Event|0|||
144237059|NCT02829723|520065892|FG001|Overall Study|Adverse Event|0|||
144237060|NCT02829723|520065893|FG002|Overall Study|Adverse Event|1|||
144237061|NCT02829723|520065894|FG003|Overall Study|Adverse Event|1|||
144237062|NCT02829723|520065895|FG004|Overall Study|Adverse Event|0|||
144237063|NCT02829723|520065896|FG005|Overall Study|Adverse Event|0|||
144237064|NCT02829723|520065897|FG006|Overall Study|Adverse Event|0|||
144237065|NCT02829723|520065898|FG007|Overall Study|Adverse Event|1|||
144237066|NCT02829723|520065899|FG008|Overall Study|Adverse Event|0|||
144237067|NCT02829723|520065900|FG009|Overall Study|Adverse Event|0|||
144237068|NCT02829723|520065901|FG010|Overall Study|Adverse Event|0|||
144237069|NCT02829723|520065902|FG011|Overall Study|Adverse Event|0|||
144237070|NCT02829723|520065903|FG012|Overall Study|Adverse Event|0|||
144237071|NCT02829723|520065904|FG013|Overall Study|Adverse Event|0|||
144237072|NCT02829723|520065905|FG014|Overall Study|Adverse Event|1|||
144237073|NCT02829723|520065906|FG015|Overall Study|Adverse Event|1|||
144237074|NCT02829723|520065907|FG016|Overall Study|Adverse Event|1|||
144237075|NCT02829723|520065908|FG017|Overall Study|Adverse Event|2|||
144237076|NCT02829723|520065909|FG018|Overall Study|Adverse Event|1|||
144237077|NCT02829723|520065910|FG019|Overall Study|Adverse Event|1|||
144237078|NCT02829723|520065911|FG020|Overall Study|Adverse Event|3|||
144237079|NCT02829723|520065912|FG021|Overall Study|Adverse Event|0|||
144237080|NCT02829723|520065913|FG022|Overall Study|Adverse Event|0|||
144237081|NCT02829723|520065914|FG023|Overall Study|Adverse Event|1|||
144237082|NCT02829723|520065915|FG024|Overall Study|Adverse Event|1|||
144237083|NCT02829723|520065916|FG025|Overall Study|Adverse Event|3|||
144237084|NCT02829723|520065917|FG026|Overall Study|Adverse Event|5|||
144237085|NCT02829723|520065891|FG000|Overall Study|Death|1|||
144237086|NCT02829723|520065892|FG001|Overall Study|Death|0|||
144237087|NCT02829723|520065893|FG002|Overall Study|Death|1|||
144237088|NCT02829723|520065894|FG003|Overall Study|Death|1|||
144237089|NCT02829723|520065895|FG004|Overall Study|Death|0|||
144237090|NCT02829723|520065896|FG005|Overall Study|Death|0|||
144237091|NCT02829723|520065897|FG006|Overall Study|Death|2|||
144237092|NCT02829723|520065898|FG007|Overall Study|Death|0|||
144237093|NCT02829723|520065899|FG008|Overall Study|Death|1|||
144237094|NCT02829723|520065900|FG009|Overall Study|Death|0|||
144237095|NCT02829723|520065901|FG010|Overall Study|Death|0|||
144237096|NCT02829723|520065902|FG011|Overall Study|Death|0|||
144237097|NCT02829723|520065903|FG012|Overall Study|Death|2|||
144237098|NCT02829723|520065904|FG013|Overall Study|Death|1|||
144237099|NCT02829723|520065905|FG014|Overall Study|Death|0|||
144237100|NCT02829723|520065906|FG015|Overall Study|Death|0|||
144237101|NCT02829723|520065907|FG016|Overall Study|Death|0|||
144237102|NCT02829723|520065908|FG017|Overall Study|Death|0|||
144237103|NCT02829723|520065909|FG018|Overall Study|Death|0|||
144237104|NCT02829723|520065910|FG019|Overall Study|Death|0|||
144237105|NCT02829723|520065911|FG020|Overall Study|Death|0|||
144237106|NCT02829723|520065912|FG021|Overall Study|Death|2|||
144237107|NCT02829723|520065913|FG022|Overall Study|Death|0|||
144237108|NCT02829723|520065914|FG023|Overall Study|Death|0|||
144237109|NCT02829723|520065915|FG024|Overall Study|Death|0|||
144237110|NCT02829723|520065916|FG025|Overall Study|Death|1|||
144237111|NCT02829723|520065917|FG026|Overall Study|Death|2|||
144237112|NCT02829723|520065891|FG000|Overall Study|Physician Decision|0|||
144237113|NCT02829723|520065892|FG001|Overall Study|Physician Decision|0|||
144237114|NCT02829723|520065893|FG002|Overall Study|Physician Decision|0|||
144237115|NCT02829723|520065894|FG003|Overall Study|Physician Decision|0|||
144237116|NCT02829723|520065895|FG004|Overall Study|Physician Decision|0|||
144237117|NCT02829723|520065896|FG005|Overall Study|Physician Decision|0|||
144237118|NCT02829723|520065897|FG006|Overall Study|Physician Decision|0|||
144237119|NCT02829723|520065898|FG007|Overall Study|Physician Decision|0|||
144237120|NCT02829723|520065899|FG008|Overall Study|Physician Decision|0|||
144237121|NCT02829723|520065900|FG009|Overall Study|Physician Decision|1|||
144237122|NCT02829723|520065901|FG010|Overall Study|Physician Decision|1|||
144237123|NCT02829723|520065902|FG011|Overall Study|Physician Decision|0|||
144237124|NCT02829723|520065903|FG012|Overall Study|Physician Decision|0|||
144237125|NCT02829723|520065904|FG013|Overall Study|Physician Decision|1|||
144237126|NCT02829723|520065905|FG014|Overall Study|Physician Decision|0|||
144237127|NCT02829723|520065906|FG015|Overall Study|Physician Decision|0|||
144237128|NCT02829723|520065907|FG016|Overall Study|Physician Decision|2|||
144237129|NCT02829723|520065908|FG017|Overall Study|Physician Decision|0|||
144237130|NCT02829723|520065909|FG018|Overall Study|Physician Decision|0|||
144237131|NCT02829723|520065910|FG019|Overall Study|Physician Decision|0|||
144237132|NCT02829723|520065911|FG020|Overall Study|Physician Decision|0|||
144237133|NCT02829723|520065912|FG021|Overall Study|Physician Decision|0|||
144237134|NCT02829723|520065913|FG022|Overall Study|Physician Decision|1|||
144237135|NCT02829723|520065914|FG023|Overall Study|Physician Decision|1|||
144237136|NCT02829723|520065915|FG024|Overall Study|Physician Decision|1|||
144237137|NCT02829723|520065916|FG025|Overall Study|Physician Decision|1|||
144237138|NCT02829723|520065917|FG026|Overall Study|Physician Decision|3|||
144237139|NCT02829723|520065891|FG000|Overall Study|Progressive disease|4|||
144237140|NCT02829723|520065892|FG001|Overall Study|Progressive disease|6|||
144237141|NCT02829723|520065893|FG002|Overall Study|Progressive disease|3|||
144237142|NCT02829723|520065894|FG003|Overall Study|Progressive disease|3|||
144237143|NCT02829723|520065895|FG004|Overall Study|Progressive disease|3|||
144237144|NCT02829723|520065896|FG005|Overall Study|Progressive disease|5|||
144237145|NCT02829723|520065897|FG006|Overall Study|Progressive disease|4|||
144237146|NCT02829723|520065898|FG007|Overall Study|Progressive disease|6|||
144237147|NCT02829723|520065899|FG008|Overall Study|Progressive disease|8|||
144237148|NCT02829723|520065900|FG009|Overall Study|Progressive disease|4|||
144237149|NCT02829723|520065901|FG010|Overall Study|Progressive disease|9|||
144237150|NCT02829723|520065902|FG011|Overall Study|Progressive disease|0|||
144237151|NCT02829723|520065903|FG012|Overall Study|Progressive disease|3|||
144237152|NCT02829723|520065904|FG013|Overall Study|Progressive disease|4|||
144237153|NCT02829723|520065905|FG014|Overall Study|Progressive disease|2|||
144237154|NCT02829723|520065906|FG015|Overall Study|Progressive disease|4|||
144237155|NCT02829723|520065907|FG016|Overall Study|Progressive disease|5|||
144237156|NCT02829723|520065908|FG017|Overall Study|Progressive disease|3|||
144237157|NCT02829723|520065909|FG018|Overall Study|Progressive disease|4|||
144237158|NCT02829723|520065910|FG019|Overall Study|Progressive disease|4|||
144237159|NCT02829723|520065911|FG020|Overall Study|Progressive disease|7|||
144237160|NCT02829723|520065912|FG021|Overall Study|Progressive disease|6|||
144237161|NCT02829723|520065913|FG022|Overall Study|Progressive disease|3|||
144237162|NCT02829723|520065914|FG023|Overall Study|Progressive disease|3|||
144237163|NCT02829723|520065915|FG024|Overall Study|Progressive disease|3|||
144237164|NCT02829723|520065916|FG025|Overall Study|Progressive disease|16|||
144237165|NCT02829723|520065917|FG026|Overall Study|Progressive disease|10|||
144237166|NCT02829723|520065891|FG000|Overall Study|Subject/guardian decision|0|||
144237167|NCT02829723|520065892|FG001|Overall Study|Subject/guardian decision|1|||
144237168|NCT02829723|520065893|FG002|Overall Study|Subject/guardian decision|0|||
144237169|NCT02829723|520065894|FG003|Overall Study|Subject/guardian decision|1|||
144237170|NCT02829723|520065895|FG004|Overall Study|Subject/guardian decision|0|||
144237171|NCT02829723|520065896|FG005|Overall Study|Subject/guardian decision|0|||
144237172|NCT02829723|520065897|FG006|Overall Study|Subject/guardian decision|0|||
144237173|NCT02829723|520065898|FG007|Overall Study|Subject/guardian decision|1|||
144237174|NCT02829723|520065899|FG008|Overall Study|Subject/guardian decision|0|||
144237175|NCT02829723|520065900|FG009|Overall Study|Subject/guardian decision|0|||
144237176|NCT02829723|520065901|FG010|Overall Study|Subject/guardian decision|0|||
144237177|NCT02829723|520065902|FG011|Overall Study|Subject/guardian decision|0|||
144237178|NCT02829723|520065903|FG012|Overall Study|Subject/guardian decision|0|||
144237179|NCT02829723|520065904|FG013|Overall Study|Subject/guardian decision|0|||
144237180|NCT02829723|520065905|FG014|Overall Study|Subject/guardian decision|1|||
144237181|NCT02829723|520065906|FG015|Overall Study|Subject/guardian decision|0|||
144237182|NCT02829723|520065907|FG016|Overall Study|Subject/guardian decision|1|||
144237183|NCT02829723|520065908|FG017|Overall Study|Subject/guardian decision|0|||
144237184|NCT02829723|520065909|FG018|Overall Study|Subject/guardian decision|1|||
144237185|NCT02829723|520065910|FG019|Overall Study|Subject/guardian decision|0|||
144237186|NCT02829723|520065911|FG020|Overall Study|Subject/guardian decision|1|||
144237187|NCT02829723|520065912|FG021|Overall Study|Subject/guardian decision|0|||
144237188|NCT02829723|520065913|FG022|Overall Study|Subject/guardian decision|0|||
144237189|NCT02829723|520065914|FG023|Overall Study|Subject/guardian decision|1|||
144237190|NCT02829723|520065915|FG024|Overall Study|Subject/guardian decision|0|||
144237191|NCT02829723|520065916|FG025|Overall Study|Subject/guardian decision|1|||
144237192|NCT02829723|520065917|FG026|Overall Study|Subject/guardian decision|1|||
144237193|NCT02829723|520065891|FG000|Overall Study|Study terminated by sponsor|0|||
144237194|NCT02829723|520065892|FG001|Overall Study|Study terminated by sponsor|0|||
144237195|NCT02829723|520065893|FG002|Overall Study|Study terminated by sponsor|0|||
144237196|NCT02829723|520065894|FG003|Overall Study|Study terminated by sponsor|0|||
144237197|NCT02829723|520065895|FG004|Overall Study|Study terminated by sponsor|0|||
144237198|NCT02829723|520065896|FG005|Overall Study|Study terminated by sponsor|0|||
144237199|NCT02829723|520065897|FG006|Overall Study|Study terminated by sponsor|0|||
144237200|NCT02829723|520065898|FG007|Overall Study|Study terminated by sponsor|0|||
144237201|NCT02829723|520065899|FG008|Overall Study|Study terminated by sponsor|0|||
144237202|NCT02829723|520065900|FG009|Overall Study|Study terminated by sponsor|0|||
144237203|NCT02829723|520065901|FG010|Overall Study|Study terminated by sponsor|0|||
144237204|NCT02829723|520065902|FG011|Overall Study|Study terminated by sponsor|0|||
144237205|NCT02829723|520065903|FG012|Overall Study|Study terminated by sponsor|0|||
144237206|NCT02829723|520065904|FG013|Overall Study|Study terminated by sponsor|0|||
144237207|NCT02829723|520065905|FG014|Overall Study|Study terminated by sponsor|0|||
144237208|NCT02829723|520065906|FG015|Overall Study|Study terminated by sponsor|0|||
144237209|NCT02829723|520065907|FG016|Overall Study|Study terminated by sponsor|0|||
144237210|NCT02829723|520065908|FG017|Overall Study|Study terminated by sponsor|0|||
144237211|NCT02829723|520065909|FG018|Overall Study|Study terminated by sponsor|0|||
144237212|NCT02829723|520065910|FG019|Overall Study|Study terminated by sponsor|0|||
144237213|NCT02829723|520065911|FG020|Overall Study|Study terminated by sponsor|0|||
144237214|NCT02829723|520065912|FG021|Overall Study|Study terminated by sponsor|1|||
144237215|NCT02829723|520065913|FG022|Overall Study|Study terminated by sponsor|0|||
144237216|NCT02829723|520065914|FG023|Overall Study|Study terminated by sponsor|0|||
144237217|NCT02829723|520065915|FG024|Overall Study|Study terminated by sponsor|0|||
144237218|NCT02829723|520065916|FG025|Overall Study|Study terminated by sponsor|0|||
144237219|NCT02829723|520065917|FG026|Overall Study|Study terminated by sponsor|0|||
144237220|NCT02989649|520065918|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
144237221|NCT02989649|520065918|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
144237222|NCT02989649|520065918|FG000|Overall Study|Lost For Observation During Study|3|||
144237223|NCT02989649|520065918|FG000|Overall Study|Reason Not Specified|13|||
144237224|NCT00256854|520065919|FG000|Overall Study|Withdrawal by Subject|2|||
144237225|NCT00256854|520065920|FG001|Overall Study|Withdrawal by Subject|3|||
144237226|NCT00256854|520065921|FG002|Overall Study|Withdrawal by Subject|0|||
144237227|NCT00256854|520065922|FG003|Overall Study|Withdrawal by Subject|0|||
144237228|NCT00256854|520065923|FG004|Overall Study|Withdrawal by Subject|0|||
144237229|NCT00256854|520065924|FG005|Overall Study|Withdrawal by Subject|0|||
144237230|NCT00256854|520065919|FG000|Overall Study|Lack of Efficacy|1|||
144237231|NCT00256854|520065920|FG001|Overall Study|Lack of Efficacy|0|||
144237232|NCT00256854|520065921|FG002|Overall Study|Lack of Efficacy|0|||
144237233|NCT00256854|520065922|FG003|Overall Study|Lack of Efficacy|0|||
144237234|NCT00256854|520065923|FG004|Overall Study|Lack of Efficacy|0|||
144237235|NCT00256854|520065924|FG005|Overall Study|Lack of Efficacy|0|||
144237236|NCT00256854|520065919|FG000|Overall Study|Protocol Violation|0|||
144237237|NCT00256854|520065920|FG001|Overall Study|Protocol Violation|1|||
144237238|NCT00256854|520065921|FG002|Overall Study|Protocol Violation|1|||
144237239|NCT00256854|520065922|FG003|Overall Study|Protocol Violation|1|||
144237240|NCT00256854|520065923|FG004|Overall Study|Protocol Violation|0|||
144237241|NCT00256854|520065924|FG005|Overall Study|Protocol Violation|0|||
144237242|NCT00256854|520065919|FG000|Overall Study|Adverse Event|0|||
144237243|NCT00256854|520065920|FG001|Overall Study|Adverse Event|0|||
144237244|NCT00256854|520065921|FG002|Overall Study|Adverse Event|2|||
144237245|NCT00256854|520065922|FG003|Overall Study|Adverse Event|2|||
144237246|NCT00256854|520065923|FG004|Overall Study|Adverse Event|0|||
144237247|NCT00256854|520065924|FG005|Overall Study|Adverse Event|1|||
144237248|NCT00256854|520065919|FG000|Overall Study|Not compliant with the study drug|0|||
144237249|NCT00256854|520065920|FG001|Overall Study|Not compliant with the study drug|0|||
144237250|NCT00256854|520065921|FG002|Overall Study|Not compliant with the study drug|0|||
144237251|NCT00256854|520065922|FG003|Overall Study|Not compliant with the study drug|0|||
144237252|NCT00256854|520065923|FG004|Overall Study|Not compliant with the study drug|1|||
144237253|NCT00256854|520065924|FG005|Overall Study|Not compliant with the study drug|0|||
144237254|NCT02353442|520065925|FG000|Overall Study|Withdrawal by Subject|3|||
144237255|NCT02353442|520065926|FG001|Overall Study|Withdrawal by Subject|4|||
144237256|NCT06586788|520065927|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
144237257|NCT03990571|520065928|FG000|Overall Study|Withdrawal by Subject|1|||
144237258|NCT03990571|520065928|FG000|Overall Study|Insurance Issues|3|||
144237259|NCT03990571|520065928|FG000|Overall Study|Covid Restrictions|2|||
144237260|NCT02004886|520065929|FG000|Overall Study|Adverse Event|0|||
144237261|NCT02004886|520065930|FG001|Overall Study|Adverse Event|1|||
144237262|NCT02004886|520065931|FG002|Overall Study|Adverse Event|0|||
144237263|NCT02004886|520065932|FG003|Overall Study|Adverse Event|0|||
144237264|NCT02004886|520065929|FG000|Overall Study|Unable to attend future visits|1|||
144237265|NCT02004886|520065930|FG001|Overall Study|Unable to attend future visits|0|||
144237266|NCT02004886|520065931|FG002|Overall Study|Unable to attend future visits|0|||
144237267|NCT02004886|520065932|FG003|Overall Study|Unable to attend future visits|0|||
144237268|NCT02691936|520065934|FG000|Overall Study|Withdrawal by Subject|2|||
144237269|NCT02691936|520065935|FG001|Overall Study|Withdrawal by Subject|5|||
144237270|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
144237271|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
144237272|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
144237273|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
144237274|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
144237275|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
144237276|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
144237277|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
144237278|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
144237279|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
144237280|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Death|1|||
144237281|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Death|0|||
144237282|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
144237283|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
144237284|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
144237285|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
144237286|NCT01876784|520065936|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
144237287|NCT01876784|520065937|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
144237288|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
144237289|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
144237290|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Adverse Event|2|||
144237291|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Adverse Event|6|||
144237292|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
144237293|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
144237294|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Progressive disease|4|||
144237295|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Progressive disease|35|||
144237296|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
144237297|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
144237298|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
144237299|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
144237300|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Death|0|||
144237301|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Death|1|||
144237302|NCT01876784|520065936|FG000|Open-label Period (31 Months)|Other than specified above|9|||
144237303|NCT01876784|520065937|FG001|Open-label Period (31 Months)|Other than specified above|18|||
144237304|NCT01878084|520065938|FG000|Overall Study|Physician Decision|2|||
144237305|NCT05239494|520065940|FG000|Overall Study|Lost to Follow-up|1|||
144237306|NCT03891862|520065941|FG000|Open-label Period|Adverse Event|2|||
144237307|NCT03891862|520065942|FG001|Open-label Period|Adverse Event|0|||
144237308|NCT03891862|520065943|FG002|Open-label Period|Adverse Event|0|||
144237309|NCT03891862|520065941|FG000|Open-label Period|Protocol Violation|5|||
144237310|NCT03891862|520065942|FG001|Open-label Period|Protocol Violation|0|||
144237311|NCT03891862|520065943|FG002|Open-label Period|Protocol Violation|0|||
144237312|NCT03891862|520065941|FG000|Open-label Period|Withdrawal by Subject|6|||
144237313|NCT03891862|520065942|FG001|Open-label Period|Withdrawal by Subject|0|||
144237314|NCT03891862|520065943|FG002|Open-label Period|Withdrawal by Subject|0|||
144237315|NCT03891862|520065941|FG000|Open-label Period|Death|1|||
144237316|NCT03891862|520065942|FG001|Open-label Period|Death|0|||
144237317|NCT03891862|520065943|FG002|Open-label Period|Death|0|||
144237318|NCT03891862|520065941|FG000|Open-label Period|Lost to Follow-up|2|||
144237319|NCT03891862|520065942|FG001|Open-label Period|Lost to Follow-up|0|||
144237320|NCT03891862|520065943|FG002|Open-label Period|Lost to Follow-up|0|||
144237321|NCT03891862|520065941|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
144237322|NCT03891862|520065942|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
144237323|NCT03891862|520065943|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
144237324|NCT03891862|520065941|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
144237325|NCT03891862|520065942|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
144237326|NCT03891862|520065943|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
144237327|NCT03891862|520065941|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
144237328|NCT03891862|520065942|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
144237329|NCT03891862|520065943|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
144237330|NCT03891862|520065941|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
144237331|NCT03891862|520065942|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
144237332|NCT03891862|520065943|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
144237333|NCT01194531|520065944|FG000|Overall Study|Withdrawal by Subject|1|||
144237334|NCT01194531|520065945|FG001|Overall Study|Withdrawal by Subject|0|||
144237335|NCT01194531|520065944|FG000|Overall Study|Protocol Violation|4|||
144237336|NCT01194531|520065945|FG001|Overall Study|Protocol Violation|1|||
144237337|NCT01194531|520065944|FG000|Overall Study|Physician Decision|0|||
144237338|NCT01194531|520065945|FG001|Overall Study|Physician Decision|2|||
144237339|NCT01053962|520065948|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
144237340|NCT01053962|520065949|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
144237341|NCT01053962|520065950|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
144237342|NCT01053962|520065951|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
144237343|NCT01053962|520065952|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
144237344|NCT01053962|520065948|FG000|Pretreatment Period|Venipuncture Failure|0|||
144237345|NCT01053962|520065949|FG001|Pretreatment Period|Venipuncture Failure|0|||
144237346|NCT01053962|520065950|FG002|Pretreatment Period|Venipuncture Failure|1|||
144237347|NCT01053962|520065951|FG003|Pretreatment Period|Venipuncture Failure|0|||
144237348|NCT01053962|520065952|FG004|Pretreatment Period|Venipuncture Failure|0|||
144237349|NCT01053962|520065948|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
144237350|NCT01053962|520065949|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
144237351|NCT01053962|520065950|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
144237352|NCT01053962|520065951|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
144237353|NCT01053962|520065952|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
144237354|NCT01053962|520065948|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
144237355|NCT01053962|520065949|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
144237356|NCT01053962|520065950|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
144237357|NCT01053962|520065951|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
144237358|NCT01053962|520065952|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
144237359|NCT01053962|520065948|FG000|Treatment Period|Lack of Efficacy|0|||
144237360|NCT01053962|520065949|FG001|Treatment Period|Lack of Efficacy|0|||
144237361|NCT01053962|520065950|FG002|Treatment Period|Lack of Efficacy|0|||
144237362|NCT01053962|520065951|FG003|Treatment Period|Lack of Efficacy|0|||
144237363|NCT01053962|520065952|FG004|Treatment Period|Lack of Efficacy|1|||
144237364|NCT01053962|520065948|FG000|Treatment Period|Adverse Event|0|||
144237365|NCT01053962|520065949|FG001|Treatment Period|Adverse Event|0|||
144237366|NCT01053962|520065950|FG002|Treatment Period|Adverse Event|0|||
144237367|NCT01053962|520065951|FG003|Treatment Period|Adverse Event|0|||
144237368|NCT01053962|520065952|FG004|Treatment Period|Adverse Event|1|||
144237369|NCT01053962|520065948|FG000|Treatment Period|Withdrawal by Subject|0|||
144237370|NCT01053962|520065949|FG001|Treatment Period|Withdrawal by Subject|0|||
144237371|NCT01053962|520065950|FG002|Treatment Period|Withdrawal by Subject|0|||
144237372|NCT01053962|520065951|FG003|Treatment Period|Withdrawal by Subject|0|||
144237373|NCT01053962|520065952|FG004|Treatment Period|Withdrawal by Subject|1|||
144237374|NCT01053962|520065948|FG000|Treatment Period|Noncompliance with protocol|1|||
144237375|NCT01053962|520065949|FG001|Treatment Period|Noncompliance with protocol|0|||
144237376|NCT01053962|520065950|FG002|Treatment Period|Noncompliance with protocol|0|||
144237377|NCT01053962|520065951|FG003|Treatment Period|Noncompliance with protocol|0|||
144237378|NCT01053962|520065952|FG004|Treatment Period|Noncompliance with protocol|0|||
144237379|NCT02892422|520065953|FG000|Overall Study|Enrolled not treated|4|||
144237380|NCT02892422|520065953|FG000|Overall Study|Adverse Event|38|||
144237381|NCT02892422|520065953|FG000|Overall Study|Lack of Efficacy|32|||
144237382|NCT02892422|520065953|FG000|Overall Study|Non-compliance with study drug|11|||
144237383|NCT02892422|520065953|FG000|Overall Study|Protocol Violation|4|||
144237384|NCT02892422|520065953|FG000|Overall Study|Withdrawal by Subject|56|||
144237385|NCT02892422|520065953|FG000|Overall Study|Lost to Follow-up|5|||
144237386|NCT02892422|520065953|FG000|Overall Study|sponsor information 16159A results|21|||
144237387|NCT02892422|520065953|FG000|Overall Study|withdrawal of consent|13|||
144237388|NCT02892422|520065953|FG000|Overall Study|exclusion criteria met|3|||
144237389|NCT02892422|520065953|FG000|Overall Study|moving elsewhere|4|||
144237390|NCT02892422|520065953|FG000|Overall Study|non-compliance|10|||
144237391|NCT02892422|520065953|FG000|Overall Study|patient legally incapable|1|||
144237392|NCT02892422|520065953|FG000|Overall Study|patient decision|7|||
144237393|NCT02892422|520065953|FG000|Overall Study|Investigator decision|1|||
144237394|NCT03089697|520065954|FG000|Overall Study|Adverse Event|1|||
144237395|NCT03089697|520065955|FG001|Overall Study|Adverse Event|2|||
144237396|NCT03089697|520065954|FG000|Overall Study|Withdrawal by Subject|1|||
144237397|NCT03089697|520065955|FG001|Overall Study|Withdrawal by Subject|0|||
144237398|NCT04603482|520065967|FG000|Overall Study|Lost to Follow-up|15|||
144237399|NCT04603482|520065968|FG001|Overall Study|Lost to Follow-up|15|||
144237400|NCT04603482|520065969|FG002|Overall Study|Lost to Follow-up|15|||
144237401|NCT00179673|520065971|FG000|Overall Study|Adverse Event|7|||
144237402|NCT00179673|520065971|FG000|Overall Study|Lack of Efficacy|15|||
144237403|NCT00179673|520065971|FG000|Overall Study|Withdrawal by Subject|3|||
144237404|NCT00179673|520065971|FG000|Overall Study|Death|4|||
144237405|NCT00179673|520065971|FG000|Overall Study|Other Observations and options|14|||
144237406|NCT00492648|520065972|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
144237407|NCT00492648|520065973|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
144237408|NCT02387957|520065974|FG000|Overall Study|The study was discontinued|21|||
144237409|NCT02387957|520065975|FG001|Overall Study|The study was discontinued|21|||
144237410|NCT02387957|520065976|FG002|Overall Study|The study was discontinued|20|||
144237411|NCT02294396|520065977|FG000|Overall Study|Adverse Event|26|||
144237412|NCT02294396|520065978|FG001|Overall Study|Adverse Event|25|||
144237413|NCT02294396|520065979|FG002|Overall Study|Adverse Event|21|||
144237414|NCT02294396|520065980|FG003|Overall Study|Adverse Event|24|||
144237415|NCT02294396|520065977|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
144237416|NCT02294396|520065978|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
144237417|NCT02294396|520065979|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
144237418|NCT02294396|520065980|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
144237419|NCT02294396|520065977|FG000|Overall Study|Withdrawal by Subject|8|||
144237420|NCT02294396|520065978|FG001|Overall Study|Withdrawal by Subject|6|||
144237421|NCT02294396|520065979|FG002|Overall Study|Withdrawal by Subject|6|||
144237422|NCT02294396|520065980|FG003|Overall Study|Withdrawal by Subject|8|||
144237423|NCT02294396|520065977|FG000|Overall Study|Lost to Follow-up|0|||
144237424|NCT02294396|520065978|FG001|Overall Study|Lost to Follow-up|0|||
144237425|NCT02294396|520065979|FG002|Overall Study|Lost to Follow-up|1|||
144237426|NCT02294396|520065980|FG003|Overall Study|Lost to Follow-up|1|||
144237427|NCT02294396|520065977|FG000|Overall Study|Protocol Deviation|3|||
144237428|NCT02294396|520065978|FG001|Overall Study|Protocol Deviation|2|||
144237429|NCT02294396|520065979|FG002|Overall Study|Protocol Deviation|2|||
144237430|NCT02294396|520065980|FG003|Overall Study|Protocol Deviation|1|||
144237431|NCT02294396|520065977|FG000|Overall Study|Miscellaneous|2|||
144237432|NCT02294396|520065978|FG001|Overall Study|Miscellaneous|0|||
144237433|NCT02294396|520065979|FG002|Overall Study|Miscellaneous|5|||
144237434|NCT02294396|520065980|FG003|Overall Study|Miscellaneous|2|||
144237435|NCT02120833|520065981|FG000|Overall Study|Adverse Event|1|||
144237436|NCT02120833|520065982|FG001|Overall Study|Adverse Event|0|||
144237437|NCT02120833|520065981|FG000|Overall Study|Withdrawal by Subject|2|||
144237438|NCT02120833|520065982|FG001|Overall Study|Withdrawal by Subject|0|||
144237439|NCT02120833|520065981|FG000|Overall Study|Lost to Follow-up|1|||
144237440|NCT02120833|520065982|FG001|Overall Study|Lost to Follow-up|1|||
144237441|NCT03613649|520065983|FG000|Second Treatment|Lost to Follow-up|0|||
144237442|NCT03613649|520065984|FG001|Second Treatment|Lost to Follow-up|0|||
144237443|NCT03613649|520065985|FG002|Second Treatment|Lost to Follow-up|1|||
144237444|NCT03613649|520065986|FG003|Second Treatment|Lost to Follow-up|0|||
144237445|NCT03613649|520065987|FG004|Second Treatment|Lost to Follow-up|0|||
144237446|NCT03613649|520065988|FG005|Second Treatment|Lost to Follow-up|0|||
144237447|NCT03613649|520065989|FG006|Second Treatment|Lost to Follow-up|0|||
144237448|NCT03613649|520065990|FG007|Second Treatment|Lost to Follow-up|0|||
144237449|NCT03613649|520065991|FG008|Second Treatment|Lost to Follow-up|0|||
144237450|NCT03613649|520065992|FG009|Second Treatment|Lost to Follow-up|0|||
144237451|NCT03613649|520065993|FG010|Second Treatment|Lost to Follow-up|0|||
144237452|NCT03613649|520065994|FG011|Second Treatment|Lost to Follow-up|0|||
144237453|NCT03613649|520065983|FG000|Second Treatment|Withdrawal by Subject|0|||
144237454|NCT03613649|520065984|FG001|Second Treatment|Withdrawal by Subject|0|||
144237455|NCT03613649|520065985|FG002|Second Treatment|Withdrawal by Subject|0|||
144237456|NCT03613649|520065986|FG003|Second Treatment|Withdrawal by Subject|0|||
144237457|NCT03613649|520065987|FG004|Second Treatment|Withdrawal by Subject|1|||
144237458|NCT03613649|520065988|FG005|Second Treatment|Withdrawal by Subject|0|||
144237459|NCT03613649|520065989|FG006|Second Treatment|Withdrawal by Subject|0|||
144237460|NCT03613649|520065990|FG007|Second Treatment|Withdrawal by Subject|0|||
144237461|NCT03613649|520065991|FG008|Second Treatment|Withdrawal by Subject|0|||
144237462|NCT03613649|520065992|FG009|Second Treatment|Withdrawal by Subject|0|||
144237463|NCT03613649|520065993|FG010|Second Treatment|Withdrawal by Subject|0|||
144237464|NCT03613649|520065994|FG011|Second Treatment|Withdrawal by Subject|0|||
144237465|NCT03613649|520065983|FG000|Third Treatment|Lost to Follow-up|0|||
144237466|NCT03613649|520065984|FG001|Third Treatment|Lost to Follow-up|0|||
144237467|NCT03613649|520065985|FG002|Third Treatment|Lost to Follow-up|0|||
144237468|NCT03613649|520065986|FG003|Third Treatment|Lost to Follow-up|0|||
144237469|NCT03613649|520065987|FG004|Third Treatment|Lost to Follow-up|1|||
144237470|NCT03613649|520065988|FG005|Third Treatment|Lost to Follow-up|0|||
144237471|NCT03613649|520065989|FG006|Third Treatment|Lost to Follow-up|0|||
144237472|NCT03613649|520065990|FG007|Third Treatment|Lost to Follow-up|0|||
144237473|NCT03613649|520065991|FG008|Third Treatment|Lost to Follow-up|0|||
144237474|NCT03613649|520065992|FG009|Third Treatment|Lost to Follow-up|0|||
144237475|NCT03613649|520065993|FG010|Third Treatment|Lost to Follow-up|0|||
144237476|NCT03613649|520065994|FG011|Third Treatment|Lost to Follow-up|1|||
144237477|NCT03613649|520065983|FG000|Third Treatment|Protocol Violation|0|||
144237478|NCT03613649|520065984|FG001|Third Treatment|Protocol Violation|0|||
144237479|NCT03613649|520065985|FG002|Third Treatment|Protocol Violation|0|||
144237480|NCT03613649|520065986|FG003|Third Treatment|Protocol Violation|0|||
144237481|NCT03613649|520065987|FG004|Third Treatment|Protocol Violation|0|||
144237482|NCT03613649|520065988|FG005|Third Treatment|Protocol Violation|0|||
144237483|NCT03613649|520065989|FG006|Third Treatment|Protocol Violation|1|||
144237484|NCT03613649|520065990|FG007|Third Treatment|Protocol Violation|0|||
144237485|NCT03613649|520065991|FG008|Third Treatment|Protocol Violation|0|||
144237486|NCT03613649|520065992|FG009|Third Treatment|Protocol Violation|0|||
144237487|NCT03613649|520065993|FG010|Third Treatment|Protocol Violation|0|||
144237488|NCT03613649|520065994|FG011|Third Treatment|Protocol Violation|1|||
144237489|NCT03613649|520065983|FG000|Fourth Treatment|Protocol Violation|1|||
144237490|NCT03613649|520065984|FG001|Fourth Treatment|Protocol Violation|0|||
144237491|NCT03613649|520065985|FG002|Fourth Treatment|Protocol Violation|0|||
144237492|NCT03613649|520065986|FG003|Fourth Treatment|Protocol Violation|0|||
144237493|NCT03613649|520065987|FG004|Fourth Treatment|Protocol Violation|1|||
144237494|NCT03613649|520065988|FG005|Fourth Treatment|Protocol Violation|0|||
144237495|NCT03613649|520065989|FG006|Fourth Treatment|Protocol Violation|0|||
144237496|NCT03613649|520065990|FG007|Fourth Treatment|Protocol Violation|0|||
144237497|NCT03613649|520065991|FG008|Fourth Treatment|Protocol Violation|0|||
144237498|NCT03613649|520065992|FG009|Fourth Treatment|Protocol Violation|0|||
144237499|NCT03613649|520065993|FG010|Fourth Treatment|Protocol Violation|0|||
144237500|NCT03613649|520065994|FG011|Fourth Treatment|Protocol Violation|0|||
144237501|NCT03613649|520065983|FG000|Fourth Treatment|Physician Decision|0|||
144237502|NCT03613649|520065984|FG001|Fourth Treatment|Physician Decision|0|||
144237503|NCT03613649|520065985|FG002|Fourth Treatment|Physician Decision|0|||
144237504|NCT03613649|520065986|FG003|Fourth Treatment|Physician Decision|0|||
144237505|NCT03613649|520065987|FG004|Fourth Treatment|Physician Decision|0|||
144237506|NCT03613649|520065988|FG005|Fourth Treatment|Physician Decision|0|||
144237507|NCT03613649|520065989|FG006|Fourth Treatment|Physician Decision|1|||
144237508|NCT03613649|520065990|FG007|Fourth Treatment|Physician Decision|0|||
144237509|NCT03613649|520065991|FG008|Fourth Treatment|Physician Decision|0|||
144237510|NCT03613649|520065992|FG009|Fourth Treatment|Physician Decision|0|||
144237511|NCT03613649|520065993|FG010|Fourth Treatment|Physician Decision|0|||
144237512|NCT03613649|520065994|FG011|Fourth Treatment|Physician Decision|0|||
144237513|NCT02693171|520065995|FG000|Overall Study|Adverse Event|1|||
144237514|NCT02693171|520065995|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
144237515|NCT00750139|520065996|FG000|Overall Study|Adverse Event|1|||
144237516|NCT00750139|520065997|FG001|Overall Study|Adverse Event|2|||
144237517|NCT00750139|520065998|FG002|Overall Study|Adverse Event|0|||
144237518|NCT00750139|520065999|FG003|Overall Study|Adverse Event|1|||
144237519|NCT00750139|520065996|FG000|Overall Study|Lost to Follow-up|17|||
144237520|NCT00750139|520065997|FG001|Overall Study|Lost to Follow-up|12|||
144237521|NCT00750139|520065998|FG002|Overall Study|Lost to Follow-up|15|||
144237522|NCT00750139|520065999|FG003|Overall Study|Lost to Follow-up|6|||
144237523|NCT00750139|520065996|FG000|Overall Study|Withdrawal by Subject|3|||
144237524|NCT00750139|520065997|FG001|Overall Study|Withdrawal by Subject|2|||
144237525|NCT00750139|520065998|FG002|Overall Study|Withdrawal by Subject|6|||
144237526|NCT00750139|520065999|FG003|Overall Study|Withdrawal by Subject|2|||
144237527|NCT00750139|520065996|FG000|Overall Study|Physician Decision|1|||
144237528|NCT00750139|520065997|FG001|Overall Study|Physician Decision|1|||
144237529|NCT00750139|520065998|FG002|Overall Study|Physician Decision|0|||
144237530|NCT00750139|520065999|FG003|Overall Study|Physician Decision|0|||
144237531|NCT00750139|520065996|FG000|Overall Study|Non-compliance|1|||
144237532|NCT00750139|520065997|FG001|Overall Study|Non-compliance|0|||
144237533|NCT00750139|520065998|FG002|Overall Study|Non-compliance|1|||
144237534|NCT00750139|520065999|FG003|Overall Study|Non-compliance|3|||
144237535|NCT00750139|520065996|FG000|Overall Study|Termination by sponsor|4|||
144237536|NCT00750139|520065997|FG001|Overall Study|Termination by sponsor|0|||
144237537|NCT00750139|520065998|FG002|Overall Study|Termination by sponsor|0|||
144237538|NCT00750139|520065999|FG003|Overall Study|Termination by sponsor|1|||
144237539|NCT00750139|520065996|FG000|Overall Study|Non-specific|62|||
144237540|NCT00750139|520065997|FG001|Overall Study|Non-specific|42|||
144237541|NCT00750139|520065998|FG002|Overall Study|Non-specific|79|||
144237542|NCT00750139|520065999|FG003|Overall Study|Non-specific|33|||
144237543|NCT00595517|520066000|FG000|Overall Study|Adverse Event|6|||
144237544|NCT00595517|520066000|FG000|Overall Study|Withdrawal by Subject|4|||
144237545|NCT00595517|520066000|FG000|Overall Study|Protocol Violation|2|||
144237546|NCT00595517|520066000|FG000|Overall Study|Recurrence of ulcer|5|||
144237547|NCT00595517|520066000|FG000|Overall Study|usage of prohibited treatment|1|||
144237548|NCT00595517|520066000|FG000|Overall Study|No intention to attend regularly|1|||
144237549|NCT01167881|520066001|FG000|Overall Study|Adverse Event|47|||
144237550|NCT01167881|520066002|FG001|Overall Study|Adverse Event|51|||
144237551|NCT01167881|520066001|FG000|Overall Study|Lack of Efficacy|4|||
144237552|NCT01167881|520066002|FG001|Overall Study|Lack of Efficacy|7|||
144237553|NCT01167881|520066001|FG000|Overall Study|Non compliant with protocol|9|||
144237554|NCT01167881|520066002|FG001|Overall Study|Non compliant with protocol|18|||
144237555|NCT01167881|520066001|FG000|Overall Study|Lost to Follow-up|19|||
144237556|NCT01167881|520066002|FG001|Overall Study|Lost to Follow-up|20|||
144237557|NCT01167881|520066001|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
144237558|NCT01167881|520066002|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
144237559|NCT01167881|520066001|FG000|Overall Study|Not treated|4|||
144237560|NCT01167881|520066002|FG001|Overall Study|Not treated|0|||
144237561|NCT01167881|520066001|FG000|Overall Study|Other not defined above|31|||
144237562|NCT01167881|520066002|FG001|Overall Study|Other not defined above|55|||
144237563|NCT01992653|520066003|FG000|Overall Study|Death|0|||
144237564|NCT01992653|520066004|FG001|Overall Study|Death|0|||
144237565|NCT01992653|520066005|FG002|Overall Study|Death|1|||
144237566|NCT01992653|520066006|FG003|Overall Study|Death|0|||
144237567|NCT01992653|520066007|FG004|Overall Study|Death|1|||
144237568|NCT01992653|520066008|FG005|Overall Study|Death|0|||
144237569|NCT01992653|520066009|FG006|Overall Study|Death|4|||
144237570|NCT01992653|520066010|FG007|Overall Study|Death|2|||
144237571|NCT01992653|520066003|FG000|Overall Study|Lost to Follow-up|0|||
144237572|NCT01992653|520066004|FG001|Overall Study|Lost to Follow-up|0|||
144237573|NCT01992653|520066005|FG002|Overall Study|Lost to Follow-up|0|||
144237574|NCT01992653|520066006|FG003|Overall Study|Lost to Follow-up|0|||
144237575|NCT01992653|520066007|FG004|Overall Study|Lost to Follow-up|0|||
144237576|NCT01992653|520066008|FG005|Overall Study|Lost to Follow-up|0|||
144237577|NCT01992653|520066009|FG006|Overall Study|Lost to Follow-up|0|||
144237578|NCT01992653|520066010|FG007|Overall Study|Lost to Follow-up|1|||
144237579|NCT01992653|520066003|FG000|Overall Study|Study Completed|0|||
144237580|NCT01992653|520066004|FG001|Overall Study|Study Completed|0|||
144237581|NCT01992653|520066005|FG002|Overall Study|Study Completed|0|||
144237582|NCT01992653|520066006|FG003|Overall Study|Study Completed|0|||
144237583|NCT01992653|520066007|FG004|Overall Study|Study Completed|0|||
144237584|NCT01992653|520066008|FG005|Overall Study|Study Completed|0|||
144237585|NCT01992653|520066009|FG006|Overall Study|Study Completed|0|||
144237586|NCT01992653|520066010|FG007|Overall Study|Study Completed|1|||
144237587|NCT01992653|520066003|FG000|Overall Study|Disease Progression|0|||
144237588|NCT01992653|520066004|FG001|Overall Study|Disease Progression|0|||
144237589|NCT01992653|520066005|FG002|Overall Study|Disease Progression|0|||
144237590|NCT01992653|520066006|FG003|Overall Study|Disease Progression|0|||
144237591|NCT01992653|520066007|FG004|Overall Study|Disease Progression|0|||
144237592|NCT01992653|520066008|FG005|Overall Study|Disease Progression|0|||
144237593|NCT01992653|520066009|FG006|Overall Study|Disease Progression|4|||
144237594|NCT01992653|520066010|FG007|Overall Study|Disease Progression|0|||
144237595|NCT00556933|520066016|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
144237596|NCT00556933|520066017|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
144237597|NCT00556933|520066018|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
144237598|NCT00556933|520066019|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
144237599|NCT00556933|520066016|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
144237600|NCT00556933|520066017|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
144237601|NCT00556933|520066018|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
144237602|NCT00556933|520066019|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
144237603|NCT00556933|520066016|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
144237604|NCT00556933|520066017|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
144237605|NCT00556933|520066018|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
144237606|NCT00556933|520066019|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
144237607|NCT00556933|520066016|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
144237608|NCT00556933|520066017|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
144237609|NCT00556933|520066018|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
144237610|NCT00556933|520066019|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
144237611|NCT00556933|520066016|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
144237612|NCT00556933|520066017|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
144237613|NCT00556933|520066018|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
144237614|NCT00556933|520066019|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
144237615|NCT00556933|520066016|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
144237616|NCT00556933|520066017|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
144237617|NCT00556933|520066018|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
144237618|NCT00556933|520066019|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
144237619|NCT00556933|520066016|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
144237620|NCT00556933|520066017|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
144237621|NCT00556933|520066018|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
144237622|NCT00556933|520066019|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
144237623|NCT00556933|520066016|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
144237624|NCT00556933|520066017|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
144237625|NCT00556933|520066018|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
144237626|NCT00556933|520066019|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
144237627|NCT00556933|520066016|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
144237628|NCT00556933|520066017|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
144237629|NCT00556933|520066018|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
144237630|NCT00556933|520066019|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
144237631|NCT00556933|520066016|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
144237632|NCT00556933|520066017|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
144237633|NCT00556933|520066018|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
144237634|NCT00556933|520066019|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
144237635|NCT00556933|520066016|FG000|CNI Withdrawal vs. Minimization|Death|0|||
144237636|NCT00556933|520066017|FG001|CNI Withdrawal vs. Minimization|Death|0|||
144237637|NCT00556933|520066018|FG002|CNI Withdrawal vs. Minimization|Death|0|||
144237638|NCT00556933|520066019|FG003|CNI Withdrawal vs. Minimization|Death|1|||
144237639|NCT03887442|520066020|FG000|Overall Study|Adverse Event|1|||
144237640|NCT03887442|520066021|FG001|Overall Study|Adverse Event|0|||
144237641|NCT00022698|520066024|FG000|Overall Study|Adverse Event|5|||
144237642|NCT00022698|520066025|FG001|Overall Study|Adverse Event|9|||
144237643|NCT00022698|520066024|FG000|Overall Study|Death|0|||
144269821|NCT01677741|520191425|FG001|Overall Study|Enrolled in a rollover study|3|||
144269822|NCT01677741|520191426|FG002|Overall Study|Enrolled in a rollover study|2|||
144269823|NCT01677741|520191427|FG003|Overall Study|Enrolled in a rollover study|1|||
144237644|NCT00022698|520066025|FG001|Overall Study|Death|2|||
144237645|NCT00022698|520066024|FG000|Overall Study|Failure to return|0|||
144237646|NCT00022698|520066025|FG001|Overall Study|Failure to return|1|||
144237647|NCT00022698|520066024|FG000|Overall Study|Refused treatment|0|||
144237648|NCT00022698|520066025|FG001|Overall Study|Refused treatment|2|||
144237649|NCT00022698|520066024|FG000|Overall Study|Insufficient therapeutic response|2|||
144237650|NCT00022698|520066025|FG001|Overall Study|Insufficient therapeutic response|14|||
144237651|NCT00022698|520066024|FG000|Overall Study|Administrative /other|1|||
144237652|NCT00022698|520066025|FG001|Overall Study|Administrative /other|7|||
144237653|NCT01628198|520066026|FG000|Overall Study|Lost to Follow-up|7|||
144237654|NCT01628198|520066026|FG000|Overall Study|Withdrawal by Subject|10|||
144237655|NCT01628198|520066026|FG000|Overall Study|Screen failure|1|||
144237656|NCT02504827|520066028|FG000|Overall Study|Could not produce sputum|1|||
144237657|NCT03386994|520066029|FG000|Overall Study|Lung transplant|1|||
144237658|NCT03386994|520066029|FG000|Overall Study|Adverse Event|14|||
144237659|NCT03386994|520066029|FG000|Overall Study|Lost to Follow-up|4|||
144237660|NCT03386994|520066029|FG000|Overall Study|Withdrawal by Subject|3|||
144237661|NCT03386994|520066029|FG000|Overall Study|Death|16|||
144237662|NCT01743560|520066030|FG000|Overall Study|Disease progression|26|||
144237663|NCT01743560|520066030|FG000|Overall Study|Adverse Event|8|||
144237664|NCT01743560|520066030|FG000|Overall Study|Death|3|||
144237665|NCT01743560|520066030|FG000|Overall Study|Withdrawal by Subject|2|||
144237666|NCT01743560|520066030|FG000|Overall Study|Protocol Violation|1|||
144237667|NCT01743560|520066030|FG000|Overall Study|>1 dose of study drug|3|||
144237668|NCT03033602|520066032|FG000|Overall Study|Withdrawal by Subject|11|||
144237669|NCT03033602|520066033|FG001|Overall Study|Withdrawal by Subject|21|||
144237670|NCT03033602|520066032|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
144237671|NCT03033602|520066033|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
144237672|NCT03425396|520066034|FG000|Overall Study|Lost to Follow-up|2|||
144237673|NCT03425396|520066035|FG001|Overall Study|Lost to Follow-up|5|||
144237674|NCT03425396|520066036|FG002|Overall Study|Lost to Follow-up|2|||
144237675|NCT03425396|520066037|FG003|Overall Study|Lost to Follow-up|0|||
144237676|NCT03425396|520066038|FG004|Overall Study|Lost to Follow-up|0|||
144237677|NCT03425396|520066034|FG000|Overall Study|Withdrawal by Subject|0|||
144237678|NCT03425396|520066035|FG001|Overall Study|Withdrawal by Subject|1|||
144237679|NCT03425396|520066036|FG002|Overall Study|Withdrawal by Subject|0|||
144237680|NCT03425396|520066037|FG003|Overall Study|Withdrawal by Subject|1|||
144237681|NCT03425396|520066038|FG004|Overall Study|Withdrawal by Subject|0|||
144237682|NCT03425396|520066034|FG000|Overall Study|Other|0|||
144237683|NCT03425396|520066035|FG001|Overall Study|Other|1|||
144237684|NCT03425396|520066036|FG002|Overall Study|Other|1|||
144237685|NCT03425396|520066037|FG003|Overall Study|Other|0|||
144237686|NCT03425396|520066038|FG004|Overall Study|Other|1|||
144237687|NCT01441765|520066039|FG000|Overall Study|Death|1|||
144237688|NCT01441765|520066040|FG001|Overall Study|Death|0|||
144237689|NCT00940823|520066041|FG000|Overall Study|Death|8|||
144237690|NCT00940823|520066042|FG001|Overall Study|Death|12|||
144237691|NCT00940823|520066041|FG000|Overall Study|Lost to Follow-up|27|||
144237692|NCT00940823|520066042|FG001|Overall Study|Lost to Follow-up|20|||
144237693|NCT00986921|520066045|FG000|Overall Study|Physician Decision|1|||
144237694|NCT00986921|520066046|FG001|Overall Study|Physician Decision|0|||
144237695|NCT00813813|520066047|FG000|Overall Study|Withdrawal by Subject|1|||
144269824|NCT01677741|520191428|FG004|Overall Study|Enrolled in a rollover study|6|||
144269825|NCT01677741|520191429|FG005|Overall Study|Enrolled in a rollover study|6|||
144237696|NCT00813813|520066048|FG001|Overall Study|Withdrawal by Subject|1|||
144237697|NCT00813813|520066047|FG000|Overall Study|Lost to Follow-up|2|||
144237698|NCT00813813|520066048|FG001|Overall Study|Lost to Follow-up|7|||
144237699|NCT00813813|520066047|FG000|Overall Study|Other|0|||
144237700|NCT00813813|520066048|FG001|Overall Study|Other|1|||
144237701|NCT04445714|520066049|FG000|Overall Study|Discontinuation of the study|14|||
144237702|NCT04445714|520066049|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
144237703|NCT04445714|520066049|FG000|Overall Study|Withdrawal of Informed Consent|8|||
144237704|NCT02805660|520066050|FG000|Overall Study|Death|5|||
144237705|NCT02805660|520066051|FG001|Overall Study|Death|2|||
144237706|NCT02805660|520066052|FG002|Overall Study|Death|9|||
144237707|NCT02805660|520066053|FG003|Overall Study|Death|5|||
144237708|NCT02805660|520066054|FG004|Overall Study|Death|0|||
144237709|NCT02805660|520066055|FG005|Overall Study|Death|14|||
144237710|NCT02805660|520066056|FG006|Overall Study|Death|12|||
144237711|NCT02805660|520066050|FG000|Overall Study|Lost to Follow-up|0|||
144237712|NCT02805660|520066051|FG001|Overall Study|Lost to Follow-up|1|||
144237713|NCT02805660|520066052|FG002|Overall Study|Lost to Follow-up|1|||
144237714|NCT02805660|520066053|FG003|Overall Study|Lost to Follow-up|2|||
144237715|NCT02805660|520066054|FG004|Overall Study|Lost to Follow-up|0|||
144237716|NCT02805660|520066055|FG005|Overall Study|Lost to Follow-up|0|||
144237717|NCT02805660|520066056|FG006|Overall Study|Lost to Follow-up|0|||
144237718|NCT02805660|520066050|FG000|Overall Study|Withdrawal by Subject|0|||
144237719|NCT02805660|520066051|FG001|Overall Study|Withdrawal by Subject|0|||
144237720|NCT02805660|520066052|FG002|Overall Study|Withdrawal by Subject|0|||
144237721|NCT02805660|520066053|FG003|Overall Study|Withdrawal by Subject|3|||
144237722|NCT02805660|520066054|FG004|Overall Study|Withdrawal by Subject|1|||
144237723|NCT02805660|520066055|FG005|Overall Study|Withdrawal by Subject|0|||
144237724|NCT02805660|520066056|FG006|Overall Study|Withdrawal by Subject|2|||
144237725|NCT02805660|520066050|FG000|Overall Study|Study terminated by Sponsor|0|||
144237726|NCT02805660|520066051|FG001|Overall Study|Study terminated by Sponsor|0|||
144237727|NCT02805660|520066052|FG002|Overall Study|Study terminated by Sponsor|1|||
144237728|NCT02805660|520066053|FG003|Overall Study|Study terminated by Sponsor|4|||
144237729|NCT02805660|520066054|FG004|Overall Study|Study terminated by Sponsor|2|||
144237730|NCT02805660|520066055|FG005|Overall Study|Study terminated by Sponsor|3|||
144237731|NCT02805660|520066056|FG006|Overall Study|Study terminated by Sponsor|1|||
144237732|NCT02805660|520066050|FG000|Overall Study|Miscellaneous|0|||
144237733|NCT02805660|520066051|FG001|Overall Study|Miscellaneous|1|||
144237734|NCT02805660|520066052|FG002|Overall Study|Miscellaneous|0|||
144237735|NCT02805660|520066053|FG003|Overall Study|Miscellaneous|4|||
144237736|NCT02805660|520066054|FG004|Overall Study|Miscellaneous|0|||
144237737|NCT02805660|520066055|FG005|Overall Study|Miscellaneous|6|||
144237738|NCT02805660|520066056|FG006|Overall Study|Miscellaneous|4|||
144237739|NCT02778074|520066057|FG000|Overall Study|Lost to Follow-up|7|||
144237740|NCT02778074|520066058|FG001|Overall Study|Lost to Follow-up|10|||
144237741|NCT01684943|520066059|FG000|Overall Study|Inadequate Venous Access|3|||
144237742|NCT01684943|520066060|FG001|Overall Study|Inadequate Venous Access|0|||
144237743|NCT01684943|520066061|FG002|Overall Study|Inadequate Venous Access|0|||
144237744|NCT01684943|520066059|FG000|Overall Study|Principal Investigator Determination|1|||
144237745|NCT01684943|520066060|FG001|Overall Study|Principal Investigator Determination|0|||
144237746|NCT01684943|520066061|FG002|Overall Study|Principal Investigator Determination|0|||
144237747|NCT01684943|520066059|FG000|Overall Study|Excluded from Analysis|1|||
144237748|NCT01684943|520066060|FG001|Overall Study|Excluded from Analysis|1|||
144237749|NCT01684943|520066061|FG002|Overall Study|Excluded from Analysis|1|||
144237750|NCT01684943|520066059|FG000|Overall Study|Lost to Follow-up|3|||
144237751|NCT01684943|520066060|FG001|Overall Study|Lost to Follow-up|0|||
144237752|NCT01684943|520066061|FG002|Overall Study|Lost to Follow-up|0|||
144237753|NCT01684943|520066059|FG000|Overall Study|Planning Pregnancy|1|||
144237754|NCT01684943|520066060|FG001|Overall Study|Planning Pregnancy|0|||
144237755|NCT01684943|520066061|FG002|Overall Study|Planning Pregnancy|0|||
144237756|NCT00199797|520067421|FG000|Overall Study|Progressive Disease|1|||
144237757|NCT00199797|520067421|FG000|Overall Study|Adverse Event|1|||
144237758|NCT00199797|520067421|FG000|Overall Study|Physician Decision|1|||
144237759|NCT04250350|520067422|FG000|Overall Study|Withdrawal by Subject|13|||
144237760|NCT04250350|520067422|FG000|Overall Study|Lost to Follow-up|8|||
144237761|NCT04250350|520067422|FG000|Overall Study|Adverse Event|5|||
144237762|NCT04250350|520067422|FG000|Overall Study|Lack of Efficacy|4|||
144237763|NCT04250350|520067422|FG000|Overall Study|Physician Decision|1|||
144237764|NCT04250350|520067422|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
144237765|NCT02836236|520067423|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
144237766|NCT02836236|520067424|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
144237767|NCT02836236|520067425|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
144237768|NCT02836236|520067426|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
144237769|NCT02836236|520067423|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
144237770|NCT02836236|520067424|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
144237771|NCT02836236|520067425|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
144237772|NCT02836236|520067426|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
144237773|NCT02836236|520067423|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
144237774|NCT02836236|520067424|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
144237775|NCT02836236|520067425|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
144237776|NCT02836236|520067426|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
144237777|NCT02836236|520067423|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
144237778|NCT02836236|520067424|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
144237779|NCT02836236|520067425|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
144237780|NCT02836236|520067426|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
144237781|NCT02836236|520067423|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
144237782|NCT02836236|520067424|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
144237783|NCT02836236|520067425|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
144237784|NCT02836236|520067426|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
144237785|NCT02836236|520067423|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
144237786|NCT02836236|520067424|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
144237787|NCT02836236|520067425|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
144237788|NCT02836236|520067426|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
144237789|NCT02836236|520067423|FG000|Open-Label TAF Treatment Phase|Death|0|||
144237790|NCT02836236|520067424|FG001|Open-Label TAF Treatment Phase|Death|0|||
144237791|NCT02836236|520067425|FG002|Open-Label TAF Treatment Phase|Death|1|||
144237792|NCT02836236|520067426|FG003|Open-Label TAF Treatment Phase|Death|1|||
144237793|NCT02836236|520067423|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
144237794|NCT02836236|520067424|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
144237795|NCT02836236|520067425|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
144237796|NCT02836236|520067426|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
144237797|NCT03937908|520067428|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
144237798|NCT03937908|520067429|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
144237799|NCT03875092|520067430|FG000|Overall Study|Adverse Event|2|||
144237800|NCT03875092|520067431|FG001|Overall Study|Adverse Event|5|||
144237801|NCT03875092|520067430|FG000|Overall Study|Death|44|||
144237802|NCT03875092|520067431|FG001|Overall Study|Death|51|||
144237803|NCT03875092|520067430|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
144237804|NCT03875092|520067431|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
144237805|NCT03205761|520067432|FG000|Overall Study|Withdrawal by Subject|1|||
144237806|NCT03205761|520067432|FG000|Overall Study|Progressive Disease|10|||
144237807|NCT00452673|520067435|FG000|Dose Escalation Period|Disease Progression|6|||
144237808|NCT00452673|520067436|FG001|Dose Escalation Period|Disease Progression|6|||
144237809|NCT00452673|520067437|FG002|Dose Escalation Period|Disease Progression|2|||
144237810|NCT00452673|520067438|FG003|Dose Escalation Period|Disease Progression|6|||
144237811|NCT00452673|520067439|FG004|Dose Escalation Period|Disease Progression|0|||
144237812|NCT00452673|520067435|FG000|Dose Escalation Period|study drug toxicity|1|||
144237813|NCT00452673|520067436|FG001|Dose Escalation Period|study drug toxicity|3|||
144237814|NCT00452673|520067437|FG002|Dose Escalation Period|study drug toxicity|3|||
144237815|NCT00452673|520067438|FG003|Dose Escalation Period|study drug toxicity|1|||
144237816|NCT00452673|520067439|FG004|Dose Escalation Period|study drug toxicity|0|||
144237817|NCT00452673|520067435|FG000|Dose Escalation Period|Other|0|||
144237818|NCT00452673|520067436|FG001|Dose Escalation Period|Other|0|||
144237819|NCT00452673|520067437|FG002|Dose Escalation Period|Other|1|||
144237820|NCT00452673|520067438|FG003|Dose Escalation Period|Other|0|||
144237821|NCT00452673|520067439|FG004|Dose Escalation Period|Other|0|||
144237822|NCT00452673|520067435|FG000|Dose Escalation Period|Adverse Event|0|||
144237823|NCT00452673|520067436|FG001|Dose Escalation Period|Adverse Event|0|||
144237824|NCT00452673|520067437|FG002|Dose Escalation Period|Adverse Event|0|||
144237825|NCT00452673|520067438|FG003|Dose Escalation Period|Adverse Event|1|||
144237826|NCT00452673|520067439|FG004|Dose Escalation Period|Adverse Event|0|||
144237827|NCT00452673|520067435|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
144237828|NCT00452673|520067436|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
144237829|NCT00452673|520067437|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
144237830|NCT00452673|520067438|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
144237831|NCT00452673|520067439|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
144237832|NCT00452673|520067435|FG000|Dose Expansion Period|Disease Progression|0|||
144237833|NCT00452673|520067436|FG001|Dose Expansion Period|Disease Progression|0|||
144237834|NCT00452673|520067437|FG002|Dose Expansion Period|Disease Progression|0|||
144237835|NCT00452673|520067438|FG003|Dose Expansion Period|Disease Progression|0|||
144237836|NCT00452673|520067439|FG004|Dose Expansion Period|Disease Progression|19|||
144237837|NCT00452673|520067435|FG000|Dose Expansion Period|Other|0|||
144237838|NCT00452673|520067436|FG001|Dose Expansion Period|Other|0|||
144237839|NCT00452673|520067437|FG002|Dose Expansion Period|Other|0|||
144237840|NCT00452673|520067438|FG003|Dose Expansion Period|Other|0|||
144237841|NCT00452673|520067439|FG004|Dose Expansion Period|Other|2|||
144237842|NCT02461524|520067441|FG000|Overall Study|Death|16|||
144237843|NCT02461524|520067441|FG000|Overall Study|Withdrawal by Subject|4|||
144237844|NCT02461524|520067441|FG000|Overall Study|Device Explanted|5|||
144237845|NCT02461524|520067441|FG000|Overall Study|Missed Visit|6|||
144237846|NCT00843037|520067445|FG000|Overall Study|Lost to Follow-up|1|||
144237847|NCT04984278|520067446|FG000|Period 1|Withdrawal by Subject|1|||
144237848|NCT04984278|520067447|FG001|Period 1|Withdrawal by Subject|0|||
144237849|NCT04984278|520067446|FG000|Period 1|Other|0|||
144237850|NCT04984278|520067447|FG001|Period 1|Other|1|||
144237851|NCT04984278|520067446|FG000|Period 2|Adverse Event|1|||
144237852|NCT04984278|520067447|FG001|Period 2|Adverse Event|0|||
144237853|NCT04984278|520067446|FG000|Period 2|Other|0|||
144237854|NCT04984278|520067447|FG001|Period 2|Other|1|||
144269826|NCT01677741|520191430|FG006|Overall Study|Enrolled in a rollover study|7|||
144269827|NCT01677741|520191431|FG007|Overall Study|Enrolled in a rollover study|0|||
144269828|NCT01677741|520191424|FG000|Overall Study|Progressive disease|1|||
144269829|NCT01677741|520191425|FG001|Overall Study|Progressive disease|0|||
144269830|NCT01677741|520191426|FG002|Overall Study|Progressive disease|1|||
144269831|NCT01677741|520191427|FG003|Overall Study|Progressive disease|0|||
144269832|NCT01677741|520191428|FG004|Overall Study|Progressive disease|0|||
144269833|NCT01677741|520191429|FG005|Overall Study|Progressive disease|1|||
144269834|NCT01677741|520191430|FG006|Overall Study|Progressive disease|0|||
144269835|NCT01677741|520191431|FG007|Overall Study|Progressive disease|0|||
144269836|NCT00720499|520191432|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
144269837|NCT00720499|520191433|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
144269838|NCT00720499|520191432|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
144269839|NCT00720499|520191433|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
144269840|NCT00720499|520191432|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
144269841|NCT00720499|520191433|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
144269842|NCT00828711|520191435|FG000|Overall Study|Lost to Follow-up|1|||
144269843|NCT00828711|520191436|FG001|Overall Study|Lost to Follow-up|0|||
144269844|NCT00828711|520191437|FG002|Overall Study|Lost to Follow-up|0|||
144269845|NCT01618968|520191438|FG000|Overall Study|Adverse Event|1|||
144269846|NCT01618968|520191439|FG001|Overall Study|Adverse Event|0|||
144269847|NCT01618968|520191440|FG002|Overall Study|Adverse Event|0|||
144269848|NCT01618968|520191441|FG003|Overall Study|Adverse Event|0|||
144269849|NCT01618968|520191438|FG000|Overall Study|Death|0|||
144269850|NCT01618968|520191439|FG001|Overall Study|Death|0|||
144269851|NCT01618968|520191440|FG002|Overall Study|Death|0|||
144269852|NCT01618968|520191441|FG003|Overall Study|Death|1|||
144269853|NCT01326871|520191443|FG000|Overall Study|Major surgery|0|||
144269854|NCT01326871|520191444|FG001|Overall Study|Major surgery|1|||
144269855|NCT01326871|520191445|FG002|Overall Study|Major surgery|0|||
144269856|NCT01326871|520191443|FG000|Overall Study|SAE and death|0|||
144269857|NCT01326871|520191444|FG001|Overall Study|SAE and death|2|||
144269858|NCT01326871|520191445|FG002|Overall Study|SAE and death|0|||
144269859|NCT01326871|520191443|FG000|Overall Study|Physician decision and decreased performance status|0|||
144269860|NCT01326871|520191444|FG001|Overall Study|Physician decision and decreased performance status|1|||
144269861|NCT01326871|520191445|FG002|Overall Study|Physician decision and decreased performance status|0|||
144269862|NCT01326871|520191443|FG000|Overall Study|Disease progression|0|||
144269863|NCT01326871|520191444|FG001|Overall Study|Disease progression|11|||
144269864|NCT01326871|520191445|FG002|Overall Study|Disease progression|5|||
144269865|NCT01326871|520191443|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
144269866|NCT01326871|520191444|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
144269867|NCT01326871|520191445|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
144269868|NCT01326871|520191443|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
144269869|NCT01326871|520191444|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
144269870|NCT01326871|520191445|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
144269871|NCT01326871|520191443|FG000|Overall Study|Withdrawal by Subject|0|||
144269872|NCT01326871|520191444|FG001|Overall Study|Withdrawal by Subject|1|||
144269873|NCT01326871|520191445|FG002|Overall Study|Withdrawal by Subject|0|||
144269874|NCT01326871|520191443|FG000|Overall Study|DLT|0|||
144269875|NCT01326871|520191444|FG001|Overall Study|DLT|2|||
144269876|NCT01326871|520191445|FG002|Overall Study|DLT|0|||
144237855|NCT03535194|520067448|FG000|Induction Period|Adverse Event|2|||
144237856|NCT03535194|520067449|FG001|Induction Period|Adverse Event|2|||
144237857|NCT03535194|520067450|FG002|Induction Period|Adverse Event|1|||
144237858|NCT03535194|520067451|FG003|Induction Period|Adverse Event|3|||
144237859|NCT03535194|520067452|FG004|Induction Period|Adverse Event|0|||
144237860|NCT03535194|520067448|FG000|Induction Period|Death|0|||
144237861|NCT03535194|520067449|FG001|Induction Period|Death|1|||
144237862|NCT03535194|520067450|FG002|Induction Period|Death|0|||
144237863|NCT03535194|520067451|FG003|Induction Period|Death|0|||
144237864|NCT03535194|520067452|FG004|Induction Period|Death|0|||
144237865|NCT03535194|520067448|FG000|Induction Period|Lack of Efficacy|1|||
144269877|NCT01326871|520191443|FG000|Overall Study|SAE, disease progression and subject decision|0|||
144269878|NCT01326871|520191444|FG001|Overall Study|SAE, disease progression and subject decision|1|||
144269879|NCT01326871|520191445|FG002|Overall Study|SAE, disease progression and subject decision|0|||
144269880|NCT01326871|520191443|FG000|Overall Study|Death|0|||
144237866|NCT03535194|520067449|FG001|Induction Period|Lack of Efficacy|3|||
144237867|NCT03535194|520067450|FG002|Induction Period|Lack of Efficacy|2|||
144269881|NCT01326871|520191444|FG001|Overall Study|Death|1|||
144269882|NCT01326871|520191445|FG002|Overall Study|Death|0|||
144269883|NCT01326871|520191443|FG000|Overall Study|Other|0|||
144269884|NCT01326871|520191444|FG001|Overall Study|Other|3|||
144237868|NCT03535194|520067451|FG003|Induction Period|Lack of Efficacy|2|||
144237869|NCT03535194|520067452|FG004|Induction Period|Lack of Efficacy|0|||
144237870|NCT03535194|520067448|FG000|Induction Period|Lost to Follow-up|3|||
144269885|NCT01326871|520191445|FG002|Overall Study|Other|0|||
144269886|NCT01326871|520191443|FG000|Overall Study|SAE and disease progression|0|||
144237871|NCT03535194|520067449|FG001|Induction Period|Lost to Follow-up|5|||
144237872|NCT03535194|520067450|FG002|Induction Period|Lost to Follow-up|2|||
144237873|NCT03535194|520067451|FG003|Induction Period|Lost to Follow-up|3|||
144237874|NCT03535194|520067452|FG004|Induction Period|Lost to Follow-up|0|||
144237875|NCT03535194|520067448|FG000|Induction Period|Physician Decision|1|||
144237876|NCT03535194|520067449|FG001|Induction Period|Physician Decision|1|||
144237877|NCT03535194|520067450|FG002|Induction Period|Physician Decision|0|||
144237878|NCT03535194|520067451|FG003|Induction Period|Physician Decision|0|||
144237879|NCT03535194|520067452|FG004|Induction Period|Physician Decision|0|||
144237880|NCT03535194|520067448|FG000|Induction Period|Protocol Violation|1|||
144237881|NCT03535194|520067449|FG001|Induction Period|Protocol Violation|0|||
144237882|NCT03535194|520067450|FG002|Induction Period|Protocol Violation|0|||
144237883|NCT03535194|520067451|FG003|Induction Period|Protocol Violation|1|||
144237884|NCT03535194|520067452|FG004|Induction Period|Protocol Violation|0|||
144237885|NCT03535194|520067448|FG000|Induction Period|Screen Failure|0|||
144237886|NCT03535194|520067449|FG001|Induction Period|Screen Failure|1|||
144237887|NCT03535194|520067450|FG002|Induction Period|Screen Failure|0|||
144237888|NCT03535194|520067451|FG003|Induction Period|Screen Failure|0|||
144237889|NCT03535194|520067452|FG004|Induction Period|Screen Failure|0|||
144237890|NCT03535194|520067448|FG000|Induction Period|Withdrawal by Subject|3|||
144237891|NCT03535194|520067449|FG001|Induction Period|Withdrawal by Subject|4|||
144237892|NCT03535194|520067450|FG002|Induction Period|Withdrawal by Subject|3|||
144237893|NCT03535194|520067451|FG003|Induction Period|Withdrawal by Subject|2|||
144237894|NCT03535194|520067452|FG004|Induction Period|Withdrawal by Subject|0|||
144237895|NCT03535194|520067448|FG000|Maintenance Period|Adverse Event|6|||
144237896|NCT03535194|520067449|FG001|Maintenance Period|Adverse Event|5|||
144237897|NCT03535194|520067450|FG002|Maintenance Period|Adverse Event|1|||
144237898|NCT03535194|520067451|FG003|Maintenance Period|Adverse Event|11|||
144237899|NCT03535194|520067452|FG004|Maintenance Period|Adverse Event|4|||
144237900|NCT03535194|520067448|FG000|Maintenance Period|Lack of Efficacy|3|||
144237901|NCT03535194|520067449|FG001|Maintenance Period|Lack of Efficacy|2|||
144237902|NCT03535194|520067450|FG002|Maintenance Period|Lack of Efficacy|5|||
144237903|NCT03535194|520067451|FG003|Maintenance Period|Lack of Efficacy|9|||
144237904|NCT03535194|520067452|FG004|Maintenance Period|Lack of Efficacy|0|||
144237905|NCT03535194|520067448|FG000|Maintenance Period|Lost to Follow-up|4|||
144237906|NCT03535194|520067449|FG001|Maintenance Period|Lost to Follow-up|2|||
144237907|NCT03535194|520067450|FG002|Maintenance Period|Lost to Follow-up|1|||
144237908|NCT03535194|520067451|FG003|Maintenance Period|Lost to Follow-up|5|||
144237909|NCT03535194|520067452|FG004|Maintenance Period|Lost to Follow-up|2|||
144237910|NCT03535194|520067448|FG000|Maintenance Period|Other|1|||
144237911|NCT03535194|520067449|FG001|Maintenance Period|Other|2|||
144237912|NCT03535194|520067450|FG002|Maintenance Period|Other|0|||
144237913|NCT03535194|520067451|FG003|Maintenance Period|Other|0|||
144237914|NCT03535194|520067452|FG004|Maintenance Period|Other|0|||
144237915|NCT03535194|520067448|FG000|Maintenance Period|Physician Decision|1|||
144237916|NCT03535194|520067449|FG001|Maintenance Period|Physician Decision|2|||
144237917|NCT03535194|520067450|FG002|Maintenance Period|Physician Decision|0|||
144237918|NCT03535194|520067451|FG003|Maintenance Period|Physician Decision|2|||
144237919|NCT03535194|520067452|FG004|Maintenance Period|Physician Decision|0|||
144237920|NCT03535194|520067448|FG000|Maintenance Period|Pregnancy|0|||
144237921|NCT03535194|520067449|FG001|Maintenance Period|Pregnancy|0|||
144237922|NCT03535194|520067450|FG002|Maintenance Period|Pregnancy|0|||
144237923|NCT03535194|520067451|FG003|Maintenance Period|Pregnancy|2|||
144237924|NCT03535194|520067452|FG004|Maintenance Period|Pregnancy|0|||
144237925|NCT03535194|520067448|FG000|Maintenance Period|Protocol Violation|0|||
144237926|NCT03535194|520067449|FG001|Maintenance Period|Protocol Violation|1|||
144237927|NCT03535194|520067450|FG002|Maintenance Period|Protocol Violation|0|||
144237928|NCT03535194|520067451|FG003|Maintenance Period|Protocol Violation|0|||
144269887|NCT01326871|520191444|FG001|Overall Study|SAE and disease progression|0|||
144269888|NCT01326871|520191445|FG002|Overall Study|SAE and disease progression|1|||
144269889|NCT01326871|520191443|FG000|Overall Study|SAE and physician decision|0|||
144269890|NCT01326871|520191444|FG001|Overall Study|SAE and physician decision|0|||
144269891|NCT01326871|520191445|FG002|Overall Study|SAE and physician decision|1|||
144269892|NCT01326871|520191443|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
144297090|NCT01182350|520292443|FG004|Overall Study|Unevaluable for Biopsy|3|||
144237929|NCT03535194|520067452|FG004|Maintenance Period|Protocol Violation|0|||
144237930|NCT03535194|520067448|FG000|Maintenance Period|Withdrawal by Subject|7|||
144237931|NCT03535194|520067449|FG001|Maintenance Period|Withdrawal by Subject|2|||
144237932|NCT03535194|520067450|FG002|Maintenance Period|Withdrawal by Subject|1|||
144237933|NCT03535194|520067451|FG003|Maintenance Period|Withdrawal by Subject|8|||
144237934|NCT03535194|520067452|FG004|Maintenance Period|Withdrawal by Subject|0|||
144237935|NCT03535194|520067448|FG000|Post-Treatment Followup Period|Adverse Event|4|||
144237936|NCT03535194|520067449|FG001|Post-Treatment Followup Period|Adverse Event|5|||
144237937|NCT03535194|520067450|FG002|Post-Treatment Followup Period|Adverse Event|1|||
144237938|NCT03535194|520067451|FG003|Post-Treatment Followup Period|Adverse Event|8|||
144237939|NCT03535194|520067452|FG004|Post-Treatment Followup Period|Adverse Event|0|||
144237940|NCT03535194|520067448|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
144237941|NCT03535194|520067449|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
144237942|NCT03535194|520067450|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
144237943|NCT03535194|520067451|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
144237944|NCT03535194|520067452|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
144237945|NCT03535194|520067448|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
144237946|NCT03535194|520067449|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
144237947|NCT03535194|520067450|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
144237948|NCT03535194|520067451|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
144237949|NCT03535194|520067452|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
144237950|NCT03535194|520067448|FG000|Post-Treatment Followup Period|Other|1|||
144237951|NCT03535194|520067449|FG001|Post-Treatment Followup Period|Other|0|||
144237952|NCT03535194|520067450|FG002|Post-Treatment Followup Period|Other|0|||
144237953|NCT03535194|520067451|FG003|Post-Treatment Followup Period|Other|5|||
144237954|NCT03535194|520067452|FG004|Post-Treatment Followup Period|Other|0|||
144237955|NCT03535194|520067448|FG000|Post-Treatment Followup Period|Physician Decision|0|||
144237956|NCT03535194|520067449|FG001|Post-Treatment Followup Period|Physician Decision|2|||
144237957|NCT03535194|520067450|FG002|Post-Treatment Followup Period|Physician Decision|1|||
144237958|NCT03535194|520067451|FG003|Post-Treatment Followup Period|Physician Decision|1|||
144237959|NCT03535194|520067452|FG004|Post-Treatment Followup Period|Physician Decision|0|||
144237960|NCT03535194|520067448|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
144237961|NCT03535194|520067449|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
144237962|NCT03535194|520067450|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
144237963|NCT03535194|520067451|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
144237964|NCT03535194|520067452|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144237965|NCT03991299|520067455|FG000|Overall Study|Study closed, sponsor decision|3|||
144237966|NCT03991299|520067455|FG000|Overall Study|Withdrawal by Subject|1|||
144237967|NCT04304235|520067456|FG000|Overall Study|incomplete triage data|0|||
144237968|NCT04304235|520067457|FG001|Overall Study|incomplete triage data|69|||
144237969|NCT04304235|520067458|FG002|Overall Study|incomplete triage data|0|||
144237970|NCT04304235|520067459|FG003|Overall Study|incomplete triage data|0|||
144237971|NCT04304235|520067460|FG004|Overall Study|incomplete triage data|289|||
144237972|NCT04304235|520067461|FG005|Overall Study|incomplete triage data|123|||
144237973|NCT04304235|520067462|FG006|Overall Study|incomplete triage data|65|||
144237974|NCT00330343|520067463|FG000|Overall Study|Lost to Follow-up|5|||
144237975|NCT00281632|520067464|FG000|Overall Study|Adverse Event|7|||
144237976|NCT00281632|520067464|FG000|Overall Study|Withdrawal by Subject|2|||
144237977|NCT00281632|520067464|FG000|Overall Study|Disease Progression|22|||
144237978|NCT00281632|520067464|FG000|Overall Study|Death|1|||
144237979|NCT00281632|520067464|FG000|Overall Study|Physician Decision|1|||
144237980|NCT00281632|520067464|FG000|Overall Study|Ongoing|3|||
144237981|NCT02980341|520067467|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
144237982|NCT02980341|520067468|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
144237983|NCT02980341|520067469|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
144237984|NCT02980341|520067470|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
144237985|NCT02980341|520067471|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
144237986|NCT02980341|520067472|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
144237987|NCT02980341|520067473|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
144237988|NCT02980341|520067474|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
144269893|NCT01326871|520191444|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
144297091|NCT03605693|520292446|FG000|Overall Study|Lost to Follow-up|4|||
144237989|NCT02980341|520067475|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
144237990|NCT02980341|520067476|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
144237991|NCT02980341|520067477|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
144237992|NCT02980341|520067467|FG000|Dose Escalation|Clinical progression|0|||
144237993|NCT02980341|520067468|FG001|Dose Escalation|Clinical progression|0|||
144237994|NCT02980341|520067469|FG002|Dose Escalation|Clinical progression|2|||
144237995|NCT02980341|520067470|FG003|Dose Escalation|Clinical progression|1|||
144237996|NCT02980341|520067471|FG004|Dose Escalation|Clinical progression|0|||
144237997|NCT02980341|520067472|FG005|Dose Escalation|Clinical progression|0|||
144237998|NCT02980341|520067473|FG006|Dose Escalation|Clinical progression|0|||
144237999|NCT02980341|520067474|FG007|Dose Escalation|Clinical progression|0|||
144238000|NCT02980341|520067475|FG008|Dose Escalation|Clinical progression|0|||
144238001|NCT02980341|520067476|FG009|Dose Escalation|Clinical progression|0|||
144238002|NCT02980341|520067477|FG010|Dose Escalation|Clinical progression|0|||
144238003|NCT02980341|520067467|FG000|Dose Escalation|Adverse Event|0|||
144238004|NCT02980341|520067468|FG001|Dose Escalation|Adverse Event|0|||
144238005|NCT02980341|520067469|FG002|Dose Escalation|Adverse Event|1|||
144238006|NCT02980341|520067470|FG003|Dose Escalation|Adverse Event|2|||
144238007|NCT02980341|520067471|FG004|Dose Escalation|Adverse Event|2|||
144238008|NCT02980341|520067472|FG005|Dose Escalation|Adverse Event|0|||
144238009|NCT02980341|520067473|FG006|Dose Escalation|Adverse Event|0|||
144238010|NCT02980341|520067474|FG007|Dose Escalation|Adverse Event|0|||
144238011|NCT02980341|520067475|FG008|Dose Escalation|Adverse Event|0|||
144238012|NCT02980341|520067476|FG009|Dose Escalation|Adverse Event|0|||
144238013|NCT02980341|520067477|FG010|Dose Escalation|Adverse Event|0|||
144238014|NCT02980341|520067467|FG000|Dose Escalation|Withdrawal by Subject|0|||
144238015|NCT02980341|520067468|FG001|Dose Escalation|Withdrawal by Subject|0|||
144238016|NCT02980341|520067469|FG002|Dose Escalation|Withdrawal by Subject|1|||
144238017|NCT02980341|520067470|FG003|Dose Escalation|Withdrawal by Subject|0|||
144238018|NCT02980341|520067471|FG004|Dose Escalation|Withdrawal by Subject|0|||
144238019|NCT02980341|520067472|FG005|Dose Escalation|Withdrawal by Subject|0|||
144238020|NCT02980341|520067473|FG006|Dose Escalation|Withdrawal by Subject|0|||
144238021|NCT02980341|520067474|FG007|Dose Escalation|Withdrawal by Subject|0|||
144238022|NCT02980341|520067475|FG008|Dose Escalation|Withdrawal by Subject|0|||
144238023|NCT02980341|520067476|FG009|Dose Escalation|Withdrawal by Subject|0|||
144238024|NCT02980341|520067477|FG010|Dose Escalation|Withdrawal by Subject|0|||
144238025|NCT02980341|520067467|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238026|NCT02980341|520067468|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238027|NCT02980341|520067469|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238028|NCT02980341|520067470|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
144238029|NCT02980341|520067471|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238030|NCT02980341|520067472|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238031|NCT02980341|520067473|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238032|NCT02980341|520067474|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238033|NCT02980341|520067475|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238034|NCT02980341|520067476|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238035|NCT02980341|520067477|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
144238036|NCT02980341|520067467|FG000|Dose Escalation|Due to investigator's decision|0|||
144238037|NCT02980341|520067468|FG001|Dose Escalation|Due to investigator's decision|0|||
144238038|NCT02980341|520067469|FG002|Dose Escalation|Due to investigator's decision|0|||
144238039|NCT02980341|520067470|FG003|Dose Escalation|Due to investigator's decision|0|||
144238040|NCT02980341|520067471|FG004|Dose Escalation|Due to investigator's decision|1|||
144238041|NCT02980341|520067472|FG005|Dose Escalation|Due to investigator's decision|0|||
144297092|NCT03605693|520292447|FG001|Overall Study|Lost to Follow-up|0|||
144238042|NCT02980341|520067473|FG006|Dose Escalation|Due to investigator's decision|0|||
144238043|NCT02980341|520067474|FG007|Dose Escalation|Due to investigator's decision|0|||
144269894|NCT01326871|520191445|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
144269895|NCT01326871|520191443|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
144269896|NCT01326871|520191444|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
144269897|NCT01326871|520191445|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
144269898|NCT01326871|520191443|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
144269899|NCT01326871|520191444|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
144269900|NCT01326871|520191445|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
144269901|NCT01326871|520191443|FG000|Overall Study|Physician Decision|0|||
144269902|NCT01326871|520191444|FG001|Overall Study|Physician Decision|0|||
144269903|NCT01326871|520191445|FG002|Overall Study|Physician Decision|1|||
144269904|NCT01326871|520191443|FG000|Overall Study|SAE|0|||
144269905|NCT01326871|520191444|FG001|Overall Study|SAE|0|||
144269906|NCT01326871|520191445|FG002|Overall Study|SAE|1|||
144269907|NCT01326871|520191443|FG000|Overall Study|Disease progression and death|0|||
144269908|NCT01326871|520191444|FG001|Overall Study|Disease progression and death|0|||
144269909|NCT01326871|520191445|FG002|Overall Study|Disease progression and death|1|||
144269910|NCT01326871|520191443|FG000|Overall Study|Subject decision|0|||
144269911|NCT01326871|520191444|FG001|Overall Study|Subject decision|0|||
144269912|NCT01326871|520191445|FG002|Overall Study|Subject decision|1|||
144269913|NCT01387269|520191448|FG000|Overall Study|Death|38|||
144269914|NCT01387269|520191449|FG001|Overall Study|Death|20|||
144269915|NCT01387269|520191448|FG000|Overall Study|Other|8|||
144238044|NCT02980341|520067475|FG008|Dose Escalation|Due to investigator's decision|0|||
144238045|NCT02980341|520067476|FG009|Dose Escalation|Due to investigator's decision|0|||
144238046|NCT02980341|520067477|FG010|Dose Escalation|Due to investigator's decision|0|||
144238047|NCT02980341|520067467|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238048|NCT02980341|520067468|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238049|NCT02980341|520067469|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238050|NCT02980341|520067470|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238051|NCT02980341|520067471|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238052|NCT02980341|520067472|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
144238053|NCT02980341|520067473|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
144238054|NCT02980341|520067474|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238055|NCT02980341|520067475|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238056|NCT02980341|520067476|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238057|NCT02980341|520067477|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
144238058|NCT02980341|520067467|FG000|Dose Finding|Adverse Event|0|||
144238059|NCT02980341|520067468|FG001|Dose Finding|Adverse Event|0|||
144238060|NCT02980341|520067469|FG002|Dose Finding|Adverse Event|0|||
144238061|NCT02980341|520067470|FG003|Dose Finding|Adverse Event|0|||
144238062|NCT02980341|520067471|FG004|Dose Finding|Adverse Event|0|||
144238063|NCT02980341|520067472|FG005|Dose Finding|Adverse Event|3|||
144238064|NCT02980341|520067473|FG006|Dose Finding|Adverse Event|0|||
144238065|NCT02980341|520067474|FG007|Dose Finding|Adverse Event|0|||
144238066|NCT02980341|520067475|FG008|Dose Finding|Adverse Event|0|||
144238067|NCT02980341|520067476|FG009|Dose Finding|Adverse Event|0|||
144238068|NCT02980341|520067477|FG010|Dose Finding|Adverse Event|0|||
144238069|NCT02980341|520067467|FG000|Dose Finding|Withdrawal by Subject|0|||
144238070|NCT02980341|520067468|FG001|Dose Finding|Withdrawal by Subject|0|||
144238071|NCT02980341|520067469|FG002|Dose Finding|Withdrawal by Subject|0|||
144238072|NCT02980341|520067470|FG003|Dose Finding|Withdrawal by Subject|0|||
144238073|NCT02980341|520067471|FG004|Dose Finding|Withdrawal by Subject|0|||
144238074|NCT02980341|520067472|FG005|Dose Finding|Withdrawal by Subject|1|||
144238075|NCT02980341|520067473|FG006|Dose Finding|Withdrawal by Subject|1|||
144238076|NCT02980341|520067474|FG007|Dose Finding|Withdrawal by Subject|0|||
144238077|NCT02980341|520067475|FG008|Dose Finding|Withdrawal by Subject|0|||
144238078|NCT02980341|520067476|FG009|Dose Finding|Withdrawal by Subject|0|||
144238079|NCT02980341|520067477|FG010|Dose Finding|Withdrawal by Subject|0|||
144238080|NCT02980341|520067467|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238081|NCT02980341|520067468|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238082|NCT02980341|520067469|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238083|NCT02980341|520067470|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238084|NCT02980341|520067471|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238085|NCT02980341|520067472|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238086|NCT02980341|520067473|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
144238087|NCT02980341|520067474|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
144238088|NCT02980341|520067475|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
144238089|NCT02980341|520067476|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
144238090|NCT02980341|520067477|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
144238091|NCT02980341|520067467|FG000|Dose Expansion|Clinical progression|0|||
144238092|NCT02980341|520067468|FG001|Dose Expansion|Clinical progression|0|||
144238093|NCT02980341|520067469|FG002|Dose Expansion|Clinical progression|0|||
144238094|NCT02980341|520067470|FG003|Dose Expansion|Clinical progression|0|||
144238095|NCT02980341|520067471|FG004|Dose Expansion|Clinical progression|0|||
144238096|NCT02980341|520067472|FG005|Dose Expansion|Clinical progression|0|||
144238097|NCT02980341|520067473|FG006|Dose Expansion|Clinical progression|0|||
144238098|NCT02980341|520067474|FG007|Dose Expansion|Clinical progression|4|||
144238099|NCT02980341|520067475|FG008|Dose Expansion|Clinical progression|3|||
144238100|NCT02980341|520067476|FG009|Dose Expansion|Clinical progression|1|||
144238101|NCT02980341|520067477|FG010|Dose Expansion|Clinical progression|4|||
144238102|NCT02980341|520067467|FG000|Dose Expansion|Adverse Event|0|||
144238103|NCT02980341|520067468|FG001|Dose Expansion|Adverse Event|0|||
144238104|NCT02980341|520067469|FG002|Dose Expansion|Adverse Event|0|||
144238105|NCT02980341|520067470|FG003|Dose Expansion|Adverse Event|0|||
144238106|NCT02980341|520067471|FG004|Dose Expansion|Adverse Event|0|||
144238107|NCT02980341|520067472|FG005|Dose Expansion|Adverse Event|0|||
144238108|NCT02980341|520067473|FG006|Dose Expansion|Adverse Event|0|||
144238109|NCT02980341|520067474|FG007|Dose Expansion|Adverse Event|3|||
144238110|NCT02980341|520067475|FG008|Dose Expansion|Adverse Event|0|||
144238111|NCT02980341|520067476|FG009|Dose Expansion|Adverse Event|1|||
144238112|NCT02980341|520067477|FG010|Dose Expansion|Adverse Event|3|||
144238113|NCT02980341|520067467|FG000|Dose Expansion|Death|0|||
144238114|NCT02980341|520067468|FG001|Dose Expansion|Death|0|||
144238115|NCT02980341|520067469|FG002|Dose Expansion|Death|0|||
144238116|NCT02980341|520067470|FG003|Dose Expansion|Death|0|||
144238117|NCT02980341|520067471|FG004|Dose Expansion|Death|0|||
144238118|NCT02980341|520067472|FG005|Dose Expansion|Death|0|||
144238119|NCT02980341|520067473|FG006|Dose Expansion|Death|0|||
144238120|NCT02980341|520067474|FG007|Dose Expansion|Death|0|||
144238121|NCT02980341|520067475|FG008|Dose Expansion|Death|2|||
144238122|NCT02980341|520067476|FG009|Dose Expansion|Death|1|||
144238123|NCT02980341|520067477|FG010|Dose Expansion|Death|0|||
144238124|NCT02980341|520067467|FG000|Dose Expansion|Withdrawal by Subject|0|||
144238125|NCT02980341|520067468|FG001|Dose Expansion|Withdrawal by Subject|0|||
144269916|NCT01387269|520191449|FG001|Overall Study|Other|7|||
144269917|NCT01387269|520191448|FG000|Overall Study|Unrelated AE|12|||
144269918|NCT01387269|520191449|FG001|Overall Study|Unrelated AE|3|||
144238126|NCT02980341|520067469|FG002|Dose Expansion|Withdrawal by Subject|0|||
144238127|NCT02980341|520067470|FG003|Dose Expansion|Withdrawal by Subject|0|||
144238128|NCT02980341|520067471|FG004|Dose Expansion|Withdrawal by Subject|0|||
144238129|NCT02980341|520067472|FG005|Dose Expansion|Withdrawal by Subject|0|||
144238130|NCT02980341|520067473|FG006|Dose Expansion|Withdrawal by Subject|0|||
144238131|NCT02980341|520067474|FG007|Dose Expansion|Withdrawal by Subject|2|||
144238132|NCT02980341|520067475|FG008|Dose Expansion|Withdrawal by Subject|0|||
144238133|NCT02980341|520067476|FG009|Dose Expansion|Withdrawal by Subject|1|||
144238134|NCT02980341|520067477|FG010|Dose Expansion|Withdrawal by Subject|0|||
144238135|NCT02980341|520067467|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238136|NCT02980341|520067468|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238137|NCT02980341|520067469|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238138|NCT02980341|520067470|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238139|NCT02980341|520067471|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238140|NCT02980341|520067472|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238141|NCT02980341|520067473|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238142|NCT02980341|520067474|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
144238143|NCT02980341|520067475|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238144|NCT02980341|520067476|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238145|NCT02980341|520067477|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
144238146|NCT02980341|520067467|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238147|NCT02980341|520067468|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238148|NCT02980341|520067469|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238149|NCT02980341|520067470|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238150|NCT02980341|520067471|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238151|NCT02980341|520067472|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238152|NCT02980341|520067473|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238153|NCT02980341|520067474|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238154|NCT02980341|520067475|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
144238155|NCT02980341|520067476|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238156|NCT02980341|520067477|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
144238157|NCT02980341|520067467|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238158|NCT02980341|520067468|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238159|NCT02980341|520067469|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238160|NCT02980341|520067470|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238161|NCT02980341|520067471|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238162|NCT02980341|520067472|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238163|NCT02980341|520067473|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238164|NCT02980341|520067474|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238165|NCT02980341|520067475|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
144238166|NCT02980341|520067476|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238167|NCT02980341|520067477|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
144238168|NCT02980341|520067467|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238169|NCT02980341|520067468|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238170|NCT02980341|520067469|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238171|NCT02980341|520067470|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238172|NCT02980341|520067471|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238173|NCT02980341|520067472|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238174|NCT02980341|520067473|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238175|NCT02980341|520067474|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238176|NCT02980341|520067475|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238177|NCT02980341|520067476|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
144238178|NCT02980341|520067477|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
144238179|NCT00749684|520067482|FG000|Overall Study|Death|1|||
144238180|NCT00749684|520067482|FG000|Overall Study|Adverse Event|27|||
144238181|NCT00749684|520067482|FG000|Overall Study|Participant's Wish|10|||
144238182|NCT00749684|520067482|FG000|Overall Study|Not Documented|1|||
144238183|NCT00749684|520067482|FG000|Overall Study|Progressive Desease|31|||
144297093|NCT03605693|520292446|FG000|Overall Study|Physician Decision|1|||
144238184|NCT00749684|520067482|FG000|Overall Study|Therapy according to protocol + AE|2|||
144238185|NCT00749684|520067482|FG000|Overall Study|AE+discontinuation on participants wish|1|||
144238186|NCT00749684|520067482|FG000|Overall Study|Missing|9|||
144238187|NCT03696108|520067483|FG000|Overall Study|Physician Decision|1|||
144238188|NCT03696108|520067484|FG001|Overall Study|Physician Decision|0|||
144238189|NCT03696108|520067483|FG000|Overall Study|Withdrawal by Subject|3|||
144238190|NCT03696108|520067484|FG001|Overall Study|Withdrawal by Subject|6|||
144238191|NCT01054196|520067488|FG000|Overall Study|Physician Decision|0|||
144238192|NCT01054196|520067489|FG001|Overall Study|Physician Decision|0|||
144238193|NCT01054196|520067490|FG002|Overall Study|Physician Decision|0|||
144238194|NCT01054196|520067491|FG003|Overall Study|Physician Decision|1|||
144238195|NCT01054196|520067492|FG004|Overall Study|Physician Decision|0|||
144238196|NCT01054196|520067493|FG005|Overall Study|Physician Decision|0|||
144238197|NCT01054196|520067494|FG006|Overall Study|Physician Decision|1|||
144238198|NCT00282113|520067495|FG000|Overall Study|Removed at parents request|1|||
144238199|NCT00282113|520067496|FG001|Overall Study|Removed at parents request|0|||
144238200|NCT00282113|520067497|FG002|Overall Study|Removed at parents request|0|||
144238201|NCT03382834|520067498|FG000|Step 1|Lost to Follow-up|0|||
144238202|NCT03382834|520067499|FG001|Step 1|Lost to Follow-up|1|||
144238203|NCT03382834|520067498|FG000|Step 2|Death|1|||
144238204|NCT03382834|520067499|FG001|Step 2|Death|0|||
144238205|NCT03382834|520067498|FG000|Step 2|Lost to Follow-up|2|||
144238206|NCT03382834|520067499|FG001|Step 2|Lost to Follow-up|2|||
144238207|NCT03382834|520067498|FG000|Step 2|Site Terminated by Sponsor|1|||
144238208|NCT03382834|520067499|FG001|Step 2|Site Terminated by Sponsor|0|||
144238209|NCT02949843|520067500|FG000|Overall Study|Withdrawal by Subject|0|||
144238210|NCT02949843|520067501|FG001|Overall Study|Withdrawal by Subject|1|||
144238211|NCT02949843|520067502|FG002|Overall Study|Withdrawal by Subject|1|||
144238212|NCT03429244|520067503|FG000|Overall Study|Withdrawal by Subject|2|||
144238213|NCT03429244|520067504|FG001|Overall Study|Withdrawal by Subject|1|||
144238214|NCT03429244|520067505|FG002|Overall Study|Withdrawal by Subject|1|||
144238215|NCT00977314|520067506|FG000|Overall Study|Withdrawal by Subject|1|||
144238216|NCT00977314|520067507|FG001|Overall Study|Withdrawal by Subject|0|||
144238217|NCT00977314|520067506|FG000|Overall Study|Physician Decision|1|||
144238218|NCT00977314|520067507|FG001|Overall Study|Physician Decision|0|||
144238219|NCT01295827|520067516|FG000|Overall Study|Adverse Event|1|||
144238220|NCT01295827|520067517|FG001|Overall Study|Adverse Event|2|||
144238221|NCT01295827|520067518|FG002|Overall Study|Adverse Event|2|||
144238222|NCT01295827|520067519|FG003|Overall Study|Adverse Event|1|||
144238223|NCT01295827|520067520|FG004|Overall Study|Adverse Event|1|||
144238224|NCT01295827|520067521|FG005|Overall Study|Adverse Event|4|||
144238225|NCT01295827|520067522|FG006|Overall Study|Adverse Event|15|||
144238226|NCT01295827|520067523|FG007|Overall Study|Adverse Event|49|||
144238227|NCT01295827|520067524|FG008|Overall Study|Adverse Event|22|||
144238228|NCT01295827|520067525|FG009|Overall Study|Adverse Event|7|||
144238229|NCT01295827|520067526|FG010|Overall Study|Adverse Event|50|||
144238230|NCT01295827|520067527|FG011|Overall Study|Adverse Event|21|||
144238231|NCT01295827|520067528|FG012|Overall Study|Adverse Event|0|||
144238232|NCT01295827|520067529|FG013|Overall Study|Adverse Event|0|||
144238233|NCT01295827|520067530|FG014|Overall Study|Adverse Event|0|||
144238234|NCT01295827|520067516|FG000|Overall Study|Lost to Follow-up|0|||
144238235|NCT01295827|520067517|FG001|Overall Study|Lost to Follow-up|0|||
144238236|NCT01295827|520067518|FG002|Overall Study|Lost to Follow-up|3|||
144238237|NCT01295827|520067519|FG003|Overall Study|Lost to Follow-up|0|||
144238238|NCT01295827|520067520|FG004|Overall Study|Lost to Follow-up|1|||
144238239|NCT01295827|520067521|FG005|Overall Study|Lost to Follow-up|0|||
144238240|NCT01295827|520067522|FG006|Overall Study|Lost to Follow-up|4|||
144238241|NCT01295827|520067523|FG007|Overall Study|Lost to Follow-up|8|||
144238242|NCT01295827|520067524|FG008|Overall Study|Lost to Follow-up|7|||
144238243|NCT01295827|520067525|FG009|Overall Study|Lost to Follow-up|4|||
144238244|NCT01295827|520067526|FG010|Overall Study|Lost to Follow-up|7|||
144238245|NCT01295827|520067527|FG011|Overall Study|Lost to Follow-up|3|||
144238246|NCT01295827|520067528|FG012|Overall Study|Lost to Follow-up|0|||
144238247|NCT01295827|520067529|FG013|Overall Study|Lost to Follow-up|0|||
144238248|NCT01295827|520067530|FG014|Overall Study|Lost to Follow-up|0|||
144238249|NCT01295827|520067516|FG000|Overall Study|Not Reported|0|||
144238250|NCT01295827|520067517|FG001|Overall Study|Not Reported|0|||
144238251|NCT01295827|520067518|FG002|Overall Study|Not Reported|0|||
144238252|NCT01295827|520067519|FG003|Overall Study|Not Reported|1|||
144238253|NCT01295827|520067520|FG004|Overall Study|Not Reported|0|||
144238254|NCT01295827|520067521|FG005|Overall Study|Not Reported|0|||
144238255|NCT01295827|520067522|FG006|Overall Study|Not Reported|24|||
144238256|NCT01295827|520067523|FG007|Overall Study|Not Reported|58|||
144238257|NCT01295827|520067524|FG008|Overall Study|Not Reported|41|||
144238258|NCT01295827|520067525|FG009|Overall Study|Not Reported|2|||
144238259|NCT01295827|520067526|FG010|Overall Study|Not Reported|23|||
144238260|NCT01295827|520067527|FG011|Overall Study|Not Reported|13|||
144238261|NCT01295827|520067528|FG012|Overall Study|Not Reported|0|||
144238262|NCT01295827|520067529|FG013|Overall Study|Not Reported|0|||
144238263|NCT01295827|520067530|FG014|Overall Study|Not Reported|0|||
144238264|NCT01295827|520067516|FG000|Overall Study|Progressive Disease|2|||
144238265|NCT01295827|520067517|FG001|Overall Study|Progressive Disease|1|||
144238266|NCT01295827|520067518|FG002|Overall Study|Progressive Disease|5|||
144238267|NCT01295827|520067519|FG003|Overall Study|Progressive Disease|2|||
144238268|NCT01295827|520067520|FG004|Overall Study|Progressive Disease|0|||
144238269|NCT01295827|520067521|FG005|Overall Study|Progressive Disease|1|||
144238270|NCT01295827|520067522|FG006|Overall Study|Progressive Disease|87|||
144238271|NCT01295827|520067523|FG007|Overall Study|Progressive Disease|144|||
144238272|NCT01295827|520067524|FG008|Overall Study|Progressive Disease|85|||
144238273|NCT01295827|520067525|FG009|Overall Study|Progressive Disease|40|||
144238274|NCT01295827|520067526|FG010|Overall Study|Progressive Disease|175|||
144238275|NCT01295827|520067527|FG011|Overall Study|Progressive Disease|136|||
144238276|NCT01295827|520067528|FG012|Overall Study|Progressive Disease|0|||
144238277|NCT01295827|520067529|FG013|Overall Study|Progressive Disease|0|||
144238278|NCT01295827|520067530|FG014|Overall Study|Progressive Disease|0|||
144238279|NCT01295827|520067516|FG000|Overall Study|Screen Failure|0|||
144238280|NCT01295827|520067517|FG001|Overall Study|Screen Failure|0|||
144238281|NCT01295827|520067518|FG002|Overall Study|Screen Failure|0|||
144238282|NCT01295827|520067519|FG003|Overall Study|Screen Failure|0|||
144238283|NCT01295827|520067520|FG004|Overall Study|Screen Failure|0|||
144238284|NCT01295827|520067521|FG005|Overall Study|Screen Failure|0|||
144238285|NCT01295827|520067522|FG006|Overall Study|Screen Failure|2|||
144238286|NCT01295827|520067523|FG007|Overall Study|Screen Failure|2|||
144238287|NCT01295827|520067524|FG008|Overall Study|Screen Failure|2|||
144238288|NCT01295827|520067525|FG009|Overall Study|Screen Failure|0|||
144238289|NCT01295827|520067526|FG010|Overall Study|Screen Failure|1|||
144238290|NCT01295827|520067527|FG011|Overall Study|Screen Failure|0|||
144238291|NCT01295827|520067528|FG012|Overall Study|Screen Failure|0|||
144238292|NCT01295827|520067529|FG013|Overall Study|Screen Failure|0|||
144238293|NCT01295827|520067530|FG014|Overall Study|Screen Failure|0|||
144238294|NCT01295827|520067516|FG000|Overall Study|Withdrawal by Subject|1|||
144238295|NCT01295827|520067517|FG001|Overall Study|Withdrawal by Subject|0|||
144238296|NCT01295827|520067518|FG002|Overall Study|Withdrawal by Subject|2|||
144238297|NCT01295827|520067519|FG003|Overall Study|Withdrawal by Subject|0|||
144238298|NCT01295827|520067520|FG004|Overall Study|Withdrawal by Subject|0|||
144238299|NCT01295827|520067521|FG005|Overall Study|Withdrawal by Subject|1|||
144238300|NCT01295827|520067522|FG006|Overall Study|Withdrawal by Subject|13|||
144238301|NCT01295827|520067523|FG007|Overall Study|Withdrawal by Subject|35|||
144238302|NCT01295827|520067524|FG008|Overall Study|Withdrawal by Subject|11|||
144238303|NCT01295827|520067525|FG009|Overall Study|Withdrawal by Subject|2|||
144238304|NCT01295827|520067526|FG010|Overall Study|Withdrawal by Subject|18|||
144238305|NCT01295827|520067527|FG011|Overall Study|Withdrawal by Subject|13|||
144238306|NCT01295827|520067528|FG012|Overall Study|Withdrawal by Subject|0|||
144238307|NCT01295827|520067529|FG013|Overall Study|Withdrawal by Subject|0|||
144238308|NCT01295827|520067530|FG014|Overall Study|Withdrawal by Subject|0|||
144238309|NCT01295827|520067516|FG000|Overall Study|Other|0|||
144238310|NCT01295827|520067517|FG001|Overall Study|Other|0|||
144238311|NCT01295827|520067518|FG002|Overall Study|Other|0|||
144238312|NCT01295827|520067519|FG003|Overall Study|Other|0|||
144238313|NCT01295827|520067520|FG004|Overall Study|Other|0|||
144238314|NCT01295827|520067521|FG005|Overall Study|Other|0|||
144238315|NCT01295827|520067522|FG006|Overall Study|Other|1|||
144238316|NCT01295827|520067523|FG007|Overall Study|Other|1|||
144238317|NCT01295827|520067524|FG008|Overall Study|Other|1|||
144238318|NCT01295827|520067525|FG009|Overall Study|Other|0|||
144238319|NCT01295827|520067526|FG010|Overall Study|Other|2|||
144238320|NCT01295827|520067527|FG011|Overall Study|Other|0|||
144238321|NCT01295827|520067528|FG012|Overall Study|Other|0|||
144238322|NCT01295827|520067529|FG013|Overall Study|Other|0|||
144238323|NCT01295827|520067530|FG014|Overall Study|Other|0|||
144238324|NCT01668173|520067531|FG000|Overall Study|Adverse Event|3|||
144238325|NCT01668173|520067531|FG000|Overall Study|Trial suspension|4|||
144238326|NCT00072280|520067532|FG000|Treatment|Found ineligible|1|||
144238327|NCT00072280|520067533|FG001|Treatment|Found ineligible|2|||
144238328|NCT00072280|520067532|FG000|Follow-up|Early termination of study|2|||
144238329|NCT00072280|520067533|FG001|Follow-up|Early termination of study|2|||
144238330|NCT00746564|520067534|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
144238331|NCT00877487|520067539|FG000|Open-label Treatment Phase|Adverse Event|1|||
144238332|NCT00877487|520067540|FG001|Open-label Treatment Phase|Adverse Event|0|||
144238333|NCT00877487|520067539|FG000|Open-label Treatment Phase|Protocol Violation|3|||
144238334|NCT00877487|520067540|FG001|Open-label Treatment Phase|Protocol Violation|0|||
144238335|NCT00877487|520067539|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
144238336|NCT00877487|520067540|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
144238337|NCT00877487|520067539|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
144238338|NCT00877487|520067540|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
144238339|NCT00877487|520067539|FG000|Open-label Treatment Phase|Out of country for business|1|||
144238340|NCT00877487|520067540|FG001|Open-label Treatment Phase|Out of country for business|0|||
144238341|NCT00877487|520067539|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
144238342|NCT00877487|520067540|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
144238343|NCT00877487|520067539|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
144238344|NCT00877487|520067540|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
144238345|NCT00877487|520067539|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
144238346|NCT00877487|520067540|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
144238347|NCT00877487|520067539|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
144238348|NCT00877487|520067540|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
144238349|NCT01516008|520067541|FG000|Overall Study|Adverse Event|0|||
144238350|NCT01516008|520067542|FG001|Overall Study|Adverse Event|2|||
144238351|NCT01516008|520067543|FG002|Overall Study|Adverse Event|7|||
144238352|NCT01516008|520067541|FG000|Overall Study|Lack of Efficacy|44|||
144238353|NCT01516008|520067542|FG001|Overall Study|Lack of Efficacy|14|||
144238354|NCT01516008|520067543|FG002|Overall Study|Lack of Efficacy|10|||
144238355|NCT01516008|520067541|FG000|Overall Study|Protocol Violation|1|||
144238356|NCT01516008|520067542|FG001|Overall Study|Protocol Violation|0|||
144238357|NCT01516008|520067543|FG002|Overall Study|Protocol Violation|0|||
144238358|NCT01516008|520067541|FG000|Overall Study|Reason not specified|0|||
144238359|NCT01516008|520067542|FG001|Overall Study|Reason not specified|0|||
144238360|NCT01516008|520067543|FG002|Overall Study|Reason not specified|1|||
144238361|NCT01217476|520067546|FG000|Overall Study|Adverse Event|6|||
144238362|NCT01217476|520067547|FG001|Overall Study|Adverse Event|1|||
144238363|NCT01217476|520067546|FG000|Overall Study|Physician Decision|0|||
144238364|NCT01217476|520067547|FG001|Overall Study|Physician Decision|1|||
144238365|NCT01217476|520067546|FG000|Overall Study|Withdrawal by Subject|3|||
144238366|NCT01217476|520067547|FG001|Overall Study|Withdrawal by Subject|3|||
144238367|NCT01217476|520067546|FG000|Overall Study|Surgery on the Target Limb|0|||
144238368|NCT01217476|520067547|FG001|Overall Study|Surgery on the Target Limb|2|||
144238369|NCT01217476|520067546|FG000|Overall Study|Protocol Deviation|1|||
144238370|NCT01217476|520067547|FG001|Overall Study|Protocol Deviation|0|||
144238371|NCT01217476|520067546|FG000|Overall Study|Other|2|||
144238372|NCT01217476|520067547|FG001|Overall Study|Other|0|||
144238373|NCT03512210|520067548|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
144238374|NCT03512210|520067548|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
144238375|NCT03512210|520067548|FG000|Step 2:Post-MINMON|Death|2|||
144238376|NCT03512210|520067548|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
144238377|NCT03512210|520067548|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
144238378|NCT01672710|520067551|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
144238379|NCT01672710|520067552|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
144238380|NCT01672710|520067551|FG000|3 Month Follow up|Lost to Follow-up|2|||
144238381|NCT01672710|520067552|FG001|3 Month Follow up|Lost to Follow-up|3|||
144238382|NCT01672710|520067551|FG000|3 Month Follow up|follow up due after termination date|4|||
144238383|NCT01672710|520067552|FG001|3 Month Follow up|follow up due after termination date|1|||
144238384|NCT02122887|520067553|FG000|Overall Study|Withdrawal by Subject|20|||
144238385|NCT02122887|520067554|FG001|Overall Study|Withdrawal by Subject|2|||
144238386|NCT00636194|520069470|FG000|Overall Study|Study related symptoms and complaints|1|||
144238387|NCT00636194|520069471|FG001|Overall Study|Study related symptoms and complaints|0|||
144238388|NCT00636194|520069470|FG000|Overall Study|Protocol Violation|2|||
144238389|NCT00636194|520069471|FG001|Overall Study|Protocol Violation|0|||
144238390|NCT04114357|520069472|FG000|Baseline-Randomization|Adverse Event|2|||
144238391|NCT04114357|520069473|FG001|Baseline-Randomization|Adverse Event|1|||
144238392|NCT04114357|520069472|FG000|Baseline-Randomization|Lost to Follow-up|1|||
144238393|NCT04114357|520069473|FG001|Baseline-Randomization|Lost to Follow-up|1|||
144238394|NCT04114357|520069472|FG000|Cross-over|Adverse Event|0|||
144238395|NCT04114357|520069473|FG001|Cross-over|Adverse Event|1|||
144238396|NCT02163226|520069474|FG000|Overall Study|Death|2|||
144238397|NCT02163226|520069475|FG001|Overall Study|Death|1|||
144238398|NCT02163226|520069474|FG000|Overall Study|Withdrawal by Subject|5|||
144238399|NCT02163226|520069475|FG001|Overall Study|Withdrawal by Subject|2|||
144238400|NCT02163226|520069474|FG000|Overall Study|Returned home, local radiotherapy|3|||
144238401|NCT02163226|520069475|FG001|Overall Study|Returned home, local radiotherapy|0|||
144238402|NCT02163226|520069474|FG000|Overall Study|Repeat imaging showed no disease|2|||
144238403|NCT02163226|520069475|FG001|Overall Study|Repeat imaging showed no disease|0|||
144238404|NCT02163226|520069474|FG000|Overall Study|Incomplete radiotherapy|3|||
144238405|NCT02163226|520069475|FG001|Overall Study|Incomplete radiotherapy|0|||
144238406|NCT02163226|520069474|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
144238407|NCT02163226|520069475|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
144238408|NCT02163226|520069474|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
144238409|NCT02163226|520069475|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
144238410|NCT02163226|520069474|FG000|Overall Study|ineligible|0|||
144238411|NCT02163226|520069475|FG001|Overall Study|ineligible|3|||
144238412|NCT00477750|520069476|FG000|Overall Study|Currently Receiving Treatment|11|||
144238413|NCT03558152|520069478|FG000|Overall Study|Adverse Event|0|||
144238414|NCT03558152|520069479|FG001|Overall Study|Adverse Event|0|||
144238415|NCT03558152|520069480|FG002|Overall Study|Adverse Event|1|||
144238416|NCT03558152|520069481|FG003|Overall Study|Adverse Event|1|||
144238417|NCT03558152|520069482|FG004|Overall Study|Adverse Event|2|||
144238418|NCT03558152|520069483|FG005|Overall Study|Adverse Event|1|||
144238419|NCT03558152|520069484|FG006|Overall Study|Adverse Event|1|||
144238420|NCT03558152|520069485|FG007|Overall Study|Adverse Event|0|||
144238421|NCT03558152|520069478|FG000|Overall Study|Death|0|||
144238422|NCT03558152|520069479|FG001|Overall Study|Death|0|||
144238423|NCT03558152|520069480|FG002|Overall Study|Death|0|||
144238424|NCT03558152|520069481|FG003|Overall Study|Death|0|||
144238425|NCT03558152|520069482|FG004|Overall Study|Death|1|||
144238426|NCT03558152|520069483|FG005|Overall Study|Death|0|||
144238427|NCT03558152|520069484|FG006|Overall Study|Death|0|||
144238428|NCT03558152|520069485|FG007|Overall Study|Death|0|||
144238429|NCT03558152|520069478|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
144238430|NCT03558152|520069479|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238431|NCT03558152|520069480|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238432|NCT03558152|520069481|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238433|NCT03558152|520069482|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238434|NCT03558152|520069483|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238435|NCT03558152|520069484|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238436|NCT03558152|520069485|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
144238437|NCT03558152|520069478|FG000|Overall Study|Miscalculation in mmcs|0|||
144238438|NCT03558152|520069479|FG001|Overall Study|Miscalculation in mmcs|0|||
144238439|NCT03558152|520069480|FG002|Overall Study|Miscalculation in mmcs|0|||
144238440|NCT03558152|520069481|FG003|Overall Study|Miscalculation in mmcs|0|||
144238441|NCT03558152|520069482|FG004|Overall Study|Miscalculation in mmcs|0|||
144238442|NCT03558152|520069483|FG005|Overall Study|Miscalculation in mmcs|0|||
144238443|NCT03558152|520069484|FG006|Overall Study|Miscalculation in mmcs|1|||
144238444|NCT03558152|520069485|FG007|Overall Study|Miscalculation in mmcs|0|||
144238445|NCT03558152|520069478|FG000|Overall Study|Mistake in calculation|0|||
144238446|NCT03558152|520069479|FG001|Overall Study|Mistake in calculation|0|||
144238447|NCT03558152|520069480|FG002|Overall Study|Mistake in calculation|0|||
144238448|NCT03558152|520069481|FG003|Overall Study|Mistake in calculation|1|||
144238449|NCT03558152|520069482|FG004|Overall Study|Mistake in calculation|0|||
144238450|NCT03558152|520069483|FG005|Overall Study|Mistake in calculation|0|||
144238451|NCT03558152|520069484|FG006|Overall Study|Mistake in calculation|0|||
144238452|NCT03558152|520069485|FG007|Overall Study|Mistake in calculation|0|||
144238453|NCT03558152|520069478|FG000|Overall Study|Mistake in evaluation of disease status|0|||
144238454|NCT03558152|520069479|FG001|Overall Study|Mistake in evaluation of disease status|0|||
144238455|NCT03558152|520069480|FG002|Overall Study|Mistake in evaluation of disease status|0|||
144238456|NCT03558152|520069481|FG003|Overall Study|Mistake in evaluation of disease status|0|||
144238457|NCT03558152|520069482|FG004|Overall Study|Mistake in evaluation of disease status|0|||
144238458|NCT03558152|520069483|FG005|Overall Study|Mistake in evaluation of disease status|0|||
144238459|NCT03558152|520069484|FG006|Overall Study|Mistake in evaluation of disease status|0|||
144238460|NCT03558152|520069485|FG007|Overall Study|Mistake in evaluation of disease status|1|||
144238461|NCT03558152|520069478|FG000|Overall Study|Physician Decision|0|||
144238462|NCT03558152|520069479|FG001|Overall Study|Physician Decision|0|||
144238463|NCT03558152|520069480|FG002|Overall Study|Physician Decision|0|||
144238464|NCT03558152|520069481|FG003|Overall Study|Physician Decision|0|||
144238465|NCT03558152|520069482|FG004|Overall Study|Physician Decision|0|||
144238466|NCT03558152|520069483|FG005|Overall Study|Physician Decision|0|||
144238467|NCT03558152|520069484|FG006|Overall Study|Physician Decision|1|||
144238468|NCT03558152|520069485|FG007|Overall Study|Physician Decision|0|||
144238469|NCT03558152|520069478|FG000|Overall Study|Withdrawal by Subject|2|||
144238470|NCT03558152|520069479|FG001|Overall Study|Withdrawal by Subject|3|||
144238471|NCT03558152|520069480|FG002|Overall Study|Withdrawal by Subject|2|||
144238472|NCT03558152|520069481|FG003|Overall Study|Withdrawal by Subject|1|||
144238473|NCT03558152|520069482|FG004|Overall Study|Withdrawal by Subject|1|||
144238474|NCT03558152|520069483|FG005|Overall Study|Withdrawal by Subject|1|||
144238475|NCT03558152|520069484|FG006|Overall Study|Withdrawal by Subject|3|||
144238476|NCT03558152|520069485|FG007|Overall Study|Withdrawal by Subject|2|||
144238477|NCT03558152|520069478|FG000|Overall Study|Lack of Efficacy|11|||
144238478|NCT03558152|520069479|FG001|Overall Study|Lack of Efficacy|11|||
144238479|NCT03558152|520069480|FG002|Overall Study|Lack of Efficacy|10|||
144238480|NCT03558152|520069481|FG003|Overall Study|Lack of Efficacy|11|||
144238481|NCT03558152|520069482|FG004|Overall Study|Lack of Efficacy|14|||
144238482|NCT03558152|520069483|FG005|Overall Study|Lack of Efficacy|12|||
144238483|NCT03558152|520069484|FG006|Overall Study|Lack of Efficacy|14|||
144238484|NCT03558152|520069485|FG007|Overall Study|Lack of Efficacy|13|||
144238485|NCT03558152|520069478|FG000|Overall Study|Protocol Violation|1|||
144238486|NCT03558152|520069479|FG001|Overall Study|Protocol Violation|1|||
144238487|NCT03558152|520069480|FG002|Overall Study|Protocol Violation|0|||
144238488|NCT03558152|520069481|FG003|Overall Study|Protocol Violation|1|||
144238489|NCT03558152|520069482|FG004|Overall Study|Protocol Violation|1|||
144238490|NCT03558152|520069483|FG005|Overall Study|Protocol Violation|0|||
144238491|NCT03558152|520069484|FG006|Overall Study|Protocol Violation|2|||
144238492|NCT03558152|520069485|FG007|Overall Study|Protocol Violation|0|||
144238493|NCT03693612|520069486|FG000|Overall Study|Lost to Follow-up|0|||
144238494|NCT03693612|520069487|FG001|Overall Study|Lost to Follow-up|0|||
144238495|NCT03693612|520069488|FG002|Overall Study|Lost to Follow-up|0|||
144238496|NCT03693612|520069489|FG003|Overall Study|Lost to Follow-up|0|||
144238497|NCT03693612|520069490|FG004|Overall Study|Lost to Follow-up|1|||
144238498|NCT03693612|520069491|FG005|Overall Study|Lost to Follow-up|0|||
144238499|NCT03693612|520069492|FG006|Overall Study|Lost to Follow-up|0|||
144238500|NCT03693612|520069486|FG000|Overall Study|Withdrawal by Subject|0|||
144238501|NCT03693612|520069487|FG001|Overall Study|Withdrawal by Subject|0|||
144238502|NCT03693612|520069488|FG002|Overall Study|Withdrawal by Subject|1|||
144238503|NCT03693612|520069489|FG003|Overall Study|Withdrawal by Subject|0|||
144238504|NCT03693612|520069490|FG004|Overall Study|Withdrawal by Subject|2|||
144238505|NCT03693612|520069491|FG005|Overall Study|Withdrawal by Subject|0|||
144238506|NCT03693612|520069492|FG006|Overall Study|Withdrawal by Subject|0|||
144238507|NCT03693612|520069486|FG000|Overall Study|Study Terminated by Sponsor|0|||
144238508|NCT03693612|520069487|FG001|Overall Study|Study Terminated by Sponsor|1|||
144238509|NCT03693612|520069488|FG002|Overall Study|Study Terminated by Sponsor|0|||
144238510|NCT03693612|520069489|FG003|Overall Study|Study Terminated by Sponsor|0|||
144238511|NCT03693612|520069490|FG004|Overall Study|Study Terminated by Sponsor|3|||
144238512|NCT03693612|520069491|FG005|Overall Study|Study Terminated by Sponsor|0|||
144238513|NCT03693612|520069492|FG006|Overall Study|Study Terminated by Sponsor|0|||
144238514|NCT05318092|520069493|FG000|Overall Study|Lost to Follow-up|3|||
144238515|NCT05318092|520069493|FG000|Overall Study|Withdrawal by Subject|1|||
144238516|NCT04434469|520069494|FG000|Overall Study|Death|2|||
144238517|NCT04434469|520069495|FG001|Overall Study|Death|3|||
144238518|NCT04434469|520069496|FG002|Overall Study|Death|2|||
144238519|NCT04434469|520069497|FG003|Overall Study|Death|2|||
144238520|NCT04434469|520069498|FG004|Overall Study|Death|2|||
144238521|NCT04434469|520069499|FG005|Overall Study|Death|0|||
144238522|NCT04434469|520069494|FG000|Overall Study|Lost to Follow-up|0|||
144238523|NCT04434469|520069495|FG001|Overall Study|Lost to Follow-up|0|||
144238524|NCT04434469|520069496|FG002|Overall Study|Lost to Follow-up|0|||
144238525|NCT04434469|520069497|FG003|Overall Study|Lost to Follow-up|1|||
144238526|NCT04434469|520069498|FG004|Overall Study|Lost to Follow-up|1|||
144238527|NCT04434469|520069499|FG005|Overall Study|Lost to Follow-up|0|||
144238528|NCT04434469|520069494|FG000|Overall Study|Study terminated by sponsor|1|||
144238529|NCT04434469|520069495|FG001|Overall Study|Study terminated by sponsor|1|||
144238530|NCT04434469|520069496|FG002|Overall Study|Study terminated by sponsor|1|||
144238531|NCT04434469|520069497|FG003|Overall Study|Study terminated by sponsor|2|||
144238532|NCT04434469|520069498|FG004|Overall Study|Study terminated by sponsor|3|||
144238533|NCT04434469|520069499|FG005|Overall Study|Study terminated by sponsor|3|||
144238534|NCT04434469|520069494|FG000|Overall Study|Withdrawal by Subject|0|||
144238535|NCT04434469|520069495|FG001|Overall Study|Withdrawal by Subject|0|||
144238536|NCT04434469|520069496|FG002|Overall Study|Withdrawal by Subject|1|||
144238537|NCT04434469|520069497|FG003|Overall Study|Withdrawal by Subject|0|||
144238538|NCT04434469|520069498|FG004|Overall Study|Withdrawal by Subject|0|||
144238539|NCT04434469|520069499|FG005|Overall Study|Withdrawal by Subject|0|||
144238540|NCT01669174|520069500|FG000|Overall Study|Subject withdrew consent|2|||
144238541|NCT01669174|520069501|FG001|Overall Study|Subject withdrew consent|2|||
144238542|NCT01669174|520069500|FG000|Overall Study|Lost to Follow-up|1|||
144238543|NCT01669174|520069501|FG001|Overall Study|Lost to Follow-up|0|||
144238544|NCT01669174|520069500|FG000|Overall Study|Adverse Event|2|||
144238545|NCT01669174|520069501|FG001|Overall Study|Adverse Event|2|||
144238546|NCT01669174|520069500|FG000|Overall Study|Administrative problems|1|||
144238547|NCT01669174|520069501|FG001|Overall Study|Administrative problems|2|||
144238548|NCT01953601|520069502|FG000|Part 1 (Base Study)|Adverse Event|24|||
144238549|NCT01953601|520069503|FG001|Part 1 (Base Study)|Adverse Event|37|||
144238550|NCT01953601|520069504|FG002|Part 1 (Base Study)|Adverse Event|15|||
144238551|NCT01953601|520069502|FG000|Part 1 (Base Study)|Death|2|||
144238552|NCT01953601|520069503|FG001|Part 1 (Base Study)|Death|0|||
144238553|NCT01953601|520069504|FG002|Part 1 (Base Study)|Death|3|||
144238554|NCT01953601|520069502|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
144238555|NCT01953601|520069503|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
144238556|NCT01953601|520069504|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
144238557|NCT01953601|520069502|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
144238558|NCT01953601|520069503|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
144238559|NCT01953601|520069504|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
144238560|NCT01953601|520069502|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
144238561|NCT01953601|520069503|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
144238562|NCT01953601|520069504|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
144238563|NCT01953601|520069502|FG000|Part 1 (Base Study)|Physician Decision|3|||
144238564|NCT01953601|520069503|FG001|Part 1 (Base Study)|Physician Decision|7|||
144238565|NCT01953601|520069504|FG002|Part 1 (Base Study)|Physician Decision|4|||
144238566|NCT01953601|520069502|FG000|Part 1 (Base Study)|Screen failure|1|||
144238567|NCT01953601|520069503|FG001|Part 1 (Base Study)|Screen failure|0|||
144238568|NCT01953601|520069504|FG002|Part 1 (Base Study)|Screen failure|1|||
144238569|NCT01953601|520069502|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
144238570|NCT01953601|520069503|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
144238571|NCT01953601|520069504|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
144238572|NCT01953601|520069502|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
144238573|NCT01953601|520069503|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
144238574|NCT01953601|520069504|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
144238575|NCT01953601|520069502|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
144238576|NCT01953601|520069503|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
144238577|NCT01953601|520069504|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
144238578|NCT01953601|520069502|FG000|Part 1 (Base Study)|Subject moved|2|||
144238579|NCT01953601|520069503|FG001|Part 1 (Base Study)|Subject moved|2|||
144238580|NCT01953601|520069504|FG002|Part 1 (Base Study)|Subject moved|1|||
144238581|NCT01953601|520069502|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
144238582|NCT01953601|520069503|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
144238583|NCT01953601|520069504|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
144238584|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Adverse Event|1|||
144238585|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Adverse Event|1|||
144238586|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Adverse Event|10|||
144238587|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Death|0|||
144238588|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Death|3|||
144238589|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Death|0|||
144238590|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
144238591|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
144238592|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
144238593|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
144238594|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
144238595|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
144238596|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Physician Decision|2|||
144238597|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Physician Decision|0|||
144238598|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Physician Decision|2|||
144238599|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
144238600|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
144238601|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
144238602|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
144238603|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
144238604|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
144238605|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
144238606|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
144238607|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
144238608|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Subject moved|0|||
144238609|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Subject moved|0|||
144238610|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Subject moved|1|||
144238611|NCT01953601|520069502|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
144238612|NCT01953601|520069503|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
144238613|NCT01953601|520069504|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
144238614|NCT00614523|520069509|FG000|Overall Study|Adverse Event|4|||
144238615|NCT00614523|520069510|FG001|Overall Study|Adverse Event|20|||
144238616|NCT00614523|520069509|FG000|Overall Study|Death|5|||
144238617|NCT00614523|520069510|FG001|Overall Study|Death|8|||
144238618|NCT00614523|520069509|FG000|Overall Study|Lack of Efficacy|9|||
144238619|NCT00614523|520069510|FG001|Overall Study|Lack of Efficacy|11|||
144238620|NCT00614523|520069509|FG000|Overall Study|Lost to Follow-up|0|||
144238621|NCT00614523|520069510|FG001|Overall Study|Lost to Follow-up|1|||
144238622|NCT00614523|520069509|FG000|Overall Study|Protocol Violation|3|||
144238623|NCT00614523|520069510|FG001|Overall Study|Protocol Violation|2|||
144238624|NCT00614523|520069509|FG000|Overall Study|Withdrawal by Subject|12|||
144238625|NCT00614523|520069510|FG001|Overall Study|Withdrawal by Subject|22|||
144238626|NCT00614523|520069509|FG000|Overall Study|Other|6|||
144238627|NCT00614523|520069510|FG001|Overall Study|Other|11|||
144238628|NCT00614523|520069509|FG000|Overall Study|Ineligibility Determined|1|||
144238629|NCT00614523|520069510|FG001|Overall Study|Ineligibility Determined|2|||
144238630|NCT00614523|520069509|FG000|Overall Study|Disease Progression|0|||
144238631|NCT00614523|520069510|FG001|Overall Study|Disease Progression|8|||
144238632|NCT00614523|520069509|FG000|Overall Study|Administrative Decision|23|||
144238633|NCT00614523|520069510|FG001|Overall Study|Administrative Decision|46|||
144238634|NCT00723255|520069511|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
144238635|NCT00723255|520069511|FG000|Overall Study|Ineligible: Second primary|1|||
144238636|NCT00723255|520069511|FG000|Overall Study|Ineligible: Wrong Primary|2|||
144238637|NCT03962790|520069512|FG000|Period 1|Adverse Event|0|||
144238638|NCT03962790|520069513|FG001|Period 1|Adverse Event|1|||
144238639|NCT03962790|520069512|FG000|Period 1|Failed to meet all eligibility criteria|1|||
144269919|NCT01387269|520191448|FG000|Overall Study|Withdrawal by patient|32|||
144269920|NCT01387269|520191449|FG001|Overall Study|Withdrawal by patient|10|||
144269921|NCT01387269|520191448|FG000|Overall Study|Study drug-related AE|1|||
144238640|NCT03962790|520069513|FG001|Period 1|Failed to meet all eligibility criteria|1|||
144238641|NCT03962790|520069512|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
144238642|NCT03962790|520069513|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
144238643|NCT03962790|520069512|FG000|Period 1|Withdrawal by Subject|1|||
144238644|NCT03962790|520069513|FG001|Period 1|Withdrawal by Subject|0|||
144238645|NCT03854370|520069521|FG000|Overall Study|samples not collected|1|||
144238646|NCT03854370|520069522|FG001|Overall Study|samples not collected|1|||
144238647|NCT03854370|520069523|FG002|Overall Study|samples not collected|1|||
144238648|NCT03854370|520069524|FG003|Overall Study|samples not collected|1|||
144238649|NCT01300338|520069533|FG000|Overall Study|Lost to Follow-up|5|||
144297094|NCT03605693|520292447|FG001|Overall Study|Physician Decision|0|||
144238650|NCT01300338|520069534|FG001|Overall Study|Lost to Follow-up|0|||
144238651|NCT01482065|520069535|FG000|Overall Study|Withdrawal by Subject|0|||
144238652|NCT01482065|520069536|FG001|Overall Study|Withdrawal by Subject|1|||
144238653|NCT01942486|520069537|FG000|Overall Study|Lost to Follow-up|27|||
144238654|NCT03728426|520069538|FG000|Overall Study|Death|3|||
144238655|NCT00231114|520069541|FG000|Randomized|Withdrawal by Subject|6|||
144238656|NCT00231114|520069542|FG001|Randomized|Withdrawal by Subject|3|||
144238657|NCT00231114|520069541|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
144238658|NCT00231114|520069542|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
144238659|NCT00231114|520069541|FG000|Post-Treatment Period|Lost to Follow-up|6|||
144238660|NCT00231114|520069542|FG001|Post-Treatment Period|Lost to Follow-up|1|||
144238661|NCT00231114|520069541|FG000|Post-Treatment Period|Physician Decision|1|||
144238662|NCT00231114|520069542|FG001|Post-Treatment Period|Physician Decision|0|||
144238663|NCT00231114|520069541|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
144238664|NCT00231114|520069542|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
144238665|NCT02048826|520069543|FG000|Overall Study|Withdrawal by Subject|1|||
144238666|NCT02048826|520069544|FG001|Overall Study|Withdrawal by Subject|0|||
144238667|NCT02703272|520069545|FG000|Overall Study|Death|4|||
144238668|NCT02703272|520069546|FG001|Overall Study|Death|9|||
144238669|NCT02703272|520069547|FG002|Overall Study|Death|19|||
144238670|NCT02703272|520069548|FG003|Overall Study|Death|10|||
144238671|NCT02703272|520069545|FG000|Overall Study|Withdrawal by Subject|0|||
144238672|NCT02703272|520069546|FG001|Overall Study|Withdrawal by Subject|0|||
144238673|NCT02703272|520069547|FG002|Overall Study|Withdrawal by Subject|4|||
144238674|NCT02703272|520069548|FG003|Overall Study|Withdrawal by Subject|2|||
144238675|NCT02703272|520069545|FG000|Overall Study|Study Terminated by Sponsor|6|||
144238676|NCT02703272|520069546|FG001|Overall Study|Study Terminated by Sponsor|1|||
144238677|NCT02703272|520069547|FG002|Overall Study|Study Terminated by Sponsor|12|||
144238678|NCT02703272|520069548|FG003|Overall Study|Study Terminated by Sponsor|4|||
144238679|NCT02703272|520069545|FG000|Overall Study|Other|1|||
144238680|NCT02703272|520069546|FG001|Overall Study|Other|0|||
144238681|NCT02703272|520069547|FG002|Overall Study|Other|0|||
144238682|NCT02703272|520069548|FG003|Overall Study|Other|0|||
144238683|NCT01194999|520069549|FG000|Overall Study|Lost to Follow-up|17|||
144238684|NCT02222545|520069552|FG000|Overall Study|Adverse Event|1|||
144238685|NCT02222545|520069553|FG001|Overall Study|Adverse Event|0|||
144238686|NCT02222545|520069554|FG002|Overall Study|Adverse Event|2|||
144238687|NCT02222545|520069552|FG000|Overall Study|Death|0|||
144238688|NCT02222545|520069553|FG001|Overall Study|Death|0|||
144238689|NCT02222545|520069554|FG002|Overall Study|Death|9|||
144238690|NCT02222545|520069552|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
144238691|NCT02222545|520069553|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
144238692|NCT02222545|520069554|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
144238693|NCT02222545|520069552|FG000|Overall Study|Withdrawal by Subject|0|||
144238694|NCT02222545|520069553|FG001|Overall Study|Withdrawal by Subject|0|||
144238695|NCT02222545|520069554|FG002|Overall Study|Withdrawal by Subject|3|||
144238696|NCT02222545|520069552|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
144238697|NCT02222545|520069553|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
144238698|NCT02222545|520069554|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
144238699|NCT02651155|520069556|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
144238700|NCT02651155|520069557|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
144238701|NCT02651155|520069556|FG000|Overall Study|Voluntary Withdrawal|5|||
144238702|NCT02651155|520069557|FG001|Overall Study|Voluntary Withdrawal|0|||
144238703|NCT00537316|520069558|FG000|Part 1|Adverse Event|7|||
144238704|NCT00537316|520069559|FG001|Part 1|Adverse Event|11|||
144238705|NCT00537316|520069560|FG002|Part 1|Adverse Event|8|||
144238706|NCT00537316|520069561|FG003|Part 1|Adverse Event|0|||
144238707|NCT00537316|520069562|FG004|Part 1|Adverse Event|0|||
144238708|NCT00537316|520069563|FG005|Part 1|Adverse Event|0|||
144238709|NCT00537316|520069564|FG006|Part 1|Adverse Event|0|||
144238710|NCT00537316|520069558|FG000|Part 1|Protocol defined clinical event|1|||
144238711|NCT00537316|520069559|FG001|Part 1|Protocol defined clinical event|0|||
144238712|NCT00537316|520069560|FG002|Part 1|Protocol defined clinical event|0|||
144238713|NCT00537316|520069561|FG003|Part 1|Protocol defined clinical event|0|||
144238714|NCT00537316|520069562|FG004|Part 1|Protocol defined clinical event|0|||
144238715|NCT00537316|520069563|FG005|Part 1|Protocol defined clinical event|0|||
144238716|NCT00537316|520069564|FG006|Part 1|Protocol defined clinical event|0|||
144238717|NCT00537316|520069558|FG000|Part 1|Lost to Follow-up|1|||
144238718|NCT00537316|520069559|FG001|Part 1|Lost to Follow-up|0|||
144238719|NCT00537316|520069560|FG002|Part 1|Lost to Follow-up|0|||
144238720|NCT00537316|520069561|FG003|Part 1|Lost to Follow-up|0|||
144238721|NCT00537316|520069562|FG004|Part 1|Lost to Follow-up|0|||
144238722|NCT00537316|520069563|FG005|Part 1|Lost to Follow-up|0|||
144238723|NCT00537316|520069564|FG006|Part 1|Lost to Follow-up|0|||
144238724|NCT00537316|520069558|FG000|Part 1|Withdrawal by Subject|3|||
144238725|NCT00537316|520069559|FG001|Part 1|Withdrawal by Subject|8|||
144238726|NCT00537316|520069560|FG002|Part 1|Withdrawal by Subject|4|||
144238727|NCT00537316|520069561|FG003|Part 1|Withdrawal by Subject|0|||
144238728|NCT00537316|520069562|FG004|Part 1|Withdrawal by Subject|0|||
144238729|NCT00537316|520069563|FG005|Part 1|Withdrawal by Subject|0|||
144238730|NCT00537316|520069564|FG006|Part 1|Withdrawal by Subject|0|||
144238731|NCT00537316|520069558|FG000|Part 1|Protocol Violation|1|||
144238732|NCT00537316|520069559|FG001|Part 1|Protocol Violation|5|||
144238733|NCT00537316|520069560|FG002|Part 1|Protocol Violation|1|||
144238734|NCT00537316|520069561|FG003|Part 1|Protocol Violation|0|||
144238735|NCT00537316|520069562|FG004|Part 1|Protocol Violation|0|||
144238736|NCT00537316|520069563|FG005|Part 1|Protocol Violation|0|||
144238737|NCT00537316|520069564|FG006|Part 1|Protocol Violation|0|||
144238738|NCT00537316|520069558|FG000|Part 1|Did not meet protocol eligibility|1|||
144238739|NCT00537316|520069559|FG001|Part 1|Did not meet protocol eligibility|3|||
144238740|NCT00537316|520069560|FG002|Part 1|Did not meet protocol eligibility|2|||
144238741|NCT00537316|520069561|FG003|Part 1|Did not meet protocol eligibility|0|||
144238742|NCT00537316|520069562|FG004|Part 1|Did not meet protocol eligibility|0|||
144238743|NCT00537316|520069563|FG005|Part 1|Did not meet protocol eligibility|0|||
144238744|NCT00537316|520069564|FG006|Part 1|Did not meet protocol eligibility|0|||
144238745|NCT00537316|520069558|FG000|Part 1|Administrative|0|||
144238746|NCT00537316|520069559|FG001|Part 1|Administrative|0|||
144238747|NCT00537316|520069560|FG002|Part 1|Administrative|2|||
144238748|NCT00537316|520069561|FG003|Part 1|Administrative|0|||
144238749|NCT00537316|520069562|FG004|Part 1|Administrative|0|||
144238750|NCT00537316|520069563|FG005|Part 1|Administrative|0|||
144238751|NCT00537316|520069564|FG006|Part 1|Administrative|0|||
144238752|NCT00537316|520069558|FG000|Part 2|Never entered follow-up|0|||
144238753|NCT00537316|520069559|FG001|Part 2|Never entered follow-up|0|||
144238754|NCT00537316|520069560|FG002|Part 2|Never entered follow-up|0|||
144238755|NCT00537316|520069561|FG003|Part 2|Never entered follow-up|0|||
144238756|NCT00537316|520069562|FG004|Part 2|Never entered follow-up|0|||
144238757|NCT00537316|520069563|FG005|Part 2|Never entered follow-up|0|||
144238758|NCT00537316|520069564|FG006|Part 2|Never entered follow-up|1|||
144238759|NCT00537316|520069558|FG000|Part 2|Adverse Event|4|||
144238760|NCT00537316|520069559|FG001|Part 2|Adverse Event|0|||
144238761|NCT00537316|520069560|FG002|Part 2|Adverse Event|2|||
144238762|NCT00537316|520069561|FG003|Part 2|Adverse Event|0|||
144238763|NCT00537316|520069562|FG004|Part 2|Adverse Event|0|||
144238764|NCT00537316|520069563|FG005|Part 2|Adverse Event|0|||
144238765|NCT00537316|520069564|FG006|Part 2|Adverse Event|0|||
144238766|NCT00537316|520069558|FG000|Part 2|Lost to Follow-up|1|||
144238767|NCT00537316|520069559|FG001|Part 2|Lost to Follow-up|0|||
144238768|NCT00537316|520069560|FG002|Part 2|Lost to Follow-up|2|||
144238769|NCT00537316|520069561|FG003|Part 2|Lost to Follow-up|0|||
144238770|NCT00537316|520069562|FG004|Part 2|Lost to Follow-up|0|||
144238771|NCT00537316|520069563|FG005|Part 2|Lost to Follow-up|0|||
144238772|NCT00537316|520069564|FG006|Part 2|Lost to Follow-up|0|||
144238773|NCT00537316|520069558|FG000|Part 2|Withdrawal by Subject|5|||
144238774|NCT00537316|520069559|FG001|Part 2|Withdrawal by Subject|1|||
144238775|NCT00537316|520069560|FG002|Part 2|Withdrawal by Subject|4|||
144238776|NCT00537316|520069561|FG003|Part 2|Withdrawal by Subject|0|||
144238777|NCT00537316|520069562|FG004|Part 2|Withdrawal by Subject|0|||
144238778|NCT00537316|520069563|FG005|Part 2|Withdrawal by Subject|0|||
144238779|NCT00537316|520069564|FG006|Part 2|Withdrawal by Subject|0|||
144238780|NCT00537316|520069558|FG000|Part 2|Administrative|16|||
144238781|NCT00537316|520069559|FG001|Part 2|Administrative|8|||
144238782|NCT00537316|520069560|FG002|Part 2|Administrative|24|||
144238783|NCT00537316|520069561|FG003|Part 2|Administrative|3|||
144238784|NCT00537316|520069562|FG004|Part 2|Administrative|1|||
144238785|NCT00537316|520069563|FG005|Part 2|Administrative|4|||
144238786|NCT00537316|520069564|FG006|Part 2|Administrative|1|||
144238787|NCT04533412|520069565|FG000|Overall Study|Withdrawal by Subject|1|||
144238788|NCT04533412|520069566|FG001|Overall Study|Withdrawal by Subject|1|||
144238789|NCT04533412|520069565|FG000|Overall Study|Lost to Follow-up|1|||
144238790|NCT04533412|520069566|FG001|Overall Study|Lost to Follow-up|4|||
144238791|NCT03452488|520069568|FG000|Overall Study|Adverse Event|4|||
144238792|NCT03452488|520069569|FG001|Overall Study|Adverse Event|6|||
144238793|NCT03452488|520069570|FG002|Overall Study|Adverse Event|1|||
144238794|NCT03452488|520069568|FG000|Overall Study|Death|0|||
144238795|NCT03452488|520069569|FG001|Overall Study|Death|0|||
144238796|NCT03452488|520069570|FG002|Overall Study|Death|1|||
144238797|NCT03452488|520069568|FG000|Overall Study|Lost to Follow-up|1|||
144238798|NCT03452488|520069569|FG001|Overall Study|Lost to Follow-up|2|||
144238799|NCT03452488|520069570|FG002|Overall Study|Lost to Follow-up|0|||
144238800|NCT03452488|520069568|FG000|Overall Study|PI Decision|1|||
144238801|NCT03452488|520069569|FG001|Overall Study|PI Decision|0|||
144238802|NCT03452488|520069570|FG002|Overall Study|PI Decision|0|||
144238803|NCT03452488|520069568|FG000|Overall Study|Withdrew consent|4|||
144238804|NCT03452488|520069569|FG001|Overall Study|Withdrew consent|2|||
144238805|NCT03452488|520069570|FG002|Overall Study|Withdrew consent|2|||
144238806|NCT03452488|520069568|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
144238807|NCT03452488|520069569|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
144238808|NCT03452488|520069570|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
144238809|NCT03452488|520069568|FG000|Overall Study|Other|0|||
144238810|NCT03452488|520069569|FG001|Overall Study|Other|2|||
144238811|NCT03452488|520069570|FG002|Overall Study|Other|2|||
144238812|NCT00658775|520069571|FG000|Overall Study|Adverse Event|4|||
144238813|NCT00658775|520069572|FG001|Overall Study|Adverse Event|6|||
144238814|NCT00658775|520069571|FG000|Overall Study|Lost to Follow-up|17|||
144238815|NCT00658775|520069572|FG001|Overall Study|Lost to Follow-up|18|||
144238816|NCT00658775|520069571|FG000|Overall Study|Withdrawal by Subject|6|||
144238817|NCT00658775|520069572|FG001|Overall Study|Withdrawal by Subject|4|||
144238818|NCT00658775|520069571|FG000|Overall Study|Withdrawal of consent|8|||
144238819|NCT00658775|520069572|FG001|Overall Study|Withdrawal of consent|7|||
144238820|NCT00658775|520069571|FG000|Overall Study|Other|7|||
144238821|NCT00658775|520069572|FG001|Overall Study|Other|8|||
144238822|NCT02107859|520069573|FG000|Overall Study|Withdrawal by Subject|14|||
144238823|NCT02107859|520069573|FG000|Overall Study|Adverse Event|3|||
144238824|NCT02107859|520069573|FG000|Overall Study|Study closure|41|||
144238825|NCT02107859|520069573|FG000|Overall Study|Other than specified|3|||
144238826|NCT04439214|520069579|FG000|Overall Study|Adverse Event|13|||
144238827|NCT04439214|520069579|FG000|Overall Study|Disease progression|16|||
144238828|NCT04439214|520069579|FG000|Overall Study|Death|1|||
144238829|NCT04439214|520069579|FG000|Overall Study|Withdrawal by Subject|2|||
144238830|NCT04439214|520069579|FG000|Overall Study|Declining health|1|||
144238831|NCT04439214|520069579|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
144238832|NCT04439214|520069579|FG000|Overall Study|Ineligible|5|||
144238833|NCT02235077|520069580|FG000|Overall Study|Death|5|||
144238834|NCT02235077|520069581|FG001|Overall Study|Death|7|||
144238835|NCT02235077|520069580|FG000|Overall Study|Lost to Follow-up|5|||
144238836|NCT02235077|520069581|FG001|Overall Study|Lost to Follow-up|6|||
144238837|NCT02235077|520069580|FG000|Overall Study|Withdrawal by Subject|8|||
144238838|NCT02235077|520069581|FG001|Overall Study|Withdrawal by Subject|5|||
144238839|NCT02235077|520069580|FG000|Overall Study|Physician Decision|0|||
144238840|NCT02235077|520069581|FG001|Overall Study|Physician Decision|1|||
144238841|NCT03852628|520069582|FG000|Overall Study|Lost to Follow-up|7|||
144238842|NCT03852628|520069583|FG001|Overall Study|Lost to Follow-up|6|||
144238843|NCT03852628|520069582|FG000|Overall Study|Lack of Efficacy|6|||
144238844|NCT03852628|520069583|FG001|Overall Study|Lack of Efficacy|6|||
144238845|NCT02964208|520069584|FG000|Overall Study|Death|103|||
144238846|NCT02964208|520069584|FG000|Overall Study|Withdrawal by Subject|6|||
144238847|NCT02964208|520069584|FG000|Overall Study|Lost to Follow-up|6|||
144238848|NCT02964208|520069584|FG000|Overall Study|Unsuccessful Procedure|5|||
144238849|NCT02964208|520069584|FG000|Overall Study|Device Explant|1|||
144238850|NCT02964208|520069584|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
144238851|NCT03226769|520069589|FG000|Overall Study|Withdrawal by Subject|0|||
144238852|NCT03226769|520069590|FG001|Overall Study|Withdrawal by Subject|1|||
144238853|NCT02640677|520069593|FG000|Overall Study|Lost to Follow-up|1|||
144238854|NCT02640677|520069593|FG000|Overall Study|Withdrawal by Subject|1|||
144238855|NCT00957268|520069603|FG000|Overall Study|Voluntary Withdrawal|0|||
144238856|NCT00957268|520069604|FG001|Overall Study|Voluntary Withdrawal|0|||
144238857|NCT00957268|520069605|FG002|Overall Study|Voluntary Withdrawal|1|||
144269922|NCT01387269|520191449|FG001|Overall Study|Study drug-related AE|0|||
144269923|NCT01387269|520191448|FG000|Overall Study|Lost to Follow-up|1|||
144269924|NCT01387269|520191449|FG001|Overall Study|Lost to Follow-up|0|||
144238858|NCT00957268|520069606|FG003|Overall Study|Voluntary Withdrawal|0|||
144238859|NCT00957268|520069607|FG004|Overall Study|Voluntary Withdrawal|0|||
144238860|NCT01758731|520069608|FG000|Overall Study|Physician Decision|1|||
144269925|NCT01200329|520191450|FG000|Overall Study|Lack of financial coverage|2|||
144238861|NCT02396420|520069610|FG000|Overall Study|Death|1|||
144269926|NCT01200329|520191450|FG000|Overall Study|Progressive disease|1|||
144238862|NCT01493284|520069617|FG000|Overall Study|Death|29|||
144238863|NCT01493284|520069617|FG000|Overall Study|Withdrawal by Subject|32|||
144238864|NCT00519428|520069618|FG000|Overall Study|Adverse Event|5|||
144238865|NCT00519428|520069619|FG001|Overall Study|Adverse Event|2|||
144238866|NCT00519428|520069620|FG002|Overall Study|Adverse Event|10|||
144238867|NCT00519428|520069618|FG000|Overall Study|Lost to Follow-up|7|||
144238868|NCT00519428|520069619|FG001|Overall Study|Lost to Follow-up|7|||
144238869|NCT00519428|520069620|FG002|Overall Study|Lost to Follow-up|6|||
144238870|NCT00519428|520069618|FG000|Overall Study|Withdrawal by Subject|8|||
144238871|NCT00519428|520069619|FG001|Overall Study|Withdrawal by Subject|3|||
144238872|NCT00519428|520069620|FG002|Overall Study|Withdrawal by Subject|7|||
144238873|NCT00519428|520069618|FG000|Overall Study|unstated|1|||
144238874|NCT00519428|520069619|FG001|Overall Study|unstated|3|||
144238875|NCT00519428|520069620|FG002|Overall Study|unstated|2|||
144238876|NCT03489707|520069621|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
144238877|NCT03489707|520069622|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
144238878|NCT03489707|520069621|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
144238879|NCT03489707|520069622|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
144238880|NCT00325156|520069623|FG000|Overall Study|Protocol Violation|8|||
144238881|NCT00325156|520069623|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
144238882|NCT00325156|520069623|FG000|Overall Study|Migrated/moved from study area|12|||
144238883|NCT00325156|520069623|FG000|Overall Study|Adverse event, non-fatal|3|||
144238884|NCT00325156|520069623|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
144238885|NCT00325156|520069623|FG000|Overall Study|Other|1|||
144238886|NCT00325156|520069623|FG000|Overall Study|Withdrawal by Subject|31|||
144238887|NCT04064411|520069624|FG000|Overall Study|Adverse Event|29|||
144238888|NCT04064411|520069625|FG001|Overall Study|Adverse Event|19|||
144238889|NCT04064411|520069624|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
144238890|NCT04064411|520069625|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
144238891|NCT04064411|520069624|FG000|Overall Study|Protocol Deviation|0|||
144238892|NCT04064411|520069625|FG001|Overall Study|Protocol Deviation|2|||
144238893|NCT04064411|520069624|FG000|Overall Study|Withdrawal by Subject|25|||
144238894|NCT04064411|520069625|FG001|Overall Study|Withdrawal by Subject|29|||
144238895|NCT04064411|520069624|FG000|Overall Study|Lost to Follow-up|5|||
144238896|NCT04064411|520069625|FG001|Overall Study|Lost to Follow-up|2|||
144238897|NCT04064411|520069624|FG000|Overall Study|Other than Specified|4|||
144238898|NCT04064411|520069625|FG001|Overall Study|Other than Specified|1|||
144238899|NCT04064411|520069624|FG000|Overall Study|Death|1|||
144238900|NCT04064411|520069625|FG001|Overall Study|Death|0|||
144238901|NCT03395184|520069626|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
144238902|NCT03395184|520069627|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
144238903|NCT03395184|520069628|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
144238904|NCT03395184|520069629|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
144238905|NCT03395184|520069630|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
144238906|NCT03395184|520069631|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
144238907|NCT03395184|520069632|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
144238908|NCT03395184|520069626|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
144238909|NCT03395184|520069627|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
144238910|NCT03395184|520069628|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
144238911|NCT03395184|520069629|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
144238912|NCT03395184|520069630|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
144238913|NCT03395184|520069631|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
144238914|NCT03395184|520069632|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
144238915|NCT03395184|520069626|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
144238916|NCT03395184|520069627|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
144238917|NCT03395184|520069628|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
144238918|NCT03395184|520069629|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
144238919|NCT03395184|520069630|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
144238920|NCT03395184|520069631|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
144238921|NCT03395184|520069632|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
144238922|NCT03395184|520069626|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
144238923|NCT03395184|520069627|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
144238924|NCT03395184|520069628|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
144238925|NCT03395184|520069629|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
144238926|NCT03395184|520069630|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
144238927|NCT03395184|520069631|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
144238928|NCT03395184|520069632|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
144269927|NCT03087058|520191452|FG000|Overall Study|Withdrawal by Subject|2|||
144269928|NCT03087058|520191453|FG001|Overall Study|Withdrawal by Subject|0|||
144269929|NCT03087058|520191454|FG002|Overall Study|Withdrawal by Subject|0|||
144269930|NCT02577029|520191455|FG000|Overall Study|Adverse Event|1|||
144238929|NCT03395184|520069626|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
144238930|NCT03395184|520069627|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144238931|NCT03395184|520069628|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
144269931|NCT02577029|520191456|FG001|Overall Study|Adverse Event|0|||
144269932|NCT02577029|520191457|FG002|Overall Study|Adverse Event|2|||
144269933|NCT02577029|520191458|FG003|Overall Study|Adverse Event|0|||
144269934|NCT02577029|520191459|FG004|Overall Study|Adverse Event|1|||
144269935|NCT02577029|520191460|FG005|Overall Study|Adverse Event|0|||
144269936|NCT02577029|520191461|FG006|Overall Study|Adverse Event|0|||
144269937|NCT02577029|520191462|FG007|Overall Study|Adverse Event|0|||
144269938|NCT02577029|520191455|FG000|Overall Study|Withdrawal by Subject|0|||
144269939|NCT02577029|520191456|FG001|Overall Study|Withdrawal by Subject|0|||
144269940|NCT02577029|520191457|FG002|Overall Study|Withdrawal by Subject|0|||
144269941|NCT02577029|520191458|FG003|Overall Study|Withdrawal by Subject|0|||
144269942|NCT02577029|520191459|FG004|Overall Study|Withdrawal by Subject|0|||
144269943|NCT02577029|520191460|FG005|Overall Study|Withdrawal by Subject|1|||
144269944|NCT02577029|520191461|FG006|Overall Study|Withdrawal by Subject|0|||
144269945|NCT02577029|520191462|FG007|Overall Study|Withdrawal by Subject|0|||
144269946|NCT02577029|520191455|FG000|Overall Study|Sponsor Termination of the Study|9|||
144269947|NCT02577029|520191456|FG001|Overall Study|Sponsor Termination of the Study|2|||
144269948|NCT02577029|520191457|FG002|Overall Study|Sponsor Termination of the Study|5|||
144269949|NCT02577029|520191458|FG003|Overall Study|Sponsor Termination of the Study|12|||
144269950|NCT02577029|520191459|FG004|Overall Study|Sponsor Termination of the Study|10|||
144269951|NCT02577029|520191460|FG005|Overall Study|Sponsor Termination of the Study|12|||
144269952|NCT02577029|520191461|FG006|Overall Study|Sponsor Termination of the Study|12|||
144269953|NCT02577029|520191462|FG007|Overall Study|Sponsor Termination of the Study|12|||
144269954|NCT02078817|520191463|FG000|Overall Study|Withdrawal by Subject|1|||
144269955|NCT00855218|520191464|FG000|Overall Study|Adverse Event|43|||
144269956|NCT00855218|520191465|FG001|Overall Study|Adverse Event|27|||
144269957|NCT00855218|520191464|FG000|Overall Study|Withdrawal by Subject|10|||
144269958|NCT00855218|520191465|FG001|Overall Study|Withdrawal by Subject|6|||
144269959|NCT00855218|520191464|FG000|Overall Study|Physician Decision|18|||
144269960|NCT00855218|520191465|FG001|Overall Study|Physician Decision|11|||
144269961|NCT00855218|520191464|FG000|Overall Study|Lost to Follow-up|0|||
144269962|NCT00855218|520191465|FG001|Overall Study|Lost to Follow-up|1|||
144269963|NCT00855218|520191464|FG000|Overall Study|Protocol Violation|5|||
144269964|NCT00855218|520191465|FG001|Overall Study|Protocol Violation|9|||
144269965|NCT00855218|520191464|FG000|Overall Study|non-compliant with study drug|3|||
144269966|NCT00855218|520191465|FG001|Overall Study|non-compliant with study drug|1|||
144269967|NCT00855218|520191464|FG000|Overall Study|patient convenience|2|||
144269968|NCT00855218|520191465|FG001|Overall Study|patient convenience|0|||
144269969|NCT00855218|520191464|FG000|Overall Study|technical problems|2|||
144269970|NCT00855218|520191465|FG001|Overall Study|technical problems|1|||
144269971|NCT00855218|520191464|FG000|Overall Study|Still treated with study medication|0|||
144269972|NCT00855218|520191465|FG001|Overall Study|Still treated with study medication|1|||
144269973|NCT00855218|520191464|FG000|Overall Study|Untreatable disease progression|54|||
144269974|NCT00855218|520191465|FG001|Overall Study|Untreatable disease progression|67|||
144269975|NCT00855218|520191464|FG000|Overall Study|Second malignancy|0|||
144269976|NCT00855218|520191465|FG001|Overall Study|Second malignancy|1|||
144269977|NCT00855218|520191464|FG000|Overall Study|Progression measurement proven|7|||
144269978|NCT00855218|520191465|FG001|Overall Study|Progression measurement proven|15|||
144269979|NCT00855218|520191464|FG000|Overall Study|Clinical endpoint reached|10|||
144269980|NCT00855218|520191465|FG001|Overall Study|Clinical endpoint reached|13|||
144269981|NCT01441973|520191470|FG000|Overall Study|Disease progression|8|||
144269982|NCT01441973|520191471|FG001|Overall Study|Disease progression|6|||
144269983|NCT01441973|520191470|FG000|Overall Study|Adverse event unrelated to study drug|3|||
144269984|NCT01441973|520191471|FG001|Overall Study|Adverse event unrelated to study drug|2|||
144269985|NCT01441973|520191470|FG000|Overall Study|Participant request to discontinue|1|||
144269986|NCT01441973|520191471|FG001|Overall Study|Participant request to discontinue|1|||
144269987|NCT01441973|520191470|FG000|Overall Study|Poor compliance/noncompliance|0|||
144269988|NCT01441973|520191471|FG001|Overall Study|Poor compliance/noncompliance|1|||
144269989|NCT01441973|520191470|FG000|Overall Study|Administrative reason by sponsor|3|||
144269990|NCT01441973|520191471|FG001|Overall Study|Administrative reason by sponsor|5|||
144238932|NCT03395184|520069629|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144238933|NCT03395184|520069630|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144238934|NCT03395184|520069631|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144238935|NCT03395184|520069632|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144238936|NCT03395184|520069626|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
144238937|NCT03395184|520069627|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
144238938|NCT03395184|520069628|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
144238939|NCT03395184|520069629|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
144238940|NCT03395184|520069630|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
144238941|NCT03395184|520069631|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
144269991|NCT01441973|520191470|FG000|Overall Study|Participant withdrew consent|0|||
144238942|NCT03395184|520069632|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
144269992|NCT01441973|520191471|FG001|Overall Study|Participant withdrew consent|1|||
144269993|NCT02370511|520191472|FG000|Overall Study|Death|10|||
144238943|NCT03395184|520069626|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
144238944|NCT03395184|520069627|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
144238945|NCT03395184|520069628|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
144238946|NCT03395184|520069629|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
144238947|NCT03395184|520069630|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
144238948|NCT03395184|520069631|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
144238949|NCT03395184|520069632|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
144238950|NCT03395184|520069626|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
144238951|NCT03395184|520069627|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
144238952|NCT03395184|520069628|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
144238953|NCT03395184|520069629|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
144238954|NCT03395184|520069630|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
144238955|NCT03395184|520069631|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
144238956|NCT03395184|520069632|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
144238957|NCT03395184|520069626|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
144238958|NCT03395184|520069627|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
144238959|NCT03395184|520069628|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
144238960|NCT03395184|520069629|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
144238961|NCT03395184|520069630|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
144238962|NCT03395184|520069631|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
144238963|NCT03395184|520069632|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
144238964|NCT03395184|520069626|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
144238965|NCT03395184|520069627|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
144238966|NCT03395184|520069628|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
144238967|NCT03395184|520069629|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
144238968|NCT03395184|520069630|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
144238969|NCT03395184|520069631|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
144238970|NCT03395184|520069632|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
144238971|NCT03395184|520069626|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
144238972|NCT03395184|520069627|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
144238973|NCT03395184|520069628|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
144238974|NCT03395184|520069629|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
144238975|NCT03395184|520069630|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
144238976|NCT03395184|520069631|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
144238977|NCT03395184|520069632|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
144238978|NCT03395184|520069626|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
144238979|NCT03395184|520069627|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
144238980|NCT03395184|520069628|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
144238981|NCT03395184|520069629|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
144238982|NCT03395184|520069630|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
144238983|NCT03395184|520069631|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
144238984|NCT03395184|520069632|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
144238985|NCT01817582|520069633|FG000|Overall Study|Withdrawal by Subject|0|||
144238986|NCT01817582|520069634|FG001|Overall Study|Withdrawal by Subject|1|||
144238987|NCT01817582|520069635|FG002|Overall Study|Withdrawal by Subject|0|||
144238988|NCT01817582|520069633|FG000|Overall Study|Participant revealed masked treatment|1|||
144238989|NCT01817582|520069634|FG001|Overall Study|Participant revealed masked treatment|0|||
144238990|NCT01817582|520069635|FG002|Overall Study|Participant revealed masked treatment|0|||
144238991|NCT01817582|520069633|FG000|Overall Study|Randomized but exclusion criteria met|1|||
144238992|NCT01817582|520069634|FG001|Overall Study|Randomized but exclusion criteria met|0|||
144238993|NCT01817582|520069635|FG002|Overall Study|Randomized but exclusion criteria met|0|||
144238994|NCT03617770|520069638|FG000|Overall Study|Lost to Follow-up|1|||
144238995|NCT03617770|520069639|FG001|Overall Study|Lost to Follow-up|0|||
144238996|NCT00356135|520069640|FG000|Overall Study|Protocol Violation|1|||
144238997|NCT00356135|520069641|FG001|Overall Study|Protocol Violation|0|||
144238998|NCT00356135|520069642|FG002|Overall Study|Protocol Violation|0|||
144238999|NCT00356135|520069640|FG000|Overall Study|Adverse Event|1|||
144239000|NCT00356135|520069641|FG001|Overall Study|Adverse Event|0|||
144239001|NCT00356135|520069642|FG002|Overall Study|Adverse Event|0|||
144239002|NCT00356135|520069640|FG000|Overall Study|Lost to Follow-up|0|||
144239003|NCT00356135|520069641|FG001|Overall Study|Lost to Follow-up|0|||
144239004|NCT00356135|520069642|FG002|Overall Study|Lost to Follow-up|1|||
144239005|NCT00356135|520069640|FG000|Overall Study|Physician Decision|1|||
144239006|NCT00356135|520069641|FG001|Overall Study|Physician Decision|1|||
144239007|NCT00356135|520069642|FG002|Overall Study|Physician Decision|1|||
144239008|NCT00356135|520069640|FG000|Overall Study|Subject non-compliance|1|||
144239009|NCT00356135|520069641|FG001|Overall Study|Subject non-compliance|1|||
144239010|NCT00356135|520069642|FG002|Overall Study|Subject non-compliance|3|||
144239011|NCT03963232|520069643|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
144239012|NCT03963232|520069644|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
144239013|NCT03963232|520069643|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
144239014|NCT03963232|520069644|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
144239015|NCT03963232|520069643|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
144239016|NCT03963232|520069644|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
144239017|NCT03963232|520069643|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
144239018|NCT03963232|520069644|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
144239019|NCT03963232|520069643|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
144239020|NCT03963232|520069644|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
144239021|NCT03963232|520069643|FG000|Open-Label Treatment Phase|Adverse Event|1|||
144239022|NCT03963232|520069644|FG001|Open-Label Treatment Phase|Adverse Event|2|||
144239023|NCT03963232|520069643|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
144239024|NCT03963232|520069644|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
144239025|NCT03963232|520069643|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
144239026|NCT03963232|520069644|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
144239027|NCT03963232|520069643|FG000|Open-Label Treatment Phase|Pregnancy|1|||
144239028|NCT03963232|520069644|FG001|Open-Label Treatment Phase|Pregnancy|0|||
144239029|NCT03963232|520069643|FG000|Follow-up Phase|Withdrawal by Subject|7|||
144239030|NCT03963232|520069644|FG001|Follow-up Phase|Withdrawal by Subject|5|||
144239031|NCT03963232|520069643|FG000|Follow-up Phase|Protocol Violation|0|||
144239032|NCT03963232|520069644|FG001|Follow-up Phase|Protocol Violation|2|||
144239033|NCT03963232|520069643|FG000|Follow-up Phase|Adverse Event|0|||
144239034|NCT03963232|520069644|FG001|Follow-up Phase|Adverse Event|1|||
144239035|NCT03963232|520069643|FG000|Follow-up Phase|Lost to Follow-up|0|||
144239036|NCT03963232|520069644|FG001|Follow-up Phase|Lost to Follow-up|1|||
144239037|NCT03725761|520069646|FG000|Overall Study|still on study|1|||
144239038|NCT01397786|520071644|FG000|Phase A|Lost to Follow-up|0|||
144239039|NCT01397786|520071645|FG001|Phase A|Lost to Follow-up|0|||
144239040|NCT01397786|520071646|FG002|Phase A|Lost to Follow-up|6|||
144239041|NCT01397786|520071644|FG000|Phase A|Adverse Event|0|||
144239042|NCT01397786|520071645|FG001|Phase A|Adverse Event|0|||
144239043|NCT01397786|520071646|FG002|Phase A|Adverse Event|8|||
144239044|NCT01397786|520071644|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
144239045|NCT01397786|520071645|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
144239046|NCT01397786|520071646|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
144239047|NCT01397786|520071644|FG000|Phase A|Physician Decision|0|||
144239048|NCT01397786|520071645|FG001|Phase A|Physician Decision|0|||
144239049|NCT01397786|520071646|FG002|Phase A|Physician Decision|1|||
144239050|NCT01397786|520071644|FG000|Phase A|Withdrawal by Subject|0|||
144239051|NCT01397786|520071645|FG001|Phase A|Withdrawal by Subject|0|||
144239052|NCT01397786|520071646|FG002|Phase A|Withdrawal by Subject|5|||
144239053|NCT01397786|520071644|FG000|Phase A|Lack of Efficacy|0|||
144239054|NCT01397786|520071645|FG001|Phase A|Lack of Efficacy|0|||
144239055|NCT01397786|520071646|FG002|Phase A|Lack of Efficacy|1|||
144239056|NCT01397786|520071644|FG000|Phase B|Lost to Follow-up|22|||
144239057|NCT01397786|520071645|FG001|Phase B|Lost to Follow-up|12|||
144239058|NCT01397786|520071646|FG002|Phase B|Lost to Follow-up|22|||
144239059|NCT01397786|520071644|FG000|Phase B|Adverse Event|109|||
144239060|NCT01397786|520071645|FG001|Phase B|Adverse Event|23|||
144239061|NCT01397786|520071646|FG002|Phase B|Adverse Event|27|||
144239062|NCT01397786|520071644|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
144239063|NCT01397786|520071645|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
144239064|NCT01397786|520071646|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
144239065|NCT01397786|520071644|FG000|Phase B|Physician Decision|9|||
144239066|NCT01397786|520071645|FG001|Phase B|Physician Decision|1|||
144239067|NCT01397786|520071646|FG002|Phase B|Physician Decision|3|||
144239068|NCT01397786|520071644|FG000|Phase B|Withdrawal by Subject|102|||
144239069|NCT01397786|520071645|FG001|Phase B|Withdrawal by Subject|45|||
144239070|NCT01397786|520071646|FG002|Phase B|Withdrawal by Subject|30|||
144239071|NCT01397786|520071644|FG000|Phase B|Protocol Deviation|1|||
144239072|NCT01397786|520071645|FG001|Phase B|Protocol Deviation|2|||
144239073|NCT01397786|520071646|FG002|Phase B|Protocol Deviation|4|||
144239074|NCT01397786|520071644|FG000|Phase B|Lack of Efficacy|22|||
144239075|NCT01397786|520071645|FG001|Phase B|Lack of Efficacy|7|||
144239076|NCT01397786|520071646|FG002|Phase B|Lack of Efficacy|14|||
144239077|NCT00784550|520071650|FG000|Overall Study|Adverse Event|12|||
144239078|NCT00784550|520071651|FG001|Overall Study|Adverse Event|10|||
144239079|NCT00784550|520071650|FG000|Overall Study|Lack of Efficacy|0|||
144239080|NCT00784550|520071651|FG001|Overall Study|Lack of Efficacy|1|||
144239081|NCT00784550|520071650|FG000|Overall Study|Protocol Violation|10|||
144239082|NCT00784550|520071651|FG001|Overall Study|Protocol Violation|10|||
144239083|NCT00784550|520071650|FG000|Overall Study|Lost to Follow-up|8|||
144239084|NCT00784550|520071651|FG001|Overall Study|Lost to Follow-up|5|||
144239085|NCT00784550|520071650|FG000|Overall Study|Physician Decision|2|||
144239086|NCT00784550|520071651|FG001|Overall Study|Physician Decision|3|||
144239087|NCT00784550|520071650|FG000|Overall Study|Withdrawal by Subject|4|||
144239088|NCT00784550|520071651|FG001|Overall Study|Withdrawal by Subject|13|||
144239089|NCT00688701|520071652|FG000|Overall Study|Adverse Event|1|||
144239090|NCT00688701|520071653|FG001|Overall Study|Adverse Event|0|||
144239091|NCT00688701|520071654|FG002|Overall Study|Adverse Event|5|||
144239092|NCT00688701|520071655|FG003|Overall Study|Adverse Event|3|||
144239093|NCT00688701|520071652|FG000|Overall Study|Lack of Efficacy|0|||
144239094|NCT00688701|520071653|FG001|Overall Study|Lack of Efficacy|1|||
144239095|NCT00688701|520071654|FG002|Overall Study|Lack of Efficacy|0|||
144239096|NCT00688701|520071655|FG003|Overall Study|Lack of Efficacy|0|||
144239097|NCT00688701|520071652|FG000|Overall Study|Withdrawal by Subject|3|||
144239098|NCT00688701|520071653|FG001|Overall Study|Withdrawal by Subject|3|||
144239099|NCT00688701|520071654|FG002|Overall Study|Withdrawal by Subject|4|||
144239100|NCT00688701|520071655|FG003|Overall Study|Withdrawal by Subject|8|||
144239101|NCT00688701|520071652|FG000|Overall Study|Poor compliance to protocol|0|||
144239102|NCT00688701|520071653|FG001|Overall Study|Poor compliance to protocol|1|||
144239103|NCT00688701|520071654|FG002|Overall Study|Poor compliance to protocol|1|||
144239104|NCT00688701|520071655|FG003|Overall Study|Poor compliance to protocol|0|||
144239105|NCT01275755|520071661|FG000|Double-blind Treatment Period|Adverse Event|0|||
144239106|NCT01275755|520071662|FG001|Double-blind Treatment Period|Adverse Event|2|||
144239107|NCT01275755|520071661|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
144239108|NCT01275755|520071662|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
144239109|NCT01275755|520071661|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
144239110|NCT01275755|520071662|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
144239111|NCT01275755|520071661|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
144239112|NCT01275755|520071662|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
144239113|NCT00174967|520071663|FG000|Overall Study|Adverse Event|1|||
144239114|NCT00174967|520071664|FG001|Overall Study|Adverse Event|2|||
144239115|NCT00174967|520071665|FG002|Overall Study|Adverse Event|2|||
144239116|NCT00174967|520071666|FG003|Overall Study|Adverse Event|1|||
144239117|NCT00174967|520071663|FG000|Overall Study|Gout Flare|0|||
144239118|NCT00174967|520071664|FG001|Overall Study|Gout Flare|0|||
144239119|NCT00174967|520071665|FG002|Overall Study|Gout Flare|0|||
144239120|NCT00174967|520071666|FG003|Overall Study|Gout Flare|1|||
144239121|NCT00174967|520071663|FG000|Overall Study|Other|0|||
144239122|NCT00174967|520071664|FG001|Overall Study|Other|1|||
144239123|NCT00174967|520071665|FG002|Overall Study|Other|0|||
144239124|NCT00174967|520071666|FG003|Overall Study|Other|0|||
144239125|NCT04420585|520071667|FG000|Overall Study|Adverse Event|1|||
144239126|NCT04420585|520071667|FG000|Overall Study|Never initiated medication|2|||
144239127|NCT00601172|520071668|FG000|Overall Study|Adverse Event|43|||
144239128|NCT00601172|520071669|FG001|Overall Study|Adverse Event|32|||
144239129|NCT00601172|520071668|FG000|Overall Study|Lack of Efficacy|11|||
144239130|NCT00601172|520071669|FG001|Overall Study|Lack of Efficacy|12|||
144239131|NCT00601172|520071668|FG000|Overall Study|Protocol Violation|2|||
144239132|NCT00601172|520071669|FG001|Overall Study|Protocol Violation|5|||
144239133|NCT00601172|520071668|FG000|Overall Study|Lost to Follow-up|4|||
144239134|NCT00601172|520071669|FG001|Overall Study|Lost to Follow-up|3|||
144239135|NCT00601172|520071668|FG000|Overall Study|Physician Decision|27|||
144239136|NCT00601172|520071669|FG001|Overall Study|Physician Decision|28|||
144239137|NCT00601172|520071668|FG000|Overall Study|Withdrawal by Subject|35|||
144239138|NCT00601172|520071669|FG001|Overall Study|Withdrawal by Subject|27|||
144239139|NCT00601172|520071668|FG000|Overall Study|Did not meet continuation criteria|19|||
144239140|NCT00601172|520071669|FG001|Overall Study|Did not meet continuation criteria|20|||
144239141|NCT03917472|520071673|FG000|Overall Study|Physician Decision|4|||
144239142|NCT03917472|520071674|FG001|Overall Study|Physician Decision|0|||
144239143|NCT03917472|520071673|FG000|Overall Study|Adverse Event|3|||
144239144|NCT03917472|520071674|FG001|Overall Study|Adverse Event|1|||
144239145|NCT03917472|520071673|FG000|Overall Study|Death|7|||
144239146|NCT03917472|520071674|FG001|Overall Study|Death|5|||
144239147|NCT03917472|520071673|FG000|Overall Study|Withdrawal by Subject|11|||
144239148|NCT03917472|520071674|FG001|Overall Study|Withdrawal by Subject|4|||
144239149|NCT03917472|520071673|FG000|Overall Study|Lost to Follow-up|10|||
144239150|NCT03917472|520071674|FG001|Overall Study|Lost to Follow-up|5|||
144239151|NCT01154296|520071683|FG000|Randomization and Intervention|Decided to decline|1|||
144239152|NCT01154296|520071684|FG001|Randomization and Intervention|Decided to decline|1|||
144239153|NCT01154296|520071683|FG000|Randomization and Intervention|Declined by staff|1|||
144239154|NCT01154296|520071684|FG001|Randomization and Intervention|Declined by staff|0|||
144239155|NCT01154296|520071683|FG000|Randomization and Intervention|Did not return|1|||
144239156|NCT01154296|520071684|FG001|Randomization and Intervention|Did not return|0|||
144239157|NCT01154296|520071683|FG000|Randomization and Intervention|Left before test|0|||
144239158|NCT01154296|520071684|FG001|Randomization and Intervention|Left before test|1|||
144239159|NCT01154296|520071683|FG000|Randomization and Intervention|Left clinic early|2|||
144239160|NCT01154296|520071684|FG001|Randomization and Intervention|Left clinic early|0|||
144239161|NCT01154296|520071683|FG000|6-month Follow-up|Lost contact|269|||
144239162|NCT01154296|520071684|FG001|6-month Follow-up|Lost contact|275|||
144239163|NCT01154296|520071683|FG000|6-month Follow-up|Incarcerated|37|||
144239164|NCT01154296|520071684|FG001|6-month Follow-up|Incarcerated|32|||
144239165|NCT01154296|520071683|FG000|6-month Follow-up|Withdrew consent|14|||
144239166|NCT01154296|520071684|FG001|6-month Follow-up|Withdrew consent|15|||
144239167|NCT01154296|520071683|FG000|6-month Follow-up|Death|3|||
144239168|NCT01154296|520071684|FG001|6-month Follow-up|Death|2|||
144239169|NCT01154296|520071683|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
144239170|NCT01154296|520071684|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
144239171|NCT04310397|520071686|FG000|Overall Study|Lack of Efficacy|3|||
144239172|NCT04310397|520071686|FG000|Overall Study|Withdrawal by Subject|1|||
144239173|NCT01936181|520071692|FG000|Randomised, Double-blind|Adverse Event|27|||
144239174|NCT01936181|520071693|FG001|Randomised, Double-blind|Adverse Event|21|||
144239175|NCT01936181|520071694|FG002|Randomised, Double-blind|Adverse Event|0|||
144239176|NCT01936181|520071695|FG003|Randomised, Double-blind|Adverse Event|0|||
144239177|NCT01936181|520071692|FG000|Randomised, Double-blind|Protocol Violation|1|||
144239178|NCT01936181|520071693|FG001|Randomised, Double-blind|Protocol Violation|5|||
144239179|NCT01936181|520071694|FG002|Randomised, Double-blind|Protocol Violation|0|||
144239180|NCT01936181|520071695|FG003|Randomised, Double-blind|Protocol Violation|0|||
144239181|NCT01936181|520071692|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
144239182|NCT01936181|520071693|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
144239183|NCT01936181|520071694|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
144239184|NCT01936181|520071695|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
144239185|NCT01936181|520071692|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
144239186|NCT01936181|520071693|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
144239187|NCT01936181|520071694|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
144239188|NCT01936181|520071695|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
144239189|NCT01936181|520071692|FG000|Randomised, Double-blind|Pregnancy|0|||
144239190|NCT01936181|520071693|FG001|Randomised, Double-blind|Pregnancy|1|||
144239191|NCT01936181|520071694|FG002|Randomised, Double-blind|Pregnancy|0|||
144239192|NCT01936181|520071695|FG003|Randomised, Double-blind|Pregnancy|0|||
144239193|NCT01936181|520071692|FG000|Randomised, Double-blind|Physician Decision|4|||
144239194|NCT01936181|520071693|FG001|Randomised, Double-blind|Physician Decision|4|||
144239195|NCT01936181|520071694|FG002|Randomised, Double-blind|Physician Decision|0|||
144239196|NCT01936181|520071695|FG003|Randomised, Double-blind|Physician Decision|0|||
144239197|NCT01936181|520071692|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
144239198|NCT01936181|520071693|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
144239199|NCT01936181|520071694|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
144239200|NCT01936181|520071695|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
144239201|NCT01936181|520071692|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
144239202|NCT01936181|520071693|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
144239203|NCT01936181|520071694|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
144239204|NCT01936181|520071695|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
144239205|NCT01936181|520071692|FG000|Transition-extension|Adverse Event|3|||
144239206|NCT01936181|520071693|FG001|Transition-extension|Adverse Event|0|||
144239207|NCT01936181|520071694|FG002|Transition-extension|Adverse Event|3|||
144239208|NCT01936181|520071695|FG003|Transition-extension|Adverse Event|1|||
144239209|NCT01936181|520071692|FG000|Transition-extension|Lost to Follow-up|3|||
144239210|NCT01936181|520071693|FG001|Transition-extension|Lost to Follow-up|0|||
144239211|NCT01936181|520071694|FG002|Transition-extension|Lost to Follow-up|1|||
144239212|NCT01936181|520071695|FG003|Transition-extension|Lost to Follow-up|2|||
144239213|NCT01936181|520071692|FG000|Transition-extension|Physician Decision|2|||
144239214|NCT01936181|520071693|FG001|Transition-extension|Physician Decision|0|||
144239215|NCT01936181|520071694|FG002|Transition-extension|Physician Decision|0|||
144239216|NCT01936181|520071695|FG003|Transition-extension|Physician Decision|1|||
144239217|NCT01936181|520071692|FG000|Transition-extension|Withdrawal by Subject|7|||
144239218|NCT01936181|520071693|FG001|Transition-extension|Withdrawal by Subject|0|||
144239219|NCT01936181|520071694|FG002|Transition-extension|Withdrawal by Subject|2|||
144239220|NCT01936181|520071695|FG003|Transition-extension|Withdrawal by Subject|1|||
144239221|NCT00970632|520071700|FG000|Overall Study|Adverse Event|2|||
144239222|NCT00970632|520071701|FG001|Overall Study|Adverse Event|2|||
144239223|NCT00970632|520071702|FG002|Overall Study|Adverse Event|1|||
144239224|NCT00970632|520071700|FG000|Overall Study|Lack of Efficacy|3|||
144239225|NCT00970632|520071701|FG001|Overall Study|Lack of Efficacy|0|||
144239226|NCT00970632|520071702|FG002|Overall Study|Lack of Efficacy|0|||
144239227|NCT00970632|520071700|FG000|Overall Study|Lost to Follow-up|3|||
144239228|NCT00970632|520071701|FG001|Overall Study|Lost to Follow-up|0|||
144239229|NCT00970632|520071702|FG002|Overall Study|Lost to Follow-up|2|||
144239230|NCT00970632|520071700|FG000|Overall Study|Protocol Violation|8|||
144239231|NCT00970632|520071701|FG001|Overall Study|Protocol Violation|5|||
144239232|NCT00970632|520071702|FG002|Overall Study|Protocol Violation|8|||
144239233|NCT00970632|520071700|FG000|Overall Study|Withdrawal by Subject|7|||
144239234|NCT00970632|520071701|FG001|Overall Study|Withdrawal by Subject|6|||
144239235|NCT00970632|520071702|FG002|Overall Study|Withdrawal by Subject|4|||
144239236|NCT00970632|520071700|FG000|Overall Study|Entry criteria not met|0|||
144239237|NCT00970632|520071701|FG001|Overall Study|Entry criteria not met|2|||
144239238|NCT00970632|520071702|FG002|Overall Study|Entry criteria not met|2|||
144239239|NCT00970632|520071700|FG000|Overall Study|Sponsor decision|1|||
144239240|NCT00970632|520071701|FG001|Overall Study|Sponsor decision|0|||
144239241|NCT00970632|520071702|FG002|Overall Study|Sponsor decision|1|||
144239242|NCT00900757|520071703|FG000|Overall Study|screen failure|19|||
144239243|NCT03320850|520071704|FG000|Overall Study|Lost to Follow-up|0|||
144239244|NCT03320850|520071705|FG001|Overall Study|Lost to Follow-up|0|||
144239245|NCT03320850|520071706|FG002|Overall Study|Lost to Follow-up|0|||
144239246|NCT03320850|520071707|FG003|Overall Study|Lost to Follow-up|0|||
144239247|NCT03320850|520071708|FG004|Overall Study|Lost to Follow-up|1|||
144239248|NCT03320850|520071709|FG005|Overall Study|Lost to Follow-up|2|||
144239249|NCT03320850|520071710|FG006|Overall Study|Lost to Follow-up|2|||
144239250|NCT03320850|520071711|FG007|Overall Study|Lost to Follow-up|0|||
144239251|NCT03320850|520071712|FG008|Overall Study|Lost to Follow-up|6|||
144239252|NCT03320850|520071713|FG009|Overall Study|Lost to Follow-up|4|||
144239253|NCT03320850|520071704|FG000|Overall Study|Withdrawal by Subject|0|||
144239254|NCT03320850|520071705|FG001|Overall Study|Withdrawal by Subject|0|||
144239255|NCT03320850|520071706|FG002|Overall Study|Withdrawal by Subject|0|||
144239256|NCT03320850|520071707|FG003|Overall Study|Withdrawal by Subject|0|||
144239257|NCT03320850|520071708|FG004|Overall Study|Withdrawal by Subject|1|||
144239258|NCT03320850|520071709|FG005|Overall Study|Withdrawal by Subject|2|||
144239259|NCT03320850|520071710|FG006|Overall Study|Withdrawal by Subject|4|||
144239260|NCT03320850|520071711|FG007|Overall Study|Withdrawal by Subject|5|||
144239261|NCT03320850|520071712|FG008|Overall Study|Withdrawal by Subject|2|||
144239262|NCT03320850|520071713|FG009|Overall Study|Withdrawal by Subject|1|||
144239263|NCT03320850|520071704|FG000|Overall Study|Lack of Efficacy|0|||
144239264|NCT03320850|520071705|FG001|Overall Study|Lack of Efficacy|0|||
144239265|NCT03320850|520071706|FG002|Overall Study|Lack of Efficacy|0|||
144239266|NCT03320850|520071707|FG003|Overall Study|Lack of Efficacy|1|||
144239267|NCT03320850|520071708|FG004|Overall Study|Lack of Efficacy|0|||
144239268|NCT03320850|520071709|FG005|Overall Study|Lack of Efficacy|1|||
144239269|NCT03320850|520071710|FG006|Overall Study|Lack of Efficacy|0|||
144239270|NCT03320850|520071711|FG007|Overall Study|Lack of Efficacy|2|||
144239271|NCT03320850|520071712|FG008|Overall Study|Lack of Efficacy|0|||
144239272|NCT03320850|520071713|FG009|Overall Study|Lack of Efficacy|3|||
144239273|NCT03320850|520071704|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
144239274|NCT03320850|520071705|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
144239275|NCT03320850|520071706|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
144239276|NCT03320850|520071707|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
144239277|NCT03320850|520071708|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
144239278|NCT03320850|520071709|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
144239279|NCT03320850|520071710|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
144239280|NCT03320850|520071711|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
144239281|NCT03320850|520071712|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
144239282|NCT03320850|520071713|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
144239283|NCT03320850|520071704|FG000|Overall Study|Adverse Event|0|||
144239284|NCT03320850|520071705|FG001|Overall Study|Adverse Event|0|||
144239285|NCT03320850|520071706|FG002|Overall Study|Adverse Event|0|||
144239286|NCT03320850|520071707|FG003|Overall Study|Adverse Event|0|||
144239287|NCT03320850|520071708|FG004|Overall Study|Adverse Event|0|||
144239288|NCT03320850|520071709|FG005|Overall Study|Adverse Event|2|||
144239289|NCT03320850|520071710|FG006|Overall Study|Adverse Event|1|||
144239290|NCT03320850|520071711|FG007|Overall Study|Adverse Event|0|||
144239291|NCT03320850|520071712|FG008|Overall Study|Adverse Event|2|||
144239292|NCT03320850|520071713|FG009|Overall Study|Adverse Event|0|||
144239293|NCT03320850|520071704|FG000|Overall Study|Reason Not Specified|0|||
144239294|NCT03320850|520071705|FG001|Overall Study|Reason Not Specified|0|||
144239295|NCT03320850|520071706|FG002|Overall Study|Reason Not Specified|0|||
144239296|NCT03320850|520071707|FG003|Overall Study|Reason Not Specified|0|||
144239297|NCT03320850|520071708|FG004|Overall Study|Reason Not Specified|0|||
144239298|NCT03320850|520071709|FG005|Overall Study|Reason Not Specified|1|||
144239299|NCT03320850|520071710|FG006|Overall Study|Reason Not Specified|0|||
144239300|NCT03320850|520071711|FG007|Overall Study|Reason Not Specified|0|||
144239301|NCT03320850|520071712|FG008|Overall Study|Reason Not Specified|0|||
144239302|NCT03320850|520071713|FG009|Overall Study|Reason Not Specified|1|||
144239303|NCT01286168|520071718|FG000|Overall Study|Withdrawal by Subject|1|||
144239304|NCT01286168|520071718|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
144239305|NCT01424514|520071719|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
144239306|NCT01424514|520071720|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
144239307|NCT01424514|520071719|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
144239308|NCT01424514|520071720|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
144239309|NCT02002533|520071721|FG000|Overall Study|Withdrawal by Subject|6|||
144239310|NCT02002533|520071722|FG001|Overall Study|Withdrawal by Subject|13|||
144239311|NCT02002533|520071721|FG000|Overall Study|Protocol Violation|0|||
144239312|NCT02002533|520071722|FG001|Overall Study|Protocol Violation|1|||
144239313|NCT02002533|520071721|FG000|Overall Study|Adverse Event|0|||
144239314|NCT02002533|520071722|FG001|Overall Study|Adverse Event|3|||
144239315|NCT02002533|520071721|FG000|Overall Study|Lost to Follow-up|0|||
144239316|NCT02002533|520071722|FG001|Overall Study|Lost to Follow-up|1|||
144239317|NCT04598451|520071723|FG000|Overall Study|Adverse Event|3|||
144239318|NCT04598451|520071724|FG001|Overall Study|Adverse Event|2|||
144239319|NCT04598451|520071723|FG000|Overall Study|Withdrawal by Subject|3|||
144239320|NCT04598451|520071724|FG001|Overall Study|Withdrawal by Subject|7|||
144239321|NCT04598451|520071723|FG000|Overall Study|Lost to Follow-up|2|||
144239322|NCT04598451|520071724|FG001|Overall Study|Lost to Follow-up|0|||
144239323|NCT04598451|520071723|FG000|Overall Study|Physician Decision|4|||
144239324|NCT04598451|520071724|FG001|Overall Study|Physician Decision|1|||
144239325|NCT04598451|520071723|FG000|Overall Study|Requires Prohibited Medication|1|||
144239326|NCT04598451|520071724|FG001|Overall Study|Requires Prohibited Medication|0|||
144239327|NCT04598451|520071723|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
144239328|NCT04598451|520071724|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
144239329|NCT02653170|520071725|FG000|Overall Study|Withdrawal by Subject|3|||
144239330|NCT02653170|520071726|FG001|Overall Study|Withdrawal by Subject|8|||
144239331|NCT02653170|520071727|FG002|Overall Study|Withdrawal by Subject|3|||
144239332|NCT02653170|520071725|FG000|Overall Study|withdrawn by study team|2|||
144239333|NCT02653170|520071726|FG001|Overall Study|withdrawn by study team|4|||
144239334|NCT02653170|520071727|FG002|Overall Study|withdrawn by study team|5|||
144239335|NCT02653170|520071725|FG000|Overall Study|Lost to Follow-up|12|||
144239336|NCT02653170|520071726|FG001|Overall Study|Lost to Follow-up|4|||
144239337|NCT02653170|520071727|FG002|Overall Study|Lost to Follow-up|10|||
144239338|NCT00381238|520071735|FG000|Overall Study|Adverse Event|3|||
144239339|NCT00381238|520071735|FG000|Overall Study|Protocol Violation|1|||
144239340|NCT00381238|520071735|FG000|Overall Study|Withdrawal by Subject|4|||
144239341|NCT00381238|520071735|FG000|Overall Study|Lack of Efficacy|2|||
144239342|NCT00381238|520071735|FG000|Overall Study|Withdrew by physician|1|||
144239343|NCT00381238|520071735|FG000|Overall Study|Disease progression|1|||
144239344|NCT02086448|520071737|FG000|Overall Study|Withdrawal by Subject|1|||
144239345|NCT02086448|520071738|FG001|Overall Study|Withdrawal by Subject|0|||
144239346|NCT02086448|520071739|FG002|Overall Study|Withdrawal by Subject|0|||
144239347|NCT02086448|520071740|FG003|Overall Study|Withdrawal by Subject|2|||
144239348|NCT00401544|520071751|FG000|Overall Study|Adverse Event|5|||
144239349|NCT00401544|520071752|FG001|Overall Study|Adverse Event|1|||
144239350|NCT00401544|520071753|FG002|Overall Study|Adverse Event|1|||
144239351|NCT00401544|520071754|FG003|Overall Study|Adverse Event|1|||
144239352|NCT00401544|520071751|FG000|Overall Study|Death|3|||
144239353|NCT00401544|520071752|FG001|Overall Study|Death|6|||
144239354|NCT00401544|520071753|FG002|Overall Study|Death|2|||
144239355|NCT00401544|520071754|FG003|Overall Study|Death|5|||
144239356|NCT00401544|520071751|FG000|Overall Study|Lost to Follow-up|2|||
144239357|NCT00401544|520071752|FG001|Overall Study|Lost to Follow-up|0|||
144239358|NCT00401544|520071753|FG002|Overall Study|Lost to Follow-up|1|||
144239359|NCT00401544|520071754|FG003|Overall Study|Lost to Follow-up|1|||
144239360|NCT00401544|520071751|FG000|Overall Study|Withdrawal by Subject|7|||
144239361|NCT00401544|520071752|FG001|Overall Study|Withdrawal by Subject|6|||
144239362|NCT00401544|520071753|FG002|Overall Study|Withdrawal by Subject|6|||
144239363|NCT00401544|520071754|FG003|Overall Study|Withdrawal by Subject|5|||
144239364|NCT00401544|520071751|FG000|Overall Study|Physician Decision|1|||
144239365|NCT00401544|520071752|FG001|Overall Study|Physician Decision|3|||
144239366|NCT00401544|520071753|FG002|Overall Study|Physician Decision|0|||
144239367|NCT00401544|520071754|FG003|Overall Study|Physician Decision|0|||
144239368|NCT00401544|520071751|FG000|Overall Study|Ineligibility determined|0|||
144239369|NCT00401544|520071752|FG001|Overall Study|Ineligibility determined|1|||
144239370|NCT00401544|520071753|FG002|Overall Study|Ineligibility determined|0|||
144239371|NCT00401544|520071754|FG003|Overall Study|Ineligibility determined|2|||
144239372|NCT00401544|520071751|FG000|Overall Study|Disease progression|0|||
144239373|NCT00401544|520071752|FG001|Overall Study|Disease progression|1|||
144239374|NCT00401544|520071753|FG002|Overall Study|Disease progression|0|||
144239375|NCT00401544|520071754|FG003|Overall Study|Disease progression|0|||
144239376|NCT00401544|520071751|FG000|Overall Study|Other|0|||
144239377|NCT00401544|520071752|FG001|Overall Study|Other|0|||
144239378|NCT00401544|520071753|FG002|Overall Study|Other|2|||
144239379|NCT00401544|520071754|FG003|Overall Study|Other|2|||
144239380|NCT02005692|520071765|FG000|Overall Study|Protocol Violation|1|||
144239381|NCT02005692|520071765|FG000|Overall Study|Withdrawal by Subject|1|||
144239382|NCT02005692|520071765|FG000|Overall Study|Discharged earlier than anticipated|5|||
144239383|NCT05139303|520071766|FG000|Overall Study|Lost to Follow-up|3|||
144239384|NCT05139303|520071767|FG001|Overall Study|Lost to Follow-up|0|||
144239385|NCT05139303|520071766|FG000|Overall Study|Adverse Event|1|||
144239386|NCT05139303|520071767|FG001|Overall Study|Adverse Event|0|||
144239387|NCT00976820|520071770|FG000|Overall Study|Lost to Follow-up|5|||
144239388|NCT00976820|520071771|FG001|Overall Study|Lost to Follow-up|16|||
144239389|NCT00976820|520071772|FG002|Overall Study|Lost to Follow-up|2|||
144239390|NCT00976820|520071773|FG003|Overall Study|Lost to Follow-up|3|||
144239391|NCT00976820|520071770|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
144239392|NCT00976820|520071771|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
144239393|NCT00976820|520071772|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
144239394|NCT00976820|520071773|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
144239395|NCT00976820|520071770|FG000|Overall Study|Withdrawal by Subject|2|||
144239396|NCT00976820|520071771|FG001|Overall Study|Withdrawal by Subject|4|||
144239397|NCT00976820|520071772|FG002|Overall Study|Withdrawal by Subject|1|||
144239398|NCT00976820|520071773|FG003|Overall Study|Withdrawal by Subject|4|||
144239399|NCT01489254|520071776|FG000|Double-blind Part|Adverse Event|7|||
144239400|NCT01489254|520071777|FG001|Double-blind Part|Adverse Event|2|||
144239401|NCT01489254|520071778|FG002|Double-blind Part|Adverse Event|2|||
144239402|NCT01489254|520071779|FG003|Double-blind Part|Adverse Event|0|||
144239403|NCT01489254|520071776|FG000|Double-blind Part|Pregnancy|1|||
144239404|NCT01489254|520071777|FG001|Double-blind Part|Pregnancy|3|||
144239405|NCT01489254|520071778|FG002|Double-blind Part|Pregnancy|0|||
144239406|NCT01489254|520071779|FG003|Double-blind Part|Pregnancy|0|||
144239407|NCT01489254|520071776|FG000|Double-blind Part|Withdrawal by Subject|12|||
144239408|NCT01489254|520071777|FG001|Double-blind Part|Withdrawal by Subject|20|||
144239409|NCT01489254|520071778|FG002|Double-blind Part|Withdrawal by Subject|1|||
144239410|NCT01489254|520071779|FG003|Double-blind Part|Withdrawal by Subject|0|||
144239411|NCT01489254|520071776|FG000|Double-blind Part|Lost to Follow-up|1|||
144239412|NCT01489254|520071777|FG001|Double-blind Part|Lost to Follow-up|2|||
144239413|NCT01489254|520071778|FG002|Double-blind Part|Lost to Follow-up|0|||
144239414|NCT01489254|520071779|FG003|Double-blind Part|Lost to Follow-up|0|||
144239415|NCT01489254|520071776|FG000|Double-blind Part|Other reasons for not completing study|4|||
144239416|NCT01489254|520071777|FG001|Double-blind Part|Other reasons for not completing study|6|||
144239417|NCT01489254|520071778|FG002|Double-blind Part|Other reasons for not completing study|0|||
144239418|NCT01489254|520071779|FG003|Double-blind Part|Other reasons for not completing study|0|||
144239419|NCT01489254|520071776|FG000|Open-label Extension Part|Adverse Event|0|||
144239420|NCT01489254|520071777|FG001|Open-label Extension Part|Adverse Event|0|||
144239421|NCT01489254|520071778|FG002|Open-label Extension Part|Adverse Event|0|||
144239422|NCT01489254|520071779|FG003|Open-label Extension Part|Adverse Event|10|||
144239423|NCT01489254|520071776|FG000|Open-label Extension Part|Pregnancy|0|||
144239424|NCT01489254|520071777|FG001|Open-label Extension Part|Pregnancy|0|||
144239425|NCT01489254|520071778|FG002|Open-label Extension Part|Pregnancy|0|||
144239426|NCT01489254|520071779|FG003|Open-label Extension Part|Pregnancy|3|||
144239427|NCT01489254|520071776|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
144239428|NCT01489254|520071777|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
144239429|NCT01489254|520071778|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
144239430|NCT01489254|520071779|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
144239431|NCT01489254|520071776|FG000|Open-label Extension Part|Protocol Violation|0|||
144239432|NCT01489254|520071777|FG001|Open-label Extension Part|Protocol Violation|0|||
144239433|NCT01489254|520071778|FG002|Open-label Extension Part|Protocol Violation|0|||
144239434|NCT01489254|520071779|FG003|Open-label Extension Part|Protocol Violation|1|||
144239435|NCT01489254|520071776|FG000|Open-label Extension Part|Lost to Follow-up|0|||
144239436|NCT01489254|520071777|FG001|Open-label Extension Part|Lost to Follow-up|0|||
144239437|NCT01489254|520071778|FG002|Open-label Extension Part|Lost to Follow-up|0|||
144239438|NCT01489254|520071779|FG003|Open-label Extension Part|Lost to Follow-up|9|||
144239439|NCT01489254|520071776|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
144239440|NCT01489254|520071777|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
144239441|NCT01489254|520071778|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
144239442|NCT01489254|520071779|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
144239443|NCT00507819|520071780|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
144239444|NCT00507819|520071781|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
144239445|NCT03261674|520071784|FG000|Overall Study|Lost to Follow-up|6|||
144239446|NCT03261674|520071785|FG001|Overall Study|Lost to Follow-up|7|||
144239447|NCT03261674|520071784|FG000|Overall Study|Protocol Violation|1|||
144239448|NCT03261674|520071785|FG001|Overall Study|Protocol Violation|4|||
144239449|NCT03261674|520071784|FG000|Overall Study|Withdrawal by Subject|1|||
144239450|NCT03261674|520071785|FG001|Overall Study|Withdrawal by Subject|4|||
144239451|NCT03261674|520071784|FG000|Overall Study|Physician Decision|1|||
144239452|NCT03261674|520071785|FG001|Overall Study|Physician Decision|0|||
144239453|NCT01075646|520071788|FG000|Overall Study|Lost to Follow-up|4|||
144239454|NCT01075646|520071789|FG001|Overall Study|Lost to Follow-up|3|||
144239455|NCT01075646|520071790|FG002|Overall Study|Lost to Follow-up|1|||
144239456|NCT01075646|520071791|FG003|Overall Study|Lost to Follow-up|2|||
144239457|NCT01676896|520071792|FG000|Overall Study|Withdrawal by Subject|12|||
144269994|NCT02370511|520191473|FG001|Overall Study|Death|7|||
144269995|NCT02370511|520191474|FG002|Overall Study|Death|1|||
144269996|NCT02370511|520191472|FG000|Overall Study|Withdrawal by Subject|2|||
144269997|NCT02370511|520191473|FG001|Overall Study|Withdrawal by Subject|0|||
144269998|NCT02370511|520191474|FG002|Overall Study|Withdrawal by Subject|0|||
144269999|NCT02370511|520191472|FG000|Overall Study|Lost to Follow-up|0|||
144270000|NCT02370511|520191473|FG001|Overall Study|Lost to Follow-up|4|||
144270001|NCT02370511|520191474|FG002|Overall Study|Lost to Follow-up|0|||
144270002|NCT04356937|520191477|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
144270003|NCT04356937|520191478|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
144270004|NCT02003144|520191479|FG000|Open Label Maintenance Phase|Other than specified|2|||
144270005|NCT02003144|520191480|FG001|Open Label Maintenance Phase|Other than specified|4|||
144270006|NCT02003144|520191479|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
144270007|NCT02003144|520191480|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
144270008|NCT02003144|520191479|FG000|Open Label Maintenance Phase|Pregnancy|0|||
144270009|NCT02003144|520191480|FG001|Open Label Maintenance Phase|Pregnancy|2|||
144270010|NCT02003144|520191479|FG000|Open Label Maintenance Phase|Physician Decision|1|||
144239458|NCT01676896|520071793|FG001|Overall Study|Withdrawal by Subject|7|||
144239459|NCT01676896|520071794|FG002|Overall Study|Withdrawal by Subject|19|||
144239460|NCT01647516|520071795|FG000|Induction Period (IP)|Physician Decision|2|||
144239461|NCT01647516|520071796|FG001|Induction Period (IP)|Physician Decision|0|||
144239462|NCT01647516|520071797|FG002|Induction Period (IP)|Physician Decision|0|||
144239463|NCT01647516|520071798|FG003|Induction Period (IP)|Physician Decision|0|||
144239464|NCT01647516|520071799|FG004|Induction Period (IP)|Physician Decision|0|||
144239465|NCT01647516|520071800|FG005|Induction Period (IP)|Physician Decision|0|||
144239466|NCT01647516|520071795|FG000|Induction Period (IP)|Adverse Event|1|||
144239467|NCT01647516|520071796|FG001|Induction Period (IP)|Adverse Event|2|||
144239468|NCT01647516|520071797|FG002|Induction Period (IP)|Adverse Event|0|||
144239469|NCT01647516|520071798|FG003|Induction Period (IP)|Adverse Event|0|||
144239470|NCT01647516|520071799|FG004|Induction Period (IP)|Adverse Event|0|||
144239471|NCT01647516|520071800|FG005|Induction Period (IP)|Adverse Event|0|||
144239472|NCT01647516|520071795|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
144239473|NCT01647516|520071796|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
144239474|NCT01647516|520071797|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
144239475|NCT01647516|520071798|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
144239476|NCT01647516|520071799|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
144239477|NCT01647516|520071800|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
144239478|NCT01647516|520071795|FG000|Induction Period (IP)|Participant Choice|0|||
144239479|NCT01647516|520071796|FG001|Induction Period (IP)|Participant Choice|0|||
144239480|NCT01647516|520071797|FG002|Induction Period (IP)|Participant Choice|1|||
144239481|NCT01647516|520071798|FG003|Induction Period (IP)|Participant Choice|0|||
144239482|NCT01647516|520071799|FG004|Induction Period (IP)|Participant Choice|0|||
144239483|NCT01647516|520071800|FG005|Induction Period (IP)|Participant Choice|0|||
144239484|NCT01647516|520071795|FG000|Induction Period (IP)|Lack of Efficacy|1|||
144239485|NCT01647516|520071796|FG001|Induction Period (IP)|Lack of Efficacy|0|||
144239486|NCT01647516|520071797|FG002|Induction Period (IP)|Lack of Efficacy|0|||
144239487|NCT01647516|520071798|FG003|Induction Period (IP)|Lack of Efficacy|0|||
144239488|NCT01647516|520071799|FG004|Induction Period (IP)|Lack of Efficacy|0|||
144239489|NCT01647516|520071800|FG005|Induction Period (IP)|Lack of Efficacy|0|||
144239490|NCT01647516|520071795|FG000|Induction Period (IP)|No study drug received|1|||
144239491|NCT01647516|520071796|FG001|Induction Period (IP)|No study drug received|1|||
144239492|NCT01647516|520071797|FG002|Induction Period (IP)|No study drug received|0|||
144270011|NCT02003144|520191480|FG001|Open Label Maintenance Phase|Physician Decision|1|||
144270012|NCT02003144|520191479|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
144239493|NCT01647516|520071798|FG003|Induction Period (IP)|No study drug received|0|||
144239494|NCT01647516|520071799|FG004|Induction Period (IP)|No study drug received|0|||
144239495|NCT01647516|520071800|FG005|Induction Period (IP)|No study drug received|0|||
144239496|NCT01647516|520071795|FG000|Maintenance Period (MP)|Adverse Event|2|||
144239497|NCT01647516|520071796|FG001|Maintenance Period (MP)|Adverse Event|1|||
144239498|NCT01647516|520071797|FG002|Maintenance Period (MP)|Adverse Event|0|||
144239499|NCT01647516|520071798|FG003|Maintenance Period (MP)|Adverse Event|0|||
144239500|NCT01647516|520071799|FG004|Maintenance Period (MP)|Adverse Event|0|||
144239501|NCT01647516|520071800|FG005|Maintenance Period (MP)|Adverse Event|0|||
144239502|NCT01647516|520071795|FG000|Maintenance Period (MP)|Non-compliance|1|||
144239503|NCT01647516|520071796|FG001|Maintenance Period (MP)|Non-compliance|0|||
144239504|NCT01647516|520071797|FG002|Maintenance Period (MP)|Non-compliance|0|||
144239505|NCT01647516|520071798|FG003|Maintenance Period (MP)|Non-compliance|0|||
144239506|NCT01647516|520071799|FG004|Maintenance Period (MP)|Non-compliance|0|||
144239507|NCT01647516|520071800|FG005|Maintenance Period (MP)|Non-compliance|0|||
144239508|NCT01647516|520071795|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
144239509|NCT01647516|520071796|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
144239510|NCT01647516|520071797|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
144239511|NCT01647516|520071798|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
144239512|NCT01647516|520071799|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
144239513|NCT01647516|520071800|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
144239514|NCT01647516|520071795|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
144239515|NCT01647516|520071796|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
144239516|NCT01647516|520071797|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
144239517|NCT01647516|520071798|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
144239518|NCT01647516|520071799|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
144239519|NCT01647516|520071800|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
144239520|NCT01647516|520071795|FG000|Open-Label Period|Adverse Event|0|||
144239521|NCT01647516|520071796|FG001|Open-Label Period|Adverse Event|0|||
144239522|NCT01647516|520071797|FG002|Open-Label Period|Adverse Event|0|||
144239523|NCT01647516|520071798|FG003|Open-Label Period|Adverse Event|5|||
144239524|NCT01647516|520071799|FG004|Open-Label Period|Adverse Event|6|||
144239525|NCT01647516|520071800|FG005|Open-Label Period|Adverse Event|3|||
144239526|NCT01647516|520071795|FG000|Open-Label Period|Pregnancy|0|||
144239527|NCT01647516|520071796|FG001|Open-Label Period|Pregnancy|0|||
144239528|NCT01647516|520071797|FG002|Open-Label Period|Pregnancy|0|||
144239529|NCT01647516|520071798|FG003|Open-Label Period|Pregnancy|0|||
144239530|NCT01647516|520071799|FG004|Open-Label Period|Pregnancy|0|||
144239531|NCT01647516|520071800|FG005|Open-Label Period|Pregnancy|1|||
144239532|NCT01647516|520071795|FG000|Open-Label Period|Non-compliance|0|||
144239533|NCT01647516|520071796|FG001|Open-Label Period|Non-compliance|0|||
144239534|NCT01647516|520071797|FG002|Open-Label Period|Non-compliance|0|||
144239535|NCT01647516|520071798|FG003|Open-Label Period|Non-compliance|1|||
144239536|NCT01647516|520071799|FG004|Open-Label Period|Non-compliance|0|||
144239537|NCT01647516|520071800|FG005|Open-Label Period|Non-compliance|1|||
144239538|NCT01647516|520071795|FG000|Open-Label Period|Physician Decision|0|||
144239539|NCT01647516|520071796|FG001|Open-Label Period|Physician Decision|0|||
144239540|NCT01647516|520071797|FG002|Open-Label Period|Physician Decision|0|||
144239541|NCT01647516|520071798|FG003|Open-Label Period|Physician Decision|1|||
144239542|NCT01647516|520071799|FG004|Open-Label Period|Physician Decision|1|||
144239543|NCT01647516|520071800|FG005|Open-Label Period|Physician Decision|0|||
144239544|NCT01647516|520071795|FG000|Open-Label Period|Withdrawal by Subject|0|||
144239545|NCT01647516|520071796|FG001|Open-Label Period|Withdrawal by Subject|0|||
144239546|NCT01647516|520071797|FG002|Open-Label Period|Withdrawal by Subject|0|||
144239547|NCT01647516|520071798|FG003|Open-Label Period|Withdrawal by Subject|9|||
144239548|NCT01647516|520071799|FG004|Open-Label Period|Withdrawal by Subject|11|||
144239549|NCT01647516|520071800|FG005|Open-Label Period|Withdrawal by Subject|6|||
144239550|NCT01647516|520071795|FG000|Open-Label Period|Lost to Follow-up|0|||
144239551|NCT01647516|520071796|FG001|Open-Label Period|Lost to Follow-up|0|||
144239552|NCT01647516|520071797|FG002|Open-Label Period|Lost to Follow-up|0|||
144239553|NCT01647516|520071798|FG003|Open-Label Period|Lost to Follow-up|1|||
144239554|NCT01647516|520071799|FG004|Open-Label Period|Lost to Follow-up|0|||
144239555|NCT01647516|520071800|FG005|Open-Label Period|Lost to Follow-up|1|||
144239556|NCT01647516|520071795|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
144239557|NCT01647516|520071796|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
144239558|NCT01647516|520071797|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
144239559|NCT01647516|520071798|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
144239560|NCT01647516|520071799|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
144239561|NCT01647516|520071800|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
144239562|NCT01647516|520071795|FG000|Open-Label Period|Lack of Efficacy|0|||
144239563|NCT01647516|520071796|FG001|Open-Label Period|Lack of Efficacy|0|||
144239564|NCT01647516|520071797|FG002|Open-Label Period|Lack of Efficacy|0|||
144239565|NCT01647516|520071798|FG003|Open-Label Period|Lack of Efficacy|7|||
144239566|NCT01647516|520071799|FG004|Open-Label Period|Lack of Efficacy|9|||
144239567|NCT01647516|520071800|FG005|Open-Label Period|Lack of Efficacy|10|||
144239568|NCT01647516|520071795|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
144239569|NCT01647516|520071796|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
144239570|NCT01647516|520071797|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
144239571|NCT01647516|520071798|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
144239572|NCT01647516|520071799|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
144239573|NCT01647516|520071800|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
144239574|NCT01647516|520071795|FG000|Open-Label Period|No completion / discontinuation visit|0|||
144239575|NCT01647516|520071796|FG001|Open-Label Period|No completion / discontinuation visit|0|||
144239576|NCT01647516|520071797|FG002|Open-Label Period|No completion / discontinuation visit|0|||
144239577|NCT01647516|520071798|FG003|Open-Label Period|No completion / discontinuation visit|0|||
144239578|NCT01647516|520071799|FG004|Open-Label Period|No completion / discontinuation visit|2|||
144239579|NCT01647516|520071800|FG005|Open-Label Period|No completion / discontinuation visit|1|||
144239580|NCT01613222|520071803|FG000|Overall Study|Physician Decision|1|||
144239581|NCT01613222|520071803|FG000|Overall Study|Unable to place arterial line|1|||
144239582|NCT01613222|520071803|FG000|Overall Study|Reused disposable sensors|10|||
144239583|NCT01895608|520071804|FG000|Overall Study|change in health status|0|||
144239584|NCT01895608|520071805|FG001|Overall Study|change in health status|1|||
144239585|NCT01895608|520071806|FG002|Overall Study|change in health status|1|||
144239586|NCT01895608|520071807|FG003|Overall Study|change in health status|0|||
144239587|NCT01895608|520071804|FG000|Overall Study|Withdrawal by Subject|0|||
144239588|NCT01895608|520071805|FG001|Overall Study|Withdrawal by Subject|0|||
144239589|NCT01895608|520071806|FG002|Overall Study|Withdrawal by Subject|2|||
144239590|NCT01895608|520071807|FG003|Overall Study|Withdrawal by Subject|0|||
144239591|NCT03505593|520071808|FG000|Overall Study|Withdrawal by Subject|1|||
144239592|NCT03505593|520071808|FG000|Overall Study|Died before procedure|1|||
144239593|NCT03505593|520071808|FG000|Overall Study|Anatomical abnormality|1|||
144239594|NCT03505593|520071808|FG000|Overall Study|Unable to pass through esophagus|1|||
144239595|NCT03505593|520071808|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
144239596|NCT04143594|520071810|FG000|Overall Study|Withdrew consent|3|||
144239597|NCT04143594|520071811|FG001|Overall Study|Withdrew consent|10|||
144239598|NCT04143594|520071812|FG002|Overall Study|Withdrew consent|3|||
144239599|NCT04143594|520071813|FG003|Overall Study|Withdrew consent|1|||
144239600|NCT04143594|520071810|FG000|Overall Study|Lost to Follow-up|3|||
144239601|NCT04143594|520071811|FG001|Overall Study|Lost to Follow-up|5|||
144239602|NCT04143594|520071812|FG002|Overall Study|Lost to Follow-up|11|||
144239603|NCT04143594|520071813|FG003|Overall Study|Lost to Follow-up|0|||
144239604|NCT04143594|520071810|FG000|Overall Study|Investigator's discretion|2|||
144239605|NCT04143594|520071811|FG001|Overall Study|Investigator's discretion|2|||
144239606|NCT04143594|520071812|FG002|Overall Study|Investigator's discretion|0|||
144239607|NCT04143594|520071813|FG003|Overall Study|Investigator's discretion|0|||
144239608|NCT04143594|520071810|FG000|Overall Study|Randomized but never treated|0|||
144239609|NCT04143594|520071811|FG001|Overall Study|Randomized but never treated|0|||
144239610|NCT04143594|520071812|FG002|Overall Study|Randomized but never treated|0|||
144239611|NCT04143594|520071813|FG003|Overall Study|Randomized but never treated|1|||
144239612|NCT04143594|520071810|FG000|Overall Study|Death|1|||
144239613|NCT04143594|520071811|FG001|Overall Study|Death|0|||
144239614|NCT04143594|520071812|FG002|Overall Study|Death|1|||
144239615|NCT04143594|520071813|FG003|Overall Study|Death|0|||
144239616|NCT04143594|520071810|FG000|Overall Study|Adverse Event|1|||
144239617|NCT04143594|520071811|FG001|Overall Study|Adverse Event|0|||
144239618|NCT04143594|520071812|FG002|Overall Study|Adverse Event|0|||
144239619|NCT04143594|520071813|FG003|Overall Study|Adverse Event|0|||
144239620|NCT04143594|520071810|FG000|Overall Study|Pregnancy|0|||
144239621|NCT04143594|520071811|FG001|Overall Study|Pregnancy|0|||
144239622|NCT04143594|520071812|FG002|Overall Study|Pregnancy|1|||
144239623|NCT04143594|520071813|FG003|Overall Study|Pregnancy|0|||
144239624|NCT04143594|520071810|FG000|Overall Study|Lack of Efficacy|1|||
144239625|NCT04143594|520071811|FG001|Overall Study|Lack of Efficacy|1|||
144239626|NCT04143594|520071812|FG002|Overall Study|Lack of Efficacy|0|||
144239627|NCT04143594|520071813|FG003|Overall Study|Lack of Efficacy|0|||
144239628|NCT00373958|520071815|FG000|Infant Series|Withdrawal by Subject|13|||
144239629|NCT00373958|520071816|FG001|Infant Series|Withdrawal by Subject|15|||
144239630|NCT00373958|520071815|FG000|Infant Series|Failed to return|8|||
144239631|NCT00373958|520071816|FG001|Infant Series|Failed to return|13|||
144239632|NCT00373958|520071815|FG000|Infant Series|Lost to Follow-up|6|||
144239633|NCT00373958|520071816|FG001|Infant Series|Lost to Follow-up|5|||
144239634|NCT00373958|520071815|FG000|Infant Series|Protocol Violation|3|||
144239635|NCT00373958|520071816|FG001|Infant Series|Protocol Violation|7|||
144239636|NCT00373958|520071815|FG000|Infant Series|Lost Kaiser coverage|4|||
144239637|NCT00373958|520071816|FG001|Infant Series|Lost Kaiser coverage|0|||
144239638|NCT00373958|520071815|FG000|Infant Series|Child relocated|1|||
144239639|NCT00373958|520071816|FG001|Infant Series|Child relocated|0|||
144239640|NCT00373958|520071815|FG000|Infant Series|Consent was not received|1|||
144239641|NCT00373958|520071816|FG001|Infant Series|Consent was not received|0|||
144239642|NCT00373958|520071815|FG000|Infant Series|Adverse Event|3|||
144239643|NCT00373958|520071816|FG001|Infant Series|Adverse Event|1|||
144239644|NCT00373958|520071815|FG000|Infant Series|Physician Decision|1|||
144239645|NCT00373958|520071816|FG001|Infant Series|Physician Decision|1|||
144239646|NCT00373958|520071815|FG000|Toddler Dose|Lost to Follow-up|5|||
144239647|NCT00373958|520071816|FG001|Toddler Dose|Lost to Follow-up|8|||
144239648|NCT00373958|520071815|FG000|Toddler Dose|Withdrawal by Subject|2|||
144239649|NCT00373958|520071816|FG001|Toddler Dose|Withdrawal by Subject|2|||
144239650|NCT00373958|520071815|FG000|Toddler Dose|Failed to return|1|||
144239651|NCT00373958|520071816|FG001|Toddler Dose|Failed to return|2|||
144239652|NCT00373958|520071815|FG000|Toddler Dose|Protocol Violation|0|||
144239653|NCT00373958|520071816|FG001|Toddler Dose|Protocol Violation|1|||
144239654|NCT00373958|520071815|FG000|Toddler Dose|Withdrawn after infant series|22|||
144239655|NCT00373958|520071816|FG001|Toddler Dose|Withdrawn after infant series|25|||
144239656|NCT04240457|520071817|FG000|Overall Study|Lost to Follow-up|5|||
144239657|NCT04240457|520071818|FG001|Overall Study|Lost to Follow-up|1|||
144239658|NCT01820572|520071825|FG000|Randomization|Not Treated|2|||
144239659|NCT01820572|520071826|FG001|Randomization|Not Treated|1|||
144239660|NCT01820572|520071825|FG000|Treatment Period|Adverse Event|12|||
144239661|NCT01820572|520071826|FG001|Treatment Period|Adverse Event|7|||
144239662|NCT01820572|520071825|FG000|Treatment Period|Death|3|||
144239663|NCT01820572|520071826|FG001|Treatment Period|Death|3|||
144239664|NCT01820572|520071825|FG000|Treatment Period|Lack of Efficacy|1|||
144239665|NCT01820572|520071826|FG001|Treatment Period|Lack of Efficacy|0|||
144239666|NCT01820572|520071825|FG000|Treatment Period|poor/non compliance|0|||
144239667|NCT01820572|520071826|FG001|Treatment Period|poor/non compliance|3|||
144239668|NCT01820572|520071825|FG000|Treatment Period|request to discontinue|6|||
144239669|NCT01820572|520071826|FG001|Treatment Period|request to discontinue|11|||
144239670|NCT01820572|520071825|FG000|Treatment Period|No longer meets study criteria|3|||
144239671|NCT01820572|520071826|FG001|Treatment Period|No longer meets study criteria|10|||
144239672|NCT01820572|520071825|FG000|Treatment Period|withdrew consent|1|||
144239673|NCT01820572|520071826|FG001|Treatment Period|withdrew consent|2|||
144239674|NCT03634033|520074105|FG000|Overall Study|Did not have a post-assessment|384|||
144239675|NCT03634033|520074106|FG001|Overall Study|Did not have a post-assessment|291|||
144239676|NCT03634033|520074107|FG002|Overall Study|Did not have a post-assessment|114|||
144239677|NCT03634033|520074108|FG003|Overall Study|Did not have a post-assessment|161|||
144239678|NCT03634033|520074109|FG004|Overall Study|Did not have a post-assessment|5|||
144239679|NCT03634033|520074110|FG005|Overall Study|Did not have a post-assessment|0|||
144239680|NCT03634033|520074111|FG006|Overall Study|Did not have a post-assessment|0|||
144239681|NCT03634033|520074105|FG000|Overall Study|Death|0|||
144239682|NCT03634033|520074106|FG001|Overall Study|Death|0|||
144239683|NCT03634033|520074107|FG002|Overall Study|Death|0|||
144239684|NCT03634033|520074108|FG003|Overall Study|Death|0|||
144239685|NCT03634033|520074109|FG004|Overall Study|Death|0|||
144239686|NCT03634033|520074110|FG005|Overall Study|Death|7|||
144239687|NCT03634033|520074111|FG006|Overall Study|Death|7|||
144239688|NCT03634033|520074105|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
144239689|NCT03634033|520074106|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
144239690|NCT03634033|520074107|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
144239691|NCT03634033|520074108|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
144239692|NCT03634033|520074109|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
144239693|NCT03634033|520074110|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
144239694|NCT03634033|520074111|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
144239695|NCT03634033|520074105|FG000|Overall Study|Lost to Follow-up|0|||
144239696|NCT03634033|520074106|FG001|Overall Study|Lost to Follow-up|0|||
144239697|NCT03634033|520074107|FG002|Overall Study|Lost to Follow-up|0|||
144239698|NCT03634033|520074108|FG003|Overall Study|Lost to Follow-up|0|||
144239699|NCT03634033|520074109|FG004|Overall Study|Lost to Follow-up|0|||
144239700|NCT03634033|520074110|FG005|Overall Study|Lost to Follow-up|1|||
144239701|NCT03634033|520074111|FG006|Overall Study|Lost to Follow-up|2|||
144239702|NCT03634033|520074105|FG000|Overall Study|Withdrawal by Subject|0|||
144239703|NCT03634033|520074106|FG001|Overall Study|Withdrawal by Subject|0|||
144239704|NCT03634033|520074107|FG002|Overall Study|Withdrawal by Subject|0|||
144239705|NCT03634033|520074108|FG003|Overall Study|Withdrawal by Subject|0|||
144239706|NCT03634033|520074109|FG004|Overall Study|Withdrawal by Subject|0|||
144239707|NCT03634033|520074110|FG005|Overall Study|Withdrawal by Subject|0|||
144239708|NCT03634033|520074111|FG006|Overall Study|Withdrawal by Subject|1|||
144239709|NCT06366087|520074112|FG000|Overall Study|Withdrawal by Subject|0|||
144239710|NCT06366087|520074113|FG001|Overall Study|Withdrawal by Subject|1|||
144239711|NCT00860249|520074119|FG000|Overall Study|trial was terminated prior to completion|21|||
144239712|NCT00860249|520074120|FG001|Overall Study|trial was terminated prior to completion|18|||
144239713|NCT00860249|520074121|FG002|Overall Study|trial was terminated prior to completion|21|||
144239714|NCT00743288|520074122|FG000|Overall Study|Adverse Event|1|||
144239715|NCT00743288|520074123|FG001|Overall Study|Adverse Event|1|||
144239716|NCT00743288|520074124|FG002|Overall Study|Adverse Event|2|||
144239717|NCT00743288|520074125|FG003|Overall Study|Adverse Event|2|||
144239718|NCT00743288|520074126|FG004|Overall Study|Adverse Event|1|||
144239719|NCT00743288|520074127|FG005|Overall Study|Adverse Event|1|||
144239720|NCT00743288|520074128|FG006|Overall Study|Adverse Event|2|||
144239721|NCT00743288|520074122|FG000|Overall Study|Withdrawal by Subject|0|||
144239722|NCT00743288|520074123|FG001|Overall Study|Withdrawal by Subject|0|||
144239723|NCT00743288|520074124|FG002|Overall Study|Withdrawal by Subject|1|||
144239724|NCT00743288|520074125|FG003|Overall Study|Withdrawal by Subject|0|||
144239725|NCT00743288|520074126|FG004|Overall Study|Withdrawal by Subject|0|||
144239726|NCT00743288|520074127|FG005|Overall Study|Withdrawal by Subject|1|||
144239727|NCT00743288|520074128|FG006|Overall Study|Withdrawal by Subject|1|||
144239728|NCT00743288|520074122|FG000|Overall Study|Progressive disease (PD)|2|||
144239729|NCT00743288|520074123|FG001|Overall Study|Progressive disease (PD)|0|||
144239730|NCT00743288|520074124|FG002|Overall Study|Progressive disease (PD)|1|||
144239731|NCT00743288|520074125|FG003|Overall Study|Progressive disease (PD)|4|||
144239732|NCT00743288|520074126|FG004|Overall Study|Progressive disease (PD)|5|||
144239733|NCT00743288|520074127|FG005|Overall Study|Progressive disease (PD)|3|||
144239734|NCT00743288|520074128|FG006|Overall Study|Progressive disease (PD)|6|||
144239735|NCT00743288|520074122|FG000|Overall Study|Worsening of condition (Not PD)|0|||
144239736|NCT00743288|520074123|FG001|Overall Study|Worsening of condition (Not PD)|2|||
144239737|NCT00743288|520074124|FG002|Overall Study|Worsening of condition (Not PD)|1|||
144239738|NCT00743288|520074125|FG003|Overall Study|Worsening of condition (Not PD)|1|||
144239739|NCT00743288|520074126|FG004|Overall Study|Worsening of condition (Not PD)|0|||
144239740|NCT00743288|520074127|FG005|Overall Study|Worsening of condition (Not PD)|0|||
144239741|NCT00743288|520074128|FG006|Overall Study|Worsening of condition (Not PD)|0|||
144239742|NCT05903924|520074129|FG000|Overall Study|Lost to Follow-up|1|||
144239743|NCT05903924|520074130|FG001|Overall Study|Lost to Follow-up|0|||
144239744|NCT05903924|520074131|FG002|Overall Study|Lost to Follow-up|0|||
144239745|NCT02706886|520074140|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
144239746|NCT02706886|520074141|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
144239747|NCT02706886|520074142|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
144239748|NCT02706886|520074143|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
144239749|NCT02706886|520074144|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
144239750|NCT02706886|520074145|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
144239751|NCT02706886|520074146|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
144239752|NCT02706886|520074147|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
144239753|NCT02706886|520074148|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
144239754|NCT02759055|520074149|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
144239755|NCT02759055|520074150|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
144239756|NCT04934189|520074151|FG000|Overall Study|Lost to Follow-up|4|||
144239757|NCT04934189|520074151|FG000|Overall Study|Withdrawal by Subject|17|||
144239758|NCT02487771|520074158|FG000|Overall Study|Lost to Follow-up|2|||
144239759|NCT02487771|520074159|FG001|Overall Study|Lost to Follow-up|3|||
144239760|NCT02487771|520074158|FG000|Overall Study|Moved out of area|5|||
144239761|NCT02487771|520074159|FG001|Overall Study|Moved out of area|6|||
144239762|NCT02487771|520074158|FG000|Overall Study|Withdrawal by Subject|3|||
144239763|NCT02487771|520074159|FG001|Overall Study|Withdrawal by Subject|5|||
144239764|NCT01871402|520074166|FG000|Overall Study|Lost to Follow-up|1|||
144239765|NCT01871402|520074167|FG001|Overall Study|Lost to Follow-up|0|||
144239766|NCT01871402|520074166|FG000|Overall Study|Withdrawal by Subject|0|||
144239767|NCT01871402|520074167|FG001|Overall Study|Withdrawal by Subject|2|||
144239768|NCT01871402|520074166|FG000|Overall Study|Non-compliance|0|||
144239769|NCT01871402|520074167|FG001|Overall Study|Non-compliance|1|||
144239770|NCT04594941|520074168|FG000|Overall Study|Other|0|||
144239771|NCT04594941|520074169|FG001|Overall Study|Other|3|||
144239772|NCT04594941|520074170|FG002|Overall Study|Other|1|||
144239773|NCT04594941|520074171|FG003|Overall Study|Other|0|||
144239774|NCT01895270|520074174|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
144239775|NCT01895270|520074175|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
144239776|NCT01895270|520074174|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
144239777|NCT01895270|520074175|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
144239778|NCT01895270|520074174|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
144239779|NCT01895270|520074175|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
144239780|NCT01895270|520074174|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
144239781|NCT01895270|520074175|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
144239782|NCT01895270|520074174|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
144239783|NCT01895270|520074175|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
144239784|NCT01895270|520074174|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
144239785|NCT01895270|520074175|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
144239786|NCT01895270|520074174|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
144270013|NCT02003144|520191480|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
144239787|NCT01895270|520074175|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
144239788|NCT02091375|520074176|FG000|Overall Study|Adverse Event|8|||
144239789|NCT02091375|520074177|FG001|Overall Study|Adverse Event|1|||
144239790|NCT02091375|520074176|FG000|Overall Study|Lost to Follow-up|0|||
144239791|NCT02091375|520074177|FG001|Overall Study|Lost to Follow-up|1|||
144239792|NCT02091375|520074176|FG000|Overall Study|Withdrawal by Subject|0|||
144239793|NCT02091375|520074177|FG001|Overall Study|Withdrawal by Subject|1|||
144239794|NCT02091375|520074176|FG000|Overall Study|Withdrawn by the investigator|1|||
144239795|NCT02091375|520074177|FG001|Overall Study|Withdrawn by the investigator|0|||
144239796|NCT02682823|520074178|FG000|Overall Study|Withdrawal by Subject|0|||
144239797|NCT02682823|520074179|FG001|Overall Study|Withdrawal by Subject|0|||
144239798|NCT02682823|520074180|FG002|Overall Study|Withdrawal by Subject|1|||
144239799|NCT02682823|520074181|FG003|Overall Study|Withdrawal by Subject|0|||
144239800|NCT02682823|520074182|FG004|Overall Study|Withdrawal by Subject|1|||
144239801|NCT02682823|520074178|FG000|Overall Study|Protocol Deviation|0|||
144239802|NCT02682823|520074179|FG001|Overall Study|Protocol Deviation|1|||
144239803|NCT02682823|520074180|FG002|Overall Study|Protocol Deviation|0|||
144239804|NCT02682823|520074181|FG003|Overall Study|Protocol Deviation|0|||
144239805|NCT02682823|520074182|FG004|Overall Study|Protocol Deviation|0|||
144239806|NCT02682823|520074178|FG000|Overall Study|Adverse Event|0|||
144239807|NCT02682823|520074179|FG001|Overall Study|Adverse Event|0|||
144239808|NCT02682823|520074180|FG002|Overall Study|Adverse Event|0|||
144239809|NCT02682823|520074181|FG003|Overall Study|Adverse Event|1|||
144239810|NCT02682823|520074182|FG004|Overall Study|Adverse Event|0|||
144239811|NCT03781583|520074183|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
144239812|NCT03781583|520074184|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
144239813|NCT03781583|520074185|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
144239814|NCT03781583|520074186|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
144239815|NCT03781583|520074183|FG000|Overall Study|Technology did not work for that person in that environment|1|||
144239816|NCT03781583|520074184|FG001|Overall Study|Technology did not work for that person in that environment|0|||
144239817|NCT03781583|520074185|FG002|Overall Study|Technology did not work for that person in that environment|0|||
144239818|NCT03781583|520074186|FG003|Overall Study|Technology did not work for that person in that environment|0|||
144239819|NCT03781583|520074183|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
144239820|NCT03781583|520074184|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
144239821|NCT03781583|520074185|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
144239822|NCT03781583|520074186|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
144239823|NCT03781583|520074183|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
144239824|NCT03781583|520074184|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
144239825|NCT03781583|520074185|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
144239826|NCT03781583|520074186|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
144239827|NCT01938430|520074187|FG000|Overall Study|Randomized but Not Treated|0|||
144239828|NCT01938430|520074188|FG001|Overall Study|Randomized but Not Treated|0|||
144239829|NCT01938430|520074189|FG002|Overall Study|Randomized but Not Treated|0|||
144239830|NCT01938430|520074190|FG003|Overall Study|Randomized but Not Treated|0|||
144239831|NCT01938430|520074191|FG004|Overall Study|Randomized but Not Treated|0|||
144239832|NCT01938430|520074192|FG005|Overall Study|Randomized but Not Treated|0|||
144239833|NCT01938430|520074193|FG006|Overall Study|Randomized but Not Treated|0|||
144239834|NCT01938430|520074194|FG007|Overall Study|Randomized but Not Treated|0|||
144239835|NCT01938430|520074195|FG008|Overall Study|Randomized but Not Treated|0|||
144239836|NCT01938430|520074196|FG009|Overall Study|Randomized but Not Treated|0|||
144239837|NCT01938430|520074197|FG010|Overall Study|Randomized but Not Treated|1|||
144239838|NCT01938430|520074198|FG011|Overall Study|Randomized but Not Treated|0|||
144239839|NCT01938430|520074199|FG012|Overall Study|Randomized but Not Treated|0|||
144239840|NCT01938430|520074200|FG013|Overall Study|Randomized but Not Treated|1|||
144239841|NCT01938430|520074187|FG000|Overall Study|Adverse Event|0|||
144239842|NCT01938430|520074188|FG001|Overall Study|Adverse Event|0|||
144239843|NCT01938430|520074189|FG002|Overall Study|Adverse Event|0|||
144239844|NCT01938430|520074190|FG003|Overall Study|Adverse Event|0|||
144239845|NCT01938430|520074191|FG004|Overall Study|Adverse Event|0|||
144239846|NCT01938430|520074192|FG005|Overall Study|Adverse Event|0|||
144239847|NCT01938430|520074193|FG006|Overall Study|Adverse Event|1|||
144239848|NCT01938430|520074194|FG007|Overall Study|Adverse Event|0|||
144239849|NCT01938430|520074195|FG008|Overall Study|Adverse Event|0|||
144239850|NCT01938430|520074196|FG009|Overall Study|Adverse Event|0|||
144239851|NCT01938430|520074197|FG010|Overall Study|Adverse Event|0|||
144239852|NCT01938430|520074198|FG011|Overall Study|Adverse Event|0|||
144239853|NCT01938430|520074199|FG012|Overall Study|Adverse Event|0|||
144239854|NCT01938430|520074200|FG013|Overall Study|Adverse Event|0|||
144239855|NCT01938430|520074187|FG000|Overall Study|Death|1|||
144239856|NCT01938430|520074188|FG001|Overall Study|Death|2|||
144239857|NCT01938430|520074189|FG002|Overall Study|Death|2|||
144239858|NCT01938430|520074190|FG003|Overall Study|Death|1|||
144239859|NCT01938430|520074191|FG004|Overall Study|Death|0|||
144239860|NCT01938430|520074192|FG005|Overall Study|Death|0|||
144239861|NCT01938430|520074193|FG006|Overall Study|Death|1|||
144239862|NCT01938430|520074194|FG007|Overall Study|Death|1|||
144239863|NCT01938430|520074195|FG008|Overall Study|Death|2|||
144239864|NCT01938430|520074196|FG009|Overall Study|Death|3|||
144239865|NCT01938430|520074197|FG010|Overall Study|Death|0|||
144239866|NCT01938430|520074198|FG011|Overall Study|Death|0|||
144239867|NCT01938430|520074199|FG012|Overall Study|Death|0|||
144239868|NCT01938430|520074200|FG013|Overall Study|Death|0|||
144239869|NCT01938430|520074187|FG000|Overall Study|Investigator's Discretion|0|||
144239870|NCT01938430|520074188|FG001|Overall Study|Investigator's Discretion|0|||
144239871|NCT01938430|520074189|FG002|Overall Study|Investigator's Discretion|1|||
144239872|NCT01938430|520074190|FG003|Overall Study|Investigator's Discretion|0|||
144239873|NCT01938430|520074191|FG004|Overall Study|Investigator's Discretion|0|||
144239874|NCT01938430|520074192|FG005|Overall Study|Investigator's Discretion|0|||
144239875|NCT01938430|520074193|FG006|Overall Study|Investigator's Discretion|0|||
144239876|NCT01938430|520074194|FG007|Overall Study|Investigator's Discretion|0|||
144239877|NCT01938430|520074195|FG008|Overall Study|Investigator's Discretion|0|||
144239878|NCT01938430|520074196|FG009|Overall Study|Investigator's Discretion|0|||
144239879|NCT01938430|520074197|FG010|Overall Study|Investigator's Discretion|0|||
144239880|NCT01938430|520074198|FG011|Overall Study|Investigator's Discretion|0|||
144239881|NCT01938430|520074199|FG012|Overall Study|Investigator's Discretion|0|||
144239882|NCT01938430|520074200|FG013|Overall Study|Investigator's Discretion|0|||
144239883|NCT01938430|520074187|FG000|Overall Study|Lack of Efficacy|3|||
144239884|NCT01938430|520074188|FG001|Overall Study|Lack of Efficacy|1|||
144239885|NCT01938430|520074189|FG002|Overall Study|Lack of Efficacy|1|||
144239886|NCT01938430|520074190|FG003|Overall Study|Lack of Efficacy|1|||
144239887|NCT01938430|520074191|FG004|Overall Study|Lack of Efficacy|0|||
144239888|NCT01938430|520074192|FG005|Overall Study|Lack of Efficacy|0|||
144239889|NCT01938430|520074193|FG006|Overall Study|Lack of Efficacy|0|||
144239890|NCT01938430|520074194|FG007|Overall Study|Lack of Efficacy|0|||
144239891|NCT01938430|520074195|FG008|Overall Study|Lack of Efficacy|1|||
144239892|NCT01938430|520074196|FG009|Overall Study|Lack of Efficacy|0|||
144239893|NCT01938430|520074197|FG010|Overall Study|Lack of Efficacy|2|||
144239894|NCT01938430|520074198|FG011|Overall Study|Lack of Efficacy|1|||
144239895|NCT01938430|520074199|FG012|Overall Study|Lack of Efficacy|0|||
144239896|NCT01938430|520074200|FG013|Overall Study|Lack of Efficacy|0|||
144239897|NCT01938430|520074187|FG000|Overall Study|Lost to Follow-up|0|||
144239898|NCT01938430|520074188|FG001|Overall Study|Lost to Follow-up|0|||
144239899|NCT01938430|520074189|FG002|Overall Study|Lost to Follow-up|1|||
144239900|NCT01938430|520074190|FG003|Overall Study|Lost to Follow-up|0|||
144239901|NCT01938430|520074191|FG004|Overall Study|Lost to Follow-up|0|||
144239902|NCT01938430|520074192|FG005|Overall Study|Lost to Follow-up|1|||
144239903|NCT01938430|520074193|FG006|Overall Study|Lost to Follow-up|0|||
144239904|NCT01938430|520074194|FG007|Overall Study|Lost to Follow-up|0|||
144239905|NCT01938430|520074195|FG008|Overall Study|Lost to Follow-up|0|||
144239906|NCT01938430|520074196|FG009|Overall Study|Lost to Follow-up|0|||
144239907|NCT01938430|520074197|FG010|Overall Study|Lost to Follow-up|0|||
144239908|NCT01938430|520074198|FG011|Overall Study|Lost to Follow-up|0|||
144239909|NCT01938430|520074199|FG012|Overall Study|Lost to Follow-up|0|||
144239910|NCT01938430|520074200|FG013|Overall Study|Lost to Follow-up|0|||
144239911|NCT01938430|520074187|FG000|Overall Study|Withdrew Consent|0|||
144239912|NCT01938430|520074188|FG001|Overall Study|Withdrew Consent|0|||
144239913|NCT01938430|520074189|FG002|Overall Study|Withdrew Consent|0|||
144239914|NCT01938430|520074190|FG003|Overall Study|Withdrew Consent|0|||
144239915|NCT01938430|520074191|FG004|Overall Study|Withdrew Consent|0|||
144239916|NCT01938430|520074192|FG005|Overall Study|Withdrew Consent|0|||
144239917|NCT01938430|520074193|FG006|Overall Study|Withdrew Consent|0|||
144239918|NCT01938430|520074194|FG007|Overall Study|Withdrew Consent|0|||
144239919|NCT01938430|520074195|FG008|Overall Study|Withdrew Consent|1|||
144239920|NCT01938430|520074196|FG009|Overall Study|Withdrew Consent|0|||
144239921|NCT01938430|520074197|FG010|Overall Study|Withdrew Consent|0|||
144239922|NCT01938430|520074198|FG011|Overall Study|Withdrew Consent|0|||
144239923|NCT01938430|520074199|FG012|Overall Study|Withdrew Consent|0|||
144239924|NCT01938430|520074200|FG013|Overall Study|Withdrew Consent|0|||
144239925|NCT03875482|520074201|FG000|Overall Study|Adverse Event|0|||
144239926|NCT03875482|520074202|FG001|Overall Study|Adverse Event|1|||
144239927|NCT03875482|520074201|FG000|Overall Study|Withdrew consent|5|||
144239928|NCT03875482|520074202|FG001|Overall Study|Withdrew consent|6|||
144239929|NCT03875482|520074201|FG000|Overall Study|Lost to Follow-up|8|||
144239930|NCT03875482|520074202|FG001|Overall Study|Lost to Follow-up|2|||
144239931|NCT03875482|520074201|FG000|Overall Study|Lack of Efficacy|0|||
144239932|NCT03875482|520074202|FG001|Overall Study|Lack of Efficacy|11|||
144239933|NCT02045862|520074203|FG000|Overall Study|Death|0|||
144239934|NCT02045862|520074204|FG001|Overall Study|Death|0|||
144239935|NCT02045862|520074205|FG002|Overall Study|Death|1|||
144239936|NCT02045862|520074203|FG000|Overall Study|Miscellaneous|5|||
144239937|NCT02045862|520074204|FG001|Overall Study|Miscellaneous|0|||
144239938|NCT02045862|520074205|FG002|Overall Study|Miscellaneous|8|||
144239939|NCT02045862|520074203|FG000|Overall Study|Withdrawal by Patient|18|||
144239940|NCT02045862|520074204|FG001|Overall Study|Withdrawal by Patient|27|||
144239941|NCT02045862|520074205|FG002|Overall Study|Withdrawal by Patient|57|||
144239942|NCT02045862|520074203|FG000|Overall Study|Protocol Violation|0|||
144239943|NCT02045862|520074204|FG001|Overall Study|Protocol Violation|0|||
144239944|NCT02045862|520074205|FG002|Overall Study|Protocol Violation|6|||
144239945|NCT02045862|520074203|FG000|Overall Study|Lack of Efficacy|8|||
144239946|NCT02045862|520074204|FG001|Overall Study|Lack of Efficacy|4|||
144239947|NCT02045862|520074205|FG002|Overall Study|Lack of Efficacy|13|||
144239948|NCT02045862|520074203|FG000|Overall Study|Randomized but not Received Study Drug|0|||
144239949|NCT02045862|520074204|FG001|Overall Study|Randomized but not Received Study Drug|2|||
144239950|NCT02045862|520074205|FG002|Overall Study|Randomized but not Received Study Drug|8|||
144239951|NCT02045862|520074203|FG000|Overall Study|Adverse Event|7|||
144239952|NCT02045862|520074204|FG001|Overall Study|Adverse Event|5|||
144239953|NCT02045862|520074205|FG002|Overall Study|Adverse Event|27|||
144239954|NCT02045862|520074203|FG000|Overall Study|Lost to Follow-up|1|||
144239955|NCT02045862|520074204|FG001|Overall Study|Lost to Follow-up|2|||
144239956|NCT02045862|520074205|FG002|Overall Study|Lost to Follow-up|6|||
144239957|NCT00623935|520074206|FG000|Overall Study|Death|1|||
144239958|NCT00623935|520074206|FG000|Overall Study|Patient Declined Transplant|1|||
144239959|NCT04507256|520074207|FG000|Overall Study|Withdrawal by Subject|1|||
144239960|NCT04507256|520074208|FG001|Overall Study|Withdrawal by Subject|0|||
144239961|NCT04507256|520074209|FG002|Overall Study|Withdrawal by Subject|0|||
144239962|NCT04507256|520074210|FG003|Overall Study|Withdrawal by Subject|1|||
144239963|NCT04507256|520074211|FG004|Overall Study|Withdrawal by Subject|0|||
144239964|NCT04507256|520074212|FG005|Overall Study|Withdrawal by Subject|0|||
144239965|NCT00631410|520074219|FG000|Overall Study|Adverse Event|1|||
144239966|NCT00631410|520074220|FG001|Overall Study|Adverse Event|3|||
144239967|NCT00631410|520074219|FG000|Overall Study|Objective Progression or Relapse|4|||
144239968|NCT00631410|520074220|FG001|Overall Study|Objective Progression or Relapse|3|||
144239969|NCT00631410|520074219|FG000|Overall Study|Surgery|1|||
144239970|NCT00631410|520074220|FG001|Overall Study|Surgery|0|||
144239971|NCT00782184|520074227|FG000|Overall Study|Adverse Event|1|||
144239972|NCT00782184|520074228|FG001|Overall Study|Adverse Event|2|||
144239973|NCT00782184|520074227|FG000|Overall Study|Protocol Violation|0|||
144239974|NCT00782184|520074228|FG001|Overall Study|Protocol Violation|1|||
144239975|NCT00782184|520074227|FG000|Overall Study|Withdrawal by Subject|3|||
144239976|NCT00782184|520074228|FG001|Overall Study|Withdrawal by Subject|2|||
144239977|NCT00890084|520074229|FG000|Overall Study|Adverse Event|16|||
144239978|NCT00890084|520074229|FG000|Overall Study|Lost to Follow-up|126|||
144239979|NCT01023256|520074238|FG000|Overall Study|Protocol Violation|2|||
144239980|NCT01023256|520074239|FG001|Overall Study|Protocol Violation|3|||
144239981|NCT01023256|520074240|FG002|Overall Study|Protocol Violation|0|||
144239982|NCT01023256|520074241|FG003|Overall Study|Protocol Violation|0|||
144239983|NCT01023256|520074238|FG000|Overall Study|Randomized but not treated|1|||
144239984|NCT01023256|520074239|FG001|Overall Study|Randomized but not treated|0|||
144239985|NCT01023256|520074240|FG002|Overall Study|Randomized but not treated|1|||
144239986|NCT01023256|520074241|FG003|Overall Study|Randomized but not treated|0|||
144239987|NCT01023256|520074238|FG000|Overall Study|Other|1|||
144239988|NCT01023256|520074239|FG001|Overall Study|Other|0|||
144239989|NCT01023256|520074240|FG002|Overall Study|Other|0|||
144239990|NCT01023256|520074241|FG003|Overall Study|Other|2|||
144239991|NCT01023256|520074238|FG000|Overall Study|Adverse Event|0|||
144239992|NCT01023256|520074239|FG001|Overall Study|Adverse Event|0|||
144239993|NCT01023256|520074240|FG002|Overall Study|Adverse Event|0|||
144239994|NCT01023256|520074241|FG003|Overall Study|Adverse Event|1|||
144239995|NCT01023256|520074238|FG000|Overall Study|Withdrawal by Subject|0|||
144239996|NCT01023256|520074239|FG001|Overall Study|Withdrawal by Subject|0|||
144239997|NCT01023256|520074240|FG002|Overall Study|Withdrawal by Subject|0|||
144239998|NCT01023256|520074241|FG003|Overall Study|Withdrawal by Subject|2|||
144239999|NCT03155178|520074242|FG000|Overall Study|Did not meet treatment day baseline|7|||
144240000|NCT03155178|520074243|FG001|Overall Study|Did not meet treatment day baseline|7|||
144240001|NCT03155178|520074244|FG002|Overall Study|Did not meet treatment day baseline|7|||
144240002|NCT03155178|520074245|FG003|Overall Study|Did not meet treatment day baseline|7|||
144240003|NCT04323306|520074246|FG000|Overall Study|Physician Decision|1|||
144240004|NCT04323306|520074247|FG001|Overall Study|Physician Decision|0|||
144240005|NCT04323306|520074248|FG002|Overall Study|Physician Decision|0|||
144240006|NCT04323306|520074249|FG003|Overall Study|Physician Decision|0|||
144240007|NCT04323306|520074250|FG004|Overall Study|Physician Decision|0|||
144240008|NCT04323306|520074251|FG005|Overall Study|Physician Decision|0|||
144240009|NCT04323306|520074252|FG006|Overall Study|Physician Decision|0|||
144240010|NCT04323306|520074253|FG007|Overall Study|Physician Decision|0|||
144240011|NCT04323306|520074254|FG008|Overall Study|Physician Decision|0|||
144240012|NCT04323306|520074246|FG000|Overall Study|Withdrawal by Subject|0|||
144240013|NCT04323306|520074247|FG001|Overall Study|Withdrawal by Subject|0|||
144240014|NCT04323306|520074248|FG002|Overall Study|Withdrawal by Subject|0|||
144240015|NCT04323306|520074249|FG003|Overall Study|Withdrawal by Subject|0|||
144240016|NCT04323306|520074250|FG004|Overall Study|Withdrawal by Subject|0|||
144240017|NCT04323306|520074251|FG005|Overall Study|Withdrawal by Subject|1|||
144240018|NCT04323306|520074252|FG006|Overall Study|Withdrawal by Subject|3|||
144240019|NCT04323306|520074253|FG007|Overall Study|Withdrawal by Subject|0|||
144240020|NCT04323306|520074254|FG008|Overall Study|Withdrawal by Subject|1|||
144240021|NCT01646021|520074255|FG000|Overall Study|Death|77|||
144240022|NCT01646021|520074256|FG001|Overall Study|Death|83|||
144240023|NCT01646021|520074255|FG000|Overall Study|Study Terminated by Sponsor|50|||
144240024|NCT01646021|520074256|FG001|Overall Study|Study Terminated by Sponsor|41|||
144240025|NCT01646021|520074255|FG000|Overall Study|Lost to Follow-up|2|||
144240026|NCT01646021|520074256|FG001|Overall Study|Lost to Follow-up|2|||
144240027|NCT01646021|520074255|FG000|Overall Study|Withdrawal by Subject|10|||
144240028|NCT01646021|520074256|FG001|Overall Study|Withdrawal by Subject|15|||
144240029|NCT05129137|520074259|FG000|Second Period|Adverse Event|1|||
144240030|NCT05129137|520074260|FG001|Second Period|Adverse Event|0|||
144240031|NCT05129137|520074261|FG002|Second Period|Adverse Event|0|||
144240032|NCT05129137|520074262|FG003|Second Period|Adverse Event|0|||
144240033|NCT05129137|520074259|FG000|Second Period|Protocol Violation|0|||
144240034|NCT05129137|520074260|FG001|Second Period|Protocol Violation|0|||
144240035|NCT05129137|520074261|FG002|Second Period|Protocol Violation|0|||
144240036|NCT05129137|520074262|FG003|Second Period|Protocol Violation|1|||
144240037|NCT05129137|520074259|FG000|Third Period|Protocol Violation|0|||
144240038|NCT05129137|520074260|FG001|Third Period|Protocol Violation|0|||
144240039|NCT05129137|520074261|FG002|Third Period|Protocol Violation|0|||
144240040|NCT05129137|520074262|FG003|Third Period|Protocol Violation|1|||
144240041|NCT05129137|520074259|FG000|Forth Period|Protocol Violation|0|||
144240042|NCT05129137|520074260|FG001|Forth Period|Protocol Violation|1|||
144240043|NCT05129137|520074261|FG002|Forth Period|Protocol Violation|0|||
144240044|NCT05129137|520074262|FG003|Forth Period|Protocol Violation|0|||
144240045|NCT05129137|520074259|FG000|Forth Period|Withdrawal by Subject|0|||
144240046|NCT05129137|520074260|FG001|Forth Period|Withdrawal by Subject|0|||
144240047|NCT05129137|520074261|FG002|Forth Period|Withdrawal by Subject|1|||
144240048|NCT05129137|520074262|FG003|Forth Period|Withdrawal by Subject|0|||
144240049|NCT01869699|520074263|FG000|Overall Study|Withdrawal by Subject|1|||
144240050|NCT01869699|520074264|FG001|Overall Study|Withdrawal by Subject|0|||
144240051|NCT01475851|520074267|FG000|Overall Study|Protocol defined stopping criteria|1|||
144240052|NCT01475851|520074268|FG001|Overall Study|Protocol defined stopping criteria|0|||
144240053|NCT02447497|520074271|FG000|Overall Study|Did not meet treatment day baseline.|6|||
144240054|NCT02447497|520074272|FG001|Overall Study|Did not meet treatment day baseline.|5|||
144240055|NCT02447497|520074273|FG002|Overall Study|Did not meet treatment day baseline.|2|||
144240056|NCT02447497|520074274|FG003|Overall Study|Did not meet treatment day baseline.|2|||
144240057|NCT02447497|520074271|FG000|Overall Study|Dressing was compromised|0|||
144240058|NCT02447497|520074272|FG001|Overall Study|Dressing was compromised|1|||
144240059|NCT02447497|520074273|FG002|Overall Study|Dressing was compromised|0|||
144240060|NCT02447497|520074274|FG003|Overall Study|Dressing was compromised|0|||
144240061|NCT01322035|520074275|FG000|Overall Study|Lost to Follow-up|8|||
144240062|NCT01322035|520074276|FG001|Overall Study|Lost to Follow-up|3|||
144240063|NCT00727844|520074277|FG000|Initial Randomization|Physician Decision|2|||
144240064|NCT00727844|520074278|FG001|Initial Randomization|Physician Decision|0|||
144240065|NCT00727844|520074279|FG002|Initial Randomization|Physician Decision|0|||
144240066|NCT00727844|520074280|FG003|Initial Randomization|Physician Decision|0|||
144240067|NCT00732758|520074281|FG000|Overall Study|Lost to Follow-up|8|||
144240068|NCT00732758|520074282|FG001|Overall Study|Lost to Follow-up|16|||
144240069|NCT01552915|520074283|FG000|Overall Study|Adverse Event|3|||
144240070|NCT01552915|520074284|FG001|Overall Study|Adverse Event|14|||
144240071|NCT01552915|520074285|FG002|Overall Study|Adverse Event|3|||
144240072|NCT01552915|520074283|FG000|Overall Study|Lost to Follow-up|4|||
144240073|NCT01552915|520074284|FG001|Overall Study|Lost to Follow-up|6|||
144240074|NCT01552915|520074285|FG002|Overall Study|Lost to Follow-up|5|||
144240075|NCT01552915|520074283|FG000|Overall Study|Withdrawal by Subject|6|||
144240076|NCT01552915|520074284|FG001|Overall Study|Withdrawal by Subject|4|||
144240077|NCT01552915|520074285|FG002|Overall Study|Withdrawal by Subject|5|||
144240078|NCT01552915|520074283|FG000|Overall Study|Protocol Violation|0|||
144240079|NCT01552915|520074284|FG001|Overall Study|Protocol Violation|4|||
144240080|NCT01552915|520074285|FG002|Overall Study|Protocol Violation|4|||
144240081|NCT01552915|520074283|FG000|Overall Study|Lack of Efficacy|8|||
144240082|NCT01552915|520074284|FG001|Overall Study|Lack of Efficacy|1|||
144240083|NCT01552915|520074285|FG002|Overall Study|Lack of Efficacy|4|||
144240084|NCT01552915|520074283|FG000|Overall Study|Other|2|||
144240085|NCT01552915|520074284|FG001|Overall Study|Other|0|||
144240086|NCT01552915|520074285|FG002|Overall Study|Other|6|||
144240087|NCT02858180|520074292|FG000|Overall Study|Lost to Follow-up|0|||
144240088|NCT02858180|520074293|FG001|Overall Study|Lost to Follow-up|2|||
144240089|NCT00844480|520074294|FG000|Overall Study|Withdrawal by Subject|2|||
144240090|NCT00844480|520074295|FG001|Overall Study|Withdrawal by Subject|3|||
144240091|NCT00979420|520074296|FG000|Overall Study|Adverse Event|1|||
144240092|NCT00979420|520074297|FG001|Overall Study|Adverse Event|0|||
144240093|NCT00979420|520074298|FG002|Overall Study|Adverse Event|0|||
144240094|NCT00979420|520074299|FG003|Overall Study|Adverse Event|0|||
144240095|NCT00979420|520074296|FG000|Overall Study|Lack of Efficacy|3|||
144240096|NCT00979420|520074297|FG001|Overall Study|Lack of Efficacy|0|||
144240097|NCT00979420|520074298|FG002|Overall Study|Lack of Efficacy|1|||
144240098|NCT00979420|520074299|FG003|Overall Study|Lack of Efficacy|1|||
144240099|NCT00979420|520074296|FG000|Overall Study|Other reasons not related to Viramune|3|||
144240100|NCT00979420|520074297|FG001|Overall Study|Other reasons not related to Viramune|0|||
144240101|NCT00979420|520074298|FG002|Overall Study|Other reasons not related to Viramune|0|||
144240102|NCT00979420|520074299|FG003|Overall Study|Other reasons not related to Viramune|1|||
144240103|NCT00319592|520074306|FG000|Overall Study|Protocol Violation|1|||
144240104|NCT00319592|520074307|FG001|Overall Study|Protocol Violation|0|||
144240105|NCT00319592|520074306|FG000|Overall Study|Physician Decision|0|||
144240106|NCT00319592|520074307|FG001|Overall Study|Physician Decision|1|||
144240107|NCT02572076|520074308|FG000|Overall Study|Protocol Violation|1|||
144240108|NCT02272842|520074311|FG000|Overall Study|Lost to Follow-up|8|||
144240109|NCT02272842|520074312|FG001|Overall Study|Lost to Follow-up|8|||
144240110|NCT02272842|520074311|FG000|Overall Study|Withdrawal by Subject|8|||
144240111|NCT02272842|520074312|FG001|Overall Study|Withdrawal by Subject|2|||
144240112|NCT01273623|520074316|FG000|Overall Study|did not meet IVUS criteria|29|||
144240113|NCT03053063|520074328|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
144240114|NCT03053063|520074329|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
144240115|NCT03053063|520074330|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
144240116|NCT03053063|520074331|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
144240117|NCT03053063|520074328|FG000|Randomized Phase|Withdrew consent|8|||
144240118|NCT03053063|520074329|FG001|Randomized Phase|Withdrew consent|11|||
144240119|NCT03053063|520074330|FG002|Randomized Phase|Withdrew consent|5|||
144240120|NCT03053063|520074331|FG003|Randomized Phase|Withdrew consent|0|||
144240121|NCT03053063|520074328|FG000|Randomized Phase|Investigator's Discretion|8|||
144240122|NCT03053063|520074329|FG001|Randomized Phase|Investigator's Discretion|6|||
144240123|NCT03053063|520074330|FG002|Randomized Phase|Investigator's Discretion|2|||
144240124|NCT03053063|520074331|FG003|Randomized Phase|Investigator's Discretion|0|||
144240125|NCT03053063|520074328|FG000|Randomized Phase|Lost to Follow-up|3|||
144240126|NCT03053063|520074329|FG001|Randomized Phase|Lost to Follow-up|5|||
144240127|NCT03053063|520074330|FG002|Randomized Phase|Lost to Follow-up|1|||
144240128|NCT03053063|520074331|FG003|Randomized Phase|Lost to Follow-up|0|||
144240129|NCT03053063|520074328|FG000|Randomized Phase|Adverse Event|0|||
144240130|NCT03053063|520074329|FG001|Randomized Phase|Adverse Event|1|||
144240131|NCT03053063|520074330|FG002|Randomized Phase|Adverse Event|0|||
144240132|NCT03053063|520074331|FG003|Randomized Phase|Adverse Event|0|||
144240133|NCT03053063|520074328|FG000|Randomized Phase|Randomized but Never Treated|1|||
144240134|NCT03053063|520074329|FG001|Randomized Phase|Randomized but Never Treated|3|||
144240135|NCT03053063|520074330|FG002|Randomized Phase|Randomized but Never Treated|2|||
144240136|NCT03053063|520074331|FG003|Randomized Phase|Randomized but Never Treated|0|||
144240137|NCT03053063|520074328|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
144240138|NCT03053063|520074329|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
144240139|NCT03053063|520074330|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
144240140|NCT03053063|520074331|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
144240141|NCT03053063|520074328|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
144240142|NCT03053063|520074329|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
144240143|NCT03053063|520074330|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
144240144|NCT03053063|520074331|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
144240145|NCT03053063|520074328|FG000|Open-Label Phase|Death|0|||
144240146|NCT03053063|520074329|FG001|Open-Label Phase|Death|0|||
144240147|NCT03053063|520074330|FG002|Open-Label Phase|Death|0|||
144240148|NCT03053063|520074331|FG003|Open-Label Phase|Death|2|||
144240149|NCT03053063|520074328|FG000|Open-Label Phase|Investigator's discretion|0|||
144240150|NCT03053063|520074329|FG001|Open-Label Phase|Investigator's discretion|0|||
144240151|NCT03053063|520074330|FG002|Open-Label Phase|Investigator's discretion|0|||
144240152|NCT03053063|520074331|FG003|Open-Label Phase|Investigator's discretion|2|||
144240153|NCT05033262|520074333|FG000|Overall Study|Lost to Follow-up|1|||
144240154|NCT05033262|520074334|FG001|Overall Study|Lost to Follow-up|0|||
144240155|NCT05033262|520074335|FG002|Overall Study|Lost to Follow-up|0|||
144240156|NCT05033262|520074336|FG003|Overall Study|Lost to Follow-up|1|||
144240157|NCT05270395|520074337|FG000|Overall Study|Lost to Follow-up|2|||
144240158|NCT05270395|520074338|FG001|Overall Study|Lost to Follow-up|2|||
144240159|NCT05270395|520074337|FG000|Overall Study|Death|1|||
144240160|NCT05270395|520074338|FG001|Overall Study|Death|2|||
144240161|NCT05270395|520074337|FG000|Overall Study|Study Team Withdrew|1|||
144240162|NCT05270395|520074338|FG001|Overall Study|Study Team Withdrew|0|||
144240163|NCT02738879|520076560|FG000|Overall Study|Adverse Event|1|||
144240164|NCT02738879|520076561|FG001|Overall Study|Adverse Event|1|||
144240165|NCT02738879|520076560|FG000|Overall Study|Death|0|||
144240166|NCT02738879|520076561|FG001|Overall Study|Death|2|||
144240167|NCT02738879|520076560|FG000|Overall Study|Lost to Follow-up|1|||
144240168|NCT02738879|520076561|FG001|Overall Study|Lost to Follow-up|5|||
144240169|NCT02738879|520076560|FG000|Overall Study|Protocol Violation|1|||
144240170|NCT02738879|520076561|FG001|Overall Study|Protocol Violation|3|||
144240171|NCT02738879|520076560|FG000|Overall Study|Physician Decision|3|||
144240172|NCT02738879|520076561|FG001|Overall Study|Physician Decision|4|||
144240173|NCT02738879|520076560|FG000|Overall Study|Pregnancy|0|||
144240174|NCT02738879|520076561|FG001|Overall Study|Pregnancy|1|||
144240175|NCT02738879|520076560|FG000|Overall Study|Screen Failure|1|||
144240176|NCT02738879|520076561|FG001|Overall Study|Screen Failure|2|||
144240177|NCT02738879|520076560|FG000|Overall Study|Site Discontinued Study Participation|1|||
144240178|NCT02738879|520076561|FG001|Overall Study|Site Discontinued Study Participation|0|||
144240179|NCT02738879|520076560|FG000|Overall Study|Withdrawal by Subject|5|||
144240180|NCT02738879|520076561|FG001|Overall Study|Withdrawal by Subject|7|||
144240181|NCT01438294|520076562|FG000|Overall Study|Lost to Follow-up|3|||
144240182|NCT01438294|520076563|FG001|Overall Study|Lost to Follow-up|7|||
144240183|NCT01730534|520076564|FG000|Overall Study|Withdrawal by Subject|97|||
144240184|NCT01730534|520076565|FG001|Overall Study|Withdrawal by Subject|127|||
144240185|NCT01730534|520076564|FG000|Overall Study|Lost to Follow-up|12|||
144240186|NCT01730534|520076565|FG001|Overall Study|Lost to Follow-up|18|||
144240187|NCT02256982|520076566|FG000|Overall Study|Disease Progression|0|||
144240188|NCT02256982|520076567|FG001|Overall Study|Disease Progression|1|||
144240189|NCT03614078|520076568|FG000|Overall Study|Withdrawal by Subject|2|||
144240190|NCT03614078|520076569|FG001|Overall Study|Withdrawal by Subject|2|||
144240191|NCT03614078|520076570|FG002|Overall Study|Withdrawal by Subject|3|||
144240192|NCT03614078|520076568|FG000|Overall Study|Participant Did Not Return for Visit|0|||
144240193|NCT03614078|520076569|FG001|Overall Study|Participant Did Not Return for Visit|1|||
144240194|NCT03614078|520076570|FG002|Overall Study|Participant Did Not Return for Visit|0|||
144240195|NCT03614078|520076568|FG000|Overall Study|High Neutrophils|0|||
144240196|NCT03614078|520076569|FG001|Overall Study|High Neutrophils|0|||
144240197|NCT03614078|520076570|FG002|Overall Study|High Neutrophils|2|||
144240198|NCT03614078|520076568|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
144240199|NCT03614078|520076569|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
144240200|NCT03614078|520076570|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
144240201|NCT03614078|520076568|FG000|Overall Study|Exacerbation of Psoriasis|0|||
144240202|NCT03614078|520076569|FG001|Overall Study|Exacerbation of Psoriasis|1|||
144240203|NCT03614078|520076570|FG002|Overall Study|Exacerbation of Psoriasis|0|||
144240204|NCT03614078|520076568|FG000|Overall Study|Adverse Event|0|||
144240205|NCT03614078|520076569|FG001|Overall Study|Adverse Event|2|||
144240206|NCT03614078|520076570|FG002|Overall Study|Adverse Event|0|||
144240207|NCT03614078|520076568|FG000|Overall Study|Dizziness and Rash|0|||
144240208|NCT03614078|520076569|FG001|Overall Study|Dizziness and Rash|1|||
144240209|NCT03614078|520076570|FG002|Overall Study|Dizziness and Rash|0|||
144240210|NCT04964544|520076573|FG000|Overall Study|Screen failure or other uncategorised|10|||
144240211|NCT04964544|520076573|FG000|Overall Study|Physician Decision|4|||
144240212|NCT04964544|520076573|FG000|Overall Study|Lost to Follow-up|9|||
144240213|NCT04964544|520076573|FG000|Overall Study|Withdrawal by Subject|18|||
144240214|NCT04964544|520076573|FG000|Overall Study|Death|1|||
144240215|NCT02822573|520076579|FG000|Overall Study|Lost to Follow-up|5|||
144240216|NCT02822573|520076580|FG001|Overall Study|Lost to Follow-up|3|||
144240217|NCT02822573|520076579|FG000|Overall Study|Physician Decision|1|||
144240218|NCT02822573|520076580|FG001|Overall Study|Physician Decision|1|||
144240219|NCT02822573|520076579|FG000|Overall Study|Withdrawal by Subject|9|||
144240220|NCT02822573|520076580|FG001|Overall Study|Withdrawal by Subject|5|||
144240221|NCT02822573|520076579|FG000|Overall Study|Protocol Violation|6|||
144240222|NCT02822573|520076580|FG001|Overall Study|Protocol Violation|4|||
144240223|NCT02822573|520076579|FG000|Overall Study|Too sick or ill|2|||
144240224|NCT02822573|520076580|FG001|Overall Study|Too sick or ill|1|||
144240225|NCT02822573|520076579|FG000|Overall Study|Disease Progression|1|||
144240226|NCT02822573|520076580|FG001|Overall Study|Disease Progression|1|||
144240227|NCT02822573|520076579|FG000|Overall Study|No reason given|6|||
144240228|NCT02822573|520076580|FG001|Overall Study|No reason given|4|||
144240229|NCT02855359|520076583|FG000|Overall Study|Death|2|||
144240230|NCT02855359|520076584|FG001|Overall Study|Death|2|||
144240231|NCT02855359|520076585|FG002|Overall Study|Death|0|||
144240232|NCT02855359|520076586|FG003|Overall Study|Death|0|||
144240233|NCT02855359|520076583|FG000|Overall Study|Study Termination by Sponsor|9|||
144240234|NCT02855359|520076584|FG001|Overall Study|Study Termination by Sponsor|11|||
144240235|NCT02855359|520076585|FG002|Overall Study|Study Termination by Sponsor|0|||
144240236|NCT02855359|520076586|FG003|Overall Study|Study Termination by Sponsor|0|||
144240237|NCT02833844|520076587|FG000|Double-Blind Period|Withdrawal by Subject|2|||
144240238|NCT02833844|520076588|FG001|Double-Blind Period|Withdrawal by Subject|3|||
144240239|NCT02833844|520076587|FG000|Double-Blind Period|Protocol Violation|0|||
144240240|NCT02833844|520076588|FG001|Double-Blind Period|Protocol Violation|4|||
144240241|NCT02833844|520076587|FG000|Open-Label Period|Death|0|||
144240242|NCT02833844|520076588|FG001|Open-Label Period|Death|2|||
144240243|NCT02833844|520076587|FG000|Open-Label Period|Lost to Follow-up|1|||
144240244|NCT02833844|520076588|FG001|Open-Label Period|Lost to Follow-up|0|||
144240245|NCT02833844|520076587|FG000|Open-Label Period|Withdrawal by Subject|1|||
144240246|NCT02833844|520076588|FG001|Open-Label Period|Withdrawal by Subject|0|||
144240247|NCT00308087|520076589|FG000|Overall Study|Progressive Disease|19|||
144240248|NCT00308087|520076590|FG001|Overall Study|Progressive Disease|21|||
144240249|NCT00308087|520076589|FG000|Overall Study|Study Closure|11|||
144240250|NCT00308087|520076590|FG001|Overall Study|Study Closure|12|||
144240251|NCT00308087|520076589|FG000|Overall Study|Withdrawal by Subject|2|||
144240252|NCT00308087|520076590|FG001|Overall Study|Withdrawal by Subject|1|||
144240253|NCT00308087|520076589|FG000|Overall Study|Other|4|||
144240254|NCT00308087|520076590|FG001|Overall Study|Other|3|||
144240255|NCT01899742|520076593|FG000|Overall Study|Adverse Event|5|||
144240256|NCT01899742|520076594|FG001|Overall Study|Adverse Event|4|||
144240257|NCT01899742|520076593|FG000|Overall Study|Lack of Efficacy|1|||
144240258|NCT01899742|520076594|FG001|Overall Study|Lack of Efficacy|5|||
144240259|NCT01899742|520076593|FG000|Overall Study|Protocol Violation|2|||
144240260|NCT01899742|520076594|FG001|Overall Study|Protocol Violation|2|||
144240261|NCT01899742|520076593|FG000|Overall Study|Withdrawal by Subject|9|||
144240262|NCT01899742|520076594|FG001|Overall Study|Withdrawal by Subject|5|||
144240263|NCT01044290|520076595|FG000|Follow-up 1|Death|3|||
144240264|NCT01044290|520076596|FG001|Follow-up 1|Death|3|||
144240265|NCT01044290|520076597|FG002|Follow-up 1|Death|1|||
144240266|NCT01044290|520076595|FG000|Follow-up 1|Withdrawal by Subject|2|||
144270014|NCT02003144|520191479|FG000|Open Label Maintenance Phase|Adverse Event|2|||
144270015|NCT02003144|520191480|FG001|Open Label Maintenance Phase|Adverse Event|1|||
144270016|NCT02034006|520193254|FG000|Overall Study|Withdrawal by Subject|7|||
144270017|NCT02034006|520193254|FG000|Overall Study|Lost to Follow-up|5|||
144270018|NCT02034006|520193254|FG000|Overall Study|Death|1|||
144270019|NCT02034006|520193254|FG000|Overall Study|Pregnancy|1|||
144270020|NCT01855958|520193258|FG000|Overall Study|Withdrawal by Subject|1|||
144270021|NCT01855958|520193259|FG001|Overall Study|Withdrawal by Subject|0|||
144270022|NCT04539275|520193262|FG000|Overall Study|Death|2|||
144270023|NCT04539275|520193263|FG001|Overall Study|Death|4|||
144270024|NCT04539275|520193262|FG000|Overall Study|Lost to Follow-up|1|||
144270025|NCT04539275|520193263|FG001|Overall Study|Lost to Follow-up|1|||
144270026|NCT04539275|520193262|FG000|Overall Study|Withdrawal by Subject|3|||
144270027|NCT04539275|520193263|FG001|Overall Study|Withdrawal by Subject|0|||
144270028|NCT01125930|520193264|FG000|Overall Study|Adverse Event|0|||
144270029|NCT01125930|520193265|FG001|Overall Study|Adverse Event|1|||
144270030|NCT01125930|520193264|FG000|Overall Study|Withdrawal by Subject|1|||
144270031|NCT01125930|520193265|FG001|Overall Study|Withdrawal by Subject|6|||
144270032|NCT01125930|520193264|FG000|Overall Study|Protocol Violation|0|||
144270033|NCT01125930|520193265|FG001|Overall Study|Protocol Violation|1|||
144270034|NCT01125930|520193264|FG000|Overall Study|Lost to Follow-up|0|||
144270035|NCT01125930|520193265|FG001|Overall Study|Lost to Follow-up|2|||
144240267|NCT01044290|520076596|FG001|Follow-up 1|Withdrawal by Subject|2|||
144240268|NCT01044290|520076597|FG002|Follow-up 1|Withdrawal by Subject|0|||
144240269|NCT01044290|520076595|FG000|Follow-Up 2|Death|0|||
144240270|NCT01044290|520076596|FG001|Follow-Up 2|Death|1|||
144240271|NCT01044290|520076597|FG002|Follow-Up 2|Death|1|||
144240272|NCT01044290|520076595|FG000|Follow-Up 2|Withdrawal by Subject|0|||
144240273|NCT01044290|520076596|FG001|Follow-Up 2|Withdrawal by Subject|1|||
144240274|NCT01044290|520076597|FG002|Follow-Up 2|Withdrawal by Subject|1|||
144240275|NCT00089778|520076599|FG000|Overall Study|Protocol Violation|0|||
144240276|NCT00089778|520076600|FG001|Overall Study|Protocol Violation|0|||
144240277|NCT00089778|520076601|FG002|Overall Study|Protocol Violation|1|||
144240278|NCT02677038|520076604|FG000|Overall Study|Physician Decision|1|||
144240279|NCT02677038|520076604|FG000|Overall Study|Withdrawal by Subject|1|||
144240280|NCT04712019|520076605|FG000|Overall Study|Withdrawal by Subject|2|||
144240281|NCT04712019|520076606|FG001|Overall Study|Withdrawal by Subject|2|||
144240282|NCT04712019|520076605|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
144240283|NCT04712019|520076606|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
144240284|NCT01967706|520076612|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
144240285|NCT01967706|520076613|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
144240286|NCT01967706|520076614|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
144240287|NCT01967706|520076615|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
144240288|NCT02347891|520076616|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
144270036|NCT00547339|520193268|FG000|Overall Study|Physician Decision|0|||
144270037|NCT00547339|520193269|FG001|Overall Study|Physician Decision|0|||
144240289|NCT02347891|520076617|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
144240290|NCT02347891|520076616|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
144240291|NCT02347891|520076617|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
144240292|NCT00834639|520076618|FG000|Second Intervention|Physician Decision|0|||
144270038|NCT00547339|520193270|FG002|Overall Study|Physician Decision|1|||
144270039|NCT00547339|520193271|FG003|Overall Study|Physician Decision|0|||
144270040|NCT01516216|520193272|FG000|Overall Study|Adverse Event|2|||
144270041|NCT01516216|520193273|FG001|Overall Study|Adverse Event|4|||
144240293|NCT00834639|520076619|FG001|Second Intervention|Physician Decision|2|||
144240294|NCT00614120|520076623|FG000|Overall Study|Adverse Event|9|||
144240295|NCT00614120|520076624|FG001|Overall Study|Adverse Event|22|||
144270042|NCT01516216|520193272|FG000|Overall Study|Disease Progression|38|||
144270043|NCT01516216|520193273|FG001|Overall Study|Disease Progression|34|||
144270044|NCT01516216|520193272|FG000|Overall Study|Withdrawal by Subject|9|||
144270045|NCT01516216|520193273|FG001|Overall Study|Withdrawal by Subject|11|||
144270046|NCT01516216|520193272|FG000|Overall Study|Potentially Curative Resection|6|||
144270047|NCT01516216|520193273|FG001|Overall Study|Potentially Curative Resection|12|||
144240296|NCT00614120|520076625|FG002|Overall Study|Adverse Event|30|||
144240297|NCT00614120|520076626|FG003|Overall Study|Adverse Event|3|||
144240298|NCT00614120|520076623|FG000|Overall Study|Lack of Efficacy|3|||
144240299|NCT00614120|520076624|FG001|Overall Study|Lack of Efficacy|3|||
144240300|NCT00614120|520076625|FG002|Overall Study|Lack of Efficacy|2|||
144240301|NCT00614120|520076626|FG003|Overall Study|Lack of Efficacy|2|||
144240302|NCT00614120|520076623|FG000|Overall Study|Protocol Violation|2|||
144240303|NCT00614120|520076624|FG001|Overall Study|Protocol Violation|5|||
144240304|NCT00614120|520076625|FG002|Overall Study|Protocol Violation|3|||
144240305|NCT00614120|520076626|FG003|Overall Study|Protocol Violation|1|||
144240306|NCT00614120|520076623|FG000|Overall Study|Withdrawal criteria|1|||
144240307|NCT00614120|520076624|FG001|Overall Study|Withdrawal criteria|0|||
144240308|NCT00614120|520076625|FG002|Overall Study|Withdrawal criteria|0|||
144240309|NCT00614120|520076626|FG003|Overall Study|Withdrawal criteria|0|||
144240310|NCT00614120|520076623|FG000|Overall Study|Withdrawal by Subject|9|||
144240311|NCT00614120|520076624|FG001|Overall Study|Withdrawal by Subject|10|||
144240312|NCT00614120|520076625|FG002|Overall Study|Withdrawal by Subject|16|||
144240313|NCT00614120|520076626|FG003|Overall Study|Withdrawal by Subject|3|||
144240314|NCT00614120|520076623|FG000|Overall Study|Did not meet trial criteria|0|||
144240315|NCT00614120|520076624|FG001|Overall Study|Did not meet trial criteria|1|||
144240316|NCT00614120|520076625|FG002|Overall Study|Did not meet trial criteria|1|||
144240317|NCT00614120|520076626|FG003|Overall Study|Did not meet trial criteria|1|||
144240318|NCT00614120|520076623|FG000|Overall Study|hCG positive (not pregnant)|0|||
144240319|NCT00614120|520076624|FG001|Overall Study|hCG positive (not pregnant)|0|||
144240320|NCT00614120|520076625|FG002|Overall Study|hCG positive (not pregnant)|1|||
144240321|NCT00614120|520076626|FG003|Overall Study|hCG positive (not pregnant)|0|||
144240322|NCT00614120|520076623|FG000|Overall Study|Hypoglycaemia|0|||
144240323|NCT00614120|520076624|FG001|Overall Study|Hypoglycaemia|0|||
144240324|NCT00614120|520076625|FG002|Overall Study|Hypoglycaemia|0|||
144240325|NCT00614120|520076626|FG003|Overall Study|Hypoglycaemia|1|||
144240326|NCT00614120|520076623|FG000|Overall Study|Lack of trial product|3|||
144240327|NCT00614120|520076624|FG001|Overall Study|Lack of trial product|3|||
144240328|NCT00614120|520076625|FG002|Overall Study|Lack of trial product|2|||
144240329|NCT00614120|520076626|FG003|Overall Study|Lack of trial product|0|||
144240330|NCT00614120|520076623|FG000|Overall Study|Late syphilis, latent|1|||
144240331|NCT00614120|520076624|FG001|Overall Study|Late syphilis, latent|0|||
144240332|NCT00614120|520076625|FG002|Overall Study|Late syphilis, latent|0|||
144270048|NCT01516216|520193272|FG000|Overall Study|Nonadherence|2|||
144270049|NCT01516216|520193273|FG001|Overall Study|Nonadherence|3|||
144270050|NCT01516216|520193272|FG000|Overall Study|Physician Decision|6|||
144270051|NCT01516216|520193273|FG001|Overall Study|Physician Decision|3|||
144270052|NCT01516216|520193272|FG000|Overall Study|Prolonged Treatment Delay|5|||
144270053|NCT01516216|520193273|FG001|Overall Study|Prolonged Treatment Delay|1|||
144270054|NCT01516216|520193272|FG000|Overall Study|Intercurrent Illness|1|||
144240333|NCT00614120|520076626|FG003|Overall Study|Late syphilis, latent|0|||
144240334|NCT00614120|520076623|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
144240335|NCT00614120|520076624|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
144240336|NCT00614120|520076625|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
144240337|NCT00614120|520076626|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
144240338|NCT00614120|520076623|FG000|Overall Study|Lost to Follow-up|1|||
144240339|NCT00614120|520076624|FG001|Overall Study|Lost to Follow-up|2|||
144240340|NCT00614120|520076625|FG002|Overall Study|Lost to Follow-up|3|||
144240341|NCT00614120|520076626|FG003|Overall Study|Lost to Follow-up|4|||
144270055|NCT01516216|520193273|FG001|Overall Study|Intercurrent Illness|0|||
144270056|NCT01516216|520193272|FG000|Overall Study|Death|1|||
144270057|NCT01516216|520193273|FG001|Overall Study|Death|1|||
144240342|NCT04569968|520076628|FG000|Overall Study|Lost to Follow-up|2|||
144240343|NCT04569968|520076629|FG001|Overall Study|Lost to Follow-up|5|||
144240344|NCT04569968|520076628|FG000|Overall Study|Story of head and/or neck surgery|2|||
144240345|NCT04569968|520076629|FG001|Overall Study|Story of head and/or neck surgery|2|||
144270058|NCT03098979|520193274|FG000|Overall Study|Adverse Event|1|||
144240346|NCT04569968|520076628|FG000|Overall Study|Time of stroke onset|8|||
144240347|NCT04569968|520076629|FG001|Overall Study|Time of stroke onset|7|||
144240348|NCT04569968|520076628|FG000|Overall Study|Type of strokr|12|||
144240349|NCT04569968|520076629|FG001|Overall Study|Type of strokr|8|||
144240350|NCT04569968|520076628|FG000|Overall Study|Cooperation|8|||
144240351|NCT04569968|520076629|FG001|Overall Study|Cooperation|8|||
144240352|NCT04569968|520076628|FG000|Overall Study|Age interval|17|||
144240353|NCT04569968|520076629|FG001|Overall Study|Age interval|6|||
144270059|NCT03098979|520193275|FG001|Overall Study|Adverse Event|0|||
144270060|NCT03098979|520193276|FG002|Overall Study|Adverse Event|1|||
144270061|NCT03098979|520193277|FG003|Overall Study|Adverse Event|4|||
144240354|NCT04569968|520076628|FG000|Overall Study|Denial of participation to the study|0|||
144240355|NCT04569968|520076629|FG001|Overall Study|Denial of participation to the study|3|||
144240356|NCT04569968|520076628|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
144240357|NCT04569968|520076629|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
144240358|NCT04569968|520076628|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
144240359|NCT04569968|520076629|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
144240360|NCT04569968|520076628|FG000|Overall Study|Quarantine|1|||
144240361|NCT04569968|520076629|FG001|Overall Study|Quarantine|0|||
144240362|NCT04569968|520076628|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
144240363|NCT04569968|520076629|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
144240364|NCT04569968|520076628|FG000|Overall Study|Repetitive stroke|8|||
144240365|NCT04569968|520076629|FG001|Overall Study|Repetitive stroke|0|||
144240366|NCT04569968|520076628|FG000|Overall Study|Insufficient mastication|1|||
144240367|NCT04569968|520076629|FG001|Overall Study|Insufficient mastication|0|||
144240368|NCT04569968|520076628|FG000|Overall Study|Infection|1|||
144240369|NCT04569968|520076629|FG001|Overall Study|Infection|0|||
144240370|NCT00574249|520076634|FG000|Overall Study|Adverse Event|6|||
144240371|NCT00574249|520076635|FG001|Overall Study|Adverse Event|18|||
144240372|NCT00574249|520076634|FG000|Overall Study|Lack of Efficacy|5|||
144240373|NCT00574249|520076635|FG001|Overall Study|Lack of Efficacy|3|||
144240374|NCT00574249|520076634|FG000|Overall Study|Lost to Follow-up|4|||
144240375|NCT00574249|520076635|FG001|Overall Study|Lost to Follow-up|3|||
144240376|NCT00574249|520076634|FG000|Overall Study|Protocol Violation|5|||
144240377|NCT00574249|520076635|FG001|Overall Study|Protocol Violation|2|||
144240378|NCT00574249|520076634|FG000|Overall Study|History of carcinoma|1|||
144240379|NCT00574249|520076635|FG001|Overall Study|History of carcinoma|0|||
144240380|NCT00574249|520076634|FG000|Overall Study|Withdrawal by Subject|3|||
144240381|NCT00574249|520076635|FG001|Overall Study|Withdrawal by Subject|0|||
144240382|NCT00574249|520076634|FG000|Overall Study|Physician Decision|1|||
144240383|NCT00574249|520076635|FG001|Overall Study|Physician Decision|0|||
144240384|NCT00574249|520076634|FG000|Overall Study|Pregnancy|1|||
144240385|NCT00574249|520076635|FG001|Overall Study|Pregnancy|0|||
144240386|NCT00574249|520076634|FG000|Overall Study|Excluded by company|0|||
144240387|NCT00574249|520076635|FG001|Overall Study|Excluded by company|1|||
144240388|NCT00574249|520076634|FG000|Overall Study|PPD test taken twice|0|||
144240389|NCT00574249|520076635|FG001|Overall Study|PPD test taken twice|1|||
144240390|NCT01618019|520076637|FG000|Overall Study|Withdrawal by Subject|14|||
144240391|NCT01618019|520076638|FG001|Overall Study|Withdrawal by Subject|14|||
144240392|NCT01542034|520076639|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
144240393|NCT01542034|520076640|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
144240394|NCT01542034|520076639|FG000|Overall Study|Administrative decision|0|||
144240395|NCT01542034|520076640|FG001|Overall Study|Administrative decision|3|||
144240396|NCT01542034|520076639|FG000|Overall Study|Subject Noncompliance|1|||
144240397|NCT01542034|520076640|FG001|Overall Study|Subject Noncompliance|0|||
144240398|NCT01542034|520076639|FG000|Overall Study|Adverse Event|2|||
144240399|NCT01542034|520076640|FG001|Overall Study|Adverse Event|2|||
144240400|NCT01542034|520076639|FG000|Overall Study|Lost to Follow-up|7|||
144240401|NCT01542034|520076640|FG001|Overall Study|Lost to Follow-up|6|||
144240402|NCT01508130|520076641|FG000|Overall Study|Adverse Event|81|||
144240403|NCT01508130|520076642|FG001|Overall Study|Adverse Event|28|||
144240404|NCT01508130|520076641|FG000|Overall Study|Death|3|||
144240405|NCT01508130|520076642|FG001|Overall Study|Death|1|||
144240406|NCT01508130|520076641|FG000|Overall Study|Protocol Violation|2|||
144240407|NCT01508130|520076642|FG001|Overall Study|Protocol Violation|0|||
144240408|NCT01508130|520076641|FG000|Overall Study|Lost to Follow-up|25|||
144240409|NCT01508130|520076642|FG001|Overall Study|Lost to Follow-up|2|||
144240410|NCT01508130|520076641|FG000|Overall Study|Withdrawal by Subject|3|||
144240411|NCT01508130|520076642|FG001|Overall Study|Withdrawal by Subject|3|||
144240412|NCT01508130|520076641|FG000|Overall Study|Subject's substantial non-compliance|25|||
144240413|NCT01508130|520076642|FG001|Overall Study|Subject's substantial non-compliance|9|||
144240414|NCT01508130|520076641|FG000|Overall Study|Insufficient therapeutic response|74|||
144240415|NCT01508130|520076642|FG001|Overall Study|Insufficient therapeutic response|23|||
144240416|NCT01508130|520076641|FG000|Overall Study|Administrative|14|||
144240417|NCT01508130|520076642|FG001|Overall Study|Administrative|3|||
144240418|NCT01680159|520076643|FG000|Screening Period|Not meet criteria for dose-up period|7|||
144240419|NCT01680159|520076643|FG000|Increased Dose Period|Adverse Event|6|||
144240420|NCT01680159|520076643|FG000|Increased Dose Period|Withdrawal by Subject|2|||
144240421|NCT02783729|520076644|FG000|Overall Study|Lack of Efficacy|1|||
144240422|NCT02783729|520076645|FG001|Overall Study|Lack of Efficacy|0|||
144240423|NCT02783729|520076646|FG002|Overall Study|Lack of Efficacy|0|||
144240424|NCT02783729|520076647|FG003|Overall Study|Lack of Efficacy|0|||
144240425|NCT02783729|520076644|FG000|Overall Study|Adverse Event|2|||
144240426|NCT02783729|520076645|FG001|Overall Study|Adverse Event|6|||
144240427|NCT02783729|520076646|FG002|Overall Study|Adverse Event|2|||
144240428|NCT02783729|520076647|FG003|Overall Study|Adverse Event|3|||
144240429|NCT02783729|520076644|FG000|Overall Study|Other|1|||
144240430|NCT02783729|520076645|FG001|Overall Study|Other|6|||
144240431|NCT02783729|520076646|FG002|Overall Study|Other|2|||
144240432|NCT02783729|520076647|FG003|Overall Study|Other|3|||
144270062|NCT03098979|520193278|FG004|Overall Study|Adverse Event|6|||
144240433|NCT02783729|520076644|FG000|Overall Study|Withdrawal by Subject|2|||
144240434|NCT02783729|520076645|FG001|Overall Study|Withdrawal by Subject|3|||
144240435|NCT02783729|520076646|FG002|Overall Study|Withdrawal by Subject|1|||
144240436|NCT02783729|520076647|FG003|Overall Study|Withdrawal by Subject|2|||
144240437|NCT02783729|520076644|FG000|Overall Study|Participant's choice|2|||
144240438|NCT02783729|520076645|FG001|Overall Study|Participant's choice|1|||
144240439|NCT02783729|520076646|FG002|Overall Study|Participant's choice|2|||
144240440|NCT02783729|520076647|FG003|Overall Study|Participant's choice|1|||
144270063|NCT03098979|520193279|FG005|Overall Study|Adverse Event|1|||
144240441|NCT02783729|520076644|FG000|Overall Study|Lost to Follow-up|2|||
144240442|NCT02783729|520076645|FG001|Overall Study|Lost to Follow-up|1|||
144240443|NCT02783729|520076646|FG002|Overall Study|Lost to Follow-up|1|||
144240444|NCT02783729|520076647|FG003|Overall Study|Lost to Follow-up|0|||
144240445|NCT04021121|520076650|FG000|Overall Study|Death|3|||
144240446|NCT04021121|520076651|FG001|Overall Study|Death|3|||
144240447|NCT04021121|520076652|FG002|Overall Study|Death|5|||
144240448|NCT04021121|520076653|FG003|Overall Study|Death|4|||
144240449|NCT02288091|520076656|FG000|Overall Study|Lost to Follow-up|1|||
144240450|NCT02288091|520076656|FG000|Overall Study|Screen fail|7|||
144240451|NCT03843632|520076662|FG000|Overall Study|Withdrawal by Subject|1|||
144240452|NCT03843632|520076663|FG001|Overall Study|Withdrawal by Subject|0|||
144240453|NCT03843632|520076664|FG002|Overall Study|Withdrawal by Subject|0|||
144240454|NCT03843632|520076665|FG003|Overall Study|Withdrawal by Subject|0|||
144240455|NCT03403751|520076666|FG000|Overall Study|Death|5|||
144240456|NCT03403751|520076667|FG001|Overall Study|Death|6|||
144240457|NCT03403751|520076666|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
144240458|NCT03403751|520076667|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
144240459|NCT05036668|520076670|FG000|Overall Study|lost to follow Up|0|||
144240460|NCT05036668|520076671|FG001|Overall Study|lost to follow Up|0|||
144240461|NCT05036668|520076672|FG002|Overall Study|lost to follow Up|1|||
144240462|NCT00387010|520076674|FG000|Dose Titration Period|Adverse Event|12|||
144240463|NCT00387010|520076674|FG000|Dose Titration Period|Lack of Efficacy|5|||
144240464|NCT00387010|520076674|FG000|Dose Titration Period|Withdrawal by Subject|3|||
144240465|NCT00387010|520076674|FG000|Dose Titration Period|Protocol Violation|1|||
144240466|NCT00387010|520076674|FG000|Dose Titration Period|Lost to Follow-up|2|||
144240467|NCT00387010|520076674|FG000|Dose Titration Period|Noncompliance with study medication|8|||
144240468|NCT00387010|520076674|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
144240469|NCT00387010|520076674|FG000|Treatment Period|Adverse Event|4|||
144240470|NCT00387010|520076674|FG000|Treatment Period|Withdrawal by Subject|1|||
144240471|NCT00387010|520076674|FG000|Treatment Period|Noncompliance with study medication|2|||
144240472|NCT00387010|520076674|FG000|Treatment Period|Noncompliance with study procedures|3|||
144240473|NCT00387010|520076674|FG000|Treatment Period|Participant reported study drug stolen|1|||
144240474|NCT00520481|520076675|FG000|Overall Study|Adverse Event|4|||
144240475|NCT00520481|520076676|FG001|Overall Study|Adverse Event|1|||
144240476|NCT00520481|520076675|FG000|Overall Study|Withdrawal by Subject|3|||
144240477|NCT00520481|520076676|FG001|Overall Study|Withdrawal by Subject|0|||
144240478|NCT01931956|520076686|FG000|Overall Study|Death|42|||
144240479|NCT01931956|520076687|FG001|Overall Study|Death|7|||
144240480|NCT01931956|520076688|FG002|Overall Study|Death|379|||
144240481|NCT01931956|520076689|FG003|Overall Study|Death|96|||
144240482|NCT01931956|520076686|FG000|Overall Study|Withdrawal by Subject|5|||
144240483|NCT01931956|520076687|FG001|Overall Study|Withdrawal by Subject|0|||
144240484|NCT01931956|520076688|FG002|Overall Study|Withdrawal by Subject|70|||
144240485|NCT01931956|520076689|FG003|Overall Study|Withdrawal by Subject|30|||
144240486|NCT01931956|520076686|FG000|Overall Study|Lost to Follow-up|2|||
144240487|NCT01931956|520076687|FG001|Overall Study|Lost to Follow-up|0|||
144240488|NCT01931956|520076688|FG002|Overall Study|Lost to Follow-up|11|||
144240489|NCT01931956|520076689|FG003|Overall Study|Lost to Follow-up|7|||
144240490|NCT01931956|520076686|FG000|Overall Study|Expected|2|||
144240491|NCT01931956|520076687|FG001|Overall Study|Expected|0|||
144240492|NCT01931956|520076688|FG002|Overall Study|Expected|6|||
144240493|NCT01931956|520076689|FG003|Overall Study|Expected|0|||
144240494|NCT01931956|520076686|FG000|Overall Study|Not due|0|||
144240495|NCT01931956|520076687|FG001|Overall Study|Not due|0|||
144240496|NCT01931956|520076688|FG002|Overall Study|Not due|21|||
144240497|NCT01931956|520076689|FG003|Overall Study|Not due|0|||
144240498|NCT02841280|520076690|FG000|Overall Study|Adverse Event|2|||
144240499|NCT02841280|520076691|FG001|Overall Study|Adverse Event|1|||
144240500|NCT02841280|520076690|FG000|Overall Study|Death|1|||
144240501|NCT02841280|520076691|FG001|Overall Study|Death|0|||
144240502|NCT02841280|520076690|FG000|Overall Study|Lost to Follow-up|2|||
144240503|NCT02841280|520076691|FG001|Overall Study|Lost to Follow-up|2|||
144240504|NCT02841280|520076690|FG000|Overall Study|Withdrawal by Subject|7|||
144270064|NCT03098979|520193274|FG000|Overall Study|Withdrawal by Subject|2|||
144270065|NCT03098979|520193275|FG001|Overall Study|Withdrawal by Subject|1|||
144240505|NCT02841280|520076691|FG001|Overall Study|Withdrawal by Subject|3|||
144240506|NCT02841280|520076690|FG000|Overall Study|Stop Point: BP above threshold|2|||
144240507|NCT02841280|520076691|FG001|Overall Study|Stop Point: BP above threshold|0|||
144240508|NCT04553471|520076692|FG000|Overall Study|Did not start treatment on protocol|3|||
144240509|NCT04553471|520076692|FG000|Overall Study|Death|1|||
144240510|NCT01340027|520076694|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
144240511|NCT01340027|520076695|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
144240512|NCT01340027|520076696|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
144240513|NCT01340027|520076697|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
144240514|NCT01340027|520076698|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
144240515|NCT01340027|520076699|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
144240516|NCT01340027|520076700|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
144240517|NCT01340027|520076701|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
144240518|NCT01340027|520076702|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
144240519|NCT01340027|520076703|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
144240520|NCT01340027|520076704|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
144240521|NCT01340027|520076705|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
144240522|NCT01340027|520076694|FG000|Overall Study|Adverse Event|0|||
144240523|NCT01340027|520076695|FG001|Overall Study|Adverse Event|1|||
144240524|NCT01340027|520076696|FG002|Overall Study|Adverse Event|2|||
144240525|NCT01340027|520076697|FG003|Overall Study|Adverse Event|0|||
144240526|NCT01340027|520076698|FG004|Overall Study|Adverse Event|1|||
144240527|NCT01340027|520076699|FG005|Overall Study|Adverse Event|2|||
144240528|NCT01340027|520076700|FG006|Overall Study|Adverse Event|2|||
144240529|NCT01340027|520076701|FG007|Overall Study|Adverse Event|1|||
144240530|NCT01340027|520076702|FG008|Overall Study|Adverse Event|4|||
144240531|NCT01340027|520076703|FG009|Overall Study|Adverse Event|1|||
144240532|NCT01340027|520076704|FG010|Overall Study|Adverse Event|1|||
144240533|NCT01340027|520076705|FG011|Overall Study|Adverse Event|3|||
144240534|NCT01340027|520076694|FG000|Overall Study|Lack of Efficacy|0|||
144240535|NCT01340027|520076695|FG001|Overall Study|Lack of Efficacy|0|||
144240536|NCT01340027|520076696|FG002|Overall Study|Lack of Efficacy|0|||
144240537|NCT01340027|520076697|FG003|Overall Study|Lack of Efficacy|0|||
144240538|NCT01340027|520076698|FG004|Overall Study|Lack of Efficacy|0|||
144240539|NCT01340027|520076699|FG005|Overall Study|Lack of Efficacy|0|||
144240540|NCT01340027|520076700|FG006|Overall Study|Lack of Efficacy|1|||
144240541|NCT01340027|520076701|FG007|Overall Study|Lack of Efficacy|1|||
144240542|NCT01340027|520076702|FG008|Overall Study|Lack of Efficacy|1|||
144240543|NCT01340027|520076703|FG009|Overall Study|Lack of Efficacy|0|||
144240544|NCT01340027|520076704|FG010|Overall Study|Lack of Efficacy|0|||
144240545|NCT01340027|520076705|FG011|Overall Study|Lack of Efficacy|0|||
144240546|NCT01340027|520076694|FG000|Overall Study|Lost to Follow-up|0|||
144240547|NCT01340027|520076695|FG001|Overall Study|Lost to Follow-up|1|||
144240548|NCT01340027|520076696|FG002|Overall Study|Lost to Follow-up|0|||
144240549|NCT01340027|520076697|FG003|Overall Study|Lost to Follow-up|0|||
144240550|NCT01340027|520076698|FG004|Overall Study|Lost to Follow-up|0|||
144240551|NCT01340027|520076699|FG005|Overall Study|Lost to Follow-up|0|||
144240552|NCT01340027|520076700|FG006|Overall Study|Lost to Follow-up|1|||
144240553|NCT01340027|520076701|FG007|Overall Study|Lost to Follow-up|0|||
144240554|NCT01340027|520076702|FG008|Overall Study|Lost to Follow-up|0|||
144240555|NCT01340027|520076703|FG009|Overall Study|Lost to Follow-up|1|||
144240556|NCT01340027|520076704|FG010|Overall Study|Lost to Follow-up|0|||
144240557|NCT01340027|520076705|FG011|Overall Study|Lost to Follow-up|0|||
144240558|NCT01340027|520076694|FG000|Overall Study|Protocol Violation|1|||
144240559|NCT01340027|520076695|FG001|Overall Study|Protocol Violation|2|||
144240560|NCT01340027|520076696|FG002|Overall Study|Protocol Violation|0|||
144240561|NCT01340027|520076697|FG003|Overall Study|Protocol Violation|0|||
144240562|NCT01340027|520076698|FG004|Overall Study|Protocol Violation|6|||
144240563|NCT01340027|520076699|FG005|Overall Study|Protocol Violation|0|||
144240564|NCT01340027|520076700|FG006|Overall Study|Protocol Violation|0|||
144240565|NCT01340027|520076701|FG007|Overall Study|Protocol Violation|1|||
144240566|NCT01340027|520076702|FG008|Overall Study|Protocol Violation|2|||
144240567|NCT01340027|520076703|FG009|Overall Study|Protocol Violation|2|||
144240568|NCT01340027|520076704|FG010|Overall Study|Protocol Violation|0|||
144240569|NCT01340027|520076705|FG011|Overall Study|Protocol Violation|0|||
144240570|NCT01340027|520076694|FG000|Overall Study|Withdrawal by Subject|4|||
144240571|NCT01340027|520076695|FG001|Overall Study|Withdrawal by Subject|3|||
144240572|NCT01340027|520076696|FG002|Overall Study|Withdrawal by Subject|1|||
144240573|NCT01340027|520076697|FG003|Overall Study|Withdrawal by Subject|3|||
144240574|NCT01340027|520076698|FG004|Overall Study|Withdrawal by Subject|3|||
144240575|NCT01340027|520076699|FG005|Overall Study|Withdrawal by Subject|2|||
144240576|NCT01340027|520076700|FG006|Overall Study|Withdrawal by Subject|3|||
144240577|NCT01340027|520076701|FG007|Overall Study|Withdrawal by Subject|4|||
144240578|NCT01340027|520076702|FG008|Overall Study|Withdrawal by Subject|1|||
144240579|NCT01340027|520076703|FG009|Overall Study|Withdrawal by Subject|2|||
144240580|NCT01340027|520076704|FG010|Overall Study|Withdrawal by Subject|0|||
144240581|NCT01340027|520076705|FG011|Overall Study|Withdrawal by Subject|1|||
144240582|NCT01340027|520076694|FG000|Overall Study|Miscellaneous|0|||
144240583|NCT01340027|520076695|FG001|Overall Study|Miscellaneous|0|||
144240584|NCT01340027|520076696|FG002|Overall Study|Miscellaneous|0|||
144240585|NCT01340027|520076697|FG003|Overall Study|Miscellaneous|1|||
144240586|NCT01340027|520076698|FG004|Overall Study|Miscellaneous|0|||
144240587|NCT01340027|520076699|FG005|Overall Study|Miscellaneous|0|||
144240588|NCT01340027|520076700|FG006|Overall Study|Miscellaneous|0|||
144240589|NCT01340027|520076701|FG007|Overall Study|Miscellaneous|0|||
144240590|NCT01340027|520076702|FG008|Overall Study|Miscellaneous|0|||
144240591|NCT01340027|520076703|FG009|Overall Study|Miscellaneous|0|||
144240592|NCT01340027|520076704|FG010|Overall Study|Miscellaneous|1|||
144240593|NCT01340027|520076705|FG011|Overall Study|Miscellaneous|0|||
144240594|NCT00833482|520076706|FG000|Days 11-20|Adverse Event|0|||
144240595|NCT00833482|520076707|FG001|Days 11-20|Adverse Event|2|||
144240596|NCT00833482|520076708|FG002|Days 11-20|Adverse Event|0|||
144240597|NCT00833482|520076709|FG003|Days 11-20|Adverse Event|0|||
144240598|NCT00833482|520076710|FG004|Days 11-20|Adverse Event|0|||
144240599|NCT00833482|520076711|FG005|Days 11-20|Adverse Event|0|||
144240600|NCT00833482|520076706|FG000|Days 11-20|Withdrawal by Subject|0|||
144240601|NCT00833482|520076707|FG001|Days 11-20|Withdrawal by Subject|1|||
144240602|NCT00833482|520076708|FG002|Days 11-20|Withdrawal by Subject|0|||
144240603|NCT00833482|520076709|FG003|Days 11-20|Withdrawal by Subject|0|||
144240604|NCT00833482|520076710|FG004|Days 11-20|Withdrawal by Subject|0|||
144240605|NCT00833482|520076711|FG005|Days 11-20|Withdrawal by Subject|0|||
144240606|NCT00833482|520076706|FG000|Days 21-30|Adverse Event|0|||
144240607|NCT00833482|520076707|FG001|Days 21-30|Adverse Event|0|||
144240608|NCT00833482|520076708|FG002|Days 21-30|Adverse Event|1|||
144240609|NCT00833482|520076709|FG003|Days 21-30|Adverse Event|0|||
144240610|NCT00833482|520076710|FG004|Days 21-30|Adverse Event|0|||
144240611|NCT00833482|520076711|FG005|Days 21-30|Adverse Event|0|||
144240612|NCT00833482|520076706|FG000|Days 21-30|Withdrawal by Subject|0|||
144240613|NCT00833482|520076707|FG001|Days 21-30|Withdrawal by Subject|0|||
144240614|NCT00833482|520076708|FG002|Days 21-30|Withdrawal by Subject|0|||
144240615|NCT00833482|520076709|FG003|Days 21-30|Withdrawal by Subject|0|||
144240616|NCT00833482|520076710|FG004|Days 21-30|Withdrawal by Subject|1|||
144240617|NCT00833482|520076711|FG005|Days 21-30|Withdrawal by Subject|0|||
144240618|NCT02496091|520076712|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
144240619|NCT01970475|520076716|FG000|Overall Study|Withdrawal by Subject|11|||
144240620|NCT01970475|520076717|FG001|Overall Study|Withdrawal by Subject|6|||
144240621|NCT01970475|520076716|FG000|Overall Study|Adverse Event|7|||
144240622|NCT01970475|520076717|FG001|Overall Study|Adverse Event|3|||
144240623|NCT01970475|520076716|FG000|Overall Study|Lost to Follow-up|2|||
144240624|NCT01970475|520076717|FG001|Overall Study|Lost to Follow-up|2|||
144240625|NCT01970475|520076716|FG000|Overall Study|Protocol Violation|1|||
144240626|NCT01970475|520076717|FG001|Overall Study|Protocol Violation|0|||
144240627|NCT04166591|520078334|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
144240628|NCT04166591|520078335|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
144240629|NCT04166591|520078336|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144240630|NCT04166591|520078337|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144240631|NCT04166591|520078334|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
144240632|NCT04166591|520078335|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
144240633|NCT04166591|520078336|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144240634|NCT04166591|520078337|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
144240635|NCT03030989|520078338|FG000|Overall Study|Fever|2|||
144240636|NCT03030989|520078339|FG001|Overall Study|Fever|2|||
144240637|NCT03030989|520078338|FG000|Overall Study|Rash|2|||
144240638|NCT03030989|520078339|FG001|Overall Study|Rash|1|||
144240639|NCT03030989|520078338|FG000|Overall Study|Fatigue/Overwhelmed|1|||
144240640|NCT03030989|520078339|FG001|Overall Study|Fatigue/Overwhelmed|5|||
144240641|NCT03030989|520078338|FG000|Overall Study|Positive Blood Cultures|2|||
144240642|NCT03030989|520078339|FG001|Overall Study|Positive Blood Cultures|1|||
144240643|NCT03030989|520078338|FG000|Overall Study|Line Removed|0|||
144240644|NCT03030989|520078339|FG001|Overall Study|Line Removed|2|||
144240645|NCT03030989|520078338|FG000|Overall Study|No longer interested|5|||
144240646|NCT03030989|520078339|FG001|Overall Study|No longer interested|3|||
144240647|NCT02730377|520078340|FG000|Overall Study|Other|5|||
144240648|NCT02730377|520078341|FG001|Overall Study|Other|4|||
144240649|NCT02730377|520078340|FG000|Overall Study|Death|1|||
144240650|NCT02730377|520078341|FG001|Overall Study|Death|8|||
144240651|NCT02730377|520078340|FG000|Overall Study|Inadequate glycaemic control|368|||
144240652|NCT02730377|520078341|FG001|Overall Study|Inadequate glycaemic control|473|||
144240653|NCT02730377|520078340|FG000|Overall Study|Adverse Event|79|||
144240654|NCT02730377|520078341|FG001|Overall Study|Adverse Event|41|||
144240655|NCT02730377|520078340|FG000|Overall Study|Protocol Violation|23|||
144240656|NCT02730377|520078341|FG001|Overall Study|Protocol Violation|30|||
144240657|NCT02730377|520078340|FG000|Overall Study|Lack of Efficacy|4|||
144240658|NCT02730377|520078341|FG001|Overall Study|Lack of Efficacy|13|||
144240659|NCT02730377|520078340|FG000|Overall Study|Pregnancy|0|||
144240660|NCT02730377|520078341|FG001|Overall Study|Pregnancy|1|||
144240661|NCT02730377|520078340|FG000|Overall Study|Withdrawal by Subject|45|||
144240662|NCT02730377|520078341|FG001|Overall Study|Withdrawal by Subject|42|||
144240663|NCT02730377|520078340|FG000|Overall Study|Lost to Follow-up|25|||
144240664|NCT02730377|520078341|FG001|Overall Study|Lost to Follow-up|21|||
144270066|NCT03098979|520193276|FG002|Overall Study|Withdrawal by Subject|1|||
144270067|NCT03098979|520193277|FG003|Overall Study|Withdrawal by Subject|1|||
144270068|NCT03098979|520193278|FG004|Overall Study|Withdrawal by Subject|2|||
144270069|NCT03098979|520193279|FG005|Overall Study|Withdrawal by Subject|1|||
144270070|NCT03098979|520193274|FG000|Overall Study|Death|1|||
144270071|NCT03098979|520193275|FG001|Overall Study|Death|0|||
144270072|NCT03098979|520193276|FG002|Overall Study|Death|2|||
144270073|NCT03098979|520193277|FG003|Overall Study|Death|0|||
144270074|NCT03098979|520193278|FG004|Overall Study|Death|1|||
144270075|NCT03098979|520193279|FG005|Overall Study|Death|0|||
144270076|NCT03098979|520193274|FG000|Overall Study|Physician Decision|2|||
144270077|NCT03098979|520193275|FG001|Overall Study|Physician Decision|1|||
144270078|NCT03098979|520193276|FG002|Overall Study|Physician Decision|0|||
144270079|NCT03098979|520193277|FG003|Overall Study|Physician Decision|0|||
144270080|NCT03098979|520193278|FG004|Overall Study|Physician Decision|0|||
144270081|NCT03098979|520193279|FG005|Overall Study|Physician Decision|0|||
144270082|NCT03098979|520193274|FG000|Overall Study|Non-compliance|0|||
144270083|NCT03098979|520193275|FG001|Overall Study|Non-compliance|0|||
144270084|NCT03098979|520193276|FG002|Overall Study|Non-compliance|0|||
144270085|NCT03098979|520193277|FG003|Overall Study|Non-compliance|0|||
144270086|NCT03098979|520193278|FG004|Overall Study|Non-compliance|0|||
144270087|NCT03098979|520193279|FG005|Overall Study|Non-compliance|1|||
144270088|NCT03098979|520193274|FG000|Overall Study|Protocol Violation|0|||
144270089|NCT03098979|520193275|FG001|Overall Study|Protocol Violation|0|||
144270090|NCT03098979|520193276|FG002|Overall Study|Protocol Violation|0|||
144270091|NCT03098979|520193277|FG003|Overall Study|Protocol Violation|0|||
144270092|NCT03098979|520193278|FG004|Overall Study|Protocol Violation|0|||
144270093|NCT03098979|520193279|FG005|Overall Study|Protocol Violation|1|||
144270094|NCT03736967|520193280|FG000|Overall Study|Withdrawal by Subject|26|||
144270095|NCT03736967|520193281|FG001|Overall Study|Withdrawal by Subject|25|||
144270096|NCT03736967|520193282|FG002|Overall Study|Withdrawal by Subject|23|||
144270097|NCT03736967|520193283|FG003|Overall Study|Withdrawal by Subject|26|||
144270098|NCT03736967|520193280|FG000|Overall Study|Lost to Follow-up|3|||
144270099|NCT03736967|520193281|FG001|Overall Study|Lost to Follow-up|2|||
144270100|NCT03736967|520193282|FG002|Overall Study|Lost to Follow-up|1|||
144270101|NCT03736967|520193283|FG003|Overall Study|Lost to Follow-up|1|||
144270102|NCT03736967|520193280|FG000|Overall Study|Physician Decision|1|||
144270103|NCT03736967|520193281|FG001|Overall Study|Physician Decision|0|||
144270104|NCT03736967|520193282|FG002|Overall Study|Physician Decision|0|||
144270105|NCT03736967|520193283|FG003|Overall Study|Physician Decision|1|||
144270106|NCT03736967|520193280|FG000|Overall Study|Adverse Event|0|||
144270107|NCT03736967|520193281|FG001|Overall Study|Adverse Event|1|||
144270108|NCT03736967|520193282|FG002|Overall Study|Adverse Event|0|||
144270109|NCT03736967|520193283|FG003|Overall Study|Adverse Event|1|||
144270110|NCT03736967|520193280|FG000|Overall Study|Death|0|||
144270111|NCT03736967|520193281|FG001|Overall Study|Death|0|||
144270112|NCT03736967|520193282|FG002|Overall Study|Death|0|||
144270113|NCT03736967|520193283|FG003|Overall Study|Death|1|||
144270114|NCT03736967|520193280|FG000|Overall Study|Randomized but never treated|1|||
144270115|NCT03736967|520193281|FG001|Overall Study|Randomized but never treated|0|||
144270116|NCT03736967|520193282|FG002|Overall Study|Randomized but never treated|0|||
144270117|NCT03736967|520193283|FG003|Overall Study|Randomized but never treated|0|||
144270118|NCT02369653|520193284|FG000|Overall Study|Lost to Follow-up|0|||
144270119|NCT02369653|520193285|FG001|Overall Study|Lost to Follow-up|1|||
144270120|NCT02369653|520193284|FG000|Overall Study|Administrative reason by sponsor|0|||
144270121|NCT02369653|520193285|FG001|Overall Study|Administrative reason by sponsor|1|||
144270122|NCT02369653|520193284|FG000|Overall Study|Death|1|||
144270123|NCT02369653|520193285|FG001|Overall Study|Death|2|||
144270124|NCT02369653|520193284|FG000|Overall Study|Participant withdrew consent|13|||
144270125|NCT02369653|520193285|FG001|Overall Study|Participant withdrew consent|3|||
144270126|NCT02419807|520193286|FG000|Overall Study|Withdrawal by Subject|4|||
144270127|NCT02419807|520193286|FG000|Overall Study|Physician Decision|1|||
144270128|NCT02419807|520193286|FG000|Overall Study|Protocol Violation|5|||
144270129|NCT03587636|520193287|FG000|Overall Study|Lost to Follow-up|2|||
144270130|NCT03587636|520193288|FG001|Overall Study|Lost to Follow-up|5|||
144270131|NCT00316004|520193289|FG000|Overall Study|Subject was not given study fluid.|14|||
144270132|NCT00316004|520193290|FG001|Overall Study|Subject was not given study fluid.|14|||
144270133|NCT00316004|520193291|FG002|Overall Study|Subject was not given study fluid.|21|||
144270134|NCT01065818|520193292|FG000|Overall Study|Withdrawal by Subject|1|||
144270135|NCT01065818|520193292|FG000|Overall Study|Not a candidate for surgery|1|||
144270136|NCT04459338|520193295|FG000|Overall Study|Loss of IV during study|1|||
144270137|NCT04459338|520193296|FG001|Overall Study|Loss of IV during study|0|||
144270138|NCT02665117|520193297|FG000|Overall Study|Physician Decision|1|||
144270139|NCT02665117|520193298|FG001|Overall Study|Physician Decision|0|||
144270140|NCT03502798|520193299|FG000|Overall Study|equipment failure|0|||
144270141|NCT03502798|520193300|FG001|Overall Study|equipment failure|7|||
144270142|NCT01603277|520193302|FG000|Overall Study|Adverse Event|1|||
144270143|NCT01603277|520193303|FG001|Overall Study|Adverse Event|2|||
144270144|NCT01603277|520193302|FG000|Overall Study|Physician Decision|0|||
144270145|NCT01603277|520193303|FG001|Overall Study|Physician Decision|1|||
144270146|NCT01603277|520193302|FG000|Overall Study|Protocol Violation|6|||
144270147|NCT01603277|520193303|FG001|Overall Study|Protocol Violation|10|||
144270148|NCT01603277|520193302|FG000|Overall Study|Withdrawal by Subject|5|||
144270149|NCT01603277|520193303|FG001|Overall Study|Withdrawal by Subject|4|||
144270150|NCT01603277|520193302|FG000|Overall Study|Non-Compliance|2|||
144270151|NCT01603277|520193303|FG001|Overall Study|Non-Compliance|1|||
144270152|NCT01692119|520193304|FG000|Overall Study|Protocol Violation|3|||
144270153|NCT01692119|520193305|FG001|Overall Study|Protocol Violation|1|||
144270154|NCT01692119|520193304|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
144270155|NCT01692119|520193305|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
144270156|NCT00112957|520193306|FG000|Overall Study|Progressive disease|18|||
144270157|NCT00112957|520193306|FG000|Overall Study|Physician Decision|1|||
144270158|NCT03307174|520193307|FG000|Overall Study|Unplanned ICU Administrion|5|||
144270159|NCT03307174|520193308|FG001|Overall Study|Unplanned ICU Administrion|3|||
144270160|NCT03307174|520193307|FG000|Overall Study|Aborted Surgery|1|||
144270161|NCT03307174|520193308|FG001|Overall Study|Aborted Surgery|2|||
144270162|NCT03307174|520193307|FG000|Overall Study|Hypotension|6|||
144270163|NCT03307174|520193308|FG001|Overall Study|Hypotension|0|||
144270164|NCT03307174|520193307|FG000|Overall Study|Nonfunctional epidural|1|||
144270165|NCT03307174|520193308|FG001|Overall Study|Nonfunctional epidural|1|||
144270166|NCT03307174|520193307|FG000|Overall Study|Planned epidural removal|1|||
144270167|NCT03307174|520193308|FG001|Overall Study|Planned epidural removal|0|||
144270168|NCT03307174|520193307|FG000|Overall Study|Intrathecal catheter placement|0|||
144270169|NCT03307174|520193308|FG001|Overall Study|Intrathecal catheter placement|1|||
144270170|NCT03444584|520193311|FG000|Overall Study|Withdrawal by Subject|0|||
144270171|NCT03444584|520193312|FG001|Overall Study|Withdrawal by Subject|1|||
144270172|NCT03444584|520193311|FG000|Overall Study|Other|0|||
144270173|NCT03444584|520193312|FG001|Overall Study|Other|1|||
144270174|NCT03451045|520193313|FG000|Overall Study|Lack of Efficacy|3|||
144270175|NCT03451045|520193314|FG001|Overall Study|Lack of Efficacy|2|||
144270176|NCT03451045|520193315|FG002|Overall Study|Lack of Efficacy|2|||
144270177|NCT03451045|520193313|FG000|Overall Study|Physician Decision|1|||
144270178|NCT03451045|520193314|FG001|Overall Study|Physician Decision|1|||
144270179|NCT03451045|520193315|FG002|Overall Study|Physician Decision|1|||
144270180|NCT03451045|520193313|FG000|Overall Study|Withdrawal by Subject|4|||
144270181|NCT03451045|520193314|FG001|Overall Study|Withdrawal by Subject|0|||
144270182|NCT03451045|520193315|FG002|Overall Study|Withdrawal by Subject|5|||
144270183|NCT03451045|520193313|FG000|Overall Study|Pregnancy|0|||
144270184|NCT03451045|520193314|FG001|Overall Study|Pregnancy|0|||
144270185|NCT03451045|520193315|FG002|Overall Study|Pregnancy|2|||
144270186|NCT03451045|520193313|FG000|Overall Study|Adverse Event|7|||
144270187|NCT03451045|520193314|FG001|Overall Study|Adverse Event|1|||
144270188|NCT03451045|520193315|FG002|Overall Study|Adverse Event|3|||
144270189|NCT03451045|520193313|FG000|Overall Study|Non-compliance with study|2|||
144270190|NCT03451045|520193314|FG001|Overall Study|Non-compliance with study|0|||
144270191|NCT03451045|520193315|FG002|Overall Study|Non-compliance with study|1|||
144270192|NCT03451045|520193313|FG000|Overall Study|any other reason|10|||
144270193|NCT03451045|520193314|FG001|Overall Study|any other reason|2|||
144270194|NCT03451045|520193315|FG002|Overall Study|any other reason|13|||
144270195|NCT01142336|520193316|FG000|Overall Study|Adverse Event|1|||
144270196|NCT01142336|520193317|FG001|Overall Study|Adverse Event|1|||
144270197|NCT01142336|520193316|FG000|Overall Study|Lost to Follow-up|0|||
144270198|NCT01142336|520193317|FG001|Overall Study|Lost to Follow-up|1|||
144270199|NCT00423046|520193318|FG000|Overall Study|Other|340|||
144270200|NCT00423046|520193319|FG001|Overall Study|Other|345|||
144270201|NCT02722967|520193320|FG000|Overall Study|Adverse Event|1|||
144270202|NCT02722967|520193321|FG001|Overall Study|Adverse Event|0|||
144270203|NCT02722967|520193322|FG002|Overall Study|Adverse Event|0|||
144270204|NCT02722967|520193320|FG000|Overall Study|Lost to Follow-up|0|||
144270205|NCT02722967|520193321|FG001|Overall Study|Lost to Follow-up|1|||
144270206|NCT02722967|520193322|FG002|Overall Study|Lost to Follow-up|0|||
144270207|NCT02722967|520193320|FG000|Overall Study|Non-compliance with patch wearing|2|||
144270208|NCT02722967|520193321|FG001|Overall Study|Non-compliance with patch wearing|1|||
144270209|NCT02722967|520193322|FG002|Overall Study|Non-compliance with patch wearing|1|||
144270210|NCT02722967|520193320|FG000|Overall Study|Withdrawal by Subject|1|||
144270211|NCT02722967|520193321|FG001|Overall Study|Withdrawal by Subject|0|||
144270212|NCT02722967|520193322|FG002|Overall Study|Withdrawal by Subject|1|||
144270213|NCT02722967|520193320|FG000|Overall Study|Physician Decision|1|||
144270214|NCT02722967|520193321|FG001|Overall Study|Physician Decision|0|||
144270215|NCT02722967|520193322|FG002|Overall Study|Physician Decision|0|||
144270216|NCT02722967|520193320|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
144240665|NCT02031640|520078342|FG000|Screening Period|Adverse Event|1|||
144240666|NCT02031640|520078343|FG001|Screening Period|Adverse Event|0|||
144240667|NCT02031640|520078344|FG002|Screening Period|Adverse Event|0|||
144240668|NCT02031640|520078345|FG003|Screening Period|Adverse Event|0|||
144240669|NCT02031640|520078346|FG004|Screening Period|Adverse Event|0|||
144240670|NCT02031640|520078347|FG005|Screening Period|Adverse Event|0|||
144240671|NCT02031640|520078342|FG000|Screening Period|Withdrawal by Subject|29|||
144240672|NCT02031640|520078343|FG001|Screening Period|Withdrawal by Subject|0|||
144240673|NCT02031640|520078344|FG002|Screening Period|Withdrawal by Subject|0|||
144240674|NCT02031640|520078345|FG003|Screening Period|Withdrawal by Subject|0|||
144240675|NCT02031640|520078346|FG004|Screening Period|Withdrawal by Subject|0|||
144240676|NCT02031640|520078347|FG005|Screening Period|Withdrawal by Subject|0|||
144240677|NCT02031640|520078342|FG000|Screening Period|Inclusion criteria not met|312|||
144240678|NCT02031640|520078343|FG001|Screening Period|Inclusion criteria not met|0|||
144240679|NCT02031640|520078344|FG002|Screening Period|Inclusion criteria not met|0|||
144240680|NCT02031640|520078345|FG003|Screening Period|Inclusion criteria not met|0|||
144270217|NCT02722967|520193321|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
144270218|NCT02722967|520193322|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
144270219|NCT02391337|520193323|FG000|6 Months Follow-up|Death|5|||
144270220|NCT02391337|520193324|FG001|6 Months Follow-up|Death|4|||
144270221|NCT02391337|520193323|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
144270222|NCT02391337|520193324|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
144270223|NCT02391337|520193323|FG000|12 Months Follow-up|Death|2|||
144270224|NCT02391337|520193324|FG001|12 Months Follow-up|Death|0|||
144270225|NCT02391337|520193323|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
144270226|NCT02391337|520193324|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
144270227|NCT02391337|520193323|FG000|12 Months Follow-up|Lost to Follow-up|0|||
144270228|NCT02391337|520193324|FG001|12 Months Follow-up|Lost to Follow-up|2|||
144270229|NCT01286129|520193326|FG000|Overall Study|Withdrawal by Subject|4|||
144270230|NCT01286129|520193327|FG001|Overall Study|Withdrawal by Subject|1|||
144270231|NCT01286129|520193326|FG000|Overall Study|Could not comply with study requirements|4|||
144270232|NCT01286129|520193327|FG001|Overall Study|Could not comply with study requirements|4|||
144270233|NCT00830128|520193328|FG000|Overall Study|Adverse Event|5|||
144270234|NCT00830128|520193328|FG000|Overall Study|Lack of Efficacy|7|||
144270235|NCT00830128|520193328|FG000|Overall Study|Protocol Violation|1|||
144270236|NCT00830128|520193328|FG000|Overall Study|Withdrawal by Subject|2|||
144270237|NCT00830128|520193328|FG000|Overall Study|Family obligation|1|||
144270238|NCT00830128|520193328|FG000|Overall Study|Relocation|1|||
144270239|NCT00830128|520193328|FG000|Overall Study|Work obligation|1|||
144270240|NCT00830128|520193328|FG000|Overall Study|Operating a vehicle|1|||
144270241|NCT04142242|520193333|FG000|Stage I|Non-compliance with the protocol|1|||
144270242|NCT04142242|520193334|FG001|Stage I|Non-compliance with the protocol|0|||
144270243|NCT04142242|520193335|FG002|Stage I|Non-compliance with the protocol|0|||
144270244|NCT04142242|520193336|FG003|Stage I|Non-compliance with the protocol|0|||
144270245|NCT04142242|520193337|FG004|Stage I|Non-compliance with the protocol|0|||
144270246|NCT04142242|520193338|FG005|Stage I|Non-compliance with the protocol|1|||
144270247|NCT04142242|520193333|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
144270248|NCT04142242|520193334|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
144270249|NCT04142242|520193335|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
144270250|NCT04142242|520193336|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
144270251|NCT04142242|520193337|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
144270252|NCT04142242|520193338|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
144270253|NCT04142242|520193333|FG000|Stage II|Non-compliance with the protocol|0|||
144270254|NCT04142242|520193334|FG001|Stage II|Non-compliance with the protocol|0|||
144270255|NCT04142242|520193335|FG002|Stage II|Non-compliance with the protocol|0|||
144270256|NCT04142242|520193336|FG003|Stage II|Non-compliance with the protocol|2|||
144270257|NCT04142242|520193337|FG004|Stage II|Non-compliance with the protocol|0|||
144270258|NCT04142242|520193338|FG005|Stage II|Non-compliance with the protocol|0|||
144270259|NCT04142242|520193333|FG000|Stage II|Lost to Follow-up|0|||
144270260|NCT04142242|520193334|FG001|Stage II|Lost to Follow-up|0|||
144270261|NCT04142242|520193335|FG002|Stage II|Lost to Follow-up|1|||
144270262|NCT04142242|520193336|FG003|Stage II|Lost to Follow-up|2|||
144270263|NCT04142242|520193337|FG004|Stage II|Lost to Follow-up|0|||
144270264|NCT04142242|520193338|FG005|Stage II|Lost to Follow-up|0|||
144270265|NCT04142242|520193333|FG000|Stage II|Withdrawal by Subject|0|||
144270266|NCT04142242|520193334|FG001|Stage II|Withdrawal by Subject|0|||
144270267|NCT04142242|520193335|FG002|Stage II|Withdrawal by Subject|5|||
144270268|NCT04142242|520193336|FG003|Stage II|Withdrawal by Subject|9|||
144270269|NCT04142242|520193337|FG004|Stage II|Withdrawal by Subject|0|||
144270270|NCT04142242|520193338|FG005|Stage II|Withdrawal by Subject|0|||
144270271|NCT00846053|520193341|FG000|Overall Study|Physician Decision|3|||
144270272|NCT00846053|520193342|FG001|Overall Study|Physician Decision|0|||
144270273|NCT00467519|520193351|FG000|Overall Study|Protocol Violation|8|||
144270274|NCT00467519|520193352|FG001|Overall Study|Protocol Violation|4|||
144270275|NCT00467519|520193351|FG000|Overall Study|Lost to Follow-up|2|||
144270276|NCT00467519|520193352|FG001|Overall Study|Lost to Follow-up|9|||
144270277|NCT00467519|520193351|FG000|Overall Study|Withdrawal by Subject|4|||
144270278|NCT00467519|520193352|FG001|Overall Study|Withdrawal by Subject|10|||
144270279|NCT01218802|520193353|FG000|Overall Study|Lost to Follow-up|5|||
144270280|NCT01218802|520193354|FG001|Overall Study|Lost to Follow-up|6|||
144270281|NCT01218802|520193353|FG000|Overall Study|Withdrawal by Subject|3|||
144270282|NCT01218802|520193354|FG001|Overall Study|Withdrawal by Subject|10|||
144270283|NCT01218802|520193353|FG000|Overall Study|Adverse Event|0|||
144270284|NCT01218802|520193354|FG001|Overall Study|Adverse Event|2|||
144270285|NCT01218802|520193353|FG000|Overall Study|Incarcerated|2|||
144270286|NCT01218802|520193354|FG001|Overall Study|Incarcerated|0|||
144270287|NCT00062166|520193357|FG000|Overall Study|Withdrawal by Subject|6|||
144270288|NCT02475369|520193361|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
144270289|NCT02475369|520193362|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
144270290|NCT03883386|520193368|FG000|First Assignment|Lost to Follow-up|1|||
144270291|NCT03883386|520193369|FG001|First Assignment|Lost to Follow-up|0|||
144270292|NCT03883386|520193368|FG000|First Assignment|Withdrawal by Subject|1|||
144270293|NCT03883386|520193369|FG001|First Assignment|Withdrawal by Subject|1|||
144270294|NCT00251758|520193370|FG000|Overall Study|Adverse Event|7|||
144270295|NCT00251758|520193371|FG001|Overall Study|Adverse Event|9|||
144270296|NCT00251758|520193372|FG002|Overall Study|Adverse Event|11|||
144270297|NCT00251758|520193370|FG000|Overall Study|Lost to Follow-up|4|||
144270298|NCT00251758|520193371|FG001|Overall Study|Lost to Follow-up|2|||
144270299|NCT00251758|520193372|FG002|Overall Study|Lost to Follow-up|5|||
144270300|NCT00251758|520193370|FG000|Overall Study|Withdrawal by Subject|13|||
144270301|NCT00251758|520193371|FG001|Overall Study|Withdrawal by Subject|7|||
144270302|NCT00251758|520193372|FG002|Overall Study|Withdrawal by Subject|3|||
144270303|NCT00251758|520193370|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
144270304|NCT00251758|520193371|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
144270305|NCT00251758|520193372|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
144270306|NCT00251758|520193370|FG000|Overall Study|Lack of Efficacy|3|||
144270307|NCT00251758|520193371|FG001|Overall Study|Lack of Efficacy|0|||
144270308|NCT00251758|520193372|FG002|Overall Study|Lack of Efficacy|0|||
144270309|NCT00251758|520193370|FG000|Overall Study|Noncompliant|0|||
144270310|NCT00251758|520193371|FG001|Overall Study|Noncompliant|2|||
144270311|NCT00251758|520193372|FG002|Overall Study|Noncompliant|2|||
144270312|NCT00251758|520193370|FG000|Overall Study|Pregnancy|0|||
144270313|NCT00251758|520193371|FG001|Overall Study|Pregnancy|1|||
144270314|NCT00251758|520193372|FG002|Overall Study|Pregnancy|0|||
144270315|NCT00251758|520193370|FG000|Overall Study|Per Subject Request|0|||
144270316|NCT00251758|520193371|FG001|Overall Study|Per Subject Request|0|||
144270317|NCT00251758|520193372|FG002|Overall Study|Per Subject Request|1|||
144270318|NCT00251758|520193370|FG000|Overall Study|Per Investigator Request|1|||
144270319|NCT00251758|520193371|FG001|Overall Study|Per Investigator Request|0|||
144270320|NCT00251758|520193372|FG002|Overall Study|Per Investigator Request|0|||
144270321|NCT03641508|520193376|FG000|First Injection|Lost to Follow-up|2|||
144270322|NCT03641508|520193377|FG001|First Injection|Lost to Follow-up|0|||
144270323|NCT00769561|520193381|FG000|Overall Study|Withdrawal by Subject|2|||
144270324|NCT00769561|520193382|FG001|Overall Study|Withdrawal by Subject|2|||
144270325|NCT00769561|520193381|FG000|Overall Study|Lost to Follow-up|1|||
144270326|NCT00769561|520193382|FG001|Overall Study|Lost to Follow-up|3|||
144270327|NCT03824561|520193390|FG000|Overall Study|Protocol Violation|19|||
144270328|NCT03191552|520193391|FG000|Overall Study|Lost to Follow-up|1|||
144270329|NCT03191552|520193392|FG001|Overall Study|Lost to Follow-up|0|||
144270330|NCT03191552|520193393|FG002|Overall Study|Lost to Follow-up|0|||
144270331|NCT03191552|520193391|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
144270332|NCT03191552|520193392|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
144270333|NCT03191552|520193393|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
144270334|NCT01149655|520193394|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
144270335|NCT01149655|520193395|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
144270336|NCT01149655|520193396|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
144270337|NCT01149655|520193397|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
144270338|NCT01149655|520193394|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
144270339|NCT01149655|520193395|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
144270340|NCT01149655|520193396|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
144270341|NCT01149655|520193397|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
144270342|NCT01149655|520193394|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
144270343|NCT01149655|520193395|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
144270344|NCT01149655|520193396|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
144270345|NCT01149655|520193397|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
144270346|NCT01149655|520193394|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
144270347|NCT01149655|520193395|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
144270348|NCT01149655|520193396|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
144270349|NCT01149655|520193397|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
144270350|NCT01149655|520193394|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
144270351|NCT01149655|520193395|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
144270352|NCT01149655|520193396|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
144270353|NCT01149655|520193397|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
144270354|NCT01149655|520193394|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
144270355|NCT01149655|520193395|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
144270356|NCT01149655|520193396|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
144270357|NCT01149655|520193397|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
144270358|NCT01149655|520193394|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
144270359|NCT01149655|520193395|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
144270360|NCT01149655|520193396|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
144270361|NCT01149655|520193397|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
144270362|NCT01149655|520193394|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
144270363|NCT01149655|520193395|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
144270364|NCT01149655|520193396|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
144270365|NCT01149655|520193397|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
144270366|NCT01149655|520193394|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
144270367|NCT01149655|520193395|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
144270368|NCT01149655|520193396|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
144270369|NCT01149655|520193397|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
144270370|NCT01149655|520193394|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
144270371|NCT01149655|520193395|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
144270372|NCT01149655|520193396|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
144270373|NCT01149655|520193397|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
144270374|NCT01149655|520193394|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
144270375|NCT01149655|520193395|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
144270376|NCT01149655|520193396|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
144270377|NCT01149655|520193397|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
144270378|NCT01149655|520193394|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
144270379|NCT01149655|520193395|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
144270380|NCT01149655|520193396|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
144270381|NCT01149655|520193397|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
144270382|NCT01149655|520193394|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
144270383|NCT01149655|520193395|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
144270384|NCT01149655|520193396|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
144270385|NCT01149655|520193397|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
144270386|NCT01149655|520193394|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
144270387|NCT01149655|520193395|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
144270388|NCT01149655|520193396|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
144270389|NCT01149655|520193397|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
144270390|NCT01149655|520193394|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
144270391|NCT01149655|520193395|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
144270392|NCT01149655|520193396|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
144270393|NCT01149655|520193397|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
144270394|NCT01149655|520193394|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
144270395|NCT01149655|520193395|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
144270396|NCT01149655|520193396|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
144270397|NCT01149655|520193397|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
144270398|NCT01265498|520193398|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
144270399|NCT01265498|520193399|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
144270400|NCT00617279|520193406|FG000|Overall Study|Study terminated by Sponsor|10|||
144270401|NCT00617279|520193407|FG001|Overall Study|Study terminated by Sponsor|15|||
144270402|NCT00617279|520193406|FG000|Overall Study|Graft abandonment|2|||
144270403|NCT00617279|520193407|FG001|Overall Study|Graft abandonment|0|||
144270404|NCT00617279|520193406|FG000|Overall Study|Lost to Follow-up|1|||
144270405|NCT00617279|520193407|FG001|Overall Study|Lost to Follow-up|0|||
144270406|NCT00617279|520193406|FG000|Overall Study|Death|1|||
144270407|NCT00617279|520193407|FG001|Overall Study|Death|2|||
144270408|NCT00921024|520193408|FG000|Overall Study|Lost to Follow-up|2|||
144270409|NCT00921024|520193409|FG001|Overall Study|Lost to Follow-up|0|||
144270410|NCT00921024|520193408|FG000|Overall Study|Received concomittant therapy|2|||
144270411|NCT00921024|520193409|FG001|Overall Study|Received concomittant therapy|0|||
144270412|NCT00921024|520193408|FG000|Overall Study|Withdrawal by Subject|0|||
144270413|NCT00921024|520193409|FG001|Overall Study|Withdrawal by Subject|3|||
144270414|NCT01715831|520195557|FG000|Overall Study|Adverse Event|1|||
144270415|NCT03261401|520195558|FG000|Overall Study|Withdrawal by Subject|0|||
144270416|NCT03261401|520195559|FG001|Overall Study|Withdrawal by Subject|0|||
144270417|NCT03261401|520195560|FG002|Overall Study|Withdrawal by Subject|0|||
144270418|NCT03261401|520195561|FG003|Overall Study|Withdrawal by Subject|0|||
144270419|NCT03261401|520195562|FG004|Overall Study|Withdrawal by Subject|0|||
144270420|NCT03261401|520195563|FG005|Overall Study|Withdrawal by Subject|1|||
144270421|NCT03261401|520195564|FG006|Overall Study|Withdrawal by Subject|0|||
144270422|NCT03261401|520195565|FG007|Overall Study|Withdrawal by Subject|0|||
144270423|NCT03261401|520195566|FG008|Overall Study|Withdrawal by Subject|0|||
144270424|NCT03261401|520195567|FG009|Overall Study|Withdrawal by Subject|0|||
144270425|NCT03261401|520195568|FG010|Overall Study|Withdrawal by Subject|0|||
144270426|NCT03261401|520195569|FG011|Overall Study|Withdrawal by Subject|0|||
144270427|NCT03261401|520195570|FG012|Overall Study|Withdrawal by Subject|0|||
144270428|NCT03261401|520195558|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
144270429|NCT03261401|520195559|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
144270430|NCT03261401|520195560|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
144270431|NCT03261401|520195561|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
144270432|NCT03261401|520195562|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
144270433|NCT03261401|520195563|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
144270434|NCT03261401|520195564|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
144270435|NCT03261401|520195565|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
144270436|NCT03261401|520195566|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
144270437|NCT03261401|520195567|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
144270438|NCT03261401|520195568|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
144270439|NCT03261401|520195569|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
144270440|NCT03261401|520195570|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
144270441|NCT00941928|520195577|FG000|Overall Study|Withdrawal by Subject|1|||
144270442|NCT00941928|520195577|FG000|Overall Study|Disease Progression|1|||
144270443|NCT02300610|520195578|FG000|Overall Study|Withdrawal by Subject|1|||
144270444|NCT02300610|520195579|FG001|Overall Study|Withdrawal by Subject|0|||
144270445|NCT02300610|520195580|FG002|Overall Study|Withdrawal by Subject|1|||
144270446|NCT02897349|520195584|FG000|Overall Study|Lost to Follow-up|2|||
144270447|NCT02897349|520195585|FG001|Overall Study|Lost to Follow-up|2|||
144270448|NCT02897349|520195584|FG000|Overall Study|Adverse Event|3|||
144270449|NCT02897349|520195585|FG001|Overall Study|Adverse Event|3|||
144270450|NCT02897349|520195584|FG000|Overall Study|Other than listed above|0|||
144270451|NCT02897349|520195585|FG001|Overall Study|Other than listed above|1|||
144270452|NCT01829347|520195587|FG000|VTI-210|Death|5|||
144270453|NCT01829347|520195588|FG001|VTI-210|Death|3|||
144270454|NCT01829347|520195587|FG000|VTI-210|Withdrawal by Subject|1|||
144270455|NCT01829347|520195588|FG001|VTI-210|Withdrawal by Subject|0|||
144270456|NCT01829347|520195587|FG000|VTI-210E|Death|2|||
144270457|NCT01829347|520195588|FG001|VTI-210E|Death|1|||
144270458|NCT01829347|520195587|FG000|VTI-210E|Study terminated prematurely|1|||
144270459|NCT01829347|520195588|FG001|VTI-210E|Study terminated prematurely|5|||
144270460|NCT03435055|520195590|FG000|Screening|Physician Decision|2|||
144270461|NCT03435055|520195590|FG000|Received Intervention|Did not complete nitrous administration|3|||
144270462|NCT04018066|520195595|FG000|Overall Study|participants started taking medications during the study period|3|||
144270463|NCT04018066|520195595|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
144270464|NCT02732639|520195601|FG000|Overall Study|Lost to Follow-up|1|||
144270465|NCT00856180|520195602|FG000|Overall Study|Adverse Event|4|||
144270466|NCT00856180|520195602|FG000|Overall Study|Progressive Disease|16|||
144270467|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
144270468|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
144270469|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
144270470|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
144270471|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
144270472|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
144270473|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
144270474|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
144240681|NCT02031640|520078346|FG004|Screening Period|Inclusion criteria not met|0|||
144240682|NCT02031640|520078347|FG005|Screening Period|Inclusion criteria not met|0|||
144240683|NCT02031640|520078342|FG000|Screening Period|Exclusion criteria met|30|||
144240684|NCT02031640|520078343|FG001|Screening Period|Exclusion criteria met|0|||
144240685|NCT02031640|520078344|FG002|Screening Period|Exclusion criteria met|0|||
144240686|NCT02031640|520078345|FG003|Screening Period|Exclusion criteria met|0|||
144240687|NCT02031640|520078346|FG004|Screening Period|Exclusion criteria met|0|||
144240688|NCT02031640|520078347|FG005|Screening Period|Exclusion criteria met|0|||
144240689|NCT02031640|520078342|FG000|Screening Period|Lost to Follow-up|14|||
144240690|NCT02031640|520078343|FG001|Screening Period|Lost to Follow-up|0|||
144240691|NCT02031640|520078344|FG002|Screening Period|Lost to Follow-up|0|||
144240692|NCT02031640|520078345|FG003|Screening Period|Lost to Follow-up|0|||
144240693|NCT02031640|520078346|FG004|Screening Period|Lost to Follow-up|0|||
144240694|NCT02031640|520078347|FG005|Screening Period|Lost to Follow-up|0|||
144240695|NCT02031640|520078342|FG000|Screening Period|Enrollment closed|26|||
144240696|NCT02031640|520078343|FG001|Screening Period|Enrollment closed|0|||
144240697|NCT02031640|520078344|FG002|Screening Period|Enrollment closed|0|||
144240698|NCT02031640|520078345|FG003|Screening Period|Enrollment closed|0|||
144240699|NCT02031640|520078346|FG004|Screening Period|Enrollment closed|0|||
144240700|NCT02031640|520078347|FG005|Screening Period|Enrollment closed|0|||
144240701|NCT02031640|520078342|FG000|Run-In Period|Adverse Event|4|||
144240702|NCT02031640|520078343|FG001|Run-In Period|Adverse Event|0|||
144240703|NCT02031640|520078344|FG002|Run-In Period|Adverse Event|0|||
144240704|NCT02031640|520078345|FG003|Run-In Period|Adverse Event|0|||
144240705|NCT02031640|520078346|FG004|Run-In Period|Adverse Event|0|||
144240706|NCT02031640|520078347|FG005|Run-In Period|Adverse Event|0|||
144240707|NCT02031640|520078342|FG000|Run-In Period|Withdrawal by Subject|17|||
144240708|NCT02031640|520078343|FG001|Run-In Period|Withdrawal by Subject|0|||
144240709|NCT02031640|520078344|FG002|Run-In Period|Withdrawal by Subject|0|||
144240710|NCT02031640|520078345|FG003|Run-In Period|Withdrawal by Subject|0|||
144240711|NCT02031640|520078346|FG004|Run-In Period|Withdrawal by Subject|0|||
144240712|NCT02031640|520078347|FG005|Run-In Period|Withdrawal by Subject|0|||
144240713|NCT02031640|520078342|FG000|Run-In Period|Inclusion criteria not met|38|||
144240714|NCT02031640|520078343|FG001|Run-In Period|Inclusion criteria not met|0|||
144240715|NCT02031640|520078344|FG002|Run-In Period|Inclusion criteria not met|0|||
144240716|NCT02031640|520078345|FG003|Run-In Period|Inclusion criteria not met|0|||
144240717|NCT02031640|520078346|FG004|Run-In Period|Inclusion criteria not met|0|||
144240718|NCT02031640|520078347|FG005|Run-In Period|Inclusion criteria not met|0|||
144240719|NCT02031640|520078342|FG000|Run-In Period|Exclusion criteria met|8|||
144240720|NCT02031640|520078343|FG001|Run-In Period|Exclusion criteria met|0|||
144240721|NCT02031640|520078344|FG002|Run-In Period|Exclusion criteria met|0|||
144240722|NCT02031640|520078345|FG003|Run-In Period|Exclusion criteria met|0|||
144240723|NCT02031640|520078346|FG004|Run-In Period|Exclusion criteria met|0|||
144240724|NCT02031640|520078347|FG005|Run-In Period|Exclusion criteria met|0|||
144240725|NCT02031640|520078342|FG000|Run-In Period|Randomization criteria not met|85|||
144240726|NCT02031640|520078343|FG001|Run-In Period|Randomization criteria not met|0|||
144240727|NCT02031640|520078344|FG002|Run-In Period|Randomization criteria not met|0|||
144240728|NCT02031640|520078345|FG003|Run-In Period|Randomization criteria not met|0|||
144240729|NCT02031640|520078346|FG004|Run-In Period|Randomization criteria not met|0|||
144240730|NCT02031640|520078347|FG005|Run-In Period|Randomization criteria not met|0|||
144240731|NCT02031640|520078342|FG000|Run-In Period|Various administrative reasons|17|||
144240732|NCT02031640|520078343|FG001|Run-In Period|Various administrative reasons|0|||
144240733|NCT02031640|520078344|FG002|Run-In Period|Various administrative reasons|0|||
144240734|NCT02031640|520078345|FG003|Run-In Period|Various administrative reasons|0|||
144240735|NCT02031640|520078346|FG004|Run-In Period|Various administrative reasons|0|||
144240736|NCT02031640|520078347|FG005|Run-In Period|Various administrative reasons|0|||
144240737|NCT02031640|520078342|FG000|Double-blind Treatment Period|Protocol deviation|0|||
144240738|NCT02031640|520078343|FG001|Double-blind Treatment Period|Protocol deviation|2|||
144240739|NCT02031640|520078344|FG002|Double-blind Treatment Period|Protocol deviation|0|||
144240740|NCT02031640|520078345|FG003|Double-blind Treatment Period|Protocol deviation|1|||
144240741|NCT02031640|520078346|FG004|Double-blind Treatment Period|Protocol deviation|3|||
144240742|NCT02031640|520078347|FG005|Double-blind Treatment Period|Protocol deviation|1|||
144240743|NCT02031640|520078342|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
144240744|NCT02031640|520078343|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
144240745|NCT02031640|520078344|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
144240746|NCT02031640|520078345|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
144240747|NCT02031640|520078346|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
144240748|NCT02031640|520078347|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
144240749|NCT02031640|520078342|FG000|Double-blind Treatment Period|Non-compliance|0|||
144240750|NCT02031640|520078343|FG001|Double-blind Treatment Period|Non-compliance|1|||
144240751|NCT02031640|520078344|FG002|Double-blind Treatment Period|Non-compliance|0|||
144240752|NCT02031640|520078345|FG003|Double-blind Treatment Period|Non-compliance|1|||
144270475|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
144240753|NCT02031640|520078346|FG004|Double-blind Treatment Period|Non-compliance|1|||
144240754|NCT02031640|520078347|FG005|Double-blind Treatment Period|Non-compliance|0|||
144240755|NCT02031640|520078342|FG000|Double-blind Treatment Period|Adverse Event|0|||
144240756|NCT02031640|520078343|FG001|Double-blind Treatment Period|Adverse Event|0|||
144240757|NCT02031640|520078344|FG002|Double-blind Treatment Period|Adverse Event|0|||
144240758|NCT02031640|520078345|FG003|Double-blind Treatment Period|Adverse Event|2|||
144240759|NCT02031640|520078346|FG004|Double-blind Treatment Period|Adverse Event|0|||
144240760|NCT02031640|520078347|FG005|Double-blind Treatment Period|Adverse Event|0|||
144240761|NCT02031640|520078342|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
144240762|NCT02031640|520078343|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
144240763|NCT02031640|520078344|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
144240764|NCT02031640|520078345|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
144240765|NCT02031640|520078346|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
144240766|NCT02031640|520078347|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
144240767|NCT02031640|520078342|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144240768|NCT02031640|520078343|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
144240769|NCT02031640|520078344|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
144240770|NCT02031640|520078345|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
144240771|NCT02031640|520078346|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
144240772|NCT02031640|520078347|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
144240773|NCT03085238|520078352|FG000|Overall Study|Adverse Event|2|||
144240774|NCT03085238|520078352|FG000|Overall Study|Death|2|||
144240775|NCT05896527|520078353|FG000|Overall Study|Withdrawal by Subject|11|||
144240776|NCT05896527|520078354|FG001|Overall Study|Withdrawal by Subject|10|||
144240777|NCT05896527|520078355|FG002|Overall Study|Withdrawal by Subject|4|||
144240778|NCT05896527|520078356|FG003|Overall Study|Withdrawal by Subject|3|||
144240779|NCT05896527|520078357|FG004|Overall Study|Withdrawal by Subject|2|||
144240780|NCT05896527|520078353|FG000|Overall Study|Lost to Follow-up|0|||
144240781|NCT05896527|520078354|FG001|Overall Study|Lost to Follow-up|2|||
144240782|NCT05896527|520078355|FG002|Overall Study|Lost to Follow-up|2|||
144240783|NCT05896527|520078356|FG003|Overall Study|Lost to Follow-up|2|||
144240784|NCT05896527|520078357|FG004|Overall Study|Lost to Follow-up|1|||
144240785|NCT05896527|520078353|FG000|Overall Study|Significant protocol noncompliance|0|||
144240786|NCT05896527|520078354|FG001|Overall Study|Significant protocol noncompliance|1|||
144240787|NCT05896527|520078355|FG002|Overall Study|Significant protocol noncompliance|0|||
144240788|NCT05896527|520078356|FG003|Overall Study|Significant protocol noncompliance|0|||
144240789|NCT05896527|520078357|FG004|Overall Study|Significant protocol noncompliance|0|||
144240790|NCT05896527|520078353|FG000|Overall Study|Eligibility criteria not met|1|||
144240791|NCT05896527|520078354|FG001|Overall Study|Eligibility criteria not met|0|||
144240792|NCT05896527|520078355|FG002|Overall Study|Eligibility criteria not met|0|||
144240793|NCT05896527|520078356|FG003|Overall Study|Eligibility criteria not met|0|||
144240794|NCT05896527|520078357|FG004|Overall Study|Eligibility criteria not met|0|||
144240795|NCT05896527|520078353|FG000|Overall Study|Sponsor's decision|0|||
144240796|NCT05896527|520078354|FG001|Overall Study|Sponsor's decision|0|||
144240797|NCT05896527|520078355|FG002|Overall Study|Sponsor's decision|0|||
144240798|NCT05896527|520078356|FG003|Overall Study|Sponsor's decision|1|||
144240799|NCT05896527|520078357|FG004|Overall Study|Sponsor's decision|0|||
144240800|NCT05896527|520078353|FG000|Overall Study|Investigator's decision|0|||
144240801|NCT05896527|520078354|FG001|Overall Study|Investigator's decision|1|||
144240802|NCT05896527|520078355|FG002|Overall Study|Investigator's decision|0|||
144240803|NCT05896527|520078356|FG003|Overall Study|Investigator's decision|0|||
144240804|NCT05896527|520078357|FG004|Overall Study|Investigator's decision|0|||
144240805|NCT05896527|520078353|FG000|Overall Study|Pregnancy of his partner|0|||
144240806|NCT05896527|520078354|FG001|Overall Study|Pregnancy of his partner|0|||
144240807|NCT05896527|520078355|FG002|Overall Study|Pregnancy of his partner|0|||
144240808|NCT05896527|520078356|FG003|Overall Study|Pregnancy of his partner|1|||
144240809|NCT05896527|520078357|FG004|Overall Study|Pregnancy of his partner|0|||
144240810|NCT01279070|520078358|FG000|Overall Study|Withdrawal by Subject|2|||
144240811|NCT01279070|520078359|FG001|Overall Study|Withdrawal by Subject|3|||
144240812|NCT01279070|520078358|FG000|Overall Study|Acute exacerbation|3|||
144240813|NCT01279070|520078359|FG001|Overall Study|Acute exacerbation|1|||
144240814|NCT01741792|520078360|FG000|Overall Study|Death|6|||
144240815|NCT01741792|520078361|FG001|Overall Study|Death|1|||
144240816|NCT01741792|520078362|FG002|Overall Study|Death|12|||
144240817|NCT02662764|520078363|FG000|Overall Study|Adverse Event|6|||
144240818|NCT02662764|520078363|FG000|Overall Study|Lack of Efficacy|8|||
144240819|NCT02662764|520078363|FG000|Overall Study|Protocol Violation|1|||
144240820|NCT02662764|520078363|FG000|Overall Study|Withdrawal by Subject|5|||
144240821|NCT02662764|520078363|FG000|Overall Study|Device failure|4|||
144240822|NCT02662764|520078363|FG000|Overall Study|Patient changed treatment|1|||
144240823|NCT02662764|520078363|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
144240824|NCT02777970|520078372|FG000|Overall Study|Lost to Follow-up|0|||
144240825|NCT02777970|520078373|FG001|Overall Study|Lost to Follow-up|1|||
144240826|NCT02777970|520078374|FG002|Overall Study|Lost to Follow-up|0|||
144240827|NCT02777970|520078372|FG000|Overall Study|Protocol Violation|1|||
144240828|NCT02777970|520078373|FG001|Overall Study|Protocol Violation|0|||
144240829|NCT02777970|520078374|FG002|Overall Study|Protocol Violation|0|||
144240830|NCT05845567|520078377|FG000|Overall Study|Withdrawal by Subject|1|||
144240831|NCT02541669|520078381|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
144240832|NCT02541669|520078382|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
144240833|NCT02541669|520078383|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
144240834|NCT02541669|520078384|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
144240835|NCT02541669|520078385|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
144240836|NCT04739722|520078386|FG000|Overall Study|Lost to Follow-up|5301|||
144240837|NCT04739722|520078386|FG000|Overall Study|Withdrawal by Subject|42|||
144240838|NCT04739722|520078386|FG000|Overall Study|Non Average-risk|1157|||
144240839|NCT00725608|520078387|FG000|Overall Study|Lost to Follow-up|60|||
144240840|NCT00725608|520078387|FG000|Overall Study|Adverse Event|14|||
144240841|NCT00725608|520078387|FG000|Overall Study|Individual reasons|86|||
144240842|NCT00725608|520078387|FG000|Overall Study|Other|7|||
144240843|NCT03047720|520078388|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
144240844|NCT03047720|520078389|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
144240845|NCT01154088|520078390|FG000|Overall Study|Lost to Follow-up|4|||
144240846|NCT01154088|520078391|FG001|Overall Study|Lost to Follow-up|6|||
144240847|NCT01154088|520078392|FG002|Overall Study|Lost to Follow-up|7|||
144240848|NCT01084668|520078395|FG000|Overall Study|Lack of Efficacy|5|||
144240849|NCT01084668|520078395|FG000|Overall Study|Withdrawal by Subject|2|||
144240850|NCT01084668|520078395|FG000|Overall Study|Pregnancy|1|||
144240851|NCT01084668|520078395|FG000|Overall Study|Non-compliance|1|||
144240852|NCT01104246|520078396|FG000|Overall Study|Withdrawal by Subject|1|||
144240853|NCT01104246|520078396|FG000|Overall Study|did not meet inclusion criteria|4|||
144240854|NCT05178641|520078397|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
144240855|NCT05178641|520078398|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
144240856|NCT05178641|520078397|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
144240857|NCT05178641|520078398|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
144240858|NCT01083186|520078399|FG000|Overall Study|Lost to Follow-up|48|||
144240859|NCT01083186|520078399|FG000|Overall Study|Consent Withdrawal|7|||
144240860|NCT01083186|520078399|FG000|Overall Study|Death|3|||
144240861|NCT01083186|520078399|FG000|Overall Study|Adverse Event|3|||
144240862|NCT01083186|520078399|FG000|Overall Study|Lack of Efficacy|2|||
144240863|NCT01083186|520078399|FG000|Overall Study|Hemodialysis Initiation|28|||
144240864|NCT01083186|520078399|FG000|Overall Study|Administrative Reasons|2|||
144240865|NCT01083186|520078399|FG000|Overall Study|Non-compliance to Study Treatment|1|||
144240866|NCT00108485|520078402|FG000|Overall Study|Withdrawal by Subject|3|||
144240867|NCT00108485|520078403|FG001|Overall Study|Withdrawal by Subject|0|||
144240868|NCT00108485|520078402|FG000|Overall Study|Lost to Follow-up|0|||
144240869|NCT00108485|520078403|FG001|Overall Study|Lost to Follow-up|2|||
144240870|NCT01867294|520078413|FG000|Overall Study|Withdrawal by Subject|1|||
144240871|NCT01867294|520078414|FG001|Overall Study|Withdrawal by Subject|1|||
144240872|NCT01867294|520078415|FG002|Overall Study|Withdrawal by Subject|0|||
144240873|NCT01867294|520078416|FG003|Overall Study|Withdrawal by Subject|0|||
144240874|NCT00278148|520078417|FG000|Phase II - Expansion Phase|Disease progression|0|||
144240875|NCT00278148|520078418|FG001|Phase II - Expansion Phase|Disease progression|0|||
144240876|NCT00278148|520078419|FG002|Phase II - Expansion Phase|Disease progression|4|||
144240877|NCT00278148|520078417|FG000|Phase II - Expansion Phase|Adverse Event|0|||
144240878|NCT00278148|520078418|FG001|Phase II - Expansion Phase|Adverse Event|0|||
144240879|NCT00278148|520078419|FG002|Phase II - Expansion Phase|Adverse Event|2|||
144240880|NCT03419598|520078420|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
144240881|NCT01740128|520078421|FG000|Overall Study|Pregnancy|0|||
144240882|NCT01740128|520078422|FG001|Overall Study|Pregnancy|1|||
144240883|NCT01740128|520078421|FG000|Overall Study|Protocol Violation|1|||
144240884|NCT01740128|520078422|FG001|Overall Study|Protocol Violation|2|||
144240885|NCT01740128|520078421|FG000|Overall Study|Lost to Follow-up|2|||
144240886|NCT01740128|520078422|FG001|Overall Study|Lost to Follow-up|2|||
144240887|NCT01740128|520078421|FG000|Overall Study|Withdrawal by Subject|1|||
144240888|NCT01740128|520078422|FG001|Overall Study|Withdrawal by Subject|0|||
144240889|NCT01740128|520078421|FG000|Overall Study|Insufficient protocol compliance|2|||
144240890|NCT01740128|520078422|FG001|Overall Study|Insufficient protocol compliance|2|||
144240891|NCT02474589|520078423|FG000|Overall Study|Adverse Event|6|||
144240892|NCT02474589|520078424|FG001|Overall Study|Adverse Event|2|||
144240893|NCT02474589|520078423|FG000|Overall Study|Lost to Follow-up|6|||
144240894|NCT02474589|520078424|FG001|Overall Study|Lost to Follow-up|1|||
144240895|NCT02474589|520078423|FG000|Overall Study|Protocol Violation|4|||
144240896|NCT02474589|520078424|FG001|Overall Study|Protocol Violation|1|||
144240897|NCT02474589|520078423|FG000|Overall Study|Withdrawal by Subject|4|||
144240898|NCT02474589|520078424|FG001|Overall Study|Withdrawal by Subject|0|||
144240899|NCT02474589|520078423|FG000|Overall Study|Inability to complete study procedures|5|||
144240900|NCT02474589|520078424|FG001|Overall Study|Inability to complete study procedures|1|||
144240901|NCT00380081|520078427|FG000|Overall Study|Withdrawal by Subject|0|||
144240902|NCT00380081|520078428|FG001|Overall Study|Withdrawal by Subject|0|||
144240903|NCT00380081|520078429|FG002|Overall Study|Withdrawal by Subject|0|||
144240904|NCT00380081|520078430|FG003|Overall Study|Withdrawal by Subject|0|||
144240905|NCT00380081|520078431|FG004|Overall Study|Withdrawal by Subject|1|||
144240906|NCT00380081|520078432|FG005|Overall Study|Withdrawal by Subject|0|||
144270476|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
144270477|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
144270478|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
144270479|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
144270480|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
144270481|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
144270482|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
144270483|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
144270484|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
144270485|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
144270486|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
144270487|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
144270488|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
144270489|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
144270490|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
144270491|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
144270492|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
144270493|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
144270494|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
144270495|NCT01668797|520195603|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
144270496|NCT01668797|520195604|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
144270497|NCT01668797|520195605|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
144270498|NCT01668797|520195606|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
144270499|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
144270500|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
144270501|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
144270502|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
144270503|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
144270504|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
144270505|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
144270506|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
144270507|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
144270508|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
144270509|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
144270510|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
144270511|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
144270512|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
144270513|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
144270514|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
144270515|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
144270516|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
144270517|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
144270518|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
144270519|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
144270520|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
144270521|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
144270522|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
144270523|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
144270524|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
144270525|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
144270526|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
144270527|NCT01668797|520195603|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
144270528|NCT01668797|520195604|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
144270529|NCT01668797|520195605|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
144270530|NCT01668797|520195606|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
144270531|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
144270532|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
144270533|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
144270534|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
144240907|NCT00380081|520078427|FG000|Overall Study|Family Emergency|0|||
144240908|NCT00380081|520078428|FG001|Overall Study|Family Emergency|0|||
144240909|NCT00380081|520078429|FG002|Overall Study|Family Emergency|0|||
144240910|NCT00380081|520078430|FG003|Overall Study|Family Emergency|0|||
144240911|NCT00380081|520078431|FG004|Overall Study|Family Emergency|0|||
144240912|NCT00380081|520078432|FG005|Overall Study|Family Emergency|1|||
144240913|NCT02658734|520078433|FG000|Overall Study|Adverse Event|2|||
144240914|NCT02658734|520078433|FG000|Overall Study|Death|4|||
144240915|NCT02658734|520078433|FG000|Overall Study|Lost to Follow-up|7|||
144240916|NCT02658734|520078433|FG000|Overall Study|Withdrawal of Consent|16|||
144240917|NCT02658734|520078433|FG000|Overall Study|Disease Progression|28|||
144240918|NCT00189306|520078435|FG000|Treatment Period|Withdrawal by Subject|2|||
144240919|NCT00189306|520078435|FG000|Treatment Period|Adverse Event|2|||
144240920|NCT00189306|520078435|FG000|Treatment Period|Protocol Violation|1|||
144240921|NCT00189306|520078435|FG000|Posttreatment Period|Death|1|||
144240922|NCT00189306|520078435|FG000|Posttreatment Period|Withdrawal by Subject|2|||
144240923|NCT00189306|520078435|FG000|Posttreatment Period|Noncompliance|1|||
144240924|NCT00189306|520078435|FG000|Posttreatment Period|Target lesion excised|1|||
144240925|NCT00189306|520078435|FG000|Posttreatment Period|Protocol Violation|1|||
144240926|NCT00189306|520078435|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
144240927|NCT00189306|520078435|FG000|Posttreatment Period|Local skin reaction/sign|1|||
144240928|NCT00189306|520078435|FG000|Long-Term Follow-up|Adverse Event|2|||
144240929|NCT00189306|520078435|FG000|Long-Term Follow-up|Death|4|||
144240930|NCT00189306|520078435|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
144240931|NCT00189306|520078435|FG000|Long-Term Follow-up|Intercurrent disease|2|||
144240932|NCT00189306|520078435|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
144240933|NCT00189306|520078435|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
144240934|NCT00459706|520078436|FG000|Overall Study|Adverse Event|19|||
144240935|NCT00459706|520078437|FG001|Overall Study|Adverse Event|13|||
144240936|NCT00459706|520078436|FG000|Overall Study|Withdrawal by Subject|1|||
144240937|NCT00459706|520078437|FG001|Overall Study|Withdrawal by Subject|6|||
144240938|NCT00459706|520078436|FG000|Overall Study|Physician Decision|2|||
144240939|NCT00459706|520078437|FG001|Overall Study|Physician Decision|0|||
144240940|NCT00459706|520078436|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
144240941|NCT00459706|520078437|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
144240942|NCT00459706|520078436|FG000|Overall Study|Protocol Violation|2|||
144240943|NCT00459706|520078437|FG001|Overall Study|Protocol Violation|1|||
144240944|NCT00459706|520078436|FG000|Overall Study|Failed to Return|1|||
144240945|NCT00459706|520078437|FG001|Overall Study|Failed to Return|0|||
144240946|NCT00459706|520078436|FG000|Overall Study|Other|0|||
144240947|NCT00459706|520078437|FG001|Overall Study|Other|1|||
144240948|NCT02017912|520078438|FG000|Overall Study|Withdrawal by Subject|2|||
144240949|NCT02017912|520078439|FG001|Overall Study|Withdrawal by Subject|1|||
144240950|NCT02017912|520078438|FG000|Overall Study|miscellaneous|1|||
144240951|NCT02017912|520078439|FG001|Overall Study|miscellaneous|1|||
144240952|NCT03640481|520078440|FG000|Overall Study|Death|14|||
144240953|NCT03640481|520078441|FG001|Overall Study|Death|14|||
144240954|NCT03640481|520078442|FG002|Overall Study|Death|0|||
144240955|NCT03640481|520078443|FG003|Overall Study|Death|0|||
144240956|NCT03640481|520078440|FG000|Overall Study|Lost to Follow-up|2|||
144240957|NCT03640481|520078441|FG001|Overall Study|Lost to Follow-up|0|||
144240958|NCT03640481|520078442|FG002|Overall Study|Lost to Follow-up|0|||
144240959|NCT03640481|520078443|FG003|Overall Study|Lost to Follow-up|0|||
144240960|NCT03640481|520078440|FG000|Overall Study|Site terminated by sponsor|1|||
144240961|NCT03640481|520078441|FG001|Overall Study|Site terminated by sponsor|3|||
144240962|NCT03640481|520078442|FG002|Overall Study|Site terminated by sponsor|0|||
144240963|NCT03640481|520078443|FG003|Overall Study|Site terminated by sponsor|0|||
144240964|NCT03640481|520078440|FG000|Overall Study|Study terminated by sponsor|29|||
144240965|NCT03640481|520078441|FG001|Overall Study|Study terminated by sponsor|42|||
144240966|NCT03640481|520078442|FG002|Overall Study|Study terminated by sponsor|1|||
144240967|NCT03640481|520078443|FG003|Overall Study|Study terminated by sponsor|0|||
144240968|NCT03640481|520078440|FG000|Overall Study|Withdrawal by Subject|5|||
144240969|NCT03640481|520078441|FG001|Overall Study|Withdrawal by Subject|4|||
144240970|NCT03640481|520078442|FG002|Overall Study|Withdrawal by Subject|0|||
144240971|NCT03640481|520078443|FG003|Overall Study|Withdrawal by Subject|1|||
144240972|NCT03640481|520078440|FG000|Overall Study|Other|26|||
144240973|NCT03640481|520078441|FG001|Overall Study|Other|12|||
144240974|NCT03640481|520078442|FG002|Overall Study|Other|1|||
144240975|NCT03640481|520078443|FG003|Overall Study|Other|0|||
144240976|NCT03640481|520078440|FG000|Overall Study|Randomized, but not treated|1|||
144240977|NCT03640481|520078441|FG001|Overall Study|Randomized, but not treated|3|||
144240978|NCT03640481|520078442|FG002|Overall Study|Randomized, but not treated|0|||
144240979|NCT03640481|520078443|FG003|Overall Study|Randomized, but not treated|0|||
144240980|NCT00423189|520078448|FG000|Overall Study|Death|0|||
144240981|NCT00423189|520078449|FG001|Overall Study|Death|1|||
144240982|NCT00423189|520078450|FG002|Overall Study|Death|0|||
144240983|NCT00070018|520078455|FG000|Overall Study|Adverse Event|2|||
144240984|NCT00070018|520078455|FG000|Overall Study|Lack of Efficacy|1|||
144240985|NCT00070018|520078455|FG000|Overall Study|Withdrawal by Subject|1|||
144240986|NCT02939716|520078456|FG000|Overall Study|scanner failure|0|||
144240987|NCT02939716|520078457|FG001|Overall Study|scanner failure|0|||
144240988|NCT02939716|520078458|FG002|Overall Study|scanner failure|0|||
144240989|NCT02939716|520078459|FG003|Overall Study|scanner failure|1|||
144240990|NCT02939716|520078460|FG004|Overall Study|scanner failure|1|||
144240991|NCT02939716|520078461|FG005|Overall Study|scanner failure|1|||
144240992|NCT00985959|520078462|FG000|Overall Study|Adverse Event|0|||
144240993|NCT00985959|520078463|FG001|Overall Study|Adverse Event|0|||
144240994|NCT00985959|520078464|FG002|Overall Study|Adverse Event|19|||
144240995|NCT00985959|520078462|FG000|Overall Study|Withdrawal by Subject|0|||
144240996|NCT00985959|520078463|FG001|Overall Study|Withdrawal by Subject|0|||
144240997|NCT00985959|520078464|FG002|Overall Study|Withdrawal by Subject|8|||
144240998|NCT00985959|520078462|FG000|Overall Study|Progressive disease|1|||
144240999|NCT00985959|520078463|FG001|Overall Study|Progressive disease|2|||
144241000|NCT00985959|520078464|FG002|Overall Study|Progressive disease|8|||
144241001|NCT00985959|520078462|FG000|Overall Study|Unrecovered toxicity|0|||
144241002|NCT00985959|520078463|FG001|Overall Study|Unrecovered toxicity|0|||
144241003|NCT00985959|520078464|FG002|Overall Study|Unrecovered toxicity|7|||
144241004|NCT00985959|520078462|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
144241005|NCT00985959|520078463|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
144241006|NCT00985959|520078464|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
144241007|NCT00985959|520078462|FG000|Overall Study|Complete response observed over 2 cycles|0|||
144241008|NCT00985959|520078463|FG001|Overall Study|Complete response observed over 2 cycles|1|||
144241009|NCT00985959|520078464|FG002|Overall Study|Complete response observed over 2 cycles|4|||
144241010|NCT00985959|520078462|FG000|Overall Study|Other|0|||
144241011|NCT00985959|520078463|FG001|Overall Study|Other|0|||
144241012|NCT00985959|520078464|FG002|Overall Study|Other|11|||
144241013|NCT03197870|520078472|FG000|Overall Study|Adverse Event|9|||
144241014|NCT03197870|520078473|FG001|Overall Study|Adverse Event|4|||
144241015|NCT03197870|520078474|FG002|Overall Study|Adverse Event|6|||
144241016|NCT03197870|520078472|FG000|Overall Study|Withdrawal by Subject|2|||
144241017|NCT03197870|520078473|FG001|Overall Study|Withdrawal by Subject|3|||
144241018|NCT03197870|520078474|FG002|Overall Study|Withdrawal by Subject|0|||
144241019|NCT03197870|520078472|FG000|Overall Study|Lost to Follow-up|2|||
144241020|NCT03197870|520078473|FG001|Overall Study|Lost to Follow-up|2|||
144241021|NCT03197870|520078474|FG002|Overall Study|Lost to Follow-up|0|||
144241022|NCT03197870|520078472|FG000|Overall Study|data not available|1|||
144241023|NCT03197870|520078473|FG001|Overall Study|data not available|1|||
144241024|NCT03197870|520078474|FG002|Overall Study|data not available|0|||
144241025|NCT01446237|520078478|FG000|Overall Study|Adverse Event|1|||
144241026|NCT01446237|520078478|FG000|Overall Study|Lost to Follow-up|2|||
144241027|NCT01446237|520078478|FG000|Overall Study|Withdrawal by Subject|7|||
144241028|NCT02847494|520078479|FG000|Overall Study|Lost to Follow-up|8|||
144241029|NCT02847494|520078480|FG001|Overall Study|Lost to Follow-up|5|||
144241030|NCT02294175|520078481|FG000|Overall Study|Withdrawal by Subject|1|||
144241031|NCT02294175|520078482|FG001|Overall Study|Withdrawal by Subject|2|||
144241032|NCT02294175|520078481|FG000|Overall Study|pt taking excluded medication|3|||
144241033|NCT02294175|520078482|FG001|Overall Study|pt taking excluded medication|1|||
144241034|NCT02294175|520078481|FG000|Overall Study|Protocol Violation|1|||
144241035|NCT02294175|520078482|FG001|Overall Study|Protocol Violation|0|||
144241036|NCT02294175|520078481|FG000|Overall Study|Lost to Follow-up|0|||
144241037|NCT02294175|520078482|FG001|Overall Study|Lost to Follow-up|1|||
144241038|NCT02294175|520078481|FG000|Overall Study|wound healed|0|||
144241039|NCT02294175|520078482|FG001|Overall Study|wound healed|2|||
144241040|NCT01901653|520078483|FG000|Overall Study|Death|2|||
144241041|NCT01901653|520078484|FG001|Overall Study|Death|1|||
144241042|NCT01901653|520078485|FG002|Overall Study|Death|8|||
144241043|NCT01901653|520078486|FG003|Overall Study|Death|3|||
144241044|NCT01901653|520078487|FG004|Overall Study|Death|2|||
144241045|NCT01901653|520078488|FG005|Overall Study|Death|2|||
144241046|NCT01901653|520078489|FG006|Overall Study|Death|6|||
144241047|NCT01901653|520078490|FG007|Overall Study|Death|9|||
144241048|NCT01901653|520078491|FG008|Overall Study|Death|1|||
144241049|NCT01901653|520078492|FG009|Overall Study|Death|16|||
144241050|NCT01901653|520078493|FG010|Overall Study|Death|2|||
144241051|NCT01901653|520078494|FG011|Overall Study|Death|15|||
144241052|NCT01901653|520078495|FG012|Overall Study|Death|4|||
144241053|NCT01901653|520078483|FG000|Overall Study|Lost to Follow-up|1|||
144241054|NCT01901653|520078484|FG001|Overall Study|Lost to Follow-up|0|||
144241055|NCT01901653|520078485|FG002|Overall Study|Lost to Follow-up|2|||
144241056|NCT01901653|520078486|FG003|Overall Study|Lost to Follow-up|0|||
144241057|NCT01901653|520078487|FG004|Overall Study|Lost to Follow-up|0|||
144241058|NCT01901653|520078488|FG005|Overall Study|Lost to Follow-up|1|||
144241059|NCT01901653|520078489|FG006|Overall Study|Lost to Follow-up|0|||
144241060|NCT01901653|520078490|FG007|Overall Study|Lost to Follow-up|1|||
144241061|NCT01901653|520078491|FG008|Overall Study|Lost to Follow-up|0|||
144241062|NCT01901653|520078492|FG009|Overall Study|Lost to Follow-up|0|||
144241063|NCT01901653|520078493|FG010|Overall Study|Lost to Follow-up|0|||
144241064|NCT01901653|520078494|FG011|Overall Study|Lost to Follow-up|0|||
144241065|NCT01901653|520078495|FG012|Overall Study|Lost to Follow-up|0|||
144241066|NCT01901653|520078483|FG000|Overall Study|Withdrawal by Subject|0|||
144241067|NCT01901653|520078484|FG001|Overall Study|Withdrawal by Subject|0|||
144241068|NCT01901653|520078485|FG002|Overall Study|Withdrawal by Subject|0|||
144241069|NCT01901653|520078486|FG003|Overall Study|Withdrawal by Subject|0|||
144241070|NCT01901653|520078487|FG004|Overall Study|Withdrawal by Subject|0|||
144241071|NCT01901653|520078488|FG005|Overall Study|Withdrawal by Subject|0|||
144241072|NCT01901653|520078489|FG006|Overall Study|Withdrawal by Subject|1|||
144241073|NCT01901653|520078490|FG007|Overall Study|Withdrawal by Subject|0|||
144241074|NCT01901653|520078491|FG008|Overall Study|Withdrawal by Subject|0|||
144241075|NCT01901653|520078492|FG009|Overall Study|Withdrawal by Subject|0|||
144241076|NCT01901653|520078493|FG010|Overall Study|Withdrawal by Subject|0|||
144241077|NCT01901653|520078494|FG011|Overall Study|Withdrawal by Subject|0|||
144241078|NCT01901653|520078495|FG012|Overall Study|Withdrawal by Subject|0|||
144241079|NCT01901653|520078483|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
144241080|NCT01901653|520078484|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
144241081|NCT01901653|520078485|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
144241082|NCT01901653|520078486|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
144241083|NCT01901653|520078487|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
144241084|NCT01901653|520078488|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
144241085|NCT01901653|520078489|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
144241086|NCT01901653|520078490|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
144241087|NCT01901653|520078491|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
144241088|NCT01901653|520078492|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
144241089|NCT01901653|520078493|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
144241090|NCT01901653|520078494|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
144241091|NCT01901653|520078495|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
144241092|NCT04696354|520078498|FG000|Overall Study|Study termination|6|||
144241093|NCT04696354|520078499|FG001|Overall Study|Study termination|6|||
144241094|NCT00965341|520078500|FG000|Overall Study|Withdrew consent|1|||
144241095|NCT00965341|520078501|FG001|Overall Study|Withdrew consent|5|||
144241096|NCT00965341|520078500|FG000|Overall Study|Lost to Follow-up|1|||
144241097|NCT00965341|520078501|FG001|Overall Study|Lost to Follow-up|0|||
144241098|NCT00965341|520078500|FG000|Overall Study|Transportation issues|4|||
144241099|NCT00965341|520078501|FG001|Overall Study|Transportation issues|3|||
144241100|NCT03055494|520080106|FG000|Overall Study|Lost to Follow-up|6|||
144241101|NCT03055494|520080107|FG001|Overall Study|Lost to Follow-up|0|||
144241102|NCT03055494|520080106|FG000|Overall Study|Physician Decision|2|||
144241103|NCT03055494|520080107|FG001|Overall Study|Physician Decision|0|||
144241104|NCT03055494|520080106|FG000|Overall Study|Withdrawal by Subject|1|||
144241105|NCT03055494|520080107|FG001|Overall Study|Withdrawal by Subject|0|||
144241106|NCT03055494|520080106|FG000|Overall Study|Adverse Event|0|||
144241107|NCT03055494|520080107|FG001|Overall Study|Adverse Event|1|||
144241108|NCT03055494|520080106|FG000|Overall Study|Non-compliance with study treatment|1|||
144241109|NCT03055494|520080107|FG001|Overall Study|Non-compliance with study treatment|0|||
144241110|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
144241111|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
144241112|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
144241113|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
144241114|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
144241115|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
144241116|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
144241117|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
144241118|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
144241119|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
144241120|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
144241121|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
144241122|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
144241123|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
144241124|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
144241125|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
144241126|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
144241127|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
144241128|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
144241129|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
144241130|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
144241131|NCT04488419|520080108|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
144241132|NCT04488419|520080109|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
144241133|NCT04488419|520080110|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
144241134|NCT04488419|520080108|FG000|Primary Analysis Population|Adverse Event|6|||
144241135|NCT04488419|520080109|FG001|Primary Analysis Population|Adverse Event|9|||
144241136|NCT04488419|520080110|FG002|Primary Analysis Population|Adverse Event|0|||
144241137|NCT04488419|520080108|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
144241138|NCT04488419|520080109|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
144241139|NCT04488419|520080110|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
144241140|NCT04488419|520080108|FG000|Primary Analysis Population|Protocol Violation|1|||
144241141|NCT04488419|520080109|FG001|Primary Analysis Population|Protocol Violation|1|||
144241142|NCT04488419|520080110|FG002|Primary Analysis Population|Protocol Violation|0|||
144241143|NCT04488419|520080108|FG000|Primary Analysis Population|Undetermined|7|||
144241144|NCT04488419|520080109|FG001|Primary Analysis Population|Undetermined|3|||
144241145|NCT04488419|520080110|FG002|Primary Analysis Population|Undetermined|0|||
144241146|NCT04488419|520080108|FG000|Primary Analysis Population|>1 Reason|2|||
144241147|NCT04488419|520080109|FG001|Primary Analysis Population|>1 Reason|4|||
144241148|NCT04488419|520080110|FG002|Primary Analysis Population|>1 Reason|0|||
144241149|NCT04338269|520080113|FG000|Overall Study|Death|86|||
144241150|NCT04338269|520080114|FG001|Overall Study|Death|89|||
144241151|NCT04338269|520080113|FG000|Overall Study|Lost to Follow-up|1|||
144241152|NCT04338269|520080114|FG001|Overall Study|Lost to Follow-up|2|||
144241153|NCT04338269|520080113|FG000|Overall Study|Physician Decision|1|||
144241154|NCT04338269|520080114|FG001|Overall Study|Physician Decision|0|||
144241155|NCT04338269|520080113|FG000|Overall Study|Withdrawal by Subject|14|||
144241156|NCT04338269|520080114|FG001|Overall Study|Withdrawal by Subject|11|||
144241157|NCT03339726|520080115|FG000|Overall Study|Withdrawal by Subject|1|||
144241158|NCT03339726|520080116|FG001|Overall Study|Withdrawal by Subject|0|||
144241159|NCT03339726|520080117|FG002|Overall Study|Withdrawal by Subject|0|||
144241160|NCT03339726|520080115|FG000|Overall Study|Lost to Follow-up|0|||
144241161|NCT03339726|520080116|FG001|Overall Study|Lost to Follow-up|1|||
144241162|NCT03339726|520080117|FG002|Overall Study|Lost to Follow-up|0|||
144241163|NCT03960021|520080123|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
144241164|NCT02203851|520080124|FG000|Overall Study|Lost to Follow-up|4|||
144241165|NCT02203851|520080124|FG000|Overall Study|Withdrawal by Subject|6|||
144241166|NCT02203851|520080124|FG000|Overall Study|Other|1|||
144241167|NCT04161079|520080125|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
144241168|NCT02515994|520080126|FG000|Overall Study|Protocol Violation|3|||
144241169|NCT02515994|520080127|FG001|Overall Study|Protocol Violation|5|||
144241170|NCT02515994|520080126|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
144241171|NCT02515994|520080127|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
144241172|NCT02515994|520080126|FG000|Overall Study|Adverse Event|3|||
144241173|NCT02515994|520080127|FG001|Overall Study|Adverse Event|1|||
144241174|NCT02515994|520080126|FG000|Overall Study|Withdrawal by Subject|2|||
144241175|NCT02515994|520080127|FG001|Overall Study|Withdrawal by Subject|0|||
144241176|NCT03391232|520080128|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
144241177|NCT03391232|520080129|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
144241178|NCT03391232|520080128|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
144241179|NCT03391232|520080129|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
144241180|NCT02091960|520080130|FG000|Overall Study|Death|7|||
144241181|NCT02091960|520080130|FG000|Overall Study|Withdrawal by Subject|1|||
144241182|NCT02091960|520080130|FG000|Overall Study|Miscellaneous Reasons|37|||
144241183|NCT02424630|520080131|FG000|Overall Study|No rotator cuff tear|1|||
144241184|NCT02424630|520080132|FG001|Overall Study|No rotator cuff tear|2|||
144241185|NCT02424630|520080131|FG000|Overall Study|Open procedure|0|||
144241186|NCT02424630|520080132|FG001|Overall Study|Open procedure|1|||
144241187|NCT02637895|520080133|FG000|Overall Study|Lost to Follow-up|4|||
144241188|NCT02637895|520080134|FG001|Overall Study|Lost to Follow-up|0|||
144241189|NCT02637895|520080133|FG000|Overall Study|Protocol Violation|0|||
144241190|NCT02637895|520080134|FG001|Overall Study|Protocol Violation|1|||
144241191|NCT02637895|520080133|FG000|Overall Study|Lack of Efficacy|1|||
144241192|NCT02637895|520080134|FG001|Overall Study|Lack of Efficacy|0|||
144241193|NCT02637895|520080133|FG000|Overall Study|Withdrawal by Subject|1|||
144241194|NCT02637895|520080134|FG001|Overall Study|Withdrawal by Subject|1|||
144241195|NCT02637895|520080133|FG000|Overall Study|Abnormal baseline lab|0|||
144241196|NCT02637895|520080134|FG001|Overall Study|Abnormal baseline lab|1|||
144241197|NCT00761280|520080135|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
144241198|NCT00761280|520080136|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
144241199|NCT00761280|520080135|FG000|Randomization to First Dose|Sponsor decision|1|||
144241200|NCT00761280|520080136|FG001|Randomization to First Dose|Sponsor decision|0|||
144241201|NCT00761280|520080135|FG000|Randomization to First Dose|Other|1|||
144241202|NCT00761280|520080136|FG001|Randomization to First Dose|Other|0|||
144241203|NCT00761280|520080135|FG000|First Dose to End of Study|End of trial|5|||
144241204|NCT00761280|520080136|FG001|First Dose to End of Study|End of trial|5|||
144241205|NCT00761280|520080135|FG000|First Dose to End of Study|Progressive disease|5|||
144241206|NCT00761280|520080136|FG001|First Dose to End of Study|Progressive disease|3|||
144241207|NCT00761280|520080135|FG000|First Dose to End of Study|Sponsor decision|1|||
144241208|NCT00761280|520080136|FG001|First Dose to End of Study|Sponsor decision|2|||
144241209|NCT00761280|520080135|FG000|First Dose to End of Study|Death|1|||
144241210|NCT00761280|520080136|FG001|First Dose to End of Study|Death|0|||
144241211|NCT00761280|520080135|FG000|First Dose to End of Study|Lost to Follow-up|0|||
144241212|NCT00761280|520080136|FG001|First Dose to End of Study|Lost to Follow-up|1|||
144241213|NCT02691013|520080140|FG000|Overall Study|Withdrawal by Subject|3|||
144241214|NCT02691013|520080141|FG001|Overall Study|Withdrawal by Subject|0|||
144241215|NCT01346189|520080145|FG000|Overall Study|Withdrawal by Subject|7|||
144241216|NCT01346189|520080146|FG001|Overall Study|Withdrawal by Subject|5|||
144241217|NCT01346189|520080147|FG002|Overall Study|Withdrawal by Subject|3|||
144241218|NCT01346189|520080148|FG003|Overall Study|Withdrawal by Subject|5|||
144241219|NCT01346189|520080145|FG000|Overall Study|Physician Decision|4|||
144241220|NCT01346189|520080146|FG001|Overall Study|Physician Decision|0|||
144241221|NCT01346189|520080147|FG002|Overall Study|Physician Decision|0|||
144241222|NCT01346189|520080148|FG003|Overall Study|Physician Decision|0|||
144241223|NCT01346189|520080145|FG000|Overall Study|Moved|3|||
144241224|NCT01346189|520080146|FG001|Overall Study|Moved|0|||
144241225|NCT01346189|520080147|FG002|Overall Study|Moved|4|||
144241226|NCT01346189|520080148|FG003|Overall Study|Moved|0|||
144241227|NCT01346189|520080145|FG000|Overall Study|Other|2|||
144241228|NCT01346189|520080146|FG001|Overall Study|Other|4|||
144241229|NCT01346189|520080147|FG002|Overall Study|Other|7|||
144241230|NCT01346189|520080148|FG003|Overall Study|Other|3|||
144241231|NCT01346189|520080145|FG000|Overall Study|Death|0|||
144241232|NCT01346189|520080146|FG001|Overall Study|Death|3|||
144241233|NCT01346189|520080147|FG002|Overall Study|Death|0|||
144241234|NCT01346189|520080148|FG003|Overall Study|Death|0|||
144241235|NCT01346189|520080145|FG000|Overall Study|Non-health system primary care physician|0|||
144241236|NCT01346189|520080146|FG001|Overall Study|Non-health system primary care physician|5|||
144241237|NCT01346189|520080147|FG002|Overall Study|Non-health system primary care physician|0|||
144241238|NCT01346189|520080148|FG003|Overall Study|Non-health system primary care physician|0|||
144241239|NCT01346189|520080145|FG000|Overall Study|Travel|0|||
144241240|NCT01346189|520080146|FG001|Overall Study|Travel|0|||
144241241|NCT01346189|520080147|FG002|Overall Study|Travel|0|||
144241242|NCT01346189|520080148|FG003|Overall Study|Travel|3|||
144241243|NCT00759785|520080158|FG000|Overall Study|Participant sample not evaluable|11|||
144241244|NCT00759785|520080159|FG001|Overall Study|Participant sample not evaluable|2|||
144241245|NCT00759785|520080158|FG000|Overall Study|Participant sample lost|0|||
144241246|NCT00759785|520080159|FG001|Overall Study|Participant sample lost|1|||
144241247|NCT00759785|520080158|FG000|Overall Study|Protocol Violation|1|||
144241248|NCT00759785|520080159|FG001|Overall Study|Protocol Violation|0|||
144241249|NCT00759785|520080158|FG000|Overall Study|Physician Decision|0|||
144241250|NCT00759785|520080159|FG001|Overall Study|Physician Decision|1|||
144241251|NCT00759785|520080158|FG000|Overall Study|Withdrawal by Subject|0|||
144241252|NCT00759785|520080159|FG001|Overall Study|Withdrawal by Subject|1|||
144241253|NCT00177307|520080162|FG000|Overall Study|Withdrawal by Subject|1|||
144241254|NCT04521621|520080163|FG000|Overall Study|Death|17|||
144241255|NCT04521621|520080164|FG001|Overall Study|Death|8|||
144241256|NCT04521621|520080165|FG002|Overall Study|Death|8|||
144241257|NCT04521621|520080166|FG003|Overall Study|Death|5|||
144241258|NCT04521621|520080167|FG004|Overall Study|Death|2|||
144241259|NCT04521621|520080168|FG005|Overall Study|Death|7|||
144241260|NCT04521621|520080169|FG006|Overall Study|Death|0|||
144241261|NCT04521621|520080170|FG007|Overall Study|Death|0|||
144241262|NCT04521621|520080163|FG000|Overall Study|Study Terminated by Sponsor|4|||
144241263|NCT04521621|520080164|FG001|Overall Study|Study Terminated by Sponsor|6|||
144241264|NCT04521621|520080165|FG002|Overall Study|Study Terminated by Sponsor|8|||
144241265|NCT04521621|520080166|FG003|Overall Study|Study Terminated by Sponsor|0|||
144241266|NCT04521621|520080167|FG004|Overall Study|Study Terminated by Sponsor|1|||
144241267|NCT04521621|520080168|FG005|Overall Study|Study Terminated by Sponsor|7|||
144241268|NCT04521621|520080169|FG006|Overall Study|Study Terminated by Sponsor|0|||
144241269|NCT04521621|520080170|FG007|Overall Study|Study Terminated by Sponsor|0|||
144241270|NCT04521621|520080163|FG000|Overall Study|Withdrawal by Subject|0|||
144241271|NCT04521621|520080164|FG001|Overall Study|Withdrawal by Subject|0|||
144241272|NCT04521621|520080165|FG002|Overall Study|Withdrawal by Subject|1|||
144241273|NCT04521621|520080166|FG003|Overall Study|Withdrawal by Subject|1|||
144241274|NCT04521621|520080167|FG004|Overall Study|Withdrawal by Subject|0|||
144241275|NCT04521621|520080168|FG005|Overall Study|Withdrawal by Subject|0|||
144241276|NCT04521621|520080169|FG006|Overall Study|Withdrawal by Subject|0|||
144241277|NCT04521621|520080170|FG007|Overall Study|Withdrawal by Subject|0|||
144241278|NCT04521621|520080163|FG000|Overall Study|Allocated in error without study intervention|1|||
144241279|NCT04521621|520080164|FG001|Overall Study|Allocated in error without study intervention|0|||
144241280|NCT04521621|520080165|FG002|Overall Study|Allocated in error without study intervention|0|||
144241281|NCT04521621|520080166|FG003|Overall Study|Allocated in error without study intervention|0|||
144241282|NCT04521621|520080167|FG004|Overall Study|Allocated in error without study intervention|0|||
144241283|NCT04521621|520080168|FG005|Overall Study|Allocated in error without study intervention|0|||
144241284|NCT04521621|520080169|FG006|Overall Study|Allocated in error without study intervention|0|||
144270535|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
144270536|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
144270537|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
144270538|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
144270539|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
144270540|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
144270541|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
144270542|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
144270543|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
144270544|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
144270545|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
144270546|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
144270547|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
144270548|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
144270549|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
144270550|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
144270551|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
144270552|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
144270553|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
144270554|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
144270555|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
144270556|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
144270557|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
144270558|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
144270559|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
144241285|NCT04521621|520080170|FG007|Overall Study|Allocated in error without study intervention|0|||
144241286|NCT03671564|520080171|FG000|Overall Study|Progressive Disease|3|||
144241287|NCT03671564|520080172|FG001|Overall Study|Progressive Disease|5|||
144241288|NCT03671564|520080173|FG002|Overall Study|Progressive Disease|3|||
144241289|NCT03671564|520080171|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
144241290|NCT03671564|520080172|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
144241291|NCT03671564|520080173|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
144241292|NCT03671564|520080171|FG000|Overall Study|Withdrawal by Subject|1|||
144241293|NCT03671564|520080172|FG001|Overall Study|Withdrawal by Subject|1|||
144241294|NCT03671564|520080173|FG002|Overall Study|Withdrawal by Subject|0|||
144241295|NCT03729570|520080176|FG000|Overall Study|Lost to Follow-up|16|||
144241296|NCT03729570|520080177|FG001|Overall Study|Lost to Follow-up|20|||
144241297|NCT03729570|520080176|FG000|Overall Study|Seroconversion|5|||
144241298|NCT03729570|520080177|FG001|Overall Study|Seroconversion|0|||
144241299|NCT03729570|520080176|FG000|Overall Study|Moved out of the city|1|||
144241300|NCT03729570|520080177|FG001|Overall Study|Moved out of the city|0|||
144241301|NCT03729570|520080176|FG000|Overall Study|Time Conflict|1|||
144241302|NCT03729570|520080177|FG001|Overall Study|Time Conflict|0|||
144241303|NCT03729570|520080176|FG000|Overall Study|Time Commitment|2|||
144241304|NCT03729570|520080177|FG001|Overall Study|Time Commitment|0|||
144241305|NCT03729570|520080176|FG000|Overall Study|Bad Experience|0|||
144241306|NCT03729570|520080177|FG001|Overall Study|Bad Experience|1|||
144241307|NCT03729570|520080176|FG000|Overall Study|No reason provided|2|||
144241308|NCT03729570|520080177|FG001|Overall Study|No reason provided|1|||
144241309|NCT03729570|520080176|FG000|Overall Study|Family Conflict|0|||
144241310|NCT03729570|520080177|FG001|Overall Study|Family Conflict|1|||
144241311|NCT03729570|520080176|FG000|Overall Study|Did not want to continue taking medications|0|||
144241312|NCT03729570|520080177|FG001|Overall Study|Did not want to continue taking medications|1|||
144241313|NCT03729570|520080176|FG000|Overall Study|Found another PrEP provider|1|||
144241314|NCT03729570|520080177|FG001|Overall Study|Found another PrEP provider|0|||
144241315|NCT03729570|520080176|FG000|Overall Study|Did not enjoy being in the control group|0|||
144241316|NCT03729570|520080177|FG001|Overall Study|Did not enjoy being in the control group|1|||
144270560|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
144270561|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
144270562|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
144241317|NCT02062944|520080178|FG000|Overall Study|Lost to Follow-up|1|||
144241318|NCT02062944|520080178|FG000|Overall Study|New hemotological disorder identified|1|||
144241319|NCT02062944|520080178|FG000|Overall Study|Uncontrolled Hypertension|1|||
144241320|NCT02062944|520080178|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
144241321|NCT02122770|520080180|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
144241322|NCT02122770|520080181|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
144241323|NCT02122770|520080182|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
144241324|NCT02122770|520080183|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
144241325|NCT02122770|520080184|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
144241326|NCT02122770|520080185|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
144241327|NCT02122770|520080180|FG000|Part A: Drug-drug Interaction 2|Other|0|||
144241328|NCT02122770|520080181|FG001|Part A: Drug-drug Interaction 2|Other|0|||
144241329|NCT02122770|520080182|FG002|Part A: Drug-drug Interaction 2|Other|1|||
144241330|NCT02122770|520080183|FG003|Part A: Drug-drug Interaction 2|Other|0|||
144241331|NCT02122770|520080184|FG004|Part A: Drug-drug Interaction 2|Other|0|||
144241332|NCT02122770|520080185|FG005|Part A: Drug-drug Interaction 2|Other|0|||
144241333|NCT02122770|520080180|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
144241334|NCT02122770|520080181|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
144241335|NCT02122770|520080182|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
144241336|NCT02122770|520080183|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
144241337|NCT02122770|520080184|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
144241338|NCT02122770|520080185|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
144241339|NCT02122770|520080180|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
144241340|NCT02122770|520080181|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
144241341|NCT02122770|520080182|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
144241342|NCT02122770|520080183|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
144241343|NCT02122770|520080184|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
144241344|NCT02122770|520080185|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
144241345|NCT02122770|520080180|FG000|Part B: Standard of Care|Adverse Event|0|||
144241346|NCT02122770|520080181|FG001|Part B: Standard of Care|Adverse Event|0|||
144241347|NCT02122770|520080182|FG002|Part B: Standard of Care|Adverse Event|0|||
144241348|NCT02122770|520080183|FG003|Part B: Standard of Care|Adverse Event|0|||
144241349|NCT02122770|520080184|FG004|Part B: Standard of Care|Adverse Event|4|||
144241350|NCT02122770|520080185|FG005|Part B: Standard of Care|Adverse Event|1|||
144241351|NCT02122770|520080180|FG000|Part B: Standard of Care|Other|0|||
144241352|NCT02122770|520080181|FG001|Part B: Standard of Care|Other|0|||
144241353|NCT02122770|520080182|FG002|Part B: Standard of Care|Other|0|||
144241354|NCT02122770|520080183|FG003|Part B: Standard of Care|Other|0|||
144241355|NCT02122770|520080184|FG004|Part B: Standard of Care|Other|0|||
144241356|NCT02122770|520080185|FG005|Part B: Standard of Care|Other|2|||
144241357|NCT02122770|520080180|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
144241358|NCT02122770|520080181|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
144241359|NCT02122770|520080182|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
144241360|NCT02122770|520080183|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
144241361|NCT02122770|520080184|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
144241362|NCT02122770|520080185|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
144241363|NCT02122770|520080180|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
144241364|NCT02122770|520080181|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
144241365|NCT02122770|520080182|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
144241366|NCT02122770|520080183|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
144241367|NCT02122770|520080184|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
144241368|NCT02122770|520080185|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
144241369|NCT02122770|520080180|FG000|Part B: Standard of Care|Progressive Disease|0|||
144241370|NCT02122770|520080181|FG001|Part B: Standard of Care|Progressive Disease|0|||
144241371|NCT02122770|520080182|FG002|Part B: Standard of Care|Progressive Disease|0|||
144241372|NCT02122770|520080183|FG003|Part B: Standard of Care|Progressive Disease|0|||
144241373|NCT02122770|520080184|FG004|Part B: Standard of Care|Progressive Disease|10|||
144241374|NCT02122770|520080185|FG005|Part B: Standard of Care|Progressive Disease|8|||
144241375|NCT02083185|520080186|FG000|Overall Study|Lost to Follow-up|0|||
144241376|NCT02083185|520080187|FG001|Overall Study|Lost to Follow-up|3|||
144241377|NCT02083185|520080188|FG002|Overall Study|Lost to Follow-up|0|||
144241378|NCT02083185|520080186|FG000|Overall Study|Withdrawal by Subject|9|||
144241379|NCT02083185|520080187|FG001|Overall Study|Withdrawal by Subject|15|||
144241380|NCT02083185|520080188|FG002|Overall Study|Withdrawal by Subject|1|||
144241381|NCT02083185|520080186|FG000|Overall Study|Death|2|||
144241382|NCT02083185|520080187|FG001|Overall Study|Death|2|||
144241383|NCT02083185|520080188|FG002|Overall Study|Death|1|||
144241384|NCT02083185|520080186|FG000|Overall Study|Reason not Specified|9|||
144241385|NCT02083185|520080187|FG001|Overall Study|Reason not Specified|6|||
144241386|NCT02083185|520080188|FG002|Overall Study|Reason not Specified|5|||
144241387|NCT02083185|520080186|FG000|Overall Study|Study Terminated by Sponsor|0|||
144241388|NCT02083185|520080187|FG001|Overall Study|Study Terminated by Sponsor|1|||
144241389|NCT02083185|520080188|FG002|Overall Study|Study Terminated by Sponsor|0|||
144241390|NCT02083185|520080186|FG000|Overall Study|Did not Receive Study Drug|0|||
144241391|NCT02083185|520080187|FG001|Overall Study|Did not Receive Study Drug|2|||
144241392|NCT02083185|520080188|FG002|Overall Study|Did not Receive Study Drug|0|||
144241393|NCT01041976|520080189|FG000|Overall Study|Withdrawal by Subject|3|||
144241394|NCT01041976|520080190|FG001|Overall Study|Withdrawal by Subject|0|||
144241395|NCT01041976|520080189|FG000|Overall Study|Incarceration|2|||
144241396|NCT01041976|520080190|FG001|Overall Study|Incarceration|0|||
144241397|NCT01041976|520080189|FG000|Overall Study|Death|0|||
144241398|NCT01041976|520080190|FG001|Overall Study|Death|4|||
144241399|NCT00535847|520080191|FG000|Overall Study|Adverse Event|5|||
144241400|NCT00535847|520080192|FG001|Overall Study|Adverse Event|3|||
144241401|NCT00535847|520080193|FG002|Overall Study|Adverse Event|2|||
144241402|NCT00535847|520080191|FG000|Overall Study|Non compliance|1|||
144241403|NCT00535847|520080192|FG001|Overall Study|Non compliance|1|||
144241404|NCT00535847|520080193|FG002|Overall Study|Non compliance|0|||
144241405|NCT00535847|520080191|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
144241406|NCT00535847|520080192|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
144241407|NCT00535847|520080193|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
144241408|NCT01546168|520080194|FG000|Overall Study|Lost to Follow-up|1|||
144241409|NCT01546168|520080195|FG001|Overall Study|Lost to Follow-up|0|||
144241410|NCT01546168|520080194|FG000|Overall Study|Withdrawal by Subject|1|||
144241411|NCT01546168|520080195|FG001|Overall Study|Withdrawal by Subject|0|||
144241412|NCT01546168|520080194|FG000|Overall Study|ineligible after signing consent|2|||
144241413|NCT01546168|520080195|FG001|Overall Study|ineligible after signing consent|0|||
144241414|NCT01258075|520080198|FG000|Overall Study|Adverse Event|8|||
144241415|NCT01258075|520080199|FG001|Overall Study|Adverse Event|3|||
144241416|NCT01258075|520080198|FG000|Overall Study|Lost to Follow-up|11|||
144241417|NCT01258075|520080199|FG001|Overall Study|Lost to Follow-up|6|||
144241418|NCT01258075|520080198|FG000|Overall Study|Withdrawal by Subject|10|||
144241419|NCT01258075|520080199|FG001|Overall Study|Withdrawal by Subject|7|||
144241420|NCT01258075|520080198|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
144241421|NCT01258075|520080199|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
144241422|NCT01258075|520080198|FG000|Overall Study|Other|12|||
144241423|NCT01258075|520080199|FG001|Overall Study|Other|5|||
144241424|NCT00976209|520080202|FG000|Treatment Period 1|Protocol Violation|1|||
144241425|NCT00976209|520080203|FG001|Treatment Period 1|Protocol Violation|0|||
144241426|NCT00976209|520080202|FG000|Treatment Period 1|Lost to Follow-up|2|||
144241427|NCT00976209|520080203|FG001|Treatment Period 1|Lost to Follow-up|0|||
144241428|NCT00976209|520080202|FG000|Treatment Period 1|Other|0|||
144241429|NCT00976209|520080203|FG001|Treatment Period 1|Other|1|||
144241430|NCT00976209|520080202|FG000|Wash-out Period|Adverse Event|1|||
144241431|NCT00976209|520080203|FG001|Wash-out Period|Adverse Event|2|||
144241432|NCT00976209|520080202|FG000|Wash-out Period|Lost to Follow-up|1|||
144241433|NCT00976209|520080203|FG001|Wash-out Period|Lost to Follow-up|0|||
144241434|NCT00976209|520080202|FG000|Wash-out Period|Protocol Violation|1|||
144241435|NCT00976209|520080203|FG001|Wash-out Period|Protocol Violation|0|||
144241436|NCT00976209|520080202|FG000|Wash-out Period|Other|1|||
144241437|NCT00976209|520080203|FG001|Wash-out Period|Other|0|||
144241438|NCT00976209|520080202|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144241439|NCT00976209|520080203|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144241440|NCT00976209|520080202|FG000|Treatment Period 2|Lost to Follow-up|0|||
144241441|NCT00976209|520080203|FG001|Treatment Period 2|Lost to Follow-up|1|||
144241442|NCT01252563|520080204|FG000|Overall Study|Contract Deviation|41|||
144241443|NCT01252563|520080204|FG000|Overall Study|Centralized Registration Deviation|30|||
144241444|NCT01252563|520080204|FG000|Overall Study|Lost to Follow-up|161|||
144241445|NCT01252563|520080204|FG000|Overall Study|No visit after first day of treatment|194|||
144241446|NCT01252563|520080204|FG000|Overall Study|No drug administration|6|||
144241447|NCT00978250|520080206|FG000|Overall Study|Late determination of ineligibility|0|||
144241448|NCT00978250|520080207|FG001|Overall Study|Late determination of ineligibility|1|||
144241449|NCT00978250|520080208|FG002|Overall Study|Late determination of ineligibility|0|||
144241450|NCT00978250|520080209|FG003|Overall Study|Late determination of ineligibility|1|||
144241451|NCT00471718|520080210|FG000|Overall Study|Adverse Event|3|||
144241452|NCT00471718|520080210|FG000|Overall Study|other complicating disease|1|||
144241453|NCT00471718|520080210|FG000|Overall Study|disease progression|22|||
144241454|NCT00471718|520080210|FG000|Overall Study|Withdrawal by Subject|1|||
144241455|NCT00381043|520080211|FG000|Overall Study|Lost to Follow-up|8|||
144241456|NCT00381043|520080212|FG001|Overall Study|Lost to Follow-up|6|||
144241457|NCT00381043|520080211|FG000|Overall Study|Withdrawal by Subject|3|||
144241458|NCT00381043|520080212|FG001|Overall Study|Withdrawal by Subject|1|||
144241459|NCT00381043|520080211|FG000|Overall Study|wanted more care|0|||
144241460|NCT00381043|520080212|FG001|Overall Study|wanted more care|1|||
144241461|NCT00381043|520080211|FG000|Overall Study|incarcerated|1|||
144241462|NCT00381043|520080212|FG001|Overall Study|incarcerated|0|||
144241463|NCT02880865|520080215|FG000|Overall Study|Adverse Event|1|||
144241464|NCT02880865|520080216|FG001|Overall Study|Adverse Event|0|||
144241465|NCT02880865|520080215|FG000|Overall Study|Withdrawal by Subject|0|||
144241466|NCT02880865|520080216|FG001|Overall Study|Withdrawal by Subject|2|||
144241467|NCT02880865|520080215|FG000|Overall Study|Physician Decision|0|||
144241468|NCT02880865|520080216|FG001|Overall Study|Physician Decision|1|||
144241469|NCT03045276|520080217|FG000|Intervention Phase|Withdrawal by Subject|7|||
144241470|NCT03045276|520080218|FG001|Intervention Phase|Withdrawal by Subject|2|||
144241471|NCT03045276|520080219|FG002|Intervention Phase|Withdrawal by Subject|3|||
144241472|NCT03045276|520080220|FG003|Intervention Phase|Withdrawal by Subject|7|||
144241473|NCT03045276|520080217|FG000|Intervention Phase|Developed exclusionary criteria|3|||
144241474|NCT03045276|520080218|FG001|Intervention Phase|Developed exclusionary criteria|3|||
144241475|NCT03045276|520080219|FG002|Intervention Phase|Developed exclusionary criteria|0|||
144241476|NCT03045276|520080220|FG003|Intervention Phase|Developed exclusionary criteria|0|||
144241477|NCT03045276|520080217|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
144241478|NCT03045276|520080218|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
144241479|NCT03045276|520080219|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
144241480|NCT03045276|520080220|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
144241481|NCT03045276|520080217|FG000|Follow-Up Phase|Lost to Follow-up|0|||
144241482|NCT03045276|520080218|FG001|Follow-Up Phase|Lost to Follow-up|1|||
144241483|NCT03045276|520080219|FG002|Follow-Up Phase|Lost to Follow-up|0|||
144241484|NCT03045276|520080220|FG003|Follow-Up Phase|Lost to Follow-up|1|||
144241485|NCT03045276|520080217|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
144241486|NCT03045276|520080218|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
144241487|NCT03045276|520080219|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
144241488|NCT03045276|520080220|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
144241489|NCT02727777|520080224|FG000|Overall Study|Screen Failure|2|||
144241490|NCT02727777|520080225|FG001|Overall Study|Screen Failure|0|||
144241491|NCT02727777|520080226|FG002|Overall Study|Screen Failure|0|||
144241492|NCT02727777|520080224|FG000|Overall Study|Progressive disease|2|||
144241493|NCT02727777|520080225|FG001|Overall Study|Progressive disease|0|||
144241494|NCT02727777|520080226|FG002|Overall Study|Progressive disease|0|||
144241495|NCT01738503|520080227|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
144241496|NCT01738503|520080228|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
144241497|NCT01738503|520080229|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
144241498|NCT01738503|520080230|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
144241499|NCT01738503|520080231|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
144241500|NCT01738503|520080232|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
144241501|NCT01738503|520080233|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
144241502|NCT01738503|520080227|FG000|Treatment Period|Adverse Event|0|||
144241503|NCT01738503|520080228|FG001|Treatment Period|Adverse Event|1|||
144241504|NCT01738503|520080229|FG002|Treatment Period|Adverse Event|0|||
144241505|NCT01738503|520080230|FG003|Treatment Period|Adverse Event|1|||
144241506|NCT01738503|520080231|FG004|Treatment Period|Adverse Event|2|||
144241507|NCT01738503|520080232|FG005|Treatment Period|Adverse Event|2|||
144241508|NCT01738503|520080233|FG006|Treatment Period|Adverse Event|2|||
144241509|NCT01738503|520080227|FG000|Treatment Period|Lost to Follow-up|0|||
144241510|NCT01738503|520080228|FG001|Treatment Period|Lost to Follow-up|0|||
144241511|NCT01738503|520080229|FG002|Treatment Period|Lost to Follow-up|3|||
144241512|NCT01738503|520080230|FG003|Treatment Period|Lost to Follow-up|4|||
144241513|NCT01738503|520080231|FG004|Treatment Period|Lost to Follow-up|1|||
144241514|NCT01738503|520080232|FG005|Treatment Period|Lost to Follow-up|1|||
144241515|NCT01738503|520080233|FG006|Treatment Period|Lost to Follow-up|5|||
144241516|NCT01738503|520080227|FG000|Treatment Period|Withdrawal by Subject|0|||
144241517|NCT01738503|520080228|FG001|Treatment Period|Withdrawal by Subject|1|||
144241518|NCT01738503|520080229|FG002|Treatment Period|Withdrawal by Subject|0|||
144241519|NCT01738503|520080230|FG003|Treatment Period|Withdrawal by Subject|1|||
144241520|NCT01738503|520080231|FG004|Treatment Period|Withdrawal by Subject|1|||
144241521|NCT01738503|520080232|FG005|Treatment Period|Withdrawal by Subject|1|||
144241522|NCT01738503|520080233|FG006|Treatment Period|Withdrawal by Subject|1|||
144241523|NCT01738503|520080227|FG000|Treatment Period|Protocol Violation|0|||
144241524|NCT01738503|520080228|FG001|Treatment Period|Protocol Violation|3|||
144241525|NCT01738503|520080229|FG002|Treatment Period|Protocol Violation|1|||
144241526|NCT01738503|520080230|FG003|Treatment Period|Protocol Violation|0|||
144241527|NCT01738503|520080231|FG004|Treatment Period|Protocol Violation|4|||
144241528|NCT01738503|520080232|FG005|Treatment Period|Protocol Violation|2|||
144241529|NCT01738503|520080233|FG006|Treatment Period|Protocol Violation|0|||
144241530|NCT01738503|520080227|FG000|Treatment Period|Other|0|||
144241531|NCT01738503|520080228|FG001|Treatment Period|Other|0|||
144241532|NCT01738503|520080229|FG002|Treatment Period|Other|1|||
144241533|NCT01738503|520080230|FG003|Treatment Period|Other|0|||
144241534|NCT01738503|520080231|FG004|Treatment Period|Other|0|||
144241535|NCT01738503|520080232|FG005|Treatment Period|Other|0|||
144241536|NCT01738503|520080233|FG006|Treatment Period|Other|0|||
144241537|NCT01738503|520080227|FG000|PET Imaging Sub-study|Adverse Event|0|||
144241538|NCT01738503|520080228|FG001|PET Imaging Sub-study|Adverse Event|0|||
144241539|NCT01738503|520080229|FG002|PET Imaging Sub-study|Adverse Event|0|||
144241540|NCT01738503|520080230|FG003|PET Imaging Sub-study|Adverse Event|0|||
144241541|NCT01738503|520080231|FG004|PET Imaging Sub-study|Adverse Event|0|||
144241542|NCT01738503|520080232|FG005|PET Imaging Sub-study|Adverse Event|1|||
144241543|NCT01738503|520080233|FG006|PET Imaging Sub-study|Adverse Event|0|||
144241544|NCT01738503|520080227|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
144241545|NCT01738503|520080228|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
144241546|NCT01738503|520080229|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
144241547|NCT01738503|520080230|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
144241548|NCT01738503|520080231|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
144241549|NCT01738503|520080232|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
144241550|NCT01738503|520080233|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
144241551|NCT03005327|520080234|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
144241552|NCT03005327|520080235|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
144241553|NCT03005327|520080236|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
144241554|NCT03005327|520080237|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
144241555|NCT03005327|520080234|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144241556|NCT03005327|520080235|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
144241557|NCT03005327|520080236|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144241558|NCT03005327|520080237|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
144241559|NCT04687072|520080238|FG000|Overall Study|Adverse Event|2|||
144241560|NCT04687072|520080239|FG001|Overall Study|Adverse Event|0|||
144241561|NCT04687072|520080238|FG000|Overall Study|Death|1|||
144241562|NCT04687072|520080239|FG001|Overall Study|Death|0|||
144241563|NCT04687072|520080238|FG000|Overall Study|Lack of Efficacy|2|||
144241564|NCT04687072|520080239|FG001|Overall Study|Lack of Efficacy|1|||
144241565|NCT04687072|520080238|FG000|Overall Study|Physician Decision|1|||
144241566|NCT04687072|520080239|FG001|Overall Study|Physician Decision|0|||
144241567|NCT04687072|520080238|FG000|Overall Study|Pregnancy|1|||
144241568|NCT04687072|520080239|FG001|Overall Study|Pregnancy|0|||
144241569|NCT04687072|520080238|FG000|Overall Study|Requires Prohibited Medication|2|||
144241570|NCT04687072|520080239|FG001|Overall Study|Requires Prohibited Medication|0|||
144241571|NCT04687072|520080238|FG000|Overall Study|Withdrawal of Consent|11|||
144241572|NCT04687072|520080239|FG001|Overall Study|Withdrawal of Consent|6|||
144241573|NCT04687072|520080238|FG000|Overall Study|Miscellaneous|4|||
144241574|NCT04687072|520080239|FG001|Overall Study|Miscellaneous|1|||
144241575|NCT02600845|520080244|FG000|Overall Study|Reason Not Specified|3|||
144241576|NCT02600845|520080244|FG000|Overall Study|Non-compliance with Study Procedures|10|||
144241577|NCT02600845|520080244|FG000|Overall Study|Consent Withdrawal|5|||
144241578|NCT00960986|520080252|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
144241579|NCT00960986|520080253|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
144241580|NCT00960986|520080254|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
144241581|NCT00960986|520080255|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
144241582|NCT00960986|520080252|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
144241583|NCT00960986|520080253|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
144241584|NCT00960986|520080254|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
144241585|NCT00960986|520080255|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
144241586|NCT00960986|520080252|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
144241587|NCT00960986|520080253|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
144241588|NCT00960986|520080254|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
144241589|NCT00960986|520080255|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
144241590|NCT00960986|520080252|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
144241591|NCT00960986|520080253|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
144241592|NCT00960986|520080254|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
144241593|NCT00960986|520080255|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
144241594|NCT00960986|520080252|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
144241595|NCT00960986|520080253|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
144241596|NCT00960986|520080254|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
144241597|NCT00960986|520080255|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
144241598|NCT00960986|520080252|FG000|Period 3 (7-week Therapy Period)|Death|0|||
144241599|NCT00960986|520080253|FG001|Period 3 (7-week Therapy Period)|Death|0|||
144241600|NCT00960986|520080254|FG002|Period 3 (7-week Therapy Period)|Death|1|||
144241601|NCT00960986|520080255|FG003|Period 3 (7-week Therapy Period)|Death|0|||
144241602|NCT00960986|520080252|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
144241603|NCT00960986|520080253|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
144241604|NCT00960986|520080254|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
144241605|NCT00960986|520080255|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
144241606|NCT00960986|520080252|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
144241607|NCT00960986|520080253|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
144241608|NCT00960986|520080254|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
144241609|NCT00960986|520080255|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
144241610|NCT00960986|520080252|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
144241611|NCT00960986|520080253|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
144241612|NCT00960986|520080254|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
144241613|NCT00960986|520080255|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
144241614|NCT00960986|520080252|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
144241615|NCT00960986|520080253|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
144241616|NCT00960986|520080254|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
144241617|NCT00960986|520080255|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
144241618|NCT02234596|520080256|FG000|Overall Study|Participant not treated|2|||
144241619|NCT04852679|520080257|FG000|Main Intervention Period|Withdrawal by Subject|3|||
144241620|NCT04852679|520080257|FG000|Main Intervention Period|Adverse Event|1|||
144241621|NCT04852679|520080257|FG000|Main Intervention Period|Progressive Disease|16|||
144241622|NCT04852679|520080257|FG000|Main Intervention Period|Refused study visit|1|||
144241623|NCT04852679|520080257|FG000|Independent Injection Period|Missed study visit|1|||
144241624|NCT02017717|520082203|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241625|NCT02017717|520082204|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241626|NCT02017717|520082205|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241627|NCT02017717|520082206|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241628|NCT02017717|520082207|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241629|NCT02017717|520082208|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241630|NCT02017717|520082209|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241631|NCT02017717|520082210|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
144241632|NCT02017717|520082211|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
144241633|NCT02017717|520082203|FG000|Before Treatment Period|Participant request to stop therapy|0|||
144241634|NCT02017717|520082204|FG001|Before Treatment Period|Participant request to stop therapy|0|||
144241635|NCT02017717|520082205|FG002|Before Treatment Period|Participant request to stop therapy|0|||
144241636|NCT02017717|520082206|FG003|Before Treatment Period|Participant request to stop therapy|0|||
144241637|NCT02017717|520082207|FG004|Before Treatment Period|Participant request to stop therapy|0|||
144241638|NCT02017717|520082208|FG005|Before Treatment Period|Participant request to stop therapy|0|||
144241639|NCT02017717|520082209|FG006|Before Treatment Period|Participant request to stop therapy|0|||
144241640|NCT02017717|520082210|FG007|Before Treatment Period|Participant request to stop therapy|0|||
144241641|NCT02017717|520082211|FG008|Before Treatment Period|Participant request to stop therapy|5|||
144241642|NCT02017717|520082203|FG000|Before Treatment Period|Participant withdrew consent|0|||
144241643|NCT02017717|520082204|FG001|Before Treatment Period|Participant withdrew consent|0|||
144241644|NCT02017717|520082205|FG002|Before Treatment Period|Participant withdrew consent|0|||
144241645|NCT02017717|520082206|FG003|Before Treatment Period|Participant withdrew consent|0|||
144241646|NCT02017717|520082207|FG004|Before Treatment Period|Participant withdrew consent|0|||
144241647|NCT02017717|520082208|FG005|Before Treatment Period|Participant withdrew consent|0|||
144241648|NCT02017717|520082209|FG006|Before Treatment Period|Participant withdrew consent|2|||
144241649|NCT02017717|520082210|FG007|Before Treatment Period|Participant withdrew consent|0|||
144241650|NCT02017717|520082211|FG008|Before Treatment Period|Participant withdrew consent|11|||
144241651|NCT02017717|520082203|FG000|Before Treatment Period|Lost to Follow-up|0|||
144241652|NCT02017717|520082204|FG001|Before Treatment Period|Lost to Follow-up|0|||
144241653|NCT02017717|520082205|FG002|Before Treatment Period|Lost to Follow-up|0|||
144241654|NCT02017717|520082206|FG003|Before Treatment Period|Lost to Follow-up|0|||
144241655|NCT02017717|520082207|FG004|Before Treatment Period|Lost to Follow-up|0|||
144241656|NCT02017717|520082208|FG005|Before Treatment Period|Lost to Follow-up|0|||
144241657|NCT02017717|520082209|FG006|Before Treatment Period|Lost to Follow-up|0|||
144241658|NCT02017717|520082210|FG007|Before Treatment Period|Lost to Follow-up|0|||
144241659|NCT02017717|520082211|FG008|Before Treatment Period|Lost to Follow-up|1|||
144241660|NCT02017717|520082203|FG000|Before Treatment Period|Participant no longer met criteria|0|||
144241661|NCT02017717|520082204|FG001|Before Treatment Period|Participant no longer met criteria|0|||
144270563|NCT01668797|520195603|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
144270564|NCT01668797|520195604|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
144270565|NCT01668797|520195605|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
144270566|NCT01668797|520195606|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
144270567|NCT02515227|520195607|FG000|Overall Study|Adverse Event|0|||
144270568|NCT02515227|520195608|FG001|Overall Study|Adverse Event|2|||
144270569|NCT02515227|520195607|FG000|Overall Study|Progressive disease|2|||
144270570|NCT02515227|520195608|FG001|Overall Study|Progressive disease|9|||
144270571|NCT00929669|520195612|FG000|Overall Study|elevated glucose levels|1|||
144270572|NCT02714153|520195613|FG000|Overall Study|Death|1|||
144270573|NCT00686972|520195614|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
144270574|NCT01901185|520195615|FG000|Overall Study|Withdrawal by Subject|2|||
144270575|NCT01027845|520195617|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
144270576|NCT01027845|520195618|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
144270577|NCT01027845|520195619|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
144270578|NCT01027845|520195620|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
144270579|NCT01027845|520195617|FG000|Primary Vaccination Phase|Adverse Event|1|||
144270580|NCT01027845|520195618|FG001|Primary Vaccination Phase|Adverse Event|0|||
144270581|NCT01027845|520195619|FG002|Primary Vaccination Phase|Adverse Event|0|||
144270582|NCT01027845|520195620|FG003|Primary Vaccination Phase|Adverse Event|0|||
144270583|NCT01027845|520195617|FG000|Primary Vaccination Phase|Protocol Violation|1|||
144270584|NCT01027845|520195618|FG001|Primary Vaccination Phase|Protocol Violation|0|||
144270585|NCT01027845|520195619|FG002|Primary Vaccination Phase|Protocol Violation|0|||
144270586|NCT01027845|520195620|FG003|Primary Vaccination Phase|Protocol Violation|0|||
144270587|NCT01027845|520195617|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
144270588|NCT01027845|520195618|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
144270589|NCT01027845|520195619|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
144270590|NCT01027845|520195620|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
144270591|NCT01027845|520195617|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
144270592|NCT01027845|520195618|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
144270593|NCT01027845|520195619|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
144270594|NCT01027845|520195620|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
144270595|NCT01027845|520195617|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
144270596|NCT01027845|520195618|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
144270597|NCT01027845|520195619|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
144270598|NCT01027845|520195620|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
144270599|NCT04465422|520195633|FG000|Overall Study|Lost to Follow-up|0|||
144270600|NCT04465422|520195634|FG001|Overall Study|Lost to Follow-up|2|||
144270601|NCT00863707|520195637|FG000|Overall Study|Randomized, but drug not received|4|||
144270602|NCT00863707|520195638|FG001|Overall Study|Randomized, but drug not received|3|||
144270603|NCT00111761|520195639|FG000|Part 1|Physician Decision|0|||
144270604|NCT00111761|520195640|FG001|Part 1|Physician Decision|1|||
144270605|NCT00111761|520195639|FG000|Part 1|Death|0|||
144270606|NCT00111761|520195640|FG001|Part 1|Death|2|||
144270607|NCT00111761|520195639|FG000|Part 1|Other|0|||
144270608|NCT00111761|520195640|FG001|Part 1|Other|1|||
144270609|NCT00111761|520195639|FG000|Part 1|Withdrawal by Subject|0|||
144270610|NCT00111761|520195640|FG001|Part 1|Withdrawal by Subject|1|||
144270611|NCT00111761|520195639|FG000|Part 2|Adverse Event|1|||
144270612|NCT00111761|520195640|FG001|Part 2|Adverse Event|0|||
144270613|NCT00111761|520195639|FG000|Part 2|Physician Decision|1|||
144270614|NCT00111761|520195640|FG001|Part 2|Physician Decision|0|||
144270615|NCT00111761|520195639|FG000|Part 2|Death|1|||
144270616|NCT00111761|520195640|FG001|Part 2|Death|0|||
144270617|NCT00111761|520195639|FG000|Part 2|Disease progression|3|||
144270618|NCT00111761|520195640|FG001|Part 2|Disease progression|0|||
144270619|NCT00111761|520195639|FG000|Part 2|Protocol-specified criteria|1|||
144270620|NCT00111761|520195640|FG001|Part 2|Protocol-specified criteria|0|||
144270621|NCT00111761|520195639|FG000|Part 2|Other|1|||
144270622|NCT00111761|520195640|FG001|Part 2|Other|0|||
144270623|NCT01123655|520195641|FG000|Overall Study|Medication for RA had to be changed|1|||
144270624|NCT01123655|520195642|FG001|Overall Study|Medication for RA had to be changed|0|||
144270625|NCT01123655|520195643|FG002|Overall Study|Medication for RA had to be changed|0|||
144270626|NCT01123655|520195641|FG000|Overall Study|new illness|0|||
144270627|NCT01123655|520195642|FG001|Overall Study|new illness|1|||
144270628|NCT01123655|520195643|FG002|Overall Study|new illness|0|||
144270629|NCT01123655|520195641|FG000|Overall Study|began prohibitive drug|0|||
144270630|NCT01123655|520195642|FG001|Overall Study|began prohibitive drug|0|||
144270631|NCT01123655|520195643|FG002|Overall Study|began prohibitive drug|1|||
144270632|NCT01776554|520195646|FG000|Overall Study|Adverse Event|1|||
144270633|NCT01776554|520195647|FG001|Overall Study|Adverse Event|0|||
144270634|NCT01776554|520195646|FG000|Overall Study|Withdrawal by Subject|3|||
144270635|NCT01776554|520195647|FG001|Overall Study|Withdrawal by Subject|8|||
144270636|NCT01776554|520195646|FG000|Overall Study|Lost to Follow-up|6|||
144270637|NCT01776554|520195647|FG001|Overall Study|Lost to Follow-up|9|||
144270638|NCT01776554|520195646|FG000|Overall Study|Administrative Reason|2|||
144270639|NCT01776554|520195647|FG001|Overall Study|Administrative Reason|5|||
144270640|NCT01776554|520195646|FG000|Overall Study|Protocol Violation|1|||
144270641|NCT01776554|520195647|FG001|Overall Study|Protocol Violation|0|||
144270642|NCT01776554|520195646|FG000|Overall Study|Unclassified|4|||
144270643|NCT01776554|520195647|FG001|Overall Study|Unclassified|1|||
144270644|NCT01991795|520195648|FG000|Overall Study|Lost to Follow-up|6|||
144270645|NCT01991795|520195649|FG001|Overall Study|Lost to Follow-up|4|||
144270646|NCT01991795|520195648|FG000|Overall Study|Withdrawal by Subject|117|||
144270647|NCT01991795|520195649|FG001|Overall Study|Withdrawal by Subject|94|||
144270648|NCT01991795|520195648|FG000|Overall Study|Site prematurely closed by sponsor|26|||
144270649|NCT01991795|520195649|FG001|Overall Study|Site prematurely closed by sponsor|25|||
144270650|NCT04798027|520195650|FG000|Overall Study|Protocol Violation|0|||
144270651|NCT04798027|520195651|FG001|Overall Study|Protocol Violation|0|||
144270652|NCT04798027|520195652|FG002|Overall Study|Protocol Violation|0|||
144270653|NCT04798027|520195653|FG003|Overall Study|Protocol Violation|0|||
144270654|NCT04798027|520195654|FG004|Overall Study|Protocol Violation|1|||
144270655|NCT04798027|520195655|FG005|Overall Study|Protocol Violation|0|||
144270656|NCT04798027|520195656|FG006|Overall Study|Protocol Violation|0|||
144270657|NCT04798027|520195657|FG007|Overall Study|Protocol Violation|1|||
144270658|NCT04798027|520195658|FG008|Overall Study|Protocol Violation|0|||
144270659|NCT04798027|520195650|FG000|Overall Study|Withdrawal by Subject|1|||
144270660|NCT04798027|520195651|FG001|Overall Study|Withdrawal by Subject|0|||
144270661|NCT04798027|520195652|FG002|Overall Study|Withdrawal by Subject|1|||
144270662|NCT04798027|520195653|FG003|Overall Study|Withdrawal by Subject|1|||
144270663|NCT04798027|520195654|FG004|Overall Study|Withdrawal by Subject|1|||
144270664|NCT04798027|520195655|FG005|Overall Study|Withdrawal by Subject|1|||
144270665|NCT04798027|520195656|FG006|Overall Study|Withdrawal by Subject|3|||
144270666|NCT04798027|520195657|FG007|Overall Study|Withdrawal by Subject|2|||
144270667|NCT04798027|520195658|FG008|Overall Study|Withdrawal by Subject|2|||
144270668|NCT04798027|520195650|FG000|Overall Study|Lost to Follow-up|1|||
144270669|NCT04798027|520195651|FG001|Overall Study|Lost to Follow-up|3|||
144270670|NCT04798027|520195652|FG002|Overall Study|Lost to Follow-up|0|||
144270671|NCT04798027|520195653|FG003|Overall Study|Lost to Follow-up|0|||
144270672|NCT04798027|520195654|FG004|Overall Study|Lost to Follow-up|0|||
144270673|NCT04798027|520195655|FG005|Overall Study|Lost to Follow-up|1|||
144270674|NCT04798027|520195656|FG006|Overall Study|Lost to Follow-up|0|||
144270675|NCT04798027|520195657|FG007|Overall Study|Lost to Follow-up|0|||
144270676|NCT04798027|520195658|FG008|Overall Study|Lost to Follow-up|1|||
144270677|NCT04798027|520195650|FG000|Overall Study|Withdrawal by Sponsor|8|||
144270678|NCT04798027|520195651|FG001|Overall Study|Withdrawal by Sponsor|22|||
144270679|NCT04798027|520195652|FG002|Overall Study|Withdrawal by Sponsor|9|||
144270680|NCT04798027|520195653|FG003|Overall Study|Withdrawal by Sponsor|26|||
144270681|NCT04798027|520195654|FG004|Overall Study|Withdrawal by Sponsor|24|||
144270682|NCT04798027|520195655|FG005|Overall Study|Withdrawal by Sponsor|11|||
144270683|NCT04798027|520195656|FG006|Overall Study|Withdrawal by Sponsor|25|||
144270684|NCT04798027|520195657|FG007|Overall Study|Withdrawal by Sponsor|26|||
144270685|NCT04798027|520195658|FG008|Overall Study|Withdrawal by Sponsor|11|||
144270686|NCT00885118|520195659|FG000|Overall Study|Adverse Event|1|||
144270687|NCT00885118|520195660|FG001|Overall Study|Adverse Event|0|||
144270688|NCT00885118|520195661|FG002|Overall Study|Adverse Event|0|||
144270689|NCT00885118|520195662|FG003|Overall Study|Adverse Event|0|||
144270690|NCT00885118|520195663|FG004|Overall Study|Adverse Event|0|||
144270691|NCT00885118|520195659|FG000|Overall Study|Withdrawal by Subject|0|||
144270692|NCT00885118|520195660|FG001|Overall Study|Withdrawal by Subject|0|||
144270693|NCT00885118|520195661|FG002|Overall Study|Withdrawal by Subject|0|||
144270694|NCT00885118|520195662|FG003|Overall Study|Withdrawal by Subject|0|||
144270695|NCT00885118|520195663|FG004|Overall Study|Withdrawal by Subject|1|||
144270696|NCT00885118|520195659|FG000|Overall Study|Other reason not defined above|0|||
144270697|NCT00885118|520195660|FG001|Overall Study|Other reason not defined above|0|||
144270698|NCT00885118|520195661|FG002|Overall Study|Other reason not defined above|1|||
144270699|NCT00885118|520195662|FG003|Overall Study|Other reason not defined above|0|||
144270700|NCT00885118|520195663|FG004|Overall Study|Other reason not defined above|0|||
144270701|NCT03642990|520195664|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
144270702|NCT03642990|520195664|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
144270703|NCT00094445|520195665|FG000|Overall Study|Withdrawal by Subject|3|||
144270704|NCT00094445|520195665|FG000|Overall Study|Lost to Follow-up|1|||
144270705|NCT00094445|520195665|FG000|Overall Study|Progressive Disease|2|||
144270706|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
144270707|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
144270708|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
144270709|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
144270710|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
144270711|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
144270712|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
144270713|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
144270714|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
144270715|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
144270716|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
144270717|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
144270718|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
144270719|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
144270720|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
144270721|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
144270722|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
144270723|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
144270724|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
144270725|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
144270726|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
144270727|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
144270728|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
144270729|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
144270730|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
144270731|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
144270732|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
144270733|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
144270734|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
144270735|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
144270736|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
144270737|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
144270738|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
144270739|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
144270740|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
144270741|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
144241662|NCT02017717|520082205|FG002|Before Treatment Period|Participant no longer met criteria|0|||
144241663|NCT02017717|520082206|FG003|Before Treatment Period|Participant no longer met criteria|0|||
144241664|NCT02017717|520082207|FG004|Before Treatment Period|Participant no longer met criteria|0|||
144241665|NCT02017717|520082208|FG005|Before Treatment Period|Participant no longer met criteria|1|||
144241666|NCT02017717|520082209|FG006|Before Treatment Period|Participant no longer met criteria|0|||
144241667|NCT02017717|520082210|FG007|Before Treatment Period|Participant no longer met criteria|1|||
144241668|NCT02017717|520082211|FG008|Before Treatment Period|Participant no longer met criteria|2|||
144241669|NCT02017717|520082203|FG000|Before Treatment Period|other reason|0|||
144241670|NCT02017717|520082204|FG001|Before Treatment Period|other reason|0|||
144241671|NCT02017717|520082205|FG002|Before Treatment Period|other reason|0|||
144241672|NCT02017717|520082206|FG003|Before Treatment Period|other reason|0|||
144241673|NCT02017717|520082207|FG004|Before Treatment Period|other reason|0|||
144241674|NCT02017717|520082208|FG005|Before Treatment Period|other reason|0|||
144241675|NCT02017717|520082209|FG006|Before Treatment Period|other reason|0|||
144241676|NCT02017717|520082210|FG007|Before Treatment Period|other reason|0|||
144241677|NCT02017717|520082211|FG008|Before Treatment Period|other reason|1|||
144241678|NCT02017717|520082203|FG000|Treatment Period|Disease progression|7|||
144241679|NCT02017717|520082204|FG001|Treatment Period|Disease progression|9|||
144241680|NCT02017717|520082205|FG002|Treatment Period|Disease progression|12|||
144241681|NCT02017717|520082206|FG003|Treatment Period|Disease progression|20|||
144241682|NCT02017717|520082207|FG004|Treatment Period|Disease progression|26|||
144241683|NCT02017717|520082208|FG005|Treatment Period|Disease progression|16|||
144241684|NCT02017717|520082209|FG006|Treatment Period|Disease progression|22|||
144241685|NCT02017717|520082210|FG007|Treatment Period|Disease progression|165|||
144241686|NCT02017717|520082211|FG008|Treatment Period|Disease progression|135|||
144241687|NCT02017717|520082203|FG000|Treatment Period|Study drug toxicity|3|||
144241688|NCT02017717|520082204|FG001|Treatment Period|Study drug toxicity|0|||
144241689|NCT02017717|520082205|FG002|Treatment Period|Study drug toxicity|1|||
144241690|NCT02017717|520082206|FG003|Treatment Period|Study drug toxicity|4|||
144241691|NCT02017717|520082207|FG004|Treatment Period|Study drug toxicity|4|||
144241692|NCT02017717|520082208|FG005|Treatment Period|Study drug toxicity|5|||
144241693|NCT02017717|520082209|FG006|Treatment Period|Study drug toxicity|3|||
144241694|NCT02017717|520082210|FG007|Treatment Period|Study drug toxicity|7|||
144241695|NCT02017717|520082211|FG008|Treatment Period|Study drug toxicity|11|||
144241696|NCT02017717|520082203|FG000|Treatment Period|Death|0|||
144241697|NCT02017717|520082204|FG001|Treatment Period|Death|0|||
144241698|NCT02017717|520082205|FG002|Treatment Period|Death|1|||
144241699|NCT02017717|520082206|FG003|Treatment Period|Death|0|||
144241700|NCT02017717|520082207|FG004|Treatment Period|Death|0|||
144241701|NCT02017717|520082208|FG005|Treatment Period|Death|2|||
144241702|NCT02017717|520082209|FG006|Treatment Period|Death|0|||
144241703|NCT02017717|520082210|FG007|Treatment Period|Death|0|||
144241704|NCT02017717|520082211|FG008|Treatment Period|Death|0|||
144241705|NCT02017717|520082203|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
144241706|NCT02017717|520082204|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
144241707|NCT02017717|520082205|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
144241708|NCT02017717|520082206|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
144241709|NCT02017717|520082207|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
144241710|NCT02017717|520082208|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
144241711|NCT02017717|520082209|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
144241712|NCT02017717|520082210|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
144241713|NCT02017717|520082211|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
144241714|NCT02017717|520082203|FG000|Treatment Period|Participant request to stop therapy|0|||
144241715|NCT02017717|520082204|FG001|Treatment Period|Participant request to stop therapy|0|||
144241716|NCT02017717|520082205|FG002|Treatment Period|Participant request to stop therapy|3|||
144241717|NCT02017717|520082206|FG003|Treatment Period|Participant request to stop therapy|6|||
144241718|NCT02017717|520082207|FG004|Treatment Period|Participant request to stop therapy|0|||
144241719|NCT02017717|520082208|FG005|Treatment Period|Participant request to stop therapy|2|||
144241720|NCT02017717|520082209|FG006|Treatment Period|Participant request to stop therapy|1|||
144241721|NCT02017717|520082210|FG007|Treatment Period|Participant request to stop therapy|4|||
144241722|NCT02017717|520082211|FG008|Treatment Period|Participant request to stop therapy|7|||
144241723|NCT02017717|520082203|FG000|Treatment Period|Participant withdrew consent|0|||
144241724|NCT02017717|520082204|FG001|Treatment Period|Participant withdrew consent|0|||
144241725|NCT02017717|520082205|FG002|Treatment Period|Participant withdrew consent|1|||
144241726|NCT02017717|520082206|FG003|Treatment Period|Participant withdrew consent|0|||
144241727|NCT02017717|520082207|FG004|Treatment Period|Participant withdrew consent|0|||
144241728|NCT02017717|520082208|FG005|Treatment Period|Participant withdrew consent|2|||
144241729|NCT02017717|520082209|FG006|Treatment Period|Participant withdrew consent|0|||
144241730|NCT02017717|520082210|FG007|Treatment Period|Participant withdrew consent|1|||
144241731|NCT02017717|520082211|FG008|Treatment Period|Participant withdrew consent|4|||
144241732|NCT02017717|520082203|FG000|Treatment Period|Participant no longer met criteria|0|||
144241733|NCT02017717|520082204|FG001|Treatment Period|Participant no longer met criteria|0|||
144241734|NCT02017717|520082205|FG002|Treatment Period|Participant no longer met criteria|0|||
144241735|NCT02017717|520082206|FG003|Treatment Period|Participant no longer met criteria|0|||
144241736|NCT02017717|520082207|FG004|Treatment Period|Participant no longer met criteria|0|||
144241737|NCT02017717|520082208|FG005|Treatment Period|Participant no longer met criteria|0|||
144241738|NCT02017717|520082209|FG006|Treatment Period|Participant no longer met criteria|0|||
144241739|NCT02017717|520082210|FG007|Treatment Period|Participant no longer met criteria|0|||
144241740|NCT02017717|520082211|FG008|Treatment Period|Participant no longer met criteria|1|||
144241741|NCT02017717|520082203|FG000|Treatment Period|Other reasons|0|||
144241742|NCT02017717|520082204|FG001|Treatment Period|Other reasons|0|||
144241743|NCT02017717|520082205|FG002|Treatment Period|Other reasons|0|||
144241744|NCT02017717|520082206|FG003|Treatment Period|Other reasons|1|||
144241745|NCT02017717|520082207|FG004|Treatment Period|Other reasons|0|||
144241746|NCT02017717|520082208|FG005|Treatment Period|Other reasons|1|||
144241747|NCT02017717|520082209|FG006|Treatment Period|Other reasons|1|||
144241748|NCT02017717|520082210|FG007|Treatment Period|Other reasons|1|||
144241749|NCT02017717|520082211|FG008|Treatment Period|Other reasons|1|||
144241750|NCT02017717|520082203|FG000|Treatment Period|Maximum clinical benefit|0|||
144241751|NCT02017717|520082204|FG001|Treatment Period|Maximum clinical benefit|0|||
144241752|NCT02017717|520082205|FG002|Treatment Period|Maximum clinical benefit|0|||
144241753|NCT02017717|520082206|FG003|Treatment Period|Maximum clinical benefit|0|||
144270742|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
144270743|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
144270744|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
144270745|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
144270746|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
144270747|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
144270748|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
144270749|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
144270750|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
144270751|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
144270752|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
144270753|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
144270754|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
144270755|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
144270756|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
144270757|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
144270758|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
144270759|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
144270760|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
144270761|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
144270762|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
144270763|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
144270764|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
144270765|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
144270766|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
144270767|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
144270768|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
144270769|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
144270770|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
144270771|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
144270772|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
144270773|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
144270774|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
144270775|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
144270776|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
144270777|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
144270778|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
144270779|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
144270780|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
144270781|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
144270782|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
144270783|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
144270784|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
144270785|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
144270786|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
144270787|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
144270788|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
144270789|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
144270790|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
144270791|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
144270792|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
144270793|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
144270794|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
144270795|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
144270796|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
144270797|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
144270798|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
144270799|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
144270800|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
144270801|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
144270802|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
144270803|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
144270804|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
144270805|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
144270806|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
144270807|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
144270808|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
144270809|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
144270810|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
144270811|NCT02717195|520195666|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
144270812|NCT02717195|520195667|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
144270813|NCT02717195|520195668|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
144270814|NCT02717195|520195669|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
144270815|NCT02717195|520195670|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
144270816|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
144270817|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
144270818|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
144270819|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
144270820|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
144270821|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
144270822|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
144270823|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
144270824|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
144270825|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
144270826|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
144270827|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
144270828|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
144270829|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
144270830|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
144270831|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
144270832|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
144270833|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
144270834|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
144270835|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
144270836|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144270837|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
144270838|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
144270839|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
144270840|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
144270841|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
144270842|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
144270843|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
144241754|NCT02017717|520082207|FG004|Treatment Period|Maximum clinical benefit|0|||
144241755|NCT02017717|520082208|FG005|Treatment Period|Maximum clinical benefit|0|||
144241756|NCT02017717|520082209|FG006|Treatment Period|Maximum clinical benefit|0|||
144241757|NCT02017717|520082210|FG007|Treatment Period|Maximum clinical benefit|0|||
144270844|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
144270845|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
144270846|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
144270847|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
144270848|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
144270849|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
144270850|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
144270851|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
144270852|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
144270853|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
144270854|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
144270855|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
144270856|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
144270857|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
144270858|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
144270859|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
144270860|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
144270861|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
144270862|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
144270863|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
144270864|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
144270865|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
144270866|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
144270867|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
144270868|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
144270869|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
144270870|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
144270871|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
144270872|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
144270873|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
144270874|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
144270875|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
144270876|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
144270877|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
144270878|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
144270879|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
144241758|NCT02017717|520082211|FG008|Treatment Period|Maximum clinical benefit|1|||
144241759|NCT02017717|520082203|FG000|Treatment Period|Not reported|0|||
144241760|NCT02017717|520082204|FG001|Treatment Period|Not reported|1|||
144241761|NCT02017717|520082205|FG002|Treatment Period|Not reported|0|||
144241762|NCT02017717|520082206|FG003|Treatment Period|Not reported|0|||
144241763|NCT02017717|520082207|FG004|Treatment Period|Not reported|0|||
144241764|NCT02017717|520082208|FG005|Treatment Period|Not reported|0|||
144241765|NCT02017717|520082209|FG006|Treatment Period|Not reported|0|||
144241766|NCT02017717|520082210|FG007|Treatment Period|Not reported|0|||
144270880|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
144270881|NCT02717195|520195666|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
144270882|NCT02717195|520195667|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
144270883|NCT02717195|520195668|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
144270884|NCT02717195|520195669|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
144270885|NCT02717195|520195670|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
144270886|NCT03054428|520195673|FG000|Overall Study|Physician Decision|0|||
144270887|NCT03054428|520195674|FG001|Overall Study|Physician Decision|1|||
144270888|NCT03054428|520195675|FG002|Overall Study|Physician Decision|1|||
144270889|NCT03054428|520195673|FG000|Overall Study|Lack of Efficacy|3|||
144270890|NCT03054428|520195674|FG001|Overall Study|Lack of Efficacy|1|||
144270891|NCT03054428|520195675|FG002|Overall Study|Lack of Efficacy|0|||
144270892|NCT03054428|520195673|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
144270893|NCT03054428|520195674|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
144270894|NCT03054428|520195675|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
144270895|NCT03054428|520195673|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
144270896|NCT03054428|520195674|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
144270897|NCT03054428|520195675|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
144270898|NCT03054428|520195673|FG000|Overall Study|Transitioned to OLE study|76|||
144270899|NCT03054428|520195674|FG001|Overall Study|Transitioned to OLE study|76|||
144270900|NCT03054428|520195675|FG002|Overall Study|Transitioned to OLE study|73|||
144270901|NCT03054428|520195673|FG000|Overall Study|Withdrawal by Subject|3|||
144270902|NCT03054428|520195674|FG001|Overall Study|Withdrawal by Subject|2|||
144270903|NCT03054428|520195675|FG002|Overall Study|Withdrawal by Subject|3|||
144270904|NCT03054428|520195673|FG000|Overall Study|Lost to Follow-up|0|||
144270905|NCT03054428|520195674|FG001|Overall Study|Lost to Follow-up|0|||
144270906|NCT03054428|520195675|FG002|Overall Study|Lost to Follow-up|1|||
144270907|NCT03092752|520195676|FG000|Overall Study|Aged <40 years|14209|||
144270908|NCT03092752|520195676|FG000|Overall Study|At least one claim with T2DM|61299|||
144270909|NCT03092752|520195676|FG000|Overall Study|Having no claim of study drugs|29282|||
144270910|NCT03092752|520195676|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
144270911|NCT03092752|520195676|FG000|Overall Study|<6 month history|245900|||
144270912|NCT03882918|520195677|FG000|Overall Study|Study terminated by sponsor|98|||
144270913|NCT03882918|520195677|FG000|Overall Study|Protocol Violation|1|||
144270914|NCT03882918|520195677|FG000|Overall Study|Other|9|||
144270915|NCT03882918|520195677|FG000|Overall Study|Lack of Efficacy|14|||
144270916|NCT03882918|520195677|FG000|Overall Study|Adverse Event|13|||
144270917|NCT03882918|520195677|FG000|Overall Study|Withdrawal by Subject|5|||
144270918|NCT01499810|520195678|FG000|Overall Study|Lost to Follow-up|10|||
144270919|NCT01499810|520195678|FG000|Overall Study|Protocol Violation|1|||
144270920|NCT01499810|520195678|FG000|Overall Study|Withdrawal by Subject|1|||
144270921|NCT06996301|520195679|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
144270922|NCT06996301|520195680|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
144270923|NCT06996301|520195679|FG000|Overall Study|Patients with discordant diagnostic results|107|||
144270924|NCT06996301|520195680|FG001|Overall Study|Patients with discordant diagnostic results|90|||
144270925|NCT06996301|520195679|FG000|Overall Study|Lost to Follow-up|31|||
144270926|NCT06996301|520195680|FG001|Overall Study|Lost to Follow-up|56|||
144270927|NCT06996301|520195679|FG000|Overall Study|Withdrawal by Subject|12|||
144270928|NCT06996301|520195680|FG001|Overall Study|Withdrawal by Subject|7|||
144270929|NCT04030598|520195681|FG000|Overall Study|Voluntary Withdrawal|0|||
144270930|NCT04030598|520195682|FG001|Overall Study|Voluntary Withdrawal|1|||
144270931|NCT04030598|520195683|FG002|Overall Study|Voluntary Withdrawal|0|||
144270932|NCT05117060|520195686|FG000|Overall Study|Adverse Event|3|||
144270933|NCT05117060|520195687|FG001|Overall Study|Adverse Event|5|||
144270934|NCT05117060|520195688|FG002|Overall Study|Adverse Event|6|||
144270935|NCT05117060|520195689|FG003|Overall Study|Adverse Event|1|||
144270936|NCT05117060|520195686|FG000|Overall Study|Lost to Follow-up|0|||
144270937|NCT05117060|520195687|FG001|Overall Study|Lost to Follow-up|0|||
144270938|NCT05117060|520195688|FG002|Overall Study|Lost to Follow-up|0|||
144270939|NCT05117060|520195689|FG003|Overall Study|Lost to Follow-up|1|||
144270940|NCT05117060|520195686|FG000|Overall Study|Lack of Efficacy|4|||
144270941|NCT05117060|520195687|FG001|Overall Study|Lack of Efficacy|5|||
144270942|NCT05117060|520195688|FG002|Overall Study|Lack of Efficacy|2|||
144270943|NCT05117060|520195689|FG003|Overall Study|Lack of Efficacy|6|||
144270944|NCT05117060|520195686|FG000|Overall Study|Withdrawal by Subject|8|||
144270945|NCT05117060|520195687|FG001|Overall Study|Withdrawal by Subject|5|||
144270946|NCT05117060|520195688|FG002|Overall Study|Withdrawal by Subject|5|||
144270947|NCT05117060|520195689|FG003|Overall Study|Withdrawal by Subject|6|||
144270948|NCT05117060|520195686|FG000|Overall Study|Other|2|||
144270949|NCT05117060|520195687|FG001|Overall Study|Other|1|||
144270950|NCT05117060|520195688|FG002|Overall Study|Other|3|||
144270951|NCT05117060|520195689|FG003|Overall Study|Other|1|||
144270952|NCT03141359|520195690|FG000|Overall Study|Death|32|||
144270953|NCT03141359|520195690|FG000|Overall Study|Still On Study (in follow up)|29|||
144270954|NCT05079321|520195691|FG000|Overall Study|Withdrawal by Subject|2|||
144270955|NCT05079321|520195692|FG001|Overall Study|Withdrawal by Subject|2|||
144270956|NCT05079321|520195691|FG000|Overall Study|Lost to Follow-up|0|||
144270957|NCT05079321|520195692|FG001|Overall Study|Lost to Follow-up|1|||
144270958|NCT01884597|520195693|FG000|Overall Study|Adverse Event|0|||
144270959|NCT01884597|520195694|FG001|Overall Study|Adverse Event|0|||
144270960|NCT01884597|520195695|FG002|Overall Study|Adverse Event|1|||
144270961|NCT01884597|520195693|FG000|Overall Study|Lack of Efficacy|1|||
144270962|NCT01884597|520195694|FG001|Overall Study|Lack of Efficacy|0|||
144270963|NCT01884597|520195695|FG002|Overall Study|Lack of Efficacy|0|||
144270964|NCT01884597|520195693|FG000|Overall Study|Death|0|||
144270965|NCT01884597|520195694|FG001|Overall Study|Death|1|||
144270966|NCT01884597|520195695|FG002|Overall Study|Death|0|||
144270967|NCT02097823|520195696|FG000|Overall Study|Withdrawal by Subject|1|||
144270968|NCT02097823|520195697|FG001|Overall Study|Withdrawal by Subject|1|||
144270969|NCT01081626|520195698|FG000|Overall Study|Dosing error|1|||
144270970|NCT01081626|520195699|FG001|Overall Study|Dosing error|1|||
144270971|NCT01081626|520195698|FG000|Overall Study|Missing Estradiol|25|||
144270972|NCT01081626|520195699|FG001|Overall Study|Missing Estradiol|28|||
144241767|NCT02017717|520082211|FG008|Treatment Period|Not reported|0|||
144241768|NCT04045132|520082214|FG000|Overall Study|Lost to Follow-up|3|||
144241769|NCT04045132|520082215|FG001|Overall Study|Lost to Follow-up|6|||
144241770|NCT02143791|520082220|FG000|Enrolled|Withdrawal by Subject|4|||
144241771|NCT02143791|520082220|FG000|Trial Stimulation|Lack of Efficacy|21|||
144241772|NCT02143791|520082220|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
144241773|NCT02143791|520082220|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
144241774|NCT02143791|520082220|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
144241775|NCT02143791|520082220|FG000|Any Programming (3-6 Months)|Missing Data|1|||
144241776|NCT02143791|520082220|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
144241777|NCT04327661|520082223|FG000|Overall Study|Withdrawal by Subject|1|||
144241778|NCT04327661|520082224|FG001|Overall Study|Withdrawal by Subject|0|||
144241779|NCT04327661|520082225|FG002|Overall Study|Withdrawal by Subject|0|||
144241780|NCT01995175|520082232|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
144241781|NCT01995175|520082232|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
144241782|NCT01995175|520082232|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
144241783|NCT01995175|520082232|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
144241784|NCT01995175|520082232|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
144241785|NCT01995175|520082232|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
144241786|NCT01995175|520082232|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
144241787|NCT01995175|520082232|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
144241788|NCT01995175|520082232|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
144241789|NCT01877551|520082233|FG000|Overall Study|Physician Decision|0|||
144241790|NCT01877551|520082234|FG001|Overall Study|Physician Decision|1|||
144241791|NCT00984061|520082235|FG000|Clarithromycin Alone|Protocol Violation|1|||
144241792|NCT02111785|520082239|FG000|Overall Study|Death|0|||
144241793|NCT02111785|520082240|FG001|Overall Study|Death|1|||
144241794|NCT02111785|520082241|FG002|Overall Study|Death|0|||
144241795|NCT02111785|520082242|FG003|Overall Study|Death|0|||
144241796|NCT01282164|520082246|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
144241797|NCT01282164|520082247|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
144241798|NCT01968707|520082255|FG000|Overall Study|Did not meet treatment day baseline|49|||
144241799|NCT01968707|520082256|FG001|Overall Study|Did not meet treatment day baseline|12|||
144241800|NCT01968707|520082257|FG002|Overall Study|Did not meet treatment day baseline|41|||
144241801|NCT01968707|520082258|FG003|Overall Study|Did not meet treatment day baseline|44|||
144241802|NCT01968707|520082259|FG004|Overall Study|Did not meet treatment day baseline|36|||
144241803|NCT01968707|520082260|FG005|Overall Study|Did not meet treatment day baseline|11|||
144241804|NCT01968707|520082261|FG006|Overall Study|Did not meet treatment day baseline|34|||
144241805|NCT01968707|520082262|FG007|Overall Study|Did not meet treatment day baseline|35|||
144241806|NCT01185509|520082263|FG000|Overall Study|Progression/Relapse|9|||
144241807|NCT01185509|520082264|FG001|Overall Study|Progression/Relapse|15|||
144241808|NCT01185509|520082263|FG000|Overall Study|Physician Decision|2|||
144241809|NCT01185509|520082264|FG001|Overall Study|Physician Decision|2|||
144241810|NCT01185509|520082263|FG000|Overall Study|Withdrawal by Subject|0|||
144241811|NCT01185509|520082264|FG001|Overall Study|Withdrawal by Subject|1|||
144241812|NCT01185509|520082263|FG000|Overall Study|Death|0|||
144241813|NCT01185509|520082264|FG001|Overall Study|Death|1|||
144241814|NCT01185509|520082263|FG000|Overall Study|Intercurrent Illness|0|||
144241815|NCT01185509|520082264|FG001|Overall Study|Intercurrent Illness|1|||
144241816|NCT02231879|520082279|FG000|Overall Study|Adverse Event|2|||
144241817|NCT02231879|520082280|FG001|Overall Study|Adverse Event|1|||
144241818|NCT02231879|520082279|FG000|Overall Study|Lack of Efficacy|0|||
144241819|NCT02231879|520082280|FG001|Overall Study|Lack of Efficacy|1|||
144241820|NCT05007041|520082281|FG000|Overall Study|Missing Diary Entries|0|||
144241821|NCT05007041|520082282|FG001|Overall Study|Missing Diary Entries|1|||
144270973|NCT01081626|520195698|FG000|Overall Study|Low antral follicle count|1|||
144270974|NCT01081626|520195699|FG001|Overall Study|Low antral follicle count|0|||
144270975|NCT01081626|520195698|FG000|Overall Study|Overstimulation|0|||
144270976|NCT01081626|520195699|FG001|Overall Study|Overstimulation|1|||
144270977|NCT01081626|520195698|FG000|Overall Study|Lost to Follow-up|0|||
144270978|NCT01081626|520195699|FG001|Overall Study|Lost to Follow-up|1|||
144270979|NCT01081626|520195698|FG000|Overall Study|Other|33|||
144270980|NCT01081626|520195699|FG001|Overall Study|Other|30|||
144270981|NCT01419535|520195701|FG000|Overall Study|could not maintain iv line|1|||
144270982|NCT01419535|520195702|FG001|Overall Study|could not maintain iv line|1|||
144270983|NCT01419535|520195701|FG000|Overall Study|Withdrawal by Subject|0|||
144270984|NCT01419535|520195702|FG001|Overall Study|Withdrawal by Subject|1|||
144270985|NCT05965752|520195705|FG000|Overall Study|Adverse Event|0|||
144270986|NCT05965752|520195706|FG001|Overall Study|Adverse Event|1|||
144270987|NCT05965752|520195707|FG002|Overall Study|Adverse Event|0|||
144270988|NCT05965752|520195708|FG003|Overall Study|Adverse Event|1|||
144270989|NCT05965752|520195709|FG004|Overall Study|Adverse Event|3|||
144270990|NCT05965752|520195705|FG000|Overall Study|Lost to Follow-up|2|||
144270991|NCT05965752|520195706|FG001|Overall Study|Lost to Follow-up|0|||
144270992|NCT05965752|520195707|FG002|Overall Study|Lost to Follow-up|1|||
144270993|NCT05965752|520195708|FG003|Overall Study|Lost to Follow-up|1|||
144241822|NCT02370667|520082283|FG000|Overall Study|Lost to Follow-up|0|||
144241823|NCT02370667|520082284|FG001|Overall Study|Lost to Follow-up|1|||
144241824|NCT02370667|520082285|FG002|Overall Study|Lost to Follow-up|0|||
144241825|NCT02850016|520082286|FG000|Overall Study|Withdrawal by Subject|1|||
144270994|NCT05965752|520195709|FG004|Overall Study|Lost to Follow-up|1|||
144270995|NCT05965752|520195705|FG000|Overall Study|Withdrawal by Subject|2|||
144270996|NCT05965752|520195706|FG001|Overall Study|Withdrawal by Subject|2|||
144270997|NCT05965752|520195707|FG002|Overall Study|Withdrawal by Subject|1|||
144270998|NCT05965752|520195708|FG003|Overall Study|Withdrawal by Subject|5|||
144270999|NCT05965752|520195709|FG004|Overall Study|Withdrawal by Subject|0|||
144271000|NCT05965752|520195705|FG000|Overall Study|Disease Relapse|1|||
144271001|NCT05965752|520195706|FG001|Overall Study|Disease Relapse|0|||
144271002|NCT05965752|520195707|FG002|Overall Study|Disease Relapse|1|||
144271003|NCT05965752|520195708|FG003|Overall Study|Disease Relapse|0|||
144271004|NCT05965752|520195709|FG004|Overall Study|Disease Relapse|0|||
144271005|NCT05965752|520195705|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
144271006|NCT05965752|520195706|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
144271007|NCT05965752|520195707|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
144271008|NCT05965752|520195708|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
144271009|NCT05965752|520195709|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
144271010|NCT05965752|520195705|FG000|Overall Study|Unable to Return for Study Visits|0|||
144271011|NCT05965752|520195706|FG001|Overall Study|Unable to Return for Study Visits|1|||
144271012|NCT05965752|520195707|FG002|Overall Study|Unable to Return for Study Visits|0|||
144271013|NCT05965752|520195708|FG003|Overall Study|Unable to Return for Study Visits|3|||
144271014|NCT05965752|520195709|FG004|Overall Study|Unable to Return for Study Visits|1|||
144271015|NCT05965752|520195705|FG000|Overall Study|Early Termination|0|||
144271016|NCT05965752|520195706|FG001|Overall Study|Early Termination|0|||
144271017|NCT05965752|520195707|FG002|Overall Study|Early Termination|1|||
144241826|NCT02850016|520082287|FG001|Overall Study|Withdrawal by Subject|2|||
144241827|NCT02612610|520082289|FG000|Overall Study|Withdrawal by Subject|1|||
144241828|NCT02612610|520082290|FG001|Overall Study|Withdrawal by Subject|1|||
144241829|NCT02612610|520082291|FG002|Overall Study|Withdrawal by Subject|0|||
144241830|NCT02612610|520082292|FG003|Overall Study|Withdrawal by Subject|2|||
144241831|NCT02612610|520082289|FG000|Overall Study|Adverse Event|2|||
144241832|NCT02612610|520082290|FG001|Overall Study|Adverse Event|2|||
144241833|NCT02612610|520082291|FG002|Overall Study|Adverse Event|3|||
144241834|NCT02612610|520082292|FG003|Overall Study|Adverse Event|10|||
144241835|NCT02612610|520082289|FG000|Overall Study|Lost to Follow-up|0|||
144241836|NCT02612610|520082290|FG001|Overall Study|Lost to Follow-up|1|||
144241837|NCT02612610|520082291|FG002|Overall Study|Lost to Follow-up|0|||
144241838|NCT02612610|520082292|FG003|Overall Study|Lost to Follow-up|0|||
144241839|NCT02612610|520082289|FG000|Overall Study|Protocol Violation|0|||
144241840|NCT02612610|520082290|FG001|Overall Study|Protocol Violation|1|||
144241841|NCT02612610|520082291|FG002|Overall Study|Protocol Violation|1|||
144241842|NCT02612610|520082292|FG003|Overall Study|Protocol Violation|0|||
144241843|NCT02612610|520082289|FG000|Overall Study|Lack of Efficacy|1|||
144241844|NCT02612610|520082290|FG001|Overall Study|Lack of Efficacy|2|||
144241845|NCT02612610|520082291|FG002|Overall Study|Lack of Efficacy|0|||
144241846|NCT02612610|520082292|FG003|Overall Study|Lack of Efficacy|1|||
144241847|NCT02612610|520082289|FG000|Overall Study|Physician Decision|0|||
144241848|NCT02612610|520082290|FG001|Overall Study|Physician Decision|1|||
144241849|NCT02612610|520082291|FG002|Overall Study|Physician Decision|0|||
144241850|NCT02612610|520082292|FG003|Overall Study|Physician Decision|0|||
144241851|NCT02612610|520082289|FG000|Overall Study|Noncompliance|1|||
144241852|NCT02612610|520082290|FG001|Overall Study|Noncompliance|0|||
144241853|NCT02612610|520082291|FG002|Overall Study|Noncompliance|0|||
144241854|NCT02612610|520082292|FG003|Overall Study|Noncompliance|0|||
144241855|NCT02612610|520082289|FG000|Overall Study|Cough Improvement|0|||
144241856|NCT02612610|520082290|FG001|Overall Study|Cough Improvement|0|||
144241857|NCT02612610|520082291|FG002|Overall Study|Cough Improvement|1|||
144241858|NCT02612610|520082292|FG003|Overall Study|Cough Improvement|0|||
144241859|NCT01801280|520082293|FG000|Period 1|Withdrawal by Subject|0|||
144271018|NCT05965752|520195708|FG003|Overall Study|Early Termination|0|||
144271019|NCT05965752|520195709|FG004|Overall Study|Early Termination|0|||
144241860|NCT01801280|520082294|FG001|Period 1|Withdrawal by Subject|1|||
144241861|NCT01801280|520082295|FG002|Period 1|Withdrawal by Subject|0|||
144241862|NCT01801280|520082296|FG003|Period 1|Withdrawal by Subject|0|||
144241863|NCT01801280|520082293|FG000|Period 2|Withdrawal by Subject|1|||
144241864|NCT01801280|520082294|FG001|Period 2|Withdrawal by Subject|0|||
144241865|NCT01801280|520082295|FG002|Period 2|Withdrawal by Subject|0|||
144241866|NCT01801280|520082296|FG003|Period 2|Withdrawal by Subject|0|||
144241867|NCT01801280|520082293|FG000|Period 4|Protocol Violation|0|||
144241868|NCT01801280|520082294|FG001|Period 4|Protocol Violation|0|||
144241869|NCT01801280|520082295|FG002|Period 4|Protocol Violation|1|||
144241870|NCT01801280|520082296|FG003|Period 4|Protocol Violation|0|||
144241871|NCT00176644|520082297|FG000|Overall Study|Withdrawal by Subject|1|||
144241872|NCT01866657|520082303|FG000|Overall Study|Surgery canceled|2|||
144241873|NCT01866657|520082304|FG001|Overall Study|Surgery canceled|0|||
144241874|NCT03973918|520082310|FG000|Overall Study|Adverse Event|0|||
144241875|NCT03973918|520082311|FG001|Overall Study|Adverse Event|0|||
144241876|NCT03973918|520082312|FG002|Overall Study|Adverse Event|0|||
144241877|NCT03973918|520082313|FG003|Overall Study|Adverse Event|1|||
144241878|NCT03973918|520082310|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
144241879|NCT03973918|520082311|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
144241880|NCT03973918|520082312|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
144241881|NCT03973918|520082313|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
144241882|NCT02951533|520082319|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
144241883|NCT02951533|520082320|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
144241884|NCT02951533|520082321|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
144241885|NCT02951533|520082319|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
144241886|NCT02951533|520082320|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
144241887|NCT02951533|520082321|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
144241888|NCT02951533|520082319|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
144241889|NCT02951533|520082320|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
144271020|NCT05965752|520195705|FG000|Overall Study|Reported Unwanted Symptoms|0|||
144271021|NCT05965752|520195706|FG001|Overall Study|Reported Unwanted Symptoms|0|||
144271022|NCT05965752|520195707|FG002|Overall Study|Reported Unwanted Symptoms|0|||
144271023|NCT05965752|520195708|FG003|Overall Study|Reported Unwanted Symptoms|0|||
144271024|NCT05965752|520195709|FG004|Overall Study|Reported Unwanted Symptoms|1|||
144271025|NCT05965752|520195705|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
144271026|NCT05965752|520195706|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
144241890|NCT02951533|520082321|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
144241891|NCT02951533|520082319|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
144241892|NCT02951533|520082320|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
144271027|NCT05965752|520195707|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
144271028|NCT05965752|520195708|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
144271029|NCT05965752|520195709|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
144271030|NCT01274351|520195711|FG000|Overall Study|Lost to Follow-up|1|||
144271031|NCT01274351|520195711|FG000|Overall Study|patient not compliant with the protocol|1|||
144271032|NCT01274351|520195711|FG000|Overall Study|Pregnancy|1|||
144271033|NCT01274351|520195711|FG000|Overall Study|Death|2|||
144271034|NCT01274351|520195711|FG000|Overall Study|Withdrawal by Subject|3|||
144271035|NCT01274351|520195711|FG000|Overall Study|Adverse Event|8|||
144271036|NCT01274351|520195711|FG000|Overall Study|progression of disease|3|||
144271037|NCT01274351|520195711|FG000|Overall Study|hospitalization|1|||
144271038|NCT01296412|520195714|FG000|Overall Study|Adverse Event|8|||
144271039|NCT01296412|520195715|FG001|Overall Study|Adverse Event|29|||
144271040|NCT01296412|520195714|FG000|Overall Study|Lack of Efficacy|1|||
144271041|NCT01296412|520195715|FG001|Overall Study|Lack of Efficacy|0|||
144271042|NCT01296412|520195714|FG000|Overall Study|Lost to Follow-up|10|||
144271043|NCT01296412|520195715|FG001|Overall Study|Lost to Follow-up|7|||
144271044|NCT01296412|520195714|FG000|Overall Study|Non-compliance with study drug|1|||
144271045|NCT01296412|520195715|FG001|Overall Study|Non-compliance with study drug|2|||
144271046|NCT01296412|520195714|FG000|Overall Study|Other reason not specified|20|||
144271047|NCT01296412|520195715|FG001|Overall Study|Other reason not specified|15|||
144271048|NCT01296412|520195714|FG000|Overall Study|Physician Decision|1|||
144271049|NCT01296412|520195715|FG001|Overall Study|Physician Decision|3|||
144271050|NCT01296412|520195714|FG000|Overall Study|Pregnancy|0|||
144271051|NCT01296412|520195715|FG001|Overall Study|Pregnancy|1|||
144271052|NCT01296412|520195714|FG000|Overall Study|Withdrawal by Subject|10|||
144271053|NCT01296412|520195715|FG001|Overall Study|Withdrawal by Subject|13|||
144271054|NCT02160626|520195716|FG000|Overall Study|Adverse Event|1|||
144271055|NCT02160626|520195717|FG001|Overall Study|Adverse Event|0|||
144271056|NCT02160626|520195718|FG002|Overall Study|Adverse Event|0|||
144271057|NCT02160626|520195716|FG000|Overall Study|Schedule not conducive to study visits|0|||
144271058|NCT02160626|520195717|FG001|Overall Study|Schedule not conducive to study visits|0|||
144271059|NCT02160626|520195718|FG002|Overall Study|Schedule not conducive to study visits|1|||
144271060|NCT02160626|520195716|FG000|Overall Study|Withdrawal by Subject|0|||
144271061|NCT02160626|520195717|FG001|Overall Study|Withdrawal by Subject|1|||
144271062|NCT02160626|520195718|FG002|Overall Study|Withdrawal by Subject|0|||
144271063|NCT04239924|520195724|FG000|Overall Study|Lost to Follow-up|2|||
144271064|NCT00666237|520195725|FG000|Overall Study|Death|5|||
144271065|NCT00666237|520195726|FG001|Overall Study|Death|5|||
144271066|NCT00666237|520195725|FG000|Overall Study|Lost to Follow-up|29|||
144271067|NCT00666237|520195726|FG001|Overall Study|Lost to Follow-up|25|||
144271068|NCT00750269|520197558|FG000|Overall Study|Protocol Violation|0|||
144271069|NCT00750269|520197559|FG001|Overall Study|Protocol Violation|1|||
144271070|NCT00750269|520197560|FG002|Overall Study|Protocol Violation|1|||
144271071|NCT00750269|520197561|FG003|Overall Study|Protocol Violation|2|||
144271072|NCT00750269|520197562|FG004|Overall Study|Protocol Violation|4|||
144271073|NCT00750269|520197558|FG000|Overall Study|Withdrawal by Subject|0|||
144271074|NCT00750269|520197559|FG001|Overall Study|Withdrawal by Subject|0|||
144271075|NCT00750269|520197560|FG002|Overall Study|Withdrawal by Subject|2|||
144271076|NCT00750269|520197561|FG003|Overall Study|Withdrawal by Subject|2|||
144271077|NCT00750269|520197562|FG004|Overall Study|Withdrawal by Subject|2|||
144271078|NCT00750269|520197558|FG000|Overall Study|Physician Decision|0|||
144271079|NCT00750269|520197559|FG001|Overall Study|Physician Decision|0|||
144271080|NCT00750269|520197560|FG002|Overall Study|Physician Decision|0|||
144271081|NCT00750269|520197561|FG003|Overall Study|Physician Decision|0|||
144271082|NCT00750269|520197562|FG004|Overall Study|Physician Decision|2|||
144271083|NCT00750269|520197558|FG000|Overall Study|Patient too large for positioning|0|||
144271084|NCT00750269|520197559|FG001|Overall Study|Patient too large for positioning|0|||
144271085|NCT00750269|520197560|FG002|Overall Study|Patient too large for positioning|1|||
144271086|NCT00750269|520197561|FG003|Overall Study|Patient too large for positioning|0|||
144271087|NCT00750269|520197562|FG004|Overall Study|Patient too large for positioning|0|||
144271088|NCT00750269|520197558|FG000|Overall Study|Site error|0|||
144271089|NCT00750269|520197559|FG001|Overall Study|Site error|0|||
144271090|NCT00750269|520197560|FG002|Overall Study|Site error|0|||
144271091|NCT00750269|520197561|FG003|Overall Study|Site error|1|||
144271092|NCT00750269|520197562|FG004|Overall Study|Site error|0|||
144271093|NCT00750269|520197558|FG000|Overall Study|SBRT plan could not be drawn|0|||
144271094|NCT00750269|520197559|FG001|Overall Study|SBRT plan could not be drawn|0|||
144271095|NCT00750269|520197560|FG002|Overall Study|SBRT plan could not be drawn|0|||
144271096|NCT00750269|520197561|FG003|Overall Study|SBRT plan could not be drawn|0|||
144271097|NCT00750269|520197562|FG004|Overall Study|SBRT plan could not be drawn|1|||
144271098|NCT00750269|520197558|FG000|Overall Study|Fiducials could not be placed|0|||
144271099|NCT00750269|520197559|FG001|Overall Study|Fiducials could not be placed|0|||
144271100|NCT00750269|520197560|FG002|Overall Study|Fiducials could not be placed|0|||
144271101|NCT00750269|520197561|FG003|Overall Study|Fiducials could not be placed|0|||
144271102|NCT00750269|520197562|FG004|Overall Study|Fiducials could not be placed|1|||
144271103|NCT02934178|520197563|FG000|Received Vaccination 2|Death|0|||
144271104|NCT02934178|520197564|FG001|Received Vaccination 2|Death|1|||
144271105|NCT02934178|520197563|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
144271106|NCT02934178|520197564|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
144271107|NCT01075048|520197566|FG000|Overall Study|Death|4|||
144271108|NCT01075048|520197567|FG001|Overall Study|Death|17|||
144271109|NCT01075048|520197568|FG002|Overall Study|Death|12|||
144271110|NCT01075048|520197566|FG000|Overall Study|Start of other or new therapy|4|||
144271111|NCT01075048|520197567|FG001|Overall Study|Start of other or new therapy|36|||
144271112|NCT01075048|520197568|FG002|Overall Study|Start of other or new therapy|46|||
144271113|NCT01075048|520197566|FG000|Overall Study|Withdrawal by Subject|1|||
144271114|NCT01075048|520197567|FG001|Overall Study|Withdrawal by Subject|6|||
144271115|NCT01075048|520197568|FG002|Overall Study|Withdrawal by Subject|3|||
144271116|NCT01075048|520197566|FG000|Overall Study|Lost to Follow-up|0|||
144271117|NCT01075048|520197567|FG001|Overall Study|Lost to Follow-up|1|||
144271118|NCT01075048|520197568|FG002|Overall Study|Lost to Follow-up|1|||
144271119|NCT00761319|520197570|FG000|Overall Study|Protocol Violation|21|||
144271120|NCT00761319|520197571|FG001|Overall Study|Protocol Violation|14|||
144271121|NCT00761319|520197570|FG000|Overall Study|Adverse Event|11|||
144271122|NCT00761319|520197571|FG001|Overall Study|Adverse Event|7|||
144271123|NCT00761319|520197570|FG000|Overall Study|Withdrawal by Subject|8|||
144271124|NCT00761319|520197571|FG001|Overall Study|Withdrawal by Subject|7|||
144271125|NCT00761319|520197570|FG000|Overall Study|Noncompliance|4|||
144271126|NCT00761319|520197571|FG001|Overall Study|Noncompliance|3|||
144271127|NCT00761319|520197570|FG000|Overall Study|Lost to Follow-up|1|||
144271128|NCT00761319|520197571|FG001|Overall Study|Lost to Follow-up|1|||
144271129|NCT00761319|520197570|FG000|Overall Study|Nonspecified|2|||
144271130|NCT00761319|520197571|FG001|Overall Study|Nonspecified|2|||
144271131|NCT00761319|520197570|FG000|Overall Study|Missing|1|||
144271132|NCT00761319|520197571|FG001|Overall Study|Missing|0|||
144271133|NCT00900562|520197572|FG000|Overall Study|Progressive disease|9|||
144271134|NCT00900562|520197573|FG001|Overall Study|Progressive disease|5|||
144271135|NCT00900562|520197572|FG000|Overall Study|Toxicity|1|||
144271136|NCT00900562|520197573|FG001|Overall Study|Toxicity|0|||
144271137|NCT00900562|520197572|FG000|Overall Study|Death|1|||
144271138|NCT00900562|520197573|FG001|Overall Study|Death|1|||
144271139|NCT00900562|520197572|FG000|Overall Study|Withdrawal by Subject|0|||
144271140|NCT00900562|520197573|FG001|Overall Study|Withdrawal by Subject|1|||
144271141|NCT00900562|520197572|FG000|Overall Study|Unrelated adverse event|1|||
144271142|NCT00900562|520197573|FG001|Overall Study|Unrelated adverse event|0|||
144271143|NCT01006629|520197574|FG000|Overall Study|Adverse Event|1|||
144271144|NCT01006629|520197574|FG000|Overall Study|Parent refused to continue participation|1|||
144271145|NCT01006629|520197574|FG000|Overall Study|Parent unable to perform site visit|4|||
144271146|NCT00784875|520197575|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
144271147|NCT00784875|520197576|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
144271148|NCT00784875|520197577|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
144271149|NCT00784875|520197578|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
144271150|NCT00784875|520197575|FG000|Period A - Baseline|Adverse Event|0|||
144271151|NCT00784875|520197576|FG001|Period A - Baseline|Adverse Event|0|||
144271152|NCT00784875|520197577|FG002|Period A - Baseline|Adverse Event|0|||
144271153|NCT00784875|520197578|FG003|Period A - Baseline|Adverse Event|8|||
144271154|NCT00784875|520197575|FG000|Period A - Baseline|Protocol Violation|0|||
144271155|NCT00784875|520197576|FG001|Period A - Baseline|Protocol Violation|0|||
144271156|NCT00784875|520197577|FG002|Period A - Baseline|Protocol Violation|0|||
144241893|NCT02951533|520082321|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
144241894|NCT02951533|520082319|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
144241895|NCT02951533|520082320|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
144241896|NCT02951533|520082321|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
144241897|NCT02951533|520082319|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
144241898|NCT02951533|520082320|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
144241899|NCT02951533|520082321|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
144241900|NCT02951533|520082319|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
144241901|NCT02951533|520082320|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
144241902|NCT02951533|520082321|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
144241903|NCT02951533|520082319|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
144271157|NCT00784875|520197578|FG003|Period A - Baseline|Protocol Violation|25|||
144271158|NCT00784875|520197575|FG000|Period A - Baseline|Withdrawal by Subject|0|||
144271159|NCT00784875|520197576|FG001|Period A - Baseline|Withdrawal by Subject|0|||
144271160|NCT00784875|520197577|FG002|Period A - Baseline|Withdrawal by Subject|0|||
144271161|NCT00784875|520197578|FG003|Period A - Baseline|Withdrawal by Subject|27|||
144271162|NCT00784875|520197575|FG000|Period A - Baseline|Physician Decision|0|||
144271163|NCT00784875|520197576|FG001|Period A - Baseline|Physician Decision|0|||
144271164|NCT00784875|520197577|FG002|Period A - Baseline|Physician Decision|0|||
144271165|NCT00784875|520197578|FG003|Period A - Baseline|Physician Decision|2|||
144271166|NCT00784875|520197575|FG000|Period A - Baseline|Sponsor Decision|0|||
144271167|NCT00784875|520197576|FG001|Period A - Baseline|Sponsor Decision|0|||
144271168|NCT00784875|520197577|FG002|Period A - Baseline|Sponsor Decision|0|||
144271169|NCT00784875|520197578|FG003|Period A - Baseline|Sponsor Decision|113|||
144271170|NCT00784875|520197575|FG000|Period A - Baseline|Lost to Follow-up|0|||
144271171|NCT00784875|520197576|FG001|Period A - Baseline|Lost to Follow-up|0|||
144271172|NCT00784875|520197577|FG002|Period A - Baseline|Lost to Follow-up|0|||
144271173|NCT00784875|520197578|FG003|Period A - Baseline|Lost to Follow-up|2|||
144271174|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
144271175|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
144271176|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
144271177|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
144271178|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
144271179|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
144271180|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
144271181|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
144271182|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
144271183|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
144271184|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
144271185|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
144271186|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
144271187|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
144271188|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
144271189|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
144271190|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
144241904|NCT02951533|520082320|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
144271191|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
144271192|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
144271193|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
144271194|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
144271195|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
144271196|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
144271197|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
144271198|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
144271199|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
144271200|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
144271201|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
144271202|NCT00784875|520197575|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
144271203|NCT00784875|520197576|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
144271204|NCT00784875|520197577|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
144271205|NCT00784875|520197578|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
144271206|NCT00784875|520197575|FG000|Period C|Adverse Event|1|||
144271207|NCT00784875|520197576|FG001|Period C|Adverse Event|0|||
144271208|NCT00784875|520197577|FG002|Period C|Adverse Event|4|||
144271209|NCT00784875|520197578|FG003|Period C|Adverse Event|2|||
144271210|NCT00784875|520197575|FG000|Period C|Protocol Violation|0|||
144271211|NCT00784875|520197576|FG001|Period C|Protocol Violation|0|||
144271212|NCT00784875|520197577|FG002|Period C|Protocol Violation|1|||
144271213|NCT00784875|520197578|FG003|Period C|Protocol Violation|2|||
144271214|NCT00784875|520197575|FG000|Period C|Lack of Efficacy|0|||
144271215|NCT00784875|520197576|FG001|Period C|Lack of Efficacy|0|||
144271216|NCT00784875|520197577|FG002|Period C|Lack of Efficacy|1|||
144271217|NCT00784875|520197578|FG003|Period C|Lack of Efficacy|0|||
144271218|NCT00784875|520197575|FG000|Period C|Withdrawal by Subject|1|||
144271219|NCT00784875|520197576|FG001|Period C|Withdrawal by Subject|1|||
144271220|NCT00784875|520197577|FG002|Period C|Withdrawal by Subject|2|||
144271221|NCT00784875|520197578|FG003|Period C|Withdrawal by Subject|0|||
144271222|NCT00784875|520197575|FG000|Period C|Physician Decision|0|||
144271223|NCT00784875|520197576|FG001|Period C|Physician Decision|0|||
144271224|NCT00784875|520197577|FG002|Period C|Physician Decision|1|||
144271225|NCT00784875|520197578|FG003|Period C|Physician Decision|1|||
144271226|NCT00784875|520197575|FG000|Period C|Sponsor Decision|5|||
144271227|NCT00784875|520197576|FG001|Period C|Sponsor Decision|5|||
144271228|NCT00784875|520197577|FG002|Period C|Sponsor Decision|4|||
144271229|NCT00784875|520197578|FG003|Period C|Sponsor Decision|2|||
144271230|NCT00784875|520197575|FG000|Period D|Adverse Event|0|||
144271231|NCT00784875|520197576|FG001|Period D|Adverse Event|2|||
144271232|NCT00784875|520197577|FG002|Period D|Adverse Event|2|||
144271233|NCT00784875|520197578|FG003|Period D|Adverse Event|0|||
144271234|NCT00784875|520197575|FG000|Period D|Protocol Violation|1|||
144271235|NCT00784875|520197576|FG001|Period D|Protocol Violation|0|||
144271236|NCT00784875|520197577|FG002|Period D|Protocol Violation|0|||
144271237|NCT00784875|520197578|FG003|Period D|Protocol Violation|0|||
144271238|NCT00784875|520197575|FG000|Period D|Withdrawal by Subject|2|||
144271239|NCT00784875|520197576|FG001|Period D|Withdrawal by Subject|0|||
144271240|NCT00784875|520197577|FG002|Period D|Withdrawal by Subject|2|||
144271241|NCT00784875|520197578|FG003|Period D|Withdrawal by Subject|0|||
144271242|NCT00784875|520197575|FG000|Period D|Physician Decision|0|||
144271243|NCT00784875|520197576|FG001|Period D|Physician Decision|1|||
144271244|NCT00784875|520197577|FG002|Period D|Physician Decision|0|||
144271245|NCT00784875|520197578|FG003|Period D|Physician Decision|0|||
144271246|NCT00784875|520197575|FG000|Period D|Sponsor Decision|1|||
144271247|NCT00784875|520197576|FG001|Period D|Sponsor Decision|1|||
144271248|NCT00784875|520197577|FG002|Period D|Sponsor Decision|1|||
144271249|NCT00784875|520197578|FG003|Period D|Sponsor Decision|0|||
144241905|NCT02951533|520082321|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
144241906|NCT02951533|520082319|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
144241907|NCT02951533|520082320|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
144241908|NCT02951533|520082321|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
144241909|NCT02951533|520082319|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
144241910|NCT02951533|520082320|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
144241911|NCT02951533|520082321|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
144241912|NCT02951533|520082319|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
144241913|NCT02951533|520082320|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
144241914|NCT02951533|520082321|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
144241915|NCT02029989|520082322|FG000|Overall Study|Withdrawal by Subject|1|||
144241916|NCT02029989|520082323|FG001|Overall Study|Withdrawal by Subject|0|||
144241917|NCT02029989|520082322|FG000|Overall Study|Withdrawal: Fear of needles|1|||
144241918|NCT02029989|520082323|FG001|Overall Study|Withdrawal: Fear of needles|0|||
144241919|NCT02029989|520082322|FG000|Overall Study|Change of location|2|||
144241920|NCT02029989|520082323|FG001|Overall Study|Change of location|3|||
144241921|NCT02029989|520082322|FG000|Overall Study|Physician Decision|2|||
144241922|NCT02029989|520082323|FG001|Overall Study|Physician Decision|0|||
144241923|NCT02029989|520082322|FG000|Overall Study|Lost to Follow-up|9|||
144241924|NCT02029989|520082323|FG001|Overall Study|Lost to Follow-up|7|||
144241925|NCT02029989|520082322|FG000|Overall Study|Death|0|||
144241926|NCT02029989|520082323|FG001|Overall Study|Death|1|||
144241927|NCT02029989|520082322|FG000|Overall Study|Protocol Violation|1|||
144241928|NCT02029989|520082323|FG001|Overall Study|Protocol Violation|0|||
144241929|NCT04351373|520082324|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
144241930|NCT03379753|520082332|FG000|Overall Study|Withdrawal by Subject|2|||
144241931|NCT03379753|520082333|FG001|Overall Study|Withdrawal by Subject|1|||
144271250|NCT00784875|520197575|FG000|Period D|Lost to Follow-up|1|||
144271251|NCT00784875|520197576|FG001|Period D|Lost to Follow-up|0|||
144271252|NCT00784875|520197577|FG002|Period D|Lost to Follow-up|1|||
144271253|NCT00784875|520197578|FG003|Period D|Lost to Follow-up|1|||
144271254|NCT01027949|520197581|FG000|Overall Study|Death|174|||
144271255|NCT01027949|520197581|FG000|Overall Study|Progressive Disease|163|||
144271256|NCT01027949|520197581|FG000|Overall Study|Adverse Event|172|||
144271257|NCT01027949|520197581|FG000|Overall Study|Withdrawal by Subject|113|||
144271258|NCT01027949|520197581|FG000|Overall Study|Lost to Follow-up|17|||
144271259|NCT01027949|520197581|FG000|Overall Study|Protocol Violation|13|||
144271260|NCT01027949|520197581|FG000|Overall Study|PI Decision|8|||
144271261|NCT01027949|520197581|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
144271262|NCT01027949|520197581|FG000|Overall Study|Non-compliance with Study Procedures|7|||
144271263|NCT01027949|520197581|FG000|Overall Study|Lung Transplant|5|||
144271264|NCT01027949|520197581|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
144271265|NCT01027949|520197581|FG000|Overall Study|Use of Excluded Medication|2|||
144271266|NCT01027949|520197581|FG000|Overall Study|Patient Self-discontinuation|1|||
144271267|NCT01027949|520197581|FG000|Overall Study|Pregnancy|1|||
144271268|NCT01027949|520197581|FG000|Overall Study|Surgery|1|||
144271269|NCT00671749|520197582|FG000|Overall Study|Adverse Event|2|||
144271270|NCT00671749|520197582|FG000|Overall Study|Withdrawal by Subject|4|||
144271271|NCT00671749|520197582|FG000|Overall Study|Protocol Violation|1|||
144271272|NCT00671749|520197582|FG000|Overall Study|Lost to Follow-up|1|||
144271273|NCT02834975|520197585|FG000|Overall Study|Physician Decision|2|||
144271274|NCT02834975|520197585|FG000|Overall Study|Adverse Event|1|||
144271275|NCT02834975|520197585|FG000|Overall Study|Withdrawal by Subject|1|||
144271276|NCT02834975|520197585|FG000|Overall Study|Lack of Efficacy|1|||
144271277|NCT01200355|520197591|FG000|Overall Study|Death|7|||
144271278|NCT01200355|520197592|FG001|Overall Study|Death|2|||
144271279|NCT00250588|520197593|FG000|Overall Study|Withdrawal by Subject|3|||
144271280|NCT00250588|520197594|FG001|Overall Study|Withdrawal by Subject|6|||
144271281|NCT00250588|520197595|FG002|Overall Study|Withdrawal by Subject|0|||
144271282|NCT00250588|520197593|FG000|Overall Study|Lost to Follow-up|6|||
144271283|NCT00250588|520197594|FG001|Overall Study|Lost to Follow-up|13|||
144271284|NCT00250588|520197595|FG002|Overall Study|Lost to Follow-up|13|||
144271285|NCT00485303|520197598|FG000|Overall Study|Adverse Event|5|||
144271286|NCT00485303|520197598|FG000|Overall Study|Progressive Disease|44|||
144271287|NCT00485303|520197598|FG000|Overall Study|Other|3|||
144271288|NCT00485303|520197598|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
144271289|NCT00485303|520197598|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
144271290|NCT00296335|520197600|FG000|Overall Study|Recurrence|3|||
144271291|NCT00296335|520197601|FG001|Overall Study|Recurrence|51|||
144271292|NCT00296335|520197600|FG000|Overall Study|Adverse Event|17|||
144271293|NCT00296335|520197601|FG001|Overall Study|Adverse Event|27|||
144271294|NCT00296335|520197600|FG000|Overall Study|Lost to Follow-up|7|||
144271295|NCT00296335|520197601|FG001|Overall Study|Lost to Follow-up|33|||
144271296|NCT00296335|520197600|FG000|Overall Study|Physician Decision|3|||
144271297|NCT00296335|520197601|FG001|Overall Study|Physician Decision|11|||
144271298|NCT01401322|520197602|FG000|Overall Study|Withdrawal by Subject|1|||
144271299|NCT01401322|520197602|FG000|Overall Study|Physician Decision|1|||
144271300|NCT00486044|520197603|FG000|Overall Study|Withdrawal by Subject|2|||
144271301|NCT00486044|520197604|FG001|Overall Study|Withdrawal by Subject|1|||
144271302|NCT00486044|520197603|FG000|Overall Study|Adverse Event|0|||
144271303|NCT00486044|520197604|FG001|Overall Study|Adverse Event|1|||
144271304|NCT00486044|520197603|FG000|Overall Study|Lost to Follow-up|0|||
144271305|NCT00486044|520197604|FG001|Overall Study|Lost to Follow-up|1|||
144271306|NCT01670292|520197606|FG000|Overall Study|Lost to Follow-up|14|||
144271307|NCT00087178|520197609|FG000|Overall Study|No follow up data|5|||
144271308|NCT00087178|520197610|FG001|Overall Study|No follow up data|15|||
144271309|NCT00087178|520197609|FG000|Overall Study|No clinical assessment|1|||
144271310|NCT00087178|520197610|FG001|Overall Study|No clinical assessment|2|||
144271311|NCT00087178|520197609|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
144271312|NCT00087178|520197610|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
144271313|NCT04494646|520197611|FG000|Overall Study|Adverse Event|0|||
144271314|NCT04494646|520197612|FG001|Overall Study|Adverse Event|1|||
144271315|NCT04494646|520197611|FG000|Overall Study|Withdrawal by Subject|0|||
144271316|NCT04494646|520197612|FG001|Overall Study|Withdrawal by Subject|1|||
144271317|NCT01192815|520197623|FG000|Overall Study|Withdrawal by Subject|1|||
144271318|NCT01192815|520197623|FG000|Overall Study|Lack of Efficacy|1|||
144271319|NCT03704064|520197626|FG000|Overall Study|Lost to Follow-up|8|||
144271320|NCT03704064|520197627|FG001|Overall Study|Lost to Follow-up|4|||
144271321|NCT03704064|520197626|FG000|Overall Study|Withdrawal by Subject|1|||
144271322|NCT03704064|520197627|FG001|Overall Study|Withdrawal by Subject|1|||
144271323|NCT03704064|520197626|FG000|Overall Study|No longer available for study visits|0|||
144271324|NCT03704064|520197627|FG001|Overall Study|No longer available for study visits|1|||
144271325|NCT03704064|520197626|FG000|Overall Study|Censoring event|1|||
144271326|NCT03704064|520197627|FG001|Overall Study|Censoring event|0|||
144271327|NCT00289276|520197630|FG000|Second Part of FAST Study (Expansion)|Death|0|||
144271328|NCT00289276|520197631|FG001|Second Part of FAST Study (Expansion)|Death|2|||
144271329|NCT00289276|520197630|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
144271330|NCT00289276|520197631|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
144271331|NCT01604785|520197632|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
144271332|NCT01604785|520197633|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
144271333|NCT00726609|520197634|FG000|Overall Study|Adverse Event|10|||
144271334|NCT00726609|520197634|FG000|Overall Study|Withdrawal by Subject|2|||
144241932|NCT03379753|520082332|FG000|Overall Study|not having correct procedure|1|||
144241933|NCT03379753|520082333|FG001|Overall Study|not having correct procedure|2|||
144241934|NCT03379753|520082332|FG000|Overall Study|No primary outcome|12|||
144241935|NCT03379753|520082333|FG001|Overall Study|No primary outcome|22|||
144241936|NCT02091986|520082345|FG000|Overall Study|7 rand in error 1 patient decision|2|||
144241937|NCT02091986|520082346|FG001|Overall Study|7 rand in error 1 patient decision|3|||
144241938|NCT02091986|520082347|FG002|Overall Study|7 rand in error 1 patient decision|3|||
144241939|NCT02091986|520082345|FG000|Overall Study|Lost to Follow-up|1|||
144241940|NCT02091986|520082346|FG001|Overall Study|Lost to Follow-up|0|||
144241941|NCT02091986|520082347|FG002|Overall Study|Lost to Follow-up|0|||
144241942|NCT02091986|520082345|FG000|Overall Study|Withdrawal by Subject|4|||
144241943|NCT02091986|520082346|FG001|Overall Study|Withdrawal by Subject|8|||
144241944|NCT02091986|520082347|FG002|Overall Study|Withdrawal by Subject|3|||
144241945|NCT02091986|520082345|FG000|Overall Study|Adverse Event|0|||
144241946|NCT02091986|520082346|FG001|Overall Study|Adverse Event|0|||
144241947|NCT02091986|520082347|FG002|Overall Study|Adverse Event|2|||
144241948|NCT00915876|520082348|FG000|Overall Study|Adverse Event|0|||
144241949|NCT00915876|520082349|FG001|Overall Study|Adverse Event|1|||
144241950|NCT04545567|520082351|FG000|Overall Study|tested positive for SARS-co-V2|1|||
144241951|NCT04545567|520082352|FG001|Overall Study|tested positive for SARS-co-V2|1|||
144241952|NCT04545567|520082351|FG000|Overall Study|Withdrawal by Subject|0|||
144241953|NCT04545567|520082352|FG001|Overall Study|Withdrawal by Subject|1|||
144241954|NCT01984892|520082355|FG000|Overall Study|Progressive disease|7|||
144241955|NCT04464720|520082356|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
144241956|NCT04413552|520082358|FG000|Overall Study|Adverse Event|0|||
144241957|NCT04413552|520082359|FG001|Overall Study|Adverse Event|0|||
144241958|NCT04413552|520082360|FG002|Overall Study|Adverse Event|0|||
144241959|NCT04413552|520082361|FG003|Overall Study|Adverse Event|0|||
144241960|NCT04413552|520082362|FG004|Overall Study|Adverse Event|0|||
144241961|NCT04413552|520082363|FG005|Overall Study|Adverse Event|0|||
144241962|NCT04413552|520082364|FG006|Overall Study|Adverse Event|1|||
144241963|NCT04413552|520082365|FG007|Overall Study|Adverse Event|0|||
144241964|NCT04413552|520082366|FG008|Overall Study|Adverse Event|0|||
144241965|NCT04413552|520082367|FG009|Overall Study|Adverse Event|0|||
144241966|NCT01794793|520082370|FG000|Treatment Period|Withdrawal by Subject|24|||
144241967|NCT01794793|520082370|FG000|Treatment Period|Lack of Efficacy|22|||
144241968|NCT01794793|520082370|FG000|Treatment Period|Adverse Event|17|||
144241969|NCT01794793|520082370|FG000|Treatment Period|Physician Decision|14|||
144241970|NCT01794793|520082370|FG000|Treatment Period|Lost to Follow-up|7|||
144241971|NCT01794793|520082370|FG000|Treatment Period|Death|6|||
144241972|NCT01794793|520082370|FG000|Treatment Period|Protocol Violation|5|||
144241973|NCT01794793|520082370|FG000|Treatment Period|administrative problem|3|||
144241974|NCT01794793|520082370|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
144241975|NCT01794793|520082370|FG000|Post-treatment Follow-up|Adverse Event|8|||
144241976|NCT01794793|520082370|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
144241977|NCT01794793|520082370|FG000|Post-treatment Follow-up|administrative problem|5|||
144241978|NCT01794793|520082370|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
144241979|NCT01794793|520082370|FG000|Post-treatment Follow-up|Protocol Violation|3|||
144241980|NCT03197467|520083876|FG000|Overall Study|Withdrawal by Subject|1|||
144241981|NCT03666533|520083878|FG000|Overall Study|Lost to Follow-up|2|||
144241982|NCT03666533|520083879|FG001|Overall Study|Lost to Follow-up|2|||
144241983|NCT01632150|520083880|FG000|Overall Study|Disease progression|27|||
144241984|NCT01632150|520083880|FG000|Overall Study|Study drug toxicity|1|||
144241985|NCT01632150|520083880|FG000|Overall Study|Unrelated adverse event|7|||
144241986|NCT01632150|520083880|FG000|Overall Study|Withdrawal by Subject|2|||
144241987|NCT01632150|520083880|FG000|Overall Study|Patient underwent autologous transplant|1|||
144271335|NCT00726609|520197634|FG000|Overall Study|Lack of Efficacy|25|||
144271336|NCT00726609|520197634|FG000|Overall Study|Other|16|||
144271337|NCT00726609|520197634|FG000|Overall Study|Missing|42|||
144271338|NCT00726609|520197634|FG000|Overall Study|Other|3|||
144271339|NCT00746551|520197637|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
144271340|NCT00746551|520197638|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
144271341|NCT00746551|520197637|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
144271342|NCT00746551|520197638|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
144271343|NCT00746551|520197637|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
144271344|NCT00746551|520197638|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
144271345|NCT02029417|520197639|FG000|Overall Study|Death|1|||
144271346|NCT02029417|520197639|FG000|Overall Study|Adverse Event|1|||
144271347|NCT00171249|520197641|FG000|Overall Study|Withdrawal by Subject|2|||
144271348|NCT00171249|520197642|FG001|Overall Study|Withdrawal by Subject|0|||
144271349|NCT00171249|520197643|FG002|Overall Study|Withdrawal by Subject|0|||
144271350|NCT00171249|520197644|FG003|Overall Study|Withdrawal by Subject|6|||
144271351|NCT00171249|520197645|FG004|Overall Study|Withdrawal by Subject|0|||
144271352|NCT00171249|520197646|FG005|Overall Study|Withdrawal by Subject|0|||
144271353|NCT00171249|520197647|FG006|Overall Study|Withdrawal by Subject|0|||
144271354|NCT00171249|520197641|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
144271355|NCT00171249|520197642|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144271356|NCT00171249|520197643|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
144271357|NCT00171249|520197644|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
144271358|NCT00171249|520197645|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
144271359|NCT00171249|520197646|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
144271360|NCT00171249|520197647|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
144271361|NCT00171249|520197641|FG000|Overall Study|Death|7|||
144271362|NCT00171249|520197642|FG001|Overall Study|Death|1|||
144271363|NCT00171249|520197643|FG002|Overall Study|Death|0|||
144271364|NCT00171249|520197644|FG003|Overall Study|Death|4|||
144271365|NCT00171249|520197645|FG004|Overall Study|Death|0|||
144271366|NCT00171249|520197646|FG005|Overall Study|Death|3|||
144271367|NCT00171249|520197647|FG006|Overall Study|Death|1|||
144271368|NCT00171249|520197641|FG000|Overall Study|Other|10|||
144271369|NCT00171249|520197642|FG001|Overall Study|Other|0|||
144271370|NCT00171249|520197643|FG002|Overall Study|Other|0|||
144241988|NCT01632150|520083880|FG000|Overall Study|Moved to compassionate program|2|||
144241989|NCT02879994|520083881|FG000|Overall Study|off treatment early|7|||
144241990|NCT02879994|520083881|FG000|Overall Study|Adverse Event|2|||
144241991|NCT02879994|520083881|FG000|Overall Study|Death|2|||
144271371|NCT00171249|520197644|FG003|Overall Study|Other|43|||
144271372|NCT00171249|520197645|FG004|Overall Study|Other|0|||
144241992|NCT03408444|520083887|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
144241993|NCT03408444|520083888|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
144271373|NCT00171249|520197646|FG005|Overall Study|Other|2|||
144271374|NCT00171249|520197647|FG006|Overall Study|Other|0|||
144271375|NCT00171249|520197641|FG000|Overall Study|No Longer Requires Study Drug|4|||
144271376|NCT00171249|520197642|FG001|Overall Study|No Longer Requires Study Drug|0|||
144271377|NCT00171249|520197643|FG002|Overall Study|No Longer Requires Study Drug|0|||
144271378|NCT00171249|520197644|FG003|Overall Study|No Longer Requires Study Drug|3|||
144241994|NCT03408444|520083889|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
144241995|NCT03408444|520083890|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
144241996|NCT03408444|520083887|FG000|Overall Study|Lens Discomfort|0|||
144241997|NCT03408444|520083888|FG001|Overall Study|Lens Discomfort|1|||
144241998|NCT03408444|520083889|FG002|Overall Study|Lens Discomfort|0|||
144241999|NCT03408444|520083890|FG003|Overall Study|Lens Discomfort|0|||
144242000|NCT03408444|520083887|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
144242001|NCT03408444|520083888|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
144242002|NCT03408444|520083889|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
144242003|NCT03408444|520083890|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
144242004|NCT03408444|520083887|FG000|Overall Study|Withdrawal by Subject|0|||
144242005|NCT03408444|520083888|FG001|Overall Study|Withdrawal by Subject|2|||
144242006|NCT03408444|520083889|FG002|Overall Study|Withdrawal by Subject|3|||
144242007|NCT03408444|520083890|FG003|Overall Study|Withdrawal by Subject|0|||
144242008|NCT03408444|520083887|FG000|Overall Study|Lost to Follow-up|0|||
144242009|NCT03408444|520083888|FG001|Overall Study|Lost to Follow-up|0|||
144242010|NCT03408444|520083889|FG002|Overall Study|Lost to Follow-up|1|||
144242011|NCT03408444|520083890|FG003|Overall Study|Lost to Follow-up|0|||
144242012|NCT03408444|520083887|FG000|Overall Study|Adverse Event|0|||
144242013|NCT03408444|520083888|FG001|Overall Study|Adverse Event|0|||
144242014|NCT03408444|520083889|FG002|Overall Study|Adverse Event|0|||
144242015|NCT03408444|520083890|FG003|Overall Study|Adverse Event|1|||
144242016|NCT03408444|520083887|FG000|Overall Study|Lens Handling Difficulties|0|||
144242017|NCT03408444|520083888|FG001|Overall Study|Lens Handling Difficulties|0|||
144242018|NCT03408444|520083889|FG002|Overall Study|Lens Handling Difficulties|1|||
144242019|NCT03408444|520083890|FG003|Overall Study|Lens Handling Difficulties|0|||
144242020|NCT03408444|520083887|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
144242021|NCT03408444|520083888|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
144242022|NCT03408444|520083889|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
144242023|NCT03408444|520083890|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
144242024|NCT04984681|520083891|FG000|Overall Study|Lost to Follow-up|3|||
144242025|NCT04984681|520083892|FG001|Overall Study|Lost to Follow-up|1|||
144242026|NCT01214252|520083893|FG000|Overall Study|Not eligible per protocol|82|||
144242027|NCT00738881|520083896|FG000|Overall Study|Withdrawal by Subject|0|||
144242028|NCT00738881|520083897|FG001|Overall Study|Withdrawal by Subject|2|||
144242029|NCT00348790|520083898|FG000|Completed Treatment|Withdrawal by Subject|4|||
144242030|NCT00348790|520083898|FG000|Completed Treatment|Disease progression|14|||
144242031|NCT00348790|520083898|FG000|Completed Treatment|Adverse Event|4|||
144242032|NCT00348790|520083898|FG000|Completed Treatment|Required surgery|2|||
144242033|NCT00348790|520083898|FG000|Completed Treatment|Unable to travel to study site|1|||
144242034|NCT03409107|520083899|FG000|Overall Study|Withdrawal by Subject|4|||
144242035|NCT03409107|520083900|FG001|Overall Study|Withdrawal by Subject|2|||
144242036|NCT03409107|520083899|FG000|Overall Study|Physician Decision|1|||
144242037|NCT03409107|520083900|FG001|Overall Study|Physician Decision|0|||
144242038|NCT03409107|520083899|FG000|Overall Study|Lost to Follow-up|7|||
144242039|NCT03409107|520083900|FG001|Overall Study|Lost to Follow-up|2|||
144242040|NCT03409107|520083899|FG000|Overall Study|Adverse Event|5|||
144242041|NCT03409107|520083900|FG001|Overall Study|Adverse Event|3|||
144242042|NCT00581542|520083901|FG000|Overall Study|they met an exclusion criteria|2|||
144242043|NCT00581542|520083902|FG001|Overall Study|they met an exclusion criteria|2|||
144242044|NCT00581542|520083901|FG000|Overall Study|Lost to Follow-up|9|||
144242045|NCT00581542|520083902|FG001|Overall Study|Lost to Follow-up|21|||
144242046|NCT01546571|520083903|FG000|Overall Study|Adverse Event|1|||
144242047|NCT01546571|520083904|FG001|Overall Study|Adverse Event|0|||
144242048|NCT01546571|520083905|FG002|Overall Study|Adverse Event|0|||
144242049|NCT01546571|520083906|FG003|Overall Study|Adverse Event|1|||
144242050|NCT01546571|520083907|FG004|Overall Study|Adverse Event|0|||
144242051|NCT01546571|520083903|FG000|Overall Study|assigned placebo in Part A|0|||
144242052|NCT01546571|520083904|FG001|Overall Study|assigned placebo in Part A|0|||
144242053|NCT01546571|520083905|FG002|Overall Study|assigned placebo in Part A|22|||
144242054|NCT01546571|520083906|FG003|Overall Study|assigned placebo in Part A|0|||
144242055|NCT01546571|520083907|FG004|Overall Study|assigned placebo in Part A|0|||
144242056|NCT01546571|520083903|FG000|Overall Study|Death|0|||
144242057|NCT01546571|520083904|FG001|Overall Study|Death|1|||
144242058|NCT01546571|520083905|FG002|Overall Study|Death|0|||
144242059|NCT01546571|520083906|FG003|Overall Study|Death|0|||
144242060|NCT01546571|520083907|FG004|Overall Study|Death|0|||
144242061|NCT01546571|520083903|FG000|Overall Study|Lost to Follow-up|0|||
144242062|NCT01546571|520083904|FG001|Overall Study|Lost to Follow-up|0|||
144242063|NCT01546571|520083905|FG002|Overall Study|Lost to Follow-up|2|||
144242064|NCT01546571|520083906|FG003|Overall Study|Lost to Follow-up|2|||
144242065|NCT01546571|520083907|FG004|Overall Study|Lost to Follow-up|3|||
144242066|NCT01546571|520083903|FG000|Overall Study|Pregnancy|0|||
144242067|NCT01546571|520083904|FG001|Overall Study|Pregnancy|0|||
144242068|NCT01546571|520083905|FG002|Overall Study|Pregnancy|0|||
144242069|NCT01546571|520083906|FG003|Overall Study|Pregnancy|1|||
144242070|NCT01546571|520083907|FG004|Overall Study|Pregnancy|0|||
144242071|NCT01546571|520083903|FG000|Overall Study|Disease Progression|20|||
144242072|NCT01546571|520083904|FG001|Overall Study|Disease Progression|18|||
144242073|NCT01546571|520083905|FG002|Overall Study|Disease Progression|15|||
144242074|NCT01546571|520083906|FG003|Overall Study|Disease Progression|73|||
144242075|NCT01546571|520083907|FG004|Overall Study|Disease Progression|37|||
144242076|NCT01546571|520083903|FG000|Overall Study|Withdrawal by Subject|1|||
144242077|NCT01546571|520083904|FG001|Overall Study|Withdrawal by Subject|2|||
144242078|NCT01546571|520083905|FG002|Overall Study|Withdrawal by Subject|4|||
144242079|NCT01546571|520083906|FG003|Overall Study|Withdrawal by Subject|9|||
144242080|NCT01546571|520083907|FG004|Overall Study|Withdrawal by Subject|2|||
144242081|NCT01546571|520083903|FG000|Overall Study|Intercurrent Illness|1|||
144271379|NCT00171249|520197645|FG004|Overall Study|No Longer Requires Study Drug|0|||
144271380|NCT00171249|520197646|FG005|Overall Study|No Longer Requires Study Drug|5|||
144271381|NCT00171249|520197647|FG006|Overall Study|No Longer Requires Study Drug|0|||
144271382|NCT00171249|520197641|FG000|Overall Study|Administrative Problems|1|||
144271383|NCT00171249|520197642|FG001|Overall Study|Administrative Problems|0|||
144271384|NCT00171249|520197643|FG002|Overall Study|Administrative Problems|0|||
144271385|NCT00171249|520197644|FG003|Overall Study|Administrative Problems|2|||
144271386|NCT00171249|520197645|FG004|Overall Study|Administrative Problems|0|||
144271387|NCT00171249|520197646|FG005|Overall Study|Administrative Problems|0|||
144271388|NCT00171249|520197647|FG006|Overall Study|Administrative Problems|0|||
144242082|NCT01546571|520083904|FG001|Overall Study|Intercurrent Illness|2|||
144242083|NCT01546571|520083905|FG002|Overall Study|Intercurrent Illness|0|||
144242084|NCT01546571|520083906|FG003|Overall Study|Intercurrent Illness|0|||
144242085|NCT01546571|520083907|FG004|Overall Study|Intercurrent Illness|0|||
144242086|NCT01546571|520083903|FG000|Overall Study|Other Cancers|0|||
144242087|NCT01546571|520083904|FG001|Overall Study|Other Cancers|0|||
144242088|NCT01546571|520083905|FG002|Overall Study|Other Cancers|0|||
144242089|NCT01546571|520083906|FG003|Overall Study|Other Cancers|3|||
144242090|NCT01546571|520083907|FG004|Overall Study|Other Cancers|1|||
144242091|NCT01546571|520083903|FG000|Overall Study|Other|0|||
144242092|NCT01546571|520083904|FG001|Overall Study|Other|0|||
144242093|NCT01546571|520083905|FG002|Overall Study|Other|3|||
144242094|NCT01546571|520083906|FG003|Overall Study|Other|0|||
144242095|NCT01546571|520083907|FG004|Overall Study|Other|0|||
144242096|NCT01880086|520083910|FG000|Overall Study|Lost to Follow-up|1|||
144242097|NCT01880086|520083911|FG001|Overall Study|Lost to Follow-up|1|||
144242098|NCT05174949|520083912|FG000|Overall Study|Physician Decision|1|||
144242099|NCT05174949|520083913|FG001|Overall Study|Physician Decision|2|||
144242100|NCT05174949|520083914|FG002|Overall Study|Physician Decision|0|||
144242101|NCT05174949|520083915|FG003|Overall Study|Physician Decision|1|||
144242102|NCT05174949|520083916|FG004|Overall Study|Physician Decision|0|||
144242103|NCT05174949|520083917|FG005|Overall Study|Physician Decision|0|||
144242104|NCT05174949|520083912|FG000|Overall Study|Withdrawal by Subject|0|||
144242105|NCT05174949|520083913|FG001|Overall Study|Withdrawal by Subject|1|||
144242106|NCT05174949|520083914|FG002|Overall Study|Withdrawal by Subject|0|||
144242107|NCT05174949|520083915|FG003|Overall Study|Withdrawal by Subject|0|||
144242108|NCT05174949|520083916|FG004|Overall Study|Withdrawal by Subject|0|||
144242109|NCT05174949|520083917|FG005|Overall Study|Withdrawal by Subject|0|||
144242110|NCT05174949|520083912|FG000|Overall Study|Lost to Follow-up|0|||
144242111|NCT05174949|520083913|FG001|Overall Study|Lost to Follow-up|0|||
144242112|NCT05174949|520083914|FG002|Overall Study|Lost to Follow-up|0|||
144242113|NCT05174949|520083915|FG003|Overall Study|Lost to Follow-up|1|||
144242114|NCT05174949|520083916|FG004|Overall Study|Lost to Follow-up|0|||
144242115|NCT05174949|520083917|FG005|Overall Study|Lost to Follow-up|0|||
144242116|NCT01123941|520083920|FG000|Overall Study|Lost to Follow-up|2|||
144242117|NCT01123941|520083921|FG001|Overall Study|Lost to Follow-up|1|||
144242118|NCT05083923|520083929|FG000|Overall Study|Adverse Event|2|||
144242119|NCT05083923|520083930|FG001|Overall Study|Adverse Event|0|||
144242120|NCT05083923|520083929|FG000|Overall Study|Lack of Efficacy|1|||
144242121|NCT05083923|520083930|FG001|Overall Study|Lack of Efficacy|3|||
144242122|NCT05083923|520083929|FG000|Overall Study|Withdrawal by Subject|2|||
144242123|NCT05083923|520083930|FG001|Overall Study|Withdrawal by Subject|6|||
144242124|NCT05083923|520083929|FG000|Overall Study|Reason Not Specified|0|||
144242125|NCT05083923|520083930|FG001|Overall Study|Reason Not Specified|1|||
144242126|NCT06011161|520083935|FG000|Overall Study|Withdrawal by Subject|2|||
144242127|NCT06011161|520083935|FG000|Overall Study|Lost to Follow-up|5|||
144242128|NCT00430352|520083936|FG000|Overall Study|Disease progression|58|||
144242129|NCT00430352|520083936|FG000|Overall Study|Withdrawal by Subject|11|||
144242130|NCT00430352|520083936|FG000|Overall Study|Adverse Event|16|||
144242131|NCT00430352|520083936|FG000|Overall Study|Death|5|||
144242132|NCT00430352|520083936|FG000|Overall Study|Other|48|||
144242133|NCT03099694|520083937|FG000|Overall Study|Withdrawal by Subject|11|||
144242134|NCT03099694|520083938|FG001|Overall Study|Withdrawal by Subject|13|||
144242135|NCT03099694|520083937|FG000|Overall Study|Lost to Follow-up|9|||
144242136|NCT03099694|520083938|FG001|Overall Study|Lost to Follow-up|5|||
144242137|NCT02291601|520083939|FG000|Abdomen|Did not qualify|333|||
144242138|NCT02291601|520083940|FG001|Abdomen|Did not qualify|54|||
144242139|NCT02291601|520083941|FG002|Abdomen|Did not qualify|339|||
144242140|NCT02291601|520083939|FG000|Groin|Did not qualify|183|||
144242141|NCT02291601|520083940|FG001|Groin|Did not qualify|30|||
144242142|NCT02291601|520083941|FG002|Groin|Did not qualify|177|||
144242143|NCT01597375|520083947|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
144242144|NCT01597375|520083948|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
144271389|NCT00171249|520197641|FG000|Overall Study|Adverse Event|3|||
144271390|NCT00171249|520197642|FG001|Overall Study|Adverse Event|1|||
144271391|NCT00171249|520197643|FG002|Overall Study|Adverse Event|0|||
144271392|NCT00171249|520197644|FG003|Overall Study|Adverse Event|15|||
144271393|NCT00171249|520197645|FG004|Overall Study|Adverse Event|0|||
144271394|NCT00171249|520197646|FG005|Overall Study|Adverse Event|2|||
144271395|NCT00171249|520197647|FG006|Overall Study|Adverse Event|0|||
144271396|NCT00171249|520197641|FG000|Overall Study|Lost to Follow-up|5|||
144271397|NCT00171249|520197642|FG001|Overall Study|Lost to Follow-up|0|||
144271398|NCT00171249|520197643|FG002|Overall Study|Lost to Follow-up|0|||
144271399|NCT00171249|520197644|FG003|Overall Study|Lost to Follow-up|9|||
144271400|NCT00171249|520197645|FG004|Overall Study|Lost to Follow-up|0|||
144271401|NCT00171249|520197646|FG005|Overall Study|Lost to Follow-up|0|||
144271402|NCT00171249|520197647|FG006|Overall Study|Lost to Follow-up|0|||
144271403|NCT00471497|520197648|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
144271404|NCT00471497|520197649|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
144271405|NCT00471497|520197650|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
144271406|NCT00471497|520197648|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
144271407|NCT00471497|520197649|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
144271408|NCT00471497|520197650|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
144271409|NCT00471497|520197648|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
144271410|NCT00471497|520197649|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
144271411|NCT00471497|520197650|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
144271412|NCT00471497|520197648|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
144271413|NCT00471497|520197649|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
144271414|NCT00471497|520197650|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
144271415|NCT00471497|520197648|FG000|Core Treatment Phase|Lost to Follow-up|6|||
144271416|NCT00471497|520197649|FG001|Core Treatment Phase|Lost to Follow-up|6|||
144271417|NCT00471497|520197650|FG002|Core Treatment Phase|Lost to Follow-up|3|||
144271418|NCT00471497|520197648|FG000|Core Treatment Phase|Death|3|||
144271419|NCT00471497|520197649|FG001|Core Treatment Phase|Death|9|||
144271420|NCT00471497|520197650|FG002|Core Treatment Phase|Death|3|||
144271421|NCT00471497|520197648|FG000|Core Treatment Phase|Disease Progression|10|||
144271422|NCT00471497|520197649|FG001|Core Treatment Phase|Disease Progression|2|||
144271423|NCT00471497|520197650|FG002|Core Treatment Phase|Disease Progression|4|||
144271424|NCT00471497|520197648|FG000|Core Treatment Phase|Protocol Violation|6|||
144271425|NCT00471497|520197649|FG001|Core Treatment Phase|Protocol Violation|15|||
144271426|NCT00471497|520197650|FG002|Core Treatment Phase|Protocol Violation|11|||
144271427|NCT00471497|520197648|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
144271428|NCT00471497|520197649|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
144271429|NCT00471497|520197650|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
144271430|NCT00471497|520197648|FG000|Core Treatment Phase|Administrative problems|14|||
144271431|NCT00471497|520197649|FG001|Core Treatment Phase|Administrative problems|14|||
144271432|NCT00471497|520197650|FG002|Core Treatment Phase|Administrative problems|12|||
144271433|NCT00471497|520197648|FG000|Core Treatment Phase|Adverse Event|43|||
144271434|NCT00471497|520197649|FG001|Core Treatment Phase|Adverse Event|53|||
144271435|NCT00471497|520197650|FG002|Core Treatment Phase|Adverse Event|89|||
144271436|NCT00471497|520197648|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
144271437|NCT00471497|520197649|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
144271438|NCT00471497|520197650|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
144271439|NCT00471497|520197648|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
144271440|NCT00471497|520197649|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
144271441|NCT00471497|520197650|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
144271442|NCT00471497|520197648|FG000|Extension Phase|Adverse Event|9|||
144271443|NCT00471497|520197649|FG001|Extension Phase|Adverse Event|5|||
144271444|NCT00471497|520197650|FG002|Extension Phase|Adverse Event|1|||
144271445|NCT00471497|520197648|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
144271446|NCT00471497|520197649|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
144271447|NCT00471497|520197650|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
144271448|NCT00471497|520197648|FG000|Extension Phase|Withdrawal by Subject|3|||
144271449|NCT00471497|520197649|FG001|Extension Phase|Withdrawal by Subject|1|||
144271450|NCT00471497|520197650|FG002|Extension Phase|Withdrawal by Subject|0|||
144271451|NCT00471497|520197648|FG000|Extension Phase|Lost to Follow-up|2|||
144271452|NCT00471497|520197649|FG001|Extension Phase|Lost to Follow-up|0|||
144271453|NCT00471497|520197650|FG002|Extension Phase|Lost to Follow-up|0|||
144271454|NCT00471497|520197648|FG000|Extension Phase|Death|1|||
144271455|NCT00471497|520197649|FG001|Extension Phase|Death|0|||
144271456|NCT00471497|520197650|FG002|Extension Phase|Death|0|||
144271457|NCT00471497|520197648|FG000|Extension Phase|Disease progression|2|||
144271458|NCT00471497|520197649|FG001|Extension Phase|Disease progression|0|||
144271459|NCT00471497|520197650|FG002|Extension Phase|Disease progression|0|||
144271460|NCT00471497|520197648|FG000|Extension Phase|Protocol Violation|2|||
144271461|NCT00471497|520197649|FG001|Extension Phase|Protocol Violation|2|||
144271462|NCT00471497|520197650|FG002|Extension Phase|Protocol Violation|0|||
144242145|NCT01597375|520083947|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
144242146|NCT01597375|520083948|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
144271463|NCT00392223|520197651|FG000|Overall Study|Adverse Event|5|||
144271464|NCT00392223|520197652|FG001|Overall Study|Adverse Event|4|||
144271465|NCT00392223|520197651|FG000|Overall Study|Lost to Follow-up|1|||
144271466|NCT00392223|520197652|FG001|Overall Study|Lost to Follow-up|4|||
144271467|NCT00392223|520197651|FG000|Overall Study|Protocol Violation|0|||
144271468|NCT00392223|520197652|FG001|Overall Study|Protocol Violation|3|||
144271469|NCT00392223|520197651|FG000|Overall Study|Withdrawal by Subject|3|||
144271470|NCT00392223|520197652|FG001|Overall Study|Withdrawal by Subject|2|||
144271471|NCT02908347|520197655|FG000|Overall Study|Adverse Event|0|||
144271472|NCT02908347|520197656|FG001|Overall Study|Adverse Event|1|||
144271473|NCT02908347|520197655|FG000|Overall Study|Lost to Follow-up|1|||
144271474|NCT02908347|520197656|FG001|Overall Study|Lost to Follow-up|0|||
144271475|NCT00269152|520197657|FG000|Overall Study|Adverse Event|9|||
144271476|NCT00269152|520197658|FG001|Overall Study|Adverse Event|3|||
144271477|NCT00269152|520197657|FG000|Overall Study|Withdrawal by Subject|7|||
144271478|NCT00269152|520197658|FG001|Overall Study|Withdrawal by Subject|3|||
144271479|NCT00269152|520197657|FG000|Overall Study|Physician Decision|2|||
144271480|NCT00269152|520197658|FG001|Overall Study|Physician Decision|3|||
144271481|NCT00269152|520197657|FG000|Overall Study|Protocol Violation|0|||
144271482|NCT00269152|520197658|FG001|Overall Study|Protocol Violation|1|||
144271483|NCT03104374|520197659|FG000|Period 1|Adverse Event|7|||
144271484|NCT03104374|520197660|FG001|Period 1|Adverse Event|7|||
144271485|NCT03104374|520197661|FG002|Period 1|Adverse Event|12|||
144271486|NCT03104374|520197662|FG003|Period 1|Adverse Event|14|||
144271487|NCT03104374|520197659|FG000|Period 1|Withdrawal by Subject|18|||
144271488|NCT03104374|520197660|FG001|Period 1|Withdrawal by Subject|9|||
144271489|NCT03104374|520197661|FG002|Period 1|Withdrawal by Subject|10|||
144271490|NCT03104374|520197662|FG003|Period 1|Withdrawal by Subject|17|||
144271491|NCT03104374|520197659|FG000|Period 1|Lost to Follow-up|4|||
144271492|NCT03104374|520197660|FG001|Period 1|Lost to Follow-up|4|||
144271493|NCT03104374|520197661|FG002|Period 1|Lost to Follow-up|6|||
144271494|NCT03104374|520197662|FG003|Period 1|Lost to Follow-up|8|||
144271495|NCT03104374|520197659|FG000|Period 1|Lack of Efficacy|6|||
144271496|NCT03104374|520197660|FG001|Period 1|Lack of Efficacy|7|||
144271497|NCT03104374|520197661|FG002|Period 1|Lack of Efficacy|12|||
144271498|NCT03104374|520197662|FG003|Period 1|Lack of Efficacy|6|||
144271499|NCT03104374|520197659|FG000|Period 1|Other|2|||
144271500|NCT03104374|520197660|FG001|Period 1|Other|2|||
144271501|NCT03104374|520197661|FG002|Period 1|Other|4|||
144271502|NCT03104374|520197662|FG003|Period 1|Other|7|||
144271503|NCT03104374|520197659|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
144271504|NCT03104374|520197660|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
144271505|NCT03104374|520197661|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
144271506|NCT03104374|520197662|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
144271507|NCT03104374|520197659|FG000|Period 2|Adverse Event|4|||
144271508|NCT03104374|520197660|FG001|Period 2|Adverse Event|7|||
144271509|NCT03104374|520197661|FG002|Period 2|Adverse Event|10|||
144271510|NCT03104374|520197662|FG003|Period 2|Adverse Event|10|||
144271511|NCT03104374|520197659|FG000|Period 2|Withdrawal by Subject|3|||
144271512|NCT03104374|520197660|FG001|Period 2|Withdrawal by Subject|7|||
144271513|NCT03104374|520197661|FG002|Period 2|Withdrawal by Subject|13|||
144271514|NCT03104374|520197662|FG003|Period 2|Withdrawal by Subject|16|||
144271515|NCT03104374|520197659|FG000|Period 2|Lost to Follow-up|2|||
144271516|NCT03104374|520197660|FG001|Period 2|Lost to Follow-up|2|||
144271517|NCT03104374|520197661|FG002|Period 2|Lost to Follow-up|3|||
144271518|NCT03104374|520197662|FG003|Period 2|Lost to Follow-up|5|||
144271519|NCT03104374|520197659|FG000|Period 2|Lack of Efficacy|2|||
144271520|NCT03104374|520197660|FG001|Period 2|Lack of Efficacy|4|||
144271521|NCT03104374|520197661|FG002|Period 2|Lack of Efficacy|7|||
144271522|NCT03104374|520197662|FG003|Period 2|Lack of Efficacy|4|||
144271523|NCT03104374|520197659|FG000|Period 2|COVID-19 Infection|0|||
144271524|NCT03104374|520197660|FG001|Period 2|COVID-19 Infection|0|||
144271525|NCT03104374|520197661|FG002|Period 2|COVID-19 Infection|1|||
144271526|NCT03104374|520197662|FG003|Period 2|COVID-19 Infection|0|||
144271527|NCT03104374|520197659|FG000|Period 2|Other|3|||
144271528|NCT03104374|520197660|FG001|Period 2|Other|2|||
144271529|NCT03104374|520197661|FG002|Period 2|Other|2|||
144271530|NCT03104374|520197662|FG003|Period 2|Other|4|||
144271531|NCT02121210|520197663|FG000|Overall Study|Adverse Event|5|||
144271532|NCT02121210|520197664|FG001|Overall Study|Adverse Event|7|||
144271533|NCT02121210|520197663|FG000|Overall Study|Lack of Efficacy|2|||
144271534|NCT02121210|520197664|FG001|Overall Study|Lack of Efficacy|0|||
144271535|NCT02121210|520197663|FG000|Overall Study|Other than specified above|0|||
144271536|NCT02121210|520197664|FG001|Overall Study|Other than specified above|2|||
144271537|NCT04609514|520197665|FG000|Overall Study|Lost to Follow-up|5|||
144271538|NCT04609514|520197666|FG001|Overall Study|Lost to Follow-up|4|||
144271539|NCT04609514|520197665|FG000|Overall Study|Withdrawal by PI|0|||
144242147|NCT01597375|520083947|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
144242148|NCT01597375|520083948|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
144242149|NCT01597375|520083947|FG000|Washout (2 Weeks)|Adverse Event|1|||
144242150|NCT01597375|520083948|FG001|Washout (2 Weeks)|Adverse Event|0|||
144242151|NCT01597375|520083947|FG000|Second Intervention|Failed to react at both Aspirin|1|||
144242152|NCT01597375|520083948|FG001|Second Intervention|Failed to react at both Aspirin|1|||
144242153|NCT00347919|520083949|FG000|Overall Study|Lost to Follow-up|11|||
144242154|NCT00347919|520083950|FG001|Overall Study|Lost to Follow-up|13|||
144242155|NCT00347919|520083951|FG002|Overall Study|Lost to Follow-up|0|||
144242156|NCT00347919|520083949|FG000|Overall Study|Withdrawal by Subject|6|||
144242157|NCT00347919|520083950|FG001|Overall Study|Withdrawal by Subject|8|||
144242158|NCT00347919|520083951|FG002|Overall Study|Withdrawal by Subject|0|||
144242159|NCT00347919|520083949|FG000|Overall Study|Physician Decision|1|||
144242160|NCT00347919|520083950|FG001|Overall Study|Physician Decision|1|||
144242161|NCT00347919|520083951|FG002|Overall Study|Physician Decision|0|||
144242162|NCT00347919|520083949|FG000|Overall Study|Sponsor terminated study|15|||
144242163|NCT00347919|520083950|FG001|Overall Study|Sponsor terminated study|10|||
144242164|NCT00347919|520083951|FG002|Overall Study|Sponsor terminated study|16|||
144242165|NCT00347919|520083949|FG000|Overall Study|Death|35|||
144242166|NCT00347919|520083950|FG001|Overall Study|Death|42|||
144242167|NCT00347919|520083951|FG002|Overall Study|Death|19|||
144242168|NCT00347919|520083949|FG000|Overall Study|Par. Started Other Treatment|1|||
144242169|NCT00347919|520083950|FG001|Overall Study|Par. Started Other Treatment|1|||
144242170|NCT00347919|520083951|FG002|Overall Study|Par. Started Other Treatment|1|||
144242171|NCT00347919|520083949|FG000|Overall Study|Missing|2|||
144242172|NCT00347919|520083950|FG001|Overall Study|Missing|1|||
144242173|NCT00347919|520083951|FG002|Overall Study|Missing|2|||
144242174|NCT02225366|520083960|FG000|Overall Study|Lack of Efficacy|1|||
144242175|NCT02225366|520083961|FG001|Overall Study|Lack of Efficacy|0|||
144242176|NCT04017832|520083971|FG000|Overall Study|Withdrawal by Subject|13|||
144242177|NCT04017832|520083972|FG001|Overall Study|Withdrawal by Subject|12|||
144242178|NCT04017832|520083973|FG002|Overall Study|Withdrawal by Subject|21|||
144242179|NCT04017832|520083974|FG003|Overall Study|Withdrawal by Subject|7|||
144242180|NCT04017832|520083971|FG000|Overall Study|Lost to Follow-up|0|||
144242181|NCT04017832|520083972|FG001|Overall Study|Lost to Follow-up|3|||
144242182|NCT04017832|520083973|FG002|Overall Study|Lost to Follow-up|3|||
144242183|NCT04017832|520083974|FG003|Overall Study|Lost to Follow-up|1|||
144242184|NCT04017832|520083971|FG000|Overall Study|Physician Decision|1|||
144242185|NCT04017832|520083972|FG001|Overall Study|Physician Decision|1|||
144242186|NCT04017832|520083973|FG002|Overall Study|Physician Decision|1|||
144242187|NCT04017832|520083974|FG003|Overall Study|Physician Decision|1|||
144271540|NCT04609514|520197666|FG001|Overall Study|Withdrawal by PI|2|||
144271541|NCT00909870|520197667|FG000|Overall Study|Adverse Event|13|||
144271542|NCT00909870|520197668|FG001|Overall Study|Adverse Event|7|||
144271543|NCT00909870|520197667|FG000|Overall Study|Protocol Violation|1|||
144271544|NCT00909870|520197668|FG001|Overall Study|Protocol Violation|2|||
144271545|NCT00909870|520197667|FG000|Overall Study|Withdrawal by Subject|5|||
144271546|NCT00909870|520197668|FG001|Overall Study|Withdrawal by Subject|8|||
144271547|NCT00909870|520197667|FG000|Overall Study|Lost to Follow-up|3|||
144271548|NCT00909870|520197668|FG001|Overall Study|Lost to Follow-up|3|||
144271549|NCT00909870|520197667|FG000|Overall Study|Physician Decision|0|||
144271550|NCT00909870|520197668|FG001|Overall Study|Physician Decision|2|||
144271551|NCT00909870|520197667|FG000|Overall Study|Other|1|||
144271552|NCT00909870|520197668|FG001|Overall Study|Other|5|||
144271553|NCT01981616|520197674|FG000|Overall Study|Adverse Event|0|||
144271554|NCT01981616|520197675|FG001|Overall Study|Adverse Event|1|||
144271555|NCT01981616|520197674|FG000|Overall Study|Protocol Violation|1|||
144271556|NCT01981616|520197675|FG001|Overall Study|Protocol Violation|0|||
144271557|NCT01420536|520197676|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
144271558|NCT01420536|520197677|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
144271559|NCT00764790|520197678|FG000|Overall Study|Protocol Violation|0|||
144271560|NCT00764790|520197679|FG001|Overall Study|Protocol Violation|0|||
144271561|NCT00764790|520197680|FG002|Overall Study|Protocol Violation|1|||
144271562|NCT00764790|520197678|FG000|Overall Study|Withdrawal by Subject|10|||
144271563|NCT00764790|520197679|FG001|Overall Study|Withdrawal by Subject|12|||
144271564|NCT00764790|520197680|FG002|Overall Study|Withdrawal by Subject|6|||
144271565|NCT00764790|520197678|FG000|Overall Study|Lost to Follow-up|28|||
144271566|NCT00764790|520197679|FG001|Overall Study|Lost to Follow-up|29|||
144271567|NCT00764790|520197680|FG002|Overall Study|Lost to Follow-up|23|||
144271568|NCT01773928|520197681|FG000|Overall Study|Adverse Event|0|||
144271569|NCT01773928|520197682|FG001|Overall Study|Adverse Event|0|||
144271570|NCT01773928|520197683|FG002|Overall Study|Adverse Event|0|||
144271571|NCT01773928|520197684|FG003|Overall Study|Adverse Event|0|||
144271572|NCT01773928|520197685|FG004|Overall Study|Adverse Event|0|||
144271573|NCT01773928|520197686|FG005|Overall Study|Adverse Event|0|||
144271574|NCT01773928|520197687|FG006|Overall Study|Adverse Event|0|||
144271575|NCT01773928|520197688|FG007|Overall Study|Adverse Event|1|||
144271576|NCT01773928|520197689|FG008|Overall Study|Adverse Event|0|||
144271577|NCT01773928|520197681|FG000|Overall Study|Physician Decision|0|||
144271578|NCT01773928|520197682|FG001|Overall Study|Physician Decision|0|||
144271579|NCT01773928|520197683|FG002|Overall Study|Physician Decision|0|||
144271580|NCT01773928|520197684|FG003|Overall Study|Physician Decision|1|||
144271581|NCT01773928|520197685|FG004|Overall Study|Physician Decision|0|||
144271582|NCT01773928|520197686|FG005|Overall Study|Physician Decision|0|||
144271583|NCT01773928|520197687|FG006|Overall Study|Physician Decision|0|||
144271584|NCT01773928|520197688|FG007|Overall Study|Physician Decision|0|||
144271585|NCT01773928|520197689|FG008|Overall Study|Physician Decision|0|||
144271586|NCT01773928|520197681|FG000|Overall Study|Withdrawal by Subject|5|||
144271587|NCT01773928|520197682|FG001|Overall Study|Withdrawal by Subject|4|||
144271588|NCT01773928|520197683|FG002|Overall Study|Withdrawal by Subject|4|||
144271589|NCT01773928|520197684|FG003|Overall Study|Withdrawal by Subject|4|||
144271590|NCT01773928|520197685|FG004|Overall Study|Withdrawal by Subject|7|||
144271591|NCT01773928|520197686|FG005|Overall Study|Withdrawal by Subject|1|||
144271592|NCT01773928|520197687|FG006|Overall Study|Withdrawal by Subject|0|||
144271593|NCT01773928|520197688|FG007|Overall Study|Withdrawal by Subject|0|||
144271594|NCT01773928|520197689|FG008|Overall Study|Withdrawal by Subject|1|||
144271595|NCT01773928|520197681|FG000|Overall Study|Lost to Follow-up|0|||
144271596|NCT01773928|520197682|FG001|Overall Study|Lost to Follow-up|0|||
144271597|NCT01773928|520197683|FG002|Overall Study|Lost to Follow-up|0|||
144271598|NCT01773928|520197684|FG003|Overall Study|Lost to Follow-up|0|||
144271599|NCT01773928|520197685|FG004|Overall Study|Lost to Follow-up|0|||
144271600|NCT01773928|520197686|FG005|Overall Study|Lost to Follow-up|1|||
144271601|NCT01773928|520197687|FG006|Overall Study|Lost to Follow-up|0|||
144271602|NCT01773928|520197688|FG007|Overall Study|Lost to Follow-up|0|||
144271603|NCT01773928|520197689|FG008|Overall Study|Lost to Follow-up|0|||
144271604|NCT01773928|520197681|FG000|Overall Study|Subject misrepresented age|0|||
144271605|NCT01773928|520197682|FG001|Overall Study|Subject misrepresented age|1|||
144271606|NCT01773928|520197683|FG002|Overall Study|Subject misrepresented age|0|||
144271607|NCT01773928|520197684|FG003|Overall Study|Subject misrepresented age|0|||
144271608|NCT01773928|520197685|FG004|Overall Study|Subject misrepresented age|0|||
144271609|NCT01773928|520197686|FG005|Overall Study|Subject misrepresented age|0|||
144271610|NCT01773928|520197687|FG006|Overall Study|Subject misrepresented age|0|||
144271611|NCT01773928|520197688|FG007|Overall Study|Subject misrepresented age|0|||
144271612|NCT01773928|520197689|FG008|Overall Study|Subject misrepresented age|0|||
144271613|NCT01773928|520197681|FG000|Overall Study|Subject met exclusion criteria|0|||
144271614|NCT01773928|520197682|FG001|Overall Study|Subject met exclusion criteria|0|||
144271615|NCT01773928|520197683|FG002|Overall Study|Subject met exclusion criteria|0|||
144271616|NCT01773928|520197684|FG003|Overall Study|Subject met exclusion criteria|0|||
144271617|NCT01773928|520197685|FG004|Overall Study|Subject met exclusion criteria|0|||
144271618|NCT01773928|520197686|FG005|Overall Study|Subject met exclusion criteria|0|||
144271619|NCT01773928|520197687|FG006|Overall Study|Subject met exclusion criteria|0|||
144271620|NCT01773928|520197688|FG007|Overall Study|Subject met exclusion criteria|0|||
144271621|NCT01773928|520197689|FG008|Overall Study|Subject met exclusion criteria|1|||
144271622|NCT01773928|520197681|FG000|Overall Study|Randomized, had to leave, never returned|0|||
144271623|NCT01773928|520197682|FG001|Overall Study|Randomized, had to leave, never returned|0|||
144271624|NCT01773928|520197683|FG002|Overall Study|Randomized, had to leave, never returned|0|||
144271625|NCT01773928|520197684|FG003|Overall Study|Randomized, had to leave, never returned|1|||
144271626|NCT01773928|520197685|FG004|Overall Study|Randomized, had to leave, never returned|0|||
144271627|NCT01773928|520197686|FG005|Overall Study|Randomized, had to leave, never returned|0|||
144271628|NCT01773928|520197687|FG006|Overall Study|Randomized, had to leave, never returned|0|||
144271629|NCT01773928|520197688|FG007|Overall Study|Randomized, had to leave, never returned|0|||
144271630|NCT01773928|520197689|FG008|Overall Study|Randomized, had to leave, never returned|0|||
144271631|NCT01773928|520197681|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
144271632|NCT01773928|520197682|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
144271633|NCT01773928|520197683|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
144271634|NCT01773928|520197684|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
144271635|NCT01773928|520197685|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
144271636|NCT01773928|520197686|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
144271637|NCT01773928|520197687|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
144271638|NCT01773928|520197688|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
144271639|NCT01773928|520197689|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
144271640|NCT01652690|520197690|FG000|Overall Study|Withdrawal by Subject|16|||
144271641|NCT01652690|520197691|FG001|Overall Study|Withdrawal by Subject|4|||
144271642|NCT01652690|520197690|FG000|Overall Study|Other|8|||
144271643|NCT01652690|520197691|FG001|Overall Study|Other|9|||
144271644|NCT01652690|520197690|FG000|Overall Study|Lost to Follow-up|6|||
144271645|NCT01652690|520197691|FG001|Overall Study|Lost to Follow-up|6|||
144271646|NCT01652690|520197690|FG000|Overall Study|Death|5|||
144271647|NCT01652690|520197691|FG001|Overall Study|Death|2|||
144271648|NCT03533751|520197692|FG000|Overall Study|Withdrawal by Subject|12|||
144271649|NCT03533751|520197693|FG001|Overall Study|Withdrawal by Subject|6|||
144271650|NCT03533751|520197694|FG002|Overall Study|Withdrawal by Subject|11|||
144271651|NCT03533751|520197695|FG003|Overall Study|Withdrawal by Subject|9|||
144271652|NCT03533751|520197696|FG004|Overall Study|Withdrawal by Subject|10|||
144271653|NCT03533751|520197692|FG000|Overall Study|Adverse Event|4|||
144271654|NCT03533751|520197693|FG001|Overall Study|Adverse Event|7|||
144271655|NCT03533751|520197694|FG002|Overall Study|Adverse Event|2|||
144271656|NCT03533751|520197695|FG003|Overall Study|Adverse Event|4|||
144271657|NCT03533751|520197696|FG004|Overall Study|Adverse Event|5|||
144271658|NCT03533751|520197692|FG000|Overall Study|Physician Decision|0|||
144271659|NCT03533751|520197693|FG001|Overall Study|Physician Decision|2|||
144271660|NCT03533751|520197694|FG002|Overall Study|Physician Decision|1|||
144271661|NCT03533751|520197695|FG003|Overall Study|Physician Decision|2|||
144271662|NCT03533751|520197696|FG004|Overall Study|Physician Decision|1|||
144271663|NCT03533751|520197692|FG000|Overall Study|Sponsor Decision|0|||
144271664|NCT03533751|520197693|FG001|Overall Study|Sponsor Decision|0|||
144271665|NCT03533751|520197694|FG002|Overall Study|Sponsor Decision|1|||
144271666|NCT03533751|520197695|FG003|Overall Study|Sponsor Decision|1|||
144271667|NCT03533751|520197696|FG004|Overall Study|Sponsor Decision|0|||
144271668|NCT03533751|520197692|FG000|Overall Study|Lost to Follow-up|3|||
144271669|NCT03533751|520197693|FG001|Overall Study|Lost to Follow-up|7|||
144271670|NCT03533751|520197694|FG002|Overall Study|Lost to Follow-up|6|||
144271671|NCT03533751|520197695|FG003|Overall Study|Lost to Follow-up|4|||
144271672|NCT03533751|520197696|FG004|Overall Study|Lost to Follow-up|3|||
144271673|NCT03533751|520197692|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
144271674|NCT03533751|520197693|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
144271675|NCT03533751|520197694|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
144271676|NCT03533751|520197695|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
144271677|NCT03533751|520197696|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
144271678|NCT03533751|520197692|FG000|Overall Study|Other|0|||
144271679|NCT03533751|520197693|FG001|Overall Study|Other|2|||
144271680|NCT03533751|520197694|FG002|Overall Study|Other|1|||
144271681|NCT03533751|520197695|FG003|Overall Study|Other|0|||
144271682|NCT03533751|520197696|FG004|Overall Study|Other|3|||
144271683|NCT03225287|520197697|FG000|Overall Study|Adverse Event|0|||
144271684|NCT03225287|520197698|FG001|Overall Study|Adverse Event|0|||
144271685|NCT03225287|520197699|FG002|Overall Study|Adverse Event|1|||
144271686|NCT03225287|520197697|FG000|Overall Study|Protocol non-compliance|0|||
144271687|NCT03225287|520197698|FG001|Overall Study|Protocol non-compliance|0|||
144271688|NCT03225287|520197699|FG002|Overall Study|Protocol non-compliance|1|||
144271689|NCT03225287|520197697|FG000|Overall Study|Subject withdraws consent|3|||
144271690|NCT03225287|520197698|FG001|Overall Study|Subject withdraws consent|0|||
144271691|NCT03225287|520197699|FG002|Overall Study|Subject withdraws consent|0|||
144271692|NCT03225287|520197697|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
144271693|NCT03225287|520197698|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
144271694|NCT03225287|520197699|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
144271695|NCT03225287|520197697|FG000|Overall Study|Trial drug not effective|0|||
144271696|NCT03225287|520197698|FG001|Overall Study|Trial drug not effective|1|||
144271697|NCT03225287|520197699|FG002|Overall Study|Trial drug not effective|0|||
144271698|NCT03225287|520197697|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
144271699|NCT03225287|520197698|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
144271700|NCT03225287|520197699|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
144271701|NCT03225287|520197697|FG000|Overall Study|Stem cell transplantation|0|||
144271702|NCT03225287|520197698|FG001|Overall Study|Stem cell transplantation|1|||
144271703|NCT03225287|520197699|FG002|Overall Study|Stem cell transplantation|0|||
144271704|NCT02074514|520197702|FG000|Overall Study|Lack of Efficacy|3|||
144271705|NCT02074514|520197703|FG001|Overall Study|Lack of Efficacy|2|||
144271706|NCT02074514|520197702|FG000|Overall Study|Lost to Follow-up|0|||
144271707|NCT02074514|520197703|FG001|Overall Study|Lost to Follow-up|1|||
144271708|NCT02074514|520197702|FG000|Overall Study|Withdrew Consent|0|||
144271709|NCT02074514|520197703|FG001|Overall Study|Withdrew Consent|1|||
144271710|NCT03082729|520197704|FG000|Overall Study|Lost to Follow-up|7|||
144271711|NCT03082729|520197704|FG000|Overall Study|Physician Decision|2|||
144271712|NCT03082729|520197704|FG000|Overall Study|Withdrawal by Subject|1|||
144271713|NCT03082729|520197704|FG000|Overall Study|Lack of Efficacy|9|||
144271714|NCT03082729|520197704|FG000|Overall Study|Adverse Event|4|||
144271715|NCT03082729|520197704|FG000|Overall Study|Protocol Violation|6|||
144271716|NCT03082729|520197704|FG000|Overall Study|Fear of study procedure|1|||
144271717|NCT03082729|520197704|FG000|Overall Study|Scheduling conflict|1|||
144271718|NCT05399680|520199546|FG000|Overall Study|Lost to Follow-up|1|||
144271719|NCT05399680|520199547|FG001|Overall Study|Lost to Follow-up|0|||
144271720|NCT05399680|520199546|FG000|Overall Study|Death|0|||
144271721|NCT05399680|520199547|FG001|Overall Study|Death|1|||
144271722|NCT02659865|520199548|FG000|Period 1|Withdrawal by Subject|1|||
144271723|NCT02659865|520199549|FG001|Period 1|Withdrawal by Subject|0|||
144271724|NCT02659865|520199550|FG002|Period 1|Withdrawal by Subject|0|||
144271725|NCT02659865|520199551|FG003|Period 1|Withdrawal by Subject|0|||
144271726|NCT02659865|520199552|FG004|Period 1|Withdrawal by Subject|0|||
144271727|NCT02659865|520199548|FG000|Period 1|Adverse Event|0|||
144271728|NCT02659865|520199549|FG001|Period 1|Adverse Event|0|||
144271729|NCT02659865|520199550|FG002|Period 1|Adverse Event|0|||
144271730|NCT02659865|520199551|FG003|Period 1|Adverse Event|0|||
144271731|NCT02659865|520199552|FG004|Period 1|Adverse Event|1|||
144271732|NCT03370172|520199553|FG000|Overall Study|Withdrawal by Subject|0|||
144271733|NCT03370172|520199554|FG001|Overall Study|Withdrawal by Subject|1|||
144271734|NCT00753519|520199556|FG000|Overall Study|Withdrawal by Subject|0|||
144271735|NCT00753519|520199557|FG001|Overall Study|Withdrawal by Subject|2|||
144271736|NCT00959751|520199558|FG000|Overall Study|Lost to Follow-up|2|||
144271737|NCT00959751|520199559|FG001|Overall Study|Lost to Follow-up|3|||
144271738|NCT00959751|520199558|FG000|Overall Study|Consent Withdrawn|0|||
144271739|NCT00959751|520199559|FG001|Overall Study|Consent Withdrawn|1|||
144271740|NCT00959751|520199558|FG000|Overall Study|Non-compliance to Study Procedures|0|||
144271741|NCT00959751|520199559|FG001|Overall Study|Non-compliance to Study Procedures|1|||
144271742|NCT00959751|520199558|FG000|Overall Study|No migraine headache without aura|7|||
144271743|NCT00959751|520199559|FG001|Overall Study|No migraine headache without aura|7|||
144271744|NCT03255187|520199560|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
144271745|NCT03255187|520199561|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
144271746|NCT03255187|520199560|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
144271747|NCT03255187|520199561|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
144271748|NCT01898078|520199564|FG000|Overall Study|Progressive Disease|1|||
144271749|NCT01898078|520199565|FG001|Overall Study|Progressive Disease|5|||
144271750|NCT01898078|520199564|FG000|Overall Study|Adverse Event|2|||
144271751|NCT01898078|520199565|FG001|Overall Study|Adverse Event|1|||
144271752|NCT01898078|520199564|FG000|Overall Study|Withdrawal by Subject|1|||
144271753|NCT01898078|520199565|FG001|Overall Study|Withdrawal by Subject|1|||
144271754|NCT01898078|520199564|FG000|Overall Study|Symptomatic Deterioration|2|||
144271755|NCT01898078|520199565|FG001|Overall Study|Symptomatic Deterioration|0|||
144271756|NCT01898078|520199564|FG000|Overall Study|Reason not Specified|0|||
144271757|NCT01898078|520199565|FG001|Overall Study|Reason not Specified|1|||
144271758|NCT00296244|520199570|FG000|Overall Study|Underwent retransplant|0|||
144271759|NCT00296244|520199571|FG001|Overall Study|Underwent retransplant|1|||
144271760|NCT03617588|520199572|FG000|Overall Study|Withdrawal by Subject|1|||
144271761|NCT03617588|520199573|FG001|Overall Study|Withdrawal by Subject|0|||
144271762|NCT03157089|520199574|FG000|Overall Study|Treated only with pembrolizumab|1|||
144271763|NCT03157089|520199575|FG001|Overall Study|Treated only with pembrolizumab|0|||
144271764|NCT03157089|520199574|FG000|Overall Study|Adverse Event|5|||
144271765|NCT03157089|520199575|FG001|Overall Study|Adverse Event|4|||
144271766|NCT03157089|520199574|FG000|Overall Study|Progressive disease|6|||
144271767|NCT03157089|520199575|FG001|Overall Study|Progressive disease|8|||
144271768|NCT00977197|520199580|FG000|Overall Study|Withdrawal by Subject|3|||
144271769|NCT00977197|520199581|FG001|Overall Study|Withdrawal by Subject|4|||
144271770|NCT00977197|520199580|FG000|Overall Study|Adverse Event|3|||
144271771|NCT00977197|520199581|FG001|Overall Study|Adverse Event|1|||
144271772|NCT00977197|520199580|FG000|Overall Study|Lack of Efficacy|1|||
144271773|NCT00977197|520199581|FG001|Overall Study|Lack of Efficacy|0|||
144271774|NCT00977197|520199580|FG000|Overall Study|Lost to Follow-up|1|||
144271775|NCT00977197|520199581|FG001|Overall Study|Lost to Follow-up|3|||
144271776|NCT00977197|520199580|FG000|Overall Study|Nonadherence|1|||
144271777|NCT00977197|520199581|FG001|Overall Study|Nonadherence|1|||
144271778|NCT01432951|520199582|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
144271779|NCT00853385|520199583|FG000|Overall Study|Death|0|||
144271780|NCT00853385|520199584|FG001|Overall Study|Death|0|||
144271781|NCT00853385|520199585|FG002|Overall Study|Death|0|||
144271782|NCT00853385|520199586|FG003|Overall Study|Death|0|||
144271783|NCT00853385|520199587|FG004|Overall Study|Death|1|||
144271784|NCT00853385|520199583|FG000|Overall Study|Adverse Event|24|||
144271785|NCT00853385|520199584|FG001|Overall Study|Adverse Event|24|||
144271786|NCT00853385|520199585|FG002|Overall Study|Adverse Event|2|||
144271787|NCT00853385|520199586|FG003|Overall Study|Adverse Event|5|||
144271788|NCT00853385|520199587|FG004|Overall Study|Adverse Event|22|||
144271789|NCT00853385|520199583|FG000|Overall Study|Lack of Efficacy|6|||
144271790|NCT00853385|520199584|FG001|Overall Study|Lack of Efficacy|7|||
144271791|NCT00853385|520199585|FG002|Overall Study|Lack of Efficacy|3|||
144271792|NCT00853385|520199586|FG003|Overall Study|Lack of Efficacy|3|||
144271793|NCT00853385|520199587|FG004|Overall Study|Lack of Efficacy|6|||
144271794|NCT00853385|520199583|FG000|Overall Study|Lost to Follow-up|2|||
144271795|NCT00853385|520199584|FG001|Overall Study|Lost to Follow-up|1|||
144242188|NCT04017832|520083971|FG000|Overall Study|Death|2|||
144242189|NCT04017832|520083972|FG001|Overall Study|Death|2|||
144242190|NCT04017832|520083973|FG002|Overall Study|Death|1|||
144242191|NCT04017832|520083974|FG003|Overall Study|Death|0|||
144242192|NCT01419080|520083977|FG000|Overall Study|Withdrawal by Subject|75|||
144242193|NCT01419080|520083977|FG000|Overall Study|Death|30|||
144242194|NCT01419080|520083977|FG000|Overall Study|Lost to Follow-up|23|||
144242195|NCT01419080|520083977|FG000|Overall Study|Too Ill|3|||
144242196|NCT02375555|520083980|FG000|Induction Period|Adverse Event|7|||
144242197|NCT02375555|520083980|FG000|Induction Period|Withdrawal by Subject|2|||
144242198|NCT02375555|520083980|FG000|Induction Period|Other|1|||
144242199|NCT02375555|520083980|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
144242200|NCT02375555|520083980|FG000|Maintenance Period|Adverse Event|2|||
144242201|NCT02375555|520083980|FG000|Maintenance Period|Withdrawal by Subject|4|||
144242202|NCT02375555|520083980|FG000|Maintenance Period|Death|1|||
144242203|NCT02375555|520083980|FG000|Maintenance Period|Disease Progression|5|||
144242204|NCT02375555|520083980|FG000|Maintenance Period|Patient Non-compliance|1|||
144242205|NCT02375555|520083980|FG000|Maintenance Period|Still on maintenance|16|||
144242206|NCT02548351|520083993|FG000|Overall Study|Withdrawal by Subject|149|||
144242207|NCT02548351|520083994|FG001|Overall Study|Withdrawal by Subject|154|||
144242208|NCT02548351|520083995|FG002|Overall Study|Withdrawal by Subject|152|||
144242209|NCT02548351|520083993|FG000|Overall Study|Death|11|||
144242210|NCT02548351|520083994|FG001|Overall Study|Death|15|||
144242211|NCT02548351|520083995|FG002|Overall Study|Death|12|||
144242212|NCT02548351|520083993|FG000|Overall Study|Adverse Event|22|||
144242213|NCT02548351|520083994|FG001|Overall Study|Adverse Event|56|||
144242214|NCT02548351|520083995|FG002|Overall Study|Adverse Event|36|||
144242215|NCT02548351|520083993|FG000|Overall Study|Study Terminated by Sponsor|549|||
144242216|NCT02548351|520083994|FG001|Overall Study|Study Terminated by Sponsor|509|||
144242217|NCT02548351|520083995|FG002|Overall Study|Study Terminated by Sponsor|528|||
144242218|NCT02548351|520083993|FG000|Overall Study|Site Closure|14|||
144242219|NCT02548351|520083994|FG001|Overall Study|Site Closure|5|||
144242220|NCT02548351|520083995|FG002|Overall Study|Site Closure|7|||
144242221|NCT02548351|520083993|FG000|Overall Study|Non-compliance with Study Drug|4|||
144242222|NCT02548351|520083994|FG001|Overall Study|Non-compliance with Study Drug|2|||
144242223|NCT02548351|520083995|FG002|Overall Study|Non-compliance with Study Drug|0|||
144242224|NCT02548351|520083993|FG000|Overall Study|Protocol Violation|2|||
144242225|NCT02548351|520083994|FG001|Overall Study|Protocol Violation|1|||
144242226|NCT02548351|520083995|FG002|Overall Study|Protocol Violation|2|||
144242227|NCT02548351|520083993|FG000|Overall Study|Physician Decision|11|||
144242228|NCT02548351|520083994|FG001|Overall Study|Physician Decision|18|||
144242229|NCT02548351|520083995|FG002|Overall Study|Physician Decision|11|||
144242230|NCT02548351|520083993|FG000|Overall Study|Lost to Follow-up|43|||
144242231|NCT02548351|520083994|FG001|Overall Study|Lost to Follow-up|50|||
144242232|NCT02548351|520083995|FG002|Overall Study|Lost to Follow-up|57|||
144242233|NCT02548351|520083993|FG000|Overall Study|Other|19|||
144242234|NCT02548351|520083994|FG001|Overall Study|Other|16|||
144242235|NCT02548351|520083995|FG002|Overall Study|Other|20|||
144242236|NCT02548351|520083993|FG000|Overall Study|Missing|1|||
144242237|NCT02548351|520083994|FG001|Overall Study|Missing|1|||
144242238|NCT02548351|520083995|FG002|Overall Study|Missing|0|||
144242239|NCT01744184|520083996|FG000|Overall Study|Adverse Event|1|||
144242240|NCT01744184|520083997|FG001|Overall Study|Adverse Event|0|||
144242241|NCT01744184|520083996|FG000|Overall Study|Withdrawal by Subject|0|||
144242242|NCT01744184|520083997|FG001|Overall Study|Withdrawal by Subject|1|||
144242243|NCT00125242|520084002|FG000|Overall Study|did not qualify|7|||
144242244|NCT00125242|520084003|FG001|Overall Study|did not qualify|2|||
144242245|NCT01664949|520084006|FG000|Overall Study|Adverse Event|11|||
144242246|NCT01664949|520084007|FG001|Overall Study|Adverse Event|12|||
144242247|NCT01664949|520084006|FG000|Overall Study|Lack of Efficacy|1|||
144242248|NCT01664949|520084007|FG001|Overall Study|Lack of Efficacy|1|||
144242249|NCT01664949|520084006|FG000|Overall Study|Lost to Follow-up|1|||
144242250|NCT01664949|520084007|FG001|Overall Study|Lost to Follow-up|2|||
144242251|NCT01664949|520084006|FG000|Overall Study|Personal Reasons|3|||
144242252|NCT01664949|520084007|FG001|Overall Study|Personal Reasons|4|||
144242253|NCT01664949|520084006|FG000|Overall Study|Protocol Violation|5|||
144242254|NCT01664949|520084007|FG001|Overall Study|Protocol Violation|5|||
144242255|NCT01664949|520084006|FG000|Overall Study|Other Miscellaneous Reasons|3|||
144242256|NCT01664949|520084007|FG001|Overall Study|Other Miscellaneous Reasons|1|||
144242257|NCT02537431|520084012|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
144242258|NCT00794040|520084013|FG000|Overall Study|Withdrawal by Subject|3|||
144242259|NCT00794040|520084014|FG001|Overall Study|Withdrawal by Subject|4|||
144242260|NCT00794040|520084013|FG000|Overall Study|Physician Decision|0|||
144242261|NCT00794040|520084014|FG001|Overall Study|Physician Decision|1|||
144242262|NCT01263782|520084015|FG000|Overall Study|Death|0|||
144242263|NCT01263782|520084016|FG001|Overall Study|Death|0|||
144242264|NCT01263782|520084017|FG002|Overall Study|Death|1|||
144242265|NCT01263782|520084018|FG003|Overall Study|Death|0|||
144242266|NCT01263782|520084015|FG000|Overall Study|Progressive disease|0|||
144271796|NCT00853385|520199585|FG002|Overall Study|Lost to Follow-up|0|||
144271797|NCT00853385|520199586|FG003|Overall Study|Lost to Follow-up|0|||
144271798|NCT00853385|520199587|FG004|Overall Study|Lost to Follow-up|0|||
144271799|NCT00853385|520199583|FG000|Overall Study|Withdrawal by Subject|4|||
144271800|NCT00853385|520199584|FG001|Overall Study|Withdrawal by Subject|2|||
144271801|NCT00853385|520199585|FG002|Overall Study|Withdrawal by Subject|0|||
144271802|NCT00853385|520199586|FG003|Overall Study|Withdrawal by Subject|1|||
144271803|NCT00853385|520199587|FG004|Overall Study|Withdrawal by Subject|1|||
144271804|NCT00853385|520199583|FG000|Overall Study|Other|18|||
144271805|NCT00853385|520199584|FG001|Overall Study|Other|9|||
144271806|NCT00853385|520199585|FG002|Overall Study|Other|4|||
144271807|NCT00853385|520199586|FG003|Overall Study|Other|4|||
144271808|NCT00853385|520199587|FG004|Overall Study|Other|12|||
144271809|NCT03248037|520199588|FG000|Overall Study|Withdrawal by Subject|6|||
144271810|NCT03248037|520199589|FG001|Overall Study|Withdrawal by Subject|9|||
144271811|NCT03248037|520199588|FG000|Overall Study|Adverse Event|15|||
144271812|NCT03248037|520199589|FG001|Overall Study|Adverse Event|0|||
144271813|NCT02765035|520199592|FG000|First Intervention (90 Days)|Adverse Event|1|||
144271814|NCT02765035|520199593|FG001|First Intervention (90 Days)|Adverse Event|1|||
144271815|NCT02765035|520199592|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
144271816|NCT02765035|520199593|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
144271817|NCT01259245|520199602|FG000|Overall Study|Withdrawal by Subject|27|||
144271818|NCT01259245|520199603|FG001|Overall Study|Withdrawal by Subject|24|||
144271819|NCT01259245|520199602|FG000|Overall Study|Death|1|||
144271820|NCT01259245|520199603|FG001|Overall Study|Death|2|||
144271821|NCT03451071|520199604|FG000|First Vaccine|Withdrawal by Subject|1|||
144271822|NCT03451071|520199604|FG000|Second Vaccine|Lost to Follow-up|19|||
144271823|NCT03451071|520199604|FG000|Third Vaccine|Lost to Follow-up|22|||
144271824|NCT03451071|520199604|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
144271825|NCT03363906|520199605|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
144271826|NCT03363906|520199606|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
144271827|NCT03363906|520199605|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
144271828|NCT03363906|520199606|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
144271829|NCT03363906|520199605|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
144271830|NCT03363906|520199606|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
144271831|NCT03363906|520199605|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
144271832|NCT03363906|520199606|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
144271833|NCT02065557|520199609|FG000|Induction Period|Withdrawal by Subject|2|||
144271834|NCT02065557|520199610|FG001|Induction Period|Withdrawal by Subject|1|||
144271835|NCT02065557|520199611|FG002|Induction Period|Withdrawal by Subject|0|||
144271836|NCT02065557|520199612|FG003|Induction Period|Withdrawal by Subject|0|||
144271837|NCT02065557|520199613|FG004|Induction Period|Withdrawal by Subject|0|||
144271838|NCT02065557|520199614|FG005|Induction Period|Withdrawal by Subject|0|||
144271839|NCT02065557|520199609|FG000|Induction Period|Lack of Efficacy|2|||
144271840|NCT02065557|520199610|FG001|Induction Period|Lack of Efficacy|1|||
144271841|NCT02065557|520199611|FG002|Induction Period|Lack of Efficacy|1|||
144271842|NCT02065557|520199612|FG003|Induction Period|Lack of Efficacy|0|||
144271843|NCT02065557|520199613|FG004|Induction Period|Lack of Efficacy|0|||
144271844|NCT02065557|520199614|FG005|Induction Period|Lack of Efficacy|0|||
144271845|NCT02065557|520199609|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
144271846|NCT02065557|520199610|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
144271847|NCT02065557|520199611|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
144271848|NCT02065557|520199612|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
144271849|NCT02065557|520199613|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
144271850|NCT02065557|520199614|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
144271851|NCT02065557|520199609|FG000|Induction Period|Non-Responder at Week 8|4|||
144271852|NCT02065557|520199610|FG001|Induction Period|Non-Responder at Week 8|4|||
144271853|NCT02065557|520199611|FG002|Induction Period|Non-Responder at Week 8|0|||
144271854|NCT02065557|520199612|FG003|Induction Period|Non-Responder at Week 8|0|||
144271855|NCT02065557|520199613|FG004|Induction Period|Non-Responder at Week 8|0|||
144271856|NCT02065557|520199614|FG005|Induction Period|Non-Responder at Week 8|0|||
144271857|NCT02065557|520199609|FG000|Induction Period|Adverse Event|1|||
144271858|NCT02065557|520199610|FG001|Induction Period|Adverse Event|1|||
144271859|NCT02065557|520199611|FG002|Induction Period|Adverse Event|0|||
144271860|NCT02065557|520199612|FG003|Induction Period|Adverse Event|0|||
144271861|NCT02065557|520199613|FG004|Induction Period|Adverse Event|0|||
144271862|NCT02065557|520199614|FG005|Induction Period|Adverse Event|0|||
144271863|NCT02065557|520199609|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
144271864|NCT02065557|520199610|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
144271865|NCT02065557|520199611|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
144271866|NCT02065557|520199612|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
144271867|NCT02065557|520199613|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
144271868|NCT02065557|520199614|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
144271869|NCT02065557|520199609|FG000|Maintenance Period|Withdrawal by Subject|0|||
144271870|NCT02065557|520199610|FG001|Maintenance Period|Withdrawal by Subject|0|||
144271871|NCT02065557|520199611|FG002|Maintenance Period|Withdrawal by Subject|0|||
144271872|NCT02065557|520199612|FG003|Maintenance Period|Withdrawal by Subject|0|||
144271873|NCT02065557|520199613|FG004|Maintenance Period|Withdrawal by Subject|2|||
144271874|NCT02065557|520199614|FG005|Maintenance Period|Withdrawal by Subject|1|||
144271875|NCT02065557|520199609|FG000|Maintenance Period|Lack of Efficacy|0|||
144271876|NCT02065557|520199610|FG001|Maintenance Period|Lack of Efficacy|0|||
144271877|NCT02065557|520199611|FG002|Maintenance Period|Lack of Efficacy|0|||
144271878|NCT02065557|520199612|FG003|Maintenance Period|Lack of Efficacy|0|||
144271879|NCT02065557|520199613|FG004|Maintenance Period|Lack of Efficacy|5|||
144271880|NCT02065557|520199614|FG005|Maintenance Period|Lack of Efficacy|2|||
144271881|NCT02065557|520199609|FG000|Maintenance Period|Subject Non-Compliance|0|||
144271882|NCT02065557|520199610|FG001|Maintenance Period|Subject Non-Compliance|0|||
144271883|NCT02065557|520199611|FG002|Maintenance Period|Subject Non-Compliance|0|||
144271884|NCT02065557|520199612|FG003|Maintenance Period|Subject Non-Compliance|0|||
144271885|NCT02065557|520199613|FG004|Maintenance Period|Subject Non-Compliance|0|||
144271886|NCT02065557|520199614|FG005|Maintenance Period|Subject Non-Compliance|1|||
144271887|NCT00706797|520199615|FG000|Overall Study|Lack of Efficacy|3|||
144271888|NCT00706797|520199616|FG001|Overall Study|Lack of Efficacy|0|||
144271889|NCT00706797|520199615|FG000|Overall Study|Adverse Event|0|||
144271890|NCT00706797|520199616|FG001|Overall Study|Adverse Event|3|||
144271891|NCT00706797|520199615|FG000|Overall Study|Withdrawal by Subject|8|||
144271892|NCT00706797|520199616|FG001|Overall Study|Withdrawal by Subject|1|||
144271893|NCT00706797|520199615|FG000|Overall Study|Death|1|||
144271894|NCT00706797|520199616|FG001|Overall Study|Death|0|||
144271895|NCT00706797|520199615|FG000|Overall Study|Discontinuation of study by sponsor|52|||
144271896|NCT00706797|520199616|FG001|Overall Study|Discontinuation of study by sponsor|63|||
144271897|NCT00706797|520199615|FG000|Overall Study|Protocol Violation|3|||
144271898|NCT00706797|520199616|FG001|Overall Study|Protocol Violation|2|||
144271899|NCT00706797|520199615|FG000|Overall Study|Lost to Follow-up|1|||
144271900|NCT00706797|520199616|FG001|Overall Study|Lost to Follow-up|2|||
144271901|NCT00706797|520199615|FG000|Overall Study|Other|1|||
144271902|NCT00706797|520199616|FG001|Overall Study|Other|0|||
144271903|NCT00368550|520199620|FG000|Overall Study|Adverse Event|7|||
144271904|NCT00368550|520199621|FG001|Overall Study|Adverse Event|4|||
144271905|NCT00368550|520199620|FG000|Overall Study|Lack of Efficacy|4|||
144271906|NCT00368550|520199621|FG001|Overall Study|Lack of Efficacy|9|||
144271907|NCT00368550|520199620|FG000|Overall Study|Withdrawal by Subject|17|||
144271908|NCT00368550|520199621|FG001|Overall Study|Withdrawal by Subject|10|||
144271909|NCT01206764|520199622|FG000|Overall Study|Adverse Event|20|||
144271910|NCT01206764|520199622|FG000|Overall Study|Abnormal laboratory value|2|||
144271911|NCT01206764|520199622|FG000|Overall Study|Abnormal test procedure result|1|||
144271912|NCT01206764|520199622|FG000|Overall Study|Patient withdrew consent|5|||
144271913|NCT01206764|520199622|FG000|Overall Study|Lost to Follow-up|6|||
144271914|NCT01206764|520199622|FG000|Overall Study|Death|11|||
144271915|NCT01206764|520199622|FG000|Overall Study|New cancer therapy|2|||
144271916|NCT01206764|520199622|FG000|Overall Study|Disease progression|88|||
144271917|NCT01206764|520199622|FG000|Overall Study|Protocol deviation|3|||
144271918|NCT00997893|520199623|FG000|Overall Study|Adverse Event|1|||
144271919|NCT00997893|520199624|FG001|Overall Study|Adverse Event|0|||
144271920|NCT00997893|520199625|FG002|Overall Study|Adverse Event|0|||
144271921|NCT00997893|520199623|FG000|Overall Study|Unable to meet study timelines|1|||
144271922|NCT00997893|520199624|FG001|Overall Study|Unable to meet study timelines|0|||
144271923|NCT00997893|520199625|FG002|Overall Study|Unable to meet study timelines|0|||
144271924|NCT00997893|520199623|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
144271925|NCT00997893|520199624|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
144271926|NCT00997893|520199625|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
144271927|NCT02309359|520199626|FG000|Overall Study|Adverse Event|4|||
144271928|NCT02309359|520199627|FG001|Overall Study|Adverse Event|5|||
144271929|NCT02309359|520199628|FG002|Overall Study|Adverse Event|5|||
144271930|NCT02309359|520199629|FG003|Overall Study|Adverse Event|4|||
144271931|NCT02309359|520199630|FG004|Overall Study|Adverse Event|4|||
144271932|NCT02309359|520199626|FG000|Overall Study|Death|1|||
144271933|NCT02309359|520199627|FG001|Overall Study|Death|0|||
144271934|NCT02309359|520199628|FG002|Overall Study|Death|0|||
144271935|NCT02309359|520199629|FG003|Overall Study|Death|0|||
144271936|NCT02309359|520199630|FG004|Overall Study|Death|0|||
144271937|NCT02309359|520199626|FG000|Overall Study|Withdrawal by Subject|2|||
144271938|NCT02309359|520199627|FG001|Overall Study|Withdrawal by Subject|2|||
144271939|NCT02309359|520199628|FG002|Overall Study|Withdrawal by Subject|4|||
144271940|NCT02309359|520199629|FG003|Overall Study|Withdrawal by Subject|4|||
144271941|NCT02309359|520199630|FG004|Overall Study|Withdrawal by Subject|0|||
144271942|NCT02309359|520199626|FG000|Overall Study|Lack of Efficacy|3|||
144271943|NCT02309359|520199627|FG001|Overall Study|Lack of Efficacy|1|||
144271944|NCT02309359|520199628|FG002|Overall Study|Lack of Efficacy|0|||
144271945|NCT02309359|520199629|FG003|Overall Study|Lack of Efficacy|0|||
144271946|NCT02309359|520199630|FG004|Overall Study|Lack of Efficacy|3|||
144271947|NCT02309359|520199626|FG000|Overall Study|Lost to Follow-up|0|||
144271948|NCT02309359|520199627|FG001|Overall Study|Lost to Follow-up|0|||
144271949|NCT02309359|520199628|FG002|Overall Study|Lost to Follow-up|0|||
144271950|NCT02309359|520199629|FG003|Overall Study|Lost to Follow-up|1|||
144271951|NCT02309359|520199630|FG004|Overall Study|Lost to Follow-up|0|||
144271952|NCT02309359|520199626|FG000|Overall Study|Other|2|||
144271953|NCT02309359|520199627|FG001|Overall Study|Other|0|||
144271954|NCT02309359|520199628|FG002|Overall Study|Other|2|||
144271955|NCT02309359|520199629|FG003|Overall Study|Other|3|||
144271956|NCT02309359|520199630|FG004|Overall Study|Other|2|||
144271957|NCT00701363|520199631|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
144271958|NCT00701363|520199632|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
144271959|NCT00701363|520199633|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
144271960|NCT00701363|520199634|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
144271961|NCT00701363|520199631|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
144271962|NCT00701363|520199632|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
144271963|NCT00701363|520199633|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
144271964|NCT00701363|520199634|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
144271965|NCT00701363|520199631|FG000|Treatment Phase 1|Adverse Event|7|||
144271966|NCT00701363|520199632|FG001|Treatment Phase 1|Adverse Event|0|||
144271967|NCT00701363|520199633|FG002|Treatment Phase 1|Adverse Event|0|||
144271968|NCT00701363|520199634|FG003|Treatment Phase 1|Adverse Event|0|||
144271969|NCT00701363|520199631|FG000|Treatment Phase 1|Protocol Violation|1|||
144271970|NCT00701363|520199632|FG001|Treatment Phase 1|Protocol Violation|0|||
144271971|NCT00701363|520199633|FG002|Treatment Phase 1|Protocol Violation|0|||
144271972|NCT00701363|520199634|FG003|Treatment Phase 1|Protocol Violation|0|||
144271973|NCT00701363|520199631|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
144271974|NCT00701363|520199632|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
144271975|NCT00701363|520199633|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
144271976|NCT00701363|520199634|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
144271977|NCT00701363|520199631|FG000|Treatment Phase 1|Lack of Efficacy|1|||
144271978|NCT00701363|520199632|FG001|Treatment Phase 1|Lack of Efficacy|0|||
144271979|NCT00701363|520199633|FG002|Treatment Phase 1|Lack of Efficacy|0|||
144271980|NCT00701363|520199634|FG003|Treatment Phase 1|Lack of Efficacy|0|||
144271981|NCT00701363|520199631|FG000|Treatment Phase 2|Adverse Event|0|||
144271982|NCT00701363|520199632|FG001|Treatment Phase 2|Adverse Event|0|||
144271983|NCT00701363|520199633|FG002|Treatment Phase 2|Adverse Event|1|||
144271984|NCT00701363|520199634|FG003|Treatment Phase 2|Adverse Event|0|||
144271985|NCT00701363|520199631|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
144271986|NCT00701363|520199632|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
144271987|NCT00701363|520199633|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
144271988|NCT00701363|520199634|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
144271989|NCT04759131|520199635|FG000|Overall Study|Investigator's discretion|1|||
144271990|NCT04759131|520199636|FG001|Overall Study|Investigator's discretion|0|||
144271991|NCT04759131|520199635|FG000|Overall Study|Subject withdrawal|1|||
144271992|NCT04759131|520199636|FG001|Overall Study|Subject withdrawal|0|||
144271993|NCT05144945|520199637|FG000|Overall Study|Withdrawal by Subject|1|||
144271994|NCT05144945|520199638|FG001|Overall Study|Withdrawal by Subject|0|||
144271995|NCT02592824|520199639|FG000|Overall Study|Protocol Violation|5|||
144271996|NCT02592824|520199640|FG001|Overall Study|Protocol Violation|3|||
144271997|NCT02592824|520199639|FG000|Overall Study|Lost to Follow-up|2|||
144271998|NCT02592824|520199640|FG001|Overall Study|Lost to Follow-up|1|||
144271999|NCT03040726|520199641|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
144272000|NCT03040726|520199642|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
144272001|NCT03040726|520199641|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
144272002|NCT03040726|520199642|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
144272003|NCT03040726|520199641|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
144272004|NCT03040726|520199642|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
144272005|NCT03040726|520199641|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
144272006|NCT03040726|520199642|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
144272007|NCT03040726|520199641|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
144272008|NCT03040726|520199642|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
144272009|NCT00465179|520199645|FG000|Overall Study|Adverse Event|4|||
144272010|NCT00465179|520199645|FG000|Overall Study|Withdrawal by Subject|2|||
144272011|NCT00465179|520199645|FG000|Overall Study|Progression of Disease|47|||
144272012|NCT00833755|520199648|FG000|Overall Study|Physician Decision|4|||
144272013|NCT00833755|520199649|FG001|Overall Study|Physician Decision|4|||
144272014|NCT00833755|520199650|FG002|Overall Study|Physician Decision|2|||
144272015|NCT00833755|520199651|FG003|Overall Study|Physician Decision|6|||
144272016|NCT00833755|520199648|FG000|Overall Study|Subject had scheduling issues|0|||
144272017|NCT00833755|520199649|FG001|Overall Study|Subject had scheduling issues|1|||
144272018|NCT00833755|520199650|FG002|Overall Study|Subject had scheduling issues|0|||
144272019|NCT00833755|520199651|FG003|Overall Study|Subject had scheduling issues|0|||
144272020|NCT00262925|520199652|FG000|Overall Study|Lack of Efficacy|3|||
144272021|NCT00262925|520199652|FG000|Overall Study|Adverse Event|4|||
144272022|NCT00262925|520199652|FG000|Overall Study|Death|2|||
144272023|NCT00262925|520199652|FG000|Overall Study|alternative therapy|1|||
144272024|NCT00262925|520199652|FG000|Overall Study|Other|1|||
144272025|NCT04682301|520199653|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
144272026|NCT04682301|520199653|FG000|Overall Study|Death|2|||
144272027|NCT05219162|520199654|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
144272028|NCT05219162|520199654|FG000|Overall Study|Withdrawal by Subject|23|||
144272029|NCT02187783|520199663|FG000|Overall Study|Adverse Event|8|||
144272030|NCT02187783|520199663|FG000|Overall Study|Death|3|||
144272031|NCT02187783|520199663|FG000|Overall Study|Progressive disease|80|||
144272032|NCT02187783|520199663|FG000|Overall Study|Protocol Violation|3|||
144272033|NCT02187783|520199663|FG000|Overall Study|Physician Decision|2|||
144272034|NCT02187783|520199663|FG000|Overall Study|Withdrawal by Subject|9|||
144272035|NCT02187783|520199663|FG000|Overall Study|Study terminated by sponsor|1|||
144272036|NCT03344757|520199664|FG000|Overall Study|Withdrawal by Subject|18|||
144272037|NCT03344757|520199665|FG001|Overall Study|Withdrawal by Subject|16|||
144272038|NCT03344757|520199664|FG000|Overall Study|Lost to Follow-up|0|||
144272039|NCT03344757|520199665|FG001|Overall Study|Lost to Follow-up|2|||
144272040|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
144272041|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
144272042|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272043|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272044|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272045|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272046|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272047|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272048|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272049|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
144272050|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
144272051|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
144272052|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272053|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272054|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272055|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272056|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272057|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272058|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272059|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
144272060|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
144272061|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272062|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272063|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272064|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272065|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272066|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272067|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272068|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272069|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
144272070|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
144272071|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
144272072|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272073|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272074|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272075|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272076|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272077|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272078|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272079|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
144272080|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
144272081|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
144272082|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272083|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272084|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272085|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272086|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272087|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272088|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272089|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
144272090|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
144272091|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
144272092|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272093|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272094|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272095|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272096|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272097|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272098|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272099|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
144272100|NCT01232283|520199668|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
144272101|NCT01232283|520199669|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
144272102|NCT01232283|520199670|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272103|NCT01232283|520199671|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272104|NCT01232283|520199672|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272105|NCT01232283|520199673|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272106|NCT01232283|520199674|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272107|NCT01232283|520199675|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272108|NCT01232283|520199676|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272109|NCT01232283|520199677|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
144272110|NCT01232283|520199668|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272111|NCT01232283|520199669|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272112|NCT01232283|520199670|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
144272113|NCT01232283|520199671|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
144272114|NCT01232283|520199672|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272115|NCT01232283|520199673|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272116|NCT01232283|520199674|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272117|NCT01232283|520199675|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272118|NCT01232283|520199676|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272119|NCT01232283|520199677|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
144272120|NCT01232283|520199668|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272121|NCT01232283|520199669|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272122|NCT01232283|520199670|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
144272123|NCT01232283|520199671|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
144272124|NCT01232283|520199672|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272125|NCT01232283|520199673|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272126|NCT01232283|520199674|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272127|NCT01232283|520199675|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272128|NCT01232283|520199676|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272129|NCT01232283|520199677|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
144272130|NCT01232283|520199668|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272131|NCT01232283|520199669|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272132|NCT01232283|520199670|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
144272133|NCT01232283|520199671|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272134|NCT01232283|520199672|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272135|NCT01232283|520199673|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272136|NCT01232283|520199674|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272137|NCT01232283|520199675|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272138|NCT01232283|520199676|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272139|NCT01232283|520199677|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
144272140|NCT01232283|520199668|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272141|NCT01232283|520199669|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272142|NCT01232283|520199670|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
144272143|NCT01232283|520199671|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
144272144|NCT01232283|520199672|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272145|NCT01232283|520199673|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272146|NCT01232283|520199674|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272147|NCT01232283|520199675|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272148|NCT01232283|520199676|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272149|NCT01232283|520199677|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
144272150|NCT01232283|520199668|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272151|NCT01232283|520199669|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272152|NCT01232283|520199670|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
144272153|NCT01232283|520199671|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
144272154|NCT01232283|520199672|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272155|NCT01232283|520199673|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272156|NCT01232283|520199674|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272157|NCT01232283|520199675|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272158|NCT01232283|520199676|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272159|NCT01232283|520199677|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
144272160|NCT01232283|520199668|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
144272161|NCT01232283|520199669|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
144272162|NCT01232283|520199670|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
144272163|NCT01232283|520199671|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
144272164|NCT01232283|520199672|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
144272165|NCT01232283|520199673|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
144272166|NCT01232283|520199674|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
144272167|NCT01232283|520199675|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
144272168|NCT01232283|520199676|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
144272169|NCT01232283|520199677|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
144272170|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272171|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272172|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272173|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272174|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
144272175|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
144272176|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272177|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
144272178|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272179|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
144272180|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272181|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272182|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272183|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272184|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
144272185|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272186|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
144272187|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
144272188|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272189|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
144272190|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
144272191|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
144272192|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
144272193|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
144272194|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
144272195|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
144272196|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
144272197|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
144272198|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
144272199|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
144272200|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272201|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272202|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272203|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272204|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
144272205|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272206|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272207|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272208|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272209|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
144272210|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272211|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272212|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272213|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272214|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
144272215|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272216|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
144272217|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
144272218|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272219|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
144272220|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272221|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272222|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272223|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272224|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272225|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272226|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272227|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
144272228|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272229|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
144272230|NCT01232283|520199668|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272231|NCT01232283|520199669|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272232|NCT01232283|520199670|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272233|NCT01232283|520199671|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272234|NCT01232283|520199672|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272235|NCT01232283|520199673|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
144272236|NCT01232283|520199674|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272237|NCT01232283|520199675|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272238|NCT01232283|520199676|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272239|NCT01232283|520199677|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
144272240|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272241|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272242|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272243|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272244|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272245|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272246|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272247|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
144272248|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
144272249|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
144272250|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272251|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272252|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272253|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272254|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272255|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272256|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272257|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
144272258|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
144272259|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
144272260|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272261|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272262|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272263|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272264|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272265|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272266|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272267|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
144272268|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
144272269|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
144272270|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272271|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272272|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272273|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272274|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272275|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272276|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272277|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
144272278|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
144272279|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
144272280|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272281|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272282|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272283|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272284|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272285|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272286|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272287|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
144272288|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
144272289|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
144272290|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272291|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272292|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272293|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272294|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272295|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272296|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272297|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272298|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
144272299|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
144272300|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272301|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272302|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272303|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272304|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272305|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272306|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272307|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272308|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
144272309|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
144272310|NCT01232283|520199668|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272311|NCT01232283|520199669|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272312|NCT01232283|520199670|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272313|NCT01232283|520199671|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272314|NCT01232283|520199672|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272315|NCT01232283|520199673|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272316|NCT01232283|520199674|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272317|NCT01232283|520199675|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
144272318|NCT01232283|520199676|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
144272319|NCT01232283|520199677|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
144272320|NCT00402831|520199678|FG000|Overall Study|Lost to Follow-up|1|||
144272321|NCT00402831|520199679|FG001|Overall Study|Lost to Follow-up|2|||
144272322|NCT00402831|520199678|FG000|Overall Study|Non-compliance with protocol|0|||
144272323|NCT00402831|520199679|FG001|Overall Study|Non-compliance with protocol|1|||
144272324|NCT00671788|520199682|FG000|Overall Study|Adverse Event|8|||
144272325|NCT00671788|520199682|FG000|Overall Study|Refused further treatment|3|||
144272326|NCT00671788|520199682|FG000|Overall Study|Ineligible|1|||
144272327|NCT00671788|520199682|FG000|Overall Study|MD Decision|1|||
144272328|NCT00671788|520199682|FG000|Overall Study|Other|1|||
144272329|NCT02792504|520199685|FG000|Overall Study|Lost to Follow-up|24|||
144272330|NCT02792504|520199685|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
144272331|NCT01035138|520199692|FG000|Overall Study|Adverse Event|4|||
144272332|NCT01035138|520199693|FG001|Overall Study|Adverse Event|0|||
144272333|NCT01035138|520199694|FG002|Overall Study|Adverse Event|2|||
144272334|NCT01035138|520199692|FG000|Overall Study|Caregiver Decision|2|||
144272335|NCT01035138|520199693|FG001|Overall Study|Caregiver Decision|0|||
144272336|NCT01035138|520199694|FG002|Overall Study|Caregiver Decision|1|||
144272337|NCT01035138|520199692|FG000|Overall Study|Withdrawal by Subject|1|||
144272338|NCT01035138|520199693|FG001|Overall Study|Withdrawal by Subject|0|||
144272339|NCT01035138|520199694|FG002|Overall Study|Withdrawal by Subject|0|||
144272340|NCT01035138|520199692|FG000|Overall Study|Physician Decision|0|||
144272341|NCT01035138|520199693|FG001|Overall Study|Physician Decision|0|||
144272342|NCT01035138|520199694|FG002|Overall Study|Physician Decision|1|||
144272343|NCT01035138|520199692|FG000|Overall Study|Sponsor Decision|66|||
144272344|NCT01035138|520199693|FG001|Overall Study|Sponsor Decision|60|||
144272345|NCT01035138|520199694|FG002|Overall Study|Sponsor Decision|42|||
144272346|NCT01035138|520199692|FG000|Overall Study|Lost to Follow-up|0|||
144272347|NCT01035138|520199693|FG001|Overall Study|Lost to Follow-up|0|||
144272348|NCT01035138|520199694|FG002|Overall Study|Lost to Follow-up|1|||
144272349|NCT00848497|520199695|FG000|Overall Study|Screen failure|2|||
144272350|NCT00848497|520199696|FG001|Overall Study|Screen failure|0|||
144272351|NCT00848497|520199695|FG000|Overall Study|Withdrawal by Subject|0|||
144272352|NCT00848497|520199696|FG001|Overall Study|Withdrawal by Subject|1|||
144272353|NCT01832766|520199697|FG000|Washout|Lost to Follow-up|0|||
144272354|NCT01832766|520199698|FG001|Washout|Lost to Follow-up|1|||
144272355|NCT01114724|520199701|FG000|Overall Study|Death|8|||
144272356|NCT01114724|520199701|FG000|Overall Study|Lost to Follow-up|1|||
144272357|NCT01114724|520199701|FG000|Overall Study|Withdrawal by Subject|1|||
144272358|NCT04711005|520199711|FG000|Overall Study|Withdrawal by Subject|0|||
144272359|NCT04711005|520199712|FG001|Overall Study|Withdrawal by Subject|0|||
144272360|NCT04711005|520199713|FG002|Overall Study|Withdrawal by Subject|0|||
144272361|NCT04711005|520199714|FG003|Overall Study|Withdrawal by Subject|0|||
144272362|NCT04711005|520199715|FG004|Overall Study|Withdrawal by Subject|0|||
144272363|NCT04711005|520199716|FG005|Overall Study|Withdrawal by Subject|0|||
144272364|NCT04711005|520199717|FG006|Overall Study|Withdrawal by Subject|0|||
144272365|NCT04711005|520199718|FG007|Overall Study|Withdrawal by Subject|1|||
144272366|NCT04711005|520199719|FG008|Overall Study|Withdrawal by Subject|0|||
144272367|NCT04711005|520199720|FG009|Overall Study|Withdrawal by Subject|0|||
144272368|NCT04711005|520199711|FG000|Overall Study|Physician Decision|0|||
144272369|NCT04711005|520199712|FG001|Overall Study|Physician Decision|0|||
144272370|NCT04711005|520199713|FG002|Overall Study|Physician Decision|0|||
144272371|NCT04711005|520199714|FG003|Overall Study|Physician Decision|0|||
144272372|NCT04711005|520199715|FG004|Overall Study|Physician Decision|0|||
144272373|NCT04711005|520199716|FG005|Overall Study|Physician Decision|0|||
144272374|NCT04711005|520199717|FG006|Overall Study|Physician Decision|0|||
144272375|NCT04711005|520199718|FG007|Overall Study|Physician Decision|2|||
144272376|NCT04711005|520199719|FG008|Overall Study|Physician Decision|1|||
144272377|NCT04711005|520199720|FG009|Overall Study|Physician Decision|0|||
144272378|NCT03415178|520199728|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
144272379|NCT03415178|520199729|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
144272380|NCT03415178|520199728|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
144272381|NCT03415178|520199729|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
144272382|NCT02781324|520199730|FG000|Overall Study|Withdrawal by Subject|1|||
144272383|NCT02781324|520199731|FG001|Overall Study|Withdrawal by Subject|0|||
144272384|NCT02781324|520199730|FG000|Overall Study|Physician Decision|1|||
144272385|NCT02781324|520199731|FG001|Overall Study|Physician Decision|2|||
144272386|NCT01171534|520201406|FG000|Overall Study|Lost to Follow-up|0|||
144272387|NCT01171534|520201407|FG001|Overall Study|Lost to Follow-up|2|||
144272388|NCT01171534|520201406|FG000|Overall Study|screen failure|0|||
144272389|NCT01171534|520201407|FG001|Overall Study|screen failure|1|||
144272390|NCT03861039|520201408|FG000|Overall Study|Adverse Event|2|||
144272391|NCT03861039|520201409|FG001|Overall Study|Adverse Event|5|||
144272392|NCT03861039|520201410|FG002|Overall Study|Adverse Event|11|||
144272393|NCT03861039|520201408|FG000|Overall Study|Withdrawal by Subject|1|||
144272394|NCT03861039|520201409|FG001|Overall Study|Withdrawal by Subject|3|||
144272395|NCT03861039|520201410|FG002|Overall Study|Withdrawal by Subject|4|||
144272396|NCT01113749|520201411|FG000|Overall Study|Lost to Follow-up|1|||
144272397|NCT01113749|520201412|FG001|Overall Study|Lost to Follow-up|2|||
144272398|NCT03427892|520201414|FG000|Overall Study|Lost to Follow-up|2|||
144272399|NCT00548327|520201415|FG000|Overall Study|Adverse Event|0|||
144272400|NCT00548327|520201416|FG001|Overall Study|Adverse Event|1|||
144272401|NCT01673386|520201417|FG000|Overall Study|Study terminated by sponsor|16|||
144272402|NCT01673386|520201418|FG001|Overall Study|Study terminated by sponsor|22|||
144272403|NCT01673386|520201417|FG000|Overall Study|Adverse Event|5|||
144272404|NCT01673386|520201418|FG001|Overall Study|Adverse Event|2|||
144272405|NCT01673386|520201417|FG000|Overall Study|Progressive disease|4|||
144272406|NCT01673386|520201418|FG001|Overall Study|Progressive disease|1|||
144272407|NCT01673386|520201417|FG000|Overall Study|Withdrawal by Subject|0|||
144272408|NCT01673386|520201418|FG001|Overall Study|Withdrawal by Subject|2|||
144272409|NCT00109343|520201419|FG000|Overall Study|Adverse Event|1|||
144272410|NCT00109343|520201420|FG001|Overall Study|Adverse Event|0|||
144272411|NCT00109343|520201421|FG002|Overall Study|Adverse Event|2|||
144272412|NCT00109343|520201419|FG000|Overall Study|Lack of Efficacy|1|||
144272413|NCT00109343|520201420|FG001|Overall Study|Lack of Efficacy|0|||
144272414|NCT00109343|520201421|FG002|Overall Study|Lack of Efficacy|0|||
144272415|NCT00109343|520201419|FG000|Overall Study|Lost to Follow-up|35|||
144272416|NCT00109343|520201420|FG001|Overall Study|Lost to Follow-up|20|||
144272417|NCT00109343|520201421|FG002|Overall Study|Lost to Follow-up|14|||
144272418|NCT00109343|520201419|FG000|Overall Study|Protocol Violation|1|||
144272419|NCT00109343|520201420|FG001|Overall Study|Protocol Violation|2|||
144272420|NCT00109343|520201421|FG002|Overall Study|Protocol Violation|2|||
144272421|NCT00109343|520201419|FG000|Overall Study|Withdrawal by Subject|15|||
144272422|NCT00109343|520201420|FG001|Overall Study|Withdrawal by Subject|11|||
144272423|NCT00109343|520201421|FG002|Overall Study|Withdrawal by Subject|10|||
144272424|NCT00109343|520201419|FG000|Overall Study|Subject Moved|6|||
144272425|NCT00109343|520201420|FG001|Overall Study|Subject Moved|2|||
144272426|NCT00109343|520201421|FG002|Overall Study|Subject Moved|1|||
144272427|NCT00109343|520201419|FG000|Overall Study|Other|5|||
144272428|NCT00109343|520201420|FG001|Overall Study|Other|2|||
144272429|NCT00109343|520201421|FG002|Overall Study|Other|1|||
144272430|NCT02100631|520201422|FG000|Overall Study|Withdrawal by Subject|1|||
144272431|NCT02100631|520201423|FG001|Overall Study|Withdrawal by Subject|0|||
144272432|NCT02100631|520201424|FG002|Overall Study|Withdrawal by Subject|0|||
144272433|NCT02100631|520201422|FG000|Overall Study|Lost to Follow-up|3|||
144272434|NCT02100631|520201423|FG001|Overall Study|Lost to Follow-up|4|||
144272435|NCT02100631|520201424|FG002|Overall Study|Lost to Follow-up|0|||
144272436|NCT02100631|520201422|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
144242267|NCT01263782|520084016|FG001|Overall Study|Progressive disease|0|||
144242268|NCT01263782|520084017|FG002|Overall Study|Progressive disease|0|||
144242269|NCT01263782|520084018|FG003|Overall Study|Progressive disease|1|||
144242270|NCT01263782|520084015|FG000|Overall Study|Too early|0|||
144242271|NCT01263782|520084016|FG001|Overall Study|Too early|0|||
144242272|NCT01263782|520084017|FG002|Overall Study|Too early|1|||
144242273|NCT01263782|520084018|FG003|Overall Study|Too early|0|||
144242274|NCT01263782|520084015|FG000|Overall Study|Inevaluable|0|||
144242275|NCT01263782|520084016|FG001|Overall Study|Inevaluable|0|||
144242276|NCT01263782|520084017|FG002|Overall Study|Inevaluable|1|||
144242277|NCT01263782|520084018|FG003|Overall Study|Inevaluable|0|||
144242278|NCT02419612|520084020|FG000|Short-term Treatment Period|Adverse Event|1|||
144242279|NCT02419612|520084021|FG001|Short-term Treatment Period|Adverse Event|1|||
144242280|NCT02419612|520084020|FG000|Short-term Treatment Period|Death|0|||
144242281|NCT02419612|520084021|FG001|Short-term Treatment Period|Death|2|||
144242282|NCT02419612|520084020|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
144242283|NCT02419612|520084021|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
144242284|NCT02419612|520084020|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
144242285|NCT02419612|520084021|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
144242286|NCT02419612|520084020|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
144242287|NCT02419612|520084021|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
144242288|NCT02419612|520084020|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
144242289|NCT02419612|520084021|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
144242290|NCT02419612|520084020|FG000|Short-term Treatment Period|Worsening of liver function|0|||
144242291|NCT02419612|520084021|FG001|Short-term Treatment Period|Worsening of liver function|1|||
144242292|NCT02419612|520084020|FG000|Short-term Treatment Period|Subject moved out of state|0|||
144242293|NCT02419612|520084021|FG001|Short-term Treatment Period|Subject moved out of state|1|||
144242294|NCT02419612|520084020|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
144242295|NCT02419612|520084021|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
144242296|NCT02419612|520084020|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
144242297|NCT02419612|520084021|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
144242298|NCT02419612|520084020|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
144242299|NCT02419612|520084021|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
144242300|NCT02419612|520084020|FG000|Long-term Treatment Period|Death|0|||
144242301|NCT02419612|520084021|FG001|Long-term Treatment Period|Death|1|||
144242302|NCT02419612|520084020|FG000|Long-term Treatment Period|Adverse Event|0|||
144242303|NCT02419612|520084021|FG001|Long-term Treatment Period|Adverse Event|5|||
144242304|NCT02419612|520084020|FG000|Long-term Treatment Period|Other|4|||
144242305|NCT02419612|520084021|FG001|Long-term Treatment Period|Other|4|||
144242306|NCT02419612|520084020|FG000|Long-term Treatment Period|Subject Decision|2|||
144242307|NCT02419612|520084021|FG001|Long-term Treatment Period|Subject Decision|4|||
144242308|NCT02419612|520084020|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
144242309|NCT02419612|520084021|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
144242310|NCT03626363|520084022|FG000|Overall Study|Protocol Violation|4|||
144242311|NCT03626363|520084023|FG001|Overall Study|Protocol Violation|0|||
144242312|NCT03626363|520084022|FG000|Overall Study|Lost to Follow-up|5|||
144242313|NCT03626363|520084023|FG001|Overall Study|Lost to Follow-up|7|||
144242314|NCT00533702|520084024|FG000|Overall Study|Withdrawal by Subject|3|||
144242315|NCT00533702|520084025|FG001|Overall Study|Withdrawal by Subject|1|||
144242316|NCT00533702|520084024|FG000|Overall Study|Found ineligible after randomization|2|||
144242317|NCT00533702|520084025|FG001|Overall Study|Found ineligible after randomization|1|||
144242318|NCT01095978|520084026|FG000|Overall Study|Did not take Klacid SR|2|||
144242319|NCT01095978|520084026|FG000|Overall Study|Adverse Event|1|||
144242320|NCT01294696|520084032|FG000|Overall Study|Screening failures|7|||
144242321|NCT01294696|520084032|FG000|Overall Study|Protocol Violation|8|||
144242322|NCT01294696|520084032|FG000|Overall Study|Missing BPI Response|7|||
144242323|NCT01294696|520084032|FG000|Overall Study|Site closure|52|||
144242324|NCT02417961|520085804|FG000|Overall Study|Adverse Event|1|||
144242325|NCT02417961|520085804|FG000|Overall Study|Lost to Follow-up|1|||
144242326|NCT02417961|520085804|FG000|Overall Study|Withdrawal by Subject|2|||
144242327|NCT05079750|520085805|FG000|Overall Study|Lost to Follow-up|0|||
144242328|NCT05079750|520085806|FG001|Overall Study|Lost to Follow-up|0|||
144242329|NCT05079750|520085807|FG002|Overall Study|Lost to Follow-up|1|||
144242330|NCT05091346|520085808|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
144242331|NCT05091346|520085809|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
144242332|NCT05091346|520085810|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
144242333|NCT05091346|520085811|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
144242334|NCT05091346|520085812|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
144242335|NCT05091346|520085808|FG000|Overall Study|Death|6|||
144242336|NCT05091346|520085809|FG001|Overall Study|Death|5|||
144242337|NCT05091346|520085810|FG002|Overall Study|Death|8|||
144242338|NCT05091346|520085811|FG003|Overall Study|Death|16|||
144242339|NCT05091346|520085812|FG004|Overall Study|Death|26|||
144272437|NCT02100631|520201423|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
144272438|NCT02100631|520201424|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
144272439|NCT03944616|520201425|FG000|Overall Study|Lost to Follow-up|0|||
144272440|NCT03944616|520201426|FG001|Overall Study|Lost to Follow-up|2|||
144272441|NCT01287936|520201427|FG000|Overall Study|Lost to Follow-up|0|||
144272442|NCT01287936|520201428|FG001|Overall Study|Lost to Follow-up|1|||
144272443|NCT01287936|520201429|FG002|Overall Study|Lost to Follow-up|1|||
144272444|NCT01721798|520201430|FG000|Overall Study|Death|0|||
144272445|NCT01721798|520201431|FG001|Overall Study|Death|0|||
144272446|NCT01721798|520201432|FG002|Overall Study|Death|1|||
144272447|NCT01721798|520201433|FG003|Overall Study|Death|1|||
144272448|NCT01721798|520201430|FG000|Overall Study|Lost to Follow-up|2|||
144272449|NCT01721798|520201431|FG001|Overall Study|Lost to Follow-up|2|||
144272450|NCT01721798|520201432|FG002|Overall Study|Lost to Follow-up|9|||
144272451|NCT01721798|520201433|FG003|Overall Study|Lost to Follow-up|9|||
144272452|NCT01721798|520201430|FG000|Overall Study|Pregnancy|0|||
144272453|NCT01721798|520201431|FG001|Overall Study|Pregnancy|0|||
144272454|NCT01721798|520201432|FG002|Overall Study|Pregnancy|1|||
144272455|NCT01721798|520201433|FG003|Overall Study|Pregnancy|1|||
144272456|NCT01721798|520201430|FG000|Overall Study|Withdrawal by Subject|1|||
144272457|NCT01721798|520201431|FG001|Overall Study|Withdrawal by Subject|0|||
144272458|NCT01721798|520201432|FG002|Overall Study|Withdrawal by Subject|2|||
144272459|NCT01721798|520201433|FG003|Overall Study|Withdrawal by Subject|1|||
144272460|NCT01721798|520201430|FG000|Overall Study|Not eligible for 24 month visit|1|||
144272461|NCT01721798|520201431|FG001|Overall Study|Not eligible for 24 month visit|0|||
144272462|NCT01721798|520201432|FG002|Overall Study|Not eligible for 24 month visit|8|||
144272463|NCT01721798|520201433|FG003|Overall Study|Not eligible for 24 month visit|7|||
144272464|NCT00703534|520201434|FG000|Overall Study|Adverse Event|14|||
144272465|NCT00703534|520201435|FG001|Overall Study|Adverse Event|3|||
144272466|NCT00703534|520201434|FG000|Overall Study|Withdrawal by Subject|8|||
144272467|NCT00703534|520201435|FG001|Overall Study|Withdrawal by Subject|7|||
144272468|NCT00703534|520201434|FG000|Overall Study|Incorrect Enrollment|6|||
144272469|NCT00703534|520201435|FG001|Overall Study|Incorrect Enrollment|6|||
144272470|NCT00703534|520201434|FG000|Overall Study|Lost to Follow-up|1|||
144272471|NCT00703534|520201435|FG001|Overall Study|Lost to Follow-up|4|||
144272472|NCT00703534|520201434|FG000|Overall Study|Severe Non Compliance|1|||
144272473|NCT00703534|520201435|FG001|Overall Study|Severe Non Compliance|5|||
144272474|NCT00427934|520201436|FG000|Overall Study|Adverse Event|1|||
144272475|NCT00427934|520201437|FG001|Overall Study|Adverse Event|0|||
144272476|NCT00427934|520201438|FG002|Overall Study|Adverse Event|5|||
144272477|NCT00427934|520201439|FG003|Overall Study|Adverse Event|4|||
144272478|NCT00427934|520201436|FG000|Overall Study|Lack of Efficacy|0|||
144272479|NCT00427934|520201437|FG001|Overall Study|Lack of Efficacy|0|||
144272480|NCT00427934|520201438|FG002|Overall Study|Lack of Efficacy|5|||
144272481|NCT00427934|520201439|FG003|Overall Study|Lack of Efficacy|2|||
144272482|NCT00427934|520201436|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
144272483|NCT00427934|520201437|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
144272484|NCT00427934|520201438|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
144272485|NCT00427934|520201439|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
144272486|NCT00427934|520201436|FG000|Overall Study|Other|0|||
144272487|NCT00427934|520201437|FG001|Overall Study|Other|0|||
144272488|NCT00427934|520201438|FG002|Overall Study|Other|11|||
144272489|NCT00427934|520201439|FG003|Overall Study|Other|5|||
144272490|NCT00427934|520201436|FG000|Overall Study|Withdrawal by Subject|0|||
144272491|NCT00427934|520201437|FG001|Overall Study|Withdrawal by Subject|0|||
144272492|NCT00427934|520201438|FG002|Overall Study|Withdrawal by Subject|1|||
144272493|NCT00427934|520201439|FG003|Overall Study|Withdrawal by Subject|3|||
144272494|NCT01649765|520201440|FG000|Overall Study|Adverse Event|5|||
144272495|NCT01649765|520201441|FG001|Overall Study|Adverse Event|3|||
144272496|NCT01649765|520201440|FG000|Overall Study|Lack of Efficacy|1|||
144272497|NCT01649765|520201441|FG001|Overall Study|Lack of Efficacy|1|||
144272498|NCT01649765|520201440|FG000|Overall Study|Physician Decision|0|||
144272499|NCT01649765|520201441|FG001|Overall Study|Physician Decision|3|||
144272500|NCT01649765|520201440|FG000|Overall Study|Protocol Violation|1|||
144272501|NCT01649765|520201441|FG001|Overall Study|Protocol Violation|0|||
144272502|NCT01649765|520201440|FG000|Overall Study|Withdrawal by Subject|2|||
144272503|NCT01649765|520201441|FG001|Overall Study|Withdrawal by Subject|1|||
144272504|NCT02194465|520201442|FG000|Overall Study|Adverse Event|6|||
144272505|NCT02194465|520201443|FG001|Overall Study|Adverse Event|1|||
144272506|NCT02194465|520201444|FG002|Overall Study|Adverse Event|4|||
144272507|NCT02194465|520201445|FG003|Overall Study|Adverse Event|4|||
144272508|NCT02194465|520201446|FG004|Overall Study|Adverse Event|4|||
144272509|NCT02194465|520201447|FG005|Overall Study|Adverse Event|2|||
144272510|NCT02194465|520201448|FG006|Overall Study|Adverse Event|0|||
144272511|NCT02194465|520201442|FG000|Overall Study|Lost to Follow-up|0|||
144272512|NCT02194465|520201443|FG001|Overall Study|Lost to Follow-up|0|||
144272513|NCT02194465|520201444|FG002|Overall Study|Lost to Follow-up|0|||
144272514|NCT02194465|520201445|FG003|Overall Study|Lost to Follow-up|1|||
144272515|NCT02194465|520201446|FG004|Overall Study|Lost to Follow-up|0|||
144272516|NCT02194465|520201447|FG005|Overall Study|Lost to Follow-up|1|||
144272517|NCT02194465|520201448|FG006|Overall Study|Lost to Follow-up|0|||
144272518|NCT02194465|520201442|FG000|Overall Study|Physician Decision|1|||
144272519|NCT02194465|520201443|FG001|Overall Study|Physician Decision|0|||
144272520|NCT02194465|520201444|FG002|Overall Study|Physician Decision|0|||
144272521|NCT02194465|520201445|FG003|Overall Study|Physician Decision|0|||
144272522|NCT02194465|520201446|FG004|Overall Study|Physician Decision|0|||
144272523|NCT02194465|520201447|FG005|Overall Study|Physician Decision|0|||
144272524|NCT02194465|520201448|FG006|Overall Study|Physician Decision|0|||
144272525|NCT02194465|520201442|FG000|Overall Study|Protocol Violation|1|||
144272526|NCT02194465|520201443|FG001|Overall Study|Protocol Violation|1|||
144272527|NCT02194465|520201444|FG002|Overall Study|Protocol Violation|2|||
144272528|NCT02194465|520201445|FG003|Overall Study|Protocol Violation|1|||
144272529|NCT02194465|520201446|FG004|Overall Study|Protocol Violation|1|||
144272530|NCT02194465|520201447|FG005|Overall Study|Protocol Violation|0|||
144272531|NCT02194465|520201448|FG006|Overall Study|Protocol Violation|0|||
144272532|NCT02194465|520201442|FG000|Overall Study|Withdrawal by Subject|1|||
144272533|NCT02194465|520201443|FG001|Overall Study|Withdrawal by Subject|3|||
144272534|NCT02194465|520201444|FG002|Overall Study|Withdrawal by Subject|1|||
144272535|NCT02194465|520201445|FG003|Overall Study|Withdrawal by Subject|2|||
144272536|NCT02194465|520201446|FG004|Overall Study|Withdrawal by Subject|2|||
144272537|NCT02194465|520201447|FG005|Overall Study|Withdrawal by Subject|1|||
144272538|NCT02194465|520201448|FG006|Overall Study|Withdrawal by Subject|2|||
144272539|NCT02194465|520201442|FG000|Overall Study|Discontinued follow-up period|0|||
144272540|NCT02194465|520201443|FG001|Overall Study|Discontinued follow-up period|2|||
144272541|NCT02194465|520201444|FG002|Overall Study|Discontinued follow-up period|1|||
144272542|NCT02194465|520201445|FG003|Overall Study|Discontinued follow-up period|0|||
144272543|NCT02194465|520201446|FG004|Overall Study|Discontinued follow-up period|2|||
144272544|NCT02194465|520201447|FG005|Overall Study|Discontinued follow-up period|0|||
144272545|NCT02194465|520201448|FG006|Overall Study|Discontinued follow-up period|0|||
144272546|NCT00961064|520201449|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
144272547|NCT00961064|520201449|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
144272548|NCT00961064|520201449|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
144272549|NCT00961064|520201449|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
144272550|NCT00961064|520201449|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
144272551|NCT00961064|520201449|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
144272552|NCT00961064|520201449|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
144272553|NCT00961064|520201449|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
144272554|NCT01408641|520201450|FG000|Overall Study|Physician Decision|1|||
144272555|NCT01408641|520201451|FG001|Overall Study|Physician Decision|0|||
144272556|NCT00715208|520201452|FG000|Overall Study|Withdrawal by Subject|1|||
144272557|NCT00715208|520201453|FG001|Overall Study|Withdrawal by Subject|1|||
144272558|NCT00715208|520201452|FG000|Overall Study|Adverse Event|0|||
144272559|NCT00715208|520201453|FG001|Overall Study|Adverse Event|6|||
144272560|NCT00715208|520201452|FG000|Overall Study|Lack of Efficacy|0|||
144272561|NCT00715208|520201453|FG001|Overall Study|Lack of Efficacy|2|||
144272562|NCT01648764|520201454|FG000|Overall Study|Progressive Disease|0|||
144272563|NCT01648764|520201455|FG001|Overall Study|Progressive Disease|1|||
144272564|NCT01648764|520201456|FG002|Overall Study|Progressive Disease|0|||
144272565|NCT01648764|520201457|FG003|Overall Study|Progressive Disease|0|||
144272566|NCT01648764|520201458|FG004|Overall Study|Progressive Disease|0|||
144272567|NCT01648764|520201459|FG005|Overall Study|Progressive Disease|1|||
144272568|NCT01648764|520201460|FG006|Overall Study|Progressive Disease|1|||
144272569|NCT01648764|520201461|FG007|Overall Study|Progressive Disease|0|||
144272570|NCT01648764|520201462|FG008|Overall Study|Progressive Disease|0|||
144272571|NCT01648764|520201463|FG009|Overall Study|Progressive Disease|2|||
144272572|NCT01648764|520201464|FG010|Overall Study|Progressive Disease|0|||
144272573|NCT01648764|520201465|FG011|Overall Study|Progressive Disease|1|||
144272574|NCT01648764|520201466|FG012|Overall Study|Progressive Disease|2|||
144272575|NCT01648764|520201467|FG013|Overall Study|Progressive Disease|1|||
144272576|NCT01648764|520201454|FG000|Overall Study|Adverse Event|0|||
144272577|NCT01648764|520201455|FG001|Overall Study|Adverse Event|0|||
144272578|NCT01648764|520201456|FG002|Overall Study|Adverse Event|0|||
144272579|NCT01648764|520201457|FG003|Overall Study|Adverse Event|0|||
144272580|NCT01648764|520201458|FG004|Overall Study|Adverse Event|0|||
144272581|NCT01648764|520201459|FG005|Overall Study|Adverse Event|1|||
144272582|NCT01648764|520201460|FG006|Overall Study|Adverse Event|0|||
144272583|NCT01648764|520201461|FG007|Overall Study|Adverse Event|0|||
144272584|NCT01648764|520201462|FG008|Overall Study|Adverse Event|0|||
144272585|NCT01648764|520201463|FG009|Overall Study|Adverse Event|1|||
144272586|NCT01648764|520201464|FG010|Overall Study|Adverse Event|0|||
144272587|NCT01648764|520201465|FG011|Overall Study|Adverse Event|3|||
144272588|NCT01648764|520201466|FG012|Overall Study|Adverse Event|1|||
144272589|NCT01648764|520201467|FG013|Overall Study|Adverse Event|1|||
144272590|NCT01648764|520201454|FG000|Overall Study|Death|0|||
144272591|NCT01648764|520201455|FG001|Overall Study|Death|0|||
144272592|NCT01648764|520201456|FG002|Overall Study|Death|0|||
144272593|NCT01648764|520201457|FG003|Overall Study|Death|0|||
144272594|NCT01648764|520201458|FG004|Overall Study|Death|0|||
144272595|NCT01648764|520201459|FG005|Overall Study|Death|0|||
144272596|NCT01648764|520201460|FG006|Overall Study|Death|1|||
144272597|NCT01648764|520201461|FG007|Overall Study|Death|0|||
144272598|NCT01648764|520201462|FG008|Overall Study|Death|0|||
144272599|NCT01648764|520201463|FG009|Overall Study|Death|0|||
144272600|NCT01648764|520201464|FG010|Overall Study|Death|0|||
144272601|NCT01648764|520201465|FG011|Overall Study|Death|0|||
144272602|NCT01648764|520201466|FG012|Overall Study|Death|0|||
144272603|NCT01648764|520201467|FG013|Overall Study|Death|1|||
144272604|NCT01648764|520201454|FG000|Overall Study|Withdrawal by Subject|0|||
144272605|NCT01648764|520201455|FG001|Overall Study|Withdrawal by Subject|0|||
144272606|NCT01648764|520201456|FG002|Overall Study|Withdrawal by Subject|0|||
144272607|NCT01648764|520201457|FG003|Overall Study|Withdrawal by Subject|0|||
144272608|NCT01648764|520201458|FG004|Overall Study|Withdrawal by Subject|0|||
144272609|NCT01648764|520201459|FG005|Overall Study|Withdrawal by Subject|0|||
144272610|NCT01648764|520201460|FG006|Overall Study|Withdrawal by Subject|2|||
144272611|NCT01648764|520201461|FG007|Overall Study|Withdrawal by Subject|0|||
144272612|NCT01648764|520201462|FG008|Overall Study|Withdrawal by Subject|0|||
144272613|NCT01648764|520201463|FG009|Overall Study|Withdrawal by Subject|0|||
144272614|NCT01648764|520201464|FG010|Overall Study|Withdrawal by Subject|0|||
144272615|NCT01648764|520201465|FG011|Overall Study|Withdrawal by Subject|0|||
144272616|NCT01648764|520201466|FG012|Overall Study|Withdrawal by Subject|1|||
144272617|NCT01648764|520201467|FG013|Overall Study|Withdrawal by Subject|0|||
144272618|NCT01648764|520201454|FG000|Overall Study|Investigator Decision|0|||
144272619|NCT01648764|520201455|FG001|Overall Study|Investigator Decision|0|||
144272620|NCT01648764|520201456|FG002|Overall Study|Investigator Decision|0|||
144242340|NCT05091346|520085808|FG000|Overall Study|Lost to Follow-up|0|||
144242341|NCT05091346|520085809|FG001|Overall Study|Lost to Follow-up|0|||
144242342|NCT05091346|520085810|FG002|Overall Study|Lost to Follow-up|0|||
144242343|NCT05091346|520085811|FG003|Overall Study|Lost to Follow-up|1|||
144242344|NCT05091346|520085812|FG004|Overall Study|Lost to Follow-up|0|||
144242345|NCT05091346|520085808|FG000|Overall Study|Withdrawal by Subject|0|||
144242346|NCT05091346|520085809|FG001|Overall Study|Withdrawal by Subject|1|||
144242347|NCT05091346|520085810|FG002|Overall Study|Withdrawal by Subject|2|||
144242348|NCT05091346|520085811|FG003|Overall Study|Withdrawal by Subject|2|||
144242349|NCT05091346|520085812|FG004|Overall Study|Withdrawal by Subject|1|||
144242350|NCT00197002|520085813|FG000|Overall Study|Adverse Event|0|||
144242351|NCT00197002|520085814|FG001|Overall Study|Adverse Event|1|||
144242352|NCT00197002|520085815|FG002|Overall Study|Adverse Event|0|||
144242353|NCT00197002|520085813|FG000|Overall Study|Protocol Violation|1|||
144242354|NCT00197002|520085814|FG001|Overall Study|Protocol Violation|0|||
144242355|NCT00197002|520085815|FG002|Overall Study|Protocol Violation|2|||
144242356|NCT00197002|520085813|FG000|Overall Study|Withdrawal by Subject|9|||
144242357|NCT00197002|520085814|FG001|Overall Study|Withdrawal by Subject|5|||
144242358|NCT00197002|520085815|FG002|Overall Study|Withdrawal by Subject|7|||
144242359|NCT00197002|520085813|FG000|Overall Study|Migrated/moved from study area|3|||
144242360|NCT00197002|520085814|FG001|Overall Study|Migrated/moved from study area|5|||
144242361|NCT00197002|520085815|FG002|Overall Study|Migrated/moved from study area|1|||
144242362|NCT00197002|520085813|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
144242363|NCT00197002|520085814|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
144272621|NCT01648764|520201457|FG003|Overall Study|Investigator Decision|0|||
144272622|NCT01648764|520201458|FG004|Overall Study|Investigator Decision|0|||
144272623|NCT01648764|520201459|FG005|Overall Study|Investigator Decision|0|||
144272624|NCT01648764|520201460|FG006|Overall Study|Investigator Decision|1|||
144272625|NCT01648764|520201461|FG007|Overall Study|Investigator Decision|0|||
144272626|NCT01648764|520201462|FG008|Overall Study|Investigator Decision|0|||
144272627|NCT01648764|520201463|FG009|Overall Study|Investigator Decision|0|||
144272628|NCT01648764|520201464|FG010|Overall Study|Investigator Decision|0|||
144272629|NCT01648764|520201465|FG011|Overall Study|Investigator Decision|1|||
144272630|NCT01648764|520201466|FG012|Overall Study|Investigator Decision|0|||
144272631|NCT01648764|520201467|FG013|Overall Study|Investigator Decision|0|||
144272632|NCT00076570|520201468|FG000|Overall Study|Drug intolerance|8|||
144272633|NCT00076570|520201469|FG001|Overall Study|Drug intolerance|8|||
144272634|NCT01294046|520201470|FG000|Overall Study|Infection and surgical explant|1|||
144272635|NCT01294046|520201470|FG000|Overall Study|Eligibility criteria expanded|1|||
144272636|NCT01294046|520201470|FG000|Overall Study|Stimulation response inadqequate|1|||
144272637|NCT00420745|520201471|FG000|Overall Study|Adverse Event|2|||
144272638|NCT00420745|520201472|FG001|Overall Study|Adverse Event|2|||
144272639|NCT00420745|520201471|FG000|Overall Study|Lost to Follow-up|10|||
144272640|NCT00420745|520201472|FG001|Overall Study|Lost to Follow-up|2|||
144272641|NCT00420745|520201471|FG000|Overall Study|Protocol Violation|1|||
144272642|NCT00420745|520201472|FG001|Overall Study|Protocol Violation|0|||
144272643|NCT00420745|520201471|FG000|Overall Study|Physician Decision|1|||
144272644|NCT00420745|520201472|FG001|Overall Study|Physician Decision|1|||
144272645|NCT00420745|520201471|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
144272646|NCT00420745|520201472|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
144272647|NCT00420745|520201471|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
144272648|NCT00420745|520201472|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
144272649|NCT01715298|520201475|FG000|Overall Study|Lost to Follow-up|0|||
144272650|NCT01715298|520201476|FG001|Overall Study|Lost to Follow-up|2|||
144272651|NCT01715298|520201475|FG000|Overall Study|Patient/guardian decision|7|||
144272652|NCT01715298|520201476|FG001|Overall Study|Patient/guardian decision|9|||
144272653|NCT01499511|520201479|FG000|Overall Study|Death|1|||
144272654|NCT01499511|520201480|FG001|Overall Study|Death|0|||
144272655|NCT00998946|520201481|FG000|Overall Study|Lost to Follow-up|1|||
144272656|NCT00998946|520201481|FG000|Overall Study|Withdrawal by Subject|1|||
144272657|NCT00998946|520201481|FG000|Overall Study|Death|2|||
144272658|NCT00998946|520201481|FG000|Overall Study|Reason Unspecified|3|||
144272659|NCT00998946|520201481|FG000|Overall Study|Enrolled but not Dosed|2|||
144272660|NCT01454284|520201484|FG000|Overall Study|Adverse Event|20|||
144272661|NCT01454284|520201485|FG001|Overall Study|Adverse Event|7|||
144272662|NCT01454284|520201484|FG000|Overall Study|Death|0|||
144272663|NCT01454284|520201485|FG001|Overall Study|Death|3|||
144272664|NCT01454284|520201484|FG000|Overall Study|Lost to Follow-up|13|||
144272665|NCT01454284|520201485|FG001|Overall Study|Lost to Follow-up|8|||
144272666|NCT01454284|520201484|FG000|Overall Study|Protocol Violation|9|||
144272667|NCT01454284|520201485|FG001|Overall Study|Protocol Violation|6|||
144272668|NCT01454284|520201484|FG000|Overall Study|Withdrawal by Subject|58|||
144272669|NCT01454284|520201485|FG001|Overall Study|Withdrawal by Subject|36|||
144272670|NCT01454284|520201484|FG000|Overall Study|Physician Decision|16|||
144272671|NCT01454284|520201485|FG001|Overall Study|Physician Decision|11|||
144272672|NCT01454284|520201484|FG000|Overall Study|Sponsor Decision|0|||
144272673|NCT01454284|520201485|FG001|Overall Study|Sponsor Decision|2|||
144272674|NCT02842866|520201486|FG000|Overall Study|Serious Adverse Event|0|||
144272675|NCT02842866|520201487|FG001|Overall Study|Serious Adverse Event|1|||
144272676|NCT02842866|520201486|FG000|Overall Study|Protocol Violation|4|||
144272677|NCT02842866|520201487|FG001|Overall Study|Protocol Violation|2|||
144272678|NCT02842866|520201486|FG000|Overall Study|Lost to Follow-up|2|||
144272679|NCT02842866|520201487|FG001|Overall Study|Lost to Follow-up|0|||
144272680|NCT02842866|520201486|FG000|Overall Study|Withdrawal by Subject|1|||
144272681|NCT02842866|520201487|FG001|Overall Study|Withdrawal by Subject|0|||
144272682|NCT01432327|520201488|FG000|Posttest 3 Months|depression|3|||
144272683|NCT01432327|520201489|FG001|Posttest 3 Months|depression|0|||
144272684|NCT01432327|520201490|FG002|Posttest 3 Months|depression|0|||
144272685|NCT01432327|520201491|FG003|Posttest 3 Months|depression|0|||
144272686|NCT01432327|520201488|FG000|Posttest 3 Months|Lost to Follow-up|1|||
144272687|NCT01432327|520201489|FG001|Posttest 3 Months|Lost to Follow-up|0|||
144272688|NCT01432327|520201490|FG002|Posttest 3 Months|Lost to Follow-up|2|||
144272689|NCT01432327|520201491|FG003|Posttest 3 Months|Lost to Follow-up|1|||
144272690|NCT01432327|520201488|FG000|Posttest 3 Months|Allergic reaction|0|||
144272691|NCT01432327|520201489|FG001|Posttest 3 Months|Allergic reaction|2|||
144272692|NCT01432327|520201490|FG002|Posttest 3 Months|Allergic reaction|0|||
144272693|NCT01432327|520201491|FG003|Posttest 3 Months|Allergic reaction|0|||
144272694|NCT01432327|520201488|FG000|Posttest 6 Months|Lost to Follow-up|0|||
144272695|NCT01432327|520201489|FG001|Posttest 6 Months|Lost to Follow-up|0|||
144272696|NCT01432327|520201490|FG002|Posttest 6 Months|Lost to Follow-up|3|||
144272697|NCT01432327|520201491|FG003|Posttest 6 Months|Lost to Follow-up|2|||
144272698|NCT01432327|520201488|FG000|Posttest 6 Months|Allergic reaction|0|||
144272699|NCT01432327|520201489|FG001|Posttest 6 Months|Allergic reaction|0|||
144272700|NCT01432327|520201490|FG002|Posttest 6 Months|Allergic reaction|1|||
144272701|NCT01432327|520201491|FG003|Posttest 6 Months|Allergic reaction|0|||
144272702|NCT01432327|520201488|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
144272703|NCT01432327|520201489|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
144272704|NCT01432327|520201490|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
144272705|NCT01432327|520201491|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
144272706|NCT01432327|520201488|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
144272707|NCT01432327|520201489|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
144272708|NCT01432327|520201490|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
144272709|NCT01432327|520201491|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
144272710|NCT01432327|520201488|FG000|Posttest 1 Year|Lost to Follow-up|0|||
144272711|NCT01432327|520201489|FG001|Posttest 1 Year|Lost to Follow-up|0|||
144272712|NCT01432327|520201490|FG002|Posttest 1 Year|Lost to Follow-up|4|||
144272713|NCT01432327|520201491|FG003|Posttest 1 Year|Lost to Follow-up|2|||
144272714|NCT01432327|520201488|FG000|Posttest 1 Year|Allergic reaction|0|||
144272715|NCT01432327|520201489|FG001|Posttest 1 Year|Allergic reaction|0|||
144272716|NCT01432327|520201490|FG002|Posttest 1 Year|Allergic reaction|1|||
144272717|NCT01432327|520201491|FG003|Posttest 1 Year|Allergic reaction|1|||
144272718|NCT00577408|520201492|FG000|Overall Study|Stopped attending study visits|9|||
144272719|NCT00577408|520201493|FG001|Overall Study|Stopped attending study visits|11|||
144272720|NCT00577408|520201492|FG000|Overall Study|Continued opioid use|3|||
144272721|NCT00577408|520201493|FG001|Overall Study|Continued opioid use|2|||
144272722|NCT00577408|520201492|FG000|Overall Study|Non-compliance with study meds|0|||
144272723|NCT00577408|520201493|FG001|Overall Study|Non-compliance with study meds|3|||
144272724|NCT00577408|520201492|FG000|Overall Study|Refused Oral Naltrexone|0|||
144272725|NCT00577408|520201493|FG001|Overall Study|Refused Oral Naltrexone|1|||
144272726|NCT00577408|520201492|FG000|Overall Study|Moved out of state|0|||
144272727|NCT00577408|520201493|FG001|Overall Study|Moved out of state|1|||
144272728|NCT00577408|520201492|FG000|Overall Study|Scheduling Issues|0|||
144272729|NCT00577408|520201493|FG001|Overall Study|Scheduling Issues|3|||
144272730|NCT00577408|520201492|FG000|Overall Study|Death|0|||
144272731|NCT00577408|520201493|FG001|Overall Study|Death|1|||
144272732|NCT00577408|520201492|FG000|Overall Study|Psychiatric hospitalization|0|||
144272733|NCT00577408|520201493|FG001|Overall Study|Psychiatric hospitalization|1|||
144272734|NCT03817528|520201494|FG000|Overall Study|Withdrawal by Subject|1|||
144272735|NCT03817528|520201494|FG000|Overall Study|Adverse Event|2|||
144272736|NCT03937778|520201500|FG000|Overall Study|Withdrawal by Subject|1|||
144272737|NCT03937778|520201500|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
144272738|NCT04810962|520201503|FG000|Overall Study|Adverse Event|0|||
144272739|NCT04810962|520201504|FG001|Overall Study|Adverse Event|1|||
144272740|NCT04810962|520201503|FG000|Overall Study|Lost to Follow-up|2|||
144272741|NCT04810962|520201504|FG001|Overall Study|Lost to Follow-up|1|||
144272742|NCT04810962|520201503|FG000|Overall Study|Physician Decision|1|||
144272743|NCT04810962|520201504|FG001|Overall Study|Physician Decision|0|||
144272744|NCT04810962|520201503|FG000|Overall Study|Withdrawal by Subject|1|||
144272745|NCT04810962|520201504|FG001|Overall Study|Withdrawal by Subject|3|||
144272746|NCT04810962|520201503|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
144272747|NCT04810962|520201504|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
144272748|NCT01281306|520201507|FG000|Overall Study|Lack of Efficacy|0|||
144272749|NCT01281306|520201508|FG001|Overall Study|Lack of Efficacy|1|||
144272750|NCT01281306|520201509|FG002|Overall Study|Lack of Efficacy|3|||
144272751|NCT01281306|520201510|FG003|Overall Study|Lack of Efficacy|0|||
144272752|NCT01281306|520201511|FG004|Overall Study|Lack of Efficacy|2|||
144272753|NCT01281306|520201512|FG005|Overall Study|Lack of Efficacy|0|||
144272754|NCT01281306|520201513|FG006|Overall Study|Lack of Efficacy|1|||
144272755|NCT01281306|520201507|FG000|Overall Study|Withdrawal by Subject|1|||
144272756|NCT01281306|520201508|FG001|Overall Study|Withdrawal by Subject|0|||
144272757|NCT01281306|520201509|FG002|Overall Study|Withdrawal by Subject|2|||
144272758|NCT01281306|520201510|FG003|Overall Study|Withdrawal by Subject|4|||
144272759|NCT01281306|520201511|FG004|Overall Study|Withdrawal by Subject|1|||
144272760|NCT01281306|520201512|FG005|Overall Study|Withdrawal by Subject|3|||
144272761|NCT01281306|520201513|FG006|Overall Study|Withdrawal by Subject|1|||
144272762|NCT01281306|520201507|FG000|Overall Study|Protocol deviation|0|||
144272763|NCT01281306|520201508|FG001|Overall Study|Protocol deviation|1|||
144272764|NCT01281306|520201509|FG002|Overall Study|Protocol deviation|1|||
144272765|NCT01281306|520201510|FG003|Overall Study|Protocol deviation|1|||
144272766|NCT01281306|520201511|FG004|Overall Study|Protocol deviation|1|||
144272767|NCT01281306|520201512|FG005|Overall Study|Protocol deviation|0|||
144272768|NCT01281306|520201513|FG006|Overall Study|Protocol deviation|0|||
144272769|NCT01281306|520201507|FG000|Overall Study|Condition no longer requires study drug|1|||
144272770|NCT01281306|520201508|FG001|Overall Study|Condition no longer requires study drug|0|||
144272771|NCT01281306|520201509|FG002|Overall Study|Condition no longer requires study drug|0|||
144272772|NCT01281306|520201510|FG003|Overall Study|Condition no longer requires study drug|0|||
144272773|NCT01281306|520201511|FG004|Overall Study|Condition no longer requires study drug|0|||
144272774|NCT01281306|520201512|FG005|Overall Study|Condition no longer requires study drug|1|||
144272775|NCT01281306|520201513|FG006|Overall Study|Condition no longer requires study drug|1|||
144272776|NCT01281306|520201507|FG000|Overall Study|Lost to Follow-up|1|||
144272777|NCT01281306|520201508|FG001|Overall Study|Lost to Follow-up|0|||
144272778|NCT01281306|520201509|FG002|Overall Study|Lost to Follow-up|0|||
144272779|NCT01281306|520201510|FG003|Overall Study|Lost to Follow-up|2|||
144272780|NCT01281306|520201511|FG004|Overall Study|Lost to Follow-up|0|||
144272781|NCT01281306|520201512|FG005|Overall Study|Lost to Follow-up|0|||
144272782|NCT01281306|520201513|FG006|Overall Study|Lost to Follow-up|1|||
144272783|NCT01281306|520201507|FG000|Overall Study|Death|1|||
144272784|NCT01281306|520201508|FG001|Overall Study|Death|0|||
144272785|NCT01281306|520201509|FG002|Overall Study|Death|0|||
144272786|NCT01281306|520201510|FG003|Overall Study|Death|0|||
144272787|NCT01281306|520201511|FG004|Overall Study|Death|0|||
144272788|NCT01281306|520201512|FG005|Overall Study|Death|0|||
144272789|NCT01281306|520201513|FG006|Overall Study|Death|0|||
144272790|NCT01281306|520201507|FG000|Overall Study|Adverse Event|3|||
144272791|NCT01281306|520201508|FG001|Overall Study|Adverse Event|2|||
144272792|NCT01281306|520201509|FG002|Overall Study|Adverse Event|2|||
144272793|NCT01281306|520201510|FG003|Overall Study|Adverse Event|3|||
144272794|NCT01281306|520201511|FG004|Overall Study|Adverse Event|5|||
144272795|NCT01281306|520201512|FG005|Overall Study|Adverse Event|3|||
144272796|NCT01281306|520201513|FG006|Overall Study|Adverse Event|3|||
144272797|NCT01281306|520201507|FG000|Overall Study|Randomized in error|1|||
144272798|NCT01281306|520201508|FG001|Overall Study|Randomized in error|0|||
144272799|NCT01281306|520201509|FG002|Overall Study|Randomized in error|0|||
144272800|NCT01281306|520201510|FG003|Overall Study|Randomized in error|1|||
144272801|NCT01281306|520201511|FG004|Overall Study|Randomized in error|0|||
144272802|NCT01281306|520201512|FG005|Overall Study|Randomized in error|0|||
144272803|NCT01281306|520201513|FG006|Overall Study|Randomized in error|0|||
144272804|NCT03185208|520201514|FG000|Overall Study|Did not start study medication|0|||
144272805|NCT03185208|520201515|FG001|Overall Study|Did not start study medication|3|||
144272806|NCT02410629|520201516|FG000|Overall Study|Family cannot commit to the study|2|||
144272807|NCT02410629|520201517|FG001|Overall Study|Family cannot commit to the study|1|||
144272808|NCT02410629|520201516|FG000|Overall Study|Subject returned to work|1|||
144272809|NCT02410629|520201517|FG001|Overall Study|Subject returned to work|0|||
144272810|NCT02410629|520201516|FG000|Overall Study|Subject moved back to home country|0|||
144272811|NCT02410629|520201517|FG001|Overall Study|Subject moved back to home country|1|||
144272812|NCT02410629|520201516|FG000|Overall Study|Subject underwent heart surgery|0|||
144272813|NCT02410629|520201517|FG001|Overall Study|Subject underwent heart surgery|1|||
144272814|NCT02701634|520201518|FG000|Overall Study|Adverse Event|2|||
144272815|NCT02701634|520201519|FG001|Overall Study|Adverse Event|3|||
144272816|NCT02701634|520201518|FG000|Overall Study|Death|1|||
144272817|NCT02701634|520201519|FG001|Overall Study|Death|0|||
144272818|NCT02701634|520201518|FG000|Overall Study|Investigator's Discretion|7|||
144272819|NCT02701634|520201519|FG001|Overall Study|Investigator's Discretion|4|||
144272820|NCT02701634|520201518|FG000|Overall Study|Study terminated by Sponsor|15|||
144272821|NCT02701634|520201519|FG001|Overall Study|Study terminated by Sponsor|17|||
144272822|NCT02701634|520201518|FG000|Overall Study|Withdrew Consent|6|||
144272823|NCT02701634|520201519|FG001|Overall Study|Withdrew Consent|7|||
144272824|NCT02701634|520201518|FG000|Overall Study|Randomized but not treated|1|||
144272825|NCT02701634|520201519|FG001|Overall Study|Randomized but not treated|0|||
144272826|NCT05853120|520201522|FG000|Overall Study|Lost to Follow-up|4|||
144272827|NCT05853120|520201523|FG001|Overall Study|Lost to Follow-up|4|||
144272828|NCT05853120|520201522|FG000|Overall Study|Physician Decision|3|||
144272829|NCT05853120|520201523|FG001|Overall Study|Physician Decision|0|||
144272830|NCT05853120|520201522|FG000|Overall Study|Withdrawal by Subject|5|||
144272831|NCT05853120|520201523|FG001|Overall Study|Withdrawal by Subject|2|||
144272832|NCT00465517|520201529|FG000|Overall Study|Adverse Event|7|||
144272833|NCT00465517|520201530|FG001|Overall Study|Adverse Event|3|||
144272834|NCT00465517|520201529|FG000|Overall Study|Lost to Follow-up|1|||
144272835|NCT00465517|520201530|FG001|Overall Study|Lost to Follow-up|0|||
144272836|NCT00465517|520201529|FG000|Overall Study|Withdrawal by Subject|4|||
144272837|NCT00465517|520201530|FG001|Overall Study|Withdrawal by Subject|1|||
144272838|NCT00869960|520201533|FG000|Overall Study|Lost to Follow-up|2|||
144272839|NCT00071981|520201540|FG000|Overall Study|Lack of Efficacy|37|||
144272840|NCT00071981|520201541|FG001|Overall Study|Lack of Efficacy|29|||
144272841|NCT00071981|520201542|FG002|Overall Study|Lack of Efficacy|30|||
144272842|NCT00071981|520201543|FG003|Overall Study|Lack of Efficacy|43|||
144272843|NCT00071981|520201540|FG000|Overall Study|Adverse Event|4|||
144272844|NCT00071981|520201541|FG001|Overall Study|Adverse Event|4|||
144272845|NCT00071981|520201542|FG002|Overall Study|Adverse Event|3|||
144272846|NCT00071981|520201543|FG003|Overall Study|Adverse Event|1|||
144272847|NCT00071981|520201540|FG000|Overall Study|Death|0|||
144272848|NCT00071981|520201541|FG001|Overall Study|Death|0|||
144272849|NCT00071981|520201542|FG002|Overall Study|Death|1|||
144272850|NCT00071981|520201543|FG003|Overall Study|Death|1|||
144272851|NCT00071981|520201540|FG000|Overall Study|Withdrawal by Subject|3|||
144272852|NCT00071981|520201541|FG001|Overall Study|Withdrawal by Subject|1|||
144272853|NCT00071981|520201542|FG002|Overall Study|Withdrawal by Subject|0|||
144272854|NCT00071981|520201543|FG003|Overall Study|Withdrawal by Subject|0|||
144272855|NCT00071981|520201540|FG000|Overall Study|No protocol therapy|2|||
144272856|NCT00071981|520201541|FG001|Overall Study|No protocol therapy|5|||
144272857|NCT00071981|520201542|FG002|Overall Study|No protocol therapy|1|||
144272858|NCT00071981|520201543|FG003|Overall Study|No protocol therapy|0|||
144272859|NCT00071981|520201540|FG000|Overall Study|others (not specified in the study)|0|||
144272860|NCT00071981|520201541|FG001|Overall Study|others (not specified in the study)|2|||
144272861|NCT00071981|520201542|FG002|Overall Study|others (not specified in the study)|2|||
144272862|NCT00071981|520201543|FG003|Overall Study|others (not specified in the study)|0|||
144272863|NCT00560404|520201546|FG000|Overall Study|Adverse Event|2|||
144272864|NCT00560404|520201547|FG001|Overall Study|Adverse Event|3|||
144272865|NCT00560404|520201546|FG000|Overall Study|Death|3|||
144272866|NCT00560404|520201547|FG001|Overall Study|Death|3|||
144272867|NCT00560404|520201546|FG000|Overall Study|Protocol Violation|12|||
144272868|NCT00560404|520201547|FG001|Overall Study|Protocol Violation|7|||
144272869|NCT00560404|520201546|FG000|Overall Study|Administrative Reasons|1|||
144272870|NCT00560404|520201547|FG001|Overall Study|Administrative Reasons|1|||
144272871|NCT00560404|520201546|FG000|Overall Study|Withdrew Consent|4|||
144272872|NCT00560404|520201547|FG001|Overall Study|Withdrew Consent|0|||
144272873|NCT00560404|520201546|FG000|Overall Study|Failure to return|1|||
144272874|NCT00560404|520201547|FG001|Overall Study|Failure to return|2|||
144272875|NCT00560404|520201546|FG000|Overall Study|Other withdrawal reason|13|||
144272876|NCT00560404|520201547|FG001|Overall Study|Other withdrawal reason|5|||
144272877|NCT00834041|520201554|FG000|Overall Study|Withdrawal by Subject|1|||
144272878|NCT00834041|520201555|FG001|Overall Study|Withdrawal by Subject|0|||
144272879|NCT00834041|520201554|FG000|Overall Study|Lost to Follow-up|0|||
144272880|NCT00834041|520201555|FG001|Overall Study|Lost to Follow-up|1|||
144272881|NCT04530630|520203072|FG000|Overall Study|Physician Decision|1|||
144272882|NCT03675308|520203075|FG000|Overall Study|Adverse Event|3|||
144272883|NCT03675308|520203076|FG001|Overall Study|Adverse Event|2|||
144272884|NCT03675308|520203075|FG000|Overall Study|Withdrawal by Subject|6|||
144272885|NCT03675308|520203076|FG001|Overall Study|Withdrawal by Subject|4|||
144272886|NCT03675308|520203075|FG000|Overall Study|Lost to Follow-up|3|||
144272887|NCT03675308|520203076|FG001|Overall Study|Lost to Follow-up|0|||
144272888|NCT03675308|520203075|FG000|Overall Study|Lack of Efficacy|1|||
144272889|NCT03675308|520203076|FG001|Overall Study|Lack of Efficacy|1|||
144272890|NCT03675308|520203075|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
144272891|NCT03675308|520203076|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
144272892|NCT03675308|520203075|FG000|Overall Study|Other|0|||
144272893|NCT03675308|520203076|FG001|Overall Study|Other|1|||
144272894|NCT02807259|520203081|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
144272895|NCT02807259|520203082|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
144272896|NCT02807259|520203081|FG000|Midline (3 Months)|migration, refusal, not available|30|||
144272897|NCT02807259|520203082|FG001|Midline (3 Months)|migration, refusal, not available|34|||
144272898|NCT02807259|520203081|FG000|Endline (3 Months)|migration, refusal, not available|35|||
144272899|NCT02807259|520203082|FG001|Endline (3 Months)|migration, refusal, not available|87|||
144272900|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
144272901|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
144272902|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
144272903|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
144272904|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
144272905|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
144272906|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
144272907|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
144272908|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
144272909|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
144272910|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
144272911|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
144272912|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
144272913|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
144272914|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
144272915|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
144272916|NCT00849056|520203083|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
144272917|NCT00849056|520203084|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
144272918|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
144272919|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
144272920|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
144272921|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
144272922|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
144272923|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
144272924|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
144272925|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
144272926|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
144272927|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
144272928|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
144272929|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
144272930|NCT00849056|520203083|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
144272931|NCT00849056|520203084|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
144272932|NCT00274456|520203088|FG000|Overall Study|Still on treatment|2|||
144272933|NCT00274456|520203089|FG001|Overall Study|Still on treatment|3|||
144272934|NCT00274456|520203090|FG002|Overall Study|Still on treatment|5|||
144272935|NCT00274456|520203091|FG003|Overall Study|Still on treatment|1|||
144272936|NCT00274456|520203088|FG000|Overall Study|Unacceptable toxicity|10|||
144272937|NCT00274456|520203089|FG001|Overall Study|Unacceptable toxicity|5|||
144272938|NCT00274456|520203090|FG002|Overall Study|Unacceptable toxicity|12|||
144272939|NCT00274456|520203091|FG003|Overall Study|Unacceptable toxicity|16|||
144272940|NCT00274456|520203088|FG000|Overall Study|Adverse Event|0|||
144272941|NCT00274456|520203089|FG001|Overall Study|Adverse Event|1|||
144272942|NCT00274456|520203090|FG002|Overall Study|Adverse Event|2|||
144272943|NCT00274456|520203091|FG003|Overall Study|Adverse Event|2|||
144272944|NCT00274456|520203088|FG000|Overall Study|Physician Decision|7|||
144272945|NCT00274456|520203089|FG001|Overall Study|Physician Decision|5|||
144272946|NCT00274456|520203090|FG002|Overall Study|Physician Decision|6|||
144272947|NCT00274456|520203091|FG003|Overall Study|Physician Decision|13|||
144272948|NCT00274456|520203088|FG000|Overall Study|Lost to Follow-up|0|||
144272949|NCT00274456|520203089|FG001|Overall Study|Lost to Follow-up|0|||
144272950|NCT00274456|520203090|FG002|Overall Study|Lost to Follow-up|1|||
144272951|NCT00274456|520203091|FG003|Overall Study|Lost to Follow-up|0|||
144272952|NCT00274456|520203088|FG000|Overall Study|Withdrawal by Subject|18|||
144272953|NCT00274456|520203089|FG001|Overall Study|Withdrawal by Subject|13|||
144272954|NCT00274456|520203090|FG002|Overall Study|Withdrawal by Subject|9|||
144272955|NCT00274456|520203091|FG003|Overall Study|Withdrawal by Subject|13|||
144272956|NCT00375752|520203092|FG000|Overall Study|Lack of Efficacy|4|||
144272957|NCT00375752|520203093|FG001|Overall Study|Lack of Efficacy|4|||
144272958|NCT00375752|520203092|FG000|Overall Study|Adverse Event|1|||
144272959|NCT00375752|520203093|FG001|Overall Study|Adverse Event|6|||
144272960|NCT00375752|520203092|FG000|Overall Study|Withdrawal by Subject|6|||
144272961|NCT00375752|520203093|FG001|Overall Study|Withdrawal by Subject|1|||
144272962|NCT00375752|520203092|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
144272963|NCT00375752|520203093|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
144272964|NCT00375752|520203092|FG000|Overall Study|Protocol Violation|0|||
144272965|NCT00375752|520203093|FG001|Overall Study|Protocol Violation|2|||
144272966|NCT00375752|520203092|FG000|Overall Study|Administrative Problems|0|||
144272967|NCT00375752|520203093|FG001|Overall Study|Administrative Problems|1|||
144272968|NCT01140906|520203100|FG000|Overall Study|Adverse Event|7|||
144272969|NCT01140906|520203101|FG001|Overall Study|Adverse Event|10|||
144272970|NCT01140906|520203102|FG002|Overall Study|Adverse Event|17|||
144272971|NCT01140906|520203103|FG003|Overall Study|Adverse Event|7|||
144272972|NCT01140906|520203100|FG000|Overall Study|Lack of Efficacy|6|||
144272973|NCT01140906|520203101|FG001|Overall Study|Lack of Efficacy|8|||
144272974|NCT01140906|520203102|FG002|Overall Study|Lack of Efficacy|2|||
144272975|NCT01140906|520203103|FG003|Overall Study|Lack of Efficacy|1|||
144272976|NCT01140906|520203100|FG000|Overall Study|Non-compliance|0|||
144272977|NCT01140906|520203101|FG001|Overall Study|Non-compliance|1|||
144272978|NCT01140906|520203102|FG002|Overall Study|Non-compliance|0|||
144272979|NCT01140906|520203103|FG003|Overall Study|Non-compliance|1|||
144272980|NCT01140906|520203100|FG000|Overall Study|Protocol Violation|5|||
144272981|NCT01140906|520203101|FG001|Overall Study|Protocol Violation|3|||
144272982|NCT01140906|520203102|FG002|Overall Study|Protocol Violation|2|||
144272983|NCT01140906|520203103|FG003|Overall Study|Protocol Violation|1|||
144272984|NCT01140906|520203100|FG000|Overall Study|Withdrawal of consent|6|||
144272985|NCT01140906|520203101|FG001|Overall Study|Withdrawal of consent|6|||
144272986|NCT01140906|520203102|FG002|Overall Study|Withdrawal of consent|2|||
144272987|NCT01140906|520203103|FG003|Overall Study|Withdrawal of consent|2|||
144272988|NCT01140906|520203100|FG000|Overall Study|Lost to Follow-up|1|||
144272989|NCT01140906|520203101|FG001|Overall Study|Lost to Follow-up|1|||
144272990|NCT01140906|520203102|FG002|Overall Study|Lost to Follow-up|0|||
144272991|NCT01140906|520203103|FG003|Overall Study|Lost to Follow-up|2|||
144272992|NCT01140906|520203100|FG000|Overall Study|Administrative or other reason|0|||
144272993|NCT01140906|520203101|FG001|Overall Study|Administrative or other reason|5|||
144272994|NCT01140906|520203102|FG002|Overall Study|Administrative or other reason|3|||
144272995|NCT01140906|520203103|FG003|Overall Study|Administrative or other reason|2|||
144272996|NCT00336544|520203104|FG000|Overall Study|Lack of Efficacy|8|||
144272997|NCT00336544|520203105|FG001|Overall Study|Lack of Efficacy|5|||
144272998|NCT00336544|520203104|FG000|Overall Study|Adverse Event|4|||
144272999|NCT00336544|520203105|FG001|Overall Study|Adverse Event|9|||
144273000|NCT00336544|520203104|FG000|Overall Study|Withdrawal by Subject|4|||
144273001|NCT00336544|520203105|FG001|Overall Study|Withdrawal by Subject|3|||
144273002|NCT00336544|520203104|FG000|Overall Study|Other|3|||
144273003|NCT00336544|520203105|FG001|Overall Study|Other|5|||
144273004|NCT00576758|520203106|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
144273005|NCT00576758|520203107|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
144273006|NCT00576758|520203106|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
144273007|NCT00576758|520203107|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
144273008|NCT00576758|520203106|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
144273009|NCT00576758|520203107|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
144273010|NCT00576758|520203106|FG000|Induction Treatment Period|Death|1|||
144273011|NCT00576758|520203107|FG001|Induction Treatment Period|Death|0|||
144273012|NCT00576758|520203106|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
144273013|NCT00576758|520203107|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
144273014|NCT00576758|520203106|FG000|Induction Treatment Period|Withdrew consent|1|||
144273015|NCT00576758|520203107|FG001|Induction Treatment Period|Withdrew consent|0|||
144273016|NCT00576758|520203106|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
144273017|NCT00576758|520203107|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
144273018|NCT00576758|520203106|FG000|Extension Treatment Period|Death|1|||
144273019|NCT00576758|520203107|FG001|Extension Treatment Period|Death|1|||
144273020|NCT00576758|520203106|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
144273021|NCT00576758|520203107|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
144273022|NCT00576758|520203106|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
144273023|NCT00576758|520203107|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
144273024|NCT00576758|520203106|FG000|Extension Treatment Period|Administrative/Other|3|||
144273025|NCT00576758|520203107|FG001|Extension Treatment Period|Administrative/Other|1|||
144273026|NCT00576758|520203106|FG000|Follow-up Period|Administrative/Other|6|||
144273027|NCT00576758|520203107|FG001|Follow-up Period|Administrative/Other|8|||
144273028|NCT00576758|520203106|FG000|Follow-up Period|Death|3|||
144273029|NCT00576758|520203107|FG001|Follow-up Period|Death|3|||
144273030|NCT00576758|520203106|FG000|Follow-up Period|Insufficient therapeutic response|16|||
144273031|NCT00576758|520203107|FG001|Follow-up Period|Insufficient therapeutic response|5|||
144273032|NCT00576758|520203106|FG000|Follow-up Period|Withdrew consent|2|||
144273033|NCT00576758|520203107|FG001|Follow-up Period|Withdrew consent|1|||
144273034|NCT01316614|520203108|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
144273035|NCT01316614|520203108|FG000|Overall Study|Cytology slides not available for review|4|||
144273036|NCT01316614|520203108|FG000|Overall Study|Cystic lesion|5|||
144273037|NCT01316614|520203108|FG000|Overall Study|Inadequate number of passes|2|||
144273038|NCT01316614|520203108|FG000|Overall Study|Medically unstable|1|||
144273039|NCT03427411|520203109|FG000|Overall Study|Screen failure - platelets too low|0|||
144273040|NCT03427411|520203110|FG001|Overall Study|Screen failure - platelets too low|1|||
144273041|NCT00903968|520203111|FG000|Overall Study|Adverse Event|0|||
144273042|NCT00903968|520203112|FG001|Overall Study|Adverse Event|0|||
144273043|NCT00903968|520203113|FG002|Overall Study|Adverse Event|0|||
144273044|NCT00903968|520203114|FG003|Overall Study|Adverse Event|0|||
144273045|NCT00903968|520203115|FG004|Overall Study|Adverse Event|0|||
144273046|NCT00903968|520203116|FG005|Overall Study|Adverse Event|0|||
144273047|NCT00903968|520203117|FG006|Overall Study|Adverse Event|1|||
144273048|NCT00903968|520203118|FG007|Overall Study|Adverse Event|8|||
144273049|NCT00903968|520203111|FG000|Overall Study|DLT|0|||
144273050|NCT00903968|520203112|FG001|Overall Study|DLT|0|||
144273051|NCT00903968|520203113|FG002|Overall Study|DLT|0|||
144273052|NCT00903968|520203114|FG003|Overall Study|DLT|0|||
144273053|NCT00903968|520203115|FG004|Overall Study|DLT|0|||
144273054|NCT00903968|520203116|FG005|Overall Study|DLT|0|||
144273055|NCT00903968|520203117|FG006|Overall Study|DLT|2|||
144273056|NCT00903968|520203118|FG007|Overall Study|DLT|0|||
144273057|NCT00903968|520203111|FG000|Overall Study|Withdrawal by Subject|1|||
144273058|NCT00903968|520203112|FG001|Overall Study|Withdrawal by Subject|0|||
144273059|NCT00903968|520203113|FG002|Overall Study|Withdrawal by Subject|1|||
144273060|NCT00903968|520203114|FG003|Overall Study|Withdrawal by Subject|0|||
144273061|NCT00903968|520203115|FG004|Overall Study|Withdrawal by Subject|1|||
144273062|NCT00903968|520203116|FG005|Overall Study|Withdrawal by Subject|1|||
144273063|NCT00903968|520203117|FG006|Overall Study|Withdrawal by Subject|0|||
144273064|NCT00903968|520203118|FG007|Overall Study|Withdrawal by Subject|4|||
144273065|NCT00903968|520203111|FG000|Overall Study|Non-Compliance|0|||
144273066|NCT00903968|520203112|FG001|Overall Study|Non-Compliance|0|||
144273067|NCT00903968|520203113|FG002|Overall Study|Non-Compliance|0|||
144273068|NCT00903968|520203114|FG003|Overall Study|Non-Compliance|0|||
144273069|NCT00903968|520203115|FG004|Overall Study|Non-Compliance|0|||
144273070|NCT00903968|520203116|FG005|Overall Study|Non-Compliance|1|||
144273071|NCT00903968|520203117|FG006|Overall Study|Non-Compliance|0|||
144273072|NCT00903968|520203118|FG007|Overall Study|Non-Compliance|0|||
144273073|NCT00903968|520203111|FG000|Overall Study|Physician Decision|0|||
144273074|NCT00903968|520203112|FG001|Overall Study|Physician Decision|0|||
144273075|NCT00903968|520203113|FG002|Overall Study|Physician Decision|0|||
144273076|NCT00903968|520203114|FG003|Overall Study|Physician Decision|0|||
144273077|NCT00903968|520203115|FG004|Overall Study|Physician Decision|0|||
144273078|NCT00903968|520203116|FG005|Overall Study|Physician Decision|1|||
144273079|NCT00903968|520203117|FG006|Overall Study|Physician Decision|0|||
144273080|NCT00903968|520203118|FG007|Overall Study|Physician Decision|0|||
144273081|NCT00903968|520203111|FG000|Overall Study|Progressive Disease|2|||
144273082|NCT00903968|520203112|FG001|Overall Study|Progressive Disease|3|||
144273083|NCT00903968|520203113|FG002|Overall Study|Progressive Disease|2|||
144273084|NCT00903968|520203114|FG003|Overall Study|Progressive Disease|3|||
144273085|NCT00903968|520203115|FG004|Overall Study|Progressive Disease|3|||
144273086|NCT00903968|520203116|FG005|Overall Study|Progressive Disease|3|||
144273087|NCT00903968|520203117|FG006|Overall Study|Progressive Disease|0|||
144273088|NCT00903968|520203118|FG007|Overall Study|Progressive Disease|18|||
144273089|NCT00903968|520203111|FG000|Overall Study|Lack of Efficacy|0|||
144273090|NCT00903968|520203112|FG001|Overall Study|Lack of Efficacy|0|||
144273091|NCT00903968|520203113|FG002|Overall Study|Lack of Efficacy|0|||
144273092|NCT00903968|520203114|FG003|Overall Study|Lack of Efficacy|0|||
144273093|NCT00903968|520203115|FG004|Overall Study|Lack of Efficacy|0|||
144273094|NCT00903968|520203116|FG005|Overall Study|Lack of Efficacy|0|||
144273095|NCT00903968|520203117|FG006|Overall Study|Lack of Efficacy|0|||
144273096|NCT00903968|520203118|FG007|Overall Study|Lack of Efficacy|3|||
144273097|NCT00089648|520203119|FG000|Overall Study|Adverse Event|7|||
144273098|NCT00089648|520203119|FG000|Overall Study|Withdrawal by Subject|1|||
144273099|NCT00089648|520203119|FG000|Overall Study|Lack of Efficacy|33|||
144273100|NCT00423605|520203120|FG000|Overall Study|Adverse Event|129|||
144273101|NCT00423605|520203120|FG000|Overall Study|Withdrawal by Subject|36|||
144273102|NCT00423605|520203120|FG000|Overall Study|Lost to Follow-up|15|||
144273103|NCT00423605|520203120|FG000|Overall Study|Lack of Efficacy|38|||
144273104|NCT00423605|520203120|FG000|Overall Study|Sponsor Decision|3|||
144273105|NCT00423605|520203120|FG000|Overall Study|Physician Decision|8|||
144273106|NCT00423605|520203120|FG000|Overall Study|Protocol Violation|7|||
144273107|NCT00423605|520203120|FG000|Overall Study|Not one of the pre-specified options|5|||
144273108|NCT03183908|520203124|FG000|Overall Study|Missing Symptom Diary Data|0|||
144273109|NCT03183908|520203125|FG001|Overall Study|Missing Symptom Diary Data|2|||
144273110|NCT04889040|520203126|FG000|Overall Study|Withdrawal by Subject|3|||
144273111|NCT04889040|520203127|FG001|Overall Study|Withdrawal by Subject|3|||
144273112|NCT04889040|520203126|FG000|Overall Study|Lost to Follow-up|0|||
144273113|NCT04889040|520203127|FG001|Overall Study|Lost to Follow-up|1|||
144273114|NCT04889040|520203126|FG000|Overall Study|Adverse Event|2|||
144273115|NCT04889040|520203127|FG001|Overall Study|Adverse Event|1|||
144273116|NCT03738696|520203128|FG000|Overall Study|Withdrawal by Subject|0|||
144273117|NCT03738696|520203129|FG001|Overall Study|Withdrawal by Subject|1|||
144273118|NCT03738696|520203128|FG000|Overall Study|Lost to Follow-up|8|||
144273119|NCT03738696|520203129|FG001|Overall Study|Lost to Follow-up|14|||
144273120|NCT02058095|520203135|FG000|Overall Study|Adverse Event|1|||
144273121|NCT02058095|520203136|FG001|Overall Study|Adverse Event|0|||
144273122|NCT00726453|520203137|FG000|Primary Enrollment Group|Death|18|||
144273123|NCT00726453|520203138|FG001|Primary Enrollment Group|Death|0|||
144273124|NCT00726453|520203137|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
144273125|NCT00726453|520203138|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
144273126|NCT00726453|520203137|FG000|38 mm Length Group|Death|0|||
144273127|NCT00726453|520203138|FG001|38 mm Length Group|Death|3|||
144273128|NCT02690727|520203141|FG000|Overall Study|Adverse Event|2|||
144273129|NCT02690727|520203142|FG001|Overall Study|Adverse Event|2|||
144273130|NCT00915525|520203145|FG000|Overall Study|Protocol Violation|9|||
144273131|NCT00915525|520203146|FG001|Overall Study|Protocol Violation|4|||
144273132|NCT00915525|520203145|FG000|Overall Study|Withdrawal by Subject|59|||
144273133|NCT00915525|520203146|FG001|Overall Study|Withdrawal by Subject|21|||
144273134|NCT00915525|520203145|FG000|Overall Study|Lost to Follow-up|27|||
144273135|NCT00915525|520203146|FG001|Overall Study|Lost to Follow-up|16|||
144273136|NCT00915525|520203145|FG000|Overall Study|Pregnancy|2|||
144273137|NCT00915525|520203146|FG001|Overall Study|Pregnancy|0|||
144273138|NCT00915525|520203145|FG000|Overall Study|Lack of Efficacy|15|||
144273139|NCT00915525|520203146|FG001|Overall Study|Lack of Efficacy|32|||
144273140|NCT00915525|520203145|FG000|Overall Study|Adverse Event|29|||
144273141|NCT00915525|520203146|FG001|Overall Study|Adverse Event|13|||
144273142|NCT00915525|520203145|FG000|Overall Study|Missing|12|||
144273143|NCT00915525|520203146|FG001|Overall Study|Missing|1|||
144273144|NCT00915525|520203145|FG000|Overall Study|Other Reason|35|||
144273145|NCT00915525|520203146|FG001|Overall Study|Other Reason|12|||
144273146|NCT00915525|520203145|FG000|Overall Study|Site Closed|27|||
144273147|NCT00915525|520203146|FG001|Overall Study|Site Closed|9|||
144273148|NCT00915525|520203145|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
144273149|NCT00915525|520203146|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
144273150|NCT00915525|520203145|FG000|Overall Study|Study Burden|28|||
144273151|NCT00915525|520203146|FG001|Overall Study|Study Burden|12|||
144273152|NCT00915525|520203145|FG000|Overall Study|Non-Compliance|3|||
144273153|NCT00915525|520203146|FG001|Overall Study|Non-Compliance|1|||
144273154|NCT00915525|520203145|FG000|Overall Study|Patient Moved|15|||
144273155|NCT00915525|520203146|FG001|Overall Study|Patient Moved|9|||
144273156|NCT01712178|520203151|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
144273157|NCT01712178|520203152|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
144273158|NCT01712178|520203151|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
144273159|NCT01712178|520203152|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
144273160|NCT01712178|520203151|FG000|Overall Study|Lost to Follow-up|0|||
144273161|NCT01712178|520203152|FG001|Overall Study|Lost to Follow-up|1|||
144273162|NCT00091819|520203153|FG000|Overall Study|Adverse Event|1|||
144273163|NCT00091819|520203154|FG001|Overall Study|Adverse Event|1|||
144273164|NCT00091819|520203153|FG000|Overall Study|Death|4|||
144273165|NCT00091819|520203154|FG001|Overall Study|Death|5|||
144273166|NCT00091819|520203153|FG000|Overall Study|Lost to Follow-up|26|||
144273167|NCT00091819|520203154|FG001|Overall Study|Lost to Follow-up|23|||
144273168|NCT00091819|520203153|FG000|Overall Study|Withdrawal by Subject|5|||
144273169|NCT00091819|520203154|FG001|Overall Study|Withdrawal by Subject|8|||
144273170|NCT00091819|520203153|FG000|Overall Study|Protocol Violation|1|||
144273171|NCT00091819|520203154|FG001|Overall Study|Protocol Violation|2|||
144273172|NCT00091819|520203153|FG000|Overall Study|Other|2|||
144273173|NCT00091819|520203154|FG001|Overall Study|Other|3|||
144273174|NCT00091819|520203153|FG000|Overall Study|Never received study treatment|3|||
144273175|NCT00091819|520203154|FG001|Overall Study|Never received study treatment|4|||
144273176|NCT00827567|520203155|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
144273177|NCT03482024|520203160|FG000|Overall Study|Physician Decision|1|||
144273178|NCT03482024|520203161|FG001|Overall Study|Physician Decision|0|||
144273179|NCT03482024|520203162|FG002|Overall Study|Physician Decision|0|||
144273180|NCT03482024|520203163|FG003|Overall Study|Physician Decision|0|||
144273181|NCT03482024|520203164|FG004|Overall Study|Physician Decision|0|||
144273182|NCT00676143|520203167|FG000|Overall Study|Adverse Event|34|||
144273183|NCT00676143|520203168|FG001|Overall Study|Adverse Event|60|||
144273184|NCT00676143|520203167|FG000|Overall Study|Death|4|||
144273185|NCT00676143|520203168|FG001|Overall Study|Death|4|||
144273186|NCT00676143|520203167|FG000|Overall Study|Lack of Efficacy|0|||
144273187|NCT00676143|520203168|FG001|Overall Study|Lack of Efficacy|6|||
144273188|NCT00676143|520203167|FG000|Overall Study|Lost to Follow-up|0|||
144273189|NCT00676143|520203168|FG001|Overall Study|Lost to Follow-up|13|||
144273190|NCT00676143|520203167|FG000|Overall Study|Physician Decision|5|||
144273191|NCT00676143|520203168|FG001|Overall Study|Physician Decision|8|||
144273192|NCT00676143|520203167|FG000|Overall Study|Protocol Violation|4|||
144273193|NCT00676143|520203168|FG001|Overall Study|Protocol Violation|8|||
144273194|NCT00676143|520203167|FG000|Overall Study|Withdrawal by Subject|24|||
144273195|NCT00676143|520203168|FG001|Overall Study|Withdrawal by Subject|42|||
144273196|NCT00676143|520203167|FG000|Overall Study|Discontinuation of study by sponsor|65|||
144273197|NCT00676143|520203168|FG001|Overall Study|Discontinuation of study by sponsor|88|||
144273198|NCT00676143|520203167|FG000|Overall Study|Failed to return|2|||
144273199|NCT00676143|520203168|FG001|Overall Study|Failed to return|1|||
144273200|NCT00676143|520203167|FG000|Overall Study|Loss of caregiver|5|||
144273201|NCT00676143|520203168|FG001|Overall Study|Loss of caregiver|3|||
144273202|NCT00676143|520203167|FG000|Overall Study|Other|11|||
144273203|NCT00676143|520203168|FG001|Overall Study|Other|20|||
144273204|NCT00676143|520203167|FG000|Overall Study|Participant participation unknown|1|||
144273205|NCT00676143|520203168|FG001|Overall Study|Participant participation unknown|4|||
144273206|NCT00676143|520203167|FG000|Overall Study|Vasogenic edema recurrence|1|||
144273207|NCT00676143|520203168|FG001|Overall Study|Vasogenic edema recurrence|3|||
144273208|NCT02412657|520203174|FG000|Overall Study|Lost to Follow-up|1|||
144273209|NCT02412657|520203175|FG001|Overall Study|Lost to Follow-up|0|||
144273210|NCT02412657|520203176|FG002|Overall Study|Lost to Follow-up|0|||
144273211|NCT02412657|520203174|FG000|Overall Study|Protocol Violation|0|||
144273212|NCT02412657|520203175|FG001|Overall Study|Protocol Violation|2|||
144273213|NCT02412657|520203176|FG002|Overall Study|Protocol Violation|3|||
144273214|NCT03834350|520203180|FG000|Overall Study|Withdrawal by Subject|1|||
144273215|NCT00961415|520203183|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
144273216|NCT00961415|520203184|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
144273217|NCT00961415|520203185|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
144273218|NCT00961415|520203183|FG000|Induction Treatment Phase|Death|77|||
144273219|NCT00961415|520203184|FG001|Induction Treatment Phase|Death|0|||
144273220|NCT00961415|520203185|FG002|Induction Treatment Phase|Death|0|||
144273221|NCT00961415|520203183|FG000|Induction Treatment Phase|Protocol Violation|1|||
144273222|NCT00961415|520203184|FG001|Induction Treatment Phase|Protocol Violation|0|||
144273223|NCT00961415|520203185|FG002|Induction Treatment Phase|Protocol Violation|0|||
144273224|NCT00961415|520203183|FG000|Induction Treatment Phase|Physician Decision|2|||
144273225|NCT00961415|520203184|FG001|Induction Treatment Phase|Physician Decision|0|||
144273226|NCT00961415|520203185|FG002|Induction Treatment Phase|Physician Decision|0|||
144273227|NCT00961415|520203183|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
144273228|NCT00961415|520203184|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
144273229|NCT00961415|520203185|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
144273230|NCT00961415|520203183|FG000|Induction Treatment Phase|Other Reason|5|||
144273231|NCT00961415|520203184|FG001|Induction Treatment Phase|Other Reason|0|||
144273232|NCT00961415|520203185|FG002|Induction Treatment Phase|Other Reason|0|||
144273233|NCT00961415|520203183|FG000|Maintenance Treatment Phase|Death|0|||
144273234|NCT00961415|520203184|FG001|Maintenance Treatment Phase|Death|42|||
144273235|NCT00961415|520203185|FG002|Maintenance Treatment Phase|Death|34|||
144273236|NCT00961415|520203183|FG000|Maintenance Treatment Phase|Investigators decision|0|||
144273237|NCT00961415|520203184|FG001|Maintenance Treatment Phase|Investigators decision|2|||
144273238|NCT00961415|520203185|FG002|Maintenance Treatment Phase|Investigators decision|0|||
144273239|NCT00961415|520203183|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
144273240|NCT00961415|520203184|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
144273241|NCT00961415|520203185|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
144273242|NCT00961415|520203183|FG000|Maintenance Treatment Phase|Other reason|0|||
144273243|NCT00961415|520203184|FG001|Maintenance Treatment Phase|Other reason|1|||
144273244|NCT00961415|520203185|FG002|Maintenance Treatment Phase|Other reason|3|||
144273245|NCT00226655|520203186|FG000|Overall Study|Death|13|||
144273246|NCT00226655|520203186|FG000|Overall Study|Withdrawal by Subject|15|||
144273247|NCT00226655|520203186|FG000|Overall Study|Adverse Event|35|||
144273248|NCT00226655|520203186|FG000|Overall Study|Physician Decision|6|||
144273249|NCT00226655|520203186|FG000|Overall Study|Clinical deterioration|10|||
144273250|NCT01311661|520203189|FG000|Overall Study|Adverse Event|2|||
144273251|NCT01311661|520203189|FG000|Overall Study|Protocol Violation|3|||
144273252|NCT01311661|520203189|FG000|Overall Study|Withdrawal by Subject|2|||
144273253|NCT00284856|520203190|FG000|Overall Study|Adverse Event|3|||
144273254|NCT00284856|520203191|FG001|Overall Study|Adverse Event|3|||
144273255|NCT00284856|520203192|FG002|Overall Study|Adverse Event|3|||
144273256|NCT00284856|520203190|FG000|Overall Study|Lack of Efficacy|2|||
144273257|NCT00284856|520203191|FG001|Overall Study|Lack of Efficacy|1|||
144273258|NCT00284856|520203192|FG002|Overall Study|Lack of Efficacy|8|||
144273259|NCT00284856|520203190|FG000|Overall Study|Lost to Follow-up|25|||
144273260|NCT00284856|520203191|FG001|Overall Study|Lost to Follow-up|21|||
144273261|NCT00284856|520203192|FG002|Overall Study|Lost to Follow-up|22|||
144273262|NCT00284856|520203190|FG000|Overall Study|Protocol Violation|5|||
144273263|NCT00284856|520203191|FG001|Overall Study|Protocol Violation|4|||
144273264|NCT00284856|520203192|FG002|Overall Study|Protocol Violation|5|||
144273265|NCT00284856|520203190|FG000|Overall Study|Withdrawal by Subject|12|||
144273266|NCT00284856|520203191|FG001|Overall Study|Withdrawal by Subject|16|||
144273267|NCT00284856|520203192|FG002|Overall Study|Withdrawal by Subject|18|||
144273268|NCT00284856|520203190|FG000|Overall Study|Other|4|||
144273269|NCT00284856|520203191|FG001|Overall Study|Other|5|||
144273270|NCT00284856|520203192|FG002|Overall Study|Other|4|||
144273271|NCT03692949|520203193|FG000|Overall Study|Lost to Follow-up|0|||
144273272|NCT03692949|520203194|FG001|Overall Study|Lost to Follow-up|0|||
144273273|NCT03692949|520203195|FG002|Overall Study|Lost to Follow-up|0|||
144273274|NCT03692949|520203196|FG003|Overall Study|Lost to Follow-up|0|||
144273275|NCT03692949|520203197|FG004|Overall Study|Lost to Follow-up|0|||
144273276|NCT03692949|520203198|FG005|Overall Study|Lost to Follow-up|0|||
144273277|NCT03692949|520203199|FG006|Overall Study|Lost to Follow-up|0|||
144273278|NCT03692949|520203200|FG007|Overall Study|Lost to Follow-up|1|||
144273279|NCT03426878|520203204|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
144273280|NCT03426878|520203204|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
144273281|NCT03426878|520203204|FG000|Overall Study|Declined to receive results|3|||
144273282|NCT03426878|520203204|FG000|Overall Study|Received negative results by mailed letter|65|||
144273283|NCT03426878|520203204|FG000|Overall Study|Lost to Follow-up|177|||
144273284|NCT03074500|520203205|FG000|Overall Study|Lost to Follow-up|1|||
144273285|NCT03074500|520203206|FG001|Overall Study|Lost to Follow-up|0|||
144273286|NCT03074500|520203207|FG002|Overall Study|Lost to Follow-up|0|||
144273287|NCT03074500|520203205|FG000|Overall Study|Lack of Efficacy|0|||
144273288|NCT03074500|520203206|FG001|Overall Study|Lack of Efficacy|1|||
144273289|NCT03074500|520203207|FG002|Overall Study|Lack of Efficacy|0|||
144273290|NCT03074500|520203205|FG000|Overall Study|Adverse Event|0|||
144273291|NCT03074500|520203206|FG001|Overall Study|Adverse Event|0|||
144273292|NCT03074500|520203207|FG002|Overall Study|Adverse Event|1|||
144273293|NCT03321721|520203208|FG000|Overall Study|Lost to Follow-up|4|||
144273294|NCT03321721|520203209|FG001|Overall Study|Lost to Follow-up|8|||
144273295|NCT03321721|520203210|FG002|Overall Study|Lost to Follow-up|11|||
144273296|NCT01416571|520203213|FG000|Overall Study|Lost to Follow-up|2|||
144273297|NCT03608163|520203214|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
144273298|NCT03608163|520203215|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
144273299|NCT03353220|520203216|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
144273300|NCT03353220|520203217|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
144273301|NCT00661388|520203223|FG000|Overall Study|Adverse Event|14|||
144273302|NCT00661388|520203223|FG000|Overall Study|Protocol Violation|7|||
144273303|NCT00661388|520203223|FG000|Overall Study|Renal transplantation|1|||
144273304|NCT00661388|520203223|FG000|Overall Study|Dialysis initiation|1|||
144273305|NCT00661388|520203223|FG000|Overall Study|Administrative reasons|1|||
144273306|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
144273307|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
144273308|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
144273309|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Death|1|||
144273310|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Death|1|||
144273311|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Death|0|||
144273312|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
144273313|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
144273314|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
144273315|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
144273316|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
144273317|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
144273318|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
144273319|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
144273320|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
144273321|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
144273322|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
144273323|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
144273324|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
144273325|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
144273326|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
144273327|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
144273328|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
144273329|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
144273330|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
144273331|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
144273332|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
144273333|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
144273334|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
144273335|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
144273336|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Other|10|||
144273337|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Other|4|||
144273338|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Other|0|||
144273339|NCT04006457|520204791|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
144273340|NCT04006457|520204792|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
144273341|NCT04006457|520204793|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
144273342|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
144273343|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
144273344|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
144273345|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
144273346|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
144273347|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
144273348|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
144273349|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
144273350|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
144273351|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
144273352|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
144273353|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
144273354|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
144273355|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
144273356|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
144273357|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Other|2|||
144273358|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Other|3|||
144273359|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Other|0|||
144273360|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
144273361|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
144273362|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
144273363|NCT04006457|520204791|FG000|Main Study: Treatment Period 2|Ongoing|86|||
144273364|NCT04006457|520204792|FG001|Main Study: Treatment Period 2|Ongoing|96|||
144273365|NCT04006457|520204793|FG002|Main Study: Treatment Period 2|Ongoing|0|||
144273366|NCT04006457|520204791|FG000|Main Study Observation Period|Adverse Event|1|||
144273367|NCT04006457|520204792|FG001|Main Study Observation Period|Adverse Event|1|||
144273368|NCT04006457|520204793|FG002|Main Study Observation Period|Adverse Event|0|||
144273369|NCT04006457|520204791|FG000|Main Study Observation Period|Lost to Follow-up|0|||
144273370|NCT04006457|520204792|FG001|Main Study Observation Period|Lost to Follow-up|1|||
144273371|NCT04006457|520204793|FG002|Main Study Observation Period|Lost to Follow-up|0|||
144273372|NCT04006457|520204791|FG000|Main Study Observation Period|Pregnancy|1|||
144273373|NCT04006457|520204792|FG001|Main Study Observation Period|Pregnancy|0|||
144273374|NCT04006457|520204793|FG002|Main Study Observation Period|Pregnancy|0|||
144273375|NCT04006457|520204791|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
144273376|NCT04006457|520204792|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
144273377|NCT04006457|520204793|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
144273378|NCT04006457|520204791|FG000|Main Study Observation Period|Other|8|||
144273379|NCT04006457|520204792|FG001|Main Study Observation Period|Other|16|||
144273380|NCT04006457|520204793|FG002|Main Study Observation Period|Other|0|||
144273381|NCT04006457|520204791|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
144273382|NCT04006457|520204792|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
144273383|NCT04006457|520204793|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
144273384|NCT04006457|520204791|FG000|Main Study Observation Period|Ongoing|2|||
144273385|NCT04006457|520204792|FG001|Main Study Observation Period|Ongoing|1|||
144273386|NCT04006457|520204793|FG002|Main Study Observation Period|Ongoing|0|||
144273387|NCT04006457|520204791|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
144273388|NCT04006457|520204792|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
144273389|NCT04006457|520204793|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
144273390|NCT03729362|520204794|FG000|Overall Study|Withdrawal by Subject|2|||
144273391|NCT03729362|520204795|FG001|Overall Study|Withdrawal by Subject|0|||
144273392|NCT03729362|520204794|FG000|Overall Study|Physician Decision|1|||
144273393|NCT03729362|520204795|FG001|Overall Study|Physician Decision|0|||
144273394|NCT03729362|520204794|FG000|Overall Study|COVID-19 Pandemic|1|||
144273395|NCT03729362|520204795|FG001|Overall Study|COVID-19 Pandemic|0|||
144273396|NCT03729362|520204794|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
144273397|NCT03729362|520204795|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
144273398|NCT03729362|520204794|FG000|Overall Study|Adverse Event|0|||
144273399|NCT03729362|520204795|FG001|Overall Study|Adverse Event|1|||
144273400|NCT03729362|520204794|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
144273401|NCT03729362|520204795|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
144273402|NCT03979313|520204796|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
144273403|NCT03979313|520204797|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
144273404|NCT03979313|520204796|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
144273405|NCT03979313|520204797|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
144273406|NCT03979313|520204796|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
144273407|NCT03979313|520204797|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
144273408|NCT03979313|520204796|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
144273409|NCT03979313|520204797|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
144273410|NCT03979313|520204796|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
144273411|NCT03979313|520204797|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
144273412|NCT03979313|520204796|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
144273413|NCT03979313|520204797|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
144273414|NCT03979313|520204796|FG000|All Subjects|Any Other Reason|16|||
144273415|NCT03979313|520204797|FG001|All Subjects|Any Other Reason|23|||
144273416|NCT03979313|520204796|FG000|All Subjects|Covid-19|1|||
144273417|NCT03979313|520204797|FG001|All Subjects|Covid-19|3|||
144273418|NCT03979313|520204796|FG000|All Subjects|Withdrawal by Subject|35|||
144273419|NCT03979313|520204797|FG001|All Subjects|Withdrawal by Subject|44|||
144273420|NCT03979313|520204796|FG000|All Subjects|Death|0|||
144273421|NCT03979313|520204797|FG001|All Subjects|Death|5|||
144273422|NCT03979313|520204796|FG000|All Subjects|Lost to Follow-up|28|||
144273423|NCT03979313|520204797|FG001|All Subjects|Lost to Follow-up|61|||
144273424|NCT01588509|520204798|FG000|Overall Study|Lost to Follow-up|1|||
144273425|NCT01588509|520204799|FG001|Overall Study|Lost to Follow-up|0|||
144273426|NCT01983930|520204800|FG000|Overall Study|Withdrawal by Subject|9|||
144273427|NCT01983930|520204801|FG001|Overall Study|Withdrawal by Subject|8|||
144273428|NCT01983930|520204800|FG000|Overall Study|Adverse Event|0|||
144273429|NCT01983930|520204801|FG001|Overall Study|Adverse Event|1|||
144273430|NCT00393367|520204802|FG000|Overall Study|Protocol Violation|2|||
144273431|NCT00393367|520204803|FG001|Overall Study|Protocol Violation|5|||
144273432|NCT00393367|520204802|FG000|Overall Study|Withdrawal by Subject|0|||
144273433|NCT00393367|520204803|FG001|Overall Study|Withdrawal by Subject|2|||
144273434|NCT00634504|520204804|FG000|Overall Study|Protocol Violation|1|||
144273435|NCT00634504|520204805|FG001|Overall Study|Protocol Violation|0|||
144273436|NCT05001620|520204806|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
144273437|NCT05001620|520204807|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
144273438|NCT02736617|520204808|FG000|Treatment|Adverse Event|1|||
144273439|NCT02736617|520204808|FG000|Treatment|Lack of Efficacy|1|||
144273440|NCT02736617|520204808|FG000|Treatment|Withdrawal by Subject|1|||
144273441|NCT02736617|520204808|FG000|Maintenance|Lack of Efficacy|4|||
144273442|NCT02736617|520204808|FG000|Maintenance|Physician Decision|1|||
144273443|NCT00481676|520204811|FG000|Overall Study|Adverse Event|0|||
144273444|NCT00481676|520204812|FG001|Overall Study|Adverse Event|1|||
144273445|NCT00481676|520204811|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144273446|NCT00481676|520204812|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
144273447|NCT00481676|520204811|FG000|Overall Study|Administrative problem|1|||
144273448|NCT00481676|520204812|FG001|Overall Study|Administrative problem|0|||
144273449|NCT02911116|520204813|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144273450|NCT02911116|520204814|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144273451|NCT02911116|520204813|FG000|Overall Study|Lost to Follow-up|0|||
144273452|NCT02911116|520204814|FG001|Overall Study|Lost to Follow-up|1|||
144273453|NCT00819039|520204815|FG000|Overall Study|Physician Decision|1|||
144273454|NCT00819039|520204816|FG001|Overall Study|Physician Decision|0|||
144273455|NCT00819039|520204817|FG002|Overall Study|Physician Decision|1|||
144273456|NCT00819039|520204815|FG000|Overall Study|Protocol Violation|1|||
144273457|NCT00819039|520204816|FG001|Overall Study|Protocol Violation|0|||
144273458|NCT00819039|520204817|FG002|Overall Study|Protocol Violation|0|||
144273459|NCT04796415|520204818|FG000|Overall Study|not interested|12|||
144273460|NCT04796415|520204818|FG000|Overall Study|health issue|8|||
144273461|NCT04796415|520204818|FG000|Overall Study|Other|4|||
144273462|NCT04796415|520204818|FG000|Overall Study|discharged from home health service|3|||
144273463|NCT04796415|520204818|FG000|Overall Study|re-hospitalization|2|||
144273464|NCT04796415|520204818|FG000|Overall Study|moving to nursing home|1|||
144273465|NCT04796415|520204818|FG000|Overall Study|lost contact|1|||
144273466|NCT01240694|520204819|FG000|Overall Study|Adverse Event|9|||
144273467|NCT01240694|520204819|FG000|Overall Study|Lack of Efficacy|6|||
144273468|NCT01240694|520204819|FG000|Overall Study|Withdrawal by Subject|6|||
144273469|NCT01240694|520204819|FG000|Overall Study|Protocol Violation|2|||
144273470|NCT01240694|520204819|FG000|Overall Study|Lost to Follow-up|2|||
144273471|NCT01240694|520204819|FG000|Overall Study|Other than specified|3|||
144273472|NCT01240694|520204819|FG000|Overall Study|Withdrawn due to early study termination|107|||
144273473|NCT01513590|520204820|FG000|Overall Study|Adverse Event|2|||
144273474|NCT01513590|520204821|FG001|Overall Study|Adverse Event|3|||
144273475|NCT01513590|520204820|FG000|Overall Study|Withdrawal Criteria|3|||
144273476|NCT01513590|520204821|FG001|Overall Study|Withdrawal Criteria|0|||
144273477|NCT01513590|520204820|FG000|Overall Study|Unclassified|5|||
144273478|NCT01513590|520204821|FG001|Overall Study|Unclassified|10|||
144273479|NCT02110693|520204822|FG000|Overall Study|Withdrawal by Subject|6|||
144273480|NCT02110693|520204823|FG001|Overall Study|Withdrawal by Subject|7|||
144273481|NCT02110693|520204822|FG000|Overall Study|skipped assessment|15|||
144273482|NCT02110693|520204823|FG001|Overall Study|skipped assessment|18|||
144273483|NCT02110693|520204822|FG000|Overall Study|technical difficulties|6|||
144273484|NCT02110693|520204823|FG001|Overall Study|technical difficulties|4|||
144273485|NCT02110693|520204822|FG000|Overall Study|Other|1|||
144273486|NCT02110693|520204823|FG001|Overall Study|Other|0|||
144273487|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
144273488|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
144273489|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
144273490|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
144273491|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
144273492|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
144273493|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
144273494|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
144273495|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
144273496|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
144273497|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Death|3|||
144273498|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Death|1|||
144273499|NCT01056276|520204824|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
144273500|NCT01056276|520204825|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
144273501|NCT01056276|520204824|FG000|Maintenance Therapy|Toxicity|0|||
144273502|NCT01056276|520204825|FG001|Maintenance Therapy|Toxicity|2|||
144273503|NCT01056276|520204824|FG000|Maintenance Therapy|Progressive Disease|0|||
144273504|NCT01056276|520204825|FG001|Maintenance Therapy|Progressive Disease|9|||
144273505|NCT01056276|520204824|FG000|Maintenance Therapy|Physician Decision|0|||
144273506|NCT01056276|520204825|FG001|Maintenance Therapy|Physician Decision|1|||
144273507|NCT01056276|520204824|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
144273508|NCT01056276|520204825|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
144273509|NCT01056276|520204824|FG000|Maintenance Therapy|Intercurrent Illness|0|||
144273510|NCT01056276|520204825|FG001|Maintenance Therapy|Intercurrent Illness|1|||
144273511|NCT01056276|520204824|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
144273512|NCT01056276|520204825|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
144273513|NCT01881425|520204826|FG000|Overall Study|Death|5|||
144273514|NCT01881425|520204827|FG001|Overall Study|Death|1|||
144273515|NCT01881425|520204826|FG000|Overall Study|Withdrawal by Subject|8|||
144273516|NCT01881425|520204827|FG001|Overall Study|Withdrawal by Subject|3|||
144273517|NCT01881425|520204826|FG000|Overall Study|Physician Decision|2|||
144273518|NCT01881425|520204827|FG001|Overall Study|Physician Decision|1|||
144273519|NCT01881425|520204826|FG000|Overall Study|Adverse Event|3|||
144273520|NCT01881425|520204827|FG001|Overall Study|Adverse Event|0|||
144273521|NCT01881425|520204826|FG000|Overall Study|General Anesthesia panic attack|0|||
144273522|NCT01881425|520204827|FG001|Overall Study|General Anesthesia panic attack|1|||
144273523|NCT01881425|520204826|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
144273524|NCT01881425|520204827|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
144273525|NCT01881425|520204826|FG000|Overall Study|Lost to Follow-up|7|||
144273526|NCT01881425|520204827|FG001|Overall Study|Lost to Follow-up|2|||
144273527|NCT04154956|520204830|FG000|Overall Study|Death|109|||
144273528|NCT04154956|520204831|FG001|Overall Study|Death|110|||
144273529|NCT04154956|520204830|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
144273530|NCT04154956|520204831|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
144273531|NCT04154956|520204830|FG000|Overall Study|Withdrawal by Subject|1|||
144273532|NCT04154956|520204831|FG001|Overall Study|Withdrawal by Subject|7|||
144273533|NCT04154956|520204830|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
144273534|NCT04154956|520204831|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
144273535|NCT04424901|520204832|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
144273536|NCT04424901|520204833|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
144273537|NCT00147238|520204834|FG000|Overall Study|Inevaluable|8|||
144273538|NCT01348269|520204835|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
144273539|NCT01348269|520204836|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
144273540|NCT01348269|520204835|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
144273541|NCT01348269|520204836|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
144273542|NCT01348269|520204835|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
144273543|NCT01348269|520204836|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
144273544|NCT00805532|520204837|FG000|Overall Study|invalid data|0|||
144273545|NCT00805532|520204838|FG001|Overall Study|invalid data|1|||
144273546|NCT01859741|520204839|FG000|Overall Study|Death|3|||
144273547|NCT01859741|520204840|FG001|Overall Study|Death|2|||
144273548|NCT01859741|520204841|FG002|Overall Study|Death|4|||
144273549|NCT01859741|520204842|FG003|Overall Study|Death|3|||
144273550|NCT01859741|520204843|FG004|Overall Study|Death|5|||
144273551|NCT01859741|520204844|FG005|Overall Study|Death|4|||
144273552|NCT01859741|520204845|FG006|Overall Study|Death|51|||
144273553|NCT01859741|520204846|FG007|Overall Study|Death|51|||
144273554|NCT01859741|520204839|FG000|Overall Study|Lost to Follow-up|0|||
144273555|NCT01859741|520204840|FG001|Overall Study|Lost to Follow-up|0|||
144273556|NCT01859741|520204841|FG002|Overall Study|Lost to Follow-up|0|||
144273557|NCT01859741|520204842|FG003|Overall Study|Lost to Follow-up|0|||
144273558|NCT01859741|520204843|FG004|Overall Study|Lost to Follow-up|0|||
144273559|NCT01859741|520204844|FG005|Overall Study|Lost to Follow-up|1|||
144273560|NCT01859741|520204845|FG006|Overall Study|Lost to Follow-up|0|||
144273561|NCT01859741|520204846|FG007|Overall Study|Lost to Follow-up|4|||
144273562|NCT01859741|520204839|FG000|Overall Study|Withdrawal by Subject|0|||
144273563|NCT01859741|520204840|FG001|Overall Study|Withdrawal by Subject|1|||
144273564|NCT01859741|520204841|FG002|Overall Study|Withdrawal by Subject|2|||
144273565|NCT01859741|520204842|FG003|Overall Study|Withdrawal by Subject|0|||
144273566|NCT01859741|520204843|FG004|Overall Study|Withdrawal by Subject|0|||
144273567|NCT01859741|520204844|FG005|Overall Study|Withdrawal by Subject|1|||
144273568|NCT01859741|520204845|FG006|Overall Study|Withdrawal by Subject|1|||
144273569|NCT01859741|520204846|FG007|Overall Study|Withdrawal by Subject|1|||
144273570|NCT01859741|520204839|FG000|Overall Study|Study Terminated by Sponsor|0|||
144273571|NCT01859741|520204840|FG001|Overall Study|Study Terminated by Sponsor|0|||
144273572|NCT01859741|520204841|FG002|Overall Study|Study Terminated by Sponsor|0|||
144273573|NCT01859741|520204842|FG003|Overall Study|Study Terminated by Sponsor|0|||
144273574|NCT01859741|520204843|FG004|Overall Study|Study Terminated by Sponsor|1|||
144273575|NCT01859741|520204844|FG005|Overall Study|Study Terminated by Sponsor|0|||
144273576|NCT01859741|520204845|FG006|Overall Study|Study Terminated by Sponsor|16|||
144273577|NCT01859741|520204846|FG007|Overall Study|Study Terminated by Sponsor|14|||
144273578|NCT01859741|520204839|FG000|Overall Study|Other|0|||
144273579|NCT01859741|520204840|FG001|Overall Study|Other|0|||
144273580|NCT01859741|520204841|FG002|Overall Study|Other|0|||
144273581|NCT01859741|520204842|FG003|Overall Study|Other|0|||
144273582|NCT01859741|520204843|FG004|Overall Study|Other|0|||
144273583|NCT01859741|520204844|FG005|Overall Study|Other|0|||
144273584|NCT01859741|520204845|FG006|Overall Study|Other|2|||
144273585|NCT01859741|520204846|FG007|Overall Study|Other|0|||
144273586|NCT02606253|520204850|FG000|Overall Study|Adverse Event|2|||
144273587|NCT02606253|520204851|FG001|Overall Study|Adverse Event|0|||
144273588|NCT02606253|520204852|FG002|Overall Study|Adverse Event|0|||
144273589|NCT02606253|520204850|FG000|Overall Study|Protocol Violation|2|||
144273590|NCT02606253|520204851|FG001|Overall Study|Protocol Violation|1|||
144273591|NCT02606253|520204852|FG002|Overall Study|Protocol Violation|0|||
144273592|NCT02606253|520204850|FG000|Overall Study|Physician Decision|1|||
144273593|NCT02606253|520204851|FG001|Overall Study|Physician Decision|1|||
144273594|NCT02606253|520204852|FG002|Overall Study|Physician Decision|0|||
144273595|NCT01186770|520204853|FG000|Overall Study|Ineligibility|0|||
144273596|NCT01186770|520204854|FG001|Overall Study|Ineligibility|0|||
144273597|NCT01186770|520204855|FG002|Overall Study|Ineligibility|2|||
144273598|NCT01186770|520204856|FG003|Overall Study|Ineligibility|0|||
144273599|NCT01186770|520204853|FG000|Overall Study|Protocol Violation|7|||
144273600|NCT01186770|520204854|FG001|Overall Study|Protocol Violation|9|||
144273601|NCT01186770|520204855|FG002|Overall Study|Protocol Violation|12|||
144273602|NCT01186770|520204856|FG003|Overall Study|Protocol Violation|14|||
144273603|NCT01186770|520204853|FG000|Overall Study|Adverse Event|2|||
144273604|NCT01186770|520204854|FG001|Overall Study|Adverse Event|9|||
144273605|NCT01186770|520204855|FG002|Overall Study|Adverse Event|7|||
144273606|NCT01186770|520204856|FG003|Overall Study|Adverse Event|9|||
144273607|NCT01186770|520204853|FG000|Overall Study|Withdrawal by Subject|15|||
144273608|NCT01186770|520204854|FG001|Overall Study|Withdrawal by Subject|13|||
144273609|NCT01186770|520204855|FG002|Overall Study|Withdrawal by Subject|11|||
144273610|NCT01186770|520204856|FG003|Overall Study|Withdrawal by Subject|17|||
144273611|NCT01186770|520204853|FG000|Overall Study|Lost to Follow-up|10|||
144273612|NCT01186770|520204854|FG001|Overall Study|Lost to Follow-up|6|||
144273613|NCT01186770|520204855|FG002|Overall Study|Lost to Follow-up|14|||
144273614|NCT01186770|520204856|FG003|Overall Study|Lost to Follow-up|9|||
144273615|NCT01186770|520204853|FG000|Overall Study|Insufficient response to treatment|7|||
144273616|NCT01186770|520204854|FG001|Overall Study|Insufficient response to treatment|8|||
144273617|NCT01186770|520204855|FG002|Overall Study|Insufficient response to treatment|5|||
144273618|NCT01186770|520204856|FG003|Overall Study|Insufficient response to treatment|7|||
144273619|NCT01186770|520204853|FG000|Overall Study|Other than specified|0|||
144273620|NCT01186770|520204854|FG001|Overall Study|Other than specified|1|||
144273621|NCT01186770|520204855|FG002|Overall Study|Other than specified|1|||
144273622|NCT01186770|520204856|FG003|Overall Study|Other than specified|2|||
144273623|NCT02567188|520204857|FG000|Overall Study|Death|10|||
144273624|NCT02567188|520204857|FG000|Overall Study|Terminated Mircera Treatment|9|||
144273625|NCT02567188|520204857|FG000|Overall Study|Lost to Follow-up|5|||
144273626|NCT02567188|520204857|FG000|Overall Study|Adverse Event|1|||
144273627|NCT02567188|520204857|FG000|Overall Study|Withdrawal by Subject|1|||
144273628|NCT02567188|520204857|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
144273629|NCT02567188|520204857|FG000|Overall Study|Moved and Changed Clinic|1|||
144273630|NCT02567188|520204857|FG000|Overall Study|Started Hemodialysis|2|||
144273631|NCT02567188|520204857|FG000|Overall Study|Protocol Violation|5|||
144273632|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
144273633|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
144273634|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
144273635|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
144273636|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
144273637|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
144273638|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
144273639|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
144273640|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
144273641|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
144273642|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
144273643|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
144273644|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
144273645|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
144273646|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
144273647|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
144273648|NCT00410163|520204860|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
144273649|NCT00410163|520204861|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
144273650|NCT00410163|520204860|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
144273651|NCT00410163|520204861|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
144273652|NCT00410163|520204860|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
144273653|NCT00410163|520204861|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
144273654|NCT00410163|520204860|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
144273655|NCT00410163|520204861|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
144273656|NCT00410163|520204860|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
144273657|NCT00410163|520204861|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
144273658|NCT00410163|520204860|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
144273659|NCT00410163|520204861|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
144273660|NCT03416179|520204863|FG000|Overall Study|Death|90|||
144273661|NCT03416179|520204864|FG001|Overall Study|Death|87|||
144273662|NCT03416179|520204865|FG002|Overall Study|Death|117|||
144273663|NCT03416179|520204866|FG003|Overall Study|Death|113|||
144273664|NCT03416179|520204863|FG000|Overall Study|Withdrawal by Subject|15|||
144273665|NCT03416179|520204864|FG001|Overall Study|Withdrawal by Subject|20|||
144273666|NCT03416179|520204865|FG002|Overall Study|Withdrawal by Subject|6|||
144273667|NCT03416179|520204866|FG003|Overall Study|Withdrawal by Subject|9|||
144273668|NCT03416179|520204863|FG000|Overall Study|Lost to Follow-up|1|||
144273669|NCT03416179|520204864|FG001|Overall Study|Lost to Follow-up|1|||
144273670|NCT03416179|520204865|FG002|Overall Study|Lost to Follow-up|0|||
144273671|NCT03416179|520204866|FG003|Overall Study|Lost to Follow-up|3|||
144273672|NCT03416179|520204863|FG000|Overall Study|Study participation terminated by Sponsor|93|||
144273673|NCT03416179|520204864|FG001|Overall Study|Study participation terminated by Sponsor|91|||
144273674|NCT03416179|520204865|FG002|Overall Study|Study participation terminated by Sponsor|26|||
144273675|NCT03416179|520204866|FG003|Overall Study|Study participation terminated by Sponsor|31|||
144273676|NCT03416179|520204863|FG000|Overall Study|Other|2|||
144273677|NCT03416179|520204864|FG001|Overall Study|Other|3|||
144273678|NCT03416179|520204865|FG002|Overall Study|Other|1|||
144273679|NCT03416179|520204866|FG003|Overall Study|Other|0|||
144273680|NCT02855268|520204868|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
144273681|NCT02855268|520204869|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
144273682|NCT02855268|520204868|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
144273683|NCT02855268|520204869|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
144273684|NCT02855268|520204868|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
144273685|NCT02855268|520204869|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
144273686|NCT02855268|520204868|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
144273687|NCT02855268|520204869|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
144273688|NCT02855268|520204868|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
144273689|NCT02855268|520204869|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
144273690|NCT02855268|520204868|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
144273691|NCT02855268|520204869|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
144273692|NCT05233761|520204870|FG000|Treatment Period A|Withdrawal by Subject|12|||
144273693|NCT05233761|520204871|FG001|Treatment Period A|Withdrawal by Subject|10|||
144273694|NCT05233761|520204870|FG000|Treatment Period A|Lost to Follow-up|6|||
144273695|NCT05233761|520204871|FG001|Treatment Period A|Lost to Follow-up|12|||
144273696|NCT05233761|520204870|FG000|Treatment Period A|Protocol Violation|8|||
144273697|NCT05233761|520204871|FG001|Treatment Period A|Protocol Violation|15|||
144273698|NCT01394276|520204872|FG000|Overall Study|Related Adverse event (AEs)|15|||
144273699|NCT01394276|520204872|FG000|Overall Study|Not related AEs|9|||
144273700|NCT01394276|520204872|FG000|Overall Study|Remission of disease|2|||
144273701|NCT01394276|520204872|FG000|Overall Study|Insufficient therapeutic effect|17|||
144273702|NCT01394276|520204872|FG000|Overall Study|Insufficient compliance|9|||
144273703|NCT01394276|520204872|FG000|Overall Study|Lost to Follow-up|5|||
144273704|NCT01394276|520204872|FG000|Overall Study|Participant moved to another site|1|||
144273705|NCT01394276|520204872|FG000|Overall Study|Pregnancy|1|||
144273706|NCT01394276|520204872|FG000|Overall Study|unavailability of drug at the Hospital|2|||
144273707|NCT01394276|520204872|FG000|Overall Study|Symptoms of concurrent diseases|1|||
144273708|NCT01933594|520204873|FG000|Overall Study|Lost to Follow-up|1|||
144273709|NCT01933594|520204874|FG001|Overall Study|Lost to Follow-up|0|||
144273710|NCT01933594|520204875|FG002|Overall Study|Lost to Follow-up|0|||
144273711|NCT01933594|520204876|FG003|Overall Study|Lost to Follow-up|0|||
144273712|NCT01933594|520204877|FG004|Overall Study|Lost to Follow-up|1|||
144273713|NCT01933594|520204878|FG005|Overall Study|Lost to Follow-up|0|||
144273714|NCT01933594|520204873|FG000|Overall Study|Ineligible for subsequent study step|0|||
144273715|NCT01933594|520204874|FG001|Overall Study|Ineligible for subsequent study step|0|||
144273716|NCT01933594|520204875|FG002|Overall Study|Ineligible for subsequent study step|0|||
144273717|NCT01933594|520204876|FG003|Overall Study|Ineligible for subsequent study step|0|||
144273718|NCT01933594|520204877|FG004|Overall Study|Ineligible for subsequent study step|1|||
144273719|NCT01933594|520204878|FG005|Overall Study|Ineligible for subsequent study step|0|||
144273720|NCT04513366|520204879|FG000|Treatment Phase|Withdrawal by Subject|6|||
144273721|NCT04513366|520204880|FG001|Treatment Phase|Withdrawal by Subject|8|||
144273722|NCT04513366|520204881|FG002|Treatment Phase|Withdrawal by Subject|3|||
144273723|NCT04513366|520204879|FG000|Treatment Phase|Lost to Follow-up|1|||
144273724|NCT04513366|520204880|FG001|Treatment Phase|Lost to Follow-up|2|||
144273725|NCT04513366|520204881|FG002|Treatment Phase|Lost to Follow-up|5|||
144273726|NCT04513366|520204879|FG000|Treatment Phase|Other than Specified|1|||
144273727|NCT04513366|520204880|FG001|Treatment Phase|Other than Specified|0|||
144273728|NCT04513366|520204881|FG002|Treatment Phase|Other than Specified|2|||
144273729|NCT04513366|520204879|FG000|Treatment Phase|Physician Decision|2|||
144273730|NCT04513366|520204880|FG001|Treatment Phase|Physician Decision|0|||
144273731|NCT04513366|520204881|FG002|Treatment Phase|Physician Decision|0|||
144273732|NCT04513366|520204879|FG000|Treatment Phase|Adverse Event|0|||
144273733|NCT04513366|520204880|FG001|Treatment Phase|Adverse Event|1|||
144273734|NCT04513366|520204881|FG002|Treatment Phase|Adverse Event|1|||
144273735|NCT04513366|520204879|FG000|Extension Phase|Withdrawal by Subject|3|||
144273736|NCT04513366|520204880|FG001|Extension Phase|Withdrawal by Subject|1|||
144273737|NCT04513366|520204881|FG002|Extension Phase|Withdrawal by Subject|1|||
144273738|NCT04513366|520204879|FG000|Extension Phase|Other than Specified|4|||
144273739|NCT04513366|520204880|FG001|Extension Phase|Other than Specified|0|||
144273740|NCT04513366|520204881|FG002|Extension Phase|Other than Specified|1|||
144273741|NCT04513366|520204879|FG000|Extension Phase|Lost to Follow-up|1|||
144273742|NCT04513366|520204880|FG001|Extension Phase|Lost to Follow-up|1|||
144273743|NCT04513366|520204881|FG002|Extension Phase|Lost to Follow-up|1|||
144273744|NCT04513366|520204879|FG000|Extension Phase|Sponsor Decision|0|||
144273745|NCT04513366|520204880|FG001|Extension Phase|Sponsor Decision|1|||
144273746|NCT04513366|520204881|FG002|Extension Phase|Sponsor Decision|0|||
144273747|NCT04513366|520204879|FG000|Extension Phase|Death|0|||
144273748|NCT04513366|520204880|FG001|Extension Phase|Death|1|||
144273749|NCT04513366|520204881|FG002|Extension Phase|Death|0|||
144273750|NCT04513366|520204879|FG000|Extension Phase|Adverse Event|0|||
144273751|NCT04513366|520204880|FG001|Extension Phase|Adverse Event|0|||
144273752|NCT04513366|520204881|FG002|Extension Phase|Adverse Event|1|||
144273753|NCT01316575|520204885|FG000|Overall Study|Withdrawal by Subject|2|||
144273754|NCT01316575|520204886|FG001|Overall Study|Withdrawal by Subject|0|||
144273755|NCT01316575|520204885|FG000|Overall Study|Required alternate treatment|0|||
144273756|NCT01316575|520204886|FG001|Overall Study|Required alternate treatment|1|||
144273757|NCT02966834|520204887|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
144273758|NCT02966834|520204888|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
144273759|NCT02966834|520204889|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
144273760|NCT02966834|520204890|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
144273761|NCT02966834|520204891|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
144273762|NCT02966834|520204892|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
144273763|NCT02966834|520204887|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
144273764|NCT02966834|520204888|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144273765|NCT02966834|520204889|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144273766|NCT02966834|520204890|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144273767|NCT02966834|520204891|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144273768|NCT02966834|520204892|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
144273769|NCT02966834|520204887|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
144273770|NCT02966834|520204888|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
144273771|NCT02966834|520204889|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
144273772|NCT02966834|520204890|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
144273773|NCT02966834|520204891|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
144273774|NCT02966834|520204892|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
144273775|NCT02966834|520204887|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
144273776|NCT02966834|520204888|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
144273777|NCT02966834|520204889|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
144273778|NCT02966834|520204890|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
144273779|NCT02966834|520204891|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
144273780|NCT02966834|520204892|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
144273781|NCT02966834|520204887|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144273782|NCT02966834|520204888|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144273783|NCT02966834|520204889|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144273784|NCT02966834|520204890|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
144273785|NCT02966834|520204891|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144273786|NCT02966834|520204892|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
144273787|NCT02966834|520204887|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
144273788|NCT02966834|520204888|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
144273789|NCT02966834|520204889|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
144273790|NCT02966834|520204890|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
144273791|NCT02966834|520204891|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
144273792|NCT02966834|520204892|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
144273793|NCT02814526|520204893|FG000|Overall Study|Adverse Event|4|||
144273794|NCT02814526|520204894|FG001|Overall Study|Adverse Event|3|||
144273795|NCT02814526|520204893|FG000|Overall Study|Death|1|||
144273796|NCT02814526|520204894|FG001|Overall Study|Death|1|||
144273797|NCT02814526|520204893|FG000|Overall Study|Lost to Follow-up|3|||
144273798|NCT02814526|520204894|FG001|Overall Study|Lost to Follow-up|4|||
144273799|NCT02814526|520204893|FG000|Overall Study|non site physician decision|1|||
144273800|NCT02814526|520204894|FG001|Overall Study|non site physician decision|0|||
144273801|NCT02814526|520204893|FG000|Overall Study|participant noncompliance|1|||
144273802|NCT02814526|520204894|FG001|Overall Study|participant noncompliance|1|||
144273803|NCT02814526|520204893|FG000|Overall Study|Withdrawal by Subject|20|||
144273804|NCT02814526|520204894|FG001|Overall Study|Withdrawal by Subject|14|||
144273805|NCT02814526|520204893|FG000|Overall Study|safety risk|2|||
144273806|NCT02814526|520204894|FG001|Overall Study|safety risk|1|||
144273807|NCT02814526|520204893|FG000|Overall Study|early termination-study terminated|1|||
144273808|NCT02814526|520204894|FG001|Overall Study|early termination-study terminated|2|||
144273809|NCT02814526|520204893|FG000|Overall Study|Other|0|||
144273810|NCT02814526|520204894|FG001|Overall Study|Other|4|||
144273811|NCT00655889|520204895|FG000|Overall Study|Inadequate cell growth|1|||
144273812|NCT00655889|520204895|FG000|Overall Study|Protocol Violation|1|||
144273813|NCT04585893|520204896|FG000|Overall Study|Death|1|||
144273814|NCT04585893|520204897|FG001|Overall Study|Death|0|||
144273815|NCT03573297|520204898|FG000|Open Label Treatment Period|Adverse Event|67|||
144273816|NCT03573297|520204899|FG001|Open Label Treatment Period|Adverse Event|0|||
144273817|NCT03573297|520204900|FG002|Open Label Treatment Period|Adverse Event|0|||
144273818|NCT03573297|520204901|FG003|Open Label Treatment Period|Adverse Event|0|||
144273819|NCT03573297|520204898|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
144273820|NCT03573297|520204899|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
144273821|NCT03573297|520204900|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
144273822|NCT03573297|520204901|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
144273823|NCT03573297|520204898|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
144273824|NCT03573297|520204899|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
144273825|NCT03573297|520204900|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
144273826|NCT03573297|520204901|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
144273827|NCT03573297|520204898|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
144273828|NCT03573297|520204899|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
144273829|NCT03573297|520204900|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
144273830|NCT03573297|520204901|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
144273831|NCT03573297|520204898|FG000|Open Label Treatment Period|Pregnancy|1|||
144273832|NCT03573297|520204899|FG001|Open Label Treatment Period|Pregnancy|0|||
144273833|NCT03573297|520204900|FG002|Open Label Treatment Period|Pregnancy|0|||
144273834|NCT03573297|520204901|FG003|Open Label Treatment Period|Pregnancy|0|||
144273835|NCT03573297|520204898|FG000|Open Label Treatment Period|Protocol Violation|17|||
144273836|NCT03573297|520204899|FG001|Open Label Treatment Period|Protocol Violation|0|||
144273837|NCT03573297|520204900|FG002|Open Label Treatment Period|Protocol Violation|0|||
144273838|NCT03573297|520204901|FG003|Open Label Treatment Period|Protocol Violation|0|||
144273839|NCT03573297|520204898|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
144273840|NCT03573297|520204899|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
144273841|NCT03573297|520204900|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
144273842|NCT03573297|520204901|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
144273843|NCT03573297|520204898|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
144273844|NCT03573297|520204899|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
144273845|NCT03573297|520204900|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
144273846|NCT03573297|520204901|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
144273847|NCT03573297|520204898|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
144273848|NCT03573297|520204899|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
144273849|NCT03573297|520204900|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
144273850|NCT03573297|520204901|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
144273851|NCT03573297|520204898|FG000|Open Label Treatment Period|Other, Not Specified|7|||
144273852|NCT03573297|520204899|FG001|Open Label Treatment Period|Other, Not Specified|0|||
144273853|NCT03573297|520204900|FG002|Open Label Treatment Period|Other, Not Specified|0|||
144273854|NCT03573297|520204901|FG003|Open Label Treatment Period|Other, Not Specified|0|||
144273855|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
144273856|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
144273857|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
144273858|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
144273859|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144273860|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144273861|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Adverse Event|5|||
144273862|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Adverse Event|1|||
144273863|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
144273864|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
144273865|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
144273866|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
144273867|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144273868|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
144273869|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
144273870|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
144273871|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144273872|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
144273873|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
144273874|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
144273875|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
144273876|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
144273877|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
144273878|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
144273879|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
144273880|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
144273881|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
144273882|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
144273883|NCT03573297|520204898|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
144273884|NCT03573297|520204899|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
144273885|NCT03573297|520204900|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
144273886|NCT03573297|520204901|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
144273887|NCT01366092|520204904|FG000|Overall Study|Progressive cGVHD|2|||
144273888|NCT01366092|520204904|FG000|Overall Study|Physician Decision|1|||
144273889|NCT01366092|520204904|FG000|Overall Study|Withdrawal by Subject|1|||
144273890|NCT02273167|520204906|FG000|Overall Study|Adverse Event|1|||
144273891|NCT02273167|520204907|FG001|Overall Study|Adverse Event|0|||
144273892|NCT02273167|520204908|FG002|Overall Study|Adverse Event|0|||
144273893|NCT02273167|520204906|FG000|Overall Study|Protocol Violation|3|||
144273894|NCT02273167|520204907|FG001|Overall Study|Protocol Violation|1|||
144273895|NCT02273167|520204908|FG002|Overall Study|Protocol Violation|1|||
144273896|NCT02273167|520204906|FG000|Overall Study|Lost to Follow-up|0|||
144273897|NCT02273167|520204907|FG001|Overall Study|Lost to Follow-up|1|||
144273898|NCT02273167|520204908|FG002|Overall Study|Lost to Follow-up|1|||
144273899|NCT02273167|520204906|FG000|Overall Study|Withdrawal by Subject|10|||
144273900|NCT02273167|520204907|FG001|Overall Study|Withdrawal by Subject|12|||
144273901|NCT02273167|520204908|FG002|Overall Study|Withdrawal by Subject|11|||
144273902|NCT02273167|520204906|FG000|Overall Study|Various|10|||
144273903|NCT02273167|520204907|FG001|Overall Study|Various|9|||
144273904|NCT02273167|520204908|FG002|Overall Study|Various|8|||
144273905|NCT01093846|520204909|FG000|Overall Study|Adverse Event|0|||
144273906|NCT01093846|520204910|FG001|Overall Study|Adverse Event|0|||
144273907|NCT01093846|520204911|FG002|Overall Study|Adverse Event|1|||
144273908|NCT01093846|520204909|FG000|Overall Study|Lack of Efficacy|0|||
144273909|NCT01093846|520204910|FG001|Overall Study|Lack of Efficacy|0|||
144273910|NCT01093846|520204911|FG002|Overall Study|Lack of Efficacy|4|||
144273911|NCT01093846|520204909|FG000|Overall Study|Condition no longer required study drug|1|||
144273912|NCT01093846|520204910|FG001|Overall Study|Condition no longer required study drug|1|||
144273913|NCT01093846|520204911|FG002|Overall Study|Condition no longer required study drug|1|||
144273914|NCT01093846|520204909|FG000|Overall Study|Administrative Problems|18|||
144273915|NCT01093846|520204910|FG001|Overall Study|Administrative Problems|17|||
144273916|NCT01093846|520204911|FG002|Overall Study|Administrative Problems|15|||
144273917|NCT03454555|520206345|FG000|Overall Study|Death|6|||
144273918|NCT03454555|520206346|FG001|Overall Study|Death|6|||
144273919|NCT03454555|520206345|FG000|Overall Study|Lost to Follow-up|31|||
144273920|NCT03454555|520206346|FG001|Overall Study|Lost to Follow-up|12|||
144273921|NCT03454555|520206345|FG000|Overall Study|Physician Decision|2|||
144273922|NCT03454555|520206346|FG001|Overall Study|Physician Decision|6|||
144273923|NCT03454555|520206345|FG000|Overall Study|Withdrawal by Subject|34|||
144273924|NCT03454555|520206346|FG001|Overall Study|Withdrawal by Subject|5|||
144273925|NCT03454555|520206345|FG000|Overall Study|Ineligible|1|||
144273926|NCT03454555|520206346|FG001|Overall Study|Ineligible|5|||
144273927|NCT01288430|520206350|FG000|Part 1|Progressive disease|2|||
144273928|NCT01288430|520206351|FG001|Part 1|Progressive disease|1|||
144273929|NCT01288430|520206352|FG002|Part 1|Progressive disease|1|||
144273930|NCT01288430|520206353|FG003|Part 1|Progressive disease|6|||
144273931|NCT01288430|520206354|FG004|Part 1|Progressive disease|2|||
144273932|NCT01288430|520206355|FG005|Part 1|Progressive disease|4|||
144273933|NCT01288430|520206356|FG006|Part 1|Progressive disease|2|||
144273934|NCT01288430|520206357|FG007|Part 1|Progressive disease|0|||
144273935|NCT01288430|520206358|FG008|Part 1|Progressive disease|0|||
144273936|NCT01288430|520206359|FG009|Part 1|Progressive disease|0|||
144273937|NCT01288430|520206350|FG000|Part 1|Clinical disease progression|0|||
144273938|NCT01288430|520206351|FG001|Part 1|Clinical disease progression|0|||
144273939|NCT01288430|520206352|FG002|Part 1|Clinical disease progression|1|||
144273940|NCT01288430|520206353|FG003|Part 1|Clinical disease progression|0|||
144273941|NCT01288430|520206354|FG004|Part 1|Clinical disease progression|0|||
144273942|NCT01288430|520206355|FG005|Part 1|Clinical disease progression|2|||
144273943|NCT01288430|520206356|FG006|Part 1|Clinical disease progression|2|||
144273944|NCT01288430|520206357|FG007|Part 1|Clinical disease progression|0|||
144273945|NCT01288430|520206358|FG008|Part 1|Clinical disease progression|0|||
144273946|NCT01288430|520206359|FG009|Part 1|Clinical disease progression|0|||
144273947|NCT01288430|520206350|FG000|Part 1|Death due to disease progression|0|||
144273948|NCT01288430|520206351|FG001|Part 1|Death due to disease progression|0|||
144273949|NCT01288430|520206352|FG002|Part 1|Death due to disease progression|0|||
144273950|NCT01288430|520206353|FG003|Part 1|Death due to disease progression|0|||
144273951|NCT01288430|520206354|FG004|Part 1|Death due to disease progression|1|||
144273952|NCT01288430|520206355|FG005|Part 1|Death due to disease progression|0|||
144273953|NCT01288430|520206356|FG006|Part 1|Death due to disease progression|0|||
144273954|NCT01288430|520206357|FG007|Part 1|Death due to disease progression|0|||
144273955|NCT01288430|520206358|FG008|Part 1|Death due to disease progression|0|||
144273956|NCT01288430|520206359|FG009|Part 1|Death due to disease progression|0|||
144273957|NCT01288430|520206350|FG000|Part 1|Adverse Event|0|||
144273958|NCT01288430|520206351|FG001|Part 1|Adverse Event|0|||
144273959|NCT01288430|520206352|FG002|Part 1|Adverse Event|3|||
144273960|NCT01288430|520206353|FG003|Part 1|Adverse Event|1|||
144273961|NCT01288430|520206354|FG004|Part 1|Adverse Event|0|||
144273962|NCT01288430|520206355|FG005|Part 1|Adverse Event|0|||
144273963|NCT01288430|520206356|FG006|Part 1|Adverse Event|2|||
144273964|NCT01288430|520206357|FG007|Part 1|Adverse Event|0|||
144273965|NCT01288430|520206358|FG008|Part 1|Adverse Event|0|||
144273966|NCT01288430|520206359|FG009|Part 1|Adverse Event|0|||
144273967|NCT01288430|520206350|FG000|Part 1|Other|0|||
144273968|NCT01288430|520206351|FG001|Part 1|Other|2|||
144273969|NCT01288430|520206352|FG002|Part 1|Other|0|||
144273970|NCT01288430|520206353|FG003|Part 1|Other|0|||
144273971|NCT01288430|520206354|FG004|Part 1|Other|0|||
144273972|NCT01288430|520206355|FG005|Part 1|Other|0|||
144273973|NCT01288430|520206356|FG006|Part 1|Other|1|||
144273974|NCT01288430|520206357|FG007|Part 1|Other|0|||
144273975|NCT01288430|520206358|FG008|Part 1|Other|0|||
144273976|NCT01288430|520206359|FG009|Part 1|Other|0|||
144273977|NCT01288430|520206350|FG000|Part 2|Progressive disease|0|||
144273978|NCT01288430|520206351|FG001|Part 2|Progressive disease|0|||
144273979|NCT01288430|520206352|FG002|Part 2|Progressive disease|0|||
144273980|NCT01288430|520206353|FG003|Part 2|Progressive disease|0|||
144273981|NCT01288430|520206354|FG004|Part 2|Progressive disease|0|||
144273982|NCT01288430|520206355|FG005|Part 2|Progressive disease|0|||
144273983|NCT01288430|520206356|FG006|Part 2|Progressive disease|0|||
144273984|NCT01288430|520206357|FG007|Part 2|Progressive disease|8|||
144273985|NCT01288430|520206358|FG008|Part 2|Progressive disease|7|||
144273986|NCT01288430|520206359|FG009|Part 2|Progressive disease|2|||
144273987|NCT01288430|520206350|FG000|Part 2|Clinical disease progression|0|||
144273988|NCT01288430|520206351|FG001|Part 2|Clinical disease progression|0|||
144273989|NCT01288430|520206352|FG002|Part 2|Clinical disease progression|0|||
144273990|NCT01288430|520206353|FG003|Part 2|Clinical disease progression|0|||
144273991|NCT01288430|520206354|FG004|Part 2|Clinical disease progression|0|||
144273992|NCT01288430|520206355|FG005|Part 2|Clinical disease progression|0|||
144273993|NCT01288430|520206356|FG006|Part 2|Clinical disease progression|0|||
144273994|NCT01288430|520206357|FG007|Part 2|Clinical disease progression|2|||
144273995|NCT01288430|520206358|FG008|Part 2|Clinical disease progression|0|||
144273996|NCT01288430|520206359|FG009|Part 2|Clinical disease progression|0|||
144273997|NCT01288430|520206350|FG000|Part 2|Withdrawal by Subject|0|||
144273998|NCT01288430|520206351|FG001|Part 2|Withdrawal by Subject|0|||
144273999|NCT01288430|520206352|FG002|Part 2|Withdrawal by Subject|0|||
144274000|NCT01288430|520206353|FG003|Part 2|Withdrawal by Subject|0|||
144274001|NCT01288430|520206354|FG004|Part 2|Withdrawal by Subject|0|||
144274002|NCT01288430|520206355|FG005|Part 2|Withdrawal by Subject|0|||
144274003|NCT01288430|520206356|FG006|Part 2|Withdrawal by Subject|0|||
144274004|NCT01288430|520206357|FG007|Part 2|Withdrawal by Subject|1|||
144274005|NCT01288430|520206358|FG008|Part 2|Withdrawal by Subject|4|||
144274006|NCT01288430|520206359|FG009|Part 2|Withdrawal by Subject|0|||
144274007|NCT01288430|520206350|FG000|Part 2|Adverse Event|0|||
144274008|NCT01288430|520206351|FG001|Part 2|Adverse Event|0|||
144274009|NCT01288430|520206352|FG002|Part 2|Adverse Event|0|||
144274010|NCT01288430|520206353|FG003|Part 2|Adverse Event|0|||
144274011|NCT01288430|520206354|FG004|Part 2|Adverse Event|0|||
144274012|NCT01288430|520206355|FG005|Part 2|Adverse Event|0|||
144274013|NCT01288430|520206356|FG006|Part 2|Adverse Event|0|||
144274014|NCT01288430|520206357|FG007|Part 2|Adverse Event|1|||
144274015|NCT01288430|520206358|FG008|Part 2|Adverse Event|1|||
144274016|NCT01288430|520206359|FG009|Part 2|Adverse Event|0|||
144274017|NCT01288430|520206350|FG000|Part 2|Other|0|||
144274018|NCT01288430|520206351|FG001|Part 2|Other|0|||
144274019|NCT01288430|520206352|FG002|Part 2|Other|0|||
144274020|NCT01288430|520206353|FG003|Part 2|Other|0|||
144274021|NCT01288430|520206354|FG004|Part 2|Other|0|||
144274022|NCT01288430|520206355|FG005|Part 2|Other|0|||
144274023|NCT01288430|520206356|FG006|Part 2|Other|0|||
144274024|NCT01288430|520206357|FG007|Part 2|Other|0|||
144274025|NCT01288430|520206358|FG008|Part 2|Other|0|||
144274026|NCT01288430|520206359|FG009|Part 2|Other|1|||
144274027|NCT05172609|520206360|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
144274028|NCT05172609|520206361|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
144274029|NCT05172609|520206360|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
144274030|NCT05172609|520206361|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
144274031|NCT05172609|520206360|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
144274032|NCT05172609|520206361|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
144274033|NCT00300053|520206370|FG000|Overall Study|Patient/Caregiver Preference|2|||
144274034|NCT00300053|520206371|FG001|Overall Study|Patient/Caregiver Preference|2|||
144274035|NCT00300053|520206372|FG002|Overall Study|Patient/Caregiver Preference|3|||
144274036|NCT00300053|520206370|FG000|Overall Study|Death|0|||
144274037|NCT00300053|520206371|FG001|Overall Study|Death|0|||
144274038|NCT00300053|520206372|FG002|Overall Study|Death|3|||
144274039|NCT00300053|520206370|FG000|Overall Study|Lost to Follow-up|0|||
144274040|NCT00300053|520206371|FG001|Overall Study|Lost to Follow-up|1|||
144274041|NCT00300053|520206372|FG002|Overall Study|Lost to Follow-up|0|||
144274042|NCT00855582|520206374|FG000|Overall Study|Adverse Event|2|||
144274043|NCT00855582|520206375|FG001|Overall Study|Adverse Event|6|||
144274044|NCT00855582|520206376|FG002|Overall Study|Adverse Event|3|||
144274045|NCT00855582|520206374|FG000|Overall Study|Death|1|||
144274046|NCT00855582|520206375|FG001|Overall Study|Death|0|||
144274047|NCT00855582|520206376|FG002|Overall Study|Death|0|||
144274048|NCT00855582|520206374|FG000|Overall Study|Lack of Efficacy|1|||
144274049|NCT00855582|520206375|FG001|Overall Study|Lack of Efficacy|3|||
144274050|NCT00855582|520206376|FG002|Overall Study|Lack of Efficacy|8|||
144274051|NCT00855582|520206374|FG000|Overall Study|Lost to Follow-up|1|||
144274052|NCT00855582|520206375|FG001|Overall Study|Lost to Follow-up|3|||
144274053|NCT00855582|520206376|FG002|Overall Study|Lost to Follow-up|1|||
144274054|NCT00855582|520206374|FG000|Overall Study|Physician Decision|0|||
144274055|NCT00855582|520206375|FG001|Overall Study|Physician Decision|0|||
144274056|NCT00855582|520206376|FG002|Overall Study|Physician Decision|1|||
144274057|NCT00855582|520206374|FG000|Overall Study|Protocol Violation|6|||
144274058|NCT00855582|520206375|FG001|Overall Study|Protocol Violation|2|||
144274059|NCT00855582|520206376|FG002|Overall Study|Protocol Violation|6|||
144274060|NCT00855582|520206374|FG000|Overall Study|Entry Criteria Not Met|8|||
144274061|NCT00855582|520206375|FG001|Overall Study|Entry Criteria Not Met|6|||
144274062|NCT00855582|520206376|FG002|Overall Study|Entry Criteria Not Met|3|||
144274063|NCT00855582|520206374|FG000|Overall Study|Withdrawal by Subject|7|||
144274064|NCT00855582|520206375|FG001|Overall Study|Withdrawal by Subject|4|||
144274065|NCT00855582|520206376|FG002|Overall Study|Withdrawal by Subject|8|||
144274066|NCT03286504|520206382|FG000|Overall Study|Lost to Follow-up|19|||
144274067|NCT03286504|520206383|FG001|Overall Study|Lost to Follow-up|16|||
144274068|NCT00656617|520206384|FG000|Overall Study|Adverse Event|1|||
144274069|NCT00656617|520206384|FG000|Overall Study|Death|2|||
144274070|NCT00656617|520206384|FG000|Overall Study|Insurance Issues|2|||
144274071|NCT00656617|520206384|FG000|Overall Study|Move to different clinical trial|2|||
144274072|NCT02030600|520206385|FG000|Treatment Period 1|Adverse Event|5|||
144274073|NCT02030600|520206386|FG001|Treatment Period 1|Adverse Event|7|||
144274074|NCT02030600|520206385|FG000|Treatment Period 1|Lack of Efficacy|0|||
144274075|NCT02030600|520206386|FG001|Treatment Period 1|Lack of Efficacy|1|||
144274076|NCT02030600|520206385|FG000|Treatment Period 1|Lost to Follow-up|11|||
144274077|NCT02030600|520206386|FG001|Treatment Period 1|Lost to Follow-up|3|||
144274078|NCT02030600|520206385|FG000|Treatment Period 1|Protocol Violation|22|||
144274079|NCT02030600|520206386|FG001|Treatment Period 1|Protocol Violation|17|||
144274080|NCT02030600|520206385|FG000|Treatment Period 1|Withdrawal by Subject|13|||
144274081|NCT02030600|520206386|FG001|Treatment Period 1|Withdrawal by Subject|17|||
144274082|NCT02030600|520206385|FG000|Treatment Period 1|Casebook Unsigned|1|||
144274083|NCT02030600|520206386|FG001|Treatment Period 1|Casebook Unsigned|0|||
144274084|NCT02030600|520206385|FG000|Treatment Period 1|Unclassified|1|||
144274085|NCT02030600|520206386|FG001|Treatment Period 1|Unclassified|0|||
144274086|NCT02030600|520206385|FG000|Treatment Period 2|Adverse Event|4|||
144274087|NCT02030600|520206386|FG001|Treatment Period 2|Adverse Event|4|||
144274088|NCT02030600|520206385|FG000|Treatment Period 2|Lack of Efficacy|2|||
144274089|NCT02030600|520206386|FG001|Treatment Period 2|Lack of Efficacy|1|||
144274090|NCT02030600|520206385|FG000|Treatment Period 2|Lost to Follow-up|4|||
144274091|NCT02030600|520206386|FG001|Treatment Period 2|Lost to Follow-up|2|||
144274092|NCT02030600|520206385|FG000|Treatment Period 2|Protocol Violation|1|||
144274093|NCT02030600|520206386|FG001|Treatment Period 2|Protocol Violation|2|||
144274094|NCT02030600|520206385|FG000|Treatment Period 2|Withdrawal by Subject|13|||
144274095|NCT02030600|520206386|FG001|Treatment Period 2|Withdrawal by Subject|9|||
144274096|NCT02030600|520206385|FG000|Treatment Period 2|Unclassified|1|||
144274097|NCT02030600|520206386|FG001|Treatment Period 2|Unclassified|0|||
144274098|NCT02765165|520206393|FG000|Treatment Period|Progressive disease|3|||
144274099|NCT02765165|520206394|FG001|Treatment Period|Progressive disease|2|||
144274100|NCT02765165|520206395|FG002|Treatment Period|Progressive disease|3|||
144274101|NCT02765165|520206396|FG003|Treatment Period|Progressive disease|3|||
144274102|NCT02765165|520206397|FG004|Treatment Period|Progressive disease|4|||
144274103|NCT02765165|520206398|FG005|Treatment Period|Progressive disease|2|||
144274104|NCT02765165|520206399|FG006|Treatment Period|Progressive disease|2|||
144274105|NCT02765165|520206393|FG000|Treatment Period|Physician Decision|0|||
144274106|NCT02765165|520206394|FG001|Treatment Period|Physician Decision|1|||
144274107|NCT02765165|520206395|FG002|Treatment Period|Physician Decision|0|||
144274108|NCT02765165|520206396|FG003|Treatment Period|Physician Decision|0|||
144274109|NCT02765165|520206397|FG004|Treatment Period|Physician Decision|0|||
144274110|NCT02765165|520206398|FG005|Treatment Period|Physician Decision|0|||
144274111|NCT02765165|520206399|FG006|Treatment Period|Physician Decision|0|||
144274112|NCT02765165|520206393|FG000|Treatment Period|Adverse Event|0|||
144274113|NCT02765165|520206394|FG001|Treatment Period|Adverse Event|1|||
144274114|NCT02765165|520206395|FG002|Treatment Period|Adverse Event|0|||
144274115|NCT02765165|520206396|FG003|Treatment Period|Adverse Event|0|||
144274116|NCT02765165|520206397|FG004|Treatment Period|Adverse Event|0|||
144274117|NCT02765165|520206398|FG005|Treatment Period|Adverse Event|0|||
144274118|NCT02765165|520206399|FG006|Treatment Period|Adverse Event|0|||
144274119|NCT02765165|520206393|FG000|Treatment Period|Withdrawal by Subject|0|||
144274120|NCT02765165|520206394|FG001|Treatment Period|Withdrawal by Subject|0|||
144274121|NCT02765165|520206395|FG002|Treatment Period|Withdrawal by Subject|0|||
144274122|NCT02765165|520206396|FG003|Treatment Period|Withdrawal by Subject|0|||
144274123|NCT02765165|520206397|FG004|Treatment Period|Withdrawal by Subject|2|||
144274124|NCT02765165|520206398|FG005|Treatment Period|Withdrawal by Subject|0|||
144274125|NCT02765165|520206399|FG006|Treatment Period|Withdrawal by Subject|0|||
144274126|NCT02765165|520206393|FG000|Treatment Period|Study terminated|0|||
144274127|NCT02765165|520206394|FG001|Treatment Period|Study terminated|0|||
144274128|NCT02765165|520206395|FG002|Treatment Period|Study terminated|0|||
144274129|NCT02765165|520206396|FG003|Treatment Period|Study terminated|0|||
144274130|NCT02765165|520206397|FG004|Treatment Period|Study terminated|0|||
144274131|NCT02765165|520206398|FG005|Treatment Period|Study terminated|1|||
144274132|NCT02765165|520206399|FG006|Treatment Period|Study terminated|2|||
144274133|NCT02765165|520206393|FG000|Post-treatment Follow-up|Death|1|||
144274134|NCT02765165|520206394|FG001|Post-treatment Follow-up|Death|2|||
144274135|NCT02765165|520206395|FG002|Post-treatment Follow-up|Death|1|||
144274136|NCT02765165|520206396|FG003|Post-treatment Follow-up|Death|1|||
144274137|NCT02765165|520206397|FG004|Post-treatment Follow-up|Death|1|||
144274138|NCT02765165|520206398|FG005|Post-treatment Follow-up|Death|1|||
144274139|NCT02765165|520206399|FG006|Post-treatment Follow-up|Death|0|||
144274140|NCT02765165|520206393|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
144274141|NCT02765165|520206394|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
144274142|NCT02765165|520206395|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
144274143|NCT02765165|520206396|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
144274144|NCT02765165|520206397|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
144274145|NCT02765165|520206398|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
144274146|NCT02765165|520206399|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
144274147|NCT02765165|520206393|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
144274148|NCT02765165|520206394|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
144274149|NCT02765165|520206395|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
144274150|NCT02765165|520206396|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
144274151|NCT02765165|520206397|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
144274152|NCT02765165|520206398|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
144274153|NCT02765165|520206399|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
144274154|NCT02765165|520206393|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
144274155|NCT02765165|520206394|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
144274156|NCT02765165|520206395|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
144274157|NCT02765165|520206396|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
144274158|NCT02765165|520206397|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
144274159|NCT02765165|520206398|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
144274160|NCT02765165|520206399|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
144274161|NCT02765165|520206393|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
144274162|NCT02765165|520206394|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
144274163|NCT02765165|520206395|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
144274164|NCT02765165|520206396|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
144274165|NCT02765165|520206397|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
144274166|NCT02765165|520206398|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
144274167|NCT02765165|520206399|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
144274168|NCT02765165|520206393|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
144274169|NCT02765165|520206394|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
144274170|NCT02765165|520206395|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
144274171|NCT02765165|520206396|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
144274172|NCT02765165|520206397|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
144274173|NCT02765165|520206398|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
144274174|NCT02765165|520206399|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
144274175|NCT01189266|520206402|FG000|Overall Study|Adverse Event|1|||
144274176|NCT01189266|520206403|FG001|Overall Study|Adverse Event|0|||
144274177|NCT01189266|520206404|FG002|Overall Study|Adverse Event|5|||
144274178|NCT01189266|520206402|FG000|Overall Study|Death|0|||
144274179|NCT01189266|520206403|FG001|Overall Study|Death|0|||
144274180|NCT01189266|520206404|FG002|Overall Study|Death|5|||
144274181|NCT01189266|520206402|FG000|Overall Study|Lack of Efficacy|4|||
144274182|NCT01189266|520206403|FG001|Overall Study|Lack of Efficacy|5|||
144274183|NCT01189266|520206404|FG002|Overall Study|Lack of Efficacy|44|||
144274184|NCT01189266|520206402|FG000|Overall Study|Physician Decision|0|||
144274185|NCT01189266|520206403|FG001|Overall Study|Physician Decision|0|||
144274186|NCT01189266|520206404|FG002|Overall Study|Physician Decision|1|||
144274187|NCT01189266|520206402|FG000|Overall Study|Protocol Violation|0|||
144274188|NCT01189266|520206403|FG001|Overall Study|Protocol Violation|1|||
144274189|NCT01189266|520206404|FG002|Overall Study|Protocol Violation|1|||
144274190|NCT01189266|520206402|FG000|Overall Study|Withdrawal by Subject|0|||
144274191|NCT01189266|520206403|FG001|Overall Study|Withdrawal by Subject|0|||
144274192|NCT01189266|520206404|FG002|Overall Study|Withdrawal by Subject|1|||
144274193|NCT01189266|520206402|FG000|Overall Study|Patient refuses further therapy|1|||
144274194|NCT01189266|520206403|FG001|Overall Study|Patient refuses further therapy|0|||
144274195|NCT01189266|520206404|FG002|Overall Study|Patient refuses further therapy|7|||
144274196|NCT01189266|520206402|FG000|Overall Study|No treatment|0|||
144274197|NCT01189266|520206403|FG001|Overall Study|No treatment|0|||
144274198|NCT01189266|520206404|FG002|Overall Study|No treatment|1|||
144274199|NCT00537277|520206405|FG000|Overall Study|Adverse Event|1|||
144274200|NCT00537277|520206405|FG000|Overall Study|Lack of Efficacy|2|||
144274201|NCT00537277|520206405|FG000|Overall Study|Lost to Follow-up|12|||
144274202|NCT00537277|520206405|FG000|Overall Study|Protocol Violation|11|||
144274203|NCT00537277|520206405|FG000|Overall Study|Unclassified|4|||
144274204|NCT00537277|520206405|FG000|Overall Study|Inability to tolerate trial medication|4|||
144274205|NCT00537277|520206405|FG000|Overall Study|Non-compliance with trial procedures|15|||
144274206|NCT03620162|520206406|FG000|Overall Study|Physician Decision|4|||
144274207|NCT03620162|520206407|FG001|Overall Study|Physician Decision|0|||
144274208|NCT03620162|520206408|FG002|Overall Study|Physician Decision|1|||
144274209|NCT03620162|520206409|FG003|Overall Study|Physician Decision|0|||
144274210|NCT03620162|520206410|FG004|Overall Study|Physician Decision|2|||
144274211|NCT03620162|520206406|FG000|Overall Study|Lost to Follow-up|2|||
144274212|NCT03620162|520206407|FG001|Overall Study|Lost to Follow-up|6|||
144274213|NCT03620162|520206408|FG002|Overall Study|Lost to Follow-up|7|||
144274214|NCT03620162|520206409|FG003|Overall Study|Lost to Follow-up|3|||
144274215|NCT03620162|520206410|FG004|Overall Study|Lost to Follow-up|2|||
144274216|NCT03620162|520206406|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
144274217|NCT03620162|520206407|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
144274218|NCT03620162|520206408|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
144274219|NCT03620162|520206409|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
144274220|NCT03620162|520206410|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
144274221|NCT04009837|520206413|FG000|Overall Study|Withdrawal by Subject|5|||
144274222|NCT04009837|520206414|FG001|Overall Study|Withdrawal by Subject|4|||
144274223|NCT04009837|520206413|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
144274224|NCT04009837|520206414|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
144274225|NCT01572792|520206417|FG000|Lead-in Study|Lost to Follow-up|5|||
144274226|NCT01572792|520206418|FG001|Lead-in Study|Lost to Follow-up|9|||
144274227|NCT01572792|520206419|FG002|Lead-in Study|Lost to Follow-up|4|||
144274228|NCT01572792|520206420|FG003|Lead-in Study|Lost to Follow-up|2|||
144274229|NCT01572792|520206421|FG004|Lead-in Study|Lost to Follow-up|4|||
144274230|NCT01572792|520206417|FG000|Lead-in Study|Withdrawal by Subject|22|||
144274231|NCT01572792|520206418|FG001|Lead-in Study|Withdrawal by Subject|11|||
144274232|NCT01572792|520206419|FG002|Lead-in Study|Withdrawal by Subject|12|||
144274233|NCT01572792|520206420|FG003|Lead-in Study|Withdrawal by Subject|24|||
144274234|NCT01572792|520206421|FG004|Lead-in Study|Withdrawal by Subject|11|||
144274235|NCT01572792|520206417|FG000|Lead-in Study|Protocol Violation|19|||
144274236|NCT01572792|520206418|FG001|Lead-in Study|Protocol Violation|10|||
144274237|NCT01572792|520206419|FG002|Lead-in Study|Protocol Violation|12|||
144274238|NCT01572792|520206420|FG003|Lead-in Study|Protocol Violation|13|||
144274239|NCT01572792|520206421|FG004|Lead-in Study|Protocol Violation|21|||
144274240|NCT01572792|520206417|FG000|Lead-in Study|Lack of Efficacy|20|||
144274241|NCT01572792|520206418|FG001|Lead-in Study|Lack of Efficacy|5|||
144274242|NCT01572792|520206419|FG002|Lead-in Study|Lack of Efficacy|4|||
144274243|NCT01572792|520206420|FG003|Lead-in Study|Lack of Efficacy|8|||
144274244|NCT01572792|520206421|FG004|Lead-in Study|Lack of Efficacy|10|||
144274245|NCT01572792|520206417|FG000|Lead-in Study|Adverse Event|21|||
144274246|NCT01572792|520206418|FG001|Lead-in Study|Adverse Event|21|||
144274247|NCT01572792|520206419|FG002|Lead-in Study|Adverse Event|22|||
144274248|NCT01572792|520206420|FG003|Lead-in Study|Adverse Event|16|||
144274249|NCT01572792|520206421|FG004|Lead-in Study|Adverse Event|14|||
144274250|NCT01572792|520206417|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
144274251|NCT01572792|520206418|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
144274252|NCT01572792|520206419|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
144274253|NCT01572792|520206420|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
144274254|NCT01572792|520206421|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
144274255|NCT01572792|520206417|FG000|Extension Study|Lost to Follow-up|6|||
144274256|NCT01572792|520206418|FG001|Extension Study|Lost to Follow-up|2|||
144274257|NCT01572792|520206419|FG002|Extension Study|Lost to Follow-up|0|||
144274258|NCT01572792|520206420|FG003|Extension Study|Lost to Follow-up|3|||
144274259|NCT01572792|520206421|FG004|Extension Study|Lost to Follow-up|3|||
144274260|NCT01572792|520206417|FG000|Extension Study|Withdrawal by Subject|7|||
144274261|NCT01572792|520206418|FG001|Extension Study|Withdrawal by Subject|6|||
144274262|NCT01572792|520206419|FG002|Extension Study|Withdrawal by Subject|11|||
144274263|NCT01572792|520206420|FG003|Extension Study|Withdrawal by Subject|8|||
144274264|NCT01572792|520206421|FG004|Extension Study|Withdrawal by Subject|14|||
144274265|NCT01572792|520206417|FG000|Extension Study|Protocol Violation|0|||
144274266|NCT01572792|520206418|FG001|Extension Study|Protocol Violation|4|||
144274267|NCT01572792|520206419|FG002|Extension Study|Protocol Violation|3|||
144274268|NCT01572792|520206420|FG003|Extension Study|Protocol Violation|4|||
144274269|NCT01572792|520206421|FG004|Extension Study|Protocol Violation|3|||
144274270|NCT01572792|520206417|FG000|Extension Study|Lack of Efficacy|2|||
144274271|NCT01572792|520206418|FG001|Extension Study|Lack of Efficacy|3|||
144274272|NCT01572792|520206419|FG002|Extension Study|Lack of Efficacy|3|||
144274273|NCT01572792|520206420|FG003|Extension Study|Lack of Efficacy|2|||
144274274|NCT01572792|520206421|FG004|Extension Study|Lack of Efficacy|2|||
144274275|NCT01572792|520206417|FG000|Extension Study|Adverse Event|7|||
144274276|NCT01572792|520206418|FG001|Extension Study|Adverse Event|6|||
144274277|NCT01572792|520206419|FG002|Extension Study|Adverse Event|5|||
144274278|NCT01572792|520206420|FG003|Extension Study|Adverse Event|6|||
144274279|NCT01572792|520206421|FG004|Extension Study|Adverse Event|4|||
144274280|NCT01572792|520206417|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
144274281|NCT01572792|520206418|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
144274282|NCT01572792|520206419|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
144274283|NCT01572792|520206420|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
144274284|NCT01572792|520206421|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
144274285|NCT02472353|520206422|FG000|Overall Study|Lost to Follow-up|1|||
144274286|NCT02472353|520206423|FG001|Overall Study|Lost to Follow-up|1|||
144274287|NCT02472353|520206422|FG000|Overall Study|Withdrawal by Subject|2|||
144274288|NCT02472353|520206423|FG001|Overall Study|Withdrawal by Subject|1|||
144274289|NCT02472353|520206422|FG000|Overall Study|Study Termination|1|||
144274290|NCT02472353|520206423|FG001|Overall Study|Study Termination|4|||
144274291|NCT00797563|520206424|FG000|Overall Study|Adverse Event|1|||
144274292|NCT00688597|520206426|FG000|Overall Study|Adverse Event|2|||
144274293|NCT00688597|520206427|FG001|Overall Study|Adverse Event|0|||
144274294|NCT00688597|520206428|FG002|Overall Study|Adverse Event|0|||
144274295|NCT00688597|520206426|FG000|Overall Study|Physician Decision|1|||
144274296|NCT00688597|520206427|FG001|Overall Study|Physician Decision|0|||
144274297|NCT00688597|520206428|FG002|Overall Study|Physician Decision|0|||
144274298|NCT00844519|520206429|FG000|Overall Study|Withdrawal by Subject|1|||
144274299|NCT00844519|520206430|FG001|Overall Study|Withdrawal by Subject|1|||
144274300|NCT00844519|520206429|FG000|Overall Study|Adverse Event|1|||
144274301|NCT00844519|520206430|FG001|Overall Study|Adverse Event|0|||
144274302|NCT06438601|520206431|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
144274303|NCT06438601|520206432|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
144274304|NCT06438601|520206431|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
144274305|NCT06438601|520206432|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
144274306|NCT01056536|520206433|FG000|Overall Study|Lost to Follow-up|202|||
144274307|NCT01056536|520206434|FG001|Overall Study|Lost to Follow-up|116|||
144274308|NCT01056536|520206435|FG002|Overall Study|Lost to Follow-up|248|||
144274309|NCT01654276|520206454|FG000|Overall Study|Lack of Efficacy|1|||
144274310|NCT01654276|520206454|FG000|Overall Study|Lost to Follow-up|4|||
144274311|NCT01654276|520206454|FG000|Overall Study|Withdrawal by Subject|1|||
144274312|NCT04058717|520206455|FG000|Randomization Period|Lost to Follow-up|2|||
144274313|NCT04058717|520206456|FG001|Randomization Period|Lost to Follow-up|3|||
144274314|NCT04058717|520206457|FG002|Randomization Period|Lost to Follow-up|4|||
144274315|NCT04058717|520206458|FG003|Randomization Period|Lost to Follow-up|4|||
144274316|NCT04058717|520206455|FG000|Randomization Period|Withdrawal by Subject|1|||
144274317|NCT04058717|520206456|FG001|Randomization Period|Withdrawal by Subject|3|||
144274318|NCT04058717|520206457|FG002|Randomization Period|Withdrawal by Subject|3|||
144274319|NCT04058717|520206458|FG003|Randomization Period|Withdrawal by Subject|3|||
144274320|NCT04058717|520206455|FG000|Randomization Period|PI decision|0|||
144274321|NCT04058717|520206456|FG001|Randomization Period|PI decision|1|||
144274322|NCT04058717|520206457|FG002|Randomization Period|PI decision|0|||
144274323|NCT04058717|520206458|FG003|Randomization Period|PI decision|0|||
144274324|NCT01020123|520206462|FG000|Main Period|Withdrawal by Subject|6|||
144274325|NCT01020123|520206463|FG001|Main Period|Withdrawal by Subject|5|||
144274326|NCT01020123|520206464|FG002|Main Period|Withdrawal by Subject|3|||
144274327|NCT01020123|520206465|FG003|Main Period|Withdrawal by Subject|1|||
144274328|NCT01020123|520206466|FG004|Main Period|Withdrawal by Subject|6|||
144274329|NCT01020123|520206467|FG005|Main Period|Withdrawal by Subject|3|||
144274330|NCT01020123|520206468|FG006|Main Period|Withdrawal by Subject|2|||
144274331|NCT01020123|520206462|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
144274332|NCT01020123|520206463|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
144274333|NCT01020123|520206464|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
144274334|NCT01020123|520206465|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
144274335|NCT01020123|520206466|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
144274336|NCT01020123|520206467|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
144274337|NCT01020123|520206468|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
144274338|NCT01020123|520206462|FG000|Main Period|Adverse Event|5|||
144274339|NCT01020123|520206463|FG001|Main Period|Adverse Event|2|||
144274340|NCT01020123|520206464|FG002|Main Period|Adverse Event|2|||
144274341|NCT01020123|520206465|FG003|Main Period|Adverse Event|1|||
144274342|NCT01020123|520206466|FG004|Main Period|Adverse Event|1|||
144274343|NCT01020123|520206467|FG005|Main Period|Adverse Event|2|||
144274344|NCT01020123|520206468|FG006|Main Period|Adverse Event|1|||
144274345|NCT01020123|520206462|FG000|Main Period|Protocol Violation|4|||
144274346|NCT01020123|520206463|FG001|Main Period|Protocol Violation|4|||
144274347|NCT01020123|520206464|FG002|Main Period|Protocol Violation|2|||
144274348|NCT01020123|520206465|FG003|Main Period|Protocol Violation|5|||
144274349|NCT01020123|520206466|FG004|Main Period|Protocol Violation|2|||
144274350|NCT01020123|520206467|FG005|Main Period|Protocol Violation|3|||
144274351|NCT01020123|520206468|FG006|Main Period|Protocol Violation|2|||
144274352|NCT01020123|520206462|FG000|Main Period|Lost to Follow-up|0|||
144274353|NCT01020123|520206463|FG001|Main Period|Lost to Follow-up|2|||
144274354|NCT01020123|520206464|FG002|Main Period|Lost to Follow-up|0|||
144274355|NCT01020123|520206465|FG003|Main Period|Lost to Follow-up|0|||
144274356|NCT01020123|520206466|FG004|Main Period|Lost to Follow-up|0|||
144274357|NCT01020123|520206467|FG005|Main Period|Lost to Follow-up|0|||
144274358|NCT01020123|520206468|FG006|Main Period|Lost to Follow-up|0|||
144274359|NCT01020123|520206462|FG000|Main Period|Unclasified|2|||
144274360|NCT01020123|520206463|FG001|Main Period|Unclasified|0|||
144274361|NCT01020123|520206464|FG002|Main Period|Unclasified|1|||
144274362|NCT01020123|520206465|FG003|Main Period|Unclasified|0|||
144274363|NCT01020123|520206466|FG004|Main Period|Unclasified|1|||
144274364|NCT01020123|520206467|FG005|Main Period|Unclasified|3|||
144274365|NCT01020123|520206468|FG006|Main Period|Unclasified|6|||
144274366|NCT01020123|520206462|FG000|Extention Period|Withdrawal by Subject|2|||
144274367|NCT01020123|520206463|FG001|Extention Period|Withdrawal by Subject|1|||
144274368|NCT01020123|520206464|FG002|Extention Period|Withdrawal by Subject|1|||
144274369|NCT01020123|520206465|FG003|Extention Period|Withdrawal by Subject|0|||
144274370|NCT01020123|520206466|FG004|Extention Period|Withdrawal by Subject|0|||
144274371|NCT01020123|520206467|FG005|Extention Period|Withdrawal by Subject|0|||
144274372|NCT01020123|520206468|FG006|Extention Period|Withdrawal by Subject|0|||
144274373|NCT01020123|520206462|FG000|Extention Period|Adverse Event|0|||
144274374|NCT01020123|520206463|FG001|Extention Period|Adverse Event|0|||
144274375|NCT01020123|520206464|FG002|Extention Period|Adverse Event|0|||
144274376|NCT01020123|520206465|FG003|Extention Period|Adverse Event|1|||
144274377|NCT01020123|520206466|FG004|Extention Period|Adverse Event|0|||
144274378|NCT01020123|520206467|FG005|Extention Period|Adverse Event|0|||
144274379|NCT01020123|520206468|FG006|Extention Period|Adverse Event|0|||
144274380|NCT01020123|520206462|FG000|Extention Period|Protocol Violation|1|||
144274381|NCT01020123|520206463|FG001|Extention Period|Protocol Violation|1|||
144274382|NCT01020123|520206464|FG002|Extention Period|Protocol Violation|1|||
144274383|NCT01020123|520206465|FG003|Extention Period|Protocol Violation|0|||
144274384|NCT01020123|520206466|FG004|Extention Period|Protocol Violation|0|||
144274385|NCT01020123|520206467|FG005|Extention Period|Protocol Violation|0|||
144274386|NCT01020123|520206468|FG006|Extention Period|Protocol Violation|1|||
144274387|NCT01020123|520206462|FG000|Extention Period|Lost to Follow-up|0|||
144274388|NCT01020123|520206463|FG001|Extention Period|Lost to Follow-up|0|||
144274389|NCT01020123|520206464|FG002|Extention Period|Lost to Follow-up|0|||
144274390|NCT01020123|520206465|FG003|Extention Period|Lost to Follow-up|0|||
144274391|NCT01020123|520206466|FG004|Extention Period|Lost to Follow-up|0|||
144274392|NCT01020123|520206467|FG005|Extention Period|Lost to Follow-up|2|||
144274393|NCT01020123|520206468|FG006|Extention Period|Lost to Follow-up|0|||
144274394|NCT01925417|520206469|FG000|Overall Study|Withdrawal by Subject|2|||
144274395|NCT01925417|520206469|FG000|Overall Study|Death|1|||
144274396|NCT01047319|520206470|FG000|Overall Study|Teva requested participant withdrawal|3|||
144274397|NCT01047319|520206471|FG001|Overall Study|Teva requested participant withdrawal|0|||
144274398|NCT01047319|520206472|FG002|Overall Study|Teva requested participant withdrawal|1|||
144274399|NCT01047319|520206470|FG000|Overall Study|Protocol Violation|3|||
144274400|NCT01047319|520206471|FG001|Overall Study|Protocol Violation|2|||
144274401|NCT01047319|520206472|FG002|Overall Study|Protocol Violation|4|||
144274402|NCT01047319|520206470|FG000|Overall Study|Lack of Efficacy|4|||
144274403|NCT01047319|520206471|FG001|Overall Study|Lack of Efficacy|3|||
144274404|NCT01047319|520206472|FG002|Overall Study|Lack of Efficacy|3|||
144274405|NCT01047319|520206470|FG000|Overall Study|Death|5|||
144274406|NCT01047319|520206471|FG001|Overall Study|Death|1|||
144274407|NCT01047319|520206472|FG002|Overall Study|Death|5|||
144274408|NCT01047319|520206470|FG000|Overall Study|Pregnancy|13|||
144274409|NCT01047319|520206471|FG001|Overall Study|Pregnancy|8|||
144274410|NCT01047319|520206472|FG002|Overall Study|Pregnancy|8|||
144274411|NCT01047319|520206470|FG000|Overall Study|Physician Decision|12|||
144274412|NCT01047319|520206471|FG001|Overall Study|Physician Decision|9|||
144274413|NCT01047319|520206472|FG002|Overall Study|Physician Decision|10|||
144274414|NCT01047319|520206470|FG000|Overall Study|Lost to Follow-up|14|||
144274415|NCT01047319|520206471|FG001|Overall Study|Lost to Follow-up|10|||
144274416|NCT01047319|520206472|FG002|Overall Study|Lost to Follow-up|10|||
144274417|NCT01047319|520206470|FG000|Overall Study|Adverse Event|16|||
144274418|NCT01047319|520206471|FG001|Overall Study|Adverse Event|27|||
144274419|NCT01047319|520206472|FG002|Overall Study|Adverse Event|21|||
144274420|NCT01047319|520206470|FG000|Overall Study|Withdrawal by Subject|77|||
144274421|NCT01047319|520206471|FG001|Overall Study|Withdrawal by Subject|75|||
144274422|NCT01047319|520206472|FG002|Overall Study|Withdrawal by Subject|87|||
144274423|NCT01047319|520206470|FG000|Overall Study|Study terminated by Sponsor|198|||
144274424|NCT01047319|520206471|FG001|Overall Study|Study terminated by Sponsor|215|||
144274425|NCT01047319|520206472|FG002|Overall Study|Study terminated by Sponsor|203|||
144274426|NCT01277861|520206474|FG000|Overall Study|Physician Decision|2|||
144274427|NCT01277861|520206475|FG001|Overall Study|Physician Decision|2|||
144274428|NCT02696798|520206476|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
144274429|NCT02696798|520206477|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
144274430|NCT02696798|520206478|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
144274431|NCT02696798|520206476|FG000|Blinded Treatment Dosing Period|Death|0|||
144274432|NCT02696798|520206477|FG001|Blinded Treatment Dosing Period|Death|0|||
144274433|NCT02696798|520206478|FG002|Blinded Treatment Dosing Period|Death|1|||
144274434|NCT02696798|520206476|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
144274435|NCT02696798|520206477|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
144274436|NCT02696798|520206478|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
144274437|NCT02696798|520206476|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
144274438|NCT02696798|520206477|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
144274439|NCT02696798|520206478|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
144274440|NCT02696798|520206476|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
144274441|NCT02696798|520206477|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
144274442|NCT02696798|520206478|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
144274443|NCT02696798|520206476|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
144274444|NCT02696798|520206477|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
144274445|NCT02696798|520206478|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
144274446|NCT02696798|520206476|FG000|Extended Treatment Period|Adverse Event|1|||
144274447|NCT02696798|520206477|FG001|Extended Treatment Period|Adverse Event|4|||
144274448|NCT02696798|520206478|FG002|Extended Treatment Period|Adverse Event|5|||
144274449|NCT02696798|520206476|FG000|Extended Treatment Period|Lack of Efficacy|7|||
144274450|NCT02696798|520206477|FG001|Extended Treatment Period|Lack of Efficacy|2|||
144274451|NCT02696798|520206478|FG002|Extended Treatment Period|Lack of Efficacy|2|||
144274452|NCT02696798|520206476|FG000|Extended Treatment Period|Lost to Follow-up|1|||
144274453|NCT02696798|520206477|FG001|Extended Treatment Period|Lost to Follow-up|0|||
144274454|NCT02696798|520206478|FG002|Extended Treatment Period|Lost to Follow-up|0|||
144274455|NCT02696798|520206476|FG000|Extended Treatment Period|Physician Decision|0|||
144274456|NCT02696798|520206477|FG001|Extended Treatment Period|Physician Decision|1|||
144274457|NCT02696798|520206478|FG002|Extended Treatment Period|Physician Decision|0|||
144274458|NCT02696798|520206476|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
144274459|NCT02696798|520206477|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
144274460|NCT02696798|520206478|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
144274461|NCT02696798|520206476|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
144274462|NCT02696798|520206477|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
144274463|NCT02696798|520206478|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
144274464|NCT02696798|520206476|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
144274465|NCT02696798|520206477|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
144274466|NCT02696798|520206478|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
144274467|NCT02696798|520206476|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
144274468|NCT02696798|520206477|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
144274469|NCT02696798|520206478|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
144274470|NCT02696798|520206476|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
144274471|NCT02696798|520206477|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
144274472|NCT02696798|520206478|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
144274473|NCT02696798|520206476|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
144274474|NCT02696798|520206477|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
144274475|NCT02696798|520206478|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
144274476|NCT02696798|520206476|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
144274477|NCT02696798|520206477|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
144274478|NCT02696798|520206478|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
144274479|NCT01157845|520206479|FG000|Overall Study|Lost to Follow-up|5|||
144274480|NCT01157845|520206479|FG000|Overall Study|Withdrawal by Subject|12|||
144274481|NCT01157845|520206479|FG000|Overall Study|Physician Decision|3|||
144274482|NCT01157845|520206479|FG000|Overall Study|Protocol Violation|13|||
144274483|NCT01157845|520206479|FG000|Overall Study|Study was ended|1|||
144274484|NCT01157845|520206479|FG000|Overall Study|Device malfunction|1|||
144274485|NCT03311555|520206480|FG000|Overall Study|Adverse Event|1|||
144274486|NCT04486716|520208527|FG000|Core Phase|Subject decision|6|||
144274487|NCT04486716|520208527|FG000|Core Phase|Adverse Event|5|||
144274488|NCT04486716|520208527|FG000|Core Phase|Lost to Follow-up|1|||
144274489|NCT04486716|520208527|FG000|Core Phase|Physician Decision|1|||
144274490|NCT04486716|520208527|FG000|Core Phase|Enrolled subjects not treated|9|||
144274491|NCT03405870|520208528|FG000|Overall Study|Withdrawal|1|||
144274492|NCT03405870|520208529|FG001|Overall Study|Withdrawal|0|||
144274493|NCT03405870|520208530|FG002|Overall Study|Withdrawal|1|||
144274494|NCT03405870|520208531|FG003|Overall Study|Withdrawal|0|||
144274495|NCT03405870|520208532|FG004|Overall Study|Withdrawal|0|||
144274496|NCT03405870|520208533|FG005|Overall Study|Withdrawal|0|||
144274497|NCT03405870|520208534|FG006|Overall Study|Withdrawal|1|||
144274498|NCT03405870|520208535|FG007|Overall Study|Withdrawal|0|||
144274499|NCT03737994|520208536|FG000|Overall Study|Withdrawal by Subject|0|||
144274500|NCT03737994|520208537|FG001|Overall Study|Withdrawal by Subject|0|||
144274501|NCT03737994|520208538|FG002|Overall Study|Withdrawal by Subject|0|||
144274502|NCT03737994|520208539|FG003|Overall Study|Withdrawal by Subject|0|||
144274503|NCT03737994|520208540|FG004|Overall Study|Withdrawal by Subject|0|||
144274504|NCT03737994|520208541|FG005|Overall Study|Withdrawal by Subject|0|||
144274505|NCT03737994|520208542|FG006|Overall Study|Withdrawal by Subject|1|||
144274506|NCT03846479|520208543|FG000|Overall Study|Death|8|||
144274507|NCT03846479|520208543|FG000|Overall Study|Lost to Follow-up|1|||
144274508|NCT02332707|520208544|FG000|Overall Study|Adverse Event|0|||
144274509|NCT02332707|520208545|FG001|Overall Study|Adverse Event|0|||
144274510|NCT02332707|520208546|FG002|Overall Study|Adverse Event|0|||
144274511|NCT02332707|520208547|FG003|Overall Study|Adverse Event|0|||
144274512|NCT02332707|520208548|FG004|Overall Study|Adverse Event|0|||
144274513|NCT02332707|520208549|FG005|Overall Study|Adverse Event|0|||
144274514|NCT02332707|520208550|FG006|Overall Study|Adverse Event|0|||
144274515|NCT02332707|520208551|FG007|Overall Study|Adverse Event|0|||
144274516|NCT02332707|520208552|FG008|Overall Study|Adverse Event|0|||
144274517|NCT02332707|520208553|FG009|Overall Study|Adverse Event|0|||
144274518|NCT02332707|520208554|FG010|Overall Study|Adverse Event|0|||
144274519|NCT02332707|520208555|FG011|Overall Study|Adverse Event|0|||
144274520|NCT02332707|520208556|FG012|Overall Study|Adverse Event|1|||
144274521|NCT02332707|520208557|FG013|Overall Study|Adverse Event|0|||
144274522|NCT02332707|520208558|FG014|Overall Study|Adverse Event|0|||
144274523|NCT02332707|520208559|FG015|Overall Study|Adverse Event|0|||
144274524|NCT02332707|520208560|FG016|Overall Study|Adverse Event|0|||
144274525|NCT02332707|520208561|FG017|Overall Study|Adverse Event|0|||
144274526|NCT02332707|520208544|FG000|Overall Study|Lost to Follow-up|0|||
144274527|NCT02332707|520208545|FG001|Overall Study|Lost to Follow-up|0|||
144274528|NCT02332707|520208546|FG002|Overall Study|Lost to Follow-up|0|||
144274529|NCT02332707|520208547|FG003|Overall Study|Lost to Follow-up|0|||
144274530|NCT02332707|520208548|FG004|Overall Study|Lost to Follow-up|0|||
144274531|NCT02332707|520208549|FG005|Overall Study|Lost to Follow-up|1|||
144274532|NCT02332707|520208550|FG006|Overall Study|Lost to Follow-up|0|||
144274533|NCT02332707|520208551|FG007|Overall Study|Lost to Follow-up|0|||
144274534|NCT02332707|520208552|FG008|Overall Study|Lost to Follow-up|0|||
144274535|NCT02332707|520208553|FG009|Overall Study|Lost to Follow-up|0|||
144274536|NCT02332707|520208554|FG010|Overall Study|Lost to Follow-up|2|||
144274537|NCT02332707|520208555|FG011|Overall Study|Lost to Follow-up|0|||
144274538|NCT02332707|520208556|FG012|Overall Study|Lost to Follow-up|3|||
144274539|NCT02332707|520208557|FG013|Overall Study|Lost to Follow-up|0|||
144274540|NCT02332707|520208558|FG014|Overall Study|Lost to Follow-up|0|||
144274541|NCT02332707|520208559|FG015|Overall Study|Lost to Follow-up|0|||
144274542|NCT02332707|520208560|FG016|Overall Study|Lost to Follow-up|0|||
144274543|NCT02332707|520208561|FG017|Overall Study|Lost to Follow-up|0|||
144274544|NCT02332707|520208544|FG000|Overall Study|Physician Decision|0|||
144274545|NCT02332707|520208545|FG001|Overall Study|Physician Decision|0|||
144274546|NCT02332707|520208546|FG002|Overall Study|Physician Decision|0|||
144274547|NCT02332707|520208547|FG003|Overall Study|Physician Decision|1|||
144274548|NCT02332707|520208548|FG004|Overall Study|Physician Decision|0|||
144274549|NCT02332707|520208549|FG005|Overall Study|Physician Decision|0|||
144274550|NCT02332707|520208550|FG006|Overall Study|Physician Decision|0|||
144274551|NCT02332707|520208551|FG007|Overall Study|Physician Decision|0|||
144274552|NCT02332707|520208552|FG008|Overall Study|Physician Decision|0|||
144274553|NCT02332707|520208553|FG009|Overall Study|Physician Decision|0|||
144274554|NCT02332707|520208554|FG010|Overall Study|Physician Decision|0|||
144274555|NCT02332707|520208555|FG011|Overall Study|Physician Decision|0|||
144274556|NCT02332707|520208556|FG012|Overall Study|Physician Decision|1|||
144274557|NCT02332707|520208557|FG013|Overall Study|Physician Decision|0|||
144274558|NCT02332707|520208558|FG014|Overall Study|Physician Decision|0|||
144274559|NCT02332707|520208559|FG015|Overall Study|Physician Decision|0|||
144274560|NCT02332707|520208560|FG016|Overall Study|Physician Decision|0|||
144274561|NCT02332707|520208561|FG017|Overall Study|Physician Decision|0|||
144274562|NCT02332707|520208544|FG000|Overall Study|Withdrawal by Subject|0|||
144274563|NCT02332707|520208545|FG001|Overall Study|Withdrawal by Subject|0|||
144274564|NCT02332707|520208546|FG002|Overall Study|Withdrawal by Subject|1|||
144274565|NCT02332707|520208547|FG003|Overall Study|Withdrawal by Subject|0|||
144274566|NCT02332707|520208548|FG004|Overall Study|Withdrawal by Subject|0|||
144274567|NCT02332707|520208549|FG005|Overall Study|Withdrawal by Subject|0|||
144274568|NCT02332707|520208550|FG006|Overall Study|Withdrawal by Subject|0|||
144274569|NCT02332707|520208551|FG007|Overall Study|Withdrawal by Subject|0|||
144274570|NCT02332707|520208552|FG008|Overall Study|Withdrawal by Subject|0|||
144274571|NCT02332707|520208553|FG009|Overall Study|Withdrawal by Subject|3|||
144274572|NCT02332707|520208554|FG010|Overall Study|Withdrawal by Subject|0|||
144274573|NCT02332707|520208555|FG011|Overall Study|Withdrawal by Subject|0|||
144274574|NCT02332707|520208556|FG012|Overall Study|Withdrawal by Subject|0|||
144274575|NCT02332707|520208557|FG013|Overall Study|Withdrawal by Subject|0|||
144274576|NCT02332707|520208558|FG014|Overall Study|Withdrawal by Subject|0|||
144274577|NCT02332707|520208559|FG015|Overall Study|Withdrawal by Subject|0|||
144274578|NCT02332707|520208560|FG016|Overall Study|Withdrawal by Subject|0|||
144274579|NCT02332707|520208561|FG017|Overall Study|Withdrawal by Subject|0|||
144274580|NCT01473134|520208562|FG000|Overall Study|Lost to Follow-up|21|||
144274581|NCT01473134|520208563|FG001|Overall Study|Lost to Follow-up|13|||
144274582|NCT01473134|520208562|FG000|Overall Study|Protocol Violation|32|||
144274583|NCT01473134|520208563|FG001|Overall Study|Protocol Violation|19|||
144274584|NCT01473134|520208562|FG000|Overall Study|Withdrawal by Subject|1|||
144274585|NCT01473134|520208563|FG001|Overall Study|Withdrawal by Subject|2|||
144274586|NCT01473134|520208562|FG000|Overall Study|Death|0|||
144274587|NCT01473134|520208563|FG001|Overall Study|Death|1|||
144274588|NCT01473134|520208562|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
144274589|NCT01473134|520208563|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
144274590|NCT04761822|520208568|FG000|Overall Study|Adverse Event|3|||
144274591|NCT04761822|520208569|FG001|Overall Study|Adverse Event|1|||
144274592|NCT04761822|520208570|FG002|Overall Study|Adverse Event|1|||
144274593|NCT04761822|520208571|FG003|Overall Study|Adverse Event|3|||
144274594|NCT04761822|520208568|FG000|Overall Study|Lost to Follow-up|1|||
144274595|NCT04761822|520208569|FG001|Overall Study|Lost to Follow-up|0|||
144274596|NCT04761822|520208570|FG002|Overall Study|Lost to Follow-up|2|||
144274597|NCT04761822|520208571|FG003|Overall Study|Lost to Follow-up|3|||
144274598|NCT04761822|520208568|FG000|Overall Study|Physician Decision|0|||
144274599|NCT04761822|520208569|FG001|Overall Study|Physician Decision|1|||
144274600|NCT04761822|520208570|FG002|Overall Study|Physician Decision|0|||
144274601|NCT04761822|520208571|FG003|Overall Study|Physician Decision|0|||
144274602|NCT04761822|520208568|FG000|Overall Study|Withdrawal by Subject|3|||
144274603|NCT04761822|520208569|FG001|Overall Study|Withdrawal by Subject|8|||
144274604|NCT04761822|520208570|FG002|Overall Study|Withdrawal by Subject|1|||
144274605|NCT04761822|520208571|FG003|Overall Study|Withdrawal by Subject|11|||
144274606|NCT04761822|520208568|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
144274607|NCT04761822|520208569|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
144274608|NCT04761822|520208570|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
144274609|NCT04761822|520208571|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
144274610|NCT04761822|520208568|FG000|Overall Study|Participant requested unblinding|0|||
144274611|NCT04761822|520208569|FG001|Overall Study|Participant requested unblinding|0|||
144274612|NCT04761822|520208570|FG002|Overall Study|Participant requested unblinding|0|||
144274613|NCT04761822|520208571|FG003|Overall Study|Participant requested unblinding|1|||
144274614|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
144274615|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
144274616|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Death|1|||
144274617|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Death|3|||
144274618|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
144274619|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
144274620|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
144274621|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
144274622|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
144274623|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
144274624|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
144274625|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
144274626|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
144274627|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
144274628|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
144274629|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
144274630|NCT00362232|520208572|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
144274631|NCT00362232|520208573|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
144274632|NCT00362232|520208572|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
144274633|NCT00362232|520208573|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
144274634|NCT00362232|520208572|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
144274635|NCT00362232|520208573|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
144274636|NCT00362232|520208572|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
144274637|NCT00362232|520208573|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
144274638|NCT00362232|520208572|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
144274639|NCT00362232|520208573|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
144274640|NCT05020015|520208580|FG000|Overall Study|Ongoing on study|1|||
144274641|NCT05020015|520208581|FG001|Overall Study|Ongoing on study|3|||
144274642|NCT05020015|520208582|FG002|Overall Study|Ongoing on study|4|||
144274643|NCT05020015|520208583|FG003|Overall Study|Ongoing on study|7|||
144274644|NCT05020015|520208580|FG000|Overall Study|Death|2|||
144274645|NCT05020015|520208581|FG001|Overall Study|Death|3|||
144274646|NCT05020015|520208582|FG002|Overall Study|Death|4|||
144274647|NCT05020015|520208583|FG003|Overall Study|Death|0|||
144274648|NCT05020015|520208580|FG000|Overall Study|Withdrawal by Subject|0|||
144274649|NCT05020015|520208581|FG001|Overall Study|Withdrawal by Subject|0|||
144274650|NCT05020015|520208582|FG002|Overall Study|Withdrawal by Subject|1|||
144274651|NCT05020015|520208583|FG003|Overall Study|Withdrawal by Subject|0|||
144274652|NCT05020015|520208580|FG000|Overall Study|Reason Not Specified|0|||
144274653|NCT05020015|520208581|FG001|Overall Study|Reason Not Specified|0|||
144274654|NCT05020015|520208582|FG002|Overall Study|Reason Not Specified|2|||
144274655|NCT05020015|520208583|FG003|Overall Study|Reason Not Specified|0|||
144274656|NCT02233413|520208584|FG000|Overall Study|Lost to Follow-up|7|||
144274657|NCT02233413|520208585|FG001|Overall Study|Lost to Follow-up|9|||
144274658|NCT02233413|520208584|FG000|Overall Study|Withdrawal by Subject|4|||
144274659|NCT02233413|520208585|FG001|Overall Study|Withdrawal by Subject|5|||
144274660|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
144274661|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
144274662|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
144274663|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
144274664|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
144274665|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
144274666|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
144274667|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
144274668|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
144274669|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
144274670|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
144274671|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
144274672|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
144274673|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
144274674|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
144274675|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
144274676|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
144274677|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
144274678|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
144274679|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
144274680|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
144274681|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
144274682|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
144274683|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
144274684|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
144274685|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
144274686|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
144274687|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
144274688|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
144274689|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
144274690|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
144274691|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
144274692|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
144274693|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
144274694|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
144274695|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
144274696|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
144274697|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
144274698|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
144274699|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
144274700|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
144274701|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
144274702|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
144274703|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
144274704|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
144274705|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
144274706|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
144274707|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
144274708|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
144274709|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
144274710|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
144274711|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
144274712|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
144274713|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
144274714|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
144274715|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
144274716|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
144274717|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
144274718|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
144274719|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
144274720|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
144274721|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
144274722|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
144274723|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
144274724|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
144274725|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
144274726|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
144274727|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
144274728|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
144274729|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
144274730|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
144274731|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
144274732|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
144274733|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
144274734|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
144274735|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
144274736|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
144274737|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
144274738|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
144274739|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
144274740|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
144274741|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
144274742|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
144274743|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
144274744|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
144274745|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
144274746|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
144274747|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
144274748|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
144274749|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
144274750|NCT00090103|520208588|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
144274751|NCT00090103|520208589|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
144274752|NCT00090103|520208590|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
144274753|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
144274754|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
144274755|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
144274756|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
144274757|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
144274758|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
144274759|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
144274760|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
144274761|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
144274762|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
144274763|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
144274764|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
144274765|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
144274766|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
144274767|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
144274768|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
144274769|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
144274770|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
144274771|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
144274772|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
144274773|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
144274774|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
144274775|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
144274776|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
144274777|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
144274778|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
144274779|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
144274780|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
144274781|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
144274782|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
144274783|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
144274784|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
144274785|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
144274786|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
144274787|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
144274788|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
144274789|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
144274790|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
144274791|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
144274792|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
144274793|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
144274794|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
144274795|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
144274796|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
144274797|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
144274798|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
144274799|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
144274800|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
144274801|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Death|1|||
144274802|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Death|0|||
144274803|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Death|1|||
144274804|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
144274805|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
144274806|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
144274807|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
144274808|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
144274809|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
144274810|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
144274811|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
144274812|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
144274813|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
144274814|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
144274815|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
144274816|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
144274817|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
144274818|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
144274819|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
144274820|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
144274821|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
144274822|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
144274823|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
144274824|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
144274825|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Depression|0|||
144274826|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Depression|1|||
144274827|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Depression|0|||
144274828|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
144274829|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
144274830|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
144274831|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Jailed|0|||
144274832|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Jailed|1|||
144274833|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Jailed|0|||
144274834|NCT00090103|520208588|FG000|16-Week Safety Follow-up Period|Other|0|||
144274835|NCT00090103|520208589|FG001|16-Week Safety Follow-up Period|Other|1|||
144274836|NCT00090103|520208590|FG002|16-Week Safety Follow-up Period|Other|0|||
144274837|NCT01799889|520208591|FG000|Overall Study|Adverse Event|4|||
144274838|NCT01799889|520208592|FG001|Overall Study|Adverse Event|4|||
144274839|NCT01799889|520208593|FG002|Overall Study|Adverse Event|5|||
144274840|NCT01799889|520208594|FG003|Overall Study|Adverse Event|1|||
144274841|NCT01799889|520208595|FG004|Overall Study|Adverse Event|11|||
144274842|NCT01799889|520208596|FG005|Overall Study|Adverse Event|1|||
144274843|NCT01799889|520208597|FG006|Overall Study|Adverse Event|5|||
144274844|NCT01799889|520208598|FG007|Overall Study|Adverse Event|2|||
144274845|NCT01799889|520208599|FG008|Overall Study|Adverse Event|3|||
144274846|NCT01799889|520208600|FG009|Overall Study|Adverse Event|1|||
144274847|NCT01799889|520208601|FG010|Overall Study|Adverse Event|1|||
144274848|NCT01799889|520208602|FG011|Overall Study|Adverse Event|0|||
144274849|NCT01799889|520208591|FG000|Overall Study|Death|1|||
144274850|NCT01799889|520208592|FG001|Overall Study|Death|0|||
144274851|NCT01799889|520208593|FG002|Overall Study|Death|5|||
144274852|NCT01799889|520208594|FG003|Overall Study|Death|3|||
144274853|NCT01799889|520208595|FG004|Overall Study|Death|1|||
144274854|NCT01799889|520208596|FG005|Overall Study|Death|0|||
144274855|NCT01799889|520208597|FG006|Overall Study|Death|0|||
144274856|NCT01799889|520208598|FG007|Overall Study|Death|0|||
144274857|NCT01799889|520208599|FG008|Overall Study|Death|1|||
144274858|NCT01799889|520208600|FG009|Overall Study|Death|0|||
144274859|NCT01799889|520208601|FG010|Overall Study|Death|1|||
144274860|NCT01799889|520208602|FG011|Overall Study|Death|0|||
144274861|NCT01799889|520208591|FG000|Overall Study|Lack of Efficacy|1|||
144274862|NCT01799889|520208592|FG001|Overall Study|Lack of Efficacy|1|||
144274863|NCT01799889|520208593|FG002|Overall Study|Lack of Efficacy|0|||
144274864|NCT01799889|520208594|FG003|Overall Study|Lack of Efficacy|1|||
144274865|NCT01799889|520208595|FG004|Overall Study|Lack of Efficacy|2|||
144274866|NCT01799889|520208596|FG005|Overall Study|Lack of Efficacy|2|||
144274867|NCT01799889|520208597|FG006|Overall Study|Lack of Efficacy|0|||
144274868|NCT01799889|520208598|FG007|Overall Study|Lack of Efficacy|0|||
144274869|NCT01799889|520208599|FG008|Overall Study|Lack of Efficacy|2|||
144274870|NCT01799889|520208600|FG009|Overall Study|Lack of Efficacy|0|||
144274871|NCT01799889|520208601|FG010|Overall Study|Lack of Efficacy|1|||
144274872|NCT01799889|520208602|FG011|Overall Study|Lack of Efficacy|0|||
144274873|NCT01799889|520208591|FG000|Overall Study|Lost to Follow-up|0|||
144274874|NCT01799889|520208592|FG001|Overall Study|Lost to Follow-up|1|||
144274875|NCT01799889|520208593|FG002|Overall Study|Lost to Follow-up|0|||
144274876|NCT01799889|520208594|FG003|Overall Study|Lost to Follow-up|0|||
144274877|NCT01799889|520208595|FG004|Overall Study|Lost to Follow-up|0|||
144274878|NCT01799889|520208596|FG005|Overall Study|Lost to Follow-up|0|||
144274879|NCT01799889|520208597|FG006|Overall Study|Lost to Follow-up|0|||
144274880|NCT01799889|520208598|FG007|Overall Study|Lost to Follow-up|0|||
144274881|NCT01799889|520208599|FG008|Overall Study|Lost to Follow-up|0|||
144274882|NCT01799889|520208600|FG009|Overall Study|Lost to Follow-up|0|||
144274883|NCT01799889|520208601|FG010|Overall Study|Lost to Follow-up|0|||
144274884|NCT01799889|520208602|FG011|Overall Study|Lost to Follow-up|0|||
144274885|NCT01799889|520208591|FG000|Overall Study|Physician Decision|3|||
144274886|NCT01799889|520208592|FG001|Overall Study|Physician Decision|2|||
144274887|NCT01799889|520208593|FG002|Overall Study|Physician Decision|4|||
144274888|NCT01799889|520208594|FG003|Overall Study|Physician Decision|4|||
144274889|NCT01799889|520208595|FG004|Overall Study|Physician Decision|5|||
144274890|NCT01799889|520208596|FG005|Overall Study|Physician Decision|5|||
144274891|NCT01799889|520208597|FG006|Overall Study|Physician Decision|5|||
144274892|NCT01799889|520208598|FG007|Overall Study|Physician Decision|2|||
144274893|NCT01799889|520208599|FG008|Overall Study|Physician Decision|6|||
144274894|NCT01799889|520208600|FG009|Overall Study|Physician Decision|0|||
144274895|NCT01799889|520208601|FG010|Overall Study|Physician Decision|0|||
144274896|NCT01799889|520208602|FG011|Overall Study|Physician Decision|1|||
144274897|NCT01799889|520208591|FG000|Overall Study|Progressive Disease|30|||
144274898|NCT01799889|520208592|FG001|Overall Study|Progressive Disease|26|||
144274899|NCT01799889|520208593|FG002|Overall Study|Progressive Disease|25|||
144274900|NCT01799889|520208594|FG003|Overall Study|Progressive Disease|30|||
144274901|NCT01799889|520208595|FG004|Overall Study|Progressive Disease|23|||
144274902|NCT01799889|520208596|FG005|Overall Study|Progressive Disease|9|||
144274903|NCT01799889|520208597|FG006|Overall Study|Progressive Disease|8|||
144274904|NCT01799889|520208598|FG007|Overall Study|Progressive Disease|13|||
144274905|NCT01799889|520208599|FG008|Overall Study|Progressive Disease|18|||
144274906|NCT01799889|520208600|FG009|Overall Study|Progressive Disease|5|||
144274907|NCT01799889|520208601|FG010|Overall Study|Progressive Disease|3|||
144274908|NCT01799889|520208602|FG011|Overall Study|Progressive Disease|1|||
144274909|NCT01799889|520208591|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
144274910|NCT01799889|520208592|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
144274911|NCT01799889|520208593|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
144274912|NCT01799889|520208594|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
144274913|NCT01799889|520208595|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
144274914|NCT01799889|520208596|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
144274915|NCT01799889|520208597|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
144274916|NCT01799889|520208598|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
144274917|NCT01799889|520208599|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
144274918|NCT01799889|520208600|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
144274919|NCT01799889|520208601|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
144274920|NCT01799889|520208602|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
144274921|NCT01799889|520208591|FG000|Overall Study|Study Terminated By Sponsor|1|||
144274922|NCT01799889|520208592|FG001|Overall Study|Study Terminated By Sponsor|0|||
144274923|NCT01799889|520208593|FG002|Overall Study|Study Terminated By Sponsor|0|||
144274924|NCT01799889|520208594|FG003|Overall Study|Study Terminated By Sponsor|0|||
144274925|NCT01799889|520208595|FG004|Overall Study|Study Terminated By Sponsor|2|||
144274926|NCT01799889|520208596|FG005|Overall Study|Study Terminated By Sponsor|1|||
144274927|NCT01799889|520208597|FG006|Overall Study|Study Terminated By Sponsor|0|||
144274928|NCT01799889|520208598|FG007|Overall Study|Study Terminated By Sponsor|2|||
144274929|NCT01799889|520208599|FG008|Overall Study|Study Terminated By Sponsor|1|||
144274930|NCT01799889|520208600|FG009|Overall Study|Study Terminated By Sponsor|1|||
144274931|NCT01799889|520208601|FG010|Overall Study|Study Terminated By Sponsor|0|||
144274932|NCT01799889|520208602|FG011|Overall Study|Study Terminated By Sponsor|0|||
144274933|NCT01799889|520208591|FG000|Overall Study|Withdrawal by Subject|1|||
144274934|NCT01799889|520208592|FG001|Overall Study|Withdrawal by Subject|6|||
144274935|NCT01799889|520208593|FG002|Overall Study|Withdrawal by Subject|4|||
144274936|NCT01799889|520208594|FG003|Overall Study|Withdrawal by Subject|0|||
144274937|NCT01799889|520208595|FG004|Overall Study|Withdrawal by Subject|5|||
144274938|NCT01799889|520208596|FG005|Overall Study|Withdrawal by Subject|1|||
144274939|NCT01799889|520208597|FG006|Overall Study|Withdrawal by Subject|3|||
144274940|NCT01799889|520208598|FG007|Overall Study|Withdrawal by Subject|1|||
144274941|NCT01799889|520208599|FG008|Overall Study|Withdrawal by Subject|2|||
144274942|NCT01799889|520208600|FG009|Overall Study|Withdrawal by Subject|1|||
144274943|NCT01799889|520208601|FG010|Overall Study|Withdrawal by Subject|1|||
144274944|NCT01799889|520208602|FG011|Overall Study|Withdrawal by Subject|1|||
144274945|NCT01799889|520208591|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144274946|NCT01799889|520208592|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144274947|NCT01799889|520208593|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144274948|NCT01799889|520208594|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144274949|NCT01799889|520208595|FG004|Overall Study|Non-Compliance With Study Drug|0|||
144274950|NCT01799889|520208596|FG005|Overall Study|Non-Compliance With Study Drug|1|||
144274951|NCT01799889|520208597|FG006|Overall Study|Non-Compliance With Study Drug|0|||
144274952|NCT01799889|520208598|FG007|Overall Study|Non-Compliance With Study Drug|0|||
144274953|NCT01799889|520208599|FG008|Overall Study|Non-Compliance With Study Drug|0|||
144274954|NCT01799889|520208600|FG009|Overall Study|Non-Compliance With Study Drug|0|||
144274955|NCT01799889|520208601|FG010|Overall Study|Non-Compliance With Study Drug|0|||
144274956|NCT01799889|520208602|FG011|Overall Study|Non-Compliance With Study Drug|0|||
144274957|NCT04476043|520208605|FG000|Overall Study|Withdrawal by Subject|1|||
144274958|NCT04476043|520208606|FG001|Overall Study|Withdrawal by Subject|3|||
144274959|NCT04476043|520208607|FG002|Overall Study|Withdrawal by Subject|4|||
144274960|NCT04476043|520208608|FG003|Overall Study|Withdrawal by Subject|1|||
144274961|NCT04476043|520208605|FG000|Overall Study|Lost to Follow-up|1|||
144274962|NCT04476043|520208606|FG001|Overall Study|Lost to Follow-up|1|||
144274963|NCT04476043|520208607|FG002|Overall Study|Lost to Follow-up|2|||
144274964|NCT04476043|520208608|FG003|Overall Study|Lost to Follow-up|1|||
144274965|NCT04476043|520208605|FG000|Overall Study|Adverse Event|2|||
144274966|NCT04476043|520208606|FG001|Overall Study|Adverse Event|0|||
144274967|NCT04476043|520208607|FG002|Overall Study|Adverse Event|1|||
144274968|NCT04476043|520208608|FG003|Overall Study|Adverse Event|0|||
144274969|NCT04476043|520208605|FG000|Overall Study|Protocol Violation|0|||
144274970|NCT04476043|520208606|FG001|Overall Study|Protocol Violation|1|||
144274971|NCT04476043|520208607|FG002|Overall Study|Protocol Violation|0|||
144274972|NCT04476043|520208608|FG003|Overall Study|Protocol Violation|0|||
144274973|NCT06217380|520208609|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
144274974|NCT06217380|520208609|FG000|Overall Study|Physician Decision|1|||
144274975|NCT06217380|520208609|FG000|Overall Study|Withdrawal by Subject|2|||
144274976|NCT02469233|520208610|FG000|Overall Study|Death|1|||
144274977|NCT02469233|520208611|FG001|Overall Study|Death|1|||
144274978|NCT02469233|520208610|FG000|Overall Study|Lost to post or 6 month follow up|7|||
144274979|NCT02469233|520208611|FG001|Overall Study|Lost to post or 6 month follow up|2|||
144274980|NCT02566005|520208614|FG000|Overall Study|vaginal bleeding|0|||
144274981|NCT02566005|520208615|FG001|Overall Study|vaginal bleeding|1|||
144274982|NCT02566005|520208614|FG000|Overall Study|received foley|8|||
144274983|NCT02566005|520208615|FG001|Overall Study|received foley|0|||
144274984|NCT02566005|520208614|FG000|Overall Study|did not receive foley|0|||
144274985|NCT02566005|520208615|FG001|Overall Study|did not receive foley|1|||
144274986|NCT02566005|520208614|FG000|Overall Study|labor after randomization|0|||
144274987|NCT02566005|520208615|FG001|Overall Study|labor after randomization|4|||
144274988|NCT01294514|520208618|FG000|Overall Study|Excluded due to Arrhythmia|1|||
144274989|NCT01963611|520208619|FG000|Overall Study|Adverse Event|1|||
144274990|NCT01963611|520208620|FG001|Overall Study|Adverse Event|1|||
144274991|NCT01963611|520208621|FG002|Overall Study|Adverse Event|3|||
144274992|NCT01963611|520208622|FG003|Overall Study|Adverse Event|4|||
144274993|NCT01963611|520208623|FG004|Overall Study|Adverse Event|3|||
144274994|NCT01963611|520208619|FG000|Overall Study|Protocol Violation|0|||
144274995|NCT01963611|520208620|FG001|Overall Study|Protocol Violation|0|||
144274996|NCT01963611|520208621|FG002|Overall Study|Protocol Violation|0|||
144274997|NCT01963611|520208622|FG003|Overall Study|Protocol Violation|1|||
144274998|NCT01963611|520208623|FG004|Overall Study|Protocol Violation|0|||
144274999|NCT01963611|520208619|FG000|Overall Study|Lack of Efficacy|0|||
144275000|NCT01963611|520208620|FG001|Overall Study|Lack of Efficacy|0|||
144275001|NCT01963611|520208621|FG002|Overall Study|Lack of Efficacy|0|||
144275002|NCT01963611|520208622|FG003|Overall Study|Lack of Efficacy|1|||
144275003|NCT01963611|520208623|FG004|Overall Study|Lack of Efficacy|0|||
144275004|NCT01963611|520208619|FG000|Overall Study|Withdrawal by Subject|3|||
144275005|NCT01963611|520208620|FG001|Overall Study|Withdrawal by Subject|2|||
144275006|NCT01963611|520208621|FG002|Overall Study|Withdrawal by Subject|1|||
144275007|NCT01963611|520208622|FG003|Overall Study|Withdrawal by Subject|1|||
144275008|NCT01963611|520208623|FG004|Overall Study|Withdrawal by Subject|3|||
144275009|NCT01963611|520208619|FG000|Overall Study|Other|47|||
144275010|NCT01963611|520208620|FG001|Overall Study|Other|46|||
144275011|NCT01963611|520208621|FG002|Overall Study|Other|48|||
144275012|NCT01963611|520208622|FG003|Overall Study|Other|45|||
144275013|NCT01963611|520208623|FG004|Overall Study|Other|45|||
144275014|NCT03801252|520208624|FG000|Overall Study|Protocol Violation|1|||
144275015|NCT03801252|520208625|FG001|Overall Study|Protocol Violation|2|||
144275016|NCT02471183|520208626|FG000|Main Treatment Period|Adverse Event|1|||
144275017|NCT02471183|520208626|FG000|Main Treatment Period|Withdrawal by Subject|1|||
144275018|NCT02471183|520208626|FG000|Extended Treatment Period|Lack of Efficacy|1|||
144275019|NCT02328105|520208630|FG000|Overall Study|Death|6|||
144275020|NCT02328105|520208630|FG000|Overall Study|Withdrawal by Subject|1|||
144275021|NCT02328105|520208630|FG000|Overall Study|Still On Study in Follow-Up|4|||
144275022|NCT00614393|520208631|FG000|Overall Study|Adverse Event|20|||
144275023|NCT00614393|520208632|FG001|Overall Study|Adverse Event|2|||
144275024|NCT00614393|520208633|FG002|Overall Study|Adverse Event|3|||
144275025|NCT00614393|520208634|FG003|Overall Study|Adverse Event|13|||
144275026|NCT00614393|520208635|FG004|Overall Study|Adverse Event|21|||
144275027|NCT00614393|520208631|FG000|Overall Study|Lost to Follow-up|0|||
144275028|NCT00614393|520208632|FG001|Overall Study|Lost to Follow-up|0|||
144275029|NCT00614393|520208633|FG002|Overall Study|Lost to Follow-up|0|||
144275030|NCT00614393|520208634|FG003|Overall Study|Lost to Follow-up|1|||
144275031|NCT00614393|520208635|FG004|Overall Study|Lost to Follow-up|2|||
144275032|NCT00614393|520208631|FG000|Overall Study|Physician Decision|17|||
144275033|NCT00614393|520208632|FG001|Overall Study|Physician Decision|0|||
144275034|NCT00614393|520208633|FG002|Overall Study|Physician Decision|1|||
144275035|NCT00614393|520208634|FG003|Overall Study|Physician Decision|8|||
144275036|NCT00614393|520208635|FG004|Overall Study|Physician Decision|9|||
144275037|NCT00614393|520208631|FG000|Overall Study|Progressive Disease|118|||
144275038|NCT00614393|520208632|FG001|Overall Study|Progressive Disease|5|||
144275039|NCT00614393|520208633|FG002|Overall Study|Progressive Disease|5|||
144275040|NCT00614393|520208634|FG003|Overall Study|Progressive Disease|138|||
144275041|NCT00614393|520208635|FG004|Overall Study|Progressive Disease|130|||
144275042|NCT00614393|520208631|FG000|Overall Study|Protocol Violation|1|||
144275043|NCT00614393|520208632|FG001|Overall Study|Protocol Violation|0|||
144275044|NCT00614393|520208633|FG002|Overall Study|Protocol Violation|0|||
144275045|NCT00614393|520208634|FG003|Overall Study|Protocol Violation|0|||
144275046|NCT00614393|520208635|FG004|Overall Study|Protocol Violation|0|||
144275047|NCT00614393|520208631|FG000|Overall Study|Terminated by Sponsor|0|||
144275048|NCT00614393|520208632|FG001|Overall Study|Terminated by Sponsor|0|||
144275049|NCT00614393|520208633|FG002|Overall Study|Terminated by Sponsor|0|||
144275050|NCT00614393|520208634|FG003|Overall Study|Terminated by Sponsor|0|||
144275051|NCT00614393|520208635|FG004|Overall Study|Terminated by Sponsor|1|||
144275052|NCT00614393|520208631|FG000|Overall Study|Withdrawal by Subject|20|||
144275053|NCT00614393|520208632|FG001|Overall Study|Withdrawal by Subject|1|||
144275054|NCT00614393|520208633|FG002|Overall Study|Withdrawal by Subject|1|||
144275055|NCT00614393|520208634|FG003|Overall Study|Withdrawal by Subject|16|||
144275056|NCT00614393|520208635|FG004|Overall Study|Withdrawal by Subject|13|||
144275057|NCT00614393|520208631|FG000|Overall Study|Other|4|||
144275058|NCT00614393|520208632|FG001|Overall Study|Other|0|||
144275059|NCT00614393|520208633|FG002|Overall Study|Other|0|||
144275060|NCT00614393|520208634|FG003|Overall Study|Other|4|||
144275061|NCT00614393|520208635|FG004|Overall Study|Other|2|||
144275062|NCT00614393|520208631|FG000|Overall Study|Not Treated|0|||
144275063|NCT00614393|520208632|FG001|Overall Study|Not Treated|0|||
144275064|NCT00614393|520208633|FG002|Overall Study|Not Treated|0|||
144275065|NCT00614393|520208634|FG003|Overall Study|Not Treated|0|||
144275066|NCT00614393|520208635|FG004|Overall Study|Not Treated|2|||
144275067|NCT03345004|520208639|FG000|Overall Study|Physician Decision|1|||
144275068|NCT03345004|520208640|FG001|Overall Study|Physician Decision|0|||
144275069|NCT03345004|520208639|FG000|Overall Study|Withdrawal by Subject|0|||
144275070|NCT03345004|520208640|FG001|Overall Study|Withdrawal by Subject|1|||
144275071|NCT01013753|520208643|FG000|Overall Study|Adverse Event|8|||
144275072|NCT01013753|520208643|FG000|Overall Study|Protocol Violation|3|||
144275073|NCT01013753|520208643|FG000|Overall Study|Lost to Follow-up|1|||
144275074|NCT01013753|520208643|FG000|Overall Study|Withdrawal by Subject|2|||
144275075|NCT01013753|520208643|FG000|Overall Study|Other|2|||
144275076|NCT04757636|520208644|FG000|Overall Study|Adverse Event|25|||
144275077|NCT04757636|520208645|FG001|Overall Study|Adverse Event|8|||
144275078|NCT04757636|520208646|FG002|Overall Study|Adverse Event|11|||
144275079|NCT04757636|520208644|FG000|Overall Study|Death|9|||
144275080|NCT04757636|520208645|FG001|Overall Study|Death|12|||
144275081|NCT04757636|520208646|FG002|Overall Study|Death|6|||
144275082|NCT04757636|520208644|FG000|Overall Study|Lack of Efficacy|2|||
144275083|NCT04757636|520208645|FG001|Overall Study|Lack of Efficacy|0|||
144275084|NCT04757636|520208646|FG002|Overall Study|Lack of Efficacy|0|||
144275085|NCT04757636|520208644|FG000|Overall Study|Lost to Follow-up|1|||
144275086|NCT04757636|520208645|FG001|Overall Study|Lost to Follow-up|6|||
144275087|NCT04757636|520208646|FG002|Overall Study|Lost to Follow-up|7|||
144275088|NCT04757636|520208644|FG000|Overall Study|Physician Decision|1|||
144275089|NCT04757636|520208645|FG001|Overall Study|Physician Decision|3|||
144275090|NCT04757636|520208646|FG002|Overall Study|Physician Decision|4|||
144275091|NCT04757636|520208644|FG000|Overall Study|Withdrawal by Subject|20|||
144275092|NCT04757636|520208645|FG001|Overall Study|Withdrawal by Subject|23|||
144275093|NCT04757636|520208646|FG002|Overall Study|Withdrawal by Subject|18|||
144275094|NCT04757636|520208644|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
144275095|NCT04757636|520208645|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
144275096|NCT04757636|520208646|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
144275097|NCT04757636|520208644|FG000|Overall Study|Study Terminated by Sponsor|103|||
144275098|NCT04757636|520208645|FG001|Overall Study|Study Terminated by Sponsor|104|||
144275099|NCT04757636|520208646|FG002|Overall Study|Study Terminated by Sponsor|114|||
144275100|NCT04757636|520208644|FG000|Overall Study|Sponsor Decision|0|||
144275101|NCT04757636|520208645|FG001|Overall Study|Sponsor Decision|0|||
144275102|NCT04757636|520208646|FG002|Overall Study|Sponsor Decision|1|||
144275103|NCT04757636|520208644|FG000|Overall Study|Randomized in Error|0|||
144275104|NCT04757636|520208645|FG001|Overall Study|Randomized in Error|0|||
144275105|NCT04757636|520208646|FG002|Overall Study|Randomized in Error|2|||
144275106|NCT02349386|520208664|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
144275107|NCT02349386|520208665|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
144275108|NCT02349386|520208666|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
144275109|NCT02349386|520208667|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
144275110|NCT02349386|520208664|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
144275111|NCT02349386|520208665|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
144275112|NCT02349386|520208666|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
144275113|NCT02349386|520208667|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
144275114|NCT02349386|520208664|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
144275115|NCT02349386|520208665|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
144275116|NCT02349386|520208666|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
144275117|NCT02349386|520208667|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
144275118|NCT02349386|520208664|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
144275119|NCT02349386|520208665|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
144275120|NCT02349386|520208666|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
144275121|NCT02349386|520208667|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
144275122|NCT02349386|520208664|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
144275123|NCT02349386|520208665|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
144275124|NCT02349386|520208666|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
144275125|NCT02349386|520208667|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
144275126|NCT02349386|520208664|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
144275127|NCT02349386|520208665|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
144275128|NCT02349386|520208666|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
144275129|NCT02349386|520208667|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
144275130|NCT02471339|520208668|FG000|Overall Study|Did not provide follow-up data|2|||
144275131|NCT02471339|520208669|FG001|Overall Study|Did not provide follow-up data|0|||
144275132|NCT00984867|520208670|FG000|Overall Study|Adverse Event|3|||
144275133|NCT00984867|520208671|FG001|Overall Study|Adverse Event|7|||
144275134|NCT00984867|520208670|FG000|Overall Study|Death|1|||
144275135|NCT00984867|520208671|FG001|Overall Study|Death|0|||
144275136|NCT00984867|520208670|FG000|Overall Study|Withdrawal by Subject|13|||
144275137|NCT00984867|520208671|FG001|Overall Study|Withdrawal by Subject|4|||
144275138|NCT00984867|520208670|FG000|Overall Study|Lost to Follow-up|3|||
144275139|NCT00984867|520208671|FG001|Overall Study|Lost to Follow-up|4|||
144275140|NCT00984867|520208670|FG000|Overall Study|Poor/non-compliance|0|||
144275141|NCT00984867|520208671|FG001|Overall Study|Poor/non-compliance|1|||
144275142|NCT00984867|520208670|FG000|Overall Study|Subject no longer meets study criteria|1|||
144275143|NCT00984867|520208671|FG001|Overall Study|Subject no longer meets study criteria|1|||
144275144|NCT00984867|520208670|FG000|Overall Study|site closing|1|||
144275145|NCT00984867|520208671|FG001|Overall Study|site closing|0|||
144275146|NCT00984867|520208670|FG000|Overall Study|lack of efficacy and subject compliance|1|||
144275147|NCT00984867|520208671|FG001|Overall Study|lack of efficacy and subject compliance|0|||
144275148|NCT06057064|520208672|FG000|Overall Study|Death|2|||
144275149|NCT06057064|520208673|FG001|Overall Study|Death|0|||
144275150|NCT06057064|520208672|FG000|Overall Study|Physician Decision|1|||
144275151|NCT06057064|520208673|FG001|Overall Study|Physician Decision|0|||
144275152|NCT06057064|520208672|FG000|Overall Study|Withdrawal by Subject|1|||
144275153|NCT06057064|520208673|FG001|Overall Study|Withdrawal by Subject|1|||
144275154|NCT00626639|520208681|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
144275155|NCT00626639|520208682|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
144275156|NCT01461551|520208683|FG000|Overall Study|Physician Decision|2|||
144275157|NCT01461551|520208684|FG001|Overall Study|Physician Decision|1|||
144275158|NCT01461551|520208685|FG002|Overall Study|Physician Decision|2|||
144275159|NCT01155141|520208686|FG000|Overall Study|Withdrawal by Subject|1|||
144275160|NCT01155141|520208686|FG000|Overall Study|Screen Failure|1|||
144275161|NCT00785629|520208690|FG000|Overall Study|Adverse Event|2|||
144275162|NCT00785629|520208691|FG001|Overall Study|Adverse Event|1|||
144275163|NCT00785629|520208692|FG002|Overall Study|Adverse Event|1|||
144275164|NCT00785629|520208693|FG003|Overall Study|Adverse Event|5|||
144275165|NCT00785629|520208690|FG000|Overall Study|Protocol Violation|1|||
144275166|NCT00785629|520208691|FG001|Overall Study|Protocol Violation|2|||
144275167|NCT00785629|520208692|FG002|Overall Study|Protocol Violation|4|||
144275168|NCT00785629|520208693|FG003|Overall Study|Protocol Violation|5|||
144275169|NCT00785629|520208690|FG000|Overall Study|administrative decision|5|||
144275170|NCT00785629|520208691|FG001|Overall Study|administrative decision|1|||
144275171|NCT00785629|520208692|FG002|Overall Study|administrative decision|3|||
144275172|NCT00785629|520208693|FG003|Overall Study|administrative decision|4|||
144275173|NCT00785629|520208690|FG000|Overall Study|Withdrawal by Subject|0|||
144275174|NCT00785629|520208691|FG001|Overall Study|Withdrawal by Subject|1|||
144275175|NCT00785629|520208692|FG002|Overall Study|Withdrawal by Subject|2|||
144275176|NCT00785629|520208693|FG003|Overall Study|Withdrawal by Subject|2|||
144275177|NCT00851591|520208694|FG000|Overall Study|Withdrawal by Subject|2|||
144275178|NCT00851591|520208695|FG001|Overall Study|Withdrawal by Subject|0|||
144275179|NCT02326883|520208697|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
144275180|NCT02326883|520208698|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
144275181|NCT02326883|520208699|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
144275182|NCT02107898|520208702|FG000|Overall Study|Adverse Event|4|||
144275183|NCT02107898|520208703|FG001|Overall Study|Adverse Event|7|||
144275184|NCT02107898|520208702|FG000|Overall Study|Poor compliance to protocol|0|||
144275185|NCT02107898|520208703|FG001|Overall Study|Poor compliance to protocol|1|||
144275186|NCT02107898|520208702|FG000|Overall Study|Participant moved|0|||
144275187|NCT02107898|520208703|FG001|Overall Study|Participant moved|2|||
144275188|NCT02107898|520208702|FG000|Overall Study|Consent withdrawn by participant|2|||
144275189|NCT02107898|520208703|FG001|Overall Study|Consent withdrawn by participant|1|||
144275190|NCT02107898|520208702|FG000|Overall Study|Randomized but not treated|0|||
144275191|NCT02107898|520208703|FG001|Overall Study|Randomized but not treated|1|||
144275192|NCT03329989|520208704|FG000|Overall Study|Withdrawal by Subject|9|||
144275193|NCT03329989|520208704|FG000|Overall Study|Lost to Follow-up|8|||
144275194|NCT03329989|520208704|FG000|Overall Study|Adverse Event|5|||
144275195|NCT03329989|520208704|FG000|Overall Study|Protocol Violation|1|||
144275196|NCT00297167|520208705|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
144275197|NCT00297167|520208706|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
144275198|NCT00297167|520208707|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
144275199|NCT00297167|520208705|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
144275200|NCT00297167|520208706|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
144275201|NCT00297167|520208707|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
144275202|NCT01898130|520208709|FG000|Treatment|Withdrawal by Subject|2|||
144275203|NCT01898130|520208709|FG000|Treatment|Progressive Disease|4|||
144275204|NCT01898130|520208709|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
144275205|NCT00920816|520208710|FG000|Overall Study|Death|116|||
144275206|NCT00920816|520208711|FG001|Overall Study|Death|63|||
144275207|NCT00920816|520208712|FG002|Overall Study|Death|8|||
144275208|NCT00920816|520208713|FG003|Overall Study|Death|3|||
144275209|NCT00920816|520208710|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
144275210|NCT00920816|520208711|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
144275211|NCT00920816|520208712|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
144275212|NCT00920816|520208713|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
144275213|NCT00920816|520208710|FG000|Overall Study|Global deterioration of health status|2|||
144275214|NCT00920816|520208711|FG001|Overall Study|Global deterioration of health status|0|||
144275215|NCT00920816|520208712|FG002|Overall Study|Global deterioration of health status|0|||
144275216|NCT00920816|520208713|FG003|Overall Study|Global deterioration of health status|0|||
144275217|NCT00920816|520208710|FG000|Overall Study|Objective progression or relapse|6|||
144275218|NCT00920816|520208711|FG001|Overall Study|Objective progression or relapse|2|||
144275219|NCT00920816|520208712|FG002|Overall Study|Objective progression or relapse|0|||
144275220|NCT00920816|520208713|FG003|Overall Study|Objective progression or relapse|0|||
144275221|NCT00920816|520208710|FG000|Overall Study|Other|26|||
144275222|NCT00920816|520208711|FG001|Overall Study|Other|15|||
144275223|NCT00920816|520208712|FG002|Overall Study|Other|1|||
144275224|NCT00920816|520208713|FG003|Overall Study|Other|2|||
144275225|NCT00920816|520208710|FG000|Overall Study|Lost to Follow-up|11|||
144275226|NCT00920816|520208711|FG001|Overall Study|Lost to Follow-up|2|||
144275227|NCT00920816|520208712|FG002|Overall Study|Lost to Follow-up|0|||
144275228|NCT00920816|520208713|FG003|Overall Study|Lost to Follow-up|0|||
144275229|NCT00920816|520208710|FG000|Overall Study|Adverse Event|1|||
144275230|NCT00920816|520208711|FG001|Overall Study|Adverse Event|1|||
144275231|NCT00920816|520208712|FG002|Overall Study|Adverse Event|1|||
144275232|NCT00920816|520208713|FG003|Overall Study|Adverse Event|0|||
144275233|NCT00920816|520208710|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
144275234|NCT00920816|520208711|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
144275235|NCT00920816|520208712|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
144275236|NCT00920816|520208713|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
144275237|NCT00920816|520208710|FG000|Overall Study|Randomized but not treated|3|||
144275238|NCT00920816|520208711|FG001|Overall Study|Randomized but not treated|0|||
144275239|NCT00920816|520208712|FG002|Overall Study|Randomized but not treated|0|||
144275240|NCT00920816|520208713|FG003|Overall Study|Randomized but not treated|0|||
144275241|NCT01033136|520208714|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
144275242|NCT01033136|520208715|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
144275243|NCT00142415|520208716|FG000|Overall Study|Physician Decision|0|||
144275244|NCT00142415|520208717|FG001|Overall Study|Physician Decision|0|||
144275245|NCT00142415|520208718|FG002|Overall Study|Physician Decision|0|||
144275246|NCT00142415|520208719|FG003|Overall Study|Physician Decision|0|||
144275247|NCT00142415|520208720|FG004|Overall Study|Physician Decision|1|||
144275248|NCT00142415|520208721|FG005|Overall Study|Physician Decision|2|||
144275249|NCT02101294|520208722|FG000|Overall Study|Withdrawal by Subject|5|||
144275250|NCT02101294|520208722|FG000|Overall Study|Lost to Follow-up|6|||
144275251|NCT03836053|520210215|FG000|Overall Study|Protocol-specified criteria|0|||
144275252|NCT03836053|520210216|FG001|Overall Study|Protocol-specified criteria|2|||
144275253|NCT03836053|520210217|FG002|Overall Study|Protocol-specified criteria|1|||
144275254|NCT03836053|520210215|FG000|Overall Study|Death|1|||
144275255|NCT03836053|520210216|FG001|Overall Study|Death|6|||
144275256|NCT03836053|520210217|FG002|Overall Study|Death|4|||
144275257|NCT03836053|520210215|FG000|Overall Study|Withdrawal of consent from study|0|||
144275258|NCT03836053|520210216|FG001|Overall Study|Withdrawal of consent from study|0|||
144275259|NCT03836053|520210217|FG002|Overall Study|Withdrawal of consent from study|1|||
144275260|NCT03836053|520210215|FG000|Overall Study|Decision by sponsor|0|||
144275261|NCT03836053|520210216|FG001|Overall Study|Decision by sponsor|2|||
144275262|NCT03836053|520210217|FG002|Overall Study|Decision by sponsor|4|||
144275263|NCT00788671|520210218|FG000|Overall Study|Death|2|||
144275264|NCT00788671|520210218|FG000|Overall Study|Unable to biopsy|1|||
144275265|NCT00788671|520210218|FG000|Overall Study|Withdrawal by Subject|4|||
144275266|NCT00788671|520210218|FG000|Overall Study|IUD expulsed|1|||
144275267|NCT00788671|520210218|FG000|Overall Study|Lost to follow up|2|||
144275268|NCT06125964|520210219|FG000|Overall Study|Lost to Follow-up|0|||
144275269|NCT06125964|520210220|FG001|Overall Study|Lost to Follow-up|1|||
144275270|NCT06125964|520210221|FG002|Overall Study|Lost to Follow-up|0|||
144275271|NCT06125964|520210222|FG003|Overall Study|Lost to Follow-up|0|||
144275272|NCT06633965|520210223|FG000|Overall Study|Withdrawal by Subject|0|||
144275273|NCT06633965|520210224|FG001|Overall Study|Withdrawal by Subject|1|||
144275274|NCT00141921|520210226|FG000|Overall Study|Remain on Study|28|||
144275275|NCT00141921|520210226|FG000|Overall Study|Withdrawal by Subject|42|||
144275276|NCT00141921|520210226|FG000|Overall Study|Lost to Follow-up|19|||
144275277|NCT00141921|520210226|FG000|Overall Study|Noncompliance|17|||
144275278|NCT00141921|520210226|FG000|Overall Study|Disease Progression|7|||
144275279|NCT00141921|520210226|FG000|Overall Study|Protocol Deviation|7|||
144275280|NCT00141921|520210226|FG000|Overall Study|Adverse Event|5|||
144275281|NCT00141921|520210226|FG000|Overall Study|Administrative Decision|2|||
144275282|NCT00141921|520210226|FG000|Overall Study|Pregnancy|4|||
144275283|NCT00141921|520210226|FG000|Overall Study|Ineligibility Determined|2|||
144275284|NCT00141921|520210226|FG000|Overall Study|Other|8|||
144275285|NCT03813654|520210227|FG000|Overall Study|Protocol Violation|0|||
144275286|NCT03813654|520210228|FG001|Overall Study|Protocol Violation|1|||
144275287|NCT03813654|520210229|FG002|Overall Study|Protocol Violation|2|||
144275288|NCT03813654|520210227|FG000|Overall Study|Withdrawal by Subject|1|||
144275289|NCT03813654|520210228|FG001|Overall Study|Withdrawal by Subject|0|||
144275290|NCT03813654|520210229|FG002|Overall Study|Withdrawal by Subject|0|||
144275291|NCT01155323|520210230|FG000|First Intervention|exclusion criteria|1|||
144275292|NCT01155323|520210231|FG001|First Intervention|exclusion criteria|1|||
144275293|NCT01155323|520210230|FG000|Second Intervention|Lost to Follow-up|1|||
144275294|NCT01155323|520210231|FG001|Second Intervention|Lost to Follow-up|1|||
144275295|NCT01208051|520210232|FG000|Total Enrollment|Withdrawal by Subject|0|||
144275296|NCT01208051|520210233|FG001|Total Enrollment|Withdrawal by Subject|1|||
144275297|NCT01208051|520210234|FG002|Total Enrollment|Withdrawal by Subject|0|||
144275298|NCT01208051|520210235|FG003|Total Enrollment|Withdrawal by Subject|0|||
144275299|NCT01208051|520210236|FG004|Total Enrollment|Withdrawal by Subject|2|||
144275300|NCT01208051|520210232|FG000|Total Enrollment|Brain metastases|0|||
144275301|NCT01208051|520210233|FG001|Total Enrollment|Brain metastases|0|||
144275302|NCT01208051|520210234|FG002|Total Enrollment|Brain metastases|1|||
144275303|NCT01208051|520210235|FG003|Total Enrollment|Brain metastases|0|||
144275304|NCT01208051|520210236|FG004|Total Enrollment|Brain metastases|0|||
144275305|NCT00973973|520210238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
144275306|NCT00973973|520210239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
144275307|NCT00973973|520210238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
144275308|NCT00973973|520210239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
144275309|NCT00973973|520210238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
144275310|NCT00973973|520210239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
144275311|NCT00973973|520210238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
144275312|NCT00973973|520210239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
144275313|NCT00973973|520210238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
144275314|NCT00973973|520210239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
144275315|NCT00973973|520210238|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
144275316|NCT00973973|520210239|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
144275317|NCT00973973|520210238|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
144275318|NCT00973973|520210239|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
144275319|NCT00973973|520210238|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
144275320|NCT00973973|520210239|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
144275321|NCT00973973|520210238|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
144275322|NCT00973973|520210239|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
144275323|NCT00973973|520210238|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
144275324|NCT00973973|520210239|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
144275325|NCT00973973|520210238|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
144275326|NCT00973973|520210239|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
144275327|NCT00973973|520210238|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
144275328|NCT00973973|520210239|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
144275329|NCT00671060|520210240|FG000|Overall Study|Protocol Violation|1|||
144275330|NCT00671060|520210241|FG001|Overall Study|Protocol Violation|0|||
144275331|NCT00671060|520210240|FG000|Overall Study|Physician Decision|0|||
144275332|NCT00671060|520210241|FG001|Overall Study|Physician Decision|1|||
144275333|NCT01541748|520210242|FG000|Overall Study|Lost to Follow-up|17|||
144275334|NCT01541748|520210242|FG000|Overall Study|Moved out of state|1|||
144275335|NCT01541748|520210242|FG000|Overall Study|Withdrawal by Subject|7|||
144275336|NCT01541748|520210242|FG000|Overall Study|Screen failure|5|||
144275337|NCT01541748|520210242|FG000|Overall Study|Did not receive study device|1|||
144275338|NCT00303186|520210243|FG000|Overall Study|Other|52|||
144275339|NCT03473197|520210244|FG000|Overall Study|Adverse Event|4|||
144275340|NCT03473197|520210244|FG000|Overall Study|Lost to Follow-up|1|||
144275341|NCT03473197|520210244|FG000|Overall Study|Withdrawal by Subject|5|||
144275342|NCT02832037|520210245|FG000|Overall Study|Administrative reasons|0|||
144275343|NCT02832037|520210246|FG001|Overall Study|Administrative reasons|0|||
144275344|NCT02832037|520210247|FG002|Overall Study|Administrative reasons|1|||
144275345|NCT02832037|520210248|FG003|Overall Study|Administrative reasons|0|||
144275346|NCT02832037|520210249|FG004|Overall Study|Administrative reasons|0|||
144275347|NCT02832037|520210245|FG000|Overall Study|Protocol Violation|3|||
144275348|NCT02832037|520210246|FG001|Overall Study|Protocol Violation|0|||
144275349|NCT02832037|520210247|FG002|Overall Study|Protocol Violation|4|||
144275350|NCT02832037|520210248|FG003|Overall Study|Protocol Violation|1|||
144275351|NCT02832037|520210249|FG004|Overall Study|Protocol Violation|2|||
144275352|NCT02832037|520210245|FG000|Overall Study|Lost to Follow-up|2|||
144275353|NCT02832037|520210246|FG001|Overall Study|Lost to Follow-up|0|||
144275354|NCT02832037|520210247|FG002|Overall Study|Lost to Follow-up|3|||
144275355|NCT02832037|520210248|FG003|Overall Study|Lost to Follow-up|0|||
144275356|NCT02832037|520210249|FG004|Overall Study|Lost to Follow-up|5|||
144275357|NCT02832037|520210245|FG000|Overall Study|Withdrawal by Subject|9|||
144275358|NCT02832037|520210246|FG001|Overall Study|Withdrawal by Subject|8|||
144275359|NCT02832037|520210247|FG002|Overall Study|Withdrawal by Subject|0|||
144275360|NCT02832037|520210248|FG003|Overall Study|Withdrawal by Subject|4|||
144275361|NCT02832037|520210249|FG004|Overall Study|Withdrawal by Subject|8|||
144275362|NCT02832037|520210245|FG000|Overall Study|Adverse Event|5|||
144275363|NCT02832037|520210246|FG001|Overall Study|Adverse Event|4|||
144275364|NCT02832037|520210247|FG002|Overall Study|Adverse Event|0|||
144275365|NCT02832037|520210248|FG003|Overall Study|Adverse Event|2|||
144275366|NCT02832037|520210249|FG004|Overall Study|Adverse Event|4|||
144275367|NCT01283386|520210254|FG000|Overall Study|Death|2|||
144275368|NCT01283386|520210255|FG001|Overall Study|Death|0|||
144275369|NCT01283386|520210254|FG000|Overall Study|Withdrawal by Subject|2|||
144275370|NCT01283386|520210255|FG001|Overall Study|Withdrawal by Subject|1|||
144275371|NCT01283386|520210254|FG000|Overall Study|Relapse of underlying disease|1|||
144275372|NCT01283386|520210255|FG001|Overall Study|Relapse of underlying disease|3|||
144275373|NCT01283386|520210254|FG000|Overall Study|Progression of underlying disease|2|||
144275374|NCT01283386|520210255|FG001|Overall Study|Progression of underlying disease|7|||
144275375|NCT01283386|520210254|FG000|Overall Study|Reason not specified|1|||
144275376|NCT01283386|520210255|FG001|Overall Study|Reason not specified|0|||
144275377|NCT01283386|520210254|FG000|Overall Study|Protocol Violation|0|||
144275378|NCT01283386|520210255|FG001|Overall Study|Protocol Violation|1|||
144275379|NCT02469857|520210256|FG000|Overall Study|Death|24|||
144275380|NCT02469857|520210257|FG001|Overall Study|Death|29|||
144275381|NCT02469857|520210256|FG000|Overall Study|Discontinuation|1|||
144275382|NCT02469857|520210257|FG001|Overall Study|Discontinuation|3|||
144275383|NCT00937950|520210258|FG000|Overall Study|Withdrawal by Subject|23|||
144275384|NCT00937950|520210258|FG000|Overall Study|Migrated/moved from study area|27|||
144275385|NCT00937950|520210258|FG000|Overall Study|Lost to Follow-up|144|||
144275386|NCT00937950|520210258|FG000|Overall Study|Missing confirmed|4|||
144275387|NCT00937950|520210258|FG000|Overall Study|Other|18|||
144275388|NCT01137786|520210259|FG000|Overall Study|Lost to Follow-up|0|||
144275389|NCT01137786|520210260|FG001|Overall Study|Lost to Follow-up|2|||
144275390|NCT01137786|520210259|FG000|Overall Study|Withdrawal by Subject|1|||
144275391|NCT01137786|520210260|FG001|Overall Study|Withdrawal by Subject|1|||
144275392|NCT04727749|520210261|FG000|Overall Study|Lost to Follow-up|10|||
144275393|NCT04727749|520210262|FG001|Overall Study|Lost to Follow-up|3|||
144275394|NCT04167462|520210264|FG000|Overall Study|Other reasons|3|||
144275395|NCT04167462|520210265|FG001|Overall Study|Other reasons|2|||
144275396|NCT04167462|520210264|FG000|Overall Study|Withdrawal by Subject|6|||
144275397|NCT04167462|520210265|FG001|Overall Study|Withdrawal by Subject|7|||
144275398|NCT04167462|520210264|FG000|Overall Study|Adverse Event|4|||
144275399|NCT04167462|520210265|FG001|Overall Study|Adverse Event|0|||
144275400|NCT04167462|520210264|FG000|Overall Study|Pregnancy|1|||
144275401|NCT04167462|520210265|FG001|Overall Study|Pregnancy|0|||
144275402|NCT04167462|520210264|FG000|Overall Study|Lack of Efficacy|0|||
144275403|NCT04167462|520210265|FG001|Overall Study|Lack of Efficacy|1|||
144275404|NCT02320396|520210266|FG000|Overall Study|Adverse Event|2|||
144275405|NCT02320396|520210267|FG001|Overall Study|Adverse Event|2|||
144275406|NCT02320396|520210266|FG000|Overall Study|Pregnancy|0|||
144275407|NCT02320396|520210267|FG001|Overall Study|Pregnancy|1|||
144275408|NCT02320396|520210266|FG000|Overall Study|Protocol Violation|0|||
144275409|NCT02320396|520210267|FG001|Overall Study|Protocol Violation|1|||
144275410|NCT02320396|520210266|FG000|Overall Study|Withdrawal by Subject|2|||
144275411|NCT02320396|520210267|FG001|Overall Study|Withdrawal by Subject|0|||
144275412|NCT03331562|520210268|FG000|Overall Study|Adverse Event|2|||
144275413|NCT03331562|520210269|FG001|Overall Study|Adverse Event|0|||
144275414|NCT03331562|520210268|FG000|Overall Study|Death|1|||
144275415|NCT03331562|520210269|FG001|Overall Study|Death|0|||
144275416|NCT03718000|520210270|FG000|Overall Study|Relocation|2|||
144275417|NCT03718000|520210271|FG001|Overall Study|Relocation|4|||
144275418|NCT03718000|520210270|FG000|Overall Study|Pregnancy|0|||
144275419|NCT03718000|520210271|FG001|Overall Study|Pregnancy|1|||
144275420|NCT02475213|520210272|FG000|Overall Study|Adverse Event|2|||
144275421|NCT02475213|520210273|FG001|Overall Study|Adverse Event|0|||
144275422|NCT02475213|520210274|FG002|Overall Study|Adverse Event|0|||
144275423|NCT02475213|520210275|FG003|Overall Study|Adverse Event|1|||
144275424|NCT02475213|520210276|FG004|Overall Study|Adverse Event|1|||
144275425|NCT02475213|520210277|FG005|Overall Study|Adverse Event|4|||
144275426|NCT02475213|520210278|FG006|Overall Study|Adverse Event|6|||
144275427|NCT02475213|520210279|FG007|Overall Study|Adverse Event|2|||
144275428|NCT02475213|520210272|FG000|Overall Study|Physician Decision|1|||
144275429|NCT02475213|520210273|FG001|Overall Study|Physician Decision|1|||
144275430|NCT02475213|520210274|FG002|Overall Study|Physician Decision|1|||
144275431|NCT02475213|520210275|FG003|Overall Study|Physician Decision|0|||
144275432|NCT02475213|520210276|FG004|Overall Study|Physician Decision|0|||
144275433|NCT02475213|520210277|FG005|Overall Study|Physician Decision|1|||
144275434|NCT02475213|520210278|FG006|Overall Study|Physician Decision|4|||
144275435|NCT02475213|520210279|FG007|Overall Study|Physician Decision|0|||
144275436|NCT02475213|520210272|FG000|Overall Study|Progressive Disease|3|||
144275437|NCT02475213|520210273|FG001|Overall Study|Progressive Disease|2|||
144275438|NCT02475213|520210274|FG002|Overall Study|Progressive Disease|2|||
144275439|NCT02475213|520210275|FG003|Overall Study|Progressive Disease|13|||
144275440|NCT02475213|520210276|FG004|Overall Study|Progressive Disease|15|||
144275441|NCT02475213|520210277|FG005|Overall Study|Progressive Disease|25|||
144275442|NCT02475213|520210278|FG006|Overall Study|Progressive Disease|30|||
144275443|NCT02475213|520210279|FG007|Overall Study|Progressive Disease|10|||
144275444|NCT02475213|520210272|FG000|Overall Study|Death|0|||
144275445|NCT02475213|520210273|FG001|Overall Study|Death|0|||
144275446|NCT02475213|520210274|FG002|Overall Study|Death|0|||
144275447|NCT02475213|520210275|FG003|Overall Study|Death|0|||
144275448|NCT02475213|520210276|FG004|Overall Study|Death|0|||
144275449|NCT02475213|520210277|FG005|Overall Study|Death|4|||
144275450|NCT02475213|520210278|FG006|Overall Study|Death|1|||
144275451|NCT02475213|520210279|FG007|Overall Study|Death|0|||
144275452|NCT02475213|520210272|FG000|Overall Study|Protocol Violation|0|||
144275453|NCT02475213|520210273|FG001|Overall Study|Protocol Violation|0|||
144275454|NCT02475213|520210274|FG002|Overall Study|Protocol Violation|0|||
144275455|NCT02475213|520210275|FG003|Overall Study|Protocol Violation|0|||
144275456|NCT02475213|520210276|FG004|Overall Study|Protocol Violation|1|||
144275457|NCT02475213|520210277|FG005|Overall Study|Protocol Violation|0|||
144275458|NCT02475213|520210278|FG006|Overall Study|Protocol Violation|0|||
144275459|NCT02475213|520210279|FG007|Overall Study|Protocol Violation|0|||
144275460|NCT02475213|520210272|FG000|Overall Study|Withdrawal by Subject|0|||
144275461|NCT02475213|520210273|FG001|Overall Study|Withdrawal by Subject|0|||
144275462|NCT02475213|520210274|FG002|Overall Study|Withdrawal by Subject|0|||
144275463|NCT02475213|520210275|FG003|Overall Study|Withdrawal by Subject|1|||
144275464|NCT02475213|520210276|FG004|Overall Study|Withdrawal by Subject|0|||
144275465|NCT02475213|520210277|FG005|Overall Study|Withdrawal by Subject|2|||
144275466|NCT02475213|520210278|FG006|Overall Study|Withdrawal by Subject|2|||
144275467|NCT02475213|520210279|FG007|Overall Study|Withdrawal by Subject|0|||
144275468|NCT02475213|520210272|FG000|Overall Study|Other|0|||
144275469|NCT02475213|520210273|FG001|Overall Study|Other|0|||
144275470|NCT02475213|520210274|FG002|Overall Study|Other|0|||
144275471|NCT02475213|520210275|FG003|Overall Study|Other|1|||
144275472|NCT02475213|520210276|FG004|Overall Study|Other|3|||
144275473|NCT02475213|520210277|FG005|Overall Study|Other|1|||
144275474|NCT02475213|520210278|FG006|Overall Study|Other|0|||
144275475|NCT02475213|520210279|FG007|Overall Study|Other|0|||
144275476|NCT00505921|520210280|FG000|Overall Study|Ineligible|1|||
144275477|NCT00505921|520210280|FG000|Overall Study|Failed to Mobilize|8|||
144275478|NCT00630292|520210281|FG000|Overall Study|Withdrawal by Subject|1|||
144275479|NCT02382939|520210282|FG000|Overall Study|Adverse Event|1|||
144275480|NCT02382939|520210283|FG001|Overall Study|Adverse Event|1|||
144275481|NCT02382939|520210282|FG000|Overall Study|Withdrawal by Subject|2|||
144275482|NCT02382939|520210283|FG001|Overall Study|Withdrawal by Subject|2|||
144275483|NCT00321763|520210287|FG000|Overall Study|Adverse Event|1|||
144275484|NCT00321763|520210288|FG001|Overall Study|Adverse Event|1|||
144275485|NCT00321763|520210289|FG002|Overall Study|Adverse Event|0|||
144275486|NCT00321763|520210290|FG003|Overall Study|Adverse Event|1|||
144275487|NCT00321763|520210287|FG000|Overall Study|Withdrawal by Subject|2|||
144275488|NCT00321763|520210288|FG001|Overall Study|Withdrawal by Subject|0|||
144275489|NCT00321763|520210289|FG002|Overall Study|Withdrawal by Subject|1|||
144275490|NCT00321763|520210290|FG003|Overall Study|Withdrawal by Subject|0|||
144275491|NCT00321763|520210287|FG000|Overall Study|Lost to Follow-up|3|||
144275492|NCT00321763|520210288|FG001|Overall Study|Lost to Follow-up|1|||
144275493|NCT00321763|520210289|FG002|Overall Study|Lost to Follow-up|5|||
144275494|NCT00321763|520210290|FG003|Overall Study|Lost to Follow-up|4|||
144275495|NCT00717886|520210291|FG000|Overall Study|Withdrawal by Subject|3|||
144275496|NCT00717886|520210291|FG000|Overall Study|Treatment Failure|1|||
144275497|NCT01553851|520210292|FG000|Overall Study|Adverse Event|2|||
144275498|NCT01553851|520210292|FG000|Overall Study|constipation|1|||
144275499|NCT03530696|520210294|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
144275500|NCT03530696|520210295|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
144275501|NCT01129128|520210296|FG000|Overall Study|Lost to Follow-up|2|||
144275502|NCT01129128|520210297|FG001|Overall Study|Lost to Follow-up|2|||
144275503|NCT01129128|520210298|FG002|Overall Study|Lost to Follow-up|1|||
144275504|NCT01129128|520210296|FG000|Overall Study|Protocol Violation|0|||
144275505|NCT01129128|520210297|FG001|Overall Study|Protocol Violation|1|||
144275506|NCT01129128|520210298|FG002|Overall Study|Protocol Violation|0|||
144275507|NCT01129128|520210296|FG000|Overall Study|Withdrawal by Subject|0|||
144275508|NCT01129128|520210297|FG001|Overall Study|Withdrawal by Subject|1|||
144275509|NCT01129128|520210298|FG002|Overall Study|Withdrawal by Subject|3|||
144275510|NCT01129128|520210296|FG000|Overall Study|Physician Decision|1|||
144275511|NCT01129128|520210297|FG001|Overall Study|Physician Decision|0|||
144275512|NCT01129128|520210298|FG002|Overall Study|Physician Decision|0|||
144275513|NCT03822416|520210299|FG000|Overall Study|Lost to Follow-up|1|||
144275514|NCT03822416|520210300|FG001|Overall Study|Lost to Follow-up|0|||
144275515|NCT03822416|520210299|FG000|Overall Study|Withdrawal by Subject|0|||
144275516|NCT03822416|520210300|FG001|Overall Study|Withdrawal by Subject|1|||
144275517|NCT02755090|520210301|FG000|Overall Study|equipment malfunction|1|||
144275518|NCT02755090|520210302|FG001|Overall Study|equipment malfunction|0|||
144275519|NCT01564407|520210303|FG000|Overall Study|Lost to Follow-up|0|||
144275520|NCT01564407|520210304|FG001|Overall Study|Lost to Follow-up|1|||
144275521|NCT01564407|520210305|FG002|Overall Study|Lost to Follow-up|0|||
144275522|NCT01564407|520210306|FG003|Overall Study|Lost to Follow-up|0|||
144275523|NCT01564407|520210307|FG004|Overall Study|Lost to Follow-up|0|||
144275524|NCT01564407|520210303|FG000|Overall Study|Withdrawal by Subject|0|||
144275525|NCT01564407|520210304|FG001|Overall Study|Withdrawal by Subject|1|||
144275526|NCT01564407|520210305|FG002|Overall Study|Withdrawal by Subject|0|||
144275527|NCT01564407|520210306|FG003|Overall Study|Withdrawal by Subject|0|||
144275528|NCT01564407|520210307|FG004|Overall Study|Withdrawal by Subject|0|||
144275529|NCT01564407|520210303|FG000|Overall Study|funding lost, study ended|0|||
144275530|NCT01564407|520210304|FG001|Overall Study|funding lost, study ended|0|||
144275531|NCT01564407|520210305|FG002|Overall Study|funding lost, study ended|0|||
144275532|NCT01564407|520210306|FG003|Overall Study|funding lost, study ended|1|||
144275533|NCT01564407|520210307|FG004|Overall Study|funding lost, study ended|0|||
144275534|NCT01551173|520210308|FG000|Overall Study|Withdrawal by Subject|11|||
144275535|NCT01551173|520210309|FG001|Overall Study|Withdrawal by Subject|16|||
144275536|NCT01551173|520210308|FG000|Overall Study|Adverse Event|7|||
144275537|NCT01551173|520210309|FG001|Overall Study|Adverse Event|6|||
144275538|NCT01551173|520210308|FG000|Overall Study|Lost to Follow-up|5|||
144275539|NCT01551173|520210309|FG001|Overall Study|Lost to Follow-up|7|||
144275540|NCT01551173|520210308|FG000|Overall Study|Other|5|||
144275541|NCT01551173|520210309|FG001|Overall Study|Other|3|||
144275542|NCT04530344|520210310|FG000|Overall Study|Lost to Follow-up|3|||
144275543|NCT04530344|520210311|FG001|Overall Study|Lost to Follow-up|3|||
144275544|NCT04530344|520210312|FG002|Overall Study|Lost to Follow-up|3|||
144275545|NCT04530344|520210313|FG003|Overall Study|Lost to Follow-up|10|||
144275546|NCT04530344|520210310|FG000|Overall Study|Withdrawal by Subject|14|||
144275547|NCT04530344|520210311|FG001|Overall Study|Withdrawal by Subject|5|||
144275548|NCT04530344|520210312|FG002|Overall Study|Withdrawal by Subject|18|||
144275549|NCT04530344|520210313|FG003|Overall Study|Withdrawal by Subject|33|||
144275550|NCT04530344|520210310|FG000|Overall Study|Adverse Event|0|||
144275551|NCT04530344|520210311|FG001|Overall Study|Adverse Event|0|||
144275552|NCT04530344|520210312|FG002|Overall Study|Adverse Event|0|||
144275553|NCT04530344|520210313|FG003|Overall Study|Adverse Event|1|||
144275554|NCT04530344|520210310|FG000|Overall Study|Lack of Efficacy|0|||
144275555|NCT04530344|520210311|FG001|Overall Study|Lack of Efficacy|0|||
144275556|NCT04530344|520210312|FG002|Overall Study|Lack of Efficacy|0|||
144275557|NCT04530344|520210313|FG003|Overall Study|Lack of Efficacy|1|||
144275558|NCT04530344|520210310|FG000|Overall Study|Physician Decision|0|||
144275559|NCT04530344|520210311|FG001|Overall Study|Physician Decision|0|||
144275560|NCT04530344|520210312|FG002|Overall Study|Physician Decision|1|||
144275561|NCT04530344|520210313|FG003|Overall Study|Physician Decision|1|||
144275562|NCT04530344|520210310|FG000|Overall Study|Pregnancy|0|||
144275563|NCT04530344|520210311|FG001|Overall Study|Pregnancy|0|||
144275564|NCT04530344|520210312|FG002|Overall Study|Pregnancy|2|||
144275565|NCT04530344|520210313|FG003|Overall Study|Pregnancy|1|||
144275566|NCT04530344|520210310|FG000|Overall Study|Protocol Violation|0|||
144275567|NCT04530344|520210311|FG001|Overall Study|Protocol Violation|0|||
144275568|NCT04530344|520210312|FG002|Overall Study|Protocol Violation|0|||
144275569|NCT04530344|520210313|FG003|Overall Study|Protocol Violation|1|||
144275570|NCT04530344|520210310|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
144275571|NCT04530344|520210311|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
144275572|NCT04530344|520210312|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
144275573|NCT04530344|520210313|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
144275574|NCT04530344|520210310|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
144275575|NCT04530344|520210311|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
144275576|NCT04530344|520210312|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
144275577|NCT04530344|520210313|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
144275578|NCT04530344|520210310|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
144275579|NCT04530344|520210311|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
144275580|NCT04530344|520210312|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
144275581|NCT04530344|520210313|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
144275582|NCT04530344|520210310|FG000|Overall Study|Personal Reasons|0|||
144275583|NCT04530344|520210311|FG001|Overall Study|Personal Reasons|0|||
144275584|NCT04530344|520210312|FG002|Overall Study|Personal Reasons|0|||
144275585|NCT04530344|520210313|FG003|Overall Study|Personal Reasons|1|||
144275586|NCT04530344|520210310|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
144275587|NCT04530344|520210311|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
144275588|NCT04530344|520210312|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
144275589|NCT04530344|520210313|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
144275590|NCT05049122|520210314|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
144275591|NCT05049122|520210314|FG000|Overall Study|Participant moved|1|||
144275592|NCT05049122|520210314|FG000|Overall Study|At the direction of the doctor|1|||
144275593|NCT05722015|520210315|FG000|Overall Study|Death|57|||
144275594|NCT05722015|520210316|FG001|Overall Study|Death|37|||
144275595|NCT05722015|520210315|FG000|Overall Study|Lost to Follow-up|1|||
144275596|NCT05722015|520210316|FG001|Overall Study|Lost to Follow-up|0|||
144275597|NCT05722015|520210315|FG000|Overall Study|Withdrawal by Subject|5|||
144275598|NCT05722015|520210316|FG001|Overall Study|Withdrawal by Subject|1|||
144275599|NCT05722015|520210315|FG000|Overall Study|Participants Ongoing|188|||
144275600|NCT05722015|520210316|FG001|Overall Study|Participants Ongoing|88|||
144275601|NCT02657551|520210317|FG000|Overall Study|Adverse Event|2|||
144275602|NCT02657551|520210317|FG000|Overall Study|Withdrawal by Subject|1|||
144275603|NCT02657551|520210317|FG000|Overall Study|Non-Compliance|1|||
144275604|NCT02657551|520210317|FG000|Overall Study|Progression / Relapse|4|||
144275605|NCT04478266|520210318|FG000|Overall Study|Adverse Event|20|||
144275606|NCT04478266|520210319|FG001|Overall Study|Adverse Event|21|||
144275607|NCT04478266|520210318|FG000|Overall Study|Progressive disease|146|||
144275608|NCT04478266|520210319|FG001|Overall Study|Progressive disease|168|||
144275609|NCT04478266|520210318|FG000|Overall Study|Poor compliance to protocol|1|||
144275610|NCT04478266|520210319|FG001|Overall Study|Poor compliance to protocol|0|||
144275611|NCT04478266|520210318|FG000|Overall Study|Withdrawal by Subject|19|||
144275612|NCT04478266|520210319|FG001|Overall Study|Withdrawal by Subject|16|||
144275613|NCT04478266|520210318|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
144275614|NCT04478266|520210319|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
144275615|NCT04478266|520210318|FG000|Overall Study|Study terminated by sponsor|33|||
144275616|NCT04478266|520210319|FG001|Overall Study|Study terminated by sponsor|35|||
144275617|NCT04478266|520210318|FG000|Overall Study|Other: unspecified|5|||
144275618|NCT04478266|520210319|FG001|Overall Study|Other: unspecified|7|||
144275619|NCT04478266|520210318|FG000|Overall Study|Randomized but not treated|1|||
144275620|NCT04478266|520210319|FG001|Overall Study|Randomized but not treated|1|||
144275621|NCT01977846|520210322|FG000|Total Study - Prospective|Death|0|||
144275622|NCT01977846|520210323|FG001|Total Study - Prospective|Death|1|||
144275623|NCT01977846|520210322|FG000|Total Study - Prospective|Lost to Follow-up|0|||
144275624|NCT01977846|520210323|FG001|Total Study - Prospective|Lost to Follow-up|8|||
144275625|NCT01977846|520210322|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
144275626|NCT01977846|520210323|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
144275627|NCT01977846|520210322|FG000|Total Study - Prospective|Not available at time of visit|0|||
144275628|NCT01977846|520210323|FG001|Total Study - Prospective|Not available at time of visit|5|||
144275629|NCT01977846|520210322|FG000|Total Study - Prospective|No show|0|||
144275630|NCT01977846|520210323|FG001|Total Study - Prospective|No show|1|||
144275631|NCT01977846|520210322|FG000|Total Study - Prospective|Protocol Violation|0|||
144275632|NCT01977846|520210323|FG001|Total Study - Prospective|Protocol Violation|1|||
144275633|NCT00596635|520210324|FG000|Overall Study|Lost to Follow-up|0|||
144275634|NCT00596635|520210325|FG001|Overall Study|Lost to Follow-up|2|||
144275635|NCT00596635|520210326|FG002|Overall Study|Lost to Follow-up|0|||
144275636|NCT00596635|520210324|FG000|Overall Study|Treatment for symptomatic UTI|4|||
144275637|NCT00596635|520210325|FG001|Overall Study|Treatment for symptomatic UTI|6|||
144275638|NCT00596635|520210326|FG002|Overall Study|Treatment for symptomatic UTI|3|||
144275639|NCT00596635|520210324|FG000|Overall Study|Hip fracture|2|||
144275640|NCT00596635|520210325|FG001|Overall Study|Hip fracture|3|||
144275641|NCT00596635|520210326|FG002|Overall Study|Hip fracture|3|||
144275642|NCT00596635|520210324|FG000|Overall Study|Could not provide urine specimen|1|||
144275643|NCT00596635|520210325|FG001|Overall Study|Could not provide urine specimen|2|||
144275644|NCT00596635|520210326|FG002|Overall Study|Could not provide urine specimen|2|||
144275645|NCT01101178|520210327|FG000|Period 1|Withdrawal by Subject|1|||
144275646|NCT01101178|520210328|FG001|Period 1|Withdrawal by Subject|2|||
144275647|NCT01101178|520210327|FG000|Period 1|Positive drug screen|1|||
144275648|NCT01101178|520210328|FG001|Period 1|Positive drug screen|1|||
144275649|NCT01101178|520210327|FG000|Period 1|Adverse Event|2|||
144275650|NCT01101178|520210328|FG001|Period 1|Adverse Event|1|||
144275651|NCT01101178|520210327|FG000|Period 2|Withdrawal by Subject|0|||
144275652|NCT01101178|520210328|FG001|Period 2|Withdrawal by Subject|1|||
144275653|NCT01850641|520210329|FG000|Overall Study|Physician Decision|1|||
144275654|NCT01850641|520210329|FG000|Overall Study|Decrease in serum phosphorus|1|||
144275655|NCT01850641|520210329|FG000|Overall Study|Decrease in serum calcium|2|||
144275656|NCT01850641|520210329|FG000|Overall Study|Increase in serum ferritin|1|||
144275657|NCT00127803|520210330|FG000|Overall Study|Adverse Event|2|||
144275658|NCT00127803|520210331|FG001|Overall Study|Adverse Event|0|||
144275659|NCT00127803|520210332|FG002|Overall Study|Adverse Event|0|||
144275660|NCT00127803|520210333|FG003|Overall Study|Adverse Event|0|||
144275661|NCT00127803|520210330|FG000|Overall Study|Withdrawal by Subject|1|||
144275662|NCT00127803|520210331|FG001|Overall Study|Withdrawal by Subject|0|||
144275663|NCT00127803|520210332|FG002|Overall Study|Withdrawal by Subject|0|||
144275664|NCT00127803|520210333|FG003|Overall Study|Withdrawal by Subject|0|||
144275665|NCT00127803|520210330|FG000|Overall Study|Lost to Follow-up|0|||
144275666|NCT00127803|520210331|FG001|Overall Study|Lost to Follow-up|0|||
144275667|NCT00127803|520210332|FG002|Overall Study|Lost to Follow-up|0|||
144275668|NCT00127803|520210333|FG003|Overall Study|Lost to Follow-up|1|||
144275669|NCT00846365|520210336|FG000|Overall Study|Adverse Event|20|||
144275670|NCT00846365|520210337|FG001|Overall Study|Adverse Event|30|||
144275671|NCT00846365|520210338|FG002|Overall Study|Adverse Event|11|||
144275672|NCT00846365|520210336|FG000|Overall Study|Protocol Violation|5|||
144275673|NCT00846365|520210337|FG001|Overall Study|Protocol Violation|4|||
144275674|NCT00846365|520210338|FG002|Overall Study|Protocol Violation|0|||
144275675|NCT00846365|520210336|FG000|Overall Study|Lost to Follow-up|8|||
144275676|NCT00846365|520210337|FG001|Overall Study|Lost to Follow-up|2|||
144275677|NCT00846365|520210338|FG002|Overall Study|Lost to Follow-up|5|||
144275678|NCT00846365|520210336|FG000|Overall Study|Withdrawal by Subject|11|||
144275679|NCT00846365|520210337|FG001|Overall Study|Withdrawal by Subject|11|||
144275680|NCT00846365|520210338|FG002|Overall Study|Withdrawal by Subject|9|||
144275681|NCT00846365|520210336|FG000|Overall Study|Pregnancy|1|||
144275682|NCT00846365|520210337|FG001|Overall Study|Pregnancy|0|||
144275683|NCT00846365|520210338|FG002|Overall Study|Pregnancy|0|||
144275684|NCT00846365|520210336|FG000|Overall Study|Lack of Efficacy|1|||
144275685|NCT00846365|520210337|FG001|Overall Study|Lack of Efficacy|1|||
144275686|NCT00846365|520210338|FG002|Overall Study|Lack of Efficacy|2|||
144275687|NCT00846365|520210336|FG000|Overall Study|Other|9|||
144275688|NCT00846365|520210337|FG001|Overall Study|Other|1|||
144275689|NCT00846365|520210338|FG002|Overall Study|Other|6|||
144275690|NCT00720759|520210343|FG000|Overall Study|Lost to Follow-up|0|||
144275691|NCT00720759|520210344|FG001|Overall Study|Lost to Follow-up|1|||
144275692|NCT00720759|520210345|FG002|Overall Study|Lost to Follow-up|1|||
144275693|NCT00720759|520210346|FG003|Overall Study|Lost to Follow-up|0|||
144275694|NCT00857389|520210350|FG000|Overall Study|Did not proceed to transplant|2|||
144275695|NCT05493111|520212093|FG000|Overall Study|Adverse Event|3|||
144275696|NCT05493111|520212094|FG001|Overall Study|Adverse Event|4|||
144275697|NCT05493111|520212093|FG000|Overall Study|Withdrawal of Consent|19|||
144275698|NCT05493111|520212094|FG001|Overall Study|Withdrawal of Consent|10|||
144275699|NCT05493111|520212093|FG000|Overall Study|Non-compliance|1|||
144275700|NCT05493111|520212094|FG001|Overall Study|Non-compliance|1|||
144275701|NCT05493111|520212093|FG000|Overall Study|Lost to Follow-up|8|||
144275702|NCT05493111|520212094|FG001|Overall Study|Lost to Follow-up|1|||
144275703|NCT05493111|520212093|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
144275704|NCT05493111|520212094|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
144275705|NCT05493111|520212093|FG000|Overall Study|Withdrawal by Subject|1|||
144275706|NCT05493111|520212094|FG001|Overall Study|Withdrawal by Subject|1|||
144275707|NCT00947544|520212095|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
144275708|NCT00947544|520212096|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
144275709|NCT03095287|520212100|FG000|Overall Study|Treatment Failure|1|||
144275710|NCT03095287|520212100|FG000|Overall Study|Adverse Event|1|||
144275711|NCT02394275|520212101|FG000|Overall Study|Adverse Event|22|||
144275712|NCT02394275|520212101|FG000|Overall Study|Lost to Follow-up|7|||
144275713|NCT00782067|520212102|FG000|Overall Study|Adverse Event|35|||
144275714|NCT00782067|520212102|FG000|Overall Study|Subject withdrew consent|11|||
144275715|NCT00782067|520212102|FG000|Overall Study|Lost to Follow-up|2|||
144275716|NCT00782067|520212102|FG000|Overall Study|Administrative problems|14|||
144275717|NCT00782067|520212102|FG000|Overall Study|Death|9|||
144275718|NCT00782067|520212102|FG000|Overall Study|Disease progression|43|||
144275719|NCT00782067|520212102|FG000|Overall Study|Protocol deviation|2|||
144275720|NCT01134042|520212103|FG000|Overall Study|Adverse Event|3|||
144275721|NCT01134042|520212104|FG001|Overall Study|Adverse Event|7|||
144275722|NCT01134042|520212105|FG002|Overall Study|Adverse Event|2|||
144275723|NCT01134042|520212103|FG000|Overall Study|Lack of Efficacy|21|||
144275724|NCT01134042|520212104|FG001|Overall Study|Lack of Efficacy|6|||
144275725|NCT01134042|520212105|FG002|Overall Study|Lack of Efficacy|18|||
144275726|NCT01134042|520212103|FG000|Overall Study|Protocol Violation|5|||
144275727|NCT01134042|520212104|FG001|Overall Study|Protocol Violation|3|||
144275728|NCT01134042|520212105|FG002|Overall Study|Protocol Violation|5|||
144275729|NCT01134042|520212103|FG000|Overall Study|Lost to Follow-up|2|||
144275730|NCT01134042|520212104|FG001|Overall Study|Lost to Follow-up|0|||
144275731|NCT01134042|520212105|FG002|Overall Study|Lost to Follow-up|1|||
144275732|NCT01134042|520212103|FG000|Overall Study|Physician Decision|4|||
144275733|NCT01134042|520212104|FG001|Overall Study|Physician Decision|8|||
144275734|NCT01134042|520212105|FG002|Overall Study|Physician Decision|1|||
144275735|NCT01134042|520212103|FG000|Overall Study|Withdrawal by Subject|13|||
144275736|NCT01134042|520212104|FG001|Overall Study|Withdrawal by Subject|4|||
144275737|NCT01134042|520212105|FG002|Overall Study|Withdrawal by Subject|7|||
144275738|NCT05350423|520212113|FG000|Overall Study|Lost to Follow-up|3|||
144275739|NCT05350423|520212114|FG001|Overall Study|Lost to Follow-up|3|||
144275740|NCT05350423|520212113|FG000|Overall Study|screen failure|5|||
144275741|NCT05350423|520212114|FG001|Overall Study|screen failure|6|||
144275742|NCT02097277|520212115|FG000|Overall Study|Subject no longer meets study criteria|0|||
144275743|NCT02097277|520212116|FG001|Overall Study|Subject no longer meets study criteria|1|||
144275744|NCT02097277|520212117|FG002|Overall Study|Subject no longer meets study criteria|0|||
144275745|NCT02097277|520212118|FG003|Overall Study|Subject no longer meets study criteria|1|||
144275746|NCT02097277|520212119|FG004|Overall Study|Subject no longer meets study criteria|0|||
144275747|NCT02097277|520212115|FG000|Overall Study|Subject request to discontinue treatment|0|||
144275748|NCT02097277|520212116|FG001|Overall Study|Subject request to discontinue treatment|0|||
144275749|NCT02097277|520212117|FG002|Overall Study|Subject request to discontinue treatment|0|||
144275750|NCT02097277|520212118|FG003|Overall Study|Subject request to discontinue treatment|0|||
144275751|NCT02097277|520212119|FG004|Overall Study|Subject request to discontinue treatment|1|||
144275752|NCT02097277|520212115|FG000|Overall Study|Lost to Follow-up|0|||
144275753|NCT02097277|520212116|FG001|Overall Study|Lost to Follow-up|1|||
144275754|NCT02097277|520212117|FG002|Overall Study|Lost to Follow-up|1|||
144275755|NCT02097277|520212118|FG003|Overall Study|Lost to Follow-up|0|||
144275756|NCT02097277|520212119|FG004|Overall Study|Lost to Follow-up|0|||
144275757|NCT02097277|520212115|FG000|Overall Study|Withdrawal by Subject|2|||
144275758|NCT02097277|520212116|FG001|Overall Study|Withdrawal by Subject|1|||
144275759|NCT02097277|520212117|FG002|Overall Study|Withdrawal by Subject|0|||
144275760|NCT02097277|520212118|FG003|Overall Study|Withdrawal by Subject|1|||
144275761|NCT02097277|520212119|FG004|Overall Study|Withdrawal by Subject|0|||
144275762|NCT02097277|520212115|FG000|Overall Study|Adverse Event|0|||
144275763|NCT02097277|520212116|FG001|Overall Study|Adverse Event|0|||
144275764|NCT02097277|520212117|FG002|Overall Study|Adverse Event|1|||
144275765|NCT02097277|520212118|FG003|Overall Study|Adverse Event|2|||
144275766|NCT02097277|520212119|FG004|Overall Study|Adverse Event|0|||
144275767|NCT01091259|520212123|FG000|Overall Study|Adverse Event|3|||
144275768|NCT01091259|520212123|FG000|Overall Study|Lack of Efficacy|2|||
144275769|NCT03320369|520212124|FG000|Overall Study|Adverse Event|1|||
144275770|NCT03320369|520212124|FG000|Overall Study|Withdrawal by Subject|2|||
144275771|NCT01732692|520212128|FG000|Overall Study|Adverse Event|0|||
144275772|NCT01732692|520212129|FG001|Overall Study|Adverse Event|1|||
144275773|NCT01531153|520212136|FG000|Overall Study|Withdrawal by Subject|10|||
144275774|NCT01531153|520212137|FG001|Overall Study|Withdrawal by Subject|9|||
144275775|NCT01531153|520212138|FG002|Overall Study|Withdrawal by Subject|15|||
144275776|NCT03483103|520212139|FG000|Pre-Treatment Phase|Other reasons|1|||
144275777|NCT03483103|520212139|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
144275778|NCT03483103|520212139|FG000|Pre-Treatment Phase|Disease-related complications|1|||
144275779|NCT03483103|520212139|FG000|Pre-Treatment Phase|Death|5|||
144275780|NCT03483103|520212139|FG000|Treatment Phase|Withdrawal by Subject|7|||
144275781|NCT03483103|520212139|FG000|Treatment Phase|Other reasons|1|||
144275782|NCT03483103|520212139|FG000|Treatment Phase|Death|23|||
144275783|NCT03483103|520212139|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
144275784|NCT03483103|520212139|FG000|Treatment Phase|Received nonconforming product|1|||
144275785|NCT00770367|520212140|FG000|First Intervention|Withdrawal by Subject|0|||
144275786|NCT00770367|520212141|FG001|First Intervention|Withdrawal by Subject|2|||
144275787|NCT00770367|520212140|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
144275788|NCT00770367|520212141|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
144275789|NCT00770367|520212140|FG000|Second Intervention|Lost to Follow-up|2|||
144275790|NCT00770367|520212141|FG001|Second Intervention|Lost to Follow-up|0|||
144275791|NCT00435942|520212142|FG000|Overall Study|Death|17|||
144275792|NCT00435942|520212143|FG001|Overall Study|Death|10|||
144275793|NCT00435942|520212142|FG000|Overall Study|Withdrawal by Subject|2|||
144275794|NCT00435942|520212143|FG001|Overall Study|Withdrawal by Subject|0|||
144275795|NCT00435942|520212142|FG000|Overall Study|Lost to Follow-up|0|||
144275796|NCT00435942|520212143|FG001|Overall Study|Lost to Follow-up|16|||
144275797|NCT00435942|520212142|FG000|Overall Study|Conversion to Open Repair|1|||
144275798|NCT00435942|520212143|FG001|Overall Study|Conversion to Open Repair|0|||
144275799|NCT00435942|520212142|FG000|Overall Study|Technical Failure|3|||
144275800|NCT00435942|520212143|FG001|Overall Study|Technical Failure|0|||
144275801|NCT00435942|520212142|FG000|Overall Study|Other|0|||
144275802|NCT00435942|520212143|FG001|Overall Study|Other|1|||
144275803|NCT02378181|520212144|FG000|Overall Study|Lost to Follow-up|2|||
144275804|NCT02378181|520212145|FG001|Overall Study|Lost to Follow-up|5|||
144275805|NCT02378181|520212144|FG000|Overall Study|Withdrawal by Subject|1|||
144275806|NCT02378181|520212145|FG001|Overall Study|Withdrawal by Subject|1|||
144275807|NCT02378181|520212144|FG000|Overall Study|Incarcerated|0|||
144275808|NCT02378181|520212145|FG001|Overall Study|Incarcerated|1|||
144275809|NCT01180777|520212146|FG000|Overall Study|Protocol Violation|6|||
144275810|NCT01180777|520212146|FG000|Overall Study|Poor lens fit|4|||
144275811|NCT01180777|520212146|FG000|Overall Study|Lost to Follow-up|1|||
144275812|NCT01180777|520212146|FG000|Overall Study|Adverse Event|1|||
144275813|NCT04491994|520212147|FG000|Overall Study|Withdrawal by Subject|10|||
144275814|NCT04491994|520212148|FG001|Overall Study|Withdrawal by Subject|5|||
144275815|NCT04491994|520212147|FG000|Overall Study|developed fever > 3 days|4|||
144275816|NCT04491994|520212148|FG001|Overall Study|developed fever > 3 days|1|||
144242364|NCT00197002|520085815|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
144242365|NCT00197002|520085813|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
144242366|NCT00197002|520085814|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
144242367|NCT00197002|520085815|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
144242368|NCT00197002|520085813|FG000|Overall Study|Others|3|||
144242369|NCT00197002|520085814|FG001|Overall Study|Others|1|||
144242370|NCT00197002|520085815|FG002|Overall Study|Others|1|||
144242371|NCT03569293|520085816|FG000|Overall Study|Adverse Event|4|||
144242372|NCT03569293|520085817|FG001|Overall Study|Adverse Event|1|||
144242373|NCT03569293|520085818|FG002|Overall Study|Adverse Event|5|||
144242374|NCT03569293|520085819|FG003|Overall Study|Adverse Event|1|||
144242375|NCT03569293|520085820|FG004|Overall Study|Adverse Event|0|||
144242376|NCT03569293|520085821|FG005|Overall Study|Adverse Event|0|||
144242377|NCT03569293|520085816|FG000|Overall Study|Withdrawal by Subject|16|||
144242378|NCT03569293|520085817|FG001|Overall Study|Withdrawal by Subject|2|||
144242379|NCT03569293|520085818|FG002|Overall Study|Withdrawal by Subject|4|||
144242380|NCT03569293|520085819|FG003|Overall Study|Withdrawal by Subject|1|||
144242381|NCT03569293|520085820|FG004|Overall Study|Withdrawal by Subject|0|||
144242382|NCT03569293|520085821|FG005|Overall Study|Withdrawal by Subject|0|||
144242383|NCT03569293|520085816|FG000|Overall Study|Lost to Follow-up|1|||
144242384|NCT03569293|520085817|FG001|Overall Study|Lost to Follow-up|3|||
144242385|NCT03569293|520085818|FG002|Overall Study|Lost to Follow-up|1|||
144242386|NCT03569293|520085819|FG003|Overall Study|Lost to Follow-up|1|||
144242387|NCT03569293|520085820|FG004|Overall Study|Lost to Follow-up|0|||
144242388|NCT03569293|520085821|FG005|Overall Study|Lost to Follow-up|0|||
144242389|NCT03569293|520085816|FG000|Overall Study|Other|8|||
144242390|NCT03569293|520085817|FG001|Overall Study|Other|2|||
144242391|NCT03569293|520085818|FG002|Overall Study|Other|1|||
144242392|NCT03569293|520085819|FG003|Overall Study|Other|1|||
144242393|NCT03569293|520085820|FG004|Overall Study|Other|0|||
144242394|NCT03569293|520085821|FG005|Overall Study|Other|0|||
144242395|NCT03569293|520085816|FG000|Overall Study|Ongoing at Time of Analysis|8|||
144242396|NCT03569293|520085817|FG001|Overall Study|Ongoing at Time of Analysis|1|||
144242397|NCT03569293|520085818|FG002|Overall Study|Ongoing at Time of Analysis|3|||
144242398|NCT03569293|520085819|FG003|Overall Study|Ongoing at Time of Analysis|0|||
144242399|NCT03569293|520085820|FG004|Overall Study|Ongoing at Time of Analysis|0|||
144242400|NCT03569293|520085821|FG005|Overall Study|Ongoing at Time of Analysis|0|||
144242401|NCT05072106|520085832|FG000|Overall Study|Progressive disease|3|||
144242402|NCT05072106|520085833|FG001|Overall Study|Progressive disease|3|||
144242403|NCT05072106|520085832|FG000|Overall Study|Compassionate use|3|||
144242404|NCT05072106|520085833|FG001|Overall Study|Compassionate use|1|||
144242405|NCT05072106|520085832|FG000|Overall Study|Withdrawal by Subject|1|||
144242406|NCT05072106|520085833|FG001|Overall Study|Withdrawal by Subject|0|||
144242407|NCT03839459|520085834|FG000|Overall Study|Withdrawal by Subject|2|||
144242408|NCT03839459|520085834|FG000|Overall Study|progression of disease|3|||
144242409|NCT05376241|520085843|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
144242410|NCT05376241|520085843|FG000|Overall Study|103 did not complete the survey|103|||
144242411|NCT05376241|520085843|FG000|Overall Study|17 failed 2 attention check questions|17|||
144242412|NCT03036098|520085844|FG000|Pre-Treatment|Other Reasons|1|||
144242413|NCT03036098|520085845|FG001|Pre-Treatment|Other Reasons|2|||
144242414|NCT03036098|520085846|FG002|Pre-Treatment|Other Reasons|0|||
144242415|NCT03036098|520085847|FG003|Pre-Treatment|Other Reasons|5|||
144242416|NCT03036098|520085844|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
144242417|NCT03036098|520085845|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
144242418|NCT03036098|520085846|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
144242419|NCT03036098|520085847|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
144242420|NCT03036098|520085844|FG000|Pre-Treatment|Withdrawal by Subject|1|||
144242421|NCT03036098|520085845|FG001|Pre-Treatment|Withdrawal by Subject|14|||
144242422|NCT03036098|520085846|FG002|Pre-Treatment|Withdrawal by Subject|0|||
144242423|NCT03036098|520085847|FG003|Pre-Treatment|Withdrawal by Subject|5|||
144242424|NCT03036098|520085844|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
144242425|NCT03036098|520085845|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
144242426|NCT03036098|520085846|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
144242427|NCT03036098|520085847|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
144242428|NCT03036098|520085844|FG000|Treatment|Disease Progression|130|||
144242429|NCT03036098|520085845|FG001|Treatment|Disease Progression|77|||
144242430|NCT03036098|520085846|FG002|Treatment|Disease Progression|168|||
144242431|NCT03036098|520085847|FG003|Treatment|Disease Progression|50|||
144242432|NCT03036098|520085844|FG000|Treatment|Study Drug Toxicity|95|||
144242433|NCT03036098|520085845|FG001|Treatment|Study Drug Toxicity|45|||
144242434|NCT03036098|520085846|FG002|Treatment|Study Drug Toxicity|26|||
144242435|NCT03036098|520085847|FG003|Treatment|Study Drug Toxicity|22|||
144242436|NCT03036098|520085844|FG000|Treatment|Death|9|||
144242437|NCT03036098|520085845|FG001|Treatment|Death|3|||
144242438|NCT03036098|520085846|FG002|Treatment|Death|1|||
144242439|NCT03036098|520085847|FG003|Treatment|Death|2|||
144242440|NCT03036098|520085844|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
144242441|NCT03036098|520085845|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
144242442|NCT03036098|520085846|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
144242443|NCT03036098|520085847|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
144242444|NCT03036098|520085844|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
144242445|NCT03036098|520085845|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
144242446|NCT03036098|520085846|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
144242447|NCT03036098|520085847|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
144242448|NCT03036098|520085844|FG000|Treatment|Withdrawal by Subject|2|||
144242449|NCT03036098|520085845|FG001|Treatment|Withdrawal by Subject|9|||
144242450|NCT03036098|520085846|FG002|Treatment|Withdrawal by Subject|2|||
144242451|NCT03036098|520085847|FG003|Treatment|Withdrawal by Subject|4|||
144242452|NCT03036098|520085844|FG000|Treatment|Maximum Clinical Benefit|6|||
144242453|NCT03036098|520085845|FG001|Treatment|Maximum Clinical Benefit|1|||
144242454|NCT03036098|520085846|FG002|Treatment|Maximum Clinical Benefit|6|||
144242455|NCT03036098|520085847|FG003|Treatment|Maximum Clinical Benefit|10|||
144242456|NCT03036098|520085844|FG000|Treatment|Poor/Non Compliance|1|||
144242457|NCT03036098|520085845|FG001|Treatment|Poor/Non Compliance|2|||
144242458|NCT03036098|520085846|FG002|Treatment|Poor/Non Compliance|0|||
144242459|NCT03036098|520085847|FG003|Treatment|Poor/Non Compliance|1|||
144242460|NCT03036098|520085844|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
144242461|NCT03036098|520085845|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
144242462|NCT03036098|520085846|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
144242463|NCT03036098|520085847|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
144242464|NCT03036098|520085844|FG000|Treatment|Administrative Reason by Sponsor|1|||
144242465|NCT03036098|520085845|FG001|Treatment|Administrative Reason by Sponsor|0|||
144242466|NCT03036098|520085846|FG002|Treatment|Administrative Reason by Sponsor|2|||
144242467|NCT03036098|520085847|FG003|Treatment|Administrative Reason by Sponsor|1|||
144242468|NCT03036098|520085844|FG000|Treatment|Other Reasons|31|||
144242469|NCT03036098|520085845|FG001|Treatment|Other Reasons|5|||
144242470|NCT03036098|520085846|FG002|Treatment|Other Reasons|21|||
144242471|NCT03036098|520085847|FG003|Treatment|Other Reasons|8|||
144242472|NCT03036098|520085844|FG000|Treatment|Ongoing Treatment|0|||
144242473|NCT03036098|520085845|FG001|Treatment|Ongoing Treatment|0|||
144242474|NCT03036098|520085846|FG002|Treatment|Ongoing Treatment|23|||
144242475|NCT03036098|520085847|FG003|Treatment|Ongoing Treatment|0|||
144242476|NCT04240886|520085850|FG000|Treatment Phase|Death|4|||
144242477|NCT04240886|520085850|FG000|Treatment Phase|Discontinuation by Subject|1|||
144242478|NCT04240886|520085850|FG000|Treatment Phase|Adverse Event|5|||
144242479|NCT04240886|520085850|FG000|Follow-up Phase|Withdrawal by Subject|1|||
144242480|NCT04240886|520085850|FG000|Follow-up Phase|Discontinuation by Subject|1|||
144242481|NCT04240886|520085850|FG000|Follow-up Phase|Death|2|||
144242482|NCT02276053|520085853|FG000|Overall Study|Death|2|||
144242483|NCT02276053|520085853|FG000|Overall Study|Adverse Event|5|||
144242484|NCT02276053|520085853|FG000|Overall Study|Lack of Efficacy|2|||
144242485|NCT02276053|520085853|FG000|Overall Study|Withdrawal by Subject|1|||
144242486|NCT02276053|520085853|FG000|Overall Study|Patient does not meet selection criteria|3|||
144242487|NCT02276053|520085853|FG000|Overall Study|Patient needs to increase baseline AED|1|||
144242488|NCT04743804|520085854|FG000|Overall Study|Other|1|||
144242489|NCT04743804|520085855|FG001|Overall Study|Other|0|||
144242490|NCT04743804|520085854|FG000|Overall Study|Withdrawal by Subject|0|||
144242491|NCT04743804|520085855|FG001|Overall Study|Withdrawal by Subject|1|||
144242492|NCT04743804|520085854|FG000|Overall Study|Study Terminated by Sponsor|1|||
144242493|NCT04743804|520085855|FG001|Overall Study|Study Terminated by Sponsor|4|||
144242494|NCT04743804|520085854|FG000|Overall Study|Physician Decision|0|||
144242495|NCT04743804|520085855|FG001|Overall Study|Physician Decision|1|||
144242496|NCT04743804|520085854|FG000|Overall Study|Death|3|||
144242497|NCT04743804|520085855|FG001|Overall Study|Death|0|||
144242498|NCT01632904|520085856|FG000|Overall Study|Adverse Event|4|||
144242499|NCT01632904|520085857|FG001|Overall Study|Adverse Event|1|||
144242500|NCT01632904|520085856|FG000|Overall Study|Physician Decision|0|||
144242501|NCT01632904|520085857|FG001|Overall Study|Physician Decision|1|||
144242502|NCT01632904|520085856|FG000|Overall Study|Subject decision|3|||
144242503|NCT01632904|520085857|FG001|Overall Study|Subject decision|2|||
144242504|NCT01632904|520085856|FG000|Overall Study|Disease Progression|0|||
144242505|NCT01632904|520085857|FG001|Overall Study|Disease Progression|1|||
144242506|NCT01632904|520085856|FG000|Overall Study|Reason for discontinuation not available|0|||
144242507|NCT01632904|520085857|FG001|Overall Study|Reason for discontinuation not available|1|||
144242508|NCT01944670|520085863|FG000|Overall Study|Lost to Follow-up|2|||
144242509|NCT04777201|520085869|FG000|Main Study|Withdrawal by Subject|19|||
144242510|NCT04777201|520085870|FG001|Main Study|Withdrawal by Subject|27|||
144242511|NCT04777201|520085871|FG002|Main Study|Withdrawal by Subject|0|||
144242512|NCT04777201|520085869|FG000|Main Study|Death|13|||
144242513|NCT04777201|520085870|FG001|Main Study|Death|27|||
144242514|NCT04777201|520085871|FG002|Main Study|Death|0|||
144242515|NCT04777201|520085869|FG000|Main Study|Subject missed the safety follow-up visit|9|||
144242516|NCT04777201|520085870|FG001|Main Study|Subject missed the safety follow-up visit|10|||
144242517|NCT04777201|520085871|FG002|Main Study|Subject missed the safety follow-up visit|0|||
144242518|NCT04777201|520085869|FG000|Main Study|Physician Decision|8|||
144242519|NCT04777201|520085870|FG001|Main Study|Physician Decision|10|||
144242520|NCT04777201|520085871|FG002|Main Study|Physician Decision|0|||
144242521|NCT04777201|520085869|FG000|Main Study|Adverse Event|8|||
144242522|NCT04777201|520085870|FG001|Main Study|Adverse Event|8|||
144242523|NCT04777201|520085871|FG002|Main Study|Adverse Event|0|||
144242524|NCT04777201|520085869|FG000|Main Study|Lost to Follow-up|9|||
144242525|NCT04777201|520085870|FG001|Main Study|Lost to Follow-up|4|||
144242526|NCT04777201|520085871|FG002|Main Study|Lost to Follow-up|0|||
144242527|NCT04777201|520085869|FG000|Main Study|Reason not specified|3|||
144242528|NCT04777201|520085870|FG001|Main Study|Reason not specified|3|||
144242529|NCT04777201|520085871|FG002|Main Study|Reason not specified|0|||
144242530|NCT04777201|520085869|FG000|Main Study|Lack of Efficacy|1|||
144242531|NCT04777201|520085870|FG001|Main Study|Lack of Efficacy|1|||
144242532|NCT04777201|520085871|FG002|Main Study|Lack of Efficacy|0|||
144242533|NCT04777201|520085869|FG000|Main Study|Protocol Violation|1|||
144242534|NCT04777201|520085870|FG001|Main Study|Protocol Violation|0|||
144242535|NCT04777201|520085871|FG002|Main Study|Protocol Violation|0|||
144242536|NCT04777201|520085869|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
144242537|NCT04777201|520085870|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
144242538|NCT04777201|520085871|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
144242539|NCT04777201|520085869|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
144242540|NCT04777201|520085870|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
144242541|NCT04777201|520085871|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
144242542|NCT04777201|520085869|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
144242543|NCT04777201|520085870|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
144242544|NCT04777201|520085871|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
144242545|NCT04777201|520085869|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
144242546|NCT04777201|520085870|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
144242547|NCT04777201|520085871|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
144242548|NCT04777201|520085869|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
144242549|NCT04777201|520085870|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
144242550|NCT04777201|520085871|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
144242551|NCT04777201|520085869|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
144242552|NCT04777201|520085870|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
144242553|NCT04777201|520085871|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
144242554|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Adverse Event|6|||
144242555|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Adverse Event|14|||
144242556|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Death|3|||
144242557|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Death|1|||
144242558|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
144242559|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
144242560|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
144242561|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
144242562|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
144242563|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
144242564|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
144242565|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
144242566|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
144242567|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
144242568|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Physician Decision|2|||
144242569|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Physician Decision|4|||
144242570|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Pregnancy|2|||
144242571|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Pregnancy|1|||
144242572|NCT02275780|520085872|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
144242573|NCT02275780|520085873|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
144242574|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
144242575|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
144242576|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
144242577|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
144242578|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
144275817|NCT04491994|520212147|FG000|Overall Study|Protocol Violation|11|||
144275818|NCT04491994|520212148|FG001|Overall Study|Protocol Violation|2|||
144275819|NCT04491994|520212147|FG000|Overall Study|Lost to Follow-up|4|||
144275820|NCT04491994|520212148|FG001|Overall Study|Lost to Follow-up|3|||
144275821|NCT02441283|520212153|FG000|Overall Study|Withdrew consent|15|||
144275822|NCT02441283|520212153|FG000|Overall Study|Lost to Follow-up|42|||
144275823|NCT02441283|520212153|FG000|Overall Study|Death|1|||
144275824|NCT02441283|520212153|FG000|Overall Study|Other, not specified|32|||
144275825|NCT05383209|520212154|FG000|Overall Study|Adverse Event: Non-ocular|0|||
144275826|NCT05383209|520212155|FG001|Overall Study|Adverse Event: Non-ocular|1|||
144275827|NCT05383209|520212156|FG002|Overall Study|Adverse Event: Non-ocular|0|||
144275828|NCT05383209|520212154|FG000|Overall Study|Lost to Follow-up|2|||
144275829|NCT05383209|520212155|FG001|Overall Study|Lost to Follow-up|1|||
144275830|NCT05383209|520212156|FG002|Overall Study|Lost to Follow-up|4|||
144275831|NCT05383209|520212154|FG000|Overall Study|Withdrawal by Subject|2|||
144275832|NCT05383209|520212155|FG001|Overall Study|Withdrawal by Subject|0|||
144275833|NCT05383209|520212156|FG002|Overall Study|Withdrawal by Subject|1|||
144275834|NCT05383209|520212154|FG000|Overall Study|Death|1|||
144275835|NCT05383209|520212155|FG001|Overall Study|Death|0|||
144275836|NCT05383209|520212156|FG002|Overall Study|Death|0|||
144275837|NCT05383209|520212154|FG000|Overall Study|Other|0|||
144275838|NCT05383209|520212155|FG001|Overall Study|Other|1|||
144275839|NCT05383209|520212156|FG002|Overall Study|Other|0|||
144275840|NCT00716417|520212157|FG000|Overall Study|Adverse Event|0|||
144275841|NCT00716417|520212158|FG001|Overall Study|Adverse Event|0|||
144275842|NCT00716417|520212159|FG002|Overall Study|Adverse Event|2|||
144275843|NCT00716417|520212160|FG003|Overall Study|Adverse Event|1|||
144275844|NCT00716417|520212161|FG004|Overall Study|Adverse Event|0|||
144275845|NCT00716417|520212162|FG005|Overall Study|Adverse Event|0|||
144275846|NCT00716417|520212163|FG006|Overall Study|Adverse Event|3|||
144275847|NCT00716417|520212164|FG007|Overall Study|Adverse Event|1|||
144275848|NCT00716417|520212165|FG008|Overall Study|Adverse Event|0|||
144275849|NCT00716417|520212166|FG009|Overall Study|Adverse Event|3|||
144275850|NCT00716417|520212157|FG000|Overall Study|Withdrawal by Subject|0|||
144275851|NCT00716417|520212158|FG001|Overall Study|Withdrawal by Subject|1|||
144275852|NCT00716417|520212159|FG002|Overall Study|Withdrawal by Subject|0|||
144275853|NCT00716417|520212160|FG003|Overall Study|Withdrawal by Subject|2|||
144275854|NCT00716417|520212161|FG004|Overall Study|Withdrawal by Subject|0|||
144275855|NCT00716417|520212162|FG005|Overall Study|Withdrawal by Subject|0|||
144275856|NCT00716417|520212163|FG006|Overall Study|Withdrawal by Subject|1|||
144275857|NCT00716417|520212164|FG007|Overall Study|Withdrawal by Subject|0|||
144275858|NCT00716417|520212165|FG008|Overall Study|Withdrawal by Subject|0|||
144275859|NCT00716417|520212166|FG009|Overall Study|Withdrawal by Subject|0|||
144275860|NCT00716417|520212157|FG000|Overall Study|Progressive disease|3|||
144275861|NCT00716417|520212158|FG001|Overall Study|Progressive disease|5|||
144275862|NCT00716417|520212159|FG002|Overall Study|Progressive disease|3|||
144275863|NCT00716417|520212160|FG003|Overall Study|Progressive disease|8|||
144275864|NCT00716417|520212161|FG004|Overall Study|Progressive disease|0|||
144275865|NCT00716417|520212162|FG005|Overall Study|Progressive disease|3|||
144275866|NCT00716417|520212163|FG006|Overall Study|Progressive disease|3|||
144275867|NCT00716417|520212164|FG007|Overall Study|Progressive disease|1|||
144275868|NCT00716417|520212165|FG008|Overall Study|Progressive disease|5|||
144275869|NCT00716417|520212166|FG009|Overall Study|Progressive disease|0|||
144275870|NCT00716417|520212157|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
144275871|NCT00716417|520212158|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
144275872|NCT00716417|520212159|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
144275873|NCT00716417|520212160|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
144275874|NCT00716417|520212161|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
144275875|NCT00716417|520212162|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
144275876|NCT00716417|520212163|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
144275877|NCT00716417|520212164|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
144275878|NCT00716417|520212165|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
144275879|NCT00716417|520212166|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
144275880|NCT00716417|520212157|FG000|Overall Study|On patient request due to toxicities|0|||
144275881|NCT00716417|520212158|FG001|Overall Study|On patient request due to toxicities|0|||
144275882|NCT00716417|520212159|FG002|Overall Study|On patient request due to toxicities|0|||
144275883|NCT00716417|520212160|FG003|Overall Study|On patient request due to toxicities|0|||
144275884|NCT00716417|520212161|FG004|Overall Study|On patient request due to toxicities|0|||
144275885|NCT00716417|520212162|FG005|Overall Study|On patient request due to toxicities|0|||
144275886|NCT00716417|520212163|FG006|Overall Study|On patient request due to toxicities|0|||
144275887|NCT00716417|520212164|FG007|Overall Study|On patient request due to toxicities|1|||
144275888|NCT00716417|520212165|FG008|Overall Study|On patient request due to toxicities|0|||
144275889|NCT00716417|520212166|FG009|Overall Study|On patient request due to toxicities|0|||
144275890|NCT01303419|520212169|FG000|Overall Study|Discontinuation of study|60|||
144275891|NCT01303419|520212169|FG000|Overall Study|Did not complete both imaging methods|5|||
144275892|NCT01303419|520212169|FG000|Overall Study|Did not meet all I/E after screening|31|||
144275893|NCT02709369|520212171|FG000|Overall Study|Lost to Follow-up|15|||
144275894|NCT02709369|520212171|FG000|Overall Study|Withdrawal by Subject|10|||
144275895|NCT02709369|520212171|FG000|Overall Study|Did not received intervention|2|||
144275896|NCT01900314|520212172|FG000|Overall Study|Lost to Follow-up|1|||
144275897|NCT01900314|520212173|FG001|Overall Study|Lost to Follow-up|0|||
144275898|NCT01900314|520212172|FG000|Overall Study|Protocol Violation|0|||
144275899|NCT01900314|520212173|FG001|Overall Study|Protocol Violation|1|||
144275900|NCT01900314|520212172|FG000|Overall Study|Withdrawal by Subject|3|||
144275901|NCT01900314|520212173|FG001|Overall Study|Withdrawal by Subject|3|||
144275902|NCT01104766|520212174|FG000|Overall Study|Did not meet inc/exc criteria|1|||
144275903|NCT01104766|520212175|FG001|Overall Study|Did not meet inc/exc criteria|0|||
144275904|NCT01104766|520212176|FG002|Overall Study|Did not meet inc/exc criteria|0|||
144275905|NCT01104766|520212177|FG003|Overall Study|Did not meet inc/exc criteria|0|||
144275906|NCT01104766|520212174|FG000|Overall Study|Adverse Event|17|||
144275907|NCT01104766|520212175|FG001|Overall Study|Adverse Event|15|||
144275908|NCT01104766|520212176|FG002|Overall Study|Adverse Event|20|||
144275909|NCT01104766|520212177|FG003|Overall Study|Adverse Event|14|||
144275910|NCT01104766|520212174|FG000|Overall Study|Lack of Efficacy|20|||
144275911|NCT01104766|520212175|FG001|Overall Study|Lack of Efficacy|15|||
144275912|NCT01104766|520212176|FG002|Overall Study|Lack of Efficacy|14|||
144275913|NCT01104766|520212177|FG003|Overall Study|Lack of Efficacy|8|||
144275914|NCT01104766|520212174|FG000|Overall Study|Protocol Violation|2|||
144275915|NCT01104766|520212175|FG001|Overall Study|Protocol Violation|0|||
144275916|NCT01104766|520212176|FG002|Overall Study|Protocol Violation|0|||
144275917|NCT01104766|520212177|FG003|Overall Study|Protocol Violation|0|||
144275918|NCT01104766|520212174|FG000|Overall Study|Withdrawal by Subject|17|||
144275919|NCT01104766|520212175|FG001|Overall Study|Withdrawal by Subject|19|||
144275920|NCT01104766|520212176|FG002|Overall Study|Withdrawal by Subject|25|||
144275921|NCT01104766|520212177|FG003|Overall Study|Withdrawal by Subject|15|||
144275922|NCT01104766|520212174|FG000|Overall Study|Lost to Follow-up|1|||
144275923|NCT01104766|520212175|FG001|Overall Study|Lost to Follow-up|2|||
144275924|NCT01104766|520212176|FG002|Overall Study|Lost to Follow-up|1|||
144275925|NCT01104766|520212177|FG003|Overall Study|Lost to Follow-up|1|||
144275926|NCT03282097|520212179|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
144275927|NCT03282097|520212180|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
144275928|NCT03282097|520212179|FG000|Intervention Visit Complete|Patient Death|13|||
144275929|NCT03282097|520212180|FG001|Intervention Visit Complete|Patient Death|15|||
144275930|NCT03282097|520212179|FG000|Intervention Visit Complete|Caregiver Death|0|||
144275931|NCT03282097|520212180|FG001|Intervention Visit Complete|Caregiver Death|3|||
144275932|NCT03282097|520212179|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
144275933|NCT03282097|520212180|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
144275934|NCT03282097|520212179|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
144275935|NCT03282097|520212180|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
144275936|NCT03282097|520212179|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
144275937|NCT03282097|520212180|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
144275938|NCT03282097|520212179|FG000|Primary Outcome Data Collection Complete|Missing|2|||
144275939|NCT03282097|520212180|FG001|Primary Outcome Data Collection Complete|Missing|3|||
144275940|NCT03282097|520212179|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
144275941|NCT03282097|520212180|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
144275942|NCT03282097|520212179|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
144275943|NCT03282097|520212180|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
144275944|NCT03282097|520212179|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
144275945|NCT03282097|520212180|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
144275946|NCT03806296|520212184|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
144275947|NCT03806296|520212185|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
144275948|NCT03806296|520212186|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
144275949|NCT03806296|520212184|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
144275950|NCT03806296|520212185|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
144275951|NCT03806296|520212186|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
144275952|NCT03806296|520212184|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
144275953|NCT03806296|520212185|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
144275954|NCT03806296|520212186|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
144275955|NCT03197129|520212187|FG000|Overall Study|did not answer the VPT: shyness|4|||
144275956|NCT03197129|520212188|FG001|Overall Study|did not answer the VPT: shyness|5|||
144275957|NCT01285518|520212191|FG000|Overall Study|Lost to Follow-up|0|||
144275958|NCT01285518|520212192|FG001|Overall Study|Lost to Follow-up|0|||
144275959|NCT01285518|520212193|FG002|Overall Study|Lost to Follow-up|0|||
144275960|NCT01285518|520212194|FG003|Overall Study|Lost to Follow-up|0|||
144275961|NCT01285518|520212195|FG004|Overall Study|Lost to Follow-up|0|||
144275962|NCT01285518|520212196|FG005|Overall Study|Lost to Follow-up|1|||
144275963|NCT01285518|520212197|FG006|Overall Study|Lost to Follow-up|0|||
144275964|NCT01285518|520212198|FG007|Overall Study|Lost to Follow-up|0|||
144275965|NCT00639509|520212201|FG000|Overall Study|Death|1|||
144275966|NCT00830765|520212207|FG000|Overall Study|Protocol Violation|3|||
144275967|NCT00830765|520212208|FG001|Overall Study|Protocol Violation|2|||
144275968|NCT00296517|520212209|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
144275969|NCT00296517|520212210|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
144275970|NCT00296517|520212209|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
144275971|NCT00296517|520212210|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
144275972|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
144275973|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
144275974|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
144275975|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
144275976|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
144275977|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
144275978|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
144275979|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
144275980|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
144275981|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
144275982|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
144275983|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
144275984|NCT00296517|520212209|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
144275985|NCT00296517|520212210|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
144275986|NCT02774889|520212213|FG000|Overall Study|Lost to Follow-up|2|||
144275987|NCT02774889|520212214|FG001|Overall Study|Lost to Follow-up|1|||
144275988|NCT03479905|520212225|FG000|Overall Study|Other airway method used|4|||
144275989|NCT03479905|520212226|FG001|Overall Study|Other airway method used|5|||
144275990|NCT03479905|520212227|FG002|Overall Study|Other airway method used|5|||
144275991|NCT00862992|520212228|FG000|Overall Study|Adverse Event|2|||
144275992|NCT00862992|520212229|FG001|Overall Study|Adverse Event|1|||
144275993|NCT00862992|520212230|FG002|Overall Study|Adverse Event|1|||
144275994|NCT00862992|520212228|FG000|Overall Study|Physician Decision|1|||
144275995|NCT00862992|520212229|FG001|Overall Study|Physician Decision|0|||
144275996|NCT00862992|520212230|FG002|Overall Study|Physician Decision|0|||
144275997|NCT00862992|520212228|FG000|Overall Study|Withdrawal by Subject|0|||
144275998|NCT00862992|520212229|FG001|Overall Study|Withdrawal by Subject|0|||
144275999|NCT00862992|520212230|FG002|Overall Study|Withdrawal by Subject|2|||
144276000|NCT02318940|520212231|FG000|Overall Study|lost the record|1|||
144276001|NCT02318940|520212232|FG001|Overall Study|lost the record|0|||
144276002|NCT05032196|520212243|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
144276003|NCT05032196|520212244|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
144276004|NCT05032196|520212245|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
144276005|NCT05032196|520212246|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
144276006|NCT05032196|520212247|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
144276007|NCT05032196|520212248|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
144276008|NCT05032196|520212243|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
144276009|NCT05032196|520212244|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
144276010|NCT05032196|520212245|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
144276011|NCT05032196|520212246|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
144276012|NCT05032196|520212247|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
144276013|NCT05032196|520212248|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
144276014|NCT05032196|520212243|FG000|Period 2 (Multidose)|Physician Decision|0|||
144276015|NCT05032196|520212244|FG001|Period 2 (Multidose)|Physician Decision|0|||
144276016|NCT05032196|520212245|FG002|Period 2 (Multidose)|Physician Decision|0|||
144276017|NCT05032196|520212246|FG003|Period 2 (Multidose)|Physician Decision|0|||
144276018|NCT05032196|520212247|FG004|Period 2 (Multidose)|Physician Decision|1|||
144276019|NCT05032196|520212248|FG005|Period 2 (Multidose)|Physician Decision|0|||
144276020|NCT05260008|520212249|FG000|Overall Study|Physician Decision|0|||
144276021|NCT05260008|520212250|FG001|Overall Study|Physician Decision|1|||
144276022|NCT05260008|520212251|FG002|Overall Study|Physician Decision|0|||
144276023|NCT05260008|520212252|FG003|Overall Study|Physician Decision|0|||
144276024|NCT04817410|520213917|FG000|Overall Study|Withdrawal by Subject|5|||
144276025|NCT04817410|520213917|FG000|Overall Study|Physician Decision|3|||
144276026|NCT01787838|520213918|FG000|Overall Study|refused|1413|||
144276027|NCT02472405|520213919|FG000|Overall Study|Lost to Follow-up|9|||
144276028|NCT02472405|520213919|FG000|Overall Study|Adverse Event|1|||
144276029|NCT01431976|520213920|FG000|Overall Study|Adverse Event|6|||
144276030|NCT01431976|520213920|FG000|Overall Study|Lack of Efficacy|2|||
144276031|NCT01431976|520213920|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
144276032|NCT01431976|520213920|FG000|Overall Study|Physician Decision|1|||
144276033|NCT01431976|520213920|FG000|Overall Study|Withdrawal by Subject|1|||
144276034|NCT02020941|520213929|FG000|Overall Study|Adverse Event|1|||
144276035|NCT02020941|520213929|FG000|Overall Study|Physician Decision|2|||
144276036|NCT02020941|520213929|FG000|Overall Study|Withdrawal by Subject|1|||
144276037|NCT02020941|520213929|FG000|Overall Study|Disease Progression|4|||
144276038|NCT02239328|520213931|FG000|Overall Study|Benign disease noted at time of surgery|6|||
144276039|NCT02239328|520213931|FG000|Overall Study|Equipment or website malfunction|2|||
144276040|NCT00460798|520213932|FG000|Overall Study|Death|59|||
144276041|NCT00460798|520213932|FG000|Overall Study|Adverse Event|27|||
144276042|NCT00460798|520213932|FG000|Overall Study|Lost to Follow-up|19|||
144276043|NCT00460798|520213932|FG000|Overall Study|Progressive Disease|99|||
144276044|NCT00460798|520213932|FG000|Overall Study|Other|27|||
144276045|NCT00460798|520213932|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
144276046|NCT00460798|520213932|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
144276047|NCT04666298|520213944|FG000|Overall Study|Subject decision|1|||
144276048|NCT04666298|520213945|FG001|Overall Study|Subject decision|0|||
144276049|NCT04666298|520213946|FG002|Overall Study|Subject decision|0|||
144276050|NCT04666298|520213947|FG003|Overall Study|Subject decision|2|||
144276051|NCT04666298|520213944|FG000|Overall Study|Death|1|||
144276052|NCT04666298|520213945|FG001|Overall Study|Death|0|||
144276053|NCT04666298|520213946|FG002|Overall Study|Death|0|||
144276054|NCT04666298|520213947|FG003|Overall Study|Death|0|||
144276055|NCT04666298|520213944|FG000|Overall Study|Lost to Follow-up|0|||
144276056|NCT04666298|520213945|FG001|Overall Study|Lost to Follow-up|0|||
144276057|NCT04666298|520213946|FG002|Overall Study|Lost to Follow-up|0|||
144276058|NCT04666298|520213947|FG003|Overall Study|Lost to Follow-up|1|||
144276059|NCT04666298|520213944|FG000|Overall Study|Physician Decision|0|||
144276060|NCT04666298|520213945|FG001|Overall Study|Physician Decision|0|||
144276061|NCT04666298|520213946|FG002|Overall Study|Physician Decision|0|||
144276062|NCT04666298|520213947|FG003|Overall Study|Physician Decision|1|||
144276063|NCT04666298|520213944|FG000|Overall Study|Protocol deviation|0|||
144276064|NCT04666298|520213945|FG001|Overall Study|Protocol deviation|0|||
144276065|NCT04666298|520213946|FG002|Overall Study|Protocol deviation|1|||
144276066|NCT04666298|520213947|FG003|Overall Study|Protocol deviation|0|||
144276067|NCT02178956|520213948|FG000|Overall Study|Lost to Follow-up|4|||
144276068|NCT02178956|520213949|FG001|Overall Study|Lost to Follow-up|4|||
144276069|NCT02178956|520213948|FG000|Overall Study|Sponsor terminated study|49|||
144276070|NCT02178956|520213949|FG001|Overall Study|Sponsor terminated study|58|||
144276071|NCT02178956|520213948|FG000|Overall Study|Withdrawal by Subject|15|||
144276072|NCT02178956|520213949|FG001|Overall Study|Withdrawal by Subject|11|||
144276073|NCT02178956|520213948|FG000|Overall Study|Various Reasons|3|||
144276074|NCT02178956|520213949|FG001|Overall Study|Various Reasons|5|||
144276075|NCT01138046|520213950|FG000|Overall Study|Withdrawal due to death|6|||
144276076|NCT01136915|520213954|FG000|Overall Study|Lost to Follow-up|2|||
144276077|NCT01136915|520213955|FG001|Overall Study|Lost to Follow-up|0|||
144276078|NCT01136915|520213954|FG000|Overall Study|Exclusion criterion met|0|||
144276079|NCT01136915|520213955|FG001|Overall Study|Exclusion criterion met|1|||
144276080|NCT01756235|520213956|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
144276081|NCT04797169|520213960|FG000|Overall Study|Lost to Follow-up|84|||
144276082|NCT04797169|520213961|FG001|Overall Study|Lost to Follow-up|67|||
144276083|NCT04797169|520213960|FG000|Overall Study|Pregnancy|1|||
144276084|NCT04797169|520213961|FG001|Overall Study|Pregnancy|3|||
144276085|NCT04797169|520213960|FG000|Overall Study|Withdrawal by Subject|27|||
144276086|NCT04797169|520213961|FG001|Overall Study|Withdrawal by Subject|35|||
144276087|NCT03839641|520213964|FG000|Overall Study|Withdrawal by Subject|1|||
144276088|NCT03839641|520213965|FG001|Overall Study|Withdrawal by Subject|1|||
144276089|NCT03188822|520213966|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
144276090|NCT03188822|520213966|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
144276091|NCT02763566|520213971|FG000|Overall Study|Lost to Follow-up|1|||
144276092|NCT02763566|520213972|FG001|Overall Study|Lost to Follow-up|4|||
144276093|NCT02763566|520213973|FG002|Overall Study|Lost to Follow-up|0|||
144276094|NCT02763566|520213974|FG003|Overall Study|Lost to Follow-up|1|||
144276095|NCT02763566|520213971|FG000|Overall Study|On study treatment at study conclusion|114|||
144276096|NCT02763566|520213972|FG001|Overall Study|On study treatment at study conclusion|34|||
144276097|NCT02763566|520213973|FG002|Overall Study|On study treatment at study conclusion|54|||
144276098|NCT02763566|520213974|FG003|Overall Study|On study treatment at study conclusion|13|||
144276099|NCT02763566|520213971|FG000|Overall Study|Withdrawal by Subject|3|||
144276100|NCT02763566|520213972|FG001|Overall Study|Withdrawal by Subject|1|||
144276101|NCT02763566|520213973|FG002|Overall Study|Withdrawal by Subject|0|||
144276102|NCT02763566|520213974|FG003|Overall Study|Withdrawal by Subject|0|||
144276103|NCT04896385|520213975|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
144276104|NCT04896385|520213976|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
144276105|NCT04896385|520213977|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
144276106|NCT04896385|520213978|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
144276107|NCT04896385|520213975|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
144276108|NCT04896385|520213976|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
144276109|NCT04896385|520213977|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
144276110|NCT04896385|520213978|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
144276111|NCT04896385|520213975|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
144276112|NCT04896385|520213976|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
144276113|NCT04896385|520213977|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
144276114|NCT04896385|520213978|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
144276115|NCT04896385|520213975|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
144276116|NCT04896385|520213976|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
144276117|NCT04896385|520213977|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
144276118|NCT04896385|520213978|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
144276119|NCT04896385|520213975|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
144276120|NCT04896385|520213976|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
144276121|NCT04896385|520213977|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
144276122|NCT04896385|520213978|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
144276123|NCT04896385|520213975|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
144276124|NCT04896385|520213976|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
144276125|NCT04896385|520213977|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
144276126|NCT04896385|520213978|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
144276127|NCT00790036|520213979|FG000|Overall Study|Abnormal lab values|3|||
144276128|NCT00790036|520213980|FG001|Overall Study|Abnormal lab values|2|||
144276129|NCT00790036|520213979|FG000|Overall Study|Administrative problems|5|||
144276130|NCT00790036|520213980|FG001|Overall Study|Administrative problems|9|||
144276131|NCT00790036|520213979|FG000|Overall Study|Adverse Event|113|||
144276132|NCT00790036|520213980|FG001|Overall Study|Adverse Event|44|||
144276133|NCT00790036|520213979|FG000|Overall Study|Death|1|||
144276134|NCT00790036|520213980|FG001|Overall Study|Death|0|||
144276135|NCT00790036|520213979|FG000|Overall Study|Disease progression|24|||
144276136|NCT00790036|520213980|FG001|Overall Study|Disease progression|48|||
144276137|NCT00790036|520213979|FG000|Overall Study|Lost to Follow-up|1|||
144276138|NCT00790036|520213980|FG001|Overall Study|Lost to Follow-up|2|||
144276139|NCT00790036|520213979|FG000|Overall Study|Protocol Violation|10|||
144276140|NCT00790036|520213980|FG001|Overall Study|Protocol Violation|2|||
144276141|NCT00790036|520213979|FG000|Overall Study|Withdrawal by Subject|18|||
144276142|NCT00790036|520213980|FG001|Overall Study|Withdrawal by Subject|7|||
144276143|NCT00790036|520213979|FG000|Overall Study|Subject/guardian decision|20|||
144276144|NCT00790036|520213980|FG001|Overall Study|Subject/guardian decision|7|||
144276145|NCT00879658|520213981|FG000|Overall Study|Abnormal laboratory value(s)|3|||
144276146|NCT00879658|520213982|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144276147|NCT00879658|520213983|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144276148|NCT00879658|520213984|FG003|Overall Study|Abnormal laboratory value(s)|1|||
144276149|NCT00879658|520213985|FG004|Overall Study|Abnormal laboratory value(s)|0|||
144276150|NCT00879658|520213986|FG005|Overall Study|Abnormal laboratory value(s)|0|||
144276151|NCT00879658|520213987|FG006|Overall Study|Abnormal laboratory value(s)|0|||
144276152|NCT00879658|520213981|FG000|Overall Study|Administrative problems|2|||
144276153|NCT00879658|520213982|FG001|Overall Study|Administrative problems|1|||
144276154|NCT00879658|520213983|FG002|Overall Study|Administrative problems|0|||
144276155|NCT00879658|520213984|FG003|Overall Study|Administrative problems|1|||
144276156|NCT00879658|520213985|FG004|Overall Study|Administrative problems|0|||
144276157|NCT00879658|520213986|FG005|Overall Study|Administrative problems|0|||
144276158|NCT00879658|520213987|FG006|Overall Study|Administrative problems|0|||
144276159|NCT00879658|520213981|FG000|Overall Study|Adverse Event|6|||
144276160|NCT00879658|520213982|FG001|Overall Study|Adverse Event|4|||
144276161|NCT00879658|520213983|FG002|Overall Study|Adverse Event|3|||
144276162|NCT00879658|520213984|FG003|Overall Study|Adverse Event|1|||
144276163|NCT00879658|520213985|FG004|Overall Study|Adverse Event|2|||
144276164|NCT00879658|520213986|FG005|Overall Study|Adverse Event|0|||
144276165|NCT00879658|520213987|FG006|Overall Study|Adverse Event|0|||
144276166|NCT00879658|520213981|FG000|Overall Study|Protocol Violation|1|||
144276167|NCT00879658|520213982|FG001|Overall Study|Protocol Violation|0|||
144276168|NCT00879658|520213983|FG002|Overall Study|Protocol Violation|0|||
144276169|NCT00879658|520213984|FG003|Overall Study|Protocol Violation|0|||
144276170|NCT00879658|520213985|FG004|Overall Study|Protocol Violation|0|||
144276171|NCT00879658|520213986|FG005|Overall Study|Protocol Violation|0|||
144276172|NCT00879658|520213987|FG006|Overall Study|Protocol Violation|0|||
144276173|NCT00879658|520213981|FG000|Overall Study|Withdrawal by Subject|3|||
144276174|NCT00879658|520213982|FG001|Overall Study|Withdrawal by Subject|0|||
144276175|NCT00879658|520213983|FG002|Overall Study|Withdrawal by Subject|2|||
144276176|NCT00879658|520213984|FG003|Overall Study|Withdrawal by Subject|0|||
144276177|NCT00879658|520213985|FG004|Overall Study|Withdrawal by Subject|0|||
144276178|NCT00879658|520213986|FG005|Overall Study|Withdrawal by Subject|1|||
144276179|NCT00879658|520213987|FG006|Overall Study|Withdrawal by Subject|0|||
144276180|NCT00879658|520213981|FG000|Overall Study|Lack of Efficacy|0|||
144276181|NCT00879658|520213982|FG001|Overall Study|Lack of Efficacy|0|||
144276182|NCT00879658|520213983|FG002|Overall Study|Lack of Efficacy|2|||
144276183|NCT00879658|520213984|FG003|Overall Study|Lack of Efficacy|0|||
144276184|NCT00879658|520213985|FG004|Overall Study|Lack of Efficacy|0|||
144276185|NCT00879658|520213986|FG005|Overall Study|Lack of Efficacy|0|||
144276186|NCT00879658|520213987|FG006|Overall Study|Lack of Efficacy|0|||
144276187|NCT00879658|520213981|FG000|Overall Study|misrandomized (never received study med)|0|||
144276188|NCT00879658|520213982|FG001|Overall Study|misrandomized (never received study med)|0|||
144276189|NCT00879658|520213983|FG002|Overall Study|misrandomized (never received study med)|0|||
144276190|NCT00879658|520213984|FG003|Overall Study|misrandomized (never received study med)|1|||
144276191|NCT00879658|520213985|FG004|Overall Study|misrandomized (never received study med)|0|||
144276192|NCT00879658|520213986|FG005|Overall Study|misrandomized (never received study med)|0|||
144276193|NCT00879658|520213987|FG006|Overall Study|misrandomized (never received study med)|0|||
144276194|NCT00294658|520213988|FG000|Overall Study|Death|0|||
144276195|NCT00294658|520213989|FG001|Overall Study|Death|1|||
144276196|NCT00294658|520213988|FG000|Overall Study|Lost to Follow-up|4|||
144276197|NCT00294658|520213989|FG001|Overall Study|Lost to Follow-up|0|||
144276198|NCT00294658|520213988|FG000|Overall Study|Physician Decision|1|||
144276199|NCT00294658|520213989|FG001|Overall Study|Physician Decision|2|||
144276200|NCT00294658|520213988|FG000|Overall Study|Pregnancy|0|||
144276201|NCT00294658|520213989|FG001|Overall Study|Pregnancy|1|||
144276202|NCT00294658|520213988|FG000|Overall Study|Withdrawal by Subject|0|||
144276203|NCT00294658|520213989|FG001|Overall Study|Withdrawal by Subject|4|||
144276204|NCT00294658|520213988|FG000|Overall Study|Found to have invasive thymoma|1|||
144276205|NCT00294658|520213989|FG001|Overall Study|Found to have invasive thymoma|0|||
144276206|NCT00294658|520213988|FG000|Overall Study|Patient and family were not satisfied|0|||
144276207|NCT00294658|520213989|FG001|Overall Study|Patient and family were not satisfied|1|||
144276208|NCT00580840|520213990|FG000|Run-in|Adverse Event|17|||
144276209|NCT00580840|520213991|FG001|Run-in|Adverse Event|0|||
144276210|NCT00580840|520213992|FG002|Run-in|Adverse Event|0|||
144276211|NCT00580840|520213993|FG003|Run-in|Adverse Event|0|||
144276212|NCT00580840|520213990|FG000|Run-in|Lack of Efficacy|93|||
144276213|NCT00580840|520213991|FG001|Run-in|Lack of Efficacy|0|||
144276214|NCT00580840|520213992|FG002|Run-in|Lack of Efficacy|0|||
144276215|NCT00580840|520213993|FG003|Run-in|Lack of Efficacy|0|||
144276216|NCT00580840|520213990|FG000|Run-in|Loss of Efficacy|1|||
144276217|NCT00580840|520213991|FG001|Run-in|Loss of Efficacy|0|||
144276218|NCT00580840|520213992|FG002|Run-in|Loss of Efficacy|0|||
144276219|NCT00580840|520213993|FG003|Run-in|Loss of Efficacy|0|||
144276220|NCT00580840|520213990|FG000|Run-in|Lost to Follow-up|4|||
144276221|NCT00580840|520213991|FG001|Run-in|Lost to Follow-up|0|||
144276222|NCT00580840|520213992|FG002|Run-in|Lost to Follow-up|0|||
144276223|NCT00580840|520213993|FG003|Run-in|Lost to Follow-up|0|||
144276224|NCT00580840|520213990|FG000|Run-in|Withdrawal by Subject|5|||
144276225|NCT00580840|520213991|FG001|Run-in|Withdrawal by Subject|0|||
144276226|NCT00580840|520213992|FG002|Run-in|Withdrawal by Subject|0|||
144276227|NCT00580840|520213993|FG003|Run-in|Withdrawal by Subject|0|||
144276228|NCT00580840|520213990|FG000|Run-in|Other: Per Sponsor Request|2|||
144276229|NCT00580840|520213991|FG001|Run-in|Other: Per Sponsor Request|0|||
144276230|NCT00580840|520213992|FG002|Run-in|Other: Per Sponsor Request|0|||
144276231|NCT00580840|520213993|FG003|Run-in|Other: Per Sponsor Request|0|||
144276232|NCT00580840|520213990|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
144276233|NCT00580840|520213991|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
144276234|NCT00580840|520213992|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
144276235|NCT00580840|520213993|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
144276236|NCT00580840|520213990|FG000|Run-in|Other: Exclusionary Lab Value|1|||
144276237|NCT00580840|520213991|FG001|Run-in|Other: Exclusionary Lab Value|0|||
144276238|NCT00580840|520213992|FG002|Run-in|Other: Exclusionary Lab Value|0|||
144276239|NCT00580840|520213993|FG003|Run-in|Other: Exclusionary Lab Value|0|||
144242579|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
144242580|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
144242581|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
144242582|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
144242583|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
144242584|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
144242585|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
144242586|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
144242587|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
144242588|NCT02275780|520085872|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
144242589|NCT02275780|520085873|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
144242590|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
144242591|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
144242592|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
144242593|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
144242594|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
144242595|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
144242596|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
144242597|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
144242598|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
144242599|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
144242600|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
144242601|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
144242602|NCT02275780|520085872|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
144242603|NCT02275780|520085873|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
144242604|NCT02275780|520085872|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
144242605|NCT02275780|520085873|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
144242606|NCT02275780|520085872|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
144242607|NCT02275780|520085873|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
144242608|NCT02275780|520085872|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
144242609|NCT02275780|520085873|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
144242610|NCT02275780|520085872|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
144242611|NCT02275780|520085873|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
144242612|NCT02275780|520085872|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
144242613|NCT02275780|520085873|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
144242614|NCT02275780|520085872|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
144242615|NCT02275780|520085873|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
144242616|NCT01054300|520085874|FG000|Period 1|Adverse Event|1|||
144242617|NCT01054300|520085875|FG001|Period 1|Adverse Event|0|||
144242618|NCT01054300|520085876|FG002|Period 1|Adverse Event|0|||
144242619|NCT01054300|520085877|FG003|Period 1|Adverse Event|0|||
144242620|NCT01054300|520085874|FG000|Period 2|Withdrawal by Subject|0|||
144242621|NCT01054300|520085875|FG001|Period 2|Withdrawal by Subject|0|||
144242622|NCT01054300|520085876|FG002|Period 2|Withdrawal by Subject|1|||
144242623|NCT01054300|520085877|FG003|Period 2|Withdrawal by Subject|0|||
144242624|NCT04186806|520085881|FG000|Period 1: 7 Days|Adverse Event|1|||
144242625|NCT04186806|520085882|FG001|Period 1: 7 Days|Adverse Event|0|||
144242626|NCT00916344|520085883|FG000|Overall Study|Death|2|||
144242627|NCT00916344|520085883|FG000|Overall Study|ICD upgrade|1|||
144242628|NCT00916344|520085883|FG000|Overall Study|Drop-out|5|||
144242629|NCT03687372|520085888|FG000|Overall Study|Lost to Follow-up|12|||
144242630|NCT03687372|520085889|FG001|Overall Study|Lost to Follow-up|21|||
144242631|NCT03687372|520085888|FG000|Overall Study|Withdrawal by Subject|4|||
144242632|NCT03687372|520085889|FG001|Overall Study|Withdrawal by Subject|17|||
144242633|NCT03687372|520085888|FG000|Overall Study|Investigator Decision|1|||
144242634|NCT03687372|520085889|FG001|Overall Study|Investigator Decision|1|||
144242635|NCT03602391|520085892|FG000|Overall Study|COVID-19|7|||
144276240|NCT00580840|520213990|FG000|Double-Blind|Adverse Event|0|||
144276241|NCT00580840|520213991|FG001|Double-Blind|Adverse Event|3|||
144276242|NCT00580840|520213992|FG002|Double-Blind|Adverse Event|4|||
144276243|NCT00580840|520213993|FG003|Double-Blind|Adverse Event|1|||
144276244|NCT00580840|520213990|FG000|Double-Blind|Loss of Efficacy|0|||
144276245|NCT00580840|520213991|FG001|Double-Blind|Loss of Efficacy|1|||
144276246|NCT00580840|520213992|FG002|Double-Blind|Loss of Efficacy|2|||
144276247|NCT00580840|520213993|FG003|Double-Blind|Loss of Efficacy|10|||
144276248|NCT00580840|520213990|FG000|Double-Blind|Lost to Follow-up|0|||
144276249|NCT00580840|520213991|FG001|Double-Blind|Lost to Follow-up|1|||
144276250|NCT00580840|520213992|FG002|Double-Blind|Lost to Follow-up|0|||
144276251|NCT00580840|520213993|FG003|Double-Blind|Lost to Follow-up|2|||
144276252|NCT00580840|520213990|FG000|Double-Blind|Withdrawal by Subject|0|||
144276253|NCT00580840|520213991|FG001|Double-Blind|Withdrawal by Subject|1|||
144276254|NCT00580840|520213992|FG002|Double-Blind|Withdrawal by Subject|2|||
144276255|NCT00580840|520213993|FG003|Double-Blind|Withdrawal by Subject|2|||
144276256|NCT00580840|520213990|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
144276257|NCT00580840|520213991|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
144276258|NCT00580840|520213992|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
144276259|NCT00580840|520213993|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
144276260|NCT00580840|520213990|FG000|Double-Blind|Other: Forbidden Medication|0|||
144276261|NCT00580840|520213991|FG001|Double-Blind|Other: Forbidden Medication|0|||
144276262|NCT00580840|520213992|FG002|Double-Blind|Other: Forbidden Medication|1|||
144276263|NCT00580840|520213993|FG003|Double-Blind|Other: Forbidden Medication|0|||
144276264|NCT03507790|520213995|FG000|Overall Study|Adverse Event|0|||
144276265|NCT03507790|520213996|FG001|Overall Study|Adverse Event|11|||
144276266|NCT03507790|520213997|FG002|Overall Study|Adverse Event|3|||
144276267|NCT03507790|520213995|FG000|Overall Study|Withdrawal by Subject|2|||
144276268|NCT03507790|520213996|FG001|Overall Study|Withdrawal by Subject|0|||
144276269|NCT03507790|520213997|FG002|Overall Study|Withdrawal by Subject|0|||
144276270|NCT03507790|520213995|FG000|Overall Study|Subject moved to another location|1|||
144276271|NCT03507790|520213996|FG001|Overall Study|Subject moved to another location|2|||
144276272|NCT03507790|520213997|FG002|Overall Study|Subject moved to another location|0|||
144276273|NCT03507790|520213995|FG000|Overall Study|Non-compliance with study drug|0|||
144276274|NCT03507790|520213996|FG001|Overall Study|Non-compliance with study drug|0|||
144276275|NCT03507790|520213997|FG002|Overall Study|Non-compliance with study drug|1|||
144276276|NCT03507790|520213995|FG000|Overall Study|COVID 19 Pandemic|0|||
144276277|NCT03507790|520213996|FG001|Overall Study|COVID 19 Pandemic|1|||
144276278|NCT03507790|520213997|FG002|Overall Study|COVID 19 Pandemic|0|||
144276279|NCT03507790|520213995|FG000|Overall Study|Lost to Follow-up|0|||
144276280|NCT03507790|520213996|FG001|Overall Study|Lost to Follow-up|1|||
144276281|NCT03507790|520213997|FG002|Overall Study|Lost to Follow-up|0|||
144276282|NCT03507790|520213995|FG000|Overall Study|Discontinuation of the trial at the site|1|||
144276283|NCT03507790|520213996|FG001|Overall Study|Discontinuation of the trial at the site|1|||
144276284|NCT03507790|520213997|FG002|Overall Study|Discontinuation of the trial at the site|0|||
144276285|NCT03507790|520213995|FG000|Overall Study|Randomized in error|0|||
144276286|NCT03507790|520213996|FG001|Overall Study|Randomized in error|0|||
144276287|NCT03507790|520213997|FG002|Overall Study|Randomized in error|1|||
144276288|NCT03805841|520213999|FG000|Overall Study|Clinical Progression|2|||
144276289|NCT03805841|520214000|FG001|Overall Study|Clinical Progression|0|||
144276290|NCT03805841|520214001|FG002|Overall Study|Clinical Progression|0|||
144276291|NCT03805841|520213999|FG000|Overall Study|Death|0|||
144276292|NCT03805841|520214000|FG001|Overall Study|Death|3|||
144276293|NCT03805841|520214001|FG002|Overall Study|Death|1|||
144276294|NCT03805841|520213999|FG000|Overall Study|Lost to Follow-up|0|||
144276295|NCT03805841|520214000|FG001|Overall Study|Lost to Follow-up|0|||
144276296|NCT03805841|520214001|FG002|Overall Study|Lost to Follow-up|1|||
144276297|NCT03805841|520213999|FG000|Overall Study|Withdrawal by Subject|2|||
144276298|NCT03805841|520214000|FG001|Overall Study|Withdrawal by Subject|3|||
144276299|NCT03805841|520214001|FG002|Overall Study|Withdrawal by Subject|0|||
144276300|NCT03805841|520213999|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
144276301|NCT03805841|520214000|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
144276302|NCT03805841|520214001|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
144276303|NCT00157755|520214002|FG000|Overall Study|Death|2|||
144276304|NCT00157755|520214003|FG001|Overall Study|Death|3|||
144276305|NCT00157755|520214004|FG002|Overall Study|Death|3|||
144276306|NCT00157755|520214005|FG003|Overall Study|Death|2|||
144276307|NCT00157755|520214006|FG004|Overall Study|Death|0|||
144276308|NCT00157755|520214007|FG005|Overall Study|Death|0|||
144276309|NCT00157755|520214002|FG000|Overall Study|Lost to Follow-up|0|||
144276310|NCT00157755|520214003|FG001|Overall Study|Lost to Follow-up|0|||
144276311|NCT00157755|520214004|FG002|Overall Study|Lost to Follow-up|1|||
144276312|NCT00157755|520214005|FG003|Overall Study|Lost to Follow-up|0|||
144276313|NCT00157755|520214006|FG004|Overall Study|Lost to Follow-up|0|||
144276314|NCT00157755|520214007|FG005|Overall Study|Lost to Follow-up|0|||
144242636|NCT03602391|520085893|FG001|Overall Study|COVID-19|6|||
144242637|NCT00878969|520085896|FG000|Overall Study|Physician Decision|5|||
144242638|NCT00878969|520085897|FG001|Overall Study|Physician Decision|3|||
144242639|NCT00878969|520085898|FG002|Overall Study|Physician Decision|2|||
144242640|NCT00878969|520085896|FG000|Overall Study|Withdrawal by Subject|1|||
144242641|NCT00878969|520085897|FG001|Overall Study|Withdrawal by Subject|6|||
144242642|NCT00878969|520085898|FG002|Overall Study|Withdrawal by Subject|3|||
144242643|NCT00878969|520085896|FG000|Overall Study|kidney transplant|2|||
144242644|NCT00878969|520085897|FG001|Overall Study|kidney transplant|3|||
144242645|NCT00878969|520085898|FG002|Overall Study|kidney transplant|2|||
144242646|NCT00878969|520085896|FG000|Overall Study|Adverse Event|3|||
144242647|NCT00878969|520085897|FG001|Overall Study|Adverse Event|1|||
144242648|NCT00878969|520085898|FG002|Overall Study|Adverse Event|2|||
144242649|NCT00878969|520085896|FG000|Overall Study|Lost to Follow-up|2|||
144242650|NCT00878969|520085897|FG001|Overall Study|Lost to Follow-up|1|||
144242651|NCT00878969|520085898|FG002|Overall Study|Lost to Follow-up|0|||
144242652|NCT00878969|520085896|FG000|Overall Study|Protocol Violation|2|||
144242653|NCT00878969|520085897|FG001|Overall Study|Protocol Violation|0|||
144242654|NCT00878969|520085898|FG002|Overall Study|Protocol Violation|0|||
144242655|NCT00878969|520085896|FG000|Overall Study|Death|0|||
144242656|NCT00878969|520085897|FG001|Overall Study|Death|0|||
144242657|NCT00878969|520085898|FG002|Overall Study|Death|2|||
144242658|NCT00878969|520085896|FG000|Overall Study|Pregnancy|0|||
144242659|NCT00878969|520085897|FG001|Overall Study|Pregnancy|1|||
144242660|NCT00878969|520085898|FG002|Overall Study|Pregnancy|0|||
144242661|NCT00655733|520085899|FG000|Overall Study|Lost to Follow-up|2|||
144242662|NCT00655733|520085900|FG001|Overall Study|Lost to Follow-up|2|||
144242663|NCT00655733|520085899|FG000|Overall Study|Adverse Event|2|||
144242664|NCT00655733|520085900|FG001|Overall Study|Adverse Event|2|||
144242665|NCT00655733|520085899|FG000|Overall Study|Withdrawal by Subject|3|||
144242666|NCT00655733|520085900|FG001|Overall Study|Withdrawal by Subject|3|||
144242667|NCT00655733|520085899|FG000|Overall Study|Physician Decision|0|||
144242668|NCT00655733|520085900|FG001|Overall Study|Physician Decision|1|||
144242669|NCT02035748|520085901|FG000|Overall Study|Adverse Event|5|||
144242670|NCT02035748|520085901|FG000|Overall Study|Death|3|||
144242671|NCT02035748|520085901|FG000|Overall Study|Lost to Follow-up|2|||
144242672|NCT02035748|520085901|FG000|Overall Study|Physician Decision|3|||
144242673|NCT02035748|520085901|FG000|Overall Study|Withdrawal by Subject|6|||
144242674|NCT02035748|520085901|FG000|Overall Study|Progressive Disease|1|||
144242675|NCT01088243|520085903|FG000|Overall Study|Adverse Event|1|||
144242676|NCT01088243|520085904|FG001|Overall Study|Adverse Event|0|||
144242677|NCT00705718|520085914|FG000|Overall Study|Death|6|||
144242678|NCT00705718|520085915|FG001|Overall Study|Death|6|||
144242679|NCT00705718|520085914|FG000|Overall Study|Not due for Visit|0|||
144242680|NCT00705718|520085915|FG001|Overall Study|Not due for Visit|12|||
144242681|NCT00705718|520085914|FG000|Overall Study|Follow up not done|1|||
144242682|NCT00705718|520085915|FG001|Overall Study|Follow up not done|4|||
144242683|NCT02954653|520085916|FG000|Overall Study|Death|3|||
144242684|NCT02954653|520085917|FG001|Overall Study|Death|1|||
144242685|NCT02954653|520085918|FG002|Overall Study|Death|0|||
144242686|NCT02954653|520085919|FG003|Overall Study|Death|0|||
144242687|NCT02954653|520085920|FG004|Overall Study|Death|0|||
144242688|NCT02954653|520085921|FG005|Overall Study|Death|0|||
144242689|NCT02954653|520085922|FG006|Overall Study|Death|0|||
144242690|NCT02954653|520085923|FG007|Overall Study|Death|0|||
144242691|NCT02954653|520085924|FG008|Overall Study|Death|0|||
144242692|NCT02954653|520085916|FG000|Overall Study|Randomized but did not receive treatment|1|||
144242693|NCT02954653|520085917|FG001|Overall Study|Randomized but did not receive treatment|0|||
144242694|NCT02954653|520085918|FG002|Overall Study|Randomized but did not receive treatment|0|||
144242695|NCT02954653|520085919|FG003|Overall Study|Randomized but did not receive treatment|0|||
144242696|NCT02954653|520085920|FG004|Overall Study|Randomized but did not receive treatment|0|||
144276315|NCT00157755|520214002|FG000|Overall Study|Withdrawal by Subject|0|||
144276316|NCT00157755|520214003|FG001|Overall Study|Withdrawal by Subject|0|||
144276317|NCT00157755|520214004|FG002|Overall Study|Withdrawal by Subject|1|||
144276318|NCT00157755|520214005|FG003|Overall Study|Withdrawal by Subject|1|||
144276319|NCT00157755|520214006|FG004|Overall Study|Withdrawal by Subject|1|||
144276320|NCT00157755|520214007|FG005|Overall Study|Withdrawal by Subject|2|||
144276321|NCT00157755|520214002|FG000|Overall Study|Explant due to infection|0|||
144276322|NCT00157755|520214003|FG001|Overall Study|Explant due to infection|0|||
144276323|NCT00157755|520214004|FG002|Overall Study|Explant due to infection|1|||
144276324|NCT00157755|520214005|FG003|Overall Study|Explant due to infection|0|||
144276325|NCT00157755|520214006|FG004|Overall Study|Explant due to infection|0|||
144276326|NCT00157755|520214007|FG005|Overall Study|Explant due to infection|0|||
144276327|NCT00157755|520214002|FG000|Overall Study|Medical reason|0|||
144276328|NCT00157755|520214003|FG001|Overall Study|Medical reason|0|||
144276329|NCT00157755|520214004|FG002|Overall Study|Medical reason|1|||
144276330|NCT00157755|520214005|FG003|Overall Study|Medical reason|1|||
144276331|NCT00157755|520214006|FG004|Overall Study|Medical reason|0|||
144276332|NCT00157755|520214007|FG005|Overall Study|Medical reason|0|||
144276333|NCT00157755|520214002|FG000|Overall Study|Study site closure|0|||
144276334|NCT00157755|520214003|FG001|Overall Study|Study site closure|1|||
144276335|NCT00157755|520214004|FG002|Overall Study|Study site closure|0|||
144276336|NCT00157755|520214005|FG003|Overall Study|Study site closure|0|||
144276337|NCT00157755|520214006|FG004|Overall Study|Study site closure|0|||
144276338|NCT00157755|520214007|FG005|Overall Study|Study site closure|0|||
144276339|NCT00157755|520214002|FG000|Overall Study|Subject non-compliance|0|||
144276340|NCT00157755|520214003|FG001|Overall Study|Subject non-compliance|0|||
144276341|NCT00157755|520214004|FG002|Overall Study|Subject non-compliance|0|||
144276342|NCT00157755|520214005|FG003|Overall Study|Subject non-compliance|0|||
144276343|NCT00157755|520214006|FG004|Overall Study|Subject non-compliance|0|||
144276344|NCT00157755|520214007|FG005|Overall Study|Subject non-compliance|1|||
144276345|NCT00157755|520214002|FG000|Overall Study|Study completion|0|||
144276346|NCT00157755|520214003|FG001|Overall Study|Study completion|0|||
144276347|NCT00157755|520214004|FG002|Overall Study|Study completion|0|||
144276348|NCT00157755|520214005|FG003|Overall Study|Study completion|0|||
144276349|NCT00157755|520214006|FG004|Overall Study|Study completion|1|||
144276350|NCT00157755|520214007|FG005|Overall Study|Study completion|2|||
144276351|NCT01910441|520214008|FG000|Overall Study|Sponsor decision|0|||
144276352|NCT01910441|520214009|FG001|Overall Study|Sponsor decision|2|||
144276353|NCT01910441|520214008|FG000|Overall Study|Lost to Follow-up|6|||
144276354|NCT01910441|520214009|FG001|Overall Study|Lost to Follow-up|5|||
144276355|NCT01910441|520214008|FG000|Overall Study|Withdrawal by Subject|0|||
144276356|NCT01910441|520214009|FG001|Overall Study|Withdrawal by Subject|1|||
144276357|NCT01910441|520214008|FG000|Overall Study|Non-compliance|0|||
144276358|NCT01910441|520214009|FG001|Overall Study|Non-compliance|1|||
144276359|NCT01910441|520214008|FG000|Overall Study|Adverse Event|1|||
144276360|NCT01910441|520214009|FG001|Overall Study|Adverse Event|0|||
144276361|NCT01910441|520214008|FG000|Overall Study|Physician Decision|0|||
144276362|NCT01910441|520214009|FG001|Overall Study|Physician Decision|1|||
144276363|NCT05168800|520214013|FG000|Time 1 Survey|Did not start T1 survey|182|||
144276364|NCT05168800|520214014|FG001|Time 1 Survey|Did not start T1 survey|150|||
144276365|NCT05168800|520214015|FG002|Time 1 Survey|Did not start T1 survey|140|||
144276366|NCT05168800|520214013|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
144276367|NCT05168800|520214014|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
144276368|NCT05168800|520214015|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
144276369|NCT05168800|520214013|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
144276370|NCT05168800|520214014|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
144276371|NCT05168800|520214015|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
144276372|NCT05168800|520214013|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
144276373|NCT05168800|520214014|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
144276374|NCT05168800|520214015|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
144276375|NCT05168800|520214013|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
144276376|NCT05168800|520214014|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
144276377|NCT05168800|520214015|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
144276378|NCT05168800|520214013|FG000|Time 1 Survey|Withdrawal by Subject|6|||
144276379|NCT05168800|520214014|FG001|Time 1 Survey|Withdrawal by Subject|3|||
144276380|NCT05168800|520214015|FG002|Time 1 Survey|Withdrawal by Subject|2|||
144276381|NCT05168800|520214013|FG000|Time 2 Survey|Already excluded at Time 1|228|||
144276382|NCT05168800|520214014|FG001|Time 2 Survey|Already excluded at Time 1|202|||
144276383|NCT05168800|520214015|FG002|Time 2 Survey|Already excluded at Time 1|173|||
144276384|NCT05168800|520214013|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
144276385|NCT05168800|520214014|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
144276386|NCT05168800|520214015|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
144276387|NCT05168800|520214013|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
144276388|NCT05168800|520214014|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
144276389|NCT05168800|520214015|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
144276390|NCT05168800|520214013|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
144276391|NCT05168800|520214014|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
144276392|NCT05168800|520214015|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
144276393|NCT05168800|520214013|FG000|Time 2 Survey|Withdrawal by Subject|1|||
144276394|NCT05168800|520214014|FG001|Time 2 Survey|Withdrawal by Subject|0|||
144276395|NCT05168800|520214015|FG002|Time 2 Survey|Withdrawal by Subject|1|||
144276396|NCT05168800|520214013|FG000|Time 3 Survey|Already excluded at Time 1|228|||
144276397|NCT05168800|520214014|FG001|Time 3 Survey|Already excluded at Time 1|200|||
144276398|NCT05168800|520214015|FG002|Time 3 Survey|Already excluded at Time 1|173|||
144276399|NCT05168800|520214013|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
144276400|NCT05168800|520214014|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
144276401|NCT05168800|520214015|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
144276402|NCT05168800|520214013|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
144276403|NCT05168800|520214014|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
144276404|NCT05168800|520214015|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
144276405|NCT05168800|520214013|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
144276406|NCT05168800|520214014|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
144276407|NCT05168800|520214015|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
144276408|NCT04958707|520214016|FG000|Post Intervention|Withdrawal by Subject|1|||
144276409|NCT04958707|520214017|FG001|Post Intervention|Withdrawal by Subject|0|||
144276410|NCT04958707|520214018|FG002|Post Intervention|Withdrawal by Subject|0|||
144276411|NCT04958707|520214016|FG000|3 Months Follow- up|Lost to Follow-up|0|||
144276412|NCT04958707|520214017|FG001|3 Months Follow- up|Lost to Follow-up|3|||
144276413|NCT04958707|520214018|FG002|3 Months Follow- up|Lost to Follow-up|0|||
144276414|NCT04958707|520214016|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
144276415|NCT04958707|520214017|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
144276416|NCT04958707|520214018|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
144276417|NCT02401230|520214021|FG000|Overall Study|Adverse Event|3|||
144276418|NCT02401230|520214022|FG001|Overall Study|Adverse Event|2|||
144276419|NCT02401230|520214023|FG002|Overall Study|Adverse Event|0|||
144276420|NCT02401230|520214021|FG000|Overall Study|Withdrawal by Subject|2|||
144276421|NCT02401230|520214022|FG001|Overall Study|Withdrawal by Subject|1|||
144276422|NCT02401230|520214023|FG002|Overall Study|Withdrawal by Subject|1|||
144276423|NCT02401230|520214021|FG000|Overall Study|Lost to Follow-up|1|||
144276424|NCT02401230|520214022|FG001|Overall Study|Lost to Follow-up|3|||
144276425|NCT02401230|520214023|FG002|Overall Study|Lost to Follow-up|3|||
144276426|NCT00831844|520214026|FG000|Overall Study|Adverse Event|2|||
144276427|NCT00831844|520214027|FG001|Overall Study|Adverse Event|0|||
144276428|NCT00831844|520214028|FG002|Overall Study|Adverse Event|0|||
144276429|NCT00831844|520214029|FG003|Overall Study|Adverse Event|0|||
144276430|NCT00831844|520214030|FG004|Overall Study|Adverse Event|1|||
144276431|NCT00831844|520214031|FG005|Overall Study|Adverse Event|1|||
144276432|NCT00831844|520214032|FG006|Overall Study|Adverse Event|2|||
144276433|NCT00831844|520214033|FG007|Overall Study|Adverse Event|0|||
144276434|NCT00831844|520214034|FG008|Overall Study|Adverse Event|0|||
144276435|NCT00831844|520214035|FG009|Overall Study|Adverse Event|0|||
144276436|NCT00831844|520214026|FG000|Overall Study|Death|0|||
144276437|NCT00831844|520214027|FG001|Overall Study|Death|0|||
144276438|NCT00831844|520214028|FG002|Overall Study|Death|0|||
144276439|NCT00831844|520214029|FG003|Overall Study|Death|1|||
144276440|NCT00831844|520214030|FG004|Overall Study|Death|0|||
144276441|NCT00831844|520214031|FG005|Overall Study|Death|0|||
144276442|NCT00831844|520214032|FG006|Overall Study|Death|0|||
144276443|NCT00831844|520214033|FG007|Overall Study|Death|0|||
144276444|NCT00831844|520214034|FG008|Overall Study|Death|0|||
144276445|NCT00831844|520214035|FG009|Overall Study|Death|0|||
144276446|NCT00831844|520214026|FG000|Overall Study|Lack of Efficacy|8|||
144276447|NCT00831844|520214027|FG001|Overall Study|Lack of Efficacy|10|||
144276448|NCT00831844|520214028|FG002|Overall Study|Lack of Efficacy|15|||
144276449|NCT00831844|520214029|FG003|Overall Study|Lack of Efficacy|8|||
144276450|NCT00831844|520214030|FG004|Overall Study|Lack of Efficacy|11|||
144276451|NCT00831844|520214031|FG005|Overall Study|Lack of Efficacy|17|||
144276452|NCT00831844|520214032|FG006|Overall Study|Lack of Efficacy|8|||
144276453|NCT00831844|520214033|FG007|Overall Study|Lack of Efficacy|9|||
144276454|NCT00831844|520214034|FG008|Overall Study|Lack of Efficacy|7|||
144276455|NCT00831844|520214035|FG009|Overall Study|Lack of Efficacy|0|||
144276456|NCT00831844|520214026|FG000|Overall Study|Physician Decision|0|||
144276457|NCT00831844|520214027|FG001|Overall Study|Physician Decision|1|||
144276458|NCT00831844|520214028|FG002|Overall Study|Physician Decision|3|||
144276459|NCT00831844|520214029|FG003|Overall Study|Physician Decision|1|||
144276460|NCT00831844|520214030|FG004|Overall Study|Physician Decision|1|||
144276461|NCT00831844|520214031|FG005|Overall Study|Physician Decision|1|||
144276462|NCT00831844|520214032|FG006|Overall Study|Physician Decision|0|||
144276463|NCT00831844|520214033|FG007|Overall Study|Physician Decision|0|||
144276464|NCT00831844|520214034|FG008|Overall Study|Physician Decision|1|||
144276465|NCT00831844|520214035|FG009|Overall Study|Physician Decision|0|||
144276466|NCT00831844|520214026|FG000|Overall Study|Withdrawal by Subject|0|||
144276467|NCT00831844|520214027|FG001|Overall Study|Withdrawal by Subject|0|||
144276468|NCT00831844|520214028|FG002|Overall Study|Withdrawal by Subject|1|||
144276469|NCT00831844|520214029|FG003|Overall Study|Withdrawal by Subject|0|||
144276470|NCT00831844|520214030|FG004|Overall Study|Withdrawal by Subject|0|||
144276471|NCT00831844|520214031|FG005|Overall Study|Withdrawal by Subject|0|||
144276472|NCT00831844|520214032|FG006|Overall Study|Withdrawal by Subject|0|||
144276473|NCT00831844|520214033|FG007|Overall Study|Withdrawal by Subject|1|||
144276474|NCT00831844|520214034|FG008|Overall Study|Withdrawal by Subject|1|||
144276475|NCT00831844|520214035|FG009|Overall Study|Withdrawal by Subject|0|||
144276476|NCT00831844|520214026|FG000|Overall Study|Ineligible|0|||
144276477|NCT00831844|520214027|FG001|Overall Study|Ineligible|1|||
144276478|NCT00831844|520214028|FG002|Overall Study|Ineligible|1|||
144276479|NCT00831844|520214029|FG003|Overall Study|Ineligible|0|||
144276480|NCT00831844|520214030|FG004|Overall Study|Ineligible|1|||
144276481|NCT00831844|520214031|FG005|Overall Study|Ineligible|0|||
144276482|NCT00831844|520214032|FG006|Overall Study|Ineligible|0|||
144276483|NCT00831844|520214033|FG007|Overall Study|Ineligible|0|||
144276484|NCT00831844|520214034|FG008|Overall Study|Ineligible|0|||
144276485|NCT00831844|520214035|FG009|Overall Study|Ineligible|0|||
144276486|NCT00315445|520214036|FG000|Overall Study|Adverse Event|7|||
144276487|NCT00315445|520214037|FG001|Overall Study|Adverse Event|12|||
144276488|NCT00315445|520214038|FG002|Overall Study|Adverse Event|15|||
144276489|NCT00315445|520214036|FG000|Overall Study|Lack of Efficacy|16|||
144276490|NCT00315445|520214037|FG001|Overall Study|Lack of Efficacy|1|||
144276491|NCT00315445|520214038|FG002|Overall Study|Lack of Efficacy|7|||
144276492|NCT00315445|520214036|FG000|Overall Study|Lost to Follow-up|1|||
144276493|NCT00315445|520214037|FG001|Overall Study|Lost to Follow-up|0|||
144276494|NCT00315445|520214038|FG002|Overall Study|Lost to Follow-up|1|||
144276495|NCT00315445|520214036|FG000|Overall Study|Protocol Violation|2|||
144276496|NCT00315445|520214037|FG001|Overall Study|Protocol Violation|0|||
144276497|NCT00315445|520214038|FG002|Overall Study|Protocol Violation|1|||
144276498|NCT00315445|520214036|FG000|Overall Study|Other|1|||
144276499|NCT00315445|520214037|FG001|Overall Study|Other|3|||
144276500|NCT00315445|520214038|FG002|Overall Study|Other|0|||
144276501|NCT01299909|520214039|FG000|Overall Study|Lost to Follow-up|22|||
144276502|NCT01299909|520214040|FG001|Overall Study|Lost to Follow-up|18|||
144276503|NCT01299909|520214041|FG002|Overall Study|Lost to Follow-up|17|||
144276504|NCT02340949|520214042|FG000|Overall Study|Adverse Event|4|||
144276505|NCT02340949|520214043|FG001|Overall Study|Adverse Event|2|||
144276506|NCT02340949|520214042|FG000|Overall Study|Withdrawal by Subject|2|||
144276507|NCT02340949|520214043|FG001|Overall Study|Withdrawal by Subject|0|||
144276508|NCT02340949|520214042|FG000|Overall Study|Progression disease|6|||
144276509|NCT02340949|520214043|FG001|Overall Study|Progression disease|2|||
144276510|NCT02340949|520214042|FG000|Overall Study|Death|3|||
144276511|NCT02340949|520214043|FG001|Overall Study|Death|0|||
144276512|NCT02340949|520214042|FG000|Overall Study|Physician Decision|1|||
144276513|NCT02340949|520214043|FG001|Overall Study|Physician Decision|0|||
144276514|NCT01192178|520214044|FG000|Overall Study|Withdrawal by Subject|6|||
144276515|NCT01192178|520214045|FG001|Overall Study|Withdrawal by Subject|10|||
144276516|NCT01192178|520214044|FG000|Overall Study|Protocol Violation|10|||
144276517|NCT01192178|520214045|FG001|Overall Study|Protocol Violation|3|||
144276518|NCT01192178|520214044|FG000|Overall Study|Physician Decision|2|||
144276519|NCT01192178|520214045|FG001|Overall Study|Physician Decision|4|||
144276520|NCT01192178|520214044|FG000|Overall Study|Lost to Follow-up|3|||
144276521|NCT01192178|520214045|FG001|Overall Study|Lost to Follow-up|3|||
144276522|NCT01192178|520214044|FG000|Overall Study|Adverse Event|2|||
144276523|NCT01192178|520214045|FG001|Overall Study|Adverse Event|1|||
144276524|NCT01192178|520214044|FG000|Overall Study|Lack of Efficacy|1|||
144276525|NCT01192178|520214045|FG001|Overall Study|Lack of Efficacy|2|||
144276526|NCT02460289|520214046|FG000|Overall Study|Adverse Event|1|||
144276527|NCT02460289|520214046|FG000|Overall Study|Withdrawal by Subject|8|||
144276528|NCT02460289|520214046|FG000|Overall Study|Lost to Follow-up|1|||
144276529|NCT01155570|520214047|FG000|Overall Study|Adverse Event|39|||
144276530|NCT01155570|520214047|FG000|Overall Study|Lack of Efficacy|46|||
144276531|NCT01155570|520214047|FG000|Overall Study|Participant's Economic Reasons|17|||
144276532|NCT01155570|520214047|FG000|Overall Study|No Hospital Visits|7|||
144276533|NCT01155570|520214047|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
144276534|NCT01155570|520214047|FG000|Overall Study|Adverse Event + Other Reasons|7|||
144276535|NCT01155570|520214047|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
144276536|NCT01155570|520214047|FG000|Overall Study|Other Reasons|23|||
144276537|NCT02164916|520214048|FG000|Overall Study|Adverse Event|3|||
144276538|NCT02164916|520214049|FG001|Overall Study|Adverse Event|8|||
144276539|NCT02164916|520214048|FG000|Overall Study|Death|1|||
144276540|NCT02164916|520214049|FG001|Overall Study|Death|1|||
144276541|NCT02164916|520214048|FG000|Overall Study|Refusal unrelated to adverse event|3|||
144276542|NCT02164916|520214049|FG001|Overall Study|Refusal unrelated to adverse event|7|||
144276543|NCT02164916|520214048|FG000|Overall Study|Progression|37|||
144276544|NCT02164916|520214049|FG001|Overall Study|Progression|26|||
144276545|NCT02164916|520214048|FG000|Overall Study|Not protocol specified|5|||
144276546|NCT02164916|520214049|FG001|Overall Study|Not protocol specified|1|||
144276547|NCT02164916|520214048|FG000|Overall Study|Reason under review|1|||
144276548|NCT02164916|520214049|FG001|Overall Study|Reason under review|6|||
144276549|NCT02164916|520214048|FG000|Overall Study|Not eligible|2|||
144276550|NCT02164916|520214049|FG001|Overall Study|Not eligible|5|||
144276551|NCT00964782|520214050|FG000|Overall Study|Lost to Follow-up|1|||
144276552|NCT00964782|520214051|FG001|Overall Study|Lost to Follow-up|0|||
144276553|NCT01143324|520214057|FG000|Overall Study|Lost to Follow-up|11|||
144276554|NCT01143324|520214057|FG000|Overall Study|Withdrawal by Subject|4|||
144276555|NCT01143324|520214057|FG000|Overall Study|Explant of the device|4|||
144276556|NCT04584788|520214071|FG000|Overall Study|Physician Decision|8|||
144276557|NCT04584788|520214071|FG000|Overall Study|Withdrawal by Subject|1|||
144276558|NCT04584788|520214071|FG000|Overall Study|Adverse Event|3|||
144276559|NCT01240746|520216371|FG000|Overall Study|Adverse Event|2|||
144276560|NCT01240746|520216372|FG001|Overall Study|Adverse Event|0|||
144276561|NCT01240746|520216373|FG002|Overall Study|Adverse Event|10|||
144276562|NCT01240746|520216371|FG000|Overall Study|Lost to Follow-up|23|||
144276563|NCT01240746|520216372|FG001|Overall Study|Lost to Follow-up|20|||
144276564|NCT01240746|520216373|FG002|Overall Study|Lost to Follow-up|102|||
144276565|NCT01240746|520216371|FG000|Overall Study|Protocol Violation|24|||
144276566|NCT01240746|520216372|FG001|Overall Study|Protocol Violation|15|||
144276567|NCT01240746|520216373|FG002|Overall Study|Protocol Violation|72|||
144276568|NCT01240746|520216371|FG000|Overall Study|Withdrawal by Subject|10|||
144276569|NCT01240746|520216372|FG001|Overall Study|Withdrawal by Subject|13|||
144276570|NCT01240746|520216373|FG002|Overall Study|Withdrawal by Subject|59|||
144276571|NCT03517137|520216378|FG000|Overall Study|Lack of Efficacy|1|||
144276572|NCT03517137|520216378|FG000|Overall Study|Adverse Event|2|||
144276573|NCT03517137|520216378|FG000|Overall Study|Withdrawal by Subject|2|||
144276574|NCT03517137|520216378|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
144276575|NCT02313155|520216385|FG000|Overall Study|Lost to Follow-up|0|||
144276576|NCT02313155|520216386|FG001|Overall Study|Lost to Follow-up|1|||
144276577|NCT03881371|520216387|FG000|Overall Study|Adverse Event|8|||
144276578|NCT03881371|520216388|FG001|Overall Study|Adverse Event|9|||
144276579|NCT03881371|520216387|FG000|Overall Study|Death|1|||
144276580|NCT03881371|520216388|FG001|Overall Study|Death|0|||
144276581|NCT03881371|520216387|FG000|Overall Study|Lost to Follow-up|1|||
144276582|NCT03881371|520216388|FG001|Overall Study|Lost to Follow-up|0|||
144276583|NCT03881371|520216387|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144276584|NCT03881371|520216388|FG001|Overall Study|Non-Compliance with Study Drug|2|||
144276585|NCT03881371|520216387|FG000|Overall Study|Physician Decision|3|||
144276586|NCT03881371|520216388|FG001|Overall Study|Physician Decision|3|||
144276587|NCT03881371|520216387|FG000|Overall Study|Withdrawal by Subject|2|||
144276588|NCT03881371|520216388|FG001|Overall Study|Withdrawal by Subject|10|||
144276589|NCT03881371|520216387|FG000|Overall Study|Discontinuation from Study|1|||
144242697|NCT02954653|520085921|FG005|Overall Study|Randomized but did not receive treatment|0|||
144242698|NCT02954653|520085922|FG006|Overall Study|Randomized but did not receive treatment|0|||
144242699|NCT02954653|520085923|FG007|Overall Study|Randomized but did not receive treatment|0|||
144242700|NCT02954653|520085924|FG008|Overall Study|Randomized but did not receive treatment|0|||
144242701|NCT02954653|520085916|FG000|Overall Study|Started another anti-cancer therapy|0|||
144242702|NCT02954653|520085917|FG001|Overall Study|Started another anti-cancer therapy|1|||
144242703|NCT02954653|520085918|FG002|Overall Study|Started another anti-cancer therapy|0|||
144242704|NCT02954653|520085919|FG003|Overall Study|Started another anti-cancer therapy|0|||
144242705|NCT02954653|520085920|FG004|Overall Study|Started another anti-cancer therapy|0|||
144242706|NCT02954653|520085921|FG005|Overall Study|Started another anti-cancer therapy|0|||
144242707|NCT02954653|520085922|FG006|Overall Study|Started another anti-cancer therapy|0|||
144242708|NCT02954653|520085923|FG007|Overall Study|Started another anti-cancer therapy|0|||
144242709|NCT02954653|520085924|FG008|Overall Study|Started another anti-cancer therapy|0|||
144242710|NCT02954653|520085916|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
144242711|NCT02954653|520085917|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
144242712|NCT02954653|520085918|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
144242713|NCT02954653|520085919|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
144242714|NCT02954653|520085920|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
144242715|NCT02954653|520085921|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
144242716|NCT02954653|520085922|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
144242717|NCT02954653|520085923|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
144242718|NCT02954653|520085924|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
144242719|NCT03054064|520085925|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
144242720|NCT03054064|520085925|FG000|Overall Study|Investigator Decision|2|||
144242721|NCT03054064|520085925|FG000|Overall Study|Bladder Issue|1|||
144242722|NCT03054064|520085925|FG000|Overall Study|High Blood Pressure|1|||
144242723|NCT03054064|520085925|FG000|Overall Study|Change in Status|1|||
144242724|NCT01459718|520085928|FG000|Overall Study|Physician Decision|1|||
144242725|NCT01459718|520085928|FG000|Overall Study|Lost to Follow-up|1|||
144242726|NCT01459718|520085928|FG000|Overall Study|Adverse Event|1|||
144242727|NCT00767039|520085931|FG000|Overall Study|Death|5|||
144242728|NCT00767039|520085932|FG001|Overall Study|Death|2|||
144242729|NCT01826370|520085933|FG000|Overall Study|Protocol Violation|6|||
144242730|NCT01826370|520085933|FG000|Overall Study|Lost to Follow-up|12|||
144242731|NCT01826370|520085933|FG000|Overall Study|Other reason not defined above|2|||
144242732|NCT04416737|520085934|FG000|Week 1 (First Injection)|Physician Decision|0|||
144242733|NCT04416737|520085935|FG001|Week 1 (First Injection)|Physician Decision|1|||
144242734|NCT01472757|520085941|FG000|Overall Study|Withdrawal by Subject|1|||
144242735|NCT01472757|520085942|FG001|Overall Study|Withdrawal by Subject|2|||
144242736|NCT01472757|520085943|FG002|Overall Study|Withdrawal by Subject|2|||
144242737|NCT01472757|520085944|FG003|Overall Study|Withdrawal by Subject|0|||
144242738|NCT01472757|520085941|FG000|Overall Study|Asthma exacerbation|4|||
144242739|NCT01472757|520085942|FG001|Overall Study|Asthma exacerbation|1|||
144242740|NCT01472757|520085943|FG002|Overall Study|Asthma exacerbation|2|||
144242741|NCT01472757|520085944|FG003|Overall Study|Asthma exacerbation|1|||
144242742|NCT01472757|520085941|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
144242743|NCT01472757|520085942|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
144242744|NCT01472757|520085943|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
144242745|NCT01472757|520085944|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
144242746|NCT01472757|520085941|FG000|Overall Study|Protocol Violation|3|||
144242747|NCT01472757|520085942|FG001|Overall Study|Protocol Violation|2|||
144242748|NCT01472757|520085943|FG002|Overall Study|Protocol Violation|4|||
144242749|NCT01472757|520085944|FG003|Overall Study|Protocol Violation|4|||
144242750|NCT01472757|520085941|FG000|Overall Study|Other reasons|1|||
144242751|NCT01472757|520085942|FG001|Overall Study|Other reasons|0|||
144242752|NCT01472757|520085943|FG002|Overall Study|Other reasons|2|||
144242753|NCT01472757|520085944|FG003|Overall Study|Other reasons|2|||
144242754|NCT04489381|520085949|FG000|Overall Study|Lost to Follow-up|2|||
144242755|NCT04489381|520085950|FG001|Overall Study|Lost to Follow-up|3|||
144242756|NCT04489381|520085949|FG000|Overall Study|Withdrawal by Subject|1|||
144242757|NCT04489381|520085950|FG001|Overall Study|Withdrawal by Subject|0|||
144242758|NCT03199612|520085955|FG000|Overall Study|Adverse Event|1|||
144242759|NCT03199612|520085956|FG001|Overall Study|Adverse Event|0|||
144242760|NCT02543892|520085959|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
144242761|NCT02543892|520085960|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
144242762|NCT02543892|520085961|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
144242763|NCT02543892|520085962|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
144242764|NCT02543892|520085963|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
144242765|NCT02543892|520085964|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
144242766|NCT02543892|520085965|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
144242767|NCT02543892|520085966|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
144242768|NCT02543892|520085959|FG000|Received Vaccination 2|Physician Decision|0|||
144242769|NCT02543892|520085960|FG001|Received Vaccination 2|Physician Decision|0|||
144242770|NCT02543892|520085961|FG002|Received Vaccination 2|Physician Decision|0|||
144242771|NCT02543892|520085962|FG003|Received Vaccination 2|Physician Decision|0|||
144242772|NCT02543892|520085963|FG004|Received Vaccination 2|Physician Decision|0|||
144242773|NCT02543892|520085964|FG005|Received Vaccination 2|Physician Decision|1|||
144242774|NCT02543892|520085965|FG006|Received Vaccination 2|Physician Decision|0|||
144242775|NCT02543892|520085966|FG007|Received Vaccination 2|Physician Decision|0|||
144242776|NCT02543892|520085959|FG000|Received Vaccination 2|Adverse Event|0|||
144242777|NCT02543892|520085960|FG001|Received Vaccination 2|Adverse Event|1|||
144242778|NCT02543892|520085961|FG002|Received Vaccination 2|Adverse Event|0|||
144242779|NCT02543892|520085962|FG003|Received Vaccination 2|Adverse Event|0|||
144242780|NCT02543892|520085963|FG004|Received Vaccination 2|Adverse Event|0|||
144242781|NCT02543892|520085964|FG005|Received Vaccination 2|Adverse Event|0|||
144242782|NCT02543892|520085965|FG006|Received Vaccination 2|Adverse Event|0|||
144242783|NCT02543892|520085966|FG007|Received Vaccination 2|Adverse Event|0|||
144242784|NCT02543892|520085959|FG000|Had Immunology Data|Withdrawal by Subject|0|||
144242785|NCT02543892|520085960|FG001|Had Immunology Data|Withdrawal by Subject|0|||
144242786|NCT02543892|520085961|FG002|Had Immunology Data|Withdrawal by Subject|0|||
144242787|NCT02543892|520085962|FG003|Had Immunology Data|Withdrawal by Subject|0|||
144242788|NCT02543892|520085963|FG004|Had Immunology Data|Withdrawal by Subject|0|||
144242789|NCT02543892|520085964|FG005|Had Immunology Data|Withdrawal by Subject|0|||
144242790|NCT02543892|520085965|FG006|Had Immunology Data|Withdrawal by Subject|1|||
144242791|NCT02543892|520085966|FG007|Had Immunology Data|Withdrawal by Subject|0|||
144242792|NCT00081731|520085969|FG000|Overall Study|scientific integrity issue|8|||
144242793|NCT00081731|520085970|FG001|Overall Study|scientific integrity issue|8|||
144242794|NCT00785213|520085971|FG000|Quinine Sulfate Alone|Adverse Event|4|||
144242795|NCT00785213|520085971|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
144242796|NCT00526331|520085972|FG000|Overall Study|Sponsor Termination|55|||
144242797|NCT01259375|520085973|FG000|Overall Study|Adverse Event|1|||
144242798|NCT00478699|520085976|FG000|Overall Study|Inclusion Error|1|||
144242799|NCT00478699|520085977|FG001|Overall Study|Inclusion Error|7|||
144242800|NCT00478699|520085976|FG000|Overall Study|Not receive study treatment|6|||
144242801|NCT00478699|520085977|FG001|Overall Study|Not receive study treatment|30|||
144242802|NCT01043705|520085980|FG000|Overall Study|Death|28|||
144242803|NCT01043705|520085981|FG001|Overall Study|Death|60|||
144242804|NCT01043705|520085982|FG002|Overall Study|Death|26|||
144242805|NCT01043705|520085980|FG000|Overall Study|Lost to Follow-up|27|||
144242806|NCT01043705|520085981|FG001|Overall Study|Lost to Follow-up|12|||
144242807|NCT01043705|520085982|FG002|Overall Study|Lost to Follow-up|0|||
144242808|NCT01043705|520085980|FG000|Overall Study|Multiple Reasons|4|||
144242809|NCT01043705|520085981|FG001|Overall Study|Multiple Reasons|7|||
144242810|NCT01043705|520085982|FG002|Overall Study|Multiple Reasons|0|||
144242811|NCT01043705|520085980|FG000|Overall Study|Protocol Violation|2|||
144242812|NCT01043705|520085981|FG001|Overall Study|Protocol Violation|1|||
144242813|NCT01043705|520085982|FG002|Overall Study|Protocol Violation|0|||
144242814|NCT01043705|520085980|FG000|Overall Study|Withdrawal by Subject|8|||
144242815|NCT01043705|520085981|FG001|Overall Study|Withdrawal by Subject|6|||
144242816|NCT01043705|520085982|FG002|Overall Study|Withdrawal by Subject|0|||
144242817|NCT01043705|520085980|FG000|Overall Study|Site Closure|8|||
144242818|NCT01043705|520085981|FG001|Overall Study|Site Closure|0|||
144242819|NCT01043705|520085982|FG002|Overall Study|Site Closure|0|||
144242820|NCT01043705|520085980|FG000|Overall Study|Subsequent Procedure|9|||
144242821|NCT01043705|520085981|FG001|Overall Study|Subsequent Procedure|24|||
144242822|NCT01043705|520085982|FG002|Overall Study|Subsequent Procedure|29|||
144242823|NCT01043705|520085980|FG000|Overall Study|Adverse Event|0|||
144242824|NCT01043705|520085981|FG001|Overall Study|Adverse Event|2|||
144242825|NCT01043705|520085982|FG002|Overall Study|Adverse Event|0|||
144242826|NCT01043705|520085980|FG000|Overall Study|Screen Fail|21|||
144242827|NCT01043705|520085981|FG001|Overall Study|Screen Fail|0|||
144242828|NCT01043705|520085982|FG002|Overall Study|Screen Fail|0|||
144242829|NCT01043705|520085980|FG000|Overall Study|Other|0|||
144242830|NCT01043705|520085981|FG001|Overall Study|Other|19|||
144242831|NCT01043705|520085982|FG002|Overall Study|Other|25|||
144242832|NCT04601103|520085984|FG000|Overall Study|Needed crown & cleaning|0|||
144242833|NCT04601103|520085985|FG001|Overall Study|Needed crown & cleaning|0|||
144242834|NCT04601103|520085986|FG002|Overall Study|Needed crown & cleaning|1|||
144242835|NCT04601103|520085984|FG000|Overall Study|study was terminated|18|||
144242836|NCT04601103|520085985|FG001|Overall Study|study was terminated|18|||
144242837|NCT04601103|520085986|FG002|Overall Study|study was terminated|16|||
144242838|NCT01537068|520085987|FG000|Overall Study|Lost to Follow-up|2|||
144242839|NCT01537068|520085988|FG001|Overall Study|Lost to Follow-up|1|||
144242840|NCT01537068|520085987|FG000|Overall Study|Adverse Event|0|||
144242841|NCT01537068|520085988|FG001|Overall Study|Adverse Event|1|||
144242842|NCT01537068|520085987|FG000|Overall Study|Withdrawal by Subject|1|||
144242843|NCT01537068|520085988|FG001|Overall Study|Withdrawal by Subject|1|||
144242844|NCT01537068|520085987|FG000|Overall Study|Lack of Efficacy|1|||
144242845|NCT01537068|520085988|FG001|Overall Study|Lack of Efficacy|0|||
144242846|NCT02484651|520085989|FG000|Overall Study|Patients' data files were corrupted.|1|||
144242847|NCT02484651|520085990|FG001|Overall Study|Patients' data files were corrupted.|1|||
144242848|NCT02484651|520085989|FG000|Overall Study|BIS monitoring failed.|1|||
144242849|NCT02484651|520085990|FG001|Overall Study|BIS monitoring failed.|1|||
144242850|NCT02484651|520085989|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
144242851|NCT02484651|520085990|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
144242852|NCT05238025|520085991|FG000|Overall Study|Adverse Event|2|||
144276590|NCT03881371|520216388|FG001|Overall Study|Discontinuation from Study|0|||
144276591|NCT00933933|520216389|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
144276592|NCT00933933|520216390|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
144276593|NCT00933933|520216391|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
144276594|NCT00933933|520216389|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
144276595|NCT00933933|520216390|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
144276596|NCT00933933|520216391|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
144276597|NCT03329001|520216396|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
144276598|NCT03329001|520216397|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
144276599|NCT03329001|520216398|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
144276600|NCT03329001|520216399|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
144276601|NCT03329001|520216400|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
144276602|NCT03329001|520216401|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
144276603|NCT03329001|520216402|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
144276604|NCT03329001|520216403|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
144276605|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276606|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276607|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276608|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
144276609|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276610|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276611|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276612|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
144276613|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276614|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276615|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276616|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
144276617|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276618|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276619|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276620|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
144276621|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276622|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276623|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276624|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
144276625|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276626|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276627|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276628|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
144276629|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276630|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276631|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
144276632|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276633|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276634|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276635|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276636|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
144276637|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276638|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276639|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
144276640|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276641|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276642|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276643|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276644|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
144276645|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276646|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276647|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
144276648|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276649|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276650|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276651|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276652|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
144276653|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276654|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276655|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
144276656|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276657|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276658|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276659|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276660|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
144276661|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
144276662|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
144276663|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
144276664|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
144276665|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
144276666|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
144276667|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
144276668|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
144276669|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276670|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276671|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
144276672|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276673|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276674|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276675|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276676|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
144276677|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
144276678|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
144276679|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
144276680|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
144276681|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
144276682|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
144276683|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
144276684|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
144276685|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
144276686|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
144276687|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
144276688|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
144276689|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
144276690|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
144276691|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
144276692|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
144276693|NCT03329001|520216396|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
144276694|NCT03329001|520216397|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
144276695|NCT03329001|520216398|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
144276696|NCT03329001|520216399|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
144276697|NCT03329001|520216400|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
144276698|NCT03329001|520216401|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
144276699|NCT03329001|520216402|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
144276700|NCT03329001|520216403|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
144276701|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276702|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276703|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276704|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
144276705|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276706|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276707|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276708|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
144276709|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276710|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276711|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276712|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
144276713|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276714|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276715|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276716|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
144276717|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276718|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276719|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
144276720|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276721|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276722|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276723|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276724|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
144276725|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
144276726|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
144276727|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
144276728|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
144276729|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
144276730|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
144276731|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
144276732|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
144276733|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276734|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276735|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
144276736|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276737|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276738|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276739|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276740|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
144276741|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276742|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276743|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
144276744|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276745|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276746|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276747|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276748|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
144276749|NCT03329001|520216396|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276750|NCT03329001|520216397|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276751|NCT03329001|520216398|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276752|NCT03329001|520216399|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
144276753|NCT03329001|520216400|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276754|NCT03329001|520216401|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276755|NCT03329001|520216402|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276756|NCT03329001|520216403|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
144276757|NCT03329001|520216396|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276758|NCT03329001|520216397|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276759|NCT03329001|520216398|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276760|NCT03329001|520216399|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276761|NCT03329001|520216400|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276762|NCT03329001|520216401|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
144276763|NCT03329001|520216402|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276764|NCT03329001|520216403|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
144276765|NCT03329001|520216396|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276766|NCT03329001|520216397|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276767|NCT03329001|520216398|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276768|NCT03329001|520216399|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276769|NCT03329001|520216400|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
144276770|NCT03329001|520216401|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276771|NCT03329001|520216402|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276772|NCT03329001|520216403|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
144276773|NCT03329001|520216396|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
144276774|NCT03329001|520216397|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
144276775|NCT03329001|520216398|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
144276776|NCT03329001|520216399|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
144276777|NCT03329001|520216400|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
144276778|NCT03329001|520216401|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
144276779|NCT03329001|520216402|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
144276780|NCT03329001|520216403|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
144276781|NCT03329001|520216396|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276782|NCT03329001|520216397|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276783|NCT03329001|520216398|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276784|NCT03329001|520216399|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276785|NCT03329001|520216400|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
144276786|NCT03329001|520216401|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276787|NCT03329001|520216402|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276788|NCT03329001|520216403|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
144276789|NCT03329001|520216396|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
144276790|NCT03329001|520216397|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
144276791|NCT03329001|520216398|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
144276792|NCT03329001|520216399|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
144276793|NCT03329001|520216400|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
144297095|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
144276794|NCT03329001|520216401|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
144276795|NCT03329001|520216402|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
144276796|NCT03329001|520216403|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
144276797|NCT03329001|520216396|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
144276798|NCT03329001|520216397|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
144276799|NCT03329001|520216398|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
144276800|NCT03329001|520216399|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
144276801|NCT03329001|520216400|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
144276802|NCT03329001|520216401|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
144276803|NCT03329001|520216402|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
144276804|NCT03329001|520216403|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
144276805|NCT03329001|520216396|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276806|NCT03329001|520216397|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276807|NCT03329001|520216398|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276808|NCT03329001|520216399|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276809|NCT03329001|520216400|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276810|NCT03329001|520216401|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276811|NCT03329001|520216402|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
144276812|NCT03329001|520216403|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
144276813|NCT03329001|520216396|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
144276814|NCT03329001|520216397|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
144276815|NCT03329001|520216398|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
144276816|NCT03329001|520216399|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
144276817|NCT03329001|520216400|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
144276818|NCT03329001|520216401|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
144276819|NCT03329001|520216402|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
144276820|NCT03329001|520216403|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
144276821|NCT03329001|520216396|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
144276822|NCT03329001|520216397|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
144276823|NCT03329001|520216398|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
144276824|NCT03329001|520216399|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
144276825|NCT03329001|520216400|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
144276826|NCT03329001|520216401|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
144276827|NCT03329001|520216402|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
144276828|NCT03329001|520216403|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
144276829|NCT00963235|520216406|FG000|Overall Study|Withdrawal by Subject|22|||
144276830|NCT00963235|520216406|FG000|Overall Study|Lost to Follow-up|14|||
144276831|NCT00963235|520216406|FG000|Overall Study|Failed to return|9|||
144276832|NCT00963235|520216406|FG000|Overall Study|Protocol Violation|7|||
144276833|NCT00963235|520216406|FG000|Overall Study|Adverse Event|5|||
144276834|NCT00963235|520216406|FG000|Overall Study|Physician Decision|2|||
144276835|NCT00963235|520216406|FG000|Overall Study|Other|1|||
144276836|NCT01341470|520216407|FG000|Overall Study|Sponsor decision|0|||
144276837|NCT01341470|520216408|FG001|Overall Study|Sponsor decision|0|||
144276838|NCT01341470|520216409|FG002|Overall Study|Sponsor decision|1|||
144276839|NCT01341470|520216410|FG003|Overall Study|Sponsor decision|1|||
144276840|NCT01341470|520216411|FG004|Overall Study|Sponsor decision|0|||
144276841|NCT01341470|520216412|FG005|Overall Study|Sponsor decision|1|||
144276842|NCT05376358|520216413|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
144276843|NCT05376358|520216414|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
144276844|NCT05376358|520216413|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
144276845|NCT05376358|520216414|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
144276846|NCT05376358|520216413|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
144276847|NCT05376358|520216414|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
144276848|NCT05376358|520216413|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
144276849|NCT05376358|520216414|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
144276850|NCT05376358|520216413|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
144276851|NCT05376358|520216414|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
144276852|NCT05376358|520216413|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
144276853|NCT05376358|520216414|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
144276854|NCT04225832|520216415|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
144276855|NCT04225832|520216416|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
144276856|NCT04225832|520216415|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
144276857|NCT04225832|520216416|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
144276858|NCT00311168|520216417|FG000|First Intervention|Withdrawal by Subject|2|||
144276859|NCT00311168|520216418|FG001|First Intervention|Withdrawal by Subject|2|||
144276860|NCT00311168|520216417|FG000|First Intervention|Lost to Follow-up|1|||
144276861|NCT00311168|520216418|FG001|First Intervention|Lost to Follow-up|1|||
144276862|NCT00311168|520216417|FG000|First Intervention|Protocol Violation|1|||
144276863|NCT00311168|520216418|FG001|First Intervention|Protocol Violation|1|||
144276864|NCT00311168|520216417|FG000|First Intervention|Adverse Event|1|||
144276865|NCT00311168|520216418|FG001|First Intervention|Adverse Event|0|||
144276866|NCT00311168|520216417|FG000|First Intervention|Other|2|||
144276867|NCT00311168|520216418|FG001|First Intervention|Other|2|||
144276868|NCT00311168|520216417|FG000|Second Intervention|Lost to Follow-up|9|||
144276869|NCT00311168|520216418|FG001|Second Intervention|Lost to Follow-up|2|||
144276870|NCT00311168|520216417|FG000|Second Intervention|Withdrawal by Subject|0|||
144276871|NCT00311168|520216418|FG001|Second Intervention|Withdrawal by Subject|1|||
144276872|NCT00311168|520216417|FG000|Second Intervention|Other|1|||
144276873|NCT00311168|520216418|FG001|Second Intervention|Other|1|||
144276874|NCT03965923|520216421|FG000|Overall Study|Withdrawal by Subject|1|||
144276875|NCT03965923|520216422|FG001|Overall Study|Withdrawal by Subject|2|||
144276876|NCT03965923|520216423|FG002|Overall Study|Withdrawal by Subject|3|||
144276877|NCT03965923|520216424|FG003|Overall Study|Withdrawal by Subject|1|||
144276878|NCT03965923|520216425|FG004|Overall Study|Withdrawal by Subject|2|||
144276879|NCT03965923|520216426|FG005|Overall Study|Withdrawal by Subject|0|||
144276880|NCT03965923|520216427|FG006|Overall Study|Withdrawal by Subject|4|||
144276881|NCT03965923|520216428|FG007|Overall Study|Withdrawal by Subject|3|||
144276882|NCT03965923|520216429|FG008|Overall Study|Withdrawal by Subject|4|||
144276883|NCT03965923|520216430|FG009|Overall Study|Withdrawal by Subject|0|||
144276884|NCT03965923|520216431|FG010|Overall Study|Withdrawal by Subject|2|||
144276885|NCT03965923|520216432|FG011|Overall Study|Withdrawal by Subject|0|||
144276886|NCT03965923|520216421|FG000|Overall Study|Lost to Follow-up|2|||
144276887|NCT03965923|520216422|FG001|Overall Study|Lost to Follow-up|1|||
144276888|NCT03965923|520216423|FG002|Overall Study|Lost to Follow-up|1|||
144276889|NCT03965923|520216424|FG003|Overall Study|Lost to Follow-up|0|||
144276890|NCT03965923|520216425|FG004|Overall Study|Lost to Follow-up|2|||
144276891|NCT03965923|520216426|FG005|Overall Study|Lost to Follow-up|1|||
144276892|NCT03965923|520216427|FG006|Overall Study|Lost to Follow-up|2|||
144276893|NCT03965923|520216428|FG007|Overall Study|Lost to Follow-up|1|||
144276894|NCT03965923|520216429|FG008|Overall Study|Lost to Follow-up|0|||
144276895|NCT03965923|520216430|FG009|Overall Study|Lost to Follow-up|2|||
144276896|NCT03965923|520216431|FG010|Overall Study|Lost to Follow-up|0|||
144276897|NCT03965923|520216432|FG011|Overall Study|Lost to Follow-up|0|||
144276898|NCT03965923|520216421|FG000|Overall Study|Death|0|||
144276899|NCT03965923|520216422|FG001|Overall Study|Death|0|||
144276900|NCT03965923|520216423|FG002|Overall Study|Death|0|||
144276901|NCT03965923|520216424|FG003|Overall Study|Death|0|||
144276902|NCT03965923|520216425|FG004|Overall Study|Death|0|||
144276903|NCT03965923|520216426|FG005|Overall Study|Death|0|||
144276904|NCT03965923|520216427|FG006|Overall Study|Death|0|||
144276905|NCT03965923|520216428|FG007|Overall Study|Death|1|||
144276906|NCT03965923|520216429|FG008|Overall Study|Death|4|||
144276907|NCT03965923|520216430|FG009|Overall Study|Death|0|||
144276908|NCT03965923|520216431|FG010|Overall Study|Death|4|||
144276909|NCT03965923|520216432|FG011|Overall Study|Death|0|||
144276910|NCT03965923|520216421|FG000|Overall Study|Other reason|0|||
144276911|NCT03965923|520216422|FG001|Overall Study|Other reason|0|||
144276912|NCT03965923|520216423|FG002|Overall Study|Other reason|0|||
144276913|NCT03965923|520216424|FG003|Overall Study|Other reason|1|||
144276914|NCT03965923|520216425|FG004|Overall Study|Other reason|0|||
144276915|NCT03965923|520216426|FG005|Overall Study|Other reason|0|||
144276916|NCT03965923|520216427|FG006|Overall Study|Other reason|0|||
144276917|NCT03965923|520216428|FG007|Overall Study|Other reason|0|||
144276918|NCT03965923|520216429|FG008|Overall Study|Other reason|0|||
144276919|NCT03965923|520216430|FG009|Overall Study|Other reason|0|||
144276920|NCT03965923|520216431|FG010|Overall Study|Other reason|2|||
144276921|NCT03965923|520216432|FG011|Overall Study|Other reason|0|||
144276922|NCT02452190|520216433|FG000|Overall Study|Withdrawal by Sponsor|1|||
144276923|NCT02452190|520216434|FG001|Overall Study|Withdrawal by Sponsor|3|||
144276924|NCT02452190|520216433|FG000|Overall Study|Pregnancy|1|||
144276925|NCT02452190|520216434|FG001|Overall Study|Pregnancy|0|||
144276926|NCT02452190|520216433|FG000|Overall Study|Investigator's Decision|2|||
144276927|NCT02452190|520216434|FG001|Overall Study|Investigator's Decision|0|||
144276928|NCT02452190|520216433|FG000|Overall Study|Lack of Efficacy|3|||
144276929|NCT02452190|520216434|FG001|Overall Study|Lack of Efficacy|1|||
144276930|NCT02452190|520216433|FG000|Overall Study|Lost to Follow-up|4|||
144276931|NCT02452190|520216434|FG001|Overall Study|Lost to Follow-up|3|||
144276932|NCT02452190|520216433|FG000|Overall Study|Adverse Event|2|||
144276933|NCT02452190|520216434|FG001|Overall Study|Adverse Event|5|||
144276934|NCT02452190|520216433|FG000|Overall Study|Withdrawal by Subject|20|||
144276935|NCT02452190|520216434|FG001|Overall Study|Withdrawal by Subject|11|||
144276936|NCT02452190|520216433|FG000|Overall Study|Noncompliance with study drug|1|||
144276937|NCT02452190|520216434|FG001|Overall Study|Noncompliance with study drug|0|||
144276938|NCT02452190|520216433|FG000|Overall Study|Participant traveled abroad|1|||
144276939|NCT02452190|520216434|FG001|Overall Study|Participant traveled abroad|0|||
144276940|NCT02452190|520216433|FG000|Overall Study|Death|0|||
144276941|NCT02452190|520216434|FG001|Overall Study|Death|1|||
144276942|NCT02327078|520216437|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
144276943|NCT02327078|520216438|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
144276944|NCT02327078|520216439|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
144276945|NCT02327078|520216440|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
144276946|NCT02327078|520216441|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
144276947|NCT02327078|520216442|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
144276948|NCT02327078|520216443|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
144276949|NCT02327078|520216444|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
144276950|NCT02327078|520216445|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
144276951|NCT02327078|520216437|FG000|Overall Study|Death|2|||
144276952|NCT02327078|520216438|FG001|Overall Study|Death|4|||
144276953|NCT02327078|520216439|FG002|Overall Study|Death|10|||
144276954|NCT02327078|520216440|FG003|Overall Study|Death|6|||
144242853|NCT05238025|520085992|FG001|Overall Study|Adverse Event|2|||
144242854|NCT05238025|520085991|FG000|Overall Study|Lost to Follow-up|334|||
144242855|NCT05238025|520085992|FG001|Overall Study|Lost to Follow-up|339|||
144242856|NCT05238025|520085991|FG000|Overall Study|Withdrawal by Subject|203|||
144242857|NCT05238025|520085992|FG001|Overall Study|Withdrawal by Subject|222|||
144242858|NCT05238025|520085991|FG000|Overall Study|Physician Decision|20|||
144242859|NCT05238025|520085992|FG001|Overall Study|Physician Decision|8|||
144242860|NCT05238025|520085991|FG000|Overall Study|Protocol Violation|6|||
144242861|NCT05238025|520085992|FG001|Overall Study|Protocol Violation|2|||
144242862|NCT05238025|520085991|FG000|Overall Study|Death|38|||
144242863|NCT05238025|520085992|FG001|Overall Study|Death|32|||
144242864|NCT05238025|520085991|FG000|Overall Study|Study terminated by Sponsor|6358|||
144242865|NCT05238025|520085992|FG001|Overall Study|Study terminated by Sponsor|6358|||
144242866|NCT05238025|520085991|FG000|Overall Study|Other Reason|669|||
144242867|NCT05238025|520085992|FG001|Overall Study|Other Reason|690|||
144242868|NCT03197324|520085998|FG000|Overall Study|Adverse Event|0|||
144242869|NCT03197324|520085999|FG001|Overall Study|Adverse Event|1|||
144242870|NCT01390428|520088098|FG000|Overall Study|Elective Surgery|0|||
144242871|NCT01390428|520088099|FG001|Overall Study|Elective Surgery|0|||
144242872|NCT01390428|520088100|FG002|Overall Study|Elective Surgery|0|||
144242873|NCT01390428|520088101|FG003|Overall Study|Elective Surgery|0|||
144242874|NCT01390428|520088102|FG004|Overall Study|Elective Surgery|1|||
144242875|NCT01390428|520088103|FG005|Overall Study|Elective Surgery|0|||
144242876|NCT01390428|520088098|FG000|Overall Study|Withdrawal by Subject|0|||
144242877|NCT01390428|520088099|FG001|Overall Study|Withdrawal by Subject|0|||
144242878|NCT01390428|520088100|FG002|Overall Study|Withdrawal by Subject|1|||
144242879|NCT01390428|520088101|FG003|Overall Study|Withdrawal by Subject|0|||
144242880|NCT01390428|520088102|FG004|Overall Study|Withdrawal by Subject|0|||
144242881|NCT01390428|520088103|FG005|Overall Study|Withdrawal by Subject|0|||
144242882|NCT02059434|520088108|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
144242883|NCT02059434|520088109|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
144242884|NCT02059434|520088110|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
144242885|NCT02059434|520088111|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
144242886|NCT02059434|520088112|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
144242887|NCT02059434|520088113|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
144242888|NCT02059434|520088114|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
144242889|NCT02059434|520088115|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
144242890|NCT02059434|520088116|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
144242891|NCT02059434|520088108|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
144242892|NCT02059434|520088109|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
144242893|NCT02059434|520088110|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
144242894|NCT02059434|520088111|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
144242895|NCT02059434|520088112|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
144242896|NCT02059434|520088113|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
144242897|NCT02059434|520088114|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
144242898|NCT02059434|520088115|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
144242899|NCT02059434|520088116|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
144242900|NCT02059434|520088108|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
144242901|NCT02059434|520088109|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
144242902|NCT02059434|520088110|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
144242903|NCT02059434|520088111|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
144242904|NCT02059434|520088112|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
144242905|NCT02059434|520088113|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
144242906|NCT02059434|520088114|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
144242907|NCT02059434|520088115|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
144242908|NCT02059434|520088116|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
144242909|NCT02059434|520088108|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
144242910|NCT02059434|520088109|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
144242911|NCT02059434|520088110|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
144242912|NCT02059434|520088111|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
144242913|NCT02059434|520088112|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
144242914|NCT02059434|520088113|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
144242915|NCT02059434|520088114|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
144242916|NCT02059434|520088115|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
144242917|NCT02059434|520088116|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
144242918|NCT02059434|520088108|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242919|NCT02059434|520088109|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242920|NCT02059434|520088110|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242921|NCT02059434|520088111|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242922|NCT02059434|520088112|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242923|NCT02059434|520088113|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242924|NCT02059434|520088114|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242925|NCT02059434|520088115|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
144242926|NCT02059434|520088116|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
144242927|NCT03201874|520088119|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
144242928|NCT03201874|520088120|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
144242929|NCT03201874|520088119|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
144242930|NCT03201874|520088120|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
144242931|NCT02907593|520088123|FG000|Overall Study|Withdrawal by Subject|0|||
144242932|NCT02907593|520088124|FG001|Overall Study|Withdrawal by Subject|0|||
144242933|NCT02907593|520088125|FG002|Overall Study|Withdrawal by Subject|1|||
144242934|NCT02907593|520088126|FG003|Overall Study|Withdrawal by Subject|0|||
144242935|NCT04542499|520088138|FG000|Overall Study|Adverse Event|23|||
144242936|NCT04542499|520088139|FG001|Overall Study|Adverse Event|43|||
144242937|NCT04542499|520088138|FG000|Overall Study|Lack of Efficacy|5|||
144242938|NCT04542499|520088139|FG001|Overall Study|Lack of Efficacy|2|||
144242939|NCT04542499|520088138|FG000|Overall Study|Lost to Follow-up|3|||
144242940|NCT04542499|520088139|FG001|Overall Study|Lost to Follow-up|4|||
144242941|NCT04542499|520088138|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
144242942|NCT04542499|520088139|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
144242943|NCT04542499|520088138|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
144242944|NCT04542499|520088139|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
144242945|NCT04542499|520088138|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144242946|NCT04542499|520088139|FG001|Overall Study|Non-Compliance with Study Drug|2|||
144242947|NCT04542499|520088138|FG000|Overall Study|Physician Decision|0|||
144242948|NCT04542499|520088139|FG001|Overall Study|Physician Decision|1|||
144242949|NCT04542499|520088138|FG000|Overall Study|Site Terminated by Sponsor|3|||
144242950|NCT04542499|520088139|FG001|Overall Study|Site Terminated by Sponsor|5|||
144242951|NCT04542499|520088138|FG000|Overall Study|Withdrawal by Subject|12|||
144242952|NCT04542499|520088139|FG001|Overall Study|Withdrawal by Subject|33|||
144242953|NCT04542499|520088138|FG000|Overall Study|Other|2|||
144242954|NCT04542499|520088139|FG001|Overall Study|Other|2|||
144242955|NCT04035434|520088145|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242956|NCT04035434|520088146|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
144242957|NCT04035434|520088147|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242958|NCT04035434|520088148|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
144242959|NCT04035434|520088149|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
144242960|NCT04035434|520088150|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242961|NCT04035434|520088151|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242962|NCT04035434|520088152|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242963|NCT04035434|520088153|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242964|NCT04035434|520088154|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242965|NCT04035434|520088155|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
144242966|NCT04035434|520088156|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
144242967|NCT04035434|520088157|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144242968|NCT04035434|520088145|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
144242969|NCT04035434|520088146|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
144242970|NCT04035434|520088147|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
144242971|NCT04035434|520088148|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
144242972|NCT04035434|520088149|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
144242973|NCT04035434|520088150|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
144242974|NCT04035434|520088151|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
144242975|NCT04035434|520088152|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
144242976|NCT04035434|520088153|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
144242977|NCT04035434|520088154|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
144242978|NCT04035434|520088155|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
144242979|NCT04035434|520088156|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
144242980|NCT04035434|520088157|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
144242981|NCT04035434|520088145|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144242982|NCT04035434|520088146|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
144242983|NCT04035434|520088147|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
144242984|NCT04035434|520088148|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144242985|NCT04035434|520088149|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
144242986|NCT04035434|520088150|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
144276955|NCT02327078|520216441|FG004|Overall Study|Death|4|||
144276956|NCT02327078|520216442|FG005|Overall Study|Death|3|||
144276957|NCT02327078|520216443|FG006|Overall Study|Death|2|||
144276958|NCT02327078|520216444|FG007|Overall Study|Death|51|||
144276959|NCT02327078|520216445|FG008|Overall Study|Death|97|||
144276960|NCT02327078|520216437|FG000|Overall Study|Lost to Follow-up|0|||
144276961|NCT02327078|520216438|FG001|Overall Study|Lost to Follow-up|1|||
144276962|NCT02327078|520216439|FG002|Overall Study|Lost to Follow-up|1|||
144276963|NCT02327078|520216440|FG003|Overall Study|Lost to Follow-up|0|||
144276964|NCT02327078|520216441|FG004|Overall Study|Lost to Follow-up|0|||
144276965|NCT02327078|520216442|FG005|Overall Study|Lost to Follow-up|0|||
144276966|NCT02327078|520216443|FG006|Overall Study|Lost to Follow-up|0|||
144276967|NCT02327078|520216444|FG007|Overall Study|Lost to Follow-up|2|||
144276968|NCT02327078|520216445|FG008|Overall Study|Lost to Follow-up|5|||
144276969|NCT02327078|520216437|FG000|Overall Study|Site Terminated by Sponsor|1|||
144276970|NCT02327078|520216438|FG001|Overall Study|Site Terminated by Sponsor|0|||
144276971|NCT02327078|520216439|FG002|Overall Study|Site Terminated by Sponsor|1|||
144276972|NCT02327078|520216440|FG003|Overall Study|Site Terminated by Sponsor|4|||
144276973|NCT02327078|520216441|FG004|Overall Study|Site Terminated by Sponsor|0|||
144276974|NCT02327078|520216442|FG005|Overall Study|Site Terminated by Sponsor|0|||
144276975|NCT02327078|520216443|FG006|Overall Study|Site Terminated by Sponsor|0|||
144276976|NCT02327078|520216444|FG007|Overall Study|Site Terminated by Sponsor|11|||
144276977|NCT02327078|520216445|FG008|Overall Study|Site Terminated by Sponsor|25|||
144276978|NCT02327078|520216437|FG000|Overall Study|Physician Decision|0|||
144276979|NCT02327078|520216438|FG001|Overall Study|Physician Decision|0|||
144276980|NCT02327078|520216439|FG002|Overall Study|Physician Decision|0|||
144276981|NCT02327078|520216440|FG003|Overall Study|Physician Decision|1|||
144276982|NCT02327078|520216441|FG004|Overall Study|Physician Decision|0|||
144276983|NCT02327078|520216442|FG005|Overall Study|Physician Decision|0|||
144276984|NCT02327078|520216443|FG006|Overall Study|Physician Decision|0|||
144276985|NCT02327078|520216444|FG007|Overall Study|Physician Decision|0|||
144276986|NCT02327078|520216445|FG008|Overall Study|Physician Decision|1|||
144276987|NCT02327078|520216437|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
144276988|NCT02327078|520216438|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
144276989|NCT02327078|520216439|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
144276990|NCT02327078|520216440|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
144276991|NCT02327078|520216441|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
144276992|NCT02327078|520216442|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
144276993|NCT02327078|520216443|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
144276994|NCT02327078|520216444|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
144276995|NCT02327078|520216445|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
144276996|NCT02327078|520216437|FG000|Overall Study|Reason not Specified|0|||
144276997|NCT02327078|520216438|FG001|Overall Study|Reason not Specified|0|||
144276998|NCT02327078|520216439|FG002|Overall Study|Reason not Specified|0|||
144276999|NCT02327078|520216440|FG003|Overall Study|Reason not Specified|0|||
144277000|NCT02327078|520216441|FG004|Overall Study|Reason not Specified|0|||
144277001|NCT02327078|520216442|FG005|Overall Study|Reason not Specified|0|||
144277002|NCT02327078|520216443|FG006|Overall Study|Reason not Specified|0|||
144277003|NCT02327078|520216444|FG007|Overall Study|Reason not Specified|5|||
144277004|NCT02327078|520216445|FG008|Overall Study|Reason not Specified|12|||
144277005|NCT06001021|520216446|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
144277006|NCT06001021|520216447|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
144277007|NCT06001021|520216448|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
144277008|NCT06001021|520216449|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
144277009|NCT06001021|520216450|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
144277010|NCT06001021|520216451|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
144277011|NCT06001021|520216452|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
144277012|NCT06001021|520216446|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
144277013|NCT06001021|520216447|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
144277014|NCT06001021|520216448|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
144277015|NCT06001021|520216449|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
144277016|NCT06001021|520216450|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
144277017|NCT06001021|520216451|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
144277018|NCT06001021|520216452|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
144277019|NCT06001866|520216455|FG000|Overall Study|Withdrawal by Subject|0|||
144277020|NCT06001866|520216456|FG001|Overall Study|Withdrawal by Subject|2|||
144277021|NCT06001866|520216455|FG000|Overall Study|Protocol Violation|0|||
144277022|NCT06001866|520216456|FG001|Overall Study|Protocol Violation|2|||
144277023|NCT02337829|520216457|FG000|Overall Study|Death|0|||
144277024|NCT02337829|520216458|FG001|Overall Study|Death|1|||
144277025|NCT02337829|520216459|FG002|Overall Study|Death|0|||
144277026|NCT02337829|520216460|FG003|Overall Study|Death|0|||
144277027|NCT02337829|520216457|FG000|Overall Study|Study terminated by sponsor|12|||
144277028|NCT02337829|520216458|FG001|Overall Study|Study terminated by sponsor|10|||
144277029|NCT02337829|520216459|FG002|Overall Study|Study terminated by sponsor|5|||
144242987|NCT04035434|520088151|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144242988|NCT04035434|520088152|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144242989|NCT04035434|520088153|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
144242990|NCT04035434|520088154|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
144242991|NCT04035434|520088155|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144242992|NCT04035434|520088156|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
144242993|NCT04035434|520088157|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
144242994|NCT04035434|520088145|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144242995|NCT04035434|520088146|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144242996|NCT04035434|520088147|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144242997|NCT04035434|520088148|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
144242998|NCT04035434|520088149|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144242999|NCT04035434|520088150|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243000|NCT04035434|520088151|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243001|NCT04035434|520088152|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243002|NCT04035434|520088153|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243003|NCT04035434|520088154|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243004|NCT04035434|520088155|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243005|NCT04035434|520088156|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243006|NCT04035434|520088157|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
144243007|NCT04035434|520088145|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243008|NCT04035434|520088146|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243009|NCT04035434|520088147|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243010|NCT04035434|520088148|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243011|NCT04035434|520088149|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243012|NCT04035434|520088150|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
144243013|NCT04035434|520088151|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
144243014|NCT04035434|520088152|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243015|NCT04035434|520088153|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243016|NCT04035434|520088154|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243017|NCT04035434|520088155|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243018|NCT04035434|520088156|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243019|NCT04035434|520088157|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
144243020|NCT04035434|520088145|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243021|NCT04035434|520088146|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243022|NCT04035434|520088147|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243023|NCT04035434|520088148|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243024|NCT04035434|520088149|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243025|NCT04035434|520088150|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
144243026|NCT04035434|520088151|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
144243027|NCT04035434|520088152|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243028|NCT04035434|520088153|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243029|NCT04035434|520088154|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243030|NCT04035434|520088155|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243031|NCT04035434|520088156|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243032|NCT04035434|520088157|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
144243033|NCT04035434|520088145|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243034|NCT04035434|520088146|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243035|NCT04035434|520088147|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243036|NCT04035434|520088148|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243037|NCT04035434|520088149|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243038|NCT04035434|520088150|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
144243039|NCT04035434|520088151|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
144243040|NCT04035434|520088152|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243041|NCT04035434|520088153|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243042|NCT04035434|520088154|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243043|NCT04035434|520088155|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243044|NCT04035434|520088156|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243045|NCT04035434|520088157|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
144243046|NCT04488497|520088158|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
144243047|NCT04488497|520088159|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
144243048|NCT04488497|520088158|FG000|Intervention|Physician Decision|2|||
144243049|NCT04488497|520088159|FG001|Intervention|Physician Decision|1|||
144243050|NCT04488497|520088158|FG000|Intervention|Withdrawal by Subject|5|||
144243051|NCT04488497|520088159|FG001|Intervention|Withdrawal by Subject|6|||
144243052|NCT04488497|520088158|FG000|Intervention|Lost to Follow-up|2|||
144243053|NCT04488497|520088159|FG001|Intervention|Lost to Follow-up|0|||
144243054|NCT04488497|520088158|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
144243055|NCT04488497|520088159|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
144243056|NCT04488497|520088158|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
144243057|NCT04488497|520088159|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
144243058|NCT01668966|520088167|FG000|Overall Study|Withdrawal by Subject|1|||
144243059|NCT01668966|520088167|FG000|Overall Study|Death|1|||
144243060|NCT01668966|520088167|FG000|Overall Study|Not treated|2|||
144243061|NCT04063657|520088168|FG000|Overall Study|Lost to Follow-up|1|||
144243062|NCT04063657|520088169|FG001|Overall Study|Lost to Follow-up|0|||
144243063|NCT03226678|520088172|FG000|Part A (Core Study Phase)|Adverse Event|0|||
144243064|NCT03226678|520088173|FG001|Part A (Core Study Phase)|Adverse Event|1|||
144243065|NCT03226678|520088174|FG002|Part A (Core Study Phase)|Adverse Event|0|||
144243066|NCT03226678|520088175|FG003|Part A (Core Study Phase)|Adverse Event|0|||
144243067|NCT03226678|520088176|FG004|Part A (Core Study Phase)|Adverse Event|0|||
144243068|NCT03226678|520088177|FG005|Part A (Core Study Phase)|Adverse Event|0|||
144243069|NCT03226678|520088172|FG000|Part A (Core Study Phase)|Death|0|||
144243070|NCT03226678|520088173|FG001|Part A (Core Study Phase)|Death|0|||
144243071|NCT03226678|520088174|FG002|Part A (Core Study Phase)|Death|1|||
144243072|NCT03226678|520088175|FG003|Part A (Core Study Phase)|Death|0|||
144243073|NCT03226678|520088176|FG004|Part A (Core Study Phase)|Death|0|||
144243074|NCT03226678|520088177|FG005|Part A (Core Study Phase)|Death|0|||
144243075|NCT03226678|520088172|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
144243076|NCT03226678|520088173|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
144243077|NCT03226678|520088174|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
144243078|NCT03226678|520088175|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
144243079|NCT03226678|520088176|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
144243080|NCT03226678|520088177|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
144243081|NCT03226678|520088172|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
144243082|NCT03226678|520088173|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
144243083|NCT03226678|520088174|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
144243084|NCT03226678|520088175|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
144243085|NCT03226678|520088176|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
144243086|NCT03226678|520088177|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
144243087|NCT03226678|520088172|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
144243088|NCT03226678|520088173|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
144243089|NCT03226678|520088174|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
144243090|NCT03226678|520088175|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
144243091|NCT03226678|520088176|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
144243092|NCT03226678|520088177|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
144243093|NCT03226678|520088172|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
144243094|NCT03226678|520088173|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
144243095|NCT03226678|520088174|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
144243096|NCT03226678|520088175|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
144243097|NCT03226678|520088176|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
144243098|NCT03226678|520088177|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
144243099|NCT03226678|520088172|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
144243100|NCT03226678|520088173|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
144243101|NCT03226678|520088174|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
144277030|NCT02337829|520216460|FG003|Overall Study|Study terminated by sponsor|6|||
144243102|NCT03226678|520088175|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
144243103|NCT03226678|520088176|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
144243104|NCT03226678|520088177|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
144277031|NCT02337829|520216457|FG000|Overall Study|discontinued for other reasons|6|||
144277032|NCT02337829|520216458|FG001|Overall Study|discontinued for other reasons|3|||
144277033|NCT02337829|520216459|FG002|Overall Study|discontinued for other reasons|1|||
144277034|NCT02337829|520216460|FG003|Overall Study|discontinued for other reasons|4|||
144277035|NCT00390013|520216462|FG000|Phase 1|tired|0|||
144277036|NCT00390013|520216463|FG001|Phase 1|tired|0|||
144277037|NCT00390013|520216464|FG002|Phase 1|tired|0|||
144277038|NCT00390013|520216465|FG003|Phase 1|tired|1|||
144277039|NCT00390013|520216462|FG000|Phase 2 First Treatment|tired|1|||
144277040|NCT00390013|520216463|FG001|Phase 2 First Treatment|tired|0|||
144277041|NCT00390013|520216464|FG002|Phase 2 First Treatment|tired|0|||
144277042|NCT00390013|520216465|FG003|Phase 2 First Treatment|tired|0|||
144277043|NCT00390013|520216462|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
144277044|NCT00390013|520216463|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
144277045|NCT00390013|520216464|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
144277046|NCT00390013|520216465|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
144277047|NCT03330197|520216466|FG000|Overall Study|Adverse Event|0|||
144277048|NCT03330197|520216467|FG001|Overall Study|Adverse Event|1|||
144277049|NCT03330197|520216466|FG000|Overall Study|Withdrawal by Subject|0|||
144277050|NCT03330197|520216467|FG001|Overall Study|Withdrawal by Subject|1|||
144277051|NCT04221490|520216469|FG000|At 30 Days Follow-up|Death|7|||
144277052|NCT04221490|520216469|FG000|At 30 Days Follow-up|Missed Visit|4|||
144277053|NCT04221490|520216469|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
144277054|NCT04221490|520216469|FG000|At 6 Months Follow-up|Death|9|||
144277055|NCT04221490|520216469|FG000|At 6 Months Follow-up|Physician Decision|1|||
144277056|NCT04221490|520216469|FG000|At 6 Months Follow-up|Missed Visit|8|||
144277057|NCT04221490|520216469|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
144277058|NCT03765073|520216470|FG000|Stage 1|Lost to Follow-up|1|||
144277059|NCT03765073|520216471|FG001|Stage 1|Lost to Follow-up|0|||
144277060|NCT03765073|520216472|FG002|Stage 1|Lost to Follow-up|0|||
144277061|NCT03765073|520216473|FG003|Stage 1|Lost to Follow-up|0|||
144277062|NCT03765073|520216474|FG004|Stage 1|Lost to Follow-up|0|||
144277063|NCT03765073|520216475|FG005|Stage 1|Lost to Follow-up|0|||
144277064|NCT03765073|520216476|FG006|Stage 1|Lost to Follow-up|0|||
144277065|NCT03765073|520216477|FG007|Stage 1|Lost to Follow-up|0|||
144277066|NCT03765073|520216478|FG008|Stage 1|Lost to Follow-up|0|||
144277067|NCT03765073|520216479|FG009|Stage 1|Lost to Follow-up|0|||
144277068|NCT03765073|520216480|FG010|Stage 1|Lost to Follow-up|0|||
144277069|NCT03765073|520216481|FG011|Stage 1|Lost to Follow-up|0|||
144277070|NCT03765073|520216482|FG012|Stage 1|Lost to Follow-up|0|||
144277071|NCT03765073|520216483|FG013|Stage 1|Lost to Follow-up|0|||
144277072|NCT03765073|520216484|FG014|Stage 1|Lost to Follow-up|0|||
144277073|NCT03765073|520216485|FG015|Stage 1|Lost to Follow-up|0|||
144277074|NCT03765073|520216486|FG016|Stage 1|Lost to Follow-up|0|||
144277075|NCT03765073|520216487|FG017|Stage 1|Lost to Follow-up|0|||
144277076|NCT03765073|520216488|FG018|Stage 1|Lost to Follow-up|0|||
144277077|NCT03765073|520216489|FG019|Stage 1|Lost to Follow-up|0|||
144277078|NCT03765073|520216490|FG020|Stage 1|Lost to Follow-up|0|||
144277079|NCT03765073|520216470|FG000|Stage 1|Withdrawal by participant|0|||
144277080|NCT03765073|520216471|FG001|Stage 1|Withdrawal by participant|1|||
144277081|NCT03765073|520216472|FG002|Stage 1|Withdrawal by participant|0|||
144277082|NCT03765073|520216473|FG003|Stage 1|Withdrawal by participant|0|||
144277083|NCT03765073|520216474|FG004|Stage 1|Withdrawal by participant|0|||
144277084|NCT03765073|520216475|FG005|Stage 1|Withdrawal by participant|0|||
144277085|NCT03765073|520216476|FG006|Stage 1|Withdrawal by participant|0|||
144277086|NCT03765073|520216477|FG007|Stage 1|Withdrawal by participant|0|||
144277087|NCT03765073|520216478|FG008|Stage 1|Withdrawal by participant|0|||
144277088|NCT03765073|520216479|FG009|Stage 1|Withdrawal by participant|0|||
144277089|NCT03765073|520216480|FG010|Stage 1|Withdrawal by participant|0|||
144277090|NCT03765073|520216481|FG011|Stage 1|Withdrawal by participant|0|||
144277091|NCT03765073|520216482|FG012|Stage 1|Withdrawal by participant|0|||
144277092|NCT03765073|520216483|FG013|Stage 1|Withdrawal by participant|0|||
144277093|NCT03765073|520216484|FG014|Stage 1|Withdrawal by participant|0|||
144277094|NCT03765073|520216485|FG015|Stage 1|Withdrawal by participant|0|||
144277095|NCT03765073|520216486|FG016|Stage 1|Withdrawal by participant|0|||
144277096|NCT03765073|520216487|FG017|Stage 1|Withdrawal by participant|0|||
144277097|NCT03765073|520216488|FG018|Stage 1|Withdrawal by participant|0|||
144277098|NCT03765073|520216489|FG019|Stage 1|Withdrawal by participant|0|||
144277099|NCT03765073|520216490|FG020|Stage 1|Withdrawal by participant|0|||
144277100|NCT03765073|520216470|FG000|Stage 2|Death|0|||
144277101|NCT03765073|520216471|FG001|Stage 2|Death|0|||
144277102|NCT03765073|520216472|FG002|Stage 2|Death|0|||
144277103|NCT03765073|520216473|FG003|Stage 2|Death|0|||
144277104|NCT03765073|520216474|FG004|Stage 2|Death|0|||
144277105|NCT03765073|520216475|FG005|Stage 2|Death|0|||
144277106|NCT03765073|520216476|FG006|Stage 2|Death|0|||
144277107|NCT03765073|520216477|FG007|Stage 2|Death|0|||
144277108|NCT03765073|520216478|FG008|Stage 2|Death|0|||
144277109|NCT03765073|520216479|FG009|Stage 2|Death|1|||
144277110|NCT03765073|520216480|FG010|Stage 2|Death|0|||
144277111|NCT03765073|520216481|FG011|Stage 2|Death|1|||
144277112|NCT03765073|520216482|FG012|Stage 2|Death|0|||
144277113|NCT03765073|520216483|FG013|Stage 2|Death|0|||
144277114|NCT03765073|520216484|FG014|Stage 2|Death|0|||
144277115|NCT03765073|520216485|FG015|Stage 2|Death|0|||
144277116|NCT03765073|520216486|FG016|Stage 2|Death|2|||
144277117|NCT03765073|520216487|FG017|Stage 2|Death|0|||
144277118|NCT03765073|520216488|FG018|Stage 2|Death|0|||
144277119|NCT03765073|520216489|FG019|Stage 2|Death|0|||
144277120|NCT03765073|520216490|FG020|Stage 2|Death|0|||
144277121|NCT03765073|520216470|FG000|Stage 2|Lost to Follow-up|0|||
144277122|NCT03765073|520216471|FG001|Stage 2|Lost to Follow-up|0|||
144277123|NCT03765073|520216472|FG002|Stage 2|Lost to Follow-up|0|||
144277124|NCT03765073|520216473|FG003|Stage 2|Lost to Follow-up|5|||
144277125|NCT03765073|520216474|FG004|Stage 2|Lost to Follow-up|1|||
144277126|NCT03765073|520216475|FG005|Stage 2|Lost to Follow-up|0|||
144277127|NCT03765073|520216476|FG006|Stage 2|Lost to Follow-up|3|||
144277128|NCT03765073|520216477|FG007|Stage 2|Lost to Follow-up|3|||
144277129|NCT03765073|520216478|FG008|Stage 2|Lost to Follow-up|1|||
144277130|NCT03765073|520216479|FG009|Stage 2|Lost to Follow-up|6|||
144277131|NCT03765073|520216480|FG010|Stage 2|Lost to Follow-up|5|||
144277132|NCT03765073|520216481|FG011|Stage 2|Lost to Follow-up|1|||
144277133|NCT03765073|520216482|FG012|Stage 2|Lost to Follow-up|1|||
144277134|NCT03765073|520216483|FG013|Stage 2|Lost to Follow-up|3|||
144277135|NCT03765073|520216484|FG014|Stage 2|Lost to Follow-up|3|||
144277136|NCT03765073|520216485|FG015|Stage 2|Lost to Follow-up|1|||
144277137|NCT03765073|520216486|FG016|Stage 2|Lost to Follow-up|6|||
144277138|NCT03765073|520216487|FG017|Stage 2|Lost to Follow-up|0|||
144277139|NCT03765073|520216488|FG018|Stage 2|Lost to Follow-up|0|||
144277140|NCT03765073|520216489|FG019|Stage 2|Lost to Follow-up|0|||
144277141|NCT03765073|520216490|FG020|Stage 2|Lost to Follow-up|0|||
144277142|NCT03765073|520216470|FG000|Stage 2|Other|0|||
144277143|NCT03765073|520216471|FG001|Stage 2|Other|0|||
144277144|NCT03765073|520216472|FG002|Stage 2|Other|0|||
144277145|NCT03765073|520216473|FG003|Stage 2|Other|0|||
144277146|NCT03765073|520216474|FG004|Stage 2|Other|0|||
144277147|NCT03765073|520216475|FG005|Stage 2|Other|0|||
144277148|NCT03765073|520216476|FG006|Stage 2|Other|0|||
144277149|NCT03765073|520216477|FG007|Stage 2|Other|1|||
144277150|NCT03765073|520216478|FG008|Stage 2|Other|1|||
144277151|NCT03765073|520216479|FG009|Stage 2|Other|3|||
144277152|NCT03765073|520216480|FG010|Stage 2|Other|0|||
144277153|NCT03765073|520216481|FG011|Stage 2|Other|0|||
144277154|NCT03765073|520216482|FG012|Stage 2|Other|0|||
144277155|NCT03765073|520216483|FG013|Stage 2|Other|0|||
144277156|NCT03765073|520216484|FG014|Stage 2|Other|0|||
144277157|NCT03765073|520216485|FG015|Stage 2|Other|1|||
144277158|NCT03765073|520216486|FG016|Stage 2|Other|2|||
144277159|NCT03765073|520216487|FG017|Stage 2|Other|0|||
144277160|NCT03765073|520216488|FG018|Stage 2|Other|0|||
144277161|NCT03765073|520216489|FG019|Stage 2|Other|0|||
144277162|NCT03765073|520216490|FG020|Stage 2|Other|0|||
144277163|NCT03765073|520216470|FG000|Stage 2|Withdrawal by parent/guardian|0|||
144277164|NCT03765073|520216471|FG001|Stage 2|Withdrawal by parent/guardian|0|||
144277165|NCT03765073|520216472|FG002|Stage 2|Withdrawal by parent/guardian|0|||
144277166|NCT03765073|520216473|FG003|Stage 2|Withdrawal by parent/guardian|0|||
144277167|NCT03765073|520216474|FG004|Stage 2|Withdrawal by parent/guardian|0|||
144277168|NCT03765073|520216475|FG005|Stage 2|Withdrawal by parent/guardian|0|||
144277169|NCT03765073|520216476|FG006|Stage 2|Withdrawal by parent/guardian|0|||
144277170|NCT03765073|520216477|FG007|Stage 2|Withdrawal by parent/guardian|0|||
144277171|NCT03765073|520216478|FG008|Stage 2|Withdrawal by parent/guardian|0|||
144277172|NCT03765073|520216479|FG009|Stage 2|Withdrawal by parent/guardian|0|||
144277173|NCT03765073|520216480|FG010|Stage 2|Withdrawal by parent/guardian|3|||
144277174|NCT03765073|520216481|FG011|Stage 2|Withdrawal by parent/guardian|3|||
144277175|NCT03765073|520216482|FG012|Stage 2|Withdrawal by parent/guardian|3|||
144277176|NCT03765073|520216483|FG013|Stage 2|Withdrawal by parent/guardian|1|||
144277177|NCT03765073|520216484|FG014|Stage 2|Withdrawal by parent/guardian|1|||
144277178|NCT03765073|520216485|FG015|Stage 2|Withdrawal by parent/guardian|0|||
144277179|NCT03765073|520216486|FG016|Stage 2|Withdrawal by parent/guardian|3|||
144277180|NCT03765073|520216487|FG017|Stage 2|Withdrawal by parent/guardian|0|||
144277181|NCT03765073|520216488|FG018|Stage 2|Withdrawal by parent/guardian|0|||
144277182|NCT03765073|520216489|FG019|Stage 2|Withdrawal by parent/guardian|0|||
144277183|NCT03765073|520216490|FG020|Stage 2|Withdrawal by parent/guardian|0|||
144277184|NCT03765073|520216470|FG000|Stage 2|Withdrawal by Subject|0|||
144277185|NCT03765073|520216471|FG001|Stage 2|Withdrawal by Subject|0|||
144277186|NCT03765073|520216472|FG002|Stage 2|Withdrawal by Subject|0|||
144277187|NCT03765073|520216473|FG003|Stage 2|Withdrawal by Subject|3|||
144277188|NCT03765073|520216474|FG004|Stage 2|Withdrawal by Subject|3|||
144277189|NCT03765073|520216475|FG005|Stage 2|Withdrawal by Subject|3|||
144277190|NCT03765073|520216476|FG006|Stage 2|Withdrawal by Subject|0|||
144277191|NCT03765073|520216477|FG007|Stage 2|Withdrawal by Subject|1|||
144277192|NCT03765073|520216478|FG008|Stage 2|Withdrawal by Subject|0|||
144277193|NCT03765073|520216479|FG009|Stage 2|Withdrawal by Subject|5|||
144277194|NCT03765073|520216480|FG010|Stage 2|Withdrawal by Subject|0|||
144277195|NCT03765073|520216481|FG011|Stage 2|Withdrawal by Subject|0|||
144277196|NCT03765073|520216482|FG012|Stage 2|Withdrawal by Subject|0|||
144277197|NCT03765073|520216483|FG013|Stage 2|Withdrawal by Subject|0|||
144277198|NCT03765073|520216484|FG014|Stage 2|Withdrawal by Subject|0|||
144277199|NCT03765073|520216485|FG015|Stage 2|Withdrawal by Subject|0|||
144277200|NCT03765073|520216486|FG016|Stage 2|Withdrawal by Subject|0|||
144277201|NCT03765073|520216487|FG017|Stage 2|Withdrawal by Subject|0|||
144277202|NCT03765073|520216488|FG018|Stage 2|Withdrawal by Subject|0|||
144277203|NCT03765073|520216489|FG019|Stage 2|Withdrawal by Subject|0|||
144277204|NCT03765073|520216490|FG020|Stage 2|Withdrawal by Subject|0|||
144277205|NCT03765073|520216470|FG000|Stage 3|Adverse Event|0|||
144277206|NCT03765073|520216471|FG001|Stage 3|Adverse Event|0|||
144277207|NCT03765073|520216472|FG002|Stage 3|Adverse Event|0|||
144277208|NCT03765073|520216473|FG003|Stage 3|Adverse Event|0|||
144277209|NCT03765073|520216474|FG004|Stage 3|Adverse Event|0|||
144277210|NCT03765073|520216475|FG005|Stage 3|Adverse Event|0|||
144277211|NCT03765073|520216476|FG006|Stage 3|Adverse Event|0|||
144277212|NCT03765073|520216477|FG007|Stage 3|Adverse Event|0|||
144277213|NCT03765073|520216478|FG008|Stage 3|Adverse Event|0|||
144277214|NCT03765073|520216479|FG009|Stage 3|Adverse Event|0|||
144277215|NCT03765073|520216480|FG010|Stage 3|Adverse Event|0|||
144277216|NCT03765073|520216481|FG011|Stage 3|Adverse Event|0|||
144277217|NCT03765073|520216482|FG012|Stage 3|Adverse Event|0|||
144277218|NCT03765073|520216483|FG013|Stage 3|Adverse Event|0|||
144277219|NCT03765073|520216484|FG014|Stage 3|Adverse Event|0|||
144277220|NCT03765073|520216485|FG015|Stage 3|Adverse Event|0|||
144277221|NCT03765073|520216486|FG016|Stage 3|Adverse Event|0|||
144277222|NCT03765073|520216487|FG017|Stage 3|Adverse Event|0|||
144277223|NCT03765073|520216488|FG018|Stage 3|Adverse Event|1|||
144277224|NCT03765073|520216489|FG019|Stage 3|Adverse Event|0|||
144277225|NCT03765073|520216490|FG020|Stage 3|Adverse Event|0|||
144277226|NCT03765073|520216470|FG000|Stage 3|Death|0|||
144277227|NCT03765073|520216471|FG001|Stage 3|Death|0|||
144277228|NCT03765073|520216472|FG002|Stage 3|Death|0|||
144277229|NCT03765073|520216473|FG003|Stage 3|Death|0|||
144277230|NCT03765073|520216474|FG004|Stage 3|Death|0|||
144277231|NCT03765073|520216475|FG005|Stage 3|Death|0|||
144277232|NCT03765073|520216476|FG006|Stage 3|Death|0|||
144277233|NCT03765073|520216477|FG007|Stage 3|Death|0|||
144277234|NCT03765073|520216478|FG008|Stage 3|Death|0|||
144277235|NCT03765073|520216479|FG009|Stage 3|Death|0|||
144277236|NCT03765073|520216480|FG010|Stage 3|Death|0|||
144277237|NCT03765073|520216481|FG011|Stage 3|Death|0|||
144277238|NCT03765073|520216482|FG012|Stage 3|Death|0|||
144277239|NCT03765073|520216483|FG013|Stage 3|Death|0|||
144277240|NCT03765073|520216484|FG014|Stage 3|Death|0|||
144277241|NCT03765073|520216485|FG015|Stage 3|Death|0|||
144277242|NCT03765073|520216486|FG016|Stage 3|Death|0|||
144277243|NCT03765073|520216487|FG017|Stage 3|Death|0|||
144277244|NCT03765073|520216488|FG018|Stage 3|Death|0|||
144277245|NCT03765073|520216489|FG019|Stage 3|Death|3|||
144277246|NCT03765073|520216490|FG020|Stage 3|Death|2|||
144277247|NCT03765073|520216470|FG000|Stage 3|Lost to Follow-up|0|||
144277248|NCT03765073|520216471|FG001|Stage 3|Lost to Follow-up|0|||
144277249|NCT03765073|520216472|FG002|Stage 3|Lost to Follow-up|0|||
144277250|NCT03765073|520216473|FG003|Stage 3|Lost to Follow-up|0|||
144277251|NCT03765073|520216474|FG004|Stage 3|Lost to Follow-up|0|||
144277252|NCT03765073|520216475|FG005|Stage 3|Lost to Follow-up|0|||
144277253|NCT03765073|520216476|FG006|Stage 3|Lost to Follow-up|0|||
144277254|NCT03765073|520216477|FG007|Stage 3|Lost to Follow-up|0|||
144277255|NCT03765073|520216478|FG008|Stage 3|Lost to Follow-up|0|||
144277256|NCT03765073|520216479|FG009|Stage 3|Lost to Follow-up|0|||
144277257|NCT03765073|520216480|FG010|Stage 3|Lost to Follow-up|0|||
144277258|NCT03765073|520216481|FG011|Stage 3|Lost to Follow-up|0|||
144277259|NCT03765073|520216482|FG012|Stage 3|Lost to Follow-up|0|||
144277260|NCT03765073|520216483|FG013|Stage 3|Lost to Follow-up|0|||
144277261|NCT03765073|520216484|FG014|Stage 3|Lost to Follow-up|0|||
144277262|NCT03765073|520216485|FG015|Stage 3|Lost to Follow-up|0|||
144277263|NCT03765073|520216486|FG016|Stage 3|Lost to Follow-up|0|||
144277264|NCT03765073|520216487|FG017|Stage 3|Lost to Follow-up|8|||
144277265|NCT03765073|520216488|FG018|Stage 3|Lost to Follow-up|5|||
144277266|NCT03765073|520216489|FG019|Stage 3|Lost to Follow-up|7|||
144277267|NCT03765073|520216490|FG020|Stage 3|Lost to Follow-up|4|||
144277268|NCT03765073|520216470|FG000|Stage 3|No longer meets eligibility criteria|0|||
144277269|NCT03765073|520216471|FG001|Stage 3|No longer meets eligibility criteria|0|||
144277270|NCT03765073|520216472|FG002|Stage 3|No longer meets eligibility criteria|0|||
144277271|NCT03765073|520216473|FG003|Stage 3|No longer meets eligibility criteria|0|||
144277272|NCT03765073|520216474|FG004|Stage 3|No longer meets eligibility criteria|0|||
144277273|NCT03765073|520216475|FG005|Stage 3|No longer meets eligibility criteria|0|||
144277274|NCT03765073|520216476|FG006|Stage 3|No longer meets eligibility criteria|0|||
144277275|NCT03765073|520216477|FG007|Stage 3|No longer meets eligibility criteria|0|||
144277276|NCT03765073|520216478|FG008|Stage 3|No longer meets eligibility criteria|0|||
144277277|NCT03765073|520216479|FG009|Stage 3|No longer meets eligibility criteria|0|||
144277278|NCT03765073|520216480|FG010|Stage 3|No longer meets eligibility criteria|0|||
144277279|NCT03765073|520216481|FG011|Stage 3|No longer meets eligibility criteria|0|||
144277280|NCT03765073|520216482|FG012|Stage 3|No longer meets eligibility criteria|0|||
144277281|NCT03765073|520216483|FG013|Stage 3|No longer meets eligibility criteria|0|||
144277282|NCT03765073|520216484|FG014|Stage 3|No longer meets eligibility criteria|0|||
144277283|NCT03765073|520216485|FG015|Stage 3|No longer meets eligibility criteria|0|||
144277284|NCT03765073|520216486|FG016|Stage 3|No longer meets eligibility criteria|0|||
144277285|NCT03765073|520216487|FG017|Stage 3|No longer meets eligibility criteria|0|||
144277286|NCT03765073|520216488|FG018|Stage 3|No longer meets eligibility criteria|1|||
144277287|NCT03765073|520216489|FG019|Stage 3|No longer meets eligibility criteria|0|||
144277288|NCT03765073|520216490|FG020|Stage 3|No longer meets eligibility criteria|1|||
144277289|NCT03765073|520216470|FG000|Stage 3|Other|0|||
144277290|NCT03765073|520216471|FG001|Stage 3|Other|0|||
144277291|NCT03765073|520216472|FG002|Stage 3|Other|0|||
144277292|NCT03765073|520216473|FG003|Stage 3|Other|0|||
144277293|NCT03765073|520216474|FG004|Stage 3|Other|0|||
144277294|NCT03765073|520216475|FG005|Stage 3|Other|0|||
144277295|NCT03765073|520216476|FG006|Stage 3|Other|0|||
144277296|NCT03765073|520216477|FG007|Stage 3|Other|0|||
144277297|NCT03765073|520216478|FG008|Stage 3|Other|0|||
144277298|NCT03765073|520216479|FG009|Stage 3|Other|0|||
144277299|NCT03765073|520216480|FG010|Stage 3|Other|0|||
144277300|NCT03765073|520216481|FG011|Stage 3|Other|0|||
144277301|NCT03765073|520216482|FG012|Stage 3|Other|0|||
144277302|NCT03765073|520216483|FG013|Stage 3|Other|0|||
144277303|NCT03765073|520216484|FG014|Stage 3|Other|0|||
144277304|NCT03765073|520216485|FG015|Stage 3|Other|0|||
144277305|NCT03765073|520216486|FG016|Stage 3|Other|0|||
144277306|NCT03765073|520216487|FG017|Stage 3|Other|1|||
144277307|NCT03765073|520216488|FG018|Stage 3|Other|2|||
144277308|NCT03765073|520216489|FG019|Stage 3|Other|2|||
144277309|NCT03765073|520216490|FG020|Stage 3|Other|2|||
144277310|NCT03765073|520216470|FG000|Stage 3|Withdrawal by parent/guardian|0|||
144277311|NCT03765073|520216471|FG001|Stage 3|Withdrawal by parent/guardian|0|||
144277312|NCT03765073|520216472|FG002|Stage 3|Withdrawal by parent/guardian|0|||
144277313|NCT03765073|520216473|FG003|Stage 3|Withdrawal by parent/guardian|0|||
144277314|NCT03765073|520216474|FG004|Stage 3|Withdrawal by parent/guardian|0|||
144277315|NCT03765073|520216475|FG005|Stage 3|Withdrawal by parent/guardian|0|||
144277316|NCT03765073|520216476|FG006|Stage 3|Withdrawal by parent/guardian|0|||
144277317|NCT03765073|520216477|FG007|Stage 3|Withdrawal by parent/guardian|0|||
144277318|NCT03765073|520216478|FG008|Stage 3|Withdrawal by parent/guardian|0|||
144277319|NCT03765073|520216479|FG009|Stage 3|Withdrawal by parent/guardian|0|||
144277320|NCT03765073|520216480|FG010|Stage 3|Withdrawal by parent/guardian|0|||
144277321|NCT03765073|520216481|FG011|Stage 3|Withdrawal by parent/guardian|0|||
144277322|NCT03765073|520216482|FG012|Stage 3|Withdrawal by parent/guardian|0|||
144277323|NCT03765073|520216483|FG013|Stage 3|Withdrawal by parent/guardian|0|||
144277324|NCT03765073|520216484|FG014|Stage 3|Withdrawal by parent/guardian|0|||
144277325|NCT03765073|520216485|FG015|Stage 3|Withdrawal by parent/guardian|0|||
144277326|NCT03765073|520216486|FG016|Stage 3|Withdrawal by parent/guardian|0|||
144277327|NCT03765073|520216487|FG017|Stage 3|Withdrawal by parent/guardian|0|||
144277328|NCT03765073|520216488|FG018|Stage 3|Withdrawal by parent/guardian|0|||
144277329|NCT03765073|520216489|FG019|Stage 3|Withdrawal by parent/guardian|6|||
144277330|NCT03765073|520216490|FG020|Stage 3|Withdrawal by parent/guardian|9|||
144277331|NCT03765073|520216470|FG000|Stage 3|Withdrawal by Subject|0|||
144277332|NCT03765073|520216471|FG001|Stage 3|Withdrawal by Subject|0|||
144277333|NCT03765073|520216472|FG002|Stage 3|Withdrawal by Subject|0|||
144277334|NCT03765073|520216473|FG003|Stage 3|Withdrawal by Subject|0|||
144277335|NCT03765073|520216474|FG004|Stage 3|Withdrawal by Subject|0|||
144277336|NCT03765073|520216475|FG005|Stage 3|Withdrawal by Subject|0|||
144277337|NCT03765073|520216476|FG006|Stage 3|Withdrawal by Subject|0|||
144277338|NCT03765073|520216477|FG007|Stage 3|Withdrawal by Subject|0|||
144277339|NCT03765073|520216478|FG008|Stage 3|Withdrawal by Subject|0|||
144277340|NCT03765073|520216479|FG009|Stage 3|Withdrawal by Subject|0|||
144277341|NCT03765073|520216480|FG010|Stage 3|Withdrawal by Subject|0|||
144277342|NCT03765073|520216481|FG011|Stage 3|Withdrawal by Subject|0|||
144277343|NCT03765073|520216482|FG012|Stage 3|Withdrawal by Subject|0|||
144277344|NCT03765073|520216483|FG013|Stage 3|Withdrawal by Subject|0|||
144277345|NCT03765073|520216484|FG014|Stage 3|Withdrawal by Subject|0|||
144277346|NCT03765073|520216485|FG015|Stage 3|Withdrawal by Subject|0|||
144277347|NCT03765073|520216486|FG016|Stage 3|Withdrawal by Subject|0|||
144277348|NCT03765073|520216487|FG017|Stage 3|Withdrawal by Subject|8|||
144277349|NCT03765073|520216488|FG018|Stage 3|Withdrawal by Subject|11|||
144277350|NCT03765073|520216489|FG019|Stage 3|Withdrawal by Subject|0|||
144277351|NCT03765073|520216490|FG020|Stage 3|Withdrawal by Subject|0|||
144277352|NCT04537299|520216498|FG000|Overall Study|Withdrawal by Subject|2|||
144277353|NCT04537299|520216499|FG001|Overall Study|Withdrawal by Subject|0|||
144277354|NCT04537299|520216498|FG000|Overall Study|Protocol Violation|1|||
144277355|NCT04537299|520216499|FG001|Overall Study|Protocol Violation|1|||
144277356|NCT03034967|520216504|FG000|Overall Study|Withdrawal by Subject|9|||
144277357|NCT03034967|520216505|FG001|Overall Study|Withdrawal by Subject|2|||
144277358|NCT03034967|520216506|FG002|Overall Study|Withdrawal by Subject|6|||
144277359|NCT03034967|520216507|FG003|Overall Study|Withdrawal by Subject|6|||
144277360|NCT03034967|520216508|FG004|Overall Study|Withdrawal by Subject|9|||
144277361|NCT03034967|520216509|FG005|Overall Study|Withdrawal by Subject|2|||
144277362|NCT03034967|520216504|FG000|Overall Study|Physician Decision|1|||
144277363|NCT03034967|520216505|FG001|Overall Study|Physician Decision|0|||
144277364|NCT03034967|520216506|FG002|Overall Study|Physician Decision|1|||
144277365|NCT03034967|520216507|FG003|Overall Study|Physician Decision|1|||
144277366|NCT03034967|520216508|FG004|Overall Study|Physician Decision|1|||
144277367|NCT03034967|520216509|FG005|Overall Study|Physician Decision|0|||
144277368|NCT03034967|520216504|FG000|Overall Study|Lost to Follow-up|0|||
144277369|NCT03034967|520216505|FG001|Overall Study|Lost to Follow-up|0|||
144277370|NCT03034967|520216506|FG002|Overall Study|Lost to Follow-up|0|||
144277371|NCT03034967|520216507|FG003|Overall Study|Lost to Follow-up|1|||
144277372|NCT03034967|520216508|FG004|Overall Study|Lost to Follow-up|0|||
144277373|NCT03034967|520216509|FG005|Overall Study|Lost to Follow-up|2|||
144277374|NCT03034967|520216504|FG000|Overall Study|Liver function test abnormality|0|||
144277375|NCT03034967|520216505|FG001|Overall Study|Liver function test abnormality|0|||
144277376|NCT03034967|520216506|FG002|Overall Study|Liver function test abnormality|1|||
144277377|NCT03034967|520216507|FG003|Overall Study|Liver function test abnormality|0|||
144277378|NCT03034967|520216508|FG004|Overall Study|Liver function test abnormality|0|||
144277379|NCT03034967|520216509|FG005|Overall Study|Liver function test abnormality|0|||
144277380|NCT03034967|520216504|FG000|Overall Study|Protocol Violation|1|||
144277381|NCT03034967|520216505|FG001|Overall Study|Protocol Violation|0|||
144277382|NCT03034967|520216506|FG002|Overall Study|Protocol Violation|0|||
144277383|NCT03034967|520216507|FG003|Overall Study|Protocol Violation|0|||
144277384|NCT03034967|520216508|FG004|Overall Study|Protocol Violation|0|||
144277385|NCT03034967|520216509|FG005|Overall Study|Protocol Violation|2|||
144277386|NCT03034967|520216504|FG000|Overall Study|Lack of Efficacy|0|||
144277387|NCT03034967|520216505|FG001|Overall Study|Lack of Efficacy|1|||
144277388|NCT03034967|520216506|FG002|Overall Study|Lack of Efficacy|2|||
144277389|NCT03034967|520216507|FG003|Overall Study|Lack of Efficacy|1|||
144277390|NCT03034967|520216508|FG004|Overall Study|Lack of Efficacy|1|||
144277391|NCT03034967|520216509|FG005|Overall Study|Lack of Efficacy|0|||
144277392|NCT03034967|520216504|FG000|Overall Study|Adverse Event, non-fatal|3|||
144277393|NCT03034967|520216505|FG001|Overall Study|Adverse Event, non-fatal|1|||
144277394|NCT03034967|520216506|FG002|Overall Study|Adverse Event, non-fatal|2|||
144277395|NCT03034967|520216507|FG003|Overall Study|Adverse Event, non-fatal|0|||
144277396|NCT03034967|520216508|FG004|Overall Study|Adverse Event, non-fatal|2|||
144277397|NCT03034967|520216509|FG005|Overall Study|Adverse Event, non-fatal|8|||
144277398|NCT03034967|520216504|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
144277399|NCT03034967|520216505|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
144277400|NCT03034967|520216506|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
144277401|NCT03034967|520216507|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
144277402|NCT03034967|520216508|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
144277403|NCT03034967|520216509|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
144277404|NCT02442349|520216522|FG000|Overall Study|Death|95|||
144277405|NCT02442349|520216522|FG000|Overall Study|Withdrawal by Subject|27|||
144277406|NCT02442349|520216522|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
144277407|NCT02442349|520216522|FG000|Overall Study|Lost to Follow-up|1|||
144277408|NCT01402700|520216523|FG000|Overall Study|Death|3|||
144277409|NCT01402700|520216523|FG000|Overall Study|Withdrawal by Subject|3|||
144243105|NCT03226678|520088172|FG000|Part B (Long-Term Extension Phase)|Death|0|||
144243106|NCT03226678|520088173|FG001|Part B (Long-Term Extension Phase)|Death|0|||
144243107|NCT03226678|520088174|FG002|Part B (Long-Term Extension Phase)|Death|0|||
144243108|NCT03226678|520088175|FG003|Part B (Long-Term Extension Phase)|Death|0|||
144243109|NCT03226678|520088176|FG004|Part B (Long-Term Extension Phase)|Death|0|||
144243110|NCT03226678|520088177|FG005|Part B (Long-Term Extension Phase)|Death|1|||
144243111|NCT03226678|520088172|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
144243112|NCT03226678|520088173|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
144243113|NCT03226678|520088174|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
144243114|NCT03226678|520088175|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
144243115|NCT03226678|520088176|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
144243116|NCT03226678|520088177|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
144243117|NCT03226678|520088172|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
144243118|NCT03226678|520088173|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
144243119|NCT03226678|520088174|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
144243120|NCT03226678|520088175|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
144243121|NCT03226678|520088176|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
144243122|NCT03226678|520088177|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
144243123|NCT03226678|520088172|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
144243124|NCT03226678|520088173|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
144243125|NCT03226678|520088174|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
144243126|NCT03226678|520088175|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
144243127|NCT03226678|520088176|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
144243128|NCT03226678|520088177|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
144243129|NCT01473394|520088182|FG000|Overall Study|Adverse Event|13|||
144243130|NCT01473394|520088183|FG001|Overall Study|Adverse Event|16|||
144243131|NCT01473394|520088182|FG000|Overall Study|Insufficient Therapeutic Response|4|||
144243132|NCT01473394|520088183|FG001|Overall Study|Insufficient Therapeutic Response|1|||
144243133|NCT01473394|520088182|FG000|Overall Study|Protocol Violation|7|||
144243134|NCT01473394|520088183|FG001|Overall Study|Protocol Violation|5|||
144243135|NCT01473394|520088182|FG000|Overall Study|Withdrew Consent|12|||
144243136|NCT01473394|520088183|FG001|Overall Study|Withdrew Consent|10|||
144243137|NCT01473394|520088182|FG000|Overall Study|Lost to Follow-up|9|||
144243138|NCT01473394|520088183|FG001|Overall Study|Lost to Follow-up|11|||
144243139|NCT00552032|520088184|FG000|Overall Study|Withdrawal by Subject|2|||
144243140|NCT00552032|520088185|FG001|Overall Study|Withdrawal by Subject|2|||
144243141|NCT00552032|520088184|FG000|Overall Study|Protocol Violation|7|||
144243142|NCT00552032|520088185|FG001|Overall Study|Protocol Violation|12|||
144243143|NCT00552032|520088184|FG000|Overall Study|Lost to Follow-up|8|||
144243144|NCT00552032|520088185|FG001|Overall Study|Lost to Follow-up|5|||
144243145|NCT04430738|520088186|FG000|Phase 1: Dose Escalation|Death|1|||
144243146|NCT04430738|520088187|FG001|Phase 1: Dose Escalation|Death|4|||
144243147|NCT04430738|520088188|FG002|Phase 1: Dose Escalation|Death|4|||
144243148|NCT04430738|520088189|FG003|Phase 1: Dose Escalation|Death|1|||
144243149|NCT04430738|520088190|FG004|Phase 1: Dose Escalation|Death|6|||
144243150|NCT04430738|520088191|FG005|Phase 1: Dose Escalation|Death|0|||
144243151|NCT04430738|520088186|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
144243152|NCT04430738|520088187|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
144243153|NCT04430738|520088188|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
144243154|NCT04430738|520088189|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
144243155|NCT04430738|520088190|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
144243156|NCT04430738|520088191|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
144243157|NCT04430738|520088186|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
144243158|NCT04430738|520088187|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
144243159|NCT04430738|520088188|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
144243160|NCT04430738|520088189|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
144243161|NCT04430738|520088190|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
144243162|NCT04430738|520088191|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
144243163|NCT04430738|520088186|FG000|Phase 1: Dose Escalation|Other|1|||
144243164|NCT04430738|520088187|FG001|Phase 1: Dose Escalation|Other|0|||
144243165|NCT04430738|520088188|FG002|Phase 1: Dose Escalation|Other|0|||
144243166|NCT04430738|520088189|FG003|Phase 1: Dose Escalation|Other|0|||
144243167|NCT04430738|520088190|FG004|Phase 1: Dose Escalation|Other|0|||
144243168|NCT04430738|520088191|FG005|Phase 1: Dose Escalation|Other|0|||
144243169|NCT04430738|520088186|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
144243170|NCT04430738|520088187|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
144243171|NCT04430738|520088188|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
144243172|NCT04430738|520088189|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
144243173|NCT04430738|520088190|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
144243174|NCT04430738|520088191|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
144243175|NCT04430738|520088186|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
144243176|NCT04430738|520088187|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
144243177|NCT04430738|520088188|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
144243178|NCT04430738|520088189|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
144243179|NCT04430738|520088190|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
144243180|NCT04430738|520088191|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
144243181|NCT02659514|520088202|FG000|Overall Study|Adverse Event|3|||
144243182|NCT02659514|520088203|FG001|Overall Study|Adverse Event|12|||
144243183|NCT02659514|520088202|FG000|Overall Study|Disease Progression|23|||
144243184|NCT02659514|520088203|FG001|Overall Study|Disease Progression|13|||
144243185|NCT02659514|520088202|FG000|Overall Study|Withdrawal by Subject|0|||
144243186|NCT02659514|520088203|FG001|Overall Study|Withdrawal by Subject|4|||
144243187|NCT02659514|520088202|FG000|Overall Study|Lost to Follow-up|0|||
144243188|NCT02659514|520088203|FG001|Overall Study|Lost to Follow-up|1|||
144243189|NCT02659514|520088202|FG000|Overall Study|Death|6|||
144243190|NCT02659514|520088203|FG001|Overall Study|Death|1|||
144243191|NCT02659514|520088202|FG000|Overall Study|Reason Unspecified|0|||
144243192|NCT02659514|520088203|FG001|Overall Study|Reason Unspecified|3|||
144243193|NCT00597506|520088207|FG000|Overall Study|Subject is being followed for survival|1|||
144243194|NCT01500213|520088208|FG000|Overall Study|Adverse Event|35|||
144243195|NCT01500213|520088209|FG001|Overall Study|Adverse Event|35|||
144243196|NCT01500213|520088208|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
144243197|NCT01500213|520088209|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
144243198|NCT01500213|520088208|FG000|Overall Study|Withdrawal by Subject|28|||
144243199|NCT01500213|520088209|FG001|Overall Study|Withdrawal by Subject|37|||
144243200|NCT01500213|520088208|FG000|Overall Study|Death|7|||
144243201|NCT01500213|520088209|FG001|Overall Study|Death|3|||
144243202|NCT01500213|520088208|FG000|Overall Study|Disease Progression|13|||
144243203|NCT01500213|520088209|FG001|Overall Study|Disease Progression|21|||
144243204|NCT01500213|520088208|FG000|Overall Study|Protocol Violation|19|||
144243205|NCT01500213|520088209|FG001|Overall Study|Protocol Violation|19|||
144243206|NCT01500213|520088208|FG000|Overall Study|Physician Decision|12|||
144243207|NCT01500213|520088209|FG001|Overall Study|Physician Decision|10|||
144243208|NCT01500213|520088208|FG000|Overall Study|Lack of Efficacy|9|||
144243209|NCT01500213|520088209|FG001|Overall Study|Lack of Efficacy|7|||
144243210|NCT01500213|520088208|FG000|Overall Study|Lost to Follow-up|3|||
144243211|NCT01500213|520088209|FG001|Overall Study|Lost to Follow-up|6|||
144243212|NCT01500213|520088208|FG000|Overall Study|Other Reasons|7|||
144243213|NCT01500213|520088209|FG001|Overall Study|Other Reasons|5|||
144243214|NCT02386345|520088210|FG000|Overall Study|Not treated|14|||
144243215|NCT02386345|520088210|FG000|Overall Study|Lost to Follow-up|1|||
144243216|NCT02386345|520088210|FG000|Overall Study|Adverse Event|5|||
144243217|NCT02386345|520088210|FG000|Overall Study|Repeat Procedure|10|||
144243218|NCT02386345|520088210|FG000|Overall Study|Did not complete 12-month follow-up|72|||
144243219|NCT04713592|520088216|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
144243220|NCT04713592|520088217|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
144243221|NCT04713592|520088218|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
144243222|NCT04713592|520088219|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
144243223|NCT04713592|520088216|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
144243224|NCT04713592|520088217|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
144243225|NCT04713592|520088218|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
144243226|NCT04713592|520088219|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
144243227|NCT04713592|520088216|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
144243228|NCT04713592|520088217|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
144243229|NCT04713592|520088218|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
144243230|NCT04713592|520088219|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
144243231|NCT04713592|520088216|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144243232|NCT04713592|520088217|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
144243233|NCT04713592|520088218|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
144243234|NCT04713592|520088219|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
144243235|NCT04713592|520088216|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
144243236|NCT04713592|520088217|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
144243237|NCT04713592|520088218|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
144243238|NCT04713592|520088219|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
144243239|NCT04713592|520088216|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144243240|NCT04713592|520088217|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
144277410|NCT01402700|520216523|FG000|Overall Study|Missed Visit|1|||
144243241|NCT04713592|520088218|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
144243242|NCT04713592|520088219|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
144243243|NCT04713592|520088216|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
144243244|NCT04713592|520088217|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
144277411|NCT03314935|520216527|FG000|Phase 1|Death|4|||
144277412|NCT03314935|520216528|FG001|Phase 1|Death|2|||
144277413|NCT03314935|520216529|FG002|Phase 1|Death|5|||
144277414|NCT03314935|520216530|FG003|Phase 1|Death|4|||
144277415|NCT03314935|520216531|FG004|Phase 1|Death|3|||
144277416|NCT03314935|520216532|FG005|Phase 1|Death|4|||
144277417|NCT03314935|520216533|FG006|Phase 1|Death|5|||
144277418|NCT03314935|520216534|FG007|Phase 1|Death|4|||
144277419|NCT03314935|520216535|FG008|Phase 1|Death|3|||
144277420|NCT03314935|520216536|FG009|Phase 1|Death|0|||
144277421|NCT03314935|520216537|FG010|Phase 1|Death|0|||
144277422|NCT03314935|520216538|FG011|Phase 1|Death|0|||
144277423|NCT03314935|520216539|FG012|Phase 1|Death|0|||
144277424|NCT03314935|520216540|FG013|Phase 1|Death|0|||
144277425|NCT03314935|520216541|FG014|Phase 1|Death|0|||
144277426|NCT03314935|520216527|FG000|Phase 1|Withdrawal by Subject|2|||
144277427|NCT03314935|520216528|FG001|Phase 1|Withdrawal by Subject|1|||
144277428|NCT03314935|520216529|FG002|Phase 1|Withdrawal by Subject|1|||
144277429|NCT03314935|520216530|FG003|Phase 1|Withdrawal by Subject|2|||
144277430|NCT03314935|520216531|FG004|Phase 1|Withdrawal by Subject|1|||
144277431|NCT03314935|520216532|FG005|Phase 1|Withdrawal by Subject|0|||
144277432|NCT03314935|520216533|FG006|Phase 1|Withdrawal by Subject|1|||
144277433|NCT03314935|520216534|FG007|Phase 1|Withdrawal by Subject|0|||
144277434|NCT03314935|520216535|FG008|Phase 1|Withdrawal by Subject|1|||
144277435|NCT03314935|520216536|FG009|Phase 1|Withdrawal by Subject|0|||
144277436|NCT03314935|520216537|FG010|Phase 1|Withdrawal by Subject|0|||
144277437|NCT03314935|520216538|FG011|Phase 1|Withdrawal by Subject|0|||
144277438|NCT03314935|520216539|FG012|Phase 1|Withdrawal by Subject|0|||
144277439|NCT03314935|520216540|FG013|Phase 1|Withdrawal by Subject|0|||
144277440|NCT03314935|520216541|FG014|Phase 1|Withdrawal by Subject|0|||
144277441|NCT03314935|520216527|FG000|Phase 1|Progressive Disease|2|||
144277442|NCT03314935|520216528|FG001|Phase 1|Progressive Disease|0|||
144277443|NCT03314935|520216529|FG002|Phase 1|Progressive Disease|0|||
144277444|NCT03314935|520216530|FG003|Phase 1|Progressive Disease|1|||
144277445|NCT03314935|520216531|FG004|Phase 1|Progressive Disease|0|||
144277446|NCT03314935|520216532|FG005|Phase 1|Progressive Disease|0|||
144277447|NCT03314935|520216533|FG006|Phase 1|Progressive Disease|0|||
144277448|NCT03314935|520216534|FG007|Phase 1|Progressive Disease|0|||
144277449|NCT03314935|520216535|FG008|Phase 1|Progressive Disease|0|||
144277450|NCT03314935|520216536|FG009|Phase 1|Progressive Disease|0|||
144277451|NCT03314935|520216537|FG010|Phase 1|Progressive Disease|0|||
144277452|NCT03314935|520216538|FG011|Phase 1|Progressive Disease|0|||
144277453|NCT03314935|520216539|FG012|Phase 1|Progressive Disease|0|||
144277454|NCT03314935|520216540|FG013|Phase 1|Progressive Disease|0|||
144277455|NCT03314935|520216541|FG014|Phase 1|Progressive Disease|0|||
144277456|NCT03314935|520216527|FG000|Phase 1|Study Terminated by Sponsor|0|||
144277457|NCT03314935|520216528|FG001|Phase 1|Study Terminated by Sponsor|1|||
144277458|NCT03314935|520216529|FG002|Phase 1|Study Terminated by Sponsor|0|||
144277459|NCT03314935|520216530|FG003|Phase 1|Study Terminated by Sponsor|0|||
144277460|NCT03314935|520216531|FG004|Phase 1|Study Terminated by Sponsor|0|||
144277461|NCT03314935|520216532|FG005|Phase 1|Study Terminated by Sponsor|0|||
144277462|NCT03314935|520216533|FG006|Phase 1|Study Terminated by Sponsor|0|||
144277463|NCT03314935|520216534|FG007|Phase 1|Study Terminated by Sponsor|0|||
144277464|NCT03314935|520216535|FG008|Phase 1|Study Terminated by Sponsor|1|||
144277465|NCT03314935|520216536|FG009|Phase 1|Study Terminated by Sponsor|0|||
144277466|NCT03314935|520216537|FG010|Phase 1|Study Terminated by Sponsor|0|||
144277467|NCT03314935|520216538|FG011|Phase 1|Study Terminated by Sponsor|0|||
144277468|NCT03314935|520216539|FG012|Phase 1|Study Terminated by Sponsor|0|||
144277469|NCT03314935|520216540|FG013|Phase 1|Study Terminated by Sponsor|0|||
144277470|NCT03314935|520216541|FG014|Phase 1|Study Terminated by Sponsor|0|||
144277471|NCT03314935|520216527|FG000|Phase 1|"Captured as Other in Database"|0|||
144277472|NCT03314935|520216528|FG001|Phase 1|"Captured as Other in Database"|2|||
144277473|NCT03314935|520216529|FG002|Phase 1|"Captured as Other in Database"|0|||
144277474|NCT03314935|520216530|FG003|Phase 1|"Captured as Other in Database"|0|||
144277475|NCT03314935|520216531|FG004|Phase 1|"Captured as Other in Database"|0|||
144277476|NCT03314935|520216532|FG005|Phase 1|"Captured as Other in Database"|0|||
144277477|NCT03314935|520216533|FG006|Phase 1|"Captured as Other in Database"|1|||
144277478|NCT03314935|520216534|FG007|Phase 1|"Captured as Other in Database"|1|||
144277479|NCT03314935|520216535|FG008|Phase 1|"Captured as Other in Database"|1|||
144277480|NCT03314935|520216536|FG009|Phase 1|"Captured as Other in Database"|0|||
144277481|NCT03314935|520216537|FG010|Phase 1|"Captured as Other in Database"|0|||
144277482|NCT03314935|520216538|FG011|Phase 1|"Captured as Other in Database"|0|||
144277483|NCT03314935|520216539|FG012|Phase 1|"Captured as Other in Database"|0|||
144277484|NCT03314935|520216540|FG013|Phase 1|"Captured as Other in Database"|0|||
144277485|NCT03314935|520216541|FG014|Phase 1|"Captured as Other in Database"|0|||
144277486|NCT03314935|520216527|FG000|Phase 1|Lost to Follow-up|0|||
144277487|NCT03314935|520216528|FG001|Phase 1|Lost to Follow-up|0|||
144277488|NCT03314935|520216529|FG002|Phase 1|Lost to Follow-up|0|||
144277489|NCT03314935|520216530|FG003|Phase 1|Lost to Follow-up|0|||
144277490|NCT03314935|520216531|FG004|Phase 1|Lost to Follow-up|0|||
144277491|NCT03314935|520216532|FG005|Phase 1|Lost to Follow-up|0|||
144277492|NCT03314935|520216533|FG006|Phase 1|Lost to Follow-up|0|||
144277493|NCT03314935|520216534|FG007|Phase 1|Lost to Follow-up|0|||
144277494|NCT03314935|520216535|FG008|Phase 1|Lost to Follow-up|1|||
144277495|NCT03314935|520216536|FG009|Phase 1|Lost to Follow-up|0|||
144277496|NCT03314935|520216537|FG010|Phase 1|Lost to Follow-up|0|||
144277497|NCT03314935|520216538|FG011|Phase 1|Lost to Follow-up|0|||
144277498|NCT03314935|520216539|FG012|Phase 1|Lost to Follow-up|0|||
144277499|NCT03314935|520216540|FG013|Phase 1|Lost to Follow-up|0|||
144277500|NCT03314935|520216541|FG014|Phase 1|Lost to Follow-up|0|||
144277501|NCT03314935|520216527|FG000|Phase 2|Death|0|||
144277502|NCT03314935|520216528|FG001|Phase 2|Death|0|||
144277503|NCT03314935|520216529|FG002|Phase 2|Death|0|||
144277504|NCT03314935|520216530|FG003|Phase 2|Death|0|||
144277505|NCT03314935|520216531|FG004|Phase 2|Death|0|||
144277506|NCT03314935|520216532|FG005|Phase 2|Death|0|||
144277507|NCT03314935|520216533|FG006|Phase 2|Death|0|||
144277508|NCT03314935|520216534|FG007|Phase 2|Death|0|||
144277509|NCT03314935|520216535|FG008|Phase 2|Death|0|||
144277510|NCT03314935|520216536|FG009|Phase 2|Death|5|||
144277511|NCT03314935|520216537|FG010|Phase 2|Death|20|||
144277512|NCT03314935|520216538|FG011|Phase 2|Death|6|||
144277513|NCT03314935|520216539|FG012|Phase 2|Death|7|||
144277514|NCT03314935|520216540|FG013|Phase 2|Death|6|||
144277515|NCT03314935|520216541|FG014|Phase 2|Death|17|||
144277516|NCT03314935|520216527|FG000|Phase 2|Withdrawal by Subject|0|||
144277517|NCT03314935|520216528|FG001|Phase 2|Withdrawal by Subject|0|||
144277518|NCT03314935|520216529|FG002|Phase 2|Withdrawal by Subject|0|||
144277519|NCT03314935|520216530|FG003|Phase 2|Withdrawal by Subject|0|||
144277520|NCT03314935|520216531|FG004|Phase 2|Withdrawal by Subject|0|||
144277521|NCT03314935|520216532|FG005|Phase 2|Withdrawal by Subject|0|||
144277522|NCT03314935|520216533|FG006|Phase 2|Withdrawal by Subject|0|||
144277523|NCT03314935|520216534|FG007|Phase 2|Withdrawal by Subject|0|||
144277524|NCT03314935|520216535|FG008|Phase 2|Withdrawal by Subject|0|||
144277525|NCT03314935|520216536|FG009|Phase 2|Withdrawal by Subject|1|||
144277526|NCT03314935|520216537|FG010|Phase 2|Withdrawal by Subject|4|||
144277527|NCT03314935|520216538|FG011|Phase 2|Withdrawal by Subject|0|||
144277528|NCT03314935|520216539|FG012|Phase 2|Withdrawal by Subject|1|||
144277529|NCT03314935|520216540|FG013|Phase 2|Withdrawal by Subject|0|||
144277530|NCT03314935|520216541|FG014|Phase 2|Withdrawal by Subject|1|||
144277531|NCT03314935|520216527|FG000|Phase 2|Progressive Disease|0|||
144277532|NCT03314935|520216528|FG001|Phase 2|Progressive Disease|0|||
144277533|NCT03314935|520216529|FG002|Phase 2|Progressive Disease|0|||
144277534|NCT03314935|520216530|FG003|Phase 2|Progressive Disease|0|||
144277535|NCT03314935|520216531|FG004|Phase 2|Progressive Disease|0|||
144277536|NCT03314935|520216532|FG005|Phase 2|Progressive Disease|0|||
144277537|NCT03314935|520216533|FG006|Phase 2|Progressive Disease|0|||
144277538|NCT03314935|520216534|FG007|Phase 2|Progressive Disease|0|||
144277539|NCT03314935|520216535|FG008|Phase 2|Progressive Disease|0|||
144277540|NCT03314935|520216536|FG009|Phase 2|Progressive Disease|1|||
144277541|NCT03314935|520216537|FG010|Phase 2|Progressive Disease|1|||
144277542|NCT03314935|520216538|FG011|Phase 2|Progressive Disease|1|||
144277543|NCT03314935|520216539|FG012|Phase 2|Progressive Disease|2|||
144277544|NCT03314935|520216540|FG013|Phase 2|Progressive Disease|0|||
144277545|NCT03314935|520216541|FG014|Phase 2|Progressive Disease|1|||
144277546|NCT03314935|520216527|FG000|Phase 2|Study Terminated by Sponsor|0|||
144277547|NCT03314935|520216528|FG001|Phase 2|Study Terminated by Sponsor|0|||
144277548|NCT03314935|520216529|FG002|Phase 2|Study Terminated by Sponsor|0|||
144277549|NCT03314935|520216530|FG003|Phase 2|Study Terminated by Sponsor|0|||
144277550|NCT03314935|520216531|FG004|Phase 2|Study Terminated by Sponsor|0|||
144277551|NCT03314935|520216532|FG005|Phase 2|Study Terminated by Sponsor|0|||
144277552|NCT03314935|520216533|FG006|Phase 2|Study Terminated by Sponsor|0|||
144277553|NCT03314935|520216534|FG007|Phase 2|Study Terminated by Sponsor|0|||
144277554|NCT03314935|520216535|FG008|Phase 2|Study Terminated by Sponsor|0|||
144277555|NCT03314935|520216536|FG009|Phase 2|Study Terminated by Sponsor|0|||
144277556|NCT03314935|520216537|FG010|Phase 2|Study Terminated by Sponsor|7|||
144277557|NCT03314935|520216538|FG011|Phase 2|Study Terminated by Sponsor|2|||
144277558|NCT03314935|520216539|FG012|Phase 2|Study Terminated by Sponsor|1|||
144277559|NCT03314935|520216540|FG013|Phase 2|Study Terminated by Sponsor|4|||
144277560|NCT03314935|520216541|FG014|Phase 2|Study Terminated by Sponsor|4|||
144277561|NCT03314935|520216527|FG000|Phase 2|Lost to Follow-up|0|||
144277562|NCT03314935|520216528|FG001|Phase 2|Lost to Follow-up|0|||
144277563|NCT03314935|520216529|FG002|Phase 2|Lost to Follow-up|0|||
144277564|NCT03314935|520216530|FG003|Phase 2|Lost to Follow-up|0|||
144277565|NCT03314935|520216531|FG004|Phase 2|Lost to Follow-up|0|||
144277566|NCT03314935|520216532|FG005|Phase 2|Lost to Follow-up|0|||
144277567|NCT03314935|520216533|FG006|Phase 2|Lost to Follow-up|0|||
144277568|NCT03314935|520216534|FG007|Phase 2|Lost to Follow-up|0|||
144277569|NCT03314935|520216535|FG008|Phase 2|Lost to Follow-up|0|||
144277570|NCT03314935|520216536|FG009|Phase 2|Lost to Follow-up|1|||
144277571|NCT03314935|520216537|FG010|Phase 2|Lost to Follow-up|0|||
144277572|NCT03314935|520216538|FG011|Phase 2|Lost to Follow-up|0|||
144277573|NCT03314935|520216539|FG012|Phase 2|Lost to Follow-up|0|||
144277574|NCT03314935|520216540|FG013|Phase 2|Lost to Follow-up|0|||
144277575|NCT03314935|520216541|FG014|Phase 2|Lost to Follow-up|1|||
144277576|NCT03314935|520216527|FG000|Phase 2|Physician Decision|0|||
144277577|NCT03314935|520216528|FG001|Phase 2|Physician Decision|0|||
144277578|NCT03314935|520216529|FG002|Phase 2|Physician Decision|0|||
144277579|NCT03314935|520216530|FG003|Phase 2|Physician Decision|0|||
144277580|NCT03314935|520216531|FG004|Phase 2|Physician Decision|0|||
144277581|NCT03314935|520216532|FG005|Phase 2|Physician Decision|0|||
144277582|NCT03314935|520216533|FG006|Phase 2|Physician Decision|0|||
144277583|NCT03314935|520216534|FG007|Phase 2|Physician Decision|0|||
144277584|NCT03314935|520216535|FG008|Phase 2|Physician Decision|0|||
144277585|NCT03314935|520216536|FG009|Phase 2|Physician Decision|0|||
144277586|NCT03314935|520216537|FG010|Phase 2|Physician Decision|1|||
144277587|NCT03314935|520216538|FG011|Phase 2|Physician Decision|0|||
144277588|NCT03314935|520216539|FG012|Phase 2|Physician Decision|0|||
144277589|NCT03314935|520216540|FG013|Phase 2|Physician Decision|0|||
144277590|NCT03314935|520216541|FG014|Phase 2|Physician Decision|0|||
144277591|NCT05845619|520216542|FG000|Overall Study|duplicate enrollment|2|||
144277592|NCT05845619|520216543|FG001|Overall Study|duplicate enrollment|2|||
144277593|NCT05845619|520216544|FG002|Overall Study|duplicate enrollment|1|||
144277594|NCT03636477|520216545|FG000|Overall Study|Adverse Event|0|||
144277595|NCT03636477|520216546|FG001|Overall Study|Adverse Event|0|||
144277596|NCT03636477|520216547|FG002|Overall Study|Adverse Event|1|||
144277597|NCT04279522|520216548|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
144277598|NCT04279522|520216549|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
144277599|NCT04279522|520216548|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
144277600|NCT04279522|520216549|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
144277601|NCT04279522|520216548|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
144277602|NCT04279522|520216549|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
144277603|NCT04279522|520216548|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
144277604|NCT04279522|520216549|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
144277605|NCT04279522|520216548|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
144277606|NCT04279522|520216549|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
144277607|NCT04279522|520216548|FG000|Period 2: Open Label Phase|Physician Decision|0|||
144277608|NCT04279522|520216549|FG001|Period 2: Open Label Phase|Physician Decision|3|||
144277609|NCT04279522|520216548|FG000|Period 2: Open Label Phase|Adverse Event|0|||
144277610|NCT04279522|520216549|FG001|Period 2: Open Label Phase|Adverse Event|1|||
144277611|NCT04279522|520216548|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
144277612|NCT04279522|520216549|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
144277613|NCT02629159|520216552|FG000|Overall Study|Adverse Event|17|||
144277614|NCT02629159|520216553|FG001|Overall Study|Adverse Event|20|||
144277615|NCT02629159|520216554|FG002|Overall Study|Adverse Event|22|||
144277616|NCT02629159|520216552|FG000|Overall Study|Withdrawal by Subject|22|||
144277617|NCT02629159|520216553|FG001|Overall Study|Withdrawal by Subject|11|||
144277618|NCT02629159|520216554|FG002|Overall Study|Withdrawal by Subject|15|||
144277619|NCT02629159|520216552|FG000|Overall Study|Lost to Follow-up|7|||
144277620|NCT02629159|520216553|FG001|Overall Study|Lost to Follow-up|4|||
144277621|NCT02629159|520216554|FG002|Overall Study|Lost to Follow-up|5|||
144277622|NCT02629159|520216552|FG000|Overall Study|Lack of Efficacy|4|||
144277623|NCT02629159|520216553|FG001|Overall Study|Lack of Efficacy|0|||
144277624|NCT02629159|520216554|FG002|Overall Study|Lack of Efficacy|1|||
144277625|NCT02629159|520216552|FG000|Overall Study|Other|6|||
144277626|NCT02629159|520216553|FG001|Overall Study|Other|4|||
144277627|NCT02629159|520216554|FG002|Overall Study|Other|8|||
144277628|NCT05352399|520216562|FG000|Overall Study|Discontinued intervention|6|||
144277629|NCT05523297|520216563|FG000|Overall Study|Death|7|||
144277630|NCT05523297|520216564|FG001|Overall Study|Death|8|||
144277631|NCT05523297|520216563|FG000|Overall Study|Lost to Follow-up|2|||
144277632|NCT05523297|520216564|FG001|Overall Study|Lost to Follow-up|1|||
144277633|NCT01811238|520216570|FG000|Overall Study|Withdrawal by Subject|42|||
144277634|NCT01811238|520216570|FG000|Overall Study|Adverse Event|25|||
144277635|NCT01811238|520216570|FG000|Overall Study|Protocol Violation|4|||
144277636|NCT01811238|520216570|FG000|Overall Study|Lack of Efficacy|4|||
144277637|NCT01811238|520216570|FG000|Overall Study|subject refused study medication|6|||
144277638|NCT02916927|520216574|FG000|Overall Study|Discharged prior to study drug receipt|0|||
144277639|NCT02916927|520216575|FG001|Overall Study|Discharged prior to study drug receipt|2|||
144277640|NCT02916927|520216574|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
144277641|NCT02916927|520216575|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
144277642|NCT02916927|520216574|FG000|Overall Study|Withdrawal before first time point|1|||
144277643|NCT02916927|520216575|FG001|Overall Study|Withdrawal before first time point|0|||
144277644|NCT00141817|520216576|FG000|Overall Study|Protocol Violation|0|||
144277645|NCT00141817|520216577|FG001|Overall Study|Protocol Violation|0|||
144277646|NCT00141817|520216578|FG002|Overall Study|Protocol Violation|1|||
144277647|NCT00141817|520216579|FG003|Overall Study|Protocol Violation|0|||
144277648|NCT00141817|520216576|FG000|Overall Study|Parent request|1|||
144277649|NCT00141817|520216577|FG001|Overall Study|Parent request|0|||
144277650|NCT00141817|520216578|FG002|Overall Study|Parent request|0|||
144277651|NCT00141817|520216579|FG003|Overall Study|Parent request|0|||
144277652|NCT01349595|520216589|FG000|Overall Study|Lack of funding|2|||
144277653|NCT01349595|520216590|FG001|Overall Study|Lack of funding|2|||
144297096|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
144297097|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
144297098|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
144297099|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
144297100|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
144297101|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
144297102|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
144297103|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
144297104|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
144297105|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
144297106|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
144297107|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
144297108|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
144297109|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
144297110|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
144297111|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
144297112|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
144297113|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
144297114|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
144297115|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
144297116|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
144297117|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
144297118|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
144297119|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
144297120|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
144297121|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
144297122|NCT03093415|520292448|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
144297123|NCT03093415|520292449|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
144297124|NCT03093415|520292450|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
144297125|NCT03093415|520292448|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
144297126|NCT03093415|520292449|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
144297127|NCT03093415|520292450|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
144297128|NCT03559530|520292451|FG000|Overall Study|non-location of medical records|44|||
144297129|NCT03559530|520292452|FG001|Overall Study|non-location of medical records|0|||
144297130|NCT03559530|520292451|FG000|Overall Study|culture results not considered for treat|29|||
144297131|NCT03559530|520292452|FG001|Overall Study|culture results not considered for treat|0|||
144297132|NCT03559530|520292451|FG000|Overall Study|duplicate cases|8|||
144297133|NCT03559530|520292452|FG001|Overall Study|duplicate cases|0|||
144297134|NCT03559530|520292451|FG000|Overall Study|other species of Acinetobacte|7|||
144297135|NCT03559530|520292452|FG001|Overall Study|other species of Acinetobacte|0|||
144297136|NCT03559530|520292451|FG000|Overall Study|contamination / colonization|3|||
144277654|NCT00549055|520218438|FG000|Overall Study|Adverse Event|4|||
144277655|NCT00549055|520218438|FG000|Overall Study|Lack of Efficacy|18|||
144277656|NCT00549055|520218438|FG000|Overall Study|Stabilization|5|||
144277657|NCT00549055|520218438|FG000|Overall Study|Progression to fibrosis|2|||
144277658|NCT00549055|520218438|FG000|Overall Study|Decrease of size|1|||
144277659|NCT00549055|520218438|FG000|Overall Study|Active choroidal neovascula increased|1|||
144277660|NCT00549055|520218438|FG000|Overall Study|Vitreous hemorrhage|1|||
144277661|NCT00549055|520218438|FG000|Overall Study|Growth choroidal neovascularisation|1|||
144277662|NCT00549055|520218438|FG000|Overall Study|Choroidal neovascularization|1|||
144277663|NCT00549055|520218438|FG000|Overall Study|Very low visual acuity (VA)|1|||
144277664|NCT01126424|520218443|FG000|Overall Study|Adverse Event|0|||
144277665|NCT01126424|520218444|FG001|Overall Study|Adverse Event|0|||
144277666|NCT01126424|520218445|FG002|Overall Study|Adverse Event|0|||
144277667|NCT01126424|520218446|FG003|Overall Study|Adverse Event|0|||
144277668|NCT01126424|520218447|FG004|Overall Study|Adverse Event|1|||
144277669|NCT01126424|520218448|FG005|Overall Study|Adverse Event|0|||
144277670|NCT01126424|520218443|FG000|Overall Study|Withdrawal by Subject|0|||
144277671|NCT01126424|520218444|FG001|Overall Study|Withdrawal by Subject|0|||
144277672|NCT01126424|520218445|FG002|Overall Study|Withdrawal by Subject|1|||
144277673|NCT01126424|520218446|FG003|Overall Study|Withdrawal by Subject|3|||
144277674|NCT01126424|520218447|FG004|Overall Study|Withdrawal by Subject|1|||
144277675|NCT01126424|520218448|FG005|Overall Study|Withdrawal by Subject|0|||
144277676|NCT02127671|520218449|FG000|Overall Study|Death|2|||
144277677|NCT02127671|520218450|FG001|Overall Study|Death|2|||
144277678|NCT02127671|520218449|FG000|Overall Study|Lost to Follow-up|4|||
144277679|NCT02127671|520218450|FG001|Overall Study|Lost to Follow-up|2|||
144277680|NCT02127671|520218449|FG000|Overall Study|Physician Decision|1|||
144277681|NCT02127671|520218450|FG001|Overall Study|Physician Decision|0|||
144277682|NCT02127671|520218449|FG000|Overall Study|incarceration|0|||
144277683|NCT02127671|520218450|FG001|Overall Study|incarceration|1|||
144277684|NCT02127671|520218449|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
144277685|NCT02127671|520218450|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
144277686|NCT00764517|520218454|FG000|Overall Study|Adverse Event|9|||
144277687|NCT00764517|520218455|FG001|Overall Study|Adverse Event|3|||
144277688|NCT00764517|520218454|FG000|Overall Study|Death|3|||
144277689|NCT00764517|520218455|FG001|Overall Study|Death|11|||
144277690|NCT00764517|520218454|FG000|Overall Study|Physician Decision|3|||
144277691|NCT00764517|520218455|FG001|Overall Study|Physician Decision|0|||
144277692|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
144277693|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
144277694|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
144277695|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
144277696|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
144277697|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
144277698|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
144277699|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
144277700|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
144277701|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
144277702|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
144277703|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
144277704|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
144277705|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
144277706|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
144277707|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
144277708|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
144277709|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
144277710|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
144277711|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
144277712|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
144277713|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
144277714|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
144277715|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
144277716|NCT00620542|520218462|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
144277717|NCT00620542|520218463|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
144277718|NCT00620542|520218464|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
144277719|NCT00620542|520218465|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
144277720|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
144277721|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
144277722|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
144277723|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
144277724|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
144277725|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
144277726|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
144277727|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
144277728|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
144277729|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
144277730|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
144277731|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
144277732|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
144277733|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
144277734|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
144277735|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
144277736|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
144277737|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
144277738|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
144277739|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
144277740|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
144277741|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
144277742|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
144277743|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
144277744|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
144277745|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
144277746|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
144277747|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
144277748|NCT00620542|520218462|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
144277749|NCT00620542|520218463|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
144277750|NCT00620542|520218464|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
144243245|NCT04713592|520088218|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
144243246|NCT04713592|520088219|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
144243247|NCT01190267|520088222|FG000|Overall Study|Adverse Event|10|||
144243248|NCT01190267|520088223|FG001|Overall Study|Adverse Event|0|||
144243249|NCT01190267|520088222|FG000|Overall Study|Treatment Failure|8|||
144243250|NCT01190267|520088223|FG001|Overall Study|Treatment Failure|2|||
144243251|NCT01190267|520088222|FG000|Overall Study|Lost to Follow-up|2|||
144243252|NCT01190267|520088223|FG001|Overall Study|Lost to Follow-up|0|||
144243253|NCT01190267|520088222|FG000|Overall Study|Withdrawal by Subject|13|||
144243254|NCT01190267|520088223|FG001|Overall Study|Withdrawal by Subject|1|||
144243255|NCT01190267|520088222|FG000|Overall Study|Protocol Violation|8|||
144243256|NCT01190267|520088223|FG001|Overall Study|Protocol Violation|1|||
144243257|NCT01382225|520088226|FG000|Overall Study|Adverse Event|3|||
144243258|NCT01382225|520088227|FG001|Overall Study|Adverse Event|2|||
144243259|NCT01382225|520088226|FG000|Overall Study|Protocol Violation|2|||
144243260|NCT01382225|520088227|FG001|Overall Study|Protocol Violation|1|||
144243261|NCT01382225|520088226|FG000|Overall Study|Subject Withdrew Consent|5|||
144243262|NCT01382225|520088227|FG001|Overall Study|Subject Withdrew Consent|2|||
144243263|NCT01382225|520088226|FG000|Overall Study|Other|4|||
144243264|NCT01382225|520088227|FG001|Overall Study|Other|2|||
144243265|NCT04972968|520088231|FG000|Overall Study|Adverse Event|3|||
144243266|NCT04972968|520088232|FG001|Overall Study|Adverse Event|1|||
144243267|NCT04972968|520088233|FG002|Overall Study|Adverse Event|1|||
144243268|NCT04972968|520088234|FG003|Overall Study|Adverse Event|7|||
144243269|NCT04972968|520088231|FG000|Overall Study|Lack of Efficacy|2|||
144243270|NCT04972968|520088232|FG001|Overall Study|Lack of Efficacy|1|||
144243271|NCT04972968|520088233|FG002|Overall Study|Lack of Efficacy|0|||
144243272|NCT04972968|520088234|FG003|Overall Study|Lack of Efficacy|0|||
144243273|NCT04972968|520088231|FG000|Overall Study|Withdrawal by Subject|7|||
144243274|NCT04972968|520088232|FG001|Overall Study|Withdrawal by Subject|4|||
144243275|NCT04972968|520088233|FG002|Overall Study|Withdrawal by Subject|3|||
144243276|NCT04972968|520088234|FG003|Overall Study|Withdrawal by Subject|2|||
144243277|NCT04972968|520088231|FG000|Overall Study|Study Terminated by Sponsor|25|||
144243278|NCT04972968|520088232|FG001|Overall Study|Study Terminated by Sponsor|28|||
144243279|NCT04972968|520088233|FG002|Overall Study|Study Terminated by Sponsor|32|||
144243280|NCT04972968|520088234|FG003|Overall Study|Study Terminated by Sponsor|27|||
144243281|NCT04972968|520088231|FG000|Overall Study|Other|1|||
144243282|NCT04972968|520088232|FG001|Overall Study|Other|0|||
144243283|NCT04972968|520088233|FG002|Overall Study|Other|1|||
144243284|NCT04972968|520088234|FG003|Overall Study|Other|1|||
144243285|NCT03649178|520088235|FG000|Overall Study|Adverse Event|1|||
144243286|NCT03649178|520088236|FG001|Overall Study|Adverse Event|2|||
144243287|NCT03649178|520088235|FG000|Overall Study|Withdrawal by Subject|0|||
144243288|NCT03649178|520088236|FG001|Overall Study|Withdrawal by Subject|2|||
144243289|NCT03649178|520088235|FG000|Overall Study|COVID regulation required halt in protocol|1|||
144243290|NCT03649178|520088236|FG001|Overall Study|COVID regulation required halt in protocol|0|||
144243291|NCT03003494|520088237|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
144243292|NCT03814720|520088243|FG000|Overall Study|Lost to Follow-up|0|||
144243293|NCT03814720|520088244|FG001|Overall Study|Lost to Follow-up|1|||
144243294|NCT03814720|520088245|FG002|Overall Study|Lost to Follow-up|0|||
144243295|NCT03814720|520088246|FG003|Overall Study|Lost to Follow-up|0|||
144243296|NCT03814720|520088247|FG004|Overall Study|Lost to Follow-up|0|||
144243297|NCT02135107|520088248|FG000|Treatment Period|Withdrawal by Subject|11|||
144243298|NCT02135107|520088249|FG001|Treatment Period|Withdrawal by Subject|0|||
144243299|NCT02135107|520088250|FG002|Treatment Period|Withdrawal by Subject|0|||
144243300|NCT02135107|520088251|FG003|Treatment Period|Withdrawal by Subject|0|||
144243301|NCT02135107|520088248|FG000|Treatment Period|Adverse Event|5|||
144243302|NCT02135107|520088249|FG001|Treatment Period|Adverse Event|2|||
144243303|NCT02135107|520088250|FG002|Treatment Period|Adverse Event|0|||
144243304|NCT02135107|520088251|FG003|Treatment Period|Adverse Event|0|||
144243305|NCT02135107|520088248|FG000|Treatment Period|Pregnancy|1|||
144243306|NCT02135107|520088249|FG001|Treatment Period|Pregnancy|0|||
144243307|NCT02135107|520088250|FG002|Treatment Period|Pregnancy|0|||
144243308|NCT02135107|520088251|FG003|Treatment Period|Pregnancy|0|||
144243309|NCT02135107|520088248|FG000|Treatment Period|Other|115|||
144243310|NCT02135107|520088249|FG001|Treatment Period|Other|24|||
144243311|NCT02135107|520088250|FG002|Treatment Period|Other|0|||
144243312|NCT02135107|520088251|FG003|Treatment Period|Other|0|||
144243313|NCT02135107|520088248|FG000|Maintenance Therapy Period|Adverse Event|0|||
144243314|NCT02135107|520088249|FG001|Maintenance Therapy Period|Adverse Event|0|||
144243315|NCT02135107|520088250|FG002|Maintenance Therapy Period|Adverse Event|3|||
144243316|NCT02135107|520088251|FG003|Maintenance Therapy Period|Adverse Event|7|||
144243317|NCT02135107|520088248|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
144243318|NCT02135107|520088249|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
144243319|NCT02135107|520088250|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
144243320|NCT02135107|520088251|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
144243321|NCT02135107|520088248|FG000|Maintenance Therapy Period|Pregnancy|0|||
144243322|NCT02135107|520088249|FG001|Maintenance Therapy Period|Pregnancy|0|||
144243323|NCT02135107|520088250|FG002|Maintenance Therapy Period|Pregnancy|0|||
144243324|NCT02135107|520088251|FG003|Maintenance Therapy Period|Pregnancy|1|||
144243325|NCT02135107|520088248|FG000|Maintenance Therapy Period|Other|0|||
144243326|NCT02135107|520088249|FG001|Maintenance Therapy Period|Other|0|||
144243327|NCT02135107|520088250|FG002|Maintenance Therapy Period|Other|7|||
144243328|NCT02135107|520088251|FG003|Maintenance Therapy Period|Other|8|||
144243329|NCT02278120|520088259|FG000|Treatment Period|Progressive disease|234|||
144243330|NCT02278120|520088260|FG001|Treatment Period|Progressive disease|260|||
144243331|NCT02278120|520088259|FG000|Treatment Period|Subject/guardian decision|23|||
144243332|NCT02278120|520088260|FG001|Treatment Period|Subject/guardian decision|20|||
144243333|NCT02278120|520088259|FG000|Treatment Period|Adverse Event|16|||
144243334|NCT02278120|520088260|FG001|Treatment Period|Adverse Event|14|||
144243335|NCT02278120|520088259|FG000|Treatment Period|Physician Decision|14|||
144243336|NCT02278120|520088260|FG001|Treatment Period|Physician Decision|27|||
144243337|NCT02278120|520088259|FG000|Treatment Period|Death|3|||
144243338|NCT02278120|520088260|FG001|Treatment Period|Death|3|||
144243339|NCT02278120|520088259|FG000|Treatment Period|Lost to Follow-up|2|||
144243340|NCT02278120|520088260|FG001|Treatment Period|Lost to Follow-up|0|||
144243341|NCT02278120|520088259|FG000|Treatment Period|Protocol deviation|0|||
144243342|NCT02278120|520088260|FG001|Treatment Period|Protocol deviation|2|||
144243343|NCT02278120|520088259|FG000|Treatment Period|Study terminated as per protocol|43|||
144243344|NCT02278120|520088260|FG001|Treatment Period|Study terminated as per protocol|11|||
144243345|NCT02278120|520088259|FG000|Post-treatment Efficacy Follow-up|Death|0|||
144243346|NCT02278120|520088260|FG001|Post-treatment Efficacy Follow-up|Death|1|||
144243347|NCT02278120|520088259|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
144243348|NCT02278120|520088260|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
144243349|NCT02278120|520088259|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
144243350|NCT02278120|520088260|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
144243351|NCT02278120|520088259|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
144243352|NCT02278120|520088260|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
144243353|NCT02278120|520088259|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144243354|NCT02278120|520088260|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144243355|NCT00102531|520088261|FG000|Overall Study|Adverse Event|0|||
144243356|NCT00102531|520088262|FG001|Overall Study|Adverse Event|1|||
144243357|NCT00102531|520088261|FG000|Overall Study|Disease Progression|5|||
144243358|NCT00102531|520088262|FG001|Overall Study|Disease Progression|9|||
144243359|NCT00102531|520088261|FG000|Overall Study|Physician Decision|0|||
144243360|NCT00102531|520088262|FG001|Overall Study|Physician Decision|1|||
144243361|NCT01077739|520088264|FG000|Overall Study|Premature withdrawal|1|||
144243362|NCT01077739|520088265|FG001|Overall Study|Premature withdrawal|3|||
144243363|NCT01077739|520088264|FG000|Overall Study|Withdrawal by Subject|1|||
144243364|NCT01077739|520088265|FG001|Overall Study|Withdrawal by Subject|0|||
144243365|NCT01077739|520088264|FG000|Overall Study|Death|0|||
144243366|NCT01077739|520088265|FG001|Overall Study|Death|3|||
144243367|NCT01077739|520088264|FG000|Overall Study|Unacceptable toxicity|1|||
144243368|NCT01077739|520088265|FG001|Overall Study|Unacceptable toxicity|2|||
144243369|NCT01077739|520088264|FG000|Overall Study|Other|2|||
144243370|NCT01077739|520088265|FG001|Overall Study|Other|2|||
144243371|NCT00877071|520088266|FG000|Overall Study|disease progression|2|||
144243372|NCT05723328|520088267|FG000|Overall Study|Investigator's Decision|5|||
144243373|NCT05723328|520088268|FG001|Overall Study|Investigator's Decision|2|||
144243374|NCT00954512|520088270|FG000|Overall Study|Withdrawal by Subject|0|||
144243375|NCT00954512|520088271|FG001|Overall Study|Withdrawal by Subject|0|||
144243376|NCT00954512|520088272|FG002|Overall Study|Withdrawal by Subject|0|||
144243377|NCT00954512|520088273|FG003|Overall Study|Withdrawal by Subject|0|||
144243378|NCT00954512|520088274|FG004|Overall Study|Withdrawal by Subject|0|||
144243379|NCT00954512|520088275|FG005|Overall Study|Withdrawal by Subject|1|||
144243380|NCT00954512|520088270|FG000|Overall Study|Adverse Event|0|||
144243381|NCT00954512|520088271|FG001|Overall Study|Adverse Event|0|||
144243382|NCT00954512|520088272|FG002|Overall Study|Adverse Event|0|||
144243383|NCT00954512|520088273|FG003|Overall Study|Adverse Event|0|||
144243384|NCT00954512|520088274|FG004|Overall Study|Adverse Event|1|||
144243385|NCT00954512|520088275|FG005|Overall Study|Adverse Event|2|||
144243386|NCT00954512|520088270|FG000|Overall Study|Physician Decision|0|||
144243387|NCT00954512|520088271|FG001|Overall Study|Physician Decision|1|||
144243388|NCT00954512|520088272|FG002|Overall Study|Physician Decision|0|||
144243389|NCT00954512|520088273|FG003|Overall Study|Physician Decision|1|||
144243390|NCT00954512|520088274|FG004|Overall Study|Physician Decision|0|||
144243391|NCT00954512|520088275|FG005|Overall Study|Physician Decision|0|||
144243392|NCT00954512|520088270|FG000|Overall Study|Symptomatic Deterioration|0|||
144243393|NCT00954512|520088271|FG001|Overall Study|Symptomatic Deterioration|1|||
144243394|NCT00954512|520088272|FG002|Overall Study|Symptomatic Deterioration|0|||
144243395|NCT00954512|520088273|FG003|Overall Study|Symptomatic Deterioration|0|||
144243396|NCT00954512|520088274|FG004|Overall Study|Symptomatic Deterioration|2|||
144243397|NCT00954512|520088275|FG005|Overall Study|Symptomatic Deterioration|0|||
144243398|NCT00954512|520088270|FG000|Overall Study|Progression of Disease|2|||
144243399|NCT00954512|520088271|FG001|Overall Study|Progression of Disease|1|||
144243400|NCT00954512|520088272|FG002|Overall Study|Progression of Disease|0|||
144243401|NCT00954512|520088273|FG003|Overall Study|Progression of Disease|1|||
144243402|NCT00954512|520088274|FG004|Overall Study|Progression of Disease|1|||
144243403|NCT00954512|520088275|FG005|Overall Study|Progression of Disease|1|||
144243404|NCT03495154|520088276|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
144243405|NCT03495154|520088276|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
144243406|NCT03495154|520088276|FG000|Overall Study|Screen Failures During Surgery|6|||
144243407|NCT03495154|520088276|FG000|Overall Study|Death|2|||
144243408|NCT03495154|520088276|FG000|Overall Study|Lost to Follow-up|16|||
144243409|NCT03495154|520088276|FG000|Overall Study|Withdrawal by Subject|2|||
144243410|NCT03495154|520088276|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
144243411|NCT05685732|520088277|FG000|Overall Study|Withdrawal by Subject|2|||
144243412|NCT05685732|520088278|FG001|Overall Study|Withdrawal by Subject|0|||
144243413|NCT05685732|520088279|FG002|Overall Study|Withdrawal by Subject|2|||
144243414|NCT05685732|520088280|FG003|Overall Study|Withdrawal by Subject|3|||
144243415|NCT05685732|520088277|FG000|Overall Study|Protocol Violation|1|||
144243416|NCT05685732|520088278|FG001|Overall Study|Protocol Violation|2|||
144243417|NCT05685732|520088279|FG002|Overall Study|Protocol Violation|4|||
144243418|NCT05685732|520088280|FG003|Overall Study|Protocol Violation|1|||
144243419|NCT05685732|520088277|FG000|Overall Study|Lost to Follow-up|5|||
144243420|NCT05685732|520088278|FG001|Overall Study|Lost to Follow-up|1|||
144243421|NCT05685732|520088279|FG002|Overall Study|Lost to Follow-up|3|||
144243422|NCT05685732|520088280|FG003|Overall Study|Lost to Follow-up|1|||
144243423|NCT05685732|520088277|FG000|Overall Study|Adverse Event|2|||
144243424|NCT05685732|520088278|FG001|Overall Study|Adverse Event|1|||
144243425|NCT05685732|520088279|FG002|Overall Study|Adverse Event|0|||
144243426|NCT05685732|520088280|FG003|Overall Study|Adverse Event|0|||
144243427|NCT05685732|520088277|FG000|Overall Study|Physician Decision|1|||
144243428|NCT05685732|520088278|FG001|Overall Study|Physician Decision|0|||
144243429|NCT05685732|520088279|FG002|Overall Study|Physician Decision|0|||
144243430|NCT05685732|520088280|FG003|Overall Study|Physician Decision|0|||
144243431|NCT02640404|520088281|FG000|Overall Study|Protocol Violation|1|||
144243432|NCT02640404|520088282|FG001|Overall Study|Protocol Violation|0|||
144243433|NCT02640404|520088281|FG000|Overall Study|Withdrawal by Subject|1|||
144243434|NCT02640404|520088282|FG001|Overall Study|Withdrawal by Subject|0|||
144243435|NCT04908202|520088284|FG000|Pre-Treatment Period|OTHER REASONS|3|||
144243436|NCT04908202|520088285|FG001|Pre-Treatment Period|OTHER REASONS|1|||
144243437|NCT04908202|520088286|FG002|Pre-Treatment Period|OTHER REASONS|0|||
144277751|NCT00620542|520218465|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
144243438|NCT04908202|520088287|FG003|Pre-Treatment Period|OTHER REASONS|0|||
144243439|NCT04908202|520088284|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
144243440|NCT04908202|520088285|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144243441|NCT04908202|520088286|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144277752|NCT01970371|520218466|FG000|Overall Study|Death|8|||
144277753|NCT01970371|520218467|FG001|Overall Study|Death|13|||
144277754|NCT01970371|520218468|FG002|Overall Study|Death|12|||
144277755|NCT01970371|520218466|FG000|Overall Study|Lost to Follow-up|0|||
144277756|NCT01970371|520218467|FG001|Overall Study|Lost to Follow-up|0|||
144277757|NCT01970371|520218468|FG002|Overall Study|Lost to Follow-up|1|||
144277758|NCT01481779|520218469|FG000|Overall Study|Adverse Event|23|||
144277759|NCT01481779|520218470|FG001|Overall Study|Adverse Event|5|||
144277760|NCT01481779|520218469|FG000|Overall Study|Lost to Follow-up|3|||
144243442|NCT04908202|520088287|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144243443|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
144243444|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
144243445|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
144243446|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
144243447|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
144243448|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
144243449|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
144243450|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
144243451|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
144243452|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
144243453|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
144243454|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
144243455|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
144243456|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
144243457|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144243458|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144243459|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
144243460|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
144243461|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
144243462|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
144243463|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
144243464|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
144243465|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
144243466|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
144243467|NCT04908202|520088284|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
144243468|NCT04908202|520088285|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
144243469|NCT04908202|520088286|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
144243470|NCT04908202|520088287|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
144243471|NCT04908202|520088284|FG000|Active Treatment Period|OTHER REASONS|0|||
144243472|NCT04908202|520088285|FG001|Active Treatment Period|OTHER REASONS|0|||
144243473|NCT04908202|520088286|FG002|Active Treatment Period|OTHER REASONS|1|||
144243474|NCT04908202|520088287|FG003|Active Treatment Period|OTHER REASONS|3|||
144243475|NCT04908202|520088284|FG000|Active Treatment Period|Lack of Efficacy|0|||
144243476|NCT04908202|520088285|FG001|Active Treatment Period|Lack of Efficacy|0|||
144243477|NCT04908202|520088286|FG002|Active Treatment Period|Lack of Efficacy|4|||
144243478|NCT04908202|520088287|FG003|Active Treatment Period|Lack of Efficacy|5|||
144243479|NCT04908202|520088284|FG000|Active Treatment Period|Adverse Event|0|||
144243480|NCT04908202|520088285|FG001|Active Treatment Period|Adverse Event|0|||
144243481|NCT04908202|520088286|FG002|Active Treatment Period|Adverse Event|5|||
144243482|NCT04908202|520088287|FG003|Active Treatment Period|Adverse Event|8|||
144243483|NCT04908202|520088284|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
144243484|NCT04908202|520088285|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
144243485|NCT04908202|520088286|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
144243486|NCT04908202|520088287|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
144243487|NCT04908202|520088284|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144243488|NCT04908202|520088285|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
144243489|NCT04908202|520088286|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
144243490|NCT04908202|520088287|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
144243491|NCT04908202|520088284|FG000|Active Treatment Period|Lost to Follow-up|0|||
144243492|NCT04908202|520088285|FG001|Active Treatment Period|Lost to Follow-up|0|||
144243493|NCT04908202|520088286|FG002|Active Treatment Period|Lost to Follow-up|2|||
144243494|NCT04908202|520088287|FG003|Active Treatment Period|Lost to Follow-up|2|||
144243495|NCT04908202|520088284|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
144243496|NCT04908202|520088285|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
144243497|NCT04908202|520088286|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
144243498|NCT04908202|520088287|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
144243499|NCT04908202|520088284|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
144243500|NCT04908202|520088285|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
144277761|NCT01481779|520218470|FG001|Overall Study|Lost to Follow-up|2|||
144277762|NCT01481779|520218469|FG000|Overall Study|Protocol Violation|2|||
144277763|NCT01481779|520218470|FG001|Overall Study|Protocol Violation|3|||
144277764|NCT01481779|520218469|FG000|Overall Study|Withdrawal by Subject|26|||
144277765|NCT01481779|520218470|FG001|Overall Study|Withdrawal by Subject|13|||
144277766|NCT01481779|520218469|FG000|Overall Study|Physician Decision|13|||
144277767|NCT01481779|520218470|FG001|Overall Study|Physician Decision|4|||
144277768|NCT01481779|520218469|FG000|Overall Study|Sponsor Decision|3|||
144277769|NCT01481779|520218470|FG001|Overall Study|Sponsor Decision|1|||
144277770|NCT04115059|520218474|FG000|Overall Study|Withdrawal by Subject|1|||
144277771|NCT04115059|520218474|FG000|Overall Study|Lack of Efficacy|2|||
144277772|NCT03575364|520218482|FG000|Overall Study|Death|45|||
144277773|NCT03575364|520218482|FG000|Overall Study|Lost to Follow-up|114|||
144277774|NCT03575364|520218482|FG000|Overall Study|Withdrawal by Subject|21|||
144277775|NCT03575364|520218482|FG000|Overall Study|Physician Decision|11|||
144277776|NCT03575364|520218482|FG000|Overall Study|Subject Refused Follow-up|13|||
144277777|NCT03575364|520218482|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
144277778|NCT03575364|520218482|FG000|Overall Study|Patient moved out of the state|1|||
144277779|NCT03575364|520218482|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
144277780|NCT03575364|520218482|FG000|Overall Study|Patient is lost to follow up|1|||
144277781|NCT03575364|520218482|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
144277782|NCT05522751|520218483|FG000|Overall Study|Adverse Event|1|||
144277783|NCT06420232|520218484|FG000|Overall Study|Withdrawal by Subject|3|||
144277784|NCT01582451|520218490|FG000|Overall Study|Adverse Event|1|||
144277785|NCT01582451|520218491|FG001|Overall Study|Adverse Event|3|||
144277786|NCT01582451|520218490|FG000|Overall Study|Death|3|||
144277787|NCT01582451|520218491|FG001|Overall Study|Death|3|||
144277788|NCT01582451|520218490|FG000|Overall Study|Lost to Follow-up|0|||
144277789|NCT01582451|520218491|FG001|Overall Study|Lost to Follow-up|2|||
144277790|NCT01582451|520218490|FG000|Overall Study|Protocol Violation|11|||
144277791|NCT01582451|520218491|FG001|Overall Study|Protocol Violation|3|||
144277792|NCT01582451|520218490|FG000|Overall Study|Withdrawal by Subject|13|||
144277793|NCT01582451|520218491|FG001|Overall Study|Withdrawal by Subject|9|||
144277794|NCT01582451|520218490|FG000|Overall Study|Physician Decision|3|||
144277795|NCT01582451|520218491|FG001|Overall Study|Physician Decision|0|||
144277796|NCT01582451|520218490|FG000|Overall Study|Sponsor Decision|1|||
144277797|NCT01582451|520218491|FG001|Overall Study|Sponsor Decision|0|||
144277798|NCT01369433|520218494|FG000|Overall Study|Adverse Event|31|||
144277799|NCT01369433|520218495|FG001|Overall Study|Adverse Event|1|||
144277800|NCT01369433|520218494|FG000|Overall Study|Required significant surgical procedure|1|||
144277801|NCT01369433|520218495|FG001|Overall Study|Required significant surgical procedure|0|||
144277802|NCT01369433|520218494|FG000|Overall Study|Non-compliance|1|||
144277803|NCT01369433|520218495|FG001|Overall Study|Non-compliance|0|||
144277804|NCT01369433|520218494|FG000|Overall Study|Withdrawal by Subject|5|||
144277805|NCT01369433|520218495|FG001|Overall Study|Withdrawal by Subject|2|||
144277806|NCT01369433|520218494|FG000|Overall Study|Study terminated by Sponsor|67|||
144277807|NCT01369433|520218495|FG001|Overall Study|Study terminated by Sponsor|0|||
144277808|NCT01369433|520218494|FG000|Overall Study|Lost to Follow-up|1|||
144277809|NCT01369433|520218495|FG001|Overall Study|Lost to Follow-up|0|||
144277810|NCT01369433|520218494|FG000|Overall Study|Death|5|||
144277811|NCT01369433|520218495|FG001|Overall Study|Death|0|||
144277812|NCT01369433|520218494|FG000|Overall Study|Investigator discretion|6|||
144277813|NCT01369433|520218495|FG001|Overall Study|Investigator discretion|1|||
144277814|NCT01369433|520218494|FG000|Overall Study|Progressive Disease|92|||
144277815|NCT01369433|520218495|FG001|Overall Study|Progressive Disease|12|||
144277816|NCT00487188|520218496|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
144277817|NCT00487188|520218497|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
144277818|NCT00487188|520218498|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
144277819|NCT00487188|520218496|FG000|Induction Phase|Adverse Event|5|||
144277820|NCT00487188|520218497|FG001|Induction Phase|Adverse Event|0|||
144277821|NCT00487188|520218498|FG002|Induction Phase|Adverse Event|0|||
144277822|NCT00487188|520218496|FG000|Induction Phase|Lack of Efficacy|0|||
144277823|NCT00487188|520218497|FG001|Induction Phase|Lack of Efficacy|1|||
144277824|NCT00487188|520218498|FG002|Induction Phase|Lack of Efficacy|0|||
144277825|NCT00487188|520218496|FG000|Induction Phase|Protocol Violation|1|||
144277826|NCT00487188|520218497|FG001|Induction Phase|Protocol Violation|0|||
144277827|NCT00487188|520218498|FG002|Induction Phase|Protocol Violation|0|||
144277828|NCT00487188|520218496|FG000|Induction Phase|Refused Treatment|1|||
144277829|NCT00487188|520218497|FG001|Induction Phase|Refused Treatment|2|||
144277830|NCT00487188|520218498|FG002|Induction Phase|Refused Treatment|0|||
144277831|NCT00487188|520218496|FG000|Induction Phase|Lost to Follow-up|2|||
144277832|NCT00487188|520218497|FG001|Induction Phase|Lost to Follow-up|2|||
144277833|NCT00487188|520218498|FG002|Induction Phase|Lost to Follow-up|0|||
144277834|NCT00487188|520218496|FG000|Induction Phase|Administrative|0|||
144277835|NCT00487188|520218497|FG001|Induction Phase|Administrative|1|||
144277836|NCT00487188|520218498|FG002|Induction Phase|Administrative|0|||
144277837|NCT00487188|520218496|FG000|Maintenance Phase|Adverse Event|1|||
144243501|NCT04908202|520088286|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
144243502|NCT04908202|520088287|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
144243503|NCT04908202|520088284|FG000|Active Treatment Period|ONGOING Treatment|0|||
144243504|NCT04908202|520088285|FG001|Active Treatment Period|ONGOING Treatment|0|||
144243505|NCT04908202|520088286|FG002|Active Treatment Period|ONGOING Treatment|117|||
144243506|NCT04908202|520088287|FG003|Active Treatment Period|ONGOING Treatment|114|||
144243507|NCT05397171|520088288|FG000|Overall Study|Death|2|||
144243508|NCT05397171|520088289|FG001|Overall Study|Death|3|||
144243509|NCT05397171|520088290|FG002|Overall Study|Death|3|||
144243510|NCT05397171|520088288|FG000|Overall Study|Study Terminated By Sponsor|1|||
144243511|NCT05397171|520088289|FG001|Overall Study|Study Terminated By Sponsor|2|||
144243512|NCT05397171|520088290|FG002|Overall Study|Study Terminated By Sponsor|3|||
144243513|NCT05397171|520088288|FG000|Overall Study|Withdrawal by Subject|0|||
144243514|NCT05397171|520088289|FG001|Overall Study|Withdrawal by Subject|1|||
144243515|NCT05397171|520088290|FG002|Overall Study|Withdrawal by Subject|1|||
144243516|NCT02100670|520088291|FG000|Overall Study|Adverse Event|10|||
144243517|NCT02100670|520088292|FG001|Overall Study|Adverse Event|3|||
144243518|NCT02100670|520088293|FG002|Overall Study|Adverse Event|3|||
144243519|NCT02100670|520088294|FG003|Overall Study|Adverse Event|0|||
144243520|NCT02100670|520088291|FG000|Overall Study|Lost to Follow-up|1|||
144243521|NCT02100670|520088292|FG001|Overall Study|Lost to Follow-up|0|||
144243522|NCT02100670|520088293|FG002|Overall Study|Lost to Follow-up|0|||
144243523|NCT02100670|520088294|FG003|Overall Study|Lost to Follow-up|0|||
144243524|NCT02100670|520088291|FG000|Overall Study|Protocol Violation|0|||
144243525|NCT02100670|520088292|FG001|Overall Study|Protocol Violation|1|||
144243526|NCT02100670|520088293|FG002|Overall Study|Protocol Violation|0|||
144243527|NCT02100670|520088294|FG003|Overall Study|Protocol Violation|1|||
144243528|NCT02100670|520088291|FG000|Overall Study|Withdrawal of Consent|0|||
144243529|NCT02100670|520088292|FG001|Overall Study|Withdrawal of Consent|1|||
144243530|NCT02100670|520088293|FG002|Overall Study|Withdrawal of Consent|1|||
144243531|NCT02100670|520088294|FG003|Overall Study|Withdrawal of Consent|0|||
144243532|NCT02100670|520088291|FG000|Overall Study|No swelling no pain|1|||
144243533|NCT02100670|520088292|FG001|Overall Study|No swelling no pain|0|||
144243534|NCT02100670|520088293|FG002|Overall Study|No swelling no pain|0|||
144243535|NCT02100670|520088294|FG003|Overall Study|No swelling no pain|0|||
144243536|NCT02100670|520088291|FG000|Overall Study|Poor Efficacy|0|||
144243537|NCT02100670|520088292|FG001|Overall Study|Poor Efficacy|1|||
144243538|NCT02100670|520088293|FG002|Overall Study|Poor Efficacy|0|||
144243539|NCT02100670|520088294|FG003|Overall Study|Poor Efficacy|0|||
144243540|NCT02100670|520088291|FG000|Overall Study|Physician Decision|0|||
144243541|NCT02100670|520088292|FG001|Overall Study|Physician Decision|1|||
144243542|NCT02100670|520088293|FG002|Overall Study|Physician Decision|0|||
144243543|NCT02100670|520088294|FG003|Overall Study|Physician Decision|0|||
144243544|NCT02100670|520088291|FG000|Overall Study|Withdrawal by Subject|1|||
144243545|NCT02100670|520088292|FG001|Overall Study|Withdrawal by Subject|0|||
144243546|NCT02100670|520088293|FG002|Overall Study|Withdrawal by Subject|0|||
144243547|NCT02100670|520088294|FG003|Overall Study|Withdrawal by Subject|0|||
144243548|NCT05897827|520090252|FG000|Overall Study|Lost to Follow-up|33|||
144243549|NCT05897827|520090253|FG001|Overall Study|Lost to Follow-up|14|||
144243550|NCT05897827|520090252|FG000|Overall Study|Withdrawal by Subject|1|||
144243551|NCT05897827|520090253|FG001|Overall Study|Withdrawal by Subject|1|||
144243552|NCT01004406|520090254|FG000|Overall Study|Withdrawal by Subject|2|||
144243553|NCT01004406|520090255|FG001|Overall Study|Withdrawal by Subject|0|||
144243554|NCT01004406|520090254|FG000|Overall Study|Lost to Follow-up|1|||
144243555|NCT01004406|520090255|FG001|Overall Study|Lost to Follow-up|0|||
144277838|NCT00487188|520218497|FG001|Maintenance Phase|Adverse Event|0|||
144277839|NCT00487188|520218498|FG002|Maintenance Phase|Adverse Event|0|||
144277840|NCT00487188|520218496|FG000|Maintenance Phase|Death|1|||
144277841|NCT00487188|520218497|FG001|Maintenance Phase|Death|0|||
144277842|NCT00487188|520218498|FG002|Maintenance Phase|Death|0|||
144277843|NCT00487188|520218496|FG000|Maintenance Phase|Lost to Follow-up|1|||
144277844|NCT00487188|520218497|FG001|Maintenance Phase|Lost to Follow-up|0|||
144277845|NCT00487188|520218498|FG002|Maintenance Phase|Lost to Follow-up|0|||
144277846|NCT00487188|520218496|FG000|Maintenance Phase|Administrative|0|||
144277847|NCT00487188|520218497|FG001|Maintenance Phase|Administrative|0|||
144277848|NCT00487188|520218498|FG002|Maintenance Phase|Administrative|1|||
144277849|NCT01838876|520218499|FG000|Overall Study|Adverse Event|49|||
144277850|NCT01838876|520218499|FG000|Overall Study|Insufficient Therapeutic Response|10|||
144277851|NCT01838876|520218499|FG000|Overall Study|Protocol Violation|34|||
144277852|NCT01838876|520218499|FG000|Overall Study|Withdrawal of Consent|33|||
144277853|NCT01838876|520218499|FG000|Overall Study|Lost to Follow-up|21|||
144277854|NCT01838876|520218499|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
144277855|NCT01838876|520218499|FG000|Overall Study|Reason not Specified|7|||
144277856|NCT01838876|520218499|FG000|Overall Study|Did not meet eligibility criteria|78|||
144277857|NCT00689936|520218500|FG000|Active Treatment Phase|Adverse Event|68|||
144277858|NCT00689936|520218501|FG001|Active Treatment Phase|Adverse Event|71|||
144277859|NCT00689936|520218502|FG002|Active Treatment Phase|Adverse Event|76|||
144277860|NCT00689936|520218500|FG000|Active Treatment Phase|Disease Progression|273|||
144277861|NCT00689936|520218501|FG001|Active Treatment Phase|Disease Progression|362|||
144277862|NCT00689936|520218502|FG002|Active Treatment Phase|Disease Progression|339|||
144277863|NCT00689936|520218500|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
144277864|NCT00689936|520218501|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
144277865|NCT00689936|520218502|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
144277866|NCT00689936|520218500|FG000|Active Treatment Phase|Death|60|||
144277867|NCT00689936|520218501|FG001|Active Treatment Phase|Death|28|||
144277868|NCT00689936|520218502|FG002|Active Treatment Phase|Death|37|||
144277869|NCT00689936|520218500|FG000|Active Treatment Phase|Lost to Follow-up|0|||
144277870|NCT00689936|520218501|FG001|Active Treatment Phase|Lost to Follow-up|2|||
144277871|NCT00689936|520218502|FG002|Active Treatment Phase|Lost to Follow-up|2|||
144277872|NCT00689936|520218500|FG000|Active Treatment Phase|Protocol Violation|2|||
144277873|NCT00689936|520218501|FG001|Active Treatment Phase|Protocol Violation|2|||
144277874|NCT00689936|520218502|FG002|Active Treatment Phase|Protocol Violation|4|||
144277875|NCT00689936|520218500|FG000|Active Treatment Phase|Study Close Out|64|||
144277876|NCT00689936|520218501|FG001|Active Treatment Phase|Study Close Out|26|||
144277877|NCT00689936|520218502|FG002|Active Treatment Phase|Study Close Out|21|||
144277878|NCT00689936|520218500|FG000|Active Treatment Phase|Miscellaneous|52|||
144277879|NCT00689936|520218501|FG001|Active Treatment Phase|Miscellaneous|34|||
144277880|NCT00689936|520218502|FG002|Active Treatment Phase|Miscellaneous|47|||
144277881|NCT00689936|520218500|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
144277882|NCT00689936|520218501|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
144277883|NCT00689936|520218502|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
144277884|NCT01682031|520218503|FG000|Overall Study|Withdrawal by Subject|0|||
144277885|NCT01682031|520218504|FG001|Overall Study|Withdrawal by Subject|1|||
144277886|NCT01682031|520218503|FG000|Overall Study|Adverse Event|0|||
144277887|NCT01682031|520218504|FG001|Overall Study|Adverse Event|2|||
144277888|NCT01682031|520218503|FG000|Overall Study|MRI results indicate increased nodul|0|||
144277889|NCT01682031|520218504|FG001|Overall Study|MRI results indicate increased nodul|1|||
144277890|NCT01682031|520218503|FG000|Overall Study|Patient could not swallow tablets|1|||
144277891|NCT01682031|520218504|FG001|Overall Study|Patient could not swallow tablets|0|||
144277892|NCT01682031|520218503|FG000|Overall Study|Patient stopped selenium on his own|0|||
144277893|NCT01682031|520218504|FG001|Overall Study|Patient stopped selenium on his own|1|||
144277894|NCT01995201|520218508|FG000|From Baseline Until Week 24|Adverse Event|4|||
144277895|NCT01995201|520218509|FG001|From Baseline Until Week 24|Adverse Event|15|||
144277896|NCT01995201|520218510|FG002|From Baseline Until Week 24|Adverse Event|0|||
144277897|NCT01995201|520218511|FG003|From Baseline Until Week 24|Adverse Event|0|||
144277898|NCT01995201|520218512|FG004|From Baseline Until Week 24|Adverse Event|0|||
144277899|NCT01995201|520218513|FG005|From Baseline Until Week 24|Adverse Event|0|||
144277900|NCT01995201|520218514|FG006|From Baseline Until Week 24|Adverse Event|0|||
144277901|NCT01995201|520218508|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
144277902|NCT01995201|520218509|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
144277903|NCT01995201|520218510|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
144277904|NCT01995201|520218511|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
144277905|NCT01995201|520218512|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
144277906|NCT01995201|520218513|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
144277907|NCT01995201|520218514|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
144277908|NCT01995201|520218508|FG000|From Baseline Until Week 24|Death|0|||
144277909|NCT01995201|520218509|FG001|From Baseline Until Week 24|Death|1|||
144277910|NCT01995201|520218510|FG002|From Baseline Until Week 24|Death|0|||
144277911|NCT01995201|520218511|FG003|From Baseline Until Week 24|Death|0|||
144277912|NCT01995201|520218512|FG004|From Baseline Until Week 24|Death|0|||
144277913|NCT01995201|520218513|FG005|From Baseline Until Week 24|Death|0|||
144277914|NCT01995201|520218514|FG006|From Baseline Until Week 24|Death|0|||
144277915|NCT01995201|520218508|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
144277916|NCT01995201|520218509|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
144277917|NCT01995201|520218510|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
144277918|NCT01995201|520218511|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
144277919|NCT01995201|520218512|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
144277920|NCT01995201|520218513|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
144277921|NCT01995201|520218514|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
144277922|NCT01995201|520218508|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
144277923|NCT01995201|520218509|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
144277924|NCT01995201|520218510|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
144277925|NCT01995201|520218511|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
144277926|NCT01995201|520218512|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
144277927|NCT01995201|520218513|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
144277928|NCT01995201|520218514|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
144277929|NCT01995201|520218508|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
144277930|NCT01995201|520218509|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
144277931|NCT01995201|520218510|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
144277932|NCT01995201|520218511|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
144277933|NCT01995201|520218512|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
144277934|NCT01995201|520218513|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
144277935|NCT01995201|520218514|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
144277936|NCT01995201|520218508|FG000|From Baseline Until Week 24|Physician Decision|0|||
144277937|NCT01995201|520218509|FG001|From Baseline Until Week 24|Physician Decision|2|||
144277938|NCT01995201|520218510|FG002|From Baseline Until Week 24|Physician Decision|0|||
144277939|NCT01995201|520218511|FG003|From Baseline Until Week 24|Physician Decision|0|||
144277940|NCT01995201|520218512|FG004|From Baseline Until Week 24|Physician Decision|0|||
144277941|NCT01995201|520218513|FG005|From Baseline Until Week 24|Physician Decision|0|||
144277942|NCT01995201|520218514|FG006|From Baseline Until Week 24|Physician Decision|0|||
144277943|NCT01995201|520218508|FG000|From Baseline Until Week 24|Protocol Violation|0|||
144277944|NCT01995201|520218509|FG001|From Baseline Until Week 24|Protocol Violation|9|||
144277945|NCT01995201|520218510|FG002|From Baseline Until Week 24|Protocol Violation|0|||
144277946|NCT01995201|520218511|FG003|From Baseline Until Week 24|Protocol Violation|0|||
144277947|NCT01995201|520218512|FG004|From Baseline Until Week 24|Protocol Violation|0|||
144277948|NCT01995201|520218513|FG005|From Baseline Until Week 24|Protocol Violation|0|||
144277949|NCT01995201|520218514|FG006|From Baseline Until Week 24|Protocol Violation|0|||
144277950|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Adverse Event|0|||
144277951|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Adverse Event|0|||
144277952|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Adverse Event|2|||
144277953|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Adverse Event|1|||
144277954|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Adverse Event|1|||
144277955|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Adverse Event|3|||
144277956|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Adverse Event|1|||
144277957|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Death|0|||
144277958|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Death|0|||
144277959|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Death|0|||
144277960|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Death|0|||
144277961|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Death|0|||
144277962|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Death|2|||
144277963|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Death|0|||
144277964|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
144277965|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
144277966|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
144277967|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
144277968|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
144277969|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
144277970|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
144277971|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
144277972|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
144277973|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
144277974|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
144277975|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
144277976|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
144277977|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
144277978|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
144277979|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
144277980|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
144277981|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
144277982|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
144277983|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
144277984|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
144277985|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Physician Decision|0|||
144277986|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Physician Decision|0|||
144277987|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Physician Decision|0|||
144277988|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Physician Decision|0|||
144243556|NCT05128773|520090256|FG000|Overall Study|Sponsor decision to terminate study|3|||
144243557|NCT04697056|520090257|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
144243558|NCT04697056|520090258|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
144243559|NCT04982575|520090259|FG000|Overall Study|Withdrawal by Subject|2|||
144243560|NCT04982575|520090260|FG001|Overall Study|Withdrawal by Subject|0|||
144243561|NCT04982575|520090261|FG002|Overall Study|Withdrawal by Subject|2|||
144243562|NCT04322539|520090266|FG000|Overall Study|Adverse Event|2|||
144243563|NCT04322539|520090267|FG001|Overall Study|Adverse Event|0|||
144243564|NCT04322539|520090266|FG000|Overall Study|Death|411|||
144243565|NCT04322539|520090267|FG001|Overall Study|Death|203|||
144243566|NCT04322539|520090266|FG000|Overall Study|Lost to Follow-up|3|||
144243567|NCT04322539|520090267|FG001|Overall Study|Lost to Follow-up|1|||
144243568|NCT04322539|520090266|FG000|Overall Study|Withdrawal of consent|14|||
144243569|NCT04322539|520090267|FG001|Overall Study|Withdrawal of consent|8|||
144243570|NCT04322539|520090266|FG000|Overall Study|Radiological Disease Progression|6|||
144243571|NCT04322539|520090267|FG001|Overall Study|Radiological Disease Progression|0|||
144243572|NCT04322539|520090266|FG000|Overall Study|Sponsor Decision|19|||
144243573|NCT04322539|520090267|FG001|Overall Study|Sponsor Decision|14|||
144243574|NCT04322539|520090266|FG000|Overall Study|Other|6|||
144243575|NCT04322539|520090267|FG001|Overall Study|Other|4|||
144243576|NCT03617861|520090268|FG000|Second Intervention (1 Day)|Adverse Event|0|||
144243577|NCT03617861|520090269|FG001|Second Intervention (1 Day)|Adverse Event|0|||
144243578|NCT03617861|520090270|FG002|Second Intervention (1 Day)|Adverse Event|1|||
144243579|NCT03617861|520090271|FG003|Second Intervention (1 Day)|Adverse Event|0|||
144243580|NCT01702532|520090272|FG000|Overall Study|Adverse Event|0|||
144243581|NCT01702532|520090273|FG001|Overall Study|Adverse Event|1|||
144243582|NCT00623597|520090274|FG000|Overall Study|Failed to return|1|||
144243583|NCT00623597|520090275|FG001|Overall Study|Failed to return|0|||
144243584|NCT02339155|520090278|FG000|Overall Study|Adverse Event|0|||
144243585|NCT02339155|520090279|FG001|Overall Study|Adverse Event|6|||
144243586|NCT02339155|520090278|FG000|Overall Study|Death|1|||
144243587|NCT02339155|520090279|FG001|Overall Study|Death|1|||
144243588|NCT02339155|520090278|FG000|Overall Study|Lost to Follow-up|8|||
144243589|NCT02339155|520090279|FG001|Overall Study|Lost to Follow-up|9|||
144243590|NCT02339155|520090278|FG000|Overall Study|Physician Decision|2|||
144243591|NCT02339155|520090279|FG001|Overall Study|Physician Decision|1|||
144243592|NCT02339155|520090278|FG000|Overall Study|Withdrawal by Subject|4|||
144243593|NCT02339155|520090279|FG001|Overall Study|Withdrawal by Subject|4|||
144243594|NCT03427268|520090280|FG000|Overall Study|Progressive disease|25|||
144243595|NCT03427268|520090280|FG000|Overall Study|Never treated|2|||
144277989|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Physician Decision|1|||
144277990|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Physician Decision|0|||
144277991|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Physician Decision|0|||
144243596|NCT03427268|520090280|FG000|Overall Study|Compassionate use|1|||
144243597|NCT03427268|520090280|FG000|Overall Study|Withdrawal by Subject|1|||
144243598|NCT03427268|520090280|FG000|Overall Study|Adverse Event|3|||
144243599|NCT00345878|520090284|FG000|Overall Study|Adverse Event|1|||
144243600|NCT00345878|520090285|FG001|Overall Study|Adverse Event|0|||
144243601|NCT00345878|520090284|FG000|Overall Study|Lost to Follow-up|2|||
144243602|NCT00345878|520090285|FG001|Overall Study|Lost to Follow-up|1|||
144243603|NCT00345878|520090284|FG000|Overall Study|Other|1|||
144243604|NCT00345878|520090285|FG001|Overall Study|Other|0|||
144243605|NCT01643798|520090286|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
144243606|NCT01643798|520090287|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
144243607|NCT01349322|520090289|FG000|Overall Study|Protocol Violation|45|||
144243608|NCT01349322|520090290|FG001|Overall Study|Protocol Violation|47|||
144243609|NCT04076059|520090299|FG000|Double Blind Phase|Progressive disease|22|||
144243610|NCT04076059|520090300|FG001|Double Blind Phase|Progressive disease|26|||
144243611|NCT04076059|520090301|FG002|Double Blind Phase|Progressive disease|0|||
144243612|NCT04076059|520090299|FG000|Double Blind Phase|Withdrawal by Subject|4|||
144243613|NCT04076059|520090300|FG001|Double Blind Phase|Withdrawal by Subject|11|||
144243614|NCT04076059|520090301|FG002|Double Blind Phase|Withdrawal by Subject|0|||
144243615|NCT04076059|520090299|FG000|Double Blind Phase|Death|1|||
144243616|NCT04076059|520090300|FG001|Double Blind Phase|Death|1|||
144243617|NCT04076059|520090301|FG002|Double Blind Phase|Death|0|||
144243618|NCT04076059|520090299|FG000|Double Blind Phase|Lost to Follow-up|1|||
144243619|NCT04076059|520090300|FG001|Double Blind Phase|Lost to Follow-up|0|||
144243620|NCT04076059|520090301|FG002|Double Blind Phase|Lost to Follow-up|0|||
144243621|NCT04076059|520090299|FG000|Double Blind Phase|Adverse Event|5|||
144243622|NCT04076059|520090300|FG001|Double Blind Phase|Adverse Event|1|||
144243623|NCT04076059|520090301|FG002|Double Blind Phase|Adverse Event|0|||
144243624|NCT04076059|520090299|FG000|Double Blind Phase|Ongoing Participants|82|||
144243625|NCT04076059|520090300|FG001|Double Blind Phase|Ongoing Participants|18|||
144243626|NCT04076059|520090301|FG002|Double Blind Phase|Ongoing Participants|0|||
144243627|NCT04076059|520090299|FG000|Double Blind Phase|Miscellaneous|3|||
144243628|NCT04076059|520090300|FG001|Double Blind Phase|Miscellaneous|1|||
144243629|NCT04076059|520090301|FG002|Double Blind Phase|Miscellaneous|0|||
144243630|NCT04076059|520090299|FG000|Double Blind Phase|Protocol Deviation|1|||
144243631|NCT04076059|520090300|FG001|Double Blind Phase|Protocol Deviation|1|||
144243632|NCT04076059|520090301|FG002|Double Blind Phase|Protocol Deviation|0|||
144243633|NCT04076059|520090299|FG000|Double Blind Phase|Did not take study drug|1|||
144243634|NCT04076059|520090300|FG001|Double Blind Phase|Did not take study drug|1|||
144243635|NCT04076059|520090301|FG002|Double Blind Phase|Did not take study drug|0|||
144243636|NCT04076059|520090299|FG000|Open Label Phase|Progressive disease|0|||
144243637|NCT04076059|520090300|FG001|Open Label Phase|Progressive disease|0|||
144243638|NCT04076059|520090301|FG002|Open Label Phase|Progressive disease|7|||
144243639|NCT04076059|520090299|FG000|Open Label Phase|Withdrawal by Subject|0|||
144243640|NCT04076059|520090300|FG001|Open Label Phase|Withdrawal by Subject|0|||
144243641|NCT04076059|520090301|FG002|Open Label Phase|Withdrawal by Subject|3|||
144243642|NCT04076059|520090299|FG000|Open Label Phase|Death|0|||
144243643|NCT04076059|520090300|FG001|Open Label Phase|Death|0|||
144243644|NCT04076059|520090301|FG002|Open Label Phase|Death|2|||
144243645|NCT04076059|520090299|FG000|Open Label Phase|Ongoing Participants|0|||
144243646|NCT04076059|520090300|FG001|Open Label Phase|Ongoing Participants|0|||
144243647|NCT04076059|520090301|FG002|Open Label Phase|Ongoing Participants|11|||
144243648|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Death|117|||
144243649|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Death|197|||
144243650|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
144243651|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
144243652|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
144243653|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
144243654|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
144243655|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
144243656|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
144243657|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
144243658|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
144243659|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
144243660|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
144243661|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
144243662|NCT02677896|520090302|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
144243663|NCT02677896|520090303|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
144243664|NCT02677896|520090302|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
144243665|NCT02677896|520090303|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
144243666|NCT02677896|520090302|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
144243667|NCT02677896|520090303|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
144243668|NCT02677896|520090302|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
144243669|NCT02677896|520090303|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
144243670|NCT02677896|520090302|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
144277992|NCT01995201|520218508|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
144243671|NCT02677896|520090303|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
144243672|NCT02677896|520090302|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
144243673|NCT02677896|520090303|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
144243674|NCT02677896|520090302|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
144243675|NCT02677896|520090303|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
144243676|NCT01097421|520090308|FG000|Overall Study|Adverse Event|8|||
144243677|NCT01097421|520090308|FG000|Overall Study|Protocol Violation|2|||
144243678|NCT01097421|520090308|FG000|Overall Study|Lost to Follow-up|1|||
144243679|NCT01097421|520090308|FG000|Overall Study|Withdrawal by Subject|3|||
144243680|NCT01120249|520090311|FG000|Overall Study|No protocol treatment received|21|||
144243681|NCT01120249|520090312|FG001|Overall Study|No protocol treatment received|15|||
144243682|NCT01120249|520090311|FG000|Overall Study|Disease recurrence|107|||
144243683|NCT01120249|520090312|FG001|Overall Study|Disease recurrence|57|||
144243684|NCT01120249|520090311|FG000|Overall Study|Death|1|||
144243685|NCT01120249|520090312|FG001|Overall Study|Death|0|||
144243686|NCT01120249|520090311|FG000|Overall Study|Adverse Event|40|||
144243687|NCT01120249|520090312|FG001|Overall Study|Adverse Event|276|||
144243688|NCT01120249|520090311|FG000|Overall Study|Participant refusal|34|||
144243689|NCT01120249|520090312|FG001|Overall Study|Participant refusal|42|||
144243690|NCT01120249|520090311|FG000|Overall Study|Other reasons, not protocol specified|29|||
144243691|NCT01120249|520090312|FG001|Overall Study|Other reasons, not protocol specified|22|||
144243692|NCT01701193|520090313|FG000|Overall Study|Withdrawal by Subject|2|||
144243693|NCT01701193|520090314|FG001|Overall Study|Withdrawal by Subject|2|||
144243694|NCT01701193|520090315|FG002|Overall Study|Withdrawal by Subject|1|||
144243695|NCT01701193|520090316|FG003|Overall Study|Withdrawal by Subject|2|||
144243696|NCT01701193|520090313|FG000|Overall Study|Adverse Event|1|||
144243697|NCT01701193|520090314|FG001|Overall Study|Adverse Event|0|||
144243698|NCT01701193|520090315|FG002|Overall Study|Adverse Event|0|||
144243699|NCT01701193|520090316|FG003|Overall Study|Adverse Event|0|||
144243700|NCT01482962|520090317|FG000|Overall Study|Progressive Disease|65|||
144243701|NCT01482962|520090318|FG001|Overall Study|Progressive Disease|53|||
144243702|NCT01482962|520090317|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
144243703|NCT01482962|520090318|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
144243704|NCT01482962|520090317|FG000|Overall Study|Adverse Event|18|||
144243705|NCT01482962|520090318|FG001|Overall Study|Adverse Event|22|||
144243706|NCT01482962|520090317|FG000|Overall Study|Withdrawal by Participant|8|||
144243707|NCT01482962|520090318|FG001|Overall Study|Withdrawal by Participant|13|||
144243708|NCT01482962|520090317|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
144243709|NCT01482962|520090318|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
144243710|NCT01482962|520090317|FG000|Overall Study|Other Reason|1|||
144243711|NCT01482962|520090318|FG001|Overall Study|Other Reason|5|||
144243712|NCT01482962|520090317|FG000|Overall Study|Study Terminated by Sponsor|5|||
144243713|NCT01482962|520090318|FG001|Overall Study|Study Terminated by Sponsor|2|||
144243714|NCT01482962|520090317|FG000|Overall Study|Did not Receive Study Drug|1|||
144243715|NCT01482962|520090318|FG001|Overall Study|Did not Receive Study Drug|6|||
144243716|NCT02407457|520090319|FG000|1 Month|Death|3|||
144243717|NCT02407457|520090320|FG001|1 Month|Death|0|||
144243718|NCT02407457|520090319|FG000|1 Month|Lost to Follow-up|1|||
144243719|NCT02407457|520090320|FG001|1 Month|Lost to Follow-up|1|||
144243720|NCT02407457|520090319|FG000|1 Month|missed visit|2|||
144243721|NCT02407457|520090320|FG001|1 Month|missed visit|5|||
144243722|NCT02407457|520090319|FG000|6-Month|Death|2|||
144243723|NCT02407457|520090320|FG001|6-Month|Death|8|||
144243724|NCT02407457|520090319|FG000|6-Month|Lost to Follow-up|2|||
144243725|NCT02407457|520090320|FG001|6-Month|Lost to Follow-up|2|||
144243726|NCT02407457|520090319|FG000|6-Month|missed visit|16|||
144243727|NCT02407457|520090320|FG001|6-Month|missed visit|14|||
144243728|NCT02407457|520090319|FG000|6-Month|Open Repair|0|||
144243729|NCT02407457|520090320|FG001|6-Month|Open Repair|1|||
144243730|NCT02407457|520090319|FG000|1 Year|Death|6|||
144243731|NCT02407457|520090320|FG001|1 Year|Death|11|||
144243732|NCT02407457|520090319|FG000|1 Year|Lost to Follow-up|3|||
144243733|NCT02407457|520090320|FG001|1 Year|Lost to Follow-up|2|||
144243734|NCT02407457|520090319|FG000|1 Year|Missed Visit|24|||
144277993|NCT01995201|520218509|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
144277994|NCT01995201|520218510|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
144243735|NCT02407457|520090320|FG001|1 Year|Missed Visit|14|||
144243736|NCT02407457|520090319|FG000|1 Year|Open Repair|0|||
144243737|NCT02407457|520090320|FG001|1 Year|Open Repair|1|||
144243738|NCT02407457|520090319|FG000|2-year|Death|14|||
144243739|NCT02407457|520090320|FG001|2-year|Death|8|||
144243740|NCT02407457|520090319|FG000|2-year|Lost to Follow-up|7|||
144243741|NCT02407457|520090320|FG001|2-year|Lost to Follow-up|10|||
144243742|NCT02407457|520090319|FG000|2-year|Missed Visit|13|||
144243743|NCT02407457|520090320|FG001|2-year|Missed Visit|15|||
144243744|NCT02407457|520090319|FG000|2-year|Open Repair|0|||
144243745|NCT02407457|520090320|FG001|2-year|Open Repair|2|||
144243746|NCT02407457|520090319|FG000|3-year|Death|11|||
144243747|NCT02407457|520090320|FG001|3-year|Death|10|||
144243748|NCT02407457|520090319|FG000|3-year|Lost to Follow-up|9|||
144243749|NCT02407457|520090320|FG001|3-year|Lost to Follow-up|10|||
144277995|NCT01995201|520218511|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
144277996|NCT01995201|520218512|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
144277997|NCT01995201|520218513|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
144277998|NCT01995201|520218514|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
144277999|NCT03323502|520218520|FG000|Overall Study|Resident could not be linked to CMS data|594|||
144278000|NCT03323502|520218521|FG001|Overall Study|Resident could not be linked to CMS data|435|||
144278001|NCT03323502|520218520|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
144278002|NCT03323502|520218521|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
144278003|NCT03323502|520218520|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
144278004|NCT03323502|520218521|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
144278005|NCT03323502|520218520|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
144278006|NCT03323502|520218521|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
144278007|NCT03323502|520218520|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
144278008|NCT03323502|520218521|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
144278009|NCT02550795|520218526|FG000|Overall Study|Physician Decision|0|||
144278010|NCT02550795|520218527|FG001|Overall Study|Physician Decision|1|||
144278011|NCT02550795|520218528|FG002|Overall Study|Physician Decision|0|||
144278012|NCT02802228|520218529|FG000|Overall Study|Withdrawal by Subject|2|||
144278013|NCT02802228|520218530|FG001|Overall Study|Withdrawal by Subject|0|||
144278014|NCT02802228|520218529|FG000|Overall Study|Lost to Follow-up|1|||
144278015|NCT02802228|520218530|FG001|Overall Study|Lost to Follow-up|0|||
144278016|NCT02802228|520218529|FG000|Overall Study|Adverse Event|1|||
144278017|NCT02802228|520218530|FG001|Overall Study|Adverse Event|0|||
144278018|NCT02802228|520218529|FG000|Overall Study|Physician Decision|1|||
144278019|NCT02802228|520218530|FG001|Overall Study|Physician Decision|0|||
144278020|NCT00695019|520218531|FG000|Overall Study|Withdrawal by Subject|8|||
144278021|NCT00695019|520218532|FG001|Overall Study|Withdrawal by Subject|6|||
144278022|NCT00695019|520218533|FG002|Overall Study|Withdrawal by Subject|4|||
144278023|NCT00695019|520218531|FG000|Overall Study|Protocol Violation|1|||
144278024|NCT00695019|520218532|FG001|Overall Study|Protocol Violation|3|||
144243750|NCT02407457|520090319|FG000|3-year|Missed Visit|19|||
144243751|NCT02407457|520090320|FG001|3-year|Missed Visit|16|||
144243752|NCT02407457|520090319|FG000|4-year|Death|18|||
144243753|NCT02407457|520090320|FG001|4-year|Death|10|||
144243754|NCT02407457|520090319|FG000|4-year|Lost to Follow-up|10|||
144243755|NCT02407457|520090320|FG001|4-year|Lost to Follow-up|12|||
144243756|NCT02407457|520090319|FG000|4-year|Missed Visit|18|||
144243757|NCT02407457|520090320|FG001|4-year|Missed Visit|16|||
144243758|NCT02407457|520090319|FG000|5-year|Death|10|||
144243759|NCT02407457|520090320|FG001|5-year|Death|3|||
144243760|NCT02407457|520090319|FG000|5-year|Lost to Follow-up|22|||
144243761|NCT02407457|520090320|FG001|5-year|Lost to Follow-up|13|||
144243762|NCT02407457|520090319|FG000|5-year|Missed Visit|9|||
144243763|NCT02407457|520090320|FG001|5-year|Missed Visit|1|||
144243764|NCT04495816|520090321|FG000|Overall Study|Lost to Follow-up|10|||
144243765|NCT04495816|520090322|FG001|Overall Study|Lost to Follow-up|4|||
144243766|NCT04495816|520090321|FG000|Overall Study|Withdrawal by Subject|3|||
144243767|NCT04495816|520090322|FG001|Overall Study|Withdrawal by Subject|5|||
144243768|NCT03536949|520090323|FG000|Overall Study|Adverse Event|4|||
144243769|NCT03536949|520090324|FG001|Overall Study|Adverse Event|0|||
144243770|NCT03536949|520090323|FG000|Overall Study|Lost to Follow-up|2|||
144243771|NCT03536949|520090324|FG001|Overall Study|Lost to Follow-up|1|||
144243772|NCT03536949|520090323|FG000|Overall Study|Withdrawal by Subject|6|||
144243773|NCT03536949|520090324|FG001|Overall Study|Withdrawal by Subject|0|||
144243774|NCT03536949|520090323|FG000|Overall Study|Non-compliance|2|||
144243775|NCT03536949|520090324|FG001|Overall Study|Non-compliance|1|||
144243776|NCT06137703|520090326|FG000|Overall Study|Other|0|||
144243777|NCT06137703|520090327|FG001|Overall Study|Other|1|||
144243778|NCT06137703|520090328|FG002|Overall Study|Other|0|||
144243779|NCT06137703|520090329|FG003|Overall Study|Other|0|||
144243780|NCT06137703|520090326|FG000|Overall Study|Adverse Event|0|||
144243781|NCT06137703|520090327|FG001|Overall Study|Adverse Event|0|||
144243782|NCT06137703|520090328|FG002|Overall Study|Adverse Event|1|||
144243783|NCT06137703|520090329|FG003|Overall Study|Adverse Event|0|||
144243784|NCT04329091|520090332|FG000|Overall Study|Physician Decision|5|||
144243785|NCT00741091|520090335|FG000|Overall Study|Death|13|||
144243786|NCT00741091|520090335|FG000|Overall Study|Lost to Follow-up|16|||
144243787|NCT00741091|520090335|FG000|Overall Study|Withdrawal by Subject|6|||
144243788|NCT00741091|520090335|FG000|Overall Study|Missed Visit|22|||
144243789|NCT01801358|520090336|FG000|Overall Study|Adverse Event|0|||
144243790|NCT01801358|520090337|FG001|Overall Study|Adverse Event|2|||
144243791|NCT01801358|520090338|FG002|Overall Study|Adverse Event|1|||
144243792|NCT01801358|520090339|FG003|Overall Study|Adverse Event|0|||
144243793|NCT01801358|520090340|FG004|Overall Study|Adverse Event|0|||
144243794|NCT01801358|520090341|FG005|Overall Study|Adverse Event|1|||
144243795|NCT01801358|520090336|FG000|Overall Study|Physician Decision|0|||
144243796|NCT01801358|520090337|FG001|Overall Study|Physician Decision|0|||
144243797|NCT01801358|520090338|FG002|Overall Study|Physician Decision|1|||
144243798|NCT01801358|520090339|FG003|Overall Study|Physician Decision|0|||
144243799|NCT01801358|520090340|FG004|Overall Study|Physician Decision|0|||
144243800|NCT01801358|520090341|FG005|Overall Study|Physician Decision|0|||
144243801|NCT01801358|520090336|FG000|Overall Study|Progressive Disease|6|||
144243802|NCT01801358|520090337|FG001|Overall Study|Progressive Disease|4|||
144243803|NCT01801358|520090338|FG002|Overall Study|Progressive Disease|4|||
144243804|NCT01801358|520090339|FG003|Overall Study|Progressive Disease|5|||
144243805|NCT01801358|520090340|FG004|Overall Study|Progressive Disease|6|||
144243806|NCT01801358|520090341|FG005|Overall Study|Progressive Disease|5|||
144243807|NCT01801358|520090336|FG000|Overall Study|Withdrawal by Subject|0|||
144243808|NCT01801358|520090337|FG001|Overall Study|Withdrawal by Subject|0|||
144243809|NCT01801358|520090338|FG002|Overall Study|Withdrawal by Subject|0|||
144243810|NCT01801358|520090339|FG003|Overall Study|Withdrawal by Subject|1|||
144243811|NCT01801358|520090340|FG004|Overall Study|Withdrawal by Subject|0|||
144243812|NCT01801358|520090341|FG005|Overall Study|Withdrawal by Subject|2|||
144243813|NCT03787303|520090342|FG000|Overall Study|Death|1|||
144243814|NCT03787303|520090342|FG000|Overall Study|Premature Termination of Study|1|||
144243815|NCT01527487|520090343|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
144243816|NCT01527487|520090344|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
144243817|NCT01527487|520090343|FG000|Overall Study|Disease Progression|4|||
144243818|NCT01527487|520090344|FG001|Overall Study|Disease Progression|1|||
144243819|NCT01527487|520090343|FG000|Overall Study|Adverse Event|1|||
144243820|NCT01527487|520090344|FG001|Overall Study|Adverse Event|1|||
144243821|NCT01527487|520090343|FG000|Overall Study|Death|0|||
144243822|NCT01527487|520090344|FG001|Overall Study|Death|1|||
144243823|NCT01210495|520090347|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
144243824|NCT01210495|520090348|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
144243825|NCT01210495|520090349|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
144243826|NCT01210495|520090350|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
144243827|NCT01210495|520090347|FG000|Overall Study|Death|14|||
144243828|NCT01210495|520090348|FG001|Overall Study|Death|7|||
144243829|NCT01210495|520090349|FG002|Overall Study|Death|112|||
144243830|NCT01210495|520090350|FG003|Overall Study|Death|54|||
144243831|NCT01210495|520090347|FG000|Overall Study|Study Terminated by Sponsor|0|||
144243832|NCT01210495|520090348|FG001|Overall Study|Study Terminated by Sponsor|0|||
144243833|NCT01210495|520090349|FG002|Overall Study|Study Terminated by Sponsor|4|||
144243834|NCT01210495|520090350|FG003|Overall Study|Study Terminated by Sponsor|11|||
144243835|NCT01210495|520090347|FG000|Overall Study|Lost to Follow-up|0|||
144243836|NCT01210495|520090348|FG001|Overall Study|Lost to Follow-up|0|||
144243837|NCT01210495|520090349|FG002|Overall Study|Lost to Follow-up|1|||
144243838|NCT01210495|520090350|FG003|Overall Study|Lost to Follow-up|1|||
144243839|NCT01210495|520090347|FG000|Overall Study|Other unspecified|0|||
144243840|NCT01210495|520090348|FG001|Overall Study|Other unspecified|0|||
144243841|NCT01210495|520090349|FG002|Overall Study|Other unspecified|6|||
144243842|NCT01210495|520090350|FG003|Overall Study|Other unspecified|0|||
144243843|NCT01384019|520090351|FG000|Overall Study|Withdrawal by Subject|3|||
144243844|NCT01384019|520090352|FG001|Overall Study|Withdrawal by Subject|0|||
144243845|NCT01384019|520090351|FG000|Overall Study|Death|1|||
144243846|NCT01384019|520090352|FG001|Overall Study|Death|0|||
144243847|NCT01384019|520090351|FG000|Overall Study|MRI refusal|6|||
144243848|NCT01384019|520090352|FG001|Overall Study|MRI refusal|6|||
144243849|NCT03332628|520090355|FG000|Overall Study|Physician Decision|2|||
144243850|NCT02505334|520090358|FG000|Main Treatment Period|Adverse Event|3|||
144243851|NCT02505334|520090359|FG001|Main Treatment Period|Adverse Event|3|||
144243852|NCT02505334|520090358|FG000|Main Treatment Period|Lack of Efficacy|7|||
144243853|NCT02505334|520090359|FG001|Main Treatment Period|Lack of Efficacy|17|||
144243854|NCT02505334|520090358|FG000|Main Treatment Period|Protocol Violation|0|||
144243855|NCT02505334|520090359|FG001|Main Treatment Period|Protocol Violation|1|||
144243856|NCT02505334|520090358|FG000|Main Treatment Period|Withdrawal by Subject|1|||
144243857|NCT02505334|520090359|FG001|Main Treatment Period|Withdrawal by Subject|8|||
144278025|NCT00695019|520218533|FG002|Overall Study|Protocol Violation|1|||
144278026|NCT00695019|520218531|FG000|Overall Study|Lack of Efficacy|0|||
144278027|NCT00695019|520218532|FG001|Overall Study|Lack of Efficacy|0|||
144278028|NCT00695019|520218533|FG002|Overall Study|Lack of Efficacy|1|||
144278029|NCT00695019|520218531|FG000|Overall Study|Various|4|||
144278030|NCT00695019|520218532|FG001|Overall Study|Various|5|||
144278031|NCT00695019|520218533|FG002|Overall Study|Various|4|||
144278032|NCT02225587|520218534|FG000|Overall Study|Adverse Event|5|||
144278033|NCT02225587|520218535|FG001|Overall Study|Adverse Event|5|||
144278034|NCT02225587|520218534|FG000|Overall Study|Lost to Follow-up|5|||
144278035|NCT02225587|520218535|FG001|Overall Study|Lost to Follow-up|5|||
144278036|NCT02225587|520218534|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144278037|NCT02225587|520218535|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144278038|NCT02225587|520218534|FG000|Overall Study|Physician Decision|2|||
144278039|NCT02225587|520218535|FG001|Overall Study|Physician Decision|0|||
144278040|NCT02225587|520218534|FG000|Overall Study|Protocol Violation|1|||
144278041|NCT02225587|520218535|FG001|Overall Study|Protocol Violation|0|||
144278042|NCT02225587|520218534|FG000|Overall Study|Participant Moved|1|||
144278043|NCT02225587|520218535|FG001|Overall Study|Participant Moved|0|||
144278044|NCT02225587|520218534|FG000|Overall Study|Withdrawal by Subject|13|||
144278045|NCT02225587|520218535|FG001|Overall Study|Withdrawal by Subject|28|||
144278046|NCT00924898|520218536|FG000|Overall Study|Withdrawal by Subject|2|||
144278047|NCT05291689|520218542|FG000|Overall Study|Adverse Event|3|||
144278048|NCT05291689|520218542|FG000|Overall Study|Lack of Efficacy|10|||
144278049|NCT05291689|520218542|FG000|Overall Study|Withdrawal by Subject|4|||
144278050|NCT01931098|520218543|FG000|Overall Study|Withdrawal by Subject|0|||
144278051|NCT01931098|520218544|FG001|Overall Study|Withdrawal by Subject|1|||
144278052|NCT01931098|520218543|FG000|Overall Study|Enrolled in different protocol|0|||
144278053|NCT01931098|520218544|FG001|Overall Study|Enrolled in different protocol|1|||
144278054|NCT01931098|520218543|FG000|Overall Study|Unable to begin trmt:active infection|0|||
144278055|NCT01931098|520218544|FG001|Overall Study|Unable to begin trmt:active infection|1|||
144278056|NCT01931098|520218543|FG000|Overall Study|Refused further treatment|0|||
144278057|NCT01931098|520218544|FG001|Overall Study|Refused further treatment|1|||
144278058|NCT02278354|520218548|FG000|Overall Study|Lost to Follow-up|2|||
144278059|NCT02278354|520218549|FG001|Overall Study|Lost to Follow-up|2|||
144278060|NCT02278354|520218548|FG000|Overall Study|Withdrawal by Subject|0|||
144278061|NCT02278354|520218549|FG001|Overall Study|Withdrawal by Subject|1|||
144278062|NCT02278354|520218548|FG000|Overall Study|<10 professional fights|2|||
144278063|NCT02278354|520218549|FG001|Overall Study|<10 professional fights|0|||
144278064|NCT01901562|520218551|FG000|Overall Study|Protocol Violation|5|||
144278065|NCT01901562|520218551|FG000|Overall Study|Excluded intraoperatively|4|||
144278066|NCT01925794|520218552|FG000|180 Days|Death|2|||
144278067|NCT01925794|520218552|FG000|180 Days|Withdrawal by Subject|2|||
144278068|NCT01925794|520218552|FG000|270 Days|Death|2|||
144278069|NCT01925794|520218552|FG000|270 Days|Protocol Violation|3|||
144278070|NCT02612155|520218553|FG000|Overall Study|Death|1|||
144278071|NCT02612155|520218554|FG001|Overall Study|Death|1|||
144278072|NCT02612155|520218553|FG000|Overall Study|Lost to Follow-up|2|||
144278073|NCT02612155|520218554|FG001|Overall Study|Lost to Follow-up|2|||
144278074|NCT02879695|520218558|FG000|Overall Study|Did not start study treatment|2|||
144278075|NCT02879695|520218559|FG001|Overall Study|Did not start study treatment|0|||
144278076|NCT02879695|520218560|FG002|Overall Study|Did not start study treatment|3|||
144278077|NCT02879695|520218561|FG003|Overall Study|Did not start study treatment|0|||
144278078|NCT03126110|520218563|FG000|Phase 1|Death|2|||
144278079|NCT03126110|520218564|FG001|Phase 1|Death|2|||
144278080|NCT03126110|520218565|FG002|Phase 1|Death|4|||
144278081|NCT03126110|520218566|FG003|Phase 1|Death|3|||
144278082|NCT03126110|520218567|FG004|Phase 1|Death|4|||
144278083|NCT03126110|520218568|FG005|Phase 1|Death|4|||
144278084|NCT03126110|520218569|FG006|Phase 1|Death|3|||
144278085|NCT03126110|520218570|FG007|Phase 1|Death|4|||
144278086|NCT03126110|520218571|FG008|Phase 1|Death|5|||
144278087|NCT03126110|520218572|FG009|Phase 1|Death|2|||
144278088|NCT03126110|520218573|FG010|Phase 1|Death|6|||
144278089|NCT03126110|520218574|FG011|Phase 1|Death|0|||
144278090|NCT03126110|520218575|FG012|Phase 1|Death|0|||
144278091|NCT03126110|520218576|FG013|Phase 1|Death|0|||
144278092|NCT03126110|520218577|FG014|Phase 1|Death|0|||
144278093|NCT03126110|520218578|FG015|Phase 1|Death|0|||
144278094|NCT03126110|520218579|FG016|Phase 1|Death|0|||
144278095|NCT03126110|520218563|FG000|Phase 1|Lost to Follow-up|0|||
144278096|NCT03126110|520218564|FG001|Phase 1|Lost to Follow-up|1|||
144278097|NCT03126110|520218565|FG002|Phase 1|Lost to Follow-up|0|||
144278098|NCT03126110|520218566|FG003|Phase 1|Lost to Follow-up|0|||
144278099|NCT03126110|520218567|FG004|Phase 1|Lost to Follow-up|0|||
144278100|NCT03126110|520218568|FG005|Phase 1|Lost to Follow-up|0|||
144278101|NCT03126110|520218569|FG006|Phase 1|Lost to Follow-up|0|||
144278102|NCT03126110|520218570|FG007|Phase 1|Lost to Follow-up|0|||
144278103|NCT03126110|520218571|FG008|Phase 1|Lost to Follow-up|1|||
144278104|NCT03126110|520218572|FG009|Phase 1|Lost to Follow-up|0|||
144278105|NCT03126110|520218573|FG010|Phase 1|Lost to Follow-up|0|||
144278106|NCT03126110|520218574|FG011|Phase 1|Lost to Follow-up|0|||
144278107|NCT03126110|520218575|FG012|Phase 1|Lost to Follow-up|0|||
144278108|NCT03126110|520218576|FG013|Phase 1|Lost to Follow-up|0|||
144243858|NCT02505334|520090358|FG000|Main Treatment Period|Unclassified|4|||
144243859|NCT02505334|520090359|FG001|Main Treatment Period|Unclassified|10|||
144243860|NCT02505334|520090358|FG000|Extension Treatment Period|Adverse Event|5|||
144243861|NCT02505334|520090359|FG001|Extension Treatment Period|Adverse Event|0|||
144243862|NCT02505334|520090358|FG000|Extension Treatment Period|Lack of Efficacy|4|||
144243863|NCT02505334|520090359|FG001|Extension Treatment Period|Lack of Efficacy|0|||
144243864|NCT02505334|520090358|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
144243865|NCT02505334|520090359|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
144243866|NCT02505334|520090358|FG000|Extension Treatment Period|Unclassified|3|||
144243867|NCT02505334|520090359|FG001|Extension Treatment Period|Unclassified|0|||
144243868|NCT01629823|520090363|FG000|Trial Period|Missed visit|11|||
144243869|NCT01629823|520090364|FG001|Trial Period|Missed visit|9|||
144243870|NCT01629823|520090365|FG002|Trial Period|Missed visit|8|||
144243871|NCT01629823|520090363|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
144243872|NCT01629823|520090364|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
144243873|NCT01629823|520090365|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
144243874|NCT01629823|520090363|FG000|Trial Period|Pregnancy|1|||
144243875|NCT01629823|520090364|FG001|Trial Period|Pregnancy|0|||
144243876|NCT01629823|520090365|FG002|Trial Period|Pregnancy|0|||
144243877|NCT01629823|520090363|FG000|Trial Period|Adverse Event|0|||
144243878|NCT01629823|520090364|FG001|Trial Period|Adverse Event|1|||
144243879|NCT01629823|520090365|FG002|Trial Period|Adverse Event|0|||
144243880|NCT01629823|520090363|FG000|Trial Period|Out-of-window visit|0|||
144243881|NCT01629823|520090364|FG001|Trial Period|Out-of-window visit|2|||
144243882|NCT01629823|520090365|FG002|Trial Period|Out-of-window visit|0|||
144243883|NCT01629823|520090363|FG000|Trial Period|Failed to hold medication|0|||
144243884|NCT01629823|520090364|FG001|Trial Period|Failed to hold medication|0|||
144243885|NCT01629823|520090365|FG002|Trial Period|Failed to hold medication|1|||
144243886|NCT01629823|520090363|FG000|Washout Period|Safety|2|||
144243887|NCT01629823|520090364|FG001|Washout Period|Safety|5|||
144243888|NCT01629823|520090365|FG002|Washout Period|Safety|0|||
144243889|NCT01629823|520090363|FG000|Washout Period|Pregnancy|1|||
144243890|NCT01629823|520090364|FG001|Washout Period|Pregnancy|0|||
144243891|NCT01629823|520090365|FG002|Washout Period|Pregnancy|0|||
144243892|NCT01629823|520090363|FG000|Washout Period|Protocol Violation|0|||
144243893|NCT01629823|520090364|FG001|Washout Period|Protocol Violation|1|||
144243894|NCT01629823|520090365|FG002|Washout Period|Protocol Violation|0|||
144243895|NCT00525902|520090366|FG000|Overall Study|Lack of Efficacy|1|||
144243896|NCT02258542|520090367|FG000|Overall Study|eg. not made to the visit|7|||
144243897|NCT02258542|520090368|FG001|Overall Study|eg. not made to the visit|4|||
144243898|NCT02258542|520090369|FG002|Overall Study|eg. not made to the visit|0|||
144243899|NCT02258542|520090370|FG003|Overall Study|eg. not made to the visit|1|||
144243900|NCT02258542|520090367|FG000|Overall Study|study specific discount. criteria|1|||
144243901|NCT02258542|520090368|FG001|Overall Study|study specific discount. criteria|1|||
144243902|NCT02258542|520090369|FG002|Overall Study|study specific discount. criteria|0|||
144243903|NCT02258542|520090370|FG003|Overall Study|study specific discount. criteria|0|||
144243904|NCT02258542|520090367|FG000|Overall Study|Withdrawal by Subject|20|||
144243905|NCT02258542|520090368|FG001|Overall Study|Withdrawal by Subject|20|||
144243906|NCT02258542|520090369|FG002|Overall Study|Withdrawal by Subject|7|||
144243907|NCT02258542|520090370|FG003|Overall Study|Withdrawal by Subject|1|||
144243908|NCT02258542|520090367|FG000|Overall Study|Lost to Follow-up|5|||
144243909|NCT02258542|520090368|FG001|Overall Study|Lost to Follow-up|12|||
144243910|NCT02258542|520090369|FG002|Overall Study|Lost to Follow-up|1|||
144243911|NCT02258542|520090370|FG003|Overall Study|Lost to Follow-up|2|||
144243912|NCT02258542|520090367|FG000|Overall Study|Death|5|||
144243913|NCT02258542|520090368|FG001|Overall Study|Death|4|||
144243914|NCT02258542|520090369|FG002|Overall Study|Death|0|||
144243915|NCT02258542|520090370|FG003|Overall Study|Death|1|||
144243916|NCT02258542|520090367|FG000|Overall Study|Adverse Event|3|||
144243917|NCT02258542|520090368|FG001|Overall Study|Adverse Event|4|||
144243918|NCT02258542|520090369|FG002|Overall Study|Adverse Event|0|||
144243919|NCT02258542|520090370|FG003|Overall Study|Adverse Event|0|||
144243920|NCT02258542|520090367|FG000|Overall Study|Protocol Violation|1|||
144243921|NCT02258542|520090368|FG001|Overall Study|Protocol Violation|2|||
144243922|NCT02258542|520090369|FG002|Overall Study|Protocol Violation|0|||
144243923|NCT02258542|520090370|FG003|Overall Study|Protocol Violation|0|||
144243924|NCT02258542|520090367|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144243925|NCT02258542|520090368|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
144243926|NCT02258542|520090369|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
144243927|NCT02258542|520090370|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
144243928|NCT02003963|520090372|FG000|Overall Study|Lost to Follow-up|2|||
144243929|NCT02003963|520090373|FG001|Overall Study|Lost to Follow-up|1|||
144243930|NCT00656851|520090375|FG000|Overall Study|Withdrawal by Subject|0|||
144243931|NCT00656851|520090376|FG001|Overall Study|Withdrawal by Subject|4|||
144243932|NCT04050124|520090377|FG000|Overall Study|Death|1|||
144243933|NCT04050124|520090378|FG001|Overall Study|Death|0|||
144243934|NCT04442269|520090382|FG000|Overall Study|Adverse Event|1|||
144243935|NCT04442269|520090383|FG001|Overall Study|Adverse Event|0|||
144243936|NCT04442269|520090382|FG000|Overall Study|Death|0|||
144278109|NCT03126110|520218577|FG014|Phase 1|Lost to Follow-up|0|||
144278110|NCT03126110|520218578|FG015|Phase 1|Lost to Follow-up|0|||
144278111|NCT03126110|520218579|FG016|Phase 1|Lost to Follow-up|0|||
144278112|NCT03126110|520218563|FG000|Phase 1|Withdrawal by Subject|1|||
144278113|NCT03126110|520218564|FG001|Phase 1|Withdrawal by Subject|0|||
144278114|NCT03126110|520218565|FG002|Phase 1|Withdrawal by Subject|0|||
144278115|NCT03126110|520218566|FG003|Phase 1|Withdrawal by Subject|1|||
144278116|NCT03126110|520218567|FG004|Phase 1|Withdrawal by Subject|1|||
144278117|NCT03126110|520218568|FG005|Phase 1|Withdrawal by Subject|0|||
144278118|NCT03126110|520218569|FG006|Phase 1|Withdrawal by Subject|0|||
144278119|NCT03126110|520218570|FG007|Phase 1|Withdrawal by Subject|0|||
144278120|NCT03126110|520218571|FG008|Phase 1|Withdrawal by Subject|2|||
144278121|NCT03126110|520218572|FG009|Phase 1|Withdrawal by Subject|1|||
144278122|NCT03126110|520218573|FG010|Phase 1|Withdrawal by Subject|0|||
144278123|NCT03126110|520218574|FG011|Phase 1|Withdrawal by Subject|0|||
144278124|NCT03126110|520218575|FG012|Phase 1|Withdrawal by Subject|0|||
144278125|NCT03126110|520218576|FG013|Phase 1|Withdrawal by Subject|0|||
144278126|NCT03126110|520218577|FG014|Phase 1|Withdrawal by Subject|0|||
144278127|NCT03126110|520218578|FG015|Phase 1|Withdrawal by Subject|0|||
144278128|NCT03126110|520218579|FG016|Phase 1|Withdrawal by Subject|0|||
144278129|NCT03126110|520218563|FG000|Phase 1|Safety follow-up no longer necessary|1|||
144278130|NCT03126110|520218564|FG001|Phase 1|Safety follow-up no longer necessary|0|||
144278131|NCT03126110|520218565|FG002|Phase 1|Safety follow-up no longer necessary|0|||
144278132|NCT03126110|520218566|FG003|Phase 1|Safety follow-up no longer necessary|0|||
144278133|NCT03126110|520218567|FG004|Phase 1|Safety follow-up no longer necessary|0|||
144278134|NCT03126110|520218568|FG005|Phase 1|Safety follow-up no longer necessary|0|||
144278135|NCT03126110|520218569|FG006|Phase 1|Safety follow-up no longer necessary|0|||
144278136|NCT03126110|520218570|FG007|Phase 1|Safety follow-up no longer necessary|0|||
144278137|NCT03126110|520218571|FG008|Phase 1|Safety follow-up no longer necessary|0|||
144278138|NCT03126110|520218572|FG009|Phase 1|Safety follow-up no longer necessary|0|||
144278139|NCT03126110|520218573|FG010|Phase 1|Safety follow-up no longer necessary|0|||
144278140|NCT03126110|520218574|FG011|Phase 1|Safety follow-up no longer necessary|0|||
144278141|NCT03126110|520218575|FG012|Phase 1|Safety follow-up no longer necessary|0|||
144278142|NCT03126110|520218576|FG013|Phase 1|Safety follow-up no longer necessary|0|||
144278143|NCT03126110|520218577|FG014|Phase 1|Safety follow-up no longer necessary|0|||
144278144|NCT03126110|520218578|FG015|Phase 1|Safety follow-up no longer necessary|0|||
144278145|NCT03126110|520218579|FG016|Phase 1|Safety follow-up no longer necessary|0|||
144278146|NCT03126110|520218563|FG000|Phase 1|Survival follow-up no longer necessary|0|||
144278147|NCT03126110|520218564|FG001|Phase 1|Survival follow-up no longer necessary|0|||
144278148|NCT03126110|520218565|FG002|Phase 1|Survival follow-up no longer necessary|1|||
144278149|NCT03126110|520218566|FG003|Phase 1|Survival follow-up no longer necessary|0|||
144278150|NCT03126110|520218567|FG004|Phase 1|Survival follow-up no longer necessary|0|||
144278151|NCT03126110|520218568|FG005|Phase 1|Survival follow-up no longer necessary|0|||
144278152|NCT03126110|520218569|FG006|Phase 1|Survival follow-up no longer necessary|0|||
144278153|NCT03126110|520218570|FG007|Phase 1|Survival follow-up no longer necessary|0|||
144278154|NCT03126110|520218571|FG008|Phase 1|Survival follow-up no longer necessary|0|||
144278155|NCT03126110|520218572|FG009|Phase 1|Survival follow-up no longer necessary|0|||
144278156|NCT03126110|520218573|FG010|Phase 1|Survival follow-up no longer necessary|0|||
144278157|NCT03126110|520218574|FG011|Phase 1|Survival follow-up no longer necessary|0|||
144278158|NCT03126110|520218575|FG012|Phase 1|Survival follow-up no longer necessary|0|||
144278159|NCT03126110|520218576|FG013|Phase 1|Survival follow-up no longer necessary|0|||
144278160|NCT03126110|520218577|FG014|Phase 1|Survival follow-up no longer necessary|0|||
144278161|NCT03126110|520218578|FG015|Phase 1|Survival follow-up no longer necessary|0|||
144278162|NCT03126110|520218579|FG016|Phase 1|Survival follow-up no longer necessary|0|||
144278163|NCT03126110|520218563|FG000|Phase 2|Study terminated by the sponsor|0|||
144278164|NCT03126110|520218564|FG001|Phase 2|Study terminated by the sponsor|0|||
144278165|NCT03126110|520218565|FG002|Phase 2|Study terminated by the sponsor|0|||
144278166|NCT03126110|520218566|FG003|Phase 2|Study terminated by the sponsor|0|||
144278167|NCT03126110|520218567|FG004|Phase 2|Study terminated by the sponsor|0|||
144278168|NCT03126110|520218568|FG005|Phase 2|Study terminated by the sponsor|0|||
144278169|NCT03126110|520218569|FG006|Phase 2|Study terminated by the sponsor|0|||
144278170|NCT03126110|520218570|FG007|Phase 2|Study terminated by the sponsor|0|||
144278171|NCT03126110|520218571|FG008|Phase 2|Study terminated by the sponsor|0|||
144278172|NCT03126110|520218572|FG009|Phase 2|Study terminated by the sponsor|0|||
144278173|NCT03126110|520218573|FG010|Phase 2|Study terminated by the sponsor|0|||
144278174|NCT03126110|520218574|FG011|Phase 2|Study terminated by the sponsor|0|||
144278175|NCT03126110|520218575|FG012|Phase 2|Study terminated by the sponsor|0|||
144278176|NCT03126110|520218576|FG013|Phase 2|Study terminated by the sponsor|4|||
144278177|NCT03126110|520218577|FG014|Phase 2|Study terminated by the sponsor|0|||
144278178|NCT03126110|520218578|FG015|Phase 2|Study terminated by the sponsor|0|||
144278179|NCT03126110|520218579|FG016|Phase 2|Study terminated by the sponsor|0|||
144278180|NCT03126110|520218563|FG000|Phase 2|Withdrawal by Subject|0|||
144278181|NCT03126110|520218564|FG001|Phase 2|Withdrawal by Subject|0|||
144278182|NCT03126110|520218565|FG002|Phase 2|Withdrawal by Subject|0|||
144278183|NCT03126110|520218566|FG003|Phase 2|Withdrawal by Subject|0|||
144278184|NCT03126110|520218567|FG004|Phase 2|Withdrawal by Subject|0|||
144278185|NCT03126110|520218568|FG005|Phase 2|Withdrawal by Subject|0|||
144278186|NCT03126110|520218569|FG006|Phase 2|Withdrawal by Subject|0|||
144278187|NCT03126110|520218570|FG007|Phase 2|Withdrawal by Subject|0|||
144278188|NCT03126110|520218571|FG008|Phase 2|Withdrawal by Subject|0|||
144278189|NCT03126110|520218572|FG009|Phase 2|Withdrawal by Subject|0|||
144278190|NCT03126110|520218573|FG010|Phase 2|Withdrawal by Subject|0|||
144278191|NCT03126110|520218574|FG011|Phase 2|Withdrawal by Subject|1|||
144278192|NCT03126110|520218575|FG012|Phase 2|Withdrawal by Subject|3|||
144278193|NCT03126110|520218576|FG013|Phase 2|Withdrawal by Subject|3|||
144278194|NCT03126110|520218577|FG014|Phase 2|Withdrawal by Subject|2|||
144278195|NCT03126110|520218578|FG015|Phase 2|Withdrawal by Subject|1|||
144278196|NCT03126110|520218579|FG016|Phase 2|Withdrawal by Subject|0|||
144278197|NCT03126110|520218563|FG000|Phase 2|Lost to Follow-up|0|||
144278198|NCT03126110|520218564|FG001|Phase 2|Lost to Follow-up|0|||
144278199|NCT03126110|520218565|FG002|Phase 2|Lost to Follow-up|0|||
144278200|NCT03126110|520218566|FG003|Phase 2|Lost to Follow-up|0|||
144278201|NCT03126110|520218567|FG004|Phase 2|Lost to Follow-up|0|||
144278202|NCT03126110|520218568|FG005|Phase 2|Lost to Follow-up|0|||
144278203|NCT03126110|520218569|FG006|Phase 2|Lost to Follow-up|0|||
144278204|NCT03126110|520218570|FG007|Phase 2|Lost to Follow-up|0|||
144278205|NCT03126110|520218571|FG008|Phase 2|Lost to Follow-up|0|||
144278206|NCT03126110|520218572|FG009|Phase 2|Lost to Follow-up|0|||
144278207|NCT03126110|520218573|FG010|Phase 2|Lost to Follow-up|0|||
144278208|NCT03126110|520218574|FG011|Phase 2|Lost to Follow-up|1|||
144278209|NCT03126110|520218575|FG012|Phase 2|Lost to Follow-up|1|||
144278210|NCT03126110|520218576|FG013|Phase 2|Lost to Follow-up|1|||
144278211|NCT03126110|520218577|FG014|Phase 2|Lost to Follow-up|2|||
144278212|NCT03126110|520218578|FG015|Phase 2|Lost to Follow-up|0|||
144278213|NCT03126110|520218579|FG016|Phase 2|Lost to Follow-up|0|||
144278214|NCT03126110|520218563|FG000|Phase 2|Death|0|||
144278215|NCT03126110|520218564|FG001|Phase 2|Death|0|||
144278216|NCT03126110|520218565|FG002|Phase 2|Death|0|||
144278217|NCT03126110|520218566|FG003|Phase 2|Death|0|||
144278218|NCT03126110|520218567|FG004|Phase 2|Death|0|||
144278219|NCT03126110|520218568|FG005|Phase 2|Death|0|||
144278220|NCT03126110|520218569|FG006|Phase 2|Death|0|||
144278221|NCT03126110|520218570|FG007|Phase 2|Death|0|||
144278222|NCT03126110|520218571|FG008|Phase 2|Death|0|||
144278223|NCT03126110|520218572|FG009|Phase 2|Death|0|||
144278224|NCT03126110|520218573|FG010|Phase 2|Death|0|||
144278225|NCT03126110|520218574|FG011|Phase 2|Death|6|||
144278226|NCT03126110|520218575|FG012|Phase 2|Death|12|||
144278227|NCT03126110|520218576|FG013|Phase 2|Death|25|||
144278228|NCT03126110|520218577|FG014|Phase 2|Death|11|||
144278229|NCT03126110|520218578|FG015|Phase 2|Death|3|||
144278230|NCT03126110|520218579|FG016|Phase 2|Death|2|||
144278231|NCT03126110|520218563|FG000|Phase 2|Progressive Disease|0|||
144278232|NCT03126110|520218564|FG001|Phase 2|Progressive Disease|0|||
144278233|NCT03126110|520218565|FG002|Phase 2|Progressive Disease|0|||
144278234|NCT03126110|520218566|FG003|Phase 2|Progressive Disease|0|||
144278235|NCT03126110|520218567|FG004|Phase 2|Progressive Disease|0|||
144278236|NCT03126110|520218568|FG005|Phase 2|Progressive Disease|0|||
144278237|NCT03126110|520218569|FG006|Phase 2|Progressive Disease|0|||
144278238|NCT03126110|520218570|FG007|Phase 2|Progressive Disease|0|||
144278239|NCT03126110|520218571|FG008|Phase 2|Progressive Disease|0|||
144278240|NCT03126110|520218572|FG009|Phase 2|Progressive Disease|0|||
144278241|NCT03126110|520218573|FG010|Phase 2|Progressive Disease|0|||
144278242|NCT03126110|520218574|FG011|Phase 2|Progressive Disease|0|||
144278243|NCT03126110|520218575|FG012|Phase 2|Progressive Disease|0|||
144278244|NCT03126110|520218576|FG013|Phase 2|Progressive Disease|1|||
144278245|NCT03126110|520218577|FG014|Phase 2|Progressive Disease|0|||
144278246|NCT03126110|520218578|FG015|Phase 2|Progressive Disease|0|||
144278247|NCT03126110|520218579|FG016|Phase 2|Progressive Disease|0|||
144278248|NCT03126110|520218563|FG000|Phase 2|Started new treatment|0|||
144278249|NCT03126110|520218564|FG001|Phase 2|Started new treatment|0|||
144278250|NCT03126110|520218565|FG002|Phase 2|Started new treatment|0|||
144278251|NCT03126110|520218566|FG003|Phase 2|Started new treatment|0|||
144278252|NCT03126110|520218567|FG004|Phase 2|Started new treatment|0|||
144278253|NCT03126110|520218568|FG005|Phase 2|Started new treatment|0|||
144278254|NCT03126110|520218569|FG006|Phase 2|Started new treatment|0|||
144278255|NCT03126110|520218570|FG007|Phase 2|Started new treatment|0|||
144278256|NCT03126110|520218571|FG008|Phase 2|Started new treatment|0|||
144278257|NCT03126110|520218572|FG009|Phase 2|Started new treatment|0|||
144278258|NCT03126110|520218573|FG010|Phase 2|Started new treatment|0|||
144278259|NCT03126110|520218574|FG011|Phase 2|Started new treatment|0|||
144278260|NCT03126110|520218575|FG012|Phase 2|Started new treatment|0|||
144278261|NCT03126110|520218576|FG013|Phase 2|Started new treatment|0|||
144278262|NCT03126110|520218577|FG014|Phase 2|Started new treatment|1|||
144278263|NCT03126110|520218578|FG015|Phase 2|Started new treatment|0|||
144278264|NCT03126110|520218579|FG016|Phase 2|Started new treatment|0|||
144278265|NCT04235374|520218580|FG000|Overall Study|Death|91|||
144278266|NCT04235374|520218581|FG001|Overall Study|Death|91|||
144278267|NCT04235374|520218580|FG000|Overall Study|Refused|2|||
144278268|NCT04235374|520218581|FG001|Overall Study|Refused|2|||
144278269|NCT04235374|520218580|FG000|Overall Study|Unavailable|12|||
144278270|NCT04235374|520218581|FG001|Overall Study|Unavailable|3|||
144278271|NCT04235374|520218580|FG000|Overall Study|Withdrawal by Subject|0|||
144278272|NCT04235374|520218581|FG001|Overall Study|Withdrawal by Subject|1|||
144278273|NCT04235374|520218580|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
144278274|NCT04235374|520218581|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
144278275|NCT00314145|520218582|FG000|Overall Study|Withdrawal by Subject|8|||
144278276|NCT00314145|520218583|FG001|Overall Study|Withdrawal by Subject|10|||
144278277|NCT00314145|520218582|FG000|Overall Study|Lost to Follow-up|5|||
144278278|NCT00314145|520218583|FG001|Overall Study|Lost to Follow-up|12|||
144278279|NCT00314145|520218582|FG000|Overall Study|Physician Decision|3|||
144278280|NCT00314145|520218583|FG001|Overall Study|Physician Decision|4|||
144278281|NCT00314145|520218582|FG000|Overall Study|Adverse Event|0|||
144278282|NCT00314145|520218583|FG001|Overall Study|Adverse Event|3|||
144278283|NCT00314145|520218582|FG000|Overall Study|Protocol Violation|3|||
144278284|NCT00314145|520218583|FG001|Overall Study|Protocol Violation|0|||
144278285|NCT00314145|520218582|FG000|Overall Study|Sponsor Decision|2|||
144278286|NCT00314145|520218583|FG001|Overall Study|Sponsor Decision|0|||
144278287|NCT02572167|520218584|FG000|Overall Study|Withdrawal by Subject|0|||
144278288|NCT02572167|520218585|FG001|Overall Study|Withdrawal by Subject|3|||
144278289|NCT02572167|520218586|FG002|Overall Study|Withdrawal by Subject|0|||
144278290|NCT02572167|520218584|FG000|Overall Study|Lost to Follow-up|2|||
144278291|NCT02572167|520218585|FG001|Overall Study|Lost to Follow-up|5|||
144278292|NCT02572167|520218586|FG002|Overall Study|Lost to Follow-up|3|||
144278293|NCT02572167|520218584|FG000|Overall Study|Death|0|||
144278294|NCT02572167|520218585|FG001|Overall Study|Death|8|||
144278295|NCT02572167|520218586|FG002|Overall Study|Death|3|||
144278296|NCT02572167|520218584|FG000|Overall Study|Did not meet inclusion criteria|0|||
144278297|NCT02572167|520218585|FG001|Overall Study|Did not meet inclusion criteria|0|||
144278298|NCT02572167|520218586|FG002|Overall Study|Did not meet inclusion criteria|1|||
144278299|NCT02572167|520218584|FG000|Overall Study|Study closure by Sponsor|4|||
144278300|NCT02572167|520218585|FG001|Overall Study|Study closure by Sponsor|40|||
144278301|NCT02572167|520218586|FG002|Overall Study|Study closure by Sponsor|24|||
144278302|NCT04435626|520218593|FG000|Overall Study|Lost to Follow-up|1|||
144278303|NCT04435626|520218594|FG001|Overall Study|Lost to Follow-up|5|||
144278304|NCT04435626|520218593|FG000|Overall Study|Withdrawal by Subject|6|||
144243937|NCT04442269|520090383|FG001|Overall Study|Death|1|||
144243938|NCT04442269|520090382|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
144243939|NCT04442269|520090383|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
144243940|NCT04442269|520090382|FG000|Overall Study|Lost to Follow-up|1|||
144243941|NCT04442269|520090383|FG001|Overall Study|Lost to Follow-up|0|||
144243942|NCT04442269|520090382|FG000|Overall Study|Withdrawal by Subject|3|||
144243943|NCT04442269|520090383|FG001|Overall Study|Withdrawal by Subject|2|||
144243944|NCT04442269|520090382|FG000|Overall Study|Protocol Deviation|0|||
144243945|NCT04442269|520090383|FG001|Overall Study|Protocol Deviation|1|||
144243946|NCT04442269|520090382|FG000|Overall Study|Travel Limitations|1|||
144243947|NCT04442269|520090383|FG001|Overall Study|Travel Limitations|1|||
144243948|NCT03802565|520090387|FG000|Overall Study|Adverse Event|0|||
144243949|NCT03802565|520090388|FG001|Overall Study|Adverse Event|1|||
144243950|NCT03802565|520090389|FG002|Overall Study|Adverse Event|2|||
144243951|NCT03802565|520090390|FG003|Overall Study|Adverse Event|1|||
144243952|NCT03802565|520090391|FG004|Overall Study|Adverse Event|1|||
144243953|NCT03802565|520090387|FG000|Overall Study|Withdrawal by Subject|2|||
144243954|NCT03802565|520090388|FG001|Overall Study|Withdrawal by Subject|2|||
144243955|NCT03802565|520090389|FG002|Overall Study|Withdrawal by Subject|2|||
144243956|NCT03802565|520090390|FG003|Overall Study|Withdrawal by Subject|0|||
144243957|NCT03802565|520090391|FG004|Overall Study|Withdrawal by Subject|1|||
144243958|NCT03802565|520090387|FG000|Overall Study|Protocol Violation|2|||
144243959|NCT03802565|520090388|FG001|Overall Study|Protocol Violation|1|||
144243960|NCT03802565|520090389|FG002|Overall Study|Protocol Violation|4|||
144243961|NCT03802565|520090390|FG003|Overall Study|Protocol Violation|5|||
144243962|NCT03802565|520090391|FG004|Overall Study|Protocol Violation|1|||
144243963|NCT03802565|520090387|FG000|Overall Study|Lost to Follow-up|0|||
144243964|NCT03802565|520090388|FG001|Overall Study|Lost to Follow-up|0|||
144243965|NCT03802565|520090389|FG002|Overall Study|Lost to Follow-up|1|||
144243966|NCT03802565|520090390|FG003|Overall Study|Lost to Follow-up|0|||
144243967|NCT03802565|520090391|FG004|Overall Study|Lost to Follow-up|0|||
144278305|NCT04435626|520218594|FG001|Overall Study|Withdrawal by Subject|7|||
144278306|NCT04435626|520218593|FG000|Overall Study|major GCP violations|8|||
144278307|NCT04435626|520218594|FG001|Overall Study|major GCP violations|7|||
144278308|NCT00658528|520218600|FG000|Overall Study|Adverse Event|5|||
144278309|NCT00658528|520218601|FG001|Overall Study|Adverse Event|7|||
144278310|NCT00658528|520218600|FG000|Overall Study|Lost to Follow-up|14|||
144278311|NCT00658528|520218601|FG001|Overall Study|Lost to Follow-up|22|||
144278312|NCT00658528|520218600|FG000|Overall Study|Withdrawal by Subject|8|||
144278313|NCT00658528|520218601|FG001|Overall Study|Withdrawal by Subject|6|||
144278314|NCT00658528|520218600|FG000|Overall Study|Withdrawal of consent|5|||
144278315|NCT00658528|520218601|FG001|Overall Study|Withdrawal of consent|6|||
144278316|NCT00658528|520218600|FG000|Overall Study|Other|8|||
144278317|NCT00658528|520218601|FG001|Overall Study|Other|4|||
144278318|NCT03595748|520220085|FG000|Overall Study|Death|11|||
144278319|NCT03595748|520220086|FG001|Overall Study|Death|12|||
144278320|NCT03595748|520220085|FG000|Overall Study|Withdrawal by Subject|28|||
144278321|NCT03595748|520220086|FG001|Overall Study|Withdrawal by Subject|29|||
144278322|NCT03595748|520220085|FG000|Overall Study|Protocol Violation|0|||
144278323|NCT03595748|520220086|FG001|Overall Study|Protocol Violation|1|||
144278324|NCT04809974|520220087|FG000|Lead-in Phase|Withdrawal by Subject|3|||
144278325|NCT04809974|520220088|FG001|Lead-in Phase|Withdrawal by Subject|0|||
144278326|NCT04809974|520220089|FG002|Lead-in Phase|Withdrawal by Subject|0|||
144278327|NCT04809974|520220087|FG000|Lead-in Phase|No longer eligible|11|||
144278328|NCT04809974|520220088|FG001|Lead-in Phase|No longer eligible|0|||
144278329|NCT04809974|520220089|FG002|Lead-in Phase|No longer eligible|0|||
144278330|NCT04809974|520220087|FG000|Randomized Phase|Lost to Follow-up|0|||
144278331|NCT04809974|520220088|FG001|Randomized Phase|Lost to Follow-up|1|||
144278332|NCT04809974|520220089|FG002|Randomized Phase|Lost to Follow-up|5|||
144278333|NCT04809974|520220087|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
144278334|NCT04809974|520220088|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
144278335|NCT04809974|520220089|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
144278336|NCT04809974|520220087|FG000|Randomized Phase|Adverse Event|0|||
144278337|NCT04809974|520220088|FG001|Randomized Phase|Adverse Event|1|||
144278338|NCT04809974|520220089|FG002|Randomized Phase|Adverse Event|4|||
144278339|NCT04809974|520220087|FG000|Randomized Phase|Withdrawal by Subject|0|||
144278340|NCT04809974|520220088|FG001|Randomized Phase|Withdrawal by Subject|0|||
144278341|NCT04809974|520220089|FG002|Randomized Phase|Withdrawal by Subject|5|||
144278342|NCT00770809|520220090|FG000|Overall Study|Adverse Event|9|||
144278343|NCT00770809|520220091|FG001|Overall Study|Adverse Event|1|||
144278344|NCT00770809|520220092|FG002|Overall Study|Adverse Event|12|||
144278345|NCT00770809|520220090|FG000|Overall Study|Death|1|||
144278346|NCT00770809|520220091|FG001|Overall Study|Death|0|||
144278347|NCT00770809|520220092|FG002|Overall Study|Death|0|||
144278348|NCT00770809|520220090|FG000|Overall Study|Withdrawal by Subject|3|||
144278349|NCT00770809|520220091|FG001|Overall Study|Withdrawal by Subject|3|||
144278350|NCT00770809|520220092|FG002|Overall Study|Withdrawal by Subject|7|||
144278351|NCT00770809|520220090|FG000|Overall Study|Progression|2|||
144278352|NCT00770809|520220091|FG001|Overall Study|Progression|2|||
144278353|NCT00770809|520220092|FG002|Overall Study|Progression|0|||
144278354|NCT00770809|520220090|FG000|Overall Study|Complicating illness|0|||
144278355|NCT00770809|520220091|FG001|Overall Study|Complicating illness|0|||
144278356|NCT00770809|520220092|FG002|Overall Study|Complicating illness|1|||
144278357|NCT00770809|520220090|FG000|Overall Study|Other Medical Reasons|2|||
144278358|NCT00770809|520220091|FG001|Overall Study|Other Medical Reasons|4|||
144278359|NCT00770809|520220092|FG002|Overall Study|Other Medical Reasons|3|||
144278360|NCT00690898|520220093|FG000|SCREENING|Screen failure|18|||
144278361|NCT00690898|520220093|FG000|TREATMENT|Adverse Event|3|||
144278362|NCT00690898|520220093|FG000|TREATMENT|Lack of Efficacy|18|||
144278363|NCT00690898|520220093|FG000|TREATMENT|Withdrawal by Subject|4|||
144278364|NCT00690898|520220093|FG000|TREATMENT|Other (not otherwise specified)|1|||
144278365|NCT05977868|520220094|FG000|Overall Study|Withdrawal by Subject|1|||
144278366|NCT05977868|520220095|FG001|Overall Study|Withdrawal by Subject|2|||
144278367|NCT05977868|520220094|FG000|Overall Study|Transitioned to comfort care|1|||
144278368|NCT05977868|520220095|FG001|Overall Study|Transitioned to comfort care|0|||
144278369|NCT01136954|520220102|FG000|Overall Study|Adverse Event|3|||
144278370|NCT01136954|520220103|FG001|Overall Study|Adverse Event|2|||
144278371|NCT01136954|520220102|FG000|Overall Study|Withdrawal by Subject|6|||
144278372|NCT01136954|520220103|FG001|Overall Study|Withdrawal by Subject|2|||
144278373|NCT01136954|520220102|FG000|Overall Study|Lack of Efficacy|14|||
144278374|NCT01136954|520220103|FG001|Overall Study|Lack of Efficacy|13|||
144278375|NCT01136954|520220102|FG000|Overall Study|Physician Decision|0|||
144278376|NCT01136954|520220103|FG001|Overall Study|Physician Decision|1|||
144278377|NCT01136954|520220102|FG000|Overall Study|Other|1|||
144278378|NCT01136954|520220103|FG001|Overall Study|Other|3|||
144278379|NCT05696847|520220108|FG000|Overall Study|Withdrawal by Subject|1|||
144278380|NCT05696847|520220109|FG001|Overall Study|Withdrawal by Subject|0|||
144278381|NCT05696847|520220110|FG002|Overall Study|Withdrawal by Subject|0|||
144278382|NCT05696847|520220111|FG003|Overall Study|Withdrawal by Subject|0|||
144278383|NCT05696847|520220112|FG004|Overall Study|Withdrawal by Subject|0|||
144278384|NCT05696847|520220113|FG005|Overall Study|Withdrawal by Subject|0|||
144278385|NCT05696847|520220108|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144278386|NCT05696847|520220109|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144278387|NCT05696847|520220110|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144278388|NCT05696847|520220111|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
144278389|NCT05696847|520220112|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
144278390|NCT05696847|520220113|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
144278391|NCT05696847|520220108|FG000|Overall Study|Adverse Event|0|||
144278392|NCT05696847|520220109|FG001|Overall Study|Adverse Event|0|||
144278393|NCT05696847|520220110|FG002|Overall Study|Adverse Event|0|||
144278394|NCT05696847|520220111|FG003|Overall Study|Adverse Event|0|||
144278395|NCT05696847|520220112|FG004|Overall Study|Adverse Event|0|||
144278396|NCT05696847|520220113|FG005|Overall Study|Adverse Event|1|||
144278397|NCT05696847|520220108|FG000|Overall Study|Sponsor Decision|0|||
144278398|NCT05696847|520220109|FG001|Overall Study|Sponsor Decision|0|||
144278399|NCT05696847|520220110|FG002|Overall Study|Sponsor Decision|0|||
144278400|NCT05696847|520220111|FG003|Overall Study|Sponsor Decision|1|||
144278401|NCT05696847|520220112|FG004|Overall Study|Sponsor Decision|0|||
144278402|NCT05696847|520220113|FG005|Overall Study|Sponsor Decision|0|||
144278403|NCT01697579|520220114|FG000|Base Study-Cycle 1|Adverse Event|1|||
144278404|NCT01697579|520220115|FG001|Base Study-Cycle 1|Adverse Event|0|||
144278405|NCT01697579|520220116|FG002|Base Study-Cycle 1|Adverse Event|0|||
144278406|NCT01697579|520220117|FG003|Base Study-Cycle 1|Adverse Event|0|||
144278407|NCT01697579|520220118|FG004|Base Study-Cycle 1|Adverse Event|0|||
144278408|NCT01697579|520220119|FG005|Base Study-Cycle 1|Adverse Event|0|||
144278409|NCT01697579|520220120|FG006|Base Study-Cycle 1|Adverse Event|0|||
144278410|NCT01697579|520220114|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
144278411|NCT01697579|520220115|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
144278412|NCT01697579|520220116|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
144278413|NCT01697579|520220117|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
144278414|NCT01697579|520220118|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
144278415|NCT01697579|520220119|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
144278416|NCT01697579|520220120|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
144278417|NCT01697579|520220114|FG000|Base Study-Cycle 1|Protocol Violation|0|||
144278418|NCT01697579|520220115|FG001|Base Study-Cycle 1|Protocol Violation|0|||
144278419|NCT01697579|520220116|FG002|Base Study-Cycle 1|Protocol Violation|0|||
144278420|NCT01697579|520220117|FG003|Base Study-Cycle 1|Protocol Violation|0|||
144278421|NCT01697579|520220118|FG004|Base Study-Cycle 1|Protocol Violation|3|||
144278422|NCT01697579|520220119|FG005|Base Study-Cycle 1|Protocol Violation|0|||
144278423|NCT01697579|520220120|FG006|Base Study-Cycle 1|Protocol Violation|0|||
144278424|NCT01697579|520220114|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
144278425|NCT01697579|520220115|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
144278426|NCT01697579|520220116|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
144278427|NCT01697579|520220117|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
144278428|NCT01697579|520220118|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
144278429|NCT01697579|520220119|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
144278430|NCT01697579|520220120|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
144278431|NCT01697579|520220114|FG000|Base Study-Cycle 1|Technical Problems|0|||
144278432|NCT01697579|520220115|FG001|Base Study-Cycle 1|Technical Problems|0|||
144278433|NCT01697579|520220116|FG002|Base Study-Cycle 1|Technical Problems|1|||
144278434|NCT01697579|520220117|FG003|Base Study-Cycle 1|Technical Problems|1|||
144278435|NCT01697579|520220118|FG004|Base Study-Cycle 1|Technical Problems|0|||
144278436|NCT01697579|520220119|FG005|Base Study-Cycle 1|Technical Problems|0|||
144278437|NCT01697579|520220120|FG006|Base Study-Cycle 1|Technical Problems|0|||
144278438|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Death|0|||
144278439|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Death|0|||
144278440|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Death|0|||
144278441|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Death|0|||
144278442|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Death|0|||
144278443|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Death|0|||
144278444|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Death|2|||
144278445|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144278446|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144278447|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144278448|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144278449|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144278450|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
144278451|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
144278452|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
144278453|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
144278454|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
144278455|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
144278456|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
144278457|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
144278458|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
144278459|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
144278460|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
144278461|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
144278462|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
144278463|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
144278464|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
144278465|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
144278466|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
144278467|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
144278468|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
144278469|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
144278470|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
144278471|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
144278472|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
144278473|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
144278474|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
144278475|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
144278476|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
144278477|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
144278478|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
144278479|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
144278480|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
144278481|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
144278482|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
144278483|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
144278484|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
144278485|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
144278486|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
144278487|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
144278488|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
144278489|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
144278490|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
144278491|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
144278492|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
144278493|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
144278494|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
144278495|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
144278496|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
144278497|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
144278498|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
144278499|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
144278500|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
144278501|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
144278502|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
144278503|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
144278504|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
144278505|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
144278506|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
144278507|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
144278508|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
144278509|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
144278510|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
144278511|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
144278512|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
144278513|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
144278514|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
144278515|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
144278516|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
144278517|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
144278518|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
144278519|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
144278520|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
144278521|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
144278522|NCT01697579|520220114|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
144278523|NCT01697579|520220115|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
144278524|NCT01697579|520220116|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
144278525|NCT01697579|520220117|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
144278526|NCT01697579|520220118|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
144278527|NCT01697579|520220119|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
144278528|NCT01697579|520220120|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
144278529|NCT03112603|520220123|FG000|End of Randomization Period|Lost to Follow-up|3|||
144278530|NCT03112603|520220124|FG001|End of Randomization Period|Lost to Follow-up|0|||
144278531|NCT03112603|520220125|FG002|End of Randomization Period|Lost to Follow-up|0|||
144278532|NCT03112603|520220123|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
144278533|NCT03112603|520220124|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
144278534|NCT03112603|520220125|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
144278535|NCT03112603|520220123|FG000|End of Randomization Period|Physician Decision|43|||
144278536|NCT03112603|520220124|FG001|End of Randomization Period|Physician Decision|18|||
144278537|NCT03112603|520220125|FG002|End of Randomization Period|Physician Decision|0|||
144278538|NCT03112603|520220123|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
144278539|NCT03112603|520220124|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
144278540|NCT03112603|520220125|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
144278541|NCT03112603|520220123|FG000|End of Randomization Period|Death|10|||
144278542|NCT03112603|520220124|FG001|End of Randomization Period|Death|7|||
144278543|NCT03112603|520220125|FG002|End of Randomization Period|Death|0|||
144278544|NCT03112603|520220123|FG000|End of Randomization Period|Disease Relapse|12|||
144278545|NCT03112603|520220124|FG001|End of Randomization Period|Disease Relapse|7|||
144278546|NCT03112603|520220125|FG002|End of Randomization Period|Disease Relapse|0|||
144278547|NCT03112603|520220123|FG000|End of Randomization Period|Lack of Efficacy|25|||
144278548|NCT03112603|520220124|FG001|End of Randomization Period|Lack of Efficacy|77|||
144278549|NCT03112603|520220125|FG002|End of Randomization Period|Lack of Efficacy|0|||
144278550|NCT03112603|520220123|FG000|End of Randomization Period|Adverse Event|32|||
144278551|NCT03112603|520220124|FG001|End of Randomization Period|Adverse Event|12|||
144278552|NCT03112603|520220125|FG002|End of Randomization Period|Adverse Event|0|||
144278553|NCT03112603|520220123|FG000|End of Cross Over Period|Death|0|||
144278554|NCT03112603|520220124|FG001|End of Cross Over Period|Death|0|||
144278555|NCT03112603|520220125|FG002|End of Cross Over Period|Death|2|||
144278556|NCT03112603|520220123|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
144278557|NCT03112603|520220124|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
144278558|NCT03112603|520220125|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
144278559|NCT03112603|520220123|FG000|End of Cross Over Period|Physician Decision|0|||
144278560|NCT03112603|520220124|FG001|End of Cross Over Period|Physician Decision|0|||
144278561|NCT03112603|520220125|FG002|End of Cross Over Period|Physician Decision|29|||
144278562|NCT03112603|520220123|FG000|End of Cross Over Period|Lack of Efficacy|0|||
144278563|NCT03112603|520220124|FG001|End of Cross Over Period|Lack of Efficacy|0|||
144278564|NCT03112603|520220125|FG002|End of Cross Over Period|Lack of Efficacy|8|||
144278565|NCT03112603|520220123|FG000|End of Cross Over Period|Adverse Event|0|||
144278566|NCT03112603|520220124|FG001|End of Cross Over Period|Adverse Event|0|||
144278567|NCT03112603|520220125|FG002|End of Cross Over Period|Adverse Event|6|||
144278568|NCT03112603|520220123|FG000|End of Cross Over Period|Disease Relapse|0|||
144278569|NCT03112603|520220124|FG001|End of Cross Over Period|Disease Relapse|0|||
144278570|NCT03112603|520220125|FG002|End of Cross Over Period|Disease Relapse|2|||
144278571|NCT00207740|520220126|FG000|Overall Study|Adverse Event|4|||
144278572|NCT00207740|520220127|FG001|Overall Study|Adverse Event|14|||
144278573|NCT00207740|520220128|FG002|Overall Study|Adverse Event|14|||
144278574|NCT00207740|520220129|FG003|Overall Study|Adverse Event|11|||
144278575|NCT00207740|520220126|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144278576|NCT00207740|520220127|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144278577|NCT00207740|520220128|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144278578|NCT00207740|520220129|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
144278579|NCT00207740|520220126|FG000|Overall Study|Lost to Follow-up|0|||
144278580|NCT00207740|520220127|FG001|Overall Study|Lost to Follow-up|2|||
144278581|NCT00207740|520220128|FG002|Overall Study|Lost to Follow-up|1|||
144278582|NCT00207740|520220129|FG003|Overall Study|Lost to Follow-up|1|||
144278583|NCT00207740|520220126|FG000|Overall Study|Death|0|||
144278584|NCT00207740|520220127|FG001|Overall Study|Death|0|||
144278585|NCT00207740|520220128|FG002|Overall Study|Death|0|||
144278586|NCT00207740|520220129|FG003|Overall Study|Death|1|||
144278587|NCT00207740|520220126|FG000|Overall Study|Sponsor Directive|22|||
144278588|NCT00207740|520220127|FG001|Overall Study|Sponsor Directive|15|||
144278589|NCT00207740|520220128|FG002|Overall Study|Sponsor Directive|16|||
144278590|NCT00207740|520220129|FG003|Overall Study|Sponsor Directive|21|||
144278591|NCT00207740|520220126|FG000|Overall Study|Other|2|||
144278592|NCT00207740|520220127|FG001|Overall Study|Other|10|||
144278593|NCT00207740|520220128|FG002|Overall Study|Other|7|||
144278594|NCT00207740|520220129|FG003|Overall Study|Other|5|||
144278595|NCT03916926|520220131|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
144278596|NCT03916926|520220132|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
144278597|NCT03916926|520220131|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
144278598|NCT03916926|520220132|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
144278599|NCT03916926|520220131|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
144278600|NCT03916926|520220132|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
144278601|NCT03916926|520220131|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
144278602|NCT03916926|520220132|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
144278603|NCT04725188|520220133|FG000|Overall Study|Death|72|||
144278604|NCT04725188|520220134|FG001|Overall Study|Death|69|||
144278605|NCT04725188|520220135|FG002|Overall Study|Death|76|||
144278606|NCT04725188|520220133|FG000|Overall Study|Lost to Follow-up|1|||
144278607|NCT04725188|520220134|FG001|Overall Study|Lost to Follow-up|0|||
144278608|NCT04725188|520220135|FG002|Overall Study|Lost to Follow-up|1|||
144278609|NCT04725188|520220133|FG000|Overall Study|Withdrawal by Subject|2|||
144278610|NCT04725188|520220134|FG001|Overall Study|Withdrawal by Subject|2|||
144278611|NCT04725188|520220135|FG002|Overall Study|Withdrawal by Subject|1|||
144278612|NCT04725188|520220133|FG000|Overall Study|Sponsor Decision|12|||
144278613|NCT04725188|520220134|FG001|Overall Study|Sponsor Decision|12|||
144278614|NCT04725188|520220135|FG002|Overall Study|Sponsor Decision|7|||
144278615|NCT04225039|520220140|FG000|Overall Study|Withdrawal by Subject|1|||
144278616|NCT04225039|520220141|FG001|Overall Study|Withdrawal by Subject|0|||
144278617|NCT04225039|520220142|FG002|Overall Study|Withdrawal by Subject|0|||
144278618|NCT04225039|520220143|FG003|Overall Study|Withdrawal by Subject|1|||
144278619|NCT04225039|520220140|FG000|Overall Study|Currently active on study treatment|0|||
144278620|NCT04225039|520220141|FG001|Overall Study|Currently active on study treatment|1|||
144278621|NCT04225039|520220142|FG002|Overall Study|Currently active on study treatment|0|||
144278622|NCT04225039|520220143|FG003|Overall Study|Currently active on study treatment|0|||
144278623|NCT04225039|520220140|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
144278624|NCT04225039|520220141|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
144278625|NCT04225039|520220142|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
144278626|NCT04225039|520220143|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
144278627|NCT04225039|520220140|FG000|Overall Study|Ineligible for treatment|0|||
144278628|NCT04225039|520220141|FG001|Overall Study|Ineligible for treatment|0|||
144278629|NCT04225039|520220142|FG002|Overall Study|Ineligible for treatment|0|||
144278630|NCT04225039|520220143|FG003|Overall Study|Ineligible for treatment|4|||
144278631|NCT00088153|520220146|FG000|Overall Study|Physician Decision|3|||
144278632|NCT00088153|520220147|FG001|Overall Study|Physician Decision|3|||
144278633|NCT00088153|520220146|FG000|Overall Study|Withdrawal by Subject|10|||
144278634|NCT00088153|520220147|FG001|Overall Study|Withdrawal by Subject|10|||
144278635|NCT00088153|520220146|FG000|Overall Study|Lost to Follow-up|11|||
144278636|NCT00088153|520220147|FG001|Overall Study|Lost to Follow-up|12|||
144278637|NCT00976027|520220148|FG000|Overall Study|Serious Adverse Event|36|||
144278638|NCT00976027|520220149|FG001|Overall Study|Serious Adverse Event|17|||
144278639|NCT00976027|520220148|FG000|Overall Study|Adverse Event|0|||
144278640|NCT00976027|520220149|FG001|Overall Study|Adverse Event|2|||
144278641|NCT00976027|520220148|FG000|Overall Study|Protocol Violation|60|||
144278642|NCT00976027|520220149|FG001|Overall Study|Protocol Violation|27|||
144278643|NCT00976027|520220148|FG000|Overall Study|Lost to Follow-up|208|||
144278644|NCT00976027|520220149|FG001|Overall Study|Lost to Follow-up|103|||
144278645|NCT00976027|520220148|FG000|Overall Study|Withdrawal by Subject|107|||
144278646|NCT00976027|520220149|FG001|Overall Study|Withdrawal by Subject|66|||
144278647|NCT01771107|520220152|FG000|Overall Study|Adverse Event|1|||
144278648|NCT01771107|520220153|FG001|Overall Study|Adverse Event|3|||
144278649|NCT01771107|520220152|FG000|Overall Study|Withdrawal by Subject|0|||
144278650|NCT01771107|520220153|FG001|Overall Study|Withdrawal by Subject|2|||
144278651|NCT01771107|520220152|FG000|Overall Study|Lost to Follow-up|0|||
144278652|NCT01771107|520220153|FG001|Overall Study|Lost to Follow-up|1|||
144278653|NCT01771107|520220152|FG000|Overall Study|participant moved|0|||
144278654|NCT01771107|520220153|FG001|Overall Study|participant moved|1|||
144278655|NCT01771107|520220152|FG000|Overall Study|Other|0|||
144278656|NCT01771107|520220153|FG001|Overall Study|Other|1|||
144278657|NCT02296125|520220158|FG000|Overall Study|Withdrawal by Subject|18|||
144278658|NCT02296125|520220159|FG001|Overall Study|Withdrawal by Subject|8|||
144278659|NCT02296125|520220160|FG002|Overall Study|Withdrawal by Subject|6|||
144278660|NCT02296125|520220161|FG003|Overall Study|Withdrawal by Subject|2|||
144278661|NCT02296125|520220158|FG000|Overall Study|Adverse Event|41|||
144278662|NCT02296125|520220159|FG001|Overall Study|Adverse Event|52|||
144278663|NCT02296125|520220160|FG002|Overall Study|Adverse Event|9|||
144278664|NCT02296125|520220161|FG003|Overall Study|Adverse Event|4|||
144278665|NCT02296125|520220158|FG000|Overall Study|Severe non-compliance to protocol|0|||
144278666|NCT02296125|520220159|FG001|Overall Study|Severe non-compliance to protocol|1|||
144278667|NCT02296125|520220160|FG002|Overall Study|Severe non-compliance to protocol|0|||
144278668|NCT02296125|520220161|FG003|Overall Study|Severe non-compliance to protocol|0|||
144278669|NCT02296125|520220158|FG000|Overall Study|Condition under investigation worsened|153|||
144278670|NCT02296125|520220159|FG001|Overall Study|Condition under investigation worsened|199|||
144243968|NCT03802565|520090387|FG000|Overall Study|Subjects Related to Each Other|1|||
144243969|NCT03802565|520090388|FG001|Overall Study|Subjects Related to Each Other|0|||
144243970|NCT03802565|520090389|FG002|Overall Study|Subjects Related to Each Other|0|||
144243971|NCT03802565|520090390|FG003|Overall Study|Subjects Related to Each Other|2|||
144243972|NCT03802565|520090391|FG004|Overall Study|Subjects Related to Each Other|1|||
144243973|NCT03802565|520090387|FG000|Overall Study|Elevated Enzymes|0|||
144243974|NCT03802565|520090388|FG001|Overall Study|Elevated Enzymes|0|||
144243975|NCT03802565|520090389|FG002|Overall Study|Elevated Enzymes|0|||
144243976|NCT03802565|520090390|FG003|Overall Study|Elevated Enzymes|0|||
144243977|NCT03802565|520090391|FG004|Overall Study|Elevated Enzymes|2|||
144243978|NCT04326439|520090392|FG000|Overall Study|Withdrawal by Subject|1|||
144243979|NCT04326439|520090393|FG001|Overall Study|Withdrawal by Subject|0|||
144243980|NCT04326439|520090392|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
144243981|NCT04326439|520090393|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
144243982|NCT04326439|520090392|FG000|Overall Study|Relapse after Induction 2|0|||
144243983|NCT04326439|520090393|FG001|Overall Study|Relapse after Induction 2|1|||
144243984|NCT04326439|520090392|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
144243985|NCT04326439|520090393|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
144243986|NCT03932331|520090397|FG000|Overall Study|Death|0|||
144243987|NCT03932331|520090398|FG001|Overall Study|Death|7|||
144243988|NCT03932331|520090399|FG002|Overall Study|Death|2|||
144243989|NCT03932331|520090397|FG000|Overall Study|Withdrawal by Subject|0|||
144243990|NCT03932331|520090398|FG001|Overall Study|Withdrawal by Subject|3|||
144243991|NCT03932331|520090399|FG002|Overall Study|Withdrawal by Subject|0|||
144243992|NCT03932331|520090397|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
144243993|NCT03932331|520090398|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
144243994|NCT03932331|520090399|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
144243995|NCT03932331|520090397|FG000|Overall Study|Progressive disease|3|||
144243996|NCT03932331|520090398|FG001|Overall Study|Progressive disease|0|||
144243997|NCT03932331|520090399|FG002|Overall Study|Progressive disease|0|||
144243998|NCT03932331|520090397|FG000|Overall Study|Lung infection|1|||
144243999|NCT03932331|520090398|FG001|Overall Study|Lung infection|0|||
144244000|NCT03932331|520090399|FG002|Overall Study|Lung infection|0|||
144244001|NCT03932331|520090397|FG000|Overall Study|Other|0|||
144244002|NCT03932331|520090398|FG001|Overall Study|Other|0|||
144244003|NCT03932331|520090399|FG002|Overall Study|Other|58|||
144244004|NCT01032239|520090400|FG000|Overall Study|Lost to Follow-up|3|||
144244005|NCT01032239|520090401|FG001|Overall Study|Lost to Follow-up|2|||
144244006|NCT01032239|520090400|FG000|Overall Study|Withdrawal by Subject|2|||
144244007|NCT01032239|520090401|FG001|Overall Study|Withdrawal by Subject|3|||
144244008|NCT01032239|520090400|FG000|Overall Study|Death|1|||
144244009|NCT01032239|520090401|FG001|Overall Study|Death|0|||
144244010|NCT01032239|520090400|FG000|Overall Study|Protocol Violation|1|||
144244011|NCT01032239|520090401|FG001|Overall Study|Protocol Violation|0|||
144244012|NCT01940900|520090402|FG000|Overall Study|Physician Decision|4|||
144244013|NCT01940900|520090403|FG001|Overall Study|Physician Decision|0|||
144244014|NCT01940900|520090402|FG000|Overall Study|Adverse Event|10|||
144244015|NCT01940900|520090403|FG001|Overall Study|Adverse Event|15|||
144244016|NCT01940900|520090402|FG000|Overall Study|Withdrawal by Subject|11|||
144244017|NCT01940900|520090403|FG001|Overall Study|Withdrawal by Subject|15|||
144244018|NCT01940900|520090402|FG000|Overall Study|Lost to Follow-up|1|||
144244019|NCT01940900|520090403|FG001|Overall Study|Lost to Follow-up|0|||
144244020|NCT01940900|520090402|FG000|Overall Study|Sponsor Decision|1|||
144244021|NCT01940900|520090403|FG001|Overall Study|Sponsor Decision|0|||
144244022|NCT01940900|520090402|FG000|Overall Study|subject non-compliance|1|||
144244023|NCT01940900|520090403|FG001|Overall Study|subject non-compliance|1|||
144244024|NCT01940900|520090402|FG000|Overall Study|other|1|||
144244025|NCT01940900|520090403|FG001|Overall Study|other|0|||
144244026|NCT03782298|520090406|FG000|Overall Study|Protocol Deviation|4|||
144244027|NCT00742508|520090407|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
144244028|NCT00742508|520090408|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
144244029|NCT00742508|520090407|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
144244030|NCT00742508|520090408|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
144244031|NCT00742508|520090407|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
144244032|NCT00742508|520090408|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
144244033|NCT00742508|520090407|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
144244034|NCT00742508|520090408|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
144244035|NCT00742508|520090407|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
144244036|NCT00742508|520090408|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
144244037|NCT02431806|520090409|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
144244038|NCT02431806|520090410|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
144244039|NCT02431806|520090411|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
144278671|NCT02296125|520220160|FG002|Overall Study|Condition under investigation worsened|39|||
144278672|NCT02296125|520220161|FG003|Overall Study|Condition under investigation worsened|56|||
144278673|NCT02296125|520220158|FG000|Overall Study|Any reason not specifically recorded|6|||
144278674|NCT02296125|520220159|FG001|Overall Study|Any reason not specifically recorded|4|||
144278675|NCT02296125|520220160|FG002|Overall Study|Any reason not specifically recorded|2|||
144278676|NCT02296125|520220161|FG003|Overall Study|Any reason not specifically recorded|0|||
144278677|NCT01160614|520220162|FG000|Overall Study|Withdrawal by Subject|0|||
144278678|NCT01160614|520220163|FG001|Overall Study|Withdrawal by Subject|2|||
144278679|NCT05248386|520220164|FG000|Overall Study|Technical problems|0|||
144278680|NCT05248386|520220165|FG001|Overall Study|Technical problems|1|||
144278681|NCT05248386|520220164|FG000|Overall Study|Withdrawal by Subject|15|||
144278682|NCT05248386|520220165|FG001|Overall Study|Withdrawal by Subject|10|||
144278683|NCT05248386|520220164|FG000|Overall Study|Physician Decision|0|||
144278684|NCT05248386|520220165|FG001|Overall Study|Physician Decision|1|||
144278685|NCT05248386|520220164|FG000|Overall Study|Adverse Event|2|||
144278686|NCT05248386|520220165|FG001|Overall Study|Adverse Event|4|||
144278687|NCT05248386|520220164|FG000|Overall Study|Other|1|||
144278688|NCT05248386|520220165|FG001|Overall Study|Other|0|||
144278689|NCT05248386|520220164|FG000|Overall Study|Lack of Efficacy|14|||
144278690|NCT05248386|520220165|FG001|Overall Study|Lack of Efficacy|12|||
144278691|NCT02864992|520220166|FG000|Overall Study|still on treatment|15|||
144278692|NCT02864992|520220167|FG001|Overall Study|still on treatment|1|||
144278693|NCT02864992|520220168|FG002|Overall Study|still on treatment|33|||
144278694|NCT03621592|520220169|FG000|Overall Study|Lost to Follow-up|1|||
144278695|NCT03621592|520220170|FG001|Overall Study|Lost to Follow-up|0|||
144278696|NCT03621592|520220169|FG000|Overall Study|Lack of Improvement|1|||
144278697|NCT03621592|520220170|FG001|Overall Study|Lack of Improvement|0|||
144278698|NCT03621592|520220169|FG000|Overall Study|Preference to receive wound care closer to home|1|||
144278699|NCT03621592|520220170|FG001|Overall Study|Preference to receive wound care closer to home|0|||
144278700|NCT03621592|520220169|FG000|Overall Study|Lack of healing|0|||
144278701|NCT03621592|520220170|FG001|Overall Study|Lack of healing|2|||
144278702|NCT04967222|520220172|FG000|Randomized|Lost to Follow-up|0|||
144278703|NCT04967222|520220173|FG001|Randomized|Lost to Follow-up|1|||
144278704|NCT04967222|520220174|FG002|Randomized|Lost to Follow-up|1|||
144278705|NCT04967222|520220172|FG000|Randomized|Physician Decision|0|||
144278706|NCT04967222|520220173|FG001|Randomized|Physician Decision|0|||
144278707|NCT04967222|520220174|FG002|Randomized|Physician Decision|1|||
144278708|NCT04967222|520220172|FG000|Randomized|Withdrawal by Subject|0|||
144278709|NCT04967222|520220173|FG001|Randomized|Withdrawal by Subject|0|||
144278710|NCT04967222|520220174|FG002|Randomized|Withdrawal by Subject|2|||
144278711|NCT04967222|520220172|FG000|Randomized|abnormal finding in MRI|0|||
144278712|NCT04967222|520220173|FG001|Randomized|abnormal finding in MRI|2|||
144278713|NCT04967222|520220174|FG002|Randomized|abnormal finding in MRI|0|||
144278714|NCT02382380|520220175|FG000|Overall Study|Withdrawal by Subject|2|||
144278715|NCT02382380|520220176|FG001|Overall Study|Withdrawal by Subject|2|||
144278716|NCT02382380|520220175|FG000|Overall Study|Lost to Follow-up|0|||
144278717|NCT02382380|520220176|FG001|Overall Study|Lost to Follow-up|1|||
144278718|NCT01295944|520220177|FG000|Overall Study|Switched to alternative treatment|1|||
144278719|NCT01295944|520220177|FG000|Overall Study|Ineligible|9|||
144278720|NCT01295944|520220177|FG000|Overall Study|Withdrawal by Subject|1|||
144278721|NCT01295944|520220177|FG000|Overall Study|Participant chose to be treated in Peru|1|||
144278722|NCT01295944|520220177|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
144278723|NCT01295944|520220177|FG000|Overall Study|Physician Decision|1|||
144278724|NCT01295944|520220177|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
144278725|NCT01295944|520220177|FG000|Overall Study|Disease progression|4|||
144278726|NCT01295944|520220177|FG000|Overall Study|Transferred care before starting new treatment|1|||
144278727|NCT03785366|520220185|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
144278728|NCT03785366|520220186|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
144278729|NCT03785366|520220185|FG000|Overall Study|Lost to Follow-up|1|||
144278730|NCT03785366|520220186|FG001|Overall Study|Lost to Follow-up|0|||
144278731|NCT03785366|520220185|FG000|Overall Study|Partial IUD Expulsion|0|||
144278732|NCT03785366|520220186|FG001|Overall Study|Partial IUD Expulsion|2|||
144278733|NCT03785366|520220185|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
144278734|NCT03785366|520220186|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
144278735|NCT03240874|520220187|FG000|Overall Study|Lost to Follow-up|0|||
144278736|NCT03240874|520220188|FG001|Overall Study|Lost to Follow-up|2|||
144278737|NCT03240874|520220189|FG002|Overall Study|Lost to Follow-up|4|||
144278738|NCT03240874|520220190|FG003|Overall Study|Lost to Follow-up|1|||
144278739|NCT05252702|520220191|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
144278740|NCT05252702|520220191|FG000|Overall Study|Death|16|||
144278741|NCT05252702|520220191|FG000|Overall Study|System explant|5|||
144278742|NCT05252702|520220191|FG000|Overall Study|Lost to Follow-up|1|||
144278743|NCT05252702|520220191|FG000|Overall Study|Withdrawn by investigator|1|||
144278744|NCT05252702|520220191|FG000|Overall Study|Visit not due|306|||
144278745|NCT05252702|520220191|FG000|Overall Study|Visit within window but not completed|92|||
144278746|NCT05252702|520220191|FG000|Overall Study|Unsuccessful implant|1|||
144278747|NCT04153864|520220192|FG000|Overall Study|Withdrawal by Subject|21|||
144278748|NCT04153864|520220193|FG001|Overall Study|Withdrawal by Subject|7|||
144278749|NCT04153864|520220194|FG002|Overall Study|Withdrawal by Subject|23|||
144278750|NCT04153864|520220195|FG003|Overall Study|Withdrawal by Subject|2|||
144278751|NCT04153864|520220192|FG000|Overall Study|Lost to Follow-up|4|||
144278752|NCT04153864|520220193|FG001|Overall Study|Lost to Follow-up|0|||
144278753|NCT04153864|520220194|FG002|Overall Study|Lost to Follow-up|3|||
144278754|NCT04153864|520220195|FG003|Overall Study|Lost to Follow-up|0|||
144278755|NCT04153864|520220192|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
144278756|NCT04153864|520220193|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
144278757|NCT04153864|520220194|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
144278758|NCT04153864|520220195|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
144278759|NCT03036254|520220196|FG000|Overall Study|Adverse Event|6|||
144278760|NCT03036254|520220197|FG001|Overall Study|Adverse Event|4|||
144278761|NCT03036254|520220196|FG000|Overall Study|Death|3|||
144278762|NCT03036254|520220197|FG001|Overall Study|Death|1|||
144278763|NCT03036254|520220196|FG000|Overall Study|Lack of Efficacy|5|||
144278764|NCT03036254|520220197|FG001|Overall Study|Lack of Efficacy|1|||
144278765|NCT03036254|520220196|FG000|Overall Study|Withdrawal by Subject|3|||
144278766|NCT03036254|520220197|FG001|Overall Study|Withdrawal by Subject|5|||
144278767|NCT02783274|520220205|FG000|Overall Study|Withdrawal by Subject|16|||
144278768|NCT02783274|520220205|FG000|Overall Study|Physician Decision|6|||
144278769|NCT02783274|520220205|FG000|Overall Study|Death|9|||
144278770|NCT02783274|520220205|FG000|Overall Study|Lost to Follow-up|22|||
144278771|NCT02783274|520220205|FG000|Overall Study|Other|22|||
144278772|NCT01802281|520220209|FG000|Overall Study|Death|1|||
144278773|NCT01802281|520220210|FG001|Overall Study|Death|2|||
144278774|NCT01802281|520220209|FG000|Overall Study|Withdrawal by Subject|2|||
144278775|NCT01802281|520220210|FG001|Overall Study|Withdrawal by Subject|1|||
144278776|NCT01802281|520220209|FG000|Overall Study|Ineligible|5|||
144278777|NCT01802281|520220210|FG001|Overall Study|Ineligible|3|||
144278778|NCT04132050|520220211|FG000|Period I (Double-blind Period)|Adverse Event|3|||
144278779|NCT04132050|520220212|FG001|Period I (Double-blind Period)|Adverse Event|0|||
144278780|NCT04132050|520220211|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
144278781|NCT04132050|520220212|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
144278782|NCT04132050|520220211|FG000|R788 Treatment Period|Adverse Event|5|||
144278783|NCT04132050|520220212|FG001|R788 Treatment Period|Adverse Event|0|||
144278784|NCT04132050|520220211|FG000|R788 Treatment Period|Lack of Efficacy|5|||
144278785|NCT04132050|520220212|FG001|R788 Treatment Period|Lack of Efficacy|0|||
144278786|NCT04132050|520220211|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
144278787|NCT04132050|520220212|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
144278788|NCT02246777|520220213|FG000|Overall Study|Adverse Event|2|||
144278789|NCT02246777|520220213|FG000|Overall Study|Change of residence|1|||
144278790|NCT04133909|520220214|FG000|Overall Study|Death|11|||
144278791|NCT04133909|520220215|FG001|Overall Study|Death|11|||
144278792|NCT04133909|520220214|FG000|Overall Study|Adverse Event|4|||
144278793|NCT04133909|520220215|FG001|Overall Study|Adverse Event|5|||
144278794|NCT04133909|520220214|FG000|Overall Study|Lost to Follow-up|3|||
144278795|NCT04133909|520220215|FG001|Overall Study|Lost to Follow-up|5|||
144278796|NCT04133909|520220214|FG000|Overall Study|Physician Decision|4|||
144278797|NCT04133909|520220215|FG001|Overall Study|Physician Decision|7|||
144278798|NCT04133909|520220214|FG000|Overall Study|Withdrawal by Subject|40|||
144278799|NCT04133909|520220215|FG001|Overall Study|Withdrawal by Subject|35|||
144278800|NCT04133909|520220214|FG000|Overall Study|Lack of Efficacy|2|||
144278801|NCT04133909|520220215|FG001|Overall Study|Lack of Efficacy|7|||
144278802|NCT04133909|520220214|FG000|Overall Study|Randomized in error|1|||
144278803|NCT04133909|520220215|FG001|Overall Study|Randomized in error|1|||
144278804|NCT01063114|520220216|FG000|Overall Study|Lost to Follow-up|1|||
144278805|NCT04635423|520220217|FG000|Overall Study|Ongoing|493|||
144278806|NCT04635423|520220218|FG001|Overall Study|Ongoing|501|||
144278807|NCT04635423|520220217|FG000|Overall Study|Withdrawal by Subject|36|||
144278808|NCT04635423|520220218|FG001|Overall Study|Withdrawal by Subject|29|||
144278809|NCT05556057|520220219|FG000|Overall Study|Lost to Follow-up|5|||
144278810|NCT05556057|520220220|FG001|Overall Study|Lost to Follow-up|4|||
144278811|NCT05556057|520220219|FG000|Overall Study|Withdrawal by Subject|0|||
144278812|NCT05556057|520220220|FG001|Overall Study|Withdrawal by Subject|2|||
144278813|NCT00858988|520220228|FG000|Analysis|Lactulose unable to be detected in urine|2|||
144278814|NCT00858988|520220229|FG001|Analysis|Lactulose unable to be detected in urine|1|||
144278815|NCT01706328|520220231|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
144278816|NCT01706328|520220232|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144278817|NCT01706328|520220233|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144278818|NCT01706328|520220231|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
144278819|NCT01706328|520220232|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144278820|NCT01706328|520220233|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144278821|NCT01706328|520220231|FG000|2-week Run-in Period|Physician Decision|4|||
144278822|NCT01706328|520220232|FG001|2-week Run-in Period|Physician Decision|0|||
144278823|NCT01706328|520220233|FG002|2-week Run-in Period|Physician Decision|0|||
144278824|NCT01706328|520220231|FG000|2-week Run-in Period|Adverse Event|4|||
144278825|NCT01706328|520220232|FG001|2-week Run-in Period|Adverse Event|0|||
144278826|NCT01706328|520220233|FG002|2-week Run-in Period|Adverse Event|0|||
144278827|NCT01706328|520220231|FG000|2-week Run-in Period|Lost to Follow-up|2|||
144278828|NCT01706328|520220232|FG001|2-week Run-in Period|Lost to Follow-up|0|||
144278829|NCT01706328|520220233|FG002|2-week Run-in Period|Lost to Follow-up|0|||
144278830|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
144278831|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
144278832|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
144278833|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
144278834|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
144278835|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
144278836|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
144278837|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
144278838|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
144278839|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
144278840|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
144278841|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
144278842|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
144278843|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
144278844|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
144278845|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
144278846|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
144278847|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
144278848|NCT01706328|520220231|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144278849|NCT01706328|520220232|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
144278850|NCT01706328|520220233|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
144278851|NCT02924376|520220234|FG000|Overall Study|Progressive Disease|4|||
144278852|NCT02924376|520220235|FG001|Overall Study|Progressive Disease|0|||
144278853|NCT02924376|520220236|FG002|Overall Study|Progressive Disease|1|||
144278854|NCT02924376|520220237|FG003|Overall Study|Progressive Disease|0|||
144278855|NCT02924376|520220234|FG000|Overall Study|Death|73|||
144278856|NCT02924376|520220235|FG001|Overall Study|Death|18|||
144278857|NCT02924376|520220236|FG002|Overall Study|Death|15|||
144278858|NCT02924376|520220237|FG003|Overall Study|Death|2|||
144278859|NCT02924376|520220234|FG000|Overall Study|Lost to Follow-up|3|||
144278860|NCT02924376|520220235|FG001|Overall Study|Lost to Follow-up|0|||
144278861|NCT02924376|520220236|FG002|Overall Study|Lost to Follow-up|0|||
144278862|NCT02924376|520220237|FG003|Overall Study|Lost to Follow-up|0|||
144278863|NCT02924376|520220234|FG000|Overall Study|Study Terminated by Sponsor|19|||
144278864|NCT02924376|520220235|FG001|Overall Study|Study Terminated by Sponsor|0|||
144278865|NCT02924376|520220236|FG002|Overall Study|Study Terminated by Sponsor|0|||
144278866|NCT02924376|520220237|FG003|Overall Study|Study Terminated by Sponsor|0|||
144278867|NCT02924376|520220234|FG000|Overall Study|Physician Decision|1|||
144278868|NCT02924376|520220235|FG001|Overall Study|Physician Decision|0|||
144278869|NCT02924376|520220236|FG002|Overall Study|Physician Decision|0|||
144278870|NCT02924376|520220237|FG003|Overall Study|Physician Decision|0|||
144278871|NCT02924376|520220234|FG000|Overall Study|Withdrawal by Subject|7|||
144278872|NCT02924376|520220235|FG001|Overall Study|Withdrawal by Subject|2|||
144278873|NCT02924376|520220236|FG002|Overall Study|Withdrawal by Subject|1|||
144278874|NCT02924376|520220237|FG003|Overall Study|Withdrawal by Subject|0|||
144278875|NCT02924376|520220234|FG000|Overall Study|Rolled Over to Another Study|1|||
144278876|NCT02924376|520220235|FG001|Overall Study|Rolled Over to Another Study|0|||
144278877|NCT02924376|520220236|FG002|Overall Study|Rolled Over to Another Study|0|||
144278878|NCT02924376|520220237|FG003|Overall Study|Rolled Over to Another Study|0|||
144278879|NCT00177671|520221462|FG000|Overall Study|Withdrawal by Subject|5|||
144278880|NCT00177671|520221463|FG001|Overall Study|Withdrawal by Subject|6|||
144278881|NCT00177671|520221462|FG000|Overall Study|medical complications|2|||
144278882|NCT00177671|520221463|FG001|Overall Study|medical complications|0|||
144278883|NCT00177671|520221462|FG000|Overall Study|Adverse Event|6|||
144278884|NCT00177671|520221463|FG001|Overall Study|Adverse Event|0|||
144278885|NCT00177671|520221462|FG000|Overall Study|Physician Decision|12|||
144278886|NCT00177671|520221463|FG001|Overall Study|Physician Decision|8|||
144278887|NCT02293499|520221464|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
144278888|NCT02293499|520221465|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
144278889|NCT02293499|520221466|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
144278890|NCT02293499|520221464|FG000|Intervention - Camp|Withdrawal by Subject|3|||
144278891|NCT02293499|520221465|FG001|Intervention - Camp|Withdrawal by Subject|6|||
144278892|NCT02293499|520221466|FG002|Intervention - Camp|Withdrawal by Subject|2|||
144278893|NCT02293499|520221464|FG000|Intervention - Camp|these are those not showing up at camp|24|||
144278894|NCT02293499|520221465|FG001|Intervention - Camp|these are those not showing up at camp|28|||
144278895|NCT02293499|520221466|FG002|Intervention - Camp|these are those not showing up at camp|4|||
144278896|NCT02293499|520221464|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
144278897|NCT02293499|520221465|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
144278898|NCT02293499|520221466|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
144278899|NCT02293499|520221464|FG000|3 Month Follow Up|Lost to Follow-up|14|||
144278900|NCT02293499|520221465|FG001|3 Month Follow Up|Lost to Follow-up|15|||
144278901|NCT02293499|520221466|FG002|3 Month Follow Up|Lost to Follow-up|6|||
144278902|NCT02293499|520221464|FG000|6 Month Follow Up|Lost to Follow-up|17|||
144278903|NCT02293499|520221465|FG001|6 Month Follow Up|Lost to Follow-up|27|||
144278904|NCT02293499|520221466|FG002|6 Month Follow Up|Lost to Follow-up|6|||
144278905|NCT02293499|520221464|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
144278906|NCT02293499|520221465|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
144278907|NCT02293499|520221466|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
144278908|NCT02293499|520221464|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
144278909|NCT02293499|520221465|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
144278910|NCT02293499|520221466|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
144278911|NCT02293499|520221464|FG000|9 Month Follow Up|Lost to Follow-up|24|||
144278912|NCT02293499|520221465|FG001|9 Month Follow Up|Lost to Follow-up|28|||
144278913|NCT02293499|520221466|FG002|9 Month Follow Up|Lost to Follow-up|4|||
144278914|NCT02293499|520221464|FG000|12 Month Follow Up|Lost to Follow-up|26|||
144278915|NCT02293499|520221465|FG001|12 Month Follow Up|Lost to Follow-up|25|||
144278916|NCT02293499|520221466|FG002|12 Month Follow Up|Lost to Follow-up|6|||
144278917|NCT02293499|520221464|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
144278918|NCT02293499|520221465|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
144278919|NCT02293499|520221466|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
144278920|NCT02293499|520221464|FG000|15 Month Follow Up|Lost to Follow-up|22|||
144278921|NCT02293499|520221465|FG001|15 Month Follow Up|Lost to Follow-up|22|||
144278922|NCT02293499|520221466|FG002|15 Month Follow Up|Lost to Follow-up|7|||
144278923|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
144278924|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
144278925|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
144278926|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
144278927|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
144278928|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
144278929|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
144278930|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
144278931|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
144278932|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
144278933|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Death|0|||
144278934|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Death|0|||
144278935|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Death|1|||
144278936|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Death|0|||
144278937|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Death|0|||
144278938|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
144278939|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
144278940|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
144278941|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
144278942|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
144278943|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Other|2|||
144278944|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Other|1|||
144278945|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Other|0|||
144278946|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Other|0|||
144278947|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Other|0|||
144278948|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
144278949|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
144278950|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
144278951|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
144278952|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
144278953|NCT03317496|520221467|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
144278954|NCT03317496|520221468|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
144278955|NCT03317496|520221469|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
144278956|NCT03317496|520221470|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
144278957|NCT03317496|520221471|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
144278958|NCT03317496|520221467|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
144278959|NCT03317496|520221468|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
144278960|NCT03317496|520221469|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
144278961|NCT03317496|520221470|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
144278962|NCT03317496|520221471|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
144278963|NCT03317496|520221467|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
144278964|NCT03317496|520221468|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
144278965|NCT03317496|520221469|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
144278966|NCT03317496|520221470|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
144278967|NCT03317496|520221471|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
144278968|NCT03317496|520221467|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
144278969|NCT03317496|520221468|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
144278970|NCT03317496|520221469|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
144278971|NCT03317496|520221470|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
144278972|NCT03317496|520221471|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
144278973|NCT03317496|520221467|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
144278974|NCT03317496|520221468|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
144278975|NCT03317496|520221469|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
144278976|NCT03317496|520221470|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
144278977|NCT03317496|520221471|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
144278978|NCT03317496|520221467|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
144278979|NCT03317496|520221468|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
144278980|NCT03317496|520221469|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
144278981|NCT03317496|520221470|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
144278982|NCT03317496|520221471|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
144278983|NCT03317496|520221467|FG000|Phase 2: Treatment|Adverse Event|0|||
144278984|NCT03317496|520221468|FG001|Phase 2: Treatment|Adverse Event|0|||
144278985|NCT03317496|520221469|FG002|Phase 2: Treatment|Adverse Event|0|||
144278986|NCT03317496|520221470|FG003|Phase 2: Treatment|Adverse Event|0|||
144278987|NCT03317496|520221471|FG004|Phase 2: Treatment|Adverse Event|6|||
144278988|NCT03317496|520221467|FG000|Phase 2: Treatment|Progressive disease|0|||
144278989|NCT03317496|520221468|FG001|Phase 2: Treatment|Progressive disease|0|||
144278990|NCT03317496|520221469|FG002|Phase 2: Treatment|Progressive disease|0|||
144278991|NCT03317496|520221470|FG003|Phase 2: Treatment|Progressive disease|0|||
144278992|NCT03317496|520221471|FG004|Phase 2: Treatment|Progressive disease|22|||
144278993|NCT03317496|520221467|FG000|Phase 2: Treatment|Other|0|||
144278994|NCT03317496|520221468|FG001|Phase 2: Treatment|Other|0|||
144278995|NCT03317496|520221469|FG002|Phase 2: Treatment|Other|0|||
144278996|NCT03317496|520221470|FG003|Phase 2: Treatment|Other|0|||
144278997|NCT03317496|520221471|FG004|Phase 2: Treatment|Other|4|||
144278998|NCT03317496|520221467|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
144278999|NCT03317496|520221468|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
144279000|NCT03317496|520221469|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
144279001|NCT03317496|520221470|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
144279002|NCT03317496|520221471|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
144279003|NCT03317496|520221467|FG000|Phase 2: Treatment|Physician Decision|0|||
144279004|NCT03317496|520221468|FG001|Phase 2: Treatment|Physician Decision|0|||
144279005|NCT03317496|520221469|FG002|Phase 2: Treatment|Physician Decision|0|||
144279006|NCT03317496|520221470|FG003|Phase 2: Treatment|Physician Decision|0|||
144279007|NCT03317496|520221471|FG004|Phase 2: Treatment|Physician Decision|1|||
144279008|NCT03317496|520221467|FG000|Phase 2: Treatment|Death|0|||
144279009|NCT03317496|520221468|FG001|Phase 2: Treatment|Death|0|||
144279010|NCT03317496|520221469|FG002|Phase 2: Treatment|Death|0|||
144279011|NCT03317496|520221470|FG003|Phase 2: Treatment|Death|0|||
144279012|NCT03317496|520221471|FG004|Phase 2: Treatment|Death|1|||
144279013|NCT03317496|520221467|FG000|Phase 2: Follow-up|Death|0|||
144279014|NCT03317496|520221468|FG001|Phase 2: Follow-up|Death|0|||
144279015|NCT03317496|520221469|FG002|Phase 2: Follow-up|Death|0|||
144279016|NCT03317496|520221470|FG003|Phase 2: Follow-up|Death|0|||
144279017|NCT03317496|520221471|FG004|Phase 2: Follow-up|Death|24|||
144279018|NCT03317496|520221467|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
144279019|NCT03317496|520221468|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
144279020|NCT03317496|520221469|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
144279021|NCT03317496|520221470|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
144279022|NCT03317496|520221471|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
144279023|NCT03317496|520221467|FG000|Phase 2: Follow-up|Other|0|||
144279024|NCT03317496|520221468|FG001|Phase 2: Follow-up|Other|0|||
144279025|NCT03317496|520221469|FG002|Phase 2: Follow-up|Other|0|||
144279026|NCT03317496|520221470|FG003|Phase 2: Follow-up|Other|0|||
144279027|NCT03317496|520221471|FG004|Phase 2: Follow-up|Other|1|||
144279028|NCT03317496|520221467|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
144279029|NCT03317496|520221468|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
144279030|NCT03317496|520221469|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
144279031|NCT03317496|520221470|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
144279032|NCT03317496|520221471|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
144279033|NCT04919161|520221472|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
144279034|NCT04919161|520221473|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
144279035|NCT04919161|520221472|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
144279036|NCT04919161|520221473|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
144279037|NCT04919161|520221472|FG000|Overall Study|Acute ankle sprain after session 1|0|||
144279038|NCT04919161|520221473|FG001|Overall Study|Acute ankle sprain after session 1|1|||
144279039|NCT01044498|520221478|FG000|Overall Study|Withdrew consent|1|||
144279040|NCT01044498|520221479|FG001|Overall Study|Withdrew consent|1|||
144279041|NCT01044498|520221478|FG000|Overall Study|Adverse Event|1|||
144279042|NCT01044498|520221479|FG001|Overall Study|Adverse Event|1|||
144279043|NCT01044498|520221478|FG000|Overall Study|Other|1|||
144279044|NCT01044498|520221479|FG001|Overall Study|Other|0|||
144279045|NCT05513950|520221482|FG000|Overall Study|Not treated due to technical reasons|0|||
144279046|NCT05513950|520221483|FG001|Overall Study|Not treated due to technical reasons|0|||
144279047|NCT05513950|520221484|FG002|Overall Study|Not treated due to technical reasons|1|||
144279048|NCT05513950|520221485|FG003|Overall Study|Not treated due to technical reasons|0|||
144279049|NCT02903914|520221486|FG000|Overall Study|Adverse Event|0|||
144279050|NCT02903914|520221487|FG001|Overall Study|Adverse Event|0|||
144279051|NCT02903914|520221488|FG002|Overall Study|Adverse Event|1|||
144279052|NCT02903914|520221489|FG003|Overall Study|Adverse Event|0|||
144279053|NCT02903914|520221490|FG004|Overall Study|Adverse Event|0|||
144279054|NCT02903914|520221491|FG005|Overall Study|Adverse Event|0|||
144279055|NCT02903914|520221492|FG006|Overall Study|Adverse Event|2|||
144279056|NCT02903914|520221493|FG007|Overall Study|Adverse Event|0|||
144279057|NCT02903914|520221486|FG000|Overall Study|Withdrawal by Subject|3|||
144279058|NCT02903914|520221487|FG001|Overall Study|Withdrawal by Subject|1|||
144279059|NCT02903914|520221488|FG002|Overall Study|Withdrawal by Subject|28|||
144279060|NCT02903914|520221489|FG003|Overall Study|Withdrawal by Subject|0|||
144279061|NCT02903914|520221490|FG004|Overall Study|Withdrawal by Subject|1|||
144279062|NCT02903914|520221491|FG005|Overall Study|Withdrawal by Subject|2|||
144279063|NCT02903914|520221492|FG006|Overall Study|Withdrawal by Subject|12|||
144279064|NCT02903914|520221493|FG007|Overall Study|Withdrawal by Subject|0|||
144279065|NCT02903914|520221486|FG000|Overall Study|Progressive Disease|1|||
144279066|NCT02903914|520221487|FG001|Overall Study|Progressive Disease|0|||
144279067|NCT02903914|520221488|FG002|Overall Study|Progressive Disease|4|||
144279068|NCT02903914|520221489|FG003|Overall Study|Progressive Disease|0|||
144279069|NCT02903914|520221490|FG004|Overall Study|Progressive Disease|0|||
144279070|NCT02903914|520221491|FG005|Overall Study|Progressive Disease|0|||
144279071|NCT02903914|520221492|FG006|Overall Study|Progressive Disease|2|||
144279072|NCT02903914|520221493|FG007|Overall Study|Progressive Disease|0|||
144279073|NCT02903914|520221486|FG000|Overall Study|Death|0|||
144279074|NCT02903914|520221487|FG001|Overall Study|Death|0|||
144279075|NCT02903914|520221488|FG002|Overall Study|Death|9|||
144279076|NCT02903914|520221489|FG003|Overall Study|Death|0|||
144279077|NCT02903914|520221490|FG004|Overall Study|Death|1|||
144279078|NCT02903914|520221491|FG005|Overall Study|Death|3|||
144279079|NCT02903914|520221492|FG006|Overall Study|Death|24|||
144279080|NCT02903914|520221493|FG007|Overall Study|Death|2|||
144279081|NCT02903914|520221486|FG000|Overall Study|Lost to Follow-up|0|||
144279082|NCT02903914|520221487|FG001|Overall Study|Lost to Follow-up|1|||
144279083|NCT02903914|520221488|FG002|Overall Study|Lost to Follow-up|0|||
144279084|NCT02903914|520221489|FG003|Overall Study|Lost to Follow-up|0|||
144279085|NCT02903914|520221490|FG004|Overall Study|Lost to Follow-up|2|||
144279086|NCT02903914|520221491|FG005|Overall Study|Lost to Follow-up|0|||
144279087|NCT02903914|520221492|FG006|Overall Study|Lost to Follow-up|1|||
144279088|NCT02903914|520221493|FG007|Overall Study|Lost to Follow-up|0|||
144279089|NCT02903914|520221486|FG000|Overall Study|Physician Decision|0|||
144279090|NCT02903914|520221487|FG001|Overall Study|Physician Decision|0|||
144279091|NCT02903914|520221488|FG002|Overall Study|Physician Decision|1|||
144279092|NCT02903914|520221489|FG003|Overall Study|Physician Decision|0|||
144279093|NCT02903914|520221490|FG004|Overall Study|Physician Decision|0|||
144279094|NCT02903914|520221491|FG005|Overall Study|Physician Decision|0|||
144279095|NCT02903914|520221492|FG006|Overall Study|Physician Decision|1|||
144279096|NCT02903914|520221493|FG007|Overall Study|Physician Decision|0|||
144279097|NCT02903914|520221486|FG000|Overall Study|Symptomatic Deterioration|0|||
144279098|NCT02903914|520221487|FG001|Overall Study|Symptomatic Deterioration|0|||
144279099|NCT02903914|520221488|FG002|Overall Study|Symptomatic Deterioration|1|||
144279100|NCT02903914|520221489|FG003|Overall Study|Symptomatic Deterioration|0|||
144279101|NCT02903914|520221490|FG004|Overall Study|Symptomatic Deterioration|0|||
144279102|NCT02903914|520221491|FG005|Overall Study|Symptomatic Deterioration|0|||
144279103|NCT02903914|520221492|FG006|Overall Study|Symptomatic Deterioration|0|||
144279104|NCT02903914|520221493|FG007|Overall Study|Symptomatic Deterioration|0|||
144279105|NCT02903914|520221486|FG000|Overall Study|New Cancer Therapy|2|||
144279106|NCT02903914|520221487|FG001|Overall Study|New Cancer Therapy|2|||
144279107|NCT02903914|520221488|FG002|Overall Study|New Cancer Therapy|21|||
144279108|NCT02903914|520221489|FG003|Overall Study|New Cancer Therapy|4|||
144279109|NCT02903914|520221490|FG004|Overall Study|New Cancer Therapy|3|||
144279110|NCT02903914|520221491|FG005|Overall Study|New Cancer Therapy|6|||
144279111|NCT02903914|520221492|FG006|Overall Study|New Cancer Therapy|56|||
144279112|NCT02903914|520221493|FG007|Overall Study|New Cancer Therapy|3|||
144279113|NCT02903914|520221486|FG000|Overall Study|Didn't Return to Site|1|||
144279114|NCT02903914|520221487|FG001|Overall Study|Didn't Return to Site|0|||
144279115|NCT02903914|520221488|FG002|Overall Study|Didn't Return to Site|1|||
144279116|NCT02903914|520221489|FG003|Overall Study|Didn't Return to Site|1|||
144279117|NCT02903914|520221490|FG004|Overall Study|Didn't Return to Site|0|||
144279118|NCT02903914|520221491|FG005|Overall Study|Didn't Return to Site|0|||
144279119|NCT02903914|520221492|FG006|Overall Study|Didn't Return to Site|2|||
144279120|NCT02903914|520221493|FG007|Overall Study|Didn't Return to Site|0|||
144279121|NCT02903914|520221486|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
144279122|NCT02903914|520221487|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
144279123|NCT02903914|520221488|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
144279124|NCT02903914|520221489|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
144279125|NCT02903914|520221490|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
144279126|NCT02903914|520221491|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
144279127|NCT02903914|520221492|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
144279128|NCT02903914|520221493|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
144279129|NCT02903914|520221486|FG000|Overall Study|Follow-up Did Not Occur|0|||
144279130|NCT02903914|520221487|FG001|Overall Study|Follow-up Did Not Occur|1|||
144279131|NCT02903914|520221488|FG002|Overall Study|Follow-up Did Not Occur|1|||
144279132|NCT02903914|520221489|FG003|Overall Study|Follow-up Did Not Occur|0|||
144279133|NCT02903914|520221490|FG004|Overall Study|Follow-up Did Not Occur|2|||
144279134|NCT02903914|520221491|FG005|Overall Study|Follow-up Did Not Occur|0|||
144279135|NCT02903914|520221492|FG006|Overall Study|Follow-up Did Not Occur|8|||
144279136|NCT02903914|520221493|FG007|Overall Study|Follow-up Did Not Occur|0|||
144279137|NCT02903914|520221486|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
144279138|NCT02903914|520221487|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
144279139|NCT02903914|520221488|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
144279140|NCT02903914|520221489|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
144279141|NCT02903914|520221490|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
144279142|NCT02903914|520221491|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
144279143|NCT02903914|520221492|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
144279144|NCT02903914|520221493|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
144279145|NCT02903914|520221486|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
144279146|NCT02903914|520221487|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
144279147|NCT02903914|520221488|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
144279148|NCT02903914|520221489|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
144279149|NCT02903914|520221490|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
144279150|NCT02903914|520221491|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
144279151|NCT02903914|520221492|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
144279152|NCT02903914|520221493|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
144279153|NCT02903914|520221486|FG000|Overall Study|Clinical Disease Progression|0|||
144279154|NCT02903914|520221487|FG001|Overall Study|Clinical Disease Progression|0|||
144279155|NCT02903914|520221488|FG002|Overall Study|Clinical Disease Progression|2|||
144279156|NCT02903914|520221489|FG003|Overall Study|Clinical Disease Progression|0|||
144279157|NCT02903914|520221490|FG004|Overall Study|Clinical Disease Progression|0|||
144279158|NCT02903914|520221491|FG005|Overall Study|Clinical Disease Progression|0|||
144279159|NCT02903914|520221492|FG006|Overall Study|Clinical Disease Progression|0|||
144279160|NCT02903914|520221493|FG007|Overall Study|Clinical Disease Progression|0|||
144279161|NCT02903914|520221486|FG000|Overall Study|Completed Follow-up Period|0|||
144279162|NCT02903914|520221487|FG001|Overall Study|Completed Follow-up Period|0|||
144279163|NCT02903914|520221488|FG002|Overall Study|Completed Follow-up Period|6|||
144279164|NCT02903914|520221489|FG003|Overall Study|Completed Follow-up Period|2|||
144279165|NCT02903914|520221490|FG004|Overall Study|Completed Follow-up Period|1|||
144279166|NCT02903914|520221491|FG005|Overall Study|Completed Follow-up Period|0|||
144279167|NCT02903914|520221492|FG006|Overall Study|Completed Follow-up Period|9|||
144279168|NCT02903914|520221493|FG007|Overall Study|Completed Follow-up Period|1|||
144279169|NCT02903914|520221486|FG000|Overall Study|Taken off Treatment per Protocol|0|||
144279170|NCT02903914|520221487|FG001|Overall Study|Taken off Treatment per Protocol|0|||
144279171|NCT02903914|520221488|FG002|Overall Study|Taken off Treatment per Protocol|0|||
144279172|NCT02903914|520221489|FG003|Overall Study|Taken off Treatment per Protocol|0|||
144279173|NCT02903914|520221490|FG004|Overall Study|Taken off Treatment per Protocol|0|||
144279174|NCT02903914|520221491|FG005|Overall Study|Taken off Treatment per Protocol|1|||
144279175|NCT02903914|520221492|FG006|Overall Study|Taken off Treatment per Protocol|0|||
144279176|NCT02903914|520221493|FG007|Overall Study|Taken off Treatment per Protocol|0|||
144279177|NCT02903914|520221486|FG000|Overall Study|Refused Further Treatment/Contact|0|||
144279178|NCT02903914|520221487|FG001|Overall Study|Refused Further Treatment/Contact|0|||
144279179|NCT02903914|520221488|FG002|Overall Study|Refused Further Treatment/Contact|0|||
144279180|NCT02903914|520221489|FG003|Overall Study|Refused Further Treatment/Contact|0|||
144279181|NCT02903914|520221490|FG004|Overall Study|Refused Further Treatment/Contact|0|||
144279182|NCT02903914|520221491|FG005|Overall Study|Refused Further Treatment/Contact|0|||
144279183|NCT02903914|520221492|FG006|Overall Study|Refused Further Treatment/Contact|1|||
144279184|NCT02903914|520221493|FG007|Overall Study|Refused Further Treatment/Contact|0|||
144279185|NCT02903914|520221486|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279186|NCT02903914|520221487|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279187|NCT02903914|520221488|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279188|NCT02903914|520221489|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279189|NCT02903914|520221490|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279190|NCT02903914|520221491|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279191|NCT02903914|520221492|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
144279192|NCT02903914|520221493|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
144279193|NCT00975923|520221499|FG000|Overall Study|Withdrawal by Subject|0|||
144279194|NCT00975923|520221500|FG001|Overall Study|Withdrawal by Subject|1|||
144279195|NCT00876343|520221501|FG000|Overall Study|Adverse Event|7|||
144279196|NCT00876343|520221502|FG001|Overall Study|Adverse Event|8|||
144279197|NCT00876343|520221503|FG002|Overall Study|Adverse Event|2|||
144279198|NCT00876343|520221501|FG000|Overall Study|Withdrawal by Subject|4|||
144279199|NCT00876343|520221502|FG001|Overall Study|Withdrawal by Subject|4|||
144279200|NCT00876343|520221503|FG002|Overall Study|Withdrawal by Subject|3|||
144279201|NCT00876343|520221501|FG000|Overall Study|Lack of Efficacy|0|||
144279202|NCT00876343|520221502|FG001|Overall Study|Lack of Efficacy|0|||
144279203|NCT00876343|520221503|FG002|Overall Study|Lack of Efficacy|1|||
144279204|NCT00876343|520221501|FG000|Overall Study|Protocol Violation|4|||
144279205|NCT00876343|520221502|FG001|Overall Study|Protocol Violation|1|||
144279206|NCT00876343|520221503|FG002|Overall Study|Protocol Violation|1|||
144279207|NCT00876343|520221501|FG000|Overall Study|Physician Decision|0|||
144279208|NCT00876343|520221502|FG001|Overall Study|Physician Decision|1|||
144279209|NCT00876343|520221503|FG002|Overall Study|Physician Decision|1|||
144279210|NCT00876343|520221501|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
144279211|NCT00876343|520221502|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
144279212|NCT00876343|520221503|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
144279213|NCT00876343|520221501|FG000|Overall Study|Change of residence or other commitments|2|||
144279214|NCT00876343|520221502|FG001|Overall Study|Change of residence or other commitments|2|||
144279215|NCT00876343|520221503|FG002|Overall Study|Change of residence or other commitments|3|||
144279216|NCT06354257|520221512|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144279217|NCT06354257|520221512|FG000|Treatment Period 2|Adverse Event|1|||
144279218|NCT03331250|520221513|FG000|Overall Study|Withdrawal by Subject|1|||
144279219|NCT05020743|520221516|FG000|Overall Study|Enrollment in Interventional Study|2|||
144279220|NCT05020743|520221517|FG001|Overall Study|Enrollment in Interventional Study|9|||
144279221|NCT05020743|520221518|FG002|Overall Study|Enrollment in Interventional Study|0|||
144279222|NCT05020743|520221516|FG000|Overall Study|Withdrawal by Subject|0|||
144279223|NCT05020743|520221517|FG001|Overall Study|Withdrawal by Subject|3|||
144279224|NCT05020743|520221518|FG002|Overall Study|Withdrawal by Subject|1|||
144279225|NCT05020743|520221516|FG000|Overall Study|Lost to Follow-up|1|||
144279226|NCT05020743|520221517|FG001|Overall Study|Lost to Follow-up|0|||
144279227|NCT05020743|520221518|FG002|Overall Study|Lost to Follow-up|0|||
144279228|NCT05020743|520221516|FG000|Overall Study|Study Termination by Sponsor|10|||
144279229|NCT05020743|520221517|FG001|Overall Study|Study Termination by Sponsor|11|||
144279230|NCT05020743|520221518|FG002|Overall Study|Study Termination by Sponsor|10|||
144279231|NCT03488524|520221519|FG000|Overall Study|Withdrawal by Subject|51|||
144279232|NCT03488524|520221519|FG000|Overall Study|Death|19|||
144279233|NCT03488524|520221519|FG000|Overall Study|Study Sponsor|11|||
144279234|NCT03488524|520221519|FG000|Overall Study|Physician Decision|4|||
144279235|NCT03488524|520221519|FG000|Overall Study|Lost to Follow-up|3|||
144279236|NCT02390284|520221520|FG000|Overall Study|Physician Decision|0|||
144279237|NCT02390284|520221521|FG001|Overall Study|Physician Decision|0|||
144279238|NCT02390284|520221522|FG002|Overall Study|Physician Decision|9|||
144279239|NCT03980223|520221523|FG000|Overall Study|Lost to Follow-up|3|||
144279240|NCT03980223|520221524|FG001|Overall Study|Lost to Follow-up|7|||
144279241|NCT03980223|520221525|FG002|Overall Study|Lost to Follow-up|10|||
144279242|NCT03980223|520221526|FG003|Overall Study|Lost to Follow-up|8|||
144279243|NCT03980223|520221523|FG000|Overall Study|Withdrawal by Subject|0|||
144279244|NCT03980223|520221524|FG001|Overall Study|Withdrawal by Subject|0|||
144279245|NCT03980223|520221525|FG002|Overall Study|Withdrawal by Subject|1|||
144244040|NCT02431806|520090412|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
144244041|NCT02431806|520090409|FG000|Double-blind Treatment Period|Adverse Event|4|||
144244042|NCT02431806|520090410|FG001|Double-blind Treatment Period|Adverse Event|7|||
144244043|NCT02431806|520090411|FG002|Double-blind Treatment Period|Adverse Event|11|||
144244044|NCT02431806|520090412|FG003|Double-blind Treatment Period|Adverse Event|7|||
144244045|NCT02431806|520090409|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
144244046|NCT02431806|520090410|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
144244047|NCT02431806|520090411|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
144244048|NCT02431806|520090412|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
144244049|NCT02431806|520090409|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
144244050|NCT02431806|520090410|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
144244051|NCT02431806|520090411|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
144244052|NCT02431806|520090412|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
144244053|NCT02431806|520090409|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
144244054|NCT02431806|520090410|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
144244055|NCT02431806|520090411|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
144244056|NCT02431806|520090412|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
144244057|NCT02431806|520090409|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
144244058|NCT02431806|520090410|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
144244059|NCT02431806|520090411|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
144244060|NCT02431806|520090412|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
144244061|NCT02431806|520090409|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
144244062|NCT02431806|520090410|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
144244063|NCT02431806|520090411|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
144244064|NCT02431806|520090412|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
144244065|NCT01797081|520090413|FG000|Overall Study|Adverse Event|1|||
144244066|NCT01797081|520090414|FG001|Overall Study|Adverse Event|0|||
144244067|NCT01797081|520090415|FG002|Overall Study|Adverse Event|1|||
144244068|NCT01797081|520090416|FG003|Overall Study|Adverse Event|0|||
144244069|NCT01797081|520090413|FG000|Overall Study|Pregnancy|1|||
144244070|NCT01797081|520090414|FG001|Overall Study|Pregnancy|0|||
144244071|NCT01797081|520090415|FG002|Overall Study|Pregnancy|0|||
144244072|NCT01797081|520090416|FG003|Overall Study|Pregnancy|0|||
144244073|NCT01797081|520090413|FG000|Overall Study|Personal Reasons|12|||
144244074|NCT01797081|520090414|FG001|Overall Study|Personal Reasons|4|||
144244075|NCT01797081|520090415|FG002|Overall Study|Personal Reasons|4|||
144244076|NCT01797081|520090416|FG003|Overall Study|Personal Reasons|8|||
144244077|NCT01797081|520090413|FG000|Overall Study|Protocol Violation|0|||
144244078|NCT01797081|520090414|FG001|Overall Study|Protocol Violation|0|||
144244079|NCT01797081|520090415|FG002|Overall Study|Protocol Violation|0|||
144244080|NCT01797081|520090416|FG003|Overall Study|Protocol Violation|1|||
144244081|NCT05513703|520090420|FG000|Overall Study|Death|4|||
144244082|NCT05513703|520090420|FG000|Overall Study|Study terminated by sponsor|5|||
144244083|NCT02928770|520091725|FG000|Overall Study|Withdrawal by Subject|2|||
144244084|NCT01752634|520091726|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
144244085|NCT01752634|520091727|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
144244086|NCT01752634|520091728|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
144244087|NCT01752634|520091729|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
144244088|NCT01752634|520091730|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
144244089|NCT01752634|520091731|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
144244090|NCT01752634|520091726|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
144244091|NCT01752634|520091727|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
144244092|NCT01752634|520091728|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
144244093|NCT01752634|520091729|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
144244094|NCT01752634|520091730|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
144244095|NCT01752634|520091731|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
144244096|NCT01752634|520091726|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
144244097|NCT01752634|520091727|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
144244098|NCT01752634|520091728|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
144244099|NCT01752634|520091729|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
144244100|NCT01752634|520091730|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
144244101|NCT01752634|520091731|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
144244102|NCT01752634|520091726|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
144244103|NCT01752634|520091727|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
144244104|NCT01752634|520091728|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
144244105|NCT01752634|520091729|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
144244106|NCT01752634|520091730|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
144244107|NCT01752634|520091731|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
144244108|NCT01752634|520091726|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
144244109|NCT01752634|520091727|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
144244110|NCT01752634|520091728|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
144244111|NCT01752634|520091729|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
144244112|NCT01752634|520091730|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
144244113|NCT01752634|520091731|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
144244114|NCT01752634|520091726|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
144244115|NCT01752634|520091727|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
144244116|NCT01752634|520091728|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
144244117|NCT01752634|520091729|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
144244118|NCT01752634|520091730|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
144244119|NCT01752634|520091731|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
144244120|NCT01752634|520091726|FG000|Week 24 to Week 260|Physician Decision|1|||
144244121|NCT01752634|520091727|FG001|Week 24 to Week 260|Physician Decision|2|||
144244122|NCT01752634|520091728|FG002|Week 24 to Week 260|Physician Decision|4|||
144244123|NCT01752634|520091729|FG003|Week 24 to Week 260|Physician Decision|2|||
144244124|NCT01752634|520091730|FG004|Week 24 to Week 260|Physician Decision|1|||
144244125|NCT01752634|520091731|FG005|Week 24 to Week 260|Physician Decision|0|||
144244126|NCT01752634|520091726|FG000|Week 24 to Week 260|Death|0|||
144244127|NCT01752634|520091727|FG001|Week 24 to Week 260|Death|1|||
144244128|NCT01752634|520091728|FG002|Week 24 to Week 260|Death|0|||
144244129|NCT01752634|520091729|FG003|Week 24 to Week 260|Death|0|||
144244130|NCT01752634|520091730|FG004|Week 24 to Week 260|Death|0|||
144244131|NCT01752634|520091731|FG005|Week 24 to Week 260|Death|0|||
144244132|NCT01752634|520091726|FG000|Week 24 to Week 260|Pregnancy|0|||
144244133|NCT01752634|520091727|FG001|Week 24 to Week 260|Pregnancy|0|||
144244134|NCT01752634|520091728|FG002|Week 24 to Week 260|Pregnancy|1|||
144244135|NCT01752634|520091729|FG003|Week 24 to Week 260|Pregnancy|0|||
144244136|NCT01752634|520091730|FG004|Week 24 to Week 260|Pregnancy|0|||
144244137|NCT01752634|520091731|FG005|Week 24 to Week 260|Pregnancy|0|||
144244138|NCT01752634|520091726|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
144244139|NCT01752634|520091727|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
144244140|NCT01752634|520091728|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
144244141|NCT01752634|520091729|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
144244142|NCT01752634|520091730|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
144244143|NCT01752634|520091731|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
144244144|NCT01752634|520091726|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
144244145|NCT01752634|520091727|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
144244146|NCT01752634|520091728|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
144244147|NCT01752634|520091729|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
144244148|NCT01752634|520091730|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
144244149|NCT01752634|520091731|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
144244150|NCT01752634|520091726|FG000|Week 24 to Week 260|Adverse Event|4|||
144244151|NCT01752634|520091727|FG001|Week 24 to Week 260|Adverse Event|8|||
144244152|NCT01752634|520091728|FG002|Week 24 to Week 260|Adverse Event|8|||
144244153|NCT01752634|520091729|FG003|Week 24 to Week 260|Adverse Event|4|||
144244154|NCT01752634|520091730|FG004|Week 24 to Week 260|Adverse Event|2|||
144244155|NCT01752634|520091731|FG005|Week 24 to Week 260|Adverse Event|0|||
144244156|NCT05562934|520091735|FG000|Overall Study|Adverse Event|0|||
144244157|NCT05562934|520091736|FG001|Overall Study|Adverse Event|2|||
144244158|NCT05562934|520091737|FG002|Overall Study|Adverse Event|0|||
144244159|NCT05562934|520091738|FG003|Overall Study|Adverse Event|0|||
144244160|NCT05562934|520091739|FG004|Overall Study|Adverse Event|2|||
144244161|NCT05562934|520091735|FG000|Overall Study|Lost to Follow-up|0|||
144244162|NCT05562934|520091736|FG001|Overall Study|Lost to Follow-up|0|||
144244163|NCT05562934|520091737|FG002|Overall Study|Lost to Follow-up|0|||
144244164|NCT05562934|520091738|FG003|Overall Study|Lost to Follow-up|0|||
144244165|NCT05562934|520091739|FG004|Overall Study|Lost to Follow-up|1|||
144244166|NCT05562934|520091735|FG000|Overall Study|Protocol Violation|0|||
144244167|NCT05562934|520091736|FG001|Overall Study|Protocol Violation|0|||
144244168|NCT05562934|520091737|FG002|Overall Study|Protocol Violation|0|||
144244169|NCT05562934|520091738|FG003|Overall Study|Protocol Violation|1|||
144279246|NCT03980223|520221526|FG003|Overall Study|Withdrawal by Subject|2|||
144279247|NCT03980223|520221523|FG000|Overall Study|Physician Decision|0|||
144279248|NCT03980223|520221524|FG001|Overall Study|Physician Decision|0|||
144279249|NCT03980223|520221525|FG002|Overall Study|Physician Decision|1|||
144279250|NCT03980223|520221526|FG003|Overall Study|Physician Decision|0|||
144279251|NCT03980223|520221523|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
144279252|NCT03980223|520221524|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
144279253|NCT03980223|520221525|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
144279254|NCT03980223|520221526|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
144279255|NCT01922934|520221530|FG000|Eligible Patients|Death|0|||
144279256|NCT01922934|520221531|FG001|Eligible Patients|Death|7|||
144279257|NCT01922934|520221530|FG000|Eligible Patients|Physician Decision|17|||
144279258|NCT01922934|520221531|FG001|Eligible Patients|Physician Decision|0|||
144279259|NCT01922934|520221530|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
144279260|NCT01922934|520221531|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
144279261|NCT01922934|520221530|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
144279262|NCT01922934|520221531|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
144279263|NCT01922934|520221530|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
144279264|NCT01922934|520221531|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
144279265|NCT01922934|520221530|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
144279266|NCT01922934|520221531|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
144279267|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
144279268|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
144279269|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
144279270|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
144279271|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
144279272|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
144279273|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
144279274|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
144279275|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
144279276|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
144279277|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
144279278|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
144279279|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
144279280|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
144279281|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
144279282|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
144279283|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
144279284|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
144279285|NCT01069939|520221536|FG000|Randomised and Included in the Analyses|Removal|1|||
144279286|NCT01069939|520221537|FG001|Randomised and Included in the Analyses|Removal|0|||
144279287|NCT00724945|520221538|FG000|Period 1|non-compliance|1|||
144279288|NCT00724945|520221539|FG001|Period 1|non-compliance|0|||
144279289|NCT00724945|520221538|FG000|Period 1|Adverse Event|1|||
144279290|NCT00724945|520221539|FG001|Period 1|Adverse Event|1|||
144279291|NCT00724945|520221538|FG000|Period 1|Lost to Follow-up|1|||
144279292|NCT00724945|520221539|FG001|Period 1|Lost to Follow-up|0|||
144279293|NCT00724945|520221538|FG000|Period 2|lens comfort issue|3|||
144279294|NCT00724945|520221539|FG001|Period 2|lens comfort issue|0|||
144279295|NCT00724945|520221538|FG000|Period 2|lens physiology issue|1|||
144279296|NCT00724945|520221539|FG001|Period 2|lens physiology issue|0|||
144279297|NCT05166876|520221540|FG000|Overall Study|Withdrawal by Subject|1|||
144279298|NCT05166876|520221541|FG001|Overall Study|Withdrawal by Subject|0|||
144279299|NCT05166876|520221542|FG002|Overall Study|Withdrawal by Subject|0|||
144279300|NCT01147458|520221543|FG000|First Intervention|Study terminated by sponsor|8|||
144279301|NCT01147458|520221544|FG001|First Intervention|Study terminated by sponsor|8|||
144279302|NCT01147458|520221545|FG002|First Intervention|Study terminated by sponsor|7|||
144279303|NCT01147458|520221546|FG003|First Intervention|Study terminated by sponsor|8|||
144279304|NCT01147458|520221543|FG000|First Intervention|Protocol Violation|2|||
144279305|NCT01147458|520221544|FG001|First Intervention|Protocol Violation|3|||
144279306|NCT01147458|520221545|FG002|First Intervention|Protocol Violation|2|||
144279307|NCT01147458|520221546|FG003|First Intervention|Protocol Violation|3|||
144279308|NCT01147458|520221543|FG000|First Intervention|Withdrawal by Subject|3|||
144279309|NCT01147458|520221544|FG001|First Intervention|Withdrawal by Subject|0|||
144279310|NCT01147458|520221545|FG002|First Intervention|Withdrawal by Subject|1|||
144279311|NCT01147458|520221546|FG003|First Intervention|Withdrawal by Subject|0|||
144279312|NCT01147458|520221543|FG000|First Intervention|Adverse Event|0|||
144279313|NCT01147458|520221544|FG001|First Intervention|Adverse Event|3|||
144279314|NCT01147458|520221545|FG002|First Intervention|Adverse Event|2|||
144244170|NCT05562934|520091739|FG004|Overall Study|Protocol Violation|1|||
144244171|NCT05562934|520091735|FG000|Overall Study|Withdrawal by Subject|0|||
144244172|NCT05562934|520091736|FG001|Overall Study|Withdrawal by Subject|0|||
144244173|NCT05562934|520091737|FG002|Overall Study|Withdrawal by Subject|1|||
144244174|NCT05562934|520091738|FG003|Overall Study|Withdrawal by Subject|1|||
144244175|NCT05562934|520091739|FG004|Overall Study|Withdrawal by Subject|0|||
144244176|NCT04250714|520091746|FG000|Overall Study|Treatment - withdrawal by subject|14|||
144244177|NCT04250714|520091746|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
144244178|NCT04250714|520091746|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
144244179|NCT04250714|520091746|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
144244180|NCT04250714|520091746|FG000|Overall Study|Treatment - Death|1|||
144244181|NCT04250714|520091746|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
144244182|NCT04250714|520091746|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
144244183|NCT04250714|520091746|FG000|Overall Study|Attempt|2|||
144244184|NCT04250714|520091746|FG000|Overall Study|Intent|7|||
144244185|NCT05741346|520091747|FG000|Overall Study|Withdrawn due to termination of study|28|||
144244186|NCT05906836|520091756|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
144244187|NCT05906836|520091756|FG000|Overall Study|Lost to Follow-up|1|||
144244188|NCT01846221|520091757|FG000|Overall Study|Catheter Failure|2|||
144244189|NCT01846221|520091758|FG001|Overall Study|Catheter Failure|0|||
144244190|NCT01846221|520091757|FG000|Overall Study|Age Exclusion|1|||
144244191|NCT01846221|520091758|FG001|Overall Study|Age Exclusion|0|||
144244192|NCT04392167|520091761|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
144244193|NCT02963558|520091762|FG000|Overall Study|Withdrawn by investigator|1|||
144244194|NCT02963558|520091763|FG001|Overall Study|Withdrawn by investigator|0|||
144244195|NCT02963558|520091762|FG000|Overall Study|Withdrawal by Subject|0|||
144244196|NCT02963558|520091763|FG001|Overall Study|Withdrawal by Subject|1|||
144244197|NCT02045732|520091768|FG000|Overall Study|At the discretion of the investigator|1|||
144244198|NCT02045732|520091769|FG001|Overall Study|At the discretion of the investigator|1|||
144244199|NCT00473824|520091770|FG000|Overall Study|Virologic Breakthrough|1|||
144244200|NCT00473824|520091771|FG001|Overall Study|Virologic Breakthrough|0|||
144244201|NCT00473824|520091770|FG000|Overall Study|Adverse Event|1|||
144244202|NCT00473824|520091771|FG001|Overall Study|Adverse Event|0|||
144244203|NCT00473824|520091770|FG000|Overall Study|Death|1|||
144244204|NCT00473824|520091771|FG001|Overall Study|Death|0|||
144244205|NCT00473824|520091770|FG000|Overall Study|Lost to Follow-up|1|||
144244206|NCT00473824|520091771|FG001|Overall Study|Lost to Follow-up|0|||
144244207|NCT00473824|520091770|FG000|Overall Study|Withdrawal by physician|1|||
144244208|NCT00473824|520091771|FG001|Overall Study|Withdrawal by physician|0|||
144244209|NCT02560623|520091772|FG000|Overall Study|Unable to swallow sponge|0|||
144244210|NCT02560623|520091773|FG001|Overall Study|Unable to swallow sponge|1|||
144244211|NCT02560623|520091774|FG002|Overall Study|Unable to swallow sponge|0|||
144244212|NCT02560623|520091775|FG003|Overall Study|Unable to swallow sponge|0|||
144244213|NCT02560623|520091772|FG000|Overall Study|Intervention prior to sponge administration|0|||
144244214|NCT02560623|520091773|FG001|Overall Study|Intervention prior to sponge administration|1|||
144244215|NCT02560623|520091774|FG002|Overall Study|Intervention prior to sponge administration|0|||
144244216|NCT02560623|520091775|FG003|Overall Study|Intervention prior to sponge administration|0|||
144244217|NCT05014815|520091776|FG000|Overall Study|Death|63|||
144244218|NCT05014815|520091777|FG001|Overall Study|Death|70|||
144244219|NCT05014815|520091776|FG000|Overall Study|Withdrawal by Subject|10|||
144244220|NCT05014815|520091777|FG001|Overall Study|Withdrawal by Subject|10|||
144244221|NCT05014815|520091776|FG000|Overall Study|Lost to Follow-up|4|||
144244222|NCT05014815|520091777|FG001|Overall Study|Lost to Follow-up|2|||
144244223|NCT05014815|520091776|FG000|Overall Study|Physician Decision|2|||
144244224|NCT05014815|520091777|FG001|Overall Study|Physician Decision|4|||
144244225|NCT04247880|520091778|FG000|Overall Study|Lost to Follow-up|24|||
144244226|NCT04247880|520091779|FG001|Overall Study|Lost to Follow-up|17|||
144244227|NCT04247880|520091778|FG000|Overall Study|Withdrawal by Subject|3|||
144244228|NCT04247880|520091779|FG001|Overall Study|Withdrawal by Subject|0|||
144244229|NCT06303167|520091780|FG000|Overall Study|Ineligible|1|||
144244230|NCT06303167|520091780|FG000|Overall Study|Never start protocol therapy|2|||
144279315|NCT01147458|520221546|FG003|First Intervention|Adverse Event|3|||
144244231|NCT06303167|520091780|FG000|Overall Study|Disease progression|16|||
144244232|NCT03385304|520091781|FG000|Overall Study|Death|19|||
144244233|NCT03385304|520091782|FG001|Overall Study|Death|7|||
144244234|NCT03385304|520091781|FG000|Overall Study|Lost to Follow-up|17|||
144244235|NCT03385304|520091782|FG001|Overall Study|Lost to Follow-up|14|||
144244236|NCT03385304|520091781|FG000|Overall Study|Withdrawal by Subject|3|||
144279316|NCT01147458|520221543|FG000|First Intervention|Other|1|||
144279317|NCT01147458|520221544|FG001|First Intervention|Other|2|||
144279318|NCT01147458|520221545|FG002|First Intervention|Other|0|||
144279319|NCT01147458|520221546|FG003|First Intervention|Other|0|||
144279320|NCT01147458|520221543|FG000|Second Intervention|Study terminated by sponsor|7|||
144279321|NCT01147458|520221544|FG001|Second Intervention|Study terminated by sponsor|5|||
144279322|NCT01147458|520221545|FG002|Second Intervention|Study terminated by sponsor|5|||
144279323|NCT01147458|520221546|FG003|Second Intervention|Study terminated by sponsor|3|||
144279324|NCT01147458|520221543|FG000|Second Intervention|Protocol Violation|0|||
144279325|NCT01147458|520221544|FG001|Second Intervention|Protocol Violation|1|||
144279326|NCT01147458|520221545|FG002|Second Intervention|Protocol Violation|1|||
144279327|NCT01147458|520221546|FG003|Second Intervention|Protocol Violation|0|||
144279328|NCT01147458|520221543|FG000|Second Intervention|Withdrawal by Subject|0|||
144279329|NCT01147458|520221544|FG001|Second Intervention|Withdrawal by Subject|1|||
144279330|NCT01147458|520221545|FG002|Second Intervention|Withdrawal by Subject|0|||
144279331|NCT01147458|520221546|FG003|Second Intervention|Withdrawal by Subject|0|||
144279332|NCT01147458|520221543|FG000|Second Intervention|Adverse Event|2|||
144279333|NCT01147458|520221544|FG001|Second Intervention|Adverse Event|0|||
144279334|NCT01147458|520221545|FG002|Second Intervention|Adverse Event|1|||
144279335|NCT01147458|520221546|FG003|Second Intervention|Adverse Event|1|||
144279336|NCT01147458|520221543|FG000|Second Intervention|Other|0|||
144279337|NCT01147458|520221544|FG001|Second Intervention|Other|0|||
144279338|NCT01147458|520221545|FG002|Second Intervention|Other|1|||
144279339|NCT01147458|520221546|FG003|Second Intervention|Other|0|||
144279340|NCT00832975|520221554|FG000|Overall Study|Lost to Follow-up|7|||
144279341|NCT00832975|520221554|FG000|Overall Study|Protocol Violation|6|||
144279342|NCT00832975|520221554|FG000|Overall Study|Death|5|||
144279343|NCT00832975|520221554|FG000|Overall Study|Physician Decision|4|||
144279344|NCT00832975|520221554|FG000|Overall Study|Withdrawal by Subject|3|||
144279345|NCT00832975|520221554|FG000|Overall Study|Other reasons|14|||
144279346|NCT04603066|520221562|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
144279347|NCT04603066|520221563|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
144279348|NCT01525589|520221564|FG000|Overall Study|Non-treatment-related AE|1|||
144279349|NCT01525589|520221565|FG001|Overall Study|Non-treatment-related AE|0|||
144279350|NCT01525589|520221566|FG002|Overall Study|Non-treatment-related AE|0|||
144279351|NCT01525589|520221564|FG000|Overall Study|Progressive disease|48|||
144279352|NCT01525589|520221565|FG001|Overall Study|Progressive disease|15|||
144279353|NCT01525589|520221566|FG002|Overall Study|Progressive disease|29|||
144279354|NCT01525589|520221564|FG000|Overall Study|Never treated|2|||
144279355|NCT01525589|520221565|FG001|Overall Study|Never treated|0|||
144279356|NCT01525589|520221566|FG002|Overall Study|Never treated|0|||
144279357|NCT01525589|520221564|FG000|Overall Study|Physician Decision|4|||
144279358|NCT01525589|520221565|FG001|Overall Study|Physician Decision|2|||
144279359|NCT01525589|520221566|FG002|Overall Study|Physician Decision|2|||
144279360|NCT01525589|520221564|FG000|Overall Study|Death|0|||
144279361|NCT01525589|520221565|FG001|Overall Study|Death|0|||
144279362|NCT01525589|520221566|FG002|Overall Study|Death|2|||
144279363|NCT01525589|520221564|FG000|Overall Study|Treatment-related AE|1|||
144279364|NCT01525589|520221565|FG001|Overall Study|Treatment-related AE|1|||
144279365|NCT01525589|520221566|FG002|Overall Study|Treatment-related AE|2|||
144279366|NCT01525589|520221564|FG000|Overall Study|Other reasons|0|||
144279367|NCT01525589|520221565|FG001|Overall Study|Other reasons|1|||
144279368|NCT01525589|520221566|FG002|Overall Study|Other reasons|0|||
144279369|NCT01525589|520221564|FG000|Overall Study|Withdrawal by Subject|0|||
144279370|NCT01525589|520221565|FG001|Overall Study|Withdrawal by Subject|1|||
144279371|NCT01525589|520221566|FG002|Overall Study|Withdrawal by Subject|0|||
144279372|NCT05759338|520221567|FG000|Overall Study|Withdrawal by Subject|3|||
144279373|NCT04409002|520221568|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
144279374|NCT04835441|520221569|FG000|Overall Study|Physician Decision|4|||
144279375|NCT04835441|520221570|FG001|Overall Study|Physician Decision|4|||
144279376|NCT04835441|520221569|FG000|Overall Study|Other|1|||
144279377|NCT04835441|520221570|FG001|Overall Study|Other|1|||
144279378|NCT04835441|520221569|FG000|Overall Study|Lost to Follow-up|0|||
144279379|NCT04835441|520221570|FG001|Overall Study|Lost to Follow-up|1|||
144279380|NCT06481579|520221571|FG000|Overall Study|Death|1|||
144279381|NCT06481579|520221572|FG001|Overall Study|Death|0|||
144279382|NCT06481579|520221571|FG000|Overall Study|Withdrawal by Subject|3|||
144279383|NCT06481579|520221572|FG001|Overall Study|Withdrawal by Subject|0|||
144279384|NCT06481579|520221571|FG000|Overall Study|Other|1|||
144279385|NCT06481579|520221572|FG001|Overall Study|Other|1|||
144279386|NCT05253807|520221573|FG000|Overall Study|Death|1|||
144279387|NCT05253807|520221574|FG001|Overall Study|Death|4|||
144279388|NCT05253807|520221573|FG000|Overall Study|Withdrawal by Subject|1|||
144279389|NCT05253807|520221574|FG001|Overall Study|Withdrawal by Subject|0|||
144279390|NCT05253807|520221573|FG000|Overall Study|Study Terminated by Sponsor|1|||
144279391|NCT05253807|520221574|FG001|Overall Study|Study Terminated by Sponsor|1|||
144244237|NCT03385304|520091782|FG001|Overall Study|Withdrawal by Subject|2|||
144244238|NCT03385304|520091781|FG000|Overall Study|Incarceration|2|||
144244239|NCT03385304|520091782|FG001|Overall Study|Incarceration|3|||
144244240|NCT02720744|520091783|FG000|Overall Study|Protocol Violation|0|||
144244241|NCT02720744|520091784|FG001|Overall Study|Protocol Violation|2|||
144244242|NCT02720744|520091783|FG000|Overall Study|Pregnancy|2|||
144244243|NCT02720744|520091784|FG001|Overall Study|Pregnancy|0|||
144244244|NCT02720744|520091783|FG000|Overall Study|Lack of Efficacy|2|||
144244245|NCT02720744|520091784|FG001|Overall Study|Lack of Efficacy|8|||
144244246|NCT02720744|520091783|FG000|Overall Study|Adverse Event|21|||
144244247|NCT02720744|520091784|FG001|Overall Study|Adverse Event|3|||
144244248|NCT02720744|520091783|FG000|Overall Study|Withdrawal by Subject|11|||
144244249|NCT02720744|520091784|FG001|Overall Study|Withdrawal by Subject|11|||
144244250|NCT02720744|520091783|FG000|Overall Study|Lost to follow up|2|||
144244251|NCT02720744|520091784|FG001|Overall Study|Lost to follow up|0|||
144244252|NCT02720744|520091783|FG000|Overall Study|Non Compliance with Investigational Product|0|||
144244253|NCT02720744|520091784|FG001|Overall Study|Non Compliance with Investigational Product|1|||
144244254|NCT02720744|520091783|FG000|Overall Study|Excluded Concomitant Medication|0|||
144244255|NCT02720744|520091784|FG001|Overall Study|Excluded Concomitant Medication|1|||
144244256|NCT00723190|520091788|FG000|Overall Study|Withdrawal by Subject|45|||
144244257|NCT00723190|520091788|FG000|Overall Study|Lost to Follow-up|37|||
144244258|NCT00723190|520091788|FG000|Overall Study|Adverse Event|18|||
144244259|NCT00723190|520091788|FG000|Overall Study|Lack of Efficacy|16|||
144244260|NCT00723190|520091788|FG000|Overall Study|Protocol Violation|15|||
144244261|NCT00723190|520091788|FG000|Overall Study|Other-Premature Discontinuation|9|||
144244262|NCT00723190|520091788|FG000|Overall Study|Other-Not included in safety population|2|||
144244263|NCT00454818|520091789|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
144244264|NCT00454818|520091790|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
144244265|NCT00454818|520091791|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
144244266|NCT00454818|520091792|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
144244267|NCT00454818|520091793|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
144244268|NCT00454818|520091789|FG000|Phase I: Open-label Dose-escalation|Death|0|||
144244269|NCT00454818|520091790|FG001|Phase I: Open-label Dose-escalation|Death|1|||
144244270|NCT00454818|520091791|FG002|Phase I: Open-label Dose-escalation|Death|0|||
144244271|NCT00454818|520091792|FG003|Phase I: Open-label Dose-escalation|Death|0|||
144244272|NCT00454818|520091793|FG004|Phase I: Open-label Dose-escalation|Death|0|||
144244273|NCT00454818|520091789|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
144244274|NCT00454818|520091790|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
144244275|NCT00454818|520091791|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
144244276|NCT00454818|520091792|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
144244277|NCT00454818|520091793|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
144244278|NCT00454818|520091789|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
144244279|NCT00454818|520091790|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
144244280|NCT00454818|520091791|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
144244281|NCT00454818|520091792|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
144244282|NCT00454818|520091793|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
144244283|NCT00454818|520091789|FG000|Phase 2: Randomized Double-blind|Death|0|||
144244284|NCT00454818|520091790|FG001|Phase 2: Randomized Double-blind|Death|1|||
144244285|NCT00454818|520091791|FG002|Phase 2: Randomized Double-blind|Death|0|||
144244286|NCT00454818|520091792|FG003|Phase 2: Randomized Double-blind|Death|0|||
144244287|NCT00454818|520091793|FG004|Phase 2: Randomized Double-blind|Death|1|||
144244288|NCT00454818|520091789|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
144244289|NCT00454818|520091790|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
144244290|NCT00454818|520091791|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
144244291|NCT00454818|520091792|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
144244292|NCT00454818|520091793|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
144244293|NCT00454818|520091789|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
144244294|NCT00454818|520091790|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
144244295|NCT00454818|520091791|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
144244296|NCT00454818|520091792|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
144244297|NCT00454818|520091793|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
144244298|NCT03181503|520091796|FG000|Overall Study|Adverse Event|2|||
144244299|NCT03181503|520091797|FG001|Overall Study|Adverse Event|2|||
144244300|NCT03181503|520091796|FG000|Overall Study|Protocol Violation|1|||
144244301|NCT03181503|520091797|FG001|Overall Study|Protocol Violation|0|||
144244302|NCT03181503|520091796|FG000|Overall Study|Withdrawal by Subject|3|||
144244303|NCT03181503|520091797|FG001|Overall Study|Withdrawal by Subject|0|||
144244304|NCT03181503|520091796|FG000|Overall Study|Lost to Follow-up|1|||
144244305|NCT03181503|520091797|FG001|Overall Study|Lost to Follow-up|1|||
144244306|NCT01892085|520091798|FG000|Overall Study|Death|4|||
144244307|NCT01892085|520091799|FG001|Overall Study|Death|1|||
144244308|NCT01892085|520091800|FG002|Overall Study|Death|3|||
144244309|NCT01892085|520091798|FG000|Overall Study|Withdrawal by Subject|2|||
144244310|NCT01892085|520091799|FG001|Overall Study|Withdrawal by Subject|0|||
144244311|NCT01892085|520091800|FG002|Overall Study|Withdrawal by Subject|2|||
144244312|NCT01549041|520091801|FG000|Overall Study|Lack of Efficacy|2|||
144244313|NCT01549041|520091802|FG001|Overall Study|Lack of Efficacy|4|||
144244314|NCT01549041|520091801|FG000|Overall Study|Adverse Event|0|||
144244315|NCT01549041|520091802|FG001|Overall Study|Adverse Event|4|||
144244316|NCT04027075|520091803|FG000|Overall Study|Lost to Follow-up|41|||
144244317|NCT04027075|520091804|FG001|Overall Study|Lost to Follow-up|22|||
144244318|NCT02844907|520091805|FG000|With Dexamethasone|No IV access|1|||
144244319|NCT00550862|520091806|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
144244320|NCT00550862|520091807|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
144244321|NCT00550862|520091808|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
144244322|NCT00550862|520091809|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
144244323|NCT00550862|520091810|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
144244324|NCT00550862|520091806|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
144244325|NCT00550862|520091807|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
144244326|NCT00550862|520091808|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
144244327|NCT00550862|520091809|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
144244328|NCT00550862|520091810|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
144244329|NCT00550862|520091806|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
144244330|NCT00550862|520091807|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
144244331|NCT00550862|520091808|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
144244332|NCT00550862|520091809|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
144244333|NCT00550862|520091810|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
144244334|NCT00550862|520091806|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
144244335|NCT00550862|520091807|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
144244336|NCT00550862|520091808|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
144279392|NCT04611126|520221575|FG000|Overall Study|TIL expansion unsuccessful|1|||
144279393|NCT04611126|520221576|FG001|Overall Study|TIL expansion unsuccessful|0|||
144279394|NCT03459846|520221577|FG000|Overall Study|Death|52|||
144279395|NCT03459846|520221578|FG001|Overall Study|Death|46|||
144279396|NCT03459846|520221577|FG000|Overall Study|Study terminated by sponsor|24|||
144279397|NCT03459846|520221578|FG001|Overall Study|Study terminated by sponsor|28|||
144279398|NCT03459846|520221577|FG000|Overall Study|Withdrawal by Subject|2|||
144279399|NCT03459846|520221578|FG001|Overall Study|Withdrawal by Subject|2|||
144279400|NCT06455111|520221579|FG000|Overall Study|Withdrawal by Subject|11|||
144279401|NCT06455111|520221580|FG001|Overall Study|Withdrawal by Subject|4|||
144279402|NCT01991314|520222495|FG000|Overall Study|Adverse Event|5|||
144279403|NCT01991314|520222496|FG001|Overall Study|Adverse Event|1|||
144279404|NCT01991314|520222495|FG000|Overall Study|Lost to Follow-up|6|||
144279405|NCT01991314|520222496|FG001|Overall Study|Lost to Follow-up|10|||
144279406|NCT02034591|520222505|FG000|Overall Study|Withdrawal by Subject|0|||
144279407|NCT02034591|520222506|FG001|Overall Study|Withdrawal by Subject|0|||
144279408|NCT02034591|520222507|FG002|Overall Study|Withdrawal by Subject|0|||
144279409|NCT02034591|520222508|FG003|Overall Study|Withdrawal by Subject|0|||
144279410|NCT02034591|520222509|FG004|Overall Study|Withdrawal by Subject|1|||
144279411|NCT02034591|520222510|FG005|Overall Study|Withdrawal by Subject|0|||
144279412|NCT00817063|520222511|FG000|Overall Study|Adverse Event|32|||
144279413|NCT00817063|520222512|FG001|Overall Study|Adverse Event|13|||
144279414|NCT00817063|520222511|FG000|Overall Study|Death|1|||
144279415|NCT00817063|520222512|FG001|Overall Study|Death|1|||
144279416|NCT00817063|520222511|FG000|Overall Study|Lack of Efficacy|33|||
144279417|NCT00817063|520222512|FG001|Overall Study|Lack of Efficacy|86|||
144279418|NCT00817063|520222511|FG000|Overall Study|Failure to Return|13|||
144279419|NCT00817063|520222512|FG001|Overall Study|Failure to Return|12|||
144279420|NCT00817063|520222511|FG000|Overall Study|Violation of Selection at Entry|7|||
144279421|NCT00817063|520222512|FG001|Overall Study|Violation of Selection at Entry|4|||
144279422|NCT00817063|520222511|FG000|Overall Study|Protocol Violation|3|||
144279423|NCT00817063|520222512|FG001|Overall Study|Protocol Violation|8|||
144279424|NCT00817063|520222511|FG000|Overall Study|Withdrawal by Subject|17|||
144279425|NCT00817063|520222512|FG001|Overall Study|Withdrawal by Subject|37|||
144279426|NCT00817063|520222511|FG000|Overall Study|Early Improvement|19|||
144279427|NCT00817063|520222512|FG001|Overall Study|Early Improvement|4|||
144279428|NCT00817063|520222511|FG000|Overall Study|Administrative|10|||
144279429|NCT00817063|520222512|FG001|Overall Study|Administrative|4|||
144279430|NCT00817063|520222511|FG000|Overall Study|Abnormality of Laboratory Test|2|||
144279431|NCT00817063|520222512|FG001|Overall Study|Abnormality of Laboratory Test|1|||
144279432|NCT01496456|520222513|FG000|Overall Study|Protocol Violation|1|||
144279433|NCT01496456|520222513|FG000|Overall Study|Lost to Follow-up|7|||
144279434|NCT02489773|520222514|FG000|Overall Study|Lost to Follow-up|4|||
144279435|NCT02489773|520222515|FG001|Overall Study|Lost to Follow-up|1|||
144279436|NCT02489773|520222514|FG000|Overall Study|Physician Decision|1|||
144279437|NCT02489773|520222515|FG001|Overall Study|Physician Decision|0|||
144279438|NCT02489773|520222514|FG000|Overall Study|Withdrawal by Subject|1|||
144279439|NCT02489773|520222515|FG001|Overall Study|Withdrawal by Subject|0|||
144279440|NCT02489773|520222514|FG000|Overall Study|Leave the country or the state|1|||
144279441|NCT02489773|520222515|FG001|Overall Study|Leave the country or the state|1|||
144279442|NCT00712920|520222516|FG000|Overall Study|Adverse Event|3|||
144279443|NCT00712920|520222517|FG001|Overall Study|Adverse Event|4|||
144279444|NCT00712920|520222518|FG002|Overall Study|Adverse Event|7|||
144279445|NCT00712920|520222516|FG000|Overall Study|Withdrawal by Subject|4|||
144279446|NCT00712920|520222517|FG001|Overall Study|Withdrawal by Subject|2|||
144279447|NCT00712920|520222518|FG002|Overall Study|Withdrawal by Subject|1|||
144279448|NCT00712920|520222516|FG000|Overall Study|Lost to Follow-up|1|||
144279449|NCT00712920|520222517|FG001|Overall Study|Lost to Follow-up|4|||
144279450|NCT00712920|520222518|FG002|Overall Study|Lost to Follow-up|0|||
144279451|NCT00712920|520222516|FG000|Overall Study|Lack of Efficacy|1|||
144279452|NCT00712920|520222517|FG001|Overall Study|Lack of Efficacy|0|||
144279453|NCT00712920|520222518|FG002|Overall Study|Lack of Efficacy|1|||
144279454|NCT00712920|520222516|FG000|Overall Study|Other|5|||
144279455|NCT00712920|520222517|FG001|Overall Study|Other|7|||
144279456|NCT00712920|520222518|FG002|Overall Study|Other|3|||
144279457|NCT00712920|520222516|FG000|Overall Study|Non-compliance|3|||
144279458|NCT00712920|520222517|FG001|Overall Study|Non-compliance|0|||
144279459|NCT00712920|520222518|FG002|Overall Study|Non-compliance|0|||
144279460|NCT02696616|520222519|FG000|Overall Study|Adverse Event|0|||
144279461|NCT02696616|520222520|FG001|Overall Study|Adverse Event|1|||
144279462|NCT02696616|520222521|FG002|Overall Study|Adverse Event|0|||
144279463|NCT02696616|520222522|FG003|Overall Study|Adverse Event|0|||
144279464|NCT02696616|520222523|FG004|Overall Study|Adverse Event|0|||
144279465|NCT02696616|520222524|FG005|Overall Study|Adverse Event|0|||
144279466|NCT02696616|520222525|FG006|Overall Study|Adverse Event|0|||
144279467|NCT01732783|520222528|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
144279468|NCT01732783|520222529|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
144279469|NCT01732783|520222530|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
144279470|NCT01732783|520222528|FG000|Overall Study|Death|13|||
144244337|NCT00550862|520091809|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
144244338|NCT00550862|520091810|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
144244339|NCT00550862|520091806|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
144244340|NCT00550862|520091807|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
144244341|NCT00550862|520091808|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
144244342|NCT00550862|520091809|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
144244343|NCT00550862|520091810|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
144244344|NCT00550862|520091806|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
144244345|NCT00550862|520091807|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
144244346|NCT00550862|520091808|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
144244347|NCT00550862|520091809|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
144244348|NCT00550862|520091810|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
144244349|NCT00550862|520091806|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
144244350|NCT00550862|520091807|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
144244351|NCT00550862|520091808|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
144244352|NCT00550862|520091809|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
144244353|NCT00550862|520091810|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
144244354|NCT00550862|520091806|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
144244355|NCT00550862|520091807|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
144244356|NCT00550862|520091808|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
144244357|NCT00550862|520091809|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
144244358|NCT00550862|520091810|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
144244359|NCT00550862|520091806|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
144244360|NCT00550862|520091807|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
144244361|NCT00550862|520091808|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
144244362|NCT00550862|520091809|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
144244363|NCT00550862|520091810|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
144244364|NCT00550862|520091806|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
144244365|NCT00550862|520091807|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
144244366|NCT00550862|520091808|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
144244367|NCT00550862|520091809|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
144244368|NCT00550862|520091810|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
144244369|NCT00628095|520091816|FG000|Overall Study|Adverse Event|5|||
144244370|NCT00628095|520091817|FG001|Overall Study|Adverse Event|3|||
144244371|NCT00628095|520091816|FG000|Overall Study|Lack of Efficacy|0|||
144244372|NCT00628095|520091817|FG001|Overall Study|Lack of Efficacy|3|||
144244373|NCT00628095|520091816|FG000|Overall Study|Withdrawal by Subject|2|||
144244374|NCT00628095|520091817|FG001|Overall Study|Withdrawal by Subject|0|||
144244375|NCT00628095|520091816|FG000|Overall Study|Other|0|||
144244376|NCT00628095|520091817|FG001|Overall Study|Other|1|||
144244377|NCT03235115|520091818|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
144244378|NCT03235115|520091819|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
144244379|NCT03235115|520091820|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
144244380|NCT03235115|520091821|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
144244381|NCT03235115|520091822|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
144244382|NCT03235115|520091823|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
144244383|NCT05020366|520091826|FG000|Overall Study|Lost to Follow-up|2|||
144244384|NCT05020366|520091827|FG001|Overall Study|Lost to Follow-up|0|||
144244385|NCT05020366|520091826|FG000|Overall Study|Withdrawal by Subject|2|||
144244386|NCT05020366|520091827|FG001|Overall Study|Withdrawal by Subject|0|||
144244387|NCT01793688|520091832|FG000|Overall Study|Protocol Violation|2|||
144244388|NCT01698879|520091833|FG000|Overall Study|Withdrawal by Subject|1|||
144244389|NCT01698879|520091834|FG001|Overall Study|Withdrawal by Subject|0|||
144244390|NCT01698879|520091835|FG002|Overall Study|Withdrawal by Subject|0|||
144244391|NCT04450407|520091837|FG000|Overall Study|Withdrawal by Subject|10|||
144244392|NCT04450407|520091838|FG001|Overall Study|Withdrawal by Subject|1|||
144244393|NCT04450407|520091839|FG002|Overall Study|Withdrawal by Subject|4|||
144244394|NCT04450407|520091837|FG000|Overall Study|Adverse Event|0|||
144244395|NCT04450407|520091838|FG001|Overall Study|Adverse Event|0|||
144244396|NCT04450407|520091839|FG002|Overall Study|Adverse Event|1|||
144244397|NCT04450407|520091837|FG000|Overall Study|Lost to Follow-up|1|||
144244398|NCT04450407|520091838|FG001|Overall Study|Lost to Follow-up|0|||
144244399|NCT04450407|520091839|FG002|Overall Study|Lost to Follow-up|0|||
144244400|NCT04450407|520091837|FG000|Overall Study|Physician Decision|0|||
144244401|NCT04450407|520091838|FG001|Overall Study|Physician Decision|0|||
144244402|NCT04450407|520091839|FG002|Overall Study|Physician Decision|1|||
144244403|NCT04450407|520091837|FG000|Overall Study|Pregnancy|1|||
144244404|NCT04450407|520091838|FG001|Overall Study|Pregnancy|0|||
144244405|NCT04450407|520091839|FG002|Overall Study|Pregnancy|0|||
144244406|NCT04450407|520091837|FG000|Overall Study|Protocol Violation|2|||
144244407|NCT04450407|520091838|FG001|Overall Study|Protocol Violation|0|||
144244408|NCT04450407|520091839|FG002|Overall Study|Protocol Violation|0|||
144244409|NCT04450407|520091837|FG000|Overall Study|Investigational site terminated by sponsor|3|||
144244410|NCT04450407|520091838|FG001|Overall Study|Investigational site terminated by sponsor|0|||
144244411|NCT04450407|520091839|FG002|Overall Study|Investigational site terminated by sponsor|2|||
144244412|NCT01317797|520091840|FG000|Overall Study|Other|0|||
144244413|NCT01317797|520091841|FG001|Overall Study|Other|1|||
144244414|NCT01317797|520091842|FG002|Overall Study|Other|0|||
144244415|NCT01317797|520091840|FG000|Overall Study|Withdrawal of Patient|0|||
144244416|NCT01317797|520091841|FG001|Overall Study|Withdrawal of Patient|0|||
144244417|NCT01317797|520091842|FG002|Overall Study|Withdrawal of Patient|1|||
144244418|NCT01645891|520091843|FG000|Overall Study|Adverse Event|6|||
144244419|NCT01645891|520091844|FG001|Overall Study|Adverse Event|10|||
144244420|NCT01645891|520091843|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
144244421|NCT01645891|520091844|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
144244422|NCT01645891|520091843|FG000|Overall Study|Withdrawal by Subject|3|||
144244423|NCT01645891|520091844|FG001|Overall Study|Withdrawal by Subject|3|||
144244424|NCT01645891|520091843|FG000|Overall Study|Protocol Violation|4|||
144244425|NCT01645891|520091844|FG001|Overall Study|Protocol Violation|0|||
144244426|NCT01645891|520091843|FG000|Overall Study|Lost to Follow-up|4|||
144244427|NCT01645891|520091844|FG001|Overall Study|Lost to Follow-up|1|||
144244428|NCT01645891|520091843|FG000|Overall Study|Death|0|||
144244429|NCT01645891|520091844|FG001|Overall Study|Death|2|||
144244430|NCT01173055|520091850|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
144244431|NCT01173055|520091851|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
144244432|NCT01173055|520091850|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
144244433|NCT01173055|520091851|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
144244434|NCT04814368|520091852|FG000|Overall Study|Study Terminated by Sponsor|0|||
144244435|NCT04814368|520091853|FG001|Overall Study|Study Terminated by Sponsor|3|||
144244436|NCT04814368|520091854|FG002|Overall Study|Study Terminated by Sponsor|0|||
144244437|NCT04814368|520091855|FG003|Overall Study|Study Terminated by Sponsor|2|||
144244438|NCT04814368|520091852|FG000|Overall Study|Subject Decision|1|||
144244439|NCT04814368|520091853|FG001|Overall Study|Subject Decision|2|||
144244440|NCT04814368|520091854|FG002|Overall Study|Subject Decision|0|||
144244441|NCT04814368|520091855|FG003|Overall Study|Subject Decision|0|||
144244442|NCT01451164|520093154|FG000|Overall Study|Adverse Event|19|||
144244443|NCT01451164|520093155|FG001|Overall Study|Adverse Event|12|||
144244444|NCT01451164|520093156|FG002|Overall Study|Adverse Event|18|||
144244445|NCT01451164|520093157|FG003|Overall Study|Adverse Event|21|||
144244446|NCT01451164|520093154|FG000|Overall Study|Withdrawal Criteria|1|||
144244447|NCT01451164|520093155|FG001|Overall Study|Withdrawal Criteria|1|||
144244448|NCT01451164|520093156|FG002|Overall Study|Withdrawal Criteria|1|||
144244449|NCT01451164|520093157|FG003|Overall Study|Withdrawal Criteria|1|||
144244450|NCT01451164|520093154|FG000|Overall Study|Physician Decision|2|||
144244451|NCT01451164|520093155|FG001|Overall Study|Physician Decision|0|||
144244452|NCT01451164|520093156|FG002|Overall Study|Physician Decision|1|||
144244453|NCT01451164|520093157|FG003|Overall Study|Physician Decision|0|||
144244454|NCT01451164|520093154|FG000|Overall Study|Withdrawal by Subject|14|||
144244455|NCT01451164|520093155|FG001|Overall Study|Withdrawal by Subject|11|||
144244456|NCT01451164|520093156|FG002|Overall Study|Withdrawal by Subject|16|||
144244457|NCT01451164|520093157|FG003|Overall Study|Withdrawal by Subject|17|||
144244458|NCT01451164|520093154|FG000|Overall Study|Protocol Violation|0|||
144244459|NCT01451164|520093155|FG001|Overall Study|Protocol Violation|1|||
144244460|NCT01451164|520093156|FG002|Overall Study|Protocol Violation|0|||
144244461|NCT01451164|520093157|FG003|Overall Study|Protocol Violation|0|||
144244462|NCT01451164|520093154|FG000|Overall Study|Lack of Efficacy|7|||
144279471|NCT01732783|520222529|FG001|Overall Study|Death|4|||
144244463|NCT01451164|520093155|FG001|Overall Study|Lack of Efficacy|9|||
144244464|NCT01451164|520093156|FG002|Overall Study|Lack of Efficacy|9|||
144244465|NCT01451164|520093157|FG003|Overall Study|Lack of Efficacy|7|||
144244466|NCT04599933|520093158|FG000|Overall Study|Adverse Event|4|||
144244467|NCT04599933|520093159|FG001|Overall Study|Adverse Event|1|||
144244468|NCT04599933|520093158|FG000|Overall Study|Withdrawal by Subject|4|||
144279472|NCT01732783|520222530|FG002|Overall Study|Death|1|||
144244469|NCT04599933|520093159|FG001|Overall Study|Withdrawal by Subject|2|||
144279473|NCT01732783|520222528|FG000|Overall Study|Lost to Follow-up|7|||
144244470|NCT04599933|520093158|FG000|Overall Study|Lost to Follow-up|0|||
144244471|NCT04599933|520093159|FG001|Overall Study|Lost to Follow-up|1|||
144244472|NCT04599933|520093158|FG000|Overall Study|Physician Decision|0|||
144244473|NCT04599933|520093159|FG001|Overall Study|Physician Decision|1|||
144244474|NCT04599933|520093158|FG000|Overall Study|Screen Failure|1|||
144244475|NCT04599933|520093159|FG001|Overall Study|Screen Failure|2|||
144244476|NCT01199822|520093170|FG000|Overall Study|Investigator discontinued therapy|0|||
144244477|NCT01199822|520093171|FG001|Overall Study|Investigator discontinued therapy|1|||
144244478|NCT01199822|520093172|FG002|Overall Study|Investigator discontinued therapy|0|||
144244479|NCT00480493|520093173|FG000|Overall Study|moved|2|||
144244480|NCT00480493|520093174|FG001|Overall Study|moved|7|||
144244481|NCT00455520|520093175|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
144244482|NCT00455520|520093176|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
144244483|NCT00455520|520093175|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
144244484|NCT00455520|520093176|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
144244485|NCT00455520|520093175|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
144244486|NCT00455520|520093176|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
144244487|NCT00455520|520093175|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
144244488|NCT00455520|520093176|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
144244489|NCT00455520|520093175|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
144244490|NCT00455520|520093176|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
144244491|NCT00455520|520093175|FG000|Open Label Tapentadol Extended Release|All other|33|||
144244492|NCT00455520|520093176|FG001|Open Label Tapentadol Extended Release|All other|0|||
144244493|NCT00455520|520093175|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
144244494|NCT00455520|520093176|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
144244495|NCT00455520|520093175|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
144244496|NCT00455520|520093176|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
144244497|NCT00455520|520093175|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
144244498|NCT00455520|520093176|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
144279474|NCT01732783|520222529|FG001|Overall Study|Lost to Follow-up|1|||
144279475|NCT01732783|520222530|FG002|Overall Study|Lost to Follow-up|1|||
144279476|NCT01732783|520222528|FG000|Overall Study|Administrative Decision|8|||
144279477|NCT01732783|520222529|FG001|Overall Study|Administrative Decision|2|||
144279478|NCT01732783|520222530|FG002|Overall Study|Administrative Decision|1|||
144279479|NCT01732783|520222528|FG000|Overall Study|Withdrawal by Subject|1|||
144279480|NCT01732783|520222529|FG001|Overall Study|Withdrawal by Subject|0|||
144279481|NCT01732783|520222530|FG002|Overall Study|Withdrawal by Subject|0|||
144279482|NCT01500083|520222531|FG000|Overall Study|Adverse Event|4|||
144279483|NCT01500083|520222532|FG001|Overall Study|Adverse Event|17|||
144279484|NCT01500083|520222531|FG000|Overall Study|Death|0|||
144279485|NCT01500083|520222532|FG001|Overall Study|Death|2|||
144279486|NCT01500083|520222531|FG000|Overall Study|Lost to Follow-up|1|||
144279487|NCT01500083|520222532|FG001|Overall Study|Lost to Follow-up|0|||
144279488|NCT01500083|520222531|FG000|Overall Study|Withdrawal of Consent|0|||
144279489|NCT01500083|520222532|FG001|Overall Study|Withdrawal of Consent|1|||
144279490|NCT01500083|520222531|FG000|Overall Study|Disease Progression|2|||
144279491|NCT01500083|520222532|FG001|Overall Study|Disease Progression|10|||
144279492|NCT01500083|520222531|FG000|Overall Study|Investigator Discretion|3|||
144279493|NCT01500083|520222532|FG001|Overall Study|Investigator Discretion|8|||
144279494|NCT01500083|520222531|FG000|Overall Study|Other Reasons|2|||
144279495|NCT01500083|520222532|FG001|Overall Study|Other Reasons|5|||
144279496|NCT01555931|520222533|FG000|Overall Study|Lost to Follow-up|2|||
144279497|NCT01555931|520222534|FG001|Overall Study|Lost to Follow-up|5|||
144279498|NCT02299167|520222537|FG000|Overall Study|patients were excluded from the study|11|||
144279499|NCT03600428|520222538|FG000|Overall Study|Not eligible|0|||
144279500|NCT03600428|520222539|FG001|Overall Study|Not eligible|1|||
144279501|NCT03600428|520222538|FG000|Overall Study|Lost to Follow-up|5|||
144279502|NCT03600428|520222539|FG001|Overall Study|Lost to Follow-up|4|||
144279503|NCT04092777|520222541|FG000|Overall Study|Lost to Follow-up|28|||
144279504|NCT04092777|520222542|FG001|Overall Study|Lost to Follow-up|46|||
144279505|NCT04092777|520222541|FG000|Overall Study|Withdrawal by Subject|8|||
144279506|NCT04092777|520222542|FG001|Overall Study|Withdrawal by Subject|5|||
144279507|NCT04717557|520222549|FG000|Overall Study|Withdrawal by Subject|2|||
144279508|NCT04717557|520222550|FG001|Overall Study|Withdrawal by Subject|0|||
144279509|NCT04717557|520222549|FG000|Overall Study|Death|1|||
144279510|NCT04717557|520222550|FG001|Overall Study|Death|0|||
144279511|NCT02685735|520222551|FG000|Overall Study|Surgery Cancelled|4|||
144279512|NCT02685735|520222552|FG001|Overall Study|Surgery Cancelled|9|||
144279513|NCT02685735|520222551|FG000|Overall Study|Adverse Event|10|||
144279514|NCT02685735|520222552|FG001|Overall Study|Adverse Event|3|||
144279515|NCT02685735|520222551|FG000|Overall Study|Preop testing found to be incomplete|2|||
144279516|NCT02685735|520222552|FG001|Overall Study|Preop testing found to be incomplete|2|||
144279517|NCT02685735|520222551|FG000|Overall Study|Withdrawal by Subject|1|||
144279518|NCT02685735|520222552|FG001|Overall Study|Withdrawal by Subject|2|||
144279519|NCT02685735|520222551|FG000|Overall Study|Death|1|||
144279520|NCT02685735|520222552|FG001|Overall Study|Death|0|||
144279521|NCT00927472|520222560|FG000|Overall Study|Withdrawal by Subject|10|||
144279522|NCT00927472|520222561|FG001|Overall Study|Withdrawal by Subject|11|||
144279523|NCT00927472|520222560|FG000|Overall Study|Lost to Follow-up|1|||
144279524|NCT00927472|520222561|FG001|Overall Study|Lost to Follow-up|6|||
144279525|NCT00927472|520222560|FG000|Overall Study|Protocol Violation|0|||
144279526|NCT00927472|520222561|FG001|Overall Study|Protocol Violation|1|||
144279527|NCT00927472|520222560|FG000|Overall Study|Post treatment Assessment out of window|0|||
144279528|NCT00927472|520222561|FG001|Overall Study|Post treatment Assessment out of window|4|||
144279529|NCT00433537|520222562|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
144279530|NCT00433537|520222563|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
144279531|NCT00433537|520222564|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
144279532|NCT00433537|520222562|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
144279533|NCT00433537|520222563|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
144279534|NCT00433537|520222564|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
144279535|NCT00433537|520222562|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
144279536|NCT00433537|520222563|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
144279537|NCT00433537|520222564|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
144279538|NCT00433537|520222562|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
144279539|NCT00433537|520222563|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
144279540|NCT00433537|520222564|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
144279541|NCT00433537|520222562|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
144279542|NCT00433537|520222563|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
144279543|NCT00433537|520222564|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
144279544|NCT00433537|520222562|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
144279545|NCT00433537|520222563|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
144279546|NCT00433537|520222564|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
144279547|NCT00433537|520222562|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
144279548|NCT00433537|520222563|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
144279549|NCT00433537|520222564|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
144279550|NCT00433537|520222562|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
144279551|NCT00433537|520222563|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
144279552|NCT00433537|520222564|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
144279553|NCT00433537|520222562|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
144279554|NCT00433537|520222563|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
144279555|NCT00433537|520222564|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
144279556|NCT05436613|520222565|FG000|Overall Study|Lost to Follow-up|9|||
144279557|NCT05436613|520222565|FG000|Overall Study|Withdrawal by Subject|3|||
144279558|NCT05317546|520222568|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
144279559|NCT05317546|520222569|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
144279560|NCT03069989|520222579|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
144279561|NCT03069989|520222580|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
144279562|NCT06717399|520222581|FG000|Overall Study|Death|1|||
144244499|NCT00455520|520093175|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
144244500|NCT00455520|520093176|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
144244501|NCT00455520|520093175|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
144244502|NCT00455520|520093176|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
144244503|NCT00455520|520093175|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
144244504|NCT00455520|520093176|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
144244505|NCT03488225|520093177|FG000|Overall Study|Off Protocol Therapy|2|||
144244506|NCT03488225|520093177|FG000|Overall Study|Stem Cell Transplant|2|||
144244507|NCT01472965|520093180|FG000|Overall Study|Withdrawal by Subject|1|||
144244508|NCT01472965|520093181|FG001|Overall Study|Withdrawal by Subject|0|||
144244509|NCT00986986|520093182|FG000|Overall Study|Lost to Follow-up|0|||
144244510|NCT00986986|520093183|FG001|Overall Study|Lost to Follow-up|1|||
144244511|NCT00955968|520093186|FG000|Overall Study|Death|2|||
144244512|NCT00955968|520093187|FG001|Overall Study|Death|4|||
144244513|NCT00955968|520093186|FG000|Overall Study|Withdrawal by Subject|35|||
144244514|NCT00955968|520093187|FG001|Overall Study|Withdrawal by Subject|31|||
144244515|NCT00955968|520093186|FG000|Overall Study|Lost to Follow-up|45|||
144244516|NCT00955968|520093187|FG001|Overall Study|Lost to Follow-up|39|||
144244517|NCT00955968|520093186|FG000|Overall Study|Site closed|55|||
144244518|NCT00955968|520093187|FG001|Overall Study|Site closed|52|||
144244519|NCT05020899|520093189|FG000|8 Week Follow-up|Lost to Follow-up|3|||
144244520|NCT05020899|520093190|FG001|8 Week Follow-up|Lost to Follow-up|6|||
144244521|NCT05020899|520093189|FG000|12 Week Follow-up|Lost to Follow-up|1|||
144244522|NCT05020899|520093190|FG001|12 Week Follow-up|Lost to Follow-up|0|||
144244523|NCT05020899|520093189|FG000|12 Week Follow-up|Death|0|||
144244524|NCT05020899|520093190|FG001|12 Week Follow-up|Death|1|||
144244525|NCT01068626|520093193|FG000|Overall Study|Adverse Event|3|||
144244526|NCT01068626|520093194|FG001|Overall Study|Adverse Event|0|||
144244527|NCT01068626|520093193|FG000|Overall Study|Withdrawal by Subject|0|||
144244528|NCT01068626|520093194|FG001|Overall Study|Withdrawal by Subject|2|||
144244529|NCT01785849|520093195|FG000|Overall Study|Death|7|||
144244530|NCT01785849|520093196|FG001|Overall Study|Death|9|||
144244531|NCT01785849|520093195|FG000|Overall Study|Protocol Specified Criteria|29|||
144244532|NCT01785849|520093196|FG001|Overall Study|Protocol Specified Criteria|1|||
144244533|NCT01785849|520093195|FG000|Overall Study|Withdrawal by Subject|15|||
144244534|NCT01785849|520093196|FG001|Overall Study|Withdrawal by Subject|12|||
144244535|NCT01785849|520093195|FG000|Overall Study|Sponsor Decision|0|||
144244536|NCT01785849|520093196|FG001|Overall Study|Sponsor Decision|1|||
144244537|NCT01785849|520093195|FG000|Overall Study|Lost to Follow-up|10|||
144244538|NCT01785849|520093196|FG001|Overall Study|Lost to Follow-up|11|||
144244539|NCT00474045|520093199|FG000|Overall Study|Adverse Event|18|||
144244540|NCT00474045|520093200|FG001|Overall Study|Adverse Event|8|||
144244541|NCT00474045|520093199|FG000|Overall Study|Unclassified|1|||
144244542|NCT00474045|520093200|FG001|Overall Study|Unclassified|3|||
144244543|NCT00474045|520093199|FG000|Overall Study|Lack of Efficacy|0|||
144244544|NCT00474045|520093200|FG001|Overall Study|Lack of Efficacy|9|||
144244545|NCT00474045|520093199|FG000|Overall Study|Lost to Follow-up|1|||
144244546|NCT00474045|520093200|FG001|Overall Study|Lost to Follow-up|1|||
144244547|NCT00474045|520093199|FG000|Overall Study|Protocol Violation|10|||
144244548|NCT00474045|520093200|FG001|Overall Study|Protocol Violation|12|||
144244549|NCT00474045|520093199|FG000|Overall Study|Withdrawal by Subject|16|||
144244550|NCT00474045|520093200|FG001|Overall Study|Withdrawal by Subject|18|||
144244551|NCT00474045|520093199|FG000|Overall Study|Withdrawal criteria|60|||
144244552|NCT00474045|520093200|FG001|Overall Study|Withdrawal criteria|50|||
144279563|NCT02145390|520222582|FG000|Overall Study|Withdrawal by Subject|1|||
144279564|NCT00143507|520223978|FG000|Overall Study|Death|572|||
144279565|NCT00143507|520223979|FG001|Overall Study|Death|547|||
144279566|NCT00143507|520223978|FG000|Overall Study|Withdrawal by Subject|114|||
144279567|NCT00143507|520223979|FG001|Overall Study|Withdrawal by Subject|102|||
144279568|NCT00143507|520223978|FG000|Overall Study|Lost to Follow-up|1|||
144279569|NCT00143507|520223979|FG001|Overall Study|Lost to Follow-up|0|||
144279570|NCT00143507|520223978|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
144279571|NCT00143507|520223979|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
144279572|NCT00876395|520223980|FG000|Overall Study|Untreated|8|||
144279573|NCT00876395|520223981|FG001|Overall Study|Untreated|1|||
144279574|NCT00876395|520223980|FG000|Overall Study|Adverse Event|63|||
144279575|NCT00876395|520223981|FG001|Overall Study|Adverse Event|11|||
144279576|NCT00876395|520223980|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144279577|NCT00876395|520223981|FG001|Overall Study|Abnormal test procedure result(s)|0|||
144279578|NCT00876395|520223980|FG000|Overall Study|Disease progression|259|||
144279579|NCT00876395|520223981|FG001|Overall Study|Disease progression|162|||
144279580|NCT00876395|520223980|FG000|Overall Study|New cancer therapy|25|||
144279581|NCT00876395|520223981|FG001|Overall Study|New cancer therapy|7|||
144279582|NCT00876395|520223980|FG000|Overall Study|Protocol Violation|5|||
144279583|NCT00876395|520223981|FG001|Overall Study|Protocol Violation|2|||
144279584|NCT00876395|520223980|FG000|Overall Study|Withdrawal by Subject|66|||
144279585|NCT00876395|520223981|FG001|Overall Study|Withdrawal by Subject|33|||
144279586|NCT00876395|520223980|FG000|Overall Study|Lost to Follow-up|2|||
144279587|NCT00876395|520223981|FG001|Overall Study|Lost to Follow-up|0|||
144279588|NCT00876395|520223980|FG000|Overall Study|Administrative problems|39|||
144279589|NCT00876395|520223981|FG001|Overall Study|Administrative problems|23|||
144279590|NCT00876395|520223980|FG000|Overall Study|Death|12|||
144279591|NCT00876395|520223981|FG001|Overall Study|Death|0|||
144279592|NCT00662259|520223983|FG000|Overall Study|Adverse Event|2|||
144279593|NCT00662259|520223984|FG001|Overall Study|Adverse Event|0|||
144279594|NCT00599313|520223985|FG000|Overall Study|Adverse Event|19|||
144279595|NCT00599313|520223985|FG000|Overall Study|Disease Progression|12|||
144279596|NCT00599313|520223985|FG000|Overall Study|Patient Request|4|||
144279597|NCT00599313|520223985|FG000|Overall Study|Ineligible|1|||
144279598|NCT04398134|520223989|FG000|Overall Study|Adverse Event|0|||
144279599|NCT04398134|520223990|FG001|Overall Study|Adverse Event|0|||
144279600|NCT04398134|520223991|FG002|Overall Study|Adverse Event|1|||
144279601|NCT04398134|520223992|FG003|Overall Study|Adverse Event|0|||
144279602|NCT04398134|520223989|FG000|Overall Study|Withdrawal by Subject|2|||
144279603|NCT04398134|520223990|FG001|Overall Study|Withdrawal by Subject|0|||
144279604|NCT04398134|520223991|FG002|Overall Study|Withdrawal by Subject|0|||
144279605|NCT04398134|520223992|FG003|Overall Study|Withdrawal by Subject|1|||
144279606|NCT04398134|520223989|FG000|Overall Study|Study Terminated by Sponsor|30|||
144279607|NCT04398134|520223990|FG001|Overall Study|Study Terminated by Sponsor|11|||
144279608|NCT04398134|520223991|FG002|Overall Study|Study Terminated by Sponsor|32|||
144279609|NCT04398134|520223992|FG003|Overall Study|Study Terminated by Sponsor|11|||
144279610|NCT00005047|520223994|FG000|Overall Study|Withdrawal by Subject|12|||
144279611|NCT00005047|520223995|FG001|Overall Study|Withdrawal by Subject|0|||
144279612|NCT00005047|520223996|FG002|Overall Study|Withdrawal by Subject|0|||
144279613|NCT00005047|520223997|FG003|Overall Study|Withdrawal by Subject|0|||
144279614|NCT00005047|520223994|FG000|Overall Study|Adverse Event|5|||
144279615|NCT00005047|520223995|FG001|Overall Study|Adverse Event|0|||
144279616|NCT00005047|520223996|FG002|Overall Study|Adverse Event|0|||
144279617|NCT00005047|520223997|FG003|Overall Study|Adverse Event|0|||
144279618|NCT00005047|520223994|FG000|Overall Study|Lost to Follow-up|1|||
144279619|NCT00005047|520223995|FG001|Overall Study|Lost to Follow-up|0|||
144279620|NCT00005047|520223996|FG002|Overall Study|Lost to Follow-up|0|||
144279621|NCT00005047|520223997|FG003|Overall Study|Lost to Follow-up|0|||
144279622|NCT00005047|520223994|FG000|Overall Study|Lack of Efficacy|1|||
144279623|NCT00005047|520223995|FG001|Overall Study|Lack of Efficacy|0|||
144279624|NCT00005047|520223996|FG002|Overall Study|Lack of Efficacy|0|||
144279625|NCT00005047|520223997|FG003|Overall Study|Lack of Efficacy|0|||
144279626|NCT03168672|520224008|FG000|Overall Study|Withdrawal by Subject|13|||
144279627|NCT03168672|520224008|FG000|Overall Study|Death|3|||
144279628|NCT03168672|520224008|FG000|Overall Study|Investigator's Decision|137|||
144279629|NCT03168672|520224008|FG000|Overall Study|Adverse Event|1|||
144279630|NCT03168672|520224008|FG000|Overall Study|Other|2|||
144279631|NCT03168672|520224008|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
144279632|NCT03506477|520224009|FG000|Overall Study|Withdrawal by Subject|1|||
144279633|NCT03506477|520224010|FG001|Overall Study|Withdrawal by Subject|0|||
144279634|NCT03462680|520224011|FG000|Overall Study|Withdrawal by Subject|3|||
144279635|NCT03462680|520224012|FG001|Overall Study|Withdrawal by Subject|5|||
144279636|NCT01757847|520224013|FG000|Overall Study|Withdrawal by Subject|3|||
144279637|NCT01757847|520224014|FG001|Overall Study|Withdrawal by Subject|4|||
144279638|NCT04556097|520224015|FG000|Overall Study|Death|0|||
144279639|NCT04556097|520224016|FG001|Overall Study|Death|5|||
144279640|NCT04556097|520224017|FG002|Overall Study|Death|0|||
144279641|NCT04556097|520224018|FG003|Overall Study|Death|0|||
144279642|NCT04556097|520224015|FG000|Overall Study|No caregiver|43|||
144279643|NCT04556097|520224016|FG001|Overall Study|No caregiver|53|||
144279644|NCT04556097|520224017|FG002|Overall Study|No caregiver|0|||
144279645|NCT04556097|520224018|FG003|Overall Study|No caregiver|0|||
144279646|NCT04556097|520224015|FG000|Overall Study|Ineligible, SNF|2|||
144279647|NCT04556097|520224016|FG001|Overall Study|Ineligible, SNF|2|||
144279648|NCT04556097|520224017|FG002|Overall Study|Ineligible, SNF|0|||
144279649|NCT04556097|520224018|FG003|Overall Study|Ineligible, SNF|0|||
144279650|NCT04556097|520224015|FG000|Overall Study|Ineligible, health|3|||
144279651|NCT04556097|520224016|FG001|Overall Study|Ineligible, health|4|||
144279652|NCT04556097|520224017|FG002|Overall Study|Ineligible, health|0|||
144279653|NCT04556097|520224018|FG003|Overall Study|Ineligible, health|0|||
144279654|NCT04556097|520224015|FG000|Overall Study|Ineligible, language|0|||
144279655|NCT04556097|520224016|FG001|Overall Study|Ineligible, language|1|||
144279656|NCT04556097|520224017|FG002|Overall Study|Ineligible, language|0|||
144279657|NCT04556097|520224018|FG003|Overall Study|Ineligible, language|0|||
144279658|NCT04556097|520224015|FG000|Overall Study|Ineligible, no longer in care management|0|||
144279659|NCT04556097|520224016|FG001|Overall Study|Ineligible, no longer in care management|2|||
144279660|NCT04556097|520224017|FG002|Overall Study|Ineligible, no longer in care management|1|||
144279661|NCT04556097|520224018|FG003|Overall Study|Ineligible, no longer in care management|0|||
144279662|NCT04556097|520224015|FG000|Overall Study|No dementia|13|||
144279663|NCT04556097|520224016|FG001|Overall Study|No dementia|3|||
144279664|NCT04556097|520224017|FG002|Overall Study|No dementia|0|||
144279665|NCT04556097|520224018|FG003|Overall Study|No dementia|0|||
144279666|NCT04556097|520224015|FG000|Overall Study|Missing identifier|2|||
144279667|NCT04556097|520224016|FG001|Overall Study|Missing identifier|4|||
144279668|NCT04556097|520224017|FG002|Overall Study|Missing identifier|0|||
144279669|NCT04556097|520224018|FG003|Overall Study|Missing identifier|0|||
144279670|NCT04556097|520224015|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
144279671|NCT04556097|520224016|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
144279672|NCT04556097|520224017|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
144279673|NCT04556097|520224018|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
144279674|NCT02516241|520224019|FG000|Overall Study|Death|255|||
144279675|NCT02516241|520224020|FG001|Overall Study|Death|262|||
144279676|NCT02516241|520224021|FG002|Overall Study|Death|270|||
144279677|NCT02516241|520224019|FG000|Overall Study|Lost to Follow-up|1|||
144279678|NCT02516241|520224020|FG001|Overall Study|Lost to Follow-up|1|||
144279679|NCT02516241|520224021|FG002|Overall Study|Lost to Follow-up|3|||
144279680|NCT02516241|520224019|FG000|Overall Study|Withdrawal by Subject|2|||
144279681|NCT02516241|520224020|FG001|Overall Study|Withdrawal by Subject|7|||
144279682|NCT02516241|520224021|FG002|Overall Study|Withdrawal by Subject|12|||
144279683|NCT02516241|520224019|FG000|Overall Study|participants ongoing at data cut-off|84|||
144279684|NCT02516241|520224020|FG001|Overall Study|participants ongoing at data cut-off|76|||
144279685|NCT02516241|520224021|FG002|Overall Study|participants ongoing at data cut-off|59|||
144279686|NCT04590963|520224022|FG000|Overall Study|Death|118|||
144279687|NCT04590963|520224023|FG001|Overall Study|Death|59|||
144279688|NCT04590963|520224022|FG000|Overall Study|Lost to Follow-up|1|||
144279689|NCT04590963|520224023|FG001|Overall Study|Lost to Follow-up|1|||
144279690|NCT04590963|520224022|FG000|Overall Study|Progressive disease|0|||
144279691|NCT04590963|520224023|FG001|Overall Study|Progressive disease|1|||
144279692|NCT04590963|520224022|FG000|Overall Study|Study terminated by sponsor|103|||
144279693|NCT04590963|520224023|FG001|Overall Study|Study terminated by sponsor|50|||
144279694|NCT04590963|520224022|FG000|Overall Study|Withdrawal by Subject|15|||
144279695|NCT04590963|520224023|FG001|Overall Study|Withdrawal by Subject|8|||
144279696|NCT04590963|520224022|FG000|Overall Study|Ongoing at data cut-off|9|||
144279697|NCT04590963|520224023|FG001|Overall Study|Ongoing at data cut-off|4|||
144279698|NCT04590963|520224022|FG000|Overall Study|Screen failure|1|||
144279699|NCT04590963|520224023|FG001|Overall Study|Screen failure|0|||
144279700|NCT04057365|520224024|FG000|Overall Study|Withdrawal by Subject|2|||
144279701|NCT04057365|520224025|FG001|Overall Study|Withdrawal by Subject|0|||
144279702|NCT04738487|520224026|FG000|Overall Study|Participant Ongoing in Study|298|||
144279703|NCT04738487|520224027|FG001|Overall Study|Participant Ongoing in Study|297|||
144279704|NCT04738487|520224026|FG000|Overall Study|Withdrawal by Subject|7|||
144279705|NCT04738487|520224027|FG001|Overall Study|Withdrawal by Subject|9|||
144279706|NCT04738487|520224026|FG000|Overall Study|Lost to Follow-up|2|||
144279707|NCT04738487|520224027|FG001|Overall Study|Lost to Follow-up|0|||
144279708|NCT04738487|520224026|FG000|Overall Study|Death|287|||
144279709|NCT04738487|520224027|FG001|Overall Study|Death|306|||
144279710|NCT05350202|520224028|FG000|Visit 1 - Baseline|Not-treated|18|||
144279711|NCT05350202|520224029|FG001|Visit 1 - Baseline|Not-treated|0|||
144279712|NCT05350202|520224028|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
144279713|NCT05350202|520224029|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
144279714|NCT05350202|520224028|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
144279715|NCT05350202|520224029|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
144279716|NCT05350202|520224028|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
144279717|NCT05350202|520224029|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
144279718|NCT05350202|520224028|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
144279719|NCT05350202|520224029|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
144279720|NCT05350202|520224028|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
144279721|NCT05350202|520224029|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
144279722|NCT05350202|520224028|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
144279723|NCT05350202|520224029|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
144279724|NCT00325416|520224056|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
144279725|NCT00325416|520224057|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
144279726|NCT00325416|520224056|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
144279727|NCT00325416|520224057|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
144279728|NCT00325416|520224056|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
144279729|NCT00325416|520224057|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
144279730|NCT00325416|520224056|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
144279731|NCT00325416|520224057|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
144279732|NCT00325416|520224056|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
144279733|NCT00325416|520224057|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
144279734|NCT00325416|520224056|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
144279735|NCT00325416|520224057|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
144279736|NCT06239610|520224058|FG000|Overall Study|no usable migration data for minimum of one day|11|||
144279737|NCT04589650|520224059|FG000|Overall Study|Subject decision|6|||
144279738|NCT04589650|520224060|FG001|Overall Study|Subject decision|2|||
144279739|NCT04589650|520224061|FG002|Overall Study|Subject decision|2|||
144279740|NCT04589650|520224062|FG003|Overall Study|Subject decision|0|||
144279741|NCT04589650|520224063|FG004|Overall Study|Subject decision|0|||
144279742|NCT04589650|520224064|FG005|Overall Study|Subject decision|0|||
144279743|NCT04589650|520224059|FG000|Overall Study|Adverse Event|3|||
144279744|NCT04589650|520224060|FG001|Overall Study|Adverse Event|1|||
144279745|NCT04589650|520224061|FG002|Overall Study|Adverse Event|1|||
144279746|NCT04589650|520224062|FG003|Overall Study|Adverse Event|1|||
144279747|NCT04589650|520224063|FG004|Overall Study|Adverse Event|0|||
144279748|NCT04589650|520224064|FG005|Overall Study|Adverse Event|1|||
144279749|NCT04589650|520224059|FG000|Overall Study|Physician Decision|1|||
144279750|NCT04589650|520224060|FG001|Overall Study|Physician Decision|1|||
144279751|NCT04589650|520224061|FG002|Overall Study|Physician Decision|0|||
144279752|NCT04589650|520224062|FG003|Overall Study|Physician Decision|0|||
144279753|NCT04589650|520224063|FG004|Overall Study|Physician Decision|0|||
144279754|NCT04589650|520224064|FG005|Overall Study|Physician Decision|0|||
144279755|NCT04589650|520224059|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144279756|NCT04589650|520224060|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144279757|NCT04589650|520224061|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144279758|NCT04589650|520224062|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
144279759|NCT04589650|520224063|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
144279760|NCT04589650|520224064|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
144279761|NCT04589650|520224059|FG000|Overall Study|Death|0|||
144279762|NCT04589650|520224060|FG001|Overall Study|Death|0|||
144279763|NCT04589650|520224061|FG002|Overall Study|Death|0|||
144279764|NCT04589650|520224062|FG003|Overall Study|Death|1|||
144279765|NCT04589650|520224063|FG004|Overall Study|Death|0|||
144279766|NCT04589650|520224064|FG005|Overall Study|Death|0|||
144279767|NCT04589650|520224059|FG000|Overall Study|Guardian Decision|0|||
144279768|NCT04589650|520224060|FG001|Overall Study|Guardian Decision|0|||
144279769|NCT04589650|520224061|FG002|Overall Study|Guardian Decision|0|||
144279770|NCT04589650|520224062|FG003|Overall Study|Guardian Decision|1|||
144279771|NCT04589650|520224063|FG004|Overall Study|Guardian Decision|0|||
144279772|NCT04589650|520224064|FG005|Overall Study|Guardian Decision|0|||
144279773|NCT02324153|520224065|FG000|Overall Study|Withdrawal by Subject|4|||
144279774|NCT02324153|520224066|FG001|Overall Study|Withdrawal by Subject|1|||
144279775|NCT02324153|520224065|FG000|Overall Study|Surgery postponed after randomization|3|||
144279776|NCT02324153|520224066|FG001|Overall Study|Surgery postponed after randomization|0|||
144279777|NCT02324153|520224065|FG000|Overall Study|Developed delirium preoperatively|1|||
144279778|NCT02324153|520224066|FG001|Overall Study|Developed delirium preoperatively|0|||
144279779|NCT01937299|520224070|FG000|Overall Study|Adverse Event|13|||
144279780|NCT01937299|520224071|FG001|Overall Study|Adverse Event|0|||
144279781|NCT01937299|520224070|FG000|Overall Study|Lack of Efficacy|0|||
144279782|NCT01937299|520224071|FG001|Overall Study|Lack of Efficacy|4|||
144279783|NCT01937299|520224070|FG000|Overall Study|Withdrawal by Subject|1|||
144279784|NCT01937299|520224071|FG001|Overall Study|Withdrawal by Subject|0|||
144279785|NCT04017962|520224072|FG000|Overall Study|Death|2|||
144279786|NCT04017962|520224073|FG001|Overall Study|Death|0|||
144279787|NCT04017962|520224072|FG000|Overall Study|Lost to Follow-up|2|||
144279788|NCT04017962|520224073|FG001|Overall Study|Lost to Follow-up|0|||
144279789|NCT04017962|520224072|FG000|Overall Study|Physician Decision|1|||
144279790|NCT04017962|520224073|FG001|Overall Study|Physician Decision|0|||
144279791|NCT04017962|520224072|FG000|Overall Study|Discontinued LTV|5|||
144279792|NCT04017962|520224073|FG001|Overall Study|Discontinued LTV|0|||
144279793|NCT01260948|520224074|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
144279794|NCT01260948|520224075|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
144279795|NCT01260948|520224074|FG000|Second Intervention|Emesis|0|||
144279796|NCT01260948|520224075|FG001|Second Intervention|Emesis|1|||
144279797|NCT00765076|520224076|FG000|Overall Study|Adverse Event|1|||
144279798|NCT00765076|520224077|FG001|Overall Study|Adverse Event|0|||
144279799|NCT00765076|520224078|FG002|Overall Study|Adverse Event|0|||
144279800|NCT00765076|520224076|FG000|Overall Study|Withdrawal by Subject|0|||
144279801|NCT00765076|520224077|FG001|Overall Study|Withdrawal by Subject|0|||
144279802|NCT00765076|520224078|FG002|Overall Study|Withdrawal by Subject|1|||
144279803|NCT01163617|520224079|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279804|NCT01163617|520224080|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
144279805|NCT01163617|520224081|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279806|NCT01163617|520224082|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279807|NCT01163617|520224083|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279808|NCT01163617|520224084|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279809|NCT01163617|520224085|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279810|NCT01163617|520224086|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
144279811|NCT01163617|520224079|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279812|NCT01163617|520224080|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
144279813|NCT01163617|520224081|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279814|NCT01163617|520224082|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279815|NCT01163617|520224083|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279816|NCT01163617|520224084|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279817|NCT01163617|520224085|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279818|NCT01163617|520224086|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
144279819|NCT01163617|520224079|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279820|NCT01163617|520224080|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279821|NCT01163617|520224081|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
144279822|NCT01163617|520224082|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279823|NCT01163617|520224083|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279824|NCT01163617|520224084|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279825|NCT01163617|520224085|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279826|NCT01163617|520224086|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
144279827|NCT02875080|520224087|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
144279828|NCT02875080|520224088|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
144279829|NCT02875080|520224089|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
144279830|NCT02394756|520224090|FG000|Period 1|Lens Discomfort|0|||
144279831|NCT02394756|520224091|FG001|Period 1|Lens Discomfort|0|||
144279832|NCT02394756|520224092|FG002|Period 1|Lens Discomfort|0|||
144279833|NCT02394756|520224093|FG003|Period 1|Lens Discomfort|0|||
144279834|NCT02394756|520224094|FG004|Period 1|Lens Discomfort|0|||
144279835|NCT02394756|520224095|FG005|Period 1|Lens Discomfort|1|||
144279836|NCT02394756|520224090|FG000|Period 1|Withdrawal by Subject|0|||
144279837|NCT02394756|520224091|FG001|Period 1|Withdrawal by Subject|1|||
144279838|NCT02394756|520224092|FG002|Period 1|Withdrawal by Subject|1|||
144279839|NCT02394756|520224093|FG003|Period 1|Withdrawal by Subject|1|||
144279840|NCT02394756|520224094|FG004|Period 1|Withdrawal by Subject|0|||
144279841|NCT02394756|520224095|FG005|Period 1|Withdrawal by Subject|0|||
144279842|NCT02394756|520224090|FG000|Period 2|Unsatisfactory Visual Response|0|||
144279843|NCT02394756|520224091|FG001|Period 2|Unsatisfactory Visual Response|0|||
144279844|NCT02394756|520224092|FG002|Period 2|Unsatisfactory Visual Response|0|||
144279845|NCT02394756|520224093|FG003|Period 2|Unsatisfactory Visual Response|0|||
144279846|NCT02394756|520224094|FG004|Period 2|Unsatisfactory Visual Response|1|||
144279847|NCT02394756|520224095|FG005|Period 2|Unsatisfactory Visual Response|0|||
144279848|NCT00768053|520224096|FG000|Overall Study|Adverse Event|10|||
144279849|NCT00768053|520224096|FG000|Overall Study|Lost to Follow-up|1|||
144279850|NCT01164475|520224097|FG000|Overall Study|Lack of Efficacy|1|||
144279851|NCT01164475|520224098|FG001|Overall Study|Lack of Efficacy|0|||
144279852|NCT01164475|520224097|FG000|Overall Study|Other|0|||
144279853|NCT01164475|520224098|FG001|Overall Study|Other|1|||
144279854|NCT01164475|520224097|FG000|Overall Study|Progressive disease|0|||
144279855|NCT01164475|520224098|FG001|Overall Study|Progressive disease|1|||
144279856|NCT01164475|520224097|FG000|Overall Study|Protocol Violation|1|||
144279857|NCT01164475|520224098|FG001|Overall Study|Protocol Violation|0|||
144279858|NCT02335944|520224099|FG000|Treatment Phase|Progressive Disease|2|||
144279859|NCT02335944|520224100|FG001|Treatment Phase|Progressive Disease|5|||
144279860|NCT02335944|520224101|FG002|Treatment Phase|Progressive Disease|2|||
144279861|NCT02335944|520224102|FG003|Treatment Phase|Progressive Disease|11|||
144279862|NCT02335944|520224103|FG004|Treatment Phase|Progressive Disease|4|||
144279863|NCT02335944|520224104|FG005|Treatment Phase|Progressive Disease|25|||
144279864|NCT02335944|520224105|FG006|Treatment Phase|Progressive Disease|2|||
144279865|NCT02335944|520224106|FG007|Treatment Phase|Progressive Disease|30|||
144279866|NCT02335944|520224107|FG008|Treatment Phase|Progressive Disease|27|||
144279867|NCT02335944|520224108|FG009|Treatment Phase|Progressive Disease|0|||
144279868|NCT02335944|520224099|FG000|Treatment Phase|Adverse Event|2|||
144279869|NCT02335944|520224100|FG001|Treatment Phase|Adverse Event|0|||
144279870|NCT02335944|520224101|FG002|Treatment Phase|Adverse Event|0|||
144279871|NCT02335944|520224102|FG003|Treatment Phase|Adverse Event|2|||
144279872|NCT02335944|520224103|FG004|Treatment Phase|Adverse Event|1|||
144279873|NCT02335944|520224104|FG005|Treatment Phase|Adverse Event|15|||
144279874|NCT02335944|520224105|FG006|Treatment Phase|Adverse Event|0|||
144279875|NCT02335944|520224106|FG007|Treatment Phase|Adverse Event|5|||
144279876|NCT02335944|520224107|FG008|Treatment Phase|Adverse Event|7|||
144279877|NCT02335944|520224108|FG009|Treatment Phase|Adverse Event|0|||
144279878|NCT02335944|520224099|FG000|Treatment Phase|Physician Decision|0|||
144279879|NCT02335944|520224100|FG001|Treatment Phase|Physician Decision|0|||
144279880|NCT02335944|520224101|FG002|Treatment Phase|Physician Decision|0|||
144279881|NCT02335944|520224102|FG003|Treatment Phase|Physician Decision|1|||
144279882|NCT02335944|520224103|FG004|Treatment Phase|Physician Decision|0|||
144279883|NCT02335944|520224104|FG005|Treatment Phase|Physician Decision|6|||
144279884|NCT02335944|520224105|FG006|Treatment Phase|Physician Decision|1|||
144279885|NCT02335944|520224106|FG007|Treatment Phase|Physician Decision|2|||
144279886|NCT02335944|520224107|FG008|Treatment Phase|Physician Decision|1|||
144279887|NCT02335944|520224108|FG009|Treatment Phase|Physician Decision|0|||
144279888|NCT02335944|520224099|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
144279889|NCT02335944|520224100|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
144279890|NCT02335944|520224101|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
144279891|NCT02335944|520224102|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
144279892|NCT02335944|520224103|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
144279893|NCT02335944|520224104|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
144279894|NCT02335944|520224105|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
144279895|NCT02335944|520224106|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
144279896|NCT02335944|520224107|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
144279897|NCT02335944|520224108|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
144279898|NCT02335944|520224099|FG000|Treatment Phase|Subject/Guardian Decision|0|||
144279899|NCT02335944|520224100|FG001|Treatment Phase|Subject/Guardian Decision|0|||
144279900|NCT02335944|520224101|FG002|Treatment Phase|Subject/Guardian Decision|1|||
144279901|NCT02335944|520224102|FG003|Treatment Phase|Subject/Guardian Decision|0|||
144279902|NCT02335944|520224103|FG004|Treatment Phase|Subject/Guardian Decision|0|||
144279903|NCT02335944|520224104|FG005|Treatment Phase|Subject/Guardian Decision|1|||
144279904|NCT02335944|520224105|FG006|Treatment Phase|Subject/Guardian Decision|0|||
144279905|NCT02335944|520224106|FG007|Treatment Phase|Subject/Guardian Decision|4|||
144279906|NCT02335944|520224107|FG008|Treatment Phase|Subject/Guardian Decision|0|||
144279907|NCT02335944|520224108|FG009|Treatment Phase|Subject/Guardian Decision|0|||
144279908|NCT02335944|520224099|FG000|Post-treatment Follow-up|Progressive Disease|0|||
144279909|NCT02335944|520224100|FG001|Post-treatment Follow-up|Progressive Disease|0|||
144279910|NCT02335944|520224101|FG002|Post-treatment Follow-up|Progressive Disease|0|||
144279911|NCT02335944|520224102|FG003|Post-treatment Follow-up|Progressive Disease|1|||
144279912|NCT02335944|520224103|FG004|Post-treatment Follow-up|Progressive Disease|0|||
144279913|NCT02335944|520224104|FG005|Post-treatment Follow-up|Progressive Disease|9|||
144279914|NCT02335944|520224105|FG006|Post-treatment Follow-up|Progressive Disease|0|||
144279915|NCT02335944|520224106|FG007|Post-treatment Follow-up|Progressive Disease|2|||
144279916|NCT02335944|520224107|FG008|Post-treatment Follow-up|Progressive Disease|3|||
144279917|NCT02335944|520224108|FG009|Post-treatment Follow-up|Progressive Disease|0|||
144279918|NCT02335944|520224099|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279919|NCT02335944|520224100|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279920|NCT02335944|520224101|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279921|NCT02335944|520224102|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279922|NCT02335944|520224103|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279923|NCT02335944|520224104|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
144279924|NCT02335944|520224105|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279925|NCT02335944|520224106|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279926|NCT02335944|520224107|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279927|NCT02335944|520224108|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
144279928|NCT02335944|520224099|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279929|NCT02335944|520224100|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279930|NCT02335944|520224101|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279931|NCT02335944|520224102|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279932|NCT02335944|520224103|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279933|NCT02335944|520224104|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279934|NCT02335944|520224105|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279935|NCT02335944|520224106|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
144279936|NCT02335944|520224107|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279937|NCT02335944|520224108|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
144279938|NCT02335944|520224099|FG000|Post-treatment Follow-up|Adverse Event|0|||
144279939|NCT02335944|520224100|FG001|Post-treatment Follow-up|Adverse Event|0|||
144279940|NCT02335944|520224101|FG002|Post-treatment Follow-up|Adverse Event|0|||
144279941|NCT02335944|520224102|FG003|Post-treatment Follow-up|Adverse Event|0|||
144279942|NCT02335944|520224103|FG004|Post-treatment Follow-up|Adverse Event|0|||
144279943|NCT02335944|520224104|FG005|Post-treatment Follow-up|Adverse Event|1|||
144279944|NCT02335944|520224105|FG006|Post-treatment Follow-up|Adverse Event|0|||
144279945|NCT02335944|520224106|FG007|Post-treatment Follow-up|Adverse Event|0|||
144279946|NCT02335944|520224107|FG008|Post-treatment Follow-up|Adverse Event|0|||
144279947|NCT02335944|520224108|FG009|Post-treatment Follow-up|Adverse Event|0|||
144279948|NCT02335944|520224099|FG000|Post-treatment Follow-up|Death|0|||
144279949|NCT02335944|520224100|FG001|Post-treatment Follow-up|Death|0|||
144279950|NCT02335944|520224101|FG002|Post-treatment Follow-up|Death|0|||
144279951|NCT02335944|520224102|FG003|Post-treatment Follow-up|Death|1|||
144279952|NCT02335944|520224103|FG004|Post-treatment Follow-up|Death|0|||
144279953|NCT02335944|520224104|FG005|Post-treatment Follow-up|Death|1|||
144279954|NCT02335944|520224105|FG006|Post-treatment Follow-up|Death|0|||
144279955|NCT02335944|520224106|FG007|Post-treatment Follow-up|Death|0|||
144279956|NCT02335944|520224107|FG008|Post-treatment Follow-up|Death|0|||
144279957|NCT02335944|520224108|FG009|Post-treatment Follow-up|Death|0|||
144279958|NCT02335944|520224099|FG000|Post-treatment Follow-up|Physician Decision|1|||
144279959|NCT02335944|520224100|FG001|Post-treatment Follow-up|Physician Decision|0|||
144279960|NCT02335944|520224101|FG002|Post-treatment Follow-up|Physician Decision|0|||
144279961|NCT02335944|520224102|FG003|Post-treatment Follow-up|Physician Decision|0|||
144279962|NCT02335944|520224103|FG004|Post-treatment Follow-up|Physician Decision|0|||
144279963|NCT02335944|520224104|FG005|Post-treatment Follow-up|Physician Decision|0|||
144279964|NCT02335944|520224105|FG006|Post-treatment Follow-up|Physician Decision|0|||
144279965|NCT02335944|520224106|FG007|Post-treatment Follow-up|Physician Decision|1|||
144279966|NCT02335944|520224107|FG008|Post-treatment Follow-up|Physician Decision|0|||
144279967|NCT02335944|520224108|FG009|Post-treatment Follow-up|Physician Decision|0|||
144279968|NCT02811159|520224109|FG000|Treatment Course 1|Lost to Follow-up|1|||
144279969|NCT05578872|520224116|FG000|Overall Study|Withdrawal by Subject|2|||
144279970|NCT05578872|520224117|FG001|Overall Study|Withdrawal by Subject|1|||
144279971|NCT05578872|520224116|FG000|Overall Study|Adverse Event|1|||
144279972|NCT05578872|520224117|FG001|Overall Study|Adverse Event|1|||
144279973|NCT05578872|520224116|FG000|Overall Study|Physician Decision|1|||
144279974|NCT05578872|520224117|FG001|Overall Study|Physician Decision|2|||
144279975|NCT05578872|520224116|FG000|Overall Study|Progressive disease|10|||
144279976|NCT05578872|520224117|FG001|Overall Study|Progressive disease|9|||
144279977|NCT05578872|520224116|FG000|Overall Study|Sponsor decision|0|||
144279978|NCT05578872|520224117|FG001|Overall Study|Sponsor decision|1|||
144279979|NCT05578872|520224116|FG000|Overall Study|Toxicity and Patient's decision|0|||
144279980|NCT05578872|520224117|FG001|Overall Study|Toxicity and Patient's decision|1|||
144279981|NCT00970944|520225327|FG000|Overall Study|Death|1|||
144279982|NCT00970944|520225328|FG001|Overall Study|Death|0|||
144279983|NCT00970944|520225327|FG000|Overall Study|Physician Decision|0|||
144279984|NCT00970944|520225328|FG001|Overall Study|Physician Decision|2|||
144279985|NCT02008370|520225329|FG000|Overall Study|Lost to Follow-up|7|||
144279986|NCT00972738|520225330|FG000|Overall Study|Adverse Event|7|||
144279987|NCT00972738|520225331|FG001|Overall Study|Adverse Event|1|||
144279988|NCT00972738|520225332|FG002|Overall Study|Adverse Event|8|||
144279989|NCT00972738|520225330|FG000|Overall Study|Protocol Violation|2|||
144279990|NCT00972738|520225331|FG001|Overall Study|Protocol Violation|1|||
144279991|NCT00972738|520225332|FG002|Overall Study|Protocol Violation|3|||
144279992|NCT00972738|520225330|FG000|Overall Study|Lost to Follow-up|1|||
144279993|NCT00972738|520225331|FG001|Overall Study|Lost to Follow-up|0|||
144279994|NCT00972738|520225332|FG002|Overall Study|Lost to Follow-up|1|||
144279995|NCT00972738|520225330|FG000|Overall Study|Lack of Efficacy|5|||
144279996|NCT00972738|520225331|FG001|Overall Study|Lack of Efficacy|1|||
144279997|NCT00972738|520225332|FG002|Overall Study|Lack of Efficacy|11|||
144279998|NCT00972738|520225330|FG000|Overall Study|Withdrawal by Subject|5|||
144279999|NCT00972738|520225331|FG001|Overall Study|Withdrawal by Subject|1|||
144280000|NCT00972738|520225332|FG002|Overall Study|Withdrawal by Subject|4|||
144280001|NCT00972738|520225330|FG000|Overall Study|Moved|0|||
144280002|NCT00972738|520225331|FG001|Overall Study|Moved|0|||
144280003|NCT00972738|520225332|FG002|Overall Study|Moved|1|||
144280004|NCT00972738|520225330|FG000|Overall Study|Other|1|||
144280005|NCT00972738|520225331|FG001|Overall Study|Other|2|||
144280006|NCT00972738|520225332|FG002|Overall Study|Other|1|||
144280007|NCT03915067|520225334|FG000|Overall Study|Adverse Event|0|||
144280008|NCT03915067|520225335|FG001|Overall Study|Adverse Event|0|||
144280009|NCT03915067|520225336|FG002|Overall Study|Adverse Event|1|||
144280010|NCT03915067|520225334|FG000|Overall Study|Withdrawal by Subject|4|||
144280011|NCT03915067|520225335|FG001|Overall Study|Withdrawal by Subject|3|||
144280012|NCT03915067|520225336|FG002|Overall Study|Withdrawal by Subject|0|||
144280013|NCT03915067|520225334|FG000|Overall Study|Lost to Follow-up|3|||
144280014|NCT03915067|520225335|FG001|Overall Study|Lost to Follow-up|2|||
144280015|NCT03915067|520225336|FG002|Overall Study|Lost to Follow-up|0|||
144280016|NCT03915067|520225334|FG000|Overall Study|Protocol Deviation|0|||
144280017|NCT03915067|520225335|FG001|Overall Study|Protocol Deviation|0|||
144280018|NCT03915067|520225336|FG002|Overall Study|Protocol Deviation|1|||
144280019|NCT03915067|520225334|FG000|Overall Study|Covid-19 Related Issues|2|||
144280020|NCT03915067|520225335|FG001|Overall Study|Covid-19 Related Issues|4|||
144280021|NCT03915067|520225336|FG002|Overall Study|Covid-19 Related Issues|4|||
144280022|NCT03915067|520225334|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
144280023|NCT03915067|520225335|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
144280024|NCT03915067|520225336|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
144280025|NCT02693418|520225337|FG000|Overall Study|Lost to Follow-up|1|||
144280026|NCT02693418|520225338|FG001|Overall Study|Lost to Follow-up|2|||
144280027|NCT02693418|520225339|FG002|Overall Study|Lost to Follow-up|0|||
144280028|NCT02693418|520225340|FG003|Overall Study|Lost to Follow-up|0|||
144280029|NCT02693418|520225341|FG004|Overall Study|Lost to Follow-up|0|||
144280030|NCT02693418|520225337|FG000|Overall Study|Menses during study period|0|||
144280031|NCT02693418|520225338|FG001|Overall Study|Menses during study period|0|||
144280032|NCT02693418|520225339|FG002|Overall Study|Menses during study period|2|||
144280033|NCT02693418|520225340|FG003|Overall Study|Menses during study period|0|||
144280034|NCT02693418|520225341|FG004|Overall Study|Menses during study period|0|||
144280035|NCT01750346|520225343|FG000|Overall Study|Adverse Event|1|||
144280036|NCT01750346|520225344|FG001|Overall Study|Adverse Event|0|||
144280037|NCT01750346|520225345|FG002|Overall Study|Adverse Event|0|||
144280038|NCT01001104|520225346|FG000|Overall Study|Adverse Event|2|||
144280039|NCT01001104|520225347|FG001|Overall Study|Adverse Event|1|||
144280040|NCT01001104|520225348|FG002|Overall Study|Adverse Event|0|||
144280041|NCT01001104|520225349|FG003|Overall Study|Adverse Event|0|||
144280042|NCT01001104|520225346|FG000|Overall Study|Lost to Follow-up|0|||
144280043|NCT01001104|520225347|FG001|Overall Study|Lost to Follow-up|0|||
144280044|NCT01001104|520225348|FG002|Overall Study|Lost to Follow-up|1|||
144280045|NCT01001104|520225349|FG003|Overall Study|Lost to Follow-up|0|||
144280046|NCT01001104|520225346|FG000|Overall Study|Entry Criteria Not Met|0|||
144280047|NCT01001104|520225347|FG001|Overall Study|Entry Criteria Not Met|0|||
144280048|NCT01001104|520225348|FG002|Overall Study|Entry Criteria Not Met|0|||
144280049|NCT01001104|520225349|FG003|Overall Study|Entry Criteria Not Met|1|||
144280050|NCT01001104|520225346|FG000|Overall Study|Withdrawal by Subject|0|||
144280051|NCT01001104|520225347|FG001|Overall Study|Withdrawal by Subject|0|||
144280052|NCT01001104|520225348|FG002|Overall Study|Withdrawal by Subject|0|||
144280053|NCT01001104|520225349|FG003|Overall Study|Withdrawal by Subject|2|||
144280054|NCT01793935|520225350|FG000|Overall Study|Pregnancy|1|||
144280055|NCT01793935|520225351|FG001|Overall Study|Pregnancy|0|||
144280056|NCT01793935|520225350|FG000|Overall Study|Protocol Violation|2|||
144280057|NCT01793935|520225351|FG001|Overall Study|Protocol Violation|1|||
144280058|NCT01793935|520225350|FG000|Overall Study|Adverse Event|2|||
144280059|NCT01793935|520225351|FG001|Overall Study|Adverse Event|0|||
144280060|NCT01793935|520225350|FG000|Overall Study|Patient did not take study medication|1|||
144280061|NCT01793935|520225351|FG001|Overall Study|Patient did not take study medication|1|||
144280062|NCT01793935|520225350|FG000|Overall Study|Lost to Follow-up|0|||
144280063|NCT01793935|520225351|FG001|Overall Study|Lost to Follow-up|1|||
144280064|NCT01121926|520225352|FG000|First Intervention Period|Adverse Event|1|||
144280065|NCT01121926|520225353|FG001|First Intervention Period|Adverse Event|0|||
144280066|NCT01121926|520225352|FG000|Washout Period|Adverse Event|0|||
144280067|NCT01121926|520225353|FG001|Washout Period|Adverse Event|1|||
144280068|NCT01121926|520225352|FG000|Washout Period|Positive pregnancy test|0|||
144280069|NCT01121926|520225353|FG001|Washout Period|Positive pregnancy test|1|||
144280070|NCT02782468|520225354|FG000|Overall Study|Progressive Disease|2|||
144280071|NCT02782468|520225355|FG001|Overall Study|Progressive Disease|5|||
144280072|NCT02782468|520225356|FG002|Overall Study|Progressive Disease|0|||
144280073|NCT02782468|520225357|FG003|Overall Study|Progressive Disease|4|||
144280074|NCT02782468|520225354|FG000|Overall Study|Adverse Event|0|||
144280075|NCT02782468|520225355|FG001|Overall Study|Adverse Event|2|||
144280076|NCT02782468|520225356|FG002|Overall Study|Adverse Event|2|||
144280077|NCT02782468|520225357|FG003|Overall Study|Adverse Event|3|||
144280078|NCT02782468|520225354|FG000|Overall Study|Other|0|||
144280079|NCT02782468|520225355|FG001|Overall Study|Other|0|||
144280080|NCT02782468|520225356|FG002|Overall Study|Other|1|||
144280081|NCT02782468|520225357|FG003|Overall Study|Other|1|||
144280082|NCT02782468|520225354|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
144280083|NCT02782468|520225355|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
144280084|NCT02782468|520225356|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
144280085|NCT02782468|520225357|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
144280086|NCT02782468|520225354|FG000|Overall Study|Symptomatic Deterioration|0|||
144280087|NCT02782468|520225355|FG001|Overall Study|Symptomatic Deterioration|0|||
144280088|NCT02782468|520225356|FG002|Overall Study|Symptomatic Deterioration|0|||
144280089|NCT02782468|520225357|FG003|Overall Study|Symptomatic Deterioration|1|||
144280090|NCT02782468|520225354|FG000|Overall Study|Withdrawal by Subject|1|||
144280091|NCT02782468|520225355|FG001|Overall Study|Withdrawal by Subject|0|||
144280092|NCT02782468|520225356|FG002|Overall Study|Withdrawal by Subject|0|||
144280093|NCT02782468|520225357|FG003|Overall Study|Withdrawal by Subject|0|||
144280094|NCT00356590|520225364|FG000|Overall Study|Adverse Event|54|||
144280095|NCT00356590|520225364|FG000|Overall Study|Death|10|||
144280096|NCT00356590|520225364|FG000|Overall Study|Lost to Follow-up|35|||
144280097|NCT00356590|520225364|FG000|Overall Study|Physician Decision|46|||
144244553|NCT02009397|520093203|FG000|Overall Study|Protocol Violation|6|||
144244554|NCT02009397|520093203|FG000|Overall Study|Death|8|||
144244555|NCT02009397|520093203|FG000|Overall Study|Lost to Follow-up|6|||
144244556|NCT00808639|520093207|FG000|Overall Study|Disease progression before surgery.|1|||
144244557|NCT00191282|520093208|FG000|Overall Study|Adverse Event|5|||
144244558|NCT00191282|520093209|FG001|Overall Study|Adverse Event|6|||
144244559|NCT00191282|520093208|FG000|Overall Study|Death|51|||
144244560|NCT00191282|520093209|FG001|Overall Study|Death|51|||
144244561|NCT00191282|520093208|FG000|Overall Study|Lack of Efficacy|11|||
144244562|NCT00191282|520093209|FG001|Overall Study|Lack of Efficacy|6|||
144244563|NCT00191282|520093208|FG000|Overall Study|Noncompliance|14|||
144244564|NCT00191282|520093209|FG001|Overall Study|Noncompliance|17|||
144244565|NCT00191282|520093208|FG000|Overall Study|Patient moved|11|||
144244566|NCT00191282|520093209|FG001|Overall Study|Patient moved|14|||
144244567|NCT00191282|520093208|FG000|Overall Study|Withdrawal by Subject|59|||
144244568|NCT00191282|520093209|FG001|Overall Study|Withdrawal by Subject|44|||
144244569|NCT00191282|520093208|FG000|Overall Study|Physician Decision|18|||
144244570|NCT00191282|520093209|FG001|Overall Study|Physician Decision|15|||
144244571|NCT00191282|520093208|FG000|Overall Study|Protocol entry criteria not met|14|||
144244572|NCT00191282|520093209|FG001|Overall Study|Protocol entry criteria not met|9|||
144244573|NCT00191282|520093208|FG000|Overall Study|Protocol Violation|9|||
144244574|NCT00191282|520093209|FG001|Overall Study|Protocol Violation|12|||
144244575|NCT00191282|520093208|FG000|Overall Study|Severity of outcome|2|||
144244576|NCT00191282|520093209|FG001|Overall Study|Severity of outcome|5|||
144244577|NCT00191282|520093208|FG000|Overall Study|Sponsor's decision|2|||
144244578|NCT00191282|520093209|FG001|Overall Study|Sponsor's decision|2|||
144244579|NCT00191282|520093208|FG000|Overall Study|Lost to Follow-up|24|||
144244580|NCT00191282|520093209|FG001|Overall Study|Lost to Follow-up|31|||
144244581|NCT04756154|520093212|FG000|Overall Study|Did not meet treatment day baseline|30|||
144244582|NCT04756154|520093213|FG001|Overall Study|Did not meet treatment day baseline|28|||
144244583|NCT04756154|520093214|FG002|Overall Study|Did not meet treatment day baseline|7|||
144244584|NCT04756154|520093212|FG000|Overall Study|Did not return for final sample collection|1|||
144244585|NCT04756154|520093213|FG001|Overall Study|Did not return for final sample collection|1|||
144244586|NCT04756154|520093214|FG002|Overall Study|Did not return for final sample collection|0|||
144244587|NCT01790828|520093215|FG000|Overall Study|Other|34|||
144244588|NCT03589976|520093216|FG000|Overall Study|Death|5|||
144244589|NCT03589976|520093217|FG001|Overall Study|Death|1|||
144244590|NCT03589976|520093216|FG000|Overall Study|Adverse Event|5|||
144244591|NCT03589976|520093217|FG001|Overall Study|Adverse Event|1|||
144244592|NCT03589976|520093216|FG000|Overall Study|Withdrawal by Subject|4|||
144244593|NCT03589976|520093217|FG001|Overall Study|Withdrawal by Subject|1|||
144244594|NCT03589976|520093216|FG000|Overall Study|Lost to Follow-up|1|||
144244595|NCT03589976|520093217|FG001|Overall Study|Lost to Follow-up|0|||
144244596|NCT03589976|520093216|FG000|Overall Study|Other|4|||
144244597|NCT03589976|520093217|FG001|Overall Study|Other|3|||
144244598|NCT02089334|520093218|FG000|Overall Study|Withdrawal by Subject|0|||
144244599|NCT02089334|520093219|FG001|Overall Study|Withdrawal by Subject|0|||
144244600|NCT02089334|520093220|FG002|Overall Study|Withdrawal by Subject|0|||
144244601|NCT02089334|520093221|FG003|Overall Study|Withdrawal by Subject|2|||
144244602|NCT02089334|520093218|FG000|Overall Study|Adverse Event|0|||
144244603|NCT02089334|520093219|FG001|Overall Study|Adverse Event|0|||
144244604|NCT02089334|520093220|FG002|Overall Study|Adverse Event|0|||
144244605|NCT02089334|520093221|FG003|Overall Study|Adverse Event|2|||
144244606|NCT02089334|520093218|FG000|Overall Study|Progressive disease|0|||
144244607|NCT02089334|520093219|FG001|Overall Study|Progressive disease|0|||
144244608|NCT02089334|520093220|FG002|Overall Study|Progressive disease|0|||
144244609|NCT02089334|520093221|FG003|Overall Study|Progressive disease|2|||
144244610|NCT02089334|520093218|FG000|Overall Study|Physician Decision|0|||
144244611|NCT02089334|520093219|FG001|Overall Study|Physician Decision|0|||
144244612|NCT02089334|520093220|FG002|Overall Study|Physician Decision|1|||
144244613|NCT02089334|520093221|FG003|Overall Study|Physician Decision|1|||
144244614|NCT04778059|520093222|FG000|Overall Study|Death|2|||
144244615|NCT04778059|520093223|FG001|Overall Study|Death|2|||
144280098|NCT00356590|520225364|FG000|Overall Study|Withdrawal by Subject|41|||
144280099|NCT00356590|520225364|FG000|Overall Study|Completed month 12 only|2|||
144280100|NCT00356590|520225364|FG000|Overall Study|Protocol issues|6|||
144280101|NCT00356590|520225364|FG000|Overall Study|Response status|28|||
144280102|NCT00356590|520225364|FG000|Overall Study|Other|52|||
144280103|NCT03439514|520225370|FG000|Double-Blind Treatment Period|Other|4|||
144280104|NCT03439514|520225371|FG001|Double-Blind Treatment Period|Other|1|||
144280105|NCT03439514|520225370|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
144280106|NCT03439514|520225371|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144280107|NCT03439514|520225370|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
144280108|NCT03439514|520225371|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
144280109|NCT03439514|520225370|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
144280110|NCT03439514|520225371|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
144280111|NCT03439514|520225370|FG000|Double-Blind Treatment Period|Death|1|||
144280112|NCT03439514|520225371|FG001|Double-Blind Treatment Period|Death|2|||
144280113|NCT02175758|520225372|FG000|Treatment Phase|Lost to Follow-up|0|||
144280114|NCT02175758|520225373|FG001|Treatment Phase|Lost to Follow-up|1|||
144280115|NCT02175758|520225374|FG002|Treatment Phase|Lost to Follow-up|0|||
144280116|NCT02175758|520225375|FG003|Treatment Phase|Lost to Follow-up|0|||
144280117|NCT02175758|520225376|FG004|Treatment Phase|Lost to Follow-up|0|||
144280118|NCT02175758|520225377|FG005|Treatment Phase|Lost to Follow-up|0|||
144280119|NCT02175758|520225372|FG000|Treatment Phase|Adverse Event|0|||
144280120|NCT02175758|520225373|FG001|Treatment Phase|Adverse Event|0|||
144280121|NCT02175758|520225374|FG002|Treatment Phase|Adverse Event|0|||
144280122|NCT02175758|520225375|FG003|Treatment Phase|Adverse Event|0|||
144280123|NCT02175758|520225376|FG004|Treatment Phase|Adverse Event|1|||
144280124|NCT02175758|520225377|FG005|Treatment Phase|Adverse Event|0|||
144280125|NCT02362451|520225378|FG000|Overall Study|Withdrawal by Subject|0|||
144280126|NCT02362451|520225379|FG001|Overall Study|Withdrawal by Subject|1|||
144280127|NCT02362451|520225378|FG000|Overall Study|Lack of Efficacy|2|||
144280128|NCT02362451|520225379|FG001|Overall Study|Lack of Efficacy|0|||
144280129|NCT02362451|520225378|FG000|Overall Study|Progression|1|||
144280130|NCT02362451|520225379|FG001|Overall Study|Progression|0|||
144280131|NCT02362451|520225378|FG000|Overall Study|Participant chose other therapy.|1|||
144280132|NCT02362451|520225379|FG001|Overall Study|Participant chose other therapy.|0|||
144280133|NCT01879852|520225382|FG000|Overall Study|Withdrawal by Subject|2|||
144280134|NCT01879852|520225383|FG001|Overall Study|Withdrawal by Subject|0|||
144280135|NCT01913353|520225386|FG000|Overall Study|Adverse Event|2|||
144280136|NCT01913353|520225387|FG001|Overall Study|Adverse Event|0|||
144280137|NCT01913353|520225386|FG000|Overall Study|Physician Decision|0|||
144280138|NCT01913353|520225387|FG001|Overall Study|Physician Decision|2|||
144280139|NCT01913353|520225386|FG000|Overall Study|Withdrawal by Subject|20|||
144280140|NCT01913353|520225387|FG001|Overall Study|Withdrawal by Subject|6|||
144280141|NCT01913353|520225386|FG000|Overall Study|multiple reasons|10|||
144280142|NCT01913353|520225387|FG001|Overall Study|multiple reasons|7|||
144280143|NCT00385840|520225388|FG000|Overall Study|Adverse Event|1|||
144280144|NCT00385840|520225389|FG001|Overall Study|Adverse Event|1|||
144280145|NCT00385840|520225388|FG000|Overall Study|Lost to Follow-up|3|||
144280146|NCT00385840|520225389|FG001|Overall Study|Lost to Follow-up|13|||
144280147|NCT00462462|520225390|FG000|Overall Study|Physician Decision|0|||
144280148|NCT00462462|520225391|FG001|Overall Study|Physician Decision|1|||
144280149|NCT02555878|520225392|FG000|Overall Study|Lost to Follow-up|2|||
144280150|NCT02555878|520225393|FG001|Overall Study|Lost to Follow-up|3|||
144280151|NCT02555878|520225392|FG000|Overall Study|Withdrawal by Subject|48|||
144280152|NCT02555878|520225393|FG001|Overall Study|Withdrawal by Subject|48|||
144280153|NCT02555878|520225392|FG000|Overall Study|Adverse Event|12|||
144280154|NCT02555878|520225393|FG001|Overall Study|Adverse Event|8|||
144280155|NCT02555878|520225392|FG000|Overall Study|Death|74|||
144280156|NCT02555878|520225393|FG001|Overall Study|Death|59|||
144280157|NCT02555878|520225392|FG000|Overall Study|Protocol Violation|1|||
144280158|NCT02555878|520225393|FG001|Overall Study|Protocol Violation|2|||
144280159|NCT02555878|520225392|FG000|Overall Study|Physician Decision|12|||
144280160|NCT02555878|520225393|FG001|Overall Study|Physician Decision|13|||
144280161|NCT02555878|520225392|FG000|Overall Study|Other|17|||
144280162|NCT02555878|520225393|FG001|Overall Study|Other|17|||
144280163|NCT01202591|520225394|FG000|Overall Study|Adverse Event|2|||
144280164|NCT01202591|520225395|FG001|Overall Study|Adverse Event|1|||
144280165|NCT01202591|520225396|FG002|Overall Study|Adverse Event|4|||
144280166|NCT01202591|520225397|FG003|Overall Study|Adverse Event|4|||
144280167|NCT01202591|520225398|FG004|Overall Study|Adverse Event|0|||
144280168|NCT01202591|520225399|FG005|Overall Study|Adverse Event|0|||
144280169|NCT01202591|520225394|FG000|Overall Study|Other reason as per investigator|3|||
144280170|NCT01202591|520225395|FG001|Overall Study|Other reason as per investigator|4|||
144280171|NCT01202591|520225396|FG002|Overall Study|Other reason as per investigator|7|||
144280172|NCT01202591|520225397|FG003|Overall Study|Other reason as per investigator|3|||
144280173|NCT01202591|520225398|FG004|Overall Study|Other reason as per investigator|1|||
144280174|NCT01202591|520225399|FG005|Overall Study|Other reason as per investigator|3|||
144280175|NCT01202591|520225394|FG000|Overall Study|Withdrawal by Subject|0|||
144280176|NCT01202591|520225395|FG001|Overall Study|Withdrawal by Subject|0|||
144280177|NCT01202591|520225396|FG002|Overall Study|Withdrawal by Subject|0|||
144280178|NCT01202591|520225397|FG003|Overall Study|Withdrawal by Subject|0|||
144280179|NCT01202591|520225398|FG004|Overall Study|Withdrawal by Subject|2|||
144280180|NCT01202591|520225399|FG005|Overall Study|Withdrawal by Subject|1|||
144280181|NCT01202591|520225394|FG000|Overall Study|Objective Disease Progression|0|||
144280182|NCT01202591|520225395|FG001|Overall Study|Objective Disease Progression|0|||
144280183|NCT01202591|520225396|FG002|Overall Study|Objective Disease Progression|0|||
144280184|NCT01202591|520225397|FG003|Overall Study|Objective Disease Progression|0|||
144280185|NCT01202591|520225398|FG004|Overall Study|Objective Disease Progression|2|||
144280186|NCT01202591|520225399|FG005|Overall Study|Objective Disease Progression|0|||
144280187|NCT03018938|520225400|FG000|Overall Study|Death|0|||
144280188|NCT03018938|520225401|FG001|Overall Study|Death|1|||
144280189|NCT03018938|520225400|FG000|Overall Study|Lost to Follow-up|21|||
144280190|NCT03018938|520225401|FG001|Overall Study|Lost to Follow-up|32|||
144280191|NCT03018938|520225400|FG000|Overall Study|Withdrawal by Subject|38|||
144280192|NCT03018938|520225401|FG001|Overall Study|Withdrawal by Subject|45|||
144280193|NCT03018938|520225400|FG000|Overall Study|Physician Decision|3|||
144280194|NCT03018938|520225401|FG001|Overall Study|Physician Decision|2|||
144280195|NCT03018938|520225400|FG000|Overall Study|Sponsor Decision|0|||
144280196|NCT03018938|520225401|FG001|Overall Study|Sponsor Decision|1|||
144280197|NCT03018938|520225400|FG000|Overall Study|Screen failure-After randomization|4|||
144280198|NCT03018938|520225401|FG001|Overall Study|Screen failure-After randomization|2|||
144280199|NCT03018938|520225400|FG000|Overall Study|Not recorded|0|||
144280200|NCT03018938|520225401|FG001|Overall Study|Not recorded|2|||
144280201|NCT00191100|520225404|FG000|Overall Study|Adverse Event|18|||
144280202|NCT00191100|520225405|FG001|Overall Study|Adverse Event|1|||
144280203|NCT00191100|520225404|FG000|Overall Study|Lost to Follow-up|2|||
144280204|NCT00191100|520225405|FG001|Overall Study|Lost to Follow-up|0|||
144280205|NCT00191100|520225404|FG000|Overall Study|Patient Moved|0|||
144280206|NCT00191100|520225405|FG001|Overall Study|Patient Moved|1|||
144280207|NCT00191100|520225404|FG000|Overall Study|Withdrawal by Subject|9|||
144280208|NCT00191100|520225405|FG001|Overall Study|Withdrawal by Subject|3|||
144280209|NCT00191100|520225404|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
144280210|NCT00191100|520225405|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
144280211|NCT00191100|520225404|FG000|Overall Study|Clinical Relapse|2|||
144280212|NCT00191100|520225405|FG001|Overall Study|Clinical Relapse|1|||
144280213|NCT00191100|520225404|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
144280214|NCT00191100|520225405|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
144280215|NCT00191100|520225404|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
144280216|NCT00191100|520225405|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
144280217|NCT00191100|520225404|FG000|Overall Study|Physician Decision|3|||
144280218|NCT00191100|520225405|FG001|Overall Study|Physician Decision|1|||
144280219|NCT00191100|520225404|FG000|Overall Study|Death from Study Drug Toxicity|2|||
144280220|NCT00191100|520225405|FG001|Overall Study|Death from Study Drug Toxicity|0|||
144280221|NCT00191100|520225404|FG000|Overall Study|Protocol Violation|1|||
144280222|NCT00191100|520225405|FG001|Overall Study|Protocol Violation|1|||
144280223|NCT00191100|520225404|FG000|Overall Study|Death from Other Cause|1|||
144280224|NCT00191100|520225405|FG001|Overall Study|Death from Other Cause|0|||
144280225|NCT00191100|520225404|FG000|Overall Study|Reason Not Specified|0|||
144280226|NCT00191100|520225405|FG001|Overall Study|Reason Not Specified|1|||
144280227|NCT02406612|520225406|FG000|Overall Study|Screening Failure|3|||
144280228|NCT02406612|520225407|FG001|Overall Study|Screening Failure|0|||
144280229|NCT02406612|520225406|FG000|Overall Study|Intra-procedural Exclusion|1|||
144280230|NCT02406612|520225407|FG001|Overall Study|Intra-procedural Exclusion|3|||
144280231|NCT02406612|520225406|FG000|Overall Study|Guidewire Failure|0|||
144280232|NCT02406612|520225407|FG001|Overall Study|Guidewire Failure|1|||
144280233|NCT02916771|520225412|FG000|Overall Study|Withdrawal by Subject|9|||
144280234|NCT02916771|520225412|FG000|Overall Study|Physician Decision|1|||
144280235|NCT02916771|520225412|FG000|Overall Study|Began treatment for another active malignancy|1|||
144280236|NCT00313170|520225904|FG000|Overall Study|Death|2|||
144280237|NCT00313170|520225905|FG001|Overall Study|Death|4|||
144280238|NCT00313170|520225906|FG002|Overall Study|Death|2|||
144280239|NCT00313170|520225904|FG000|Overall Study|Adverse Event|1|||
144280240|NCT00313170|520225905|FG001|Overall Study|Adverse Event|2|||
144280241|NCT00313170|520225906|FG002|Overall Study|Adverse Event|0|||
144280242|NCT00313170|520225904|FG000|Overall Study|Disease progression|31|||
144280243|NCT00313170|520225905|FG001|Overall Study|Disease progression|26|||
144280244|NCT00313170|520225906|FG002|Overall Study|Disease progression|27|||
144280245|NCT00313170|520225904|FG000|Overall Study|Withdrawal by Subject|1|||
144280246|NCT00313170|520225905|FG001|Overall Study|Withdrawal by Subject|0|||
144280247|NCT00313170|520225906|FG002|Overall Study|Withdrawal by Subject|1|||
144280248|NCT00313170|520225904|FG000|Overall Study|Incorrect enrollment|0|||
144280249|NCT00313170|520225905|FG001|Overall Study|Incorrect enrollment|2|||
144280250|NCT00313170|520225906|FG002|Overall Study|Incorrect enrollment|1|||
144280251|NCT00313170|520225904|FG000|Overall Study|Lost to Follow-up|0|||
144280252|NCT00313170|520225905|FG001|Overall Study|Lost to Follow-up|0|||
144280253|NCT00313170|520225906|FG002|Overall Study|Lost to Follow-up|1|||
144280254|NCT00313170|520225904|FG000|Overall Study|Progression (investigators opinion)|1|||
144280255|NCT00313170|520225905|FG001|Overall Study|Progression (investigators opinion)|0|||
144280256|NCT00313170|520225906|FG002|Overall Study|Progression (investigators opinion)|0|||
144280257|NCT02115386|520225907|FG000|Overall Study|Protocol Violation|1|||
144280258|NCT02115386|520225907|FG000|Overall Study|Administrative - trial was terminated|6|||
144280259|NCT02453048|520225910|FG000|Overall Study|Only part of initial 6 mo. study|0|||
144280260|NCT02453048|520225911|FG001|Overall Study|Only part of initial 6 mo. study|0|||
144280261|NCT02453048|520225912|FG002|Overall Study|Only part of initial 6 mo. study|0|||
144280262|NCT02453048|520225913|FG003|Overall Study|Only part of initial 6 mo. study|0|||
144280263|NCT02453048|520225914|FG004|Overall Study|Only part of initial 6 mo. study|6|||
144280264|NCT02453048|520225910|FG000|Overall Study|Lost to Follow-up|0|||
144280265|NCT02453048|520225911|FG001|Overall Study|Lost to Follow-up|1|||
144280266|NCT02453048|520225912|FG002|Overall Study|Lost to Follow-up|2|||
144280267|NCT02453048|520225913|FG003|Overall Study|Lost to Follow-up|0|||
144280268|NCT02453048|520225914|FG004|Overall Study|Lost to Follow-up|0|||
144280269|NCT01482221|520225915|FG000|Overall Study|Lack of Efficacy|1|||
144280270|NCT01482221|520225916|FG001|Overall Study|Lack of Efficacy|0|||
144280271|NCT01482221|520225917|FG002|Overall Study|Lack of Efficacy|1|||
144280272|NCT01482221|520225915|FG000|Overall Study|Lost to Follow-up|3|||
144280273|NCT01482221|520225916|FG001|Overall Study|Lost to Follow-up|2|||
144280274|NCT01482221|520225917|FG002|Overall Study|Lost to Follow-up|1|||
144280275|NCT01482221|520225915|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
144280276|NCT01482221|520225916|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
144280277|NCT01482221|520225917|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
144280278|NCT01482221|520225915|FG000|Overall Study|Condition under Investigation Worsened|3|||
144280279|NCT01482221|520225916|FG001|Overall Study|Condition under Investigation Worsened|2|||
144280280|NCT01482221|520225917|FG002|Overall Study|Condition under Investigation Worsened|4|||
144280281|NCT01482221|520225915|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
144280282|NCT01482221|520225916|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
144280283|NCT01482221|520225917|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
144280284|NCT01482221|520225915|FG000|Overall Study|Adverse Event|1|||
144280285|NCT01482221|520225916|FG001|Overall Study|Adverse Event|7|||
144280286|NCT01482221|520225917|FG002|Overall Study|Adverse Event|3|||
144280287|NCT01482221|520225915|FG000|Overall Study|Withdrawal by Subject|10|||
144280288|NCT01482221|520225916|FG001|Overall Study|Withdrawal by Subject|7|||
144280289|NCT01482221|520225917|FG002|Overall Study|Withdrawal by Subject|12|||
144280290|NCT01482221|520225915|FG000|Overall Study|Incorrect randomization|0|||
144280291|NCT01482221|520225916|FG001|Overall Study|Incorrect randomization|1|||
144280292|NCT01482221|520225917|FG002|Overall Study|Incorrect randomization|0|||
144280293|NCT01482221|520225915|FG000|Overall Study|Physician Decision|0|||
144280294|NCT01482221|520225916|FG001|Overall Study|Physician Decision|1|||
144280295|NCT01482221|520225917|FG002|Overall Study|Physician Decision|0|||
144280296|NCT03086343|520225918|FG000|Period 1|Adverse Event|7|||
144280297|NCT03086343|520225919|FG001|Period 1|Adverse Event|7|||
144280298|NCT03086343|520225920|FG002|Period 1|Adverse Event|0|||
144280299|NCT03086343|520225921|FG003|Period 1|Adverse Event|1|||
144280300|NCT03086343|520225918|FG000|Period 1|Withdrawal by Subject|6|||
144280301|NCT03086343|520225919|FG001|Period 1|Withdrawal by Subject|10|||
144280302|NCT03086343|520225920|FG002|Period 1|Withdrawal by Subject|0|||
144280303|NCT03086343|520225921|FG003|Period 1|Withdrawal by Subject|0|||
144280304|NCT03086343|520225918|FG000|Period 1|Lost to Follow-up|1|||
144280305|NCT03086343|520225919|FG001|Period 1|Lost to Follow-up|3|||
144280306|NCT03086343|520225920|FG002|Period 1|Lost to Follow-up|1|||
144280307|NCT03086343|520225921|FG003|Period 1|Lost to Follow-up|0|||
144280308|NCT03086343|520225918|FG000|Period 1|Other, Not Specified|10|||
144280309|NCT03086343|520225919|FG001|Period 1|Other, Not Specified|12|||
144280310|NCT03086343|520225920|FG002|Period 1|Other, Not Specified|2|||
144280311|NCT03086343|520225921|FG003|Period 1|Other, Not Specified|1|||
144280312|NCT03086343|520225918|FG000|Period 1|Missing|1|||
144280313|NCT03086343|520225919|FG001|Period 1|Missing|0|||
144280314|NCT03086343|520225920|FG002|Period 1|Missing|0|||
144280315|NCT03086343|520225921|FG003|Period 1|Missing|0|||
144280316|NCT03086343|520225918|FG000|Period 2|Adverse Event|20|||
144280317|NCT03086343|520225919|FG001|Period 2|Adverse Event|11|||
144280318|NCT03086343|520225920|FG002|Period 2|Adverse Event|1|||
144280319|NCT03086343|520225921|FG003|Period 2|Adverse Event|2|||
144280320|NCT03086343|520225918|FG000|Period 2|Withdrawal by Subject|15|||
144280321|NCT03086343|520225919|FG001|Period 2|Withdrawal by Subject|25|||
144280322|NCT03086343|520225920|FG002|Period 2|Withdrawal by Subject|2|||
144280323|NCT03086343|520225921|FG003|Period 2|Withdrawal by Subject|2|||
144280324|NCT03086343|520225918|FG000|Period 2|Lost to Follow-up|6|||
144280325|NCT03086343|520225919|FG001|Period 2|Lost to Follow-up|11|||
144280326|NCT03086343|520225920|FG002|Period 2|Lost to Follow-up|1|||
144280327|NCT03086343|520225921|FG003|Period 2|Lost to Follow-up|0|||
144280328|NCT03086343|520225918|FG000|Period 2|COVID-19 Infection|5|||
144280329|NCT03086343|520225919|FG001|Period 2|COVID-19 Infection|0|||
144280330|NCT03086343|520225920|FG002|Period 2|COVID-19 Infection|0|||
144280331|NCT03086343|520225921|FG003|Period 2|COVID-19 Infection|0|||
144280332|NCT03086343|520225918|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
144280333|NCT03086343|520225919|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
144280334|NCT03086343|520225920|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
144280335|NCT03086343|520225921|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
144280336|NCT03086343|520225918|FG000|Period 2|Other, Not Specified|23|||
144280337|NCT03086343|520225919|FG001|Period 2|Other, Not Specified|22|||
144280338|NCT03086343|520225920|FG002|Period 2|Other, Not Specified|2|||
144280339|NCT03086343|520225921|FG003|Period 2|Other, Not Specified|4|||
144280340|NCT00741611|520225922|FG000|Overall Study|Death|0|||
144280341|NCT00741611|520225923|FG001|Overall Study|Death|0|||
144280342|NCT00741611|520225924|FG002|Overall Study|Death|1|||
144280343|NCT00741611|520225922|FG000|Overall Study|Withdrawal by Subject|0|||
144280344|NCT00741611|520225923|FG001|Overall Study|Withdrawal by Subject|2|||
144280345|NCT00741611|520225924|FG002|Overall Study|Withdrawal by Subject|2|||
144280346|NCT02403271|520225929|FG000|Period 1|Other varied reasons|1|||
144280347|NCT02403271|520225930|FG001|Period 1|Other varied reasons|0|||
144280348|NCT02403271|520225929|FG000|Period 2|Withdrawal by Subject|0|||
144280349|NCT02403271|520225930|FG001|Period 2|Withdrawal by Subject|14|||
144280350|NCT02403271|520225929|FG000|Period 2|Death|0|||
144280351|NCT02403271|520225930|FG001|Period 2|Death|84|||
144280352|NCT02403271|520225929|FG000|Period 2|Lost to Follow-up|0|||
144280353|NCT02403271|520225930|FG001|Period 2|Lost to Follow-up|2|||
144280354|NCT02403271|520225929|FG000|Period 2|Study Terminated by Sponsor|0|||
144280355|NCT02403271|520225930|FG001|Period 2|Study Terminated by Sponsor|14|||
144280356|NCT02403271|520225929|FG000|Period 2|Other varied reasons|0|||
144280357|NCT02403271|520225930|FG001|Period 2|Other varied reasons|10|||
144280358|NCT01018979|520225931|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
144280359|NCT01018979|520225932|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
144280360|NCT01018979|520225931|FG000|Overall Study|Not received at least one dose|0|||
144280361|NCT01018979|520225932|FG001|Overall Study|Not received at least one dose|1|||
144280362|NCT02830087|520225933|FG000|Overall Study|No study staff to follow-up patients|4|||
144280363|NCT02830087|520225934|FG001|Overall Study|No study staff to follow-up patients|4|||
144280364|NCT02830087|520225935|FG002|Overall Study|No study staff to follow-up patients|4|||
144280365|NCT02830087|520225936|FG003|Overall Study|No study staff to follow-up patients|3|||
144280366|NCT02830087|520225937|FG004|Overall Study|No study staff to follow-up patients|3|||
144280367|NCT02830087|520225938|FG005|Overall Study|No study staff to follow-up patients|3|||
144280368|NCT06170827|520225939|FG000|Overall Study|Withdrawal by Subject|1|||
144280369|NCT06170827|520225940|FG001|Overall Study|Withdrawal by Subject|1|||
144280370|NCT03043573|520225948|FG000|Overall Study|Lost to Follow-up|3|||
144280371|NCT03043573|520225949|FG001|Overall Study|Lost to Follow-up|3|||
144280372|NCT03043573|520225948|FG000|Overall Study|Physician Decision|0|||
144280373|NCT03043573|520225949|FG001|Overall Study|Physician Decision|5|||
144280374|NCT03043573|520225948|FG000|Overall Study|Withdrawal by Subject|0|||
144280375|NCT03043573|520225949|FG001|Overall Study|Withdrawal by Subject|4|||
144280376|NCT02337686|520225952|FG000|Overall Study|Adverse Event|1|||
144280377|NCT01239680|520227162|FG000|Overall Study|Withdrawal by Subject|2|||
144280378|NCT01239680|520227163|FG001|Overall Study|Withdrawal by Subject|0|||
144280379|NCT03033901|520227164|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
144280380|NCT03033901|520227164|FG000|Overall Study|Refused PSG|23|||
144280381|NCT03033901|520227164|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
144280382|NCT03033901|520227164|FG000|Overall Study|Missing Oximetry Data|3|||
144280383|NCT00729586|520227165|FG000|Overall Study|Ineligible|0|||
144280384|NCT00729586|520227166|FG001|Overall Study|Ineligible|1|||
144280385|NCT00729586|520227165|FG000|Overall Study|never treated|1|||
144280386|NCT00729586|520227166|FG001|Overall Study|never treated|0|||
144280387|NCT05177094|520227169|FG000|Overall Study|Adverse Event|5|||
144280388|NCT05177094|520227170|FG001|Overall Study|Adverse Event|5|||
144280389|NCT05177094|520227169|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
144280390|NCT05177094|520227170|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
144280391|NCT05177094|520227169|FG000|Overall Study|Protocol Deviation|3|||
144280392|NCT05177094|520227170|FG001|Overall Study|Protocol Deviation|0|||
144280393|NCT05177094|520227169|FG000|Overall Study|Withdrawal by Subject|6|||
144280394|NCT05177094|520227170|FG001|Overall Study|Withdrawal by Subject|3|||
144280395|NCT05177094|520227169|FG000|Overall Study|Participant could not tolerate long study visits|1|||
144280396|NCT05177094|520227170|FG001|Overall Study|Participant could not tolerate long study visits|0|||
144280397|NCT01033942|520227173|FG000|Overall Study|Withdrawal by Subject|1|||
144280398|NCT01033942|520227174|FG001|Overall Study|Withdrawal by Subject|1|||
144280399|NCT01033942|520227175|FG002|Overall Study|Withdrawal by Subject|1|||
144280400|NCT01033942|520227173|FG000|Overall Study|Lost to Follow-up|1|||
144280401|NCT01033942|520227174|FG001|Overall Study|Lost to Follow-up|0|||
144280402|NCT01033942|520227175|FG002|Overall Study|Lost to Follow-up|0|||
144280403|NCT01033942|520227173|FG000|Overall Study|Enrolled in Extension Study|0|||
144280404|NCT01033942|520227174|FG001|Overall Study|Enrolled in Extension Study|3|||
144280405|NCT01033942|520227175|FG002|Overall Study|Enrolled in Extension Study|0|||
144280406|NCT02737618|520227176|FG000|Overall Study|Withdrawal by Subject|9|||
144280407|NCT02513199|520227177|FG000|Treatment|Death|1|||
144280408|NCT02513199|520227177|FG000|Treatment|Lost to Follow-up|1|||
144280409|NCT02513199|520227177|FG000|Follow-Up|Death|11|||
144280410|NCT02260986|520227185|FG000|Overall Study|Adverse Event|24|||
144280411|NCT02260986|520227186|FG001|Overall Study|Adverse Event|0|||
144280412|NCT02260986|520227187|FG002|Overall Study|Adverse Event|11|||
144280413|NCT02260986|520227185|FG000|Overall Study|Lack of Efficacy|27|||
144280414|NCT02260986|520227186|FG001|Overall Study|Lack of Efficacy|3|||
144280415|NCT02260986|520227187|FG002|Overall Study|Lack of Efficacy|0|||
144280416|NCT02260986|520227185|FG000|Overall Study|Protocol Violation|14|||
144280417|NCT02260986|520227186|FG001|Overall Study|Protocol Violation|5|||
144280418|NCT02260986|520227187|FG002|Overall Study|Protocol Violation|16|||
144280419|NCT02260986|520227185|FG000|Overall Study|Car accident|0|||
144280420|NCT02260986|520227186|FG001|Overall Study|Car accident|0|||
144280421|NCT02260986|520227187|FG002|Overall Study|Car accident|1|||
144280422|NCT02260986|520227185|FG000|Overall Study|Withdrawal by Subject|17|||
144280423|NCT02260986|520227186|FG001|Overall Study|Withdrawal by Subject|4|||
144280424|NCT02260986|520227187|FG002|Overall Study|Withdrawal by Subject|9|||
144280425|NCT02260986|520227185|FG000|Overall Study|Incorrect randomization|0|||
144280426|NCT02260986|520227186|FG001|Overall Study|Incorrect randomization|1|||
144280427|NCT02260986|520227187|FG002|Overall Study|Incorrect randomization|0|||
144280428|NCT02260986|520227185|FG000|Overall Study|Lack of investigation product supply|2|||
144280429|NCT02260986|520227186|FG001|Overall Study|Lack of investigation product supply|0|||
144280430|NCT02260986|520227187|FG002|Overall Study|Lack of investigation product supply|1|||
144280431|NCT02260986|520227185|FG000|Overall Study|Lost to Follow-up|4|||
144280432|NCT02260986|520227186|FG001|Overall Study|Lost to Follow-up|0|||
144280433|NCT02260986|520227187|FG002|Overall Study|Lost to Follow-up|3|||
144280434|NCT02260986|520227185|FG000|Overall Study|Pregnancy|2|||
144280435|NCT02260986|520227186|FG001|Overall Study|Pregnancy|0|||
144280436|NCT02260986|520227187|FG002|Overall Study|Pregnancy|0|||
144280437|NCT02397837|520227188|FG000|Overall Study|Withdrawal by Subject|6|||
144280438|NCT02397837|520227189|FG001|Overall Study|Withdrawal by Subject|5|||
144280439|NCT02397837|520227188|FG000|Overall Study|Physician Decision|1|||
144280440|NCT02397837|520227189|FG001|Overall Study|Physician Decision|1|||
144280441|NCT00407511|520227198|FG000|Overall Study|Adverse Event|9|||
144280442|NCT00407511|520227198|FG000|Overall Study|Lost to Follow-up|4|||
144280443|NCT00407511|520227198|FG000|Overall Study|Other|5|||
144280444|NCT00407511|520227198|FG000|Overall Study|Withdrawal by Subject|4|||
144280445|NCT00529035|520227199|FG000|Overall Study|Withdrawal by Subject|1|||
144280446|NCT02493855|520227200|FG000|Overall Study|Non-compliance|1|||
144280447|NCT02493855|520227201|FG001|Overall Study|Non-compliance|0|||
144280448|NCT02493855|520227202|FG002|Overall Study|Non-compliance|0|||
144280449|NCT02493855|520227200|FG000|Overall Study|Adverse Event|0|||
144280450|NCT02493855|520227201|FG001|Overall Study|Adverse Event|1|||
144280451|NCT02493855|520227202|FG002|Overall Study|Adverse Event|0|||
144280452|NCT02493855|520227200|FG000|Overall Study|Withdrawal by Subject|1|||
144280453|NCT02493855|520227201|FG001|Overall Study|Withdrawal by Subject|0|||
144280454|NCT02493855|520227202|FG002|Overall Study|Withdrawal by Subject|0|||
144280455|NCT04339972|520227206|FG000|Overall Study|Scheduling Issues|3|||
144280456|NCT04339972|520227207|FG001|Overall Study|Scheduling Issues|3|||
144280457|NCT04339972|520227206|FG000|Overall Study|dropout|1|||
144280458|NCT04339972|520227207|FG001|Overall Study|dropout|1|||
144280459|NCT04339972|520227206|FG000|Overall Study|Technical issues|1|||
144280460|NCT04339972|520227207|FG001|Overall Study|Technical issues|0|||
144280461|NCT04339972|520227206|FG000|Overall Study|Claustraphobia|0|||
144280462|NCT04339972|520227207|FG001|Overall Study|Claustraphobia|1|||
144280463|NCT00776997|520227208|FG000|Overall Study|Adverse Event|2|||
144280464|NCT05221866|520227211|FG000|Overall Study|Withdrawal by Subject|5|||
144280465|NCT05221866|520227212|FG001|Overall Study|Withdrawal by Subject|7|||
144280466|NCT05221866|520227213|FG002|Overall Study|Withdrawal by Subject|6|||
144280467|NCT05221866|520227214|FG003|Overall Study|Withdrawal by Subject|4|||
144280468|NCT05221866|520227211|FG000|Overall Study|Physician Decision|3|||
144280469|NCT05221866|520227212|FG001|Overall Study|Physician Decision|2|||
144280470|NCT05221866|520227213|FG002|Overall Study|Physician Decision|1|||
144280471|NCT05221866|520227214|FG003|Overall Study|Physician Decision|4|||
144280472|NCT05221866|520227211|FG000|Overall Study|Lost to Follow-up|12|||
144280473|NCT05221866|520227212|FG001|Overall Study|Lost to Follow-up|17|||
144280474|NCT05221866|520227213|FG002|Overall Study|Lost to Follow-up|14|||
144280475|NCT05221866|520227214|FG003|Overall Study|Lost to Follow-up|14|||
144280476|NCT05221866|520227211|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
144280477|NCT05221866|520227212|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
144280478|NCT05221866|520227213|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
144280479|NCT05221866|520227214|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
144280480|NCT03487445|520227215|FG000|Randomization|Not treated for administrative reasons|1|||
144280481|NCT03487445|520227216|FG001|Randomization|Not treated for administrative reasons|0|||
144280482|NCT00221104|520227217|FG000|Overall Study|Adverse Event|1|||
144280483|NCT00221104|520227218|FG001|Overall Study|Adverse Event|0|||
144280484|NCT00221104|520227217|FG000|Overall Study|Physician Decision|1|||
144280485|NCT00221104|520227218|FG001|Overall Study|Physician Decision|0|||
144280486|NCT00221104|520227217|FG000|Overall Study|Protocol Violation|2|||
144280487|NCT00221104|520227218|FG001|Overall Study|Protocol Violation|0|||
144280488|NCT00221104|520227217|FG000|Overall Study|Withdrawal by Subject|42|||
144280489|NCT00221104|520227218|FG001|Overall Study|Withdrawal by Subject|29|||
144280490|NCT00221104|520227217|FG000|Overall Study|Others|37|||
144280491|NCT00221104|520227218|FG001|Overall Study|Others|47|||
144280492|NCT02989389|520227219|FG000|Period 1|Lost to Follow-up|0|||
144280493|NCT02989389|520227220|FG001|Period 1|Lost to Follow-up|1|||
144280494|NCT02989389|520227221|FG002|Period 1|Lost to Follow-up|0|||
144280495|NCT02989389|520227222|FG003|Period 1|Lost to Follow-up|0|||
144280496|NCT02989389|520227223|FG004|Period 1|Lost to Follow-up|0|||
144280497|NCT02989389|520227224|FG005|Period 1|Lost to Follow-up|0|||
144280498|NCT02989389|520227225|FG006|Period 1|Lost to Follow-up|0|||
144280499|NCT02989389|520227226|FG007|Period 1|Lost to Follow-up|0|||
144280500|NCT02989389|520227227|FG008|Period 1|Lost to Follow-up|0|||
144244616|NCT04778059|520093224|FG002|Overall Study|Death|1|||
144244617|NCT04778059|520093225|FG003|Overall Study|Death|1|||
144244618|NCT04778059|520093226|FG004|Overall Study|Death|1|||
144244619|NCT04778059|520093222|FG000|Overall Study|Lost to Follow-up|0|||
144244620|NCT04778059|520093223|FG001|Overall Study|Lost to Follow-up|0|||
144244621|NCT04778059|520093224|FG002|Overall Study|Lost to Follow-up|0|||
144244622|NCT04778059|520093225|FG003|Overall Study|Lost to Follow-up|0|||
144244623|NCT04778059|520093226|FG004|Overall Study|Lost to Follow-up|1|||
144244624|NCT04778059|520093222|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
144244625|NCT04778059|520093223|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
144244626|NCT04778059|520093224|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
144244627|NCT04778059|520093225|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
144244628|NCT04778059|520093226|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
144244629|NCT02832375|520093227|FG000|Overall Study|Lost to Follow-up|1|||
144244630|NCT02832375|520093228|FG001|Overall Study|Lost to Follow-up|0|||
144244631|NCT02832375|520093227|FG000|Overall Study|Withdrawal of Consent|1|||
144244632|NCT02832375|520093228|FG001|Overall Study|Withdrawal of Consent|0|||
144244633|NCT00514904|520093234|FG000|Overall Study|Withdrawal by Subject|3|||
144244634|NCT00514904|520093235|FG001|Overall Study|Withdrawal by Subject|2|||
144244635|NCT00514904|520093234|FG000|Overall Study|Lost to Follow-up|21|||
144244636|NCT00514904|520093235|FG001|Overall Study|Lost to Follow-up|3|||
144244637|NCT03430895|520093236|FG000|Overall Study|Not Treated|2|||
144244638|NCT03026530|520093242|FG000|Overall Study|Lost to Follow-up|19|||
144244639|NCT03026530|520093243|FG001|Overall Study|Lost to Follow-up|24|||
144244640|NCT03026530|520093242|FG000|Overall Study|Protocol Violation|2|||
144244641|NCT03026530|520093243|FG001|Overall Study|Protocol Violation|5|||
144244642|NCT03301740|520093244|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
144244643|NCT03301740|520093245|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
144244644|NCT03301740|520093244|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
144244645|NCT03301740|520093245|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
144280501|NCT02989389|520227228|FG009|Period 1|Lost to Follow-up|0|||
144280502|NCT02989389|520227219|FG000|Period 1|Physician Decision|0|||
144280503|NCT02989389|520227220|FG001|Period 1|Physician Decision|0|||
144280504|NCT02989389|520227221|FG002|Period 1|Physician Decision|0|||
144280505|NCT02989389|520227222|FG003|Period 1|Physician Decision|0|||
144280506|NCT02989389|520227223|FG004|Period 1|Physician Decision|0|||
144280507|NCT02989389|520227224|FG005|Period 1|Physician Decision|0|||
144280508|NCT02989389|520227225|FG006|Period 1|Physician Decision|0|||
144280509|NCT02989389|520227226|FG007|Period 1|Physician Decision|0|||
144280510|NCT02989389|520227227|FG008|Period 1|Physician Decision|1|||
144280511|NCT02989389|520227228|FG009|Period 1|Physician Decision|0|||
144280512|NCT01666652|520227229|FG000|Overall Study|Serious Adverse Event|0|||
144280513|NCT01666652|520227230|FG001|Overall Study|Serious Adverse Event|0|||
144280514|NCT01666652|520227231|FG002|Overall Study|Serious Adverse Event|0|||
144280515|NCT01666652|520227232|FG003|Overall Study|Serious Adverse Event|1|||
144280516|NCT01666652|520227233|FG004|Overall Study|Serious Adverse Event|0|||
144280517|NCT01666652|520227229|FG000|Overall Study|Withdrawal by Subject|0|||
144280518|NCT01666652|520227230|FG001|Overall Study|Withdrawal by Subject|0|||
144280519|NCT01666652|520227231|FG002|Overall Study|Withdrawal by Subject|0|||
144280520|NCT01666652|520227232|FG003|Overall Study|Withdrawal by Subject|0|||
144280521|NCT01666652|520227233|FG004|Overall Study|Withdrawal by Subject|1|||
144280522|NCT01666652|520227229|FG000|Overall Study|Moved from study area|1|||
144280523|NCT01666652|520227230|FG001|Overall Study|Moved from study area|0|||
144280524|NCT01666652|520227231|FG002|Overall Study|Moved from study area|0|||
144280525|NCT01666652|520227232|FG003|Overall Study|Moved from study area|2|||
144280526|NCT01666652|520227233|FG004|Overall Study|Moved from study area|0|||
144280527|NCT01666652|520227229|FG000|Overall Study|Lost to Follow-up|1|||
144280528|NCT01666652|520227230|FG001|Overall Study|Lost to Follow-up|1|||
144280529|NCT01666652|520227231|FG002|Overall Study|Lost to Follow-up|1|||
144280530|NCT01666652|520227232|FG003|Overall Study|Lost to Follow-up|1|||
144280531|NCT01666652|520227233|FG004|Overall Study|Lost to Follow-up|0|||
144280532|NCT04470427|520227234|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
144280533|NCT04470427|520227235|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
144280534|NCT04470427|520227236|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
144280535|NCT04470427|520227237|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
144280536|NCT04470427|520227238|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
144280537|NCT04470427|520227239|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
144280538|NCT04470427|520227234|FG000|Part B :Open-label|Other than specified|0|||
144280539|NCT04470427|520227235|FG001|Part B :Open-label|Other than specified|0|||
144280540|NCT04470427|520227236|FG002|Part B :Open-label|Other than specified|788|||
144280541|NCT04470427|520227237|FG003|Part B :Open-label|Other than specified|0|||
144280542|NCT04470427|520227238|FG004|Part B :Open-label|Other than specified|523|||
144280543|NCT04470427|520227239|FG005|Part B :Open-label|Other than specified|0|||
144280544|NCT04470427|520227234|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
144280545|NCT04470427|520227235|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
144280546|NCT04470427|520227236|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
144280547|NCT04470427|520227237|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
144280548|NCT04470427|520227238|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
144280549|NCT04470427|520227239|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
144280550|NCT04470427|520227234|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
144280551|NCT04470427|520227235|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
144280552|NCT04470427|520227236|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
144280553|NCT04470427|520227237|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
144280554|NCT04470427|520227238|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
144280555|NCT04470427|520227239|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
144280556|NCT01695746|520227240|FG000|Overall Study|Adverse Event|1|||
144280557|NCT01695746|520227240|FG000|Overall Study|Non-compliance by the participant|3|||
144280558|NCT01695746|520227240|FG000|Overall Study|Protocol Violation|5|||
144280559|NCT01695746|520227240|FG000|Overall Study|Participant not willing to participate|3|||
144280560|NCT03976375|520227243|FG000|Overall Study|Death|158|||
144280561|NCT03976375|520227244|FG001|Overall Study|Death|160|||
144280562|NCT03976375|520227245|FG002|Overall Study|Death|42|||
144280563|NCT03976375|520227243|FG000|Overall Study|Lost to Follow-up|2|||
144280564|NCT03976375|520227244|FG001|Overall Study|Lost to Follow-up|1|||
144280565|NCT03976375|520227245|FG002|Overall Study|Lost to Follow-up|1|||
144280566|NCT03976375|520227243|FG000|Overall Study|Withdrawal by Subject|5|||
144280567|NCT03976375|520227244|FG001|Overall Study|Withdrawal by Subject|9|||
144280568|NCT03976375|520227245|FG002|Overall Study|Withdrawal by Subject|4|||
144280569|NCT03976375|520227243|FG000|Overall Study|Sponsor decision|20|||
144280570|NCT03976375|520227244|FG001|Overall Study|Sponsor decision|19|||
144280571|NCT03976375|520227245|FG002|Overall Study|Sponsor decision|1|||
144280572|NCT02717611|520227246|FG000|Overall Study|Death|13|||
144280573|NCT02717611|520227246|FG000|Overall Study|Withdrawal by Subject|6|||
144280574|NCT02717611|520227246|FG000|Overall Study|Active, not recruiting|40|||
144280575|NCT02717611|520227246|FG000|Overall Study|Complicating disease|1|||
144280576|NCT04598828|520227247|FG000|Overall Study|Physician Decision|1|||
144280577|NCT04598828|520227248|FG001|Overall Study|Physician Decision|0|||
144280578|NCT04598828|520227247|FG000|Overall Study|Withdrawal by Subject|0|||
144280579|NCT04598828|520227248|FG001|Overall Study|Withdrawal by Subject|1|||
144280580|NCT04598828|520227247|FG000|Overall Study|Withdrawal by Subject|0|||
144280581|NCT04598828|520227248|FG001|Overall Study|Withdrawal by Subject|1|||
144280582|NCT02676973|520227249|FG000|Overall Study|Withdrawal by Subject|9|||
144280583|NCT02676973|520227250|FG001|Overall Study|Withdrawal by Subject|8|||
144280584|NCT02676973|520227251|FG002|Overall Study|Withdrawal by Subject|11|||
144280585|NCT02676973|520227249|FG000|Overall Study|Lost to Follow-up|8|||
144280586|NCT02676973|520227250|FG001|Overall Study|Lost to Follow-up|12|||
144280587|NCT02676973|520227251|FG002|Overall Study|Lost to Follow-up|8|||
144280588|NCT02676973|520227249|FG000|Overall Study|Death|2|||
144280589|NCT02676973|520227250|FG001|Overall Study|Death|1|||
144280590|NCT02676973|520227251|FG002|Overall Study|Death|5|||
144280591|NCT01078662|520227252|FG000|Overall Study|Death|41|||
144280592|NCT01078662|520227253|FG001|Overall Study|Death|103|||
144280593|NCT01078662|520227254|FG002|Overall Study|Death|18|||
144280594|NCT01078662|520227255|FG003|Overall Study|Death|5|||
144280595|NCT01078662|520227256|FG004|Overall Study|Death|8|||
144280596|NCT01078662|520227252|FG000|Overall Study|Patients reached data cut-off|12|||
144280597|NCT01078662|520227253|FG001|Overall Study|Patients reached data cut-off|53|||
144280598|NCT01078662|520227254|FG002|Overall Study|Patients reached data cut-off|2|||
144280599|NCT01078662|520227255|FG003|Overall Study|Patients reached data cut-off|2|||
144280600|NCT01078662|520227256|FG004|Overall Study|Patients reached data cut-off|3|||
144280601|NCT01078662|520227252|FG000|Overall Study|Withdrawal by Subject|4|||
144280602|NCT01078662|520227253|FG001|Overall Study|Withdrawal by Subject|11|||
144280603|NCT01078662|520227254|FG002|Overall Study|Withdrawal by Subject|1|||
144280604|NCT01078662|520227255|FG003|Overall Study|Withdrawal by Subject|0|||
144280605|NCT01078662|520227256|FG004|Overall Study|Withdrawal by Subject|0|||
144280606|NCT01078662|520227252|FG000|Overall Study|Protocol Violation|0|||
144280607|NCT01078662|520227253|FG001|Overall Study|Protocol Violation|1|||
144280608|NCT01078662|520227254|FG002|Overall Study|Protocol Violation|0|||
144280609|NCT01078662|520227255|FG003|Overall Study|Protocol Violation|0|||
144280610|NCT01078662|520227256|FG004|Overall Study|Protocol Violation|0|||
144280611|NCT01078662|520227252|FG000|Overall Study|Lost to Follow-up|1|||
144244646|NCT01037127|520093247|FG000|Overall Study|Lost to Follow-up|2|||
144244647|NCT01037127|520093248|FG001|Overall Study|Lost to Follow-up|4|||
144244648|NCT01037127|520093247|FG000|Overall Study|Physician Decision|1|||
144244649|NCT01037127|520093248|FG001|Overall Study|Physician Decision|0|||
144244650|NCT01037127|520093247|FG000|Overall Study|Study Closed Terminated|2|||
144244651|NCT01037127|520093248|FG001|Overall Study|Study Closed Terminated|17|||
144244652|NCT02637713|520093252|FG000|Overall Study|Screen Failure|2|||
144244653|NCT02847182|520093253|FG000|Overall Study|Withdrawal by Subject|0|||
144244654|NCT02847182|520093254|FG001|Overall Study|Withdrawal by Subject|1|||
144244655|NCT04325698|520093256|FG000|Overall Study|Study Terminated By Sponsor|1|||
144244656|NCT04325698|520093257|FG001|Overall Study|Study Terminated By Sponsor|1|||
144244657|NCT04325698|520093256|FG000|Overall Study|Withdrawal by Subject|0|||
144244658|NCT04325698|520093257|FG001|Overall Study|Withdrawal by Subject|2|||
144244659|NCT04253782|520093258|FG000|Overall Study|Death|2|||
144244660|NCT04253782|520093259|FG001|Overall Study|Death|0|||
144244661|NCT04216589|520093260|FG000|Overall Study|Withdrawal by Subject|2|||
144244662|NCT04216589|520093260|FG000|Overall Study|Protocol Violation|1|||
144244663|NCT04216589|520093260|FG000|Overall Study|Incarceration|1|||
144244664|NCT03721835|520093262|FG000|Overall Study|Participant not able to return|1|||
144244665|NCT03721835|520093262|FG000|Overall Study|Lost to Follow-up|1|||
144244666|NCT03721835|520093262|FG000|Overall Study|Revision of the components of the study device|2|||
144244667|NCT03721835|520093262|FG000|Overall Study|Sponsor terminated study|6|||
144244668|NCT03721835|520093262|FG000|Overall Study|Death|1|||
144244669|NCT03721835|520093262|FG000|Overall Study|Sponsor decision|1|||
144244670|NCT01306045|520093267|FG000|Met General Eligibility Criteria|Screen failures|193|||
144280612|NCT01078662|520227253|FG001|Overall Study|Lost to Follow-up|0|||
144244671|NCT01306045|520093268|FG001|Met General Eligibility Criteria|Screen failures|11|||
144244672|NCT01306045|520093269|FG002|Met General Eligibility Criteria|Screen failures|8|||
144244673|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
144244674|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
144244675|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
144244676|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
144244677|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
144244678|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
144244679|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
144244680|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
144244681|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
144244682|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
144244683|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
144244684|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
144280613|NCT01078662|520227254|FG002|Overall Study|Lost to Follow-up|0|||
144244685|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
144244686|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
144244687|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
144244688|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
144244689|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
144244690|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
144244691|NCT02294461|520093276|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
144280614|NCT01078662|520227255|FG003|Overall Study|Lost to Follow-up|0|||
144280615|NCT01078662|520227256|FG004|Overall Study|Lost to Follow-up|0|||
144280616|NCT03244189|520227258|FG000|Overall Study|Death|0|||
144280617|NCT03244189|520227259|FG001|Overall Study|Death|2|||
144280618|NCT03244189|520227258|FG000|Overall Study|Lost to Follow-up|92|||
144280619|NCT03244189|520227259|FG001|Overall Study|Lost to Follow-up|107|||
144280620|NCT03244189|520227258|FG000|Overall Study|Physician Decision|4|||
144280621|NCT03244189|520227259|FG001|Overall Study|Physician Decision|2|||
144280622|NCT03244189|520227258|FG000|Overall Study|Pregnancy|7|||
144280623|NCT03244189|520227259|FG001|Overall Study|Pregnancy|5|||
144280624|NCT03244189|520227258|FG000|Overall Study|Protocol Violation|0|||
144280625|NCT03244189|520227259|FG001|Overall Study|Protocol Violation|2|||
144280626|NCT03244189|520227258|FG000|Overall Study|Withdrawal by Subject|45|||
144280627|NCT03244189|520227259|FG001|Overall Study|Withdrawal by Subject|23|||
144280628|NCT03244189|520227258|FG000|Overall Study|Technical Problems|2|||
144280629|NCT03244189|520227259|FG001|Overall Study|Technical Problems|0|||
144280630|NCT00632359|520227260|FG000|Overall Study|Withdrawal by Subject|2|||
144280631|NCT01363076|520228412|FG000|Overall Study|Withdrawal by Subject|0|||
144280632|NCT01363076|520228413|FG001|Overall Study|Withdrawal by Subject|1|||
144280633|NCT03641924|520228414|FG000|Overall Study|Withdrawal by Subject|26|||
144280634|NCT03641924|520228414|FG000|Overall Study|Lost to Follow-up|16|||
144280635|NCT03641924|520228414|FG000|Overall Study|Protocol Violation|10|||
144280636|NCT01565694|520228415|FG000|Dose-Titration Period|Adverse Event|4|||
144280637|NCT01565694|520228415|FG000|Dose-Titration Period|Protocol Violation|10|||
144280638|NCT01565694|520228415|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
144280639|NCT01373229|520228416|FG000|Overall Study|Death|3|||
144280640|NCT01373229|520228416|FG000|Overall Study|Physician Decision|3|||
144244692|NCT02294461|520093277|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
144244693|NCT02294461|520093278|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
144244694|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
144244695|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
144244696|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
144244697|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
144244698|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
144244699|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
144244700|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
144244701|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
144244702|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
144244703|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
144244704|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
144244705|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
144244706|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
144244707|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
144244708|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
144244709|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
144244710|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
144280641|NCT00484159|520228418|FG000|Overall Study|Lost to Follow-up|1|||
144280642|NCT00484159|520228419|FG001|Overall Study|Lost to Follow-up|1|||
144280643|NCT00484159|520228420|FG002|Overall Study|Lost to Follow-up|0|||
144280644|NCT04766333|520228421|FG000|Overall Study|Lost to Follow-up|40|||
144280645|NCT04766333|520228422|FG001|Overall Study|Lost to Follow-up|826|||
144280646|NCT03234881|520228423|FG000|Overall Study|Lost to Follow-up|9|||
144280647|NCT03234881|520228424|FG001|Overall Study|Lost to Follow-up|3|||
144280648|NCT03807843|520228425|FG000|Overall Study|Lost to Follow-up|1|||
144280649|NCT03807843|520228426|FG001|Overall Study|Lost to Follow-up|0|||
144280650|NCT01312129|520228427|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
144280651|NCT01312129|520228428|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
144280652|NCT03720847|520228429|FG000|Washout|Physician Decision|1|||
144280653|NCT03720847|520228430|FG001|Washout|Physician Decision|2|||
144280654|NCT01047501|520228436|FG000|Overall Study|Adverse Event|7|||
144280655|NCT01047501|520228437|FG001|Overall Study|Adverse Event|8|||
144280656|NCT01047501|520228438|FG002|Overall Study|Adverse Event|5|||
144280657|NCT01047501|520228436|FG000|Overall Study|Withdrew Consent|6|||
144280658|NCT01047501|520228437|FG001|Overall Study|Withdrew Consent|2|||
144280659|NCT01047501|520228438|FG002|Overall Study|Withdrew Consent|4|||
144280660|NCT01047501|520228436|FG000|Overall Study|Lost to Follow-up|0|||
144280661|NCT01047501|520228437|FG001|Overall Study|Lost to Follow-up|1|||
144280662|NCT01047501|520228438|FG002|Overall Study|Lost to Follow-up|1|||
144280663|NCT01047501|520228436|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
144280664|NCT01047501|520228437|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
144280665|NCT01047501|520228438|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
144280666|NCT01047501|520228436|FG000|Overall Study|Death|1|||
144280667|NCT01047501|520228437|FG001|Overall Study|Death|0|||
144280668|NCT01047501|520228438|FG002|Overall Study|Death|0|||
144280669|NCT01047501|520228436|FG000|Overall Study|Other discontinuation|1|||
144280670|NCT01047501|520228437|FG001|Overall Study|Other discontinuation|0|||
144280671|NCT01047501|520228438|FG002|Overall Study|Other discontinuation|1|||
144280672|NCT01047501|520228436|FG000|Overall Study|Investigator judgement|0|||
144280673|NCT01047501|520228437|FG001|Overall Study|Investigator judgement|0|||
144280674|NCT01047501|520228438|FG002|Overall Study|Investigator judgement|1|||
144280675|NCT00429299|520228440|FG000|Overall Study|Disease Progression|1|||
144280676|NCT00429299|520228441|FG001|Overall Study|Disease Progression|1|||
144280677|NCT00429299|520228442|FG002|Overall Study|Disease Progression|0|||
144280678|NCT00429299|520228440|FG000|Overall Study|Adverse Event|2|||
144280679|NCT00429299|520228441|FG001|Overall Study|Adverse Event|5|||
144280680|NCT00429299|520228442|FG002|Overall Study|Adverse Event|1|||
144280681|NCT00429299|520228440|FG000|Overall Study|Protocol Violation|1|||
144280682|NCT00429299|520228441|FG001|Overall Study|Protocol Violation|0|||
144280683|NCT00429299|520228442|FG002|Overall Study|Protocol Violation|0|||
144280684|NCT00429299|520228440|FG000|Overall Study|Withdrawal by Subject|0|||
144280685|NCT00429299|520228441|FG001|Overall Study|Withdrawal by Subject|1|||
144280686|NCT00429299|520228442|FG002|Overall Study|Withdrawal by Subject|3|||
144280687|NCT01510756|520228443|FG000|Overall Study|Death|1|||
144280688|NCT01510756|520228443|FG000|Overall Study|Lack of Efficacy|2|||
144280689|NCT01510756|520228443|FG000|Overall Study|Physician Decision|1|||
144280690|NCT02447029|520228444|FG000|Overall Study|Withdrawal by Subject|3|||
144280691|NCT02447029|520228445|FG001|Overall Study|Withdrawal by Subject|2|||
144280692|NCT00153920|520228447|FG000|Overall Study|Adverse Event|9|||
144280693|NCT00153920|520228447|FG000|Overall Study|Progressive Disease|9|||
144280694|NCT00153920|520228447|FG000|Overall Study|Physician Decision|3|||
144280695|NCT00153920|520228447|FG000|Overall Study|Lack of Response|3|||
144280696|NCT00153920|520228447|FG000|Overall Study|Death|2|||
144280697|NCT00153920|520228447|FG000|Overall Study|Withdrawal by Subject|1|||
144280698|NCT00153920|520228447|FG000|Overall Study|Non-Protocol Therapy|1|||
144280699|NCT00153920|520228447|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
144280700|NCT00153920|520228447|FG000|Overall Study|Progressive Disease before Trt|1|||
144280701|NCT02202616|520228448|FG000|Overall Study|Screen failed|24|||
144280702|NCT02202616|520228448|FG000|Overall Study|Adverse Event|32|||
144280703|NCT02202616|520228448|FG000|Overall Study|Protocol deviation|18|||
144280704|NCT02202616|520228448|FG000|Overall Study|Patient withdrew consent|12|||
144280705|NCT02202616|520228448|FG000|Overall Study|Lost to Follow-up|6|||
144280706|NCT02202616|520228448|FG000|Overall Study|Administrative problems|6|||
144280707|NCT02202616|520228448|FG000|Overall Study|Abnormal test procedure result|1|||
144280708|NCT02202616|520228448|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144280709|NCT01334515|520228449|FG000|Overall Study|Adverse Event|1|||
144280710|NCT01334515|520228450|FG001|Overall Study|Adverse Event|6|||
144280711|NCT01334515|520228449|FG000|Overall Study|Death|1|||
144280712|NCT01334515|520228450|FG001|Overall Study|Death|0|||
144280713|NCT01334515|520228449|FG000|Overall Study|Lack of Efficacy|8|||
144280714|NCT01334515|520228450|FG001|Overall Study|Lack of Efficacy|21|||
144280715|NCT01334515|520228449|FG000|Overall Study|Physician Decision|1|||
144280716|NCT01334515|520228450|FG001|Overall Study|Physician Decision|1|||
144280717|NCT01334515|520228449|FG000|Overall Study|Withdrawal by Subject|1|||
144280718|NCT01334515|520228450|FG001|Overall Study|Withdrawal by Subject|1|||
144280719|NCT00376506|520228451|FG000|Overall Study|Death|0|||
144280720|NCT00376506|520228452|FG001|Overall Study|Death|2|||
144280721|NCT02948400|520228454|FG000|Overall Study|Withdrawal by Subject|17|||
144280722|NCT02948400|520228455|FG001|Overall Study|Withdrawal by Subject|10|||
144280723|NCT02948400|520228454|FG000|Overall Study|failed to attend appointments|47|||
144280724|NCT02948400|520228455|FG001|Overall Study|failed to attend appointments|34|||
144280725|NCT02948400|520228454|FG000|Overall Study|COVID-related closure|6|||
144280726|NCT02948400|520228455|FG001|Overall Study|COVID-related closure|2|||
144280727|NCT02948400|520228454|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
144280728|NCT02948400|520228455|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
144280729|NCT02948400|520228454|FG000|Overall Study|motion sickness in virtual reality|2|||
144280730|NCT02948400|520228455|FG001|Overall Study|motion sickness in virtual reality|0|||
144280731|NCT04818112|520228458|FG000|Overall Study|Withdrawal by Subject|54|||
144280732|NCT04818112|520228459|FG001|Overall Study|Withdrawal by Subject|12|||
144280733|NCT04818112|520228458|FG000|Overall Study|Lost to Follow-up|38|||
144280734|NCT04818112|520228459|FG001|Overall Study|Lost to Follow-up|10|||
144280735|NCT03122106|520228461|FG000|Overall Study|Not enough tissue|1|||
144280736|NCT03122106|520228461|FG000|Overall Study|Disease progression during screening|2|||
144280737|NCT03122106|520228461|FG000|Overall Study|Poor RNA quality for vaccine|1|||
144280738|NCT00700635|520228462|FG000|Overall Study|Adverse Event|1|||
144280739|NCT00700635|520228463|FG001|Overall Study|Adverse Event|0|||
144280740|NCT00700635|520228464|FG002|Overall Study|Adverse Event|0|||
144280741|NCT00700635|520228462|FG000|Overall Study|Lost to Follow-up|1|||
144280742|NCT00700635|520228463|FG001|Overall Study|Lost to Follow-up|3|||
144280743|NCT00700635|520228464|FG002|Overall Study|Lost to Follow-up|0|||
144280744|NCT00700635|520228462|FG000|Overall Study|Protocol Violation|2|||
144280745|NCT00700635|520228463|FG001|Overall Study|Protocol Violation|2|||
144280746|NCT00700635|520228464|FG002|Overall Study|Protocol Violation|0|||
144280747|NCT00700635|520228462|FG000|Overall Study|Withdrawal by Subject|7|||
144280748|NCT00700635|520228463|FG001|Overall Study|Withdrawal by Subject|3|||
144280749|NCT00700635|520228464|FG002|Overall Study|Withdrawal by Subject|1|||
144280750|NCT03611946|520228467|FG000|Overall Study|Withdrawal by Subject|0|||
144280751|NCT03611946|520228468|FG001|Overall Study|Withdrawal by Subject|0|||
144280752|NCT03611946|520228469|FG002|Overall Study|Withdrawal by Subject|1|||
144280753|NCT03611946|520228470|FG003|Overall Study|Withdrawal by Subject|0|||
144280754|NCT02872714|520228474|FG000|Overall Study|Progressive Disease|1|||
144280755|NCT02872714|520228475|FG001|Overall Study|Progressive Disease|2|||
144280756|NCT02872714|520228476|FG002|Overall Study|Progressive Disease|0|||
144280757|NCT02872714|520228477|FG003|Overall Study|Progressive Disease|0|||
144280758|NCT02872714|520228478|FG004|Overall Study|Progressive Disease|0|||
144280759|NCT02872714|520228474|FG000|Overall Study|Death|87|||
144280760|NCT02872714|520228475|FG001|Overall Study|Death|36|||
144280761|NCT02872714|520228476|FG002|Overall Study|Death|8|||
144280762|NCT02872714|520228477|FG003|Overall Study|Death|81|||
144280763|NCT02872714|520228478|FG004|Overall Study|Death|2|||
144280764|NCT02872714|520228474|FG000|Overall Study|Lost to Follow-up|2|||
144280765|NCT02872714|520228475|FG001|Overall Study|Lost to Follow-up|1|||
144280766|NCT02872714|520228476|FG002|Overall Study|Lost to Follow-up|0|||
144280767|NCT02872714|520228477|FG003|Overall Study|Lost to Follow-up|3|||
144280768|NCT02872714|520228478|FG004|Overall Study|Lost to Follow-up|0|||
144280769|NCT02872714|520228474|FG000|Overall Study|Physician Decision|0|||
144280770|NCT02872714|520228475|FG001|Overall Study|Physician Decision|0|||
144280771|NCT02872714|520228476|FG002|Overall Study|Physician Decision|0|||
144280772|NCT02872714|520228477|FG003|Overall Study|Physician Decision|1|||
144280773|NCT02872714|520228478|FG004|Overall Study|Physician Decision|0|||
144280774|NCT02872714|520228474|FG000|Overall Study|Withdrawal by Subject|1|||
144280775|NCT02872714|520228475|FG001|Overall Study|Withdrawal by Subject|3|||
144280776|NCT02872714|520228476|FG002|Overall Study|Withdrawal by Subject|0|||
144280777|NCT02872714|520228477|FG003|Overall Study|Withdrawal by Subject|2|||
144280778|NCT02872714|520228478|FG004|Overall Study|Withdrawal by Subject|0|||
144280779|NCT02872714|520228474|FG000|Overall Study|Captured as Other|2|||
144280780|NCT02872714|520228475|FG001|Overall Study|Captured as Other|0|||
144280781|NCT02872714|520228476|FG002|Overall Study|Captured as Other|0|||
144280782|NCT02872714|520228477|FG003|Overall Study|Captured as Other|1|||
144280783|NCT02872714|520228478|FG004|Overall Study|Captured as Other|0|||
144280784|NCT05800145|520228484|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
144280785|NCT05800145|520228485|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144280786|NCT05800145|520228486|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144280787|NCT05800145|520228487|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
144280788|NCT05800145|520228488|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144280789|NCT05800145|520228489|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144280790|NCT05800145|520228484|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
144280791|NCT05800145|520228485|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
144280792|NCT05800145|520228486|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
144280793|NCT05800145|520228487|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
144280794|NCT05800145|520228488|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
144280795|NCT05800145|520228489|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
144280796|NCT05800145|520228484|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
144280797|NCT05800145|520228485|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
144280798|NCT05800145|520228486|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
144280799|NCT05800145|520228487|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
144280800|NCT05800145|520228488|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
144280801|NCT05800145|520228489|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
144280802|NCT02850406|520228490|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280803|NCT02850406|520228491|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280804|NCT02850406|520228492|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280805|NCT02850406|520228493|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
144280806|NCT02850406|520228494|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280807|NCT02850406|520228495|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280808|NCT02850406|520228496|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280809|NCT02850406|520228497|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
144280810|NCT02850406|520228490|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
144280811|NCT02850406|520228491|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
144280812|NCT02850406|520228492|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
144280813|NCT02850406|520228493|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
144280814|NCT02850406|520228494|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
144280815|NCT02850406|520228495|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
144280816|NCT02850406|520228496|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
144280817|NCT02850406|520228497|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
144280818|NCT02850406|520228490|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280819|NCT02850406|520228491|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280820|NCT02850406|520228492|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
144280821|NCT02850406|520228493|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280822|NCT02850406|520228494|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280823|NCT02850406|520228495|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280824|NCT02850406|520228496|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280825|NCT02850406|520228497|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
144280826|NCT02850406|520228490|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
144280827|NCT02850406|520228491|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
144280828|NCT02850406|520228492|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
144280829|NCT02850406|520228493|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
144280830|NCT02850406|520228494|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
144280831|NCT02850406|520228495|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
144280832|NCT02850406|520228496|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
144280833|NCT02850406|520228497|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
144280834|NCT02850406|520228490|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
144280835|NCT02850406|520228491|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
144280836|NCT02850406|520228492|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
144280837|NCT02850406|520228493|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
144280838|NCT02850406|520228494|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
144280839|NCT02850406|520228495|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
144280840|NCT02850406|520228496|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
144244711|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
144244712|NCT02294461|520093276|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
144244713|NCT02294461|520093277|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
144244714|NCT02294461|520093278|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
144244715|NCT01573767|520094558|FG000|Overall Study|Adverse Event|0|||
144244716|NCT01573767|520094559|FG001|Overall Study|Adverse Event|1|||
144244717|NCT01573767|520094560|FG002|Overall Study|Adverse Event|0|||
144244718|NCT01573767|520094561|FG003|Overall Study|Adverse Event|1|||
144244719|NCT01573767|520094558|FG000|Overall Study|Lack of Efficacy|18|||
144244720|NCT01573767|520094559|FG001|Overall Study|Lack of Efficacy|15|||
144244721|NCT01573767|520094560|FG002|Overall Study|Lack of Efficacy|12|||
144244722|NCT01573767|520094561|FG003|Overall Study|Lack of Efficacy|17|||
144244723|NCT01573767|520094558|FG000|Overall Study|Protocol Violation|3|||
144244724|NCT01573767|520094559|FG001|Overall Study|Protocol Violation|1|||
144244725|NCT01573767|520094560|FG002|Overall Study|Protocol Violation|1|||
144244726|NCT01573767|520094561|FG003|Overall Study|Protocol Violation|3|||
144244727|NCT01573767|520094558|FG000|Overall Study|Lost to Follow-up|0|||
144244728|NCT01573767|520094559|FG001|Overall Study|Lost to Follow-up|1|||
144244729|NCT01573767|520094560|FG002|Overall Study|Lost to Follow-up|1|||
144244730|NCT01573767|520094561|FG003|Overall Study|Lost to Follow-up|1|||
144244731|NCT01573767|520094558|FG000|Overall Study|Physician Decision|1|||
144244732|NCT01573767|520094559|FG001|Overall Study|Physician Decision|2|||
144244733|NCT01573767|520094560|FG002|Overall Study|Physician Decision|0|||
144244734|NCT01573767|520094561|FG003|Overall Study|Physician Decision|2|||
144244735|NCT01573767|520094558|FG000|Overall Study|Withdrawal by Subject|0|||
144244736|NCT01573767|520094559|FG001|Overall Study|Withdrawal by Subject|1|||
144280841|NCT02850406|520228497|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
144280842|NCT02850406|520228490|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
144244737|NCT01573767|520094560|FG002|Overall Study|Withdrawal by Subject|0|||
144244738|NCT01573767|520094561|FG003|Overall Study|Withdrawal by Subject|0|||
144244739|NCT03117881|520094562|FG000|Baseline|Withdrawal by Subject|21|||
144244740|NCT03117881|520094563|FG001|Baseline|Withdrawal by Subject|10|||
144244741|NCT03117881|520094564|FG002|Baseline|Withdrawal by Subject|0|||
144244742|NCT03117881|520094562|FG000|Baseline|Lost to Follow-up|22|||
144244743|NCT03117881|520094563|FG001|Baseline|Lost to Follow-up|25|||
144244744|NCT03117881|520094564|FG002|Baseline|Lost to Follow-up|0|||
144244745|NCT03117881|520094562|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
144244746|NCT03117881|520094563|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
144244747|NCT03117881|520094564|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
144244748|NCT03117881|520094562|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
144244749|NCT03117881|520094563|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
144244750|NCT03117881|520094564|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
144244751|NCT03117881|520094562|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
144244752|NCT03117881|520094563|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
144244753|NCT03117881|520094564|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
144244754|NCT03117881|520094562|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
144244755|NCT03117881|520094563|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
144244756|NCT03117881|520094564|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
144244757|NCT03117881|520094562|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
144244758|NCT03117881|520094563|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
144244759|NCT03117881|520094564|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
144244760|NCT03117881|520094562|FG000|6-Month Follow-Up|Did not complete test|53|||
144244761|NCT03117881|520094563|FG001|6-Month Follow-Up|Did not complete test|25|||
144244762|NCT03117881|520094564|FG002|6-Month Follow-Up|Did not complete test|7|||
144244763|NCT03117881|520094562|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
144244764|NCT03117881|520094563|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
144244765|NCT03117881|520094564|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
144244766|NCT03117881|520094562|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
144244767|NCT03117881|520094563|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
144244768|NCT03117881|520094564|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
144244769|NCT03117881|520094562|FG000|12-Month Follow-Up|Did not complete test|40|||
144244770|NCT03117881|520094563|FG001|12-Month Follow-Up|Did not complete test|0|||
144244771|NCT03117881|520094564|FG002|12-Month Follow-Up|Did not complete test|0|||
144244772|NCT00308750|520094567|FG000|Overall Study|Adverse Event|9|||
144244773|NCT00308750|520094568|FG001|Overall Study|Adverse Event|9|||
144244774|NCT00308750|520094569|FG002|Overall Study|Adverse Event|13|||
144244775|NCT00308750|520094567|FG000|Overall Study|Withdrawal by Subject|6|||
144244776|NCT00308750|520094568|FG001|Overall Study|Withdrawal by Subject|2|||
144244777|NCT00308750|520094569|FG002|Overall Study|Withdrawal by Subject|3|||
144244778|NCT00308750|520094567|FG000|Overall Study|Physician Decision|3|||
144244779|NCT00308750|520094568|FG001|Overall Study|Physician Decision|4|||
144244780|NCT00308750|520094569|FG002|Overall Study|Physician Decision|3|||
144244781|NCT00308750|520094567|FG000|Overall Study|Sponsor Decision|1|||
144244782|NCT00308750|520094568|FG001|Overall Study|Sponsor Decision|0|||
144244783|NCT00308750|520094569|FG002|Overall Study|Sponsor Decision|0|||
144244784|NCT00308750|520094567|FG000|Overall Study|Disease Progression|47|||
144244785|NCT00308750|520094568|FG001|Overall Study|Disease Progression|24|||
144280843|NCT02850406|520228491|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280844|NCT02850406|520228492|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280845|NCT02850406|520228493|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280846|NCT02850406|520228494|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
144280847|NCT02850406|520228495|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
144280848|NCT02850406|520228496|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280849|NCT02850406|520228497|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280850|NCT02850406|520228490|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280851|NCT02850406|520228491|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280852|NCT02850406|520228492|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280853|NCT02850406|520228493|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280854|NCT02850406|520228494|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
144280855|NCT02850406|520228495|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280856|NCT02850406|520228496|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280857|NCT02850406|520228497|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
144280858|NCT02850406|520228490|FG000|Part C (Up to 52 Weeks)|Other|0|||
144280859|NCT02850406|520228491|FG001|Part C (Up to 52 Weeks)|Other|0|||
144280860|NCT02850406|520228492|FG002|Part C (Up to 52 Weeks)|Other|0|||
144280861|NCT02850406|520228493|FG003|Part C (Up to 52 Weeks)|Other|0|||
144280862|NCT02850406|520228494|FG004|Part C (Up to 52 Weeks)|Other|1|||
144280863|NCT02850406|520228495|FG005|Part C (Up to 52 Weeks)|Other|3|||
144280864|NCT02850406|520228496|FG006|Part C (Up to 52 Weeks)|Other|0|||
144280865|NCT02850406|520228497|FG007|Part C (Up to 52 Weeks)|Other|0|||
144280866|NCT02850406|520228490|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280867|NCT02850406|520228491|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280868|NCT02850406|520228492|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280869|NCT02850406|520228493|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280870|NCT02850406|520228494|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280871|NCT02850406|520228495|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280872|NCT02850406|520228496|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
144280873|NCT02850406|520228497|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
144280874|NCT02850406|520228490|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280875|NCT02850406|520228491|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280876|NCT02850406|520228492|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280877|NCT02850406|520228493|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280878|NCT02850406|520228494|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280879|NCT02850406|520228495|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280880|NCT02850406|520228496|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
144280881|NCT02850406|520228497|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
144280882|NCT02850406|520228490|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
144280883|NCT02850406|520228491|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
144280884|NCT02850406|520228492|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
144280885|NCT02850406|520228493|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
144280886|NCT02850406|520228494|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
144280887|NCT02850406|520228495|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
144280888|NCT02850406|520228496|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
144280889|NCT02850406|520228497|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
144280890|NCT02850406|520228490|FG000|Part D (Up to 52 Weeks)|Other|0|||
144280891|NCT02850406|520228491|FG001|Part D (Up to 52 Weeks)|Other|0|||
144280892|NCT02850406|520228492|FG002|Part D (Up to 52 Weeks)|Other|0|||
144280893|NCT02850406|520228493|FG003|Part D (Up to 52 Weeks)|Other|0|||
144280894|NCT02850406|520228494|FG004|Part D (Up to 52 Weeks)|Other|0|||
144280895|NCT02850406|520228495|FG005|Part D (Up to 52 Weeks)|Other|0|||
144280896|NCT02850406|520228496|FG006|Part D (Up to 52 Weeks)|Other|0|||
144280897|NCT02850406|520228497|FG007|Part D (Up to 52 Weeks)|Other|1|||
144280898|NCT04167670|520229557|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
144280899|NCT04167670|520229558|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
144280900|NCT04167670|520229559|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
144280901|NCT04167670|520229557|FG000|Overall Study|Significant protocol deviation|3|||
144280902|NCT04167670|520229558|FG001|Overall Study|Significant protocol deviation|1|||
144280903|NCT04167670|520229559|FG002|Overall Study|Significant protocol deviation|0|||
144280904|NCT04167670|520229557|FG000|Overall Study|Lost to Follow-up|0|||
144280905|NCT04167670|520229558|FG001|Overall Study|Lost to Follow-up|3|||
144280906|NCT04167670|520229559|FG002|Overall Study|Lost to Follow-up|3|||
144280907|NCT04167670|520229557|FG000|Overall Study|Voluntary Withdrawal|0|||
144280908|NCT04167670|520229558|FG001|Overall Study|Voluntary Withdrawal|1|||
144280909|NCT04167670|520229559|FG002|Overall Study|Voluntary Withdrawal|1|||
144280910|NCT04167670|520229557|FG000|Overall Study|Withdrawal of Consent|4|||
144280911|NCT04167670|520229558|FG001|Overall Study|Withdrawal of Consent|1|||
144280912|NCT04167670|520229559|FG002|Overall Study|Withdrawal of Consent|3|||
144280913|NCT04167670|520229557|FG000|Overall Study|Miscellaneous|7|||
144280914|NCT04167670|520229558|FG001|Overall Study|Miscellaneous|5|||
144280915|NCT04167670|520229559|FG002|Overall Study|Miscellaneous|3|||
144280916|NCT04333498|520229560|FG000|Overall Study|Lost to Follow-up|1|||
144280917|NCT04333498|520229561|FG001|Overall Study|Lost to Follow-up|0|||
144280918|NCT04333498|520229560|FG000|Overall Study|Lost to Follow-up|0|||
144280919|NCT04333498|520229561|FG001|Overall Study|Lost to Follow-up|1|||
144280920|NCT00479232|520229562|FG000|Overall Study|Adverse Event|0|||
144280921|NCT00479232|520229563|FG001|Overall Study|Adverse Event|0|||
144280922|NCT00479232|520229564|FG002|Overall Study|Adverse Event|5|||
144280923|NCT00479232|520229565|FG003|Overall Study|Adverse Event|0|||
144280924|NCT00479232|520229566|FG004|Overall Study|Adverse Event|0|||
144280925|NCT00479232|520229567|FG005|Overall Study|Adverse Event|10|||
144280926|NCT00479232|520229562|FG000|Overall Study|Deviation from Protocol|0|||
144280927|NCT00479232|520229563|FG001|Overall Study|Deviation from Protocol|0|||
144280928|NCT00479232|520229564|FG002|Overall Study|Deviation from Protocol|1|||
144280929|NCT00479232|520229565|FG003|Overall Study|Deviation from Protocol|0|||
144280930|NCT00479232|520229566|FG004|Overall Study|Deviation from Protocol|0|||
144280931|NCT00479232|520229567|FG005|Overall Study|Deviation from Protocol|0|||
144280932|NCT00479232|520229562|FG000|Overall Study|Lack of Efficacy|0|||
144280933|NCT00479232|520229563|FG001|Overall Study|Lack of Efficacy|0|||
144280934|NCT00479232|520229564|FG002|Overall Study|Lack of Efficacy|2|||
144280935|NCT00479232|520229565|FG003|Overall Study|Lack of Efficacy|0|||
144280936|NCT00479232|520229566|FG004|Overall Study|Lack of Efficacy|0|||
144280937|NCT00479232|520229567|FG005|Overall Study|Lack of Efficacy|4|||
144280938|NCT00479232|520229562|FG000|Overall Study|Physician Decision|0|||
144280939|NCT00479232|520229563|FG001|Overall Study|Physician Decision|0|||
144280940|NCT00479232|520229564|FG002|Overall Study|Physician Decision|2|||
144280941|NCT00479232|520229565|FG003|Overall Study|Physician Decision|0|||
144280942|NCT00479232|520229566|FG004|Overall Study|Physician Decision|0|||
144280943|NCT00479232|520229567|FG005|Overall Study|Physician Decision|1|||
144280944|NCT00479232|520229562|FG000|Overall Study|Progressive Disease|3|||
144280945|NCT00479232|520229563|FG001|Overall Study|Progressive Disease|1|||
144280946|NCT00479232|520229564|FG002|Overall Study|Progressive Disease|12|||
144280947|NCT00479232|520229565|FG003|Overall Study|Progressive Disease|3|||
144280948|NCT00479232|520229566|FG004|Overall Study|Progressive Disease|3|||
144280949|NCT00479232|520229567|FG005|Overall Study|Progressive Disease|12|||
144280950|NCT00479232|520229562|FG000|Overall Study|Withdrew Consent|0|||
144280951|NCT00479232|520229563|FG001|Overall Study|Withdrew Consent|2|||
144280952|NCT00479232|520229564|FG002|Overall Study|Withdrew Consent|6|||
144280953|NCT00479232|520229565|FG003|Overall Study|Withdrew Consent|0|||
144280954|NCT00479232|520229566|FG004|Overall Study|Withdrew Consent|1|||
144280955|NCT00479232|520229567|FG005|Overall Study|Withdrew Consent|3|||
144280956|NCT05399771|520229568|FG000|Overall Study|Physician Decision|3|||
144280957|NCT05399771|520229568|FG000|Overall Study|Adverse Event|1|||
144280958|NCT01797185|520229570|FG000|Overall Study|Adverse Event|5|||
144280959|NCT01797185|520229571|FG001|Overall Study|Adverse Event|15|||
144280960|NCT01797185|520229572|FG002|Overall Study|Adverse Event|6|||
144280961|NCT01797185|520229570|FG000|Overall Study|Withdrawal by Subject|6|||
144280962|NCT01797185|520229571|FG001|Overall Study|Withdrawal by Subject|9|||
144280963|NCT01797185|520229572|FG002|Overall Study|Withdrawal by Subject|5|||
144280964|NCT01797185|520229570|FG000|Overall Study|Site terminated|8|||
144280965|NCT01797185|520229571|FG001|Overall Study|Site terminated|4|||
144280966|NCT01797185|520229572|FG002|Overall Study|Site terminated|0|||
144280967|NCT01797185|520229570|FG000|Overall Study|Lost to Follow-up|2|||
144280968|NCT01797185|520229571|FG001|Overall Study|Lost to Follow-up|6|||
144280969|NCT01797185|520229572|FG002|Overall Study|Lost to Follow-up|1|||
144280970|NCT01797185|520229570|FG000|Overall Study|Withdrawn per sponsor|5|||
144280971|NCT01797185|520229571|FG001|Overall Study|Withdrawn per sponsor|0|||
144280972|NCT01797185|520229572|FG002|Overall Study|Withdrawn per sponsor|0|||
144280973|NCT01797185|520229570|FG000|Overall Study|Physician Decision|1|||
144280974|NCT01797185|520229571|FG001|Overall Study|Physician Decision|3|||
144280975|NCT01797185|520229572|FG002|Overall Study|Physician Decision|0|||
144280976|NCT01797185|520229570|FG000|Overall Study|Protocol Violation|1|||
144280977|NCT01797185|520229571|FG001|Overall Study|Protocol Violation|1|||
144280978|NCT01797185|520229572|FG002|Overall Study|Protocol Violation|0|||
144280979|NCT04602000|520229573|FG000|Overall Study|Withdrawal by Subject|3|||
144280980|NCT04602000|520229574|FG001|Overall Study|Withdrawal by Subject|6|||
144280981|NCT04602000|520229575|FG002|Overall Study|Withdrawal by Subject|3|||
144280982|NCT04602000|520229576|FG003|Overall Study|Withdrawal by Subject|27|||
144280983|NCT04602000|520229577|FG004|Overall Study|Withdrawal by Subject|39|||
144280984|NCT04602000|520229573|FG000|Overall Study|Physician Decision|1|||
144280985|NCT04602000|520229574|FG001|Overall Study|Physician Decision|0|||
144280986|NCT04602000|520229575|FG002|Overall Study|Physician Decision|0|||
144280987|NCT04602000|520229576|FG003|Overall Study|Physician Decision|2|||
144280988|NCT04602000|520229577|FG004|Overall Study|Physician Decision|2|||
144280989|NCT04602000|520229573|FG000|Overall Study|Death|0|||
144280990|NCT04602000|520229574|FG001|Overall Study|Death|1|||
144280991|NCT04602000|520229575|FG002|Overall Study|Death|0|||
144280992|NCT04602000|520229576|FG003|Overall Study|Death|1|||
144280993|NCT04602000|520229577|FG004|Overall Study|Death|2|||
144280994|NCT04602000|520229573|FG000|Overall Study|Lost to Follow-up|0|||
144280995|NCT04602000|520229574|FG001|Overall Study|Lost to Follow-up|0|||
144244786|NCT00308750|520094569|FG002|Overall Study|Disease Progression|28|||
144244787|NCT00308750|520094567|FG000|Overall Study|Unrelated Complication|3|||
144244788|NCT00308750|520094568|FG001|Overall Study|Unrelated Complication|0|||
144244789|NCT00308750|520094569|FG002|Overall Study|Unrelated Complication|1|||
144244790|NCT00308750|520094567|FG000|Overall Study|Death|1|||
144244791|NCT00308750|520094568|FG001|Overall Study|Death|0|||
144244792|NCT00308750|520094569|FG002|Overall Study|Death|1|||
144244793|NCT00308750|520094567|FG000|Overall Study|Protocol Violation|1|||
144244794|NCT00308750|520094568|FG001|Overall Study|Protocol Violation|0|||
144244795|NCT00308750|520094569|FG002|Overall Study|Protocol Violation|0|||
144244796|NCT00308750|520094567|FG000|Overall Study|New Primary Disease Identified|1|||
144244797|NCT00308750|520094568|FG001|Overall Study|New Primary Disease Identified|1|||
144244798|NCT00308750|520094569|FG002|Overall Study|New Primary Disease Identified|0|||
144244799|NCT01358578|520094570|FG000|Induction Period|Adverse Event|2|||
144244800|NCT01358578|520094571|FG001|Induction Period|Adverse Event|4|||
144244801|NCT01358578|520094572|FG002|Induction Period|Adverse Event|2|||
144244802|NCT01358578|520094573|FG003|Induction Period|Adverse Event|6|||
144244803|NCT01358578|520094574|FG004|Induction Period|Adverse Event|0|||
144244804|NCT01358578|520094575|FG005|Induction Period|Adverse Event|0|||
144244805|NCT01358578|520094570|FG000|Induction Period|Lack of Efficacy|0|||
144244806|NCT01358578|520094571|FG001|Induction Period|Lack of Efficacy|0|||
144244807|NCT01358578|520094572|FG002|Induction Period|Lack of Efficacy|9|||
144244808|NCT01358578|520094573|FG003|Induction Period|Lack of Efficacy|1|||
144244809|NCT01358578|520094574|FG004|Induction Period|Lack of Efficacy|0|||
144244810|NCT01358578|520094575|FG005|Induction Period|Lack of Efficacy|0|||
144244811|NCT01358578|520094570|FG000|Induction Period|Lost to Follow-up|0|||
144244812|NCT01358578|520094571|FG001|Induction Period|Lost to Follow-up|0|||
144244813|NCT01358578|520094572|FG002|Induction Period|Lost to Follow-up|1|||
144244814|NCT01358578|520094573|FG003|Induction Period|Lost to Follow-up|4|||
144244815|NCT01358578|520094574|FG004|Induction Period|Lost to Follow-up|0|||
144244816|NCT01358578|520094575|FG005|Induction Period|Lost to Follow-up|0|||
144244817|NCT01358578|520094570|FG000|Induction Period|Physician Decision|2|||
144244818|NCT01358578|520094571|FG001|Induction Period|Physician Decision|1|||
144244819|NCT01358578|520094572|FG002|Induction Period|Physician Decision|2|||
144244820|NCT01358578|520094573|FG003|Induction Period|Physician Decision|0|||
144244821|NCT01358578|520094574|FG004|Induction Period|Physician Decision|0|||
144244822|NCT01358578|520094575|FG005|Induction Period|Physician Decision|0|||
144244823|NCT01358578|520094570|FG000|Induction Period|Protocol Deviation|3|||
144244824|NCT01358578|520094571|FG001|Induction Period|Protocol Deviation|5|||
144244825|NCT01358578|520094572|FG002|Induction Period|Protocol Deviation|0|||
144244826|NCT01358578|520094573|FG003|Induction Period|Protocol Deviation|3|||
144244827|NCT01358578|520094574|FG004|Induction Period|Protocol Deviation|0|||
144244828|NCT01358578|520094575|FG005|Induction Period|Protocol Deviation|0|||
144244829|NCT01358578|520094570|FG000|Induction Period|technical problems|0|||
144244830|NCT01358578|520094571|FG001|Induction Period|technical problems|0|||
144244831|NCT01358578|520094572|FG002|Induction Period|technical problems|1|||
144244832|NCT01358578|520094573|FG003|Induction Period|technical problems|1|||
144244833|NCT01358578|520094574|FG004|Induction Period|technical problems|0|||
144244834|NCT01358578|520094575|FG005|Induction Period|technical problems|0|||
144244835|NCT01358578|520094570|FG000|Induction Period|Withdrawal by Subject|5|||
144244836|NCT01358578|520094571|FG001|Induction Period|Withdrawal by Subject|5|||
144244837|NCT01358578|520094572|FG002|Induction Period|Withdrawal by Subject|10|||
144244838|NCT01358578|520094573|FG003|Induction Period|Withdrawal by Subject|6|||
144244839|NCT01358578|520094574|FG004|Induction Period|Withdrawal by Subject|0|||
144244840|NCT01358578|520094575|FG005|Induction Period|Withdrawal by Subject|0|||
144244841|NCT01358578|520094570|FG000|Maintenance Period|Adverse Event|2|||
144244842|NCT01358578|520094571|FG001|Maintenance Period|Adverse Event|7|||
144244843|NCT01358578|520094572|FG002|Maintenance Period|Adverse Event|0|||
144244844|NCT01358578|520094573|FG003|Maintenance Period|Adverse Event|6|||
144244845|NCT01358578|520094574|FG004|Maintenance Period|Adverse Event|4|||
144244846|NCT01358578|520094575|FG005|Maintenance Period|Adverse Event|3|||
144244847|NCT01358578|520094570|FG000|Maintenance Period|Lack of Efficacy|10|||
144244848|NCT01358578|520094571|FG001|Maintenance Period|Lack of Efficacy|2|||
144244849|NCT01358578|520094572|FG002|Maintenance Period|Lack of Efficacy|0|||
144244850|NCT01358578|520094573|FG003|Maintenance Period|Lack of Efficacy|11|||
144244851|NCT01358578|520094574|FG004|Maintenance Period|Lack of Efficacy|3|||
144244852|NCT01358578|520094575|FG005|Maintenance Period|Lack of Efficacy|0|||
144244853|NCT01358578|520094570|FG000|Maintenance Period|Lost to Follow-up|4|||
144244854|NCT01358578|520094571|FG001|Maintenance Period|Lost to Follow-up|0|||
144244855|NCT01358578|520094572|FG002|Maintenance Period|Lost to Follow-up|0|||
144244856|NCT01358578|520094573|FG003|Maintenance Period|Lost to Follow-up|5|||
144244857|NCT01358578|520094574|FG004|Maintenance Period|Lost to Follow-up|1|||
144244858|NCT01358578|520094575|FG005|Maintenance Period|Lost to Follow-up|1|||
144244859|NCT01358578|520094570|FG000|Maintenance Period|Non-compliance with study treatment|3|||
144244860|NCT01358578|520094571|FG001|Maintenance Period|Non-compliance with study treatment|1|||
144244861|NCT01358578|520094572|FG002|Maintenance Period|Non-compliance with study treatment|0|||
144244862|NCT01358578|520094573|FG003|Maintenance Period|Non-compliance with study treatment|2|||
144244863|NCT01358578|520094574|FG004|Maintenance Period|Non-compliance with study treatment|1|||
144244864|NCT01358578|520094575|FG005|Maintenance Period|Non-compliance with study treatment|2|||
144244865|NCT01358578|520094570|FG000|Maintenance Period|Physician Decision|0|||
144244866|NCT01358578|520094571|FG001|Maintenance Period|Physician Decision|1|||
144244867|NCT01358578|520094572|FG002|Maintenance Period|Physician Decision|0|||
144244868|NCT01358578|520094573|FG003|Maintenance Period|Physician Decision|1|||
144244869|NCT01358578|520094574|FG004|Maintenance Period|Physician Decision|0|||
144244870|NCT01358578|520094575|FG005|Maintenance Period|Physician Decision|0|||
144244871|NCT01358578|520094570|FG000|Maintenance Period|Pregnancy|1|||
144244872|NCT01358578|520094571|FG001|Maintenance Period|Pregnancy|0|||
144244873|NCT01358578|520094572|FG002|Maintenance Period|Pregnancy|0|||
144244874|NCT01358578|520094573|FG003|Maintenance Period|Pregnancy|0|||
144244875|NCT01358578|520094574|FG004|Maintenance Period|Pregnancy|0|||
144244876|NCT01358578|520094575|FG005|Maintenance Period|Pregnancy|0|||
144244877|NCT01358578|520094570|FG000|Maintenance Period|Protocol deviation|7|||
144244878|NCT01358578|520094571|FG001|Maintenance Period|Protocol deviation|4|||
144244879|NCT01358578|520094572|FG002|Maintenance Period|Protocol deviation|0|||
144244880|NCT01358578|520094573|FG003|Maintenance Period|Protocol deviation|2|||
144244881|NCT01358578|520094574|FG004|Maintenance Period|Protocol deviation|2|||
144244882|NCT01358578|520094575|FG005|Maintenance Period|Protocol deviation|2|||
144244883|NCT01358578|520094570|FG000|Maintenance Period|Withdrawal by Subject|12|||
144244884|NCT01358578|520094571|FG001|Maintenance Period|Withdrawal by Subject|7|||
144244885|NCT01358578|520094572|FG002|Maintenance Period|Withdrawal by Subject|2|||
144244886|NCT01358578|520094573|FG003|Maintenance Period|Withdrawal by Subject|15|||
144244887|NCT01358578|520094574|FG004|Maintenance Period|Withdrawal by Subject|6|||
144244888|NCT01358578|520094575|FG005|Maintenance Period|Withdrawal by Subject|3|||
144244889|NCT01358578|520094570|FG000|Follow-up Period|Adverse Event|1|||
144244890|NCT01358578|520094571|FG001|Follow-up Period|Adverse Event|1|||
144244891|NCT01358578|520094572|FG002|Follow-up Period|Adverse Event|0|||
144244892|NCT01358578|520094573|FG003|Follow-up Period|Adverse Event|0|||
144244893|NCT01358578|520094574|FG004|Follow-up Period|Adverse Event|0|||
144244894|NCT01358578|520094575|FG005|Follow-up Period|Adverse Event|0|||
144244895|NCT01358578|520094570|FG000|Follow-up Period|Lack of Efficacy|3|||
144244896|NCT01358578|520094571|FG001|Follow-up Period|Lack of Efficacy|0|||
144244897|NCT01358578|520094572|FG002|Follow-up Period|Lack of Efficacy|4|||
144244898|NCT01358578|520094573|FG003|Follow-up Period|Lack of Efficacy|1|||
144244899|NCT01358578|520094574|FG004|Follow-up Period|Lack of Efficacy|0|||
144244900|NCT01358578|520094575|FG005|Follow-up Period|Lack of Efficacy|0|||
144244901|NCT01358578|520094570|FG000|Follow-up Period|Lost to Follow-up|0|||
144244902|NCT01358578|520094571|FG001|Follow-up Period|Lost to Follow-up|1|||
144244903|NCT01358578|520094572|FG002|Follow-up Period|Lost to Follow-up|0|||
144244904|NCT01358578|520094573|FG003|Follow-up Period|Lost to Follow-up|4|||
144244905|NCT01358578|520094574|FG004|Follow-up Period|Lost to Follow-up|0|||
144244906|NCT01358578|520094575|FG005|Follow-up Period|Lost to Follow-up|0|||
144244907|NCT01358578|520094570|FG000|Follow-up Period|non- compliance with study treatment|1|||
144244908|NCT01358578|520094571|FG001|Follow-up Period|non- compliance with study treatment|0|||
144244909|NCT01358578|520094572|FG002|Follow-up Period|non- compliance with study treatment|0|||
144244910|NCT01358578|520094573|FG003|Follow-up Period|non- compliance with study treatment|0|||
144244911|NCT01358578|520094574|FG004|Follow-up Period|non- compliance with study treatment|0|||
144244912|NCT01358578|520094575|FG005|Follow-up Period|non- compliance with study treatment|0|||
144244913|NCT01358578|520094570|FG000|Follow-up Period|Pregnancy|1|||
144244914|NCT01358578|520094571|FG001|Follow-up Period|Pregnancy|0|||
144244915|NCT01358578|520094572|FG002|Follow-up Period|Pregnancy|0|||
144244916|NCT01358578|520094573|FG003|Follow-up Period|Pregnancy|0|||
144244917|NCT01358578|520094574|FG004|Follow-up Period|Pregnancy|0|||
144244918|NCT01358578|520094575|FG005|Follow-up Period|Pregnancy|0|||
144244919|NCT01358578|520094570|FG000|Follow-up Period|Withdrawal by Subject|3|||
144244920|NCT01358578|520094571|FG001|Follow-up Period|Withdrawal by Subject|3|||
144244921|NCT01358578|520094572|FG002|Follow-up Period|Withdrawal by Subject|1|||
144244922|NCT01358578|520094573|FG003|Follow-up Period|Withdrawal by Subject|12|||
144244923|NCT01358578|520094574|FG004|Follow-up Period|Withdrawal by Subject|0|||
144244924|NCT01358578|520094575|FG005|Follow-up Period|Withdrawal by Subject|0|||
144244925|NCT01358578|520094570|FG000|Follow-up Period|Physician Decision|1|||
144244926|NCT01358578|520094571|FG001|Follow-up Period|Physician Decision|1|||
144244927|NCT01358578|520094572|FG002|Follow-up Period|Physician Decision|0|||
144244928|NCT01358578|520094573|FG003|Follow-up Period|Physician Decision|2|||
144280996|NCT04602000|520229575|FG002|Overall Study|Lost to Follow-up|0|||
144280997|NCT04602000|520229576|FG003|Overall Study|Lost to Follow-up|3|||
144280998|NCT04602000|520229577|FG004|Overall Study|Lost to Follow-up|4|||
144280999|NCT04602000|520229573|FG000|Overall Study|Other|4|||
144281000|NCT04602000|520229574|FG001|Overall Study|Other|1|||
144281001|NCT04602000|520229575|FG002|Overall Study|Other|2|||
144281002|NCT04602000|520229576|FG003|Overall Study|Other|5|||
144281003|NCT04602000|520229577|FG004|Overall Study|Other|4|||
144281004|NCT04602000|520229573|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
144281005|NCT04602000|520229574|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
144281006|NCT04602000|520229575|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
144281007|NCT04602000|520229576|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
144281008|NCT04602000|520229577|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
144281009|NCT05607043|520229578|FG000|Overall Study|Lost to Follow-up|2|||
144281010|NCT01239745|520229582|FG000|Overall Study|Study terminated by sponsor|45|||
144281011|NCT01239745|520229582|FG000|Overall Study|Adverse Event|1|||
144281012|NCT00081458|520229585|FG000|Overall Study|Adverse Event|1|||
144281013|NCT00081458|520229586|FG001|Overall Study|Adverse Event|5|||
144281014|NCT00081458|520229587|FG002|Overall Study|Adverse Event|2|||
144281015|NCT00081458|520229585|FG000|Overall Study|Withdrawal by Subject|0|||
144281016|NCT00081458|520229586|FG001|Overall Study|Withdrawal by Subject|3|||
144281017|NCT00081458|520229587|FG002|Overall Study|Withdrawal by Subject|1|||
144281018|NCT00081458|520229585|FG000|Overall Study|Randomized but not dosed|0|||
144281019|NCT00081458|520229586|FG001|Overall Study|Randomized but not dosed|0|||
144281020|NCT00081458|520229587|FG002|Overall Study|Randomized but not dosed|1|||
144281021|NCT00549328|520229590|FG000|Overall Study|Adverse Event|2|||
144281022|NCT00549328|520229590|FG000|Overall Study|Disease Progression|10|||
144281023|NCT00549328|520229590|FG000|Overall Study|Death|1|||
144281024|NCT00549328|520229590|FG000|Overall Study|Use of Prohibited Medication|1|||
144281025|NCT03097315|520229595|FG000|Overall Study|Withdrawal by Subject|1|||
144281026|NCT01946802|520229596|FG000|Overall Study|Death|1|||
144281027|NCT01946802|520229596|FG000|Overall Study|Withdrawal by Subject|2|||
144281028|NCT01946802|520229596|FG000|Overall Study|Combined septic shock|1|||
144281029|NCT01946802|520229596|FG000|Overall Study|Protocol Violation|1|||
144281030|NCT03384966|520229600|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
144281031|NCT03384966|520229601|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
144281032|NCT03384966|520229602|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
144281033|NCT03384966|520229600|FG000|Follow-up Period|Adverse Event|1|||
144281034|NCT03384966|520229601|FG001|Follow-up Period|Adverse Event|0|||
144281035|NCT03384966|520229602|FG002|Follow-up Period|Adverse Event|0|||
144281036|NCT04327271|520229603|FG000|Overall Study|Death|1|||
144281037|NCT04327271|520229604|FG001|Overall Study|Death|0|||
144281038|NCT04327271|520229603|FG000|Overall Study|Withdrawal by Subject|1|||
144281039|NCT04327271|520229604|FG001|Overall Study|Withdrawal by Subject|0|||
144281040|NCT04327271|520229603|FG000|Overall Study|randomization error (data capture)|4|||
144281041|NCT04327271|520229604|FG001|Overall Study|randomization error (data capture)|3|||
144281042|NCT04795323|520229607|FG000|Overall Study|Did not interact with TARA|1|||
144281043|NCT04795323|520229608|FG001|Overall Study|Did not interact with TARA|0|||
144281044|NCT01479530|520229609|FG000|Overall Study|Adverse Event|5|||
144281045|NCT01479530|520229610|FG001|Overall Study|Adverse Event|6|||
144281046|NCT01479530|520229609|FG000|Overall Study|Lack of Efficacy|0|||
144281047|NCT01479530|520229610|FG001|Overall Study|Lack of Efficacy|1|||
144281048|NCT01479530|520229609|FG000|Overall Study|Protocol Violation|2|||
144281049|NCT01479530|520229610|FG001|Overall Study|Protocol Violation|3|||
144281050|NCT01479530|520229609|FG000|Overall Study|Withdrawal of Consent|3|||
144281051|NCT01479530|520229610|FG001|Overall Study|Withdrawal of Consent|2|||
144281052|NCT00303628|520229613|FG000|Overall Study|Disease progression|0|||
144281053|NCT00303628|520229614|FG001|Overall Study|Disease progression|1|||
144281054|NCT00303628|520229613|FG000|Overall Study|Adverse Event|26|||
144281055|NCT00303628|520229614|FG001|Overall Study|Adverse Event|36|||
144281056|NCT00303628|520229613|FG000|Overall Study|Death|0|||
144281057|NCT00303628|520229614|FG001|Overall Study|Death|1|||
144281058|NCT00303628|520229613|FG000|Overall Study|Withdrawal by Subject|11|||
144281059|NCT00303628|520229614|FG001|Overall Study|Withdrawal by Subject|20|||
144281060|NCT00303628|520229613|FG000|Overall Study|Alternative therapy|2|||
144281061|NCT00303628|520229614|FG001|Overall Study|Alternative therapy|0|||
144281062|NCT00303628|520229613|FG000|Overall Study|Other complicating disease|0|||
144281063|NCT00303628|520229614|FG001|Overall Study|Other complicating disease|1|||
144281064|NCT00303628|520229613|FG000|Overall Study|Not start protocol therapy|3|||
144281065|NCT00303628|520229614|FG001|Overall Study|Not start protocol therapy|5|||
144281066|NCT00303628|520229613|FG000|Overall Study|Other|8|||
144281067|NCT00303628|520229614|FG001|Overall Study|Other|9|||
144281068|NCT04925934|520229615|FG000|Overall Study|Adverse Event|1|||
144281069|NCT04925934|520229616|FG001|Overall Study|Adverse Event|0|||
144281070|NCT04925934|520229617|FG002|Overall Study|Adverse Event|0|||
144281071|NCT04925934|520229615|FG000|Overall Study|Lost to Follow-up|2|||
144281072|NCT04925934|520229616|FG001|Overall Study|Lost to Follow-up|0|||
144281073|NCT04925934|520229617|FG002|Overall Study|Lost to Follow-up|1|||
144281074|NCT04925934|520229615|FG000|Overall Study|Death|0|||
144281075|NCT04925934|520229616|FG001|Overall Study|Death|1|||
144281076|NCT04925934|520229617|FG002|Overall Study|Death|0|||
144281077|NCT04925934|520229615|FG000|Overall Study|Withdrawal by Subject|8|||
144281078|NCT04925934|520229616|FG001|Overall Study|Withdrawal by Subject|5|||
144281079|NCT04925934|520229617|FG002|Overall Study|Withdrawal by Subject|9|||
144281080|NCT04925934|520229615|FG000|Overall Study|Other|2|||
144281081|NCT04925934|520229616|FG001|Overall Study|Other|2|||
144281082|NCT04925934|520229617|FG002|Overall Study|Other|2|||
144281083|NCT04925934|520229615|FG000|Overall Study|Eastern European Conflict|7|||
144281084|NCT04925934|520229616|FG001|Overall Study|Eastern European Conflict|3|||
144281085|NCT04925934|520229617|FG002|Overall Study|Eastern European Conflict|2|||
144281086|NCT01716156|520229621|FG000|Overall Study|Protocol Violation|1|||
144281087|NCT01716156|520229622|FG001|Overall Study|Protocol Violation|0|||
144281088|NCT01716156|520229623|FG002|Overall Study|Protocol Violation|0|||
144281089|NCT01716156|520229621|FG000|Overall Study|Withdrawal by Subject|0|||
144281090|NCT01716156|520229622|FG001|Overall Study|Withdrawal by Subject|1|||
144281091|NCT01716156|520229623|FG002|Overall Study|Withdrawal by Subject|2|||
144281092|NCT01716156|520229621|FG000|Overall Study|Lost to Follow-up|1|||
144281093|NCT01716156|520229622|FG001|Overall Study|Lost to Follow-up|0|||
144281094|NCT01716156|520229623|FG002|Overall Study|Lost to Follow-up|0|||
144281095|NCT01132755|520229627|FG000|Overall Study|Procedure not done due to medical reason|23|||
144281096|NCT01132755|520229627|FG000|Overall Study|Protocol Violation|15|||
144281097|NCT01132755|520229627|FG000|Overall Study|Withdrawal by Subject|4|||
144281098|NCT02393755|520229628|FG000|Overall Study|Withdrawal by Subject|0|||
144281099|NCT02393755|520229629|FG001|Overall Study|Withdrawal by Subject|3|||
144281100|NCT02393755|520229628|FG000|Overall Study|Adverse Event|0|||
144281101|NCT02393755|520229629|FG001|Overall Study|Adverse Event|2|||
144281102|NCT02393755|520229628|FG000|Overall Study|Physician Decision|0|||
144281103|NCT02393755|520229629|FG001|Overall Study|Physician Decision|2|||
144281104|NCT02949934|520229632|FG000|Natural Drinking Period|Adverse Event|1|||
144281105|NCT02949934|520229633|FG001|Natural Drinking Period|Adverse Event|0|||
144281106|NCT02949934|520229634|FG002|Natural Drinking Period|Adverse Event|0|||
144281107|NCT02949934|520229635|FG003|Natural Drinking Period|Adverse Event|1|||
144281108|NCT02949934|520229636|FG004|Natural Drinking Period|Adverse Event|0|||
144281109|NCT02949934|520229637|FG005|Natural Drinking Period|Adverse Event|0|||
144281110|NCT02949934|520229632|FG000|Natural Drinking Period|Lost to Follow-up|0|||
144281111|NCT02949934|520229633|FG001|Natural Drinking Period|Lost to Follow-up|0|||
144281112|NCT02949934|520229634|FG002|Natural Drinking Period|Lost to Follow-up|0|||
144281113|NCT02949934|520229635|FG003|Natural Drinking Period|Lost to Follow-up|0|||
144281114|NCT02949934|520229636|FG004|Natural Drinking Period|Lost to Follow-up|1|||
144281115|NCT02949934|520229637|FG005|Natural Drinking Period|Lost to Follow-up|0|||
144281116|NCT02949934|520229632|FG000|Neuroimaging|Protocol Violation|2|||
144281117|NCT02949934|520229633|FG001|Neuroimaging|Protocol Violation|0|||
144281118|NCT02949934|520229634|FG002|Neuroimaging|Protocol Violation|0|||
144281119|NCT02949934|520229635|FG003|Neuroimaging|Protocol Violation|0|||
144281120|NCT02949934|520229636|FG004|Neuroimaging|Protocol Violation|1|||
144281121|NCT02949934|520229637|FG005|Neuroimaging|Protocol Violation|0|||
144281122|NCT02949934|520229632|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
144281123|NCT02949934|520229633|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
144281124|NCT02949934|520229634|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
144281125|NCT02949934|520229635|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
144281126|NCT02949934|520229636|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
144281127|NCT02949934|520229637|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
144281128|NCT02949934|520229632|FG000|Neuroimaging|Not scanned|0|||
144281129|NCT02949934|520229633|FG001|Neuroimaging|Not scanned|0|||
144281130|NCT02949934|520229634|FG002|Neuroimaging|Not scanned|1|||
144281131|NCT02949934|520229635|FG003|Neuroimaging|Not scanned|0|||
144281132|NCT02949934|520229636|FG004|Neuroimaging|Not scanned|0|||
144281133|NCT02949934|520229637|FG005|Neuroimaging|Not scanned|2|||
144281134|NCT02949934|520229632|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
144281135|NCT02949934|520229633|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
144281136|NCT02949934|520229634|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
144281137|NCT02949934|520229635|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
144281138|NCT02949934|520229636|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
144281139|NCT02949934|520229637|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
144281140|NCT02949934|520229632|FG000|Bar Laboratory|Adverse Event|1|||
144281141|NCT02949934|520229633|FG001|Bar Laboratory|Adverse Event|0|||
144281142|NCT02949934|520229634|FG002|Bar Laboratory|Adverse Event|2|||
144281143|NCT02949934|520229635|FG003|Bar Laboratory|Adverse Event|0|||
144281144|NCT02949934|520229636|FG004|Bar Laboratory|Adverse Event|1|||
144281145|NCT02949934|520229637|FG005|Bar Laboratory|Adverse Event|0|||
144281146|NCT02949934|520229632|FG000|Bar Laboratory|Protocol Violation|0|||
144281147|NCT02949934|520229633|FG001|Bar Laboratory|Protocol Violation|0|||
144281148|NCT02949934|520229634|FG002|Bar Laboratory|Protocol Violation|0|||
144281149|NCT02949934|520229635|FG003|Bar Laboratory|Protocol Violation|1|||
144281150|NCT02949934|520229636|FG004|Bar Laboratory|Protocol Violation|0|||
144281151|NCT02949934|520229637|FG005|Bar Laboratory|Protocol Violation|0|||
144281152|NCT04069520|520229641|FG000|Overall Study|Lost to Follow-up|0|||
144281153|NCT04069520|520229642|FG001|Overall Study|Lost to Follow-up|2|||
144281154|NCT04069520|520229641|FG000|Overall Study|Withdrawal by Subject|0|||
144281155|NCT04069520|520229642|FG001|Overall Study|Withdrawal by Subject|1|||
144281156|NCT04069520|520229641|FG000|Overall Study|Prior Injury|1|||
144281157|NCT04069520|520229642|FG001|Overall Study|Prior Injury|0|||
144281158|NCT04069520|520229641|FG000|Overall Study|Orthodontia|1|||
144281159|NCT04069520|520229642|FG001|Overall Study|Orthodontia|0|||
144281160|NCT04069520|520229641|FG000|Overall Study|Cut from team|0|||
144281161|NCT04069520|520229642|FG001|Overall Study|Cut from team|2|||
144281162|NCT00849472|520229643|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
144281163|NCT00849472|520229643|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
144281164|NCT00849472|520229643|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
144281165|NCT00849472|520229643|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
144281166|NCT00849472|520229643|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
144281167|NCT00849472|520229643|FG000|Weekly Paclitaxel|Disease Progression|1|||
144281168|NCT00849472|520229643|FG000|Weekly Paclitaxel|Adverse Event|11|||
144281169|NCT00849472|520229643|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
144281170|NCT00849472|520229643|FG000|Weekly Paclitaxel|Physician Decision|3|||
144281171|NCT00849472|520229643|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
144281172|NCT00849472|520229643|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
144281173|NCT00849472|520229643|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
144281174|NCT00849472|520229643|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
144281175|NCT00849472|520229643|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
144281176|NCT00849472|520229643|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
144281177|NCT00849472|520229643|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
144244929|NCT01358578|520094574|FG004|Follow-up Period|Physician Decision|0|||
144244930|NCT01358578|520094575|FG005|Follow-up Period|Physician Decision|0|||
144244931|NCT01027897|520094576|FG000|Overall Study|Protocol Violation|1|||
144244932|NCT01027897|520094576|FG000|Overall Study|Withdrawal by Subject|1|||
144244933|NCT01911780|520094577|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
144244934|NCT01911780|520094578|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
144244935|NCT01911780|520094577|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
144244936|NCT01911780|520094578|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
144244937|NCT01911780|520094577|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
144244938|NCT01911780|520094578|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
144244939|NCT01911780|520094577|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
144244940|NCT01911780|520094578|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
144244941|NCT01911780|520094577|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
144244942|NCT01911780|520094578|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
144244943|NCT01911780|520094577|FG000|Extension Period (52 Weeks)|Personal reason|1|||
144244944|NCT01911780|520094578|FG001|Extension Period (52 Weeks)|Personal reason|1|||
144244945|NCT02539134|520094582|FG000|Overall Study|Lost to Follow-up|1|||
144244946|NCT02539134|520094583|FG001|Overall Study|Lost to Follow-up|0|||
144244947|NCT02539134|520094584|FG002|Overall Study|Lost to Follow-up|0|||
144244948|NCT02539134|520094585|FG003|Overall Study|Lost to Follow-up|0|||
144244949|NCT02539134|520094586|FG004|Overall Study|Lost to Follow-up|0|||
144244950|NCT02539134|520094587|FG005|Overall Study|Lost to Follow-up|0|||
144244951|NCT00985426|520094588|FG000|Overall Study|Adverse Event|0|||
144244952|NCT00985426|520094589|FG001|Overall Study|Adverse Event|1|||
144244953|NCT00985426|520094588|FG000|Overall Study|Subject Non-Compliance|3|||
144244954|NCT00985426|520094589|FG001|Overall Study|Subject Non-Compliance|3|||
144244955|NCT00985426|520094588|FG000|Overall Study|Withdrawal by Subject|12|||
144244956|NCT00985426|520094589|FG001|Overall Study|Withdrawal by Subject|16|||
144244957|NCT00985426|520094588|FG000|Overall Study|Lost to Follow-up|8|||
144244958|NCT00985426|520094589|FG001|Overall Study|Lost to Follow-up|10|||
144244959|NCT00985426|520094588|FG000|Overall Study|Death|7|||
144244960|NCT00985426|520094589|FG001|Overall Study|Death|3|||
144244961|NCT00985426|520094588|FG000|Overall Study|Protocol Violation|2|||
144244962|NCT00985426|520094589|FG001|Overall Study|Protocol Violation|0|||
144244963|NCT00985426|520094588|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
144244964|NCT00985426|520094589|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
144244965|NCT01661933|520094591|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
144244966|NCT01661933|520094591|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
144244967|NCT02052596|520094600|FG000|Active Phase|Adverse Event|3|||
144244968|NCT02052596|520094601|FG001|Active Phase|Adverse Event|2|||
144244969|NCT02052596|520094600|FG000|Active Phase|Lost to Follow-up|8|||
144244970|NCT02052596|520094601|FG001|Active Phase|Lost to Follow-up|11|||
144244971|NCT02052596|520094600|FG000|Active Phase|Protocol Violation|1|||
144244972|NCT02052596|520094601|FG001|Active Phase|Protocol Violation|2|||
144244973|NCT02052596|520094600|FG000|Active Phase|Withdrawal by Subject|3|||
144244974|NCT02052596|520094601|FG001|Active Phase|Withdrawal by Subject|4|||
144244975|NCT02052596|520094600|FG000|Active Phase|Enrolled in error|1|||
144244976|NCT02052596|520094601|FG001|Active Phase|Enrolled in error|0|||
144244977|NCT02052596|520094600|FG000|Active Phase|Lost due to Crohn's disease|0|||
144244978|NCT02052596|520094601|FG001|Active Phase|Lost due to Crohn's disease|1|||
144244979|NCT02052596|520094600|FG000|Safety Phase|Adverse Event|6|||
144244980|NCT02052596|520094601|FG001|Safety Phase|Adverse Event|3|||
144244981|NCT02052596|520094600|FG000|Safety Phase|Lost to Follow-up|11|||
144244982|NCT02052596|520094601|FG001|Safety Phase|Lost to Follow-up|18|||
144244983|NCT02052596|520094600|FG000|Safety Phase|Protocol Violation|1|||
144244984|NCT02052596|520094601|FG001|Safety Phase|Protocol Violation|2|||
144244985|NCT02052596|520094600|FG000|Safety Phase|Withdrawal by Subject|8|||
144244986|NCT02052596|520094601|FG001|Safety Phase|Withdrawal by Subject|11|||
144244987|NCT02052596|520094600|FG000|Safety Phase|Enrolled in error|1|||
144244988|NCT02052596|520094601|FG001|Safety Phase|Enrolled in error|0|||
144244989|NCT02052596|520094600|FG000|Safety Phase|Lost due to Crohn's disease|0|||
144244990|NCT02052596|520094601|FG001|Safety Phase|Lost due to Crohn's disease|1|||
144244991|NCT00558896|520094602|FG000|Overall Study|Adverse Event|1|||
144244992|NCT00558896|520094603|FG001|Overall Study|Adverse Event|1|||
144244993|NCT00558896|520094604|FG002|Overall Study|Adverse Event|1|||
144244994|NCT00558896|520094605|FG003|Overall Study|Adverse Event|3|||
144281178|NCT00849472|520229643|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
144281179|NCT04822194|520229644|FG000|Overall Study|Withdrawal by Subject|5|||
144281180|NCT04822194|520229645|FG001|Overall Study|Withdrawal by Subject|4|||
144281181|NCT04822194|520229644|FG000|Overall Study|Technical issues with MR scanner|1|||
144281182|NCT04822194|520229645|FG001|Overall Study|Technical issues with MR scanner|0|||
144281183|NCT04822194|520229644|FG000|Overall Study|Lost to Follow-up|5|||
144281184|NCT04822194|520229645|FG001|Overall Study|Lost to Follow-up|7|||
144281185|NCT04615507|520229646|FG000|Period 1|Covid-19 exposure|2|||
144281186|NCT04615507|520229647|FG001|Period 1|Covid-19 exposure|1|||
144281187|NCT04615507|520229646|FG000|Period 2|Covid-19 exposure|0|||
144281188|NCT04615507|520229647|FG001|Period 2|Covid-19 exposure|1|||
144281189|NCT04615507|520229646|FG000|Period 2|Protocol Violation|1|||
144281190|NCT04615507|520229647|FG001|Period 2|Protocol Violation|0|||
144281191|NCT04615507|520229646|FG000|Period 2|Withdrawal by Subject|1|||
144281192|NCT04615507|520229647|FG001|Period 2|Withdrawal by Subject|0|||
144281193|NCT04615507|520229646|FG000|Period 2|Adverse Event|0|||
144281194|NCT04615507|520229647|FG001|Period 2|Adverse Event|1|||
144281195|NCT04615507|520229646|FG000|Period 3|Covid-19 exposure|0|||
144281196|NCT04615507|520229647|FG001|Period 3|Covid-19 exposure|1|||
144281197|NCT05172570|520229656|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
144281198|NCT05172570|520229657|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
144281199|NCT05172570|520229658|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
144281200|NCT05172570|520229656|FG000|Overall Study|PI Decision due to equipment shortages|0|||
144281201|NCT05172570|520229657|FG001|Overall Study|PI Decision due to equipment shortages|0|||
144281202|NCT05172570|520229658|FG002|Overall Study|PI Decision due to equipment shortages|1|||
144281203|NCT03010501|520229659|FG000|Study Week 1|Withdrawal by Subject|2|||
144281204|NCT03010501|520229660|FG001|Study Week 1|Withdrawal by Subject|1|||
144281205|NCT03010501|520229661|FG002|Study Week 1|Withdrawal by Subject|0|||
144281206|NCT03010501|520229662|FG003|Study Week 1|Withdrawal by Subject|2|||
144281207|NCT03010501|520229663|FG004|Study Week 1|Withdrawal by Subject|0|||
144281208|NCT03010501|520229664|FG005|Study Week 1|Withdrawal by Subject|0|||
144281209|NCT03010501|520229659|FG000|Study Week 3|Withdrawal by Subject|0|||
144281210|NCT03010501|520229660|FG001|Study Week 3|Withdrawal by Subject|0|||
144281211|NCT03010501|520229661|FG002|Study Week 3|Withdrawal by Subject|0|||
144281212|NCT03010501|520229662|FG003|Study Week 3|Withdrawal by Subject|1|||
144281213|NCT03010501|520229663|FG004|Study Week 3|Withdrawal by Subject|0|||
144281214|NCT03010501|520229664|FG005|Study Week 3|Withdrawal by Subject|0|||
144281215|NCT00640289|520229667|FG000|Overall Study|Death|3|||
144281216|NCT00640289|520229667|FG000|Overall Study|Withdrawal by Subject|1|||
144281217|NCT00640289|520229667|FG000|Overall Study|Lost to Follow-up|1|||
144281218|NCT00640289|520229667|FG000|Overall Study|Data collected under different amendment|2|||
144281219|NCT00640289|520229667|FG000|Overall Study|Transferred to another center|1|||
144281220|NCT00640289|520229667|FG000|Overall Study|Missing status|5|||
144281221|NCT03550209|520229668|FG000|Overall Study|Lost to Follow-up|1|||
144281222|NCT03550209|520229669|FG001|Overall Study|Lost to Follow-up|0|||
144281223|NCT03550209|520229670|FG002|Overall Study|Lost to Follow-up|1|||
144281224|NCT03550209|520229671|FG003|Overall Study|Lost to Follow-up|0|||
144281225|NCT03550209|520229668|FG000|Overall Study|Withdrawal by Subject|0|||
144281226|NCT03550209|520229669|FG001|Overall Study|Withdrawal by Subject|3|||
144281227|NCT03550209|520229670|FG002|Overall Study|Withdrawal by Subject|1|||
144281228|NCT03550209|520229671|FG003|Overall Study|Withdrawal by Subject|2|||
144281229|NCT03550209|520229668|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
144281230|NCT03550209|520229669|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
144281231|NCT03550209|520229670|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
144281232|NCT03550209|520229671|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
144281233|NCT04937387|520229676|FG000|Overall Study|Adverse Event|1|||
144281234|NCT04937387|520229677|FG001|Overall Study|Adverse Event|0|||
144281235|NCT04937387|520229678|FG002|Overall Study|Adverse Event|2|||
144281236|NCT04937387|520229679|FG003|Overall Study|Adverse Event|0|||
144281237|NCT04937387|520229676|FG000|Overall Study|Lack of Efficacy|1|||
144281238|NCT04937387|520229677|FG001|Overall Study|Lack of Efficacy|0|||
144281239|NCT04937387|520229678|FG002|Overall Study|Lack of Efficacy|0|||
144281240|NCT04937387|520229679|FG003|Overall Study|Lack of Efficacy|1|||
144281241|NCT04937387|520229676|FG000|Overall Study|Withdrawal by Subject|1|||
144281242|NCT04937387|520229677|FG001|Overall Study|Withdrawal by Subject|0|||
144281243|NCT04937387|520229678|FG002|Overall Study|Withdrawal by Subject|1|||
144281244|NCT04937387|520229679|FG003|Overall Study|Withdrawal by Subject|1|||
144281245|NCT04937387|520229676|FG000|Overall Study|Randomized in error|0|||
144281246|NCT04937387|520229677|FG001|Overall Study|Randomized in error|0|||
144281247|NCT04937387|520229678|FG002|Overall Study|Randomized in error|0|||
144281248|NCT04937387|520229679|FG003|Overall Study|Randomized in error|1|||
144281249|NCT03599713|520229680|FG000|Overall Study|Death|38|||
144281250|NCT03599713|520229681|FG001|Overall Study|Death|3|||
144281251|NCT03599713|520229680|FG000|Overall Study|Withdrawal by Subject|17|||
144281252|NCT03599713|520229681|FG001|Overall Study|Withdrawal by Subject|0|||
144281253|NCT03599713|520229680|FG000|Overall Study|Lost to Follow-up|4|||
144281254|NCT03599713|520229681|FG001|Overall Study|Lost to Follow-up|0|||
144281255|NCT03599713|520229680|FG000|Overall Study|Discontinued Due to End of Study|42|||
144281256|NCT03599713|520229681|FG001|Overall Study|Discontinued Due to End of Study|3|||
144281257|NCT03580928|520229686|FG000|Overall Study|Death|0|||
144281258|NCT03580928|520229687|FG001|Overall Study|Death|3|||
144281259|NCT03580928|520229686|FG000|Overall Study|Withdrawal by Subject|2|||
144281260|NCT03580928|520229687|FG001|Overall Study|Withdrawal by Subject|1|||
144281261|NCT03580928|520229686|FG000|Overall Study|Lost to Follow-up|2|||
144281262|NCT03580928|520229687|FG001|Overall Study|Lost to Follow-up|0|||
144281263|NCT03580928|520229686|FG000|Overall Study|Progressive Disease|0|||
144281264|NCT03580928|520229687|FG001|Overall Study|Progressive Disease|1|||
144281265|NCT05643794|520230657|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
144281266|NCT05643794|520230658|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
144281267|NCT05643794|520230659|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
144281268|NCT05643794|520230657|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
144281269|NCT05643794|520230658|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144281270|NCT05643794|520230659|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
144281271|NCT05643794|520230657|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
144281272|NCT05643794|520230658|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
144281273|NCT05643794|520230659|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
144281274|NCT05643794|520230657|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
144281275|NCT05643794|520230658|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
144281276|NCT05643794|520230659|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
144281277|NCT05643794|520230657|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
144281278|NCT05643794|520230658|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
144281279|NCT05643794|520230659|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
144281280|NCT05643794|520230657|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
144281281|NCT05643794|520230658|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
144281282|NCT05643794|520230659|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
144281283|NCT01127061|520230664|FG000|Overall Study|Lost to Follow-up|7|||
144281284|NCT01127061|520230665|FG001|Overall Study|Lost to Follow-up|10|||
144281285|NCT01127061|520230664|FG000|Overall Study|Physician Decision|3|||
144281286|NCT01127061|520230665|FG001|Overall Study|Physician Decision|3|||
144281287|NCT04827446|520230666|FG000|Overall Study|Lost to Follow-up|1|||
144281288|NCT04827446|520230667|FG001|Overall Study|Lost to Follow-up|1|||
144281289|NCT04827446|520230666|FG000|Overall Study|Death|2|||
144281290|NCT04827446|520230667|FG001|Overall Study|Death|0|||
144281291|NCT04827446|520230666|FG000|Overall Study|Withdrawal by Subject|2|||
144281292|NCT04827446|520230667|FG001|Overall Study|Withdrawal by Subject|2|||
144281293|NCT01112267|520230668|FG000|Overall Study|Adverse Event|24|||
144281294|NCT01112267|520230669|FG001|Overall Study|Adverse Event|6|||
144281295|NCT01112267|520230668|FG000|Overall Study|Withdrawal by Subject|3|||
144281296|NCT01112267|520230669|FG001|Overall Study|Withdrawal by Subject|5|||
144281297|NCT01112267|520230668|FG000|Overall Study|Protocol Violation|5|||
144281298|NCT01112267|520230669|FG001|Overall Study|Protocol Violation|3|||
144281299|NCT01112267|520230668|FG000|Overall Study|Participants not compliant|1|||
144281300|NCT01112267|520230669|FG001|Overall Study|Participants not compliant|2|||
144281301|NCT01112267|520230668|FG000|Overall Study|Participants not receive any study drug|1|||
144281302|NCT01112267|520230669|FG001|Overall Study|Participants not receive any study drug|2|||
144281303|NCT00003456|520230670|FG000|Overall Study|Not evaluable|8|||
144281304|NCT00420407|520230672|FG000|Overall Study|Lost to Follow-up|0|||
144281305|NCT00420407|520230673|FG001|Overall Study|Lost to Follow-up|3|||
144281306|NCT00420407|520230672|FG000|Overall Study|Physician Decision|2|||
144281307|NCT00420407|520230673|FG001|Overall Study|Physician Decision|1|||
144281308|NCT00420407|520230672|FG000|Overall Study|subject identified as detainee|1|||
144281309|NCT00420407|520230673|FG001|Overall Study|subject identified as detainee|0|||
144281310|NCT00420407|520230672|FG000|Overall Study|subject identified as Jehovah's witness|1|||
144281311|NCT00420407|520230673|FG001|Overall Study|subject identified as Jehovah's witness|0|||
144281312|NCT00420407|520230672|FG000|Overall Study|Withdrawal by Subject|0|||
144281313|NCT00420407|520230673|FG001|Overall Study|Withdrawal by Subject|2|||
144281314|NCT00587457|520230678|FG000|Overall Study|Adverse Event|1|||
144281315|NCT00587457|520230679|FG001|Overall Study|Adverse Event|2|||
144281316|NCT00587457|520230680|FG002|Overall Study|Adverse Event|1|||
144281317|NCT00587457|520230678|FG000|Overall Study|Disease progression|2|||
144281318|NCT00587457|520230679|FG001|Overall Study|Disease progression|0|||
144281319|NCT00587457|520230680|FG002|Overall Study|Disease progression|2|||
144281320|NCT00587457|520230678|FG000|Overall Study|Initiation of alternative therapy|0|||
144281321|NCT00587457|520230679|FG001|Overall Study|Initiation of alternative therapy|1|||
144281322|NCT00587457|520230680|FG002|Overall Study|Initiation of alternative therapy|0|||
144281323|NCT00587457|520230678|FG000|Overall Study|Undefined|0|||
144281324|NCT00587457|520230679|FG001|Overall Study|Undefined|0|||
144281325|NCT00587457|520230680|FG002|Overall Study|Undefined|1|||
144281326|NCT00587457|520230678|FG000|Overall Study|Development of neutralizing Abs|0|||
144281327|NCT00587457|520230679|FG001|Overall Study|Development of neutralizing Abs|0|||
144281328|NCT00587457|520230680|FG002|Overall Study|Development of neutralizing Abs|1|||
144281329|NCT00541229|520230681|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
144281330|NCT00541229|520230682|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
144281331|NCT00541229|520230683|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
144281332|NCT00541229|520230684|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
144281333|NCT00541229|520230685|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
144281334|NCT00541229|520230686|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
144281335|NCT00541229|520230681|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
144281336|NCT00541229|520230682|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
144281337|NCT00541229|520230683|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
144281338|NCT00541229|520230684|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
144281339|NCT00541229|520230685|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
144281340|NCT00541229|520230686|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
144281341|NCT00541229|520230681|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
144281342|NCT00541229|520230682|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
144281343|NCT00541229|520230683|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
144281344|NCT00541229|520230684|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
144281345|NCT00541229|520230685|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
144281346|NCT00541229|520230686|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
144281347|NCT00541229|520230681|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
144281348|NCT00541229|520230682|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
144281349|NCT00541229|520230683|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
144281350|NCT00541229|520230684|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
144281351|NCT00541229|520230685|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
144281352|NCT00541229|520230686|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
144281353|NCT00541229|520230681|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
144281354|NCT00541229|520230682|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
144281355|NCT00541229|520230683|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
144281356|NCT00541229|520230684|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
144281357|NCT00541229|520230685|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
144281358|NCT00541229|520230686|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
144281359|NCT00541229|520230681|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
144281360|NCT00541229|520230682|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
144281361|NCT00541229|520230683|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
144281362|NCT00541229|520230684|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
144281363|NCT00541229|520230685|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
144281364|NCT00541229|520230686|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
144281365|NCT00541229|520230681|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
144281366|NCT00541229|520230682|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
144281367|NCT00541229|520230683|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
144281368|NCT00541229|520230684|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
144281369|NCT00541229|520230685|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
144281370|NCT00541229|520230686|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
144281371|NCT00541229|520230681|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
144281372|NCT00541229|520230682|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
144281373|NCT00541229|520230683|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
144281374|NCT00541229|520230684|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
144281375|NCT00541229|520230685|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
144281376|NCT00541229|520230686|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
144281377|NCT00541229|520230681|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
144281378|NCT00541229|520230682|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
144281379|NCT00541229|520230683|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
144281380|NCT00541229|520230684|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
144281381|NCT00541229|520230685|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
144281382|NCT00541229|520230686|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
144281383|NCT00541229|520230681|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
144281384|NCT00541229|520230682|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
144281385|NCT00541229|520230683|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
144281386|NCT00541229|520230684|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
144281387|NCT00541229|520230685|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
144281388|NCT00541229|520230686|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
144281389|NCT00541229|520230681|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
144281390|NCT00541229|520230682|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
144281391|NCT00541229|520230683|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
144281392|NCT00541229|520230684|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
144281393|NCT00541229|520230685|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
144281394|NCT00541229|520230686|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
144281395|NCT00541229|520230681|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
144281396|NCT00541229|520230682|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
144281397|NCT00541229|520230683|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
144281398|NCT00541229|520230684|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
144281399|NCT00541229|520230685|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
144281400|NCT00541229|520230686|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
144281401|NCT00541229|520230681|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
144281402|NCT00541229|520230682|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
144281403|NCT00541229|520230683|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
144244995|NCT00558896|520094606|FG004|Overall Study|Adverse Event|4|||
144244996|NCT00558896|520094607|FG005|Overall Study|Adverse Event|10|||
144244997|NCT00558896|520094608|FG006|Overall Study|Adverse Event|3|||
144244998|NCT00558896|520094602|FG000|Overall Study|Death|3|||
144244999|NCT00558896|520094603|FG001|Overall Study|Death|0|||
144245000|NCT00558896|520094604|FG002|Overall Study|Death|2|||
144245001|NCT00558896|520094605|FG003|Overall Study|Death|3|||
144245002|NCT00558896|520094606|FG004|Overall Study|Death|2|||
144245003|NCT00558896|520094607|FG005|Overall Study|Death|2|||
144245004|NCT00558896|520094608|FG006|Overall Study|Death|6|||
144245005|NCT00558896|520094602|FG000|Overall Study|Withdrawal by Subject|2|||
144245006|NCT00558896|520094603|FG001|Overall Study|Withdrawal by Subject|1|||
144245007|NCT00558896|520094604|FG002|Overall Study|Withdrawal by Subject|1|||
144245008|NCT00558896|520094605|FG003|Overall Study|Withdrawal by Subject|1|||
144245009|NCT00558896|520094606|FG004|Overall Study|Withdrawal by Subject|1|||
144245010|NCT00558896|520094607|FG005|Overall Study|Withdrawal by Subject|5|||
144245011|NCT00558896|520094608|FG006|Overall Study|Withdrawal by Subject|5|||
144245012|NCT00558896|520094602|FG000|Overall Study|Alternative Treatment|2|||
144245013|NCT00558896|520094603|FG001|Overall Study|Alternative Treatment|2|||
144245014|NCT00558896|520094604|FG002|Overall Study|Alternative Treatment|0|||
144245015|NCT00558896|520094605|FG003|Overall Study|Alternative Treatment|2|||
144245016|NCT00558896|520094606|FG004|Overall Study|Alternative Treatment|6|||
144245017|NCT00558896|520094607|FG005|Overall Study|Alternative Treatment|7|||
144245018|NCT00558896|520094608|FG006|Overall Study|Alternative Treatment|1|||
144245019|NCT00558896|520094602|FG000|Overall Study|Physician discretion|3|||
144245020|NCT00558896|520094603|FG001|Overall Study|Physician discretion|2|||
144245021|NCT00558896|520094604|FG002|Overall Study|Physician discretion|1|||
144245022|NCT00558896|520094605|FG003|Overall Study|Physician discretion|2|||
144245023|NCT00558896|520094606|FG004|Overall Study|Physician discretion|1|||
144245024|NCT00558896|520094607|FG005|Overall Study|Physician discretion|3|||
144245025|NCT00558896|520094608|FG006|Overall Study|Physician discretion|3|||
144245026|NCT00558896|520094602|FG000|Overall Study|Continues on treatment|10|||
144245027|NCT00558896|520094603|FG001|Overall Study|Continues on treatment|1|||
144245028|NCT00558896|520094604|FG002|Overall Study|Continues on treatment|0|||
144245029|NCT00558896|520094605|FG003|Overall Study|Continues on treatment|1|||
144245030|NCT00558896|520094606|FG004|Overall Study|Continues on treatment|9|||
144245031|NCT00558896|520094607|FG005|Overall Study|Continues on treatment|25|||
144245032|NCT00558896|520094608|FG006|Overall Study|Continues on treatment|6|||
144245033|NCT00250458|520094612|FG000|Overall Study|Lost to Follow-up|4|||
144245034|NCT00250458|520094613|FG001|Overall Study|Lost to Follow-up|2|||
144245035|NCT00250458|520094612|FG000|Overall Study|Protocol Violation|0|||
144245036|NCT00250458|520094613|FG001|Overall Study|Protocol Violation|1|||
144245037|NCT00250458|520094612|FG000|Overall Study|Withdrawal by Subject|4|||
144245038|NCT00250458|520094613|FG001|Overall Study|Withdrawal by Subject|2|||
144245039|NCT00250458|520094612|FG000|Overall Study|Lack of Migraine Attack|20|||
144245040|NCT00250458|520094613|FG001|Overall Study|Lack of Migraine Attack|9|||
144245041|NCT00250458|520094612|FG000|Overall Study|Qualifying migraine but did not treat|3|||
144245042|NCT00250458|520094613|FG001|Overall Study|Qualifying migraine but did not treat|3|||
144245043|NCT00250458|520094612|FG000|Overall Study|Other|1|||
144245044|NCT00250458|520094613|FG001|Overall Study|Other|0|||
144245045|NCT03448939|520094616|FG000|Overall Study|Adverse Event|5|||
144245046|NCT03448939|520094617|FG001|Overall Study|Adverse Event|1|||
144245047|NCT03448939|520094616|FG000|Overall Study|Lost to Follow-up|6|||
144245048|NCT03448939|520094617|FG001|Overall Study|Lost to Follow-up|6|||
144245049|NCT03448939|520094616|FG000|Overall Study|Pregnancy|1|||
144245050|NCT03448939|520094617|FG001|Overall Study|Pregnancy|1|||
144245051|NCT03448939|520094616|FG000|Overall Study|Withdrawal by Subject|9|||
144245052|NCT03448939|520094617|FG001|Overall Study|Withdrawal by Subject|3|||
144245053|NCT04631107|520094620|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
144245054|NCT04631107|520094620|FG000|Second Intervention (1 Night)|Adverse Event|1|||
144245055|NCT04631107|520094620|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
144245056|NCT04631107|520094620|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
144245057|NCT00096993|520094627|FG000|Overall Study|Death|1|||
144245058|NCT00096993|520094628|FG001|Overall Study|Death|0|||
144245059|NCT00096993|520094627|FG000|Overall Study|Disease progression|56|||
144245060|NCT00096993|520094628|FG001|Overall Study|Disease progression|53|||
144245061|NCT00096993|520094627|FG000|Overall Study|Adverse Event|2|||
144245062|NCT00096993|520094628|FG001|Overall Study|Adverse Event|8|||
144245063|NCT00096993|520094627|FG000|Overall Study|Subject's decision|3|||
144245064|NCT00096993|520094628|FG001|Overall Study|Subject's decision|1|||
144245065|NCT00096993|520094627|FG000|Overall Study|Physician Decision|2|||
144245066|NCT00096993|520094628|FG001|Overall Study|Physician Decision|1|||
144245067|NCT00096993|520094627|FG000|Overall Study|Non-compliance|0|||
144245068|NCT00096993|520094628|FG001|Overall Study|Non-compliance|1|||
144245069|NCT00096993|520094627|FG000|Overall Study|Other unspecified|1|||
144245070|NCT00096993|520094628|FG001|Overall Study|Other unspecified|1|||
144245071|NCT01935128|520094629|FG000|Overall Study|Death|1|||
144245072|NCT01935128|520094629|FG000|Overall Study|Adverse Event|6|||
144245073|NCT00150800|520094633|FG000|Overall Study|Adverse Event|89|||
144245074|NCT00150800|520094633|FG000|Overall Study|Death|18|||
144245075|NCT00150800|520094633|FG000|Overall Study|Lack of Efficacy|166|||
144245076|NCT00150800|520094633|FG000|Overall Study|Lost to Follow-up|58|||
144245077|NCT00150800|520094633|FG000|Overall Study|Subject's choice|90|||
144245078|NCT00150800|520094633|FG000|Overall Study|No compliance|18|||
144245079|NCT00150800|520094633|FG000|Overall Study|IP misshandling|1|||
144245080|NCT00150800|520094633|FG000|Overall Study|Site closure|24|||
144245081|NCT00150800|520094633|FG000|Overall Study|Protocol non-adherence|2|||
144245082|NCT00150800|520094633|FG000|Overall Study|Nobody to accompany patient|1|||
144245083|NCT00150800|520094633|FG000|Overall Study|Distance too long for patient|1|||
144245084|NCT00150800|520094633|FG000|Overall Study|Neurosurgery|2|||
144245085|NCT00150800|520094633|FG000|Overall Study|BRV monotherapy|1|||
144245086|NCT00150800|520094633|FG000|Overall Study|Visit refusal|3|||
144245087|NCT00150800|520094633|FG000|Overall Study|Sponsor's request|2|||
144245088|NCT00150800|520094633|FG000|Overall Study|Generalized Epilepsy|1|||
144245089|NCT00150800|520094633|FG000|Overall Study|Moved from area/country|8|||
144245090|NCT00150800|520094633|FG000|Overall Study|PI retiring|2|||
144245091|NCT00150800|520094633|FG000|Overall Study|PI leaving site|2|||
144245092|NCT00150800|520094633|FG000|Overall Study|Patient insurance|1|||
144245093|NCT00150800|520094633|FG000|Overall Study|Surgical intervention|4|||
144245094|NCT00150800|520094633|FG000|Overall Study|Pregnancy planned|1|||
144245095|NCT00150800|520094633|FG000|Overall Study|PI discontinuation request|1|||
144245096|NCT01966068|520094635|FG000|Overall Study|Withdrawal by Subject|57|||
144245097|NCT01966068|520094635|FG000|Overall Study|Lost to Follow-up|81|||
144245098|NCT00710684|520094642|FG000|Overall Study|Adverse Event|11|||
144245099|NCT00710684|520094643|FG001|Overall Study|Adverse Event|19|||
144245100|NCT00710684|520094644|FG002|Overall Study|Adverse Event|16|||
144245101|NCT00710684|520094642|FG000|Overall Study|Lack of Efficacy|4|||
144245102|NCT00710684|520094643|FG001|Overall Study|Lack of Efficacy|3|||
144245103|NCT00710684|520094644|FG002|Overall Study|Lack of Efficacy|5|||
144245104|NCT00710684|520094642|FG000|Overall Study|Protocol Violation|5|||
144245105|NCT00710684|520094643|FG001|Overall Study|Protocol Violation|5|||
144245106|NCT00710684|520094644|FG002|Overall Study|Protocol Violation|5|||
144245107|NCT00710684|520094642|FG000|Overall Study|Lost to Follow-up|4|||
144245108|NCT00710684|520094643|FG001|Overall Study|Lost to Follow-up|6|||
144245109|NCT00710684|520094644|FG002|Overall Study|Lost to Follow-up|7|||
144245110|NCT00710684|520094642|FG000|Overall Study|Physician Decision|0|||
144245111|NCT00710684|520094643|FG001|Overall Study|Physician Decision|2|||
144245112|NCT00710684|520094644|FG002|Overall Study|Physician Decision|4|||
144245113|NCT00710684|520094642|FG000|Overall Study|Withdrawal by Subject|24|||
144245114|NCT00710684|520094643|FG001|Overall Study|Withdrawal by Subject|18|||
144245115|NCT00710684|520094644|FG002|Overall Study|Withdrawal by Subject|11|||
144245116|NCT00710684|520094642|FG000|Overall Study|Missing|1|||
144245117|NCT00710684|520094643|FG001|Overall Study|Missing|0|||
144245118|NCT00710684|520094644|FG002|Overall Study|Missing|0|||
144245119|NCT00710684|520094642|FG000|Overall Study|Did not continue after week 24|25|||
144245120|NCT00710684|520094643|FG001|Overall Study|Did not continue after week 24|21|||
144245121|NCT00710684|520094644|FG002|Overall Study|Did not continue after week 24|16|||
144281404|NCT00541229|520230684|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
144281405|NCT00541229|520230685|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
144281406|NCT00541229|520230686|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
144281407|NCT00541229|520230681|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
144281408|NCT00541229|520230682|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
144281409|NCT00541229|520230683|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
144281410|NCT00541229|520230684|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
144281411|NCT00541229|520230685|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
144281412|NCT00541229|520230686|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
144281413|NCT00541229|520230681|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
144281414|NCT00541229|520230682|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
144281415|NCT00541229|520230683|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
144281416|NCT00541229|520230684|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
144281417|NCT00541229|520230685|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
144281418|NCT00541229|520230686|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
144281419|NCT00541229|520230681|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
144281420|NCT00541229|520230682|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
144281421|NCT00541229|520230683|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
144281422|NCT00541229|520230684|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
144281423|NCT00541229|520230685|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
144281424|NCT00541229|520230686|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
144281425|NCT00924651|520230687|FG000|Overall Study|Chemo started too soon|2|||
144281426|NCT00924651|520230688|FG001|Overall Study|Chemo started too soon|3|||
144281427|NCT00924651|520230687|FG000|Overall Study|No Reason|3|||
144281428|NCT00924651|520230688|FG001|Overall Study|No Reason|7|||
144281429|NCT00924651|520230687|FG000|Overall Study|Overwhelmed|6|||
144281430|NCT00924651|520230688|FG001|Overall Study|Overwhelmed|6|||
144281431|NCT00924651|520230687|FG000|Overall Study|Noncompliant|1|||
144281432|NCT00924651|520230688|FG001|Overall Study|Noncompliant|4|||
144281433|NCT00924651|520230687|FG000|Overall Study|Medical|1|||
144281434|NCT00924651|520230688|FG001|Overall Study|Medical|3|||
144281435|NCT00924651|520230687|FG000|Overall Study|Changed Mind|10|||
144281436|NCT00924651|520230688|FG001|Overall Study|Changed Mind|1|||
144281437|NCT00924651|520230687|FG000|Overall Study|Incomplete Form|2|||
144281438|NCT00924651|520230688|FG001|Overall Study|Incomplete Form|1|||
144281439|NCT02582632|520230689|FG000|Overall Study|Other|1|||
144281440|NCT04307394|520230692|FG000|Overall Study|Lost to Follow-up|3|||
144281441|NCT04307394|520230692|FG000|Overall Study|Withdrawal by Subject|2|||
144281442|NCT02536794|520230693|FG000|Reached 1st Response Assessment|Adverse Event|2|||
144281443|NCT02536794|520230693|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
144281444|NCT02536794|520230693|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
144281445|NCT02536794|520230693|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
144281446|NCT02536794|520230693|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
144281447|NCT02536794|520230693|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
144281448|NCT00416949|520230694|FG000|Overall Study|Patients refused to participate|5|||
144281449|NCT03418675|520230696|FG000|Overall Study|Lost to Follow-up|13|||
144281450|NCT03418675|520230697|FG001|Overall Study|Lost to Follow-up|10|||
144281451|NCT03418675|520230696|FG000|Overall Study|Adverse Event|2|||
144281452|NCT03418675|520230697|FG001|Overall Study|Adverse Event|0|||
144281453|NCT00800540|520230698|FG000|Period One: 6 Weeks|Noncompliance|1|||
144281454|NCT00800540|520230699|FG001|Period One: 6 Weeks|Noncompliance|0|||
144281455|NCT00800540|520230698|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
144281456|NCT00800540|520230699|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
144281457|NCT00800540|520230698|FG000|Period 2: 6 Weeks|Adverse Event|0|||
144281458|NCT00800540|520230699|FG001|Period 2: 6 Weeks|Adverse Event|1|||
144281459|NCT01922011|520230702|FG000|Overall Study|Protocol Violation|0|||
144281460|NCT01922011|520230703|FG001|Overall Study|Protocol Violation|1|||
144281461|NCT01922011|520230702|FG000|Overall Study|Physician Decision|0|||
144281462|NCT01922011|520230703|FG001|Overall Study|Physician Decision|1|||
144281463|NCT01922011|520230702|FG000|Overall Study|Parent/Guardian Decision|3|||
144281464|NCT01922011|520230703|FG001|Overall Study|Parent/Guardian Decision|0|||
144281465|NCT01922011|520230702|FG000|Overall Study|Lost to Follow-up|0|||
144281466|NCT01922011|520230703|FG001|Overall Study|Lost to Follow-up|1|||
144281467|NCT01922011|520230702|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
144281468|NCT01922011|520230703|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
144281469|NCT01922011|520230702|FG000|Overall Study|Not Treated|1|||
144281470|NCT01922011|520230703|FG001|Overall Study|Not Treated|0|||
144281471|NCT01922011|520230702|FG000|Overall Study|Lack of willing home health agency|1|||
144281472|NCT01922011|520230703|FG001|Overall Study|Lack of willing home health agency|0|||
144281473|NCT01922011|520230702|FG000|Overall Study|Randomized in error|1|||
144281474|NCT01922011|520230703|FG001|Overall Study|Randomized in error|0|||
144281475|NCT04871113|520230704|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281476|NCT04871113|520230705|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281477|NCT04871113|520230706|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281478|NCT04871113|520230707|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281479|NCT04871113|520230708|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281480|NCT04871113|520230709|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
144281481|NCT04871113|520230710|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281482|NCT04871113|520230711|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281483|NCT04871113|520230712|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281484|NCT04871113|520230713|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
144281485|NCT04871113|520230704|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281486|NCT04871113|520230705|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281487|NCT04871113|520230706|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281488|NCT04871113|520230707|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281489|NCT04871113|520230708|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281490|NCT04871113|520230709|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281491|NCT04871113|520230710|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
144281492|NCT04871113|520230711|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
144281493|NCT04871113|520230712|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281494|NCT04871113|520230713|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
144281495|NCT00770484|520230716|FG000|Overall Study|Withdrawal by Subject|1|||
144281496|NCT00770484|520230717|FG001|Overall Study|Withdrawal by Subject|0|||
144281497|NCT00195429|520230718|FG000|Overall Study|Adverse Event|2|||
144281498|NCT00195429|520230719|FG001|Overall Study|Adverse Event|4|||
144281499|NCT00195429|520230718|FG000|Overall Study|Lack of Efficacy|2|||
144281500|NCT00195429|520230719|FG001|Overall Study|Lack of Efficacy|1|||
144281501|NCT00195429|520230718|FG000|Overall Study|Lost to Follow-up|1|||
144281502|NCT00195429|520230719|FG001|Overall Study|Lost to Follow-up|0|||
144281503|NCT02143778|520230720|FG000|Overall Study|Withdrawal by Subject|2|||
144281504|NCT02143778|520230720|FG000|Overall Study|Device malfunction|1|||
144281505|NCT00367458|520230721|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
144281506|NCT00367458|520230722|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
144281507|NCT03158688|520230726|FG000|Overall Study|Withdrawal by Subject|14|||
144281508|NCT03158688|520230727|FG001|Overall Study|Withdrawal by Subject|28|||
144281509|NCT03158688|520230726|FG000|Overall Study|Decision by sponsor|13|||
144281510|NCT03158688|520230727|FG001|Overall Study|Decision by sponsor|37|||
144281511|NCT03158688|520230726|FG000|Overall Study|Lost to Follow-up|4|||
144281512|NCT03158688|520230727|FG001|Overall Study|Lost to Follow-up|3|||
144281513|NCT03158688|520230726|FG000|Overall Study|Death|74|||
144281514|NCT03158688|520230727|FG001|Overall Study|Death|142|||
144281515|NCT00825175|520230729|FG000|Overall Study|Withdrawal by Subject|0|||
144281516|NCT00825175|520230730|FG001|Overall Study|Withdrawal by Subject|5|||
144281517|NCT00118287|520230731|FG000|Overall Study|Intracranial haemorrhage|1|||
144281518|NCT00118287|520230731|FG000|Overall Study|Muscle pain|1|||
144281519|NCT03091439|520230732|FG000|Overall Study|Study Terminated by the Sponsor|1|||
144281520|NCT03091439|520230733|FG001|Overall Study|Study Terminated by the Sponsor|0|||
144281521|NCT02347787|520230737|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
144281522|NCT02347787|520230738|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
144281523|NCT02347787|520230737|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
144281524|NCT02347787|520230738|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
144281525|NCT02347787|520230737|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
144281526|NCT02347787|520230738|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
144281527|NCT02347787|520230737|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
144281528|NCT02347787|520230738|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
144281529|NCT00544882|520230748|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
144281530|NCT00544882|520230749|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
144281531|NCT00544882|520230750|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
144281532|NCT00544882|520230748|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
144281533|NCT00544882|520230749|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
144281534|NCT00544882|520230750|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
144281535|NCT00544882|520230748|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
144281536|NCT00544882|520230749|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
144281537|NCT00544882|520230750|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
144281538|NCT00544882|520230748|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
144281539|NCT00544882|520230749|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
144281540|NCT00544882|520230750|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
144281541|NCT00544882|520230748|FG000|Cycle 3: Follow-up|Noncompliance|0|||
144281542|NCT00544882|520230749|FG001|Cycle 3: Follow-up|Noncompliance|1|||
144281543|NCT00544882|520230750|FG002|Cycle 3: Follow-up|Noncompliance|0|||
144281544|NCT00544882|520230748|FG000|Cycle 3: Follow-up|Pregnancy|0|||
144281545|NCT00544882|520230749|FG001|Cycle 3: Follow-up|Pregnancy|1|||
144281546|NCT00544882|520230750|FG002|Cycle 3: Follow-up|Pregnancy|0|||
144281547|NCT02583269|520230751|FG000|Overall Study|Patient hospitalized prior to start|1|||
144281548|NCT02583269|520230752|FG001|Overall Study|Patient hospitalized prior to start|0|||
144281549|NCT02583269|520230753|FG002|Overall Study|Patient hospitalized prior to start|0|||
144281550|NCT02583269|520230754|FG003|Overall Study|Patient hospitalized prior to start|0|||
144281551|NCT02583269|520230755|FG004|Overall Study|Patient hospitalized prior to start|0|||
144281552|NCT01039675|520230756|FG000|Overall Study|Adverse Event|0|||
144281553|NCT01039675|520230757|FG001|Overall Study|Adverse Event|2|||
144281554|NCT01039675|520230756|FG000|Overall Study|Lack of Efficacy|0|||
144281555|NCT01039675|520230757|FG001|Overall Study|Lack of Efficacy|2|||
144281556|NCT01039675|520230756|FG000|Overall Study|Withdrawal by Subject|0|||
144281557|NCT01039675|520230757|FG001|Overall Study|Withdrawal by Subject|1|||
144281558|NCT01039675|520230756|FG000|Overall Study|Lost to Follow-up|0|||
144281559|NCT01039675|520230757|FG001|Overall Study|Lost to Follow-up|1|||
144281560|NCT01039675|520230756|FG000|Overall Study|Physician Decision|0|||
144281561|NCT01039675|520230757|FG001|Overall Study|Physician Decision|1|||
144281562|NCT02207608|520230759|FG000|Overall Study|Adverse Event|1|||
144281563|NCT02207608|520230760|FG001|Overall Study|Adverse Event|0|||
144699993|NCT05182840|521754493|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699994|NCT05182840|521754494|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699995|NCT05182840|521754495|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699996|NCT05182840|521754496|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
144699997|NCT05182840|521754487|FG000|Treatment Period|Reason missing|0|||
144699998|NCT05182840|521754488|FG001|Treatment Period|Reason missing|0|||
144699999|NCT05182840|521754489|FG002|Treatment Period|Reason missing|1|||
144700000|NCT05182840|521754490|FG003|Treatment Period|Reason missing|0|||
144700001|NCT05182840|521754491|FG004|Treatment Period|Reason missing|0|||
144700002|NCT05182840|521754492|FG005|Treatment Period|Reason missing|0|||
144700003|NCT05182840|521754493|FG006|Treatment Period|Reason missing|0|||
144700004|NCT05182840|521754494|FG007|Treatment Period|Reason missing|0|||
144700005|NCT05182840|521754495|FG008|Treatment Period|Reason missing|0|||
144700006|NCT05182840|521754496|FG009|Treatment Period|Reason missing|0|||
144700007|NCT05182840|521754487|FG000|Treatment Period|Other but not sponsor termination|0|||
144700008|NCT05182840|521754488|FG001|Treatment Period|Other but not sponsor termination|0|||
144700009|NCT05182840|521754489|FG002|Treatment Period|Other but not sponsor termination|8|||
144700010|NCT05182840|521754490|FG003|Treatment Period|Other but not sponsor termination|6|||
144700011|NCT05182840|521754491|FG004|Treatment Period|Other but not sponsor termination|6|||
144700012|NCT05182840|521754492|FG005|Treatment Period|Other but not sponsor termination|7|||
144700013|NCT05182840|521754493|FG006|Treatment Period|Other but not sponsor termination|5|||
144700014|NCT05182840|521754494|FG007|Treatment Period|Other but not sponsor termination|8|||
144700015|NCT05182840|521754495|FG008|Treatment Period|Other but not sponsor termination|7|||
144700016|NCT05182840|521754496|FG009|Treatment Period|Other but not sponsor termination|2|||
144700017|NCT05182840|521754487|FG000|Treatment Period|Protocol deviation|0|||
144700018|NCT05182840|521754488|FG001|Treatment Period|Protocol deviation|0|||
144700019|NCT05182840|521754489|FG002|Treatment Period|Protocol deviation|0|||
144700020|NCT05182840|521754490|FG003|Treatment Period|Protocol deviation|0|||
144700021|NCT05182840|521754491|FG004|Treatment Period|Protocol deviation|0|||
144700022|NCT05182840|521754492|FG005|Treatment Period|Protocol deviation|0|||
144700023|NCT05182840|521754493|FG006|Treatment Period|Protocol deviation|0|||
144700024|NCT05182840|521754494|FG007|Treatment Period|Protocol deviation|0|||
144700025|NCT05182840|521754495|FG008|Treatment Period|Protocol deviation|1|||
144700026|NCT05182840|521754496|FG009|Treatment Period|Protocol deviation|0|||
144700027|NCT05182840|521754487|FG000|Treatment Period|No reason available|0|||
144700028|NCT05182840|521754488|FG001|Treatment Period|No reason available|0|||
144700029|NCT05182840|521754489|FG002|Treatment Period|No reason available|0|||
144700030|NCT05182840|521754490|FG003|Treatment Period|No reason available|1|||
144700031|NCT05182840|521754491|FG004|Treatment Period|No reason available|0|||
144700032|NCT05182840|521754492|FG005|Treatment Period|No reason available|2|||
144700033|NCT05182840|521754493|FG006|Treatment Period|No reason available|0|||
144700034|NCT05182840|521754494|FG007|Treatment Period|No reason available|1|||
144700035|NCT05182840|521754495|FG008|Treatment Period|No reason available|0|||
144700036|NCT05182840|521754496|FG009|Treatment Period|No reason available|0|||
144700037|NCT05182840|521754487|FG000|Treatment Period|Burden of study procedures|0|||
144700038|NCT05182840|521754488|FG001|Treatment Period|Burden of study procedures|0|||
144700039|NCT05182840|521754489|FG002|Treatment Period|Burden of study procedures|0|||
144700040|NCT05182840|521754490|FG003|Treatment Period|Burden of study procedures|0|||
144700041|NCT05182840|521754491|FG004|Treatment Period|Burden of study procedures|1|||
144700042|NCT05182840|521754492|FG005|Treatment Period|Burden of study procedures|0|||
144700043|NCT05182840|521754493|FG006|Treatment Period|Burden of study procedures|0|||
144281584|NCT03298061|520231722|FG000|Overall Study|Adverse Event|3|||
144281585|NCT03298061|520231722|FG000|Overall Study|Lack of Efficacy|6|||
144281586|NCT03298061|520231722|FG000|Overall Study|Protocol Violation|1|||
144281587|NCT03298061|520231722|FG000|Overall Study|Physician Decision|7|||
144281588|NCT03298061|520231722|FG000|Overall Study|Withdrawal by Subject|10|||
144281589|NCT00992836|520231724|FG000|Overall Study|Lost to Follow-up|1|||
144281590|NCT00992836|520231724|FG000|Overall Study|Withdrawal by Subject|2|||
144281591|NCT00992836|520231724|FG000|Overall Study|Protocol Violation|2|||
144281592|NCT01617967|520231728|FG000|Overall Study|Protocol Violation|0|||
144281593|NCT01617967|520231729|FG001|Overall Study|Protocol Violation|0|||
144281594|NCT01617967|520231730|FG002|Overall Study|Protocol Violation|0|||
144281595|NCT01617967|520231731|FG003|Overall Study|Protocol Violation|1|||
144281596|NCT01617967|520231732|FG004|Overall Study|Protocol Violation|0|||
144281597|NCT01617967|520231733|FG005|Overall Study|Protocol Violation|0|||
144281598|NCT01617967|520231728|FG000|Overall Study|Withdrawal by Subject|0|||
144281599|NCT01617967|520231729|FG001|Overall Study|Withdrawal by Subject|0|||
144281600|NCT01617967|520231730|FG002|Overall Study|Withdrawal by Subject|0|||
144281601|NCT01617967|520231731|FG003|Overall Study|Withdrawal by Subject|0|||
144281602|NCT01617967|520231732|FG004|Overall Study|Withdrawal by Subject|0|||
144281603|NCT01617967|520231733|FG005|Overall Study|Withdrawal by Subject|1|||
144281604|NCT01617967|520231728|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
144281605|NCT01617967|520231729|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
144281606|NCT01617967|520231730|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
144281607|NCT01617967|520231731|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
144281608|NCT01617967|520231732|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
144281609|NCT01617967|520231733|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
144281610|NCT02506036|520231735|FG000|First Intervention (4-6 Weeks)|Death|1|||
144281611|NCT02506036|520231736|FG001|First Intervention (4-6 Weeks)|Death|0|||
144281612|NCT02506036|520231735|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
144281613|NCT02506036|520231736|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
144281614|NCT02506036|520231735|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
144281615|NCT02506036|520231736|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
144281616|NCT05276804|520231739|FG000|Overall Study|screen failure|23|||
144281617|NCT05276804|520231740|FG001|Overall Study|screen failure|0|||
144281618|NCT01410604|520231741|FG000|Overall Study|Adverse Event|2|||
144281619|NCT01410604|520231742|FG001|Overall Study|Adverse Event|1|||
144281620|NCT01410604|520231741|FG000|Overall Study|Lost to Follow-up|1|||
144281621|NCT01410604|520231742|FG001|Overall Study|Lost to Follow-up|0|||
144281622|NCT01410604|520231741|FG000|Overall Study|Physician Decision|0|||
144281623|NCT01410604|520231742|FG001|Overall Study|Physician Decision|1|||
144281624|NCT02827708|520231743|FG000|Overall Study|Lost to Follow-up|3|||
144281625|NCT02827708|520231744|FG001|Overall Study|Lost to Follow-up|1|||
144281626|NCT02827708|520231743|FG000|Overall Study|Withdrawal by Subject|1|||
144281627|NCT02827708|520231744|FG001|Overall Study|Withdrawal by Subject|2|||
144281628|NCT02827708|520231743|FG000|Overall Study|Death|1|||
144281629|NCT02827708|520231744|FG001|Overall Study|Death|2|||
144281630|NCT00898807|520231745|FG000|Overall Study|Withdrawal by Subject|5|||
144281631|NCT00898807|520231746|FG001|Overall Study|Withdrawal by Subject|3|||
144281632|NCT00898807|520231745|FG000|Overall Study|Family pressure to discontinue|2|||
144281633|NCT00898807|520231746|FG001|Overall Study|Family pressure to discontinue|2|||
144281634|NCT00898807|520231745|FG000|Overall Study|Lost to Follow-up|1|||
144281635|NCT00898807|520231746|FG001|Overall Study|Lost to Follow-up|3|||
144281636|NCT00898807|520231745|FG000|Overall Study|Death|0|||
144281637|NCT00898807|520231746|FG001|Overall Study|Death|1|||
144281638|NCT01521364|520231749|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
144281639|NCT01521364|520231749|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
144281640|NCT02636283|520231750|FG000|Overall Study|Adverse Event|2|||
144281641|NCT02636283|520231751|FG001|Overall Study|Adverse Event|0|||
144281642|NCT02636283|520231750|FG000|Overall Study|Trial Terminated Prematurely|0|||
144281643|NCT02636283|520231751|FG001|Overall Study|Trial Terminated Prematurely|3|||
144281644|NCT01178411|520231752|FG000|Overall Study|Adverse Event|5|||
144281645|NCT01178411|520231752|FG000|Overall Study|Withdrawal by Subject|4|||
144281646|NCT01178411|520231752|FG000|Overall Study|Protocol Violation|1|||
144281647|NCT01178411|520231752|FG000|Overall Study|Progressive disease per RECIST|32|||
144281648|NCT01178411|520231752|FG000|Overall Study|Progressive disease per clinician|9|||
144281649|NCT01178411|520231752|FG000|Overall Study|Physician Decision|6|||
144281650|NCT01178411|520231752|FG000|Overall Study|Death|1|||
144281651|NCT01178411|520231752|FG000|Overall Study|No reason provided|1|||
144281652|NCT01178411|520231752|FG000|Overall Study|Drug manufacturing ended|1|||
144281653|NCT02383173|520231756|FG000|Overall Study|Palliative Care Team withdrew|0|||
144281654|NCT02383173|520231757|FG001|Overall Study|Palliative Care Team withdrew|2|||
144281655|NCT04900272|520231758|FG000|Overall Study|Lost to Follow-up|2|||
144281656|NCT04900272|520231758|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
144281657|NCT04900272|520231758|FG000|Overall Study|Withdrawal by Subject|1|||
144281658|NCT01625182|520231759|FG000|Overall Study|Administrative problems|1|||
144281659|NCT01625182|520231760|FG001|Overall Study|Administrative problems|0|||
144281660|NCT01625182|520231759|FG000|Overall Study|Protocol deviation|0|||
144281661|NCT01625182|520231760|FG001|Overall Study|Protocol deviation|2|||
144281662|NCT01625182|520231759|FG000|Overall Study|Adverse Event|2|||
144281663|NCT01625182|520231760|FG001|Overall Study|Adverse Event|0|||
144281664|NCT01625182|520231759|FG000|Overall Study|Withdrawal by Subject|5|||
144281665|NCT01625182|520231760|FG001|Overall Study|Withdrawal by Subject|1|||
144281666|NCT01625182|520231759|FG000|Overall Study|Lack of Efficacy|12|||
144281667|NCT01625182|520231760|FG001|Overall Study|Lack of Efficacy|8|||
144281668|NCT00263562|520231761|FG000|Overall Study|Protocol Violation|3|||
144281669|NCT00263562|520231762|FG001|Overall Study|Protocol Violation|0|||
144281670|NCT05059080|520231763|FG000|Overall Study|Withdrawal by Subject|3|||
144281671|NCT05059080|520231763|FG000|Overall Study|Study Terminated by Sponsor|64|||
144281672|NCT03927157|520231765|FG000|Overall Study|Adverse Event|1|||
144281673|NCT03927157|520231766|FG001|Overall Study|Adverse Event|3|||
144281674|NCT03927157|520231765|FG000|Overall Study|Protocol Violation|1|||
144281675|NCT03927157|520231766|FG001|Overall Study|Protocol Violation|2|||
144281676|NCT03927157|520231765|FG000|Overall Study|Withdrawal by Subject|8|||
144281677|NCT03927157|520231766|FG001|Overall Study|Withdrawal by Subject|21|||
144281678|NCT03927157|520231765|FG000|Overall Study|Due to COVID-19 pandemic|5|||
144281679|NCT03927157|520231766|FG001|Overall Study|Due to COVID-19 pandemic|2|||
144281680|NCT03927157|520231765|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
144281681|NCT03927157|520231766|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
144281682|NCT03927157|520231765|FG000|Overall Study|Other than above|0|||
144281683|NCT03927157|520231766|FG001|Overall Study|Other than above|1|||
144281684|NCT00726557|520231767|FG000|Overall Study|Screening failure|4|||
144281685|NCT00726557|520231767|FG000|Overall Study|No end of treatment documentation|37|||
144281686|NCT00726557|520231767|FG000|Overall Study|No follow-up documentation available|55|||
144281687|NCT00726557|520231767|FG000|Overall Study|Treatment less than 3 months|17|||
144281688|NCT00726557|520231767|FG000|Overall Study|Inclusion criteria not met|15|||
144281689|NCT01257542|520231772|FG000|Overall Study|Protocol Violation|3|||
144281690|NCT01257542|520231773|FG001|Overall Study|Protocol Violation|5|||
144281691|NCT01257542|520231772|FG000|Overall Study|Withdrawal by Subject|0|||
144281692|NCT01257542|520231773|FG001|Overall Study|Withdrawal by Subject|2|||
144281693|NCT03637374|520231774|FG000|Overall Study|Death|2|||
144281694|NCT03637374|520231775|FG001|Overall Study|Death|0|||
144281695|NCT05561140|520231780|FG000|Randomized Treatment Period|Adverse Event|1|||
144281696|NCT05561140|520231781|FG001|Randomized Treatment Period|Adverse Event|0|||
144281697|NCT05561140|520231780|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
144281698|NCT05561140|520231781|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
144281699|NCT05561140|520231780|FG000|Open Label Treatment Period|Adverse Event|6|||
144281700|NCT05561140|520231781|FG001|Open Label Treatment Period|Adverse Event|4|||
144281701|NCT05561140|520231780|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
144281702|NCT05561140|520231781|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
144281703|NCT05561140|520231780|FG000|Open Label Treatment Period|Physician Decision|0|||
144281704|NCT05561140|520231781|FG001|Open Label Treatment Period|Physician Decision|1|||
144281705|NCT05561140|520231780|FG000|Open Label Treatment Period|Pregnancy|1|||
144281706|NCT05561140|520231781|FG001|Open Label Treatment Period|Pregnancy|0|||
144281707|NCT05561140|520231780|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
144281708|NCT05561140|520231781|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
144281709|NCT05561140|520231780|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
144281710|NCT05561140|520231781|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
144281711|NCT05561140|520231780|FG000|Open Label Treatment Period|Other|1|||
144281712|NCT05561140|520231781|FG001|Open Label Treatment Period|Other|0|||
144281713|NCT03301714|520231784|FG000|Overall Study|Lost to Follow-up|10|||
144281714|NCT03301714|520231785|FG001|Overall Study|Lost to Follow-up|4|||
144281715|NCT03301714|520231786|FG002|Overall Study|Lost to Follow-up|4|||
144281716|NCT03301714|520231784|FG000|Overall Study|Did not receive allocated intervention|0|||
144281717|NCT03301714|520231785|FG001|Overall Study|Did not receive allocated intervention|2|||
144281718|NCT03301714|520231786|FG002|Overall Study|Did not receive allocated intervention|3|||
144281719|NCT02112552|520231789|FG000|Overall Study|Withdrawal by Subject|1|||
144281720|NCT02112552|520231789|FG000|Overall Study|Adverse Event|1|||
144281721|NCT03349515|520231790|FG000|Overall Study|Lack of Efficacy|2|||
144281722|NCT03349515|520231791|FG001|Overall Study|Lack of Efficacy|0|||
144281723|NCT03349515|520231790|FG000|Overall Study|Physician Decision|3|||
144281724|NCT03349515|520231791|FG001|Overall Study|Physician Decision|1|||
144281725|NCT03412890|520231798|FG000|Overall Study|Adverse Event|5|||
144281726|NCT03412890|520231799|FG001|Overall Study|Adverse Event|5|||
144281727|NCT03412890|520231800|FG002|Overall Study|Adverse Event|9|||
144281728|NCT03412890|520231798|FG000|Overall Study|Protocol deviation|2|||
144281729|NCT03412890|520231799|FG001|Overall Study|Protocol deviation|1|||
144281730|NCT03412890|520231800|FG002|Overall Study|Protocol deviation|2|||
144281731|NCT03412890|520231798|FG000|Overall Study|Lost to Follow-up|7|||
144281732|NCT03412890|520231799|FG001|Overall Study|Lost to Follow-up|10|||
144281733|NCT03412890|520231800|FG002|Overall Study|Lost to Follow-up|10|||
144281734|NCT03412890|520231798|FG000|Overall Study|Withdrawal by Subject|9|||
144281735|NCT03412890|520231799|FG001|Overall Study|Withdrawal by Subject|12|||
144281736|NCT03412890|520231800|FG002|Overall Study|Withdrawal by Subject|11|||
144281737|NCT03412890|520231798|FG000|Overall Study|Lack of Efficacy|2|||
144281738|NCT03412890|520231799|FG001|Overall Study|Lack of Efficacy|7|||
144281739|NCT03412890|520231800|FG002|Overall Study|Lack of Efficacy|5|||
144281740|NCT03412890|520231798|FG000|Overall Study|Other|5|||
144281741|NCT03412890|520231799|FG001|Overall Study|Other|6|||
144281742|NCT03412890|520231800|FG002|Overall Study|Other|5|||
144281743|NCT03412890|520231798|FG000|Overall Study|Participants who did not receive any study drug|0|||
144281744|NCT03412890|520231799|FG001|Overall Study|Participants who did not receive any study drug|1|||
144281745|NCT03412890|520231800|FG002|Overall Study|Participants who did not receive any study drug|0|||
144281746|NCT02503865|520231801|FG000|Overall Study|Moved out of area|1|||
144281747|NCT02503865|520231802|FG001|Overall Study|Moved out of area|8|||
144281748|NCT02503865|520231803|FG002|Overall Study|Moved out of area|0|||
144281749|NCT02503865|520231801|FG000|Overall Study|Refused treatment|4|||
144281750|NCT02503865|520231802|FG001|Overall Study|Refused treatment|39|||
144281751|NCT02503865|520231803|FG002|Overall Study|Refused treatment|2|||
144281752|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
144281753|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
144281754|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
144281755|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Death|1|||
144281756|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Death|0|||
144281757|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Death|0|||
144281758|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
144281759|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
144281760|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
144281761|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
144281762|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
144281763|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
144281764|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
144281765|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
144281766|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
144281767|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
144281768|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
144281769|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
144281770|NCT05073315|520231804|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
144281771|NCT05073315|520231805|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
144281772|NCT05073315|520231806|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
144281773|NCT05073315|520231804|FG000|Period 2|Adverse Event|0|||
144281774|NCT05073315|520231805|FG001|Period 2|Adverse Event|3|||
144281775|NCT05073315|520231806|FG002|Period 2|Adverse Event|6|||
144281776|NCT05073315|520231804|FG000|Period 2|Lost to Follow-up|0|||
144281777|NCT05073315|520231805|FG001|Period 2|Lost to Follow-up|5|||
144281778|NCT05073315|520231806|FG002|Period 2|Lost to Follow-up|5|||
144281779|NCT05073315|520231804|FG000|Period 2|Withdrawal by Subject|0|||
144281780|NCT05073315|520231805|FG001|Period 2|Withdrawal by Subject|4|||
144281781|NCT05073315|520231806|FG002|Period 2|Withdrawal by Subject|9|||
144281782|NCT05073315|520231804|FG000|Period 2|Protocol Violation|0|||
144281783|NCT05073315|520231805|FG001|Period 2|Protocol Violation|0|||
144281784|NCT05073315|520231806|FG002|Period 2|Protocol Violation|1|||
144281785|NCT01529268|520231807|FG000|Overall Study|Lost to Follow-up|9|||
144281786|NCT01529268|520231808|FG001|Overall Study|Lost to Follow-up|3|||
144281787|NCT01529268|520231807|FG000|Overall Study|Moved|3|||
144281788|NCT01529268|520231808|FG001|Overall Study|Moved|0|||
144281789|NCT00303953|520231809|FG000|Overall Study|Ineligible|1|||
144281790|NCT00303953|520231809|FG000|Overall Study|Death|1|||
144281791|NCT00303953|520231809|FG000|Overall Study|Adverse Event|4|||
144281792|NCT00303953|520231809|FG000|Overall Study|Lack of Efficacy|12|||
144281793|NCT00303953|520231809|FG000|Overall Study|Physician Decision|1|||
144281794|NCT00021255|520231810|FG000|Overall Study|Death|1|||
144281795|NCT00021255|520231811|FG001|Overall Study|Death|0|||
144281796|NCT00021255|520231812|FG002|Overall Study|Death|2|||
144281797|NCT00021255|520231810|FG000|Overall Study|Breast cancer relapse|5|||
144281798|NCT00021255|520231811|FG001|Overall Study|Breast cancer relapse|18|||
144281799|NCT00021255|520231812|FG002|Overall Study|Breast cancer relapse|11|||
144281800|NCT00021255|520231810|FG000|Overall Study|Second primary malignancy|0|||
144281801|NCT00021255|520231811|FG001|Overall Study|Second primary malignancy|4|||
144281802|NCT00021255|520231812|FG002|Overall Study|Second primary malignancy|1|||
144281803|NCT00021255|520231810|FG000|Overall Study|Withdrawal by Subject|41|||
144281804|NCT00021255|520231811|FG001|Overall Study|Withdrawal by Subject|64|||
144281805|NCT00021255|520231812|FG002|Overall Study|Withdrawal by Subject|26|||
144281806|NCT00021255|520231810|FG000|Overall Study|Lost to Follow-up|0|||
144281807|NCT00021255|520231811|FG001|Overall Study|Lost to Follow-up|2|||
144281808|NCT00021255|520231812|FG002|Overall Study|Lost to Follow-up|3|||
144281809|NCT00021255|520231810|FG000|Overall Study|Cardiac toxicity|0|||
144281810|NCT00021255|520231811|FG001|Overall Study|Cardiac toxicity|61|||
144281811|NCT00021255|520231812|FG002|Overall Study|Cardiac toxicity|32|||
144281812|NCT00021255|520231810|FG000|Overall Study|Herceptin toxicity|0|||
144281813|NCT00021255|520231811|FG001|Overall Study|Herceptin toxicity|22|||
144281814|NCT00021255|520231812|FG002|Overall Study|Herceptin toxicity|6|||
144281815|NCT00021255|520231810|FG000|Overall Study|Adverse Event|46|||
144281816|NCT00021255|520231811|FG001|Overall Study|Adverse Event|30|||
144281817|NCT00021255|520231812|FG002|Overall Study|Adverse Event|18|||
144281818|NCT00021255|520231810|FG000|Overall Study|Protocol Violation|0|||
144281819|NCT00021255|520231811|FG001|Overall Study|Protocol Violation|2|||
144281820|NCT00021255|520231812|FG002|Overall Study|Protocol Violation|0|||
144281821|NCT00021255|520231810|FG000|Overall Study|Other than specified above|0|||
144281822|NCT00021255|520231811|FG001|Overall Study|Other than specified above|38|||
144281823|NCT00021255|520231812|FG002|Overall Study|Other than specified above|19|||
144281824|NCT00021255|520231810|FG000|Overall Study|Missing|0|||
144281825|NCT00021255|520231811|FG001|Overall Study|Missing|27|||
144281826|NCT00021255|520231812|FG002|Overall Study|Missing|13|||
144281827|NCT00021255|520231810|FG000|Overall Study|Randomized but not treated|28|||
144281828|NCT00021255|520231811|FG001|Overall Study|Randomized but not treated|2|||
144281829|NCT00021255|520231812|FG002|Overall Study|Randomized but not treated|18|||
144281830|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
144281831|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
144281832|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
144281833|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
144281834|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
144281835|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
144281836|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
144281837|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
144281838|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
144281839|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
144281840|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
144281841|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
144281842|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
144281843|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
144281844|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
144281845|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
144281846|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
144281847|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
144281848|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
144281849|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
144281850|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
144281851|NCT02337946|520231813|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
144281852|NCT02337946|520231814|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
144281853|NCT02337946|520231815|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
144281854|NCT02337946|520231813|FG000|In-between Period|Without Informed Consent|1|||
144281855|NCT02337946|520231814|FG001|In-between Period|Without Informed Consent|0|||
144281856|NCT02337946|520231815|FG002|In-between Period|Without Informed Consent|0|||
144281857|NCT02337946|520231813|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
144281858|NCT02337946|520231814|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
144281859|NCT02337946|520231815|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
144281860|NCT02337946|520231813|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
144281861|NCT02337946|520231814|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
144281862|NCT02337946|520231815|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
144281863|NCT02337946|520231813|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
144281864|NCT02337946|520231814|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
144281865|NCT02337946|520231815|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
144281866|NCT02337946|520231813|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
144281867|NCT02337946|520231814|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
144281868|NCT02337946|520231815|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
144281869|NCT02337946|520231813|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
144281870|NCT02337946|520231814|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
144281871|NCT02337946|520231815|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
144245122|NCT00084318|520094646|FG000|Overall Study|Withdrawal by Subject|5|||
144245123|NCT00084318|520094647|FG001|Overall Study|Withdrawal by Subject|2|||
144245124|NCT00084318|520094646|FG000|Overall Study|Protocol Violation|15|||
144245125|NCT00084318|520094647|FG001|Overall Study|Protocol Violation|11|||
144245126|NCT00084318|520094646|FG000|Overall Study|No protocol treatment|2|||
144245127|NCT00084318|520094647|FG001|Overall Study|No protocol treatment|0|||
144245128|NCT00138073|520094649|FG000|Overall Study|lack of resources|55|||
144245129|NCT02345889|520094653|FG000|Overall Study|Inadequate Bowel Prep|17|||
144245130|NCT02345889|520094654|FG001|Overall Study|Inadequate Bowel Prep|16|||
144245131|NCT02345889|520094655|FG002|Overall Study|Inadequate Bowel Prep|18|||
144245132|NCT02345889|520094656|FG003|Overall Study|Inadequate Bowel Prep|14|||
144245133|NCT02345889|520094653|FG000|Overall Study|Polyposis identified during procedure|1|||
144245134|NCT02345889|520094654|FG001|Overall Study|Polyposis identified during procedure|1|||
144245135|NCT02345889|520094655|FG002|Overall Study|Polyposis identified during procedure|0|||
144245136|NCT02345889|520094656|FG003|Overall Study|Polyposis identified during procedure|1|||
144245137|NCT02345889|520094653|FG000|Overall Study|Recognized ineligible post-randomization|1|||
144245138|NCT02345889|520094654|FG001|Overall Study|Recognized ineligible post-randomization|0|||
144245139|NCT02345889|520094655|FG002|Overall Study|Recognized ineligible post-randomization|2|||
144245140|NCT02345889|520094656|FG003|Overall Study|Recognized ineligible post-randomization|1|||
144245141|NCT02345889|520094653|FG000|Overall Study|Ulcerative Colitis identified|1|||
144245142|NCT02345889|520094654|FG001|Overall Study|Ulcerative Colitis identified|0|||
144245143|NCT02345889|520094655|FG002|Overall Study|Ulcerative Colitis identified|0|||
144245144|NCT02345889|520094656|FG003|Overall Study|Ulcerative Colitis identified|0|||
144245145|NCT02345889|520094653|FG000|Overall Study|Cecum not intubated|1|||
144245146|NCT02345889|520094654|FG001|Overall Study|Cecum not intubated|0|||
144245147|NCT02345889|520094655|FG002|Overall Study|Cecum not intubated|0|||
144245148|NCT02345889|520094656|FG003|Overall Study|Cecum not intubated|0|||
144245149|NCT00962091|520094657|FG000|Overall Study|Withdrawal by Subject|1|||
144281872|NCT02337946|520231813|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
144281873|NCT02337946|520231814|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
144281874|NCT02337946|520231815|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
144281875|NCT05324371|520231817|FG000|Overall Study|Withdrawal by Subject|1|||
144281876|NCT05324371|520231817|FG000|Overall Study|Death|1|||
144281877|NCT01131585|520231818|FG000|Overall Study|Adverse Event|0|||
144281878|NCT01131585|520231819|FG001|Overall Study|Adverse Event|2|||
144281879|NCT01131585|520231818|FG000|Overall Study|Abnormal laboratory value|1|||
144281880|NCT01131585|520231819|FG001|Overall Study|Abnormal laboratory value|0|||
144281881|NCT01131585|520231818|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144281882|NCT01131585|520231819|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144281883|NCT01131585|520231818|FG000|Overall Study|Protocol Violation|2|||
144281884|NCT01131585|520231819|FG001|Overall Study|Protocol Violation|1|||
144281885|NCT01131585|520231818|FG000|Overall Study|Withdrawal by Subject|3|||
144281886|NCT01131585|520231819|FG001|Overall Study|Withdrawal by Subject|3|||
144281887|NCT01131585|520231818|FG000|Overall Study|Lost to Follow-up|0|||
144281888|NCT01131585|520231819|FG001|Overall Study|Lost to Follow-up|1|||
144281889|NCT01131585|520231818|FG000|Overall Study|Administrative problems|1|||
144281890|NCT01131585|520231819|FG001|Overall Study|Administrative problems|1|||
144281891|NCT01131585|520231818|FG000|Overall Study|Study termination|78|||
144281892|NCT01131585|520231819|FG001|Overall Study|Study termination|32|||
144281893|NCT01068912|520231824|FG000|Overall Study|Adverse Event|2|||
144281894|NCT01068912|520231825|FG001|Overall Study|Adverse Event|3|||
144281895|NCT01068912|520231826|FG002|Overall Study|Adverse Event|2|||
144281896|NCT01068912|520231824|FG000|Overall Study|Withdrawal by Subject|5|||
144281897|NCT01068912|520231825|FG001|Overall Study|Withdrawal by Subject|6|||
144281898|NCT01068912|520231826|FG002|Overall Study|Withdrawal by Subject|6|||
144281899|NCT01068912|520231824|FG000|Overall Study|Lost to Follow-up|3|||
144281900|NCT01068912|520231825|FG001|Overall Study|Lost to Follow-up|7|||
144281901|NCT01068912|520231826|FG002|Overall Study|Lost to Follow-up|3|||
144281902|NCT01068912|520231824|FG000|Overall Study|Protocol Violation|0|||
144281903|NCT01068912|520231825|FG001|Overall Study|Protocol Violation|2|||
144281904|NCT01068912|520231826|FG002|Overall Study|Protocol Violation|0|||
144281905|NCT01068912|520231824|FG000|Overall Study|aggravation influenza|1|||
144281906|NCT01068912|520231825|FG001|Overall Study|aggravation influenza|1|||
144281907|NCT01068912|520231826|FG002|Overall Study|aggravation influenza|1|||
144281908|NCT01068912|520231824|FG000|Overall Study|other underlying illness|0|||
144281909|NCT01068912|520231825|FG001|Overall Study|other underlying illness|3|||
144281910|NCT01068912|520231826|FG002|Overall Study|other underlying illness|3|||
144281911|NCT03442569|520231830|FG000|Overall Study|Subject was ineligible after enrollment|1|||
144281912|NCT00308685|520231832|FG000|Overall Study|Lost to Follow-up|1|||
144281913|NCT00308685|520231833|FG001|Overall Study|Lost to Follow-up|0|||
144281914|NCT00308685|520231832|FG000|Overall Study|Need to administer prohibited medication|1|||
144281915|NCT00308685|520231833|FG001|Overall Study|Need to administer prohibited medication|2|||
144281916|NCT00308685|520231832|FG000|Overall Study|Other than specified|1|||
144281917|NCT00308685|520231833|FG001|Overall Study|Other than specified|3|||
144281918|NCT03770455|520231834|FG000|Overall Study|Screen failures|3|||
144281919|NCT03921541|520233090|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
144281920|NCT03921541|520233091|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
144281921|NCT04706403|520233094|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
144281922|NCT04706403|520233095|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
144281923|NCT04706403|520233096|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
144281924|NCT04706403|520233097|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
144281925|NCT04706403|520233098|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
144281926|NCT00182637|520233099|FG000|Overall Study|Adverse Event|2|||
144281927|NCT00182637|520233099|FG000|Overall Study|Disease Progression|1|||
144281928|NCT02642679|520233100|FG000|Overall Study|Withdrawal by Subject|1|||
144281929|NCT02642679|520233100|FG000|Overall Study|Physician Decision|1|||
144281930|NCT02642679|520233100|FG000|Overall Study|Physician Decision|1|||
144281931|NCT04941898|520233101|FG000|Overall Study|Protocol Violation|1|||
144281932|NCT01653262|520233102|FG000|Overall Study|Lack of Efficacy|1|||
144281933|NCT01653262|520233102|FG000|Overall Study|SAE, non-fatal|1|||
144281934|NCT01653262|520233102|FG000|Overall Study|AE, non-serious non-fatal|1|||
144281935|NCT04633447|520233106|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
144281936|NCT04633447|520233107|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
144281937|NCT04633447|520233106|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
144281938|NCT04633447|520233107|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
144281939|NCT04633447|520233106|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
144281940|NCT04633447|520233107|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
144281941|NCT04633447|520233106|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
144281942|NCT04633447|520233107|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
144281943|NCT04633447|520233106|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
144281944|NCT04633447|520233107|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
144281945|NCT04633447|520233106|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
144281946|NCT04633447|520233107|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
144281947|NCT05417113|520233111|FG000|Overall Study|Lost to Follow-up|2|||
144281948|NCT05417113|520233112|FG001|Overall Study|Lost to Follow-up|2|||
144281949|NCT01022580|520233113|FG000|Overall Study|Death|18|||
144281950|NCT01022580|520233114|FG001|Overall Study|Death|22|||
144281951|NCT00134719|520233115|FG000|Primary Vaccination Phase|Adverse Event|4|||
144281952|NCT00134719|520233116|FG001|Primary Vaccination Phase|Adverse Event|0|||
144281953|NCT00134719|520233117|FG002|Primary Vaccination Phase|Adverse Event|0|||
144281954|NCT00134719|520233115|FG000|Primary Vaccination Phase|Protocol Violation|1|||
144281955|NCT00134719|520233116|FG001|Primary Vaccination Phase|Protocol Violation|0|||
144281956|NCT00134719|520233117|FG002|Primary Vaccination Phase|Protocol Violation|0|||
144281957|NCT00134719|520233115|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
144281958|NCT00134719|520233116|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
144281959|NCT00134719|520233117|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
144281960|NCT00134719|520233115|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
144281961|NCT00134719|520233116|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
144281962|NCT00134719|520233117|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
144281963|NCT00134719|520233115|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
144281964|NCT00134719|520233116|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
144281965|NCT00134719|520233117|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
144281966|NCT00134719|520233115|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
144281967|NCT00134719|520233116|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
144281968|NCT00134719|520233117|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
144281969|NCT03439839|520233118|FG000|Overall Study|Death|3|||
144281970|NCT03439839|520233119|FG001|Overall Study|Death|0|||
144281971|NCT01807520|520233120|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
144281972|NCT01807520|520233121|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
144281973|NCT01807520|520233122|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
144281974|NCT01807520|520233123|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
144281975|NCT01807520|520233124|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
144281976|NCT01807520|520233125|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
144281977|NCT01807520|520233126|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
144281978|NCT01807520|520233120|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
144281979|NCT01807520|520233121|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
144281980|NCT01807520|520233122|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
144281981|NCT01807520|520233123|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
144281982|NCT01807520|520233124|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
144281983|NCT01807520|520233125|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
144281984|NCT01807520|520233126|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
144281985|NCT01807520|520233120|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
144281986|NCT01807520|520233121|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
144281987|NCT01807520|520233122|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
144281988|NCT01807520|520233123|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
144281989|NCT01807520|520233124|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
144281990|NCT01807520|520233125|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
144281991|NCT01807520|520233126|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
144281992|NCT01807520|520233120|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
144281993|NCT01807520|520233121|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
144281994|NCT01807520|520233122|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
144281995|NCT01807520|520233123|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
144281996|NCT01807520|520233124|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
144281997|NCT01807520|520233125|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
144281998|NCT01807520|520233126|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
144281999|NCT01807520|520233120|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
144282000|NCT01807520|520233121|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
144282001|NCT01807520|520233122|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
144282002|NCT01807520|520233123|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
144282003|NCT01807520|520233124|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
144282004|NCT01807520|520233125|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
144282005|NCT01807520|520233126|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
144282006|NCT01807520|520233120|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
144282007|NCT01807520|520233121|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
144282008|NCT01807520|520233122|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
144282009|NCT01807520|520233123|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
144282010|NCT01807520|520233124|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
144282011|NCT01807520|520233125|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
144282012|NCT01807520|520233126|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
144282013|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
144282014|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
144282015|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
144282016|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
144282017|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
144282018|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
144282019|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
144282020|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
144282021|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
144282022|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
144282023|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
144282024|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
144282025|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
144282026|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
144282027|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
144282028|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
144282029|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
144282030|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
144282031|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
144282032|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
144282033|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
144282034|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
144282035|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
144282036|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
144282037|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
144282038|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
144282039|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
144282040|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
144282041|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
144282042|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
144282043|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
144282044|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
144282045|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
144282046|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
144282047|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
144282048|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
144282049|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
144282050|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
144282051|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
144282052|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
144282053|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
144282054|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
144282055|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
144282056|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
144282057|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
144282058|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
144282059|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
144282060|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
144282061|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
144282062|NCT01807520|520233120|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
144282063|NCT01807520|520233121|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
144282064|NCT01807520|520233122|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
144282065|NCT01807520|520233123|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
144282066|NCT01807520|520233124|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
144282067|NCT01807520|520233125|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
144282068|NCT01807520|520233126|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
144282069|NCT01807520|520233120|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
144282070|NCT01807520|520233121|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
144282071|NCT01807520|520233122|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
144282072|NCT01807520|520233123|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
144282073|NCT01807520|520233124|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
144282074|NCT01807520|520233125|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
144282075|NCT01807520|520233126|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
144282076|NCT01807520|520233120|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
144282077|NCT01807520|520233121|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
144282078|NCT01807520|520233122|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
144282079|NCT01807520|520233123|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
144282080|NCT01807520|520233124|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
144282081|NCT01807520|520233125|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
144282082|NCT01807520|520233126|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
144282083|NCT01807520|520233120|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
144282084|NCT01807520|520233121|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
144282085|NCT01807520|520233122|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
144282086|NCT01807520|520233123|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
144282087|NCT01807520|520233124|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
144282088|NCT01807520|520233125|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
144282089|NCT01807520|520233126|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
144282090|NCT01500096|520233129|FG000|Overall Study|Lost to Follow-up|1|||
144282091|NCT01500096|520233130|FG001|Overall Study|Lost to Follow-up|0|||
144282092|NCT01500096|520233131|FG002|Overall Study|Lost to Follow-up|0|||
144282093|NCT01500096|520233132|FG003|Overall Study|Lost to Follow-up|2|||
144282094|NCT00639379|520233136|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
144282095|NCT00639379|520233137|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
144282096|NCT00639379|520233136|FG000|Period 1 - 2 Weeks|lens issue|3|||
144282097|NCT00639379|520233137|FG001|Period 1 - 2 Weeks|lens issue|0|||
144282098|NCT00723944|520233140|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
144282099|NCT00723944|520233141|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
144282100|NCT00723944|520233140|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
144282101|NCT00723944|520233141|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
144282102|NCT00723944|520233140|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
144282103|NCT00723944|520233141|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
144282104|NCT01631188|520233142|FG000|Overall Study|Physician Decision|75|||
144282105|NCT01471574|520233147|FG000|Treatment Period|Lack of Efficacy|12|||
144282106|NCT01471574|520233148|FG001|Treatment Period|Lack of Efficacy|4|||
144282107|NCT01471574|520233149|FG002|Treatment Period|Lack of Efficacy|14|||
144282108|NCT01471574|520233150|FG003|Treatment Period|Lack of Efficacy|1|||
144282109|NCT01471574|520233147|FG000|Treatment Period|Adverse Event|7|||
144282110|NCT01471574|520233148|FG001|Treatment Period|Adverse Event|3|||
144282111|NCT01471574|520233149|FG002|Treatment Period|Adverse Event|6|||
144282112|NCT01471574|520233150|FG003|Treatment Period|Adverse Event|1|||
144282113|NCT01471574|520233147|FG000|Treatment Period|Withdrawal by Subject|5|||
144282114|NCT01471574|520233148|FG001|Treatment Period|Withdrawal by Subject|1|||
144282115|NCT01471574|520233149|FG002|Treatment Period|Withdrawal by Subject|1|||
144282116|NCT01471574|520233150|FG003|Treatment Period|Withdrawal by Subject|0|||
144282117|NCT01471574|520233147|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
144282118|NCT01471574|520233148|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
144282119|NCT01471574|520233149|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
144282120|NCT01471574|520233150|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
144282121|NCT01471574|520233147|FG000|Treatment Period|Lost to Follow-up|1|||
144282122|NCT01471574|520233148|FG001|Treatment Period|Lost to Follow-up|2|||
144282123|NCT01471574|520233149|FG002|Treatment Period|Lost to Follow-up|2|||
144282124|NCT01471574|520233150|FG003|Treatment Period|Lost to Follow-up|0|||
144282125|NCT01471574|520233147|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
144282126|NCT01471574|520233148|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
144282127|NCT01471574|520233149|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
144245150|NCT00962091|520094658|FG001|Overall Study|Withdrawal by Subject|2|||
144245151|NCT00962091|520094659|FG002|Overall Study|Withdrawal by Subject|1|||
144245152|NCT00962091|520094660|FG003|Overall Study|Withdrawal by Subject|1|||
144245153|NCT00962091|520094661|FG004|Overall Study|Withdrawal by Subject|0|||
144245154|NCT00962091|520094662|FG005|Overall Study|Withdrawal by Subject|1|||
144245155|NCT00962091|520094663|FG006|Overall Study|Withdrawal by Subject|0|||
144245156|NCT00962091|520094657|FG000|Overall Study|Adverse Event|0|||
144245157|NCT00962091|520094658|FG001|Overall Study|Adverse Event|0|||
144245158|NCT00962091|520094659|FG002|Overall Study|Adverse Event|0|||
144245159|NCT00962091|520094660|FG003|Overall Study|Adverse Event|0|||
144245160|NCT00962091|520094661|FG004|Overall Study|Adverse Event|0|||
144245161|NCT00962091|520094662|FG005|Overall Study|Adverse Event|0|||
144245162|NCT00962091|520094663|FG006|Overall Study|Adverse Event|1|||
144245163|NCT03521817|520094664|FG000|Overall Study|Protocol Violation|0|||
144245164|NCT03521817|520094665|FG001|Overall Study|Protocol Violation|1|||
144245165|NCT00778102|520094666|FG000|Overall Study|Adverse Event|8|||
144245166|NCT00778102|520094667|FG001|Overall Study|Adverse Event|5|||
144245167|NCT00778102|520094666|FG000|Overall Study|Death|1|||
144245168|NCT00778102|520094667|FG001|Overall Study|Death|1|||
144245169|NCT00778102|520094666|FG000|Overall Study|Lost to Follow-up|1|||
144245170|NCT00778102|520094667|FG001|Overall Study|Lost to Follow-up|0|||
144245171|NCT00778102|520094666|FG000|Overall Study|Violation of Selection Criteria|1|||
144245172|NCT00778102|520094667|FG001|Overall Study|Violation of Selection Criteria|1|||
144245173|NCT00778102|520094666|FG000|Overall Study|Protocol Violation|0|||
144245174|NCT00778102|520094667|FG001|Overall Study|Protocol Violation|1|||
144245175|NCT00778102|520094666|FG000|Overall Study|Refused Treatment|2|||
144245176|NCT00778102|520094667|FG001|Overall Study|Refused Treatment|3|||
144245177|NCT00778102|520094666|FG000|Overall Study|Withdrawal by Subject|1|||
144245178|NCT00778102|520094667|FG001|Overall Study|Withdrawal by Subject|1|||
144245179|NCT00778102|520094666|FG000|Overall Study|Administrative Reason|7|||
144245180|NCT00778102|520094667|FG001|Overall Study|Administrative Reason|10|||
144245181|NCT01328548|520094668|FG000|Overall Study|Death|3|||
144245182|NCT01328548|520094669|FG001|Overall Study|Death|0|||
144245183|NCT01328548|520094668|FG000|Overall Study|Protocol Violation|1|||
144245184|NCT01328548|520094669|FG001|Overall Study|Protocol Violation|0|||
144245185|NCT04506905|520094672|FG000|Overall Study|Lost to Follow-up|1|||
144245186|NCT04506905|520094673|FG001|Overall Study|Lost to Follow-up|0|||
144245187|NCT04506905|520094674|FG002|Overall Study|Lost to Follow-up|0|||
144245188|NCT04506905|520094675|FG003|Overall Study|Lost to Follow-up|1|||
144245189|NCT04506905|520094676|FG004|Overall Study|Lost to Follow-up|0|||
144245190|NCT04506905|520094677|FG005|Overall Study|Lost to Follow-up|0|||
144245191|NCT04506905|520094678|FG006|Overall Study|Lost to Follow-up|0|||
144245192|NCT04506905|520094679|FG007|Overall Study|Lost to Follow-up|0|||
144245193|NCT04506905|520094680|FG008|Overall Study|Lost to Follow-up|0|||
144245194|NCT04506905|520094672|FG000|Overall Study|Withdrawal by Subject|0|||
144245195|NCT04506905|520094673|FG001|Overall Study|Withdrawal by Subject|0|||
144245196|NCT04506905|520094674|FG002|Overall Study|Withdrawal by Subject|0|||
144245197|NCT04506905|520094675|FG003|Overall Study|Withdrawal by Subject|2|||
144245198|NCT04506905|520094676|FG004|Overall Study|Withdrawal by Subject|0|||
144245199|NCT04506905|520094677|FG005|Overall Study|Withdrawal by Subject|0|||
144245200|NCT04506905|520094678|FG006|Overall Study|Withdrawal by Subject|0|||
144245201|NCT04506905|520094679|FG007|Overall Study|Withdrawal by Subject|0|||
144245202|NCT04506905|520094680|FG008|Overall Study|Withdrawal by Subject|0|||
144245203|NCT03976323|520094683|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
144245204|NCT03976323|520094684|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
144245205|NCT03976323|520094685|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
144245206|NCT03976323|520094683|FG000|Induction Phase|Death|80|||
144245207|NCT03976323|520094684|FG001|Induction Phase|Death|0|||
144245208|NCT03976323|520094685|FG002|Induction Phase|Death|0|||
144245209|NCT03976323|520094683|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
144245210|NCT03976323|520094684|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
144245211|NCT03976323|520094685|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
144245212|NCT03976323|520094683|FG000|Maintenance Phase|Withdrawal by Subject|0|||
144245213|NCT03976323|520094684|FG001|Maintenance Phase|Withdrawal by Subject|9|||
144245214|NCT03976323|520094685|FG002|Maintenance Phase|Withdrawal by Subject|3|||
144245215|NCT03976323|520094683|FG000|Maintenance Phase|Physician Decision|0|||
144245216|NCT03976323|520094684|FG001|Maintenance Phase|Physician Decision|0|||
144245217|NCT03976323|520094685|FG002|Maintenance Phase|Physician Decision|1|||
144245218|NCT03976323|520094683|FG000|Maintenance Phase|Death|0|||
144245219|NCT03976323|520094684|FG001|Maintenance Phase|Death|228|||
144245220|NCT03976323|520094685|FG002|Maintenance Phase|Death|234|||
144245221|NCT00224406|520096125|FG000|Overall Study|Re-transplant|0|||
144245222|NCT00224406|520096126|FG001|Overall Study|Re-transplant|2|||
144245223|NCT00224406|520096125|FG000|Overall Study|Death|0|||
144245224|NCT00224406|520096126|FG001|Overall Study|Death|1|||
144245225|NCT00224406|520096125|FG000|Overall Study|Transplant cancelled|0|||
144245226|NCT00224406|520096126|FG001|Overall Study|Transplant cancelled|4|||
144245227|NCT00224406|520096125|FG000|Overall Study|Drug not delivered|2|||
144282128|NCT01471574|520233150|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
144282129|NCT01471574|520233147|FG000|Treatment Period|Other|1|||
144282130|NCT01471574|520233148|FG001|Treatment Period|Other|0|||
144282131|NCT01471574|520233149|FG002|Treatment Period|Other|0|||
144282132|NCT01471574|520233150|FG003|Treatment Period|Other|0|||
144282133|NCT01471574|520233147|FG000|Follow-up Period|Withdrawal by Subject|3|||
144282134|NCT01471574|520233148|FG001|Follow-up Period|Withdrawal by Subject|0|||
144282135|NCT01471574|520233149|FG002|Follow-up Period|Withdrawal by Subject|3|||
144282136|NCT01471574|520233150|FG003|Follow-up Period|Withdrawal by Subject|1|||
144282137|NCT01471574|520233147|FG000|Follow-up Period|Lost to Follow-up|4|||
144282138|NCT01471574|520233148|FG001|Follow-up Period|Lost to Follow-up|1|||
144282139|NCT01471574|520233149|FG002|Follow-up Period|Lost to Follow-up|3|||
144282140|NCT01471574|520233150|FG003|Follow-up Period|Lost to Follow-up|2|||
144282141|NCT01471574|520233147|FG000|Follow-up Period|Death|0|||
144282142|NCT01471574|520233148|FG001|Follow-up Period|Death|0|||
144282143|NCT01471574|520233149|FG002|Follow-up Period|Death|1|||
144282144|NCT01471574|520233150|FG003|Follow-up Period|Death|0|||
144282145|NCT01471574|520233147|FG000|Follow-up Period|Follow-up no longer required|0|||
144282146|NCT01471574|520233148|FG001|Follow-up Period|Follow-up no longer required|1|||
144282147|NCT01471574|520233149|FG002|Follow-up Period|Follow-up no longer required|0|||
144282148|NCT01471574|520233150|FG003|Follow-up Period|Follow-up no longer required|0|||
144282149|NCT01137812|520233151|FG000|Overall Study|Adverse Event|21|||
144282150|NCT01137812|520233152|FG001|Overall Study|Adverse Event|14|||
144282151|NCT01137812|520233151|FG000|Overall Study|Lost to Follow-up|6|||
144282152|NCT01137812|520233152|FG001|Overall Study|Lost to Follow-up|8|||
144282153|NCT01137812|520233151|FG000|Overall Study|Physician Decision|25|||
144282154|NCT01137812|520233152|FG001|Overall Study|Physician Decision|17|||
144282155|NCT01137812|520233151|FG000|Overall Study|Protocol Violation|5|||
144282156|NCT01137812|520233152|FG001|Overall Study|Protocol Violation|4|||
144282157|NCT01137812|520233151|FG000|Overall Study|Withdrawal by Subject|5|||
144282158|NCT01137812|520233152|FG001|Overall Study|Withdrawal by Subject|13|||
144282159|NCT01137812|520233151|FG000|Overall Study|Death|2|||
144282160|NCT01137812|520233152|FG001|Overall Study|Death|0|||
144282161|NCT01137812|520233151|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
144282162|NCT01137812|520233152|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
144282163|NCT01137812|520233151|FG000|Overall Study|Other|19|||
144282164|NCT01137812|520233152|FG001|Overall Study|Other|27|||
144282165|NCT00845182|520233153|FG000|Overall Study|Lost to Follow-up|3|||
144282166|NCT00845182|520233154|FG001|Overall Study|Lost to Follow-up|3|||
144282167|NCT00845182|520233155|FG002|Overall Study|Lost to Follow-up|4|||
144282168|NCT00845182|520233153|FG000|Overall Study|Adverse Event|0|||
144282169|NCT00845182|520233154|FG001|Overall Study|Adverse Event|1|||
144282170|NCT00845182|520233155|FG002|Overall Study|Adverse Event|1|||
144282171|NCT00845182|520233153|FG000|Overall Study|Physician Decision|0|||
144282172|NCT00845182|520233154|FG001|Overall Study|Physician Decision|0|||
144282173|NCT00845182|520233155|FG002|Overall Study|Physician Decision|1|||
144282174|NCT04621760|520233156|FG000|Overall Study|Lost to Follow-up|2|||
144282175|NCT04621760|520233157|FG001|Overall Study|Lost to Follow-up|4|||
144282176|NCT04621760|520233156|FG000|Overall Study|Withdrawal by Subject|1|||
144282177|NCT04621760|520233157|FG001|Overall Study|Withdrawal by Subject|0|||
144282178|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
144282179|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
144282180|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
144282181|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
144282182|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
144282183|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
144282184|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
144282185|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
144282186|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
144282187|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
144282188|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
144282189|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
144282190|NCT00447278|520233160|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
144282191|NCT00447278|520233161|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
144282192|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
144282193|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
144282194|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
144282195|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
144282196|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
144282197|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
144282198|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
144282199|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
144282200|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
144245228|NCT00224406|520096126|FG001|Overall Study|Drug not delivered|0|||
144245229|NCT00224406|520096125|FG000|Overall Study|Other|4|||
144245230|NCT00224406|520096126|FG001|Overall Study|Other|0|||
144245231|NCT00224406|520096125|FG000|Overall Study|Transplant cancelled|3|||
144245232|NCT00224406|520096126|FG001|Overall Study|Transplant cancelled|0|||
144245233|NCT01556997|520096127|FG000|Overall Study|Adverse Event|10|||
144245234|NCT01556997|520096128|FG001|Overall Study|Adverse Event|12|||
144245235|NCT01556997|520096129|FG002|Overall Study|Adverse Event|12|||
144245236|NCT01556997|520096127|FG000|Overall Study|Lost to Follow-up|6|||
144245237|NCT01556997|520096128|FG001|Overall Study|Lost to Follow-up|6|||
144245238|NCT01556997|520096129|FG002|Overall Study|Lost to Follow-up|4|||
144245239|NCT01556997|520096127|FG000|Overall Study|Physician Decision|1|||
144245240|NCT01556997|520096128|FG001|Overall Study|Physician Decision|1|||
144245241|NCT01556997|520096129|FG002|Overall Study|Physician Decision|1|||
144245242|NCT01556997|520096127|FG000|Overall Study|Withdrawal by Subject|7|||
144245243|NCT01556997|520096128|FG001|Overall Study|Withdrawal by Subject|6|||
144245244|NCT01556997|520096129|FG002|Overall Study|Withdrawal by Subject|8|||
144245245|NCT01556997|520096127|FG000|Overall Study|Other|2|||
144245246|NCT01556997|520096128|FG001|Overall Study|Other|3|||
144245247|NCT01556997|520096129|FG002|Overall Study|Other|7|||
144245248|NCT01250171|520096133|FG000|Overall Study|Administrative reasons|1|||
144245249|NCT01250171|520096134|FG001|Overall Study|Administrative reasons|0|||
144245250|NCT01250171|520096135|FG002|Overall Study|Administrative reasons|0|||
144245251|NCT04676412|520096136|FG000|Overall Study|Death|28|||
144245252|NCT04676412|520096137|FG001|Overall Study|Death|31|||
144245253|NCT04676412|520096136|FG000|Overall Study|Lost to Follow-up|1|||
144245254|NCT04676412|520096137|FG001|Overall Study|Lost to Follow-up|2|||
144245255|NCT04676412|520096136|FG000|Overall Study|Sponsor Decision|20|||
144245256|NCT04676412|520096137|FG001|Overall Study|Sponsor Decision|23|||
144245257|NCT04676412|520096136|FG000|Overall Study|Withdrawal by Subject|0|||
144245258|NCT04676412|520096137|FG001|Overall Study|Withdrawal by Subject|2|||
144245259|NCT04550832|520096138|FG000|Overall Study|Adverse Event|0|||
144245260|NCT04550832|520096139|FG001|Overall Study|Adverse Event|0|||
144245261|NCT04550832|520096140|FG002|Overall Study|Adverse Event|2|||
144245262|NCT04550832|520096141|FG003|Overall Study|Adverse Event|0|||
144245263|NCT04550832|520096142|FG004|Overall Study|Adverse Event|1|||
144245264|NCT04823130|520096143|FG000|Overall Study|Withdrawal by Subject|2|||
144245265|NCT04823130|520096144|FG001|Overall Study|Withdrawal by Subject|3|||
144245266|NCT04823130|520096143|FG000|Overall Study|Failure to meet inclusion criteria|6|||
144245267|NCT04823130|520096144|FG001|Overall Study|Failure to meet inclusion criteria|4|||
144245268|NCT04823130|520096143|FG000|Overall Study|Other-unspecified|1|||
144245269|NCT04823130|520096144|FG001|Overall Study|Other-unspecified|0|||
144245270|NCT03315455|520096146|FG000|Overall Study|Ongoing in the Study|13|||
144245271|NCT03315455|520096147|FG001|Overall Study|Ongoing in the Study|24|||
144245272|NCT03315455|520096148|FG002|Overall Study|Ongoing in the Study|17|||
144245273|NCT03315455|520096149|FG003|Overall Study|Ongoing in the Study|15|||
144245274|NCT03315455|520096146|FG000|Overall Study|Withdrawal by Subject|0|||
144245275|NCT03315455|520096147|FG001|Overall Study|Withdrawal by Subject|1|||
144245276|NCT03315455|520096148|FG002|Overall Study|Withdrawal by Subject|0|||
144245277|NCT03315455|520096149|FG003|Overall Study|Withdrawal by Subject|0|||
144245278|NCT04439357|520096150|FG000|Overall Study|Disease Progression|4|||
144245279|NCT01458951|520096158|FG000|Overall Study|Other|1|||
144245280|NCT01458951|520096159|FG001|Overall Study|Other|0|||
144245281|NCT01458951|520096160|FG002|Overall Study|Other|0|||
144245282|NCT01458951|520096158|FG000|Overall Study|Protocol Violation|5|||
144245283|NCT01458951|520096159|FG001|Overall Study|Protocol Violation|1|||
144245284|NCT01458951|520096160|FG002|Overall Study|Protocol Violation|0|||
144245285|NCT01458951|520096158|FG000|Overall Study|Withdrawal by Subject|2|||
144245286|NCT01458951|520096159|FG001|Overall Study|Withdrawal by Subject|0|||
144245287|NCT01458951|520096160|FG002|Overall Study|Withdrawal by Subject|2|||
144245288|NCT01458951|520096158|FG000|Overall Study|Adverse Event|7|||
144245289|NCT01458951|520096159|FG001|Overall Study|Adverse Event|0|||
144245290|NCT01458951|520096160|FG002|Overall Study|Adverse Event|2|||
144245291|NCT01458951|520096158|FG000|Overall Study|Insufficient Clinical Response|17|||
144245292|NCT01458951|520096159|FG001|Overall Study|Insufficient Clinical Response|0|||
144245293|NCT01458951|520096160|FG002|Overall Study|Insufficient Clinical Response|11|||
144245294|NCT01371877|520096163|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
144245295|NCT01371877|520096164|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
144245296|NCT05932225|520096165|FG000|Overall Study|Lost to Follow-up|0|||
144245297|NCT05932225|520096166|FG001|Overall Study|Lost to Follow-up|1|||
144245298|NCT05932225|520096167|FG002|Overall Study|Lost to Follow-up|0|||
144245299|NCT05932225|520096165|FG000|Overall Study|Withdrawal by Subject|1|||
144245300|NCT05932225|520096166|FG001|Overall Study|Withdrawal by Subject|0|||
144245301|NCT05932225|520096167|FG002|Overall Study|Withdrawal by Subject|0|||
144245302|NCT05932225|520096165|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
144245303|NCT05932225|520096166|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
144245304|NCT05932225|520096167|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
144245305|NCT03605849|520096168|FG000|Overall Study|Adverse Event|20|||
144282201|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
144282202|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
144282203|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
144282204|NCT00447278|520233160|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
144282205|NCT00447278|520233161|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
144282206|NCT03677401|520233162|FG000|Overall Study|Adverse Event|4|||
144282207|NCT03677401|520233163|FG001|Overall Study|Adverse Event|14|||
144282208|NCT03677401|520233162|FG000|Overall Study|Lack of Efficacy|3|||
144282209|NCT03677401|520233163|FG001|Overall Study|Lack of Efficacy|1|||
144282210|NCT03677401|520233162|FG000|Overall Study|Withdrawal by Subject|2|||
144282211|NCT03677401|520233163|FG001|Overall Study|Withdrawal by Subject|2|||
144282212|NCT03677401|520233162|FG000|Overall Study|Sponsor decision|0|||
144282213|NCT03677401|520233163|FG001|Overall Study|Sponsor decision|1|||
144282214|NCT03677401|520233162|FG000|Overall Study|Reason Unspecified|1|||
144282215|NCT03677401|520233163|FG001|Overall Study|Reason Unspecified|0|||
144282216|NCT01177410|520233166|FG000|Overall Study|Adverse Event|0|||
144282217|NCT01177410|520233167|FG001|Overall Study|Adverse Event|2|||
144282218|NCT01177410|520233168|FG002|Overall Study|Adverse Event|2|||
144282219|NCT01177410|520233166|FG000|Overall Study|Withdrawal by Subject|1|||
144282220|NCT01177410|520233167|FG001|Overall Study|Withdrawal by Subject|4|||
144282221|NCT01177410|520233168|FG002|Overall Study|Withdrawal by Subject|3|||
144282222|NCT01177410|520233166|FG000|Overall Study|Lost to Follow-up|0|||
144282223|NCT01177410|520233167|FG001|Overall Study|Lost to Follow-up|1|||
144282224|NCT01177410|520233168|FG002|Overall Study|Lost to Follow-up|0|||
144282225|NCT00471354|520233172|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
144282226|NCT00471354|520233172|FG000|Overall Study|Adverse Event|13|||
144282227|NCT00471354|520233172|FG000|Overall Study|Protocol Violation|12|||
144282228|NCT00471354|520233172|FG000|Overall Study|Withdrawal by Subject|1|||
144282229|NCT00471354|520233172|FG000|Overall Study|Physician Decision|4|||
144282230|NCT00471354|520233172|FG000|Overall Study|Sponsor Decision|1|||
144282231|NCT00471354|520233172|FG000|Overall Study|Lost to Follow-up|3|||
144282232|NCT00471354|520233172|FG000|Overall Study|Lack of Efficacy|5|||
144282233|NCT00471354|520233172|FG000|Overall Study|Patient/Caregiver Decision|12|||
144282234|NCT05427916|520233173|FG000|Overall Study|Adverse Event|3|||
144282235|NCT05427916|520233174|FG001|Overall Study|Adverse Event|0|||
144282236|NCT05427916|520233173|FG000|Overall Study|Lack of Efficacy|6|||
144282237|NCT05427916|520233174|FG001|Overall Study|Lack of Efficacy|0|||
144282238|NCT05427916|520233173|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
144282239|NCT05427916|520233174|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
144282240|NCT02836769|520233177|FG000|Overall Study|Lost to Follow-up|10|||
144282241|NCT02836769|520233177|FG000|Overall Study|Medical withdrawal|2|||
144282242|NCT02836769|520233177|FG000|Overall Study|Withdrawal by Subject|3|||
144282243|NCT03142750|520233185|FG000|Overall Study|Lost to Follow-up|4|||
144282244|NCT03142750|520233186|FG001|Overall Study|Lost to Follow-up|1|||
144282245|NCT02942407|520233187|FG000|Overall Study|Lost to Follow-up|3|||
144282246|NCT02942407|520233188|FG001|Overall Study|Lost to Follow-up|2|||
144282247|NCT02942407|520233187|FG000|Overall Study|Withdrawal by Subject|7|||
144282248|NCT02942407|520233188|FG001|Overall Study|Withdrawal by Subject|9|||
144282249|NCT02942407|520233187|FG000|Overall Study|Death|16|||
144282250|NCT02942407|520233188|FG001|Overall Study|Death|13|||
144282251|NCT02315625|520233191|FG000|First Intervention|Disease Progression|1|||
144282252|NCT02315625|520233192|FG001|First Intervention|Disease Progression|0|||
144282253|NCT02315625|520233191|FG000|Second Intervention|Physician Decision|2|||
144282254|NCT02315625|520233192|FG001|Second Intervention|Physician Decision|1|||
144282255|NCT02315625|520233191|FG000|Second Intervention|Study closure|1|||
144282256|NCT02315625|520233192|FG001|Second Intervention|Study closure|0|||
144282257|NCT02315625|520233191|FG000|Second Intervention|Disease Progression|1|||
144282258|NCT02315625|520233192|FG001|Second Intervention|Disease Progression|0|||
144282259|NCT02232698|520233193|FG000|Overall Study|Pregnancy|1|||
144282260|NCT02232698|520233194|FG001|Overall Study|Pregnancy|1|||
144282261|NCT02232698|520233193|FG000|Overall Study|Met exclusion criteria|1|||
144282262|NCT02232698|520233194|FG001|Overall Study|Met exclusion criteria|1|||
144282263|NCT02232698|520233193|FG000|Overall Study|Had device-associated symptoms|7|||
144282264|NCT02232698|520233194|FG001|Overall Study|Had device-associated symptoms|0|||
144282265|NCT02232698|520233193|FG000|Overall Study|Non-compliance with study device|1|||
144282266|NCT02232698|520233194|FG001|Overall Study|Non-compliance with study device|4|||
144282267|NCT02232698|520233193|FG000|Overall Study|Allocated to control group|0|||
144282268|NCT02232698|520233194|FG001|Overall Study|Allocated to control group|3|||
144282269|NCT02232698|520233193|FG000|Overall Study|Withdrawal by Subject|0|||
144282270|NCT02232698|520233194|FG001|Overall Study|Withdrawal by Subject|11|||
144282271|NCT00812097|520233195|FG000|Overall Study|Death|3|||
144282272|NCT00812097|520233196|FG001|Overall Study|Death|10|||
144282273|NCT00812097|520233197|FG002|Overall Study|Death|3|||
144282274|NCT00812097|520233198|FG003|Overall Study|Death|3|||
144282275|NCT00812097|520233195|FG000|Overall Study|Withdrawal by Subject|14|||
144282276|NCT00812097|520233196|FG001|Overall Study|Withdrawal by Subject|12|||
144282277|NCT00812097|520233197|FG002|Overall Study|Withdrawal by Subject|8|||
144282278|NCT00812097|520233198|FG003|Overall Study|Withdrawal by Subject|2|||
144282279|NCT00812097|520233195|FG000|Overall Study|Lost to Follow-up|90|||
144282280|NCT00812097|520233196|FG001|Overall Study|Lost to Follow-up|14|||
144282281|NCT00812097|520233197|FG002|Overall Study|Lost to Follow-up|17|||
144282282|NCT00812097|520233198|FG003|Overall Study|Lost to Follow-up|5|||
144282283|NCT00812097|520233195|FG000|Overall Study|Explantation of study device(s)|27|||
144245306|NCT03605849|520096169|FG001|Overall Study|Adverse Event|21|||
144245307|NCT03605849|520096170|FG002|Overall Study|Adverse Event|29|||
144245308|NCT03605849|520096171|FG003|Overall Study|Adverse Event|11|||
144245309|NCT03605849|520096168|FG000|Overall Study|Lack of Efficacy|4|||
144245310|NCT03605849|520096169|FG001|Overall Study|Lack of Efficacy|7|||
144245311|NCT03605849|520096170|FG002|Overall Study|Lack of Efficacy|9|||
144245312|NCT03605849|520096171|FG003|Overall Study|Lack of Efficacy|2|||
144245313|NCT03605849|520096168|FG000|Overall Study|Lost to Follow-up|8|||
144245314|NCT03605849|520096169|FG001|Overall Study|Lost to Follow-up|8|||
144245315|NCT03605849|520096170|FG002|Overall Study|Lost to Follow-up|14|||
144245316|NCT03605849|520096171|FG003|Overall Study|Lost to Follow-up|11|||
144245317|NCT03605849|520096168|FG000|Overall Study|Non-compliance With IMP|6|||
144245318|NCT03605849|520096169|FG001|Overall Study|Non-compliance With IMP|5|||
144245319|NCT03605849|520096170|FG002|Overall Study|Non-compliance With IMP|2|||
144245320|NCT03605849|520096171|FG003|Overall Study|Non-compliance With IMP|1|||
144245321|NCT03605849|520096168|FG000|Overall Study|Protocol Deviation|1|||
144245322|NCT03605849|520096169|FG001|Overall Study|Protocol Deviation|2|||
144245323|NCT03605849|520096170|FG002|Overall Study|Protocol Deviation|1|||
144245324|NCT03605849|520096171|FG003|Overall Study|Protocol Deviation|3|||
144245325|NCT03605849|520096168|FG000|Overall Study|Withdrawal by Subject|33|||
144245326|NCT03605849|520096169|FG001|Overall Study|Withdrawal by Subject|28|||
144245327|NCT03605849|520096170|FG002|Overall Study|Withdrawal by Subject|30|||
144245328|NCT03605849|520096171|FG003|Overall Study|Withdrawal by Subject|28|||
144245329|NCT03605849|520096168|FG000|Overall Study|Site Terminated by Sponsor|0|||
144245330|NCT03605849|520096169|FG001|Overall Study|Site Terminated by Sponsor|0|||
144245331|NCT03605849|520096170|FG002|Overall Study|Site Terminated by Sponsor|0|||
144245332|NCT03605849|520096171|FG003|Overall Study|Site Terminated by Sponsor|1|||
144245333|NCT03605849|520096168|FG000|Overall Study|Physician Decision|2|||
144245334|NCT03605849|520096169|FG001|Overall Study|Physician Decision|1|||
144245335|NCT03605849|520096170|FG002|Overall Study|Physician Decision|2|||
144245336|NCT03605849|520096171|FG003|Overall Study|Physician Decision|1|||
144245337|NCT03605849|520096168|FG000|Overall Study|Enrolled, but not Treated|2|||
144245338|NCT03605849|520096169|FG001|Overall Study|Enrolled, but not Treated|2|||
144245339|NCT03605849|520096170|FG002|Overall Study|Enrolled, but not Treated|3|||
144245340|NCT03605849|520096171|FG003|Overall Study|Enrolled, but not Treated|2|||
144245341|NCT03605849|520096168|FG000|Overall Study|Other (COVID-19 Related)|0|||
144245342|NCT03605849|520096169|FG001|Overall Study|Other (COVID-19 Related)|1|||
144245343|NCT03605849|520096170|FG002|Overall Study|Other (COVID-19 Related)|1|||
144245344|NCT03605849|520096171|FG003|Overall Study|Other (COVID-19 Related)|0|||
144245345|NCT03605849|520096168|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
144245346|NCT03605849|520096169|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
144245347|NCT03605849|520096170|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
144245348|NCT03605849|520096171|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
144245349|NCT02304380|520096172|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
144245350|NCT02304380|520096173|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
144245351|NCT02304380|520096174|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
144245352|NCT02304380|520096175|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
144245353|NCT02304380|520096176|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
144245354|NCT02304380|520096177|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
144245355|NCT00328094|520096178|FG000|Overall Study|Physician Decision|3|||
144245356|NCT00328094|520096179|FG001|Overall Study|Physician Decision|3|||
144245357|NCT02667626|520096180|FG000|Overall Study|Withdrawal by Subject|0|||
144245358|NCT02667626|520096181|FG001|Overall Study|Withdrawal by Subject|1|||
144245359|NCT02309723|520096182|FG000|Overall Study|Withdrawal by Subject|24|||
144245360|NCT02309723|520096183|FG001|Overall Study|Withdrawal by Subject|23|||
144245361|NCT02309723|520096184|FG002|Overall Study|Withdrawal by Subject|24|||
144245362|NCT02453282|520096185|FG000|Overall Study|Death|275|||
144282284|NCT00812097|520233196|FG001|Overall Study|Explantation of study device(s)|29|||
144282285|NCT00812097|520233197|FG002|Overall Study|Explantation of study device(s)|14|||
144282286|NCT00812097|520233198|FG003|Overall Study|Explantation of study device(s)|20|||
144282287|NCT00812097|520233195|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
144282288|NCT00812097|520233196|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
144282289|NCT00812097|520233197|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
144282290|NCT00812097|520233198|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
144282291|NCT00927082|520233199|FG000|Overall Study|Lost to Follow-up|9|||
144282292|NCT00927082|520233200|FG001|Overall Study|Lost to Follow-up|8|||
144282293|NCT00927082|520233201|FG002|Overall Study|Lost to Follow-up|12|||
144282294|NCT00927082|520233202|FG003|Overall Study|Lost to Follow-up|16|||
144282295|NCT00927082|520233199|FG000|Overall Study|Withdrawal by Subject|3|||
144282296|NCT00927082|520233200|FG001|Overall Study|Withdrawal by Subject|2|||
144282297|NCT00927082|520233201|FG002|Overall Study|Withdrawal by Subject|7|||
144282298|NCT00927082|520233202|FG003|Overall Study|Withdrawal by Subject|2|||
144282299|NCT00927082|520233199|FG000|Overall Study|Death|0|||
144282300|NCT00927082|520233200|FG001|Overall Study|Death|0|||
144282301|NCT00927082|520233201|FG002|Overall Study|Death|1|||
144282302|NCT00927082|520233202|FG003|Overall Study|Death|0|||
144282303|NCT00927082|520233199|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
144282304|NCT00927082|520233200|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
144282305|NCT00927082|520233201|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
144282306|NCT00927082|520233202|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
144282307|NCT01786109|520233203|FG000|Overall Study|fail manometry barostat tube placement|1|||
144282308|NCT01786109|520233204|FG001|Overall Study|fail manometry barostat tube placement|0|||
144282309|NCT01786109|520233205|FG002|Overall Study|fail manometry barostat tube placement|0|||
144245363|NCT02453282|520096186|FG001|Overall Study|Death|277|||
144245364|NCT02453282|520096187|FG002|Overall Study|Death|296|||
144245365|NCT02453282|520096185|FG000|Overall Study|Lost to Follow-up|1|||
144245366|NCT02453282|520096186|FG001|Overall Study|Lost to Follow-up|0|||
144245367|NCT02453282|520096187|FG002|Overall Study|Lost to Follow-up|2|||
144245368|NCT02453282|520096185|FG000|Overall Study|Withdrawal by Subject|12|||
144245369|NCT02453282|520096186|FG001|Overall Study|Withdrawal by Subject|10|||
144245370|NCT02453282|520096187|FG002|Overall Study|Withdrawal by Subject|11|||
144245371|NCT02453282|520096185|FG000|Overall Study|Participants ongoing at data cut-off|85|||
144245372|NCT02453282|520096186|FG001|Overall Study|Participants ongoing at data cut-off|84|||
144245373|NCT02453282|520096187|FG002|Overall Study|Participants ongoing at data cut-off|62|||
144245374|NCT02453282|520096185|FG000|Overall Study|Other|1|||
144245375|NCT02453282|520096186|FG001|Overall Study|Other|1|||
144245376|NCT02453282|520096187|FG002|Overall Study|Other|1|||
144245377|NCT01143064|520096188|FG000|Overall Study|Death|109|||
144245378|NCT01143064|520096189|FG001|Overall Study|Death|91|||
144245379|NCT01143064|520096188|FG000|Overall Study|Adverse Event|0|||
144245380|NCT01143064|520096189|FG001|Overall Study|Adverse Event|1|||
144245381|NCT01143064|520096188|FG000|Overall Study|Withdrawal by Subject|7|||
144245382|NCT01143064|520096189|FG001|Overall Study|Withdrawal by Subject|5|||
144245383|NCT01143064|520096188|FG000|Overall Study|Lost to Follow-up|17|||
144245384|NCT01143064|520096189|FG001|Overall Study|Lost to Follow-up|14|||
144245385|NCT01143064|520096188|FG000|Overall Study|Physician Decision|0|||
144245386|NCT01143064|520096189|FG001|Overall Study|Physician Decision|4|||
144245387|NCT04258254|520096192|FG000|Overall Study|Withdrawal by Subject|0|||
144245388|NCT04258254|520096193|FG001|Overall Study|Withdrawal by Subject|1|||
144245389|NCT04258254|520096194|FG002|Overall Study|Withdrawal by Subject|0|||
144245390|NCT02255552|520096195|FG000|Overall Study|Participants enrolled into another study|0|||
144245391|NCT02255552|520096196|FG001|Overall Study|Participants enrolled into another study|11|||
144245392|NCT02255552|520096195|FG000|Overall Study|Withdrawal by Subject|1|||
144245393|NCT02255552|520096196|FG001|Overall Study|Withdrawal by Subject|4|||
144245394|NCT01447446|520096197|FG000|Overall Study|Death|6|||
144245395|NCT01447446|520096198|FG001|Overall Study|Death|3|||
144245396|NCT01447446|520096199|FG002|Overall Study|Death|2|||
144245397|NCT01447446|520096200|FG003|Overall Study|Death|1|||
144245398|NCT01447446|520096201|FG004|Overall Study|Death|7|||
144245399|NCT01447446|520096202|FG005|Overall Study|Death|0|||
144245400|NCT01447446|520096197|FG000|Overall Study|Adverse Event|3|||
144245401|NCT01447446|520096198|FG001|Overall Study|Adverse Event|0|||
144245402|NCT01447446|520096199|FG002|Overall Study|Adverse Event|1|||
144245403|NCT01447446|520096200|FG003|Overall Study|Adverse Event|0|||
144282310|NCT01786109|520233203|FG000|Overall Study|unrelated illness|0|||
144282311|NCT01786109|520233204|FG001|Overall Study|unrelated illness|0|||
144282312|NCT01786109|520233205|FG002|Overall Study|unrelated illness|1|||
144282313|NCT01786109|520233203|FG000|Overall Study|adverse effects colon preparation|0|||
144282314|NCT01786109|520233204|FG001|Overall Study|adverse effects colon preparation|0|||
144282315|NCT01786109|520233205|FG002|Overall Study|adverse effects colon preparation|1|||
144282316|NCT02762604|520233206|FG000|Overall Study|Lost to Follow-up|2|||
144282317|NCT02762604|520233207|FG001|Overall Study|Lost to Follow-up|7|||
144282318|NCT02762604|520233206|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
144282319|NCT02762604|520233207|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
144282320|NCT05399485|520234624|FG000|DBT Phase|Other|6|||
144282321|NCT05399485|520234625|FG001|DBT Phase|Other|5|||
144282322|NCT05399485|520234624|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
144282323|NCT05399485|520234625|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
144282324|NCT05399485|520234624|FG000|DBT Phase|Withdrawal by Subject|3|||
144282325|NCT05399485|520234625|FG001|DBT Phase|Withdrawal by Subject|2|||
144282326|NCT05399485|520234624|FG000|DBT Phase|Protocol Violation|2|||
144282327|NCT05399485|520234625|FG001|DBT Phase|Protocol Violation|1|||
144282328|NCT05399485|520234624|FG000|DBT Phase|Physician Decision|0|||
144282329|NCT05399485|520234625|FG001|DBT Phase|Physician Decision|1|||
144282330|NCT05399485|520234624|FG000|DBT Phase|Adverse Event|2|||
144282331|NCT05399485|520234625|FG001|DBT Phase|Adverse Event|1|||
144282332|NCT05399485|520234624|FG000|OLE Phase|Protocol deviation|1|||
144282333|NCT05399485|520234625|FG001|OLE Phase|Protocol deviation|0|||
144282334|NCT05399485|520234624|FG000|OLE Phase|Other|5|||
144282335|NCT05399485|520234625|FG001|OLE Phase|Other|5|||
144282336|NCT05399485|520234624|FG000|OLE Phase|Withdrawal by Subject|12|||
144282337|NCT05399485|520234625|FG001|OLE Phase|Withdrawal by Subject|7|||
144282338|NCT05399485|520234624|FG000|OLE Phase|Pregnancy|0|||
144282339|NCT05399485|520234625|FG001|OLE Phase|Pregnancy|2|||
144282340|NCT05399485|520234624|FG000|OLE Phase|Physician Decision|3|||
144282341|NCT05399485|520234625|FG001|OLE Phase|Physician Decision|0|||
144282342|NCT05399485|520234624|FG000|OLE Phase|Adverse Event|2|||
144282343|NCT05399485|520234625|FG001|OLE Phase|Adverse Event|2|||
144282344|NCT02068794|520234626|FG000|Overall Study|Withdrawal by Subject|0|||
144282345|NCT02068794|520234627|FG001|Overall Study|Withdrawal by Subject|1|||
144282346|NCT02068794|520234628|FG002|Overall Study|Withdrawal by Subject|2|||
144282347|NCT02068794|520234626|FG000|Overall Study|Early Progression|1|||
144282348|NCT02068794|520234627|FG001|Overall Study|Early Progression|0|||
144282349|NCT02068794|520234628|FG002|Overall Study|Early Progression|1|||
144282350|NCT02068794|520234626|FG000|Overall Study|Ineligible|0|||
144282351|NCT02068794|520234627|FG001|Overall Study|Ineligible|0|||
144282352|NCT02068794|520234628|FG002|Overall Study|Ineligible|1|||
144282353|NCT04439175|520234629|FG000|Overall Study|Never started treatment|4|||
144282354|NCT04439175|520234629|FG000|Overall Study|Ineligible|5|||
144282355|NCT04439175|520234629|FG000|Overall Study|Adverse Event|6|||
144282356|NCT04439175|520234629|FG000|Overall Study|Death|4|||
144282357|NCT04439175|520234629|FG000|Overall Study|Disease progression|44|||
144282358|NCT04439175|520234629|FG000|Overall Study|Withdrawal by Subject|4|||
144282359|NCT04439175|520234629|FG000|Overall Study|Alternative Therapy|1|||
144282360|NCT04439175|520234629|FG000|Overall Study|Other|2|||
144282361|NCT01847209|520234630|FG000|Overall Study|Withdrawal by Subject|1|||
144282362|NCT01847209|520234630|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
144282363|NCT03600350|520234631|FG000|Overall Study|Death|1|||
144245404|NCT01447446|520096201|FG004|Overall Study|Adverse Event|2|||
144245405|NCT01447446|520096202|FG005|Overall Study|Adverse Event|0|||
144245406|NCT01447446|520096197|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
144245407|NCT01447446|520096198|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
144245408|NCT01447446|520096199|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
144282364|NCT03600350|520234631|FG000|Overall Study|On Follow Up|18|||
144282365|NCT04575324|520234632|FG000|Overall Study|Lost to Follow-up|29|||
144282366|NCT04575324|520234633|FG001|Overall Study|Lost to Follow-up|25|||
144282367|NCT04575324|520234632|FG000|Overall Study|Death|1|||
144282368|NCT04575324|520234633|FG001|Overall Study|Death|2|||
144282369|NCT04575324|520234632|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
144282370|NCT04575324|520234633|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
144282371|NCT01771913|520234640|FG000|Overall Study|Withdrawal by Subject|1|||
144282372|NCT01771913|520234641|FG001|Overall Study|Withdrawal by Subject|0|||
144282373|NCT02965716|520234652|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
144282374|NCT02965716|520234653|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
144282375|NCT02965716|520234652|FG000|Overall Study|Progression/Relapse|8|||
144282376|NCT02965716|520234653|FG001|Overall Study|Progression/Relapse|16|||
144282377|NCT02965716|520234652|FG000|Overall Study|Death|1|||
144282378|NCT02965716|520234653|FG001|Overall Study|Death|0|||
144282379|NCT02965716|520234652|FG000|Overall Study|Not Protocol Specified|1|||
144282380|NCT02965716|520234653|FG001|Overall Study|Not Protocol Specified|3|||
144282381|NCT06262607|520234654|FG000|Overall Study|Physician Decision|0|||
144282382|NCT06262607|520234655|FG001|Overall Study|Physician Decision|1|||
144282383|NCT06262607|520234654|FG000|Overall Study|Withdrawal by Subject|2|||
144282384|NCT06262607|520234655|FG001|Overall Study|Withdrawal by Subject|0|||
144282385|NCT02029443|520234657|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
144282386|NCT02029443|520234658|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
144282387|NCT02029443|520234659|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
144282388|NCT02029443|520234660|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
144282389|NCT02029443|520234661|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
144282390|NCT02029443|520234657|FG000|Overall Study|Death|13|||
144282391|NCT02029443|520234658|FG001|Overall Study|Death|2|||
144282392|NCT02029443|520234659|FG002|Overall Study|Death|2|||
144282393|NCT02029443|520234660|FG003|Overall Study|Death|11|||
144282394|NCT02029443|520234661|FG004|Overall Study|Death|2|||
144282395|NCT02029443|520234657|FG000|Overall Study|Lost to Follow-up|1|||
144282396|NCT02029443|520234658|FG001|Overall Study|Lost to Follow-up|0|||
144282397|NCT02029443|520234659|FG002|Overall Study|Lost to Follow-up|1|||
144282398|NCT02029443|520234660|FG003|Overall Study|Lost to Follow-up|1|||
144282399|NCT02029443|520234661|FG004|Overall Study|Lost to Follow-up|0|||
144282400|NCT02029443|520234657|FG000|Overall Study|Started other anti-cancer therapy|17|||
144282401|NCT02029443|520234658|FG001|Overall Study|Started other anti-cancer therapy|4|||
144282402|NCT02029443|520234659|FG002|Overall Study|Started other anti-cancer therapy|7|||
144282403|NCT02029443|520234660|FG003|Overall Study|Started other anti-cancer therapy|9|||
144282404|NCT02029443|520234661|FG004|Overall Study|Started other anti-cancer therapy|3|||
144282405|NCT02029443|520234657|FG000|Overall Study|Withdrawal by Subject|3|||
144282406|NCT02029443|520234658|FG001|Overall Study|Withdrawal by Subject|1|||
144282407|NCT02029443|520234659|FG002|Overall Study|Withdrawal by Subject|1|||
144282408|NCT02029443|520234660|FG003|Overall Study|Withdrawal by Subject|1|||
144282409|NCT02029443|520234661|FG004|Overall Study|Withdrawal by Subject|0|||
144282410|NCT02029443|520234657|FG000|Overall Study|Other|6|||
144282411|NCT02029443|520234658|FG001|Overall Study|Other|6|||
144282412|NCT02029443|520234659|FG002|Overall Study|Other|4|||
144282413|NCT02029443|520234660|FG003|Overall Study|Other|2|||
144282414|NCT02029443|520234661|FG004|Overall Study|Other|0|||
144282415|NCT05630755|520234663|FG000|Overall Study|Lost to Follow-up|7|||
144282416|NCT05630755|520234664|FG001|Overall Study|Lost to Follow-up|0|||
144282417|NCT05630755|520234663|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
144282418|NCT05630755|520234664|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
144282419|NCT05630755|520234663|FG000|Overall Study|Withdrawal by Subject|9|||
144282420|NCT05630755|520234664|FG001|Overall Study|Withdrawal by Subject|3|||
144282421|NCT05630755|520234663|FG000|Overall Study|Participant moved away from trial site|0|||
144282422|NCT05630755|520234664|FG001|Overall Study|Participant moved away from trial site|1|||
144282423|NCT05630755|520234663|FG000|Overall Study|Status not Recorded|316|||
144282424|NCT05630755|520234664|FG001|Overall Study|Status not Recorded|161|||
144282425|NCT05950906|520234666|FG000|Overall Study|Adverse Event|0|||
144282426|NCT05950906|520234667|FG001|Overall Study|Adverse Event|0|||
144282427|NCT05950906|520234668|FG002|Overall Study|Adverse Event|0|||
144282428|NCT05950906|520234669|FG003|Overall Study|Adverse Event|0|||
144282429|NCT05950906|520234670|FG004|Overall Study|Adverse Event|0|||
144282430|NCT05950906|520234671|FG005|Overall Study|Adverse Event|0|||
144282431|NCT05950906|520234672|FG006|Overall Study|Adverse Event|0|||
144282432|NCT05950906|520234673|FG007|Overall Study|Adverse Event|0|||
144282433|NCT05950906|520234674|FG008|Overall Study|Adverse Event|0|||
144282434|NCT05950906|520234675|FG009|Overall Study|Adverse Event|0|||
144282435|NCT05950906|520234676|FG010|Overall Study|Adverse Event|0|||
144282436|NCT05950906|520234677|FG011|Overall Study|Adverse Event|0|||
144282437|NCT05950906|520234678|FG012|Overall Study|Adverse Event|1|||
144282438|NCT05950906|520234679|FG013|Overall Study|Adverse Event|0|||
144282439|NCT05950906|520234666|FG000|Overall Study|Physician Decision|0|||
144282440|NCT05950906|520234667|FG001|Overall Study|Physician Decision|0|||
144282441|NCT05950906|520234668|FG002|Overall Study|Physician Decision|0|||
144282442|NCT05950906|520234669|FG003|Overall Study|Physician Decision|0|||
144282443|NCT05950906|520234670|FG004|Overall Study|Physician Decision|0|||
144282444|NCT05950906|520234671|FG005|Overall Study|Physician Decision|0|||
144282445|NCT05950906|520234672|FG006|Overall Study|Physician Decision|0|||
144282446|NCT05950906|520234673|FG007|Overall Study|Physician Decision|0|||
144282447|NCT05950906|520234674|FG008|Overall Study|Physician Decision|0|||
144282448|NCT05950906|520234675|FG009|Overall Study|Physician Decision|0|||
144282449|NCT05950906|520234676|FG010|Overall Study|Physician Decision|0|||
144282450|NCT05950906|520234677|FG011|Overall Study|Physician Decision|0|||
144282451|NCT05950906|520234678|FG012|Overall Study|Physician Decision|1|||
144282452|NCT05950906|520234679|FG013|Overall Study|Physician Decision|0|||
144282453|NCT04868682|520234680|FG000|Post-treatment|Lost to Follow-up|1|||
144282454|NCT04868682|520234681|FG001|Post-treatment|Lost to Follow-up|1|||
144282455|NCT04868682|520234680|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
144282456|NCT04868682|520234681|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
144282457|NCT04868682|520234680|FG000|Six-month Assessment|Lost to Follow-up|1|||
144282458|NCT04868682|520234681|FG001|Six-month Assessment|Lost to Follow-up|0|||
144282459|NCT04868682|520234680|FG000|Six-month Assessment|Death|1|||
144245409|NCT01447446|520096200|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
144245410|NCT01447446|520096201|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
144245411|NCT01447446|520096202|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
144245412|NCT01447446|520096197|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
144245413|NCT01447446|520096198|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
144245414|NCT01447446|520096199|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
144245415|NCT01447446|520096200|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
144245416|NCT01447446|520096201|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
144245417|NCT01447446|520096202|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
144245418|NCT01447446|520096197|FG000|Overall Study|Administrative/Other|34|||
144245419|NCT01447446|520096198|FG001|Overall Study|Administrative/Other|9|||
144245420|NCT01447446|520096199|FG002|Overall Study|Administrative/Other|10|||
144245421|NCT01447446|520096200|FG003|Overall Study|Administrative/Other|2|||
144245422|NCT01447446|520096201|FG004|Overall Study|Administrative/Other|33|||
144245423|NCT01447446|520096202|FG005|Overall Study|Administrative/Other|4|||
144245424|NCT01447446|520096197|FG000|Overall Study|SVR12 Assessment|13|||
144245425|NCT01447446|520096198|FG001|Overall Study|SVR12 Assessment|1|||
144245426|NCT01447446|520096199|FG002|Overall Study|SVR12 Assessment|2|||
144245427|NCT01447446|520096200|FG003|Overall Study|SVR12 Assessment|1|||
144245428|NCT01447446|520096201|FG004|Overall Study|SVR12 Assessment|5|||
144245429|NCT01447446|520096202|FG005|Overall Study|SVR12 Assessment|5|||
144245430|NCT01447446|520096197|FG000|Overall Study|New Treatment Started|8|||
144245431|NCT01447446|520096198|FG001|Overall Study|New Treatment Started|2|||
144245432|NCT01447446|520096199|FG002|Overall Study|New Treatment Started|1|||
144245433|NCT01447446|520096200|FG003|Overall Study|New Treatment Started|0|||
144245434|NCT01447446|520096201|FG004|Overall Study|New Treatment Started|2|||
144245435|NCT01447446|520096202|FG005|Overall Study|New Treatment Started|0|||
144245436|NCT01447446|520096197|FG000|Overall Study|Reason not Specified|1|||
144245437|NCT01447446|520096198|FG001|Overall Study|Reason not Specified|1|||
144245438|NCT01447446|520096199|FG002|Overall Study|Reason not Specified|1|||
144245439|NCT01447446|520096200|FG003|Overall Study|Reason not Specified|1|||
144245440|NCT01447446|520096201|FG004|Overall Study|Reason not Specified|1|||
144245441|NCT01447446|520096202|FG005|Overall Study|Reason not Specified|0|||
144245442|NCT02609724|520096206|FG000|Overall Study|Death|2|||
144245443|NCT02609724|520096207|FG001|Overall Study|Death|0|||
144245444|NCT02609724|520096208|FG002|Overall Study|Death|1|||
144245445|NCT02609724|520096206|FG000|Overall Study|Withdrawal by Subject|1|||
144282460|NCT04868682|520234681|FG001|Six-month Assessment|Death|0|||
144282461|NCT04868682|520234680|FG000|Six-month Assessment|Refused|0|||
144282462|NCT04868682|520234681|FG001|Six-month Assessment|Refused|1|||
144282463|NCT04868682|520234680|FG000|12-month Assessment|Lost to Follow-up|2|||
144282464|NCT04868682|520234681|FG001|12-month Assessment|Lost to Follow-up|1|||
144282465|NCT04868682|520234680|FG000|12-month Assessment|Death|0|||
144245446|NCT02609724|520096207|FG001|Overall Study|Withdrawal by Subject|2|||
144245447|NCT02609724|520096208|FG002|Overall Study|Withdrawal by Subject|3|||
144282466|NCT04868682|520234681|FG001|12-month Assessment|Death|1|||
144282467|NCT02541903|520234682|FG000|Overall Study|Death|1|||
144282468|NCT03880565|520234687|FG000|Overall Study|Withdrawal by Subject|1|||
144282469|NCT03880565|520234688|FG001|Overall Study|Withdrawal by Subject|0|||
144282470|NCT02969018|520234689|FG000|Overall Study|Adverse Event|2|||
144282471|NCT02969018|520234690|FG001|Overall Study|Adverse Event|4|||
144282472|NCT02969018|520234691|FG002|Overall Study|Adverse Event|1|||
144282473|NCT02969018|520234692|FG003|Overall Study|Adverse Event|2|||
144282474|NCT02969018|520234693|FG004|Overall Study|Adverse Event|0|||
144282475|NCT02969018|520234694|FG005|Overall Study|Adverse Event|1|||
144282476|NCT02969018|520234695|FG006|Overall Study|Adverse Event|2|||
144282477|NCT02969018|520234696|FG007|Overall Study|Adverse Event|0|||
144282478|NCT02969018|520234689|FG000|Overall Study|Lack of Efficacy|0|||
144282479|NCT02969018|520234690|FG001|Overall Study|Lack of Efficacy|1|||
144282480|NCT02969018|520234691|FG002|Overall Study|Lack of Efficacy|0|||
144282481|NCT02969018|520234692|FG003|Overall Study|Lack of Efficacy|0|||
144282482|NCT02969018|520234693|FG004|Overall Study|Lack of Efficacy|1|||
144282483|NCT02969018|520234694|FG005|Overall Study|Lack of Efficacy|1|||
144282484|NCT02969018|520234695|FG006|Overall Study|Lack of Efficacy|1|||
144282485|NCT02969018|520234696|FG007|Overall Study|Lack of Efficacy|1|||
144282486|NCT02969018|520234689|FG000|Overall Study|Lost to Follow-up|1|||
144282487|NCT02969018|520234690|FG001|Overall Study|Lost to Follow-up|2|||
144282488|NCT02969018|520234691|FG002|Overall Study|Lost to Follow-up|2|||
144282489|NCT02969018|520234692|FG003|Overall Study|Lost to Follow-up|0|||
144282490|NCT02969018|520234693|FG004|Overall Study|Lost to Follow-up|1|||
144282491|NCT02969018|520234694|FG005|Overall Study|Lost to Follow-up|1|||
144282492|NCT02969018|520234695|FG006|Overall Study|Lost to Follow-up|0|||
144282493|NCT02969018|520234696|FG007|Overall Study|Lost to Follow-up|1|||
144282494|NCT02969018|520234689|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282495|NCT02969018|520234690|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282496|NCT02969018|520234691|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282497|NCT02969018|520234692|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282498|NCT02969018|520234693|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282499|NCT02969018|520234694|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282500|NCT02969018|520234695|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
144282501|NCT02969018|520234696|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
144282502|NCT02969018|520234689|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144282503|NCT02969018|520234690|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144282504|NCT02969018|520234691|FG002|Overall Study|Non-Compliance With Study Drug|0|||
144282505|NCT02969018|520234692|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144282506|NCT02969018|520234693|FG004|Overall Study|Non-Compliance With Study Drug|0|||
144282507|NCT02969018|520234694|FG005|Overall Study|Non-Compliance With Study Drug|0|||
144282508|NCT02969018|520234695|FG006|Overall Study|Non-Compliance With Study Drug|0|||
144282509|NCT02969018|520234696|FG007|Overall Study|Non-Compliance With Study Drug|0|||
144282510|NCT02969018|520234689|FG000|Overall Study|Other|0|||
144282511|NCT02969018|520234690|FG001|Overall Study|Other|0|||
144282512|NCT02969018|520234691|FG002|Overall Study|Other|0|||
144282513|NCT02969018|520234692|FG003|Overall Study|Other|1|||
144282514|NCT02969018|520234693|FG004|Overall Study|Other|0|||
144282515|NCT02969018|520234694|FG005|Overall Study|Other|0|||
144282516|NCT02969018|520234695|FG006|Overall Study|Other|0|||
144282517|NCT02969018|520234696|FG007|Overall Study|Other|2|||
144282518|NCT02969018|520234689|FG000|Overall Study|Pregnancy|0|||
144282519|NCT02969018|520234690|FG001|Overall Study|Pregnancy|0|||
144282520|NCT02969018|520234691|FG002|Overall Study|Pregnancy|0|||
144282521|NCT02969018|520234692|FG003|Overall Study|Pregnancy|0|||
144282522|NCT02969018|520234693|FG004|Overall Study|Pregnancy|0|||
144282523|NCT02969018|520234694|FG005|Overall Study|Pregnancy|1|||
144282524|NCT02969018|520234695|FG006|Overall Study|Pregnancy|0|||
144282525|NCT02969018|520234696|FG007|Overall Study|Pregnancy|0|||
144282526|NCT02969018|520234689|FG000|Overall Study|Protocol Violation|0|||
144282527|NCT02969018|520234690|FG001|Overall Study|Protocol Violation|0|||
144282528|NCT02969018|520234691|FG002|Overall Study|Protocol Violation|1|||
144282529|NCT02969018|520234692|FG003|Overall Study|Protocol Violation|1|||
144282530|NCT02969018|520234693|FG004|Overall Study|Protocol Violation|0|||
144282531|NCT02969018|520234694|FG005|Overall Study|Protocol Violation|0|||
144282532|NCT02969018|520234695|FG006|Overall Study|Protocol Violation|0|||
144282533|NCT02969018|520234696|FG007|Overall Study|Protocol Violation|0|||
144282534|NCT02969018|520234689|FG000|Overall Study|Withdrawal by Subject|0|||
144282535|NCT02969018|520234690|FG001|Overall Study|Withdrawal by Subject|1|||
144282536|NCT02969018|520234691|FG002|Overall Study|Withdrawal by Subject|2|||
144282537|NCT02969018|520234692|FG003|Overall Study|Withdrawal by Subject|1|||
144282538|NCT02969018|520234693|FG004|Overall Study|Withdrawal by Subject|0|||
144282539|NCT02969018|520234694|FG005|Overall Study|Withdrawal by Subject|4|||
144282540|NCT02969018|520234695|FG006|Overall Study|Withdrawal by Subject|4|||
144282541|NCT02969018|520234696|FG007|Overall Study|Withdrawal by Subject|3|||
144282542|NCT02691663|520234700|FG000|Overall Study|Screen failure after baseline|2|||
144282543|NCT02691663|520234701|FG001|Overall Study|Screen failure after baseline|2|||
144282544|NCT02691663|520234700|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
144282545|NCT02691663|520234701|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
144282546|NCT02691663|520234700|FG000|Overall Study|Withdrawn after Follow up 2|1|||
144282547|NCT02691663|520234701|FG001|Overall Study|Withdrawn after Follow up 2|1|||
144282548|NCT02691663|520234700|FG000|Overall Study|Lost to Follow-up|3|||
144282549|NCT02691663|520234701|FG001|Overall Study|Lost to Follow-up|2|||
144282550|NCT00933166|520234704|FG000|Overall Study|Lost to Follow-up|4|||
144282551|NCT00933166|520234704|FG000|Overall Study|Lack of Efficacy|9|||
144282552|NCT00933166|520234704|FG000|Overall Study|Unavailable|4|||
144282553|NCT00933166|520234704|FG000|Overall Study|Withdrawal by Subject|1|||
144282554|NCT04618471|520234705|FG000|Overall Study|Screen Failure|62|||
144282555|NCT04618471|520234705|FG000|Overall Study|Withdrawal by Subject|6|||
144282556|NCT04618471|520234705|FG000|Overall Study|Physician Decision|2|||
144282557|NCT04618471|520234705|FG000|Overall Study|Lost to Follow-up|1|||
144282558|NCT04618471|520234705|FG000|Overall Study|Various other reasons|2|||
144297137|NCT03559530|520292452|FG001|Overall Study|contamination / colonization|0|||
144245448|NCT02609724|520096206|FG000|Overall Study|Illness|2|||
144245449|NCT02609724|520096207|FG001|Overall Study|Illness|1|||
144245450|NCT02609724|520096208|FG002|Overall Study|Illness|0|||
144245451|NCT03077659|520096209|FG000|Overall Study|Withdrawal by Subject|0|||
144245452|NCT03077659|520096210|FG001|Overall Study|Withdrawal by Subject|0|||
144245453|NCT03077659|520096211|FG002|Overall Study|Withdrawal by Subject|1|||
144245454|NCT00435487|520096217|FG000|Overall Study|Death|3|||
144245455|NCT00435487|520096218|FG001|Overall Study|Death|4|||
144245456|NCT00435487|520096217|FG000|Overall Study|Adverse Event|0|||
144245457|NCT00435487|520096218|FG001|Overall Study|Adverse Event|3|||
144245458|NCT00435487|520096217|FG000|Overall Study|Lost to Follow-up|2|||
144245459|NCT00435487|520096218|FG001|Overall Study|Lost to Follow-up|2|||
144245460|NCT00435487|520096217|FG000|Overall Study|Other|5|||
144282559|NCT04618471|520234705|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
144282560|NCT04425018|520234706|FG000|Overall Study|Withdrawal by Subject|1|||
144282561|NCT04425018|520234707|FG001|Overall Study|Withdrawal by Subject|2|||
144282562|NCT01944774|520234708|FG000|Overall Study|Withdrawal by Subject|2|||
144282563|NCT01944774|520234709|FG001|Overall Study|Withdrawal by Subject|3|||
144282564|NCT01944774|520234710|FG002|Overall Study|Withdrawal by Subject|3|||
144282565|NCT01944774|520234708|FG000|Overall Study|Adverse Event|3|||
144282566|NCT01944774|520234709|FG001|Overall Study|Adverse Event|2|||
144282567|NCT01944774|520234710|FG002|Overall Study|Adverse Event|3|||
144282568|NCT01944774|520234708|FG000|Overall Study|Lack of Efficacy|1|||
144282569|NCT01944774|520234709|FG001|Overall Study|Lack of Efficacy|2|||
144282570|NCT01944774|520234710|FG002|Overall Study|Lack of Efficacy|2|||
144282571|NCT01944774|520234708|FG000|Overall Study|Lost to Follow-up|0|||
144282572|NCT01944774|520234709|FG001|Overall Study|Lost to Follow-up|1|||
144282573|NCT01944774|520234710|FG002|Overall Study|Lost to Follow-up|0|||
144282574|NCT05774977|520234711|FG000|Overall Study|Withdrawal by Subject|2|||
144282575|NCT00374868|520234714|FG000|Overall Study|Adverse Event|12|||
144282576|NCT00374868|520234714|FG000|Overall Study|Progressive Disease|7|||
144282577|NCT00374868|520234714|FG000|Overall Study|Physician Decision|13|||
144282578|NCT00374868|520234714|FG000|Overall Study|Lost to Follow-up|1|||
144282579|NCT00374868|520234714|FG000|Overall Study|Death|2|||
144282580|NCT00374868|520234714|FG000|Overall Study|Other - Not Specified|1|||
144282581|NCT03188185|520234715|FG000|Stage 1|Adverse Event|4|||
144282582|NCT03188185|520234716|FG001|Stage 1|Adverse Event|12|||
144282583|NCT03188185|520234717|FG002|Stage 1|Adverse Event|0|||
144282584|NCT03188185|520234718|FG003|Stage 1|Adverse Event|0|||
144282585|NCT03188185|520234715|FG000|Stage 1|Lack of Efficacy|0|||
144282586|NCT03188185|520234716|FG001|Stage 1|Lack of Efficacy|2|||
144282587|NCT03188185|520234717|FG002|Stage 1|Lack of Efficacy|0|||
144282588|NCT03188185|520234718|FG003|Stage 1|Lack of Efficacy|0|||
144282589|NCT03188185|520234715|FG000|Stage 1|Lost to Follow-up|6|||
144282590|NCT03188185|520234716|FG001|Stage 1|Lost to Follow-up|1|||
144282591|NCT03188185|520234717|FG002|Stage 1|Lost to Follow-up|0|||
144282592|NCT03188185|520234718|FG003|Stage 1|Lost to Follow-up|0|||
144282593|NCT03188185|520234715|FG000|Stage 1|Withdrawal by Subject|9|||
144282594|NCT03188185|520234716|FG001|Stage 1|Withdrawal by Subject|0|||
144282595|NCT03188185|520234717|FG002|Stage 1|Withdrawal by Subject|0|||
144282596|NCT03188185|520234718|FG003|Stage 1|Withdrawal by Subject|0|||
144282597|NCT03188185|520234715|FG000|Stage 1|Identified as a professional patient|0|||
144282598|NCT03188185|520234716|FG001|Stage 1|Identified as a professional patient|1|||
144282599|NCT03188185|520234717|FG002|Stage 1|Identified as a professional patient|0|||
144245461|NCT00435487|520096218|FG001|Overall Study|Other|2|||
144245462|NCT00435487|520096217|FG000|Overall Study|Withdrawal by Subject|2|||
144245463|NCT00435487|520096218|FG001|Overall Study|Withdrawal by Subject|1|||
144245464|NCT00435487|520096217|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
144245465|NCT00435487|520096218|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
144245466|NCT00435487|520096217|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
144245467|NCT00435487|520096218|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
144245468|NCT00835679|520096222|FG000|Overall Study|Withdrawal by Subject|1|||
144245469|NCT00835679|520096223|FG001|Overall Study|Withdrawal by Subject|0|||
144297138|NCT03038087|520292457|FG000|Overall Study|lost data|1|||
144297139|NCT01605097|520292458|FG000|Overall Study|Protocol Violation|1|||
144245470|NCT00835679|520096224|FG002|Overall Study|Withdrawal by Subject|0|||
144245471|NCT00835679|520096225|FG003|Overall Study|Withdrawal by Subject|0|||
144245472|NCT00483704|520096228|FG000|Randomization|Withdrawal by Subject|19|||
144245473|NCT00483704|520096229|FG001|Randomization|Withdrawal by Subject|28|||
144245474|NCT00483704|520096230|FG002|Randomization|Withdrawal by Subject|18|||
144245475|NCT00483704|520096228|FG000|Randomization|Protocol Violation|14|||
144245476|NCT00483704|520096229|FG001|Randomization|Protocol Violation|25|||
144245477|NCT00483704|520096230|FG002|Randomization|Protocol Violation|22|||
144245478|NCT00483704|520096228|FG000|Randomization|Lost to Follow-up|14|||
144245479|NCT00483704|520096229|FG001|Randomization|Lost to Follow-up|14|||
144245480|NCT00483704|520096230|FG002|Randomization|Lost to Follow-up|19|||
144245481|NCT00483704|520096228|FG000|Randomization|Pregnancy|1|||
144245482|NCT00483704|520096229|FG001|Randomization|Pregnancy|0|||
144245483|NCT00483704|520096230|FG002|Randomization|Pregnancy|0|||
144245484|NCT00483704|520096228|FG000|Randomization|Physician Decision|2|||
144245485|NCT00483704|520096229|FG001|Randomization|Physician Decision|4|||
144245486|NCT00483704|520096230|FG002|Randomization|Physician Decision|0|||
144245487|NCT00483704|520096228|FG000|Randomization|Progressive disease|0|||
144245488|NCT00483704|520096229|FG001|Randomization|Progressive disease|0|||
144245489|NCT00483704|520096230|FG002|Randomization|Progressive disease|1|||
144245490|NCT00483704|520096228|FG000|Randomization|Lack of qualifying migraines|21|||
144245491|NCT00483704|520096229|FG001|Randomization|Lack of qualifying migraines|25|||
144245492|NCT00483704|520096230|FG002|Randomization|Lack of qualifying migraines|31|||
144245493|NCT00483704|520096228|FG000|Treatment|Lack of qualifying migraines|101|||
144245494|NCT00483704|520096229|FG001|Treatment|Lack of qualifying migraines|99|||
144245495|NCT00483704|520096230|FG002|Treatment|Lack of qualifying migraines|116|||
144245496|NCT00483704|520096228|FG000|Treatment|Adverse Event|3|||
144245497|NCT00483704|520096229|FG001|Treatment|Adverse Event|5|||
144245498|NCT00483704|520096230|FG002|Treatment|Adverse Event|4|||
144245499|NCT00483704|520096228|FG000|Treatment|Withdrawal by Subject|16|||
144245500|NCT00483704|520096229|FG001|Treatment|Withdrawal by Subject|12|||
144245501|NCT00483704|520096230|FG002|Treatment|Withdrawal by Subject|21|||
144245502|NCT00483704|520096228|FG000|Treatment|Protocol Violation|6|||
144245503|NCT00483704|520096229|FG001|Treatment|Protocol Violation|3|||
144245504|NCT00483704|520096230|FG002|Treatment|Protocol Violation|5|||
144245505|NCT00483704|520096228|FG000|Treatment|Lost to Follow-up|2|||
144245506|NCT00483704|520096229|FG001|Treatment|Lost to Follow-up|7|||
144245507|NCT00483704|520096230|FG002|Treatment|Lost to Follow-up|5|||
144245508|NCT00483704|520096228|FG000|Treatment|Lack of Efficacy|1|||
144245509|NCT00483704|520096229|FG001|Treatment|Lack of Efficacy|1|||
144245510|NCT00483704|520096230|FG002|Treatment|Lack of Efficacy|1|||
144245511|NCT00483704|520096228|FG000|Treatment|Pregnancy|0|||
144245512|NCT00483704|520096229|FG001|Treatment|Pregnancy|1|||
144245513|NCT00483704|520096230|FG002|Treatment|Pregnancy|0|||
144245514|NCT00483704|520096228|FG000|Treatment|Physician Decision|0|||
144245515|NCT00483704|520096229|FG001|Treatment|Physician Decision|1|||
144245516|NCT00483704|520096230|FG002|Treatment|Physician Decision|4|||
144282600|NCT03188185|520234718|FG003|Stage 1|Identified as a professional patient|0|||
144282601|NCT03188185|520234715|FG000|Stage 2|Adverse Event|0|||
144282602|NCT03188185|520234716|FG001|Stage 2|Adverse Event|0|||
144282603|NCT03188185|520234717|FG002|Stage 2|Adverse Event|2|||
144282604|NCT03188185|520234718|FG003|Stage 2|Adverse Event|4|||
144282605|NCT03188185|520234715|FG000|Stage 2|Lack of Efficacy|0|||
144282606|NCT03188185|520234716|FG001|Stage 2|Lack of Efficacy|0|||
144245517|NCT00204477|520096232|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
144245518|NCT00204477|520096233|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
144245519|NCT00204477|520096232|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
144245520|NCT00204477|520096233|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
144245521|NCT03619902|520096234|FG000|Overall Study|Termination of Study by Investigator|1|||
144245522|NCT03619902|520096234|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
144245523|NCT02923245|520096235|FG000|Overall Study|ultrasound order was cancelled|2|||
144282607|NCT03188185|520234717|FG002|Stage 2|Lack of Efficacy|3|||
144282608|NCT03188185|520234718|FG003|Stage 2|Lack of Efficacy|0|||
144282609|NCT03188185|520234715|FG000|Stage 2|Lost to Follow-up|0|||
144282610|NCT03188185|520234716|FG001|Stage 2|Lost to Follow-up|0|||
144282611|NCT03188185|520234717|FG002|Stage 2|Lost to Follow-up|1|||
144282612|NCT03188185|520234718|FG003|Stage 2|Lost to Follow-up|0|||
144282613|NCT03188185|520234715|FG000|Stage 2|Physician Decision|0|||
144282614|NCT03188185|520234716|FG001|Stage 2|Physician Decision|0|||
144282615|NCT03188185|520234717|FG002|Stage 2|Physician Decision|0|||
144282616|NCT03188185|520234718|FG003|Stage 2|Physician Decision|1|||
144282617|NCT03188185|520234715|FG000|Stage 2|Withdrawal by Subject|0|||
144282618|NCT03188185|520234716|FG001|Stage 2|Withdrawal by Subject|0|||
144282619|NCT03188185|520234717|FG002|Stage 2|Withdrawal by Subject|3|||
144282620|NCT03188185|520234718|FG003|Stage 2|Withdrawal by Subject|1|||
144282621|NCT03325439|520234719|FG000|Overall Study|Ineligibility|3|||
144282622|NCT00774748|520234720|FG000|Overall Study|Lost to Follow-up|3|||
144282623|NCT03998462|520234721|FG000|Overall Study|Withdrawal by Subject|10|||
144282624|NCT03998462|520234722|FG001|Overall Study|Withdrawal by Subject|4|||
144282625|NCT03998462|520234721|FG000|Overall Study|Lost to Follow-up|1|||
144282626|NCT03998462|520234722|FG001|Overall Study|Lost to Follow-up|0|||
144282627|NCT03998462|520234721|FG000|Overall Study|Technical Difficulties|1|||
144282628|NCT03998462|520234722|FG001|Overall Study|Technical Difficulties|2|||
144282629|NCT02965833|520234723|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
144282630|NCT02965833|520234724|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
144282631|NCT02965833|520234723|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
144282632|NCT02965833|520234724|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
144282633|NCT02965833|520234723|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
144282634|NCT02965833|520234724|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
144282635|NCT02965833|520234723|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
144297140|NCT02038647|520292459|FG000|Overall Study|Progressive Disease|50|||
144282636|NCT02965833|520234724|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
144282637|NCT02965833|520234723|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
144282638|NCT02965833|520234724|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
144282639|NCT03370302|520234729|FG000|Dose Escalation Phase|Other|0|||
144282640|NCT03370302|520234730|FG001|Dose Escalation Phase|Other|1|||
144282641|NCT03370302|520234731|FG002|Dose Escalation Phase|Other|1|||
144282642|NCT03370302|520234732|FG003|Dose Escalation Phase|Other|0|||
144282643|NCT03370302|520234733|FG004|Dose Escalation Phase|Other|0|||
144282644|NCT03370302|520234734|FG005|Dose Escalation Phase|Other|0|||
144282645|NCT03370302|520234729|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
144282646|NCT03370302|520234730|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
144282647|NCT03370302|520234731|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
144282648|NCT03370302|520234732|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144282649|NCT03370302|520234733|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
144282650|NCT03370302|520234734|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
144282651|NCT03370302|520234729|FG000|Dose Escalation Phase|Adverse Event|1|||
144282652|NCT03370302|520234730|FG001|Dose Escalation Phase|Adverse Event|0|||
144282653|NCT03370302|520234731|FG002|Dose Escalation Phase|Adverse Event|2|||
144282654|NCT03370302|520234732|FG003|Dose Escalation Phase|Adverse Event|0|||
144282655|NCT03370302|520234733|FG004|Dose Escalation Phase|Adverse Event|0|||
144282656|NCT03370302|520234734|FG005|Dose Escalation Phase|Adverse Event|0|||
144282657|NCT03370302|520234729|FG000|Dose Escalation Phase|Progressive Disease|2|||
144282658|NCT03370302|520234730|FG001|Dose Escalation Phase|Progressive Disease|4|||
144282659|NCT03370302|520234731|FG002|Dose Escalation Phase|Progressive Disease|2|||
144282660|NCT03370302|520234732|FG003|Dose Escalation Phase|Progressive Disease|0|||
144282661|NCT03370302|520234733|FG004|Dose Escalation Phase|Progressive Disease|3|||
144282662|NCT03370302|520234734|FG005|Dose Escalation Phase|Progressive Disease|1|||
144282663|NCT03370302|520234729|FG000|Dose Expansion Phase|Progressive Disease|0|||
144282664|NCT03370302|520234730|FG001|Dose Expansion Phase|Progressive Disease|0|||
144282665|NCT03370302|520234731|FG002|Dose Expansion Phase|Progressive Disease|0|||
144282666|NCT03370302|520234732|FG003|Dose Expansion Phase|Progressive Disease|6|||
144282667|NCT03370302|520234733|FG004|Dose Expansion Phase|Progressive Disease|0|||
144282668|NCT03370302|520234734|FG005|Dose Expansion Phase|Progressive Disease|0|||
144282669|NCT06061952|520234736|FG000|Overall Study|Withdrawal by Subject|1|||
144282670|NCT06061952|520234737|FG001|Overall Study|Withdrawal by Subject|2|||
144282671|NCT06061952|520234736|FG000|Overall Study|Lost to Follow-up|2|||
144282672|NCT06061952|520234737|FG001|Overall Study|Lost to Follow-up|2|||
144282673|NCT01685437|520234741|FG000|Overall Study|Withdrawal by Subject|22|||
144282674|NCT01685437|520234741|FG000|Overall Study|Lost to Follow-up|3|||
144282675|NCT01685437|520234741|FG000|Overall Study|Adverse Event|1|||
144282676|NCT01685437|520234741|FG000|Overall Study|Protocol Violation|4|||
144282677|NCT01685437|520234741|FG000|Overall Study|Unable to make visits due to work|1|||
144282678|NCT00552058|520235680|FG000|Overall Study|Adverse Event|8|||
144282679|NCT00552058|520235681|FG001|Overall Study|Adverse Event|7|||
144282680|NCT00552058|520235680|FG000|Overall Study|Lack of Efficacy|1|||
144282681|NCT00552058|520235681|FG001|Overall Study|Lack of Efficacy|5|||
144282682|NCT00552058|520235680|FG000|Overall Study|Lost to Follow-up|1|||
144282683|NCT00552058|520235681|FG001|Overall Study|Lost to Follow-up|0|||
144282684|NCT00552058|520235680|FG000|Overall Study|Withdrawal by Subject|4|||
144282685|NCT00552058|520235681|FG001|Overall Study|Withdrawal by Subject|4|||
144282686|NCT00552058|520235680|FG000|Overall Study|Other: Protocol Violation|0|||
144282687|NCT00552058|520235681|FG001|Overall Study|Other: Protocol Violation|1|||
144282688|NCT00552058|520235680|FG000|Overall Study|Other: Non Compliance|1|||
144282689|NCT00552058|520235681|FG001|Overall Study|Other: Non Compliance|2|||
144282690|NCT00552058|520235680|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
144282691|NCT00552058|520235681|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
144282692|NCT00552058|520235680|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
144282693|NCT00552058|520235681|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
144282694|NCT00552058|520235680|FG000|Overall Study|Other: Positive Stool Result|0|||
144282695|NCT00552058|520235681|FG001|Overall Study|Other: Positive Stool Result|1|||
144282696|NCT00552058|520235680|FG000|Overall Study|Other: Randomized in error|0|||
144282697|NCT00552058|520235681|FG001|Overall Study|Other: Randomized in error|1|||
144282698|NCT00552058|520235680|FG000|Overall Study|Other: Sponsors Decision|0|||
144282699|NCT00552058|520235681|FG001|Overall Study|Other: Sponsors Decision|1|||
144282700|NCT00552058|520235680|FG000|Overall Study|Other: Early Roll Over|1|||
144282701|NCT00552058|520235681|FG001|Overall Study|Other: Early Roll Over|0|||
144282702|NCT05278065|520235682|FG000|Overall Study|Withdrawal by Subject|1|||
144282703|NCT05278065|520235683|FG001|Overall Study|Withdrawal by Subject|0|||
144282704|NCT03925220|520235686|FG000|Overall Study|Withdrawal by Subject|4|||
144245524|NCT02923245|520096236|FG001|Overall Study|ultrasound order was cancelled|1|||
144245525|NCT02326298|520096242|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245526|NCT02326298|520096243|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245527|NCT02326298|520096244|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
144245528|NCT02326298|520096245|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245529|NCT02326298|520096246|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245530|NCT02326298|520096247|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245531|NCT02326298|520096248|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245532|NCT02326298|520096249|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245533|NCT02326298|520096250|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245534|NCT02326298|520096251|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245535|NCT02326298|520096252|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245536|NCT02326298|520096253|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245537|NCT02326298|520096254|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245538|NCT02326298|520096255|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
144245539|NCT02326298|520096242|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
144245540|NCT02326298|520096243|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245541|NCT02326298|520096244|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245542|NCT02326298|520096245|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245543|NCT02326298|520096246|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245544|NCT02326298|520096247|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245545|NCT02326298|520096248|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245546|NCT02326298|520096249|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245547|NCT02326298|520096250|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245548|NCT02326298|520096251|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245549|NCT02326298|520096252|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245550|NCT02326298|520096253|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245551|NCT02326298|520096254|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245552|NCT02326298|520096255|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
144245553|NCT02326298|520096242|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
144245554|NCT02326298|520096243|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
144245555|NCT02326298|520096244|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245556|NCT02326298|520096245|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144297141|NCT02038647|520292460|FG001|Overall Study|Progressive Disease|59|||
144245557|NCT02326298|520096246|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245558|NCT02326298|520096247|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245559|NCT02326298|520096248|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245560|NCT02326298|520096249|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245561|NCT02326298|520096250|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245562|NCT02326298|520096251|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245563|NCT02326298|520096252|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245564|NCT02326298|520096253|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245565|NCT02326298|520096254|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245566|NCT02326298|520096255|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
144245567|NCT02326298|520096242|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
144245568|NCT02326298|520096243|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
144245569|NCT02326298|520096244|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245570|NCT02326298|520096245|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245571|NCT02326298|520096246|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245572|NCT02326298|520096247|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245573|NCT02326298|520096248|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245574|NCT02326298|520096249|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245575|NCT02326298|520096250|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245576|NCT02326298|520096251|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245577|NCT02326298|520096252|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245578|NCT02326298|520096253|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245579|NCT02326298|520096254|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245580|NCT02326298|520096255|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
144245581|NCT02326298|520096242|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245582|NCT02326298|520096243|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245583|NCT02326298|520096244|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
144245584|NCT02326298|520096245|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245585|NCT02326298|520096246|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245586|NCT02326298|520096247|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245587|NCT02326298|520096248|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245588|NCT02326298|520096249|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245589|NCT02326298|520096250|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245590|NCT02326298|520096251|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245591|NCT02326298|520096252|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245592|NCT02326298|520096253|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245593|NCT02326298|520096254|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245594|NCT02326298|520096255|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
144245595|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144282705|NCT03925220|520235687|FG001|Overall Study|Withdrawal by Subject|4|||
144282706|NCT03925220|520235688|FG002|Overall Study|Withdrawal by Subject|4|||
144282707|NCT03925220|520235689|FG003|Overall Study|Withdrawal by Subject|4|||
144282708|NCT03925220|520235686|FG000|Overall Study|Lost to Follow-up|40|||
144282709|NCT03925220|520235687|FG001|Overall Study|Lost to Follow-up|46|||
144282710|NCT03925220|520235688|FG002|Overall Study|Lost to Follow-up|37|||
144282711|NCT03925220|520235689|FG003|Overall Study|Lost to Follow-up|38|||
144282712|NCT00866320|520235690|FG000|Overall Study|Withdrawal by Subject|4|||
144282713|NCT00866320|520235690|FG000|Overall Study|Death|2|||
144282714|NCT02063724|520235691|FG000|Overall Study|Disease progression|1|||
144282715|NCT01327703|520235692|FG000|Second Treatment Period|Adverse Event|1|||
144282716|NCT01327703|520235693|FG001|Second Treatment Period|Adverse Event|1|||
144282717|NCT01327703|520235692|FG000|Second Treatment Period|Protocol Violation|0|||
144282718|NCT01327703|520235693|FG001|Second Treatment Period|Protocol Violation|1|||
144282719|NCT02513563|520235694|FG000|Overall Study|Death|4|||
144282720|NCT02513563|520235694|FG000|Overall Study|Withdrawal by Subject|4|||
144282721|NCT02513563|520235694|FG000|Overall Study|Physician Decision|1|||
144282722|NCT06042855|520235696|FG000|Overall Study|No Receipt of Study Drug|48|||
144282723|NCT06042855|520235697|FG001|Overall Study|No Receipt of Study Drug|57|||
144282724|NCT06042855|520235696|FG000|Overall Study|Administratively Withdrawn|59|||
144282725|NCT06042855|520235697|FG001|Overall Study|Administratively Withdrawn|59|||
144282726|NCT06038643|520235701|FG000|Overall Study|Withdrawal by Subject|9|||
144282727|NCT06038643|520235702|FG001|Overall Study|Withdrawal by Subject|4|||
144282728|NCT06038643|520235701|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
144282729|NCT06038643|520235702|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
144282730|NCT05710224|520235704|FG000|Overall Study|Death|1|||
144282731|NCT05710224|520235705|FG001|Overall Study|Death|0|||
144282732|NCT05710224|520235704|FG000|Overall Study|Lost to Follow-up|16|||
144282733|NCT05710224|520235705|FG001|Overall Study|Lost to Follow-up|7|||
144282734|NCT05710224|520235704|FG000|Overall Study|Withdrawal by Subject|4|||
144282735|NCT05710224|520235705|FG001|Overall Study|Withdrawal by Subject|6|||
144282736|NCT05710224|520235704|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144282737|NCT05710224|520235705|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
144282738|NCT05710224|520235704|FG000|Overall Study|Participants Left The City|0|||
144282739|NCT05710224|520235705|FG001|Overall Study|Participants Left The City|2|||
144282740|NCT03369223|520235706|FG000|Overall Study|Lost to Follow-up|0|||
144282741|NCT03369223|520235707|FG001|Overall Study|Lost to Follow-up|0|||
144282742|NCT03369223|520235708|FG002|Overall Study|Lost to Follow-up|0|||
144282743|NCT03369223|520235709|FG003|Overall Study|Lost to Follow-up|0|||
144282744|NCT03369223|520235710|FG004|Overall Study|Lost to Follow-up|0|||
144282745|NCT03369223|520235711|FG005|Overall Study|Lost to Follow-up|0|||
144282746|NCT03369223|520235712|FG006|Overall Study|Lost to Follow-up|0|||
144282747|NCT03369223|520235713|FG007|Overall Study|Lost to Follow-up|0|||
144282748|NCT03369223|520235714|FG008|Overall Study|Lost to Follow-up|0|||
144282749|NCT03369223|520235715|FG009|Overall Study|Lost to Follow-up|0|||
144282750|NCT03369223|520235716|FG010|Overall Study|Lost to Follow-up|0|||
144282751|NCT03369223|520235717|FG011|Overall Study|Lost to Follow-up|0|||
144282752|NCT03369223|520235718|FG012|Overall Study|Lost to Follow-up|0|||
144282753|NCT03369223|520235719|FG013|Overall Study|Lost to Follow-up|0|||
144282754|NCT03369223|520235720|FG014|Overall Study|Lost to Follow-up|0|||
144282755|NCT03369223|520235721|FG015|Overall Study|Lost to Follow-up|0|||
144282756|NCT03369223|520235722|FG016|Overall Study|Lost to Follow-up|0|||
144282757|NCT03369223|520235723|FG017|Overall Study|Lost to Follow-up|0|||
144282758|NCT03369223|520235724|FG018|Overall Study|Lost to Follow-up|2|||
144282759|NCT03369223|520235725|FG019|Overall Study|Lost to Follow-up|1|||
144282760|NCT03369223|520235706|FG000|Overall Study|Participant no longer meets study criteria|0|||
144282761|NCT03369223|520235707|FG001|Overall Study|Participant no longer meets study criteria|0|||
144282762|NCT03369223|520235708|FG002|Overall Study|Participant no longer meets study criteria|0|||
144282763|NCT03369223|520235709|FG003|Overall Study|Participant no longer meets study criteria|0|||
144282764|NCT03369223|520235710|FG004|Overall Study|Participant no longer meets study criteria|0|||
144282765|NCT03369223|520235711|FG005|Overall Study|Participant no longer meets study criteria|0|||
144282766|NCT03369223|520235712|FG006|Overall Study|Participant no longer meets study criteria|0|||
144282767|NCT03369223|520235713|FG007|Overall Study|Participant no longer meets study criteria|0|||
144282768|NCT03369223|520235714|FG008|Overall Study|Participant no longer meets study criteria|0|||
144282769|NCT03369223|520235715|FG009|Overall Study|Participant no longer meets study criteria|0|||
144282770|NCT03369223|520235716|FG010|Overall Study|Participant no longer meets study criteria|0|||
144282771|NCT03369223|520235717|FG011|Overall Study|Participant no longer meets study criteria|0|||
144282772|NCT03369223|520235718|FG012|Overall Study|Participant no longer meets study criteria|0|||
144282773|NCT03369223|520235719|FG013|Overall Study|Participant no longer meets study criteria|0|||
144282774|NCT03369223|520235720|FG014|Overall Study|Participant no longer meets study criteria|2|||
144282775|NCT03369223|520235721|FG015|Overall Study|Participant no longer meets study criteria|0|||
144282776|NCT03369223|520235722|FG016|Overall Study|Participant no longer meets study criteria|2|||
144282777|NCT03369223|520235723|FG017|Overall Study|Participant no longer meets study criteria|0|||
144282778|NCT03369223|520235724|FG018|Overall Study|Participant no longer meets study criteria|0|||
144282779|NCT03369223|520235725|FG019|Overall Study|Participant no longer meets study criteria|0|||
144282780|NCT03369223|520235706|FG000|Overall Study|Other reasons|0|||
144282781|NCT03369223|520235707|FG001|Overall Study|Other reasons|0|||
144282782|NCT03369223|520235708|FG002|Overall Study|Other reasons|0|||
144282783|NCT03369223|520235709|FG003|Overall Study|Other reasons|0|||
144282784|NCT03369223|520235710|FG004|Overall Study|Other reasons|0|||
144282785|NCT03369223|520235711|FG005|Overall Study|Other reasons|0|||
144282786|NCT03369223|520235712|FG006|Overall Study|Other reasons|0|||
144282787|NCT03369223|520235713|FG007|Overall Study|Other reasons|0|||
144282788|NCT03369223|520235714|FG008|Overall Study|Other reasons|0|||
144282789|NCT03369223|520235715|FG009|Overall Study|Other reasons|0|||
144282790|NCT03369223|520235716|FG010|Overall Study|Other reasons|0|||
144282791|NCT03369223|520235717|FG011|Overall Study|Other reasons|0|||
144282792|NCT03369223|520235718|FG012|Overall Study|Other reasons|0|||
144282793|NCT03369223|520235719|FG013|Overall Study|Other reasons|1|||
144282794|NCT03369223|520235720|FG014|Overall Study|Other reasons|2|||
144282795|NCT03369223|520235721|FG015|Overall Study|Other reasons|0|||
144282796|NCT03369223|520235722|FG016|Overall Study|Other reasons|1|||
144282797|NCT03369223|520235723|FG017|Overall Study|Other reasons|0|||
144282798|NCT03369223|520235724|FG018|Overall Study|Other reasons|0|||
144282799|NCT03369223|520235725|FG019|Overall Study|Other reasons|2|||
144282800|NCT03369223|520235706|FG000|Overall Study|Death|0|||
144282801|NCT03369223|520235707|FG001|Overall Study|Death|0|||
144282802|NCT03369223|520235708|FG002|Overall Study|Death|0|||
144282803|NCT03369223|520235709|FG003|Overall Study|Death|0|||
144282804|NCT03369223|520235710|FG004|Overall Study|Death|0|||
144282805|NCT03369223|520235711|FG005|Overall Study|Death|0|||
144282806|NCT03369223|520235712|FG006|Overall Study|Death|0|||
144282807|NCT03369223|520235713|FG007|Overall Study|Death|0|||
144282808|NCT03369223|520235714|FG008|Overall Study|Death|0|||
144282809|NCT03369223|520235715|FG009|Overall Study|Death|0|||
144282810|NCT03369223|520235716|FG010|Overall Study|Death|0|||
144282811|NCT03369223|520235717|FG011|Overall Study|Death|0|||
144282812|NCT03369223|520235718|FG012|Overall Study|Death|0|||
144282813|NCT03369223|520235719|FG013|Overall Study|Death|1|||
144282814|NCT03369223|520235720|FG014|Overall Study|Death|0|||
144282815|NCT03369223|520235721|FG015|Overall Study|Death|0|||
144282816|NCT03369223|520235722|FG016|Overall Study|Death|0|||
144282817|NCT03369223|520235723|FG017|Overall Study|Death|0|||
144282818|NCT03369223|520235724|FG018|Overall Study|Death|1|||
144282819|NCT03369223|520235725|FG019|Overall Study|Death|0|||
144282820|NCT03369223|520235706|FG000|Overall Study|Adverse event unrelated to study drug|0|||
144282821|NCT03369223|520235707|FG001|Overall Study|Adverse event unrelated to study drug|0|||
144282822|NCT03369223|520235708|FG002|Overall Study|Adverse event unrelated to study drug|0|||
144282823|NCT03369223|520235709|FG003|Overall Study|Adverse event unrelated to study drug|0|||
144282824|NCT03369223|520235710|FG004|Overall Study|Adverse event unrelated to study drug|0|||
144282825|NCT03369223|520235711|FG005|Overall Study|Adverse event unrelated to study drug|0|||
144282826|NCT03369223|520235712|FG006|Overall Study|Adverse event unrelated to study drug|1|||
144282827|NCT03369223|520235713|FG007|Overall Study|Adverse event unrelated to study drug|0|||
144282828|NCT03369223|520235714|FG008|Overall Study|Adverse event unrelated to study drug|0|||
144282829|NCT03369223|520235715|FG009|Overall Study|Adverse event unrelated to study drug|1|||
144282830|NCT03369223|520235716|FG010|Overall Study|Adverse event unrelated to study drug|0|||
144282831|NCT03369223|520235717|FG011|Overall Study|Adverse event unrelated to study drug|0|||
144282832|NCT03369223|520235718|FG012|Overall Study|Adverse event unrelated to study drug|0|||
144282833|NCT03369223|520235719|FG013|Overall Study|Adverse event unrelated to study drug|4|||
144282834|NCT03369223|520235720|FG014|Overall Study|Adverse event unrelated to study drug|2|||
144282835|NCT03369223|520235721|FG015|Overall Study|Adverse event unrelated to study drug|0|||
144282836|NCT03369223|520235722|FG016|Overall Study|Adverse event unrelated to study drug|2|||
144282837|NCT03369223|520235723|FG017|Overall Study|Adverse event unrelated to study drug|1|||
144282838|NCT03369223|520235724|FG018|Overall Study|Adverse event unrelated to study drug|3|||
144282839|NCT03369223|520235725|FG019|Overall Study|Adverse event unrelated to study drug|2|||
144282840|NCT03369223|520235706|FG000|Overall Study|Disease progression|6|||
144282841|NCT03369223|520235707|FG001|Overall Study|Disease progression|8|||
144282842|NCT03369223|520235708|FG002|Overall Study|Disease progression|5|||
144282843|NCT03369223|520235709|FG003|Overall Study|Disease progression|1|||
144282844|NCT03369223|520235710|FG004|Overall Study|Disease progression|9|||
144282845|NCT03369223|520235711|FG005|Overall Study|Disease progression|9|||
144282846|NCT03369223|520235712|FG006|Overall Study|Disease progression|4|||
144282847|NCT03369223|520235713|FG007|Overall Study|Disease progression|6|||
144282848|NCT03369223|520235714|FG008|Overall Study|Disease progression|10|||
144282849|NCT03369223|520235715|FG009|Overall Study|Disease progression|7|||
144282850|NCT03369223|520235716|FG010|Overall Study|Disease progression|4|||
144282851|NCT03369223|520235717|FG011|Overall Study|Disease progression|1|||
144282852|NCT03369223|520235718|FG012|Overall Study|Disease progression|1|||
144282853|NCT03369223|520235719|FG013|Overall Study|Disease progression|25|||
144282854|NCT03369223|520235720|FG014|Overall Study|Disease progression|22|||
144282855|NCT03369223|520235721|FG015|Overall Study|Disease progression|2|||
144282856|NCT03369223|520235722|FG016|Overall Study|Disease progression|10|||
144282857|NCT03369223|520235723|FG017|Overall Study|Disease progression|1|||
144282858|NCT03369223|520235724|FG018|Overall Study|Disease progression|18|||
144282859|NCT03369223|520235725|FG019|Overall Study|Disease progression|28|||
144282860|NCT03369223|520235706|FG000|Overall Study|Study drug toxicity|0|||
144282861|NCT03369223|520235707|FG001|Overall Study|Study drug toxicity|1|||
144282862|NCT03369223|520235708|FG002|Overall Study|Study drug toxicity|4|||
144282863|NCT03369223|520235709|FG003|Overall Study|Study drug toxicity|0|||
144282864|NCT03369223|520235710|FG004|Overall Study|Study drug toxicity|1|||
144282865|NCT03369223|520235711|FG005|Overall Study|Study drug toxicity|2|||
144282866|NCT03369223|520235712|FG006|Overall Study|Study drug toxicity|4|||
144282867|NCT03369223|520235713|FG007|Overall Study|Study drug toxicity|2|||
144282868|NCT03369223|520235714|FG008|Overall Study|Study drug toxicity|2|||
144282869|NCT03369223|520235715|FG009|Overall Study|Study drug toxicity|0|||
144282870|NCT03369223|520235716|FG010|Overall Study|Study drug toxicity|6|||
144282871|NCT03369223|520235717|FG011|Overall Study|Study drug toxicity|1|||
144282872|NCT03369223|520235718|FG012|Overall Study|Study drug toxicity|2|||
144282873|NCT03369223|520235719|FG013|Overall Study|Study drug toxicity|19|||
144282874|NCT03369223|520235720|FG014|Overall Study|Study drug toxicity|19|||
144282875|NCT03369223|520235721|FG015|Overall Study|Study drug toxicity|0|||
144282876|NCT03369223|520235722|FG016|Overall Study|Study drug toxicity|18|||
144282877|NCT03369223|520235723|FG017|Overall Study|Study drug toxicity|3|||
144282878|NCT03369223|520235724|FG018|Overall Study|Study drug toxicity|11|||
144282879|NCT03369223|520235725|FG019|Overall Study|Study drug toxicity|7|||
144282880|NCT03369223|520235706|FG000|Overall Study|Participant request to discontinue study treatment|0|||
144282881|NCT03369223|520235707|FG001|Overall Study|Participant request to discontinue study treatment|1|||
144282882|NCT03369223|520235708|FG002|Overall Study|Participant request to discontinue study treatment|0|||
144282883|NCT03369223|520235709|FG003|Overall Study|Participant request to discontinue study treatment|0|||
144282884|NCT03369223|520235710|FG004|Overall Study|Participant request to discontinue study treatment|1|||
144282885|NCT03369223|520235711|FG005|Overall Study|Participant request to discontinue study treatment|1|||
144282886|NCT03369223|520235712|FG006|Overall Study|Participant request to discontinue study treatment|1|||
144282887|NCT03369223|520235713|FG007|Overall Study|Participant request to discontinue study treatment|0|||
144282888|NCT03369223|520235714|FG008|Overall Study|Participant request to discontinue study treatment|0|||
144282889|NCT03369223|520235715|FG009|Overall Study|Participant request to discontinue study treatment|0|||
144282890|NCT03369223|520235716|FG010|Overall Study|Participant request to discontinue study treatment|0|||
144282891|NCT03369223|520235717|FG011|Overall Study|Participant request to discontinue study treatment|0|||
144282892|NCT03369223|520235718|FG012|Overall Study|Participant request to discontinue study treatment|0|||
144282893|NCT03369223|520235719|FG013|Overall Study|Participant request to discontinue study treatment|1|||
144282894|NCT03369223|520235720|FG014|Overall Study|Participant request to discontinue study treatment|1|||
144282895|NCT03369223|520235721|FG015|Overall Study|Participant request to discontinue study treatment|0|||
144282896|NCT03369223|520235722|FG016|Overall Study|Participant request to discontinue study treatment|0|||
144282897|NCT03369223|520235723|FG017|Overall Study|Participant request to discontinue study treatment|0|||
144282898|NCT03369223|520235724|FG018|Overall Study|Participant request to discontinue study treatment|1|||
144282899|NCT03369223|520235725|FG019|Overall Study|Participant request to discontinue study treatment|0|||
144282900|NCT03369223|520235706|FG000|Overall Study|Participant withdrew consent|0|||
144282901|NCT03369223|520235707|FG001|Overall Study|Participant withdrew consent|1|||
144282902|NCT03369223|520235708|FG002|Overall Study|Participant withdrew consent|1|||
144282903|NCT03369223|520235709|FG003|Overall Study|Participant withdrew consent|0|||
144282904|NCT03369223|520235710|FG004|Overall Study|Participant withdrew consent|0|||
144282905|NCT03369223|520235711|FG005|Overall Study|Participant withdrew consent|0|||
144282906|NCT03369223|520235712|FG006|Overall Study|Participant withdrew consent|1|||
144282907|NCT03369223|520235713|FG007|Overall Study|Participant withdrew consent|1|||
144282908|NCT03369223|520235714|FG008|Overall Study|Participant withdrew consent|1|||
144282909|NCT03369223|520235715|FG009|Overall Study|Participant withdrew consent|0|||
144282910|NCT03369223|520235716|FG010|Overall Study|Participant withdrew consent|0|||
144282911|NCT03369223|520235717|FG011|Overall Study|Participant withdrew consent|1|||
144282912|NCT03369223|520235718|FG012|Overall Study|Participant withdrew consent|0|||
144282913|NCT03369223|520235719|FG013|Overall Study|Participant withdrew consent|0|||
144282914|NCT03369223|520235720|FG014|Overall Study|Participant withdrew consent|3|||
144282915|NCT03369223|520235721|FG015|Overall Study|Participant withdrew consent|0|||
144282916|NCT03369223|520235722|FG016|Overall Study|Participant withdrew consent|1|||
144282917|NCT03369223|520235723|FG017|Overall Study|Participant withdrew consent|0|||
144282918|NCT03369223|520235724|FG018|Overall Study|Participant withdrew consent|4|||
144282919|NCT03369223|520235725|FG019|Overall Study|Participant withdrew consent|2|||
144282920|NCT03369223|520235706|FG000|Overall Study|Randomized but not treated|0|||
144282921|NCT03369223|520235707|FG001|Overall Study|Randomized but not treated|0|||
144282922|NCT03369223|520235708|FG002|Overall Study|Randomized but not treated|0|||
144282923|NCT03369223|520235709|FG003|Overall Study|Randomized but not treated|0|||
144282924|NCT03369223|520235710|FG004|Overall Study|Randomized but not treated|0|||
144282925|NCT03369223|520235711|FG005|Overall Study|Randomized but not treated|0|||
144282926|NCT03369223|520235712|FG006|Overall Study|Randomized but not treated|0|||
144282927|NCT03369223|520235713|FG007|Overall Study|Randomized but not treated|0|||
144282928|NCT03369223|520235714|FG008|Overall Study|Randomized but not treated|0|||
144282929|NCT03369223|520235715|FG009|Overall Study|Randomized but not treated|0|||
144282930|NCT03369223|520235716|FG010|Overall Study|Randomized but not treated|0|||
144282931|NCT03369223|520235717|FG011|Overall Study|Randomized but not treated|0|||
144282932|NCT03369223|520235718|FG012|Overall Study|Randomized but not treated|0|||
144282933|NCT03369223|520235719|FG013|Overall Study|Randomized but not treated|1|||
144282934|NCT03369223|520235720|FG014|Overall Study|Randomized but not treated|1|||
144282935|NCT03369223|520235721|FG015|Overall Study|Randomized but not treated|0|||
144282936|NCT03369223|520235722|FG016|Overall Study|Randomized but not treated|0|||
144282937|NCT03369223|520235723|FG017|Overall Study|Randomized but not treated|0|||
144282938|NCT03369223|520235724|FG018|Overall Study|Randomized but not treated|0|||
144282939|NCT03369223|520235725|FG019|Overall Study|Randomized but not treated|0|||
144282940|NCT05942040|520235726|FG000|Overall Study|No longer employed at study site.|0|||
144282941|NCT05942040|520235727|FG001|Overall Study|No longer employed at study site.|0|||
144282942|NCT05942040|520235728|FG002|Overall Study|No longer employed at study site.|3|||
144282943|NCT03659916|520235729|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
144282944|NCT03659916|520235730|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
144282945|NCT03659916|520235731|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
144282946|NCT03659916|520235729|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
144282947|NCT03659916|520235730|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
144282948|NCT03659916|520235731|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
144282949|NCT03659916|520235729|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
144282950|NCT03659916|520235730|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
144282951|NCT03659916|520235731|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
144282952|NCT03659916|520235729|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
144282953|NCT03659916|520235730|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
144282954|NCT03659916|520235731|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
144282955|NCT03659916|520235729|FG000|Treatment Period (72 Weeks)|Other|1|||
144282956|NCT03659916|520235730|FG001|Treatment Period (72 Weeks)|Other|3|||
144282957|NCT03659916|520235731|FG002|Treatment Period (72 Weeks)|Other|9|||
144282958|NCT03659916|520235729|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
144282959|NCT03659916|520235730|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
144282960|NCT03659916|520235731|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
144282961|NCT03659916|520235729|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
144282962|NCT03659916|520235730|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
144282963|NCT03659916|520235731|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
144282964|NCT03659916|520235729|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
144282965|NCT03659916|520235730|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
144282966|NCT03659916|520235731|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
144282967|NCT03659916|520235729|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
144282968|NCT03659916|520235730|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
144282969|NCT03659916|520235731|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
144282970|NCT03659916|520235729|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
144282971|NCT03659916|520235730|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
144282972|NCT03659916|520235731|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
144282973|NCT03659916|520235729|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
144282974|NCT03659916|520235730|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
144282975|NCT03659916|520235731|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
144282976|NCT01068249|520235732|FG000|Overall Study|Death|1|||
144282977|NCT01068249|520235732|FG000|Overall Study|Withdrawal by Subject|3|||
144282978|NCT04337021|520235739|FG000|Overall Study|Lost to Follow-up|54|||
144282979|NCT04337021|520235740|FG001|Overall Study|Lost to Follow-up|66|||
144282980|NCT06375655|520235742|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
144282981|NCT06375655|520235743|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
144282982|NCT03011372|520235752|FG000|Overall Study|Death|16|||
144282983|NCT03011372|520235752|FG000|Overall Study|Lost to Follow-up|2|||
144282984|NCT03011372|520235752|FG000|Overall Study|Sponsor Decision|17|||
144282985|NCT03011372|520235752|FG000|Overall Study|Withdrawal by Subject|7|||
144282986|NCT03011372|520235752|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
144282987|NCT03011372|520235752|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
144282988|NCT03011372|520235752|FG000|Overall Study|Sponsor's Decision|2|||
144282989|NCT03860584|520235753|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
144282990|NCT03860584|520235754|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
144282991|NCT03860584|520235753|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
144282992|NCT03860584|520235754|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
144282993|NCT03860584|520235753|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
144282994|NCT03860584|520235754|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
144282995|NCT03860584|520235753|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
144282996|NCT03860584|520235754|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
144282997|NCT05865886|520235755|FG000|Overall Study|Serious adverse event|0|||
144282998|NCT05865886|520235756|FG001|Overall Study|Serious adverse event|1|||
144282999|NCT02369458|520235757|FG000|Overall Study|Determined to be not eligible|1|||
144283000|NCT02369458|520235758|FG001|Overall Study|Determined to be not eligible|0|||
144283001|NCT03853798|520235761|FG000|Overall Study|Death|0|||
144283002|NCT03853798|520235762|FG001|Overall Study|Death|0|||
144283003|NCT03853798|520235763|FG002|Overall Study|Death|0|||
144283004|NCT03853798|520235764|FG003|Overall Study|Death|0|||
144283005|NCT03853798|520235765|FG004|Overall Study|Death|0|||
144283006|NCT03853798|520235766|FG005|Overall Study|Death|1|||
144283007|NCT03853798|520235767|FG006|Overall Study|Death|0|||
144283008|NCT03853798|520235768|FG007|Overall Study|Death|0|||
144283009|NCT03853798|520235769|FG008|Overall Study|Death|0|||
144283010|NCT03853798|520235761|FG000|Overall Study|Adverse Event|0|||
144283011|NCT03853798|520235762|FG001|Overall Study|Adverse Event|0|||
144283012|NCT03853798|520235763|FG002|Overall Study|Adverse Event|2|||
144283013|NCT03853798|520235764|FG003|Overall Study|Adverse Event|0|||
144283014|NCT03853798|520235765|FG004|Overall Study|Adverse Event|0|||
144283015|NCT03853798|520235766|FG005|Overall Study|Adverse Event|0|||
144283016|NCT03853798|520235767|FG006|Overall Study|Adverse Event|0|||
144283017|NCT03853798|520235768|FG007|Overall Study|Adverse Event|0|||
144283018|NCT03853798|520235769|FG008|Overall Study|Adverse Event|0|||
144283019|NCT03853798|520235761|FG000|Overall Study|Withdrawal by Subject|0|||
144283020|NCT03853798|520235762|FG001|Overall Study|Withdrawal by Subject|1|||
144283021|NCT03853798|520235763|FG002|Overall Study|Withdrawal by Subject|4|||
144283022|NCT03853798|520235764|FG003|Overall Study|Withdrawal by Subject|0|||
144283023|NCT03853798|520235765|FG004|Overall Study|Withdrawal by Subject|0|||
144283024|NCT03853798|520235766|FG005|Overall Study|Withdrawal by Subject|5|||
144283025|NCT03853798|520235767|FG006|Overall Study|Withdrawal by Subject|0|||
144283026|NCT03853798|520235768|FG007|Overall Study|Withdrawal by Subject|0|||
144283027|NCT03853798|520235769|FG008|Overall Study|Withdrawal by Subject|4|||
144283028|NCT03853798|520235761|FG000|Overall Study|Physician Decision|1|||
144283029|NCT03853798|520235762|FG001|Overall Study|Physician Decision|0|||
144283030|NCT03853798|520235763|FG002|Overall Study|Physician Decision|0|||
144283031|NCT03853798|520235764|FG003|Overall Study|Physician Decision|0|||
144283032|NCT03853798|520235765|FG004|Overall Study|Physician Decision|0|||
144283033|NCT03853798|520235766|FG005|Overall Study|Physician Decision|0|||
144283034|NCT03853798|520235767|FG006|Overall Study|Physician Decision|0|||
144283035|NCT03853798|520235768|FG007|Overall Study|Physician Decision|0|||
144283036|NCT03853798|520235769|FG008|Overall Study|Physician Decision|1|||
144283037|NCT03853798|520235761|FG000|Overall Study|Lack of Efficacy|0|||
144283038|NCT03853798|520235762|FG001|Overall Study|Lack of Efficacy|0|||
144283039|NCT03853798|520235763|FG002|Overall Study|Lack of Efficacy|2|||
144283040|NCT03853798|520235764|FG003|Overall Study|Lack of Efficacy|0|||
144283041|NCT03853798|520235765|FG004|Overall Study|Lack of Efficacy|0|||
144283042|NCT03853798|520235766|FG005|Overall Study|Lack of Efficacy|0|||
144283043|NCT03853798|520235767|FG006|Overall Study|Lack of Efficacy|0|||
144283044|NCT03853798|520235768|FG007|Overall Study|Lack of Efficacy|0|||
144283045|NCT03853798|520235769|FG008|Overall Study|Lack of Efficacy|1|||
144283046|NCT03853798|520235761|FG000|Overall Study|Approved Drug Available for Indication|0|||
144283047|NCT03853798|520235762|FG001|Overall Study|Approved Drug Available for Indication|0|||
144283048|NCT03853798|520235763|FG002|Overall Study|Approved Drug Available for Indication|1|||
144283049|NCT03853798|520235764|FG003|Overall Study|Approved Drug Available for Indication|0|||
144283050|NCT03853798|520235765|FG004|Overall Study|Approved Drug Available for Indication|0|||
144283051|NCT03853798|520235766|FG005|Overall Study|Approved Drug Available for Indication|1|||
144283052|NCT03853798|520235767|FG006|Overall Study|Approved Drug Available for Indication|0|||
144283053|NCT03853798|520235768|FG007|Overall Study|Approved Drug Available for Indication|0|||
144283054|NCT03853798|520235769|FG008|Overall Study|Approved Drug Available for Indication|0|||
144283055|NCT03853798|520235761|FG000|Overall Study|Other un-specified|0|||
144283056|NCT03853798|520235762|FG001|Overall Study|Other un-specified|0|||
144283057|NCT03853798|520235763|FG002|Overall Study|Other un-specified|2|||
144283058|NCT03853798|520235764|FG003|Overall Study|Other un-specified|0|||
144283059|NCT03853798|520235765|FG004|Overall Study|Other un-specified|0|||
144283060|NCT03853798|520235766|FG005|Overall Study|Other un-specified|1|||
144283061|NCT03853798|520235767|FG006|Overall Study|Other un-specified|0|||
144283062|NCT03853798|520235768|FG007|Overall Study|Other un-specified|0|||
144283063|NCT03853798|520235769|FG008|Overall Study|Other un-specified|0|||
144283064|NCT02743494|520235770|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
144283065|NCT02743494|520235771|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
144283066|NCT02743494|520235770|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
144283067|NCT02743494|520235771|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
144283068|NCT02743494|520235770|FG000|Treatment Period|Disease recurrence|152|||
144283069|NCT02743494|520235771|FG001|Treatment Period|Disease recurrence|115|||
144283070|NCT02743494|520235770|FG000|Treatment Period|Study drug toxicity|56|||
144283071|NCT02743494|520235771|FG001|Treatment Period|Study drug toxicity|8|||
144283072|NCT02743494|520235770|FG000|Treatment Period|Death|1|||
144283073|NCT02743494|520235771|FG001|Treatment Period|Death|1|||
144283074|NCT02743494|520235770|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
144283075|NCT02743494|520235771|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
144283076|NCT02743494|520235770|FG000|Treatment Period|Participant request to discontinue treatment|31|||
144283077|NCT02743494|520235771|FG001|Treatment Period|Participant request to discontinue treatment|5|||
144283078|NCT02743494|520235770|FG000|Treatment Period|Participant withdrew consent|11|||
144283079|NCT02743494|520235771|FG001|Treatment Period|Participant withdrew consent|4|||
144283080|NCT02743494|520235770|FG000|Treatment Period|Lost to Follow-up|0|||
144283081|NCT02743494|520235771|FG001|Treatment Period|Lost to Follow-up|1|||
144283082|NCT02743494|520235770|FG000|Treatment Period|Poor/Non-compliance|2|||
144283083|NCT02743494|520235771|FG001|Treatment Period|Poor/Non-compliance|0|||
144283084|NCT02743494|520235770|FG000|Treatment Period|Other reasons|4|||
144283085|NCT02743494|520235771|FG001|Treatment Period|Other reasons|1|||
144283086|NCT02400736|520236923|FG000|Overall Study|Lost to Follow-up|6|||
144283087|NCT02400736|520236924|FG001|Overall Study|Lost to Follow-up|6|||
144283088|NCT02400736|520236923|FG000|Overall Study|Withdrawal by Subject|2|||
144283089|NCT02400736|520236924|FG001|Overall Study|Withdrawal by Subject|1|||
144283090|NCT02400736|520236923|FG000|Overall Study|Moved from the area|3|||
144283091|NCT02400736|520236924|FG001|Overall Study|Moved from the area|1|||
144283092|NCT02927145|520236926|FG000|Initial Recruitment|Withdrawal by Subject|0|||
144283093|NCT02927145|520236927|FG001|Initial Recruitment|Withdrawal by Subject|1|||
144283094|NCT02927145|520236928|FG002|Initial Recruitment|Withdrawal by Subject|1|||
144283095|NCT02927145|520236929|FG003|Initial Recruitment|Withdrawal by Subject|4|||
144283096|NCT02927145|520236930|FG004|Initial Recruitment|Withdrawal by Subject|1|||
144283097|NCT02927145|520236931|FG005|Initial Recruitment|Withdrawal by Subject|1|||
144283098|NCT02927145|520236932|FG006|Initial Recruitment|Withdrawal by Subject|0|||
144283099|NCT02927145|520236933|FG007|Initial Recruitment|Withdrawal by Subject|0|||
144283100|NCT02927145|520236934|FG008|Initial Recruitment|Withdrawal by Subject|2|||
144283101|NCT02927145|520236926|FG000|Initial Recruitment|Adverse Event|0|||
144283102|NCT02927145|520236927|FG001|Initial Recruitment|Adverse Event|0|||
144283103|NCT02927145|520236928|FG002|Initial Recruitment|Adverse Event|0|||
144283104|NCT02927145|520236929|FG003|Initial Recruitment|Adverse Event|0|||
144283105|NCT02927145|520236930|FG004|Initial Recruitment|Adverse Event|2|||
144283106|NCT02927145|520236931|FG005|Initial Recruitment|Adverse Event|0|||
144283107|NCT02927145|520236932|FG006|Initial Recruitment|Adverse Event|0|||
144283108|NCT02927145|520236933|FG007|Initial Recruitment|Adverse Event|0|||
144283109|NCT02927145|520236934|FG008|Initial Recruitment|Adverse Event|0|||
144283110|NCT02927145|520236926|FG000|Invitation for Additional Challenge|Pregnancy|0|||
144283111|NCT02927145|520236927|FG001|Invitation for Additional Challenge|Pregnancy|0|||
144283112|NCT02927145|520236928|FG002|Invitation for Additional Challenge|Pregnancy|0|||
144283113|NCT02927145|520236929|FG003|Invitation for Additional Challenge|Pregnancy|0|||
144283114|NCT02927145|520236930|FG004|Invitation for Additional Challenge|Pregnancy|0|||
144283115|NCT02927145|520236931|FG005|Invitation for Additional Challenge|Pregnancy|0|||
144283116|NCT02927145|520236932|FG006|Invitation for Additional Challenge|Pregnancy|1|||
144283117|NCT02927145|520236933|FG007|Invitation for Additional Challenge|Pregnancy|0|||
144283118|NCT02927145|520236934|FG008|Invitation for Additional Challenge|Pregnancy|0|||
144283119|NCT01002105|520236935|FG000|Overall Study|Lost to Follow-up|10|||
144283120|NCT01002105|520236936|FG001|Overall Study|Lost to Follow-up|16|||
144283121|NCT01002105|520236935|FG000|Overall Study|non compliance|5|||
144283122|NCT01002105|520236936|FG001|Overall Study|non compliance|3|||
144283123|NCT01002105|520236935|FG000|Overall Study|condition worsened|4|||
144283124|NCT01002105|520236936|FG001|Overall Study|condition worsened|2|||
144283125|NCT01363440|520236937|FG000|Overall Study|Adverse Event|5|||
144283126|NCT01363440|520236938|FG001|Overall Study|Adverse Event|4|||
144283127|NCT01363440|520236939|FG002|Overall Study|Adverse Event|4|||
144283128|NCT01363440|520236937|FG000|Overall Study|Death|3|||
144283129|NCT01363440|520236938|FG001|Overall Study|Death|7|||
144283130|NCT01363440|520236939|FG002|Overall Study|Death|5|||
144283131|NCT01363440|520236937|FG000|Overall Study|Withdrawal by Subject|9|||
144283132|NCT01363440|520236938|FG001|Overall Study|Withdrawal by Subject|11|||
144283133|NCT01363440|520236939|FG002|Overall Study|Withdrawal by Subject|11|||
144283134|NCT01363440|520236937|FG000|Overall Study|Lost to Follow-up|2|||
144283135|NCT01363440|520236938|FG001|Overall Study|Lost to Follow-up|4|||
144283136|NCT01363440|520236939|FG002|Overall Study|Lost to Follow-up|5|||
144283137|NCT01363440|520236937|FG000|Overall Study|Other|4|||
144283138|NCT01363440|520236938|FG001|Overall Study|Other|5|||
144283139|NCT01363440|520236939|FG002|Overall Study|Other|2|||
144283140|NCT03695094|520236941|FG000|Overall Study|Adverse Event|1|||
144283141|NCT03695094|520236942|FG001|Overall Study|Adverse Event|1|||
144283142|NCT03695094|520236941|FG000|Overall Study|Withdrawal by Subject|1|||
144283143|NCT03695094|520236942|FG001|Overall Study|Withdrawal by Subject|0|||
144283144|NCT00266812|520236943|FG000|Overall Study|Disease Progression|9|||
144283145|NCT00266812|520236944|FG001|Overall Study|Disease Progression|3|||
144283146|NCT00266812|520236943|FG000|Overall Study|Death|5|||
144283147|NCT00266812|520236944|FG001|Overall Study|Death|4|||
144283148|NCT00266812|520236943|FG000|Overall Study|Adverse Event|3|||
144283149|NCT00266812|520236944|FG001|Overall Study|Adverse Event|1|||
144283150|NCT00266812|520236943|FG000|Overall Study|Protocol Violation|0|||
144283151|NCT00266812|520236944|FG001|Overall Study|Protocol Violation|1|||
144283152|NCT00266812|520236943|FG000|Overall Study|Withdrawal by Subject|0|||
144283153|NCT00266812|520236944|FG001|Overall Study|Withdrawal by Subject|2|||
144283154|NCT00266812|520236943|FG000|Overall Study|Discontinued before starting study drug|4|||
144283155|NCT00266812|520236944|FG001|Overall Study|Discontinued before starting study drug|0|||
144283156|NCT03520569|520236945|FG000|Overall Study|Withdrawal by Subject|1|||
144283157|NCT05558410|520236949|FG000|Overall Study|Adverse Event|1|||
144283158|NCT05558410|520236950|FG001|Overall Study|Adverse Event|2|||
144283159|NCT05558410|520236951|FG002|Overall Study|Adverse Event|0|||
144283160|NCT05558410|520236949|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
144283161|NCT05558410|520236950|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
144283162|NCT05558410|520236951|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
144283163|NCT05558410|520236949|FG000|Overall Study|Lost to Follow-up|10|||
144283164|NCT05558410|520236950|FG001|Overall Study|Lost to Follow-up|17|||
144283165|NCT05558410|520236951|FG002|Overall Study|Lost to Follow-up|19|||
144283166|NCT05558410|520236949|FG000|Overall Study|Death|1|||
144283167|NCT05558410|520236950|FG001|Overall Study|Death|0|||
144283168|NCT05558410|520236951|FG002|Overall Study|Death|0|||
144283169|NCT05558410|520236949|FG000|Overall Study|Other non-compliance|0|||
144283170|NCT05558410|520236950|FG001|Overall Study|Other non-compliance|1|||
144283171|NCT05558410|520236951|FG002|Overall Study|Other non-compliance|2|||
144283172|NCT05558410|520236949|FG000|Overall Study|Sponsor Decision|1|||
144283173|NCT05558410|520236950|FG001|Overall Study|Sponsor Decision|0|||
144283174|NCT05558410|520236951|FG002|Overall Study|Sponsor Decision|0|||
144283175|NCT05558410|520236949|FG000|Overall Study|Other|1|||
144283176|NCT05558410|520236950|FG001|Overall Study|Other|0|||
144283177|NCT05558410|520236951|FG002|Overall Study|Other|1|||
144283178|NCT02265744|520236954|FG000|Overall Study|Poor/Non-compliance|1|||
144283179|NCT02265744|520236955|FG001|Overall Study|Poor/Non-compliance|1|||
144283180|NCT02265744|520236956|FG002|Overall Study|Poor/Non-compliance|0|||
144283181|NCT02265744|520236957|FG003|Overall Study|Poor/Non-compliance|0|||
144283182|NCT02265744|520236958|FG004|Overall Study|Poor/Non-compliance|2|||
144283183|NCT02265744|520236954|FG000|Overall Study|Lost to Follow-up|0|||
144283184|NCT02265744|520236955|FG001|Overall Study|Lost to Follow-up|0|||
144283185|NCT02265744|520236956|FG002|Overall Study|Lost to Follow-up|0|||
144283186|NCT02265744|520236957|FG003|Overall Study|Lost to Follow-up|1|||
144283187|NCT02265744|520236958|FG004|Overall Study|Lost to Follow-up|0|||
144283188|NCT02265744|520236954|FG000|Overall Study|Death|0|||
144283189|NCT02265744|520236955|FG001|Overall Study|Death|0|||
144283190|NCT02265744|520236956|FG002|Overall Study|Death|0|||
144283191|NCT02265744|520236957|FG003|Overall Study|Death|2|||
144283192|NCT02265744|520236958|FG004|Overall Study|Death|0|||
144283193|NCT02265744|520236954|FG000|Overall Study|Withdrawal by Subject|2|||
144283194|NCT02265744|520236955|FG001|Overall Study|Withdrawal by Subject|0|||
144283195|NCT02265744|520236956|FG002|Overall Study|Withdrawal by Subject|0|||
144283196|NCT02265744|520236957|FG003|Overall Study|Withdrawal by Subject|2|||
144283197|NCT02265744|520236958|FG004|Overall Study|Withdrawal by Subject|0|||
144283198|NCT02265744|520236954|FG000|Overall Study|Participant request to discontinue|2|||
144283199|NCT02265744|520236955|FG001|Overall Study|Participant request to discontinue|2|||
144283200|NCT02265744|520236956|FG002|Overall Study|Participant request to discontinue|2|||
144283201|NCT02265744|520236957|FG003|Overall Study|Participant request to discontinue|0|||
144297142|NCT02038647|520292459|FG000|Overall Study|Adverse Event|18|||
144283202|NCT02265744|520236958|FG004|Overall Study|Participant request to discontinue|0|||
144283203|NCT02265744|520236954|FG000|Overall Study|Adverse Event|8|||
144283204|NCT02265744|520236955|FG001|Overall Study|Adverse Event|4|||
144283205|NCT02265744|520236956|FG002|Overall Study|Adverse Event|9|||
144283206|NCT02265744|520236957|FG003|Overall Study|Adverse Event|8|||
144283207|NCT02265744|520236958|FG004|Overall Study|Adverse Event|2|||
144283208|NCT02265744|520236954|FG000|Overall Study|Lack of Efficacy|2|||
144283209|NCT02265744|520236955|FG001|Overall Study|Lack of Efficacy|4|||
144283210|NCT02265744|520236956|FG002|Overall Study|Lack of Efficacy|3|||
144283211|NCT02265744|520236957|FG003|Overall Study|Lack of Efficacy|4|||
144283212|NCT02265744|520236958|FG004|Overall Study|Lack of Efficacy|5|||
144283213|NCT02265744|520236954|FG000|Overall Study|Reason not provided by Investigator|1|||
144283214|NCT02265744|520236955|FG001|Overall Study|Reason not provided by Investigator|0|||
144283215|NCT02265744|520236956|FG002|Overall Study|Reason not provided by Investigator|0|||
144283216|NCT02265744|520236957|FG003|Overall Study|Reason not provided by Investigator|2|||
144283217|NCT02265744|520236958|FG004|Overall Study|Reason not provided by Investigator|0|||
144283218|NCT02265744|520236954|FG000|Overall Study|Administrative reason by sponsor|3|||
144283219|NCT02265744|520236955|FG001|Overall Study|Administrative reason by sponsor|2|||
144283220|NCT02265744|520236956|FG002|Overall Study|Administrative reason by sponsor|2|||
144283221|NCT02265744|520236957|FG003|Overall Study|Administrative reason by sponsor|3|||
144283222|NCT02265744|520236958|FG004|Overall Study|Administrative reason by sponsor|3|||
144283223|NCT02265744|520236954|FG000|Overall Study|Subject no longer meets study criteria|0|||
144283224|NCT02265744|520236955|FG001|Overall Study|Subject no longer meets study criteria|0|||
144283225|NCT02265744|520236956|FG002|Overall Study|Subject no longer meets study criteria|0|||
144283226|NCT02265744|520236957|FG003|Overall Study|Subject no longer meets study criteria|0|||
144283227|NCT02265744|520236958|FG004|Overall Study|Subject no longer meets study criteria|1|||
144283228|NCT02265744|520236954|FG000|Overall Study|Pregnancy|1|||
144283229|NCT02265744|520236955|FG001|Overall Study|Pregnancy|2|||
144283230|NCT02265744|520236956|FG002|Overall Study|Pregnancy|1|||
144283231|NCT02265744|520236957|FG003|Overall Study|Pregnancy|1|||
144283232|NCT02265744|520236958|FG004|Overall Study|Pregnancy|0|||
144283233|NCT00574951|520236959|FG000|Overall Study|Ineligible - improper prior treatment|1|||
144283234|NCT05161936|520236960|FG000|Overall Study|Study terminated by Sponsor|1|||
144283235|NCT05161936|520236961|FG001|Overall Study|Study terminated by Sponsor|0|||
144283236|NCT05161936|520236962|FG002|Overall Study|Study terminated by Sponsor|0|||
144283237|NCT05161936|520236960|FG000|Overall Study|Withdrawal by Subject|0|||
144283238|NCT05161936|520236961|FG001|Overall Study|Withdrawal by Subject|0|||
144283239|NCT05161936|520236962|FG002|Overall Study|Withdrawal by Subject|1|||
144283240|NCT02639559|520236963|FG000|Overall Study|Mobilization failure|0|||
144283241|NCT02639559|520236964|FG001|Overall Study|Mobilization failure|3|||
144283242|NCT02639559|520236963|FG000|Overall Study|Issues with vascular acess|1|||
144283243|NCT02639559|520236964|FG001|Overall Study|Issues with vascular acess|0|||
144283244|NCT04999020|520236965|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
144283245|NCT04999020|520236966|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
144283246|NCT04999020|520236967|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
144283247|NCT04999020|520236968|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
144283248|NCT04999020|520236965|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
144283249|NCT04999020|520236966|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
144283250|NCT04999020|520236967|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
144283251|NCT04999020|520236968|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
144283252|NCT04999020|520236965|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
144283253|NCT04999020|520236966|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
144283254|NCT04999020|520236967|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
144283255|NCT04999020|520236968|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
144283256|NCT04999020|520236965|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144283257|NCT04999020|520236966|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144283258|NCT04999020|520236967|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
144283259|NCT04999020|520236968|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
144283260|NCT04999020|520236965|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
144283261|NCT04999020|520236966|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
144283262|NCT04999020|520236967|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
144283263|NCT04999020|520236968|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
144283264|NCT04999020|520236965|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
144283265|NCT04999020|520236966|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
144283266|NCT04999020|520236967|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
144283267|NCT04999020|520236968|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
144283268|NCT04999020|520236965|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
144283269|NCT04999020|520236966|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
144283270|NCT04999020|520236967|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
144283271|NCT04999020|520236968|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
144283272|NCT04999020|520236965|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
144283273|NCT04999020|520236966|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
144283274|NCT04999020|520236967|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
144283275|NCT04999020|520236968|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
144283276|NCT03670628|520236969|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
144283277|NCT03670628|520236970|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
144283278|NCT03670628|520236969|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
144283279|NCT03670628|520236970|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
144283280|NCT04828486|520236973|FG000|Overall Study|Adverse Event|2|||
144283281|NCT04828486|520236973|FG000|Overall Study|Death|1|||
144283282|NCT04828486|520236973|FG000|Overall Study|Disease Progression|8|||
144283283|NCT04828486|520236973|FG000|Overall Study|Other Complicating Disease|1|||
144283284|NCT04828486|520236973|FG000|Overall Study|Withdrawal by Subject|1|||
144283285|NCT00896233|520236974|FG000|Overall Study|Claustrophobia during MRI|1|||
144283286|NCT02965456|520236975|FG000|Overall Study|Lost to Follow-up|40|||
144283287|NCT02965456|520236976|FG001|Overall Study|Lost to Follow-up|18|||
144283288|NCT02965456|520236975|FG000|Overall Study|Subject Request|22|||
144283289|NCT02965456|520236976|FG001|Overall Study|Subject Request|13|||
144283290|NCT02965456|520236975|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
144283291|NCT02965456|520236976|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
144283292|NCT02965456|520236975|FG000|Overall Study|Adverse Event|3|||
144283293|NCT02965456|520236976|FG001|Overall Study|Adverse Event|0|||
144283294|NCT02965456|520236975|FG000|Overall Study|Noncompliance with Study Drug|1|||
144283295|NCT02965456|520236976|FG001|Overall Study|Noncompliance with Study Drug|1|||
144283296|NCT02965456|520236975|FG000|Overall Study|Worsening Condition|0|||
144283297|NCT02965456|520236976|FG001|Overall Study|Worsening Condition|2|||
144283298|NCT02965456|520236975|FG000|Overall Study|Lack of Efficacy|1|||
144283299|NCT02965456|520236976|FG001|Overall Study|Lack of Efficacy|0|||
144283300|NCT02965456|520236975|FG000|Overall Study|Physician Decision|0|||
144283301|NCT02965456|520236976|FG001|Overall Study|Physician Decision|1|||
144283302|NCT02965456|520236975|FG000|Overall Study|Pregnancy|1|||
144283303|NCT02965456|520236976|FG001|Overall Study|Pregnancy|0|||
144283304|NCT02965456|520236975|FG000|Overall Study|Protocol Violation|0|||
144283305|NCT02965456|520236976|FG001|Overall Study|Protocol Violation|1|||
144283306|NCT02965456|520236975|FG000|Overall Study|Participant ran out of study drug|0|||
144283307|NCT02965456|520236976|FG001|Overall Study|Participant ran out of study drug|1|||
144283308|NCT04465955|520236977|FG000|Overall Study|Withdrew consent|6|||
144283309|NCT04465955|520236978|FG001|Overall Study|Withdrew consent|10|||
144283310|NCT04465955|520236979|FG002|Overall Study|Withdrew consent|7|||
144283311|NCT04465955|520236977|FG000|Overall Study|Adverse Event|6|||
144283312|NCT04465955|520236978|FG001|Overall Study|Adverse Event|5|||
144283313|NCT04465955|520236979|FG002|Overall Study|Adverse Event|1|||
144283314|NCT04465955|520236977|FG000|Overall Study|Lost to Follow-up|2|||
144283315|NCT04465955|520236978|FG001|Overall Study|Lost to Follow-up|0|||
144283316|NCT04465955|520236979|FG002|Overall Study|Lost to Follow-up|3|||
144283317|NCT04465955|520236977|FG000|Overall Study|Other|1|||
144283318|NCT04465955|520236978|FG001|Overall Study|Other|1|||
144283319|NCT04465955|520236979|FG002|Overall Study|Other|3|||
144283320|NCT00387127|520236980|FG000|Overall Study|Lost to Follow-up|0|||
144283321|NCT00387127|520236981|FG001|Overall Study|Lost to Follow-up|4|||
144283322|NCT00387127|520236980|FG000|Overall Study|Death|16|||
144283323|NCT00387127|520236981|FG001|Overall Study|Death|16|||
144245596|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245597|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245598|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245599|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245600|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144245601|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
144245602|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144245603|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144245604|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
144245605|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245606|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245607|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245608|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
144245609|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245610|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245611|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245612|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245613|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245614|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
144245615|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
144245616|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245617|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
144245618|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245619|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245620|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245621|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245622|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
144245623|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245624|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245625|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245626|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245627|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245628|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
144245629|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245630|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245631|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245632|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245633|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245634|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245635|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245636|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
144245637|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245638|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245639|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245640|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245641|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245642|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245643|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
144245644|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245645|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245646|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245647|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245648|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245649|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245650|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
144245651|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245652|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245653|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245654|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245655|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245656|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245657|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245658|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
144245659|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245660|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245661|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245662|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245663|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245664|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
144245665|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245666|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245667|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245668|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245669|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245670|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245671|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
144245672|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
144245673|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245674|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245675|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245676|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245677|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245678|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
144245679|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245680|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245681|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245682|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245683|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245684|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245685|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245686|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
144245687|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245688|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245689|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245690|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245691|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245692|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
144245693|NCT02326298|520096242|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245694|NCT02326298|520096243|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245695|NCT02326298|520096244|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245696|NCT02326298|520096245|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245697|NCT02326298|520096246|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245698|NCT02326298|520096247|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
144245699|NCT02326298|520096248|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245700|NCT02326298|520096249|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245701|NCT02326298|520096250|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245702|NCT02326298|520096251|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245703|NCT02326298|520096252|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245704|NCT02326298|520096253|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245705|NCT02326298|520096254|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144245706|NCT02326298|520096255|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
144283324|NCT00387127|520236980|FG000|Overall Study|Physician Decision|0|||
144283325|NCT00387127|520236981|FG001|Overall Study|Physician Decision|1|||
144245707|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
144245708|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
144245709|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
144245710|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
144245711|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
144245712|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
144245713|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
144245714|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
144245715|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
144245716|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
144245717|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
144245718|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
144245719|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
144245720|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
144245721|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245722|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245723|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245724|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245725|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245726|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245727|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245728|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245729|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245730|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245731|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245732|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
144245733|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
144245734|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
144245735|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245736|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245737|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245738|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245739|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245740|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245741|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245742|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245743|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245744|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245745|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245746|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
144245747|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
144245748|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
144245749|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245750|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245751|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245752|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245753|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245754|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245755|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245756|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245757|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245758|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245759|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245760|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245761|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
144245762|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
144245763|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245764|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245765|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245766|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245767|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245768|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245769|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144283326|NCT00387127|520236980|FG000|Overall Study|Withdrawal by Subject|3|||
144283327|NCT00387127|520236981|FG001|Overall Study|Withdrawal by Subject|2|||
144283328|NCT00387127|520236980|FG000|Overall Study|Required by Protocol Amendment #4|12|||
144283329|NCT00387127|520236981|FG001|Overall Study|Required by Protocol Amendment #4|10|||
144283330|NCT00387127|520236980|FG000|Overall Study|Serious Adverse Event|1|||
144283331|NCT00387127|520236981|FG001|Overall Study|Serious Adverse Event|1|||
144283332|NCT00387127|520236980|FG000|Overall Study|Sponsor Unblinded|1|||
144283333|NCT00387127|520236981|FG001|Overall Study|Sponsor Unblinded|0|||
144283334|NCT05101317|520236984|FG000|Week1-13|Adverse Event|0|||
144283335|NCT05101317|520236985|FG001|Week1-13|Adverse Event|1|||
144283336|NCT05101317|520236986|FG002|Week1-13|Adverse Event|0|||
144283337|NCT05101317|520236987|FG003|Week1-13|Adverse Event|0|||
144283338|NCT05101317|520236984|FG000|Week1-13|Withdrawal by Subject|0|||
144283339|NCT05101317|520236985|FG001|Week1-13|Withdrawal by Subject|2|||
144283340|NCT05101317|520236986|FG002|Week1-13|Withdrawal by Subject|0|||
144283341|NCT05101317|520236987|FG003|Week1-13|Withdrawal by Subject|0|||
144283342|NCT05101317|520236984|FG000|Week1-13|Early Withdrawl|0|||
144283343|NCT05101317|520236985|FG001|Week1-13|Early Withdrawl|0|||
144283344|NCT05101317|520236986|FG002|Week1-13|Early Withdrawl|0|||
144283345|NCT05101317|520236987|FG003|Week1-13|Early Withdrawl|1|||
144283346|NCT05101317|520236984|FG000|Week 13-25|Lost to Follow-up|0|||
144283347|NCT05101317|520236985|FG001|Week 13-25|Lost to Follow-up|0|||
144283348|NCT05101317|520236986|FG002|Week 13-25|Lost to Follow-up|1|||
144283349|NCT05101317|520236987|FG003|Week 13-25|Lost to Follow-up|0|||
144283350|NCT05101317|520236984|FG000|Week 13-25|Withdrawal by Subject|1|||
144283351|NCT05101317|520236985|FG001|Week 13-25|Withdrawal by Subject|1|||
144283352|NCT05101317|520236986|FG002|Week 13-25|Withdrawal by Subject|0|||
144283353|NCT05101317|520236987|FG003|Week 13-25|Withdrawal by Subject|0|||
144283354|NCT05101317|520236984|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
144283355|NCT05101317|520236985|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
144283356|NCT05101317|520236986|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
144283357|NCT05101317|520236987|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
144283358|NCT00317369|520236994|FG000|Overall Study|Adverse Event|2|||
144283359|NCT00317369|520236995|FG001|Overall Study|Adverse Event|1|||
144283360|NCT00317369|520236996|FG002|Overall Study|Adverse Event|0|||
144283361|NCT00317369|520236994|FG000|Overall Study|Lack of Efficacy|0|||
144283362|NCT00317369|520236995|FG001|Overall Study|Lack of Efficacy|1|||
144283363|NCT00317369|520236996|FG002|Overall Study|Lack of Efficacy|1|||
144283364|NCT00317369|520236994|FG000|Overall Study|Withdrawal by Subject|0|||
144283365|NCT00317369|520236995|FG001|Overall Study|Withdrawal by Subject|0|||
144283366|NCT00317369|520236996|FG002|Overall Study|Withdrawal by Subject|1|||
144283367|NCT03674411|520236999|FG000|Overall Study|Non-treatment|4|||
144283368|NCT02227199|520237001|FG000|Overall Study|Physician Decision|0|||
144283369|NCT02227199|520237002|FG001|Overall Study|Physician Decision|0|||
144283370|NCT02227199|520237003|FG002|Overall Study|Physician Decision|1|||
144283371|NCT02227199|520237001|FG000|Overall Study|Adverse Event|0|||
144283372|NCT02227199|520237002|FG001|Overall Study|Adverse Event|0|||
144283373|NCT02227199|520237003|FG002|Overall Study|Adverse Event|3|||
144283374|NCT03573882|520237004|FG000|Overall Study|Study Terminated by Sponsor|22|||
144283375|NCT03573882|520237005|FG001|Overall Study|Study Terminated by Sponsor|17|||
144283376|NCT03573882|520237006|FG002|Overall Study|Study Terminated by Sponsor|18|||
144283377|NCT03573882|520237004|FG000|Overall Study|Withdrawal by Subject|6|||
144283378|NCT03573882|520237005|FG001|Overall Study|Withdrawal by Subject|11|||
144283379|NCT03573882|520237006|FG002|Overall Study|Withdrawal by Subject|7|||
144283380|NCT03573882|520237004|FG000|Overall Study|Adverse Event|7|||
144283381|NCT03573882|520237005|FG001|Overall Study|Adverse Event|5|||
144283382|NCT03573882|520237006|FG002|Overall Study|Adverse Event|6|||
144283383|NCT03573882|520237004|FG000|Overall Study|Lost to Follow-up|2|||
144283384|NCT03573882|520237005|FG001|Overall Study|Lost to Follow-up|5|||
144283385|NCT03573882|520237006|FG002|Overall Study|Lost to Follow-up|3|||
144283386|NCT03573882|520237004|FG000|Overall Study|Physician Decision|4|||
144283387|NCT03573882|520237005|FG001|Overall Study|Physician Decision|3|||
144283388|NCT03573882|520237006|FG002|Overall Study|Physician Decision|2|||
144283389|NCT03573882|520237004|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
144283390|NCT03573882|520237005|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
144283391|NCT03573882|520237006|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
144283392|NCT03573882|520237004|FG000|Overall Study|Pregnancy|1|||
144283393|NCT03573882|520237005|FG001|Overall Study|Pregnancy|2|||
144283394|NCT03573882|520237006|FG002|Overall Study|Pregnancy|0|||
144283395|NCT03573882|520237004|FG000|Overall Study|Other|4|||
144283396|NCT03573882|520237005|FG001|Overall Study|Other|2|||
144283397|NCT03573882|520237006|FG002|Overall Study|Other|2|||
144283398|NCT03407482|520237007|FG000|Overall Study|Adverse Event|12|||
144283399|NCT03407482|520237007|FG000|Overall Study|Disease Relapse|1|||
144283400|NCT03407482|520237007|FG000|Overall Study|Lost to Follow-up|1|||
144283401|NCT03407482|520237007|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144283402|NCT03407482|520237007|FG000|Overall Study|Pregnancy|2|||
144283403|NCT03407482|520237007|FG000|Overall Study|Protocol Violation|1|||
144283404|NCT03407482|520237007|FG000|Overall Study|Study Terminated By Sponsor|106|||
144297143|NCT02038647|520292460|FG001|Overall Study|Adverse Event|10|||
144283405|NCT03407482|520237007|FG000|Overall Study|Withdrawal by Subject|6|||
144283406|NCT03407482|520237007|FG000|Overall Study|Data Entry Error|1|||
144283407|NCT04439123|520237010|FG000|Overall Study|Adverse Event|11|||
144283408|NCT04439123|520237010|FG000|Overall Study|Death|1|||
144283409|NCT04439123|520237010|FG000|Overall Study|Disease progression|19|||
144283410|NCT04439123|520237010|FG000|Overall Study|Withdrawal by Subject|2|||
144283411|NCT04439123|520237010|FG000|Overall Study|Still on treatment|2|||
144283412|NCT00835978|520238318|FG000|Overall Study|Death|33|||
144283413|NCT00835978|520238319|FG001|Overall Study|Death|40|||
144283414|NCT00835978|520238320|FG002|Overall Study|Death|49|||
144283415|NCT00835978|520238321|FG003|Overall Study|Death|4|||
144283416|NCT00835978|520238318|FG000|Overall Study|Lost to Follow-up|3|||
144283417|NCT00835978|520238319|FG001|Overall Study|Lost to Follow-up|4|||
144283418|NCT00835978|520238320|FG002|Overall Study|Lost to Follow-up|2|||
144283419|NCT00835978|520238321|FG003|Overall Study|Lost to Follow-up|1|||
144283420|NCT00835978|520238318|FG000|Overall Study|Other|5|||
144283421|NCT00835978|520238319|FG001|Overall Study|Other|1|||
144283422|NCT00835978|520238320|FG002|Overall Study|Other|8|||
144283423|NCT00835978|520238321|FG003|Overall Study|Other|0|||
144283424|NCT00835978|520238318|FG000|Overall Study|Objective progression or relapse|2|||
144283425|NCT00835978|520238319|FG001|Overall Study|Objective progression or relapse|0|||
144283426|NCT00835978|520238320|FG002|Overall Study|Objective progression or relapse|1|||
144283427|NCT00835978|520238321|FG003|Overall Study|Objective progression or relapse|0|||
144283428|NCT00835978|520238318|FG000|Overall Study|Adverse Event|1|||
144283429|NCT00835978|520238319|FG001|Overall Study|Adverse Event|0|||
144283430|NCT00835978|520238320|FG002|Overall Study|Adverse Event|1|||
144283431|NCT00835978|520238321|FG003|Overall Study|Adverse Event|0|||
144283432|NCT00835978|520238318|FG000|Overall Study|Withdrawal by Subject|0|||
144283433|NCT00835978|520238319|FG001|Overall Study|Withdrawal by Subject|3|||
144283434|NCT00835978|520238320|FG002|Overall Study|Withdrawal by Subject|0|||
144283435|NCT00835978|520238321|FG003|Overall Study|Withdrawal by Subject|5|||
144283436|NCT00835978|520238318|FG000|Overall Study|Study terminated by sponsor|12|||
144283437|NCT00835978|520238319|FG001|Overall Study|Study terminated by sponsor|8|||
144283438|NCT00835978|520238320|FG002|Overall Study|Study terminated by sponsor|30|||
144283439|NCT00835978|520238321|FG003|Overall Study|Study terminated by sponsor|0|||
144283440|NCT01166945|520238324|FG000|Randomized|diagnosed with Group A strep|4|||
144283441|NCT01166945|520238325|FG001|Randomized|diagnosed with Group A strep|4|||
144283442|NCT01166945|520238324|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
144283443|NCT01166945|520238325|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
144283444|NCT01166945|520238324|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
144283445|NCT01166945|520238325|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
144283446|NCT01166945|520238324|FG000|Day 30|Lost to Follow-up|4|||
144283447|NCT01166945|520238325|FG001|Day 30|Lost to Follow-up|3|||
144283448|NCT00923702|520238329|FG000|Overall Study|Ongoing enrollment|0|||
144283449|NCT00923702|520238330|FG001|Overall Study|Ongoing enrollment|0|||
144283450|NCT00923702|520238331|FG002|Overall Study|Ongoing enrollment|0|||
144283451|NCT00923702|520238332|FG003|Overall Study|Ongoing enrollment|0|||
144283452|NCT00923702|520238333|FG004|Overall Study|Ongoing enrollment|354|||
144283453|NCT01158404|520238336|FG000|Overall Study|Withdrawal by Subject|0|||
144283454|NCT01158404|520238337|FG001|Overall Study|Withdrawal by Subject|1|||
144283455|NCT01158404|520238338|FG002|Overall Study|Withdrawal by Subject|0|||
144283456|NCT01158404|520238339|FG003|Overall Study|Withdrawal by Subject|0|||
144283457|NCT01158404|520238340|FG004|Overall Study|Withdrawal by Subject|3|||
144283458|NCT01158404|520238341|FG005|Overall Study|Withdrawal by Subject|1|||
144283459|NCT01158404|520238342|FG006|Overall Study|Withdrawal by Subject|0|||
144283460|NCT01158404|520238343|FG007|Overall Study|Withdrawal by Subject|1|||
144283461|NCT01158404|520238336|FG000|Overall Study|Physician Decision|0|||
144283462|NCT01158404|520238337|FG001|Overall Study|Physician Decision|0|||
144283463|NCT01158404|520238338|FG002|Overall Study|Physician Decision|0|||
144283464|NCT01158404|520238339|FG003|Overall Study|Physician Decision|0|||
144283465|NCT01158404|520238340|FG004|Overall Study|Physician Decision|0|||
144283466|NCT01158404|520238341|FG005|Overall Study|Physician Decision|0|||
144283467|NCT01158404|520238342|FG006|Overall Study|Physician Decision|0|||
144283468|NCT01158404|520238343|FG007|Overall Study|Physician Decision|1|||
144283469|NCT01158404|520238336|FG000|Overall Study|Progressive Disease|0|||
144283470|NCT01158404|520238337|FG001|Overall Study|Progressive Disease|0|||
144283471|NCT01158404|520238338|FG002|Overall Study|Progressive Disease|0|||
144283472|NCT01158404|520238339|FG003|Overall Study|Progressive Disease|0|||
144283473|NCT01158404|520238340|FG004|Overall Study|Progressive Disease|0|||
144283474|NCT01158404|520238341|FG005|Overall Study|Progressive Disease|0|||
144283475|NCT01158404|520238342|FG006|Overall Study|Progressive Disease|1|||
144283476|NCT01158404|520238343|FG007|Overall Study|Progressive Disease|0|||
144283477|NCT02400580|520238346|FG000|Overall Study|Withdrawal by Subject|1|||
144283478|NCT02400580|520238347|FG001|Overall Study|Withdrawal by Subject|1|||
144283479|NCT02400580|520238346|FG000|Overall Study|Adverse Event|1|||
144283480|NCT02400580|520238347|FG001|Overall Study|Adverse Event|0|||
144283481|NCT01336972|520238355|FG000|Overall Study|Adverse Event|1|||
144283482|NCT01336972|520238356|FG001|Overall Study|Adverse Event|1|||
144283483|NCT01336972|520238357|FG002|Overall Study|Adverse Event|0|||
144283484|NCT02448043|520238360|FG000|Overall Study|Withdrawal by Subject|2|||
144283485|NCT02448043|520238361|FG001|Overall Study|Withdrawal by Subject|2|||
144283486|NCT02448043|520238360|FG000|Overall Study|Protocol Violation|1|||
144283487|NCT02448043|520238361|FG001|Overall Study|Protocol Violation|2|||
144283488|NCT00827242|520238363|FG000|Overall Study|Withdrawal by Subject|2|||
144283489|NCT00827242|520238364|FG001|Overall Study|Withdrawal by Subject|4|||
144283490|NCT00827242|520238363|FG000|Overall Study|Protocol Violation|1|||
144283491|NCT00827242|520238364|FG001|Overall Study|Protocol Violation|3|||
144283492|NCT00827242|520238363|FG000|Overall Study|Lost to Follow-up|0|||
144283493|NCT00827242|520238364|FG001|Overall Study|Lost to Follow-up|3|||
144283494|NCT00827242|520238363|FG000|Overall Study|Adverse Event Excluding Death|2|||
144283495|NCT00827242|520238364|FG001|Overall Study|Adverse Event Excluding Death|1|||
144283496|NCT00827242|520238363|FG000|Overall Study|Entry Criteria Not Met|4|||
144283497|NCT00827242|520238364|FG001|Overall Study|Entry Criteria Not Met|1|||
144283498|NCT00827242|520238363|FG000|Overall Study|Physician Decision|2|||
144283499|NCT00827242|520238364|FG001|Overall Study|Physician Decision|0|||
144283500|NCT00827242|520238363|FG000|Overall Study|Death|1|||
144283501|NCT00827242|520238364|FG001|Overall Study|Death|0|||
144283502|NCT00827242|520238363|FG000|Overall Study|Lack of Efficacy|1|||
144283503|NCT00827242|520238364|FG001|Overall Study|Lack of Efficacy|0|||
144283504|NCT00471107|520238369|FG000|Overall Study|Technical problems/data loss|3|||
144283505|NCT00471107|520238370|FG001|Overall Study|Technical problems/data loss|1|||
144283506|NCT00471107|520238371|FG002|Overall Study|Technical problems/data loss|3|||
144283507|NCT00699751|520238372|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
144283508|NCT00699751|520238373|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
144283509|NCT00699751|520238372|FG000|Period 1: Without/Before Drug Switch|Death|28|||
144283510|NCT00699751|520238373|FG001|Period 1: Without/Before Drug Switch|Death|29|||
144283511|NCT00699751|520238372|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
144283512|NCT00699751|520238373|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
144283513|NCT00699751|520238372|FG000|Period 1: Without/Before Drug Switch|Other|30|||
144283514|NCT00699751|520238373|FG001|Period 1: Without/Before Drug Switch|Other|20|||
144283515|NCT00699751|520238372|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
144283516|NCT00699751|520238373|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
144283517|NCT00699751|520238372|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
144283518|NCT00699751|520238373|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
144283519|NCT00699751|520238372|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
144283520|NCT00699751|520238373|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
144283521|NCT00699751|520238372|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
144283522|NCT00699751|520238373|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
144283523|NCT01947933|520238374|FG000|Overall Study|Withdrawal by Subject|0|||
144283524|NCT01947933|520238375|FG001|Overall Study|Withdrawal by Subject|0|||
144283525|NCT01947933|520238376|FG002|Overall Study|Withdrawal by Subject|1|||
144283526|NCT01947933|520238377|FG003|Overall Study|Withdrawal by Subject|0|||
144283527|NCT01947933|520238378|FG004|Overall Study|Withdrawal by Subject|0|||
144283528|NCT01947933|520238379|FG005|Overall Study|Withdrawal by Subject|0|||
144283529|NCT01947933|520238380|FG006|Overall Study|Withdrawal by Subject|0|||
144283530|NCT01947933|520238381|FG007|Overall Study|Withdrawal by Subject|0|||
144283531|NCT01947933|520238382|FG008|Overall Study|Withdrawal by Subject|0|||
144283532|NCT01947933|520238374|FG000|Overall Study|Lost to Follow-up|0|||
144283533|NCT01947933|520238375|FG001|Overall Study|Lost to Follow-up|0|||
144283534|NCT01947933|520238376|FG002|Overall Study|Lost to Follow-up|0|||
144283535|NCT01947933|520238377|FG003|Overall Study|Lost to Follow-up|0|||
144283536|NCT01947933|520238378|FG004|Overall Study|Lost to Follow-up|0|||
144283537|NCT01947933|520238379|FG005|Overall Study|Lost to Follow-up|0|||
144283538|NCT01947933|520238380|FG006|Overall Study|Lost to Follow-up|0|||
144283539|NCT01947933|520238381|FG007|Overall Study|Lost to Follow-up|0|||
144283540|NCT01947933|520238382|FG008|Overall Study|Lost to Follow-up|1|||
144283541|NCT00294398|520238383|FG000|Overall Study|Lost to Follow-up|21|||
144283542|NCT00294398|520238384|FG001|Overall Study|Lost to Follow-up|26|||
144283543|NCT01428128|520238385|FG000|Overall Study|Withdrawal by Subject|4|||
144283544|NCT01428128|520238385|FG000|Overall Study|Screen failure by p53|10|||
144283545|NCT01428128|520238385|FG000|Overall Study|Received Neulasta in one cycle|2|||
144283546|NCT01428128|520238385|FG000|Overall Study|Adverse Event|1|||
144283547|NCT00250718|520238389|FG000|Overall Study|Death|1|||
144283548|NCT00250718|520238389|FG000|Overall Study|Adverse Event|1|||
144283549|NCT00250718|520238389|FG000|Overall Study|Withdrawal by Subject|1|||
144283550|NCT00985790|520238390|FG000|Overall Study|Withdrawal by Subject|1|||
144283551|NCT00985790|520238391|FG001|Overall Study|Withdrawal by Subject|1|||
144283552|NCT00985790|520238390|FG000|Overall Study|Lost to Follow-up|6|||
144283553|NCT00985790|520238391|FG001|Overall Study|Lost to Follow-up|7|||
144283554|NCT06100250|520238397|FG000|Overall Study|Lost to Follow-up|5|||
144283555|NCT05259033|520238400|FG000|Overall Study|Withdrawal by Subject|10|||
144283556|NCT05259033|520238401|FG001|Overall Study|Withdrawal by Subject|5|||
144283557|NCT05259033|520238400|FG000|Overall Study|Lost to Follow-up|1|||
144283558|NCT05259033|520238401|FG001|Overall Study|Lost to Follow-up|0|||
144283559|NCT05259033|520238400|FG000|Overall Study|Death|2|||
144283560|NCT05259033|520238401|FG001|Overall Study|Death|0|||
144283561|NCT01405911|520238402|FG000|Overall Study|Pre-treatment lab AE|0|||
144283562|NCT01405911|520238403|FG001|Overall Study|Pre-treatment lab AE|1|||
144283563|NCT01405911|520238404|FG002|Overall Study|Pre-treatment lab AE|0|||
144283564|NCT01405911|520238402|FG000|Overall Study|Lost to Follow-up|0|||
144283565|NCT01405911|520238403|FG001|Overall Study|Lost to Follow-up|1|||
144283566|NCT01405911|520238404|FG002|Overall Study|Lost to Follow-up|0|||
144283567|NCT01405911|520238402|FG000|Overall Study|Protocol Violation|1|||
144283568|NCT01405911|520238403|FG001|Overall Study|Protocol Violation|0|||
144283569|NCT01405911|520238404|FG002|Overall Study|Protocol Violation|0|||
144283570|NCT01405911|520238402|FG000|Overall Study|Withdrawal by Subject|3|||
144283571|NCT01405911|520238403|FG001|Overall Study|Withdrawal by Subject|1|||
144283572|NCT01405911|520238404|FG002|Overall Study|Withdrawal by Subject|1|||
144283573|NCT04124965|520238408|FG000|Overall Study|Adverse event, non-fatal|3|||
144283574|NCT04124965|520238409|FG001|Overall Study|Adverse event, non-fatal|1|||
144283575|NCT04124965|520238408|FG000|Overall Study|Withdrawal by Subject|1|||
144283576|NCT04124965|520238409|FG001|Overall Study|Withdrawal by Subject|1|||
144283577|NCT04124965|520238408|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
144283578|NCT04124965|520238409|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
144283579|NCT04124965|520238408|FG000|Overall Study|Pregnancy|1|||
144283580|NCT04124965|520238409|FG001|Overall Study|Pregnancy|0|||
144283581|NCT04124965|520238408|FG000|Overall Study|Sponsor and participant decision|0|||
144283582|NCT04124965|520238409|FG001|Overall Study|Sponsor and participant decision|1|||
144283583|NCT04124965|520238408|FG000|Overall Study|Personal surgery|0|||
144283584|NCT04124965|520238409|FG001|Overall Study|Personal surgery|1|||
144283585|NCT04124965|520238408|FG000|Overall Study|Physician Decision|0|||
144283586|NCT04124965|520238409|FG001|Overall Study|Physician Decision|1|||
144283587|NCT02184156|520238410|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
144283588|NCT02184156|520238411|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
144283589|NCT02184156|520238410|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
144283590|NCT02184156|520238411|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
144283591|NCT00002874|520238418|FG000|Overall Study|Withdrawal by Subject|1|||
144283592|NCT00002874|520238419|FG001|Overall Study|Withdrawal by Subject|1|||
144283593|NCT00002874|520238418|FG000|Overall Study|Protocol Violation|44|||
144283594|NCT00002874|520238419|FG001|Overall Study|Protocol Violation|34|||
144283595|NCT02114684|520238422|FG000|Overall Study|Death|6|||
144283596|NCT02114684|520238423|FG001|Overall Study|Death|4|||
144283597|NCT02114684|520238422|FG000|Overall Study|Lost to Follow-up|1|||
144283598|NCT02114684|520238423|FG001|Overall Study|Lost to Follow-up|2|||
144283599|NCT02114684|520238422|FG000|Overall Study|Withdrawal by Subject|1|||
144283600|NCT02114684|520238423|FG001|Overall Study|Withdrawal by Subject|2|||
144283601|NCT02114684|520238422|FG000|Overall Study|Relocation|3|||
144283602|NCT02114684|520238423|FG001|Overall Study|Relocation|1|||
144283603|NCT02114684|520238422|FG000|Overall Study|Rifampicin resistant on culture|0|||
144283604|NCT02114684|520238423|FG001|Overall Study|Rifampicin resistant on culture|1|||
144283605|NCT02114684|520238422|FG000|Overall Study|Patient Incarcerated|1|||
144283606|NCT02114684|520238423|FG001|Overall Study|Patient Incarcerated|0|||
144283607|NCT02530242|520238429|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
144283608|NCT02530242|520238430|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
144283609|NCT00283959|520238431|FG000|Extension Period|Low Compliance|1|||
144283610|NCT01214720|520238432|FG000|Overall Study|Alive and still on treatment|34|||
144283611|NCT01214720|520238433|FG001|Overall Study|Alive and still on treatment|18|||
144283612|NCT01214720|520238432|FG000|Overall Study|Alive and in follow-up|45|||
144283613|NCT01214720|520238433|FG001|Overall Study|Alive and in follow-up|48|||
144283614|NCT01214720|520238432|FG000|Overall Study|Lost to Follow-up|6|||
144283615|NCT01214720|520238433|FG001|Overall Study|Lost to Follow-up|2|||
144283616|NCT05591755|520238434|FG000|Overall Study|Screen Failure|1|||
144283617|NCT05591755|520238435|FG001|Overall Study|Screen Failure|0|||
144283618|NCT05591755|520238436|FG002|Overall Study|Screen Failure|0|||
144283619|NCT05591755|520238437|FG003|Overall Study|Screen Failure|0|||
144283620|NCT05591755|520238434|FG000|Overall Study|Protocol Violation|0|||
144283621|NCT05591755|520238435|FG001|Overall Study|Protocol Violation|0|||
144283622|NCT05591755|520238436|FG002|Overall Study|Protocol Violation|2|||
144283623|NCT05591755|520238437|FG003|Overall Study|Protocol Violation|0|||
144283624|NCT05591755|520238434|FG000|Overall Study|Withdrawal by Subject|0|||
144283625|NCT05591755|520238435|FG001|Overall Study|Withdrawal by Subject|1|||
144283626|NCT05591755|520238436|FG002|Overall Study|Withdrawal by Subject|0|||
144283627|NCT05591755|520238437|FG003|Overall Study|Withdrawal by Subject|0|||
144283628|NCT01397747|520238446|FG000|Overall Study|Multitarget DNA test excluded|689|||
144283629|NCT01397747|520238446|FG000|Overall Study|Colonoscopy excluded|304|||
144283630|NCT01397747|520238446|FG000|Overall Study|FIT excluded|34|||
144283631|NCT03828383|520238449|FG000|Overall Study|Lost to Follow-up|3|||
144283632|NCT03828383|520238450|FG001|Overall Study|Lost to Follow-up|2|||
144283633|NCT03828383|520238449|FG000|Overall Study|Withdrawal by Subject|4|||
144283634|NCT03828383|520238450|FG001|Overall Study|Withdrawal by Subject|5|||
144283635|NCT00504309|520238452|FG000|Overall Study|Death|0|||
144283636|NCT00504309|520238453|FG001|Overall Study|Death|0|||
144283637|NCT00504309|520238454|FG002|Overall Study|Death|0|||
144283638|NCT00504309|520238455|FG003|Overall Study|Death|0|||
144283639|NCT00504309|520238456|FG004|Overall Study|Death|1|||
144283640|NCT00504309|520238457|FG005|Overall Study|Death|0|||
144283641|NCT00504309|520238452|FG000|Overall Study|Withdrawal by Subject|0|||
144283642|NCT00504309|520238453|FG001|Overall Study|Withdrawal by Subject|0|||
144283643|NCT00504309|520238454|FG002|Overall Study|Withdrawal by Subject|1|||
144283644|NCT00504309|520238455|FG003|Overall Study|Withdrawal by Subject|0|||
144283645|NCT00504309|520238456|FG004|Overall Study|Withdrawal by Subject|0|||
144283646|NCT00504309|520238457|FG005|Overall Study|Withdrawal by Subject|0|||
144283647|NCT03345095|520238458|FG000|Overall Study|Lack of Efficacy|184|||
144283648|NCT03345095|520238459|FG001|Overall Study|Lack of Efficacy|156|||
144283649|NCT03345095|520238458|FG000|Overall Study|Adverse Event|36|||
144283650|NCT03345095|520238459|FG001|Overall Study|Adverse Event|118|||
144283651|NCT03345095|520238458|FG000|Overall Study|Withdrawal by Subject|22|||
144283652|NCT03345095|520238459|FG001|Overall Study|Withdrawal by Subject|59|||
144283653|NCT03345095|520238458|FG000|Overall Study|Physician Decision|3|||
144283654|NCT03345095|520238459|FG001|Overall Study|Physician Decision|18|||
144283655|NCT03345095|520238458|FG000|Overall Study|Death|2|||
144283656|NCT03345095|520238459|FG001|Overall Study|Death|4|||
144283657|NCT03345095|520238458|FG000|Overall Study|Other reasons|2|||
144283658|NCT03345095|520238459|FG001|Overall Study|Other reasons|11|||
144283659|NCT03345095|520238458|FG000|Overall Study|Protocol Violation|0|||
144283660|NCT03345095|520238459|FG001|Overall Study|Protocol Violation|1|||
144283661|NCT01121575|520238460|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
144283662|NCT01121575|520238461|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
144283663|NCT01121575|520238462|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
144283664|NCT01121575|520238463|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
144283665|NCT01121575|520238464|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
144283666|NCT01121575|520238465|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
144283667|NCT01121575|520238460|FG000|Overall Study|Unspecified Reasons|8|||
144283668|NCT01121575|520238461|FG001|Overall Study|Unspecified Reasons|6|||
144283669|NCT01121575|520238462|FG002|Overall Study|Unspecified Reasons|7|||
144283670|NCT01121575|520238463|FG003|Overall Study|Unspecified Reasons|5|||
144283671|NCT01121575|520238464|FG004|Overall Study|Unspecified Reasons|13|||
144283672|NCT01121575|520238465|FG005|Overall Study|Unspecified Reasons|10|||
144283673|NCT01121575|520238460|FG000|Overall Study|Death|6|||
144283674|NCT01121575|520238461|FG001|Overall Study|Death|0|||
144283675|NCT01121575|520238462|FG002|Overall Study|Death|0|||
144283676|NCT01121575|520238463|FG003|Overall Study|Death|1|||
144283677|NCT01121575|520238464|FG004|Overall Study|Death|7|||
144283678|NCT01121575|520238465|FG005|Overall Study|Death|1|||
144283679|NCT03158311|520238466|FG000|Overall Study|Subject/Guardian Decision|10|||
144283680|NCT03158311|520238467|FG001|Overall Study|Subject/Guardian Decision|6|||
144283681|NCT03158311|520238468|FG002|Overall Study|Subject/Guardian Decision|11|||
144283682|NCT03158311|520238466|FG000|Overall Study|Adverse Event|5|||
144283683|NCT03158311|520238467|FG001|Overall Study|Adverse Event|3|||
144283684|NCT03158311|520238468|FG002|Overall Study|Adverse Event|3|||
144283685|NCT03158311|520238466|FG000|Overall Study|Techinical Problems|3|||
144283686|NCT03158311|520238467|FG001|Overall Study|Techinical Problems|1|||
144283687|NCT03158311|520238468|FG002|Overall Study|Techinical Problems|5|||
144283688|NCT03158311|520238466|FG000|Overall Study|Physician Decision|2|||
144283689|NCT03158311|520238467|FG001|Overall Study|Physician Decision|3|||
144283690|NCT03158311|520238468|FG002|Overall Study|Physician Decision|7|||
144283691|NCT03158311|520238466|FG000|Overall Study|Lost to Follow-up|1|||
144283692|NCT03158311|520238467|FG001|Overall Study|Lost to Follow-up|1|||
144283693|NCT03158311|520238468|FG002|Overall Study|Lost to Follow-up|1|||
144283694|NCT03158311|520238466|FG000|Overall Study|Sponsor decision|1|||
144283695|NCT03158311|520238467|FG001|Overall Study|Sponsor decision|0|||
144283696|NCT03158311|520238468|FG002|Overall Study|Sponsor decision|0|||
144283697|NCT03158311|520238466|FG000|Overall Study|Pregnancy|0|||
144283698|NCT03158311|520238467|FG001|Overall Study|Pregnancy|2|||
144283699|NCT03158311|520238468|FG002|Overall Study|Pregnancy|0|||
144283700|NCT03158311|520238466|FG000|Overall Study|Randomized in error|0|||
144283701|NCT03158311|520238467|FG001|Overall Study|Randomized in error|0|||
144283702|NCT03158311|520238468|FG002|Overall Study|Randomized in error|1|||
144283703|NCT02665455|520238469|FG000|Overall Study|Withdrawal by Subject|6|||
144283704|NCT02665455|520238469|FG000|Overall Study|Lost to Follow-up|1|||
144283705|NCT02665455|520238469|FG000|Overall Study|Adverse Event|1|||
144283706|NCT02665455|520238469|FG000|Overall Study|Protocol Violation|1|||
144283707|NCT02564978|520238473|FG000|Overall Study|Adverse Event|8|||
144283708|NCT02564978|520238473|FG000|Overall Study|Death|1|||
144283709|NCT02564978|520238473|FG000|Overall Study|Lost to Follow-up|1|||
144283710|NCT02564978|520238473|FG000|Overall Study|Withdrawal by Subject|15|||
144283711|NCT02564978|520238473|FG000|Overall Study|Early Study Closure|2|||
144283712|NCT02564978|520238473|FG000|Overall Study|Other Reason|5|||
144283713|NCT04971837|520240983|FG000|Overall Study|Long Term Illness|1|||
144283714|NCT04971837|520240983|FG000|Overall Study|BMI too low|9|||
144283715|NCT04971837|520240983|FG000|Overall Study|geographic location|1|||
144283716|NCT04971837|520240983|FG000|Overall Study|Discontinued scheduling conflict|1|||
144283717|NCT00504231|520240986|FG000|Overall Study|Discrepant chart documentation re route|0|||
144283718|NCT00504231|520240987|FG001|Overall Study|Discrepant chart documentation re route|0|||
144283719|NCT00504231|520240988|FG002|Overall Study|Discrepant chart documentation re route|1|||
144283720|NCT00504231|520240989|FG003|Overall Study|Discrepant chart documentation re route|0|||
144283721|NCT01105130|520240990|FG000|Overall Study|Withdrawal by Subject|4|||
144283722|NCT01105130|520240991|FG001|Overall Study|Withdrawal by Subject|6|||
144283723|NCT01105130|520240992|FG002|Overall Study|Withdrawal by Subject|2|||
144283724|NCT01105130|520240990|FG000|Overall Study|Never Started|2|||
144283725|NCT01105130|520240991|FG001|Overall Study|Never Started|2|||
144283726|NCT01105130|520240992|FG002|Overall Study|Never Started|4|||
144283727|NCT01105130|520240990|FG000|Overall Study|Toxicity|1|||
144283728|NCT01105130|520240991|FG001|Overall Study|Toxicity|3|||
144283729|NCT01105130|520240992|FG002|Overall Study|Toxicity|2|||
144283730|NCT01105130|520240990|FG000|Overall Study|Multiple Reasons|3|||
144283731|NCT01105130|520240991|FG001|Overall Study|Multiple Reasons|0|||
144283732|NCT01105130|520240992|FG002|Overall Study|Multiple Reasons|2|||
144283733|NCT00327171|520240993|FG000|Overall Study|Did not receive study medication|3|||
144283734|NCT00327171|520240994|FG001|Overall Study|Did not receive study medication|0|||
144283735|NCT00327171|520240993|FG000|Overall Study|Adverse Event|23|||
144283736|NCT00327171|520240994|FG001|Overall Study|Adverse Event|23|||
144283737|NCT00327171|520240993|FG000|Overall Study|Disease progression/lack of efficacy|68|||
144283738|NCT00327171|520240994|FG001|Overall Study|Disease progression/lack of efficacy|69|||
144283739|NCT00327171|520240993|FG000|Overall Study|Investigator/participant request|1|||
144283740|NCT00327171|520240994|FG001|Overall Study|Investigator/participant request|8|||
144283741|NCT00327171|520240993|FG000|Overall Study|Clinical progression|12|||
144283742|NCT00327171|520240994|FG001|Overall Study|Clinical progression|8|||
144283743|NCT00327171|520240993|FG000|Overall Study|Undisclosed history of ischemia|0|||
144283744|NCT00327171|520240994|FG001|Overall Study|Undisclosed history of ischemia|1|||
144283745|NCT00327171|520240993|FG000|Overall Study|Other|1|||
144283746|NCT00327171|520240994|FG001|Overall Study|Other|0|||
144283747|NCT02323334|520240995|FG000|Period 3|Lost to Follow-up|0|||
144283748|NCT02323334|520240996|FG001|Period 3|Lost to Follow-up|0|||
144283749|NCT02323334|520240997|FG002|Period 3|Lost to Follow-up|1|||
144283750|NCT02323334|520240998|FG003|Period 3|Lost to Follow-up|0|||
144283751|NCT02323334|520240999|FG004|Period 3|Lost to Follow-up|0|||
144283752|NCT02323334|520241000|FG005|Period 3|Lost to Follow-up|0|||
144283753|NCT02323334|520241001|FG006|Period 3|Lost to Follow-up|0|||
144283754|NCT02323334|520241002|FG007|Period 3|Lost to Follow-up|0|||
144283755|NCT02323334|520241003|FG008|Period 3|Lost to Follow-up|0|||
144283756|NCT02323334|520241004|FG009|Period 3|Lost to Follow-up|0|||
144283757|NCT02323334|520241005|FG010|Period 3|Lost to Follow-up|0|||
144283758|NCT02323334|520241006|FG011|Period 3|Lost to Follow-up|0|||
144283759|NCT02323334|520241007|FG012|Period 3|Lost to Follow-up|0|||
144283760|NCT02323334|520241008|FG013|Period 3|Lost to Follow-up|0|||
144283761|NCT02323334|520241009|FG014|Period 3|Lost to Follow-up|0|||
144283762|NCT02323334|520241010|FG015|Period 3|Lost to Follow-up|0|||
144283763|NCT02323334|520241011|FG016|Period 3|Lost to Follow-up|0|||
144283764|NCT02323334|520240995|FG000|Period 3|Withdrawal by Subject|1|||
144283765|NCT02323334|520240996|FG001|Period 3|Withdrawal by Subject|0|||
144283766|NCT02323334|520240997|FG002|Period 3|Withdrawal by Subject|0|||
144283767|NCT02323334|520240998|FG003|Period 3|Withdrawal by Subject|0|||
144283768|NCT02323334|520240999|FG004|Period 3|Withdrawal by Subject|0|||
144283769|NCT02323334|520241000|FG005|Period 3|Withdrawal by Subject|0|||
144283770|NCT02323334|520241001|FG006|Period 3|Withdrawal by Subject|0|||
144283771|NCT02323334|520241002|FG007|Period 3|Withdrawal by Subject|0|||
144283772|NCT02323334|520241003|FG008|Period 3|Withdrawal by Subject|0|||
144283773|NCT02323334|520241004|FG009|Period 3|Withdrawal by Subject|0|||
144283774|NCT02323334|520241005|FG010|Period 3|Withdrawal by Subject|0|||
144283775|NCT02323334|520241006|FG011|Period 3|Withdrawal by Subject|0|||
144283776|NCT02323334|520241007|FG012|Period 3|Withdrawal by Subject|0|||
144283777|NCT02323334|520241008|FG013|Period 3|Withdrawal by Subject|0|||
144283778|NCT02323334|520241009|FG014|Period 3|Withdrawal by Subject|0|||
144283779|NCT02323334|520241010|FG015|Period 3|Withdrawal by Subject|0|||
144283780|NCT02323334|520241011|FG016|Period 3|Withdrawal by Subject|0|||
144283781|NCT00530075|520241012|FG000|Overall Study|Adverse Event|1|||
144283782|NCT00530075|520241012|FG000|Overall Study|Death|1|||
144283783|NCT00530075|520241012|FG000|Overall Study|Lack of Efficacy|3|||
144283784|NCT00530075|520241012|FG000|Overall Study|Protocol Violation|1|||
144283785|NCT00530075|520241012|FG000|Overall Study|Withdrawal by Subject|1|||
144283786|NCT03422718|520241013|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
144283787|NCT03422718|520241014|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
144283788|NCT03422718|520241015|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
144283789|NCT03422718|520241016|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
144283790|NCT03422718|520241017|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
144283791|NCT03422718|520241018|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
144283792|NCT03422718|520241019|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
144283793|NCT03422718|520241020|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
144283794|NCT03422718|520241013|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
144283795|NCT03422718|520241014|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
144283796|NCT03422718|520241015|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
144283797|NCT03422718|520241016|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
144283798|NCT03422718|520241017|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
144283799|NCT03422718|520241018|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
144283800|NCT03422718|520241019|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
144283801|NCT03422718|520241020|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
144283802|NCT03422718|520241013|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
144283803|NCT03422718|520241014|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
144283804|NCT03422718|520241015|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
144283805|NCT03422718|520241016|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
144283806|NCT03422718|520241017|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
144283807|NCT03422718|520241018|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
144283808|NCT03422718|520241019|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
144283809|NCT03422718|520241020|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
144283810|NCT03422718|520241013|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
144283811|NCT03422718|520241014|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
144283812|NCT03422718|520241015|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
144283813|NCT03422718|520241016|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
144283814|NCT03422718|520241017|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
144283815|NCT03422718|520241018|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
144283816|NCT03422718|520241019|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
144245770|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245771|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245772|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245773|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
144245774|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
144245775|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
144245776|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
144245777|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245778|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245779|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245780|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245781|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245782|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245783|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245784|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245785|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245786|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245787|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
144245788|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
144245789|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
144245790|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
144245791|NCT02326298|520096242|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245792|NCT02326298|520096243|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245793|NCT02326298|520096244|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245794|NCT02326298|520096245|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245795|NCT02326298|520096246|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245796|NCT02326298|520096247|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245797|NCT02326298|520096248|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245798|NCT02326298|520096249|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245799|NCT02326298|520096250|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245800|NCT02326298|520096251|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144283817|NCT03422718|520241020|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
144283818|NCT03422718|520241013|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
144283819|NCT03422718|520241014|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
144283820|NCT03422718|520241015|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
144283821|NCT03422718|520241016|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
144283822|NCT03422718|520241017|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
144283823|NCT03422718|520241018|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
144283824|NCT03422718|520241019|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
144283825|NCT03422718|520241020|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
144283826|NCT03422718|520241013|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
144283827|NCT03422718|520241014|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
144283828|NCT03422718|520241015|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
144283829|NCT03422718|520241016|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
144283830|NCT03422718|520241017|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
144283831|NCT03422718|520241018|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
144283832|NCT03422718|520241019|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
144283833|NCT03422718|520241020|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
144283834|NCT03309605|520241021|FG000|Overall Study|Adverse Event|0|||
144283835|NCT03309605|520241022|FG001|Overall Study|Adverse Event|0|||
144283836|NCT03309605|520241023|FG002|Overall Study|Adverse Event|0|||
144283837|NCT03309605|520241024|FG003|Overall Study|Adverse Event|1|||
144283838|NCT03309605|520241025|FG004|Overall Study|Adverse Event|0|||
144283839|NCT03309605|520241026|FG005|Overall Study|Adverse Event|0|||
144283840|NCT03309605|520241027|FG006|Overall Study|Adverse Event|2|||
144283841|NCT03309605|520241028|FG007|Overall Study|Adverse Event|1|||
144283842|NCT03309605|520241021|FG000|Overall Study|Withdrawal by Subject|0|||
144283843|NCT03309605|520241022|FG001|Overall Study|Withdrawal by Subject|0|||
144283844|NCT03309605|520241023|FG002|Overall Study|Withdrawal by Subject|0|||
144283845|NCT03309605|520241024|FG003|Overall Study|Withdrawal by Subject|0|||
144283846|NCT03309605|520241025|FG004|Overall Study|Withdrawal by Subject|1|||
144283847|NCT03309605|520241026|FG005|Overall Study|Withdrawal by Subject|0|||
144283848|NCT03309605|520241027|FG006|Overall Study|Withdrawal by Subject|1|||
144283849|NCT03309605|520241028|FG007|Overall Study|Withdrawal by Subject|1|||
144283850|NCT01129284|520241029|FG000|Overall Study|Adverse Event|2|||
144283851|NCT01129284|520241030|FG001|Overall Study|Adverse Event|0|||
144283852|NCT01129284|520241031|FG002|Overall Study|Adverse Event|1|||
144283853|NCT00784927|520241034|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
144283854|NCT00784927|520241034|FG000|Overall Study|Protocol Violation|1|||
144283855|NCT00784927|520241034|FG000|Overall Study|Ineligible|1|||
144283856|NCT00422461|520241041|FG000|Overall Study|Adverse Event|1|||
144283857|NCT00422461|520241042|FG001|Overall Study|Adverse Event|2|||
144283858|NCT00422461|520241043|FG002|Overall Study|Adverse Event|1|||
144283859|NCT00422461|520241044|FG003|Overall Study|Adverse Event|1|||
144283860|NCT00422461|520241041|FG000|Overall Study|Other|0|||
144283861|NCT00422461|520241042|FG001|Overall Study|Other|0|||
144283862|NCT00422461|520241043|FG002|Overall Study|Other|0|||
144283863|NCT00422461|520241044|FG003|Overall Study|Other|2|||
144283864|NCT00422461|520241041|FG000|Overall Study|Participants no longer willing to participate in study|1|||
144283865|NCT00422461|520241042|FG001|Overall Study|Participants no longer willing to participate in study|0|||
144283866|NCT00422461|520241043|FG002|Overall Study|Participants no longer willing to participate in study|0|||
144283867|NCT00422461|520241044|FG003|Overall Study|Participants no longer willing to participate in study|0|||
144283868|NCT00422461|520241041|FG000|Overall Study|Randomized but not treated|1|||
144283869|NCT00422461|520241042|FG001|Overall Study|Randomized but not treated|1|||
144283870|NCT00422461|520241043|FG002|Overall Study|Randomized but not treated|0|||
144283871|NCT00422461|520241044|FG003|Overall Study|Randomized but not treated|0|||
144283872|NCT01795937|520241046|FG000|Overall Study|Withdrawal by Subject|1|||
144283873|NCT01795937|520241047|FG001|Overall Study|Withdrawal by Subject|0|||
144283874|NCT01795937|520241048|FG002|Overall Study|Withdrawal by Subject|0|||
144283875|NCT01795937|520241046|FG000|Overall Study|Physician Decision|0|||
144283876|NCT01795937|520241047|FG001|Overall Study|Physician Decision|1|||
144283877|NCT01795937|520241048|FG002|Overall Study|Physician Decision|0|||
144283878|NCT04027946|520241049|FG000|Overall Study|Screen failures|3|||
144283879|NCT01028053|520241054|FG000|Overall Study|Screen Failure|113|||
144283880|NCT01028053|520241054|FG000|Overall Study|Patient Request|11|||
144283881|NCT01028053|520241054|FG000|Overall Study|Protocol Violation|1|||
144283882|NCT01028053|520241054|FG000|Overall Study|Physician Decision|2|||
144283883|NCT01028053|520241054|FG000|Overall Study|Technical Problem|1|||
144283884|NCT01028053|520241054|FG000|Overall Study|Terminated by Sponsor|1|||
144283885|NCT01028053|520241054|FG000|Overall Study|Various reasons|4|||
144283886|NCT03315689|520241055|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
144283887|NCT03315689|520241056|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
144283888|NCT03315689|520241055|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
144283889|NCT03315689|520241056|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
144283890|NCT03315689|520241055|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
144283891|NCT03315689|520241056|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
144283892|NCT00864513|520241058|FG000|Overall Study|Withdrawal by Subject|3|||
144283893|NCT03073109|520241059|FG000|Overall Study|Adverse Event|0|||
144283894|NCT03073109|520241060|FG001|Overall Study|Adverse Event|1|||
144283895|NCT03073109|520241059|FG000|Overall Study|Other|2|||
144283896|NCT03073109|520241060|FG001|Overall Study|Other|0|||
144283897|NCT03073109|520241059|FG000|Overall Study|Lost to Follow-up|8|||
144283898|NCT03073109|520241060|FG001|Overall Study|Lost to Follow-up|1|||
144283899|NCT01297244|520241061|FG000|Overall Study|Progressive disease|22|||
144283900|NCT01297244|520241062|FG001|Overall Study|Progressive disease|3|||
144283901|NCT01297244|520241061|FG000|Overall Study|Adverse Event|9|||
144283902|NCT01297244|520241062|FG001|Overall Study|Adverse Event|1|||
144283903|NCT01297244|520241061|FG000|Overall Study|Death|1|||
144283904|NCT01297244|520241062|FG001|Overall Study|Death|1|||
144283905|NCT01297244|520241061|FG000|Overall Study|Clinical progression|1|||
144283906|NCT01297244|520241062|FG001|Overall Study|Clinical progression|1|||
144283907|NCT01297244|520241061|FG000|Overall Study|Withdrawal by Subject|2|||
144283908|NCT01297244|520241062|FG001|Overall Study|Withdrawal by Subject|0|||
144283909|NCT00875667|520241065|FG000|Overall Study|Adverse Event|29|||
144283910|NCT00875667|520241066|FG001|Overall Study|Adverse Event|10|||
144283911|NCT00875667|520241065|FG000|Overall Study|Withdrawal by Subject|17|||
144283912|NCT00875667|520241066|FG001|Overall Study|Withdrawal by Subject|5|||
144283913|NCT00875667|520241065|FG000|Overall Study|Death|7|||
144283914|NCT00875667|520241066|FG001|Overall Study|Death|2|||
144283915|NCT00875667|520241065|FG000|Overall Study|Protocol Violation|2|||
144283916|NCT00875667|520241066|FG001|Overall Study|Protocol Violation|0|||
144283917|NCT00875667|520241065|FG000|Overall Study|Disease Progression|100|||
144283918|NCT00875667|520241066|FG001|Overall Study|Disease Progression|49|||
144283919|NCT00875667|520241065|FG000|Overall Study|Miscellaneous|12|||
144283920|NCT00875667|520241066|FG001|Overall Study|Miscellaneous|6|||
144283921|NCT00875667|520241065|FG000|Overall Study|Randomized but no Study Drug Given|3|||
144283922|NCT00875667|520241066|FG001|Overall Study|Randomized but no Study Drug Given|1|||
144283923|NCT01913470|520241072|FG000|Overall Study|Lost to Follow-up|0|||
144283924|NCT01913470|520241073|FG001|Overall Study|Lost to Follow-up|1|||
144283925|NCT01913470|520241072|FG000|Overall Study|Physician Decision|0|||
144283926|NCT01913470|520241073|FG001|Overall Study|Physician Decision|1|||
144283927|NCT01913470|520241072|FG000|Overall Study|Withdrawal by Subject|0|||
144283928|NCT01913470|520241073|FG001|Overall Study|Withdrawal by Subject|1|||
144283929|NCT00245570|520241074|FG000|Washout Between Periods III and IV|Adverse Event|0|||
144283930|NCT00245570|520241075|FG001|Washout Between Periods III and IV|Adverse Event|1|||
144283931|NCT00245570|520241076|FG002|Washout Between Periods III and IV|Adverse Event|0|||
144283932|NCT00245570|520241077|FG003|Washout Between Periods III and IV|Adverse Event|0|||
144283933|NCT00245570|520241078|FG004|Washout Between Periods III and IV|Adverse Event|0|||
144283934|NCT00245570|520241079|FG005|Washout Between Periods III and IV|Adverse Event|0|||
144283935|NCT02384460|520241102|FG000|Overall Study|Protocol Violation|0|||
144283936|NCT02384460|520241103|FG001|Overall Study|Protocol Violation|1|||
144283937|NCT02384460|520241102|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
144283938|NCT02384460|520241103|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
144283939|NCT02384460|520241102|FG000|Overall Study|Adverse Event|5|||
144283940|NCT02384460|520241103|FG001|Overall Study|Adverse Event|2|||
144283941|NCT02384460|520241102|FG000|Overall Study|Withdrawal by Subject|0|||
144283942|NCT02384460|520241103|FG001|Overall Study|Withdrawal by Subject|3|||
144283943|NCT02384460|520241102|FG000|Overall Study|Elective medical treatment|1|||
144283944|NCT02384460|520241103|FG001|Overall Study|Elective medical treatment|0|||
144283945|NCT02384460|520241102|FG000|Overall Study|Non-compliance|1|||
144283946|NCT02384460|520241103|FG001|Overall Study|Non-compliance|0|||
144283947|NCT00965094|520241104|FG000|Overall Study|Adverse Event|5|||
144283948|NCT00965094|520241105|FG001|Overall Study|Adverse Event|0|||
144283949|NCT00965094|520241104|FG000|Overall Study|Lost to Follow-up|0|||
144283950|NCT00965094|520241105|FG001|Overall Study|Lost to Follow-up|1|||
144283951|NCT01060111|520241106|FG000|Overall Study|Adverse Event|9|||
144283952|NCT01060111|520241107|FG001|Overall Study|Adverse Event|5|||
144283953|NCT01060111|520241108|FG002|Overall Study|Adverse Event|18|||
144283954|NCT01060111|520241106|FG000|Overall Study|Lack of Efficacy|2|||
144283955|NCT01060111|520241107|FG001|Overall Study|Lack of Efficacy|1|||
144283956|NCT01060111|520241108|FG002|Overall Study|Lack of Efficacy|0|||
144283957|NCT01060111|520241106|FG000|Overall Study|Inappropriate participant|5|||
144283958|NCT01060111|520241107|FG001|Overall Study|Inappropriate participant|4|||
144283959|NCT01060111|520241108|FG002|Overall Study|Inappropriate participant|5|||
144283960|NCT01060111|520241106|FG000|Overall Study|Participants' evasion for hospital visit|0|||
144283961|NCT01060111|520241107|FG001|Overall Study|Participants' evasion for hospital visit|3|||
144283962|NCT01060111|520241108|FG002|Overall Study|Participants' evasion for hospital visit|2|||
144283963|NCT01060111|520241106|FG000|Overall Study|Participants' non-cooperation|8|||
144283964|NCT01060111|520241107|FG001|Overall Study|Participants' non-cooperation|6|||
144283965|NCT01060111|520241108|FG002|Overall Study|Participants' non-cooperation|6|||
144283966|NCT01060111|520241106|FG000|Overall Study|Adverse event and insufficient effect|0|||
144283967|NCT01060111|520241107|FG001|Overall Study|Adverse event and insufficient effect|1|||
144283968|NCT01060111|520241108|FG002|Overall Study|Adverse event and insufficient effect|0|||
144283969|NCT01060111|520241106|FG000|Overall Study|Participants' non-cooperation|1|||
144283970|NCT01060111|520241107|FG001|Overall Study|Participants' non-cooperation|0|||
144283971|NCT01060111|520241108|FG002|Overall Study|Participants' non-cooperation|0|||
144283972|NCT01060111|520241106|FG000|Overall Study|Other|2|||
144283973|NCT01060111|520241107|FG001|Overall Study|Other|3|||
144283974|NCT01060111|520241108|FG002|Overall Study|Other|4|||
144283975|NCT02441114|520241110|FG000|Washout2|Withdrawal by Subject|4|||
144283976|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
144283977|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
144283978|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
144283979|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
144283980|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
144283981|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
144283982|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
144283983|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
144283984|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
144283985|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
144283986|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
144283987|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
144283988|NCT03446573|520241111|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
144283989|NCT03446573|520241112|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
144283990|NCT03446573|520241111|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
144283991|NCT03446573|520241112|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
144283992|NCT03446573|520241111|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
144283993|NCT03446573|520241112|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
144283994|NCT03446573|520241111|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
144283995|NCT03446573|520241112|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
144283996|NCT03446573|520241111|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
144283997|NCT03446573|520241112|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
144283998|NCT03446573|520241111|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
144283999|NCT03446573|520241112|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
144284000|NCT03446573|520241111|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
144284001|NCT03446573|520241112|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
144284002|NCT00625378|520241117|FG000|Overall Study|Adverse Event|22|||
144284003|NCT00625378|520241118|FG001|Overall Study|Adverse Event|0|||
144284004|NCT00625378|520241117|FG000|Overall Study|Withdrawal by Subject|16|||
144284005|NCT00625378|520241118|FG001|Overall Study|Withdrawal by Subject|0|||
144284006|NCT00625378|520241117|FG000|Overall Study|Death|38|||
144284007|NCT00625378|520241118|FG001|Overall Study|Death|0|||
144284008|NCT00625378|520241117|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
144284009|NCT00625378|520241118|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
144284010|NCT00625378|520241117|FG000|Overall Study|Lost to Follow-up|17|||
144284011|NCT00625378|520241118|FG001|Overall Study|Lost to Follow-up|0|||
144284012|NCT00625378|520241117|FG000|Overall Study|Non-compliant with study medication|3|||
144284013|NCT00625378|520241118|FG001|Overall Study|Non-compliant with study medication|0|||
144284014|NCT00625378|520241117|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
144284015|NCT00625378|520241118|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
144284016|NCT00625378|520241117|FG000|Overall Study|Medical decision|1|||
144284017|NCT00625378|520241118|FG001|Overall Study|Medical decision|0|||
144284018|NCT00625378|520241117|FG000|Overall Study|Multiple toxicities|1|||
144284019|NCT00625378|520241118|FG001|Overall Study|Multiple toxicities|0|||
144284020|NCT00625378|520241117|FG000|Overall Study|New cancer|1|||
144284021|NCT00625378|520241118|FG001|Overall Study|New cancer|0|||
144284022|NCT00625378|520241117|FG000|Overall Study|PTA program|2|||
144284023|NCT00625378|520241118|FG001|Overall Study|PTA program|0|||
144284024|NCT00625378|520241117|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
144284025|NCT00625378|520241118|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
144284026|NCT00625378|520241117|FG000|Overall Study|Sponsor decision|1|||
144284027|NCT00625378|520241118|FG001|Overall Study|Sponsor decision|0|||
144284028|NCT00625378|520241117|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
144284029|NCT00625378|520241118|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
144284030|NCT00625378|520241117|FG000|Overall Study|Switch to commercial drug|6|||
144284031|NCT00625378|520241118|FG001|Overall Study|Switch to commercial drug|1|||
144284032|NCT00625378|520241117|FG000|Overall Study|Missing|2|||
144284033|NCT00625378|520241118|FG001|Overall Study|Missing|0|||
144284034|NCT00625378|520241117|FG000|Overall Study|End of treatment not available|2|||
144284035|NCT00625378|520241118|FG001|Overall Study|End of treatment not available|0|||
144284036|NCT00625378|520241117|FG000|Overall Study|Never treated|2|||
144284037|NCT00625378|520241118|FG001|Overall Study|Never treated|0|||
144284038|NCT04270760|520241119|FG000|Overall Study|Withdrawal by Subject|0|||
144284039|NCT04270760|520241120|FG001|Overall Study|Withdrawal by Subject|1|||
144284040|NCT04270760|520241121|FG002|Overall Study|Withdrawal by Subject|3|||
144284041|NCT04270760|520241122|FG003|Overall Study|Withdrawal by Subject|0|||
144284042|NCT04270760|520241123|FG004|Overall Study|Withdrawal by Subject|0|||
144284043|NCT04270760|520241119|FG000|Overall Study|Lost to Follow-up|1|||
144284044|NCT04270760|520241120|FG001|Overall Study|Lost to Follow-up|2|||
144284045|NCT04270760|520241121|FG002|Overall Study|Lost to Follow-up|1|||
144284046|NCT04270760|520241122|FG003|Overall Study|Lost to Follow-up|0|||
144284047|NCT04270760|520241123|FG004|Overall Study|Lost to Follow-up|0|||
144284048|NCT04270760|520241119|FG000|Overall Study|Death|0|||
144284049|NCT04270760|520241120|FG001|Overall Study|Death|0|||
144284050|NCT04270760|520241121|FG002|Overall Study|Death|0|||
144284051|NCT04270760|520241122|FG003|Overall Study|Death|0|||
144284052|NCT04270760|520241123|FG004|Overall Study|Death|1|||
144284053|NCT02070991|520241124|FG000|Overall Study|Death|2|||
144284054|NCT02070991|520241125|FG001|Overall Study|Death|0|||
144284055|NCT02070991|520241124|FG000|Overall Study|Withdrawal by Subject|1|||
144284056|NCT02070991|520241125|FG001|Overall Study|Withdrawal by Subject|0|||
144284057|NCT04790201|520241126|FG000|Overall Study|Lost to Follow-up|0|||
144284058|NCT04790201|520241127|FG001|Overall Study|Lost to Follow-up|0|||
144284059|NCT04790201|520241128|FG002|Overall Study|Lost to Follow-up|2|||
144284060|NCT04790201|520241126|FG000|Overall Study|Death|0|||
144284061|NCT04790201|520241127|FG001|Overall Study|Death|1|||
144284062|NCT04790201|520241128|FG002|Overall Study|Death|0|||
144284063|NCT04790201|520241126|FG000|Overall Study|Protocol Violation|1|||
144284064|NCT04790201|520241127|FG001|Overall Study|Protocol Violation|0|||
144284065|NCT04790201|520241128|FG002|Overall Study|Protocol Violation|1|||
144284066|NCT02609633|520241129|FG000|Overall Study|Consent Withdrawn|0|||
144284067|NCT02609633|520241130|FG001|Overall Study|Consent Withdrawn|1|||
144284068|NCT02609633|520241129|FG000|Overall Study|Protocol Deviation|1|||
144284069|NCT02609633|520241130|FG001|Overall Study|Protocol Deviation|0|||
144284070|NCT02609633|520241129|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
144284071|NCT02609633|520241130|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
144284072|NCT02609633|520241129|FG000|Overall Study|Reason not Specified|2|||
144284073|NCT02609633|520241130|FG001|Overall Study|Reason not Specified|1|||
144284074|NCT05762679|520241133|FG000|Overall Study|Withdrawal by Subject|1|||
144284075|NCT05762679|520241133|FG000|Overall Study|No analyzable imaging data|1|||
144284076|NCT00997126|520241134|FG000|Overall Study|Physician Decision|7|||
144284077|NCT00997126|520241135|FG001|Overall Study|Physician Decision|11|||
144284078|NCT01769443|520241136|FG000|Overall Study|Study closure|1|||
144284079|NCT01769443|520241137|FG001|Overall Study|Study closure|0|||
144284080|NCT04149353|520241155|FG000|Overall Study|Study terminated|1|||
144284081|NCT02068599|520241156|FG000|Overall Study|Adverse Event|4|||
144284082|NCT02068599|520241157|FG001|Overall Study|Adverse Event|1|||
144284083|NCT02068599|520241158|FG002|Overall Study|Adverse Event|1|||
144284084|NCT02068599|520241156|FG000|Overall Study|Withdrawal by Subject|2|||
144284085|NCT02068599|520241157|FG001|Overall Study|Withdrawal by Subject|7|||
144284086|NCT02068599|520241158|FG002|Overall Study|Withdrawal by Subject|5|||
144284087|NCT02068599|520241156|FG000|Overall Study|Protocol Violation|4|||
144284088|NCT02068599|520241157|FG001|Overall Study|Protocol Violation|2|||
144284089|NCT02068599|520241158|FG002|Overall Study|Protocol Violation|3|||
144284090|NCT02068599|520241156|FG000|Overall Study|Lost to Follow-up|1|||
144284091|NCT02068599|520241157|FG001|Overall Study|Lost to Follow-up|0|||
144284092|NCT02068599|520241158|FG002|Overall Study|Lost to Follow-up|0|||
144284093|NCT02068599|520241156|FG000|Overall Study|Lack of Efficacy|0|||
144284094|NCT02068599|520241157|FG001|Overall Study|Lack of Efficacy|0|||
144284095|NCT02068599|520241158|FG002|Overall Study|Lack of Efficacy|3|||
144284096|NCT02068599|520241156|FG000|Overall Study|Noncompliance|0|||
144284097|NCT02068599|520241157|FG001|Overall Study|Noncompliance|0|||
144284098|NCT02068599|520241158|FG002|Overall Study|Noncompliance|1|||
144284099|NCT01871727|520241159|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
144284100|NCT01871727|520241160|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
144284101|NCT01871727|520241161|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
144284102|NCT01871727|520241162|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
144284103|NCT01871727|520241163|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
144284104|NCT01871727|520241159|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
144284105|NCT01871727|520241160|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
144284106|NCT01871727|520241161|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
144284107|NCT01871727|520241162|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
144284108|NCT01871727|520241163|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
144284109|NCT01871727|520241159|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
144284110|NCT01871727|520241160|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
144284111|NCT01871727|520241161|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
144284112|NCT01871727|520241162|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
144284113|NCT01871727|520241163|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
144284114|NCT01871727|520241159|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
144284115|NCT01871727|520241160|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
144284116|NCT01871727|520241161|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
144284117|NCT01871727|520241162|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
144284118|NCT01871727|520241163|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
144284119|NCT01871727|520241159|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
144284120|NCT01871727|520241160|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
144284121|NCT01871727|520241161|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
144284122|NCT01871727|520241162|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
144284123|NCT01871727|520241163|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
144284124|NCT01871727|520241159|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
144284125|NCT01871727|520241160|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
144284126|NCT01871727|520241161|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
144284127|NCT01871727|520241162|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
144284128|NCT01871727|520241163|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
144284129|NCT01871727|520241159|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
144284130|NCT01871727|520241160|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
144284131|NCT01871727|520241161|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
144284132|NCT01871727|520241162|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
144284133|NCT01871727|520241163|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
144284134|NCT01263028|520241164|FG000|Overall Study|Withdrawal by Subject|1|||
144284135|NCT01263028|520241164|FG000|Overall Study|Adverse Event|1|||
144284136|NCT01263028|520241164|FG000|Overall Study|Study terminated due to low enrollment.|4|||
144284137|NCT03019588|520241165|FG000|Overall Study|Death|44|||
144284138|NCT03019588|520241166|FG001|Overall Study|Death|46|||
144284139|NCT03019588|520241165|FG000|Overall Study|Study terminated by Sponsor|3|||
144284140|NCT03019588|520241166|FG001|Overall Study|Study terminated by Sponsor|1|||
144284141|NCT00887588|520241169|FG000|Core Period|Death|1|||
144284142|NCT00887588|520241170|FG001|Core Period|Death|1|||
144284143|NCT00887588|520241169|FG000|Core Period|Lost to Follow-up|3|||
144284144|NCT00887588|520241170|FG001|Core Period|Lost to Follow-up|1|||
144284145|NCT00887588|520241169|FG000|Core Period|Withdrawal by Subject|6|||
144284146|NCT00887588|520241170|FG001|Core Period|Withdrawal by Subject|8|||
144284147|NCT00887588|520241169|FG000|Core Period|Adverse Event|9|||
144284148|NCT00887588|520241170|FG001|Core Period|Adverse Event|11|||
144284149|NCT00887588|520241169|FG000|Extension Period|Adverse Event|4|||
144284150|NCT00887588|520241170|FG001|Extension Period|Adverse Event|4|||
144284151|NCT00887588|520241169|FG000|Extension Period|Death|0|||
144284152|NCT00887588|520241170|FG001|Extension Period|Death|1|||
144284153|NCT00887588|520241169|FG000|Extension Period|Protocol deviation|1|||
144284154|NCT00887588|520241170|FG001|Extension Period|Protocol deviation|0|||
144284155|NCT00887588|520241169|FG000|Extension Period|Lost to Follow-up|1|||
144284156|NCT00887588|520241170|FG001|Extension Period|Lost to Follow-up|0|||
144284157|NCT00366535|520241171|FG000|First Phase: 12 Weeks|Adverse Event|1|||
144284158|NCT00366535|520241172|FG001|First Phase: 12 Weeks|Adverse Event|3|||
144284159|NCT00366535|520241171|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
144284160|NCT00366535|520241172|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
144284161|NCT00366535|520241171|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
144284162|NCT00366535|520241172|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
144284163|NCT00366535|520241171|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
144284164|NCT00366535|520241172|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
144284165|NCT02958527|520241177|FG000|Overall Study|Not collected CRFs|12|||
144284166|NCT02691572|520241178|FG000|Overall Study|Withdrawal by Subject|1|||
144284167|NCT02691572|520241179|FG001|Overall Study|Withdrawal by Subject|0|||
144284168|NCT02691572|520241178|FG000|Overall Study|Protocol Violation|0|||
144284169|NCT02691572|520241179|FG001|Overall Study|Protocol Violation|1|||
144284170|NCT03753542|520241180|FG000|Overall Study|Lost to Follow-up|9|||
144284171|NCT03753542|520241181|FG001|Overall Study|Lost to Follow-up|14|||
144284172|NCT05089357|520241182|FG000|Overall Study|Withdrawal by Subject|23|||
144284173|NCT05089357|520241182|FG000|Overall Study|Lost to Follow-up|6|||
144284174|NCT05089357|520241182|FG000|Overall Study|Medical reason|1|||
144284175|NCT05089357|520241182|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
144284176|NCT05089357|520241182|FG000|Overall Study|Pregnancy|2|||
144284177|NCT04180696|520241183|FG000|Overall Study|Death|5|||
144284178|NCT04180696|520241184|FG001|Overall Study|Death|6|||
144284179|NCT04180696|520241183|FG000|Overall Study|Lost to Follow-up|1|||
144284180|NCT04180696|520241184|FG001|Overall Study|Lost to Follow-up|0|||
144284181|NCT04180696|520241183|FG000|Overall Study|Withdrawal by Subject|0|||
144284182|NCT04180696|520241184|FG001|Overall Study|Withdrawal by Subject|1|||
144284183|NCT05537571|520241185|FG000|Overall Study|Withdrawal by Subject|1|||
144284184|NCT05537571|520241186|FG001|Overall Study|Withdrawal by Subject|1|||
144284185|NCT05537571|520241187|FG002|Overall Study|Withdrawal by Subject|0|||
144284186|NCT05537571|520241188|FG003|Overall Study|Withdrawal by Subject|0|||
144284187|NCT05537571|520241189|FG004|Overall Study|Withdrawal by Subject|0|||
144284188|NCT05537571|520241185|FG000|Overall Study|Adverse Event|2|||
144284189|NCT05537571|520241186|FG001|Overall Study|Adverse Event|0|||
144284190|NCT05537571|520241187|FG002|Overall Study|Adverse Event|0|||
144284191|NCT05537571|520241188|FG003|Overall Study|Adverse Event|0|||
144284192|NCT05537571|520241189|FG004|Overall Study|Adverse Event|0|||
144284193|NCT05537571|520241185|FG000|Overall Study|Hepatitis A screening result|2|||
144284194|NCT05537571|520241186|FG001|Overall Study|Hepatitis A screening result|0|||
144284195|NCT05537571|520241187|FG002|Overall Study|Hepatitis A screening result|0|||
144284196|NCT05537571|520241188|FG003|Overall Study|Hepatitis A screening result|0|||
144284197|NCT05537571|520241189|FG004|Overall Study|Hepatitis A screening result|0|||
144284198|NCT05537571|520241185|FG000|Overall Study|Lost to Follow-up|0|||
144284199|NCT05537571|520241186|FG001|Overall Study|Lost to Follow-up|0|||
144284200|NCT05537571|520241187|FG002|Overall Study|Lost to Follow-up|1|||
144284201|NCT05537571|520241188|FG003|Overall Study|Lost to Follow-up|0|||
144284202|NCT05537571|520241189|FG004|Overall Study|Lost to Follow-up|1|||
144284203|NCT04210375|520241190|FG000|Overall Study|Death|0|||
144284204|NCT04210375|520241191|FG001|Overall Study|Death|1|||
144284205|NCT04210375|520241192|FG002|Overall Study|Death|0|||
144284206|NCT04210375|520241193|FG003|Overall Study|Death|0|||
144284207|NCT05752487|520241194|FG000|Overall Study|Enrolled, not treated|9|||
144284208|NCT05752487|520241194|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
144284209|NCT05752487|520241194|FG000|Overall Study|Withdrawal by Subject|2|||
144284210|NCT00424008|520241195|FG000|Overall Study|Adverse Event|8|||
144284211|NCT00424008|520241196|FG001|Overall Study|Adverse Event|6|||
144284212|NCT00424008|520241195|FG000|Overall Study|Lack of Efficacy|40|||
144284213|NCT00424008|520241196|FG001|Overall Study|Lack of Efficacy|34|||
144284214|NCT00424008|520241195|FG000|Overall Study|Lost to Follow-up|1|||
144284215|NCT00424008|520241196|FG001|Overall Study|Lost to Follow-up|2|||
144284216|NCT00424008|520241195|FG000|Overall Study|Withdrawal by Subject|5|||
144284217|NCT00424008|520241196|FG001|Overall Study|Withdrawal by Subject|8|||
144284218|NCT00424008|520241195|FG000|Overall Study|Noncompliance with protocol|13|||
144284219|NCT00424008|520241196|FG001|Overall Study|Noncompliance with protocol|7|||
144284220|NCT00424008|520241195|FG000|Overall Study|Did not meet protocol eligibility|16|||
144284221|NCT00424008|520241196|FG001|Overall Study|Did not meet protocol eligibility|21|||
144284222|NCT00424008|520241195|FG000|Overall Study|Administrative|266|||
144284223|NCT00424008|520241196|FG001|Overall Study|Administrative|257|||
144284224|NCT01860989|520241197|FG000|Overall Study|Unsatisfactory therapeutic|5|||
144284225|NCT02593864|520241198|FG000|Overall Study|Withdrawal by Subject|3|||
144284226|NCT02593864|520241198|FG000|Overall Study|Lost to Follow-up|3|||
144284227|NCT00433290|520241201|FG000|Overall Study|Adverse Event|24|||
144284228|NCT00433290|520241202|FG001|Overall Study|Adverse Event|7|||
144284229|NCT00433290|520241201|FG000|Overall Study|Lack of Efficacy|1|||
144284230|NCT00433290|520241202|FG001|Overall Study|Lack of Efficacy|5|||
144284231|NCT00433290|520241201|FG000|Overall Study|Withdrawal by Subject|4|||
144284232|NCT00433290|520241202|FG001|Overall Study|Withdrawal by Subject|2|||
144284233|NCT00433290|520241201|FG000|Overall Study|Protocol Violation|3|||
144284234|NCT00433290|520241202|FG001|Overall Study|Protocol Violation|2|||
144284235|NCT00433290|520241201|FG000|Overall Study|Physician Decision|2|||
144284236|NCT00433290|520241202|FG001|Overall Study|Physician Decision|0|||
144284237|NCT00433290|520241201|FG000|Overall Study|Entry Criteria Not Met|0|||
144284238|NCT00433290|520241202|FG001|Overall Study|Entry Criteria Not Met|1|||
144284239|NCT00433290|520241201|FG000|Overall Study|Lost to Follow-up|1|||
144284240|NCT00433290|520241202|FG001|Overall Study|Lost to Follow-up|0|||
144284241|NCT01018953|520241207|FG000|Overall Study|Adverse Event|2|||
144284242|NCT01018953|520241207|FG000|Overall Study|Withdrawal by Subject|1|||
144284243|NCT01018953|520241207|FG000|Overall Study|Study termination by sponsor|5|||
144284244|NCT00724503|520241208|FG000|Overall Study|Lost to Follow-up|4|||
144284245|NCT00724503|520241209|FG001|Overall Study|Lost to Follow-up|8|||
144284246|NCT00724503|520241208|FG000|Overall Study|Withdrawal by Subject|11|||
144284247|NCT00724503|520241209|FG001|Overall Study|Withdrawal by Subject|23|||
144284248|NCT00724503|520241208|FG000|Overall Study|Death|190|||
144284249|NCT00724503|520241209|FG001|Overall Study|Death|182|||
144284250|NCT00724503|520241208|FG000|Overall Study|Adverse Event|1|||
144284251|NCT00724503|520241209|FG001|Overall Study|Adverse Event|0|||
144284252|NCT00724503|520241208|FG000|Overall Study|Not otherwise specified|4|||
144284253|NCT00724503|520241209|FG001|Overall Study|Not otherwise specified|7|||
144284254|NCT01186419|520241212|FG000|Overall Study|Withdrawal by Subject|5|||
144284255|NCT01186419|520241213|FG001|Overall Study|Withdrawal by Subject|3|||
144284256|NCT01186419|520241212|FG000|Overall Study|Adverse Event|1|||
144284257|NCT01186419|520241213|FG001|Overall Study|Adverse Event|2|||
144284258|NCT01186419|520241212|FG000|Overall Study|Physician Decision|0|||
144284259|NCT01186419|520241213|FG001|Overall Study|Physician Decision|3|||
144284260|NCT01186419|520241212|FG000|Overall Study|Other|1|||
144284261|NCT01186419|520241213|FG001|Overall Study|Other|1|||
144284262|NCT01033071|520241215|FG000|Overall Study|Adverse Event|28|||
144284263|NCT01033071|520241216|FG001|Overall Study|Adverse Event|51|||
144284264|NCT01033071|520241217|FG002|Overall Study|Adverse Event|26|||
144284265|NCT01033071|520241215|FG000|Overall Study|Protocol Violation|0|||
144284266|NCT01033071|520241216|FG001|Overall Study|Protocol Violation|2|||
144284267|NCT01033071|520241217|FG002|Overall Study|Protocol Violation|1|||
144284268|NCT01033071|520241215|FG000|Overall Study|Lost to Follow-up|4|||
144284269|NCT01033071|520241216|FG001|Overall Study|Lost to Follow-up|5|||
144284270|NCT01033071|520241217|FG002|Overall Study|Lost to Follow-up|5|||
144284271|NCT01033071|520241215|FG000|Overall Study|Withdrawal by Subject|17|||
144284272|NCT01033071|520241216|FG001|Overall Study|Withdrawal by Subject|14|||
144284273|NCT01033071|520241217|FG002|Overall Study|Withdrawal by Subject|11|||
144284274|NCT01033071|520241215|FG000|Overall Study|Lack of Efficacy|0|||
144284275|NCT01033071|520241216|FG001|Overall Study|Lack of Efficacy|1|||
144284276|NCT01033071|520241217|FG002|Overall Study|Lack of Efficacy|1|||
144284277|NCT01033071|520241215|FG000|Overall Study|Other|6|||
144284278|NCT01033071|520241216|FG001|Overall Study|Other|4|||
144284279|NCT01033071|520241217|FG002|Overall Study|Other|3|||
144284280|NCT03735498|520242605|FG000|Overall Study|Withdrawal by Subject|3|||
144284281|NCT03735498|520242605|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
144284282|NCT05638737|520242606|FG000|Overall Study|Withdrawal by Subject|4|||
144284283|NCT05638737|520242607|FG001|Overall Study|Withdrawal by Subject|7|||
144284284|NCT00567580|520242608|FG000|Overall Study|Protocol Violation|28|||
144284285|NCT00567580|520242609|FG001|Overall Study|Protocol Violation|24|||
144284286|NCT00567580|520242610|FG002|Overall Study|Protocol Violation|24|||
144284287|NCT03022630|520242612|FG000|Overall Study|Death|9|||
144284288|NCT03022630|520242613|FG001|Overall Study|Death|7|||
144284289|NCT03022630|520242612|FG000|Overall Study|Withdrawal by Subject|0|||
144284290|NCT03022630|520242613|FG001|Overall Study|Withdrawal by Subject|5|||
144284291|NCT00884949|520242614|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
144284292|NCT00884949|520242614|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
144284293|NCT01734928|520242615|FG000|Randomization|Physician Decision|0|||
144284294|NCT01734928|520242616|FG001|Randomization|Physician Decision|1|||
144284295|NCT01734928|520242615|FG000|Randomization|clinical progression|0|||
144284296|NCT01734928|520242616|FG001|Randomization|clinical progression|1|||
144284297|NCT01734928|520242615|FG000|Randomization|progressive disease|0|||
144284298|NCT01734928|520242616|FG001|Randomization|progressive disease|2|||
144284299|NCT01734928|520242615|FG000|Randomization|Withdrew informed consent|0|||
144284300|NCT01734928|520242616|FG001|Randomization|Withdrew informed consent|4|||
144284301|NCT01734928|520242615|FG000|Randomization|Death|1|||
144284302|NCT01734928|520242616|FG001|Randomization|Death|0|||
144284303|NCT01734928|520242615|FG000|Randomization|Randomization error|1|||
144284304|NCT01734928|520242616|FG001|Randomization|Randomization error|0|||
144284305|NCT01734928|520242615|FG000|Randomization|Lost to Follow-up|1|||
144284306|NCT01734928|520242616|FG001|Randomization|Lost to Follow-up|0|||
144284307|NCT01734928|520242615|FG000|Treatment Period|Lost to Follow-up|0|||
144284308|NCT01734928|520242616|FG001|Treatment Period|Lost to Follow-up|2|||
144284309|NCT01734928|520242615|FG000|Treatment Period|Progressive Disease|167|||
144284310|NCT01734928|520242616|FG001|Treatment Period|Progressive Disease|165|||
144284311|NCT01734928|520242615|FG000|Treatment Period|Adverse Event|39|||
144284312|NCT01734928|520242616|FG001|Treatment Period|Adverse Event|52|||
144284313|NCT01734928|520242615|FG000|Treatment Period|Withdrawal of Consent|25|||
144284314|NCT01734928|520242616|FG001|Treatment Period|Withdrawal of Consent|22|||
144284315|NCT01734928|520242615|FG000|Treatment Period|Death|20|||
144284316|NCT01734928|520242616|FG001|Treatment Period|Death|9|||
144284317|NCT01734928|520242615|FG000|Treatment Period|Other Reasons|27|||
144284318|NCT01734928|520242616|FG001|Treatment Period|Other Reasons|19|||
144284319|NCT01734928|520242615|FG000|Treatment Period|Pregnancy|0|||
144284320|NCT01734928|520242616|FG001|Treatment Period|Pregnancy|1|||
144284321|NCT00620035|520242619|FG000|Overall Study|Adverse Event|106|||
144284322|NCT00620035|520242619|FG000|Overall Study|Withdrawal of Informed Consent|1|||
144284323|NCT00620035|520242619|FG000|Overall Study|Other Reason|38|||
144284324|NCT01778985|520242620|FG000|Overall Study|Lost to Follow-up|1|||
144284325|NCT01778985|520242621|FG001|Overall Study|Lost to Follow-up|0|||
144284326|NCT01778985|520242620|FG000|Overall Study|Physician Decision|2|||
144284327|NCT01778985|520242621|FG001|Overall Study|Physician Decision|2|||
144284328|NCT01778985|520242620|FG000|Overall Study|Protocol Violation|4|||
144284329|NCT01778985|520242621|FG001|Overall Study|Protocol Violation|1|||
144284330|NCT00088881|520242622|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
144284331|NCT00088881|520242622|FG000|Step 1 - R-CHOP|Adverse Event|1|||
144284332|NCT00088881|520242622|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
144284333|NCT00088881|520242622|FG000|Step 1 - R-CHOP|Physician Decision|1|||
144284334|NCT00088881|520242622|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
144284335|NCT00088881|520242622|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
144284336|NCT00088881|520242622|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
144284337|NCT00456612|520242623|FG000|Overall Study|Withdrawal by Subject|3|||
144284338|NCT00758043|520242626|FG000|Overall Study|Adverse Event|1|||
144284339|NCT00758043|520242627|FG001|Overall Study|Adverse Event|20|||
144284340|NCT00758043|520242628|FG002|Overall Study|Adverse Event|12|||
144284341|NCT00758043|520242629|FG003|Overall Study|Adverse Event|62|||
144284342|NCT00758043|520242626|FG000|Overall Study|Lack of Efficacy|0|||
144284343|NCT00758043|520242627|FG001|Overall Study|Lack of Efficacy|6|||
144284344|NCT00758043|520242628|FG002|Overall Study|Lack of Efficacy|18|||
144284345|NCT00758043|520242629|FG003|Overall Study|Lack of Efficacy|12|||
144284346|NCT00758043|520242626|FG000|Overall Study|Refused Further Treatment|0|||
144284347|NCT00758043|520242627|FG001|Overall Study|Refused Further Treatment|11|||
144284348|NCT00758043|520242628|FG002|Overall Study|Refused Further Treatment|5|||
144284349|NCT00758043|520242629|FG003|Overall Study|Refused Further Treatment|8|||
144284350|NCT00758043|520242626|FG000|Overall Study|Lost to Follow-up|0|||
144284351|NCT00758043|520242627|FG001|Overall Study|Lost to Follow-up|2|||
144284352|NCT00758043|520242628|FG002|Overall Study|Lost to Follow-up|2|||
144284353|NCT00758043|520242629|FG003|Overall Study|Lost to Follow-up|5|||
144284354|NCT00758043|520242626|FG000|Overall Study|Withdrawal by Subject|0|||
144284355|NCT00758043|520242627|FG001|Overall Study|Withdrawal by Subject|1|||
144284356|NCT00758043|520242628|FG002|Overall Study|Withdrawal by Subject|1|||
144284357|NCT00758043|520242629|FG003|Overall Study|Withdrawal by Subject|4|||
144284358|NCT00758043|520242626|FG000|Overall Study|Required Prohibited Medication|0|||
144284359|NCT00758043|520242627|FG001|Overall Study|Required Prohibited Medication|0|||
144284360|NCT00758043|520242628|FG002|Overall Study|Required Prohibited Medication|1|||
144284361|NCT00758043|520242629|FG003|Overall Study|Required Prohibited Medication|3|||
144284362|NCT00758043|520242626|FG000|Overall Study|Non-Compliant With study Drug|0|||
144284363|NCT00758043|520242627|FG001|Overall Study|Non-Compliant With study Drug|0|||
144284364|NCT00758043|520242628|FG002|Overall Study|Non-Compliant With study Drug|0|||
144284365|NCT00758043|520242629|FG003|Overall Study|Non-Compliant With study Drug|1|||
144284366|NCT00758043|520242626|FG000|Overall Study|Other Reasons|0|||
144284367|NCT00758043|520242627|FG001|Overall Study|Other Reasons|1|||
144284368|NCT00758043|520242628|FG002|Overall Study|Other Reasons|0|||
144284369|NCT00758043|520242629|FG003|Overall Study|Other Reasons|5|||
144284370|NCT05788328|520242635|FG000|Treatment Period 4 (5 Days)|Other|1|||
144284371|NCT05788328|520242635|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
144284372|NCT00145327|520242639|FG000|Overall Study|Withdrawal by Subject|77|||
144284373|NCT00145327|520242640|FG001|Overall Study|Withdrawal by Subject|72|||
144284374|NCT00145327|520242641|FG002|Overall Study|Withdrawal by Subject|164|||
144284375|NCT00145327|520242639|FG000|Overall Study|Death|26|||
144284376|NCT00145327|520242640|FG001|Overall Study|Death|18|||
144284377|NCT00145327|520242641|FG002|Overall Study|Death|30|||
144284378|NCT00145327|520242639|FG000|Overall Study|Adverse Event|14|||
144284379|NCT00145327|520242640|FG001|Overall Study|Adverse Event|11|||
144284380|NCT00145327|520242641|FG002|Overall Study|Adverse Event|22|||
144284381|NCT00145327|520242639|FG000|Overall Study|Lost to Follow-up|9|||
144284382|NCT00145327|520242640|FG001|Overall Study|Lost to Follow-up|14|||
144284383|NCT00145327|520242641|FG002|Overall Study|Lost to Follow-up|14|||
144284384|NCT00145327|520242639|FG000|Overall Study|Administrative problems|12|||
144284385|NCT00145327|520242640|FG001|Overall Study|Administrative problems|9|||
144284386|NCT00145327|520242641|FG002|Overall Study|Administrative problems|13|||
144284387|NCT00145327|520242639|FG000|Overall Study|Protocol Violation|2|||
144284388|NCT00145327|520242640|FG001|Overall Study|Protocol Violation|0|||
144284389|NCT00145327|520242641|FG002|Overall Study|Protocol Violation|2|||
144284390|NCT00145327|520242639|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144284391|NCT00145327|520242640|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144284392|NCT00145327|520242641|FG002|Overall Study|Abnormal laboratory value(s)|2|||
144284393|NCT00145327|520242639|FG000|Overall Study|Missing - not stated|1|||
144284394|NCT00145327|520242640|FG001|Overall Study|Missing - not stated|0|||
144284395|NCT00145327|520242641|FG002|Overall Study|Missing - not stated|1|||
144284396|NCT01348698|520242642|FG000|Overall Study|Does not meet lesion size criteria|1|||
144284397|NCT01348698|520242642|FG000|Overall Study|Death|3|||
144284398|NCT01348698|520242642|FG000|Overall Study|PI decision to close study|68|||
144284399|NCT01875237|520242643|FG000|Overall Study|GVDH before DLI|1|||
144284400|NCT01875237|520242644|FG001|Overall Study|GVDH before DLI|0|||
144284401|NCT01875237|520242643|FG000|Overall Study|DLI cells could not be produced|1|||
144284402|NCT01875237|520242644|FG001|Overall Study|DLI cells could not be produced|0|||
144284403|NCT01967277|520242647|FG000|Overall Study|Lost to Follow-up|1|||
144284404|NCT01967277|520242648|FG001|Overall Study|Lost to Follow-up|2|||
144284405|NCT01967277|520242647|FG000|Overall Study|Unrelated illness|0|||
144284406|NCT01967277|520242648|FG001|Overall Study|Unrelated illness|1|||
144284407|NCT02573467|520242649|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
144284408|NCT02573467|520242650|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
144284409|NCT02573467|520242651|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
144284410|NCT02573467|520242652|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
144284411|NCT02573467|520242649|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
144284412|NCT02573467|520242650|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
144284413|NCT02573467|520242651|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
144284414|NCT02573467|520242652|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
144284415|NCT02573467|520242649|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
144284416|NCT02573467|520242650|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
144284417|NCT02573467|520242651|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
144284418|NCT02573467|520242652|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
144284419|NCT02573467|520242649|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
144284420|NCT02573467|520242650|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
144284421|NCT02573467|520242651|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
144284422|NCT02573467|520242652|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
144284423|NCT02573467|520242649|FG000|Post-treatment Follow up Epoch|Death|1|||
144284424|NCT02573467|520242650|FG001|Post-treatment Follow up Epoch|Death|1|||
144284425|NCT02573467|520242651|FG002|Post-treatment Follow up Epoch|Death|0|||
144284426|NCT02573467|520242652|FG003|Post-treatment Follow up Epoch|Death|1|||
144284427|NCT02573467|520242649|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
144284428|NCT02573467|520242650|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
144284429|NCT02573467|520242651|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
144284430|NCT02573467|520242652|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
144284431|NCT02573467|520242649|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
144284432|NCT02573467|520242650|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
144284433|NCT02573467|520242651|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
144284434|NCT02573467|520242652|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
144284435|NCT01829165|520242653|FG000|Overall Study|Did not complete intervention|2|||
144284436|NCT01829165|520242654|FG001|Overall Study|Did not complete intervention|0|||
144284437|NCT00710970|520242657|FG000|Overall Study|Never took drug|3|||
144284438|NCT01028560|520242658|FG000|Overall Study|Lack of Efficacy|3|||
144284439|NCT01028560|520242659|FG001|Overall Study|Lack of Efficacy|6|||
144284440|NCT01028560|520242658|FG000|Overall Study|Withdrawal by Subject|7|||
144284441|NCT01028560|520242659|FG001|Overall Study|Withdrawal by Subject|12|||
144284442|NCT01960842|520242662|FG000|Overall Study|Adverse Event|1|||
144284443|NCT01960842|520242662|FG000|Overall Study|Withdrawal by Subject|2|||
144284444|NCT00397930|520242663|FG000|Overall Study|Personal reasons|14|||
144284445|NCT00397930|520242664|FG001|Overall Study|Personal reasons|8|||
144284446|NCT00397930|520242663|FG000|Overall Study|Other medical|9|||
144284447|NCT00397930|520242664|FG001|Overall Study|Other medical|4|||
144284448|NCT00397930|520242663|FG000|Overall Study|Unknown reasons|9|||
144284449|NCT00397930|520242664|FG001|Overall Study|Unknown reasons|14|||
144284450|NCT00397930|520242663|FG000|Overall Study|Noncompliant|3|||
144284451|NCT00397930|520242664|FG001|Overall Study|Noncompliant|2|||
144284452|NCT00397930|520242663|FG000|Overall Study|Too time-consuming|2|||
144284453|NCT00397930|520242664|FG001|Overall Study|Too time-consuming|9|||
144284454|NCT00397930|520242663|FG000|Overall Study|Started own yoga program|1|||
144284455|NCT00397930|520242664|FG001|Overall Study|Started own yoga program|1|||
144284456|NCT00397930|520242663|FG000|Overall Study|Did not want to be in control group|0|||
144284457|NCT00397930|520242664|FG001|Overall Study|Did not want to be in control group|1|||
144284458|NCT00397930|520242663|FG000|Overall Study|Withdrawal by Subject|0|||
144284459|NCT00397930|520242664|FG001|Overall Study|Withdrawal by Subject|8|||
144284460|NCT00397930|520242663|FG000|Overall Study|Missing data|0|||
144284461|NCT00397930|520242664|FG001|Overall Study|Missing data|4|||
144284462|NCT02391584|520242665|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
144284463|NCT02391584|520242666|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
144284464|NCT02391584|520242665|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
144284465|NCT02391584|520242666|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
144284466|NCT02391584|520242665|FG000|3 Month|Lost to Follow-up|1|||
144284467|NCT02391584|520242666|FG001|3 Month|Lost to Follow-up|0|||
144284468|NCT02391584|520242665|FG000|6 Month|Withdrawal by Subject|1|||
144284469|NCT02391584|520242666|FG001|6 Month|Withdrawal by Subject|0|||
144284470|NCT02391584|520242665|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
144284471|NCT02391584|520242666|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
144284472|NCT04233580|520242680|FG000|Overall Study|Adverse Event|3|||
144284473|NCT04233580|520242681|FG001|Overall Study|Adverse Event|3|||
144284474|NCT04233580|520242680|FG000|Overall Study|Withdrawal by Subject|2|||
144284475|NCT04233580|520242681|FG001|Overall Study|Withdrawal by Subject|1|||
144284476|NCT01371565|520242682|FG000|Overall Study|Withdrawal by Subject|1|||
144284477|NCT01371565|520242682|FG000|Overall Study|Death|1|||
144284478|NCT01371565|520242682|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
144284479|NCT04996264|520242683|FG000|Overall Study|Lost to Follow-up|0|||
144284480|NCT04996264|520242684|FG001|Overall Study|Lost to Follow-up|1|||
144284481|NCT04996264|520242683|FG000|Overall Study|Withdrawal by Subject|4|||
144284482|NCT04996264|520242684|FG001|Overall Study|Withdrawal by Subject|3|||
144284483|NCT04996264|520242683|FG000|Overall Study|1 left AMA|0|||
144284484|NCT04996264|520242684|FG001|Overall Study|1 left AMA|1|||
144284485|NCT04996264|520242683|FG000|Overall Study|Subject changed hospitals|0|||
144284486|NCT04996264|520242684|FG001|Overall Study|Subject changed hospitals|1|||
144284487|NCT04996264|520242683|FG000|Overall Study|unable to complete due to work|0|||
144284488|NCT04996264|520242684|FG001|Overall Study|unable to complete due to work|1|||
144284489|NCT04392635|520242685|FG000|Overall Study|Lost to Follow-up|0|||
144284490|NCT04392635|520242686|FG001|Overall Study|Lost to Follow-up|1|||
144284491|NCT02030418|520242688|FG000|Overall Study|Death|78|||
144284492|NCT02030418|520242688|FG000|Overall Study|Missed 12-Month Visit|9|||
144284493|NCT02030418|520242688|FG000|Overall Study|Withdrawn|57|||
144284494|NCT05061706|520242689|FG000|Overall Study|Adverse Event|29|||
144284495|NCT05061706|520242690|FG001|Overall Study|Adverse Event|1|||
144284496|NCT05061706|520242689|FG000|Overall Study|Lack of Efficacy|0|||
144284497|NCT05061706|520242690|FG001|Overall Study|Lack of Efficacy|1|||
144284498|NCT05061706|520242689|FG000|Overall Study|Lost to Follow-up|2|||
144284499|NCT05061706|520242690|FG001|Overall Study|Lost to Follow-up|2|||
144284500|NCT05061706|520242689|FG000|Overall Study|Protocol Violation|3|||
144284501|NCT05061706|520242690|FG001|Overall Study|Protocol Violation|1|||
144284502|NCT05061706|520242689|FG000|Overall Study|Withdrawal by Subject|3|||
144284503|NCT05061706|520242690|FG001|Overall Study|Withdrawal by Subject|9|||
144284504|NCT01179516|520242691|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
144284505|NCT01179516|520242692|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
144284506|NCT01179516|520242693|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
144284507|NCT01179516|520242691|FG000|Overall Study|Lack of Efficacy|4|||
144284508|NCT01179516|520242692|FG001|Overall Study|Lack of Efficacy|2|||
144284509|NCT01179516|520242693|FG002|Overall Study|Lack of Efficacy|0|||
144284510|NCT01179516|520242691|FG000|Overall Study|Noncompliance with Study Drug|2|||
144284511|NCT01179516|520242692|FG001|Overall Study|Noncompliance with Study Drug|0|||
144284512|NCT01179516|520242693|FG002|Overall Study|Noncompliance with Study Drug|1|||
144284513|NCT01179516|520242691|FG000|Overall Study|Protocol Deviations|4|||
144284514|NCT01179516|520242692|FG001|Overall Study|Protocol Deviations|3|||
144284515|NCT01179516|520242693|FG002|Overall Study|Protocol Deviations|3|||
144284516|NCT01179516|520242691|FG000|Overall Study|Withdrawal of Consent|2|||
144284517|NCT01179516|520242692|FG001|Overall Study|Withdrawal of Consent|6|||
144284518|NCT01179516|520242693|FG002|Overall Study|Withdrawal of Consent|10|||
144284519|NCT01179516|520242691|FG000|Overall Study|Lost to Follow-up|7|||
144284520|NCT01179516|520242692|FG001|Overall Study|Lost to Follow-up|7|||
144284521|NCT01179516|520242693|FG002|Overall Study|Lost to Follow-up|3|||
144284522|NCT01179516|520242691|FG000|Overall Study|Other|2|||
144284523|NCT01179516|520242692|FG001|Overall Study|Other|0|||
144284524|NCT01179516|520242693|FG002|Overall Study|Other|2|||
144284525|NCT02697422|520242697|FG000|Overall Study|Declined exit survey|9|||
144284526|NCT02697422|520242698|FG001|Overall Study|Declined exit survey|2|||
144284527|NCT02697422|520242697|FG000|Overall Study|Lost to Follow-up|13|||
144284528|NCT02697422|520242698|FG001|Overall Study|Lost to Follow-up|8|||
144284529|NCT02697422|520242697|FG000|Overall Study|Death|2|||
144284530|NCT02697422|520242698|FG001|Overall Study|Death|1|||
144284531|NCT02697422|520242697|FG000|Overall Study|Withdrawal by Subject|0|||
144284532|NCT02697422|520242698|FG001|Overall Study|Withdrawal by Subject|1|||
144284533|NCT02697422|520242697|FG000|Overall Study|Physician Decision|1|||
144284534|NCT02697422|520242698|FG001|Overall Study|Physician Decision|1|||
144284535|NCT02697422|520242697|FG000|Overall Study|Exit survey data lost|1|||
144284536|NCT02697422|520242698|FG001|Overall Study|Exit survey data lost|0|||
144284537|NCT03501277|520242699|FG000|Intervention Period 1 (4 Days)|Other|0|||
144284538|NCT03501277|520242700|FG001|Intervention Period 1 (4 Days)|Other|0|||
144284539|NCT03501277|520242701|FG002|Intervention Period 1 (4 Days)|Other|1|||
144284540|NCT03501277|520242702|FG003|Intervention Period 1 (4 Days)|Other|0|||
144284541|NCT03501277|520242699|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
144284542|NCT03501277|520242700|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
144284543|NCT03501277|520242701|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
144284544|NCT03501277|520242702|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
144284545|NCT03501277|520242699|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
144284546|NCT03501277|520242700|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
144284547|NCT03501277|520242701|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
144284548|NCT03501277|520242702|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
144284549|NCT03501277|520242699|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
144284550|NCT03501277|520242700|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
144284551|NCT03501277|520242701|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
144284552|NCT03501277|520242702|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
144284553|NCT01873833|520242703|FG000|Overall Study|Withdrawal by Subject|1|||
144284554|NCT03983109|520242704|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
144284555|NCT03983109|520242705|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
144284556|NCT04739709|520242713|FG000|Overall Study|Physician Decision|1|||
144284557|NCT04739709|520242714|FG001|Overall Study|Physician Decision|0|||
144284558|NCT01928771|520242715|FG000|Overall Study|Adverse Event|6|||
144284559|NCT01928771|520242716|FG001|Overall Study|Adverse Event|5|||
144284560|NCT01928771|520242717|FG002|Overall Study|Adverse Event|1|||
144284561|NCT01928771|520242715|FG000|Overall Study|Death|2|||
144284562|NCT01928771|520242716|FG001|Overall Study|Death|2|||
144284563|NCT01928771|520242717|FG002|Overall Study|Death|2|||
144284564|NCT01928771|520242715|FG000|Overall Study|Lost to Follow-up|5|||
144284565|NCT01928771|520242716|FG001|Overall Study|Lost to Follow-up|6|||
144284566|NCT01928771|520242717|FG002|Overall Study|Lost to Follow-up|3|||
144284567|NCT01928771|520242715|FG000|Overall Study|Withdrawal by Subject|20|||
144284568|NCT01928771|520242716|FG001|Overall Study|Withdrawal by Subject|15|||
144284569|NCT01928771|520242717|FG002|Overall Study|Withdrawal by Subject|17|||
144284570|NCT01928771|520242715|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
144284571|NCT01928771|520242716|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
144284572|NCT01928771|520242717|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
144284573|NCT01928771|520242715|FG000|Overall Study|Other Reasons|9|||
144284574|NCT01928771|520242716|FG001|Overall Study|Other Reasons|9|||
144284575|NCT01928771|520242717|FG002|Overall Study|Other Reasons|14|||
144284576|NCT01928771|520242715|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
144284577|NCT01928771|520242716|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
144284578|NCT01928771|520242717|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
144284579|NCT01937117|520242718|FG000|Overall Study|Disease Progression|7|||
144284580|NCT01937117|520242718|FG000|Overall Study|Physician Decision|4|||
144284581|NCT01937117|520242718|FG000|Overall Study|Adverse Event|2|||
144284582|NCT01407367|520242721|FG000|Overall Study|Death|24|||
144284583|NCT01407367|520242722|FG001|Overall Study|Death|32|||
144284584|NCT01407367|520242721|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
144284585|NCT01407367|520242722|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
144284586|NCT01407367|520242721|FG000|Overall Study|Withdrawal by Subject|4|||
144284587|NCT01407367|520242722|FG001|Overall Study|Withdrawal by Subject|15|||
144284588|NCT01407367|520242721|FG000|Overall Study|Lost to Follow-up|0|||
144284589|NCT01407367|520242722|FG001|Overall Study|Lost to Follow-up|2|||
144284590|NCT01245062|520242725|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
144284591|NCT01245062|520242726|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
144284592|NCT01245062|520242727|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
144284593|NCT01245062|520242725|FG000|Randomization and Crossover Phase|Physician Decision|2|||
144284594|NCT01245062|520242726|FG001|Randomization and Crossover Phase|Physician Decision|4|||
144284595|NCT01245062|520242727|FG002|Randomization and Crossover Phase|Physician Decision|0|||
144284596|NCT01245062|520242725|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
144284597|NCT01245062|520242726|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
144284598|NCT01245062|520242727|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
144284599|NCT01245062|520242725|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
144284600|NCT01245062|520242726|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
144284601|NCT01245062|520242727|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
144284602|NCT01245062|520242725|FG000|Cross-over Phase|Lost to Follow-up|0|||
144284603|NCT01245062|520242726|FG001|Cross-over Phase|Lost to Follow-up|0|||
144284604|NCT01245062|520242727|FG002|Cross-over Phase|Lost to Follow-up|1|||
144284605|NCT01245062|520242725|FG000|Cross-over Phase|Physician Decision|0|||
144284606|NCT01245062|520242726|FG001|Cross-over Phase|Physician Decision|0|||
144284607|NCT01245062|520242727|FG002|Cross-over Phase|Physician Decision|1|||
144284608|NCT01245062|520242725|FG000|Cross-over Phase|Withdrew Consent|0|||
144284609|NCT01245062|520242726|FG001|Cross-over Phase|Withdrew Consent|0|||
144284610|NCT01245062|520242727|FG002|Cross-over Phase|Withdrew Consent|4|||
144284611|NCT01245062|520242725|FG000|Cross-over Phase|Study closed/ terminated|0|||
144284612|NCT01245062|520242726|FG001|Cross-over Phase|Study closed/ terminated|0|||
144284613|NCT01245062|520242727|FG002|Cross-over Phase|Study closed/ terminated|11|||
144284614|NCT01452347|520242728|FG000|Overall Study|Adverse Event|2|||
144284615|NCT01452347|520242729|FG001|Overall Study|Adverse Event|1|||
144284616|NCT01452347|520242728|FG000|Overall Study|Non compliance protocol|2|||
144284617|NCT01452347|520242729|FG001|Overall Study|Non compliance protocol|0|||
144284618|NCT01452347|520242728|FG000|Overall Study|Lost to Follow-up|2|||
144284619|NCT01452347|520242729|FG001|Overall Study|Lost to Follow-up|0|||
144284620|NCT01452347|520242728|FG000|Overall Study|Withdrawal by Subject|3|||
144284621|NCT01452347|520242729|FG001|Overall Study|Withdrawal by Subject|3|||
144284622|NCT01452347|520242728|FG000|Overall Study|Not treated|6|||
144284623|NCT01452347|520242729|FG001|Overall Study|Not treated|3|||
144284624|NCT01452347|520242728|FG000|Overall Study|Other reason not defined above|2|||
144284625|NCT01452347|520242729|FG001|Overall Study|Other reason not defined above|0|||
144284626|NCT01671059|520242730|FG000|Overall Study|Adverse Event|4|||
144284627|NCT01671059|520242730|FG000|Overall Study|Lack of Efficacy|1|||
144284628|NCT00853047|520242736|FG000|Core Phase|Participant Request|0|||
144284629|NCT00853047|520242737|FG001|Core Phase|Participant Request|0|||
144284630|NCT00853047|520242738|FG002|Core Phase|Participant Request|0|||
144284631|NCT00853047|520242739|FG003|Core Phase|Participant Request|1|||
144284632|NCT00853047|520242740|FG004|Core Phase|Participant Request|0|||
144284633|NCT00853047|520242741|FG005|Core Phase|Participant Request|0|||
144284634|NCT00853047|520242736|FG000|Open-Label Extension Phase|Participant Request|0|||
144284635|NCT00853047|520242737|FG001|Open-Label Extension Phase|Participant Request|0|||
144284636|NCT00853047|520242738|FG002|Open-Label Extension Phase|Participant Request|0|||
144284637|NCT00853047|520242739|FG003|Open-Label Extension Phase|Participant Request|0|||
144284638|NCT00853047|520242740|FG004|Open-Label Extension Phase|Participant Request|0|||
144284639|NCT00853047|520242741|FG005|Open-Label Extension Phase|Participant Request|7|||
144284640|NCT00853047|520242736|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
144284641|NCT00853047|520242737|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
144284642|NCT00853047|520242738|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
144284643|NCT00853047|520242739|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
144284644|NCT00853047|520242740|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
144284645|NCT00853047|520242741|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
144284646|NCT00853047|520242736|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
144284647|NCT00853047|520242737|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
144284648|NCT00853047|520242738|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
144284649|NCT00853047|520242739|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
144284650|NCT00853047|520242740|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
144284651|NCT00853047|520242741|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
144284652|NCT00853047|520242736|FG000|Open-Label Extension Phase|Investigator Decision|0|||
144284653|NCT00853047|520242737|FG001|Open-Label Extension Phase|Investigator Decision|0|||
144284654|NCT00853047|520242738|FG002|Open-Label Extension Phase|Investigator Decision|0|||
144284655|NCT00853047|520242739|FG003|Open-Label Extension Phase|Investigator Decision|0|||
144284656|NCT00853047|520242740|FG004|Open-Label Extension Phase|Investigator Decision|0|||
144284657|NCT00853047|520242741|FG005|Open-Label Extension Phase|Investigator Decision|1|||
144284658|NCT00853047|520242736|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
144284659|NCT00853047|520242737|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
144284660|NCT00853047|520242738|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
144284661|NCT00853047|520242739|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
144284662|NCT00853047|520242740|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
144284663|NCT00853047|520242741|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
144284664|NCT03554473|520244709|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
144284665|NCT03554473|520244710|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
144284666|NCT03554473|520244711|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
144284667|NCT03554473|520244709|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
144284668|NCT03554473|520244710|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
144284669|NCT03554473|520244711|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
144284670|NCT03554473|520244709|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
144284671|NCT03554473|520244710|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
144284672|NCT03554473|520244711|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
144284673|NCT05206604|520244715|FG000|Overall Study|Non-compliance with study drug|0|||
144284674|NCT05206604|520244716|FG001|Overall Study|Non-compliance with study drug|0|||
144284675|NCT05206604|520244717|FG002|Overall Study|Non-compliance with study drug|0|||
144284676|NCT05206604|520244718|FG003|Overall Study|Non-compliance with study drug|0|||
144284677|NCT05206604|520244719|FG004|Overall Study|Non-compliance with study drug|0|||
144284678|NCT05206604|520244720|FG005|Overall Study|Non-compliance with study drug|1|||
144284679|NCT05206604|520244721|FG006|Overall Study|Non-compliance with study drug|0|||
144284680|NCT05206604|520244722|FG007|Overall Study|Non-compliance with study drug|0|||
144284681|NCT00160615|520244723|FG000|Overall Study|Adverse Event|5|||
144284682|NCT00160615|520244724|FG001|Overall Study|Adverse Event|12|||
144284683|NCT00160615|520244723|FG000|Overall Study|Withdrawal by Subject|0|||
144284684|NCT00160615|520244724|FG001|Overall Study|Withdrawal by Subject|2|||
144284685|NCT00160615|520244723|FG000|Overall Study|Lack of Efficacy|11|||
144284686|NCT00160615|520244724|FG001|Overall Study|Lack of Efficacy|23|||
144284687|NCT00160615|520244723|FG000|Overall Study|Patient decision|1|||
144284688|NCT00160615|520244724|FG001|Overall Study|Patient decision|2|||
144284689|NCT00160615|520244723|FG000|Overall Study|Investigator decision|1|||
144284690|NCT00160615|520244724|FG001|Overall Study|Investigator decision|1|||
144284691|NCT00160615|520244723|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
144284692|NCT00160615|520244724|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
144284693|NCT00160615|520244723|FG000|Overall Study|Switch to surgical treatment|0|||
144284694|NCT00160615|520244724|FG001|Overall Study|Switch to surgical treatment|2|||
144284695|NCT00160615|520244723|FG000|Overall Study|Non-compliance was suspected|0|||
144284696|NCT00160615|520244724|FG001|Overall Study|Non-compliance was suspected|1|||
144284697|NCT00160615|520244723|FG000|Overall Study|Poor compliance|0|||
144284698|NCT00160615|520244724|FG001|Overall Study|Poor compliance|1|||
144284699|NCT03166631|520244725|FG000|Overall Study|Progressive disease|2|||
144284700|NCT03166631|520244726|FG001|Overall Study|Progressive disease|1|||
144284701|NCT03166631|520244727|FG002|Overall Study|Progressive disease|3|||
144284702|NCT03166631|520244728|FG003|Overall Study|Progressive disease|4|||
144284703|NCT03166631|520244729|FG004|Overall Study|Progressive disease|2|||
144284704|NCT03166631|520244730|FG005|Overall Study|Progressive disease|2|||
144284705|NCT03166631|520244731|FG006|Overall Study|Progressive disease|5|||
144284706|NCT03166631|520244732|FG007|Overall Study|Progressive disease|6|||
144284707|NCT03166631|520244733|FG008|Overall Study|Progressive disease|11|||
144284708|NCT03166631|520244734|FG009|Overall Study|Progressive disease|5|||
144284709|NCT03166631|520244735|FG010|Overall Study|Progressive disease|7|||
144284710|NCT03166631|520244725|FG000|Overall Study|Physician Decision|0|||
144284711|NCT03166631|520244726|FG001|Overall Study|Physician Decision|0|||
144284712|NCT03166631|520244727|FG002|Overall Study|Physician Decision|0|||
144284713|NCT03166631|520244728|FG003|Overall Study|Physician Decision|0|||
144284714|NCT03166631|520244729|FG004|Overall Study|Physician Decision|0|||
144284715|NCT03166631|520244730|FG005|Overall Study|Physician Decision|0|||
144284716|NCT03166631|520244731|FG006|Overall Study|Physician Decision|1|||
144284717|NCT03166631|520244732|FG007|Overall Study|Physician Decision|0|||
144284718|NCT03166631|520244733|FG008|Overall Study|Physician Decision|1|||
144284719|NCT03166631|520244734|FG009|Overall Study|Physician Decision|0|||
144284720|NCT03166631|520244735|FG010|Overall Study|Physician Decision|1|||
144284721|NCT03166631|520244725|FG000|Overall Study|Death|0|||
144284722|NCT03166631|520244726|FG001|Overall Study|Death|0|||
144284723|NCT03166631|520244727|FG002|Overall Study|Death|0|||
144284724|NCT03166631|520244728|FG003|Overall Study|Death|0|||
144284725|NCT03166631|520244729|FG004|Overall Study|Death|1|||
144284726|NCT03166631|520244730|FG005|Overall Study|Death|0|||
144284727|NCT03166631|520244731|FG006|Overall Study|Death|1|||
144284728|NCT03166631|520244732|FG007|Overall Study|Death|0|||
144284729|NCT03166631|520244733|FG008|Overall Study|Death|0|||
144284730|NCT03166631|520244734|FG009|Overall Study|Death|0|||
144284731|NCT03166631|520244735|FG010|Overall Study|Death|0|||
144284732|NCT03166631|520244725|FG000|Overall Study|Adverse Event|1|||
144284733|NCT03166631|520244726|FG001|Overall Study|Adverse Event|0|||
144284734|NCT03166631|520244727|FG002|Overall Study|Adverse Event|0|||
144284735|NCT03166631|520244728|FG003|Overall Study|Adverse Event|0|||
144284736|NCT03166631|520244729|FG004|Overall Study|Adverse Event|0|||
144284737|NCT03166631|520244730|FG005|Overall Study|Adverse Event|1|||
144284738|NCT03166631|520244731|FG006|Overall Study|Adverse Event|1|||
144284739|NCT03166631|520244732|FG007|Overall Study|Adverse Event|0|||
144284740|NCT03166631|520244733|FG008|Overall Study|Adverse Event|1|||
144284741|NCT03166631|520244734|FG009|Overall Study|Adverse Event|2|||
144284742|NCT03166631|520244735|FG010|Overall Study|Adverse Event|1|||
144284743|NCT03166631|520244725|FG000|Overall Study|Withdrawal by Subject|0|||
144284744|NCT03166631|520244726|FG001|Overall Study|Withdrawal by Subject|0|||
144284745|NCT03166631|520244727|FG002|Overall Study|Withdrawal by Subject|0|||
144284746|NCT03166631|520244728|FG003|Overall Study|Withdrawal by Subject|0|||
144284747|NCT03166631|520244729|FG004|Overall Study|Withdrawal by Subject|0|||
144284748|NCT03166631|520244730|FG005|Overall Study|Withdrawal by Subject|0|||
144284749|NCT03166631|520244731|FG006|Overall Study|Withdrawal by Subject|0|||
144284750|NCT03166631|520244732|FG007|Overall Study|Withdrawal by Subject|0|||
144284751|NCT03166631|520244733|FG008|Overall Study|Withdrawal by Subject|1|||
144284752|NCT03166631|520244734|FG009|Overall Study|Withdrawal by Subject|1|||
144284753|NCT03166631|520244735|FG010|Overall Study|Withdrawal by Subject|0|||
144284754|NCT03787212|520244739|FG000|Period 1|Study Termination|2|||
144284755|NCT03787212|520244740|FG001|Period 1|Study Termination|2|||
144284756|NCT02014103|520244741|FG000|Overall Study|Protocol Violation|7|||
144284757|NCT02014103|520244742|FG001|Overall Study|Protocol Violation|7|||
144284758|NCT02014103|520244741|FG000|Overall Study|Adverse Event|1|||
144284759|NCT02014103|520244742|FG001|Overall Study|Adverse Event|0|||
144284760|NCT02014103|520244741|FG000|Overall Study|Lost venous access|1|||
144284761|NCT02014103|520244742|FG001|Overall Study|Lost venous access|0|||
144284762|NCT02014103|520244741|FG000|Overall Study|Withdrawal by Subject|0|||
144284763|NCT02014103|520244742|FG001|Overall Study|Withdrawal by Subject|2|||
144284764|NCT00382070|520244745|FG000|Overall Study|No follow up data mapped to Other|17|||
144284765|NCT00382070|520244746|FG001|Overall Study|No follow up data mapped to Other|19|||
144284766|NCT00382070|520244745|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
144284767|NCT00382070|520244746|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
144284768|NCT00382070|520244745|FG000|Overall Study|No clinical assessment|9|||
144284769|NCT00382070|520244746|FG001|Overall Study|No clinical assessment|11|||
144284770|NCT04289298|520244747|FG000|Overall Study|Lost to Follow-up|5|||
144284771|NCT04289298|520244748|FG001|Overall Study|Lost to Follow-up|0|||
144284772|NCT04289298|520244747|FG000|Overall Study|Withdrawal by Subject|2|||
144284773|NCT04289298|520244748|FG001|Overall Study|Withdrawal by Subject|0|||
144284774|NCT01629563|520244750|FG000|Overall Study|Adverse Event|16|||
144284775|NCT01629563|520244751|FG001|Overall Study|Adverse Event|16|||
144284776|NCT01629563|520244750|FG000|Overall Study|Death|2|||
144284777|NCT01629563|520244751|FG001|Overall Study|Death|0|||
144284778|NCT01629563|520244750|FG000|Overall Study|Lack of Efficacy|2|||
144284779|NCT01629563|520244751|FG001|Overall Study|Lack of Efficacy|3|||
144284780|NCT01629563|520244750|FG000|Overall Study|Lost to Follow-up|1|||
144284781|NCT01629563|520244751|FG001|Overall Study|Lost to Follow-up|0|||
144284782|NCT01629563|520244750|FG000|Overall Study|Pregnancy|1|||
144284783|NCT01629563|520244751|FG001|Overall Study|Pregnancy|2|||
144284784|NCT01629563|520244750|FG000|Overall Study|Protocol Violation|0|||
144284785|NCT01629563|520244751|FG001|Overall Study|Protocol Violation|1|||
144284786|NCT01629563|520244750|FG000|Overall Study|Withdrawal by Subject|27|||
144284787|NCT01629563|520244751|FG001|Overall Study|Withdrawal by Subject|20|||
144284788|NCT01629563|520244750|FG000|Overall Study|surgery|0|||
144284789|NCT01629563|520244751|FG001|Overall Study|surgery|3|||
144284790|NCT01629563|520244750|FG000|Overall Study|Lack of return of menses|12|||
144284791|NCT01629563|520244751|FG001|Overall Study|Lack of return of menses|7|||
144284792|NCT01629563|520244750|FG000|Overall Study|Protocol Violation|0|||
144284793|NCT01629563|520244751|FG001|Overall Study|Protocol Violation|1|||
144284794|NCT02370394|520244761|FG000|Overall Study|Lost to Follow-up|2|||
144284795|NCT02370394|520244762|FG001|Overall Study|Lost to Follow-up|1|||
144284796|NCT02370394|520244761|FG000|Overall Study|Withdrawal by Subject|0|||
144284797|NCT02370394|520244762|FG001|Overall Study|Withdrawal by Subject|1|||
144284798|NCT03684057|520244763|FG000|Overall Study|Withdrawal by Subject|4|||
144284799|NCT03684057|520244764|FG001|Overall Study|Withdrawal by Subject|5|||
144284800|NCT02316613|520244765|FG000|Overall Study|Death|63|||
144284801|NCT02316613|520244765|FG000|Overall Study|Lost to Follow-up|9|||
144284802|NCT02316613|520244765|FG000|Overall Study|Lymphoma transformation|2|||
144284803|NCT02316613|520244765|FG000|Overall Study|Participant moved/changed medical team|11|||
144284804|NCT02316613|520244765|FG000|Overall Study|No data and duplicate cases|5|||
144284805|NCT02316613|520244765|FG000|Overall Study|Did not met selection criteria|14|||
144284806|NCT03197935|520244766|FG000|Overall Study|Death due to any cause|26|||
144284807|NCT03197935|520244767|FG001|Overall Study|Death due to any cause|15|||
144284808|NCT03197935|520244766|FG000|Overall Study|Lost to Follow-up|3|||
144284809|NCT03197935|520244767|FG001|Overall Study|Lost to Follow-up|5|||
144284810|NCT03197935|520244766|FG000|Overall Study|Physician Decision|2|||
144284811|NCT03197935|520244767|FG001|Overall Study|Physician Decision|1|||
144284812|NCT03197935|520244766|FG000|Overall Study|Withdrawal by Subject|16|||
144284813|NCT03197935|520244767|FG001|Overall Study|Withdrawal by Subject|8|||
144284814|NCT05938010|520244768|FG000|Overall Study|Lost to Follow-up|2|||
144284815|NCT01562444|520244772|FG000|Overall Study|Did not meet entry criteria|2|||
144284816|NCT01562444|520244773|FG001|Overall Study|Did not meet entry criteria|0|||
144284817|NCT01562444|520244774|FG002|Overall Study|Did not meet entry criteria|3|||
144284818|NCT01562444|520244772|FG000|Overall Study|Did not comply with blood draw schedule|1|||
144284819|NCT01562444|520244773|FG001|Overall Study|Did not comply with blood draw schedule|0|||
144284820|NCT01562444|520244774|FG002|Overall Study|Did not comply with blood draw schedule|1|||
144284821|NCT01562444|520244772|FG000|Overall Study|Unavailable serological results|0|||
144284822|NCT01562444|520244773|FG001|Overall Study|Unavailable serological results|2|||
144284823|NCT01562444|520244774|FG002|Overall Study|Unavailable serological results|2|||
144284824|NCT01562444|520244772|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
144284825|NCT01562444|520244773|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
144284826|NCT01562444|520244774|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
144284827|NCT01562444|520244772|FG000|Overall Study|Protocol forbidden medication|1|||
144284828|NCT01562444|520244773|FG001|Overall Study|Protocol forbidden medication|0|||
144284829|NCT01562444|520244774|FG002|Overall Study|Protocol forbidden medication|0|||
144284830|NCT03387046|520244780|FG000|Overall Study|Adverse Event|1|||
144284831|NCT03387046|520244781|FG001|Overall Study|Adverse Event|1|||
144284832|NCT03558672|520244782|FG000|Overall Study|Study Early Termination|10|||
144284833|NCT00983957|520244783|FG000|Overall Study|Adverse Event|1|||
144284834|NCT00983957|520244783|FG000|Overall Study|Personal Reasons|1|||
144284835|NCT03055195|520244784|FG000|Overall Study|Lack of Efficacy|1|||
144284836|NCT03055195|520244785|FG001|Overall Study|Lack of Efficacy|0|||
144284837|NCT03055195|520244784|FG000|Overall Study|Withdrawal by Subject|6|||
144284838|NCT03055195|520244785|FG001|Overall Study|Withdrawal by Subject|7|||
144284839|NCT03055195|520244784|FG000|Overall Study|Study Terminated by Sponsor|2|||
144284840|NCT03055195|520244785|FG001|Overall Study|Study Terminated by Sponsor|6|||
144284841|NCT03055195|520244784|FG000|Overall Study|Protocol Violation|2|||
144284842|NCT03055195|520244785|FG001|Overall Study|Protocol Violation|1|||
144284843|NCT03055195|520244784|FG000|Overall Study|Physician Decision|1|||
144284844|NCT03055195|520244785|FG001|Overall Study|Physician Decision|0|||
144284845|NCT00986232|520244786|FG000|Overall Study|Adverse Event|1|||
144284846|NCT00986232|520244787|FG001|Overall Study|Adverse Event|2|||
144284847|NCT00986232|520244788|FG002|Overall Study|Adverse Event|3|||
144284848|NCT00986232|520244789|FG003|Overall Study|Adverse Event|0|||
144284849|NCT00986232|520244786|FG000|Overall Study|Lost to Follow-up|19|||
144284850|NCT00986232|520244787|FG001|Overall Study|Lost to Follow-up|12|||
144284851|NCT00986232|520244788|FG002|Overall Study|Lost to Follow-up|12|||
144284852|NCT00986232|520244789|FG003|Overall Study|Lost to Follow-up|7|||
144284853|NCT00986232|520244786|FG000|Overall Study|Protocol Violation|2|||
144284854|NCT00986232|520244787|FG001|Overall Study|Protocol Violation|3|||
144284855|NCT00986232|520244788|FG002|Overall Study|Protocol Violation|0|||
144284856|NCT00986232|520244789|FG003|Overall Study|Protocol Violation|1|||
144284857|NCT00986232|520244786|FG000|Overall Study|Withdrawal by Subject|13|||
144284858|NCT00986232|520244787|FG001|Overall Study|Withdrawal by Subject|16|||
144284859|NCT00986232|520244788|FG002|Overall Study|Withdrawal by Subject|12|||
144284860|NCT00986232|520244789|FG003|Overall Study|Withdrawal by Subject|3|||
144284861|NCT00986232|520244786|FG000|Overall Study|Missed one or more bleeds|13|||
144284862|NCT00986232|520244787|FG001|Overall Study|Missed one or more bleeds|10|||
144284863|NCT00986232|520244788|FG002|Overall Study|Missed one or more bleeds|6|||
144284864|NCT00986232|520244789|FG003|Overall Study|Missed one or more bleeds|7|||
144284865|NCT00986232|520244786|FG000|Overall Study|Incomplete safety follow-up|3|||
144284866|NCT00986232|520244787|FG001|Overall Study|Incomplete safety follow-up|7|||
144284867|NCT00986232|520244788|FG002|Overall Study|Incomplete safety follow-up|2|||
144284868|NCT00986232|520244789|FG003|Overall Study|Incomplete safety follow-up|2|||
144284869|NCT00790933|520244790|FG000|Overall Study|Adverse Event|94|||
144284870|NCT00790933|520244791|FG001|Overall Study|Adverse Event|119|||
144284871|NCT00790933|520244792|FG002|Overall Study|Adverse Event|65|||
144284872|NCT00790933|520244793|FG003|Overall Study|Adverse Event|5|||
144284873|NCT00790933|520244794|FG004|Overall Study|Adverse Event|69|||
144284874|NCT00790933|520244790|FG000|Overall Study|Protocol Violation(s)|8|||
144284875|NCT00790933|520244791|FG001|Overall Study|Protocol Violation(s)|18|||
144284876|NCT00790933|520244792|FG002|Overall Study|Protocol Violation(s)|7|||
144284877|NCT00790933|520244793|FG003|Overall Study|Protocol Violation(s)|0|||
144284878|NCT00790933|520244794|FG004|Overall Study|Protocol Violation(s)|12|||
144284879|NCT00790933|520244790|FG000|Overall Study|Lack of Efficacy|192|||
144284880|NCT00790933|520244791|FG001|Overall Study|Lack of Efficacy|176|||
144284881|NCT00790933|520244792|FG002|Overall Study|Lack of Efficacy|130|||
144284882|NCT00790933|520244793|FG003|Overall Study|Lack of Efficacy|1|||
144284883|NCT00790933|520244794|FG004|Overall Study|Lack of Efficacy|121|||
144284884|NCT00790933|520244790|FG000|Overall Study|Study Terminated by Sponsor|0|||
144284885|NCT00790933|520244791|FG001|Overall Study|Study Terminated by Sponsor|0|||
144284886|NCT00790933|520244792|FG002|Overall Study|Study Terminated by Sponsor|1|||
144284887|NCT00790933|520244793|FG003|Overall Study|Study Terminated by Sponsor|0|||
144284888|NCT00790933|520244794|FG004|Overall Study|Study Terminated by Sponsor|0|||
144284889|NCT00790933|520244790|FG000|Overall Study|Withdrawal by Subject|123|||
144284890|NCT00790933|520244791|FG001|Overall Study|Withdrawal by Subject|120|||
144284891|NCT00790933|520244792|FG002|Overall Study|Withdrawal by Subject|52|||
144284892|NCT00790933|520244793|FG003|Overall Study|Withdrawal by Subject|6|||
144284893|NCT00790933|520244794|FG004|Overall Study|Withdrawal by Subject|50|||
144284894|NCT00790933|520244790|FG000|Overall Study|Lost to Follow-up|13|||
144284895|NCT00790933|520244791|FG001|Overall Study|Lost to Follow-up|31|||
144284896|NCT00790933|520244792|FG002|Overall Study|Lost to Follow-up|10|||
144284897|NCT00790933|520244793|FG003|Overall Study|Lost to Follow-up|1|||
144284898|NCT00790933|520244794|FG004|Overall Study|Lost to Follow-up|15|||
144284899|NCT00790933|520244790|FG000|Overall Study|Reason Not Specified|8|||
144284900|NCT00790933|520244791|FG001|Overall Study|Reason Not Specified|16|||
144284901|NCT00790933|520244792|FG002|Overall Study|Reason Not Specified|4|||
144284902|NCT00790933|520244793|FG003|Overall Study|Reason Not Specified|1|||
144284903|NCT00790933|520244794|FG004|Overall Study|Reason Not Specified|9|||
144284904|NCT00894647|520244795|FG000|Overall Study|Adverse Event|5|||
144284905|NCT00894647|520244796|FG001|Overall Study|Adverse Event|4|||
144284906|NCT00894647|520244795|FG000|Overall Study|Withdrawal by Subject|4|||
144284907|NCT00894647|520244796|FG001|Overall Study|Withdrawal by Subject|4|||
144284908|NCT00894647|520244795|FG000|Overall Study|Lost to Follow-up|0|||
144284909|NCT00894647|520244796|FG001|Overall Study|Lost to Follow-up|2|||
144284910|NCT00894647|520244795|FG000|Overall Study|Non-compliance with study procedures|0|||
144284911|NCT00894647|520244796|FG001|Overall Study|Non-compliance with study procedures|2|||
144284912|NCT00894647|520244795|FG000|Overall Study|Other, not due to AE|1|||
144284913|NCT00894647|520244796|FG001|Overall Study|Other, not due to AE|2|||
144284914|NCT02153827|520244797|FG000|Overall Study|Lost to Follow-up|3|||
144284915|NCT02153827|520244798|FG001|Overall Study|Lost to Follow-up|9|||
144284916|NCT04676646|520244799|FG000|Open-label Run-in Phase|Adverse Event|3|||
144284917|NCT04676646|520244800|FG001|Open-label Run-in Phase|Adverse Event|0|||
144284918|NCT04676646|520244801|FG002|Open-label Run-in Phase|Adverse Event|0|||
144284919|NCT04676646|520244799|FG000|Open-label Run-in Phase|Death|3|||
144284920|NCT04676646|520244800|FG001|Open-label Run-in Phase|Death|0|||
144284921|NCT04676646|520244801|FG002|Open-label Run-in Phase|Death|0|||
144284922|NCT04676646|520244799|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
144284923|NCT04676646|520244800|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
144284924|NCT04676646|520244801|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
144284925|NCT04676646|520244799|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
144284926|NCT04676646|520244800|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
144284927|NCT04676646|520244801|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
144284928|NCT04676646|520244799|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
144284929|NCT04676646|520244800|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
144284930|NCT04676646|520244801|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
144284931|NCT04676646|520244799|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
144284932|NCT04676646|520244800|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
144284933|NCT04676646|520244801|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
144284934|NCT04676646|520244799|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
144284935|NCT04676646|520244800|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
144284936|NCT04676646|520244801|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
144284937|NCT04676646|520244799|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
144284938|NCT04676646|520244800|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
144284939|NCT04676646|520244801|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
144284940|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
144284941|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
144284942|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
144284943|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Death|0|||
144284944|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Death|1|||
144284945|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Death|2|||
144284946|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
144284947|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
144284948|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
144284949|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
144284950|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
144284951|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
144284952|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
144284953|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
144284954|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
144284955|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
144284956|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
144284957|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
144284958|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
144284959|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
144284960|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
144284961|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
144284962|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
144284963|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
144284964|NCT04676646|520244799|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
144284965|NCT04676646|520244800|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
144284966|NCT04676646|520244801|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
144284967|NCT02061592|520244802|FG000|Period 1|Withdrawal by Subject|1|||
144284968|NCT02061592|520244803|FG001|Period 1|Withdrawal by Subject|0|||
144284969|NCT02061592|520244802|FG000|Period 1|Protocol Violation|1|||
144284970|NCT02061592|520244803|FG001|Period 1|Protocol Violation|0|||
144284971|NCT02061592|520244802|FG000|Period 2|Lost to Follow-up|0|||
144284972|NCT02061592|520244803|FG001|Period 2|Lost to Follow-up|1|||
144284973|NCT04433975|520244804|FG000|1-month Follow Up|Withdrawal by Subject|1|||
144284974|NCT04433975|520244805|FG001|1-month Follow Up|Withdrawal by Subject|1|||
144284975|NCT04433975|520244804|FG000|1-month Follow Up|Lost to Follow-up|21|||
144284976|NCT04433975|520244805|FG001|1-month Follow Up|Lost to Follow-up|25|||
144284977|NCT04433975|520244804|FG000|3-month Follow Up|Lost to Follow-up|20|||
144284978|NCT04433975|520244805|FG001|3-month Follow Up|Lost to Follow-up|24|||
144284979|NCT04433975|520244804|FG000|3-month Follow Up|Death|1|||
144284980|NCT04433975|520244805|FG001|3-month Follow Up|Death|0|||
144284981|NCT04433975|520244804|FG000|3-month Follow Up|Withdrawal by Subject|2|||
144284982|NCT04433975|520244805|FG001|3-month Follow Up|Withdrawal by Subject|0|||
144284983|NCT04433975|520244804|FG000|6-month Follow Up|Lost to Follow-up|23|||
144284984|NCT04433975|520244805|FG001|6-month Follow Up|Lost to Follow-up|28|||
144284985|NCT04433975|520244804|FG000|6-month Follow Up|Withdrawal by Subject|1|||
144284986|NCT04433975|520244805|FG001|6-month Follow Up|Withdrawal by Subject|1|||
144284987|NCT04433975|520244804|FG000|9-month Follow Up|Lost to Follow-up|27|||
144284988|NCT04433975|520244805|FG001|9-month Follow Up|Lost to Follow-up|36|||
144284989|NCT04433975|520244804|FG000|9-month Follow Up|Death|0|||
144284990|NCT04433975|520244805|FG001|9-month Follow Up|Death|1|||
144284991|NCT04433975|520244804|FG000|12-month Follow Up|Lost to Follow-up|27|||
144284992|NCT04433975|520244805|FG001|12-month Follow Up|Lost to Follow-up|31|||
144284993|NCT00685698|520244806|FG000|Overall Study|Withdrawal by Subject|1|||
144284994|NCT00685698|520244806|FG000|Overall Study|Protocol Violation|6|||
144284995|NCT00685698|520244806|FG000|Overall Study|Adverse Event|3|||
144284996|NCT00685698|520244806|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
144284997|NCT00685698|520244806|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
144284998|NCT00685698|520244806|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
144284999|NCT02583477|520244809|FG000|Overall Study|Adverse Event|0|||
144285000|NCT02583477|520244810|FG001|Overall Study|Adverse Event|2|||
144285001|NCT02583477|520244809|FG000|Overall Study|Death|1|||
144285002|NCT02583477|520244810|FG001|Overall Study|Death|16|||
144285003|NCT02583477|520244809|FG000|Overall Study|Study terminated|2|||
144285004|NCT02583477|520244810|FG001|Overall Study|Study terminated|2|||
144285005|NCT02939781|520244814|FG000|Overall Study|Protocol Violation|8|||
144285006|NCT02939781|520244814|FG000|Overall Study|Withdrawal by Subject|1|||
144285007|NCT01740427|520244815|FG000|Overall Study|Objective Progression or Relapse|286|||
144285008|NCT01740427|520244816|FG001|Overall Study|Objective Progression or Relapse|172|||
144285009|NCT01740427|520244815|FG000|Overall Study|Adverse Event|32|||
144285010|NCT01740427|520244816|FG001|Overall Study|Adverse Event|9|||
144285011|NCT01740427|520244815|FG000|Overall Study|Global Deterioration of Health Status|28|||
144285012|NCT01740427|520244816|FG001|Overall Study|Global Deterioration of Health Status|12|||
144285013|NCT01740427|520244815|FG000|Overall Study|Participant Refused Continued Treatment|27|||
144285014|NCT01740427|520244816|FG001|Overall Study|Participant Refused Continued Treatment|15|||
144285015|NCT01740427|520244815|FG000|Overall Study|Unspecified reasons|52|||
144285016|NCT01740427|520244816|FG001|Overall Study|Unspecified reasons|8|||
144285017|NCT01740427|520244815|FG000|Overall Study|Death|10|||
144285018|NCT01740427|520244816|FG001|Overall Study|Death|3|||
144285019|NCT01740427|520244815|FG000|Overall Study|Protocol Violation|5|||
144285020|NCT01740427|520244816|FG001|Overall Study|Protocol Violation|3|||
144285021|NCT01740427|520244815|FG000|Overall Study|Lost to Follow-up|3|||
144285022|NCT01740427|520244816|FG001|Overall Study|Lost to Follow-up|0|||
144285023|NCT01740427|520244815|FG000|Overall Study|Site Terminated by Sponsor|1|||
144285024|NCT01740427|520244816|FG001|Overall Study|Site Terminated by Sponsor|0|||
144285025|NCT01980888|520244817|FG000|Overall Study|Study Terminated by Sponsor|116|||
144285026|NCT01980888|520244818|FG001|Overall Study|Study Terminated by Sponsor|122|||
144285027|NCT01980888|520244817|FG000|Overall Study|Withdrew Consent|17|||
144285028|NCT01980888|520244818|FG001|Overall Study|Withdrew Consent|6|||
144285029|NCT01980888|520244817|FG000|Overall Study|Investigator's Discretion|8|||
144285030|NCT01980888|520244818|FG001|Overall Study|Investigator's Discretion|3|||
144285031|NCT01980888|520244817|FG000|Overall Study|Non-Compliance with Study Drug|3|||
144285032|NCT01980888|520244818|FG001|Overall Study|Non-Compliance with Study Drug|2|||
144285033|NCT04625972|520244820|FG000|Overall Study|Death|3|||
144285034|NCT04625972|520244821|FG001|Overall Study|Death|2|||
144285035|NCT04625972|520244820|FG000|Overall Study|Lost to Follow-up|82|||
144285036|NCT04625972|520244821|FG001|Overall Study|Lost to Follow-up|38|||
144285037|NCT04625972|520244820|FG000|Overall Study|Physician Decision|2|||
144285038|NCT04625972|520244821|FG001|Overall Study|Physician Decision|0|||
144285039|NCT04625972|520244820|FG000|Overall Study|Protocol Violation|0|||
144285040|NCT04625972|520244821|FG001|Overall Study|Protocol Violation|1|||
144285041|NCT04625972|520244820|FG000|Overall Study|Withdrawal by Subject|37|||
144285042|NCT04625972|520244821|FG001|Overall Study|Withdrawal by Subject|24|||
144285043|NCT04625972|520244820|FG000|Overall Study|Not specified elsewhere|8|||
144285044|NCT04625972|520244821|FG001|Overall Study|Not specified elsewhere|6|||
144285045|NCT01483651|520244822|FG000|Overall Study|Withdrawal by Subject|0|||
144285046|NCT01483651|520244823|FG001|Overall Study|Withdrawal by Subject|1|||
144285047|NCT01483651|520244824|FG002|Overall Study|Withdrawal by Subject|1|||
144285048|NCT01483651|520244825|FG003|Overall Study|Withdrawal by Subject|0|||
144285049|NCT01483651|520244826|FG004|Overall Study|Withdrawal by Subject|0|||
144285050|NCT01483651|520244827|FG005|Overall Study|Withdrawal by Subject|1|||
144285051|NCT05762744|520244829|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
144285052|NCT05762744|520244830|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
144285053|NCT05762744|520244829|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
144285054|NCT05762744|520244830|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
144285055|NCT03334175|520244831|FG000|Overall Study|Lost to Follow-up|0|||
144285056|NCT03334175|520244832|FG001|Overall Study|Lost to Follow-up|1|||
144285057|NCT03738215|520244833|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
144285058|NCT03738215|520244834|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
144285059|NCT03738215|520244835|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
144285060|NCT03738215|520244833|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
144285061|NCT03738215|520244834|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
144285062|NCT03738215|520244835|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
144285063|NCT03738215|520244833|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
144285064|NCT03738215|520244834|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
144285065|NCT03738215|520244835|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
144285066|NCT03738215|520244833|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
144285067|NCT03738215|520244834|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
144285068|NCT03738215|520244835|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
144285069|NCT03738215|520244833|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
144285070|NCT03738215|520244834|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
144285071|NCT03738215|520244835|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
144285072|NCT03738215|520244833|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
144285073|NCT03738215|520244834|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
144285074|NCT03738215|520244835|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
144285075|NCT03738215|520244833|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
144285076|NCT03738215|520244834|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
144285077|NCT03738215|520244835|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
144285078|NCT03738215|520244833|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
144285079|NCT03738215|520244834|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
144285080|NCT03738215|520244835|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
144285081|NCT03738215|520244833|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
144285082|NCT03738215|520244834|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
144285083|NCT03738215|520244835|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
144285084|NCT03738215|520244833|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
144285085|NCT03738215|520244834|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
144285086|NCT03738215|520244835|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
144285087|NCT01695772|520244836|FG000|Overall Study|Withdrawal by Subject|18|||
144285088|NCT01695772|520244836|FG000|Overall Study|Progressive Disease|8|||
144285089|NCT01695772|520244836|FG000|Overall Study|Investigator Decision|5|||
144285090|NCT01695772|520244836|FG000|Overall Study|Lost to Follow-up|4|||
144285091|NCT01695772|520244836|FG000|Overall Study|Protocol Violation|2|||
144285092|NCT01695772|520244836|FG000|Overall Study|Unspecified Reason|1|||
144285093|NCT00004859|520244839|FG000|Overall Study|Lack of Efficacy|43|||
144285094|NCT00004859|520244840|FG001|Overall Study|Lack of Efficacy|113|||
144285095|NCT00004859|520244839|FG000|Overall Study|Adverse Event|31|||
144285096|NCT00004859|520244840|FG001|Overall Study|Adverse Event|93|||
144285097|NCT00004859|520244839|FG000|Overall Study|Death|5|||
144285098|NCT00004859|520244840|FG001|Overall Study|Death|5|||
144285099|NCT00004859|520244839|FG000|Overall Study|Withdrawal by Subject|7|||
144285100|NCT00004859|520244840|FG001|Overall Study|Withdrawal by Subject|33|||
144285101|NCT00004859|520244839|FG000|Overall Study|Protocol Violation|2|||
144285102|NCT00004859|520244840|FG001|Overall Study|Protocol Violation|2|||
144285103|NCT00004859|520244839|FG000|Overall Study|other disease|0|||
144285104|NCT00004859|520244840|FG001|Overall Study|other disease|3|||
144285105|NCT00004859|520244839|FG000|Overall Study|error|3|||
144285106|NCT00004859|520244840|FG001|Overall Study|error|1|||
144285107|NCT00004859|520244839|FG000|Overall Study|missing data|14|||
144285108|NCT00004859|520244840|FG001|Overall Study|missing data|11|||
144285109|NCT00004859|520244839|FG000|Overall Study|Other|13|||
144285110|NCT00004859|520244840|FG001|Overall Study|Other|21|||
144285111|NCT02724644|520246382|FG000|Overall Study|Adverse Event|7|||
144285112|NCT02724644|520246383|FG001|Overall Study|Adverse Event|1|||
144285113|NCT02724644|520246382|FG000|Overall Study|Lost to Follow-up|6|||
144285114|NCT02724644|520246383|FG001|Overall Study|Lost to Follow-up|2|||
144285115|NCT02724644|520246382|FG000|Overall Study|Withdrawal by Subject|7|||
144285116|NCT02724644|520246383|FG001|Overall Study|Withdrawal by Subject|1|||
144285117|NCT02724644|520246382|FG000|Overall Study|Administrative|1|||
144285118|NCT02724644|520246383|FG001|Overall Study|Administrative|0|||
144285119|NCT01108796|520246384|FG000|Overall Study|Adverse Event|0|||
144285120|NCT01108796|520246385|FG001|Overall Study|Adverse Event|1|||
144285121|NCT01108796|520246384|FG000|Overall Study|Lost to Follow-up|7|||
144285122|NCT01108796|520246385|FG001|Overall Study|Lost to Follow-up|6|||
144285123|NCT02545127|520246388|FG000|Overall Study|Lost to Follow-up|1|||
144285124|NCT02545127|520246389|FG001|Overall Study|Lost to Follow-up|0|||
144285125|NCT00960856|520246391|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
144285126|NCT00960856|520246392|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
144285127|NCT00960856|520246393|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
144285128|NCT00960856|520246394|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
144285129|NCT00960856|520246391|FG000|Washout Period of 7 Days|Adverse Event|0|||
144285130|NCT00960856|520246392|FG001|Washout Period of 7 Days|Adverse Event|0|||
144285131|NCT00960856|520246393|FG002|Washout Period of 7 Days|Adverse Event|1|||
144285132|NCT00960856|520246394|FG003|Washout Period of 7 Days|Adverse Event|0|||
144285133|NCT02595749|520246398|FG000|Overall Study|Withdrawal by Subject|12|||
144285134|NCT02595749|520246399|FG001|Overall Study|Withdrawal by Subject|7|||
144285135|NCT00421733|520246402|FG000|Overall Study|Adverse Event|4|||
144285136|NCT00421733|520246403|FG001|Overall Study|Adverse Event|9|||
144285137|NCT00421733|520246404|FG002|Overall Study|Adverse Event|2|||
144285138|NCT00421733|520246402|FG000|Overall Study|Lost to Follow-up|1|||
144285139|NCT00421733|520246403|FG001|Overall Study|Lost to Follow-up|2|||
144285140|NCT00421733|520246404|FG002|Overall Study|Lost to Follow-up|4|||
144285141|NCT00421733|520246402|FG000|Overall Study|Withdrawal by Subject|1|||
144285142|NCT00421733|520246403|FG001|Overall Study|Withdrawal by Subject|2|||
144285143|NCT00421733|520246404|FG002|Overall Study|Withdrawal by Subject|7|||
144285144|NCT00421733|520246402|FG000|Overall Study|Death|0|||
144285145|NCT00421733|520246403|FG001|Overall Study|Death|3|||
144285146|NCT00421733|520246404|FG002|Overall Study|Death|0|||
144285147|NCT00421733|520246402|FG000|Overall Study|Required dialysis|1|||
144285148|NCT00421733|520246403|FG001|Overall Study|Required dialysis|0|||
144285149|NCT00421733|520246404|FG002|Overall Study|Required dialysis|0|||
144285150|NCT00421733|520246402|FG000|Overall Study|Administrative|2|||
144285151|NCT00421733|520246403|FG001|Overall Study|Administrative|0|||
144285152|NCT00421733|520246404|FG002|Overall Study|Administrative|0|||
144285153|NCT00421733|520246402|FG000|Overall Study|Did not satisfy entry criteria|1|||
144285154|NCT00421733|520246403|FG001|Overall Study|Did not satisfy entry criteria|3|||
144285155|NCT00421733|520246404|FG002|Overall Study|Did not satisfy entry criteria|2|||
144285156|NCT00421733|520246402|FG000|Overall Study|Sponsor request|1|||
144285157|NCT00421733|520246403|FG001|Overall Study|Sponsor request|0|||
144285158|NCT00421733|520246404|FG002|Overall Study|Sponsor request|3|||
144285159|NCT00421733|520246402|FG000|Overall Study|Protocol deviation|4|||
144285160|NCT00421733|520246403|FG001|Overall Study|Protocol deviation|7|||
144285161|NCT00421733|520246404|FG002|Overall Study|Protocol deviation|2|||
144285162|NCT00103506|520246408|FG000|Overall Study|Study closed by sponsor|34|||
144285163|NCT00103506|520246409|FG001|Overall Study|Study closed by sponsor|37|||
144285164|NCT00103506|520246408|FG000|Overall Study|Death|257|||
144285165|NCT00103506|520246409|FG001|Overall Study|Death|253|||
144285166|NCT00103506|520246408|FG000|Overall Study|Lost to Follow-up|13|||
144285167|NCT00103506|520246409|FG001|Overall Study|Lost to Follow-up|13|||
144285168|NCT00103506|520246408|FG000|Overall Study|Withdrawal by Subject|18|||
144285169|NCT00103506|520246409|FG001|Overall Study|Withdrawal by Subject|21|||
144285170|NCT00585585|520246410|FG000|Overall Study|Adverse Event|1|||
144285171|NCT01433978|520246413|FG000|Core Study|Adverse Event, Non-Fatal|0|||
144285172|NCT01433978|520246414|FG001|Core Study|Adverse Event, Non-Fatal|1|||
144285173|NCT01433978|520246415|FG002|Core Study|Adverse Event, Non-Fatal|0|||
144285174|NCT01433978|520246413|FG000|Core Study|Lack of Efficacy|5|||
144285175|NCT01433978|520246414|FG001|Core Study|Lack of Efficacy|1|||
144285176|NCT01433978|520246415|FG002|Core Study|Lack of Efficacy|0|||
144285177|NCT01433978|520246413|FG000|Core Study|Study Terminated by Sponsor|6|||
144285178|NCT01433978|520246414|FG001|Core Study|Study Terminated by Sponsor|9|||
144285179|NCT01433978|520246415|FG002|Core Study|Study Terminated by Sponsor|0|||
144285180|NCT01433978|520246413|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
144285181|NCT01433978|520246414|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
144285182|NCT01433978|520246415|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
144285183|NCT01433978|520246413|FG000|Extension Phase|Lack of Efficacy|0|||
144285184|NCT01433978|520246414|FG001|Extension Phase|Lack of Efficacy|0|||
144285185|NCT01433978|520246415|FG002|Extension Phase|Lack of Efficacy|1|||
144285186|NCT01433978|520246413|FG000|Extension Phase|Study Terminated by Sponsor|0|||
144285187|NCT01433978|520246414|FG001|Extension Phase|Study Terminated by Sponsor|0|||
144285188|NCT01433978|520246415|FG002|Extension Phase|Study Terminated by Sponsor|4|||
144285189|NCT03954938|520246416|FG000|Overall Study|Withdrawal by Subject|2|||
144285190|NCT03954938|520246416|FG000|Overall Study|Adverse Event|1|||
144285191|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
144285192|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
144285193|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
144285194|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
144285195|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
144285196|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
144285197|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
144285198|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
144285199|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
144285200|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
144285201|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
144285202|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
144285203|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
144285204|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
144285205|NCT00976391|520246422|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
144285206|NCT00976391|520246423|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
144285207|NCT00976391|520246422|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
144285208|NCT00976391|520246423|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
144285209|NCT00976391|520246422|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
144285210|NCT00976391|520246423|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
144285211|NCT00976391|520246422|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
144285212|NCT00976391|520246423|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
144285213|NCT00976391|520246422|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
144285214|NCT00976391|520246423|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
144285215|NCT00976391|520246422|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
144285216|NCT00976391|520246423|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
144285217|NCT00976391|520246422|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
144285218|NCT00976391|520246423|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
144285219|NCT02565186|520246424|FG000|Overall Study|Adverse Event|113|||
144285220|NCT02565186|520246425|FG001|Overall Study|Adverse Event|148|||
144285221|NCT02565186|520246424|FG000|Overall Study|Lost to Follow-up|102|||
144285222|NCT02565186|520246425|FG001|Overall Study|Lost to Follow-up|93|||
144285223|NCT02565186|520246424|FG000|Overall Study|Non-Compliance|57|||
144285224|NCT02565186|520246425|FG001|Overall Study|Non-Compliance|55|||
144285225|NCT02565186|520246424|FG000|Overall Study|Withdrawal by Subject|229|||
144285226|NCT02565186|520246425|FG001|Overall Study|Withdrawal by Subject|214|||
144285227|NCT02565186|520246424|FG000|Overall Study|Physician Decision|18|||
144285228|NCT02565186|520246425|FG001|Overall Study|Physician Decision|16|||
144285229|NCT02565186|520246424|FG000|Overall Study|Sponsor Request|5|||
144285230|NCT02565186|520246425|FG001|Overall Study|Sponsor Request|9|||
144285231|NCT02565186|520246424|FG000|Overall Study|Missing|1|||
144285232|NCT02565186|520246425|FG001|Overall Study|Missing|0|||
144285233|NCT02565186|520246424|FG000|Overall Study|Did Not Receive Study Drug|55|||
144285234|NCT02565186|520246425|FG001|Overall Study|Did Not Receive Study Drug|86|||
144285235|NCT00617903|520246426|FG000|Overall Study|Withdrawal by Subject|2|||
144285236|NCT00617903|520246427|FG001|Overall Study|Withdrawal by Subject|3|||
144285237|NCT00617903|520246426|FG000|Overall Study|Lost to Follow-up|1|||
144285238|NCT00617903|520246427|FG001|Overall Study|Lost to Follow-up|1|||
144285239|NCT00617903|520246426|FG000|Overall Study|Lack of Efficacy|0|||
144285240|NCT00617903|520246427|FG001|Overall Study|Lack of Efficacy|1|||
144285241|NCT00617903|520246426|FG000|Overall Study|Adverse Event|0|||
144285242|NCT00617903|520246427|FG001|Overall Study|Adverse Event|1|||
144285243|NCT00617903|520246426|FG000|Overall Study|noncompliance|0|||
144285244|NCT00617903|520246427|FG001|Overall Study|noncompliance|1|||
144285245|NCT02217982|520246428|FG000|Overall Study|Trial discontinued|1|||
144285246|NCT02217982|520246429|FG001|Overall Study|Trial discontinued|0|||
144285247|NCT02217982|520246428|FG000|Overall Study|Adverse Event|0|||
144285248|NCT02217982|520246429|FG001|Overall Study|Adverse Event|1|||
144285249|NCT02421510|520246433|FG000|Overall Study|Other|4|||
144285250|NCT02421510|520246434|FG001|Overall Study|Other|2|||
144285251|NCT02421510|520246435|FG002|Overall Study|Other|3|||
144285252|NCT02421510|520246433|FG000|Overall Study|Protocol Violation|1|||
144285253|NCT02421510|520246434|FG001|Overall Study|Protocol Violation|2|||
144285254|NCT02421510|520246435|FG002|Overall Study|Protocol Violation|0|||
144285255|NCT02421510|520246433|FG000|Overall Study|Death|1|||
144285256|NCT02421510|520246434|FG001|Overall Study|Death|0|||
144285257|NCT02421510|520246435|FG002|Overall Study|Death|0|||
144285258|NCT02421510|520246433|FG000|Overall Study|Noncompliance with study drug|1|||
144285259|NCT02421510|520246434|FG001|Overall Study|Noncompliance with study drug|0|||
144285260|NCT02421510|520246435|FG002|Overall Study|Noncompliance with study drug|0|||
144285261|NCT02421510|520246433|FG000|Overall Study|Physician Decision|1|||
144285262|NCT02421510|520246434|FG001|Overall Study|Physician Decision|1|||
144285263|NCT02421510|520246435|FG002|Overall Study|Physician Decision|3|||
144285264|NCT02421510|520246433|FG000|Overall Study|Adverse Event|9|||
144285265|NCT02421510|520246434|FG001|Overall Study|Adverse Event|10|||
144285266|NCT02421510|520246435|FG002|Overall Study|Adverse Event|18|||
144285267|NCT02421510|520246433|FG000|Overall Study|Pregnancy|1|||
144285268|NCT02421510|520246434|FG001|Overall Study|Pregnancy|1|||
144285269|NCT02421510|520246435|FG002|Overall Study|Pregnancy|0|||
144285270|NCT02421510|520246433|FG000|Overall Study|Withdrawal by Subject|14|||
144285271|NCT02421510|520246434|FG001|Overall Study|Withdrawal by Subject|18|||
144285272|NCT02421510|520246435|FG002|Overall Study|Withdrawal by Subject|12|||
144285273|NCT02421510|520246433|FG000|Overall Study|Lost to Follow-up|1|||
144285274|NCT02421510|520246434|FG001|Overall Study|Lost to Follow-up|1|||
144285275|NCT02421510|520246435|FG002|Overall Study|Lost to Follow-up|0|||
144285276|NCT02852434|520246436|FG000|Overall Study|Withdrawal by Subject|0|||
144285277|NCT02852434|520246437|FG001|Overall Study|Withdrawal by Subject|1|||
144285278|NCT02852434|520246436|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
144285279|NCT02852434|520246437|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
144285280|NCT01814332|520246443|FG000|Overall Study|Adverse Event|8|||
144285281|NCT01814332|520246444|FG001|Overall Study|Adverse Event|3|||
144285282|NCT01814332|520246443|FG000|Overall Study|Withdrawal by Subject|3|||
144285283|NCT01814332|520246444|FG001|Overall Study|Withdrawal by Subject|8|||
144285284|NCT01814332|520246443|FG000|Overall Study|Protocol Violation|0|||
144285285|NCT01814332|520246444|FG001|Overall Study|Protocol Violation|4|||
144285286|NCT01814332|520246443|FG000|Overall Study|Lost to Follow-up|5|||
144285287|NCT01814332|520246444|FG001|Overall Study|Lost to Follow-up|1|||
144285288|NCT01755637|520246445|FG000|Period 1|Adverse Event|0|||
144285289|NCT01755637|520246446|FG001|Period 1|Adverse Event|1|||
144285290|NCT05987540|520246447|FG000|Overall Study|Withdrawal by Subject|2|||
144285291|NCT05987540|520246447|FG000|Overall Study|Death|1|||
144285292|NCT05987540|520246447|FG000|Overall Study|Study Termination|1|||
144285293|NCT05987540|520246447|FG000|Overall Study|Adverse Event|2|||
144285294|NCT03338023|520246448|FG000|Overall Study|Withdrawal by Subject|3|||
144285295|NCT03338023|520246449|FG001|Overall Study|Withdrawal by Subject|4|||
144285296|NCT03338023|520246448|FG000|Overall Study|Protocol Violation|3|||
144285297|NCT03338023|520246449|FG001|Overall Study|Protocol Violation|3|||
144285298|NCT03338023|520246448|FG000|Overall Study|Lost to Follow-up|2|||
144285299|NCT03338023|520246449|FG001|Overall Study|Lost to Follow-up|1|||
144285300|NCT03338023|520246448|FG000|Overall Study|Physician Decision|1|||
144285301|NCT03338023|520246449|FG001|Overall Study|Physician Decision|2|||
144285302|NCT04882215|520246452|FG000|Overall Study|Withdrawal by Subject|5|||
144285303|NCT04882215|520246453|FG001|Overall Study|Withdrawal by Subject|0|||
144285304|NCT04098302|520246456|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
144285305|NCT04098302|520246457|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
144285306|NCT04098302|520246458|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
144285307|NCT04098302|520246459|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
144285308|NCT04098302|520246456|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
144285309|NCT04098302|520246457|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
144285310|NCT04098302|520246458|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
144285311|NCT04098302|520246459|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
144285312|NCT04098302|520246456|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
144285313|NCT04098302|520246457|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
144285314|NCT04098302|520246458|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
144285315|NCT04098302|520246459|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
144285316|NCT04098302|520246456|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
144285317|NCT04098302|520246457|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
144285318|NCT04098302|520246458|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
144285319|NCT04098302|520246459|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
144285320|NCT04098302|520246456|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
144285321|NCT04098302|520246457|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
144285322|NCT04098302|520246458|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
144285323|NCT04098302|520246459|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
144285324|NCT04098302|520246456|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
144285325|NCT04098302|520246457|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
144285326|NCT04098302|520246458|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
144285327|NCT04098302|520246459|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
144285328|NCT04098302|520246456|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
144285329|NCT04098302|520246457|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
144285330|NCT04098302|520246458|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
144285331|NCT04098302|520246459|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
144285332|NCT04098302|520246456|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
144245801|NCT02326298|520096252|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
144245802|NCT02326298|520096253|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
144245803|NCT02326298|520096254|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
144245804|NCT02326298|520096255|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
144245805|NCT03191864|520096256|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
144245806|NCT03191864|520096257|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
144245807|NCT03191864|520096258|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
144245808|NCT03191864|520096259|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
144245809|NCT03191864|520096260|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
144245810|NCT03191864|520096261|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
144245811|NCT03191864|520096256|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
144245812|NCT03191864|520096257|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
144245813|NCT03191864|520096258|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
144245814|NCT03191864|520096259|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
144245815|NCT03191864|520096260|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
144245816|NCT03191864|520096261|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
144245817|NCT03191864|520096256|FG000|Baseline Symptom Assessment|Adverse Event|0|||
144245818|NCT03191864|520096257|FG001|Baseline Symptom Assessment|Adverse Event|0|||
144245819|NCT03191864|520096258|FG002|Baseline Symptom Assessment|Adverse Event|0|||
144245820|NCT03191864|520096259|FG003|Baseline Symptom Assessment|Adverse Event|0|||
144245821|NCT03191864|520096260|FG004|Baseline Symptom Assessment|Adverse Event|0|||
144245822|NCT03191864|520096261|FG005|Baseline Symptom Assessment|Adverse Event|2|||
144245823|NCT03191864|520096256|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
144245824|NCT03191864|520096257|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
144245825|NCT03191864|520096258|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
144245826|NCT03191864|520096259|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
144245827|NCT03191864|520096260|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
144245828|NCT03191864|520096261|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
144245829|NCT03191864|520096256|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
144245830|NCT03191864|520096257|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
144245831|NCT03191864|520096258|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
144245832|NCT03191864|520096259|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
144245833|NCT03191864|520096260|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
144245834|NCT03191864|520096261|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
144245835|NCT03191864|520096256|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
144245836|NCT03191864|520096257|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
144245837|NCT03191864|520096258|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
144245838|NCT03191864|520096259|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
144245839|NCT03191864|520096260|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
144245840|NCT03191864|520096261|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
144245841|NCT03191864|520096256|FG000|Part 1 - Induction|Adverse Event|0|||
144245842|NCT03191864|520096257|FG001|Part 1 - Induction|Adverse Event|2|||
144245843|NCT03191864|520096258|FG002|Part 1 - Induction|Adverse Event|0|||
144245844|NCT03191864|520096259|FG003|Part 1 - Induction|Adverse Event|1|||
144245845|NCT03191864|520096260|FG004|Part 1 - Induction|Adverse Event|0|||
144245846|NCT03191864|520096261|FG005|Part 1 - Induction|Adverse Event|2|||
144245847|NCT03191864|520096256|FG000|Part 1 - Induction|Randomized but never dosed|0|||
144245848|NCT03191864|520096257|FG001|Part 1 - Induction|Randomized but never dosed|0|||
144245849|NCT03191864|520096258|FG002|Part 1 - Induction|Randomized but never dosed|1|||
144245850|NCT03191864|520096259|FG003|Part 1 - Induction|Randomized but never dosed|0|||
144245851|NCT03191864|520096260|FG004|Part 1 - Induction|Randomized but never dosed|0|||
144245852|NCT03191864|520096261|FG005|Part 1 - Induction|Randomized but never dosed|0|||
144245853|NCT03191864|520096256|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
144245854|NCT03191864|520096257|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
144245855|NCT03191864|520096258|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
144245856|NCT03191864|520096259|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
144245857|NCT03191864|520096260|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
144245858|NCT03191864|520096261|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
144245859|NCT03191864|520096256|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
144245860|NCT03191864|520096257|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
144245861|NCT03191864|520096258|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
144245862|NCT03191864|520096259|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
144245863|NCT03191864|520096260|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
144245864|NCT03191864|520096261|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
144285333|NCT04098302|520246457|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
144285334|NCT04098302|520246458|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
144285335|NCT04098302|520246459|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
144285336|NCT01290731|520246464|FG000|Overall Study|Withdrawal by Subject|1|||
144285337|NCT01668537|520246467|FG000|Overall Study|Request to Discontinue Prematurely|1|||
144285338|NCT01668537|520246468|FG001|Overall Study|Request to Discontinue Prematurely|1|||
144285339|NCT01668537|520246467|FG000|Overall Study|Subject unwilling/unable to comply|5|||
144285340|NCT01668537|520246468|FG001|Overall Study|Subject unwilling/unable to comply|0|||
144285341|NCT01668537|520246467|FG000|Overall Study|Reason Precludes Participation|1|||
144285342|NCT01668537|520246468|FG001|Overall Study|Reason Precludes Participation|0|||
144285343|NCT01668537|520246467|FG000|Overall Study|Lost to Follow-up|13|||
144285344|NCT01668537|520246468|FG001|Overall Study|Lost to Follow-up|6|||
144285345|NCT01668537|520246467|FG000|Overall Study|Other|2|||
144285346|NCT01668537|520246468|FG001|Overall Study|Other|3|||
144285347|NCT01149538|520246473|FG000|Overall Study|Lost to Follow-up|0|||
144285348|NCT01149538|520246474|FG001|Overall Study|Lost to Follow-up|1|||
144285349|NCT01149538|520246473|FG000|Overall Study|Withdrawal by Subject|5|||
144285350|NCT01149538|520246474|FG001|Overall Study|Withdrawal by Subject|3|||
144285351|NCT00888849|520246475|FG000|Overall Study|Death|4|||
144285352|NCT00888849|520246476|FG001|Overall Study|Death|7|||
144285353|NCT00888849|520246475|FG000|Overall Study|Lost to Follow-up|1|||
144285354|NCT00888849|520246476|FG001|Overall Study|Lost to Follow-up|2|||
144285355|NCT02336503|520246478|FG000|Overall Study|Lost to Follow-up|0|||
144285356|NCT02336503|520246479|FG001|Overall Study|Lost to Follow-up|3|||
144285357|NCT02336503|520246480|FG002|Overall Study|Lost to Follow-up|0|||
144285358|NCT02336503|520246481|FG003|Overall Study|Lost to Follow-up|2|||
144285359|NCT02336503|520246478|FG000|Overall Study|Withdrawal by Subject|2|||
144285360|NCT02336503|520246479|FG001|Overall Study|Withdrawal by Subject|0|||
144285361|NCT02336503|520246480|FG002|Overall Study|Withdrawal by Subject|0|||
144285362|NCT02336503|520246481|FG003|Overall Study|Withdrawal by Subject|4|||
144285363|NCT02336503|520246478|FG000|Overall Study|Adverse Event|0|||
144285364|NCT02336503|520246479|FG001|Overall Study|Adverse Event|0|||
144285365|NCT02336503|520246480|FG002|Overall Study|Adverse Event|1|||
144285366|NCT02336503|520246481|FG003|Overall Study|Adverse Event|0|||
144285367|NCT04576949|520246482|FG000|Overall Study|Adverse Event|1|||
144285368|NCT04576949|520246483|FG001|Overall Study|Adverse Event|3|||
144285369|NCT04576949|520246484|FG002|Overall Study|Adverse Event|2|||
144285370|NCT04576949|520246482|FG000|Overall Study|Withdrawal by Subject|41|||
144285371|NCT04576949|520246483|FG001|Overall Study|Withdrawal by Subject|26|||
144285372|NCT04576949|520246484|FG002|Overall Study|Withdrawal by Subject|18|||
144285373|NCT04576949|520246482|FG000|Overall Study|Physician Decision|3|||
144285374|NCT04576949|520246483|FG001|Overall Study|Physician Decision|0|||
144285375|NCT04576949|520246484|FG002|Overall Study|Physician Decision|0|||
144285376|NCT04576949|520246482|FG000|Overall Study|Death|0|||
144285377|NCT04576949|520246483|FG001|Overall Study|Death|1|||
144285378|NCT04576949|520246484|FG002|Overall Study|Death|0|||
144285379|NCT04576949|520246482|FG000|Overall Study|Lost to Follow-up|29|||
144285380|NCT04576949|520246483|FG001|Overall Study|Lost to Follow-up|37|||
144285381|NCT04576949|520246484|FG002|Overall Study|Lost to Follow-up|24|||
144285382|NCT04576949|520246482|FG000|Overall Study|Other, Not Specified|2|||
144285383|NCT04576949|520246483|FG001|Overall Study|Other, Not Specified|3|||
144285384|NCT04576949|520246484|FG002|Overall Study|Other, Not Specified|1|||
144285385|NCT04576949|520246482|FG000|Overall Study|Other|1|||
144285386|NCT04576949|520246483|FG001|Overall Study|Other|0|||
144285387|NCT04576949|520246484|FG002|Overall Study|Other|0|||
144285388|NCT04584554|520246485|FG000|Overall Study|Withdrawal by Subject|2|||
144285389|NCT04584554|520246486|FG001|Overall Study|Withdrawal by Subject|2|||
144285390|NCT00514917|520246487|FG000|Overall Study|Death|4|||
144285391|NCT00514917|520246488|FG001|Overall Study|Death|10|||
144285392|NCT00514917|520246487|FG000|Overall Study|Protocol Violation|1|||
144285393|NCT00514917|520246488|FG001|Overall Study|Protocol Violation|0|||
144285394|NCT00514917|520246487|FG000|Overall Study|Lost to Follow-up|4|||
144285395|NCT00514917|520246488|FG001|Overall Study|Lost to Follow-up|3|||
144285396|NCT00514917|520246487|FG000|Overall Study|Withdrawal by Subject|18|||
144285397|NCT00514917|520246488|FG001|Overall Study|Withdrawal by Subject|16|||
144285398|NCT00514917|520246487|FG000|Overall Study|Discontinued due to study closure|88|||
144285399|NCT00514917|520246488|FG001|Overall Study|Discontinued due to study closure|81|||
144285400|NCT00514917|520246487|FG000|Overall Study|Undefined|11|||
144285401|NCT00514917|520246488|FG001|Overall Study|Undefined|5|||
144285402|NCT03767894|520246489|FG000|Overall Study|Withdrawal by Subject|1|||
144285403|NCT00977561|520246491|FG000|Overall Study|Death|3|||
144285404|NCT00977561|520246492|FG001|Overall Study|Death|2|||
144285405|NCT00977561|520246491|FG000|Overall Study|Study terminated|0|||
144285406|NCT00977561|520246492|FG001|Overall Study|Study terminated|2|||
144285407|NCT00977561|520246491|FG000|Overall Study|Other|2|||
144285408|NCT00977561|520246492|FG001|Overall Study|Other|0|||
144285409|NCT01860404|520246497|FG000|Overall Study|Lost to Follow-up|3|||
144285410|NCT01860404|520246498|FG001|Overall Study|Lost to Follow-up|4|||
144285411|NCT01860404|520246499|FG002|Overall Study|Lost to Follow-up|1|||
144285412|NCT01860404|520246500|FG003|Overall Study|Lost to Follow-up|6|||
144285413|NCT01860404|520246501|FG004|Overall Study|Lost to Follow-up|4|||
144285414|NCT01860404|520246497|FG000|Overall Study|Withdrawal by Subject|0|||
144285415|NCT01860404|520246498|FG001|Overall Study|Withdrawal by Subject|0|||
144285416|NCT01860404|520246499|FG002|Overall Study|Withdrawal by Subject|4|||
144285417|NCT01860404|520246500|FG003|Overall Study|Withdrawal by Subject|0|||
144285418|NCT01860404|520246501|FG004|Overall Study|Withdrawal by Subject|0|||
144285419|NCT00309244|520246504|FG000|Overall Study|Adverse Event|29|||
144285420|NCT00309244|520246505|FG001|Overall Study|Adverse Event|12|||
144285421|NCT00309244|520246504|FG000|Overall Study|Lost to Follow-up|6|||
144285422|NCT00309244|520246505|FG001|Overall Study|Lost to Follow-up|22|||
144285423|NCT00309244|520246504|FG000|Overall Study|Physician Decision|5|||
144285424|NCT00309244|520246505|FG001|Overall Study|Physician Decision|8|||
144285425|NCT00309244|520246504|FG000|Overall Study|Protocol Violation|6|||
144285426|NCT00309244|520246505|FG001|Overall Study|Protocol Violation|3|||
144285427|NCT00309244|520246504|FG000|Overall Study|Withdrawal by Subject|50|||
144285428|NCT00309244|520246505|FG001|Overall Study|Withdrawal by Subject|32|||
144285429|NCT00309244|520246504|FG000|Overall Study|Various|7|||
144285430|NCT00309244|520246505|FG001|Overall Study|Various|7|||
144285431|NCT00309244|520246504|FG000|Overall Study|Randomized but not dosed|11|||
144285432|NCT00309244|520246505|FG001|Overall Study|Randomized but not dosed|12|||
144285433|NCT00309244|520246504|FG000|Overall Study|Death|4|||
144285434|NCT00309244|520246505|FG001|Overall Study|Death|1|||
144285435|NCT02187055|520246506|FG000|Overall Study|Lack of Efficacy|10|||
144285436|NCT02187055|520246507|FG001|Overall Study|Lack of Efficacy|3|||
144285437|NCT02187055|520246508|FG002|Overall Study|Lack of Efficacy|7|||
144285438|NCT02187055|520246506|FG000|Overall Study|Lost to Follow-up|2|||
144285439|NCT02187055|520246507|FG001|Overall Study|Lost to Follow-up|7|||
144285440|NCT02187055|520246508|FG002|Overall Study|Lost to Follow-up|3|||
144285441|NCT02187055|520246506|FG000|Overall Study|No longer meets eligibility criteria|0|||
144285442|NCT02187055|520246507|FG001|Overall Study|No longer meets eligibility criteria|2|||
144285443|NCT02187055|520246508|FG002|Overall Study|No longer meets eligibility criteria|0|||
144285444|NCT02187055|520246506|FG000|Overall Study|No longer willing to participate|6|||
144285445|NCT02187055|520246507|FG001|Overall Study|No longer willing to participate|8|||
144285446|NCT02187055|520246508|FG002|Overall Study|No longer willing to participate|10|||
144285447|NCT02187055|520246506|FG000|Overall Study|Other|5|||
144285448|NCT02187055|520246507|FG001|Overall Study|Other|6|||
144285449|NCT02187055|520246508|FG002|Overall Study|Other|3|||
144285450|NCT02187055|520246506|FG000|Overall Study|Protocol Violation|9|||
144285451|NCT02187055|520246507|FG001|Overall Study|Protocol Violation|9|||
144285452|NCT02187055|520246508|FG002|Overall Study|Protocol Violation|4|||
144285453|NCT02187055|520246506|FG000|Overall Study|Pregnancy|3|||
144285454|NCT02187055|520246507|FG001|Overall Study|Pregnancy|1|||
144285455|NCT02187055|520246508|FG002|Overall Study|Pregnancy|0|||
144285456|NCT02187055|520246506|FG000|Overall Study|Withdrawal by Subject|11|||
144285457|NCT02187055|520246507|FG001|Overall Study|Withdrawal by Subject|11|||
144285458|NCT02187055|520246508|FG002|Overall Study|Withdrawal by Subject|11|||
144285459|NCT02187055|520246506|FG000|Overall Study|Adverse Event|21|||
144285460|NCT02187055|520246507|FG001|Overall Study|Adverse Event|26|||
144285461|NCT02187055|520246508|FG002|Overall Study|Adverse Event|36|||
144285462|NCT02187055|520246506|FG000|Overall Study|Death|2|||
144285463|NCT02187055|520246507|FG001|Overall Study|Death|0|||
144285464|NCT02187055|520246508|FG002|Overall Study|Death|0|||
144285465|NCT03336866|520246509|FG000|Overall Study|Lost to Follow-up|2|||
144285466|NCT03336866|520246510|FG001|Overall Study|Lost to Follow-up|0|||
144285467|NCT03336866|520246511|FG002|Overall Study|Lost to Follow-up|3|||
144285468|NCT03336866|520246509|FG000|Overall Study|Withdrawal by Subject|1|||
144285469|NCT03336866|520246510|FG001|Overall Study|Withdrawal by Subject|1|||
144285470|NCT03336866|520246511|FG002|Overall Study|Withdrawal by Subject|0|||
144285471|NCT03336866|520246509|FG000|Overall Study|Noncompliance with clinic house rules|0|||
144285472|NCT03336866|520246510|FG001|Overall Study|Noncompliance with clinic house rules|0|||
144285473|NCT03336866|520246511|FG002|Overall Study|Noncompliance with clinic house rules|1|||
144285474|NCT00421993|520246512|FG000|Overall Study|Withdrawal by Subject|22|||
144285475|NCT00421993|520246513|FG001|Overall Study|Withdrawal by Subject|23|||
144285476|NCT00421993|520246514|FG002|Overall Study|Withdrawal by Subject|23|||
144285477|NCT00421993|520246515|FG003|Overall Study|Withdrawal by Subject|24|||
144285478|NCT00421993|520246512|FG000|Overall Study|Lost to Follow-up|18|||
144285479|NCT00421993|520246513|FG001|Overall Study|Lost to Follow-up|19|||
144285480|NCT00421993|520246514|FG002|Overall Study|Lost to Follow-up|22|||
144285481|NCT00421993|520246515|FG003|Overall Study|Lost to Follow-up|20|||
144285482|NCT00421993|520246512|FG000|Overall Study|Adverse Event|11|||
144285483|NCT00421993|520246513|FG001|Overall Study|Adverse Event|1|||
144285484|NCT00421993|520246514|FG002|Overall Study|Adverse Event|6|||
144285485|NCT00421993|520246515|FG003|Overall Study|Adverse Event|4|||
144285486|NCT00421993|520246512|FG000|Overall Study|Protocol Violation|2|||
144285487|NCT00421993|520246513|FG001|Overall Study|Protocol Violation|2|||
144285488|NCT00421993|520246514|FG002|Overall Study|Protocol Violation|0|||
144285489|NCT00421993|520246515|FG003|Overall Study|Protocol Violation|1|||
144285490|NCT00421993|520246512|FG000|Overall Study|Lack of Efficacy|0|||
144285491|NCT00421993|520246513|FG001|Overall Study|Lack of Efficacy|3|||
144285492|NCT00421993|520246514|FG002|Overall Study|Lack of Efficacy|0|||
144285493|NCT00421993|520246515|FG003|Overall Study|Lack of Efficacy|5|||
144285494|NCT00421993|520246512|FG000|Overall Study|Pregnancy|0|||
144285495|NCT00421993|520246513|FG001|Overall Study|Pregnancy|1|||
144285496|NCT00421993|520246514|FG002|Overall Study|Pregnancy|1|||
144285497|NCT00421993|520246515|FG003|Overall Study|Pregnancy|2|||
144285498|NCT00421993|520246512|FG000|Overall Study|Subject transportation issues|0|||
144285499|NCT00421993|520246513|FG001|Overall Study|Subject transportation issues|0|||
144285500|NCT00421993|520246514|FG002|Overall Study|Subject transportation issues|0|||
144285501|NCT00421993|520246515|FG003|Overall Study|Subject transportation issues|1|||
144285502|NCT02015104|520246516|FG000|Overall Study|Withdrew consent after first dose drug|1|||
144285503|NCT02015104|520246517|FG001|Overall Study|Withdrew consent after first dose drug|0|||
144285504|NCT02015104|520246516|FG000|Overall Study|Withdrew consent prior to treatment|0|||
144285505|NCT02015104|520246517|FG001|Overall Study|Withdrew consent prior to treatment|1|||
144285506|NCT06025695|520246518|FG000|Overall Study|Adverse Event|5|||
144285507|NCT06025695|520246519|FG001|Overall Study|Adverse Event|6|||
144285508|NCT06025695|520246518|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
144285509|NCT06025695|520246519|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
144285510|NCT06025695|520246518|FG000|Overall Study|Other|23|||
144285511|NCT06025695|520246519|FG001|Overall Study|Other|19|||
144285512|NCT06025695|520246518|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
144285513|NCT06025695|520246519|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
144285514|NCT01560416|520246523|FG000|Randomized Phase|Crossover Participants|7|||
144285515|NCT01560416|520246524|FG001|Randomized Phase|Crossover Participants|0|||
144285516|NCT01301092|520246525|FG000|Overall Study|Lost to Follow-up|0|||
144285517|NCT01301092|520246526|FG001|Overall Study|Lost to Follow-up|0|||
144285518|NCT01301092|520246527|FG002|Overall Study|Lost to Follow-up|1|||
144285519|NCT01350973|520246528|FG000|Overall Study|Adverse Event|4|||
144285520|NCT01350973|520246529|FG001|Overall Study|Adverse Event|7|||
144285521|NCT01350973|520246530|FG002|Overall Study|Adverse Event|7|||
144285522|NCT01350973|520246528|FG000|Overall Study|Voluntary Withdrawal|2|||
144285523|NCT01350973|520246529|FG001|Overall Study|Voluntary Withdrawal|1|||
144285524|NCT01350973|520246530|FG002|Overall Study|Voluntary Withdrawal|1|||
144285525|NCT02638493|520246531|FG000|Overall Study|Inability to provide semen samples|2|||
144285526|NCT02638493|520246532|FG001|Overall Study|Inability to provide semen samples|0|||
144285527|NCT02638493|520246533|FG002|Overall Study|Inability to provide semen samples|0|||
144285528|NCT04073407|520246537|FG000|Part 1|Withdrawal by Subject|1|||
144285529|NCT04073407|520246538|FG001|Part 1|Withdrawal by Subject|0|||
144285530|NCT04073407|520246537|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
144285531|NCT04073407|520246538|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
144285532|NCT04073407|520246537|FG000|Part 2|Withdrawal by Subject|0|||
144285533|NCT04073407|520246538|FG001|Part 2|Withdrawal by Subject|1|||
144285534|NCT02082483|520248330|FG000|Overall Study|Lost to Follow-up|1|||
144285535|NCT02082483|520248331|FG001|Overall Study|Lost to Follow-up|1|||
144285536|NCT02082483|520248330|FG000|Overall Study|Withdrawal by Subject|2|||
144285537|NCT02082483|520248331|FG001|Overall Study|Withdrawal by Subject|1|||
144285538|NCT02082483|520248330|FG000|Overall Study|Physician Decision|1|||
144285539|NCT02082483|520248331|FG001|Overall Study|Physician Decision|1|||
144285540|NCT02082483|520248330|FG000|Overall Study|Death|2|||
144285541|NCT02082483|520248331|FG001|Overall Study|Death|3|||
144285542|NCT00762788|520248332|FG000|Overall Study|Lost to Follow-up|26|||
144285543|NCT00762788|520248333|FG001|Overall Study|Lost to Follow-up|37|||
144285544|NCT00762788|520248334|FG002|Overall Study|Lost to Follow-up|21|||
144285545|NCT00762788|520248335|FG003|Overall Study|Lost to Follow-up|26|||
144285546|NCT00762788|520248336|FG004|Overall Study|Lost to Follow-up|13|||
144285547|NCT00762788|520248337|FG005|Overall Study|Lost to Follow-up|21|||
144285548|NCT01783015|520248338|FG000|Blinded Treatment|Adverse Event|0|||
144285549|NCT01783015|520248339|FG001|Blinded Treatment|Adverse Event|1|||
144285550|NCT01783015|520248340|FG002|Blinded Treatment|Adverse Event|0|||
144285551|NCT01783015|520248338|FG000|Blinded Treatment|Protocol Violation|0|||
144285552|NCT01783015|520248339|FG001|Blinded Treatment|Protocol Violation|1|||
144285553|NCT01783015|520248340|FG002|Blinded Treatment|Protocol Violation|0|||
144285554|NCT01783015|520248338|FG000|Blinded Treatment|Withdrawal by Subject|0|||
144285555|NCT01783015|520248339|FG001|Blinded Treatment|Withdrawal by Subject|1|||
144285556|NCT01783015|520248340|FG002|Blinded Treatment|Withdrawal by Subject|0|||
144285557|NCT01783015|520248338|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
144285558|NCT01783015|520248339|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
144285559|NCT01783015|520248340|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
144285560|NCT01783015|520248338|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
144285561|NCT01783015|520248339|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
144285562|NCT01783015|520248340|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
144285563|NCT00985192|520248341|FG000|Overall Study|Withdrawal by Subject|1|||
144285564|NCT00985192|520248341|FG000|Overall Study|Disease Progression|1|||
144285565|NCT00985192|520248341|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
144285566|NCT00669331|520248342|FG000|Randomisation to First Dose|Adverse Event|1|||
144285567|NCT00669331|520248343|FG001|Randomisation to First Dose|Adverse Event|0|||
144285568|NCT00669331|520248342|FG000|Randomisation to First Dose|Protocol Violation|1|||
144285569|NCT00669331|520248343|FG001|Randomisation to First Dose|Protocol Violation|0|||
144285570|NCT00669331|520248342|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
144285571|NCT00669331|520248343|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
144285572|NCT00669331|520248342|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
144285573|NCT00669331|520248343|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
144285574|NCT00669331|520248342|FG000|Randomisation to First Dose|Death|1|||
144285575|NCT00669331|520248343|FG001|Randomisation to First Dose|Death|0|||
144285576|NCT00669331|520248342|FG000|Randomisation to First Dose|Sponsor decision|0|||
144285577|NCT00669331|520248343|FG001|Randomisation to First Dose|Sponsor decision|1|||
144285578|NCT00669331|520248342|FG000|Randomisation to First Dose|Randomised in error|3|||
144285579|NCT00669331|520248343|FG001|Randomisation to First Dose|Randomised in error|10|||
144285580|NCT00669331|520248342|FG000|Blinded Treatment Period|Adverse Event|16|||
144285581|NCT00669331|520248343|FG001|Blinded Treatment Period|Adverse Event|10|||
144285582|NCT00669331|520248342|FG000|Blinded Treatment Period|Protocol Violation|1|||
144285583|NCT00669331|520248343|FG001|Blinded Treatment Period|Protocol Violation|1|||
144285584|NCT00669331|520248342|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
144285585|NCT00669331|520248343|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
144285586|NCT00669331|520248342|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
144285587|NCT00669331|520248343|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
144285588|NCT00669331|520248342|FG000|Blinded Treatment Period|Death|0|||
144285589|NCT00669331|520248343|FG001|Blinded Treatment Period|Death|2|||
144285590|NCT00669331|520248342|FG000|Blinded Treatment Period|Physician Decision|3|||
144285591|NCT00669331|520248343|FG001|Blinded Treatment Period|Physician Decision|3|||
144285592|NCT00669331|520248342|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
144285593|NCT00669331|520248343|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
144285594|NCT01454063|520248344|FG000|Randomized|Adverse Event|1|||
144285595|NCT01454063|520248345|FG001|Randomized|Adverse Event|1|||
144285596|NCT01454063|520248344|FG000|Randomized|Protocol Violation|0|||
144285597|NCT01454063|520248345|FG001|Randomized|Protocol Violation|1|||
144285598|NCT00509600|520248349|FG000|Overall Study|Adverse Event|1|||
144285599|NCT02568423|520248352|FG000|Overall Study|Lost to Follow-up|0|||
144285600|NCT02568423|520248353|FG001|Overall Study|Lost to Follow-up|2|||
144285601|NCT02568423|520248354|FG002|Overall Study|Lost to Follow-up|0|||
144285602|NCT02568423|520248355|FG003|Overall Study|Lost to Follow-up|0|||
144285603|NCT02568423|520248356|FG004|Overall Study|Lost to Follow-up|0|||
144285604|NCT02568423|520248357|FG005|Overall Study|Lost to Follow-up|0|||
144285605|NCT02568423|520248358|FG006|Overall Study|Lost to Follow-up|0|||
144285606|NCT02568423|520248359|FG007|Overall Study|Lost to Follow-up|0|||
144285607|NCT02568423|520248352|FG000|Overall Study|Physician Decision|0|||
144285608|NCT02568423|520248353|FG001|Overall Study|Physician Decision|0|||
144285609|NCT02568423|520248354|FG002|Overall Study|Physician Decision|0|||
144285610|NCT02568423|520248355|FG003|Overall Study|Physician Decision|0|||
144285611|NCT02568423|520248356|FG004|Overall Study|Physician Decision|0|||
144285612|NCT02568423|520248357|FG005|Overall Study|Physician Decision|1|||
144285613|NCT02568423|520248358|FG006|Overall Study|Physician Decision|0|||
144285614|NCT02568423|520248359|FG007|Overall Study|Physician Decision|0|||
144285615|NCT03794544|520248360|FG000|Overall Study|Withdrawal by Subject|1|||
144285616|NCT03794544|520248361|FG001|Overall Study|Withdrawal by Subject|1|||
144285617|NCT03794544|520248362|FG002|Overall Study|Withdrawal by Subject|0|||
144285618|NCT03794544|520248363|FG003|Overall Study|Withdrawal by Subject|0|||
144285619|NCT03794544|520248360|FG000|Overall Study|Death|0|||
144285620|NCT03794544|520248361|FG001|Overall Study|Death|0|||
144285621|NCT03794544|520248362|FG002|Overall Study|Death|0|||
144285622|NCT03794544|520248363|FG003|Overall Study|Death|1|||
144285623|NCT03794544|520248360|FG000|Overall Study|Lost to Follow-up|0|||
144285624|NCT03794544|520248361|FG001|Overall Study|Lost to Follow-up|1|||
144285625|NCT03794544|520248362|FG002|Overall Study|Lost to Follow-up|1|||
144285626|NCT03794544|520248363|FG003|Overall Study|Lost to Follow-up|0|||
144285627|NCT03794544|520248360|FG000|Overall Study|Other|0|||
144285628|NCT03794544|520248361|FG001|Overall Study|Other|1|||
144285629|NCT03794544|520248362|FG002|Overall Study|Other|0|||
144285630|NCT03794544|520248363|FG003|Overall Study|Other|0|||
144285631|NCT01027416|520248364|FG000|Overall Study|Withdrawal by Subject|0|||
144285632|NCT01027416|520248365|FG001|Overall Study|Withdrawal by Subject|1|||
144285633|NCT01027416|520248364|FG000|Overall Study|Physician Decision|1|||
144285634|NCT01027416|520248365|FG001|Overall Study|Physician Decision|4|||
144285635|NCT00120250|520248366|FG000|Overall Study|Lost to Follow-up|1|||
144285636|NCT00120250|520248367|FG001|Overall Study|Lost to Follow-up|1|||
144285637|NCT00120250|520248366|FG000|Overall Study|Protocol Violation|0|||
144285638|NCT00120250|520248367|FG001|Overall Study|Protocol Violation|1|||
144285639|NCT00720083|520248368|FG000|Overall Study|Ineligible|1|||
144285640|NCT00720083|520248369|FG001|Overall Study|Ineligible|2|||
144285641|NCT02056288|520248370|FG000|In-Hospital Data|Surgery cancelled|1|||
144285642|NCT02056288|520248371|FG001|In-Hospital Data|Surgery cancelled|0|||
144285643|NCT02056288|520248370|FG000|In-Hospital Data|Protocol Violation|3|||
144285644|NCT02056288|520248371|FG001|In-Hospital Data|Protocol Violation|0|||
144285645|NCT02056288|520248370|FG000|In-Hospital Data|Physician Decision|1|||
144285646|NCT02056288|520248371|FG001|In-Hospital Data|Physician Decision|0|||
144285647|NCT02056288|520248370|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
144285648|NCT02056288|520248371|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
144285649|NCT01441414|520248372|FG000|Overall Study|Participant died|9|||
144285650|NCT01441414|520248372|FG000|Overall Study|Other reasons|3|||
144285651|NCT01441414|520248372|FG000|Overall Study|Study terminated by sponsor|2|||
144285652|NCT01441414|520248372|FG000|Overall Study|Subject refused further follow-up|1|||
144285653|NCT01773889|520248373|FG000|Overall Study|lack of funding|2|||
144285654|NCT00500110|520248374|FG000|Overall Study|Withdrawal by Subject|3|||
144285655|NCT05156125|520248375|FG000|Overall Study|Lack of Efficacy|1|||
144285656|NCT05156125|520248376|FG001|Overall Study|Lack of Efficacy|1|||
144285657|NCT05156125|520248377|FG002|Overall Study|Lack of Efficacy|1|||
144285658|NCT05156125|520248375|FG000|Overall Study|Physician Decision|0|||
144285659|NCT05156125|520248376|FG001|Overall Study|Physician Decision|0|||
144285660|NCT05156125|520248377|FG002|Overall Study|Physician Decision|1|||
144285661|NCT05156125|520248375|FG000|Overall Study|Non-compliance|0|||
144285662|NCT05156125|520248376|FG001|Overall Study|Non-compliance|1|||
144285663|NCT05156125|520248377|FG002|Overall Study|Non-compliance|1|||
144285664|NCT05156125|520248375|FG000|Overall Study|Withdrawal by Subject|0|||
144285665|NCT05156125|520248376|FG001|Overall Study|Withdrawal by Subject|0|||
144285666|NCT05156125|520248377|FG002|Overall Study|Withdrawal by Subject|1|||
144285667|NCT05156125|520248375|FG000|Overall Study|Adverse Event|2|||
144285668|NCT05156125|520248376|FG001|Overall Study|Adverse Event|1|||
144285669|NCT05156125|520248377|FG002|Overall Study|Adverse Event|0|||
144285670|NCT03123588|520248380|FG000|Overall Study|Study Terminated by Sponsor|2|||
144285671|NCT03123588|520248381|FG001|Overall Study|Study Terminated by Sponsor|5|||
144285672|NCT03123588|520248380|FG000|Overall Study|Withdrawal by Subject|1|||
144285673|NCT03123588|520248381|FG001|Overall Study|Withdrawal by Subject|0|||
144285674|NCT03123588|520248380|FG000|Overall Study|Adverse Event|1|||
144285675|NCT03123588|520248381|FG001|Overall Study|Adverse Event|0|||
144285676|NCT03123588|520248380|FG000|Overall Study|Physician Decision|2|||
144285677|NCT03123588|520248381|FG001|Overall Study|Physician Decision|1|||
144285678|NCT01717859|520248383|FG000|Overall Study|Adverse Event|5|||
144285679|NCT01717859|520248383|FG000|Overall Study|Moved out of state|1|||
144285680|NCT01717859|520248383|FG000|Overall Study|Patient concerned about mental health|1|||
144285681|NCT01717859|520248383|FG000|Overall Study|Lost to Follow-up|1|||
144285682|NCT01717859|520248383|FG000|Overall Study|Withdrawal by Subject|2|||
144285683|NCT01623752|520248384|FG000|Phase 1 (78 Weeks)|No Data|249|||
144285684|NCT01623752|520248385|FG001|Phase 1 (78 Weeks)|No Data|66|||
144285685|NCT01623752|520248386|FG002|Phase 1 (78 Weeks)|No Data|2|||
144285686|NCT01623752|520248384|FG000|Phase 1 (78 Weeks)|Other|33|||
144285687|NCT01623752|520248385|FG001|Phase 1 (78 Weeks)|Other|20|||
144285688|NCT01623752|520248386|FG002|Phase 1 (78 Weeks)|Other|0|||
144285689|NCT01623752|520248384|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
144285690|NCT01623752|520248385|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
144285691|NCT01623752|520248386|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
144285692|NCT01623752|520248384|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
144285693|NCT01623752|520248385|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
144285694|NCT01623752|520248386|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
144285695|NCT01623752|520248384|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
144285696|NCT01623752|520248385|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
144285697|NCT01623752|520248386|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
144285698|NCT01623752|520248384|FG000|Phase 2 (78 Weeks)|Other|5|||
144285699|NCT01623752|520248385|FG001|Phase 2 (78 Weeks)|Other|1|||
144285700|NCT01623752|520248386|FG002|Phase 2 (78 Weeks)|Other|0|||
144285701|NCT01623752|520248384|FG000|Phase 2 (78 Weeks)|No Data|43|||
144285702|NCT01623752|520248385|FG001|Phase 2 (78 Weeks)|No Data|11|||
144285703|NCT01623752|520248386|FG002|Phase 2 (78 Weeks)|No Data|0|||
144285704|NCT01623752|520248384|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
144285705|NCT01623752|520248385|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
144285706|NCT01623752|520248386|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
144285707|NCT04389671|520248389|FG000|Overall Study|Death|7|||
144285708|NCT00899847|520248390|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
144285709|NCT02287025|520248391|FG000|Overall Study|Not treated|2|||
144285710|NCT02287025|520248392|FG001|Overall Study|Not treated|0|||
144285711|NCT02287025|520248391|FG000|Overall Study|Progression of disease|3|||
144285712|NCT02287025|520248392|FG001|Overall Study|Progression of disease|2|||
144285713|NCT02287025|520248391|FG000|Overall Study|Adverse Event|2|||
144285714|NCT02287025|520248392|FG001|Overall Study|Adverse Event|4|||
144285715|NCT02287025|520248391|FG000|Overall Study|Withdrawal by Subject|2|||
144285716|NCT02287025|520248392|FG001|Overall Study|Withdrawal by Subject|2|||
144285717|NCT02287025|520248391|FG000|Overall Study|Screening failed|1|||
144285718|NCT02287025|520248392|FG001|Overall Study|Screening failed|1|||
144285719|NCT04053452|520248393|FG000|Overall Study|Withdrawal by Subject|1|||
144285720|NCT04053452|520248394|FG001|Overall Study|Withdrawal by Subject|0|||
144285721|NCT04053452|520248393|FG000|Overall Study|Time restraint due to inpatient needs|1|||
144285722|NCT04053452|520248394|FG001|Overall Study|Time restraint due to inpatient needs|2|||
144285723|NCT01421134|520248395|FG000|Overall Study|Adverse Event|3|||
144285724|NCT01421134|520248396|FG001|Overall Study|Adverse Event|5|||
144285725|NCT01421134|520248395|FG000|Overall Study|Lack of Efficacy|2|||
144285726|NCT01421134|520248396|FG001|Overall Study|Lack of Efficacy|4|||
144285727|NCT01421134|520248395|FG000|Overall Study|Protocol Violation|0|||
144285728|NCT01421134|520248396|FG001|Overall Study|Protocol Violation|3|||
144285729|NCT01421134|520248395|FG000|Overall Study|Withdrawal by Subject|1|||
144285730|NCT01421134|520248396|FG001|Overall Study|Withdrawal by Subject|1|||
144285731|NCT01421134|520248395|FG000|Overall Study|Administrative|0|||
144285732|NCT01421134|520248396|FG001|Overall Study|Administrative|1|||
144285733|NCT01421134|520248395|FG000|Overall Study|Lost to Follow-up|1|||
144285734|NCT01421134|520248396|FG001|Overall Study|Lost to Follow-up|1|||
144285735|NCT02959892|520248397|FG000|Overall Study|PET tracer synthesis failure|1|||
144285736|NCT02959892|520248398|FG001|Overall Study|PET tracer synthesis failure|0|||
144285737|NCT02959892|520248397|FG000|Overall Study|Study termination|0|||
144285738|NCT02959892|520248398|FG001|Overall Study|Study termination|1|||
144285739|NCT03528577|520248399|FG000|Sequence 1|Failed Spirometry|1|||
144285740|NCT03528577|520248399|FG000|Sequence 1|Restricted medication|1|||
144285741|NCT03528577|520248399|FG000|Sequence 2|Adverse Event|1|||
144285742|NCT03528577|520248399|FG000|Sequence 2|Withdrawal by Subject|1|||
144285743|NCT03528577|520248399|FG000|Sequence 2|Failed Spirometry|1|||
144285744|NCT03528577|520248399|FG000|Sequence 3|Failed Spirometry|1|||
144285745|NCT03528577|520248399|FG000|Sequence 4|Failed Spirometry|2|||
144285746|NCT03528577|520248399|FG000|Sequence 4|Adverse Event|1|||
144285747|NCT00724893|520248400|FG000|Overall Study|Adverse Event|76|||
144285748|NCT00724893|520248401|FG001|Overall Study|Adverse Event|142|||
144285749|NCT00724893|520248400|FG000|Overall Study|Withdrawal by Subject|0|||
144285750|NCT00724893|520248401|FG001|Overall Study|Withdrawal by Subject|1|||
144285751|NCT00724893|520248400|FG000|Overall Study|Lack of virologic response|94|||
144285752|NCT00724893|520248401|FG001|Overall Study|Lack of virologic response|202|||
144285753|NCT00724893|520248400|FG000|Overall Study|Reason not specified|193|||
144285754|NCT00724893|520248401|FG001|Overall Study|Reason not specified|7|||
144285755|NCT00724893|520248400|FG000|Overall Study|Patient choice|0|||
144285756|NCT00724893|520248401|FG001|Overall Study|Patient choice|26|||
144285757|NCT00724893|520248400|FG000|Overall Study|Geographic reasons|0|||
144285758|NCT00724893|520248401|FG001|Overall Study|Geographic reasons|11|||
144285759|NCT00724893|520248400|FG000|Overall Study|Incarceration|0|||
144285760|NCT00724893|520248401|FG001|Overall Study|Incarceration|9|||
144285761|NCT00724893|520248400|FG000|Overall Study|Substance abuse|0|||
144285762|NCT00724893|520248401|FG001|Overall Study|Substance abuse|3|||
144285763|NCT00724893|520248400|FG000|Overall Study|Financial reasons|0|||
144285764|NCT00724893|520248401|FG001|Overall Study|Financial reasons|2|||
144285765|NCT00724893|520248400|FG000|Overall Study|Assigned shorter treatment|0|||
144285766|NCT00724893|520248401|FG001|Overall Study|Assigned shorter treatment|2|||
144285767|NCT00724893|520248400|FG000|Overall Study|Lost to Follow-up|0|||
144285768|NCT00724893|520248401|FG001|Overall Study|Lost to Follow-up|52|||
144285769|NCT00724893|520248400|FG000|Overall Study|Unknown, missing data|1|||
144285770|NCT00724893|520248401|FG001|Overall Study|Unknown, missing data|1|||
144285771|NCT01279200|520248402|FG000|Overall Study|Withdrawal by Subject|1|||
144285772|NCT01279200|520248403|FG001|Overall Study|Withdrawal by Subject|3|||
144285773|NCT01279200|520248402|FG000|Overall Study|Patient withdrawal due to high cost|0|||
144285774|NCT01279200|520248403|FG001|Overall Study|Patient withdrawal due to high cost|1|||
144285775|NCT01279200|520248402|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
144285776|NCT01279200|520248403|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
144285777|NCT01279200|520248402|FG000|Overall Study|ultrasound screening failure|0|||
144285778|NCT01279200|520248403|FG001|Overall Study|ultrasound screening failure|1|||
144285779|NCT01279200|520248402|FG000|Overall Study|Lost to Follow-up|0|||
144285780|NCT01279200|520248403|FG001|Overall Study|Lost to Follow-up|1|||
144285781|NCT01279200|520248402|FG000|Overall Study|Adverse Event|1|||
144285782|NCT01279200|520248403|FG001|Overall Study|Adverse Event|0|||
144285783|NCT01399099|520248404|FG000|Overall Study|Lost to Follow-up|14|||
144285784|NCT01399099|520248404|FG000|Overall Study|Physician Decision|1|||
144285785|NCT01399099|520248404|FG000|Overall Study|Protocol Violation|1|||
144285786|NCT01399099|520248404|FG000|Overall Study|Skin Irritation|13|||
144285787|NCT01399099|520248404|FG000|Overall Study|Infection|1|||
144285788|NCT01399099|520248404|FG000|Overall Study|Miscellaneous|4|||
144285789|NCT00629239|520248409|FG000|Overall Study|Adverse Event|7|||
144285790|NCT00629239|520248410|FG001|Overall Study|Adverse Event|4|||
144285791|NCT00629239|520248409|FG000|Overall Study|Physician Decision|1|||
144285792|NCT00629239|520248410|FG001|Overall Study|Physician Decision|0|||
144285793|NCT01181128|520248411|FG000|Overall Study|Withdrawal by Subject|2|||
144285794|NCT01181128|520248412|FG001|Overall Study|Withdrawal by Subject|2|||
144285795|NCT01181128|520248413|FG002|Overall Study|Withdrawal by Subject|0|||
144285796|NCT01181128|520248411|FG000|Overall Study|Death|1|||
144285797|NCT01181128|520248412|FG001|Overall Study|Death|0|||
144285798|NCT01181128|520248413|FG002|Overall Study|Death|0|||
144285799|NCT01181128|520248411|FG000|Overall Study|Physician Decision|2|||
144285800|NCT01181128|520248412|FG001|Overall Study|Physician Decision|0|||
144285801|NCT01181128|520248413|FG002|Overall Study|Physician Decision|0|||
144285802|NCT01181128|520248411|FG000|Overall Study|Adverse Event|0|||
144285803|NCT01181128|520248412|FG001|Overall Study|Adverse Event|2|||
144285804|NCT01181128|520248413|FG002|Overall Study|Adverse Event|0|||
144285805|NCT01181128|520248411|FG000|Overall Study|Other|1|||
144285806|NCT01181128|520248412|FG001|Overall Study|Other|1|||
144285807|NCT01181128|520248413|FG002|Overall Study|Other|1|||
144285808|NCT00183391|520248416|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
144285809|NCT00183391|520248417|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
144285810|NCT00183391|520248416|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
144285811|NCT00183391|520248417|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
144285812|NCT01543503|520248418|FG000|Overall Study|Lost to Follow-up|32|||
144285813|NCT01543503|520248419|FG001|Overall Study|Lost to Follow-up|36|||
144285814|NCT01543503|520248418|FG000|Overall Study|Adverse Event|9|||
144285815|NCT01543503|520248419|FG001|Overall Study|Adverse Event|13|||
144285816|NCT01543503|520248418|FG000|Overall Study|Lack of Efficacy|4|||
144285817|NCT01543503|520248419|FG001|Overall Study|Lack of Efficacy|16|||
144285818|NCT01543503|520248418|FG000|Overall Study|Participant withdrew informed consent|8|||
144285819|NCT01543503|520248419|FG001|Overall Study|Participant withdrew informed consent|10|||
144285820|NCT01543503|520248418|FG000|Overall Study|Change of jobs|0|||
144285821|NCT01543503|520248419|FG001|Overall Study|Change of jobs|1|||
144285822|NCT01543503|520248418|FG000|Overall Study|Intolerance to the biologic treatment|0|||
144285823|NCT01543503|520248419|FG001|Overall Study|Intolerance to the biologic treatment|1|||
144285824|NCT01543503|520248418|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
144285825|NCT01543503|520248419|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
144285826|NCT01543503|520248418|FG000|Overall Study|Participant did not complete last visit|0|||
144285827|NCT01543503|520248419|FG001|Overall Study|Participant did not complete last visit|2|||
144285828|NCT01543503|520248418|FG000|Overall Study|Refused to continue treatment|7|||
144285829|NCT01543503|520248419|FG001|Overall Study|Refused to continue treatment|0|||
144285830|NCT01543503|520248418|FG000|Overall Study|Incorrect medication received|1|||
144285831|NCT01543503|520248419|FG001|Overall Study|Incorrect medication received|0|||
144285832|NCT01543503|520248418|FG000|Overall Study|Participant moved to another city|2|||
144285833|NCT01543503|520248419|FG001|Overall Study|Participant moved to another city|0|||
144285834|NCT01543503|520248418|FG000|Overall Study|Participant will not return for visits|0|||
144285835|NCT01543503|520248419|FG001|Overall Study|Participant will not return for visits|2|||
144285836|NCT01543503|520248418|FG000|Overall Study|Participant transferred to another city|1|||
144285837|NCT01543503|520248419|FG001|Overall Study|Participant transferred to another city|0|||
144285838|NCT01543503|520248418|FG000|Overall Study|Participant moved to Scotland|1|||
144285839|NCT01543503|520248419|FG001|Overall Study|Participant moved to Scotland|0|||
144285840|NCT01543503|520248418|FG000|Overall Study|Participant decision to stop treatment|1|||
144285841|NCT01543503|520248419|FG001|Overall Study|Participant decision to stop treatment|0|||
144285842|NCT01543503|520248418|FG000|Overall Study|Investigator did not wish to participate|1|||
144285843|NCT01543503|520248419|FG001|Overall Study|Investigator did not wish to participate|1|||
144285844|NCT01543503|520248418|FG000|Overall Study|Participant recruited after closing date|0|||
144285845|NCT01543503|520248419|FG001|Overall Study|Participant recruited after closing date|1|||
144285846|NCT01543503|520248418|FG000|Overall Study|Site stopped participation|5|||
144285847|NCT01543503|520248419|FG001|Overall Study|Site stopped participation|1|||
144285848|NCT01543503|520248418|FG000|Overall Study|Participant did not attend a visit|1|||
144285849|NCT01543503|520248419|FG001|Overall Study|Participant did not attend a visit|0|||
144285850|NCT01543503|520248418|FG000|Overall Study|Moved to other rheumatologic site|0|||
144285851|NCT01543503|520248419|FG001|Overall Study|Moved to other rheumatologic site|1|||
144285852|NCT01543503|520248418|FG000|Overall Study|Participant consented to another study|0|||
144285853|NCT01543503|520248419|FG001|Overall Study|Participant consented to another study|2|||
144285854|NCT01543503|520248418|FG000|Overall Study|Participant went to United States|1|||
144285855|NCT01543503|520248419|FG001|Overall Study|Participant went to United States|0|||
144285856|NCT01543503|520248418|FG000|Overall Study|Screen failure|1|||
144285857|NCT01543503|520248419|FG001|Overall Study|Screen failure|0|||
144285858|NCT02460380|520248420|FG000|Overall Study|Withdrawal by Subject|10|||
144285859|NCT02460380|520248421|FG001|Overall Study|Withdrawal by Subject|5|||
144285860|NCT00052715|520248425|FG000|Overall Study|wrong histology|1|||
144285861|NCT01936974|520248426|FG000|Overall Study|Physician Decision|2|||
144285862|NCT01936974|520248427|FG001|Overall Study|Physician Decision|5|||
144285863|NCT02807181|520248428|FG000|Overall Study|Death|28|||
144285864|NCT02807181|520248429|FG001|Overall Study|Death|24|||
144285865|NCT02807181|520248428|FG000|Overall Study|Withdrawal by Subject|1|||
144285866|NCT02807181|520248429|FG001|Overall Study|Withdrawal by Subject|1|||
144285867|NCT02807181|520248428|FG000|Overall Study|Lost to Follow-up|0|||
144285868|NCT02807181|520248429|FG001|Overall Study|Lost to Follow-up|2|||
144285869|NCT02807181|520248428|FG000|Overall Study|Subject decision|1|||
144285870|NCT02807181|520248429|FG001|Overall Study|Subject decision|0|||
144285871|NCT02807181|520248428|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
144285872|NCT02807181|520248429|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
144285873|NCT02807181|520248428|FG000|Overall Study|In Study|3|||
144285874|NCT02807181|520248429|FG001|Overall Study|In Study|3|||
144285875|NCT02807181|520248428|FG000|Overall Study|Post Progression|3|||
144285876|NCT02807181|520248429|FG001|Overall Study|Post Progression|2|||
144285877|NCT05507450|520248431|FG000|Overall Study|Death|0|||
144285878|NCT05507450|520248432|FG001|Overall Study|Death|0|||
144285879|NCT05507450|520248433|FG002|Overall Study|Death|1|||
144285880|NCT05507450|520248434|FG003|Overall Study|Death|0|||
144285881|NCT05507450|520248431|FG000|Overall Study|Lost to Follow-up|22|||
144285882|NCT05507450|520248432|FG001|Overall Study|Lost to Follow-up|20|||
144285883|NCT05507450|520248433|FG002|Overall Study|Lost to Follow-up|20|||
144285884|NCT05507450|520248434|FG003|Overall Study|Lost to Follow-up|7|||
144285885|NCT05507450|520248431|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144285886|NCT05507450|520248432|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
144285887|NCT05507450|520248433|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144285888|NCT05507450|520248434|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144285889|NCT05507450|520248431|FG000|Overall Study|Withdrawal by Subject|4|||
144285890|NCT05507450|520248432|FG001|Overall Study|Withdrawal by Subject|11|||
144285891|NCT05507450|520248433|FG002|Overall Study|Withdrawal by Subject|7|||
144285892|NCT05507450|520248434|FG003|Overall Study|Withdrawal by Subject|3|||
144285893|NCT05507450|520248431|FG000|Overall Study|Participant left the country|0|||
144285894|NCT05507450|520248432|FG001|Overall Study|Participant left the country|0|||
144285895|NCT05507450|520248433|FG002|Overall Study|Participant left the country|1|||
144285896|NCT05507450|520248434|FG003|Overall Study|Participant left the country|0|||
144285897|NCT01078545|520248435|FG000|Overall Study|Lost to Follow-up|13|||
144285898|NCT01078545|520248435|FG000|Overall Study|Physician Decision|6|||
144285899|NCT01078545|520248435|FG000|Overall Study|Withdrawal by Subject|3|||
144285900|NCT01078545|520248435|FG000|Overall Study|Death|3|||
144285901|NCT01078545|520248435|FG000|Overall Study|Participant moved to another physician|1|||
144285902|NCT02497755|520248436|FG000|Overall Study|Protocol Violation|1|||
144285903|NCT02497755|520248437|FG001|Overall Study|Protocol Violation|0|||
144285904|NCT01774370|520248438|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
144285905|NCT01774370|520248438|FG000|Overall Study|Administered prior to the contract date|4|||
144285906|NCT01774370|520248438|FG000|Overall Study|Subjects of contraindications|34|||
144285907|NCT01774370|520248438|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
144285908|NCT01774370|520248438|FG000|Overall Study|Follow-up failure|34|||
144285909|NCT05436288|520248439|FG000|Overall Study|Lost to Follow-up|1|||
144285910|NCT05436288|520248439|FG000|Overall Study|Adverse Event|1|||
144285911|NCT02280499|520248445|FG000|Overall Study|Death|14|||
144285912|NCT02280499|520248445|FG000|Overall Study|Lost to Follow-up|42|||
144285913|NCT02280499|520248445|FG000|Overall Study|Adverse Event|5|||
144285914|NCT01436500|520248446|FG000|Overall Study|Death|1|||
144285915|NCT01436500|520248447|FG001|Overall Study|Death|0|||
144285916|NCT01436500|520248448|FG002|Overall Study|Death|0|||
144285917|NCT01436500|520248449|FG003|Overall Study|Death|0|||
144285918|NCT01436500|520248450|FG004|Overall Study|Death|0|||
144285919|NCT01436500|520248446|FG000|Overall Study|Adverse Event|0|||
144285920|NCT01436500|520248447|FG001|Overall Study|Adverse Event|2|||
144285921|NCT01436500|520248448|FG002|Overall Study|Adverse Event|2|||
144285922|NCT01436500|520248449|FG003|Overall Study|Adverse Event|0|||
144285923|NCT01436500|520248450|FG004|Overall Study|Adverse Event|1|||
144285924|NCT01436500|520248446|FG000|Overall Study|Withdrawal by Subject|0|||
144285925|NCT01436500|520248447|FG001|Overall Study|Withdrawal by Subject|0|||
144285926|NCT01436500|520248448|FG002|Overall Study|Withdrawal by Subject|2|||
144285927|NCT01436500|520248449|FG003|Overall Study|Withdrawal by Subject|0|||
144285928|NCT01436500|520248450|FG004|Overall Study|Withdrawal by Subject|2|||
144285929|NCT01436500|520248446|FG000|Overall Study|Physician Decision|0|||
144285930|NCT01436500|520248447|FG001|Overall Study|Physician Decision|0|||
144285931|NCT01436500|520248448|FG002|Overall Study|Physician Decision|1|||
144285932|NCT01436500|520248449|FG003|Overall Study|Physician Decision|0|||
144285933|NCT01436500|520248450|FG004|Overall Study|Physician Decision|0|||
144285934|NCT01436500|520248446|FG000|Overall Study|liver transplant|1|||
144285935|NCT01436500|520248447|FG001|Overall Study|liver transplant|0|||
144285936|NCT01436500|520248448|FG002|Overall Study|liver transplant|0|||
144285937|NCT01436500|520248449|FG003|Overall Study|liver transplant|0|||
144285938|NCT01436500|520248450|FG004|Overall Study|liver transplant|0|||
144285939|NCT01436500|520248446|FG000|Overall Study|initiation of dialysis|0|||
144285940|NCT01436500|520248447|FG001|Overall Study|initiation of dialysis|0|||
144285941|NCT01436500|520248448|FG002|Overall Study|initiation of dialysis|0|||
144285942|NCT01436500|520248449|FG003|Overall Study|initiation of dialysis|0|||
144285943|NCT01436500|520248450|FG004|Overall Study|initiation of dialysis|1|||
144285944|NCT01436500|520248446|FG000|Overall Study|discontinued study drug|1|||
144285945|NCT01436500|520248447|FG001|Overall Study|discontinued study drug|0|||
144285946|NCT01436500|520248448|FG002|Overall Study|discontinued study drug|0|||
144285947|NCT01436500|520248449|FG003|Overall Study|discontinued study drug|0|||
144285948|NCT01436500|520248450|FG004|Overall Study|discontinued study drug|0|||
144285949|NCT01436500|520248446|FG000|Overall Study|Other|0|||
144285950|NCT01436500|520248447|FG001|Overall Study|Other|1|||
144285951|NCT01436500|520248448|FG002|Overall Study|Other|0|||
144285952|NCT01436500|520248449|FG003|Overall Study|Other|1|||
144285953|NCT01436500|520248450|FG004|Overall Study|Other|0|||
144285954|NCT01663987|520248459|FG000|Overall Study|Adverse Event|7|||
144285955|NCT01663987|520248460|FG001|Overall Study|Adverse Event|2|||
144285956|NCT01663987|520248459|FG000|Overall Study|Lost to Follow-up|1|||
144285957|NCT01663987|520248460|FG001|Overall Study|Lost to Follow-up|1|||
144285958|NCT01663987|520248459|FG000|Overall Study|Withdrawal by Subject|2|||
144285959|NCT01663987|520248460|FG001|Overall Study|Withdrawal by Subject|3|||
144285960|NCT01663987|520248459|FG000|Overall Study|Other reason not defined above|3|||
144285961|NCT01663987|520248460|FG001|Overall Study|Other reason not defined above|0|||
144285962|NCT03808909|520248465|FG000|Overall Study|Lost to Follow-up|3|||
144285963|NCT03808909|520248466|FG001|Overall Study|Lost to Follow-up|0|||
144285964|NCT00356421|520248467|FG000|Overall Study|Lack of Efficacy|3|||
144285965|NCT00356421|520248468|FG001|Overall Study|Lack of Efficacy|0|||
144285966|NCT00356421|520248467|FG000|Overall Study|Withdrawal by Subject|9|||
144285967|NCT00356421|520248468|FG001|Overall Study|Withdrawal by Subject|2|||
144285968|NCT00356421|520248467|FG000|Overall Study|Related to study drug|15|||
144285969|NCT00356421|520248468|FG001|Overall Study|Related to study drug|12|||
144285970|NCT00356421|520248467|FG000|Overall Study|Not related to study drug|5|||
144285971|NCT00356421|520248468|FG001|Overall Study|Not related to study drug|3|||
144285972|NCT01487161|520248469|FG000|Overall Study|Adverse Event|1|||
144285973|NCT01487161|520248470|FG001|Overall Study|Adverse Event|0|||
144285974|NCT01487161|520248471|FG002|Overall Study|Adverse Event|0|||
144285975|NCT01487161|520248472|FG003|Overall Study|Adverse Event|0|||
144285976|NCT01487161|520248469|FG000|Overall Study|Withdrawal by Subject|1|||
144285977|NCT01487161|520248470|FG001|Overall Study|Withdrawal by Subject|1|||
144285978|NCT01487161|520248471|FG002|Overall Study|Withdrawal by Subject|1|||
144285979|NCT01487161|520248472|FG003|Overall Study|Withdrawal by Subject|2|||
144285980|NCT01487161|520248469|FG000|Overall Study|missing data|0|||
144285981|NCT01487161|520248470|FG001|Overall Study|missing data|1|||
144285982|NCT01487161|520248471|FG002|Overall Study|missing data|0|||
144285983|NCT01487161|520248472|FG003|Overall Study|missing data|0|||
144285984|NCT01030900|520248473|FG000|Overall Study|Not treated due to congestive heart failure|1|||
144285985|NCT01030900|520248473|FG000|Overall Study|Not treated due to rapid disease|1|||
144285986|NCT01179399|520248474|FG000|Overall Study|Adverse Event|1|||
144285987|NCT01179399|520248474|FG000|Overall Study|Lack of Efficacy|30|||
144285988|NCT01179399|520248474|FG000|Overall Study|Withdrawal by Subject|1|||
144285989|NCT00441896|520248475|FG000|Overall Study|Withdrawal by Subject|0|||
144285990|NCT00441896|520248476|FG001|Overall Study|Withdrawal by Subject|0|||
144285991|NCT00441896|520248477|FG002|Overall Study|Withdrawal by Subject|0|||
144285992|NCT00441896|520248478|FG003|Overall Study|Withdrawal by Subject|1|||
144285993|NCT00441896|520248479|FG004|Overall Study|Withdrawal by Subject|0|||
144285994|NCT00441896|520248480|FG005|Overall Study|Withdrawal by Subject|0|||
144285995|NCT00441896|520248481|FG006|Overall Study|Withdrawal by Subject|0|||
144285996|NCT00441896|520248482|FG007|Overall Study|Withdrawal by Subject|0|||
144285997|NCT00441896|520248483|FG008|Overall Study|Withdrawal by Subject|0|||
144285998|NCT00441896|520248484|FG009|Overall Study|Withdrawal by Subject|0|||
144285999|NCT00441896|520248475|FG000|Overall Study|Other|0|||
144286000|NCT00441896|520248476|FG001|Overall Study|Other|0|||
144286001|NCT00441896|520248477|FG002|Overall Study|Other|0|||
144286002|NCT00441896|520248478|FG003|Overall Study|Other|0|||
144286003|NCT00441896|520248479|FG004|Overall Study|Other|1|||
144286004|NCT00441896|520248480|FG005|Overall Study|Other|0|||
144286005|NCT00441896|520248481|FG006|Overall Study|Other|0|||
144286006|NCT00441896|520248482|FG007|Overall Study|Other|0|||
144286007|NCT00441896|520248483|FG008|Overall Study|Other|0|||
144286008|NCT00441896|520248484|FG009|Overall Study|Other|0|||
144286009|NCT03882801|520250904|FG000|Period 1|Adverse Event|0|||
144286010|NCT03882801|520250905|FG001|Period 1|Adverse Event|1|||
144286011|NCT03882801|520250904|FG000|Period 1|Non-compliance with study drug|1|||
144286012|NCT03882801|520250905|FG001|Period 1|Non-compliance with study drug|1|||
144286013|NCT03882801|520250904|FG000|Period 1|Never treated with study drug|1|||
144286014|NCT03882801|520250905|FG001|Period 1|Never treated with study drug|0|||
144286015|NCT03882801|520250904|FG000|Washout Period|Physician Decision|0|||
144286016|NCT03882801|520250905|FG001|Washout Period|Physician Decision|1|||
144286017|NCT03882801|520250904|FG000|Period 2|Non-compliance with study drug|0|||
144286018|NCT03882801|520250905|FG001|Period 2|Non-compliance with study drug|1|||
144286019|NCT04193176|520250906|FG000|Overall Study|Withdrawal by Subject|6|||
144286020|NCT04193176|520250907|FG001|Overall Study|Withdrawal by Subject|10|||
144286021|NCT00944645|520250908|FG000|Period 2|Adverse Event|1|||
144286022|NCT00944645|520250909|FG001|Period 2|Adverse Event|0|||
144286023|NCT00944645|520250908|FG000|Period 2|Lost to Follow-up|0|||
144286024|NCT00944645|520250909|FG001|Period 2|Lost to Follow-up|3|||
144286025|NCT00944645|520250908|FG000|Period 2|Withdrawal by Subject|7|||
144286026|NCT00944645|520250909|FG001|Period 2|Withdrawal by Subject|6|||
144286027|NCT03928704|520250913|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
144286028|NCT03928704|520250914|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
144286029|NCT03928704|520250915|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
144286030|NCT03928704|520250916|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
144286031|NCT03928704|520250917|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
144286032|NCT03928704|520250918|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
144286033|NCT03928704|520250913|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
144286034|NCT03928704|520250914|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
144286035|NCT03928704|520250915|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
144286036|NCT03928704|520250916|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
144286037|NCT03928704|520250917|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
144286038|NCT03928704|520250918|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
144245865|NCT03191864|520096256|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
144245866|NCT03191864|520096257|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
144245867|NCT03191864|520096258|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
144245868|NCT03191864|520096259|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
144245869|NCT03191864|520096260|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
144245870|NCT03191864|520096261|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
144245871|NCT03191864|520096256|FG000|Part 2 - Maintenance|Physician Decision|1|||
144245872|NCT03191864|520096257|FG001|Part 2 - Maintenance|Physician Decision|0|||
144245873|NCT03191864|520096258|FG002|Part 2 - Maintenance|Physician Decision|0|||
144245874|NCT03191864|520096259|FG003|Part 2 - Maintenance|Physician Decision|0|||
144245875|NCT03191864|520096260|FG004|Part 2 - Maintenance|Physician Decision|0|||
144245876|NCT03191864|520096261|FG005|Part 2 - Maintenance|Physician Decision|0|||
144245877|NCT03191864|520096256|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
144245878|NCT03191864|520096257|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
144245879|NCT03191864|520096258|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
144245880|NCT03191864|520096259|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
144245881|NCT03191864|520096260|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
144245882|NCT03191864|520096261|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
144245883|NCT03191864|520096256|FG000|Part 2 - Maintenance|Adverse Event|0|||
144245884|NCT03191864|520096257|FG001|Part 2 - Maintenance|Adverse Event|0|||
144245885|NCT03191864|520096258|FG002|Part 2 - Maintenance|Adverse Event|0|||
144245886|NCT03191864|520096259|FG003|Part 2 - Maintenance|Adverse Event|0|||
144245887|NCT03191864|520096260|FG004|Part 2 - Maintenance|Adverse Event|1|||
144245888|NCT03191864|520096261|FG005|Part 2 - Maintenance|Adverse Event|0|||
144245889|NCT03191864|520096256|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
144245890|NCT03191864|520096257|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
144245891|NCT03191864|520096258|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
144245892|NCT03191864|520096259|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
144245893|NCT03191864|520096260|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
144245894|NCT03191864|520096261|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
144245895|NCT03191864|520096256|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
144245896|NCT03191864|520096257|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
144245897|NCT03191864|520096258|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
144245898|NCT03191864|520096259|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
144245899|NCT03191864|520096260|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
144245900|NCT03191864|520096261|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
144245901|NCT05072964|520096262|FG000|Overall Study|Withdrawal by Subject|4|||
144245902|NCT05072964|520096262|FG000|Overall Study|Death|1|||
144245903|NCT03800836|520096266|FG000|Overall Study|Other|2|||
144245904|NCT03800836|520096267|FG001|Overall Study|Other|1|||
144245905|NCT03800836|520096268|FG002|Overall Study|Other|0|||
144245906|NCT03800836|520096269|FG003|Overall Study|Other|2|||
144245907|NCT03800836|520096270|FG004|Overall Study|Other|0|||
144245908|NCT03800836|520096271|FG005|Overall Study|Other|1|||
144245909|NCT03800836|520096266|FG000|Overall Study|Lost to Follow-up|2|||
144245910|NCT03800836|520096267|FG001|Overall Study|Lost to Follow-up|0|||
144245911|NCT03800836|520096268|FG002|Overall Study|Lost to Follow-up|1|||
144245912|NCT03800836|520096269|FG003|Overall Study|Lost to Follow-up|1|||
144245913|NCT03800836|520096270|FG004|Overall Study|Lost to Follow-up|3|||
144245914|NCT03800836|520096271|FG005|Overall Study|Lost to Follow-up|0|||
144245915|NCT03800836|520096266|FG000|Overall Study|Withdrawal by Subject|1|||
144245916|NCT03800836|520096267|FG001|Overall Study|Withdrawal by Subject|0|||
144245917|NCT03800836|520096268|FG002|Overall Study|Withdrawal by Subject|0|||
144245918|NCT03800836|520096269|FG003|Overall Study|Withdrawal by Subject|0|||
144245919|NCT03800836|520096270|FG004|Overall Study|Withdrawal by Subject|0|||
144245920|NCT03800836|520096271|FG005|Overall Study|Withdrawal by Subject|0|||
144245921|NCT03800836|520096266|FG000|Overall Study|Physician Decision|31|||
144245922|NCT03800836|520096267|FG001|Overall Study|Physician Decision|3|||
144245923|NCT03800836|520096268|FG002|Overall Study|Physician Decision|6|||
144245924|NCT03800836|520096269|FG003|Overall Study|Physician Decision|4|||
144245925|NCT03800836|520096270|FG004|Overall Study|Physician Decision|4|||
144245926|NCT03800836|520096271|FG005|Overall Study|Physician Decision|5|||
144245927|NCT03800836|520096266|FG000|Overall Study|Death|34|||
144245928|NCT03800836|520096267|FG001|Overall Study|Death|16|||
144245929|NCT03800836|520096268|FG002|Overall Study|Death|5|||
144245930|NCT03800836|520096269|FG003|Overall Study|Death|5|||
144245931|NCT03800836|520096270|FG004|Overall Study|Death|10|||
144245932|NCT03800836|520096271|FG005|Overall Study|Death|0|||
144245933|NCT03800836|520096266|FG000|Overall Study|Symptomatic Deterioration|1|||
144286039|NCT03928704|520250913|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
144286040|NCT03928704|520250914|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
144286041|NCT03928704|520250915|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
144286042|NCT03928704|520250916|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
144286043|NCT03928704|520250917|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
144286044|NCT03928704|520250918|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
144286045|NCT03928704|520250913|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
144286046|NCT03928704|520250914|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
144286047|NCT03928704|520250915|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
144286048|NCT03928704|520250916|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
144286049|NCT03928704|520250917|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
144286050|NCT03928704|520250918|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
144286051|NCT03928704|520250913|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
144286052|NCT03928704|520250914|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
144286053|NCT03928704|520250915|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
144286054|NCT03928704|520250916|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
144286055|NCT03928704|520250917|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
144286056|NCT03928704|520250918|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
144286057|NCT03928704|520250913|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
144286058|NCT03928704|520250914|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
144286059|NCT03928704|520250915|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
144286060|NCT03928704|520250916|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
144286061|NCT03928704|520250917|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
144286062|NCT03928704|520250918|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
144286063|NCT03928704|520250913|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
144286064|NCT03928704|520250914|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
144286065|NCT03928704|520250915|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
144286066|NCT03928704|520250916|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
144286067|NCT03928704|520250917|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
144286068|NCT03928704|520250918|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
144286069|NCT03928704|520250913|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
144286070|NCT03928704|520250914|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
144286071|NCT03928704|520250915|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
144286072|NCT03928704|520250916|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
144286073|NCT03928704|520250917|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
144286074|NCT03928704|520250918|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
144286075|NCT03928704|520250913|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
144286076|NCT03928704|520250914|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
144286077|NCT03928704|520250915|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
144286078|NCT03928704|520250916|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
144286079|NCT03928704|520250917|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
144286080|NCT03928704|520250918|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
144286081|NCT03928704|520250913|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
144286082|NCT03928704|520250914|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
144286083|NCT03928704|520250915|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
144286084|NCT03928704|520250916|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
144286085|NCT03928704|520250917|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
144286086|NCT03928704|520250918|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
144286087|NCT01245751|520250923|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
144286088|NCT01245751|520250924|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
144286089|NCT01245751|520250925|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
144286090|NCT01245751|520250926|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
144286091|NCT01245751|520250923|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
144286092|NCT01245751|520250924|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
144286093|NCT01245751|520250925|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
144286094|NCT01245751|520250926|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
144286095|NCT01245751|520250923|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
144286096|NCT01245751|520250924|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
144286097|NCT01245751|520250925|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
144286098|NCT01245751|520250926|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
144286099|NCT02181621|520250927|FG000|Overall Study|Adverse Event|1|||
144286100|NCT02181621|520250928|FG001|Overall Study|Adverse Event|0|||
144286101|NCT02181621|520250927|FG000|Overall Study|Previously Enrolled|0|||
144286102|NCT02181621|520250928|FG001|Overall Study|Previously Enrolled|1|||
144286103|NCT02181621|520250927|FG000|Overall Study|Enrollment Hold|1|||
144286104|NCT02181621|520250928|FG001|Overall Study|Enrollment Hold|1|||
144286105|NCT00289978|520250932|FG000|Overall Study|Withdrawal by Subject|31|||
144286106|NCT00289978|520250933|FG001|Overall Study|Withdrawal by Subject|17|||
144286107|NCT00289978|520250934|FG002|Overall Study|Withdrawal by Subject|28|||
144286108|NCT00289978|520250932|FG000|Overall Study|Adverse Event|22|||
144286109|NCT00289978|520250933|FG001|Overall Study|Adverse Event|13|||
144286110|NCT00289978|520250934|FG002|Overall Study|Adverse Event|18|||
144286111|NCT00289978|520250932|FG000|Overall Study|Lack of Efficacy|13|||
144286112|NCT00289978|520250933|FG001|Overall Study|Lack of Efficacy|6|||
144286113|NCT00289978|520250934|FG002|Overall Study|Lack of Efficacy|25|||
144286114|NCT00289978|520250932|FG000|Overall Study|Abnormal laboratory value(s)|20|||
144286115|NCT00289978|520250933|FG001|Overall Study|Abnormal laboratory value(s)|9|||
144286116|NCT00289978|520250934|FG002|Overall Study|Abnormal laboratory value(s)|1|||
144286117|NCT00289978|520250932|FG000|Overall Study|Lost to Follow-up|3|||
144286118|NCT00289978|520250933|FG001|Overall Study|Lost to Follow-up|5|||
144286119|NCT00289978|520250934|FG002|Overall Study|Lost to Follow-up|7|||
144286120|NCT00289978|520250932|FG000|Overall Study|Protocol Violation|5|||
144286121|NCT00289978|520250933|FG001|Overall Study|Protocol Violation|5|||
144286122|NCT00289978|520250934|FG002|Overall Study|Protocol Violation|4|||
144286123|NCT00289978|520250932|FG000|Overall Study|Abnormal test procedure result(s)|2|||
144286124|NCT00289978|520250933|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144286125|NCT00289978|520250934|FG002|Overall Study|Abnormal test procedure result(s)|1|||
144286126|NCT00289978|520250932|FG000|Overall Study|Death|1|||
144286127|NCT00289978|520250933|FG001|Overall Study|Death|0|||
144286128|NCT00289978|520250934|FG002|Overall Study|Death|2|||
144286129|NCT01524705|520250935|FG000|Overall Study|Adverse Event|2|||
144286130|NCT01524705|520250936|FG001|Overall Study|Adverse Event|0|||
144286131|NCT01524705|520250935|FG000|Overall Study|Death|1|||
144286132|NCT01524705|520250936|FG001|Overall Study|Death|0|||
144286133|NCT01524705|520250935|FG000|Overall Study|Lost to Follow-up|0|||
144286134|NCT01524705|520250936|FG001|Overall Study|Lost to Follow-up|1|||
144286135|NCT01524705|520250935|FG000|Overall Study|Withdrawal by Subject|0|||
144286136|NCT01524705|520250936|FG001|Overall Study|Withdrawal by Subject|1|||
144286137|NCT01524705|520250935|FG000|Overall Study|Pancreatic Cancer|0|||
144286138|NCT01524705|520250936|FG001|Overall Study|Pancreatic Cancer|1|||
144286139|NCT03055221|520250937|FG000|Overall Study|Adverse Event|2|||
144286140|NCT03055221|520250937|FG000|Overall Study|Withdrawal by Subject|4|||
144286141|NCT03055221|520250937|FG000|Overall Study|Death|6|||
144286142|NCT03055221|520250937|FG000|Overall Study|Physician Decision|1|||
144286143|NCT03055221|520250937|FG000|Overall Study|Study terminated by Sponsor|3|||
144286144|NCT03055221|520250937|FG000|Overall Study|Lost to Follow-up|4|||
144286145|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
144286146|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
144286147|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
144286148|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
144286149|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
144286150|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
144286151|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
144286152|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
144286153|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
144286154|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
144286155|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
144286156|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
144286157|NCT01243424|520250938|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
144286158|NCT01243424|520250939|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
144286159|NCT01243424|520250938|FG000|Discontinuation From Treatment|Not treated|5|||
144286160|NCT01243424|520250939|FG001|Discontinuation From Treatment|Not treated|4|||
144286161|NCT01243424|520250938|FG000|Discontinuation From Treatment|Adverse Event|457|||
144286162|NCT01243424|520250939|FG001|Discontinuation From Treatment|Adverse Event|523|||
144286163|NCT01243424|520250938|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
144286164|NCT01243424|520250939|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
144286165|NCT01243424|520250938|FG000|Discontinuation From Treatment|Protocol Violation|46|||
144286166|NCT01243424|520250939|FG001|Discontinuation From Treatment|Protocol Violation|47|||
144286167|NCT01243424|520250938|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
144286168|NCT01243424|520250939|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
144286169|NCT01243424|520250938|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
144286170|NCT01243424|520250939|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
144286171|NCT01243424|520250938|FG000|Discontinuation From Treatment|Other than listed above|230|||
144286172|NCT01243424|520250939|FG001|Discontinuation From Treatment|Other than listed above|211|||
144286173|NCT01160744|520250946|FG000|Overall Study|Withdrawal by Subject|11|||
144286174|NCT01160744|520250947|FG001|Overall Study|Withdrawal by Subject|5|||
144286175|NCT01160744|520250948|FG002|Overall Study|Withdrawal by Subject|6|||
144286176|NCT01160744|520250949|FG003|Overall Study|Withdrawal by Subject|4|||
144286177|NCT01160744|520250946|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
144286178|NCT01160744|520250947|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
144286179|NCT01160744|520250948|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
144286180|NCT01160744|520250949|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
144286181|NCT02301429|520250952|FG000|Overall Study|not acceptable vascular anatomy|3|||
144286182|NCT01502072|520250953|FG000|Overall Study|Withdrawal by Subject|1|||
144286183|NCT01502072|520250954|FG001|Overall Study|Withdrawal by Subject|0|||
144286184|NCT01502072|520250955|FG002|Overall Study|Withdrawal by Subject|0|||
144286185|NCT01502072|520250953|FG000|Overall Study|Death|0|||
144286186|NCT01502072|520250954|FG001|Overall Study|Death|1|||
144286187|NCT01502072|520250955|FG002|Overall Study|Death|0|||
144286188|NCT01096186|520250960|FG000|Overall Study|Adverse Event|16|||
144286189|NCT01096186|520250960|FG000|Overall Study|Death|4|||
144286190|NCT01096186|520250960|FG000|Overall Study|Lack of Efficacy|4|||
144286191|NCT01096186|520250960|FG000|Overall Study|Lost to Follow-up|2|||
144286192|NCT01096186|520250960|FG000|Overall Study|Withdrawal by Subject|22|||
144286193|NCT01096186|520250960|FG000|Overall Study|Physician Decision|1|||
144286194|NCT01096186|520250960|FG000|Overall Study|Noncompliance with study drug|1|||
144286195|NCT00122187|520250965|FG000|Overall Study|Withdrew because of resource limitations|2|||
144286196|NCT00122187|520250966|FG001|Overall Study|Withdrew because of resource limitations|2|||
144286197|NCT00799864|520250970|FG000|Overall Study|Participant reached a virologic endpoint|9|||
144286198|NCT00799864|520250971|FG001|Overall Study|Participant reached a virologic endpoint|2|||
144286199|NCT00799864|520250972|FG002|Overall Study|Participant reached a virologic endpoint|2|||
144286200|NCT00799864|520250973|FG003|Overall Study|Participant reached a virologic endpoint|0|||
144286201|NCT00799864|520250974|FG004|Overall Study|Participant reached a virologic endpoint|0|||
144286202|NCT00799864|520250970|FG000|Overall Study|Other|2|||
144286203|NCT00799864|520250971|FG001|Overall Study|Other|1|||
144286204|NCT00799864|520250972|FG002|Overall Study|Other|0|||
144286205|NCT00799864|520250973|FG003|Overall Study|Other|0|||
144286206|NCT00799864|520250974|FG004|Overall Study|Other|0|||
144286207|NCT04865978|520250975|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
144286208|NCT04865978|520250976|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
144286209|NCT04263532|520250977|FG000|Overall Study|Withdrawal by Subject|2|||
144286210|NCT04263532|520250978|FG001|Overall Study|Withdrawal by Subject|0|||
144286211|NCT02181738|520250979|FG000|Overall Study|Participant Withdrew Consent|2|||
144286212|NCT02181738|520250980|FG001|Overall Study|Participant Withdrew Consent|1|||
144286213|NCT02181738|520250981|FG002|Overall Study|Participant Withdrew Consent|1|||
144286214|NCT02181738|520250982|FG003|Overall Study|Participant Withdrew Consent|1|||
144286215|NCT02181738|520250979|FG000|Overall Study|Lost to Follow-up|1|||
144286216|NCT02181738|520250980|FG001|Overall Study|Lost to Follow-up|2|||
144286217|NCT02181738|520250981|FG002|Overall Study|Lost to Follow-up|1|||
144286218|NCT02181738|520250982|FG003|Overall Study|Lost to Follow-up|1|||
144286219|NCT02181738|520250979|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
144286220|NCT02181738|520250980|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
144286221|NCT02181738|520250981|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
144286222|NCT02181738|520250982|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
144286223|NCT02181738|520250979|FG000|Overall Study|Poor/Non-Compliance|1|||
144286224|NCT02181738|520250980|FG001|Overall Study|Poor/Non-Compliance|0|||
144286225|NCT02181738|520250981|FG002|Overall Study|Poor/Non-Compliance|2|||
144286226|NCT02181738|520250982|FG003|Overall Study|Poor/Non-Compliance|1|||
144286227|NCT02181738|520250979|FG000|Overall Study|Disease Progression|28|||
144286228|NCT02181738|520250980|FG001|Overall Study|Disease Progression|35|||
144286229|NCT02181738|520250981|FG002|Overall Study|Disease Progression|40|||
144286230|NCT02181738|520250982|FG003|Overall Study|Disease Progression|0|||
144286231|NCT02181738|520250979|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
144286232|NCT02181738|520250980|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
144286233|NCT02181738|520250981|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
144286234|NCT02181738|520250982|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
144286235|NCT02181738|520250979|FG000|Overall Study|Study Drug Toxicity|6|||
144286236|NCT02181738|520250980|FG001|Overall Study|Study Drug Toxicity|11|||
144286237|NCT02181738|520250981|FG002|Overall Study|Study Drug Toxicity|8|||
144286238|NCT02181738|520250982|FG003|Overall Study|Study Drug Toxicity|1|||
144286239|NCT02181738|520250979|FG000|Overall Study|Other Reasons|14|||
144286240|NCT02181738|520250980|FG001|Overall Study|Other Reasons|16|||
144286241|NCT02181738|520250981|FG002|Overall Study|Other Reasons|28|||
144286242|NCT02181738|520250982|FG003|Overall Study|Other Reasons|0|||
144286243|NCT02181738|520250979|FG000|Overall Study|Maximum Clinical Benefit|3|||
144286244|NCT02181738|520250980|FG001|Overall Study|Maximum Clinical Benefit|0|||
144286245|NCT02181738|520250981|FG002|Overall Study|Maximum Clinical Benefit|1|||
144286246|NCT02181738|520250982|FG003|Overall Study|Maximum Clinical Benefit|0|||
144286247|NCT02181738|520250979|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
144286248|NCT02181738|520250980|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
144286249|NCT02181738|520250981|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
144286250|NCT02181738|520250982|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
144286251|NCT05064800|520250983|FG000|Period 3|Withdrawal by Subject|0|||
144286252|NCT05064800|520250984|FG001|Period 3|Withdrawal by Subject|0|||
144286253|NCT05064800|520250985|FG002|Period 3|Withdrawal by Subject|0|||
144286254|NCT05064800|520250986|FG003|Period 3|Withdrawal by Subject|0|||
144286255|NCT05064800|520250987|FG004|Period 3|Withdrawal by Subject|1|||
144286256|NCT05064800|520250988|FG005|Period 3|Withdrawal by Subject|0|||
144286257|NCT01851369|520250989|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286258|NCT01851369|520250990|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286259|NCT01851369|520250991|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286260|NCT01851369|520250992|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286261|NCT01851369|520250993|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286262|NCT01851369|520250994|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
144286263|NCT01851369|520250995|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286264|NCT01851369|520250996|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286265|NCT01851369|520250997|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286266|NCT01851369|520250998|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286267|NCT01851369|520250999|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286268|NCT01851369|520251000|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286269|NCT01851369|520251001|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
144286270|NCT00395512|520251002|FG000|Overall Study|Adverse Event|3|||
144286271|NCT00395512|520251003|FG001|Overall Study|Adverse Event|8|||
144286272|NCT00395512|520251004|FG002|Overall Study|Adverse Event|6|||
144286273|NCT00395512|520251005|FG003|Overall Study|Adverse Event|6|||
144286274|NCT00395512|520251002|FG000|Overall Study|Protocol Violation|2|||
144286275|NCT00395512|520251003|FG001|Overall Study|Protocol Violation|3|||
144286276|NCT00395512|520251004|FG002|Overall Study|Protocol Violation|6|||
144286277|NCT00395512|520251005|FG003|Overall Study|Protocol Violation|7|||
144286278|NCT00395512|520251002|FG000|Overall Study|Lost to Follow-up|2|||
144286279|NCT00395512|520251003|FG001|Overall Study|Lost to Follow-up|6|||
144286280|NCT00395512|520251004|FG002|Overall Study|Lost to Follow-up|5|||
144286281|NCT00395512|520251005|FG003|Overall Study|Lost to Follow-up|5|||
144286282|NCT00395512|520251002|FG000|Overall Study|Withdrawal by Subject|6|||
144286283|NCT00395512|520251003|FG001|Overall Study|Withdrawal by Subject|5|||
144286284|NCT00395512|520251004|FG002|Overall Study|Withdrawal by Subject|5|||
144286285|NCT00395512|520251005|FG003|Overall Study|Withdrawal by Subject|12|||
144286286|NCT00395512|520251002|FG000|Overall Study|Physician Decision|6|||
144286287|NCT00395512|520251003|FG001|Overall Study|Physician Decision|4|||
144286288|NCT00395512|520251004|FG002|Overall Study|Physician Decision|2|||
144286289|NCT00395512|520251005|FG003|Overall Study|Physician Decision|2|||
144286290|NCT00395512|520251002|FG000|Overall Study|Other|1|||
144286291|NCT00395512|520251003|FG001|Overall Study|Other|1|||
144286292|NCT00395512|520251004|FG002|Overall Study|Other|0|||
144286293|NCT00395512|520251005|FG003|Overall Study|Other|0|||
144286294|NCT00395512|520251002|FG000|Overall Study|Hyperglycemic Rescue|18|||
144286295|NCT00395512|520251003|FG001|Overall Study|Hyperglycemic Rescue|10|||
144286296|NCT00395512|520251004|FG002|Overall Study|Hyperglycemic Rescue|4|||
144286297|NCT00395512|520251005|FG003|Overall Study|Hyperglycemic Rescue|6|||
144286298|NCT04243837|520251008|FG000|Overall Study|Adverse Event|2|||
144286299|NCT04243837|520251009|FG001|Overall Study|Adverse Event|1|||
144286300|NCT04243837|520251008|FG000|Overall Study|Withdrawal by Subject|4|||
144286301|NCT04243837|520251009|FG001|Overall Study|Withdrawal by Subject|2|||
144286302|NCT04243837|520251008|FG000|Overall Study|Covid-19 lock down|1|||
144286303|NCT04243837|520251009|FG001|Overall Study|Covid-19 lock down|0|||
144286304|NCT04243837|520251008|FG000|Overall Study|Study Terminated by Sponsor|11|||
144286305|NCT04243837|520251009|FG001|Overall Study|Study Terminated by Sponsor|12|||
144286306|NCT03511066|520251018|FG000|Overall Study|Withdrawal by Subject|1|||
144286307|NCT03511066|520251019|FG001|Overall Study|Withdrawal by Subject|2|||
144286308|NCT03511066|520251020|FG002|Overall Study|Withdrawal by Subject|3|||
144286309|NCT03511066|520251018|FG000|Overall Study|Lost to Follow-up|2|||
144286310|NCT03511066|520251019|FG001|Overall Study|Lost to Follow-up|3|||
144286311|NCT03511066|520251020|FG002|Overall Study|Lost to Follow-up|0|||
144286312|NCT04560309|520251021|FG000|Overall Study|Meet drop out criteria|1|||
144286313|NCT04560309|520251022|FG001|Overall Study|Meet drop out criteria|1|||
144286314|NCT05085405|520251023|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
144286315|NCT05085405|520251024|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
144286316|NCT05085405|520251025|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
144286317|NCT05085405|520251026|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
144286318|NCT05085405|520251027|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
144286319|NCT05085405|520251028|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
144286320|NCT05085405|520251023|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
144286321|NCT05085405|520251024|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
144286322|NCT05085405|520251025|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
144286323|NCT05085405|520251026|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
144286324|NCT05085405|520251027|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
144286325|NCT05085405|520251028|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
144286326|NCT00455455|520251029|FG000|Washout|Withdrawal by Subject|0|||
144286327|NCT00455455|520251030|FG001|Washout|Withdrawal by Subject|1|||
144286328|NCT00455455|520251029|FG000|Washout|Withdrawal by Subject|1|||
144286329|NCT00455455|520251030|FG001|Washout|Withdrawal by Subject|0|||
144286330|NCT00501085|520251032|FG000|Overall Study|Lost to Follow-up|195|||
144286331|NCT00501085|520251032|FG000|Overall Study|Withdrawal by Subject|34|||
144286332|NCT00501085|520251032|FG000|Overall Study|Subject Decision|1|||
144286333|NCT00501085|520251032|FG000|Overall Study|Revision Surgery|7|||
144286334|NCT00501085|520251032|FG000|Overall Study|Explantation Surgery|26|||
144286335|NCT00501085|520251032|FG000|Overall Study|Adverse Event|4|||
144286336|NCT00501085|520251032|FG000|Overall Study|Non-Compliance|24|||
144286337|NCT00501085|520251032|FG000|Overall Study|Study closed by sponsor|109|||
144286338|NCT00501085|520251032|FG000|Overall Study|Other loss to follow-up|32|||
144286339|NCT00567112|520251033|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
144286340|NCT00567112|520251034|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
144286341|NCT00567112|520251035|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
144286342|NCT00567112|520251033|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
144286343|NCT00567112|520251034|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
144286344|NCT00567112|520251035|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
144286345|NCT00567112|520251033|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
144286346|NCT00567112|520251034|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
144286347|NCT00567112|520251035|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
144286348|NCT02945046|520251036|FG000|Overall Study|Adverse Event|1|||
144286349|NCT02945046|520251037|FG001|Overall Study|Adverse Event|0|||
144286350|NCT02945046|520251038|FG002|Overall Study|Adverse Event|2|||
144286351|NCT02945046|520251036|FG000|Overall Study|Withdrawal by Subject|3|||
144286352|NCT02945046|520251037|FG001|Overall Study|Withdrawal by Subject|3|||
144286353|NCT02945046|520251038|FG002|Overall Study|Withdrawal by Subject|3|||
144286354|NCT02945046|520251036|FG000|Overall Study|Protocol Violation|2|||
144286355|NCT02945046|520251037|FG001|Overall Study|Protocol Violation|3|||
144286356|NCT02945046|520251038|FG002|Overall Study|Protocol Violation|2|||
144286357|NCT02945046|520251036|FG000|Overall Study|Lost to Follow-up|1|||
144286358|NCT02945046|520251037|FG001|Overall Study|Lost to Follow-up|1|||
144286359|NCT02945046|520251038|FG002|Overall Study|Lost to Follow-up|0|||
144286360|NCT02945046|520251036|FG000|Overall Study|Lack of Efficacy|1|||
144286361|NCT02945046|520251037|FG001|Overall Study|Lack of Efficacy|2|||
144286362|NCT02945046|520251038|FG002|Overall Study|Lack of Efficacy|1|||
144286363|NCT02945046|520251036|FG000|Overall Study|Other than specified|5|||
144286364|NCT02945046|520251037|FG001|Overall Study|Other than specified|4|||
144286365|NCT02945046|520251038|FG002|Overall Study|Other than specified|7|||
144286366|NCT03113136|520251039|FG000|Overall Study|Lost to Follow-up|22|||
144286367|NCT03113136|520251040|FG001|Overall Study|Lost to Follow-up|47|||
144286368|NCT03113136|520251041|FG002|Overall Study|Lost to Follow-up|54|||
144286369|NCT03113136|520251039|FG000|Overall Study|Withdrawal by Subject|4|||
144286370|NCT03113136|520251040|FG001|Overall Study|Withdrawal by Subject|13|||
144286371|NCT03113136|520251041|FG002|Overall Study|Withdrawal by Subject|14|||
144286372|NCT03113136|520251039|FG000|Overall Study|Ineligible|0|||
144286373|NCT03113136|520251040|FG001|Overall Study|Ineligible|2|||
144286374|NCT03113136|520251041|FG002|Overall Study|Ineligible|1|||
144286375|NCT03113136|520251039|FG000|Overall Study|Study Team Decision|1|||
144286376|NCT03113136|520251040|FG001|Overall Study|Study Team Decision|4|||
144286377|NCT03113136|520251041|FG002|Overall Study|Study Team Decision|0|||
144286378|NCT04689009|520251046|FG000|Overall Study|Adverse Event|1|||
144286379|NCT04689009|520251047|FG001|Overall Study|Adverse Event|0|||
144286380|NCT04689009|520251046|FG000|Overall Study|Lost to Follow-up|1|||
144286381|NCT04689009|520251047|FG001|Overall Study|Lost to Follow-up|2|||
144286382|NCT04689009|520251046|FG000|Overall Study|Withdrawal by Subject|4|||
144286383|NCT04689009|520251047|FG001|Overall Study|Withdrawal by Subject|3|||
144286384|NCT04689009|520251046|FG000|Overall Study|Protocol Violation|1|||
144286385|NCT04689009|520251047|FG001|Overall Study|Protocol Violation|0|||
144286386|NCT02362412|520251048|FG000|Treatment Period III|Lost to Follow-up|0|||
144286387|NCT02362412|520251049|FG001|Treatment Period III|Lost to Follow-up|1|||
144286388|NCT02675452|520251051|FG000|Overall Study|Sponsor decision|0|||
144286389|NCT02675452|520251052|FG001|Overall Study|Sponsor decision|0|||
144286390|NCT02675452|520251053|FG002|Overall Study|Sponsor decision|0|||
144286391|NCT02675452|520251054|FG003|Overall Study|Sponsor decision|0|||
144286392|NCT02675452|520251055|FG004|Overall Study|Sponsor decision|0|||
144286393|NCT02675452|520251056|FG005|Overall Study|Sponsor decision|0|||
144286394|NCT02675452|520251057|FG006|Overall Study|Sponsor decision|0|||
144286395|NCT02675452|520251058|FG007|Overall Study|Sponsor decision|0|||
144286396|NCT02675452|520251059|FG008|Overall Study|Sponsor decision|0|||
144286397|NCT02675452|520251060|FG009|Overall Study|Sponsor decision|1|||
144286398|NCT02675452|520251061|FG010|Overall Study|Sponsor decision|0|||
144286399|NCT02675452|520251062|FG011|Overall Study|Sponsor decision|0|||
144286400|NCT02675452|520251063|FG012|Overall Study|Sponsor decision|0|||
144286401|NCT02675452|520251064|FG013|Overall Study|Sponsor decision|2|||
144286402|NCT02675452|520251065|FG014|Overall Study|Sponsor decision|1|||
144286403|NCT02675452|520251066|FG015|Overall Study|Sponsor decision|0|||
144286404|NCT02675452|520251067|FG016|Overall Study|Sponsor decision|1|||
144286405|NCT02675452|520251068|FG017|Overall Study|Sponsor decision|0|||
144286406|NCT02675452|520251069|FG018|Overall Study|Sponsor decision|0|||
144286407|NCT02675452|520251070|FG019|Overall Study|Sponsor decision|0|||
144286408|NCT02675452|520251071|FG020|Overall Study|Sponsor decision|0|||
144286409|NCT02675452|520251072|FG021|Overall Study|Sponsor decision|0|||
144286410|NCT02675452|520251073|FG022|Overall Study|Sponsor decision|0|||
144286411|NCT02675452|520251074|FG023|Overall Study|Sponsor decision|0|||
144286412|NCT02675452|520251075|FG024|Overall Study|Sponsor decision|0|||
144286413|NCT02675452|520251076|FG025|Overall Study|Sponsor decision|0|||
144286414|NCT02675452|520251077|FG026|Overall Study|Sponsor decision|2|||
144286415|NCT02675452|520251078|FG027|Overall Study|Sponsor decision|0|||
144286416|NCT02675452|520251079|FG028|Overall Study|Sponsor decision|0|||
144286417|NCT02675452|520251051|FG000|Overall Study|Withdrawal by Subject|0|||
144286418|NCT02675452|520251052|FG001|Overall Study|Withdrawal by Subject|0|||
144286419|NCT02675452|520251053|FG002|Overall Study|Withdrawal by Subject|0|||
144286420|NCT02675452|520251054|FG003|Overall Study|Withdrawal by Subject|0|||
144286421|NCT02675452|520251055|FG004|Overall Study|Withdrawal by Subject|0|||
144286422|NCT02675452|520251056|FG005|Overall Study|Withdrawal by Subject|0|||
144286423|NCT02675452|520251057|FG006|Overall Study|Withdrawal by Subject|0|||
144286424|NCT02675452|520251058|FG007|Overall Study|Withdrawal by Subject|0|||
144286425|NCT02675452|520251059|FG008|Overall Study|Withdrawal by Subject|0|||
144286426|NCT02675452|520251060|FG009|Overall Study|Withdrawal by Subject|1|||
144286427|NCT02675452|520251061|FG010|Overall Study|Withdrawal by Subject|0|||
144286428|NCT02675452|520251062|FG011|Overall Study|Withdrawal by Subject|1|||
144286429|NCT02675452|520251063|FG012|Overall Study|Withdrawal by Subject|0|||
144286430|NCT02675452|520251064|FG013|Overall Study|Withdrawal by Subject|1|||
144286431|NCT02675452|520251065|FG014|Overall Study|Withdrawal by Subject|1|||
144286432|NCT02675452|520251066|FG015|Overall Study|Withdrawal by Subject|0|||
144286433|NCT02675452|520251067|FG016|Overall Study|Withdrawal by Subject|2|||
144286434|NCT02675452|520251068|FG017|Overall Study|Withdrawal by Subject|0|||
144286435|NCT02675452|520251069|FG018|Overall Study|Withdrawal by Subject|0|||
144286436|NCT02675452|520251070|FG019|Overall Study|Withdrawal by Subject|0|||
144286437|NCT02675452|520251071|FG020|Overall Study|Withdrawal by Subject|0|||
144286438|NCT02675452|520251072|FG021|Overall Study|Withdrawal by Subject|0|||
144286439|NCT02675452|520251073|FG022|Overall Study|Withdrawal by Subject|3|||
144286440|NCT02675452|520251074|FG023|Overall Study|Withdrawal by Subject|0|||
144286441|NCT02675452|520251075|FG024|Overall Study|Withdrawal by Subject|1|||
144286442|NCT02675452|520251076|FG025|Overall Study|Withdrawal by Subject|0|||
144286443|NCT02675452|520251077|FG026|Overall Study|Withdrawal by Subject|1|||
144286444|NCT02675452|520251078|FG027|Overall Study|Withdrawal by Subject|3|||
144286445|NCT02675452|520251079|FG028|Overall Study|Withdrawal by Subject|4|||
144286446|NCT02675452|520251051|FG000|Overall Study|Death|0|||
144286447|NCT02675452|520251052|FG001|Overall Study|Death|0|||
144286448|NCT02675452|520251053|FG002|Overall Study|Death|1|||
144286449|NCT02675452|520251054|FG003|Overall Study|Death|0|||
144286450|NCT02675452|520251055|FG004|Overall Study|Death|0|||
144245934|NCT03800836|520096267|FG001|Overall Study|Symptomatic Deterioration|0|||
144245935|NCT03800836|520096268|FG002|Overall Study|Symptomatic Deterioration|1|||
144245936|NCT03800836|520096269|FG003|Overall Study|Symptomatic Deterioration|0|||
144245937|NCT03800836|520096270|FG004|Overall Study|Symptomatic Deterioration|0|||
144245938|NCT03800836|520096271|FG005|Overall Study|Symptomatic Deterioration|0|||
144245939|NCT02000882|520098188|FG000|Overall Study|Adverse Event|3|||
144245940|NCT02000882|520098188|FG000|Overall Study|Physician Decision|2|||
144245941|NCT02000882|520098188|FG000|Overall Study|Withdrawal by Subject|1|||
144245942|NCT00549601|520098189|FG000|Randomized|Protocol Violation|0|||
144245943|NCT00549601|520098190|FG001|Randomized|Protocol Violation|0|||
144245944|NCT00549601|520098191|FG002|Randomized|Protocol Violation|1|||
144245945|NCT00549601|520098189|FG000|Randomized|Withdrawal by Subject|0|||
144245946|NCT00549601|520098190|FG001|Randomized|Withdrawal by Subject|1|||
144245947|NCT00549601|520098191|FG002|Randomized|Withdrawal by Subject|1|||
144245948|NCT00549601|520098189|FG000|Received Study Drug|Adverse Event|2|||
144245949|NCT00549601|520098190|FG001|Received Study Drug|Adverse Event|5|||
144245950|NCT00549601|520098191|FG002|Received Study Drug|Adverse Event|1|||
144245951|NCT00549601|520098189|FG000|Received Study Drug|Death|0|||
144245952|NCT00549601|520098190|FG001|Received Study Drug|Death|1|||
144245953|NCT00549601|520098191|FG002|Received Study Drug|Death|0|||
144245954|NCT00549601|520098189|FG000|Received Study Drug|Lost to Follow-up|0|||
144245955|NCT00549601|520098190|FG001|Received Study Drug|Lost to Follow-up|1|||
144245956|NCT00549601|520098191|FG002|Received Study Drug|Lost to Follow-up|1|||
144245957|NCT00549601|520098189|FG000|Received Study Drug|Protocol Violation|3|||
144245958|NCT00549601|520098190|FG001|Received Study Drug|Protocol Violation|4|||
144245959|NCT00549601|520098191|FG002|Received Study Drug|Protocol Violation|1|||
144245960|NCT00549601|520098189|FG000|Received Study Drug|Withdrawal by Subject|2|||
144245961|NCT00549601|520098190|FG001|Received Study Drug|Withdrawal by Subject|0|||
144245962|NCT00549601|520098191|FG002|Received Study Drug|Withdrawal by Subject|1|||
144245963|NCT02949908|520098195|FG000|Overall Study|Study termination|2|||
144245964|NCT02607280|520098198|FG000|Overall Study|Adverse Event|4|||
144245965|NCT02607280|520098199|FG001|Overall Study|Adverse Event|0|||
144245966|NCT02607280|520098198|FG000|Overall Study|Decrease in CrCl <15|0|||
144245967|NCT02607280|520098199|FG001|Overall Study|Decrease in CrCl <15|1|||
144245968|NCT00590538|520098200|FG000|Overall Study|Study terminated before completed|2|||
144245969|NCT01125813|520098201|FG000|Overall Study|Death|1|||
144245970|NCT01125813|520098201|FG000|Overall Study|Withdrawal by Subject|1|||
144245971|NCT01125813|520098201|FG000|Overall Study|Screen Failures|4|||
144245972|NCT02327013|520098202|FG000|Overall Study|Adverse Event|4|||
144245973|NCT02327013|520098203|FG001|Overall Study|Adverse Event|4|||
144245974|NCT02327013|520098204|FG002|Overall Study|Adverse Event|3|||
144245975|NCT02327013|520098205|FG003|Overall Study|Adverse Event|0|||
144245976|NCT02327013|520098206|FG004|Overall Study|Adverse Event|1|||
144245977|NCT02327013|520098202|FG000|Overall Study|Lack of Efficacy|2|||
144245978|NCT02327013|520098203|FG001|Overall Study|Lack of Efficacy|0|||
144245979|NCT02327013|520098204|FG002|Overall Study|Lack of Efficacy|5|||
144245980|NCT02327013|520098205|FG003|Overall Study|Lack of Efficacy|0|||
144245981|NCT02327013|520098206|FG004|Overall Study|Lack of Efficacy|1|||
144245982|NCT02327013|520098202|FG000|Overall Study|Non-compliance with IMP|1|||
144245983|NCT02327013|520098203|FG001|Overall Study|Non-compliance with IMP|2|||
144245984|NCT02327013|520098204|FG002|Overall Study|Non-compliance with IMP|7|||
144245985|NCT02327013|520098205|FG003|Overall Study|Non-compliance with IMP|0|||
144245986|NCT02327013|520098206|FG004|Overall Study|Non-compliance with IMP|0|||
144245987|NCT02327013|520098202|FG000|Overall Study|Withdrawal of Consent|1|||
144245988|NCT02327013|520098203|FG001|Overall Study|Withdrawal of Consent|0|||
144245989|NCT02327013|520098204|FG002|Overall Study|Withdrawal of Consent|3|||
144245990|NCT02327013|520098205|FG003|Overall Study|Withdrawal of Consent|0|||
144245991|NCT02327013|520098206|FG004|Overall Study|Withdrawal of Consent|0|||
144245992|NCT02327013|520098202|FG000|Overall Study|Lost to Follow-up|2|||
144245993|NCT02327013|520098203|FG001|Overall Study|Lost to Follow-up|4|||
144245994|NCT02327013|520098204|FG002|Overall Study|Lost to Follow-up|5|||
144245995|NCT02327013|520098205|FG003|Overall Study|Lost to Follow-up|0|||
144245996|NCT02327013|520098206|FG004|Overall Study|Lost to Follow-up|0|||
144245997|NCT02327013|520098202|FG000|Overall Study|Administrative or other reason(s)|1|||
144245998|NCT02327013|520098203|FG001|Overall Study|Administrative or other reason(s)|5|||
144245999|NCT02327013|520098204|FG002|Overall Study|Administrative or other reason(s)|11|||
144246000|NCT02327013|520098205|FG003|Overall Study|Administrative or other reason(s)|1|||
144246001|NCT02327013|520098206|FG004|Overall Study|Administrative or other reason(s)|1|||
144246002|NCT02327013|520098202|FG000|Overall Study|Protocol Violation|0|||
144246003|NCT02327013|520098203|FG001|Overall Study|Protocol Violation|0|||
144246004|NCT02327013|520098204|FG002|Overall Study|Protocol Violation|3|||
144246005|NCT02327013|520098205|FG003|Overall Study|Protocol Violation|0|||
144246006|NCT02327013|520098206|FG004|Overall Study|Protocol Violation|1|||
144246007|NCT02327013|520098202|FG000|Overall Study|Withdrawal before treatment|2|||
144246008|NCT02327013|520098203|FG001|Overall Study|Withdrawal before treatment|1|||
144246009|NCT02327013|520098204|FG002|Overall Study|Withdrawal before treatment|5|||
144246010|NCT02327013|520098205|FG003|Overall Study|Withdrawal before treatment|0|||
144246011|NCT02327013|520098206|FG004|Overall Study|Withdrawal before treatment|0|||
144286451|NCT02675452|520251056|FG005|Overall Study|Death|1|||
144286452|NCT02675452|520251057|FG006|Overall Study|Death|0|||
144286453|NCT02675452|520251058|FG007|Overall Study|Death|0|||
144286454|NCT02675452|520251059|FG008|Overall Study|Death|1|||
144286455|NCT02675452|520251060|FG009|Overall Study|Death|0|||
144286456|NCT02675452|520251061|FG010|Overall Study|Death|0|||
144286457|NCT02675452|520251062|FG011|Overall Study|Death|0|||
144286458|NCT02675452|520251063|FG012|Overall Study|Death|1|||
144286459|NCT02675452|520251064|FG013|Overall Study|Death|0|||
144286460|NCT02675452|520251065|FG014|Overall Study|Death|0|||
144286461|NCT02675452|520251066|FG015|Overall Study|Death|2|||
144286462|NCT02675452|520251067|FG016|Overall Study|Death|0|||
144286463|NCT02675452|520251068|FG017|Overall Study|Death|0|||
144286464|NCT02675452|520251069|FG018|Overall Study|Death|4|||
144286465|NCT02675452|520251070|FG019|Overall Study|Death|3|||
144286466|NCT02675452|520251071|FG020|Overall Study|Death|3|||
144286467|NCT02675452|520251072|FG021|Overall Study|Death|3|||
144286468|NCT02675452|520251073|FG022|Overall Study|Death|7|||
144286469|NCT02675452|520251074|FG023|Overall Study|Death|5|||
144286470|NCT02675452|520251075|FG024|Overall Study|Death|3|||
144286471|NCT02675452|520251076|FG025|Overall Study|Death|4|||
144286472|NCT02675452|520251077|FG026|Overall Study|Death|7|||
144286473|NCT02675452|520251078|FG027|Overall Study|Death|6|||
144286474|NCT02675452|520251079|FG028|Overall Study|Death|9|||
144286475|NCT02675452|520251051|FG000|Overall Study|Lost to Follow-up|0|||
144286476|NCT02675452|520251052|FG001|Overall Study|Lost to Follow-up|1|||
144286477|NCT02675452|520251053|FG002|Overall Study|Lost to Follow-up|0|||
144286478|NCT02675452|520251054|FG003|Overall Study|Lost to Follow-up|0|||
144286479|NCT02675452|520251055|FG004|Overall Study|Lost to Follow-up|0|||
144286480|NCT02675452|520251056|FG005|Overall Study|Lost to Follow-up|0|||
144286481|NCT02675452|520251057|FG006|Overall Study|Lost to Follow-up|0|||
144286482|NCT02675452|520251058|FG007|Overall Study|Lost to Follow-up|0|||
144286483|NCT02675452|520251059|FG008|Overall Study|Lost to Follow-up|0|||
144286484|NCT02675452|520251060|FG009|Overall Study|Lost to Follow-up|0|||
144286485|NCT02675452|520251061|FG010|Overall Study|Lost to Follow-up|0|||
144286486|NCT02675452|520251062|FG011|Overall Study|Lost to Follow-up|0|||
144286487|NCT02675452|520251063|FG012|Overall Study|Lost to Follow-up|1|||
144286488|NCT02675452|520251064|FG013|Overall Study|Lost to Follow-up|0|||
144286489|NCT02675452|520251065|FG014|Overall Study|Lost to Follow-up|0|||
144286490|NCT02675452|520251066|FG015|Overall Study|Lost to Follow-up|0|||
144286491|NCT02675452|520251067|FG016|Overall Study|Lost to Follow-up|0|||
144286492|NCT02675452|520251068|FG017|Overall Study|Lost to Follow-up|0|||
144286493|NCT02675452|520251069|FG018|Overall Study|Lost to Follow-up|0|||
144286494|NCT02675452|520251070|FG019|Overall Study|Lost to Follow-up|0|||
144286495|NCT02675452|520251071|FG020|Overall Study|Lost to Follow-up|0|||
144286496|NCT02675452|520251072|FG021|Overall Study|Lost to Follow-up|0|||
144286497|NCT02675452|520251073|FG022|Overall Study|Lost to Follow-up|0|||
144286498|NCT02675452|520251074|FG023|Overall Study|Lost to Follow-up|0|||
144286499|NCT02675452|520251075|FG024|Overall Study|Lost to Follow-up|0|||
144286500|NCT02675452|520251076|FG025|Overall Study|Lost to Follow-up|0|||
144286501|NCT02675452|520251077|FG026|Overall Study|Lost to Follow-up|1|||
144286502|NCT02675452|520251078|FG027|Overall Study|Lost to Follow-up|0|||
144286503|NCT02675452|520251079|FG028|Overall Study|Lost to Follow-up|0|||
144286504|NCT02675452|520251051|FG000|Overall Study|Other|0|||
144286505|NCT02675452|520251052|FG001|Overall Study|Other|0|||
144286506|NCT02675452|520251053|FG002|Overall Study|Other|0|||
144286507|NCT02675452|520251054|FG003|Overall Study|Other|0|||
144286508|NCT02675452|520251055|FG004|Overall Study|Other|0|||
144286509|NCT02675452|520251056|FG005|Overall Study|Other|0|||
144286510|NCT02675452|520251057|FG006|Overall Study|Other|0|||
144286511|NCT02675452|520251058|FG007|Overall Study|Other|0|||
144286512|NCT02675452|520251059|FG008|Overall Study|Other|0|||
144286513|NCT02675452|520251060|FG009|Overall Study|Other|0|||
144286514|NCT02675452|520251061|FG010|Overall Study|Other|0|||
144286515|NCT02675452|520251062|FG011|Overall Study|Other|0|||
144286516|NCT02675452|520251063|FG012|Overall Study|Other|0|||
144286517|NCT02675452|520251064|FG013|Overall Study|Other|0|||
144286518|NCT02675452|520251065|FG014|Overall Study|Other|0|||
144286519|NCT02675452|520251066|FG015|Overall Study|Other|0|||
144286520|NCT02675452|520251067|FG016|Overall Study|Other|0|||
144286521|NCT02675452|520251068|FG017|Overall Study|Other|0|||
144286522|NCT02675452|520251069|FG018|Overall Study|Other|0|||
144286523|NCT02675452|520251070|FG019|Overall Study|Other|0|||
144286524|NCT02675452|520251071|FG020|Overall Study|Other|0|||
144286525|NCT02675452|520251072|FG021|Overall Study|Other|0|||
144286526|NCT02675452|520251073|FG022|Overall Study|Other|0|||
144286527|NCT02675452|520251074|FG023|Overall Study|Other|0|||
144286528|NCT02675452|520251075|FG024|Overall Study|Other|0|||
144286529|NCT02675452|520251076|FG025|Overall Study|Other|0|||
144286530|NCT02675452|520251077|FG026|Overall Study|Other|1|||
144286531|NCT02675452|520251078|FG027|Overall Study|Other|0|||
144286532|NCT02675452|520251079|FG028|Overall Study|Other|0|||
144286533|NCT00545948|520251080|FG000|Overall Study|Not Treated|1|||
144286534|NCT00545948|520251081|FG001|Overall Study|Not Treated|1|||
144286535|NCT00545948|520251082|FG002|Overall Study|Not Treated|7|||
144286536|NCT03467945|520251083|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144286537|NCT03467945|520251084|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144286538|NCT03467945|520251085|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144286539|NCT03467945|520251086|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144286540|NCT03467945|520251083|FG000|Treatment Period 3|Withdrawal by Subject|1|||
144286541|NCT03467945|520251084|FG001|Treatment Period 3|Withdrawal by Subject|0|||
144286542|NCT03467945|520251085|FG002|Treatment Period 3|Withdrawal by Subject|2|||
144286543|NCT03467945|520251086|FG003|Treatment Period 3|Withdrawal by Subject|1|||
144286544|NCT00541775|520251101|FG000|Overall Study|Adverse Event|3|||
144286545|NCT00541775|520251102|FG001|Overall Study|Adverse Event|2|||
144286546|NCT00541775|520251103|FG002|Overall Study|Adverse Event|1|||
144286547|NCT00541775|520251101|FG000|Overall Study|Lack of Efficacy|0|||
144286548|NCT00541775|520251102|FG001|Overall Study|Lack of Efficacy|0|||
144286549|NCT00541775|520251103|FG002|Overall Study|Lack of Efficacy|3|||
144286550|NCT00541775|520251101|FG000|Overall Study|Lost to Follow-up|0|||
144286551|NCT00541775|520251102|FG001|Overall Study|Lost to Follow-up|0|||
144286552|NCT00541775|520251103|FG002|Overall Study|Lost to Follow-up|2|||
144286553|NCT00541775|520251101|FG000|Overall Study|Protocol Violation|1|||
144286554|NCT00541775|520251102|FG001|Overall Study|Protocol Violation|0|||
144286555|NCT00541775|520251103|FG002|Overall Study|Protocol Violation|0|||
144286556|NCT00541775|520251101|FG000|Overall Study|Withdrawal by Subject and Other|5|||
144286557|NCT00541775|520251102|FG001|Overall Study|Withdrawal by Subject and Other|0|||
144286558|NCT00541775|520251103|FG002|Overall Study|Withdrawal by Subject and Other|2|||
144286559|NCT00032487|520251104|FG000|Overall Study|Withdrawal by Subject|67|||
144286560|NCT00032487|520251105|FG001|Overall Study|Withdrawal by Subject|43|||
144286561|NCT00032487|520251104|FG000|Overall Study|Adverse Event|3|||
144286562|NCT00032487|520251105|FG001|Overall Study|Adverse Event|7|||
144286563|NCT00032487|520251104|FG000|Overall Study|Lost to Follow-up|57|||
144286564|NCT00032487|520251105|FG001|Overall Study|Lost to Follow-up|58|||
144286565|NCT00032487|520251104|FG000|Overall Study|Had other reason|12|||
144286566|NCT00032487|520251105|FG001|Overall Study|Had other reason|12|||
144286567|NCT04913675|520251107|FG000|Main Study (Up to Week 36)|Death|0|||
144286568|NCT04913675|520251108|FG001|Main Study (Up to Week 36)|Death|2|||
144286569|NCT04913675|520251109|FG002|Main Study (Up to Week 36)|Death|2|||
144286570|NCT04913675|520251110|FG003|Main Study (Up to Week 36)|Death|0|||
144286571|NCT04913675|520251107|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
144286572|NCT04913675|520251108|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
144286573|NCT04913675|520251109|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
144286574|NCT04913675|520251110|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
144286575|NCT04913675|520251107|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
144286576|NCT04913675|520251108|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
144286577|NCT04913675|520251109|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
144286578|NCT04913675|520251110|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
144286579|NCT04913675|520251107|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
144286580|NCT04913675|520251108|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
144286581|NCT04913675|520251109|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
144286582|NCT04913675|520251110|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
144286583|NCT04913675|520251107|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
144286584|NCT04913675|520251108|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
144286585|NCT04913675|520251109|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
144286586|NCT04913675|520251110|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
144286587|NCT02975700|520251111|FG000|Overall Study|Adverse Event|1|||
144286588|NCT02975700|520251111|FG000|Overall Study|Progressive disease|3|||
144286589|NCT02975700|520251111|FG000|Overall Study|Failed screening criteria|2|||
144286590|NCT01541254|520251113|FG000|Overall Study|Withdrawal by Subject|1|||
144286591|NCT01541254|520251113|FG000|Overall Study|excluded - metal allergy|1|||
144286592|NCT01541254|520251113|FG000|Overall Study|enrolled after study closed|1|||
144286593|NCT01541254|520251113|FG000|Overall Study|GI bleed prior to procedure|1|||
144286594|NCT01541254|520251113|FG000|Overall Study|stent not required|1|||
144286595|NCT01541254|520251113|FG000|Overall Study|alternate stent used|1|||
144286596|NCT03462563|520251117|FG000|Overall Study|Death|1|||
144286597|NCT03462563|520251118|FG001|Overall Study|Death|1|||
144286598|NCT03462563|520251117|FG000|Overall Study|Termination of study|2|||
144286599|NCT03462563|520251118|FG001|Overall Study|Termination of study|1|||
144286600|NCT03462563|520251117|FG000|Overall Study|Adverse Event|1|||
144286601|NCT03462563|520251118|FG001|Overall Study|Adverse Event|3|||
144286602|NCT03462563|520251117|FG000|Overall Study|Unspecified reason|10|||
144286603|NCT03462563|520251118|FG001|Overall Study|Unspecified reason|12|||
144286604|NCT03462563|520251117|FG000|Overall Study|Physician Decision|1|||
144286605|NCT03462563|520251118|FG001|Overall Study|Physician Decision|0|||
144286606|NCT05737745|520251119|FG000|Overall Study|Withdrawal by Subject|0|||
144286607|NCT05737745|520251120|FG001|Overall Study|Withdrawal by Subject|6|||
144286608|NCT05737745|520251121|FG002|Overall Study|Withdrawal by Subject|1|||
144286609|NCT02021318|520251122|FG000|Overall Study|Adverse Event|2|||
144286610|NCT02021318|520251123|FG001|Overall Study|Adverse Event|1|||
144286611|NCT02021318|520251122|FG000|Overall Study|Death|33|||
144286612|NCT02021318|520251123|FG001|Overall Study|Death|34|||
144286613|NCT02021318|520251122|FG000|Overall Study|Lost to Follow-up|3|||
144286614|NCT02021318|520251123|FG001|Overall Study|Lost to Follow-up|3|||
144286615|NCT02021318|520251122|FG000|Overall Study|Progressive Disease|0|||
144286616|NCT02021318|520251123|FG001|Overall Study|Progressive Disease|1|||
144286617|NCT02021318|520251122|FG000|Overall Study|Withdrawal by Subject|30|||
144286618|NCT02021318|520251123|FG001|Overall Study|Withdrawal by Subject|18|||
144286619|NCT02021318|520251122|FG000|Overall Study|Physician Decision|3|||
144286620|NCT02021318|520251123|FG001|Overall Study|Physician Decision|3|||
144286621|NCT02021318|520251122|FG000|Overall Study|Miscellaneous|2|||
144286622|NCT02021318|520251123|FG001|Overall Study|Miscellaneous|3|||
144286623|NCT02569242|520251124|FG000|Overall Study|Death|1|||
144286624|NCT02569242|520251125|FG001|Overall Study|Death|0|||
144286625|NCT02569242|520251124|FG000|Overall Study|Withdrawal by Subject|0|||
144286626|NCT02569242|520251125|FG001|Overall Study|Withdrawal by Subject|1|||
144286627|NCT00689052|520251126|FG000|Overall Study|Adverse Event|4|||
144286628|NCT00689052|520251127|FG001|Overall Study|Adverse Event|6|||
144286629|NCT00689052|520251126|FG000|Overall Study|Protocol Violation|1|||
144286630|NCT00689052|520251127|FG001|Overall Study|Protocol Violation|0|||
144286631|NCT00689052|520251126|FG000|Overall Study|Lost to Follow-up|2|||
144286632|NCT00689052|520251127|FG001|Overall Study|Lost to Follow-up|0|||
144286633|NCT00689052|520251126|FG000|Overall Study|Withdrawal by Subject|2|||
144286634|NCT00689052|520251127|FG001|Overall Study|Withdrawal by Subject|0|||
144286635|NCT00689052|520251126|FG000|Overall Study|Early termination of the trial|22|||
144286636|NCT00689052|520251127|FG001|Overall Study|Early termination of the trial|24|||
144286637|NCT04796207|520251130|FG000|Overall Study|Lost to Follow-up|7|||
144286638|NCT04796207|520251131|FG001|Overall Study|Lost to Follow-up|2|||
144286639|NCT03003468|520251134|FG000|Overall Study|Withdrawal by Subject|0|||
144286640|NCT03003468|520251135|FG001|Overall Study|Withdrawal by Subject|0|||
144286641|NCT03003468|520251136|FG002|Overall Study|Withdrawal by Subject|1|||
144286642|NCT03003468|520251134|FG000|Overall Study|No measurable lesions|0|||
144286643|NCT03003468|520251135|FG001|Overall Study|No measurable lesions|0|||
144286644|NCT03003468|520251136|FG002|Overall Study|No measurable lesions|1|||
144286645|NCT02405962|520251137|FG000|Overall Study|Lost to Follow-up|1|||
144286646|NCT02405962|520251138|FG001|Overall Study|Lost to Follow-up|4|||
144286647|NCT02405962|520251137|FG000|Overall Study|A participant has moved to another place|0|||
144286648|NCT02405962|520251138|FG001|Overall Study|A participant has moved to another place|1|||
144286649|NCT00165698|520251139|FG000|Overall Study|Adverse Event|2|||
144286650|NCT00165698|520251140|FG001|Overall Study|Adverse Event|10|||
144286651|NCT00165698|520251139|FG000|Overall Study|Lost to Follow-up|2|||
144286652|NCT00165698|520251140|FG001|Overall Study|Lost to Follow-up|2|||
144286653|NCT00165698|520251139|FG000|Overall Study|Withdrawal by Subject|2|||
144286654|NCT00165698|520251140|FG001|Overall Study|Withdrawal by Subject|1|||
144286655|NCT00165698|520251139|FG000|Overall Study|Protocol Violation|1|||
144286656|NCT00165698|520251140|FG001|Overall Study|Protocol Violation|0|||
144286657|NCT00165698|520251139|FG000|Overall Study|Not Taken/Lost the medicine|1|||
144286658|NCT00165698|520251140|FG001|Overall Study|Not Taken/Lost the medicine|2|||
144286659|NCT01107457|520251141|FG000|Part A|Adverse Event|1|||
144286660|NCT01107457|520251142|FG001|Part A|Adverse Event|2|||
144286661|NCT01107457|520251143|FG002|Part A|Adverse Event|1|||
144286662|NCT01107457|520251144|FG003|Part A|Adverse Event|0|||
144286663|NCT01107457|520251145|FG004|Part A|Adverse Event|0|||
144286664|NCT01107457|520251146|FG005|Part A|Adverse Event|0|||
144286665|NCT01107457|520251141|FG000|Part A|Withdrawal by Subject|3|||
144286666|NCT01107457|520251142|FG001|Part A|Withdrawal by Subject|3|||
144286667|NCT01107457|520251143|FG002|Part A|Withdrawal by Subject|0|||
144286668|NCT01107457|520251144|FG003|Part A|Withdrawal by Subject|3|||
144286669|NCT01107457|520251145|FG004|Part A|Withdrawal by Subject|1|||
144286670|NCT01107457|520251146|FG005|Part A|Withdrawal by Subject|0|||
144286671|NCT01107457|520251141|FG000|Part A|Lost to Follow-up|0|||
144286672|NCT01107457|520251142|FG001|Part A|Lost to Follow-up|1|||
144286673|NCT01107457|520251143|FG002|Part A|Lost to Follow-up|0|||
144286674|NCT01107457|520251144|FG003|Part A|Lost to Follow-up|0|||
144286675|NCT01107457|520251145|FG004|Part A|Lost to Follow-up|0|||
144286676|NCT01107457|520251146|FG005|Part A|Lost to Follow-up|0|||
144286677|NCT01107457|520251141|FG000|Part A|Lack of Efficacy|1|||
144286678|NCT01107457|520251142|FG001|Part A|Lack of Efficacy|0|||
144286679|NCT01107457|520251143|FG002|Part A|Lack of Efficacy|0|||
144286680|NCT01107457|520251144|FG003|Part A|Lack of Efficacy|0|||
144286681|NCT01107457|520251145|FG004|Part A|Lack of Efficacy|0|||
144286682|NCT01107457|520251146|FG005|Part A|Lack of Efficacy|0|||
144286683|NCT01107457|520251141|FG000|Part A|Protocol Violation|0|||
144286684|NCT01107457|520251142|FG001|Part A|Protocol Violation|1|||
144286685|NCT01107457|520251143|FG002|Part A|Protocol Violation|0|||
144286686|NCT01107457|520251144|FG003|Part A|Protocol Violation|0|||
144286687|NCT01107457|520251145|FG004|Part A|Protocol Violation|0|||
144286688|NCT01107457|520251146|FG005|Part A|Protocol Violation|0|||
144286689|NCT01107457|520251141|FG000|Part B and C|Adverse Event|0|||
144286690|NCT01107457|520251142|FG001|Part B and C|Adverse Event|0|||
144286691|NCT01107457|520251143|FG002|Part B and C|Adverse Event|0|||
144286692|NCT01107457|520251144|FG003|Part B and C|Adverse Event|0|||
144286693|NCT01107457|520251145|FG004|Part B and C|Adverse Event|0|||
144286694|NCT01107457|520251146|FG005|Part B and C|Adverse Event|12|||
144286695|NCT01107457|520251141|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
144286696|NCT01107457|520251142|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
144286697|NCT01107457|520251143|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
144286698|NCT01107457|520251144|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
144286699|NCT01107457|520251145|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
144286700|NCT01107457|520251146|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
144286701|NCT01107457|520251141|FG000|Part B and C|Physician Decision|0|||
144286702|NCT01107457|520251142|FG001|Part B and C|Physician Decision|0|||
144286703|NCT01107457|520251143|FG002|Part B and C|Physician Decision|0|||
144286704|NCT01107457|520251144|FG003|Part B and C|Physician Decision|0|||
144286705|NCT01107457|520251145|FG004|Part B and C|Physician Decision|0|||
144286706|NCT01107457|520251146|FG005|Part B and C|Physician Decision|3|||
144286707|NCT01107457|520251141|FG000|Part B and C|Lack of Efficacy|0|||
144286708|NCT01107457|520251142|FG001|Part B and C|Lack of Efficacy|0|||
144286709|NCT01107457|520251143|FG002|Part B and C|Lack of Efficacy|0|||
144286710|NCT01107457|520251144|FG003|Part B and C|Lack of Efficacy|0|||
144286711|NCT01107457|520251145|FG004|Part B and C|Lack of Efficacy|0|||
144286712|NCT01107457|520251146|FG005|Part B and C|Lack of Efficacy|7|||
144286713|NCT01107457|520251141|FG000|Part B and C|Lost to Follow-up|0|||
144286714|NCT01107457|520251142|FG001|Part B and C|Lost to Follow-up|0|||
144286715|NCT01107457|520251143|FG002|Part B and C|Lost to Follow-up|0|||
144286716|NCT01107457|520251144|FG003|Part B and C|Lost to Follow-up|0|||
144286717|NCT01107457|520251145|FG004|Part B and C|Lost to Follow-up|0|||
144286718|NCT01107457|520251146|FG005|Part B and C|Lost to Follow-up|10|||
144286719|NCT01107457|520251141|FG000|Part B and C|Protocol Violation|0|||
144286720|NCT01107457|520251142|FG001|Part B and C|Protocol Violation|0|||
144286721|NCT01107457|520251143|FG002|Part B and C|Protocol Violation|0|||
144286722|NCT01107457|520251144|FG003|Part B and C|Protocol Violation|0|||
144286723|NCT01107457|520251145|FG004|Part B and C|Protocol Violation|0|||
144286724|NCT01107457|520251146|FG005|Part B and C|Protocol Violation|1|||
144286725|NCT01107457|520251141|FG000|Part B and C|Sponsor Decision|0|||
144286726|NCT01107457|520251142|FG001|Part B and C|Sponsor Decision|0|||
144286727|NCT01107457|520251143|FG002|Part B and C|Sponsor Decision|0|||
144286728|NCT01107457|520251144|FG003|Part B and C|Sponsor Decision|0|||
144286729|NCT01107457|520251145|FG004|Part B and C|Sponsor Decision|0|||
144286730|NCT01107457|520251146|FG005|Part B and C|Sponsor Decision|66|||
144286731|NCT01107457|520251141|FG000|Part B and C|Withdrawal by Subject|0|||
144286732|NCT01107457|520251142|FG001|Part B and C|Withdrawal by Subject|0|||
144286733|NCT01107457|520251143|FG002|Part B and C|Withdrawal by Subject|0|||
144286734|NCT01107457|520251144|FG003|Part B and C|Withdrawal by Subject|0|||
144286735|NCT01107457|520251145|FG004|Part B and C|Withdrawal by Subject|0|||
144286736|NCT01107457|520251146|FG005|Part B and C|Withdrawal by Subject|16|||
144286737|NCT01107457|520251141|FG000|Part B and C|Clinical Relapse|0|||
144286738|NCT01107457|520251142|FG001|Part B and C|Clinical Relapse|0|||
144286739|NCT01107457|520251143|FG002|Part B and C|Clinical Relapse|0|||
144286740|NCT01107457|520251144|FG003|Part B and C|Clinical Relapse|0|||
144286741|NCT01107457|520251145|FG004|Part B and C|Clinical Relapse|0|||
144286742|NCT01107457|520251146|FG005|Part B and C|Clinical Relapse|4|||
144286743|NCT02547935|520251147|FG000|Overall Study|Other|0|||
144286744|NCT02547935|520251148|FG001|Overall Study|Other|1|||
144286745|NCT02547935|520251149|FG002|Overall Study|Other|0|||
144286746|NCT02547935|520251147|FG000|Overall Study|Withdrawal by Subject|2|||
144286747|NCT02547935|520251148|FG001|Overall Study|Withdrawal by Subject|3|||
144286748|NCT02547935|520251149|FG002|Overall Study|Withdrawal by Subject|4|||
144286749|NCT02547935|520251147|FG000|Overall Study|Screen Failure|2|||
144286750|NCT02547935|520251148|FG001|Overall Study|Screen Failure|0|||
144286751|NCT02547935|520251149|FG002|Overall Study|Screen Failure|0|||
144286752|NCT02547935|520251147|FG000|Overall Study|Physician Decision|0|||
144286753|NCT02547935|520251148|FG001|Overall Study|Physician Decision|1|||
144286754|NCT02547935|520251149|FG002|Overall Study|Physician Decision|0|||
144286755|NCT02547935|520251147|FG000|Overall Study|Lost to Follow-up|0|||
144286756|NCT02547935|520251148|FG001|Overall Study|Lost to Follow-up|2|||
144286757|NCT02547935|520251149|FG002|Overall Study|Lost to Follow-up|1|||
144286758|NCT02547935|520251147|FG000|Overall Study|Death|1|||
144286759|NCT02547935|520251148|FG001|Overall Study|Death|1|||
144286760|NCT02547935|520251149|FG002|Overall Study|Death|0|||
144286761|NCT00003474|520251153|FG000|Overall Study|Not Evaluable|14|||
144286762|NCT02186171|520251154|FG000|Overall Study|Withdrawal by Subject|1|||
144286763|NCT02186171|520251155|FG001|Overall Study|Withdrawal by Subject|9|||
144286764|NCT02186171|520251154|FG000|Overall Study|Lost to Follow-up|2|||
144286765|NCT02186171|520251155|FG001|Overall Study|Lost to Follow-up|2|||
144286766|NCT02186171|520251154|FG000|Overall Study|Death|1|||
144286767|NCT02186171|520251155|FG001|Overall Study|Death|2|||
144286768|NCT02186171|520251154|FG000|Overall Study|Protocol-specified Criteria|0|||
144286769|NCT02186171|520251155|FG001|Overall Study|Protocol-specified Criteria|2|||
144286770|NCT01567085|520253183|FG000|Overall Study|Death|6|||
144286771|NCT01567085|520253183|FG000|Overall Study|Adverse Event|6|||
144286772|NCT01567085|520253183|FG000|Overall Study|Lost to Follow-up|3|||
144286773|NCT01567085|520253183|FG000|Overall Study|Graft loss|2|||
144286774|NCT01567085|520253183|FG000|Overall Study|Renal transplantectomy|1|||
144286775|NCT01567085|520253183|FG000|Overall Study|Returned to chronic dialysis|1|||
144286776|NCT01567085|520253183|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
144286777|NCT03312114|520253189|FG000|Overall Study|All the five enrolled dropped out of the|5|||
144286778|NCT03537729|520253190|FG000|Overall Study|Death|2|||
144286779|NCT03537729|520253191|FG001|Overall Study|Death|2|||
144286780|NCT03537729|520253192|FG002|Overall Study|Death|7|||
144286781|NCT03537729|520253190|FG000|Overall Study|Withdrawal by Subject|3|||
144286782|NCT03537729|520253191|FG001|Overall Study|Withdrawal by Subject|3|||
144286783|NCT03537729|520253192|FG002|Overall Study|Withdrawal by Subject|0|||
144286784|NCT03537729|520253190|FG000|Overall Study|Subject Moved|8|||
144286785|NCT03537729|520253191|FG001|Overall Study|Subject Moved|5|||
144286786|NCT03537729|520253192|FG002|Overall Study|Subject Moved|4|||
144286787|NCT03537729|520253190|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
144286788|NCT03537729|520253191|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
144286789|NCT03537729|520253192|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
144286790|NCT03537729|520253190|FG000|Overall Study|COVID-19 Site Restrictions|11|||
144286791|NCT03537729|520253191|FG001|Overall Study|COVID-19 Site Restrictions|15|||
144286792|NCT03537729|520253192|FG002|Overall Study|COVID-19 Site Restrictions|18|||
144286793|NCT03537729|520253190|FG000|Overall Study|Decline in Health|5|||
144286794|NCT03537729|520253191|FG001|Overall Study|Decline in Health|9|||
144286795|NCT03537729|520253192|FG002|Overall Study|Decline in Health|4|||
144286796|NCT03537729|520253190|FG000|Overall Study|Determined Ineligible|0|||
144286797|NCT03537729|520253191|FG001|Overall Study|Determined Ineligible|0|||
144286798|NCT03537729|520253192|FG002|Overall Study|Determined Ineligible|1|||
144286799|NCT00284934|520253193|FG000|Overall Study|Adverse Event|1|||
144286800|NCT00284934|520253194|FG001|Overall Study|Adverse Event|2|||
144286801|NCT00284934|520253193|FG000|Overall Study|Other reasons|3|||
144286802|NCT00284934|520253194|FG001|Overall Study|Other reasons|1|||
144286803|NCT00454142|520253195|FG000|Overall Study|Withdrawal by Subject|1|||
144286804|NCT00520572|520253203|FG000|Overall Study|Adverse Event|9|||
144286805|NCT00520572|520253204|FG001|Overall Study|Adverse Event|3|||
144286806|NCT00520572|520253205|FG002|Overall Study|Adverse Event|6|||
144286807|NCT00520572|520253206|FG003|Overall Study|Adverse Event|9|||
144286808|NCT00520572|520253207|FG004|Overall Study|Adverse Event|7|||
144286809|NCT00520572|520253208|FG005|Overall Study|Adverse Event|2|||
144286810|NCT00520572|520253203|FG000|Overall Study|Withdrawal by Subject|0|||
144286811|NCT00520572|520253204|FG001|Overall Study|Withdrawal by Subject|9|||
144286812|NCT00520572|520253205|FG002|Overall Study|Withdrawal by Subject|5|||
144286813|NCT00520572|520253206|FG003|Overall Study|Withdrawal by Subject|2|||
144286814|NCT00520572|520253207|FG004|Overall Study|Withdrawal by Subject|2|||
144286815|NCT00520572|520253208|FG005|Overall Study|Withdrawal by Subject|0|||
144286816|NCT00520572|520253203|FG000|Overall Study|Protocol Violation|0|||
144286817|NCT00520572|520253204|FG001|Overall Study|Protocol Violation|0|||
144286818|NCT00520572|520253205|FG002|Overall Study|Protocol Violation|1|||
144286819|NCT00520572|520253206|FG003|Overall Study|Protocol Violation|0|||
144286820|NCT00520572|520253207|FG004|Overall Study|Protocol Violation|0|||
144286821|NCT00520572|520253208|FG005|Overall Study|Protocol Violation|0|||
144286822|NCT00520572|520253203|FG000|Overall Study|Lack of Efficacy|1|||
144286823|NCT00520572|520253204|FG001|Overall Study|Lack of Efficacy|1|||
144286824|NCT00520572|520253205|FG002|Overall Study|Lack of Efficacy|1|||
144286825|NCT00520572|520253206|FG003|Overall Study|Lack of Efficacy|2|||
144286826|NCT00520572|520253207|FG004|Overall Study|Lack of Efficacy|1|||
144286827|NCT00520572|520253208|FG005|Overall Study|Lack of Efficacy|0|||
144286828|NCT00520572|520253203|FG000|Overall Study|Lost to Follow-up|0|||
144286829|NCT00520572|520253204|FG001|Overall Study|Lost to Follow-up|0|||
144286830|NCT00520572|520253205|FG002|Overall Study|Lost to Follow-up|0|||
144286831|NCT00520572|520253206|FG003|Overall Study|Lost to Follow-up|0|||
144286832|NCT00520572|520253207|FG004|Overall Study|Lost to Follow-up|1|||
144286833|NCT00520572|520253208|FG005|Overall Study|Lost to Follow-up|0|||
144286834|NCT00520572|520253203|FG000|Overall Study|Incorrect enrollment|1|||
144286835|NCT00520572|520253204|FG001|Overall Study|Incorrect enrollment|0|||
144286836|NCT00520572|520253205|FG002|Overall Study|Incorrect enrollment|1|||
144286837|NCT00520572|520253206|FG003|Overall Study|Incorrect enrollment|0|||
144286838|NCT00520572|520253207|FG004|Overall Study|Incorrect enrollment|1|||
144286839|NCT00520572|520253208|FG005|Overall Study|Incorrect enrollment|0|||
144286840|NCT00520572|520253203|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
144286841|NCT00520572|520253204|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
144286842|NCT00520572|520253205|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
144286843|NCT00520572|520253206|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
144286844|NCT00520572|520253207|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
144286845|NCT00520572|520253208|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
144286846|NCT00520572|520253203|FG000|Overall Study|Long break in taking Medication|0|||
144286847|NCT00520572|520253204|FG001|Overall Study|Long break in taking Medication|0|||
144286848|NCT00520572|520253205|FG002|Overall Study|Long break in taking Medication|0|||
144286849|NCT00520572|520253206|FG003|Overall Study|Long break in taking Medication|1|||
144286850|NCT00520572|520253207|FG004|Overall Study|Long break in taking Medication|0|||
144286851|NCT00520572|520253208|FG005|Overall Study|Long break in taking Medication|0|||
144286852|NCT00520572|520253203|FG000|Overall Study|Did not receive Treatment|1|||
144286853|NCT00520572|520253204|FG001|Overall Study|Did not receive Treatment|0|||
144286854|NCT00520572|520253205|FG002|Overall Study|Did not receive Treatment|1|||
144286855|NCT00520572|520253206|FG003|Overall Study|Did not receive Treatment|0|||
144286856|NCT00520572|520253207|FG004|Overall Study|Did not receive Treatment|0|||
144286857|NCT00520572|520253208|FG005|Overall Study|Did not receive Treatment|0|||
144286858|NCT02802865|520253211|FG000|Overall Study|Pregnancy|1|||
144286859|NCT02802865|520253212|FG001|Overall Study|Pregnancy|1|||
144286860|NCT02802865|520253211|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
144286861|NCT02802865|520253212|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
144286862|NCT01748552|520253215|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
144286863|NCT01748552|520253216|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
144286864|NCT01748552|520253217|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
144286865|NCT01748552|520253218|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
144286866|NCT01748552|520253219|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
144286867|NCT01748552|520253220|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
144286868|NCT01748552|520253221|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
144286869|NCT01748552|520253222|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
144286870|NCT01748552|520253223|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
144286871|NCT01748552|520253224|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
144286872|NCT01748552|520253225|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
144286873|NCT01748552|520253226|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
144286874|NCT01748552|520253215|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286875|NCT01748552|520253216|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286876|NCT01748552|520253217|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286877|NCT01748552|520253218|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286878|NCT01748552|520253219|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286879|NCT01748552|520253220|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286880|NCT01748552|520253221|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
144286881|NCT01748552|520253222|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
144286882|NCT01748552|520253223|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
144286883|NCT01748552|520253224|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286884|NCT01748552|520253225|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286885|NCT01748552|520253226|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
144286886|NCT01529112|520253227|FG000|Overall Study|Adverse Event|2|||
144286887|NCT01529112|520253228|FG001|Overall Study|Adverse Event|0|||
144286888|NCT01529112|520253227|FG000|Overall Study|Death|59|||
144286889|NCT01529112|520253228|FG001|Overall Study|Death|38|||
144286890|NCT01529112|520253227|FG000|Overall Study|Protocol Violation|1|||
144286891|NCT01529112|520253228|FG001|Overall Study|Protocol Violation|0|||
144286892|NCT01529112|520253227|FG000|Overall Study|Withdrawal by Subject|7|||
144286893|NCT01529112|520253228|FG001|Overall Study|Withdrawal by Subject|3|||
144286894|NCT03607695|520253230|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
144286895|NCT03607695|520253230|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
144286896|NCT02930941|520253231|FG000|Overall Study|Lost to Follow-up|1|||
144286897|NCT02930941|520253232|FG001|Overall Study|Lost to Follow-up|2|||
144286898|NCT01428713|520253233|FG000|Overall Study|Non-compliance|2|||
144286899|NCT01428713|520253234|FG001|Overall Study|Non-compliance|2|||
144286900|NCT01428713|520253233|FG000|Overall Study|Withdrawal by Subject|1|||
144286901|NCT01428713|520253234|FG001|Overall Study|Withdrawal by Subject|1|||
144286902|NCT01428713|520253233|FG000|Overall Study|Adverse Event|0|||
144286903|NCT01428713|520253234|FG001|Overall Study|Adverse Event|2|||
144286904|NCT00585169|520253237|FG000|Overall Study|Withdrawal by Subject|1|||
144286905|NCT01964560|520253240|FG000|Overall Study|Adverse Event|23|||
144286906|NCT01964560|520253240|FG000|Overall Study|Lack of Efficacy|46|||
144286907|NCT01964560|520253240|FG000|Overall Study|Protocol deviation|2|||
144286908|NCT01964560|520253240|FG000|Overall Study|Lost to Follow-up|4|||
144286909|NCT01964560|520253240|FG000|Overall Study|Withdrawal by Subject|64|||
144286910|NCT01964560|520253240|FG000|Overall Study|Surgery-hemispherotomy|1|||
144286911|NCT01964560|520253240|FG000|Overall Study|Surgery|1|||
144286912|NCT01964560|520253240|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
144286913|NCT01964560|520253240|FG000|Overall Study|Patient and Investigator choice|1|||
144286914|NCT01964560|520253240|FG000|Overall Study|Patient was prescribed CBD|1|||
144286915|NCT01964560|520253240|FG000|Overall Study|Participant moved to another country|1|||
144286916|NCT00710554|520253246|FG000|Overall Study|Adverse Event|24|||
144286917|NCT00710554|520253247|FG001|Overall Study|Adverse Event|7|||
144286918|NCT00710554|520253246|FG000|Overall Study|Withdrawal by Subject|7|||
144286919|NCT00710554|520253247|FG001|Overall Study|Withdrawal by Subject|3|||
144286920|NCT00710554|520253246|FG000|Overall Study|Lost to Follow-up|7|||
144286921|NCT00710554|520253247|FG001|Overall Study|Lost to Follow-up|1|||
144286922|NCT00710554|520253246|FG000|Overall Study|Lack of Efficacy|11|||
144286923|NCT00710554|520253247|FG001|Overall Study|Lack of Efficacy|12|||
144286924|NCT00710554|520253246|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
144286925|NCT00710554|520253247|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
144286926|NCT01093885|520253248|FG000|Overall Study|Adverse Event|4|||
144286927|NCT01093885|520253248|FG000|Overall Study|Lost to Follow-up|1|||
144286928|NCT01301001|520253249|FG000|First Intervention|Lost to Follow-up|4|||
144286929|NCT01301001|520253250|FG001|First Intervention|Lost to Follow-up|4|||
144286930|NCT01301001|520253249|FG000|First Intervention|Withdrawal by Subject|1|||
144286931|NCT01301001|520253250|FG001|First Intervention|Withdrawal by Subject|4|||
144286932|NCT01301001|520253249|FG000|First Intervention|Adverse Event|5|||
144286933|NCT01301001|520253250|FG001|First Intervention|Adverse Event|0|||
144286934|NCT01301001|520253249|FG000|First Intervention|Protocol Violation|0|||
144286935|NCT01301001|520253250|FG001|First Intervention|Protocol Violation|1|||
144286936|NCT01301001|520253249|FG000|Second Intervention|Adverse Event|2|||
144286937|NCT01301001|520253250|FG001|Second Intervention|Adverse Event|0|||
144286938|NCT01301001|520253249|FG000|Second Intervention|Withdrawal by Subject|2|||
144286939|NCT01301001|520253250|FG001|Second Intervention|Withdrawal by Subject|0|||
144286940|NCT02018887|520253257|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
144286941|NCT02018887|520253258|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286942|NCT02018887|520253259|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286943|NCT02018887|520253260|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286944|NCT02018887|520253261|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286945|NCT02018887|520253262|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286946|NCT02018887|520253263|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286947|NCT02018887|520253264|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286948|NCT02018887|520253265|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286949|NCT02018887|520253266|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286950|NCT02018887|520253267|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
144286951|NCT02018887|520253257|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286952|NCT02018887|520253258|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286953|NCT02018887|520253259|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286954|NCT02018887|520253260|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286955|NCT02018887|520253261|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
144246012|NCT02380859|520098207|FG000|Overall Study|Withdrawal by Subject|2|||
144246013|NCT02380859|520098208|FG001|Overall Study|Withdrawal by Subject|0|||
144246014|NCT01565668|520098209|FG000|Overall Study|Death|2|||
144246015|NCT01565668|520098210|FG001|Overall Study|Death|1|||
144246016|NCT01565668|520098209|FG000|Overall Study|Lack of Efficacy|4|||
144246017|NCT01565668|520098210|FG001|Overall Study|Lack of Efficacy|2|||
144246018|NCT01565668|520098209|FG000|Overall Study|Participant went on Hospice Care|1|||
144246019|NCT01565668|520098210|FG001|Overall Study|Participant went on Hospice Care|0|||
144246020|NCT01565668|520098209|FG000|Overall Study|Adverse Event|6|||
144246021|NCT01565668|520098210|FG001|Overall Study|Adverse Event|1|||
144246022|NCT01565668|520098209|FG000|Overall Study|Randomized, but never received drug|0|||
144246023|NCT01565668|520098210|FG001|Overall Study|Randomized, but never received drug|2|||
144246024|NCT01565668|520098209|FG000|Overall Study|Progressive disease|13|||
144246025|NCT01565668|520098210|FG001|Overall Study|Progressive disease|14|||
144246026|NCT01565668|520098209|FG000|Overall Study|Withdrawal by Subject|1|||
144246027|NCT01565668|520098210|FG001|Overall Study|Withdrawal by Subject|3|||
144246028|NCT01565668|520098209|FG000|Overall Study|HSCT Transplant|11|||
144246029|NCT01565668|520098210|FG001|Overall Study|HSCT Transplant|15|||
144246030|NCT04829331|520098211|FG000|Overall Study|Lost to Follow-up|1|||
144246031|NCT04829331|520098212|FG001|Overall Study|Lost to Follow-up|0|||
144246032|NCT02604550|520098217|FG000|Overall Study|Lost to Follow-up|7|||
144246033|NCT02604550|520098218|FG001|Overall Study|Lost to Follow-up|6|||
144246034|NCT02604550|520098217|FG000|Overall Study|Withdrawal by Subject|0|||
144246035|NCT02604550|520098218|FG001|Overall Study|Withdrawal by Subject|1|||
144246036|NCT02604550|520098217|FG000|Overall Study|Incomplete data using paper journal|18|||
144246037|NCT02604550|520098218|FG001|Overall Study|Incomplete data using paper journal|19|||
144246038|NCT03747302|520098219|FG000|Overall Study|Withdrawal by Subject|1|||
144246039|NCT03747302|520098220|FG001|Overall Study|Withdrawal by Subject|2|||
144246040|NCT01032070|520098223|FG000|Overall Study|Disease progression|13|||
144246041|NCT01032070|520098224|FG001|Overall Study|Disease progression|8|||
144246042|NCT01032070|520098223|FG000|Overall Study|Medical or ethical reasons|0|||
144246043|NCT01032070|520098224|FG001|Overall Study|Medical or ethical reasons|2|||
144246044|NCT01032070|520098223|FG000|Overall Study|Withdrawal by Subject|0|||
144246045|NCT01032070|520098224|FG001|Overall Study|Withdrawal by Subject|2|||
144246046|NCT00738062|520098225|FG000|Open Label Treatment|Lack of Efficacy|5|||
144246047|NCT00738062|520098226|FG001|Open Label Treatment|Lack of Efficacy|0|||
144246048|NCT00738062|520098227|FG002|Open Label Treatment|Lack of Efficacy|0|||
144246049|NCT00738062|520098225|FG000|Open Label Treatment|Adverse Event|11|||
144246050|NCT00738062|520098226|FG001|Open Label Treatment|Adverse Event|0|||
144246051|NCT00738062|520098227|FG002|Open Label Treatment|Adverse Event|0|||
144286956|NCT02018887|520253262|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286957|NCT02018887|520253263|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
144286958|NCT02018887|520253264|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
144286959|NCT02018887|520253265|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286960|NCT02018887|520253266|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286961|NCT02018887|520253267|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
144286962|NCT02018887|520253257|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
144286963|NCT02018887|520253258|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
144286964|NCT02018887|520253259|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
144286965|NCT02018887|520253260|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
144286966|NCT02018887|520253261|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
144286967|NCT02018887|520253262|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
144286968|NCT02018887|520253263|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
144286969|NCT02018887|520253264|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
144286970|NCT02018887|520253265|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
144286971|NCT02018887|520253266|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
144286972|NCT02018887|520253267|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
144286973|NCT02018887|520253257|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
144286974|NCT02018887|520253258|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
144286975|NCT02018887|520253259|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
144286976|NCT02018887|520253260|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
144286977|NCT02018887|520253261|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
144286978|NCT02018887|520253262|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
144286979|NCT02018887|520253263|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
144286980|NCT02018887|520253264|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
144286981|NCT02018887|520253265|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
144286982|NCT02018887|520253266|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
144286983|NCT02018887|520253267|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
144286984|NCT01058005|520253268|FG000|Overall Study|Adverse Event|0|||
144286985|NCT01058005|520253269|FG001|Overall Study|Adverse Event|2|||
144286986|NCT01058005|520253270|FG002|Overall Study|Adverse Event|1|||
144286987|NCT01058005|520253268|FG000|Overall Study|Physician Decision|2|||
144286988|NCT01058005|520253269|FG001|Overall Study|Physician Decision|2|||
144286989|NCT01058005|520253270|FG002|Overall Study|Physician Decision|0|||
144286990|NCT01058005|520253268|FG000|Overall Study|Withdrawal by Subject|4|||
144286991|NCT01058005|520253269|FG001|Overall Study|Withdrawal by Subject|5|||
144286992|NCT01058005|520253270|FG002|Overall Study|Withdrawal by Subject|11|||
144286993|NCT01058005|520253268|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
144286994|NCT01058005|520253269|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
144286995|NCT01058005|520253270|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
144286996|NCT01058005|520253268|FG000|Overall Study|Reason Missing|5|||
144286997|NCT01058005|520253269|FG001|Overall Study|Reason Missing|3|||
144286998|NCT01058005|520253270|FG002|Overall Study|Reason Missing|1|||
144286999|NCT01145222|520253271|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
144287000|NCT01145222|520253272|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
144287001|NCT01145222|520253273|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
144287002|NCT01145222|520253274|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
144287003|NCT01145222|520253271|FG000|Overall Study|Poor bowel preparation|0|||
144287004|NCT01145222|520253272|FG001|Overall Study|Poor bowel preparation|0|||
144287005|NCT01145222|520253273|FG002|Overall Study|Poor bowel preparation|0|||
144287006|NCT01145222|520253274|FG003|Overall Study|Poor bowel preparation|1|||
144287007|NCT01698008|520253275|FG000|Overall Study|Withdrawal by Subject|1|||
144287008|NCT01698008|520253276|FG001|Overall Study|Withdrawal by Subject|2|||
144287009|NCT01011283|520253278|FG000|Overall Study|Adverse Event|4|||
144287010|NCT01011283|520253279|FG001|Overall Study|Adverse Event|2|||
144287011|NCT01011283|520253278|FG000|Overall Study|Progressive Disease|0|||
144287012|NCT01011283|520253279|FG001|Overall Study|Progressive Disease|2|||
144287013|NCT01011283|520253278|FG000|Overall Study|Terminated by Sponsor|5|||
144287014|NCT01011283|520253279|FG001|Overall Study|Terminated by Sponsor|5|||
144287015|NCT01011283|520253278|FG000|Overall Study|Other|2|||
144287016|NCT01011283|520253279|FG001|Overall Study|Other|2|||
144287017|NCT04477486|520253291|FG000|Overall Study|Death|2|||
144287018|NCT04477486|520253291|FG000|Overall Study|Ongoing at Time of Analysis|11|||
144287019|NCT01478087|520253293|FG000|Overall Study|due to sponsor closing study|1|||
144287020|NCT01210443|520253299|FG000|Overall Study|Study terminated by sponsor|2|||
144287021|NCT00063999|520253302|FG000|Overall Study|Withdrawal by Subject|1|||
144287022|NCT00063999|520253303|FG001|Overall Study|Withdrawal by Subject|0|||
144287023|NCT00063999|520253302|FG000|Overall Study|Ineligible|44|||
144287024|NCT00063999|520253303|FG001|Overall Study|Ineligible|24|||
144287025|NCT02829957|520253305|FG000|Overall Study|Lost to Follow-up|2|||
144287026|NCT02829957|520253306|FG001|Overall Study|Lost to Follow-up|1|||
144287027|NCT04146909|520253309|FG000|Overall Study|Withdrawal by Subject|3|||
144287028|NCT04146909|520253309|FG000|Overall Study|Did not qualify after consented|1|||
144287029|NCT04193527|520253311|FG000|Overall Study|Other|1|||
144287030|NCT04193527|520253312|FG001|Overall Study|Other|1|||
144287031|NCT04193527|520253313|FG002|Overall Study|Other|0|||
144287032|NCT00676689|520253314|FG000|Overall Study|Screen Failure|2|||
144287033|NCT00676689|520253314|FG000|Overall Study|Death|2|||
144287034|NCT00676689|520253314|FG000|Overall Study|Lost to Follow-up|4|||
144287035|NCT00676689|520253314|FG000|Overall Study|Physician Decision|1|||
144287036|NCT00676689|520253314|FG000|Overall Study|Withdrawal by Subject|3|||
144287037|NCT00676689|520253314|FG000|Overall Study|Continuing FU|49|||
144287038|NCT01827943|520253315|FG000|Overall Study|Protocol Violation|8|||
144287039|NCT01827943|520253315|FG000|Overall Study|Never treated because of an rapid progression|1|||
144287040|NCT00663351|520253316|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
144287041|NCT00663351|520253317|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
144287042|NCT00663351|520253316|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
144287043|NCT00663351|520253317|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
144287044|NCT00663351|520253316|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
144287045|NCT00663351|520253317|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
144287046|NCT00663351|520253316|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
144287047|NCT00663351|520253317|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
144287048|NCT00663351|520253316|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
144287049|NCT00663351|520253317|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
144287050|NCT00663351|520253316|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
144287051|NCT00663351|520253317|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
144287052|NCT04518410|520253320|FG000|Overall Study|Lost to Follow-up|1|||
144287053|NCT04518410|520253321|FG001|Overall Study|Lost to Follow-up|1|||
144287054|NCT04518410|520253322|FG002|Overall Study|Lost to Follow-up|8|||
144287055|NCT04518410|520253323|FG003|Overall Study|Lost to Follow-up|5|||
144287056|NCT04518410|520253324|FG004|Overall Study|Lost to Follow-up|92|||
144287057|NCT04518410|520253325|FG005|Overall Study|Lost to Follow-up|25|||
144287058|NCT04518410|520253326|FG006|Overall Study|Lost to Follow-up|25|||
144287059|NCT04518410|520253327|FG007|Overall Study|Lost to Follow-up|3|||
144287060|NCT04518410|520253328|FG008|Overall Study|Lost to Follow-up|2|||
144287061|NCT04518410|520253329|FG009|Overall Study|Lost to Follow-up|13|||
144287062|NCT04518410|520253330|FG010|Overall Study|Lost to Follow-up|9|||
144287063|NCT04518410|520253331|FG011|Overall Study|Lost to Follow-up|13|||
144287064|NCT04518410|520253332|FG012|Overall Study|Lost to Follow-up|9|||
144287065|NCT04518410|520253333|FG013|Overall Study|Lost to Follow-up|13|||
144287066|NCT04518410|520253334|FG014|Overall Study|Lost to Follow-up|8|||
144287067|NCT04518410|520253335|FG015|Overall Study|Lost to Follow-up|10|||
144287068|NCT04518410|520253336|FG016|Overall Study|Lost to Follow-up|6|||
144287069|NCT04518410|520253337|FG017|Overall Study|Lost to Follow-up|13|||
144287070|NCT04518410|520253338|FG018|Overall Study|Lost to Follow-up|21|||
144287071|NCT04518410|520253339|FG019|Overall Study|Lost to Follow-up|6|||
144287072|NCT04518410|520253340|FG020|Overall Study|Lost to Follow-up|7|||
144287073|NCT04518410|520253341|FG021|Overall Study|Lost to Follow-up|21|||
144287074|NCT04518410|520253342|FG022|Overall Study|Lost to Follow-up|1|||
144287075|NCT04518410|520253343|FG023|Overall Study|Lost to Follow-up|7|||
144287076|NCT04518410|520253344|FG024|Overall Study|Lost to Follow-up|6|||
144287077|NCT04518410|520253320|FG000|Overall Study|Withdrawal by Subject|1|||
144287078|NCT04518410|520253321|FG001|Overall Study|Withdrawal by Subject|2|||
144287079|NCT04518410|520253322|FG002|Overall Study|Withdrawal by Subject|2|||
144287080|NCT04518410|520253323|FG003|Overall Study|Withdrawal by Subject|3|||
144287081|NCT04518410|520253324|FG004|Overall Study|Withdrawal by Subject|20|||
144287082|NCT04518410|520253325|FG005|Overall Study|Withdrawal by Subject|20|||
144287083|NCT04518410|520253326|FG006|Overall Study|Withdrawal by Subject|25|||
144287084|NCT04518410|520253327|FG007|Overall Study|Withdrawal by Subject|6|||
144287085|NCT04518410|520253328|FG008|Overall Study|Withdrawal by Subject|1|||
144287086|NCT04518410|520253329|FG009|Overall Study|Withdrawal by Subject|12|||
144287087|NCT04518410|520253330|FG010|Overall Study|Withdrawal by Subject|5|||
144287088|NCT04518410|520253331|FG011|Overall Study|Withdrawal by Subject|7|||
144287089|NCT04518410|520253332|FG012|Overall Study|Withdrawal by Subject|2|||
144287090|NCT04518410|520253333|FG013|Overall Study|Withdrawal by Subject|13|||
144287091|NCT04518410|520253334|FG014|Overall Study|Withdrawal by Subject|4|||
144287092|NCT04518410|520253335|FG015|Overall Study|Withdrawal by Subject|9|||
144287093|NCT04518410|520253336|FG016|Overall Study|Withdrawal by Subject|0|||
144287094|NCT04518410|520253337|FG017|Overall Study|Withdrawal by Subject|15|||
144287095|NCT04518410|520253338|FG018|Overall Study|Withdrawal by Subject|12|||
144287096|NCT04518410|520253339|FG019|Overall Study|Withdrawal by Subject|9|||
144287097|NCT04518410|520253340|FG020|Overall Study|Withdrawal by Subject|14|||
144287098|NCT04518410|520253341|FG021|Overall Study|Withdrawal by Subject|3|||
144287099|NCT04518410|520253342|FG022|Overall Study|Withdrawal by Subject|2|||
144287100|NCT04518410|520253343|FG023|Overall Study|Withdrawal by Subject|9|||
144287101|NCT04518410|520253344|FG024|Overall Study|Withdrawal by Subject|8|||
144287102|NCT04518410|520253320|FG000|Overall Study|Other|1|||
144287103|NCT04518410|520253321|FG001|Overall Study|Other|0|||
144287104|NCT04518410|520253322|FG002|Overall Study|Other|0|||
144287105|NCT04518410|520253323|FG003|Overall Study|Other|1|||
144287106|NCT04518410|520253324|FG004|Overall Study|Other|6|||
144287107|NCT04518410|520253325|FG005|Overall Study|Other|6|||
144287108|NCT04518410|520253326|FG006|Overall Study|Other|5|||
144287109|NCT04518410|520253327|FG007|Overall Study|Other|2|||
144287110|NCT04518410|520253328|FG008|Overall Study|Other|0|||
144287111|NCT04518410|520253329|FG009|Overall Study|Other|1|||
144287112|NCT04518410|520253330|FG010|Overall Study|Other|0|||
144287113|NCT04518410|520253331|FG011|Overall Study|Other|2|||
144287114|NCT04518410|520253332|FG012|Overall Study|Other|0|||
144287115|NCT04518410|520253333|FG013|Overall Study|Other|0|||
144287116|NCT04518410|520253334|FG014|Overall Study|Other|0|||
144287117|NCT04518410|520253335|FG015|Overall Study|Other|3|||
144287118|NCT04518410|520253336|FG016|Overall Study|Other|1|||
144287119|NCT04518410|520253337|FG017|Overall Study|Other|1|||
144287120|NCT04518410|520253338|FG018|Overall Study|Other|1|||
144287121|NCT04518410|520253339|FG019|Overall Study|Other|0|||
144287122|NCT04518410|520253340|FG020|Overall Study|Other|1|||
144287123|NCT04518410|520253341|FG021|Overall Study|Other|0|||
144287124|NCT04518410|520253342|FG022|Overall Study|Other|1|||
144287125|NCT04518410|520253343|FG023|Overall Study|Other|2|||
144287126|NCT04518410|520253344|FG024|Overall Study|Other|2|||
144287127|NCT04518410|520253320|FG000|Overall Study|Protocol Violation|0|||
144287128|NCT04518410|520253321|FG001|Overall Study|Protocol Violation|0|||
144287129|NCT04518410|520253322|FG002|Overall Study|Protocol Violation|0|||
144287130|NCT04518410|520253323|FG003|Overall Study|Protocol Violation|2|||
144287131|NCT04518410|520253324|FG004|Overall Study|Protocol Violation|17|||
144287132|NCT04518410|520253325|FG005|Overall Study|Protocol Violation|1|||
144287133|NCT04518410|520253326|FG006|Overall Study|Protocol Violation|2|||
144287134|NCT04518410|520253327|FG007|Overall Study|Protocol Violation|1|||
144287135|NCT04518410|520253328|FG008|Overall Study|Protocol Violation|0|||
144287136|NCT04518410|520253329|FG009|Overall Study|Protocol Violation|0|||
144287137|NCT04518410|520253330|FG010|Overall Study|Protocol Violation|0|||
144287138|NCT04518410|520253331|FG011|Overall Study|Protocol Violation|0|||
144287139|NCT04518410|520253332|FG012|Overall Study|Protocol Violation|0|||
144287140|NCT04518410|520253333|FG013|Overall Study|Protocol Violation|0|||
144287141|NCT04518410|520253334|FG014|Overall Study|Protocol Violation|0|||
144287142|NCT04518410|520253335|FG015|Overall Study|Protocol Violation|0|||
144287143|NCT04518410|520253336|FG016|Overall Study|Protocol Violation|1|||
144287144|NCT04518410|520253337|FG017|Overall Study|Protocol Violation|1|||
144287145|NCT04518410|520253338|FG018|Overall Study|Protocol Violation|0|||
144287146|NCT04518410|520253339|FG019|Overall Study|Protocol Violation|0|||
144287147|NCT04518410|520253340|FG020|Overall Study|Protocol Violation|1|||
144287148|NCT04518410|520253341|FG021|Overall Study|Protocol Violation|2|||
144287149|NCT04518410|520253342|FG022|Overall Study|Protocol Violation|0|||
144287150|NCT04518410|520253343|FG023|Overall Study|Protocol Violation|3|||
144287151|NCT04518410|520253344|FG024|Overall Study|Protocol Violation|0|||
144287152|NCT04518410|520253320|FG000|Overall Study|Death|0|||
144287153|NCT04518410|520253321|FG001|Overall Study|Death|0|||
144287154|NCT04518410|520253322|FG002|Overall Study|Death|0|||
144287155|NCT04518410|520253323|FG003|Overall Study|Death|0|||
144287156|NCT04518410|520253324|FG004|Overall Study|Death|12|||
144287157|NCT04518410|520253325|FG005|Overall Study|Death|2|||
144287158|NCT04518410|520253326|FG006|Overall Study|Death|11|||
144287159|NCT04518410|520253327|FG007|Overall Study|Death|0|||
144287160|NCT04518410|520253328|FG008|Overall Study|Death|1|||
144287161|NCT04518410|520253329|FG009|Overall Study|Death|0|||
144287162|NCT04518410|520253330|FG010|Overall Study|Death|0|||
144287163|NCT04518410|520253331|FG011|Overall Study|Death|0|||
144287164|NCT04518410|520253332|FG012|Overall Study|Death|0|||
144287165|NCT04518410|520253333|FG013|Overall Study|Death|1|||
144287166|NCT04518410|520253334|FG014|Overall Study|Death|1|||
144287167|NCT04518410|520253335|FG015|Overall Study|Death|0|||
144287168|NCT04518410|520253336|FG016|Overall Study|Death|0|||
144287169|NCT04518410|520253337|FG017|Overall Study|Death|1|||
144287170|NCT04518410|520253338|FG018|Overall Study|Death|4|||
144287171|NCT04518410|520253339|FG019|Overall Study|Death|4|||
144287172|NCT04518410|520253340|FG020|Overall Study|Death|1|||
144287173|NCT04518410|520253341|FG021|Overall Study|Death|0|||
144287174|NCT04518410|520253342|FG022|Overall Study|Death|0|||
144287175|NCT04518410|520253343|FG023|Overall Study|Death|0|||
144287176|NCT04518410|520253344|FG024|Overall Study|Death|0|||
144287177|NCT04518410|520253320|FG000|Overall Study|Requirement to start alternative therapy|0|||
144287178|NCT04518410|520253321|FG001|Overall Study|Requirement to start alternative therapy|0|||
144287179|NCT04518410|520253322|FG002|Overall Study|Requirement to start alternative therapy|1|||
144287180|NCT04518410|520253323|FG003|Overall Study|Requirement to start alternative therapy|0|||
144287181|NCT04518410|520253324|FG004|Overall Study|Requirement to start alternative therapy|0|||
144287182|NCT04518410|520253325|FG005|Overall Study|Requirement to start alternative therapy|0|||
144287183|NCT04518410|520253326|FG006|Overall Study|Requirement to start alternative therapy|0|||
144287184|NCT04518410|520253327|FG007|Overall Study|Requirement to start alternative therapy|0|||
144287185|NCT04518410|520253328|FG008|Overall Study|Requirement to start alternative therapy|0|||
144287186|NCT04518410|520253329|FG009|Overall Study|Requirement to start alternative therapy|0|||
144287187|NCT04518410|520253330|FG010|Overall Study|Requirement to start alternative therapy|0|||
144287188|NCT04518410|520253331|FG011|Overall Study|Requirement to start alternative therapy|0|||
144287189|NCT04518410|520253332|FG012|Overall Study|Requirement to start alternative therapy|0|||
144287190|NCT04518410|520253333|FG013|Overall Study|Requirement to start alternative therapy|0|||
144287191|NCT04518410|520253334|FG014|Overall Study|Requirement to start alternative therapy|0|||
144287192|NCT04518410|520253335|FG015|Overall Study|Requirement to start alternative therapy|0|||
144287193|NCT04518410|520253336|FG016|Overall Study|Requirement to start alternative therapy|0|||
144287194|NCT04518410|520253337|FG017|Overall Study|Requirement to start alternative therapy|0|||
144287195|NCT04518410|520253338|FG018|Overall Study|Requirement to start alternative therapy|0|||
144287196|NCT04518410|520253339|FG019|Overall Study|Requirement to start alternative therapy|0|||
144287197|NCT04518410|520253340|FG020|Overall Study|Requirement to start alternative therapy|0|||
144287198|NCT04518410|520253341|FG021|Overall Study|Requirement to start alternative therapy|0|||
144287199|NCT04518410|520253342|FG022|Overall Study|Requirement to start alternative therapy|0|||
144287200|NCT04518410|520253343|FG023|Overall Study|Requirement to start alternative therapy|0|||
144287201|NCT04518410|520253344|FG024|Overall Study|Requirement to start alternative therapy|0|||
144287202|NCT04518410|520253320|FG000|Overall Study|Randomized but not treated|0|||
144287203|NCT04518410|520253321|FG001|Overall Study|Randomized but not treated|0|||
144287204|NCT04518410|520253322|FG002|Overall Study|Randomized but not treated|0|||
144287205|NCT04518410|520253323|FG003|Overall Study|Randomized but not treated|2|||
144287206|NCT04518410|520253324|FG004|Overall Study|Randomized but not treated|6|||
144287207|NCT04518410|520253325|FG005|Overall Study|Randomized but not treated|4|||
144287208|NCT04518410|520253326|FG006|Overall Study|Randomized but not treated|3|||
144287209|NCT04518410|520253327|FG007|Overall Study|Randomized but not treated|3|||
144287210|NCT04518410|520253328|FG008|Overall Study|Randomized but not treated|0|||
144287211|NCT04518410|520253329|FG009|Overall Study|Randomized but not treated|4|||
144287212|NCT04518410|520253330|FG010|Overall Study|Randomized but not treated|0|||
144287213|NCT04518410|520253331|FG011|Overall Study|Randomized but not treated|0|||
144287214|NCT04518410|520253332|FG012|Overall Study|Randomized but not treated|1|||
144287215|NCT04518410|520253333|FG013|Overall Study|Randomized but not treated|3|||
144287216|NCT04518410|520253334|FG014|Overall Study|Randomized but not treated|3|||
144287217|NCT04518410|520253335|FG015|Overall Study|Randomized but not treated|3|||
144287218|NCT04518410|520253336|FG016|Overall Study|Randomized but not treated|4|||
144287219|NCT04518410|520253337|FG017|Overall Study|Randomized but not treated|5|||
144287220|NCT04518410|520253338|FG018|Overall Study|Randomized but not treated|4|||
144287221|NCT04518410|520253339|FG019|Overall Study|Randomized but not treated|0|||
144287222|NCT04518410|520253340|FG020|Overall Study|Randomized but not treated|0|||
144287223|NCT04518410|520253341|FG021|Overall Study|Randomized but not treated|5|||
144287224|NCT04518410|520253342|FG022|Overall Study|Randomized but not treated|0|||
144287225|NCT04518410|520253343|FG023|Overall Study|Randomized but not treated|3|||
144287226|NCT04518410|520253344|FG024|Overall Study|Randomized but not treated|1|||
144287227|NCT04518410|520253320|FG000|Overall Study|Screen Fail but Randomized|0|||
144287228|NCT04518410|520253321|FG001|Overall Study|Screen Fail but Randomized|0|||
144287229|NCT04518410|520253322|FG002|Overall Study|Screen Fail but Randomized|0|||
144287230|NCT04518410|520253323|FG003|Overall Study|Screen Fail but Randomized|0|||
144287231|NCT04518410|520253324|FG004|Overall Study|Screen Fail but Randomized|2|||
144287232|NCT04518410|520253325|FG005|Overall Study|Screen Fail but Randomized|0|||
144287233|NCT04518410|520253326|FG006|Overall Study|Screen Fail but Randomized|0|||
144287234|NCT04518410|520253327|FG007|Overall Study|Screen Fail but Randomized|0|||
144287235|NCT04518410|520253328|FG008|Overall Study|Screen Fail but Randomized|0|||
144287236|NCT04518410|520253329|FG009|Overall Study|Screen Fail but Randomized|0|||
144287237|NCT04518410|520253330|FG010|Overall Study|Screen Fail but Randomized|0|||
144287238|NCT04518410|520253331|FG011|Overall Study|Screen Fail but Randomized|0|||
144287239|NCT04518410|520253332|FG012|Overall Study|Screen Fail but Randomized|0|||
144287240|NCT04518410|520253333|FG013|Overall Study|Screen Fail but Randomized|0|||
144287241|NCT04518410|520253334|FG014|Overall Study|Screen Fail but Randomized|0|||
144287242|NCT04518410|520253335|FG015|Overall Study|Screen Fail but Randomized|0|||
144287243|NCT04518410|520253336|FG016|Overall Study|Screen Fail but Randomized|0|||
144287244|NCT04518410|520253337|FG017|Overall Study|Screen Fail but Randomized|0|||
144287245|NCT04518410|520253338|FG018|Overall Study|Screen Fail but Randomized|0|||
144287246|NCT04518410|520253339|FG019|Overall Study|Screen Fail but Randomized|0|||
144287247|NCT04518410|520253340|FG020|Overall Study|Screen Fail but Randomized|0|||
144287248|NCT04518410|520253341|FG021|Overall Study|Screen Fail but Randomized|0|||
144287249|NCT04518410|520253342|FG022|Overall Study|Screen Fail but Randomized|0|||
144287250|NCT04518410|520253343|FG023|Overall Study|Screen Fail but Randomized|0|||
144287251|NCT04518410|520253344|FG024|Overall Study|Screen Fail but Randomized|0|||
144287252|NCT04518410|520253320|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287253|NCT04518410|520253321|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287254|NCT04518410|520253322|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287255|NCT04518410|520253323|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287256|NCT04518410|520253324|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
144297144|NCT02038647|520292459|FG000|Overall Study|Symptomatic Deterioration|7|||
144287257|NCT04518410|520253325|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
144287258|NCT04518410|520253326|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
144287259|NCT04518410|520253327|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
144287260|NCT04518410|520253328|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
144287261|NCT04518410|520253329|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
144287262|NCT04518410|520253330|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
144287263|NCT04518410|520253331|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287264|NCT04518410|520253332|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287265|NCT04518410|520253333|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
144287266|NCT04518410|520253334|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
144287267|NCT04518410|520253335|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
144287268|NCT04518410|520253336|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
144287269|NCT04518410|520253337|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
144287270|NCT04518410|520253338|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
144287271|NCT04518410|520253339|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
144287272|NCT04518410|520253340|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
144287273|NCT04518410|520253341|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
144287274|NCT04518410|520253342|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
144287275|NCT04518410|520253343|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
144287276|NCT04518410|520253344|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
144287277|NCT04518410|520253320|FG000|Overall Study|Dual Enrolled Subject|0|||
144287278|NCT04518410|520253321|FG001|Overall Study|Dual Enrolled Subject|0|||
144287279|NCT04518410|520253322|FG002|Overall Study|Dual Enrolled Subject|0|||
144287280|NCT04518410|520253323|FG003|Overall Study|Dual Enrolled Subject|0|||
144287281|NCT04518410|520253324|FG004|Overall Study|Dual Enrolled Subject|0|||
144287282|NCT04518410|520253325|FG005|Overall Study|Dual Enrolled Subject|0|||
144287283|NCT04518410|520253326|FG006|Overall Study|Dual Enrolled Subject|0|||
144287284|NCT04518410|520253327|FG007|Overall Study|Dual Enrolled Subject|0|||
144287285|NCT04518410|520253328|FG008|Overall Study|Dual Enrolled Subject|0|||
144287286|NCT04518410|520253329|FG009|Overall Study|Dual Enrolled Subject|0|||
144287287|NCT04518410|520253330|FG010|Overall Study|Dual Enrolled Subject|0|||
144287288|NCT04518410|520253331|FG011|Overall Study|Dual Enrolled Subject|0|||
144287289|NCT04518410|520253332|FG012|Overall Study|Dual Enrolled Subject|0|||
144287290|NCT04518410|520253333|FG013|Overall Study|Dual Enrolled Subject|0|||
144287291|NCT04518410|520253334|FG014|Overall Study|Dual Enrolled Subject|0|||
144287292|NCT04518410|520253335|FG015|Overall Study|Dual Enrolled Subject|0|||
144287293|NCT04518410|520253336|FG016|Overall Study|Dual Enrolled Subject|0|||
144287294|NCT04518410|520253337|FG017|Overall Study|Dual Enrolled Subject|1|||
144287295|NCT04518410|520253338|FG018|Overall Study|Dual Enrolled Subject|0|||
144287296|NCT04518410|520253339|FG019|Overall Study|Dual Enrolled Subject|0|||
144287297|NCT04518410|520253340|FG020|Overall Study|Dual Enrolled Subject|0|||
144287298|NCT04518410|520253341|FG021|Overall Study|Dual Enrolled Subject|0|||
144287299|NCT04518410|520253342|FG022|Overall Study|Dual Enrolled Subject|0|||
144287300|NCT04518410|520253343|FG023|Overall Study|Dual Enrolled Subject|0|||
144287301|NCT04518410|520253344|FG024|Overall Study|Dual Enrolled Subject|0|||
144287302|NCT01751685|520253345|FG000|6-mo Followup|Missed study visit|1|||
144287303|NCT01751685|520253346|FG001|6-mo Followup|Missed study visit|0|||
144287304|NCT01751685|520253345|FG000|6-mo Followup|Withdrawal by Subject|2|||
144287305|NCT01751685|520253346|FG001|6-mo Followup|Withdrawal by Subject|2|||
144287306|NCT01751685|520253345|FG000|6-mo Followup|Lost to Follow-up|0|||
144287307|NCT01751685|520253346|FG001|6-mo Followup|Lost to Follow-up|1|||
144287308|NCT01751685|520253345|FG000|12-mo Followup|Lost to Follow-up|5|||
144287309|NCT01751685|520253346|FG001|12-mo Followup|Lost to Follow-up|0|||
144287310|NCT01028391|520253347|FG000|Overall Study|Adverse Event|4|||
144287311|NCT01028391|520253348|FG001|Overall Study|Adverse Event|0|||
144287312|NCT01028391|520253347|FG000|Overall Study|Lack of Efficacy|0|||
144287313|NCT01028391|520253348|FG001|Overall Study|Lack of Efficacy|2|||
144287314|NCT01028391|520253347|FG000|Overall Study|Lost to Follow-up|3|||
144287315|NCT01028391|520253348|FG001|Overall Study|Lost to Follow-up|4|||
144287316|NCT01028391|520253347|FG000|Overall Study|Physician Decision|0|||
144287317|NCT01028391|520253348|FG001|Overall Study|Physician Decision|1|||
144287318|NCT01028391|520253347|FG000|Overall Study|Withdrawal by Subject|6|||
144287319|NCT01028391|520253348|FG001|Overall Study|Withdrawal by Subject|3|||
144287320|NCT01028391|520253347|FG000|Overall Study|Needed excluded medication|1|||
144287321|NCT01028391|520253348|FG001|Overall Study|Needed excluded medication|1|||
144287322|NCT00694161|520253349|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
144287323|NCT00694161|520253349|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
144287324|NCT00694161|520253349|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
144287325|NCT03601052|520253350|FG000|Overall Study|Lost to Follow-up|2|||
144287326|NCT01227395|520253351|FG000|Overall Study|Protocol Violation|0|||
144287327|NCT01227395|520253352|FG001|Overall Study|Protocol Violation|1|||
144287328|NCT03259308|520253367|FG000|Overall Study|Adverse Event|5|||
144287329|NCT03259308|520253368|FG001|Overall Study|Adverse Event|4|||
144287330|NCT03259308|520253369|FG002|Overall Study|Adverse Event|1|||
144287331|NCT03259308|520253367|FG000|Overall Study|Withdrawal by Subject|2|||
144287332|NCT03259308|520253368|FG001|Overall Study|Withdrawal by Subject|1|||
144287333|NCT03259308|520253369|FG002|Overall Study|Withdrawal by Subject|3|||
144287334|NCT03259308|520253367|FG000|Overall Study|Lost to Follow-up|0|||
144287335|NCT03259308|520253368|FG001|Overall Study|Lost to Follow-up|0|||
144287336|NCT03259308|520253369|FG002|Overall Study|Lost to Follow-up|1|||
144287337|NCT03259308|520253367|FG000|Overall Study|Pregnancy|0|||
144287338|NCT03259308|520253368|FG001|Overall Study|Pregnancy|0|||
144287339|NCT03259308|520253369|FG002|Overall Study|Pregnancy|1|||
144287340|NCT03259308|520253367|FG000|Overall Study|Protocol Deviation|0|||
144287341|NCT03259308|520253368|FG001|Overall Study|Protocol Deviation|3|||
144287342|NCT03259308|520253369|FG002|Overall Study|Protocol Deviation|0|||
144287343|NCT03259308|520253367|FG000|Overall Study|Lack of Efficacy|0|||
144287344|NCT03259308|520253368|FG001|Overall Study|Lack of Efficacy|0|||
144287345|NCT03259308|520253369|FG002|Overall Study|Lack of Efficacy|1|||
144287346|NCT03020888|520253372|FG000|Overall Study|Physician Decision|4|||
144287347|NCT03020888|520253372|FG000|Overall Study|Withdrawal by Subject|6|||
144287348|NCT03020888|520253372|FG000|Overall Study|Insurance coverage|2|||
144287349|NCT03020888|520253372|FG000|Overall Study|Lost to Follow-up|1|||
144287350|NCT01348490|520253375|FG000|Overall Study|Death|1|||
144287351|NCT01348490|520253375|FG000|Overall Study|Adverse Event|3|||
144287352|NCT01348490|520253375|FG000|Overall Study|Consent withdrawn|7|||
144287353|NCT01348490|520253375|FG000|Overall Study|Disease progression|3|||
144287354|NCT01348490|520253375|FG000|Overall Study|Lost to Follow-up|1|||
144287355|NCT01348490|520253375|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
144287356|NCT01348490|520253375|FG000|Overall Study|Other Unspecified|8|||
144287357|NCT00300495|520253376|FG000|Overall Study|Protocol Violation|4|||
144287358|NCT00300495|520253377|FG001|Overall Study|Protocol Violation|1|||
144287359|NCT01184118|520253378|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
144287360|NCT01184118|520253378|FG000|Overall Study|No physiologic confirmation of asthma|8|||
144287361|NCT01184118|520253378|FG000|Overall Study|FEV1 <60% predicted|2|||
144287362|NCT01184118|520253378|FG000|Overall Study|Exclusionary medical condition|2|||
144287363|NCT01184118|520253378|FG000|Overall Study|Withdrawal by Subject|5|||
144287364|NCT03834883|520253391|FG000|Second Treatment|Withdrawal by Subject|1|||
144287365|NCT03834883|520253392|FG001|Second Treatment|Withdrawal by Subject|0|||
144287366|NCT03834883|520253393|FG002|Second Treatment|Withdrawal by Subject|0|||
144287367|NCT03834883|520253394|FG003|Second Treatment|Withdrawal by Subject|0|||
144287368|NCT03834883|520253391|FG000|Second Treatment|COVID-19 pandemic|1|||
144287369|NCT03834883|520253392|FG001|Second Treatment|COVID-19 pandemic|0|||
144287370|NCT03834883|520253393|FG002|Second Treatment|COVID-19 pandemic|1|||
144287371|NCT03834883|520253394|FG003|Second Treatment|COVID-19 pandemic|1|||
144287372|NCT01793129|520254862|FG000|Overall Study|Lost to Follow-up|3|||
144287373|NCT01793129|520254863|FG001|Overall Study|Lost to Follow-up|7|||
144287374|NCT01793129|520254862|FG000|Overall Study|Withdrawal by Subject|0|||
144287375|NCT01793129|520254863|FG001|Overall Study|Withdrawal by Subject|2|||
144287376|NCT03548415|520254866|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
144287377|NCT03548415|520254867|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
144287378|NCT03548415|520254868|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
144287379|NCT03548415|520254869|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
144287380|NCT03548415|520254870|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
144287381|NCT04605588|520254872|FG000|Overall Study|Withdrawal by Subject|1|||
144287382|NCT04605588|520254873|FG001|Overall Study|Withdrawal by Subject|0|||
144287383|NCT01230814|520254874|FG000|Overall Study|Lost to Follow-up|11|||
144287384|NCT01230814|520254875|FG001|Overall Study|Lost to Follow-up|3|||
144287385|NCT01230814|520254874|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
144287386|NCT01230814|520254875|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
144287387|NCT01803737|520254878|FG000|Overall Study|Lack of Time|1|||
144287388|NCT01803737|520254879|FG001|Overall Study|Lack of Time|0|||
144287389|NCT01803737|520254878|FG000|Overall Study|Medical Reason|0|||
144287390|NCT01803737|520254879|FG001|Overall Study|Medical Reason|1|||
144287391|NCT01803737|520254878|FG000|Overall Study|Lost to Follow-up|0|||
144287392|NCT01803737|520254879|FG001|Overall Study|Lost to Follow-up|2|||
144287393|NCT00504556|520254882|FG000|Overall Study|Adverse Event|11|||
144287394|NCT00504556|520254883|FG001|Overall Study|Adverse Event|11|||
144287395|NCT00504556|520254884|FG002|Overall Study|Adverse Event|14|||
144287396|NCT00504556|520254885|FG003|Overall Study|Adverse Event|13|||
144287397|NCT00504556|520254886|FG004|Overall Study|Adverse Event|5|||
144287398|NCT00504556|520254882|FG000|Overall Study|Death|3|||
144287399|NCT00504556|520254883|FG001|Overall Study|Death|3|||
144287400|NCT00504556|520254884|FG002|Overall Study|Death|1|||
144287401|NCT00504556|520254885|FG003|Overall Study|Death|0|||
144287402|NCT00504556|520254886|FG004|Overall Study|Death|2|||
144287403|NCT00504556|520254882|FG000|Overall Study|Protocol Violation|1|||
144287404|NCT00504556|520254883|FG001|Overall Study|Protocol Violation|3|||
144287405|NCT00504556|520254884|FG002|Overall Study|Protocol Violation|2|||
144287406|NCT00504556|520254885|FG003|Overall Study|Protocol Violation|1|||
144287407|NCT00504556|520254886|FG004|Overall Study|Protocol Violation|2|||
144287408|NCT00504556|520254882|FG000|Overall Study|Lost to Follow-up|0|||
144287409|NCT00504556|520254883|FG001|Overall Study|Lost to Follow-up|0|||
144287410|NCT00504556|520254884|FG002|Overall Study|Lost to Follow-up|1|||
144287411|NCT00504556|520254885|FG003|Overall Study|Lost to Follow-up|1|||
144287412|NCT00504556|520254886|FG004|Overall Study|Lost to Follow-up|1|||
144287413|NCT00504556|520254882|FG000|Overall Study|Withdrawal by Subject|16|||
144287414|NCT00504556|520254883|FG001|Overall Study|Withdrawal by Subject|16|||
144287415|NCT00504556|520254884|FG002|Overall Study|Withdrawal by Subject|7|||
144287416|NCT00504556|520254885|FG003|Overall Study|Withdrawal by Subject|8|||
144287417|NCT00504556|520254886|FG004|Overall Study|Withdrawal by Subject|12|||
144287418|NCT00504556|520254882|FG000|Overall Study|administrative reasons|0|||
144287419|NCT00504556|520254883|FG001|Overall Study|administrative reasons|2|||
144287420|NCT00504556|520254884|FG002|Overall Study|administrative reasons|2|||
144287421|NCT00504556|520254885|FG003|Overall Study|administrative reasons|1|||
144287422|NCT00504556|520254886|FG004|Overall Study|administrative reasons|2|||
144287423|NCT00504556|520254882|FG000|Overall Study|did not meet entry criteria|2|||
144287424|NCT00504556|520254883|FG001|Overall Study|did not meet entry criteria|0|||
144287425|NCT00504556|520254884|FG002|Overall Study|did not meet entry criteria|1|||
144287426|NCT00504556|520254885|FG003|Overall Study|did not meet entry criteria|1|||
144287427|NCT00504556|520254886|FG004|Overall Study|did not meet entry criteria|0|||
144287428|NCT00504556|520254882|FG000|Overall Study|data monitor committee decision|0|||
144287429|NCT00504556|520254883|FG001|Overall Study|data monitor committee decision|0|||
144287430|NCT00504556|520254884|FG002|Overall Study|data monitor committee decision|0|||
144287431|NCT00504556|520254885|FG003|Overall Study|data monitor committee decision|100|||
144287432|NCT00504556|520254886|FG004|Overall Study|data monitor committee decision|0|||
144287433|NCT00504556|520254882|FG000|Overall Study|Other|2|||
144287434|NCT00504556|520254883|FG001|Overall Study|Other|2|||
144287435|NCT00504556|520254884|FG002|Overall Study|Other|2|||
144287436|NCT00504556|520254885|FG003|Overall Study|Other|3|||
144287437|NCT00504556|520254886|FG004|Overall Study|Other|0|||
144287438|NCT00504556|520254882|FG000|Overall Study|not in safety analysis set|0|||
144287439|NCT00504556|520254883|FG001|Overall Study|not in safety analysis set|1|||
144287440|NCT00504556|520254884|FG002|Overall Study|not in safety analysis set|1|||
144287441|NCT00504556|520254885|FG003|Overall Study|not in safety analysis set|0|||
144287442|NCT00504556|520254886|FG004|Overall Study|not in safety analysis set|1|||
144287443|NCT02741193|520254889|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
144287444|NCT02741193|520254889|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
144287445|NCT02502383|520254890|FG000|Overall Study|Lost to Follow-up|130|||
144287446|NCT02502383|520254891|FG001|Overall Study|Lost to Follow-up|131|||
144287447|NCT02502383|520254890|FG000|Overall Study|Withdrawal by Subject|31|||
144287448|NCT02502383|520254891|FG001|Overall Study|Withdrawal by Subject|24|||
144287449|NCT00676052|520254892|FG000|Overall Study|Adverse Event|0|||
144287450|NCT00676052|520254893|FG001|Overall Study|Adverse Event|1|||
144287451|NCT00676052|520254894|FG002|Overall Study|Adverse Event|1|||
144287452|NCT00676052|520254895|FG003|Overall Study|Adverse Event|2|||
144287453|NCT00676052|520254896|FG004|Overall Study|Adverse Event|2|||
144287454|NCT00676052|520254897|FG005|Overall Study|Adverse Event|2|||
144287455|NCT00676052|520254892|FG000|Overall Study|Lack of Efficacy|2|||
144287456|NCT00676052|520254893|FG001|Overall Study|Lack of Efficacy|2|||
144287457|NCT00676052|520254894|FG002|Overall Study|Lack of Efficacy|1|||
144287458|NCT00676052|520254895|FG003|Overall Study|Lack of Efficacy|1|||
144287459|NCT00676052|520254896|FG004|Overall Study|Lack of Efficacy|2|||
144287460|NCT00676052|520254897|FG005|Overall Study|Lack of Efficacy|1|||
144287461|NCT00676052|520254892|FG000|Overall Study|Protocol Violation|5|||
144287462|NCT00676052|520254893|FG001|Overall Study|Protocol Violation|3|||
144287463|NCT00676052|520254894|FG002|Overall Study|Protocol Violation|2|||
144287464|NCT00676052|520254895|FG003|Overall Study|Protocol Violation|2|||
144287465|NCT00676052|520254896|FG004|Overall Study|Protocol Violation|1|||
144287466|NCT00676052|520254897|FG005|Overall Study|Protocol Violation|2|||
144287467|NCT00676052|520254892|FG000|Overall Study|Lost to Follow-up|0|||
144287468|NCT00676052|520254893|FG001|Overall Study|Lost to Follow-up|0|||
144287469|NCT00676052|520254894|FG002|Overall Study|Lost to Follow-up|0|||
144287470|NCT00676052|520254895|FG003|Overall Study|Lost to Follow-up|0|||
144287471|NCT00676052|520254896|FG004|Overall Study|Lost to Follow-up|1|||
144287472|NCT00676052|520254897|FG005|Overall Study|Lost to Follow-up|0|||
144287473|NCT00676052|520254892|FG000|Overall Study|Physician Decision|1|||
144287474|NCT00676052|520254893|FG001|Overall Study|Physician Decision|1|||
144287475|NCT00676052|520254894|FG002|Overall Study|Physician Decision|1|||
144287476|NCT00676052|520254895|FG003|Overall Study|Physician Decision|0|||
144287477|NCT00676052|520254896|FG004|Overall Study|Physician Decision|0|||
144287478|NCT00676052|520254897|FG005|Overall Study|Physician Decision|1|||
144287479|NCT00676052|520254892|FG000|Overall Study|Withdrawal by Subject|1|||
144287480|NCT00676052|520254893|FG001|Overall Study|Withdrawal by Subject|0|||
144287481|NCT00676052|520254894|FG002|Overall Study|Withdrawal by Subject|1|||
144287482|NCT00676052|520254895|FG003|Overall Study|Withdrawal by Subject|0|||
144287483|NCT00676052|520254896|FG004|Overall Study|Withdrawal by Subject|0|||
144287484|NCT00676052|520254897|FG005|Overall Study|Withdrawal by Subject|0|||
144287485|NCT01560988|520254911|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
144287486|NCT01560988|520254912|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
144287487|NCT01560988|520254911|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
144287488|NCT01560988|520254912|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
144287489|NCT01560988|520254911|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
144287490|NCT01560988|520254912|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
144287491|NCT01346709|520254913|FG000|Overall Study|Protocol Violation|35|||
144287492|NCT01346709|520254913|FG000|Overall Study|Lost to Follow-up|31|||
144287493|NCT01346709|520254913|FG000|Overall Study|Missing data in candidate risk factor|285|||
144287494|NCT00458705|520254914|FG000|Overall Study|Adverse Event|4|||
144287495|NCT00458705|520254914|FG000|Overall Study|Not Treated|1|||
144287496|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
144287497|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
144287498|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
144287499|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
144287500|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
144287501|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
144287502|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
144287503|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
144287504|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
144287505|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
144287506|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
144287507|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
144287508|NCT00290758|520254916|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
144287509|NCT00290758|520254917|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
144287510|NCT00290758|520254916|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
144287511|NCT00290758|520254917|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
144287512|NCT03994120|520254919|FG000|Overall Study|Lost to Follow-up|3|||
144287513|NCT03994120|520254920|FG001|Overall Study|Lost to Follow-up|1|||
144287514|NCT01111292|520254921|FG000|Treatment|Physician Decision|1|||
144287515|NCT01111292|520254922|FG001|Treatment|Physician Decision|1|||
144287516|NCT02619812|520254923|FG000|Overall Study|Withdrawal by Subject|0|||
144287517|NCT02619812|520254924|FG001|Overall Study|Withdrawal by Subject|0|||
144287518|NCT02619812|520254925|FG002|Overall Study|Withdrawal by Subject|1|||
144287519|NCT02619812|520254926|FG003|Overall Study|Withdrawal by Subject|2|||
144287520|NCT03835117|520254927|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
144287521|NCT03835117|520254928|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
144287522|NCT03892915|520254929|FG000|Overall Study|Lost to Follow-up|6|||
144287523|NCT03892915|520254930|FG001|Overall Study|Lost to Follow-up|12|||
144287524|NCT03892915|520254929|FG000|Overall Study|Death|0|||
144287525|NCT03892915|520254930|FG001|Overall Study|Death|2|||
144287526|NCT03892915|520254929|FG000|Overall Study|Withdrawal by Subject|1|||
144287527|NCT03892915|520254930|FG001|Overall Study|Withdrawal by Subject|1|||
144287528|NCT03892915|520254929|FG000|Overall Study|unsuccessful delivery|13|||
144287529|NCT03892915|520254930|FG001|Overall Study|unsuccessful delivery|18|||
144287530|NCT00191152|520254931|FG000|Initial Treatment|Adverse Event|43|||
144287531|NCT00191152|520254932|FG001|Initial Treatment|Adverse Event|67|||
144287532|NCT00191152|520254931|FG000|Initial Treatment|Physician Decision|40|||
144287533|NCT00191152|520254932|FG001|Initial Treatment|Physician Decision|31|||
144287534|NCT00191152|520254931|FG000|Initial Treatment|Withdrawal by Subject|40|||
144287535|NCT00191152|520254932|FG001|Initial Treatment|Withdrawal by Subject|28|||
144287536|NCT00191152|520254931|FG000|Initial Treatment|Lost to Follow-up|0|||
144287537|NCT00191152|520254932|FG001|Initial Treatment|Lost to Follow-up|6|||
144287538|NCT00191152|520254931|FG000|Initial Treatment|Other|18|||
144287539|NCT00191152|520254932|FG001|Initial Treatment|Other|21|||
144287540|NCT00191152|520254931|FG000|Crossover Treatment|Adverse Event|8|||
144287541|NCT00191152|520254932|FG001|Crossover Treatment|Adverse Event|8|||
144287542|NCT00191152|520254931|FG000|Crossover Treatment|Physician Decision|7|||
144287543|NCT00191152|520254932|FG001|Crossover Treatment|Physician Decision|7|||
144287544|NCT00191152|520254931|FG000|Crossover Treatment|Withdrawal by Subject|6|||
144287545|NCT00191152|520254932|FG001|Crossover Treatment|Withdrawal by Subject|9|||
144287546|NCT00191152|520254931|FG000|Crossover Treatment|Lost to Follow-up|2|||
144287547|NCT00191152|520254932|FG001|Crossover Treatment|Lost to Follow-up|1|||
144287548|NCT00191152|520254931|FG000|Crossover Treatment|Other|4|||
144287549|NCT00191152|520254932|FG001|Crossover Treatment|Other|3|||
144287550|NCT00114777|520254933|FG000|Randomization to Month 36|Death|10|||
144287551|NCT00114777|520254934|FG001|Randomization to Month 36|Death|4|||
144287552|NCT00114777|520254935|FG002|Randomization to Month 36|Death|3|||
144287553|NCT00114777|520254933|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
144287554|NCT00114777|520254934|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
144287555|NCT00114777|520254935|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
144287556|NCT00114777|520254933|FG000|Randomization to Month 36|Lack of Efficacy|19|||
144287557|NCT00114777|520254934|FG001|Randomization to Month 36|Lack of Efficacy|15|||
144287558|NCT00114777|520254935|FG002|Randomization to Month 36|Lack of Efficacy|17|||
144287559|NCT00114777|520254933|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
144287560|NCT00114777|520254934|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
144287561|NCT00114777|520254935|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
144287562|NCT00114777|520254933|FG000|Randomization to Month 36|Adverse Event|34|||
144287563|NCT00114777|520254934|FG001|Randomization to Month 36|Adverse Event|35|||
144287564|NCT00114777|520254935|FG002|Randomization to Month 36|Adverse Event|44|||
144287565|NCT00114777|520254933|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
144287566|NCT00114777|520254934|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
144287567|NCT00114777|520254935|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
144287568|NCT00114777|520254933|FG000|Randomization to Month 36|Other|9|||
144287569|NCT00114777|520254934|FG001|Randomization to Month 36|Other|3|||
144287570|NCT00114777|520254935|FG002|Randomization to Month 36|Other|12|||
144287571|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Death|8|||
144287572|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Death|13|||
144287573|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Death|7|||
144287574|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
144287575|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
144287576|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
144287577|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
144287578|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
144287579|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
144287580|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
144287581|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
144287582|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
144287583|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
144287584|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
144287585|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
144287586|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
144287587|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
144287588|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
144287589|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
144287590|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
144287591|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
144287592|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
144287593|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
144287594|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
144287595|NCT00114777|520254933|FG000|Long-Term Extension to Month 84|Other|2|||
144287596|NCT00114777|520254934|FG001|Long-Term Extension to Month 84|Other|0|||
144287597|NCT00114777|520254935|FG002|Long-Term Extension to Month 84|Other|2|||
144287598|NCT03364686|520254938|FG000|Overall Study|Physician Decision|2|||
144287599|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Adverse Event|14|||
144287600|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Adverse Event|27|||
144287601|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Adverse Event|60|||
144287602|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Adverse Event|0|||
144287603|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Adverse Event|0|||
144287604|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Pregnancy|0|||
144287605|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Pregnancy|7|||
144287606|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Pregnancy|9|||
144287607|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Pregnancy|0|||
144287608|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Pregnancy|0|||
144287609|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
144287610|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
144287611|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
144287612|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
144287613|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
144287614|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
144287615|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
144287616|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
144287617|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
144287618|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
144287619|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Death|1|||
144287620|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Death|2|||
144287621|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Death|2|||
144287622|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Death|0|||
144287623|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Death|0|||
144287624|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
144287625|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
144287626|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
144287627|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
144287628|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
144287629|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
144287630|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
144287631|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
144287632|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
144287633|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
144287634|NCT00098293|520254942|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
144287635|NCT00098293|520254943|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
144287636|NCT00098293|520254944|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
144287637|NCT00098293|520254945|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
144287638|NCT00098293|520254946|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
144287639|NCT00098293|520254942|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
144287640|NCT00098293|520254943|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
144287641|NCT00098293|520254944|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
144287642|NCT00098293|520254945|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
144287643|NCT00098293|520254946|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
144287644|NCT00098293|520254942|FG000|Open-label (OL) Phase|Adverse Event|0|||
144287645|NCT00098293|520254943|FG001|Open-label (OL) Phase|Adverse Event|3|||
144287646|NCT00098293|520254944|FG002|Open-label (OL) Phase|Adverse Event|7|||
144287647|NCT00098293|520254945|FG003|Open-label (OL) Phase|Adverse Event|6|||
144287648|NCT00098293|520254946|FG004|Open-label (OL) Phase|Adverse Event|0|||
144287649|NCT00098293|520254942|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
144287650|NCT00098293|520254943|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
144287651|NCT00098293|520254944|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
144287652|NCT00098293|520254945|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
144287653|NCT00098293|520254946|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
144287654|NCT00098293|520254942|FG000|Open-label (OL) Phase|Pregnancy|0|||
144287655|NCT00098293|520254943|FG001|Open-label (OL) Phase|Pregnancy|1|||
144287656|NCT00098293|520254944|FG002|Open-label (OL) Phase|Pregnancy|0|||
144287657|NCT00098293|520254945|FG003|Open-label (OL) Phase|Pregnancy|3|||
144287658|NCT00098293|520254946|FG004|Open-label (OL) Phase|Pregnancy|0|||
144287659|NCT00098293|520254942|FG000|Open-label (OL) Phase|Protocol Violation|0|||
144287660|NCT00098293|520254943|FG001|Open-label (OL) Phase|Protocol Violation|6|||
144287661|NCT00098293|520254944|FG002|Open-label (OL) Phase|Protocol Violation|13|||
144287662|NCT00098293|520254945|FG003|Open-label (OL) Phase|Protocol Violation|16|||
144287663|NCT00098293|520254946|FG004|Open-label (OL) Phase|Protocol Violation|0|||
144287664|NCT00098293|520254942|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
144287665|NCT00098293|520254943|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
144287666|NCT00098293|520254944|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
144287667|NCT00098293|520254945|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
144287668|NCT00098293|520254946|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
144287669|NCT00098293|520254942|FG000|Open-label (OL) Phase|Death|0|||
144287670|NCT00098293|520254943|FG001|Open-label (OL) Phase|Death|2|||
144287671|NCT00098293|520254944|FG002|Open-label (OL) Phase|Death|3|||
144287672|NCT00098293|520254945|FG003|Open-label (OL) Phase|Death|0|||
144287673|NCT00098293|520254946|FG004|Open-label (OL) Phase|Death|0|||
144287674|NCT00098293|520254942|FG000|Supplemental Phase (SP)|Death|0|||
144287675|NCT00098293|520254943|FG001|Supplemental Phase (SP)|Death|0|||
144287676|NCT00098293|520254944|FG002|Supplemental Phase (SP)|Death|0|||
144287677|NCT00098293|520254945|FG003|Supplemental Phase (SP)|Death|0|||
144287678|NCT00098293|520254946|FG004|Supplemental Phase (SP)|Death|1|||
144287679|NCT00098293|520254942|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
144287680|NCT00098293|520254943|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
144287681|NCT00098293|520254944|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
144287682|NCT00098293|520254945|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
144287683|NCT00098293|520254946|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
144287684|NCT00098293|520254942|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
144287685|NCT00098293|520254943|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
144287686|NCT00098293|520254944|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
144287687|NCT00098293|520254945|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
144287688|NCT00098293|520254946|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
144287689|NCT00098293|520254942|FG000|Supplemental Phase (SP)|Other|0|||
144287690|NCT00098293|520254943|FG001|Supplemental Phase (SP)|Other|0|||
144287691|NCT00098293|520254944|FG002|Supplemental Phase (SP)|Other|0|||
144287692|NCT00098293|520254945|FG003|Supplemental Phase (SP)|Other|0|||
144287693|NCT00098293|520254946|FG004|Supplemental Phase (SP)|Other|22|||
144287694|NCT01968785|520254947|FG000|Overall Study|Withdrawal by Subject|1|||
144287695|NCT01968785|520254948|FG001|Overall Study|Withdrawal by Subject|0|||
144287696|NCT00754559|520254951|FG000|Overall Study|Adverse Event|15|||
144287697|NCT00754559|520254951|FG000|Overall Study|Protocol Violation|11|||
144287698|NCT00754559|520254951|FG000|Overall Study|Lack of Efficacy|10|||
144287699|NCT00754559|520254951|FG000|Overall Study|Lost to Follow-up|2|||
144287700|NCT00754559|520254951|FG000|Overall Study|Administrative reason|1|||
144287701|NCT00754559|520254951|FG000|Overall Study|Other|5|||
144287702|NCT00754559|520254951|FG000|Overall Study|Withdrawal by Subject|3|||
144287703|NCT04000724|520254955|FG000|Overall Study|Withdrawal by Subject|5|||
144287704|NCT04000724|520254956|FG001|Overall Study|Withdrawal by Subject|3|||
144287705|NCT04000724|520254957|FG002|Overall Study|Withdrawal by Subject|4|||
144287706|NCT04000724|520254955|FG000|Overall Study|Lost to Follow-up|11|||
144287707|NCT04000724|520254956|FG001|Overall Study|Lost to Follow-up|7|||
144287708|NCT04000724|520254957|FG002|Overall Study|Lost to Follow-up|13|||
144287709|NCT01370538|520254958|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
144287710|NCT01370538|520254959|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
144287711|NCT01370538|520254958|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144287712|NCT01370538|520254959|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144287713|NCT01370538|520254958|FG000|Overall Study|Adverse Event|1|||
144287714|NCT01370538|520254959|FG001|Overall Study|Adverse Event|0|||
144287715|NCT01370538|520254958|FG000|Overall Study|Protocol Violation|8|||
144287716|NCT01370538|520254959|FG001|Overall Study|Protocol Violation|5|||
144287717|NCT01370538|520254958|FG000|Overall Study|Development of study specific withdrawal|1|||
144287718|NCT01370538|520254959|FG001|Overall Study|Development of study specific withdrawal|1|||
144287719|NCT01370538|520254958|FG000|Overall Study|Lost to follow up|6|||
144287720|NCT01370538|520254959|FG001|Overall Study|Lost to follow up|10|||
144287721|NCT04595370|520254961|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
144287722|NCT04595370|520254962|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
144287723|NCT04595370|520254963|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
144287724|NCT04595370|520254964|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
144287725|NCT04595370|520254965|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
144287726|NCT04595370|520254966|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
144287727|NCT04595370|520254961|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
144287728|NCT04595370|520254962|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
144287729|NCT04595370|520254963|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
144287730|NCT04595370|520254964|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
144287731|NCT04595370|520254965|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
144287732|NCT04595370|520254966|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
144287733|NCT04595370|520254961|FG000|Overall Study|Adverse Event|0|||
144287734|NCT04595370|520254962|FG001|Overall Study|Adverse Event|4|||
144287735|NCT04595370|520254963|FG002|Overall Study|Adverse Event|3|||
144287736|NCT04595370|520254964|FG003|Overall Study|Adverse Event|1|||
144287737|NCT04595370|520254965|FG004|Overall Study|Adverse Event|1|||
144287738|NCT04595370|520254966|FG005|Overall Study|Adverse Event|1|||
144287739|NCT04595370|520254961|FG000|Overall Study|Withdrawal of Consent|1|||
144287740|NCT04595370|520254962|FG001|Overall Study|Withdrawal of Consent|1|||
144287741|NCT04595370|520254963|FG002|Overall Study|Withdrawal of Consent|1|||
144287742|NCT04595370|520254964|FG003|Overall Study|Withdrawal of Consent|0|||
144287743|NCT04595370|520254965|FG004|Overall Study|Withdrawal of Consent|0|||
144287744|NCT04595370|520254966|FG005|Overall Study|Withdrawal of Consent|0|||
144287745|NCT04595370|520254961|FG000|Overall Study|Death|0|||
144287746|NCT04595370|520254962|FG001|Overall Study|Death|1|||
144287747|NCT04595370|520254963|FG002|Overall Study|Death|0|||
144287748|NCT04595370|520254964|FG003|Overall Study|Death|0|||
144287749|NCT04595370|520254965|FG004|Overall Study|Death|1|||
144287750|NCT04595370|520254966|FG005|Overall Study|Death|0|||
144287751|NCT04595370|520254961|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144287752|NCT04595370|520254962|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144287753|NCT04595370|520254963|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
144287754|NCT04595370|520254964|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144287755|NCT04595370|520254965|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144287756|NCT04595370|520254966|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144287757|NCT04595370|520254961|FG000|Overall Study|Withdrawal by Subject|0|||
144287758|NCT04595370|520254962|FG001|Overall Study|Withdrawal by Subject|0|||
144287759|NCT04595370|520254963|FG002|Overall Study|Withdrawal by Subject|1|||
144287760|NCT04595370|520254964|FG003|Overall Study|Withdrawal by Subject|0|||
144287761|NCT04595370|520254965|FG004|Overall Study|Withdrawal by Subject|2|||
144287762|NCT04595370|520254966|FG005|Overall Study|Withdrawal by Subject|0|||
144287763|NCT04595370|520254961|FG000|Overall Study|Lost to Follow-up|0|||
144287764|NCT04595370|520254962|FG001|Overall Study|Lost to Follow-up|0|||
144287765|NCT04595370|520254963|FG002|Overall Study|Lost to Follow-up|0|||
144287766|NCT04595370|520254964|FG003|Overall Study|Lost to Follow-up|0|||
144287767|NCT04595370|520254965|FG004|Overall Study|Lost to Follow-up|1|||
144287768|NCT04595370|520254966|FG005|Overall Study|Lost to Follow-up|0|||
144287769|NCT04595370|520254961|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
144287770|NCT04595370|520254962|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
144287771|NCT04595370|520254963|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
144287772|NCT04595370|520254964|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
144287773|NCT04595370|520254965|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
144287774|NCT04595370|520254966|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
144287775|NCT01666314|520254967|FG000|Overall Study|Adverse Event|3|||
144287776|NCT01666314|520254968|FG001|Overall Study|Adverse Event|13|||
144287777|NCT01666314|520254969|FG002|Overall Study|Adverse Event|7|||
144287778|NCT01666314|520254970|FG003|Overall Study|Adverse Event|7|||
144287779|NCT01666314|520254967|FG000|Overall Study|Progressive Disease|11|||
144287780|NCT01666314|520254968|FG001|Overall Study|Progressive Disease|9|||
144287781|NCT01666314|520254969|FG002|Overall Study|Progressive Disease|19|||
144287782|NCT01666314|520254970|FG003|Overall Study|Progressive Disease|20|||
144287783|NCT01666314|520254967|FG000|Overall Study|Symptomatic Deterioration|1|||
144287784|NCT01666314|520254968|FG001|Overall Study|Symptomatic Deterioration|0|||
144287785|NCT01666314|520254969|FG002|Overall Study|Symptomatic Deterioration|2|||
144287786|NCT01666314|520254970|FG003|Overall Study|Symptomatic Deterioration|0|||
144287787|NCT01666314|520254967|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
144287788|NCT01666314|520254968|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
144287789|NCT01666314|520254969|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
144287790|NCT01666314|520254970|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
144287791|NCT01666314|520254967|FG000|Overall Study|Withdrawal by Subject|1|||
144287792|NCT01666314|520254968|FG001|Overall Study|Withdrawal by Subject|1|||
144287793|NCT01666314|520254969|FG002|Overall Study|Withdrawal by Subject|2|||
144287794|NCT01666314|520254970|FG003|Overall Study|Withdrawal by Subject|3|||
144287795|NCT01666314|520254967|FG000|Overall Study|Reason not Specified|10|||
144287796|NCT01666314|520254968|FG001|Overall Study|Reason not Specified|7|||
144287797|NCT01666314|520254969|FG002|Overall Study|Reason not Specified|5|||
144287798|NCT01666314|520254970|FG003|Overall Study|Reason not Specified|5|||
144287799|NCT05660538|520254971|FG000|Overall Study|Adverse Event|0|||
144287800|NCT05660538|520254972|FG001|Overall Study|Adverse Event|0|||
144287801|NCT05660538|520254973|FG002|Overall Study|Adverse Event|1|||
144287802|NCT05660538|520254974|FG003|Overall Study|Adverse Event|0|||
144287803|NCT05660538|520254971|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
144287804|NCT05660538|520254972|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
144287805|NCT05660538|520254973|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
144287806|NCT05660538|520254974|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
144287807|NCT05660538|520254971|FG000|Overall Study|Lost to Follow-up|0|||
144287808|NCT05660538|520254972|FG001|Overall Study|Lost to Follow-up|0|||
144287809|NCT05660538|520254973|FG002|Overall Study|Lost to Follow-up|1|||
144287810|NCT05660538|520254974|FG003|Overall Study|Lost to Follow-up|1|||
144287811|NCT05660538|520254971|FG000|Overall Study|Death|0|||
144287812|NCT05660538|520254972|FG001|Overall Study|Death|0|||
144287813|NCT05660538|520254973|FG002|Overall Study|Death|1|||
144287814|NCT05660538|520254974|FG003|Overall Study|Death|0|||
144287815|NCT05660538|520254971|FG000|Overall Study|Physician Decision|0|||
144287816|NCT05660538|520254972|FG001|Overall Study|Physician Decision|0|||
144287817|NCT05660538|520254973|FG002|Overall Study|Physician Decision|0|||
144287818|NCT05660538|520254974|FG003|Overall Study|Physician Decision|1|||
144287819|NCT05660538|520254971|FG000|Overall Study|Sponsor Decision|1|||
144287820|NCT05660538|520254972|FG001|Overall Study|Sponsor Decision|0|||
144287821|NCT05660538|520254973|FG002|Overall Study|Sponsor Decision|0|||
144287822|NCT05660538|520254974|FG003|Overall Study|Sponsor Decision|0|||
144287823|NCT05660538|520254971|FG000|Overall Study|Other|1|||
144287824|NCT05660538|520254972|FG001|Overall Study|Other|0|||
144287825|NCT05660538|520254973|FG002|Overall Study|Other|0|||
144287826|NCT05660538|520254974|FG003|Overall Study|Other|1|||
144287827|NCT05660538|520254971|FG000|Overall Study|Randomized but did not receive study drug|1|||
144287828|NCT05660538|520254972|FG001|Overall Study|Randomized but did not receive study drug|0|||
144287829|NCT05660538|520254973|FG002|Overall Study|Randomized but did not receive study drug|0|||
144287830|NCT05660538|520254974|FG003|Overall Study|Randomized but did not receive study drug|1|||
144287831|NCT05660538|520254971|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
144287832|NCT05660538|520254972|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
144287833|NCT05660538|520254973|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
144287834|NCT05660538|520254974|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
144287835|NCT01125748|520254976|FG000|Overall Study|Adverse Event|0|||
144287836|NCT01125748|520254977|FG001|Overall Study|Adverse Event|2|||
144287837|NCT01125748|520254976|FG000|Overall Study|Lost to Follow-up|0|||
144287838|NCT01125748|520254977|FG001|Overall Study|Lost to Follow-up|1|||
144287839|NCT01125748|520254976|FG000|Overall Study|Physician Decision|8|||
144287840|NCT01125748|520254977|FG001|Overall Study|Physician Decision|7|||
144287841|NCT01125748|520254976|FG000|Overall Study|Patient Decision to Withdraw|2|||
144287842|NCT01125748|520254977|FG001|Overall Study|Patient Decision to Withdraw|4|||
144287843|NCT00837330|520254978|FG000|Overall Study|Lost to Follow-up|1|||
144287844|NCT00837330|520254979|FG001|Overall Study|Lost to Follow-up|3|||
144287845|NCT00694122|520254980|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
144287846|NCT00694122|520254981|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
144287847|NCT00694122|520254980|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
144287848|NCT00694122|520254981|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
144287849|NCT00694122|520254980|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
144287850|NCT00694122|520254981|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
144287851|NCT00086307|520254982|FG000|Overall Study|Lack of Efficacy|1|||
144287852|NCT00086307|520254983|FG001|Overall Study|Lack of Efficacy|1|||
144287853|NCT00086307|520254984|FG002|Overall Study|Lack of Efficacy|2|||
144287854|NCT00086307|520254982|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
144287855|NCT00086307|520254983|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
144287856|NCT00086307|520254984|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
144287857|NCT00086307|520254982|FG000|Overall Study|Nausea and headaches|0|||
144287858|NCT00086307|520254983|FG001|Overall Study|Nausea and headaches|0|||
144287859|NCT00086307|520254984|FG002|Overall Study|Nausea and headaches|1|||
144287860|NCT00086307|520254982|FG000|Overall Study|Constipation and sleepiness|0|||
144287861|NCT00086307|520254983|FG001|Overall Study|Constipation and sleepiness|0|||
144287862|NCT00086307|520254984|FG002|Overall Study|Constipation and sleepiness|1|||
144287863|NCT00086307|520254982|FG000|Overall Study|Suicidal ideation|0|||
144287864|NCT00086307|520254983|FG001|Overall Study|Suicidal ideation|0|||
144287865|NCT00086307|520254984|FG002|Overall Study|Suicidal ideation|1|||
144287866|NCT00086307|520254982|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
144287867|NCT00086307|520254983|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
144287868|NCT00086307|520254984|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
144287869|NCT00086307|520254982|FG000|Overall Study|Withdrawal by Subject|0|||
144287870|NCT00086307|520254983|FG001|Overall Study|Withdrawal by Subject|0|||
144287871|NCT00086307|520254984|FG002|Overall Study|Withdrawal by Subject|2|||
144287872|NCT00105508|520254985|FG000|Overall Study|Prephase Dropout|1|||
144287873|NCT00105508|520254986|FG001|Overall Study|Prephase Dropout|0|||
144287874|NCT00105508|520254985|FG000|Overall Study|Adverse Event|16|||
144287875|NCT00105508|520254986|FG001|Overall Study|Adverse Event|19|||
144287876|NCT00105508|520254985|FG000|Overall Study|Insufficient Efficacy|1|||
144287877|NCT00105508|520254986|FG001|Overall Study|Insufficient Efficacy|0|||
144287878|NCT00105508|520254985|FG000|Overall Study|Withdrawal by Subject|10|||
144287879|NCT00105508|520254986|FG001|Overall Study|Withdrawal by Subject|6|||
144287880|NCT00105508|520254985|FG000|Overall Study|Lost to Follow-up|3|||
144287881|NCT00105508|520254986|FG001|Overall Study|Lost to Follow-up|0|||
144287882|NCT00105508|520254985|FG000|Overall Study|Protocol Violation|1|||
144287883|NCT00105508|520254986|FG001|Overall Study|Protocol Violation|2|||
144287884|NCT00105508|520254985|FG000|Overall Study|Other|8|||
144287885|NCT00105508|520254986|FG001|Overall Study|Other|9|||
144287886|NCT00683384|520254987|FG000|Overall Study|Death|1|||
144287887|NCT00683384|520254987|FG000|Overall Study|Adverse Event|1|||
144287888|NCT00120874|520254988|FG000|Overall Study|Death|0|||
144287889|NCT00120874|520254989|FG001|Overall Study|Death|1|||
144287890|NCT01727154|520254990|FG000|Overall Study|Death|17|||
144287891|NCT01727154|520254990|FG000|Overall Study|Withdrawal by Subject|14|||
144287892|NCT01727154|520254990|FG000|Overall Study|Subject Withdrew Consent|18|||
144287893|NCT01727154|520254990|FG000|Overall Study|Study Terminated|6|||
144287894|NCT01727154|520254990|FG000|Overall Study|No Discontinuation Documentation|4|||
144287895|NCT01198548|520255000|FG000|Overall Study|Disease Progression|9|||
144287896|NCT01198548|520255000|FG000|Overall Study|Administrative Decision|1|||
144287897|NCT01049828|520255001|FG000|Overall Study|Claustrophibia and Frustration|2|||
144287898|NCT00290238|520255002|FG000|Overall Study|Study terminated|27|||
144287899|NCT00290238|520255003|FG001|Overall Study|Study terminated|27|||
144287900|NCT00290238|520255002|FG000|Overall Study|Lost to Follow-up|0|||
144287901|NCT00290238|520255003|FG001|Overall Study|Lost to Follow-up|1|||
144287902|NCT00290238|520255002|FG000|Overall Study|Withdrawal by Subject|15|||
144287903|NCT00290238|520255003|FG001|Overall Study|Withdrawal by Subject|13|||
144287904|NCT03572218|520255007|FG000|Overall Study|Lost to Follow-up|3|||
144287905|NCT03572218|520255008|FG001|Overall Study|Lost to Follow-up|2|||
144287906|NCT03572218|520255007|FG000|Overall Study|No longer available for study visits|2|||
144287907|NCT03572218|520255008|FG001|Overall Study|No longer available for study visits|1|||
144287908|NCT03572218|520255007|FG000|Overall Study|No longer interested|1|||
144287909|NCT03572218|520255008|FG001|Overall Study|No longer interested|2|||
144287910|NCT02487199|520255009|FG000|Overall Study|Withdrew Consent|0|||
144287911|NCT02487199|520255010|FG001|Overall Study|Withdrew Consent|1|||
144287912|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
144287913|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
144287914|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
144287915|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
144287916|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
144287917|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
144287918|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
144287919|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
144287920|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
144287921|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
144287922|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
144287923|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
144287924|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
144287925|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
144287926|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
144287927|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
144287928|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
144287929|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
144287930|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
144287931|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
144287932|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
144287933|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
144287934|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
144287935|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
144287936|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
144287937|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
144287938|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
144287939|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
144287940|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
144287941|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
144287942|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
144287943|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
144287944|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
144287945|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
144287946|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
144287947|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
144287948|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
144287949|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
144287950|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
144287951|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
144287952|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
144287953|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
144287954|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
144287955|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
144287956|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
144287957|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
144287958|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
144287959|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
144287960|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
144287961|NCT01557244|520257234|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
144287962|NCT01557244|520257235|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
144287963|NCT01557244|520257236|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
144287964|NCT01557244|520257237|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
144287965|NCT01557244|520257238|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
144287966|NCT01557244|520257239|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
144287967|NCT01557244|520257240|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
144287968|NCT01557244|520257234|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
144287969|NCT01557244|520257235|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
144287970|NCT01557244|520257236|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
144287971|NCT01557244|520257237|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
144287972|NCT01557244|520257238|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
144287973|NCT01557244|520257239|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
144287974|NCT01557244|520257240|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
144287975|NCT01557244|520257234|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
144287976|NCT01557244|520257235|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
144287977|NCT01557244|520257236|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
144287978|NCT01557244|520257237|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
144287979|NCT01557244|520257238|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
144287980|NCT01557244|520257239|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
144287981|NCT01557244|520257240|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
144287982|NCT01557244|520257234|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
144287983|NCT01557244|520257235|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
144287984|NCT01557244|520257236|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
144287985|NCT01557244|520257237|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
144287986|NCT01557244|520257238|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
144287987|NCT01557244|520257239|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
144287988|NCT01557244|520257240|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
144287989|NCT01557244|520257234|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
144287990|NCT01557244|520257235|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
144287991|NCT01557244|520257236|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
144287992|NCT01557244|520257237|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
144287993|NCT01557244|520257238|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
144287994|NCT01557244|520257239|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
144287995|NCT01557244|520257240|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
144287996|NCT01313676|520257241|FG000|Overall Study|Adverse Event|395|||
144287997|NCT01313676|520257242|FG001|Overall Study|Adverse Event|365|||
144287998|NCT01313676|520257243|FG002|Overall Study|Adverse Event|372|||
144287999|NCT01313676|520257244|FG003|Overall Study|Adverse Event|333|||
144288000|NCT01313676|520257241|FG000|Overall Study|Lack of Efficacy|98|||
144288001|NCT01313676|520257242|FG001|Overall Study|Lack of Efficacy|90|||
144288002|NCT01313676|520257243|FG002|Overall Study|Lack of Efficacy|65|||
144288003|NCT01313676|520257244|FG003|Overall Study|Lack of Efficacy|46|||
144288004|NCT01313676|520257241|FG000|Overall Study|Protocol Violation|37|||
144288005|NCT01313676|520257242|FG001|Overall Study|Protocol Violation|44|||
144288006|NCT01313676|520257243|FG002|Overall Study|Protocol Violation|46|||
144288007|NCT01313676|520257244|FG003|Overall Study|Protocol Violation|44|||
144288008|NCT01313676|520257241|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
144288009|NCT01313676|520257242|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
144288010|NCT01313676|520257243|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
144288011|NCT01313676|520257244|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
144288012|NCT01313676|520257241|FG000|Overall Study|Study Closed/terminated|7|||
144288013|NCT01313676|520257242|FG001|Overall Study|Study Closed/terminated|6|||
144288014|NCT01313676|520257243|FG002|Overall Study|Study Closed/terminated|9|||
144288015|NCT01313676|520257244|FG003|Overall Study|Study Closed/terminated|9|||
144288016|NCT01313676|520257241|FG000|Overall Study|Lost to Follow-up|0|||
144288017|NCT01313676|520257242|FG001|Overall Study|Lost to Follow-up|0|||
144288018|NCT01313676|520257243|FG002|Overall Study|Lost to Follow-up|1|||
144288019|NCT01313676|520257244|FG003|Overall Study|Lost to Follow-up|0|||
144288020|NCT01313676|520257241|FG000|Overall Study|Physician Decision|53|||
144288021|NCT01313676|520257242|FG001|Overall Study|Physician Decision|64|||
144288022|NCT01313676|520257243|FG002|Overall Study|Physician Decision|62|||
144288023|NCT01313676|520257244|FG003|Overall Study|Physician Decision|48|||
144288024|NCT01313676|520257241|FG000|Overall Study|Decision by Participant or Proxy|643|||
144288025|NCT01313676|520257242|FG001|Overall Study|Decision by Participant or Proxy|527|||
144288026|NCT01313676|520257243|FG002|Overall Study|Decision by Participant or Proxy|515|||
144288027|NCT01313676|520257244|FG003|Overall Study|Decision by Participant or Proxy|492|||
144288028|NCT01313676|520257241|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
144288029|NCT01313676|520257242|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
144288030|NCT01313676|520257243|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
144288031|NCT01313676|520257244|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
144288032|NCT01313676|520257241|FG000|Overall Study|Investigator Site Closed|12|||
144288033|NCT01313676|520257242|FG001|Overall Study|Investigator Site Closed|11|||
144288034|NCT01313676|520257243|FG002|Overall Study|Investigator Site Closed|15|||
144288035|NCT01313676|520257244|FG003|Overall Study|Investigator Site Closed|10|||
144288036|NCT01313676|520257241|FG000|Overall Study|Missing|1|||
144288037|NCT01313676|520257242|FG001|Overall Study|Missing|1|||
144288038|NCT01313676|520257243|FG002|Overall Study|Missing|1|||
144288039|NCT01313676|520257244|FG003|Overall Study|Missing|0|||
144288040|NCT03931785|520257245|FG000|Overall Study|Lost to Follow-up|4|||
144288041|NCT03931785|520257246|FG001|Overall Study|Lost to Follow-up|1|||
144288042|NCT03931785|520257247|FG002|Overall Study|Lost to Follow-up|4|||
144288043|NCT03931785|520257248|FG003|Overall Study|Lost to Follow-up|3|||
144288044|NCT03931785|520257245|FG000|Overall Study|Adverse Event|1|||
144288045|NCT03931785|520257246|FG001|Overall Study|Adverse Event|0|||
144288046|NCT03931785|520257247|FG002|Overall Study|Adverse Event|3|||
144288047|NCT03931785|520257248|FG003|Overall Study|Adverse Event|4|||
144288048|NCT03931785|520257245|FG000|Overall Study|Protocol Violation|0|||
144288049|NCT03931785|520257246|FG001|Overall Study|Protocol Violation|1|||
144288050|NCT03931785|520257247|FG002|Overall Study|Protocol Violation|0|||
144288051|NCT03931785|520257248|FG003|Overall Study|Protocol Violation|0|||
144288052|NCT03931785|520257245|FG000|Overall Study|Noncompliance With Study drug|0|||
144288053|NCT03931785|520257246|FG001|Overall Study|Noncompliance With Study drug|1|||
144288054|NCT03931785|520257247|FG002|Overall Study|Noncompliance With Study drug|0|||
144288055|NCT03931785|520257248|FG003|Overall Study|Noncompliance With Study drug|0|||
144288056|NCT03931785|520257245|FG000|Overall Study|Other Not specified|0|||
144288057|NCT03931785|520257246|FG001|Overall Study|Other Not specified|2|||
144288058|NCT03931785|520257247|FG002|Overall Study|Other Not specified|2|||
144288059|NCT03931785|520257248|FG003|Overall Study|Other Not specified|2|||
144288060|NCT03931785|520257245|FG000|Overall Study|Withdrawal by Subject|0|||
144288061|NCT03931785|520257246|FG001|Overall Study|Withdrawal by Subject|2|||
144288062|NCT03931785|520257247|FG002|Overall Study|Withdrawal by Subject|4|||
144288063|NCT03931785|520257248|FG003|Overall Study|Withdrawal by Subject|1|||
144288064|NCT03931785|520257245|FG000|Overall Study|Pregnancy|0|||
144288065|NCT03931785|520257246|FG001|Overall Study|Pregnancy|0|||
144288066|NCT03931785|520257247|FG002|Overall Study|Pregnancy|0|||
144288067|NCT03931785|520257248|FG003|Overall Study|Pregnancy|1|||
144288068|NCT00903344|520257249|FG000|Overall Study|Pregnancy|2|||
144288069|NCT00903344|520257250|FG001|Overall Study|Pregnancy|3|||
144288070|NCT00903344|520257249|FG000|Overall Study|Lost to Follow-up|3|||
144288071|NCT00903344|520257250|FG001|Overall Study|Lost to Follow-up|0|||
144288072|NCT01530256|520257253|FG000|Overall Study|Death|2|||
144288073|NCT00527748|520257255|FG000|Overall Study|Other|3|||
144288074|NCT00292370|520257256|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
144288075|NCT00292370|520257257|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
144288076|NCT00292370|520257258|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
144288077|NCT00292370|520257256|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
144288078|NCT00292370|520257257|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
144288079|NCT00292370|520257258|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
144288080|NCT00292370|520257256|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
144288081|NCT00292370|520257257|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
144288082|NCT00292370|520257258|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
144288083|NCT00292370|520257256|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
144288084|NCT00292370|520257257|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
144288085|NCT00292370|520257258|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
144288086|NCT00292370|520257256|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
144288087|NCT00292370|520257257|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
144288088|NCT00292370|520257258|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
144288089|NCT00292370|520257256|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
144288090|NCT00292370|520257257|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
144288091|NCT00292370|520257258|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
144288092|NCT00605657|520257261|FG000|Overall Study|Adverse Event|1|||
144288093|NCT00605657|520257261|FG000|Overall Study|Protocol Violation|1|||
144288094|NCT00378560|520257264|FG000|Overall Study|Adverse Event|1|||
144288095|NCT00378560|520257265|FG001|Overall Study|Adverse Event|0|||
144288096|NCT00378560|520257264|FG000|Overall Study|Lost to Follow-up|24|||
144288097|NCT00378560|520257265|FG001|Overall Study|Lost to Follow-up|29|||
144288098|NCT00378560|520257264|FG000|Overall Study|Protocol Violation|2|||
144288099|NCT00378560|520257265|FG001|Overall Study|Protocol Violation|0|||
144288100|NCT00378560|520257264|FG000|Overall Study|Withdrawal by Subject|17|||
144288101|NCT00378560|520257265|FG001|Overall Study|Withdrawal by Subject|21|||
144288102|NCT00378560|520257264|FG000|Overall Study|Moved|4|||
144288103|NCT00378560|520257265|FG001|Overall Study|Moved|3|||
144288104|NCT00378560|520257264|FG000|Overall Study|Pregnancy|7|||
144288105|NCT00378560|520257265|FG001|Overall Study|Pregnancy|5|||
144288106|NCT00378560|520257264|FG000|Overall Study|Laboratory test values abnormal|1|||
144288107|NCT00378560|520257265|FG001|Overall Study|Laboratory test values abnormal|0|||
144288108|NCT02773537|520257266|FG000|Overall Study|Lost to Follow-up|0|||
144288109|NCT02773537|520257267|FG001|Overall Study|Lost to Follow-up|1|||
144288110|NCT02773537|520257268|FG002|Overall Study|Lost to Follow-up|4|||
144288111|NCT01975285|520257282|FG000|Overall Study|Failed Block and follow up|2|||
144288112|NCT01975285|520257283|FG001|Overall Study|Failed Block and follow up|2|||
144288113|NCT04535362|520257284|FG000|Overall Study|Lost to Follow-up|3|||
144288114|NCT04535362|520257285|FG001|Overall Study|Lost to Follow-up|1|||
144288115|NCT03791060|520257286|FG000|Overall Study|Withdrawal by Subject|1|||
144288116|NCT03774810|520257287|FG000|Phase 1|Lack of Efficacy|21|||
144288117|NCT03774810|520257288|FG001|Phase 1|Lack of Efficacy|0|||
144288118|NCT03774810|520257289|FG002|Phase 1|Lack of Efficacy|0|||
144288119|NCT03774810|520257290|FG003|Phase 1|Lack of Efficacy|0|||
144288120|NCT03774810|520257291|FG004|Phase 1|Lack of Efficacy|0|||
144288121|NCT03774810|520257287|FG000|Phase 1|Withdrawal by Subject|9|||
144288122|NCT03774810|520257288|FG001|Phase 1|Withdrawal by Subject|0|||
144288123|NCT03774810|520257289|FG002|Phase 1|Withdrawal by Subject|0|||
144288124|NCT03774810|520257290|FG003|Phase 1|Withdrawal by Subject|0|||
144288125|NCT03774810|520257291|FG004|Phase 1|Withdrawal by Subject|0|||
144288126|NCT03774810|520257287|FG000|Phase 1|Lost to Follow-up|2|||
144288127|NCT03774810|520257288|FG001|Phase 1|Lost to Follow-up|0|||
144288128|NCT03774810|520257289|FG002|Phase 1|Lost to Follow-up|0|||
144288129|NCT03774810|520257290|FG003|Phase 1|Lost to Follow-up|0|||
144288130|NCT03774810|520257291|FG004|Phase 1|Lost to Follow-up|0|||
144288131|NCT03774810|520257287|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
144288132|NCT03774810|520257288|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
144288133|NCT03774810|520257289|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
144288134|NCT03774810|520257290|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
144288135|NCT03774810|520257291|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
144288136|NCT03774810|520257287|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
144288137|NCT03774810|520257288|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
144288138|NCT03774810|520257289|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
144288139|NCT03774810|520257290|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
144288140|NCT03774810|520257291|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
144288141|NCT03774810|520257287|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
144288142|NCT03774810|520257288|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
144288143|NCT03774810|520257289|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
144288144|NCT03774810|520257290|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
144288145|NCT03774810|520257291|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
144288146|NCT03774810|520257287|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
144288147|NCT03774810|520257288|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
144288148|NCT03774810|520257289|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
144288149|NCT03774810|520257290|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
144288150|NCT03774810|520257291|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
144288151|NCT03774810|520257287|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
144288152|NCT03774810|520257288|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
144288153|NCT03774810|520257289|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
144288154|NCT03774810|520257290|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
144288155|NCT03774810|520257291|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
144288156|NCT03774810|520257287|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
144288157|NCT03774810|520257288|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
144288158|NCT03774810|520257289|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
144288159|NCT03774810|520257290|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
144288160|NCT03774810|520257291|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
144288161|NCT01174459|520257295|FG000|Overall Study|case report form (CRF) not collected|5|||
144288162|NCT00927186|520257296|FG000|12 Months Primary Study|Adverse Event|5|||
144288163|NCT00927186|520257297|FG001|12 Months Primary Study|Adverse Event|2|||
144288164|NCT00927186|520257296|FG000|12 Months Primary Study|Lost to Follow-up|1|||
144288165|NCT00927186|520257297|FG001|12 Months Primary Study|Lost to Follow-up|0|||
144288166|NCT00927186|520257296|FG000|12 Months Primary Study|Protocol Violation|0|||
144288167|NCT00927186|520257297|FG001|12 Months Primary Study|Protocol Violation|1|||
144288168|NCT00927186|520257296|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
144288169|NCT00927186|520257297|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
144288170|NCT00604383|520257298|FG000|Overall Study|Withdrawal by Subject|33|||
144288171|NCT00604383|520257299|FG001|Overall Study|Withdrawal by Subject|31|||
144288172|NCT00604383|520257298|FG000|Overall Study|Lost to Follow-up|24|||
144288173|NCT00604383|520257299|FG001|Overall Study|Lost to Follow-up|19|||
144288174|NCT00604383|520257298|FG000|Overall Study|Death|14|||
144288175|NCT00604383|520257299|FG001|Overall Study|Death|22|||
144288176|NCT00604383|520257298|FG000|Overall Study|Adverse Event|16|||
144288177|NCT00604383|520257299|FG001|Overall Study|Adverse Event|9|||
144288178|NCT00604383|520257298|FG000|Overall Study|Physician Decision|0|||
144288179|NCT00604383|520257299|FG001|Overall Study|Physician Decision|3|||
144288180|NCT03757715|520257311|FG000|Overall Study|Lost to Follow-up|4|||
144288181|NCT03757715|520257312|FG001|Overall Study|Lost to Follow-up|9|||
144288182|NCT03757715|520257311|FG000|Overall Study|Withdrawal by Subject|1|||
144288183|NCT03757715|520257312|FG001|Overall Study|Withdrawal by Subject|1|||
144288184|NCT03156621|520257313|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
144288185|NCT03156621|520257314|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
144288186|NCT03156621|520257313|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
144288187|NCT03156621|520257314|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
144288188|NCT03302936|520257315|FG000|Overall Study|Protocol Violation|3|||
144288189|NCT03302936|520257316|FG001|Overall Study|Protocol Violation|4|||
144288190|NCT02346370|520257317|FG000|Overall Study|Not treated|1|||
144288191|NCT02346370|520257318|FG001|Overall Study|Not treated|0|||
144288192|NCT02346370|520257319|FG002|Overall Study|Not treated|0|||
144288193|NCT02346370|520257317|FG000|Overall Study|Withdrawal of consent|1|||
144288194|NCT02346370|520257318|FG001|Overall Study|Withdrawal of consent|0|||
144288195|NCT02346370|520257319|FG002|Overall Study|Withdrawal of consent|0|||
144288196|NCT02346370|520257317|FG000|Overall Study|Death|1|||
144288197|NCT02346370|520257318|FG001|Overall Study|Death|3|||
144288198|NCT02346370|520257319|FG002|Overall Study|Death|1|||
144288199|NCT02346370|520257317|FG000|Overall Study|Sponsor discontinued study|5|||
144288200|NCT02346370|520257318|FG001|Overall Study|Sponsor discontinued study|0|||
144288201|NCT02346370|520257319|FG002|Overall Study|Sponsor discontinued study|2|||
144288202|NCT02346370|520257317|FG000|Overall Study|Radiologic progression|0|||
144288203|NCT02346370|520257318|FG001|Overall Study|Radiologic progression|0|||
144288204|NCT02346370|520257319|FG002|Overall Study|Radiologic progression|1|||
144288205|NCT02346370|520257317|FG000|Overall Study|Physician Decision|0|||
144288206|NCT02346370|520257318|FG001|Overall Study|Physician Decision|1|||
144288207|NCT02346370|520257319|FG002|Overall Study|Physician Decision|0|||
144288208|NCT01217047|520257320|FG000|Overall Study|Lost to Follow-up|0|||
144288209|NCT01217047|520257321|FG001|Overall Study|Lost to Follow-up|1|||
144288210|NCT01217047|520257322|FG002|Overall Study|Lost to Follow-up|0|||
144288211|NCT06399471|520257323|FG000|Overall Study|Withdrawal by Subject|1|||
144288212|NCT05529173|520257324|FG000|Overall Study|Physician Decision|3|||
144288213|NCT05529173|520257325|FG001|Overall Study|Physician Decision|6|||
144288214|NCT05529173|520257324|FG000|Overall Study|Sample shipment delay more than one day|4|||
144288215|NCT05529173|520257325|FG001|Overall Study|Sample shipment delay more than one day|0|||
144288216|NCT05587998|520257326|FG000|Overall Study|Withdrawal by Subject|1|||
144288217|NCT05587998|520257327|FG001|Overall Study|Withdrawal by Subject|1|||
144288218|NCT05587998|520257326|FG000|Overall Study|Not treated|3|||
144288219|NCT05587998|520257327|FG001|Overall Study|Not treated|1|||
144288220|NCT05587998|520257326|FG000|Overall Study|Non-compliance with study procedures|0|||
144288221|NCT05587998|520257327|FG001|Overall Study|Non-compliance with study procedures|1|||
144288222|NCT01362270|520257329|FG000|Overall Study|Withdrawal by Subject|1|||
144288223|NCT01362270|520257330|FG001|Overall Study|Withdrawal by Subject|0|||
144288224|NCT01362270|520257329|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
144288225|NCT01362270|520257330|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
144288226|NCT01362270|520257329|FG000|Overall Study|Met excl. criteria before 1st session|1|||
144288227|NCT01362270|520257330|FG001|Overall Study|Met excl. criteria before 1st session|1|||
144288228|NCT02318277|520257331|FG000|Overall Study|Physician Decision|0|||
144288229|NCT02318277|520257332|FG001|Overall Study|Physician Decision|0|||
144288230|NCT02318277|520257333|FG002|Overall Study|Physician Decision|0|||
144288231|NCT02318277|520257334|FG003|Overall Study|Physician Decision|0|||
144288232|NCT02318277|520257335|FG004|Overall Study|Physician Decision|0|||
144288233|NCT02318277|520257336|FG005|Overall Study|Physician Decision|0|||
144288234|NCT02318277|520257337|FG006|Overall Study|Physician Decision|0|||
144288235|NCT02318277|520257338|FG007|Overall Study|Physician Decision|1|||
144288236|NCT02318277|520257331|FG000|Overall Study|Other|0|||
144288237|NCT02318277|520257332|FG001|Overall Study|Other|0|||
144288238|NCT02318277|520257333|FG002|Overall Study|Other|0|||
144288239|NCT02318277|520257334|FG003|Overall Study|Other|0|||
144288240|NCT02318277|520257335|FG004|Overall Study|Other|0|||
144288241|NCT02318277|520257336|FG005|Overall Study|Other|0|||
144288242|NCT02318277|520257337|FG006|Overall Study|Other|1|||
144288243|NCT02318277|520257338|FG007|Overall Study|Other|0|||
144288244|NCT02318277|520257331|FG000|Overall Study|Withdrawal by Subject|0|||
144288245|NCT02318277|520257332|FG001|Overall Study|Withdrawal by Subject|0|||
144288246|NCT02318277|520257333|FG002|Overall Study|Withdrawal by Subject|1|||
144288247|NCT02318277|520257334|FG003|Overall Study|Withdrawal by Subject|0|||
144288248|NCT02318277|520257335|FG004|Overall Study|Withdrawal by Subject|1|||
144288249|NCT02318277|520257336|FG005|Overall Study|Withdrawal by Subject|1|||
144288250|NCT02318277|520257337|FG006|Overall Study|Withdrawal by Subject|6|||
144288251|NCT02318277|520257338|FG007|Overall Study|Withdrawal by Subject|14|||
144288252|NCT02318277|520257331|FG000|Overall Study|Participant trial terminated by sponsor|0|||
144288253|NCT02318277|520257332|FG001|Overall Study|Participant trial terminated by sponsor|0|||
144288254|NCT02318277|520257333|FG002|Overall Study|Participant trial terminated by sponsor|1|||
144288255|NCT02318277|520257334|FG003|Overall Study|Participant trial terminated by sponsor|0|||
144288256|NCT02318277|520257335|FG004|Overall Study|Participant trial terminated by sponsor|1|||
144288257|NCT02318277|520257336|FG005|Overall Study|Participant trial terminated by sponsor|2|||
144288258|NCT02318277|520257337|FG006|Overall Study|Participant trial terminated by sponsor|5|||
144288259|NCT02318277|520257338|FG007|Overall Study|Participant trial terminated by sponsor|16|||
144288260|NCT02318277|520257331|FG000|Overall Study|Lost to Follow-up|1|||
144288261|NCT02318277|520257332|FG001|Overall Study|Lost to Follow-up|0|||
144288262|NCT02318277|520257333|FG002|Overall Study|Lost to Follow-up|1|||
144288263|NCT02318277|520257334|FG003|Overall Study|Lost to Follow-up|0|||
144288264|NCT02318277|520257335|FG004|Overall Study|Lost to Follow-up|0|||
144288265|NCT02318277|520257336|FG005|Overall Study|Lost to Follow-up|0|||
144288266|NCT02318277|520257337|FG006|Overall Study|Lost to Follow-up|3|||
144288267|NCT02318277|520257338|FG007|Overall Study|Lost to Follow-up|4|||
144288268|NCT02318277|520257331|FG000|Overall Study|Death|5|||
144288269|NCT02318277|520257332|FG001|Overall Study|Death|3|||
144288270|NCT02318277|520257333|FG002|Overall Study|Death|1|||
144288271|NCT02318277|520257334|FG003|Overall Study|Death|4|||
144288272|NCT02318277|520257335|FG004|Overall Study|Death|6|||
144288273|NCT02318277|520257336|FG005|Overall Study|Death|5|||
144288274|NCT02318277|520257337|FG006|Overall Study|Death|34|||
144288275|NCT02318277|520257338|FG007|Overall Study|Death|58|||
144288276|NCT02318277|520257331|FG000|Overall Study|Transitioned to Hospice|0|||
144288277|NCT02318277|520257332|FG001|Overall Study|Transitioned to Hospice|0|||
144288278|NCT02318277|520257333|FG002|Overall Study|Transitioned to Hospice|0|||
144288279|NCT02318277|520257334|FG003|Overall Study|Transitioned to Hospice|0|||
144288280|NCT02318277|520257335|FG004|Overall Study|Transitioned to Hospice|0|||
144288281|NCT02318277|520257336|FG005|Overall Study|Transitioned to Hospice|1|||
144288282|NCT02318277|520257337|FG006|Overall Study|Transitioned to Hospice|0|||
144288283|NCT02318277|520257338|FG007|Overall Study|Transitioned to Hospice|0|||
144288284|NCT01986751|520257345|FG000|Overall Study|improperly consented|10|||
144288285|NCT01986751|520257346|FG001|Overall Study|improperly consented|2|||
144288286|NCT03566550|520257348|FG000|Overall Study|Withdrawal by Subject|0|||
144288287|NCT03566550|520257349|FG001|Overall Study|Withdrawal by Subject|1|||
144288288|NCT00407030|520257350|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
144288289|NCT00407030|520257351|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
144288290|NCT00407030|520257352|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
144288291|NCT00407030|520257350|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
144288292|NCT00407030|520257351|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
144288293|NCT00407030|520257352|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
144288294|NCT00407030|520257350|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
144288295|NCT00407030|520257351|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
144288296|NCT00407030|520257352|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
144288297|NCT00407030|520257350|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
144288298|NCT00407030|520257351|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
144288299|NCT00407030|520257352|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
144288300|NCT00407030|520257350|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
144288301|NCT00407030|520257351|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
144288302|NCT00407030|520257352|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
144288303|NCT00407030|520257350|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
144288304|NCT00407030|520257351|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
144288305|NCT00407030|520257352|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
144288306|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
144288307|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
144288308|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
144288309|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
144288310|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
144288311|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
144288312|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
144288313|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
144288314|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
144288315|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
144288316|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
144288317|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
144288318|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
144288319|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
144288320|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
144288321|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
144288322|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
144288323|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
144288324|NCT00407030|520257350|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
144288325|NCT00407030|520257351|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
144288326|NCT00407030|520257352|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
144288327|NCT01489358|520257353|FG000|Overall Study|Lost to Follow-up|0|||
144288328|NCT01489358|520257354|FG001|Overall Study|Lost to Follow-up|0|||
144288329|NCT01489358|520257355|FG002|Overall Study|Lost to Follow-up|2|||
144288330|NCT03722030|520257356|FG000|Overall Study|Withdrawal by Subject|1|||
144288331|NCT03722030|520257357|FG001|Overall Study|Withdrawal by Subject|0|||
144288332|NCT00736476|520257358|FG000|Overall Study|Adverse Event|1|||
144288333|NCT00736476|520257359|FG001|Overall Study|Adverse Event|0|||
144288334|NCT03518203|520257360|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
144288335|NCT03518203|520257360|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
144288336|NCT00345592|520257361|FG000|Overall Study|Death|14|||
144288337|NCT00345592|520257362|FG001|Overall Study|Death|16|||
144288338|NCT00345592|520257361|FG000|Overall Study|Withdrawal by Subject|11|||
144288339|NCT00345592|520257362|FG001|Overall Study|Withdrawal by Subject|8|||
144288340|NCT01084135|520257364|FG000|20 Week|Physician Decision|0|||
144288341|NCT01084135|520257365|FG001|20 Week|Physician Decision|1|||
144288342|NCT03335566|520257366|FG000|Overall Study|Adverse Event|0|||
144288343|NCT03335566|520257367|FG001|Overall Study|Adverse Event|1|||
144288344|NCT03335566|520257366|FG000|Overall Study|Lost to Follow-up|1|||
144288345|NCT03335566|520257367|FG001|Overall Study|Lost to Follow-up|0|||
144288346|NCT03335566|520257366|FG000|Overall Study|Technical Problems|1|||
144288347|NCT03335566|520257367|FG001|Overall Study|Technical Problems|0|||
144288348|NCT03335566|520257366|FG000|Overall Study|Protocol Violation|1|||
144288349|NCT03335566|520257367|FG001|Overall Study|Protocol Violation|0|||
144288350|NCT03335566|520257366|FG000|Overall Study|Other than specified above|1|||
144288351|NCT03335566|520257367|FG001|Overall Study|Other than specified above|2|||
144288352|NCT01016015|520257368|FG000|Overall Study|Not Treated|3|||
144288353|NCT01016015|520257368|FG000|Overall Study|Withdrawal by Subject|1|||
144288354|NCT01016015|520257368|FG000|Overall Study|Adverse Event|15|||
144288355|NCT02218268|520257369|FG000|24 Hour Washout|Physician Decision|11|||
144288356|NCT02218268|520257370|FG001|24 Hour Washout|Physician Decision|9|||
144288357|NCT03651336|520257371|FG000|Overall Study|Withdrawal by Subject|4|||
144288358|NCT01341990|520257372|FG000|Overall Study|Adverse Event|0|||
144288359|NCT01341990|520257373|FG001|Overall Study|Adverse Event|1|||
144288360|NCT01341990|520257372|FG000|Overall Study|Torn Study Lens|1|||
144288361|NCT01341990|520257373|FG001|Overall Study|Torn Study Lens|0|||
144288362|NCT01341990|520257372|FG000|Overall Study|Withdrawal by Subject|2|||
144288363|NCT01341990|520257373|FG001|Overall Study|Withdrawal by Subject|0|||
144288364|NCT03632720|520257375|FG000|Overall Study|Adverse Event|2|||
144288365|NCT03632720|520257376|FG001|Overall Study|Adverse Event|0|||
144288366|NCT03632720|520257377|FG002|Overall Study|Adverse Event|0|||
144288367|NCT03632720|520257375|FG000|Overall Study|Lost to Follow-up|0|||
144288368|NCT03632720|520257376|FG001|Overall Study|Lost to Follow-up|1|||
144288369|NCT03632720|520257377|FG002|Overall Study|Lost to Follow-up|0|||
144288370|NCT03632720|520257375|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
144288371|NCT03632720|520257376|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
144288372|NCT03632720|520257377|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
144288373|NCT03632720|520257375|FG000|Overall Study|Screen failure|0|||
144288374|NCT03632720|520257376|FG001|Overall Study|Screen failure|1|||
144288375|NCT03632720|520257377|FG002|Overall Study|Screen failure|0|||
144288376|NCT00682435|520257378|FG000|Overall Study|Insufficient data|5|||
144288377|NCT00682435|520257378|FG000|Overall Study|Erroneously enrolled twice|2|||
144288378|NCT01117350|520257379|FG000|Comparative Period|Not Treated|5|||
144288379|NCT01117350|520257380|FG001|Comparative Period|Not Treated|8|||
144288380|NCT01117350|520257379|FG000|Comparative Period|Adverse Event|6|||
144288381|NCT01117350|520257380|FG001|Comparative Period|Adverse Event|33|||
144288382|NCT01117350|520257379|FG000|Comparative Period|Lost to Follow-up|11|||
144288383|NCT01117350|520257380|FG001|Comparative Period|Lost to Follow-up|7|||
144288384|NCT01117350|520257379|FG000|Comparative Period|Withdrawal by Subject|9|||
144288385|NCT01117350|520257380|FG001|Comparative Period|Withdrawal by Subject|13|||
144288386|NCT01117350|520257379|FG000|Comparative Period|Protocol Violation|8|||
144288387|NCT01117350|520257380|FG001|Comparative Period|Protocol Violation|12|||
144288388|NCT01117350|520257379|FG000|Comparative Period|Lack of Efficacy|1|||
144288389|NCT01117350|520257380|FG001|Comparative Period|Lack of Efficacy|0|||
144288390|NCT01117350|520257379|FG000|Comparative Period|Physician Decision|0|||
144288391|NCT01117350|520257380|FG001|Comparative Period|Physician Decision|1|||
144288392|NCT01117350|520257379|FG000|Comparative Period|Move to another city/country|2|||
144288393|NCT01117350|520257380|FG001|Comparative Period|Move to another city/country|1|||
144288394|NCT01117350|520257379|FG000|Extension Period|Not included in extension, not treated|0|||
144288395|NCT01117350|520257380|FG001|Extension Period|Not included in extension, not treated|50|||
144288396|NCT01117350|520257379|FG000|Extension Period|Adverse Event|0|||
144288397|NCT01117350|520257380|FG001|Extension Period|Adverse Event|2|||
144288398|NCT01117350|520257379|FG000|Extension Period|Protocol Violation|0|||
144288399|NCT01117350|520257380|FG001|Extension Period|Protocol Violation|2|||
144288400|NCT01117350|520257379|FG000|Extension Period|Lost to Follow-up|0|||
144288401|NCT01117350|520257380|FG001|Extension Period|Lost to Follow-up|2|||
144288402|NCT01117350|520257379|FG000|Extension Period|Withdrawal by Subject|0|||
144288403|NCT01117350|520257380|FG001|Extension Period|Withdrawal by Subject|3|||
144288404|NCT01117350|520257379|FG000|Extension Period|Lack of Efficacy|0|||
144288405|NCT01117350|520257380|FG001|Extension Period|Lack of Efficacy|2|||
144288406|NCT01117350|520257379|FG000|Extension Period|Inclusion criteria not respected|0|||
144288407|NCT01117350|520257380|FG001|Extension Period|Inclusion criteria not respected|1|||
144288408|NCT01117350|520257379|FG000|Extension Period|Prohibited medication|0|||
144288409|NCT01117350|520257380|FG001|Extension Period|Prohibited medication|1|||
144288410|NCT00286455|520257385|FG000|Overall Study|Hyperglycemia rescue|19|||
144288411|NCT00286455|520257386|FG001|Overall Study|Hyperglycemia rescue|13|||
144288412|NCT00286455|520257387|FG002|Overall Study|Hyperglycemia rescue|10|||
144288413|NCT00286455|520257385|FG000|Overall Study|Adverse Event|1|||
144288414|NCT00286455|520257386|FG001|Overall Study|Adverse Event|3|||
144288415|NCT00286455|520257387|FG002|Overall Study|Adverse Event|2|||
144288416|NCT00286455|520257385|FG000|Overall Study|Lost to Follow-up|0|||
144288417|NCT00286455|520257386|FG001|Overall Study|Lost to Follow-up|3|||
144288418|NCT00286455|520257387|FG002|Overall Study|Lost to Follow-up|3|||
144288419|NCT00286455|520257385|FG000|Overall Study|Physician Decision|3|||
144288420|NCT00286455|520257386|FG001|Overall Study|Physician Decision|0|||
144288421|NCT00286455|520257387|FG002|Overall Study|Physician Decision|2|||
144288422|NCT00286455|520257385|FG000|Overall Study|Protocol Violation|1|||
144288423|NCT00286455|520257386|FG001|Overall Study|Protocol Violation|1|||
144288424|NCT00286455|520257387|FG002|Overall Study|Protocol Violation|0|||
144288425|NCT00286455|520257385|FG000|Overall Study|Participant Non-compliance|1|||
144288426|NCT00286455|520257386|FG001|Overall Study|Participant Non-compliance|0|||
144288427|NCT00286455|520257387|FG002|Overall Study|Participant Non-compliance|0|||
144288428|NCT00286455|520257385|FG000|Overall Study|Withdrawal by Subject|0|||
144288429|NCT00286455|520257386|FG001|Overall Study|Withdrawal by Subject|8|||
144288430|NCT00286455|520257387|FG002|Overall Study|Withdrawal by Subject|7|||
144288431|NCT04495478|520257388|FG000|Overall Study|Withdrawal by Subject|0|||
144288432|NCT04495478|520257389|FG001|Overall Study|Withdrawal by Subject|0|||
144288433|NCT04495478|520257390|FG002|Overall Study|Withdrawal by Subject|0|||
144288434|NCT04495478|520257391|FG003|Overall Study|Withdrawal by Subject|1|||
144288435|NCT04495478|520257392|FG004|Overall Study|Withdrawal by Subject|0|||
144288436|NCT04495478|520257393|FG005|Overall Study|Withdrawal by Subject|0|||
144288437|NCT04495478|520257394|FG006|Overall Study|Withdrawal by Subject|0|||
144288438|NCT04495478|520257388|FG000|Overall Study|Physician Decision|0|||
144288439|NCT04495478|520257389|FG001|Overall Study|Physician Decision|1|||
144288440|NCT04495478|520257390|FG002|Overall Study|Physician Decision|0|||
144288441|NCT04495478|520257391|FG003|Overall Study|Physician Decision|0|||
144288442|NCT04495478|520257392|FG004|Overall Study|Physician Decision|1|||
144288443|NCT04495478|520257393|FG005|Overall Study|Physician Decision|0|||
144288444|NCT04495478|520257394|FG006|Overall Study|Physician Decision|0|||
144288445|NCT01213251|520259144|FG000|Overall Study|Death|2|||
144288446|NCT01213251|520259145|FG001|Overall Study|Death|1|||
144288447|NCT01213251|520259146|FG002|Overall Study|Death|2|||
144288448|NCT01213251|520259144|FG000|Overall Study|Exit|3|||
144288449|NCT01213251|520259145|FG001|Overall Study|Exit|2|||
144288450|NCT01213251|520259146|FG002|Overall Study|Exit|8|||
144288451|NCT01213251|520259144|FG000|Overall Study|Protocol Violation|1|||
144288452|NCT01213251|520259145|FG001|Overall Study|Protocol Violation|1|||
144288453|NCT01213251|520259146|FG002|Overall Study|Protocol Violation|0|||
144288454|NCT01213251|520259144|FG000|Overall Study|Missed 18-Month Follow-up|0|||
144288455|NCT01213251|520259145|FG001|Overall Study|Missed 18-Month Follow-up|0|||
144288456|NCT01213251|520259146|FG002|Overall Study|Missed 18-Month Follow-up|1|||
144288457|NCT01862029|520259151|FG000|Overall Study|Physician Decision|1|||
144288458|NCT02004275|520259159|FG000|Phase 1|Ineligible|0|||
144288459|NCT02004275|520259160|FG001|Phase 1|Ineligible|0|||
144288460|NCT02004275|520259161|FG002|Phase 1|Ineligible|0|||
144288461|NCT02004275|520259162|FG003|Phase 1|Ineligible|1|||
144288462|NCT02004275|520259163|FG004|Phase 1|Ineligible|1|||
144288463|NCT02004275|520259164|FG005|Phase 1|Ineligible|0|||
144288464|NCT02004275|520259159|FG000|Phase 1|Protocol Violation|0|||
144288465|NCT02004275|520259160|FG001|Phase 1|Protocol Violation|0|||
144288466|NCT02004275|520259161|FG002|Phase 1|Protocol Violation|0|||
144288467|NCT02004275|520259162|FG003|Phase 1|Protocol Violation|1|||
144288468|NCT02004275|520259163|FG004|Phase 1|Protocol Violation|0|||
144288469|NCT02004275|520259164|FG005|Phase 1|Protocol Violation|5|||
144288470|NCT02004275|520259159|FG000|Phase 2 Part 1|Ineligible|6|||
144288471|NCT02004275|520259160|FG001|Phase 2 Part 1|Ineligible|9|||
144288472|NCT02004275|520259161|FG002|Phase 2 Part 1|Ineligible|0|||
144288473|NCT02004275|520259162|FG003|Phase 2 Part 1|Ineligible|0|||
144288474|NCT02004275|520259163|FG004|Phase 2 Part 1|Ineligible|0|||
144288475|NCT02004275|520259164|FG005|Phase 2 Part 1|Ineligible|0|||
144288476|NCT02004275|520259159|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
144288477|NCT02004275|520259160|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
144288478|NCT02004275|520259161|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
144288479|NCT02004275|520259162|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
144288480|NCT02004275|520259163|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
144288481|NCT02004275|520259164|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
144288482|NCT04621786|520259165|FG000|Overall Study|Lost to Follow-up|9|||
144288483|NCT04621786|520259165|FG000|Overall Study|Protocol Violation|3|||
144288484|NCT02533674|520259166|FG000|Dose Level I|Progressive disease|1|||
144288485|NCT02533674|520259167|FG001|Dose Level I|Progressive disease|0|||
144288486|NCT02533674|520259168|FG002|Dose Level I|Progressive disease|0|||
144288487|NCT02533674|520259169|FG003|Dose Level I|Progressive disease|0|||
144288488|NCT02533674|520259170|FG004|Dose Level I|Progressive disease|0|||
144288489|NCT02533674|520259171|FG005|Dose Level I|Progressive disease|0|||
144288490|NCT02533674|520259172|FG006|Dose Level I|Progressive disease|0|||
144288491|NCT02533674|520259173|FG007|Dose Level I|Progressive disease|0|||
144288492|NCT02533674|520259166|FG000|Dose Level I|Withdrawal by Subject|1|||
144288493|NCT02533674|520259167|FG001|Dose Level I|Withdrawal by Subject|0|||
144288494|NCT02533674|520259168|FG002|Dose Level I|Withdrawal by Subject|0|||
144288495|NCT02533674|520259169|FG003|Dose Level I|Withdrawal by Subject|0|||
144288496|NCT02533674|520259170|FG004|Dose Level I|Withdrawal by Subject|0|||
144288497|NCT02533674|520259171|FG005|Dose Level I|Withdrawal by Subject|0|||
144288498|NCT02533674|520259172|FG006|Dose Level I|Withdrawal by Subject|0|||
144288499|NCT02533674|520259173|FG007|Dose Level I|Withdrawal by Subject|0|||
144288500|NCT02533674|520259166|FG000|Dose Level I|Physician Decision|1|||
144288501|NCT02533674|520259167|FG001|Dose Level I|Physician Decision|0|||
144288502|NCT02533674|520259168|FG002|Dose Level I|Physician Decision|0|||
144288503|NCT02533674|520259169|FG003|Dose Level I|Physician Decision|0|||
144288504|NCT02533674|520259170|FG004|Dose Level I|Physician Decision|0|||
144288505|NCT02533674|520259171|FG005|Dose Level I|Physician Decision|0|||
144288506|NCT02533674|520259172|FG006|Dose Level I|Physician Decision|0|||
144288507|NCT02533674|520259173|FG007|Dose Level I|Physician Decision|0|||
144288508|NCT02533674|520259166|FG000|Dose Level I|Death|1|||
144288509|NCT02533674|520259167|FG001|Dose Level I|Death|0|||
144288510|NCT02533674|520259168|FG002|Dose Level I|Death|0|||
144288511|NCT02533674|520259169|FG003|Dose Level I|Death|0|||
144288512|NCT02533674|520259170|FG004|Dose Level I|Death|0|||
144288513|NCT02533674|520259171|FG005|Dose Level I|Death|0|||
144288514|NCT02533674|520259172|FG006|Dose Level I|Death|0|||
144288515|NCT02533674|520259173|FG007|Dose Level I|Death|0|||
144288516|NCT02533674|520259166|FG000|Dose Level I|Never Treated|1|||
144288517|NCT02533674|520259167|FG001|Dose Level I|Never Treated|0|||
144288518|NCT02533674|520259168|FG002|Dose Level I|Never Treated|0|||
144288519|NCT02533674|520259169|FG003|Dose Level I|Never Treated|0|||
144288520|NCT02533674|520259170|FG004|Dose Level I|Never Treated|0|||
144288521|NCT02533674|520259171|FG005|Dose Level I|Never Treated|0|||
144288522|NCT02533674|520259172|FG006|Dose Level I|Never Treated|0|||
144288523|NCT02533674|520259173|FG007|Dose Level I|Never Treated|0|||
144288524|NCT02533674|520259166|FG000|Dose Level II|Progressive disease|0|||
144288525|NCT02533674|520259167|FG001|Dose Level II|Progressive disease|3|||
144288526|NCT02533674|520259168|FG002|Dose Level II|Progressive disease|0|||
144288527|NCT02533674|520259169|FG003|Dose Level II|Progressive disease|0|||
144288528|NCT02533674|520259170|FG004|Dose Level II|Progressive disease|0|||
144288529|NCT02533674|520259171|FG005|Dose Level II|Progressive disease|0|||
144288530|NCT02533674|520259172|FG006|Dose Level II|Progressive disease|0|||
144288531|NCT02533674|520259173|FG007|Dose Level II|Progressive disease|0|||
144288532|NCT02533674|520259166|FG000|Dose Level II|Withdrawal by Subject|0|||
144288533|NCT02533674|520259167|FG001|Dose Level II|Withdrawal by Subject|1|||
144288534|NCT02533674|520259168|FG002|Dose Level II|Withdrawal by Subject|0|||
144288535|NCT02533674|520259169|FG003|Dose Level II|Withdrawal by Subject|0|||
144288536|NCT02533674|520259170|FG004|Dose Level II|Withdrawal by Subject|0|||
144288537|NCT02533674|520259171|FG005|Dose Level II|Withdrawal by Subject|0|||
144288538|NCT02533674|520259172|FG006|Dose Level II|Withdrawal by Subject|0|||
144288539|NCT02533674|520259173|FG007|Dose Level II|Withdrawal by Subject|0|||
144288540|NCT02533674|520259166|FG000|Dose Level II|Treatment-related AE|0|||
144288541|NCT02533674|520259167|FG001|Dose Level II|Treatment-related AE|1|||
144288542|NCT02533674|520259168|FG002|Dose Level II|Treatment-related AE|0|||
144288543|NCT02533674|520259169|FG003|Dose Level II|Treatment-related AE|0|||
144288544|NCT02533674|520259170|FG004|Dose Level II|Treatment-related AE|0|||
144288545|NCT02533674|520259171|FG005|Dose Level II|Treatment-related AE|0|||
144288546|NCT02533674|520259172|FG006|Dose Level II|Treatment-related AE|0|||
144288547|NCT02533674|520259173|FG007|Dose Level II|Treatment-related AE|0|||
144288548|NCT02533674|520259166|FG000|Dose Level II|Physician Decision|0|||
144288549|NCT02533674|520259167|FG001|Dose Level II|Physician Decision|1|||
144288550|NCT02533674|520259168|FG002|Dose Level II|Physician Decision|0|||
144288551|NCT02533674|520259169|FG003|Dose Level II|Physician Decision|0|||
144288552|NCT02533674|520259170|FG004|Dose Level II|Physician Decision|0|||
144288553|NCT02533674|520259171|FG005|Dose Level II|Physician Decision|0|||
144288554|NCT02533674|520259172|FG006|Dose Level II|Physician Decision|0|||
144288555|NCT02533674|520259173|FG007|Dose Level II|Physician Decision|0|||
144288556|NCT02533674|520259166|FG000|Dose Level II|Non-treatment-related AE|0|||
144288557|NCT02533674|520259167|FG001|Dose Level II|Non-treatment-related AE|1|||
144288558|NCT02533674|520259168|FG002|Dose Level II|Non-treatment-related AE|0|||
144288559|NCT02533674|520259169|FG003|Dose Level II|Non-treatment-related AE|0|||
144288560|NCT02533674|520259170|FG004|Dose Level II|Non-treatment-related AE|0|||
144288561|NCT02533674|520259171|FG005|Dose Level II|Non-treatment-related AE|0|||
144288562|NCT02533674|520259172|FG006|Dose Level II|Non-treatment-related AE|0|||
144288563|NCT02533674|520259173|FG007|Dose Level II|Non-treatment-related AE|0|||
144288564|NCT02533674|520259166|FG000|Dose Level III|Progressive disease|0|||
144288565|NCT02533674|520259167|FG001|Dose Level III|Progressive disease|0|||
144288566|NCT02533674|520259168|FG002|Dose Level III|Progressive disease|2|||
144288567|NCT02533674|520259169|FG003|Dose Level III|Progressive disease|0|||
144288568|NCT02533674|520259170|FG004|Dose Level III|Progressive disease|0|||
144288569|NCT02533674|520259171|FG005|Dose Level III|Progressive disease|0|||
144288570|NCT02533674|520259172|FG006|Dose Level III|Progressive disease|0|||
144288571|NCT02533674|520259173|FG007|Dose Level III|Progressive disease|0|||
144288572|NCT02533674|520259166|FG000|Dose Level III|Withdrawal by Subject|0|||
144288573|NCT02533674|520259167|FG001|Dose Level III|Withdrawal by Subject|0|||
144288574|NCT02533674|520259168|FG002|Dose Level III|Withdrawal by Subject|1|||
144288575|NCT02533674|520259169|FG003|Dose Level III|Withdrawal by Subject|0|||
144288576|NCT02533674|520259170|FG004|Dose Level III|Withdrawal by Subject|0|||
144288577|NCT02533674|520259171|FG005|Dose Level III|Withdrawal by Subject|0|||
144288578|NCT02533674|520259172|FG006|Dose Level III|Withdrawal by Subject|0|||
144288579|NCT02533674|520259173|FG007|Dose Level III|Withdrawal by Subject|0|||
144288580|NCT02533674|520259166|FG000|Dose Level III|Treatment-related AE|0|||
144288581|NCT02533674|520259167|FG001|Dose Level III|Treatment-related AE|0|||
144288582|NCT02533674|520259168|FG002|Dose Level III|Treatment-related AE|1|||
144288583|NCT02533674|520259169|FG003|Dose Level III|Treatment-related AE|0|||
144288584|NCT02533674|520259170|FG004|Dose Level III|Treatment-related AE|0|||
144288585|NCT02533674|520259171|FG005|Dose Level III|Treatment-related AE|0|||
144288586|NCT02533674|520259172|FG006|Dose Level III|Treatment-related AE|0|||
144288587|NCT02533674|520259173|FG007|Dose Level III|Treatment-related AE|0|||
144288588|NCT02533674|520259166|FG000|Dose Level IV|Progressive disease|0|||
144288589|NCT02533674|520259167|FG001|Dose Level IV|Progressive disease|0|||
144288590|NCT02533674|520259168|FG002|Dose Level IV|Progressive disease|0|||
144288591|NCT02533674|520259169|FG003|Dose Level IV|Progressive disease|3|||
144288592|NCT02533674|520259170|FG004|Dose Level IV|Progressive disease|0|||
144288593|NCT02533674|520259171|FG005|Dose Level IV|Progressive disease|0|||
144288594|NCT02533674|520259172|FG006|Dose Level IV|Progressive disease|0|||
144288595|NCT02533674|520259173|FG007|Dose Level IV|Progressive disease|0|||
144288596|NCT02533674|520259166|FG000|Dose Level IV|Withdrawal by Subject|0|||
144288597|NCT02533674|520259167|FG001|Dose Level IV|Withdrawal by Subject|0|||
144288598|NCT02533674|520259168|FG002|Dose Level IV|Withdrawal by Subject|0|||
144288599|NCT02533674|520259169|FG003|Dose Level IV|Withdrawal by Subject|1|||
144288600|NCT02533674|520259170|FG004|Dose Level IV|Withdrawal by Subject|0|||
144288601|NCT02533674|520259171|FG005|Dose Level IV|Withdrawal by Subject|0|||
144288602|NCT02533674|520259172|FG006|Dose Level IV|Withdrawal by Subject|0|||
144288603|NCT02533674|520259173|FG007|Dose Level IV|Withdrawal by Subject|0|||
144288604|NCT02533674|520259166|FG000|Dose Level IV|Physician Decision|0|||
144288605|NCT02533674|520259167|FG001|Dose Level IV|Physician Decision|0|||
144288606|NCT02533674|520259168|FG002|Dose Level IV|Physician Decision|0|||
144288607|NCT02533674|520259169|FG003|Dose Level IV|Physician Decision|1|||
144288608|NCT02533674|520259170|FG004|Dose Level IV|Physician Decision|0|||
144288609|NCT02533674|520259171|FG005|Dose Level IV|Physician Decision|0|||
144288610|NCT02533674|520259172|FG006|Dose Level IV|Physician Decision|0|||
144288611|NCT02533674|520259173|FG007|Dose Level IV|Physician Decision|0|||
144288612|NCT02533674|520259166|FG000|Dose Level V|Progressive disease|0|||
144288613|NCT02533674|520259167|FG001|Dose Level V|Progressive disease|0|||
144288614|NCT02533674|520259168|FG002|Dose Level V|Progressive disease|0|||
144288615|NCT02533674|520259169|FG003|Dose Level V|Progressive disease|0|||
144288616|NCT02533674|520259170|FG004|Dose Level V|Progressive disease|3|||
144288617|NCT02533674|520259171|FG005|Dose Level V|Progressive disease|0|||
144288618|NCT02533674|520259172|FG006|Dose Level V|Progressive disease|0|||
144288619|NCT02533674|520259173|FG007|Dose Level V|Progressive disease|0|||
144288620|NCT02533674|520259166|FG000|Dose Level V|Withdrawal by Subject|0|||
144288621|NCT02533674|520259167|FG001|Dose Level V|Withdrawal by Subject|0|||
144288622|NCT02533674|520259168|FG002|Dose Level V|Withdrawal by Subject|0|||
144288623|NCT02533674|520259169|FG003|Dose Level V|Withdrawal by Subject|0|||
144288624|NCT02533674|520259170|FG004|Dose Level V|Withdrawal by Subject|1|||
144288625|NCT02533674|520259171|FG005|Dose Level V|Withdrawal by Subject|0|||
144288626|NCT02533674|520259172|FG006|Dose Level V|Withdrawal by Subject|0|||
144288627|NCT02533674|520259173|FG007|Dose Level V|Withdrawal by Subject|0|||
144288628|NCT02533674|520259166|FG000|Dose Level V|Physician Decision|0|||
144288629|NCT02533674|520259167|FG001|Dose Level V|Physician Decision|0|||
144288630|NCT02533674|520259168|FG002|Dose Level V|Physician Decision|0|||
144288631|NCT02533674|520259169|FG003|Dose Level V|Physician Decision|0|||
144288632|NCT02533674|520259170|FG004|Dose Level V|Physician Decision|1|||
144288633|NCT02533674|520259171|FG005|Dose Level V|Physician Decision|0|||
144288634|NCT02533674|520259172|FG006|Dose Level V|Physician Decision|0|||
144288635|NCT02533674|520259173|FG007|Dose Level V|Physician Decision|0|||
144288636|NCT02533674|520259166|FG000|Dose Level VI|Progressive disease|0|||
144288637|NCT02533674|520259167|FG001|Dose Level VI|Progressive disease|0|||
144288638|NCT02533674|520259168|FG002|Dose Level VI|Progressive disease|0|||
144288639|NCT02533674|520259169|FG003|Dose Level VI|Progressive disease|0|||
144288640|NCT02533674|520259170|FG004|Dose Level VI|Progressive disease|0|||
144288641|NCT02533674|520259171|FG005|Dose Level VI|Progressive disease|7|||
144288642|NCT02533674|520259172|FG006|Dose Level VI|Progressive disease|0|||
144288643|NCT02533674|520259173|FG007|Dose Level VI|Progressive disease|0|||
144288644|NCT02533674|520259166|FG000|Dose Level VI|Withdrawal by Subject|0|||
144288645|NCT02533674|520259167|FG001|Dose Level VI|Withdrawal by Subject|0|||
144288646|NCT02533674|520259168|FG002|Dose Level VI|Withdrawal by Subject|0|||
144288647|NCT02533674|520259169|FG003|Dose Level VI|Withdrawal by Subject|0|||
144288648|NCT02533674|520259170|FG004|Dose Level VI|Withdrawal by Subject|0|||
144288649|NCT02533674|520259171|FG005|Dose Level VI|Withdrawal by Subject|1|||
144288650|NCT02533674|520259172|FG006|Dose Level VI|Withdrawal by Subject|0|||
144288651|NCT02533674|520259173|FG007|Dose Level VI|Withdrawal by Subject|0|||
144288652|NCT02533674|520259166|FG000|Dose Level VI|Treatment-related AE|0|||
144288653|NCT02533674|520259167|FG001|Dose Level VI|Treatment-related AE|0|||
144288654|NCT02533674|520259168|FG002|Dose Level VI|Treatment-related AE|0|||
144288655|NCT02533674|520259169|FG003|Dose Level VI|Treatment-related AE|0|||
144288656|NCT02533674|520259170|FG004|Dose Level VI|Treatment-related AE|0|||
144288657|NCT02533674|520259171|FG005|Dose Level VI|Treatment-related AE|1|||
144288658|NCT02533674|520259172|FG006|Dose Level VI|Treatment-related AE|0|||
144288659|NCT02533674|520259173|FG007|Dose Level VI|Treatment-related AE|0|||
144288660|NCT02533674|520259166|FG000|Dose Level VII|Progressive disease|0|||
144288661|NCT02533674|520259167|FG001|Dose Level VII|Progressive disease|0|||
144288662|NCT02533674|520259168|FG002|Dose Level VII|Progressive disease|0|||
144288663|NCT02533674|520259169|FG003|Dose Level VII|Progressive disease|0|||
144288664|NCT02533674|520259170|FG004|Dose Level VII|Progressive disease|0|||
144288665|NCT02533674|520259171|FG005|Dose Level VII|Progressive disease|0|||
144288666|NCT02533674|520259172|FG006|Dose Level VII|Progressive disease|10|||
144288667|NCT02533674|520259173|FG007|Dose Level VII|Progressive disease|0|||
144288668|NCT02533674|520259166|FG000|Dose Level VII|Withdrawal by Subject|0|||
144288669|NCT02533674|520259167|FG001|Dose Level VII|Withdrawal by Subject|0|||
144288670|NCT02533674|520259168|FG002|Dose Level VII|Withdrawal by Subject|0|||
144288671|NCT02533674|520259169|FG003|Dose Level VII|Withdrawal by Subject|0|||
144288672|NCT02533674|520259170|FG004|Dose Level VII|Withdrawal by Subject|0|||
144288673|NCT02533674|520259171|FG005|Dose Level VII|Withdrawal by Subject|0|||
144288674|NCT02533674|520259172|FG006|Dose Level VII|Withdrawal by Subject|3|||
144288675|NCT02533674|520259173|FG007|Dose Level VII|Withdrawal by Subject|0|||
144288676|NCT02533674|520259166|FG000|Dose Level VII|Treatment-related AE|0|||
144288677|NCT02533674|520259167|FG001|Dose Level VII|Treatment-related AE|0|||
144288678|NCT02533674|520259168|FG002|Dose Level VII|Treatment-related AE|0|||
144288679|NCT02533674|520259169|FG003|Dose Level VII|Treatment-related AE|0|||
144288680|NCT02533674|520259170|FG004|Dose Level VII|Treatment-related AE|0|||
144288681|NCT02533674|520259171|FG005|Dose Level VII|Treatment-related AE|0|||
144288682|NCT02533674|520259172|FG006|Dose Level VII|Treatment-related AE|1|||
144288683|NCT02533674|520259173|FG007|Dose Level VII|Treatment-related AE|0|||
144288684|NCT02533674|520259166|FG000|Dose Level VII|Death|0|||
144288685|NCT02533674|520259167|FG001|Dose Level VII|Death|0|||
144288686|NCT02533674|520259168|FG002|Dose Level VII|Death|0|||
144288687|NCT02533674|520259169|FG003|Dose Level VII|Death|0|||
144288688|NCT02533674|520259170|FG004|Dose Level VII|Death|0|||
144288689|NCT02533674|520259171|FG005|Dose Level VII|Death|0|||
144288690|NCT02533674|520259172|FG006|Dose Level VII|Death|2|||
144288691|NCT02533674|520259173|FG007|Dose Level VII|Death|0|||
144288692|NCT02533674|520259166|FG000|Dose Level VIII|Progressive disease|0|||
144288693|NCT02533674|520259167|FG001|Dose Level VIII|Progressive disease|0|||
144288694|NCT02533674|520259168|FG002|Dose Level VIII|Progressive disease|0|||
144288695|NCT02533674|520259169|FG003|Dose Level VIII|Progressive disease|0|||
144288696|NCT02533674|520259170|FG004|Dose Level VIII|Progressive disease|0|||
144288697|NCT02533674|520259171|FG005|Dose Level VIII|Progressive disease|0|||
144288698|NCT02533674|520259172|FG006|Dose Level VIII|Progressive disease|0|||
144288699|NCT02533674|520259173|FG007|Dose Level VIII|Progressive disease|3|||
144288700|NCT02533674|520259166|FG000|Dose Level VIII|Withdrawal by Subject|0|||
144288701|NCT02533674|520259167|FG001|Dose Level VIII|Withdrawal by Subject|0|||
144288702|NCT02533674|520259168|FG002|Dose Level VIII|Withdrawal by Subject|0|||
144288703|NCT02533674|520259169|FG003|Dose Level VIII|Withdrawal by Subject|0|||
144288704|NCT02533674|520259170|FG004|Dose Level VIII|Withdrawal by Subject|0|||
144288705|NCT02533674|520259171|FG005|Dose Level VIII|Withdrawal by Subject|0|||
144288706|NCT02533674|520259172|FG006|Dose Level VIII|Withdrawal by Subject|0|||
144288707|NCT02533674|520259173|FG007|Dose Level VIII|Withdrawal by Subject|1|||
144288708|NCT02533674|520259166|FG000|Dose Level VIII|Treatment-related AE|0|||
144288709|NCT02533674|520259167|FG001|Dose Level VIII|Treatment-related AE|0|||
144288710|NCT02533674|520259168|FG002|Dose Level VIII|Treatment-related AE|0|||
144288711|NCT02533674|520259169|FG003|Dose Level VIII|Treatment-related AE|0|||
144288712|NCT02533674|520259170|FG004|Dose Level VIII|Treatment-related AE|0|||
144288713|NCT02533674|520259171|FG005|Dose Level VIII|Treatment-related AE|0|||
144288714|NCT02533674|520259172|FG006|Dose Level VIII|Treatment-related AE|0|||
144288715|NCT02533674|520259173|FG007|Dose Level VIII|Treatment-related AE|1|||
144288716|NCT02533674|520259166|FG000|Dose Level VIII|Never treated|0|||
144288717|NCT02533674|520259167|FG001|Dose Level VIII|Never treated|0|||
144288718|NCT02533674|520259168|FG002|Dose Level VIII|Never treated|0|||
144288719|NCT02533674|520259169|FG003|Dose Level VIII|Never treated|0|||
144288720|NCT02533674|520259170|FG004|Dose Level VIII|Never treated|0|||
144288721|NCT02533674|520259171|FG005|Dose Level VIII|Never treated|0|||
144288722|NCT02533674|520259172|FG006|Dose Level VIII|Never treated|0|||
144288723|NCT02533674|520259173|FG007|Dose Level VIII|Never treated|1|||
144288724|NCT02365064|520259180|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
144288725|NCT02365064|520259181|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
144288726|NCT02365064|520259180|FG000|Overall Study|Withdrawal by Subject|6|||
144288727|NCT02365064|520259181|FG001|Overall Study|Withdrawal by Subject|9|||
144288728|NCT02365064|520259180|FG000|Overall Study|Treatment intolerance|2|||
144288729|NCT02365064|520259181|FG001|Overall Study|Treatment intolerance|4|||
144288730|NCT04821245|520259186|FG000|Overall Study|Withdrawal by Subject|3|||
144288731|NCT04821245|520259186|FG000|Overall Study|Physician Decision|1|||
144288732|NCT04821245|520259186|FG000|Overall Study|Protocol Violation|5|||
144288733|NCT02123511|520259187|FG000|Overall Study|Cancelled treatment|1|||
144288734|NCT02123511|520259188|FG001|Overall Study|Cancelled treatment|0|||
144288735|NCT02123511|520259187|FG000|Overall Study|Incomplete data|1|||
144288736|NCT02123511|520259188|FG001|Overall Study|Incomplete data|3|||
144288737|NCT02123511|520259187|FG000|Overall Study|Ineligible|0|||
144288738|NCT02123511|520259188|FG001|Overall Study|Ineligible|1|||
144288739|NCT00397046|520259191|FG000|Overall Study|Disease Progression|3|||
144288740|NCT00397046|520259192|FG001|Overall Study|Disease Progression|3|||
144288741|NCT00397046|520259193|FG002|Overall Study|Disease Progression|10|||
144288742|NCT00397046|520259194|FG003|Overall Study|Disease Progression|5|||
144288743|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
144288744|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
144288745|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
144288746|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
144288747|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
144288748|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
144288749|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
144288750|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
144288751|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
144288752|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
144288753|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
144288754|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
144288755|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Other|6|||
144288756|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Other|3|||
144288757|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Other|0|||
144288758|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
144288759|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
144288760|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
144288761|NCT03636269|520259196|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
144288762|NCT03636269|520259197|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
144288763|NCT03636269|520259198|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
144288764|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Adverse Event|0|||
144288765|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Adverse Event|0|||
144288766|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Adverse Event|21|||
144288767|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
144288768|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
144288769|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
144288770|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
144288771|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
144288772|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
144288773|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
144288774|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
144288775|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
144288776|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Administrative|0|||
144288777|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Administrative|0|||
144288778|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Administrative|36|||
144288779|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Other|0|||
144288780|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Other|0|||
144246052|NCT00738062|520098225|FG000|Open Label Treatment|Protocol Violation|2|||
144246053|NCT00738062|520098226|FG001|Open Label Treatment|Protocol Violation|0|||
144246054|NCT00738062|520098227|FG002|Open Label Treatment|Protocol Violation|0|||
144246055|NCT00738062|520098225|FG000|Open Label Treatment|Withdrawal by Subject|9|||
144246056|NCT00738062|520098226|FG001|Open Label Treatment|Withdrawal by Subject|0|||
144246057|NCT00738062|520098227|FG002|Open Label Treatment|Withdrawal by Subject|0|||
144246058|NCT00738062|520098225|FG000|Open Label Treatment|Investigator Decision|1|||
144246059|NCT00738062|520098226|FG001|Open Label Treatment|Investigator Decision|0|||
144246060|NCT00738062|520098227|FG002|Open Label Treatment|Investigator Decision|0|||
144246061|NCT00738062|520098225|FG000|Open-Label Extension|Adverse Event|5|||
144246062|NCT00738062|520098226|FG001|Open-Label Extension|Adverse Event|0|||
144246063|NCT00738062|520098227|FG002|Open-Label Extension|Adverse Event|0|||
144246064|NCT00738062|520098225|FG000|Open-Label Extension|Physician Decision|1|||
144246065|NCT00738062|520098226|FG001|Open-Label Extension|Physician Decision|0|||
144246066|NCT00738062|520098227|FG002|Open-Label Extension|Physician Decision|0|||
144246067|NCT00738062|520098225|FG000|Open-Label Extension|Lack of Efficacy|2|||
144246068|NCT00738062|520098226|FG001|Open-Label Extension|Lack of Efficacy|0|||
144246069|NCT00738062|520098227|FG002|Open-Label Extension|Lack of Efficacy|0|||
144246070|NCT00738062|520098225|FG000|Open-Label Extension|Withdrawal by Subject|6|||
144246071|NCT00738062|520098226|FG001|Open-Label Extension|Withdrawal by Subject|0|||
144246072|NCT00738062|520098227|FG002|Open-Label Extension|Withdrawal by Subject|0|||
144246073|NCT00738062|520098225|FG000|Open-Label Extension|Protocol Violation|1|||
144246074|NCT00738062|520098226|FG001|Open-Label Extension|Protocol Violation|0|||
144246075|NCT00738062|520098227|FG002|Open-Label Extension|Protocol Violation|0|||
144246076|NCT00738062|520098225|FG000|Open-Label Extension|Study Terminated|2|||
144246077|NCT00738062|520098226|FG001|Open-Label Extension|Study Terminated|0|||
144246078|NCT00738062|520098227|FG002|Open-Label Extension|Study Terminated|0|||
144246079|NCT02772276|520098228|FG000|Overall Study|Lost to Follow-up|0|||
144246080|NCT02772276|520098229|FG001|Overall Study|Lost to Follow-up|0|||
144246081|NCT02772276|520098230|FG002|Overall Study|Lost to Follow-up|0|||
144246082|NCT02772276|520098231|FG003|Overall Study|Lost to Follow-up|0|||
144246083|NCT02772276|520098232|FG004|Overall Study|Lost to Follow-up|0|||
144246084|NCT02772276|520098233|FG005|Overall Study|Lost to Follow-up|0|||
144246085|NCT02772276|520098234|FG006|Overall Study|Lost to Follow-up|1|||
144246086|NCT02772276|520098235|FG007|Overall Study|Lost to Follow-up|0|||
144246087|NCT02772276|520098236|FG008|Overall Study|Lost to Follow-up|0|||
144246088|NCT02772276|520098237|FG009|Overall Study|Lost to Follow-up|0|||
144246089|NCT02772276|520098238|FG010|Overall Study|Lost to Follow-up|0|||
144246090|NCT02772276|520098239|FG011|Overall Study|Lost to Follow-up|0|||
144246091|NCT02772276|520098240|FG012|Overall Study|Lost to Follow-up|0|||
144246092|NCT02772276|520098228|FG000|Overall Study|Withdrew consent|0|||
144246093|NCT02772276|520098229|FG001|Overall Study|Withdrew consent|0|||
144246094|NCT02772276|520098230|FG002|Overall Study|Withdrew consent|0|||
144246095|NCT02772276|520098231|FG003|Overall Study|Withdrew consent|0|||
144246096|NCT02772276|520098232|FG004|Overall Study|Withdrew consent|0|||
144246097|NCT02772276|520098233|FG005|Overall Study|Withdrew consent|0|||
144246098|NCT02772276|520098234|FG006|Overall Study|Withdrew consent|0|||
144246099|NCT02772276|520098235|FG007|Overall Study|Withdrew consent|1|||
144246100|NCT02772276|520098236|FG008|Overall Study|Withdrew consent|0|||
144246101|NCT02772276|520098237|FG009|Overall Study|Withdrew consent|0|||
144246102|NCT02772276|520098238|FG010|Overall Study|Withdrew consent|0|||
144246103|NCT02772276|520098239|FG011|Overall Study|Withdrew consent|0|||
144246104|NCT02772276|520098240|FG012|Overall Study|Withdrew consent|0|||
144246105|NCT02248974|520098241|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
144246106|NCT02248974|520098242|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
144246107|NCT02248974|520098241|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
144246108|NCT02248974|520098242|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
144246109|NCT02248974|520098241|FG000|1-Day Follow-Up|Enrolled in another study|1|||
144246110|NCT02248974|520098242|FG001|1-Day Follow-Up|Enrolled in another study|0|||
144246111|NCT02248974|520098241|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
144246112|NCT02248974|520098242|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
144246113|NCT02248974|520098241|FG000|1-Week Follow-Up|Enrolled in another study|1|||
144246114|NCT02248974|520098242|FG001|1-Week Follow-Up|Enrolled in another study|1|||
144246115|NCT02248974|520098241|FG000|1-Week Follow-Up|Transferred to another facility|1|||
144246116|NCT02248974|520098242|FG001|1-Week Follow-Up|Transferred to another facility|0|||
144246117|NCT02248974|520098241|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
144246118|NCT02248974|520098242|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
144246119|NCT02248974|520098241|FG000|1-Week Follow-Up|Death|1|||
144246120|NCT02248974|520098242|FG001|1-Week Follow-Up|Death|1|||
144246121|NCT02248974|520098241|FG000|1-Week Follow-Up|Excluded because of age|0|||
144246122|NCT02248974|520098242|FG001|1-Week Follow-Up|Excluded because of age|1|||
144246123|NCT02248974|520098241|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
144246124|NCT02248974|520098242|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
144246125|NCT02248974|520098241|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
144246126|NCT02248974|520098242|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
144246127|NCT02248974|520098241|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
144288781|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Other|9|||
144288782|NCT03636269|520259196|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
144288783|NCT03636269|520259197|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
144288784|NCT03636269|520259198|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
144288785|NCT00493285|520259207|FG000|Overall Study|Lost to Follow-up|0|||
144288786|NCT00493285|520259208|FG001|Overall Study|Lost to Follow-up|0|||
144288787|NCT00493285|520259209|FG002|Overall Study|Lost to Follow-up|0|||
144288788|NCT00493285|520259210|FG003|Overall Study|Lost to Follow-up|0|||
144288789|NCT00493285|520259211|FG004|Overall Study|Lost to Follow-up|1|||
144288790|NCT00493285|520259212|FG005|Overall Study|Lost to Follow-up|0|||
144288791|NCT03021005|520259213|FG000|Overall Study|Lost to Follow-up|39|||
144288792|NCT03021005|520259214|FG001|Overall Study|Lost to Follow-up|26|||
144288793|NCT00337194|520259215|FG000|Overall Study|Adverse Event|5|||
144288794|NCT00337194|520259216|FG001|Overall Study|Adverse Event|1|||
144288795|NCT00337194|520259215|FG000|Overall Study|Death|2|||
144288796|NCT00337194|520259216|FG001|Overall Study|Death|0|||
144288797|NCT00337194|520259215|FG000|Overall Study|Withdrawal by Subject|1|||
144288798|NCT00337194|520259216|FG001|Overall Study|Withdrawal by Subject|0|||
144288799|NCT00337194|520259215|FG000|Overall Study|Disease progression|1|||
144288800|NCT00337194|520259216|FG001|Overall Study|Disease progression|2|||
144288801|NCT00337194|520259215|FG000|Overall Study|Subsequent non-protocol therapy|3|||
144288802|NCT00337194|520259216|FG001|Overall Study|Subsequent non-protocol therapy|1|||
144288803|NCT03188705|520259217|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
144288804|NCT03188705|520259217|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
144288805|NCT00981175|520259224|FG000|Primary Dose Vaccination|Adverse Event|1|||
144288806|NCT00981175|520259225|FG001|Primary Dose Vaccination|Adverse Event|0|||
144288807|NCT00981175|520259224|FG000|Primary Dose Vaccination|Protocol Violation|0|||
144288808|NCT00981175|520259225|FG001|Primary Dose Vaccination|Protocol Violation|1|||
144288809|NCT00981175|520259224|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
144288810|NCT00981175|520259225|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
144288811|NCT00981175|520259224|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
144288812|NCT00981175|520259225|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
144288813|NCT01750281|520259226|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
144288814|NCT01750281|520259227|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
144288815|NCT01750281|520259228|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
144288816|NCT01750281|520259226|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
144288817|NCT01750281|520259227|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
144288818|NCT01750281|520259228|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
144288819|NCT01750281|520259226|FG000|Overall Study|Did not receive treatment|0|||
144288820|NCT01750281|520259227|FG001|Overall Study|Did not receive treatment|1|||
144288821|NCT01750281|520259228|FG002|Overall Study|Did not receive treatment|0|||
144288822|NCT04189588|520259229|FG000|Overall Study|Death|0|||
144288823|NCT04189588|520259230|FG001|Overall Study|Death|1|||
144288824|NCT04189588|520259229|FG000|Overall Study|Lost to Follow-up|0|||
144288825|NCT04189588|520259230|FG001|Overall Study|Lost to Follow-up|1|||
144288826|NCT01658735|520259237|FG000|Overall Study|Lack of Efficacy|1|||
144288827|NCT01658735|520259238|FG001|Overall Study|Lack of Efficacy|0|||
144288828|NCT01658735|520259239|FG002|Overall Study|Lack of Efficacy|1|||
144288829|NCT01658735|520259237|FG000|Overall Study|Lost to Follow-up|1|||
144288830|NCT01658735|520259238|FG001|Overall Study|Lost to Follow-up|1|||
144288831|NCT01658735|520259239|FG002|Overall Study|Lost to Follow-up|0|||
144288832|NCT01658735|520259237|FG000|Overall Study|Protocol Violation|0|||
144288833|NCT01658735|520259238|FG001|Overall Study|Protocol Violation|1|||
144288834|NCT01658735|520259239|FG002|Overall Study|Protocol Violation|0|||
144288835|NCT01658735|520259237|FG000|Overall Study|Withdrawal by Subject|3|||
144288836|NCT01658735|520259238|FG001|Overall Study|Withdrawal by Subject|5|||
144288837|NCT01658735|520259239|FG002|Overall Study|Withdrawal by Subject|3|||
144288838|NCT01379937|520259240|FG000|Overall Study|Protocol Violation|0|||
144288839|NCT01379937|520259241|FG001|Overall Study|Protocol Violation|0|||
144288840|NCT01379937|520259242|FG002|Overall Study|Protocol Violation|0|||
144288841|NCT01379937|520259243|FG003|Overall Study|Protocol Violation|1|||
144288842|NCT01379937|520259240|FG000|Overall Study|Consent withdrawal|0|||
144288843|NCT01379937|520259241|FG001|Overall Study|Consent withdrawal|1|||
144288844|NCT01379937|520259242|FG002|Overall Study|Consent withdrawal|0|||
144288845|NCT01379937|520259243|FG003|Overall Study|Consent withdrawal|0|||
144288846|NCT01379937|520259240|FG000|Overall Study|Lost to Follow-up|1|||
144288847|NCT01379937|520259241|FG001|Overall Study|Lost to Follow-up|2|||
144288848|NCT01379937|520259242|FG002|Overall Study|Lost to Follow-up|2|||
144288849|NCT01379937|520259243|FG003|Overall Study|Lost to Follow-up|0|||
144288850|NCT01122680|520259244|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
144288851|NCT01122680|520259245|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
144288852|NCT01122680|520259246|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
144288853|NCT01122680|520259247|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
144288854|NCT01122680|520259244|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
144288855|NCT01122680|520259245|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
144288856|NCT01122680|520259246|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
144288857|NCT01122680|520259247|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
144288858|NCT01122680|520259244|FG000|Period 1 (4 Weeks)|Other|1|||
144288859|NCT01122680|520259245|FG001|Period 1 (4 Weeks)|Other|1|||
144288860|NCT01122680|520259246|FG002|Period 1 (4 Weeks)|Other|0|||
144288861|NCT01122680|520259247|FG003|Period 1 (4 Weeks)|Other|0|||
144288862|NCT01122680|520259244|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
144288863|NCT01122680|520259245|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
144288864|NCT01122680|520259246|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
144288865|NCT01122680|520259247|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
144288866|NCT01122680|520259244|FG000|Period 2 (4 Weeks)|Other|1|||
144288867|NCT01122680|520259245|FG001|Period 2 (4 Weeks)|Other|0|||
144288868|NCT01122680|520259246|FG002|Period 2 (4 Weeks)|Other|0|||
144288869|NCT01122680|520259247|FG003|Period 2 (4 Weeks)|Other|0|||
144288870|NCT01122680|520259244|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
144288871|NCT01122680|520259245|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
144288872|NCT01122680|520259246|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
144288873|NCT01122680|520259247|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
144288874|NCT01122680|520259244|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144288875|NCT01122680|520259245|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
144288876|NCT01122680|520259246|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144288877|NCT01122680|520259247|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
144288878|NCT04985682|520259248|FG000|Overall Study|Withdrawal by Subject|1|||
144288879|NCT03016403|520259255|FG000|Baseline|Death|5|||
144288880|NCT03016403|520259256|FG001|Baseline|Death|8|||
144288881|NCT03016403|520259257|FG002|Baseline|Death|1|||
144288882|NCT03016403|520259258|FG003|Baseline|Death|0|||
144288883|NCT03016403|520259255|FG000|Baseline|Withdrawal by Subject|2|||
144288884|NCT03016403|520259256|FG001|Baseline|Withdrawal by Subject|8|||
144288885|NCT03016403|520259257|FG002|Baseline|Withdrawal by Subject|4|||
144288886|NCT03016403|520259258|FG003|Baseline|Withdrawal by Subject|10|||
144288887|NCT03016403|520259255|FG000|Baseline|Lost to Follow-up|9|||
144288888|NCT03016403|520259256|FG001|Baseline|Lost to Follow-up|11|||
144288889|NCT03016403|520259257|FG002|Baseline|Lost to Follow-up|6|||
144288890|NCT03016403|520259258|FG003|Baseline|Lost to Follow-up|24|||
144288891|NCT03016403|520259255|FG000|6-week Follow-up|Death|1|||
144288892|NCT03016403|520259256|FG001|6-week Follow-up|Death|4|||
144288893|NCT03016403|520259257|FG002|6-week Follow-up|Death|0|||
144288894|NCT03016403|520259258|FG003|6-week Follow-up|Death|0|||
144288895|NCT03016403|520259255|FG000|6-week Follow-up|Lost to Follow-up|2|||
144288896|NCT03016403|520259256|FG001|6-week Follow-up|Lost to Follow-up|7|||
144288897|NCT03016403|520259257|FG002|6-week Follow-up|Lost to Follow-up|4|||
144288898|NCT03016403|520259258|FG003|6-week Follow-up|Lost to Follow-up|8|||
144288899|NCT03016403|520259255|FG000|6-week Follow-up|Withdrawal by Subject|0|||
144288900|NCT03016403|520259256|FG001|6-week Follow-up|Withdrawal by Subject|2|||
144288901|NCT03016403|520259257|FG002|6-week Follow-up|Withdrawal by Subject|0|||
144288902|NCT03016403|520259258|FG003|6-week Follow-up|Withdrawal by Subject|1|||
144288903|NCT03016403|520259255|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
144288904|NCT03016403|520259256|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
144288905|NCT03016403|520259257|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
144288906|NCT03016403|520259258|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
144288907|NCT03016403|520259255|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
144288908|NCT03016403|520259256|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
144288909|NCT03016403|520259257|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
144288910|NCT03016403|520259258|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
144288911|NCT03016403|520259255|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
144288912|NCT03016403|520259256|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
144288913|NCT03016403|520259257|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
144288914|NCT03016403|520259258|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
144288915|NCT05463705|520259260|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
144288916|NCT05463705|520259261|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
144288917|NCT05463705|520259262|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
144288918|NCT05463705|520259263|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
144288919|NCT05463705|520259264|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
144288920|NCT05463705|520259265|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
144288921|NCT00621322|520259266|FG000|Overall Study|Lost to Follow-up|0|||
144288922|NCT00621322|520259267|FG001|Overall Study|Lost to Follow-up|0|||
144288923|NCT00621322|520259268|FG002|Overall Study|Lost to Follow-up|0|||
144288924|NCT00621322|520259269|FG003|Overall Study|Lost to Follow-up|0|||
144288925|NCT00621322|520259270|FG004|Overall Study|Lost to Follow-up|1|||
144288926|NCT00621322|520259271|FG005|Overall Study|Lost to Follow-up|0|||
144288927|NCT00621322|520259266|FG000|Overall Study|Physician Decision|0|||
144288928|NCT00621322|520259267|FG001|Overall Study|Physician Decision|0|||
144288929|NCT00621322|520259268|FG002|Overall Study|Physician Decision|1|||
144288930|NCT00621322|520259269|FG003|Overall Study|Physician Decision|1|||
144288931|NCT00621322|520259270|FG004|Overall Study|Physician Decision|0|||
144288932|NCT00621322|520259271|FG005|Overall Study|Physician Decision|0|||
144288933|NCT00621322|520259266|FG000|Overall Study|Withdrawal by Subject|0|||
144288934|NCT00621322|520259267|FG001|Overall Study|Withdrawal by Subject|0|||
144288935|NCT00621322|520259268|FG002|Overall Study|Withdrawal by Subject|0|||
144288936|NCT00621322|520259269|FG003|Overall Study|Withdrawal by Subject|1|||
144288937|NCT00621322|520259270|FG004|Overall Study|Withdrawal by Subject|0|||
144288938|NCT00621322|520259271|FG005|Overall Study|Withdrawal by Subject|2|||
144288939|NCT00621322|520259266|FG000|Overall Study|Migrated/moved from study area|1|||
144288940|NCT00621322|520259267|FG001|Overall Study|Migrated/moved from study area|0|||
144288941|NCT00621322|520259268|FG002|Overall Study|Migrated/moved from study area|1|||
144288942|NCT00621322|520259269|FG003|Overall Study|Migrated/moved from study area|1|||
144288943|NCT00621322|520259270|FG004|Overall Study|Migrated/moved from study area|0|||
144288944|NCT00621322|520259271|FG005|Overall Study|Migrated/moved from study area|2|||
144288945|NCT00576407|520259272|FG000|Overall Study|Death|7|||
144288946|NCT00576407|520259272|FG000|Overall Study|Physician Decision|1|||
144288947|NCT04641975|520259273|FG000|Overall Study|Protocol Violation|1|||
144288948|NCT04641975|520259274|FG001|Overall Study|Protocol Violation|2|||
144288949|NCT04641975|520259275|FG002|Overall Study|Protocol Violation|0|||
144288950|NCT04641975|520259276|FG003|Overall Study|Protocol Violation|0|||
144288951|NCT04641975|520259273|FG000|Overall Study|Adverse Event|0|||
144288952|NCT04641975|520259274|FG001|Overall Study|Adverse Event|0|||
144288953|NCT04641975|520259275|FG002|Overall Study|Adverse Event|1|||
144288954|NCT04641975|520259276|FG003|Overall Study|Adverse Event|1|||
144288955|NCT04641975|520259273|FG000|Overall Study|Withdrawal by Subject|1|||
144288956|NCT04641975|520259274|FG001|Overall Study|Withdrawal by Subject|0|||
144288957|NCT04641975|520259275|FG002|Overall Study|Withdrawal by Subject|0|||
144288958|NCT04641975|520259276|FG003|Overall Study|Withdrawal by Subject|0|||
144288959|NCT01259024|520259277|FG000|Overall Study|Physician Decision|1|||
144288960|NCT00756444|520259278|FG000|Overall Study|Adverse Event|1|||
144288961|NCT00756444|520259279|FG001|Overall Study|Adverse Event|1|||
144288962|NCT00756444|520259278|FG000|Overall Study|Withdrawal by Subject|6|||
144288963|NCT00756444|520259279|FG001|Overall Study|Withdrawal by Subject|8|||
144288964|NCT00756444|520259278|FG000|Overall Study|Lost to Follow-up|0|||
144288965|NCT00756444|520259279|FG001|Overall Study|Lost to Follow-up|1|||
144288966|NCT00756444|520259278|FG000|Overall Study|Death|5|||
144288967|NCT00756444|520259279|FG001|Overall Study|Death|4|||
144288968|NCT00756444|520259278|FG000|Overall Study|Disease Progression|2|||
144288969|NCT00756444|520259279|FG001|Overall Study|Disease Progression|7|||
144288970|NCT00756444|520259278|FG000|Overall Study|Ineligibility Determined|1|||
144288971|NCT00756444|520259279|FG001|Overall Study|Ineligibility Determined|0|||
144288972|NCT02264821|520259280|FG000|Overall Study|Protocol Violation|1|||
144288973|NCT02264821|520259281|FG001|Overall Study|Protocol Violation|3|||
144288974|NCT02264821|520259282|FG002|Overall Study|Protocol Violation|6|||
144288975|NCT00552279|520259283|FG000|Overall Study|Adverse Event|0|||
144288976|NCT00552279|520259284|FG001|Overall Study|Adverse Event|1|||
144288977|NCT00552279|520259283|FG000|Overall Study|Withdrawal by Subject|12|||
144288978|NCT00552279|520259284|FG001|Overall Study|Withdrawal by Subject|1|||
144288979|NCT00552279|520259283|FG000|Overall Study|Lost to Follow-up|1|||
144288980|NCT00552279|520259284|FG001|Overall Study|Lost to Follow-up|0|||
144288981|NCT00552279|520259283|FG000|Overall Study|Other|1|||
144288982|NCT00552279|520259284|FG001|Overall Study|Other|1|||
144288983|NCT03142334|520259286|FG000|Overall Study|Death|18|||
144288984|NCT03142334|520259287|FG001|Overall Study|Death|33|||
144288985|NCT03142334|520259286|FG000|Overall Study|Withdrawal by Subject|15|||
144288986|NCT03142334|520259287|FG001|Overall Study|Withdrawal by Subject|11|||
144288987|NCT03142334|520259286|FG000|Overall Study|Ongoing on trial follow up|463|||
144288988|NCT03142334|520259287|FG001|Overall Study|Ongoing on trial follow up|454|||
144288989|NCT03071965|520259288|FG000|Overall Study|Adverse Event|0|||
144288990|NCT03071965|520259289|FG001|Overall Study|Adverse Event|0|||
144288991|NCT03071965|520259290|FG002|Overall Study|Adverse Event|1|||
144288992|NCT03071965|520259291|FG003|Overall Study|Adverse Event|0|||
144288993|NCT03071965|520259288|FG000|Overall Study|Death|0|||
144288994|NCT03071965|520259289|FG001|Overall Study|Death|0|||
144288995|NCT03071965|520259290|FG002|Overall Study|Death|1|||
144288996|NCT03071965|520259291|FG003|Overall Study|Death|1|||
144288997|NCT03071965|520259288|FG000|Overall Study|COVID-19|0|||
144288998|NCT03071965|520259289|FG001|Overall Study|COVID-19|1|||
144288999|NCT03071965|520259290|FG002|Overall Study|COVID-19|0|||
144289000|NCT03071965|520259291|FG003|Overall Study|COVID-19|1|||
144289001|NCT03071965|520259288|FG000|Overall Study|Other Health Reason|0|||
144289002|NCT03071965|520259289|FG001|Overall Study|Other Health Reason|0|||
144289003|NCT03071965|520259290|FG002|Overall Study|Other Health Reason|0|||
144289004|NCT03071965|520259291|FG003|Overall Study|Other Health Reason|1|||
144289005|NCT01655069|520259292|FG000|Overall Study|Physician Decision|0|||
144289006|NCT01655069|520259293|FG001|Overall Study|Physician Decision|0|||
144289007|NCT01655069|520259294|FG002|Overall Study|Physician Decision|0|||
144289008|NCT01655069|520259295|FG003|Overall Study|Physician Decision|1|||
144289009|NCT01655069|520259292|FG000|Overall Study|Adverse Event|6|||
144289010|NCT01655069|520259293|FG001|Overall Study|Adverse Event|7|||
144289011|NCT01655069|520259294|FG002|Overall Study|Adverse Event|2|||
144289012|NCT01655069|520259295|FG003|Overall Study|Adverse Event|3|||
144289013|NCT01655069|520259292|FG000|Overall Study|Lack of Efficacy|0|||
144289014|NCT01655069|520259293|FG001|Overall Study|Lack of Efficacy|1|||
144289015|NCT01655069|520259294|FG002|Overall Study|Lack of Efficacy|0|||
144289016|NCT01655069|520259295|FG003|Overall Study|Lack of Efficacy|0|||
144289017|NCT01655069|520259292|FG000|Overall Study|No Treatment Needed|0|||
144289018|NCT01655069|520259293|FG001|Overall Study|No Treatment Needed|1|||
144289019|NCT01655069|520259294|FG002|Overall Study|No Treatment Needed|0|||
144289020|NCT01655069|520259295|FG003|Overall Study|No Treatment Needed|0|||
144289021|NCT01655069|520259292|FG000|Overall Study|Withdrawal by Subject|2|||
144289022|NCT01655069|520259293|FG001|Overall Study|Withdrawal by Subject|3|||
144289023|NCT01655069|520259294|FG002|Overall Study|Withdrawal by Subject|0|||
144289024|NCT01655069|520259295|FG003|Overall Study|Withdrawal by Subject|0|||
144289025|NCT04034056|520259296|FG000|Overall Study|Withdrawal by Subject|2|||
144289026|NCT04034056|520259296|FG000|Overall Study|Reason Not Specified|13|||
144289027|NCT04034056|520259296|FG000|Overall Study|Adverse Event|56|||
144289028|NCT03225989|520259297|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
144289029|NCT03225989|520259298|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
144289030|NCT03225989|520259299|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
144289031|NCT03225989|520259297|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
144289032|NCT03225989|520259298|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
144289033|NCT03225989|520259299|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
144289034|NCT03225989|520259297|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
144289035|NCT03225989|520259298|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
144289036|NCT03225989|520259299|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
144289037|NCT03225989|520259297|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
144289038|NCT03225989|520259298|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
144289039|NCT03225989|520259299|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
144289040|NCT03225989|520259297|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
144289041|NCT03225989|520259298|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
144289042|NCT03225989|520259299|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
144289043|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
144289044|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
144289045|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
144289046|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
144289047|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
144289048|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
144289049|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
144289050|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
144289051|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
144289052|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
144289053|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
144289054|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
144289055|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
144289056|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
144289057|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
144289058|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
144289059|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
144289060|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
144289061|NCT03225989|520259297|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
144289062|NCT03225989|520259298|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
144289063|NCT03225989|520259299|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
144289064|NCT03093870|520259300|FG000|Overall Study|Withdrawal by Subject|2|||
144289065|NCT03093870|520259301|FG001|Overall Study|Withdrawal by Subject|6|||
144289066|NCT03093870|520259302|FG002|Overall Study|Withdrawal by Subject|5|||
144289067|NCT03093870|520259300|FG000|Overall Study|Death|1|||
144289068|NCT03093870|520259301|FG001|Overall Study|Death|35|||
144289069|NCT03093870|520259302|FG002|Overall Study|Death|35|||
144289070|NCT03093870|520259300|FG000|Overall Study|Radiographic disease progression|10|||
144289071|NCT03093870|520259301|FG001|Overall Study|Radiographic disease progression|0|||
144289072|NCT03093870|520259302|FG002|Overall Study|Radiographic disease progression|0|||
144289073|NCT03093870|520259300|FG000|Overall Study|Clinical disease progression|1|||
144289074|NCT03093870|520259301|FG001|Overall Study|Clinical disease progression|0|||
144289075|NCT03093870|520259302|FG002|Overall Study|Clinical disease progression|0|||
144289076|NCT03093870|520259300|FG000|Overall Study|Physician Decision|2|||
144289077|NCT03093870|520259301|FG001|Overall Study|Physician Decision|0|||
144289078|NCT03093870|520259302|FG002|Overall Study|Physician Decision|0|||
144289079|NCT03093870|520259300|FG000|Overall Study|Adverse Event|7|||
144289080|NCT03093870|520259301|FG001|Overall Study|Adverse Event|0|||
144289081|NCT03093870|520259302|FG002|Overall Study|Adverse Event|0|||
144289082|NCT03093870|520259300|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
144289083|NCT03093870|520259301|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
144289084|NCT03093870|520259302|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
144289085|NCT03093870|520259300|FG000|Overall Study|Lost to Follow-up|0|||
144289086|NCT03093870|520259301|FG001|Overall Study|Lost to Follow-up|0|||
144289087|NCT03093870|520259302|FG002|Overall Study|Lost to Follow-up|1|||
144289088|NCT00601107|520259303|FG000|Overall Study|Adverse Event|0|||
144289089|NCT00601107|520259304|FG001|Overall Study|Adverse Event|1|||
144289090|NCT00601107|520259305|FG002|Overall Study|Adverse Event|3|||
144289091|NCT00601107|520259306|FG003|Overall Study|Adverse Event|0|||
144289092|NCT00601107|520259303|FG000|Overall Study|Withdrawal by Subject|5|||
144289093|NCT00601107|520259304|FG001|Overall Study|Withdrawal by Subject|4|||
144289094|NCT00601107|520259305|FG002|Overall Study|Withdrawal by Subject|7|||
144289095|NCT00601107|520259306|FG003|Overall Study|Withdrawal by Subject|4|||
144289096|NCT00601107|520259303|FG000|Overall Study|Lost to Follow-up|3|||
144289097|NCT00601107|520259304|FG001|Overall Study|Lost to Follow-up|3|||
144289098|NCT00601107|520259305|FG002|Overall Study|Lost to Follow-up|0|||
144289099|NCT00601107|520259306|FG003|Overall Study|Lost to Follow-up|3|||
144289100|NCT00601107|520259303|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
144289101|NCT00601107|520259304|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
144289102|NCT00601107|520259305|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
144289103|NCT00601107|520259306|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
144289104|NCT00601107|520259303|FG000|Overall Study|Worsening of Psoriasis|4|||
144289105|NCT00601107|520259304|FG001|Overall Study|Worsening of Psoriasis|1|||
144289106|NCT00601107|520259305|FG002|Overall Study|Worsening of Psoriasis|1|||
144289107|NCT00601107|520259306|FG003|Overall Study|Worsening of Psoriasis|4|||
144289108|NCT00601107|520259303|FG000|Overall Study|Undefined|1|||
144289109|NCT00601107|520259304|FG001|Overall Study|Undefined|0|||
144289110|NCT00601107|520259305|FG002|Overall Study|Undefined|1|||
144289111|NCT00601107|520259306|FG003|Overall Study|Undefined|0|||
144289112|NCT01530997|520259307|FG000|Overall Study|Physician Decision|1|||
144289113|NCT01530997|520259307|FG000|Overall Study|Withdrawal by Subject|1|||
144289114|NCT00609973|520259308|FG000|Overall Study|Adverse Event|2|||
144289115|NCT00609973|520259309|FG001|Overall Study|Adverse Event|1|||
144289116|NCT00609973|520259308|FG000|Overall Study|Protocol Violation|4|||
144289117|NCT00609973|520259309|FG001|Overall Study|Protocol Violation|3|||
144289118|NCT00609973|520259308|FG000|Overall Study|Lost to Follow-up|2|||
144289119|NCT00609973|520259309|FG001|Overall Study|Lost to Follow-up|1|||
144289120|NCT00609973|520259308|FG000|Overall Study|Withdrawal by Subject|0|||
144289121|NCT00609973|520259309|FG001|Overall Study|Withdrawal by Subject|1|||
144289122|NCT02453191|520259311|FG000|Overall Study|Withdrawal by Subject|1|||
144289123|NCT01520714|520259312|FG000|Overall Study|Protocol Violation|0|||
144289124|NCT01520714|520259313|FG001|Overall Study|Protocol Violation|3|||
144289125|NCT01520714|520259312|FG000|Overall Study|Adverse Event|0|||
144289126|NCT01520714|520259313|FG001|Overall Study|Adverse Event|2|||
144289127|NCT01520714|520259312|FG000|Overall Study|Lack of Efficacy|0|||
144289128|NCT01520714|520259313|FG001|Overall Study|Lack of Efficacy|1|||
144289129|NCT01340170|520259314|FG000|Overall Study|Lost to Follow-up|2|||
144289130|NCT01340170|520259315|FG001|Overall Study|Lost to Follow-up|4|||
144289131|NCT01340170|520259316|FG002|Overall Study|Lost to Follow-up|0|||
144289132|NCT01340170|520259314|FG000|Overall Study|Implant failure|1|||
144289133|NCT01340170|520259315|FG001|Overall Study|Implant failure|3|||
144289134|NCT01340170|520259316|FG002|Overall Study|Implant failure|0|||
144289135|NCT02366130|520259317|FG000|Overall Study|Withdrawal by Subject|3|||
144289136|NCT02366130|520259317|FG000|Overall Study|Ineligible|6|||
144289137|NCT05661734|520259318|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
144289138|NCT05661734|520259318|FG000|Overall Study|Lost to Follow-up|13|||
144289139|NCT05661734|520259318|FG000|Overall Study|Enrolled but not dosed|2|||
144289140|NCT00362609|520259319|FG000|Overall Study|Withdrawal by Subject|0|||
144289141|NCT00362609|520259320|FG001|Overall Study|Withdrawal by Subject|1|||
144289142|NCT00362609|520259319|FG000|Overall Study|Protocol Violation|0|||
144289143|NCT00362609|520259320|FG001|Overall Study|Protocol Violation|1|||
144289144|NCT01800058|520259321|FG000|Overall Study|Lost to Follow-up|1|||
144289145|NCT02946996|520259322|FG000|Overall Study|non-evaluable|3|||
144289146|NCT02946996|520259323|FG001|Overall Study|non-evaluable|6|||
144289147|NCT02946996|520259324|FG002|Overall Study|non-evaluable|5|||
144289148|NCT01245049|520259325|FG000|Overall Study|Migrated/moved from study area|0|||
144289149|NCT01245049|520259326|FG001|Overall Study|Migrated/moved from study area|1|||
144289150|NCT01245049|520259325|FG000|Overall Study|Withdrawal by Subject|0|||
144289151|NCT01245049|520259326|FG001|Overall Study|Withdrawal by Subject|1|||
144289152|NCT01245049|520259325|FG000|Overall Study|Lost to Follow-up|1|||
144289153|NCT01245049|520259326|FG001|Overall Study|Lost to Follow-up|2|||
144289154|NCT00450749|520259327|FG000|Overall Study|Withdrawal by Subject|0|||
144289155|NCT00450749|520259328|FG001|Overall Study|Withdrawal by Subject|0|||
144289156|NCT00450749|520259329|FG002|Overall Study|Withdrawal by Subject|2|||
144289157|NCT00450749|520259327|FG000|Overall Study|Noncompliant|0|||
144289158|NCT00450749|520259328|FG001|Overall Study|Noncompliant|1|||
144289159|NCT00450749|520259329|FG002|Overall Study|Noncompliant|0|||
144289160|NCT03178942|520259330|FG000|Overall Study|Withdrawal by Subject|2|||
144289161|NCT03178942|520259331|FG001|Overall Study|Withdrawal by Subject|0|||
144289162|NCT03178942|520259330|FG000|Overall Study|Lost to Follow-up|1|||
144289163|NCT03178942|520259331|FG001|Overall Study|Lost to Follow-up|2|||
144289164|NCT06097273|520259332|FG000|Overall Study|Death|2|||
144289165|NCT06097273|520259333|FG001|Overall Study|Death|1|||
144289166|NCT06097273|520259334|FG002|Overall Study|Death|2|||
144289167|NCT06097273|520259335|FG003|Overall Study|Death|2|||
144289168|NCT06097273|520259332|FG000|Overall Study|Lost to Follow-up|27|||
144289169|NCT06097273|520259333|FG001|Overall Study|Lost to Follow-up|18|||
144289170|NCT06097273|520259334|FG002|Overall Study|Lost to Follow-up|36|||
144289171|NCT06097273|520259335|FG003|Overall Study|Lost to Follow-up|31|||
144289172|NCT06097273|520259332|FG000|Overall Study|Physician Decision|0|||
144289173|NCT06097273|520259333|FG001|Overall Study|Physician Decision|1|||
144289174|NCT06097273|520259334|FG002|Overall Study|Physician Decision|0|||
144289175|NCT06097273|520259335|FG003|Overall Study|Physician Decision|3|||
144289176|NCT06097273|520259332|FG000|Overall Study|Protocol Violation|1|||
144289177|NCT06097273|520259333|FG001|Overall Study|Protocol Violation|1|||
144289178|NCT06097273|520259334|FG002|Overall Study|Protocol Violation|2|||
144289179|NCT06097273|520259335|FG003|Overall Study|Protocol Violation|1|||
144289180|NCT06097273|520259332|FG000|Overall Study|Withdrawal by Subject|14|||
144289181|NCT06097273|520259333|FG001|Overall Study|Withdrawal by Subject|11|||
144289182|NCT06097273|520259334|FG002|Overall Study|Withdrawal by Subject|14|||
144289183|NCT06097273|520259335|FG003|Overall Study|Withdrawal by Subject|15|||
144289184|NCT06097273|520259332|FG000|Overall Study|Other Than Specified|7|||
144289185|NCT06097273|520259333|FG001|Overall Study|Other Than Specified|3|||
144289186|NCT06097273|520259334|FG002|Overall Study|Other Than Specified|11|||
144289187|NCT06097273|520259335|FG003|Overall Study|Other Than Specified|6|||
144289188|NCT00662038|520260558|FG000|Overall Study|Reason not specified|3|||
144289189|NCT00662038|520260558|FG000|Overall Study|Withdrawn consent|22|||
144289190|NCT00662038|520260558|FG000|Overall Study|Withdrawal by Subject|83|||
144289191|NCT00662038|520260558|FG000|Overall Study|Sponsor decision|1|||
144289192|NCT00662038|520260558|FG000|Overall Study|Physician Decision|19|||
144289193|NCT00662038|520260558|FG000|Overall Study|Lung transplantation|44|||
144289194|NCT00662038|520260558|FG000|Overall Study|Lost to Follow-up|1|||
144289195|NCT00662038|520260558|FG000|Overall Study|Death|95|||
144289196|NCT00662038|520260558|FG000|Overall Study|Adverse Event|358|||
144289197|NCT00662038|520260558|FG000|Overall Study|Continued treatment|5|||
144289198|NCT01840163|520260559|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
144289199|NCT01840163|520260560|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
144289200|NCT01840163|520260559|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
144289201|NCT01840163|520260560|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
144289202|NCT01840163|520260559|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
144289203|NCT01840163|520260560|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
144289204|NCT04914000|520260561|FG000|Overall Study|Lost to Follow-up|8|||
144289205|NCT04914000|520260561|FG000|Overall Study|Withdrawal by Subject|1|||
144289206|NCT00079781|520260563|FG000|Pre-implant Period|Withdrawal by Subject|2|||
144289207|NCT00079781|520260564|FG001|Pre-implant Period|Withdrawal by Subject|0|||
144289208|NCT00079781|520260565|FG002|Pre-implant Period|Withdrawal by Subject|0|||
144289209|NCT00079781|520260563|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
144289210|NCT00079781|520260564|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
144289211|NCT00079781|520260565|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
144289212|NCT00079781|520260563|FG000|Follow-up Period|Withdrawal by Subject|3|||
144289213|NCT00079781|520260564|FG001|Follow-up Period|Withdrawal by Subject|0|||
144289214|NCT00079781|520260565|FG002|Follow-up Period|Withdrawal by Subject|1|||
144289215|NCT00079781|520260563|FG000|Follow-up Period|Lost to Follow-up|1|||
144289216|NCT00079781|520260564|FG001|Follow-up Period|Lost to Follow-up|0|||
144289217|NCT00079781|520260565|FG002|Follow-up Period|Lost to Follow-up|0|||
144289218|NCT00079781|520260563|FG000|Follow-up Period|Death|0|||
144289219|NCT00079781|520260564|FG001|Follow-up Period|Death|0|||
144289220|NCT00079781|520260565|FG002|Follow-up Period|Death|1|||
144289221|NCT00225758|520260566|FG000|Overall Study|Adverse Event|4|||
144289222|NCT01657500|520260570|FG000|Overall Study|set impropperly matched|3|||
144289223|NCT01657500|520260571|FG001|Overall Study|set impropperly matched|3|||
144289224|NCT01657500|520260570|FG000|Overall Study|Lost to Follow-up|2|||
144289225|NCT01657500|520260571|FG001|Overall Study|Lost to Follow-up|2|||
144289226|NCT00564070|520260574|FG000|Overall Study|Lost to Follow-up|9|||
144289227|NCT00564070|520260575|FG001|Overall Study|Lost to Follow-up|7|||
144289228|NCT00564070|520260574|FG000|Overall Study|Worsening depression, referred to care|3|||
144289229|NCT00564070|520260575|FG001|Overall Study|Worsening depression, referred to care|0|||
144289230|NCT06083493|520260577|FG000|Overall Study|Technical issues with the interventional device|2|||
144289231|NCT06083493|520260578|FG001|Overall Study|Technical issues with the interventional device|2|||
144289232|NCT06083493|520260577|FG000|Overall Study|Performed incorrect visual task|1|||
144289233|NCT06083493|520260578|FG001|Overall Study|Performed incorrect visual task|0|||
144289234|NCT06083493|520260577|FG000|Overall Study|Insufficient baseline performance|0|||
144289235|NCT06083493|520260578|FG001|Overall Study|Insufficient baseline performance|1|||
144289236|NCT01063881|520260580|FG000|Overall Study|Adverse Event|12|||
144289237|NCT01063881|520260581|FG001|Overall Study|Adverse Event|2|||
144289238|NCT01063881|520260582|FG002|Overall Study|Adverse Event|0|||
144289239|NCT01063881|520260580|FG000|Overall Study|Lost to Follow-up|13|||
144289240|NCT01063881|520260581|FG001|Overall Study|Lost to Follow-up|7|||
144289241|NCT01063881|520260582|FG002|Overall Study|Lost to Follow-up|1|||
144289242|NCT01063881|520260580|FG000|Overall Study|Withdrawal by Subject|25|||
144289243|NCT01063881|520260581|FG001|Overall Study|Withdrawal by Subject|1|||
144289244|NCT01063881|520260582|FG002|Overall Study|Withdrawal by Subject|0|||
144289245|NCT01063881|520260580|FG000|Overall Study|Reason for not completed not specified|5|||
144289246|NCT01063881|520260581|FG001|Overall Study|Reason for not completed not specified|1|||
144289247|NCT01063881|520260582|FG002|Overall Study|Reason for not completed not specified|0|||
144289248|NCT01309100|520260583|FG000|Overall Study|Protocol Violation|1|||
144289249|NCT01309100|520260583|FG000|Overall Study|Positive Slit lamp finding|1|||
144289250|NCT01927861|520260586|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
144289251|NCT01927861|520260587|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
144289252|NCT01927861|520260586|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
144289253|NCT01927861|520260587|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
144289254|NCT01248468|520260589|FG000|Overall Study|Administrative problem|1|||
144289255|NCT01248468|520260590|FG001|Overall Study|Administrative problem|0|||
144289256|NCT01248468|520260591|FG002|Overall Study|Administrative problem|0|||
144289257|NCT01248468|520260589|FG000|Overall Study|Lost to Follow-up|9|||
144289258|NCT01248468|520260590|FG001|Overall Study|Lost to Follow-up|12|||
144289259|NCT01248468|520260591|FG002|Overall Study|Lost to Follow-up|4|||
144289260|NCT01248468|520260589|FG000|Overall Study|Pregnancy|1|||
144289261|NCT01248468|520260590|FG001|Overall Study|Pregnancy|0|||
144289262|NCT01248468|520260591|FG002|Overall Study|Pregnancy|0|||
144289263|NCT01248468|520260589|FG000|Overall Study|Withdrawal by Subject|4|||
144289264|NCT01248468|520260590|FG001|Overall Study|Withdrawal by Subject|2|||
144289265|NCT01248468|520260591|FG002|Overall Study|Withdrawal by Subject|0|||
144289266|NCT02006654|520260592|FG000|Overall Study|Withdrawal before treatment|4|||
144289267|NCT02006654|520260593|FG001|Overall Study|Withdrawal before treatment|2|||
144289268|NCT02006654|520260592|FG000|Overall Study|Adverse Event|16|||
144289269|NCT02006654|520260593|FG001|Overall Study|Adverse Event|17|||
144289270|NCT02006654|520260592|FG000|Overall Study|Death|1|||
144289271|NCT02006654|520260593|FG001|Overall Study|Death|0|||
144289272|NCT02006654|520260592|FG000|Overall Study|Withdrawal by Subject|14|||
144289273|NCT02006654|520260593|FG001|Overall Study|Withdrawal by Subject|12|||
144289274|NCT02006654|520260592|FG000|Overall Study|Protocol Violation|5|||
144289275|NCT02006654|520260593|FG001|Overall Study|Protocol Violation|8|||
144289276|NCT02006654|520260592|FG000|Overall Study|Lost to Follow-up|1|||
144289277|NCT02006654|520260593|FG001|Overall Study|Lost to Follow-up|0|||
144289278|NCT02006654|520260592|FG000|Overall Study|patient's will|2|||
144289279|NCT02006654|520260593|FG001|Overall Study|patient's will|1|||
144289280|NCT02006654|520260592|FG000|Overall Study|insufficient compliance|1|||
144289281|NCT02006654|520260593|FG001|Overall Study|insufficient compliance|0|||
144289282|NCT02006654|520260592|FG000|Overall Study|worsening cognitive condition|0|||
144289283|NCT02006654|520260593|FG001|Overall Study|worsening cognitive condition|1|||
144289284|NCT02006654|520260592|FG000|Overall Study|faecal incontinence|0|||
144289285|NCT02006654|520260593|FG001|Overall Study|faecal incontinence|1|||
144289286|NCT02006654|520260592|FG000|Overall Study|mood disorder|0|||
144289287|NCT02006654|520260593|FG001|Overall Study|mood disorder|1|||
144289288|NCT02006654|520260592|FG000|Overall Study|disallowed medication|1|||
144289289|NCT02006654|520260593|FG001|Overall Study|disallowed medication|0|||
144289290|NCT02006654|520260592|FG000|Overall Study|moving out of state|0|||
144289291|NCT02006654|520260593|FG001|Overall Study|moving out of state|1|||
144289292|NCT01065766|520260594|FG000|Overall Study|Assessed before the contracted date|1|||
144289293|NCT01065766|520260594|FG000|Overall Study|Contraindication to administration|6|||
144289294|NCT01065766|520260594|FG000|Overall Study|Violated dosage/administration|25|||
144289295|NCT04223687|520260598|FG000|Overall Study|Missing primary outcome|1|||
144289296|NCT04223687|520260599|FG001|Overall Study|Missing primary outcome|0|||
144289297|NCT01608308|520260603|FG000|Overall Study|pretreatment medical and billing reasons|0|||
144289298|NCT01608308|520260604|FG001|Overall Study|pretreatment medical and billing reasons|2|||
144289299|NCT04128228|520260605|FG000|Overall Study|Withdrawal by Subject|3|||
144289300|NCT04128228|520260606|FG001|Overall Study|Withdrawal by Subject|3|||
144289301|NCT04128228|520260607|FG002|Overall Study|Withdrawal by Subject|0|||
144289302|NCT04128228|520260608|FG003|Overall Study|Withdrawal by Subject|0|||
144289303|NCT04128228|520260605|FG000|Overall Study|noncompliance|2|||
144289304|NCT04128228|520260606|FG001|Overall Study|noncompliance|2|||
144289305|NCT04128228|520260607|FG002|Overall Study|noncompliance|0|||
144289306|NCT04128228|520260608|FG003|Overall Study|noncompliance|0|||
144289307|NCT01945242|520260609|FG000|Overall Study|Physician Decision|3|||
144289308|NCT01945242|520260610|FG001|Overall Study|Physician Decision|3|||
144289309|NCT05652140|520260611|FG000|Overall Study|Lost to Follow-up|7|||
144289310|NCT05652140|520260612|FG001|Overall Study|Lost to Follow-up|16|||
144289311|NCT05652140|520260613|FG002|Overall Study|Lost to Follow-up|22|||
144289312|NCT05652140|520260614|FG003|Overall Study|Lost to Follow-up|31|||
144289313|NCT04648241|520260618|FG000|Overall Study|Lost to Follow-up|1|||
144289314|NCT04648241|520260619|FG001|Overall Study|Lost to Follow-up|0|||
144289315|NCT02057666|520260620|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
144289316|NCT02057666|520260621|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
144289317|NCT02057666|520260620|FG000|Double Blind Treatment Period|Poor tolerability|7|||
144289318|NCT02057666|520260621|FG001|Double Blind Treatment Period|Poor tolerability|2|||
144289319|NCT02057666|520260620|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
144289320|NCT02057666|520260621|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
144289321|NCT02057666|520260620|FG000|Double Blind Treatment Period|Physician Decision|1|||
144289322|NCT02057666|520260621|FG001|Double Blind Treatment Period|Physician Decision|0|||
144289323|NCT02057666|520260620|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
144289324|NCT02057666|520260621|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
144289325|NCT02057666|520260620|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
144289326|NCT02057666|520260621|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
144289327|NCT02057666|520260620|FG000|Double Blind Treatment Period|Sponsor's request|70|||
144289328|NCT02057666|520260621|FG001|Double Blind Treatment Period|Sponsor's request|34|||
144289329|NCT02057666|520260620|FG000|Open-Label Treatment Period|Poor tolerability|0|||
144289330|NCT02057666|520260621|FG001|Open-Label Treatment Period|Poor tolerability|1|||
144289331|NCT02057666|520260620|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
144289332|NCT02057666|520260621|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
144289333|NCT02057666|520260620|FG000|Open-Label Treatment Period|Sponsor's request|0|||
144289334|NCT02057666|520260621|FG001|Open-Label Treatment Period|Sponsor's request|4|||
144289335|NCT04401293|520260622|FG000|Overall Study|Withdrawal by Subject|1|||
144289336|NCT04401293|520260623|FG001|Overall Study|Withdrawal by Subject|3|||
144289337|NCT01026038|520260624|FG000|Overall Study|Lost to Follow-up|1|||
144289338|NCT01026038|520260625|FG001|Overall Study|Lost to Follow-up|1|||
144289339|NCT01026038|520260626|FG002|Overall Study|Lost to Follow-up|0|||
144289340|NCT03679884|520260627|FG000|Overall Study|Other|12|||
144289341|NCT03679884|520260628|FG001|Overall Study|Other|12|||
144289342|NCT03679884|520260629|FG002|Overall Study|Other|12|||
144289343|NCT03679884|520260630|FG003|Overall Study|Other|7|||
144289344|NCT03679884|520260631|FG004|Overall Study|Other|8|||
144289345|NCT03679884|520260627|FG000|Overall Study|Lack of Efficacy|15|||
144289346|NCT03679884|520260628|FG001|Overall Study|Lack of Efficacy|29|||
144289347|NCT03679884|520260629|FG002|Overall Study|Lack of Efficacy|13|||
144289348|NCT03679884|520260630|FG003|Overall Study|Lack of Efficacy|29|||
144289349|NCT03679884|520260631|FG004|Overall Study|Lack of Efficacy|10|||
144289350|NCT03679884|520260627|FG000|Overall Study|Death|1|||
144289351|NCT03679884|520260628|FG001|Overall Study|Death|0|||
144289352|NCT03679884|520260629|FG002|Overall Study|Death|0|||
144289353|NCT03679884|520260630|FG003|Overall Study|Death|0|||
144289354|NCT03679884|520260631|FG004|Overall Study|Death|0|||
144289355|NCT03679884|520260627|FG000|Overall Study|Adverse Event|2|||
144289356|NCT03679884|520260628|FG001|Overall Study|Adverse Event|10|||
144289357|NCT03679884|520260629|FG002|Overall Study|Adverse Event|9|||
144289358|NCT03679884|520260630|FG003|Overall Study|Adverse Event|6|||
144289359|NCT03679884|520260631|FG004|Overall Study|Adverse Event|6|||
144289360|NCT03679884|520260627|FG000|Overall Study|Withdrawal by Subject|12|||
144289361|NCT03679884|520260628|FG001|Overall Study|Withdrawal by Subject|23|||
144289362|NCT03679884|520260629|FG002|Overall Study|Withdrawal by Subject|8|||
144289363|NCT03679884|520260630|FG003|Overall Study|Withdrawal by Subject|8|||
144289364|NCT03679884|520260631|FG004|Overall Study|Withdrawal by Subject|9|||
144289365|NCT03679884|520260627|FG000|Overall Study|Lost to Follow-up|1|||
144289366|NCT03679884|520260628|FG001|Overall Study|Lost to Follow-up|4|||
144289367|NCT03679884|520260629|FG002|Overall Study|Lost to Follow-up|2|||
144289368|NCT03679884|520260630|FG003|Overall Study|Lost to Follow-up|0|||
144289369|NCT03679884|520260631|FG004|Overall Study|Lost to Follow-up|3|||
144289370|NCT01108055|520260637|FG000|Overall Study|Ineligible|11|||
144289371|NCT01108055|520260637|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
144289372|NCT03339453|520260641|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
144289373|NCT03339453|520260642|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
144289374|NCT00236197|520260646|FG000|Overall Study|Withdrawal by Subject|3|||
144289375|NCT00236197|520260647|FG001|Overall Study|Withdrawal by Subject|2|||
144289376|NCT00236197|520260646|FG000|Overall Study|Lost to Follow-up|1|||
144289377|NCT00236197|520260647|FG001|Overall Study|Lost to Follow-up|5|||
144289378|NCT00236197|520260646|FG000|Overall Study|Protocol Violation|0|||
144289379|NCT00236197|520260647|FG001|Overall Study|Protocol Violation|3|||
144289380|NCT00236197|520260646|FG000|Overall Study|Medication non-compliance|1|||
144289381|NCT00236197|520260647|FG001|Overall Study|Medication non-compliance|2|||
144289382|NCT00236197|520260646|FG000|Overall Study|Other|0|||
144289383|NCT00236197|520260647|FG001|Overall Study|Other|2|||
144289384|NCT03760666|520260650|FG000|Overall Study|Adverse Event|2|||
144289385|NCT03760666|520260651|FG001|Overall Study|Adverse Event|4|||
144289386|NCT03760666|520260652|FG002|Overall Study|Adverse Event|1|||
144289387|NCT03760666|520260650|FG000|Overall Study|AML Disease Progression|3|||
144289388|NCT03760666|520260651|FG001|Overall Study|AML Disease Progression|3|||
144289389|NCT03760666|520260652|FG002|Overall Study|AML Disease Progression|0|||
144289390|NCT03760666|520260650|FG000|Overall Study|Physician Decision|0|||
144289391|NCT03760666|520260651|FG001|Overall Study|Physician Decision|3|||
144289392|NCT03760666|520260652|FG002|Overall Study|Physician Decision|0|||
144289393|NCT03760666|520260650|FG000|Overall Study|Withdrawal by Subject|0|||
144289394|NCT03760666|520260651|FG001|Overall Study|Withdrawal by Subject|1|||
144289395|NCT03760666|520260652|FG002|Overall Study|Withdrawal by Subject|0|||
144289396|NCT00800384|520260658|FG000|Overall Study|Withdrawal by Subject|24|||
144289397|NCT00800384|520260659|FG001|Overall Study|Withdrawal by Subject|17|||
144289398|NCT00800384|520260658|FG000|Overall Study|Lost to Follow-up|17|||
144289399|NCT00800384|520260659|FG001|Overall Study|Lost to Follow-up|26|||
144289400|NCT01064622|520260660|FG000|Randomized Phase II|Withdrawal by Subject|2|||
144289401|NCT01064622|520260661|FG001|Randomized Phase II|Withdrawal by Subject|2|||
144289402|NCT01064622|520260660|FG000|Randomized Phase II|Protocol Violation|0|||
144289403|NCT01064622|520260661|FG001|Randomized Phase II|Protocol Violation|1|||
144289404|NCT06868667|520260664|FG000|Overall Study|Death|0|||
144289405|NCT06868667|520260665|FG001|Overall Study|Death|4|||
144289406|NCT06868667|520260664|FG000|Overall Study|Lost to Follow-up|0|||
144289407|NCT06868667|520260665|FG001|Overall Study|Lost to Follow-up|1|||
144289408|NCT06868667|520260664|FG000|Overall Study|Withdrawal by Subject|1|||
144289409|NCT06868667|520260665|FG001|Overall Study|Withdrawal by Subject|0|||
144289410|NCT06868667|520260664|FG000|Overall Study|Ongoing|9|||
144289411|NCT06868667|520260665|FG001|Overall Study|Ongoing|9|||
144289412|NCT05330429|520260668|FG000|Overall Study|Study Terminated by Sponsor|4|||
144289413|NCT05330429|520260669|FG001|Overall Study|Study Terminated by Sponsor|33|||
144289414|NCT05330429|520260670|FG002|Overall Study|Study Terminated by Sponsor|12|||
144289415|NCT05330429|520260668|FG000|Overall Study|Death|5|||
144289416|NCT05330429|520260669|FG001|Overall Study|Death|2|||
144289417|NCT05330429|520260670|FG002|Overall Study|Death|4|||
144289418|NCT05330429|520260668|FG000|Overall Study|Withdrew Consent|0|||
144289419|NCT05330429|520260669|FG001|Overall Study|Withdrew Consent|5|||
144289420|NCT05330429|520260670|FG002|Overall Study|Withdrew Consent|4|||
144289421|NCT05330429|520260668|FG000|Overall Study|Investigator's Discretion|0|||
144289422|NCT05330429|520260669|FG001|Overall Study|Investigator's Discretion|1|||
144289423|NCT05330429|520260670|FG002|Overall Study|Investigator's Discretion|3|||
144289424|NCT05330429|520260668|FG000|Overall Study|Subject Decision|1|||
144289425|NCT05330429|520260669|FG001|Overall Study|Subject Decision|2|||
144289426|NCT05330429|520260670|FG002|Overall Study|Subject Decision|0|||
144289427|NCT05330429|520260668|FG000|Overall Study|Lost to Follow-up|0|||
144289428|NCT05330429|520260669|FG001|Overall Study|Lost to Follow-up|1|||
144289429|NCT05330429|520260670|FG002|Overall Study|Lost to Follow-up|0|||
144289430|NCT02151604|520260671|FG000|Overall Study|Lost to Follow-up|3|||
144289431|NCT02151604|520260671|FG000|Overall Study|Withdrawal by Subject|2|||
144289432|NCT02151604|520260671|FG000|Overall Study|Physician Decision|3|||
144289433|NCT02151604|520260671|FG000|Overall Study|Death|1|||
144289434|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
144289435|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
144289436|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
144289437|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Adverse Event|5|||
144289438|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Adverse Event|1|||
144289439|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Adverse Event|0|||
144289440|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
144289441|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
144289442|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
144289443|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Death|8|||
144289444|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Death|24|||
144289445|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Death|0|||
144289446|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
144289447|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
144289448|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
144289449|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
144289450|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
144289451|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
144289452|NCT02931539|520260673|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
144289453|NCT02931539|520260674|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
144289454|NCT02931539|520260675|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
144289455|NCT02931539|520260673|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
144289456|NCT02931539|520260674|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
144289457|NCT02931539|520260675|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
144289458|NCT00655746|520260676|FG000|Overall Study|Withdrawal by Subject|1|||
144289459|NCT03004183|520262226|FG000|Overall Study|Adverse Event|7|||
144289460|NCT03004183|520262226|FG000|Overall Study|Lost to Follow-up|1|||
144289461|NCT03004183|520262226|FG000|Overall Study|Physician Decision|40|||
144289462|NCT03004183|520262226|FG000|Overall Study|Withdrawal by Subject|1|||
144289463|NCT03004183|520262226|FG000|Overall Study|COVID-19|1|||
144289464|NCT02529488|520262227|FG000|Overall Study|Adverse Event|1|||
144289465|NCT02529488|520262227|FG000|Overall Study|Death|3|||
144289466|NCT02698787|520262228|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
144289467|NCT02698787|520262229|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
144289468|NCT02821000|520262233|FG000|Overall Study|Death|89|||
144289469|NCT02821000|520262233|FG000|Overall Study|Sponsor Decision|12|||
144289470|NCT02821000|520262233|FG000|Overall Study|Withdrawal by Subject|2|||
144289471|NCT00326495|520262234|FG000|Overall Study|Switched to alternative treatment|1|||
144289472|NCT00326495|520262234|FG000|Overall Study|Disease progression before treatment|1|||
144289473|NCT00326495|520262234|FG000|Overall Study|Refused further treatment|2|||
144289474|NCT00326495|520262234|FG000|Overall Study|Subject off study before assessment|1|||
144289475|NCT04359680|520262235|FG000|Overall Study|Withdrawal by Subject|29|||
144289476|NCT04359680|520262236|FG001|Overall Study|Withdrawal by Subject|24|||
144289477|NCT04359680|520262235|FG000|Overall Study|Adverse Event|6|||
144289478|NCT04359680|520262236|FG001|Overall Study|Adverse Event|2|||
144289479|NCT04359680|520262235|FG000|Overall Study|Lost to Follow-up|56|||
144289480|NCT04359680|520262236|FG001|Overall Study|Lost to Follow-up|59|||
144289481|NCT04359680|520262235|FG000|Overall Study|Protocol Violation|3|||
144289482|NCT04359680|520262236|FG001|Overall Study|Protocol Violation|5|||
144289483|NCT04359680|520262235|FG000|Overall Study|Physician Decision|1|||
144289484|NCT04359680|520262236|FG001|Overall Study|Physician Decision|1|||
144289485|NCT04359680|520262235|FG000|Overall Study|Sponsor Decision|0|||
144289486|NCT04359680|520262236|FG001|Overall Study|Sponsor Decision|1|||
144289487|NCT01654250|520262237|FG000|Overall Study|Lost to Follow-up|1|||
144289488|NCT01654250|520262238|FG001|Overall Study|Lost to Follow-up|0|||
144289489|NCT03280615|520262239|FG000|Overall Study|Lost to Follow-up|1|||
144289490|NCT03280615|520262240|FG001|Overall Study|Lost to Follow-up|2|||
144289491|NCT03280615|520262239|FG000|Overall Study|Adverse Event|1|||
144289492|NCT03280615|520262240|FG001|Overall Study|Adverse Event|1|||
144289493|NCT03280615|520262239|FG000|Overall Study|Withdrawal by Subject|2|||
144289494|NCT03280615|520262240|FG001|Overall Study|Withdrawal by Subject|2|||
144289495|NCT01013870|520262245|FG000|Overall Study|Lost to Follow-up|1|||
144289496|NCT01013870|520262246|FG001|Overall Study|Lost to Follow-up|3|||
144289497|NCT01386645|520262247|FG000|Overall Study|Physician Decision|0|||
144289498|NCT01386645|520262248|FG001|Overall Study|Physician Decision|0|||
144289499|NCT01386645|520262249|FG002|Overall Study|Physician Decision|1|||
144289500|NCT01386645|520262247|FG000|Overall Study|Withdrawal by Subject|0|||
144289501|NCT01386645|520262248|FG001|Overall Study|Withdrawal by Subject|1|||
144289502|NCT01386645|520262249|FG002|Overall Study|Withdrawal by Subject|1|||
144289503|NCT00432991|520262250|FG000|Overall Study|Protocol Violation|7|||
144289504|NCT00432991|520262251|FG001|Overall Study|Protocol Violation|12|||
144289505|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
144289506|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
144289507|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
144289508|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
144289509|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
144289510|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
144289511|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
144289512|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
144289513|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
144289514|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
144289515|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
144289516|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
144289517|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
144289518|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
144289519|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
144289520|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
144289521|NCT01755156|520262261|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
144289522|NCT01755156|520262262|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
144289523|NCT01755156|520262261|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
144289524|NCT01755156|520262262|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
144289525|NCT01755156|520262261|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
144289526|NCT01755156|520262262|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
144289527|NCT02168439|520262263|FG000|Overall Study|Protocol Violation|0|||
144289528|NCT02168439|520262264|FG001|Overall Study|Protocol Violation|2|||
144289529|NCT01292473|520262265|FG000|Overall Study|Adverse Event|1|||
144289530|NCT01292473|520262266|FG001|Overall Study|Adverse Event|0|||
144289531|NCT01292473|520262267|FG002|Overall Study|Adverse Event|1|||
144289532|NCT01292473|520262268|FG003|Overall Study|Adverse Event|1|||
144289533|NCT01292473|520262265|FG000|Overall Study|Lost to Follow-up|1|||
144289534|NCT01292473|520262266|FG001|Overall Study|Lost to Follow-up|1|||
144289535|NCT01292473|520262267|FG002|Overall Study|Lost to Follow-up|2|||
144289536|NCT01292473|520262268|FG003|Overall Study|Lost to Follow-up|2|||
144289537|NCT01292473|520262265|FG000|Overall Study|Withdrawal by Subject|3|||
144289538|NCT01292473|520262266|FG001|Overall Study|Withdrawal by Subject|4|||
144289539|NCT01292473|520262267|FG002|Overall Study|Withdrawal by Subject|3|||
144289540|NCT01292473|520262268|FG003|Overall Study|Withdrawal by Subject|3|||
144289541|NCT01292473|520262265|FG000|Overall Study|Physician Decision|0|||
144289542|NCT01292473|520262266|FG001|Overall Study|Physician Decision|1|||
144289543|NCT01292473|520262267|FG002|Overall Study|Physician Decision|0|||
144289544|NCT01292473|520262268|FG003|Overall Study|Physician Decision|0|||
144289545|NCT01292473|520262265|FG000|Overall Study|Disease Progression|0|||
144289546|NCT01292473|520262266|FG001|Overall Study|Disease Progression|1|||
144289547|NCT01292473|520262267|FG002|Overall Study|Disease Progression|3|||
144289548|NCT01292473|520262268|FG003|Overall Study|Disease Progression|6|||
144289549|NCT04432298|520262269|FG000|Overall Study|Other than specified|1|||
144289550|NCT04432298|520262270|FG001|Overall Study|Other than specified|0|||
144289551|NCT04432298|520262269|FG000|Overall Study|Lost to Follow-up|0|||
144289552|NCT04432298|520262270|FG001|Overall Study|Lost to Follow-up|1|||
144289553|NCT04432298|520262269|FG000|Overall Study|Death|3|||
144289554|NCT04432298|520262270|FG001|Overall Study|Death|2|||
144289555|NCT04432298|520262269|FG000|Overall Study|Withdrawal by Subject|2|||
144289556|NCT04432298|520262270|FG001|Overall Study|Withdrawal by Subject|0|||
144289557|NCT01550965|520262283|FG000|Overall Study|Adverse Event|26|||
144289558|NCT01550965|520262283|FG000|Overall Study|Withdrawal by Subject|10|||
144289559|NCT01550965|520262283|FG000|Overall Study|Lost to Follow-up|2|||
144289560|NCT01550965|520262283|FG000|Overall Study|Lack of Efficacy|59|||
144289561|NCT01550965|520262283|FG000|Overall Study|Other|13|||
144289562|NCT02067156|520262294|FG000|Overall Study|Lost to Follow-up|4|||
144289563|NCT00986102|520262295|FG000|Overall Study|Lost to Follow-up|0|||
144289564|NCT00986102|520262296|FG001|Overall Study|Lost to Follow-up|1|||
144289565|NCT00986102|520262297|FG002|Overall Study|Lost to Follow-up|0|||
144289566|NCT00986102|520262298|FG003|Overall Study|Lost to Follow-up|1|||
144289567|NCT00986102|520262295|FG000|Overall Study|Withdrawal by Subject|1|||
144289568|NCT00986102|520262296|FG001|Overall Study|Withdrawal by Subject|1|||
144289569|NCT00986102|520262297|FG002|Overall Study|Withdrawal by Subject|0|||
144289570|NCT00986102|520262298|FG003|Overall Study|Withdrawal by Subject|0|||
144289571|NCT01691482|520262301|FG000|Treatment Period 2|Adverse Event|0|||
144289572|NCT01691482|520262302|FG001|Treatment Period 2|Adverse Event|1|||
144289573|NCT01691482|520262301|FG000|Treatment Period 2|Protocol Violation|1|||
144289574|NCT01691482|520262302|FG001|Treatment Period 2|Protocol Violation|1|||
144246128|NCT02248974|520098242|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
144246129|NCT02248974|520098241|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
144246130|NCT02248974|520098242|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
144246131|NCT02248974|520098241|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
144246132|NCT02248974|520098242|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
144246133|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
144246134|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
144246135|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
144246136|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
144246137|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|Death|1|||
144246138|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|Death|1|||
144246139|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
144246140|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
144246141|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
144246142|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
144246143|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
144246144|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
144246145|NCT00033657|520098243|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
144246146|NCT00033657|520098244|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
144246147|NCT00033657|520098243|FG000|Surgical Resection|not complete resection|0|||
144246148|NCT00033657|520098244|FG001|Surgical Resection|not complete resection|3|||
144246149|NCT00033657|520098243|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
144246150|NCT00033657|520098244|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
144246151|NCT00033657|520098243|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
144246152|NCT00033657|520098244|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
144246153|NCT00033657|520098243|FG000|Adjuvant Chemotherapy|Death|2|||
144246154|NCT00033657|520098244|FG001|Adjuvant Chemotherapy|Death|1|||
144246155|NCT00033657|520098243|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
144246156|NCT00033657|520098244|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
144246157|NCT00033657|520098243|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
144246158|NCT00033657|520098244|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
144246159|NCT00033657|520098243|FG000|Adjuvant Chemotherapy|Other|0|||
144246160|NCT00033657|520098244|FG001|Adjuvant Chemotherapy|Other|2|||
144246161|NCT02332239|520098245|FG000|Overall Study|Lost to Follow-up|4|||
144246162|NCT02332239|520098246|FG001|Overall Study|Lost to Follow-up|6|||
144246163|NCT00894790|520098247|FG000|Overall Study|Protocol Violation|0|||
144246164|NCT00894790|520098248|FG001|Overall Study|Protocol Violation|1|||
144246165|NCT00894790|520098247|FG000|Overall Study|Lost to Follow-up|0|||
144246166|NCT00894790|520098248|FG001|Overall Study|Lost to Follow-up|1|||
144246167|NCT00894790|520098247|FG000|Overall Study|Did not meet entrance criteria|1|||
144246168|NCT00894790|520098248|FG001|Overall Study|Did not meet entrance criteria|0|||
144246169|NCT04093492|520098249|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
144246170|NCT04093492|520098250|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
144246171|NCT04093492|520098251|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
144246172|NCT04093492|520098252|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
144246173|NCT04093492|520098249|FG000|25 Weeks Gestational Age (GA)|No response|5|||
144246174|NCT04093492|520098250|FG001|25 Weeks Gestational Age (GA)|No response|5|||
144246175|NCT04093492|520098251|FG002|25 Weeks Gestational Age (GA)|No response|5|||
144246176|NCT04093492|520098252|FG003|25 Weeks Gestational Age (GA)|No response|2|||
144246177|NCT04093492|520098249|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
144246178|NCT04093492|520098250|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
144246179|NCT04093492|520098251|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
144246180|NCT04093492|520098252|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
144246181|NCT04093492|520098249|FG000|30 Weeks GA|Delivered before assessment|1|||
144246182|NCT04093492|520098250|FG001|30 Weeks GA|Delivered before assessment|2|||
144246183|NCT04093492|520098251|FG002|30 Weeks GA|Delivered before assessment|0|||
144246184|NCT04093492|520098252|FG003|30 Weeks GA|Delivered before assessment|0|||
144246185|NCT04093492|520098249|FG000|30 Weeks GA|No response|7|||
144246186|NCT04093492|520098250|FG001|30 Weeks GA|No response|5|||
144246187|NCT04093492|520098251|FG002|30 Weeks GA|No response|5|||
144246188|NCT04093492|520098252|FG003|30 Weeks GA|No response|2|||
144246189|NCT04093492|520098249|FG000|30 Weeks GA|Lost to Follow-up|0|||
144246190|NCT04093492|520098250|FG001|30 Weeks GA|Lost to Follow-up|1|||
144246191|NCT04093492|520098251|FG002|30 Weeks GA|Lost to Follow-up|0|||
144246192|NCT04093492|520098252|FG003|30 Weeks GA|Lost to Follow-up|0|||
144246193|NCT04093492|520098249|FG000|34 Weeks GA|Delivered before assessment|6|||
144289575|NCT01392495|520262303|FG000|Overall Study|Death|3|||
144289576|NCT01392495|520262303|FG000|Overall Study|Administrative problems|8|||
144289577|NCT01392495|520262303|FG000|Overall Study|Withdrawal by Subject|2|||
144289578|NCT01392495|520262303|FG000|Overall Study|Adverse Event|3|||
144289579|NCT01452789|520262313|FG000|Overall Study|Withdrawal by Subject|3|||
144289580|NCT01452789|520262314|FG001|Overall Study|Withdrawal by Subject|2|||
144289581|NCT01796470|520262315|FG000|Overall Study|Adverse Event|4|||
144289582|NCT01796470|520262316|FG001|Overall Study|Adverse Event|2|||
144289583|NCT01796470|520262317|FG002|Overall Study|Adverse Event|2|||
144289584|NCT01796470|520262318|FG003|Overall Study|Adverse Event|1|||
144289585|NCT01796470|520262319|FG004|Overall Study|Adverse Event|3|||
144289586|NCT01796470|520262315|FG000|Overall Study|Death|2|||
144289587|NCT01796470|520262316|FG001|Overall Study|Death|0|||
144289588|NCT01796470|520262317|FG002|Overall Study|Death|0|||
144289589|NCT01796470|520262318|FG003|Overall Study|Death|0|||
144289590|NCT01796470|520262319|FG004|Overall Study|Death|1|||
144289591|NCT01796470|520262315|FG000|Overall Study|Initiated New Therapy|9|||
144289592|NCT01796470|520262316|FG001|Overall Study|Initiated New Therapy|0|||
144289593|NCT01796470|520262317|FG002|Overall Study|Initiated New Therapy|0|||
144289594|NCT01796470|520262318|FG003|Overall Study|Initiated New Therapy|0|||
144289595|NCT01796470|520262319|FG004|Overall Study|Initiated New Therapy|2|||
144289596|NCT01796470|520262315|FG000|Overall Study|Lost to Follow-up|0|||
144289597|NCT01796470|520262316|FG001|Overall Study|Lost to Follow-up|1|||
144289598|NCT01796470|520262317|FG002|Overall Study|Lost to Follow-up|0|||
144289599|NCT01796470|520262318|FG003|Overall Study|Lost to Follow-up|0|||
144289600|NCT01796470|520262319|FG004|Overall Study|Lost to Follow-up|0|||
144289601|NCT01796470|520262315|FG000|Overall Study|Physician Decision|5|||
144289602|NCT01796470|520262316|FG001|Overall Study|Physician Decision|4|||
144289603|NCT01796470|520262317|FG002|Overall Study|Physician Decision|1|||
144289604|NCT01796470|520262318|FG003|Overall Study|Physician Decision|0|||
144289605|NCT01796470|520262319|FG004|Overall Study|Physician Decision|1|||
144289606|NCT01796470|520262315|FG000|Overall Study|Progressive Disease|7|||
144289607|NCT01796470|520262316|FG001|Overall Study|Progressive Disease|7|||
144289608|NCT01796470|520262317|FG002|Overall Study|Progressive Disease|3|||
144289609|NCT01796470|520262318|FG003|Overall Study|Progressive Disease|2|||
144289610|NCT01796470|520262319|FG004|Overall Study|Progressive Disease|0|||
144289611|NCT01796470|520262315|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
144289612|NCT01796470|520262316|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
144289613|NCT01796470|520262317|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
144289614|NCT01796470|520262318|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
144289615|NCT01796470|520262319|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
144289616|NCT01796470|520262315|FG000|Overall Study|Withdrawal by Subject|7|||
144289617|NCT01796470|520262316|FG001|Overall Study|Withdrawal by Subject|0|||
144289618|NCT01796470|520262317|FG002|Overall Study|Withdrawal by Subject|0|||
144289619|NCT01796470|520262318|FG003|Overall Study|Withdrawal by Subject|0|||
144289620|NCT01796470|520262319|FG004|Overall Study|Withdrawal by Subject|1|||
144289621|NCT00147537|520262320|FG000|Phase 1b|Death|0|||
144289622|NCT00147537|520262321|FG001|Phase 1b|Death|1|||
144289623|NCT00147537|520262322|FG002|Phase 1b|Death|2|||
144289624|NCT00147537|520262323|FG003|Phase 1b|Death|1|||
144289625|NCT00147537|520262324|FG004|Phase 1b|Death|2|||
144289626|NCT00147537|520262325|FG005|Phase 1b|Death|2|||
144289627|NCT00147537|520262326|FG006|Phase 1b|Death|1|||
144289628|NCT00147537|520262327|FG007|Phase 1b|Death|3|||
144289629|NCT00147537|520262328|FG008|Phase 1b|Death|9|||
144289630|NCT00147537|520262329|FG009|Phase 1b|Death|0|||
144289631|NCT00147537|520262330|FG010|Phase 1b|Death|0|||
144289632|NCT00147537|520262320|FG000|Phase 1b|Lost to Follow-up|2|||
144289633|NCT00147537|520262321|FG001|Phase 1b|Lost to Follow-up|1|||
144289634|NCT00147537|520262322|FG002|Phase 1b|Lost to Follow-up|0|||
144289635|NCT00147537|520262323|FG003|Phase 1b|Lost to Follow-up|0|||
144289636|NCT00147537|520262324|FG004|Phase 1b|Lost to Follow-up|0|||
144289637|NCT00147537|520262325|FG005|Phase 1b|Lost to Follow-up|0|||
144289638|NCT00147537|520262326|FG006|Phase 1b|Lost to Follow-up|2|||
144289639|NCT00147537|520262327|FG007|Phase 1b|Lost to Follow-up|0|||
144289640|NCT00147537|520262328|FG008|Phase 1b|Lost to Follow-up|1|||
144289641|NCT00147537|520262329|FG009|Phase 1b|Lost to Follow-up|0|||
144289642|NCT00147537|520262330|FG010|Phase 1b|Lost to Follow-up|0|||
144289643|NCT00147537|520262320|FG000|Phase 1b|Other|0|||
144289644|NCT00147537|520262321|FG001|Phase 1b|Other|0|||
144289645|NCT00147537|520262322|FG002|Phase 1b|Other|2|||
144289646|NCT00147537|520262323|FG003|Phase 1b|Other|1|||
144289647|NCT00147537|520262324|FG004|Phase 1b|Other|1|||
144289648|NCT00147537|520262325|FG005|Phase 1b|Other|1|||
144289649|NCT00147537|520262326|FG006|Phase 1b|Other|14|||
144289650|NCT00147537|520262327|FG007|Phase 1b|Other|4|||
144289651|NCT00147537|520262328|FG008|Phase 1b|Other|4|||
144289652|NCT00147537|520262329|FG009|Phase 1b|Other|0|||
144246194|NCT04093492|520098250|FG001|34 Weeks GA|Delivered before assessment|3|||
144246195|NCT04093492|520098251|FG002|34 Weeks GA|Delivered before assessment|0|||
144246196|NCT04093492|520098252|FG003|34 Weeks GA|Delivered before assessment|0|||
144246197|NCT04093492|520098249|FG000|34 Weeks GA|No response|0|||
144246198|NCT04093492|520098250|FG001|34 Weeks GA|No response|7|||
144246199|NCT04093492|520098251|FG002|34 Weeks GA|No response|5|||
144246200|NCT04093492|520098252|FG003|34 Weeks GA|No response|3|||
144246201|NCT04093492|520098249|FG000|34 Weeks GA|Lost to Follow-up|0|||
144246202|NCT04093492|520098250|FG001|34 Weeks GA|Lost to Follow-up|1|||
144246203|NCT04093492|520098251|FG002|34 Weeks GA|Lost to Follow-up|0|||
144246204|NCT04093492|520098252|FG003|34 Weeks GA|Lost to Follow-up|0|||
144246205|NCT00006305|520098258|FG000|Overall Study|Withdrawal by Subject|17|||
144246206|NCT00006305|520098259|FG001|Overall Study|Withdrawal by Subject|10|||
144246207|NCT00006305|520098260|FG002|Overall Study|Withdrawal by Subject|15|||
144246208|NCT00006305|520098261|FG003|Overall Study|Withdrawal by Subject|14|||
144246209|NCT00662558|520098262|FG000|Overall Study|Adverse Event|21|||
144246210|NCT00662558|520098263|FG001|Overall Study|Adverse Event|59|||
144246211|NCT00662558|520098262|FG000|Overall Study|Lack of Efficacy|4|||
144246212|NCT00662558|520098263|FG001|Overall Study|Lack of Efficacy|7|||
144246213|NCT00662558|520098262|FG000|Overall Study|Lost to Follow-up|13|||
144246214|NCT00662558|520098263|FG001|Overall Study|Lost to Follow-up|10|||
144246215|NCT00662558|520098262|FG000|Overall Study|Other|9|||
144246216|NCT00662558|520098263|FG001|Overall Study|Other|14|||
144246217|NCT00662558|520098262|FG000|Overall Study|Withdrawal by Subject|7|||
144246218|NCT00662558|520098263|FG001|Overall Study|Withdrawal by Subject|12|||
144246219|NCT00662558|520098262|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
144246220|NCT00662558|520098263|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
144246221|NCT00783224|520098266|FG000|Overall Study|Adverse Event|0|||
144246222|NCT00783224|520098267|FG001|Overall Study|Adverse Event|0|||
144246223|NCT00783224|520098268|FG002|Overall Study|Adverse Event|1|||
144246224|NCT00783224|520098269|FG003|Overall Study|Adverse Event|0|||
144246225|NCT00783224|520098266|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
144246226|NCT00783224|520098267|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
144246227|NCT00783224|520098268|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
144246228|NCT00783224|520098269|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
144246229|NCT00783224|520098266|FG000|Overall Study|Inappropriate as a study subject|0|||
144246230|NCT00783224|520098267|FG001|Overall Study|Inappropriate as a study subject|0|||
144246231|NCT00783224|520098268|FG002|Overall Study|Inappropriate as a study subject|0|||
144246232|NCT00783224|520098269|FG003|Overall Study|Inappropriate as a study subject|1|||
144246233|NCT01711619|520098270|FG000|Overall Study|Early study termination|10|||
144246234|NCT01711619|520098271|FG001|Overall Study|Early study termination|14|||
144246235|NCT01711619|520098270|FG000|Overall Study|Withdrawal by Subject|3|||
144246236|NCT01711619|520098271|FG001|Overall Study|Withdrawal by Subject|7|||
144246237|NCT01711619|520098270|FG000|Overall Study|Protocol Violation|2|||
144246238|NCT01711619|520098271|FG001|Overall Study|Protocol Violation|3|||
144246239|NCT01711619|520098270|FG000|Overall Study|Adverse Event|2|||
144246240|NCT01711619|520098271|FG001|Overall Study|Adverse Event|0|||
144246241|NCT01711619|520098270|FG000|Overall Study|Lost to Follow-up|1|||
144246242|NCT01711619|520098271|FG001|Overall Study|Lost to Follow-up|0|||
144246243|NCT00503997|520098282|FG000|Overall Study|disease progression|1|||
144246244|NCT00503997|520098282|FG000|Overall Study|Adverse Event|5|||
144246245|NCT00503997|520098282|FG000|Overall Study|Death|1|||
144246246|NCT00503997|520098282|FG000|Overall Study|Withdrawal by Subject|1|||
144246247|NCT01195844|520098283|FG000|Overall Study|Fecal sample not collected|40|||
144246248|NCT00087126|520098287|FG000|Overall Study|Ineligible - second primary|1|||
144246249|NCT00087126|520098287|FG000|Overall Study|Never treated|1|||
144246250|NCT01432275|520098288|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
144246251|NCT01432275|520098289|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
144246252|NCT01432275|520098288|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
144246253|NCT01432275|520098289|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
144246254|NCT01432275|520098288|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
144246255|NCT01432275|520098289|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
144246256|NCT01432275|520098288|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
144246257|NCT01432275|520098289|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
144246258|NCT01432275|520098288|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
144246259|NCT01432275|520098289|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
144246260|NCT01432275|520098288|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
144246261|NCT01432275|520098289|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
144246262|NCT01432275|520098288|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
144289653|NCT00147537|520262330|FG010|Phase 1b|Other|0|||
144289654|NCT00147537|520262320|FG000|Phase 1b|Withdrawal by Subject|0|||
144289655|NCT00147537|520262321|FG001|Phase 1b|Withdrawal by Subject|0|||
144289656|NCT00147537|520262322|FG002|Phase 1b|Withdrawal by Subject|0|||
144289657|NCT00147537|520262323|FG003|Phase 1b|Withdrawal by Subject|0|||
144289658|NCT00147537|520262324|FG004|Phase 1b|Withdrawal by Subject|0|||
144289659|NCT00147537|520262325|FG005|Phase 1b|Withdrawal by Subject|0|||
144289660|NCT00147537|520262326|FG006|Phase 1b|Withdrawal by Subject|0|||
144246263|NCT01432275|520098289|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
144246264|NCT01432275|520098288|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
144246265|NCT01432275|520098289|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
144246266|NCT01432275|520098288|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
144246267|NCT01432275|520098289|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
144246268|NCT01935700|520098292|FG000|Overall Study|Withdrawal by Subject|1|||
144246269|NCT01935700|520098293|FG001|Overall Study|Withdrawal by Subject|0|||
144246270|NCT01935700|520098292|FG000|Overall Study|Physician Decision|4|||
144246271|NCT01935700|520098293|FG001|Overall Study|Physician Decision|0|||
144246272|NCT01440569|520098295|FG000|Main Study|Enrolled but not treated|1|||
144246273|NCT01440569|520098296|FG001|Main Study|Enrolled but not treated|0|||
144246274|NCT01440569|520098295|FG000|Main Study|Adverse Event|9|||
144246275|NCT01440569|520098296|FG001|Main Study|Adverse Event|0|||
144246276|NCT01440569|520098295|FG000|Main Study|Pregnancy|1|||
144246277|NCT01440569|520098296|FG001|Main Study|Pregnancy|0|||
144246278|NCT01440569|520098295|FG000|Main Study|Investigator's Discretion|1|||
144246279|NCT01440569|520098296|FG001|Main Study|Investigator's Discretion|1|||
144246280|NCT01440569|520098295|FG000|Main Study|Withdrew Consent|7|||
144246281|NCT01440569|520098296|FG001|Main Study|Withdrew Consent|1|||
144246282|NCT01440569|520098295|FG000|Main Study|Lost to Follow-up|13|||
144246283|NCT01440569|520098296|FG001|Main Study|Lost to Follow-up|2|||
144246284|NCT01440569|520098295|FG000|Main Study|Subject Non-Compliance|3|||
144246285|NCT01440569|520098296|FG001|Main Study|Subject Non-Compliance|0|||
144246286|NCT01440569|520098295|FG000|Main Study|Protocol Violation|1|||
144246287|NCT01440569|520098296|FG001|Main Study|Protocol Violation|0|||
144246288|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Adverse Event|3|||
144246289|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Adverse Event|0|||
144246290|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Pregnancy|1|||
144246291|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Pregnancy|0|||
144246292|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
144246293|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
144246294|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
144246295|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
144246296|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
144246297|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
144246298|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
144246299|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
144246300|NCT01440569|520098295|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
144246301|NCT01440569|520098296|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
144246302|NCT03689543|520098300|FG000|Overall Study|Adverse Event|0|||
144246303|NCT03689543|520098301|FG001|Overall Study|Adverse Event|0|||
144246304|NCT03689543|520098302|FG002|Overall Study|Adverse Event|1|||
144246305|NCT00932451|520098303|FG000|Overall Study|Withdrawal by Subject|69|||
144246306|NCT00932451|520098303|FG000|Overall Study|Lost to Follow-up|22|||
144246307|NCT00932451|520098303|FG000|Overall Study|Death|726|||
144246308|NCT00932451|520098303|FG000|Overall Study|Other reasons|5|||
144246309|NCT01634659|520098321|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
144246310|NCT01634659|520098322|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
144246311|NCT01634659|520098321|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
144246312|NCT01634659|520098322|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
144246313|NCT03627416|520098323|FG000|Overall Study|Adverse Event|0|||
144246314|NCT03627416|520098324|FG001|Overall Study|Adverse Event|1|||
144246315|NCT02968433|520098325|FG000|Overall Study|Withdrawal by Subject|1|||
144246316|NCT01294371|520098326|FG000|Overall Study|Adverse Event|1|||
144246317|NCT01294371|520098326|FG000|Overall Study|Withdrawal by Subject|12|||
144289661|NCT00147537|520262327|FG007|Phase 1b|Withdrawal by Subject|0|||
144246318|NCT01294371|520098326|FG000|Overall Study|Lost to Follow-up|6|||
144246319|NCT01294371|520098326|FG000|Overall Study|Administrative Reason|1|||
144246320|NCT01294371|520098326|FG000|Overall Study|Other|14|||
144246321|NCT05619536|520098327|FG000|Overall Study|Withdrawal by Subject|0|||
144246322|NCT05619536|520098328|FG001|Overall Study|Withdrawal by Subject|1|||
144246323|NCT05619536|520098329|FG002|Overall Study|Withdrawal by Subject|0|||
144246324|NCT05619536|520098330|FG003|Overall Study|Withdrawal by Subject|1|||
144246325|NCT05619536|520098327|FG000|Overall Study|Lost to Follow-up|0|||
144246326|NCT05619536|520098328|FG001|Overall Study|Lost to Follow-up|1|||
144246327|NCT05619536|520098329|FG002|Overall Study|Lost to Follow-up|1|||
144246328|NCT05619536|520098330|FG003|Overall Study|Lost to Follow-up|0|||
144289662|NCT00147537|520262328|FG008|Phase 1b|Withdrawal by Subject|2|||
144289663|NCT00147537|520262329|FG009|Phase 1b|Withdrawal by Subject|0|||
144289664|NCT00147537|520262330|FG010|Phase 1b|Withdrawal by Subject|0|||
144289665|NCT00147537|520262320|FG000|Phase 1b|Randomized but not treated|0|||
144289666|NCT00147537|520262321|FG001|Phase 1b|Randomized but not treated|0|||
144289667|NCT00147537|520262322|FG002|Phase 1b|Randomized but not treated|0|||
144289668|NCT00147537|520262323|FG003|Phase 1b|Randomized but not treated|0|||
144289669|NCT00147537|520262324|FG004|Phase 1b|Randomized but not treated|0|||
144289670|NCT00147537|520262325|FG005|Phase 1b|Randomized but not treated|0|||
144289671|NCT00147537|520262326|FG006|Phase 1b|Randomized but not treated|1|||
144289672|NCT00147537|520262327|FG007|Phase 1b|Randomized but not treated|0|||
144289673|NCT00147537|520262328|FG008|Phase 1b|Randomized but not treated|1|||
144289674|NCT00147537|520262329|FG009|Phase 1b|Randomized but not treated|0|||
144289675|NCT00147537|520262330|FG010|Phase 1b|Randomized but not treated|0|||
144289676|NCT00147537|520262320|FG000|Phase 2|Death|0|||
144289677|NCT00147537|520262321|FG001|Phase 2|Death|0|||
144289678|NCT00147537|520262322|FG002|Phase 2|Death|0|||
144289679|NCT00147537|520262323|FG003|Phase 2|Death|0|||
144289680|NCT00147537|520262324|FG004|Phase 2|Death|0|||
144289681|NCT00147537|520262325|FG005|Phase 2|Death|0|||
144289682|NCT00147537|520262326|FG006|Phase 2|Death|0|||
144289683|NCT00147537|520262327|FG007|Phase 2|Death|0|||
144289684|NCT00147537|520262328|FG008|Phase 2|Death|0|||
144289685|NCT00147537|520262329|FG009|Phase 2|Death|85|||
144289686|NCT00147537|520262330|FG010|Phase 2|Death|31|||
144289687|NCT00147537|520262320|FG000|Phase 2|Lost to Follow-up|0|||
144289688|NCT00147537|520262321|FG001|Phase 2|Lost to Follow-up|0|||
144289689|NCT00147537|520262322|FG002|Phase 2|Lost to Follow-up|0|||
144289690|NCT00147537|520262323|FG003|Phase 2|Lost to Follow-up|0|||
144289691|NCT00147537|520262324|FG004|Phase 2|Lost to Follow-up|0|||
144289692|NCT00147537|520262325|FG005|Phase 2|Lost to Follow-up|0|||
144289693|NCT00147537|520262326|FG006|Phase 2|Lost to Follow-up|0|||
144289694|NCT00147537|520262327|FG007|Phase 2|Lost to Follow-up|0|||
144289695|NCT00147537|520262328|FG008|Phase 2|Lost to Follow-up|0|||
144289696|NCT00147537|520262329|FG009|Phase 2|Lost to Follow-up|12|||
144289697|NCT00147537|520262330|FG010|Phase 2|Lost to Follow-up|4|||
144289698|NCT00147537|520262320|FG000|Phase 2|Other|0|||
144289699|NCT00147537|520262321|FG001|Phase 2|Other|0|||
144289700|NCT00147537|520262322|FG002|Phase 2|Other|0|||
144289701|NCT00147537|520262323|FG003|Phase 2|Other|0|||
144289702|NCT00147537|520262324|FG004|Phase 2|Other|0|||
144289703|NCT00147537|520262325|FG005|Phase 2|Other|0|||
144289704|NCT00147537|520262326|FG006|Phase 2|Other|0|||
144289705|NCT00147537|520262327|FG007|Phase 2|Other|0|||
144289706|NCT00147537|520262328|FG008|Phase 2|Other|0|||
144289707|NCT00147537|520262329|FG009|Phase 2|Other|47|||
144289708|NCT00147537|520262330|FG010|Phase 2|Other|12|||
144289709|NCT00147537|520262320|FG000|Phase 2|Withdrawal by Subject|0|||
144289710|NCT00147537|520262321|FG001|Phase 2|Withdrawal by Subject|0|||
144289711|NCT00147537|520262322|FG002|Phase 2|Withdrawal by Subject|0|||
144289712|NCT00147537|520262323|FG003|Phase 2|Withdrawal by Subject|0|||
144289713|NCT00147537|520262324|FG004|Phase 2|Withdrawal by Subject|0|||
144289714|NCT00147537|520262325|FG005|Phase 2|Withdrawal by Subject|0|||
144289715|NCT00147537|520262326|FG006|Phase 2|Withdrawal by Subject|0|||
144289716|NCT00147537|520262327|FG007|Phase 2|Withdrawal by Subject|0|||
144289717|NCT00147537|520262328|FG008|Phase 2|Withdrawal by Subject|0|||
144289718|NCT00147537|520262329|FG009|Phase 2|Withdrawal by Subject|16|||
144289719|NCT00147537|520262330|FG010|Phase 2|Withdrawal by Subject|4|||
144289720|NCT00147537|520262320|FG000|Phase 2|Randomized but not treated|0|||
144289721|NCT00147537|520262321|FG001|Phase 2|Randomized but not treated|0|||
144289722|NCT00147537|520262322|FG002|Phase 2|Randomized but not treated|0|||
144289723|NCT00147537|520262323|FG003|Phase 2|Randomized but not treated|0|||
144289724|NCT00147537|520262324|FG004|Phase 2|Randomized but not treated|0|||
144289725|NCT00147537|520262325|FG005|Phase 2|Randomized but not treated|0|||
144289726|NCT00147537|520262326|FG006|Phase 2|Randomized but not treated|0|||
144289727|NCT00147537|520262327|FG007|Phase 2|Randomized but not treated|0|||
144246329|NCT00875433|520098331|FG000|Overall Study|Progressive disease|41|||
144246330|NCT00875433|520098331|FG000|Overall Study|Other Adverse Event|14|||
144246331|NCT00875433|520098331|FG000|Overall Study|Withdrawal by Subject|2|||
144246332|NCT00875433|520098331|FG000|Overall Study|Other|3|||
144246333|NCT00637806|520098332|FG000|Double-blind Phase|Study Discontinued|2|||
144246334|NCT00637806|520098333|FG001|Double-blind Phase|Study Discontinued|0|||
144246335|NCT00637806|520098334|FG002|Double-blind Phase|Study Discontinued|1|||
144246336|NCT00637806|520098335|FG003|Double-blind Phase|Study Discontinued|0|||
144246337|NCT00637806|520098332|FG000|Extension Phase|Study Discontinued|0|||
144246338|NCT00637806|520098333|FG001|Extension Phase|Study Discontinued|0|||
144246339|NCT00637806|520098334|FG002|Extension Phase|Study Discontinued|0|||
144246340|NCT00637806|520098335|FG003|Extension Phase|Study Discontinued|1|||
144246341|NCT04272606|520098336|FG000|Overall Study|Protocol Violation|1|||
144246342|NCT04272606|520098337|FG001|Overall Study|Protocol Violation|1|||
144246343|NCT04272606|520098336|FG000|Overall Study|Physician Decision|0|||
144246344|NCT04272606|520098337|FG001|Overall Study|Physician Decision|1|||
144246345|NCT00725101|520098338|FG000|Overall Study|Death|3|||
144246346|NCT00725101|520098338|FG000|Overall Study|Lost to Follow-up|353|||
144246347|NCT00725101|520098338|FG000|Overall Study|Protocol Violation|1|||
144246348|NCT00725101|520098338|FG000|Overall Study|Withdrawal by Subject|127|||
144246349|NCT00725101|520098338|FG000|Overall Study|not specified/no reason given|11|||
144246350|NCT01592292|520098339|FG000|Overall Study|Follow-up loss|3|||
144246351|NCT01592292|520098340|FG001|Overall Study|Follow-up loss|3|||
144246352|NCT01592292|520098341|FG002|Overall Study|Follow-up loss|1|||
144246353|NCT01592292|520098342|FG003|Overall Study|Follow-up loss|0|||
144246354|NCT01592292|520098339|FG000|Overall Study|Withdrew consent|2|||
144246355|NCT01592292|520098340|FG001|Overall Study|Withdrew consent|1|||
144246356|NCT01592292|520098341|FG002|Overall Study|Withdrew consent|0|||
144246357|NCT01592292|520098342|FG003|Overall Study|Withdrew consent|0|||
144246358|NCT01592292|520098339|FG000|Overall Study|Other|1|||
144246359|NCT01592292|520098340|FG001|Overall Study|Other|1|||
144246360|NCT01592292|520098341|FG002|Overall Study|Other|2|||
144246361|NCT01592292|520098342|FG003|Overall Study|Other|1|||
144246362|NCT00819780|520098343|FG000|Overall Study|Did not receive study drug|3|||
144246363|NCT00819780|520098344|FG001|Overall Study|Did not receive study drug|4|||
144246364|NCT00819780|520098343|FG000|Overall Study|Still in treatment|25|||
144246365|NCT00819780|520098344|FG001|Overall Study|Still in treatment|17|||
144246366|NCT00622336|520098345|FG000|Treatment Phase|Progression of Disease|181|||
144246367|NCT00622336|520098345|FG000|Treatment Phase|Adverse Event|46|||
144246368|NCT00622336|520098345|FG000|Treatment Phase|Other|40|||
144246369|NCT00622336|520098345|FG000|Treatment Phase|Death|14|||
144246370|NCT00622336|520098345|FG000|Treatment Phase|Lack of therapeutic effect|13|||
144246371|NCT00622336|520098345|FG000|Treatment Phase|Withdrawal by Subject|13|||
144246372|NCT00622336|520098345|FG000|Treatment Phase|Lost to Follow-up|2|||
144246373|NCT00622336|520098345|FG000|Extension Phase|Adverse Event|2|||
144246374|NCT00622336|520098345|FG000|Extension Phase|Progressive Disease|6|||
144246375|NCT00622336|520098345|FG000|Extension Phase|Lack of therapeutic effect|2|||
144246376|NCT00622336|520098345|FG000|Extension Phase|Withdrawal by Subject|1|||
144246377|NCT00622336|520098345|FG000|Extension Phase|Lost to Follow-up|1|||
144246378|NCT00622336|520098345|FG000|Extension Phase|Other|9|||
144246379|NCT02520427|520098346|FG000|Overall Study|Decision by sponsor|0|||
144246380|NCT02520427|520098347|FG001|Overall Study|Decision by sponsor|0|||
144246381|NCT02520427|520098348|FG002|Overall Study|Decision by sponsor|0|||
144246382|NCT02520427|520098349|FG003|Overall Study|Decision by sponsor|0|||
144246383|NCT02520427|520098350|FG004|Overall Study|Decision by sponsor|0|||
144246384|NCT02520427|520098351|FG005|Overall Study|Decision by sponsor|0|||
144246385|NCT02520427|520098352|FG006|Overall Study|Decision by sponsor|0|||
144289728|NCT00147537|520262328|FG008|Phase 2|Randomized but not treated|0|||
144289729|NCT00147537|520262329|FG009|Phase 2|Randomized but not treated|1|||
144246386|NCT02520427|520098353|FG007|Overall Study|Decision by sponsor|0|||
144246387|NCT02520427|520098354|FG008|Overall Study|Decision by sponsor|1|||
144246388|NCT02520427|520098355|FG009|Overall Study|Decision by sponsor|1|||
144246389|NCT02520427|520098356|FG010|Overall Study|Decision by sponsor|0|||
144246390|NCT02520427|520098357|FG011|Overall Study|Decision by sponsor|0|||
144246391|NCT02520427|520098358|FG012|Overall Study|Decision by sponsor|0|||
144246392|NCT02520427|520098359|FG013|Overall Study|Decision by sponsor|0|||
144246393|NCT02520427|520098360|FG014|Overall Study|Decision by sponsor|0|||
144246394|NCT02520427|520098361|FG015|Overall Study|Decision by sponsor|0|||
144246395|NCT02520427|520098362|FG016|Overall Study|Decision by sponsor|0|||
144246396|NCT02520427|520098363|FG017|Overall Study|Decision by sponsor|0|||
144246397|NCT02520427|520098364|FG018|Overall Study|Decision by sponsor|0|||
144289730|NCT00147537|520262330|FG010|Phase 2|Randomized but not treated|1|||
144289731|NCT01089543|520262331|FG000|Overall Study|Withdrawal by Subject|2|||
144289732|NCT01089543|520262332|FG001|Overall Study|Withdrawal by Subject|3|||
144289733|NCT01089543|520262333|FG002|Overall Study|Withdrawal by Subject|3|||
144289734|NCT01089543|520262334|FG003|Overall Study|Withdrawal by Subject|1|||
144289735|NCT01089543|520262331|FG000|Overall Study|Physician Decision|1|||
144289736|NCT01089543|520262332|FG001|Overall Study|Physician Decision|0|||
144289737|NCT01089543|520262333|FG002|Overall Study|Physician Decision|0|||
144289738|NCT01089543|520262334|FG003|Overall Study|Physician Decision|1|||
144289739|NCT01089543|520262331|FG000|Overall Study|Adverse Event|0|||
144289740|NCT01089543|520262332|FG001|Overall Study|Adverse Event|1|||
144289741|NCT01089543|520262333|FG002|Overall Study|Adverse Event|0|||
144289742|NCT01089543|520262334|FG003|Overall Study|Adverse Event|0|||
144289743|NCT00468546|520262336|FG000|Week 24 Analysis|Lack of Efficacy|83|||
144289744|NCT00468546|520262337|FG001|Week 24 Analysis|Lack of Efficacy|37|||
144289745|NCT00468546|520262336|FG000|Week 24 Analysis|Refused treatment|5|||
144289746|NCT00468546|520262337|FG001|Week 24 Analysis|Refused treatment|5|||
144289747|NCT00468546|520262336|FG000|Week 24 Analysis|Adverse Event|1|||
144289748|NCT00468546|520262337|FG001|Week 24 Analysis|Adverse Event|8|||
144289749|NCT00468546|520262336|FG000|Week 24 Analysis|Failure to return|3|||
144289750|NCT00468546|520262337|FG001|Week 24 Analysis|Failure to return|4|||
144289751|NCT00468546|520262336|FG000|Week 24 Analysis|Rescue therapy|2|||
144289752|NCT00468546|520262337|FG001|Week 24 Analysis|Rescue therapy|0|||
144289753|NCT00468546|520262336|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
144289754|NCT00468546|520262337|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
144289755|NCT00468546|520262336|FG000|Week 24 Analysis|Due to clinical hold|1|||
144289756|NCT00468546|520262337|FG001|Week 24 Analysis|Due to clinical hold|0|||
144289757|NCT00468546|520262336|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
144289758|NCT00468546|520262337|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
144289759|NCT00468546|520262336|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
144289760|NCT00468546|520262337|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
144289761|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
144289762|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
144289763|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Death|1|||
144289764|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Death|0|||
144289765|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
144289766|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
144289767|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
144289768|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
144289769|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
144289770|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
144289771|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
144289772|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
144289773|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
144289774|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
144289775|NCT00468546|520262336|FG000|Week 24 to Week 104 Analysis|Other|17|||
144289776|NCT00468546|520262337|FG001|Week 24 to Week 104 Analysis|Other|14|||
144289777|NCT00472641|520262339|FG000|Overall Study|Lack of Efficacy|3|||
144289778|NCT00472641|520262339|FG000|Overall Study|Adverse Event|3|||
144289779|NCT00472641|520262339|FG000|Overall Study|Lost to Follow-up|1|||
144289780|NCT01905267|520262342|FG000|Overall Study|Physician Decision|2|||
144289781|NCT01905267|520262343|FG001|Overall Study|Physician Decision|2|||
144289782|NCT03438656|520262344|FG000|Overall Study|Lost to Follow-up|2|||
144289783|NCT02991859|520262347|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289784|NCT02991859|520262348|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
144289785|NCT02991859|520262349|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289786|NCT02991859|520262350|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289787|NCT02991859|520262351|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
144289788|NCT02991859|520262352|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289789|NCT02991859|520262353|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289790|NCT02991859|520262354|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289791|NCT02991859|520262355|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289792|NCT02991859|520262356|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289793|NCT02991859|520262357|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289794|NCT02991859|520262358|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289795|NCT02991859|520262359|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289796|NCT02991859|520262360|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289797|NCT02991859|520262361|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289798|NCT02991859|520262362|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289799|NCT02991859|520262363|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
144289800|NCT02991859|520262347|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289801|NCT02991859|520262348|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289802|NCT02991859|520262349|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289803|NCT02991859|520262350|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289804|NCT02991859|520262351|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289805|NCT02991859|520262352|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289806|NCT02991859|520262353|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289807|NCT02991859|520262354|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289808|NCT02991859|520262355|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289809|NCT02991859|520262356|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289810|NCT02991859|520262357|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289811|NCT02991859|520262358|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289812|NCT02991859|520262359|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
144289813|NCT02991859|520262360|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
144289814|NCT02991859|520262361|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289815|NCT02991859|520262362|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289816|NCT02991859|520262363|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
144289817|NCT02991859|520262347|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289818|NCT02991859|520262348|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289819|NCT02991859|520262349|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289820|NCT02991859|520262350|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289821|NCT02991859|520262351|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289822|NCT02991859|520262352|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
144289823|NCT02991859|520262353|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289824|NCT02991859|520262354|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289825|NCT02991859|520262355|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289826|NCT02991859|520262356|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289827|NCT02991859|520262357|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289828|NCT02991859|520262358|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289829|NCT02991859|520262359|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289830|NCT02991859|520262360|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289831|NCT02991859|520262361|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289832|NCT02991859|520262362|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289833|NCT02991859|520262363|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
144289834|NCT02991859|520262347|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289835|NCT02991859|520262348|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289836|NCT02991859|520262349|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289837|NCT02991859|520262350|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289838|NCT02991859|520262351|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289839|NCT02991859|520262352|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289840|NCT02991859|520262353|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289841|NCT02991859|520262354|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289842|NCT02991859|520262355|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289843|NCT02991859|520262356|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
144289844|NCT02991859|520262357|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289845|NCT02991859|520262358|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289846|NCT02991859|520262359|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289847|NCT02991859|520262360|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289848|NCT02991859|520262361|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289849|NCT02991859|520262362|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289850|NCT02991859|520262363|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
144289851|NCT02991859|520262347|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289852|NCT02991859|520262348|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289853|NCT02991859|520262349|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289854|NCT02991859|520262350|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289855|NCT02991859|520262351|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289856|NCT02991859|520262352|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289857|NCT02991859|520262353|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289858|NCT02991859|520262354|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289859|NCT02991859|520262355|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
144289860|NCT02991859|520262356|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289861|NCT02991859|520262357|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289862|NCT02991859|520262358|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289863|NCT02991859|520262359|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144246398|NCT02520427|520098365|FG019|Overall Study|Decision by sponsor|0|||
144246399|NCT02520427|520098366|FG020|Overall Study|Decision by sponsor|0|||
144246400|NCT02520427|520098367|FG021|Overall Study|Decision by sponsor|0|||
144246401|NCT02520427|520098368|FG022|Overall Study|Decision by sponsor|0|||
144246402|NCT02520427|520098369|FG023|Overall Study|Decision by sponsor|0|||
144246403|NCT02520427|520098370|FG024|Overall Study|Decision by sponsor|0|||
144246404|NCT02520427|520098371|FG025|Overall Study|Decision by sponsor|0|||
144246405|NCT02520427|520098346|FG000|Overall Study|Withdrawal by Subject|0|||
144246406|NCT02520427|520098347|FG001|Overall Study|Withdrawal by Subject|0|||
144246407|NCT02520427|520098348|FG002|Overall Study|Withdrawal by Subject|1|||
144246408|NCT02520427|520098349|FG003|Overall Study|Withdrawal by Subject|0|||
144246409|NCT02520427|520098350|FG004|Overall Study|Withdrawal by Subject|0|||
144246410|NCT02520427|520098351|FG005|Overall Study|Withdrawal by Subject|0|||
144246411|NCT02520427|520098352|FG006|Overall Study|Withdrawal by Subject|0|||
144246412|NCT02520427|520098353|FG007|Overall Study|Withdrawal by Subject|0|||
144246413|NCT02520427|520098354|FG008|Overall Study|Withdrawal by Subject|0|||
144246414|NCT02520427|520098355|FG009|Overall Study|Withdrawal by Subject|0|||
144246415|NCT02520427|520098356|FG010|Overall Study|Withdrawal by Subject|0|||
144246416|NCT02520427|520098357|FG011|Overall Study|Withdrawal by Subject|0|||
144246417|NCT02520427|520098358|FG012|Overall Study|Withdrawal by Subject|1|||
144246418|NCT02520427|520098359|FG013|Overall Study|Withdrawal by Subject|1|||
144246419|NCT02520427|520098360|FG014|Overall Study|Withdrawal by Subject|1|||
144246420|NCT02520427|520098361|FG015|Overall Study|Withdrawal by Subject|0|||
144246421|NCT02520427|520098362|FG016|Overall Study|Withdrawal by Subject|1|||
144246422|NCT02520427|520098363|FG017|Overall Study|Withdrawal by Subject|0|||
144246423|NCT02520427|520098364|FG018|Overall Study|Withdrawal by Subject|0|||
144246424|NCT02520427|520098365|FG019|Overall Study|Withdrawal by Subject|3|||
144246425|NCT02520427|520098366|FG020|Overall Study|Withdrawal by Subject|2|||
144246426|NCT02520427|520098367|FG021|Overall Study|Withdrawal by Subject|0|||
144246427|NCT02520427|520098368|FG022|Overall Study|Withdrawal by Subject|0|||
144246428|NCT02520427|520098369|FG023|Overall Study|Withdrawal by Subject|0|||
144246429|NCT02520427|520098370|FG024|Overall Study|Withdrawal by Subject|0|||
144246430|NCT02520427|520098371|FG025|Overall Study|Withdrawal by Subject|0|||
144246431|NCT02520427|520098346|FG000|Overall Study|Death|1|||
144246432|NCT02520427|520098347|FG001|Overall Study|Death|0|||
144246433|NCT02520427|520098348|FG002|Overall Study|Death|0|||
144246434|NCT02520427|520098349|FG003|Overall Study|Death|0|||
144246435|NCT02520427|520098350|FG004|Overall Study|Death|0|||
144246436|NCT02520427|520098351|FG005|Overall Study|Death|0|||
144246437|NCT02520427|520098352|FG006|Overall Study|Death|0|||
144246438|NCT02520427|520098353|FG007|Overall Study|Death|0|||
144246439|NCT02520427|520098354|FG008|Overall Study|Death|0|||
144246440|NCT02520427|520098355|FG009|Overall Study|Death|0|||
144246441|NCT02520427|520098356|FG010|Overall Study|Death|0|||
144246442|NCT02520427|520098357|FG011|Overall Study|Death|0|||
144246443|NCT02520427|520098358|FG012|Overall Study|Death|0|||
144246444|NCT02520427|520098359|FG013|Overall Study|Death|0|||
144246445|NCT02520427|520098360|FG014|Overall Study|Death|0|||
144246446|NCT02520427|520098361|FG015|Overall Study|Death|0|||
144246447|NCT02520427|520098362|FG016|Overall Study|Death|2|||
144246448|NCT02520427|520098363|FG017|Overall Study|Death|1|||
144246449|NCT02520427|520098364|FG018|Overall Study|Death|3|||
144246450|NCT02520427|520098365|FG019|Overall Study|Death|2|||
144246451|NCT02520427|520098366|FG020|Overall Study|Death|0|||
144246452|NCT02520427|520098367|FG021|Overall Study|Death|0|||
144246453|NCT02520427|520098368|FG022|Overall Study|Death|1|||
144246454|NCT02520427|520098369|FG023|Overall Study|Death|0|||
144246455|NCT02520427|520098370|FG024|Overall Study|Death|1|||
144246456|NCT02520427|520098371|FG025|Overall Study|Death|0|||
144246457|NCT02889835|520098373|FG000|Overall Study|Lost to Follow-up|13|||
144246458|NCT02889835|520098374|FG001|Overall Study|Lost to Follow-up|13|||
144246459|NCT02889835|520098375|FG002|Overall Study|Lost to Follow-up|13|||
144246460|NCT02889835|520098373|FG000|Overall Study|Withdrawal by Subject|2|||
144246461|NCT02889835|520098374|FG001|Overall Study|Withdrawal by Subject|2|||
144246462|NCT02889835|520098375|FG002|Overall Study|Withdrawal by Subject|2|||
144246463|NCT02889835|520098373|FG000|Overall Study|Protocol Violation|1|||
144246464|NCT02889835|520098374|FG001|Overall Study|Protocol Violation|1|||
144246465|NCT02889835|520098375|FG002|Overall Study|Protocol Violation|1|||
144246466|NCT02889835|520098373|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
144246467|NCT02889835|520098374|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
144246468|NCT02889835|520098375|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
144289864|NCT02991859|520262360|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289865|NCT02991859|520262361|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289866|NCT02991859|520262362|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289867|NCT02991859|520262363|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
144289868|NCT03520387|520262366|FG000|Pre-Randomization|Withdrawal by Subject|1|||
144289869|NCT03520387|520262367|FG001|Pre-Randomization|Withdrawal by Subject|0|||
144289870|NCT03520387|520262368|FG002|Pre-Randomization|Withdrawal by Subject|0|||
144289871|NCT03520387|520262369|FG003|Pre-Randomization|Withdrawal by Subject|0|||
144289872|NCT03520387|520262370|FG004|Pre-Randomization|Withdrawal by Subject|0|||
144289873|NCT03520387|520262366|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
144289874|NCT03520387|520262367|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
144289875|NCT03520387|520262368|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
144289876|NCT03520387|520262369|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
144246469|NCT02889835|520098373|FG000|Overall Study|Death|1|||
144246470|NCT02889835|520098374|FG001|Overall Study|Death|1|||
144246471|NCT02889835|520098375|FG002|Overall Study|Death|1|||
144246472|NCT00908596|520100413|FG000|Overall Study|Other reasons|46|||
144246473|NCT00908596|520100414|FG001|Overall Study|Other reasons|6|||
144246474|NCT00908596|520100415|FG002|Overall Study|Other reasons|2|||
144246475|NCT00908596|520100416|FG003|Overall Study|Other reasons|0|||
144246476|NCT00908596|520100413|FG000|Overall Study|Lost to Follow-up|0|||
144246477|NCT00908596|520100414|FG001|Overall Study|Lost to Follow-up|1|||
144246478|NCT00908596|520100415|FG002|Overall Study|Lost to Follow-up|12|||
144246479|NCT00908596|520100416|FG003|Overall Study|Lost to Follow-up|4|||
144246480|NCT00908596|520100413|FG000|Overall Study|Death|0|||
144246481|NCT00908596|520100414|FG001|Overall Study|Death|5|||
144246482|NCT00908596|520100415|FG002|Overall Study|Death|57|||
144246483|NCT00908596|520100416|FG003|Overall Study|Death|32|||
144246484|NCT00908596|520100413|FG000|Overall Study|Protocol Violation|1|||
144246485|NCT00908596|520100414|FG001|Overall Study|Protocol Violation|0|||
144246486|NCT00908596|520100415|FG002|Overall Study|Protocol Violation|0|||
144246487|NCT00908596|520100416|FG003|Overall Study|Protocol Violation|0|||
144246488|NCT00908596|520100413|FG000|Overall Study|Withdrawal by Subject|0|||
144246489|NCT00908596|520100414|FG001|Overall Study|Withdrawal by Subject|1|||
144246490|NCT00908596|520100415|FG002|Overall Study|Withdrawal by Subject|3|||
144246491|NCT00908596|520100416|FG003|Overall Study|Withdrawal by Subject|1|||
144246492|NCT02542293|520100420|FG000|Overall Study|Death|367|||
144246493|NCT02542293|520100421|FG001|Overall Study|Death|377|||
144246494|NCT02542293|520100420|FG000|Overall Study|Withdrawal by Subject|8|||
144246495|NCT02542293|520100421|FG001|Overall Study|Withdrawal by Subject|19|||
144246496|NCT03030118|520100422|FG000|Overall Study|Achieved SLE Diagnosis|11|||
144246497|NCT03030118|520100423|FG001|Overall Study|Achieved SLE Diagnosis|10|||
144246498|NCT03030118|520100422|FG000|Overall Study|Adverse Event|1|||
144246499|NCT03030118|520100423|FG001|Overall Study|Adverse Event|1|||
144246500|NCT03030118|520100422|FG000|Overall Study|Pregnancy|2|||
144246501|NCT03030118|520100423|FG001|Overall Study|Pregnancy|2|||
144246502|NCT03030118|520100422|FG000|Overall Study|Lost to Follow-up|5|||
144246503|NCT03030118|520100423|FG001|Overall Study|Lost to Follow-up|6|||
144246504|NCT03030118|520100422|FG000|Overall Study|Concomitant Medications|1|||
144246505|NCT03030118|520100423|FG001|Overall Study|Concomitant Medications|1|||
144246506|NCT03030118|520100422|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
144246507|NCT03030118|520100423|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
144246508|NCT03030118|520100422|FG000|Overall Study|Other|2|||
144246509|NCT03030118|520100423|FG001|Overall Study|Other|0|||
144246510|NCT03030118|520100422|FG000|Overall Study|Withdrawal by Subject|26|||
144246511|NCT03030118|520100423|FG001|Overall Study|Withdrawal by Subject|21|||
144246512|NCT03030118|520100422|FG000|Overall Study|Protocol Violation|1|||
144246513|NCT03030118|520100423|FG001|Overall Study|Protocol Violation|6|||
144246514|NCT04529850|520100424|FG000|Overall Study|Death|2|||
144246515|NCT04529850|520100424|FG000|Overall Study|Physician Decision|1|||
144246516|NCT04529850|520100424|FG000|Overall Study|Withdrawal by Subject|2|||
144246517|NCT00078949|520100427|FG000|Overall Study|No treated|4|||
144246518|NCT00078949|520100428|FG001|Overall Study|No treated|5|||
144246519|NCT00078949|520100429|FG002|Overall Study|No treated|3|||
144246520|NCT00078949|520100430|FG003|Overall Study|No treated|3|||
144246521|NCT00577005|520100431|FG000|Overall Study|Lost to Follow-up|3|||
144289877|NCT03520387|520262370|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
144246522|NCT00577005|520100432|FG001|Overall Study|Lost to Follow-up|2|||
144246523|NCT00577005|520100431|FG000|Overall Study|Withdrawal by Subject|2|||
144246524|NCT00577005|520100432|FG001|Overall Study|Withdrawal by Subject|1|||
144246525|NCT01004432|520100433|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
144246526|NCT01004432|520100434|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
144246527|NCT01004432|520100435|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
144246528|NCT01004432|520100436|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
144246529|NCT01004432|520100437|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
144246530|NCT01004432|520100433|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
144246531|NCT01004432|520100434|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
144246532|NCT01004432|520100435|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
144246533|NCT01004432|520100436|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
144246534|NCT01004432|520100437|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
144246535|NCT01004432|520100433|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
144246536|NCT01004432|520100434|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
144246537|NCT01004432|520100435|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
144246538|NCT01004432|520100436|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
144246539|NCT01004432|520100437|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
144246540|NCT01004432|520100433|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
144246541|NCT01004432|520100434|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
144246542|NCT01004432|520100435|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
144246543|NCT01004432|520100436|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
144246544|NCT01004432|520100437|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
144246545|NCT01004432|520100433|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
144246546|NCT01004432|520100434|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
144246547|NCT01004432|520100435|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
144246548|NCT01004432|520100436|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
144246549|NCT01004432|520100437|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
144246550|NCT01004432|520100433|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
144246551|NCT01004432|520100434|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
144246552|NCT01004432|520100435|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
144246553|NCT01004432|520100436|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
144246554|NCT01004432|520100437|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
144246555|NCT01004432|520100433|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
144246556|NCT01004432|520100434|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
144246557|NCT01004432|520100435|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
144246558|NCT01004432|520100436|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
144246559|NCT01004432|520100437|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
144246560|NCT01004432|520100433|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
144246561|NCT01004432|520100434|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
144246562|NCT01004432|520100435|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
144246563|NCT01004432|520100436|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
144246564|NCT01004432|520100437|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
144246565|NCT01004432|520100433|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
144246566|NCT01004432|520100434|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
144246567|NCT01004432|520100435|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
144246568|NCT01004432|520100436|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
144246569|NCT01004432|520100437|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
144246570|NCT01004432|520100433|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
144246571|NCT01004432|520100434|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
144246572|NCT01004432|520100435|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
144246573|NCT01004432|520100436|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
144246574|NCT01004432|520100437|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
144246575|NCT01004432|520100433|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
144246576|NCT01004432|520100434|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
144246577|NCT01004432|520100435|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
144246578|NCT01004432|520100436|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
144246579|NCT01004432|520100437|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
144246580|NCT01004432|520100433|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
144246581|NCT01004432|520100434|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
144289878|NCT03163264|520262371|FG000|Overall Study|Withdrawal by Subject|13|||
144289879|NCT03163264|520262372|FG001|Overall Study|Withdrawal by Subject|3|||
144289880|NCT03163264|520262373|FG002|Overall Study|Withdrawal by Subject|4|||
144289881|NCT03163264|520262374|FG003|Overall Study|Withdrawal by Subject|2|||
144289882|NCT03163264|520262371|FG000|Overall Study|Lost to Follow-up|17|||
144289883|NCT03163264|520262372|FG001|Overall Study|Lost to Follow-up|20|||
144289884|NCT03163264|520262373|FG002|Overall Study|Lost to Follow-up|0|||
144289885|NCT03163264|520262374|FG003|Overall Study|Lost to Follow-up|0|||
144289886|NCT03163264|520262371|FG000|Overall Study|Death|0|||
144289887|NCT03163264|520262372|FG001|Overall Study|Death|2|||
144289888|NCT03163264|520262373|FG002|Overall Study|Death|0|||
144289889|NCT03163264|520262374|FG003|Overall Study|Death|0|||
144289890|NCT02489045|520262377|FG000|Overall Study|unable to collect usable data|53|||
144289891|NCT02489045|520262377|FG000|Follow-up|Lost to Follow-up|10|||
144289892|NCT02774278|520262379|FG000|Overall Study|Lack of Efficacy|199|||
144289893|NCT02774278|520262379|FG000|Overall Study|Death|29|||
144289894|NCT02774278|520262379|FG000|Overall Study|Adverse event/intercurrent illness|16|||
144289895|NCT02774278|520262379|FG000|Overall Study|Refused treatment/did not cooperate|9|||
144289896|NCT02774278|520262379|FG000|Overall Study|Administrative reasons|6|||
144289897|NCT02774278|520262379|FG000|Overall Study|Withdrawal by Subject|3|||
144289898|NCT02774278|520262379|FG000|Overall Study|Protocol Violation|2|||
144289899|NCT00930176|520262384|FG000|Overall Study|Death|1|||
144289900|NCT05486065|520262386|FG000|Overall Study|Withdrawal by Subject|1|||
144289901|NCT05486065|520262387|FG001|Overall Study|Withdrawal by Subject|5|||
144289902|NCT05486065|520262388|FG002|Overall Study|Withdrawal by Subject|4|||
144289903|NCT05486065|520262389|FG003|Overall Study|Withdrawal by Subject|3|||
144289904|NCT05486065|520262386|FG000|Overall Study|Lost to Follow-up|4|||
144289905|NCT05486065|520262387|FG001|Overall Study|Lost to Follow-up|2|||
144289906|NCT05486065|520262388|FG002|Overall Study|Lost to Follow-up|2|||
144289907|NCT05486065|520262389|FG003|Overall Study|Lost to Follow-up|2|||
144289908|NCT05486065|520262386|FG000|Overall Study|Physician Decision|0|||
144289909|NCT05486065|520262387|FG001|Overall Study|Physician Decision|1|||
144289910|NCT05486065|520262388|FG002|Overall Study|Physician Decision|1|||
144289911|NCT05486065|520262389|FG003|Overall Study|Physician Decision|0|||
144289912|NCT05486065|520262386|FG000|Overall Study|Failure to meet randomization criteria|0|||
144289913|NCT05486065|520262387|FG001|Overall Study|Failure to meet randomization criteria|0|||
144289914|NCT05486065|520262388|FG002|Overall Study|Failure to meet randomization criteria|0|||
144289915|NCT05486065|520262389|FG003|Overall Study|Failure to meet randomization criteria|1|||
144289916|NCT01926509|520264320|FG000|Overall Study|vital sign met discontinuation criteria|1|||
144289917|NCT01926509|520264321|FG001|Overall Study|vital sign met discontinuation criteria|0|||
144289918|NCT01926509|520264322|FG002|Overall Study|vital sign met discontinuation criteria|0|||
144289919|NCT01926509|520264323|FG003|Overall Study|vital sign met discontinuation criteria|0|||
144289920|NCT02730169|520264324|FG000|Overall Study|Protocol Violation|1|||
144289921|NCT02730169|520264325|FG001|Overall Study|Protocol Violation|0|||
144289922|NCT02730169|520264326|FG002|Overall Study|Protocol Violation|0|||
144289923|NCT02730169|520264327|FG003|Overall Study|Protocol Violation|1|||
144289924|NCT02730169|520264324|FG000|Overall Study|Adverse Event|2|||
144289925|NCT02730169|520264325|FG001|Overall Study|Adverse Event|3|||
144289926|NCT02730169|520264326|FG002|Overall Study|Adverse Event|3|||
144289927|NCT02730169|520264327|FG003|Overall Study|Adverse Event|0|||
144289928|NCT02730169|520264324|FG000|Overall Study|Adverse Event of Special Interest|0|||
144289929|NCT02730169|520264325|FG001|Overall Study|Adverse Event of Special Interest|1|||
144289930|NCT02730169|520264326|FG002|Overall Study|Adverse Event of Special Interest|2|||
144289931|NCT02730169|520264327|FG003|Overall Study|Adverse Event of Special Interest|0|||
144289932|NCT02730169|520264324|FG000|Overall Study|Withdrawal by Subject|6|||
144289933|NCT02730169|520264325|FG001|Overall Study|Withdrawal by Subject|11|||
144289934|NCT02730169|520264326|FG002|Overall Study|Withdrawal by Subject|6|||
144289935|NCT02730169|520264327|FG003|Overall Study|Withdrawal by Subject|8|||
144289936|NCT02730169|520264324|FG000|Overall Study|Lost to Follow-up|5|||
144289937|NCT02730169|520264325|FG001|Overall Study|Lost to Follow-up|6|||
144289938|NCT02730169|520264326|FG002|Overall Study|Lost to Follow-up|5|||
144289939|NCT02730169|520264327|FG003|Overall Study|Lost to Follow-up|6|||
144289940|NCT02730169|520264324|FG000|Overall Study|Other|0|||
144289941|NCT02730169|520264325|FG001|Overall Study|Other|0|||
144289942|NCT02730169|520264326|FG002|Overall Study|Other|1|||
144289943|NCT02730169|520264327|FG003|Overall Study|Other|1|||
144289944|NCT03681093|520264328|FG000|Overall Study|Subject decision|0|||
144289945|NCT03681093|520264329|FG001|Overall Study|Subject decision|2|||
144289946|NCT03681093|520264330|FG002|Overall Study|Subject decision|1|||
144289947|NCT01027754|520264331|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
144289948|NCT01027754|520264332|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
144289949|NCT01027754|520264331|FG000|Overall Study|Withdrawal by Subject|0|||
144289950|NCT01027754|520264332|FG001|Overall Study|Withdrawal by Subject|5|||
144289951|NCT01882829|520264333|FG000|Overall Study|Adverse Event|4|||
144289952|NCT01882829|520264333|FG000|Overall Study|Protocol Violation|1|||
144289953|NCT01882829|520264333|FG000|Overall Study|Withdrawal by Subject|1|||
144289954|NCT02562040|520264339|FG000|Overall Study|Lost to Follow-up|20|||
144289955|NCT02562040|520264340|FG001|Overall Study|Lost to Follow-up|28|||
144289956|NCT02562040|520264339|FG000|Overall Study|Withdrawal by Subject|8|||
144289957|NCT02562040|520264340|FG001|Overall Study|Withdrawal by Subject|7|||
144289958|NCT02562040|520264339|FG000|Overall Study|Adverse Event|1|||
144289959|NCT02562040|520264340|FG001|Overall Study|Adverse Event|0|||
144289960|NCT01902303|520264343|FG000|Overall Study|Adverse Event|0|||
144289961|NCT01902303|520264344|FG001|Overall Study|Adverse Event|1|||
144289962|NCT01902303|520264343|FG000|Overall Study|Lost to Follow-up|0|||
144289963|NCT01902303|520264344|FG001|Overall Study|Lost to Follow-up|1|||
144289964|NCT01902303|520264343|FG000|Overall Study|Protocol Violation|2|||
144289965|NCT01902303|520264344|FG001|Overall Study|Protocol Violation|2|||
144289966|NCT01902303|520264343|FG000|Overall Study|subject lost investigational product|0|||
144289967|NCT01902303|520264344|FG001|Overall Study|subject lost investigational product|1|||
144289968|NCT01902303|520264343|FG000|Overall Study|Did not develop a cold sore|21|||
144289969|NCT01902303|520264344|FG001|Overall Study|Did not develop a cold sore|19|||
144289970|NCT01699685|520264345|FG000|Period 1|Adverse Event|1|||
144289971|NCT01699685|520264346|FG001|Period 1|Adverse Event|1|||
144289972|NCT01699685|520264345|FG000|Period 1|Medical or ethical, noncompliance|2|||
144289973|NCT01699685|520264346|FG001|Period 1|Medical or ethical, noncompliance|0|||
144289974|NCT01699685|520264345|FG000|Period 1|Other|0|||
144289975|NCT01699685|520264346|FG001|Period 1|Other|1|||
144289976|NCT01699685|520264345|FG000|Period 1|Patient request|0|||
144289977|NCT01699685|520264346|FG001|Period 1|Patient request|1|||
144289978|NCT01699685|520264345|FG000|Period 2|Lost to Follow-up|1|||
144289979|NCT01699685|520264346|FG001|Period 2|Lost to Follow-up|0|||
144289980|NCT03635996|520264347|FG000|Overall Study|Study terminated by Sponsor|94|||
144289981|NCT03635996|520264347|FG000|Overall Study|Withdrawal by Subject|20|||
144289982|NCT03635996|520264347|FG000|Overall Study|Ablation|26|||
144289983|NCT03635996|520264347|FG000|Overall Study|Adverse Event|7|||
144289984|NCT03635996|520264347|FG000|Overall Study|Physician Decision|3|||
144289985|NCT03635996|520264347|FG000|Overall Study|Prohibited medication|5|||
144289986|NCT03635996|520264347|FG000|Overall Study|Did not meet eligibility criteria|5|||
144289987|NCT03635996|520264347|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
144289988|NCT03635996|520264347|FG000|Overall Study|Protocol Violation|1|||
144289989|NCT03635996|520264347|FG000|Overall Study|Lost to Follow-up|1|||
144289990|NCT02933151|520264348|FG000|Overall Study|Lost to Follow-up|19|||
144289991|NCT02933151|520264349|FG001|Overall Study|Lost to Follow-up|18|||
144289992|NCT02933151|520264348|FG000|Overall Study|Death|1732|||
144289993|NCT02933151|520264349|FG001|Overall Study|Death|1827|||
144289994|NCT02933151|520264348|FG000|Overall Study|Transplant|210|||
144289995|NCT02933151|520264349|FG001|Overall Study|Transplant|278|||
144289996|NCT02933151|520264348|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
144289997|NCT02933151|520264349|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
144289998|NCT02933151|520264348|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
144289999|NCT02933151|520264349|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
144290000|NCT02933151|520264348|FG000|Overall Study|Recovered Kidney Function|47|||
144290001|NCT02933151|520264349|FG001|Overall Study|Recovered Kidney Function|29|||
144290002|NCT00394472|520264350|FG000|Overall Study|Protocol Violation|1|||
144290003|NCT00394472|520264351|FG001|Overall Study|Protocol Violation|3|||
144290004|NCT00394472|520264350|FG000|Overall Study|incorrect enrolment|4|||
144290005|NCT00394472|520264351|FG001|Overall Study|incorrect enrolment|2|||
144290006|NCT00394472|520264350|FG000|Overall Study|Adverse Event|4|||
144290007|NCT00394472|520264351|FG001|Overall Study|Adverse Event|2|||
144290008|NCT00394472|520264350|FG000|Overall Study|Withdrawal by Subject|0|||
144290009|NCT00394472|520264351|FG001|Overall Study|Withdrawal by Subject|2|||
144290010|NCT00394472|520264350|FG000|Overall Study|Physician Decision|0|||
144290011|NCT00394472|520264351|FG001|Overall Study|Physician Decision|1|||
144290012|NCT00394472|520264350|FG000|Overall Study|Lost to Follow-up|0|||
144290013|NCT00394472|520264351|FG001|Overall Study|Lost to Follow-up|1|||
144290014|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
144290015|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
144290016|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
144290017|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
144290018|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
144290019|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
144290020|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
144290021|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
144290022|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
144290023|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
144290024|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
144290025|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
144246582|NCT01004432|520100435|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
144246583|NCT01004432|520100436|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
144246584|NCT01004432|520100437|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
144246585|NCT01004432|520100433|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
144246586|NCT01004432|520100434|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
144246587|NCT01004432|520100435|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
144246588|NCT01004432|520100436|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
144246589|NCT01004432|520100437|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
144246590|NCT01004432|520100433|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
144246591|NCT01004432|520100434|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
144246592|NCT01004432|520100435|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
144246593|NCT01004432|520100436|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
144246594|NCT01004432|520100437|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
144246595|NCT01004432|520100433|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
144246596|NCT01004432|520100434|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
144246597|NCT01004432|520100435|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
144246598|NCT01004432|520100436|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
144246599|NCT01004432|520100437|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
144246600|NCT01404208|520100441|FG000|Overall Study|Discontinued|3|||
144246601|NCT01404208|520100442|FG001|Overall Study|Discontinued|0|||
144246602|NCT00908076|520100445|FG000|Overall Study|Lack of Efficacy|1|||
144246603|NCT00908076|520100446|FG001|Overall Study|Lack of Efficacy|1|||
144246604|NCT02382796|520100447|FG000|Overall Study|Global deterioration of health status|1|||
144246605|NCT02382796|520100447|FG000|Overall Study|Objective progression or relapse|3|||
144246606|NCT02382796|520100447|FG000|Overall Study|Commercial dacomitinib became available|3|||
144246607|NCT04007107|520100458|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
144246608|NCT04007107|520100459|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
144246609|NCT04007107|520100460|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
144246610|NCT04007107|520100461|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
144246611|NCT04526574|520100462|FG000|Overall Study|Protocol Violation|3|||
144246612|NCT04526574|520100463|FG001|Overall Study|Protocol Violation|1|||
144246613|NCT04526574|520100462|FG000|Overall Study|Withdrawal by Subject|12|||
144246614|NCT04526574|520100463|FG001|Overall Study|Withdrawal by Subject|9|||
144246615|NCT04526574|520100462|FG000|Overall Study|Other|1|||
144246616|NCT04526574|520100463|FG001|Overall Study|Other|2|||
144246617|NCT04526574|520100462|FG000|Overall Study|Adverse Event|1|||
144246618|NCT04526574|520100463|FG001|Overall Study|Adverse Event|1|||
144246619|NCT04526574|520100462|FG000|Overall Study|Death|2|||
144246620|NCT04526574|520100463|FG001|Overall Study|Death|3|||
144246621|NCT04526574|520100462|FG000|Overall Study|Lost to Follow-up|9|||
144246622|NCT04526574|520100463|FG001|Overall Study|Lost to Follow-up|9|||
144246623|NCT04526574|520100462|FG000|Overall Study|No longer meets eligibility criteria|8|||
144246624|NCT04526574|520100463|FG001|Overall Study|No longer meets eligibility criteria|8|||
144246625|NCT03769675|520100464|FG000|Overall Study|Lost to Follow-up|1|||
144246626|NCT04068688|520100470|FG000|Overall Study|Lost to Follow-up|1|||
144246627|NCT04068688|520100471|FG001|Overall Study|Lost to Follow-up|1|||
144246628|NCT04068688|520100472|FG002|Overall Study|Lost to Follow-up|0|||
144246629|NCT04068688|520100473|FG003|Overall Study|Lost to Follow-up|0|||
144246630|NCT04068688|520100474|FG004|Overall Study|Lost to Follow-up|5|||
144246631|NCT04068688|520100475|FG005|Overall Study|Lost to Follow-up|5|||
144246632|NCT04068688|520100476|FG006|Overall Study|Lost to Follow-up|0|||
144246633|NCT04068688|520100477|FG007|Overall Study|Lost to Follow-up|0|||
144246634|NCT04068688|520100478|FG008|Overall Study|Lost to Follow-up|1|||
144246635|NCT04068688|520100479|FG009|Overall Study|Lost to Follow-up|0|||
144246636|NCT04068688|520100470|FG000|Overall Study|Withdrawal by Subject|1|||
144246637|NCT04068688|520100471|FG001|Overall Study|Withdrawal by Subject|1|||
144246638|NCT04068688|520100472|FG002|Overall Study|Withdrawal by Subject|0|||
144246639|NCT04068688|520100473|FG003|Overall Study|Withdrawal by Subject|0|||
144246640|NCT04068688|520100474|FG004|Overall Study|Withdrawal by Subject|0|||
144246641|NCT04068688|520100475|FG005|Overall Study|Withdrawal by Subject|0|||
144246642|NCT04068688|520100476|FG006|Overall Study|Withdrawal by Subject|0|||
144246643|NCT04068688|520100477|FG007|Overall Study|Withdrawal by Subject|0|||
144246644|NCT04068688|520100478|FG008|Overall Study|Withdrawal by Subject|0|||
144246645|NCT04068688|520100479|FG009|Overall Study|Withdrawal by Subject|0|||
144246646|NCT04068688|520100470|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
144246647|NCT04068688|520100471|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
144246648|NCT04068688|520100472|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144246649|NCT04068688|520100473|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144246650|NCT04068688|520100474|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144246651|NCT04068688|520100475|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144290026|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
144290027|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
144290028|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
144290029|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
144290030|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
144290031|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
144290032|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
144290033|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
144290034|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
144290035|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
144290036|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
144290037|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
144290038|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
144290039|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
144290040|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
144290041|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
144290042|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
144290043|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
144290044|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
144290045|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
144290046|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
144290047|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
144290048|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
144290049|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
144290050|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
144290051|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
144290052|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
144290053|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
144290054|NCT02596893|520264352|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
144290055|NCT02596893|520264353|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
144290056|NCT02596893|520264354|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
144290057|NCT02596893|520264355|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
144290058|NCT00004228|520264356|FG000|Overall Study|Adverse Event|0|||
144290059|NCT00004228|520264357|FG001|Overall Study|Adverse Event|1|||
144290060|NCT00004228|520264358|FG002|Overall Study|Adverse Event|0|||
144290061|NCT00004228|520264359|FG003|Overall Study|Adverse Event|0|||
144290062|NCT00004228|520264360|FG004|Overall Study|Adverse Event|1|||
144290063|NCT00004228|520264361|FG005|Overall Study|Adverse Event|0|||
144290064|NCT00004228|520264362|FG006|Overall Study|Adverse Event|0|||
144290065|NCT00004228|520264356|FG000|Overall Study|Death|0|||
144290066|NCT00004228|520264357|FG001|Overall Study|Death|1|||
144290067|NCT00004228|520264358|FG002|Overall Study|Death|2|||
144290068|NCT00004228|520264359|FG003|Overall Study|Death|0|||
144290069|NCT00004228|520264360|FG004|Overall Study|Death|1|||
144290070|NCT00004228|520264361|FG005|Overall Study|Death|0|||
144290071|NCT00004228|520264362|FG006|Overall Study|Death|0|||
144290072|NCT00004228|520264356|FG000|Overall Study|Lack of Efficacy|1|||
144290073|NCT00004228|520264357|FG001|Overall Study|Lack of Efficacy|6|||
144290074|NCT00004228|520264358|FG002|Overall Study|Lack of Efficacy|5|||
144290075|NCT00004228|520264359|FG003|Overall Study|Lack of Efficacy|3|||
144290076|NCT00004228|520264360|FG004|Overall Study|Lack of Efficacy|9|||
144290077|NCT00004228|520264361|FG005|Overall Study|Lack of Efficacy|8|||
144290078|NCT00004228|520264362|FG006|Overall Study|Lack of Efficacy|4|||
144290079|NCT00004228|520264356|FG000|Overall Study|Lost to Follow-up|0|||
144290080|NCT00004228|520264357|FG001|Overall Study|Lost to Follow-up|0|||
144290081|NCT00004228|520264358|FG002|Overall Study|Lost to Follow-up|1|||
144290082|NCT00004228|520264359|FG003|Overall Study|Lost to Follow-up|0|||
144290083|NCT00004228|520264360|FG004|Overall Study|Lost to Follow-up|0|||
144290084|NCT00004228|520264361|FG005|Overall Study|Lost to Follow-up|0|||
144290085|NCT00004228|520264362|FG006|Overall Study|Lost to Follow-up|0|||
144290086|NCT00004228|520264356|FG000|Overall Study|Physician Decision|1|||
144290087|NCT00004228|520264357|FG001|Overall Study|Physician Decision|0|||
144290088|NCT00004228|520264358|FG002|Overall Study|Physician Decision|3|||
144290089|NCT00004228|520264359|FG003|Overall Study|Physician Decision|2|||
144290090|NCT00004228|520264360|FG004|Overall Study|Physician Decision|1|||
144290091|NCT00004228|520264361|FG005|Overall Study|Physician Decision|1|||
144290092|NCT00004228|520264362|FG006|Overall Study|Physician Decision|1|||
144290093|NCT00004228|520264356|FG000|Overall Study|Protocol Violation|0|||
144290094|NCT00004228|520264357|FG001|Overall Study|Protocol Violation|5|||
144290095|NCT00004228|520264358|FG002|Overall Study|Protocol Violation|2|||
144290096|NCT00004228|520264359|FG003|Overall Study|Protocol Violation|1|||
144290097|NCT00004228|520264360|FG004|Overall Study|Protocol Violation|1|||
144290098|NCT00004228|520264361|FG005|Overall Study|Protocol Violation|2|||
144290099|NCT00004228|520264362|FG006|Overall Study|Protocol Violation|0|||
144290100|NCT00004228|520264356|FG000|Overall Study|Withdrawal by Subject|3|||
144290101|NCT00004228|520264357|FG001|Overall Study|Withdrawal by Subject|0|||
144290102|NCT00004228|520264358|FG002|Overall Study|Withdrawal by Subject|1|||
144290103|NCT00004228|520264359|FG003|Overall Study|Withdrawal by Subject|0|||
144290104|NCT00004228|520264360|FG004|Overall Study|Withdrawal by Subject|2|||
144290105|NCT00004228|520264361|FG005|Overall Study|Withdrawal by Subject|1|||
144290106|NCT00004228|520264362|FG006|Overall Study|Withdrawal by Subject|2|||
144290107|NCT00004228|520264356|FG000|Overall Study|Other|0|||
144290108|NCT00004228|520264357|FG001|Overall Study|Other|0|||
144290109|NCT00004228|520264358|FG002|Overall Study|Other|1|||
144290110|NCT00004228|520264359|FG003|Overall Study|Other|0|||
144290111|NCT00004228|520264360|FG004|Overall Study|Other|0|||
144290112|NCT00004228|520264361|FG005|Overall Study|Other|0|||
144290113|NCT00004228|520264362|FG006|Overall Study|Other|0|||
144290114|NCT00004228|520264356|FG000|Overall Study|ineligible|4|||
144290115|NCT00004228|520264357|FG001|Overall Study|ineligible|2|||
144290116|NCT00004228|520264358|FG002|Overall Study|ineligible|4|||
144290117|NCT00004228|520264359|FG003|Overall Study|ineligible|1|||
144290118|NCT00004228|520264360|FG004|Overall Study|ineligible|1|||
144290119|NCT00004228|520264361|FG005|Overall Study|ineligible|2|||
144290120|NCT00004228|520264362|FG006|Overall Study|ineligible|5|||
144290121|NCT02255279|520264363|FG000|Overall Study|Lost to Follow-up|2|||
144290122|NCT02255279|520264364|FG001|Overall Study|Lost to Follow-up|2|||
144290123|NCT02255279|520264363|FG000|Overall Study|Protocol Violation|0|||
144290124|NCT02255279|520264364|FG001|Overall Study|Protocol Violation|1|||
144290125|NCT02255279|520264363|FG000|Overall Study|Withdrawal by Subject|3|||
144290126|NCT02255279|520264364|FG001|Overall Study|Withdrawal by Subject|6|||
144290127|NCT00363467|520264365|FG000|Overall Study|Physician Decision|1|||
144290128|NCT03142451|520264366|FG000|Overall Study|Adverse Event|5|||
144290129|NCT03142451|520264367|FG001|Overall Study|Adverse Event|2|||
144290130|NCT03142451|520264366|FG000|Overall Study|Lost to Follow-up|25|||
144290131|NCT03142451|520264367|FG001|Overall Study|Lost to Follow-up|8|||
144290132|NCT03142451|520264366|FG000|Overall Study|Participant request|24|||
144290133|NCT03142451|520264367|FG001|Overall Study|Participant request|12|||
144290134|NCT03142451|520264366|FG000|Overall Study|Protocol Violation|3|||
144290135|NCT03142451|520264367|FG001|Overall Study|Protocol Violation|1|||
144290136|NCT03142451|520264366|FG000|Overall Study|Other|1|||
144290137|NCT03142451|520264367|FG001|Overall Study|Other|1|||
144290138|NCT00090402|520264368|FG000|Overall Study|Death|1|||
144290139|NCT00090402|520264369|FG001|Overall Study|Death|1|||
144290140|NCT00090402|520264370|FG002|Overall Study|Death|0|||
144290141|NCT00090402|520264368|FG000|Overall Study|subject moved|0|||
144290142|NCT00090402|520264369|FG001|Overall Study|subject moved|1|||
144290143|NCT00090402|520264370|FG002|Overall Study|subject moved|0|||
144290144|NCT00090402|520264368|FG000|Overall Study|stopped taking study medication|1|||
144290145|NCT00090402|520264369|FG001|Overall Study|stopped taking study medication|0|||
144290146|NCT00090402|520264370|FG002|Overall Study|stopped taking study medication|1|||
144290147|NCT03048019|520264373|FG000|Overall Study|Adverse Event|1|||
144290148|NCT03048019|520264374|FG001|Overall Study|Adverse Event|0|||
144290149|NCT00862277|520264375|FG000|Overall Study|Protocol Violation|1|||
144290150|NCT00862277|520264376|FG001|Overall Study|Protocol Violation|2|||
144290151|NCT00862277|520264377|FG002|Overall Study|Protocol Violation|5|||
144290152|NCT00382863|520264378|FG000|Overall Study|Death|9|||
144290153|NCT00382863|520264379|FG001|Overall Study|Death|9|||
144290154|NCT00382863|520264378|FG000|Overall Study|Lost to Follow-up|1|||
144290155|NCT00382863|520264379|FG001|Overall Study|Lost to Follow-up|2|||
144290156|NCT00382863|520264378|FG000|Overall Study|Withdrawal by Subject|5|||
144290157|NCT00382863|520264379|FG001|Overall Study|Withdrawal by Subject|25|||
144290158|NCT02451007|520264382|FG000|Overall Study|Withdrawal by Subject|4|||
144290159|NCT02451007|520264382|FG000|Overall Study|Adverse Event|1|||
144290160|NCT02451007|520264382|FG000|Overall Study|Disease Progression|2|||
144290161|NCT01716559|520264383|FG000|Overall Study|Adverse Event|11|||
144290162|NCT01716559|520264383|FG000|Overall Study|Death|21|||
144290163|NCT01716559|520264383|FG000|Overall Study|Withdrawal by Subject|4|||
144290164|NCT01716559|520264383|FG000|Overall Study|Other withdrawal reason|75|||
144290165|NCT00348374|520264384|FG000|Overall Study|Adverse Event|1|||
144290166|NCT00348374|520264385|FG001|Overall Study|Adverse Event|4|||
144290167|NCT00348374|520264384|FG000|Overall Study|Lost to Follow-up|1|||
144290168|NCT00348374|520264385|FG001|Overall Study|Lost to Follow-up|3|||
144290169|NCT00348374|520264384|FG000|Overall Study|Withdrawal by Subject|5|||
144290170|NCT00348374|520264385|FG001|Overall Study|Withdrawal by Subject|5|||
144290171|NCT00348374|520264384|FG000|Overall Study|Other|11|||
144290172|NCT00348374|520264385|FG001|Overall Study|Other|12|||
144290173|NCT00348374|520264384|FG000|Overall Study|ongoing at date of cutoff|1|||
144290174|NCT00348374|520264385|FG001|Overall Study|ongoing at date of cutoff|1|||
144290175|NCT00348374|520264384|FG000|Overall Study|randomized but did not receive treatment|0|||
144290176|NCT00348374|520264385|FG001|Overall Study|randomized but did not receive treatment|7|||
144290177|NCT02180672|520264398|FG000|Overall Study|Lost to Follow-up|5|||
144290178|NCT02180672|520264399|FG001|Overall Study|Lost to Follow-up|7|||
144290179|NCT00661687|520264401|FG000|Overall Study|Study related symptoms and complaints|5|||
144290180|NCT00661687|520264401|FG000|Overall Study|Positive slit lamp findings|4|||
144290181|NCT00661687|520264401|FG000|Overall Study|Inability to maintain wearing schedule|3|||
144290182|NCT00661687|520264401|FG000|Overall Study|Physician Decision|1|||
144290183|NCT00661687|520264401|FG000|Overall Study|Adverse Event|2|||
144290184|NCT01362530|520264402|FG000|Base Study (Cycle 1)|Adverse Event|2|||
144290185|NCT01362530|520264403|FG001|Base Study (Cycle 1)|Adverse Event|0|||
144290186|NCT01362530|520264402|FG000|Base Study (Cycle 1)|Physician Decision|0|||
144290187|NCT01362530|520264403|FG001|Base Study (Cycle 1)|Physician Decision|1|||
144290188|NCT01362530|520264402|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
144290189|NCT01362530|520264403|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
144290190|NCT01362530|520264402|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
144290191|NCT01362530|520264403|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
144290192|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
144290193|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
144290194|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
144290195|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
144290196|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
144290197|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
144290198|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
144290199|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
144290200|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
144290201|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
144290202|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
144290203|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
144290204|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
144246652|NCT04068688|520100476|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144290205|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
144290206|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
144290207|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
144290208|NCT01362530|520264402|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
144290209|NCT01362530|520264403|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
144290210|NCT01133977|520264404|FG000|Overall Study|Adverse Event|0|||
144290211|NCT01133977|520264405|FG001|Overall Study|Adverse Event|0|||
144290212|NCT01133977|520264406|FG002|Overall Study|Adverse Event|1|||
144290213|NCT01133977|520264407|FG003|Overall Study|Adverse Event|0|||
144290214|NCT01133977|520264408|FG004|Overall Study|Adverse Event|0|||
144290215|NCT01133977|520264404|FG000|Overall Study|Death|1|||
144290216|NCT01133977|520264405|FG001|Overall Study|Death|1|||
144290217|NCT01133977|520264406|FG002|Overall Study|Death|1|||
144290218|NCT01133977|520264407|FG003|Overall Study|Death|7|||
144246653|NCT04068688|520100477|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144290219|NCT01133977|520264408|FG004|Overall Study|Death|3|||
144290220|NCT01133977|520264404|FG000|Overall Study|Started a New Line of Therapy|2|||
144290221|NCT01133977|520264405|FG001|Overall Study|Started a New Line of Therapy|6|||
144290222|NCT01133977|520264406|FG002|Overall Study|Started a New Line of Therapy|4|||
144290223|NCT01133977|520264407|FG003|Overall Study|Started a New Line of Therapy|25|||
144290224|NCT01133977|520264408|FG004|Overall Study|Started a New Line of Therapy|33|||
144290225|NCT01133977|520264404|FG000|Overall Study|Lost to Follow-up|0|||
144290226|NCT01133977|520264405|FG001|Overall Study|Lost to Follow-up|0|||
144290227|NCT01133977|520264406|FG002|Overall Study|Lost to Follow-up|0|||
144290228|NCT01133977|520264407|FG003|Overall Study|Lost to Follow-up|2|||
144290229|NCT01133977|520264408|FG004|Overall Study|Lost to Follow-up|1|||
144290230|NCT01133977|520264404|FG000|Overall Study|Withdrawal by Subject|0|||
144290231|NCT01133977|520264405|FG001|Overall Study|Withdrawal by Subject|0|||
144290232|NCT01133977|520264406|FG002|Overall Study|Withdrawal by Subject|0|||
144290233|NCT01133977|520264407|FG003|Overall Study|Withdrawal by Subject|5|||
144290234|NCT01133977|520264408|FG004|Overall Study|Withdrawal by Subject|1|||
144290235|NCT02105012|520264413|FG000|Overall Study|Withdrawal by Subject|11|||
144290236|NCT02105012|520264413|FG000|Overall Study|Protocol Specified Criteria|9|||
144290237|NCT02105012|520264413|FG000|Overall Study|Lost to Follow-up|4|||
144290238|NCT02105012|520264413|FG000|Overall Study|Protocol Violation|4|||
144290239|NCT02105012|520264413|FG000|Overall Study|Physician Decision|3|||
144246654|NCT04068688|520100478|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144246655|NCT04068688|520100479|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
144246656|NCT04679051|520100480|FG000|Overall Study|felt tired after restricted time in bed|3|||
144246657|NCT04679051|520100481|FG001|Overall Study|felt tired after restricted time in bed|0|||
144246658|NCT04679051|520100480|FG000|Overall Study|discomfort with blood pressure cuff|2|||
144246659|NCT04679051|520100481|FG001|Overall Study|discomfort with blood pressure cuff|0|||
144246660|NCT04679051|520100480|FG000|Overall Study|scheduling conflict|1|||
144246661|NCT04679051|520100481|FG001|Overall Study|scheduling conflict|1|||
144246662|NCT04679051|520100480|FG000|Overall Study|Protocol Violation|0|||
144246663|NCT04679051|520100481|FG001|Overall Study|Protocol Violation|4|||
144246664|NCT00426660|520100482|FG000|Overall Study|Death|14|||
144246665|NCT00426660|520100482|FG000|Overall Study|Adverse Event|23|||
144246666|NCT00426660|520100482|FG000|Overall Study|Insufficient Clinical Response|22|||
144246667|NCT00426660|520100482|FG000|Overall Study|Lost to Follow-up|15|||
144246668|NCT00426660|520100482|FG000|Overall Study|Other|23|||
144246669|NCT00426660|520100482|FG000|Overall Study|Withdrawal by Subject|18|||
144290240|NCT02105012|520264413|FG000|Overall Study|Adverse Event|1|||
144290241|NCT02105012|520264413|FG000|Overall Study|Lack of Efficacy|1|||
144290242|NCT00474968|520264416|FG000|Overall Study|Withdrawal by Subject|8|||
144290243|NCT00474968|520264417|FG001|Overall Study|Withdrawal by Subject|7|||
144290244|NCT00474968|520264416|FG000|Overall Study|Protocol Violation|9|||
144290245|NCT00474968|520264417|FG001|Overall Study|Protocol Violation|8|||
144290246|NCT00474968|520264416|FG000|Overall Study|Sample not collected|1|||
144290247|NCT00474968|520264417|FG001|Overall Study|Sample not collected|1|||
144290248|NCT00215553|520264418|FG000|Overall Study|Adverse Event|0|||
144290249|NCT00215553|520264419|FG001|Overall Study|Adverse Event|1|||
144290250|NCT00215553|520264420|FG002|Overall Study|Adverse Event|2|||
144290251|NCT00215553|520264421|FG003|Overall Study|Adverse Event|1|||
144290252|NCT00215553|520264422|FG004|Overall Study|Adverse Event|2|||
144290253|NCT00215553|520264423|FG005|Overall Study|Adverse Event|6|||
144290254|NCT00215553|520264424|FG006|Overall Study|Adverse Event|0|||
144290255|NCT01429623|520264425|FG000|Overall Study|Death|1|||
144290256|NCT01429623|520264426|FG001|Overall Study|Death|0|||
144290257|NCT01429623|520264425|FG000|Overall Study|Adverse Event|7|||
144290258|NCT01429623|520264426|FG001|Overall Study|Adverse Event|14|||
144290259|NCT01429623|520264425|FG000|Overall Study|Withdrawal by Subject|19|||
144290260|NCT01429623|520264426|FG001|Overall Study|Withdrawal by Subject|13|||
144290261|NCT01429623|520264425|FG000|Overall Study|Physician Decision|2|||
144290262|NCT01429623|520264426|FG001|Overall Study|Physician Decision|3|||
144290263|NCT01429623|520264425|FG000|Overall Study|Protocol Violation|3|||
144290264|NCT01429623|520264426|FG001|Overall Study|Protocol Violation|2|||
144290265|NCT01429623|520264425|FG000|Overall Study|Assorted|1|||
144290266|NCT01429623|520264426|FG001|Overall Study|Assorted|2|||
144290267|NCT01429623|520264425|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
144290268|NCT01429623|520264426|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
144290269|NCT01429623|520264425|FG000|Overall Study|No post baseline data|4|||
144246670|NCT00426660|520100482|FG000|Overall Study|Protocol Violation|1|||
144246671|NCT00426660|520100482|FG000|Overall Study|Enrolled Not Treated|15|||
144246672|NCT00980174|520100483|FG000|Overall Study|Withdrawal by Subject|1|||
144246673|NCT00980174|520100484|FG001|Overall Study|Withdrawal by Subject|4|||
144246674|NCT00980174|520100483|FG000|Overall Study|Adverse Event|0|||
144246675|NCT00980174|520100484|FG001|Overall Study|Adverse Event|3|||
144246676|NCT00980174|520100483|FG000|Overall Study|Ineligibility determined|2|||
144246677|NCT00980174|520100484|FG001|Overall Study|Ineligibility determined|1|||
144246678|NCT00980174|520100483|FG000|Overall Study|Death|1|||
144246679|NCT00980174|520100484|FG001|Overall Study|Death|1|||
144246680|NCT00980174|520100483|FG000|Overall Study|Other|0|||
144246681|NCT00980174|520100484|FG001|Overall Study|Other|1|||
144246682|NCT02554318|520100487|FG000|Overall Study|Withdrawal by Subject|10|||
144246683|NCT02554318|520100488|FG001|Overall Study|Withdrawal by Subject|8|||
144246684|NCT00934856|520100493|FG000|Feasibility Part|Progressive disease|4|||
144246685|NCT00934856|520100494|FG001|Feasibility Part|Progressive disease|4|||
144246686|NCT00934856|520100495|FG002|Feasibility Part|Progressive disease|2|||
144246687|NCT00934856|520100496|FG003|Feasibility Part|Progressive disease|3|||
144246688|NCT00934856|520100497|FG004|Feasibility Part|Progressive disease|0|||
144246689|NCT00934856|520100498|FG005|Feasibility Part|Progressive disease|0|||
144246690|NCT00934856|520100493|FG000|Feasibility Part|Physician Decision|0|||
144246691|NCT00934856|520100494|FG001|Feasibility Part|Physician Decision|0|||
144246692|NCT00934856|520100495|FG002|Feasibility Part|Physician Decision|1|||
144246693|NCT00934856|520100496|FG003|Feasibility Part|Physician Decision|0|||
144246694|NCT00934856|520100497|FG004|Feasibility Part|Physician Decision|0|||
144246695|NCT00934856|520100498|FG005|Feasibility Part|Physician Decision|0|||
144246696|NCT00934856|520100493|FG000|Feasibility Part|Adverse Event|1|||
144246697|NCT00934856|520100494|FG001|Feasibility Part|Adverse Event|1|||
144246698|NCT00934856|520100495|FG002|Feasibility Part|Adverse Event|0|||
144246699|NCT00934856|520100496|FG003|Feasibility Part|Adverse Event|1|||
144246700|NCT00934856|520100497|FG004|Feasibility Part|Adverse Event|0|||
144246701|NCT00934856|520100498|FG005|Feasibility Part|Adverse Event|2|||
144246702|NCT00934856|520100493|FG000|Feasibility Part|Withdrawal by Subject|0|||
144246703|NCT00934856|520100494|FG001|Feasibility Part|Withdrawal by Subject|0|||
144246704|NCT00934856|520100495|FG002|Feasibility Part|Withdrawal by Subject|0|||
144246705|NCT00934856|520100496|FG003|Feasibility Part|Withdrawal by Subject|1|||
144246706|NCT00934856|520100497|FG004|Feasibility Part|Withdrawal by Subject|0|||
144246707|NCT00934856|520100498|FG005|Feasibility Part|Withdrawal by Subject|1|||
144246708|NCT00934856|520100493|FG000|Extension Part|Adverse Event|0|||
144246709|NCT00934856|520100494|FG001|Extension Part|Adverse Event|0|||
144246710|NCT00934856|520100495|FG002|Extension Part|Adverse Event|0|||
144246711|NCT00934856|520100496|FG003|Extension Part|Adverse Event|1|||
144246712|NCT00934856|520100497|FG004|Extension Part|Adverse Event|4|||
144246713|NCT00934856|520100498|FG005|Extension Part|Adverse Event|4|||
144290270|NCT01429623|520264426|FG001|Overall Study|No post baseline data|4|||
144290271|NCT05345405|520264427|FG000|Overall Study|Withdrawal by Subject|2|||
144290272|NCT05345405|520264428|FG001|Overall Study|Withdrawal by Subject|0|||
144290273|NCT05345405|520264429|FG002|Overall Study|Withdrawal by Subject|0|||
144290274|NCT05345405|520264427|FG000|Overall Study|Did not meet eligibility criteria|0|||
144290275|NCT05345405|520264428|FG001|Overall Study|Did not meet eligibility criteria|2|||
144290276|NCT05345405|520264429|FG002|Overall Study|Did not meet eligibility criteria|0|||
144290277|NCT05345405|520264427|FG000|Overall Study|Lost to Follow-up|0|||
144290278|NCT05345405|520264428|FG001|Overall Study|Lost to Follow-up|0|||
144290279|NCT05345405|520264429|FG002|Overall Study|Lost to Follow-up|1|||
144290280|NCT01896986|520264430|FG000|Overall Study|samples lost|14|||
144290281|NCT01896986|520264431|FG001|Overall Study|samples lost|23|||
144290282|NCT02771145|520264434|FG000|Overall Study|Adverse Event|3|||
144290283|NCT02771145|520264434|FG000|Overall Study|Lost to Follow-up|1|||
144290284|NCT04135352|520264436|FG000|Overall Study|Not treated-randomization error|0|||
144290285|NCT04135352|520264437|FG001|Overall Study|Not treated-randomization error|0|||
144290286|NCT04135352|520264438|FG002|Overall Study|Not treated-randomization error|1|||
144290287|NCT04135352|520264439|FG003|Overall Study|Not treated-randomization error|0|||
144290288|NCT04135352|520264440|FG004|Overall Study|Not treated-randomization error|0|||
144290289|NCT04135352|520264441|FG005|Overall Study|Not treated-randomization error|0|||
144290290|NCT04135352|520264442|FG006|Overall Study|Not treated-randomization error|0|||
144290291|NCT04135352|520264443|FG007|Overall Study|Not treated-randomization error|0|||
144290292|NCT04135352|520264436|FG000|Overall Study|Withdrawal by Subject|0|||
144290293|NCT04135352|520264437|FG001|Overall Study|Withdrawal by Subject|0|||
144290294|NCT04135352|520264438|FG002|Overall Study|Withdrawal by Subject|2|||
144290295|NCT04135352|520264439|FG003|Overall Study|Withdrawal by Subject|0|||
144290296|NCT04135352|520264440|FG004|Overall Study|Withdrawal by Subject|0|||
144290297|NCT04135352|520264441|FG005|Overall Study|Withdrawal by Subject|0|||
144290298|NCT04135352|520264442|FG006|Overall Study|Withdrawal by Subject|0|||
144290299|NCT04135352|520264443|FG007|Overall Study|Withdrawal by Subject|0|||
144290300|NCT04135352|520264436|FG000|Overall Study|Sponsor Decision|0|||
144290301|NCT04135352|520264437|FG001|Overall Study|Sponsor Decision|0|||
144290302|NCT04135352|520264438|FG002|Overall Study|Sponsor Decision|2|||
144290303|NCT04135352|520264439|FG003|Overall Study|Sponsor Decision|5|||
144290304|NCT04135352|520264440|FG004|Overall Study|Sponsor Decision|1|||
144290305|NCT04135352|520264441|FG005|Overall Study|Sponsor Decision|4|||
144290306|NCT04135352|520264442|FG006|Overall Study|Sponsor Decision|0|||
144290307|NCT04135352|520264443|FG007|Overall Study|Sponsor Decision|0|||
144290308|NCT04135352|520264436|FG000|Overall Study|Physician Decision|0|||
144290309|NCT04135352|520264437|FG001|Overall Study|Physician Decision|0|||
144290310|NCT04135352|520264438|FG002|Overall Study|Physician Decision|1|||
144290311|NCT04135352|520264439|FG003|Overall Study|Physician Decision|0|||
144290312|NCT04135352|520264440|FG004|Overall Study|Physician Decision|1|||
144290313|NCT04135352|520264441|FG005|Overall Study|Physician Decision|0|||
144290314|NCT04135352|520264442|FG006|Overall Study|Physician Decision|0|||
144290315|NCT04135352|520264443|FG007|Overall Study|Physician Decision|0|||
144290316|NCT04135352|520264436|FG000|Overall Study|Death|3|||
144290317|NCT04135352|520264437|FG001|Overall Study|Death|4|||
144290318|NCT04135352|520264438|FG002|Overall Study|Death|7|||
144290319|NCT04135352|520264439|FG003|Overall Study|Death|0|||
144290320|NCT04135352|520264440|FG004|Overall Study|Death|3|||
144290321|NCT04135352|520264441|FG005|Overall Study|Death|1|||
144290322|NCT04135352|520264442|FG006|Overall Study|Death|0|||
144290323|NCT04135352|520264443|FG007|Overall Study|Death|0|||
144290324|NCT01696214|520264445|FG000|Overall Study|Lost to Follow-up|1|||
144290325|NCT01696214|520264446|FG001|Overall Study|Lost to Follow-up|0|||
144290326|NCT01696214|520264447|FG002|Overall Study|Lost to Follow-up|0|||
144290327|NCT01696214|520264448|FG003|Overall Study|Lost to Follow-up|0|||
144290328|NCT00819832|520264451|FG000|Overall Study|Sponsor Termination of Study|3|||
144290329|NCT00819832|520264452|FG001|Overall Study|Sponsor Termination of Study|0|||
144290330|NCT00819832|520264453|FG002|Overall Study|Sponsor Termination of Study|0|||
144290331|NCT00819832|520264454|FG003|Overall Study|Sponsor Termination of Study|0|||
144290332|NCT00819832|520264455|FG004|Overall Study|Sponsor Termination of Study|0|||
144290333|NCT00819832|520264456|FG005|Overall Study|Sponsor Termination of Study|0|||
144290334|NCT00066170|520264458|FG000|Overall Study|Adverse Event|2|||
144290335|NCT00066170|520264459|FG001|Overall Study|Adverse Event|4|||
144290336|NCT00066170|520264460|FG002|Overall Study|Adverse Event|1|||
144290337|NCT00066170|520264461|FG003|Overall Study|Adverse Event|7|||
144290338|NCT00066170|520264458|FG000|Overall Study|Serious Adverse Event|0|||
144290339|NCT00066170|520264459|FG001|Overall Study|Serious Adverse Event|0|||
144290340|NCT00066170|520264460|FG002|Overall Study|Serious Adverse Event|1|||
144290341|NCT00066170|520264461|FG003|Overall Study|Serious Adverse Event|1|||
144290342|NCT00066170|520264458|FG000|Overall Study|Lost to Follow-up|0|||
144290343|NCT00066170|520264459|FG001|Overall Study|Lost to Follow-up|1|||
144290344|NCT00066170|520264460|FG002|Overall Study|Lost to Follow-up|0|||
144290345|NCT00066170|520264461|FG003|Overall Study|Lost to Follow-up|0|||
144290346|NCT00066170|520264458|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
144290347|NCT00066170|520264459|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
144290348|NCT00066170|520264460|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
144290349|NCT00066170|520264461|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
144290350|NCT00066170|520264458|FG000|Overall Study|Protocol Violation|3|||
144290351|NCT00066170|520264459|FG001|Overall Study|Protocol Violation|0|||
144290352|NCT00066170|520264460|FG002|Overall Study|Protocol Violation|0|||
144290353|NCT00066170|520264461|FG003|Overall Study|Protocol Violation|0|||
144290354|NCT00066170|520264458|FG000|Overall Study|Other|1|||
144290355|NCT00066170|520264459|FG001|Overall Study|Other|5|||
144290356|NCT00066170|520264460|FG002|Overall Study|Other|2|||
144290357|NCT00066170|520264461|FG003|Overall Study|Other|0|||
144290358|NCT01370642|520264462|FG000|Overall Study|Adverse Event|2|||
144290359|NCT01370642|520264463|FG001|Overall Study|Adverse Event|1|||
144290360|NCT01370642|520264464|FG002|Overall Study|Adverse Event|1|||
144290361|NCT01370642|520264462|FG000|Overall Study|Detectable HCV RNA|0|||
144290362|NCT01370642|520264463|FG001|Overall Study|Detectable HCV RNA|0|||
144290363|NCT01370642|520264464|FG002|Overall Study|Detectable HCV RNA|22|||
144290364|NCT01370642|520264462|FG000|Overall Study|Lost to Follow-up|0|||
144290365|NCT01370642|520264463|FG001|Overall Study|Lost to Follow-up|0|||
144290366|NCT01370642|520264464|FG002|Overall Study|Lost to Follow-up|1|||
144246714|NCT00934856|520100493|FG000|Extension Part|Progressive disease|0|||
144246715|NCT00934856|520100494|FG001|Extension Part|Progressive disease|0|||
144246716|NCT00934856|520100495|FG002|Extension Part|Progressive disease|0|||
144246717|NCT00934856|520100496|FG003|Extension Part|Progressive disease|1|||
144246718|NCT00934856|520100497|FG004|Extension Part|Progressive disease|0|||
144246719|NCT00934856|520100498|FG005|Extension Part|Progressive disease|0|||
144246720|NCT00934856|520100493|FG000|Extension Part|Non-compliance with drug|0|||
144246721|NCT00934856|520100494|FG001|Extension Part|Non-compliance with drug|0|||
144246722|NCT00934856|520100495|FG002|Extension Part|Non-compliance with drug|0|||
144246723|NCT00934856|520100496|FG003|Extension Part|Non-compliance with drug|0|||
144246724|NCT00934856|520100497|FG004|Extension Part|Non-compliance with drug|0|||
144246725|NCT00934856|520100498|FG005|Extension Part|Non-compliance with drug|1|||
144246726|NCT00772005|520100499|FG000|Overall Study|Adverse Event|9|||
144246727|NCT00772005|520100500|FG001|Overall Study|Adverse Event|14|||
144246728|NCT00772005|520100501|FG002|Overall Study|Adverse Event|10|||
144246729|NCT00772005|520100502|FG003|Overall Study|Adverse Event|13|||
144246730|NCT00772005|520100499|FG000|Overall Study|Lack of Efficacy|0|||
144246731|NCT00772005|520100500|FG001|Overall Study|Lack of Efficacy|1|||
144246732|NCT00772005|520100501|FG002|Overall Study|Lack of Efficacy|0|||
144246733|NCT00772005|520100502|FG003|Overall Study|Lack of Efficacy|0|||
144246734|NCT00772005|520100499|FG000|Overall Study|Withdrawal by Subject|3|||
144246735|NCT00772005|520100500|FG001|Overall Study|Withdrawal by Subject|7|||
144246736|NCT00772005|520100501|FG002|Overall Study|Withdrawal by Subject|10|||
144246737|NCT00772005|520100502|FG003|Overall Study|Withdrawal by Subject|2|||
144246738|NCT00772005|520100499|FG000|Overall Study|Protocol Violation|2|||
144246739|NCT00772005|520100500|FG001|Overall Study|Protocol Violation|4|||
144246740|NCT00772005|520100501|FG002|Overall Study|Protocol Violation|1|||
144246741|NCT00772005|520100502|FG003|Overall Study|Protocol Violation|6|||
144246742|NCT00772005|520100499|FG000|Overall Study|Lost to Follow-up|7|||
144246743|NCT00772005|520100500|FG001|Overall Study|Lost to Follow-up|3|||
144246744|NCT00772005|520100501|FG002|Overall Study|Lost to Follow-up|6|||
144246745|NCT00772005|520100502|FG003|Overall Study|Lost to Follow-up|3|||
144246746|NCT00772005|520100499|FG000|Overall Study|Non-compliance with study procedures|1|||
144246747|NCT00772005|520100500|FG001|Overall Study|Non-compliance with study procedures|1|||
144246748|NCT00772005|520100501|FG002|Overall Study|Non-compliance with study procedures|0|||
144246749|NCT00772005|520100502|FG003|Overall Study|Non-compliance with study procedures|1|||
144246750|NCT00772005|520100499|FG000|Overall Study|Non-compliance with drug administration|3|||
144246751|NCT00772005|520100500|FG001|Overall Study|Non-compliance with drug administration|0|||
144246752|NCT00772005|520100501|FG002|Overall Study|Non-compliance with drug administration|1|||
144246753|NCT00772005|520100502|FG003|Overall Study|Non-compliance with drug administration|1|||
144246754|NCT01162122|520100510|FG000|Overall Study|Withdrawal by Subject|52|||
144246755|NCT01162122|520100511|FG001|Overall Study|Withdrawal by Subject|43|||
144246756|NCT01162122|520100510|FG000|Overall Study|Lost to Follow-up|73|||
144246757|NCT01162122|520100511|FG001|Overall Study|Lost to Follow-up|91|||
144246758|NCT01162122|520100510|FG000|Overall Study|Adverse Event|3|||
144246759|NCT01162122|520100511|FG001|Overall Study|Adverse Event|2|||
144246760|NCT01162122|520100510|FG000|Overall Study|Death|51|||
144246761|NCT01162122|520100511|FG001|Overall Study|Death|46|||
144246762|NCT01162122|520100510|FG000|Overall Study|Protocol Violation|2|||
144246763|NCT01162122|520100511|FG001|Overall Study|Protocol Violation|2|||
144246764|NCT01162122|520100510|FG000|Overall Study|Inappropriate enrollment|5|||
144246765|NCT01162122|520100511|FG001|Overall Study|Inappropriate enrollment|4|||
144246766|NCT01162122|520100510|FG000|Overall Study|Administrative reason|1|||
144246767|NCT01162122|520100511|FG001|Overall Study|Administrative reason|1|||
144246768|NCT01162122|520100510|FG000|Overall Study|Unable to classify|3|||
144246769|NCT01162122|520100511|FG001|Overall Study|Unable to classify|7|||
144246770|NCT01162122|520100510|FG000|Overall Study|Missing primary reason|1|||
144246771|NCT01162122|520100511|FG001|Overall Study|Missing primary reason|0|||
144246772|NCT00926536|520100522|FG000|Overall Study|Physician Decision|1|||
144246773|NCT00926536|520100523|FG001|Overall Study|Physician Decision|2|||
144246774|NCT05087966|520100524|FG000|Overall Study|Lost to Follow-up|1|||
144246775|NCT05087966|520100524|FG000|Overall Study|Withdrawal by Subject|5|||
144246776|NCT01267201|520100525|FG000|First Intervention Period|Withdrawal by Subject|1|||
144246777|NCT01267201|520100526|FG001|First Intervention Period|Withdrawal by Subject|0|||
144246778|NCT01267201|520100527|FG002|First Intervention Period|Withdrawal by Subject|0|||
144246779|NCT01267201|520100528|FG003|First Intervention Period|Withdrawal by Subject|0|||
144246780|NCT01267201|520100529|FG004|First Intervention Period|Withdrawal by Subject|0|||
144246781|NCT01267201|520100530|FG005|First Intervention Period|Withdrawal by Subject|0|||
144246782|NCT01267201|520100525|FG000|Second Intervention Period|Withdrawal by Subject|0|||
144246783|NCT01267201|520100526|FG001|Second Intervention Period|Withdrawal by Subject|1|||
144246784|NCT01267201|520100527|FG002|Second Intervention Period|Withdrawal by Subject|0|||
144246785|NCT01267201|520100528|FG003|Second Intervention Period|Withdrawal by Subject|0|||
144246786|NCT01267201|520100529|FG004|Second Intervention Period|Withdrawal by Subject|0|||
144246787|NCT01267201|520100530|FG005|Second Intervention Period|Withdrawal by Subject|0|||
144246788|NCT02124759|520100531|FG000|Overall Study|Withdrawal by Subject|3|||
144246789|NCT02124759|520100532|FG001|Overall Study|Withdrawal by Subject|1|||
144246790|NCT02124759|520100533|FG002|Overall Study|Withdrawal by Subject|1|||
144246791|NCT02124759|520100531|FG000|Overall Study|Screen Fail|2|||
144246792|NCT02124759|520100532|FG001|Overall Study|Screen Fail|2|||
144246793|NCT02124759|520100533|FG002|Overall Study|Screen Fail|3|||
144246794|NCT00948506|520100534|FG000|Overall Study|Withdrawal by Subject|3|||
144246795|NCT00948506|520100535|FG001|Overall Study|Withdrawal by Subject|1|||
144246796|NCT03912428|520100536|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
144246797|NCT03912428|520100537|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
144246798|NCT03912428|520100538|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
144246799|NCT03912428|520100539|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
144246800|NCT03912428|520100536|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
144246801|NCT03912428|520100537|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
144246802|NCT03912428|520100538|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
144246803|NCT03912428|520100539|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
144246804|NCT03912428|520100536|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
144246805|NCT03912428|520100537|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
144246806|NCT03912428|520100538|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
144246807|NCT03912428|520100539|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
144246808|NCT03233204|520100540|FG000|Overall Study|Adverse Event|1|||
144246809|NCT03233204|520100540|FG000|Overall Study|Death|1|||
144246810|NCT03233204|520100540|FG000|Overall Study|Withdrawal by Subject|1|||
144246811|NCT03233204|520100540|FG000|Overall Study|Progressive Disease|3|||
144246812|NCT00793624|520100541|FG000|Overall Study|Adverse Event|18|||
144246813|NCT00793624|520100542|FG001|Overall Study|Adverse Event|16|||
144246814|NCT00793624|520100543|FG002|Overall Study|Adverse Event|15|||
144246815|NCT00793624|520100544|FG003|Overall Study|Adverse Event|20|||
144246816|NCT00793624|520100541|FG000|Overall Study|Lost to Follow-up|2|||
144246817|NCT00793624|520100542|FG001|Overall Study|Lost to Follow-up|2|||
144246818|NCT00793624|520100543|FG002|Overall Study|Lost to Follow-up|4|||
144246819|NCT00793624|520100544|FG003|Overall Study|Lost to Follow-up|0|||
144246820|NCT00793624|520100541|FG000|Overall Study|Withdrawal by Subject|20|||
144246821|NCT00793624|520100542|FG001|Overall Study|Withdrawal by Subject|9|||
144246822|NCT00793624|520100543|FG002|Overall Study|Withdrawal by Subject|11|||
144246823|NCT00793624|520100544|FG003|Overall Study|Withdrawal by Subject|14|||
144246824|NCT00793624|520100541|FG000|Overall Study|Lack of Efficacy|9|||
144246825|NCT00793624|520100542|FG001|Overall Study|Lack of Efficacy|2|||
144246826|NCT00793624|520100543|FG002|Overall Study|Lack of Efficacy|1|||
144246827|NCT00793624|520100544|FG003|Overall Study|Lack of Efficacy|3|||
144246828|NCT00793624|520100541|FG000|Overall Study|Non compliance with protocol|2|||
144246829|NCT00793624|520100542|FG001|Overall Study|Non compliance with protocol|3|||
144246830|NCT00793624|520100543|FG002|Overall Study|Non compliance with protocol|2|||
144246831|NCT00793624|520100544|FG003|Overall Study|Non compliance with protocol|3|||
144246832|NCT00793624|520100541|FG000|Overall Study|Other reason not described above|6|||
144246833|NCT00793624|520100542|FG001|Overall Study|Other reason not described above|4|||
144246834|NCT00793624|520100543|FG002|Overall Study|Other reason not described above|6|||
144246835|NCT00793624|520100544|FG003|Overall Study|Other reason not described above|3|||
144246836|NCT02044874|520100545|FG000|Overall Study|Adverse Event|5|||
144246837|NCT02044874|520100546|FG001|Overall Study|Adverse Event|6|||
144246838|NCT02044874|520100547|FG002|Overall Study|Adverse Event|6|||
144246839|NCT02044874|520100545|FG000|Overall Study|Withdrawal by Subject|8|||
144246840|NCT02044874|520100546|FG001|Overall Study|Withdrawal by Subject|16|||
144246841|NCT02044874|520100547|FG002|Overall Study|Withdrawal by Subject|23|||
144246842|NCT02044874|520100545|FG000|Overall Study|Physician Decision|0|||
144246843|NCT02044874|520100546|FG001|Overall Study|Physician Decision|2|||
144246844|NCT02044874|520100547|FG002|Overall Study|Physician Decision|1|||
144246845|NCT02044874|520100545|FG000|Overall Study|Lost to Follow-up|10|||
144246846|NCT02044874|520100546|FG001|Overall Study|Lost to Follow-up|27|||
144246847|NCT02044874|520100547|FG002|Overall Study|Lost to Follow-up|21|||
144246848|NCT02044874|520100545|FG000|Overall Study|Sponsor Decision|0|||
144246849|NCT02044874|520100546|FG001|Overall Study|Sponsor Decision|1|||
144246850|NCT02044874|520100547|FG002|Overall Study|Sponsor Decision|1|||
144246851|NCT02044874|520100545|FG000|Overall Study|Other|7|||
144246852|NCT02044874|520100546|FG001|Overall Study|Other|3|||
144246853|NCT02044874|520100547|FG002|Overall Study|Other|8|||
144246854|NCT02987972|520100548|FG000|Overall Study|Adverse Event|1|||
144246855|NCT02987972|520100549|FG001|Overall Study|Adverse Event|1|||
144246856|NCT02987972|520100550|FG002|Overall Study|Adverse Event|0|||
144246857|NCT02987972|520100548|FG000|Overall Study|Death|1|||
144246858|NCT02987972|520100549|FG001|Overall Study|Death|0|||
144246859|NCT02987972|520100550|FG002|Overall Study|Death|0|||
144246860|NCT02987972|520100548|FG000|Overall Study|Lack of Efficacy|9|||
144246861|NCT02987972|520100549|FG001|Overall Study|Lack of Efficacy|12|||
144246862|NCT02987972|520100550|FG002|Overall Study|Lack of Efficacy|12|||
144246863|NCT02987972|520100548|FG000|Overall Study|Lost to Follow-up|7|||
144246864|NCT02987972|520100549|FG001|Overall Study|Lost to Follow-up|8|||
144246865|NCT02987972|520100550|FG002|Overall Study|Lost to Follow-up|4|||
144290367|NCT01370642|520264462|FG000|Overall Study|Physician Decision|4|||
144290368|NCT01370642|520264463|FG001|Overall Study|Physician Decision|1|||
144290369|NCT01370642|520264464|FG002|Overall Study|Physician Decision|2|||
144290370|NCT01370642|520264462|FG000|Overall Study|Withdrawal by Subject|2|||
144290371|NCT01370642|520264463|FG001|Overall Study|Withdrawal by Subject|4|||
144290372|NCT01370642|520264464|FG002|Overall Study|Withdrawal by Subject|3|||
144290373|NCT00987935|520264471|FG000|Overall Study|Progressive disease|3|||
144290374|NCT00987935|520264472|FG001|Overall Study|Progressive disease|2|||
144290375|NCT00987935|520264473|FG002|Overall Study|Progressive disease|3|||
144290376|NCT00987935|520264474|FG003|Overall Study|Progressive disease|2|||
144290377|NCT00987935|520264475|FG004|Overall Study|Progressive disease|5|||
144290378|NCT00987935|520264476|FG005|Overall Study|Progressive disease|3|||
144290379|NCT00987935|520264477|FG006|Overall Study|Progressive disease|9|||
144290380|NCT00987935|520264478|FG007|Overall Study|Progressive disease|48|||
144290381|NCT00987935|520264479|FG008|Overall Study|Progressive disease|23|||
144290382|NCT00987935|520264471|FG000|Overall Study|Adverse Event|0|||
144290383|NCT00987935|520264472|FG001|Overall Study|Adverse Event|1|||
144290384|NCT00987935|520264473|FG002|Overall Study|Adverse Event|0|||
144290385|NCT00987935|520264474|FG003|Overall Study|Adverse Event|1|||
144290386|NCT00987935|520264475|FG004|Overall Study|Adverse Event|1|||
144290387|NCT00987935|520264476|FG005|Overall Study|Adverse Event|0|||
144290388|NCT00987935|520264477|FG006|Overall Study|Adverse Event|2|||
144290389|NCT00987935|520264478|FG007|Overall Study|Adverse Event|10|||
144290390|NCT00987935|520264479|FG008|Overall Study|Adverse Event|6|||
144290391|NCT00987935|520264471|FG000|Overall Study|Refused to continue taking trial med.|1|||
144290392|NCT00987935|520264472|FG001|Overall Study|Refused to continue taking trial med.|0|||
144290393|NCT00987935|520264473|FG002|Overall Study|Refused to continue taking trial med.|0|||
144290394|NCT00987935|520264474|FG003|Overall Study|Refused to continue taking trial med.|0|||
144290395|NCT00987935|520264475|FG004|Overall Study|Refused to continue taking trial med.|1|||
144290396|NCT00987935|520264476|FG005|Overall Study|Refused to continue taking trial med.|0|||
144290397|NCT00987935|520264477|FG006|Overall Study|Refused to continue taking trial med.|4|||
144290398|NCT00987935|520264478|FG007|Overall Study|Refused to continue taking trial med.|4|||
144290399|NCT00987935|520264479|FG008|Overall Study|Refused to continue taking trial med.|2|||
144290400|NCT00987935|520264471|FG000|Overall Study|Reason other than those specified above|0|||
144290401|NCT00987935|520264472|FG001|Overall Study|Reason other than those specified above|0|||
144290402|NCT00987935|520264473|FG002|Overall Study|Reason other than those specified above|0|||
144290403|NCT00987935|520264474|FG003|Overall Study|Reason other than those specified above|0|||
144290404|NCT00987935|520264475|FG004|Overall Study|Reason other than those specified above|0|||
144290405|NCT00987935|520264476|FG005|Overall Study|Reason other than those specified above|0|||
144290406|NCT00987935|520264477|FG006|Overall Study|Reason other than those specified above|0|||
144290407|NCT00987935|520264478|FG007|Overall Study|Reason other than those specified above|0|||
144290408|NCT00987935|520264479|FG008|Overall Study|Reason other than those specified above|1|||
144290409|NCT00452530|520264480|FG000|Overall Study|Death|1|||
144290410|NCT00452530|520264481|FG001|Overall Study|Death|0|||
144290411|NCT00452530|520264480|FG000|Overall Study|Adverse Event|40|||
144290412|NCT00452530|520264481|FG001|Overall Study|Adverse Event|44|||
144290413|NCT00452530|520264480|FG000|Overall Study|Withdrawal by Subject|68|||
144290414|NCT00452530|520264481|FG001|Overall Study|Withdrawal by Subject|57|||
144290415|NCT00452530|520264480|FG000|Overall Study|Lost to Follow-up|1|||
144290416|NCT00452530|520264481|FG001|Overall Study|Lost to Follow-up|0|||
144290417|NCT00452530|520264480|FG000|Overall Study|Poor compliance/noncompliance|1|||
144290418|NCT00452530|520264481|FG001|Overall Study|Poor compliance/noncompliance|2|||
144290419|NCT00452530|520264480|FG000|Overall Study|No longer met study criteria|18|||
144290420|NCT00452530|520264481|FG001|Overall Study|No longer met study criteria|22|||
144290421|NCT00452530|520264480|FG000|Overall Study|Other|7|||
144290422|NCT00452530|520264481|FG001|Overall Study|Other|11|||
144290423|NCT03888482|520264482|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
144290424|NCT03888482|520264483|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
144290425|NCT03888482|520264482|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
144290426|NCT03888482|520264483|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
144290427|NCT01189227|520264484|FG000|Overall Study|Study terminated due to low accrual|6|||
144290428|NCT01189227|520264485|FG001|Overall Study|Study terminated due to low accrual|3|||
144290429|NCT00563316|520264486|FG000|Overall Study|Adverse Event|2|||
144290430|NCT00563316|520264486|FG000|Overall Study|Physician Decision|1|||
144290431|NCT00563316|520264486|FG000|Overall Study|Lost to Follow-up|2|||
144290432|NCT00563316|520264486|FG000|Overall Study|Death|1|||
144290433|NCT00563316|520264486|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
144290434|NCT00563316|520264486|FG000|Overall Study|Other|1|||
144290435|NCT00425854|520264488|FG000|Overall Study|Progressive Disease|19|||
144290436|NCT00425854|520264489|FG001|Overall Study|Progressive Disease|12|||
144290437|NCT00425854|520264488|FG000|Overall Study|Dose reduction toxicity AE|8|||
144290438|NCT00425854|520264489|FG001|Overall Study|Dose reduction toxicity AE|7|||
144290439|NCT00425854|520264488|FG000|Overall Study|Other Adverse Event|2|||
144290440|NCT00425854|520264489|FG001|Overall Study|Other Adverse Event|2|||
144290441|NCT01630811|520264495|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
144290442|NCT01630811|520264496|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
144290443|NCT04818086|520264499|FG000|Overall Study|Physician Decision|1|||
144290444|NCT04818086|520264500|FG001|Overall Study|Physician Decision|0|||
144290445|NCT04818086|520264499|FG000|Overall Study|Withdrawal by Subject|0|||
144290446|NCT04818086|520264500|FG001|Overall Study|Withdrawal by Subject|1|||
144290447|NCT06048705|520264502|FG000|Overall Study|Physician Decision|1|||
144290448|NCT06048705|520264503|FG001|Overall Study|Physician Decision|0|||
144290449|NCT06048705|520264504|FG002|Overall Study|Physician Decision|0|||
144290450|NCT06048705|520264502|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
144290451|NCT06048705|520264503|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
144290452|NCT06048705|520264504|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
144290453|NCT06048705|520264502|FG000|Overall Study|Death prior to lymphodepletion|0|||
144290454|NCT06048705|520264503|FG001|Overall Study|Death prior to lymphodepletion|0|||
144290455|NCT06048705|520264504|FG002|Overall Study|Death prior to lymphodepletion|1|||
144290456|NCT00954538|520264510|FG000|Part III|Withdrawal by Subject|0|||
144290457|NCT00954538|520264511|FG001|Part III|Withdrawal by Subject|0|||
144290458|NCT00954538|520264512|FG002|Part III|Withdrawal by Subject|0|||
144290459|NCT00954538|520264513|FG003|Part III|Withdrawal by Subject|0|||
144290460|NCT00954538|520264514|FG004|Part III|Withdrawal by Subject|1|||
144290461|NCT00954538|520264515|FG005|Part III|Withdrawal by Subject|0|||
144290462|NCT01905683|520264516|FG000|Overall Study|Protocol Violation|1|||
144290463|NCT01905683|520264516|FG000|Overall Study|Re-injection criteria not met; others|13|||
144290464|NCT01905683|520264516|FG000|Overall Study|Physician Decision|1|||
144290465|NCT01905683|520264516|FG000|Overall Study|Lack of Efficacy|8|||
144290466|NCT01905683|520264516|FG000|Overall Study|Withdrawal by Subject|20|||
144290467|NCT01905683|520264516|FG000|Overall Study|Adverse Event|4|||
144290468|NCT01905683|520264516|FG000|Overall Study|Lost to Follow-up|4|||
144290469|NCT00537082|520264521|FG000|Overall Study|Adverse Event|6|||
144290470|NCT00537082|520264522|FG001|Overall Study|Adverse Event|6|||
144290471|NCT00537082|520264523|FG002|Overall Study|Adverse Event|3|||
144290472|NCT00537082|520264521|FG000|Overall Study|Protocol Violation|0|||
144290473|NCT00537082|520264522|FG001|Overall Study|Protocol Violation|2|||
144290474|NCT00537082|520264523|FG002|Overall Study|Protocol Violation|1|||
144290475|NCT00537082|520264521|FG000|Overall Study|Lack of Efficacy|0|||
144290476|NCT00537082|520264522|FG001|Overall Study|Lack of Efficacy|0|||
144290477|NCT00537082|520264523|FG002|Overall Study|Lack of Efficacy|2|||
144290478|NCT00537082|520264521|FG000|Overall Study|Withdrawal by Subject|0|||
144290479|NCT00537082|520264522|FG001|Overall Study|Withdrawal by Subject|1|||
144290480|NCT00537082|520264523|FG002|Overall Study|Withdrawal by Subject|0|||
144290481|NCT00537082|520264521|FG000|Overall Study|Discontinued before initiating treatment|3|||
144290482|NCT00537082|520264522|FG001|Overall Study|Discontinued before initiating treatment|0|||
144290483|NCT00537082|520264523|FG002|Overall Study|Discontinued before initiating treatment|0|||
144290484|NCT02568254|520264524|FG000|Period 2|Adverse Event|0|||
144290485|NCT02568254|520264525|FG001|Period 2|Adverse Event|0|||
144290486|NCT02568254|520264526|FG002|Period 2|Adverse Event|1|||
144290487|NCT02568254|520264527|FG003|Period 2|Adverse Event|0|||
144290488|NCT02568254|520264528|FG004|Period 2|Adverse Event|0|||
144290489|NCT02568254|520264529|FG005|Period 2|Adverse Event|0|||
144290490|NCT02568254|520264524|FG000|Period 3|Unstatisfactory Lens fitting|0|||
144290491|NCT02568254|520264525|FG001|Period 3|Unstatisfactory Lens fitting|0|||
144290492|NCT02568254|520264526|FG002|Period 3|Unstatisfactory Lens fitting|0|||
144290493|NCT02568254|520264527|FG003|Period 3|Unstatisfactory Lens fitting|0|||
144290494|NCT02568254|520264528|FG004|Period 3|Unstatisfactory Lens fitting|1|||
144290495|NCT02568254|520264529|FG005|Period 3|Unstatisfactory Lens fitting|0|||
144290496|NCT03061214|520264534|FG000|Overall Study|Withdrawal by Subject|21|||
144290497|NCT03061214|520264535|FG001|Overall Study|Withdrawal by Subject|26|||
144290498|NCT03061214|520264536|FG002|Overall Study|Withdrawal by Subject|9|||
144290499|NCT03061214|520264534|FG000|Overall Study|Lost to Follow-up|3|||
144290500|NCT03061214|520264535|FG001|Overall Study|Lost to Follow-up|1|||
144290501|NCT03061214|520264536|FG002|Overall Study|Lost to Follow-up|1|||
144290502|NCT03061214|520264534|FG000|Overall Study|Death|1|||
144290503|NCT03061214|520264535|FG001|Overall Study|Death|1|||
144290504|NCT03061214|520264536|FG002|Overall Study|Death|0|||
144290505|NCT01569763|520266574|FG000|Overall Study|Lack of Efficacy|2|||
144290506|NCT01569763|520266575|FG001|Overall Study|Lack of Efficacy|7|||
144290507|NCT01569763|520266574|FG000|Overall Study|Adverse Event|1|||
144290508|NCT01569763|520266575|FG001|Overall Study|Adverse Event|0|||
144290509|NCT02469961|520266577|FG000|Overall Study|Physician Decision|4|||
144290510|NCT02469961|520266578|FG001|Overall Study|Physician Decision|1|||
144290511|NCT00368849|520266583|FG000|Overall Study|Withdrawal by Subject|0|||
144290512|NCT00368849|520266584|FG001|Overall Study|Withdrawal by Subject|1|||
144290513|NCT00368849|520266583|FG000|Overall Study|Physician Decision|0|||
144290514|NCT00368849|520266584|FG001|Overall Study|Physician Decision|1|||
144290515|NCT05058456|520266588|FG000|Overall Study|Death|1|||
144290516|NCT05058456|520266588|FG000|Overall Study|End of Study data not yet due for release|34|||
144290517|NCT01832038|520266589|FG000|Overall Study|Death|5|||
144290518|NCT01832038|520266589|FG000|Overall Study|Adverse Event|50|||
144290519|NCT01832038|520266589|FG000|Overall Study|Lack of Efficacy|81|||
144290520|NCT01832038|520266589|FG000|Overall Study|Protocol Violation|7|||
144290521|NCT01832038|520266589|FG000|Overall Study|Lost to Follow-up|10|||
144290522|NCT01832038|520266589|FG000|Overall Study|Withdrawal by Subject|49|||
144290523|NCT01832038|520266589|FG000|Overall Study|Visit non-compliance|2|||
144290524|NCT01832038|520266589|FG000|Overall Study|Subject refused to return visit|2|||
144290525|NCT01832038|520266589|FG000|Overall Study|Not convenient to come back to site|2|||
144290526|NCT01832038|520266589|FG000|Overall Study|Participant was asked to quit|5|||
144290527|NCT01832038|520266589|FG000|Overall Study|Back home|1|||
144290528|NCT01832038|520266589|FG000|Overall Study|Pregnancy|1|||
144290529|NCT01832038|520266589|FG000|Overall Study|Low compliance|3|||
144290530|NCT01832038|520266589|FG000|Overall Study|Prohibit procedure|2|||
144290531|NCT01832038|520266589|FG000|Overall Study|Not possible to visit the hospital|1|||
144290532|NCT01832038|520266589|FG000|Overall Study|Changes of implementation system|3|||
144290533|NCT01832038|520266589|FG000|Overall Study|Plan to pregnancy|7|||
144290534|NCT01832038|520266589|FG000|Overall Study|Bad mood and has suicidal thought|1|||
144290535|NCT01832038|520266589|FG000|Overall Study|Prohibited concomitant medication|1|||
144290536|NCT01832038|520266589|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
144290537|NCT01832038|520266589|FG000|Overall Study|Subject considered the efficacy was poor|1|||
144290538|NCT03211858|520266590|FG000|Overall Study|Adverse Event|8|||
144290539|NCT03211858|520266591|FG001|Overall Study|Adverse Event|6|||
144290540|NCT03211858|520266590|FG000|Overall Study|Lack of Efficacy|0|||
144290541|NCT03211858|520266591|FG001|Overall Study|Lack of Efficacy|4|||
144290542|NCT03211858|520266590|FG000|Overall Study|Poor compliance to protocol|6|||
144290543|NCT03211858|520266591|FG001|Overall Study|Poor compliance to protocol|2|||
144290544|NCT03211858|520266590|FG000|Overall Study|Non-serious Hypoglycemia|1|||
144290545|NCT03211858|520266591|FG001|Overall Study|Non-serious Hypoglycemia|0|||
144290546|NCT03211858|520266590|FG000|Overall Study|Other than specified above|22|||
144290547|NCT03211858|520266591|FG001|Overall Study|Other than specified above|21|||
144290548|NCT01730729|520266593|FG000|Overall Study|Adverse Event|1|||
144290549|NCT01730729|520266593|FG000|Overall Study|Death|1|||
144290550|NCT01730729|520266593|FG000|Overall Study|Progressive Disease|12|||
144290551|NCT01052428|520266594|FG000|Overall Study|Death|1|||
144290552|NCT01052428|520266595|FG001|Overall Study|Death|0|||
144290553|NCT01052428|520266594|FG000|Overall Study|Withdrawal by Subject|0|||
144290554|NCT01052428|520266595|FG001|Overall Study|Withdrawal by Subject|1|||
144290555|NCT00871000|520266596|FG000|Overall Study|Withdrawal by Subject|1|||
144290556|NCT00871000|520266597|FG001|Overall Study|Withdrawal by Subject|0|||
144290557|NCT03400787|520266598|FG000|Overall Study|Lost to Follow-up|1|||
144290558|NCT03400787|520266599|FG001|Overall Study|Lost to Follow-up|0|||
144290559|NCT03400787|520266598|FG000|Overall Study|Death|1|||
144290560|NCT03400787|520266599|FG001|Overall Study|Death|0|||
144290561|NCT03400787|520266598|FG000|Overall Study|Protocol Violation|0|||
144290562|NCT03400787|520266599|FG001|Overall Study|Protocol Violation|2|||
144290563|NCT03400787|520266598|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
144290564|NCT03400787|520266599|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
144290565|NCT02402907|520266604|FG000|Overall Study|Delivered vaginally|9|||
144290566|NCT02402907|520266605|FG001|Overall Study|Delivered vaginally|3|||
144290567|NCT02402907|520266604|FG000|Overall Study|Delivered outside of Sinai|1|||
144290568|NCT02402907|520266605|FG001|Overall Study|Delivered outside of Sinai|1|||
144290569|NCT02402907|520266604|FG000|Overall Study|Lost to follow up after C-Section|10|||
144290570|NCT02402907|520266605|FG001|Overall Study|Lost to follow up after C-Section|23|||
144290571|NCT02595437|520266611|FG000|Triferic Via IV|Withdrawal by Subject|1|||
144290572|NCT01423084|520266612|FG000|Overall Study|Adverse Event|0|||
144290573|NCT01423084|520266613|FG001|Overall Study|Adverse Event|1|||
144290574|NCT01423084|520266612|FG000|Overall Study|Withdrawal by Subject|2|||
144290575|NCT01423084|520266613|FG001|Overall Study|Withdrawal by Subject|3|||
144290576|NCT03574389|520266617|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
144290577|NCT03574389|520266618|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
144290578|NCT03574389|520266619|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
144290579|NCT03574389|520266620|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
144290580|NCT03574389|520266621|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
144290581|NCT03574389|520266622|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
144290582|NCT03574389|520266623|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
144290583|NCT03574389|520266617|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
144290584|NCT03574389|520266618|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
144290585|NCT03574389|520266619|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
144290586|NCT03574389|520266620|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
144290587|NCT03574389|520266621|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
144290588|NCT03574389|520266622|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
144290589|NCT03574389|520266623|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
144290590|NCT03574389|520266617|FG000|Vaccination Period|Other|6|||
144290591|NCT03574389|520266618|FG001|Vaccination Period|Other|0|||
144290592|NCT03574389|520266619|FG002|Vaccination Period|Other|0|||
144290593|NCT03574389|520266620|FG003|Vaccination Period|Other|0|||
144290594|NCT03574389|520266621|FG004|Vaccination Period|Other|0|||
144290595|NCT03574389|520266622|FG005|Vaccination Period|Other|0|||
144290596|NCT03574389|520266623|FG006|Vaccination Period|Other|0|||
144290597|NCT03574389|520266617|FG000|Vaccination Period|Adverse Event|0|||
144290598|NCT03574389|520266618|FG001|Vaccination Period|Adverse Event|1|||
144290599|NCT03574389|520266619|FG002|Vaccination Period|Adverse Event|0|||
144290600|NCT03574389|520266620|FG003|Vaccination Period|Adverse Event|0|||
144290601|NCT03574389|520266621|FG004|Vaccination Period|Adverse Event|0|||
144290602|NCT03574389|520266622|FG005|Vaccination Period|Adverse Event|0|||
144290603|NCT03574389|520266623|FG006|Vaccination Period|Adverse Event|0|||
144290604|NCT03574389|520266617|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
144290605|NCT03574389|520266618|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
144290606|NCT03574389|520266619|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
144290607|NCT03574389|520266620|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
144290608|NCT03574389|520266621|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
144290609|NCT03574389|520266622|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
144290610|NCT03574389|520266623|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
144290611|NCT02837952|520266624|FG000|Overall Study|Adverse Event|0|||
144290612|NCT02837952|520266625|FG001|Overall Study|Adverse Event|1|||
144290613|NCT02837952|520266624|FG000|Overall Study|Withdrawal by Subject|4|||
144290614|NCT02837952|520266625|FG001|Overall Study|Withdrawal by Subject|5|||
144290615|NCT02837952|520266624|FG000|Overall Study|Medication Error|1|||
144290616|NCT02837952|520266625|FG001|Overall Study|Medication Error|0|||
144290617|NCT02070380|520266626|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
144290618|NCT02070380|520266627|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
144290619|NCT02070380|520266628|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
144290620|NCT02070380|520266629|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
144290621|NCT02070380|520266626|FG000|Second Injection|Image sets missing or technically inadeq|0|||
144290622|NCT02070380|520266627|FG001|Second Injection|Image sets missing or technically inadeq|1|||
144290623|NCT02070380|520266628|FG002|Second Injection|Image sets missing or technically inadeq|0|||
144290624|NCT02070380|520266629|FG003|Second Injection|Image sets missing or technically inadeq|0|||
144290625|NCT02070380|520266626|FG000|Second Injection|Protocol Violation|0|||
144290626|NCT02070380|520266627|FG001|Second Injection|Protocol Violation|1|||
144290627|NCT02070380|520266628|FG002|Second Injection|Protocol Violation|1|||
144290628|NCT02070380|520266629|FG003|Second Injection|Protocol Violation|5|||
144290629|NCT01682603|520266640|FG000|Overall Study|Lost to Follow-up|3|||
144290630|NCT01791205|520266642|FG000|Phase II|Lack of Efficacy|6|||
144290631|NCT01791205|520266643|FG001|Phase II|Lack of Efficacy|0|||
144290632|NCT01791205|520266642|FG000|Phase II|Adverse Event|2|||
144290633|NCT01791205|520266643|FG001|Phase II|Adverse Event|0|||
144290634|NCT01791205|520266642|FG000|Phase II|Safety|1|||
144290635|NCT01791205|520266643|FG001|Phase II|Safety|0|||
144290636|NCT01791205|520266642|FG000|Phase II|Lost to Follow-up|1|||
144290637|NCT01791205|520266643|FG001|Phase II|Lost to Follow-up|0|||
144290638|NCT01791205|520266642|FG000|Phase II|Remission of disease|1|||
144290639|NCT01791205|520266643|FG001|Phase II|Remission of disease|0|||
144290640|NCT01791205|520266642|FG000|Phase II|Physician's decision|1|||
144290641|NCT01791205|520266643|FG001|Phase II|Physician's decision|0|||
144290642|NCT01908699|520266644|FG000|Overall Study|Adverse Event|8|||
144290643|NCT01908699|520266645|FG001|Overall Study|Adverse Event|12|||
144290644|NCT01908699|520266644|FG000|Overall Study|Lack of Efficacy|2|||
144290645|NCT01908699|520266645|FG001|Overall Study|Lack of Efficacy|2|||
144290646|NCT01908699|520266644|FG000|Overall Study|Lost to Follow-up|2|||
144290647|NCT01908699|520266645|FG001|Overall Study|Lost to Follow-up|4|||
144290648|NCT01908699|520266644|FG000|Overall Study|Physician Decision|8|||
144290649|NCT01908699|520266645|FG001|Overall Study|Physician Decision|8|||
144290650|NCT01908699|520266644|FG000|Overall Study|Withdrawal by Subject|15|||
144290651|NCT01908699|520266645|FG001|Overall Study|Withdrawal by Subject|10|||
144290652|NCT01908699|520266644|FG000|Overall Study|Pregnancy|0|||
144290653|NCT01908699|520266645|FG001|Overall Study|Pregnancy|1|||
144290654|NCT01908699|520266644|FG000|Overall Study|Randomized in Error|1|||
144290655|NCT01908699|520266645|FG001|Overall Study|Randomized in Error|0|||
144290656|NCT01908699|520266644|FG000|Overall Study|Death|9|||
144290657|NCT01908699|520266645|FG001|Overall Study|Death|12|||
144290658|NCT01908699|520266644|FG000|Overall Study|Progressive Disease|30|||
144290659|NCT01908699|520266645|FG001|Overall Study|Progressive Disease|29|||
144290660|NCT01697501|520266646|FG000|Overall Study|Protocol Violation|2|||
144290661|NCT02242903|520266647|FG000|Overall Study|Withdrawal by Subject|1|||
144290662|NCT02242903|520266648|FG001|Overall Study|Withdrawal by Subject|0|||
144290663|NCT02242903|520266649|FG002|Overall Study|Withdrawal by Subject|0|||
144290664|NCT02242903|520266650|FG003|Overall Study|Withdrawal by Subject|0|||
144290665|NCT02242903|520266651|FG004|Overall Study|Withdrawal by Subject|0|||
144290666|NCT02242903|520266652|FG005|Overall Study|Withdrawal by Subject|0|||
144290667|NCT02242903|520266653|FG006|Overall Study|Withdrawal by Subject|0|||
144290668|NCT03436420|520266656|FG000|Overall Study|Lack of Efficacy|3|||
144290669|NCT00281580|520266658|FG000|Overall Study|Adverse Event|2|||
144290670|NCT00281580|520266659|FG001|Overall Study|Adverse Event|0|||
144290671|NCT00281580|520266660|FG002|Overall Study|Adverse Event|2|||
144290672|NCT00281580|520266661|FG003|Overall Study|Adverse Event|4|||
144290673|NCT00281580|520266662|FG004|Overall Study|Adverse Event|1|||
144290674|NCT00281580|520266663|FG005|Overall Study|Adverse Event|0|||
144290675|NCT00281580|520266664|FG006|Overall Study|Adverse Event|1|||
144290676|NCT00281580|520266665|FG007|Overall Study|Adverse Event|0|||
144290677|NCT00281580|520266666|FG008|Overall Study|Adverse Event|1|||
144290678|NCT00281580|520266667|FG009|Overall Study|Adverse Event|6|||
144290679|NCT00281580|520266668|FG010|Overall Study|Adverse Event|0|||
144290680|NCT00281580|520266669|FG011|Overall Study|Adverse Event|5|||
144290681|NCT00281580|520266670|FG012|Overall Study|Adverse Event|8|||
144290682|NCT00281580|520266671|FG013|Overall Study|Adverse Event|2|||
144290683|NCT00281580|520266672|FG014|Overall Study|Adverse Event|3|||
144290684|NCT00281580|520266673|FG015|Overall Study|Adverse Event|3|||
144290685|NCT00281580|520266658|FG000|Overall Study|Protocol Violation|0|||
144290686|NCT00281580|520266659|FG001|Overall Study|Protocol Violation|0|||
144290687|NCT00281580|520266660|FG002|Overall Study|Protocol Violation|1|||
144290688|NCT00281580|520266661|FG003|Overall Study|Protocol Violation|1|||
144290689|NCT00281580|520266662|FG004|Overall Study|Protocol Violation|0|||
144290690|NCT00281580|520266663|FG005|Overall Study|Protocol Violation|0|||
144290691|NCT00281580|520266664|FG006|Overall Study|Protocol Violation|1|||
144290692|NCT00281580|520266665|FG007|Overall Study|Protocol Violation|0|||
144290693|NCT00281580|520266666|FG008|Overall Study|Protocol Violation|2|||
144290694|NCT00281580|520266667|FG009|Overall Study|Protocol Violation|0|||
144290695|NCT00281580|520266668|FG010|Overall Study|Protocol Violation|1|||
144290696|NCT00281580|520266669|FG011|Overall Study|Protocol Violation|2|||
144290697|NCT00281580|520266670|FG012|Overall Study|Protocol Violation|0|||
144290698|NCT00281580|520266671|FG013|Overall Study|Protocol Violation|1|||
144290699|NCT00281580|520266672|FG014|Overall Study|Protocol Violation|1|||
144290700|NCT00281580|520266673|FG015|Overall Study|Protocol Violation|3|||
144290701|NCT00281580|520266658|FG000|Overall Study|Withdrawal by Subject|3|||
144290702|NCT00281580|520266659|FG001|Overall Study|Withdrawal by Subject|0|||
144290703|NCT00281580|520266660|FG002|Overall Study|Withdrawal by Subject|1|||
144290704|NCT00281580|520266661|FG003|Overall Study|Withdrawal by Subject|1|||
144290705|NCT00281580|520266662|FG004|Overall Study|Withdrawal by Subject|1|||
144290706|NCT00281580|520266663|FG005|Overall Study|Withdrawal by Subject|2|||
144290707|NCT00281580|520266664|FG006|Overall Study|Withdrawal by Subject|2|||
144290708|NCT00281580|520266665|FG007|Overall Study|Withdrawal by Subject|0|||
144290709|NCT00281580|520266666|FG008|Overall Study|Withdrawal by Subject|1|||
144290710|NCT00281580|520266667|FG009|Overall Study|Withdrawal by Subject|4|||
144290711|NCT00281580|520266668|FG010|Overall Study|Withdrawal by Subject|1|||
144290712|NCT00281580|520266669|FG011|Overall Study|Withdrawal by Subject|1|||
144290713|NCT00281580|520266670|FG012|Overall Study|Withdrawal by Subject|2|||
144290714|NCT00281580|520266671|FG013|Overall Study|Withdrawal by Subject|2|||
144290715|NCT00281580|520266672|FG014|Overall Study|Withdrawal by Subject|1|||
144290716|NCT00281580|520266673|FG015|Overall Study|Withdrawal by Subject|5|||
144290717|NCT00281580|520266658|FG000|Overall Study|Lack of Efficacy|2|||
144290718|NCT00281580|520266659|FG001|Overall Study|Lack of Efficacy|1|||
144290719|NCT00281580|520266660|FG002|Overall Study|Lack of Efficacy|1|||
144290720|NCT00281580|520266661|FG003|Overall Study|Lack of Efficacy|6|||
144290721|NCT00281580|520266662|FG004|Overall Study|Lack of Efficacy|2|||
144290722|NCT00281580|520266663|FG005|Overall Study|Lack of Efficacy|0|||
144290723|NCT00281580|520266664|FG006|Overall Study|Lack of Efficacy|0|||
144290724|NCT00281580|520266665|FG007|Overall Study|Lack of Efficacy|0|||
144290725|NCT00281580|520266666|FG008|Overall Study|Lack of Efficacy|0|||
144290726|NCT00281580|520266667|FG009|Overall Study|Lack of Efficacy|0|||
144290727|NCT00281580|520266668|FG010|Overall Study|Lack of Efficacy|0|||
144290728|NCT00281580|520266669|FG011|Overall Study|Lack of Efficacy|1|||
144290729|NCT00281580|520266670|FG012|Overall Study|Lack of Efficacy|0|||
144290730|NCT00281580|520266671|FG013|Overall Study|Lack of Efficacy|2|||
144290731|NCT00281580|520266672|FG014|Overall Study|Lack of Efficacy|1|||
144290732|NCT00281580|520266673|FG015|Overall Study|Lack of Efficacy|0|||
144290733|NCT00281580|520266658|FG000|Overall Study|Lost to Follow-up|0|||
144290734|NCT00281580|520266659|FG001|Overall Study|Lost to Follow-up|0|||
144290735|NCT00281580|520266660|FG002|Overall Study|Lost to Follow-up|0|||
144290736|NCT00281580|520266661|FG003|Overall Study|Lost to Follow-up|3|||
144290737|NCT00281580|520266662|FG004|Overall Study|Lost to Follow-up|0|||
144290738|NCT00281580|520266663|FG005|Overall Study|Lost to Follow-up|1|||
144290739|NCT00281580|520266664|FG006|Overall Study|Lost to Follow-up|0|||
144290740|NCT00281580|520266665|FG007|Overall Study|Lost to Follow-up|1|||
144290741|NCT00281580|520266666|FG008|Overall Study|Lost to Follow-up|2|||
144290742|NCT00281580|520266667|FG009|Overall Study|Lost to Follow-up|1|||
144290743|NCT00281580|520266668|FG010|Overall Study|Lost to Follow-up|1|||
144290744|NCT00281580|520266669|FG011|Overall Study|Lost to Follow-up|0|||
144290745|NCT00281580|520266670|FG012|Overall Study|Lost to Follow-up|1|||
144290746|NCT00281580|520266671|FG013|Overall Study|Lost to Follow-up|0|||
144290747|NCT00281580|520266672|FG014|Overall Study|Lost to Follow-up|0|||
144290748|NCT00281580|520266673|FG015|Overall Study|Lost to Follow-up|0|||
144290749|NCT00281580|520266658|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
144290750|NCT00281580|520266659|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
144290751|NCT00281580|520266660|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
144290752|NCT00281580|520266661|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
144290753|NCT00281580|520266662|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
144290754|NCT00281580|520266663|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
144290755|NCT00281580|520266664|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
144290756|NCT00281580|520266665|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
144290757|NCT00281580|520266666|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
144290758|NCT00281580|520266667|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
144290759|NCT00281580|520266668|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
144290760|NCT00281580|520266669|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
144290761|NCT00281580|520266670|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
144290762|NCT00281580|520266671|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
144290763|NCT00281580|520266672|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
144290764|NCT00281580|520266673|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
144290765|NCT03596983|520266680|FG000|Overall Study|Withdrawal by Subject|3|||
144290766|NCT03473301|520266681|FG000|Overall Study|Protocol Violation|4|||
144290767|NCT03473301|520266682|FG001|Overall Study|Protocol Violation|0|||
144290768|NCT03473301|520266683|FG002|Overall Study|Protocol Violation|0|||
144290769|NCT03473301|520266681|FG000|Overall Study|Withdrawal by Subject|0|||
144290770|NCT03473301|520266682|FG001|Overall Study|Withdrawal by Subject|1|||
144290771|NCT03473301|520266683|FG002|Overall Study|Withdrawal by Subject|0|||
144290772|NCT03473301|520266681|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
144290773|NCT03473301|520266682|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
144290774|NCT03473301|520266683|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
144290775|NCT04829214|520266684|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
144290776|NCT04829214|520266685|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
144290777|NCT04829214|520266684|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
144290778|NCT04829214|520266685|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
144290779|NCT05287685|520266686|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
144290780|NCT05287685|520266687|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
144290781|NCT05287685|520266686|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
144290782|NCT05287685|520266687|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
144290783|NCT01714063|520266693|FG000|Overall Study|Equipment malfunction|2|||
144290784|NCT02191397|520266695|FG000|Overall Study|Adverse Event|28|||
144290785|NCT02191397|520266696|FG001|Overall Study|Adverse Event|17|||
144290786|NCT02191397|520266695|FG000|Overall Study|Lack of Efficacy|10|||
144290787|NCT02191397|520266696|FG001|Overall Study|Lack of Efficacy|5|||
144290788|NCT02191397|520266695|FG000|Overall Study|Protocol Violation|0|||
144290789|NCT02191397|520266696|FG001|Overall Study|Protocol Violation|3|||
144290790|NCT02191397|520266695|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
144290791|NCT02191397|520266696|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
144290792|NCT02191397|520266695|FG000|Overall Study|Lost to Follow-up|10|||
144290793|NCT02191397|520266696|FG001|Overall Study|Lost to Follow-up|11|||
144290794|NCT02191397|520266695|FG000|Overall Study|Physician Decision|8|||
144290795|NCT02191397|520266696|FG001|Overall Study|Physician Decision|3|||
144290796|NCT02191397|520266695|FG000|Overall Study|Withdrawal by Subject|22|||
144290797|NCT02191397|520266696|FG001|Overall Study|Withdrawal by Subject|27|||
144290798|NCT01725308|520266700|FG000|Treatment Period I|Did Not Receive Drug|1|||
144290799|NCT01725308|520266701|FG001|Treatment Period I|Did Not Receive Drug|0|||
144290800|NCT01725308|520266702|FG002|Treatment Period I|Did Not Receive Drug|0|||
144290801|NCT01725308|520266700|FG000|Treatment Period I|Adverse Event|5|||
144290802|NCT01725308|520266701|FG001|Treatment Period I|Adverse Event|4|||
144290803|NCT01725308|520266702|FG002|Treatment Period I|Adverse Event|21|||
144290804|NCT01725308|520266700|FG000|Treatment Period I|Insufficient Response|7|||
144290805|NCT01725308|520266701|FG001|Treatment Period I|Insufficient Response|0|||
144290806|NCT01725308|520266702|FG002|Treatment Period I|Insufficient Response|5|||
144290807|NCT01725308|520266700|FG000|Treatment Period I|Worsening of the Target Disease|8|||
144290808|NCT01725308|520266701|FG001|Treatment Period I|Worsening of the Target Disease|0|||
144290809|NCT01725308|520266702|FG002|Treatment Period I|Worsening of the Target Disease|2|||
144290810|NCT01725308|520266700|FG000|Treatment Period I|Changes in the Episodes|3|||
144290811|NCT01725308|520266701|FG001|Treatment Period I|Changes in the Episodes|0|||
144290812|NCT01725308|520266702|FG002|Treatment Period I|Changes in the Episodes|2|||
144290813|NCT01725308|520266700|FG000|Treatment Period I|Withdrawal of Consent|12|||
144290814|NCT01725308|520266701|FG001|Treatment Period I|Withdrawal of Consent|7|||
144290815|NCT01725308|520266702|FG002|Treatment Period I|Withdrawal of Consent|5|||
144290816|NCT01725308|520266700|FG000|Treatment Period I|Lost to Follow-up|3|||
144290817|NCT01725308|520266701|FG001|Treatment Period I|Lost to Follow-up|2|||
144290818|NCT01725308|520266702|FG002|Treatment Period I|Lost to Follow-up|2|||
144246866|NCT02987972|520100548|FG000|Overall Study|Physician Decision|1|||
144246867|NCT02987972|520100549|FG001|Overall Study|Physician Decision|6|||
144246868|NCT02987972|520100550|FG002|Overall Study|Physician Decision|0|||
144246869|NCT02987972|520100548|FG000|Overall Study|Protocol Violation|2|||
144246870|NCT02987972|520100549|FG001|Overall Study|Protocol Violation|1|||
144246871|NCT02987972|520100550|FG002|Overall Study|Protocol Violation|5|||
144246872|NCT02987972|520100548|FG000|Overall Study|Withdrawal by Subject|22|||
144246873|NCT02987972|520100549|FG001|Overall Study|Withdrawal by Subject|17|||
144246874|NCT02987972|520100550|FG002|Overall Study|Withdrawal by Subject|21|||
144246875|NCT02342548|520100551|FG000|Overall Study|Adverse Event|12|||
144246876|NCT02342548|520100552|FG001|Overall Study|Adverse Event|17|||
144246877|NCT02342548|520100553|FG002|Overall Study|Adverse Event|13|||
144246878|NCT02342548|520100551|FG000|Overall Study|Lost to Follow-up|0|||
144246879|NCT02342548|520100552|FG001|Overall Study|Lost to Follow-up|1|||
144246880|NCT02342548|520100553|FG002|Overall Study|Lost to Follow-up|0|||
144246881|NCT02342548|520100551|FG000|Overall Study|Study terminated by sponsor|20|||
144246882|NCT02342548|520100552|FG001|Overall Study|Study terminated by sponsor|39|||
144246883|NCT02342548|520100553|FG002|Overall Study|Study terminated by sponsor|25|||
144246884|NCT02342548|520100551|FG000|Overall Study|Protocol Violation|0|||
144246885|NCT02342548|520100552|FG001|Overall Study|Protocol Violation|1|||
144246886|NCT02342548|520100553|FG002|Overall Study|Protocol Violation|0|||
144246887|NCT02342548|520100551|FG000|Overall Study|Withdrawal by Subject|1|||
144246888|NCT02342548|520100552|FG001|Overall Study|Withdrawal by Subject|3|||
144246889|NCT02342548|520100553|FG002|Overall Study|Withdrawal by Subject|4|||
144246890|NCT02342548|520100551|FG000|Overall Study|Other|1|||
144246891|NCT02342548|520100552|FG001|Overall Study|Other|1|||
144246892|NCT02342548|520100553|FG002|Overall Study|Other|1|||
144246893|NCT01047332|520100554|FG000|Overall Study|SEMS Obstruction|11|||
144246894|NCT01047332|520100555|FG001|Overall Study|SEMS Obstruction|20|||
144246895|NCT01047332|520100554|FG000|Overall Study|Died Unobstructed|38|||
144246896|NCT01047332|520100555|FG001|Overall Study|Died Unobstructed|41|||
144246897|NCT01047332|520100554|FG000|Overall Study|Lost to Follow-up|8|||
144246898|NCT01047332|520100555|FG001|Overall Study|Lost to Follow-up|3|||
144246899|NCT00073983|520100560|FG000|Overall Study|not evaluable|1|||
144246900|NCT01777139|520102367|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
144246901|NCT01777139|520102368|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
144246902|NCT01777139|520102367|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
144246903|NCT01777139|520102368|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
144246904|NCT01777139|520102367|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
144246905|NCT01777139|520102368|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
144246906|NCT01777139|520102367|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
144246907|NCT01777139|520102368|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
144246908|NCT01777139|520102367|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
144246909|NCT01777139|520102368|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
144246910|NCT01777139|520102367|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
144246911|NCT01777139|520102368|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
144246912|NCT01777139|520102367|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
144246913|NCT01777139|520102368|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
144246914|NCT01777139|520102367|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
144246915|NCT01777139|520102368|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
144246916|NCT01887288|520102369|FG000|Overall Study|The study was terminated and the PI has|16|||
144246917|NCT01092637|520102370|FG000|Overall Study|Death|47|||
144246918|NCT01092637|520102371|FG001|Overall Study|Death|49|||
144246919|NCT02921750|520102372|FG000|Overall Study|Adverse Event|1|||
144246920|NCT02921750|520102373|FG001|Overall Study|Adverse Event|2|||
144246921|NCT02921750|520102372|FG000|Overall Study|Withdrawal by Subject|1|||
144246922|NCT02921750|520102373|FG001|Overall Study|Withdrawal by Subject|1|||
144246923|NCT02921750|520102372|FG000|Overall Study|Lost to Follow-up|3|||
144246924|NCT02921750|520102373|FG001|Overall Study|Lost to Follow-up|3|||
144246925|NCT02921750|520102372|FG000|Overall Study|Wound healed|3|||
144246926|NCT02921750|520102373|FG001|Overall Study|Wound healed|3|||
144246927|NCT02921750|520102372|FG000|Overall Study|Serious Adverse Event|1|||
144246928|NCT02921750|520102373|FG001|Overall Study|Serious Adverse Event|2|||
144246929|NCT03292458|520102374|FG000|Period 1|Adverse Event|2|||
144246930|NCT03292458|520102375|FG001|Period 1|Adverse Event|0|||
144246931|NCT00593606|520102376|FG000|Overall Study|Adverse Event|13|||
144246932|NCT00593606|520102376|FG000|Overall Study|Withdrawal by Subject|1|||
144246933|NCT00593606|520102376|FG000|Overall Study|Protocol Violation|3|||
144246934|NCT00593606|520102376|FG000|Overall Study|Lost to Follow-up|2|||
144246935|NCT00593606|520102376|FG000|Overall Study|Run-In Failure|5|||
144246936|NCT00593606|520102376|FG000|Overall Study|Screen Failure|3|||
144290819|NCT01725308|520266700|FG000|Treatment Period I|Protocol Deviations|3|||
144246937|NCT03309696|520102377|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
144246938|NCT03309696|520102378|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
144246939|NCT03309696|520102379|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
144290820|NCT01725308|520266701|FG001|Treatment Period I|Protocol Deviations|1|||
144290821|NCT01725308|520266702|FG002|Treatment Period I|Protocol Deviations|1|||
144290822|NCT01725308|520266700|FG000|Treatment Period I|Miscellaneous|2|||
144290823|NCT01725308|520266701|FG001|Treatment Period I|Miscellaneous|0|||
144290824|NCT01725308|520266702|FG002|Treatment Period I|Miscellaneous|3|||
144290825|NCT01725308|520266700|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
144290826|NCT01725308|520266701|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
144290827|NCT01725308|520266702|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
144290828|NCT01725308|520266700|FG000|Treatment Period II|Did Not Receive Drug|4|||
144290829|NCT01725308|520266701|FG001|Treatment Period II|Did Not Receive Drug|0|||
144290830|NCT01725308|520266702|FG002|Treatment Period II|Did Not Receive Drug|0|||
144290831|NCT01725308|520266700|FG000|Treatment Period II|Adverse Event|13|||
144290832|NCT01725308|520266701|FG001|Treatment Period II|Adverse Event|8|||
144290833|NCT01725308|520266702|FG002|Treatment Period II|Adverse Event|20|||
144290834|NCT01725308|520266700|FG000|Treatment Period II|Insufficient Response|2|||
144290835|NCT01725308|520266701|FG001|Treatment Period II|Insufficient Response|4|||
144290836|NCT01725308|520266702|FG002|Treatment Period II|Insufficient Response|6|||
144290837|NCT01725308|520266700|FG000|Treatment Period II|Worsening of the Target Disease|1|||
144290838|NCT01725308|520266701|FG001|Treatment Period II|Worsening of the Target Disease|4|||
144290839|NCT01725308|520266702|FG002|Treatment Period II|Worsening of the Target Disease|2|||
144290840|NCT01725308|520266700|FG000|Treatment Period II|Changes in the Episodes|1|||
144290841|NCT01725308|520266701|FG001|Treatment Period II|Changes in the Episodes|0|||
144290842|NCT01725308|520266702|FG002|Treatment Period II|Changes in the Episodes|5|||
144290843|NCT01725308|520266700|FG000|Treatment Period II|Withdrawal of Consent|28|||
144290844|NCT01725308|520266701|FG001|Treatment Period II|Withdrawal of Consent|2|||
144290845|NCT01725308|520266702|FG002|Treatment Period II|Withdrawal of Consent|16|||
144290846|NCT01725308|520266700|FG000|Treatment Period II|Lost to Follow-up|1|||
144290847|NCT01725308|520266701|FG001|Treatment Period II|Lost to Follow-up|5|||
144290848|NCT01725308|520266702|FG002|Treatment Period II|Lost to Follow-up|3|||
144246940|NCT03309696|520102380|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
144246941|NCT02278367|520102381|FG000|Overall Study|Physician Decision|5|||
144246942|NCT02278367|520102382|FG001|Overall Study|Physician Decision|0|||
144246943|NCT02278367|520102381|FG000|Overall Study|Withdrawal by Subject|5|||
144246944|NCT02278367|520102382|FG001|Overall Study|Withdrawal by Subject|0|||
144246945|NCT04643964|520102384|FG000|Overall Study|Lost to Follow-up|55|||
144246946|NCT04643964|520102385|FG001|Overall Study|Lost to Follow-up|59|||
144246947|NCT04643964|520102386|FG002|Overall Study|Lost to Follow-up|54|||
144246948|NCT04643964|520102387|FG003|Overall Study|Lost to Follow-up|129|||
144246949|NCT04643964|520102388|FG004|Overall Study|Lost to Follow-up|48|||
144246950|NCT04643964|520102384|FG000|Overall Study|Failed attention check|1|||
144290849|NCT01725308|520266700|FG000|Treatment Period II|Protocol Deviations|0|||
144290850|NCT01725308|520266701|FG001|Treatment Period II|Protocol Deviations|0|||
144290851|NCT01725308|520266702|FG002|Treatment Period II|Protocol Deviations|1|||
144290852|NCT01725308|520266700|FG000|Treatment Period II|Miscellaneous|5|||
144290853|NCT01725308|520266701|FG001|Treatment Period II|Miscellaneous|3|||
144290854|NCT01725308|520266702|FG002|Treatment Period II|Miscellaneous|7|||
144290855|NCT00215657|520266705|FG000|Overall Study|Adverse Event|5|||
144290856|NCT00215657|520266706|FG001|Overall Study|Adverse Event|1|||
144290857|NCT00215657|520266707|FG002|Overall Study|Adverse Event|3|||
144290858|NCT00215657|520266708|FG003|Overall Study|Adverse Event|0|||
144290859|NCT00215657|520266709|FG004|Overall Study|Adverse Event|3|||
144290860|NCT00215657|520266710|FG005|Overall Study|Adverse Event|1|||
144290861|NCT00215657|520266711|FG006|Overall Study|Adverse Event|0|||
144290862|NCT00215657|520266712|FG007|Overall Study|Adverse Event|3|||
144290863|NCT00215657|520266705|FG000|Overall Study|Withdrawal by Subject|6|||
144290864|NCT00215657|520266706|FG001|Overall Study|Withdrawal by Subject|3|||
144290865|NCT00215657|520266707|FG002|Overall Study|Withdrawal by Subject|3|||
144290866|NCT00215657|520266708|FG003|Overall Study|Withdrawal by Subject|1|||
144290867|NCT00215657|520266709|FG004|Overall Study|Withdrawal by Subject|6|||
144290868|NCT00215657|520266710|FG005|Overall Study|Withdrawal by Subject|1|||
144290869|NCT00215657|520266711|FG006|Overall Study|Withdrawal by Subject|10|||
144290870|NCT00215657|520266712|FG007|Overall Study|Withdrawal by Subject|3|||
144290871|NCT00215657|520266705|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
144290872|NCT00215657|520266706|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
144290873|NCT00215657|520266707|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
144290874|NCT00215657|520266708|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
144290875|NCT00215657|520266709|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
144290876|NCT00215657|520266710|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
144290877|NCT00215657|520266711|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
144290878|NCT00215657|520266712|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
144290879|NCT00215657|520266705|FG000|Overall Study|Insufficient testosterone response|5|||
144290880|NCT00215657|520266706|FG001|Overall Study|Insufficient testosterone response|4|||
144290881|NCT00215657|520266707|FG002|Overall Study|Insufficient testosterone response|1|||
144290882|NCT00215657|520266708|FG003|Overall Study|Insufficient testosterone response|12|||
144290883|NCT00215657|520266709|FG004|Overall Study|Insufficient testosterone response|8|||
144290884|NCT00215657|520266710|FG005|Overall Study|Insufficient testosterone response|12|||
144290885|NCT00215657|520266711|FG006|Overall Study|Insufficient testosterone response|4|||
144290886|NCT00215657|520266712|FG007|Overall Study|Insufficient testosterone response|7|||
144290887|NCT00215657|520266705|FG000|Overall Study|Other|3|||
144290888|NCT00215657|520266706|FG001|Overall Study|Other|1|||
144290889|NCT00215657|520266707|FG002|Overall Study|Other|2|||
144290890|NCT00215657|520266708|FG003|Overall Study|Other|3|||
144290891|NCT00215657|520266709|FG004|Overall Study|Other|5|||
144290892|NCT00215657|520266710|FG005|Overall Study|Other|4|||
144290893|NCT00215657|520266711|FG006|Overall Study|Other|6|||
144290894|NCT00215657|520266712|FG007|Overall Study|Other|1|||
144290895|NCT02614066|520266713|FG000|Overall Study|Death|6|||
144290896|NCT02614066|520266714|FG001|Overall Study|Death|14|||
144290897|NCT02614066|520266715|FG002|Overall Study|Death|11|||
144290898|NCT02614066|520266716|FG003|Overall Study|Death|29|||
144290899|NCT02614066|520266713|FG000|Overall Study|Full consent withdrawn|0|||
144290900|NCT02614066|520266714|FG001|Overall Study|Full consent withdrawn|1|||
144290901|NCT02614066|520266715|FG002|Overall Study|Full consent withdrawn|0|||
144290902|NCT02614066|520266716|FG003|Overall Study|Full consent withdrawn|8|||
144290903|NCT02614066|520266713|FG000|Overall Study|Lost to Follow-up|0|||
144290904|NCT02614066|520266714|FG001|Overall Study|Lost to Follow-up|2|||
144290905|NCT02614066|520266715|FG002|Overall Study|Lost to Follow-up|2|||
144290906|NCT02614066|520266716|FG003|Overall Study|Lost to Follow-up|2|||
144290907|NCT02614066|520266713|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
144246951|NCT04643964|520102385|FG001|Overall Study|Failed attention check|8|||
144246952|NCT04643964|520102386|FG002|Overall Study|Failed attention check|2|||
144246953|NCT04643964|520102387|FG003|Overall Study|Failed attention check|14|||
144246954|NCT04643964|520102388|FG004|Overall Study|Failed attention check|11|||
144246955|NCT02638129|520102389|FG000|Overall Study|Study terminated|28|||
144246956|NCT02638129|520102390|FG001|Overall Study|Study terminated|30|||
144246957|NCT00869557|520102391|FG000|Randomized Phase|Lost to Follow-up|2|||
144246958|NCT00869557|520102392|FG001|Randomized Phase|Lost to Follow-up|1|||
144246959|NCT00869557|520102391|FG000|Randomized Phase|Investigator's Discretion|1|||
144246960|NCT00869557|520102392|FG001|Randomized Phase|Investigator's Discretion|0|||
144246961|NCT00869557|520102391|FG000|Randomized Phase|Withdrew Consent|0|||
144246962|NCT00869557|520102392|FG001|Randomized Phase|Withdrew Consent|1|||
144246963|NCT00869557|520102391|FG000|Extension Phase|Adverse Event|2|||
144246964|NCT00869557|520102392|FG001|Extension Phase|Adverse Event|2|||
144246965|NCT00869557|520102391|FG000|Extension Phase|Lack of Efficacy|1|||
144246966|NCT00869557|520102392|FG001|Extension Phase|Lack of Efficacy|0|||
144246967|NCT00869557|520102391|FG000|Extension Phase|Lost to Follow-up|3|||
144246968|NCT00869557|520102392|FG001|Extension Phase|Lost to Follow-up|1|||
144246969|NCT00869557|520102391|FG000|Extension Phase|Investigator's Discretion|2|||
144246970|NCT00869557|520102392|FG001|Extension Phase|Investigator's Discretion|0|||
144246971|NCT00869557|520102391|FG000|Extension Phase|Withdrew Consent|2|||
144246972|NCT00869557|520102392|FG001|Extension Phase|Withdrew Consent|0|||
144246973|NCT02368210|520102395|FG000|Overall Study|Withdrawal by Subject|1|||
144246974|NCT02368210|520102396|FG001|Overall Study|Withdrawal by Subject|0|||
144246975|NCT02368210|520102395|FG000|Overall Study|Adverse Event|0|||
144246976|NCT02368210|520102396|FG001|Overall Study|Adverse Event|1|||
144246977|NCT01149421|520102397|FG000|Overall Study|Adverse Event|22|||
144246978|NCT01149421|520102398|FG001|Overall Study|Adverse Event|6|||
144246979|NCT01149421|520102399|FG002|Overall Study|Adverse Event|11|||
144246980|NCT01149421|520102397|FG000|Overall Study|Withdrawal by Subject|20|||
144246981|NCT01149421|520102398|FG001|Overall Study|Withdrawal by Subject|12|||
144246982|NCT01149421|520102399|FG002|Overall Study|Withdrawal by Subject|13|||
144246983|NCT01149421|520102397|FG000|Overall Study|Sponsor Decision|0|||
144246984|NCT01149421|520102398|FG001|Overall Study|Sponsor Decision|1|||
144246985|NCT01149421|520102399|FG002|Overall Study|Sponsor Decision|1|||
144246986|NCT01149421|520102397|FG000|Overall Study|Lost to Follow-up|2|||
144246987|NCT01149421|520102398|FG001|Overall Study|Lost to Follow-up|4|||
144246988|NCT01149421|520102399|FG002|Overall Study|Lost to Follow-up|5|||
144246989|NCT01149421|520102397|FG000|Overall Study|Physician Decision|5|||
144246990|NCT01149421|520102398|FG001|Overall Study|Physician Decision|3|||
144246991|NCT01149421|520102399|FG002|Overall Study|Physician Decision|6|||
144246992|NCT01149421|520102397|FG000|Overall Study|Entry Criteria Not Met|1|||
144246993|NCT01149421|520102398|FG001|Overall Study|Entry Criteria Not Met|1|||
144246994|NCT01149421|520102399|FG002|Overall Study|Entry Criteria Not Met|2|||
144246995|NCT01149421|520102397|FG000|Overall Study|Protocol Violation|2|||
144246996|NCT01149421|520102398|FG001|Overall Study|Protocol Violation|2|||
144246997|NCT01149421|520102399|FG002|Overall Study|Protocol Violation|6|||
144246998|NCT03738800|520102405|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
144246999|NCT03738800|520102406|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
144247000|NCT03738800|520102407|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144247001|NCT03738800|520102405|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
144247002|NCT03738800|520102406|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
144247003|NCT03738800|520102407|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
144247004|NCT03738800|520102405|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
144247005|NCT03738800|520102406|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
144247006|NCT03738800|520102407|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
144247007|NCT02223819|520102411|FG000|Overall Study|Lost to Follow-up|2|||
144247008|NCT02956057|520102413|FG000|Overall Study|Discontinued intervention|14|||
144247009|NCT02956057|520102414|FG001|Overall Study|Discontinued intervention|10|||
144247010|NCT02956057|520102415|FG002|Overall Study|Discontinued intervention|7|||
144247011|NCT02956057|520102416|FG003|Overall Study|Discontinued intervention|14|||
144247012|NCT02956057|520102417|FG004|Overall Study|Discontinued intervention|4|||
144247013|NCT02956057|520102418|FG005|Overall Study|Discontinued intervention|17|||
144247014|NCT02956057|520102413|FG000|Overall Study|Lost to Follow-up|0|||
144247015|NCT02956057|520102414|FG001|Overall Study|Lost to Follow-up|2|||
144247016|NCT02956057|520102415|FG002|Overall Study|Lost to Follow-up|1|||
144247017|NCT02956057|520102416|FG003|Overall Study|Lost to Follow-up|1|||
144247018|NCT02956057|520102417|FG004|Overall Study|Lost to Follow-up|1|||
144247019|NCT02956057|520102418|FG005|Overall Study|Lost to Follow-up|0|||
144247020|NCT03435224|520102421|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
144247021|NCT00367484|520102422|FG000|Overall Study|Adverse Event|7|||
144247022|NCT00367484|520102422|FG000|Overall Study|Withdrew informed consent|5|||
144247023|NCT00367484|520102422|FG000|Overall Study|Travel to USA|1|||
144247024|NCT00367484|520102422|FG000|Overall Study|Lost to Follow-up|1|||
144247025|NCT00367484|520102422|FG000|Overall Study|Protocol Violation|1|||
144247026|NCT00367484|520102422|FG000|Overall Study|The choice of the patient|1|||
144247027|NCT00367484|520102422|FG000|Overall Study|Lack of Efficacy|1|||
144247028|NCT00329641|520102424|FG000|Overall Study|Did not start treatment|1|||
144247029|NCT00329641|520102424|FG000|Overall Study|Not eligible|1|||
144247030|NCT00329641|520102424|FG000|Overall Study|Adverse Event|3|||
144247031|NCT00329641|520102424|FG000|Overall Study|Other reason, not protocol specified|1|||
144247032|NCT00396877|520102426|FG000|Overall Study|Lost to Follow-up|2|||
144247033|NCT00396877|520102427|FG001|Overall Study|Lost to Follow-up|1|||
144247034|NCT00396877|520102426|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
144247035|NCT00396877|520102427|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
144247036|NCT02945254|520102428|FG000|Overall Study|Lost to Follow-up|1|||
144247037|NCT02945254|520102429|FG001|Overall Study|Lost to Follow-up|0|||
144247038|NCT02945254|520102428|FG000|Overall Study|Withdrawal by Subject|1|||
144247039|NCT02945254|520102429|FG001|Overall Study|Withdrawal by Subject|0|||
144247040|NCT00334802|520102430|FG000|Overall Study|Progressive Disease|2|||
144247041|NCT00334802|520102431|FG001|Overall Study|Progressive Disease|24|||
144247042|NCT00334802|520102430|FG000|Overall Study|Toxicity|1|||
144247043|NCT00334802|520102431|FG001|Overall Study|Toxicity|5|||
144247044|NCT00334802|520102430|FG000|Overall Study|Lack of Efficacy|1|||
144247045|NCT00334802|520102431|FG001|Overall Study|Lack of Efficacy|3|||
144247046|NCT00334802|520102430|FG000|Overall Study|Patient Condition Aggrevated|1|||
144247047|NCT00334802|520102431|FG001|Overall Study|Patient Condition Aggrevated|0|||
144247048|NCT00334802|520102430|FG000|Overall Study|Physician Decision|1|||
144247049|NCT00334802|520102431|FG001|Overall Study|Physician Decision|0|||
144247050|NCT00334802|520102430|FG000|Overall Study|Withdrawal by Subject|0|||
144247051|NCT00334802|520102431|FG001|Overall Study|Withdrawal by Subject|4|||
144247052|NCT00334802|520102430|FG000|Overall Study|Adverse Event|0|||
144247053|NCT00334802|520102431|FG001|Overall Study|Adverse Event|3|||
144247054|NCT00334802|520102430|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
144247055|NCT00334802|520102431|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
144247056|NCT02470403|520102432|FG000|Overall Study|Adverse Event|1|||
144247057|NCT02470403|520102433|FG001|Overall Study|Adverse Event|0|||
144247058|NCT02470403|520102434|FG002|Overall Study|Adverse Event|0|||
144247059|NCT02470403|520102435|FG003|Overall Study|Adverse Event|0|||
144247060|NCT02470403|520102436|FG004|Overall Study|Adverse Event|0|||
144247061|NCT02470403|520102432|FG000|Overall Study|Lost to Follow-up|0|||
144247062|NCT02470403|520102433|FG001|Overall Study|Lost to Follow-up|1|||
144247063|NCT02470403|520102434|FG002|Overall Study|Lost to Follow-up|0|||
144247064|NCT02470403|520102435|FG003|Overall Study|Lost to Follow-up|0|||
144247065|NCT02470403|520102436|FG004|Overall Study|Lost to Follow-up|0|||
144247066|NCT02470403|520102432|FG000|Overall Study|Subject/guardian decision|1|||
144247067|NCT02470403|520102433|FG001|Overall Study|Subject/guardian decision|0|||
144247068|NCT02470403|520102434|FG002|Overall Study|Subject/guardian decision|0|||
144247069|NCT02470403|520102435|FG003|Overall Study|Subject/guardian decision|4|||
144247070|NCT02470403|520102436|FG004|Overall Study|Subject/guardian decision|0|||
144247071|NCT03422159|520102437|FG000|Overall Study|Exclusion due to terminal disease|2|||
144247072|NCT03422159|520102438|FG001|Overall Study|Exclusion due to terminal disease|1|||
144247073|NCT03436199|520102439|FG000|Overall Study|Adverse Event|15|||
144247074|NCT03436199|520102440|FG001|Overall Study|Adverse Event|40|||
144247075|NCT03436199|520102441|FG002|Overall Study|Adverse Event|7|||
144247076|NCT03436199|520102439|FG000|Overall Study|Withdrawal by Subject|4|||
144247077|NCT03436199|520102440|FG001|Overall Study|Withdrawal by Subject|10|||
144247078|NCT03436199|520102441|FG002|Overall Study|Withdrawal by Subject|3|||
144247079|NCT03436199|520102439|FG000|Overall Study|Lost to Follow-up|1|||
144247080|NCT03436199|520102440|FG001|Overall Study|Lost to Follow-up|0|||
144247081|NCT03436199|520102441|FG002|Overall Study|Lost to Follow-up|2|||
144247082|NCT03436199|520102439|FG000|Overall Study|Protocol Violation|1|||
144247083|NCT03436199|520102440|FG001|Overall Study|Protocol Violation|1|||
144247084|NCT03436199|520102441|FG002|Overall Study|Protocol Violation|0|||
144247085|NCT03436199|520102439|FG000|Overall Study|Physician Decision|0|||
144247086|NCT03436199|520102440|FG001|Overall Study|Physician Decision|1|||
144247087|NCT03436199|520102441|FG002|Overall Study|Physician Decision|0|||
144247088|NCT03436199|520102439|FG000|Overall Study|Could not return to clinic|1|||
144247089|NCT03436199|520102440|FG001|Overall Study|Could not return to clinic|0|||
144247090|NCT03436199|520102441|FG002|Overall Study|Could not return to clinic|0|||
144247091|NCT03436199|520102439|FG000|Overall Study|Withdrawn per physician|0|||
144247092|NCT03436199|520102440|FG001|Overall Study|Withdrawn per physician|1|||
144247093|NCT03436199|520102441|FG002|Overall Study|Withdrawn per physician|0|||
144247094|NCT02631070|520102442|FG000|Overall Study|Withdrawal by Subject|35|||
144247095|NCT02631070|520102443|FG001|Overall Study|Withdrawal by Subject|13|||
144247096|NCT02631070|520102442|FG000|Overall Study|Death|45|||
144247097|NCT02631070|520102443|FG001|Overall Study|Death|24|||
144247098|NCT02631070|520102442|FG000|Overall Study|Lost to Follow-up|5|||
144247099|NCT02631070|520102443|FG001|Overall Study|Lost to Follow-up|1|||
144247100|NCT02631070|520102442|FG000|Overall Study|Transition to rollover protocol|52|||
144247101|NCT02631070|520102443|FG001|Overall Study|Transition to rollover protocol|21|||
144247102|NCT02631070|520102442|FG000|Overall Study|Other reasons|12|||
144247103|NCT02631070|520102443|FG001|Overall Study|Other reasons|5|||
144247104|NCT00085098|520102446|FG000|Overall Study|Withdrawal by Subject|0|||
144290908|NCT02614066|520266714|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
144290909|NCT02614066|520266715|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
144290910|NCT02614066|520266716|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
144290911|NCT02614066|520266713|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
144290912|NCT02614066|520266714|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
144290913|NCT02614066|520266715|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
144290914|NCT02614066|520266716|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
144290915|NCT02614066|520266713|FG000|Overall Study|Reason not specified|0|||
144290916|NCT02614066|520266714|FG001|Overall Study|Reason not specified|2|||
144290917|NCT02614066|520266715|FG002|Overall Study|Reason not specified|1|||
144290918|NCT02614066|520266716|FG003|Overall Study|Reason not specified|1|||
144290919|NCT01185366|520266721|FG000|First Line Therapy|Insurance Coverage Denied|1|||
144290920|NCT01185366|520266722|FG001|First Line Therapy|Insurance Coverage Denied|1|||
144290921|NCT01185366|520266721|FG000|First Line Therapy|Withdrawal by Subject|1|||
144290922|NCT01185366|520266722|FG001|First Line Therapy|Withdrawal by Subject|0|||
144290923|NCT01185366|520266721|FG000|First Line Therapy|Lack of Metastatic Site|1|||
144290924|NCT01185366|520266722|FG001|First Line Therapy|Lack of Metastatic Site|0|||
144290925|NCT01185366|520266721|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
144290926|NCT01185366|520266722|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
144290927|NCT01185366|520266721|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
144290928|NCT01185366|520266722|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
144290929|NCT01185366|520266721|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
144290930|NCT01185366|520266722|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
144290931|NCT01185366|520266721|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
144290932|NCT01185366|520266722|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
144290933|NCT01539525|520266723|FG000|Overall Study|Lost to Follow-up|19|||
144290934|NCT01539525|520266724|FG001|Overall Study|Lost to Follow-up|12|||
144290935|NCT01539525|520266725|FG002|Overall Study|Lost to Follow-up|11|||
144290936|NCT01539525|520266723|FG000|Overall Study|Withdrawal by Subject|0|||
144290937|NCT01539525|520266724|FG001|Overall Study|Withdrawal by Subject|3|||
144290938|NCT01539525|520266725|FG002|Overall Study|Withdrawal by Subject|2|||
144290939|NCT01539525|520266723|FG000|Overall Study|Protocol Violation|1|||
144290940|NCT01539525|520266724|FG001|Overall Study|Protocol Violation|1|||
144290941|NCT01539525|520266725|FG002|Overall Study|Protocol Violation|4|||
144290942|NCT02205359|520266726|FG000|Overall Study|Death|293|||
144290943|NCT02205359|520266727|FG001|Overall Study|Death|327|||
144290944|NCT02205359|520266726|FG000|Overall Study|Lost to Follow-up|182|||
144290945|NCT02205359|520266727|FG001|Overall Study|Lost to Follow-up|162|||
144290946|NCT02205359|520266726|FG000|Overall Study|Physician Decision|51|||
144290947|NCT02205359|520266727|FG001|Overall Study|Physician Decision|53|||
144290948|NCT02205359|520266726|FG000|Overall Study|Withdrawal by Subject|167|||
144290949|NCT02205359|520266727|FG001|Overall Study|Withdrawal by Subject|169|||
144290950|NCT00553475|520266732|FG000|Overall Study|Adverse Event|7|||
144290951|NCT00553475|520266733|FG001|Overall Study|Adverse Event|17|||
144290952|NCT00553475|520266734|FG002|Overall Study|Adverse Event|13|||
144290953|NCT00553475|520266732|FG000|Overall Study|Lack of Efficacy|7|||
144290954|NCT00553475|520266733|FG001|Overall Study|Lack of Efficacy|1|||
144290955|NCT00553475|520266734|FG002|Overall Study|Lack of Efficacy|0|||
144290956|NCT00553475|520266732|FG000|Overall Study|Withdrawal by Subject|1|||
144290957|NCT00553475|520266733|FG001|Overall Study|Withdrawal by Subject|1|||
144290958|NCT00553475|520266734|FG002|Overall Study|Withdrawal by Subject|0|||
144290959|NCT00553475|520266732|FG000|Overall Study|Physician Decision|1|||
144290960|NCT00553475|520266733|FG001|Overall Study|Physician Decision|0|||
144290961|NCT00553475|520266734|FG002|Overall Study|Physician Decision|0|||
144290962|NCT00553475|520266732|FG000|Overall Study|Due to moving|0|||
144290963|NCT00553475|520266733|FG001|Overall Study|Due to moving|1|||
144290964|NCT00553475|520266734|FG002|Overall Study|Due to moving|0|||
144290965|NCT02496156|520266735|FG000|Overall Study|Lost to Follow-up|5|||
144290966|NCT02496156|520266736|FG001|Overall Study|Lost to Follow-up|0|||
144290967|NCT02496156|520266735|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
144290968|NCT02496156|520266736|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
144290969|NCT00089583|520266737|FG000|Overall Study|Adverse Event|0|||
144290970|NCT00089583|520266738|FG001|Overall Study|Adverse Event|3|||
144290971|NCT00089583|520266737|FG000|Overall Study|Insufficient Viral Load Response|5|||
144290972|NCT00089583|520266738|FG001|Overall Study|Insufficient Viral Load Response|5|||
144290973|NCT00089583|520266737|FG000|Overall Study|Withdrawal by Subject|0|||
144290974|NCT00089583|520266738|FG001|Overall Study|Withdrawal by Subject|4|||
144290975|NCT00089583|520266737|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
144290976|NCT00089583|520266738|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
144290977|NCT00089583|520266737|FG000|Overall Study|Participant Refused Study Medication|0|||
144290978|NCT00089583|520266738|FG001|Overall Study|Participant Refused Study Medication|2|||
144290979|NCT00089583|520266737|FG000|Overall Study|Non-Compliance|0|||
144290980|NCT00089583|520266738|FG001|Overall Study|Non-Compliance|4|||
144290981|NCT00089583|520266737|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
144290982|NCT00089583|520266738|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
144290983|NCT00089583|520266737|FG000|Overall Study|Participant Management Criteria Met|0|||
144290984|NCT00089583|520266738|FG001|Overall Study|Participant Management Criteria Met|1|||
144290985|NCT00089583|520266737|FG000|Overall Study|Reason Not Provided|0|||
144290986|NCT00089583|520266738|FG001|Overall Study|Reason Not Provided|1|||
144290987|NCT00089583|520266737|FG000|Overall Study|Protocol Violation|0|||
144290988|NCT00089583|520266738|FG001|Overall Study|Protocol Violation|3|||
144290989|NCT00089583|520266737|FG000|Overall Study|Principal Investigator Decision|0|||
144290990|NCT00089583|520266738|FG001|Overall Study|Principal Investigator Decision|10|||
144290991|NCT00089583|520266737|FG000|Overall Study|Start of Disallowed Medication|0|||
144290992|NCT00089583|520266738|FG001|Overall Study|Start of Disallowed Medication|1|||
144290993|NCT00089583|520266737|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
144290994|NCT00089583|520266738|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
144290995|NCT00089583|520266737|FG000|Overall Study|Participant Incarcerated|0|||
144290996|NCT00089583|520266738|FG001|Overall Study|Participant Incarcerated|1|||
144290997|NCT01623154|520266739|FG000|Overall Study|Did not drink Pranactin Citric|4|||
144290998|NCT03810495|520266740|FG000|Overall Study|Lost to Follow-up|2|||
144290999|NCT03810495|520266740|FG000|Overall Study|Withdrawal by Subject|1|||
144291000|NCT02457546|520268670|FG000|Overall Study|Other reasons|4|||
144291001|NCT02457546|520268671|FG001|Overall Study|Other reasons|1|||
144291002|NCT02457546|520268670|FG000|Overall Study|Refused to complete study/procedures|1|||
144291003|NCT02457546|520268671|FG001|Overall Study|Refused to complete study/procedures|1|||
144291004|NCT02457546|520268670|FG000|Overall Study|Lost to Follow-up|4|||
144291005|NCT02457546|520268671|FG001|Overall Study|Lost to Follow-up|1|||
144291006|NCT02457546|520268670|FG000|Overall Study|Adverse Event|0|||
144291007|NCT02457546|520268671|FG001|Overall Study|Adverse Event|1|||
144291008|NCT01897896|520268672|FG000|Overall Study|Death|1|||
144291009|NCT01897896|520268673|FG001|Overall Study|Death|0|||
144291010|NCT01897896|520268672|FG000|Overall Study|Adverse Event|11|||
144291011|NCT01897896|520268673|FG001|Overall Study|Adverse Event|1|||
144291012|NCT01897896|520268672|FG000|Overall Study|Lost to Follow-up|1|||
144291013|NCT01897896|520268673|FG001|Overall Study|Lost to Follow-up|0|||
144291014|NCT01897896|520268672|FG000|Overall Study|Non-compliance with study drug dosing|1|||
144291015|NCT01897896|520268673|FG001|Overall Study|Non-compliance with study drug dosing|1|||
144291016|NCT01897896|520268672|FG000|Overall Study|Withdrawal by Subject|7|||
144291017|NCT01897896|520268673|FG001|Overall Study|Withdrawal by Subject|1|||
144291018|NCT01897896|520268672|FG000|Overall Study|Require drug that interfere with study|1|||
144291019|NCT01897896|520268673|FG001|Overall Study|Require drug that interfere with study|4|||
144291020|NCT01897896|520268672|FG000|Overall Study|Protocol Violation|1|||
144291021|NCT01897896|520268673|FG001|Overall Study|Protocol Violation|1|||
144291022|NCT01897896|520268672|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
144291023|NCT01897896|520268673|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
144291024|NCT01897896|520268672|FG000|Overall Study|Caregiver can no longer participate|0|||
144291025|NCT01897896|520268673|FG001|Overall Study|Caregiver can no longer participate|2|||
144291026|NCT01897896|520268672|FG000|Overall Study|Other than specified|2|||
144291027|NCT01897896|520268673|FG001|Overall Study|Other than specified|1|||
144291028|NCT05069415|520268676|FG000|Overall Study|Withdrawal by Subject|2|||
144291029|NCT05069415|520268677|FG001|Overall Study|Withdrawal by Subject|0|||
144291030|NCT05069415|520268676|FG000|Overall Study|Adverse Event|2|||
144291031|NCT05069415|520268677|FG001|Overall Study|Adverse Event|0|||
144291032|NCT03160573|520268678|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
144291033|NCT03160573|520268679|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
144291034|NCT03160573|520268680|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
144291035|NCT03160573|520268681|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
144291036|NCT00101400|520268682|FG000|Survival Follow-Up|Alive|7|||
144291037|NCT05333965|520268686|FG000|First Intervention|Adverse Event|0|||
144291038|NCT05333965|520268687|FG001|First Intervention|Adverse Event|1|||
144291039|NCT05333965|520268686|FG000|First Intervention|Withdrawal by Subject|0|||
144291040|NCT05333965|520268687|FG001|First Intervention|Withdrawal by Subject|1|||
144291041|NCT02462057|520268690|FG000|Overall Study|Left Vitality|32|||
144291042|NCT02462057|520268691|FG001|Overall Study|Left Vitality|27|||
144291043|NCT02462057|520268692|FG002|Overall Study|Left Vitality|23|||
144291044|NCT02462057|520268693|FG003|Overall Study|Left Vitality|35|||
144291045|NCT02462057|520268694|FG004|Overall Study|Left Vitality|33|||
144291046|NCT02462057|520268690|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
144291047|NCT02462057|520268691|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
144291048|NCT02462057|520268692|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
144291049|NCT02462057|520268693|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
144291050|NCT02462057|520268694|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
144291051|NCT01061710|520268695|FG000|Overall Study|Protocol Violation|14|||
144291052|NCT00159874|520268696|FG000|Overall Study|Adverse Event|2|||
144291053|NCT00159874|520268697|FG001|Overall Study|Adverse Event|2|||
144291054|NCT00159874|520268698|FG002|Overall Study|Adverse Event|5|||
144291055|NCT00159874|520268699|FG003|Overall Study|Adverse Event|1|||
144291056|NCT00159874|520268700|FG004|Overall Study|Adverse Event|1|||
144291057|NCT00159874|520268701|FG005|Overall Study|Adverse Event|2|||
144291058|NCT00159874|520268702|FG006|Overall Study|Adverse Event|0|||
144291059|NCT00159874|520268696|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
144291060|NCT00159874|520268697|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
144291061|NCT00159874|520268698|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
144291062|NCT00159874|520268699|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
144291063|NCT00159874|520268700|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
144291064|NCT00159874|520268701|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
144291065|NCT00159874|520268702|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
144291066|NCT00159874|520268696|FG000|Overall Study|Lack of Efficacy|2|||
144291067|NCT00159874|520268697|FG001|Overall Study|Lack of Efficacy|0|||
144291068|NCT00159874|520268698|FG002|Overall Study|Lack of Efficacy|1|||
144291069|NCT00159874|520268699|FG003|Overall Study|Lack of Efficacy|1|||
144291070|NCT00159874|520268700|FG004|Overall Study|Lack of Efficacy|0|||
144291071|NCT00159874|520268701|FG005|Overall Study|Lack of Efficacy|3|||
144291072|NCT00159874|520268702|FG006|Overall Study|Lack of Efficacy|0|||
144291073|NCT00159874|520268696|FG000|Overall Study|Lost to Follow-up|1|||
144291074|NCT00159874|520268697|FG001|Overall Study|Lost to Follow-up|0|||
144291075|NCT00159874|520268698|FG002|Overall Study|Lost to Follow-up|3|||
144291076|NCT00159874|520268699|FG003|Overall Study|Lost to Follow-up|0|||
144291077|NCT00159874|520268700|FG004|Overall Study|Lost to Follow-up|1|||
144291078|NCT00159874|520268701|FG005|Overall Study|Lost to Follow-up|2|||
144291079|NCT00159874|520268702|FG006|Overall Study|Lost to Follow-up|1|||
144291080|NCT00159874|520268696|FG000|Overall Study|Other|8|||
144291081|NCT00159874|520268697|FG001|Overall Study|Other|8|||
144291082|NCT00159874|520268698|FG002|Overall Study|Other|8|||
144291083|NCT00159874|520268699|FG003|Overall Study|Other|0|||
144291084|NCT00159874|520268700|FG004|Overall Study|Other|2|||
144291085|NCT00159874|520268701|FG005|Overall Study|Other|1|||
144291086|NCT00159874|520268702|FG006|Overall Study|Other|3|||
144291087|NCT00159874|520268696|FG000|Overall Study|Protocol Violation|0|||
144291088|NCT00159874|520268697|FG001|Overall Study|Protocol Violation|5|||
144291089|NCT00159874|520268698|FG002|Overall Study|Protocol Violation|2|||
144291090|NCT00159874|520268699|FG003|Overall Study|Protocol Violation|0|||
144291091|NCT00159874|520268700|FG004|Overall Study|Protocol Violation|0|||
144291092|NCT00159874|520268701|FG005|Overall Study|Protocol Violation|0|||
144291093|NCT00159874|520268702|FG006|Overall Study|Protocol Violation|0|||
144291094|NCT00159874|520268696|FG000|Overall Study|Death|3|||
144291095|NCT00159874|520268697|FG001|Overall Study|Death|8|||
144291096|NCT00159874|520268698|FG002|Overall Study|Death|15|||
144291097|NCT00159874|520268699|FG003|Overall Study|Death|0|||
144291098|NCT00159874|520268700|FG004|Overall Study|Death|1|||
144291099|NCT00159874|520268701|FG005|Overall Study|Death|2|||
144291100|NCT00159874|520268702|FG006|Overall Study|Death|0|||
144291101|NCT00159874|520268696|FG000|Overall Study|Withdrawal by Subject|2|||
144291102|NCT00159874|520268697|FG001|Overall Study|Withdrawal by Subject|6|||
144291103|NCT00159874|520268698|FG002|Overall Study|Withdrawal by Subject|8|||
144291104|NCT00159874|520268699|FG003|Overall Study|Withdrawal by Subject|4|||
144291105|NCT00159874|520268700|FG004|Overall Study|Withdrawal by Subject|3|||
144291106|NCT00159874|520268701|FG005|Overall Study|Withdrawal by Subject|2|||
144291107|NCT00159874|520268702|FG006|Overall Study|Withdrawal by Subject|1|||
144291108|NCT00159874|520268696|FG000|Overall Study|Pregnancy|1|||
144291109|NCT00159874|520268697|FG001|Overall Study|Pregnancy|1|||
144291110|NCT00159874|520268698|FG002|Overall Study|Pregnancy|0|||
144291111|NCT00159874|520268699|FG003|Overall Study|Pregnancy|0|||
144291112|NCT00159874|520268700|FG004|Overall Study|Pregnancy|0|||
144291113|NCT00159874|520268701|FG005|Overall Study|Pregnancy|0|||
144291114|NCT00159874|520268702|FG006|Overall Study|Pregnancy|0|||
144291115|NCT04008069|520268704|FG000|Open-Label Period|Adverse Event|1|||
144291116|NCT04008069|520268705|FG001|Open-Label Period|Adverse Event|0|||
144291117|NCT04008069|520268706|FG002|Open-Label Period|Adverse Event|0|||
144291118|NCT04008069|520268704|FG000|Open-Label Period|Lack of Efficacy|4|||
144291119|NCT04008069|520268705|FG001|Open-Label Period|Lack of Efficacy|0|||
144291120|NCT04008069|520268706|FG002|Open-Label Period|Lack of Efficacy|0|||
144291121|NCT04008069|520268704|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
144291122|NCT04008069|520268705|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
144291123|NCT04008069|520268706|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
144291124|NCT04008069|520268704|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
144291125|NCT04008069|520268705|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
144291126|NCT04008069|520268706|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
144291127|NCT00511199|520268707|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
144291128|NCT00511199|520268708|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
144291129|NCT00511199|520268707|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
144291130|NCT00511199|520268708|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
144291131|NCT00511199|520268707|FG000|Overall Study|Withdrawal of Informed Consent|19|||
144291132|NCT00511199|520268708|FG001|Overall Study|Withdrawal of Informed Consent|4|||
144291133|NCT00511199|520268707|FG000|Overall Study|Pregnancy|6|||
144291134|NCT00511199|520268708|FG001|Overall Study|Pregnancy|3|||
144291135|NCT00511199|520268707|FG000|Overall Study|Pregnancy Wish|16|||
144291136|NCT00511199|520268708|FG001|Overall Study|Pregnancy Wish|8|||
144291137|NCT00511199|520268707|FG000|Overall Study|Lost to Follow-up|40|||
144291138|NCT00511199|520268708|FG001|Overall Study|Lost to Follow-up|17|||
144291139|NCT00511199|520268707|FG000|Overall Study|Other Reason|78|||
144291140|NCT00511199|520268708|FG001|Overall Study|Other Reason|37|||
144291141|NCT02314247|520268710|FG000|Overall Study|Adverse Event|2|||
144291142|NCT02314247|520268711|FG001|Overall Study|Adverse Event|1|||
144291143|NCT02314247|520268712|FG002|Overall Study|Adverse Event|0|||
144291144|NCT02314247|520268710|FG000|Overall Study|Withdrawal by Subject|1|||
144291145|NCT02314247|520268711|FG001|Overall Study|Withdrawal by Subject|3|||
144291146|NCT02314247|520268712|FG002|Overall Study|Withdrawal by Subject|1|||
144291147|NCT02314247|520268710|FG000|Overall Study|Progression of Disease|6|||
144291148|NCT02314247|520268711|FG001|Overall Study|Progression of Disease|2|||
144291149|NCT02314247|520268712|FG002|Overall Study|Progression of Disease|0|||
144291150|NCT01953354|520268713|FG000|Overall Study|Withdrawal by Subject|0|||
144291151|NCT01953354|520268714|FG001|Overall Study|Withdrawal by Subject|1|||
144291152|NCT01953354|520268713|FG000|Overall Study|Decision of Sponsor|0|||
144291153|NCT01953354|520268714|FG001|Overall Study|Decision of Sponsor|1|||
144291154|NCT01953354|520268713|FG000|Overall Study|Disease Exacerbation|1|||
144291155|NCT01953354|520268714|FG001|Overall Study|Disease Exacerbation|0|||
144291156|NCT02571244|520268715|FG000|Overall Study|Lost to Follow-up|0|||
144291157|NCT02571244|520268716|FG001|Overall Study|Lost to Follow-up|1|||
144291158|NCT02571244|520268715|FG000|Overall Study|Unable to reach out post discharge|3|||
144291159|NCT02571244|520268716|FG001|Overall Study|Unable to reach out post discharge|0|||
144291160|NCT01570192|520268717|FG000|Overall Study|no qualifying organism|6|||
144291161|NCT01570192|520268718|FG001|Overall Study|no qualifying organism|12|||
144291162|NCT01570192|520268717|FG000|Overall Study|changed to palliative care|1|||
144291163|NCT01570192|520268718|FG001|Overall Study|changed to palliative care|0|||
144291164|NCT01570192|520268717|FG000|Overall Study|Physician Decision|0|||
144291165|NCT01570192|520268718|FG001|Overall Study|Physician Decision|1|||
144291166|NCT02965976|520268719|FG000|Overall Study|Withdrawal by Subject|2|||
144291167|NCT02965976|520268720|FG001|Overall Study|Withdrawal by Subject|0|||
144291168|NCT02134028|520268721|FG000|Overall Study|Lack of Efficacy|1|||
144291169|NCT02134028|520268722|FG001|Overall Study|Lack of Efficacy|0|||
144291170|NCT02134028|520268723|FG002|Overall Study|Lack of Efficacy|3|||
144291171|NCT02134028|520268724|FG003|Overall Study|Lack of Efficacy|2|||
144291172|NCT02134028|520268725|FG004|Overall Study|Lack of Efficacy|1|||
144291173|NCT02134028|520268726|FG005|Overall Study|Lack of Efficacy|2|||
144291174|NCT02134028|520268727|FG006|Overall Study|Lack of Efficacy|1|||
144291175|NCT02134028|520268728|FG007|Overall Study|Lack of Efficacy|0|||
144291176|NCT02134028|520268721|FG000|Overall Study|Poor compliance to protocol|1|||
144291177|NCT02134028|520268722|FG001|Overall Study|Poor compliance to protocol|1|||
144291178|NCT02134028|520268723|FG002|Overall Study|Poor compliance to protocol|3|||
144291179|NCT02134028|520268724|FG003|Overall Study|Poor compliance to protocol|7|||
144291180|NCT02134028|520268725|FG004|Overall Study|Poor compliance to protocol|1|||
144291181|NCT02134028|520268726|FG005|Overall Study|Poor compliance to protocol|1|||
144291182|NCT02134028|520268727|FG006|Overall Study|Poor compliance to protocol|0|||
144291183|NCT02134028|520268728|FG007|Overall Study|Poor compliance to protocol|0|||
144291184|NCT02134028|520268721|FG000|Overall Study|Other unspecified|4|||
144291185|NCT02134028|520268722|FG001|Overall Study|Other unspecified|22|||
144291186|NCT02134028|520268723|FG002|Overall Study|Other unspecified|33|||
144291187|NCT02134028|520268724|FG003|Overall Study|Other unspecified|64|||
144291188|NCT02134028|520268725|FG004|Overall Study|Other unspecified|8|||
144291189|NCT02134028|520268726|FG005|Overall Study|Other unspecified|6|||
144291190|NCT02134028|520268727|FG006|Overall Study|Other unspecified|2|||
144291191|NCT02134028|520268728|FG007|Overall Study|Other unspecified|1|||
144291192|NCT02134028|520268721|FG000|Overall Study|Adverse Event|3|||
144291193|NCT02134028|520268722|FG001|Overall Study|Adverse Event|19|||
144291194|NCT02134028|520268723|FG002|Overall Study|Adverse Event|13|||
144291195|NCT02134028|520268724|FG003|Overall Study|Adverse Event|32|||
144291196|NCT02134028|520268725|FG004|Overall Study|Adverse Event|4|||
144291197|NCT02134028|520268726|FG005|Overall Study|Adverse Event|5|||
144291198|NCT02134028|520268727|FG006|Overall Study|Adverse Event|1|||
144291199|NCT02134028|520268728|FG007|Overall Study|Adverse Event|2|||
144291200|NCT00806026|520268729|FG000|Overall Study|Death|0|||
144291201|NCT00806026|520268730|FG001|Overall Study|Death|0|||
144291202|NCT00806026|520268731|FG002|Overall Study|Death|0|||
144291203|NCT00806026|520268732|FG003|Overall Study|Death|1|||
144291204|NCT00806026|520268733|FG004|Overall Study|Death|0|||
144291205|NCT00806026|520268734|FG005|Overall Study|Death|0|||
144291206|NCT00806026|520268729|FG000|Overall Study|Did not meet entrance criteria|4|||
144291207|NCT00806026|520268730|FG001|Overall Study|Did not meet entrance criteria|1|||
144291208|NCT00806026|520268731|FG002|Overall Study|Did not meet entrance criteria|2|||
144291209|NCT00806026|520268732|FG003|Overall Study|Did not meet entrance criteria|1|||
144291210|NCT00806026|520268733|FG004|Overall Study|Did not meet entrance criteria|0|||
144291211|NCT00806026|520268734|FG005|Overall Study|Did not meet entrance criteria|0|||
144291212|NCT00806026|520268729|FG000|Overall Study|Lack of Efficacy|5|||
144291213|NCT00806026|520268730|FG001|Overall Study|Lack of Efficacy|18|||
144291214|NCT00806026|520268731|FG002|Overall Study|Lack of Efficacy|13|||
144291215|NCT00806026|520268732|FG003|Overall Study|Lack of Efficacy|4|||
144291216|NCT00806026|520268733|FG004|Overall Study|Lack of Efficacy|8|||
144291217|NCT00806026|520268734|FG005|Overall Study|Lack of Efficacy|7|||
144291218|NCT00806026|520268729|FG000|Overall Study|Lost to Follow-up|8|||
144291219|NCT00806026|520268730|FG001|Overall Study|Lost to Follow-up|15|||
144291220|NCT00806026|520268731|FG002|Overall Study|Lost to Follow-up|8|||
144291221|NCT00806026|520268732|FG003|Overall Study|Lost to Follow-up|2|||
144291222|NCT00806026|520268733|FG004|Overall Study|Lost to Follow-up|6|||
144291223|NCT00806026|520268734|FG005|Overall Study|Lost to Follow-up|6|||
144291224|NCT00806026|520268729|FG000|Overall Study|Withdrawal by Subject|14|||
144291225|NCT00806026|520268730|FG001|Overall Study|Withdrawal by Subject|17|||
144291226|NCT00806026|520268731|FG002|Overall Study|Withdrawal by Subject|9|||
144291227|NCT00806026|520268732|FG003|Overall Study|Withdrawal by Subject|2|||
144291228|NCT00806026|520268733|FG004|Overall Study|Withdrawal by Subject|5|||
144291229|NCT00806026|520268734|FG005|Overall Study|Withdrawal by Subject|3|||
144291230|NCT00806026|520268729|FG000|Overall Study|Other|3|||
144291231|NCT00806026|520268730|FG001|Overall Study|Other|6|||
144291232|NCT00806026|520268731|FG002|Overall Study|Other|8|||
144291233|NCT00806026|520268732|FG003|Overall Study|Other|2|||
144291234|NCT00806026|520268733|FG004|Overall Study|Other|0|||
144291235|NCT00806026|520268734|FG005|Overall Study|Other|4|||
144291236|NCT00806026|520268729|FG000|Overall Study|Protocol Violation|6|||
144291237|NCT00806026|520268730|FG001|Overall Study|Protocol Violation|9|||
144291238|NCT00806026|520268731|FG002|Overall Study|Protocol Violation|9|||
144291239|NCT00806026|520268732|FG003|Overall Study|Protocol Violation|0|||
144291240|NCT00806026|520268733|FG004|Overall Study|Protocol Violation|2|||
144291241|NCT00806026|520268734|FG005|Overall Study|Protocol Violation|3|||
144291242|NCT00806026|520268729|FG000|Overall Study|Adverse Event|52|||
144291243|NCT00806026|520268730|FG001|Overall Study|Adverse Event|35|||
144291244|NCT00806026|520268731|FG002|Overall Study|Adverse Event|44|||
144291245|NCT00806026|520268732|FG003|Overall Study|Adverse Event|17|||
144291246|NCT00806026|520268733|FG004|Overall Study|Adverse Event|9|||
144291247|NCT00806026|520268734|FG005|Overall Study|Adverse Event|9|||
144291248|NCT01687595|520268735|FG000|Overall Study|Withdrawal by Subject|8|||
144291249|NCT01687595|520268736|FG001|Overall Study|Withdrawal by Subject|0|||
144291250|NCT01687595|520268735|FG000|Overall Study|Lost to Follow-up|3|||
144291251|NCT01687595|520268736|FG001|Overall Study|Lost to Follow-up|1|||
144291252|NCT01687595|520268735|FG000|Overall Study|Investigator's decision|1|||
144291253|NCT01687595|520268736|FG001|Overall Study|Investigator's decision|0|||
144291254|NCT01687595|520268735|FG000|Overall Study|Sponsor's decision|1|||
144291255|NCT01687595|520268736|FG001|Overall Study|Sponsor's decision|0|||
144291256|NCT01687595|520268735|FG000|Overall Study|Noncompliance|1|||
144291257|NCT01687595|520268736|FG001|Overall Study|Noncompliance|2|||
144291258|NCT01687595|520268735|FG000|Overall Study|Other than specified|56|||
144291259|NCT01687595|520268736|FG001|Overall Study|Other than specified|7|||
144291260|NCT00489359|520268737|FG000|Overall Study|Death|0|||
144291261|NCT00489359|520268738|FG001|Overall Study|Death|2|||
144291262|NCT00489359|520268737|FG000|Overall Study|Progressive Disease|5|||
144291263|NCT00489359|520268738|FG001|Overall Study|Progressive Disease|6|||
144291264|NCT00489359|520268737|FG000|Overall Study|Lost to Follow-up|1|||
144291265|NCT00489359|520268738|FG001|Overall Study|Lost to Follow-up|0|||
144291266|NCT00489359|520268737|FG000|Overall Study|Withdrawal by Subject|1|||
144291267|NCT00489359|520268738|FG001|Overall Study|Withdrawal by Subject|5|||
144291268|NCT00489359|520268737|FG000|Overall Study|Adverse Event|0|||
144291269|NCT00489359|520268738|FG001|Overall Study|Adverse Event|16|||
144291270|NCT03180138|520268739|FG000|Overall Study|Mobile-phone could not be verified|2|||
144291271|NCT03180138|520268740|FG001|Overall Study|Mobile-phone could not be verified|13|||
144291272|NCT03180138|520268741|FG002|Overall Study|Mobile-phone could not be verified|15|||
144291273|NCT03180138|520268739|FG000|Overall Study|No prior immunization records|17|||
144291274|NCT03180138|520268740|FG001|Overall Study|No prior immunization records|0|||
144291275|NCT03180138|520268741|FG002|Overall Study|No prior immunization records|6|||
144291276|NCT03180138|520268739|FG000|Overall Study|Found to be >24 mon after randomization|3|||
144291277|NCT03180138|520268740|FG001|Overall Study|Found to be >24 mon after randomization|0|||
144291278|NCT03180138|520268741|FG002|Overall Study|Found to be >24 mon after randomization|3|||
144291279|NCT04191733|520268743|FG000|Overall Study|Withdrawn due to study closure|13|||
144291280|NCT04191733|520268744|FG001|Overall Study|Withdrawn due to study closure|14|||
144291281|NCT04191733|520268743|FG000|Overall Study|Withdrawal by Subject|2|||
144291282|NCT04191733|520268744|FG001|Overall Study|Withdrawal by Subject|4|||
144291283|NCT04191733|520268743|FG000|Overall Study|Physician Decision|1|||
144291284|NCT04191733|520268744|FG001|Overall Study|Physician Decision|1|||
144291285|NCT04191733|520268743|FG000|Overall Study|Lost to Follow-up|5|||
144291286|NCT04191733|520268744|FG001|Overall Study|Lost to Follow-up|6|||
144291287|NCT04191733|520268743|FG000|Overall Study|Death|0|||
144291288|NCT04191733|520268744|FG001|Overall Study|Death|1|||
144291289|NCT01260311|520268745|FG000|Overall Study|Adverse Event|11|||
144291290|NCT01260311|520268745|FG000|Overall Study|Lack of Efficacy|4|||
144291291|NCT01260311|520268745|FG000|Overall Study|Lost to Follow-up|25|||
144291292|NCT01260311|520268745|FG000|Overall Study|Withdrawal by Subject|6|||
144291293|NCT01260311|520268745|FG000|Overall Study|Financial Constraints|77|||
144291294|NCT01260311|520268745|FG000|Overall Study|Gone to Province|2|||
144291295|NCT01260311|520268745|FG000|Overall Study|Medication Stopped|1|||
144291296|NCT01260311|520268745|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
144291297|NCT01903733|520268746|FG000|Overall Study|Death|23|||
144291298|NCT01903733|520268747|FG001|Overall Study|Death|54|||
144291299|NCT01903733|520268748|FG002|Overall Study|Death|30|||
144291300|NCT01903733|520268749|FG003|Overall Study|Death|98|||
144291301|NCT01903733|520268746|FG000|Overall Study|Participant refused further follow-up|35|||
144291302|NCT01903733|520268747|FG001|Overall Study|Participant refused further follow-up|38|||
144291303|NCT01903733|520268748|FG002|Overall Study|Participant refused further follow-up|13|||
144291304|NCT01903733|520268749|FG003|Overall Study|Participant refused further follow-up|9|||
144291305|NCT01903733|520268746|FG000|Overall Study|Lost to Follow-up|18|||
144291306|NCT01903733|520268747|FG001|Overall Study|Lost to Follow-up|19|||
144291307|NCT01903733|520268748|FG002|Overall Study|Lost to Follow-up|6|||
144291308|NCT01903733|520268749|FG003|Overall Study|Lost to Follow-up|9|||
144291309|NCT01903733|520268746|FG000|Overall Study|Other|10|||
144291310|NCT01903733|520268747|FG001|Overall Study|Other|15|||
144291311|NCT01903733|520268748|FG002|Overall Study|Other|12|||
144291312|NCT01903733|520268749|FG003|Overall Study|Other|3|||
144291313|NCT01903733|520268746|FG000|Overall Study|Missing|2|||
144291314|NCT01903733|520268747|FG001|Overall Study|Missing|0|||
144291315|NCT01903733|520268748|FG002|Overall Study|Missing|0|||
144291316|NCT01903733|520268749|FG003|Overall Study|Missing|0|||
144291317|NCT01903733|520268746|FG000|Overall Study|Investigator request|18|||
144291318|NCT01903733|520268747|FG001|Overall Study|Investigator request|0|||
144291319|NCT01903733|520268748|FG002|Overall Study|Investigator request|0|||
144291320|NCT01903733|520268749|FG003|Overall Study|Investigator request|0|||
144291321|NCT03878602|520268750|FG000|Overall Study|cord blood donation|7|||
144291322|NCT03878602|520268751|FG001|Overall Study|cord blood donation|1|||
144291323|NCT03878602|520268750|FG000|Overall Study|incomplete data collection|2|||
144291324|NCT03878602|520268751|FG001|Overall Study|incomplete data collection|0|||
144291325|NCT02633527|520268752|FG000|Overall Study|Failed to meet eligibility|0|||
144291326|NCT02633527|520268753|FG001|Overall Study|Failed to meet eligibility|1|||
144291327|NCT02633527|520268754|FG002|Overall Study|Failed to meet eligibility|1|||
144291328|NCT02633527|520268755|FG003|Overall Study|Failed to meet eligibility|0|||
144291329|NCT02633527|520268756|FG004|Overall Study|Failed to meet eligibility|1|||
144291330|NCT02633527|520268752|FG000|Overall Study|Adverse Event|0|||
144291331|NCT02633527|520268753|FG001|Overall Study|Adverse Event|4|||
144291332|NCT02633527|520268754|FG002|Overall Study|Adverse Event|3|||
144291333|NCT02633527|520268755|FG003|Overall Study|Adverse Event|1|||
144291334|NCT02633527|520268756|FG004|Overall Study|Adverse Event|5|||
144291335|NCT02633527|520268752|FG000|Overall Study|Lost to Follow-up|1|||
144291336|NCT02633527|520268753|FG001|Overall Study|Lost to Follow-up|2|||
144291337|NCT02633527|520268754|FG002|Overall Study|Lost to Follow-up|5|||
144291338|NCT02633527|520268755|FG003|Overall Study|Lost to Follow-up|5|||
144291339|NCT02633527|520268756|FG004|Overall Study|Lost to Follow-up|4|||
144291340|NCT02633527|520268752|FG000|Overall Study|Withdrawal by Subject|0|||
144291341|NCT02633527|520268753|FG001|Overall Study|Withdrawal by Subject|3|||
144291342|NCT02633527|520268754|FG002|Overall Study|Withdrawal by Subject|5|||
144291343|NCT02633527|520268755|FG003|Overall Study|Withdrawal by Subject|4|||
144291344|NCT02633527|520268756|FG004|Overall Study|Withdrawal by Subject|4|||
144291345|NCT02633527|520268752|FG000|Overall Study|Protocol Violation|0|||
144291346|NCT02633527|520268753|FG001|Overall Study|Protocol Violation|1|||
144291347|NCT02633527|520268754|FG002|Overall Study|Protocol Violation|1|||
144291348|NCT02633527|520268755|FG003|Overall Study|Protocol Violation|1|||
144291349|NCT02633527|520268756|FG004|Overall Study|Protocol Violation|1|||
144291350|NCT02633527|520268752|FG000|Overall Study|Physician Decision|0|||
144291351|NCT02633527|520268753|FG001|Overall Study|Physician Decision|0|||
144291352|NCT02633527|520268754|FG002|Overall Study|Physician Decision|0|||
144291353|NCT02633527|520268755|FG003|Overall Study|Physician Decision|0|||
144291354|NCT02633527|520268756|FG004|Overall Study|Physician Decision|1|||
144291355|NCT02633527|520268752|FG000|Overall Study|Administrative reason|1|||
144291356|NCT02633527|520268753|FG001|Overall Study|Administrative reason|0|||
144291357|NCT02633527|520268754|FG002|Overall Study|Administrative reason|0|||
144291358|NCT02633527|520268755|FG003|Overall Study|Administrative reason|1|||
144291359|NCT02633527|520268756|FG004|Overall Study|Administrative reason|0|||
144291360|NCT02633527|520268752|FG000|Overall Study|Multiple reasons|1|||
144291361|NCT02633527|520268753|FG001|Overall Study|Multiple reasons|0|||
144291362|NCT02633527|520268754|FG002|Overall Study|Multiple reasons|2|||
144291363|NCT02633527|520268755|FG003|Overall Study|Multiple reasons|2|||
144291364|NCT02633527|520268756|FG004|Overall Study|Multiple reasons|1|||
144291365|NCT02100644|520268758|FG000|LTG Escalation Phase|Adverse Event|9|||
144291366|NCT02100644|520268759|FG001|LTG Escalation Phase|Adverse Event|0|||
144247105|NCT00085098|520102447|FG001|Overall Study|Withdrawal by Subject|1|||
144247106|NCT00085098|520102446|FG000|Overall Study|Ineligible|1|||
144247107|NCT00085098|520102447|FG001|Overall Study|Ineligible|1|||
144247108|NCT03329248|520102450|FG000|Overall Study|Progressive Disease|6|||
144247109|NCT01886781|520102451|FG000|Overall Study|Protocol Violation|5|||
144247110|NCT01886781|520102452|FG001|Overall Study|Protocol Violation|0|||
144247111|NCT01886781|520102451|FG000|Overall Study|Adverse Event|1|||
144247112|NCT01886781|520102452|FG001|Overall Study|Adverse Event|0|||
144247113|NCT01886781|520102451|FG000|Overall Study|Lost to Follow-up|5|||
144247114|NCT01886781|520102452|FG001|Overall Study|Lost to Follow-up|0|||
144247115|NCT01886781|520102451|FG000|Overall Study|Withdrawal by Subject|2|||
144247116|NCT01886781|520102452|FG001|Overall Study|Withdrawal by Subject|1|||
144247117|NCT01886781|520102451|FG000|Overall Study|Worsening of symptoms|1|||
144247118|NCT01886781|520102452|FG001|Overall Study|Worsening of symptoms|1|||
144247119|NCT00980018|520102457|FG000|Overall Study|Adverse Event|8|||
144247120|NCT00980018|520102457|FG000|Overall Study|Patient withdrew consent|3|||
144247121|NCT00980018|520102457|FG000|Overall Study|Lost to Follow-up|1|||
144247122|NCT01522235|520102458|FG000|Overall Study|Physician Decision|1|||
144247123|NCT01522235|520102459|FG001|Overall Study|Physician Decision|1|||
144247124|NCT03000530|520102460|FG000|Overall Study|Adverse Event|0|||
144247125|NCT03000530|520102461|FG001|Overall Study|Adverse Event|0|||
144247126|NCT03000530|520102462|FG002|Overall Study|Adverse Event|2|||
144247127|NCT03000530|520102460|FG000|Overall Study|Lost to Follow-up|0|||
144247128|NCT03000530|520102461|FG001|Overall Study|Lost to Follow-up|3|||
144247129|NCT03000530|520102462|FG002|Overall Study|Lost to Follow-up|1|||
144247130|NCT03000530|520102460|FG000|Overall Study|Withdrawal by Subject|0|||
144247131|NCT03000530|520102461|FG001|Overall Study|Withdrawal by Subject|2|||
144247132|NCT03000530|520102462|FG002|Overall Study|Withdrawal by Subject|1|||
144247133|NCT05385224|520102463|FG000|Overall Study|Unable to swallow capsule|2|||
144247134|NCT05385224|520102463|FG000|Overall Study|Withdrawal by Subject|2|||
144291367|NCT02100644|520268760|FG002|LTG Escalation Phase|Adverse Event|0|||
144291368|NCT02100644|520268758|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
144291369|NCT02100644|520268759|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
144291370|NCT02100644|520268760|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
144291371|NCT02100644|520268758|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
144291372|NCT02100644|520268759|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
144291373|NCT02100644|520268760|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
144291374|NCT00478140|520268763|FG000|Overall Study|Clinical Disease Progression|1|||
144291375|NCT00728182|520268764|FG000|Overall Study|Adverse Event|1|||
144291376|NCT00728182|520268765|FG001|Overall Study|Adverse Event|0|||
144291377|NCT00728182|520268764|FG000|Overall Study|Lost to Follow-up|2|||
144291378|NCT00728182|520268765|FG001|Overall Study|Lost to Follow-up|0|||
144291379|NCT00728182|520268764|FG000|Overall Study|Death|0|||
144291380|NCT00728182|520268765|FG001|Overall Study|Death|2|||
144291381|NCT00728182|520268764|FG000|Overall Study|Protocol Noncompliance|0|||
144291382|NCT00728182|520268765|FG001|Overall Study|Protocol Noncompliance|1|||
144291383|NCT03721107|520268766|FG000|Overall Study|Adverse Event|1|||
144291384|NCT03721107|520268767|FG001|Overall Study|Adverse Event|1|||
144291385|NCT03721107|520268768|FG002|Overall Study|Adverse Event|6|||
144291386|NCT03721107|520268769|FG003|Overall Study|Adverse Event|5|||
144291387|NCT03721107|520268766|FG000|Overall Study|Lost to Follow-up|2|||
144291388|NCT03721107|520268767|FG001|Overall Study|Lost to Follow-up|0|||
144291389|NCT03721107|520268768|FG002|Overall Study|Lost to Follow-up|3|||
144291390|NCT03721107|520268769|FG003|Overall Study|Lost to Follow-up|0|||
144291391|NCT03721107|520268766|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
144291392|NCT03721107|520268767|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
144291393|NCT03721107|520268768|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
144291394|NCT03721107|520268769|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
144291395|NCT03721107|520268766|FG000|Overall Study|Physician Decision|0|||
144291396|NCT03721107|520268767|FG001|Overall Study|Physician Decision|1|||
144291397|NCT03721107|520268768|FG002|Overall Study|Physician Decision|0|||
144291398|NCT03721107|520268769|FG003|Overall Study|Physician Decision|0|||
144291399|NCT03721107|520268766|FG000|Overall Study|Pregnancy|0|||
144291400|NCT03721107|520268767|FG001|Overall Study|Pregnancy|0|||
144291401|NCT03721107|520268768|FG002|Overall Study|Pregnancy|1|||
144291402|NCT03721107|520268769|FG003|Overall Study|Pregnancy|0|||
144291403|NCT03721107|520268766|FG000|Overall Study|Withdrawal by Subject|1|||
144291404|NCT03721107|520268767|FG001|Overall Study|Withdrawal by Subject|1|||
144291405|NCT03721107|520268768|FG002|Overall Study|Withdrawal by Subject|5|||
144291406|NCT03721107|520268769|FG003|Overall Study|Withdrawal by Subject|5|||
144291407|NCT03721107|520268766|FG000|Overall Study|Other|1|||
144291408|NCT03721107|520268767|FG001|Overall Study|Other|0|||
144291409|NCT03721107|520268768|FG002|Overall Study|Other|0|||
144291410|NCT03721107|520268769|FG003|Overall Study|Other|1|||
144291411|NCT02294019|520268770|FG000|Overall Study|Adverse Event|2|||
144291412|NCT02294019|520268770|FG000|Overall Study|Protocol Violation|68|||
144291413|NCT02294019|520268770|FG000|Overall Study|Lost to Follow-up|31|||
144291414|NCT02294019|520268770|FG000|Overall Study|Other|1|||
144291415|NCT02294019|520268770|FG000|Overall Study|Withdrawal by Subject|1|||
144291416|NCT02554474|520268772|FG000|Overall Study|Protocol Violation|1|||
144291417|NCT02554474|520268773|FG001|Overall Study|Protocol Violation|1|||
144291418|NCT02554474|520268772|FG000|Overall Study|Health issue not related to the study|1|||
144291419|NCT02554474|520268773|FG001|Overall Study|Health issue not related to the study|0|||
144291420|NCT02554474|520268772|FG000|Overall Study|Withdrawal by Subject|1|||
144291421|NCT02554474|520268773|FG001|Overall Study|Withdrawal by Subject|1|||
144291422|NCT03211832|520268774|FG000|Overall Study|No longer with agency|32|||
144291423|NCT03211832|520268775|FG001|Overall Study|No longer with agency|49|||
144291424|NCT03211832|520268776|FG002|Overall Study|No longer with agency|30|||
144291425|NCT03211832|520268774|FG000|Overall Study|Declined survey|3|||
144291426|NCT03211832|520268775|FG001|Overall Study|Declined survey|3|||
144291427|NCT03211832|520268776|FG002|Overall Study|Declined survey|2|||
144291428|NCT03211832|520268774|FG000|Overall Study|Not available during data collection|1|||
144291429|NCT03211832|520268775|FG001|Overall Study|Not available during data collection|0|||
144291430|NCT03211832|520268776|FG002|Overall Study|Not available during data collection|2|||
144291431|NCT03511209|520268780|FG000|Overall Study|Withdrawal by Subject|2|||
144291432|NCT03511209|520268781|FG001|Overall Study|Withdrawal by Subject|4|||
144291433|NCT03511209|520268780|FG000|Overall Study|Death|1|||
144291434|NCT03511209|520268781|FG001|Overall Study|Death|0|||
144291435|NCT03511209|520268780|FG000|Overall Study|Lost to Follow-up|0|||
144291436|NCT03511209|520268781|FG001|Overall Study|Lost to Follow-up|2|||
144291437|NCT02971137|520268785|FG000|Overall Study|Lost to Follow-up|44|||
144291438|NCT02971137|520268786|FG001|Overall Study|Lost to Follow-up|56|||
144291439|NCT00127933|520268800|FG000|Overall Study|Randomized but not dosed|1|||
144291440|NCT00127933|520268801|FG001|Overall Study|Randomized but not dosed|0|||
144291441|NCT01783938|520268807|FG000|Overall Study|Disease Progression|18|||
144291442|NCT01783938|520268808|FG001|Overall Study|Disease Progression|41|||
144291443|NCT01783938|520268807|FG000|Overall Study|Study Drug Toxicity|27|||
144291444|NCT01783938|520268808|FG001|Overall Study|Study Drug Toxicity|14|||
144291445|NCT01783938|520268807|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
144291446|NCT01783938|520268808|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
144291447|NCT01783938|520268807|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
144291448|NCT01783938|520268808|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
144291449|NCT01783938|520268807|FG000|Overall Study|Participant Withdrew Consent|2|||
144291450|NCT01783938|520268808|FG001|Overall Study|Participant Withdrew Consent|0|||
144291451|NCT01783938|520268807|FG000|Overall Study|Maximum Clinical Benefit|1|||
144291452|NCT01783938|520268808|FG001|Overall Study|Maximum Clinical Benefit|0|||
144291453|NCT01783938|520268807|FG000|Overall Study|Other Reasons|3|||
144291454|NCT01783938|520268808|FG001|Overall Study|Other Reasons|1|||
144291455|NCT03072875|520268809|FG000|Overall Study|Lost to Follow-up|1|||
144291456|NCT03111732|520268810|FG000|Overall Study|Enrolled in different study|1|||
144291457|NCT03111732|520268810|FG000|Overall Study|Progressive disease|3|||
144291458|NCT03111732|520268810|FG000|Overall Study|Withdrawal by Subject|1|||
144291459|NCT00401830|520268814|FG000|Overall Study|Adverse Event|10|||
144291460|NCT00401830|520268815|FG001|Overall Study|Adverse Event|18|||
144291461|NCT00401830|520268814|FG000|Overall Study|Lack of Efficacy|11|||
144291462|NCT00401830|520268815|FG001|Overall Study|Lack of Efficacy|5|||
144291463|NCT00401830|520268814|FG000|Overall Study|Withdrawal by Subject|4|||
144291464|NCT00401830|520268815|FG001|Overall Study|Withdrawal by Subject|3|||
144291465|NCT00401830|520268814|FG000|Overall Study|Protocol Violation|3|||
144291466|NCT00401830|520268815|FG001|Overall Study|Protocol Violation|3|||
144291467|NCT00401830|520268814|FG000|Overall Study|Non-compliance with drug study|1|||
144291468|NCT00401830|520268815|FG001|Overall Study|Non-compliance with drug study|0|||
144291469|NCT00401830|520268814|FG000|Overall Study|Lost to Follow-up|1|||
144291470|NCT00401830|520268815|FG001|Overall Study|Lost to Follow-up|3|||
144291471|NCT00401830|520268814|FG000|Overall Study|Other: Personal / Family problems|1|||
144291472|NCT00401830|520268815|FG001|Overall Study|Other: Personal / Family problems|0|||
144291473|NCT01943825|520268818|FG000|Overall Study|Lost to Follow-up|9|||
144291474|NCT01943825|520268819|FG001|Overall Study|Lost to Follow-up|3|||
144291475|NCT01943825|520268820|FG002|Overall Study|Lost to Follow-up|12|||
144291476|NCT01943825|520268821|FG003|Overall Study|Lost to Follow-up|8|||
144291477|NCT01943825|520268818|FG000|Overall Study|Withdrawal by Subject|1|||
144291478|NCT01943825|520268819|FG001|Overall Study|Withdrawal by Subject|0|||
144291479|NCT01943825|520268820|FG002|Overall Study|Withdrawal by Subject|3|||
144291480|NCT01943825|520268821|FG003|Overall Study|Withdrawal by Subject|2|||
144291481|NCT01943825|520268818|FG000|Overall Study|Other than specified above|0|||
144291482|NCT01943825|520268819|FG001|Overall Study|Other than specified above|1|||
144291483|NCT01943825|520268820|FG002|Overall Study|Other than specified above|0|||
144291484|NCT01943825|520268821|FG003|Overall Study|Other than specified above|1|||
144291485|NCT00452400|520268822|FG000|Overall Study|Adverse Event|1|||
144291486|NCT00452400|520268823|FG001|Overall Study|Adverse Event|1|||
144291487|NCT00452400|520268824|FG002|Overall Study|Adverse Event|5|||
144291488|NCT00452400|520268825|FG003|Overall Study|Adverse Event|0|||
144291489|NCT00452400|520268826|FG004|Overall Study|Adverse Event|2|||
144291490|NCT00452400|520268822|FG000|Overall Study|Protocol Violation|0|||
144291491|NCT00452400|520268823|FG001|Overall Study|Protocol Violation|0|||
144291492|NCT00452400|520268824|FG002|Overall Study|Protocol Violation|1|||
144291493|NCT00452400|520268825|FG003|Overall Study|Protocol Violation|0|||
144291494|NCT00452400|520268826|FG004|Overall Study|Protocol Violation|0|||
144291495|NCT00452400|520268822|FG000|Overall Study|Lost to Follow-up|1|||
144291496|NCT00452400|520268823|FG001|Overall Study|Lost to Follow-up|0|||
144291497|NCT00452400|520268824|FG002|Overall Study|Lost to Follow-up|0|||
144291498|NCT00452400|520268825|FG003|Overall Study|Lost to Follow-up|0|||
144291499|NCT00452400|520268826|FG004|Overall Study|Lost to Follow-up|0|||
144291500|NCT00452400|520268822|FG000|Overall Study|Withdrawal by Subject|1|||
144291501|NCT00452400|520268823|FG001|Overall Study|Withdrawal by Subject|0|||
144291502|NCT00452400|520268824|FG002|Overall Study|Withdrawal by Subject|1|||
144291503|NCT00452400|520268825|FG003|Overall Study|Withdrawal by Subject|0|||
144291504|NCT00452400|520268826|FG004|Overall Study|Withdrawal by Subject|0|||
144291505|NCT00452400|520268822|FG000|Overall Study|Lack of Efficacy|2|||
144291506|NCT00452400|520268823|FG001|Overall Study|Lack of Efficacy|0|||
144291507|NCT00452400|520268824|FG002|Overall Study|Lack of Efficacy|0|||
144291508|NCT00452400|520268825|FG003|Overall Study|Lack of Efficacy|0|||
144291509|NCT00452400|520268826|FG004|Overall Study|Lack of Efficacy|0|||
144291510|NCT00452400|520268822|FG000|Overall Study|Other reasons not listed above|0|||
144291511|NCT00452400|520268823|FG001|Overall Study|Other reasons not listed above|0|||
144291512|NCT00452400|520268824|FG002|Overall Study|Other reasons not listed above|0|||
144291513|NCT00452400|520268825|FG003|Overall Study|Other reasons not listed above|1|||
144291514|NCT00452400|520268826|FG004|Overall Study|Other reasons not listed above|1|||
144291515|NCT02792257|520268831|FG000|Overall Study|Lost to Follow-up|3|||
144291516|NCT02792257|520268832|FG001|Overall Study|Lost to Follow-up|4|||
144291517|NCT02792257|520268831|FG000|Overall Study|Allergy|0|||
144291518|NCT02792257|520268832|FG001|Overall Study|Allergy|1|||
144291519|NCT02792257|520268831|FG000|Overall Study|Protocol Violation|2|||
144291520|NCT02792257|520268832|FG001|Overall Study|Protocol Violation|0|||
144291521|NCT02792257|520268831|FG000|Overall Study|Excessive Agitation|0|||
144291522|NCT02792257|520268832|FG001|Overall Study|Excessive Agitation|1|||
144291523|NCT02792257|520268831|FG000|Overall Study|Not Feeling Well|0|||
144291524|NCT02792257|520268832|FG001|Overall Study|Not Feeling Well|1|||
144291525|NCT05130281|520271055|FG000|Overall Study|Withdrawal by Subject|0|||
144291526|NCT05130281|520271056|FG001|Overall Study|Withdrawal by Subject|0|||
144291527|NCT05130281|520271057|FG002|Overall Study|Withdrawal by Subject|1|||
144291528|NCT03810365|520271059|FG000|Overall Study|Lost to Follow-up|2|||
144291529|NCT03810365|520271060|FG001|Overall Study|Lost to Follow-up|2|||
144291530|NCT03810365|520271059|FG000|Overall Study|Withdrawal by Subject|4|||
144291531|NCT03810365|520271060|FG001|Overall Study|Withdrawal by Subject|5|||
144291532|NCT00107614|520271063|FG000|Overall Study|Physician Decision|10|||
144291533|NCT00107614|520271063|FG000|Overall Study|Death|2|||
144291534|NCT02144337|520271064|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
144291535|NCT02144337|520271065|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
144291536|NCT02144337|520271064|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
144291537|NCT02144337|520271065|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
144291538|NCT02144337|520271064|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
144291539|NCT02144337|520271065|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
144291540|NCT02144337|520271064|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
144291541|NCT02144337|520271065|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
144291542|NCT02144337|520271064|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
144291543|NCT02144337|520271065|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
144291544|NCT00449787|520271066|FG000|Overall Study|Lost to Follow-up|10|||
144291545|NCT00449787|520271067|FG001|Overall Study|Lost to Follow-up|8|||
144291546|NCT00449787|520271066|FG000|Overall Study|Did not require medication|95|||
144291547|NCT00449787|520271067|FG001|Overall Study|Did not require medication|92|||
144291548|NCT03701074|520271068|FG000|Overall Study|Physician Decision|1|||
144291549|NCT03701074|520271069|FG001|Overall Study|Physician Decision|0|||
144291550|NCT01661595|520271070|FG000|Phase 1: Week 0-4|Adverse Event|1|||
144291551|NCT01661595|520271071|FG001|Phase 1: Week 0-4|Adverse Event|0|||
144291552|NCT01661595|520271072|FG002|Phase 1: Week 0-4|Adverse Event|0|||
144291553|NCT01661595|520271073|FG003|Phase 1: Week 0-4|Adverse Event|0|||
144291554|NCT01661595|520271070|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
144291555|NCT01661595|520271071|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
144291556|NCT01661595|520271072|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
144291557|NCT01661595|520271073|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
144291558|NCT01034657|520271074|FG000|Core Phase|Withdrawal by Subject|1|||
144291559|NCT01034657|520271075|FG001|Core Phase|Withdrawal by Subject|0|||
144291560|NCT01034657|520271076|FG002|Core Phase|Withdrawal by Subject|0|||
144291561|NCT01034657|520271074|FG000|Core Phase|Lack of Efficacy|2|||
144291562|NCT01034657|520271075|FG001|Core Phase|Lack of Efficacy|0|||
144291563|NCT01034657|520271076|FG002|Core Phase|Lack of Efficacy|0|||
144291564|NCT01034657|520271074|FG000|Core Phase|Abnormal laboratory value|1|||
144291565|NCT01034657|520271075|FG001|Core Phase|Abnormal laboratory value|0|||
144291566|NCT01034657|520271076|FG002|Core Phase|Abnormal laboratory value|0|||
144291567|NCT01034657|520271074|FG000|Core Phase|Adverse Event|8|||
144291568|NCT01034657|520271075|FG001|Core Phase|Adverse Event|0|||
144291569|NCT01034657|520271076|FG002|Core Phase|Adverse Event|0|||
144291570|NCT01034657|520271074|FG000|Core Phase|Protocol Violation|2|||
144291571|NCT01034657|520271075|FG001|Core Phase|Protocol Violation|0|||
144291572|NCT01034657|520271076|FG002|Core Phase|Protocol Violation|0|||
144291573|NCT01034657|520271074|FG000|Randomized Phase|Withdrawal by Subject|0|||
144291574|NCT01034657|520271075|FG001|Randomized Phase|Withdrawal by Subject|2|||
144291575|NCT01034657|520271076|FG002|Randomized Phase|Withdrawal by Subject|0|||
144291576|NCT01034657|520271074|FG000|Randomized Phase|Lack of Efficacy|5|||
144291577|NCT01034657|520271075|FG001|Randomized Phase|Lack of Efficacy|1|||
144291578|NCT01034657|520271076|FG002|Randomized Phase|Lack of Efficacy|0|||
144291579|NCT01034657|520271074|FG000|Randomized Phase|Abnormal laboratory value|0|||
144291580|NCT01034657|520271075|FG001|Randomized Phase|Abnormal laboratory value|1|||
144291581|NCT01034657|520271076|FG002|Randomized Phase|Abnormal laboratory value|0|||
144291582|NCT01034657|520271074|FG000|Randomized Phase|Adverse Event|0|||
144291583|NCT01034657|520271075|FG001|Randomized Phase|Adverse Event|2|||
144291584|NCT01034657|520271076|FG002|Randomized Phase|Adverse Event|1|||
144291585|NCT01633112|520271077|FG000|Overall Study|Lack of Efficacy|1|||
144291586|NCT01633112|520271078|FG001|Overall Study|Lack of Efficacy|6|||
144291587|NCT01633112|520271079|FG002|Overall Study|Lack of Efficacy|13|||
144291588|NCT01633112|520271077|FG000|Overall Study|Abnormal laboratory value(s)|3|||
144291589|NCT01633112|520271078|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144291590|NCT01633112|520271079|FG002|Overall Study|Abnormal laboratory value(s)|0|||
144291591|NCT01633112|520271077|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144291592|NCT01633112|520271078|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144291593|NCT01633112|520271079|FG002|Overall Study|Abnormal test procedure result(s)|0|||
144291594|NCT01633112|520271077|FG000|Overall Study|Administrative problems|1|||
144291595|NCT01633112|520271078|FG001|Overall Study|Administrative problems|2|||
144291596|NCT01633112|520271079|FG002|Overall Study|Administrative problems|5|||
144291597|NCT01633112|520271077|FG000|Overall Study|Adverse Event|16|||
144291598|NCT01633112|520271078|FG001|Overall Study|Adverse Event|18|||
144291599|NCT01633112|520271079|FG002|Overall Study|Adverse Event|20|||
144291600|NCT01633112|520271077|FG000|Overall Study|Lost to Follow-up|7|||
144291601|NCT01633112|520271078|FG001|Overall Study|Lost to Follow-up|19|||
144291602|NCT01633112|520271079|FG002|Overall Study|Lost to Follow-up|6|||
144291603|NCT01633112|520271077|FG000|Overall Study|Protocol Violation|4|||
144291604|NCT01633112|520271078|FG001|Overall Study|Protocol Violation|0|||
144291605|NCT01633112|520271079|FG002|Overall Study|Protocol Violation|2|||
144291606|NCT01633112|520271077|FG000|Overall Study|Subject no longer requires study drug|0|||
144291607|NCT01633112|520271078|FG001|Overall Study|Subject no longer requires study drug|0|||
144291608|NCT01633112|520271079|FG002|Overall Study|Subject no longer requires study drug|1|||
144291609|NCT01633112|520271077|FG000|Overall Study|Withdrawal by Subject|20|||
144291610|NCT01633112|520271078|FG001|Overall Study|Withdrawal by Subject|12|||
144291611|NCT01633112|520271079|FG002|Overall Study|Withdrawal by Subject|41|||
144291612|NCT01633112|520271077|FG000|Overall Study|missing Study Completion CRF|1|||
144291613|NCT01633112|520271078|FG001|Overall Study|missing Study Completion CRF|1|||
144291614|NCT01633112|520271079|FG002|Overall Study|missing Study Completion CRF|4|||
144291615|NCT01959919|520271080|FG000|Overall Study|Did not meet the eligibility criteria|2|||
144291616|NCT03439072|520271081|FG000|Overall Study|Withdrawal by Subject|2|||
144291617|NCT03439072|520271082|FG001|Overall Study|Withdrawal by Subject|3|||
144291618|NCT03439072|520271081|FG000|Overall Study|Physician Decision|0|||
144291619|NCT03439072|520271082|FG001|Overall Study|Physician Decision|1|||
144291620|NCT02094885|520271084|FG000|Overall Study|Death|1|||
144291621|NCT02094885|520271085|FG001|Overall Study|Death|5|||
144291622|NCT02094885|520271084|FG000|Overall Study|Withdrawn due to age|1|||
144291623|NCT02094885|520271085|FG001|Overall Study|Withdrawn due to age|0|||
144291624|NCT02003898|520271086|FG000|Overall Study|Death|3|||
144291625|NCT02003898|520271086|FG000|Overall Study|Lost to Follow-up|12|||
144291626|NCT02003898|520271086|FG000|Overall Study|Withdrawal by Subject|52|||
144291627|NCT01537432|520271087|FG000|Overall Study|Lost to Follow-up|3|||
144291628|NCT01537432|520271088|FG001|Overall Study|Lost to Follow-up|1|||
144291629|NCT01537432|520271087|FG000|Overall Study|Withdrawal by Subject|0|||
144291630|NCT01537432|520271088|FG001|Overall Study|Withdrawal by Subject|1|||
144291631|NCT01537432|520271087|FG000|Overall Study|Administrative problems|1|||
144291632|NCT01537432|520271088|FG001|Overall Study|Administrative problems|0|||
144291633|NCT01537432|520271087|FG000|Overall Study|Adverse Event|1|||
144291634|NCT01537432|520271088|FG001|Overall Study|Adverse Event|0|||
144291635|NCT01537432|520271087|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144291636|NCT01537432|520271088|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144291637|NCT05166902|520271089|FG000|First Intervention|Lost to Follow-up|0|||
144291638|NCT05166902|520271090|FG001|First Intervention|Lost to Follow-up|1|||
144291639|NCT01998477|520271091|FG000|Overall Study|Lost to Follow-up|4|||
144291640|NCT01998477|520271092|FG001|Overall Study|Lost to Follow-up|5|||
144291641|NCT01998477|520271091|FG000|Overall Study|Withdrawal by Subject|6|||
144291642|NCT01998477|520271092|FG001|Overall Study|Withdrawal by Subject|0|||
144291643|NCT00779909|520271093|FG000|Overall Study|Lost to Follow-up|1|||
144291644|NCT00779909|520271094|FG001|Overall Study|Lost to Follow-up|0|||
144291645|NCT00779909|520271095|FG002|Overall Study|Lost to Follow-up|0|||
144291646|NCT00779909|520271096|FG003|Overall Study|Lost to Follow-up|1|||
144291647|NCT00779909|520271093|FG000|Overall Study|Withdrawal by Subject|0|||
144291648|NCT00779909|520271094|FG001|Overall Study|Withdrawal by Subject|1|||
144291649|NCT00779909|520271095|FG002|Overall Study|Withdrawal by Subject|0|||
144291650|NCT00779909|520271096|FG003|Overall Study|Withdrawal by Subject|0|||
144291651|NCT00128492|520271097|FG000|Overall Study|AE unrelated to study|2|||
144291652|NCT00128492|520271098|FG001|Overall Study|AE unrelated to study|9|||
144291653|NCT00128492|520271097|FG000|Overall Study|Study drug intolerance (AE)|2|||
144291654|NCT00128492|520271098|FG001|Overall Study|Study drug intolerance (AE)|8|||
144291655|NCT00128492|520271097|FG000|Overall Study|AE related to study|1|||
144291656|NCT00128492|520271098|FG001|Overall Study|AE related to study|4|||
144291657|NCT00128492|520271097|FG000|Overall Study|Death|1|||
144291658|NCT00128492|520271098|FG001|Overall Study|Death|0|||
144291659|NCT00128492|520271097|FG000|Overall Study|Lost to Follow-up|1|||
144291660|NCT00128492|520271098|FG001|Overall Study|Lost to Follow-up|5|||
144291661|NCT00128492|520271097|FG000|Overall Study|Noncompliance|0|||
144291662|NCT00128492|520271098|FG001|Overall Study|Noncompliance|5|||
144291663|NCT00128492|520271097|FG000|Overall Study|Personal or administrative|10|||
144291664|NCT00128492|520271098|FG001|Overall Study|Personal or administrative|22|||
144291665|NCT00128492|520271097|FG000|Overall Study|Withdrawal by Subject|3|||
144291666|NCT00128492|520271098|FG001|Overall Study|Withdrawal by Subject|5|||
144291667|NCT00128492|520271097|FG000|Overall Study|Pregnancy|0|||
144291668|NCT00128492|520271098|FG001|Overall Study|Pregnancy|1|||
144291669|NCT01104870|520271099|FG000|Overall Study|Adverse Event|1|||
144291670|NCT01104870|520271100|FG001|Overall Study|Adverse Event|1|||
144291671|NCT01104870|520271101|FG002|Overall Study|Adverse Event|0|||
144291672|NCT01104870|520271099|FG000|Overall Study|Death|0|||
144291673|NCT01104870|520271100|FG001|Overall Study|Death|0|||
144291674|NCT01104870|520271101|FG002|Overall Study|Death|1|||
144291675|NCT01104870|520271099|FG000|Overall Study|Withdrawal by Subject|0|||
144291676|NCT01104870|520271100|FG001|Overall Study|Withdrawal by Subject|0|||
144291677|NCT01104870|520271101|FG002|Overall Study|Withdrawal by Subject|1|||
144291678|NCT00276380|520271106|FG000|Overall Study|Adverse Event|5|||
144291679|NCT00276380|520271107|FG001|Overall Study|Adverse Event|3|||
144291680|NCT00276380|520271106|FG000|Overall Study|Lost to Follow-up|1|||
144291681|NCT00276380|520271107|FG001|Overall Study|Lost to Follow-up|1|||
144291682|NCT00276380|520271106|FG000|Overall Study|Withdrawal by Subject|3|||
144291683|NCT00276380|520271107|FG001|Overall Study|Withdrawal by Subject|6|||
144291684|NCT00276380|520271106|FG000|Overall Study|Death|5|||
144291685|NCT00276380|520271107|FG001|Overall Study|Death|3|||
144291686|NCT00276380|520271106|FG000|Overall Study|Abnormal aPPT Levels|0|||
144291687|NCT00276380|520271107|FG001|Overall Study|Abnormal aPPT Levels|1|||
144291688|NCT02150863|520271108|FG000|Overall Study|Lost to Follow-up|0|||
144291689|NCT02150863|520271109|FG001|Overall Study|Lost to Follow-up|1|||
144291690|NCT02150863|520271110|FG002|Overall Study|Lost to Follow-up|0|||
144291691|NCT01651208|520271111|FG000|Overall Study|Lost to Follow-up|14|||
144291692|NCT01651208|520271112|FG001|Overall Study|Lost to Follow-up|16|||
144291693|NCT00835549|520271115|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
144291694|NCT00835549|520271116|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
144291695|NCT04893811|520271117|FG000|Vaccination Phase|Death|1|||
144291696|NCT04893811|520271118|FG001|Vaccination Phase|Death|0|||
144291697|NCT04893811|520271117|FG000|Vaccination Phase|Lost to Follow-up|1|||
144291698|NCT04893811|520271118|FG001|Vaccination Phase|Lost to Follow-up|1|||
144291699|NCT04893811|520271117|FG000|Vaccination Phase|Protocol Violation|2|||
144291700|NCT04893811|520271118|FG001|Vaccination Phase|Protocol Violation|0|||
144291701|NCT04893811|520271117|FG000|Vaccination Phase|Withdrawal by Subject|2|||
144291702|NCT04893811|520271118|FG001|Vaccination Phase|Withdrawal by Subject|1|||
144291703|NCT04893811|520271117|FG000|Vaccination Phase|Other|0|||
144291704|NCT04893811|520271118|FG001|Vaccination Phase|Other|1|||
144291705|NCT04893811|520271117|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
144291706|NCT04893811|520271118|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
144291707|NCT04893811|520271117|FG000|Follow-up Phase|Lost to Follow-up|0|||
144291708|NCT04893811|520271118|FG001|Follow-up Phase|Lost to Follow-up|1|||
144291709|NCT02662582|520271132|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
144291710|NCT02662582|520271133|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
144291711|NCT02662582|520271132|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
144291712|NCT02662582|520271133|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
144291713|NCT02662582|520271132|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
144291714|NCT02662582|520271133|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
144291715|NCT02662582|520271132|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144291716|NCT02662582|520271133|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144291717|NCT05451329|520271135|FG000|Overall Study|Adverse Event|1|||
144291718|NCT05451329|520271136|FG001|Overall Study|Adverse Event|1|||
144291719|NCT05451329|520271137|FG002|Overall Study|Adverse Event|0|||
144291720|NCT05451329|520271135|FG000|Overall Study|Withdrawal by Subject|1|||
144291721|NCT05451329|520271136|FG001|Overall Study|Withdrawal by Subject|0|||
144291722|NCT05451329|520271137|FG002|Overall Study|Withdrawal by Subject|0|||
144291723|NCT05451329|520271135|FG000|Overall Study|Investigational Product Lot exchange|1|||
144291724|NCT05451329|520271136|FG001|Overall Study|Investigational Product Lot exchange|1|||
144291725|NCT05451329|520271137|FG002|Overall Study|Investigational Product Lot exchange|0|||
144291726|NCT02176525|520271140|FG000|Overall Study|Adverse Event|0|||
144291727|NCT02176525|520271141|FG001|Overall Study|Adverse Event|0|||
144291728|NCT02176525|520271142|FG002|Overall Study|Adverse Event|0|||
144291729|NCT02176525|520271143|FG003|Overall Study|Adverse Event|1|||
144291730|NCT02176525|520271144|FG004|Overall Study|Adverse Event|1|||
144291731|NCT02176525|520271145|FG005|Overall Study|Adverse Event|0|||
144291732|NCT02176525|520271146|FG006|Overall Study|Adverse Event|1|||
144291733|NCT02176525|520271147|FG007|Overall Study|Adverse Event|0|||
144291734|NCT02176525|520271140|FG000|Overall Study|not treated|1|||
144291735|NCT02176525|520271141|FG001|Overall Study|not treated|0|||
144291736|NCT02176525|520271142|FG002|Overall Study|not treated|0|||
144291737|NCT02176525|520271143|FG003|Overall Study|not treated|0|||
144291738|NCT02176525|520271144|FG004|Overall Study|not treated|0|||
144291739|NCT02176525|520271145|FG005|Overall Study|not treated|1|||
144291740|NCT02176525|520271146|FG006|Overall Study|not treated|0|||
144291741|NCT02176525|520271147|FG007|Overall Study|not treated|0|||
144291742|NCT02852005|520271150|FG000|Overall Study|Lost to Follow-up|0|||
144291743|NCT02852005|520271151|FG001|Overall Study|Lost to Follow-up|0|||
144291744|NCT02852005|520271152|FG002|Overall Study|Lost to Follow-up|0|||
144291745|NCT02852005|520271153|FG003|Overall Study|Lost to Follow-up|0|||
144291746|NCT02852005|520271154|FG004|Overall Study|Lost to Follow-up|1|||
144291747|NCT02852005|520271150|FG000|Overall Study|Withdrawal by Subject|1|||
144291748|NCT02852005|520271151|FG001|Overall Study|Withdrawal by Subject|0|||
144291749|NCT02852005|520271152|FG002|Overall Study|Withdrawal by Subject|0|||
144291750|NCT02852005|520271153|FG003|Overall Study|Withdrawal by Subject|0|||
144291751|NCT02852005|520271154|FG004|Overall Study|Withdrawal by Subject|0|||
144291752|NCT04629521|520271155|FG000|Overall Study|Death|1|||
144291753|NCT04629521|520271155|FG000|Overall Study|Lost to Follow-up|3|||
144291754|NCT04629521|520271155|FG000|Overall Study|Subject withdrew consent|3|||
144291755|NCT04629521|520271155|FG000|Overall Study|Enrolled in error|1|||
144291756|NCT01898091|520271159|FG000|Overall Study|Lost to Follow-up|1|||
144291757|NCT01898091|520271160|FG001|Overall Study|Lost to Follow-up|1|||
144291758|NCT01898091|520271159|FG000|Overall Study|Withdrawal by Subject|1|||
144291759|NCT01898091|520271160|FG001|Overall Study|Withdrawal by Subject|5|||
144291760|NCT02369159|520271163|FG000|Overall Study|Adverse Event|0|||
144291761|NCT02369159|520271164|FG001|Overall Study|Adverse Event|1|||
144291762|NCT02369159|520271163|FG000|Overall Study|Lost to Follow-up|1|||
144291763|NCT02369159|520271164|FG001|Overall Study|Lost to Follow-up|1|||
144291764|NCT02369159|520271163|FG000|Overall Study|Withdrawal by Subject|7|||
144291765|NCT02369159|520271164|FG001|Overall Study|Withdrawal by Subject|0|||
144291766|NCT02913326|520271171|FG000|Overall Study|Reason not listed|0|||
144291767|NCT02913326|520271172|FG001|Overall Study|Reason not listed|1|||
144291768|NCT02913326|520271171|FG000|Overall Study|Lost to Follow-up|0|||
144291769|NCT02913326|520271172|FG001|Overall Study|Lost to Follow-up|1|||
144291770|NCT02913326|520271171|FG000|Overall Study|Adverse Event|1|||
144291771|NCT02913326|520271172|FG001|Overall Study|Adverse Event|0|||
144291772|NCT01514422|520271173|FG000|Overall Study|Lost to Follow-up|1|||
144291773|NCT05259722|520271177|FG000|Overall Study|Adverse Event|2|||
144291774|NCT05259722|520271178|FG001|Overall Study|Adverse Event|24|||
144291775|NCT05259722|520271177|FG000|Overall Study|Lost to Follow-up|5|||
144291776|NCT05259722|520271178|FG001|Overall Study|Lost to Follow-up|1|||
144291777|NCT05259722|520271177|FG000|Overall Study|Lack of Efficacy|8|||
144291778|NCT05259722|520271178|FG001|Overall Study|Lack of Efficacy|26|||
144291779|NCT05259722|520271177|FG000|Overall Study|Withdrawal by Subject|15|||
144291780|NCT05259722|520271178|FG001|Overall Study|Withdrawal by Subject|33|||
144291781|NCT05259722|520271177|FG000|Overall Study|Various reasons|3|||
144291782|NCT05259722|520271178|FG001|Overall Study|Various reasons|9|||
144291783|NCT05259722|520271177|FG000|Overall Study|Not exposed to IMP|1|||
144291784|NCT05259722|520271178|FG001|Overall Study|Not exposed to IMP|12|||
144291785|NCT05259722|520271177|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
144291786|NCT05259722|520271178|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
144291787|NCT00962650|520271179|FG000|Overall Study|Transgastric DP was not completed|2|||
144291788|NCT00968968|520271180|FG000|Overall Study|Study closed/terminated|10|||
144291789|NCT00968968|520271181|FG001|Overall Study|Study closed/terminated|10|||
144291790|NCT00968968|520271180|FG000|Overall Study|Protocol defined stopping criteria|3|||
144291791|NCT00968968|520271181|FG001|Overall Study|Protocol defined stopping criteria|1|||
144291792|NCT00968968|520271180|FG000|Overall Study|Withdrawal by Subject|2|||
144291793|NCT00968968|520271181|FG001|Overall Study|Withdrawal by Subject|0|||
144291794|NCT00968968|520271180|FG000|Overall Study|Physician Decision|1|||
144291795|NCT00968968|520271181|FG001|Overall Study|Physician Decision|2|||
144291796|NCT00968968|520271180|FG000|Overall Study|Lost to Follow-up|0|||
144291797|NCT00968968|520271181|FG001|Overall Study|Lost to Follow-up|1|||
144291798|NCT03624036|520271182|FG000|Overall Study|Death|2|||
144291799|NCT03624036|520271183|FG001|Overall Study|Death|3|||
144291800|NCT03624036|520271184|FG002|Overall Study|Death|0|||
144291801|NCT03624036|520271185|FG003|Overall Study|Death|1|||
144291802|NCT03624036|520271182|FG000|Overall Study|Withdrawal by Subject|1|||
144291803|NCT03624036|520271183|FG001|Overall Study|Withdrawal by Subject|0|||
144291804|NCT03624036|520271184|FG002|Overall Study|Withdrawal by Subject|1|||
144291805|NCT03624036|520271185|FG003|Overall Study|Withdrawal by Subject|0|||
144291806|NCT03624036|520271182|FG000|Overall Study|Enrolled but Never Treated|1|||
144291807|NCT03624036|520271183|FG001|Overall Study|Enrolled but Never Treated|0|||
144291808|NCT03624036|520271184|FG002|Overall Study|Enrolled but Never Treated|0|||
144291809|NCT03624036|520271185|FG003|Overall Study|Enrolled but Never Treated|0|||
144291810|NCT03624036|520271182|FG000|Overall Study|Reason not Specified|3|||
144291811|NCT03624036|520271183|FG001|Overall Study|Reason not Specified|0|||
144291812|NCT03624036|520271184|FG002|Overall Study|Reason not Specified|2|||
144291813|NCT03624036|520271185|FG003|Overall Study|Reason not Specified|2|||
144291814|NCT00498485|520271188|FG000|Overall Study|Adverse Event|1|||
144291815|NCT00498485|520271189|FG001|Overall Study|Adverse Event|5|||
144291816|NCT03478787|520271190|FG000|Overall Study|Adverse Event|5|||
144291817|NCT03478787|520271191|FG001|Overall Study|Adverse Event|1|||
144291818|NCT03478787|520271190|FG000|Overall Study|Protocol Violation|3|||
144291819|NCT03478787|520271191|FG001|Overall Study|Protocol Violation|0|||
144291820|NCT03478787|520271190|FG000|Overall Study|Lack of Efficacy|7|||
144291821|NCT03478787|520271191|FG001|Overall Study|Lack of Efficacy|1|||
144291822|NCT03478787|520271190|FG000|Overall Study|Lost to Follow-up|9|||
144291823|NCT03478787|520271191|FG001|Overall Study|Lost to Follow-up|5|||
144291824|NCT03478787|520271190|FG000|Overall Study|Withdrawal by Subject|2|||
144291825|NCT03478787|520271191|FG001|Overall Study|Withdrawal by Subject|6|||
144291826|NCT03478787|520271190|FG000|Overall Study|Other, Not Specified|3|||
144291827|NCT03478787|520271191|FG001|Overall Study|Other, Not Specified|0|||
144291828|NCT01712074|520271192|FG000|Placebo Run-in Period|Adverse Event|2|||
144291829|NCT01712074|520271193|FG001|Placebo Run-in Period|Adverse Event|0|||
144291830|NCT01712074|520271194|FG002|Placebo Run-in Period|Adverse Event|0|||
144291831|NCT01712074|520271192|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
144291832|NCT01712074|520271193|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
144291833|NCT01712074|520271194|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
144291834|NCT01712074|520271192|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
144291835|NCT01712074|520271193|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
144291836|NCT01712074|520271194|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
144291837|NCT01712074|520271192|FG000|Placebo Run-in Period|Other|1|||
144291838|NCT01712074|520271193|FG001|Placebo Run-in Period|Other|0|||
144291839|NCT01712074|520271194|FG002|Placebo Run-in Period|Other|0|||
144291840|NCT01712074|520271192|FG000|Placebo Run-in Period|No longer willing to participate|1|||
144291841|NCT01712074|520271193|FG001|Placebo Run-in Period|No longer willing to participate|0|||
144291842|NCT01712074|520271194|FG002|Placebo Run-in Period|No longer willing to participate|0|||
144291843|NCT01712074|520271192|FG000|Double Blind Period|Adverse Event|0|||
144291844|NCT01712074|520271193|FG001|Double Blind Period|Adverse Event|2|||
144291845|NCT01712074|520271194|FG002|Double Blind Period|Adverse Event|1|||
144291846|NCT01712074|520271192|FG000|Double Blind Period|No longer willing to participate|0|||
144291847|NCT01712074|520271193|FG001|Double Blind Period|No longer willing to participate|2|||
144291848|NCT01712074|520271194|FG002|Double Blind Period|No longer willing to participate|4|||
144291849|NCT01712074|520271192|FG000|Double Blind Period|Death|0|||
144291850|NCT01712074|520271193|FG001|Double Blind Period|Death|1|||
144291851|NCT01712074|520271194|FG002|Double Blind Period|Death|0|||
144291852|NCT01712074|520271192|FG000|Double Blind Period|Lost to Follow-up|0|||
144291853|NCT01712074|520271193|FG001|Double Blind Period|Lost to Follow-up|2|||
144291854|NCT01712074|520271194|FG002|Double Blind Period|Lost to Follow-up|1|||
144291855|NCT01712074|520271192|FG000|Double Blind Period|Other|0|||
144291856|NCT01712074|520271193|FG001|Double Blind Period|Other|4|||
144291857|NCT01712074|520271194|FG002|Double Blind Period|Other|1|||
144291858|NCT01712074|520271192|FG000|Double Blind Period|Protocol Violation|0|||
144291859|NCT01712074|520271193|FG001|Double Blind Period|Protocol Violation|0|||
144291860|NCT01712074|520271194|FG002|Double Blind Period|Protocol Violation|1|||
144291861|NCT01712074|520271192|FG000|Double Blind Period|No longer met eligibility criteria|0|||
144291862|NCT01712074|520271193|FG001|Double Blind Period|No longer met eligibility criteria|3|||
144291863|NCT01712074|520271194|FG002|Double Blind Period|No longer met eligibility criteria|0|||
144291864|NCT03378635|520271195|FG000|Overall Study|Adverse Event|1|||
144291865|NCT03378635|520271196|FG001|Overall Study|Adverse Event|0|||
144291866|NCT03378635|520271197|FG002|Overall Study|Adverse Event|0|||
144291867|NCT03378635|520271195|FG000|Overall Study|Withdrawal by Subject|1|||
144291868|NCT03378635|520271196|FG001|Overall Study|Withdrawal by Subject|0|||
144291869|NCT03378635|520271197|FG002|Overall Study|Withdrawal by Subject|0|||
144291870|NCT02413346|520271198|FG000|Overall Study|Adverse Event|6|||
144291871|NCT02413346|520271199|FG001|Overall Study|Adverse Event|6|||
144291872|NCT02413346|520271198|FG000|Overall Study|Withdrawal by Subject|30|||
144291873|NCT02413346|520271199|FG001|Overall Study|Withdrawal by Subject|40|||
144291874|NCT02413346|520271198|FG000|Overall Study|Lost to Follow-up|17|||
144291875|NCT02413346|520271199|FG001|Overall Study|Lost to Follow-up|21|||
144291876|NCT02413346|520271198|FG000|Overall Study|Protocol Violation|2|||
144291877|NCT02413346|520271199|FG001|Overall Study|Protocol Violation|0|||
144291878|NCT02413346|520271198|FG000|Overall Study|Other Miscellaneous Reasons|4|||
144291879|NCT02413346|520271199|FG001|Overall Study|Other Miscellaneous Reasons|3|||
144291880|NCT02539394|520271200|FG000|Overall Study|Protocol Violation|1|||
144291881|NCT02539394|520271201|FG001|Overall Study|Protocol Violation|3|||
144291882|NCT02539394|520271200|FG000|Overall Study|Lost to Follow-up|1|||
144291883|NCT02539394|520271201|FG001|Overall Study|Lost to Follow-up|2|||
144291884|NCT02539394|520271200|FG000|Overall Study|Incomplete dataset|6|||
144291885|NCT02539394|520271201|FG001|Overall Study|Incomplete dataset|6|||
144291886|NCT00890097|520271221|FG000|Overall Study|Adverse Event|21|||
144291887|NCT00890097|520271222|FG001|Overall Study|Adverse Event|32|||
144291888|NCT00890097|520271223|FG002|Overall Study|Adverse Event|28|||
144291889|NCT00890097|520271221|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
144291890|NCT00890097|520271222|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
144291891|NCT00890097|520271223|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
144291892|NCT00890097|520271221|FG000|Overall Study|Withdrew Consent|9|||
144291893|NCT00890097|520271222|FG001|Overall Study|Withdrew Consent|6|||
144291894|NCT00890097|520271223|FG002|Overall Study|Withdrew Consent|9|||
144291895|NCT00890097|520271221|FG000|Overall Study|Lost to Follow-up|5|||
144291896|NCT00890097|520271222|FG001|Overall Study|Lost to Follow-up|5|||
144291897|NCT00890097|520271223|FG002|Overall Study|Lost to Follow-up|5|||
144291898|NCT00890097|520271221|FG000|Overall Study|Noncompliance|0|||
144291899|NCT00890097|520271222|FG001|Overall Study|Noncompliance|4|||
144291900|NCT00890097|520271223|FG002|Overall Study|Noncompliance|4|||
144291901|NCT00890097|520271221|FG000|Overall Study|Sponsor Decision|7|||
144291902|NCT00890097|520271222|FG001|Overall Study|Sponsor Decision|11|||
144291903|NCT00890097|520271223|FG002|Overall Study|Sponsor Decision|7|||
144291904|NCT00890097|520271221|FG000|Overall Study|Did not attend final visit|2|||
144291905|NCT00890097|520271222|FG001|Overall Study|Did not attend final visit|3|||
144291906|NCT00890097|520271223|FG002|Overall Study|Did not attend final visit|0|||
144291907|NCT00890097|520271221|FG000|Overall Study|Subject Decision|3|||
144291908|NCT00890097|520271222|FG001|Overall Study|Subject Decision|2|||
144291909|NCT00890097|520271223|FG002|Overall Study|Subject Decision|6|||
144291910|NCT00890097|520271221|FG000|Overall Study|Randomization Error|2|||
144291911|NCT00890097|520271222|FG001|Overall Study|Randomization Error|0|||
144291912|NCT00890097|520271223|FG002|Overall Study|Randomization Error|0|||
144291913|NCT00890097|520271221|FG000|Overall Study|Failed inclusion criteria|3|||
144291914|NCT00890097|520271222|FG001|Overall Study|Failed inclusion criteria|4|||
144291915|NCT00890097|520271223|FG002|Overall Study|Failed inclusion criteria|0|||
144291916|NCT00890097|520271221|FG000|Overall Study|Transportation|0|||
144291917|NCT00890097|520271222|FG001|Overall Study|Transportation|2|||
144291918|NCT00890097|520271223|FG002|Overall Study|Transportation|0|||
144291919|NCT00890097|520271221|FG000|Overall Study|Subject Moved|0|||
144291920|NCT00890097|520271222|FG001|Overall Study|Subject Moved|4|||
144291921|NCT00890097|520271223|FG002|Overall Study|Subject Moved|0|||
144291922|NCT00890097|520271221|FG000|Overall Study|Protocol Deviation|1|||
144291923|NCT00890097|520271222|FG001|Overall Study|Protocol Deviation|1|||
144291924|NCT00890097|520271223|FG002|Overall Study|Protocol Deviation|1|||
144291925|NCT01694771|520271224|FG000|Overall Study|Adverse Event|18|||
144291926|NCT01694771|520271225|FG001|Overall Study|Adverse Event|16|||
144291927|NCT01694771|520271224|FG000|Overall Study|Lack of Efficacy|1|||
144291928|NCT01694771|520271225|FG001|Overall Study|Lack of Efficacy|0|||
144291929|NCT01694771|520271224|FG000|Overall Study|Non compliance protocol|7|||
144291930|NCT01694771|520271225|FG001|Overall Study|Non compliance protocol|6|||
144291931|NCT01694771|520271224|FG000|Overall Study|Lost to Follow-up|2|||
144291932|NCT01694771|520271225|FG001|Overall Study|Lost to Follow-up|3|||
144291933|NCT01694771|520271224|FG000|Overall Study|Consent withdrawn|7|||
144291934|NCT01694771|520271225|FG001|Overall Study|Consent withdrawn|9|||
144291935|NCT01694771|520271224|FG000|Overall Study|Other reasons|5|||
144291936|NCT01694771|520271225|FG001|Overall Study|Other reasons|6|||
144291937|NCT00289900|520271226|FG000|Overall Study|Adverse Event|28|||
144291938|NCT00289900|520271227|FG001|Overall Study|Adverse Event|40|||
144291939|NCT00289900|520271228|FG002|Overall Study|Adverse Event|13|||
144291940|NCT00289900|520271229|FG003|Overall Study|Adverse Event|19|||
144291941|NCT00289900|520271230|FG004|Overall Study|Adverse Event|20|||
144291942|NCT00289900|520271231|FG005|Overall Study|Adverse Event|33|||
144291943|NCT00289900|520271226|FG000|Overall Study|Lost to Follow-up|7|||
144291944|NCT00289900|520271227|FG001|Overall Study|Lost to Follow-up|7|||
144291945|NCT00289900|520271228|FG002|Overall Study|Lost to Follow-up|8|||
144291946|NCT00289900|520271229|FG003|Overall Study|Lost to Follow-up|8|||
144291947|NCT00289900|520271230|FG004|Overall Study|Lost to Follow-up|4|||
144291948|NCT00289900|520271231|FG005|Overall Study|Lost to Follow-up|8|||
144291949|NCT00289900|520271226|FG000|Overall Study|Participant had flushing|18|||
144291950|NCT00289900|520271227|FG001|Overall Study|Participant had flushing|42|||
144291951|NCT00289900|520271228|FG002|Overall Study|Participant had flushing|1|||
144291952|NCT00289900|520271229|FG003|Overall Study|Participant had flushing|2|||
144291953|NCT00289900|520271230|FG004|Overall Study|Participant had flushing|0|||
144291954|NCT00289900|520271231|FG005|Overall Study|Participant had flushing|4|||
144291955|NCT00289900|520271226|FG000|Overall Study|Other|0|||
144291956|NCT00289900|520271227|FG001|Overall Study|Other|0|||
144291957|NCT00289900|520271228|FG002|Overall Study|Other|0|||
144291958|NCT00289900|520271229|FG003|Overall Study|Other|5|||
144291959|NCT00289900|520271230|FG004|Overall Study|Other|1|||
144291960|NCT00289900|520271231|FG005|Overall Study|Other|0|||
144291961|NCT00289900|520271226|FG000|Overall Study|Participant moved|1|||
144291962|NCT00289900|520271227|FG001|Overall Study|Participant moved|0|||
144291963|NCT00289900|520271228|FG002|Overall Study|Participant moved|0|||
144291964|NCT00289900|520271229|FG003|Overall Study|Participant moved|1|||
144291965|NCT00289900|520271230|FG004|Overall Study|Participant moved|1|||
144291966|NCT00289900|520271231|FG005|Overall Study|Participant moved|1|||
144291967|NCT00289900|520271226|FG000|Overall Study|Withdrawal by Subject|10|||
144291968|NCT00289900|520271227|FG001|Overall Study|Withdrawal by Subject|21|||
144291969|NCT00289900|520271228|FG002|Overall Study|Withdrawal by Subject|8|||
144291970|NCT00289900|520271229|FG003|Overall Study|Withdrawal by Subject|18|||
144291971|NCT00289900|520271230|FG004|Overall Study|Withdrawal by Subject|12|||
144291972|NCT00289900|520271231|FG005|Overall Study|Withdrawal by Subject|11|||
144291973|NCT00289900|520271226|FG000|Overall Study|Protocol Violation|3|||
144291974|NCT00289900|520271227|FG001|Overall Study|Protocol Violation|9|||
144291975|NCT00289900|520271228|FG002|Overall Study|Protocol Violation|2|||
144291976|NCT00289900|520271229|FG003|Overall Study|Protocol Violation|6|||
144291977|NCT00289900|520271230|FG004|Overall Study|Protocol Violation|7|||
144291978|NCT00289900|520271231|FG005|Overall Study|Protocol Violation|4|||
144291979|NCT00289900|520271226|FG000|Overall Study|site terminated|1|||
144291980|NCT00289900|520271227|FG001|Overall Study|site terminated|0|||
144291981|NCT00289900|520271228|FG002|Overall Study|site terminated|1|||
144291982|NCT00289900|520271229|FG003|Overall Study|site terminated|0|||
144291983|NCT00289900|520271230|FG004|Overall Study|site terminated|0|||
144291984|NCT00289900|520271231|FG005|Overall Study|site terminated|0|||
144291985|NCT00289900|520271226|FG000|Overall Study|Not treated|0|||
144291986|NCT00289900|520271227|FG001|Overall Study|Not treated|1|||
144291987|NCT00289900|520271228|FG002|Overall Study|Not treated|0|||
144291988|NCT00289900|520271229|FG003|Overall Study|Not treated|0|||
144291989|NCT00289900|520271230|FG004|Overall Study|Not treated|0|||
144291990|NCT00289900|520271231|FG005|Overall Study|Not treated|0|||
144291991|NCT01703221|520271234|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
144291992|NCT01703221|520271235|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
144291993|NCT01703221|520271236|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
144291994|NCT01703221|520271234|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
144291995|NCT01703221|520271235|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
144291996|NCT01703221|520271236|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
144291997|NCT01703221|520271234|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
144291998|NCT01703221|520271235|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144291999|NCT01703221|520271236|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
144292000|NCT01703221|520271234|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
144292001|NCT01703221|520271235|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
144292002|NCT01703221|520271236|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
144292003|NCT01703221|520271234|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144292004|NCT01703221|520271235|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
144292005|NCT01703221|520271236|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
144292006|NCT01703221|520271234|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
144292007|NCT01703221|520271235|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
144292008|NCT01703221|520271236|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
144292009|NCT01703221|520271234|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
144292010|NCT01703221|520271235|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
144292011|NCT01703221|520271236|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
144292012|NCT01703221|520271234|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
144292013|NCT01703221|520271235|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
144292014|NCT01703221|520271236|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
144292015|NCT01152385|520271237|FG000|Overall Study|Withdrawal by Subject|3|||
144292016|NCT01152385|520271238|FG001|Overall Study|Withdrawal by Subject|1|||
144292017|NCT01152385|520271239|FG002|Overall Study|Withdrawal by Subject|1|||
144292018|NCT01152385|520271240|FG003|Overall Study|Withdrawal by Subject|1|||
144292019|NCT01152385|520271237|FG000|Overall Study|Protocol Violation|0|||
144292020|NCT01152385|520271238|FG001|Overall Study|Protocol Violation|0|||
144292021|NCT01152385|520271239|FG002|Overall Study|Protocol Violation|0|||
144292022|NCT01152385|520271240|FG003|Overall Study|Protocol Violation|1|||
144292023|NCT01152385|520271237|FG000|Overall Study|Adverse Event|1|||
144292024|NCT01152385|520271238|FG001|Overall Study|Adverse Event|1|||
144292025|NCT01152385|520271239|FG002|Overall Study|Adverse Event|0|||
144292026|NCT01152385|520271240|FG003|Overall Study|Adverse Event|0|||
144292027|NCT01152385|520271237|FG000|Overall Study|Study-specific withdrawal criteria|1|||
144292028|NCT01152385|520271238|FG001|Overall Study|Study-specific withdrawal criteria|1|||
144292029|NCT01152385|520271239|FG002|Overall Study|Study-specific withdrawal criteria|2|||
144292030|NCT01152385|520271240|FG003|Overall Study|Study-specific withdrawal criteria|0|||
144292031|NCT01152385|520271237|FG000|Overall Study|Other|4|||
144292032|NCT01152385|520271238|FG001|Overall Study|Other|3|||
144292033|NCT01152385|520271239|FG002|Overall Study|Other|2|||
144292034|NCT01152385|520271240|FG003|Overall Study|Other|3|||
144292035|NCT03878069|520271241|FG000|Overall Study|Death|0|||
144292036|NCT03878069|520271242|FG001|Overall Study|Death|1|||
144292037|NCT03878069|520271243|FG002|Overall Study|Death|0|||
144292038|NCT03449147|520271244|FG000|52-week Treatment Period|Death|0|||
144292039|NCT03449147|520271245|FG001|52-week Treatment Period|Death|1|||
144292040|NCT03449147|520271246|FG002|52-week Treatment Period|Death|0|||
144292041|NCT03449147|520271244|FG000|52-week Treatment Period|Lost to Follow-up|6|||
144292042|NCT03449147|520271245|FG001|52-week Treatment Period|Lost to Follow-up|2|||
144292043|NCT03449147|520271246|FG002|52-week Treatment Period|Lost to Follow-up|5|||
144292044|NCT03449147|520271244|FG000|52-week Treatment Period|Other|0|||
144292045|NCT03449147|520271245|FG001|52-week Treatment Period|Other|1|||
144292046|NCT03449147|520271246|FG002|52-week Treatment Period|Other|2|||
144292047|NCT03449147|520271244|FG000|52-week Treatment Period|Physician Decision|1|||
144292048|NCT03449147|520271245|FG001|52-week Treatment Period|Physician Decision|0|||
144292049|NCT03449147|520271246|FG002|52-week Treatment Period|Physician Decision|3|||
144292050|NCT03449147|520271244|FG000|52-week Treatment Period|Screen Failure|1|||
144292051|NCT03449147|520271245|FG001|52-week Treatment Period|Screen Failure|2|||
144292052|NCT03449147|520271246|FG002|52-week Treatment Period|Screen Failure|0|||
144292053|NCT03449147|520271244|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
144292054|NCT03449147|520271245|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
144292055|NCT03449147|520271246|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
144292056|NCT03449147|520271244|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
144292057|NCT03449147|520271245|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
144292058|NCT03449147|520271246|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
144292059|NCT03449147|520271244|FG000|12-Week Off-Treatment Durability Period|Other|0|||
144292060|NCT03449147|520271245|FG001|12-Week Off-Treatment Durability Period|Other|1|||
144292061|NCT03449147|520271246|FG002|12-Week Off-Treatment Durability Period|Other|0|||
144292062|NCT00974233|520271250|FG000|Induction Chemoimmunotherapy|Death|2|||
144292063|NCT00974233|520271250|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
144292064|NCT00974233|520271250|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
144292065|NCT00974233|520271250|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
144292066|NCT00974233|520271250|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
144292067|NCT00974233|520271250|FG000|Maintenance Lenalidomide|Adverse Event|8|||
144292068|NCT02113878|520272956|FG000|Overall Study|Adverse Event|1|||
144292069|NCT02113878|520272957|FG001|Overall Study|Adverse Event|0|||
144292070|NCT02113878|520272956|FG000|Overall Study|Withdrawal by Subject|1|||
144292071|NCT02113878|520272957|FG001|Overall Study|Withdrawal by Subject|0|||
144292072|NCT02113878|520272956|FG000|Overall Study|patient non-compliance|1|||
144292073|NCT02113878|520272957|FG001|Overall Study|patient non-compliance|0|||
144292074|NCT00530257|520272958|FG000|Overall Study|Lost to Follow-up|1|||
144292075|NCT06844812|520272961|FG000|Overall Study|Lost to Follow-up|5|||
144292076|NCT06844812|520272961|FG000|Overall Study|stigmatization concerns|2|||
144292077|NCT06844812|520272961|FG000|Overall Study|medication refusal|2|||
144292078|NCT06844812|520272961|FG000|Overall Study|concerns about possible side effects|2|||
144292079|NCT06844812|520272961|FG000|Overall Study|wanting to seek another specialist opinion|2|||
144292080|NCT06844812|520272961|FG000|Overall Study|side effects (dizziness)|1|||
144292081|NCT00203242|520272984|FG000|Overall Study|Lost to Follow-up|1|||
144292082|NCT01500135|520272985|FG000|Overall Study|Withdrawal of Consent|4|||
144292083|NCT01500135|520272986|FG001|Overall Study|Withdrawal of Consent|0|||
144292084|NCT01500135|520272985|FG000|Overall Study|Lost to Follow-up|6|||
144292085|NCT01500135|520272986|FG001|Overall Study|Lost to Follow-up|4|||
144292086|NCT01500135|520272985|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
144292087|NCT01500135|520272986|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
144292088|NCT01500135|520272985|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
144292089|NCT01500135|520272986|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
144292090|NCT01500135|520272985|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
144292091|NCT01500135|520272986|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
144292092|NCT01500135|520272985|FG000|Overall Study|Participant was a Safety Concern|1|||
144292093|NCT01500135|520272986|FG001|Overall Study|Participant was a Safety Concern|0|||
144292094|NCT01500135|520272985|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
144292095|NCT01500135|520272986|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
144292096|NCT00912509|520272987|FG000|Overall Study|Lost to Follow-up|1|||
144292097|NCT00912509|520272988|FG001|Overall Study|Lost to Follow-up|0|||
144292098|NCT00912509|520272987|FG000|Overall Study|Lack of Efficacy|4|||
144292099|NCT00912509|520272988|FG001|Overall Study|Lack of Efficacy|3|||
144292100|NCT02872142|520272999|FG000|Overall Study|Adverse Event|2|||
144292101|NCT02872142|520272999|FG000|Overall Study|Death|1|||
144292102|NCT02872142|520272999|FG000|Overall Study|Participant Decision|3|||
144292103|NCT03627468|520273004|FG000|Overall Study|Adverse Event|5|||
144292104|NCT03627468|520273005|FG001|Overall Study|Adverse Event|33|||
144292105|NCT03627468|520273004|FG000|Overall Study|Withdrawal by Subject|13|||
144292106|NCT03627468|520273005|FG001|Overall Study|Withdrawal by Subject|23|||
144292107|NCT03627468|520273004|FG000|Overall Study|Physician Decision|1|||
144292108|NCT03627468|520273005|FG001|Overall Study|Physician Decision|0|||
144292109|NCT03627468|520273004|FG000|Overall Study|Protocol Violation|0|||
144292110|NCT03627468|520273005|FG001|Overall Study|Protocol Violation|2|||
144292111|NCT03627468|520273004|FG000|Overall Study|Lost to Follow-up|10|||
144292112|NCT03627468|520273005|FG001|Overall Study|Lost to Follow-up|16|||
144292113|NCT03627468|520273004|FG000|Overall Study|Death|1|||
144292114|NCT03627468|520273005|FG001|Overall Study|Death|0|||
144292115|NCT03627468|520273004|FG000|Overall Study|Pregnancy|1|||
144292116|NCT03627468|520273005|FG001|Overall Study|Pregnancy|1|||
144292117|NCT03627468|520273004|FG000|Overall Study|Lack of Efficacy|0|||
144292118|NCT03627468|520273005|FG001|Overall Study|Lack of Efficacy|2|||
144292119|NCT03627468|520273004|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
144292120|NCT03627468|520273005|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
144292121|NCT05122143|520273006|FG000|Overall Study|Adverse Event|1|||
144292122|NCT05122143|520273007|FG001|Overall Study|Adverse Event|0|||
144292123|NCT05122143|520273008|FG002|Overall Study|Adverse Event|0|||
144292124|NCT05122143|520273009|FG003|Overall Study|Adverse Event|0|||
144292125|NCT05122143|520273010|FG004|Overall Study|Adverse Event|1|||
144292126|NCT05122143|520273011|FG005|Overall Study|Adverse Event|0|||
144292127|NCT05122143|520273006|FG000|Overall Study|Protocol non-compliance|0|||
144292128|NCT05122143|520273007|FG001|Overall Study|Protocol non-compliance|0|||
144292129|NCT05122143|520273008|FG002|Overall Study|Protocol non-compliance|1|||
144292130|NCT05122143|520273009|FG003|Overall Study|Protocol non-compliance|0|||
144292131|NCT05122143|520273010|FG004|Overall Study|Protocol non-compliance|0|||
144292132|NCT05122143|520273011|FG005|Overall Study|Protocol non-compliance|0|||
144292133|NCT05122143|520273006|FG000|Overall Study|Covid contact|0|||
144292134|NCT05122143|520273007|FG001|Overall Study|Covid contact|0|||
144292135|NCT05122143|520273008|FG002|Overall Study|Covid contact|0|||
144292136|NCT05122143|520273009|FG003|Overall Study|Covid contact|0|||
144292137|NCT05122143|520273010|FG004|Overall Study|Covid contact|1|||
144292138|NCT05122143|520273011|FG005|Overall Study|Covid contact|0|||
144292139|NCT00692237|520273012|FG000|Overall Study|Withdrawal by Subject|1|||
144292140|NCT00692237|520273013|FG001|Overall Study|Withdrawal by Subject|3|||
144292141|NCT00692237|520273012|FG000|Overall Study|Adverse Event|0|||
144292142|NCT00692237|520273013|FG001|Overall Study|Adverse Event|1|||
144292143|NCT00309946|520273014|FG000|Overall Study|Withdrawal by Subject|1|||
144292144|NCT02244957|520273015|FG000|Overall Study|Lack of Efficacy|1|||
144292145|NCT02244957|520273016|FG001|Overall Study|Lack of Efficacy|0|||
144292146|NCT00395447|520273017|FG000|Overall Study|Death|37|||
144292147|NCT00395447|520273018|FG001|Overall Study|Death|32|||
144292148|NCT00395447|520273017|FG000|Overall Study|Lost to Follow-up|52|||
144292149|NCT00395447|520273018|FG001|Overall Study|Lost to Follow-up|43|||
144292150|NCT00395447|520273017|FG000|Overall Study|Withdrawal by Subject|24|||
144292151|NCT00395447|520273018|FG001|Overall Study|Withdrawal by Subject|19|||
144292152|NCT00395447|520273017|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
144292153|NCT00395447|520273018|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
144292154|NCT02624687|520273020|FG000|Overall Study|Withdrawal by Subject|1|||
144292155|NCT02624687|520273021|FG001|Overall Study|Withdrawal by Subject|1|||
144292156|NCT02624687|520273020|FG000|Overall Study|medical leave from work|0|||
144292157|NCT02624687|520273021|FG001|Overall Study|medical leave from work|1|||
144292158|NCT03111108|520273022|FG000|Overall Study|Death|0|||
144292159|NCT03111108|520273023|FG001|Overall Study|Death|1|||
144292160|NCT03111108|520273022|FG000|Overall Study|Withdrawal by Subject|1|||
144292161|NCT03111108|520273023|FG001|Overall Study|Withdrawal by Subject|0|||
144292162|NCT00347269|520273024|FG000|Overall Study|Lost to Follow-up|74|||
144292163|NCT00347269|520273025|FG001|Overall Study|Lost to Follow-up|65|||
144292164|NCT00347269|520273024|FG000|Overall Study|Withdrawal by Subject|18|||
144292165|NCT00347269|520273025|FG001|Overall Study|Withdrawal by Subject|38|||
144292166|NCT00347269|520273024|FG000|Overall Study|Death|2|||
144292167|NCT00347269|520273025|FG001|Overall Study|Death|3|||
144292168|NCT01853280|520273026|FG000|Overall Study|Lack of Efficacy|2|||
144292169|NCT01853280|520273027|FG001|Overall Study|Lack of Efficacy|2|||
144292170|NCT01853280|520273026|FG000|Overall Study|Lost to Follow-up|0|||
144292171|NCT01853280|520273027|FG001|Overall Study|Lost to Follow-up|1|||
144292172|NCT01853280|520273026|FG000|Overall Study|Physician Decision|0|||
144292173|NCT01853280|520273027|FG001|Overall Study|Physician Decision|1|||
144292174|NCT01853280|520273026|FG000|Overall Study|Withdrawal by Subject|0|||
144292175|NCT01853280|520273027|FG001|Overall Study|Withdrawal by Subject|1|||
144292176|NCT01853280|520273026|FG000|Overall Study|Ineligible|0|||
144292177|NCT01853280|520273027|FG001|Overall Study|Ineligible|1|||
144292178|NCT00104884|520273028|FG000|Overall Study|Disease progression|4|||
144292179|NCT03032484|520273029|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
144292180|NCT03032484|520273030|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
144292181|NCT03032484|520273029|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
144292182|NCT03032484|520273030|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
144292183|NCT03654326|520273031|FG000|Overall Study|Withdrawal by Subject|5|||
144292184|NCT03654326|520273032|FG001|Overall Study|Withdrawal by Subject|3|||
144292185|NCT03654326|520273031|FG000|Overall Study|Physician Decision|0|||
144292186|NCT03654326|520273032|FG001|Overall Study|Physician Decision|1|||
144292187|NCT03654326|520273031|FG000|Overall Study|Unable to adhere to study schedule|0|||
144292188|NCT03654326|520273032|FG001|Overall Study|Unable to adhere to study schedule|1|||
144292189|NCT03654326|520273031|FG000|Overall Study|Lost to Follow-up|1|||
144292190|NCT03654326|520273032|FG001|Overall Study|Lost to Follow-up|1|||
144292191|NCT01689649|520273033|FG000|Overall Study|Lack of Efficacy|3|||
144292192|NCT01689649|520273033|FG000|Overall Study|Non-compliance|11|||
144292193|NCT01689649|520273033|FG000|Overall Study|Protocol Violation|3|||
144292194|NCT01689649|520273033|FG000|Overall Study|Lost to Follow-up|5|||
144292195|NCT00835042|520273034|FG000|First Intervention|Withdrawal by Subject|3|||
144292196|NCT00835042|520273035|FG001|First Intervention|Withdrawal by Subject|0|||
144292197|NCT00835042|520273034|FG000|First Intervention|Adverse Event|1|||
144292198|NCT00835042|520273035|FG001|First Intervention|Adverse Event|2|||
144292199|NCT00835042|520273034|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
144292200|NCT00835042|520273035|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
144292201|NCT04064567|520273036|FG000|Overall Study|Lost to Follow-up|23|||
144292202|NCT04064567|520273037|FG001|Overall Study|Lost to Follow-up|22|||
144292203|NCT04064567|520273036|FG000|Overall Study|Withdrawal by Subject|0|||
144292204|NCT04064567|520273037|FG001|Overall Study|Withdrawal by Subject|1|||
144292205|NCT04064567|520273036|FG000|Overall Study|Reincarcerated|7|||
144292206|NCT04064567|520273037|FG001|Overall Study|Reincarcerated|10|||
144292207|NCT04064567|520273036|FG000|Overall Study|Moved out of U.S.|0|||
144292208|NCT04064567|520273037|FG001|Overall Study|Moved out of U.S.|1|||
144292209|NCT02758626|520273041|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
144292210|NCT02758626|520273042|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
144292211|NCT02758626|520273041|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
144292212|NCT02758626|520273042|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
144292213|NCT02758626|520273041|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
144292214|NCT02758626|520273042|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
144292215|NCT02758626|520273041|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
144292216|NCT02758626|520273042|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
144292217|NCT02739828|520273048|FG000|Overall Study|Adverse Event|1|||
144292218|NCT02739828|520273048|FG000|Overall Study|Lost to Follow-up|4|||
144292219|NCT00489476|520273052|FG000|Overall Study|Lost to Follow-up|0|||
144292220|NCT00489476|520273053|FG001|Overall Study|Lost to Follow-up|1|||
144292221|NCT00489476|520273054|FG002|Overall Study|Lost to Follow-up|0|||
144292222|NCT00489476|520273055|FG003|Overall Study|Lost to Follow-up|0|||
144700044|NCT05182840|521754494|FG007|Treatment Period|Burden of study procedures|0|||
144700045|NCT05182840|521754495|FG008|Treatment Period|Burden of study procedures|0|||
144700046|NCT05182840|521754496|FG009|Treatment Period|Burden of study procedures|0|||
144700047|NCT05182840|521754487|FG000|Treatment Period|Change of residence|0|||
144700048|NCT05182840|521754488|FG001|Treatment Period|Change of residence|0|||
144700049|NCT05182840|521754489|FG002|Treatment Period|Change of residence|0|||
144700050|NCT05182840|521754490|FG003|Treatment Period|Change of residence|0|||
144700051|NCT05182840|521754491|FG004|Treatment Period|Change of residence|0|||
144700052|NCT05182840|521754492|FG005|Treatment Period|Change of residence|1|||
144700053|NCT05182840|521754493|FG006|Treatment Period|Change of residence|0|||
144700054|NCT05182840|521754494|FG007|Treatment Period|Change of residence|0|||
144700055|NCT05182840|521754495|FG008|Treatment Period|Change of residence|0|||
144700056|NCT05182840|521754496|FG009|Treatment Period|Change of residence|0|||
144700057|NCT05182840|521754487|FG000|Treatment Period|Adverse Event|0|||
144700058|NCT05182840|521754488|FG001|Treatment Period|Adverse Event|0|||
144700059|NCT05182840|521754489|FG002|Treatment Period|Adverse Event|4|||
144700060|NCT05182840|521754490|FG003|Treatment Period|Adverse Event|16|||
144700061|NCT05182840|521754491|FG004|Treatment Period|Adverse Event|12|||
144292229|NCT02757963|520273068|FG000|Overall Study|Adverse Event|3|||
144292230|NCT02757963|520273068|FG000|Overall Study|Reached Stopping Criteria|1054|||
144292231|NCT02757963|520273068|FG000|Overall Study|Lost to Follow-up|5|||
144292232|NCT02757963|520273068|FG000|Overall Study|Physician Decision|1|||
144292233|NCT02757963|520273068|FG000|Overall Study|Withdrawal by Subject|34|||
144292234|NCT00911157|520273069|FG000|Overall Study|Adverse Event|4|||
144292235|NCT00911157|520273070|FG001|Overall Study|Adverse Event|1|||
144292236|NCT00911157|520273069|FG000|Overall Study|Withdrawal by Subject|1|||
144292237|NCT00911157|520273070|FG001|Overall Study|Withdrawal by Subject|1|||
144292238|NCT00911157|520273069|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
144292239|NCT00911157|520273070|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
144292240|NCT00911157|520273069|FG000|Overall Study|Need to treat for lung cancer|1|||
144292241|NCT00911157|520273070|FG001|Overall Study|Need to treat for lung cancer|0|||
144292242|NCT03769467|520273071|FG000|Overall Study|Adverse Event|1|||
144292243|NCT03769467|520273072|FG001|Overall Study|Adverse Event|1|||
144292244|NCT03769467|520273073|FG002|Overall Study|Adverse Event|0|||
144292245|NCT03769467|520273071|FG000|Overall Study|Death|3|||
144292246|NCT03769467|520273072|FG001|Overall Study|Death|3|||
144292247|NCT03769467|520273073|FG002|Overall Study|Death|0|||
144292248|NCT03769467|520273071|FG000|Overall Study|Study Terminated By Sponsor|2|||
144292249|NCT03769467|520273072|FG001|Overall Study|Study Terminated By Sponsor|1|||
144292250|NCT03769467|520273073|FG002|Overall Study|Study Terminated By Sponsor|0|||
144292251|NCT03769467|520273071|FG000|Overall Study|Withdrawal by Subject|0|||
144292252|NCT03769467|520273072|FG001|Overall Study|Withdrawal by Subject|1|||
144292253|NCT03769467|520273073|FG002|Overall Study|Withdrawal by Subject|0|||
144292254|NCT04565756|520273074|FG000|Overall Study|Withdrawal by Subject|0|||
144292255|NCT04565756|520273075|FG001|Overall Study|Withdrawal by Subject|0|||
144292256|NCT04565756|520273076|FG002|Overall Study|Withdrawal by Subject|0|||
144292257|NCT04565756|520273077|FG003|Overall Study|Withdrawal by Subject|0|||
144292258|NCT04565756|520273078|FG004|Overall Study|Withdrawal by Subject|1|||
144292259|NCT04565756|520273079|FG005|Overall Study|Withdrawal by Subject|0|||
144292260|NCT04565756|520273074|FG000|Overall Study|Protocol Violation|0|||
144292261|NCT04565756|520273075|FG001|Overall Study|Protocol Violation|0|||
144292262|NCT04565756|520273076|FG002|Overall Study|Protocol Violation|0|||
144292263|NCT04565756|520273077|FG003|Overall Study|Protocol Violation|0|||
144292264|NCT04565756|520273078|FG004|Overall Study|Protocol Violation|0|||
144292265|NCT04565756|520273079|FG005|Overall Study|Protocol Violation|1|||
144292266|NCT01887600|520273080|FG000|Overall Study|Death|39|||
144292267|NCT01887600|520273081|FG001|Overall Study|Death|16|||
144292268|NCT01887600|520273080|FG000|Overall Study|Lack of Efficacy|3|||
144292269|NCT01887600|520273081|FG001|Overall Study|Lack of Efficacy|26|||
144292270|NCT01887600|520273080|FG000|Overall Study|Lost to Follow-up|5|||
144292271|NCT01887600|520273081|FG001|Overall Study|Lost to Follow-up|1|||
144292272|NCT01887600|520273080|FG000|Overall Study|Physician Decision|7|||
144292273|NCT01887600|520273081|FG001|Overall Study|Physician Decision|8|||
144292274|NCT01887600|520273080|FG000|Overall Study|Protocol Deviation|3|||
144292275|NCT01887600|520273081|FG001|Overall Study|Protocol Deviation|0|||
144292276|NCT01887600|520273080|FG000|Overall Study|Withdrawal by Subject|58|||
144292277|NCT01887600|520273081|FG001|Overall Study|Withdrawal by Subject|52|||
144292278|NCT01887600|520273080|FG000|Overall Study|Adverse Event|21|||
144292279|NCT01887600|520273081|FG001|Overall Study|Adverse Event|9|||
144292280|NCT01887600|520273080|FG000|Overall Study|Non-compliance with study drug|3|||
144292281|NCT01887600|520273081|FG001|Overall Study|Non-compliance with study drug|0|||
144292282|NCT01887600|520273080|FG000|Overall Study|Miscellaneous|6|||
144292283|NCT01887600|520273081|FG001|Overall Study|Miscellaneous|2|||
144292284|NCT01887600|520273080|FG000|Overall Study|Progressive Disease|1|||
144292285|NCT01887600|520273081|FG001|Overall Study|Progressive Disease|0|||
144292286|NCT03688139|520273082|FG000|Overall Study|Lost to Follow-up|2|||
144292287|NCT03688139|520273083|FG001|Overall Study|Lost to Follow-up|0|||
144292288|NCT03688139|520273082|FG000|Overall Study|Physician Decision|0|||
144292289|NCT03688139|520273083|FG001|Overall Study|Physician Decision|1|||
144292290|NCT03688139|520273082|FG000|Overall Study|Withdrawal by Subject|2|||
144292291|NCT03688139|520273083|FG001|Overall Study|Withdrawal by Subject|3|||
144292292|NCT00231465|520273084|FG000|Overall Study|Completed only one cycle|1|||
144292293|NCT00231465|520273084|FG000|Overall Study|Did not have follow up CT scans|1|||
144292294|NCT00420056|520273085|FG000|Overall Study|Objective progression or relapse|17|||
144292295|NCT01390584|520273093|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
144292296|NCT01390584|520273094|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
144292297|NCT01390584|520273095|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
144292298|NCT02268851|520273098|FG000|Overall Study|Death|0|||
144292299|NCT02268851|520273099|FG001|Overall Study|Death|0|||
144292300|NCT02268851|520273100|FG002|Overall Study|Death|0|||
144292301|NCT02268851|520273101|FG003|Overall Study|Death|1|||
144292302|NCT02268851|520273102|FG004|Overall Study|Death|2|||
144292303|NCT02268851|520273103|FG005|Overall Study|Death|1|||
144292304|NCT02268851|520273098|FG000|Overall Study|Adverse Event|0|||
144292305|NCT02268851|520273099|FG001|Overall Study|Adverse Event|0|||
144292306|NCT02268851|520273100|FG002|Overall Study|Adverse Event|0|||
144292307|NCT02268851|520273101|FG003|Overall Study|Adverse Event|0|||
144292308|NCT02268851|520273102|FG004|Overall Study|Adverse Event|2|||
144292309|NCT02268851|520273103|FG005|Overall Study|Adverse Event|2|||
144292310|NCT02268851|520273098|FG000|Overall Study|Withdrawal by Subject|0|||
144292311|NCT02268851|520273099|FG001|Overall Study|Withdrawal by Subject|0|||
144292312|NCT02268851|520273100|FG002|Overall Study|Withdrawal by Subject|0|||
144292313|NCT02268851|520273101|FG003|Overall Study|Withdrawal by Subject|2|||
144292314|NCT02268851|520273102|FG004|Overall Study|Withdrawal by Subject|0|||
144292315|NCT02268851|520273103|FG005|Overall Study|Withdrawal by Subject|1|||
144292316|NCT02268851|520273098|FG000|Overall Study|Progressive Disease|1|||
144292317|NCT02268851|520273099|FG001|Overall Study|Progressive Disease|3|||
144292318|NCT02268851|520273100|FG002|Overall Study|Progressive Disease|0|||
144292319|NCT02268851|520273101|FG003|Overall Study|Progressive Disease|0|||
144292320|NCT02268851|520273102|FG004|Overall Study|Progressive Disease|1|||
144292321|NCT02268851|520273103|FG005|Overall Study|Progressive Disease|4|||
144292322|NCT02268851|520273098|FG000|Overall Study|Physician Decision|0|||
144292323|NCT02268851|520273099|FG001|Overall Study|Physician Decision|0|||
144292324|NCT02268851|520273100|FG002|Overall Study|Physician Decision|1|||
144292325|NCT02268851|520273101|FG003|Overall Study|Physician Decision|0|||
144292326|NCT02268851|520273102|FG004|Overall Study|Physician Decision|0|||
144292327|NCT02268851|520273103|FG005|Overall Study|Physician Decision|1|||
144292328|NCT02268851|520273098|FG000|Overall Study|Patient Compliance|0|||
144292329|NCT02268851|520273099|FG001|Overall Study|Patient Compliance|0|||
144292330|NCT02268851|520273100|FG002|Overall Study|Patient Compliance|0|||
144292331|NCT02268851|520273101|FG003|Overall Study|Patient Compliance|0|||
144292332|NCT02268851|520273102|FG004|Overall Study|Patient Compliance|1|||
144292333|NCT02268851|520273103|FG005|Overall Study|Patient Compliance|1|||
144292334|NCT02268851|520273098|FG000|Overall Study|Co-Morbid Condition|0|||
144292335|NCT02268851|520273099|FG001|Overall Study|Co-Morbid Condition|0|||
144292336|NCT02268851|520273100|FG002|Overall Study|Co-Morbid Condition|0|||
144292337|NCT02268851|520273101|FG003|Overall Study|Co-Morbid Condition|0|||
144292338|NCT02268851|520273102|FG004|Overall Study|Co-Morbid Condition|1|||
144292339|NCT02268851|520273103|FG005|Overall Study|Co-Morbid Condition|1|||
144292340|NCT01472835|520273108|FG000|Overall Study|Lost to Follow-up|2|||
144292341|NCT01472835|520273109|FG001|Overall Study|Lost to Follow-up|0|||
144292342|NCT03425188|520273110|FG000|Overall Study|Withdrawal by Subject|1|||
144292343|NCT01835431|520273111|FG000|Overall Study|Adverse Event|1|||
144292344|NCT01835431|520273112|FG001|Overall Study|Adverse Event|0|||
144292345|NCT01835431|520273111|FG000|Overall Study|other|0|||
144292346|NCT01835431|520273112|FG001|Overall Study|other|2|||
144292347|NCT01835431|520273111|FG000|Overall Study|Withdrawal by Subject|6|||
144292348|NCT01835431|520273112|FG001|Overall Study|Withdrawal by Subject|10|||
144292349|NCT01835431|520273111|FG000|Overall Study|Protocol Violation|1|||
144292350|NCT01835431|520273112|FG001|Overall Study|Protocol Violation|0|||
144292351|NCT01316900|520273117|FG000|Overall Study|Adverse Event|10|||
144292352|NCT01316900|520273118|FG001|Overall Study|Adverse Event|10|||
144292353|NCT01316900|520273119|FG002|Overall Study|Adverse Event|15|||
144292354|NCT01316900|520273120|FG003|Overall Study|Adverse Event|9|||
144292355|NCT01316900|520273117|FG000|Overall Study|Lack of Efficacy|17|||
144292356|NCT01316900|520273118|FG001|Overall Study|Lack of Efficacy|9|||
144292357|NCT01316900|520273119|FG002|Overall Study|Lack of Efficacy|5|||
144292358|NCT01316900|520273120|FG003|Overall Study|Lack of Efficacy|7|||
144292359|NCT01316900|520273117|FG000|Overall Study|Protocol Violation|7|||
144292360|NCT01316900|520273118|FG001|Overall Study|Protocol Violation|1|||
144292361|NCT01316900|520273119|FG002|Overall Study|Protocol Violation|4|||
144292362|NCT01316900|520273120|FG003|Overall Study|Protocol Violation|0|||
144292363|NCT01316900|520273117|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
144292364|NCT01316900|520273118|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
144292365|NCT01316900|520273119|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
144292366|NCT01316900|520273120|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
144292367|NCT01316900|520273117|FG000|Overall Study|Lost to Follow-up|1|||
144292368|NCT01316900|520273118|FG001|Overall Study|Lost to Follow-up|0|||
144292369|NCT01316900|520273119|FG002|Overall Study|Lost to Follow-up|1|||
144292370|NCT01316900|520273120|FG003|Overall Study|Lost to Follow-up|1|||
144292371|NCT01316900|520273117|FG000|Overall Study|Withdrawal by Subject|7|||
144292372|NCT01316900|520273118|FG001|Overall Study|Withdrawal by Subject|8|||
144292373|NCT01316900|520273119|FG002|Overall Study|Withdrawal by Subject|6|||
144292374|NCT01316900|520273120|FG003|Overall Study|Withdrawal by Subject|9|||
144292375|NCT00562861|520273121|FG000|Overall Study|Adverse Event|1|||
144292376|NCT00562861|520273122|FG001|Overall Study|Adverse Event|1|||
144292377|NCT00562861|520273121|FG000|Overall Study|Lack of Efficacy|5|||
144292378|NCT00562861|520273122|FG001|Overall Study|Lack of Efficacy|5|||
144292379|NCT00562861|520273121|FG000|Overall Study|noncompliance, moved|7|||
144292380|NCT00562861|520273122|FG001|Overall Study|noncompliance, moved|2|||
144292381|NCT00562861|520273121|FG000|Overall Study|Lost to Follow-up|7|||
144292382|NCT00562861|520273122|FG001|Overall Study|Lost to Follow-up|3|||
144292383|NCT00655356|520273123|FG000|Overall Study|Withdrawal by Subject|3|||
144292384|NCT00655356|520273124|FG001|Overall Study|Withdrawal by Subject|4|||
144292385|NCT00655356|520273123|FG000|Overall Study|Sponsor Request|10|||
144292386|NCT00655356|520273124|FG001|Overall Study|Sponsor Request|4|||
144292387|NCT00655356|520273123|FG000|Overall Study|Adverse Event|1|||
144292388|NCT00655356|520273124|FG001|Overall Study|Adverse Event|1|||
144292389|NCT00655356|520273123|FG000|Overall Study|Protocol Violation|2|||
144292390|NCT00655356|520273124|FG001|Overall Study|Protocol Violation|1|||
144292391|NCT00655356|520273123|FG000|Overall Study|Other Reason|1|||
144292392|NCT00655356|520273124|FG001|Overall Study|Other Reason|0|||
144292393|NCT01684033|520273125|FG000|Period 1, First 30 Days|Adverse Event|1|||
144292394|NCT01684033|520273126|FG001|Period 1, First 30 Days|Adverse Event|1|||
144292395|NCT01684033|520273125|FG000|Period 1, First 30 Days|Noncompliance|1|||
144292396|NCT01684033|520273126|FG001|Period 1, First 30 Days|Noncompliance|0|||
144292397|NCT01684033|520273125|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
144292398|NCT01684033|520273126|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
144292399|NCT01684033|520273125|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
144292400|NCT01684033|520273126|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
144292401|NCT01684033|520273125|FG000|Period 2, Second 30 Days|Adverse Event|1|||
144292402|NCT01684033|520273126|FG001|Period 2, Second 30 Days|Adverse Event|0|||
144292403|NCT01044459|520273127|FG000|Overall Study|Withdrawal by Subject|21|||
144292404|NCT01044459|520273128|FG001|Overall Study|Withdrawal by Subject|28|||
144292405|NCT01044459|520273127|FG000|Overall Study|Terminated by Sponsor|22|||
144292406|NCT01044459|520273128|FG001|Overall Study|Terminated by Sponsor|21|||
144292407|NCT01044459|520273127|FG000|Overall Study|Adverse Event|22|||
144292408|NCT01044459|520273128|FG001|Overall Study|Adverse Event|20|||
144292409|NCT01044459|520273127|FG000|Overall Study|Lack of Efficacy|23|||
144292410|NCT01044459|520273128|FG001|Overall Study|Lack of Efficacy|12|||
144292411|NCT01044459|520273127|FG000|Overall Study|Protocol Violation|11|||
144292412|NCT01044459|520273128|FG001|Overall Study|Protocol Violation|16|||
144292413|NCT01044459|520273127|FG000|Overall Study|Other Reason|7|||
144292414|NCT01044459|520273128|FG001|Overall Study|Other Reason|14|||
144292415|NCT01044459|520273127|FG000|Overall Study|COPD exacerbation|9|||
144292416|NCT01044459|520273128|FG001|Overall Study|COPD exacerbation|8|||
144292417|NCT01044459|520273127|FG000|Overall Study|Lost to Follow-up|18|||
144292418|NCT01044459|520273128|FG001|Overall Study|Lost to Follow-up|12|||
144292419|NCT04105725|520273129|FG000|Primary Intervention|Lost to Follow-up|0|||
144292420|NCT04105725|520273130|FG001|Primary Intervention|Lost to Follow-up|2|||
144292421|NCT04105725|520273129|FG000|Primary Intervention|Withdrawal by Subject|0|||
144292422|NCT04105725|520273130|FG001|Primary Intervention|Withdrawal by Subject|1|||
144292423|NCT05346640|520273131|FG000|Overall Study|Lack of Efficacy|2|||
144292424|NCT05346640|520273131|FG000|Overall Study|Lost to Follow-up|14|||
144292425|NCT05346640|520273131|FG000|Overall Study|Protocol Violation|4|||
144292426|NCT05346640|520273131|FG000|Overall Study|Withdrawal by Subject|2|||
144292427|NCT05346640|520273131|FG000|Overall Study|Physiological Complications|3|||
144292428|NCT05346640|520273131|FG000|Overall Study|Other Reason|3|||
144292429|NCT00480025|520273132|FG000|Overall Study|Protocol Violation|12|||
144292430|NCT00480025|520273133|FG001|Overall Study|Protocol Violation|7|||
144292431|NCT00480025|520273132|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
144292432|NCT00480025|520273133|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
144292433|NCT00480025|520273132|FG000|Overall Study|Disease Progression / Recurrence|449|||
144292434|NCT00480025|520273133|FG001|Overall Study|Disease Progression / Recurrence|224|||
144292435|NCT00480025|520273132|FG000|Overall Study|Adverse Event|44|||
144292436|NCT00480025|520273133|FG001|Overall Study|Adverse Event|12|||
144292437|NCT00480025|520273132|FG000|Overall Study|Other|70|||
144292438|NCT00480025|520273133|FG001|Overall Study|Other|29|||
144292439|NCT00480025|520273132|FG000|Overall Study|SAE including intercurrent illness|76|||
144292440|NCT00480025|520273133|FG001|Overall Study|SAE including intercurrent illness|42|||
144292441|NCT04634331|520273134|FG000|Overall Study|Withdrawal by Subject|2|||
144292442|NCT04634331|520273135|FG001|Overall Study|Withdrawal by Subject|2|||
144292443|NCT03726879|520273137|FG000|Overall Study|Death|11|||
144292444|NCT03726879|520273138|FG001|Overall Study|Death|13|||
144292445|NCT03726879|520273137|FG000|Overall Study|Physician Decision|0|||
144292446|NCT03726879|520273138|FG001|Overall Study|Physician Decision|2|||
144292447|NCT03726879|520273137|FG000|Overall Study|Protocol Violation|0|||
144292448|NCT03726879|520273138|FG001|Overall Study|Protocol Violation|1|||
144292449|NCT03726879|520273137|FG000|Overall Study|Withdrawal by Subject|5|||
144292450|NCT03726879|520273138|FG001|Overall Study|Withdrawal by Subject|6|||
144292451|NCT03726879|520273137|FG000|Overall Study|TSH result is unstable|0|||
144292452|NCT03726879|520273138|FG001|Overall Study|TSH result is unstable|1|||
144292453|NCT03726879|520273137|FG000|Overall Study|Disease relapse|1|||
144292454|NCT03726879|520273138|FG001|Overall Study|Disease relapse|0|||
144292455|NCT03726879|520273137|FG000|Overall Study|Lost to Follow-up|3|||
144292456|NCT03726879|520273138|FG001|Overall Study|Lost to Follow-up|0|||
144292457|NCT02766478|520273140|FG000|Overall Study|Withdrawal by Subject|1|||
144292458|NCT02766478|520273141|FG001|Overall Study|Withdrawal by Subject|1|||
144292459|NCT05626686|520273142|FG000|Overall Study|Protocol Violation|3|||
144292460|NCT05626686|520273142|FG000|Overall Study|Withdrawal by Subject|3|||
144292461|NCT01093573|520273143|FG000|Overall Study|Physician Decision|0|||
144292462|NCT01093573|520273144|FG001|Overall Study|Physician Decision|0|||
144292463|NCT01093573|520273145|FG002|Overall Study|Physician Decision|1|||
144292464|NCT01093573|520273143|FG000|Overall Study|Insurance Denied|0|||
144292465|NCT01093573|520273144|FG001|Overall Study|Insurance Denied|0|||
144292466|NCT01093573|520273145|FG002|Overall Study|Insurance Denied|1|||
144292467|NCT00507507|520273146|FG000|Treatment Period|Lost to Follow-up|0|||
144292468|NCT00507507|520273147|FG001|Treatment Period|Lost to Follow-up|2|||
144292469|NCT00507507|520273146|FG000|Treatment Period|Physician Decision|4|||
144292470|NCT00507507|520273147|FG001|Treatment Period|Physician Decision|1|||
144292471|NCT00507507|520273146|FG000|Treatment Period|Protocol Violation|1|||
144292472|NCT00507507|520273147|FG001|Treatment Period|Protocol Violation|2|||
144292473|NCT00507507|520273146|FG000|Treatment Period|Adverse Event|1|||
144292474|NCT00507507|520273147|FG001|Treatment Period|Adverse Event|1|||
144292475|NCT00507507|520273146|FG000|Treatment Period|Withdrawal by Subject|46|||
144292476|NCT00507507|520273147|FG001|Treatment Period|Withdrawal by Subject|47|||
144292477|NCT00507507|520273146|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
144292478|NCT00507507|520273147|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
144292479|NCT00507507|520273146|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
144292480|NCT00507507|520273147|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
144292481|NCT00507507|520273146|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
144292482|NCT00507507|520273147|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
144292483|NCT02916433|520273148|FG000|Overall Study|Withdrawal by Subject|1|||
144292484|NCT02916433|520273149|FG001|Overall Study|Withdrawal by Subject|0|||
144292485|NCT02916433|520273148|FG000|Overall Study|Physician Decision|1|||
144292486|NCT02916433|520273149|FG001|Overall Study|Physician Decision|0|||
144292487|NCT01412983|520273151|FG000|1st Period|Ineligible|0|||
144292488|NCT01412983|520273152|FG001|1st Period|Ineligible|1|||
144292489|NCT01412983|520273151|FG000|1st Period|Positive slit lamp finding|0|||
144292490|NCT01412983|520273152|FG001|1st Period|Positive slit lamp finding|1|||
144292491|NCT01412983|520273151|FG000|1st Period|Unacceptable lens movement|0|||
144292492|NCT01412983|520273152|FG001|1st Period|Unacceptable lens movement|1|||
144292493|NCT01412983|520273151|FG000|1st Period|Inability to maintain wear|0|||
144292494|NCT01412983|520273152|FG001|1st Period|Inability to maintain wear|1|||
144292495|NCT04349098|520273153|FG000|Overall Study|Death|16|||
144292496|NCT04349098|520273154|FG001|Overall Study|Death|8|||
144292497|NCT04349098|520273153|FG000|Overall Study|Lost to Follow-up|11|||
144292498|NCT04349098|520273154|FG001|Overall Study|Lost to Follow-up|8|||
144292499|NCT04349098|520273153|FG000|Overall Study|Withdrawal by Subject|8|||
144292500|NCT04349098|520273154|FG001|Overall Study|Withdrawal by Subject|5|||
144292501|NCT04349098|520273153|FG000|Overall Study|Other|3|||
144292502|NCT04349098|520273154|FG001|Overall Study|Other|5|||
144292503|NCT02656173|520273155|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
144292504|NCT02656173|520273156|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
144292505|NCT02656173|520273155|FG000|Overall Study|Adverse Event|7|||
144292506|NCT02656173|520273156|FG001|Overall Study|Adverse Event|5|||
144292507|NCT02656173|520273155|FG000|Overall Study|Withdrawal by Subject|1|||
144292508|NCT02656173|520273156|FG001|Overall Study|Withdrawal by Subject|3|||
144292509|NCT02656173|520273155|FG000|Overall Study|Protocol Violation|0|||
144292510|NCT02656173|520273156|FG001|Overall Study|Protocol Violation|1|||
144292511|NCT02656173|520273155|FG000|Overall Study|Miscellaneous|2|||
144292512|NCT02656173|520273156|FG001|Overall Study|Miscellaneous|0|||
144292513|NCT03927846|520273157|FG000|Overall Study|Lost to Follow-up|10|||
144292514|NCT03927846|520273158|FG001|Overall Study|Lost to Follow-up|11|||
144292515|NCT00992394|520273159|FG000|Overall Study|Lack of Efficacy|6|||
144292516|NCT00992394|520273160|FG001|Overall Study|Lack of Efficacy|3|||
144292517|NCT00992394|520273159|FG000|Overall Study|Adverse Event|4|||
144292518|NCT00992394|520273160|FG001|Overall Study|Adverse Event|5|||
144292519|NCT00992394|520273159|FG000|Overall Study|Withdrawal by Subject|8|||
144292520|NCT00992394|520273160|FG001|Overall Study|Withdrawal by Subject|2|||
144292521|NCT00992394|520273159|FG000|Overall Study|Physician Decision|1|||
144292522|NCT00992394|520273160|FG001|Overall Study|Physician Decision|0|||
144292523|NCT00992394|520273159|FG000|Overall Study|Protocol Violation|2|||
144292524|NCT00992394|520273160|FG001|Overall Study|Protocol Violation|4|||
144292525|NCT00992394|520273159|FG000|Overall Study|Lost to Follow-up|2|||
144292526|NCT00992394|520273160|FG001|Overall Study|Lost to Follow-up|0|||
144292527|NCT00992394|520273159|FG000|Overall Study|Other event|1|||
144292528|NCT00992394|520273160|FG001|Overall Study|Other event|0|||
144292529|NCT01251965|520274361|FG000|Overall Study|Participant/physician decision|1|||
144292530|NCT01251965|520274362|FG001|Overall Study|Participant/physician decision|2|||
144292531|NCT01251965|520274363|FG002|Overall Study|Participant/physician decision|0|||
144292532|NCT01251965|520274361|FG000|Overall Study|Death|0|||
144292533|NCT01251965|520274362|FG001|Overall Study|Death|0|||
144292534|NCT01251965|520274363|FG002|Overall Study|Death|11|||
144292535|NCT05401409|520274364|FG000|Overall Study|Lost to Follow-up|1|||
144292536|NCT05401409|520274365|FG001|Overall Study|Lost to Follow-up|0|||
144292537|NCT02371889|520274366|FG000|Overall Study|Adverse medication effect|11|||
144292538|NCT02371889|520274367|FG001|Overall Study|Adverse medication effect|2|||
144292539|NCT02371889|520274366|FG000|Overall Study|Lost to Follow-up|6|||
144292540|NCT02371889|520274367|FG001|Overall Study|Lost to Follow-up|5|||
144292541|NCT02371889|520274366|FG000|Overall Study|Personal time constraints|2|||
144292542|NCT02371889|520274367|FG001|Overall Study|Personal time constraints|4|||
144292543|NCT02371889|520274366|FG000|Overall Study|Lack of Efficacy|0|||
144292544|NCT02371889|520274367|FG001|Overall Study|Lack of Efficacy|2|||
144292545|NCT02371889|520274366|FG000|Overall Study|Relapse|0|||
144292546|NCT02371889|520274367|FG001|Overall Study|Relapse|1|||
144292547|NCT05520333|520274368|FG000|Overall Study|Lost to Follow-up|3|||
144292548|NCT05520333|520274369|FG001|Overall Study|Lost to Follow-up|6|||
144292549|NCT02410200|520274370|FG000|Overall Study|Adverse Event|2|||
144292550|NCT05538728|520274371|FG000|Overall Study|Withdrawal by Subject|1|||
144292551|NCT05538728|520274372|FG001|Overall Study|Withdrawal by Subject|1|||
144292552|NCT02715856|520274373|FG000|Overall Study|Software Issues|12|||
144292553|NCT02715856|520274374|FG001|Overall Study|Software Issues|7|||
144292554|NCT02715856|520274373|FG000|Overall Study|Death|6|||
144292555|NCT02715856|520274374|FG001|Overall Study|Death|5|||
144292556|NCT02715856|520274373|FG000|Overall Study|Non- Compliant|0|||
144292557|NCT02715856|520274374|FG001|Overall Study|Non- Compliant|40|||
144292558|NCT01517178|520274375|FG000|Period 1|Adverse Event|1|||
144292559|NCT01517178|520274376|FG001|Period 1|Adverse Event|2|||
144292560|NCT01517178|520274375|FG000|Period 1|Lack of Efficacy|0|||
144292561|NCT01517178|520274376|FG001|Period 1|Lack of Efficacy|1|||
144292562|NCT01517178|520274375|FG000|Period 1|E.g. study termination|3|||
144292563|NCT01517178|520274376|FG001|Period 1|E.g. study termination|1|||
144292564|NCT01517178|520274375|FG000|Period 1|Withdrawal by Subject|0|||
144292565|NCT01517178|520274376|FG001|Period 1|Withdrawal by Subject|1|||
144292566|NCT01517178|520274375|FG000|Period 2|Adverse Event|1|||
144292567|NCT01517178|520274376|FG001|Period 2|Adverse Event|0|||
144292568|NCT01517178|520274375|FG000|Period 2|Withdrawal by Subject|3|||
144292569|NCT01517178|520274376|FG001|Period 2|Withdrawal by Subject|0|||
144292570|NCT01517178|520274375|FG000|Period 2|E.g. study termination|2|||
144292571|NCT01517178|520274376|FG001|Period 2|E.g. study termination|2|||
144292572|NCT00756314|520274381|FG000|Overall Study|Lost to Follow-up|2|||
144292573|NCT00756314|520274382|FG001|Overall Study|Lost to Follow-up|59|||
144292574|NCT02605967|520274383|FG000|Overall Study|subject / guardian decision|1|||
144292575|NCT02605967|520274384|FG001|Overall Study|subject / guardian decision|2|||
144292576|NCT02605967|520274383|FG000|Overall Study|Physician Decision|10|||
144292577|NCT02605967|520274384|FG001|Overall Study|Physician Decision|1|||
144292578|NCT02605967|520274383|FG000|Overall Study|Death|4|||
144292579|NCT02605967|520274384|FG001|Overall Study|Death|2|||
144292580|NCT02605967|520274383|FG000|Overall Study|Adverse Event|1|||
144292581|NCT02605967|520274384|FG001|Overall Study|Adverse Event|0|||
144292582|NCT02605967|520274383|FG000|Overall Study|progressive disease|66|||
144292583|NCT02605967|520274384|FG001|Overall Study|progressive disease|35|||
144292584|NCT01903720|520274385|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
144292585|NCT01903720|520274385|FG000|Overall Study|Adverse Event|1|||
144292586|NCT01903720|520274385|FG000|Overall Study|Rescinding of informed consent|2|||
144292587|NCT01903720|520274385|FG000|Overall Study|Lost to Follow-up|2|||
144292588|NCT01903720|520274385|FG000|Overall Study|Treatment with alternative drug|1|||
144292589|NCT01347086|520274390|FG000|Overall Study|failed screening visit|0|||
144292590|NCT01347086|520274391|FG001|Overall Study|failed screening visit|0|||
144292591|NCT01347086|520274392|FG002|Overall Study|failed screening visit|1|||
144292592|NCT01347086|520274393|FG003|Overall Study|failed screening visit|0|||
144292593|NCT01347086|520274394|FG004|Overall Study|failed screening visit|0|||
144292594|NCT01347086|520274395|FG005|Overall Study|failed screening visit|0|||
144292595|NCT01347086|520274396|FG006|Overall Study|failed screening visit|1|||
144292596|NCT01347086|520274397|FG007|Overall Study|failed screening visit|1|||
144292597|NCT01347086|520274398|FG008|Overall Study|failed screening visit|0|||
144292598|NCT01347086|520274399|FG009|Overall Study|failed screening visit|1|||
144292599|NCT03760081|520274400|FG000|Overall Study|Miscellaneous|0|||
144292600|NCT03760081|520274401|FG001|Overall Study|Miscellaneous|1|||
144292601|NCT03760081|520274400|FG000|Overall Study|Progressive Disease|5|||
144292602|NCT03760081|520274401|FG001|Overall Study|Progressive Disease|10|||
144292603|NCT03760081|520274400|FG000|Overall Study|Death|1|||
144292604|NCT03760081|520274401|FG001|Overall Study|Death|1|||
144292605|NCT01725282|520274402|FG000|Overall Study|Adverse Event|1|||
144292606|NCT01725282|520274403|FG001|Overall Study|Adverse Event|3|||
144292607|NCT01725282|520274404|FG002|Overall Study|Adverse Event|6|||
144292608|NCT01725282|520274405|FG003|Overall Study|Adverse Event|4|||
144292609|NCT01725282|520274402|FG000|Overall Study|Exacerbation of Target Disease|1|||
144292610|NCT01725282|520274403|FG001|Overall Study|Exacerbation of Target Disease|0|||
144292611|NCT01725282|520274404|FG002|Overall Study|Exacerbation of Target Disease|0|||
144292612|NCT01725282|520274405|FG003|Overall Study|Exacerbation of Target Disease|1|||
144292613|NCT01725282|520274402|FG000|Overall Study|Met Exclusion Criteria|0|||
144292614|NCT01725282|520274403|FG001|Overall Study|Met Exclusion Criteria|0|||
144292615|NCT01725282|520274404|FG002|Overall Study|Met Exclusion Criteria|1|||
144292616|NCT01725282|520274405|FG003|Overall Study|Met Exclusion Criteria|0|||
144292617|NCT01725282|520274402|FG000|Overall Study|Study Site Withdrawal|0|||
144292618|NCT01725282|520274403|FG001|Overall Study|Study Site Withdrawal|1|||
144292619|NCT01725282|520274404|FG002|Overall Study|Study Site Withdrawal|0|||
144292620|NCT01725282|520274405|FG003|Overall Study|Study Site Withdrawal|0|||
144292621|NCT01725282|520274402|FG000|Overall Study|Withdrawal by Subject|0|||
144292622|NCT01725282|520274403|FG001|Overall Study|Withdrawal by Subject|0|||
144292623|NCT01725282|520274404|FG002|Overall Study|Withdrawal by Subject|1|||
144292624|NCT01725282|520274405|FG003|Overall Study|Withdrawal by Subject|1|||
144292625|NCT01725282|520274402|FG000|Overall Study|Lack of Efficacy|0|||
144292626|NCT01725282|520274403|FG001|Overall Study|Lack of Efficacy|1|||
144292627|NCT01725282|520274404|FG002|Overall Study|Lack of Efficacy|0|||
144292628|NCT01725282|520274405|FG003|Overall Study|Lack of Efficacy|1|||
144292629|NCT05524948|520274408|FG000|Overall Study|Withdrawal by Subject|1|||
144292630|NCT05524948|520274409|FG001|Overall Study|Withdrawal by Subject|0|||
144292631|NCT05524948|520274408|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
144292632|NCT05524948|520274409|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
144292633|NCT01682720|520274419|FG000|Overall Study|Randomized but Not Treated|0|||
144292634|NCT01682720|520274420|FG001|Overall Study|Randomized but Not Treated|1|||
144292635|NCT01682720|520274421|FG002|Overall Study|Randomized but Not Treated|1|||
144292636|NCT01682720|520274422|FG003|Overall Study|Randomized but Not Treated|0|||
144292637|NCT01682720|520274419|FG000|Overall Study|Terminated by Sponsor|83|||
144292638|NCT01682720|520274420|FG001|Overall Study|Terminated by Sponsor|0|||
144292639|NCT01682720|520274421|FG002|Overall Study|Terminated by Sponsor|0|||
144292640|NCT01682720|520274422|FG003|Overall Study|Terminated by Sponsor|0|||
144292641|NCT01682720|520274419|FG000|Overall Study|Efficacy Failure|0|||
144292642|NCT01682720|520274420|FG001|Overall Study|Efficacy Failure|3|||
144292643|NCT01682720|520274421|FG002|Overall Study|Efficacy Failure|3|||
144292644|NCT01682720|520274422|FG003|Overall Study|Efficacy Failure|30|||
144292645|NCT01682720|520274419|FG000|Overall Study|Lost to Follow-up|1|||
144292646|NCT01682720|520274420|FG001|Overall Study|Lost to Follow-up|1|||
144292647|NCT01682720|520274421|FG002|Overall Study|Lost to Follow-up|0|||
144292648|NCT01682720|520274422|FG003|Overall Study|Lost to Follow-up|6|||
144292649|NCT01682720|520274419|FG000|Overall Study|Subject Withdrew Consent|0|||
144292650|NCT01682720|520274420|FG001|Overall Study|Subject Withdrew Consent|0|||
144292651|NCT01682720|520274421|FG002|Overall Study|Subject Withdrew Consent|2|||
144292652|NCT01682720|520274422|FG003|Overall Study|Subject Withdrew Consent|2|||
144292653|NCT01682720|520274419|FG000|Overall Study|Adverse Event|1|||
144292654|NCT01682720|520274420|FG001|Overall Study|Adverse Event|0|||
144292655|NCT01682720|520274421|FG002|Overall Study|Adverse Event|1|||
144292656|NCT01682720|520274422|FG003|Overall Study|Adverse Event|1|||
144292657|NCT04204902|520274425|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
144292658|NCT04204902|520274426|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
144292659|NCT02202577|520274427|FG000|Overall Study|Lost to Follow-up|6|||
144292660|NCT02202577|520274428|FG001|Overall Study|Lost to Follow-up|16|||
144292661|NCT02202577|520274427|FG000|Overall Study|Protocol Violation|7|||
144292662|NCT02202577|520274428|FG001|Overall Study|Protocol Violation|3|||
144292663|NCT01618708|520274429|FG000|Overall Study|Adverse Event|10|||
144292664|NCT01618708|520274430|FG001|Overall Study|Adverse Event|10|||
144292665|NCT01618708|520274429|FG000|Overall Study|Lost to Follow-up|3|||
144292666|NCT01618708|520274430|FG001|Overall Study|Lost to Follow-up|3|||
144292667|NCT01618708|520274429|FG000|Overall Study|Withdrawal by Subject|17|||
144292668|NCT01618708|520274430|FG001|Overall Study|Withdrawal by Subject|22|||
144292669|NCT01618708|520274429|FG000|Overall Study|Lack of Efficacy|8|||
144292670|NCT01618708|520274430|FG001|Overall Study|Lack of Efficacy|8|||
144292671|NCT01618708|520274429|FG000|Overall Study|Technical problems|2|||
144292672|NCT01618708|520274430|FG001|Overall Study|Technical problems|0|||
144292673|NCT01618708|520274429|FG000|Overall Study|Other than specified above|1|||
144292674|NCT01618708|520274430|FG001|Overall Study|Other than specified above|1|||
144292675|NCT01618708|520274429|FG000|Overall Study|Randomized but not treated|3|||
144292676|NCT01618708|520274430|FG001|Overall Study|Randomized but not treated|2|||
144292677|NCT01421459|520274431|FG000|Overall Study|Adverse Event|6|||
144292678|NCT01421459|520274432|FG001|Overall Study|Adverse Event|10|||
144292679|NCT01421459|520274431|FG000|Overall Study|Death|1|||
144292680|NCT01421459|520274432|FG001|Overall Study|Death|1|||
144292681|NCT01421459|520274431|FG000|Overall Study|Lack of Efficacy|1|||
144292682|NCT01421459|520274432|FG001|Overall Study|Lack of Efficacy|2|||
144292683|NCT01421459|520274431|FG000|Overall Study|Lost to Follow-up|8|||
144292684|NCT01421459|520274432|FG001|Overall Study|Lost to Follow-up|9|||
144292685|NCT01421459|520274431|FG000|Overall Study|Physician Decision|9|||
144292686|NCT01421459|520274432|FG001|Overall Study|Physician Decision|9|||
144292687|NCT01421459|520274431|FG000|Overall Study|Protocol Violation|8|||
144292688|NCT01421459|520274432|FG001|Overall Study|Protocol Violation|5|||
144292689|NCT01421459|520274431|FG000|Overall Study|Withdrawal by Subject|12|||
144292690|NCT01421459|520274432|FG001|Overall Study|Withdrawal by Subject|16|||
144292691|NCT03769116|520274439|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
144292692|NCT03769116|520274440|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
144292693|NCT03769116|520274439|FG000|Part 3 - Open Label|Physician Decision|1|||
144292694|NCT03769116|520274440|FG001|Part 3 - Open Label|Physician Decision|0|||
144292695|NCT03769116|520274439|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
144292696|NCT03769116|520274440|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
144292697|NCT02181413|520274443|FG000|Overall Study|Withdrawal by Subject|45|||
144292698|NCT02181413|520274444|FG001|Overall Study|Withdrawal by Subject|61|||
144292699|NCT02181413|520274443|FG000|Overall Study|Reason Not Specified|2|||
144292700|NCT02181413|520274444|FG001|Overall Study|Reason Not Specified|5|||
144292701|NCT02181413|520274443|FG000|Overall Study|Lost to Follow-up|8|||
144292702|NCT02181413|520274444|FG001|Overall Study|Lost to Follow-up|7|||
144292703|NCT04003142|520274445|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
144292704|NCT04003142|520274446|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
144292705|NCT04003142|520274447|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
144292706|NCT04003142|520274448|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
144292707|NCT04003142|520274449|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
144292708|NCT04003142|520274445|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
144292709|NCT04003142|520274446|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
144292710|NCT04003142|520274447|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
144292711|NCT04003142|520274448|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
144292712|NCT04003142|520274449|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
144292713|NCT04003142|520274445|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
144292714|NCT04003142|520274446|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
144292715|NCT04003142|520274447|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
144292716|NCT04003142|520274448|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
144292717|NCT04003142|520274449|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
144292718|NCT04003142|520274445|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
144292719|NCT04003142|520274446|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
144292720|NCT04003142|520274447|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
144292721|NCT04003142|520274448|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
144292722|NCT04003142|520274449|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
144292723|NCT04003142|520274445|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
144292724|NCT04003142|520274446|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
144292725|NCT04003142|520274447|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
144292726|NCT04003142|520274448|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
144292727|NCT04003142|520274449|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
144292728|NCT04003142|520274445|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
144292729|NCT04003142|520274446|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
144292730|NCT04003142|520274447|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
144292731|NCT04003142|520274448|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
144292732|NCT04003142|520274449|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
144292733|NCT04003142|520274445|FG000|Extension Period (40 Weeks)|Death|0|||
144292734|NCT04003142|520274446|FG001|Extension Period (40 Weeks)|Death|0|||
144292735|NCT04003142|520274447|FG002|Extension Period (40 Weeks)|Death|0|||
144292736|NCT04003142|520274448|FG003|Extension Period (40 Weeks)|Death|0|||
144292737|NCT04003142|520274449|FG004|Extension Period (40 Weeks)|Death|1|||
144292738|NCT04003142|520274445|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
144292739|NCT04003142|520274446|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
144292740|NCT04003142|520274447|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
144292741|NCT04003142|520274448|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
144292742|NCT04003142|520274449|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
144292743|NCT04003142|520274445|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
144292744|NCT04003142|520274446|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
144292745|NCT04003142|520274447|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
144292746|NCT04003142|520274448|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
144292747|NCT04003142|520274449|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
144292748|NCT04003142|520274445|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
144292749|NCT04003142|520274446|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
144292750|NCT04003142|520274447|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
144292751|NCT04003142|520274448|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
144292752|NCT04003142|520274449|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
144292753|NCT04003142|520274445|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
144292754|NCT04003142|520274446|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
144292755|NCT04003142|520274447|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
144292756|NCT04003142|520274448|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
144292757|NCT04003142|520274449|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
144292758|NCT03382873|520274450|FG000|Overall Study|Lost to Follow-up|9|||
144292759|NCT03382873|520274451|FG001|Overall Study|Lost to Follow-up|10|||
144292760|NCT03382873|520274450|FG000|Overall Study|Withdrawal by Subject|6|||
144292761|NCT03382873|520274451|FG001|Overall Study|Withdrawal by Subject|11|||
144292762|NCT03382873|520274450|FG000|Overall Study|Visit not completed due to pandemic|16|||
144292763|NCT03382873|520274451|FG001|Overall Study|Visit not completed due to pandemic|41|||
144292764|NCT04755231|520274455|FG000|Overall Study|Lost to Follow-up|5|||
144292765|NCT04755231|520274455|FG000|Overall Study|Withdrawal by Subject|5|||
144292766|NCT04754399|520274456|FG000|Overall Study|Adverse Event|5|||
144292767|NCT04754399|520274456|FG000|Overall Study|Withdrawal by Subject|6|||
144292768|NCT00025233|520274457|FG000|Overall Study|Ineligible: wrong cell type|1|||
144292769|NCT00025233|520274457|FG000|Overall Study|Ineligible: wrong primary|1|||
144292770|NCT00025233|520274457|FG000|Overall Study|Ineligible: improper prior treatment|1|||
144292771|NCT00025233|520274457|FG000|Overall Study|Never treated|1|||
144292772|NCT01720602|520274458|FG000|Overall Study|Adverse Event|3|||
144292773|NCT01720602|520274458|FG000|Overall Study|Progressive disease on therapy|2|||
144292774|NCT00834587|520274463|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
144292775|NCT00834587|520274464|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
144292776|NCT00176254|520274465|FG000|Overall Study|Lost to Follow-up|1|||
144292777|NCT03289741|520274466|FG000|Overall Study|Adverse Event|1|||
144292778|NCT03289741|520274467|FG001|Overall Study|Adverse Event|1|||
144292779|NCT03289741|520274466|FG000|Overall Study|Physician Decision|2|||
144292780|NCT03289741|520274467|FG001|Overall Study|Physician Decision|2|||
144292781|NCT03289741|520274466|FG000|Overall Study|Withdrawal by Subject|1|||
144292782|NCT03289741|520274467|FG001|Overall Study|Withdrawal by Subject|0|||
144292783|NCT02536339|520274469|FG000|Overall Study|Death|20|||
144292784|NCT02536339|520274469|FG000|Overall Study|Withdrawal by Subject|3|||
144292785|NCT02536339|520274469|FG000|Overall Study|Lost to Follow-up|2|||
144292786|NCT02536339|520274469|FG000|Overall Study|Treatment discontinued|2|||
144292787|NCT02536339|520274469|FG000|Overall Study|Physician Decision|1|||
144292788|NCT02037984|520274471|FG000|Overall Study|Lack of Efficacy|0|||
144292789|NCT02037984|520274472|FG001|Overall Study|Lack of Efficacy|0|||
144292790|NCT02037984|520274473|FG002|Overall Study|Lack of Efficacy|3|||
144292791|NCT02037984|520274474|FG003|Overall Study|Lack of Efficacy|10|||
144292792|NCT02037984|520274475|FG004|Overall Study|Lack of Efficacy|2|||
144292793|NCT02037984|520274476|FG005|Overall Study|Lack of Efficacy|2|||
144292794|NCT02037984|520274477|FG006|Overall Study|Lack of Efficacy|4|||
144292795|NCT02037984|520274478|FG007|Overall Study|Lack of Efficacy|3|||
144292796|NCT02037984|520274471|FG000|Overall Study|Lost to Follow-up|1|||
144292797|NCT02037984|520274472|FG001|Overall Study|Lost to Follow-up|0|||
144292798|NCT02037984|520274473|FG002|Overall Study|Lost to Follow-up|3|||
144292799|NCT02037984|520274474|FG003|Overall Study|Lost to Follow-up|5|||
144292800|NCT02037984|520274475|FG004|Overall Study|Lost to Follow-up|2|||
144292801|NCT02037984|520274476|FG005|Overall Study|Lost to Follow-up|2|||
144292802|NCT02037984|520274477|FG006|Overall Study|Lost to Follow-up|2|||
144292803|NCT02037984|520274478|FG007|Overall Study|Lost to Follow-up|4|||
144292804|NCT02037984|520274471|FG000|Overall Study|Physician Decision|0|||
144292805|NCT02037984|520274472|FG001|Overall Study|Physician Decision|0|||
144292806|NCT02037984|520274473|FG002|Overall Study|Physician Decision|0|||
144292807|NCT02037984|520274474|FG003|Overall Study|Physician Decision|0|||
144292808|NCT02037984|520274475|FG004|Overall Study|Physician Decision|0|||
144292809|NCT02037984|520274476|FG005|Overall Study|Physician Decision|0|||
144292810|NCT02037984|520274477|FG006|Overall Study|Physician Decision|1|||
144292811|NCT02037984|520274478|FG007|Overall Study|Physician Decision|0|||
144292812|NCT02037984|520274471|FG000|Overall Study|Protocol Violation|0|||
144292813|NCT02037984|520274472|FG001|Overall Study|Protocol Violation|0|||
144292814|NCT02037984|520274473|FG002|Overall Study|Protocol Violation|0|||
144292815|NCT02037984|520274474|FG003|Overall Study|Protocol Violation|0|||
144292816|NCT02037984|520274475|FG004|Overall Study|Protocol Violation|0|||
144292817|NCT02037984|520274476|FG005|Overall Study|Protocol Violation|1|||
144292818|NCT02037984|520274477|FG006|Overall Study|Protocol Violation|2|||
144292819|NCT02037984|520274478|FG007|Overall Study|Protocol Violation|0|||
144292820|NCT02037984|520274471|FG000|Overall Study|Technical Problems|0|||
144292821|NCT02037984|520274472|FG001|Overall Study|Technical Problems|0|||
144292822|NCT02037984|520274473|FG002|Overall Study|Technical Problems|3|||
144292823|NCT02037984|520274474|FG003|Overall Study|Technical Problems|3|||
144292824|NCT02037984|520274475|FG004|Overall Study|Technical Problems|2|||
144292825|NCT02037984|520274476|FG005|Overall Study|Technical Problems|3|||
144292826|NCT02037984|520274477|FG006|Overall Study|Technical Problems|4|||
144292827|NCT02037984|520274478|FG007|Overall Study|Technical Problems|2|||
144292828|NCT02037984|520274471|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144292829|NCT02037984|520274472|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144292830|NCT02037984|520274473|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
144292831|NCT02037984|520274474|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
144292832|NCT02037984|520274475|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
144292833|NCT02037984|520274476|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
144292834|NCT02037984|520274477|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
144292835|NCT02037984|520274478|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
144292836|NCT02037984|520274471|FG000|Overall Study|Withdrawal by Subject|0|||
144292837|NCT02037984|520274472|FG001|Overall Study|Withdrawal by Subject|0|||
144292838|NCT02037984|520274473|FG002|Overall Study|Withdrawal by Subject|0|||
144292839|NCT02037984|520274474|FG003|Overall Study|Withdrawal by Subject|1|||
144292840|NCT02037984|520274475|FG004|Overall Study|Withdrawal by Subject|1|||
144292841|NCT02037984|520274476|FG005|Overall Study|Withdrawal by Subject|3|||
144292842|NCT02037984|520274477|FG006|Overall Study|Withdrawal by Subject|0|||
144292843|NCT02037984|520274478|FG007|Overall Study|Withdrawal by Subject|1|||
144292844|NCT00866775|520276023|FG000|Overall Study|Adverse Event|5|||
144292845|NCT00866775|520276024|FG001|Overall Study|Adverse Event|19|||
144292846|NCT00866775|520276023|FG000|Overall Study|Death|1|||
144292847|NCT00866775|520276024|FG001|Overall Study|Death|0|||
144292848|NCT00866775|520276023|FG000|Overall Study|Lost to Follow-up|0|||
144292849|NCT00866775|520276024|FG001|Overall Study|Lost to Follow-up|4|||
144292850|NCT00866775|520276023|FG000|Overall Study|Physician Decision|0|||
144292851|NCT00866775|520276024|FG001|Overall Study|Physician Decision|3|||
144292852|NCT00866775|520276023|FG000|Overall Study|Protocol Violation|3|||
144292853|NCT00866775|520276024|FG001|Overall Study|Protocol Violation|4|||
144292854|NCT00866775|520276023|FG000|Overall Study|Withdrawal by Subject|4|||
144292855|NCT00866775|520276024|FG001|Overall Study|Withdrawal by Subject|4|||
144292856|NCT00866775|520276023|FG000|Overall Study|met exit criteria|23|||
144292857|NCT00866775|520276024|FG001|Overall Study|met exit criteria|17|||
144292858|NCT00866775|520276023|FG000|Overall Study|discontinued due to communication error|0|||
144292859|NCT00866775|520276024|FG001|Overall Study|discontinued due to communication error|1|||
144292860|NCT01050218|520276025|FG000|Overall Study|Adverse Event|37|||
144292861|NCT01050218|520276025|FG000|Overall Study|Lack of Efficacy|8|||
144292862|NCT01050218|520276025|FG000|Overall Study|Protocol Violation|3|||
144292863|NCT01050218|520276025|FG000|Overall Study|Withdrawal by Subject|18|||
144292864|NCT01050218|520276025|FG000|Overall Study|Discontinued by sponsor|18|||
144292865|NCT01050218|520276025|FG000|Overall Study|Compliance|2|||
144292866|NCT01050218|520276025|FG000|Overall Study|Failed to return|7|||
144292867|NCT01050218|520276025|FG000|Overall Study|Serious Adverse Event|1|||
144292868|NCT01050218|520276025|FG000|Overall Study|Family emergency|1|||
144292869|NCT01772693|520276026|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
144292870|NCT01772693|520276027|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
144292871|NCT01772693|520276026|FG000|Overall Study|Withdrawal by Subject|2|||
144292872|NCT01772693|520276027|FG001|Overall Study|Withdrawal by Subject|0|||
144292873|NCT01772693|520276026|FG000|Overall Study|Alternative Treatment|2|||
144292874|NCT01772693|520276027|FG001|Overall Study|Alternative Treatment|0|||
144292875|NCT03682367|520276037|FG000|Overall Study|Protocol Violation|2|||
144292876|NCT03682367|520276038|FG001|Overall Study|Protocol Violation|1|||
144292877|NCT03682367|520276037|FG000|Overall Study|Closed Study Early|0|||
144292878|NCT03682367|520276038|FG001|Overall Study|Closed Study Early|3|||
144292879|NCT03707821|520276039|FG000|Overall Study|Protocol Violation|0|||
144292880|NCT03707821|520276040|FG001|Overall Study|Protocol Violation|1|||
144292881|NCT03707821|520276039|FG000|Overall Study|Unsatisfactory Visual Response|1|||
144292882|NCT03707821|520276040|FG001|Overall Study|Unsatisfactory Visual Response|0|||
144292883|NCT03707821|520276039|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
144292884|NCT03707821|520276040|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
144292885|NCT00889005|520276041|FG000|Overall Study|Lost to Follow-up|4|||
144292886|NCT00889005|520276042|FG001|Overall Study|Lost to Follow-up|2|||
144292887|NCT00889005|520276041|FG000|Overall Study|Withdrawal by Subject|4|||
144292888|NCT00889005|520276042|FG001|Overall Study|Withdrawal by Subject|0|||
144292889|NCT00124657|520276043|FG000|Overall Study|Toxicity|0|||
144292890|NCT00124657|520276044|FG001|Overall Study|Toxicity|0|||
144292891|NCT00124657|520276045|FG002|Overall Study|Toxicity|1|||
144292892|NCT00124657|520276043|FG000|Overall Study|Non-compliance|1|||
144292893|NCT00124657|520276044|FG001|Overall Study|Non-compliance|0|||
144292894|NCT00124657|520276045|FG002|Overall Study|Non-compliance|4|||
144292895|NCT00124657|520276043|FG000|Overall Study|Progressive disease|14|||
144292896|NCT00124657|520276044|FG001|Overall Study|Progressive disease|5|||
144247135|NCT05385224|520102463|FG000|Overall Study|Did not meet study criteria|1|||
144292897|NCT00124657|520276045|FG002|Overall Study|Progressive disease|27|||
144292898|NCT00124657|520276043|FG000|Overall Study|Intercurrent illness|1|||
144292899|NCT00124657|520276044|FG001|Overall Study|Intercurrent illness|0|||
144292900|NCT00124657|520276045|FG002|Overall Study|Intercurrent illness|0|||
144292901|NCT01475825|520276050|FG000|Overall Study|Adverse Event|41|||
144292902|NCT01475825|520276051|FG001|Overall Study|Adverse Event|15|||
144292903|NCT01475825|520276052|FG002|Overall Study|Adverse Event|27|||
144292904|NCT01475825|520276053|FG003|Overall Study|Adverse Event|11|||
144292905|NCT01475825|520276050|FG000|Overall Study|Death|1|||
144292906|NCT01475825|520276051|FG001|Overall Study|Death|0|||
144292907|NCT01475825|520276052|FG002|Overall Study|Death|1|||
144292908|NCT01475825|520276053|FG003|Overall Study|Death|0|||
144292909|NCT01475825|520276050|FG000|Overall Study|Lack of Efficacy|0|||
144292910|NCT01475825|520276051|FG001|Overall Study|Lack of Efficacy|0|||
144292911|NCT01475825|520276052|FG002|Overall Study|Lack of Efficacy|1|||
144292912|NCT01475825|520276053|FG003|Overall Study|Lack of Efficacy|0|||
144292913|NCT01475825|520276050|FG000|Overall Study|Lost to Follow-up|0|||
144292914|NCT01475825|520276051|FG001|Overall Study|Lost to Follow-up|0|||
144292915|NCT01475825|520276052|FG002|Overall Study|Lost to Follow-up|3|||
144292916|NCT01475825|520276053|FG003|Overall Study|Lost to Follow-up|1|||
144292917|NCT01475825|520276050|FG000|Overall Study|Non-compliance with Study Drug|1|||
144247136|NCT01430624|520102464|FG000|Overall Study|Lost to Follow-up|23|||
144247137|NCT01430624|520102465|FG001|Overall Study|Lost to Follow-up|29|||
144247138|NCT01430624|520102466|FG002|Overall Study|Lost to Follow-up|27|||
144247139|NCT01430624|520102464|FG000|Overall Study|technical or eligibility|5|||
144247140|NCT01430624|520102465|FG001|Overall Study|technical or eligibility|5|||
144247141|NCT01430624|520102466|FG002|Overall Study|technical or eligibility|2|||
144247142|NCT01832818|520102468|FG000|Overall Study|Lost to Follow-up|6|||
144247143|NCT00551161|520102469|FG000|Overall Study|Withdrawal by Subject|1|||
144247144|NCT02565706|520102470|FG000|Overall Study|Withdrawal by Subject|5|||
144247145|NCT02565706|520102471|FG001|Overall Study|Withdrawal by Subject|7|||
144247146|NCT02565706|520102472|FG002|Overall Study|Withdrawal by Subject|7|||
144247147|NCT02565706|520102473|FG003|Overall Study|Withdrawal by Subject|11|||
144247148|NCT02565706|520102470|FG000|Overall Study|Lost to Follow-up|72|||
144247149|NCT02565706|520102471|FG001|Overall Study|Lost to Follow-up|75|||
144247150|NCT02565706|520102472|FG002|Overall Study|Lost to Follow-up|82|||
144247151|NCT02565706|520102473|FG003|Overall Study|Lost to Follow-up|74|||
144247152|NCT03887117|520102481|FG000|Overall Study|Discontinued prematurely|0|||
144247153|NCT03887117|520102482|FG001|Overall Study|Discontinued prematurely|1|||
144247154|NCT03887117|520102483|FG002|Overall Study|Discontinued prematurely|1|||
144247155|NCT03887117|520102484|FG003|Overall Study|Discontinued prematurely|2|||
144247156|NCT02584959|520102485|FG000|Period 1|Withdrawn from study|3|||
144292918|NCT01475825|520276051|FG001|Overall Study|Non-compliance with Study Drug|2|||
144292919|NCT01475825|520276052|FG002|Overall Study|Non-compliance with Study Drug|4|||
144292920|NCT01475825|520276053|FG003|Overall Study|Non-compliance with Study Drug|0|||
144292921|NCT01475825|520276050|FG000|Overall Study|Other: Not available|0|||
144292922|NCT01475825|520276051|FG001|Overall Study|Other: Not available|0|||
144292923|NCT01475825|520276052|FG002|Overall Study|Other: Not available|2|||
144292924|NCT01475825|520276053|FG003|Overall Study|Other: Not available|0|||
144292925|NCT01475825|520276050|FG000|Overall Study|Protocol Violation|1|||
144292926|NCT01475825|520276051|FG001|Overall Study|Protocol Violation|0|||
144292927|NCT01475825|520276052|FG002|Overall Study|Protocol Violation|0|||
144292928|NCT01475825|520276053|FG003|Overall Study|Protocol Violation|0|||
144292929|NCT01475825|520276050|FG000|Overall Study|Physician Decision|0|||
144292930|NCT01475825|520276051|FG001|Overall Study|Physician Decision|1|||
144292931|NCT01475825|520276052|FG002|Overall Study|Physician Decision|0|||
144292932|NCT01475825|520276053|FG003|Overall Study|Physician Decision|0|||
144292933|NCT01475825|520276050|FG000|Overall Study|Withdrawal by Subject|8|||
144292934|NCT01475825|520276051|FG001|Overall Study|Withdrawal by Subject|3|||
144292935|NCT01475825|520276052|FG002|Overall Study|Withdrawal by Subject|11|||
144292936|NCT01475825|520276053|FG003|Overall Study|Withdrawal by Subject|7|||
144292937|NCT01475825|520276050|FG000|Overall Study|Did not enter OLC|15|||
144292938|NCT01475825|520276051|FG001|Overall Study|Did not enter OLC|11|||
144292939|NCT01475825|520276052|FG002|Overall Study|Did not enter OLC|15|||
144292940|NCT01475825|520276053|FG003|Overall Study|Did not enter OLC|11|||
144292941|NCT04157738|520276054|FG000|Overall Study|Moved out of state|0|||
144292942|NCT04157738|520276055|FG001|Overall Study|Moved out of state|2|||
144292943|NCT04157738|520276054|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
144292944|NCT04157738|520276055|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
144292945|NCT00160563|520276056|FG000|Overall Study|Adverse Event|1|||
144292946|NCT00160563|520276057|FG001|Overall Study|Adverse Event|1|||
144292947|NCT00160563|520276058|FG002|Overall Study|Adverse Event|1|||
144292948|NCT00160563|520276056|FG000|Overall Study|Lost to Follow-up|1|||
144292949|NCT00160563|520276057|FG001|Overall Study|Lost to Follow-up|1|||
144292950|NCT00160563|520276058|FG002|Overall Study|Lost to Follow-up|2|||
144292951|NCT00160563|520276056|FG000|Overall Study|Protocol Violation|0|||
144292952|NCT00160563|520276057|FG001|Overall Study|Protocol Violation|0|||
144292953|NCT00160563|520276058|FG002|Overall Study|Protocol Violation|3|||
144292954|NCT00160563|520276056|FG000|Overall Study|Withdrawal by Subject|1|||
144292955|NCT00160563|520276057|FG001|Overall Study|Withdrawal by Subject|2|||
144292956|NCT00160563|520276058|FG002|Overall Study|Withdrawal by Subject|3|||
144292957|NCT00160563|520276056|FG000|Overall Study|Other (listed in the study report)|48|||
144292958|NCT00160563|520276057|FG001|Overall Study|Other (listed in the study report)|40|||
144292959|NCT00160563|520276058|FG002|Overall Study|Other (listed in the study report)|81|||
144292960|NCT00160563|520276056|FG000|Overall Study|Missing reason|0|||
144292961|NCT00160563|520276057|FG001|Overall Study|Missing reason|1|||
144292962|NCT00160563|520276058|FG002|Overall Study|Missing reason|0|||
144292963|NCT01514357|520276063|FG000|Overall Study|Screen failure|2|||
144292964|NCT01514357|520276064|FG001|Overall Study|Screen failure|0|||
144292965|NCT01514357|520276063|FG000|Overall Study|Withdrawal by Subject|2|||
144292966|NCT01514357|520276064|FG001|Overall Study|Withdrawal by Subject|0|||
144292967|NCT01047540|520276067|FG000|Overall Study|Protocol Violation|1|||
144292968|NCT01047540|520276068|FG001|Overall Study|Protocol Violation|0|||
144292969|NCT01047540|520276069|FG002|Overall Study|Protocol Violation|0|||
144292970|NCT01047540|520276070|FG003|Overall Study|Protocol Violation|0|||
144292971|NCT01047540|520276071|FG004|Overall Study|Protocol Violation|0|||
144292972|NCT01047540|520276067|FG000|Overall Study|Lost to Follow-up|1|||
144292973|NCT01047540|520276068|FG001|Overall Study|Lost to Follow-up|0|||
144292974|NCT01047540|520276069|FG002|Overall Study|Lost to Follow-up|0|||
144292975|NCT01047540|520276070|FG003|Overall Study|Lost to Follow-up|0|||
144292976|NCT01047540|520276071|FG004|Overall Study|Lost to Follow-up|0|||
144292977|NCT01047540|520276067|FG000|Overall Study|Withdrawal by Subject|1|||
144292978|NCT01047540|520276068|FG001|Overall Study|Withdrawal by Subject|0|||
144292979|NCT01047540|520276069|FG002|Overall Study|Withdrawal by Subject|3|||
144292980|NCT01047540|520276070|FG003|Overall Study|Withdrawal by Subject|0|||
144292981|NCT01047540|520276071|FG004|Overall Study|Withdrawal by Subject|1|||
144292982|NCT01047540|520276067|FG000|Overall Study|Pregnancy|1|||
144292983|NCT01047540|520276068|FG001|Overall Study|Pregnancy|0|||
144292984|NCT01047540|520276069|FG002|Overall Study|Pregnancy|0|||
144292985|NCT01047540|520276070|FG003|Overall Study|Pregnancy|0|||
144292986|NCT01047540|520276071|FG004|Overall Study|Pregnancy|0|||
144292987|NCT01047540|520276067|FG000|Overall Study|Adverse Event|1|||
144292988|NCT01047540|520276068|FG001|Overall Study|Adverse Event|0|||
144292989|NCT01047540|520276069|FG002|Overall Study|Adverse Event|0|||
144292990|NCT01047540|520276070|FG003|Overall Study|Adverse Event|0|||
144292991|NCT01047540|520276071|FG004|Overall Study|Adverse Event|0|||
144292992|NCT05261490|520276074|FG000|Overall Study|Other|1|||
144292993|NCT05261490|520276075|FG001|Overall Study|Other|0|||
144292994|NCT05261490|520276076|FG002|Overall Study|Other|0|||
144292995|NCT05261490|520276074|FG000|Overall Study|Study Terminated by Sponsor|1|||
144292996|NCT05261490|520276075|FG001|Overall Study|Study Terminated by Sponsor|1|||
144292997|NCT05261490|520276076|FG002|Overall Study|Study Terminated by Sponsor|4|||
144292998|NCT05261490|520276074|FG000|Overall Study|Death|1|||
144292999|NCT05261490|520276075|FG001|Overall Study|Death|2|||
144293000|NCT05261490|520276076|FG002|Overall Study|Death|0|||
144293001|NCT00456365|520276084|FG000|Overall Study|Lost to Follow-up|1|||
144293002|NCT00456365|520276085|FG001|Overall Study|Lost to Follow-up|3|||
144293003|NCT00456365|520276084|FG000|Overall Study|Withdrawal by Subject|4|||
144293004|NCT00456365|520276085|FG001|Overall Study|Withdrawal by Subject|7|||
144293005|NCT00456365|520276084|FG000|Overall Study|Pregnancy|1|||
144293006|NCT00456365|520276085|FG001|Overall Study|Pregnancy|1|||
144293007|NCT00456365|520276084|FG000|Overall Study|oncologic diagnosis|1|||
144293008|NCT00456365|520276085|FG001|Overall Study|oncologic diagnosis|1|||
144293009|NCT06091956|520276086|FG000|Overall Study|Withdrawal by Subject|1|||
144293010|NCT06091956|520276086|FG000|Overall Study|Complicating Disease|1|||
144293011|NCT01681849|520276096|FG000|Overall Study|Protocol Violation|2|||
144293012|NCT01681849|520276097|FG001|Overall Study|Protocol Violation|0|||
144293013|NCT01681849|520276098|FG002|Overall Study|Protocol Violation|0|||
144293014|NCT01681849|520276096|FG000|Overall Study|Withdrawal by Subject|3|||
144293015|NCT01681849|520276097|FG001|Overall Study|Withdrawal by Subject|5|||
144293016|NCT01681849|520276098|FG002|Overall Study|Withdrawal by Subject|33|||
144293017|NCT01681849|520276096|FG000|Overall Study|Lost to Follow-up|3|||
144293018|NCT01681849|520276097|FG001|Overall Study|Lost to Follow-up|2|||
144293019|NCT01681849|520276098|FG002|Overall Study|Lost to Follow-up|6|||
144293020|NCT04525183|520276101|FG000|Overall Study|Withdrawal by Subject|0|||
144293021|NCT04525183|520276102|FG001|Overall Study|Withdrawal by Subject|0|||
144293022|NCT04525183|520276103|FG002|Overall Study|Withdrawal by Subject|3|||
144293023|NCT04525183|520276101|FG000|Overall Study|Study non-compliance|0|||
144293024|NCT04525183|520276102|FG001|Overall Study|Study non-compliance|0|||
144293025|NCT04525183|520276103|FG002|Overall Study|Study non-compliance|1|||
144293026|NCT04525183|520276101|FG000|Overall Study|Recurrent disease before starting on study|0|||
144293027|NCT04525183|520276102|FG001|Overall Study|Recurrent disease before starting on study|0|||
144293028|NCT04525183|520276103|FG002|Overall Study|Recurrent disease before starting on study|1|||
144293029|NCT01166646|520276104|FG000|Overall Study|Protocol Violation|0|||
144293030|NCT01166646|520276105|FG001|Overall Study|Protocol Violation|1|||
144293031|NCT01166646|520276104|FG000|Overall Study|Adverse Event|1|||
144293032|NCT01166646|520276105|FG001|Overall Study|Adverse Event|0|||
144293033|NCT02420314|520276106|FG000|Overall Study|Withdrawal by Subject|1|||
144293034|NCT02420314|520276106|FG000|Overall Study|Protocol Violation|1|||
144293035|NCT03760068|520276107|FG000|Overall Study|Withdrawal by Subject|7|||
144293036|NCT03760068|520276108|FG001|Overall Study|Withdrawal by Subject|8|||
144293037|NCT03760068|520276107|FG000|Overall Study|Adverse Event|1|||
144293038|NCT03760068|520276108|FG001|Overall Study|Adverse Event|2|||
144293039|NCT03760068|520276107|FG000|Overall Study|Administrative Decision by Sponsor|0|||
144293040|NCT03760068|520276108|FG001|Overall Study|Administrative Decision by Sponsor|2|||
144293041|NCT03760068|520276107|FG000|Overall Study|Physician Decision|1|||
144293042|NCT03760068|520276108|FG001|Overall Study|Physician Decision|2|||
144293043|NCT03760068|520276107|FG000|Overall Study|Lost to Follow-up|4|||
144293044|NCT03760068|520276108|FG001|Overall Study|Lost to Follow-up|9|||
144293045|NCT03760068|520276107|FG000|Overall Study|Subject Moved Out of State|1|||
144293046|NCT03760068|520276108|FG001|Overall Study|Subject Moved Out of State|0|||
144293047|NCT05430919|520276109|FG000|Overall Study|Protocol Violation|0|||
144293048|NCT05430919|520276110|FG001|Overall Study|Protocol Violation|0|||
144293049|NCT05430919|520276111|FG002|Overall Study|Protocol Violation|1|||
144293050|NCT05430919|520276112|FG003|Overall Study|Protocol Violation|0|||
144293051|NCT05430919|520276109|FG000|Overall Study|Lost to Follow-up|0|||
144293052|NCT05430919|520276110|FG001|Overall Study|Lost to Follow-up|1|||
144293053|NCT05430919|520276111|FG002|Overall Study|Lost to Follow-up|0|||
144293054|NCT05430919|520276112|FG003|Overall Study|Lost to Follow-up|0|||
144293055|NCT05430919|520276109|FG000|Overall Study|Withdrawal by Subject|3|||
144293056|NCT05430919|520276110|FG001|Overall Study|Withdrawal by Subject|0|||
144293057|NCT05430919|520276111|FG002|Overall Study|Withdrawal by Subject|0|||
144293058|NCT05430919|520276112|FG003|Overall Study|Withdrawal by Subject|1|||
144293059|NCT01335685|520276115|FG000|Overall Study|Study Terminated by Sponsor|2|||
144293060|NCT01335685|520276116|FG001|Overall Study|Study Terminated by Sponsor|1|||
144293061|NCT01335685|520276117|FG002|Overall Study|Study Terminated by Sponsor|1|||
144293062|NCT01335685|520276118|FG003|Overall Study|Study Terminated by Sponsor|10|||
144293063|NCT01335685|520276119|FG004|Overall Study|Study Terminated by Sponsor|0|||
144293064|NCT01335685|520276120|FG005|Overall Study|Study Terminated by Sponsor|4|||
144293065|NCT01335685|520276121|FG006|Overall Study|Study Terminated by Sponsor|2|||
144293066|NCT01335685|520276122|FG007|Overall Study|Study Terminated by Sponsor|3|||
144293067|NCT01335685|520276115|FG000|Overall Study|Withdrawal by Subject|1|||
144293068|NCT01335685|520276116|FG001|Overall Study|Withdrawal by Subject|0|||
144293069|NCT01335685|520276117|FG002|Overall Study|Withdrawal by Subject|0|||
144293070|NCT01335685|520276118|FG003|Overall Study|Withdrawal by Subject|1|||
144293071|NCT01335685|520276119|FG004|Overall Study|Withdrawal by Subject|0|||
144293072|NCT01335685|520276120|FG005|Overall Study|Withdrawal by Subject|0|||
144293073|NCT01335685|520276121|FG006|Overall Study|Withdrawal by Subject|0|||
144293074|NCT01335685|520276122|FG007|Overall Study|Withdrawal by Subject|0|||
144293075|NCT01335685|520276115|FG000|Overall Study|Reason not Specified|0|||
144293076|NCT01335685|520276116|FG001|Overall Study|Reason not Specified|0|||
144293077|NCT01335685|520276117|FG002|Overall Study|Reason not Specified|1|||
144293078|NCT01335685|520276118|FG003|Overall Study|Reason not Specified|0|||
144293079|NCT01335685|520276119|FG004|Overall Study|Reason not Specified|0|||
144293080|NCT01335685|520276120|FG005|Overall Study|Reason not Specified|1|||
144293081|NCT01335685|520276121|FG006|Overall Study|Reason not Specified|0|||
144293082|NCT01335685|520276122|FG007|Overall Study|Reason not Specified|0|||
144293083|NCT03777020|520276125|FG000|Overall Study|Withdrawal by Subject|4|||
144293084|NCT03777020|520276126|FG001|Overall Study|Withdrawal by Subject|4|||
144293085|NCT03777020|520276125|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
144293086|NCT03777020|520276126|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
144293087|NCT03460704|520276127|FG000|Overall Study|Withdrawal by Subject|11|||
144293088|NCT03460704|520276128|FG001|Overall Study|Withdrawal by Subject|14|||
144293089|NCT03460704|520276127|FG000|Overall Study|Study terminated by the Sponsor|29|||
144293090|NCT03460704|520276128|FG001|Overall Study|Study terminated by the Sponsor|19|||
144293091|NCT03460704|520276127|FG000|Overall Study|Adverse Event|10|||
144293092|NCT03460704|520276128|FG001|Overall Study|Adverse Event|5|||
144293093|NCT03460704|520276127|FG000|Overall Study|Death|3|||
144293094|NCT03460704|520276128|FG001|Overall Study|Death|2|||
144293095|NCT03460704|520276127|FG000|Overall Study|Non-Compliance with Study Drug|3|||
144293096|NCT03460704|520276128|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144293097|NCT03460704|520276127|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144293098|NCT03460704|520276128|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
144293099|NCT03460704|520276127|FG000|Overall Study|Other|2|||
144293100|NCT03460704|520276128|FG001|Overall Study|Other|1|||
144293101|NCT01767857|520276129|FG000|Overall Study|Adverse Event|27|||
144293102|NCT01767857|520276130|FG001|Overall Study|Adverse Event|7|||
144293103|NCT01767857|520276129|FG000|Overall Study|Death|28|||
144293104|NCT01767857|520276130|FG001|Overall Study|Death|13|||
144293105|NCT01767857|520276129|FG000|Overall Study|Lack of Efficacy|299|||
144293106|NCT01767857|520276130|FG001|Overall Study|Lack of Efficacy|151|||
144293107|NCT01767857|520276129|FG000|Overall Study|Lost to Follow-up|1|||
144293108|NCT01767857|520276130|FG001|Overall Study|Lost to Follow-up|1|||
144293109|NCT01767857|520276129|FG000|Overall Study|Withdrawal by Subject|38|||
144293110|NCT01767857|520276130|FG001|Overall Study|Withdrawal by Subject|18|||
144293111|NCT01767857|520276129|FG000|Overall Study|Physician Decision|17|||
144293112|NCT01767857|520276130|FG001|Overall Study|Physician Decision|10|||
144293113|NCT01767857|520276129|FG000|Overall Study|Protocol Terminated|1|||
144293114|NCT01767857|520276130|FG001|Overall Study|Protocol Terminated|0|||
144293115|NCT01767857|520276129|FG000|Overall Study|Randomized But Never Treated|19|||
144293116|NCT01767857|520276130|FG001|Overall Study|Randomized But Never Treated|13|||
144293117|NCT04126174|520276133|FG000|Overall Study|Lost to Follow-up|3|||
144293118|NCT04126174|520276134|FG001|Overall Study|Lost to Follow-up|3|||
144293119|NCT04439903|520276149|FG000|Overall Study|Withdrawal by Subject|2|||
144247157|NCT02584959|520102486|FG001|Period 1|Withdrawn from study|4|||
144247158|NCT02584959|520102487|FG002|Period 1|Withdrawn from study|0|||
144247159|NCT02584959|520102485|FG000|Period 2|Withdrawn from study|6|||
144247160|NCT02584959|520102486|FG001|Period 2|Withdrawn from study|1|||
144247161|NCT02584959|520102487|FG002|Period 2|Withdrawn from study|2|||
144247162|NCT00195494|520102492|FG000|Year 1|Adverse Event|0|||
144247163|NCT00195494|520102493|FG001|Year 1|Adverse Event|0|||
144247164|NCT00195494|520102494|FG002|Year 1|Adverse Event|0|||
144247165|NCT00195494|520102495|FG003|Year 1|Adverse Event|0|||
144247166|NCT00195494|520102496|FG004|Year 1|Adverse Event|34|||
144247167|NCT00195494|520102497|FG005|Year 1|Adverse Event|27|||
144247168|NCT00195494|520102492|FG000|Year 1|System Toxicity|0|||
144247169|NCT00195494|520102493|FG001|Year 1|System Toxicity|0|||
144247170|NCT00195494|520102494|FG002|Year 1|System Toxicity|0|||
144293120|NCT04439903|520276149|FG000|Overall Study|Screen Failure|1|||
144247171|NCT00195494|520102495|FG003|Year 1|System Toxicity|0|||
144293121|NCT02899754|520276150|FG000|Overall Study|Lost to Follow-up|7|||
144293122|NCT02899754|520276151|FG001|Overall Study|Lost to Follow-up|9|||
144293123|NCT04818229|520276152|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
144293124|NCT04818229|520276153|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
144293125|NCT04818229|520276154|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
144293126|NCT04818229|520276152|FG000|Overall Study|Adverse Event|3|||
144293127|NCT04818229|520276153|FG001|Overall Study|Adverse Event|1|||
144293128|NCT04818229|520276154|FG002|Overall Study|Adverse Event|1|||
144293129|NCT04818229|520276152|FG000|Overall Study|Withdrawal by Subject|0|||
144293130|NCT04818229|520276153|FG001|Overall Study|Withdrawal by Subject|0|||
144293131|NCT04818229|520276154|FG002|Overall Study|Withdrawal by Subject|2|||
144293132|NCT04818229|520276152|FG000|Overall Study|Lost to Follow-up|0|||
144293133|NCT04818229|520276153|FG001|Overall Study|Lost to Follow-up|0|||
144293134|NCT04818229|520276154|FG002|Overall Study|Lost to Follow-up|1|||
144293135|NCT03996395|520276156|FG000|Overall Study|Lost to Follow-up|4|||
144293136|NCT03996395|520276156|FG000|Overall Study|Withdrawal by Subject|1|||
144293137|NCT03996395|520276156|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
144293138|NCT01691092|520276167|FG000|Overall Study|Lost to Follow-up|10|||
144293139|NCT01691092|520276167|FG000|Overall Study|Physician Decision|4|||
144293140|NCT01691092|520276167|FG000|Overall Study|Withdrawal by Subject|3|||
144293141|NCT01691092|520276167|FG000|Overall Study|non-compliance|3|||
144293142|NCT01691092|520276167|FG000|Overall Study|used for different study|2|||
144293143|NCT01691092|520276167|FG000|Overall Study|screen fail|19|||
144293144|NCT00561821|520276168|FG000|Overall Study|Not treated|0|||
144293145|NCT00561821|520276169|FG001|Overall Study|Not treated|0|||
144293146|NCT00561821|520276170|FG002|Overall Study|Not treated|1|||
144293147|NCT00561821|520276171|FG003|Overall Study|Not treated|0|||
144293148|NCT00561821|520276168|FG000|Overall Study|Withdrawal by Subject|0|||
144293149|NCT00561821|520276169|FG001|Overall Study|Withdrawal by Subject|1|||
144293150|NCT00561821|520276170|FG002|Overall Study|Withdrawal by Subject|0|||
144293151|NCT00561821|520276171|FG003|Overall Study|Withdrawal by Subject|2|||
144293152|NCT00561821|520276168|FG000|Overall Study|Reasons not related to trial|2|||
144293153|NCT00561821|520276169|FG001|Overall Study|Reasons not related to trial|1|||
144293154|NCT00561821|520276170|FG002|Overall Study|Reasons not related to trial|0|||
144293155|NCT00561821|520276171|FG003|Overall Study|Reasons not related to trial|0|||
144293156|NCT00561821|520276168|FG000|Overall Study|Other (reason not specified)|1|||
144293157|NCT00561821|520276169|FG001|Overall Study|Other (reason not specified)|1|||
144293158|NCT00561821|520276170|FG002|Overall Study|Other (reason not specified)|0|||
144293159|NCT00561821|520276171|FG003|Overall Study|Other (reason not specified)|0|||
144293160|NCT00561821|520276168|FG000|Overall Study|Adverse Event|2|||
144293161|NCT00561821|520276169|FG001|Overall Study|Adverse Event|3|||
144247172|NCT00195494|520102496|FG004|Year 1|System Toxicity|0|||
144247173|NCT00195494|520102497|FG005|Year 1|System Toxicity|1|||
144247174|NCT00195494|520102492|FG000|Year 1|Lack of Efficacy|0|||
144247175|NCT00195494|520102493|FG001|Year 1|Lack of Efficacy|0|||
144247176|NCT00195494|520102494|FG002|Year 1|Lack of Efficacy|0|||
144247177|NCT00195494|520102495|FG003|Year 1|Lack of Efficacy|0|||
144247178|NCT00195494|520102496|FG004|Year 1|Lack of Efficacy|24|||
144247179|NCT00195494|520102497|FG005|Year 1|Lack of Efficacy|9|||
144247180|NCT00195494|520102492|FG000|Year 1|Compliance|0|||
144247181|NCT00195494|520102493|FG001|Year 1|Compliance|0|||
144247182|NCT00195494|520102494|FG002|Year 1|Compliance|0|||
144247183|NCT00195494|520102495|FG003|Year 1|Compliance|0|||
144247184|NCT00195494|520102496|FG004|Year 1|Compliance|5|||
144247185|NCT00195494|520102497|FG005|Year 1|Compliance|1|||
144247186|NCT00195494|520102492|FG000|Year 1|Lost to Follow-up|0|||
144247187|NCT00195494|520102493|FG001|Year 1|Lost to Follow-up|0|||
144247188|NCT00195494|520102494|FG002|Year 1|Lost to Follow-up|0|||
144247189|NCT00195494|520102495|FG003|Year 1|Lost to Follow-up|0|||
144247190|NCT00195494|520102496|FG004|Year 1|Lost to Follow-up|1|||
144247191|NCT00195494|520102497|FG005|Year 1|Lost to Follow-up|0|||
144247192|NCT00195494|520102492|FG000|Year 1|Missed >4 consecutive doses|0|||
144247193|NCT00195494|520102493|FG001|Year 1|Missed >4 consecutive doses|0|||
144247194|NCT00195494|520102494|FG002|Year 1|Missed >4 consecutive doses|0|||
144247195|NCT00195494|520102495|FG003|Year 1|Missed >4 consecutive doses|0|||
144247196|NCT00195494|520102496|FG004|Year 1|Missed >4 consecutive doses|3|||
144247197|NCT00195494|520102497|FG005|Year 1|Missed >4 consecutive doses|2|||
144293162|NCT00561821|520276170|FG002|Overall Study|Adverse Event|1|||
144293163|NCT00561821|520276171|FG003|Overall Study|Adverse Event|1|||
144293164|NCT01657942|520276172|FG000|Overall Study|Alternative Treatment|7|||
144293165|NCT01657942|520276172|FG000|Overall Study|Lost to Follow-up|1|||
144293166|NCT01197300|520277448|FG000|Overall Study|Lost to Follow-up|0|||
144293167|NCT01197300|520277449|FG001|Overall Study|Lost to Follow-up|1|||
144293168|NCT01197300|520277448|FG000|Overall Study|Protocol Violation|0|||
144293169|NCT01197300|520277449|FG001|Overall Study|Protocol Violation|1|||
144293170|NCT04744831|520277450|FG000|Overall Study|Progressive Disease|31|||
144293171|NCT04744831|520277451|FG001|Overall Study|Progressive Disease|27|||
144293172|NCT04744831|520277452|FG002|Overall Study|Progressive Disease|25|||
144293173|NCT04744831|520277450|FG000|Overall Study|Adverse Event|3|||
144293174|NCT04744831|520277451|FG001|Overall Study|Adverse Event|3|||
144293175|NCT04744831|520277452|FG002|Overall Study|Adverse Event|3|||
144293176|NCT04744831|520277450|FG000|Overall Study|Clinical Progression|3|||
144293177|NCT04744831|520277451|FG001|Overall Study|Clinical Progression|2|||
144293178|NCT04744831|520277452|FG002|Overall Study|Clinical Progression|5|||
144293179|NCT04744831|520277450|FG000|Overall Study|Other|0|||
144293180|NCT04744831|520277451|FG001|Overall Study|Other|2|||
144293181|NCT04744831|520277452|FG002|Overall Study|Other|1|||
144293182|NCT04744831|520277450|FG000|Overall Study|Death|0|||
144293183|NCT04744831|520277451|FG001|Overall Study|Death|2|||
144293184|NCT04744831|520277452|FG002|Overall Study|Death|1|||
144293185|NCT00590317|520277457|FG000|Overall Study|Lack of Efficacy|1|||
144293186|NCT00590317|520277458|FG001|Overall Study|Lack of Efficacy|5|||
144293187|NCT03443401|520277465|FG000|Overall Study|Lost to Follow-up|13|||
144293188|NCT03443401|520277465|FG000|Overall Study|Influential outlier|1|||
144293189|NCT02363283|520277466|FG000|Overall Study|Withdrawal by Subject|1|||
144293190|NCT02363283|520277466|FG000|Overall Study|Not eligible due to transaminitis|1|||
144293191|NCT04616196|520277473|FG000|Overall Study|Progressive Disease|3|||
144293192|NCT04616196|520277474|FG001|Overall Study|Progressive Disease|0|||
144293193|NCT04616196|520277475|FG002|Overall Study|Progressive Disease|4|||
144293194|NCT04616196|520277476|FG003|Overall Study|Progressive Disease|1|||
144293195|NCT04616196|520277473|FG000|Overall Study|Death|2|||
144293196|NCT04616196|520277474|FG001|Overall Study|Death|4|||
144293197|NCT04616196|520277475|FG002|Overall Study|Death|1|||
144293198|NCT04616196|520277476|FG003|Overall Study|Death|0|||
144293199|NCT04616196|520277473|FG000|Overall Study|Withdrawal by Subject|0|||
144293200|NCT04616196|520277474|FG001|Overall Study|Withdrawal by Subject|2|||
144293201|NCT04616196|520277475|FG002|Overall Study|Withdrawal by Subject|0|||
144293202|NCT04616196|520277476|FG003|Overall Study|Withdrawal by Subject|0|||
144293203|NCT04616196|520277473|FG000|Overall Study|Lost to Follow-up|1|||
144293204|NCT04616196|520277474|FG001|Overall Study|Lost to Follow-up|0|||
144293205|NCT04616196|520277475|FG002|Overall Study|Lost to Follow-up|0|||
144293206|NCT04616196|520277476|FG003|Overall Study|Lost to Follow-up|0|||
144293207|NCT04616196|520277473|FG000|Overall Study|Sponsor request|2|||
144293208|NCT04616196|520277474|FG001|Overall Study|Sponsor request|1|||
144293209|NCT04616196|520277475|FG002|Overall Study|Sponsor request|1|||
144293210|NCT04616196|520277476|FG003|Overall Study|Sponsor request|2|||
144293211|NCT01394185|520277477|FG000|Overall Study|Withdrawal by Subject|2|||
144293212|NCT01394185|520277478|FG001|Overall Study|Withdrawal by Subject|0|||
144293213|NCT01394185|520277479|FG002|Overall Study|Withdrawal by Subject|0|||
144293214|NCT01394185|520277480|FG003|Overall Study|Withdrawal by Subject|0|||
144293215|NCT01394185|520277481|FG004|Overall Study|Withdrawal by Subject|1|||
144293216|NCT01394185|520277482|FG005|Overall Study|Withdrawal by Subject|0|||
144293217|NCT01394185|520277477|FG000|Overall Study|Change in protocol|3|||
144293218|NCT01394185|520277478|FG001|Overall Study|Change in protocol|0|||
144293219|NCT01394185|520277479|FG002|Overall Study|Change in protocol|0|||
144293220|NCT01394185|520277480|FG003|Overall Study|Change in protocol|0|||
144293221|NCT01394185|520277481|FG004|Overall Study|Change in protocol|3|||
144293222|NCT01394185|520277482|FG005|Overall Study|Change in protocol|0|||
144293223|NCT01394185|520277477|FG000|Overall Study|Protocol Violation|1|||
144293224|NCT01394185|520277478|FG001|Overall Study|Protocol Violation|0|||
144293225|NCT01394185|520277479|FG002|Overall Study|Protocol Violation|0|||
144293226|NCT01394185|520277480|FG003|Overall Study|Protocol Violation|1|||
144293227|NCT01394185|520277481|FG004|Overall Study|Protocol Violation|0|||
144293228|NCT01394185|520277482|FG005|Overall Study|Protocol Violation|1|||
144293229|NCT02904265|520277483|FG000|Overall Study|Physician Decision|1|||
144293230|NCT02904265|520277484|FG001|Overall Study|Physician Decision|2|||
144293231|NCT02579759|520277485|FG000|Overall Study|Protocol Violation|2|||
144293232|NCT02579759|520277486|FG001|Overall Study|Protocol Violation|0|||
144293233|NCT02579759|520277487|FG002|Overall Study|Protocol Violation|0|||
144293234|NCT02579759|520277485|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
144293235|NCT02579759|520277486|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
144293236|NCT02579759|520277487|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
144293237|NCT02579759|520277485|FG000|Overall Study|BfArM hold|13|||
144293238|NCT02579759|520277486|FG001|Overall Study|BfArM hold|12|||
144293239|NCT02579759|520277487|FG002|Overall Study|BfArM hold|12|||
144293240|NCT02579759|520277485|FG000|Overall Study|Sponsor stopped Dose 2|0|||
144293241|NCT02579759|520277486|FG001|Overall Study|Sponsor stopped Dose 2|41|||
144293242|NCT02579759|520277487|FG002|Overall Study|Sponsor stopped Dose 2|0|||
144293243|NCT02579759|520277485|FG000|Overall Study|Non compliance|0|||
144293244|NCT02579759|520277486|FG001|Overall Study|Non compliance|1|||
144293245|NCT02579759|520277487|FG002|Overall Study|Non compliance|0|||
144293246|NCT02579759|520277485|FG000|Overall Study|Pregnancy|0|||
144293247|NCT02579759|520277486|FG001|Overall Study|Pregnancy|1|||
144293248|NCT02579759|520277487|FG002|Overall Study|Pregnancy|0|||
144293249|NCT02579759|520277485|FG000|Overall Study|Inclusion/exclusion criteria|0|||
144293250|NCT02579759|520277486|FG001|Overall Study|Inclusion/exclusion criteria|0|||
144293251|NCT02579759|520277487|FG002|Overall Study|Inclusion/exclusion criteria|1|||
144293252|NCT02579759|520277485|FG000|Overall Study|Adverse Event|4|||
144293253|NCT02579759|520277486|FG001|Overall Study|Adverse Event|3|||
144293254|NCT02579759|520277487|FG002|Overall Study|Adverse Event|1|||
144293255|NCT02579759|520277485|FG000|Overall Study|Withdrawal by Subject|3|||
144293256|NCT02579759|520277486|FG001|Overall Study|Withdrawal by Subject|3|||
144293257|NCT02579759|520277487|FG002|Overall Study|Withdrawal by Subject|5|||
144293258|NCT02579759|520277485|FG000|Overall Study|Lost to Follow-up|2|||
144293259|NCT02579759|520277486|FG001|Overall Study|Lost to Follow-up|2|||
144293260|NCT02579759|520277487|FG002|Overall Study|Lost to Follow-up|2|||
144293261|NCT00003907|520277498|FG000|Overall Study|Adverse Event|2|||
144293262|NCT00003907|520277499|FG001|Overall Study|Adverse Event|11|||
144293263|NCT00003907|520277498|FG000|Overall Study|Death|2|||
144293264|NCT00003907|520277499|FG001|Overall Study|Death|0|||
144293265|NCT00003907|520277498|FG000|Overall Study|Withdrawal by Subject|1|||
144293266|NCT00003907|520277499|FG001|Overall Study|Withdrawal by Subject|3|||
144293267|NCT00003907|520277498|FG000|Overall Study|Progressive disease|4|||
144293268|NCT00003907|520277499|FG001|Overall Study|Progressive disease|4|||
144293269|NCT00003907|520277498|FG000|Overall Study|Complicating disease|1|||
144293270|NCT00003907|520277499|FG001|Overall Study|Complicating disease|0|||
144293271|NCT00003907|520277498|FG000|Overall Study|Other|1|||
144293272|NCT00003907|520277499|FG001|Overall Study|Other|3|||
144247198|NCT00195494|520102492|FG000|Year 1|Protocol deviation|0|||
144247199|NCT00195494|520102493|FG001|Year 1|Protocol deviation|0|||
144247200|NCT00195494|520102494|FG002|Year 1|Protocol deviation|0|||
144247201|NCT00195494|520102495|FG003|Year 1|Protocol deviation|0|||
144247202|NCT00195494|520102496|FG004|Year 1|Protocol deviation|2|||
144247203|NCT00195494|520102497|FG005|Year 1|Protocol deviation|3|||
144247204|NCT00195494|520102492|FG000|Year 1|Physician Decision|0|||
144247205|NCT00195494|520102493|FG001|Year 1|Physician Decision|0|||
144247206|NCT00195494|520102494|FG002|Year 1|Physician Decision|0|||
144247207|NCT00195494|520102495|FG003|Year 1|Physician Decision|0|||
144247208|NCT00195494|520102496|FG004|Year 1|Physician Decision|1|||
144247209|NCT00195494|520102497|FG005|Year 1|Physician Decision|0|||
144247210|NCT00195494|520102492|FG000|Year 1|Withdrawal by Subject|0|||
144247211|NCT00195494|520102493|FG001|Year 1|Withdrawal by Subject|0|||
144247212|NCT00195494|520102494|FG002|Year 1|Withdrawal by Subject|0|||
144247213|NCT00195494|520102495|FG003|Year 1|Withdrawal by Subject|0|||
144247214|NCT00195494|520102496|FG004|Year 1|Withdrawal by Subject|8|||
144247215|NCT00195494|520102497|FG005|Year 1|Withdrawal by Subject|9|||
144247216|NCT00195494|520102492|FG000|Year 1|Protocol Violation|0|||
144247217|NCT00195494|520102493|FG001|Year 1|Protocol Violation|0|||
144247218|NCT00195494|520102494|FG002|Year 1|Protocol Violation|0|||
144247219|NCT00195494|520102495|FG003|Year 1|Protocol Violation|0|||
144247220|NCT00195494|520102496|FG004|Year 1|Protocol Violation|1|||
144247221|NCT00195494|520102497|FG005|Year 1|Protocol Violation|1|||
144247222|NCT00195494|520102492|FG000|Year 2|Adverse Event|3|||
144247223|NCT00195494|520102493|FG001|Year 2|Adverse Event|7|||
144247224|NCT00195494|520102494|FG002|Year 2|Adverse Event|5|||
144247225|NCT00195494|520102495|FG003|Year 2|Adverse Event|9|||
144247226|NCT00195494|520102496|FG004|Year 2|Adverse Event|0|||
144247227|NCT00195494|520102497|FG005|Year 2|Adverse Event|0|||
144247228|NCT00195494|520102492|FG000|Year 2|Lack of Efficacy|0|||
144247229|NCT00195494|520102493|FG001|Year 2|Lack of Efficacy|1|||
144247230|NCT00195494|520102494|FG002|Year 2|Lack of Efficacy|7|||
144247231|NCT00195494|520102495|FG003|Year 2|Lack of Efficacy|7|||
144247232|NCT00195494|520102496|FG004|Year 2|Lack of Efficacy|0|||
144247233|NCT00195494|520102497|FG005|Year 2|Lack of Efficacy|0|||
144247234|NCT00195494|520102492|FG000|Year 2|Compliance|1|||
144247235|NCT00195494|520102493|FG001|Year 2|Compliance|0|||
144247236|NCT00195494|520102494|FG002|Year 2|Compliance|0|||
144247237|NCT00195494|520102495|FG003|Year 2|Compliance|2|||
144247238|NCT00195494|520102496|FG004|Year 2|Compliance|0|||
144247239|NCT00195494|520102497|FG005|Year 2|Compliance|0|||
144247240|NCT00195494|520102492|FG000|Year 2|Lost to Follow-up|0|||
144247241|NCT00195494|520102493|FG001|Year 2|Lost to Follow-up|0|||
144247242|NCT00195494|520102494|FG002|Year 2|Lost to Follow-up|1|||
144247243|NCT00195494|520102495|FG003|Year 2|Lost to Follow-up|1|||
144247244|NCT00195494|520102496|FG004|Year 2|Lost to Follow-up|0|||
144247245|NCT00195494|520102497|FG005|Year 2|Lost to Follow-up|0|||
144293273|NCT00003907|520277498|FG000|Overall Study|ineligible or not treated|2|||
144293274|NCT00003907|520277499|FG001|Overall Study|ineligible or not treated|2|||
144293275|NCT02336555|520277500|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
144293276|NCT02336555|520277501|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
144293277|NCT02336555|520277500|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
144293278|NCT02336555|520277501|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
144293279|NCT02336555|520277500|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
144293280|NCT02336555|520277501|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
144293281|NCT00993473|520277502|FG000|Overall Study|Adverse Event|0|||
144293282|NCT00993473|520277503|FG001|Overall Study|Adverse Event|2|||
144293283|NCT00993473|520277502|FG000|Overall Study|Protocol Violation|1|||
144293284|NCT00993473|520277503|FG001|Overall Study|Protocol Violation|2|||
144293285|NCT00993473|520277502|FG000|Overall Study|Lost to Follow-up|1|||
144293286|NCT00993473|520277503|FG001|Overall Study|Lost to Follow-up|0|||
144293287|NCT00993473|520277502|FG000|Overall Study|Withdrawal by Subject|1|||
144293288|NCT00993473|520277503|FG001|Overall Study|Withdrawal by Subject|5|||
144293289|NCT00993473|520277502|FG000|Overall Study|Technical problem with CGM device|0|||
144293290|NCT00993473|520277503|FG001|Overall Study|Technical problem with CGM device|1|||
144293291|NCT00993473|520277502|FG000|Overall Study|Family event|1|||
144293292|NCT00993473|520277503|FG001|Overall Study|Family event|0|||
144293293|NCT00770679|520277506|FG000|Overall Study|Lost to Follow-up|3|||
144293294|NCT00770679|520277506|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
144293295|NCT00129974|520277507|FG000|Overall Study|Other|1|||
144293296|NCT00414609|520277508|FG000|Core Study|Adverse Event|9|||
144293297|NCT00414609|520277509|FG001|Core Study|Adverse Event|11|||
144293298|NCT00414609|520277510|FG002|Core Study|Adverse Event|0|||
144293299|NCT00414609|520277508|FG000|Core Study|Abnormal laboratory values|0|||
144293300|NCT00414609|520277509|FG001|Core Study|Abnormal laboratory values|1|||
144293301|NCT00414609|520277510|FG002|Core Study|Abnormal laboratory values|0|||
144293302|NCT00414609|520277508|FG000|Core Study|Abnormal test procedure results|1|||
144293303|NCT00414609|520277509|FG001|Core Study|Abnormal test procedure results|1|||
144293304|NCT00414609|520277510|FG002|Core Study|Abnormal test procedure results|0|||
144293305|NCT00414609|520277508|FG000|Core Study|Protocol deviation|0|||
144293306|NCT00414609|520277509|FG001|Core Study|Protocol deviation|1|||
144293307|NCT00414609|520277510|FG002|Core Study|Protocol deviation|0|||
144293308|NCT00414609|520277508|FG000|Core Study|Patient withdrew consent|10|||
144293309|NCT00414609|520277509|FG001|Core Study|Patient withdrew consent|11|||
144293310|NCT00414609|520277510|FG002|Core Study|Patient withdrew consent|0|||
144293311|NCT00414609|520277508|FG000|Core Study|Lost to Follow-up|7|||
144293312|NCT00414609|520277509|FG001|Core Study|Lost to Follow-up|4|||
144293313|NCT00414609|520277510|FG002|Core Study|Lost to Follow-up|0|||
144293314|NCT00414609|520277508|FG000|Core Study|Administrative problems|0|||
144293315|NCT00414609|520277509|FG001|Core Study|Administrative problems|2|||
144293316|NCT00414609|520277510|FG002|Core Study|Administrative problems|0|||
144293317|NCT00414609|520277508|FG000|Core Study|Death|7|||
144293318|NCT00414609|520277509|FG001|Core Study|Death|14|||
144293319|NCT00414609|520277510|FG002|Core Study|Death|0|||
144293320|NCT00414609|520277508|FG000|Extension Study|Adverse Event|0|||
144293321|NCT00414609|520277509|FG001|Extension Study|Adverse Event|0|||
144293322|NCT00414609|520277510|FG002|Extension Study|Adverse Event|14|||
144293323|NCT00414609|520277508|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
144293324|NCT00414609|520277509|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
144293325|NCT00414609|520277510|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
144293326|NCT00414609|520277508|FG000|Extension Study|Withdrawal by Subject|0|||
144293327|NCT00414609|520277509|FG001|Extension Study|Withdrawal by Subject|0|||
144293328|NCT00414609|520277510|FG002|Extension Study|Withdrawal by Subject|13|||
144293329|NCT00414609|520277508|FG000|Extension Study|Lost to Follow-up|0|||
144293330|NCT00414609|520277509|FG001|Extension Study|Lost to Follow-up|0|||
144293331|NCT00414609|520277510|FG002|Extension Study|Lost to Follow-up|10|||
144293332|NCT00414609|520277508|FG000|Extension Study|Administrative problems|0|||
144247246|NCT00195494|520102492|FG000|Year 2|Missed >4 consecutive doses|1|||
144293333|NCT00414609|520277509|FG001|Extension Study|Administrative problems|0|||
144293334|NCT00414609|520277510|FG002|Extension Study|Administrative problems|1|||
144293335|NCT00414609|520277508|FG000|Extension Study|Death|0|||
144293336|NCT00414609|520277509|FG001|Extension Study|Death|0|||
144293337|NCT00414609|520277510|FG002|Extension Study|Death|17|||
144293338|NCT00266032|520277516|FG000|Treatment|Adverse Event|42|||
144293339|NCT00266032|520277517|FG001|Treatment|Adverse Event|26|||
144293340|NCT00266032|520277518|FG002|Treatment|Adverse Event|10|||
144293341|NCT00266032|520277516|FG000|Treatment|Lost to Follow-up|19|||
144293342|NCT00266032|520277517|FG001|Treatment|Lost to Follow-up|4|||
144293343|NCT00266032|520277518|FG002|Treatment|Lost to Follow-up|2|||
144293344|NCT00266032|520277516|FG000|Treatment|Pregnancy|3|||
144293345|NCT00266032|520277517|FG001|Treatment|Pregnancy|2|||
144293346|NCT00266032|520277518|FG002|Treatment|Pregnancy|2|||
144293347|NCT00266032|520277516|FG000|Treatment|Protocol Violation|6|||
144293348|NCT00266032|520277517|FG001|Treatment|Protocol Violation|14|||
144293349|NCT00266032|520277518|FG002|Treatment|Protocol Violation|13|||
144293350|NCT00266032|520277516|FG000|Treatment|Withdrawal by Subject|28|||
144293351|NCT00266032|520277517|FG001|Treatment|Withdrawal by Subject|13|||
144293352|NCT00266032|520277518|FG002|Treatment|Withdrawal by Subject|12|||
144247247|NCT00195494|520102493|FG001|Year 2|Missed >4 consecutive doses|1|||
144247248|NCT00195494|520102494|FG002|Year 2|Missed >4 consecutive doses|1|||
144247249|NCT00195494|520102495|FG003|Year 2|Missed >4 consecutive doses|0|||
144247250|NCT00195494|520102496|FG004|Year 2|Missed >4 consecutive doses|0|||
144247251|NCT00195494|520102497|FG005|Year 2|Missed >4 consecutive doses|0|||
144247252|NCT00195494|520102492|FG000|Year 2|Protocol deviation|0|||
144247253|NCT00195494|520102493|FG001|Year 2|Protocol deviation|1|||
144247254|NCT00195494|520102494|FG002|Year 2|Protocol deviation|0|||
144247255|NCT00195494|520102495|FG003|Year 2|Protocol deviation|0|||
144247256|NCT00195494|520102496|FG004|Year 2|Protocol deviation|0|||
144247257|NCT00195494|520102497|FG005|Year 2|Protocol deviation|0|||
144247258|NCT00195494|520102492|FG000|Year 2|Physician Decision|1|||
144247259|NCT00195494|520102493|FG001|Year 2|Physician Decision|1|||
144247260|NCT00195494|520102494|FG002|Year 2|Physician Decision|0|||
144247261|NCT00195494|520102495|FG003|Year 2|Physician Decision|0|||
144247262|NCT00195494|520102496|FG004|Year 2|Physician Decision|0|||
144247263|NCT00195494|520102497|FG005|Year 2|Physician Decision|0|||
144247264|NCT00195494|520102492|FG000|Year 2|Withdrawal by Subject|1|||
144247265|NCT00195494|520102493|FG001|Year 2|Withdrawal by Subject|5|||
144247266|NCT00195494|520102494|FG002|Year 2|Withdrawal by Subject|4|||
144247267|NCT00195494|520102495|FG003|Year 2|Withdrawal by Subject|3|||
144247268|NCT00195494|520102496|FG004|Year 2|Withdrawal by Subject|0|||
144247269|NCT00195494|520102497|FG005|Year 2|Withdrawal by Subject|0|||
144247270|NCT00195494|520102492|FG000|Year 2|System toxicity|0|||
144247271|NCT00195494|520102493|FG001|Year 2|System toxicity|0|||
144247272|NCT00195494|520102494|FG002|Year 2|System toxicity|0|||
144247273|NCT00195494|520102495|FG003|Year 2|System toxicity|1|||
144293353|NCT00266032|520277516|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
144293354|NCT00266032|520277517|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
144293355|NCT00266032|520277518|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
144293356|NCT00266032|520277516|FG000|Open-label Safety Extension|Adverse Event|5|||
144293357|NCT00266032|520277517|FG001|Open-label Safety Extension|Adverse Event|0|||
144247274|NCT00195494|520102496|FG004|Year 2|System toxicity|0|||
144247275|NCT00195494|520102497|FG005|Year 2|System toxicity|0|||
144247276|NCT00513357|520102498|FG000|Overall Study|did not receive allocated placebo|2|||
144293358|NCT00266032|520277518|FG002|Open-label Safety Extension|Adverse Event|4|||
144293359|NCT00266032|520277516|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
144293360|NCT00266032|520277517|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
144293361|NCT00266032|520277518|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
144293362|NCT00266032|520277516|FG000|Open-label Safety Extension|Pregnancy|4|||
144293363|NCT00266032|520277517|FG001|Open-label Safety Extension|Pregnancy|1|||
144293364|NCT00266032|520277518|FG002|Open-label Safety Extension|Pregnancy|2|||
144293365|NCT00266032|520277516|FG000|Open-label Safety Extension|Protocol Violation|1|||
144293366|NCT00266032|520277517|FG001|Open-label Safety Extension|Protocol Violation|3|||
144293367|NCT00266032|520277518|FG002|Open-label Safety Extension|Protocol Violation|2|||
144293368|NCT00266032|520277516|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
144293369|NCT00266032|520277517|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
144293370|NCT00266032|520277518|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
144293371|NCT00266032|520277516|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
144293372|NCT00266032|520277517|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
144293373|NCT00266032|520277518|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
144293374|NCT03766906|520277519|FG000|Overall Study|Withdrawal by Subject|6|||
144293375|NCT00752219|520277520|FG000|Overall Study|Clinical failure|0|||
144293376|NCT00752219|520277521|FG001|Overall Study|Clinical failure|1|||
144293377|NCT00752219|520277520|FG000|Overall Study|Adverse Event|5|||
144293378|NCT00752219|520277521|FG001|Overall Study|Adverse Event|3|||
144293379|NCT00752219|520277520|FG000|Overall Study|Protocol deviation|1|||
144293380|NCT00752219|520277521|FG001|Overall Study|Protocol deviation|0|||
144293381|NCT00752219|520277520|FG000|Overall Study|Lost to Follow-up|1|||
144293382|NCT00752219|520277521|FG001|Overall Study|Lost to Follow-up|2|||
144293383|NCT00752219|520277520|FG000|Overall Study|Randomized but not treated|1|||
144293384|NCT00752219|520277521|FG001|Overall Study|Randomized but not treated|0|||
144293385|NCT00752219|520277520|FG000|Overall Study|Other|3|||
144293386|NCT00752219|520277521|FG001|Overall Study|Other|0|||
144293387|NCT04691115|520277522|FG000|Overall Study|Withdrawal by Subject|0|||
144293388|NCT04691115|520277523|FG001|Overall Study|Withdrawal by Subject|0|||
144293389|NCT04691115|520277524|FG002|Overall Study|Withdrawal by Subject|0|||
144293390|NCT04691115|520277525|FG003|Overall Study|Withdrawal by Subject|0|||
144293391|NCT04691115|520277526|FG004|Overall Study|Withdrawal by Subject|0|||
144293392|NCT04691115|520277527|FG005|Overall Study|Withdrawal by Subject|1|||
144293393|NCT04691115|520277528|FG006|Overall Study|Withdrawal by Subject|0|||
144293394|NCT04691115|520277529|FG007|Overall Study|Withdrawal by Subject|0|||
144293395|NCT04691115|520277530|FG008|Overall Study|Withdrawal by Subject|0|||
144293396|NCT04691115|520277531|FG009|Overall Study|Withdrawal by Subject|0|||
144293397|NCT04691115|520277532|FG010|Overall Study|Withdrawal by Subject|0|||
144293398|NCT04691115|520277533|FG011|Overall Study|Withdrawal by Subject|0|||
144293399|NCT04691115|520277534|FG012|Overall Study|Withdrawal by Subject|0|||
144293400|NCT04691115|520277535|FG013|Overall Study|Withdrawal by Subject|0|||
144293401|NCT00836901|520277541|FG000|First Intervention|Withdrawal by Subject|1|||
144293402|NCT00836901|520277542|FG001|First Intervention|Withdrawal by Subject|0|||
144293403|NCT00830336|520277543|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
144293404|NCT00830336|520277544|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
144293405|NCT00867334|520277545|FG000|Overall Study|Withdrawal by Subject|0|||
144293406|NCT00867334|520277546|FG001|Overall Study|Withdrawal by Subject|1|||
144293407|NCT00867334|520277545|FG000|Overall Study|Withdrawal by Subject|1|||
144293408|NCT00867334|520277546|FG001|Overall Study|Withdrawal by Subject|0|||
144293409|NCT00867334|520277545|FG000|Overall Study|Withdrawal by Subject|1|||
144293410|NCT00867334|520277546|FG001|Overall Study|Withdrawal by Subject|0|||
144293411|NCT01148771|520277549|FG000|Washout Period|Withdrawal by Subject|0|||
144247277|NCT00513357|520102499|FG001|Overall Study|did not receive allocated placebo|3|||
144247278|NCT00513357|520102498|FG000|Overall Study|Adverse Event|4|||
144247279|NCT00513357|520102499|FG001|Overall Study|Adverse Event|2|||
144247280|NCT00513357|520102498|FG000|Overall Study|Death|2|||
144247281|NCT00513357|520102499|FG001|Overall Study|Death|0|||
144247282|NCT00513357|520102498|FG000|Overall Study|Withdrawal by Subject|5|||
144247283|NCT00513357|520102499|FG001|Overall Study|Withdrawal by Subject|4|||
144247284|NCT00513357|520102498|FG000|Overall Study|Disease Progression|2|||
144247285|NCT00513357|520102499|FG001|Overall Study|Disease Progression|1|||
144247286|NCT02020512|520102500|FG000|Overall Study|Adverse Event|1|||
144247287|NCT02020512|520102500|FG000|Overall Study|Lost to Follow-up|3|||
144247288|NCT02020512|520102500|FG000|Overall Study|Protocol Violation|4|||
144247289|NCT03301844|520102501|FG000|Overall Study|suspected colon cancer|1|||
144247290|NCT03301844|520102502|FG001|Overall Study|suspected colon cancer|1|||
144247291|NCT01217385|520102503|FG000|Overall Study|Withdrawal by Subject|3|||
144247292|NCT01217385|520102503|FG000|Overall Study|DOSI not performed/not eval|12|||
144293412|NCT01148771|520277550|FG001|Washout Period|Withdrawal by Subject|1|||
144293413|NCT01437189|520277558|FG000|Overall Study|Adverse Event|3|||
144293414|NCT01437189|520277558|FG000|Overall Study|Lack of Efficacy|4|||
144293415|NCT01437189|520277558|FG000|Overall Study|Withdrawal by Subject|8|||
144293416|NCT01229111|520277559|FG000|Overall Study|Death|1|||
144293417|NCT04102514|520277560|FG000|Overall Study|Death|3|||
144293418|NCT04102514|520277561|FG001|Overall Study|Death|0|||
144293419|NCT04102514|520277562|FG002|Overall Study|Death|0|||
144293420|NCT04102514|520277563|FG003|Overall Study|Death|0|||
144293421|NCT04102514|520277560|FG000|Overall Study|Lost to Follow-up|0|||
144293422|NCT04102514|520277561|FG001|Overall Study|Lost to Follow-up|0|||
144293423|NCT04102514|520277562|FG002|Overall Study|Lost to Follow-up|3|||
144293424|NCT04102514|520277563|FG003|Overall Study|Lost to Follow-up|0|||
144293425|NCT04102514|520277560|FG000|Overall Study|Physician Decision|0|||
144293426|NCT04102514|520277561|FG001|Overall Study|Physician Decision|0|||
144293427|NCT04102514|520277562|FG002|Overall Study|Physician Decision|1|||
144293428|NCT04102514|520277563|FG003|Overall Study|Physician Decision|0|||
144293429|NCT04102514|520277560|FG000|Overall Study|Withdrawal by Subject|7|||
144293430|NCT04102514|520277561|FG001|Overall Study|Withdrawal by Subject|13|||
144293431|NCT04102514|520277562|FG002|Overall Study|Withdrawal by Subject|7|||
144293432|NCT04102514|520277563|FG003|Overall Study|Withdrawal by Subject|14|||
144293433|NCT04102514|520277560|FG000|Overall Study|Moved to longterm care facility|6|||
144293434|NCT04102514|520277561|FG001|Overall Study|Moved to longterm care facility|0|||
144293435|NCT04102514|520277562|FG002|Overall Study|Moved to longterm care facility|4|||
144293436|NCT04102514|520277563|FG003|Overall Study|Moved to longterm care facility|0|||
144293437|NCT03268499|520277564|FG000|Overall Study|Withdrawal by Subject|2|||
144293438|NCT03268499|520277565|FG001|Overall Study|Withdrawal by Subject|1|||
144293439|NCT03533491|520277574|FG000|Overall Study|Lost to Follow-up|2|||
144293440|NCT05071027|520277583|FG000|Overall Study|Lost to Follow-up|1|||
144293441|NCT05071027|520277584|FG001|Overall Study|Lost to Follow-up|4|||
144293442|NCT04576481|520277585|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
144293443|NCT04576481|520277586|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
144293444|NCT04576481|520277587|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
144293445|NCT04576481|520277588|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
144293446|NCT05463952|520277593|FG000|Treatment|Progressive disease|4|||
144293447|NCT05463952|520277593|FG000|Treatment|Ongoing|2|||
144293448|NCT03247673|520277595|FG000|Overall Study|Withdrawal by Subject|1|||
144293449|NCT03247673|520277596|FG001|Overall Study|Withdrawal by Subject|0|||
144293450|NCT03247673|520277597|FG002|Overall Study|Withdrawal by Subject|3|||
144293451|NCT03247673|520277595|FG000|Overall Study|Lost to Follow-up|0|||
144293452|NCT03247673|520277596|FG001|Overall Study|Lost to Follow-up|0|||
144293453|NCT03247673|520277597|FG002|Overall Study|Lost to Follow-up|1|||
144293454|NCT02184442|520277601|FG000|Overall Study|Death|61|||
144293455|NCT02184442|520277602|FG001|Overall Study|Death|65|||
144293456|NCT02184442|520277601|FG000|Overall Study|Withdrawal by Subject|3|||
144293457|NCT02184442|520277602|FG001|Overall Study|Withdrawal by Subject|11|||
144293458|NCT00581100|520278688|FG000|Overall Study|Death|1|||
144293459|NCT00581100|520278689|FG001|Overall Study|Death|0|||
144293460|NCT00581100|520278688|FG000|Overall Study|Adverse Event|2|||
144293461|NCT00581100|520278689|FG001|Overall Study|Adverse Event|1|||
144293462|NCT00581100|520278688|FG000|Overall Study|Withdrawal by Subject|1|||
144293463|NCT00581100|520278689|FG001|Overall Study|Withdrawal by Subject|4|||
144293464|NCT00581100|520278688|FG000|Overall Study|Other|3|||
144293465|NCT00581100|520278689|FG001|Overall Study|Other|0|||
144293466|NCT04129398|520278692|FG000|Overall Study|Physician Decision|2|||
144293467|NCT03058952|520278693|FG000|Overall Study|Adverse Event|1|||
144293468|NCT03058952|520278694|FG001|Overall Study|Adverse Event|0|||
144293469|NCT03058952|520278693|FG000|Overall Study|Lost to Follow-up|15|||
144293470|NCT03058952|520278694|FG001|Overall Study|Lost to Follow-up|15|||
144293471|NCT03058952|520278693|FG000|Overall Study|Withdrawal by Subject|7|||
144293472|NCT03058952|520278694|FG001|Overall Study|Withdrawal by Subject|11|||
144293473|NCT00267488|520278697|FG000|Overall Study|Sponsor Terminated Study|9|||
144293474|NCT00267488|520278697|FG000|Overall Study|Protocol Violation|1|||
144293475|NCT00267488|520278697|FG000|Overall Study|Other (Disease Progression)|1|||
144293476|NCT02801578|520278702|FG000|Overall Study|Adverse Event|2|||
144293477|NCT00668642|520278706|FG000|First Off-cycle|Cancer progression|1|||
144293478|NCT00668642|520278707|FG001|First Off-cycle|Cancer progression|0|||
144293479|NCT00668642|520278706|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
144293480|NCT00668642|520278707|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
144293481|NCT00814983|520278708|FG000|Overall Study|Screen failure|1|||
144293482|NCT00814983|520278709|FG001|Overall Study|Screen failure|0|||
144293483|NCT00814983|520278708|FG000|Overall Study|Withdrawal by Subject|1|||
144293484|NCT00814983|520278709|FG001|Overall Study|Withdrawal by Subject|0|||
144293485|NCT00814983|520278708|FG000|Overall Study|Graft failure|1|||
144293486|NCT00814983|520278709|FG001|Overall Study|Graft failure|0|||
144293487|NCT01935947|520278710|FG000|Overall Study|Adverse Event|0|||
144293488|NCT01935947|520278711|FG001|Overall Study|Adverse Event|2|||
144293489|NCT01935947|520278712|FG002|Overall Study|Adverse Event|0|||
144293490|NCT01935947|520278710|FG000|Overall Study|Diease Progression|2|||
144293491|NCT01935947|520278711|FG001|Overall Study|Diease Progression|2|||
144293492|NCT01935947|520278712|FG002|Overall Study|Diease Progression|2|||
144293493|NCT01935947|520278710|FG000|Overall Study|Death|1|||
144293494|NCT01935947|520278711|FG001|Overall Study|Death|0|||
144293495|NCT01935947|520278712|FG002|Overall Study|Death|0|||
144293496|NCT00425555|520278715|FG000|Overall Study|Withdrawal by Subject|11|||
144247293|NCT01217385|520102503|FG000|Overall Study|Central Path not Available|1|||
144247294|NCT01217385|520102503|FG000|Overall Study|Normal Breast TOI not available|10|||
144247295|NCT00501059|520102504|FG000|Overall Study|Protocol Violation|80|||
144247296|NCT00501059|520102505|FG001|Overall Study|Protocol Violation|69|||
144247297|NCT00501059|520102504|FG000|Overall Study|Death|140|||
144247298|NCT00501059|520102505|FG001|Overall Study|Death|137|||
144247299|NCT00501059|520102504|FG000|Overall Study|Other|236|||
144247300|NCT00501059|520102505|FG001|Overall Study|Other|239|||
144247301|NCT00501059|520102504|FG000|Overall Study|Missing end-of-study page|91|||
144247302|NCT00501059|520102505|FG001|Overall Study|Missing end-of-study page|92|||
144247303|NCT00501059|520102504|FG000|Overall Study|Clinical endpoint reached|110|||
144247304|NCT00501059|520102505|FG001|Overall Study|Clinical endpoint reached|123|||
144247305|NCT00501059|520102504|FG000|Overall Study|Insufficient therapeutic effect|4|||
144247306|NCT00501059|520102505|FG001|Overall Study|Insufficient therapeutic effect|5|||
144247307|NCT00501059|520102504|FG000|Overall Study|Consent withdrawn by subject|817|||
144247308|NCT00501059|520102505|FG001|Overall Study|Consent withdrawn by subject|873|||
144247309|NCT00501059|520102504|FG000|Overall Study|Non-compliant with study treatment|23|||
144247310|NCT00501059|520102505|FG001|Overall Study|Non-compliant with study treatment|16|||
144247311|NCT00501059|520102504|FG000|Overall Study|Reason not given|3|||
144247312|NCT00501059|520102505|FG001|Overall Study|Reason not given|1|||
144247313|NCT00501059|520102504|FG000|Overall Study|Adverse Event|129|||
144247314|NCT00501059|520102505|FG001|Overall Study|Adverse Event|122|||
144247315|NCT00501059|520102504|FG000|Overall Study|Lost to Follow-up|210|||
144247316|NCT00501059|520102505|FG001|Overall Study|Lost to Follow-up|198|||
144247317|NCT00501059|520102504|FG000|Overall Study|Not treated|25|||
144247318|NCT00501059|520102505|FG001|Overall Study|Not treated|17|||
144247319|NCT00157248|520102508|FG000|Overall Study|Adverse Event|36|||
144247320|NCT00157248|520102509|FG001|Overall Study|Adverse Event|25|||
144247321|NCT00157248|520102510|FG002|Overall Study|Adverse Event|13|||
144247322|NCT00157248|520102511|FG003|Overall Study|Adverse Event|33|||
144247323|NCT00157248|520102508|FG000|Overall Study|Protocol Violation|4|||
144247324|NCT00157248|520102509|FG001|Overall Study|Protocol Violation|0|||
144247325|NCT00157248|520102510|FG002|Overall Study|Protocol Violation|2|||
144247326|NCT00157248|520102511|FG003|Overall Study|Protocol Violation|2|||
144247327|NCT00157248|520102508|FG000|Overall Study|Lost to Follow-up|0|||
144247328|NCT00157248|520102509|FG001|Overall Study|Lost to Follow-up|1|||
144247329|NCT00157248|520102510|FG002|Overall Study|Lost to Follow-up|0|||
144247330|NCT00157248|520102511|FG003|Overall Study|Lost to Follow-up|0|||
144247331|NCT00157248|520102508|FG000|Overall Study|Withdrawal by Subject|1|||
144247332|NCT00157248|520102509|FG001|Overall Study|Withdrawal by Subject|4|||
144247333|NCT00157248|520102510|FG002|Overall Study|Withdrawal by Subject|3|||
144247334|NCT00157248|520102511|FG003|Overall Study|Withdrawal by Subject|3|||
144247335|NCT00157248|520102508|FG000|Overall Study|site closures, subject moving|7|||
144247336|NCT00157248|520102509|FG001|Overall Study|site closures, subject moving|7|||
144247337|NCT00157248|520102510|FG002|Overall Study|site closures, subject moving|3|||
144247338|NCT00157248|520102511|FG003|Overall Study|site closures, subject moving|9|||
144247339|NCT01447927|520102512|FG000|Overall Study|Adverse Event|4|||
144247340|NCT01447927|520102513|FG001|Overall Study|Adverse Event|3|||
144247341|NCT01447927|520102512|FG000|Overall Study|Withdrawal by Subject|1|||
144247342|NCT01447927|520102513|FG001|Overall Study|Withdrawal by Subject|0|||
144247343|NCT02093390|520102518|FG000|Overall Study|Withdrawal by Subject|0|||
144247344|NCT02093390|520102519|FG001|Overall Study|Withdrawal by Subject|1|||
144293497|NCT00425555|520278716|FG001|Overall Study|Withdrawal by Subject|8|||
144293498|NCT00425555|520278715|FG000|Overall Study|Lost to Follow-up|0|||
144293499|NCT00425555|520278716|FG001|Overall Study|Lost to Follow-up|1|||
144293500|NCT00425555|520278715|FG000|Overall Study|Administrative problems|3|||
144293501|NCT00425555|520278716|FG001|Overall Study|Administrative problems|0|||
144293502|NCT00425555|520278715|FG000|Overall Study|Death|1|||
144293503|NCT00425555|520278716|FG001|Overall Study|Death|2|||
144293504|NCT00425555|520278715|FG000|Overall Study|New cancer therapy|2|||
144293505|NCT00425555|520278716|FG001|Overall Study|New cancer therapy|1|||
144293506|NCT00425555|520278715|FG000|Overall Study|Disease progression|36|||
144293507|NCT00425555|520278716|FG001|Overall Study|Disease progression|33|||
144293508|NCT00425555|520278715|FG000|Overall Study|Adverse Event|25|||
144293509|NCT00425555|520278716|FG001|Overall Study|Adverse Event|15|||
144293510|NCT00425555|520278715|FG000|Overall Study|Protocol Violation|1|||
144293511|NCT00425555|520278716|FG001|Overall Study|Protocol Violation|0|||
144293512|NCT03464461|520278719|FG000|Overall Study|exclusionary medication given ,|1|||
144293513|NCT03464461|520278720|FG001|Overall Study|exclusionary medication given ,|2|||
144293514|NCT03464461|520278721|FG002|Overall Study|exclusionary medication given ,|0|||
144293515|NCT03464461|520278719|FG000|Overall Study|Physician Decision|0|||
144293516|NCT03464461|520278720|FG001|Overall Study|Physician Decision|1|||
144293517|NCT03464461|520278721|FG002|Overall Study|Physician Decision|0|||
144293518|NCT00595075|520278722|FG000|Overall Study|Withdrawal by Subject|1|||
144293519|NCT00595075|520278723|FG001|Overall Study|Withdrawal by Subject|0|||
144293520|NCT02096354|520278728|FG000|Overall Study|Physician Decision|4|||
144293521|NCT02096354|520278729|FG001|Overall Study|Physician Decision|5|||
144293522|NCT02096354|520278730|FG002|Overall Study|Physician Decision|0|||
144293523|NCT02096354|520278728|FG000|Overall Study|Withdrawal by Subject|3|||
144293524|NCT02096354|520278729|FG001|Overall Study|Withdrawal by Subject|1|||
144293525|NCT02096354|520278730|FG002|Overall Study|Withdrawal by Subject|0|||
144293526|NCT02096354|520278728|FG000|Overall Study|Adverse Event|7|||
144293527|NCT02096354|520278729|FG001|Overall Study|Adverse Event|4|||
144293528|NCT02096354|520278730|FG002|Overall Study|Adverse Event|0|||
144293529|NCT02096354|520278728|FG000|Overall Study|Ineligible|0|||
144293530|NCT02096354|520278729|FG001|Overall Study|Ineligible|0|||
144293531|NCT02096354|520278730|FG002|Overall Study|Ineligible|11|||
144293532|NCT03579719|520278733|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
144293533|NCT00069953|520278734|FG000|Overall Study|Protocol Violation|2|||
144293534|NCT01646216|520278735|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
144293535|NCT01646216|520278736|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
144293536|NCT01646216|520278735|FG000|Overall Study|Did not complete training|0|||
144293537|NCT01646216|520278736|FG001|Overall Study|Did not complete training|2|||
144293538|NCT01646216|520278735|FG000|Overall Study|Investigator decision|1|||
144293539|NCT01646216|520278736|FG001|Overall Study|Investigator decision|1|||
144293540|NCT00113373|520278739|FG000|Overall Study|Ineligible: wrong primary|1|||
144293541|NCT00113373|520278739|FG000|Overall Study|Ineligible: second primary|1|||
144293542|NCT00113373|520278739|FG000|Overall Study|Never Treated|1|||
144293543|NCT02395627|520278740|FG000|Overall Study|Withdrawal by Subject|0|||
144293544|NCT02395627|520278741|FG001|Overall Study|Withdrawal by Subject|2|||
144293545|NCT02395627|520278742|FG002|Overall Study|Withdrawal by Subject|0|||
144293546|NCT02395627|520278740|FG000|Overall Study|Did not receive pembrolizumab|3|||
144293547|NCT02395627|520278741|FG001|Overall Study|Did not receive pembrolizumab|1|||
144293548|NCT02395627|520278742|FG002|Overall Study|Did not receive pembrolizumab|0|||
144293549|NCT03253627|520278743|FG000|Overall Study|Lost to Follow-up|1|||
144293550|NCT03253627|520278744|FG001|Overall Study|Lost to Follow-up|2|||
144293551|NCT03253627|520278743|FG000|Overall Study|Withdrawal by Subject|0|||
144293552|NCT03253627|520278744|FG001|Overall Study|Withdrawal by Subject|2|||
144293553|NCT03253627|520278743|FG000|Overall Study|Inability to complete MRI|1|||
144293554|NCT03253627|520278744|FG001|Overall Study|Inability to complete MRI|0|||
144293555|NCT03829683|520278745|FG000|Overall Study|Lost to Follow-up|1|||
144293556|NCT03829683|520278746|FG001|Overall Study|Lost to Follow-up|0|||
144293557|NCT03829683|520278745|FG000|Overall Study|Physician Decision|3|||
144293558|NCT03829683|520278746|FG001|Overall Study|Physician Decision|1|||
144293559|NCT03829683|520278745|FG000|Overall Study|Withdrawal by Subject|0|||
144293560|NCT03829683|520278746|FG001|Overall Study|Withdrawal by Subject|1|||
144293561|NCT03829683|520278745|FG000|Overall Study|Discharge from hospital|1|||
144293562|NCT03829683|520278746|FG001|Overall Study|Discharge from hospital|0|||
144293563|NCT03163667|520278747|FG000|Overall Study|Death|15|||
144293564|NCT03163667|520278748|FG001|Overall Study|Death|27|||
144293565|NCT03163667|520278747|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
144293566|NCT03163667|520278748|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
144293567|NCT00979407|520278749|FG000|Overall Study|Withdrawal by Subject|3|||
144293568|NCT00979407|520278750|FG001|Overall Study|Withdrawal by Subject|4|||
144293569|NCT00979407|520278749|FG000|Overall Study|Lost to Follow-up|3|||
144293570|NCT00979407|520278750|FG001|Overall Study|Lost to Follow-up|3|||
144293571|NCT00855166|520278754|FG000|Overall Study|Adverse Event|0|||
144293572|NCT00855166|520278755|FG001|Overall Study|Adverse Event|2|||
144293573|NCT00855166|520278754|FG000|Overall Study|Death|0|||
144293574|NCT00855166|520278755|FG001|Overall Study|Death|1|||
144293575|NCT00855166|520278754|FG000|Overall Study|Withdrawal by Subject|1|||
144293576|NCT00855166|520278755|FG001|Overall Study|Withdrawal by Subject|4|||
144293577|NCT00855166|520278754|FG000|Overall Study|Poor/non-compliance|2|||
144293578|NCT00855166|520278755|FG001|Overall Study|Poor/non-compliance|0|||
144293579|NCT00855166|520278754|FG000|Overall Study|Administrative reasons by sponsor|1|||
144293580|NCT00855166|520278755|FG001|Overall Study|Administrative reasons by sponsor|0|||
144293581|NCT00855166|520278754|FG000|Overall Study|Subject no longer meets study criteria|1|||
144293582|NCT00855166|520278755|FG001|Overall Study|Subject no longer meets study criteria|1|||
144293583|NCT00803049|520278756|FG000|Overall Study|Adverse Event|21|||
144293584|NCT00803049|520278757|FG001|Overall Study|Adverse Event|33|||
144293585|NCT00803049|520278758|FG002|Overall Study|Adverse Event|13|||
144293586|NCT00803049|520278759|FG003|Overall Study|Adverse Event|27|||
144293587|NCT00803049|520278756|FG000|Overall Study|Lack of Efficacy|10|||
144293588|NCT00803049|520278757|FG001|Overall Study|Lack of Efficacy|19|||
144293589|NCT00803049|520278758|FG002|Overall Study|Lack of Efficacy|6|||
144293590|NCT00803049|520278759|FG003|Overall Study|Lack of Efficacy|13|||
144293591|NCT00803049|520278756|FG000|Overall Study|Lost to Follow-up|0|||
144293592|NCT00803049|520278757|FG001|Overall Study|Lost to Follow-up|2|||
144293593|NCT00803049|520278758|FG002|Overall Study|Lost to Follow-up|0|||
144293594|NCT00803049|520278759|FG003|Overall Study|Lost to Follow-up|3|||
144293595|NCT00803049|520278756|FG000|Overall Study|Death|2|||
144293596|NCT00803049|520278757|FG001|Overall Study|Death|1|||
144293597|NCT00803049|520278758|FG002|Overall Study|Death|0|||
144293598|NCT00803049|520278759|FG003|Overall Study|Death|2|||
144293599|NCT00803049|520278756|FG000|Overall Study|Progressive Disease|6|||
144293600|NCT00803049|520278757|FG001|Overall Study|Progressive Disease|10|||
144293601|NCT00803049|520278758|FG002|Overall Study|Progressive Disease|6|||
144293602|NCT00803049|520278759|FG003|Overall Study|Progressive Disease|6|||
144293603|NCT00803049|520278756|FG000|Overall Study|Withdrawal by Subject|19|||
144293604|NCT00803049|520278757|FG001|Overall Study|Withdrawal by Subject|43|||
144293605|NCT00803049|520278758|FG002|Overall Study|Withdrawal by Subject|16|||
144293606|NCT00803049|520278759|FG003|Overall Study|Withdrawal by Subject|44|||
144293607|NCT00803049|520278756|FG000|Overall Study|Protocol Violation|0|||
144293608|NCT00803049|520278757|FG001|Overall Study|Protocol Violation|1|||
144293609|NCT00803049|520278758|FG002|Overall Study|Protocol Violation|1|||
144293610|NCT00803049|520278759|FG003|Overall Study|Protocol Violation|0|||
144293611|NCT00803049|520278756|FG000|Overall Study|Randomized and Not Treated|0|||
144293612|NCT00803049|520278757|FG001|Overall Study|Randomized and Not Treated|0|||
144293613|NCT00803049|520278758|FG002|Overall Study|Randomized and Not Treated|0|||
144293614|NCT00803049|520278759|FG003|Overall Study|Randomized and Not Treated|2|||
144293615|NCT00803049|520278756|FG000|Overall Study|Other than Specified Above|3|||
144293616|NCT00803049|520278757|FG001|Overall Study|Other than Specified Above|9|||
144293617|NCT00803049|520278758|FG002|Overall Study|Other than Specified Above|2|||
144293618|NCT00803049|520278759|FG003|Overall Study|Other than Specified Above|5|||
144293619|NCT01422382|520278760|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
144293620|NCT04082364|520278763|FG000|Overall Study|Death|23|||
144293621|NCT04082364|520278764|FG001|Overall Study|Death|1|||
144293622|NCT04082364|520278765|FG002|Overall Study|Death|1|||
144293623|NCT04082364|520278766|FG003|Overall Study|Death|2|||
144293624|NCT04082364|520278767|FG004|Overall Study|Death|1|||
144293625|NCT04082364|520278763|FG000|Overall Study|Lost to Follow-up|1|||
144293626|NCT04082364|520278764|FG001|Overall Study|Lost to Follow-up|0|||
144293627|NCT04082364|520278765|FG002|Overall Study|Lost to Follow-up|0|||
144293628|NCT04082364|520278766|FG003|Overall Study|Lost to Follow-up|0|||
144293629|NCT04082364|520278767|FG004|Overall Study|Lost to Follow-up|1|||
144293630|NCT04082364|520278763|FG000|Overall Study|Physician Decision|1|||
144293631|NCT04082364|520278764|FG001|Overall Study|Physician Decision|1|||
144293632|NCT04082364|520278765|FG002|Overall Study|Physician Decision|0|||
144293633|NCT04082364|520278766|FG003|Overall Study|Physician Decision|2|||
144293634|NCT04082364|520278767|FG004|Overall Study|Physician Decision|1|||
144293635|NCT04082364|520278763|FG000|Overall Study|Withdrawal by Subject|1|||
144293636|NCT04082364|520278764|FG001|Overall Study|Withdrawal by Subject|1|||
144293637|NCT04082364|520278765|FG002|Overall Study|Withdrawal by Subject|0|||
144293638|NCT04082364|520278766|FG003|Overall Study|Withdrawal by Subject|0|||
144293639|NCT04082364|520278767|FG004|Overall Study|Withdrawal by Subject|1|||
144293640|NCT04082364|520278763|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
144293641|NCT04082364|520278764|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
144293642|NCT04082364|520278765|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
144293643|NCT04082364|520278766|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
144293644|NCT04082364|520278767|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
144293645|NCT04082364|520278763|FG000|Overall Study|Disease progression|0|||
144293646|NCT04082364|520278764|FG001|Overall Study|Disease progression|0|||
144293647|NCT04082364|520278765|FG002|Overall Study|Disease progression|0|||
144293648|NCT04082364|520278766|FG003|Overall Study|Disease progression|1|||
144293649|NCT04082364|520278767|FG004|Overall Study|Disease progression|0|||
144293650|NCT03186378|520278768|FG000|Overall Study|Lost to Follow-up|1|||
144293651|NCT03186378|520278769|FG001|Overall Study|Lost to Follow-up|0|||
144293652|NCT02514746|520278770|FG000|Overall Study|Chronically Ill|1|||
144293653|NCT02514746|520278771|FG001|Overall Study|Chronically Ill|2|||
144293654|NCT02514746|520278770|FG000|Overall Study|Physician Decision|4|||
144293655|NCT02514746|520278771|FG001|Overall Study|Physician Decision|2|||
144293656|NCT02514746|520278770|FG000|Overall Study|Withdrawal by Subject|12|||
144293657|NCT02514746|520278771|FG001|Overall Study|Withdrawal by Subject|10|||
144293658|NCT02514746|520278770|FG000|Overall Study|Other|5|||
144293659|NCT02514746|520278771|FG001|Overall Study|Other|1|||
144293660|NCT04042311|520278772|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
144293661|NCT04042311|520278772|FG000|Overall Study|Unable to tolerate|4|||
144293662|NCT04042311|520278772|FG000|Overall Study|Concurrent illness|2|||
144293663|NCT04042311|520278772|FG000|Overall Study|Adverse Event|2|||
144293664|NCT04042311|520278772|FG000|Overall Study|No longer meeting inclusion criteria|2|||
144293665|NCT04042311|520278772|FG000|Overall Study|No reason given|1|||
144293666|NCT04042311|520278772|FG000|Overall Study|Withdrawal by Subject|4|||
144293667|NCT05021224|520278773|FG000|Overall Study|Did not complete all survey items|4|||
144293668|NCT05021224|520278774|FG001|Overall Study|Did not complete all survey items|1|||
144293669|NCT05021224|520278775|FG002|Overall Study|Did not complete all survey items|0|||
144293670|NCT05021224|520278776|FG003|Overall Study|Did not complete all survey items|2|||
144293671|NCT05375929|520278777|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
144293672|NCT05375929|520278778|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
144293673|NCT05375929|520278779|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
144293674|NCT05375929|520278780|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
144293675|NCT05375929|520278777|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
144293676|NCT05375929|520278778|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
144293677|NCT05375929|520278779|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
144293678|NCT05375929|520278780|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
144293679|NCT05375929|520278777|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
144293680|NCT05375929|520278778|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
144293681|NCT05375929|520278779|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
144293682|NCT05375929|520278780|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
144293683|NCT05375929|520278777|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
144293684|NCT05375929|520278778|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
144293685|NCT05375929|520278779|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
144293686|NCT05375929|520278780|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
144293687|NCT05375929|520278777|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
144293688|NCT05375929|520278778|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
144293689|NCT05375929|520278779|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
144293690|NCT05375929|520278780|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
144293691|NCT05375929|520278777|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
144293692|NCT05375929|520278778|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
144293693|NCT05375929|520278779|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
144293694|NCT05375929|520278780|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
144293695|NCT05375929|520278777|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
144293696|NCT05375929|520278778|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
144293697|NCT05375929|520278779|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
144293698|NCT05375929|520278780|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
144293699|NCT05375929|520278777|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
144293700|NCT05375929|520278778|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
144293701|NCT05375929|520278779|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
144293702|NCT05375929|520278780|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
144293703|NCT05375929|520278777|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
144293704|NCT05375929|520278778|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
144293705|NCT05375929|520278779|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
144293706|NCT05375929|520278780|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
144293707|NCT05375929|520278777|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
144293708|NCT05375929|520278778|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
144293709|NCT05375929|520278779|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
144293710|NCT05375929|520278780|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
144293711|NCT03973489|520278781|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
144293712|NCT03973489|520278782|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
144293713|NCT03973489|520278783|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
144293714|NCT03973489|520278784|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
144293715|NCT03973489|520278785|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
144293716|NCT03973489|520278786|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
144293717|NCT03973489|520278787|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
144293718|NCT03973489|520278788|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
144293719|NCT03973489|520278781|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
144293720|NCT03973489|520278782|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
144293721|NCT03973489|520278783|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
144293722|NCT03973489|520278784|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
144293723|NCT03973489|520278785|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
144293724|NCT03973489|520278786|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
144293725|NCT03973489|520278787|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
144293726|NCT03973489|520278788|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
144293727|NCT03973489|520278781|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
144293728|NCT03973489|520278782|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
144293729|NCT03973489|520278783|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
144293730|NCT03973489|520278784|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
144293731|NCT03973489|520278785|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
144293732|NCT03973489|520278786|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
144293733|NCT03973489|520278787|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
144293734|NCT03973489|520278788|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
144293735|NCT03973489|520278781|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
144293736|NCT03973489|520278782|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
144293737|NCT03973489|520278783|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
144293738|NCT03973489|520278784|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
144293739|NCT03973489|520278785|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
144293740|NCT03973489|520278786|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
144293741|NCT03973489|520278787|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
144293742|NCT03973489|520278788|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
144293743|NCT03973489|520278781|FG000|Second Intervention (1 Day)|Adverse Event|0|||
144293744|NCT03973489|520278782|FG001|Second Intervention (1 Day)|Adverse Event|0|||
144293745|NCT03973489|520278783|FG002|Second Intervention (1 Day)|Adverse Event|0|||
144293746|NCT03973489|520278784|FG003|Second Intervention (1 Day)|Adverse Event|1|||
144293747|NCT03973489|520278785|FG004|Second Intervention (1 Day)|Adverse Event|0|||
144293748|NCT03973489|520278786|FG005|Second Intervention (1 Day)|Adverse Event|0|||
144293749|NCT03973489|520278787|FG006|Second Intervention (1 Day)|Adverse Event|0|||
144293750|NCT03973489|520278788|FG007|Second Intervention (1 Day)|Adverse Event|0|||
144293751|NCT03301415|520278789|FG000|Overall Study|Lost to Follow-up|2|||
144293752|NCT03301415|520278789|FG000|Overall Study|Unable to comply with visit schedule|2|||
144293753|NCT04091438|520278790|FG000|Treatment Period 1 (1 Day)|Other|1|||
144293754|NCT04091438|520278791|FG001|Treatment Period 1 (1 Day)|Other|0|||
144293755|NCT04091438|520278790|FG000|Washout Period (1 Day)|Protocol deviation|0|||
144293756|NCT04091438|520278791|FG001|Washout Period (1 Day)|Protocol deviation|1|||
144293757|NCT04091438|520278790|FG000|Washout Period (1 Day)|Other|0|||
144293758|NCT04091438|520278791|FG001|Washout Period (1 Day)|Other|1|||
144293759|NCT02691494|520278796|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
144293760|NCT02691494|520278797|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
144293761|NCT02691494|520278798|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
144293762|NCT02691494|520278796|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
144293763|NCT02691494|520278797|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
144293764|NCT02691494|520278798|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
144293765|NCT02691494|520278796|FG000|Post-Treatment Follow-Up Period|Other|2|||
144293766|NCT02691494|520278797|FG001|Post-Treatment Follow-Up Period|Other|1|||
144293767|NCT02691494|520278798|FG002|Post-Treatment Follow-Up Period|Other|1|||
144293768|NCT02691494|520278796|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
144293769|NCT02691494|520278797|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
144293770|NCT02691494|520278798|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
144293771|NCT02691494|520278796|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
144293772|NCT02691494|520278797|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
144293773|NCT02691494|520278798|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
144293774|NCT03249558|520278799|FG000|Overall Study|Lost to Follow-up|2|||
144293775|NCT03249558|520278800|FG001|Overall Study|Lost to Follow-up|1|||
144293776|NCT03249558|520278801|FG002|Overall Study|Lost to Follow-up|4|||
144293777|NCT03249558|520278799|FG000|Overall Study|Physician Decision|1|||
144293778|NCT03249558|520278800|FG001|Overall Study|Physician Decision|0|||
144293779|NCT03249558|520278801|FG002|Overall Study|Physician Decision|0|||
144293780|NCT03249558|520278799|FG000|Overall Study|Withdrawal by Subject|6|||
144293781|NCT03249558|520278800|FG001|Overall Study|Withdrawal by Subject|5|||
144293782|NCT03249558|520278801|FG002|Overall Study|Withdrawal by Subject|7|||
144293783|NCT03249558|520278799|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
144293784|NCT03249558|520278800|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
144293785|NCT03249558|520278801|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
144293786|NCT03249558|520278799|FG000|Overall Study|Protocol Violation|1|||
144293787|NCT03249558|520278800|FG001|Overall Study|Protocol Violation|1|||
144293788|NCT03249558|520278801|FG002|Overall Study|Protocol Violation|2|||
144293789|NCT00908141|520278802|FG000|Overall Study|Withdrawal by Subject|0|||
144293790|NCT00908141|520278803|FG001|Overall Study|Withdrawal by Subject|1|||
144293791|NCT03379870|520280368|FG000|Overall Study|Lost to Follow-up|1|||
144293792|NCT03379870|520280369|FG001|Overall Study|Lost to Follow-up|0|||
144293793|NCT03379870|520280368|FG000|Overall Study|Protocol Violation|1|||
144293794|NCT03379870|520280369|FG001|Overall Study|Protocol Violation|1|||
144293795|NCT02471144|520280370|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
144293796|NCT02471144|520280371|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
144293797|NCT02471144|520280372|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
144293798|NCT02471144|520280373|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
144293799|NCT02471144|520280374|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
144293800|NCT02471144|520280375|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
144293801|NCT02471144|520280376|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
144293802|NCT02471144|520280377|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
144293803|NCT02471144|520280378|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
144293804|NCT02471144|520280379|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
144293805|NCT02471144|520280380|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
144293806|NCT02471144|520280370|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293807|NCT02471144|520280371|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293808|NCT02471144|520280372|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293809|NCT02471144|520280373|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
144293810|NCT02471144|520280374|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293811|NCT02471144|520280375|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293812|NCT02471144|520280376|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293813|NCT02471144|520280377|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293814|NCT02471144|520280378|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293815|NCT02471144|520280379|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293816|NCT02471144|520280380|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
144293817|NCT02471144|520280370|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293818|NCT02471144|520280371|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293819|NCT02471144|520280372|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
144293820|NCT02471144|520280373|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293821|NCT02471144|520280374|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293822|NCT02471144|520280375|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293823|NCT02471144|520280376|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293824|NCT02471144|520280377|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293825|NCT02471144|520280378|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293826|NCT02471144|520280379|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293827|NCT02471144|520280380|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
144293828|NCT02471144|520280370|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
144293829|NCT02471144|520280371|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
144293830|NCT02471144|520280372|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293831|NCT02471144|520280373|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293832|NCT02471144|520280374|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293833|NCT02471144|520280375|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293834|NCT02471144|520280376|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293835|NCT02471144|520280377|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293836|NCT02471144|520280378|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293837|NCT02471144|520280379|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293838|NCT02471144|520280380|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
144293839|NCT02471144|520280370|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293840|NCT02471144|520280371|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293841|NCT02471144|520280372|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293842|NCT02471144|520280373|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293843|NCT02471144|520280374|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
144293844|NCT02471144|520280375|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293845|NCT02471144|520280376|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
144293846|NCT02471144|520280377|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293847|NCT02471144|520280378|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
144293848|NCT02471144|520280379|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293849|NCT02471144|520280380|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
144293850|NCT02471144|520280370|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293851|NCT02471144|520280371|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293852|NCT02471144|520280372|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293853|NCT02471144|520280373|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293854|NCT02471144|520280374|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293855|NCT02471144|520280375|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
144293856|NCT02471144|520280376|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293857|NCT02471144|520280377|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293858|NCT02471144|520280378|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
144293859|NCT02471144|520280379|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293860|NCT02471144|520280380|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
144293861|NCT02471144|520280370|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293862|NCT02471144|520280371|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293863|NCT02471144|520280372|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293864|NCT02471144|520280373|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293865|NCT02471144|520280374|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293866|NCT02471144|520280375|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293867|NCT02471144|520280376|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293868|NCT02471144|520280377|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293869|NCT02471144|520280378|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
144293870|NCT02471144|520280379|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293871|NCT02471144|520280380|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
144293872|NCT02471144|520280370|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293873|NCT02471144|520280371|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293874|NCT02471144|520280372|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293875|NCT02471144|520280373|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293876|NCT02471144|520280374|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293877|NCT02471144|520280375|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293878|NCT02471144|520280376|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293879|NCT02471144|520280377|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
144293880|NCT02471144|520280378|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
144293881|NCT02471144|520280379|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293882|NCT02471144|520280380|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
144293883|NCT02471144|520280370|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293884|NCT02471144|520280371|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293885|NCT02471144|520280372|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293886|NCT02471144|520280373|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293887|NCT02471144|520280374|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293888|NCT02471144|520280375|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293889|NCT02471144|520280376|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293890|NCT02471144|520280377|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293891|NCT02471144|520280378|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
144293892|NCT02471144|520280379|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
144293893|NCT02471144|520280380|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
144293894|NCT02471144|520280370|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293895|NCT02471144|520280371|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293896|NCT02471144|520280372|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293897|NCT02471144|520280373|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293898|NCT02471144|520280374|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293899|NCT02471144|520280375|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293900|NCT02471144|520280376|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293901|NCT02471144|520280377|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293902|NCT02471144|520280378|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293903|NCT02471144|520280379|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
144293904|NCT02471144|520280380|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
144293905|NCT02471144|520280370|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293906|NCT02471144|520280371|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293907|NCT02471144|520280372|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293908|NCT02471144|520280373|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293909|NCT02471144|520280374|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293910|NCT02471144|520280375|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293911|NCT02471144|520280376|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293912|NCT02471144|520280377|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293913|NCT02471144|520280378|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293914|NCT02471144|520280379|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
144293915|NCT02471144|520280380|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
144293916|NCT02471144|520280370|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293917|NCT02471144|520280371|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293918|NCT02471144|520280372|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293919|NCT02471144|520280373|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293920|NCT02471144|520280374|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293921|NCT02471144|520280375|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293922|NCT02471144|520280376|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293923|NCT02471144|520280377|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293924|NCT02471144|520280378|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
144293925|NCT02471144|520280379|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
144293926|NCT02471144|520280380|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
144293927|NCT02471144|520280370|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293928|NCT02471144|520280371|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293929|NCT02471144|520280372|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293930|NCT02471144|520280373|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293931|NCT02471144|520280374|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293932|NCT02471144|520280375|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293933|NCT02471144|520280376|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293934|NCT02471144|520280377|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293935|NCT02471144|520280378|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293936|NCT02471144|520280379|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
144293937|NCT02471144|520280380|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
144293938|NCT02471144|520280370|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293939|NCT02471144|520280371|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293940|NCT02471144|520280372|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293941|NCT02471144|520280373|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293942|NCT02471144|520280374|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293943|NCT02471144|520280375|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293944|NCT02471144|520280376|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293945|NCT02471144|520280377|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293946|NCT02471144|520280378|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
144293947|NCT02471144|520280379|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
144293948|NCT02471144|520280380|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
144293949|NCT04280783|520280381|FG000|Overall Study|Family issues unrelated to the study.|1|||
144293950|NCT04280783|520280382|FG001|Overall Study|Family issues unrelated to the study.|0|||
144293951|NCT04280783|520280381|FG000|Overall Study|Withdrawal by Subject|0|||
144293952|NCT04280783|520280382|FG001|Overall Study|Withdrawal by Subject|1|||
144293953|NCT04110145|520280383|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
144293954|NCT04110145|520280384|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
144293955|NCT04110145|520280385|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
144293956|NCT04110145|520280386|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
144293957|NCT04110145|520280387|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
144293958|NCT00980044|520280388|FG000|Overall Study|Withdrawal by Subject|5|||
144293959|NCT00980044|520280389|FG001|Overall Study|Withdrawal by Subject|7|||
144293960|NCT00980044|520280390|FG002|Overall Study|Withdrawal by Subject|3|||
144293961|NCT00980044|520280388|FG000|Overall Study|Protocol Violation|0|||
144293962|NCT00980044|520280389|FG001|Overall Study|Protocol Violation|0|||
144293963|NCT00980044|520280390|FG002|Overall Study|Protocol Violation|2|||
144293964|NCT02254291|520280391|FG000|Overall Study|Withdrawal by Subject|0|||
144293965|NCT02254291|520280392|FG001|Overall Study|Withdrawal by Subject|3|||
144293966|NCT02254291|520280393|FG002|Overall Study|Withdrawal by Subject|1|||
144293967|NCT02254291|520280391|FG000|Overall Study|Missing follow-up information|0|||
144293968|NCT02254291|520280392|FG001|Overall Study|Missing follow-up information|0|||
144293969|NCT02254291|520280393|FG002|Overall Study|Missing follow-up information|1|||
144293970|NCT00185614|520280398|FG000|Inter-treatment Period|Physician Decision|1|||
144293971|NCT00185614|520280398|FG000|Inter-treatment Period|Relapse|2|||
144293972|NCT00185614|520280398|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
144293973|NCT00833703|520280405|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
144293974|NCT00833703|520280406|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
144293975|NCT01557569|520280407|FG000|Overall Study|Adverse Event|2|||
144293976|NCT01557569|520280408|FG001|Overall Study|Adverse Event|0|||
144293977|NCT01557569|520280407|FG000|Overall Study|high blood pressure|0|||
144293978|NCT01557569|520280408|FG001|Overall Study|high blood pressure|1|||
144293979|NCT01557569|520280407|FG000|Overall Study|Withdrawal by Subject|3|||
144293980|NCT01557569|520280408|FG001|Overall Study|Withdrawal by Subject|5|||
144293981|NCT01557569|520280407|FG000|Overall Study|noncompliance with rules of residential|0|||
144293982|NCT01557569|520280408|FG001|Overall Study|noncompliance with rules of residential|1|||
144293983|NCT02254460|520280409|FG000|Overall Study|Adverse Event|1|||
144293984|NCT02254460|520280410|FG001|Overall Study|Adverse Event|0|||
144293985|NCT01149460|520280411|FG000|Overall Study|Withdrawal by Subject|0|||
144293986|NCT01149460|520280412|FG001|Overall Study|Withdrawal by Subject|2|||
144293987|NCT01904279|520280418|FG000|Overall Study|Lack of Efficacy|2|||
144293988|NCT01904279|520280419|FG001|Overall Study|Lack of Efficacy|3|||
144293989|NCT01904279|520280418|FG000|Overall Study|Withdrawal by Subject|1|||
144293990|NCT01904279|520280419|FG001|Overall Study|Withdrawal by Subject|0|||
144293991|NCT03257657|520280427|FG000|Overall Study|Lost to Follow-up|0|||
144293992|NCT03257657|520280428|FG001|Overall Study|Lost to Follow-up|3|||
144293993|NCT03257657|520280427|FG000|Overall Study|Withdrawn|0|||
144293994|NCT03257657|520280428|FG001|Overall Study|Withdrawn|1|||
144293995|NCT03257657|520280427|FG000|Overall Study|Noted not eligible right after enrolled|0|||
144293996|NCT03257657|520280428|FG001|Overall Study|Noted not eligible right after enrolled|1|||
144293997|NCT00137449|520280429|FG000|Overall Study|Disease Progression|8|||
144293998|NCT00137449|520280430|FG001|Overall Study|Disease Progression|13|||
144293999|NCT00137449|520280429|FG000|Overall Study|Death|4|||
144294000|NCT00137449|520280430|FG001|Overall Study|Death|3|||
144294001|NCT00137449|520280429|FG000|Overall Study|Adverse Event|3|||
144294002|NCT00137449|520280430|FG001|Overall Study|Adverse Event|1|||
144294003|NCT00137449|520280429|FG000|Overall Study|Withdrawal by Subject|1|||
144294004|NCT00137449|520280430|FG001|Overall Study|Withdrawal by Subject|1|||
144294005|NCT01356940|520280438|FG000|First Intervention (28 Days)|Adverse Event|1|||
144294006|NCT01356940|520280439|FG001|First Intervention (28 Days)|Adverse Event|0|||
144294007|NCT01356940|520280438|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
144294008|NCT01356940|520280439|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
144294009|NCT03412591|520280440|FG000|Overall Study|Withdrawal by Subject|1|||
144294010|NCT03412591|520280441|FG001|Overall Study|Withdrawal by Subject|8|||
144294011|NCT03412591|520280440|FG000|Overall Study|Adverse Event|0|||
144294012|NCT03412591|520280441|FG001|Overall Study|Adverse Event|1|||
144294013|NCT02272985|520280442|FG000|Overall Study|Withdrawal by Subject|1|||
144294014|NCT02272985|520280442|FG000|Overall Study|hip fracture|1|||
144294015|NCT02272985|520280442|FG000|Overall Study|kidney transplantation|1|||
144294016|NCT02263547|520280447|FG000|Overall Study|Adverse Event|1|||
144294017|NCT02263547|520280447|FG000|Overall Study|Lost to Follow-up|2|||
144294018|NCT00505687|520280450|FG000|Overall Study|Important protocol violation|2|||
144294019|NCT00505687|520280450|FG000|Overall Study|Lack of Efficacy|15|||
144294020|NCT00505687|520280450|FG000|Overall Study|Adverse Event|48|||
144294021|NCT00505687|520280450|FG000|Overall Study|Subject withdrew consent|15|||
144294022|NCT00505687|520280450|FG000|Overall Study|Lost to Follow-up|1|||
144294023|NCT00505687|520280450|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
144294024|NCT00505687|520280450|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
144294025|NCT00505687|520280450|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
144294026|NCT00505687|520280450|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
144294027|NCT00505687|520280450|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
144294028|NCT00505687|520280450|FG000|Overall Study|Other: Disease Progression|1|||
144294029|NCT00505687|520280450|FG000|Overall Study|Other: As Per Sponsor|8|||
144294030|NCT03427619|520280451|FG000|Overall Study|Physician Decision|3|||
144294031|NCT03427619|520280451|FG000|Overall Study|Withdrawal by Subject|4|||
144294032|NCT03427619|520280451|FG000|Overall Study|Lost to Follow-up|5|||
144294033|NCT03427619|520280451|FG000|Overall Study|Administrative|4|||
144294034|NCT03427619|520280451|FG000|Overall Study|Other|2|||
144294035|NCT03427619|520280451|FG000|Overall Study|Unknown or Missing Completion Status|48|||
144294036|NCT04661839|520280452|FG000|Overall Study|Not Treated|0|||
144294037|NCT04661839|520280453|FG001|Overall Study|Not Treated|0|||
144294038|NCT04661839|520280454|FG002|Overall Study|Not Treated|1|||
144294039|NCT04661839|520280455|FG003|Overall Study|Not Treated|0|||
144294040|NCT04661839|520280452|FG000|Overall Study|Lost to Follow-up|1|||
144294041|NCT04661839|520280453|FG001|Overall Study|Lost to Follow-up|0|||
144294042|NCT04661839|520280454|FG002|Overall Study|Lost to Follow-up|0|||
144294043|NCT04661839|520280455|FG003|Overall Study|Lost to Follow-up|1|||
144294044|NCT01946880|520280456|FG000|Overall Study|Lost to Follow-up|1|||
144294045|NCT01946880|520280457|FG001|Overall Study|Lost to Follow-up|0|||
144294046|NCT01946880|520280456|FG000|Overall Study|Physician Decision|1|||
144294047|NCT01946880|520280457|FG001|Overall Study|Physician Decision|1|||
144294048|NCT01946880|520280456|FG000|Overall Study|Withdrawal by Subject|3|||
144294049|NCT01946880|520280457|FG001|Overall Study|Withdrawal by Subject|2|||
144294050|NCT01946880|520280456|FG000|Overall Study|Met Primary Endpoint|1|||
144294051|NCT01946880|520280457|FG001|Overall Study|Met Primary Endpoint|0|||
144294052|NCT01946880|520280456|FG000|Overall Study|Personal and Family Issues|1|||
144294053|NCT01946880|520280457|FG001|Overall Study|Personal and Family Issues|0|||
144294054|NCT02951819|520280461|FG000|Overall Study|Death|9|||
144294055|NCT02951819|520280462|FG001|Overall Study|Death|7|||
144294056|NCT02951819|520280461|FG000|Overall Study|Withdrawal by Subject|3|||
144294057|NCT02951819|520280462|FG001|Overall Study|Withdrawal by Subject|0|||
144294058|NCT02951819|520280461|FG000|Overall Study|Adverse Event|1|||
144294059|NCT02951819|520280462|FG001|Overall Study|Adverse Event|0|||
144294060|NCT02951819|520280461|FG000|Overall Study|Lack of Efficacy|4|||
144294061|NCT02951819|520280462|FG001|Overall Study|Lack of Efficacy|0|||
144294062|NCT02951819|520280461|FG000|Overall Study|Lost to Follow-up|1|||
144294063|NCT02951819|520280462|FG001|Overall Study|Lost to Follow-up|0|||
144294064|NCT02951819|520280461|FG000|Overall Study|Progressive Disease|1|||
144294065|NCT02951819|520280462|FG001|Overall Study|Progressive Disease|0|||
144294066|NCT02951819|520280461|FG000|Overall Study|Other|9|||
144294067|NCT02951819|520280462|FG001|Overall Study|Other|0|||
144294068|NCT03715829|520280463|FG000|Dose Ranging Period|Adverse Event|2|||
144294069|NCT03715829|520280464|FG001|Dose Ranging Period|Adverse Event|4|||
144294070|NCT03715829|520280465|FG002|Dose Ranging Period|Adverse Event|5|||
144294071|NCT03715829|520280466|FG003|Dose Ranging Period|Adverse Event|2|||
144294072|NCT03715829|520280467|FG004|Dose Ranging Period|Adverse Event|3|||
144294073|NCT03715829|520280468|FG005|Dose Ranging Period|Adverse Event|3|||
144294074|NCT03715829|520280469|FG006|Dose Ranging Period|Adverse Event|0|||
144294075|NCT03715829|520280470|FG007|Dose Ranging Period|Adverse Event|0|||
144294076|NCT03715829|520280471|FG008|Dose Ranging Period|Adverse Event|0|||
144294077|NCT03715829|520280472|FG009|Dose Ranging Period|Adverse Event|0|||
144294078|NCT03715829|520280473|FG010|Dose Ranging Period|Adverse Event|0|||
144294079|NCT03715829|520280463|FG000|Dose Ranging Period|Lack of Efficacy|0|||
144294080|NCT03715829|520280464|FG001|Dose Ranging Period|Lack of Efficacy|1|||
144294081|NCT03715829|520280465|FG002|Dose Ranging Period|Lack of Efficacy|0|||
144294082|NCT03715829|520280466|FG003|Dose Ranging Period|Lack of Efficacy|1|||
144294083|NCT03715829|520280467|FG004|Dose Ranging Period|Lack of Efficacy|0|||
144294084|NCT03715829|520280468|FG005|Dose Ranging Period|Lack of Efficacy|0|||
144294085|NCT03715829|520280469|FG006|Dose Ranging Period|Lack of Efficacy|0|||
144294086|NCT03715829|520280470|FG007|Dose Ranging Period|Lack of Efficacy|0|||
144294087|NCT03715829|520280471|FG008|Dose Ranging Period|Lack of Efficacy|0|||
144294088|NCT03715829|520280472|FG009|Dose Ranging Period|Lack of Efficacy|0|||
144294089|NCT03715829|520280473|FG010|Dose Ranging Period|Lack of Efficacy|0|||
144294090|NCT03715829|520280463|FG000|Dose Ranging Period|Lost to Follow-up|2|||
144294091|NCT03715829|520280464|FG001|Dose Ranging Period|Lost to Follow-up|0|||
144294092|NCT03715829|520280465|FG002|Dose Ranging Period|Lost to Follow-up|1|||
144294093|NCT03715829|520280466|FG003|Dose Ranging Period|Lost to Follow-up|1|||
144294094|NCT03715829|520280467|FG004|Dose Ranging Period|Lost to Follow-up|1|||
144294095|NCT03715829|520280468|FG005|Dose Ranging Period|Lost to Follow-up|2|||
144294096|NCT03715829|520280469|FG006|Dose Ranging Period|Lost to Follow-up|0|||
144294097|NCT03715829|520280470|FG007|Dose Ranging Period|Lost to Follow-up|0|||
144294098|NCT03715829|520280471|FG008|Dose Ranging Period|Lost to Follow-up|0|||
144294099|NCT03715829|520280472|FG009|Dose Ranging Period|Lost to Follow-up|0|||
144294100|NCT03715829|520280473|FG010|Dose Ranging Period|Lost to Follow-up|0|||
144294101|NCT03715829|520280463|FG000|Dose Ranging Period|Protocol Violation|0|||
144294102|NCT03715829|520280464|FG001|Dose Ranging Period|Protocol Violation|0|||
144294103|NCT03715829|520280465|FG002|Dose Ranging Period|Protocol Violation|0|||
144294104|NCT03715829|520280466|FG003|Dose Ranging Period|Protocol Violation|1|||
144294105|NCT03715829|520280467|FG004|Dose Ranging Period|Protocol Violation|0|||
144294106|NCT03715829|520280468|FG005|Dose Ranging Period|Protocol Violation|0|||
144294107|NCT03715829|520280469|FG006|Dose Ranging Period|Protocol Violation|0|||
144294108|NCT03715829|520280470|FG007|Dose Ranging Period|Protocol Violation|0|||
144294109|NCT03715829|520280471|FG008|Dose Ranging Period|Protocol Violation|0|||
144294110|NCT03715829|520280472|FG009|Dose Ranging Period|Protocol Violation|0|||
144294111|NCT03715829|520280473|FG010|Dose Ranging Period|Protocol Violation|0|||
144294112|NCT03715829|520280463|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
144294113|NCT03715829|520280464|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
144294114|NCT03715829|520280465|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
144294115|NCT03715829|520280466|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
144294116|NCT03715829|520280467|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
144294117|NCT03715829|520280468|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
144294118|NCT03715829|520280469|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
144294119|NCT03715829|520280470|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
144294120|NCT03715829|520280471|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
144294121|NCT03715829|520280472|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
144294122|NCT03715829|520280473|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
144294123|NCT03715829|520280463|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294124|NCT03715829|520280464|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294125|NCT03715829|520280465|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
144294126|NCT03715829|520280466|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294127|NCT03715829|520280467|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294128|NCT03715829|520280468|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294129|NCT03715829|520280469|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294130|NCT03715829|520280470|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294131|NCT03715829|520280471|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294132|NCT03715829|520280472|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294133|NCT03715829|520280473|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
144294134|NCT03715829|520280463|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294135|NCT03715829|520280464|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294136|NCT03715829|520280465|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
144294137|NCT03715829|520280466|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294138|NCT03715829|520280467|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
144294139|NCT03715829|520280468|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294140|NCT03715829|520280469|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294141|NCT03715829|520280470|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294142|NCT03715829|520280471|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294143|NCT03715829|520280472|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294144|NCT03715829|520280473|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
144294145|NCT03715829|520280463|FG000|Dose Ranging Period|Other|0|||
144294146|NCT03715829|520280464|FG001|Dose Ranging Period|Other|0|||
144294147|NCT03715829|520280465|FG002|Dose Ranging Period|Other|2|||
144294148|NCT03715829|520280466|FG003|Dose Ranging Period|Other|0|||
144294149|NCT03715829|520280467|FG004|Dose Ranging Period|Other|0|||
144294150|NCT03715829|520280468|FG005|Dose Ranging Period|Other|3|||
144294151|NCT03715829|520280469|FG006|Dose Ranging Period|Other|0|||
144294152|NCT03715829|520280470|FG007|Dose Ranging Period|Other|0|||
144294153|NCT03715829|520280471|FG008|Dose Ranging Period|Other|0|||
144294154|NCT03715829|520280472|FG009|Dose Ranging Period|Other|0|||
144294155|NCT03715829|520280473|FG010|Dose Ranging Period|Other|0|||
144294156|NCT03715829|520280463|FG000|Extension Period|Adverse Event|0|||
144294157|NCT03715829|520280464|FG001|Extension Period|Adverse Event|0|||
144294158|NCT03715829|520280465|FG002|Extension Period|Adverse Event|0|||
144294159|NCT03715829|520280466|FG003|Extension Period|Adverse Event|0|||
144294160|NCT03715829|520280467|FG004|Extension Period|Adverse Event|0|||
144294161|NCT03715829|520280468|FG005|Extension Period|Adverse Event|0|||
144294162|NCT03715829|520280469|FG006|Extension Period|Adverse Event|3|||
144294163|NCT03715829|520280470|FG007|Extension Period|Adverse Event|1|||
144294164|NCT03715829|520280471|FG008|Extension Period|Adverse Event|6|||
144294165|NCT03715829|520280472|FG009|Extension Period|Adverse Event|0|||
144294166|NCT03715829|520280473|FG010|Extension Period|Adverse Event|0|||
144294167|NCT03715829|520280463|FG000|Extension Period|Lack of Efficacy|0|||
144294168|NCT03715829|520280464|FG001|Extension Period|Lack of Efficacy|0|||
144294169|NCT03715829|520280465|FG002|Extension Period|Lack of Efficacy|0|||
144294170|NCT03715829|520280466|FG003|Extension Period|Lack of Efficacy|0|||
144294171|NCT03715829|520280467|FG004|Extension Period|Lack of Efficacy|0|||
144294172|NCT03715829|520280468|FG005|Extension Period|Lack of Efficacy|0|||
144294173|NCT03715829|520280469|FG006|Extension Period|Lack of Efficacy|1|||
144294174|NCT03715829|520280470|FG007|Extension Period|Lack of Efficacy|9|||
144294175|NCT03715829|520280471|FG008|Extension Period|Lack of Efficacy|2|||
144294176|NCT03715829|520280472|FG009|Extension Period|Lack of Efficacy|0|||
144294177|NCT03715829|520280473|FG010|Extension Period|Lack of Efficacy|0|||
144294178|NCT03715829|520280463|FG000|Extension Period|Lost to Follow-up|0|||
144294179|NCT03715829|520280464|FG001|Extension Period|Lost to Follow-up|0|||
144294180|NCT03715829|520280465|FG002|Extension Period|Lost to Follow-up|0|||
144294181|NCT03715829|520280466|FG003|Extension Period|Lost to Follow-up|0|||
144294182|NCT03715829|520280467|FG004|Extension Period|Lost to Follow-up|0|||
144294183|NCT03715829|520280468|FG005|Extension Period|Lost to Follow-up|0|||
144294184|NCT03715829|520280469|FG006|Extension Period|Lost to Follow-up|0|||
144294185|NCT03715829|520280470|FG007|Extension Period|Lost to Follow-up|0|||
144294186|NCT03715829|520280471|FG008|Extension Period|Lost to Follow-up|2|||
144294187|NCT03715829|520280472|FG009|Extension Period|Lost to Follow-up|0|||
144294188|NCT03715829|520280473|FG010|Extension Period|Lost to Follow-up|0|||
144294189|NCT03715829|520280463|FG000|Extension Period|Protocol Violation|0|||
144294190|NCT03715829|520280464|FG001|Extension Period|Protocol Violation|0|||
144294191|NCT03715829|520280465|FG002|Extension Period|Protocol Violation|0|||
144294192|NCT03715829|520280466|FG003|Extension Period|Protocol Violation|0|||
144294193|NCT03715829|520280467|FG004|Extension Period|Protocol Violation|0|||
144294194|NCT03715829|520280468|FG005|Extension Period|Protocol Violation|0|||
144294195|NCT03715829|520280469|FG006|Extension Period|Protocol Violation|0|||
144294196|NCT03715829|520280470|FG007|Extension Period|Protocol Violation|0|||
144294197|NCT03715829|520280471|FG008|Extension Period|Protocol Violation|1|||
144294198|NCT03715829|520280472|FG009|Extension Period|Protocol Violation|0|||
144294199|NCT03715829|520280473|FG010|Extension Period|Protocol Violation|0|||
144294200|NCT03715829|520280463|FG000|Extension Period|Withdrawal by Subject|0|||
144294201|NCT03715829|520280464|FG001|Extension Period|Withdrawal by Subject|0|||
144294202|NCT03715829|520280465|FG002|Extension Period|Withdrawal by Subject|0|||
144294203|NCT03715829|520280466|FG003|Extension Period|Withdrawal by Subject|0|||
144294204|NCT03715829|520280467|FG004|Extension Period|Withdrawal by Subject|0|||
144294205|NCT03715829|520280468|FG005|Extension Period|Withdrawal by Subject|0|||
144294206|NCT03715829|520280469|FG006|Extension Period|Withdrawal by Subject|3|||
144294207|NCT03715829|520280470|FG007|Extension Period|Withdrawal by Subject|3|||
144294208|NCT03715829|520280471|FG008|Extension Period|Withdrawal by Subject|12|||
144294209|NCT03715829|520280472|FG009|Extension Period|Withdrawal by Subject|3|||
144294210|NCT03715829|520280473|FG010|Extension Period|Withdrawal by Subject|0|||
144294211|NCT03715829|520280463|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294212|NCT03715829|520280464|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294213|NCT03715829|520280465|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294214|NCT03715829|520280466|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294215|NCT03715829|520280467|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294216|NCT03715829|520280468|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294217|NCT03715829|520280469|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294218|NCT03715829|520280470|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
144294219|NCT03715829|520280471|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
144294220|NCT03715829|520280472|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294221|NCT03715829|520280473|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
144294222|NCT03715829|520280463|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294223|NCT03715829|520280464|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294224|NCT03715829|520280465|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294225|NCT03715829|520280466|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294226|NCT03715829|520280467|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294227|NCT03715829|520280468|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294228|NCT03715829|520280469|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294229|NCT03715829|520280470|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294230|NCT03715829|520280471|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
144294231|NCT03715829|520280472|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294232|NCT03715829|520280473|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
144294233|NCT03715829|520280463|FG000|Extension Period|Other|0|||
144294234|NCT03715829|520280464|FG001|Extension Period|Other|0|||
144294235|NCT03715829|520280465|FG002|Extension Period|Other|0|||
144294236|NCT03715829|520280466|FG003|Extension Period|Other|0|||
144294237|NCT03715829|520280467|FG004|Extension Period|Other|0|||
144294238|NCT03715829|520280468|FG005|Extension Period|Other|0|||
144294239|NCT03715829|520280469|FG006|Extension Period|Other|1|||
144294240|NCT03715829|520280470|FG007|Extension Period|Other|2|||
144294241|NCT03715829|520280471|FG008|Extension Period|Other|4|||
144294242|NCT03715829|520280472|FG009|Extension Period|Other|0|||
144294243|NCT03715829|520280473|FG010|Extension Period|Other|0|||
144294244|NCT01443026|520280474|FG000|Overall Study|Physician Decision|1|||
144294245|NCT01443026|520280475|FG001|Overall Study|Physician Decision|0|||
144294246|NCT01443026|520280474|FG000|Overall Study|Death|0|||
144294247|NCT01443026|520280475|FG001|Overall Study|Death|1|||
144294248|NCT01443026|520280474|FG000|Overall Study|Withdrawal by Subject|0|||
144294249|NCT01443026|520280475|FG001|Overall Study|Withdrawal by Subject|3|||
144294250|NCT01443026|520280474|FG000|Overall Study|Lost to Follow-up|2|||
144294251|NCT01443026|520280475|FG001|Overall Study|Lost to Follow-up|1|||
144294252|NCT02034565|520280476|FG000|Overall Study|Adverse Event|1|||
144294253|NCT02034565|520280477|FG001|Overall Study|Adverse Event|0|||
144294254|NCT00581919|520280478|FG000|Overall Study|Adverse Event|8|||
144294255|NCT00581919|520280478|FG000|Overall Study|Death|1|||
144294256|NCT00581919|520280478|FG000|Overall Study|Disease Progression|10|||
144294257|NCT00581919|520280478|FG000|Overall Study|Physician Decision|1|||
144294258|NCT00581919|520280478|FG000|Overall Study|Other Complicating Disease|1|||
144294259|NCT00581919|520280478|FG000|Overall Study|Started Non-Protocol Therapy|2|||
144294260|NCT00581919|520280478|FG000|Overall Study|Withdrawal by Subject|1|||
144294261|NCT01813357|520280480|FG000|Overall Study|Lost to Follow-up|5|||
144294262|NCT01813357|520280481|FG001|Overall Study|Lost to Follow-up|6|||
144294263|NCT03131479|520280482|FG000|Overall Study|Adverse Event|0|||
144294264|NCT03131479|520280483|FG001|Overall Study|Adverse Event|0|||
144294265|NCT03131479|520280484|FG002|Overall Study|Adverse Event|1|||
144294266|NCT03131479|520280485|FG003|Overall Study|Adverse Event|1|||
144294267|NCT03131479|520280486|FG004|Overall Study|Adverse Event|0|||
144294268|NCT03131479|520280482|FG000|Overall Study|Subject/Guardian Decision|0|||
144294269|NCT03131479|520280483|FG001|Overall Study|Subject/Guardian Decision|0|||
144294270|NCT03131479|520280484|FG002|Overall Study|Subject/Guardian Decision|0|||
144294271|NCT03131479|520280485|FG003|Overall Study|Subject/Guardian Decision|1|||
144294272|NCT03131479|520280486|FG004|Overall Study|Subject/Guardian Decision|0|||
144294273|NCT01272219|520280487|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
144294274|NCT01272219|520280488|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
144294275|NCT01272219|520280489|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
144294276|NCT01272219|520280490|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
144294277|NCT01272219|520280491|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
144294278|NCT01272219|520280492|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
144294279|NCT01272219|520280487|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
144294280|NCT01272219|520280488|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
144700062|NCT05182840|521754492|FG005|Treatment Period|Adverse Event|6|||
144700063|NCT05182840|521754493|FG006|Treatment Period|Adverse Event|4|||
144700064|NCT05182840|521754494|FG007|Treatment Period|Adverse Event|8|||
144700065|NCT05182840|521754495|FG008|Treatment Period|Adverse Event|16|||
144700066|NCT05182840|521754496|FG009|Treatment Period|Adverse Event|5|||
144700067|NCT05182840|521754487|FG000|Treatment Period|Not treated with study drug|0|||
144700068|NCT05182840|521754488|FG001|Treatment Period|Not treated with study drug|0|||
144700069|NCT05182840|521754489|FG002|Treatment Period|Not treated with study drug|0|||
144700070|NCT05182840|521754490|FG003|Treatment Period|Not treated with study drug|1|||
144700071|NCT05182840|521754491|FG004|Treatment Period|Not treated with study drug|0|||
144700072|NCT05182840|521754492|FG005|Treatment Period|Not treated with study drug|0|||
144700073|NCT05182840|521754493|FG006|Treatment Period|Not treated with study drug|1|||
144700074|NCT05182840|521754494|FG007|Treatment Period|Not treated with study drug|1|||
144700075|NCT05182840|521754495|FG008|Treatment Period|Not treated with study drug|0|||
144700076|NCT05182840|521754496|FG009|Treatment Period|Not treated with study drug|0|||
144700077|NCT02161380|521754497|FG000|Overall Study|Lost to Follow-up|0|||
144294281|NCT01272219|520280489|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
144294282|NCT01272219|520280490|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
144294283|NCT01272219|520280491|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
144294284|NCT01272219|520280492|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
144294285|NCT01272219|520280487|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
144294286|NCT01272219|520280488|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
144294287|NCT01272219|520280489|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
144294288|NCT01272219|520280490|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
144294289|NCT01272219|520280491|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
144294290|NCT01272219|520280492|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
144294291|NCT01272219|520280487|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
144294292|NCT01272219|520280488|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
144294293|NCT01272219|520280489|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
144294294|NCT01272219|520280490|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
144294295|NCT01272219|520280491|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
144294296|NCT01272219|520280492|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
144294297|NCT01272219|520280487|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
144294298|NCT01272219|520280488|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
144294299|NCT01272219|520280489|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
144294300|NCT01272219|520280490|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
144294301|NCT01272219|520280491|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
144294302|NCT01272219|520280492|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
144294303|NCT01272219|520280487|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
144294304|NCT01272219|520280488|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
144294305|NCT01272219|520280489|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
144294306|NCT01272219|520280490|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
144294307|NCT01272219|520280491|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
144294308|NCT01272219|520280492|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
144294309|NCT01272219|520280487|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
144294310|NCT01272219|520280488|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
144294311|NCT01272219|520280489|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
144294312|NCT01272219|520280490|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
144294313|NCT01272219|520280491|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
144294314|NCT01272219|520280492|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
144294315|NCT01272219|520280487|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
144294316|NCT01272219|520280488|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
144294317|NCT01272219|520280489|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
144294318|NCT01272219|520280490|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
144294319|NCT01272219|520280491|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
144294320|NCT01272219|520280492|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
144294321|NCT01272219|520280487|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
144294322|NCT01272219|520280488|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
144294323|NCT01272219|520280489|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
144294324|NCT01272219|520280490|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
144294325|NCT01272219|520280491|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
144294326|NCT01272219|520280492|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
144294327|NCT01272219|520280487|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
144294328|NCT01272219|520280488|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
144294329|NCT01272219|520280489|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
144294330|NCT01272219|520280490|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
144294331|NCT01272219|520280491|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
144294332|NCT01272219|520280492|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
144294333|NCT01272219|520280487|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
144294334|NCT01272219|520280488|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
144294335|NCT01272219|520280489|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
144294336|NCT01272219|520280490|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
144294337|NCT01272219|520280491|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
144294338|NCT01272219|520280492|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
144294339|NCT01272219|520280487|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
144294340|NCT01272219|520280488|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
144294341|NCT01272219|520280489|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
144294342|NCT01272219|520280490|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
144294343|NCT01272219|520280491|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
144294344|NCT01272219|520280492|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
144294345|NCT01272219|520280487|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
144294346|NCT01272219|520280488|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
144294347|NCT01272219|520280489|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
144294348|NCT01272219|520280490|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
144294349|NCT01272219|520280491|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
144294350|NCT01272219|520280492|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
144294351|NCT01272219|520280487|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
144294352|NCT01272219|520280488|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
144294353|NCT01272219|520280489|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
144294354|NCT01272219|520280490|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
144294355|NCT01272219|520280491|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
144294356|NCT01272219|520280492|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
144294357|NCT01272219|520280487|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
144294358|NCT01272219|520280488|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
144294359|NCT01272219|520280489|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
144294360|NCT01272219|520280490|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
144294361|NCT01272219|520280491|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
144294362|NCT01272219|520280492|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
144294363|NCT01272219|520280487|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
144294364|NCT01272219|520280488|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
144294365|NCT01272219|520280489|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
144294366|NCT01272219|520280490|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
144294367|NCT01272219|520280491|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
144294368|NCT01272219|520280492|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
144294369|NCT01491919|520280493|FG000|Overall Study|Insufficient PK sampling|1|||
144294370|NCT01491919|520280494|FG001|Overall Study|Insufficient PK sampling|2|||
144294371|NCT01491919|520280495|FG002|Overall Study|Insufficient PK sampling|1|||
144294372|NCT04806373|520280501|FG000|Overall Study|Withdrawal by Subject|1|||
144294373|NCT04806373|520280502|FG001|Overall Study|Withdrawal by Subject|1|||
144294374|NCT05810597|520280503|FG000|Period 1|Adverse Event|2|||
144294375|NCT05810597|520280504|FG001|Period 1|Adverse Event|0|||
144294376|NCT05810597|520280503|FG000|Period 1|Physician Decision|1|||
144294377|NCT05810597|520280504|FG001|Period 1|Physician Decision|0|||
144294378|NCT02061085|520280509|FG000|Overall Study|Adverse Event|8|||
144294379|NCT04903093|520280510|FG000|Overall Study|Withdrawal by Subject|0|||
144294380|NCT04903093|520280511|FG001|Overall Study|Withdrawal by Subject|0|||
144294381|NCT04903093|520280512|FG002|Overall Study|Withdrawal by Subject|0|||
144294382|NCT04903093|520280513|FG003|Overall Study|Withdrawal by Subject|1|||
144294383|NCT04903093|520280514|FG004|Overall Study|Withdrawal by Subject|0|||
144294384|NCT04903093|520280515|FG005|Overall Study|Withdrawal by Subject|0|||
144294385|NCT02412436|520280525|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
144294386|NCT02412436|520280525|FG000|Overall Study|Lost to Follow-up|6|||
144294387|NCT02412436|520280525|FG000|Overall Study|Unable to get to clinic|3|||
144294388|NCT02412436|520280525|FG000|Overall Study|Death|1|||
144294389|NCT02412436|520280525|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
144294390|NCT00392288|520280526|FG000|Overall Study|Adverse Event|17|||
144294391|NCT00392288|520280527|FG001|Overall Study|Adverse Event|7|||
144294392|NCT00392288|520280528|FG002|Overall Study|Adverse Event|8|||
144294393|NCT00392288|520280526|FG000|Overall Study|Lack of Efficacy|8|||
144294394|NCT00392288|520280527|FG001|Overall Study|Lack of Efficacy|5|||
144294395|NCT00392288|520280528|FG002|Overall Study|Lack of Efficacy|3|||
144294396|NCT00392288|520280526|FG000|Overall Study|Protocol Violation|1|||
144294397|NCT00392288|520280527|FG001|Overall Study|Protocol Violation|3|||
144294398|NCT00392288|520280528|FG002|Overall Study|Protocol Violation|1|||
144294399|NCT00392288|520280526|FG000|Overall Study|Lost to Follow-up|1|||
144294400|NCT00392288|520280527|FG001|Overall Study|Lost to Follow-up|1|||
144294401|NCT00392288|520280528|FG002|Overall Study|Lost to Follow-up|1|||
144294402|NCT00392288|520280526|FG000|Overall Study|Withdrawal by Subject|1|||
144294403|NCT00392288|520280527|FG001|Overall Study|Withdrawal by Subject|0|||
144294404|NCT00392288|520280528|FG002|Overall Study|Withdrawal by Subject|2|||
144294405|NCT00392288|520280526|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
144294406|NCT00392288|520280527|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
144294407|NCT00392288|520280528|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
144294408|NCT00392288|520280526|FG000|Overall Study|Other|3|||
144294409|NCT00392288|520280527|FG001|Overall Study|Other|4|||
144294410|NCT00392288|520280528|FG002|Overall Study|Other|1|||
144294411|NCT02544763|520280529|FG000|Overall Study|Adverse Event|8|||
144294412|NCT02544763|520280530|FG001|Overall Study|Adverse Event|8|||
144294413|NCT02544763|520280531|FG002|Overall Study|Adverse Event|0|||
144294414|NCT02544763|520280529|FG000|Overall Study|Withdrawn by parent/guardian|1|||
144294415|NCT02544763|520280530|FG001|Overall Study|Withdrawn by parent/guardian|1|||
144294416|NCT02544763|520280531|FG002|Overall Study|Withdrawn by parent/guardian|1|||
144294417|NCT02544763|520280529|FG000|Overall Study|Met withdrawal criteria|0|||
144294418|NCT02544763|520280530|FG001|Overall Study|Met withdrawal criteria|2|||
144294419|NCT02544763|520280531|FG002|Overall Study|Met withdrawal criteria|0|||
144294420|NCT02544763|520280529|FG000|Overall Study|Physician Decision|0|||
144294421|NCT02544763|520280530|FG001|Overall Study|Physician Decision|1|||
144294422|NCT02544763|520280531|FG002|Overall Study|Physician Decision|0|||
144294423|NCT02544763|520280529|FG000|Overall Study|Difficulties taking IMP|1|||
144294424|NCT02544763|520280530|FG001|Overall Study|Difficulties taking IMP|0|||
144294425|NCT02544763|520280531|FG002|Overall Study|Difficulties taking IMP|0|||
144294426|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
144294427|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144294428|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144294429|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144294430|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
144294431|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
144294432|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144294433|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144294434|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144294435|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
144294436|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
144294437|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144294438|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144294439|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144294440|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
144294441|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
144294442|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
144294443|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
144294444|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
144294445|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
144294446|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
144294447|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
144294448|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
144294449|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
144294450|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
144294451|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
144294452|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
144294453|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
144294454|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
144294455|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
144294456|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
144294457|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144294458|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144294459|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144294460|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
144294461|NCT01111552|520280532|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
144294462|NCT01111552|520280533|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
144294463|NCT01111552|520280534|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
144294464|NCT01111552|520280535|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
144294465|NCT01111552|520280536|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
144294466|NCT01111552|520280532|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144294467|NCT01111552|520280533|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144294468|NCT01111552|520280534|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144294469|NCT01111552|520280535|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
144294470|NCT01111552|520280536|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
144294471|NCT01111552|520280532|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
144294472|NCT01111552|520280533|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
144294473|NCT01111552|520280534|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
144294474|NCT01111552|520280535|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
144294475|NCT01111552|520280536|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
144294476|NCT01111552|520280532|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
144294477|NCT01111552|520280533|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
144294478|NCT01111552|520280534|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
144294479|NCT01111552|520280535|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
144294480|NCT01111552|520280536|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
144294481|NCT01111552|520280532|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
144294482|NCT01111552|520280533|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
144294483|NCT01111552|520280534|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
144294484|NCT01111552|520280535|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
144294485|NCT01111552|520280536|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
144294486|NCT01111552|520280532|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
144294487|NCT01111552|520280533|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
144294488|NCT01111552|520280534|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
144294489|NCT01111552|520280535|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
144294490|NCT01111552|520280536|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
144294491|NCT01111552|520280532|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144294492|NCT01111552|520280533|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144294493|NCT01111552|520280534|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
144294494|NCT01111552|520280535|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144294495|NCT01111552|520280536|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
144294496|NCT01027351|520280538|FG000|Overall Study|Withdrawal by Subject|1|||
144294497|NCT01027351|520280539|FG001|Overall Study|Withdrawal by Subject|0|||
144294498|NCT01027351|520280540|FG002|Overall Study|Withdrawal by Subject|1|||
144294499|NCT01027351|520280541|FG003|Overall Study|Withdrawal by Subject|0|||
144294500|NCT01027351|520280542|FG004|Overall Study|Withdrawal by Subject|3|||
144294501|NCT01027351|520280543|FG005|Overall Study|Withdrawal by Subject|5|||
144294502|NCT01027351|520280538|FG000|Overall Study|Lost to Follow-up|1|||
144294503|NCT01027351|520280539|FG001|Overall Study|Lost to Follow-up|1|||
144294504|NCT01027351|520280540|FG002|Overall Study|Lost to Follow-up|0|||
144294505|NCT01027351|520280541|FG003|Overall Study|Lost to Follow-up|1|||
144294506|NCT01027351|520280542|FG004|Overall Study|Lost to Follow-up|6|||
144294507|NCT01027351|520280543|FG005|Overall Study|Lost to Follow-up|0|||
144294508|NCT01027351|520280538|FG000|Overall Study|Inappropriate enrollment|0|||
144294509|NCT01027351|520280539|FG001|Overall Study|Inappropriate enrollment|0|||
144294510|NCT01027351|520280540|FG002|Overall Study|Inappropriate enrollment|0|||
144294511|NCT01027351|520280541|FG003|Overall Study|Inappropriate enrollment|0|||
144294512|NCT01027351|520280542|FG004|Overall Study|Inappropriate enrollment|1|||
144294513|NCT01027351|520280543|FG005|Overall Study|Inappropriate enrollment|0|||
144294514|NCT01027351|520280538|FG000|Overall Study|Protocol Violation|1|||
144294515|NCT01027351|520280539|FG001|Overall Study|Protocol Violation|0|||
144294516|NCT01027351|520280540|FG002|Overall Study|Protocol Violation|0|||
144294517|NCT01027351|520280541|FG003|Overall Study|Protocol Violation|1|||
144294518|NCT01027351|520280542|FG004|Overall Study|Protocol Violation|1|||
144294519|NCT01027351|520280543|FG005|Overall Study|Protocol Violation|0|||
144294520|NCT04650893|520280544|FG000|Overall Study|Lost to Follow-up|11|||
144294521|NCT04650893|520280545|FG001|Overall Study|Lost to Follow-up|10|||
144294522|NCT04650893|520280546|FG002|Overall Study|Lost to Follow-up|11|||
144294523|NCT02657356|520281954|FG000|Overall Study|Death|1|||
144294524|NCT02657356|520281955|FG001|Overall Study|Death|0|||
144294525|NCT02657356|520281954|FG000|Overall Study|Withdrawal by Subject|5|||
144294526|NCT02657356|520281955|FG001|Overall Study|Withdrawal by Subject|6|||
144294527|NCT02657356|520281954|FG000|Overall Study|Terminated by Sponsor|8|||
144294528|NCT02657356|520281955|FG001|Overall Study|Terminated by Sponsor|5|||
144294529|NCT02657356|520281954|FG000|Overall Study|Rolled over to EAP study|6|||
144294530|NCT02657356|520281955|FG001|Overall Study|Rolled over to EAP study|4|||
144294531|NCT05654181|520281956|FG000|Overall Study|Adverse Event|1|||
144294532|NCT05654181|520281957|FG001|Overall Study|Adverse Event|0|||
144294533|NCT05654181|520281958|FG002|Overall Study|Adverse Event|0|||
144294534|NCT05654181|520281959|FG003|Overall Study|Adverse Event|0|||
144294535|NCT05654181|520281960|FG004|Overall Study|Adverse Event|0|||
144294536|NCT05654181|520281961|FG005|Overall Study|Adverse Event|0|||
144294537|NCT05654181|520281962|FG006|Overall Study|Adverse Event|0|||
144294538|NCT05654181|520281963|FG007|Overall Study|Adverse Event|1|||
144294539|NCT05654181|520281964|FG008|Overall Study|Adverse Event|0|||
144294540|NCT05654181|520281965|FG009|Overall Study|Adverse Event|0|||
144294541|NCT05654181|520281956|FG000|Overall Study|Withdrawal by Subject|0|||
144294542|NCT05654181|520281957|FG001|Overall Study|Withdrawal by Subject|0|||
144294543|NCT05654181|520281958|FG002|Overall Study|Withdrawal by Subject|0|||
144294544|NCT05654181|520281959|FG003|Overall Study|Withdrawal by Subject|0|||
144294545|NCT05654181|520281960|FG004|Overall Study|Withdrawal by Subject|0|||
144294546|NCT05654181|520281961|FG005|Overall Study|Withdrawal by Subject|0|||
144294547|NCT05654181|520281962|FG006|Overall Study|Withdrawal by Subject|0|||
144294548|NCT05654181|520281963|FG007|Overall Study|Withdrawal by Subject|1|||
144294549|NCT05654181|520281964|FG008|Overall Study|Withdrawal by Subject|0|||
144294550|NCT05654181|520281965|FG009|Overall Study|Withdrawal by Subject|0|||
144294551|NCT05654181|520281956|FG000|Overall Study|Other|0|||
144294552|NCT05654181|520281957|FG001|Overall Study|Other|0|||
144294553|NCT05654181|520281958|FG002|Overall Study|Other|0|||
144294554|NCT05654181|520281959|FG003|Overall Study|Other|0|||
144294555|NCT05654181|520281960|FG004|Overall Study|Other|1|||
144294556|NCT05654181|520281961|FG005|Overall Study|Other|1|||
144294557|NCT05654181|520281962|FG006|Overall Study|Other|0|||
144294558|NCT05654181|520281963|FG007|Overall Study|Other|0|||
144294559|NCT05654181|520281964|FG008|Overall Study|Other|0|||
144294560|NCT05654181|520281965|FG009|Overall Study|Other|0|||
144294561|NCT04101331|520281966|FG000|Overall Study|Adverse Event|9|||
144294562|NCT04101331|520281966|FG000|Overall Study|Disease progression|82|||
144294563|NCT04101331|520281966|FG000|Overall Study|Withdrawal by Subject|1|||
144294564|NCT04101331|520281966|FG000|Overall Study|Investigator decision|6|||
144294565|NCT04101331|520281966|FG000|Overall Study|Death|6|||
144294566|NCT04101331|520281966|FG000|Overall Study|Allogenic transplant|1|||
144294567|NCT02489279|520281967|FG000|Overall Study|Lost to Follow-up|12|||
144294568|NCT02489279|520281968|FG001|Overall Study|Lost to Follow-up|10|||
144294569|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
144294570|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
144294571|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
144294572|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
144294573|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
144294574|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
144294575|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
144294576|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
144294577|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
144294578|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
144294579|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
144294580|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
144294581|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
144294582|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
144294583|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
144294584|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
144294585|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
144294586|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
144294587|NCT01432444|520281969|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
144294588|NCT01432444|520281970|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
144294589|NCT01432444|520281971|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
144294590|NCT01432444|520281969|FG000|Treatment Phase|Lost to Follow-up|0|||
144294591|NCT01432444|520281970|FG001|Treatment Phase|Lost to Follow-up|33|||
144294592|NCT01432444|520281971|FG002|Treatment Phase|Lost to Follow-up|0|||
144294593|NCT01432444|520281969|FG000|Treatment Phase|Adverse Event|0|||
144294594|NCT01432444|520281970|FG001|Treatment Phase|Adverse Event|37|||
144294595|NCT01432444|520281971|FG002|Treatment Phase|Adverse Event|0|||
144294596|NCT01432444|520281969|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
144294597|NCT01432444|520281970|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
144294598|NCT01432444|520281971|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
144294599|NCT01432444|520281969|FG000|Treatment Phase|Physician Decision|0|||
144294600|NCT01432444|520281970|FG001|Treatment Phase|Physician Decision|5|||
144294601|NCT01432444|520281971|FG002|Treatment Phase|Physician Decision|0|||
144294602|NCT01432444|520281969|FG000|Treatment Phase|Withdrawal by Subject|0|||
144294603|NCT01432444|520281970|FG001|Treatment Phase|Withdrawal by Subject|41|||
144294604|NCT01432444|520281971|FG002|Treatment Phase|Withdrawal by Subject|0|||
144294605|NCT01432444|520281969|FG000|Treatment Phase|Protocol Deviation|0|||
144294606|NCT01432444|520281970|FG001|Treatment Phase|Protocol Deviation|3|||
144294607|NCT01432444|520281971|FG002|Treatment Phase|Protocol Deviation|0|||
144294608|NCT01432444|520281969|FG000|Treatment Phase|Lack of Efficacy|0|||
144294609|NCT01432444|520281970|FG001|Treatment Phase|Lack of Efficacy|10|||
144294610|NCT01432444|520281971|FG002|Treatment Phase|Lack of Efficacy|0|||
144294611|NCT01432444|520281969|FG000|Extension Phase|Lost to Follow-up|0|||
144294612|NCT01432444|520281970|FG001|Extension Phase|Lost to Follow-up|0|||
144294613|NCT01432444|520281971|FG002|Extension Phase|Lost to Follow-up|17|||
144294614|NCT01432444|520281969|FG000|Extension Phase|Adverse Event|0|||
144294615|NCT01432444|520281970|FG001|Extension Phase|Adverse Event|0|||
144294616|NCT01432444|520281971|FG002|Extension Phase|Adverse Event|10|||
144294617|NCT01432444|520281969|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
144294618|NCT01432444|520281970|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
144294619|NCT01432444|520281971|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
144294620|NCT01432444|520281969|FG000|Extension Phase|Met Withdrawal Criteria|0|||
144294621|NCT01432444|520281970|FG001|Extension Phase|Met Withdrawal Criteria|0|||
144294622|NCT01432444|520281971|FG002|Extension Phase|Met Withdrawal Criteria|144|||
144294623|NCT01432444|520281969|FG000|Extension Phase|Physician Decision|0|||
144294624|NCT01432444|520281970|FG001|Extension Phase|Physician Decision|0|||
144294625|NCT01432444|520281971|FG002|Extension Phase|Physician Decision|1|||
144294626|NCT01432444|520281969|FG000|Extension Phase|Withdrawal by Subject|0|||
144294627|NCT01432444|520281970|FG001|Extension Phase|Withdrawal by Subject|0|||
144294628|NCT01432444|520281971|FG002|Extension Phase|Withdrawal by Subject|13|||
144294629|NCT03283241|520281972|FG000|Overall Study|Adverse Event|4|||
144294630|NCT03283241|520281973|FG001|Overall Study|Adverse Event|1|||
144294631|NCT03283241|520281972|FG000|Overall Study|Withdrawal by Subject|0|||
144294632|NCT03283241|520281973|FG001|Overall Study|Withdrawal by Subject|1|||
144294633|NCT03283241|520281972|FG000|Overall Study|Subject relocated to Finland|0|||
144294634|NCT03283241|520281973|FG001|Overall Study|Subject relocated to Finland|1|||
144294635|NCT00666263|520281976|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
144294636|NCT00666263|520281977|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
144294637|NCT00666263|520281976|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
144294638|NCT00666263|520281977|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
144294639|NCT00666263|520281976|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
144294640|NCT00666263|520281977|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
144294641|NCT00586157|520281978|FG000|First Intervention|Worsening behavior|1|||
144294642|NCT00586157|520281979|FG001|First Intervention|Worsening behavior|0|||
144294643|NCT00586157|520281978|FG000|Second Intervention|Withdrawal by Subject|1|||
144294644|NCT00586157|520281979|FG001|Second Intervention|Withdrawal by Subject|0|||
144294645|NCT00586157|520281978|FG000|Second Intervention|Worsening behavior|1|||
144294646|NCT00586157|520281979|FG001|Second Intervention|Worsening behavior|0|||
144294647|NCT00586157|520281978|FG000|Second Intervention|Adverse Event|0|||
144294648|NCT00586157|520281979|FG001|Second Intervention|Adverse Event|1|||
144294649|NCT02014467|520281981|FG000|Overall Study|Adverse Event|4|||
144294650|NCT02014467|520281982|FG001|Overall Study|Adverse Event|0|||
144294651|NCT02014467|520281981|FG000|Overall Study|Protocol Violation|3|||
144294652|NCT02014467|520281982|FG001|Overall Study|Protocol Violation|0|||
144294653|NCT02014467|520281981|FG000|Overall Study|Physician Decision|2|||
144294654|NCT02014467|520281982|FG001|Overall Study|Physician Decision|3|||
144294655|NCT02014467|520281981|FG000|Overall Study|Withdrawal by Subject|16|||
144294656|NCT02014467|520281982|FG001|Overall Study|Withdrawal by Subject|4|||
144294657|NCT03802916|520281983|FG000|Overall Study|Adverse Event|0|||
144294658|NCT03802916|520281984|FG001|Overall Study|Adverse Event|1|||
144294659|NCT03802916|520281983|FG000|Overall Study|Withdrawal by Subject|0|||
144294660|NCT03802916|520281984|FG001|Overall Study|Withdrawal by Subject|1|||
144294661|NCT00480532|520281985|FG000|Overall Study|Withdrawal by Subject|2|||
144294662|NCT00480532|520281986|FG001|Overall Study|Withdrawal by Subject|4|||
144294663|NCT00480532|520281987|FG002|Overall Study|Withdrawal by Subject|3|||
144294664|NCT00480532|520281988|FG003|Overall Study|Withdrawal by Subject|1|||
144294665|NCT00480532|520281985|FG000|Overall Study|Protocol Violation|0|||
144294666|NCT00480532|520281986|FG001|Overall Study|Protocol Violation|0|||
144294667|NCT00480532|520281987|FG002|Overall Study|Protocol Violation|1|||
144294668|NCT00480532|520281988|FG003|Overall Study|Protocol Violation|0|||
144294669|NCT01817777|520281989|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
144294670|NCT01817777|520281990|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
144294671|NCT01817777|520281991|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
144294672|NCT01817777|520281989|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
144294673|NCT01817777|520281990|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
144294674|NCT01817777|520281991|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
144294675|NCT01817777|520281989|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
144294676|NCT01817777|520281990|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
144294677|NCT01817777|520281991|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
144294678|NCT01817777|520281989|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
144294679|NCT01817777|520281990|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
144294680|NCT01817777|520281991|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
144294681|NCT01817777|520281989|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
144294682|NCT01817777|520281990|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
144294683|NCT01817777|520281991|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
144294684|NCT03242434|520281992|FG000|Overall Study|Death|0|||
144294685|NCT03242434|520281993|FG001|Overall Study|Death|2|||
144294686|NCT01592747|520281994|FG000|Overall Study|Loss of Therapeutic Response|107|||
144294687|NCT01592747|520281995|FG001|Overall Study|Loss of Therapeutic Response|108|||
144294688|NCT01592747|520281996|FG002|Overall Study|Loss of Therapeutic Response|100|||
144294689|NCT01592747|520281994|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
144294690|NCT01592747|520281995|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
144294691|NCT01592747|520281996|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
144294692|NCT01592747|520281994|FG000|Overall Study|Adverse Event|1|||
144294693|NCT01592747|520281995|FG001|Overall Study|Adverse Event|0|||
144294694|NCT01592747|520281996|FG002|Overall Study|Adverse Event|0|||
144294695|NCT01592747|520281994|FG000|Overall Study|Protocol Violation|4|||
144294696|NCT01592747|520281995|FG001|Overall Study|Protocol Violation|0|||
144294697|NCT01592747|520281996|FG002|Overall Study|Protocol Violation|4|||
144294698|NCT01592747|520281994|FG000|Overall Study|Lack of Efficacy|0|||
144294699|NCT01592747|520281995|FG001|Overall Study|Lack of Efficacy|1|||
144294700|NCT01592747|520281996|FG002|Overall Study|Lack of Efficacy|0|||
144294701|NCT01592747|520281994|FG000|Overall Study|Withdrawal by Subject|2|||
144294702|NCT01592747|520281995|FG001|Overall Study|Withdrawal by Subject|0|||
144294703|NCT01592747|520281996|FG002|Overall Study|Withdrawal by Subject|2|||
144294704|NCT01592747|520281994|FG000|Overall Study|Lost to Follow-up|1|||
144294705|NCT01592747|520281995|FG001|Overall Study|Lost to Follow-up|0|||
144294706|NCT01592747|520281996|FG002|Overall Study|Lost to Follow-up|1|||
144294707|NCT01592747|520281994|FG000|Overall Study|Other Reasons|1|||
144294708|NCT01592747|520281995|FG001|Overall Study|Other Reasons|1|||
144294709|NCT01592747|520281996|FG002|Overall Study|Other Reasons|0|||
144294710|NCT02367885|520281997|FG000|Overall Study|Lost to Follow-up|1|||
144294711|NCT02367885|520281998|FG001|Overall Study|Lost to Follow-up|0|||
144294712|NCT02367885|520281999|FG002|Overall Study|Lost to Follow-up|0|||
144294713|NCT02367885|520281997|FG000|Overall Study|Withdrawal by Subject|1|||
144294714|NCT02367885|520281998|FG001|Overall Study|Withdrawal by Subject|0|||
144294715|NCT02367885|520281999|FG002|Overall Study|Withdrawal by Subject|0|||
144294716|NCT00619918|520282003|FG000|Overall Study|Withdrawal by Subject|4|||
144294717|NCT00619918|520282004|FG001|Overall Study|Withdrawal by Subject|3|||
144294718|NCT00619918|520282003|FG000|Overall Study|Physician Decision|2|||
144294719|NCT00619918|520282004|FG001|Overall Study|Physician Decision|4|||
144294720|NCT00619918|520282003|FG000|Overall Study|Transfer to outside facility|3|||
144294721|NCT00619918|520282004|FG001|Overall Study|Transfer to outside facility|3|||
144294722|NCT00619918|520282003|FG000|Overall Study|Left before receiving first dose|7|||
144294723|NCT00619918|520282004|FG001|Overall Study|Left before receiving first dose|6|||
144294724|NCT00619918|520282003|FG000|Overall Study|ICU admission|4|||
144294725|NCT00619918|520282004|FG001|Overall Study|ICU admission|6|||
144294726|NCT05418426|520282005|FG000|Overall Study|Adverse Event|0|||
144294727|NCT05418426|520282006|FG001|Overall Study|Adverse Event|1|||
144294728|NCT05418426|520282007|FG002|Overall Study|Adverse Event|0|||
144294729|NCT05418426|520282005|FG000|Overall Study|Withdrawal by Subject|0|||
144294730|NCT05418426|520282006|FG001|Overall Study|Withdrawal by Subject|1|||
144294731|NCT05418426|520282007|FG002|Overall Study|Withdrawal by Subject|0|||
144294732|NCT05418426|520282005|FG000|Overall Study|Protocol Violation|0|||
144294733|NCT05418426|520282006|FG001|Overall Study|Protocol Violation|0|||
144294734|NCT05418426|520282007|FG002|Overall Study|Protocol Violation|1|||
144294735|NCT03647137|520282010|FG000|Overall Study|Scan Limitation|2|||
144294736|NCT03647137|520282011|FG001|Overall Study|Scan Limitation|1|||
144294737|NCT03647137|520282012|FG002|Overall Study|Scan Limitation|1|||
144294738|NCT03647137|520282013|FG003|Overall Study|Scan Limitation|2|||
144294739|NCT03773562|520282019|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
144294740|NCT03773562|520282019|FG000|Overall Study|Lost to Follow-up|10|||
144294741|NCT03773562|520282019|FG000|Overall Study|Withdrawal by Subject|1|||
144294742|NCT04003389|520282020|FG000|Overall Study|Adverse Event|27|||
144294743|NCT04003389|520282021|FG001|Overall Study|Adverse Event|34|||
144294744|NCT04003389|520282022|FG002|Overall Study|Adverse Event|28|||
144294745|NCT04003389|520282020|FG000|Overall Study|Lost to Follow-up|39|||
144294746|NCT04003389|520282021|FG001|Overall Study|Lost to Follow-up|30|||
144294747|NCT04003389|520282022|FG002|Overall Study|Lost to Follow-up|33|||
144294748|NCT04003389|520282020|FG000|Overall Study|Protocol Violation|1|||
144294749|NCT04003389|520282021|FG001|Overall Study|Protocol Violation|6|||
144294750|NCT04003389|520282022|FG002|Overall Study|Protocol Violation|5|||
144294751|NCT04003389|520282020|FG000|Overall Study|Withdrawal by Subject|119|||
144294752|NCT04003389|520282021|FG001|Overall Study|Withdrawal by Subject|79|||
144294753|NCT04003389|520282022|FG002|Overall Study|Withdrawal by Subject|85|||
144294754|NCT04003389|520282020|FG000|Overall Study|Miscellaneous|14|||
144294755|NCT04003389|520282021|FG001|Overall Study|Miscellaneous|11|||
144294756|NCT04003389|520282022|FG002|Overall Study|Miscellaneous|14|||
144294757|NCT04003389|520282020|FG000|Overall Study|Participant did not receive study drug|1|||
144294758|NCT04003389|520282021|FG001|Overall Study|Participant did not receive study drug|0|||
144294759|NCT04003389|520282022|FG002|Overall Study|Participant did not receive study drug|0|||
144294760|NCT03204812|520282023|FG000|Overall Study|Adverse Event|3|||
144294761|NCT04090749|520282026|FG000|Open Label Pilot|Lost to Follow-up|1|||
144294762|NCT04090749|520282027|FG001|Open Label Pilot|Lost to Follow-up|0|||
144294763|NCT04090749|520282028|FG002|Open Label Pilot|Lost to Follow-up|0|||
144294764|NCT04090749|520282026|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
144294765|NCT04090749|520282027|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
144294766|NCT04090749|520282028|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
144294767|NCT04090749|520282026|FG000|Pilot Trial|Lost to Follow-up|0|||
144294768|NCT04090749|520282027|FG001|Pilot Trial|Lost to Follow-up|1|||
144294769|NCT04090749|520282028|FG002|Pilot Trial|Lost to Follow-up|1|||
144294770|NCT02528305|520282029|FG000|Overall Study|Withdrawal by Subject|1|||
144294771|NCT02528305|520282029|FG000|Overall Study|Adverse Event|1|||
144294772|NCT02528305|520282029|FG000|Overall Study|Physician Decision|1|||
144294773|NCT00421408|520282030|FG000|Overall Study|Lost to Follow-up|30|||
144294774|NCT00421408|520282031|FG001|Overall Study|Lost to Follow-up|20|||
144294775|NCT00421408|520282030|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
144294776|NCT00421408|520282031|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
144294777|NCT00787800|520282034|FG000|Overall Study|Withdrawal by Subject|3|||
144294778|NCT00787800|520282035|FG001|Overall Study|Withdrawal by Subject|5|||
144294779|NCT00787800|520282034|FG000|Overall Study|Death|0|||
144294780|NCT00787800|520282035|FG001|Overall Study|Death|2|||
144294781|NCT04309500|520282039|FG000|Overall Study|Lost to Follow-up|1|||
144294782|NCT04309500|520282040|FG001|Overall Study|Lost to Follow-up|0|||
144294783|NCT04309500|520282041|FG002|Overall Study|Lost to Follow-up|0|||
144294784|NCT04309500|520282042|FG003|Overall Study|Lost to Follow-up|0|||
144294785|NCT00913835|520282044|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
144294786|NCT00913835|520282045|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
144294787|NCT00913835|520282044|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
144294788|NCT00913835|520282045|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
144294789|NCT00913835|520282044|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
144294790|NCT00913835|520282045|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
144294791|NCT00913835|520282044|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
144294792|NCT00913835|520282045|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
144294793|NCT00913835|520282044|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
144294794|NCT00913835|520282045|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
144294795|NCT00773461|520282046|FG000|Overall Study|Adverse Event|1|||
144294796|NCT00773461|520282047|FG001|Overall Study|Adverse Event|3|||
144294797|NCT00773461|520282046|FG000|Overall Study|Withdrawal by Subject|4|||
144294798|NCT00773461|520282047|FG001|Overall Study|Withdrawal by Subject|1|||
144294799|NCT00637156|520282050|FG000|Overall Study|Withdrawal by Subject|0|||
144294800|NCT00637156|520282051|FG001|Overall Study|Withdrawal by Subject|7|||
144294801|NCT00637156|520282050|FG000|Overall Study|Death|0|||
144294802|NCT00637156|520282051|FG001|Overall Study|Death|1|||
144294803|NCT00637156|520282050|FG000|Overall Study|Lost to Follow-up|10|||
144294804|NCT00637156|520282051|FG001|Overall Study|Lost to Follow-up|16|||
144294805|NCT00461812|520282052|FG000|Overall Study|study terminated|10|||
144294806|NCT01308788|520282053|FG000|2-year Treatment|medication change by treating physician|4|||
144294807|NCT01308788|520282054|FG001|2-year Treatment|medication change by treating physician|11|||
144294808|NCT00322218|520282055|FG000|Overall Study|Death|3|||
144294809|NCT00322218|520282056|FG001|Overall Study|Death|6|||
144294810|NCT03193437|520282063|FG000|Overall Study|Adverse Event|4|||
144294811|NCT03193437|520282063|FG000|Overall Study|Withdrawal by Subject|2|||
144294812|NCT03193437|520282063|FG000|Overall Study|Disease Progression|2|||
144294813|NCT02414841|520282066|FG000|Overall Study|Withdrawal by Subject|7|||
144294814|NCT02414841|520282067|FG001|Overall Study|Withdrawal by Subject|5|||
144294815|NCT02414841|520282066|FG000|Overall Study|Lost to Follow-up|13|||
144294816|NCT02414841|520282067|FG001|Overall Study|Lost to Follow-up|6|||
144294817|NCT02414841|520282066|FG000|Overall Study|Death|17|||
144294818|NCT02414841|520282067|FG001|Overall Study|Death|14|||
144294819|NCT02414841|520282066|FG000|Overall Study|Received a Kidney Transplant|13|||
144294820|NCT02414841|520282067|FG001|Overall Study|Received a Kidney Transplant|4|||
144294821|NCT02414841|520282066|FG000|Overall Study|Randomized But Not Treated|6|||
144294822|NCT02414841|520282067|FG001|Overall Study|Randomized But Not Treated|4|||
144294823|NCT03941093|520282077|FG000|Overall Study|Protocol Violation|0|||
144294824|NCT03941093|520282078|FG001|Overall Study|Protocol Violation|1|||
144294825|NCT03941093|520282077|FG000|Overall Study|Withdrawal by Subject|9|||
144294826|NCT03941093|520282078|FG001|Overall Study|Withdrawal by Subject|6|||
144294827|NCT01444781|520283901|FG000|Overall Study|Lost to Follow-up|0|||
144294828|NCT01444781|520283902|FG001|Overall Study|Lost to Follow-up|3|||
144294829|NCT01444781|520283903|FG002|Overall Study|Lost to Follow-up|1|||
144294830|NCT01444781|520283901|FG000|Overall Study|Withdrawal by Subject|3|||
144294831|NCT01444781|520283902|FG001|Overall Study|Withdrawal by Subject|1|||
144294832|NCT01444781|520283903|FG002|Overall Study|Withdrawal by Subject|2|||
144294833|NCT02301897|520283904|FG000|Treatment Course 1|Non-Compliance|0|||
144294834|NCT02301897|520283905|FG001|Treatment Course 1|Non-Compliance|0|||
144294835|NCT02301897|520283906|FG002|Treatment Course 1|Non-Compliance|1|||
144294836|NCT02301897|520283904|FG000|Treatment Course 1|Adverse Event|1|||
144294837|NCT02301897|520283905|FG001|Treatment Course 1|Adverse Event|1|||
144294838|NCT02301897|520283906|FG002|Treatment Course 1|Adverse Event|0|||
144294839|NCT02301897|520283904|FG000|Treatment Course 1|Lost to Follow-up|1|||
144294840|NCT02301897|520283905|FG001|Treatment Course 1|Lost to Follow-up|2|||
144294841|NCT02301897|520283906|FG002|Treatment Course 1|Lost to Follow-up|1|||
144294842|NCT02301897|520283904|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
144294843|NCT02301897|520283905|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
144294844|NCT02301897|520283906|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
144294845|NCT02301897|520283904|FG000|Treatment Course 1|Withdrawal by Subject|0|||
144294846|NCT02301897|520283905|FG001|Treatment Course 1|Withdrawal by Subject|0|||
144294847|NCT02301897|520283906|FG002|Treatment Course 1|Withdrawal by Subject|2|||
144294848|NCT02301897|520283904|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
144294849|NCT02301897|520283905|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
144294850|NCT02301897|520283906|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
144294851|NCT02301897|520283904|FG000|Treatment Course 2|Lost to Follow-up|0|||
144294852|NCT02301897|520283905|FG001|Treatment Course 2|Lost to Follow-up|2|||
144294853|NCT02301897|520283906|FG002|Treatment Course 2|Lost to Follow-up|0|||
144294854|NCT02301897|520283904|FG000|Treatment Course 2|Pregnancy|0|||
144294855|NCT02301897|520283905|FG001|Treatment Course 2|Pregnancy|1|||
144294856|NCT02301897|520283906|FG002|Treatment Course 2|Pregnancy|1|||
144294857|NCT02301897|520283904|FG000|Treatment Course 2|Withdrawal by Subject|0|||
144294858|NCT02301897|520283905|FG001|Treatment Course 2|Withdrawal by Subject|2|||
144294859|NCT02301897|520283906|FG002|Treatment Course 2|Withdrawal by Subject|0|||
144294860|NCT02301897|520283904|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
144294861|NCT02301897|520283905|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
144294862|NCT02301897|520283906|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
144294863|NCT02439957|520283907|FG000|Overall Study|Study Terminated|3|||
144294864|NCT02439957|520283908|FG001|Overall Study|Study Terminated|3|||
144294865|NCT01230060|520283909|FG000|Overall Study|Withdrawal by Subject|1|||
144294866|NCT00831389|520283912|FG000|Overall Study|Withdrawal by Subject|0|||
144294867|NCT00831389|520283913|FG001|Overall Study|Withdrawal by Subject|1|||
144294868|NCT00278161|520283915|FG000|Overall Study|Death|11|||
144294869|NCT00443456|520283916|FG000|Overall Study|Adverse Event|16|||
144294870|NCT00443456|520283916|FG000|Overall Study|Move|1|||
144294871|NCT00443456|520283916|FG000|Overall Study|Withdrawal by Subject|1|||
144294872|NCT02157610|520283917|FG000|Overall Study|Death|4|||
144294873|NCT02157610|520283918|FG001|Overall Study|Death|4|||
144294874|NCT01602484|520283919|FG000|Overall Study|Airway issues unrelated to study|0|||
144294875|NCT01602484|520283920|FG001|Overall Study|Airway issues unrelated to study|1|||
144294876|NCT01378195|520283921|FG000|Overall Study|Lost to Follow-up|29|||
144294877|NCT01378195|520283922|FG001|Overall Study|Lost to Follow-up|18|||
144294878|NCT05763381|520283925|FG000|Overall Study|Lost to Follow-up|2|||
144294879|NCT05763381|520283926|FG001|Overall Study|Lost to Follow-up|3|||
144294880|NCT05763381|520283925|FG000|Overall Study|Withdrawal by Subject|1|||
144294881|NCT05763381|520283926|FG001|Overall Study|Withdrawal by Subject|2|||
144294882|NCT03787615|520283931|FG000|Overall Study|Withdrawal by Subject|2|||
144294883|NCT03787615|520283931|FG000|Overall Study|Lost to Follow-up|2|||
144294884|NCT00605189|520283934|FG000|Overall Study|Adverse Event|1|||
144294885|NCT00605189|520283935|FG001|Overall Study|Adverse Event|0|||
144294886|NCT00605189|520283936|FG002|Overall Study|Adverse Event|0|||
144294887|NCT00605189|520283934|FG000|Overall Study|Other|2|||
144294888|NCT00605189|520283935|FG001|Overall Study|Other|2|||
144294889|NCT00605189|520283936|FG002|Overall Study|Other|0|||
144294890|NCT02697448|520283937|FG000|Overall Study|Protocol Violation|2|||
144294891|NCT02697448|520283938|FG001|Overall Study|Protocol Violation|4|||
144294892|NCT02697448|520283937|FG000|Overall Study|Clinical concerns during ablation|1|||
144294893|NCT02697448|520283938|FG001|Overall Study|Clinical concerns during ablation|1|||
144294894|NCT02697448|520283937|FG000|Overall Study|No data collected|2|||
144294895|NCT02697448|520283938|FG001|Overall Study|No data collected|0|||
144294896|NCT01674062|520283940|FG000|Overall Study|Insufficient Therapeutic Response|56|||
144294897|NCT01674062|520283941|FG001|Overall Study|Insufficient Therapeutic Response|26|||
144294898|NCT01674062|520283940|FG000|Overall Study|Other|8|||
144294899|NCT01674062|520283941|FG001|Overall Study|Other|1|||
144294900|NCT01674062|520283940|FG000|Overall Study|Adverse Event|1|||
144294901|NCT01674062|520283941|FG001|Overall Study|Adverse Event|1|||
144294902|NCT01674062|520283940|FG000|Overall Study|Death|0|||
144294903|NCT01674062|520283941|FG001|Overall Study|Death|1|||
144294904|NCT01674062|520283940|FG000|Overall Study|Programming Error|1|||
144294905|NCT01674062|520283941|FG001|Overall Study|Programming Error|0|||
144294906|NCT04620668|520283942|FG000|Overall Study|Withdrawal by Subject|2|||
144294907|NCT04620668|520283943|FG001|Overall Study|Withdrawal by Subject|0|||
144294908|NCT04620668|520283942|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
144294909|NCT04620668|520283943|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
144294910|NCT04620668|520283942|FG000|Overall Study|Removed before analysis: missing data|2|||
144294911|NCT04620668|520283943|FG001|Overall Study|Removed before analysis: missing data|0|||
144294912|NCT04620668|520283942|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
144294913|NCT04620668|520283943|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
144294914|NCT04620668|520283942|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
144294915|NCT04620668|520283943|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
144294916|NCT03685149|520283944|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
144294917|NCT03685149|520283945|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
144294918|NCT03685149|520283944|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144294919|NCT03685149|520283945|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
144294920|NCT03685149|520283944|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
144294921|NCT03685149|520283945|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
144294922|NCT02655601|520283947|FG000|Overall Study|Adverse Event|0|||
144294923|NCT02655601|520283948|FG001|Overall Study|Adverse Event|0|||
144294924|NCT02655601|520283949|FG002|Overall Study|Adverse Event|0|||
144294925|NCT02655601|520283950|FG003|Overall Study|Adverse Event|1|||
144294926|NCT02655601|520283951|FG004|Overall Study|Adverse Event|1|||
144294927|NCT02655601|520283952|FG005|Overall Study|Adverse Event|0|||
144294928|NCT02655601|520283947|FG000|Overall Study|Physician Decision|0|||
144294929|NCT02655601|520283948|FG001|Overall Study|Physician Decision|0|||
144294930|NCT02655601|520283949|FG002|Overall Study|Physician Decision|0|||
144294931|NCT02655601|520283950|FG003|Overall Study|Physician Decision|0|||
144294932|NCT02655601|520283951|FG004|Overall Study|Physician Decision|1|||
144294933|NCT02655601|520283952|FG005|Overall Study|Physician Decision|1|||
144294934|NCT02655601|520283947|FG000|Overall Study|Withdrawal by Subject|0|||
144294935|NCT02655601|520283948|FG001|Overall Study|Withdrawal by Subject|0|||
144294936|NCT02655601|520283949|FG002|Overall Study|Withdrawal by Subject|0|||
144294937|NCT02655601|520283950|FG003|Overall Study|Withdrawal by Subject|0|||
144294938|NCT02655601|520283951|FG004|Overall Study|Withdrawal by Subject|4|||
144294939|NCT02655601|520283952|FG005|Overall Study|Withdrawal by Subject|8|||
144294940|NCT02655601|520283947|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
144294941|NCT02655601|520283948|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
144294942|NCT02655601|520283949|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
144294943|NCT02655601|520283950|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
144294944|NCT02655601|520283951|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
144294945|NCT02655601|520283952|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
144294946|NCT00829868|520283953|FG000|Washout|Physician Decision|1|||
144294947|NCT00829868|520283954|FG001|Washout|Physician Decision|0|||
144294948|NCT01969409|520283955|FG000|Overall Study|Death|2|||
144294949|NCT01969409|520283956|FG001|Overall Study|Death|2|||
144294950|NCT01969409|520283955|FG000|Overall Study|Transplant|1|||
144294951|NCT01969409|520283956|FG001|Overall Study|Transplant|1|||
144294952|NCT01969409|520283955|FG000|Overall Study|Withdrawal by Subject|0|||
144294953|NCT01969409|520283956|FG001|Overall Study|Withdrawal by Subject|1|||
144294954|NCT02799043|520283957|FG000|Overall Study|Adverse Event|0|||
144294955|NCT02799043|520283958|FG001|Overall Study|Adverse Event|1|||
144294956|NCT02799043|520283957|FG000|Overall Study|Death|1|||
144294957|NCT02799043|520283958|FG001|Overall Study|Death|1|||
144294958|NCT02799043|520283957|FG000|Overall Study|Lost to Follow-up|3|||
144294959|NCT02799043|520283958|FG001|Overall Study|Lost to Follow-up|6|||
144294960|NCT02799043|520283957|FG000|Overall Study|Withdrawal by Subject|4|||
144294961|NCT02799043|520283958|FG001|Overall Study|Withdrawal by Subject|4|||
144294962|NCT02799043|520283957|FG000|Overall Study|Moved to different country|0|||
144294963|NCT02799043|520283958|FG001|Overall Study|Moved to different country|1|||
144294964|NCT02799043|520283957|FG000|Overall Study|Trial Screen Failure|1|||
144294965|NCT02799043|520283958|FG001|Overall Study|Trial Screen Failure|0|||
144294966|NCT02799043|520283957|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
144294967|NCT02799043|520283958|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
144294968|NCT01554904|520283959|FG000|Overall Study|Withdrawal by Subject|3|||
144294969|NCT01554904|520283959|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
144294970|NCT01051661|520283962|FG000|Overall Study|Adverse Event|1|||
144294971|NCT01051661|520283963|FG001|Overall Study|Adverse Event|1|||
144294972|NCT01051661|520283964|FG002|Overall Study|Adverse Event|1|||
144294973|NCT01051661|520283965|FG003|Overall Study|Adverse Event|1|||
144294974|NCT01051661|520283966|FG004|Overall Study|Adverse Event|0|||
144294975|NCT01051661|520283967|FG005|Overall Study|Adverse Event|0|||
144294976|NCT01051661|520283962|FG000|Overall Study|Lost to Follow-up|13|||
144294977|NCT01051661|520283963|FG001|Overall Study|Lost to Follow-up|22|||
144294978|NCT01051661|520283964|FG002|Overall Study|Lost to Follow-up|15|||
144294979|NCT01051661|520283965|FG003|Overall Study|Lost to Follow-up|17|||
144294980|NCT01051661|520283966|FG004|Overall Study|Lost to Follow-up|10|||
144294981|NCT01051661|520283967|FG005|Overall Study|Lost to Follow-up|24|||
144294982|NCT01051661|520283962|FG000|Overall Study|Migrated/moved from study area|1|||
144294983|NCT01051661|520283963|FG001|Overall Study|Migrated/moved from study area|6|||
144294984|NCT01051661|520283964|FG002|Overall Study|Migrated/moved from study area|6|||
144294985|NCT01051661|520283965|FG003|Overall Study|Migrated/moved from study area|8|||
144294986|NCT01051661|520283966|FG004|Overall Study|Migrated/moved from study area|7|||
144294987|NCT01051661|520283967|FG005|Overall Study|Migrated/moved from study area|3|||
144294988|NCT01051661|520283962|FG000|Overall Study|Refused blood sampling|0|||
144294989|NCT01051661|520283963|FG001|Overall Study|Refused blood sampling|0|||
144294990|NCT01051661|520283964|FG002|Overall Study|Refused blood sampling|0|||
144294991|NCT01051661|520283965|FG003|Overall Study|Refused blood sampling|0|||
144294992|NCT01051661|520283966|FG004|Overall Study|Refused blood sampling|0|||
144294993|NCT01051661|520283967|FG005|Overall Study|Refused blood sampling|1|||
144294994|NCT01051661|520283962|FG000|Overall Study|Data not reliable|1|||
144294995|NCT01051661|520283963|FG001|Overall Study|Data not reliable|0|||
144294996|NCT01051661|520283964|FG002|Overall Study|Data not reliable|0|||
144294997|NCT01051661|520283965|FG003|Overall Study|Data not reliable|0|||
144294998|NCT01051661|520283966|FG004|Overall Study|Data not reliable|0|||
144294999|NCT01051661|520283967|FG005|Overall Study|Data not reliable|1|||
144295000|NCT01051661|520283962|FG000|Overall Study|Unable to attend visit(s)|2|||
144295001|NCT01051661|520283963|FG001|Overall Study|Unable to attend visit(s)|4|||
144295002|NCT01051661|520283964|FG002|Overall Study|Unable to attend visit(s)|2|||
144295003|NCT01051661|520283965|FG003|Overall Study|Unable to attend visit(s)|1|||
144295004|NCT01051661|520283966|FG004|Overall Study|Unable to attend visit(s)|3|||
144295005|NCT01051661|520283967|FG005|Overall Study|Unable to attend visit(s)|2|||
144295006|NCT01051661|520283962|FG000|Overall Study|Consent not received from both parents|0|||
144295007|NCT01051661|520283963|FG001|Overall Study|Consent not received from both parents|0|||
144295008|NCT01051661|520283964|FG002|Overall Study|Consent not received from both parents|0|||
144295009|NCT01051661|520283965|FG003|Overall Study|Consent not received from both parents|0|||
144295010|NCT01051661|520283966|FG004|Overall Study|Consent not received from both parents|0|||
144295011|NCT01051661|520283967|FG005|Overall Study|Consent not received from both parents|1|||
144295012|NCT01051661|520283962|FG000|Overall Study|Failure to comply with protocol|0|||
144295013|NCT01051661|520283963|FG001|Overall Study|Failure to comply with protocol|0|||
144295014|NCT01051661|520283964|FG002|Overall Study|Failure to comply with protocol|2|||
144295015|NCT01051661|520283965|FG003|Overall Study|Failure to comply with protocol|0|||
144295016|NCT01051661|520283966|FG004|Overall Study|Failure to comply with protocol|0|||
144295017|NCT01051661|520283967|FG005|Overall Study|Failure to comply with protocol|0|||
144295018|NCT01051661|520283962|FG000|Overall Study|Subject lost legal representation|0|||
144295019|NCT01051661|520283963|FG001|Overall Study|Subject lost legal representation|0|||
144295020|NCT01051661|520283964|FG002|Overall Study|Subject lost legal representation|0|||
144295021|NCT01051661|520283965|FG003|Overall Study|Subject lost legal representation|0|||
144295022|NCT01051661|520283966|FG004|Overall Study|Subject lost legal representation|1|||
144295023|NCT01051661|520283967|FG005|Overall Study|Subject lost legal representation|0|||
144295024|NCT01051661|520283962|FG000|Overall Study|Protocol Violation|0|||
144295025|NCT01051661|520283963|FG001|Overall Study|Protocol Violation|0|||
144295026|NCT01051661|520283964|FG002|Overall Study|Protocol Violation|0|||
144295027|NCT01051661|520283965|FG003|Overall Study|Protocol Violation|1|||
144295028|NCT01051661|520283966|FG004|Overall Study|Protocol Violation|2|||
144295029|NCT01051661|520283967|FG005|Overall Study|Protocol Violation|1|||
144295030|NCT01051661|520283962|FG000|Overall Study|Withdrawal by Subject|16|||
144295031|NCT01051661|520283963|FG001|Overall Study|Withdrawal by Subject|30|||
144295032|NCT01051661|520283964|FG002|Overall Study|Withdrawal by Subject|13|||
144295033|NCT01051661|520283965|FG003|Overall Study|Withdrawal by Subject|28|||
144295034|NCT01051661|520283966|FG004|Overall Study|Withdrawal by Subject|12|||
144295035|NCT01051661|520283967|FG005|Overall Study|Withdrawal by Subject|34|||
144295036|NCT01922895|520283968|FG000|Overall Study|Death|0|||
144295037|NCT01922895|520283969|FG001|Overall Study|Death|1|||
144295038|NCT01922895|520283968|FG000|Overall Study|Withdrawal by Subject|1|||
144295039|NCT01922895|520283969|FG001|Overall Study|Withdrawal by Subject|2|||
144295040|NCT01922895|520283968|FG000|Overall Study|Lost to Follow-up|5|||
144295041|NCT01922895|520283969|FG001|Overall Study|Lost to Follow-up|11|||
144295042|NCT01916226|520283970|FG000|Overall Study|Adverse Event|1|||
144295043|NCT01916226|520283971|FG001|Overall Study|Adverse Event|0|||
144295044|NCT01916226|520283972|FG002|Overall Study|Adverse Event|1|||
144295045|NCT01916226|520283973|FG003|Overall Study|Adverse Event|1|||
144295046|NCT01916226|520283970|FG000|Overall Study|Lack of Efficacy|0|||
144295047|NCT01916226|520283971|FG001|Overall Study|Lack of Efficacy|0|||
144295048|NCT01916226|520283972|FG002|Overall Study|Lack of Efficacy|2|||
144295049|NCT01916226|520283973|FG003|Overall Study|Lack of Efficacy|1|||
144295050|NCT01916226|520283970|FG000|Overall Study|Protocol Violation|0|||
144295051|NCT01916226|520283971|FG001|Overall Study|Protocol Violation|1|||
144295052|NCT01916226|520283972|FG002|Overall Study|Protocol Violation|0|||
144295053|NCT01916226|520283973|FG003|Overall Study|Protocol Violation|1|||
144295054|NCT01916226|520283970|FG000|Overall Study|Physician Decision|0|||
144295055|NCT01916226|520283971|FG001|Overall Study|Physician Decision|0|||
144295056|NCT01916226|520283972|FG002|Overall Study|Physician Decision|0|||
144295057|NCT01916226|520283973|FG003|Overall Study|Physician Decision|1|||
144295058|NCT04079920|520283976|FG000|Overall Study|Adverse event, not related to study drug|2|||
144295059|NCT04079920|520283976|FG000|Overall Study|Adverse event related to study drug|10|||
144295060|NCT04079920|520283976|FG000|Overall Study|Death|2|||
144295061|NCT04079920|520283976|FG000|Overall Study|Lost to Follow-up|22|||
144295062|NCT04079920|520283976|FG000|Overall Study|Physician Decision|1|||
144295063|NCT04079920|520283976|FG000|Overall Study|Withdrawal by Subject|11|||
144295064|NCT00680914|520283979|FG000|Overall Study|Consent withdrawal|6|||
144295065|NCT00680914|520283980|FG001|Overall Study|Consent withdrawal|3|||
144295066|NCT00680914|520283979|FG000|Overall Study|Lost to Follow-up|4|||
144295067|NCT00680914|520283980|FG001|Overall Study|Lost to Follow-up|0|||
144295068|NCT00680914|520283979|FG000|Overall Study|serious adverse event (SAE)|0|||
144295069|NCT00680914|520283980|FG001|Overall Study|serious adverse event (SAE)|1|||
144295070|NCT01848457|520283981|FG000|Overall Study|Death|1|||
144295071|NCT01848457|520283982|FG001|Overall Study|Death|0|||
144295072|NCT01848457|520283983|FG002|Overall Study|Death|0|||
144295073|NCT01848457|520283984|FG003|Overall Study|Death|0|||
144295074|NCT00522379|520283985|FG000|Overall Study|Adverse Event|12|||
144295075|NCT00522379|520283986|FG001|Overall Study|Adverse Event|15|||
144295076|NCT00522379|520283987|FG002|Overall Study|Adverse Event|12|||
144295077|NCT00522379|520283988|FG003|Overall Study|Adverse Event|5|||
144295078|NCT00522379|520283989|FG004|Overall Study|Adverse Event|17|||
144295079|NCT00522379|520283985|FG000|Overall Study|Lack of Efficacy|3|||
144295080|NCT00522379|520283986|FG001|Overall Study|Lack of Efficacy|0|||
144295081|NCT00522379|520283987|FG002|Overall Study|Lack of Efficacy|2|||
144295082|NCT00522379|520283988|FG003|Overall Study|Lack of Efficacy|2|||
144295083|NCT00522379|520283989|FG004|Overall Study|Lack of Efficacy|7|||
144295084|NCT00522379|520283985|FG000|Overall Study|Withdrawal by Subject|2|||
144295085|NCT00522379|520283986|FG001|Overall Study|Withdrawal by Subject|3|||
144295086|NCT00522379|520283987|FG002|Overall Study|Withdrawal by Subject|1|||
144295087|NCT00522379|520283988|FG003|Overall Study|Withdrawal by Subject|2|||
144295088|NCT00522379|520283989|FG004|Overall Study|Withdrawal by Subject|0|||
144295089|NCT00522379|520283985|FG000|Overall Study|Protocol Violation|1|||
144295090|NCT00522379|520283986|FG001|Overall Study|Protocol Violation|1|||
144295091|NCT00522379|520283987|FG002|Overall Study|Protocol Violation|2|||
144295092|NCT00522379|520283988|FG003|Overall Study|Protocol Violation|0|||
144295093|NCT00522379|520283989|FG004|Overall Study|Protocol Violation|0|||
144295094|NCT00522379|520283985|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
144295095|NCT00522379|520283986|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
144295096|NCT00522379|520283987|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
144295097|NCT00522379|520283988|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
144295098|NCT00522379|520283989|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
144295099|NCT00522379|520283985|FG000|Overall Study|Lost to Follow-up|1|||
144295100|NCT00522379|520283986|FG001|Overall Study|Lost to Follow-up|0|||
144295101|NCT00522379|520283987|FG002|Overall Study|Lost to Follow-up|4|||
144295102|NCT00522379|520283988|FG003|Overall Study|Lost to Follow-up|2|||
144295103|NCT00522379|520283989|FG004|Overall Study|Lost to Follow-up|2|||
144295104|NCT00522379|520283985|FG000|Overall Study|Randomization error|0|||
144295105|NCT00522379|520283986|FG001|Overall Study|Randomization error|0|||
144295106|NCT00522379|520283987|FG002|Overall Study|Randomization error|0|||
144295107|NCT00522379|520283988|FG003|Overall Study|Randomization error|0|||
144295108|NCT00522379|520283989|FG004|Overall Study|Randomization error|1|||
144295109|NCT00522379|520283985|FG000|Overall Study|Dispensing error|1|||
144295110|NCT00522379|520283986|FG001|Overall Study|Dispensing error|0|||
144295111|NCT00522379|520283987|FG002|Overall Study|Dispensing error|0|||
144295112|NCT00522379|520283988|FG003|Overall Study|Dispensing error|1|||
144295113|NCT00522379|520283989|FG004|Overall Study|Dispensing error|0|||
144295114|NCT00522379|520283985|FG000|Overall Study|Subject Moved|1|||
144295115|NCT00522379|520283986|FG001|Overall Study|Subject Moved|1|||
144295116|NCT00522379|520283987|FG002|Overall Study|Subject Moved|0|||
144295117|NCT00522379|520283988|FG003|Overall Study|Subject Moved|0|||
144295118|NCT00522379|520283989|FG004|Overall Study|Subject Moved|0|||
144295119|NCT00522379|520283985|FG000|Overall Study|Sponsor Request|0|||
144295120|NCT00522379|520283986|FG001|Overall Study|Sponsor Request|1|||
144295121|NCT00522379|520283987|FG002|Overall Study|Sponsor Request|0|||
144295122|NCT00522379|520283988|FG003|Overall Study|Sponsor Request|0|||
144295123|NCT00522379|520283989|FG004|Overall Study|Sponsor Request|0|||
144295124|NCT00522379|520283985|FG000|Overall Study|Family Problem|0|||
144295125|NCT00522379|520283986|FG001|Overall Study|Family Problem|0|||
144295126|NCT00522379|520283987|FG002|Overall Study|Family Problem|1|||
144295127|NCT00522379|520283988|FG003|Overall Study|Family Problem|0|||
144295128|NCT00522379|520283989|FG004|Overall Study|Family Problem|0|||
144295129|NCT00522379|520283985|FG000|Overall Study|Site Closed|0|||
144295130|NCT00522379|520283986|FG001|Overall Study|Site Closed|0|||
144295131|NCT00522379|520283987|FG002|Overall Study|Site Closed|0|||
144295132|NCT00522379|520283988|FG003|Overall Study|Site Closed|1|||
144295133|NCT00522379|520283989|FG004|Overall Study|Site Closed|0|||
144295134|NCT00522379|520283985|FG000|Overall Study|Subject Withdrawal|0|||
144295135|NCT00522379|520283986|FG001|Overall Study|Subject Withdrawal|0|||
144295136|NCT00522379|520283987|FG002|Overall Study|Subject Withdrawal|0|||
144295137|NCT00522379|520283988|FG003|Overall Study|Subject Withdrawal|1|||
144295138|NCT00522379|520283989|FG004|Overall Study|Subject Withdrawal|0|||
144295139|NCT00967499|520283990|FG000|Overall Study|Adverse Event|0|||
144295140|NCT00967499|520283991|FG001|Overall Study|Adverse Event|1|||
144295141|NCT00967499|520283990|FG000|Overall Study|Protocol Violation|1|||
144295142|NCT00967499|520283991|FG001|Overall Study|Protocol Violation|0|||
144295143|NCT00967499|520283990|FG000|Overall Study|Sponsor Decision|1|||
144295144|NCT00967499|520283991|FG001|Overall Study|Sponsor Decision|0|||
144295145|NCT00967499|520283990|FG000|Overall Study|Randomized but not treated|63|||
144295146|NCT00967499|520283991|FG001|Overall Study|Randomized but not treated|59|||
144295147|NCT02298946|520283995|FG000|Overall Study|Did not receive treatment|2|||
144295148|NCT02298946|520283996|FG001|Overall Study|Did not receive treatment|0|||
144295149|NCT02298946|520283995|FG000|Overall Study|Unevaluable|2|||
144295150|NCT02298946|520283996|FG001|Overall Study|Unevaluable|1|||
144295151|NCT00050011|520283997|FG000|Overall Study|Adverse Event|41|||
144295152|NCT00050011|520283998|FG001|Overall Study|Adverse Event|46|||
144295153|NCT00050011|520283997|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144295154|NCT00050011|520283998|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144295155|NCT00050011|520283997|FG000|Overall Study|Abnormal test procedure results|0|||
144295156|NCT00050011|520283998|FG001|Overall Study|Abnormal test procedure results|1|||
144295157|NCT00050011|520283997|FG000|Overall Study|Lack of Efficacy|16|||
144295158|NCT00050011|520283998|FG001|Overall Study|Lack of Efficacy|21|||
144295159|NCT00050011|520283997|FG000|Overall Study|Participant condition no longer required|1|||
144295160|NCT00050011|520283998|FG001|Overall Study|Participant condition no longer required|0|||
144295161|NCT00050011|520283997|FG000|Overall Study|Protocol Violation|4|||
144295162|NCT00050011|520283998|FG001|Overall Study|Protocol Violation|10|||
144295163|NCT00050011|520283997|FG000|Overall Study|Withdrawal by Subject|34|||
144295164|NCT00050011|520283998|FG001|Overall Study|Withdrawal by Subject|26|||
144295165|NCT00050011|520283997|FG000|Overall Study|Lost to Follow-up|7|||
144295166|NCT00050011|520283998|FG001|Overall Study|Lost to Follow-up|9|||
144295167|NCT00050011|520283997|FG000|Overall Study|Administrative problems|10|||
144295168|NCT00050011|520283998|FG001|Overall Study|Administrative problems|6|||
144295169|NCT00050011|520283997|FG000|Overall Study|Death|7|||
144295170|NCT00050011|520283998|FG001|Overall Study|Death|4|||
144295171|NCT00050011|520283997|FG000|Overall Study|Unknown - Reason is missing|0|||
144295172|NCT00050011|520283998|FG001|Overall Study|Unknown - Reason is missing|2|||
144295173|NCT05535972|520283999|FG000|Overall Study|Withdrawal by Subject|31|||
144295174|NCT05535972|520283999|FG000|Overall Study|Lost to Follow-up|5|||
144295175|NCT05535972|520283999|FG000|Overall Study|Adverse Event|6|||
144295176|NCT05535972|520283999|FG000|Overall Study|Protocol Deviation|2|||
144295177|NCT04197583|520284002|FG000|Overall Study|Study Stent Replacement|34|||
144295178|NCT04197583|520284003|FG001|Overall Study|Study Stent Replacement|8|||
144295179|NCT04197583|520284002|FG000|Overall Study|Lost to Follow-up|14|||
144295180|NCT04197583|520284003|FG001|Overall Study|Lost to Follow-up|3|||
144295181|NCT04197583|520284002|FG000|Overall Study|Death|3|||
144295182|NCT04197583|520284003|FG001|Overall Study|Death|0|||
144295183|NCT04197583|520284002|FG000|Overall Study|Physician Decision|1|||
144295184|NCT04197583|520284003|FG001|Overall Study|Physician Decision|0|||
144295185|NCT04197583|520284002|FG000|Overall Study|Withdrawal by Subject|1|||
144295186|NCT04197583|520284003|FG001|Overall Study|Withdrawal by Subject|1|||
144295187|NCT04197583|520284002|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
144295188|NCT04197583|520284003|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
144295189|NCT04197583|520284002|FG000|Overall Study|Screen Failure|0|||
144295190|NCT04197583|520284003|FG001|Overall Study|Screen Failure|20|||
144295191|NCT04629196|520284004|FG000|Overall Study|Subject discontinued study drug|1|||
144295192|NCT04629196|520284005|FG001|Overall Study|Subject discontinued study drug|0|||
144295193|NCT04629196|520284004|FG000|Overall Study|Subject study drug dosing increased|1|||
144295194|NCT04629196|520284005|FG001|Overall Study|Subject study drug dosing increased|1|||
144295195|NCT04629196|520284004|FG000|Overall Study|Withdrawal by Subject|1|||
144295196|NCT04629196|520284005|FG001|Overall Study|Withdrawal by Subject|2|||
144295197|NCT01450631|520284009|FG000|Overall Study|Lost to Follow-up|2|||
144295198|NCT01450631|520284010|FG001|Overall Study|Lost to Follow-up|4|||
144295199|NCT01450631|520284009|FG000|Overall Study|Withdrawal by Subject|1|||
144295200|NCT01450631|520284010|FG001|Overall Study|Withdrawal by Subject|0|||
144295201|NCT00323622|520284013|FG000|Overall Study|Other|30|||
144295202|NCT00323622|520284014|FG001|Overall Study|Other|91|||
144295203|NCT00323622|520284015|FG002|Overall Study|Other|4|||
144295204|NCT00323622|520284016|FG003|Overall Study|Other|12|||
144295205|NCT00323622|520284017|FG004|Overall Study|Other|32|||
144295206|NCT00323622|520284018|FG005|Overall Study|Other|74|||
144295207|NCT00323622|520284019|FG006|Overall Study|Other|5|||
144295208|NCT00323622|520284020|FG007|Overall Study|Other|13|||
144295209|NCT00323622|520284013|FG000|Overall Study|Death|1|||
144295210|NCT00323622|520284014|FG001|Overall Study|Death|1|||
144295211|NCT00323622|520284015|FG002|Overall Study|Death|0|||
144295212|NCT00323622|520284016|FG003|Overall Study|Death|0|||
144295213|NCT00323622|520284017|FG004|Overall Study|Death|7|||
144295214|NCT00323622|520284018|FG005|Overall Study|Death|0|||
144295215|NCT00323622|520284019|FG006|Overall Study|Death|0|||
144295216|NCT00323622|520284020|FG007|Overall Study|Death|2|||
144295217|NCT00835354|520284021|FG000|First Intervention|Adverse Event|0|||
144295218|NCT00835354|520284022|FG001|First Intervention|Adverse Event|1|||
144295219|NCT02097225|520284027|FG000|Dose Level 4|Adverse Event|0|||
144295220|NCT02097225|520284028|FG001|Dose Level 4|Adverse Event|0|||
144295221|NCT02097225|520284029|FG002|Dose Level 4|Adverse Event|0|||
144295222|NCT02097225|520284030|FG003|Dose Level 4|Adverse Event|0|||
144295223|NCT02097225|520284031|FG004|Dose Level 4|Adverse Event|1|||
144295224|NCT01852214|520284033|FG000|Period 1|Adverse Event|1|||
144295225|NCT01852214|520284034|FG001|Period 1|Adverse Event|2|||
144295226|NCT01852214|520284033|FG000|Period 1|Withdrawal by Subject|0|||
144295227|NCT01852214|520284034|FG001|Period 1|Withdrawal by Subject|1|||
144295228|NCT01852214|520284033|FG000|Washout Period|Withdrawal by Subject|0|||
144295229|NCT01852214|520284034|FG001|Washout Period|Withdrawal by Subject|1|||
144295230|NCT05487378|520284035|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
144295231|NCT05487378|520284036|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
144295232|NCT05487378|520284035|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
144295233|NCT05487378|520284036|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
144295234|NCT03648372|520284045|FG000|Overall Study|Withdrawal by Subject|2|||
144295235|NCT03648372|520284046|FG001|Overall Study|Withdrawal by Subject|0|||
144295236|NCT03648372|520284047|FG002|Overall Study|Withdrawal by Subject|0|||
144295237|NCT03648372|520284048|FG003|Overall Study|Withdrawal by Subject|0|||
144295238|NCT03648372|520284049|FG004|Overall Study|Withdrawal by Subject|0|||
144295239|NCT03648372|520284050|FG005|Overall Study|Withdrawal by Subject|1|||
144295240|NCT03648372|520284051|FG006|Overall Study|Withdrawal by Subject|2|||
144295241|NCT03648372|520284052|FG007|Overall Study|Withdrawal by Subject|0|||
144295242|NCT03648372|520284053|FG008|Overall Study|Withdrawal by Subject|0|||
144295243|NCT03648372|520284054|FG009|Overall Study|Withdrawal by Subject|0|||
144295244|NCT03648372|520284055|FG010|Overall Study|Withdrawal by Subject|2|||
144295245|NCT03648372|520284056|FG011|Overall Study|Withdrawal by Subject|0|||
144295246|NCT03648372|520284057|FG012|Overall Study|Withdrawal by Subject|2|||
144295247|NCT03648372|520284058|FG013|Overall Study|Withdrawal by Subject|0|||
144295248|NCT03648372|520284059|FG014|Overall Study|Withdrawal by Subject|0|||
144295249|NCT03648372|520284060|FG015|Overall Study|Withdrawal by Subject|0|||
144295250|NCT03648372|520284061|FG016|Overall Study|Withdrawal by Subject|1|||
144295251|NCT03648372|520284062|FG017|Overall Study|Withdrawal by Subject|0|||
144295252|NCT03648372|520284063|FG018|Overall Study|Withdrawal by Subject|0|||
144295253|NCT03648372|520284064|FG019|Overall Study|Withdrawal by Subject|0|||
144295254|NCT03648372|520284065|FG020|Overall Study|Withdrawal by Subject|0|||
144295255|NCT03648372|520284045|FG000|Overall Study|Progressive Disease|2|||
144295256|NCT03648372|520284046|FG001|Overall Study|Progressive Disease|3|||
144295257|NCT03648372|520284047|FG002|Overall Study|Progressive Disease|4|||
144295258|NCT03648372|520284048|FG003|Overall Study|Progressive Disease|3|||
144295259|NCT03648372|520284049|FG004|Overall Study|Progressive Disease|2|||
144295260|NCT03648372|520284050|FG005|Overall Study|Progressive Disease|2|||
144295261|NCT03648372|520284051|FG006|Overall Study|Progressive Disease|3|||
144295262|NCT03648372|520284052|FG007|Overall Study|Progressive Disease|3|||
144295263|NCT03648372|520284053|FG008|Overall Study|Progressive Disease|5|||
144295264|NCT03648372|520284054|FG009|Overall Study|Progressive Disease|5|||
144295265|NCT03648372|520284055|FG010|Overall Study|Progressive Disease|2|||
144295266|NCT03648372|520284056|FG011|Overall Study|Progressive Disease|3|||
144295267|NCT03648372|520284057|FG012|Overall Study|Progressive Disease|3|||
144295268|NCT03648372|520284058|FG013|Overall Study|Progressive Disease|3|||
144295269|NCT03648372|520284059|FG014|Overall Study|Progressive Disease|6|||
144295270|NCT03648372|520284060|FG015|Overall Study|Progressive Disease|0|||
144295271|NCT03648372|520284061|FG016|Overall Study|Progressive Disease|0|||
144295272|NCT03648372|520284062|FG017|Overall Study|Progressive Disease|0|||
144295273|NCT03648372|520284063|FG018|Overall Study|Progressive Disease|0|||
144295274|NCT03648372|520284064|FG019|Overall Study|Progressive Disease|0|||
144295275|NCT03648372|520284065|FG020|Overall Study|Progressive Disease|0|||
144295276|NCT03648372|520284045|FG000|Overall Study|Other|0|||
144295277|NCT03648372|520284046|FG001|Overall Study|Other|0|||
144295278|NCT03648372|520284047|FG002|Overall Study|Other|0|||
144295279|NCT03648372|520284048|FG003|Overall Study|Other|0|||
144295280|NCT03648372|520284049|FG004|Overall Study|Other|1|||
144295281|NCT03648372|520284050|FG005|Overall Study|Other|0|||
144295282|NCT03648372|520284051|FG006|Overall Study|Other|0|||
144295283|NCT03648372|520284052|FG007|Overall Study|Other|0|||
144295284|NCT03648372|520284053|FG008|Overall Study|Other|0|||
144295285|NCT03648372|520284054|FG009|Overall Study|Other|0|||
144295286|NCT03648372|520284055|FG010|Overall Study|Other|1|||
144295287|NCT03648372|520284056|FG011|Overall Study|Other|2|||
144295288|NCT03648372|520284057|FG012|Overall Study|Other|1|||
144295289|NCT03648372|520284058|FG013|Overall Study|Other|3|||
144295290|NCT03648372|520284059|FG014|Overall Study|Other|0|||
144295291|NCT03648372|520284060|FG015|Overall Study|Other|5|||
144295292|NCT03648372|520284061|FG016|Overall Study|Other|1|||
144295293|NCT03648372|520284062|FG017|Overall Study|Other|5|||
144295294|NCT03648372|520284063|FG018|Overall Study|Other|0|||
144295295|NCT03648372|520284064|FG019|Overall Study|Other|1|||
144295296|NCT03648372|520284065|FG020|Overall Study|Other|0|||
144295297|NCT03648372|520284045|FG000|Overall Study|Lost to Follow-up|0|||
144295298|NCT03648372|520284046|FG001|Overall Study|Lost to Follow-up|0|||
144295299|NCT03648372|520284047|FG002|Overall Study|Lost to Follow-up|0|||
144295300|NCT03648372|520284048|FG003|Overall Study|Lost to Follow-up|0|||
144295301|NCT03648372|520284049|FG004|Overall Study|Lost to Follow-up|0|||
144295302|NCT03648372|520284050|FG005|Overall Study|Lost to Follow-up|0|||
144295303|NCT03648372|520284051|FG006|Overall Study|Lost to Follow-up|0|||
144295304|NCT03648372|520284052|FG007|Overall Study|Lost to Follow-up|0|||
144295305|NCT03648372|520284053|FG008|Overall Study|Lost to Follow-up|0|||
144295306|NCT03648372|520284054|FG009|Overall Study|Lost to Follow-up|0|||
144295307|NCT03648372|520284055|FG010|Overall Study|Lost to Follow-up|0|||
144295308|NCT03648372|520284056|FG011|Overall Study|Lost to Follow-up|0|||
144295309|NCT03648372|520284057|FG012|Overall Study|Lost to Follow-up|0|||
144295310|NCT03648372|520284058|FG013|Overall Study|Lost to Follow-up|1|||
144295311|NCT03648372|520284059|FG014|Overall Study|Lost to Follow-up|0|||
144295312|NCT03648372|520284060|FG015|Overall Study|Lost to Follow-up|1|||
144295313|NCT03648372|520284061|FG016|Overall Study|Lost to Follow-up|0|||
144295314|NCT03648372|520284062|FG017|Overall Study|Lost to Follow-up|1|||
144295315|NCT03648372|520284063|FG018|Overall Study|Lost to Follow-up|0|||
144295316|NCT03648372|520284064|FG019|Overall Study|Lost to Follow-up|0|||
144295317|NCT03648372|520284065|FG020|Overall Study|Lost to Follow-up|0|||
144295318|NCT03648372|520284045|FG000|Overall Study|Start of a New Systemic Treatment|0|||
144295319|NCT03648372|520284046|FG001|Overall Study|Start of a New Systemic Treatment|0|||
144295320|NCT03648372|520284047|FG002|Overall Study|Start of a New Systemic Treatment|0|||
144295321|NCT03648372|520284048|FG003|Overall Study|Start of a New Systemic Treatment|0|||
144295322|NCT03648372|520284049|FG004|Overall Study|Start of a New Systemic Treatment|0|||
144295323|NCT03648372|520284050|FG005|Overall Study|Start of a New Systemic Treatment|0|||
144295324|NCT03648372|520284051|FG006|Overall Study|Start of a New Systemic Treatment|0|||
144295325|NCT03648372|520284052|FG007|Overall Study|Start of a New Systemic Treatment|2|||
144295326|NCT03648372|520284053|FG008|Overall Study|Start of a New Systemic Treatment|0|||
144295327|NCT03648372|520284054|FG009|Overall Study|Start of a New Systemic Treatment|0|||
144295328|NCT03648372|520284055|FG010|Overall Study|Start of a New Systemic Treatment|1|||
144295329|NCT03648372|520284056|FG011|Overall Study|Start of a New Systemic Treatment|0|||
144295330|NCT03648372|520284057|FG012|Overall Study|Start of a New Systemic Treatment|0|||
144295331|NCT03648372|520284058|FG013|Overall Study|Start of a New Systemic Treatment|0|||
144295332|NCT03648372|520284059|FG014|Overall Study|Start of a New Systemic Treatment|0|||
144295333|NCT03648372|520284060|FG015|Overall Study|Start of a New Systemic Treatment|0|||
144295334|NCT03648372|520284061|FG016|Overall Study|Start of a New Systemic Treatment|0|||
144295335|NCT03648372|520284062|FG017|Overall Study|Start of a New Systemic Treatment|0|||
144295336|NCT03648372|520284063|FG018|Overall Study|Start of a New Systemic Treatment|0|||
144295337|NCT03648372|520284064|FG019|Overall Study|Start of a New Systemic Treatment|0|||
144295338|NCT03648372|520284065|FG020|Overall Study|Start of a New Systemic Treatment|0|||
144295339|NCT04191135|520284066|FG000|Induction Treatment|Not Treated|2|||
144295340|NCT04191135|520284067|FG001|Induction Treatment|Not Treated|0|||
144295341|NCT04191135|520284068|FG002|Induction Treatment|Not Treated|0|||
144295342|NCT04191135|520284066|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
144295343|NCT04191135|520284067|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
144295344|NCT04191135|520284068|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
144295345|NCT04191135|520284066|FG000|Induction Treatment|Adverse Event|25|||
144295346|NCT04191135|520284067|FG001|Induction Treatment|Adverse Event|0|||
144295347|NCT04191135|520284068|FG002|Induction Treatment|Adverse Event|0|||
144295348|NCT04191135|520284066|FG000|Induction Treatment|Clinical Progression|8|||
144295349|NCT04191135|520284067|FG001|Induction Treatment|Clinical Progression|0|||
144295350|NCT04191135|520284068|FG002|Induction Treatment|Clinical Progression|0|||
144295351|NCT04191135|520284066|FG000|Induction Treatment|Excluded Medication|1|||
144295352|NCT04191135|520284067|FG001|Induction Treatment|Excluded Medication|0|||
144295353|NCT04191135|520284068|FG002|Induction Treatment|Excluded Medication|0|||
144295354|NCT04191135|520284066|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
144295355|NCT04191135|520284067|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
144295356|NCT04191135|520284068|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
144295357|NCT04191135|520284066|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
144295358|NCT04191135|520284067|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
144295359|NCT04191135|520284068|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
144295360|NCT04191135|520284066|FG000|Induction Treatment|Physician Decision|2|||
144295361|NCT04191135|520284067|FG001|Induction Treatment|Physician Decision|0|||
144295362|NCT04191135|520284068|FG002|Induction Treatment|Physician Decision|0|||
144295363|NCT04191135|520284066|FG000|Induction Treatment|Progressive Disease|135|||
144295364|NCT04191135|520284067|FG001|Induction Treatment|Progressive Disease|0|||
144295365|NCT04191135|520284068|FG002|Induction Treatment|Progressive Disease|0|||
144295366|NCT04191135|520284066|FG000|Induction Treatment|Protocol Violation|10|||
144295367|NCT04191135|520284067|FG001|Induction Treatment|Protocol Violation|0|||
144295368|NCT04191135|520284068|FG002|Induction Treatment|Protocol Violation|0|||
144295369|NCT04191135|520284066|FG000|Induction Treatment|Withdrawal by Subject|4|||
144295370|NCT04191135|520284067|FG001|Induction Treatment|Withdrawal by Subject|0|||
144295371|NCT04191135|520284068|FG002|Induction Treatment|Withdrawal by Subject|0|||
144295372|NCT04191135|520284066|FG000|Randomized Treatment|Death|0|||
144295373|NCT04191135|520284067|FG001|Randomized Treatment|Death|50|||
144295374|NCT04191135|520284068|FG002|Randomized Treatment|Death|54|||
144295375|NCT04191135|520284066|FG000|Randomized Treatment|Lost to Follow-up|0|||
144295376|NCT04191135|520284067|FG001|Randomized Treatment|Lost to Follow-up|0|||
144295377|NCT04191135|520284068|FG002|Randomized Treatment|Lost to Follow-up|1|||
144295378|NCT04191135|520284066|FG000|Randomized Treatment|Withdrawal by Subject|0|||
144295379|NCT04191135|520284067|FG001|Randomized Treatment|Withdrawal by Subject|2|||
144295380|NCT04191135|520284068|FG002|Randomized Treatment|Withdrawal by Subject|0|||
144295381|NCT04191135|520284066|FG000|Randomized Treatment|Ongoing in Trial|0|||
144295382|NCT04191135|520284067|FG001|Randomized Treatment|Ongoing in Trial|83|||
144295383|NCT04191135|520284068|FG002|Randomized Treatment|Ongoing in Trial|81|||
144295384|NCT03514134|520285563|FG000|Overall Study|Lost to Follow-up|0|||
144295385|NCT03514134|520285564|FG001|Overall Study|Lost to Follow-up|1|||
144295386|NCT00003645|520285565|FG000|Overall Study|Death|4|||
144295387|NCT00003645|520285566|FG001|Overall Study|Death|1|||
144295388|NCT00003645|520285565|FG000|Overall Study|Lost to Follow-up|7|||
144295389|NCT00003645|520285566|FG001|Overall Study|Lost to Follow-up|8|||
144295390|NCT00003645|520285565|FG000|Overall Study|Withdrawal by Subject|1|||
144295391|NCT00003645|520285566|FG001|Overall Study|Withdrawal by Subject|3|||
144295392|NCT03768336|520285569|FG000|Overall Study|Lost to Follow-up|3|||
144295393|NCT03768336|520285570|FG001|Overall Study|Lost to Follow-up|2|||
144295394|NCT03768336|520285569|FG000|Overall Study|Became Ineligible|2|||
144295395|NCT03768336|520285570|FG001|Overall Study|Became Ineligible|0|||
144295396|NCT03768336|520285569|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
144295397|NCT03768336|520285570|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
144295398|NCT03768336|520285569|FG000|Overall Study|Missed final survey (post-treatment|0|||
144295399|NCT03768336|520285570|FG001|Overall Study|Missed final survey (post-treatment|1|||
144295400|NCT06790303|520285571|FG000|Overall Study|Study Terminated by sponsor|4|||
144295401|NCT06790303|520285571|FG000|Overall Study|Death|4|||
144295402|NCT00500331|520285574|FG000|Overall Study|Adverse Event|0|||
144295403|NCT00500331|520285575|FG001|Overall Study|Adverse Event|2|||
144295404|NCT00500331|520285576|FG002|Overall Study|Adverse Event|0|||
144295405|NCT00500331|520285577|FG003|Overall Study|Adverse Event|1|||
144295406|NCT00500331|520285578|FG004|Overall Study|Adverse Event|2|||
144295407|NCT00500331|520285579|FG005|Overall Study|Adverse Event|2|||
144295408|NCT00500331|520285580|FG006|Overall Study|Adverse Event|0|||
144295409|NCT00500331|520285574|FG000|Overall Study|Lost to Follow-up|1|||
144295410|NCT00500331|520285575|FG001|Overall Study|Lost to Follow-up|1|||
144295411|NCT00500331|520285576|FG002|Overall Study|Lost to Follow-up|1|||
144295412|NCT00500331|520285577|FG003|Overall Study|Lost to Follow-up|2|||
144295413|NCT00500331|520285578|FG004|Overall Study|Lost to Follow-up|1|||
144295414|NCT00500331|520285579|FG005|Overall Study|Lost to Follow-up|0|||
144295415|NCT00500331|520285580|FG006|Overall Study|Lost to Follow-up|0|||
144295416|NCT00500331|520285574|FG000|Overall Study|Protocol Violation|3|||
144295417|NCT00500331|520285575|FG001|Overall Study|Protocol Violation|1|||
144295418|NCT00500331|520285576|FG002|Overall Study|Protocol Violation|1|||
144295419|NCT00500331|520285577|FG003|Overall Study|Protocol Violation|0|||
144295420|NCT00500331|520285578|FG004|Overall Study|Protocol Violation|1|||
144295421|NCT00500331|520285579|FG005|Overall Study|Protocol Violation|1|||
144295422|NCT00500331|520285580|FG006|Overall Study|Protocol Violation|1|||
144295423|NCT00500331|520285574|FG000|Overall Study|Withdrawal by Subject|4|||
144295424|NCT00500331|520285575|FG001|Overall Study|Withdrawal by Subject|0|||
144295425|NCT00500331|520285576|FG002|Overall Study|Withdrawal by Subject|1|||
144295426|NCT00500331|520285577|FG003|Overall Study|Withdrawal by Subject|5|||
144295427|NCT00500331|520285578|FG004|Overall Study|Withdrawal by Subject|0|||
144295428|NCT00500331|520285579|FG005|Overall Study|Withdrawal by Subject|1|||
144295429|NCT00500331|520285580|FG006|Overall Study|Withdrawal by Subject|1|||
144295430|NCT00500331|520285574|FG000|Overall Study|Lack of Efficacy|3|||
144295431|NCT00500331|520285575|FG001|Overall Study|Lack of Efficacy|1|||
144295432|NCT00500331|520285576|FG002|Overall Study|Lack of Efficacy|0|||
144295433|NCT00500331|520285577|FG003|Overall Study|Lack of Efficacy|0|||
144295434|NCT00500331|520285578|FG004|Overall Study|Lack of Efficacy|0|||
144295435|NCT00500331|520285579|FG005|Overall Study|Lack of Efficacy|0|||
144295436|NCT00500331|520285580|FG006|Overall Study|Lack of Efficacy|0|||
144295437|NCT00500331|520285574|FG000|Overall Study|Liver function test abnormality|0|||
144295438|NCT00500331|520285575|FG001|Overall Study|Liver function test abnormality|0|||
144295439|NCT00500331|520285576|FG002|Overall Study|Liver function test abnormality|1|||
144295440|NCT00500331|520285577|FG003|Overall Study|Liver function test abnormality|0|||
144295441|NCT00500331|520285578|FG004|Overall Study|Liver function test abnormality|0|||
144295442|NCT00500331|520285579|FG005|Overall Study|Liver function test abnormality|0|||
144295443|NCT00500331|520285580|FG006|Overall Study|Liver function test abnormality|0|||
144295444|NCT00500331|520285574|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
144295445|NCT00500331|520285575|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
144295446|NCT00500331|520285576|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
144295447|NCT00500331|520285577|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
144295448|NCT00500331|520285578|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
144295449|NCT00500331|520285579|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
144295450|NCT00500331|520285580|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
144295451|NCT00500331|520285574|FG000|Overall Study|Didn't return for continuation of study|1|||
144295452|NCT00500331|520285575|FG001|Overall Study|Didn't return for continuation of study|0|||
144295453|NCT00500331|520285576|FG002|Overall Study|Didn't return for continuation of study|0|||
144295454|NCT00500331|520285577|FG003|Overall Study|Didn't return for continuation of study|0|||
144295455|NCT00500331|520285578|FG004|Overall Study|Didn't return for continuation of study|0|||
144295456|NCT00500331|520285579|FG005|Overall Study|Didn't return for continuation of study|0|||
144295457|NCT00500331|520285580|FG006|Overall Study|Didn't return for continuation of study|0|||
144295458|NCT00500331|520285574|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
144295459|NCT00500331|520285575|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
144295460|NCT00500331|520285576|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
144295461|NCT00500331|520285577|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
144295462|NCT00500331|520285578|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
144295463|NCT00500331|520285579|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
144295464|NCT00500331|520285580|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
144295465|NCT00500331|520285574|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
144295466|NCT00500331|520285575|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
144295467|NCT00500331|520285576|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
144295468|NCT00500331|520285577|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
144295469|NCT00500331|520285578|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
144295470|NCT00500331|520285579|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
144295471|NCT00500331|520285580|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
144295472|NCT00500331|520285574|FG000|Overall Study|Participant was randomized by mistake|1|||
144295473|NCT00500331|520285575|FG001|Overall Study|Participant was randomized by mistake|0|||
144295474|NCT00500331|520285576|FG002|Overall Study|Participant was randomized by mistake|0|||
144295475|NCT00500331|520285577|FG003|Overall Study|Participant was randomized by mistake|0|||
144295476|NCT00500331|520285578|FG004|Overall Study|Participant was randomized by mistake|0|||
144295477|NCT00500331|520285579|FG005|Overall Study|Participant was randomized by mistake|0|||
144295478|NCT00500331|520285580|FG006|Overall Study|Participant was randomized by mistake|0|||
144295479|NCT00500331|520285574|FG000|Overall Study|Diabetologist nurse in the study|0|||
144295480|NCT00500331|520285575|FG001|Overall Study|Diabetologist nurse in the study|0|||
144295481|NCT00500331|520285576|FG002|Overall Study|Diabetologist nurse in the study|1|||
144295482|NCT00500331|520285577|FG003|Overall Study|Diabetologist nurse in the study|0|||
144295483|NCT00500331|520285578|FG004|Overall Study|Diabetologist nurse in the study|0|||
144295484|NCT00500331|520285579|FG005|Overall Study|Diabetologist nurse in the study|0|||
144295485|NCT00500331|520285580|FG006|Overall Study|Diabetologist nurse in the study|0|||
144295486|NCT00500331|520285574|FG000|Overall Study|State ban of biological samples export|0|||
144295487|NCT00500331|520285575|FG001|Overall Study|State ban of biological samples export|0|||
144295488|NCT00500331|520285576|FG002|Overall Study|State ban of biological samples export|0|||
144295489|NCT00500331|520285577|FG003|Overall Study|State ban of biological samples export|1|||
144295490|NCT00500331|520285578|FG004|Overall Study|State ban of biological samples export|0|||
144295491|NCT00500331|520285579|FG005|Overall Study|State ban of biological samples export|0|||
144295492|NCT00500331|520285580|FG006|Overall Study|State ban of biological samples export|0|||
144295493|NCT00500331|520285574|FG000|Overall Study|Protocol violated|0|||
144295494|NCT00500331|520285575|FG001|Overall Study|Protocol violated|0|||
144295495|NCT00500331|520285576|FG002|Overall Study|Protocol violated|0|||
144295496|NCT00500331|520285577|FG003|Overall Study|Protocol violated|1|||
144295497|NCT00500331|520285578|FG004|Overall Study|Protocol violated|0|||
144295498|NCT00500331|520285579|FG005|Overall Study|Protocol violated|0|||
144295499|NCT00500331|520285580|FG006|Overall Study|Protocol violated|0|||
144295500|NCT03345550|520285581|FG000|Overall Study|Withdrawal by Subject|1|||
144295501|NCT03345550|520285582|FG001|Overall Study|Withdrawal by Subject|0|||
144295502|NCT03345550|520285581|FG000|Overall Study|Lost to Follow-up|4|||
144295503|NCT03345550|520285582|FG001|Overall Study|Lost to Follow-up|5|||
144295504|NCT03033784|520285586|FG000|Overall Study|Anxiety related to MRI scanner|0|||
144295505|NCT03033784|520285587|FG001|Overall Study|Anxiety related to MRI scanner|1|||
144295506|NCT03033784|520285588|FG002|Overall Study|Anxiety related to MRI scanner|0|||
144295507|NCT03033784|520285589|FG003|Overall Study|Anxiety related to MRI scanner|0|||
144295508|NCT03033784|520285590|FG004|Overall Study|Anxiety related to MRI scanner|0|||
144295509|NCT03033784|520285591|FG005|Overall Study|Anxiety related to MRI scanner|0|||
144295510|NCT03033784|520285592|FG006|Overall Study|Anxiety related to MRI scanner|0|||
144295511|NCT03033784|520285593|FG007|Overall Study|Anxiety related to MRI scanner|0|||
144295512|NCT03033784|520285594|FG008|Overall Study|Anxiety related to MRI scanner|0|||
144295513|NCT03033784|520285595|FG009|Overall Study|Anxiety related to MRI scanner|0|||
144295514|NCT03033784|520285596|FG010|Overall Study|Anxiety related to MRI scanner|0|||
144295515|NCT03033784|520285597|FG011|Overall Study|Anxiety related to MRI scanner|0|||
144295516|NCT03033784|520285598|FG012|Overall Study|Anxiety related to MRI scanner|0|||
144295517|NCT03033784|520285586|FG000|Overall Study|Withdrawal by Subject|0|||
144295518|NCT03033784|520285587|FG001|Overall Study|Withdrawal by Subject|0|||
144295519|NCT03033784|520285588|FG002|Overall Study|Withdrawal by Subject|0|||
144295520|NCT03033784|520285589|FG003|Overall Study|Withdrawal by Subject|0|||
144295521|NCT03033784|520285590|FG004|Overall Study|Withdrawal by Subject|0|||
144295522|NCT03033784|520285591|FG005|Overall Study|Withdrawal by Subject|0|||
144295523|NCT03033784|520285592|FG006|Overall Study|Withdrawal by Subject|0|||
144295524|NCT03033784|520285593|FG007|Overall Study|Withdrawal by Subject|0|||
144295525|NCT03033784|520285594|FG008|Overall Study|Withdrawal by Subject|0|||
144295526|NCT03033784|520285595|FG009|Overall Study|Withdrawal by Subject|0|||
144295527|NCT03033784|520285596|FG010|Overall Study|Withdrawal by Subject|0|||
144295528|NCT03033784|520285597|FG011|Overall Study|Withdrawal by Subject|0|||
144295529|NCT03033784|520285598|FG012|Overall Study|Withdrawal by Subject|2|||
144295530|NCT02374255|520285599|FG000|Overall Study|Withdrawal by Subject|2|||
144295531|NCT02374255|520285600|FG001|Overall Study|Withdrawal by Subject|0|||
144295532|NCT02374255|520285601|FG002|Overall Study|Withdrawal by Subject|0|||
144295533|NCT02374255|520285602|FG003|Overall Study|Withdrawal by Subject|0|||
144295534|NCT03332056|520285603|FG000|Overall Study|Incomplete questionnaires|8|||
144295535|NCT03332056|520285604|FG001|Overall Study|Incomplete questionnaires|9|||
144295536|NCT03332056|520285603|FG000|Overall Study|Passed stone prior to surgery date|1|||
144295537|NCT03332056|520285604|FG001|Overall Study|Passed stone prior to surgery date|0|||
144295538|NCT03332056|520285603|FG000|Overall Study|Did not require a ureteral stent|0|||
144295539|NCT03332056|520285604|FG001|Overall Study|Did not require a ureteral stent|1|||
144295540|NCT02093520|520285605|FG000|Overall Study|Not treated|6|||
144295541|NCT02093520|520285606|FG001|Overall Study|Not treated|22|||
144295542|NCT03014089|520285607|FG000|Overall Study|Withdrawal by Subject|0|||
144295543|NCT03014089|520285608|FG001|Overall Study|Withdrawal by Subject|1|||
144295544|NCT03014089|520285609|FG002|Overall Study|Withdrawal by Subject|1|||
144295545|NCT03014089|520285610|FG003|Overall Study|Withdrawal by Subject|1|||
144295546|NCT03014089|520285607|FG000|Overall Study|Lost to Follow-up|1|||
144295547|NCT03014089|520285608|FG001|Overall Study|Lost to Follow-up|0|||
144295548|NCT03014089|520285609|FG002|Overall Study|Lost to Follow-up|0|||
144295549|NCT03014089|520285610|FG003|Overall Study|Lost to Follow-up|0|||
144295550|NCT03014089|520285607|FG000|Overall Study|Adverse Event|1|||
144295551|NCT03014089|520285608|FG001|Overall Study|Adverse Event|0|||
144295552|NCT03014089|520285609|FG002|Overall Study|Adverse Event|1|||
144295553|NCT03014089|520285610|FG003|Overall Study|Adverse Event|0|||
144295554|NCT00851084|520285611|FG000|Overall Study|Randomized but not treated|1|||
144295555|NCT00851084|520285612|FG001|Overall Study|Randomized but not treated|0|||
144295556|NCT00851084|520285611|FG000|Overall Study|Adverse Event|26|||
144295557|NCT00851084|520285612|FG001|Overall Study|Adverse Event|36|||
144295558|NCT00851084|520285611|FG000|Overall Study|Disease progression|52|||
144295559|NCT00851084|520285612|FG001|Overall Study|Disease progression|47|||
144295560|NCT00851084|520285611|FG000|Overall Study|Poor compliance to protocol|1|||
144295561|NCT00851084|520285612|FG001|Overall Study|Poor compliance to protocol|1|||
144295562|NCT00851084|520285611|FG000|Overall Study|Physician Decision|13|||
144295563|NCT00851084|520285612|FG001|Overall Study|Physician Decision|14|||
144295564|NCT00851084|520285611|FG000|Overall Study|Consent withdrawn|0|||
144295565|NCT00851084|520285612|FG001|Overall Study|Consent withdrawn|2|||
144295566|NCT00851084|520285611|FG000|Overall Study|Withdrawal by Subject|11|||
144295567|NCT00851084|520285612|FG001|Overall Study|Withdrawal by Subject|12|||
144295568|NCT00851084|520285611|FG000|Overall Study|Metastatic surgery|6|||
144295569|NCT00851084|520285612|FG001|Overall Study|Metastatic surgery|6|||
144295570|NCT00851084|520285611|FG000|Overall Study|Other|7|||
144295571|NCT00851084|520285612|FG001|Overall Study|Other|1|||
144295572|NCT00321932|520285613|FG000|Overall Study|Death|3|||
144295573|NCT00321932|520285614|FG001|Overall Study|Death|6|||
144295574|NCT00321932|520285613|FG000|Overall Study|Withdrawal by Subject|3|||
144295575|NCT00321932|520285614|FG001|Overall Study|Withdrawal by Subject|6|||
144295576|NCT00321932|520285613|FG000|Overall Study|Early relapse|2|||
144295577|NCT00321932|520285614|FG001|Overall Study|Early relapse|8|||
144295578|NCT00321932|520285613|FG000|Overall Study|Missing data|2|||
144295579|NCT00321932|520285614|FG001|Overall Study|Missing data|1|||
144295580|NCT00734032|520285615|FG000|Overall Study|Adverse Event|0|||
144295581|NCT00734032|520285616|FG001|Overall Study|Adverse Event|1|||
144295582|NCT00734032|520285617|FG002|Overall Study|Adverse Event|0|||
144295583|NCT00734032|520285618|FG003|Overall Study|Adverse Event|0|||
144295584|NCT00337168|520285623|FG000|Overall Study|Death|5|||
144295585|NCT00337168|520285623|FG000|Overall Study|Not protocol specified|2|||
144295586|NCT00337168|520285623|FG000|Overall Study|Did not start therapy|1|||
144295587|NCT01225952|520285624|FG000|Overall Study|Lost to Follow-up|1|||
144295588|NCT01225952|520285625|FG001|Overall Study|Lost to Follow-up|0|||
144295589|NCT01225952|520285626|FG002|Overall Study|Lost to Follow-up|0|||
144295590|NCT01225952|520285624|FG000|Overall Study|Study Eye Explanted|0|||
144295591|NCT01225952|520285625|FG001|Overall Study|Study Eye Explanted|0|||
144295592|NCT01225952|520285626|FG002|Overall Study|Study Eye Explanted|1|||
144295593|NCT01225952|520285624|FG000|Overall Study|Withdrawal by Subject|4|||
144295594|NCT01225952|520285625|FG001|Overall Study|Withdrawal by Subject|4|||
144295595|NCT01225952|520285626|FG002|Overall Study|Withdrawal by Subject|5|||
144295596|NCT01225952|520285624|FG000|Overall Study|Surgical complications|1|||
144295597|NCT01225952|520285625|FG001|Overall Study|Surgical complications|0|||
144295598|NCT01225952|520285626|FG002|Overall Study|Surgical complications|0|||
144295599|NCT01217892|520285630|FG000|Overall Study|Adverse Event|1|||
144295600|NCT01217892|520285631|FG001|Overall Study|Adverse Event|1|||
144295601|NCT01217892|520285632|FG002|Overall Study|Adverse Event|1|||
144295602|NCT01217892|520285633|FG003|Overall Study|Adverse Event|0|||
144295603|NCT01217892|520285630|FG000|Overall Study|Withdrawal by Subject|0|||
144295604|NCT01217892|520285631|FG001|Overall Study|Withdrawal by Subject|2|||
144295605|NCT01217892|520285632|FG002|Overall Study|Withdrawal by Subject|1|||
144295606|NCT01217892|520285633|FG003|Overall Study|Withdrawal by Subject|0|||
144295607|NCT01217892|520285630|FG000|Overall Study|Lab value|1|||
144295608|NCT01217892|520285631|FG001|Overall Study|Lab value|0|||
144295609|NCT01217892|520285632|FG002|Overall Study|Lab value|1|||
144295610|NCT01217892|520285633|FG003|Overall Study|Lab value|0|||
144295611|NCT01217892|520285630|FG000|Overall Study|Subject no longer meets study criteria|5|||
144295612|NCT01217892|520285631|FG001|Overall Study|Subject no longer meets study criteria|2|||
144295613|NCT01217892|520285632|FG002|Overall Study|Subject no longer meets study criteria|4|||
144295614|NCT01217892|520285633|FG003|Overall Study|Subject no longer meets study criteria|8|||
144295615|NCT01217892|520285630|FG000|Overall Study|Incorrect enrollment|0|||
144295616|NCT01217892|520285631|FG001|Overall Study|Incorrect enrollment|1|||
144295617|NCT01217892|520285632|FG002|Overall Study|Incorrect enrollment|1|||
144295618|NCT01217892|520285633|FG003|Overall Study|Incorrect enrollment|0|||
144295619|NCT01217892|520285630|FG000|Overall Study|Poor/Non-Compliance|0|||
144295620|NCT01217892|520285631|FG001|Overall Study|Poor/Non-Compliance|0|||
144295621|NCT01217892|520285632|FG002|Overall Study|Poor/Non-Compliance|1|||
144295622|NCT01217892|520285633|FG003|Overall Study|Poor/Non-Compliance|0|||
144295623|NCT01052779|520285634|FG000|Overall Study|Adverse Event|1|||
144295624|NCT01052779|520285635|FG001|Overall Study|Adverse Event|4|||
144295625|NCT01052779|520285634|FG000|Overall Study|Withdrawal by Subject|1|||
144295626|NCT01052779|520285635|FG001|Overall Study|Withdrawal by Subject|2|||
144295627|NCT01052779|520285634|FG000|Overall Study|Other-Protocol Violation|1|||
144295628|NCT01052779|520285635|FG001|Overall Study|Other-Protocol Violation|1|||
144295629|NCT01052779|520285634|FG000|Overall Study|Other-Surgery|0|||
144295630|NCT01052779|520285635|FG001|Overall Study|Other-Surgery|2|||
144295631|NCT01052779|520285634|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
144295632|NCT01052779|520285635|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
144295633|NCT03663582|520285636|FG000|Overall Study|Physician Decision|1|||
144295634|NCT04507763|520285637|FG000|Overall Study|Participants did not meet entrance criteria|201|||
144295635|NCT01905540|520285638|FG000|Period 3|Other|1|||
144295636|NCT01905540|520285639|FG001|Period 3|Other|0|||
144295637|NCT01905540|520285640|FG002|Period 3|Other|1|||
144295638|NCT01905540|520285641|FG003|Period 3|Other|1|||
144295639|NCT03847519|520285642|FG000|Overall Study|Death|5|||
144295640|NCT03847519|520285643|FG001|Overall Study|Death|8|||
144295641|NCT03847519|520285644|FG002|Overall Study|Death|1|||
144295642|NCT03847519|520285642|FG000|Overall Study|Lost to Follow-up|1|||
144295643|NCT03847519|520285643|FG001|Overall Study|Lost to Follow-up|2|||
144295644|NCT03847519|520285644|FG002|Overall Study|Lost to Follow-up|0|||
144295645|NCT03847519|520285642|FG000|Overall Study|Study Terminated by Sponsor|0|||
144295646|NCT03847519|520285643|FG001|Overall Study|Study Terminated by Sponsor|3|||
144295647|NCT03847519|520285644|FG002|Overall Study|Study Terminated by Sponsor|2|||
144295648|NCT02853136|520285645|FG000|Wash-out|Adverse Event|0|||
144295649|NCT02853136|520285646|FG001|Wash-out|Adverse Event|0|||
144295650|NCT02853136|520285647|FG002|Wash-out|Adverse Event|0|||
144295651|NCT02853136|520285648|FG003|Wash-out|Adverse Event|1|||
144295652|NCT00841815|520285649|FG000|Washout|Withdrawal by Subject|0|||
144295653|NCT00841815|520285650|FG001|Washout|Withdrawal by Subject|1|||
144295654|NCT03729609|520285651|FG000|Overall Study|Protocol Violation|1|||
144295655|NCT03412929|520285654|FG000|Overall Study|Protocol Violation|3|||
144295656|NCT00209131|520285658|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
144295657|NCT00209131|520285659|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
144295658|NCT05360784|520285660|FG000|Overall Study|Discontinued|25|||
144295659|NCT05360784|520285661|FG001|Overall Study|Discontinued|11|||
144295660|NCT02796651|520285662|FG000|Overall Study|Adverse Event|6|||
144295661|NCT02796651|520285662|FG000|Overall Study|Lost to Follow-up|1|||
144295662|NCT02796651|520285662|FG000|Overall Study|Withdrawal by Subject|4|||
144295663|NCT02796651|520285662|FG000|Overall Study|Protocol Violation|4|||
144295664|NCT02796651|520285662|FG000|Overall Study|Lack of Efficacy|1|||
144295665|NCT02796651|520285662|FG000|Overall Study|Other|10|||
144295666|NCT05142306|520285666|FG000|Overall Study|Withdrawal by Subject|0|||
144295667|NCT05142306|520285667|FG001|Overall Study|Withdrawal by Subject|0|||
144295668|NCT05142306|520285668|FG002|Overall Study|Withdrawal by Subject|1|||
144295669|NCT02251041|520285669|FG000|Overall Study|Did not receive intervention|15|||
144295670|NCT02251041|520285670|FG001|Overall Study|Did not receive intervention|4|||
144295671|NCT04918771|520285671|FG000|Overall Study|Withdrawal by Subject|4|||
144295672|NCT04918771|520285672|FG001|Overall Study|Withdrawal by Subject|5|||
144295673|NCT04918771|520285671|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
144295674|NCT04918771|520285672|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
144295675|NCT05014919|520285675|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
144295676|NCT05014919|520285676|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
144295677|NCT05014919|520285677|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
144295678|NCT05014919|520285675|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
144295679|NCT05014919|520285676|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
144295680|NCT05014919|520285677|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
144295681|NCT05014919|520285675|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
144295682|NCT05014919|520285676|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
144295683|NCT05014919|520285677|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
144295684|NCT05014919|520285675|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
144295685|NCT05014919|520285676|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
144295686|NCT05014919|520285677|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
144295687|NCT05014919|520285675|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
144295688|NCT05014919|520285676|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
144295689|NCT05014919|520285677|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
144295690|NCT05014919|520285675|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
144295691|NCT05014919|520285676|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
144295692|NCT05014919|520285677|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
144295693|NCT05014919|520285675|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
144295694|NCT05014919|520285676|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
144295695|NCT05014919|520285677|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
144295696|NCT05014919|520285675|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
144295697|NCT05014919|520285676|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
144295698|NCT05014919|520285677|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
144295699|NCT02971163|520285678|FG000|Overall Study|Lost to Follow-up|4|||
144295700|NCT02971163|520285679|FG001|Overall Study|Lost to Follow-up|2|||
144295701|NCT02940223|520285688|FG000|Overall Study|Failed Requirement|2|||
144295702|NCT02940223|520285689|FG001|Overall Study|Failed Requirement|0|||
144295703|NCT05305651|520285690|FG000|Overall Study|Death|1|||
144295704|NCT05305651|520285690|FG000|Overall Study|Withdrawal by Subject|4|||
144295705|NCT05305651|520285690|FG000|Overall Study|Lost to Follow-up|4|||
144295706|NCT02871219|520285693|FG000|Overall Study|Adverse Event|15|||
144295707|NCT02871219|520285693|FG000|Overall Study|Death|3|||
144295708|NCT02871219|520285693|FG000|Overall Study|Progression|3|||
144295709|NCT02871219|520285693|FG000|Overall Study|Infections|7|||
144295710|NCT02871219|520285693|FG000|Overall Study|Infusion Related|4|||
144295711|NCT01385995|520285695|FG000|Period 1, 2 Months|Physician Decision|1|||
144295712|NCT01385995|520285696|FG001|Period 1, 2 Months|Physician Decision|0|||
144295713|NCT00112385|520285697|FG000|Overall Study|Lost to Follow-up|1|||
144295714|NCT00112385|520285698|FG001|Overall Study|Lost to Follow-up|0|||
144295715|NCT00112385|520285697|FG000|Overall Study|Withdrawal by Subject|0|||
144295716|NCT00112385|520285698|FG001|Overall Study|Withdrawal by Subject|1|||
144295717|NCT02613507|520285707|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
144295718|NCT02613507|520285708|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
144295719|NCT02613507|520285707|FG000|Pre-Treamtent|Participant withdrew consent|0|||
144295720|NCT02613507|520285708|FG001|Pre-Treamtent|Participant withdrew consent|4|||
144295721|NCT02613507|520285707|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
144295722|NCT02613507|520285708|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
144295723|NCT02613507|520285707|FG000|Treatment|Not reported|3|||
144295724|NCT02613507|520285708|FG001|Treatment|Not reported|0|||
144295725|NCT02613507|520285707|FG000|Treatment|Other reasons|8|||
144295726|NCT02613507|520285708|FG001|Treatment|Other reasons|0|||
144295727|NCT02613507|520285707|FG000|Treatment|Participant no longer meets criteria|3|||
144295728|NCT02613507|520285708|FG001|Treatment|Participant no longer meets criteria|0|||
144295729|NCT02613507|520285707|FG000|Treatment|Maximum clinical benefit|5|||
144295730|NCT02613507|520285708|FG001|Treatment|Maximum clinical benefit|10|||
144295731|NCT02613507|520285707|FG000|Treatment|Lost to Follow-up|1|||
144295732|NCT02613507|520285708|FG001|Treatment|Lost to Follow-up|0|||
144295733|NCT02613507|520285707|FG000|Treatment|Participant withdrew consent|0|||
144295734|NCT02613507|520285708|FG001|Treatment|Participant withdrew consent|2|||
144295735|NCT02613507|520285707|FG000|Treatment|Participant request to discontinue study treatment|13|||
144295736|NCT02613507|520285708|FG001|Treatment|Participant request to discontinue study treatment|17|||
144295737|NCT02613507|520285707|FG000|Treatment|Adverse event unrelated to study drug|20|||
144295738|NCT02613507|520285708|FG001|Treatment|Adverse event unrelated to study drug|3|||
144295739|NCT02613507|520285707|FG000|Treatment|Death|2|||
144295740|NCT02613507|520285708|FG001|Treatment|Death|0|||
144295741|NCT02613507|520285707|FG000|Treatment|Study drug toxicity|19|||
144295742|NCT02613507|520285708|FG001|Treatment|Study drug toxicity|14|||
144295743|NCT02613507|520285707|FG000|Treatment|Disease progression|263|||
144295744|NCT02613507|520285708|FG001|Treatment|Disease progression|110|||
144295745|NCT03360344|520287011|FG000|Overall Study|Withdrawal by Subject|0|||
144295746|NCT03360344|520287012|FG001|Overall Study|Withdrawal by Subject|1|||
144295747|NCT03360344|520287013|FG002|Overall Study|Withdrawal by Subject|1|||
144295748|NCT03468998|520287018|FG000|Overall Study|Withdrawal by Subject|1|||
144295749|NCT03468998|520287019|FG001|Overall Study|Withdrawal by Subject|1|||
144295750|NCT03468998|520287020|FG002|Overall Study|Withdrawal by Subject|0|||
144295751|NCT03468998|520287021|FG003|Overall Study|Withdrawal by Subject|4|||
144295752|NCT03468998|520287022|FG004|Overall Study|Withdrawal by Subject|1|||
144295753|NCT03468998|520287023|FG005|Overall Study|Withdrawal by Subject|0|||
144295754|NCT00133705|520287024|FG000|Overall Study|Withdrawal by Subject|2|||
144295755|NCT00133705|520287025|FG001|Overall Study|Withdrawal by Subject|3|||
144295756|NCT00959049|520287026|FG000|Overall Study|Adverse Event|1|||
144295757|NCT00959049|520287027|FG001|Overall Study|Adverse Event|0|||
144295758|NCT00959049|520287028|FG002|Overall Study|Adverse Event|0|||
144295759|NCT00959049|520287029|FG003|Overall Study|Adverse Event|0|||
144295760|NCT00959049|520287030|FG004|Overall Study|Adverse Event|0|||
144295761|NCT00959049|520287031|FG005|Overall Study|Adverse Event|0|||
144295762|NCT00959049|520287026|FG000|Overall Study|Lost to Follow-up|17|||
144295763|NCT00959049|520287027|FG001|Overall Study|Lost to Follow-up|5|||
144295764|NCT00959049|520287028|FG002|Overall Study|Lost to Follow-up|1|||
144295765|NCT00959049|520287029|FG003|Overall Study|Lost to Follow-up|10|||
144295766|NCT00959049|520287030|FG004|Overall Study|Lost to Follow-up|9|||
144295767|NCT00959049|520287031|FG005|Overall Study|Lost to Follow-up|1|||
144295768|NCT00959049|520287026|FG000|Overall Study|Contraindicated medication|0|||
144295769|NCT00959049|520287027|FG001|Overall Study|Contraindicated medication|0|||
144295770|NCT00959049|520287028|FG002|Overall Study|Contraindicated medication|0|||
144295771|NCT00959049|520287029|FG003|Overall Study|Contraindicated medication|1|||
144295772|NCT00959049|520287030|FG004|Overall Study|Contraindicated medication|0|||
144295773|NCT00959049|520287031|FG005|Overall Study|Contraindicated medication|0|||
144295774|NCT00959049|520287026|FG000|Overall Study|Withdrawal by Subject|0|||
144295775|NCT00959049|520287027|FG001|Overall Study|Withdrawal by Subject|2|||
144295776|NCT00959049|520287028|FG002|Overall Study|Withdrawal by Subject|0|||
144295777|NCT00959049|520287029|FG003|Overall Study|Withdrawal by Subject|0|||
144295778|NCT00959049|520287030|FG004|Overall Study|Withdrawal by Subject|0|||
144295779|NCT00959049|520287031|FG005|Overall Study|Withdrawal by Subject|0|||
144295780|NCT01892189|520287036|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
144295781|NCT01892189|520287037|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
144295782|NCT01892189|520287038|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
144295783|NCT01892189|520287039|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
144295784|NCT01892189|520287040|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
144295785|NCT01892189|520287041|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
144295786|NCT01892189|520287042|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
144295787|NCT01892189|520287043|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
144295788|NCT01892189|520287044|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
144295789|NCT01892189|520287036|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144295790|NCT01892189|520287037|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144295791|NCT01892189|520287038|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
144295792|NCT01892189|520287039|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
144295793|NCT01892189|520287040|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144295794|NCT01892189|520287041|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144295795|NCT01892189|520287042|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
144295796|NCT01892189|520287043|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144295797|NCT01892189|520287044|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
144295798|NCT01892189|520287036|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295799|NCT01892189|520287037|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295800|NCT01892189|520287038|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295801|NCT01892189|520287039|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295802|NCT01892189|520287040|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295803|NCT01892189|520287041|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
144295804|NCT01892189|520287042|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295805|NCT01892189|520287043|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295806|NCT01892189|520287044|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
144295807|NCT00688740|520287047|FG000|Overall Study|Adverse Event|45|||
144295808|NCT00688740|520287048|FG001|Overall Study|Adverse Event|8|||
144295809|NCT00688740|520287047|FG000|Overall Study|Death|2|||
144295810|NCT00688740|520287048|FG001|Overall Study|Death|2|||
144295811|NCT00688740|520287047|FG000|Overall Study|Lost to Follow-up|0|||
144295812|NCT00688740|520287048|FG001|Overall Study|Lost to Follow-up|1|||
144295813|NCT00688740|520287047|FG000|Overall Study|Consent Withdrawn|17|||
144295814|NCT00688740|520287048|FG001|Overall Study|Consent Withdrawn|17|||
144295815|NCT00688740|520287047|FG000|Overall Study|Breast Cancer Relapse|1|||
144295816|NCT00688740|520287048|FG001|Overall Study|Breast Cancer Relapse|4|||
144295817|NCT00688740|520287047|FG000|Overall Study|Violation of Inclusion Criteria|1|||
144295818|NCT00688740|520287048|FG001|Overall Study|Violation of Inclusion Criteria|3|||
144295819|NCT00095576|520287049|FG000|Overall Study|Adverse Event|5|||
144295820|NCT00095576|520287050|FG001|Overall Study|Adverse Event|3|||
144295821|NCT00095576|520287049|FG000|Overall Study|Lost to Follow-up|233|||
144295822|NCT00095576|520287050|FG001|Overall Study|Lost to Follow-up|229|||
144295823|NCT00095576|520287049|FG000|Overall Study|Protocol Violation|1|||
144295824|NCT00095576|520287050|FG001|Overall Study|Protocol Violation|0|||
144295825|NCT00095576|520287049|FG000|Overall Study|Withdrawal by Subject|34|||
144295826|NCT00095576|520287050|FG001|Overall Study|Withdrawal by Subject|47|||
144295827|NCT00095576|520287049|FG000|Overall Study|Option to switch to a rollover study|1097|||
144295828|NCT00095576|520287050|FG001|Overall Study|Option to switch to a rollover study|1099|||
144295829|NCT00095576|520287049|FG000|Overall Study|Site terminated|75|||
144295830|NCT00095576|520287050|FG001|Overall Study|Site terminated|67|||
144295831|NCT00095576|520287049|FG000|Overall Study|Subject moved|30|||
144295832|NCT00095576|520287050|FG001|Overall Study|Subject moved|36|||
144295833|NCT01344356|520287051|FG000|Overall Study|Physician Decision|0|||
144295834|NCT01344356|520287052|FG001|Overall Study|Physician Decision|3|||
144295835|NCT01344356|520287051|FG000|Overall Study|Lost to Follow-up|0|||
144295836|NCT01344356|520287052|FG001|Overall Study|Lost to Follow-up|6|||
144295837|NCT00567502|520287053|FG000|Overall Study|Lost to Follow-up|91|||
144295838|NCT00567502|520287054|FG001|Overall Study|Lost to Follow-up|14|||
144295839|NCT00567502|520287055|FG002|Overall Study|Lost to Follow-up|351|||
144295840|NCT00567502|520287056|FG003|Overall Study|Lost to Follow-up|2|||
144295841|NCT00567502|520287053|FG000|Overall Study|Death|65|||
144295842|NCT00567502|520287054|FG001|Overall Study|Death|16|||
144295843|NCT00567502|520287055|FG002|Overall Study|Death|360|||
144295844|NCT00567502|520287056|FG003|Overall Study|Death|5|||
144295845|NCT00567502|520287053|FG000|Overall Study|Other|64|||
144295846|NCT00567502|520287054|FG001|Overall Study|Other|2|||
144295847|NCT00567502|520287055|FG002|Overall Study|Other|134|||
144295848|NCT00567502|520287056|FG003|Overall Study|Other|6|||
144295849|NCT00567502|520287053|FG000|Overall Study|Participant request|12|||
144295850|NCT00567502|520287054|FG001|Overall Study|Participant request|1|||
144295851|NCT00567502|520287055|FG002|Overall Study|Participant request|33|||
144295852|NCT00567502|520287056|FG003|Overall Study|Participant request|1|||
144295853|NCT00567502|520287053|FG000|Overall Study|Sponsor request|9|||
144295854|NCT00567502|520287054|FG001|Overall Study|Sponsor request|0|||
144295855|NCT00567502|520287055|FG002|Overall Study|Sponsor request|30|||
144295856|NCT00567502|520287056|FG003|Overall Study|Sponsor request|1|||
144295857|NCT00567502|520287053|FG000|Overall Study|Never Initiated Treatment|0|||
144295858|NCT00567502|520287054|FG001|Overall Study|Never Initiated Treatment|0|||
144295859|NCT00567502|520287055|FG002|Overall Study|Never Initiated Treatment|0|||
144295860|NCT00567502|520287056|FG003|Overall Study|Never Initiated Treatment|72|||
144295861|NCT00856557|520287057|FG000|Overall Study|No patients with contextual flags|12|||
144295862|NCT00856557|520287058|FG001|Overall Study|No patients with contextual flags|16|||
144295863|NCT03673176|520287059|FG000|Overall Study|Death prior to intervention|1|||
144295864|NCT03673176|520287059|FG000|Overall Study|Death following intervention|3|||
144295865|NCT03673176|520287059|FG000|Overall Study|Withdrawal by Subject|1|||
144295866|NCT02378480|520287060|FG000|Overall Study|Physician Decision|1|||
144295867|NCT02378480|520287061|FG001|Overall Study|Physician Decision|1|||
144295868|NCT02378480|520287060|FG000|Overall Study|Death|1|||
144295869|NCT02378480|520287061|FG001|Overall Study|Death|2|||
144295870|NCT02378480|520287060|FG000|Overall Study|Randomized, but Not Treated|6|||
144295871|NCT02378480|520287061|FG001|Overall Study|Randomized, but Not Treated|4|||
144295872|NCT02378480|520287060|FG000|Overall Study|Adverse Event|0|||
144295873|NCT02378480|520287061|FG001|Overall Study|Adverse Event|1|||
144295874|NCT02378480|520287060|FG000|Overall Study|Missed EOT/PTE Visit|1|||
144295875|NCT02378480|520287061|FG001|Overall Study|Missed EOT/PTE Visit|2|||
144295876|NCT02378480|520287060|FG000|Overall Study|Withdrawal by Subject|9|||
144295877|NCT02378480|520287061|FG001|Overall Study|Withdrawal by Subject|4|||
144295878|NCT02378480|520287060|FG000|Overall Study|Lost to Follow-up|10|||
144295879|NCT02378480|520287061|FG001|Overall Study|Lost to Follow-up|18|||
144295880|NCT01285102|520287063|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
144295881|NCT02743962|520287064|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
144295882|NCT02743962|520287065|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
144295883|NCT00725985|520287069|FG000|ITP- Treatment Disposition|Adverse Event|20|||
144295884|NCT00725985|520287070|FG001|ITP- Treatment Disposition|Adverse Event|10|||
144295885|NCT00725985|520287071|FG002|ITP- Treatment Disposition|Adverse Event|5|||
144295886|NCT00725985|520287072|FG003|ITP- Treatment Disposition|Adverse Event|0|||
144295887|NCT00725985|520287073|FG004|ITP- Treatment Disposition|Adverse Event|0|||
144295888|NCT00725985|520287074|FG005|ITP- Treatment Disposition|Adverse Event|0|||
144295889|NCT00725985|520287075|FG006|ITP- Treatment Disposition|Adverse Event|0|||
144295890|NCT00725985|520287076|FG007|ITP- Treatment Disposition|Adverse Event|0|||
144295891|NCT00725985|520287077|FG008|ITP- Treatment Disposition|Adverse Event|0|||
144295892|NCT00725985|520287078|FG009|ITP- Treatment Disposition|Adverse Event|0|||
144295893|NCT00725985|520287079|FG010|ITP- Treatment Disposition|Adverse Event|0|||
144295894|NCT00725985|520287080|FG011|ITP- Treatment Disposition|Adverse Event|0|||
144295895|NCT00725985|520287069|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295896|NCT00725985|520287070|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295897|NCT00725985|520287071|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
144295898|NCT00725985|520287072|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295899|NCT00725985|520287073|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295900|NCT00725985|520287074|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295901|NCT00725985|520287075|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295902|NCT00725985|520287076|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295903|NCT00725985|520287077|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295904|NCT00725985|520287078|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295905|NCT00725985|520287079|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295906|NCT00725985|520287080|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
144295907|NCT00725985|520287069|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
144295908|NCT00725985|520287070|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
144295909|NCT00725985|520287071|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
144295910|NCT00725985|520287072|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
144295911|NCT00725985|520287073|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
144295912|NCT00725985|520287074|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
144295913|NCT00725985|520287075|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
144295914|NCT00725985|520287076|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
144295915|NCT00725985|520287077|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
144295916|NCT00725985|520287078|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
144295917|NCT00725985|520287079|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
144295918|NCT00725985|520287080|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
144295919|NCT00725985|520287069|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
144295920|NCT00725985|520287070|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
144295921|NCT00725985|520287071|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
144295922|NCT00725985|520287072|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
144295923|NCT00725985|520287073|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
144295924|NCT00725985|520287074|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
144295925|NCT00725985|520287075|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
144295926|NCT00725985|520287076|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
144295927|NCT00725985|520287077|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
144295928|NCT00725985|520287078|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
144295929|NCT00725985|520287079|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
144295930|NCT00725985|520287080|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
144295931|NCT00725985|520287069|FG000|ITP- Treatment Disposition|Other|50|||
144295932|NCT00725985|520287070|FG001|ITP- Treatment Disposition|Other|38|||
144295933|NCT00725985|520287071|FG002|ITP- Treatment Disposition|Other|24|||
144295934|NCT00725985|520287072|FG003|ITP- Treatment Disposition|Other|0|||
144295935|NCT00725985|520287073|FG004|ITP- Treatment Disposition|Other|0|||
144295936|NCT00725985|520287074|FG005|ITP- Treatment Disposition|Other|0|||
144295937|NCT00725985|520287075|FG006|ITP- Treatment Disposition|Other|0|||
144295938|NCT00725985|520287076|FG007|ITP- Treatment Disposition|Other|0|||
144295939|NCT00725985|520287077|FG008|ITP- Treatment Disposition|Other|0|||
144295940|NCT00725985|520287078|FG009|ITP- Treatment Disposition|Other|0|||
144295941|NCT00725985|520287079|FG010|ITP- Treatment Disposition|Other|0|||
144295942|NCT00725985|520287080|FG011|ITP- Treatment Disposition|Other|0|||
144295943|NCT00725985|520287069|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295944|NCT00725985|520287070|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295945|NCT00725985|520287071|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295946|NCT00725985|520287072|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
144295947|NCT00725985|520287073|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
144295948|NCT00725985|520287074|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
144295949|NCT00725985|520287075|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295950|NCT00725985|520287076|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295951|NCT00725985|520287077|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295952|NCT00725985|520287078|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295953|NCT00725985|520287079|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295954|NCT00725985|520287080|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
144295955|NCT00725985|520287069|FG000|OLMP (Up to 96 Weeks)|Death|0|||
144295956|NCT00725985|520287070|FG001|OLMP (Up to 96 Weeks)|Death|0|||
144295957|NCT00725985|520287071|FG002|OLMP (Up to 96 Weeks)|Death|0|||
144295958|NCT00725985|520287072|FG003|OLMP (Up to 96 Weeks)|Death|0|||
144295959|NCT00725985|520287073|FG004|OLMP (Up to 96 Weeks)|Death|1|||
144295960|NCT00725985|520287074|FG005|OLMP (Up to 96 Weeks)|Death|0|||
144295961|NCT00725985|520287075|FG006|OLMP (Up to 96 Weeks)|Death|0|||
144295962|NCT00725985|520287076|FG007|OLMP (Up to 96 Weeks)|Death|0|||
144295963|NCT00725985|520287077|FG008|OLMP (Up to 96 Weeks)|Death|0|||
144295964|NCT00725985|520287078|FG009|OLMP (Up to 96 Weeks)|Death|0|||
144295965|NCT00725985|520287079|FG010|OLMP (Up to 96 Weeks)|Death|0|||
144295966|NCT00725985|520287080|FG011|OLMP (Up to 96 Weeks)|Death|0|||
144295967|NCT00725985|520287069|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295968|NCT00725985|520287070|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295969|NCT00725985|520287071|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295970|NCT00725985|520287072|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
144295971|NCT00725985|520287073|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295972|NCT00725985|520287074|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295973|NCT00725985|520287075|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295974|NCT00725985|520287076|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295975|NCT00725985|520287077|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295976|NCT00725985|520287078|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295977|NCT00725985|520287079|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295978|NCT00725985|520287080|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
144295979|NCT00725985|520287069|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295980|NCT00725985|520287070|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295981|NCT00725985|520287071|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295982|NCT00725985|520287072|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295983|NCT00725985|520287073|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295984|NCT00725985|520287074|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
144295985|NCT00725985|520287075|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295986|NCT00725985|520287076|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295987|NCT00725985|520287077|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295988|NCT00725985|520287078|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295989|NCT00725985|520287079|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295990|NCT00725985|520287080|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
144295991|NCT00725985|520287069|FG000|OLMP (Up to 96 Weeks)|Other|0|||
144295992|NCT00725985|520287070|FG001|OLMP (Up to 96 Weeks)|Other|0|||
144295993|NCT00725985|520287071|FG002|OLMP (Up to 96 Weeks)|Other|0|||
144295994|NCT00725985|520287072|FG003|OLMP (Up to 96 Weeks)|Other|15|||
144295995|NCT00725985|520287073|FG004|OLMP (Up to 96 Weeks)|Other|20|||
144295996|NCT00725985|520287074|FG005|OLMP (Up to 96 Weeks)|Other|44|||
144295997|NCT00725985|520287075|FG006|OLMP (Up to 96 Weeks)|Other|0|||
144295998|NCT00725985|520287076|FG007|OLMP (Up to 96 Weeks)|Other|0|||
144295999|NCT00725985|520287077|FG008|OLMP (Up to 96 Weeks)|Other|0|||
144296000|NCT00725985|520287078|FG009|OLMP (Up to 96 Weeks)|Other|0|||
144296001|NCT00725985|520287079|FG010|OLMP (Up to 96 Weeks)|Other|0|||
144296002|NCT00725985|520287080|FG011|OLMP (Up to 96 Weeks)|Other|0|||
144296003|NCT00725985|520287069|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296004|NCT00725985|520287070|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296005|NCT00725985|520287071|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296006|NCT00725985|520287072|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296007|NCT00725985|520287073|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296008|NCT00725985|520287074|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296009|NCT00725985|520287075|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296010|NCT00725985|520287076|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
144296011|NCT00725985|520287077|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296012|NCT00725985|520287078|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296013|NCT00725985|520287079|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296014|NCT00725985|520287080|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
144296015|NCT00725985|520287069|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296016|NCT00725985|520287070|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296017|NCT00725985|520287071|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296018|NCT00725985|520287072|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296019|NCT00725985|520287073|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296020|NCT00725985|520287074|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296021|NCT00725985|520287075|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296022|NCT00725985|520287076|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296023|NCT00725985|520287077|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
144296024|NCT00725985|520287078|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296025|NCT00725985|520287079|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296026|NCT00725985|520287080|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
144296027|NCT00725985|520287069|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296028|NCT00725985|520287070|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296029|NCT00725985|520287071|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296030|NCT00725985|520287072|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296031|NCT00725985|520287073|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296032|NCT00725985|520287074|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296033|NCT00725985|520287075|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
144296034|NCT00725985|520287076|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
144296035|NCT00725985|520287077|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
144296036|NCT00725985|520287078|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296037|NCT00725985|520287079|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296038|NCT00725985|520287080|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
144296039|NCT00725985|520287069|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296040|NCT00725985|520287070|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296041|NCT00725985|520287071|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296042|NCT00725985|520287072|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296043|NCT00725985|520287073|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296044|NCT00725985|520287074|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296045|NCT00725985|520287075|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296046|NCT00725985|520287076|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296047|NCT00725985|520287077|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
144296048|NCT00725985|520287078|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
144296049|NCT00725985|520287079|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
144296050|NCT00725985|520287080|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
144296051|NCT01381679|520287084|FG000|Overall Study|Adverse Event|3|||
144296052|NCT01381679|520287084|FG000|Overall Study|Lost to Follow-up|885|||
144296053|NCT04023487|520287085|FG000|Overall Study|Lost to Follow-up|5|||
144296054|NCT04023487|520287086|FG001|Overall Study|Lost to Follow-up|4|||
144296055|NCT04023487|520287085|FG000|Overall Study|Pregnancy|1|||
144296056|NCT04023487|520287086|FG001|Overall Study|Pregnancy|2|||
144296057|NCT04023487|520287085|FG000|Overall Study|Withdrawal by Subject|4|||
144296058|NCT04023487|520287086|FG001|Overall Study|Withdrawal by Subject|5|||
144296059|NCT04023487|520287085|FG000|Overall Study|Partially completed testing|8|||
144296060|NCT04023487|520287086|FG001|Overall Study|Partially completed testing|4|||
144296061|NCT05473715|520287089|FG000|Overall Study|Trial terminate|2|||
144296062|NCT05473715|520287090|FG001|Overall Study|Trial terminate|1|||
144296063|NCT02592863|520287092|FG000|Overall Study|Withdrawal by Subject|2|||
144296064|NCT02592863|520287093|FG001|Overall Study|Withdrawal by Subject|2|||
144296065|NCT02592863|520287092|FG000|Overall Study|Lost to Follow-up|1|||
144296066|NCT02592863|520287093|FG001|Overall Study|Lost to Follow-up|1|||
144296067|NCT02743221|520287094|FG000|Overall Study|Progressive disease|29|||
144296068|NCT02743221|520287095|FG001|Overall Study|Progressive disease|38|||
144296069|NCT02743221|520287094|FG000|Overall Study|Adverse Event|17|||
144296070|NCT02743221|520287095|FG001|Overall Study|Adverse Event|14|||
144296071|NCT02743221|520287094|FG000|Overall Study|non medical reason|8|||
144296072|NCT02743221|520287095|FG001|Overall Study|non medical reason|2|||
144296073|NCT02743221|520287094|FG000|Overall Study|Physician Decision|2|||
144296074|NCT02743221|520287095|FG001|Overall Study|Physician Decision|5|||
144296075|NCT02743221|520287094|FG000|Overall Study|Patient not eligible, not treated|0|||
144296076|NCT02743221|520287095|FG001|Overall Study|Patient not eligible, not treated|1|||
144296077|NCT03528902|520287098|FG000|Overall Study|Adverse Event|1|||
144296078|NCT03528902|520287099|FG001|Overall Study|Adverse Event|0|||
144296079|NCT03411044|520287100|FG000|Overall Study|Death|30|||
144296080|NCT03411044|520287100|FG000|Overall Study|Withdrawal by Subject|48|||
144296081|NCT03411044|520287100|FG000|Overall Study|Lost to Follow-up|78|||
144296082|NCT03411044|520287100|FG000|Overall Study|Adverse Event|30|||
144296083|NCT03411044|520287100|FG000|Overall Study|Missing status|4|||
144296084|NCT02609503|520287102|FG000|Overall Study|Adverse Event|1|||
144296085|NCT02609503|520287102|FG000|Overall Study|Death|1|||
144296086|NCT02609503|520287102|FG000|Overall Study|Withdrawal by Subject|1|||
144296087|NCT02609503|520287102|FG000|Overall Study|Disease progression|1|||
144296088|NCT03900650|520287106|FG000|Overall Study|Withdrawal by Subject|1|||
144296089|NCT03900650|520287107|FG001|Overall Study|Withdrawal by Subject|1|||
144296090|NCT03900650|520287108|FG002|Overall Study|Withdrawal by Subject|0|||
144296091|NCT03900650|520287109|FG003|Overall Study|Withdrawal by Subject|0|||
144296092|NCT03900650|520287106|FG000|Overall Study|Withdrawn by staff|1|||
144296093|NCT03900650|520287107|FG001|Overall Study|Withdrawn by staff|0|||
144296094|NCT03900650|520287108|FG002|Overall Study|Withdrawn by staff|0|||
144296095|NCT03900650|520287109|FG003|Overall Study|Withdrawn by staff|0|||
144296096|NCT02457065|520287110|FG000|Overall Study|Lost to Follow-up|9|||
144296097|NCT02457065|520287111|FG001|Overall Study|Lost to Follow-up|11|||
144296098|NCT04642079|520287117|FG000|Overall Study|Lost to Follow-up|2|||
144296099|NCT04642079|520287118|FG001|Overall Study|Lost to Follow-up|5|||
144296100|NCT04642079|520287119|FG002|Overall Study|Lost to Follow-up|2|||
144296101|NCT04642079|520287120|FG003|Overall Study|Lost to Follow-up|0|||
144296102|NCT04642079|520287117|FG000|Overall Study|Withdrawal by Subject|0|||
144296103|NCT04642079|520287118|FG001|Overall Study|Withdrawal by Subject|4|||
144296104|NCT04642079|520287119|FG002|Overall Study|Withdrawal by Subject|1|||
144296105|NCT04642079|520287120|FG003|Overall Study|Withdrawal by Subject|2|||
144296106|NCT04642079|520287117|FG000|Overall Study|Other|0|||
144296107|NCT04642079|520287118|FG001|Overall Study|Other|0|||
144296108|NCT04642079|520287119|FG002|Overall Study|Other|0|||
144296109|NCT04642079|520287120|FG003|Overall Study|Other|1|||
144296110|NCT04642079|520287117|FG000|Overall Study|No longer met eligibility criteria|1|||
144296111|NCT04642079|520287118|FG001|Overall Study|No longer met eligibility criteria|0|||
144296112|NCT04642079|520287119|FG002|Overall Study|No longer met eligibility criteria|1|||
144296113|NCT04642079|520287120|FG003|Overall Study|No longer met eligibility criteria|1|||
144296114|NCT00526799|520287129|FG000|Overall Study|Withdrawal by Subject|1|||
144296115|NCT00526799|520287130|FG001|Overall Study|Withdrawal by Subject|0|||
144296116|NCT00526799|520287129|FG000|Overall Study|Intercurrent Complicating Disease|0|||
144296117|NCT00526799|520287130|FG001|Overall Study|Intercurrent Complicating Disease|1|||
144296118|NCT04134936|520287142|FG000|Overall Study|Adverse Event|3|||
144296119|NCT04134936|520287143|FG001|Overall Study|Adverse Event|2|||
144296120|NCT04134936|520287142|FG000|Overall Study|Withdrawal by Subject|2|||
144296121|NCT04134936|520287143|FG001|Overall Study|Withdrawal by Subject|3|||
144296122|NCT04134936|520287142|FG000|Overall Study|Physician Decision|0|||
144296123|NCT04134936|520287143|FG001|Overall Study|Physician Decision|1|||
144296124|NCT04134936|520287142|FG000|Overall Study|Progressive disease, joined another trial|1|||
144296125|NCT04134936|520287143|FG001|Overall Study|Progressive disease, joined another trial|0|||
144296126|NCT04134936|520287142|FG000|Overall Study|Progressive disease|1|||
144296127|NCT04134936|520287143|FG001|Overall Study|Progressive disease|0|||
144296128|NCT03518060|520287144|FG000|Overall Study|Death|1|||
144296129|NCT03518060|520287144|FG000|Overall Study|Poor adherence|1|||
144296130|NCT03518060|520287144|FG000|Overall Study|Withdrawal of informed consent|2|||
144296131|NCT03518060|520287144|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
144296132|NCT03518060|520287144|FG000|Overall Study|Physician Decision|7|||
144296133|NCT03518060|520287144|FG000|Overall Study|Adverse drug reactions|23|||
144296134|NCT03518060|520287144|FG000|Overall Study|Withdrawal by Subject|25|||
144296135|NCT03518060|520287144|FG000|Overall Study|Lost to Follow-up|13|||
144296136|NCT02679274|520287147|FG000|Overall Study|Withdrawal by Subject|1|||
144296137|NCT02679274|520287148|FG001|Overall Study|Withdrawal by Subject|0|||
144296138|NCT04976855|520287149|FG000|Part I|Withdrawal by Subject|0|||
144296139|NCT04976855|520287150|FG001|Part I|Withdrawal by Subject|1|||
144296140|NCT04976855|520287151|FG002|Part I|Withdrawal by Subject|0|||
144296141|NCT04976855|520287152|FG003|Part I|Withdrawal by Subject|0|||
144296142|NCT04976855|520287153|FG004|Part I|Withdrawal by Subject|0|||
144296143|NCT04976855|520287154|FG005|Part I|Withdrawal by Subject|0|||
144296144|NCT04976855|520287155|FG006|Part I|Withdrawal by Subject|0|||
144296145|NCT04976855|520287149|FG000|Part II|Adverse Event|0|||
144296146|NCT04976855|520287150|FG001|Part II|Adverse Event|0|||
144296147|NCT04976855|520287151|FG002|Part II|Adverse Event|0|||
144296148|NCT04976855|520287152|FG003|Part II|Adverse Event|1|||
144296149|NCT04976855|520287153|FG004|Part II|Adverse Event|0|||
144296150|NCT04976855|520287154|FG005|Part II|Adverse Event|0|||
144296151|NCT04976855|520287155|FG006|Part II|Adverse Event|0|||
144296152|NCT04976855|520287149|FG000|Part II|Withdrawal by Subject|0|||
144296153|NCT04976855|520287150|FG001|Part II|Withdrawal by Subject|0|||
144296154|NCT04976855|520287151|FG002|Part II|Withdrawal by Subject|0|||
144296155|NCT04976855|520287152|FG003|Part II|Withdrawal by Subject|0|||
144296156|NCT04976855|520287153|FG004|Part II|Withdrawal by Subject|1|||
144296157|NCT04976855|520287154|FG005|Part II|Withdrawal by Subject|0|||
144296158|NCT04976855|520287155|FG006|Part II|Withdrawal by Subject|0|||
144296159|NCT04976855|520287149|FG000|Part II|Lost to Follow-up|0|||
144296160|NCT04976855|520287150|FG001|Part II|Lost to Follow-up|0|||
144296161|NCT04976855|520287151|FG002|Part II|Lost to Follow-up|0|||
144296162|NCT04976855|520287152|FG003|Part II|Lost to Follow-up|0|||
144296163|NCT04976855|520287153|FG004|Part II|Lost to Follow-up|0|||
144296164|NCT04976855|520287154|FG005|Part II|Lost to Follow-up|1|||
144296165|NCT04976855|520287155|FG006|Part II|Lost to Follow-up|0|||
144296166|NCT00835172|520287170|FG000|Washout|Protocol Violation|0|||
144296167|NCT00835172|520287171|FG001|Washout|Protocol Violation|1|||
144296168|NCT00964678|520287179|FG000|Overall Study|Physician Decision|4|||
144296169|NCT03359395|520287180|FG000|First Intervention A / B|Withdrawal by Subject|1|||
144296170|NCT03359395|520287181|FG001|First Intervention A / B|Withdrawal by Subject|0|||
144296171|NCT03359395|520287180|FG000|First Intervention A / B|Lost to Follow-up|2|||
144296172|NCT03359395|520287181|FG001|First Intervention A / B|Lost to Follow-up|3|||
144296173|NCT03359395|520287180|FG000|Second Intervention B/A|Exclusion criteria|0|||
144296174|NCT03359395|520287181|FG001|Second Intervention B/A|Exclusion criteria|1|||
144296175|NCT03359395|520287180|FG000|Second Intervention B/A|Lost to Follow-up|3|||
144296176|NCT03359395|520287181|FG001|Second Intervention B/A|Lost to Follow-up|2|||
144296177|NCT01373281|520289064|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
144296178|NCT01373281|520289065|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
144296179|NCT01373281|520289064|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
144296180|NCT01373281|520289065|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
144296181|NCT01373281|520289064|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
144296182|NCT01373281|520289065|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
144296183|NCT01373281|520289064|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
144296184|NCT01373281|520289065|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
144296185|NCT01373281|520289064|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
144296186|NCT01373281|520289065|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
144296187|NCT01373281|520289064|FG000|Surveillance Expansion Period|Protocol Violation|9|||
144296188|NCT01373281|520289065|FG001|Surveillance Expansion Period|Protocol Violation|1|||
144296189|NCT01373281|520289064|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
144296190|NCT01373281|520289065|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
144296191|NCT01373281|520289064|FG000|Surveillance Expansion Period|Serious adverse event|3|||
144296192|NCT01373281|520289065|FG001|Surveillance Expansion Period|Serious adverse event|4|||
144296193|NCT01397253|520289066|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
144296194|NCT01397253|520289067|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
144296195|NCT03502681|520289072|FG000|Overall Study|Adverse Event|1|||
144296196|NCT03502681|520289073|FG001|Overall Study|Adverse Event|1|||
144296197|NCT03502681|520289072|FG000|Overall Study|Disease Progression|2|||
144296198|NCT03502681|520289073|FG001|Overall Study|Disease Progression|1|||
144296199|NCT00488293|520289076|FG000|Overall Study|Lost to Follow-up|28|||
144296200|NCT00488293|520289077|FG001|Overall Study|Lost to Follow-up|25|||
144296201|NCT00488293|520289076|FG000|Overall Study|Withdrawal by Subject|5|||
144296202|NCT00488293|520289077|FG001|Overall Study|Withdrawal by Subject|3|||
144296203|NCT00488293|520289076|FG000|Overall Study|Death|2|||
144296204|NCT00488293|520289077|FG001|Overall Study|Death|1|||
144296205|NCT00488293|520289076|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
144296206|NCT00488293|520289077|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
144296207|NCT00939185|520289078|FG000|Overall Study|Adverse Event|3|||
144296208|NCT00939185|520289078|FG000|Overall Study|Lack of Efficacy|1|||
144296209|NCT00939185|520289078|FG000|Overall Study|Lost to Follow-up|6|||
144296210|NCT00939185|520289078|FG000|Overall Study|Other|3|||
144296211|NCT00939185|520289078|FG000|Overall Study|Withdrawal by Subject|2|||
144296212|NCT00939185|520289078|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
144296213|NCT00363298|520289079|FG000|First Study Week|Lack of Efficacy|6|||
144296214|NCT00363298|520289080|FG001|First Study Week|Lack of Efficacy|5|||
144296215|NCT00363298|520289079|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
144296216|NCT00363298|520289080|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
144296217|NCT03552029|520289081|FG000|Overall Study|Death|3|||
144296218|NCT03552029|520289082|FG001|Overall Study|Death|0|||
144296219|NCT03552029|520289081|FG000|Overall Study|Adverse Event|1|||
144296220|NCT03552029|520289082|FG001|Overall Study|Adverse Event|0|||
144296221|NCT03552029|520289081|FG000|Overall Study|Lack of Efficacy|0|||
144296222|NCT03552029|520289082|FG001|Overall Study|Lack of Efficacy|2|||
144296223|NCT03552029|520289081|FG000|Overall Study|Physician Decision|0|||
144296224|NCT03552029|520289082|FG001|Overall Study|Physician Decision|1|||
144296225|NCT03552029|520289081|FG000|Overall Study|Study terminated by Sponsor|0|||
144296226|NCT03552029|520289082|FG001|Overall Study|Study terminated by Sponsor|1|||
144296227|NCT03552029|520289081|FG000|Overall Study|Other|0|||
144296228|NCT03552029|520289082|FG001|Overall Study|Other|2|||
144296229|NCT00836706|520289089|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
144296230|NCT00836706|520289090|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
144296231|NCT02989857|520289091|FG000|Randomization Phase|Not Treated|3|||
144296232|NCT02989857|520289092|FG001|Randomization Phase|Not Treated|2|||
144296233|NCT02989857|520289093|FG002|Randomization Phase|Not Treated|0|||
144296234|NCT01992757|520289096|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
144296235|NCT03440411|520289097|FG000|Overall Study|Adverse Event|0|||
144296236|NCT03440411|520289098|FG001|Overall Study|Adverse Event|0|||
144296237|NCT03440411|520289099|FG002|Overall Study|Adverse Event|1|||
144296238|NCT03440411|520289100|FG003|Overall Study|Adverse Event|0|||
144296239|NCT03440411|520289097|FG000|Overall Study|PD|2|||
144296240|NCT03440411|520289098|FG001|Overall Study|PD|1|||
144296241|NCT03440411|520289099|FG002|Overall Study|PD|1|||
144296242|NCT03440411|520289100|FG003|Overall Study|PD|1|||
144296243|NCT03440411|520289097|FG000|Overall Study|Withdrawal by Subject|1|||
144296244|NCT03440411|520289098|FG001|Overall Study|Withdrawal by Subject|0|||
144296245|NCT03440411|520289099|FG002|Overall Study|Withdrawal by Subject|0|||
144296246|NCT03440411|520289100|FG003|Overall Study|Withdrawal by Subject|0|||
144296247|NCT03440411|520289097|FG000|Overall Study|Closed study by sponsor|0|||
144296248|NCT03440411|520289098|FG001|Overall Study|Closed study by sponsor|0|||
144296249|NCT03440411|520289099|FG002|Overall Study|Closed study by sponsor|0|||
144296250|NCT03440411|520289100|FG003|Overall Study|Closed study by sponsor|1|||
144296251|NCT00557440|520289113|FG000|Treatment Period 1|Adverse Event|0|||
144296252|NCT00557440|520289114|FG001|Treatment Period 1|Adverse Event|0|||
144296253|NCT00557440|520289115|FG002|Treatment Period 1|Adverse Event|1|||
144296254|NCT03524157|520289116|FG000|Overall Study|cytology not readable|0|||
144296255|NCT03524157|520289117|FG001|Overall Study|cytology not readable|0|||
144296256|NCT03524157|520289118|FG002|Overall Study|cytology not readable|1|||
144296257|NCT00863304|520289121|FG000|Overall Study|Adverse Event|10|||
144296258|NCT00863304|520289122|FG001|Overall Study|Adverse Event|4|||
144296259|NCT00863304|520289123|FG002|Overall Study|Adverse Event|14|||
144296260|NCT00863304|520289124|FG003|Overall Study|Adverse Event|16|||
144296261|NCT00863304|520289121|FG000|Overall Study|Lost to Follow-up|1|||
144296262|NCT00863304|520289122|FG001|Overall Study|Lost to Follow-up|5|||
144296263|NCT00863304|520289123|FG002|Overall Study|Lost to Follow-up|4|||
144296264|NCT00863304|520289124|FG003|Overall Study|Lost to Follow-up|2|||
144296265|NCT00863304|520289121|FG000|Overall Study|Lack of Efficacy|57|||
144296266|NCT00863304|520289122|FG001|Overall Study|Lack of Efficacy|26|||
144296267|NCT00863304|520289123|FG002|Overall Study|Lack of Efficacy|30|||
144296268|NCT00863304|520289124|FG003|Overall Study|Lack of Efficacy|28|||
144296269|NCT00863304|520289121|FG000|Overall Study|Withdrawal by Subject|19|||
144296270|NCT00863304|520289122|FG001|Overall Study|Withdrawal by Subject|14|||
144296271|NCT00863304|520289123|FG002|Overall Study|Withdrawal by Subject|20|||
144296272|NCT00863304|520289124|FG003|Overall Study|Withdrawal by Subject|18|||
144296273|NCT00863304|520289121|FG000|Overall Study|Other|1|||
144296274|NCT00863304|520289122|FG001|Overall Study|Other|0|||
144296275|NCT00863304|520289123|FG002|Overall Study|Other|0|||
144296276|NCT00863304|520289124|FG003|Overall Study|Other|1|||
144296277|NCT00863304|520289121|FG000|Overall Study|Protocol Violation|2|||
144296278|NCT00863304|520289122|FG001|Overall Study|Protocol Violation|6|||
144296279|NCT00863304|520289123|FG002|Overall Study|Protocol Violation|2|||
144296280|NCT00863304|520289124|FG003|Overall Study|Protocol Violation|0|||
144296281|NCT00863304|520289121|FG000|Overall Study|Randomized, but not Treated|3|||
144296282|NCT00863304|520289122|FG001|Overall Study|Randomized, but not Treated|1|||
144296283|NCT00863304|520289123|FG002|Overall Study|Randomized, but not Treated|4|||
144296284|NCT00863304|520289124|FG003|Overall Study|Randomized, but not Treated|1|||
144296285|NCT00863304|520289121|FG000|Overall Study|Entered extension study|101|||
144296286|NCT00863304|520289122|FG001|Overall Study|Entered extension study|129|||
144296287|NCT00863304|520289123|FG002|Overall Study|Entered extension study|113|||
144296288|NCT00863304|520289124|FG003|Overall Study|Entered extension study|125|||
144296289|NCT02327169|520289125|FG000|Overall Study|Progressive Disease|1|||
144296290|NCT02327169|520289126|FG001|Overall Study|Progressive Disease|3|||
144296291|NCT02327169|520289127|FG002|Overall Study|Progressive Disease|4|||
144296292|NCT02327169|520289128|FG003|Overall Study|Progressive Disease|3|||
144296293|NCT02327169|520289129|FG004|Overall Study|Progressive Disease|4|||
144296294|NCT02327169|520289130|FG005|Overall Study|Progressive Disease|3|||
144296295|NCT02327169|520289131|FG006|Overall Study|Progressive Disease|3|||
144296296|NCT02327169|520289132|FG007|Overall Study|Progressive Disease|3|||
144296297|NCT02327169|520289133|FG008|Overall Study|Progressive Disease|4|||
144296298|NCT02327169|520289134|FG009|Overall Study|Progressive Disease|4|||
144296299|NCT02327169|520289135|FG010|Overall Study|Progressive Disease|4|||
144296300|NCT02327169|520289136|FG011|Overall Study|Progressive Disease|3|||
144296301|NCT02327169|520289137|FG012|Overall Study|Progressive Disease|1|||
144296302|NCT02327169|520289138|FG013|Overall Study|Progressive Disease|3|||
144296303|NCT02327169|520289139|FG014|Overall Study|Progressive Disease|3|||
144296304|NCT02327169|520289125|FG000|Overall Study|Adverse Event|2|||
144296305|NCT02327169|520289126|FG001|Overall Study|Adverse Event|0|||
144296306|NCT02327169|520289127|FG002|Overall Study|Adverse Event|1|||
144296307|NCT02327169|520289128|FG003|Overall Study|Adverse Event|0|||
144296308|NCT02327169|520289129|FG004|Overall Study|Adverse Event|1|||
144296309|NCT02327169|520289130|FG005|Overall Study|Adverse Event|0|||
144296310|NCT02327169|520289131|FG006|Overall Study|Adverse Event|0|||
144296311|NCT02327169|520289132|FG007|Overall Study|Adverse Event|0|||
144296312|NCT02327169|520289133|FG008|Overall Study|Adverse Event|0|||
144296313|NCT02327169|520289134|FG009|Overall Study|Adverse Event|2|||
144296314|NCT02327169|520289135|FG010|Overall Study|Adverse Event|0|||
144296315|NCT02327169|520289136|FG011|Overall Study|Adverse Event|3|||
144296316|NCT02327169|520289137|FG012|Overall Study|Adverse Event|0|||
144296317|NCT02327169|520289138|FG013|Overall Study|Adverse Event|2|||
144296318|NCT02327169|520289139|FG014|Overall Study|Adverse Event|1|||
144296319|NCT02327169|520289125|FG000|Overall Study|Symptomatic Deterioration|0|||
144296320|NCT02327169|520289126|FG001|Overall Study|Symptomatic Deterioration|0|||
144296321|NCT02327169|520289127|FG002|Overall Study|Symptomatic Deterioration|1|||
144296322|NCT02327169|520289128|FG003|Overall Study|Symptomatic Deterioration|0|||
144296323|NCT02327169|520289129|FG004|Overall Study|Symptomatic Deterioration|1|||
144296324|NCT02327169|520289130|FG005|Overall Study|Symptomatic Deterioration|1|||
144296325|NCT02327169|520289131|FG006|Overall Study|Symptomatic Deterioration|0|||
144296326|NCT02327169|520289132|FG007|Overall Study|Symptomatic Deterioration|0|||
144296327|NCT02327169|520289133|FG008|Overall Study|Symptomatic Deterioration|2|||
144296328|NCT02327169|520289134|FG009|Overall Study|Symptomatic Deterioration|1|||
144296329|NCT02327169|520289135|FG010|Overall Study|Symptomatic Deterioration|0|||
144296330|NCT02327169|520289136|FG011|Overall Study|Symptomatic Deterioration|0|||
144296331|NCT02327169|520289137|FG012|Overall Study|Symptomatic Deterioration|0|||
144296332|NCT02327169|520289138|FG013|Overall Study|Symptomatic Deterioration|2|||
144296333|NCT02327169|520289139|FG014|Overall Study|Symptomatic Deterioration|1|||
144296334|NCT02327169|520289125|FG000|Overall Study|Reason Not Specified|0|||
144296335|NCT02327169|520289126|FG001|Overall Study|Reason Not Specified|0|||
144296336|NCT02327169|520289127|FG002|Overall Study|Reason Not Specified|1|||
144296337|NCT02327169|520289128|FG003|Overall Study|Reason Not Specified|0|||
144296338|NCT02327169|520289129|FG004|Overall Study|Reason Not Specified|0|||
144296339|NCT02327169|520289130|FG005|Overall Study|Reason Not Specified|0|||
144296340|NCT02327169|520289131|FG006|Overall Study|Reason Not Specified|0|||
144296341|NCT02327169|520289132|FG007|Overall Study|Reason Not Specified|0|||
144296342|NCT02327169|520289133|FG008|Overall Study|Reason Not Specified|0|||
144296343|NCT02327169|520289134|FG009|Overall Study|Reason Not Specified|1|||
144296344|NCT02327169|520289135|FG010|Overall Study|Reason Not Specified|2|||
144296345|NCT02327169|520289136|FG011|Overall Study|Reason Not Specified|1|||
144296346|NCT02327169|520289137|FG012|Overall Study|Reason Not Specified|0|||
144296347|NCT02327169|520289138|FG013|Overall Study|Reason Not Specified|0|||
144296348|NCT02327169|520289139|FG014|Overall Study|Reason Not Specified|2|||
144296349|NCT02327169|520289125|FG000|Overall Study|Withdrawal by Subject|1|||
144296350|NCT02327169|520289126|FG001|Overall Study|Withdrawal by Subject|0|||
144296351|NCT02327169|520289127|FG002|Overall Study|Withdrawal by Subject|0|||
144296352|NCT02327169|520289128|FG003|Overall Study|Withdrawal by Subject|0|||
144296353|NCT02327169|520289129|FG004|Overall Study|Withdrawal by Subject|1|||
144296354|NCT02327169|520289130|FG005|Overall Study|Withdrawal by Subject|0|||
144296355|NCT02327169|520289131|FG006|Overall Study|Withdrawal by Subject|0|||
144296356|NCT02327169|520289132|FG007|Overall Study|Withdrawal by Subject|1|||
144296357|NCT02327169|520289133|FG008|Overall Study|Withdrawal by Subject|0|||
144296358|NCT02327169|520289134|FG009|Overall Study|Withdrawal by Subject|0|||
144296359|NCT02327169|520289135|FG010|Overall Study|Withdrawal by Subject|0|||
144296360|NCT02327169|520289136|FG011|Overall Study|Withdrawal by Subject|0|||
144296361|NCT02327169|520289137|FG012|Overall Study|Withdrawal by Subject|0|||
144296362|NCT02327169|520289138|FG013|Overall Study|Withdrawal by Subject|0|||
144296363|NCT02327169|520289139|FG014|Overall Study|Withdrawal by Subject|3|||
144296364|NCT02327169|520289125|FG000|Overall Study|Lost to Follow-up|0|||
144296365|NCT02327169|520289126|FG001|Overall Study|Lost to Follow-up|0|||
144296366|NCT02327169|520289127|FG002|Overall Study|Lost to Follow-up|0|||
144296367|NCT02327169|520289128|FG003|Overall Study|Lost to Follow-up|0|||
144296368|NCT02327169|520289129|FG004|Overall Study|Lost to Follow-up|1|||
144296369|NCT02327169|520289130|FG005|Overall Study|Lost to Follow-up|0|||
144296370|NCT02327169|520289131|FG006|Overall Study|Lost to Follow-up|0|||
144296371|NCT02327169|520289132|FG007|Overall Study|Lost to Follow-up|0|||
144296372|NCT02327169|520289133|FG008|Overall Study|Lost to Follow-up|0|||
144296373|NCT02327169|520289134|FG009|Overall Study|Lost to Follow-up|0|||
144296374|NCT02327169|520289135|FG010|Overall Study|Lost to Follow-up|0|||
144296375|NCT02327169|520289136|FG011|Overall Study|Lost to Follow-up|0|||
144296376|NCT02327169|520289137|FG012|Overall Study|Lost to Follow-up|0|||
144296377|NCT02327169|520289138|FG013|Overall Study|Lost to Follow-up|0|||
144296378|NCT02327169|520289139|FG014|Overall Study|Lost to Follow-up|0|||
144296379|NCT03931330|520289140|FG000|Overall Study|Physician Decision|1|||
144296380|NCT02919618|520289143|FG000|Overall Study|Death|1|||
144296381|NCT04770285|520289145|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
144296382|NCT04770285|520289146|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
144296383|NCT04770285|520289145|FG000|Overall Study|Lack of Efficacy|0|||
144296384|NCT04770285|520289146|FG001|Overall Study|Lack of Efficacy|1|||
144296385|NCT04770285|520289145|FG000|Overall Study|Lost to Follow-up|11|||
144296386|NCT04770285|520289146|FG001|Overall Study|Lost to Follow-up|8|||
144296387|NCT04770285|520289145|FG000|Overall Study|Protocol Deviation|6|||
144296388|NCT04770285|520289146|FG001|Overall Study|Protocol Deviation|6|||
144296389|NCT04770285|520289145|FG000|Overall Study|Technical Problem|0|||
144296390|NCT04770285|520289146|FG001|Overall Study|Technical Problem|1|||
144296391|NCT04770285|520289145|FG000|Overall Study|Withdrawal by Subject|9|||
144296392|NCT04770285|520289146|FG001|Overall Study|Withdrawal by Subject|8|||
144296393|NCT04770285|520289145|FG000|Overall Study|Reason Not Specified|0|||
144296394|NCT04770285|520289146|FG001|Overall Study|Reason Not Specified|1|||
144296395|NCT03766399|520289147|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296396|NCT03766399|520289148|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296397|NCT03766399|520289149|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296398|NCT03766399|520289150|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296399|NCT03766399|520289151|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296400|NCT03766399|520289152|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296401|NCT03766399|520289153|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296402|NCT03766399|520289154|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296403|NCT03766399|520289155|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296404|NCT03766399|520289156|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296405|NCT03766399|520289157|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296406|NCT03766399|520289158|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296407|NCT03766399|520289159|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296408|NCT03766399|520289160|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
144296409|NCT03766399|520289161|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296410|NCT03766399|520289162|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144700078|NCT02161380|521754498|FG001|Overall Study|Lost to Follow-up|1|||
144296411|NCT03766399|520289163|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296412|NCT03766399|520289164|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
144296413|NCT05030766|520289165|FG000|Phase 1 Participants|Lost to Follow-up|12|||
144296414|NCT05030766|520289166|FG001|Phase 1 Participants|Lost to Follow-up|22|||
144296415|NCT05030766|520289167|FG002|Phase 1 Participants|Lost to Follow-up|0|||
144296416|NCT05030766|520289168|FG003|Phase 1 Participants|Lost to Follow-up|0|||
144296417|NCT05030766|520289165|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
144296418|NCT05030766|520289166|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
144296419|NCT05030766|520289167|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
144296420|NCT05030766|520289168|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
144296421|NCT05030766|520289165|FG000|Phase 2 Participants|Lost to Follow-up|0|||
144296422|NCT05030766|520289166|FG001|Phase 2 Participants|Lost to Follow-up|0|||
144296423|NCT05030766|520289167|FG002|Phase 2 Participants|Lost to Follow-up|6|||
144296424|NCT05030766|520289168|FG003|Phase 2 Participants|Lost to Follow-up|2|||
144296425|NCT00645658|520289169|FG000|Overall Study|Withdrawal by Subject|1|||
144296426|NCT00645658|520289170|FG001|Overall Study|Withdrawal by Subject|0|||
144296427|NCT00645658|520289169|FG000|Overall Study|Did not complete all assesments|0|||
144296428|NCT00645658|520289170|FG001|Overall Study|Did not complete all assesments|2|||
144296429|NCT00023595|520289177|FG000|5 Year Follow up|Lost to Follow-up|2|||
144296430|NCT00023595|520289178|FG001|5 Year Follow up|Lost to Follow-up|2|||
144296431|NCT00023595|520289179|FG002|5 Year Follow up|Lost to Follow-up|1|||
144296432|NCT00023595|520289180|FG003|5 Year Follow up|Lost to Follow-up|7|||
144296433|NCT00023595|520289181|FG004|5 Year Follow up|Lost to Follow-up|3|||
144296434|NCT00023595|520289177|FG000|10 Year Follow up|Lost to Follow-up|12|||
144296435|NCT00023595|520289178|FG001|10 Year Follow up|Lost to Follow-up|10|||
144296436|NCT00023595|520289179|FG002|10 Year Follow up|Lost to Follow-up|3|||
144296437|NCT00023595|520289180|FG003|10 Year Follow up|Lost to Follow-up|0|||
144296438|NCT00023595|520289181|FG004|10 Year Follow up|Lost to Follow-up|0|||
144296439|NCT05889468|520289182|FG000|Overall Study|Lost to Follow-up|9|||
144296440|NCT05889468|520289183|FG001|Overall Study|Lost to Follow-up|2|||
144296441|NCT05889468|520289182|FG000|Overall Study|Withdrawal by Subject|2|||
144296442|NCT05889468|520289183|FG001|Overall Study|Withdrawal by Subject|2|||
144296443|NCT02014376|520289190|FG000|Overall Study|Adverse Event|1|||
144296444|NCT02014376|520289191|FG001|Overall Study|Adverse Event|1|||
144296445|NCT02014376|520289192|FG002|Overall Study|Adverse Event|0|||
144296446|NCT02014376|520289190|FG000|Overall Study|Lost to Follow-up|2|||
144296447|NCT02014376|520289191|FG001|Overall Study|Lost to Follow-up|0|||
144296448|NCT02014376|520289192|FG002|Overall Study|Lost to Follow-up|0|||
144296449|NCT00721110|520289197|FG000|Overall Study|Ultram use|1|||
144296450|NCT00721110|520289198|FG001|Overall Study|Ultram use|0|||
144296451|NCT00721110|520289199|FG002|Overall Study|Ultram use|0|||
144296452|NCT00721110|520289200|FG003|Overall Study|Ultram use|0|||
144296453|NCT00721110|520289197|FG000|Overall Study|vertical incision|0|||
144296454|NCT00721110|520289198|FG001|Overall Study|vertical incision|0|||
144296455|NCT00721110|520289199|FG002|Overall Study|vertical incision|1|||
144296456|NCT00721110|520289200|FG003|Overall Study|vertical incision|0|||
144296457|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
144296458|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
144296459|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
144296460|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
144296461|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
144296462|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
144296463|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
144296464|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
144296465|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
144296466|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
144296467|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
144296468|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
144296469|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
144296470|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
144296471|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
144296472|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
144296473|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
144296474|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
144296475|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
144296476|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
144296477|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
144296478|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
144296479|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
144296480|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
144296481|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
144296482|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
144296483|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
144296484|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
144296485|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
144296486|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
144296487|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
144296488|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
144296489|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
144296490|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
144296491|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
144296492|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
144296493|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
144296494|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
144296495|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
144296496|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
144296497|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
144296498|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
144296499|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
144296500|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
144296501|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
144296502|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
144296503|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
144296504|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
144296505|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
144296506|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
144296507|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
144296508|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
144296509|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
144296510|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
144296511|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
144296512|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
144296513|NCT01362790|520289202|FG000|Pilot Phase & Phase 2|Death on study|0|||
144296514|NCT01362790|520289203|FG001|Pilot Phase & Phase 2|Death on study|0|||
144296515|NCT01362790|520289204|FG002|Pilot Phase & Phase 2|Death on study|0|||
144296516|NCT01362790|520289205|FG003|Pilot Phase & Phase 2|Death on study|1|||
144296517|NCT01362790|520289206|FG004|Pilot Phase & Phase 2|Death on study|0|||
144296518|NCT01362790|520289207|FG005|Pilot Phase & Phase 2|Death on study|0|||
144296519|NCT01362790|520289208|FG006|Pilot Phase & Phase 2|Death on study|0|||
144296520|NCT01362790|520289202|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
144296521|NCT01362790|520289203|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
144296522|NCT01362790|520289204|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
144296523|NCT01362790|520289205|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
144296524|NCT01362790|520289206|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
144296525|NCT01362790|520289207|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
144296526|NCT01362790|520289208|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
144296527|NCT01362790|520289202|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
144296528|NCT01362790|520289203|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
144296529|NCT01362790|520289204|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
144296530|NCT01362790|520289205|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
144296531|NCT01362790|520289206|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
144296532|NCT01362790|520289207|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
144296533|NCT01362790|520289208|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
144296534|NCT01362790|520289202|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
144296535|NCT01362790|520289203|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
144296536|NCT01362790|520289204|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
144296537|NCT01362790|520289205|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
144296538|NCT01362790|520289206|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
144296539|NCT01362790|520289207|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
144296540|NCT01362790|520289208|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
144296541|NCT02226653|520289212|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
144296542|NCT02226653|520289213|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
144296543|NCT02226653|520289212|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
144296544|NCT02226653|520289213|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
144296545|NCT00759395|520289219|FG000|Overall Study|Adverse Event|1|||
144296546|NCT00759395|520289220|FG001|Overall Study|Adverse Event|0|||
144296547|NCT00759395|520289219|FG000|Overall Study|Withdrawal by Subject|1|||
144296548|NCT00759395|520289220|FG001|Overall Study|Withdrawal by Subject|0|||
144296549|NCT00759395|520289219|FG000|Overall Study|Lack of Efficacy|0|||
144296550|NCT00759395|520289220|FG001|Overall Study|Lack of Efficacy|2|||
144296551|NCT04875533|520289221|FG000|Overall Study|Adverse Event|6|||
144296552|NCT04875533|520289222|FG001|Overall Study|Adverse Event|4|||
144296553|NCT04875533|520289221|FG000|Overall Study|Protocol Violation|4|||
144296554|NCT04875533|520289222|FG001|Overall Study|Protocol Violation|0|||
144296555|NCT04875533|520289221|FG000|Overall Study|Withdrawal by Subject|8|||
144296556|NCT04875533|520289222|FG001|Overall Study|Withdrawal by Subject|5|||
144296557|NCT04875533|520289221|FG000|Overall Study|No longer meets eligibility criteria|1|||
144296558|NCT04875533|520289222|FG001|Overall Study|No longer meets eligibility criteria|0|||
144296559|NCT04875533|520289221|FG000|Overall Study|Other|0|||
144296560|NCT04875533|520289222|FG001|Overall Study|Other|2|||
144296561|NCT00539500|520289223|FG000|Overall Study|Disease Progression|1|||
144296562|NCT00539500|520289223|FG000|Overall Study|Lost to Follow-up|2|||
144296563|NCT02904096|520289224|FG000|Overall Study|Adverse Event|1|||
144296564|NCT02904096|520289225|FG001|Overall Study|Adverse Event|0|||
144296565|NCT02904096|520289224|FG000|Overall Study|Withdrawal by Subject|4|||
144296566|NCT02904096|520289225|FG001|Overall Study|Withdrawal by Subject|3|||
144296567|NCT02904096|520289224|FG000|Overall Study|Lost to Follow-up|10|||
144296568|NCT02904096|520289225|FG001|Overall Study|Lost to Follow-up|17|||
144296569|NCT02904096|520289224|FG000|Overall Study|Non-compliant|3|||
144296570|NCT02904096|520289225|FG001|Overall Study|Non-compliant|1|||
144296571|NCT02904096|520289224|FG000|Overall Study|Sponsor instructed|1|||
144296572|NCT02904096|520289225|FG001|Overall Study|Sponsor instructed|0|||
144296573|NCT01979185|520289228|FG000|Period 2|Other|0|||
144296574|NCT01979185|520289229|FG001|Period 2|Other|1|||
144296575|NCT00980798|520289230|FG000|Overall Study|Adverse Event|7|||
144296576|NCT00980798|520289231|FG001|Overall Study|Adverse Event|36|||
144296577|NCT00980798|520289230|FG000|Overall Study|Lack of Efficacy|16|||
144296578|NCT00980798|520289231|FG001|Overall Study|Lack of Efficacy|5|||
144296579|NCT00980798|520289230|FG000|Overall Study|Lost to Follow-up|0|||
144296580|NCT00980798|520289231|FG001|Overall Study|Lost to Follow-up|1|||
144296581|NCT00980798|520289230|FG000|Overall Study|Physician Decision|2|||
144296582|NCT00980798|520289231|FG001|Overall Study|Physician Decision|1|||
144296583|NCT00980798|520289230|FG000|Overall Study|Withdrawal by Subject|8|||
144296584|NCT00980798|520289231|FG001|Overall Study|Withdrawal by Subject|11|||
144296585|NCT00980798|520289230|FG000|Overall Study|Other|0|||
144296586|NCT00980798|520289231|FG001|Overall Study|Other|1|||
144296587|NCT03034044|520289232|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
144296588|NCT00791648|520290463|FG000|Overall Study|Physician Decision|0|||
144296589|NCT00791648|520290464|FG001|Overall Study|Physician Decision|1|||
144296590|NCT00791648|520290463|FG000|Overall Study|Withdrawal by Subject|0|||
144296591|NCT00791648|520290464|FG001|Overall Study|Withdrawal by Subject|1|||
144296592|NCT00462826|520290465|FG000|Overall Study|Ineligible - second primary|1|||
144296593|NCT00462826|520290465|FG000|Overall Study|Ineligible - wrong cell type|1|||
144296594|NCT00462826|520290465|FG000|Overall Study|Ineligible - wrong primary|2|||
144296595|NCT00462826|520290465|FG000|Overall Study|Never treated|1|||
144296596|NCT03977155|520290466|FG000|Overall Study|Adverse Event|3|||
144296597|NCT03977155|520290467|FG001|Overall Study|Adverse Event|0|||
144296598|NCT03977155|520290468|FG002|Overall Study|Adverse Event|0|||
144296599|NCT03977155|520290466|FG000|Overall Study|Lost to Follow-up|0|||
144296600|NCT03977155|520290467|FG001|Overall Study|Lost to Follow-up|1|||
144296601|NCT03977155|520290468|FG002|Overall Study|Lost to Follow-up|0|||
144296602|NCT03977155|520290466|FG000|Overall Study|Withdrawal by Subject|1|||
144296603|NCT03977155|520290467|FG001|Overall Study|Withdrawal by Subject|1|||
144296604|NCT03977155|520290468|FG002|Overall Study|Withdrawal by Subject|2|||
144296605|NCT03977155|520290466|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
144296606|NCT03977155|520290467|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
144296607|NCT03977155|520290468|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
144296608|NCT00936936|520290469|FG000|Overall Study|Adverse Event|7|||
144296609|NCT00936936|520290470|FG001|Overall Study|Adverse Event|1|||
144296610|NCT00936936|520290469|FG000|Overall Study|Disease Progression|2|||
144296611|NCT00936936|520290470|FG001|Overall Study|Disease Progression|2|||
144296612|NCT00936936|520290469|FG000|Overall Study|Unrelated|3|||
144296613|NCT00936936|520290470|FG001|Overall Study|Unrelated|1|||
144296614|NCT02278003|520290471|FG000|Overall Study|Withdrawal by Subject|11|||
144296615|NCT02278003|520290472|FG001|Overall Study|Withdrawal by Subject|0|||
144296616|NCT02278003|520290471|FG000|Overall Study|Not Treated|1|||
144296617|NCT02278003|520290472|FG001|Overall Study|Not Treated|0|||
144296618|NCT02278003|520290471|FG000|Overall Study|Recognition task improperly completed|7|||
144296619|NCT02278003|520290472|FG001|Overall Study|Recognition task improperly completed|0|||
144296620|NCT03436732|520290473|FG000|Overall Study|Not treated-enrolled in different study|1|||
144296621|NCT03436732|520290474|FG001|Overall Study|Not treated-enrolled in different study|0|||
144296622|NCT03436732|520290473|FG000|Overall Study|Off study after cycle 1|1|||
144296623|NCT03436732|520290474|FG001|Overall Study|Off study after cycle 1|0|||
144296624|NCT03436732|520290473|FG000|Overall Study|Adverse Event|2|||
144296625|NCT03436732|520290474|FG001|Overall Study|Adverse Event|0|||
144296626|NCT03436732|520290473|FG000|Overall Study|Death|0|||
144296627|NCT03436732|520290474|FG001|Overall Study|Death|1|||
144296628|NCT00633126|520290478|FG000|Overall Study|Did not receive full dose|1|||
144296629|NCT02332928|520290490|FG000|Overall Study|Withdrawal by Subject|0|||
144296630|NCT02332928|520290491|FG001|Overall Study|Withdrawal by Subject|2|||
144296631|NCT02332928|520290490|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
144296632|NCT02332928|520290491|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
144296633|NCT03243084|520290498|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
144296634|NCT03243084|520290499|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
144296635|NCT03322566|520290500|FG000|Overall Study|Death|34|||
144296636|NCT03322566|520290501|FG001|Overall Study|Death|35|||
144296637|NCT03322566|520290502|FG002|Overall Study|Death|23|||
144296638|NCT03322566|520290500|FG000|Overall Study|Physician Decision|6|||
144296639|NCT03322566|520290501|FG001|Overall Study|Physician Decision|7|||
144296640|NCT03322566|520290502|FG002|Overall Study|Physician Decision|2|||
144296641|NCT03322566|520290500|FG000|Overall Study|Withdrawal by Subject|4|||
144296642|NCT03322566|520290501|FG001|Overall Study|Withdrawal by Subject|3|||
144296643|NCT03322566|520290502|FG002|Overall Study|Withdrawal by Subject|6|||
144296644|NCT03322566|520290500|FG000|Overall Study|Lost to Follow-up|0|||
144296645|NCT03322566|520290501|FG001|Overall Study|Lost to Follow-up|0|||
144296646|NCT03322566|520290502|FG002|Overall Study|Lost to Follow-up|1|||
144296647|NCT03322566|520290500|FG000|Overall Study|Study terminated by sponsor|1|||
144296648|NCT03322566|520290501|FG001|Overall Study|Study terminated by sponsor|0|||
144296649|NCT03322566|520290502|FG002|Overall Study|Study terminated by sponsor|1|||
144296650|NCT03895372|520290509|FG000|Investigational Treatment Period|Adverse Event|1|||
144296651|NCT03895372|520290510|FG001|Investigational Treatment Period|Adverse Event|0|||
144296652|NCT03895372|520290511|FG002|Investigational Treatment Period|Adverse Event|0|||
144296653|NCT03895372|520290512|FG003|Investigational Treatment Period|Adverse Event|0|||
144296654|NCT03895372|520290513|FG004|Investigational Treatment Period|Adverse Event|0|||
144296655|NCT03895372|520290514|FG005|Investigational Treatment Period|Adverse Event|0|||
144296656|NCT03895372|520290515|FG006|Investigational Treatment Period|Adverse Event|4|||
144296657|NCT03895372|520290516|FG007|Investigational Treatment Period|Adverse Event|3|||
144296658|NCT03895372|520290509|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
144296659|NCT03895372|520290510|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
144296660|NCT03895372|520290511|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
144296661|NCT03895372|520290512|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
144296662|NCT03895372|520290513|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
144296663|NCT03895372|520290514|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
144296664|NCT03895372|520290515|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
144296665|NCT03895372|520290516|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
144296666|NCT03895372|520290509|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
144296667|NCT03895372|520290510|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
144296668|NCT03895372|520290511|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
144296669|NCT03895372|520290512|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
144296670|NCT03895372|520290513|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
144296671|NCT03895372|520290514|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
144296672|NCT03895372|520290515|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
144296673|NCT03895372|520290516|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
144296674|NCT03895372|520290509|FG000|Investigational Treatment Period|Other|0|||
144296675|NCT03895372|520290510|FG001|Investigational Treatment Period|Other|0|||
144296676|NCT03895372|520290511|FG002|Investigational Treatment Period|Other|0|||
144296677|NCT03895372|520290512|FG003|Investigational Treatment Period|Other|0|||
144296678|NCT03895372|520290513|FG004|Investigational Treatment Period|Other|0|||
144296679|NCT03895372|520290514|FG005|Investigational Treatment Period|Other|1|||
144296680|NCT03895372|520290515|FG006|Investigational Treatment Period|Other|0|||
144296681|NCT03895372|520290516|FG007|Investigational Treatment Period|Other|2|||
144296682|NCT03895372|520290509|FG000|Investigational Treatment Period|Protocol Violation|0|||
144296683|NCT03895372|520290510|FG001|Investigational Treatment Period|Protocol Violation|0|||
144296684|NCT03895372|520290511|FG002|Investigational Treatment Period|Protocol Violation|0|||
144296685|NCT03895372|520290512|FG003|Investigational Treatment Period|Protocol Violation|1|||
144296686|NCT03895372|520290513|FG004|Investigational Treatment Period|Protocol Violation|0|||
144296687|NCT03895372|520290514|FG005|Investigational Treatment Period|Protocol Violation|0|||
144296688|NCT03895372|520290515|FG006|Investigational Treatment Period|Protocol Violation|0|||
144296689|NCT03895372|520290516|FG007|Investigational Treatment Period|Protocol Violation|0|||
144296690|NCT03895372|520290509|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
144296691|NCT03895372|520290510|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
144296692|NCT03895372|520290511|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
144296693|NCT03895372|520290512|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
144296694|NCT03895372|520290513|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
144296695|NCT03895372|520290514|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
144296696|NCT03895372|520290515|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
144296697|NCT03895372|520290516|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
144296698|NCT03895372|520290509|FG000|Extension Treatment Period|Adverse Event|0|||
144296699|NCT03895372|520290510|FG001|Extension Treatment Period|Adverse Event|1|||
144296700|NCT03895372|520290511|FG002|Extension Treatment Period|Adverse Event|0|||
144296701|NCT03895372|520290512|FG003|Extension Treatment Period|Adverse Event|1|||
144296702|NCT03895372|520290513|FG004|Extension Treatment Period|Adverse Event|0|||
144296703|NCT03895372|520290514|FG005|Extension Treatment Period|Adverse Event|0|||
144296704|NCT03895372|520290515|FG006|Extension Treatment Period|Adverse Event|3|||
144296705|NCT03895372|520290516|FG007|Extension Treatment Period|Adverse Event|3|||
144296706|NCT03895372|520290509|FG000|Extension Treatment Period|Other|1|||
144296707|NCT03895372|520290510|FG001|Extension Treatment Period|Other|3|||
144296708|NCT03895372|520290511|FG002|Extension Treatment Period|Other|0|||
144296709|NCT03895372|520290512|FG003|Extension Treatment Period|Other|0|||
144296710|NCT03895372|520290513|FG004|Extension Treatment Period|Other|1|||
144296711|NCT03895372|520290514|FG005|Extension Treatment Period|Other|0|||
144296712|NCT03895372|520290515|FG006|Extension Treatment Period|Other|0|||
144296713|NCT03895372|520290516|FG007|Extension Treatment Period|Other|2|||
144296714|NCT03895372|520290509|FG000|Extension Treatment Period|Pregnancy|0|||
144296715|NCT03895372|520290510|FG001|Extension Treatment Period|Pregnancy|0|||
144296716|NCT03895372|520290511|FG002|Extension Treatment Period|Pregnancy|0|||
144296717|NCT03895372|520290512|FG003|Extension Treatment Period|Pregnancy|0|||
144296718|NCT03895372|520290513|FG004|Extension Treatment Period|Pregnancy|1|||
144296719|NCT03895372|520290514|FG005|Extension Treatment Period|Pregnancy|0|||
144296720|NCT03895372|520290515|FG006|Extension Treatment Period|Pregnancy|0|||
144296721|NCT03895372|520290516|FG007|Extension Treatment Period|Pregnancy|0|||
144296722|NCT03895372|520290509|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
144296723|NCT03895372|520290510|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
144296724|NCT03895372|520290511|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
144296725|NCT03895372|520290512|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
144296726|NCT03895372|520290513|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
144296727|NCT03895372|520290514|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
144296728|NCT03895372|520290515|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
144296729|NCT03895372|520290516|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
144296730|NCT01646827|520290517|FG000|Overall Study|Lost to Follow-up|0|||
144296731|NCT01646827|520290518|FG001|Overall Study|Lost to Follow-up|3|||
144296732|NCT01646827|520290517|FG000|Overall Study|Physician Decision|1|||
144296733|NCT01646827|520290518|FG001|Overall Study|Physician Decision|2|||
144296734|NCT01646827|520290517|FG000|Overall Study|Withdrawal by Subject|1|||
144296735|NCT01646827|520290518|FG001|Overall Study|Withdrawal by Subject|0|||
144296736|NCT01472185|520290521|FG000|Overall Study|Randomized but Not Treated|0|||
144296737|NCT01472185|520290522|FG001|Overall Study|Randomized but Not Treated|1|||
144296738|NCT01472185|520290521|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
144296739|NCT01472185|520290522|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
144296740|NCT01472185|520290521|FG000|Overall Study|Hyperglycemia|5|||
144296741|NCT01472185|520290522|FG001|Overall Study|Hyperglycemia|2|||
144296742|NCT01472185|520290521|FG000|Overall Study|Investigator's Discretion|3|||
144296743|NCT01472185|520290522|FG001|Overall Study|Investigator's Discretion|1|||
144296744|NCT01472185|520290521|FG000|Overall Study|Lost to Follow-up|4|||
144296745|NCT01472185|520290522|FG001|Overall Study|Lost to Follow-up|1|||
144296746|NCT01472185|520290521|FG000|Overall Study|Protocol Violation|5|||
144296747|NCT01472185|520290522|FG001|Overall Study|Protocol Violation|1|||
144296748|NCT01472185|520290521|FG000|Overall Study|Subject Noncompliance|8|||
144296749|NCT01472185|520290522|FG001|Overall Study|Subject Noncompliance|15|||
144296750|NCT01472185|520290521|FG000|Overall Study|Subject Withdrew Consent|6|||
144296751|NCT01472185|520290522|FG001|Overall Study|Subject Withdrew Consent|3|||
144296752|NCT01309230|520290523|FG000|Overall Study|Withdrawal by Subject|0|||
144296753|NCT01309230|520290524|FG001|Overall Study|Withdrawal by Subject|2|||
144296754|NCT01309230|520290523|FG000|Overall Study|Observation arm closed|0|||
144296755|NCT01309230|520290524|FG001|Overall Study|Observation arm closed|2|||
144296756|NCT00427700|520290525|FG000|Overall Study|Lost to Follow-up|2|||
144296757|NCT00427700|520290526|FG001|Overall Study|Lost to Follow-up|5|||
144296758|NCT00427700|520290525|FG000|Overall Study|no induction of menses|1|||
144296759|NCT00427700|520290526|FG001|Overall Study|no induction of menses|4|||
144296760|NCT00427700|520290525|FG000|Overall Study|Pregnancy|0|||
144296761|NCT00427700|520290526|FG001|Overall Study|Pregnancy|2|||
144296762|NCT00815633|520290529|FG000|Overall Study|study terminated|1|||
144296763|NCT01435356|520290530|FG000|Overall Study|Adverse Event|2|||
144296764|NCT01435356|520290531|FG001|Overall Study|Adverse Event|0|||
144296765|NCT01435356|520290530|FG000|Overall Study|Disease progression/recurrence|17|||
144296766|NCT01435356|520290531|FG001|Overall Study|Disease progression/recurrence|10|||
144296767|NCT01435356|520290530|FG000|Overall Study|Protocol Violation|0|||
144296768|NCT01435356|520290531|FG001|Overall Study|Protocol Violation|1|||
144296769|NCT01435356|520290530|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
144296770|NCT01435356|520290531|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
144296771|NCT01435356|520290530|FG000|Overall Study|Withdrawal by Subject|1|||
144296772|NCT01435356|520290531|FG001|Overall Study|Withdrawal by Subject|1|||
144296773|NCT01435356|520290530|FG000|Overall Study|Facial palsy|1|||
144296774|NCT01435356|520290531|FG001|Overall Study|Facial palsy|0|||
144296775|NCT01435356|520290530|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
144296776|NCT01435356|520290531|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
144296777|NCT01435356|520290530|FG000|Overall Study|Physician Decision|1|||
144296778|NCT01435356|520290531|FG001|Overall Study|Physician Decision|0|||
144296779|NCT01435356|520290530|FG000|Overall Study|Patient decision|3|||
144296780|NCT01435356|520290531|FG001|Overall Study|Patient decision|0|||
144296781|NCT01435356|520290530|FG000|Overall Study|Patient moved to another city|1|||
144296782|NCT01435356|520290531|FG001|Overall Study|Patient moved to another city|1|||
144296783|NCT00437073|520290532|FG000|Overall Study|Sponsor Terminated Study|1|||
144296784|NCT00437073|520290533|FG001|Overall Study|Sponsor Terminated Study|0|||
144296785|NCT00437073|520290532|FG000|Overall Study|Physician Decision|0|||
144296786|NCT00437073|520290533|FG001|Overall Study|Physician Decision|1|||
144296787|NCT03485157|520290534|FG000|Double Blind Phase|Lost to Follow-up|4|||
144296788|NCT03485157|520290535|FG001|Double Blind Phase|Lost to Follow-up|4|||
144296789|NCT03485157|520290534|FG000|Double Blind Phase|Adverse Event|2|||
144296790|NCT03485157|520290535|FG001|Double Blind Phase|Adverse Event|1|||
144296791|NCT03485157|520290534|FG000|Double Blind Phase|Withdrawal by Subject|6|||
144296792|NCT03485157|520290535|FG001|Double Blind Phase|Withdrawal by Subject|9|||
144296793|NCT03485157|520290534|FG000|Double Blind Phase|Removal by PI|3|||
144296794|NCT03485157|520290535|FG001|Double Blind Phase|Removal by PI|7|||
144296795|NCT03485157|520290534|FG000|Open Label Phase|Lost to Follow-up|1|||
144296796|NCT03485157|520290535|FG001|Open Label Phase|Lost to Follow-up|2|||
144296797|NCT03485157|520290534|FG000|Open Label Phase|Adverse Event|0|||
144296798|NCT03485157|520290535|FG001|Open Label Phase|Adverse Event|1|||
144296799|NCT03485157|520290534|FG000|Open Label Phase|Withdrawal by Subject|1|||
144296800|NCT03485157|520290535|FG001|Open Label Phase|Withdrawal by Subject|2|||
144296801|NCT03485157|520290534|FG000|Open Label Phase|Removal by PI|2|||
144296802|NCT03485157|520290535|FG001|Open Label Phase|Removal by PI|0|||
144296803|NCT05205616|520290536|FG000|Overall Study|Lost to Follow-up|4|||
144296804|NCT05205616|520290537|FG001|Overall Study|Lost to Follow-up|4|||
144296805|NCT02657343|520290540|FG000|Overall Study|Death|0|||
144296806|NCT02657343|520290541|FG001|Overall Study|Death|2|||
144296807|NCT02657343|520290542|FG002|Overall Study|Death|0|||
144296808|NCT02657343|520290543|FG003|Overall Study|Death|0|||
144296809|NCT02657343|520290544|FG004|Overall Study|Death|0|||
144296810|NCT02657343|520290545|FG005|Overall Study|Death|0|||
144296811|NCT02657343|520290540|FG000|Overall Study|Patient went to hospice|1|||
144296812|NCT02657343|520290541|FG001|Overall Study|Patient went to hospice|0|||
144296813|NCT02657343|520290542|FG002|Overall Study|Patient went to hospice|0|||
144296814|NCT02657343|520290543|FG003|Overall Study|Patient went to hospice|0|||
144296815|NCT02657343|520290544|FG004|Overall Study|Patient went to hospice|0|||
144296816|NCT02657343|520290545|FG005|Overall Study|Patient went to hospice|0|||
144296817|NCT02657343|520290540|FG000|Overall Study|Withdrawal by Subject|0|||
144296818|NCT02657343|520290541|FG001|Overall Study|Withdrawal by Subject|0|||
144296819|NCT02657343|520290542|FG002|Overall Study|Withdrawal by Subject|0|||
144296820|NCT02657343|520290543|FG003|Overall Study|Withdrawal by Subject|0|||
144296821|NCT02657343|520290544|FG004|Overall Study|Withdrawal by Subject|1|||
144296822|NCT02657343|520290545|FG005|Overall Study|Withdrawal by Subject|0|||
144296823|NCT02011542|520290547|FG000|Overall Study|Physician Decision|1|||
144296824|NCT01299961|520290548|FG000|Overall Study|Adverse Event|3|||
144296825|NCT01299961|520290548|FG000|Overall Study|Lack of Efficacy|2|||
144296826|NCT01299961|520290548|FG000|Overall Study|Lost to Follow-up|1|||
144296827|NCT00663260|520290550|FG000|Overall Study|Lack of Efficacy|2|||
144296828|NCT00663260|520290551|FG001|Overall Study|Lack of Efficacy|0|||
144296829|NCT00663260|520290552|FG002|Overall Study|Lack of Efficacy|0|||
144296830|NCT00663260|520290550|FG000|Overall Study|Adverse Event|12|||
144296831|NCT00663260|520290551|FG001|Overall Study|Adverse Event|7|||
144296832|NCT00663260|520290552|FG002|Overall Study|Adverse Event|6|||
144296833|NCT00663260|520290550|FG000|Overall Study|Withdrawal by Subject|3|||
144296834|NCT00663260|520290551|FG001|Overall Study|Withdrawal by Subject|1|||
144296835|NCT00663260|520290552|FG002|Overall Study|Withdrawal by Subject|6|||
144296836|NCT00663260|520290550|FG000|Overall Study|Death|1|||
144296837|NCT00663260|520290551|FG001|Overall Study|Death|0|||
144296838|NCT00663260|520290552|FG002|Overall Study|Death|1|||
144296839|NCT00663260|520290550|FG000|Overall Study|Lost to Follow-up|0|||
144296840|NCT00663260|520290551|FG001|Overall Study|Lost to Follow-up|1|||
144296841|NCT00663260|520290552|FG002|Overall Study|Lost to Follow-up|0|||
144296842|NCT00663260|520290550|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
144296843|NCT00663260|520290551|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
144296844|NCT00663260|520290552|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
144296845|NCT03620981|520290553|FG000|Overall Study|Adverse Event|14|||
144296846|NCT03620981|520290554|FG001|Overall Study|Adverse Event|38|||
144296847|NCT03620981|520290555|FG002|Overall Study|Adverse Event|25|||
144296848|NCT03620981|520290553|FG000|Overall Study|Lack of Efficacy|2|||
144296849|NCT03620981|520290554|FG001|Overall Study|Lack of Efficacy|1|||
144296850|NCT03620981|520290555|FG002|Overall Study|Lack of Efficacy|1|||
144296851|NCT03620981|520290553|FG000|Overall Study|Physician Decision|7|||
144296852|NCT03620981|520290554|FG001|Overall Study|Physician Decision|4|||
144296853|NCT03620981|520290555|FG002|Overall Study|Physician Decision|4|||
144296854|NCT03620981|520290553|FG000|Overall Study|Protocol Violation|1|||
144296855|NCT03620981|520290554|FG001|Overall Study|Protocol Violation|2|||
144296856|NCT03620981|520290555|FG002|Overall Study|Protocol Violation|1|||
144296857|NCT03620981|520290553|FG000|Overall Study|Withdrawal by Legal Representative|2|||
144296858|NCT03620981|520290554|FG001|Overall Study|Withdrawal by Legal Representative|1|||
144296859|NCT03620981|520290555|FG002|Overall Study|Withdrawal by Legal Representative|1|||
144296860|NCT03620981|520290553|FG000|Overall Study|Withdrawal by Care Giver|2|||
144296861|NCT03620981|520290554|FG001|Overall Study|Withdrawal by Care Giver|0|||
144296862|NCT03620981|520290555|FG002|Overall Study|Withdrawal by Care Giver|1|||
144296863|NCT03620981|520290553|FG000|Overall Study|Non-compliance with Study Drug|1|||
144296864|NCT03620981|520290554|FG001|Overall Study|Non-compliance with Study Drug|1|||
144296865|NCT03620981|520290555|FG002|Overall Study|Non-compliance with Study Drug|0|||
144296866|NCT02607722|520290556|FG000|Overall Study|No data reliability|1|||
144296867|NCT02607722|520290556|FG000|Overall Study|no patient visit|18|||
144296868|NCT02607722|520290556|FG000|Overall Study|missing info in CRF|13|||
144296869|NCT02607722|520290556|FG000|Overall Study|Withdrawal by Subject|616|||
144296870|NCT02607722|520290556|FG000|Overall Study|Lost to Follow-up|312|||
144296871|NCT02607722|520290556|FG000|Overall Study|Improved|22|||
144296872|NCT02607722|520290556|FG000|Overall Study|Lack of Efficacy|316|||
144296873|NCT02607722|520290556|FG000|Overall Study|Adverse Event|2553|||
144296874|NCT02607722|520290556|FG000|Overall Study|Not treated|1|||
144296875|NCT02607722|520290556|FG000|Overall Study|No CRF collected|138|||
144296876|NCT02607722|520290556|FG000|Overall Study|without CRF|4225|||
144296877|NCT02607722|520290556|FG000|Overall Study|Physician Decision|367|||
144296878|NCT02135133|520290557|FG000|Overall Study|Adverse Event|10|||
144296879|NCT02135133|520290557|FG000|Overall Study|regulatory mandate|5|||
144296880|NCT03238196|520290558|FG000|Overall Study|Adverse Event|3|||
144296881|NCT03238196|520290559|FG001|Overall Study|Adverse Event|0|||
144296882|NCT03238196|520290560|FG002|Overall Study|Adverse Event|2|||
144296883|NCT03238196|520290561|FG003|Overall Study|Adverse Event|2|||
144296884|NCT03238196|520290558|FG000|Overall Study|Withdrawal by Subject|4|||
144296885|NCT03238196|520290559|FG001|Overall Study|Withdrawal by Subject|1|||
144296886|NCT03238196|520290560|FG002|Overall Study|Withdrawal by Subject|1|||
144296887|NCT03238196|520290561|FG003|Overall Study|Withdrawal by Subject|0|||
144296888|NCT03238196|520290558|FG000|Overall Study|Disease progression|14|||
144296889|NCT03238196|520290559|FG001|Overall Study|Disease progression|2|||
144296890|NCT03238196|520290560|FG002|Overall Study|Disease progression|3|||
144296891|NCT03238196|520290561|FG003|Overall Study|Disease progression|2|||
144296892|NCT03238196|520290558|FG000|Overall Study|Still on treatment|1|||
144296893|NCT03238196|520290559|FG001|Overall Study|Still on treatment|0|||
144296894|NCT03238196|520290560|FG002|Overall Study|Still on treatment|0|||
144296895|NCT03238196|520290561|FG003|Overall Study|Still on treatment|0|||
144296896|NCT05081843|520290562|FG000|Overall Study|Lost to Follow-up|135|||
144296897|NCT05081843|520290563|FG001|Overall Study|Lost to Follow-up|145|||
144296898|NCT02402647|520290564|FG000|Overall Study|Lost to Follow-up|13|||
144296899|NCT02402647|520290565|FG001|Overall Study|Lost to Follow-up|7|||
144296900|NCT02402647|520290564|FG000|Overall Study|Protocol Violation|1|||
144296901|NCT02402647|520290565|FG001|Overall Study|Protocol Violation|1|||
144296902|NCT02402647|520290564|FG000|Overall Study|scheduled and timed out|2|||
144296903|NCT02402647|520290565|FG001|Overall Study|scheduled and timed out|1|||
144296904|NCT02402647|520290564|FG000|Overall Study|medical illness|2|||
144296905|NCT02402647|520290565|FG001|Overall Study|medical illness|4|||
144296906|NCT02402647|520290564|FG000|Overall Study|Moved|2|||
144296907|NCT02402647|520290565|FG001|Overall Study|Moved|0|||
144296908|NCT02402647|520290564|FG000|Overall Study|loved one illness|1|||
144296909|NCT02402647|520290565|FG001|Overall Study|loved one illness|0|||
144296910|NCT02402647|520290564|FG000|Overall Study|deceased preexisting condition|2|||
144296911|NCT02402647|520290565|FG001|Overall Study|deceased preexisting condition|0|||
144296912|NCT02402647|520290564|FG000|Overall Study|Other|2|||
144296913|NCT02402647|520290565|FG001|Overall Study|Other|1|||
144296914|NCT01877278|520290567|FG000|Overall Study|Lost to Follow-up|3|||
144296915|NCT01877278|520290568|FG001|Overall Study|Lost to Follow-up|3|||
144296916|NCT04727151|520290569|FG000|Overall Study|Death|0|||
144296917|NCT04727151|520290570|FG001|Overall Study|Death|0|||
144296918|NCT04727151|520290571|FG002|Overall Study|Death|0|||
144296919|NCT04727151|520290572|FG003|Overall Study|Death|0|||
144296920|NCT04727151|520290573|FG004|Overall Study|Death|3|||
144296921|NCT04727151|520290569|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
144296922|NCT04727151|520290570|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
144296923|NCT04727151|520290571|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
144296924|NCT04727151|520290572|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
144296925|NCT04727151|520290573|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
144296926|NCT01969058|520290574|FG000|Overall Study|Withdrawal by Subject|2|||
144296927|NCT01969058|520290575|FG001|Overall Study|Withdrawal by Subject|0|||
144296928|NCT01969058|520290574|FG000|Overall Study|Adverse Event|1|||
144296929|NCT01969058|520290575|FG001|Overall Study|Adverse Event|0|||
144296930|NCT03510715|520290576|FG000|Overall Study|Adverse Event|1|||
144296931|NCT03510715|520290577|FG001|Overall Study|Adverse Event|0|||
144296932|NCT03164356|520290584|FG000|Overall Study|Lost to Follow-up|1|||
144296933|NCT03164356|520290585|FG001|Overall Study|Lost to Follow-up|1|||
144296934|NCT03164356|520290586|FG002|Overall Study|Lost to Follow-up|2|||
144296935|NCT03164356|520290587|FG003|Overall Study|Lost to Follow-up|1|||
144296936|NCT03164356|520290584|FG000|Overall Study|Physician Decision|0|||
144296937|NCT03164356|520290585|FG001|Overall Study|Physician Decision|0|||
144296938|NCT03164356|520290586|FG002|Overall Study|Physician Decision|3|||
144296939|NCT03164356|520290587|FG003|Overall Study|Physician Decision|0|||
144296940|NCT03164356|520290584|FG000|Overall Study|Protocol Violation|2|||
144296941|NCT03164356|520290585|FG001|Overall Study|Protocol Violation|1|||
144296942|NCT03164356|520290586|FG002|Overall Study|Protocol Violation|0|||
144296943|NCT03164356|520290587|FG003|Overall Study|Protocol Violation|0|||
144296944|NCT03164356|520290584|FG000|Overall Study|Withdrawal by Subject|1|||
144296945|NCT03164356|520290585|FG001|Overall Study|Withdrawal by Subject|0|||
144296946|NCT03164356|520290586|FG002|Overall Study|Withdrawal by Subject|0|||
144296947|NCT03164356|520290587|FG003|Overall Study|Withdrawal by Subject|0|||
144296948|NCT03164356|520290584|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
144296949|NCT03164356|520290585|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
144296950|NCT03164356|520290586|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
144296951|NCT03164356|520290587|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
144296952|NCT03164356|520290584|FG000|Overall Study|Subject Incarcerated|0|||
144296953|NCT03164356|520290585|FG001|Overall Study|Subject Incarcerated|1|||
144296954|NCT03164356|520290586|FG002|Overall Study|Subject Incarcerated|0|||
144296955|NCT03164356|520290587|FG003|Overall Study|Subject Incarcerated|0|||
144296956|NCT03164356|520290584|FG000|Overall Study|Prosthetist unable to participate|0|||
144296957|NCT03164356|520290585|FG001|Overall Study|Prosthetist unable to participate|2|||
144296958|NCT03164356|520290586|FG002|Overall Study|Prosthetist unable to participate|1|||
144296959|NCT03164356|520290587|FG003|Overall Study|Prosthetist unable to participate|0|||
144296960|NCT05943990|520290594|FG000|Overall Study|Study Terminated by Sponsor|0|||
144296961|NCT05943990|520290595|FG001|Overall Study|Study Terminated by Sponsor|0|||
144296962|NCT05943990|520290596|FG002|Overall Study|Study Terminated by Sponsor|1|||
144296963|NCT04976777|520292398|FG000|Overall Study|COVID-19 Infection|1|||
144296964|NCT04976777|520292399|FG001|Overall Study|COVID-19 Infection|0|||
144296965|NCT02296476|520292400|FG000|Overall Study|Disease Progression|6|||
144296966|NCT02296476|520292401|FG001|Overall Study|Disease Progression|4|||
144296967|NCT02296476|520292402|FG002|Overall Study|Disease Progression|2|||
144296968|NCT00442702|520292403|FG000|Titration Period|Adverse Event|2|||
144296969|NCT00442702|520292404|FG001|Titration Period|Adverse Event|0|||
144296970|NCT00442702|520292403|FG000|Titration Period|Death|3|||
144296971|NCT00442702|520292404|FG001|Titration Period|Death|2|||
144296972|NCT00442702|520292403|FG000|Titration Period|Insufficient Therapeutic Response|1|||
144296973|NCT00442702|520292404|FG001|Titration Period|Insufficient Therapeutic Response|0|||
144296974|NCT00442702|520292403|FG000|Titration Period|Refused Treatment|4|||
144296975|NCT00442702|520292404|FG001|Titration Period|Refused Treatment|1|||
144296976|NCT00442702|520292403|FG000|Titration Period|Failure to return|1|||
144296977|NCT00442702|520292404|FG001|Titration Period|Failure to return|0|||
144296978|NCT00442702|520292403|FG000|Titration Period|Hospitalized in another hospital|1|||
144296979|NCT00442702|520292404|FG001|Titration Period|Hospitalized in another hospital|0|||
144296980|NCT00442702|520292403|FG000|Evaluation Period|Adverse Event|1|||
144296981|NCT00442702|520292404|FG001|Evaluation Period|Adverse Event|0|||
144296982|NCT00442702|520292403|FG000|Evaluation Period|Death|1|||
144296983|NCT00442702|520292404|FG001|Evaluation Period|Death|1|||
144296984|NCT00442702|520292403|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
144296985|NCT00442702|520292404|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
144296986|NCT00442702|520292403|FG000|Evaluation Period|Refused treatment|1|||
144296987|NCT00442702|520292404|FG001|Evaluation Period|Refused treatment|1|||
144296988|NCT00442702|520292403|FG000|Evaluation Period|Renal transplant|0|||
144296989|NCT00442702|520292404|FG001|Evaluation Period|Renal transplant|1|||
144296990|NCT00442702|520292403|FG000|Evaluation Period|Failure to return|1|||
144296991|NCT00442702|520292404|FG001|Evaluation Period|Failure to return|0|||
144296992|NCT00442702|520292403|FG000|Evaluation Period|Site closure|0|||
144296993|NCT00442702|520292404|FG001|Evaluation Period|Site closure|1|||
144296994|NCT03440385|520292416|FG000|Overall Study|Other Reason|4|||
144296995|NCT03440385|520292417|FG001|Overall Study|Other Reason|1|||
144296996|NCT03440385|520292416|FG000|Overall Study|Site Closed|1|||
144296997|NCT03440385|520292417|FG001|Overall Study|Site Closed|0|||
144296998|NCT03440385|520292416|FG000|Overall Study|Lost to Follow-up|2|||
144296999|NCT03440385|520292417|FG001|Overall Study|Lost to Follow-up|0|||
144297000|NCT03440385|520292416|FG000|Overall Study|Withdrawal by Subject|12|||
144297001|NCT03440385|520292417|FG001|Overall Study|Withdrawal by Subject|6|||
144297002|NCT03440385|520292416|FG000|Overall Study|Lack of Efficacy|9|||
144297003|NCT03440385|520292417|FG001|Overall Study|Lack of Efficacy|2|||
144297004|NCT03440385|520292416|FG000|Overall Study|Adverse Event|15|||
144297005|NCT03440385|520292417|FG001|Overall Study|Adverse Event|11|||
144297006|NCT04123704|520292418|FG000|Overall Study|Disease progression|2|||
144297007|NCT00730327|520292419|FG000|Overall Study|Lost to Follow-up|14|||
144297008|NCT00730327|520292420|FG001|Overall Study|Lost to Follow-up|16|||
144297009|NCT00730327|520292419|FG000|Overall Study|Adverse Event|8|||
144297010|NCT00730327|520292420|FG001|Overall Study|Adverse Event|1|||
144297011|NCT00730327|520292419|FG000|Overall Study|Withdrawal by Subject|3|||
144297012|NCT00730327|520292420|FG001|Overall Study|Withdrawal by Subject|13|||
144297013|NCT00730327|520292419|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
144297014|NCT00730327|520292420|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
144297015|NCT04484857|520292421|FG000|Overall Study|Adverse Event|2|||
144297016|NCT04484857|520292421|FG000|Overall Study|Death|10|||
144297017|NCT04484857|520292421|FG000|Overall Study|Withdrawal by Subject|3|||
144297018|NCT04484857|520292421|FG000|Overall Study|Transferred/Relocation|5|||
144297019|NCT04484857|520292421|FG000|Overall Study|Kidney Transplant|7|||
144297020|NCT04484857|520292421|FG000|Overall Study|Other than specified|4|||
144297021|NCT04484857|520292421|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
144297022|NCT01425814|520292422|FG000|Period 1|Stability criteria not fulfilled|0|||
144297023|NCT01425814|520292423|FG001|Period 1|Stability criteria not fulfilled|1|||
144297024|NCT01425814|520292424|FG002|Period 1|Stability criteria not fulfilled|0|||
144297025|NCT01425814|520292425|FG003|Period 1|Stability criteria not fulfilled|0|||
144297026|NCT01425814|520292426|FG004|Period 1|Stability criteria not fulfilled|0|||
144297027|NCT01425814|520292427|FG005|Period 1|Stability criteria not fulfilled|0|||
144297028|NCT01425814|520292422|FG000|Period 2|Stability criteria not fulfilled|0|||
144297029|NCT01425814|520292423|FG001|Period 2|Stability criteria not fulfilled|1|||
144297030|NCT01425814|520292424|FG002|Period 2|Stability criteria not fulfilled|0|||
144297031|NCT01425814|520292425|FG003|Period 2|Stability criteria not fulfilled|0|||
144297032|NCT01425814|520292426|FG004|Period 2|Stability criteria not fulfilled|0|||
144297033|NCT01425814|520292427|FG005|Period 2|Stability criteria not fulfilled|0|||
144297034|NCT01425814|520292422|FG000|Period 3|Adverse Event|0|||
144297035|NCT01425814|520292423|FG001|Period 3|Adverse Event|0|||
144297036|NCT01425814|520292424|FG002|Period 3|Adverse Event|0|||
144297037|NCT01425814|520292425|FG003|Period 3|Adverse Event|0|||
144297038|NCT01425814|520292426|FG004|Period 3|Adverse Event|0|||
144297039|NCT01425814|520292427|FG005|Period 3|Adverse Event|1|||
144297040|NCT01425814|520292422|FG000|Period 4|Adverse Event|1|||
144297041|NCT01425814|520292423|FG001|Period 4|Adverse Event|0|||
144297042|NCT01425814|520292424|FG002|Period 4|Adverse Event|1|||
144297043|NCT01425814|520292425|FG003|Period 4|Adverse Event|0|||
144297044|NCT01425814|520292426|FG004|Period 4|Adverse Event|0|||
144297045|NCT01425814|520292427|FG005|Period 4|Adverse Event|0|||
144297046|NCT01425814|520292422|FG000|Period 5|Stability criteria not fulfilled|0|||
144297047|NCT01425814|520292423|FG001|Period 5|Stability criteria not fulfilled|0|||
144297048|NCT01425814|520292424|FG002|Period 5|Stability criteria not fulfilled|1|||
144297049|NCT01425814|520292425|FG003|Period 5|Stability criteria not fulfilled|0|||
144297050|NCT01425814|520292426|FG004|Period 5|Stability criteria not fulfilled|0|||
144297051|NCT01425814|520292427|FG005|Period 5|Stability criteria not fulfilled|1|||
144297052|NCT02095106|520292432|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
144297053|NCT02095106|520292433|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
144297054|NCT00478257|520292436|FG000|Overall Study|Withdrawal by Subject|8|||
144297055|NCT00478257|520292437|FG001|Overall Study|Withdrawal by Subject|3|||
144297056|NCT01182350|520292439|FG000|Overall Study|Adverse Event|5|||
144297057|NCT01182350|520292440|FG001|Overall Study|Adverse Event|0|||
144297058|NCT01182350|520292441|FG002|Overall Study|Adverse Event|0|||
144297059|NCT01182350|520292442|FG003|Overall Study|Adverse Event|0|||
144297060|NCT01182350|520292443|FG004|Overall Study|Adverse Event|0|||
144297061|NCT01182350|520292439|FG000|Overall Study|Disease Progression|15|||
144297062|NCT01182350|520292440|FG001|Overall Study|Disease Progression|12|||
144297063|NCT01182350|520292441|FG002|Overall Study|Disease Progression|0|||
144297064|NCT01182350|520292442|FG003|Overall Study|Disease Progression|1|||
144297065|NCT01182350|520292443|FG004|Overall Study|Disease Progression|0|||
144297066|NCT01182350|520292439|FG000|Overall Study|Death|0|||
144297067|NCT01182350|520292440|FG001|Overall Study|Death|1|||
144297068|NCT01182350|520292441|FG002|Overall Study|Death|1|||
144297069|NCT01182350|520292442|FG003|Overall Study|Death|0|||
144297070|NCT01182350|520292443|FG004|Overall Study|Death|0|||
144297071|NCT01182350|520292439|FG000|Overall Study|Withdrawal by Subject|3|||
144297072|NCT01182350|520292440|FG001|Overall Study|Withdrawal by Subject|1|||
144297073|NCT01182350|520292441|FG002|Overall Study|Withdrawal by Subject|0|||
144297074|NCT01182350|520292442|FG003|Overall Study|Withdrawal by Subject|1|||
144297075|NCT01182350|520292443|FG004|Overall Study|Withdrawal by Subject|0|||
144297076|NCT01182350|520292439|FG000|Overall Study|Alternative Therapy|2|||
144297077|NCT01182350|520292440|FG001|Overall Study|Alternative Therapy|0|||
144297078|NCT01182350|520292441|FG002|Overall Study|Alternative Therapy|1|||
144297079|NCT01182350|520292442|FG003|Overall Study|Alternative Therapy|0|||
144297080|NCT01182350|520292443|FG004|Overall Study|Alternative Therapy|0|||
144297081|NCT01182350|520292439|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
144297082|NCT01182350|520292440|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
144297083|NCT01182350|520292441|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
144297084|NCT01182350|520292442|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
144297085|NCT01182350|520292443|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
144297086|NCT01182350|520292439|FG000|Overall Study|Unevaluable for Biopsy|0|||
144297145|NCT02038647|520292460|FG001|Overall Study|Symptomatic Deterioration|7|||
144297146|NCT02038647|520292459|FG000|Overall Study|Withdrawal by Subject|5|||
144297147|NCT02038647|520292460|FG001|Overall Study|Withdrawal by Subject|2|||
144297148|NCT02038647|520292459|FG000|Overall Study|Not Reported|0|||
144297149|NCT02038647|520292460|FG001|Overall Study|Not Reported|1|||
144297150|NCT02038647|520292459|FG000|Overall Study|Ongoing at Datacut|9|||
144297151|NCT02038647|520292460|FG001|Overall Study|Ongoing at Datacut|10|||
144297152|NCT03078868|520292461|FG000|Overall Study|Physician Decision|3|||
144297153|NCT00635050|520292464|FG000|Overall Study|Withdrawal by Subject|1|||
144297154|NCT03038620|520292465|FG000|Overall Study|Lost to Follow-up|18|||
144297155|NCT03038620|520292466|FG001|Overall Study|Lost to Follow-up|23|||
144297156|NCT03038620|520292465|FG000|Overall Study|Withdrawal by Subject|0|||
144297157|NCT03038620|520292466|FG001|Overall Study|Withdrawal by Subject|15|||
144297158|NCT03038620|520292465|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
144297159|NCT03038620|520292466|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
144297160|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
144297161|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
144297162|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
144297163|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
144297164|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
144297165|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
144297166|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
144297167|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
144297168|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
144297169|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
144297170|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
144297171|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
144297172|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
144297173|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
144297174|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
144297175|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
144297176|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
144297177|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
144297178|NCT00086515|520292467|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
144297179|NCT00086515|520292468|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
144297180|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
144297181|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
144297182|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
144297183|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
144297184|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
144297185|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
144297186|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
144297187|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
144297188|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
144297189|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
144297190|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
144297191|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
144297192|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
144297193|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
144297194|NCT00086515|520292467|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
144297195|NCT00086515|520292468|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
144297196|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
144297197|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
144297198|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
144297199|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
144297200|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
144297201|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
144297202|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
144297203|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
144297204|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
144297205|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
144297206|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
144297207|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
144297208|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
144297209|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
144297210|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
144297211|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
144297212|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
144297213|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
144297214|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
144297215|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
144297216|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
144297217|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
144297218|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
144297219|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
144297220|NCT00086515|520292467|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
144297221|NCT00086515|520292468|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
144297222|NCT01849276|520292479|FG000|Followed for Survival for 5 Years|Death|1|||
144297223|NCT01849276|520292479|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
144297224|NCT00982280|520292483|FG000|Observation Period|Not eligible to be dosed|19|||
144297225|NCT00982280|520292483|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
144297226|NCT00982280|520292483|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
144297227|NCT00982280|520292483|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
144297228|NCT00982280|520292483|FG000|Maintenance Period|Adverse Event|1|||
144297229|NCT01506726|520292489|FG000|Overall Study|Adverse Event|1|||
144297230|NCT01506726|520292490|FG001|Overall Study|Adverse Event|2|||
144297231|NCT02231580|520292491|FG000|Overall Study|Adverse Event|5|||
144297232|NCT02231580|520292492|FG001|Overall Study|Adverse Event|0|||
144297233|NCT04724837|520292493|FG000|Overall Study|Other|4|||
144297234|NCT04724837|520292494|FG001|Overall Study|Other|16|||
144297235|NCT04724837|520292495|FG002|Overall Study|Other|0|||
144297236|NCT04724837|520292493|FG000|Overall Study|Withdrawal by Subject|2|||
144297237|NCT04724837|520292494|FG001|Overall Study|Withdrawal by Subject|9|||
144297238|NCT04724837|520292495|FG002|Overall Study|Withdrawal by Subject|9|||
144297239|NCT04724837|520292493|FG000|Overall Study|Adverse Event|2|||
144297240|NCT04724837|520292494|FG001|Overall Study|Adverse Event|7|||
144297241|NCT04724837|520292495|FG002|Overall Study|Adverse Event|4|||
144297242|NCT04724837|520292493|FG000|Overall Study|Lost to Follow-up|0|||
144297243|NCT04724837|520292494|FG001|Overall Study|Lost to Follow-up|1|||
144297244|NCT04724837|520292495|FG002|Overall Study|Lost to Follow-up|3|||
144297245|NCT04724837|520292493|FG000|Overall Study|Physician Decision|1|||
144297246|NCT04724837|520292494|FG001|Overall Study|Physician Decision|2|||
144297247|NCT04724837|520292495|FG002|Overall Study|Physician Decision|0|||
144297248|NCT04724837|520292493|FG000|Overall Study|Death|0|||
144297249|NCT04724837|520292494|FG001|Overall Study|Death|0|||
144297250|NCT04724837|520292495|FG002|Overall Study|Death|1|||
144297251|NCT04724837|520292493|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
144297252|NCT04724837|520292494|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
144297253|NCT04724837|520292495|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
144297254|NCT04724837|520292493|FG000|Overall Study|Study Terminated by Sponsor|0|||
144297255|NCT04724837|520292494|FG001|Overall Study|Study Terminated by Sponsor|1|||
144297256|NCT04724837|520292495|FG002|Overall Study|Study Terminated by Sponsor|0|||
144297257|NCT00847730|520292496|FG000|Overall Study|Multiple interruptions in therapy|8|||
144297258|NCT04938427|520292499|FG000|Overall Study|Adverse Event|5|||
144297259|NCT04938427|520292500|FG001|Overall Study|Adverse Event|19|||
144297260|NCT04938427|520292499|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144297261|NCT04938427|520292500|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144297262|NCT04938427|520292499|FG000|Overall Study|Withdrawal by Subject|1|||
144297263|NCT04938427|520292500|FG001|Overall Study|Withdrawal by Subject|0|||
144297264|NCT04938427|520292499|FG000|Overall Study|Reason Not Specified|2|||
144297265|NCT04938427|520292500|FG001|Overall Study|Reason Not Specified|1|||
144297266|NCT03633058|520292509|FG000|Overall Study|Adverse Event|0|||
144297267|NCT03633058|520292510|FG001|Overall Study|Adverse Event|0|||
144297268|NCT03633058|520292511|FG002|Overall Study|Adverse Event|1|||
144297269|NCT03633058|520292512|FG003|Overall Study|Adverse Event|0|||
144297270|NCT03312543|520292515|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
144297271|NCT03312543|520292516|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
144297272|NCT03312543|520292515|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
144297273|NCT03312543|520292516|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
144297274|NCT03312543|520292515|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
144297275|NCT03312543|520292516|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
144297276|NCT03312543|520292515|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
144297277|NCT03312543|520292516|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
144297278|NCT03312543|520292515|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
144360004|NCT01601535|520525138|FG003|Phase 1|Withdrawal by Subject|2|||
144297279|NCT03312543|520292516|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
144297280|NCT03312543|520292515|FG000|Regression (Week 12 to Week 24)|Death|0|||
144297281|NCT03312543|520292516|FG001|Regression (Week 12 to Week 24)|Death|1|||
144297282|NCT03211416|520292524|FG000|Overall Study|Adverse Event|7|||
144297283|NCT03211416|520292524|FG000|Overall Study|Lack of Efficacy|2|||
144297284|NCT03211416|520292524|FG000|Overall Study|Physician Decision|1|||
144297285|NCT02420717|520292528|FG000|Overall Study|Did not receive all study medication|2|||
144297286|NCT02420717|520292529|FG001|Overall Study|Did not receive all study medication|0|||
144297287|NCT02420717|520292530|FG002|Overall Study|Did not receive all study medication|0|||
144297288|NCT04116489|520292531|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
144297289|NCT04116489|520292531|FG000|Overall Study|Withdrawal by Subject|1|||
144297290|NCT03781570|520292532|FG000|Overall Study|Technical Issues (equipment failure)|31|||
144297291|NCT03781570|520292532|FG000|Overall Study|Withdrawal by Subject|7|||
144297292|NCT03781570|520292532|FG000|Overall Study|Physical Constraints|11|||
144297293|NCT01107496|520292533|FG000|Overall Study|Adverse Event|1|||
144297294|NCT01107496|520292534|FG001|Overall Study|Adverse Event|0|||
144297295|NCT01107496|520292533|FG000|Overall Study|Lack of Efficacy|1|||
144297296|NCT01107496|520292534|FG001|Overall Study|Lack of Efficacy|0|||
144297297|NCT01107496|520292533|FG000|Overall Study|Protocol Violation|0|||
144297298|NCT01107496|520292534|FG001|Overall Study|Protocol Violation|1|||
144297299|NCT01107496|520292533|FG000|Overall Study|Lost to Follow-up|0|||
144297300|NCT01107496|520292534|FG001|Overall Study|Lost to Follow-up|1|||
144297301|NCT03709472|520292535|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
144297302|NCT03709472|520292536|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
144297303|NCT03709472|520292535|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
144297304|NCT03709472|520292536|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
144297305|NCT03559556|520292537|FG000|Overall Study|Withdrawal by Subject|1|||
144297306|NCT02496000|520292543|FG000|Overall Study|Withdrawal by Subject|1|||
144297307|NCT02496000|520292544|FG001|Overall Study|Withdrawal by Subject|2|||
144297308|NCT02496000|520292545|FG002|Overall Study|Withdrawal by Subject|0|||
144297309|NCT02496000|520292543|FG000|Overall Study|Lost to Follow-up|1|||
144297310|NCT02496000|520292544|FG001|Overall Study|Lost to Follow-up|0|||
144297311|NCT02496000|520292545|FG002|Overall Study|Lost to Follow-up|1|||
144297312|NCT02496000|520292543|FG000|Overall Study|Protocol Violation|0|||
144297313|NCT02496000|520292544|FG001|Overall Study|Protocol Violation|0|||
144297314|NCT02496000|520292545|FG002|Overall Study|Protocol Violation|1|||
144297315|NCT02496000|520292543|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
144297316|NCT02496000|520292544|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
144297317|NCT02496000|520292545|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
144297318|NCT02496000|520292543|FG000|Overall Study|undetermined|0|||
144297319|NCT02496000|520292544|FG001|Overall Study|undetermined|1|||
144297320|NCT02496000|520292545|FG002|Overall Study|undetermined|0|||
144297321|NCT02255656|520292546|FG000|Overall Study|Adverse Event|11|||
144297322|NCT02255656|520292546|FG000|Overall Study|Poor compliance to protocol|3|||
144297323|NCT02255656|520292546|FG000|Overall Study|Lost to Follow-up|30|||
144297324|NCT02255656|520292546|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
144297325|NCT02255656|520292546|FG000|Overall Study|Other|126|||
144297326|NCT01346592|520292547|FG000|Overall Study|Lost to Follow-up|62|||
144297327|NCT01346592|520292548|FG001|Overall Study|Lost to Follow-up|29|||
144297328|NCT01346592|520292549|FG002|Overall Study|Lost to Follow-up|29|||
144297329|NCT01346592|520292547|FG000|Overall Study|Protocol Violation|2|||
144297330|NCT01346592|520292548|FG001|Overall Study|Protocol Violation|1|||
144297331|NCT01346592|520292549|FG002|Overall Study|Protocol Violation|0|||
144297332|NCT01346592|520292547|FG000|Overall Study|Death|1|||
144297333|NCT01346592|520292548|FG001|Overall Study|Death|3|||
144297334|NCT01346592|520292549|FG002|Overall Study|Death|4|||
144297335|NCT01346592|520292547|FG000|Overall Study|Adverse Event|0|||
144297336|NCT01346592|520292548|FG001|Overall Study|Adverse Event|1|||
144297337|NCT01346592|520292549|FG002|Overall Study|Adverse Event|0|||
144297338|NCT01346592|520292547|FG000|Overall Study|Withdrawal by Subject|77|||
144297339|NCT01346592|520292548|FG001|Overall Study|Withdrawal by Subject|51|||
144297340|NCT01346592|520292549|FG002|Overall Study|Withdrawal by Subject|38|||
144297341|NCT01346592|520292547|FG000|Overall Study|Inappropriate enrollment|3|||
144297342|NCT01346592|520292548|FG001|Overall Study|Inappropriate enrollment|1|||
144297343|NCT01346592|520292549|FG002|Overall Study|Inappropriate enrollment|1|||
144297344|NCT01346592|520292547|FG000|Overall Study|Administrative reason|1|||
144297345|NCT01346592|520292548|FG001|Overall Study|Administrative reason|0|||
144297346|NCT01346592|520292549|FG002|Overall Study|Administrative reason|0|||
144297347|NCT01346592|520292547|FG000|Overall Study|Unable to Classify|7|||
144297348|NCT01346592|520292548|FG001|Overall Study|Unable to Classify|3|||
144297349|NCT01346592|520292549|FG002|Overall Study|Unable to Classify|6|||
144297350|NCT02038036|520292552|FG000|Core Study|Adverse Event|7|||
144297351|NCT02038036|520292553|FG001|Core Study|Adverse Event|7|||
144297352|NCT02038036|520292552|FG000|Core Study|Death|1|||
144297353|NCT02038036|520292553|FG001|Core Study|Death|1|||
144297354|NCT02038036|520292552|FG000|Core Study|Disease progression|2|||
144297355|NCT02038036|520292553|FG001|Core Study|Disease progression|2|||
144297356|NCT02038036|520292552|FG000|Core Study|Lost to Follow-up|0|||
144297357|NCT02038036|520292553|FG001|Core Study|Lost to Follow-up|1|||
144297358|NCT02038036|520292552|FG000|Core Study|Physician Decision|2|||
144297359|NCT02038036|520292553|FG001|Core Study|Physician Decision|1|||
144297360|NCT02038036|520292552|FG000|Core Study|Subject/guardian decision|0|||
144297361|NCT02038036|520292553|FG001|Core Study|Subject/guardian decision|1|||
144297362|NCT02038036|520292552|FG000|Core Study|Withdrawal by Subject|3|||
144297363|NCT02038036|520292553|FG001|Core Study|Withdrawal by Subject|1|||
144297364|NCT02038036|520292552|FG000|Crossover Period|Withdrawal by Subject|0|||
144297365|NCT02038036|520292553|FG001|Crossover Period|Withdrawal by Subject|3|||
144297366|NCT02038036|520292552|FG000|Crossover Period|Adverse Event|0|||
144297367|NCT02038036|520292553|FG001|Crossover Period|Adverse Event|9|||
144297368|NCT02038036|520292552|FG000|Crossover Period|Death|0|||
144297369|NCT02038036|520292553|FG001|Crossover Period|Death|2|||
144297370|NCT02038036|520292552|FG000|Crossover Period|Disease progression|0|||
144297371|NCT02038036|520292553|FG001|Crossover Period|Disease progression|3|||
144297372|NCT02038036|520292552|FG000|Crossover Period|Lost to Follow-up|0|||
144297373|NCT02038036|520292553|FG001|Crossover Period|Lost to Follow-up|1|||
144297374|NCT02038036|520292552|FG000|Crossover Period|Physician Decision|0|||
144297375|NCT02038036|520292553|FG001|Crossover Period|Physician Decision|2|||
144297376|NCT02520154|520292554|FG000|Overall Study|Death|1|||
144297377|NCT02520154|520292554|FG000|Overall Study|Withdrawal by Subject|2|||
144297378|NCT02520154|520292554|FG000|Overall Study|Physician Decision|2|||
144297379|NCT02552225|520294435|FG000|Overall Study|Withdrawal by Subject|1|||
144297380|NCT02552225|520294436|FG001|Overall Study|Withdrawal by Subject|0|||
144297381|NCT03122184|520294437|FG000|Overall Study|Lost to Follow-up|4|||
144297382|NCT03122184|520294438|FG001|Overall Study|Lost to Follow-up|6|||
144297383|NCT03122184|520294437|FG000|Overall Study|Withdrawal by Subject|3|||
144297384|NCT03122184|520294438|FG001|Overall Study|Withdrawal by Subject|0|||
144297385|NCT03122184|520294437|FG000|Overall Study|Terminated due to cognitive problem|1|||
144297386|NCT03122184|520294438|FG001|Overall Study|Terminated due to cognitive problem|0|||
144297387|NCT02297516|520294441|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
144297388|NCT02297516|520294442|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
144297389|NCT02297516|520294441|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
144297390|NCT02297516|520294442|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
144297391|NCT02297516|520294441|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
144297392|NCT02297516|520294442|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
144297393|NCT00710593|520294443|FG000|Overall Study|Incarceration|1|||
144297394|NCT00710593|520294444|FG001|Overall Study|Incarceration|0|||
144297395|NCT00710593|520294443|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
144297396|NCT00710593|520294444|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
144297397|NCT00710593|520294443|FG000|Overall Study|Lost to Follow-up|3|||
144297398|NCT00710593|520294444|FG001|Overall Study|Lost to Follow-up|1|||
144297399|NCT00710593|520294443|FG000|Overall Study|Moved out of area|1|||
144297400|NCT00710593|520294444|FG001|Overall Study|Moved out of area|0|||
144297401|NCT00710593|520294443|FG000|Overall Study|Failure to adhere or complete study eval|1|||
144297402|NCT00710593|520294444|FG001|Overall Study|Failure to adhere or complete study eval|1|||
144297403|NCT00710593|520294443|FG000|Overall Study|Protocol Violation|1|||
144297404|NCT00710593|520294444|FG001|Overall Study|Protocol Violation|1|||
144297405|NCT00710593|520294443|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
144297406|NCT00710593|520294444|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
144297407|NCT04490278|520294445|FG000|Overall Study|Lost to Follow-up|6|||
144297408|NCT00366457|520294446|FG000|Overall Study|never began study therapy|2|||
144297409|NCT02829996|520294447|FG000|Overall Study|Withdrawal by Subject|1|||
144297410|NCT02829996|520294448|FG001|Overall Study|Withdrawal by Subject|0|||
144297411|NCT02829996|520294449|FG002|Overall Study|Withdrawal by Subject|0|||
144297412|NCT02829996|520294450|FG003|Overall Study|Withdrawal by Subject|0|||
144297413|NCT02829996|520294451|FG004|Overall Study|Withdrawal by Subject|0|||
144297414|NCT00189423|520294452|FG000|Overall Study|Death|746|||
144297415|NCT00189423|520294453|FG001|Overall Study|Death|747|||
144297416|NCT00189423|520294452|FG000|Overall Study|Withdrawal by Subject|9|||
144297417|NCT00189423|520294453|FG001|Overall Study|Withdrawal by Subject|9|||
144297418|NCT00189423|520294452|FG000|Overall Study|Lost to Follow-up|10|||
144297419|NCT00189423|520294453|FG001|Overall Study|Lost to Follow-up|10|||
144297420|NCT01497197|520294454|FG000|Overall Study|Lost to Follow-up|1|||
144297421|NCT01497197|520294455|FG001|Overall Study|Lost to Follow-up|0|||
144297422|NCT01497197|520294454|FG000|Overall Study|Protocol Violation|0|||
144297423|NCT01497197|520294455|FG001|Overall Study|Protocol Violation|2|||
144297424|NCT01497197|520294454|FG000|Overall Study|Withdrawal by Subject|2|||
144297425|NCT01497197|520294455|FG001|Overall Study|Withdrawal by Subject|1|||
144297426|NCT01497197|520294454|FG000|Overall Study|Excessive/lack of response to treatment|1|||
144297427|NCT01497197|520294455|FG001|Overall Study|Excessive/lack of response to treatment|0|||
144297428|NCT01497197|520294454|FG000|Overall Study|Risk of OHSS|1|||
144297429|NCT01497197|520294455|FG001|Overall Study|Risk of OHSS|0|||
144297430|NCT01497197|520294454|FG000|Overall Study|No oocytes retrieved|3|||
144297431|NCT01497197|520294455|FG001|Overall Study|No oocytes retrieved|2|||
144297432|NCT01497197|520294454|FG000|Overall Study|No fertilisation|6|||
144297433|NCT01497197|520294455|FG001|Overall Study|No fertilisation|5|||
144297434|NCT01497197|520294454|FG000|Overall Study|Intention to freeze all embryos|0|||
144297435|NCT01497197|520294455|FG001|Overall Study|Intention to freeze all embryos|1|||
144297436|NCT01497197|520294454|FG000|Overall Study|All embryos discarded|0|||
144297437|NCT01497197|520294455|FG001|Overall Study|All embryos discarded|3|||
144297438|NCT01497197|520294454|FG000|Overall Study|Other|3|||
144297439|NCT01497197|520294455|FG001|Overall Study|Other|1|||
144297440|NCT04734210|520294459|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
144297441|NCT04734210|520294460|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
144297442|NCT04734210|520294461|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
144297443|NCT04734210|520294459|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
144297444|NCT04734210|520294460|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
144297445|NCT04734210|520294461|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
144297446|NCT04734210|520294459|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
144297447|NCT04734210|520294460|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
144297448|NCT04734210|520294461|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
144297449|NCT04734210|520294459|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
144359542|NCT00001832|520522780|FG012|Treatment Period|Death during treatment|0|||
144297450|NCT04734210|520294460|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
144297451|NCT04734210|520294461|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
144297452|NCT02684461|520294462|FG000|Overall Study|Adverse Event|1|||
144297453|NCT02684461|520294463|FG001|Overall Study|Adverse Event|0|||
144297454|NCT02684461|520294464|FG002|Overall Study|Adverse Event|0|||
144297455|NCT02684461|520294462|FG000|Overall Study|Lack of Efficacy|1|||
144297456|NCT02684461|520294463|FG001|Overall Study|Lack of Efficacy|2|||
144297457|NCT02684461|520294464|FG002|Overall Study|Lack of Efficacy|0|||
144297458|NCT02390076|520294465|FG000|Overall Study|Lost to Follow-up|2|||
144297459|NCT02390076|520294466|FG001|Overall Study|Lost to Follow-up|1|||
144297460|NCT02390076|520294467|FG002|Overall Study|Lost to Follow-up|4|||
144297461|NCT04507204|520294468|FG000|Overall Study|Adverse Event|8|||
144297462|NCT04507204|520294469|FG001|Overall Study|Adverse Event|13|||
144297463|NCT04507204|520294468|FG000|Overall Study|Death|0|||
144297464|NCT04507204|520294469|FG001|Overall Study|Death|1|||
144297465|NCT04507204|520294468|FG000|Overall Study|Lost to Follow-up|15|||
144297466|NCT04507204|520294469|FG001|Overall Study|Lost to Follow-up|14|||
144297467|NCT04507204|520294468|FG000|Overall Study|Poor Compliance with Protocol|2|||
144297468|NCT04507204|520294469|FG001|Overall Study|Poor Compliance with Protocol|4|||
144297469|NCT04507204|520294468|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
144297470|NCT04507204|520294469|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
144297471|NCT04507204|520294468|FG000|Overall Study|Withdrawal of Patient Consent|21|||
144297472|NCT04507204|520294469|FG001|Overall Study|Withdrawal of Patient Consent|13|||
144297473|NCT01206517|520294472|FG000|Overall Study|Withdrawal by Subject|0|||
144297474|NCT01206517|520294473|FG001|Overall Study|Withdrawal by Subject|0|||
144297475|NCT01206517|520294474|FG002|Overall Study|Withdrawal by Subject|2|||
144297476|NCT01206517|520294475|FG003|Overall Study|Withdrawal by Subject|0|||
144297477|NCT01206517|520294476|FG004|Overall Study|Withdrawal by Subject|1|||
144297478|NCT01206517|520294477|FG005|Overall Study|Withdrawal by Subject|0|||
144297479|NCT03493958|520294478|FG000|Overall Study|Withdrawal by Subject|6|||
144297480|NCT03493958|520294478|FG000|Overall Study|Lost to Follow-up|7|||
144297481|NCT03493958|520294478|FG000|Overall Study|Did not complete all required study procedures|2|||
144297482|NCT01029535|520294479|FG000|Overall Study|Lost to Follow-up|24|||
144297483|NCT01029535|520294479|FG000|Overall Study|Protocol Violation|2|||
144297484|NCT01029535|520294479|FG000|Overall Study|Participant Withdrew Consent|2|||
144297485|NCT01029535|520294479|FG000|Overall Study|Adverse Event|1|||
144297486|NCT01029535|520294479|FG000|Overall Study|Use of Another Treatment|1|||
144297487|NCT01029535|520294479|FG000|Overall Study|Death|1|||
144297488|NCT01358734|520294483|FG000|Overall Study|Adverse Event|4|||
144297489|NCT01358734|520294484|FG001|Overall Study|Adverse Event|7|||
144297490|NCT01358734|520294485|FG002|Overall Study|Adverse Event|3|||
144297491|NCT01358734|520294483|FG000|Overall Study|Lack of Efficacy|0|||
144297492|NCT01358734|520294484|FG001|Overall Study|Lack of Efficacy|1|||
144297493|NCT01358734|520294485|FG002|Overall Study|Lack of Efficacy|3|||
144297494|NCT01358734|520294483|FG000|Overall Study|Withdrawal by Subject|1|||
144297495|NCT01358734|520294484|FG001|Overall Study|Withdrawal by Subject|6|||
144297496|NCT01358734|520294485|FG002|Overall Study|Withdrawal by Subject|3|||
144297497|NCT01358734|520294483|FG000|Overall Study|Death|3|||
144297498|NCT01358734|520294484|FG001|Overall Study|Death|7|||
144297499|NCT01358734|520294485|FG002|Overall Study|Death|2|||
144297500|NCT01358734|520294483|FG000|Overall Study|Progressive Disease|5|||
144297501|NCT01358734|520294484|FG001|Overall Study|Progressive Disease|13|||
144297502|NCT01358734|520294485|FG002|Overall Study|Progressive Disease|16|||
144297503|NCT01358734|520294483|FG000|Overall Study|Non-compliance with study drug|0|||
144297504|NCT01358734|520294484|FG001|Overall Study|Non-compliance with study drug|0|||
144297505|NCT01358734|520294485|FG002|Overall Study|Non-compliance with study drug|1|||
144297506|NCT01358734|520294483|FG000|Overall Study|Other|2|||
144297507|NCT01358734|520294484|FG001|Overall Study|Other|5|||
144297508|NCT01358734|520294485|FG002|Overall Study|Other|4|||
144297509|NCT01358734|520294483|FG000|Overall Study|Protocol Violation|0|||
144297510|NCT01358734|520294484|FG001|Overall Study|Protocol Violation|0|||
144297511|NCT01358734|520294485|FG002|Overall Study|Protocol Violation|2|||
144297512|NCT00553254|520294492|FG000|Overall Study|Death|3|||
144297513|NCT00553254|520294493|FG001|Overall Study|Death|6|||
144297514|NCT00553254|520294494|FG002|Overall Study|Death|25|||
144297515|NCT00553254|520294492|FG000|Overall Study|Lost to Follow-up|0|||
144297516|NCT00553254|520294493|FG001|Overall Study|Lost to Follow-up|0|||
144297517|NCT00553254|520294494|FG002|Overall Study|Lost to Follow-up|2|||
144297518|NCT00553254|520294492|FG000|Overall Study|Withdrawal by Subject|2|||
144297519|NCT00553254|520294493|FG001|Overall Study|Withdrawal by Subject|0|||
144297520|NCT00553254|520294494|FG002|Overall Study|Withdrawal by Subject|2|||
144297521|NCT00553254|520294492|FG000|Overall Study|Study terminated by Sponsor|0|||
144297522|NCT00553254|520294493|FG001|Overall Study|Study terminated by Sponsor|0|||
144297523|NCT00553254|520294494|FG002|Overall Study|Study terminated by Sponsor|1|||
144297524|NCT00553254|520294492|FG000|Overall Study|Other|1|||
144297525|NCT00553254|520294493|FG001|Overall Study|Other|0|||
144297526|NCT00553254|520294494|FG002|Overall Study|Other|13|||
144297527|NCT02314923|520294497|FG000|Overall Study|Death|0|||
144297528|NCT02314923|520294498|FG001|Overall Study|Death|0|||
144297529|NCT02314923|520294499|FG002|Overall Study|Death|0|||
144297530|NCT02314923|520294500|FG003|Overall Study|Death|1|||
144297531|NCT02314923|520294501|FG004|Overall Study|Death|0|||
144297532|NCT02314923|520294502|FG005|Overall Study|Death|0|||
144297533|NCT02314923|520294503|FG006|Overall Study|Death|0|||
144297534|NCT02314923|520294504|FG007|Overall Study|Death|0|||
144297535|NCT02314923|520294505|FG008|Overall Study|Death|0|||
144297536|NCT02314923|520294506|FG009|Overall Study|Death|0|||
144297537|NCT02314923|520294497|FG000|Overall Study|Lost to Follow-up|2|||
144297538|NCT02314923|520294498|FG001|Overall Study|Lost to Follow-up|3|||
144297539|NCT02314923|520294499|FG002|Overall Study|Lost to Follow-up|1|||
144297540|NCT02314923|520294500|FG003|Overall Study|Lost to Follow-up|0|||
144297541|NCT02314923|520294501|FG004|Overall Study|Lost to Follow-up|0|||
144297542|NCT02314923|520294502|FG005|Overall Study|Lost to Follow-up|0|||
144297543|NCT02314923|520294503|FG006|Overall Study|Lost to Follow-up|3|||
144297544|NCT02314923|520294504|FG007|Overall Study|Lost to Follow-up|4|||
144297545|NCT02314923|520294505|FG008|Overall Study|Lost to Follow-up|2|||
144297546|NCT02314923|520294506|FG009|Overall Study|Lost to Follow-up|0|||
144297547|NCT02314923|520294497|FG000|Overall Study|Withdrawal by Subject|0|||
144297548|NCT02314923|520294498|FG001|Overall Study|Withdrawal by Subject|0|||
144297549|NCT02314923|520294499|FG002|Overall Study|Withdrawal by Subject|1|||
144297550|NCT02314923|520294500|FG003|Overall Study|Withdrawal by Subject|0|||
144297551|NCT02314923|520294501|FG004|Overall Study|Withdrawal by Subject|1|||
144297552|NCT02314923|520294502|FG005|Overall Study|Withdrawal by Subject|0|||
144297553|NCT02314923|520294503|FG006|Overall Study|Withdrawal by Subject|1|||
144297554|NCT02314923|520294504|FG007|Overall Study|Withdrawal by Subject|0|||
144297555|NCT02314923|520294505|FG008|Overall Study|Withdrawal by Subject|0|||
144297556|NCT02314923|520294506|FG009|Overall Study|Withdrawal by Subject|0|||
144297557|NCT02314923|520294497|FG000|Overall Study|Physician Decision|0|||
144297558|NCT02314923|520294498|FG001|Overall Study|Physician Decision|1|||
144297559|NCT02314923|520294499|FG002|Overall Study|Physician Decision|0|||
144297560|NCT02314923|520294500|FG003|Overall Study|Physician Decision|0|||
144297561|NCT02314923|520294501|FG004|Overall Study|Physician Decision|0|||
144297562|NCT02314923|520294502|FG005|Overall Study|Physician Decision|0|||
144297563|NCT02314923|520294503|FG006|Overall Study|Physician Decision|0|||
144297564|NCT02314923|520294504|FG007|Overall Study|Physician Decision|0|||
144297565|NCT02314923|520294505|FG008|Overall Study|Physician Decision|0|||
144297566|NCT02314923|520294506|FG009|Overall Study|Physician Decision|0|||
144297567|NCT02314923|520294497|FG000|Overall Study|Participant unavailable|0|||
144297568|NCT02314923|520294498|FG001|Overall Study|Participant unavailable|0|||
144297569|NCT02314923|520294499|FG002|Overall Study|Participant unavailable|0|||
144297570|NCT02314923|520294500|FG003|Overall Study|Participant unavailable|0|||
144297571|NCT02314923|520294501|FG004|Overall Study|Participant unavailable|0|||
144297572|NCT02314923|520294502|FG005|Overall Study|Participant unavailable|1|||
144297573|NCT02314923|520294503|FG006|Overall Study|Participant unavailable|0|||
144297574|NCT02314923|520294504|FG007|Overall Study|Participant unavailable|0|||
144297575|NCT02314923|520294505|FG008|Overall Study|Participant unavailable|0|||
144297576|NCT02314923|520294506|FG009|Overall Study|Participant unavailable|0|||
144297577|NCT02314923|520294497|FG000|Overall Study|Screen failure|0|||
144297578|NCT02314923|520294498|FG001|Overall Study|Screen failure|0|||
144297579|NCT02314923|520294499|FG002|Overall Study|Screen failure|0|||
144297580|NCT02314923|520294500|FG003|Overall Study|Screen failure|0|||
144297581|NCT02314923|520294501|FG004|Overall Study|Screen failure|0|||
144297582|NCT02314923|520294502|FG005|Overall Study|Screen failure|0|||
144297583|NCT02314923|520294503|FG006|Overall Study|Screen failure|1|||
144297584|NCT02314923|520294504|FG007|Overall Study|Screen failure|0|||
144297585|NCT02314923|520294505|FG008|Overall Study|Screen failure|0|||
144297586|NCT02314923|520294506|FG009|Overall Study|Screen failure|0|||
144297587|NCT02314923|520294497|FG000|Overall Study|Participant relocation|1|||
144297588|NCT02314923|520294498|FG001|Overall Study|Participant relocation|0|||
144297589|NCT02314923|520294499|FG002|Overall Study|Participant relocation|0|||
144297590|NCT02314923|520294500|FG003|Overall Study|Participant relocation|0|||
144297591|NCT02314923|520294501|FG004|Overall Study|Participant relocation|0|||
144297592|NCT02314923|520294502|FG005|Overall Study|Participant relocation|0|||
144297593|NCT02314923|520294503|FG006|Overall Study|Participant relocation|0|||
144297594|NCT02314923|520294504|FG007|Overall Study|Participant relocation|1|||
144297595|NCT02314923|520294505|FG008|Overall Study|Participant relocation|0|||
144297596|NCT02314923|520294506|FG009|Overall Study|Participant relocation|0|||
144297597|NCT02546323|520294507|FG000|Overall Study|Withdrawal by Subject|36|||
144297598|NCT02546323|520294508|FG001|Overall Study|Withdrawal by Subject|33|||
144297599|NCT02546323|520294507|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
144297600|NCT02546323|520294508|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
144297601|NCT02546323|520294507|FG000|Overall Study|Adverse Event|17|||
144297602|NCT02546323|520294508|FG001|Overall Study|Adverse Event|11|||
144297603|NCT02546323|520294507|FG000|Overall Study|Patient Specific Reasons|1|||
144297604|NCT02546323|520294508|FG001|Overall Study|Patient Specific Reasons|2|||
144297605|NCT02546323|520294507|FG000|Overall Study|Lost to Follow-up|2|||
144297606|NCT02546323|520294508|FG001|Overall Study|Lost to Follow-up|3|||
144297607|NCT02546323|520294507|FG000|Overall Study|Non-compliance with Study Drug|2|||
144297608|NCT02546323|520294508|FG001|Overall Study|Non-compliance with Study Drug|2|||
144297609|NCT02546323|520294507|FG000|Overall Study|Met Withdrawal Criteria|2|||
144297610|NCT02546323|520294508|FG001|Overall Study|Met Withdrawal Criteria|14|||
144297611|NCT04476784|520294509|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
144297612|NCT04476784|520294510|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
144297613|NCT01055028|520294511|FG000|Screening|Screen Failure|1|||
144297614|NCT01055028|520294512|FG001|Screening|Screen Failure|1|||
144297615|NCT01055028|520294511|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
144297616|NCT01055028|520294512|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
144297617|NCT01055028|520294511|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
144297618|NCT01055028|520294512|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
144297619|NCT01055028|520294511|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
144297620|NCT01055028|520294512|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
144297621|NCT06582732|520294513|FG000|Initial Study Period|Adverse Event|0|||
144297622|NCT06582732|520294514|FG001|Initial Study Period|Adverse Event|0|||
144297623|NCT06582732|520294515|FG002|Initial Study Period|Adverse Event|0|||
144297624|NCT06582732|520294516|FG003|Initial Study Period|Adverse Event|2|||
144297625|NCT06582732|520294517|FG004|Initial Study Period|Adverse Event|0|||
144297626|NCT06582732|520294518|FG005|Initial Study Period|Adverse Event|0|||
144297627|NCT06582732|520294519|FG006|Initial Study Period|Adverse Event|0|||
144297628|NCT06582732|520294513|FG000|Initial Study Period|Death|1|||
144297629|NCT06582732|520294514|FG001|Initial Study Period|Death|0|||
144297630|NCT06582732|520294515|FG002|Initial Study Period|Death|0|||
144297631|NCT06582732|520294516|FG003|Initial Study Period|Death|0|||
144297632|NCT06582732|520294517|FG004|Initial Study Period|Death|1|||
144297633|NCT06582732|520294518|FG005|Initial Study Period|Death|0|||
144297634|NCT06582732|520294519|FG006|Initial Study Period|Death|0|||
144297635|NCT06582732|520294513|FG000|Initial Study Period|Lost to Follow-up|0|||
144297636|NCT06582732|520294514|FG001|Initial Study Period|Lost to Follow-up|0|||
144297637|NCT06582732|520294515|FG002|Initial Study Period|Lost to Follow-up|2|||
144297638|NCT06582732|520294516|FG003|Initial Study Period|Lost to Follow-up|0|||
144297639|NCT06582732|520294517|FG004|Initial Study Period|Lost to Follow-up|0|||
144297640|NCT06582732|520294518|FG005|Initial Study Period|Lost to Follow-up|0|||
144297641|NCT06582732|520294519|FG006|Initial Study Period|Lost to Follow-up|0|||
144297642|NCT06582732|520294513|FG000|Initial Study Period|Withdrawal by Subject|0|||
144297643|NCT06582732|520294514|FG001|Initial Study Period|Withdrawal by Subject|1|||
144297644|NCT06582732|520294515|FG002|Initial Study Period|Withdrawal by Subject|0|||
144297645|NCT06582732|520294516|FG003|Initial Study Period|Withdrawal by Subject|1|||
144297646|NCT06582732|520294517|FG004|Initial Study Period|Withdrawal by Subject|3|||
144297647|NCT06582732|520294518|FG005|Initial Study Period|Withdrawal by Subject|1|||
144297648|NCT06582732|520294519|FG006|Initial Study Period|Withdrawal by Subject|2|||
144297649|NCT06582732|520294513|FG000|Initial Study Period|Moved Away|0|||
144297650|NCT06582732|520294514|FG001|Initial Study Period|Moved Away|0|||
144297651|NCT06582732|520294515|FG002|Initial Study Period|Moved Away|0|||
144297652|NCT06582732|520294516|FG003|Initial Study Period|Moved Away|0|||
144297653|NCT06582732|520294517|FG004|Initial Study Period|Moved Away|1|||
144297654|NCT06582732|520294518|FG005|Initial Study Period|Moved Away|0|||
144297655|NCT06582732|520294519|FG006|Initial Study Period|Moved Away|0|||
144297656|NCT03331354|520294520|FG000|Overall Study|Withdrawal by Subject|1|||
144297657|NCT03331354|520294521|FG001|Overall Study|Withdrawal by Subject|3|||
144297658|NCT03331354|520294520|FG000|Overall Study|Lost to Follow-up|3|||
144297659|NCT03331354|520294521|FG001|Overall Study|Lost to Follow-up|3|||
144297660|NCT03331354|520294520|FG000|Overall Study|Found employment before initiated active intervention|0|||
144297661|NCT03331354|520294521|FG001|Overall Study|Found employment before initiated active intervention|4|||
144297662|NCT05837481|520294524|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
144297663|NCT05837481|520294525|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
144297664|NCT02082977|520294526|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
144297665|NCT02082977|520294527|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
144297666|NCT02082977|520294528|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
144297667|NCT02082977|520294529|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
144297668|NCT02082977|520294530|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
144297669|NCT02082977|520294531|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
144297670|NCT02082977|520294532|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
144297671|NCT02082977|520294533|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
144297672|NCT02082977|520294534|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
144297673|NCT02082977|520294535|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
144297674|NCT02082977|520294526|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297675|NCT02082977|520294527|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297676|NCT02082977|520294528|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297677|NCT02082977|520294529|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297678|NCT02082977|520294530|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297679|NCT02082977|520294531|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297680|NCT02082977|520294532|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297681|NCT02082977|520294533|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
144297682|NCT02082977|520294534|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297683|NCT02082977|520294535|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
144297684|NCT02082977|520294526|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297685|NCT02082977|520294527|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297686|NCT02082977|520294528|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297687|NCT02082977|520294529|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297688|NCT02082977|520294530|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297689|NCT02082977|520294531|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
144297690|NCT02082977|520294532|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297691|NCT02082977|520294533|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297692|NCT02082977|520294534|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297693|NCT02082977|520294535|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
144297694|NCT02082977|520294526|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
144297695|NCT02082977|520294527|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
144297696|NCT02082977|520294528|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
144297697|NCT02082977|520294529|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
144297698|NCT02082977|520294530|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
144297699|NCT02082977|520294531|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
144297700|NCT02082977|520294532|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
144297701|NCT02082977|520294533|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
144297702|NCT02082977|520294534|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
144297703|NCT02082977|520294535|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
144297704|NCT02082977|520294526|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297705|NCT02082977|520294527|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297706|NCT02082977|520294528|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297707|NCT02082977|520294529|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297708|NCT02082977|520294530|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297709|NCT02082977|520294531|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297710|NCT02082977|520294532|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297711|NCT02082977|520294533|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
144297712|NCT02082977|520294534|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297713|NCT02082977|520294535|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
144297714|NCT00049543|520294539|FG000|Overall Study|still on treatment|2|||
144297715|NCT00049543|520294540|FG001|Overall Study|still on treatment|9|||
144297716|NCT04380142|520294541|FG000|LD/CD Stabilization Period|Adverse Event|3|||
144297717|NCT04380142|520294542|FG001|LD/CD Stabilization Period|Adverse Event|0|||
144297718|NCT04380142|520294543|FG002|LD/CD Stabilization Period|Adverse Event|0|||
144297719|NCT04380142|520294541|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
144297720|NCT04380142|520294542|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
144297721|NCT04380142|520294543|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
144297722|NCT04380142|520294541|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
144297723|NCT04380142|520294542|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
144297724|NCT04380142|520294543|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
144297725|NCT04380142|520294541|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
144297726|NCT04380142|520294542|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
144297727|NCT04380142|520294543|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
144297728|NCT04380142|520294541|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
144297729|NCT04380142|520294542|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
144297730|NCT04380142|520294543|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
144297731|NCT04380142|520294541|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
144297732|NCT04380142|520294542|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
144297733|NCT04380142|520294543|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
144297734|NCT04380142|520294541|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144297735|NCT04380142|520294542|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144297736|NCT04380142|520294543|FG002|Double-Blind Treatment Period|Adverse Event|14|||
144297737|NCT04380142|520294541|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
144297738|NCT04380142|520294542|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
144297739|NCT04380142|520294543|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
144297740|NCT04380142|520294541|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
144297741|NCT04380142|520294542|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
144297742|NCT04380142|520294543|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
144297743|NCT04380142|520294541|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
144297744|NCT04380142|520294542|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
144297745|NCT04380142|520294543|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
144297746|NCT04380142|520294541|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
144297747|NCT04380142|520294542|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
144297748|NCT04380142|520294543|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
144297749|NCT04380142|520294541|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
144297750|NCT04380142|520294542|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
144297751|NCT04380142|520294543|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
144297752|NCT02106832|520294554|FG000|Overall Study|Adverse Event|1|||
144297753|NCT02106832|520294555|FG001|Overall Study|Adverse Event|2|||
144297754|NCT02106832|520294556|FG002|Overall Study|Adverse Event|3|||
144297755|NCT02106832|520294557|FG003|Overall Study|Adverse Event|0|||
144297756|NCT02106832|520294554|FG000|Overall Study|Death|4|||
144297757|NCT02106832|520294555|FG001|Overall Study|Death|4|||
144297758|NCT02106832|520294556|FG002|Overall Study|Death|1|||
144297759|NCT02106832|520294557|FG003|Overall Study|Death|4|||
144297760|NCT02106832|520294554|FG000|Overall Study|Deterioration of general conditions|0|||
144297761|NCT02106832|520294555|FG001|Overall Study|Deterioration of general conditions|0|||
144297762|NCT02106832|520294556|FG002|Overall Study|Deterioration of general conditions|1|||
144297763|NCT02106832|520294557|FG003|Overall Study|Deterioration of general conditions|0|||
144297764|NCT02106832|520294554|FG000|Overall Study|Lost to Follow-up|0|||
144297765|NCT02106832|520294555|FG001|Overall Study|Lost to Follow-up|1|||
144297766|NCT02106832|520294556|FG002|Overall Study|Lost to Follow-up|1|||
144297767|NCT02106832|520294557|FG003|Overall Study|Lost to Follow-up|3|||
144297768|NCT02106832|520294554|FG000|Overall Study|Physician Decision|1|||
144297769|NCT02106832|520294555|FG001|Overall Study|Physician Decision|0|||
144297770|NCT02106832|520294556|FG002|Overall Study|Physician Decision|0|||
144297771|NCT02106832|520294557|FG003|Overall Study|Physician Decision|0|||
144297772|NCT02106832|520294554|FG000|Overall Study|Protocol Violation|0|||
144297773|NCT02106832|520294555|FG001|Overall Study|Protocol Violation|0|||
144297774|NCT02106832|520294556|FG002|Overall Study|Protocol Violation|0|||
144297775|NCT02106832|520294557|FG003|Overall Study|Protocol Violation|1|||
144297776|NCT02106832|520294554|FG000|Overall Study|Withdrawal by Subject|17|||
144297777|NCT02106832|520294555|FG001|Overall Study|Withdrawal by Subject|17|||
144297778|NCT02106832|520294556|FG002|Overall Study|Withdrawal by Subject|10|||
144297779|NCT02106832|520294557|FG003|Overall Study|Withdrawal by Subject|7|||
144297780|NCT02106832|520294554|FG000|Overall Study|Technical problems|0|||
144297781|NCT02106832|520294555|FG001|Overall Study|Technical problems|1|||
144297782|NCT02106832|520294556|FG002|Overall Study|Technical problems|0|||
144297783|NCT02106832|520294557|FG003|Overall Study|Technical problems|0|||
144297784|NCT01968980|520294574|FG000|Overall Study|Death|0|||
144297785|NCT01968980|520294575|FG001|Overall Study|Death|1|||
144297786|NCT01968980|520294574|FG000|Overall Study|Adverse Event|1|||
144297787|NCT01968980|520294575|FG001|Overall Study|Adverse Event|3|||
144297788|NCT01968980|520294574|FG000|Overall Study|Does not meet entry criteria|1|||
144297789|NCT01968980|520294575|FG001|Overall Study|Does not meet entry criteria|3|||
144297790|NCT01968980|520294574|FG000|Overall Study|Withdrawal by Subject|13|||
144297791|NCT01968980|520294575|FG001|Overall Study|Withdrawal by Subject|5|||
144297792|NCT01968980|520294574|FG000|Overall Study|Other unspecified|1|||
144297793|NCT01968980|520294575|FG001|Overall Study|Other unspecified|2|||
144297794|NCT00265122|520294576|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
144297795|NCT00265122|520294577|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
144297796|NCT00265122|520294578|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
144297797|NCT00265122|520294579|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
144297798|NCT00265122|520294580|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
144297799|NCT00265122|520294581|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
144297800|NCT00265122|520294576|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
144297801|NCT00265122|520294577|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
144297802|NCT00265122|520294578|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
144297803|NCT00265122|520294579|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
144297804|NCT00265122|520294580|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
144297805|NCT00265122|520294581|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
144297806|NCT00265122|520294576|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
144297807|NCT00265122|520294577|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
144297808|NCT00265122|520294578|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
144297809|NCT00265122|520294579|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
144297810|NCT00265122|520294580|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
144297811|NCT00265122|520294581|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
144297812|NCT00265122|520294576|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
144297813|NCT00265122|520294577|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
144297814|NCT00265122|520294578|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
144297815|NCT00265122|520294579|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
144297816|NCT00265122|520294580|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
144297817|NCT00265122|520294581|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
144297818|NCT00265122|520294576|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
144297819|NCT00265122|520294577|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
144297820|NCT00265122|520294578|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
144297821|NCT00265122|520294579|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
144297822|NCT00265122|520294580|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
144297823|NCT00265122|520294581|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
144297824|NCT00265122|520294576|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
144297825|NCT00265122|520294577|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
144297826|NCT00265122|520294578|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
144297827|NCT00265122|520294579|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
144297828|NCT00265122|520294580|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
144297829|NCT00265122|520294581|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
144297830|NCT04716894|520294582|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
144297831|NCT04716894|520294582|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
144297832|NCT04347538|520294593|FG000|Overall Study|Lost to Follow-up|4|||
144297833|NCT04347538|520294594|FG001|Overall Study|Lost to Follow-up|5|||
144297834|NCT04347538|520294595|FG002|Overall Study|Lost to Follow-up|7|||
144297835|NCT02259231|520294596|FG000|Overall Study|Adverse Event|1|||
144297836|NCT02259231|520294597|FG001|Overall Study|Adverse Event|1|||
144297837|NCT02259231|520294598|FG002|Overall Study|Adverse Event|2|||
144297838|NCT02259231|520294599|FG003|Overall Study|Adverse Event|0|||
144297839|NCT02259231|520294600|FG004|Overall Study|Adverse Event|0|||
144297840|NCT02259231|520294601|FG005|Overall Study|Adverse Event|0|||
144297841|NCT02259231|520294602|FG006|Overall Study|Adverse Event|0|||
144297842|NCT02259231|520294596|FG000|Overall Study|Progressive Disease|4|||
144297843|NCT02259231|520294597|FG001|Overall Study|Progressive Disease|5|||
144297844|NCT02259231|520294598|FG002|Overall Study|Progressive Disease|4|||
144297845|NCT02259231|520294599|FG003|Overall Study|Progressive Disease|5|||
144297846|NCT02259231|520294600|FG004|Overall Study|Progressive Disease|4|||
144297847|NCT02259231|520294601|FG005|Overall Study|Progressive Disease|5|||
144297848|NCT02259231|520294602|FG006|Overall Study|Progressive Disease|4|||
144297849|NCT02259231|520294596|FG000|Overall Study|Sponsor termination of study|1|||
144297850|NCT02259231|520294597|FG001|Overall Study|Sponsor termination of study|0|||
144297851|NCT02259231|520294598|FG002|Overall Study|Sponsor termination of study|0|||
144297852|NCT02259231|520294599|FG003|Overall Study|Sponsor termination of study|1|||
144297853|NCT02259231|520294600|FG004|Overall Study|Sponsor termination of study|2|||
144297854|NCT02259231|520294601|FG005|Overall Study|Sponsor termination of study|1|||
144297855|NCT02259231|520294602|FG006|Overall Study|Sponsor termination of study|1|||
144297856|NCT04507269|520294603|FG000|Overall Study|Withdrawal by Subject|1|||
144297857|NCT04507269|520294604|FG001|Overall Study|Withdrawal by Subject|1|||
144297858|NCT04507269|520294605|FG002|Overall Study|Withdrawal by Subject|0|||
144297859|NCT04507269|520294606|FG003|Overall Study|Withdrawal by Subject|0|||
144297860|NCT04507269|520294607|FG004|Overall Study|Withdrawal by Subject|0|||
144297861|NCT04507269|520294608|FG005|Overall Study|Withdrawal by Subject|0|||
144297862|NCT04507269|520294603|FG000|Overall Study|Lost to Follow-up|0|||
144297863|NCT04507269|520294604|FG001|Overall Study|Lost to Follow-up|0|||
144297864|NCT04507269|520294605|FG002|Overall Study|Lost to Follow-up|0|||
144297865|NCT04507269|520294606|FG003|Overall Study|Lost to Follow-up|0|||
144297866|NCT04507269|520294607|FG004|Overall Study|Lost to Follow-up|1|||
144297867|NCT04507269|520294608|FG005|Overall Study|Lost to Follow-up|0|||
144297868|NCT05852340|520294609|FG000|Period 5|Not completing the meal|0|||
144297869|NCT05852340|520294610|FG001|Period 5|Not completing the meal|1|||
144297870|NCT05852340|520294611|FG002|Period 5|Not completing the meal|0|||
144297871|NCT05852340|520294612|FG003|Period 5|Not completing the meal|0|||
144297872|NCT05852340|520294609|FG000|Period 5|Adverse Event|0|||
144297873|NCT05852340|520294610|FG001|Period 5|Adverse Event|0|||
144297874|NCT05852340|520294611|FG002|Period 5|Adverse Event|0|||
144297875|NCT05852340|520294612|FG003|Period 5|Adverse Event|1|||
144297876|NCT01722669|520294615|FG000|Overall Study|Withdrawal by Subject|0|||
144360005|NCT01601535|520525139|FG004|Phase 1|Withdrawal by Subject|0|||
144297877|NCT01722669|520294616|FG001|Overall Study|Withdrawal by Subject|0|||
144297878|NCT01722669|520294617|FG002|Overall Study|Withdrawal by Subject|0|||
144297879|NCT01722669|520294618|FG003|Overall Study|Withdrawal by Subject|0|||
144297880|NCT01722669|520294619|FG004|Overall Study|Withdrawal by Subject|0|||
144297881|NCT01722669|520294620|FG005|Overall Study|Withdrawal by Subject|2|||
144297882|NCT05318287|520294626|FG000|Overall Study|Lost to Follow-up|8|||
144297883|NCT04144517|520294629|FG000|Overall Study|Physician Decision|0|||
144297884|NCT04144517|520294630|FG001|Overall Study|Physician Decision|1|||
144297885|NCT04144517|520294629|FG000|Overall Study|Other|2|||
144297886|NCT04144517|520294630|FG001|Overall Study|Other|2|||
144297887|NCT04144517|520294629|FG000|Overall Study|Death|6|||
144297888|NCT04144517|520294630|FG001|Overall Study|Death|3|||
144297889|NCT02757768|520294636|FG000|Overall Study|Randomized Never Received Study Drug|3|||
144297890|NCT02757768|520294637|FG001|Overall Study|Randomized Never Received Study Drug|4|||
144297891|NCT02757768|520294636|FG000|Overall Study|Adverse Event|5|||
144297892|NCT02757768|520294637|FG001|Overall Study|Adverse Event|3|||
144297893|NCT02757768|520294636|FG000|Overall Study|Lack of Efficacy|2|||
144297894|NCT02757768|520294637|FG001|Overall Study|Lack of Efficacy|1|||
144297895|NCT02757768|520294636|FG000|Overall Study|Lost to Follow-up|1|||
144297896|NCT02757768|520294637|FG001|Overall Study|Lost to Follow-up|0|||
144297897|NCT02757768|520294636|FG000|Overall Study|Protocol Deviation|2|||
144297898|NCT02757768|520294637|FG001|Overall Study|Protocol Deviation|9|||
144297899|NCT02757768|520294636|FG000|Overall Study|Withdrawal by Subject|16|||
144297900|NCT02757768|520294637|FG001|Overall Study|Withdrawal by Subject|9|||
144297901|NCT02757768|520294636|FG000|Overall Study|Miscellaneous|4|||
144297902|NCT02757768|520294637|FG001|Overall Study|Miscellaneous|2|||
144297903|NCT02495883|520294644|FG000|Overall Study|Excessive head motion|1|||
144297904|NCT02495883|520294645|FG001|Overall Study|Excessive head motion|0|||
144297905|NCT03557502|520294646|FG000|Protocol 2|Withdrawal by Subject|1|||
144297906|NCT03557502|520294647|FG001|Protocol 2|Withdrawal by Subject|1|||
144297907|NCT03557502|520294646|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
144297908|NCT03557502|520294647|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
144297909|NCT05484895|520296256|FG000|Overall Study|Lost to Follow-up|63|||
144297910|NCT05484895|520296257|FG001|Overall Study|Lost to Follow-up|64|||
144297911|NCT01168596|520296258|FG000|Overall Study|Withdrawal by Subject|3|||
144297912|NCT01168596|520296259|FG001|Overall Study|Withdrawal by Subject|1|||
144297913|NCT00876447|520296260|FG000|Overall Study|Other miscellaneous reasons|3|||
144297914|NCT00876447|520296261|FG001|Overall Study|Other miscellaneous reasons|8|||
144297915|NCT00876447|520296260|FG000|Overall Study|Site closure|19|||
144297916|NCT00876447|520296261|FG001|Overall Study|Site closure|14|||
144297917|NCT00876447|520296260|FG000|Overall Study|Protocol Violation|9|||
144297918|NCT00876447|520296261|FG001|Overall Study|Protocol Violation|3|||
144297919|NCT00876447|520296260|FG000|Overall Study|Personal reasons|30|||
144297920|NCT00876447|520296261|FG001|Overall Study|Personal reasons|28|||
144297921|NCT00876447|520296260|FG000|Overall Study|Lost to Follow-up|6|||
144297922|NCT00876447|520296261|FG001|Overall Study|Lost to Follow-up|15|||
144297923|NCT00876447|520296260|FG000|Overall Study|Pregnancy|4|||
144297924|NCT00876447|520296261|FG001|Overall Study|Pregnancy|2|||
144297925|NCT00876447|520296260|FG000|Overall Study|Lack of Efficacy|5|||
144297926|NCT00876447|520296261|FG001|Overall Study|Lack of Efficacy|3|||
144297927|NCT00876447|520296260|FG000|Overall Study|Adverse Event|4|||
144297928|NCT00876447|520296261|FG001|Overall Study|Adverse Event|8|||
144297929|NCT00565747|520296269|FG000|Overall Study|No embryo transfer|67|||
144297930|NCT00565747|520296270|FG001|Overall Study|No embryo transfer|73|||
144297931|NCT00183248|520296271|FG000|Overall Study|Lost to Follow-up|0|||
144297932|NCT00183248|520296272|FG001|Overall Study|Lost to Follow-up|1|||
144297933|NCT00183248|520296271|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
144297934|NCT00183248|520296272|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
144297935|NCT01822925|520296276|FG000|Overall Study|Adverse Event|1|||
144297936|NCT01822925|520296277|FG001|Overall Study|Adverse Event|1|||
144297937|NCT01822925|520296278|FG002|Overall Study|Adverse Event|1|||
144297938|NCT01822925|520296279|FG003|Overall Study|Adverse Event|1|||
144297939|NCT01822925|520296276|FG000|Overall Study|Lost to Follow-up|0|||
144297940|NCT01822925|520296277|FG001|Overall Study|Lost to Follow-up|1|||
144297941|NCT01822925|520296278|FG002|Overall Study|Lost to Follow-up|0|||
144297942|NCT01822925|520296279|FG003|Overall Study|Lost to Follow-up|0|||
144297943|NCT01822925|520296276|FG000|Overall Study|Protocol Violation|1|||
144297944|NCT01822925|520296277|FG001|Overall Study|Protocol Violation|0|||
144297945|NCT01822925|520296278|FG002|Overall Study|Protocol Violation|0|||
144297946|NCT01822925|520296279|FG003|Overall Study|Protocol Violation|1|||
144297947|NCT01822925|520296276|FG000|Overall Study|Withdrawal by Subject|2|||
144297948|NCT01822925|520296277|FG001|Overall Study|Withdrawal by Subject|0|||
144297949|NCT01822925|520296278|FG002|Overall Study|Withdrawal by Subject|2|||
144297950|NCT01822925|520296279|FG003|Overall Study|Withdrawal by Subject|2|||
144297951|NCT01822925|520296276|FG000|Overall Study|Taking prohibited medication|2|||
144297952|NCT01822925|520296277|FG001|Overall Study|Taking prohibited medication|0|||
144297953|NCT01822925|520296278|FG002|Overall Study|Taking prohibited medication|0|||
144297954|NCT01822925|520296279|FG003|Overall Study|Taking prohibited medication|1|||
144297955|NCT00904371|520296283|FG000|Overall Study|Adverse Event|2|||
144297956|NCT00904371|520296283|FG000|Overall Study|Lost to Follow-up|4|||
144297957|NCT00904371|520296283|FG000|Overall Study|Discontinued at target blood pressure|2|||
144297958|NCT00904371|520296283|FG000|Overall Study|Continued with Tritace|1|||
144297959|NCT05134649|520296286|FG000|Overall Study|Lost to Follow-up|12|||
144297960|NCT05134649|520296286|FG000|Overall Study|Withdrawal by Subject|14|||
144297961|NCT05134649|520296286|FG000|Overall Study|Pregnancy|1|||
144297962|NCT05134649|520296286|FG000|Overall Study|Other, not specified|3|||
144297963|NCT01767987|520296287|FG000|Overall Study|Physician Decision|4|||
144297964|NCT01767987|520296288|FG001|Overall Study|Physician Decision|1|||
144297965|NCT03232567|520296289|FG000|Overall Study|Withdrawal by Subject|0|||
144297966|NCT03232567|520296290|FG001|Overall Study|Withdrawal by Subject|1|||
144297967|NCT03232567|520296291|FG002|Overall Study|Withdrawal by Subject|0|||
144297968|NCT03232567|520296292|FG003|Overall Study|Withdrawal by Subject|0|||
144297969|NCT01153516|520296293|FG000|Overall Study|Both subjects refused surgery|2|||
144297970|NCT01153516|520296294|FG001|Overall Study|Both subjects refused surgery|0|||
144297971|NCT04581395|520296295|FG000|Overall Study|Protocol Violation|4|||
144297972|NCT04581395|520296296|FG001|Overall Study|Protocol Violation|3|||
144297973|NCT04581395|520296297|FG002|Overall Study|Protocol Violation|2|||
144297974|NCT04581395|520296295|FG000|Overall Study|Physician Decision|0|||
144297975|NCT04581395|520296296|FG001|Overall Study|Physician Decision|1|||
144297976|NCT04581395|520296297|FG002|Overall Study|Physician Decision|0|||
144297977|NCT00105066|520296302|FG000|Overall Study|Adverse Event|2|||
144297978|NCT00105066|520296303|FG001|Overall Study|Adverse Event|5|||
144297979|NCT00787150|520296306|FG000|Overall Study|Adverse Event|4|||
144297980|NCT00787150|520296307|FG001|Overall Study|Adverse Event|4|||
144297981|NCT00787150|520296308|FG002|Overall Study|Adverse Event|4|||
144297982|NCT00787150|520296306|FG000|Overall Study|Physician Decision|1|||
144297983|NCT00787150|520296307|FG001|Overall Study|Physician Decision|2|||
144297984|NCT00787150|520296308|FG002|Overall Study|Physician Decision|1|||
144297985|NCT00787150|520296306|FG000|Overall Study|Withdrawal by Subject|2|||
144297986|NCT00787150|520296307|FG001|Overall Study|Withdrawal by Subject|1|||
144297987|NCT00787150|520296308|FG002|Overall Study|Withdrawal by Subject|0|||
144297988|NCT00787150|520296306|FG000|Overall Study|Dosing incorrect study durg|2|||
144297989|NCT00787150|520296307|FG001|Overall Study|Dosing incorrect study durg|0|||
144297990|NCT00787150|520296308|FG002|Overall Study|Dosing incorrect study durg|0|||
144297991|NCT04562090|520296317|FG000|Overall Study|Withdrawal by Subject|3|||
144297992|NCT04562090|520296318|FG001|Overall Study|Withdrawal by Subject|4|||
144297993|NCT04562090|520296317|FG000|Overall Study|Protocol Violation|2|||
144297994|NCT04562090|520296318|FG001|Overall Study|Protocol Violation|0|||
144297995|NCT04562090|520296317|FG000|Overall Study|Lack of Efficacy|0|||
144297996|NCT04562090|520296318|FG001|Overall Study|Lack of Efficacy|1|||
144297997|NCT04562090|520296317|FG000|Overall Study|Adverse Event|1|||
144297998|NCT04562090|520296318|FG001|Overall Study|Adverse Event|4|||
144297999|NCT04562090|520296317|FG000|Overall Study|Miscellaneous|0|||
144298000|NCT04562090|520296318|FG001|Overall Study|Miscellaneous|3|||
144298001|NCT00071032|520296320|FG000|Overall Study|Lost to Follow-up|1|||
144298002|NCT00071032|520296321|FG001|Overall Study|Lost to Follow-up|1|||
144298003|NCT00071032|520296320|FG000|Overall Study|Withdrawal by Subject|8|||
144298004|NCT00071032|520296321|FG001|Overall Study|Withdrawal by Subject|6|||
144298005|NCT00071032|520296320|FG000|Overall Study|Missing Primary Outcome|0|||
144298006|NCT00071032|520296321|FG001|Overall Study|Missing Primary Outcome|1|||
144298007|NCT05852470|520296322|FG000|Overall Study|Withdrawal by Subject|0|||
144298008|NCT05852470|520296323|FG001|Overall Study|Withdrawal by Subject|1|||
144298009|NCT06071104|520296324|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
144298010|NCT01903863|520296325|FG000|Overall Study|Physician Decision|2|||
144298011|NCT01903863|520296326|FG001|Overall Study|Physician Decision|0|||
144298012|NCT03636022|520296329|FG000|Overall Study|Withdrawal by Subject|1|||
144298013|NCT03636022|520296330|FG001|Overall Study|Withdrawal by Subject|3|||
144298014|NCT03448393|520296334|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298015|NCT03448393|520296335|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298016|NCT03448393|520296336|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
144298017|NCT03448393|520296337|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298018|NCT03448393|520296338|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298019|NCT03448393|520296339|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298020|NCT03448393|520296340|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298021|NCT03448393|520296341|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
144298022|NCT03448393|520296342|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
144298023|NCT03448393|520296334|FG000|Dose Expansion|Not treated - screen failure|0|||
144298024|NCT03448393|520296335|FG001|Dose Expansion|Not treated - screen failure|0|||
144298025|NCT03448393|520296336|FG002|Dose Expansion|Not treated - screen failure|0|||
144298026|NCT03448393|520296337|FG003|Dose Expansion|Not treated - screen failure|0|||
144298027|NCT03448393|520296338|FG004|Dose Expansion|Not treated - screen failure|0|||
144298028|NCT03448393|520296339|FG005|Dose Expansion|Not treated - screen failure|0|||
144298029|NCT03448393|520296340|FG006|Dose Expansion|Not treated - screen failure|0|||
144298030|NCT03448393|520296341|FG007|Dose Expansion|Not treated - screen failure|0|||
144298031|NCT03448393|520296342|FG008|Dose Expansion|Not treated - screen failure|7|||
144298032|NCT01587196|520296343|FG000|Overall Study|Lost to Follow-up|50|||
144298033|NCT01587196|520296343|FG000|Overall Study|Withdrawal by Subject|4|||
144298034|NCT00642759|520296344|FG000|Overall Study|Protocol Violation|1|||
144298035|NCT00643279|520296349|FG000|Overall Study|Death|13|||
144298036|NCT00643279|520296350|FG001|Overall Study|Death|11|||
144298037|NCT00643279|520296349|FG000|Overall Study|Withdrawal by Subject|3|||
144298038|NCT00643279|520296350|FG001|Overall Study|Withdrawal by Subject|0|||
144298039|NCT00643279|520296349|FG000|Overall Study|Lost to Follow-up|0|||
144298040|NCT00643279|520296350|FG001|Overall Study|Lost to Follow-up|1|||
144298041|NCT00643279|520296349|FG000|Overall Study|Physician Decision|0|||
144298042|NCT00643279|520296350|FG001|Overall Study|Physician Decision|1|||
144298043|NCT05185453|520296355|FG000|Overall Study|Lost to Follow-up|13|||
144298044|NCT05185453|520296356|FG001|Overall Study|Lost to Follow-up|3|||
144298045|NCT03537508|520296369|FG000|Overall Study|Adverse Event|2|||
144298046|NCT03537508|520296370|FG001|Overall Study|Adverse Event|1|||
144298047|NCT03537508|520296369|FG000|Overall Study|Protocol Violation|65|||
144298048|NCT03537508|520296370|FG001|Overall Study|Protocol Violation|48|||
144298049|NCT03537508|520296369|FG000|Overall Study|Lost to Follow-up|86|||
144298050|NCT03537508|520296370|FG001|Overall Study|Lost to Follow-up|60|||
144298051|NCT03537508|520296369|FG000|Overall Study|Withdrawal by parent/guardian|263|||
144298052|NCT03537508|520296370|FG001|Overall Study|Withdrawal by parent/guardian|149|||
144298053|NCT01972659|520296371|FG000|Overall Study|Protocol Violation|2|||
144298054|NCT01972659|520296372|FG001|Overall Study|Protocol Violation|2|||
144298055|NCT01972659|520296371|FG000|Overall Study|problems realted to acceleromyograph|2|||
144298056|NCT01972659|520296372|FG001|Overall Study|problems realted to acceleromyograph|1|||
144298057|NCT05715827|520296377|FG000|Overall Study|Physician Decision|0|||
144298058|NCT05715827|520296378|FG001|Overall Study|Physician Decision|1|||
144298059|NCT05715827|520296377|FG000|Overall Study|console communication error|0|||
144298060|NCT05715827|520296378|FG001|Overall Study|console communication error|1|||
144298061|NCT02457793|520296379|FG000|Overall Study|Reason not specified|0|||
144298062|NCT02457793|520296380|FG001|Overall Study|Reason not specified|0|||
144298063|NCT02457793|520296381|FG002|Overall Study|Reason not specified|0|||
144298064|NCT02457793|520296382|FG003|Overall Study|Reason not specified|1|||
144298065|NCT02457793|520296383|FG004|Overall Study|Reason not specified|1|||
144298066|NCT02457793|520296384|FG005|Overall Study|Reason not specified|1|||
144298067|NCT02457793|520296379|FG000|Overall Study|Withdrawal by Subject|0|||
144298068|NCT02457793|520296380|FG001|Overall Study|Withdrawal by Subject|4|||
144298069|NCT02457793|520296381|FG002|Overall Study|Withdrawal by Subject|2|||
144298070|NCT02457793|520296382|FG003|Overall Study|Withdrawal by Subject|2|||
144298071|NCT02457793|520296383|FG004|Overall Study|Withdrawal by Subject|2|||
144298072|NCT02457793|520296384|FG005|Overall Study|Withdrawal by Subject|2|||
144298073|NCT02457793|520296379|FG000|Overall Study|Adverse Event|0|||
144298074|NCT02457793|520296380|FG001|Overall Study|Adverse Event|0|||
144298075|NCT02457793|520296381|FG002|Overall Study|Adverse Event|0|||
144298076|NCT02457793|520296382|FG003|Overall Study|Adverse Event|1|||
144298077|NCT02457793|520296383|FG004|Overall Study|Adverse Event|0|||
144298078|NCT02457793|520296384|FG005|Overall Study|Adverse Event|0|||
144298079|NCT02457793|520296379|FG000|Overall Study|Physician Decision|1|||
144298080|NCT02457793|520296380|FG001|Overall Study|Physician Decision|0|||
144298081|NCT02457793|520296381|FG002|Overall Study|Physician Decision|1|||
144298082|NCT02457793|520296382|FG003|Overall Study|Physician Decision|1|||
144298083|NCT02457793|520296383|FG004|Overall Study|Physician Decision|1|||
144298084|NCT02457793|520296384|FG005|Overall Study|Physician Decision|3|||
144298085|NCT03814044|520296389|FG000|Overall Study|Protocol deviation|1|||
144298086|NCT00835367|520296401|FG000|Washout|Adverse Event|2|||
144298087|NCT00835367|520296402|FG001|Washout|Adverse Event|0|||
144298088|NCT00835367|520296401|FG000|Washout|Withdrawal by Subject|1|||
144298089|NCT00835367|520296402|FG001|Washout|Withdrawal by Subject|0|||
144298090|NCT00835367|520296401|FG000|Second Intervention|Adverse Event|1|||
144298091|NCT00835367|520296402|FG001|Second Intervention|Adverse Event|1|||
144298092|NCT05929326|520296403|FG000|Overall Study|unqualified sample|2|||
144298093|NCT05929326|520296404|FG001|Overall Study|unqualified sample|3|||
144298094|NCT05929326|520296405|FG002|Overall Study|unqualified sample|7|||
144298095|NCT04890509|520296406|FG000|Overall Study|Death|4|||
144298096|NCT04890509|520296407|FG001|Overall Study|Death|4|||
144298097|NCT04569084|520296410|FG000|Overall Study|Adverse Event|10|||
144298098|NCT04569084|520296411|FG001|Overall Study|Adverse Event|14|||
144298099|NCT04569084|520296410|FG000|Overall Study|Death|2|||
144298100|NCT04569084|520296411|FG001|Overall Study|Death|3|||
144298101|NCT04569084|520296410|FG000|Overall Study|Lost to Follow-up|1|||
144298102|NCT04569084|520296411|FG001|Overall Study|Lost to Follow-up|1|||
144298103|NCT04569084|520296410|FG000|Overall Study|Physician Decision|3|||
144298104|NCT04569084|520296411|FG001|Overall Study|Physician Decision|3|||
144298105|NCT04569084|520296410|FG000|Overall Study|Protocol Violation|2|||
144298106|NCT04569084|520296411|FG001|Overall Study|Protocol Violation|1|||
144298107|NCT04569084|520296410|FG000|Overall Study|Withdrawal by Subject|20|||
144298108|NCT04569084|520296411|FG001|Overall Study|Withdrawal by Subject|21|||
144298109|NCT04569084|520296410|FG000|Overall Study|Study terminated by sponsor|26|||
144298110|NCT04569084|520296411|FG001|Overall Study|Study terminated by sponsor|23|||
144298111|NCT04569084|520296410|FG000|Overall Study|Other|3|||
144298112|NCT04569084|520296411|FG001|Overall Study|Other|5|||
144298113|NCT03759379|520298467|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
144298114|NCT03759379|520298468|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
144298115|NCT03759379|520298467|FG000|Treatment Period|Death|2|||
144298116|NCT03759379|520298468|FG001|Treatment Period|Death|3|||
144298117|NCT03759379|520298467|FG000|Treatment Period|Lost to Follow-up|1|||
144298118|NCT03759379|520298468|FG001|Treatment Period|Lost to Follow-up|0|||
144298119|NCT03759379|520298467|FG000|Treatment Period|Physician Decision|0|||
144298120|NCT03759379|520298468|FG001|Treatment Period|Physician Decision|1|||
144298121|NCT02333799|520298469|FG000|Treatment Period|Withdrawal by Subject|1|||
144298122|NCT02333799|520298469|FG000|Treatment Period|Death|6|||
144298123|NCT02333799|520298469|FG000|6 Month Follow Up Period|Physician Decision|1|||
144298124|NCT02333799|520298469|FG000|6 Month Follow Up Period|Death|1|||
144298125|NCT02333799|520298469|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
144298126|NCT02333799|520298469|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
144298127|NCT02538614|520298470|FG000|Overall Study|Progressive Disease|2|||
144298128|NCT04622592|520298476|FG000|Overall Study|Death|0|||
144298129|NCT04622592|520298477|FG001|Overall Study|Death|0|||
144298130|NCT04622592|520298478|FG002|Overall Study|Death|1|||
144298131|NCT04622592|520298479|FG003|Overall Study|Death|0|||
144298132|NCT04622592|520298480|FG004|Overall Study|Death|0|||
144298133|NCT04622592|520298481|FG005|Overall Study|Death|0|||
144298134|NCT04622592|520298482|FG006|Overall Study|Death|0|||
144298135|NCT04622592|520298483|FG007|Overall Study|Death|1|||
144298136|NCT04622592|520298476|FG000|Overall Study|Lost to Follow-up|0|||
144298137|NCT04622592|520298477|FG001|Overall Study|Lost to Follow-up|0|||
144298138|NCT04622592|520298478|FG002|Overall Study|Lost to Follow-up|0|||
144298139|NCT04622592|520298479|FG003|Overall Study|Lost to Follow-up|3|||
144298140|NCT04622592|520298480|FG004|Overall Study|Lost to Follow-up|1|||
144298141|NCT04622592|520298481|FG005|Overall Study|Lost to Follow-up|0|||
144298142|NCT04622592|520298482|FG006|Overall Study|Lost to Follow-up|2|||
144298143|NCT04622592|520298483|FG007|Overall Study|Lost to Follow-up|2|||
144298144|NCT04622592|520298476|FG000|Overall Study|Physician Decision|0|||
144298145|NCT04622592|520298477|FG001|Overall Study|Physician Decision|0|||
144298146|NCT04622592|520298478|FG002|Overall Study|Physician Decision|0|||
144298147|NCT04622592|520298479|FG003|Overall Study|Physician Decision|0|||
144298148|NCT04622592|520298480|FG004|Overall Study|Physician Decision|1|||
144298149|NCT04622592|520298481|FG005|Overall Study|Physician Decision|0|||
144298150|NCT04622592|520298482|FG006|Overall Study|Physician Decision|0|||
144298151|NCT04622592|520298483|FG007|Overall Study|Physician Decision|0|||
144298152|NCT04622592|520298476|FG000|Overall Study|Withdrawal by Subject|1|||
144298153|NCT04622592|520298477|FG001|Overall Study|Withdrawal by Subject|0|||
144298154|NCT04622592|520298478|FG002|Overall Study|Withdrawal by Subject|2|||
144298155|NCT04622592|520298479|FG003|Overall Study|Withdrawal by Subject|0|||
144298156|NCT04622592|520298480|FG004|Overall Study|Withdrawal by Subject|0|||
144298157|NCT04622592|520298481|FG005|Overall Study|Withdrawal by Subject|0|||
144298158|NCT04622592|520298482|FG006|Overall Study|Withdrawal by Subject|1|||
144298159|NCT04622592|520298483|FG007|Overall Study|Withdrawal by Subject|4|||
144298160|NCT04622592|520298476|FG000|Overall Study|Other than specified above|0|||
144298161|NCT04622592|520298477|FG001|Overall Study|Other than specified above|0|||
144298162|NCT04622592|520298478|FG002|Overall Study|Other than specified above|1|||
144298163|NCT04622592|520298479|FG003|Overall Study|Other than specified above|0|||
144298164|NCT04622592|520298480|FG004|Overall Study|Other than specified above|0|||
144298165|NCT04622592|520298481|FG005|Overall Study|Other than specified above|0|||
144298166|NCT04622592|520298482|FG006|Overall Study|Other than specified above|0|||
144298167|NCT04622592|520298483|FG007|Overall Study|Other than specified above|0|||
144298168|NCT03580044|520298489|FG000|Overall Study|Death|2|||
144298169|NCT03580044|520298490|FG001|Overall Study|Death|1|||
144298170|NCT03580044|520298489|FG000|Overall Study|Withdrawal by Subject|1|||
144298171|NCT03580044|520298490|FG001|Overall Study|Withdrawal by Subject|1|||
144298172|NCT04903288|520298495|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
144298173|NCT04903288|520298495|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
144298174|NCT04903288|520298495|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
144298175|NCT04903288|520298495|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
144298176|NCT04617860|520298507|FG000|Overall Study|Adverse Event|0|||
144298177|NCT04617860|520298508|FG001|Overall Study|Adverse Event|2|||
144298178|NCT04617860|520298509|FG002|Overall Study|Adverse Event|2|||
144298179|NCT04617860|520298507|FG000|Overall Study|Withdrawal by Subject|0|||
144298180|NCT04617860|520298508|FG001|Overall Study|Withdrawal by Subject|0|||
144298181|NCT04617860|520298509|FG002|Overall Study|Withdrawal by Subject|2|||
144298182|NCT04617860|520298507|FG000|Overall Study|Physician Decision|0|||
144298183|NCT04617860|520298508|FG001|Overall Study|Physician Decision|1|||
144298184|NCT04617860|520298509|FG002|Overall Study|Physician Decision|0|||
144298185|NCT04617860|520298507|FG000|Overall Study|Sponsor Decision|0|||
144298186|NCT04617860|520298508|FG001|Overall Study|Sponsor Decision|3|||
144298187|NCT04617860|520298509|FG002|Overall Study|Sponsor Decision|1|||
144298188|NCT04617860|520298507|FG000|Overall Study|Termination of Study by Sponsor|8|||
144298189|NCT04617860|520298508|FG001|Overall Study|Termination of Study by Sponsor|4|||
144298190|NCT04617860|520298509|FG002|Overall Study|Termination of Study by Sponsor|13|||
144298191|NCT02300233|520298512|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
144298192|NCT02300233|520298513|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
144298193|NCT02300233|520298514|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
144298194|NCT02300233|520298512|FG000|Overall Study|Withdrawal by Subject|1|||
144298195|NCT02300233|520298513|FG001|Overall Study|Withdrawal by Subject|0|||
144298196|NCT02300233|520298514|FG002|Overall Study|Withdrawal by Subject|3|||
144298197|NCT02300233|520298512|FG000|Overall Study|Investigator Judgement|0|||
144298198|NCT02300233|520298513|FG001|Overall Study|Investigator Judgement|0|||
144298199|NCT02300233|520298514|FG002|Overall Study|Investigator Judgement|1|||
144298200|NCT02300233|520298512|FG000|Overall Study|Reason Not Specified|0|||
144298201|NCT02300233|520298513|FG001|Overall Study|Reason Not Specified|0|||
144298202|NCT02300233|520298514|FG002|Overall Study|Reason Not Specified|5|||
144298203|NCT02507934|520298515|FG000|Overall Study|Lost to Follow-up|2|||
144298204|NCT02507934|520298516|FG001|Overall Study|Lost to Follow-up|0|||
144298205|NCT02507934|520298515|FG000|Overall Study|Withdrawal by Subject|2|||
144298206|NCT02507934|520298516|FG001|Overall Study|Withdrawal by Subject|0|||
144298207|NCT02836249|520298517|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
144298208|NCT02836249|520298518|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
144298209|NCT02836249|520298519|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
144298210|NCT02836249|520298520|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
144298211|NCT02836249|520298517|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
144298212|NCT02836249|520298518|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
144298213|NCT02836249|520298519|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
144298214|NCT02836249|520298520|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
144298215|NCT02836249|520298517|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
144298216|NCT02836249|520298518|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
144298217|NCT02836249|520298519|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
144298218|NCT02836249|520298520|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
144298219|NCT02836249|520298517|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144360006|NCT01601535|520525140|FG005|Phase 1|Withdrawal by Subject|0|||
144298220|NCT02836249|520298518|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
144298221|NCT02836249|520298519|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144298222|NCT02836249|520298520|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144298223|NCT02836249|520298517|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
144298224|NCT02836249|520298518|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
144298225|NCT02836249|520298519|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
144298226|NCT02836249|520298520|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
144298227|NCT02836249|520298517|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
144298228|NCT02836249|520298518|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
144298229|NCT02836249|520298519|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
144298230|NCT02836249|520298520|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
144298231|NCT02836249|520298517|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
144298232|NCT02836249|520298518|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
144298233|NCT02836249|520298519|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
144298234|NCT02836249|520298520|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
144298235|NCT02836249|520298517|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
144298236|NCT02836249|520298518|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
144298237|NCT02836249|520298519|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
144298238|NCT02836249|520298520|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
144298239|NCT02836249|520298517|FG000|Open-Label TAF Treatment Phase|Death|0|||
144298240|NCT02836249|520298518|FG001|Open-Label TAF Treatment Phase|Death|0|||
144298241|NCT02836249|520298519|FG002|Open-Label TAF Treatment Phase|Death|1|||
144298242|NCT02836249|520298520|FG003|Open-Label TAF Treatment Phase|Death|0|||
144298243|NCT02836249|520298517|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
144298244|NCT02836249|520298518|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
144298245|NCT02836249|520298519|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
144298246|NCT02836249|520298520|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
144298247|NCT02836249|520298517|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
144298248|NCT02836249|520298518|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
144298249|NCT02836249|520298519|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
144298250|NCT02836249|520298520|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
144298251|NCT04752566|520298521|FG000|Overall Study|Protocol Violation|0|||
144298252|NCT04752566|520298522|FG001|Overall Study|Protocol Violation|1|||
144298253|NCT04752566|520298521|FG000|Overall Study|Death|1|||
144298254|NCT04752566|520298522|FG001|Overall Study|Death|0|||
144298255|NCT04752566|520298521|FG000|Overall Study|Adverse Event|1|||
144298256|NCT04752566|520298522|FG001|Overall Study|Adverse Event|0|||
144298257|NCT04752566|520298521|FG000|Overall Study|Withdrawal by Subject|2|||
144298258|NCT04752566|520298522|FG001|Overall Study|Withdrawal by Subject|0|||
144298259|NCT04752566|520298521|FG000|Overall Study|Physician Decision|1|||
144298260|NCT04752566|520298522|FG001|Overall Study|Physician Decision|1|||
144298261|NCT00928668|520298523|FG000|Overall Study|Adverse Event|1|||
144298262|NCT00928668|520298524|FG001|Overall Study|Adverse Event|0|||
144298263|NCT00928668|520298525|FG002|Overall Study|Adverse Event|0|||
144298264|NCT00928668|520298526|FG003|Overall Study|Adverse Event|0|||
144298265|NCT00928668|520298527|FG004|Overall Study|Adverse Event|0|||
144298266|NCT00928668|520298523|FG000|Overall Study|Protocol Violation|0|||
144298267|NCT00928668|520298524|FG001|Overall Study|Protocol Violation|0|||
144298268|NCT00928668|520298525|FG002|Overall Study|Protocol Violation|0|||
144298269|NCT00928668|520298526|FG003|Overall Study|Protocol Violation|0|||
144298270|NCT00928668|520298527|FG004|Overall Study|Protocol Violation|1|||
144298271|NCT00928668|520298523|FG000|Overall Study|Withdrawal by Subject|0|||
144298272|NCT00928668|520298524|FG001|Overall Study|Withdrawal by Subject|1|||
144298273|NCT00928668|520298525|FG002|Overall Study|Withdrawal by Subject|1|||
144298274|NCT00928668|520298526|FG003|Overall Study|Withdrawal by Subject|0|||
144298275|NCT00928668|520298527|FG004|Overall Study|Withdrawal by Subject|0|||
144298276|NCT00928668|520298523|FG000|Overall Study|Other reasons not listed above|0|||
144298277|NCT00928668|520298524|FG001|Overall Study|Other reasons not listed above|0|||
144298278|NCT00928668|520298525|FG002|Overall Study|Other reasons not listed above|0|||
144298279|NCT00928668|520298526|FG003|Overall Study|Other reasons not listed above|1|||
144298280|NCT00928668|520298527|FG004|Overall Study|Other reasons not listed above|0|||
144298281|NCT01559935|520298528|FG000|Car Phase|Toxicity|4|||
144298282|NCT01559935|520298528|FG000|Car Phase|Death|1|||
144298283|NCT01559935|520298528|FG000|Car Phase|Lack of Efficacy|2|||
144298284|NCT01559935|520298528|FG000|Car Phase|Lost to Follow-up|1|||
144298285|NCT01559935|520298528|FG000|Car Phase|Physician Decision|1|||
144298286|NCT01559935|520298528|FG000|Car Phase|Withdrawal by Subject|2|||
144298287|NCT01559935|520298528|FG000|Car Phase|Per protocol|1|||
144298288|NCT01559935|520298528|FG000|Car Phase|Insurance|1|||
144298289|NCT01559935|520298528|FG000|Car Phase|non-compliance|1|||
144298290|NCT01559935|520298528|FG000|BiRD Phase|Toxicity|1|||
144298291|NCT01559935|520298528|FG000|BiRD Phase|Lack of Efficacy|1|||
144298292|NCT01559935|520298528|FG000|BiRD Phase|Withdrawal by Subject|2|||
144298293|NCT01559935|520298528|FG000|Maintenance Phase|Remains on study|28|||
144298294|NCT01559935|520298528|FG000|Maintenance Phase|Toxicity|1|||
144298295|NCT01559935|520298528|FG000|Maintenance Phase|Lack of Efficacy|18|||
144298296|NCT01559935|520298528|FG000|Maintenance Phase|Withdrawal by Subject|5|||
144298297|NCT01559935|520298528|FG000|Maintenance Phase|Non-compliance|2|||
144298298|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298299|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
144298300|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298301|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
144298302|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
144298303|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
144298304|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
144298305|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298306|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298307|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298308|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298309|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298310|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298311|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298312|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298313|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
144298314|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
144298315|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
144298316|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
144298317|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
144298318|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
144298319|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
144298320|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
144298321|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
144298322|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
144298323|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
144298324|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
144298325|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
144298326|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
144298327|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
144298328|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
144298329|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
144298330|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
144298331|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
144298332|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298333|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298334|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298335|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298336|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298337|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298338|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298339|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298340|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298341|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298342|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298343|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298344|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298345|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
144298346|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
144298347|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298348|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
144298349|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
144298350|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
144298351|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
144298352|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
144298353|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298354|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298355|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298356|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298357|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298358|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298359|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298360|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298361|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144298362|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298363|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298364|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298365|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
144298366|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298367|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298368|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
144298369|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298370|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298371|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298372|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298373|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298374|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298375|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298376|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298377|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
144298378|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298379|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298380|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
144298381|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298382|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298383|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298384|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298385|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298386|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298387|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298388|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298389|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298390|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298391|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298392|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298393|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
144298394|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
144298395|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
144298396|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
144298397|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298398|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298399|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298400|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298401|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298402|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298403|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298404|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298405|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298406|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298407|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298408|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298409|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144298410|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
144298411|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
144298412|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
144298413|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
144298414|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
144298415|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
144298416|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
144298417|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
144298418|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
144298419|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
144298420|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
144298421|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
144298422|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
144298423|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
144298424|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
144298425|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
144298426|NCT02958865|520298530|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298427|NCT02958865|520298531|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298428|NCT02958865|520298532|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298429|NCT02958865|520298533|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298430|NCT02958865|520298534|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
144298431|NCT02958865|520298535|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298432|NCT02958865|520298536|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298433|NCT02958865|520298537|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298434|NCT02958865|520298538|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298435|NCT02958865|520298539|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298436|NCT02958865|520298540|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298437|NCT02958865|520298541|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298438|NCT02958865|520298542|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298439|NCT02958865|520298543|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298440|NCT02958865|520298544|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298441|NCT02958865|520298545|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144298442|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298443|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298444|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298445|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298446|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298447|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298448|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298449|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
144298450|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
144298451|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
144298452|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
144298453|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
144298454|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
144298455|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
144298456|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
144298457|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
144298458|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298459|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298460|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298461|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298462|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298463|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298464|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298465|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298466|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
144298467|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
144298468|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298469|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
144298470|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298471|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
144298472|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
144298473|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
144298474|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298475|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298476|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298477|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298478|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298479|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298480|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298481|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298482|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298483|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
144298484|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298485|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298486|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298487|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298488|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
144298489|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
144298490|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298491|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298492|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298493|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298494|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298495|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298496|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144360007|NCT01601535|520525135|FG000|Phase 1|Progressive Disease|2|||
144298497|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298498|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298499|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298500|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
144298501|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
144298502|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
144298503|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
144298504|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
144298505|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
144298506|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
144298507|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
144298508|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
144298509|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
144298510|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
144298511|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
144298512|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
144298513|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
144298514|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
144298515|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
144298516|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
144298517|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
144298518|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
144298519|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
144298520|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
144298521|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
144298522|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298523|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298524|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298525|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298526|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298527|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298528|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298529|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298530|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298531|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298532|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298533|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298534|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298535|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
144298536|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298537|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
144298538|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298539|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298540|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298541|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298542|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298543|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298544|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298545|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298546|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298547|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298548|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298549|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298550|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298551|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
144298552|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298553|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
144298554|NCT02958865|520298530|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298555|NCT02958865|520298531|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298556|NCT02958865|520298532|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298557|NCT02958865|520298533|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298558|NCT02958865|520298534|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298559|NCT02958865|520298535|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298560|NCT02958865|520298536|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298561|NCT02958865|520298537|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298562|NCT02958865|520298538|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298563|NCT02958865|520298539|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
144298564|NCT02958865|520298540|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298565|NCT02958865|520298541|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298566|NCT02958865|520298542|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298567|NCT02958865|520298543|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298568|NCT02958865|520298544|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298569|NCT02958865|520298545|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
144298570|NCT01983111|520298546|FG000|Overall Study|Withdrawal by Subject|8|||
144298571|NCT01983111|520298547|FG001|Overall Study|Withdrawal by Subject|6|||
144298572|NCT01983111|520298546|FG000|Overall Study|Adverse Event|4|||
144298573|NCT01983111|520298547|FG001|Overall Study|Adverse Event|0|||
144298574|NCT01983111|520298546|FG000|Overall Study|Protocol Violation|0|||
144298575|NCT01983111|520298547|FG001|Overall Study|Protocol Violation|1|||
144298576|NCT00855335|520298548|FG000|Overall Study|Lost to Follow-up|0|||
144298577|NCT00855335|520298549|FG001|Overall Study|Lost to Follow-up|0|||
144298578|NCT00855335|520298550|FG002|Overall Study|Lost to Follow-up|3|||
144298579|NCT00855335|520298551|FG003|Overall Study|Lost to Follow-up|1|||
144298580|NCT00855335|520298552|FG004|Overall Study|Lost to Follow-up|0|||
144298581|NCT00855335|520298548|FG000|Overall Study|Withdrawal by Subject|0|||
144298582|NCT00855335|520298549|FG001|Overall Study|Withdrawal by Subject|0|||
144298583|NCT00855335|520298550|FG002|Overall Study|Withdrawal by Subject|0|||
144298584|NCT00855335|520298551|FG003|Overall Study|Withdrawal by Subject|1|||
144298585|NCT00855335|520298552|FG004|Overall Study|Withdrawal by Subject|0|||
144298586|NCT00855335|520298548|FG000|Overall Study|Adverse Event|2|||
144298587|NCT00855335|520298549|FG001|Overall Study|Adverse Event|0|||
144298588|NCT00855335|520298550|FG002|Overall Study|Adverse Event|0|||
144298589|NCT00855335|520298551|FG003|Overall Study|Adverse Event|0|||
144298590|NCT00855335|520298552|FG004|Overall Study|Adverse Event|0|||
144298591|NCT00855335|520298548|FG000|Overall Study|Physician Decision|1|||
144298592|NCT00855335|520298549|FG001|Overall Study|Physician Decision|1|||
144298593|NCT00855335|520298550|FG002|Overall Study|Physician Decision|0|||
144298594|NCT00855335|520298551|FG003|Overall Study|Physician Decision|0|||
144298595|NCT00855335|520298552|FG004|Overall Study|Physician Decision|0|||
144298596|NCT00855335|520298548|FG000|Overall Study|Other|2|||
144298597|NCT00855335|520298549|FG001|Overall Study|Other|1|||
144298598|NCT00855335|520298550|FG002|Overall Study|Other|2|||
144298599|NCT00855335|520298551|FG003|Overall Study|Other|5|||
144298600|NCT00855335|520298552|FG004|Overall Study|Other|1|||
144298601|NCT02526290|520298553|FG000|Overall Study|Adverse Event|3|||
144298602|NCT02526290|520298553|FG000|Overall Study|Withdrawal by Subject|4|||
144298603|NCT02526290|520298553|FG000|Overall Study|Physician Decision|1|||
144298604|NCT04079738|520298556|FG000|Study Treatment|Death|1|||
144298605|NCT04079738|520298557|FG001|Study Treatment|Death|0|||
144298606|NCT04079738|520298558|FG002|Study Treatment|Death|0|||
144298607|NCT04079738|520298559|FG003|Study Treatment|Death|0|||
144298608|NCT04079738|520298556|FG000|Study Treatment|Adverse Event|2|||
144298609|NCT04079738|520298557|FG001|Study Treatment|Adverse Event|0|||
144298610|NCT04079738|520298558|FG002|Study Treatment|Adverse Event|0|||
144298611|NCT04079738|520298559|FG003|Study Treatment|Adverse Event|0|||
144298612|NCT04079738|520298556|FG000|Study Treatment|withdrawal before treatment|1|||
144298613|NCT04079738|520298557|FG001|Study Treatment|withdrawal before treatment|0|||
144298614|NCT04079738|520298558|FG002|Study Treatment|withdrawal before treatment|0|||
144298615|NCT04079738|520298559|FG003|Study Treatment|withdrawal before treatment|0|||
144298616|NCT04079738|520298556|FG000|Study Treatment|symptomatic deterioration|2|||
144298617|NCT04079738|520298557|FG001|Study Treatment|symptomatic deterioration|0|||
144298618|NCT04079738|520298558|FG002|Study Treatment|symptomatic deterioration|0|||
144298619|NCT04079738|520298559|FG003|Study Treatment|symptomatic deterioration|0|||
144298620|NCT04079738|520298556|FG000|Study Treatment|Disease Progression|1|||
144298621|NCT04079738|520298557|FG001|Study Treatment|Disease Progression|0|||
144298622|NCT04079738|520298558|FG002|Study Treatment|Disease Progression|0|||
144298623|NCT04079738|520298559|FG003|Study Treatment|Disease Progression|0|||
144298624|NCT04079738|520298556|FG000|Study Treatment|withdrawal after treatment|1|||
144298625|NCT04079738|520298557|FG001|Study Treatment|withdrawal after treatment|0|||
144298626|NCT04079738|520298558|FG002|Study Treatment|withdrawal after treatment|0|||
144298627|NCT04079738|520298559|FG003|Study Treatment|withdrawal after treatment|0|||
144298628|NCT04079738|520298556|FG000|Follow up|Withdrawal by Subject|3|||
144298629|NCT04079738|520298557|FG001|Follow up|Withdrawal by Subject|0|||
144298630|NCT04079738|520298558|FG002|Follow up|Withdrawal by Subject|0|||
144298631|NCT04079738|520298559|FG003|Follow up|Withdrawal by Subject|0|||
144298632|NCT04079738|520298556|FG000|Follow up|Death|5|||
144298633|NCT04079738|520298557|FG001|Follow up|Death|0|||
144298634|NCT04079738|520298558|FG002|Follow up|Death|0|||
144298635|NCT04079738|520298559|FG003|Follow up|Death|0|||
144298636|NCT01889251|520298562|FG000|Overall Study|Adverse Event|1|||
144298637|NCT01889251|520298563|FG001|Overall Study|Adverse Event|0|||
144298638|NCT01344226|520298566|FG000|Overall Study|Protocol Violation|2|||
144298639|NCT01344226|520298566|FG000|Overall Study|Withdrawal by Subject|3|||
144298640|NCT01344226|520298566|FG000|Overall Study|Lack of Efficacy|3|||
144298641|NCT03612570|520298567|FG000|Overall Study|Lost to Follow-up|1|||
144298642|NCT04846868|520298572|FG000|Overall Study|Adverse Event|12|||
144298643|NCT04846868|520298573|FG001|Overall Study|Adverse Event|11|||
144298644|NCT04846868|520298572|FG000|Overall Study|Protocol deviation|6|||
144298645|NCT04846868|520298573|FG001|Overall Study|Protocol deviation|2|||
144298646|NCT04846868|520298572|FG000|Overall Study|Perceived lack of efficacy|3|||
144298647|NCT04846868|520298573|FG001|Overall Study|Perceived lack of efficacy|2|||
144298648|NCT04846868|520298572|FG000|Overall Study|Change of residence|2|||
144298649|NCT04846868|520298573|FG001|Overall Study|Change of residence|3|||
144298650|NCT04846868|520298572|FG000|Overall Study|Burden of study procedures|1|||
144298651|NCT04846868|520298573|FG001|Overall Study|Burden of study procedures|1|||
144298652|NCT04846868|520298572|FG000|Overall Study|No reason available|2|||
144298653|NCT04846868|520298573|FG001|Overall Study|No reason available|5|||
144298654|NCT04846868|520298572|FG000|Overall Study|Other reason listed|20|||
144298655|NCT04846868|520298573|FG001|Overall Study|Other reason listed|10|||
144298656|NCT04846868|520298572|FG000|Overall Study|Not treated|0|||
144298657|NCT04846868|520298573|FG001|Overall Study|Not treated|1|||
144298658|NCT04116853|520298574|FG000|Overall Study|Adverse Event|1|||
144298659|NCT04116853|520298575|FG001|Overall Study|Adverse Event|3|||
144298660|NCT04116853|520298574|FG000|Overall Study|Lost to Follow-up|2|||
144298661|NCT04116853|520298575|FG001|Overall Study|Lost to Follow-up|0|||
144298662|NCT04116853|520298574|FG000|Overall Study|Incarceration|0|||
144298663|NCT04116853|520298575|FG001|Overall Study|Incarceration|1|||
144298664|NCT04116853|520298574|FG000|Overall Study|Pregnancy|1|||
144298665|NCT04116853|520298575|FG001|Overall Study|Pregnancy|1|||
144298666|NCT04116853|520298574|FG000|Overall Study|Began Other Weight Loss program|4|||
144298667|NCT04116853|520298575|FG001|Overall Study|Began Other Weight Loss program|8|||
144298668|NCT04116853|520298574|FG000|Overall Study|Began Anti-Obesity Medication|3|||
144298669|NCT04116853|520298575|FG001|Overall Study|Began Anti-Obesity Medication|3|||
144298670|NCT04116853|520298574|FG000|Overall Study|Protocol Violation|0|||
144298671|NCT04116853|520298575|FG001|Overall Study|Protocol Violation|1|||
144298672|NCT05212168|520298576|FG000|Overall Study|Lost to Follow-up|0|||
144298673|NCT05212168|520298577|FG001|Overall Study|Lost to Follow-up|3|||
144298674|NCT05212168|520298576|FG000|Overall Study|Study terminated by sponsor|30|||
144298675|NCT05212168|520298577|FG001|Overall Study|Study terminated by sponsor|27|||
144298676|NCT05212168|520298576|FG000|Overall Study|Other|4|||
144298677|NCT05212168|520298577|FG001|Overall Study|Other|7|||
144298678|NCT03274466|520298578|FG000|Overall Study|Withdrawal by Subject|7|||
144298679|NCT03274466|520298579|FG001|Overall Study|Withdrawal by Subject|3|||
144298680|NCT03274466|520298578|FG000|Overall Study|Protocol Specified Withdrawal|5|||
144298681|NCT03274466|520298579|FG001|Overall Study|Protocol Specified Withdrawal|11|||
144298682|NCT03274466|520298578|FG000|Overall Study|Lost to Follow-up|5|||
144298683|NCT03274466|520298579|FG001|Overall Study|Lost to Follow-up|7|||
144298684|NCT03274466|520298578|FG000|Overall Study|Subject Non-compliance|0|||
144298685|NCT03274466|520298579|FG001|Overall Study|Subject Non-compliance|1|||
144298686|NCT03274466|520298578|FG000|Overall Study|Adverse Event|3|||
144298687|NCT03274466|520298579|FG001|Overall Study|Adverse Event|3|||
144298688|NCT03274466|520298578|FG000|Overall Study|Physician Decision|0|||
144298689|NCT03274466|520298579|FG001|Overall Study|Physician Decision|1|||
144298690|NCT03274466|520298578|FG000|Overall Study|Protocol Violation|3|||
144298691|NCT03274466|520298579|FG001|Overall Study|Protocol Violation|3|||
144298692|NCT00618787|520298583|FG000|Overall Study|Adverse Event|0|||
144298693|NCT00618787|520298584|FG001|Overall Study|Adverse Event|1|||
144298694|NCT00618787|520298583|FG000|Overall Study|Withdrawal by Subject|2|||
144298695|NCT00618787|520298584|FG001|Overall Study|Withdrawal by Subject|1|||
144298696|NCT00618787|520298583|FG000|Overall Study|Lost to Follow-up|1|||
144298697|NCT00618787|520298584|FG001|Overall Study|Lost to Follow-up|0|||
144298698|NCT01107886|520298585|FG000|Overall Study|Lost to Follow-up|15|||
144298699|NCT01107886|520298586|FG001|Overall Study|Lost to Follow-up|13|||
144298700|NCT01107886|520298585|FG000|Overall Study|Withdrawal by Subject|180|||
144298701|NCT01107886|520298586|FG001|Overall Study|Withdrawal by Subject|196|||
144298702|NCT01107886|520298585|FG000|Overall Study|Administrative withdrawal of consent|7|||
144298703|NCT01107886|520298586|FG001|Overall Study|Administrative withdrawal of consent|5|||
144298704|NCT01994876|520298587|FG000|Test Period 1|Withdrawal by Subject|0|||
144298705|NCT01994876|520298588|FG001|Test Period 1|Withdrawal by Subject|1|||
144298706|NCT01994876|520298587|FG000|Test Period 1|Adverse Event|0|||
144298707|NCT01994876|520298588|FG001|Test Period 1|Adverse Event|1|||
144298708|NCT01994876|520298587|FG000|Test Period 2|Adverse Event|1|||
144298709|NCT01994876|520298588|FG001|Test Period 2|Adverse Event|0|||
144298710|NCT01994876|520298587|FG000|Test Period 2|Protocol Violation|0|||
144298711|NCT01994876|520298588|FG001|Test Period 2|Protocol Violation|1|||
144298712|NCT05819398|520298589|FG000|Overall Study|Withdrawal by Subject|11|||
144298713|NCT05819398|520298590|FG001|Overall Study|Withdrawal by Subject|7|||
144298714|NCT05819398|520298591|FG002|Overall Study|Withdrawal by Subject|6|||
144298715|NCT05819398|520298592|FG003|Overall Study|Withdrawal by Subject|6|||
144298716|NCT05819398|520298589|FG000|Overall Study|Lost to Follow-up|0|||
144298717|NCT05819398|520298590|FG001|Overall Study|Lost to Follow-up|2|||
144298718|NCT05819398|520298591|FG002|Overall Study|Lost to Follow-up|0|||
144298719|NCT05819398|520298592|FG003|Overall Study|Lost to Follow-up|1|||
144298720|NCT05819398|520298589|FG000|Overall Study|Adverse Event|1|||
144298721|NCT05819398|520298590|FG001|Overall Study|Adverse Event|3|||
144298722|NCT05819398|520298591|FG002|Overall Study|Adverse Event|4|||
144298723|NCT05819398|520298592|FG003|Overall Study|Adverse Event|5|||
144298724|NCT05819398|520298589|FG000|Overall Study|Other than listed|0|||
144298725|NCT05819398|520298590|FG001|Overall Study|Other than listed|2|||
144298726|NCT05819398|520298591|FG002|Overall Study|Other than listed|2|||
144298727|NCT05819398|520298592|FG003|Overall Study|Other than listed|0|||
144298728|NCT05819398|520298589|FG000|Overall Study|Lack of Efficacy|0|||
144298729|NCT05819398|520298590|FG001|Overall Study|Lack of Efficacy|1|||
144298730|NCT05819398|520298591|FG002|Overall Study|Lack of Efficacy|0|||
144298731|NCT05819398|520298592|FG003|Overall Study|Lack of Efficacy|0|||
144298732|NCT05819398|520298589|FG000|Overall Study|Study terminated by sponsor|20|||
144298733|NCT05819398|520298590|FG001|Overall Study|Study terminated by sponsor|18|||
144298734|NCT05819398|520298591|FG002|Overall Study|Study terminated by sponsor|20|||
144298735|NCT05819398|520298592|FG003|Overall Study|Study terminated by sponsor|22|||
144298736|NCT06022107|520298593|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
144298737|NCT06022107|520298593|FG000|Overall Study|Dropped out of study for higher level of care|1|||
144298738|NCT06022107|520298593|FG000|Overall Study|Lost to Follow-up|2|||
144298739|NCT01649869|520298594|FG000|Overall Study|Family member illness|1|||
144298740|NCT01649869|520298595|FG001|Overall Study|Family member illness|0|||
144298741|NCT01649869|520298594|FG000|Overall Study|Required treatment outside protocol|1|||
144298742|NCT01649869|520298595|FG001|Overall Study|Required treatment outside protocol|0|||
144298743|NCT01649869|520298594|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
144298744|NCT01649869|520298595|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
144298745|NCT02776735|520298596|FG000|Overall Study|Adverse Event|0|||
144298746|NCT02776735|520298597|FG001|Overall Study|Adverse Event|0|||
144298747|NCT02776735|520298598|FG002|Overall Study|Adverse Event|0|||
144298748|NCT02776735|520298599|FG003|Overall Study|Adverse Event|1|||
144298749|NCT02776735|520298600|FG004|Overall Study|Adverse Event|0|||
144298750|NCT02776735|520298601|FG005|Overall Study|Adverse Event|1|||
144298751|NCT02776735|520298596|FG000|Overall Study|Lost to Follow-up|0|||
144298752|NCT02776735|520298597|FG001|Overall Study|Lost to Follow-up|0|||
144298753|NCT02776735|520298598|FG002|Overall Study|Lost to Follow-up|0|||
144298754|NCT02776735|520298599|FG003|Overall Study|Lost to Follow-up|1|||
144298755|NCT02776735|520298600|FG004|Overall Study|Lost to Follow-up|0|||
144298756|NCT02776735|520298601|FG005|Overall Study|Lost to Follow-up|0|||
144298757|NCT02776735|520298596|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144298758|NCT02776735|520298597|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144298759|NCT02776735|520298598|FG002|Overall Study|Withdrawal by parent/guardian|2|||
144298760|NCT02776735|520298599|FG003|Overall Study|Withdrawal by parent/guardian|2|||
144298761|NCT02776735|520298600|FG004|Overall Study|Withdrawal by parent/guardian|0|||
144298762|NCT02776735|520298601|FG005|Overall Study|Withdrawal by parent/guardian|0|||
144298763|NCT02776735|520298596|FG000|Overall Study|Withdrawal by Subject|1|||
144298764|NCT02776735|520298597|FG001|Overall Study|Withdrawal by Subject|0|||
144298765|NCT02776735|520298598|FG002|Overall Study|Withdrawal by Subject|0|||
144298766|NCT02776735|520298599|FG003|Overall Study|Withdrawal by Subject|0|||
144298767|NCT02776735|520298600|FG004|Overall Study|Withdrawal by Subject|0|||
144298768|NCT02776735|520298601|FG005|Overall Study|Withdrawal by Subject|1|||
144298769|NCT02776735|520298596|FG000|Overall Study|Other|0|||
144298770|NCT02776735|520298597|FG001|Overall Study|Other|0|||
144298771|NCT02776735|520298598|FG002|Overall Study|Other|3|||
144298772|NCT02776735|520298599|FG003|Overall Study|Other|0|||
144298773|NCT02776735|520298600|FG004|Overall Study|Other|0|||
144298774|NCT02776735|520298601|FG005|Overall Study|Other|0|||
144298775|NCT05847686|520300537|FG000|Overall Study|Withdrawal by Subject|3|||
144298776|NCT03716830|520300538|FG000|Overall Study|Withdrawal by Subject|2|||
144298777|NCT03716830|520300539|FG001|Overall Study|Withdrawal by Subject|2|||
144298778|NCT03716830|520300540|FG002|Overall Study|Withdrawal by Subject|6|||
144298779|NCT03716830|520300541|FG003|Overall Study|Withdrawal by Subject|5|||
144298780|NCT03716830|520300538|FG000|Overall Study|Adverse Event|1|||
144298781|NCT03716830|520300539|FG001|Overall Study|Adverse Event|2|||
144298782|NCT03716830|520300540|FG002|Overall Study|Adverse Event|0|||
144298783|NCT03716830|520300541|FG003|Overall Study|Adverse Event|1|||
144298784|NCT03716830|520300538|FG000|Overall Study|Lost to Follow-up|1|||
144298785|NCT03716830|520300539|FG001|Overall Study|Lost to Follow-up|1|||
144298786|NCT03716830|520300540|FG002|Overall Study|Lost to Follow-up|0|||
144298787|NCT03716830|520300541|FG003|Overall Study|Lost to Follow-up|0|||
144298788|NCT04795531|520300542|FG000|Overall Study|Withdrawal by Subject|4|||
144298789|NCT04795531|520300543|FG001|Overall Study|Withdrawal by Subject|4|||
144298790|NCT04795531|520300542|FG000|Overall Study|Lost to Follow-up|0|||
144298791|NCT04795531|520300543|FG001|Overall Study|Lost to Follow-up|1|||
144298792|NCT04795531|520300542|FG000|Overall Study|Physician Decision|0|||
144298793|NCT04795531|520300543|FG001|Overall Study|Physician Decision|2|||
144298794|NCT04795531|520300542|FG000|Overall Study|Death|2|||
144298795|NCT04795531|520300543|FG001|Overall Study|Death|1|||
144298796|NCT04887831|520300544|FG000|Overall Study|Death|26|||
144298797|NCT04887831|520300545|FG001|Overall Study|Death|26|||
144298798|NCT04887831|520300544|FG000|Overall Study|Lost to Follow-up|0|||
144298799|NCT04887831|520300545|FG001|Overall Study|Lost to Follow-up|1|||
144298800|NCT04887831|520300544|FG000|Overall Study|Withdrawal by Subject|2|||
144298801|NCT04887831|520300545|FG001|Overall Study|Withdrawal by Subject|1|||
144298802|NCT04887831|520300544|FG000|Overall Study|Study Terminated by Sponsor|18|||
144298803|NCT04887831|520300545|FG001|Overall Study|Study Terminated by Sponsor|17|||
144298804|NCT04887831|520300544|FG000|Overall Study|Other|1|||
144298805|NCT04887831|520300545|FG001|Overall Study|Other|0|||
144298806|NCT03396445|520300546|FG000|Treatment Period|Death|2|||
144298807|NCT03396445|520300547|FG001|Treatment Period|Death|2|||
144298808|NCT03396445|520300548|FG002|Treatment Period|Death|1|||
144298809|NCT03396445|520300549|FG003|Treatment Period|Death|1|||
144298810|NCT03396445|520300550|FG004|Treatment Period|Death|3|||
144298811|NCT03396445|520300551|FG005|Treatment Period|Death|2|||
144298812|NCT03396445|520300552|FG006|Treatment Period|Death|5|||
144298813|NCT03396445|520300553|FG007|Treatment Period|Death|3|||
144298814|NCT03396445|520300554|FG008|Treatment Period|Death|3|||
144298815|NCT03396445|520300555|FG009|Treatment Period|Death|3|||
144298816|NCT03396445|520300556|FG010|Treatment Period|Death|7|||
144298817|NCT03396445|520300557|FG011|Treatment Period|Death|12|||
144298818|NCT03396445|520300558|FG012|Treatment Period|Death|28|||
144298819|NCT03396445|520300559|FG013|Treatment Period|Death|14|||
144298820|NCT03396445|520300560|FG014|Treatment Period|Death|10|||
144298821|NCT03396445|520300561|FG015|Treatment Period|Death|8|||
144298822|NCT03396445|520300562|FG016|Treatment Period|Death|18|||
144298823|NCT03396445|520300563|FG017|Treatment Period|Death|0|||
144298824|NCT03396445|520300564|FG018|Treatment Period|Death|0|||
144298825|NCT03396445|520300565|FG019|Treatment Period|Death|0|||
144298826|NCT03396445|520300566|FG020|Treatment Period|Death|0|||
144298827|NCT03396445|520300567|FG021|Treatment Period|Death|0|||
144298828|NCT03396445|520300568|FG022|Treatment Period|Death|0|||
144298829|NCT03396445|520300569|FG023|Treatment Period|Death|0|||
144298830|NCT03396445|520300570|FG024|Treatment Period|Death|0|||
144298831|NCT03396445|520300571|FG025|Treatment Period|Death|0|||
144298832|NCT03396445|520300546|FG000|Treatment Period|Lost to Follow-up|0|||
144298833|NCT03396445|520300547|FG001|Treatment Period|Lost to Follow-up|0|||
144298834|NCT03396445|520300548|FG002|Treatment Period|Lost to Follow-up|0|||
144298835|NCT03396445|520300549|FG003|Treatment Period|Lost to Follow-up|0|||
144298836|NCT03396445|520300550|FG004|Treatment Period|Lost to Follow-up|0|||
144298837|NCT03396445|520300551|FG005|Treatment Period|Lost to Follow-up|0|||
144298838|NCT03396445|520300552|FG006|Treatment Period|Lost to Follow-up|0|||
144298839|NCT03396445|520300553|FG007|Treatment Period|Lost to Follow-up|0|||
144298840|NCT03396445|520300554|FG008|Treatment Period|Lost to Follow-up|0|||
144298841|NCT03396445|520300555|FG009|Treatment Period|Lost to Follow-up|0|||
144298842|NCT03396445|520300556|FG010|Treatment Period|Lost to Follow-up|0|||
144298843|NCT03396445|520300557|FG011|Treatment Period|Lost to Follow-up|0|||
144298844|NCT03396445|520300558|FG012|Treatment Period|Lost to Follow-up|1|||
144298845|NCT03396445|520300559|FG013|Treatment Period|Lost to Follow-up|0|||
144298846|NCT03396445|520300560|FG014|Treatment Period|Lost to Follow-up|1|||
144298847|NCT03396445|520300561|FG015|Treatment Period|Lost to Follow-up|0|||
144298848|NCT03396445|520300562|FG016|Treatment Period|Lost to Follow-up|0|||
144298849|NCT03396445|520300563|FG017|Treatment Period|Lost to Follow-up|0|||
144298850|NCT03396445|520300564|FG018|Treatment Period|Lost to Follow-up|0|||
144298851|NCT03396445|520300565|FG019|Treatment Period|Lost to Follow-up|0|||
144298852|NCT03396445|520300566|FG020|Treatment Period|Lost to Follow-up|0|||
144298853|NCT03396445|520300567|FG021|Treatment Period|Lost to Follow-up|0|||
144298854|NCT03396445|520300568|FG022|Treatment Period|Lost to Follow-up|0|||
144298855|NCT03396445|520300569|FG023|Treatment Period|Lost to Follow-up|0|||
144298856|NCT03396445|520300570|FG024|Treatment Period|Lost to Follow-up|0|||
144298857|NCT03396445|520300571|FG025|Treatment Period|Lost to Follow-up|0|||
144298858|NCT03396445|520300546|FG000|Treatment Period|Physician Decision|0|||
144298859|NCT03396445|520300547|FG001|Treatment Period|Physician Decision|0|||
144298860|NCT03396445|520300548|FG002|Treatment Period|Physician Decision|0|||
144298861|NCT03396445|520300549|FG003|Treatment Period|Physician Decision|0|||
144298862|NCT03396445|520300550|FG004|Treatment Period|Physician Decision|1|||
144298863|NCT03396445|520300551|FG005|Treatment Period|Physician Decision|0|||
144298864|NCT03396445|520300552|FG006|Treatment Period|Physician Decision|0|||
144298865|NCT03396445|520300553|FG007|Treatment Period|Physician Decision|0|||
144298866|NCT03396445|520300554|FG008|Treatment Period|Physician Decision|0|||
144298867|NCT03396445|520300555|FG009|Treatment Period|Physician Decision|1|||
144298868|NCT03396445|520300556|FG010|Treatment Period|Physician Decision|0|||
144298869|NCT03396445|520300557|FG011|Treatment Period|Physician Decision|0|||
144298870|NCT03396445|520300558|FG012|Treatment Period|Physician Decision|0|||
144298871|NCT03396445|520300559|FG013|Treatment Period|Physician Decision|0|||
144298872|NCT03396445|520300560|FG014|Treatment Period|Physician Decision|0|||
144298873|NCT03396445|520300561|FG015|Treatment Period|Physician Decision|0|||
144298874|NCT03396445|520300562|FG016|Treatment Period|Physician Decision|0|||
144298875|NCT03396445|520300563|FG017|Treatment Period|Physician Decision|0|||
144298876|NCT03396445|520300564|FG018|Treatment Period|Physician Decision|0|||
144298877|NCT03396445|520300565|FG019|Treatment Period|Physician Decision|0|||
144298878|NCT03396445|520300566|FG020|Treatment Period|Physician Decision|0|||
144298879|NCT03396445|520300567|FG021|Treatment Period|Physician Decision|0|||
144298880|NCT03396445|520300568|FG022|Treatment Period|Physician Decision|0|||
144298881|NCT03396445|520300569|FG023|Treatment Period|Physician Decision|0|||
144298882|NCT03396445|520300570|FG024|Treatment Period|Physician Decision|0|||
144298883|NCT03396445|520300571|FG025|Treatment Period|Physician Decision|0|||
144298884|NCT03396445|520300546|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298885|NCT03396445|520300547|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298886|NCT03396445|520300548|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298887|NCT03396445|520300549|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298888|NCT03396445|520300550|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298889|NCT03396445|520300551|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298890|NCT03396445|520300552|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144360008|NCT01601535|520525136|FG001|Phase 1|Progressive Disease|3|||
144298891|NCT03396445|520300553|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298892|NCT03396445|520300554|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298893|NCT03396445|520300555|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298894|NCT03396445|520300556|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298895|NCT03396445|520300557|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298896|NCT03396445|520300558|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
144298897|NCT03396445|520300559|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298898|NCT03396445|520300560|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
144298899|NCT03396445|520300561|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298900|NCT03396445|520300562|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298901|NCT03396445|520300563|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298902|NCT03396445|520300564|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298903|NCT03396445|520300565|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298904|NCT03396445|520300566|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298905|NCT03396445|520300567|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298906|NCT03396445|520300568|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298907|NCT03396445|520300569|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298908|NCT03396445|520300570|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298909|NCT03396445|520300571|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
144298910|NCT03396445|520300546|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
144298911|NCT03396445|520300547|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
144298912|NCT03396445|520300548|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
144298913|NCT03396445|520300549|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
144298914|NCT03396445|520300550|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
144298915|NCT03396445|520300551|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298916|NCT03396445|520300552|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
144298917|NCT03396445|520300553|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298918|NCT03396445|520300554|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298919|NCT03396445|520300555|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298920|NCT03396445|520300556|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298921|NCT03396445|520300557|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298922|NCT03396445|520300558|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298923|NCT03396445|520300559|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298924|NCT03396445|520300560|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298925|NCT03396445|520300561|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298926|NCT03396445|520300562|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298927|NCT03396445|520300563|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298928|NCT03396445|520300564|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298929|NCT03396445|520300565|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298930|NCT03396445|520300566|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298931|NCT03396445|520300567|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298932|NCT03396445|520300568|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298933|NCT03396445|520300569|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298934|NCT03396445|520300570|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298935|NCT03396445|520300571|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
144298936|NCT03396445|520300546|FG000|Treatment Period|Withdrawal by Subject|0|||
144298937|NCT03396445|520300547|FG001|Treatment Period|Withdrawal by Subject|0|||
144298938|NCT03396445|520300548|FG002|Treatment Period|Withdrawal by Subject|0|||
144298939|NCT03396445|520300549|FG003|Treatment Period|Withdrawal by Subject|0|||
144298940|NCT03396445|520300550|FG004|Treatment Period|Withdrawal by Subject|0|||
144298941|NCT03396445|520300551|FG005|Treatment Period|Withdrawal by Subject|0|||
144298942|NCT03396445|520300552|FG006|Treatment Period|Withdrawal by Subject|0|||
144298943|NCT03396445|520300553|FG007|Treatment Period|Withdrawal by Subject|0|||
144298944|NCT03396445|520300554|FG008|Treatment Period|Withdrawal by Subject|0|||
144298945|NCT03396445|520300555|FG009|Treatment Period|Withdrawal by Subject|0|||
144298946|NCT03396445|520300556|FG010|Treatment Period|Withdrawal by Subject|0|||
144298947|NCT03396445|520300557|FG011|Treatment Period|Withdrawal by Subject|0|||
144298948|NCT03396445|520300558|FG012|Treatment Period|Withdrawal by Subject|0|||
144298949|NCT03396445|520300559|FG013|Treatment Period|Withdrawal by Subject|0|||
144298950|NCT03396445|520300560|FG014|Treatment Period|Withdrawal by Subject|1|||
144298951|NCT03396445|520300561|FG015|Treatment Period|Withdrawal by Subject|0|||
144298952|NCT03396445|520300562|FG016|Treatment Period|Withdrawal by Subject|1|||
144298953|NCT03396445|520300563|FG017|Treatment Period|Withdrawal by Subject|0|||
144298954|NCT03396445|520300564|FG018|Treatment Period|Withdrawal by Subject|0|||
144298955|NCT03396445|520300565|FG019|Treatment Period|Withdrawal by Subject|0|||
144298956|NCT03396445|520300566|FG020|Treatment Period|Withdrawal by Subject|0|||
144298957|NCT03396445|520300567|FG021|Treatment Period|Withdrawal by Subject|0|||
144298958|NCT03396445|520300568|FG022|Treatment Period|Withdrawal by Subject|0|||
144298959|NCT03396445|520300569|FG023|Treatment Period|Withdrawal by Subject|0|||
144298960|NCT03396445|520300570|FG024|Treatment Period|Withdrawal by Subject|0|||
144298961|NCT03396445|520300571|FG025|Treatment Period|Withdrawal by Subject|0|||
144298962|NCT03396445|520300546|FG000|Switch-over Period|Death|0|||
144298963|NCT03396445|520300547|FG001|Switch-over Period|Death|0|||
144298964|NCT03396445|520300548|FG002|Switch-over Period|Death|0|||
144298965|NCT03396445|520300549|FG003|Switch-over Period|Death|0|||
144298966|NCT03396445|520300550|FG004|Switch-over Period|Death|0|||
144298967|NCT03396445|520300551|FG005|Switch-over Period|Death|0|||
144298968|NCT03396445|520300552|FG006|Switch-over Period|Death|0|||
144298969|NCT03396445|520300553|FG007|Switch-over Period|Death|0|||
144298970|NCT03396445|520300554|FG008|Switch-over Period|Death|0|||
144298971|NCT03396445|520300555|FG009|Switch-over Period|Death|0|||
144298972|NCT03396445|520300556|FG010|Switch-over Period|Death|0|||
144298973|NCT03396445|520300557|FG011|Switch-over Period|Death|0|||
144298974|NCT03396445|520300558|FG012|Switch-over Period|Death|0|||
144298975|NCT03396445|520300559|FG013|Switch-over Period|Death|0|||
144298976|NCT03396445|520300560|FG014|Switch-over Period|Death|0|||
144298977|NCT03396445|520300561|FG015|Switch-over Period|Death|0|||
144298978|NCT03396445|520300562|FG016|Switch-over Period|Death|0|||
144298979|NCT03396445|520300563|FG017|Switch-over Period|Death|0|||
144298980|NCT03396445|520300564|FG018|Switch-over Period|Death|1|||
144298981|NCT03396445|520300565|FG019|Switch-over Period|Death|2|||
144298982|NCT03396445|520300566|FG020|Switch-over Period|Death|2|||
144298983|NCT03396445|520300567|FG021|Switch-over Period|Death|1|||
144298984|NCT03396445|520300568|FG022|Switch-over Period|Death|2|||
144298985|NCT03396445|520300569|FG023|Switch-over Period|Death|0|||
144298986|NCT03396445|520300570|FG024|Switch-over Period|Death|1|||
144298987|NCT03396445|520300571|FG025|Switch-over Period|Death|6|||
144298988|NCT03396445|520300546|FG000|Switch-over Period|Lost to Follow-up|0|||
144298989|NCT03396445|520300547|FG001|Switch-over Period|Lost to Follow-up|0|||
144298990|NCT03396445|520300548|FG002|Switch-over Period|Lost to Follow-up|0|||
144298991|NCT03396445|520300549|FG003|Switch-over Period|Lost to Follow-up|0|||
144298992|NCT03396445|520300550|FG004|Switch-over Period|Lost to Follow-up|0|||
144298993|NCT03396445|520300551|FG005|Switch-over Period|Lost to Follow-up|0|||
144298994|NCT03396445|520300552|FG006|Switch-over Period|Lost to Follow-up|0|||
144298995|NCT03396445|520300553|FG007|Switch-over Period|Lost to Follow-up|0|||
144298996|NCT03396445|520300554|FG008|Switch-over Period|Lost to Follow-up|0|||
144298997|NCT03396445|520300555|FG009|Switch-over Period|Lost to Follow-up|0|||
144298998|NCT03396445|520300556|FG010|Switch-over Period|Lost to Follow-up|0|||
144298999|NCT03396445|520300557|FG011|Switch-over Period|Lost to Follow-up|0|||
144299000|NCT03396445|520300558|FG012|Switch-over Period|Lost to Follow-up|0|||
144299001|NCT03396445|520300559|FG013|Switch-over Period|Lost to Follow-up|0|||
144299002|NCT03396445|520300560|FG014|Switch-over Period|Lost to Follow-up|0|||
144299003|NCT03396445|520300561|FG015|Switch-over Period|Lost to Follow-up|0|||
144299004|NCT03396445|520300562|FG016|Switch-over Period|Lost to Follow-up|0|||
144299005|NCT03396445|520300563|FG017|Switch-over Period|Lost to Follow-up|0|||
144299006|NCT03396445|520300564|FG018|Switch-over Period|Lost to Follow-up|0|||
144299007|NCT03396445|520300565|FG019|Switch-over Period|Lost to Follow-up|0|||
144299008|NCT03396445|520300566|FG020|Switch-over Period|Lost to Follow-up|0|||
144299009|NCT03396445|520300567|FG021|Switch-over Period|Lost to Follow-up|0|||
144299010|NCT03396445|520300568|FG022|Switch-over Period|Lost to Follow-up|0|||
144299011|NCT03396445|520300569|FG023|Switch-over Period|Lost to Follow-up|1|||
144299012|NCT03396445|520300570|FG024|Switch-over Period|Lost to Follow-up|0|||
144299013|NCT03396445|520300571|FG025|Switch-over Period|Lost to Follow-up|0|||
144299014|NCT03309202|520300577|FG000|Overall Study|Lost to Follow-up|1|||
144299015|NCT03309202|520300578|FG001|Overall Study|Lost to Follow-up|0|||
144299016|NCT03309202|520300579|FG002|Overall Study|Lost to Follow-up|0|||
144299017|NCT03309202|520300580|FG003|Overall Study|Lost to Follow-up|0|||
144299018|NCT01209767|520300581|FG000|Overall Study|Withdrawal by Subject|1|||
144299019|NCT01209767|520300581|FG000|Overall Study|Lost to Follow-up|3|||
144299020|NCT01702298|520300582|FG000|Overall Study|Withdrawal by Subject|1|||
144299021|NCT01664624|520300586|FG000|Overall Study|Adverse Event|0|||
144299022|NCT01664624|520300587|FG001|Overall Study|Adverse Event|1|||
144299023|NCT01664624|520300588|FG002|Overall Study|Adverse Event|0|||
144299024|NCT01664624|520300589|FG003|Overall Study|Adverse Event|0|||
144299025|NCT01517984|520300592|FG000|Overall Study|Lost to Follow-up|0|||
144299026|NCT01517984|520300593|FG001|Overall Study|Lost to Follow-up|1|||
144299027|NCT01517984|520300594|FG002|Overall Study|Lost to Follow-up|0|||
144299028|NCT01517984|520300595|FG003|Overall Study|Lost to Follow-up|0|||
144299029|NCT01517984|520300592|FG000|Overall Study|Withdrawal by Subject|1|||
144299030|NCT01517984|520300593|FG001|Overall Study|Withdrawal by Subject|8|||
144299031|NCT01517984|520300594|FG002|Overall Study|Withdrawal by Subject|4|||
144299032|NCT01517984|520300595|FG003|Overall Study|Withdrawal by Subject|1|||
144299033|NCT01517984|520300592|FG000|Overall Study|Screen Failure|4|||
144299034|NCT01517984|520300593|FG001|Overall Study|Screen Failure|0|||
144299035|NCT01517984|520300594|FG002|Overall Study|Screen Failure|0|||
144299036|NCT01517984|520300595|FG003|Overall Study|Screen Failure|0|||
144299037|NCT01517984|520300592|FG000|Overall Study|Ineligible for randomization|0|||
144299038|NCT01517984|520300593|FG001|Overall Study|Ineligible for randomization|14|||
144299039|NCT01517984|520300594|FG002|Overall Study|Ineligible for randomization|0|||
144299040|NCT01517984|520300595|FG003|Overall Study|Ineligible for randomization|0|||
144299041|NCT00573768|520300596|FG000|Overall Study|Adverse Event|1|||
144299042|NCT00573768|520300597|FG001|Overall Study|Adverse Event|1|||
144299043|NCT00573768|520300598|FG002|Overall Study|Adverse Event|2|||
144299044|NCT00573768|520300596|FG000|Overall Study|Protocol Violation|1|||
144299045|NCT00573768|520300597|FG001|Overall Study|Protocol Violation|0|||
144299046|NCT00573768|520300598|FG002|Overall Study|Protocol Violation|1|||
144299047|NCT00573768|520300596|FG000|Overall Study|Withdrawal by Subject|0|||
144299048|NCT00573768|520300597|FG001|Overall Study|Withdrawal by Subject|1|||
144299049|NCT00573768|520300598|FG002|Overall Study|Withdrawal by Subject|0|||
144299050|NCT00573768|520300596|FG000|Overall Study|Lost to Follow-up|0|||
144299051|NCT00573768|520300597|FG001|Overall Study|Lost to Follow-up|0|||
144299052|NCT00573768|520300598|FG002|Overall Study|Lost to Follow-up|1|||
144299053|NCT00583219|520300599|FG000|Phase 2|Withdrawal by Subject|1|||
144299054|NCT03898180|520300600|FG000|Overall Study|Death|178|||
144299055|NCT03898180|520300601|FG001|Overall Study|Death|173|||
144299056|NCT03898180|520300600|FG000|Overall Study|Physician Decision|1|||
144299057|NCT03898180|520300601|FG001|Overall Study|Physician Decision|0|||
144299058|NCT03898180|520300600|FG000|Overall Study|Sponsor Decision|3|||
144299059|NCT03898180|520300601|FG001|Overall Study|Sponsor Decision|0|||
144299060|NCT03898180|520300600|FG000|Overall Study|Lost to Follow-up|1|||
144299061|NCT03898180|520300601|FG001|Overall Study|Lost to Follow-up|0|||
144299062|NCT03898180|520300600|FG000|Overall Study|Withdrawal by Subject|5|||
144299063|NCT03898180|520300601|FG001|Overall Study|Withdrawal by Subject|4|||
144299064|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
144299065|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
144299066|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
144299067|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
144299068|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
144299069|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
144299070|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
144299071|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
144299072|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
144299073|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
144299074|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
144299075|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
144299076|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
144299077|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
144299078|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
144299079|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
144299080|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
144299081|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
144299082|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
144299083|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
144299084|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
144299085|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
144299086|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
144299087|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
144299088|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
144299089|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
144299090|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
144299091|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
144299092|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
144299093|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
144299094|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
144299095|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
144299096|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
144299097|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
144299098|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
144299099|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
144299100|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
144299101|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
144299102|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
144299103|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
144299104|NCT04392154|520300604|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
144299105|NCT04392154|520300605|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
144299106|NCT04392154|520300606|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
144299107|NCT04392154|520300607|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
144299108|NCT04392154|520300604|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
144299109|NCT04392154|520300605|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
144299110|NCT04392154|520300606|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
144299111|NCT04392154|520300607|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
144299112|NCT04392154|520300604|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
144299113|NCT04392154|520300605|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
144299114|NCT04392154|520300606|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
144299115|NCT04392154|520300607|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
144299116|NCT04392154|520300604|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
144299117|NCT04392154|520300605|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
144299118|NCT04392154|520300606|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
144360009|NCT01601535|520525137|FG002|Phase 1|Progressive Disease|2|||
144299119|NCT04392154|520300607|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
144299120|NCT02661815|520300610|FG000|Overall Study|Withdrawal by Subject|1|||
144299121|NCT02661815|520300611|FG001|Overall Study|Withdrawal by Subject|0|||
144299122|NCT02661815|520300612|FG002|Overall Study|Withdrawal by Subject|0|||
144299123|NCT02661815|520300613|FG003|Overall Study|Withdrawal by Subject|0|||
144299124|NCT00654355|520300623|FG000|Overall Study|Lost to Follow-up|2|||
144299125|NCT00654355|520300624|FG001|Overall Study|Lost to Follow-up|2|||
144299126|NCT05805150|520300629|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
144299127|NCT05805150|520300630|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
144299128|NCT02284893|520300631|FG000|26 Week (Short Term)|Adverse Event|1|||
144299129|NCT02284893|520300632|FG001|26 Week (Short Term)|Adverse Event|9|||
144299130|NCT02284893|520300631|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
144299131|NCT02284893|520300632|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
144299132|NCT02284893|520300631|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
144299133|NCT02284893|520300632|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
144299134|NCT02284893|520300631|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
144299135|NCT02284893|520300632|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
144299136|NCT02284893|520300631|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
144299137|NCT02284893|520300632|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
144299138|NCT02284893|520300631|FG000|26 Week (Short Term)|Other|1|||
144299139|NCT02284893|520300632|FG001|26 Week (Short Term)|Other|1|||
144299140|NCT02284893|520300631|FG000|52 Week (Long Term)|Adverse Event|3|||
144299141|NCT02284893|520300632|FG001|52 Week (Long Term)|Adverse Event|1|||
144299142|NCT02284893|520300631|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
144299143|NCT02284893|520300632|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
144299144|NCT02284893|520300631|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
144299145|NCT02284893|520300632|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
144299146|NCT02284893|520300631|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
144299147|NCT02284893|520300632|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
144299148|NCT02284893|520300631|FG000|52 Week (Long Term)|Non-Compliance|2|||
144299149|NCT02284893|520300632|FG001|52 Week (Long Term)|Non-Compliance|3|||
144299150|NCT02757430|520300635|FG000|Overall Study|Physician Decision|6|||
144299151|NCT02757430|520300635|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
144299152|NCT02757430|520300635|FG000|Overall Study|No informed consent|1|||
144299153|NCT02757430|520300635|FG000|Overall Study|No procedure performed|2|||
144299154|NCT03502200|520300638|FG000|Overall Study|Adverse Event|1|||
144299155|NCT03502200|520300639|FG001|Overall Study|Adverse Event|0|||
144299156|NCT03502200|520300638|FG000|Overall Study|Lost to Follow-up|36|||
144299157|NCT03502200|520300639|FG001|Overall Study|Lost to Follow-up|38|||
144299158|NCT03502200|520300638|FG000|Overall Study|Study Team Decision|1|||
144299159|NCT03502200|520300639|FG001|Overall Study|Study Team Decision|1|||
144299160|NCT03502200|520300638|FG000|Overall Study|Withdrawal by Subject|5|||
144299161|NCT03502200|520300639|FG001|Overall Study|Withdrawal by Subject|7|||
144299162|NCT03502200|520300638|FG000|Overall Study|Death|0|||
144299163|NCT03502200|520300639|FG001|Overall Study|Death|2|||
144299164|NCT04138056|520300644|FG000|Primary Study|Lost to Follow-up|3|||
144299165|NCT04138056|520300645|FG001|Primary Study|Lost to Follow-up|4|||
144299166|NCT04138056|520300646|FG002|Primary Study|Lost to Follow-up|1|||
144299167|NCT04138056|520300647|FG003|Primary Study|Lost to Follow-up|1|||
144299168|NCT04138056|520300648|FG004|Primary Study|Lost to Follow-up|4|||
144299169|NCT04138056|520300644|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
144299170|NCT04138056|520300645|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
144299171|NCT04138056|520300646|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
144299172|NCT04138056|520300647|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
144299173|NCT04138056|520300648|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
144299174|NCT04138056|520300644|FG000|Extension Study|Lost to Follow-up|1|||
144299175|NCT04138056|520300645|FG001|Extension Study|Lost to Follow-up|2|||
144299176|NCT04138056|520300646|FG002|Extension Study|Lost to Follow-up|1|||
144299177|NCT04138056|520300647|FG003|Extension Study|Lost to Follow-up|0|||
144299178|NCT04138056|520300648|FG004|Extension Study|Lost to Follow-up|1|||
144299179|NCT02706392|520300651|FG000|Overall Study|Death|1|||
144299180|NCT02706392|520300652|FG001|Overall Study|Death|0|||
144299181|NCT02706392|520300653|FG002|Overall Study|Death|2|||
144299182|NCT02706392|520300654|FG003|Overall Study|Death|2|||
144299183|NCT02706392|520300655|FG004|Overall Study|Death|5|||
144299184|NCT02706392|520300656|FG005|Overall Study|Death|2|||
144299185|NCT01467466|520300668|FG000|Overall Study|Withdrawal by Subject|15|||
144299186|NCT01467466|520300669|FG001|Overall Study|Withdrawal by Subject|18|||
144299187|NCT01467466|520300670|FG002|Overall Study|Withdrawal by Subject|13|||
144299188|NCT01467466|520300671|FG003|Overall Study|Withdrawal by Subject|11|||
144299189|NCT01467466|520300668|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
144299190|NCT01467466|520300669|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
144299191|NCT01467466|520300670|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
144299192|NCT01467466|520300671|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
144299193|NCT01467466|520300668|FG000|Overall Study|Procedure Cancelled|46|||
144299194|NCT01467466|520300669|FG001|Overall Study|Procedure Cancelled|45|||
144299195|NCT01467466|520300670|FG002|Overall Study|Procedure Cancelled|25|||
144299196|NCT01467466|520300671|FG003|Overall Study|Procedure Cancelled|29|||
144299197|NCT01467466|520300668|FG000|Overall Study|No Endpoint Blood Draw|38|||
144299198|NCT01467466|520300669|FG001|Overall Study|No Endpoint Blood Draw|32|||
144299199|NCT01467466|520300670|FG002|Overall Study|No Endpoint Blood Draw|51|||
144299200|NCT01467466|520300671|FG003|Overall Study|No Endpoint Blood Draw|43|||
144299201|NCT03261505|520300672|FG000|Overall Study|Withdrawal by Subject|2|||
144299202|NCT03261505|520300673|FG001|Overall Study|Withdrawal by Subject|3|||
144299203|NCT03261505|520300674|FG002|Overall Study|Withdrawal by Subject|4|||
144299204|NCT03261505|520300675|FG003|Overall Study|Withdrawal by Subject|3|||
144299205|NCT03261505|520300672|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
144299206|NCT03261505|520300673|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
144299207|NCT03261505|520300674|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
144299208|NCT03261505|520300675|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
144299209|NCT03261505|520300672|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
144299210|NCT03261505|520300673|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
144299211|NCT03261505|520300674|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
144299212|NCT03261505|520300675|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
144299213|NCT03261505|520300672|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
144299214|NCT03261505|520300673|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
144299215|NCT03261505|520300674|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
144299216|NCT03261505|520300675|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
144299217|NCT03773484|520300676|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
144299218|NCT05552859|520300677|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
144299219|NCT05552859|520300678|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
144299220|NCT04251533|520300679|FG000|Overall Study|Progressive disease|33|||
144299221|NCT04251533|520300680|FG001|Overall Study|Progressive disease|29|||
144299222|NCT04251533|520300681|FG002|Overall Study|Progressive disease|22|||
144299223|NCT04251533|520300679|FG000|Overall Study|Death|5|||
144299224|NCT04251533|520300680|FG001|Overall Study|Death|1|||
144299225|NCT04251533|520300681|FG002|Overall Study|Death|3|||
144299226|NCT04251533|520300679|FG000|Overall Study|Physician Decision|3|||
144299227|NCT04251533|520300680|FG001|Overall Study|Physician Decision|2|||
144299228|NCT04251533|520300681|FG002|Overall Study|Physician Decision|4|||
144299229|NCT04251533|520300679|FG000|Overall Study|Participant decision|1|||
144299230|NCT04251533|520300680|FG001|Overall Study|Participant decision|3|||
144299231|NCT04251533|520300681|FG002|Overall Study|Participant decision|1|||
144299232|NCT04251533|520300679|FG000|Overall Study|Adverse Event|2|||
144299233|NCT04251533|520300680|FG001|Overall Study|Adverse Event|1|||
144299234|NCT04251533|520300681|FG002|Overall Study|Adverse Event|1|||
144299235|NCT00210132|520300684|FG000|Overall Study|Protocol Violation|1|||
144299236|NCT00210132|520300685|FG001|Overall Study|Protocol Violation|4|||
144299237|NCT02711202|520300686|FG000|Overall Study|Adverse Event|3|||
144299238|NCT02711202|520300687|FG001|Overall Study|Adverse Event|0|||
144299239|NCT02711202|520300686|FG000|Overall Study|graft loss|1|||
144299240|NCT02711202|520300687|FG001|Overall Study|graft loss|0|||
144299241|NCT00432965|520300688|FG000|Overall Study|Lost to Follow-up|22|||
144299242|NCT00432965|520300689|FG001|Overall Study|Lost to Follow-up|19|||
144299243|NCT00432965|520300688|FG000|Overall Study|Withdrawal by Subject|13|||
144299244|NCT00432965|520300689|FG001|Overall Study|Withdrawal by Subject|13|||
144299245|NCT00432965|520300688|FG000|Overall Study|Physician Decision|14|||
144299246|NCT00432965|520300689|FG001|Overall Study|Physician Decision|13|||
144299247|NCT00432965|520300688|FG000|Overall Study|Lack of Efficacy|8|||
144299248|NCT00432965|520300689|FG001|Overall Study|Lack of Efficacy|13|||
144299249|NCT00432965|520300688|FG000|Overall Study|Non-compliance|7|||
144299250|NCT00432965|520300689|FG001|Overall Study|Non-compliance|0|||
144299251|NCT00432965|520300688|FG000|Overall Study|Adverse Event|22|||
144299252|NCT00432965|520300689|FG001|Overall Study|Adverse Event|19|||
144299253|NCT00432965|520300688|FG000|Overall Study|Death|3|||
144299254|NCT00432965|520300689|FG001|Overall Study|Death|4|||
144299255|NCT00432965|520300688|FG000|Overall Study|Exclusionary Methods|1|||
144299256|NCT00432965|520300689|FG001|Overall Study|Exclusionary Methods|2|||
144299257|NCT00432965|520300688|FG000|Overall Study|Incomplete Data|4|||
144299258|NCT00432965|520300689|FG001|Overall Study|Incomplete Data|3|||
144299259|NCT03189719|520300692|FG000|Overall Study|Death|325|||
144299260|NCT03189719|520300693|FG001|Overall Study|Death|361|||
144299261|NCT03189719|520300692|FG000|Overall Study|Physician Decision|1|||
144299262|NCT03189719|520300693|FG001|Overall Study|Physician Decision|0|||
144299263|NCT03189719|520300692|FG000|Overall Study|Sponsor Decision|40|||
144299264|NCT03189719|520300693|FG001|Overall Study|Sponsor Decision|12|||
144299265|NCT03189719|520300692|FG000|Overall Study|Withdrawal by Subject|7|||
144299266|NCT03189719|520300693|FG001|Overall Study|Withdrawal by Subject|3|||
144299267|NCT03330847|520300696|FG000|Overall Study|Patients ongoing study|62|||
144299268|NCT03330847|520300697|FG001|Overall Study|Patients ongoing study|65|||
144299269|NCT03330847|520300698|FG002|Overall Study|Patients ongoing study|15|||
144299270|NCT05211596|520300701|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
144299271|NCT05211596|520300701|FG000|Baseline to 6 Months|Death|1|||
144299272|NCT05211596|520300701|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
144299273|NCT05211596|520300701|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
144299274|NCT04522973|520300702|FG000|Overall Study|Lost to Follow-up|4|||
144299275|NCT04522973|520300702|FG000|Overall Study|Could not adhere to study schedule|1|||
144299276|NCT04043286|520302562|FG000|Overall Study|Withdrawal by Subject|2|||
144299277|NCT04043286|520302563|FG001|Overall Study|Withdrawal by Subject|2|||
144299278|NCT03698279|520302564|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144299279|NCT03698279|520302565|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144299280|NCT03698279|520302566|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144299281|NCT03698279|520302567|FG003|Overall Study|Withdrawal by parent/guardian|1|||
144299282|NCT03698279|520302568|FG004|Overall Study|Withdrawal by parent/guardian|0|||
144299283|NCT03698279|520302569|FG005|Overall Study|Withdrawal by parent/guardian|0|||
144299284|NCT03698279|520302564|FG000|Overall Study|Protocol deviation|1|||
144299285|NCT03698279|520302565|FG001|Overall Study|Protocol deviation|0|||
144299286|NCT03698279|520302566|FG002|Overall Study|Protocol deviation|1|||
144299287|NCT03698279|520302567|FG003|Overall Study|Protocol deviation|0|||
144299288|NCT03698279|520302568|FG004|Overall Study|Protocol deviation|0|||
144299289|NCT03698279|520302569|FG005|Overall Study|Protocol deviation|0|||
144299290|NCT03698279|520302564|FG000|Overall Study|Withdrawal by Subject|0|||
144299291|NCT03698279|520302565|FG001|Overall Study|Withdrawal by Subject|0|||
144299292|NCT03698279|520302566|FG002|Overall Study|Withdrawal by Subject|1|||
144299293|NCT03698279|520302567|FG003|Overall Study|Withdrawal by Subject|0|||
144299294|NCT03698279|520302568|FG004|Overall Study|Withdrawal by Subject|0|||
144299295|NCT03698279|520302569|FG005|Overall Study|Withdrawal by Subject|0|||
144299296|NCT03698279|520302564|FG000|Overall Study|Lost to Follow-up|3|||
144299297|NCT03698279|520302565|FG001|Overall Study|Lost to Follow-up|1|||
144299298|NCT03698279|520302566|FG002|Overall Study|Lost to Follow-up|4|||
144299299|NCT03698279|520302567|FG003|Overall Study|Lost to Follow-up|5|||
144299300|NCT03698279|520302568|FG004|Overall Study|Lost to Follow-up|0|||
144299301|NCT03698279|520302569|FG005|Overall Study|Lost to Follow-up|0|||
144299302|NCT02367456|520302575|FG000|Overall Study|Death|8|||
144299303|NCT02367456|520302576|FG001|Overall Study|Death|24|||
144299304|NCT02367456|520302577|FG002|Overall Study|Death|17|||
144299305|NCT02367456|520302575|FG000|Overall Study|Lost to Follow-up|1|||
144299306|NCT02367456|520302576|FG001|Overall Study|Lost to Follow-up|3|||
144299307|NCT02367456|520302577|FG002|Overall Study|Lost to Follow-up|1|||
144299308|NCT02367456|520302575|FG000|Overall Study|Other reason|3|||
144299309|NCT02367456|520302576|FG001|Overall Study|Other reason|3|||
144299310|NCT02367456|520302577|FG002|Overall Study|Other reason|9|||
144299311|NCT02367456|520302575|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
144299312|NCT02367456|520302576|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
144299313|NCT02367456|520302577|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
144299314|NCT00976456|520302578|FG000|Overall Study|Adverse Event|17|||
144299315|NCT00976456|520302579|FG001|Overall Study|Adverse Event|22|||
144299316|NCT00976456|520302578|FG000|Overall Study|Death|7|||
144299317|NCT00976456|520302579|FG001|Overall Study|Death|9|||
144299318|NCT00976456|520302578|FG000|Overall Study|Lack of Efficacy|5|||
144299319|NCT00976456|520302579|FG001|Overall Study|Lack of Efficacy|2|||
144299320|NCT00976456|520302578|FG000|Overall Study|Withdrawal by Subject|3|||
144299321|NCT00976456|520302579|FG001|Overall Study|Withdrawal by Subject|1|||
144299322|NCT00976456|520302578|FG000|Overall Study|screening failure, unknown|11|||
144299323|NCT00976456|520302579|FG001|Overall Study|screening failure, unknown|4|||
144299324|NCT02037529|520302580|FG000|Overall Study|Withdrawal by Subject|1|||
144299325|NCT02037529|520302581|FG001|Overall Study|Withdrawal by Subject|3|||
144299326|NCT02037529|520302580|FG000|Overall Study|Adverse Event|0|||
144299327|NCT02037529|520302581|FG001|Overall Study|Adverse Event|1|||
144299328|NCT00833690|520302587|FG000|Overall Study|Withdrawal by Subject|1|||
144299329|NCT00833690|520302588|FG001|Overall Study|Withdrawal by Subject|0|||
144299330|NCT00833690|520302589|FG002|Overall Study|Withdrawal by Subject|0|||
144299331|NCT00833690|520302587|FG000|Overall Study|Discontinued study drug|3|||
144299332|NCT00833690|520302588|FG001|Overall Study|Discontinued study drug|2|||
144299333|NCT00833690|520302589|FG002|Overall Study|Discontinued study drug|0|||
144299334|NCT01143402|520302596|FG000|Overall Study|Rapid clinical decline|1|||
144299335|NCT01143402|520302597|FG001|Overall Study|Rapid clinical decline|1|||
144299336|NCT01143402|520302598|FG002|Overall Study|Rapid clinical decline|0|||
144299337|NCT01143402|520302596|FG000|Overall Study|Not Treated|0|||
144299338|NCT01143402|520302597|FG001|Overall Study|Not Treated|0|||
144299339|NCT01143402|520302598|FG002|Overall Study|Not Treated|1|||
144299340|NCT04462471|520302599|FG000|Overall Study|Adverse Event|0|||
144299341|NCT04462471|520302600|FG001|Overall Study|Adverse Event|1|||
144299342|NCT04462471|520302601|FG002|Overall Study|Adverse Event|0|||
144299343|NCT04462471|520302602|FG003|Overall Study|Adverse Event|0|||
144299344|NCT04462471|520302599|FG000|Overall Study|Disease progression|1|||
144299345|NCT04462471|520302600|FG001|Overall Study|Disease progression|0|||
144299346|NCT04462471|520302601|FG002|Overall Study|Disease progression|0|||
144299347|NCT04462471|520302602|FG003|Overall Study|Disease progression|0|||
144299348|NCT00397540|520302607|FG000|Overall Study|short follow-up duration < 12 months|1|||
144299349|NCT00397540|520302608|FG001|Overall Study|short follow-up duration < 12 months|0|||
144299350|NCT00619866|520302609|FG000|Weeks 1 - 12|Adverse Event|0|||
144299351|NCT00619866|520302610|FG001|Weeks 1 - 12|Adverse Event|1|||
144299352|NCT00619866|520302611|FG002|Weeks 1 - 12|Adverse Event|2|||
144299353|NCT00619866|520302612|FG003|Weeks 1 - 12|Adverse Event|0|||
144299354|NCT00619866|520302613|FG004|Weeks 1 - 12|Adverse Event|0|||
144299355|NCT00619866|520302609|FG000|Weeks 1 - 12|Non-compliance|0|||
144299356|NCT00619866|520302610|FG001|Weeks 1 - 12|Non-compliance|0|||
144299357|NCT00619866|520302611|FG002|Weeks 1 - 12|Non-compliance|1|||
144299358|NCT00619866|520302612|FG003|Weeks 1 - 12|Non-compliance|0|||
144299359|NCT00619866|520302613|FG004|Weeks 1 - 12|Non-compliance|0|||
144299360|NCT00619866|520302609|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
144299361|NCT00619866|520302610|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
144299362|NCT00619866|520302611|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
144299363|NCT00619866|520302612|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
144299364|NCT00619866|520302613|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
144299365|NCT00619866|520302609|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
144299366|NCT00619866|520302610|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
144299367|NCT00619866|520302611|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
144299368|NCT00619866|520302612|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
144299369|NCT00619866|520302613|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
144299370|NCT00619866|520302609|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
144299371|NCT00619866|520302610|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
144299372|NCT00619866|520302611|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
144299373|NCT00619866|520302612|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
144299374|NCT00619866|520302613|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
144299375|NCT00619866|520302609|FG000|Weeks 1 - 12|Sponsor Decision|0|||
144299376|NCT00619866|520302610|FG001|Weeks 1 - 12|Sponsor Decision|1|||
144299377|NCT00619866|520302611|FG002|Weeks 1 - 12|Sponsor Decision|0|||
144299378|NCT00619866|520302612|FG003|Weeks 1 - 12|Sponsor Decision|0|||
144299379|NCT00619866|520302613|FG004|Weeks 1 - 12|Sponsor Decision|0|||
144299380|NCT00619866|520302609|FG000|Weeks 13 - 24|Adverse Event|0|||
144299381|NCT00619866|520302610|FG001|Weeks 13 - 24|Adverse Event|0|||
144299382|NCT00619866|520302611|FG002|Weeks 13 - 24|Adverse Event|2|||
144299383|NCT00619866|520302612|FG003|Weeks 13 - 24|Adverse Event|1|||
144299384|NCT00619866|520302613|FG004|Weeks 13 - 24|Adverse Event|0|||
144299385|NCT00619866|520302609|FG000|Weeks 13 - 24|Protocol Deviation|0|||
144299386|NCT00619866|520302610|FG001|Weeks 13 - 24|Protocol Deviation|0|||
144299387|NCT00619866|520302611|FG002|Weeks 13 - 24|Protocol Deviation|0|||
144299388|NCT00619866|520302612|FG003|Weeks 13 - 24|Protocol Deviation|1|||
144299389|NCT00619866|520302613|FG004|Weeks 13 - 24|Protocol Deviation|0|||
144299390|NCT00619866|520302609|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
144299391|NCT00619866|520302610|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
144299392|NCT00619866|520302611|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
144299393|NCT00619866|520302612|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
144299394|NCT00619866|520302613|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
144299395|NCT00619866|520302609|FG000|Weeks 13 - 24|Non-compliance|0|||
144299396|NCT00619866|520302610|FG001|Weeks 13 - 24|Non-compliance|1|||
144299397|NCT00619866|520302611|FG002|Weeks 13 - 24|Non-compliance|1|||
144299398|NCT00619866|520302612|FG003|Weeks 13 - 24|Non-compliance|0|||
144299399|NCT00619866|520302613|FG004|Weeks 13 - 24|Non-compliance|0|||
144299400|NCT00619866|520302609|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
144299401|NCT00619866|520302610|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
144299402|NCT00619866|520302611|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
144299403|NCT00619866|520302612|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
144299404|NCT00619866|520302613|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
144299405|NCT01215851|520302617|FG000|Treatment Period|Adverse Event|1|||
144299406|NCT01215851|520302618|FG001|Treatment Period|Adverse Event|1|||
144299407|NCT01215851|520302619|FG002|Treatment Period|Adverse Event|1|||
144299408|NCT01215851|520302620|FG003|Treatment Period|Adverse Event|3|||
144299409|NCT01215851|520302621|FG004|Treatment Period|Adverse Event|0|||
144299410|NCT01215851|520302622|FG005|Treatment Period|Adverse Event|1|||
144299411|NCT01215851|520302617|FG000|Follow up Period|Lost to Follow-up|0|||
144299412|NCT01215851|520302618|FG001|Follow up Period|Lost to Follow-up|0|||
144299413|NCT01215851|520302619|FG002|Follow up Period|Lost to Follow-up|0|||
144299414|NCT01215851|520302620|FG003|Follow up Period|Lost to Follow-up|0|||
144299415|NCT01215851|520302621|FG004|Follow up Period|Lost to Follow-up|0|||
144299416|NCT01215851|520302622|FG005|Follow up Period|Lost to Follow-up|1|||
144299417|NCT03510273|520302623|FG000|Overall Study|Withdrawal by Subject|2|||
144299418|NCT03510273|520302623|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
144299419|NCT03510273|520302623|FG000|Overall Study|Moved away from study area|4|||
144299420|NCT02589938|520302624|FG000|Overall Study|Withdrawal by Subject|11|||
144299421|NCT02589938|520302625|FG001|Overall Study|Withdrawal by Subject|5|||
144299422|NCT02589938|520302626|FG002|Overall Study|Withdrawal by Subject|6|||
144299423|NCT02589938|520302624|FG000|Overall Study|Lost to Follow-up|3|||
144299424|NCT02589938|520302625|FG001|Overall Study|Lost to Follow-up|3|||
144299425|NCT02589938|520302626|FG002|Overall Study|Lost to Follow-up|3|||
144299426|NCT02589938|520302624|FG000|Overall Study|Death|1|||
144299427|NCT02589938|520302625|FG001|Overall Study|Death|0|||
144299428|NCT02589938|520302626|FG002|Overall Study|Death|1|||
144299429|NCT02589938|520302624|FG000|Overall Study|Protocol Violation|6|||
144299430|NCT02589938|520302625|FG001|Overall Study|Protocol Violation|2|||
144299431|NCT02589938|520302626|FG002|Overall Study|Protocol Violation|3|||
144299432|NCT02589938|520302624|FG000|Overall Study|Physician Decision|1|||
144299433|NCT02589938|520302625|FG001|Overall Study|Physician Decision|0|||
144299434|NCT02589938|520302626|FG002|Overall Study|Physician Decision|0|||
144299435|NCT02589938|520302624|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
144299436|NCT02589938|520302625|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
144299437|NCT02589938|520302626|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
144299438|NCT01276106|520302627|FG000|Overall Study|Adverse Event|3|||
144299439|NCT01276106|520302628|FG001|Overall Study|Adverse Event|3|||
144299440|NCT01276106|520302629|FG002|Overall Study|Adverse Event|11|||
144299441|NCT01276106|520302630|FG003|Overall Study|Adverse Event|3|||
144299442|NCT01276106|520302627|FG000|Overall Study|Withdrawal by Subject|6|||
144299443|NCT01276106|520302628|FG001|Overall Study|Withdrawal by Subject|3|||
144299444|NCT01276106|520302629|FG002|Overall Study|Withdrawal by Subject|1|||
144299445|NCT01276106|520302630|FG003|Overall Study|Withdrawal by Subject|6|||
144299446|NCT01276106|520302627|FG000|Overall Study|Lack of Efficacy|0|||
144299447|NCT01276106|520302628|FG001|Overall Study|Lack of Efficacy|1|||
144299448|NCT01276106|520302629|FG002|Overall Study|Lack of Efficacy|0|||
144299449|NCT01276106|520302630|FG003|Overall Study|Lack of Efficacy|1|||
144299450|NCT01276106|520302627|FG000|Overall Study|Lost to Follow-up|2|||
144299451|NCT01276106|520302628|FG001|Overall Study|Lost to Follow-up|1|||
144299452|NCT01276106|520302629|FG002|Overall Study|Lost to Follow-up|1|||
144299453|NCT01276106|520302630|FG003|Overall Study|Lost to Follow-up|0|||
144299454|NCT01276106|520302627|FG000|Overall Study|Physician Decision|0|||
144299455|NCT01276106|520302628|FG001|Overall Study|Physician Decision|0|||
144299456|NCT01276106|520302629|FG002|Overall Study|Physician Decision|1|||
144299457|NCT01276106|520302630|FG003|Overall Study|Physician Decision|1|||
144299458|NCT01276106|520302627|FG000|Overall Study|Protocol Violation|1|||
144299459|NCT01276106|520302628|FG001|Overall Study|Protocol Violation|1|||
144299460|NCT01276106|520302629|FG002|Overall Study|Protocol Violation|0|||
144299461|NCT01276106|520302630|FG003|Overall Study|Protocol Violation|2|||
144299462|NCT01276106|520302627|FG000|Overall Study|Insufficient therapeutic effects|0|||
144299463|NCT01276106|520302628|FG001|Overall Study|Insufficient therapeutic effects|0|||
144299464|NCT01276106|520302629|FG002|Overall Study|Insufficient therapeutic effects|2|||
144299465|NCT01276106|520302630|FG003|Overall Study|Insufficient therapeutic effects|0|||
144299466|NCT01242514|520302633|FG000|Overall Study|e.g., project closure|1042|||
144299467|NCT01242514|520302634|FG001|Overall Study|e.g., project closure|305|||
144299468|NCT01242514|520302635|FG002|Overall Study|e.g., project closure|171|||
144299469|NCT01242514|520302633|FG000|Overall Study|Subject decision|33|||
144299470|NCT01242514|520302634|FG001|Overall Study|Subject decision|8|||
144299471|NCT01242514|520302635|FG002|Overall Study|Subject decision|2|||
144299472|NCT01242514|520302633|FG000|Overall Study|Severe non-compliance to protocol|5|||
144299473|NCT01242514|520302634|FG001|Overall Study|Severe non-compliance to protocol|2|||
144299474|NCT01242514|520302635|FG002|Overall Study|Severe non-compliance to protocol|1|||
144299475|NCT01242514|520302633|FG000|Overall Study|Lack of therapeutic response|99|||
144299476|NCT01242514|520302634|FG001|Overall Study|Lack of therapeutic response|16|||
144299477|NCT01242514|520302635|FG002|Overall Study|Lack of therapeutic response|10|||
144299478|NCT01242514|520302633|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
144299479|NCT01242514|520302634|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
144299480|NCT01242514|520302635|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
144299481|NCT01242514|520302633|FG000|Overall Study|Lost to Follow-up|14|||
144299482|NCT01242514|520302634|FG001|Overall Study|Lost to Follow-up|5|||
144299483|NCT01242514|520302635|FG002|Overall Study|Lost to Follow-up|4|||
144299484|NCT01242514|520302633|FG000|Overall Study|Adverse Event|129|||
144299485|NCT01242514|520302634|FG001|Overall Study|Adverse Event|18|||
144299486|NCT01242514|520302635|FG002|Overall Study|Adverse Event|19|||
144299487|NCT00862940|520302637|FG000|Overall Study|Adverse Event|15|||
144299488|NCT00862940|520302638|FG001|Overall Study|Adverse Event|12|||
144299489|NCT00862940|520302637|FG000|Overall Study|Lack of Efficacy|1|||
144299490|NCT00862940|520302638|FG001|Overall Study|Lack of Efficacy|3|||
144299491|NCT00862940|520302637|FG000|Overall Study|Protocol Violation|2|||
144299492|NCT00862940|520302638|FG001|Overall Study|Protocol Violation|5|||
144299493|NCT00862940|520302637|FG000|Overall Study|Withdrawal by Subject|4|||
144299494|NCT00862940|520302638|FG001|Overall Study|Withdrawal by Subject|6|||
144299495|NCT00862940|520302637|FG000|Overall Study|Non-compliance|4|||
144299496|NCT00862940|520302638|FG001|Overall Study|Non-compliance|0|||
144299497|NCT00862940|520302637|FG000|Overall Study|Lost to Follow-up|0|||
144299498|NCT00862940|520302638|FG001|Overall Study|Lost to Follow-up|1|||
144299499|NCT00862940|520302637|FG000|Overall Study|Administrative or other reason(s)|4|||
144299500|NCT00862940|520302638|FG001|Overall Study|Administrative or other reason(s)|3|||
144299501|NCT00879398|520302639|FG000|Overall Study|Visit Stop|399|||
144299502|NCT00879398|520302639|FG000|Overall Study|Lack of Efficacy|64|||
144299503|NCT00879398|520302639|FG000|Overall Study|Adverse Event|41|||
144299504|NCT00879398|520302639|FG000|Overall Study|Other Reasons|171|||
144299505|NCT01121757|520302643|FG000|First Drug|Death|1|||
144299506|NCT01121757|520302644|FG001|First Drug|Death|0|||
144299507|NCT01121757|520302643|FG000|First Drug|Disease Progression|0|||
144299508|NCT01121757|520302644|FG001|First Drug|Disease Progression|2|||
144299509|NCT01121757|520302643|FG000|Combination|Physician Decision|0|||
144299510|NCT01121757|520302644|FG001|Combination|Physician Decision|1|||
144299511|NCT01121757|520302643|FG000|Combination|Disease Progression|2|||
144299512|NCT01121757|520302644|FG001|Combination|Disease Progression|0|||
144299513|NCT01380080|520302663|FG000|Overall Study|Death|36|||
144299514|NCT01380080|520302664|FG001|Overall Study|Death|44|||
144299515|NCT01380080|520302663|FG000|Overall Study|Site is closing|28|||
144299516|NCT01380080|520302664|FG001|Overall Study|Site is closing|31|||
144299517|NCT01380080|520302663|FG000|Overall Study|Not able to get to clinic|7|||
144299518|NCT01380080|520302664|FG001|Overall Study|Not able to get to clinic|1|||
144299519|NCT01380080|520302663|FG000|Overall Study|Not willing to adhere to requirements|6|||
144299520|NCT01380080|520302664|FG001|Overall Study|Not willing to adhere to requirements|2|||
144299521|NCT01380080|520302663|FG000|Overall Study|Withdrawal by Subject|5|||
144299522|NCT01380080|520302664|FG001|Overall Study|Withdrawal by Subject|2|||
144299523|NCT01380080|520302663|FG000|Overall Study|Lost to Follow-up|3|||
144299524|NCT01380080|520302664|FG001|Overall Study|Lost to Follow-up|3|||
144299525|NCT05901636|520302665|FG000|Overall Study|Lost to Follow-up|0|||
144299526|NCT05901636|520302666|FG001|Overall Study|Lost to Follow-up|1|||
144299527|NCT05901636|520302667|FG002|Overall Study|Lost to Follow-up|0|||
144299528|NCT05901636|520302668|FG003|Overall Study|Lost to Follow-up|1|||
144299529|NCT05901636|520302669|FG004|Overall Study|Lost to Follow-up|1|||
144299530|NCT05901636|520302670|FG005|Overall Study|Lost to Follow-up|3|||
144299531|NCT05901636|520302671|FG006|Overall Study|Lost to Follow-up|1|||
144299532|NCT05901636|520302665|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
144299533|NCT05901636|520302666|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
144299534|NCT05901636|520302667|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
144299535|NCT05901636|520302668|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
144299536|NCT05901636|520302669|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
144299537|NCT05901636|520302670|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
144299538|NCT05901636|520302671|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
144299539|NCT05901636|520302665|FG000|Overall Study|Withdrawal by Subject|1|||
144299540|NCT05901636|520302666|FG001|Overall Study|Withdrawal by Subject|1|||
144299541|NCT05901636|520302667|FG002|Overall Study|Withdrawal by Subject|0|||
144299542|NCT05901636|520302668|FG003|Overall Study|Withdrawal by Subject|0|||
144299543|NCT05901636|520302669|FG004|Overall Study|Withdrawal by Subject|1|||
144299544|NCT05901636|520302670|FG005|Overall Study|Withdrawal by Subject|1|||
144299545|NCT05901636|520302671|FG006|Overall Study|Withdrawal by Subject|0|||
144299546|NCT05901636|520302665|FG000|Overall Study|Other|0|||
144299547|NCT05901636|520302666|FG001|Overall Study|Other|0|||
144299548|NCT05901636|520302667|FG002|Overall Study|Other|1|||
144299549|NCT05901636|520302668|FG003|Overall Study|Other|1|||
144299550|NCT05901636|520302669|FG004|Overall Study|Other|0|||
144299551|NCT05901636|520302670|FG005|Overall Study|Other|0|||
144299552|NCT05901636|520302671|FG006|Overall Study|Other|0|||
144299553|NCT02303821|520302672|FG000|Overall Study|Withdrawal by Subject|0|||
144299554|NCT02303821|520302673|FG001|Overall Study|Withdrawal by Subject|0|||
144299555|NCT02303821|520302674|FG002|Overall Study|Withdrawal by Subject|0|||
144299556|NCT02303821|520302675|FG003|Overall Study|Withdrawal by Subject|0|||
144360010|NCT01601535|520525138|FG003|Phase 1|Progressive Disease|1|||
144299557|NCT02303821|520302676|FG004|Overall Study|Withdrawal by Subject|0|||
144299558|NCT02303821|520302677|FG005|Overall Study|Withdrawal by Subject|0|||
144299559|NCT02303821|520302678|FG006|Overall Study|Withdrawal by Subject|0|||
144299560|NCT02303821|520302679|FG007|Overall Study|Withdrawal by Subject|2|||
144299561|NCT02303821|520302672|FG000|Overall Study|Death|0|||
144299562|NCT02303821|520302673|FG001|Overall Study|Death|2|||
144299563|NCT02303821|520302674|FG002|Overall Study|Death|0|||
144299564|NCT02303821|520302675|FG003|Overall Study|Death|0|||
144299565|NCT02303821|520302676|FG004|Overall Study|Death|0|||
144299566|NCT02303821|520302677|FG005|Overall Study|Death|3|||
144299567|NCT02303821|520302678|FG006|Overall Study|Death|41|||
144299568|NCT02303821|520302679|FG007|Overall Study|Death|29|||
144299569|NCT02303821|520302672|FG000|Overall Study|Lost to Follow-up|0|||
144299570|NCT02303821|520302673|FG001|Overall Study|Lost to Follow-up|0|||
144299571|NCT02303821|520302674|FG002|Overall Study|Lost to Follow-up|0|||
144299572|NCT02303821|520302675|FG003|Overall Study|Lost to Follow-up|0|||
144299573|NCT02303821|520302676|FG004|Overall Study|Lost to Follow-up|0|||
144299574|NCT02303821|520302677|FG005|Overall Study|Lost to Follow-up|0|||
144299575|NCT02303821|520302678|FG006|Overall Study|Lost to Follow-up|1|||
144299576|NCT02303821|520302679|FG007|Overall Study|Lost to Follow-up|0|||
144299577|NCT02303821|520302672|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299578|NCT02303821|520302673|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299579|NCT02303821|520302674|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299580|NCT02303821|520302675|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299581|NCT02303821|520302676|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299582|NCT02303821|520302677|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299583|NCT02303821|520302678|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
144299584|NCT02303821|520302679|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
144299585|NCT02303821|520302672|FG000|Overall Study|Decision by sponsor|0|||
144299586|NCT02303821|520302673|FG001|Overall Study|Decision by sponsor|0|||
144299587|NCT02303821|520302674|FG002|Overall Study|Decision by sponsor|0|||
144299588|NCT02303821|520302675|FG003|Overall Study|Decision by sponsor|0|||
144299589|NCT02303821|520302676|FG004|Overall Study|Decision by sponsor|0|||
144299590|NCT02303821|520302677|FG005|Overall Study|Decision by sponsor|1|||
144299591|NCT02303821|520302678|FG006|Overall Study|Decision by sponsor|0|||
144299592|NCT02303821|520302679|FG007|Overall Study|Decision by sponsor|0|||
144299593|NCT02303821|520302672|FG000|Overall Study|Protocol-specified criteria|0|||
144299594|NCT02303821|520302673|FG001|Overall Study|Protocol-specified criteria|1|||
144299595|NCT02303821|520302674|FG002|Overall Study|Protocol-specified criteria|0|||
144299596|NCT02303821|520302675|FG003|Overall Study|Protocol-specified criteria|0|||
144299597|NCT02303821|520302676|FG004|Overall Study|Protocol-specified criteria|0|||
144299598|NCT02303821|520302677|FG005|Overall Study|Protocol-specified criteria|1|||
144299599|NCT02303821|520302678|FG006|Overall Study|Protocol-specified criteria|0|||
144299600|NCT02303821|520302679|FG007|Overall Study|Protocol-specified criteria|0|||
144299601|NCT04583618|520302685|FG000|Overall Study|Adverse Event|0|||
144299602|NCT04583618|520302686|FG001|Overall Study|Adverse Event|0|||
144299603|NCT04583618|520302687|FG002|Overall Study|Adverse Event|1|||
144299604|NCT04583618|520302688|FG003|Overall Study|Adverse Event|0|||
144299605|NCT04583618|520302689|FG004|Overall Study|Adverse Event|0|||
144299606|NCT04583618|520302685|FG000|Overall Study|Protocol deviation|1|||
144299607|NCT04583618|520302686|FG001|Overall Study|Protocol deviation|1|||
144299608|NCT04583618|520302687|FG002|Overall Study|Protocol deviation|1|||
144299609|NCT04583618|520302688|FG003|Overall Study|Protocol deviation|0|||
144299610|NCT04583618|520302689|FG004|Overall Study|Protocol deviation|0|||
144299611|NCT04583618|520302685|FG000|Overall Study|Withdrawal by Subject|2|||
144299612|NCT04583618|520302686|FG001|Overall Study|Withdrawal by Subject|1|||
144299613|NCT04583618|520302687|FG002|Overall Study|Withdrawal by Subject|3|||
144299614|NCT04583618|520302688|FG003|Overall Study|Withdrawal by Subject|1|||
144299615|NCT04583618|520302689|FG004|Overall Study|Withdrawal by Subject|1|||
144299616|NCT04583618|520302685|FG000|Overall Study|Lost to Follow-up|0|||
144299617|NCT04583618|520302686|FG001|Overall Study|Lost to Follow-up|1|||
144299618|NCT04583618|520302687|FG002|Overall Study|Lost to Follow-up|3|||
144299619|NCT04583618|520302688|FG003|Overall Study|Lost to Follow-up|1|||
144299620|NCT04583618|520302689|FG004|Overall Study|Lost to Follow-up|1|||
144299621|NCT02302222|520302694|FG000|Overall Study|Physician Decision|0|||
144299622|NCT02302222|520302695|FG001|Overall Study|Physician Decision|4|||
144299623|NCT02302222|520302694|FG000|Overall Study|Lost to Follow-up|1|||
144299624|NCT02302222|520302695|FG001|Overall Study|Lost to Follow-up|0|||
144299625|NCT02302222|520302694|FG000|Overall Study|Treatment discontinued before day 5|0|||
144299626|NCT02302222|520302695|FG001|Overall Study|Treatment discontinued before day 5|1|||
144299627|NCT02302222|520302694|FG000|Overall Study|Withdrawn prior to any treatment|0|||
144299628|NCT02302222|520302695|FG001|Overall Study|Withdrawn prior to any treatment|1|||
144299629|NCT03193801|520302696|FG000|Overall Study|Physician Decision|2|||
144299630|NCT03193801|520302696|FG000|Overall Study|Withdrawal by Subject|1|||
144299631|NCT03138564|520302697|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
144299632|NCT03138564|520302698|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
144299633|NCT03138564|520302697|FG000|Overall Study|Lost to Follow-up|16|||
144299634|NCT03138564|520302698|FG001|Overall Study|Lost to Follow-up|2|||
144299635|NCT03138564|520302697|FG000|Overall Study|Withdrawal by Subject|48|||
144299636|NCT03138564|520302698|FG001|Overall Study|Withdrawal by Subject|4|||
144299637|NCT03138564|520302697|FG000|Overall Study|No longer met eligibility criteria|2|||
144299638|NCT03138564|520302698|FG001|Overall Study|No longer met eligibility criteria|0|||
144299639|NCT03138564|520302697|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
144299640|NCT03138564|520302698|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
144299641|NCT03138564|520302697|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
144299642|NCT03138564|520302698|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
144299643|NCT03138564|520302697|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
144299644|NCT03138564|520302698|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
144299645|NCT03138564|520302697|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
144299646|NCT03138564|520302698|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
144299647|NCT03909971|520302700|FG000|Overall Study|Participant transition to rollover study|26|||
144299648|NCT03909971|520302701|FG001|Overall Study|Participant transition to rollover study|9|||
144299649|NCT03909971|520302700|FG000|Overall Study|Global Deterioration of Health Status|2|||
144299650|NCT03909971|520302701|FG001|Overall Study|Global Deterioration of Health Status|2|||
144299651|NCT03909971|520302700|FG000|Overall Study|Progressive Disease|28|||
144299652|NCT03909971|520302701|FG001|Overall Study|Progressive Disease|21|||
144299653|NCT03909971|520302700|FG000|Overall Study|Death|6|||
144299654|NCT03909971|520302701|FG001|Overall Study|Death|6|||
144299655|NCT03909971|520302700|FG000|Overall Study|Adverse Event|1|||
144299656|NCT03909971|520302701|FG001|Overall Study|Adverse Event|2|||
144299657|NCT03909971|520302700|FG000|Overall Study|Withdrawal by Subject|2|||
144299658|NCT03909971|520302701|FG001|Overall Study|Withdrawal by Subject|1|||
144299659|NCT03909971|520302700|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
144299660|NCT03909971|520302701|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
144299661|NCT03909971|520302700|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
144299662|NCT03909971|520302701|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
144299663|NCT05177354|520302702|FG000|Implant to 30-day Visit|Physician Decision|1|||
144299664|NCT05177354|520302702|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
144299665|NCT05177354|520302702|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
144299666|NCT05177354|520302702|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
144299667|NCT03734536|520302703|FG000|Overall Study|Withdrew Consent|1|||
144299668|NCT03734536|520302704|FG001|Overall Study|Withdrew Consent|5|||
144299669|NCT03734536|520302703|FG000|Overall Study|Lost to Follow-up|10|||
144299670|NCT03734536|520302704|FG001|Overall Study|Lost to Follow-up|7|||
144299671|NCT06028464|520302708|FG000|Washout|Positive drug test.|1|||
144299672|NCT02769481|520302709|FG000|Overall Study|Protocol Violation|1|||
144299673|NCT02769481|520302710|FG001|Overall Study|Protocol Violation|0|||
144299674|NCT02769481|520302709|FG000|Overall Study|Adverse Event|3|||
144299675|NCT02769481|520302710|FG001|Overall Study|Adverse Event|6|||
144299676|NCT02769481|520302709|FG000|Overall Study|Entry Criteria Not Met|1|||
144299677|NCT02769481|520302710|FG001|Overall Study|Entry Criteria Not Met|2|||
144299678|NCT02769481|520302709|FG000|Overall Study|Withdrawal by Subject|14|||
144299679|NCT02769481|520302710|FG001|Overall Study|Withdrawal by Subject|16|||
144299680|NCT02769481|520302709|FG000|Overall Study|Lost to Follow-up|9|||
144299681|NCT02769481|520302710|FG001|Overall Study|Lost to Follow-up|9|||
144299682|NCT02769481|520302709|FG000|Overall Study|Physician Decision|0|||
144299683|NCT02769481|520302710|FG001|Overall Study|Physician Decision|1|||
144299684|NCT02769481|520302709|FG000|Overall Study|Terminated by Sponsor|1|||
144299685|NCT02769481|520302710|FG001|Overall Study|Terminated by Sponsor|0|||
144299686|NCT02769481|520302709|FG000|Overall Study|Death|0|||
144299687|NCT02769481|520302710|FG001|Overall Study|Death|1|||
144299688|NCT02769481|520302709|FG000|Overall Study|Undefined|4|||
144299689|NCT02769481|520302710|FG001|Overall Study|Undefined|1|||
144299690|NCT06272383|520302713|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
144299691|NCT06272383|520302714|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
144299692|NCT04398706|520302715|FG000|Overall Study|Adverse Event|0|||
144299693|NCT04398706|520302716|FG001|Overall Study|Adverse Event|0|||
144299694|NCT04398706|520302717|FG002|Overall Study|Adverse Event|0|||
144299695|NCT04398706|520302718|FG003|Overall Study|Adverse Event|0|||
144299696|NCT04398706|520302719|FG004|Overall Study|Adverse Event|0|||
144299697|NCT04398706|520302720|FG005|Overall Study|Adverse Event|1|||
144299698|NCT04398706|520302721|FG006|Overall Study|Adverse Event|1|||
144299699|NCT04398706|520302722|FG007|Overall Study|Adverse Event|0|||
144299700|NCT04398706|520302715|FG000|Overall Study|Lost to Follow-up|0|||
144299701|NCT04398706|520302716|FG001|Overall Study|Lost to Follow-up|1|||
144299702|NCT04398706|520302717|FG002|Overall Study|Lost to Follow-up|2|||
144299703|NCT04398706|520302718|FG003|Overall Study|Lost to Follow-up|1|||
144299704|NCT04398706|520302719|FG004|Overall Study|Lost to Follow-up|6|||
144299705|NCT04398706|520302720|FG005|Overall Study|Lost to Follow-up|3|||
144299706|NCT04398706|520302721|FG006|Overall Study|Lost to Follow-up|8|||
144299707|NCT04398706|520302722|FG007|Overall Study|Lost to Follow-up|2|||
144299708|NCT04398706|520302715|FG000|Overall Study|Withdrawal by parent/guardian|0|||
144299709|NCT04398706|520302716|FG001|Overall Study|Withdrawal by parent/guardian|2|||
144299710|NCT04398706|520302717|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144299711|NCT04398706|520302718|FG003|Overall Study|Withdrawal by parent/guardian|2|||
144299712|NCT04398706|520302719|FG004|Overall Study|Withdrawal by parent/guardian|19|||
144299713|NCT04398706|520302720|FG005|Overall Study|Withdrawal by parent/guardian|23|||
144299714|NCT04398706|520302721|FG006|Overall Study|Withdrawal by parent/guardian|13|||
144299715|NCT04398706|520302722|FG007|Overall Study|Withdrawal by parent/guardian|11|||
144299716|NCT04398706|520302715|FG000|Overall Study|Protocol deviation|0|||
144299717|NCT04398706|520302716|FG001|Overall Study|Protocol deviation|1|||
144299718|NCT04398706|520302717|FG002|Overall Study|Protocol deviation|0|||
144299719|NCT04398706|520302718|FG003|Overall Study|Protocol deviation|0|||
144299720|NCT04398706|520302719|FG004|Overall Study|Protocol deviation|6|||
144299721|NCT04398706|520302720|FG005|Overall Study|Protocol deviation|4|||
144299722|NCT04398706|520302721|FG006|Overall Study|Protocol deviation|6|||
144299723|NCT04398706|520302722|FG007|Overall Study|Protocol deviation|3|||
144299724|NCT01346176|520302724|FG000|Recruited|Protocol Violation|1|||
144299725|NCT01346176|520302725|FG001|Recruited|Protocol Violation|0|||
144299726|NCT01346176|520302726|FG002|Recruited|Protocol Violation|0|||
144299727|NCT01346176|520302724|FG000|Completed Advance Directive|Death|3|||
144299728|NCT01346176|520302725|FG001|Completed Advance Directive|Death|2|||
144299729|NCT01346176|520302726|FG002|Completed Advance Directive|Death|2|||
144299730|NCT01346176|520302724|FG000|Completed Advance Directive|Became Ineligible|3|||
144299731|NCT01346176|520302725|FG001|Completed Advance Directive|Became Ineligible|0|||
144299732|NCT01346176|520302726|FG002|Completed Advance Directive|Became Ineligible|1|||
144299733|NCT01346176|520302724|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
144299734|NCT01346176|520302725|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
144299735|NCT01346176|520302726|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
144299736|NCT01346176|520302724|FG000|Completed Satisfaction Survey|Death|3|||
144299737|NCT01346176|520302725|FG001|Completed Satisfaction Survey|Death|0|||
144299738|NCT01346176|520302726|FG002|Completed Satisfaction Survey|Death|2|||
144299739|NCT01346176|520302724|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
144299740|NCT01346176|520302725|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
144299741|NCT01346176|520302726|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
144299742|NCT05489328|520303790|FG000|Overall Study|Lost to Follow-up|0|||
144299743|NCT05489328|520303791|FG001|Overall Study|Lost to Follow-up|0|||
144299744|NCT05489328|520303792|FG002|Overall Study|Lost to Follow-up|1|||
144299745|NCT05489328|520303793|FG003|Overall Study|Lost to Follow-up|0|||
144299746|NCT05489328|520303794|FG004|Overall Study|Lost to Follow-up|2|||
144299747|NCT05489328|520303795|FG005|Overall Study|Lost to Follow-up|0|||
144299748|NCT05489328|520303796|FG006|Overall Study|Lost to Follow-up|0|||
144299749|NCT05489328|520303797|FG007|Overall Study|Lost to Follow-up|1|||
144299750|NCT05489328|520303798|FG008|Overall Study|Lost to Follow-up|0|||
144299751|NCT05489328|520303790|FG000|Overall Study|Withdrawal by Subject|0|||
144299752|NCT05489328|520303791|FG001|Overall Study|Withdrawal by Subject|0|||
144299753|NCT05489328|520303792|FG002|Overall Study|Withdrawal by Subject|0|||
144299754|NCT05489328|520303793|FG003|Overall Study|Withdrawal by Subject|0|||
144299755|NCT05489328|520303794|FG004|Overall Study|Withdrawal by Subject|0|||
144299756|NCT05489328|520303795|FG005|Overall Study|Withdrawal by Subject|0|||
144299757|NCT05489328|520303796|FG006|Overall Study|Withdrawal by Subject|1|||
144299758|NCT05489328|520303797|FG007|Overall Study|Withdrawal by Subject|1|||
144299759|NCT05489328|520303798|FG008|Overall Study|Withdrawal by Subject|0|||
144299760|NCT05489328|520303790|FG000|Overall Study|Other|0|||
144299761|NCT05489328|520303791|FG001|Overall Study|Other|0|||
144299762|NCT05489328|520303792|FG002|Overall Study|Other|0|||
144299763|NCT05489328|520303793|FG003|Overall Study|Other|0|||
144299764|NCT05489328|520303794|FG004|Overall Study|Other|0|||
144299765|NCT05489328|520303795|FG005|Overall Study|Other|0|||
144299766|NCT05489328|520303796|FG006|Overall Study|Other|0|||
144299767|NCT05489328|520303797|FG007|Overall Study|Other|1|||
144299768|NCT05489328|520303798|FG008|Overall Study|Other|1|||
144299769|NCT01083602|520303799|FG000|Overall Study|Adverse Event|11|||
144299770|NCT01083602|520303799|FG000|Overall Study|New Cancer Therapy|2|||
144299771|NCT01083602|520303799|FG000|Overall Study|Death|1|||
144299772|NCT01083602|520303799|FG000|Overall Study|Withdrawal by Subject|5|||
144299773|NCT01083602|520303799|FG000|Overall Study|Lack of Efficacy|36|||
144299774|NCT01657370|520303800|FG000|Overall Study|Withdrawal by Subject|0|||
144299775|NCT01657370|520303801|FG001|Overall Study|Withdrawal by Subject|0|||
144299776|NCT01657370|520303802|FG002|Overall Study|Withdrawal by Subject|1|||
144299777|NCT01657370|520303803|FG003|Overall Study|Withdrawal by Subject|0|||
144299778|NCT01657370|520303804|FG004|Overall Study|Withdrawal by Subject|0|||
144299779|NCT01657370|520303805|FG005|Overall Study|Withdrawal by Subject|1|||
144299780|NCT01657370|520303800|FG000|Overall Study|Physician Decision|2|||
144299781|NCT01657370|520303801|FG001|Overall Study|Physician Decision|3|||
144299782|NCT01657370|520303802|FG002|Overall Study|Physician Decision|1|||
144299783|NCT01657370|520303803|FG003|Overall Study|Physician Decision|2|||
144299784|NCT01657370|520303804|FG004|Overall Study|Physician Decision|5|||
144299785|NCT01657370|520303805|FG005|Overall Study|Physician Decision|0|||
144299786|NCT01657370|520303800|FG000|Overall Study|Lack of Qualifying Event|1|||
144299787|NCT01657370|520303801|FG001|Overall Study|Lack of Qualifying Event|0|||
144299788|NCT01657370|520303802|FG002|Overall Study|Lack of Qualifying Event|3|||
144299789|NCT01657370|520303803|FG003|Overall Study|Lack of Qualifying Event|2|||
144299790|NCT01657370|520303804|FG004|Overall Study|Lack of Qualifying Event|1|||
144299791|NCT01657370|520303805|FG005|Overall Study|Lack of Qualifying Event|2|||
144299792|NCT01657370|520303800|FG000|Overall Study|Adverse Event|0|||
144299793|NCT01657370|520303801|FG001|Overall Study|Adverse Event|0|||
144299794|NCT01657370|520303802|FG002|Overall Study|Adverse Event|0|||
144299795|NCT01657370|520303803|FG003|Overall Study|Adverse Event|0|||
144299796|NCT01657370|520303804|FG004|Overall Study|Adverse Event|1|||
144299797|NCT01657370|520303805|FG005|Overall Study|Adverse Event|0|||
144299798|NCT01657370|520303800|FG000|Overall Study|Protocol Violation|1|||
144299799|NCT01657370|520303801|FG001|Overall Study|Protocol Violation|1|||
144299800|NCT01657370|520303802|FG002|Overall Study|Protocol Violation|1|||
144299801|NCT01657370|520303803|FG003|Overall Study|Protocol Violation|1|||
144299802|NCT01657370|520303804|FG004|Overall Study|Protocol Violation|0|||
144299803|NCT01657370|520303805|FG005|Overall Study|Protocol Violation|0|||
144299804|NCT01657370|520303800|FG000|Overall Study|Lost to Follow-up|2|||
144299805|NCT01657370|520303801|FG001|Overall Study|Lost to Follow-up|0|||
144299806|NCT01657370|520303802|FG002|Overall Study|Lost to Follow-up|1|||
144299807|NCT01657370|520303803|FG003|Overall Study|Lost to Follow-up|0|||
144299808|NCT01657370|520303804|FG004|Overall Study|Lost to Follow-up|0|||
144299809|NCT01657370|520303805|FG005|Overall Study|Lost to Follow-up|1|||
144299810|NCT03021486|520303806|FG000|Overall Study|Withdrawal by Subject|1|||
144299811|NCT03021486|520303807|FG001|Overall Study|Withdrawal by Subject|1|||
144299812|NCT03021486|520303808|FG002|Overall Study|Withdrawal by Subject|3|||
144299813|NCT03021486|520303806|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
144299814|NCT03021486|520303807|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
144299815|NCT03021486|520303808|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
144299816|NCT00582907|520303809|FG000|1st Course|Withdrawal by Subject|1|||
144299817|NCT00582907|520303810|FG001|1st Course|Withdrawal by Subject|0|||
144299818|NCT00582907|520303811|FG002|1st Course|Withdrawal by Subject|0|||
144299819|NCT00582907|520303812|FG003|1st Course|Withdrawal by Subject|0|||
144299820|NCT00582907|520303809|FG000|1st Course|Lost to Follow-up|0|||
144299821|NCT00582907|520303810|FG001|1st Course|Lost to Follow-up|0|||
144299822|NCT00582907|520303811|FG002|1st Course|Lost to Follow-up|0|||
144299823|NCT00582907|520303812|FG003|1st Course|Lost to Follow-up|1|||
144299824|NCT00582907|520303809|FG000|2nd Course|Lack of Efficacy|1|||
144299825|NCT00582907|520303810|FG001|2nd Course|Lack of Efficacy|0|||
144299826|NCT00582907|520303811|FG002|2nd Course|Lack of Efficacy|0|||
144299827|NCT00582907|520303812|FG003|2nd Course|Lack of Efficacy|0|||
144299828|NCT01441960|520303813|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
144299829|NCT01441960|520303814|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
144299830|NCT01441960|520303813|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
144299831|NCT01441960|520303814|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
144299832|NCT01441960|520303813|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
144299833|NCT01441960|520303814|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
144299834|NCT00069641|520303816|FG000|Overall Study|Death|1|||
144299835|NCT00069641|520303817|FG001|Overall Study|Death|0|||
144299836|NCT00069641|520303818|FG002|Overall Study|Death|1|||
144299837|NCT03186638|520303819|FG000|Overall Study|Withdrawal by Subject|4|||
144299838|NCT03186638|520303820|FG001|Overall Study|Withdrawal by Subject|4|||
144299839|NCT03186638|520303819|FG000|Overall Study|Withdrawn due to medical problem|3|||
144299840|NCT03186638|520303820|FG001|Overall Study|Withdrawn due to medical problem|2|||
144299841|NCT03186638|520303819|FG000|Overall Study|Lost to Follow-up|1|||
144299842|NCT03186638|520303820|FG001|Overall Study|Lost to Follow-up|0|||
144299843|NCT02239926|520303821|FG000|Overall Study|Withdrawal by Subject|0|||
144299844|NCT02239926|520303822|FG001|Overall Study|Withdrawal by Subject|1|||
144299845|NCT00415636|520303823|FG000|Overall Study|Symptomatic deterioration|1|||
144299846|NCT00415636|520303824|FG001|Overall Study|Symptomatic deterioration|0|||
144299847|NCT00415636|520303825|FG002|Overall Study|Symptomatic deterioration|1|||
144299848|NCT00415636|520303826|FG003|Overall Study|Symptomatic deterioration|2|||
144299849|NCT00415636|520303827|FG004|Overall Study|Symptomatic deterioration|0|||
144299850|NCT00415636|520303828|FG005|Overall Study|Symptomatic deterioration|1|||
144299851|NCT00415636|520303823|FG000|Overall Study|Adverse Event|0|||
144299852|NCT00415636|520303824|FG001|Overall Study|Adverse Event|0|||
144299853|NCT00415636|520303825|FG002|Overall Study|Adverse Event|0|||
144299854|NCT00415636|520303826|FG003|Overall Study|Adverse Event|1|||
144299855|NCT00415636|520303827|FG004|Overall Study|Adverse Event|1|||
144299856|NCT00415636|520303828|FG005|Overall Study|Adverse Event|0|||
144299857|NCT00415636|520303823|FG000|Overall Study|Withdrawal by Subject|0|||
144299858|NCT00415636|520303824|FG001|Overall Study|Withdrawal by Subject|0|||
144360011|NCT01601535|520525139|FG004|Phase 1|Progressive Disease|0|||
144299859|NCT00415636|520303825|FG002|Overall Study|Withdrawal by Subject|0|||
144299860|NCT00415636|520303826|FG003|Overall Study|Withdrawal by Subject|0|||
144299861|NCT00415636|520303827|FG004|Overall Study|Withdrawal by Subject|1|||
144299862|NCT00415636|520303828|FG005|Overall Study|Withdrawal by Subject|0|||
144299863|NCT00415636|520303823|FG000|Overall Study|Disease progression|0|||
144299864|NCT00415636|520303824|FG001|Overall Study|Disease progression|0|||
144299865|NCT00415636|520303825|FG002|Overall Study|Disease progression|0|||
144299866|NCT00415636|520303826|FG003|Overall Study|Disease progression|3|||
144299867|NCT00415636|520303827|FG004|Overall Study|Disease progression|0|||
144299868|NCT00415636|520303828|FG005|Overall Study|Disease progression|1|||
144299869|NCT01263119|520303829|FG000|Period 1|Protocol Violation|2|||
144299870|NCT01263119|520303829|FG000|Period 2|Adverse Event|2|||
144299871|NCT02138825|520303830|FG000|Main Study Treatment|Adverse Event|11|||
144299872|NCT02138825|520303831|FG001|Main Study Treatment|Adverse Event|3|||
144299873|NCT02138825|520303830|FG000|Main Study Treatment|Death|1|||
144299874|NCT02138825|520303831|FG001|Main Study Treatment|Death|2|||
144299875|NCT02138825|520303830|FG000|Main Study Treatment|Protocol Violation|2|||
144299876|NCT02138825|520303831|FG001|Main Study Treatment|Protocol Violation|2|||
144299877|NCT02138825|520303830|FG000|Main Study Treatment|Sponsor decision|12|||
144299878|NCT02138825|520303831|FG001|Main Study Treatment|Sponsor decision|18|||
144299879|NCT02138825|520303830|FG000|Main Study Treatment|Study terminated by sponsor|10|||
144299880|NCT02138825|520303831|FG001|Main Study Treatment|Study terminated by sponsor|9|||
144299881|NCT02138825|520303830|FG000|Main Study Treatment|Withdrawal by Subject|3|||
144299882|NCT02138825|520303831|FG001|Main Study Treatment|Withdrawal by Subject|1|||
144299883|NCT02138825|520303830|FG000|Main Study Treatment|Medical decision|1|||
144299884|NCT02138825|520303831|FG001|Main Study Treatment|Medical decision|0|||
144299885|NCT02138825|520303830|FG000|Long-term Extension|Study termination by sponsor|32|||
144299886|NCT02138825|520303831|FG001|Long-term Extension|Study termination by sponsor|38|||
144299887|NCT02138825|520303830|FG000|Safety Follow-up|Adverse Event|4|||
144299888|NCT02138825|520303831|FG001|Safety Follow-up|Adverse Event|3|||
144299889|NCT02138825|520303830|FG000|Safety Follow-up|Death|11|||
144299890|NCT02138825|520303831|FG001|Safety Follow-up|Death|5|||
144299891|NCT02138825|520303830|FG000|Safety Follow-up|Withdrawal by Subject|5|||
144299892|NCT02138825|520303831|FG001|Safety Follow-up|Withdrawal by Subject|3|||
144299893|NCT02138825|520303830|FG000|Safety Follow-up|clinic worsening|1|||
144299894|NCT02138825|520303831|FG001|Safety Follow-up|clinic worsening|0|||
144299895|NCT02138825|520303830|FG000|Safety Follow-up|withdrawal by PI|1|||
144299896|NCT02138825|520303831|FG001|Safety Follow-up|withdrawal by PI|0|||
144299897|NCT02138825|520303830|FG000|Safety Follow-up|logistical difficulties|0|||
144299898|NCT02138825|520303831|FG001|Safety Follow-up|logistical difficulties|1|||
144299899|NCT02138825|520303830|FG000|Safety Follow-up|progressive disease|0|||
144299900|NCT02138825|520303831|FG001|Safety Follow-up|progressive disease|2|||
144299901|NCT02138825|520303830|FG000|Safety Follow-up|too unwell to attend the visit|0|||
144299902|NCT02138825|520303831|FG001|Safety Follow-up|too unwell to attend the visit|1|||
144299903|NCT02138825|520303830|FG000|Safety Follow-up|treatment unblinded|0|||
144299904|NCT02138825|520303831|FG001|Safety Follow-up|treatment unblinded|1|||
144299905|NCT02138825|520303830|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
144299906|NCT02138825|520303831|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
144299907|NCT05201807|520303832|FG000|Overall Study|Adverse Event|1|||
144299908|NCT05201807|520303832|FG000|Overall Study|COVID-19 Related|1|||
144299909|NCT02862574|520303835|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144299910|NCT02862574|520303836|FG001|Double-Blind Treatment Period|Adverse Event|1|||
144299911|NCT02862574|520303837|FG002|Double-Blind Treatment Period|Adverse Event|0|||
144299912|NCT02862574|520303835|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
144299913|NCT02862574|520303836|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
144299914|NCT02862574|520303837|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
144299915|NCT02862574|520303835|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
144299916|NCT02862574|520303836|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
144299917|NCT02862574|520303837|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
144299918|NCT04573972|520303840|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
144299919|NCT04573972|520303841|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
144299920|NCT00673920|520303846|FG000|Baseline up to Week 48|Withdrew consent|1|||
144299921|NCT00673920|520303847|FG001|Baseline up to Week 48|Withdrew consent|0|||
144299922|NCT00673920|520303848|FG002|Baseline up to Week 48|Withdrew consent|2|||
144299923|NCT00673920|520303849|FG003|Baseline up to Week 48|Withdrew consent|0|||
144299924|NCT00673920|520303850|FG004|Baseline up to Week 48|Withdrew consent|0|||
144299925|NCT00673920|520303851|FG005|Baseline up to Week 48|Withdrew consent|0|||
144299926|NCT00673920|520303852|FG006|Baseline up to Week 48|Withdrew consent|0|||
144299927|NCT00673920|520303853|FG007|Baseline up to Week 48|Withdrew consent|0|||
144299928|NCT00673920|520303846|FG000|Baseline up to Week 48|Refused treatment|1|||
144299929|NCT00673920|520303847|FG001|Baseline up to Week 48|Refused treatment|0|||
144299930|NCT00673920|520303848|FG002|Baseline up to Week 48|Refused treatment|0|||
144299931|NCT00673920|520303849|FG003|Baseline up to Week 48|Refused treatment|0|||
144299932|NCT00673920|520303850|FG004|Baseline up to Week 48|Refused treatment|0|||
144299933|NCT00673920|520303851|FG005|Baseline up to Week 48|Refused treatment|0|||
144299934|NCT00673920|520303852|FG006|Baseline up to Week 48|Refused treatment|0|||
144299935|NCT00673920|520303853|FG007|Baseline up to Week 48|Refused treatment|0|||
144299936|NCT00673920|520303846|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
144299937|NCT00673920|520303847|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
144299938|NCT00673920|520303848|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
144299939|NCT00673920|520303849|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
144299940|NCT00673920|520303850|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
144299941|NCT00673920|520303851|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
144299942|NCT00673920|520303852|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
144299943|NCT00673920|520303853|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
144299944|NCT00673920|520303846|FG000|Baseline up to Week 48|Protocol Violation|0|||
144299945|NCT00673920|520303847|FG001|Baseline up to Week 48|Protocol Violation|0|||
144299946|NCT00673920|520303848|FG002|Baseline up to Week 48|Protocol Violation|1|||
144299947|NCT00673920|520303849|FG003|Baseline up to Week 48|Protocol Violation|0|||
144299948|NCT00673920|520303850|FG004|Baseline up to Week 48|Protocol Violation|0|||
144299949|NCT00673920|520303851|FG005|Baseline up to Week 48|Protocol Violation|0|||
144299950|NCT00673920|520303852|FG006|Baseline up to Week 48|Protocol Violation|0|||
144299951|NCT00673920|520303853|FG007|Baseline up to Week 48|Protocol Violation|0|||
144299952|NCT00673920|520303846|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299953|NCT00673920|520303847|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299954|NCT00673920|520303848|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
144299955|NCT00673920|520303849|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299956|NCT00673920|520303850|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299957|NCT00673920|520303851|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299958|NCT00673920|520303852|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299959|NCT00673920|520303853|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
144299960|NCT00673920|520303846|FG000|Baseline up to Week 48|Administrative/Other|0|||
144299961|NCT00673920|520303847|FG001|Baseline up to Week 48|Administrative/Other|1|||
144299962|NCT00673920|520303848|FG002|Baseline up to Week 48|Administrative/Other|2|||
144299963|NCT00673920|520303849|FG003|Baseline up to Week 48|Administrative/Other|0|||
144299964|NCT00673920|520303850|FG004|Baseline up to Week 48|Administrative/Other|0|||
144299965|NCT00673920|520303851|FG005|Baseline up to Week 48|Administrative/Other|0|||
144299966|NCT00673920|520303852|FG006|Baseline up to Week 48|Administrative/Other|0|||
144299967|NCT00673920|520303853|FG007|Baseline up to Week 48|Administrative/Other|0|||
144299968|NCT00673920|520303846|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
144299969|NCT00673920|520303847|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
144299970|NCT00673920|520303848|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
144299971|NCT00673920|520303849|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
144299972|NCT00673920|520303850|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
144299973|NCT00673920|520303851|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
144299974|NCT00673920|520303852|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
144299975|NCT00673920|520303853|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
144299976|NCT00673920|520303846|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299977|NCT00673920|520303847|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299978|NCT00673920|520303848|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299979|NCT00673920|520303849|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299980|NCT00673920|520303850|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299981|NCT00673920|520303851|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299982|NCT00673920|520303852|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
144299983|NCT00673920|520303853|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
144299984|NCT00673920|520303846|FG000|Week 24 to Week 48|Failure to return|0|||
144299985|NCT00673920|520303847|FG001|Week 24 to Week 48|Failure to return|0|||
144299986|NCT00673920|520303848|FG002|Week 24 to Week 48|Failure to return|0|||
144299987|NCT00673920|520303849|FG003|Week 24 to Week 48|Failure to return|0|||
144299988|NCT00673920|520303850|FG004|Week 24 to Week 48|Failure to return|0|||
144299989|NCT00673920|520303851|FG005|Week 24 to Week 48|Failure to return|1|||
144299990|NCT00673920|520303852|FG006|Week 24 to Week 48|Failure to return|0|||
144299991|NCT00673920|520303853|FG007|Week 24 to Week 48|Failure to return|0|||
144299992|NCT00673920|520303846|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
144299993|NCT00673920|520303847|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
144299994|NCT00673920|520303848|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
144299995|NCT00673920|520303849|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
144299996|NCT00673920|520303850|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
144299997|NCT00673920|520303851|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
144299998|NCT00673920|520303852|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
144299999|NCT00673920|520303853|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
144300000|NCT00673920|520303846|FG000|Week 24 to Week 48|Death|0|||
144300001|NCT00673920|520303847|FG001|Week 24 to Week 48|Death|0|||
144300002|NCT00673920|520303848|FG002|Week 24 to Week 48|Death|0|||
144300003|NCT00673920|520303849|FG003|Week 24 to Week 48|Death|0|||
144300004|NCT00673920|520303850|FG004|Week 24 to Week 48|Death|0|||
144300005|NCT00673920|520303851|FG005|Week 24 to Week 48|Death|1|||
144300006|NCT00673920|520303852|FG006|Week 24 to Week 48|Death|0|||
144300007|NCT00673920|520303853|FG007|Week 24 to Week 48|Death|0|||
144300008|NCT00673920|520303846|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
144300009|NCT00673920|520303847|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
144300010|NCT00673920|520303848|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
144300011|NCT00673920|520303849|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
144300012|NCT00673920|520303850|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
144300013|NCT00673920|520303851|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
144300014|NCT00673920|520303852|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
144300015|NCT00673920|520303853|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
144300016|NCT04562116|520303859|FG000|Overall Study|Lost to Follow-up|1|||
144300017|NCT04562116|520303859|FG000|Overall Study|Withdrawal by Subject|3|||
144300018|NCT02303262|520303860|FG000|Overall Study|Withdrawal by Subject|2|||
144300019|NCT01728246|520303861|FG000|Overall Study|Participant needed rescue medication|1|||
144300020|NCT01728246|520303862|FG001|Overall Study|Participant needed rescue medication|5|||
144300021|NCT01728246|520303861|FG000|Overall Study|Protocol Violation|1|||
144300022|NCT01728246|520303862|FG001|Overall Study|Protocol Violation|0|||
144300023|NCT01728246|520303861|FG000|Overall Study|Withdrawal by Subject|2|||
144300024|NCT01728246|520303862|FG001|Overall Study|Withdrawal by Subject|3|||
144300025|NCT01728246|520303861|FG000|Overall Study|Lost to Follow-up|23|||
144300026|NCT01728246|520303862|FG001|Overall Study|Lost to Follow-up|22|||
144300027|NCT01728246|520303861|FG000|Overall Study|Lack of Efficacy|1|||
144300028|NCT01728246|520303862|FG001|Overall Study|Lack of Efficacy|1|||
144300029|NCT01728246|520303861|FG000|Overall Study|Adverse Event|8|||
144300030|NCT01728246|520303862|FG001|Overall Study|Adverse Event|5|||
144300031|NCT03097289|520303863|FG000|Overall Study|Adverse Event|1|||
144300032|NCT03097289|520303863|FG000|Overall Study|Equipment failure|2|||
144300033|NCT03097289|520303863|FG000|Overall Study|Collected platelet product unusable|3|||
144300034|NCT01656161|520303867|FG000|Overall Study|Death|3|||
144300035|NCT01656161|520303867|FG000|Overall Study|Adverse Event|2|||
144300036|NCT01656161|520303867|FG000|Overall Study|Protocol Violation|1|||
144300037|NCT01656161|520303867|FG000|Overall Study|Withdrawal by Subject|1|||
144300038|NCT00776230|520303868|FG000|Overall Study|Lost to Follow-up|2|||
144300039|NCT00776230|520303869|FG001|Overall Study|Lost to Follow-up|1|||
144300040|NCT00776230|520303870|FG002|Overall Study|Lost to Follow-up|5|||
144300041|NCT00776230|520303868|FG000|Overall Study|Not vaccinated at Day 0|1|||
144300042|NCT00776230|520303869|FG001|Overall Study|Not vaccinated at Day 0|0|||
144300043|NCT00776230|520303870|FG002|Overall Study|Not vaccinated at Day 0|0|||
144300044|NCT00776230|520303868|FG000|Overall Study|Withdrawal by Subject|0|||
144300045|NCT00776230|520303869|FG001|Overall Study|Withdrawal by Subject|1|||
144300046|NCT00776230|520303870|FG002|Overall Study|Withdrawal by Subject|0|||
144300047|NCT00776230|520303868|FG000|Overall Study|Subject missed Visit 4|0|||
144300048|NCT00776230|520303869|FG001|Overall Study|Subject missed Visit 4|1|||
144300049|NCT00776230|520303870|FG002|Overall Study|Subject missed Visit 4|0|||
144300050|NCT00485173|520303871|FG000|Overall Study|Death|4|||
144300051|NCT00485173|520303872|FG001|Overall Study|Death|3|||
144300052|NCT00485173|520303871|FG000|Overall Study|Lost to Follow-up|32|||
144300053|NCT00485173|520303872|FG001|Overall Study|Lost to Follow-up|61|||
144300054|NCT04222673|520303873|FG000|Overall Study|Lost to Follow-up|5|||
144300055|NCT03110562|520303883|FG000|Initial Treatment Period|Disease Progression|1|||
144300056|NCT03110562|520303884|FG001|Initial Treatment Period|Disease Progression|1|||
144300057|NCT03110562|520303885|FG002|Initial Treatment Period|Disease Progression|0|||
144300058|NCT03110562|520303886|FG003|Initial Treatment Period|Disease Progression|0|||
144300059|NCT03110562|520303883|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
144300060|NCT03110562|520303884|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
144300061|NCT03110562|520303885|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
144300062|NCT03110562|520303886|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
144300063|NCT03110562|520303883|FG000|Initial Treatment Period|Adverse Event|1|||
144300064|NCT03110562|520303884|FG001|Initial Treatment Period|Adverse Event|0|||
144300065|NCT03110562|520303885|FG002|Initial Treatment Period|Adverse Event|0|||
144300066|NCT03110562|520303886|FG003|Initial Treatment Period|Adverse Event|0|||
144300067|NCT03110562|520303883|FG000|Initial Treatment Period|Death|74|||
144300068|NCT03110562|520303884|FG001|Initial Treatment Period|Death|82|||
144300069|NCT03110562|520303885|FG002|Initial Treatment Period|Death|0|||
144300070|NCT03110562|520303886|FG003|Initial Treatment Period|Death|0|||
144300071|NCT03110562|520303883|FG000|Initial Treatment Period|Lost to Follow-up|13|||
144300072|NCT03110562|520303884|FG001|Initial Treatment Period|Lost to Follow-up|8|||
144300073|NCT03110562|520303885|FG002|Initial Treatment Period|Lost to Follow-up|0|||
144300074|NCT03110562|520303886|FG003|Initial Treatment Period|Lost to Follow-up|0|||
144300075|NCT03110562|520303883|FG000|Initial Treatment Period|Protocol Deviation|1|||
144300076|NCT03110562|520303884|FG001|Initial Treatment Period|Protocol Deviation|0|||
144300077|NCT03110562|520303885|FG002|Initial Treatment Period|Protocol Deviation|0|||
144300078|NCT03110562|520303886|FG003|Initial Treatment Period|Protocol Deviation|0|||
144300079|NCT03110562|520303883|FG000|Initial Treatment Period|Physician Decision|2|||
144300080|NCT03110562|520303884|FG001|Initial Treatment Period|Physician Decision|1|||
144300081|NCT03110562|520303885|FG002|Initial Treatment Period|Physician Decision|0|||
144300082|NCT03110562|520303886|FG003|Initial Treatment Period|Physician Decision|0|||
144300083|NCT03110562|520303883|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
144300084|NCT03110562|520303884|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
144300085|NCT03110562|520303885|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
144300086|NCT03110562|520303886|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
144300087|NCT03110562|520303883|FG000|Initial Treatment Period|Other|5|||
144300088|NCT03110562|520303884|FG001|Initial Treatment Period|Other|4|||
144300089|NCT03110562|520303885|FG002|Initial Treatment Period|Other|0|||
144300090|NCT03110562|520303886|FG003|Initial Treatment Period|Other|0|||
144300091|NCT03110562|520303883|FG000|Initial Treatment Period|Randomized but never treated|0|||
144300092|NCT03110562|520303884|FG001|Initial Treatment Period|Randomized but never treated|3|||
144300093|NCT03110562|520303885|FG002|Initial Treatment Period|Randomized but never treated|0|||
144300094|NCT03110562|520303886|FG003|Initial Treatment Period|Randomized but never treated|0|||
144300095|NCT03110562|520303883|FG000|Crossover Period|Disease Progression|0|||
144300096|NCT03110562|520303884|FG001|Crossover Period|Disease Progression|0|||
144300097|NCT03110562|520303885|FG002|Crossover Period|Disease Progression|1|||
144300098|NCT03110562|520303886|FG003|Crossover Period|Disease Progression|0|||
144300099|NCT03110562|520303883|FG000|Crossover Period|Withdrawal by Subject|0|||
144300100|NCT03110562|520303884|FG001|Crossover Period|Withdrawal by Subject|0|||
144300101|NCT03110562|520303885|FG002|Crossover Period|Withdrawal by Subject|8|||
144300102|NCT03110562|520303886|FG003|Crossover Period|Withdrawal by Subject|6|||
144300103|NCT03110562|520303883|FG000|Crossover Period|Death|0|||
144300104|NCT03110562|520303884|FG001|Crossover Period|Death|0|||
144300105|NCT03110562|520303885|FG002|Crossover Period|Death|37|||
144300106|NCT03110562|520303886|FG003|Crossover Period|Death|3|||
144300107|NCT03110562|520303883|FG000|Crossover Period|Lost to Follow-up|0|||
144300108|NCT03110562|520303884|FG001|Crossover Period|Lost to Follow-up|0|||
144300109|NCT03110562|520303885|FG002|Crossover Period|Lost to Follow-up|0|||
144300110|NCT03110562|520303886|FG003|Crossover Period|Lost to Follow-up|1|||
144300111|NCT03110562|520303883|FG000|Crossover Period|Other|0|||
144300112|NCT03110562|520303884|FG001|Crossover Period|Other|0|||
144300113|NCT03110562|520303885|FG002|Crossover Period|Other|1|||
144300114|NCT03110562|520303886|FG003|Crossover Period|Other|1|||
144300115|NCT03110562|520303883|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
144300116|NCT03110562|520303884|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
144300117|NCT03110562|520303885|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
144300118|NCT03110562|520303886|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
144300119|NCT03012880|520303892|FG000|Overall Study|Withdrawal by Subject|1|||
144300120|NCT03012880|520303893|FG001|Overall Study|Withdrawal by Subject|0|||
144300121|NCT03012880|520303892|FG000|Overall Study|Ineligible|1|||
144300122|NCT03012880|520303893|FG001|Overall Study|Ineligible|0|||
144300123|NCT01355627|520303894|FG000|Overall Study|Request By the Patient to Discontinue|5|||
144300124|NCT01355627|520303895|FG001|Overall Study|Request By the Patient to Discontinue|7|||
144300125|NCT01355627|520303894|FG000|Overall Study|Lost to Follow-up|8|||
144300126|NCT01355627|520303895|FG001|Overall Study|Lost to Follow-up|7|||
144300127|NCT01355627|520303894|FG000|Overall Study|Fatal Adverse Event|19|||
144300128|NCT01355627|520303895|FG001|Overall Study|Fatal Adverse Event|23|||
144300129|NCT01355627|520303894|FG000|Overall Study|Other|1|||
144300130|NCT01355627|520303895|FG001|Overall Study|Other|1|||
144300131|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
144300132|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
144300133|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
144300134|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
144300135|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
144300136|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
144300137|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
144300138|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
144300139|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
144300140|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
144300141|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
144300142|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
144300143|NCT04532749|520303896|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
144300144|NCT04532749|520303897|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
144300145|NCT04532749|520303896|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
144300146|NCT04532749|520303897|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
144300147|NCT04532749|520303896|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
144300148|NCT04532749|520303897|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
144300149|NCT04532749|520303896|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
144300150|NCT04532749|520303897|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
144300151|NCT01323192|520305267|FG000|Overall Study|Adverse Event|6|||
144300152|NCT01323192|520305268|FG001|Overall Study|Adverse Event|1|||
144300153|NCT01323192|520305267|FG000|Overall Study|Withdrawal by Subject|3|||
144300154|NCT01323192|520305268|FG001|Overall Study|Withdrawal by Subject|1|||
144300155|NCT01323192|520305267|FG000|Overall Study|Noncompliance with study medication|0|||
144300156|NCT01323192|520305268|FG001|Overall Study|Noncompliance with study medication|3|||
144300157|NCT01323192|520305267|FG000|Overall Study|Nonmedical reasons|0|||
144300158|NCT01323192|520305268|FG001|Overall Study|Nonmedical reasons|1|||
144300159|NCT02276040|520305274|FG000|Overall Study|Physician Decision|15|||
144300160|NCT02835690|520305275|FG000|Overall Study|Death|12|||
144300161|NCT02835690|520305276|FG001|Overall Study|Death|11|||
144300162|NCT02835690|520305277|FG002|Overall Study|Death|13|||
144300163|NCT02835690|520305275|FG000|Overall Study|Transferred to Extension Study|2|||
144300164|NCT02835690|520305276|FG001|Overall Study|Transferred to Extension Study|2|||
144300165|NCT02835690|520305277|FG002|Overall Study|Transferred to Extension Study|1|||
144300166|NCT02835690|520305275|FG000|Overall Study|Did Not Continue on Extension Study|0|||
144300167|NCT02835690|520305276|FG001|Overall Study|Did Not Continue on Extension Study|0|||
144300168|NCT02835690|520305277|FG002|Overall Study|Did Not Continue on Extension Study|1|||
144300169|NCT02835690|520305275|FG000|Overall Study|Not Treated|0|||
144300170|NCT02835690|520305276|FG001|Overall Study|Not Treated|2|||
144300171|NCT02835690|520305277|FG002|Overall Study|Not Treated|0|||
144300172|NCT03674281|520305278|FG000|Overall Study|screen failure|2|||
144300173|NCT03674281|520305279|FG001|Overall Study|screen failure|0|||
144300174|NCT03674281|520305280|FG002|Overall Study|screen failure|0|||
144300175|NCT03674281|520305278|FG000|Overall Study|Withdrawal by Subject|1|||
144300176|NCT03674281|520305279|FG001|Overall Study|Withdrawal by Subject|3|||
144300177|NCT03674281|520305280|FG002|Overall Study|Withdrawal by Subject|3|||
144300178|NCT03983421|520305286|FG000|Overall Study|Lost to Follow-up|1|||
144300179|NCT03386773|520305287|FG000|Overall Study|Lost to Follow-up|24|||
144300180|NCT03386773|520305288|FG001|Overall Study|Lost to Follow-up|33|||
144300181|NCT03386773|520305287|FG000|Overall Study|Withdrawal by Subject|3|||
144300182|NCT03386773|520305288|FG001|Overall Study|Withdrawal by Subject|2|||
144300183|NCT03639610|520305289|FG000|Overall Study|Adverse Event|7|||
144300184|NCT03639610|520305290|FG001|Overall Study|Adverse Event|1|||
144300185|NCT03639610|520305291|FG002|Overall Study|Adverse Event|0|||
144300186|NCT03639610|520305289|FG000|Overall Study|Physician Decision|3|||
144300187|NCT03639610|520305290|FG001|Overall Study|Physician Decision|1|||
144300188|NCT03639610|520305291|FG002|Overall Study|Physician Decision|0|||
144300189|NCT03639610|520305289|FG000|Overall Study|Disease progression|8|||
144300190|NCT03639610|520305290|FG001|Overall Study|Disease progression|5|||
144300191|NCT03639610|520305291|FG002|Overall Study|Disease progression|3|||
144300192|NCT03639610|520305289|FG000|Overall Study|Study terminated by sponsor|2|||
144300193|NCT03639610|520305290|FG001|Overall Study|Study terminated by sponsor|1|||
144300194|NCT03639610|520305291|FG002|Overall Study|Study terminated by sponsor|1|||
144300195|NCT03639610|520305289|FG000|Overall Study|Patient request to stop treatment|1|||
144300196|NCT03639610|520305290|FG001|Overall Study|Patient request to stop treatment|2|||
144300197|NCT03639610|520305291|FG002|Overall Study|Patient request to stop treatment|0|||
144300198|NCT02410772|520305293|FG000|Overall Study|Death|3|||
144300199|NCT02410772|520305294|FG001|Overall Study|Death|4|||
144300200|NCT02410772|520305295|FG002|Overall Study|Death|8|||
144300201|NCT02410772|520305293|FG000|Overall Study|Lost to Follow-up|31|||
144300202|NCT02410772|520305294|FG001|Overall Study|Lost to Follow-up|23|||
144300203|NCT02410772|520305295|FG002|Overall Study|Lost to Follow-up|22|||
144300204|NCT02410772|520305293|FG000|Overall Study|Pregnancy|8|||
144300205|NCT02410772|520305294|FG001|Overall Study|Pregnancy|4|||
144300206|NCT02410772|520305295|FG002|Overall Study|Pregnancy|5|||
144300207|NCT02410772|520305293|FG000|Overall Study|Protocol Violation|8|||
144300208|NCT02410772|520305294|FG001|Overall Study|Protocol Violation|8|||
144300209|NCT02410772|520305295|FG002|Overall Study|Protocol Violation|4|||
144300210|NCT02410772|520305293|FG000|Overall Study|Baseline Drug Resistance|49|||
144300211|NCT02410772|520305294|FG001|Overall Study|Baseline Drug Resistance|40|||
144300212|NCT02410772|520305295|FG002|Overall Study|Baseline Drug Resistance|51|||
144300213|NCT02410772|520305293|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
144300214|NCT02410772|520305294|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
144300215|NCT02410772|520305295|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
144300216|NCT02410772|520305293|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
144300217|NCT02410772|520305294|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
144300218|NCT02410772|520305295|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
144300219|NCT05067335|520305300|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
144300220|NCT05067335|520305301|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
144300221|NCT05067335|520305302|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
144300222|NCT05067335|520305303|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
144300223|NCT05067335|520305300|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
144300224|NCT05067335|520305301|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
144300225|NCT05067335|520305302|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
144300226|NCT05067335|520305303|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
144300227|NCT05067335|520305300|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
144300228|NCT05067335|520305301|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
144300229|NCT05067335|520305302|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
144300230|NCT05067335|520305303|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
144300231|NCT05067335|520305300|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
144300232|NCT05067335|520305301|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
144300233|NCT05067335|520305302|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
144300234|NCT05067335|520305303|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
144300235|NCT05067335|520305300|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
144300236|NCT05067335|520305301|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
144300237|NCT05067335|520305302|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
144300238|NCT05067335|520305303|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
144300239|NCT05067335|520305300|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
144300240|NCT05067335|520305301|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
144300241|NCT05067335|520305302|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
144300242|NCT05067335|520305303|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
144300243|NCT05067335|520305300|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
144300244|NCT05067335|520305301|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
144300245|NCT05067335|520305302|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
144300246|NCT05067335|520305303|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
144300247|NCT05067335|520305300|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
144300248|NCT05067335|520305301|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
144300249|NCT05067335|520305302|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
144300250|NCT05067335|520305303|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
144300251|NCT05067335|520305300|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
144300252|NCT05067335|520305301|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
144300253|NCT05067335|520305302|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
144300254|NCT05067335|520305303|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
144300255|NCT05067335|520305300|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
144300256|NCT05067335|520305301|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
144300257|NCT05067335|520305302|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
144300258|NCT05067335|520305303|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
144300259|NCT01645176|520305304|FG000|Overall Study|Lack of Efficacy|4|||
144300260|NCT01645176|520305304|FG000|Overall Study|did not complete final MRI|1|||
144300261|NCT00949533|520305307|FG000|Overall Study|Lost to Follow-up|0|||
144300262|NCT00949533|520305308|FG001|Overall Study|Lost to Follow-up|1|||
144300263|NCT02234362|520305309|FG000|Overall Study|Not eligible after first screening visit|17|||
144300264|NCT02234362|520305309|FG000|Overall Study|Lost to Follow-up|6|||
144300265|NCT02234362|520305309|FG000|Overall Study|Withdrawal by Subject|3|||
144300266|NCT01959529|520305310|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
144300267|NCT01959529|520305311|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
144300268|NCT01959529|520305310|FG000|Overall Study|Lost to Follow-up|4|||
144300269|NCT01959529|520305311|FG001|Overall Study|Lost to Follow-up|1|||
144300270|NCT01959529|520305310|FG000|Overall Study|Other|70|||
144300271|NCT01959529|520305311|FG001|Overall Study|Other|68|||
144300272|NCT01959529|520305310|FG000|Overall Study|Hypoglycaemia|1|||
144300273|NCT01959529|520305311|FG001|Overall Study|Hypoglycaemia|1|||
144300274|NCT01959529|520305310|FG000|Overall Study|Lack of glycaemic control|1|||
144300275|NCT01959529|520305311|FG001|Overall Study|Lack of glycaemic control|1|||
144300276|NCT00261833|520305319|FG000|Overall Study|Death|1|||
144300277|NCT00261833|520305320|FG001|Overall Study|Death|3|||
144300278|NCT00261833|520305319|FG000|Overall Study|Adverse Event|1|||
144300279|NCT00261833|520305320|FG001|Overall Study|Adverse Event|4|||
144300280|NCT00261833|520305319|FG000|Overall Study|Withdrawal by Subject|5|||
144300281|NCT00261833|520305320|FG001|Overall Study|Withdrawal by Subject|7|||
144300282|NCT00261833|520305319|FG000|Overall Study|Protocol Violation|0|||
144300283|NCT00261833|520305320|FG001|Overall Study|Protocol Violation|1|||
144300284|NCT00261833|520305319|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
144300285|NCT00261833|520305320|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
144300286|NCT00261833|520305319|FG000|Overall Study|Lung transplantation|1|||
144300287|NCT00261833|520305320|FG001|Overall Study|Lung transplantation|1|||
144300288|NCT00261833|520305319|FG000|Overall Study|Missing reason|1|||
144300289|NCT00261833|520305320|FG001|Overall Study|Missing reason|0|||
144300290|NCT00261833|520305319|FG000|Overall Study|Not interested in being participant|0|||
144300291|NCT00261833|520305320|FG001|Overall Study|Not interested in being participant|1|||
144300292|NCT01948427|520305323|FG000|Overall Study|Serious Adverse Event|3|||
144300293|NCT01948427|520305324|FG001|Overall Study|Serious Adverse Event|0|||
144300294|NCT01948427|520305325|FG002|Overall Study|Serious Adverse Event|0|||
144300295|NCT01948427|520305326|FG003|Overall Study|Serious Adverse Event|0|||
144300296|NCT01948427|520305327|FG004|Overall Study|Serious Adverse Event|1|||
144300297|NCT01948427|520305323|FG000|Overall Study|Investigator Request|0|||
144300298|NCT01948427|520305324|FG001|Overall Study|Investigator Request|8|||
144300299|NCT01948427|520305325|FG002|Overall Study|Investigator Request|0|||
144300300|NCT01948427|520305326|FG003|Overall Study|Investigator Request|0|||
144300301|NCT01948427|520305327|FG004|Overall Study|Investigator Request|6|||
144300302|NCT01948427|520305323|FG000|Overall Study|Lost to Follow-up|1|||
144300303|NCT01948427|520305324|FG001|Overall Study|Lost to Follow-up|0|||
144300304|NCT01948427|520305325|FG002|Overall Study|Lost to Follow-up|0|||
144300305|NCT01948427|520305326|FG003|Overall Study|Lost to Follow-up|0|||
144300306|NCT01948427|520305327|FG004|Overall Study|Lost to Follow-up|4|||
144300307|NCT01948427|520305323|FG000|Overall Study|Withdrawal by Subject|2|||
144300308|NCT01948427|520305324|FG001|Overall Study|Withdrawal by Subject|0|||
144300309|NCT01948427|520305325|FG002|Overall Study|Withdrawal by Subject|0|||
144300310|NCT01948427|520305326|FG003|Overall Study|Withdrawal by Subject|0|||
144300311|NCT01948427|520305327|FG004|Overall Study|Withdrawal by Subject|1|||
144300312|NCT01948427|520305323|FG000|Overall Study|Other, Not Specified|1|||
144300313|NCT01948427|520305324|FG001|Overall Study|Other, Not Specified|9|||
144300314|NCT01948427|520305325|FG002|Overall Study|Other, Not Specified|0|||
144300315|NCT01948427|520305326|FG003|Overall Study|Other, Not Specified|0|||
144300316|NCT01948427|520305327|FG004|Overall Study|Other, Not Specified|2|||
144300317|NCT00402987|520305328|FG000|Overall Study|Lack of Efficacy|0|||
144300318|NCT00402987|520305329|FG001|Overall Study|Lack of Efficacy|0|||
144300319|NCT00402987|520305330|FG002|Overall Study|Lack of Efficacy|1|||
144300320|NCT00402987|520305331|FG003|Overall Study|Lack of Efficacy|0|||
144300321|NCT02434081|520305332|FG000|Overall Study|Death (never started treatment)|2|||
144300322|NCT02434081|520305332|FG000|Overall Study|Death|2|||
144300323|NCT02434081|520305332|FG000|Overall Study|Progression|20|||
144300324|NCT02434081|520305332|FG000|Overall Study|Adverse Event|20|||
144300325|NCT02434081|520305332|FG000|Overall Study|Physician Decision|2|||
144300326|NCT02434081|520305332|FG000|Overall Study|Withdrawal by Subject|1|||
144300327|NCT02434081|520305332|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
144300328|NCT01668004|520305333|FG000|Overall Study|Adverse Event|7|||
144300329|NCT01668004|520305333|FG000|Overall Study|Withdrawal by Subject|2|||
144300330|NCT01668004|520305333|FG000|Overall Study|Lost to Follow-up|5|||
144300331|NCT01668004|520305333|FG000|Overall Study|Lack of Efficacy|9|||
144300332|NCT01668004|520305333|FG000|Overall Study|Non-compliance with treatment|2|||
144300333|NCT00419744|520305334|FG000|Overall Study|Adverse Event|39|||
144300334|NCT00419744|520305335|FG001|Overall Study|Adverse Event|40|||
144300335|NCT00419744|520305336|FG002|Overall Study|Adverse Event|50|||
144300336|NCT00419744|520305334|FG000|Overall Study|Withdrawal by Subject|45|||
144300337|NCT00419744|520305335|FG001|Overall Study|Withdrawal by Subject|49|||
144300338|NCT00419744|520305336|FG002|Overall Study|Withdrawal by Subject|52|||
144300339|NCT00419744|520305334|FG000|Overall Study|Lost to Follow-up|8|||
144300340|NCT00419744|520305335|FG001|Overall Study|Lost to Follow-up|10|||
144300341|NCT00419744|520305336|FG002|Overall Study|Lost to Follow-up|6|||
144300342|NCT00419744|520305334|FG000|Overall Study|Protocol Violation|4|||
144300343|NCT00419744|520305335|FG001|Overall Study|Protocol Violation|7|||
144300344|NCT00419744|520305336|FG002|Overall Study|Protocol Violation|8|||
144300345|NCT00419744|520305334|FG000|Overall Study|Randomized in error|9|||
144300346|NCT00419744|520305335|FG001|Overall Study|Randomized in error|6|||
144300347|NCT00419744|520305336|FG002|Overall Study|Randomized in error|7|||
144300348|NCT00419744|520305334|FG000|Overall Study|Moving out of state|2|||
144300349|NCT00419744|520305335|FG001|Overall Study|Moving out of state|0|||
144300350|NCT00419744|520305336|FG002|Overall Study|Moving out of state|1|||
144300351|NCT00419744|520305334|FG000|Overall Study|Physician Decision|10|||
144300352|NCT00419744|520305335|FG001|Overall Study|Physician Decision|5|||
144300353|NCT00419744|520305336|FG002|Overall Study|Physician Decision|6|||
144300354|NCT00419744|520305334|FG000|Overall Study|Spirometry mouthpiece issues|0|||
144300355|NCT00419744|520305335|FG001|Overall Study|Spirometry mouthpiece issues|1|||
144300356|NCT00419744|520305336|FG002|Overall Study|Spirometry mouthpiece issues|2|||
144300357|NCT00419744|520305334|FG000|Overall Study|Incorrect medication kit dispensed|0|||
144300358|NCT00419744|520305335|FG001|Overall Study|Incorrect medication kit dispensed|0|||
144300359|NCT00419744|520305336|FG002|Overall Study|Incorrect medication kit dispensed|1|||
144300360|NCT01500317|520305343|FG000|Overall Study|Withdrawal by Subject|3|||
144300361|NCT01500317|520305344|FG001|Overall Study|Withdrawal by Subject|2|||
144300362|NCT01500317|520305345|FG002|Overall Study|Withdrawal by Subject|0|||
144300363|NCT02090764|520305346|FG000|Overall Study|Adverse Event|1|||
144300364|NCT02090764|520305347|FG001|Overall Study|Adverse Event|3|||
144300365|NCT02090764|520305346|FG000|Overall Study|Lack of Efficacy|0|||
144300366|NCT02090764|520305347|FG001|Overall Study|Lack of Efficacy|13|||
144300367|NCT02090764|520305346|FG000|Overall Study|Withdrawal by Subject|2|||
144300368|NCT02090764|520305347|FG001|Overall Study|Withdrawal by Subject|1|||
144300369|NCT02090764|520305346|FG000|Overall Study|Intercurrent illness and other|1|||
144300370|NCT02090764|520305347|FG001|Overall Study|Intercurrent illness and other|1|||
144300371|NCT02090764|520305346|FG000|Overall Study|Lost to Follow-up|2|||
144300372|NCT02090764|520305347|FG001|Overall Study|Lost to Follow-up|2|||
144300373|NCT00754572|520305348|FG000|Overall Study|Adverse Event|19|||
144300374|NCT00754572|520305348|FG000|Overall Study|Other|39|||
144300375|NCT00754572|520305348|FG000|Overall Study|Protocol Violation|3|||
144300376|NCT00754572|520305348|FG000|Overall Study|Withdrawal by Subject|3|||
144300377|NCT00754572|520305348|FG000|Overall Study|Lack of Efficacy|2|||
144300378|NCT00754572|520305348|FG000|Overall Study|Death|1|||
144300379|NCT00754572|520305348|FG000|Overall Study|Administrative Reason|3|||
144300380|NCT00754572|520305348|FG000|Overall Study|Lost to Follow-up|1|||
144300381|NCT02131766|520305349|FG000|Overall Study|Withdrawal by Subject|4|||
144300382|NCT00718315|520305351|FG000|Overall Study|Adverse Event|1|||
144300383|NCT00718315|520305352|FG001|Overall Study|Adverse Event|2|||
144300384|NCT00718315|520305353|FG002|Overall Study|Adverse Event|3|||
144300385|NCT00718315|520305351|FG000|Overall Study|Death|6|||
144300386|NCT00718315|520305352|FG001|Overall Study|Death|6|||
144300387|NCT00718315|520305353|FG002|Overall Study|Death|5|||
144300388|NCT00718315|520305351|FG000|Overall Study|Lost to Follow-up|2|||
144300389|NCT00718315|520305352|FG001|Overall Study|Lost to Follow-up|3|||
144300390|NCT00718315|520305353|FG002|Overall Study|Lost to Follow-up|4|||
144300391|NCT00718315|520305351|FG000|Overall Study|Protocol Violation|5|||
144300392|NCT00718315|520305352|FG001|Overall Study|Protocol Violation|5|||
144300393|NCT00718315|520305353|FG002|Overall Study|Protocol Violation|3|||
144300394|NCT00718315|520305351|FG000|Overall Study|Erlotinib dose decreased|4|||
144300395|NCT00718315|520305352|FG001|Overall Study|Erlotinib dose decreased|3|||
144300396|NCT00718315|520305353|FG002|Overall Study|Erlotinib dose decreased|1|||
144300397|NCT00718315|520305351|FG000|Overall Study|Use of Minocyclin|1|||
144300398|NCT00718315|520305352|FG001|Overall Study|Use of Minocyclin|1|||
144300399|NCT00718315|520305353|FG002|Overall Study|Use of Minocyclin|1|||
144300400|NCT00718315|520305351|FG000|Overall Study|Disease progression|0|||
144300401|NCT00718315|520305352|FG001|Overall Study|Disease progression|1|||
144300402|NCT00718315|520305353|FG002|Overall Study|Disease progression|1|||
144300403|NCT00718315|520305351|FG000|Overall Study|Other|0|||
144300404|NCT00718315|520305352|FG001|Overall Study|Other|0|||
144300405|NCT00718315|520305353|FG002|Overall Study|Other|1|||
144300406|NCT00718315|520305351|FG000|Overall Study|Use of ATB and Corticoids|0|||
144300407|NCT00718315|520305352|FG001|Overall Study|Use of ATB and Corticoids|1|||
144300408|NCT00718315|520305353|FG002|Overall Study|Use of ATB and Corticoids|2|||
144300409|NCT00806585|520305355|FG000|Overall Study|Study terminated by Sponsor|0|||
144300410|NCT00806585|520305356|FG001|Overall Study|Study terminated by Sponsor|0|||
144300411|NCT00806585|520305357|FG002|Overall Study|Study terminated by Sponsor|1|||
144300412|NCT00806585|520305358|FG003|Overall Study|Study terminated by Sponsor|2|||
144300413|NCT00806585|520305359|FG004|Overall Study|Study terminated by Sponsor|0|||
144300414|NCT00806585|520305355|FG000|Overall Study|Protocol Violation|3|||
144300415|NCT00806585|520305356|FG001|Overall Study|Protocol Violation|1|||
144300416|NCT00806585|520305357|FG002|Overall Study|Protocol Violation|2|||
144300417|NCT00806585|520305358|FG003|Overall Study|Protocol Violation|0|||
144300418|NCT00806585|520305359|FG004|Overall Study|Protocol Violation|0|||
144300419|NCT00806585|520305355|FG000|Overall Study|Physician Decision|0|||
144300420|NCT00806585|520305356|FG001|Overall Study|Physician Decision|2|||
144300421|NCT00806585|520305357|FG002|Overall Study|Physician Decision|3|||
144300422|NCT00806585|520305358|FG003|Overall Study|Physician Decision|0|||
144300423|NCT00806585|520305359|FG004|Overall Study|Physician Decision|1|||
144300424|NCT00806585|520305355|FG000|Overall Study|Lost to Follow-up|2|||
144300425|NCT00806585|520305356|FG001|Overall Study|Lost to Follow-up|1|||
144300426|NCT00806585|520305357|FG002|Overall Study|Lost to Follow-up|2|||
144300427|NCT00806585|520305358|FG003|Overall Study|Lost to Follow-up|2|||
144300428|NCT00806585|520305359|FG004|Overall Study|Lost to Follow-up|5|||
144300429|NCT00806585|520305355|FG000|Overall Study|Lack of Efficacy|1|||
144300430|NCT00806585|520305356|FG001|Overall Study|Lack of Efficacy|0|||
144300431|NCT00806585|520305357|FG002|Overall Study|Lack of Efficacy|0|||
144300432|NCT00806585|520305358|FG003|Overall Study|Lack of Efficacy|0|||
144300433|NCT00806585|520305359|FG004|Overall Study|Lack of Efficacy|0|||
144300434|NCT00806585|520305355|FG000|Overall Study|Adverse Event|1|||
144300435|NCT00806585|520305356|FG001|Overall Study|Adverse Event|5|||
144300436|NCT00806585|520305357|FG002|Overall Study|Adverse Event|3|||
144300437|NCT00806585|520305358|FG003|Overall Study|Adverse Event|4|||
144300438|NCT00806585|520305359|FG004|Overall Study|Adverse Event|2|||
144300439|NCT00806585|520305355|FG000|Overall Study|Withdrawal by Subject|10|||
144300440|NCT00806585|520305356|FG001|Overall Study|Withdrawal by Subject|8|||
144300441|NCT00806585|520305357|FG002|Overall Study|Withdrawal by Subject|9|||
144300442|NCT00806585|520305358|FG003|Overall Study|Withdrawal by Subject|3|||
144300443|NCT00806585|520305359|FG004|Overall Study|Withdrawal by Subject|11|||
144300444|NCT00806585|520305355|FG000|Overall Study|Completion status unknown|15|||
144300445|NCT00806585|520305356|FG001|Overall Study|Completion status unknown|14|||
144300446|NCT00806585|520305357|FG002|Overall Study|Completion status unknown|12|||
144300447|NCT00806585|520305358|FG003|Overall Study|Completion status unknown|4|||
144300448|NCT00806585|520305359|FG004|Overall Study|Completion status unknown|12|||
144300449|NCT01170663|520305361|FG000|Overall Study|Lost to Follow-up|3|||
144300450|NCT01170663|520305362|FG001|Overall Study|Lost to Follow-up|9|||
144300451|NCT01170663|520305361|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
144300452|NCT01170663|520305362|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
144300453|NCT01164007|520305367|FG000|Overall Study|Adverse Event|5|||
144300454|NCT01164007|520305367|FG000|Overall Study|Progression of Disease|30|||
144300455|NCT01164007|520305367|FG000|Overall Study|Protocol Violation|1|||
144300456|NCT01164007|520305367|FG000|Overall Study|Withdrawal by Subject|1|||
144300457|NCT01164007|520305367|FG000|Overall Study|Medical Decision|3|||
144300458|NCT00894387|520305368|FG000|Overall Study|Adverse Event|44|||
144300459|NCT00894387|520305369|FG001|Overall Study|Adverse Event|45|||
144300460|NCT00894387|520305368|FG000|Overall Study|Abnormal Laboratory values|2|||
144300461|NCT00894387|520305369|FG001|Overall Study|Abnormal Laboratory values|2|||
144300462|NCT00894387|520305368|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144300463|NCT00894387|520305369|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144300464|NCT00894387|520305368|FG000|Overall Study|Lost to Follow-up|3|||
144300465|NCT00894387|520305369|FG001|Overall Study|Lost to Follow-up|5|||
144300466|NCT00894387|520305368|FG000|Overall Study|Administrative problems|2|||
144300467|NCT00894387|520305369|FG001|Overall Study|Administrative problems|2|||
144300468|NCT00894387|520305368|FG000|Overall Study|Death|77|||
144300469|NCT00894387|520305369|FG001|Overall Study|Death|76|||
144300470|NCT00894387|520305368|FG000|Overall Study|Protocol Deviation|4|||
144300471|NCT00894387|520305369|FG001|Overall Study|Protocol Deviation|0|||
144300472|NCT00894387|520305368|FG000|Overall Study|Patient's request|25|||
144300473|NCT00894387|520305369|FG001|Overall Study|Patient's request|30|||
144300474|NCT00894387|520305368|FG000|Overall Study|Other (Missing)|5|||
144300475|NCT00894387|520305369|FG001|Overall Study|Other (Missing)|3|||
144300476|NCT00894387|520305368|FG000|Overall Study|Mis-randomized|13|||
144300477|NCT00894387|520305369|FG001|Overall Study|Mis-randomized|9|||
144300478|NCT00894387|520305368|FG000|Overall Study|GCP non-compliance|0|||
144300479|NCT00894387|520305369|FG001|Overall Study|GCP non-compliance|2|||
144300480|NCT04856527|520305370|FG000|Overall Study|Unable to complete experimental task|2|||
144300481|NCT04856527|520305371|FG001|Overall Study|Unable to complete experimental task|0|||
144300486|NCT01463527|520305378|FG000|Overall Study|Protocol Violation|1|||
144300487|NCT01463527|520305379|FG001|Overall Study|Protocol Violation|1|||
144300488|NCT01463527|520305378|FG000|Overall Study|Crying >20% of sedation|5|||
144300489|NCT01463527|520305379|FG001|Overall Study|Crying >20% of sedation|6|||
144300490|NCT01493414|520305380|FG000|Overall Study|Adverse Event|405|||
144300491|NCT01493414|520305380|FG000|Overall Study|Disease progression|204|||
144300492|NCT01493414|520305380|FG000|Overall Study|Death|101|||
144300493|NCT01493414|520305380|FG000|Overall Study|Physician Decision|93|||
144300494|NCT01493414|520305380|FG000|Overall Study|Withdrawal by Subject|79|||
144300495|NCT01493414|520305380|FG000|Overall Study|Protocol deviation|27|||
144300496|NCT01493414|520305380|FG000|Overall Study|Administrative problems|25|||
144300497|NCT01493414|520305380|FG000|Overall Study|Lost to Follow-up|16|||
144300498|NCT01977222|520305383|FG000|Overall Study|Withdrawal by Subject|1|||
144300499|NCT03746015|520305384|FG000|Overall Study|Withdrawal of Consent|1|||
144300500|NCT03746015|520305385|FG001|Overall Study|Withdrawal of Consent|0|||
144300501|NCT03746015|520305386|FG002|Overall Study|Withdrawal of Consent|0|||
144300502|NCT05448950|520305387|FG000|Overall Study|Death|2|||
144300503|NCT05448950|520305387|FG000|Overall Study|Withdrawal by Subject|1|||
144300504|NCT05448950|520305387|FG000|Overall Study|AVG abandoned|4|||
144300505|NCT02921256|520305388|FG000|Arm 1a v. Arm II|Adverse Event|6|||
144300506|NCT02921256|520305389|FG001|Arm 1a v. Arm II|Adverse Event|15|||
144300507|NCT02921256|520305390|FG002|Arm 1a v. Arm II|Adverse Event|0|||
144300508|NCT02921256|520305388|FG000|Arm 1a v. Arm II|Death|0|||
144300509|NCT02921256|520305389|FG001|Arm 1a v. Arm II|Death|2|||
144300510|NCT02921256|520305390|FG002|Arm 1a v. Arm II|Death|0|||
144300511|NCT02921256|520305388|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
144300512|NCT02921256|520305389|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
144300513|NCT02921256|520305390|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
144300514|NCT02921256|520305388|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
144300515|NCT02921256|520305389|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
144300516|NCT02921256|520305390|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
144300517|NCT02921256|520305388|FG000|Arm 1a v. Arm II|Physician Decision|1|||
144300518|NCT02921256|520305389|FG001|Arm 1a v. Arm II|Physician Decision|1|||
144300519|NCT02921256|520305390|FG002|Arm 1a v. Arm II|Physician Decision|0|||
144300520|NCT02921256|520305388|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
144300521|NCT02921256|520305389|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
144300522|NCT02921256|520305390|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
144300523|NCT02921256|520305388|FG000|Arm Ib v Arm III|Adverse Event|9|||
144300524|NCT02921256|520305389|FG001|Arm Ib v Arm III|Adverse Event|0|||
144300525|NCT02921256|520305390|FG002|Arm Ib v Arm III|Adverse Event|4|||
144300526|NCT02921256|520305388|FG000|Arm Ib v Arm III|Death|1|||
144300527|NCT02921256|520305389|FG001|Arm Ib v Arm III|Death|0|||
144300528|NCT02921256|520305390|FG002|Arm Ib v Arm III|Death|1|||
144300529|NCT02921256|520305388|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
144300530|NCT02921256|520305389|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
144300531|NCT02921256|520305390|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
144300532|NCT02921256|520305388|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
144300533|NCT02921256|520305389|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
144300534|NCT02921256|520305390|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
144300535|NCT02921256|520305388|FG000|Arm Ib v Arm III|Physician Decision|4|||
144300536|NCT02921256|520305389|FG001|Arm Ib v Arm III|Physician Decision|0|||
144300537|NCT02921256|520305390|FG002|Arm Ib v Arm III|Physician Decision|1|||
144300538|NCT02921256|520305388|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
144300539|NCT02921256|520305389|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
144300540|NCT02921256|520305390|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
144300541|NCT01038323|520305391|FG000|Overall Study|Withdrawal by Subject|3|||
144300542|NCT01038323|520305392|FG001|Overall Study|Withdrawal by Subject|2|||
144300543|NCT01038323|520305393|FG002|Overall Study|Withdrawal by Subject|4|||
144300544|NCT01959932|520305394|FG000|Overall Study|Withdrawal by Subject|1|||
144300545|NCT01959932|520305395|FG001|Overall Study|Withdrawal by Subject|0|||
144300546|NCT01959932|520305396|FG002|Overall Study|Withdrawal by Subject|0|||
144300547|NCT00829244|520305399|FG000|Overall Study|Adverse Event|1|||
144300548|NCT00829244|520305400|FG001|Overall Study|Adverse Event|3|||
144300549|NCT00829244|520305399|FG000|Overall Study|Protocol Violation|1|||
144300550|NCT00829244|520305400|FG001|Overall Study|Protocol Violation|0|||
144300551|NCT00829244|520305399|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
144300552|NCT00829244|520305400|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
144300553|NCT00829244|520305399|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
144300554|NCT00829244|520305400|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
144300555|NCT00829244|520305399|FG000|Overall Study|No fertilization|2|||
144300556|NCT00829244|520305400|FG001|Overall Study|No fertilization|2|||
144300557|NCT00829244|520305399|FG000|Overall Study|All embryos discarded|0|||
144300558|NCT00829244|520305400|FG001|Overall Study|All embryos discarded|3|||
144300559|NCT00829244|520305399|FG000|Overall Study|No embryo cleavage|0|||
144300560|NCT00829244|520305400|FG001|Overall Study|No embryo cleavage|2|||
144300561|NCT03213509|520305401|FG000|Overall Study|Did not consent for verbal autopsy|4|||
144300562|NCT03213509|520305402|FG001|Overall Study|Did not consent for verbal autopsy|5|||
144300563|NCT02297412|520305403|FG000|Overall Study|Canceled|1|||
144300564|NCT02297412|520305404|FG001|Overall Study|Canceled|1|||
144300565|NCT02257528|520305411|FG000|Overall Study|Never received study treatment|1|||
144300566|NCT01897493|520307358|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
144300567|NCT00805389|520307360|FG000|Overall Study|Adverse Event|0|||
144300568|NCT00805389|520307361|FG001|Overall Study|Adverse Event|0|||
144300569|NCT00805389|520307362|FG002|Overall Study|Adverse Event|1|||
144300570|NCT00805389|520307363|FG003|Overall Study|Adverse Event|2|||
144300571|NCT00805389|520307364|FG004|Overall Study|Adverse Event|0|||
144300572|NCT00805389|520307360|FG000|Overall Study|Lost to Follow-up|4|||
144300573|NCT00805389|520307361|FG001|Overall Study|Lost to Follow-up|3|||
144300574|NCT00805389|520307362|FG002|Overall Study|Lost to Follow-up|6|||
144300575|NCT00805389|520307363|FG003|Overall Study|Lost to Follow-up|10|||
144300576|NCT00805389|520307364|FG004|Overall Study|Lost to Follow-up|9|||
144300577|NCT00805389|520307360|FG000|Overall Study|Protocol Violation|0|||
144300578|NCT00805389|520307361|FG001|Overall Study|Protocol Violation|0|||
144300579|NCT00805389|520307362|FG002|Overall Study|Protocol Violation|1|||
144300580|NCT00805389|520307363|FG003|Overall Study|Protocol Violation|0|||
144300581|NCT00805389|520307364|FG004|Overall Study|Protocol Violation|0|||
144300582|NCT00805389|520307360|FG000|Overall Study|Withdrawal by Subject|3|||
144300583|NCT00805389|520307361|FG001|Overall Study|Withdrawal by Subject|2|||
144300584|NCT00805389|520307362|FG002|Overall Study|Withdrawal by Subject|4|||
144300585|NCT00805389|520307363|FG003|Overall Study|Withdrawal by Subject|5|||
144300586|NCT00805389|520307364|FG004|Overall Study|Withdrawal by Subject|4|||
144300587|NCT01276704|520307365|FG000|Overall Study|Lost to Follow-up|2|||
144300588|NCT01276704|520307366|FG001|Overall Study|Lost to Follow-up|3|||
144300589|NCT01276704|520307365|FG000|Overall Study|Non-compliant|2|||
144300590|NCT01276704|520307366|FG001|Overall Study|Non-compliant|2|||
144300591|NCT01276704|520307365|FG000|Overall Study|Withdrawal by Subject|7|||
144300592|NCT01276704|520307366|FG001|Overall Study|Withdrawal by Subject|1|||
144300593|NCT01276704|520307365|FG000|Overall Study|Physician Decision|3|||
144300594|NCT01276704|520307366|FG001|Overall Study|Physician Decision|5|||
144300595|NCT01359956|520307367|FG000|Overall Study|Death|58|||
144300596|NCT01359956|520307368|FG001|Overall Study|Death|60|||
144300597|NCT01359956|520307369|FG002|Overall Study|Death|66|||
144300598|NCT01359956|520307370|FG003|Overall Study|Death|57|||
144300599|NCT01359956|520307367|FG000|Overall Study|Lost to Follow-up|3|||
144300600|NCT01359956|520307368|FG001|Overall Study|Lost to Follow-up|4|||
144300601|NCT01359956|520307369|FG002|Overall Study|Lost to Follow-up|1|||
144300602|NCT01359956|520307370|FG003|Overall Study|Lost to Follow-up|1|||
144300603|NCT00370292|520307371|FG000|Overall Study|Disease Progression|4|||
144300604|NCT00370292|520307371|FG000|Overall Study|Adverse Event|7|||
144300605|NCT00370292|520307371|FG000|Overall Study|Physician Decision|2|||
144300606|NCT02704208|520307372|FG000|Overall Study|Lost to Follow-up|42|||
144300607|NCT02704208|520307373|FG001|Overall Study|Lost to Follow-up|37|||
144300608|NCT03801525|520307374|FG000|Overall Study|Adverse Event|17|||
144300609|NCT03801525|520307375|FG001|Overall Study|Adverse Event|1|||
144300610|NCT03801525|520307376|FG002|Overall Study|Adverse Event|0|||
144300611|NCT03801525|520307374|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
144300612|NCT03801525|520307375|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
144300613|NCT03801525|520307376|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
144300614|NCT03801525|520307374|FG000|Overall Study|Death|29|||
144300615|NCT03801525|520307375|FG001|Overall Study|Death|1|||
144300616|NCT03801525|520307376|FG002|Overall Study|Death|4|||
144300617|NCT03801525|520307374|FG000|Overall Study|Disease Progression|6|||
144300618|NCT03801525|520307375|FG001|Overall Study|Disease Progression|0|||
144300619|NCT03801525|520307376|FG002|Overall Study|Disease Progression|1|||
144300620|NCT03801525|520307374|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
144300621|NCT03801525|520307375|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
144300622|NCT03801525|520307376|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
144300623|NCT03801525|520307374|FG000|Overall Study|Investigator Decision|18|||
144300624|NCT03801525|520307375|FG001|Overall Study|Investigator Decision|1|||
144300625|NCT03801525|520307376|FG002|Overall Study|Investigator Decision|0|||
144300626|NCT03801525|520307374|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
144300627|NCT03801525|520307375|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
144300628|NCT03801525|520307376|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
144300629|NCT03801525|520307374|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
144300630|NCT03801525|520307375|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
144300631|NCT03801525|520307376|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
144300632|NCT03801525|520307374|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
144300633|NCT03801525|520307375|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
144300634|NCT03801525|520307376|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
144300635|NCT03801525|520307374|FG000|Overall Study|Withdrawal of Subject Consent|38|||
144300636|NCT03801525|520307375|FG001|Overall Study|Withdrawal of Subject Consent|2|||
144300637|NCT03801525|520307376|FG002|Overall Study|Withdrawal of Subject Consent|1|||
144300638|NCT03801525|520307374|FG000|Overall Study|Reason not Specified|4|||
144300639|NCT03801525|520307375|FG001|Overall Study|Reason not Specified|0|||
144300640|NCT03801525|520307376|FG002|Overall Study|Reason not Specified|4|||
144300641|NCT01628913|520307379|FG000|Overall Study|Adverse Event|12|||
144300642|NCT01628913|520307380|FG001|Overall Study|Adverse Event|5|||
144300643|NCT01628913|520307379|FG000|Overall Study|Disease Progression|11|||
144300644|NCT01628913|520307380|FG001|Overall Study|Disease Progression|14|||
144300645|NCT01628913|520307379|FG000|Overall Study|Protocol Violation|1|||
144300646|NCT01628913|520307380|FG001|Overall Study|Protocol Violation|0|||
144300647|NCT01628913|520307379|FG000|Overall Study|Death|1|||
144300648|NCT01628913|520307380|FG001|Overall Study|Death|0|||
144300649|NCT01628913|520307379|FG000|Overall Study|study terminated by Sponsor|4|||
144300650|NCT01628913|520307380|FG001|Overall Study|study terminated by Sponsor|9|||
144300651|NCT01628913|520307379|FG000|Overall Study|Withdrawal by Subject|1|||
144300652|NCT01628913|520307380|FG001|Overall Study|Withdrawal by Subject|0|||
144300653|NCT01628913|520307379|FG000|Overall Study|Physician Decision|1|||
144300654|NCT01628913|520307380|FG001|Overall Study|Physician Decision|3|||
144300655|NCT04388826|520307382|FG000|Overall Study|Lost to Follow-up|3|||
144300656|NCT04388826|520307383|FG001|Overall Study|Lost to Follow-up|2|||
144300657|NCT04388826|520307382|FG000|Overall Study|Adverse Event|1|||
144300658|NCT04388826|520307383|FG001|Overall Study|Adverse Event|0|||
144300659|NCT04047446|520307384|FG000|Overall Study|Physician Decision|1|||
144300660|NCT04047446|520307385|FG001|Overall Study|Physician Decision|0|||
144300661|NCT00329420|520307386|FG000|Re-induction Phase|Lack of Efficacy|0|||
144300662|NCT00329420|520307387|FG001|Re-induction Phase|Lack of Efficacy|1|||
144300663|NCT00329420|520307388|FG002|Re-induction Phase|Lack of Efficacy|0|||
144300664|NCT00329420|520307386|FG000|Re-induction Phase|Withdrawal of Consent|0|||
144300665|NCT00329420|520307387|FG001|Re-induction Phase|Withdrawal of Consent|0|||
144300666|NCT00329420|520307388|FG002|Re-induction Phase|Withdrawal of Consent|1|||
144300667|NCT00329420|520307386|FG000|Re-induction Phase|Did not respond to re-induction|6|||
144300668|NCT00329420|520307387|FG001|Re-induction Phase|Did not respond to re-induction|5|||
144300669|NCT00329420|520307388|FG002|Re-induction Phase|Did not respond to re-induction|7|||
144300670|NCT00329420|520307386|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
144300671|NCT00329420|520307387|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
144300672|NCT00329420|520307388|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
144300673|NCT00329420|520307386|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
144300674|NCT00329420|520307387|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
144300675|NCT00329420|520307388|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
144300676|NCT00329420|520307386|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
144300677|NCT00329420|520307387|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
144300678|NCT00329420|520307388|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
144300679|NCT00892008|520307389|FG000|Overall Study|Death|5|||
144300680|NCT00892008|520307389|FG000|Overall Study|Lack of Efficacy|3|||
144300681|NCT00892008|520307389|FG000|Overall Study|Lost to Follow-up|142|||
144300682|NCT00892008|520307389|FG000|Overall Study|Other|378|||
144300683|NCT00892008|520307389|FG000|Overall Study|Adverse Event|37|||
144300684|NCT02724839|520307392|FG000|Overall Study|Withdrawal by Subject|1|||
144300685|NCT02724839|520307393|FG001|Overall Study|Withdrawal by Subject|1|||
144300686|NCT02724839|520307394|FG002|Overall Study|Withdrawal by Subject|0|||
144300687|NCT02724839|520307392|FG000|Overall Study|Lost to Follow-up|0|||
144300688|NCT02724839|520307393|FG001|Overall Study|Lost to Follow-up|3|||
144300689|NCT02724839|520307394|FG002|Overall Study|Lost to Follow-up|2|||
144300690|NCT02724839|520307392|FG000|Overall Study|Physician Decision|0|||
144300691|NCT02724839|520307393|FG001|Overall Study|Physician Decision|0|||
144300692|NCT02724839|520307394|FG002|Overall Study|Physician Decision|3|||
144300693|NCT05878067|520307396|FG000|Overall Study|Lost to Follow-up|2|||
144300694|NCT01198587|520307399|FG000|Overall Study|Lost to Follow-up|8|||
144300695|NCT01198587|520307400|FG001|Overall Study|Lost to Follow-up|0|||
144300696|NCT01198587|520307401|FG002|Overall Study|Lost to Follow-up|9|||
144300697|NCT01198587|520307402|FG003|Overall Study|Lost to Follow-up|0|||
144300698|NCT01493089|520307403|FG000|Overall Study|Protocol Violation|2|||
144300699|NCT01493089|520307404|FG001|Overall Study|Protocol Violation|2|||
144300700|NCT01493089|520307403|FG000|Overall Study|Withdrawal by Subject|1|||
144300701|NCT01493089|520307404|FG001|Overall Study|Withdrawal by Subject|0|||
144300702|NCT01493089|520307403|FG000|Overall Study|Physician Decision|0|||
144300703|NCT01493089|520307404|FG001|Overall Study|Physician Decision|1|||
144300704|NCT00560417|520307405|FG000|Overall Study|Adverse Event|3|||
144300705|NCT00560417|520307406|FG001|Overall Study|Adverse Event|2|||
144300706|NCT00560417|520307405|FG000|Overall Study|Entry Criteria Not Met|1|||
144300707|NCT00560417|520307406|FG001|Overall Study|Entry Criteria Not Met|0|||
144300708|NCT00560417|520307405|FG000|Overall Study|Lost to Follow-up|0|||
144300709|NCT00560417|520307406|FG001|Overall Study|Lost to Follow-up|1|||
144300710|NCT00560417|520307405|FG000|Overall Study|Physician Decision|2|||
144300711|NCT00560417|520307406|FG001|Overall Study|Physician Decision|6|||
144300712|NCT00560417|520307405|FG000|Overall Study|Protocol Violation|6|||
144300713|NCT00560417|520307406|FG001|Overall Study|Protocol Violation|5|||
144300714|NCT00560417|520307405|FG000|Overall Study|Sponsor Decision|2|||
144300715|NCT00560417|520307406|FG001|Overall Study|Sponsor Decision|0|||
144300716|NCT00560417|520307405|FG000|Overall Study|Withdrawal by Subject|3|||
144300717|NCT00560417|520307406|FG001|Overall Study|Withdrawal by Subject|3|||
144300718|NCT02164864|520307407|FG000|Overall Study|Trial disease worsening|7|||
144300719|NCT02164864|520307408|FG001|Overall Study|Trial disease worsening|5|||
144300720|NCT02164864|520307409|FG002|Overall Study|Trial disease worsening|1|||
144300721|NCT02164864|520307407|FG000|Overall Study|Other pre-existing disease worsening|6|||
144300722|NCT02164864|520307408|FG001|Overall Study|Other pre-existing disease worsening|4|||
144300723|NCT02164864|520307409|FG002|Overall Study|Other pre-existing disease worsening|9|||
144300724|NCT02164864|520307407|FG000|Overall Study|Other Adverse Event (AE)|52|||
144300725|NCT02164864|520307408|FG001|Overall Study|Other Adverse Event (AE)|32|||
144300726|NCT02164864|520307409|FG002|Overall Study|Other Adverse Event (AE)|49|||
144300727|NCT02164864|520307407|FG000|Overall Study|Protocol Violation|2|||
144300728|NCT02164864|520307408|FG001|Overall Study|Protocol Violation|4|||
144300729|NCT02164864|520307409|FG002|Overall Study|Protocol Violation|1|||
144300730|NCT02164864|520307407|FG000|Overall Study|Lost to Follow-up|4|||
144300731|NCT02164864|520307408|FG001|Overall Study|Lost to Follow-up|3|||
144300732|NCT02164864|520307409|FG002|Overall Study|Lost to Follow-up|2|||
144300733|NCT02164864|520307407|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
144300734|NCT02164864|520307408|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
144300735|NCT02164864|520307409|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
144300736|NCT02164864|520307407|FG000|Overall Study|Other than stated|3|||
144300737|NCT02164864|520307408|FG001|Overall Study|Other than stated|4|||
144300738|NCT02164864|520307409|FG002|Overall Study|Other than stated|14|||
144300739|NCT01870869|520307412|FG000|Overall Study|Implanted with nonstudy device|1|||
144300740|NCT01870869|520307413|FG001|Overall Study|Implanted with nonstudy device|3|||
144300741|NCT01870869|520307414|FG002|Overall Study|Implanted with nonstudy device|14|||
144300742|NCT01870869|520307415|FG003|Overall Study|Implanted with nonstudy device|4|||
144300743|NCT01870869|520307412|FG000|Overall Study|Death|0|||
144300744|NCT01870869|520307413|FG001|Overall Study|Death|0|||
144300745|NCT01870869|520307414|FG002|Overall Study|Death|7|||
144300746|NCT01870869|520307415|FG003|Overall Study|Death|1|||
144300747|NCT01870869|520307412|FG000|Overall Study|Subject choice|6|||
144300748|NCT01870869|520307413|FG001|Overall Study|Subject choice|2|||
144300749|NCT01870869|520307414|FG002|Overall Study|Subject choice|22|||
144300750|NCT01870869|520307415|FG003|Overall Study|Subject choice|8|||
144300751|NCT01870869|520307412|FG000|Overall Study|Lost to Follow-up|10|||
144300752|NCT01870869|520307413|FG001|Overall Study|Lost to Follow-up|2|||
144300753|NCT01870869|520307414|FG002|Overall Study|Lost to Follow-up|25|||
144300754|NCT01870869|520307415|FG003|Overall Study|Lost to Follow-up|3|||
144300755|NCT01870869|520307412|FG000|Overall Study|Reason not Specified|1|||
144300756|NCT01870869|520307413|FG001|Overall Study|Reason not Specified|2|||
144300757|NCT01870869|520307414|FG002|Overall Study|Reason not Specified|20|||
144300758|NCT01870869|520307415|FG003|Overall Study|Reason not Specified|4|||
144300759|NCT01870869|520307412|FG000|Overall Study|Not evaluable|10|||
144300760|NCT01870869|520307413|FG001|Overall Study|Not evaluable|5|||
144300761|NCT01870869|520307414|FG002|Overall Study|Not evaluable|42|||
144300762|NCT01870869|520307415|FG003|Overall Study|Not evaluable|10|||
144300763|NCT00557193|520307416|FG000|Induction|Adverse Event|2|||
144300764|NCT00557193|520307417|FG001|Induction|Adverse Event|0|||
144300765|NCT00557193|520307418|FG002|Induction|Adverse Event|0|||
144300766|NCT00557193|520307419|FG003|Induction|Adverse Event|0|||
144300767|NCT00557193|520307420|FG004|Induction|Adverse Event|0|||
144300768|NCT00557193|520307421|FG005|Induction|Adverse Event|0|||
144300769|NCT00557193|520307416|FG000|Induction|Death|6|||
144300770|NCT00557193|520307417|FG001|Induction|Death|0|||
144300771|NCT00557193|520307418|FG002|Induction|Death|0|||
144300772|NCT00557193|520307419|FG003|Induction|Death|0|||
144300773|NCT00557193|520307420|FG004|Induction|Death|0|||
144300774|NCT00557193|520307421|FG005|Induction|Death|0|||
144300775|NCT00557193|520307416|FG000|Induction|Physician Decision|3|||
144300776|NCT00557193|520307417|FG001|Induction|Physician Decision|0|||
144300777|NCT00557193|520307418|FG002|Induction|Physician Decision|0|||
144300778|NCT00557193|520307419|FG003|Induction|Physician Decision|0|||
144300779|NCT00557193|520307420|FG004|Induction|Physician Decision|0|||
144300780|NCT00557193|520307421|FG005|Induction|Physician Decision|0|||
144300781|NCT00557193|520307416|FG000|Induction|Withdrawal by Subject|1|||
144300782|NCT00557193|520307417|FG001|Induction|Withdrawal by Subject|0|||
144300783|NCT00557193|520307418|FG002|Induction|Withdrawal by Subject|0|||
144300784|NCT00557193|520307419|FG003|Induction|Withdrawal by Subject|0|||
144300785|NCT00557193|520307420|FG004|Induction|Withdrawal by Subject|0|||
144300786|NCT00557193|520307421|FG005|Induction|Withdrawal by Subject|0|||
144300787|NCT00557193|520307416|FG000|Induction|Refusal of Further Protocol Therapy|2|||
144300788|NCT00557193|520307417|FG001|Induction|Refusal of Further Protocol Therapy|0|||
144300789|NCT00557193|520307418|FG002|Induction|Refusal of Further Protocol Therapy|0|||
144300790|NCT00557193|520307419|FG003|Induction|Refusal of Further Protocol Therapy|0|||
144300791|NCT00557193|520307420|FG004|Induction|Refusal of Further Protocol Therapy|0|||
144300792|NCT00557193|520307421|FG005|Induction|Refusal of Further Protocol Therapy|0|||
144300793|NCT00557193|520307416|FG000|Induction|Ineligible|8|||
144300794|NCT00557193|520307417|FG001|Induction|Ineligible|0|||
144300795|NCT00557193|520307418|FG002|Induction|Ineligible|0|||
144300796|NCT00557193|520307419|FG003|Induction|Ineligible|0|||
144300797|NCT00557193|520307420|FG004|Induction|Ineligible|0|||
144300798|NCT00557193|520307421|FG005|Induction|Ineligible|0|||
144300799|NCT00557193|520307416|FG000|Induction|Inevaluable for post Induction|2|||
144300800|NCT00557193|520307417|FG001|Induction|Inevaluable for post Induction|0|||
144300801|NCT00557193|520307418|FG002|Induction|Inevaluable for post Induction|0|||
144300802|NCT00557193|520307419|FG003|Induction|Inevaluable for post Induction|0|||
144300803|NCT00557193|520307420|FG004|Induction|Inevaluable for post Induction|0|||
144300804|NCT00557193|520307421|FG005|Induction|Inevaluable for post Induction|0|||
144300805|NCT00557193|520307416|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
144300806|NCT00557193|520307417|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
144300807|NCT00557193|520307418|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
144300808|NCT00557193|520307419|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
144300809|NCT00557193|520307420|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
144300810|NCT00557193|520307421|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
144300811|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
144300812|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
144300813|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
144300814|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
144300815|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
144300816|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
144300817|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
144300818|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
144300819|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
144300820|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
144300821|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
144300822|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
144300823|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
144300824|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
144300825|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
144300826|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
144300827|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
144300828|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
144359543|NCT00001832|520522781|FG013|Treatment Period|Death during treatment|0|||
144300829|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
144300830|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
144300831|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
144300832|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
144300833|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
144300834|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
144300835|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
144300836|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
144300837|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
144300838|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
144300839|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
144300840|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
144300841|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
144300842|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
144300843|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
144300844|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
144300845|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
144300846|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
144300847|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
144300848|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
144300849|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
144300850|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
144300851|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
144300852|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
144300853|NCT00557193|520307416|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
144300854|NCT00557193|520307417|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
144300855|NCT00557193|520307418|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
144300856|NCT00557193|520307419|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
144300857|NCT00557193|520307420|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
144300858|NCT00557193|520307421|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
144300859|NCT00622726|520307422|FG000|March, 2008 to August, 2010|Death|5|||
144300860|NCT00622726|520307423|FG001|March, 2008 to August, 2010|Death|2|||
144300861|NCT00622726|520307422|FG000|August, 2010 to April, 2013|Death|1|||
144300862|NCT00622726|520307423|FG001|August, 2010 to April, 2013|Death|5|||
144300863|NCT02448381|520307425|FG000|Overall Study|Adverse Event|2|||
144300864|NCT02448381|520307426|FG001|Overall Study|Adverse Event|0|||
144300865|NCT02448381|520307425|FG000|Overall Study|Lost to Follow-up|16|||
144300866|NCT02448381|520307426|FG001|Overall Study|Lost to Follow-up|9|||
144300867|NCT02448381|520307425|FG000|Overall Study|Physician Decision|1|||
144300868|NCT02448381|520307426|FG001|Overall Study|Physician Decision|1|||
144300869|NCT02448381|520307425|FG000|Overall Study|Pregnancy|1|||
144300870|NCT02448381|520307426|FG001|Overall Study|Pregnancy|0|||
144300871|NCT02448381|520307425|FG000|Overall Study|Withdrawal by Subject|13|||
144300872|NCT02448381|520307426|FG001|Overall Study|Withdrawal by Subject|9|||
144300873|NCT02448381|520307425|FG000|Overall Study|Noncompliance with Study Procedures|2|||
144300874|NCT02448381|520307426|FG001|Overall Study|Noncompliance with Study Procedures|0|||
144300875|NCT00335829|520307429|FG000|Overall Study|Withdrawal by Subject|1|||
144300876|NCT00335829|520307429|FG000|Overall Study|Lost to Follow-up|1|||
144300877|NCT00335829|520307429|FG000|Overall Study|Adverse Event|1|||
144300878|NCT00854360|520307430|FG000|Overall Study|Adverse Event|0|||
144300879|NCT00854360|520307431|FG001|Overall Study|Adverse Event|1|||
144300880|NCT00854360|520307432|FG002|Overall Study|Adverse Event|2|||
144300881|NCT00854360|520307433|FG003|Overall Study|Adverse Event|6|||
144300882|NCT00854360|520307430|FG000|Overall Study|Withdrawal by Subject|0|||
144300883|NCT00854360|520307431|FG001|Overall Study|Withdrawal by Subject|0|||
144300884|NCT00854360|520307432|FG002|Overall Study|Withdrawal by Subject|0|||
144300885|NCT00854360|520307433|FG003|Overall Study|Withdrawal by Subject|1|||
144300886|NCT00854360|520307430|FG000|Overall Study|Pregnancy|0|||
144300887|NCT00854360|520307431|FG001|Overall Study|Pregnancy|1|||
144300888|NCT00854360|520307432|FG002|Overall Study|Pregnancy|0|||
144300889|NCT00854360|520307433|FG003|Overall Study|Pregnancy|0|||
144300890|NCT00854360|520307430|FG000|Overall Study|Lack of Efficacy|2|||
144300891|NCT00854360|520307431|FG001|Overall Study|Lack of Efficacy|1|||
144300892|NCT00854360|520307432|FG002|Overall Study|Lack of Efficacy|0|||
144300893|NCT00854360|520307433|FG003|Overall Study|Lack of Efficacy|0|||
144300894|NCT00854360|520307430|FG000|Overall Study|Other|0|||
144300895|NCT00854360|520307431|FG001|Overall Study|Other|0|||
144300896|NCT00854360|520307432|FG002|Overall Study|Other|0|||
144300897|NCT00854360|520307433|FG003|Overall Study|Other|3|||
144300898|NCT02006927|520307434|FG000|Overall Study|Adverse Event|2|||
144360012|NCT01601535|520525140|FG005|Phase 1|Progressive Disease|0|||
144300899|NCT02006927|520307434|FG000|Overall Study|Withdrawal by Subject|1|||
144300900|NCT02735200|520307437|FG000|Overall Study|Lost to Follow-up|0|||
144300901|NCT02735200|520307438|FG001|Overall Study|Lost to Follow-up|5|||
144300902|NCT02735200|520307437|FG000|Overall Study|Withdrawal by Subject|8|||
144300903|NCT02735200|520307438|FG001|Overall Study|Withdrawal by Subject|0|||
144300904|NCT02746809|520307439|FG000|Enrollment|Inclusion Exclusion not met|9|||
144300905|NCT02746809|520307439|FG000|Enrollment|Withdrawal by Subject|1|||
144300906|NCT02746809|520307439|FG000|Enrollment|Expected Enrollment Met|2|||
144300907|NCT02746809|520307439|FG000|Procedure|Death|1|||
144300908|NCT02746809|520307439|FG000|1-Month|Death|5|||
144300909|NCT02746809|520307439|FG000|6-Month|Death|2|||
144300910|NCT02746809|520307439|FG000|6-Month|Withdrawal by Subject|1|||
144300911|NCT02746809|520307439|FG000|12-Month|Death|3|||
144300912|NCT02746809|520307439|FG000|12-Month|Withdrawal by Subject|2|||
144300913|NCT02746809|520307439|FG000|24-Month|Death|1|||
144300914|NCT02746809|520307439|FG000|24-Month|Withdrawal by Subject|1|||
144300915|NCT02746809|520307439|FG000|36-Month|Death|8|||
144300916|NCT02746809|520307439|FG000|36-Month|Withdrawal by Subject|1|||
144300917|NCT02746809|520307439|FG000|48-Month|Death|7|||
144300918|NCT02746809|520307439|FG000|48-Month|Withdrawal by Subject|1|||
144300919|NCT02746809|520307439|FG000|60-Month|Death|1|||
144300920|NCT02746809|520307439|FG000|60-Month|Lost to Follow-up|2|||
144300921|NCT04165824|520307440|FG000|Overall Study|Adverse Event|23|||
144300922|NCT04165824|520307440|FG000|Overall Study|Physician Decision|1|||
144300923|NCT04165824|520307440|FG000|Overall Study|Withdrawal by Subject|17|||
144300924|NCT04165824|520307440|FG000|Overall Study|Other|5|||
144300925|NCT04403919|520307441|FG000|Overall Study|Lost to Follow-up|0|||
144300926|NCT04403919|520307442|FG001|Overall Study|Lost to Follow-up|0|||
144300927|NCT04403919|520307443|FG002|Overall Study|Lost to Follow-up|0|||
144300928|NCT04403919|520307444|FG003|Overall Study|Lost to Follow-up|1|||
144300929|NCT00016354|520307447|FG000|Overall Study|Lack of Efficacy|0|||
144300930|NCT00016354|520307448|FG001|Overall Study|Lack of Efficacy|0|||
144300931|NCT00016354|520307449|FG002|Overall Study|Lack of Efficacy|0|||
144300932|NCT00016354|520307450|FG003|Overall Study|Lack of Efficacy|0|||
144300933|NCT00016354|520307451|FG004|Overall Study|Lack of Efficacy|0|||
144300934|NCT00016354|520307452|FG005|Overall Study|Lack of Efficacy|0|||
144300935|NCT00016354|520307453|FG006|Overall Study|Lack of Efficacy|0|||
144300936|NCT00016354|520307454|FG007|Overall Study|Lack of Efficacy|1|||
144300937|NCT04756531|520307455|FG000|Overall Study|Adverse Event|0|||
144300938|NCT04756531|520307456|FG001|Overall Study|Adverse Event|0|||
144300939|NCT04756531|520307457|FG002|Overall Study|Adverse Event|0|||
144300940|NCT04756531|520307458|FG003|Overall Study|Adverse Event|0|||
144300941|NCT04756531|520307459|FG004|Overall Study|Adverse Event|1|||
144300942|NCT04756531|520307460|FG005|Overall Study|Adverse Event|0|||
144300943|NCT04756531|520307461|FG006|Overall Study|Adverse Event|0|||
144300944|NCT04756531|520307462|FG007|Overall Study|Adverse Event|0|||
144300945|NCT04756531|520307463|FG008|Overall Study|Adverse Event|0|||
144300946|NCT04756531|520307464|FG009|Overall Study|Adverse Event|0|||
144300947|NCT04756531|520307465|FG010|Overall Study|Adverse Event|0|||
144300948|NCT04756531|520307466|FG011|Overall Study|Adverse Event|0|||
144300949|NCT04756531|520307467|FG012|Overall Study|Adverse Event|0|||
144300950|NCT04756531|520307468|FG013|Overall Study|Adverse Event|0|||
144300951|NCT04756531|520307469|FG014|Overall Study|Adverse Event|0|||
144300952|NCT04756531|520307470|FG015|Overall Study|Adverse Event|0|||
144300953|NCT04756531|520307471|FG016|Overall Study|Adverse Event|0|||
144300954|NCT04756531|520307472|FG017|Overall Study|Adverse Event|0|||
144300955|NCT04756531|520307455|FG000|Overall Study|Withdrawal by Subject|0|||
144300956|NCT04756531|520307456|FG001|Overall Study|Withdrawal by Subject|0|||
144300957|NCT04756531|520307457|FG002|Overall Study|Withdrawal by Subject|0|||
144300958|NCT04756531|520307458|FG003|Overall Study|Withdrawal by Subject|0|||
144300959|NCT04756531|520307459|FG004|Overall Study|Withdrawal by Subject|0|||
144300960|NCT04756531|520307460|FG005|Overall Study|Withdrawal by Subject|0|||
144300961|NCT04756531|520307461|FG006|Overall Study|Withdrawal by Subject|1|||
144300962|NCT04756531|520307462|FG007|Overall Study|Withdrawal by Subject|0|||
144300963|NCT04756531|520307463|FG008|Overall Study|Withdrawal by Subject|0|||
144300964|NCT04756531|520307464|FG009|Overall Study|Withdrawal by Subject|0|||
144300965|NCT04756531|520307465|FG010|Overall Study|Withdrawal by Subject|0|||
144300966|NCT04756531|520307466|FG011|Overall Study|Withdrawal by Subject|0|||
144300967|NCT04756531|520307467|FG012|Overall Study|Withdrawal by Subject|0|||
144300968|NCT04756531|520307468|FG013|Overall Study|Withdrawal by Subject|0|||
144300969|NCT04756531|520307469|FG014|Overall Study|Withdrawal by Subject|0|||
144300970|NCT04756531|520307470|FG015|Overall Study|Withdrawal by Subject|0|||
144300971|NCT04756531|520307471|FG016|Overall Study|Withdrawal by Subject|0|||
144300972|NCT04756531|520307472|FG017|Overall Study|Withdrawal by Subject|0|||
144300973|NCT05643495|520307473|FG000|Overall Study|Adverse Event|0|||
144300974|NCT05643495|520307474|FG001|Overall Study|Adverse Event|1|||
144300975|NCT05643495|520307473|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
144300976|NCT05643495|520307474|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
144300977|NCT00789555|520307475|FG000|Overall Study|Protocol Amendment|78|||
144300978|NCT00789555|520307476|FG001|Overall Study|Protocol Amendment|76|||
144300979|NCT00789555|520307477|FG002|Overall Study|Protocol Amendment|80|||
144300980|NCT00789555|520307475|FG000|Overall Study|Adverse Event|17|||
144300981|NCT00789555|520307476|FG001|Overall Study|Adverse Event|7|||
144300982|NCT00789555|520307477|FG002|Overall Study|Adverse Event|10|||
144300983|NCT00789555|520307475|FG000|Overall Study|Lost to Follow-up|9|||
144300984|NCT00789555|520307476|FG001|Overall Study|Lost to Follow-up|10|||
144300985|NCT00789555|520307477|FG002|Overall Study|Lost to Follow-up|18|||
144300986|NCT00789555|520307475|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
144300987|NCT00789555|520307476|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
144300988|NCT00789555|520307477|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
144300989|NCT00789555|520307475|FG000|Overall Study|Treatment failure|11|||
144300990|NCT00789555|520307476|FG001|Overall Study|Treatment failure|8|||
144300991|NCT00789555|520307477|FG002|Overall Study|Treatment failure|12|||
144300992|NCT00789555|520307475|FG000|Overall Study|Protocol Violation|6|||
144300993|NCT00789555|520307476|FG001|Overall Study|Protocol Violation|9|||
144300994|NCT00789555|520307477|FG002|Overall Study|Protocol Violation|13|||
144300995|NCT04646005|520307481|FG000|Overall Study|Adverse Event|1|||
144300996|NCT04646005|520307481|FG000|Overall Study|Progressive Disease|71|||
144300997|NCT04646005|520307481|FG000|Overall Study|Death|20|||
144300998|NCT04646005|520307481|FG000|Overall Study|Withdrawal by Subject|12|||
144300999|NCT04646005|520307481|FG000|Overall Study|Sponsor Request|9|||
144301000|NCT04237584|520307482|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
144301001|NCT04237584|520307483|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
144301002|NCT04237584|520307484|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
144301003|NCT04237584|520307485|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
144301004|NCT04237584|520307482|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
144301005|NCT04237584|520307483|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
144301006|NCT04237584|520307484|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
144301007|NCT04237584|520307485|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
144301008|NCT04237584|520307482|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
144301009|NCT04237584|520307483|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
144301010|NCT04237584|520307484|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
144301011|NCT04237584|520307485|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
144301012|NCT04237584|520307482|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
144301013|NCT04237584|520307483|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
144301014|NCT04237584|520307484|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
144301015|NCT04237584|520307485|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
144301016|NCT04237584|520307482|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
144301017|NCT04237584|520307483|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
144301018|NCT04237584|520307484|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
144301019|NCT04237584|520307485|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
144301024|NCT05239221|520307487|FG000|Overall Study|Adverse Event|0|||
144301025|NCT05239221|520307488|FG001|Overall Study|Adverse Event|0|||
144301026|NCT05239221|520307489|FG002|Overall Study|Adverse Event|0|||
144301027|NCT05239221|520307490|FG003|Overall Study|Adverse Event|0|||
144301028|NCT05239221|520307491|FG004|Overall Study|Adverse Event|0|||
144301029|NCT05239221|520307492|FG005|Overall Study|Adverse Event|0|||
144301030|NCT05239221|520307493|FG006|Overall Study|Adverse Event|1|||
144301031|NCT05239221|520307494|FG007|Overall Study|Adverse Event|0|||
144301032|NCT05239221|520307495|FG008|Overall Study|Adverse Event|0|||
144301033|NCT05239221|520307496|FG009|Overall Study|Adverse Event|0|||
144301034|NCT05239221|520307497|FG010|Overall Study|Adverse Event|1|||
144301035|NCT05239221|520307498|FG011|Overall Study|Adverse Event|1|||
144301036|NCT05239221|520307499|FG012|Overall Study|Adverse Event|0|||
144301037|NCT05239221|520307500|FG013|Overall Study|Adverse Event|0|||
144301038|NCT05239221|520307501|FG014|Overall Study|Adverse Event|0|||
144301039|NCT05239221|520307502|FG015|Overall Study|Adverse Event|0|||
144301040|NCT05239221|520307487|FG000|Overall Study|Withdrawal by Subject|0|||
144301041|NCT05239221|520307488|FG001|Overall Study|Withdrawal by Subject|0|||
144301042|NCT05239221|520307489|FG002|Overall Study|Withdrawal by Subject|0|||
144301043|NCT05239221|520307490|FG003|Overall Study|Withdrawal by Subject|0|||
144301044|NCT05239221|520307491|FG004|Overall Study|Withdrawal by Subject|0|||
144301045|NCT05239221|520307492|FG005|Overall Study|Withdrawal by Subject|0|||
144301046|NCT05239221|520307493|FG006|Overall Study|Withdrawal by Subject|0|||
144301047|NCT05239221|520307494|FG007|Overall Study|Withdrawal by Subject|0|||
144301048|NCT05239221|520307495|FG008|Overall Study|Withdrawal by Subject|0|||
144301049|NCT05239221|520307496|FG009|Overall Study|Withdrawal by Subject|0|||
144301050|NCT05239221|520307497|FG010|Overall Study|Withdrawal by Subject|1|||
144301051|NCT05239221|520307498|FG011|Overall Study|Withdrawal by Subject|0|||
144301052|NCT05239221|520307499|FG012|Overall Study|Withdrawal by Subject|0|||
144301053|NCT05239221|520307500|FG013|Overall Study|Withdrawal by Subject|0|||
144301054|NCT05239221|520307501|FG014|Overall Study|Withdrawal by Subject|0|||
144301055|NCT05239221|520307502|FG015|Overall Study|Withdrawal by Subject|1|||
144301056|NCT02581930|520307503|FG000|Overall Study|Withdrawal by Subject|1|||
144301057|NCT02581930|520307503|FG000|Overall Study|patient declined further treatment|1|||
144301058|NCT01400412|520307504|FG000|Overall Study|Lost to Follow-up|4|||
144301059|NCT01400412|520307505|FG001|Overall Study|Lost to Follow-up|7|||
144301060|NCT01400412|520307504|FG000|Overall Study|Withdrawal by Subject|3|||
144301061|NCT01400412|520307505|FG001|Overall Study|Withdrawal by Subject|4|||
144301062|NCT01400412|520307504|FG000|Overall Study|Unable to complete|3|||
144301063|NCT01400412|520307505|FG001|Overall Study|Unable to complete|3|||
144301064|NCT01400412|520307504|FG000|Overall Study|Never started study treatment|0|||
144301065|NCT01400412|520307505|FG001|Overall Study|Never started study treatment|3|||
144301066|NCT04696146|520308731|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
144301067|NCT04696146|520308732|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
144301068|NCT04696146|520308731|FG000|Overall Study|Off hours issue with product|1|||
144301069|NCT04696146|520308732|FG001|Overall Study|Off hours issue with product|0|||
144301070|NCT01334918|520308735|FG000|Overall Study|Did not receive study drug|6|||
144301071|NCT01334918|520308736|FG001|Overall Study|Did not receive study drug|0|||
144301072|NCT01334918|520308735|FG000|Overall Study|Adverse Event|2|||
144301073|NCT01334918|520308736|FG001|Overall Study|Adverse Event|0|||
144301074|NCT01334918|520308735|FG000|Overall Study|Withdrawal by Subject|0|||
144301075|NCT01334918|520308736|FG001|Overall Study|Withdrawal by Subject|1|||
144301076|NCT00529633|520308737|FG000|Overall Study|Withdrawal by Subject|1|||
144301077|NCT00529633|520308738|FG001|Overall Study|Withdrawal by Subject|1|||
144301078|NCT01576783|520308742|FG000|Overall Study|Change in Medical Care|1|||
144301079|NCT01576783|520308743|FG001|Overall Study|Change in Medical Care|0|||
144301080|NCT01576783|520308742|FG000|Overall Study|Lost to Follow-up|14|||
144301081|NCT01576783|520308743|FG001|Overall Study|Lost to Follow-up|16|||
144301082|NCT01576783|520308742|FG000|Overall Study|Withdrawal by Subject|5|||
144301083|NCT01576783|520308743|FG001|Overall Study|Withdrawal by Subject|1|||
144301084|NCT01819272|520308745|FG000|Overall Study|Adverse Event|1|||
144301085|NCT01819272|520308746|FG001|Overall Study|Adverse Event|0|||
144301086|NCT01819272|520308747|FG002|Overall Study|Adverse Event|0|||
144301087|NCT01819272|520308748|FG003|Overall Study|Adverse Event|2|||
144301088|NCT01819272|520308749|FG004|Overall Study|Adverse Event|0|||
144301089|NCT01819272|520308750|FG005|Overall Study|Adverse Event|0|||
144301090|NCT01819272|520308745|FG000|Overall Study|Lost to Follow-up|3|||
144301091|NCT01819272|520308746|FG001|Overall Study|Lost to Follow-up|0|||
144301092|NCT01819272|520308747|FG002|Overall Study|Lost to Follow-up|1|||
144301093|NCT01819272|520308748|FG003|Overall Study|Lost to Follow-up|0|||
144301094|NCT01819272|520308749|FG004|Overall Study|Lost to Follow-up|0|||
144301095|NCT01819272|520308750|FG005|Overall Study|Lost to Follow-up|3|||
144301096|NCT01819272|520308745|FG000|Overall Study|Protocol Violation|0|||
144301097|NCT01819272|520308746|FG001|Overall Study|Protocol Violation|0|||
144301098|NCT01819272|520308747|FG002|Overall Study|Protocol Violation|0|||
144301099|NCT01819272|520308748|FG003|Overall Study|Protocol Violation|1|||
144301100|NCT01819272|520308749|FG004|Overall Study|Protocol Violation|2|||
144301101|NCT01819272|520308750|FG005|Overall Study|Protocol Violation|3|||
144301102|NCT01819272|520308745|FG000|Overall Study|Physician Decision|0|||
144301103|NCT01819272|520308746|FG001|Overall Study|Physician Decision|1|||
144301104|NCT01819272|520308747|FG002|Overall Study|Physician Decision|0|||
144301105|NCT01819272|520308748|FG003|Overall Study|Physician Decision|0|||
144301106|NCT01819272|520308749|FG004|Overall Study|Physician Decision|0|||
144301107|NCT01819272|520308750|FG005|Overall Study|Physician Decision|0|||
144301108|NCT01819272|520308745|FG000|Overall Study|Withdrawal of Consent|0|||
144301109|NCT01819272|520308746|FG001|Overall Study|Withdrawal of Consent|1|||
144301110|NCT01819272|520308747|FG002|Overall Study|Withdrawal of Consent|2|||
144301111|NCT01819272|520308748|FG003|Overall Study|Withdrawal of Consent|1|||
144301112|NCT01819272|520308749|FG004|Overall Study|Withdrawal of Consent|0|||
144301113|NCT01819272|520308750|FG005|Overall Study|Withdrawal of Consent|1|||
144301114|NCT01819272|520308745|FG000|Overall Study|Loss of Glucose Control|2|||
144301115|NCT01819272|520308746|FG001|Overall Study|Loss of Glucose Control|1|||
144301116|NCT01819272|520308747|FG002|Overall Study|Loss of Glucose Control|0|||
144301117|NCT01819272|520308748|FG003|Overall Study|Loss of Glucose Control|1|||
144301118|NCT01819272|520308749|FG004|Overall Study|Loss of Glucose Control|2|||
144301119|NCT01819272|520308750|FG005|Overall Study|Loss of Glucose Control|0|||
144301120|NCT01133665|520308751|FG000|Overall Study|Physician Decision|2|||
144301121|NCT01784029|520308752|FG000|Overall Study|Lost to Follow-up|19|||
144301122|NCT01784029|520308753|FG001|Overall Study|Lost to Follow-up|20|||
144301123|NCT01784029|520308754|FG002|Overall Study|Lost to Follow-up|22|||
144301124|NCT00276419|520308755|FG000|First Intervention|Adverse Event|1|||
144301125|NCT00276419|520308756|FG001|First Intervention|Adverse Event|0|||
144301126|NCT00276419|520308755|FG000|First Intervention|Withdrawal by Subject|0|||
144301127|NCT00276419|520308756|FG001|First Intervention|Withdrawal by Subject|2|||
144301128|NCT03545672|520308757|FG000|Overall Study|Uncertain diagnosis|2|||
144301129|NCT03545672|520308758|FG001|Overall Study|Uncertain diagnosis|1|||
144301130|NCT03545672|520308757|FG000|Overall Study|Protocol Violation|2|||
144301131|NCT03545672|520308758|FG001|Overall Study|Protocol Violation|2|||
144301132|NCT03984825|520308759|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
144301133|NCT03984825|520308759|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
144301134|NCT03984825|520308759|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
144301135|NCT02271880|520308762|FG000|Overall Study|Premature discontinuation of study|3|||
144301136|NCT02271880|520308763|FG001|Overall Study|Premature discontinuation of study|4|||
144301137|NCT00744861|520308770|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
144301138|NCT00744861|520308771|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
144301139|NCT00744861|520308772|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
144301140|NCT00744861|520308773|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
144301141|NCT00744861|520308770|FG000|Feasibility Stage 1|Pregnancy|0|||
144301142|NCT00744861|520308771|FG001|Feasibility Stage 1|Pregnancy|1|||
144301143|NCT00744861|520308772|FG002|Feasibility Stage 1|Pregnancy|0|||
144301144|NCT00744861|520308773|FG003|Feasibility Stage 1|Pregnancy|0|||
144301145|NCT00744861|520308770|FG000|Pivotal Stage 2|Adverse Event|0|||
144301146|NCT00744861|520308771|FG001|Pivotal Stage 2|Adverse Event|0|||
144301147|NCT00744861|520308772|FG002|Pivotal Stage 2|Adverse Event|6|||
144301148|NCT00744861|520308773|FG003|Pivotal Stage 2|Adverse Event|11|||
144301149|NCT00744861|520308770|FG000|Pivotal Stage 2|Death|0|||
144301150|NCT00744861|520308771|FG001|Pivotal Stage 2|Death|0|||
144301151|NCT00744861|520308772|FG002|Pivotal Stage 2|Death|0|||
144301152|NCT00744861|520308773|FG003|Pivotal Stage 2|Death|1|||
144301153|NCT00744861|520308770|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
144301154|NCT00744861|520308771|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
144301155|NCT00744861|520308772|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
144301156|NCT00744861|520308773|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
144301157|NCT00744861|520308770|FG000|Pivotal Stage 2|Physician Decision|0|||
144301158|NCT00744861|520308771|FG001|Pivotal Stage 2|Physician Decision|0|||
144301159|NCT00744861|520308772|FG002|Pivotal Stage 2|Physician Decision|3|||
144301160|NCT00744861|520308773|FG003|Pivotal Stage 2|Physician Decision|1|||
144301161|NCT00744861|520308770|FG000|Pivotal Stage 2|Protocol Violation|0|||
144301162|NCT00744861|520308771|FG001|Pivotal Stage 2|Protocol Violation|0|||
144301163|NCT00744861|520308772|FG002|Pivotal Stage 2|Protocol Violation|0|||
144301164|NCT00744861|520308773|FG003|Pivotal Stage 2|Protocol Violation|1|||
144301165|NCT00744861|520308770|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
144301166|NCT00744861|520308771|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
144301167|NCT00744861|520308772|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
144301168|NCT00744861|520308773|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
144301169|NCT00744861|520308770|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
144301170|NCT00744861|520308771|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
144301171|NCT00744861|520308772|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
144301172|NCT00744861|520308773|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
144301173|NCT02493764|520308774|FG000|Overall Study|Adverse Event|2|||
144301174|NCT02493764|520308775|FG001|Overall Study|Adverse Event|2|||
144301175|NCT02493764|520308774|FG000|Overall Study|Death|44|||
144301176|NCT02493764|520308775|FG001|Overall Study|Death|58|||
144301177|NCT02493764|520308774|FG000|Overall Study|Lost to Follow-up|2|||
144301178|NCT02493764|520308775|FG001|Overall Study|Lost to Follow-up|1|||
144301179|NCT02493764|520308774|FG000|Overall Study|Protocol Violation|6|||
144301180|NCT02493764|520308775|FG001|Overall Study|Protocol Violation|7|||
144301181|NCT02493764|520308774|FG000|Overall Study|Physician Decision|1|||
144301182|NCT02493764|520308775|FG001|Overall Study|Physician Decision|1|||
144301183|NCT02493764|520308774|FG000|Overall Study|Participant moved|17|||
144301184|NCT02493764|520308775|FG001|Overall Study|Participant moved|5|||
144301185|NCT02493764|520308774|FG000|Overall Study|Withdrawal parent/guardian|0|||
144301186|NCT02493764|520308775|FG001|Overall Study|Withdrawal parent/guardian|1|||
144301187|NCT02493764|520308774|FG000|Overall Study|Withdrawal by Subject|11|||
144301188|NCT02493764|520308775|FG001|Overall Study|Withdrawal by Subject|7|||
144301189|NCT01561976|520308776|FG000|Period 1|Adverse Event|0|||
144301190|NCT01561976|520308777|FG001|Period 1|Adverse Event|0|||
144301191|NCT01561976|520308778|FG002|Period 1|Adverse Event|1|||
144301192|NCT01561976|520308779|FG003|Period 1|Adverse Event|0|||
144301193|NCT01561976|520308780|FG004|Period 1|Adverse Event|0|||
144301194|NCT01561976|520308781|FG005|Period 1|Adverse Event|0|||
144301195|NCT01561976|520308776|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
144301196|NCT01561976|520308777|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
144301197|NCT01561976|520308778|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
144301198|NCT01561976|520308779|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
144301199|NCT01561976|520308780|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
144301200|NCT01561976|520308781|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
144301201|NCT01561976|520308776|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144301202|NCT01561976|520308777|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144301203|NCT01561976|520308778|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144301204|NCT01561976|520308779|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144301205|NCT01561976|520308780|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
144301206|NCT01561976|520308781|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
144301207|NCT01561976|520308776|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
144301208|NCT01561976|520308777|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
144301209|NCT01561976|520308778|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
144301210|NCT01561976|520308779|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
144301211|NCT01561976|520308780|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
144301212|NCT01561976|520308781|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
144301213|NCT01816295|520308784|FG000|Double Blind Phase|Adverse Event|11|||
144301214|NCT01816295|520308785|FG001|Double Blind Phase|Adverse Event|8|||
144301215|NCT01816295|520308784|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
144301216|NCT01816295|520308785|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
144301217|NCT01816295|520308784|FG000|Double Blind Phase|Lost to Follow-up|3|||
144301218|NCT01816295|520308785|FG001|Double Blind Phase|Lost to Follow-up|5|||
144301219|NCT01816295|520308784|FG000|Double Blind Phase|Physician Decision|2|||
144301220|NCT01816295|520308785|FG001|Double Blind Phase|Physician Decision|2|||
144301221|NCT01816295|520308784|FG000|Double Blind Phase|Protocol Violation|17|||
144301222|NCT01816295|520308785|FG001|Double Blind Phase|Protocol Violation|11|||
144301223|NCT01816295|520308784|FG000|Double Blind Phase|Sponsor Decision|8|||
144301224|NCT01816295|520308785|FG001|Double Blind Phase|Sponsor Decision|8|||
144301225|NCT01816295|520308784|FG000|Double Blind Phase|Withdrawal by Subject|22|||
144301226|NCT01816295|520308785|FG001|Double Blind Phase|Withdrawal by Subject|20|||
144301227|NCT01816295|520308784|FG000|OLE Phase|Adverse Event|17|||
144301228|NCT01816295|520308785|FG001|OLE Phase|Adverse Event|15|||
144301229|NCT01816295|520308784|FG000|OLE Phase|Death|1|||
144301230|NCT01816295|520308785|FG001|OLE Phase|Death|0|||
144301231|NCT01816295|520308784|FG000|OLE Phase|Entry Criteria Not Met|3|||
144301232|NCT01816295|520308785|FG001|OLE Phase|Entry Criteria Not Met|5|||
144301233|NCT01816295|520308784|FG000|OLE Phase|Lost to Follow-up|5|||
144301234|NCT01816295|520308785|FG001|OLE Phase|Lost to Follow-up|5|||
144301235|NCT01816295|520308784|FG000|OLE Phase|Physician Decision|3|||
144301236|NCT01816295|520308785|FG001|OLE Phase|Physician Decision|1|||
144301237|NCT01816295|520308784|FG000|OLE Phase|Protocol Violation|4|||
144301238|NCT01816295|520308785|FG001|OLE Phase|Protocol Violation|4|||
144301239|NCT01816295|520308784|FG000|OLE Phase|Sponsor Decision|7|||
144301240|NCT01816295|520308785|FG001|OLE Phase|Sponsor Decision|9|||
144301241|NCT01816295|520308784|FG000|OLE Phase|Withdrawal by Subject|10|||
144301242|NCT01816295|520308785|FG001|OLE Phase|Withdrawal by Subject|10|||
144301243|NCT01816295|520308784|FG000|OLE Phase|Lack of Efficacy|3|||
144301244|NCT01816295|520308785|FG001|OLE Phase|Lack of Efficacy|7|||
144301245|NCT01612676|520308788|FG000|Overall Study|Adverse Event|2|||
144301246|NCT01612676|520308789|FG001|Overall Study|Adverse Event|3|||
144301247|NCT01612676|520308790|FG002|Overall Study|Adverse Event|1|||
144301248|NCT01612676|520308791|FG003|Overall Study|Adverse Event|3|||
144301249|NCT01612676|520308788|FG000|Overall Study|Protocol Violation|0|||
144301250|NCT01612676|520308789|FG001|Overall Study|Protocol Violation|1|||
144301251|NCT01612676|520308790|FG002|Overall Study|Protocol Violation|0|||
144301252|NCT01612676|520308791|FG003|Overall Study|Protocol Violation|0|||
144301253|NCT01156844|520308794|FG000|Overall Study|Adverse Event|0|||
144301254|NCT01156844|520308795|FG001|Overall Study|Adverse Event|0|||
144301255|NCT01156844|520308796|FG002|Overall Study|Adverse Event|1|||
144301256|NCT01156844|520308797|FG003|Overall Study|Adverse Event|1|||
144301257|NCT01156844|520308794|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144301258|NCT01156844|520308795|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144301259|NCT01156844|520308796|FG002|Overall Study|Abnormal test procedure result(s)|2|||
144301260|NCT01156844|520308797|FG003|Overall Study|Abnormal test procedure result(s)|2|||
144301261|NCT01156844|520308794|FG000|Overall Study|Withdrawal by Subject|0|||
144301262|NCT01156844|520308795|FG001|Overall Study|Withdrawal by Subject|0|||
144301263|NCT01156844|520308796|FG002|Overall Study|Withdrawal by Subject|2|||
144301264|NCT01156844|520308797|FG003|Overall Study|Withdrawal by Subject|2|||
144301265|NCT01156844|520308794|FG000|Overall Study|Lost to Follow-up|0|||
144301266|NCT01156844|520308795|FG001|Overall Study|Lost to Follow-up|0|||
144301267|NCT01156844|520308796|FG002|Overall Study|Lost to Follow-up|1|||
144301268|NCT01156844|520308797|FG003|Overall Study|Lost to Follow-up|0|||
144301269|NCT01156844|520308794|FG000|Overall Study|Administrative problems|0|||
144301270|NCT01156844|520308795|FG001|Overall Study|Administrative problems|1|||
144301271|NCT01156844|520308796|FG002|Overall Study|Administrative problems|0|||
144301272|NCT01156844|520308797|FG003|Overall Study|Administrative problems|1|||
144301273|NCT01156844|520308794|FG000|Overall Study|Protocol deviation|2|||
144301274|NCT01156844|520308795|FG001|Overall Study|Protocol deviation|0|||
144301275|NCT01156844|520308796|FG002|Overall Study|Protocol deviation|0|||
144301276|NCT01156844|520308797|FG003|Overall Study|Protocol deviation|0|||
144301277|NCT04846231|520308801|FG000|Overall Study|Lost to Follow-up|1|||
144301278|NCT04846231|520308802|FG001|Overall Study|Lost to Follow-up|0|||
144301279|NCT04846231|520308803|FG002|Overall Study|Lost to Follow-up|0|||
144301280|NCT04846231|520308804|FG003|Overall Study|Lost to Follow-up|0|||
144301281|NCT04846231|520308805|FG004|Overall Study|Lost to Follow-up|0|||
144301282|NCT04846231|520308806|FG005|Overall Study|Lost to Follow-up|0|||
144301283|NCT04846231|520308807|FG006|Overall Study|Lost to Follow-up|0|||
144301284|NCT04846231|520308808|FG007|Overall Study|Lost to Follow-up|1|||
144301285|NCT04846231|520308801|FG000|Overall Study|Withdrawal by Subject|0|||
144301286|NCT04846231|520308802|FG001|Overall Study|Withdrawal by Subject|1|||
144301287|NCT04846231|520308803|FG002|Overall Study|Withdrawal by Subject|2|||
144301288|NCT04846231|520308804|FG003|Overall Study|Withdrawal by Subject|1|||
144301289|NCT04846231|520308805|FG004|Overall Study|Withdrawal by Subject|0|||
144301290|NCT04846231|520308806|FG005|Overall Study|Withdrawal by Subject|0|||
144301291|NCT04846231|520308807|FG006|Overall Study|Withdrawal by Subject|0|||
144301292|NCT04846231|520308808|FG007|Overall Study|Withdrawal by Subject|0|||
144301293|NCT04846231|520308801|FG000|Overall Study|Protocol Violation|0|||
144301294|NCT04846231|520308802|FG001|Overall Study|Protocol Violation|1|||
144301295|NCT04846231|520308803|FG002|Overall Study|Protocol Violation|0|||
144301296|NCT04846231|520308804|FG003|Overall Study|Protocol Violation|0|||
144301297|NCT04846231|520308805|FG004|Overall Study|Protocol Violation|0|||
144301298|NCT04846231|520308806|FG005|Overall Study|Protocol Violation|0|||
144301299|NCT04846231|520308807|FG006|Overall Study|Protocol Violation|0|||
144301300|NCT04846231|520308808|FG007|Overall Study|Protocol Violation|0|||
144301301|NCT04846231|520308801|FG000|Overall Study|Adverse Event|0|||
144301302|NCT04846231|520308802|FG001|Overall Study|Adverse Event|0|||
144301303|NCT04846231|520308803|FG002|Overall Study|Adverse Event|0|||
144301304|NCT04846231|520308804|FG003|Overall Study|Adverse Event|0|||
144301305|NCT04846231|520308805|FG004|Overall Study|Adverse Event|0|||
144301306|NCT04846231|520308806|FG005|Overall Study|Adverse Event|0|||
144301307|NCT04846231|520308807|FG006|Overall Study|Adverse Event|1|||
144301308|NCT04846231|520308808|FG007|Overall Study|Adverse Event|1|||
144301309|NCT02980107|520308809|FG000|Overall Study|Withdrawal by Subject|51|||
144301310|NCT02980107|520308810|FG001|Overall Study|Withdrawal by Subject|62|||
144301311|NCT04067011|520308811|FG000|Overall Study|Not Treated|8|||
144301312|NCT04067011|520308812|FG001|Overall Study|Not Treated|7|||
144301313|NCT04067011|520308813|FG002|Overall Study|Not Treated|5|||
144301314|NCT04067011|520308811|FG000|Overall Study|Adverse Event|2|||
144301315|NCT04067011|520308812|FG001|Overall Study|Adverse Event|1|||
144301316|NCT04067011|520308813|FG002|Overall Study|Adverse Event|0|||
144301317|NCT04067011|520308811|FG000|Overall Study|Withdrawal by Subject|6|||
144301318|NCT04067011|520308812|FG001|Overall Study|Withdrawal by Subject|2|||
144301319|NCT04067011|520308813|FG002|Overall Study|Withdrawal by Subject|1|||
144301320|NCT04067011|520308811|FG000|Overall Study|Lost to Follow-up|0|||
144301321|NCT04067011|520308812|FG001|Overall Study|Lost to Follow-up|0|||
144301322|NCT04067011|520308813|FG002|Overall Study|Lost to Follow-up|1|||
144301323|NCT04067011|520308811|FG000|Overall Study|Physician Decision|1|||
144301324|NCT04067011|520308812|FG001|Overall Study|Physician Decision|1|||
144301325|NCT04067011|520308813|FG002|Overall Study|Physician Decision|0|||
144301326|NCT04067011|520308811|FG000|Overall Study|Other Reasons|2|||
144301327|NCT04067011|520308812|FG001|Overall Study|Other Reasons|0|||
144301328|NCT04067011|520308813|FG002|Overall Study|Other Reasons|1|||
144301329|NCT04067011|520308811|FG000|Overall Study|Missing|0|||
144301330|NCT04067011|520308812|FG001|Overall Study|Missing|2|||
144301331|NCT04067011|520308813|FG002|Overall Study|Missing|0|||
144301332|NCT05209386|520308814|FG000|Overall Study|Withdrawal by Subject|8|||
144301333|NCT05209386|520308814|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
144301334|NCT05200845|520308816|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
144301335|NCT05200845|520308817|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
144301336|NCT05200845|520308818|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
144301337|NCT05200845|520308819|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
144301338|NCT05200845|520308816|FG000|Overall Study|Withdrawal by Subject|0|||
144301339|NCT05200845|520308817|FG001|Overall Study|Withdrawal by Subject|1|||
144301340|NCT05200845|520308818|FG002|Overall Study|Withdrawal by Subject|1|||
144301341|NCT05200845|520308819|FG003|Overall Study|Withdrawal by Subject|0|||
144301342|NCT02412670|520308820|FG000|Overall Study|Adverse Event|4|||
144301343|NCT02412670|520308821|FG001|Overall Study|Adverse Event|1|||
144301344|NCT02412670|520308820|FG000|Overall Study|Physician Decision|1|||
144301345|NCT02412670|520308821|FG001|Overall Study|Physician Decision|0|||
144301346|NCT02412670|520308820|FG000|Overall Study|Withdrawal by Subject|1|||
144301347|NCT02412670|520308821|FG001|Overall Study|Withdrawal by Subject|0|||
144301348|NCT02412670|520308820|FG000|Overall Study|Ineligible|1|||
144301349|NCT02412670|520308821|FG001|Overall Study|Ineligible|0|||
144301350|NCT04064905|520308827|FG000|Overall Study|Lost to Follow-up|0|||
144301351|NCT04064905|520308828|FG001|Overall Study|Lost to Follow-up|3|||
144301352|NCT04064905|520308829|FG002|Overall Study|Lost to Follow-up|1|||
144301353|NCT04064905|520308830|FG003|Overall Study|Lost to Follow-up|4|||
144301354|NCT04064905|520308831|FG004|Overall Study|Lost to Follow-up|2|||
144301355|NCT01567722|520308835|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
144301356|NCT01567722|520308836|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
144301357|NCT01567722|520308837|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
144301358|NCT01567722|520308835|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
144301359|NCT01567722|520308836|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
144301360|NCT01567722|520308837|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
144301361|NCT01567722|520308835|FG000|Overall Study|Protocol closure by the OCG|2|||
144301362|NCT01567722|520308836|FG001|Overall Study|Protocol closure by the OCG|0|||
144301363|NCT01567722|520308837|FG002|Overall Study|Protocol closure by the OCG|0|||
144301364|NCT01567722|520308835|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
144301365|NCT01567722|520308836|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
144301366|NCT01567722|520308837|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
144301367|NCT02170064|520308838|FG000|Overall Study|Withdrawal by Subject|5|||
144301368|NCT02170064|520308839|FG001|Overall Study|Withdrawal by Subject|1|||
144301369|NCT02170064|520308840|FG002|Overall Study|Withdrawal by Subject|1|||
144301370|NCT02170064|520308838|FG000|Overall Study|Physician Decision|1|||
144301371|NCT02170064|520308839|FG001|Overall Study|Physician Decision|1|||
144301372|NCT02170064|520308840|FG002|Overall Study|Physician Decision|0|||
144301373|NCT04211363|520308841|FG000|Overall Study|Adverse Event|5|||
144301374|NCT04211363|520308842|FG001|Overall Study|Adverse Event|2|||
144301375|NCT04211363|520308841|FG000|Overall Study|Physician Decision|0|||
144301376|NCT04211363|520308842|FG001|Overall Study|Physician Decision|1|||
144301377|NCT04211363|520308841|FG000|Overall Study|Protocol Violation|1|||
144301378|NCT04211363|520308842|FG001|Overall Study|Protocol Violation|0|||
144301379|NCT04211363|520308841|FG000|Overall Study|Pregnancy|1|||
144301380|NCT04211363|520308842|FG001|Overall Study|Pregnancy|0|||
144301381|NCT04211363|520308841|FG000|Overall Study|Lost to Follow-up|12|||
144301382|NCT04211363|520308842|FG001|Overall Study|Lost to Follow-up|4|||
144301383|NCT04211363|520308841|FG000|Overall Study|Withdrawal by Subject|11|||
144301384|NCT04211363|520308842|FG001|Overall Study|Withdrawal by Subject|11|||
144301385|NCT04211363|520308841|FG000|Overall Study|Other|1|||
144301386|NCT04211363|520308842|FG001|Overall Study|Other|2|||
144301387|NCT00404248|520308847|FG000|Overall Study|pts declining status|0|||
144301388|NCT00404248|520308848|FG001|Overall Study|pts declining status|1|||
144301389|NCT00404248|520308849|FG002|Overall Study|pts declining status|0|||
144301390|NCT00404248|520308850|FG003|Overall Study|pts declining status|0|||
144301391|NCT00404248|520308851|FG004|Overall Study|pts declining status|0|||
144301392|NCT00404248|520308852|FG005|Overall Study|pts declining status|0|||
144301393|NCT00404248|520308853|FG006|Overall Study|pts declining status|0|||
144301394|NCT00404248|520308854|FG007|Overall Study|pts declining status|0|||
144301395|NCT00404248|520308855|FG008|Overall Study|pts declining status|0|||
144301396|NCT00698841|520308856|FG000|Overall Study|Withdrawal by Subject|2|||
144301397|NCT00698841|520308856|FG000|Overall Study|Adverse Event|3|||
144301398|NCT00698841|520308856|FG000|Overall Study|Disease progression|7|||
144301399|NCT00698841|520308856|FG000|Overall Study|Failure to meet eligibility criteria|2|||
144301400|NCT00698841|520308856|FG000|Overall Study|Study drug toxicity|2|||
144301401|NCT00698841|520308856|FG000|Overall Study|Other|2|||
144301402|NCT05788991|520308858|FG000|Overall Study|Not treated with study medication|1|||
144301403|NCT05788991|520308859|FG001|Overall Study|Not treated with study medication|3|||
144301404|NCT05788991|520308858|FG000|Overall Study|Withdrawal by Subject|1|||
144301405|NCT05788991|520308859|FG001|Overall Study|Withdrawal by Subject|0|||
144301406|NCT05788991|520308858|FG000|Overall Study|Lack of Efficacy|0|||
144301407|NCT05788991|520308859|FG001|Overall Study|Lack of Efficacy|1|||
144301408|NCT05788991|520308858|FG000|Overall Study|Protocol Violation|1|||
144301409|NCT05788991|520308859|FG001|Overall Study|Protocol Violation|2|||
144301410|NCT04464473|520308860|FG000|Overall Study|New piercing could not be removed for scanning|0|||
144301411|NCT04464473|520308861|FG001|Overall Study|New piercing could not be removed for scanning|0|||
144360013|NCT01601535|520525135|FG000|Phase 1|Started Another Treatment|1|||
144301412|NCT04464473|520308862|FG002|Overall Study|New piercing could not be removed for scanning|0|||
144301413|NCT04464473|520308863|FG003|Overall Study|New piercing could not be removed for scanning|1|||
144301414|NCT04464473|520308864|FG004|Overall Study|New piercing could not be removed for scanning|0|||
144301415|NCT04464473|520308865|FG005|Overall Study|New piercing could not be removed for scanning|0|||
144301416|NCT04464473|520308860|FG000|Overall Study|Adverse Event|0|||
144301417|NCT04464473|520308861|FG001|Overall Study|Adverse Event|0|||
144301418|NCT04464473|520308862|FG002|Overall Study|Adverse Event|0|||
144301419|NCT04464473|520308863|FG003|Overall Study|Adverse Event|1|||
144301420|NCT04464473|520308864|FG004|Overall Study|Adverse Event|0|||
144301421|NCT04464473|520308865|FG005|Overall Study|Adverse Event|0|||
144301422|NCT04464473|520308860|FG000|Overall Study|Lost to Follow-up|0|||
144301423|NCT04464473|520308861|FG001|Overall Study|Lost to Follow-up|0|||
144301424|NCT04464473|520308862|FG002|Overall Study|Lost to Follow-up|0|||
144301425|NCT04464473|520308863|FG003|Overall Study|Lost to Follow-up|1|||
144301426|NCT04464473|520308864|FG004|Overall Study|Lost to Follow-up|0|||
144301427|NCT04464473|520308865|FG005|Overall Study|Lost to Follow-up|0|||
144301428|NCT03802396|520308866|FG000|Overall Study|Withdrawal by Subject|2|||
144301429|NCT03802396|520308867|FG001|Overall Study|Withdrawal by Subject|0|||
144301430|NCT03802396|520308866|FG000|Overall Study|Surgery Cancelled|1|||
144301431|NCT03802396|520308867|FG001|Overall Study|Surgery Cancelled|0|||
144301432|NCT02777086|520310402|FG000|Overall Study|Lost to Follow-up|96|||
144301433|NCT02777086|520310403|FG001|Overall Study|Lost to Follow-up|99|||
144301434|NCT02986074|520310406|FG000|First Trial Period|Adverse Event|1|||
144301435|NCT02986074|520310407|FG001|First Trial Period|Adverse Event|0|||
144301436|NCT02986074|520310408|FG002|First Trial Period|Adverse Event|0|||
144301437|NCT02986074|520310409|FG003|First Trial Period|Adverse Event|0|||
144301438|NCT02986074|520310406|FG000|Follow up Period|system explant|0|||
144301439|NCT02986074|520310407|FG001|Follow up Period|system explant|0|||
144301440|NCT02986074|520310408|FG002|Follow up Period|system explant|1|||
144301441|NCT02986074|520310409|FG003|Follow up Period|system explant|2|||
144301442|NCT02986074|520310406|FG000|Follow up Period|Physician Decision|0|||
144301443|NCT02986074|520310407|FG001|Follow up Period|Physician Decision|0|||
144301444|NCT02986074|520310408|FG002|Follow up Period|Physician Decision|0|||
144301445|NCT02986074|520310409|FG003|Follow up Period|Physician Decision|1|||
144301446|NCT00560508|520310410|FG000|12 Week Double-blind Period|Adverse Event|3|||
144301447|NCT00560508|520310411|FG001|12 Week Double-blind Period|Adverse Event|2|||
144301448|NCT00560508|520310410|FG000|12 Week Double-blind Period|Protocol Violation|1|||
144301449|NCT00560508|520310411|FG001|12 Week Double-blind Period|Protocol Violation|0|||
144301450|NCT00560508|520310410|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
144301451|NCT00560508|520310411|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
144301452|NCT00560508|520310410|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
144301453|NCT00560508|520310411|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
144301454|NCT00560508|520310410|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
144301455|NCT00560508|520310411|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
144301456|NCT00560508|520310410|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
144301457|NCT00560508|520310411|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
144301458|NCT00560508|520310410|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
144301459|NCT00560508|520310411|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
144301460|NCT01146613|520310412|FG000|Overall Study|Lost to Follow-up|3|||
144301461|NCT01146613|520310413|FG001|Overall Study|Lost to Follow-up|8|||
144301462|NCT01146613|520310412|FG000|Overall Study|Lack of Efficacy|0|||
144301463|NCT01146613|520310413|FG001|Overall Study|Lack of Efficacy|1|||
144301464|NCT01146613|520310412|FG000|Overall Study|Death|1|||
144301465|NCT01146613|520310413|FG001|Overall Study|Death|0|||
144301466|NCT01146613|520310412|FG000|Overall Study|Physician Decision|1|||
144301467|NCT01146613|520310413|FG001|Overall Study|Physician Decision|0|||
144301468|NCT01146613|520310412|FG000|Overall Study|Withdrawal by Subject|0|||
144301469|NCT01146613|520310413|FG001|Overall Study|Withdrawal by Subject|3|||
144301470|NCT01146613|520310412|FG000|Overall Study|schedule conflict|1|||
144301471|NCT01146613|520310413|FG001|Overall Study|schedule conflict|0|||
144301472|NCT01146613|520310412|FG000|Overall Study|Outpatient detox|1|||
144301473|NCT01146613|520310413|FG001|Overall Study|Outpatient detox|0|||
144301474|NCT00652834|520310414|FG000|Overall Study|Withdrawal by Subject|3|||
144301475|NCT00652834|520310414|FG000|Overall Study|Lost to Follow-up|2|||
144301476|NCT00320606|520310415|FG000|Overall Study|Adverse Event|1|||
144301477|NCT00320606|520310415|FG000|Overall Study|Protocol Violation|1|||
144301478|NCT00320606|520310415|FG000|Overall Study|Withdrawal by Subject|1|||
144301479|NCT02569853|520310416|FG000|Overall Study|Adverse Event|2|||
144301480|NCT02569853|520310417|FG001|Overall Study|Adverse Event|0|||
144301481|NCT02569853|520310416|FG000|Overall Study|Withdrawal by Subject|3|||
144301482|NCT02569853|520310417|FG001|Overall Study|Withdrawal by Subject|2|||
144301483|NCT02569853|520310416|FG000|Overall Study|Lost to Follow-up|3|||
144301484|NCT02569853|520310417|FG001|Overall Study|Lost to Follow-up|3|||
144301485|NCT02569853|520310416|FG000|Overall Study|Protocol Violation|1|||
144301486|NCT02569853|520310417|FG001|Overall Study|Protocol Violation|1|||
144301487|NCT02569853|520310416|FG000|Overall Study|Did not experience migraine attack|10|||
144301488|NCT02569853|520310417|FG001|Overall Study|Did not experience migraine attack|7|||
144301489|NCT02569853|520310416|FG000|Overall Study|Physician Decision|1|||
144301490|NCT02569853|520310417|FG001|Overall Study|Physician Decision|1|||
144301491|NCT00474903|520310423|FG000|Overall Study|Protocol Violation|1|||
144301492|NCT00474903|520310424|FG001|Overall Study|Protocol Violation|5|||
144301493|NCT00474903|520310425|FG002|Overall Study|Protocol Violation|2|||
144301494|NCT00399529|520310426|FG000|Overall Study|Off Study Prior to Treatment|2|||
144301495|NCT00742625|520310427|FG000|Remission Induction|Progression|6|||
144301496|NCT00742625|520310427|FG000|Remission Induction|Failed induction|8|||
144301497|NCT00742625|520310427|FG000|Remission Induction|Adverse Event|3|||
144301498|NCT00742625|520310427|FG000|Remission Induction|Death|10|||
144301499|NCT00742625|520310427|FG000|Remission Induction|Refusal|5|||
144301500|NCT00742625|520310427|FG000|Remission Induction|Non protocol treatment|17|||
144301501|NCT00742625|520310427|FG000|Remission Induction|Other, not specified|5|||
144301502|NCT00742625|520310427|FG000|Consolidation|Progression|5|||
144301503|NCT00742625|520310427|FG000|Consolidation|Adverse Event|1|||
144301504|NCT00742625|520310427|FG000|Consolidation|Death|1|||
144301505|NCT00742625|520310427|FG000|Consolidation|Refused|1|||
144301506|NCT00742625|520310427|FG000|Consolidation|Non protocol therapy|13|||
144301507|NCT02519842|520310428|FG000|Base Study: Cycle 1|Screening Failure|1|||
144301508|NCT02519842|520310429|FG001|Base Study: Cycle 1|Screening Failure|1|||
144301509|NCT02519842|520310430|FG002|Base Study: Cycle 1|Screening Failure|0|||
144301510|NCT02519842|520310428|FG000|Base Study: Cycle 1|Adverse Event|1|||
144301511|NCT02519842|520310429|FG001|Base Study: Cycle 1|Adverse Event|0|||
144301512|NCT02519842|520310430|FG002|Base Study: Cycle 1|Adverse Event|0|||
144301513|NCT02519842|520310428|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
144301514|NCT02519842|520310429|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
144301515|NCT02519842|520310430|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
144301516|NCT02519842|520310428|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
144301517|NCT02519842|520310429|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
144301518|NCT02519842|520310430|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
144301519|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
144301520|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
144301521|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
144301522|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
144301523|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
144301524|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
144301525|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144301526|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
144301527|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
144301528|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
144301529|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
144301530|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
144301531|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Death|0|||
144301532|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Death|0|||
144301533|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Death|1|||
144301534|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
144301535|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
144301536|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
144301537|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
144301538|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
144301539|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
144301540|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
144301541|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
144301542|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
144301543|NCT02519842|520310428|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
144301544|NCT02519842|520310429|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
144301545|NCT02519842|520310430|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
144301546|NCT01627691|520310434|FG000|Overall Study|Death|11|||
144301547|NCT01627691|520310434|FG000|Overall Study|Lost to Follow-up|3|||
144301548|NCT01627691|520310434|FG000|Overall Study|Withdrawal by Subject|1|||
144301549|NCT01627691|520310434|FG000|Overall Study|Missed the visit|3|||
144301550|NCT02115321|520310435|FG000|Overall Study|Death|1|||
144301551|NCT02115321|520310436|FG001|Overall Study|Death|0|||
144301552|NCT01908140|520310438|FG000|Overall Study|Other or Progressive Disease|5|||
144301553|NCT01908140|520310439|FG001|Overall Study|Other or Progressive Disease|12|||
144301554|NCT01908140|520310438|FG000|Overall Study|Lack of Efficacy|7|||
144301555|NCT01908140|520310439|FG001|Overall Study|Lack of Efficacy|5|||
144301556|NCT01908140|520310438|FG000|Overall Study|Withdrawal by Subject|23|||
144301557|NCT01908140|520310439|FG001|Overall Study|Withdrawal by Subject|24|||
144301558|NCT01908140|520310438|FG000|Overall Study|Lost to Follow-up|1|||
144301559|NCT01908140|520310439|FG001|Overall Study|Lost to Follow-up|6|||
144301560|NCT01908140|520310438|FG000|Overall Study|Protocol Violation|8|||
144301561|NCT01908140|520310439|FG001|Overall Study|Protocol Violation|9|||
144301562|NCT01908140|520310438|FG000|Overall Study|Adverse Event|22|||
144301563|NCT01908140|520310439|FG001|Overall Study|Adverse Event|23|||
144301564|NCT03218917|520310440|FG000|Overall Study|Adverse Event|3|||
144301565|NCT03218917|520310441|FG001|Overall Study|Adverse Event|3|||
144301566|NCT03218917|520310442|FG002|Overall Study|Adverse Event|2|||
144301567|NCT03218917|520310440|FG000|Overall Study|Subject withdrew consent|2|||
144301568|NCT03218917|520310441|FG001|Overall Study|Subject withdrew consent|4|||
144301569|NCT03218917|520310442|FG002|Overall Study|Subject withdrew consent|10|||
144301570|NCT03218917|520310440|FG000|Overall Study|Physician Decision|0|||
144301571|NCT03218917|520310441|FG001|Overall Study|Physician Decision|1|||
144301572|NCT03218917|520310442|FG002|Overall Study|Physician Decision|1|||
144301573|NCT03218917|520310440|FG000|Overall Study|Lost to Follow-up|1|||
144301574|NCT03218917|520310441|FG001|Overall Study|Lost to Follow-up|0|||
144301575|NCT03218917|520310442|FG002|Overall Study|Lost to Follow-up|0|||
144301576|NCT03218917|520310440|FG000|Overall Study|Reason Missing|0|||
144301577|NCT03218917|520310441|FG001|Overall Study|Reason Missing|2|||
144301578|NCT03218917|520310442|FG002|Overall Study|Reason Missing|0|||
144301579|NCT03218917|520310440|FG000|Overall Study|Death|0|||
144301580|NCT03218917|520310441|FG001|Overall Study|Death|1|||
144301581|NCT03218917|520310442|FG002|Overall Study|Death|0|||
144301582|NCT03218917|520310440|FG000|Overall Study|Non-Compliance with Study Drug|0|||
144301583|NCT03218917|520310441|FG001|Overall Study|Non-Compliance with Study Drug|1|||
144301584|NCT03218917|520310442|FG002|Overall Study|Non-Compliance with Study Drug|0|||
144301585|NCT01307449|520310443|FG000|Overall Study|Adverse Event|1|||
144301586|NCT01307449|520310444|FG001|Overall Study|Adverse Event|0|||
144301587|NCT01307449|520310445|FG002|Overall Study|Adverse Event|0|||
144301588|NCT01307449|520310446|FG003|Overall Study|Adverse Event|0|||
144301589|NCT02639390|520310447|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
144301590|NCT02639390|520310448|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
144301591|NCT00107276|520310451|FG000|Overall Study|Progression|46|||
144301592|NCT00107276|520310451|FG000|Overall Study|Adverse Event|6|||
144301593|NCT00107276|520310451|FG000|Overall Study|M.D. decision|2|||
144301594|NCT00107276|520310451|FG000|Overall Study|Patient refusal|1|||
144301595|NCT00107276|520310451|FG000|Overall Study|Death|1|||
144301596|NCT00107276|520310451|FG000|Overall Study|Ineligible|16|||
144301597|NCT00945659|520310452|FG000|Overall Study|Lost to Follow-up|7|||
144301598|NCT00945659|520310453|FG001|Overall Study|Lost to Follow-up|20|||
144301599|NCT00945659|520310454|FG002|Overall Study|Lost to Follow-up|17|||
144301600|NCT01448616|520310455|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
144301601|NCT01448616|520310456|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
144301602|NCT01448616|520310457|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
144301603|NCT01448616|520310458|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
144301604|NCT01448616|520310455|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
144301605|NCT01448616|520310456|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
144301606|NCT01448616|520310457|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
144301607|NCT01448616|520310458|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
144301608|NCT01448616|520310455|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
144301609|NCT01448616|520310456|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
144301610|NCT01448616|520310457|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
144301611|NCT01448616|520310458|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
144301612|NCT01448616|520310455|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
144301613|NCT01448616|520310456|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
144301614|NCT01448616|520310457|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
144301615|NCT01448616|520310458|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
144301616|NCT01448616|520310455|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
144301617|NCT01448616|520310456|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
144301618|NCT01448616|520310457|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
144301619|NCT01448616|520310458|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
144301620|NCT03323164|520310461|FG000|Overall Study|Poor quality imaging/scans|2|||
144301621|NCT03323164|520310462|FG001|Overall Study|Poor quality imaging/scans|2|||
144301622|NCT03383666|520310466|FG000|Overall Study|Withdrawal by Subject|2|||
144301623|NCT03383666|520310466|FG000|Overall Study|Lost to Follow-up|2|||
144301624|NCT02536664|520310467|FG000|Overall Study|Inadequate completion of documentation|2|||
144301625|NCT02536664|520310468|FG001|Overall Study|Inadequate completion of documentation|4|||
144301626|NCT02536664|520310467|FG000|Overall Study|Progression|13|||
144301627|NCT02536664|520310468|FG001|Overall Study|Progression|18|||
144301628|NCT02536664|520310467|FG000|Overall Study|Death due to lymphoma|2|||
144301629|NCT02536664|520310468|FG001|Overall Study|Death due to lymphoma|1|||
144301630|NCT02536664|520310467|FG000|Overall Study|Death due to other reason|3|||
144301631|NCT02536664|520310468|FG001|Overall Study|Death due to other reason|2|||
144301632|NCT02536664|520310467|FG000|Overall Study|Intolerability|8|||
144301633|NCT02536664|520310468|FG001|Overall Study|Intolerability|6|||
144301634|NCT02536664|520310467|FG000|Overall Study|Withdrawal by Subject|8|||
144301635|NCT02536664|520310468|FG001|Overall Study|Withdrawal by Subject|5|||
144301636|NCT02536664|520310467|FG000|Overall Study|Other|18|||
144301637|NCT02536664|520310468|FG001|Overall Study|Other|24|||
144301638|NCT02536664|520310467|FG000|Overall Study|Missing|53|||
144301639|NCT02536664|520310468|FG001|Overall Study|Missing|20|||
144301640|NCT03507127|520310478|FG000|Overall Study|Withdrawal by Subject|1|||
144301641|NCT03507127|520310479|FG001|Overall Study|Withdrawal by Subject|0|||
144301642|NCT03507127|520310478|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
144301643|NCT03507127|520310479|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
144301644|NCT01240863|520310480|FG000|Open-label Titration Period|Adverse Event|47|||
144301645|NCT01240863|520310481|FG001|Open-label Titration Period|Adverse Event|0|||
144301646|NCT01240863|520310482|FG002|Open-label Titration Period|Adverse Event|0|||
144301647|NCT01240863|520310480|FG000|Open-label Titration Period|Lack of Efficacy|19|||
144301648|NCT01240863|520310481|FG001|Open-label Titration Period|Lack of Efficacy|0|||
144301649|NCT01240863|520310482|FG002|Open-label Titration Period|Lack of Efficacy|0|||
144301650|NCT01240863|520310480|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
144301651|NCT01240863|520310481|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
144301652|NCT01240863|520310482|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
144301653|NCT01240863|520310480|FG000|Open-label Titration Period|Protocol Violation|7|||
144301654|NCT01240863|520310481|FG001|Open-label Titration Period|Protocol Violation|0|||
144301655|NCT01240863|520310482|FG002|Open-label Titration Period|Protocol Violation|0|||
144301656|NCT01240863|520310480|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
144301657|NCT01240863|520310481|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
144301658|NCT01240863|520310482|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
144301659|NCT01240863|520310480|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
144301660|NCT01240863|520310481|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
144301661|NCT01240863|520310482|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
144301662|NCT01240863|520310480|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
144301663|NCT01240863|520310481|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
144301664|NCT01240863|520310482|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
144301665|NCT01240863|520310480|FG000|Open-label Titration Period|Other|7|||
144301666|NCT01240863|520310481|FG001|Open-label Titration Period|Other|0|||
144301667|NCT01240863|520310482|FG002|Open-label Titration Period|Other|0|||
144301668|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
144301669|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
144301670|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
144301671|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
144301672|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
144301673|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
144301674|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
144301675|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
144301676|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
144301677|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
144301678|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
144301679|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
144301680|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
144301681|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
144301682|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
144301683|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
144301684|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
144301685|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
144301686|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
144301687|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
144301688|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
144301689|NCT01240863|520310480|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
144301690|NCT01240863|520310481|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
144301691|NCT01240863|520310482|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
144301692|NCT03961308|520310487|FG000|Overall Study|Withdrawal by Subject|1|||
144301693|NCT03961308|520310488|FG001|Overall Study|Withdrawal by Subject|0|||
144301694|NCT03961308|520310487|FG000|Overall Study|Other|1|||
144301695|NCT03961308|520310488|FG001|Overall Study|Other|0|||
144301696|NCT03961308|520310487|FG000|Overall Study|Lost to Follow-up|0|||
144301697|NCT03961308|520310488|FG001|Overall Study|Lost to Follow-up|1|||
144301698|NCT03961308|520310487|FG000|Overall Study|Adverse Event|0|||
144301699|NCT03961308|520310488|FG001|Overall Study|Adverse Event|1|||
144301700|NCT00746811|520310491|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
144301701|NCT00746811|520310492|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
144301702|NCT00659425|520310496|FG000|Overall Study|Disease progression|1|||
144301703|NCT00659425|520310497|FG001|Overall Study|Disease progression|0|||
144301704|NCT00659425|520310498|FG002|Overall Study|Disease progression|0|||
144301705|NCT00659425|520310499|FG003|Overall Study|Disease progression|1|||
144301706|NCT00659425|520310500|FG004|Overall Study|Disease progression|0|||
144301707|NCT00659425|520310501|FG005|Overall Study|Disease progression|2|||
144301708|NCT00659425|520310502|FG006|Overall Study|Disease progression|4|||
144301709|NCT00659425|520310503|FG007|Overall Study|Disease progression|3|||
144301710|NCT00659425|520310504|FG008|Overall Study|Disease progression|5|||
144301711|NCT00659425|520310505|FG009|Overall Study|Disease progression|3|||
144301712|NCT00659425|520310496|FG000|Overall Study|Death|0|||
144301713|NCT00659425|520310497|FG001|Overall Study|Death|0|||
144301714|NCT00659425|520310498|FG002|Overall Study|Death|0|||
144301715|NCT00659425|520310499|FG003|Overall Study|Death|1|||
144301716|NCT00659425|520310500|FG004|Overall Study|Death|0|||
144301717|NCT00659425|520310501|FG005|Overall Study|Death|0|||
144301718|NCT00659425|520310502|FG006|Overall Study|Death|1|||
144301719|NCT00659425|520310503|FG007|Overall Study|Death|0|||
144301720|NCT00659425|520310504|FG008|Overall Study|Death|0|||
144301721|NCT00659425|520310505|FG009|Overall Study|Death|0|||
144301722|NCT00659425|520310496|FG000|Overall Study|Adverse Event|0|||
144301723|NCT00659425|520310497|FG001|Overall Study|Adverse Event|0|||
144301724|NCT00659425|520310498|FG002|Overall Study|Adverse Event|0|||
144301725|NCT00659425|520310499|FG003|Overall Study|Adverse Event|0|||
144301726|NCT00659425|520310500|FG004|Overall Study|Adverse Event|0|||
144301727|NCT00659425|520310501|FG005|Overall Study|Adverse Event|1|||
144301728|NCT00659425|520310502|FG006|Overall Study|Adverse Event|0|||
144301729|NCT00659425|520310503|FG007|Overall Study|Adverse Event|3|||
144301730|NCT00659425|520310504|FG008|Overall Study|Adverse Event|1|||
144301731|NCT00659425|520310505|FG009|Overall Study|Adverse Event|4|||
144301732|NCT00659425|520310496|FG000|Overall Study|Investigator Discretion|0|||
144301733|NCT00659425|520310497|FG001|Overall Study|Investigator Discretion|0|||
144301734|NCT00659425|520310498|FG002|Overall Study|Investigator Discretion|0|||
144301735|NCT00659425|520310499|FG003|Overall Study|Investigator Discretion|0|||
144301736|NCT00659425|520310500|FG004|Overall Study|Investigator Discretion|0|||
144301737|NCT00659425|520310501|FG005|Overall Study|Investigator Discretion|1|||
144301738|NCT00659425|520310502|FG006|Overall Study|Investigator Discretion|0|||
144301739|NCT00659425|520310503|FG007|Overall Study|Investigator Discretion|3|||
144301740|NCT00659425|520310504|FG008|Overall Study|Investigator Discretion|0|||
144301741|NCT00659425|520310505|FG009|Overall Study|Investigator Discretion|0|||
144301742|NCT00659425|520310496|FG000|Overall Study|Other|0|||
144301743|NCT00659425|520310497|FG001|Overall Study|Other|1|||
144301744|NCT00659425|520310498|FG002|Overall Study|Other|1|||
144301745|NCT00659425|520310499|FG003|Overall Study|Other|2|||
144301746|NCT00659425|520310500|FG004|Overall Study|Other|4|||
144301747|NCT00659425|520310501|FG005|Overall Study|Other|0|||
144301748|NCT00659425|520310502|FG006|Overall Study|Other|3|||
144301749|NCT00659425|520310503|FG007|Overall Study|Other|2|||
144301750|NCT00659425|520310504|FG008|Overall Study|Other|0|||
144301751|NCT00659425|520310505|FG009|Overall Study|Other|6|||
144301752|NCT03358030|520310506|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
144301753|NCT03358030|520310507|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
144301754|NCT03358030|520310508|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
144301755|NCT03358030|520310509|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
144301756|NCT03358030|520310506|FG000|Overall Study|Ineligibility|0|||
144301757|NCT03358030|520310507|FG001|Overall Study|Ineligibility|0|||
144301758|NCT03358030|520310508|FG002|Overall Study|Ineligibility|0|||
144301759|NCT03358030|520310509|FG003|Overall Study|Ineligibility|2|||
144301760|NCT03358030|520310506|FG000|Overall Study|Voluntary Withdrawal|1|||
144301761|NCT03358030|520310507|FG001|Overall Study|Voluntary Withdrawal|1|||
144301762|NCT03358030|520310508|FG002|Overall Study|Voluntary Withdrawal|3|||
144301763|NCT03358030|520310509|FG003|Overall Study|Voluntary Withdrawal|1|||
144301764|NCT03358030|520310506|FG000|Overall Study|Other|0|||
144301765|NCT03358030|520310507|FG001|Overall Study|Other|0|||
144301766|NCT03358030|520310508|FG002|Overall Study|Other|1|||
144301767|NCT03358030|520310509|FG003|Overall Study|Other|0|||
144301768|NCT03342560|520310510|FG000|Overall Study|Lost to Follow-up|2|||
144301769|NCT02604511|520310511|FG000|Overall Study|Adverse Event|3|||
144301770|NCT02604511|520310511|FG000|Overall Study|Disease Progression|4|||
144301771|NCT02604511|520310511|FG000|Overall Study|Withdrawal by Subject|3|||
144301772|NCT02604511|520310511|FG000|Overall Study|Participant ineligible|1|||
144301773|NCT02604511|520310511|FG000|Overall Study|Intercurrent illness|1|||
144301774|NCT03770286|520310512|FG000|Overall Study|Lost to Follow-up|6|||
144301775|NCT03770286|520310513|FG001|Overall Study|Lost to Follow-up|4|||
144301776|NCT03770286|520310514|FG002|Overall Study|Lost to Follow-up|3|||
144301777|NCT03770286|520310512|FG000|Overall Study|Protocol Violation|1|||
144301778|NCT03770286|520310513|FG001|Overall Study|Protocol Violation|0|||
144301779|NCT03770286|520310514|FG002|Overall Study|Protocol Violation|2|||
144301780|NCT02293551|520310517|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
144301781|NCT02293551|520310518|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
144301782|NCT02293551|520310519|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
144301783|NCT02293551|520310520|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
144301784|NCT02293551|520310521|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
144301785|NCT02293551|520310522|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
144301786|NCT02293551|520310517|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
144301787|NCT02293551|520310518|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
144301788|NCT02293551|520310519|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
144301789|NCT02293551|520310520|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
144301790|NCT02293551|520310521|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
144301791|NCT02293551|520310522|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
144301792|NCT02293551|520310517|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
144301793|NCT02293551|520310518|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
144301794|NCT02293551|520310519|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
144301795|NCT02293551|520310520|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
144301796|NCT02293551|520310521|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
144301797|NCT02293551|520310522|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
144301798|NCT02936323|520310523|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
144301799|NCT02936323|520310524|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
144301800|NCT02936323|520310525|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
144301801|NCT02936323|520310526|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
144301802|NCT02936323|520310527|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
144301803|NCT02936323|520310528|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
144301804|NCT02936323|520310529|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
144301805|NCT02936323|520310530|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
144301806|NCT02936323|520310531|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
144301807|NCT02936323|520310532|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
144301808|NCT02936323|520310523|FG000|Phase 1 Dose Escalation|Death|2|||
144301809|NCT02936323|520310524|FG001|Phase 1 Dose Escalation|Death|1|||
144301810|NCT02936323|520310525|FG002|Phase 1 Dose Escalation|Death|3|||
144301811|NCT02936323|520310526|FG003|Phase 1 Dose Escalation|Death|1|||
144301812|NCT02936323|520310527|FG004|Phase 1 Dose Escalation|Death|2|||
144301813|NCT02936323|520310528|FG005|Phase 1 Dose Escalation|Death|3|||
144301814|NCT02936323|520310529|FG006|Phase 1 Dose Escalation|Death|3|||
144301815|NCT02936323|520310530|FG007|Phase 1 Dose Escalation|Death|0|||
144301816|NCT02936323|520310531|FG008|Phase 1 Dose Escalation|Death|0|||
144301817|NCT02936323|520310532|FG009|Phase 1 Dose Escalation|Death|0|||
144301818|NCT02936323|520310523|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301819|NCT02936323|520310524|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301820|NCT02936323|520310525|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301821|NCT02936323|520310526|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301822|NCT02936323|520310527|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301823|NCT02936323|520310528|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
144301824|NCT02936323|520310529|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301825|NCT02936323|520310530|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301826|NCT02936323|520310531|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301827|NCT02936323|520310532|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
144301828|NCT02936323|520310523|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301829|NCT02936323|520310524|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301830|NCT02936323|520310525|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301831|NCT02936323|520310526|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301832|NCT02936323|520310527|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301833|NCT02936323|520310528|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301834|NCT02936323|520310529|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
144301835|NCT02936323|520310530|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
144301836|NCT02936323|520310531|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
144301837|NCT02936323|520310532|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
144301838|NCT02936323|520310523|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
144301839|NCT02936323|520310524|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
144301840|NCT02936323|520310525|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
144301841|NCT02936323|520310526|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
144301842|NCT02936323|520310527|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
144301843|NCT02936323|520310528|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
144301844|NCT02936323|520310529|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
144301845|NCT02936323|520310530|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
144301846|NCT02936323|520310531|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
144301847|NCT02936323|520310532|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
144301848|NCT02936323|520310523|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301849|NCT02936323|520310524|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301850|NCT02936323|520310525|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301851|NCT02936323|520310526|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301852|NCT02936323|520310527|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301853|NCT02936323|520310528|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301854|NCT02936323|520310529|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301855|NCT02936323|520310530|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
144301856|NCT02936323|520310531|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
144301857|NCT02936323|520310532|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
144301858|NCT02936323|520310523|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301859|NCT02936323|520310524|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301860|NCT02936323|520310525|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301861|NCT02936323|520310526|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301862|NCT02936323|520310527|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301863|NCT02936323|520310528|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301864|NCT02936323|520310529|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301865|NCT02936323|520310530|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301866|NCT02936323|520310531|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
144301867|NCT02936323|520310532|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
144301868|NCT02936323|520310523|FG000|Phase 2a Dose Expansion|Death|0|||
144301869|NCT02936323|520310524|FG001|Phase 2a Dose Expansion|Death|0|||
144301870|NCT02936323|520310525|FG002|Phase 2a Dose Expansion|Death|0|||
144301871|NCT02936323|520310526|FG003|Phase 2a Dose Expansion|Death|0|||
144301872|NCT02936323|520310527|FG004|Phase 2a Dose Expansion|Death|0|||
144301873|NCT02936323|520310528|FG005|Phase 2a Dose Expansion|Death|0|||
144301874|NCT02936323|520310529|FG006|Phase 2a Dose Expansion|Death|0|||
144301875|NCT02936323|520310530|FG007|Phase 2a Dose Expansion|Death|4|||
144301876|NCT02936323|520310531|FG008|Phase 2a Dose Expansion|Death|8|||
144301877|NCT02936323|520310532|FG009|Phase 2a Dose Expansion|Death|10|||
144301878|NCT02781558|520310533|FG000|Overall Study|Lost to Follow-up|2|||
144301879|NCT02781558|520310534|FG001|Overall Study|Lost to Follow-up|2|||
144301880|NCT02781558|520310533|FG000|Overall Study|Adverse Event|1|||
144301881|NCT02781558|520310534|FG001|Overall Study|Adverse Event|0|||
144301882|NCT01542788|520310535|FG000|Overall Study|Randomized but Not Treated|2|||
144301883|NCT01542788|520310536|FG001|Overall Study|Randomized but Not Treated|0|||
144301884|NCT01542788|520310535|FG000|Overall Study|Lack of Efficacy|41|||
144301885|NCT01542788|520310536|FG001|Overall Study|Lack of Efficacy|71|||
144301886|NCT01542788|520310535|FG000|Overall Study|Lost to Follow-up|5|||
144301887|NCT01542788|520310536|FG001|Overall Study|Lost to Follow-up|0|||
144301888|NCT01542788|520310535|FG000|Overall Study|Death|3|||
144301889|NCT01542788|520310536|FG001|Overall Study|Death|0|||
144301890|NCT01542788|520310535|FG000|Overall Study|Protocol Violation|2|||
144301891|NCT01542788|520310536|FG001|Overall Study|Protocol Violation|0|||
144301892|NCT01542788|520310535|FG000|Overall Study|Physician Decision|1|||
144301893|NCT01542788|520310536|FG001|Overall Study|Physician Decision|0|||
144301894|NCT01542788|520310535|FG000|Overall Study|Withdrawal by Subject|1|||
144301895|NCT01542788|520310536|FG001|Overall Study|Withdrawal by Subject|0|||
144301896|NCT01729039|520310539|FG000|Overall Study|disqualified|2|||
144301897|NCT01729039|520310540|FG001|Overall Study|disqualified|5|||
144301898|NCT01729039|520310539|FG000|Overall Study|Withdrawal by Subject|8|||
144301899|NCT01729039|520310540|FG001|Overall Study|Withdrawal by Subject|7|||
144301900|NCT04712669|520310541|FG000|Double Blind Phase|Adverse Event|4|||
144301901|NCT04712669|520310542|FG001|Double Blind Phase|Adverse Event|4|||
144301902|NCT04712669|520310543|FG002|Double Blind Phase|Adverse Event|3|||
144301903|NCT04712669|520310544|FG003|Double Blind Phase|Adverse Event|0|||
144301904|NCT04712669|520310545|FG004|Double Blind Phase|Adverse Event|0|||
144301905|NCT04712669|520310546|FG005|Double Blind Phase|Adverse Event|0|||
144301906|NCT04712669|520310547|FG006|Double Blind Phase|Adverse Event|0|||
144301907|NCT04712669|520310548|FG007|Double Blind Phase|Adverse Event|0|||
144301908|NCT04712669|520310541|FG000|Double Blind Phase|Physician Decision|1|||
144301909|NCT04712669|520310542|FG001|Double Blind Phase|Physician Decision|0|||
144301910|NCT04712669|520310543|FG002|Double Blind Phase|Physician Decision|0|||
144301911|NCT04712669|520310544|FG003|Double Blind Phase|Physician Decision|0|||
144301912|NCT04712669|520310545|FG004|Double Blind Phase|Physician Decision|0|||
144301913|NCT04712669|520310546|FG005|Double Blind Phase|Physician Decision|0|||
144301914|NCT04712669|520310547|FG006|Double Blind Phase|Physician Decision|0|||
144301915|NCT04712669|520310548|FG007|Double Blind Phase|Physician Decision|0|||
144301916|NCT04712669|520310541|FG000|Double Blind Phase|Withdrawal by Subject|3|||
144301917|NCT04712669|520310542|FG001|Double Blind Phase|Withdrawal by Subject|6|||
144301918|NCT04712669|520310543|FG002|Double Blind Phase|Withdrawal by Subject|0|||
144301919|NCT04712669|520310544|FG003|Double Blind Phase|Withdrawal by Subject|0|||
144301920|NCT04712669|520310545|FG004|Double Blind Phase|Withdrawal by Subject|0|||
144301921|NCT04712669|520310546|FG005|Double Blind Phase|Withdrawal by Subject|0|||
144301922|NCT04712669|520310547|FG006|Double Blind Phase|Withdrawal by Subject|0|||
144301923|NCT04712669|520310548|FG007|Double Blind Phase|Withdrawal by Subject|0|||
144301924|NCT04712669|520310541|FG000|Double Blind Phase|Termination by Sponsor|0|||
144301925|NCT04712669|520310542|FG001|Double Blind Phase|Termination by Sponsor|0|||
144301926|NCT04712669|520310543|FG002|Double Blind Phase|Termination by Sponsor|1|||
144301927|NCT04712669|520310544|FG003|Double Blind Phase|Termination by Sponsor|0|||
144301928|NCT04712669|520310545|FG004|Double Blind Phase|Termination by Sponsor|0|||
144301929|NCT04712669|520310546|FG005|Double Blind Phase|Termination by Sponsor|0|||
144301930|NCT04712669|520310547|FG006|Double Blind Phase|Termination by Sponsor|0|||
144301931|NCT04712669|520310548|FG007|Double Blind Phase|Termination by Sponsor|0|||
144301932|NCT04712669|520310541|FG000|Open Label Phase|Adverse Event|0|||
144301933|NCT04712669|520310542|FG001|Open Label Phase|Adverse Event|0|||
144301934|NCT04712669|520310543|FG002|Open Label Phase|Adverse Event|0|||
144301935|NCT04712669|520310544|FG003|Open Label Phase|Adverse Event|1|||
144301936|NCT04712669|520310545|FG004|Open Label Phase|Adverse Event|1|||
144301937|NCT04712669|520310546|FG005|Open Label Phase|Adverse Event|3|||
144301938|NCT04712669|520310547|FG006|Open Label Phase|Adverse Event|1|||
144301939|NCT04712669|520310548|FG007|Open Label Phase|Adverse Event|2|||
144301940|NCT04712669|520310541|FG000|Open Label Phase|Death|0|||
144301941|NCT04712669|520310542|FG001|Open Label Phase|Death|0|||
144301942|NCT04712669|520310543|FG002|Open Label Phase|Death|0|||
144301943|NCT04712669|520310544|FG003|Open Label Phase|Death|1|||
144301944|NCT04712669|520310545|FG004|Open Label Phase|Death|0|||
144301945|NCT04712669|520310546|FG005|Open Label Phase|Death|0|||
144301946|NCT04712669|520310547|FG006|Open Label Phase|Death|0|||
144301947|NCT04712669|520310548|FG007|Open Label Phase|Death|0|||
144301948|NCT04712669|520310541|FG000|Open Label Phase|Lack of Efficacy|0|||
144301949|NCT04712669|520310542|FG001|Open Label Phase|Lack of Efficacy|0|||
144301950|NCT04712669|520310543|FG002|Open Label Phase|Lack of Efficacy|0|||
144301951|NCT04712669|520310544|FG003|Open Label Phase|Lack of Efficacy|0|||
144301952|NCT04712669|520310545|FG004|Open Label Phase|Lack of Efficacy|1|||
144301953|NCT04712669|520310546|FG005|Open Label Phase|Lack of Efficacy|0|||
144301954|NCT04712669|520310547|FG006|Open Label Phase|Lack of Efficacy|0|||
144301955|NCT04712669|520310548|FG007|Open Label Phase|Lack of Efficacy|0|||
144301956|NCT04712669|520310541|FG000|Open Label Phase|Lost to Follow-up|0|||
144301957|NCT04712669|520310542|FG001|Open Label Phase|Lost to Follow-up|0|||
144301958|NCT04712669|520310543|FG002|Open Label Phase|Lost to Follow-up|0|||
144301959|NCT04712669|520310544|FG003|Open Label Phase|Lost to Follow-up|0|||
144301960|NCT04712669|520310545|FG004|Open Label Phase|Lost to Follow-up|0|||
144301961|NCT04712669|520310546|FG005|Open Label Phase|Lost to Follow-up|0|||
144301962|NCT04712669|520310547|FG006|Open Label Phase|Lost to Follow-up|1|||
144301963|NCT04712669|520310548|FG007|Open Label Phase|Lost to Follow-up|1|||
144301964|NCT04712669|520310541|FG000|Open Label Phase|Physician Decision|0|||
144301965|NCT04712669|520310542|FG001|Open Label Phase|Physician Decision|0|||
144301966|NCT04712669|520310543|FG002|Open Label Phase|Physician Decision|0|||
144301967|NCT04712669|520310544|FG003|Open Label Phase|Physician Decision|1|||
144301968|NCT04712669|520310545|FG004|Open Label Phase|Physician Decision|0|||
144301969|NCT04712669|520310546|FG005|Open Label Phase|Physician Decision|0|||
144301970|NCT04712669|520310547|FG006|Open Label Phase|Physician Decision|0|||
144301971|NCT04712669|520310548|FG007|Open Label Phase|Physician Decision|0|||
144301972|NCT04712669|520310541|FG000|Open Label Phase|Withdrawal by Subject|0|||
144301973|NCT04712669|520310542|FG001|Open Label Phase|Withdrawal by Subject|0|||
144301974|NCT04712669|520310543|FG002|Open Label Phase|Withdrawal by Subject|0|||
144301975|NCT04712669|520310544|FG003|Open Label Phase|Withdrawal by Subject|1|||
144301976|NCT04712669|520310545|FG004|Open Label Phase|Withdrawal by Subject|5|||
144301977|NCT04712669|520310546|FG005|Open Label Phase|Withdrawal by Subject|5|||
144301978|NCT04712669|520310547|FG006|Open Label Phase|Withdrawal by Subject|0|||
144301979|NCT04712669|520310548|FG007|Open Label Phase|Withdrawal by Subject|4|||
144301980|NCT04712669|520310541|FG000|Open Label Phase|Termination by Sponsor|0|||
144301981|NCT04712669|520310542|FG001|Open Label Phase|Termination by Sponsor|0|||
144301982|NCT04712669|520310543|FG002|Open Label Phase|Termination by Sponsor|0|||
144301983|NCT04712669|520310544|FG003|Open Label Phase|Termination by Sponsor|11|||
144301984|NCT04712669|520310545|FG004|Open Label Phase|Termination by Sponsor|9|||
144301985|NCT04712669|520310546|FG005|Open Label Phase|Termination by Sponsor|14|||
144301986|NCT04712669|520310547|FG006|Open Label Phase|Termination by Sponsor|0|||
144301987|NCT04712669|520310548|FG007|Open Label Phase|Termination by Sponsor|14|||
144301988|NCT04577404|520310549|FG000|Overall Study|Adverse Event|31|||
144301989|NCT04577404|520310549|FG000|Overall Study|Death|1|||
144301990|NCT04577404|520310549|FG000|Overall Study|Lack of Efficacy|3|||
144301991|NCT04577404|520310549|FG000|Overall Study|Physician Decision|7|||
144301992|NCT04577404|520310549|FG000|Overall Study|Withdrawal by Subject|21|||
144301993|NCT04577404|520310549|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
144301994|NCT03586973|520310559|FG000|Overall Study|Death|15|||
144301995|NCT03586973|520310560|FG001|Overall Study|Death|8|||
144301996|NCT03586973|520310559|FG000|Overall Study|Site Terminated by Sponsor|3|||
144301997|NCT03586973|520310560|FG001|Overall Study|Site Terminated by Sponsor|6|||
144301998|NCT03586973|520310559|FG000|Overall Study|Withdrawal by Subject|1|||
144301999|NCT03586973|520310560|FG001|Overall Study|Withdrawal by Subject|0|||
144302000|NCT03586973|520310559|FG000|Overall Study|Lost to Follow-up|1|||
144302001|NCT03586973|520310560|FG001|Overall Study|Lost to Follow-up|0|||
144302002|NCT02661672|520310564|FG000|Overall Study|Lost to Follow-up|1|||
144302003|NCT02661672|520310564|FG000|Overall Study|Death|4|||
144302004|NCT02114177|520312108|FG000|Overall Study|Lost to Follow-up|1|||
144302005|NCT02114177|520312109|FG001|Overall Study|Lost to Follow-up|2|||
144302006|NCT02114177|520312108|FG000|Overall Study|Withdrawal by Subject|6|||
144302007|NCT02114177|520312109|FG001|Overall Study|Withdrawal by Subject|1|||
144302008|NCT02114177|520312108|FG000|Overall Study|Other|2|||
144302009|NCT02114177|520312109|FG001|Overall Study|Other|1|||
144302010|NCT01770743|520312110|FG000|Overall Study|Adverse Event|1|||
144302011|NCT01770743|520312111|FG001|Overall Study|Adverse Event|0|||
144302012|NCT01770743|520312112|FG002|Overall Study|Adverse Event|0|||
144302013|NCT01770743|520312113|FG003|Overall Study|Adverse Event|0|||
144302014|NCT01770743|520312114|FG004|Overall Study|Adverse Event|0|||
144302015|NCT01770743|520312110|FG000|Overall Study|Withdrawal by Subject|0|||
144302016|NCT01770743|520312111|FG001|Overall Study|Withdrawal by Subject|0|||
144302017|NCT01770743|520312112|FG002|Overall Study|Withdrawal by Subject|1|||
144302018|NCT01770743|520312113|FG003|Overall Study|Withdrawal by Subject|1|||
144302019|NCT01770743|520312114|FG004|Overall Study|Withdrawal by Subject|1|||
144302020|NCT01770743|520312110|FG000|Overall Study|Lost to Follow-up|0|||
144302021|NCT01770743|520312111|FG001|Overall Study|Lost to Follow-up|2|||
144302022|NCT01770743|520312112|FG002|Overall Study|Lost to Follow-up|0|||
144302023|NCT01770743|520312113|FG003|Overall Study|Lost to Follow-up|0|||
144302024|NCT01770743|520312114|FG004|Overall Study|Lost to Follow-up|1|||
144302025|NCT01770743|520312110|FG000|Overall Study|Sponsor Terminated Subject|1|||
144302026|NCT01770743|520312111|FG001|Overall Study|Sponsor Terminated Subject|0|||
144302027|NCT01770743|520312112|FG002|Overall Study|Sponsor Terminated Subject|0|||
144302028|NCT01770743|520312113|FG003|Overall Study|Sponsor Terminated Subject|1|||
144302029|NCT01770743|520312114|FG004|Overall Study|Sponsor Terminated Subject|0|||
144302030|NCT01770743|520312110|FG000|Overall Study|Moving Out of State|0|||
144302031|NCT01770743|520312111|FG001|Overall Study|Moving Out of State|1|||
144302032|NCT01770743|520312112|FG002|Overall Study|Moving Out of State|0|||
144302033|NCT01770743|520312113|FG003|Overall Study|Moving Out of State|0|||
144302034|NCT01770743|520312114|FG004|Overall Study|Moving Out of State|0|||
144302035|NCT01585025|520312115|FG000|Overall Study|Withdrawal by Subject|0|||
144302036|NCT01585025|520312116|FG001|Overall Study|Withdrawal by Subject|3|||
144302037|NCT01585025|520312117|FG002|Overall Study|Withdrawal by Subject|4|||
144302038|NCT01732536|520312118|FG000|Overall Study|Withdrawal by Subject|1|||
144302039|NCT01732536|520312119|FG001|Overall Study|Withdrawal by Subject|1|||
144302040|NCT05111145|520312120|FG000|Overall Study|Commercial drug is available for participant|76|||
144302041|NCT05111145|520312120|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
144302042|NCT02336815|520312123|FG000|Overall Study|Disease Progression|45|||
144302043|NCT02336815|520312124|FG001|Overall Study|Disease Progression|70|||
144302044|NCT02336815|520312123|FG000|Overall Study|Adverse Event|18|||
144302045|NCT02336815|520312124|FG001|Overall Study|Adverse Event|39|||
144302046|NCT02336815|520312123|FG000|Overall Study|Physician Decision|11|||
144302047|NCT02336815|520312124|FG001|Overall Study|Physician Decision|4|||
144302048|NCT02336815|520312123|FG000|Overall Study|Withdrawal by Subject|3|||
144302049|NCT02336815|520312124|FG001|Overall Study|Withdrawal by Subject|2|||
144302050|NCT02336815|520312123|FG000|Overall Study|Lost to Follow-up|1|||
144302051|NCT02336815|520312124|FG001|Overall Study|Lost to Follow-up|3|||
144302052|NCT02336815|520312123|FG000|Overall Study|Other|1|||
144302053|NCT02336815|520312124|FG001|Overall Study|Other|5|||
144302054|NCT00952705|520312125|FG000|Overall Study|Lost to Follow-up|24|||
144302055|NCT00952705|520312126|FG001|Overall Study|Lost to Follow-up|8|||
144302056|NCT00952705|520312127|FG002|Overall Study|Lost to Follow-up|9|||
144302057|NCT00952705|520312125|FG000|Overall Study|Withdrawal by Subject|2|||
144302058|NCT00952705|520312126|FG001|Overall Study|Withdrawal by Subject|1|||
144302059|NCT00952705|520312127|FG002|Overall Study|Withdrawal by Subject|1|||
144302060|NCT00952705|520312125|FG000|Overall Study|Death|2|||
144302061|NCT00952705|520312126|FG001|Overall Study|Death|0|||
144302062|NCT00952705|520312127|FG002|Overall Study|Death|0|||
144302063|NCT00952705|520312125|FG000|Overall Study|Incarcerated post dose|5|||
144302064|NCT00952705|520312126|FG001|Overall Study|Incarcerated post dose|0|||
144302065|NCT00952705|520312127|FG002|Overall Study|Incarcerated post dose|0|||
144302066|NCT00952705|520312125|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
144302067|NCT00952705|520312126|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
144302068|NCT00952705|520312127|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
144302069|NCT00140140|520312128|FG000|Overall Study|Unacceptable toxicity|1|||
144302070|NCT00140140|520312129|FG001|Overall Study|Unacceptable toxicity|1|||
144302071|NCT00140140|520312130|FG002|Overall Study|Unacceptable toxicity|2|||
144302072|NCT00140140|520312128|FG000|Overall Study|Physician Decision|1|||
144302073|NCT00140140|520312129|FG001|Overall Study|Physician Decision|1|||
144302074|NCT00140140|520312130|FG002|Overall Study|Physician Decision|0|||
144302075|NCT03376516|520312131|FG000|Overall Study|Not treated|1|||
144302076|NCT03376516|520312131|FG000|Overall Study|Consent withdrawn|1|||
144302077|NCT01581684|520312132|FG000|Overall Study|Other reason not defined|0|||
144302078|NCT01581684|520312133|FG001|Overall Study|Other reason not defined|0|||
144302079|NCT01581684|520312134|FG002|Overall Study|Other reason not defined|0|||
144302080|NCT01581684|520312135|FG003|Overall Study|Other reason not defined|0|||
144302081|NCT01581684|520312136|FG004|Overall Study|Other reason not defined|0|||
144302082|NCT01581684|520312137|FG005|Overall Study|Other reason not defined|0|||
144302083|NCT01581684|520312138|FG006|Overall Study|Other reason not defined|0|||
144302084|NCT01581684|520312139|FG007|Overall Study|Other reason not defined|0|||
144302085|NCT01581684|520312140|FG008|Overall Study|Other reason not defined|1|||
144302086|NCT01581684|520312141|FG009|Overall Study|Other reason not defined|0|||
144302087|NCT03728933|520312142|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144302088|NCT03728933|520312143|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144302089|NCT03728933|520312144|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
144302090|NCT03728933|520312142|FG000|Overall Study|Withdrawal by Subject|0|||
144302091|NCT03728933|520312143|FG001|Overall Study|Withdrawal by Subject|0|||
144302092|NCT03728933|520312144|FG002|Overall Study|Withdrawal by Subject|1|||
144302093|NCT03728933|520312142|FG000|Overall Study|Lost to Follow-up|0|||
144302094|NCT03728933|520312143|FG001|Overall Study|Lost to Follow-up|1|||
144302095|NCT03728933|520312144|FG002|Overall Study|Lost to Follow-up|0|||
144302096|NCT03728933|520312142|FG000|Overall Study|Adverse Event|1|||
144302097|NCT03728933|520312143|FG001|Overall Study|Adverse Event|0|||
144302098|NCT03728933|520312144|FG002|Overall Study|Adverse Event|0|||
144302099|NCT00598650|520312145|FG000|Overall Study|Withdrawal by Subject|3|||
144302100|NCT00598650|520312145|FG000|Overall Study|Adverse Event|18|||
144302101|NCT00598650|520312145|FG000|Overall Study|No treatment for 3 weeks|1|||
144302102|NCT00598650|520312145|FG000|Overall Study|Not eligible|1|||
144302103|NCT00598650|520312145|FG000|Overall Study|Prohibited Concomitant Medication|2|||
144302104|NCT00598650|520312145|FG000|Overall Study|Physician Decision|2|||
144302105|NCT02415556|520312146|FG000|Overall Study|Adverse Event|3|||
144302106|NCT02415556|520312147|FG001|Overall Study|Adverse Event|4|||
144302107|NCT02415556|520312148|FG002|Overall Study|Adverse Event|2|||
144302108|NCT02415556|520312149|FG003|Overall Study|Adverse Event|4|||
144302109|NCT02415556|520312146|FG000|Overall Study|Lost to Follow-up|4|||
144302110|NCT02415556|520312147|FG001|Overall Study|Lost to Follow-up|5|||
144302111|NCT02415556|520312148|FG002|Overall Study|Lost to Follow-up|4|||
144302112|NCT02415556|520312149|FG003|Overall Study|Lost to Follow-up|1|||
144302113|NCT02415556|520312146|FG000|Overall Study|Withdrawal by Subject|13|||
144302114|NCT02415556|520312147|FG001|Overall Study|Withdrawal by Subject|4|||
144302115|NCT02415556|520312148|FG002|Overall Study|Withdrawal by Subject|14|||
144302116|NCT02415556|520312149|FG003|Overall Study|Withdrawal by Subject|12|||
144302117|NCT02415556|520312146|FG000|Overall Study|Physician Decision|1|||
144302118|NCT02415556|520312147|FG001|Overall Study|Physician Decision|3|||
144302119|NCT02415556|520312148|FG002|Overall Study|Physician Decision|1|||
144302120|NCT02415556|520312149|FG003|Overall Study|Physician Decision|2|||
144302121|NCT02415556|520312146|FG000|Overall Study|Censored - study completion|4|||
144302122|NCT02415556|520312147|FG001|Overall Study|Censored - study completion|5|||
144302123|NCT02415556|520312148|FG002|Overall Study|Censored - study completion|1|||
144302124|NCT02415556|520312149|FG003|Overall Study|Censored - study completion|0|||
144302125|NCT02415556|520312146|FG000|Overall Study|Family-related issues|0|||
144302126|NCT02415556|520312147|FG001|Overall Study|Family-related issues|0|||
144302127|NCT02415556|520312148|FG002|Overall Study|Family-related issues|0|||
144302128|NCT02415556|520312149|FG003|Overall Study|Family-related issues|1|||
144302129|NCT00399035|520312150|FG000|Overall Study|Death|289|||
144302130|NCT00399035|520312151|FG001|Overall Study|Death|141|||
144302131|NCT00399035|520312152|FG002|Overall Study|Death|234|||
144302132|NCT00399035|520312150|FG000|Overall Study|Lost to Follow-up|2|||
144302133|NCT00399035|520312151|FG001|Overall Study|Lost to Follow-up|1|||
144302134|NCT00399035|520312152|FG002|Overall Study|Lost to Follow-up|5|||
144302135|NCT00399035|520312150|FG000|Overall Study|Withdrawal by Subject|19|||
144302136|NCT00399035|520312151|FG001|Overall Study|Withdrawal by Subject|15|||
144302137|NCT00399035|520312152|FG002|Overall Study|Withdrawal by Subject|12|||
144302138|NCT00399035|520312150|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
144302139|NCT00399035|520312151|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
144302140|NCT00399035|520312152|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
144302141|NCT00399035|520312150|FG000|Overall Study|Severe non-compliance with protocol|2|||
144302142|NCT00399035|520312151|FG001|Overall Study|Severe non-compliance with protocol|1|||
144302143|NCT00399035|520312152|FG002|Overall Study|Severe non-compliance with protocol|0|||
144302144|NCT02949011|520312153|FG000|Overall Study|Adverse Event|6|||
144302145|NCT02949011|520312154|FG001|Overall Study|Adverse Event|7|||
144302146|NCT02949011|520312155|FG002|Overall Study|Adverse Event|3|||
144302147|NCT02949011|520312153|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
144302148|NCT02949011|520312154|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
144302149|NCT02949011|520312155|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
144302150|NCT02949011|520312153|FG000|Overall Study|Protocol Deviation|5|||
144302151|NCT02949011|520312154|FG001|Overall Study|Protocol Deviation|3|||
144302152|NCT02949011|520312155|FG002|Overall Study|Protocol Deviation|3|||
144302153|NCT02949011|520312153|FG000|Overall Study|Lack of Efficacy|0|||
144302154|NCT02949011|520312154|FG001|Overall Study|Lack of Efficacy|2|||
144302155|NCT02949011|520312155|FG002|Overall Study|Lack of Efficacy|0|||
144302156|NCT02949011|520312153|FG000|Overall Study|Withdrawal by Subject|13|||
144302157|NCT02949011|520312154|FG001|Overall Study|Withdrawal by Subject|13|||
144302158|NCT02949011|520312155|FG002|Overall Study|Withdrawal by Subject|21|||
144302159|NCT02949011|520312153|FG000|Overall Study|Lost to Follow-up|7|||
144302160|NCT02949011|520312154|FG001|Overall Study|Lost to Follow-up|5|||
144302161|NCT02949011|520312155|FG002|Overall Study|Lost to Follow-up|5|||
144302162|NCT02949011|520312153|FG000|Overall Study|Death|0|||
144302163|NCT02949011|520312154|FG001|Overall Study|Death|0|||
144302164|NCT02949011|520312155|FG002|Overall Study|Death|1|||
144302165|NCT02949011|520312153|FG000|Overall Study|Miscellaneous|2|||
144302166|NCT02949011|520312154|FG001|Overall Study|Miscellaneous|4|||
144302167|NCT02949011|520312155|FG002|Overall Study|Miscellaneous|6|||
144302168|NCT01128569|520312156|FG000|Washout Period 1|Adverse Event|0|||
144302169|NCT01128569|520312157|FG001|Washout Period 1|Adverse Event|0|||
144302170|NCT01128569|520312158|FG002|Washout Period 1|Adverse Event|1|||
144302171|NCT01128569|520312159|FG003|Washout Period 1|Adverse Event|0|||
144302172|NCT01128569|520312160|FG004|Washout Period 1|Adverse Event|0|||
144302173|NCT01128569|520312161|FG005|Washout Period 1|Adverse Event|0|||
144302174|NCT01128569|520312156|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144302175|NCT01128569|520312157|FG001|Treatment Period 2|Withdrawal by Subject|1|||
144302176|NCT01128569|520312158|FG002|Treatment Period 2|Withdrawal by Subject|0|||
144302177|NCT01128569|520312159|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144302178|NCT01128569|520312160|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144302179|NCT01128569|520312161|FG005|Treatment Period 2|Withdrawal by Subject|0|||
144302180|NCT03338400|520312162|FG000|Overall Study|Lost to Follow-up|1|||
144302181|NCT03338400|520312163|FG001|Overall Study|Lost to Follow-up|2|||
144302182|NCT01865487|520312167|FG000|Overall Study|Lost to Follow-up|0|||
144302183|NCT01865487|520312168|FG001|Overall Study|Lost to Follow-up|0|||
144302184|NCT01865487|520312169|FG002|Overall Study|Lost to Follow-up|0|||
144302185|NCT01865487|520312170|FG003|Overall Study|Lost to Follow-up|1|||
144302186|NCT01865487|520312171|FG004|Overall Study|Lost to Follow-up|0|||
144302187|NCT01865487|520312172|FG005|Overall Study|Lost to Follow-up|0|||
144302188|NCT01865487|520312173|FG006|Overall Study|Lost to Follow-up|1|||
144302189|NCT01865487|520312174|FG007|Overall Study|Lost to Follow-up|0|||
144302190|NCT01865487|520312175|FG008|Overall Study|Lost to Follow-up|0|||
144302191|NCT01865487|520312176|FG009|Overall Study|Lost to Follow-up|0|||
144302192|NCT01865487|520312167|FG000|Overall Study|Withdrawal by Subject|0|||
144302193|NCT01865487|520312168|FG001|Overall Study|Withdrawal by Subject|0|||
144302194|NCT01865487|520312169|FG002|Overall Study|Withdrawal by Subject|0|||
144302195|NCT01865487|520312170|FG003|Overall Study|Withdrawal by Subject|0|||
144302196|NCT01865487|520312171|FG004|Overall Study|Withdrawal by Subject|1|||
144302197|NCT01865487|520312172|FG005|Overall Study|Withdrawal by Subject|0|||
144302198|NCT01865487|520312173|FG006|Overall Study|Withdrawal by Subject|0|||
144302199|NCT01865487|520312174|FG007|Overall Study|Withdrawal by Subject|0|||
144302200|NCT01865487|520312175|FG008|Overall Study|Withdrawal by Subject|0|||
144302201|NCT01865487|520312176|FG009|Overall Study|Withdrawal by Subject|0|||
144302202|NCT01213082|520312177|FG000|Overall Study|Lost to Follow-up|6|||
144302203|NCT01213082|520312178|FG001|Overall Study|Lost to Follow-up|7|||
144302204|NCT01213082|520312179|FG002|Overall Study|Lost to Follow-up|4|||
144302205|NCT01213082|520312177|FG000|Overall Study|Physician Decision|0|||
144302206|NCT01213082|520312178|FG001|Overall Study|Physician Decision|0|||
144302207|NCT01213082|520312179|FG002|Overall Study|Physician Decision|1|||
144302208|NCT00698828|520312180|FG000|Overall Study|Adverse Event|3|||
144302209|NCT00698828|520312181|FG001|Overall Study|Adverse Event|4|||
144302210|NCT00698828|520312182|FG002|Overall Study|Adverse Event|4|||
144302211|NCT00698828|520312180|FG000|Overall Study|Death|0|||
144302212|NCT00698828|520312181|FG001|Overall Study|Death|0|||
144302213|NCT00698828|520312182|FG002|Overall Study|Death|1|||
144302214|NCT00698828|520312180|FG000|Overall Study|Exacerbation of COPD|1|||
144302215|NCT00698828|520312181|FG001|Overall Study|Exacerbation of COPD|3|||
144302216|NCT00698828|520312182|FG002|Overall Study|Exacerbation of COPD|0|||
144302217|NCT00698828|520312180|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
144302218|NCT00698828|520312181|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
144302219|NCT00698828|520312182|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
144302220|NCT00698828|520312180|FG000|Overall Study|Investigator/Sponsor decision|1|||
144302221|NCT00698828|520312181|FG001|Overall Study|Investigator/Sponsor decision|0|||
144302222|NCT00698828|520312182|FG002|Overall Study|Investigator/Sponsor decision|2|||
144302223|NCT00698828|520312180|FG000|Overall Study|Lost to Follow-up|1|||
144302224|NCT00698828|520312181|FG001|Overall Study|Lost to Follow-up|1|||
144302225|NCT00698828|520312182|FG002|Overall Study|Lost to Follow-up|0|||
144302226|NCT00698828|520312180|FG000|Overall Study|Withdrew consent|0|||
144302227|NCT00698828|520312181|FG001|Overall Study|Withdrew consent|7|||
144302228|NCT00698828|520312182|FG002|Overall Study|Withdrew consent|4|||
144302229|NCT00698828|520312180|FG000|Overall Study|Withdrew consent (not treated)|2|||
144302230|NCT00698828|520312181|FG001|Overall Study|Withdrew consent (not treated)|0|||
144302231|NCT00698828|520312182|FG002|Overall Study|Withdrew consent (not treated)|0|||
144302232|NCT02013609|520312183|FG000|Overall Study|Withdrawal by Subject|9|||
144302233|NCT02013609|520312183|FG000|Overall Study|Lost to Follow-up|3|||
144302234|NCT02013609|520312183|FG000|Overall Study|Adverse Event|3|||
144302235|NCT02013609|520312183|FG000|Overall Study|Met Withdrawal Criteria|3|||
144302236|NCT01119287|520312184|FG000|Overall Study|Patient Decision, not related to AE|0|||
144302237|NCT01119287|520312185|FG001|Overall Study|Patient Decision, not related to AE|0|||
144302238|NCT01119287|520312186|FG002|Overall Study|Patient Decision, not related to AE|2|||
144302239|NCT01119287|520312187|FG003|Overall Study|Patient Decision, not related to AE|2|||
144302240|NCT01119287|520312188|FG004|Overall Study|Patient Decision, not related to AE|1|||
144302241|NCT01119287|520312189|FG005|Overall Study|Patient Decision, not related to AE|0|||
144302242|NCT01531998|520312194|FG000|Overall Study|Withdrawal by Subject|3|||
144302243|NCT01076010|520312199|FG000|Overall Study|Death|15|||
144302244|NCT01076010|520312200|FG001|Overall Study|Death|1|||
144302245|NCT01076010|520312201|FG002|Overall Study|Death|0|||
144302246|NCT01076010|520312199|FG000|Overall Study|Adverse Event|7|||
144302247|NCT01076010|520312200|FG001|Overall Study|Adverse Event|2|||
144302248|NCT01076010|520312201|FG002|Overall Study|Adverse Event|0|||
144302249|NCT01076010|520312199|FG000|Overall Study|Progressive disease|90|||
144302250|NCT01076010|520312200|FG001|Overall Study|Progressive disease|30|||
144302251|NCT01076010|520312201|FG002|Overall Study|Progressive disease|1|||
144302252|NCT01076010|520312199|FG000|Overall Study|Lack of Efficacy|4|||
144302253|NCT01076010|520312200|FG001|Overall Study|Lack of Efficacy|0|||
144302254|NCT01076010|520312201|FG002|Overall Study|Lack of Efficacy|0|||
144302255|NCT01076010|520312199|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
144302256|NCT01076010|520312200|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
144302257|NCT01076010|520312201|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
144302258|NCT01076010|520312199|FG000|Overall Study|Significant Surgical Procedure|0|||
144302259|NCT01076010|520312200|FG001|Overall Study|Significant Surgical Procedure|1|||
144302260|NCT01076010|520312201|FG002|Overall Study|Significant Surgical Procedure|0|||
144302261|NCT01076010|520312199|FG000|Overall Study|Protocol Violation|0|||
144302262|NCT01076010|520312200|FG001|Overall Study|Protocol Violation|1|||
144302263|NCT01076010|520312201|FG002|Overall Study|Protocol Violation|0|||
144302264|NCT01076010|520312199|FG000|Overall Study|Noncompliance|1|||
144302265|NCT01076010|520312200|FG001|Overall Study|Noncompliance|1|||
144302266|NCT01076010|520312201|FG002|Overall Study|Noncompliance|0|||
144302267|NCT01076010|520312199|FG000|Overall Study|Withdrawal by Subject|3|||
144302268|NCT01076010|520312200|FG001|Overall Study|Withdrawal by Subject|0|||
144302269|NCT01076010|520312201|FG002|Overall Study|Withdrawal by Subject|1|||
144302270|NCT01076010|520312199|FG000|Overall Study|Other|5|||
144302271|NCT01076010|520312200|FG001|Overall Study|Other|2|||
144302272|NCT01076010|520312201|FG002|Overall Study|Other|0|||
144302273|NCT04661033|520312204|FG000|Overall Study|Adverse Event|0|||
144302274|NCT04661033|520312205|FG001|Overall Study|Adverse Event|0|||
144302275|NCT04661033|520312206|FG002|Overall Study|Adverse Event|1|||
144302276|NCT04661033|520312207|FG003|Overall Study|Adverse Event|0|||
144302277|NCT04661033|520312204|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
144302278|NCT04661033|520312205|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
144302279|NCT04661033|520312206|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
144302280|NCT04661033|520312207|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
144302281|NCT04661033|520312204|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
144302282|NCT04661033|520312205|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
144302283|NCT04661033|520312206|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
144302284|NCT04661033|520312207|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
144302285|NCT04661033|520312204|FG000|Overall Study|Early discontinuation as per PI|1|||
144302286|NCT04661033|520312205|FG001|Overall Study|Early discontinuation as per PI|0|||
144302287|NCT04661033|520312206|FG002|Overall Study|Early discontinuation as per PI|0|||
144302288|NCT04661033|520312207|FG003|Overall Study|Early discontinuation as per PI|0|||
144302289|NCT00565409|520312208|FG000|Period 1 Open Label|Adverse Event|17|||
144302290|NCT00565409|520312209|FG001|Period 1 Open Label|Adverse Event|0|||
144302291|NCT00565409|520312210|FG002|Period 1 Open Label|Adverse Event|0|||
144302292|NCT00565409|520312211|FG003|Period 1 Open Label|Adverse Event|0|||
144302293|NCT00565409|520312208|FG000|Period 1 Open Label|Death|2|||
144302294|NCT00565409|520312209|FG001|Period 1 Open Label|Death|0|||
144302295|NCT00565409|520312210|FG002|Period 1 Open Label|Death|0|||
144302296|NCT00565409|520312211|FG003|Period 1 Open Label|Death|0|||
144302297|NCT00565409|520312208|FG000|Period 1 Open Label|Lost to Follow-up|1|||
144302298|NCT00565409|520312209|FG001|Period 1 Open Label|Lost to Follow-up|0|||
144302299|NCT00565409|520312210|FG002|Period 1 Open Label|Lost to Follow-up|0|||
144302300|NCT00565409|520312211|FG003|Period 1 Open Label|Lost to Follow-up|0|||
144302301|NCT00565409|520312208|FG000|Period 1 Open Label|Other|21|||
144302302|NCT00565409|520312209|FG001|Period 1 Open Label|Other|0|||
144302303|NCT00565409|520312210|FG002|Period 1 Open Label|Other|0|||
144302304|NCT00565409|520312211|FG003|Period 1 Open Label|Other|0|||
144302305|NCT00565409|520312208|FG000|Period 1 Open Label|Protocol Violation|14|||
144302306|NCT00565409|520312209|FG001|Period 1 Open Label|Protocol Violation|0|||
144302307|NCT00565409|520312210|FG002|Period 1 Open Label|Protocol Violation|0|||
144302308|NCT00565409|520312211|FG003|Period 1 Open Label|Protocol Violation|0|||
144302309|NCT00565409|520312208|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
144302310|NCT00565409|520312209|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
144302311|NCT00565409|520312210|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
144302312|NCT00565409|520312211|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
144302313|NCT00565409|520312208|FG000|Period 1 Open Label|no conclusion of participation record|1|||
144302314|NCT00565409|520312209|FG001|Period 1 Open Label|no conclusion of participation record|0|||
144302315|NCT00565409|520312210|FG002|Period 1 Open Label|no conclusion of participation record|0|||
144302316|NCT00565409|520312211|FG003|Period 1 Open Label|no conclusion of participation record|0|||
144302317|NCT00565409|520312208|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
144302318|NCT00565409|520312209|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
144302319|NCT00565409|520312210|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
144302320|NCT00565409|520312211|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
144302321|NCT00565409|520312208|FG000|Period 2 Double-Blind|Adverse Event|0|||
144302322|NCT00565409|520312209|FG001|Period 2 Double-Blind|Adverse Event|7|||
144302323|NCT00565409|520312210|FG002|Period 2 Double-Blind|Adverse Event|4|||
144302324|NCT00565409|520312211|FG003|Period 2 Double-Blind|Adverse Event|5|||
144302325|NCT00565409|520312208|FG000|Period 2 Double-Blind|Death|0|||
144302326|NCT00565409|520312209|FG001|Period 2 Double-Blind|Death|2|||
144302327|NCT00565409|520312210|FG002|Period 2 Double-Blind|Death|0|||
144302328|NCT00565409|520312211|FG003|Period 2 Double-Blind|Death|0|||
144302329|NCT00565409|520312208|FG000|Period 2 Double-Blind|Protocol Violation|0|||
144302330|NCT00565409|520312209|FG001|Period 2 Double-Blind|Protocol Violation|4|||
144302331|NCT00565409|520312210|FG002|Period 2 Double-Blind|Protocol Violation|6|||
144302332|NCT00565409|520312211|FG003|Period 2 Double-Blind|Protocol Violation|2|||
144302333|NCT00565409|520312208|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
144302334|NCT00565409|520312209|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
144302335|NCT00565409|520312210|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
144302336|NCT00565409|520312211|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
144302337|NCT00565409|520312208|FG000|Period 2 Double-Blind|Other|0|||
144302338|NCT00565409|520312209|FG001|Period 2 Double-Blind|Other|4|||
144302339|NCT00565409|520312210|FG002|Period 2 Double-Blind|Other|5|||
144302340|NCT00565409|520312211|FG003|Period 2 Double-Blind|Other|9|||
144302341|NCT00565409|520312208|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
144302342|NCT00565409|520312209|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
144302343|NCT00565409|520312210|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
144302344|NCT00565409|520312211|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
144302345|NCT02257684|520312216|FG000|Overall Study|Adverse Event|2|||
144302346|NCT02257684|520312216|FG000|Overall Study|Lack of Efficacy|1|||
144302347|NCT02257684|520312216|FG000|Overall Study|Sponsor's Decision|1|||
144302348|NCT02943473|520312217|FG000|Overall Study|enrolled but not dosed|1|||
144302349|NCT02943473|520312217|FG000|Overall Study|screen failure|1|||
144302350|NCT02943473|520312217|FG000|Overall Study|Physician Decision|4|||
144302351|NCT00431964|520312224|FG000|Overall Study|Adverse Event|1|||
144302352|NCT00431964|520312225|FG001|Overall Study|Adverse Event|0|||
144302353|NCT00431964|520312224|FG000|Overall Study|Lost to Follow-up|1|||
144302354|NCT00431964|520312225|FG001|Overall Study|Lost to Follow-up|2|||
144302355|NCT00431964|520312224|FG000|Overall Study|Physician Decision|2|||
144302356|NCT00431964|520312225|FG001|Overall Study|Physician Decision|2|||
144302357|NCT00431964|520312224|FG000|Overall Study|Withdrawal by Subject|2|||
144302358|NCT00431964|520312225|FG001|Overall Study|Withdrawal by Subject|1|||
144302359|NCT00431964|520312224|FG000|Overall Study|Parental Consent Withdrawn|0|||
144302360|NCT00431964|520312225|FG001|Overall Study|Parental Consent Withdrawn|2|||
144302361|NCT00431964|520312224|FG000|Overall Study|Due to Unstable Health|0|||
144302362|NCT00431964|520312225|FG001|Overall Study|Due to Unstable Health|1|||
144302363|NCT01823289|520312229|FG000|Overall Study|Lost to Follow-up|5|||
144302364|NCT01823289|520312229|FG000|Overall Study|Adverse Event|5|||
144302365|NCT01823289|520312229|FG000|Overall Study|Lack of Efficacy|1|||
144302366|NCT01823289|520312229|FG000|Overall Study|Physician Decision|9|||
144302367|NCT01823289|520312229|FG000|Overall Study|Administered contraindicated medicine|1|||
144302368|NCT01823289|520312229|FG000|Overall Study|Transaminase increased more than 3 times|1|||
144302369|NCT01823289|520312229|FG000|Overall Study|Drug affected efficacy and safety|1|||
144302370|NCT01823289|520312229|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
144302371|NCT01736917|520312230|FG000|Overall Study|Adverse Event|1|||
144302372|NCT01736917|520312230|FG000|Overall Study|Protocol Violation|10|||
144302373|NCT01911260|520312231|FG000|Supplementation Period|transference or evasion of school|7|||
144302374|NCT01911260|520312232|FG001|Supplementation Period|transference or evasion of school|9|||
144302375|NCT01911260|520312233|FG002|Supplementation Period|transference or evasion of school|7|||
144302376|NCT01911260|520312234|FG003|Supplementation Period|transference or evasion of school|6|||
144302377|NCT01911260|520312231|FG000|Supplementation Period|Adverse Event|2|||
144302378|NCT01911260|520312232|FG001|Supplementation Period|Adverse Event|0|||
144302379|NCT01911260|520312233|FG002|Supplementation Period|Adverse Event|1|||
144302380|NCT01911260|520312234|FG003|Supplementation Period|Adverse Event|0|||
144302381|NCT01911260|520312231|FG000|Supplementation Period|refused to receive supplement|1|||
144302382|NCT01911260|520312232|FG001|Supplementation Period|refused to receive supplement|0|||
144302383|NCT01911260|520312233|FG002|Supplementation Period|refused to receive supplement|1|||
144302384|NCT01911260|520312234|FG003|Supplementation Period|refused to receive supplement|0|||
144302385|NCT01911260|520312231|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
144302386|NCT01911260|520312232|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
144302387|NCT01911260|520312233|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
144302388|NCT01911260|520312234|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
144302389|NCT01911260|520312231|FG000|Follow-up Period|transference or evasion of school|13|||
144302390|NCT01911260|520312232|FG001|Follow-up Period|transference or evasion of school|20|||
144302391|NCT01911260|520312233|FG002|Follow-up Period|transference or evasion of school|15|||
144302392|NCT01911260|520312234|FG003|Follow-up Period|transference or evasion of school|12|||
144302393|NCT00654732|520312237|FG000|Overall Study|Adverse Event|4|||
144302394|NCT00654732|520312238|FG001|Overall Study|Adverse Event|6|||
144302395|NCT01734902|520312243|FG000|Overall Study|Other than listed|0|||
144302396|NCT01734902|520312244|FG001|Overall Study|Other than listed|2|||
144302397|NCT00060944|520312247|FG000|Overall Study|Adverse Event|12|||
144302398|NCT00060944|520312248|FG001|Overall Study|Adverse Event|10|||
144302399|NCT00060944|520312247|FG000|Overall Study|Death|2|||
144302400|NCT00060944|520312248|FG001|Overall Study|Death|3|||
144302401|NCT00060944|520312247|FG000|Overall Study|Withdrawal by Subject|18|||
144302402|NCT00060944|520312248|FG001|Overall Study|Withdrawal by Subject|5|||
144302403|NCT00060944|520312247|FG000|Overall Study|Disease Progression|93|||
144302404|NCT00060944|520312248|FG001|Overall Study|Disease Progression|94|||
144302405|NCT00060944|520312247|FG000|Overall Study|Lost to Follow-up|1|||
144302406|NCT00060944|520312248|FG001|Overall Study|Lost to Follow-up|0|||
144302407|NCT00060944|520312247|FG000|Overall Study|Subject Ineligible To Continue|2|||
144302408|NCT00060944|520312248|FG001|Overall Study|Subject Ineligible To Continue|1|||
144302409|NCT00060944|520312247|FG000|Overall Study|Treatment Switch|0|||
144302410|NCT00060944|520312248|FG001|Overall Study|Treatment Switch|13|||
144302411|NCT00060944|520312247|FG000|Overall Study|Other|2|||
144302412|NCT00060944|520312248|FG001|Overall Study|Other|4|||
144302413|NCT00060944|520312247|FG000|Overall Study|randomized but not treated|6|||
144302414|NCT00060944|520312248|FG001|Overall Study|randomized but not treated|4|||
144302415|NCT02359903|520312250|FG000|Overall Study|Adverse Event|0|||
144302416|NCT02359903|520312251|FG001|Overall Study|Adverse Event|2|||
144302417|NCT02505425|520312252|FG000|Overall Study|Lost to Follow-up|41|||
144302418|NCT02505425|520312253|FG001|Overall Study|Lost to Follow-up|61|||
144302419|NCT02505425|520312254|FG002|Overall Study|Lost to Follow-up|31|||
144302420|NCT02505425|520312255|FG003|Overall Study|Lost to Follow-up|19|||
144302421|NCT02505425|520312252|FG000|Overall Study|Withdrawal by Subject|39|||
144302422|NCT02505425|520312253|FG001|Overall Study|Withdrawal by Subject|9|||
144302423|NCT02505425|520312254|FG002|Overall Study|Withdrawal by Subject|19|||
144302424|NCT02505425|520312255|FG003|Overall Study|Withdrawal by Subject|7|||
144302425|NCT02505425|520312252|FG000|Overall Study|Death|8|||
144302426|NCT02505425|520312253|FG001|Overall Study|Death|12|||
144302427|NCT02505425|520312254|FG002|Overall Study|Death|0|||
144302428|NCT02505425|520312255|FG003|Overall Study|Death|0|||
144302429|NCT02031302|520312256|FG000|Overall Study|Death|115|||
144302430|NCT02031302|520312257|FG001|Overall Study|Death|0|||
144302431|NCT02031302|520312256|FG000|Overall Study|Not treated with study valve system|18|||
144302432|NCT02031302|520312257|FG001|Overall Study|Not treated with study valve system|0|||
144302433|NCT02031302|520312256|FG000|Overall Study|Missed Follow Up|27|||
144302434|NCT02031302|520312257|FG001|Overall Study|Missed Follow Up|0|||
144302435|NCT02031302|520312256|FG000|Overall Study|Lost to Follow-up|4|||
144302436|NCT02031302|520312257|FG001|Overall Study|Lost to Follow-up|0|||
144302437|NCT01816984|520312264|FG000|Overall Study|declining health status|1|||
144360014|NCT01601535|520525136|FG001|Phase 1|Started Another Treatment|2|||
144302438|NCT05899829|520312265|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
144302439|NCT05899829|520312266|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
144302440|NCT05899829|520312265|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
144302441|NCT05899829|520312266|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
144302442|NCT02993263|520312276|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
144302443|NCT00545779|520312277|FG000|Overall Study|Violation of selection criteria at entry|8|||
144302444|NCT00545779|520312277|FG000|Overall Study|Other protocol violation|1|||
144302445|NCT00545779|520312277|FG000|Overall Study|Did not cooperate|7|||
144302446|NCT00545779|520312277|FG000|Overall Study|Withdrawal by Subject|20|||
144302447|NCT00545779|520312277|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
144302448|NCT00545779|520312277|FG000|Overall Study|Failure to return|3|||
144302449|NCT05270863|520312280|FG000|Visit 2 First Intervention|Randomization error|0|||
144302450|NCT05270863|520312281|FG001|Visit 2 First Intervention|Randomization error|0|||
144302451|NCT05270863|520312282|FG002|Visit 2 First Intervention|Randomization error|0|||
144302452|NCT05270863|520312283|FG003|Visit 2 First Intervention|Randomization error|1|||
144302453|NCT05270863|520312284|FG004|Visit 2 First Intervention|Randomization error|0|||
144302454|NCT05270863|520312285|FG005|Visit 2 First Intervention|Randomization error|0|||
144302455|NCT05270863|520312280|FG000|First Washout|Withdrawal by Subject|0|||
144302456|NCT05270863|520312281|FG001|First Washout|Withdrawal by Subject|0|||
144302457|NCT05270863|520312282|FG002|First Washout|Withdrawal by Subject|0|||
144302458|NCT05270863|520312283|FG003|First Washout|Withdrawal by Subject|0|||
144302459|NCT05270863|520312284|FG004|First Washout|Withdrawal by Subject|1|||
144302460|NCT05270863|520312285|FG005|First Washout|Withdrawal by Subject|1|||
144302461|NCT05270863|520312280|FG000|First Washout|Lost to Follow-up|0|||
144302462|NCT05270863|520312281|FG001|First Washout|Lost to Follow-up|0|||
144302463|NCT05270863|520312282|FG002|First Washout|Lost to Follow-up|0|||
144302464|NCT05270863|520312283|FG003|First Washout|Lost to Follow-up|0|||
144302465|NCT05270863|520312284|FG004|First Washout|Lost to Follow-up|0|||
144302466|NCT05270863|520312285|FG005|First Washout|Lost to Follow-up|1|||
144302467|NCT05270863|520312280|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
144302468|NCT05270863|520312281|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
144302469|NCT05270863|520312282|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
144302470|NCT05270863|520312283|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
144302471|NCT05270863|520312284|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
144302472|NCT05270863|520312285|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
144302473|NCT05270863|520312280|FG000|Second Washout|Withdrawal by Subject|1|||
144302474|NCT05270863|520312281|FG001|Second Washout|Withdrawal by Subject|1|||
144302475|NCT05270863|520312282|FG002|Second Washout|Withdrawal by Subject|0|||
144302476|NCT05270863|520312283|FG003|Second Washout|Withdrawal by Subject|0|||
144302477|NCT05270863|520312284|FG004|Second Washout|Withdrawal by Subject|0|||
144302478|NCT05270863|520312285|FG005|Second Washout|Withdrawal by Subject|0|||
144302479|NCT05270863|520312280|FG000|Second Washout|Lost to Follow-up|0|||
144302480|NCT05270863|520312281|FG001|Second Washout|Lost to Follow-up|0|||
144302481|NCT05270863|520312282|FG002|Second Washout|Lost to Follow-up|0|||
144302482|NCT05270863|520312283|FG003|Second Washout|Lost to Follow-up|1|||
144302483|NCT05270863|520312284|FG004|Second Washout|Lost to Follow-up|0|||
144302484|NCT05270863|520312285|FG005|Second Washout|Lost to Follow-up|0|||
144302485|NCT00269113|520314030|FG000|Overall Study|Adverse Event|14|||
144302486|NCT00269113|520314031|FG001|Overall Study|Adverse Event|7|||
144302487|NCT00269113|520314030|FG000|Overall Study|Lack of Efficacy|35|||
144302488|NCT00269113|520314031|FG001|Overall Study|Lack of Efficacy|18|||
144302489|NCT00269113|520314030|FG000|Overall Study|Early Improvement|2|||
144302490|NCT00269113|520314031|FG001|Overall Study|Early Improvement|0|||
144302491|NCT00269113|520314030|FG000|Overall Study|Withdrawal by Subject|0|||
144302492|NCT00269113|520314031|FG001|Overall Study|Withdrawal by Subject|2|||
144302493|NCT00269113|520314030|FG000|Overall Study|Death|6|||
144302494|NCT00269113|520314031|FG001|Overall Study|Death|2|||
144302495|NCT00269113|520314030|FG000|Overall Study|Lost to Follow-up|2|||
144302496|NCT00269113|520314031|FG001|Overall Study|Lost to Follow-up|1|||
144302497|NCT00269113|520314030|FG000|Overall Study|Protocol Violation|15|||
144302498|NCT00269113|520314031|FG001|Overall Study|Protocol Violation|5|||
144302499|NCT00269113|520314030|FG000|Overall Study|Other|0|||
144302500|NCT00269113|520314031|FG001|Overall Study|Other|2|||
144302501|NCT00503984|520314032|FG000|Overall Study|Protocol Violation|0|||
144302502|NCT00503984|520314033|FG001|Overall Study|Protocol Violation|1|||
144302503|NCT00503984|520314034|FG002|Overall Study|Protocol Violation|0|||
144302504|NCT00503984|520314035|FG003|Overall Study|Protocol Violation|0|||
144302505|NCT00503984|520314036|FG004|Overall Study|Protocol Violation|0|||
144302506|NCT00503984|520314037|FG005|Overall Study|Protocol Violation|0|||
144302507|NCT00503984|520314032|FG000|Overall Study|Adverse Event|0|||
144302508|NCT00503984|520314033|FG001|Overall Study|Adverse Event|1|||
144302509|NCT00503984|520314034|FG002|Overall Study|Adverse Event|0|||
144302510|NCT00503984|520314035|FG003|Overall Study|Adverse Event|0|||
144302511|NCT00503984|520314036|FG004|Overall Study|Adverse Event|0|||
144302512|NCT00503984|520314037|FG005|Overall Study|Adverse Event|0|||
144302513|NCT00503984|520314032|FG000|Overall Study|Death|0|||
144302514|NCT00503984|520314033|FG001|Overall Study|Death|0|||
144302515|NCT00503984|520314034|FG002|Overall Study|Death|0|||
144302516|NCT00503984|520314035|FG003|Overall Study|Death|0|||
144302517|NCT00503984|520314036|FG004|Overall Study|Death|1|||
144302518|NCT00503984|520314037|FG005|Overall Study|Death|0|||
144302519|NCT02122380|520314041|FG000|First Intervention (30 Days)|Adverse Event|1|||
144302520|NCT02122380|520314042|FG001|First Intervention (30 Days)|Adverse Event|0|||
144302521|NCT02122380|520314041|FG000|First Intervention (30 Days)|Physician Decision|0|||
144302522|NCT02122380|520314042|FG001|First Intervention (30 Days)|Physician Decision|1|||
144302523|NCT02122380|520314041|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
144302524|NCT02122380|520314042|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
144302525|NCT02122380|520314041|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
144302526|NCT02122380|520314042|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
144302527|NCT02122380|520314041|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
144302528|NCT02122380|520314042|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
144302529|NCT00639457|520314043|FG000|Overall Study|Withdrawal by Subject|2|||
144302530|NCT00639457|520314044|FG001|Overall Study|Withdrawal by Subject|3|||
144302531|NCT03235050|520314045|FG000|Overall Study|Adverse Event|0|||
144302532|NCT03235050|520314046|FG001|Overall Study|Adverse Event|0|||
144302533|NCT03235050|520314047|FG002|Overall Study|Adverse Event|1|||
144302534|NCT03235050|520314048|FG003|Overall Study|Adverse Event|4|||
144302535|NCT03235050|520314049|FG004|Overall Study|Adverse Event|1|||
144302536|NCT03235050|520314045|FG000|Overall Study|Death|0|||
144302537|NCT03235050|520314046|FG001|Overall Study|Death|0|||
144302538|NCT03235050|520314047|FG002|Overall Study|Death|0|||
144302539|NCT03235050|520314048|FG003|Overall Study|Death|2|||
144302540|NCT03235050|520314049|FG004|Overall Study|Death|1|||
144302541|NCT03235050|520314045|FG000|Overall Study|Lost to Follow-up|1|||
144302542|NCT03235050|520314046|FG001|Overall Study|Lost to Follow-up|2|||
144302543|NCT03235050|520314047|FG002|Overall Study|Lost to Follow-up|1|||
144302544|NCT03235050|520314048|FG003|Overall Study|Lost to Follow-up|2|||
144302545|NCT03235050|520314049|FG004|Overall Study|Lost to Follow-up|0|||
144302546|NCT03235050|520314045|FG000|Overall Study|Withdrawal by Subject|3|||
144302547|NCT03235050|520314046|FG001|Overall Study|Withdrawal by Subject|2|||
144302548|NCT03235050|520314047|FG002|Overall Study|Withdrawal by Subject|2|||
144302549|NCT03235050|520314048|FG003|Overall Study|Withdrawal by Subject|5|||
144302550|NCT03235050|520314049|FG004|Overall Study|Withdrawal by Subject|7|||
144302551|NCT03235050|520314045|FG000|Overall Study|Other reasons|0|||
144302552|NCT03235050|520314046|FG001|Overall Study|Other reasons|1|||
144302553|NCT03235050|520314047|FG002|Overall Study|Other reasons|0|||
144302554|NCT03235050|520314048|FG003|Overall Study|Other reasons|1|||
144302555|NCT03235050|520314049|FG004|Overall Study|Other reasons|2|||
144302556|NCT00492557|520314052|FG000|Overall Study|Subject request|12|||
144302557|NCT00492557|520314053|FG001|Overall Study|Subject request|11|||
144302558|NCT00492557|520314052|FG000|Overall Study|Protocol Violation|7|||
144302559|NCT00492557|520314053|FG001|Overall Study|Protocol Violation|8|||
144302560|NCT00492557|520314052|FG000|Overall Study|Other|2|||
144302561|NCT00492557|520314053|FG001|Overall Study|Other|2|||
144302562|NCT00492557|520314052|FG000|Overall Study|Death|1|||
144302563|NCT00492557|520314053|FG001|Overall Study|Death|1|||
144302564|NCT00492557|520314052|FG000|Overall Study|Adverse Event|1|||
144302565|NCT00492557|520314053|FG001|Overall Study|Adverse Event|0|||
144302566|NCT00492557|520314052|FG000|Overall Study|Failed to return|1|||
144302567|NCT00492557|520314053|FG001|Overall Study|Failed to return|0|||
144302568|NCT00492557|520314052|FG000|Overall Study|Lost to Follow-up|0|||
144302569|NCT00492557|520314053|FG001|Overall Study|Lost to Follow-up|1|||
144302570|NCT03423602|520314058|FG000|Overall Study|Death|1|||
144302571|NCT03423602|520314058|FG000|Overall Study|Lost to Follow-up|6|||
144302572|NCT03423602|520314058|FG000|Overall Study|Protocol Violation|1|||
144302573|NCT03423602|520314058|FG000|Overall Study|Withdrawal by Subject|4|||
144302574|NCT04778592|520314059|FG000|Overall Study|Adverse Event|1|||
144302575|NCT04778592|520314060|FG001|Overall Study|Adverse Event|2|||
144302576|NCT04778592|520314059|FG000|Overall Study|Withdrawal by Subject|1|||
144302577|NCT04778592|520314060|FG001|Overall Study|Withdrawal by Subject|2|||
144302578|NCT03423121|520314061|FG000|Overall Study|Lost to Follow-up|2|||
144302579|NCT03423121|520314062|FG001|Overall Study|Lost to Follow-up|6|||
144302580|NCT03423121|520314061|FG000|Overall Study|Adverse Event|1|||
144302581|NCT03423121|520314062|FG001|Overall Study|Adverse Event|0|||
144302582|NCT04102007|520314063|FG000|Overall Study|Adverse Event|4|||
144302583|NCT04102007|520314063|FG000|Overall Study|Lost to Follow-up|3|||
144302584|NCT04102007|520314063|FG000|Overall Study|Withdrawal by Subject|12|||
144302585|NCT04102007|520314063|FG000|Overall Study|Eligibility Violation|5|||
144302586|NCT04102007|520314063|FG000|Overall Study|Lack of Efficacy|6|||
144302587|NCT04102007|520314063|FG000|Overall Study|Protocol Deviation|5|||
144302588|NCT04102007|520314063|FG000|Overall Study|Protocol Compliance|1|||
144302589|NCT04102007|520314063|FG000|Overall Study|Withdrew Treatment|2|||
144302590|NCT04102007|520314063|FG000|Overall Study|Pregnancy|1|||
144302591|NCT05173974|520314064|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
144302592|NCT05173974|520314065|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
144302593|NCT05173974|520314066|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
144302594|NCT05173974|520314067|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
144302595|NCT05173974|520314064|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
144302596|NCT05173974|520314065|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
144302597|NCT05173974|520314066|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
144302598|NCT05173974|520314067|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
144302599|NCT03289143|520314068|FG000|Overall Study|Caregiver Unavailability|1|||
144302600|NCT03289143|520314069|FG001|Overall Study|Caregiver Unavailability|1|||
144302601|NCT03289143|520314070|FG002|Overall Study|Caregiver Unavailability|0|||
144302602|NCT03289143|520314071|FG003|Overall Study|Caregiver Unavailability|0|||
144302603|NCT03289143|520314068|FG000|Overall Study|Research Department Closure|0|||
144302604|NCT03289143|520314069|FG001|Overall Study|Research Department Closure|0|||
144302605|NCT03289143|520314070|FG002|Overall Study|Research Department Closure|1|||
144302606|NCT03289143|520314071|FG003|Overall Study|Research Department Closure|0|||
144302607|NCT03289143|520314068|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
144302608|NCT03289143|520314069|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
144302609|NCT03289143|520314070|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
144302610|NCT03289143|520314071|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
144302611|NCT03289143|520314068|FG000|Overall Study|Medical Monitor Decision|1|||
144302612|NCT03289143|520314069|FG001|Overall Study|Medical Monitor Decision|0|||
144302613|NCT03289143|520314070|FG002|Overall Study|Medical Monitor Decision|0|||
144302614|NCT03289143|520314071|FG003|Overall Study|Medical Monitor Decision|0|||
144302615|NCT03289143|520314068|FG000|Overall Study|Participant Non-Compliance|0|||
144302616|NCT03289143|520314069|FG001|Overall Study|Participant Non-Compliance|0|||
144302617|NCT03289143|520314070|FG002|Overall Study|Participant Non-Compliance|1|||
144302618|NCT03289143|520314071|FG003|Overall Study|Participant Non-Compliance|0|||
144302619|NCT03289143|520314068|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
144302620|NCT03289143|520314069|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
144302621|NCT03289143|520314070|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
144302622|NCT03289143|520314071|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
144302623|NCT03289143|520314068|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
144302624|NCT03289143|520314069|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
144302625|NCT03289143|520314070|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
144302626|NCT03289143|520314071|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
144302627|NCT03289143|520314068|FG000|Overall Study|Caregiver Passed Away|1|||
144302628|NCT03289143|520314069|FG001|Overall Study|Caregiver Passed Away|0|||
144302629|NCT03289143|520314070|FG002|Overall Study|Caregiver Passed Away|0|||
144302630|NCT03289143|520314071|FG003|Overall Study|Caregiver Passed Away|0|||
144302631|NCT03289143|520314068|FG000|Overall Study|Physician Decision|0|||
144302632|NCT03289143|520314069|FG001|Overall Study|Physician Decision|2|||
144302633|NCT03289143|520314070|FG002|Overall Study|Physician Decision|2|||
144302634|NCT03289143|520314071|FG003|Overall Study|Physician Decision|2|||
144302635|NCT03289143|520314068|FG000|Overall Study|Protocol Deviation|2|||
144302636|NCT03289143|520314069|FG001|Overall Study|Protocol Deviation|1|||
144302637|NCT03289143|520314070|FG002|Overall Study|Protocol Deviation|3|||
144302638|NCT03289143|520314071|FG003|Overall Study|Protocol Deviation|1|||
144302639|NCT03289143|520314068|FG000|Overall Study|Study Terminated By Sponsor|101|||
144302640|NCT03289143|520314069|FG001|Overall Study|Study Terminated By Sponsor|75|||
144302641|NCT03289143|520314070|FG002|Overall Study|Study Terminated By Sponsor|100|||
144302642|NCT03289143|520314071|FG003|Overall Study|Study Terminated By Sponsor|69|||
144302643|NCT03289143|520314068|FG000|Overall Study|Withdrawal by Subject|14|||
144302644|NCT03289143|520314069|FG001|Overall Study|Withdrawal by Subject|6|||
144302645|NCT03289143|520314070|FG002|Overall Study|Withdrawal by Subject|14|||
144302646|NCT03289143|520314071|FG003|Overall Study|Withdrawal by Subject|12|||
144302647|NCT03289143|520314068|FG000|Overall Study|Adverse Event|10|||
144302648|NCT03289143|520314069|FG001|Overall Study|Adverse Event|7|||
144302649|NCT03289143|520314070|FG002|Overall Study|Adverse Event|6|||
144302650|NCT03289143|520314071|FG003|Overall Study|Adverse Event|5|||
144302651|NCT03289143|520314068|FG000|Overall Study|Death|2|||
144302652|NCT03289143|520314069|FG001|Overall Study|Death|0|||
144302653|NCT03289143|520314070|FG002|Overall Study|Death|2|||
144302654|NCT03289143|520314071|FG003|Overall Study|Death|1|||
144302655|NCT03289143|520314068|FG000|Overall Study|Lost to Follow-up|2|||
144302656|NCT03289143|520314069|FG001|Overall Study|Lost to Follow-up|1|||
144302657|NCT03289143|520314070|FG002|Overall Study|Lost to Follow-up|1|||
144302658|NCT03289143|520314071|FG003|Overall Study|Lost to Follow-up|0|||
144302659|NCT03289143|520314068|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
144302660|NCT03289143|520314069|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
144302661|NCT03289143|520314070|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
144302662|NCT03289143|520314071|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
144302663|NCT03289143|520314068|FG000|Overall Study|Withdrawal by Caregiver|0|||
144302664|NCT03289143|520314069|FG001|Overall Study|Withdrawal by Caregiver|1|||
144302665|NCT03289143|520314070|FG002|Overall Study|Withdrawal by Caregiver|0|||
144302666|NCT03289143|520314071|FG003|Overall Study|Withdrawal by Caregiver|0|||
144302667|NCT03289143|520314068|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
144302668|NCT03289143|520314069|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
144302669|NCT03289143|520314070|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
144302670|NCT03289143|520314071|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
144302671|NCT03289143|520314068|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
144302672|NCT03289143|520314069|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
144302673|NCT03289143|520314070|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
144302674|NCT03289143|520314071|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
144302675|NCT00948688|520314072|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
144302676|NCT00948688|520314073|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
144302677|NCT00948688|520314072|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
144302678|NCT00948688|520314073|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
144302679|NCT00948688|520314072|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
144302680|NCT00948688|520314073|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
144302681|NCT03610048|520314077|FG000|Overall Study|Study terminated by sponsor|84|||
144302682|NCT03610048|520314077|FG000|Overall Study|Adverse Event|32|||
144302683|NCT03610048|520314077|FG000|Overall Study|Withdrawal by Subject|31|||
144302684|NCT03610048|520314077|FG000|Overall Study|Lost to Follow-up|8|||
144302685|NCT03610048|520314077|FG000|Overall Study|Other|4|||
144302686|NCT03610048|520314077|FG000|Overall Study|Physician Decision|1|||
144302687|NCT03610048|520314077|FG000|Overall Study|Pregnancy|1|||
144302688|NCT01155050|520314078|FG000|Overall Study|Lost to Follow-up|15|||
144302689|NCT01155050|520314079|FG001|Overall Study|Lost to Follow-up|20|||
144302690|NCT01155050|520314080|FG002|Overall Study|Lost to Follow-up|19|||
144302691|NCT01155050|520314081|FG003|Overall Study|Lost to Follow-up|22|||
144302692|NCT02136914|520314082|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
144302693|NCT02136914|520314083|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
144302694|NCT02136914|520314082|FG000|Overall Study|Withdrawal by Subject|3|||
144302695|NCT02136914|520314083|FG001|Overall Study|Withdrawal by Subject|10|||
144302696|NCT02136914|520314082|FG000|Overall Study|Subject Unwilling to Proceed|7|||
144302697|NCT02136914|520314083|FG001|Overall Study|Subject Unwilling to Proceed|2|||
144302698|NCT02136914|520314082|FG000|Overall Study|Lost to Follow-up|1|||
144302699|NCT02136914|520314083|FG001|Overall Study|Lost to Follow-up|1|||
144302700|NCT02136914|520314082|FG000|Overall Study|Did Not Receive Study Drug|2|||
144302701|NCT02136914|520314083|FG001|Overall Study|Did Not Receive Study Drug|0|||
144302702|NCT02136914|520314082|FG000|Overall Study|Lack of Efficacy|1|||
144302703|NCT02136914|520314083|FG001|Overall Study|Lack of Efficacy|0|||
144302704|NCT02136914|520314082|FG000|Overall Study|Death|0|||
144302705|NCT02136914|520314083|FG001|Overall Study|Death|1|||
144302706|NCT00329030|520314084|FG000|Overall Study|Withdrawal by Subject|1|||
144302707|NCT00329030|520314085|FG001|Overall Study|Withdrawal by Subject|3|||
144302708|NCT00329030|520314084|FG000|Overall Study|Progressive Disease|6|||
144302709|NCT00329030|520314085|FG001|Overall Study|Progressive Disease|2|||
144302710|NCT00329030|520314084|FG000|Overall Study|Ineligible Pathology|1|||
144302711|NCT00329030|520314085|FG001|Overall Study|Ineligible Pathology|1|||
144302712|NCT00325143|520314086|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
144302713|NCT00325143|520314086|FG000|Overall Study|Migrated/moved from study area|1|||
144302714|NCT00325143|520314086|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
144302715|NCT00325143|520314086|FG000|Overall Study|Withdrawal by Subject|8|||
144302716|NCT03036852|520314087|FG000|Overall Study|Death|2|||
144302717|NCT03036852|520314087|FG000|Overall Study|Lack of Efficacy|2|||
144302718|NCT03036852|520314087|FG000|Overall Study|Adverse Event|1|||
144302719|NCT03036852|520314087|FG000|Overall Study|Lost to Follow-up|1|||
144302720|NCT02431325|520314088|FG000|Overall Study|Adverse Event|3|||
144302721|NCT02431325|520314089|FG001|Overall Study|Adverse Event|0|||
144302722|NCT02431325|520314088|FG000|Overall Study|Lost to Follow-up|0|||
144302723|NCT02431325|520314089|FG001|Overall Study|Lost to Follow-up|1|||
144302724|NCT02431325|520314088|FG000|Overall Study|Withdrawal by Subject|1|||
144302725|NCT02431325|520314089|FG001|Overall Study|Withdrawal by Subject|2|||
144302726|NCT02431325|520314088|FG000|Overall Study|Declined to take study medication|1|||
144302727|NCT02431325|520314089|FG001|Overall Study|Declined to take study medication|0|||
144302728|NCT02431325|520314088|FG000|Overall Study|Withdrew before starting study medication|1|||
144302729|NCT02431325|520314089|FG001|Overall Study|Withdrew before starting study medication|0|||
144302730|NCT02431325|520314088|FG000|Overall Study|Placebo shortage|2|||
144302731|NCT02431325|520314089|FG001|Overall Study|Placebo shortage|0|||
144302732|NCT01130337|520314093|FG000|Overall Study|Withdrawal by Subject|3|||
144302733|NCT01130337|520314093|FG000|Overall Study|Principal investigator decision|1|||
144302734|NCT01130337|520314093|FG000|Overall Study|Death|1|||
144302735|NCT01130337|520314093|FG000|Overall Study|Disease progression|1|||
144302736|NCT01130337|520314093|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
144302737|NCT01130337|520314093|FG000|Overall Study|Surgical resection (R2)|1|||
144302738|NCT03886493|520314095|FG000|Overall Study|Adverse Event|1|||
144302739|NCT03179761|520314097|FG000|Overall Study|Death|2|||
144302740|NCT03179761|520314098|FG001|Overall Study|Death|5|||
144302741|NCT03179761|520314097|FG000|Overall Study|Lost to Follow-up|2|||
144302742|NCT03179761|520314098|FG001|Overall Study|Lost to Follow-up|2|||
144302743|NCT03179761|520314097|FG000|Overall Study|Protocol Violation|1|||
144302744|NCT03179761|520314098|FG001|Overall Study|Protocol Violation|0|||
144302745|NCT03179761|520314097|FG000|Overall Study|Withdrawal by Subject|1|||
144302746|NCT03179761|520314098|FG001|Overall Study|Withdrawal by Subject|4|||
144302747|NCT03179761|520314097|FG000|Overall Study|Investigator Request|0|||
144302748|NCT03179761|520314098|FG001|Overall Study|Investigator Request|2|||
144302749|NCT03440008|520314101|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
144302750|NCT03440008|520314102|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
144302751|NCT03440008|520314101|FG000|Overall Study|Withdrawal by Subject|1|||
144302752|NCT03440008|520314102|FG001|Overall Study|Withdrawal by Subject|0|||
144302753|NCT03498716|520314118|FG000|Overall Study|Withdrawal by Subject|88|||
144302754|NCT03498716|520314119|FG001|Overall Study|Withdrawal by Subject|73|||
144302755|NCT03498716|520314118|FG000|Overall Study|Study Terminated By Sponsor|933|||
144302756|NCT03498716|520314119|FG001|Overall Study|Study Terminated By Sponsor|927|||
144302757|NCT03498716|520314118|FG000|Overall Study|Lost to Follow-up|15|||
144302758|NCT03498716|520314119|FG001|Overall Study|Lost to Follow-up|26|||
144302759|NCT03498716|520314118|FG000|Overall Study|Disease Relapse|0|||
144302760|NCT03498716|520314119|FG001|Overall Study|Disease Relapse|1|||
144302761|NCT03498716|520314118|FG000|Overall Study|Death|58|||
144302762|NCT03498716|520314119|FG001|Overall Study|Death|72|||
144302763|NCT03498716|520314118|FG000|Overall Study|Physician Decision|4|||
144302764|NCT03498716|520314119|FG001|Overall Study|Physician Decision|2|||
144302765|NCT02284191|520314120|FG000|Overall Study|Withdrawal by Subject|1|||
144302766|NCT02284191|520314121|FG001|Overall Study|Withdrawal by Subject|3|||
144302767|NCT02284191|520314120|FG000|Overall Study|Lost to Follow-up|1|||
144302768|NCT02284191|520314121|FG001|Overall Study|Lost to Follow-up|0|||
144302769|NCT01570387|520314125|FG000|Overall Study|Adverse Event|1|||
144302770|NCT01570387|520314126|FG001|Overall Study|Adverse Event|0|||
144302771|NCT01570387|520314127|FG002|Overall Study|Adverse Event|0|||
144302772|NCT01570387|520314128|FG003|Overall Study|Adverse Event|0|||
144302773|NCT01570387|520314125|FG000|Overall Study|Death|0|||
144302774|NCT01570387|520314126|FG001|Overall Study|Death|0|||
144302775|NCT01570387|520314127|FG002|Overall Study|Death|0|||
144302776|NCT01570387|520314128|FG003|Overall Study|Death|1|||
144302777|NCT01570387|520314125|FG000|Overall Study|Withdrawal by Subject|0|||
144302778|NCT01570387|520314126|FG001|Overall Study|Withdrawal by Subject|0|||
144302779|NCT01570387|520314127|FG002|Overall Study|Withdrawal by Subject|0|||
144302780|NCT01570387|520314128|FG003|Overall Study|Withdrawal by Subject|1|||
144302781|NCT03139448|520314129|FG000|Overall Study|Lack of Efficacy|6|||
144302782|NCT03139448|520314130|FG001|Overall Study|Lack of Efficacy|7|||
144302783|NCT03139448|520314129|FG000|Overall Study|Location of procedure changed|2|||
144302784|NCT03139448|520314130|FG001|Overall Study|Location of procedure changed|8|||
144302785|NCT03139448|520314129|FG000|Overall Study|Withdrawal by Subject|3|||
144302786|NCT03139448|520314130|FG001|Overall Study|Withdrawal by Subject|6|||
144302787|NCT03139448|520314129|FG000|Overall Study|Screen fail|1|||
144302788|NCT03139448|520314130|FG001|Overall Study|Screen fail|3|||
144302789|NCT03139448|520314129|FG000|Overall Study|Physician Decision|0|||
144302790|NCT03139448|520314130|FG001|Overall Study|Physician Decision|2|||
144302791|NCT01987557|520314131|FG000|Overall Study|Protocol Violation|1|||
144302792|NCT01987557|520314132|FG001|Overall Study|Protocol Violation|0|||
144302793|NCT01987557|520314133|FG002|Overall Study|Protocol Violation|1|||
144302794|NCT01987557|520314131|FG000|Overall Study|Withdrawal by Subject|2|||
144302795|NCT01987557|520314132|FG001|Overall Study|Withdrawal by Subject|1|||
144302796|NCT01987557|520314133|FG002|Overall Study|Withdrawal by Subject|2|||
144302797|NCT01987557|520314131|FG000|Overall Study|Adverse Event|0|||
144302798|NCT01987557|520314132|FG001|Overall Study|Adverse Event|2|||
144302799|NCT01987557|520314133|FG002|Overall Study|Adverse Event|0|||
144302800|NCT00760552|520314134|FG000|Overall Study|Death|2|||
144302801|NCT00760552|520314135|FG001|Overall Study|Death|0|||
144302802|NCT00760552|520314134|FG000|Overall Study|Lost to Follow-up|11|||
144302803|NCT00760552|520314135|FG001|Overall Study|Lost to Follow-up|10|||
144302804|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
144302805|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
144302806|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
144302807|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Death|0|||
144302808|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Death|0|||
144302809|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Death|1|||
144302810|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
144302811|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
144302812|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
144302813|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
144302814|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
144302815|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
144302816|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
144302817|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
144302818|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
144302819|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Graft loss|0|||
144302820|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Graft loss|0|||
144302821|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Graft loss|7|||
144302822|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
144302823|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
144302824|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
144302825|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
144302826|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
144302827|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
144302828|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
144302829|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
144302830|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
144302831|NCT00956293|520314141|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
144302832|NCT00956293|520314142|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
144302833|NCT00956293|520314143|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
144302834|NCT00956293|520314141|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
144302835|NCT00956293|520314142|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
144302836|NCT00956293|520314143|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
144302837|NCT00956293|520314141|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
144302838|NCT00956293|520314142|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
144302839|NCT00956293|520314143|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
144302840|NCT00956293|520314141|FG000|Main Period (Randomization)|Adverse Event|0|||
144302841|NCT00956293|520314142|FG001|Main Period (Randomization)|Adverse Event|15|||
144302842|NCT00956293|520314143|FG002|Main Period (Randomization)|Adverse Event|0|||
144302843|NCT00956293|520314141|FG000|Follow-up Period|Follow-up period was terminated.|20|||
144302844|NCT00956293|520314142|FG001|Follow-up Period|Follow-up period was terminated.|32|||
144302845|NCT00956293|520314143|FG002|Follow-up Period|Follow-up period was terminated.|0|||
144302846|NCT00636181|520314147|FG000|Overall Study|Withdrawal by Subject|8|||
144302847|NCT00636181|520314148|FG001|Overall Study|Withdrawal by Subject|6|||
144302848|NCT00636181|520314149|FG002|Overall Study|Withdrawal by Subject|10|||
144302849|NCT04549454|520314152|FG000|T1 to T2|Lost to Follow-up|22|||
144302850|NCT04549454|520314153|FG001|T1 to T2|Lost to Follow-up|26|||
144302851|NCT04549454|520314152|FG000|T1 to T3|Lost to Follow-up|31|||
144302852|NCT04549454|520314153|FG001|T1 to T3|Lost to Follow-up|36|||
144302853|NCT00867035|520314154|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
144302854|NCT00867035|520314155|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
144302855|NCT00867035|520314154|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
144302856|NCT00867035|520314155|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
144302857|NCT05076045|520314156|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
144302858|NCT05076045|520314157|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
144302859|NCT01405196|520314169|FG000|Overall Study|Study Terminated by Sponsor|0|||
144302860|NCT01405196|520314170|FG001|Overall Study|Study Terminated by Sponsor|0|||
144302861|NCT01405196|520314171|FG002|Overall Study|Study Terminated by Sponsor|9|||
144302862|NCT01405196|520314172|FG003|Overall Study|Study Terminated by Sponsor|0|||
144302863|NCT01405196|520314169|FG000|Overall Study|Other|2|||
144302864|NCT01405196|520314170|FG001|Overall Study|Other|2|||
144302865|NCT01405196|520314171|FG002|Overall Study|Other|5|||
144302866|NCT01405196|520314172|FG003|Overall Study|Other|0|||
144302867|NCT01405196|520314169|FG000|Overall Study|Withdrawal by Subject|4|||
144302868|NCT01405196|520314170|FG001|Overall Study|Withdrawal by Subject|6|||
144302869|NCT01405196|520314171|FG002|Overall Study|Withdrawal by Subject|3|||
144302870|NCT01405196|520314172|FG003|Overall Study|Withdrawal by Subject|6|||
144302871|NCT01405196|520314169|FG000|Overall Study|Adverse Event|2|||
144302872|NCT01405196|520314170|FG001|Overall Study|Adverse Event|2|||
144302873|NCT01405196|520314171|FG002|Overall Study|Adverse Event|0|||
144302874|NCT01405196|520314172|FG003|Overall Study|Adverse Event|2|||
144302875|NCT01405196|520314169|FG000|Overall Study|Death|1|||
144302876|NCT01405196|520314170|FG001|Overall Study|Death|0|||
144302877|NCT01405196|520314171|FG002|Overall Study|Death|3|||
144302878|NCT01405196|520314172|FG003|Overall Study|Death|0|||
144302879|NCT01405196|520314169|FG000|Overall Study|Lost to Follow-up|2|||
144302880|NCT01405196|520314170|FG001|Overall Study|Lost to Follow-up|2|||
144302881|NCT01405196|520314171|FG002|Overall Study|Lost to Follow-up|3|||
144302882|NCT01405196|520314172|FG003|Overall Study|Lost to Follow-up|1|||
144302883|NCT00542178|520314173|FG000|Overall Study|did not complete year 4 follow-up|75|||
144302884|NCT00542178|520314174|FG001|Overall Study|did not complete year 4 follow-up|80|||
144302885|NCT00542178|520314175|FG002|Overall Study|did not complete year 4 follow-up|74|||
144302886|NCT00542178|520314176|FG003|Overall Study|did not complete year 4 follow-up|62|||
144302887|NCT00542178|520314177|FG004|Overall Study|did not complete year 4 follow-up|64|||
144302888|NCT00542178|520314178|FG005|Overall Study|did not complete year 4 follow-up|89|||
144302889|NCT00542178|520314179|FG006|Overall Study|did not complete year 4 follow-up|87|||
144302890|NCT00542178|520314180|FG007|Overall Study|did not complete year 4 follow-up|85|||
144302891|NCT02611037|520314181|FG000|Overall Study|Withdrawal prior to treatment|2|||
144302892|NCT02611037|520314182|FG001|Overall Study|Withdrawal prior to treatment|0|||
144302893|NCT02561962|520314183|FG000|Overall Study|Withdrawal by Subject|1|||
144302894|NCT02561962|520314184|FG001|Overall Study|Withdrawal by Subject|0|||
144302895|NCT02561962|520314185|FG002|Overall Study|Withdrawal by Subject|0|||
144302896|NCT02561962|520314186|FG003|Overall Study|Withdrawal by Subject|0|||
144302897|NCT02561962|520314187|FG004|Overall Study|Withdrawal by Subject|1|||
144302898|NCT02561962|520314188|FG005|Overall Study|Withdrawal by Subject|1|||
144302899|NCT02561962|520314189|FG006|Overall Study|Withdrawal by Subject|2|||
144302900|NCT02561962|520314190|FG007|Overall Study|Withdrawal by Subject|1|||
144302901|NCT02561962|520314191|FG008|Overall Study|Withdrawal by Subject|0|||
144302902|NCT02561962|520314183|FG000|Overall Study|Decision by sponsor|0|||
144302903|NCT02561962|520314184|FG001|Overall Study|Decision by sponsor|0|||
144302904|NCT02561962|520314185|FG002|Overall Study|Decision by sponsor|0|||
144302905|NCT02561962|520314186|FG003|Overall Study|Decision by sponsor|0|||
144302906|NCT02561962|520314187|FG004|Overall Study|Decision by sponsor|1|||
144302907|NCT02561962|520314188|FG005|Overall Study|Decision by sponsor|1|||
144302908|NCT02561962|520314189|FG006|Overall Study|Decision by sponsor|0|||
144302909|NCT02561962|520314190|FG007|Overall Study|Decision by sponsor|3|||
144302910|NCT02561962|520314191|FG008|Overall Study|Decision by sponsor|0|||
144302911|NCT02561962|520314183|FG000|Overall Study|Lost to Follow-up|0|||
144302912|NCT02561962|520314184|FG001|Overall Study|Lost to Follow-up|0|||
144302913|NCT02561962|520314185|FG002|Overall Study|Lost to Follow-up|0|||
144302914|NCT02561962|520314186|FG003|Overall Study|Lost to Follow-up|0|||
144302915|NCT02561962|520314187|FG004|Overall Study|Lost to Follow-up|0|||
144302916|NCT02561962|520314188|FG005|Overall Study|Lost to Follow-up|1|||
144302917|NCT02561962|520314189|FG006|Overall Study|Lost to Follow-up|0|||
144302918|NCT02561962|520314190|FG007|Overall Study|Lost to Follow-up|0|||
144302919|NCT02561962|520314191|FG008|Overall Study|Lost to Follow-up|0|||
144302920|NCT01150357|520314192|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
144302921|NCT01150357|520314193|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
144302922|NCT01150357|520314194|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
144302923|NCT01150357|520314192|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
144302924|NCT01150357|520314193|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
144302925|NCT01150357|520314194|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
144302926|NCT01150357|520314192|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
144302927|NCT01150357|520314193|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
144302928|NCT01150357|520314194|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
144302929|NCT01150357|520314192|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
144302930|NCT01150357|520314193|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
144302931|NCT01150357|520314194|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
144302932|NCT01150357|520314192|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
144302933|NCT01150357|520314193|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
144302934|NCT01150357|520314194|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
144302935|NCT01150357|520314192|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
144302936|NCT01150357|520314193|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
144302937|NCT01150357|520314194|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
144302938|NCT01150357|520314192|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
144302939|NCT01150357|520314193|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
144302940|NCT01150357|520314194|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
144302941|NCT01492426|520315931|FG000|Treatment|Death|0|||
144302942|NCT01492426|520315932|FG001|Treatment|Death|1|||
144302943|NCT01492426|520315931|FG000|Treatment|Other|1|||
144302944|NCT01492426|520315932|FG001|Treatment|Other|0|||
144302945|NCT01492426|520315931|FG000|Treatment|Adverse Event|25|||
144302946|NCT01492426|520315932|FG001|Treatment|Adverse Event|25|||
144302947|NCT01492426|520315931|FG000|Treatment|Lack of Efficacy|38|||
144302948|NCT01492426|520315932|FG001|Treatment|Lack of Efficacy|5|||
144302949|NCT01492426|520315931|FG000|Treatment|Participant withdrew consent|1|||
144302950|NCT01492426|520315932|FG001|Treatment|Participant withdrew consent|2|||
144302951|NCT01492426|520315931|FG000|Treatment|Poor compliance/noncompliance|1|||
144302952|NCT01492426|520315932|FG001|Treatment|Poor compliance/noncompliance|0|||
144302953|NCT01492426|520315931|FG000|Treatment|Subject requested discontinue study drug|7|||
144302954|NCT01492426|520315932|FG001|Treatment|Subject requested discontinue study drug|3|||
144302955|NCT01492426|520315931|FG000|Treatment|Lost to Follow-up|9|||
144302956|NCT01492426|520315932|FG001|Treatment|Lost to Follow-up|4|||
144302957|NCT01492426|520315931|FG000|Treatment|Participant does not meet study criteria|1|||
144302958|NCT01492426|520315932|FG001|Treatment|Participant does not meet study criteria|0|||
144302959|NCT01492426|520315931|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
144302960|NCT01492426|520315932|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
144302961|NCT01492426|520315931|FG000|Follow-Up|Death|1|||
144302962|NCT01492426|520315932|FG001|Follow-Up|Death|0|||
144302963|NCT01492426|520315931|FG000|Follow-Up|Other|4|||
144302964|NCT01492426|520315932|FG001|Follow-Up|Other|2|||
144302965|NCT01492426|520315931|FG000|Follow-Up|Participant Withdrew Consent|6|||
144302966|NCT01492426|520315932|FG001|Follow-Up|Participant Withdrew Consent|1|||
144302967|NCT01492426|520315931|FG000|Follow-Up|Lost to Follow-up|12|||
144302968|NCT01492426|520315932|FG001|Follow-Up|Lost to Follow-up|6|||
144302969|NCT00652743|520315933|FG000|Months 12-18|Lost to Follow-up|1|||
144302970|NCT00652743|520315934|FG001|Months 12-18|Lost to Follow-up|2|||
144302971|NCT00652743|520315935|FG002|Months 12-18|Lost to Follow-up|7|||
144302972|NCT00652743|520315933|FG000|Months 24-30|Other|5|||
144302973|NCT00652743|520315934|FG001|Months 24-30|Other|1|||
144302974|NCT00652743|520315935|FG002|Months 24-30|Other|11|||
144302975|NCT00652743|520315933|FG000|Months 36-42|Serious Adverse Events|0|||
144302976|NCT00652743|520315934|FG001|Months 36-42|Serious Adverse Events|1|||
144302977|NCT00652743|520315935|FG002|Months 36-42|Serious Adverse Events|1|||
144302978|NCT00652743|520315933|FG000|Months 36-42|Withdrawal by Subject|1|||
144302979|NCT00652743|520315934|FG001|Months 36-42|Withdrawal by Subject|1|||
144302980|NCT00652743|520315935|FG002|Months 36-42|Withdrawal by Subject|0|||
144302981|NCT00652743|520315933|FG000|Months 36-42|Lost to Follow-up|0|||
144302982|NCT00652743|520315934|FG001|Months 36-42|Lost to Follow-up|1|||
144302983|NCT00652743|520315935|FG002|Months 36-42|Lost to Follow-up|0|||
144302984|NCT00652743|520315933|FG000|Months 36-42|Migrated/moved from study area|1|||
144302985|NCT00652743|520315934|FG001|Months 36-42|Migrated/moved from study area|0|||
144302986|NCT00652743|520315935|FG002|Months 36-42|Migrated/moved from study area|0|||
144302987|NCT00652743|520315933|FG000|Months 36-42|Other|4|||
144302988|NCT00652743|520315934|FG001|Months 36-42|Other|2|||
144302989|NCT00652743|520315935|FG002|Months 36-42|Other|8|||
144302990|NCT02026011|520315938|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
144302991|NCT02026011|520315939|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
144302992|NCT02026011|520315938|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
144302993|NCT02026011|520315939|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
144302994|NCT02026011|520315938|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
144302995|NCT02026011|520315939|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
144302996|NCT02026011|520315938|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
144302997|NCT02026011|520315939|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
144302998|NCT05010070|520315940|FG000|Overall Study|Lost to Follow-up|1|||
144302999|NCT05010070|520315940|FG000|Overall Study|Withdrawal by Subject|1|||
144303000|NCT00939107|520315941|FG000|Overall Study|Lost to Follow-up|14|||
144303001|NCT00939107|520315942|FG001|Overall Study|Lost to Follow-up|12|||
144303002|NCT01621178|520315944|FG000|Overall Study|Adverse Event|5|||
144303003|NCT01621178|520315945|FG001|Overall Study|Adverse Event|2|||
144303004|NCT01621178|520315946|FG002|Overall Study|Adverse Event|8|||
144303005|NCT01621178|520315944|FG000|Overall Study|Death|6|||
144303006|NCT01621178|520315945|FG001|Overall Study|Death|7|||
144303007|NCT01621178|520315946|FG002|Overall Study|Death|2|||
144303008|NCT01621178|520315944|FG000|Overall Study|Lost to Follow-up|1|||
144303009|NCT01621178|520315945|FG001|Overall Study|Lost to Follow-up|2|||
144303010|NCT01621178|520315946|FG002|Overall Study|Lost to Follow-up|1|||
144303011|NCT01621178|520315944|FG000|Overall Study|Withdrawal by Subject|14|||
144303012|NCT01621178|520315945|FG001|Overall Study|Withdrawal by Subject|17|||
144303013|NCT01621178|520315946|FG002|Overall Study|Withdrawal by Subject|18|||
144303014|NCT01621178|520315944|FG000|Overall Study|Physician Decision|5|||
144303015|NCT01621178|520315945|FG001|Overall Study|Physician Decision|2|||
144303016|NCT01621178|520315946|FG002|Overall Study|Physician Decision|7|||
144303017|NCT00105534|520315947|FG000|Overall Study|Adverse Event|2|||
144303018|NCT00105534|520315948|FG001|Overall Study|Adverse Event|5|||
144303019|NCT00105534|520315947|FG000|Overall Study|Protocol Violation|1|||
144303020|NCT00105534|520315948|FG001|Overall Study|Protocol Violation|4|||
144303021|NCT00105534|520315947|FG000|Overall Study|Withdrawal by Subject|6|||
144303022|NCT00105534|520315948|FG001|Overall Study|Withdrawal by Subject|6|||
144303023|NCT00105534|520315947|FG000|Overall Study|Lost to Follow-up|5|||
144303024|NCT00105534|520315948|FG001|Overall Study|Lost to Follow-up|1|||
144303025|NCT00105534|520315947|FG000|Overall Study|Lack of Efficacy|7|||
144303026|NCT00105534|520315948|FG001|Overall Study|Lack of Efficacy|15|||
144303027|NCT00105534|520315947|FG000|Overall Study|Treatment unmasked|1|||
144303028|NCT00105534|520315948|FG001|Overall Study|Treatment unmasked|0|||
144303029|NCT00105534|520315947|FG000|Overall Study|Other Reason|0|||
144303030|NCT00105534|520315948|FG001|Overall Study|Other Reason|2|||
144303031|NCT02935192|520315949|FG000|Overall Study|Withdrawal by Subject|8|||
144303032|NCT02935192|520315950|FG001|Overall Study|Withdrawal by Subject|4|||
144303033|NCT02465931|520315952|FG000|Overall Study|Lost to Follow-up|9|||
144303034|NCT02465931|520315953|FG001|Overall Study|Lost to Follow-up|11|||
144303035|NCT02465931|520315952|FG000|Overall Study|Protocol Violation|1|||
144303036|NCT02465931|520315953|FG001|Overall Study|Protocol Violation|0|||
144303037|NCT02465931|520315952|FG000|Overall Study|Withdrawal by Subject|1|||
144303038|NCT02465931|520315953|FG001|Overall Study|Withdrawal by Subject|0|||
144303039|NCT02896257|520315954|FG000|Providers|Without eligible patients|21|||
144303040|NCT02896257|520315955|FG001|Providers|Without eligible patients|28|||
144303041|NCT02896257|520315954|FG000|Patients|PFT entry criteria not met|43|||
144303042|NCT02896257|520315955|FG001|Patients|PFT entry criteria not met|50|||
144303043|NCT02896257|520315954|FG000|Patients|No capacity to review|8|||
144303044|NCT02896257|520315955|FG001|Patients|No capacity to review|11|||
144303045|NCT02896257|520315954|FG000|Patients|Appointment rescheduled/cancelled|5|||
144303046|NCT02896257|520315955|FG001|Patients|Appointment rescheduled/cancelled|7|||
144303047|NCT02896257|520315954|FG000|Patients|PCP not assigned a clinic|4|||
144303048|NCT02896257|520315955|FG001|Patients|PCP not assigned a clinic|0|||
144303049|NCT02896257|520315954|FG000|Patients|No history of COPD|0|||
144303050|NCT02896257|520315955|FG001|Patients|No history of COPD|1|||
144303051|NCT02896257|520315954|FG000|Patients|Deceased between review and index date|0|||
144303052|NCT02896257|520315955|FG001|Patients|Deceased between review and index date|1|||
144303053|NCT02896257|520315954|FG000|Patients|No ICS Rx upon review|1|||
144303054|NCT02896257|520315955|FG001|Patients|No ICS Rx upon review|1|||
144303055|NCT02896257|520315954|FG000|Patients|Protocol Violation|2|||
144303056|NCT02896257|520315955|FG001|Patients|Protocol Violation|1|||
144303057|NCT02896257|520315954|FG000|Patients|Hospice care|0|||
144303058|NCT02896257|520315955|FG001|Patients|Hospice care|1|||
144303059|NCT01192126|520315956|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
144303060|NCT01192126|520315957|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
144303061|NCT01192126|520315956|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
144303062|NCT01192126|520315957|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
144303063|NCT01354223|520315958|FG000|Overall Study|Withdrawal by Subject|3|||
144303064|NCT01354223|520315959|FG001|Overall Study|Withdrawal by Subject|1|||
144303065|NCT00730756|520315963|FG000|Overall Study|Adverse Event|2|||
144303066|NCT00730756|520315964|FG001|Overall Study|Adverse Event|0|||
144303067|NCT00730756|520315963|FG000|Overall Study|Lack of Efficacy|1|||
144303068|NCT00730756|520315964|FG001|Overall Study|Lack of Efficacy|1|||
144303069|NCT00730756|520315963|FG000|Overall Study|Protocol Deviation|1|||
144303070|NCT00730756|520315964|FG001|Overall Study|Protocol Deviation|2|||
144303071|NCT00730756|520315963|FG000|Overall Study|Lost to Follow-up|0|||
144303072|NCT00730756|520315964|FG001|Overall Study|Lost to Follow-up|1|||
144303073|NCT00730756|520315963|FG000|Overall Study|Withdrew Consent|0|||
144303074|NCT00730756|520315964|FG001|Overall Study|Withdrew Consent|1|||
144303075|NCT01977898|520315965|FG000|Overall Study|Non functioning catheter|1|||
144303076|NCT01977898|520315966|FG001|Overall Study|Non functioning catheter|1|||
144303077|NCT02660229|520315969|FG000|Overall Study|Adverse Event|2|||
144303078|NCT02660229|520315970|FG001|Overall Study|Adverse Event|0|||
144303079|NCT02660229|520315969|FG000|Overall Study|Withdrawal by Subject|0|||
144303080|NCT02660229|520315970|FG001|Overall Study|Withdrawal by Subject|1|||
144303081|NCT01466491|520315971|FG000|Overall Study|Protocol Violation|0|||
144303082|NCT01466491|520315972|FG001|Overall Study|Protocol Violation|3|||
144303083|NCT01466491|520315973|FG002|Overall Study|Protocol Violation|2|||
144303084|NCT01466491|520315974|FG003|Overall Study|Protocol Violation|0|||
144303085|NCT01466491|520315971|FG000|Overall Study|Missing Data|0|||
144303086|NCT01466491|520315972|FG001|Overall Study|Missing Data|0|||
144303087|NCT01466491|520315973|FG002|Overall Study|Missing Data|1|||
144303088|NCT01466491|520315974|FG003|Overall Study|Missing Data|0|||
144303089|NCT02852967|520315975|FG000|Overall Study|Adverse Event|3|||
144303090|NCT02852967|520315976|FG001|Overall Study|Adverse Event|1|||
144303091|NCT02852967|520315977|FG002|Overall Study|Adverse Event|0|||
144303092|NCT02852967|520315978|FG003|Overall Study|Adverse Event|1|||
144303093|NCT02852967|520315979|FG004|Overall Study|Adverse Event|0|||
144303094|NCT02852967|520315975|FG000|Overall Study|Death|1|||
144303095|NCT02852967|520315976|FG001|Overall Study|Death|0|||
144303096|NCT02852967|520315977|FG002|Overall Study|Death|0|||
144303097|NCT02852967|520315978|FG003|Overall Study|Death|0|||
144303098|NCT02852967|520315979|FG004|Overall Study|Death|0|||
144303099|NCT02852967|520315975|FG000|Overall Study|Lost to Follow-up|1|||
144303100|NCT02852967|520315976|FG001|Overall Study|Lost to Follow-up|2|||
144303101|NCT02852967|520315977|FG002|Overall Study|Lost to Follow-up|3|||
144303102|NCT02852967|520315978|FG003|Overall Study|Lost to Follow-up|4|||
144303103|NCT02852967|520315979|FG004|Overall Study|Lost to Follow-up|4|||
144303104|NCT02852967|520315975|FG000|Overall Study|Withdrawal by Subject|6|||
144303105|NCT02852967|520315976|FG001|Overall Study|Withdrawal by Subject|12|||
144303106|NCT02852967|520315977|FG002|Overall Study|Withdrawal by Subject|7|||
144303107|NCT02852967|520315978|FG003|Overall Study|Withdrawal by Subject|10|||
144303108|NCT02852967|520315979|FG004|Overall Study|Withdrawal by Subject|10|||
144303109|NCT02852967|520315975|FG000|Overall Study|SAE|0|||
144303110|NCT02852967|520315976|FG001|Overall Study|SAE|0|||
144303111|NCT02852967|520315977|FG002|Overall Study|SAE|0|||
144303112|NCT02852967|520315978|FG003|Overall Study|SAE|3|||
144303113|NCT02852967|520315979|FG004|Overall Study|SAE|0|||
144303114|NCT02852967|520315975|FG000|Overall Study|Elevated Liver Enzymes|2|||
144303115|NCT02852967|520315976|FG001|Overall Study|Elevated Liver Enzymes|0|||
144303116|NCT02852967|520315977|FG002|Overall Study|Elevated Liver Enzymes|0|||
144303117|NCT02852967|520315978|FG003|Overall Study|Elevated Liver Enzymes|2|||
144303118|NCT02852967|520315979|FG004|Overall Study|Elevated Liver Enzymes|2|||
144303119|NCT02852967|520315975|FG000|Overall Study|Physician Decision|0|||
144303120|NCT02852967|520315976|FG001|Overall Study|Physician Decision|0|||
144303121|NCT02852967|520315977|FG002|Overall Study|Physician Decision|0|||
144303122|NCT02852967|520315978|FG003|Overall Study|Physician Decision|1|||
144303123|NCT02852967|520315979|FG004|Overall Study|Physician Decision|0|||
144303124|NCT02852967|520315975|FG000|Overall Study|Lack of Efficacy|0|||
144303125|NCT02852967|520315976|FG001|Overall Study|Lack of Efficacy|1|||
144303126|NCT02852967|520315977|FG002|Overall Study|Lack of Efficacy|0|||
144303127|NCT02852967|520315978|FG003|Overall Study|Lack of Efficacy|0|||
144303128|NCT02852967|520315979|FG004|Overall Study|Lack of Efficacy|0|||
144303129|NCT02852967|520315975|FG000|Overall Study|Non-compliance|0|||
144303130|NCT02852967|520315976|FG001|Overall Study|Non-compliance|0|||
144303131|NCT02852967|520315977|FG002|Overall Study|Non-compliance|1|||
144303132|NCT02852967|520315978|FG003|Overall Study|Non-compliance|1|||
144303133|NCT02852967|520315979|FG004|Overall Study|Non-compliance|0|||
144303134|NCT02852967|520315975|FG000|Overall Study|Dispensing Drug Violation|0|||
144303135|NCT02852967|520315976|FG001|Overall Study|Dispensing Drug Violation|0|||
144303136|NCT02852967|520315977|FG002|Overall Study|Dispensing Drug Violation|1|||
144303137|NCT02852967|520315978|FG003|Overall Study|Dispensing Drug Violation|0|||
144303138|NCT02852967|520315979|FG004|Overall Study|Dispensing Drug Violation|0|||
144303139|NCT02852967|520315975|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
144303140|NCT02852967|520315976|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
144303141|NCT02852967|520315977|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
144303142|NCT02852967|520315978|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
144303143|NCT02852967|520315979|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
144303144|NCT01049373|520315980|FG000|Overall Study|Protocol Violation|9|||
144303145|NCT01049373|520315981|FG001|Overall Study|Protocol Violation|9|||
144303146|NCT01049373|520315980|FG000|Overall Study|Withdrawal by Subject|8|||
144303147|NCT01049373|520315981|FG001|Overall Study|Withdrawal by Subject|5|||
144303148|NCT01049373|520315980|FG000|Overall Study|Adverse Event|3|||
144303149|NCT01049373|520315981|FG001|Overall Study|Adverse Event|3|||
144303150|NCT01049373|520315980|FG000|Overall Study|Lost to Follow-up|9|||
144303151|NCT01049373|520315981|FG001|Overall Study|Lost to Follow-up|4|||
144303152|NCT01049373|520315980|FG000|Overall Study|no evaluable study values|9|||
144303153|NCT01049373|520315981|FG001|Overall Study|no evaluable study values|21|||
144303154|NCT01049373|520315980|FG000|Overall Study|Other|1|||
144303155|NCT01049373|520315981|FG001|Overall Study|Other|1|||
144303156|NCT01049373|520315980|FG000|Overall Study|Non-cooperation|0|||
144303157|NCT01049373|520315981|FG001|Overall Study|Non-cooperation|1|||
144303158|NCT01693367|520315982|FG000|Overall Study|Withdrawal by Subject|1|||
144303159|NCT01693367|520315983|FG001|Overall Study|Withdrawal by Subject|1|||
144303160|NCT01693367|520315982|FG000|Overall Study|Physician Decision|0|||
144303161|NCT01693367|520315983|FG001|Overall Study|Physician Decision|1|||
144303162|NCT03046446|520315986|FG000|Overall Study|Lack of Efficacy|7|||
144303163|NCT03046446|520315986|FG000|Overall Study|Adverse Event|6|||
144303164|NCT03046446|520315986|FG000|Overall Study|Lost to Follow-up|3|||
144303165|NCT03046446|520315986|FG000|Overall Study|Withdrawal by Subject|14|||
144303166|NCT03046446|520315986|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
144303167|NCT03046446|520315986|FG000|Overall Study|Disease Progression (see caveats)|25|||
144303168|NCT03046446|520315986|FG000|Overall Study|Non OA related knee surgery|1|||
144303169|NCT02808897|520315987|FG000|Overall Study|Lost to Follow-up|9|||
144303170|NCT02808897|520315988|FG001|Overall Study|Lost to Follow-up|11|||
144303171|NCT03012334|520315989|FG000|Period 1|Withdrawal by Subject|0|||
144303172|NCT03012334|520315990|FG001|Period 1|Withdrawal by Subject|0|||
144303173|NCT03012334|520315991|FG002|Period 1|Withdrawal by Subject|0|||
144303174|NCT03012334|520315992|FG003|Period 1|Withdrawal by Subject|0|||
144303175|NCT03012334|520315993|FG004|Period 1|Withdrawal by Subject|0|||
144303176|NCT03012334|520315994|FG005|Period 1|Withdrawal by Subject|0|||
144303177|NCT03012334|520315995|FG006|Period 1|Withdrawal by Subject|0|||
144303178|NCT03012334|520315996|FG007|Period 1|Withdrawal by Subject|0|||
144303179|NCT03012334|520315997|FG008|Period 1|Withdrawal by Subject|0|||
144303180|NCT03012334|520315998|FG009|Period 1|Withdrawal by Subject|1|||
144303181|NCT03012334|520315989|FG000|Period 2|Withdrawal by Subject|0|||
144303182|NCT03012334|520315990|FG001|Period 2|Withdrawal by Subject|1|||
144303183|NCT03012334|520315991|FG002|Period 2|Withdrawal by Subject|0|||
144303184|NCT03012334|520315992|FG003|Period 2|Withdrawal by Subject|0|||
144303185|NCT03012334|520315993|FG004|Period 2|Withdrawal by Subject|0|||
144303186|NCT03012334|520315994|FG005|Period 2|Withdrawal by Subject|0|||
144303187|NCT03012334|520315995|FG006|Period 2|Withdrawal by Subject|0|||
144303188|NCT03012334|520315996|FG007|Period 2|Withdrawal by Subject|0|||
144303189|NCT03012334|520315997|FG008|Period 2|Withdrawal by Subject|0|||
144303190|NCT03012334|520315998|FG009|Period 2|Withdrawal by Subject|0|||
144303191|NCT03012334|520315989|FG000|Period 2|Protocol Violation|0|||
144303192|NCT03012334|520315990|FG001|Period 2|Protocol Violation|0|||
144303193|NCT03012334|520315991|FG002|Period 2|Protocol Violation|1|||
144303194|NCT03012334|520315992|FG003|Period 2|Protocol Violation|0|||
144303195|NCT03012334|520315993|FG004|Period 2|Protocol Violation|0|||
144303196|NCT03012334|520315994|FG005|Period 2|Protocol Violation|0|||
144303197|NCT03012334|520315995|FG006|Period 2|Protocol Violation|0|||
144303198|NCT03012334|520315996|FG007|Period 2|Protocol Violation|1|||
144303199|NCT03012334|520315997|FG008|Period 2|Protocol Violation|0|||
144303200|NCT03012334|520315998|FG009|Period 2|Protocol Violation|0|||
144303201|NCT03012334|520315989|FG000|Period 4|Non-Compliance|0|||
144303202|NCT03012334|520315990|FG001|Period 4|Non-Compliance|0|||
144303203|NCT03012334|520315991|FG002|Period 4|Non-Compliance|0|||
144303204|NCT03012334|520315992|FG003|Period 4|Non-Compliance|0|||
144303205|NCT03012334|520315993|FG004|Period 4|Non-Compliance|0|||
144303206|NCT03012334|520315994|FG005|Period 4|Non-Compliance|0|||
144303207|NCT03012334|520315995|FG006|Period 4|Non-Compliance|1|||
144303208|NCT03012334|520315996|FG007|Period 4|Non-Compliance|0|||
144303209|NCT03012334|520315997|FG008|Period 4|Non-Compliance|0|||
144303210|NCT03012334|520315998|FG009|Period 4|Non-Compliance|0|||
144303211|NCT03012334|520315989|FG000|Period 4|Adverse Event|0|||
144303212|NCT03012334|520315990|FG001|Period 4|Adverse Event|0|||
144303213|NCT03012334|520315991|FG002|Period 4|Adverse Event|0|||
144303214|NCT03012334|520315992|FG003|Period 4|Adverse Event|0|||
144303215|NCT03012334|520315993|FG004|Period 4|Adverse Event|0|||
144303216|NCT03012334|520315994|FG005|Period 4|Adverse Event|0|||
144303217|NCT03012334|520315995|FG006|Period 4|Adverse Event|0|||
144303218|NCT03012334|520315996|FG007|Period 4|Adverse Event|0|||
144303219|NCT03012334|520315997|FG008|Period 4|Adverse Event|1|||
144303220|NCT03012334|520315998|FG009|Period 4|Adverse Event|0|||
144303221|NCT02286895|520315999|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
144303222|NCT02286895|520316000|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
144303223|NCT02286895|520315999|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
144303224|NCT02286895|520316000|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
144303225|NCT02286895|520315999|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
144303226|NCT02286895|520316000|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
144303227|NCT02441218|520316007|FG000|Overall Study|Death|503|||
144303228|NCT02441218|520316008|FG001|Overall Study|Death|553|||
144303229|NCT02441218|520316007|FG000|Overall Study|Withdrawal by Subject|73|||
144303230|NCT02441218|520316008|FG001|Overall Study|Withdrawal by Subject|58|||
144303231|NCT02441218|520316007|FG000|Overall Study|Lost to Follow-up|2|||
144303232|NCT02441218|520316008|FG001|Overall Study|Lost to Follow-up|1|||
144303233|NCT01541371|520316009|FG000|Overall Study|Withdrawal by Subject|14|||
144303234|NCT01541371|520316009|FG000|Overall Study|Lost to Follow-up|21|||
144303235|NCT01541371|520316009|FG000|Overall Study|Adverse Event|15|||
144303236|NCT01541371|520316009|FG000|Overall Study|Lack of Efficacy|12|||
144303237|NCT01541371|520316009|FG000|Overall Study|Protocol Violation|6|||
144303238|NCT01541371|520316009|FG000|Overall Study|Study medication non-compliance|3|||
144303239|NCT01541371|520316009|FG000|Overall Study|Other|6|||
144303240|NCT00163189|520316012|FG000|Overall Study|Other|6|||
144303241|NCT00163189|520316012|FG000|Overall Study|Lost to Follow-up|1|||
144303242|NCT00163189|520316012|FG000|Overall Study|Protocol Violation|2|||
144303243|NCT00163189|520316012|FG000|Overall Study|Death|3|||
144303244|NCT00163189|520316012|FG000|Overall Study|Adverse Event|6|||
144303245|NCT00163189|520316012|FG000|Overall Study|Lack of Efficacy|7|||
144303246|NCT00163189|520316012|FG000|Overall Study|Study terminated by sponsor|11|||
144303247|NCT00163189|520316012|FG000|Overall Study|Withdrawal by Subject|11|||
144303248|NCT00163189|520316012|FG000|Overall Study|Did not meet continuation criterion|16|||
144303249|NCT02154061|520316013|FG000|Overall Study|Pregnancy|1|||
144303250|NCT02154061|520316014|FG001|Overall Study|Pregnancy|0|||
144303251|NCT02154061|520316013|FG000|Overall Study|enrolled but not vaccinated|1|||
144303252|NCT02154061|520316014|FG001|Overall Study|enrolled but not vaccinated|0|||
144303253|NCT01936831|520316015|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303254|NCT01936831|520316016|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303255|NCT01936831|520316017|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303256|NCT01936831|520316018|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303257|NCT01936831|520316019|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303258|NCT01936831|520316020|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
144303259|NCT01936831|520316021|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303260|NCT01936831|520316022|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303261|NCT01936831|520316023|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
144303262|NCT03435380|520316024|FG000|Overall Study|Death|1|||
144303263|NCT03435380|520316025|FG001|Overall Study|Death|2|||
144303264|NCT03435380|520316026|FG002|Overall Study|Death|1|||
144303265|NCT03435380|520316024|FG000|Overall Study|Lost to Follow-up|12|||
144303266|NCT03435380|520316025|FG001|Overall Study|Lost to Follow-up|8|||
144303267|NCT03435380|520316026|FG002|Overall Study|Lost to Follow-up|6|||
144303268|NCT03435380|520316024|FG000|Overall Study|Physician Decision|1|||
144303269|NCT03435380|520316025|FG001|Overall Study|Physician Decision|0|||
144303270|NCT03435380|520316026|FG002|Overall Study|Physician Decision|0|||
144303271|NCT03435380|520316024|FG000|Overall Study|Withdrawal by Subject|0|||
144303272|NCT03435380|520316025|FG001|Overall Study|Withdrawal by Subject|1|||
144303273|NCT03435380|520316026|FG002|Overall Study|Withdrawal by Subject|1|||
144303274|NCT03435380|520316024|FG000|Overall Study|Ineligible|0|||
144303275|NCT03435380|520316025|FG001|Overall Study|Ineligible|1|||
144303276|NCT03435380|520316026|FG002|Overall Study|Ineligible|1|||
144303277|NCT02133573|520316032|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
144303278|NCT02133573|520316033|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
144303279|NCT02133573|520316032|FG000|Overall Study|Child Deaths|3|||
144303280|NCT02133573|520316033|FG001|Overall Study|Child Deaths|5|||
144303281|NCT02133573|520316032|FG000|Overall Study|Child Declined Follow Ups|2|||
144303282|NCT02133573|520316033|FG001|Overall Study|Child Declined Follow Ups|1|||
144303283|NCT02133573|520316032|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
144303284|NCT02133573|520316033|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
144303285|NCT00454116|520316035|FG000|Overall Study|Adverse Event|5|||
144303286|NCT00454116|520316036|FG001|Overall Study|Adverse Event|11|||
144303287|NCT00454116|520316037|FG002|Overall Study|Adverse Event|9|||
144303288|NCT00454116|520316035|FG000|Overall Study|Condition under investigation worsened|17|||
144303289|NCT00454116|520316036|FG001|Overall Study|Condition under investigation worsened|13|||
144303290|NCT00454116|520316037|FG002|Overall Study|Condition under investigation worsened|18|||
144303291|NCT00454116|520316035|FG000|Overall Study|Withdrawal by Subject|3|||
144303292|NCT00454116|520316036|FG001|Overall Study|Withdrawal by Subject|3|||
144303293|NCT00454116|520316037|FG002|Overall Study|Withdrawal by Subject|1|||
144303294|NCT00454116|520316035|FG000|Overall Study|Other|2|||
144303295|NCT00454116|520316036|FG001|Overall Study|Other|2|||
144303296|NCT00454116|520316037|FG002|Overall Study|Other|0|||
144303297|NCT01917318|520316040|FG000|First Treatment|Withdrawal by Subject|0|||
144303298|NCT01917318|520316041|FG001|First Treatment|Withdrawal by Subject|1|||
144303299|NCT01008618|520316042|FG000|Period 1 (Titration Period)|Physician Decision|2|||
144303300|NCT01008618|520316043|FG001|Period 1 (Titration Period)|Physician Decision|0|||
144303301|NCT01008618|520316044|FG002|Period 1 (Titration Period)|Physician Decision|0|||
144303302|NCT01008618|520316042|FG000|Period 1 (Titration Period)|Adverse Event|33|||
144303303|NCT01008618|520316043|FG001|Period 1 (Titration Period)|Adverse Event|0|||
144303304|NCT01008618|520316044|FG002|Period 1 (Titration Period)|Adverse Event|0|||
144303305|NCT01008618|520316042|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
144303306|NCT01008618|520316043|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
144303307|NCT01008618|520316044|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
144303308|NCT01008618|520316042|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
144303309|NCT01008618|520316043|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
144303310|NCT01008618|520316044|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
144303311|NCT01008618|520316042|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
144303312|NCT01008618|520316043|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
144303313|NCT01008618|520316044|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
144303314|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
144303315|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
144303316|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
144303317|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
144303318|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
144303319|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
144303320|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
144303321|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
144303322|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
144303323|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
144303324|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
144303325|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
144303326|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
144303327|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
144303328|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
144303329|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
144303330|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
144303331|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
144303332|NCT01008618|520316042|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
144303333|NCT01008618|520316043|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
144303334|NCT01008618|520316044|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
144303335|NCT02927795|520316045|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
144303336|NCT02927795|520316045|FG000|Overall Study|Not Treated|4|||
144303337|NCT01534481|520316046|FG000|Overall Study|Lost to Follow-up|29|||
144303338|NCT01534481|520316047|FG001|Overall Study|Lost to Follow-up|24|||
144303339|NCT01534481|520316046|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
144303340|NCT01534481|520316047|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
144303341|NCT05525910|520316048|FG000|Period 4|Per sponsor due to study timelines|0|||
144303342|NCT05525910|520316049|FG001|Period 4|Per sponsor due to study timelines|0|||
144303343|NCT05525910|520316050|FG002|Period 4|Per sponsor due to study timelines|1|||
144303344|NCT05525910|520316051|FG003|Period 4|Per sponsor due to study timelines|1|||
144303345|NCT05525910|520316052|FG004|Period 4|Per sponsor due to study timelines|1|||
144303346|NCT00181844|520316053|FG000|Signed Consent|Withdrawal by Subject|5|||
144303347|NCT00181844|520316053|FG000|Signed Consent|Did not meet entrance criteria|7|||
144303348|NCT00181844|520316053|FG000|Exposed to Study Medication|Adverse Event|10|||
144303349|NCT00181844|520316053|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
144303350|NCT00181844|520316053|FG000|Exposed to Study Medication|Non-compliance|2|||
144303351|NCT00181844|520316053|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
144303352|NCT00181844|520316053|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
144303353|NCT01657305|520316056|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
144303354|NCT01657305|520316056|FG000|Overall Study|Withdrawal by Subject|4|||
144303355|NCT01657305|520316056|FG000|Overall Study|Adverse Event|1|||
144303356|NCT01657305|520316056|FG000|Overall Study|Lost to Follow-up|1|||
144303357|NCT01657305|520316056|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
144303358|NCT01880957|520316058|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
144303359|NCT01880957|520316059|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
144303360|NCT01880957|520316058|FG000|Overall Study|Lost to Follow-up|11|||
144303361|NCT01880957|520316059|FG001|Overall Study|Lost to Follow-up|0|||
144303362|NCT01880957|520316058|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
144303363|NCT01880957|520316059|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
144303364|NCT01378117|520316061|FG000|Overall Study|withdrawal|2|||
144303365|NCT01378117|520316062|FG001|Overall Study|withdrawal|1|||
144303366|NCT01378117|520316063|FG002|Overall Study|withdrawal|2|||
144303367|NCT01378117|520316061|FG000|Overall Study|discharged before med given|2|||
144303368|NCT01378117|520316062|FG001|Overall Study|discharged before med given|0|||
144303369|NCT01378117|520316063|FG002|Overall Study|discharged before med given|1|||
144303370|NCT02961244|520316064|FG000|Overall Study|Protocol Violation|0|||
144303371|NCT02961244|520316065|FG001|Overall Study|Protocol Violation|1|||
144303372|NCT02961244|520316064|FG000|Overall Study|Withdrawal by Subject|1|||
144303373|NCT02961244|520316065|FG001|Overall Study|Withdrawal by Subject|2|||
144303374|NCT02961244|520316064|FG000|Overall Study|Surgery plan change after study approval|0|||
144303375|NCT02961244|520316065|FG001|Overall Study|Surgery plan change after study approval|2|||
144303376|NCT02961244|520316064|FG000|Overall Study|Lost to Follow-up|0|||
144303377|NCT02961244|520316065|FG001|Overall Study|Lost to Follow-up|2|||
144303378|NCT02961244|520316064|FG000|Overall Study|İnadequate data|0|||
144303379|NCT02961244|520316065|FG001|Overall Study|İnadequate data|2|||
144303380|NCT01854528|520316066|FG000|Overall Study|Adverse Event|0|||
144303381|NCT01854528|520316067|FG001|Overall Study|Adverse Event|4|||
144303382|NCT01854528|520316066|FG000|Overall Study|Withdrawal by Subject|0|||
144303383|NCT01854528|520316067|FG001|Overall Study|Withdrawal by Subject|2|||
144303384|NCT01854528|520316066|FG000|Overall Study|Virologic Failure|0|||
144303385|NCT01854528|520316067|FG001|Overall Study|Virologic Failure|9|||
144303386|NCT01696643|520316068|FG000|Overall Study|Adverse Event|15|||
144303387|NCT01696643|520316069|FG001|Overall Study|Adverse Event|7|||
144303388|NCT01696643|520316068|FG000|Overall Study|Death|1|||
144303389|NCT01696643|520316069|FG001|Overall Study|Death|2|||
144303390|NCT01696643|520316068|FG000|Overall Study|Lack of Efficacy|3|||
144303391|NCT01696643|520316069|FG001|Overall Study|Lack of Efficacy|0|||
144303392|NCT01696643|520316068|FG000|Overall Study|Lost to Follow-up|67|||
144303393|NCT01696643|520316069|FG001|Overall Study|Lost to Follow-up|67|||
144303394|NCT01696643|520316068|FG000|Overall Study|Physician Decision|3|||
144303395|NCT01696643|520316069|FG001|Overall Study|Physician Decision|2|||
144303396|NCT01696643|520316068|FG000|Overall Study|Pregnancy|0|||
144303397|NCT01696643|520316069|FG001|Overall Study|Pregnancy|1|||
144303398|NCT01696643|520316068|FG000|Overall Study|Protocol Violation|7|||
144303399|NCT01696643|520316069|FG001|Overall Study|Protocol Violation|7|||
144303400|NCT01696643|520316068|FG000|Overall Study|Study Terminated by Sponsor|286|||
144303401|NCT01696643|520316069|FG001|Overall Study|Study Terminated by Sponsor|294|||
144303402|NCT01696643|520316068|FG000|Overall Study|Withdrawal by Subject|142|||
144303403|NCT01696643|520316069|FG001|Overall Study|Withdrawal by Subject|149|||
144303404|NCT01696643|520316068|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
144303405|NCT01696643|520316069|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
144303406|NCT01696643|520316068|FG000|Overall Study|Site Error|2|||
144303407|NCT01696643|520316069|FG001|Overall Study|Site Error|1|||
144303408|NCT01696643|520316068|FG000|Overall Study|Participant Incarcerated|0|||
144303409|NCT01696643|520316069|FG001|Overall Study|Participant Incarcerated|1|||
144303410|NCT01696643|520316068|FG000|Overall Study|Medical Monitor Decision|0|||
144303411|NCT01696643|520316069|FG001|Overall Study|Medical Monitor Decision|2|||
144303412|NCT01696643|520316068|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
144303413|NCT01696643|520316069|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
144303414|NCT00518180|520316071|FG000|Overall Study|Withdrawal by Subject|29|||
144303415|NCT00518180|520316072|FG001|Overall Study|Withdrawal by Subject|30|||
144303416|NCT00518180|520316073|FG002|Overall Study|Withdrawal by Subject|42|||
144303417|NCT00518180|520316071|FG000|Overall Study|Lost to Follow-up|30|||
144303418|NCT00518180|520316072|FG001|Overall Study|Lost to Follow-up|28|||
144303419|NCT00518180|520316073|FG002|Overall Study|Lost to Follow-up|34|||
144303420|NCT00518180|520316071|FG000|Overall Study|Administrative reason|0|||
144303421|NCT00518180|520316072|FG001|Overall Study|Administrative reason|2|||
144303422|NCT00518180|520316073|FG002|Overall Study|Administrative reason|2|||
144303423|NCT00518180|520316071|FG000|Overall Study|Protocol Violation|5|||
144303424|NCT00518180|520316072|FG001|Overall Study|Protocol Violation|7|||
144303425|NCT00518180|520316073|FG002|Overall Study|Protocol Violation|4|||
144303426|NCT00518180|520316071|FG000|Overall Study|Unable to classify|0|||
144303427|NCT00518180|520316072|FG001|Overall Study|Unable to classify|2|||
144303428|NCT00518180|520316073|FG002|Overall Study|Unable to classify|0|||
144303429|NCT00518180|520316071|FG000|Overall Study|Adverse Event|1|||
144303430|NCT00518180|520316072|FG001|Overall Study|Adverse Event|0|||
144303431|NCT00518180|520316073|FG002|Overall Study|Adverse Event|0|||
144303432|NCT02951780|520316074|FG000|Period 1|Adverse Event|0|||
144303433|NCT02951780|520316075|FG001|Period 1|Adverse Event|0|||
144303434|NCT02951780|520316076|FG002|Period 1|Adverse Event|0|||
144303435|NCT02951780|520316077|FG003|Period 1|Adverse Event|1|||
144303436|NCT02951780|520316078|FG004|Period 1|Adverse Event|0|||
144303437|NCT02951780|520316079|FG005|Period 1|Adverse Event|0|||
144303438|NCT02951780|520316080|FG006|Period 1|Adverse Event|0|||
144303439|NCT02951780|520316081|FG007|Period 1|Adverse Event|0|||
144303440|NCT02951780|520316082|FG008|Period 1|Adverse Event|0|||
144303441|NCT02951780|520316074|FG000|Period 1|Scheduling Conflicts|0|||
144303442|NCT02951780|520316075|FG001|Period 1|Scheduling Conflicts|0|||
144303443|NCT02951780|520316076|FG002|Period 1|Scheduling Conflicts|0|||
144303444|NCT02951780|520316077|FG003|Period 1|Scheduling Conflicts|0|||
144303445|NCT02951780|520316078|FG004|Period 1|Scheduling Conflicts|0|||
144303446|NCT02951780|520316079|FG005|Period 1|Scheduling Conflicts|0|||
144303447|NCT02951780|520316080|FG006|Period 1|Scheduling Conflicts|0|||
144303448|NCT02951780|520316081|FG007|Period 1|Scheduling Conflicts|1|||
144303449|NCT02951780|520316082|FG008|Period 1|Scheduling Conflicts|0|||
144303450|NCT02951780|520316074|FG000|Period 2|Scheduling Conflicts|0|||
144303451|NCT02951780|520316075|FG001|Period 2|Scheduling Conflicts|0|||
144303452|NCT02951780|520316076|FG002|Period 2|Scheduling Conflicts|0|||
144303453|NCT02951780|520316077|FG003|Period 2|Scheduling Conflicts|0|||
144303454|NCT02951780|520316078|FG004|Period 2|Scheduling Conflicts|0|||
144303455|NCT02951780|520316079|FG005|Period 2|Scheduling Conflicts|0|||
144303456|NCT02951780|520316080|FG006|Period 2|Scheduling Conflicts|0|||
144303457|NCT02951780|520316081|FG007|Period 2|Scheduling Conflicts|1|||
144303458|NCT02951780|520316082|FG008|Period 2|Scheduling Conflicts|0|||
144303459|NCT02289469|520316085|FG000|Overall Study|Unable to match a control|6|||
144303460|NCT02289469|520316086|FG001|Overall Study|Unable to match a control|0|||
144303461|NCT03508050|520316087|FG000|Overall Study|Pleural adhesions|1|||
144303462|NCT03508050|520316088|FG001|Overall Study|Pleural adhesions|0|||
144303463|NCT03508050|520316087|FG000|Overall Study|Mucus plug|1|||
144303464|NCT03508050|520316088|FG001|Overall Study|Mucus plug|0|||
144303465|NCT03508050|520316087|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
144303466|NCT03508050|520316088|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
144303467|NCT03508050|520316087|FG000|Overall Study|Sustained desaturation|0|||
144303468|NCT03508050|520316088|FG001|Overall Study|Sustained desaturation|1|||
144303469|NCT01082614|520316089|FG000|Overall Study|Adverse Event|1|||
144303470|NCT01082614|520316090|FG001|Overall Study|Adverse Event|4|||
144303471|NCT01082614|520316089|FG000|Overall Study|Equipment Malfunction|0|||
144303472|NCT01082614|520316090|FG001|Overall Study|Equipment Malfunction|1|||
144303473|NCT01082614|520316089|FG000|Overall Study|Physician Decision|2|||
144303474|NCT01082614|520316090|FG001|Overall Study|Physician Decision|0|||
144303475|NCT03710889|520316093|FG000|Overall Study|Adverse Event|2|||
144303476|NCT03710889|520316093|FG000|Overall Study|Protocol Deviation|1|||
144303477|NCT00570713|520316094|FG000|Overall Study|Adverse Event|16|||
144303478|NCT00570713|520316095|FG001|Overall Study|Adverse Event|9|||
144303479|NCT00570713|520316094|FG000|Overall Study|Death|7|||
144303480|NCT00570713|520316095|FG001|Overall Study|Death|7|||
144303481|NCT00570713|520316094|FG000|Overall Study|Lack of Efficacy|40|||
144303482|NCT00570713|520316095|FG001|Overall Study|Lack of Efficacy|49|||
144303483|NCT00570713|520316094|FG000|Overall Study|Physician Decision|2|||
144303484|NCT00570713|520316095|FG001|Overall Study|Physician Decision|2|||
144303485|NCT00570713|520316094|FG000|Overall Study|Withdrawal by Subject|3|||
144303486|NCT00570713|520316095|FG001|Overall Study|Withdrawal by Subject|3|||
144303487|NCT00570713|520316094|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
144303488|NCT00570713|520316095|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
144303489|NCT04881760|520316096|FG000|Overall Study|Adverse Event|0|||
144303490|NCT04881760|520316097|FG001|Overall Study|Adverse Event|1|||
144303491|NCT04881760|520316098|FG002|Overall Study|Adverse Event|1|||
144303492|NCT04881760|520316099|FG003|Overall Study|Adverse Event|0|||
144303493|NCT04881760|520316100|FG004|Overall Study|Adverse Event|1|||
144303494|NCT04881760|520316101|FG005|Overall Study|Adverse Event|1|||
144303495|NCT04881760|520316102|FG006|Overall Study|Adverse Event|2|||
144303496|NCT04881760|520316096|FG000|Overall Study|Death|0|||
144303497|NCT04881760|520316097|FG001|Overall Study|Death|0|||
144303498|NCT04881760|520316098|FG002|Overall Study|Death|0|||
144303499|NCT04881760|520316099|FG003|Overall Study|Death|1|||
144303500|NCT04881760|520316100|FG004|Overall Study|Death|0|||
144303501|NCT04881760|520316101|FG005|Overall Study|Death|0|||
144303502|NCT04881760|520316102|FG006|Overall Study|Death|0|||
144303503|NCT04881760|520316096|FG000|Overall Study|Lost to Follow-up|5|||
144303504|NCT04881760|520316097|FG001|Overall Study|Lost to Follow-up|7|||
144303505|NCT04881760|520316098|FG002|Overall Study|Lost to Follow-up|5|||
144303506|NCT04881760|520316099|FG003|Overall Study|Lost to Follow-up|1|||
144303507|NCT04881760|520316100|FG004|Overall Study|Lost to Follow-up|2|||
144303508|NCT04881760|520316101|FG005|Overall Study|Lost to Follow-up|4|||
144303509|NCT04881760|520316102|FG006|Overall Study|Lost to Follow-up|4|||
144303510|NCT04881760|520316096|FG000|Overall Study|Withdrawal by Subject|13|||
144303511|NCT04881760|520316097|FG001|Overall Study|Withdrawal by Subject|1|||
144303512|NCT04881760|520316098|FG002|Overall Study|Withdrawal by Subject|1|||
144303513|NCT04881760|520316099|FG003|Overall Study|Withdrawal by Subject|4|||
144303514|NCT04881760|520316100|FG004|Overall Study|Withdrawal by Subject|2|||
144303515|NCT04881760|520316101|FG005|Overall Study|Withdrawal by Subject|1|||
144303516|NCT04881760|520316102|FG006|Overall Study|Withdrawal by Subject|2|||
144303517|NCT04881760|520316096|FG000|Overall Study|Randomized but Never Treated|0|||
144303518|NCT04881760|520316097|FG001|Overall Study|Randomized but Never Treated|0|||
144303519|NCT04881760|520316098|FG002|Overall Study|Randomized but Never Treated|0|||
144303520|NCT04881760|520316099|FG003|Overall Study|Randomized but Never Treated|1|||
144303521|NCT04881760|520316100|FG004|Overall Study|Randomized but Never Treated|0|||
144303522|NCT04881760|520316101|FG005|Overall Study|Randomized but Never Treated|0|||
144303523|NCT04881760|520316102|FG006|Overall Study|Randomized but Never Treated|0|||
144303524|NCT04881760|520316096|FG000|Overall Study|Inadvertent Enrollment|2|||
144303525|NCT04881760|520316097|FG001|Overall Study|Inadvertent Enrollment|0|||
144303526|NCT04881760|520316098|FG002|Overall Study|Inadvertent Enrollment|0|||
144303527|NCT04881760|520316099|FG003|Overall Study|Inadvertent Enrollment|0|||
144303528|NCT04881760|520316100|FG004|Overall Study|Inadvertent Enrollment|0|||
144303529|NCT04881760|520316101|FG005|Overall Study|Inadvertent Enrollment|0|||
144303530|NCT04881760|520316102|FG006|Overall Study|Inadvertent Enrollment|0|||
144303531|NCT04881760|520316096|FG000|Overall Study|Site Closure|0|||
144303532|NCT04881760|520316097|FG001|Overall Study|Site Closure|0|||
144303533|NCT04881760|520316098|FG002|Overall Study|Site Closure|0|||
144303534|NCT04881760|520316099|FG003|Overall Study|Site Closure|1|||
144303535|NCT04881760|520316100|FG004|Overall Study|Site Closure|0|||
144303536|NCT04881760|520316101|FG005|Overall Study|Site Closure|0|||
144303537|NCT04881760|520316102|FG006|Overall Study|Site Closure|0|||
144303538|NCT01538199|520316103|FG000|Overall Study|Lost to Follow-up|1|||
144303539|NCT01538199|520316104|FG001|Overall Study|Lost to Follow-up|2|||
144303540|NCT01538199|520316105|FG002|Overall Study|Lost to Follow-up|1|||
144303541|NCT01538199|520316106|FG003|Overall Study|Lost to Follow-up|0|||
144303542|NCT01538199|520316103|FG000|Overall Study|participant did not have time|1|||
144303543|NCT01538199|520316104|FG001|Overall Study|participant did not have time|0|||
144303544|NCT01538199|520316105|FG002|Overall Study|participant did not have time|0|||
144303545|NCT01538199|520316106|FG003|Overall Study|participant did not have time|2|||
144303546|NCT01538199|520316103|FG000|Overall Study|Lack of Efficacy|0|||
144303547|NCT01538199|520316104|FG001|Overall Study|Lack of Efficacy|1|||
144303548|NCT01538199|520316105|FG002|Overall Study|Lack of Efficacy|0|||
144303549|NCT01538199|520316106|FG003|Overall Study|Lack of Efficacy|0|||
144303550|NCT02081586|520316107|FG000|Overall Study|Lost to Follow-up|0|||
144303551|NCT02081586|520316108|FG001|Overall Study|Lost to Follow-up|1|||
144303552|NCT02081586|520316109|FG002|Overall Study|Lost to Follow-up|0|||
144303553|NCT02081586|520316110|FG003|Overall Study|Lost to Follow-up|1|||
144303554|NCT02081586|520316107|FG000|Overall Study|Head injury not related to study|0|||
144303555|NCT02081586|520316108|FG001|Overall Study|Head injury not related to study|0|||
144303556|NCT02081586|520316109|FG002|Overall Study|Head injury not related to study|1|||
144303557|NCT02081586|520316110|FG003|Overall Study|Head injury not related to study|0|||
144303558|NCT04704193|520316114|FG000|Overall Study|Withdrawal by Subject|1|||
144303559|NCT00829998|520316117|FG000|Washout|Adverse Event|0|||
144303560|NCT00829998|520316118|FG001|Washout|Adverse Event|1|||
144303561|NCT02735421|520317582|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
144303562|NCT02735421|520317582|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
144303563|NCT02735421|520317582|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
144303564|NCT02735421|520317582|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
144303565|NCT02735421|520317582|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
144303566|NCT02735421|520317582|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
144303567|NCT02735421|520317582|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
144303568|NCT03549338|520317583|FG000|Overall Study|Progressive Disease|1|||
144303569|NCT03549338|520317584|FG001|Overall Study|Progressive Disease|0|||
144303570|NCT03549338|520317585|FG002|Overall Study|Progressive Disease|0|||
144303571|NCT03549338|520317583|FG000|Overall Study|Clinical Progression|0|||
144303572|NCT03549338|520317584|FG001|Overall Study|Clinical Progression|1|||
144303573|NCT03549338|520317585|FG002|Overall Study|Clinical Progression|0|||
144303574|NCT01250054|520317586|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
144303575|NCT01250054|520317587|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
144303576|NCT01246960|520317594|FG000|Overall Study|Lost to Follow-up|3|||
144303577|NCT01246960|520317595|FG001|Overall Study|Lost to Follow-up|1|||
144303578|NCT01246960|520317594|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
144303579|NCT01246960|520317595|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
144303580|NCT02921789|520317596|FG000|Overall Study|Adverse Event|0|||
144303581|NCT02921789|520317597|FG001|Overall Study|Adverse Event|1|||
144303582|NCT02921789|520317596|FG000|Overall Study|Lost to Follow-up|1|||
144303583|NCT02921789|520317597|FG001|Overall Study|Lost to Follow-up|0|||
144303584|NCT02921789|520317596|FG000|Overall Study|Protocol Deviation|2|||
144303585|NCT02921789|520317597|FG001|Overall Study|Protocol Deviation|0|||
144303586|NCT02921789|520317596|FG000|Overall Study|Withdrawal by Subject|2|||
144303587|NCT02921789|520317597|FG001|Overall Study|Withdrawal by Subject|1|||
144303588|NCT02921789|520317596|FG000|Overall Study|Miscellaneous|3|||
144303589|NCT02921789|520317597|FG001|Overall Study|Miscellaneous|2|||
144303590|NCT04099277|520317598|FG000|Overall Study|Physician Decision|1|||
144303591|NCT04099277|520317598|FG000|Overall Study|Withdrawal by Subject|1|||
144303592|NCT00305877|520317599|FG000|Overall Study|Lack of Efficacy|6|||
144303593|NCT00305877|520317600|FG001|Overall Study|Lack of Efficacy|9|||
144303594|NCT00305877|520317599|FG000|Overall Study|Adverse Event|9|||
144303595|NCT00305877|520317600|FG001|Overall Study|Adverse Event|14|||
144303596|NCT00305877|520317599|FG000|Overall Study|Death|0|||
144303597|NCT00305877|520317600|FG001|Overall Study|Death|1|||
144303598|NCT00305877|520317599|FG000|Overall Study|Withdrawal by Subject|4|||
144303599|NCT00305877|520317600|FG001|Overall Study|Withdrawal by Subject|2|||
144303600|NCT00305877|520317599|FG000|Overall Study|Physician Decision|1|||
144303601|NCT00305877|520317600|FG001|Overall Study|Physician Decision|1|||
144303602|NCT00305877|520317599|FG000|Overall Study|Never start treatment|2|||
144303603|NCT00305877|520317600|FG001|Overall Study|Never start treatment|5|||
144303604|NCT00305877|520317599|FG000|Overall Study|Ineligible|2|||
144303605|NCT00305877|520317600|FG001|Overall Study|Ineligible|1|||
144303606|NCT00305877|520317599|FG000|Overall Study|Transportation issue with daily RT|0|||
144303607|NCT00305877|520317600|FG001|Overall Study|Transportation issue with daily RT|1|||
144303608|NCT01248793|520317601|FG000|Overall Study|Lost to Follow-up|0|||
144303609|NCT01248793|520317602|FG001|Overall Study|Lost to Follow-up|1|||
144303610|NCT01248793|520317601|FG000|Overall Study|Adverse Event|1|||
144303611|NCT01248793|520317602|FG001|Overall Study|Adverse Event|1|||
144303612|NCT01248793|520317601|FG000|Overall Study|Protocol Violation|0|||
144303613|NCT01248793|520317602|FG001|Overall Study|Protocol Violation|1|||
144303614|NCT01248793|520317601|FG000|Overall Study|Withdrawal by Subject|3|||
144303615|NCT01248793|520317602|FG001|Overall Study|Withdrawal by Subject|3|||
144303616|NCT01126190|520317605|FG000|Double-Blind Phase|Death|0|||
144303617|NCT01126190|520317606|FG001|Double-Blind Phase|Death|1|||
144303618|NCT01126190|520317607|FG002|Double-Blind Phase|Death|0|||
144303619|NCT01126190|520317605|FG000|Double-Blind Phase|Adverse Event|1|||
144303620|NCT01126190|520317606|FG001|Double-Blind Phase|Adverse Event|2|||
144303621|NCT01126190|520317607|FG002|Double-Blind Phase|Adverse Event|0|||
144303622|NCT01126190|520317605|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
144303623|NCT01126190|520317606|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
144303624|NCT01126190|520317607|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144303625|NCT01126190|520317605|FG000|Double-Blind Phase|Request of Investigator|1|||
144303626|NCT01126190|520317606|FG001|Double-Blind Phase|Request of Investigator|0|||
144303627|NCT01126190|520317607|FG002|Double-Blind Phase|Request of Investigator|0|||
144303628|NCT01126190|520317605|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
144303629|NCT01126190|520317606|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
144303630|NCT01126190|520317607|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
144303631|NCT01126190|520317605|FG000|Double-Blind Phase|Non-compliance|1|||
144303632|NCT01126190|520317606|FG001|Double-Blind Phase|Non-compliance|0|||
144303633|NCT01126190|520317607|FG002|Double-Blind Phase|Non-compliance|0|||
144303634|NCT01126190|520317605|FG000|Double-Blind Phase|Lost to Follow-up|1|||
144303635|NCT01126190|520317606|FG001|Double-Blind Phase|Lost to Follow-up|3|||
144303636|NCT01126190|520317607|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144303637|NCT01126190|520317605|FG000|Open-Label Phase|Death|0|||
144303638|NCT01126190|520317606|FG001|Open-Label Phase|Death|0|||
144303639|NCT01126190|520317607|FG002|Open-Label Phase|Death|1|||
144303640|NCT01126190|520317605|FG000|Open-Label Phase|Adverse Event|0|||
144303641|NCT01126190|520317606|FG001|Open-Label Phase|Adverse Event|0|||
144303642|NCT01126190|520317607|FG002|Open-Label Phase|Adverse Event|4|||
144303643|NCT01126190|520317605|FG000|Open-Label Phase|Withdrawal by Subject|0|||
144303644|NCT01126190|520317606|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144303645|NCT01126190|520317607|FG002|Open-Label Phase|Withdrawal by Subject|6|||
144303646|NCT00524121|520317608|FG000|Overall Study|Disease progression|6|||
144303647|NCT00524121|520317608|FG000|Overall Study|Adverse Event|4|||
144303648|NCT00524121|520317608|FG000|Overall Study|Patient refused|2|||
144303649|NCT00524121|520317608|FG000|Overall Study|Other|1|||
144303650|NCT00524121|520317608|FG000|Overall Study|Death|1|||
144303651|NCT00524121|520317608|FG000|Overall Study|Not treated (became ineligible)|4|||
144303652|NCT00524121|520317608|FG000|Overall Study|Not treated (changed mind)|1|||
144303653|NCT01114737|520317609|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
144303654|NCT01114737|520317610|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
144303655|NCT01114737|520317609|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
144303656|NCT01114737|520317610|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
144303657|NCT01114737|520317609|FG000|Randomized Treatment Period|Pregnancy|1|||
144303658|NCT01114737|520317610|FG001|Randomized Treatment Period|Pregnancy|0|||
144303659|NCT01114737|520317609|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
144303660|NCT01114737|520317610|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
144303661|NCT01114737|520317609|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
144303662|NCT01114737|520317610|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
144303663|NCT01114737|520317609|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
144303664|NCT01114737|520317610|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
144303665|NCT01840943|520317611|FG000|Overall Study|Withdrawal by Subject|5|||
144303666|NCT01840943|520317612|FG001|Overall Study|Withdrawal by Subject|6|||
144303667|NCT01840943|520317611|FG000|Overall Study|Physician Decision|4|||
144303668|NCT01840943|520317612|FG001|Overall Study|Physician Decision|2|||
144303669|NCT01840943|520317611|FG000|Overall Study|Lost to Follow-up|4|||
144303670|NCT01840943|520317612|FG001|Overall Study|Lost to Follow-up|4|||
144303671|NCT01446874|520317615|FG000|Overall Study|Not eligible|1|||
144303672|NCT01446874|520317616|FG001|Overall Study|Not eligible|0|||
144303673|NCT01446874|520317617|FG002|Overall Study|Not eligible|0|||
144303674|NCT01446874|520317615|FG000|Overall Study|No surgery/No qualifying surgery|1|||
144303675|NCT01446874|520317616|FG001|Overall Study|No surgery/No qualifying surgery|0|||
144303676|NCT01446874|520317617|FG002|Overall Study|No surgery/No qualifying surgery|12|||
144303677|NCT01446874|520317615|FG000|Overall Study|Non-compliance|0|||
144303678|NCT01446874|520317616|FG001|Overall Study|Non-compliance|4|||
144303679|NCT01446874|520317617|FG002|Overall Study|Non-compliance|0|||
144303680|NCT01446874|520317615|FG000|Overall Study|Antibiotics for pre-op infection|0|||
144303681|NCT01446874|520317616|FG001|Overall Study|Antibiotics for pre-op infection|0|||
144303682|NCT01446874|520317617|FG002|Overall Study|Antibiotics for pre-op infection|2|||
144303683|NCT01446874|520317615|FG000|Overall Study|Withdrawal by Subject|0|||
144303684|NCT01446874|520317616|FG001|Overall Study|Withdrawal by Subject|0|||
144303685|NCT01446874|520317617|FG002|Overall Study|Withdrawal by Subject|4|||
144303686|NCT01135992|520317618|FG000|Overall Study|Adverse Event|1|||
144303687|NCT01135992|520317618|FG000|Overall Study|Lack of Efficacy|1|||
144303688|NCT01135992|520317618|FG000|Overall Study|Protocol Violation|2|||
144303689|NCT01135992|520317618|FG000|Overall Study|Withdrawal criteria|10|||
144303690|NCT01135992|520317618|FG000|Overall Study|Unclassified|7|||
144303691|NCT02727322|520317620|FG000|Overall Study|Withdrawal by Subject|1|||
144303692|NCT02727322|520317621|FG001|Overall Study|Withdrawal by Subject|1|||
144303693|NCT02727322|520317620|FG000|Overall Study|Protocol Violation|1|||
144303694|NCT02727322|520317621|FG001|Overall Study|Protocol Violation|0|||
144303695|NCT00339040|520317622|FG000|Stage I|Not able to attend clinic|1|||
144303696|NCT00339040|520317623|FG001|Stage I|Not able to attend clinic|0|||
144303697|NCT00339040|520317622|FG000|Stage I|Protocol Violation|1|||
144303698|NCT00339040|520317623|FG001|Stage I|Protocol Violation|1|||
144303699|NCT00339040|520317622|FG000|Stage II|Lost to Follow-up|3|||
144303700|NCT00339040|520317623|FG001|Stage II|Lost to Follow-up|0|||
144303701|NCT00339040|520317622|FG000|Stage II|Withdrawal by Subject|1|||
144303702|NCT00339040|520317623|FG001|Stage II|Withdrawal by Subject|2|||
144303703|NCT00339040|520317622|FG000|Stage II|Protocol Violation|3|||
144303704|NCT00339040|520317623|FG001|Stage II|Protocol Violation|0|||
144303705|NCT00339040|520317622|FG000|Stage II|Not able to attend clinic|1|||
144303706|NCT00339040|520317623|FG001|Stage II|Not able to attend clinic|0|||
144303707|NCT00339040|520317622|FG000|Stage II|Site closing|2|||
144303708|NCT00339040|520317623|FG001|Stage II|Site closing|0|||
144303709|NCT00690794|520317624|FG000|Overall Study|Adverse Event|12|||
144303710|NCT00690794|520317625|FG001|Overall Study|Adverse Event|10|||
144303711|NCT00690794|520317624|FG000|Overall Study|Lost to Follow-up|1|||
144303712|NCT00690794|520317625|FG001|Overall Study|Lost to Follow-up|4|||
144303713|NCT00690794|520317624|FG000|Overall Study|Withdrawal by Subject|0|||
144303714|NCT00690794|520317625|FG001|Overall Study|Withdrawal by Subject|9|||
144303715|NCT00690794|520317624|FG000|Overall Study|Protocol Violation|6|||
144303716|NCT00690794|520317625|FG001|Overall Study|Protocol Violation|7|||
144303717|NCT00690794|520317624|FG000|Overall Study|Noncompliance|1|||
144303718|NCT00690794|520317625|FG001|Overall Study|Noncompliance|2|||
144303719|NCT00690794|520317624|FG000|Overall Study|Other not specified|1|||
144303720|NCT00690794|520317625|FG001|Overall Study|Other not specified|3|||
144303721|NCT01496287|520317626|FG000|Overall Study|Lost to Follow-up|1|||
144303722|NCT01496287|520317626|FG000|Overall Study|Incomplete anesthesia|5|||
144303723|NCT01823107|520317627|FG000|Overall Study|Withdrawal by Subject|1|||
144303724|NCT01073293|520317628|FG000|Overall Study|Lost to Follow-up|0|||
144303725|NCT01073293|520317629|FG001|Overall Study|Lost to Follow-up|1|||
144303726|NCT01073293|520317628|FG000|Overall Study|Withdrawal by Subject|5|||
144303727|NCT01073293|520317629|FG001|Overall Study|Withdrawal by Subject|10|||
144303728|NCT00256126|520317630|FG000|Overall Study|Adverse Event|1|||
144303729|NCT00256126|520317631|FG001|Overall Study|Adverse Event|0|||
144303730|NCT00256126|520317630|FG000|Overall Study|Other|1|||
144303731|NCT00256126|520317631|FG001|Overall Study|Other|2|||
144303732|NCT00800735|520317632|FG000|Overall Study|Administrative/Other|2|||
144303733|NCT00800735|520317632|FG000|Overall Study|Insufficient Therapeutic Response|2|||
144303734|NCT00800735|520317632|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
144303735|NCT00800735|520317632|FG000|Overall Study|Withdrew Consent|3|||
144303736|NCT01788943|520317635|FG000|Overall Study|Withdrawal by Subject|1|||
144303737|NCT01788943|520317636|FG001|Overall Study|Withdrawal by Subject|0|||
144303738|NCT03273907|520317637|FG000|Overall Study|Death|1|||
144303739|NCT03273907|520317637|FG000|Overall Study|Lost to Follow-up|4|||
144303740|NCT03273907|520317637|FG000|Overall Study|Withdrawal by Subject|2|||
144303741|NCT03273907|520317637|FG000|Overall Study|COVID 19|2|||
144303742|NCT00110214|520317638|FG000|Overall Study|Never started treatment|21|||
144303743|NCT00110214|520317639|FG001|Overall Study|Never started treatment|20|||
144303744|NCT00110214|520317638|FG000|Overall Study|Disease progression or death|260|||
144303745|NCT00110214|520317639|FG001|Overall Study|Disease progression or death|151|||
144303746|NCT00110214|520317638|FG000|Overall Study|Adverse Event|115|||
144303747|NCT00110214|520317639|FG001|Overall Study|Adverse Event|192|||
144303748|NCT00110214|520317638|FG000|Overall Study|Refused further treatment|52|||
144303749|NCT00110214|520317639|FG001|Overall Study|Refused further treatment|65|||
144303750|NCT00110214|520317638|FG000|Overall Study|Other (not specified)|61|||
144303751|NCT00110214|520317639|FG001|Overall Study|Other (not specified)|75|||
144303752|NCT01016067|520317641|FG000|Overall Study|Lost to Follow-up|1|||
144303753|NCT01016067|520317642|FG001|Overall Study|Lost to Follow-up|2|||
144303754|NCT01016067|520317641|FG000|Overall Study|Physician Decision|1|||
144303755|NCT01016067|520317642|FG001|Overall Study|Physician Decision|1|||
144303756|NCT01016067|520317641|FG000|Overall Study|Withdrew due to Relocation|0|||
144303757|NCT01016067|520317642|FG001|Overall Study|Withdrew due to Relocation|1|||
144303758|NCT02581891|520317643|FG000|Overall Study|Adverse Event|4|||
144303759|NCT02581891|520317644|FG001|Overall Study|Adverse Event|6|||
144303760|NCT02581891|520317643|FG000|Overall Study|Death|3|||
144303761|NCT02581891|520317644|FG001|Overall Study|Death|4|||
144303762|NCT02581891|520317643|FG000|Overall Study|Lost to Follow-up|1|||
144303763|NCT02581891|520317644|FG001|Overall Study|Lost to Follow-up|2|||
144303764|NCT02581891|520317643|FG000|Overall Study|Physician Decision|0|||
144303765|NCT02581891|520317644|FG001|Overall Study|Physician Decision|1|||
144303766|NCT02581891|520317643|FG000|Overall Study|Withdrawal by Subject|4|||
144303767|NCT02581891|520317644|FG001|Overall Study|Withdrawal by Subject|5|||
144303768|NCT02581891|520317643|FG000|Overall Study|Other Reasons|3|||
144303769|NCT02581891|520317644|FG001|Overall Study|Other Reasons|1|||
144303770|NCT02581891|520317643|FG000|Overall Study|Discontinued during followup|1|||
144303771|NCT02581891|520317644|FG001|Overall Study|Discontinued during followup|0|||
144303772|NCT01832727|520317649|FG000|Overall Study|Adverse Event|4|||
144303773|NCT01832727|520317650|FG001|Overall Study|Adverse Event|6|||
144303774|NCT01832727|520317651|FG002|Overall Study|Adverse Event|1|||
144303775|NCT01832727|520317652|FG003|Overall Study|Adverse Event|0|||
144303776|NCT01832727|520317653|FG004|Overall Study|Adverse Event|1|||
144303777|NCT01832727|520317654|FG005|Overall Study|Adverse Event|1|||
144303778|NCT01832727|520317655|FG006|Overall Study|Adverse Event|2|||
144303779|NCT01832727|520317656|FG007|Overall Study|Adverse Event|1|||
144303780|NCT01832727|520317657|FG008|Overall Study|Adverse Event|9|||
144303781|NCT01832727|520317649|FG000|Overall Study|Disease progression|3|||
144303782|NCT01832727|520317650|FG001|Overall Study|Disease progression|0|||
144303783|NCT01832727|520317651|FG002|Overall Study|Disease progression|2|||
144303784|NCT01832727|520317652|FG003|Overall Study|Disease progression|1|||
144303785|NCT01832727|520317653|FG004|Overall Study|Disease progression|3|||
144303786|NCT01832727|520317654|FG005|Overall Study|Disease progression|3|||
144303787|NCT01832727|520317655|FG006|Overall Study|Disease progression|6|||
144303788|NCT01832727|520317656|FG007|Overall Study|Disease progression|2|||
144303789|NCT01832727|520317657|FG008|Overall Study|Disease progression|7|||
144303790|NCT01832727|520317649|FG000|Overall Study|Lost to Follow-up|0|||
144303791|NCT01832727|520317650|FG001|Overall Study|Lost to Follow-up|0|||
144303792|NCT01832727|520317651|FG002|Overall Study|Lost to Follow-up|0|||
144303793|NCT01832727|520317652|FG003|Overall Study|Lost to Follow-up|1|||
144303794|NCT01832727|520317653|FG004|Overall Study|Lost to Follow-up|0|||
144303795|NCT01832727|520317654|FG005|Overall Study|Lost to Follow-up|0|||
144303796|NCT01832727|520317655|FG006|Overall Study|Lost to Follow-up|0|||
144303797|NCT01832727|520317656|FG007|Overall Study|Lost to Follow-up|0|||
144303798|NCT01832727|520317657|FG008|Overall Study|Lost to Follow-up|0|||
144303799|NCT01832727|520317649|FG000|Overall Study|Physician Decision|1|||
144303800|NCT01832727|520317650|FG001|Overall Study|Physician Decision|0|||
144303801|NCT01832727|520317651|FG002|Overall Study|Physician Decision|0|||
144303802|NCT01832727|520317652|FG003|Overall Study|Physician Decision|1|||
144303803|NCT01832727|520317653|FG004|Overall Study|Physician Decision|0|||
144303804|NCT01832727|520317654|FG005|Overall Study|Physician Decision|1|||
144303805|NCT01832727|520317655|FG006|Overall Study|Physician Decision|0|||
144303806|NCT01832727|520317656|FG007|Overall Study|Physician Decision|0|||
144303807|NCT01832727|520317657|FG008|Overall Study|Physician Decision|0|||
144303808|NCT01832727|520317649|FG000|Overall Study|Withdrawal by Subject|1|||
144303809|NCT01832727|520317650|FG001|Overall Study|Withdrawal by Subject|1|||
144303810|NCT01832727|520317651|FG002|Overall Study|Withdrawal by Subject|0|||
144303811|NCT01832727|520317652|FG003|Overall Study|Withdrawal by Subject|1|||
144303812|NCT01832727|520317653|FG004|Overall Study|Withdrawal by Subject|0|||
144303813|NCT01832727|520317654|FG005|Overall Study|Withdrawal by Subject|1|||
144303814|NCT01832727|520317655|FG006|Overall Study|Withdrawal by Subject|0|||
144303815|NCT01832727|520317656|FG007|Overall Study|Withdrawal by Subject|2|||
144303816|NCT01832727|520317657|FG008|Overall Study|Withdrawal by Subject|1|||
144303817|NCT01832727|520317649|FG000|Overall Study|Study terminated by sponsor|0|||
144303818|NCT01832727|520317650|FG001|Overall Study|Study terminated by sponsor|0|||
144303819|NCT01832727|520317651|FG002|Overall Study|Study terminated by sponsor|0|||
144303820|NCT01832727|520317652|FG003|Overall Study|Study terminated by sponsor|0|||
144303821|NCT01832727|520317653|FG004|Overall Study|Study terminated by sponsor|0|||
144303822|NCT01832727|520317654|FG005|Overall Study|Study terminated by sponsor|0|||
144303823|NCT01832727|520317655|FG006|Overall Study|Study terminated by sponsor|0|||
144303824|NCT01832727|520317656|FG007|Overall Study|Study terminated by sponsor|1|||
144303825|NCT01832727|520317657|FG008|Overall Study|Study terminated by sponsor|1|||
144303826|NCT03434834|520317658|FG000|Overall Study|unable to swallow OCT probe|16|||
144303827|NCT01812057|520317666|FG000|Overall Study|Protocol Violation|1|||
144303828|NCT01812057|520317667|FG001|Overall Study|Protocol Violation|0|||
144303829|NCT01812057|520317666|FG000|Overall Study|Physician Decision|1|||
144303830|NCT01812057|520317667|FG001|Overall Study|Physician Decision|0|||
144303831|NCT01133847|520317674|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
144303832|NCT01133847|520317675|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
144303833|NCT01133847|520317676|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
144303834|NCT01133847|520317674|FG000|Follow-Up Phase|Lost to Follow-up|1|||
144303835|NCT01133847|520317675|FG001|Follow-Up Phase|Lost to Follow-up|3|||
144303836|NCT01133847|520317676|FG002|Follow-Up Phase|Lost to Follow-up|7|||
144303837|NCT04436744|520317677|FG000|Overall Study|Adverse Event|1|||
144303838|NCT04436744|520317678|FG001|Overall Study|Adverse Event|1|||
144303839|NCT04436744|520317677|FG000|Overall Study|Death|1|||
144303840|NCT04436744|520317678|FG001|Overall Study|Death|0|||
144303841|NCT04436744|520317677|FG000|Overall Study|Lost to Follow-up|0|||
144303842|NCT04436744|520317678|FG001|Overall Study|Lost to Follow-up|2|||
144303843|NCT04436744|520317677|FG000|Overall Study|Physician Decision|0|||
144303844|NCT04436744|520317678|FG001|Overall Study|Physician Decision|1|||
144303845|NCT04436744|520317677|FG000|Overall Study|Progressive Disease|0|||
144303846|NCT04436744|520317678|FG001|Overall Study|Progressive Disease|4|||
144303847|NCT04436744|520317677|FG000|Overall Study|Protocol Deviation|1|||
144303848|NCT04436744|520317678|FG001|Overall Study|Protocol Deviation|1|||
144303849|NCT04436744|520317677|FG000|Overall Study|Withdrawal by Subject|1|||
144303850|NCT04436744|520317678|FG001|Overall Study|Withdrawal by Subject|2|||
144303851|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
144303852|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
144303853|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
144303854|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
144303855|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
144303856|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
144303857|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
144303858|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
144303859|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
144303860|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
144303861|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
144303862|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
144303863|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
144303864|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
144303865|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
144303866|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
144303867|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
144303868|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
144303869|NCT03789292|520317681|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
144303870|NCT03789292|520317682|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
144303871|NCT03789292|520317683|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
144303872|NCT03789292|520317681|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
144303873|NCT03789292|520317682|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
144303874|NCT03789292|520317683|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
144303875|NCT03789292|520317681|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
144303876|NCT03789292|520317682|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
144303877|NCT03789292|520317683|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
144303878|NCT03789292|520317681|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
144303879|NCT03789292|520317682|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
144303880|NCT03789292|520317683|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
144303881|NCT03789292|520317681|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
144303882|NCT03789292|520317682|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
144303883|NCT03789292|520317683|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
144303884|NCT03789292|520317681|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
144303885|NCT03789292|520317682|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
144303886|NCT03789292|520317683|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
144303887|NCT03789292|520317681|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
144303888|NCT03789292|520317682|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
144303889|NCT03789292|520317683|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
144303890|NCT00967616|520317684|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
144303891|NCT00967616|520317685|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
144303892|NCT00967616|520317684|FG000|Overall Study|Death|0|||
144303893|NCT00967616|520317685|FG001|Overall Study|Death|3|||
144303894|NCT00967616|520317684|FG000|Overall Study|Withdrawal by Subject|8|||
144303895|NCT00967616|520317685|FG001|Overall Study|Withdrawal by Subject|4|||
144303896|NCT00967616|520317684|FG000|Overall Study|Progressive Disease|31|||
144303897|NCT00967616|520317685|FG001|Overall Study|Progressive Disease|18|||
144303898|NCT00967616|520317684|FG000|Overall Study|Other|8|||
144303899|NCT00967616|520317685|FG001|Overall Study|Other|8|||
144303900|NCT00967616|520317684|FG000|Overall Study|Protocol Violation|1|||
144303901|NCT00967616|520317685|FG001|Overall Study|Protocol Violation|0|||
144303902|NCT00508482|520317686|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
144303903|NCT00508482|520317687|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
144303904|NCT00508482|520317688|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
144303905|NCT00508482|520317686|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
144303906|NCT00508482|520317687|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
144303907|NCT00508482|520317688|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
144303908|NCT00508482|520317686|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
144303909|NCT00508482|520317687|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
144303910|NCT00508482|520317688|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
144303911|NCT01374425|520317689|FG000|Overall Study|Radiographic Disease Progression|86|||
144303912|NCT01374425|520317690|FG001|Overall Study|Radiographic Disease Progression|81|||
144303913|NCT01374425|520317689|FG000|Overall Study|Clinical Disease Progression|9|||
144303914|NCT01374425|520317690|FG001|Overall Study|Clinical Disease Progression|6|||
144303915|NCT01374425|520317689|FG000|Overall Study|Adverse Event|29|||
144303916|NCT01374425|520317690|FG001|Overall Study|Adverse Event|18|||
144303917|NCT01374425|520317689|FG000|Overall Study|Death (Progression of Disease)|1|||
144303918|NCT01374425|520317690|FG001|Overall Study|Death (Progression of Disease)|0|||
144303919|NCT01374425|520317689|FG000|Overall Study|Death (Adverse Event)|2|||
144303920|NCT01374425|520317690|FG001|Overall Study|Death (Adverse Event)|4|||
144303921|NCT01374425|520317689|FG000|Overall Study|Withdrawal by Subject|6|||
144303922|NCT01374425|520317690|FG001|Overall Study|Withdrawal by Subject|7|||
144303923|NCT01374425|520317689|FG000|Overall Study|Refused Treatment|10|||
144303924|NCT01374425|520317690|FG001|Overall Study|Refused Treatment|24|||
144303925|NCT01374425|520317689|FG000|Overall Study|Protocol Violation|2|||
144303926|NCT01374425|520317690|FG001|Overall Study|Protocol Violation|3|||
144303927|NCT01374425|520317689|FG000|Overall Study|Sponsor Decision|0|||
144303928|NCT01374425|520317690|FG001|Overall Study|Sponsor Decision|1|||
144303929|NCT01374425|520317689|FG000|Overall Study|Lost to Follow-up|2|||
144303930|NCT01374425|520317690|FG001|Overall Study|Lost to Follow-up|1|||
144303931|NCT01374425|520317689|FG000|Overall Study|Other|41|||
144303932|NCT01374425|520317690|FG001|Overall Study|Other|43|||
144303933|NCT02850978|520317697|FG000|Overall Study|Uncollectable CRF|27|||
144303934|NCT02850978|520317697|FG000|Overall Study|No visit since the first visit|35|||
144303935|NCT02850978|520317697|FG000|Overall Study|Adverse Event|81|||
144303936|NCT02850978|520317697|FG000|Overall Study|Lack of Efficacy|40|||
144303937|NCT02850978|520317697|FG000|Overall Study|Improvement in condition|34|||
144303938|NCT02850978|520317697|FG000|Overall Study|Lost to Follow-up|121|||
144303939|NCT02850978|520317697|FG000|Overall Study|Reason not listed|88|||
144303940|NCT00271544|520317702|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
144303941|NCT00271544|520317702|FG000|Overall Study|Model 4196 lead not attempted|9|||
144303942|NCT00271544|520317702|FG000|Overall Study|Implant not attempted|4|||
144303943|NCT00902330|520317705|FG000|Overall Study|Too overwhelmed by treatment|2|||
144303944|NCT00902330|520317706|FG001|Overall Study|Too overwhelmed by treatment|5|||
144303945|NCT00902330|520317705|FG000|Overall Study|Adverse Event|1|||
144303946|NCT00902330|520317706|FG001|Overall Study|Adverse Event|0|||
144303947|NCT00902330|520317705|FG000|Overall Study|No post baseline data|1|||
144303948|NCT00902330|520317706|FG001|Overall Study|No post baseline data|0|||
144303949|NCT00165789|520317707|FG000|Overall Study|Adverse Event|0|||
144303950|NCT00165789|520317708|FG001|Overall Study|Adverse Event|3|||
144303951|NCT00165789|520317709|FG002|Overall Study|Adverse Event|0|||
144303952|NCT00165789|520317710|FG003|Overall Study|Adverse Event|12|||
144303953|NCT00165789|520317707|FG000|Overall Study|Withdrawal by Subject|0|||
144303954|NCT00165789|520317708|FG001|Overall Study|Withdrawal by Subject|1|||
144303955|NCT00165789|520317709|FG002|Overall Study|Withdrawal by Subject|1|||
144303956|NCT00165789|520317710|FG003|Overall Study|Withdrawal by Subject|2|||
144303957|NCT01816048|520317711|FG000|Overall Study|Adverse Event|1|||
144303958|NCT01816048|520317711|FG000|Overall Study|Death|1|||
144303959|NCT01816048|520317711|FG000|Overall Study|Withdrawal by Subject|1|||
144303960|NCT01816048|520317711|FG000|Overall Study|Disease Progression|3|||
144303961|NCT02121509|520317712|FG000|Washout Period (35 Days)|Adverse Event|1|||
144303962|NCT02121509|520317713|FG001|Washout Period (35 Days)|Adverse Event|1|||
144303963|NCT02121509|520317714|FG002|Washout Period (35 Days)|Adverse Event|0|||
144303964|NCT02121509|520317715|FG003|Washout Period (35 Days)|Adverse Event|0|||
144303965|NCT02121509|520317712|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
144303966|NCT02121509|520317713|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
144303967|NCT02121509|520317714|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
144303968|NCT02121509|520317715|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
144303969|NCT02121509|520317712|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
144303970|NCT02121509|520317713|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
144303971|NCT02121509|520317714|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
144303972|NCT02121509|520317715|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
144303973|NCT00322049|520319810|FG000|Overall Study|Moved out of area|0|||
144303974|NCT00322049|520319811|FG001|Overall Study|Moved out of area|0|||
144303975|NCT00322049|520319812|FG002|Overall Study|Moved out of area|0|||
144303976|NCT00322049|520319813|FG003|Overall Study|Moved out of area|1|||
144303977|NCT00322049|520319810|FG000|Overall Study|Infected with Dengue during study|0|||
144303978|NCT00322049|520319811|FG001|Overall Study|Infected with Dengue during study|1|||
144303979|NCT00322049|520319812|FG002|Overall Study|Infected with Dengue during study|0|||
144303980|NCT00322049|520319813|FG003|Overall Study|Infected with Dengue during study|0|||
144303981|NCT01978145|520319814|FG000|Treatment Period 1|Adverse Event|1|||
144303982|NCT01978145|520319815|FG001|Treatment Period 1|Adverse Event|9|||
144303983|NCT01978145|520319814|FG000|Treatment Period 1|Physician Decision|1|||
144303984|NCT01978145|520319815|FG001|Treatment Period 1|Physician Decision|0|||
144303985|NCT01978145|520319814|FG000|Treatment Period 1|Withdrawal by Subject|5|||
144303986|NCT01978145|520319815|FG001|Treatment Period 1|Withdrawal by Subject|4|||
144303987|NCT01978145|520319814|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
144303988|NCT01978145|520319815|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
144303989|NCT01978145|520319814|FG000|Washout Period 1|Adverse Event|0|||
144303990|NCT01978145|520319815|FG001|Washout Period 1|Adverse Event|1|||
144303991|NCT01978145|520319814|FG000|Washout Period 1|Withdrawal by Subject|1|||
144303992|NCT01978145|520319815|FG001|Washout Period 1|Withdrawal by Subject|1|||
144303993|NCT01978145|520319814|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
144303994|NCT01978145|520319815|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
144303995|NCT01978145|520319814|FG000|Treatment Period 2|Adverse Event|3|||
144303996|NCT01978145|520319815|FG001|Treatment Period 2|Adverse Event|3|||
144303997|NCT01978145|520319814|FG000|Treatment Period 2|Protocol Violation|0|||
144303998|NCT01978145|520319815|FG001|Treatment Period 2|Protocol Violation|1|||
144303999|NCT01978145|520319814|FG000|Treatment Period 2|Lost to Follow-up|1|||
144304000|NCT01978145|520319815|FG001|Treatment Period 2|Lost to Follow-up|1|||
144304001|NCT01978145|520319814|FG000|Treatment Period 2|Withdrawal by Subject|7|||
144304002|NCT01978145|520319815|FG001|Treatment Period 2|Withdrawal by Subject|4|||
144304003|NCT01978145|520319814|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
144304004|NCT01978145|520319815|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
144304005|NCT01173679|520319816|FG000|Overall Study|Death|1|||
144304006|NCT00755807|520319821|FG000|Acute Phase|Adverse Event|16|||
144304007|NCT00755807|520319822|FG001|Acute Phase|Adverse Event|5|||
144304008|NCT00755807|520319821|FG000|Acute Phase|Protocol Violation|1|||
144304009|NCT00755807|520319822|FG001|Acute Phase|Protocol Violation|3|||
144304010|NCT00755807|520319821|FG000|Acute Phase|Withdrawal by Subject|1|||
144304011|NCT00755807|520319822|FG001|Acute Phase|Withdrawal by Subject|2|||
144304012|NCT00755807|520319821|FG000|Acute Phase|Lack of Efficacy|0|||
144304013|NCT00755807|520319822|FG001|Acute Phase|Lack of Efficacy|1|||
144304014|NCT00755807|520319821|FG000|Acute Phase|Physician Decision|0|||
144304015|NCT00755807|520319822|FG001|Acute Phase|Physician Decision|1|||
144304016|NCT00755807|520319821|FG000|Open-label Extension Phase|Adverse Event|7|||
144304017|NCT00755807|520319822|FG001|Open-label Extension Phase|Adverse Event|7|||
144304018|NCT00755807|520319821|FG000|Open-label Extension Phase|Protocol Violation|5|||
144304019|NCT00755807|520319822|FG001|Open-label Extension Phase|Protocol Violation|2|||
144304020|NCT00755807|520319821|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
144304021|NCT00755807|520319822|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
144304022|NCT00755807|520319821|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
144304023|NCT00755807|520319822|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
144304024|NCT00755807|520319821|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
144304025|NCT00755807|520319822|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
144304026|NCT00755807|520319821|FG000|Open-label Extension Phase|Sponsor Decision|0|||
144304027|NCT00755807|520319822|FG001|Open-label Extension Phase|Sponsor Decision|1|||
144304028|NCT00529243|520319828|FG000|Overall Study|Adverse Event|1|||
144304029|NCT00529243|520319828|FG000|Overall Study|Death|1|||
144304030|NCT00529243|520319828|FG000|Overall Study|Relocated|1|||
144304031|NCT03257358|520319829|FG000|Overall Study|Adverse Event|25|||
144304032|NCT03257358|520319830|FG001|Overall Study|Adverse Event|12|||
144304033|NCT03257358|520319829|FG000|Overall Study|Lack of Efficacy|1|||
144304034|NCT03257358|520319830|FG001|Overall Study|Lack of Efficacy|1|||
144304035|NCT03257358|520319829|FG000|Overall Study|Lost to Follow-up|12|||
144304036|NCT03257358|520319830|FG001|Overall Study|Lost to Follow-up|4|||
144304037|NCT03257358|520319829|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
144304038|NCT03257358|520319830|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
144304039|NCT03257358|520319829|FG000|Overall Study|Physician Decision|2|||
144304040|NCT03257358|520319830|FG001|Overall Study|Physician Decision|2|||
144304041|NCT03257358|520319829|FG000|Overall Study|Protocol Violation|5|||
144304042|NCT03257358|520319830|FG001|Overall Study|Protocol Violation|3|||
144304043|NCT03257358|520319829|FG000|Overall Study|Technical problems|4|||
144304044|NCT03257358|520319830|FG001|Overall Study|Technical problems|1|||
144304045|NCT03257358|520319829|FG000|Overall Study|Withdrawal by Subject|8|||
144304046|NCT03257358|520319830|FG001|Overall Study|Withdrawal by Subject|3|||
144304047|NCT03257358|520319829|FG000|Overall Study|Withdrawal of informed consent|9|||
144304048|NCT03257358|520319830|FG001|Overall Study|Withdrawal of informed consent|5|||
144304049|NCT03257358|520319829|FG000|Overall Study|New therapy for study indication|1|||
144304050|NCT03257358|520319830|FG001|Overall Study|New therapy for study indication|0|||
144304051|NCT03257358|520319829|FG000|Overall Study|No longer requires treatment|0|||
144304052|NCT03257358|520319830|FG001|Overall Study|No longer requires treatment|1|||
144304053|NCT02580877|520319831|FG000|Overall Study|Withdrawal by Subject|1|||
144304054|NCT02580877|520319832|FG001|Overall Study|Withdrawal by Subject|3|||
144304055|NCT02580877|520319831|FG000|Overall Study|Adverse Event|0|||
144304056|NCT02580877|520319832|FG001|Overall Study|Adverse Event|1|||
144304057|NCT02903823|520319833|FG000|Overall Study|Physician Decision|5|||
144304058|NCT02903823|520319833|FG000|Overall Study|Could not advance catheter|1|||
144304059|NCT02903823|520319833|FG000|Overall Study|Catheter dislodgement|1|||
144304060|NCT00355030|520319840|FG000|Study Period 1 Treatment|Adverse Event|1|||
144304061|NCT00355030|520319841|FG001|Study Period 1 Treatment|Adverse Event|1|||
144304062|NCT00355030|520319840|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
144304063|NCT00355030|520319841|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
144304064|NCT00355030|520319840|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
144304065|NCT00355030|520319841|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
144304066|NCT00355030|520319840|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
144304067|NCT00355030|520319841|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
144304068|NCT00355030|520319840|FG000|Study Period 1 Treatment|Physician Decision|0|||
144304069|NCT00355030|520319841|FG001|Study Period 1 Treatment|Physician Decision|1|||
144304070|NCT00355030|520319840|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
144304071|NCT00355030|520319841|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
144304072|NCT00355030|520319840|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
144304073|NCT00355030|520319841|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
144304074|NCT00355030|520319840|FG000|Study Period 1 Treatment|Other|2|||
144304075|NCT00355030|520319841|FG001|Study Period 1 Treatment|Other|6|||
144304076|NCT00355030|520319840|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
144304077|NCT00355030|520319841|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
144304078|NCT00355030|520319840|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
144304079|NCT00355030|520319841|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
144304080|NCT01123148|520319842|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
144304081|NCT01123148|520319842|FG000|Overall Study|Didn't meet milestone criteria|1|||
144304082|NCT01747915|520319843|FG000|Overall Study|Other|1|||
144304083|NCT01747915|520319844|FG001|Overall Study|Other|1|||
144304084|NCT01747915|520319845|FG002|Overall Study|Other|1|||
144304085|NCT01747915|520319843|FG000|Overall Study|Adverse Event|8|||
144304086|NCT01747915|520319844|FG001|Overall Study|Adverse Event|5|||
144304087|NCT01747915|520319845|FG002|Overall Study|Adverse Event|2|||
144304088|NCT01747915|520319843|FG000|Overall Study|Death|0|||
144304089|NCT01747915|520319844|FG001|Overall Study|Death|0|||
144304090|NCT01747915|520319845|FG002|Overall Study|Death|1|||
144304091|NCT01747915|520319843|FG000|Overall Study|Lack of Efficacy|0|||
144304092|NCT01747915|520319844|FG001|Overall Study|Lack of Efficacy|1|||
144304093|NCT01747915|520319845|FG002|Overall Study|Lack of Efficacy|0|||
144304094|NCT01747915|520319843|FG000|Overall Study|Lost to Follow-up|1|||
144304095|NCT01747915|520319844|FG001|Overall Study|Lost to Follow-up|0|||
144304096|NCT01747915|520319845|FG002|Overall Study|Lost to Follow-up|0|||
144304097|NCT01747915|520319843|FG000|Overall Study|Withdrawal by Subject|4|||
144304098|NCT01747915|520319844|FG001|Overall Study|Withdrawal by Subject|4|||
144304099|NCT01747915|520319845|FG002|Overall Study|Withdrawal by Subject|1|||
144304100|NCT01747915|520319843|FG000|Overall Study|Protocol Violation|1|||
144304101|NCT01747915|520319844|FG001|Overall Study|Protocol Violation|0|||
144304102|NCT01747915|520319845|FG002|Overall Study|Protocol Violation|0|||
144304103|NCT01747915|520319843|FG000|Overall Study|Pregnancy|0|||
144304104|NCT01747915|520319844|FG001|Overall Study|Pregnancy|0|||
144304105|NCT01747915|520319845|FG002|Overall Study|Pregnancy|1|||
144304106|NCT00305448|520319848|FG000|Overall Study|Protocol Violation|0|||
144304107|NCT00305448|520319849|FG001|Overall Study|Protocol Violation|1|||
144304108|NCT00305448|520319850|FG002|Overall Study|Protocol Violation|0|||
144304109|NCT00305448|520319848|FG000|Overall Study|Withdrawal by Subject|2|||
144304110|NCT00305448|520319849|FG001|Overall Study|Withdrawal by Subject|0|||
144304111|NCT00305448|520319850|FG002|Overall Study|Withdrawal by Subject|1|||
144304112|NCT00305448|520319848|FG000|Overall Study|Adverse Event|1|||
144304113|NCT00305448|520319849|FG001|Overall Study|Adverse Event|0|||
144304114|NCT00305448|520319850|FG002|Overall Study|Adverse Event|1|||
144304115|NCT00305448|520319848|FG000|Overall Study|Disease Progression|27|||
144304116|NCT00305448|520319849|FG001|Overall Study|Disease Progression|31|||
144304117|NCT00305448|520319850|FG002|Overall Study|Disease Progression|28|||
144304118|NCT00305448|520319848|FG000|Overall Study|Subjective Disease Progression|1|||
144304119|NCT00305448|520319849|FG001|Overall Study|Subjective Disease Progression|2|||
144304120|NCT00305448|520319850|FG002|Overall Study|Subjective Disease Progression|2|||
144304121|NCT00305448|520319848|FG000|Overall Study|Tumor Marker Elevation|0|||
144304122|NCT00305448|520319849|FG001|Overall Study|Tumor Marker Elevation|0|||
144304123|NCT00305448|520319850|FG002|Overall Study|Tumor Marker Elevation|1|||
144304124|NCT01343888|520319851|FG000|Overall Study|Adverse Event|12|||
144304125|NCT01343888|520319852|FG001|Overall Study|Adverse Event|22|||
144304126|NCT01343888|520319853|FG002|Overall Study|Adverse Event|5|||
144304127|NCT01343888|520319851|FG000|Overall Study|Lack of Efficacy|9|||
144304128|NCT01343888|520319852|FG001|Overall Study|Lack of Efficacy|9|||
144304129|NCT01343888|520319853|FG002|Overall Study|Lack of Efficacy|13|||
144304130|NCT01343888|520319851|FG000|Overall Study|Lost to Follow-up|0|||
144304131|NCT01343888|520319852|FG001|Overall Study|Lost to Follow-up|2|||
144304132|NCT01343888|520319853|FG002|Overall Study|Lost to Follow-up|1|||
144304133|NCT01343888|520319851|FG000|Overall Study|Protocol Violation|0|||
144304134|NCT01343888|520319852|FG001|Overall Study|Protocol Violation|2|||
144304135|NCT01343888|520319853|FG002|Overall Study|Protocol Violation|0|||
144304136|NCT01343888|520319851|FG000|Overall Study|Withdrawal by Subject|4|||
144304137|NCT01343888|520319852|FG001|Overall Study|Withdrawal by Subject|4|||
144304138|NCT01343888|520319853|FG002|Overall Study|Withdrawal by Subject|2|||
144304139|NCT01343888|520319851|FG000|Overall Study|other than stated above|0|||
144304140|NCT01343888|520319852|FG001|Overall Study|other than stated above|0|||
144304141|NCT01343888|520319853|FG002|Overall Study|other than stated above|1|||
144304142|NCT00077974|520319854|FG000|Overall Study|Adverse Event|22|||
144304143|NCT00077974|520319854|FG000|Overall Study|Protocol Violation|1|||
144304144|NCT00077974|520319854|FG000|Overall Study|Withdrawal by Subject|3|||
144304145|NCT00077974|520319854|FG000|Overall Study|Lack of Efficacy|76|||
144304146|NCT00077974|520319854|FG000|Overall Study|Decision of Sponsor|2|||
144304147|NCT02808429|520319866|FG000|Overall Study|Lost to Follow-up|1|||
144304148|NCT02808429|520319867|FG001|Overall Study|Lost to Follow-up|0|||
144304149|NCT02808429|520319868|FG002|Overall Study|Lost to Follow-up|0|||
144304150|NCT02808429|520319866|FG000|Overall Study|Protocol Violation|0|||
144304151|NCT02808429|520319867|FG001|Overall Study|Protocol Violation|1|||
144304152|NCT02808429|520319868|FG002|Overall Study|Protocol Violation|0|||
144304153|NCT02808429|520319866|FG000|Overall Study|Premature study termination by sponsor|2|||
144304154|NCT02808429|520319867|FG001|Overall Study|Premature study termination by sponsor|0|||
144304155|NCT02808429|520319868|FG002|Overall Study|Premature study termination by sponsor|1|||
144304156|NCT02808429|520319866|FG000|Overall Study|Relocation|0|||
144304157|NCT02808429|520319867|FG001|Overall Study|Relocation|0|||
144304158|NCT02808429|520319868|FG002|Overall Study|Relocation|1|||
144304159|NCT00811954|520319870|FG000|Overall Study|Death|10|||
144304160|NCT00811954|520319871|FG001|Overall Study|Death|6|||
144304161|NCT00811954|520319872|FG002|Overall Study|Death|13|||
144304162|NCT00811954|520319870|FG000|Overall Study|Lost to Follow-up|29|||
144304163|NCT00811954|520319871|FG001|Overall Study|Lost to Follow-up|23|||
144304164|NCT00811954|520319872|FG002|Overall Study|Lost to Follow-up|34|||
144304165|NCT00811954|520319870|FG000|Overall Study|Not able to get to clinic|28|||
144304166|NCT00811954|520319871|FG001|Overall Study|Not able to get to clinic|35|||
144304167|NCT00811954|520319872|FG002|Overall Study|Not able to get to clinic|30|||
144304168|NCT00811954|520319870|FG000|Overall Study|Not willing to adhere to requirements|12|||
144304169|NCT00811954|520319871|FG001|Overall Study|Not willing to adhere to requirements|2|||
144304170|NCT00811954|520319872|FG002|Overall Study|Not willing to adhere to requirements|16|||
144304171|NCT00811954|520319870|FG000|Overall Study|Withdraw consent prior study completion|4|||
144304172|NCT00811954|520319871|FG001|Overall Study|Withdraw consent prior study completion|6|||
144304173|NCT00811954|520319872|FG002|Overall Study|Withdraw consent prior study completion|5|||
144304174|NCT00811954|520319870|FG000|Overall Study|Site Closure|4|||
144304175|NCT00811954|520319871|FG001|Overall Study|Site Closure|0|||
144304176|NCT00811954|520319872|FG002|Overall Study|Site Closure|1|||
144304177|NCT00811954|520319870|FG000|Overall Study|Severe Debilitation|2|||
144304178|NCT00811954|520319871|FG001|Overall Study|Severe Debilitation|0|||
144304179|NCT00811954|520319872|FG002|Overall Study|Severe Debilitation|1|||
144304180|NCT00811954|520319870|FG000|Overall Study|Complete Protocol: No follow-up|0|||
144304181|NCT00811954|520319871|FG001|Overall Study|Complete Protocol: No follow-up|0|||
144304182|NCT00811954|520319872|FG002|Overall Study|Complete Protocol: No follow-up|1|||
144304183|NCT04828707|520319876|FG000|Overall Study|Lost to Follow-up|3|||
144304184|NCT04828707|520319877|FG001|Overall Study|Lost to Follow-up|2|||
144304185|NCT04828707|520319876|FG000|Overall Study|Withdrawal by Subject|2|||
144304186|NCT04828707|520319877|FG001|Overall Study|Withdrawal by Subject|1|||
144304187|NCT02394561|520319883|FG000|CORE Phase|Adverse Event|7|||
144304188|NCT02394561|520319884|FG001|CORE Phase|Adverse Event|9|||
144304189|NCT02394561|520319883|FG000|CORE Phase|Death|0|||
144304190|NCT02394561|520319884|FG001|CORE Phase|Death|1|||
144304191|NCT02394561|520319883|FG000|CORE Phase|Pregnancy|1|||
144304192|NCT02394561|520319884|FG001|CORE Phase|Pregnancy|0|||
144304193|NCT02394561|520319883|FG000|CORE Phase|Lost to Follow-up|1|||
144304194|NCT02394561|520319884|FG001|CORE Phase|Lost to Follow-up|0|||
144304195|NCT02394561|520319883|FG000|CORE Phase|Physician Decision|1|||
144304196|NCT02394561|520319884|FG001|CORE Phase|Physician Decision|1|||
144304197|NCT02394561|520319883|FG000|CORE Phase|Withdrawal by Subject|2|||
144304198|NCT02394561|520319884|FG001|CORE Phase|Withdrawal by Subject|2|||
144304199|NCT02394561|520319883|FG000|CORE Phase|Lack of Efficacy|1|||
144304200|NCT02394561|520319884|FG001|CORE Phase|Lack of Efficacy|6|||
144304201|NCT02394561|520319883|FG000|Extension Phase|Adverse Event|6|||
144304202|NCT02394561|520319884|FG001|Extension Phase|Adverse Event|1|||
144304203|NCT02394561|520319883|FG000|Extension Phase|Death|0|||
144304204|NCT02394561|520319884|FG001|Extension Phase|Death|1|||
144304205|NCT02394561|520319883|FG000|Extension Phase|Protocol Violation|1|||
144304206|NCT02394561|520319884|FG001|Extension Phase|Protocol Violation|0|||
144304207|NCT02394561|520319883|FG000|Extension Phase|Lost to Follow-up|1|||
144304208|NCT02394561|520319884|FG001|Extension Phase|Lost to Follow-up|0|||
144304209|NCT02394561|520319883|FG000|Extension Phase|Physician Decision|0|||
144304210|NCT02394561|520319884|FG001|Extension Phase|Physician Decision|2|||
144304211|NCT02394561|520319883|FG000|Extension Phase|Withdrawal by Subject|0|||
144304212|NCT02394561|520319884|FG001|Extension Phase|Withdrawal by Subject|5|||
144304213|NCT02394561|520319883|FG000|Extension Phase|Lack of Efficacy|3|||
144304214|NCT02394561|520319884|FG001|Extension Phase|Lack of Efficacy|3|||
144304215|NCT00501644|520319885|FG000|Overall Study|Adverse Event|4|||
144304216|NCT00501644|520319885|FG000|Overall Study|Withdrawal by Subject|1|||
144304217|NCT02553629|520319886|FG000|Overall Study|Logistic reasons|3|||
144304218|NCT02553629|520319887|FG001|Overall Study|Logistic reasons|6|||
144304219|NCT00696878|520319890|FG000|Overall Study|Adverse Event|8|||
144304220|NCT00696878|520319890|FG000|Overall Study|Withdrawal by Subject|87|||
144304221|NCT00696878|520319890|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
144304222|NCT00696878|520319890|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
144304223|NCT00696878|520319890|FG000|Overall Study|Trial stopped|32|||
144304224|NCT00696878|520319890|FG000|Overall Study|Other reason (not specified)|55|||
144304225|NCT02259114|520319895|FG000|Overall Study|Progressive Disease|14|||
144304226|NCT02259114|520319896|FG001|Overall Study|Progressive Disease|2|||
144304227|NCT02259114|520319897|FG002|Overall Study|Progressive Disease|10|||
144304228|NCT02259114|520319898|FG003|Overall Study|Progressive Disease|2|||
144304229|NCT02259114|520319899|FG004|Overall Study|Progressive Disease|5|||
144304230|NCT02259114|520319895|FG000|Overall Study|Adverse Event|2|||
144304231|NCT02259114|520319896|FG001|Overall Study|Adverse Event|1|||
144304232|NCT02259114|520319897|FG002|Overall Study|Adverse Event|0|||
144304233|NCT02259114|520319898|FG003|Overall Study|Adverse Event|0|||
144304234|NCT02259114|520319899|FG004|Overall Study|Adverse Event|1|||
144304235|NCT02259114|520319895|FG000|Overall Study|Death|3|||
144304236|NCT02259114|520319896|FG001|Overall Study|Death|0|||
144304237|NCT02259114|520319897|FG002|Overall Study|Death|1|||
144304238|NCT02259114|520319898|FG003|Overall Study|Death|0|||
144304239|NCT02259114|520319899|FG004|Overall Study|Death|0|||
144304240|NCT02259114|520319895|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
144304241|NCT02259114|520319896|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
144304242|NCT02259114|520319897|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
144304243|NCT02259114|520319898|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
144304244|NCT02259114|520319899|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
144304245|NCT02259114|520319895|FG000|Overall Study|Withdrawal by Subject|0|||
144304246|NCT02259114|520319896|FG001|Overall Study|Withdrawal by Subject|0|||
144304247|NCT02259114|520319897|FG002|Overall Study|Withdrawal by Subject|1|||
144304248|NCT02259114|520319898|FG003|Overall Study|Withdrawal by Subject|1|||
144304249|NCT02259114|520319899|FG004|Overall Study|Withdrawal by Subject|0|||
144304250|NCT02259114|520319895|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
144304251|NCT02259114|520319896|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
144304252|NCT02259114|520319897|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
144304253|NCT02259114|520319898|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
144304254|NCT02259114|520319899|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
144304255|NCT02259114|520319895|FG000|Overall Study|Not Treated|1|||
144304256|NCT02259114|520319896|FG001|Overall Study|Not Treated|0|||
144304257|NCT02259114|520319897|FG002|Overall Study|Not Treated|0|||
144304258|NCT02259114|520319898|FG003|Overall Study|Not Treated|0|||
144304259|NCT02259114|520319899|FG004|Overall Study|Not Treated|0|||
144304260|NCT03937479|520319900|FG000|Overall Study|Adverse Event|2|||
144304261|NCT03937479|520319901|FG001|Overall Study|Adverse Event|3|||
144304262|NCT03937479|520319902|FG002|Overall Study|Adverse Event|0|||
144304263|NCT03937479|520319903|FG003|Overall Study|Adverse Event|0|||
144304264|NCT03937479|520319904|FG004|Overall Study|Adverse Event|1|||
144304265|NCT03937479|520319900|FG000|Overall Study|Withdrawal by Subject|3|||
144304266|NCT03937479|520319901|FG001|Overall Study|Withdrawal by Subject|5|||
144304267|NCT03937479|520319902|FG002|Overall Study|Withdrawal by Subject|2|||
144304268|NCT03937479|520319903|FG003|Overall Study|Withdrawal by Subject|2|||
144304269|NCT03937479|520319904|FG004|Overall Study|Withdrawal by Subject|1|||
144304270|NCT03937479|520319900|FG000|Overall Study|Protocol Violation|5|||
144304271|NCT03937479|520319901|FG001|Overall Study|Protocol Violation|6|||
144304272|NCT03937479|520319902|FG002|Overall Study|Protocol Violation|4|||
144304273|NCT03937479|520319903|FG003|Overall Study|Protocol Violation|3|||
144304274|NCT03937479|520319904|FG004|Overall Study|Protocol Violation|2|||
144304275|NCT03937479|520319900|FG000|Overall Study|Lost to Follow-up|0|||
144304276|NCT03937479|520319901|FG001|Overall Study|Lost to Follow-up|1|||
144304277|NCT03937479|520319902|FG002|Overall Study|Lost to Follow-up|0|||
144304278|NCT03937479|520319903|FG003|Overall Study|Lost to Follow-up|1|||
144304279|NCT03937479|520319904|FG004|Overall Study|Lost to Follow-up|0|||
144304280|NCT03937479|520319900|FG000|Overall Study|Physician Decision|0|||
144304281|NCT03937479|520319901|FG001|Overall Study|Physician Decision|0|||
144304282|NCT03937479|520319902|FG002|Overall Study|Physician Decision|1|||
144304283|NCT03937479|520319903|FG003|Overall Study|Physician Decision|0|||
144304284|NCT03937479|520319904|FG004|Overall Study|Physician Decision|1|||
144304285|NCT00575666|520319905|FG000|Overall Study|Withdrawal by Subject|3|||
144304286|NCT00575666|520319906|FG001|Overall Study|Withdrawal by Subject|2|||
144304287|NCT00575666|520319905|FG000|Overall Study|Physician Decision|1|||
144304288|NCT00575666|520319906|FG001|Overall Study|Physician Decision|1|||
144304289|NCT00546481|520319907|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
144304290|NCT00546481|520319908|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
144304291|NCT00546481|520319909|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
144304292|NCT00546481|520319907|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
144304293|NCT00546481|520319908|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
144304294|NCT00546481|520319909|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
144304295|NCT00546481|520319907|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
144304296|NCT00546481|520319908|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
144304297|NCT00546481|520319909|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
144304298|NCT00546481|520319907|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
144304299|NCT00546481|520319908|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
144304300|NCT00546481|520319909|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
144304301|NCT00546481|520319907|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
144304302|NCT00546481|520319908|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
144304303|NCT00546481|520319909|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
144304304|NCT00546481|520319907|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
144304305|NCT00546481|520319908|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
144304306|NCT00546481|520319909|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
144304307|NCT00546481|520319907|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
144304308|NCT00546481|520319908|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
144304309|NCT00546481|520319909|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
144304310|NCT00546481|520319907|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
144304311|NCT00546481|520319908|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
144304312|NCT00546481|520319909|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
144304313|NCT00546481|520319907|FG000|Maintenance Phase (CERA)|Other Reason|0|||
144304314|NCT00546481|520319908|FG001|Maintenance Phase (CERA)|Other Reason|0|||
144304315|NCT00546481|520319909|FG002|Maintenance Phase (CERA)|Other Reason|1|||
144304316|NCT00950651|520319912|FG000|Overall Study|Adverse Event|17|||
144304317|NCT00950651|520319913|FG001|Overall Study|Adverse Event|20|||
144304318|NCT00950651|520319912|FG000|Overall Study|Death|1|||
144304319|NCT00950651|520319913|FG001|Overall Study|Death|0|||
144304320|NCT00950651|520319912|FG000|Overall Study|Lack of Efficacy|2|||
144304321|NCT00950651|520319913|FG001|Overall Study|Lack of Efficacy|2|||
144304322|NCT00950651|520319912|FG000|Overall Study|Protocol Violation|3|||
144304323|NCT00950651|520319913|FG001|Overall Study|Protocol Violation|4|||
144304324|NCT00950651|520319912|FG000|Overall Study|Withdrawal by Subject|8|||
144304325|NCT00950651|520319913|FG001|Overall Study|Withdrawal by Subject|9|||
144304326|NCT02761642|520319914|FG000|Overall Study|Did not Receive Study Treatment|3|||
144304327|NCT02761642|520319914|FG000|Overall Study|Adverse Event|13|||
144304328|NCT02761642|520319914|FG000|Overall Study|Withdrawal by Subject|2|||
144304329|NCT02761642|520319914|FG000|Overall Study|Non-compliant|7|||
144304330|NCT02761642|520319914|FG000|Overall Study|Death|3|||
144304331|NCT02761642|520319914|FG000|Overall Study|Lack of Efficacy|20|||
144304332|NCT02761642|520319914|FG000|Overall Study|Physician Decision|1|||
144304333|NCT02761642|520319914|FG000|Overall Study|Reason Unspecified|21|||
144304334|NCT03783780|520319917|FG000|Overall Study|Withdrawn prior to completion|1|||
144304335|NCT03768427|520319918|FG000|Overall Study|Death|0|||
144304336|NCT03768427|520319919|FG001|Overall Study|Death|0|||
144304337|NCT03768427|520319920|FG002|Overall Study|Death|1|||
144304338|NCT03768427|520319921|FG003|Overall Study|Death|0|||
144304339|NCT03768427|520319918|FG000|Overall Study|Lost to Follow-up|2|||
144304340|NCT03768427|520319919|FG001|Overall Study|Lost to Follow-up|0|||
144304341|NCT03768427|520319920|FG002|Overall Study|Lost to Follow-up|0|||
144304342|NCT03768427|520319921|FG003|Overall Study|Lost to Follow-up|0|||
144304343|NCT03768427|520319918|FG000|Overall Study|Physician Decision|3|||
144304344|NCT03768427|520319919|FG001|Overall Study|Physician Decision|2|||
144304345|NCT03768427|520319920|FG002|Overall Study|Physician Decision|4|||
144304346|NCT03768427|520319921|FG003|Overall Study|Physician Decision|4|||
144304347|NCT03768427|520319918|FG000|Overall Study|Withdrawal by Subject|7|||
144304348|NCT03768427|520319919|FG001|Overall Study|Withdrawal by Subject|2|||
144304349|NCT03768427|520319920|FG002|Overall Study|Withdrawal by Subject|6|||
144304350|NCT03768427|520319921|FG003|Overall Study|Withdrawal by Subject|7|||
144304351|NCT01644643|520319924|FG000|Overall Study|Death|1|||
144304352|NCT01644643|520319925|FG001|Overall Study|Death|0|||
144304353|NCT01644643|520319926|FG002|Overall Study|Death|3|||
144304354|NCT01644643|520319927|FG003|Overall Study|Death|3|||
144304355|NCT01644643|520319924|FG000|Overall Study|Lost to Follow-up|0|||
144304356|NCT01644643|520319925|FG001|Overall Study|Lost to Follow-up|0|||
144304357|NCT01644643|520319926|FG002|Overall Study|Lost to Follow-up|0|||
144304358|NCT01644643|520319927|FG003|Overall Study|Lost to Follow-up|4|||
144304359|NCT01644643|520319924|FG000|Overall Study|Withdrawal by Subject|1|||
144304360|NCT01644643|520319925|FG001|Overall Study|Withdrawal by Subject|0|||
144304361|NCT01644643|520319926|FG002|Overall Study|Withdrawal by Subject|2|||
144304362|NCT01644643|520319927|FG003|Overall Study|Withdrawal by Subject|1|||
144304363|NCT01644643|520319924|FG000|Overall Study|Other Eligibility criteria|0|||
144304364|NCT01644643|520319925|FG001|Overall Study|Other Eligibility criteria|0|||
144304365|NCT01644643|520319926|FG002|Overall Study|Other Eligibility criteria|0|||
144304366|NCT01644643|520319927|FG003|Overall Study|Other Eligibility criteria|2|||
144304367|NCT00421148|520319934|FG000|Overall Study|Lost to Follow-up|0|||
144304368|NCT00421148|520319935|FG001|Overall Study|Lost to Follow-up|0|||
144304369|NCT00421148|520319936|FG002|Overall Study|Lost to Follow-up|0|||
144304370|NCT00421148|520319937|FG003|Overall Study|Lost to Follow-up|0|||
144304371|NCT00421148|520319938|FG004|Overall Study|Lost to Follow-up|0|||
144304372|NCT00421148|520319939|FG005|Overall Study|Lost to Follow-up|0|||
144304373|NCT00421148|520319940|FG006|Overall Study|Lost to Follow-up|0|||
144304374|NCT00421148|520319941|FG007|Overall Study|Lost to Follow-up|0|||
144304375|NCT00421148|520319942|FG008|Overall Study|Lost to Follow-up|0|||
144304376|NCT00421148|520319943|FG009|Overall Study|Lost to Follow-up|0|||
144304377|NCT00421148|520319944|FG010|Overall Study|Lost to Follow-up|0|||
144304378|NCT00421148|520319945|FG011|Overall Study|Lost to Follow-up|0|||
144304379|NCT00421148|520319946|FG012|Overall Study|Lost to Follow-up|0|||
144304380|NCT00421148|520319947|FG013|Overall Study|Lost to Follow-up|0|||
144304381|NCT00421148|520319948|FG014|Overall Study|Lost to Follow-up|0|||
144304382|NCT00421148|520319949|FG015|Overall Study|Lost to Follow-up|0|||
144304383|NCT00421148|520319950|FG016|Overall Study|Lost to Follow-up|0|||
144304384|NCT00421148|520319951|FG017|Overall Study|Lost to Follow-up|1|||
144304385|NCT00421148|520319952|FG018|Overall Study|Lost to Follow-up|0|||
144304386|NCT00421148|520319953|FG019|Overall Study|Lost to Follow-up|0|||
144304387|NCT00421148|520319934|FG000|Overall Study|Withdrawal by Subject|0|||
144304388|NCT00421148|520319935|FG001|Overall Study|Withdrawal by Subject|0|||
144304389|NCT00421148|520319936|FG002|Overall Study|Withdrawal by Subject|0|||
144304390|NCT00421148|520319937|FG003|Overall Study|Withdrawal by Subject|0|||
144304391|NCT00421148|520319938|FG004|Overall Study|Withdrawal by Subject|0|||
144304392|NCT00421148|520319939|FG005|Overall Study|Withdrawal by Subject|0|||
144304393|NCT00421148|520319940|FG006|Overall Study|Withdrawal by Subject|0|||
144304394|NCT00421148|520319941|FG007|Overall Study|Withdrawal by Subject|0|||
144304395|NCT00421148|520319942|FG008|Overall Study|Withdrawal by Subject|0|||
144304396|NCT00421148|520319943|FG009|Overall Study|Withdrawal by Subject|0|||
144304397|NCT00421148|520319944|FG010|Overall Study|Withdrawal by Subject|0|||
144304398|NCT00421148|520319945|FG011|Overall Study|Withdrawal by Subject|0|||
144304399|NCT00421148|520319946|FG012|Overall Study|Withdrawal by Subject|0|||
144304400|NCT00421148|520319947|FG013|Overall Study|Withdrawal by Subject|0|||
144304401|NCT00421148|520319948|FG014|Overall Study|Withdrawal by Subject|0|||
144304402|NCT00421148|520319949|FG015|Overall Study|Withdrawal by Subject|0|||
144304403|NCT00421148|520319950|FG016|Overall Study|Withdrawal by Subject|0|||
144304404|NCT00421148|520319951|FG017|Overall Study|Withdrawal by Subject|1|||
144304405|NCT00421148|520319952|FG018|Overall Study|Withdrawal by Subject|0|||
144304406|NCT00421148|520319953|FG019|Overall Study|Withdrawal by Subject|0|||
144304407|NCT00421148|520319934|FG000|Overall Study|Protocol Violation|0|||
144304408|NCT00421148|520319935|FG001|Overall Study|Protocol Violation|0|||
144304409|NCT00421148|520319936|FG002|Overall Study|Protocol Violation|0|||
144304410|NCT00421148|520319937|FG003|Overall Study|Protocol Violation|0|||
144304411|NCT00421148|520319938|FG004|Overall Study|Protocol Violation|0|||
144304412|NCT00421148|520319939|FG005|Overall Study|Protocol Violation|1|||
144304413|NCT00421148|520319940|FG006|Overall Study|Protocol Violation|0|||
144304414|NCT00421148|520319941|FG007|Overall Study|Protocol Violation|0|||
144304415|NCT00421148|520319942|FG008|Overall Study|Protocol Violation|0|||
144304416|NCT00421148|520319943|FG009|Overall Study|Protocol Violation|0|||
144304417|NCT00421148|520319944|FG010|Overall Study|Protocol Violation|0|||
144304418|NCT00421148|520319945|FG011|Overall Study|Protocol Violation|0|||
144304419|NCT00421148|520319946|FG012|Overall Study|Protocol Violation|0|||
144304420|NCT00421148|520319947|FG013|Overall Study|Protocol Violation|0|||
144304421|NCT00421148|520319948|FG014|Overall Study|Protocol Violation|0|||
144304422|NCT00421148|520319949|FG015|Overall Study|Protocol Violation|0|||
144304423|NCT00421148|520319950|FG016|Overall Study|Protocol Violation|0|||
144304424|NCT00421148|520319951|FG017|Overall Study|Protocol Violation|0|||
144304425|NCT00421148|520319952|FG018|Overall Study|Protocol Violation|1|||
144304426|NCT00421148|520319953|FG019|Overall Study|Protocol Violation|0|||
144304427|NCT02765399|520319957|FG000|Overall Study|Nausea|1|||
144304428|NCT02765399|520319958|FG001|Overall Study|Nausea|0|||
144304429|NCT00120627|520319963|FG000|Overall Study|Withdrawal by Subject|5|||
144304430|NCT00120627|520319964|FG001|Overall Study|Withdrawal by Subject|5|||
144304431|NCT01677988|520319967|FG000|Overall Study|Lack of Efficacy|2|||
144304432|NCT01822665|520319971|FG000|Overall Study|Adverse Event|3|||
144304433|NCT01822665|520319971|FG000|Overall Study|Other Reason|5|||
144304434|NCT04540367|520319972|FG000|Overall Study|Withdrawal by Subject|0|||
144304435|NCT04540367|520319973|FG001|Overall Study|Withdrawal by Subject|0|||
144304436|NCT04540367|520319974|FG002|Overall Study|Withdrawal by Subject|0|||
144304437|NCT04540367|520319975|FG003|Overall Study|Withdrawal by Subject|2|||
144304438|NCT04540367|520319972|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
144304439|NCT04540367|520319973|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
144304440|NCT04540367|520319974|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
144304441|NCT04540367|520319975|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
144304442|NCT04540367|520319972|FG000|Overall Study|Adverse Event|0|||
144304443|NCT04540367|520319973|FG001|Overall Study|Adverse Event|0|||
144304444|NCT04540367|520319974|FG002|Overall Study|Adverse Event|1|||
144304445|NCT04540367|520319975|FG003|Overall Study|Adverse Event|1|||
144304446|NCT00907621|520319979|FG000|Overall Study|Lost to Follow-up|6|||
144304447|NCT00907621|520319980|FG001|Overall Study|Lost to Follow-up|3|||
144304448|NCT00907621|520319979|FG000|Overall Study|intercurrent febrile illness|1|||
144304449|NCT00907621|520319980|FG001|Overall Study|intercurrent febrile illness|1|||
144304450|NCT03571971|520319983|FG000|Overall Study|Lost to Follow-up|2|||
144304451|NCT03571971|520319984|FG001|Overall Study|Lost to Follow-up|2|||
144304452|NCT03571971|520319983|FG000|Overall Study|Protocol Violation|2|||
144304453|NCT03571971|520319984|FG001|Overall Study|Protocol Violation|3|||
144304454|NCT03571971|520319983|FG000|Overall Study|Withdrawal by Subject|2|||
144304455|NCT03571971|520319984|FG001|Overall Study|Withdrawal by Subject|0|||
144304456|NCT03571971|520319983|FG000|Overall Study|Incomplete primary outcome data|2|||
144304457|NCT03571971|520319984|FG001|Overall Study|Incomplete primary outcome data|0|||
144304458|NCT04067492|520319985|FG000|Overall Study|Lost to Follow-up|0|||
144304459|NCT04067492|520319986|FG001|Overall Study|Lost to Follow-up|0|||
144304460|NCT04067492|520319987|FG002|Overall Study|Lost to Follow-up|0|||
144304461|NCT04067492|520319988|FG003|Overall Study|Lost to Follow-up|0|||
144304462|NCT04067492|520319989|FG004|Overall Study|Lost to Follow-up|0|||
144304463|NCT04067492|520319990|FG005|Overall Study|Lost to Follow-up|1|||
144304464|NCT04067492|520319985|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
144304465|NCT04067492|520319986|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
144304466|NCT04067492|520319987|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
144304467|NCT04067492|520319988|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
144304468|NCT04067492|520319989|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
144304469|NCT04067492|520319990|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
144304470|NCT04067492|520319985|FG000|Overall Study|COVID-19 epidemiological situation|0|||
144304471|NCT04067492|520319986|FG001|Overall Study|COVID-19 epidemiological situation|0|||
144304472|NCT04067492|520319987|FG002|Overall Study|COVID-19 epidemiological situation|0|||
144304473|NCT04067492|520319988|FG003|Overall Study|COVID-19 epidemiological situation|1|||
144304474|NCT04067492|520319989|FG004|Overall Study|COVID-19 epidemiological situation|0|||
144304475|NCT04067492|520319990|FG005|Overall Study|COVID-19 epidemiological situation|0|||
144304476|NCT03950856|520319991|FG000|Overall Study|Death|1|||
144304477|NCT03950856|520319992|FG001|Overall Study|Death|2|||
144304478|NCT03950856|520319993|FG002|Overall Study|Death|0|||
144304479|NCT03950856|520319994|FG003|Overall Study|Death|0|||
144304480|NCT03950856|520319991|FG000|Overall Study|Lost to Follow-up|5|||
144304481|NCT03950856|520319992|FG001|Overall Study|Lost to Follow-up|6|||
144304482|NCT03950856|520319993|FG002|Overall Study|Lost to Follow-up|8|||
144304483|NCT03950856|520319994|FG003|Overall Study|Lost to Follow-up|2|||
144304484|NCT03950856|520319991|FG000|Overall Study|Protocol Violation|2|||
144304485|NCT03950856|520319992|FG001|Overall Study|Protocol Violation|0|||
144304486|NCT03950856|520319993|FG002|Overall Study|Protocol Violation|0|||
144304487|NCT03950856|520319994|FG003|Overall Study|Protocol Violation|1|||
144304488|NCT03950856|520319991|FG000|Overall Study|Withdrawal by Subject|4|||
144304489|NCT03950856|520319992|FG001|Overall Study|Withdrawal by Subject|1|||
144304490|NCT03950856|520319993|FG002|Overall Study|Withdrawal by Subject|3|||
144304491|NCT03950856|520319994|FG003|Overall Study|Withdrawal by Subject|1|||
144304492|NCT03950856|520319991|FG000|Overall Study|Unable to phone|7|||
144304493|NCT03950856|520319992|FG001|Overall Study|Unable to phone|6|||
144304494|NCT03950856|520319993|FG002|Overall Study|Unable to phone|7|||
144304495|NCT03950856|520319994|FG003|Overall Study|Unable to phone|2|||
144304496|NCT03402841|520319995|FG000|Overall Study|Withdrawal by Subject|3|||
144304497|NCT03402841|520319995|FG000|Overall Study|Lost to Follow-up|2|||
144304498|NCT03402841|520319995|FG000|Overall Study|Death|146|||
144304499|NCT03984188|520319996|FG000|Overall Study|Death|2|||
144304500|NCT03984188|520319997|FG001|Overall Study|Death|4|||
144304501|NCT03984188|520319996|FG000|Overall Study|Physician Decision|0|||
144304502|NCT03984188|520319997|FG001|Overall Study|Physician Decision|2|||
144304503|NCT03984188|520319996|FG000|Overall Study|Lost to Follow-up|3|||
144304504|NCT03984188|520319997|FG001|Overall Study|Lost to Follow-up|2|||
144304505|NCT03984188|520319996|FG000|Overall Study|Withdrawal by Subject|6|||
144304506|NCT03984188|520319997|FG001|Overall Study|Withdrawal by Subject|0|||
144304507|NCT03384875|520319998|FG000|Overall Study|Death|1|||
144304508|NCT03384875|520319999|FG001|Overall Study|Death|1|||
144304509|NCT03384875|520320000|FG002|Overall Study|Death|0|||
144304510|NCT03384875|520319998|FG000|Overall Study|Reason not provided|1|||
144304511|NCT03384875|520319999|FG001|Overall Study|Reason not provided|0|||
144304512|NCT03384875|520320000|FG002|Overall Study|Reason not provided|0|||
144304513|NCT00272792|520321334|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
144304514|NCT00272792|520321335|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
144304515|NCT00272792|520321334|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
144304516|NCT00272792|520321335|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
144304517|NCT00272792|520321334|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
144304518|NCT00272792|520321335|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
144304519|NCT00272792|520321334|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
144304520|NCT00272792|520321335|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
144304521|NCT01047007|520321337|FG000|Overall Study|Adverse Event|0|||
144304522|NCT01047007|520321338|FG001|Overall Study|Adverse Event|2|||
144304523|NCT01047007|520321339|FG002|Overall Study|Adverse Event|1|||
144304524|NCT01047007|520321340|FG003|Overall Study|Adverse Event|0|||
144304525|NCT01047007|520321337|FG000|Overall Study|Progressive Disease|2|||
144304526|NCT01047007|520321338|FG001|Overall Study|Progressive Disease|4|||
144304527|NCT01047007|520321339|FG002|Overall Study|Progressive Disease|1|||
144304528|NCT01047007|520321340|FG003|Overall Study|Progressive Disease|0|||
144304529|NCT03759600|520321349|FG000|Overall Study|Adverse Event|2|||
144304530|NCT03759600|520321349|FG000|Overall Study|Progressive Disease|15|||
144304531|NCT03759600|520321349|FG000|Overall Study|Site Terminated by Sponsor|3|||
144304532|NCT02332187|520321350|FG000|Overall Study|Withdrawal by Subject|2|||
144304533|NCT02332187|520321351|FG001|Overall Study|Withdrawal by Subject|2|||
144304534|NCT02332187|520321350|FG000|Overall Study|Adverse Event|0|||
144304535|NCT02332187|520321351|FG001|Overall Study|Adverse Event|1|||
144304536|NCT04108273|520321352|FG000|Overall Study|COVID Pandemic|1|||
144304537|NCT04108273|520321353|FG001|Overall Study|COVID Pandemic|0|||
144304538|NCT00506142|520321354|FG000|Overall Study|Adverse Event|8|||
144304539|NCT00506142|520321355|FG001|Overall Study|Adverse Event|7|||
144304540|NCT00506142|520321354|FG000|Overall Study|Lack of Efficacy|21|||
144304541|NCT00506142|520321355|FG001|Overall Study|Lack of Efficacy|7|||
144304542|NCT00506142|520321354|FG000|Overall Study|Withdrawal by Subject|4|||
144304543|NCT00506142|520321355|FG001|Overall Study|Withdrawal by Subject|5|||
144304544|NCT00506142|520321354|FG000|Overall Study|Physician Decision|1|||
144304545|NCT00506142|520321355|FG001|Overall Study|Physician Decision|0|||
144304546|NCT00506142|520321354|FG000|Overall Study|New health condition|1|||
144304547|NCT00506142|520321355|FG001|Overall Study|New health condition|0|||
144304548|NCT03500211|520321360|FG000|Overall Study|Withdrawal by Subject|1|||
144304549|NCT03500211|520321361|FG001|Overall Study|Withdrawal by Subject|1|||
144304550|NCT04460183|520321362|FG000|Overall Study|Lost to Follow-up|3|||
144304551|NCT04460183|520321363|FG001|Overall Study|Lost to Follow-up|1|||
144304552|NCT04460183|520321362|FG000|Overall Study|Withdrawal by Subject|1|||
144304553|NCT04460183|520321363|FG001|Overall Study|Withdrawal by Subject|0|||
144304554|NCT00487981|520321364|FG000|Overall Study|Hypothyroidism diagnosis|1|||
144304555|NCT03848416|520321365|FG000|Overall Study|Withdrawal by Subject|1|||
144304556|NCT03848416|520321366|FG001|Overall Study|Withdrawal by Subject|0|||
144304557|NCT03848416|520321367|FG002|Overall Study|Withdrawal by Subject|0|||
144304558|NCT03848416|520321365|FG000|Overall Study|Death|0|||
144304559|NCT03848416|520321366|FG001|Overall Study|Death|0|||
144304560|NCT03848416|520321367|FG002|Overall Study|Death|1|||
144304561|NCT00856609|520321376|FG000|Overall Study|Adverse Event|1|||
144304562|NCT00856609|520321377|FG001|Overall Study|Adverse Event|0|||
144304563|NCT00783432|520321378|FG000|Overall Study|Adverse Event|22|||
144304564|NCT00783432|520321379|FG001|Overall Study|Adverse Event|17|||
144304565|NCT00783432|520321378|FG000|Overall Study|Lack of Efficacy|20|||
144304566|NCT00783432|520321379|FG001|Overall Study|Lack of Efficacy|21|||
144304567|NCT00783432|520321378|FG000|Overall Study|Lost to Follow-up|11|||
144304568|NCT00783432|520321379|FG001|Overall Study|Lost to Follow-up|6|||
144304569|NCT00783432|520321378|FG000|Overall Study|Withdrawal by Subject|23|||
144304570|NCT00783432|520321379|FG001|Overall Study|Withdrawal by Subject|20|||
144304571|NCT00783432|520321378|FG000|Overall Study|subject moved|3|||
144304572|NCT00783432|520321379|FG001|Overall Study|subject moved|5|||
144304573|NCT00783432|520321378|FG000|Overall Study|Protocol Violation|6|||
144304574|NCT00783432|520321379|FG001|Overall Study|Protocol Violation|9|||
144304575|NCT01436110|520321380|FG000|Overall Study|Lack of Efficacy|23|||
144304576|NCT01436110|520321381|FG001|Overall Study|Lack of Efficacy|14|||
144304577|NCT01436110|520321382|FG002|Overall Study|Lack of Efficacy|9|||
144304578|NCT01436110|520321380|FG000|Overall Study|Withdrawal by Subject|6|||
144304579|NCT01436110|520321381|FG001|Overall Study|Withdrawal by Subject|8|||
144304580|NCT01436110|520321382|FG002|Overall Study|Withdrawal by Subject|4|||
144304581|NCT01436110|520321380|FG000|Overall Study|Adverse Event|2|||
144304582|NCT01436110|520321381|FG001|Overall Study|Adverse Event|1|||
144304583|NCT01436110|520321382|FG002|Overall Study|Adverse Event|2|||
144304584|NCT01436110|520321380|FG000|Overall Study|Physician Decision|3|||
144304585|NCT01436110|520321381|FG001|Overall Study|Physician Decision|1|||
144304586|NCT01436110|520321382|FG002|Overall Study|Physician Decision|1|||
144304587|NCT01436110|520321380|FG000|Overall Study|Lost to Follow-up|1|||
144304588|NCT01436110|520321381|FG001|Overall Study|Lost to Follow-up|1|||
144304589|NCT01436110|520321382|FG002|Overall Study|Lost to Follow-up|3|||
144304590|NCT01436110|520321380|FG000|Overall Study|Protocol Violation|3|||
144304591|NCT01436110|520321381|FG001|Overall Study|Protocol Violation|1|||
144304592|NCT01436110|520321382|FG002|Overall Study|Protocol Violation|1|||
144304593|NCT01436110|520321380|FG000|Overall Study|Did Not Receive Trial Medication|1|||
144304594|NCT01436110|520321381|FG001|Overall Study|Did Not Receive Trial Medication|0|||
144304595|NCT01436110|520321382|FG002|Overall Study|Did Not Receive Trial Medication|3|||
144304596|NCT01088503|520321383|FG000|Overall Study|Withdrawal by Subject|118|||
144304597|NCT01088503|520321384|FG001|Overall Study|Withdrawal by Subject|327|||
144304598|NCT01088503|520321385|FG002|Overall Study|Withdrawal by Subject|10|||
144304599|NCT01088503|520321383|FG000|Overall Study|Death|64|||
144304600|NCT01088503|520321384|FG001|Overall Study|Death|358|||
144304601|NCT01088503|520321385|FG002|Overall Study|Death|7|||
144304602|NCT01847092|520321386|FG000|Overall Study|Adverse Event|12|||
144304603|NCT01847092|520321387|FG001|Overall Study|Adverse Event|3|||
144304604|NCT01847092|520321386|FG000|Overall Study|Withdrawal by Subject|5|||
144304605|NCT01847092|520321387|FG001|Overall Study|Withdrawal by Subject|5|||
144304606|NCT01847092|520321386|FG000|Overall Study|Protocol Specified|8|||
144304607|NCT01847092|520321387|FG001|Overall Study|Protocol Specified|0|||
144304608|NCT01847092|520321386|FG000|Overall Study|Physician Decision|1|||
144304609|NCT01847092|520321387|FG001|Overall Study|Physician Decision|1|||
144304610|NCT01847092|520321386|FG000|Overall Study|Protocol Violation|0|||
144304611|NCT01847092|520321387|FG001|Overall Study|Protocol Violation|2|||
144304612|NCT03604497|520321388|FG000|Overall Study|Protocol Violation|52|||
144304613|NCT00186628|520321389|FG000|Overall Study|Death|2|||
144304614|NCT00186628|520321389|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
144304615|NCT01331681|520321390|FG000|Overall Study|Adverse Event|10|||
144304616|NCT01331681|520321391|FG001|Overall Study|Adverse Event|13|||
144304617|NCT01331681|520321392|FG002|Overall Study|Adverse Event|10|||
144304618|NCT01331681|520321390|FG000|Overall Study|Death|6|||
144304619|NCT01331681|520321391|FG001|Overall Study|Death|6|||
144304620|NCT01331681|520321392|FG002|Overall Study|Death|2|||
144304621|NCT01331681|520321390|FG000|Overall Study|Lack of Efficacy|0|||
144304622|NCT01331681|520321391|FG001|Overall Study|Lack of Efficacy|1|||
144304623|NCT01331681|520321392|FG002|Overall Study|Lack of Efficacy|0|||
144304624|NCT01331681|520321390|FG000|Overall Study|Withdrawal by Subject|12|||
144304625|NCT01331681|520321391|FG001|Overall Study|Withdrawal by Subject|8|||
144304626|NCT01331681|520321392|FG002|Overall Study|Withdrawal by Subject|15|||
144304627|NCT01331681|520321390|FG000|Overall Study|Protocol Violation|1|||
144304628|NCT01331681|520321391|FG001|Overall Study|Protocol Violation|1|||
144304629|NCT01331681|520321392|FG002|Overall Study|Protocol Violation|0|||
144304630|NCT01331681|520321390|FG000|Overall Study|Lost to Follow-up|2|||
144304631|NCT01331681|520321391|FG001|Overall Study|Lost to Follow-up|4|||
144304632|NCT01331681|520321392|FG002|Overall Study|Lost to Follow-up|1|||
144304633|NCT01331681|520321390|FG000|Overall Study|Physician Decision|2|||
144304634|NCT01331681|520321391|FG001|Overall Study|Physician Decision|0|||
144304635|NCT01331681|520321392|FG002|Overall Study|Physician Decision|4|||
144304636|NCT01331681|520321390|FG000|Overall Study|Therapeutic procedure required|1|||
144304637|NCT01331681|520321391|FG001|Overall Study|Therapeutic procedure required|0|||
144304638|NCT01331681|520321392|FG002|Overall Study|Therapeutic procedure required|0|||
144304639|NCT01331681|520321390|FG000|Overall Study|Sponsor decision|1|||
144304640|NCT01331681|520321391|FG001|Overall Study|Sponsor decision|1|||
144304641|NCT01331681|520321392|FG002|Overall Study|Sponsor decision|0|||
144304642|NCT01331681|520321390|FG000|Overall Study|Switching to other therapy|0|||
144304643|NCT01331681|520321391|FG001|Overall Study|Switching to other therapy|0|||
144304644|NCT01331681|520321392|FG002|Overall Study|Switching to other therapy|1|||
144304645|NCT01331681|520321390|FG000|Overall Study|Not Received Study Treatment|0|||
144304646|NCT01331681|520321391|FG001|Overall Study|Not Received Study Treatment|0|||
144304647|NCT01331681|520321392|FG002|Overall Study|Not Received Study Treatment|2|||
144304648|NCT00658541|520321397|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
144304649|NCT00658541|520321398|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144304650|NCT00658541|520321397|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
144304651|NCT00658541|520321398|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
144304652|NCT00269087|520321399|FG000|Overall Study|Adverse Event|20|||
144304653|NCT00269087|520321399|FG000|Overall Study|Withdrawal by Subject|1|||
144304654|NCT00269087|520321399|FG000|Overall Study|Exacerbation of COPD|13|||
144304655|NCT00940602|520321405|FG000|Overall Study|Administrative problems|1|||
144304656|NCT00940602|520321406|FG001|Overall Study|Administrative problems|1|||
144304657|NCT00940602|520321405|FG000|Overall Study|Patient/guardian decision|13|||
144304658|NCT00940602|520321406|FG001|Overall Study|Patient/guardian decision|28|||
144304659|NCT00940602|520321405|FG000|Overall Study|Physician Decision|8|||
144304660|NCT00940602|520321406|FG001|Overall Study|Physician Decision|5|||
144304661|NCT00940602|520321405|FG000|Overall Study|Pregnancy|1|||
144304662|NCT00940602|520321406|FG001|Overall Study|Pregnancy|0|||
144304663|NCT00940602|520321405|FG000|Overall Study|Protocol Deviation (untreated)|1|||
144304664|NCT00940602|520321406|FG001|Overall Study|Protocol Deviation (untreated)|0|||
144304665|NCT00940602|520321405|FG000|Overall Study|Disease progression|8|||
144304666|NCT00940602|520321406|FG001|Overall Study|Disease progression|2|||
144304667|NCT00940602|520321405|FG000|Overall Study|Death|38|||
144304668|NCT00940602|520321406|FG001|Overall Study|Death|19|||
144304669|NCT00940602|520321405|FG000|Overall Study|Lost to Follow-up|3|||
144304670|NCT00940602|520321406|FG001|Overall Study|Lost to Follow-up|1|||
144304671|NCT00940602|520321405|FG000|Overall Study|Patient withdrew consent|26|||
144304672|NCT00940602|520321406|FG001|Overall Study|Patient withdrew consent|13|||
144304673|NCT00940602|520321405|FG000|Overall Study|Adverse Event|7|||
144304674|NCT00940602|520321406|FG001|Overall Study|Adverse Event|2|||
144304675|NCT00940602|520321405|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
144304676|NCT00940602|520321406|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
144304677|NCT01463033|520321407|FG000|Overall Study|Lost to Follow-up|4|||
144304678|NCT01463033|520321408|FG001|Overall Study|Lost to Follow-up|4|||
144304679|NCT01463033|520321407|FG000|Overall Study|Death|3|||
144304680|NCT01463033|520321408|FG001|Overall Study|Death|2|||
144304681|NCT02230189|520321409|FG000|Overall Study|Withdrawal by Subject|3|||
144304682|NCT02230189|520321410|FG001|Overall Study|Withdrawal by Subject|0|||
144304683|NCT02230189|520321411|FG002|Overall Study|Withdrawal by Subject|1|||
144304684|NCT02230189|520321409|FG000|Overall Study|Lost to Follow-up|1|||
144304685|NCT02230189|520321410|FG001|Overall Study|Lost to Follow-up|0|||
144304686|NCT02230189|520321411|FG002|Overall Study|Lost to Follow-up|0|||
144304687|NCT02230189|520321409|FG000|Overall Study|Physician Decision|1|||
144304688|NCT02230189|520321410|FG001|Overall Study|Physician Decision|0|||
144304689|NCT02230189|520321411|FG002|Overall Study|Physician Decision|0|||
144304690|NCT01077063|520321415|FG000|Overall Study|Adverse Event|3|||
144304691|NCT01077063|520321416|FG001|Overall Study|Adverse Event|0|||
144304692|NCT01077063|520321415|FG000|Overall Study|Death|1|||
144304693|NCT01077063|520321416|FG001|Overall Study|Death|1|||
144304694|NCT01077063|520321415|FG000|Overall Study|Withdrawal by Subject|0|||
144304695|NCT01077063|520321416|FG001|Overall Study|Withdrawal by Subject|2|||
144304696|NCT02750930|520321417|FG000|Overall Study|Study closed/terminated|8|||
144304697|NCT02756403|520321418|FG000|Overall Study|Unable to swallow medication|0|||
144304698|NCT02756403|520321419|FG001|Overall Study|Unable to swallow medication|1|||
144304699|NCT02756403|520321420|FG002|Overall Study|Unable to swallow medication|1|||
144304700|NCT02756403|520321421|FG003|Overall Study|Unable to swallow medication|1|||
144304701|NCT02756403|520321418|FG000|Overall Study|Did not complete Procedure|0|||
144304702|NCT02756403|520321419|FG001|Overall Study|Did not complete Procedure|1|||
144304703|NCT02756403|520321420|FG002|Overall Study|Did not complete Procedure|0|||
144304704|NCT02756403|520321421|FG003|Overall Study|Did not complete Procedure|0|||
144304705|NCT02756403|520321418|FG000|Overall Study|Changed Mind About Procedure|0|||
144304706|NCT02756403|520321419|FG001|Overall Study|Changed Mind About Procedure|0|||
144304707|NCT02756403|520321420|FG002|Overall Study|Changed Mind About Procedure|1|||
144304708|NCT02756403|520321421|FG003|Overall Study|Changed Mind About Procedure|0|||
144304709|NCT02756403|520321418|FG000|Overall Study|Protocol Violation|0|||
144304710|NCT02756403|520321419|FG001|Overall Study|Protocol Violation|1|||
144304711|NCT02756403|520321420|FG002|Overall Study|Protocol Violation|0|||
144304712|NCT02756403|520321421|FG003|Overall Study|Protocol Violation|1|||
144304713|NCT00527618|520321422|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
144304714|NCT00527618|520321423|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
144304715|NCT00527618|520321422|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
144304716|NCT00527618|520321423|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
144304717|NCT00527618|520321422|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
144304718|NCT00527618|520321423|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
144304719|NCT00527618|520321422|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
144304720|NCT00527618|520321423|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
144304721|NCT00527618|520321422|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
144304722|NCT00527618|520321423|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
144304723|NCT00527618|520321422|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
144304724|NCT00527618|520321423|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
144304725|NCT00776789|520321424|FG000|Overall Study|Consent refusal|2|||
144304726|NCT00776789|520321425|FG001|Overall Study|Consent refusal|2|||
144304727|NCT00776789|520321424|FG000|Overall Study|Poor quality video|1|||
144304728|NCT00776789|520321425|FG001|Overall Study|Poor quality video|1|||
144304729|NCT00648037|520321426|FG000|Overall Study|Not Treated|1|||
144304730|NCT00648037|520321426|FG000|Overall Study|Withdrawal by Subject|1|||
144304731|NCT00648037|520321426|FG000|Overall Study|Adverse Event|11|||
144304732|NCT00648037|520321426|FG000|Overall Study|Relapse|2|||
144304733|NCT00648037|520321426|FG000|Overall Study|Other|1|||
144304734|NCT01253369|520321428|FG000|Overall Study|Adverse Event|4|||
144304735|NCT01253369|520321428|FG000|Overall Study|Withdrawal by Subject|2|||
144304736|NCT01253369|520321428|FG000|Overall Study|Death|1|||
144304737|NCT01253369|520321428|FG000|Overall Study|Progressive disease|23|||
144304738|NCT01253369|520321428|FG000|Overall Study|Not Evaluable|3|||
144304739|NCT01055613|520321430|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
144304740|NCT01055613|520321431|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144304741|NCT01055613|520321430|FG000|Overall Study|Unacceptable lens fit|1|||
144304742|NCT01055613|520321431|FG001|Overall Study|Unacceptable lens fit|0|||
144304743|NCT01055613|520321430|FG000|Overall Study|Discomfort|2|||
144304744|NCT01055613|520321431|FG001|Overall Study|Discomfort|1|||
144304745|NCT01055613|520321430|FG000|Overall Study|Lost to Follow-up|1|||
144304746|NCT01055613|520321431|FG001|Overall Study|Lost to Follow-up|1|||
144304747|NCT01055613|520321430|FG000|Overall Study|Protocol Violation|1|||
144304748|NCT01055613|520321431|FG001|Overall Study|Protocol Violation|1|||
144304749|NCT01055613|520321430|FG000|Overall Study|Subject Disinterest|1|||
144304750|NCT01055613|520321431|FG001|Overall Study|Subject Disinterest|1|||
144304751|NCT02103062|520321434|FG000|Overall Study|Adverse Event|1|||
144304752|NCT02103062|520321435|FG001|Overall Study|Adverse Event|2|||
144304753|NCT02103062|520321434|FG000|Overall Study|Progressive Disease|17|||
144304754|NCT02103062|520321435|FG001|Overall Study|Progressive Disease|20|||
144304755|NCT02103062|520321434|FG000|Overall Study|Death|0|||
144304756|NCT02103062|520321435|FG001|Overall Study|Death|1|||
144304757|NCT04016714|520321436|FG000|Overall Study|Death|1|||
144304758|NCT04016714|520321437|FG001|Overall Study|Death|0|||
144304759|NCT04016714|520321436|FG000|Overall Study|Lost to Follow-up|3|||
144304760|NCT04016714|520321437|FG001|Overall Study|Lost to Follow-up|1|||
144304761|NCT04016714|520321436|FG000|Overall Study|Physician Decision|3|||
144304762|NCT04016714|520321437|FG001|Overall Study|Physician Decision|3|||
144304763|NCT04016714|520321436|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
144304764|NCT04016714|520321437|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
144304765|NCT00959907|520321439|FG000|Overall Study|Protocol Violation|0|||
144304766|NCT00959907|520321440|FG001|Overall Study|Protocol Violation|1|||
144304767|NCT00959907|520321439|FG000|Overall Study|Adverse Event|1|||
144304768|NCT00959907|520321440|FG001|Overall Study|Adverse Event|0|||
144304769|NCT00959907|520321439|FG000|Overall Study|Withdrawal by Subject|2|||
144304770|NCT00959907|520321440|FG001|Overall Study|Withdrawal by Subject|0|||
144304771|NCT03958331|520321441|FG000|Overall Study|Withdrawal by Subject|3|||
144304772|NCT03958331|520321442|FG001|Overall Study|Withdrawal by Subject|1|||
144304773|NCT03958331|520321443|FG002|Overall Study|Withdrawal by Subject|5|||
144304774|NCT03958331|520321441|FG000|Overall Study|Weaned from medicine|2|||
144304775|NCT03958331|520321442|FG001|Overall Study|Weaned from medicine|0|||
144304776|NCT03958331|520321443|FG002|Overall Study|Weaned from medicine|0|||
144304777|NCT03958331|520321441|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
144304778|NCT03958331|520321442|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
144304779|NCT03958331|520321443|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
144304780|NCT04290624|520321448|FG000|Overall Study|Adverse Event|1|||
144304781|NCT04290624|520321449|FG001|Overall Study|Adverse Event|0|||
144304782|NCT01847443|520321450|FG000|Study Period 1|Withdrawal by Subject|0|||
144304783|NCT01847443|520321451|FG001|Study Period 1|Withdrawal by Subject|1|||
144304784|NCT01847443|520321452|FG002|Study Period 1|Withdrawal by Subject|0|||
144304785|NCT01847443|520321453|FG003|Study Period 1|Withdrawal by Subject|0|||
144304786|NCT01847443|520321450|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
144304787|NCT01847443|520321451|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
144304788|NCT01847443|520321452|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
144304789|NCT01847443|520321453|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
144304790|NCT01847443|520321450|FG000|Washout Period Before Study Period 2|Other reason|1|||
144304791|NCT01847443|520321451|FG001|Washout Period Before Study Period 2|Other reason|0|||
144304792|NCT01847443|520321452|FG002|Washout Period Before Study Period 2|Other reason|0|||
144304793|NCT01847443|520321453|FG003|Washout Period Before Study Period 2|Other reason|0|||
144304794|NCT01847443|520321450|FG000|Washout Period Before Study Period 3|Other reason|1|||
144304795|NCT01847443|520321451|FG001|Washout Period Before Study Period 3|Other reason|0|||
144304796|NCT01847443|520321452|FG002|Washout Period Before Study Period 3|Other reason|0|||
144304797|NCT01847443|520321453|FG003|Washout Period Before Study Period 3|Other reason|0|||
144304798|NCT01847443|520321450|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
144304799|NCT01847443|520321451|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
144304800|NCT01847443|520321452|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
144304801|NCT01847443|520321453|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
144304802|NCT01847443|520321450|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
144304803|NCT01847443|520321451|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
144304804|NCT01847443|520321452|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
144304805|NCT01847443|520321453|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
144304806|NCT00656370|520321462|FG000|Overall Study|Screen Failures|7|||
144304807|NCT00656370|520321462|FG000|Overall Study|Alternates|3|||
144304808|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
144304809|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
144304810|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
144304811|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
144304812|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
144304813|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
144304814|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
144304815|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
144304816|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
144304817|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
144304818|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
144304819|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
144304820|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
144304821|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
144304822|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
144304823|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
144304824|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
144304825|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
144304826|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
144304827|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
144304828|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
144304829|NCT04021290|520321467|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
144304830|NCT04021290|520321468|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
144304831|NCT04021290|520321469|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
144304832|NCT04021290|520321467|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
144304833|NCT04021290|520321468|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
144304834|NCT04021290|520321469|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
144304835|NCT04021290|520321467|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
144304836|NCT04021290|520321468|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
144304837|NCT04021290|520321469|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
144304838|NCT04021290|520321467|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
144304839|NCT04021290|520321468|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
144304840|NCT04021290|520321469|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
144304841|NCT04021290|520321467|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
144304842|NCT04021290|520321468|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
144304843|NCT04021290|520321469|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
144304844|NCT03391882|520321470|FG000|Study Overall|Adverse Event|3|||
144304845|NCT03391882|520321471|FG001|Study Overall|Adverse Event|6|||
144304846|NCT03391882|520321472|FG002|Study Overall|Adverse Event|1|||
144304847|NCT03391882|520321473|FG003|Study Overall|Adverse Event|1|||
144304848|NCT03391882|520321474|FG004|Study Overall|Adverse Event|3|||
144304849|NCT03391882|520321475|FG005|Study Overall|Adverse Event|1|||
144304850|NCT03391882|520321470|FG000|Study Overall|Lack of Efficacy|13|||
144304851|NCT03391882|520321471|FG001|Study Overall|Lack of Efficacy|9|||
144304852|NCT03391882|520321472|FG002|Study Overall|Lack of Efficacy|0|||
144304853|NCT03391882|520321473|FG003|Study Overall|Lack of Efficacy|0|||
144304854|NCT03391882|520321474|FG004|Study Overall|Lack of Efficacy|0|||
144304855|NCT03391882|520321475|FG005|Study Overall|Lack of Efficacy|0|||
144304856|NCT03391882|520321470|FG000|Study Overall|Withdrawal by Subject|3|||
144304857|NCT03391882|520321471|FG001|Study Overall|Withdrawal by Subject|3|||
144304858|NCT03391882|520321472|FG002|Study Overall|Withdrawal by Subject|2|||
144304859|NCT03391882|520321473|FG003|Study Overall|Withdrawal by Subject|2|||
144304860|NCT03391882|520321474|FG004|Study Overall|Withdrawal by Subject|1|||
144304861|NCT03391882|520321475|FG005|Study Overall|Withdrawal by Subject|3|||
144304862|NCT03391882|520321470|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
144304863|NCT03391882|520321471|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
144304864|NCT03391882|520321472|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
144304865|NCT03391882|520321473|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
144304866|NCT03391882|520321474|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
144304867|NCT03391882|520321475|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
144304868|NCT03391882|520321470|FG000|Study Overall|Protocol Violation|1|||
144304869|NCT03391882|520321471|FG001|Study Overall|Protocol Violation|0|||
144304870|NCT03391882|520321472|FG002|Study Overall|Protocol Violation|0|||
144304871|NCT03391882|520321473|FG003|Study Overall|Protocol Violation|0|||
144304872|NCT03391882|520321474|FG004|Study Overall|Protocol Violation|0|||
144304873|NCT03391882|520321475|FG005|Study Overall|Protocol Violation|0|||
144304874|NCT03391882|520321470|FG000|Part A - Titration Phase|Adverse Event|3|||
144304875|NCT03391882|520321471|FG001|Part A - Titration Phase|Adverse Event|6|||
144304876|NCT03391882|520321472|FG002|Part A - Titration Phase|Adverse Event|0|||
144304877|NCT03391882|520321473|FG003|Part A - Titration Phase|Adverse Event|0|||
144304878|NCT03391882|520321474|FG004|Part A - Titration Phase|Adverse Event|0|||
144304879|NCT03391882|520321475|FG005|Part A - Titration Phase|Adverse Event|0|||
144304880|NCT03391882|520321470|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
144304881|NCT03391882|520321471|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
144304882|NCT03391882|520321472|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
144304883|NCT03391882|520321473|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
144304884|NCT03391882|520321474|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
144304885|NCT03391882|520321475|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
144304886|NCT03391882|520321470|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
144304887|NCT03391882|520321471|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
144304888|NCT03391882|520321472|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
144304889|NCT03391882|520321473|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
144304890|NCT03391882|520321474|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
144304891|NCT03391882|520321475|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
144304892|NCT03391882|520321470|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
144304893|NCT03391882|520321471|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
144304894|NCT03391882|520321472|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
144304895|NCT03391882|520321473|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
144304896|NCT03391882|520321474|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
144304897|NCT03391882|520321475|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
144304898|NCT03391882|520321470|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
144304899|NCT03391882|520321471|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
144304900|NCT03391882|520321472|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
144304901|NCT03391882|520321473|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
144304902|NCT03391882|520321474|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
144304903|NCT03391882|520321475|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
144304904|NCT03391882|520321470|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
144304905|NCT03391882|520321471|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
144304906|NCT03391882|520321472|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
144304907|NCT03391882|520321473|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
144304908|NCT03391882|520321474|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
144304909|NCT03391882|520321475|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
144304910|NCT03391882|520321470|FG000|Part B - Treatment Phase|Adverse Event|0|||
144304911|NCT03391882|520321471|FG001|Part B - Treatment Phase|Adverse Event|0|||
144304912|NCT03391882|520321472|FG002|Part B - Treatment Phase|Adverse Event|1|||
144304913|NCT03391882|520321473|FG003|Part B - Treatment Phase|Adverse Event|1|||
144304914|NCT03391882|520321474|FG004|Part B - Treatment Phase|Adverse Event|3|||
144304915|NCT03391882|520321475|FG005|Part B - Treatment Phase|Adverse Event|1|||
144304916|NCT03391882|520321470|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
144304917|NCT03391882|520321471|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
144304918|NCT03391882|520321472|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
144304919|NCT03391882|520321473|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
144304920|NCT03391882|520321474|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
144304921|NCT03391882|520321475|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
144304922|NCT00543985|520321476|FG000|Overall Study|Withdrawal by Subject|4|||
144304923|NCT01280968|520321477|FG000|Overall Study|Lost to Follow-up|8|||
144304924|NCT01280968|520321478|FG001|Overall Study|Lost to Follow-up|2|||
144304925|NCT01280968|520321477|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
144304926|NCT01280968|520321478|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
144304927|NCT01280968|520321477|FG000|Overall Study|Commuting Problems|2|||
144304928|NCT01280968|520321478|FG001|Overall Study|Commuting Problems|0|||
144304929|NCT01280968|520321477|FG000|Overall Study|Anxiety|2|||
144304930|NCT01280968|520321478|FG001|Overall Study|Anxiety|0|||
144304931|NCT01280968|520321477|FG000|Overall Study|Adverse Event|1|||
144304932|NCT01280968|520321478|FG001|Overall Study|Adverse Event|0|||
144304933|NCT01280968|520321477|FG000|Overall Study|Scheduling Conflicts|1|||
144304934|NCT01280968|520321478|FG001|Overall Study|Scheduling Conflicts|1|||
144304935|NCT01280968|520321477|FG000|Overall Study|Pre-existing Neurological Condition|1|||
144304936|NCT01280968|520321478|FG001|Overall Study|Pre-existing Neurological Condition|0|||
144304937|NCT01280968|520321477|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
144304938|NCT01280968|520321478|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
144304939|NCT00038948|520321479|FG000|Overall Study|Adverse Event|131|||
144304940|NCT00038948|520321480|FG001|Overall Study|Adverse Event|43|||
144304941|NCT00038948|520321479|FG000|Overall Study|Lost to Follow-up|4|||
144304942|NCT00038948|520321480|FG001|Overall Study|Lost to Follow-up|4|||
144304943|NCT00038948|520321479|FG000|Overall Study|Nonmedical event|5|||
144304944|NCT00038948|520321480|FG001|Overall Study|Nonmedical event|7|||
144304945|NCT00038948|520321479|FG000|Overall Study|Withdrawal by Subject|23|||
144304946|NCT00038948|520321480|FG001|Overall Study|Withdrawal by Subject|10|||
144304947|NCT00038948|520321479|FG000|Overall Study|Protocol Violation|3|||
144304948|NCT00038948|520321480|FG001|Overall Study|Protocol Violation|7|||
144304949|NCT00038948|520321479|FG000|Overall Study|Lack of Efficacy|3|||
144304950|NCT00038948|520321480|FG001|Overall Study|Lack of Efficacy|6|||
144304951|NCT01404234|520321481|FG000|Overall Study|Withdrawal by Subject|2|||
144304952|NCT02670473|520321482|FG000|Overall Study|Withdrawal by Subject|1|||
144304953|NCT01214837|520321483|FG000|Overall Study|Death|0|||
144304954|NCT01214837|520321484|FG001|Overall Study|Death|0|||
144304955|NCT01214837|520321485|FG002|Overall Study|Death|1|||
144304956|NCT01214837|520321483|FG000|Overall Study|Adverse Event|1|||
144304957|NCT01214837|520321484|FG001|Overall Study|Adverse Event|2|||
144304958|NCT01214837|520321485|FG002|Overall Study|Adverse Event|1|||
144304959|NCT01214837|520321483|FG000|Overall Study|Withdrawal by Subject|27|||
144304960|NCT01214837|520321484|FG001|Overall Study|Withdrawal by Subject|36|||
144304961|NCT01214837|520321485|FG002|Overall Study|Withdrawal by Subject|28|||
144304962|NCT01214837|520321483|FG000|Overall Study|Lost to Follow-up|20|||
144304963|NCT01214837|520321484|FG001|Overall Study|Lost to Follow-up|15|||
144304964|NCT01214837|520321485|FG002|Overall Study|Lost to Follow-up|21|||
144304965|NCT01214837|520321483|FG000|Overall Study|Inappropriate Enrolment|0|||
144304966|NCT01214837|520321484|FG001|Overall Study|Inappropriate Enrolment|1|||
144304967|NCT01214837|520321485|FG002|Overall Study|Inappropriate Enrolment|2|||
144304968|NCT01214837|520321483|FG000|Overall Study|Administrative Reason|2|||
144304969|NCT01214837|520321484|FG001|Overall Study|Administrative Reason|6|||
144304970|NCT01214837|520321485|FG002|Overall Study|Administrative Reason|4|||
144304971|NCT01214837|520321483|FG000|Overall Study|Protocol Violation|3|||
144304972|NCT01214837|520321484|FG001|Overall Study|Protocol Violation|1|||
144304973|NCT01214837|520321485|FG002|Overall Study|Protocol Violation|5|||
144304974|NCT01214837|520321483|FG000|Overall Study|Unable to Classify|1|||
144304975|NCT01214837|520321484|FG001|Overall Study|Unable to Classify|3|||
144304976|NCT01214837|520321485|FG002|Overall Study|Unable to Classify|0|||
144304977|NCT01088906|520321486|FG000|Overall Study|Inclusion error|1|||
144304978|NCT01088906|520321486|FG000|Overall Study|Did not receive study treatment|3|||
144304979|NCT01088906|520321486|FG000|Overall Study|Missing data|1|||
144304980|NCT02391311|520323123|FG000|Overall Study|Lost to Follow-up|2|||
144304981|NCT02391311|520323124|FG001|Overall Study|Lost to Follow-up|1|||
144304982|NCT02391311|520323123|FG000|Overall Study|deemed ineligible after baseline|1|||
144304983|NCT02391311|520323124|FG001|Overall Study|deemed ineligible after baseline|1|||
144304984|NCT03183063|520323127|FG000|Overall Study|Withdrawal by Subject|2|||
144304985|NCT03183063|520323128|FG001|Overall Study|Withdrawal by Subject|0|||
144304986|NCT03183063|520323129|FG002|Overall Study|Withdrawal by Subject|0|||
144304987|NCT03183063|520323127|FG000|Overall Study|Physician Decision|3|||
144304988|NCT03183063|520323128|FG001|Overall Study|Physician Decision|4|||
144304989|NCT03183063|520323129|FG002|Overall Study|Physician Decision|4|||
144304990|NCT00688467|520323130|FG000|Treatment Period 1|Adverse Event|2|||
144304991|NCT00688467|520323131|FG001|Treatment Period 1|Adverse Event|1|||
144304992|NCT00688467|520323130|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
144304993|NCT00688467|520323131|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
144304994|NCT00688467|520323130|FG000|Treatment Period 2|Protocol Violation|0|||
144304995|NCT00688467|520323131|FG001|Treatment Period 2|Protocol Violation|1|||
144304996|NCT00688467|520323130|FG000|Treatment Period 2|Adverse Event|0|||
144304997|NCT00688467|520323131|FG001|Treatment Period 2|Adverse Event|1|||
144304998|NCT00925002|520323132|FG000|Overall Study|Other|1|||
144304999|NCT00925002|520323133|FG001|Overall Study|Other|4|||
144305000|NCT00925002|520323134|FG002|Overall Study|Other|0|||
144305001|NCT00925002|520323132|FG000|Overall Study|Death|1|||
144305002|NCT00925002|520323133|FG001|Overall Study|Death|1|||
144305003|NCT00925002|520323134|FG002|Overall Study|Death|5|||
144305004|NCT00925002|520323132|FG000|Overall Study|Adverse Event|3|||
144305005|NCT00925002|520323133|FG001|Overall Study|Adverse Event|1|||
144305006|NCT00925002|520323134|FG002|Overall Study|Adverse Event|2|||
144305007|NCT00925002|520323132|FG000|Overall Study|Participant withdrew consent|1|||
144305008|NCT00925002|520323133|FG001|Overall Study|Participant withdrew consent|3|||
144305009|NCT00925002|520323134|FG002|Overall Study|Participant withdrew consent|3|||
144305010|NCT00002766|520323139|FG000|Overall Study|Withdrawal by Subject|0|||
144305011|NCT00002766|520323140|FG001|Overall Study|Withdrawal by Subject|1|||
144305012|NCT00002766|520323139|FG000|Overall Study|Patient Not Treated|1|||
144305013|NCT00002766|520323140|FG001|Overall Study|Patient Not Treated|2|||
144305014|NCT00002766|520323139|FG000|Overall Study|Adverse Event|1|||
144305015|NCT00002766|520323140|FG001|Overall Study|Adverse Event|1|||
144305016|NCT00002766|520323139|FG000|Overall Study|Protocol Violation|1|||
144305017|NCT00002766|520323140|FG001|Overall Study|Protocol Violation|0|||
144305018|NCT00328172|520323143|FG000|Overall Study|Adverse Event|3|||
144305019|NCT00328172|520323144|FG001|Overall Study|Adverse Event|2|||
144305020|NCT00328172|520323145|FG002|Overall Study|Adverse Event|1|||
144305021|NCT00328172|520323146|FG003|Overall Study|Adverse Event|2|||
144305022|NCT00328172|520323147|FG004|Overall Study|Adverse Event|1|||
144305023|NCT00328172|520323143|FG000|Overall Study|Protocol Violation|0|||
144305024|NCT00328172|520323144|FG001|Overall Study|Protocol Violation|1|||
144305025|NCT00328172|520323145|FG002|Overall Study|Protocol Violation|1|||
144305026|NCT00328172|520323146|FG003|Overall Study|Protocol Violation|0|||
144305027|NCT00328172|520323147|FG004|Overall Study|Protocol Violation|0|||
144305028|NCT00328172|520323143|FG000|Overall Study|Lost to Follow-up|1|||
144305029|NCT00328172|520323144|FG001|Overall Study|Lost to Follow-up|1|||
144305030|NCT00328172|520323145|FG002|Overall Study|Lost to Follow-up|2|||
144305031|NCT00328172|520323146|FG003|Overall Study|Lost to Follow-up|1|||
144305032|NCT00328172|520323147|FG004|Overall Study|Lost to Follow-up|1|||
144305033|NCT00328172|520323143|FG000|Overall Study|Withdrawal by Subject|1|||
144305034|NCT00328172|520323144|FG001|Overall Study|Withdrawal by Subject|1|||
144305035|NCT00328172|520323145|FG002|Overall Study|Withdrawal by Subject|1|||
144305036|NCT00328172|520323146|FG003|Overall Study|Withdrawal by Subject|6|||
144305037|NCT00328172|520323147|FG004|Overall Study|Withdrawal by Subject|0|||
144305038|NCT00328172|520323143|FG000|Overall Study|Lack of Efficacy|14|||
144305039|NCT00328172|520323144|FG001|Overall Study|Lack of Efficacy|9|||
144305040|NCT00328172|520323145|FG002|Overall Study|Lack of Efficacy|4|||
144305041|NCT00328172|520323146|FG003|Overall Study|Lack of Efficacy|4|||
144305042|NCT00328172|520323147|FG004|Overall Study|Lack of Efficacy|3|||
144305043|NCT00328172|520323143|FG000|Overall Study|Other reason (not specified)|3|||
144305044|NCT00328172|520323144|FG001|Overall Study|Other reason (not specified)|0|||
144305045|NCT00328172|520323145|FG002|Overall Study|Other reason (not specified)|1|||
144305046|NCT00328172|520323146|FG003|Overall Study|Other reason (not specified)|0|||
144305047|NCT00328172|520323147|FG004|Overall Study|Other reason (not specified)|0|||
144305048|NCT00558636|520323148|FG000|Treatment|Adverse Event|9|||
144305049|NCT00558636|520323149|FG001|Treatment|Adverse Event|2|||
144305050|NCT00558636|520323148|FG000|Treatment|Withdrawal by Subject|2|||
144305051|NCT00558636|520323149|FG001|Treatment|Withdrawal by Subject|0|||
144305052|NCT00558636|520323148|FG000|Treatment|Premature termination of the study|35|||
144305053|NCT00558636|520323149|FG001|Treatment|Premature termination of the study|37|||
144305054|NCT00558636|520323148|FG000|Treatment|Disease progression|1|||
144305055|NCT00558636|520323149|FG001|Treatment|Disease progression|5|||
144305056|NCT00558636|520323148|FG000|Follow-up|Premature termination of the study|12|||
144305057|NCT00558636|520323149|FG001|Follow-up|Premature termination of the study|7|||
144305058|NCT01990742|520323150|FG000|Overall Study|Withdrawal by facility|407|||
144305059|NCT01990742|520323151|FG001|Overall Study|Withdrawal by facility|1083|||
144305060|NCT01990742|520323150|FG000|Overall Study|Facility closed|0|||
144305061|NCT01990742|520323151|FG001|Overall Study|Facility closed|270|||
144305062|NCT03443687|520323152|FG000|Overall Study|Lost to Follow-up|3|||
144305063|NCT03443687|520323153|FG001|Overall Study|Lost to Follow-up|5|||
144305064|NCT03443687|520323152|FG000|Overall Study|Withdrawal by Subject|1|||
144305065|NCT03443687|520323153|FG001|Overall Study|Withdrawal by Subject|0|||
144305066|NCT03443687|520323152|FG000|Overall Study|Discontinued intervention|1|||
144305067|NCT03443687|520323153|FG001|Overall Study|Discontinued intervention|1|||
144305068|NCT01063348|520323157|FG000|Overall Study|Lost to Follow-up|3|||
144305069|NCT01063348|520323158|FG001|Overall Study|Lost to Follow-up|10|||
144305070|NCT05518461|520323159|FG000|Overall Study|Lost to Follow-up|25|||
144305071|NCT03326063|520323161|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
144305072|NCT03326063|520323162|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
144305073|NCT01188967|520323163|FG000|Overall Study|Withdrawal by Subject|1|||
144305074|NCT01188967|520323164|FG001|Overall Study|Withdrawal by Subject|1|||
144305075|NCT01188967|520323163|FG000|Overall Study|Physician Decision|1|||
144305076|NCT01188967|520323164|FG001|Overall Study|Physician Decision|1|||
144305077|NCT01188967|520323163|FG000|Overall Study|Lost to Follow-up|3|||
144305078|NCT01188967|520323164|FG001|Overall Study|Lost to Follow-up|2|||
144305079|NCT01876381|520323165|FG000|Overall Study|Lack of Efficacy|5|||
144305080|NCT01876381|520323165|FG000|Overall Study|Physician Decision|1|||
144305081|NCT01876381|520323165|FG000|Overall Study|Withdrawal by Subject|1|||
144305082|NCT00523978|520323166|FG000|Overall Study|Withdrawal by Subject|3|||
144305083|NCT00523978|520323167|FG001|Overall Study|Withdrawal by Subject|7|||
144305084|NCT00523978|520323166|FG000|Overall Study|Screen Failures|5|||
144305085|NCT00523978|520323167|FG001|Overall Study|Screen Failures|1|||
144305086|NCT00523978|520323166|FG000|Overall Study|Death|1|||
144305087|NCT00523978|520323167|FG001|Overall Study|Death|0|||
144305088|NCT00332696|520323170|FG000|Overall Study|Death|24|||
144305089|NCT00332696|520323171|FG001|Overall Study|Death|14|||
144305090|NCT00332696|520323170|FG000|Overall Study|Insufficient therapeutic effect|4|||
144305091|NCT00332696|520323171|FG001|Overall Study|Insufficient therapeutic effect|11|||
144305092|NCT00332696|520323170|FG000|Overall Study|Adverse Event|1|||
144305093|NCT00332696|520323171|FG001|Overall Study|Adverse Event|2|||
144305094|NCT00332696|520323170|FG000|Overall Study|Condition does not justify treatment|0|||
144305095|NCT00332696|520323171|FG001|Overall Study|Condition does not justify treatment|2|||
144305096|NCT00332696|520323170|FG000|Overall Study|Lost to Follow-up|0|||
144305097|NCT00332696|520323171|FG001|Overall Study|Lost to Follow-up|1|||
144305098|NCT00332696|520323170|FG000|Overall Study|Withdrawal by Subject|1|||
144305099|NCT00332696|520323171|FG001|Overall Study|Withdrawal by Subject|0|||
144305100|NCT00382174|520323172|FG000|Overall Study|Lost to Follow-up|1|||
144305101|NCT00382174|520323173|FG001|Overall Study|Lost to Follow-up|4|||
144305102|NCT00382174|520323174|FG002|Overall Study|Lost to Follow-up|5|||
144305103|NCT00382174|520323172|FG000|Overall Study|Adverse Event|1|||
144305104|NCT00382174|520323173|FG001|Overall Study|Adverse Event|4|||
144305105|NCT00382174|520323174|FG002|Overall Study|Adverse Event|5|||
144305106|NCT00382174|520323172|FG000|Overall Study|Withdrawal by Subject|1|||
144305107|NCT00382174|520323173|FG001|Overall Study|Withdrawal by Subject|4|||
144305108|NCT00382174|520323174|FG002|Overall Study|Withdrawal by Subject|5|||
144305109|NCT00382174|520323172|FG000|Overall Study|Non compliance|1|||
144305110|NCT00382174|520323173|FG001|Overall Study|Non compliance|0|||
144305111|NCT00382174|520323174|FG002|Overall Study|Non compliance|1|||
144305112|NCT00382174|520323172|FG000|Overall Study|Physician Decision|0|||
144305113|NCT00382174|520323173|FG001|Overall Study|Physician Decision|2|||
144305114|NCT00382174|520323174|FG002|Overall Study|Physician Decision|2|||
144305115|NCT00382174|520323172|FG000|Overall Study|Failed to meet criteria|0|||
144305116|NCT00382174|520323173|FG001|Overall Study|Failed to meet criteria|1|||
144305117|NCT00382174|520323174|FG002|Overall Study|Failed to meet criteria|1|||
144305118|NCT00382174|520323172|FG000|Overall Study|Wounds merged|0|||
144305119|NCT00382174|520323173|FG001|Overall Study|Wounds merged|2|||
144305120|NCT00382174|520323174|FG002|Overall Study|Wounds merged|2|||
144305121|NCT04577781|520323175|FG000|Overall Study|Adverse Event|2|||
144305122|NCT04577781|520323176|FG001|Overall Study|Adverse Event|2|||
144305123|NCT04577781|520323175|FG000|Overall Study|Physician Decision|1|||
144305124|NCT04577781|520323176|FG001|Overall Study|Physician Decision|0|||
144305125|NCT04103450|520323178|FG000|Overall Study|Adverse Event|4|||
144305126|NCT04103450|520323179|FG001|Overall Study|Adverse Event|2|||
144305127|NCT04103450|520323178|FG000|Overall Study|Lack of Efficacy|3|||
144305128|NCT04103450|520323179|FG001|Overall Study|Lack of Efficacy|0|||
144305129|NCT04103450|520323178|FG000|Overall Study|Withdrawal by Subject|5|||
144305130|NCT04103450|520323179|FG001|Overall Study|Withdrawal by Subject|3|||
144305131|NCT04103450|520323178|FG000|Overall Study|Lost to Follow-up|1|||
144305132|NCT04103450|520323179|FG001|Overall Study|Lost to Follow-up|2|||
144305133|NCT04103450|520323178|FG000|Overall Study|Physician Decision|1|||
144305134|NCT04103450|520323179|FG001|Overall Study|Physician Decision|2|||
144305135|NCT04103450|520323178|FG000|Overall Study|Protocol Violation|1|||
144305136|NCT04103450|520323179|FG001|Overall Study|Protocol Violation|0|||
144305137|NCT04103450|520323178|FG000|Overall Study|Other|1|||
144305138|NCT04103450|520323179|FG001|Overall Study|Other|1|||
144305139|NCT02712788|520323180|FG000|Overall Study|Physician Decision|1|||
144305140|NCT02712788|520323181|FG001|Overall Study|Physician Decision|0|||
144305141|NCT02712788|520323180|FG000|Overall Study|Protocol Violation|1|||
144305142|NCT02712788|520323181|FG001|Overall Study|Protocol Violation|0|||
144305143|NCT01368614|520323185|FG000|Screening Period|Screen Failure|58|||
144305144|NCT01368614|520323186|FG001|Screening Period|Screen Failure|0|||
144305145|NCT01368614|520323187|FG002|Screening Period|Screen Failure|0|||
144305146|NCT01368614|520323188|FG003|Screening Period|Screen Failure|0|||
144305147|NCT01368614|520323185|FG000|Study Period|Withdrawal by Subject|0|||
144305148|NCT01368614|520323186|FG001|Study Period|Withdrawal by Subject|1|||
144305149|NCT01368614|520323187|FG002|Study Period|Withdrawal by Subject|1|||
144305150|NCT01368614|520323188|FG003|Study Period|Withdrawal by Subject|3|||
144305151|NCT01368614|520323185|FG000|Study Period|Lost to Follow-up|0|||
144305152|NCT01368614|520323186|FG001|Study Period|Lost to Follow-up|0|||
144305153|NCT01368614|520323187|FG002|Study Period|Lost to Follow-up|1|||
144305154|NCT01368614|520323188|FG003|Study Period|Lost to Follow-up|0|||
144305155|NCT00244621|520323189|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
144305156|NCT00244621|520323190|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
144305157|NCT00244621|520323191|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
144305158|NCT00244621|520323189|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
144305159|NCT00244621|520323190|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
144305160|NCT00244621|520323191|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144305161|NCT00244621|520323189|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
144305162|NCT00244621|520323190|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
144305163|NCT00244621|520323191|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
144305164|NCT00244621|520323189|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
144305165|NCT00244621|520323190|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
144305166|NCT00244621|520323191|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
144305167|NCT00244621|520323189|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
144305168|NCT00244621|520323190|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
144305169|NCT00244621|520323191|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
144305170|NCT00244621|520323189|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
144305171|NCT00244621|520323190|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
144305172|NCT00244621|520323191|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
144305173|NCT00244621|520323189|FG000|Open-label Treatment Period|Adverse Event|0|||
144305174|NCT00244621|520323190|FG001|Open-label Treatment Period|Adverse Event|0|||
144305175|NCT00244621|520323191|FG002|Open-label Treatment Period|Adverse Event|1|||
144305176|NCT00244621|520323189|FG000|Open-label Treatment Period|Moved abroad|0|||
144305177|NCT00244621|520323190|FG001|Open-label Treatment Period|Moved abroad|0|||
144305178|NCT00244621|520323191|FG002|Open-label Treatment Period|Moved abroad|1|||
144305179|NCT01847755|520323192|FG000|Overall Study|Adverse Event|2|||
144305180|NCT01847755|520323192|FG000|Overall Study|Withdrawal by Subject|2|||
144305181|NCT01847755|520323192|FG000|Overall Study|Physician Decision|1|||
144305182|NCT01193101|520323196|FG000|Overall Study|Adverse Event|0|||
144305183|NCT01193101|520323197|FG001|Overall Study|Adverse Event|1|||
144305184|NCT01193101|520323198|FG002|Overall Study|Adverse Event|1|||
144305185|NCT01193101|520323199|FG003|Overall Study|Adverse Event|3|||
144305186|NCT01193101|520323196|FG000|Overall Study|Lack of Efficacy|3|||
144305187|NCT01193101|520323197|FG001|Overall Study|Lack of Efficacy|1|||
144305188|NCT01193101|520323198|FG002|Overall Study|Lack of Efficacy|0|||
144305189|NCT01193101|520323199|FG003|Overall Study|Lack of Efficacy|8|||
144305190|NCT01193101|520323196|FG000|Overall Study|Withdrawal by Subject|2|||
144305191|NCT01193101|520323197|FG001|Overall Study|Withdrawal by Subject|4|||
144305192|NCT01193101|520323198|FG002|Overall Study|Withdrawal by Subject|1|||
144305193|NCT01193101|520323199|FG003|Overall Study|Withdrawal by Subject|1|||
144305194|NCT01193101|520323196|FG000|Overall Study|Administrative problems|0|||
144305195|NCT01193101|520323197|FG001|Overall Study|Administrative problems|0|||
144305196|NCT01193101|520323198|FG002|Overall Study|Administrative problems|1|||
144305197|NCT01193101|520323199|FG003|Overall Study|Administrative problems|0|||
144305198|NCT01193101|520323196|FG000|Overall Study|Abnormal test procedure results|0|||
144305199|NCT01193101|520323197|FG001|Overall Study|Abnormal test procedure results|1|||
144305200|NCT01193101|520323198|FG002|Overall Study|Abnormal test procedure results|0|||
144305201|NCT01193101|520323199|FG003|Overall Study|Abnormal test procedure results|0|||
144305202|NCT02347085|520323202|FG000|Overall Study|Adverse Event|2|||
144305203|NCT02347085|520323202|FG000|Overall Study|Lack of Efficacy|1|||
144305204|NCT02347085|520323202|FG000|Overall Study|Withdrawal by Subject|4|||
144305205|NCT02347085|520323202|FG000|Overall Study|Lost to Follow-up|1|||
144305206|NCT02347085|520323202|FG000|Overall Study|Protocol Criteria|2|||
144305207|NCT02271529|520323203|FG000|Overall Study|Withdrawal by Subject|1|||
144305208|NCT01904721|520323205|FG000|Overall Study|Other Reasons|0|||
144305209|NCT01904721|520323206|FG001|Overall Study|Other Reasons|0|||
144305210|NCT01904721|520323207|FG002|Overall Study|Other Reasons|1|||
144305211|NCT01904721|520323208|FG003|Overall Study|Other Reasons|1|||
144305212|NCT01904721|520323209|FG004|Overall Study|Other Reasons|2|||
144305213|NCT01904721|520323210|FG005|Overall Study|Other Reasons|2|||
144305214|NCT01904721|520323211|FG006|Overall Study|Other Reasons|2|||
144305215|NCT01904721|520323205|FG000|Overall Study|Personal Reasons|0|||
144305216|NCT01904721|520323206|FG001|Overall Study|Personal Reasons|0|||
144305217|NCT01904721|520323207|FG002|Overall Study|Personal Reasons|0|||
144305218|NCT01904721|520323208|FG003|Overall Study|Personal Reasons|0|||
144305219|NCT01904721|520323209|FG004|Overall Study|Personal Reasons|2|||
144305220|NCT01904721|520323210|FG005|Overall Study|Personal Reasons|3|||
144305221|NCT01904721|520323211|FG006|Overall Study|Personal Reasons|3|||
144305222|NCT01904721|520323205|FG000|Overall Study|Lost to Follow-up|0|||
144305223|NCT01904721|520323206|FG001|Overall Study|Lost to Follow-up|0|||
144305224|NCT01904721|520323207|FG002|Overall Study|Lost to Follow-up|0|||
144305225|NCT01904721|520323208|FG003|Overall Study|Lost to Follow-up|0|||
144305226|NCT01904721|520323209|FG004|Overall Study|Lost to Follow-up|1|||
144305227|NCT01904721|520323210|FG005|Overall Study|Lost to Follow-up|3|||
144305228|NCT01904721|520323211|FG006|Overall Study|Lost to Follow-up|1|||
144305229|NCT01904721|520323205|FG000|Overall Study|Lack of Efficacy|0|||
144305230|NCT01904721|520323206|FG001|Overall Study|Lack of Efficacy|0|||
144305231|NCT01904721|520323207|FG002|Overall Study|Lack of Efficacy|0|||
144305232|NCT01904721|520323208|FG003|Overall Study|Lack of Efficacy|0|||
144305233|NCT01904721|520323209|FG004|Overall Study|Lack of Efficacy|0|||
144305234|NCT01904721|520323210|FG005|Overall Study|Lack of Efficacy|0|||
144305235|NCT01904721|520323211|FG006|Overall Study|Lack of Efficacy|1|||
144305236|NCT01904721|520323205|FG000|Overall Study|Adverse Event|0|||
144305237|NCT01904721|520323206|FG001|Overall Study|Adverse Event|0|||
144305238|NCT01904721|520323207|FG002|Overall Study|Adverse Event|0|||
144305239|NCT01904721|520323208|FG003|Overall Study|Adverse Event|0|||
144305240|NCT01904721|520323209|FG004|Overall Study|Adverse Event|3|||
144305241|NCT01904721|520323210|FG005|Overall Study|Adverse Event|1|||
144305242|NCT01904721|520323211|FG006|Overall Study|Adverse Event|0|||
144305243|NCT01957865|520323212|FG000|Overall Study|Found HIV negative|0|||
144305244|NCT01957865|520323213|FG001|Overall Study|Found HIV negative|0|||
144305245|NCT01957865|520323214|FG002|Overall Study|Found HIV negative|1|||
144305246|NCT01957865|520323212|FG000|Overall Study|Lost to Follow-up|0|||
144305247|NCT01957865|520323213|FG001|Overall Study|Lost to Follow-up|2|||
144305248|NCT01957865|520323214|FG002|Overall Study|Lost to Follow-up|2|||
144305249|NCT00553631|520323215|FG000|Overall Study|Withdrawal by Subject|0|||
144305250|NCT00553631|520323216|FG001|Overall Study|Withdrawal by Subject|1|||
144305251|NCT00553631|520323215|FG000|Overall Study|Lost to Follow-up|1|||
144305252|NCT00553631|520323216|FG001|Overall Study|Lost to Follow-up|0|||
144305253|NCT01490918|520323217|FG000|Overall Study|Lost to Follow-up|2|||
144305254|NCT01490918|520323218|FG001|Overall Study|Lost to Follow-up|1|||
144305255|NCT01490918|520323219|FG002|Overall Study|Lost to Follow-up|0|||
144305256|NCT01490918|520323217|FG000|Overall Study|Withdrawal by Subject|7|||
144305257|NCT01490918|520323218|FG001|Overall Study|Withdrawal by Subject|8|||
144305258|NCT01490918|520323219|FG002|Overall Study|Withdrawal by Subject|3|||
144305259|NCT01490918|520323217|FG000|Overall Study|Adverse Event|0|||
144305260|NCT01490918|520323218|FG001|Overall Study|Adverse Event|0|||
144305261|NCT01490918|520323219|FG002|Overall Study|Adverse Event|1|||
144305262|NCT01490918|520323217|FG000|Overall Study|other cause|4|||
144305263|NCT01490918|520323218|FG001|Overall Study|other cause|5|||
144305264|NCT01490918|520323219|FG002|Overall Study|other cause|8|||
144305265|NCT02967679|520323222|FG000|Overall Study|Adverse Event|1|||
144305266|NCT00114127|520323224|FG000|Overall Study|Adverse Event|2|||
144305267|NCT00114127|520323225|FG001|Overall Study|Adverse Event|1|||
144305268|NCT00114127|520323224|FG000|Overall Study|Lost to Follow-up|1|||
144305269|NCT00114127|520323225|FG001|Overall Study|Lost to Follow-up|0|||
144305270|NCT00114127|520323224|FG000|Overall Study|Withdrawal by Subject|1|||
144305271|NCT00114127|520323225|FG001|Overall Study|Withdrawal by Subject|3|||
144305272|NCT03188263|520323226|FG000|Overall Study|Withdrawal by Subject|3|||
144305273|NCT03188263|520323227|FG001|Overall Study|Withdrawal by Subject|0|||
144305274|NCT03188263|520323226|FG000|Overall Study|Physician Decision|1|||
144305275|NCT03188263|520323227|FG001|Overall Study|Physician Decision|0|||
144305276|NCT00699413|520323228|FG000|Overall Study|Withdrawal by Subject|0|||
144305277|NCT00699413|520323229|FG001|Overall Study|Withdrawal by Subject|2|||
144305278|NCT00699413|520323228|FG000|Overall Study|Study terminated by sponsor|4|||
144305279|NCT00699413|520323229|FG001|Overall Study|Study terminated by sponsor|2|||
144305280|NCT00881894|520323230|FG000|Overall Study|Consent withdrawn|0|||
144305281|NCT00881894|520323231|FG001|Overall Study|Consent withdrawn|1|||
144305282|NCT00881894|520323230|FG000|Overall Study|Other reasons for premature termination|1|||
144305283|NCT00881894|520323231|FG001|Overall Study|Other reasons for premature termination|2|||
144305284|NCT00469833|520323232|FG000|Overall Study|No IV access|2|||
144305285|NCT03289533|520323233|FG000|Overall Study|Death|12|||
144305286|NCT03289533|520323233|FG000|Overall Study|Terminated from study by sponsor|10|||
144305287|NCT01284959|520323234|FG000|Overall Study|Withdrawal by Subject|1|||
144305288|NCT01284959|520323235|FG001|Overall Study|Withdrawal by Subject|0|||
144305289|NCT01284959|520323236|FG002|Overall Study|Withdrawal by Subject|0|||
144305290|NCT01284959|520323234|FG000|Overall Study|Adverse Event|0|||
144305291|NCT01284959|520323235|FG001|Overall Study|Adverse Event|0|||
144305292|NCT01284959|520323236|FG002|Overall Study|Adverse Event|1|||
144305293|NCT00363311|520323237|FG000|Overall Study|Adverse Event|6|||
144305294|NCT00363311|520323238|FG001|Overall Study|Adverse Event|4|||
144305295|NCT00363311|520323237|FG000|Overall Study|Lost to Follow-up|3|||
144305296|NCT00363311|520323238|FG001|Overall Study|Lost to Follow-up|0|||
144305297|NCT00363311|520323237|FG000|Overall Study|Protocol Violation|1|||
144305298|NCT00363311|520323238|FG001|Overall Study|Protocol Violation|2|||
144305299|NCT00363311|520323237|FG000|Overall Study|Withdrawal by Subject|12|||
144305300|NCT00363311|520323238|FG001|Overall Study|Withdrawal by Subject|6|||
144305301|NCT00363311|520323237|FG000|Overall Study|Physician Decision|1|||
144305302|NCT00363311|520323238|FG001|Overall Study|Physician Decision|1|||
144305303|NCT00363311|520323237|FG000|Overall Study|Sponsor Terminated Study|2|||
144305304|NCT00363311|520323238|FG001|Overall Study|Sponsor Terminated Study|2|||
144305305|NCT00363311|520323237|FG000|Overall Study|Disease Progression|46|||
144305306|NCT00363311|520323238|FG001|Overall Study|Disease Progression|26|||
144305307|NCT00363311|520323237|FG000|Overall Study|Non-Compliance|1|||
144305308|NCT00363311|520323238|FG001|Overall Study|Non-Compliance|1|||
144305309|NCT00363311|520323237|FG000|Overall Study|Participant Refused Biopsy|1|||
144305310|NCT00363311|520323238|FG001|Overall Study|Participant Refused Biopsy|0|||
144305311|NCT00363311|520323237|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
144305312|NCT00363311|520323238|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
144305313|NCT00363311|520323237|FG000|Overall Study|Participant Opted for Treatment|1|||
144305314|NCT00363311|520323238|FG001|Overall Study|Participant Opted for Treatment|0|||
144305315|NCT00363311|520323237|FG000|Overall Study|Participant Moved to Another Country|1|||
144305316|NCT00363311|520323238|FG001|Overall Study|Participant Moved to Another Country|0|||
144305317|NCT00363311|520323237|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
144305318|NCT00363311|520323238|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
144305319|NCT00363311|520323237|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
144305320|NCT00363311|520323238|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
144305321|NCT00363311|520323237|FG000|Overall Study|Participant Moved to Louisiana|0|||
144305322|NCT00363311|520323238|FG001|Overall Study|Participant Moved to Louisiana|1|||
144305323|NCT01182298|520323241|FG000|Overall Study|Lack of Efficacy|4|||
144305324|NCT01182298|520323241|FG000|Overall Study|Withdrawal by Subject|2|||
144305325|NCT01595529|520323242|FG000|Overall Study|Adverse Event|2|||
144305326|NCT01595529|520323243|FG001|Overall Study|Adverse Event|0|||
144305327|NCT01595529|520323242|FG000|Overall Study|Subject Non-Compliant|2|||
144305328|NCT01595529|520323243|FG001|Overall Study|Subject Non-Compliant|0|||
144305329|NCT01595529|520323242|FG000|Overall Study|Lost to Follow-up|8|||
144305330|NCT01595529|520323243|FG001|Overall Study|Lost to Follow-up|14|||
144305331|NCT01595529|520323242|FG000|Overall Study|Protocol Violation|1|||
144305332|NCT01595529|520323243|FG001|Overall Study|Protocol Violation|2|||
144305333|NCT01595529|520323242|FG000|Overall Study|Physician Decision|1|||
144305334|NCT01595529|520323243|FG001|Overall Study|Physician Decision|0|||
144305335|NCT01595529|520323242|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
144360015|NCT01601535|520525137|FG002|Phase 1|Started Another Treatment|0|||
144305336|NCT01595529|520323243|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
144305337|NCT01595529|520323242|FG000|Overall Study|Administrative Decision|1|||
144305338|NCT01595529|520323243|FG001|Overall Study|Administrative Decision|0|||
144305339|NCT01595529|520323242|FG000|Overall Study|Entry Failure/Screening Failure|6|||
144305340|NCT01595529|520323243|FG001|Overall Study|Entry Failure/Screening Failure|1|||
144305341|NCT02629861|520323248|FG000|Overall Study|Adverse Event|7|||
144305342|NCT02629861|520323249|FG001|Overall Study|Adverse Event|5|||
144305343|NCT02629861|520323250|FG002|Overall Study|Adverse Event|4|||
144305344|NCT02629861|520323248|FG000|Overall Study|Withdrawal by Subject|5|||
144305345|NCT02629861|520323249|FG001|Overall Study|Withdrawal by Subject|8|||
144305346|NCT02629861|520323250|FG002|Overall Study|Withdrawal by Subject|13|||
144305347|NCT02629861|520323248|FG000|Overall Study|Protocol Violation|2|||
144305348|NCT02629861|520323249|FG001|Overall Study|Protocol Violation|3|||
144305349|NCT02629861|520323250|FG002|Overall Study|Protocol Violation|7|||
144305350|NCT02629861|520323248|FG000|Overall Study|Lost to Follow-up|12|||
144305351|NCT02629861|520323249|FG001|Overall Study|Lost to Follow-up|9|||
144305352|NCT02629861|520323250|FG002|Overall Study|Lost to Follow-up|4|||
144305353|NCT02629861|520323248|FG000|Overall Study|Other|1|||
144305354|NCT02629861|520323249|FG001|Overall Study|Other|1|||
144305355|NCT02629861|520323250|FG002|Overall Study|Other|0|||
144305356|NCT02629861|520323248|FG000|Overall Study|Pregnancy|2|||
144305357|NCT02629861|520323249|FG001|Overall Study|Pregnancy|1|||
144305358|NCT02629861|520323250|FG002|Overall Study|Pregnancy|0|||
144305359|NCT00730886|520323251|FG000|Overall Study|Lost to Follow-up|1|||
144305360|NCT00730886|520323252|FG001|Overall Study|Lost to Follow-up|0|||
144305361|NCT00730886|520323251|FG000|Overall Study|Physician Decision|1|||
144305362|NCT00730886|520323252|FG001|Overall Study|Physician Decision|0|||
144305363|NCT01991483|520323253|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
144305364|NCT01991483|520323254|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
144305365|NCT01991483|520323255|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
144305366|NCT01991483|520323256|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
144305367|NCT01991483|520323253|FG000|Dose Level 600 mg|Physician Decision|0|||
144305368|NCT01991483|520323254|FG001|Dose Level 600 mg|Physician Decision|0|||
144305369|NCT01991483|520323255|FG002|Dose Level 600 mg|Physician Decision|1|||
144305370|NCT01991483|520323256|FG003|Dose Level 600 mg|Physician Decision|0|||
144305371|NCT01991483|520323253|FG000|Dose Level 1000 mg|Protocol Violation|0|||
144305372|NCT01991483|520323254|FG001|Dose Level 1000 mg|Protocol Violation|0|||
144305373|NCT01991483|520323255|FG002|Dose Level 1000 mg|Protocol Violation|0|||
144305374|NCT01991483|520323256|FG003|Dose Level 1000 mg|Protocol Violation|1|||
144305375|NCT02030821|520323259|FG000|Overall Study|Physician Decision|2|||
144305376|NCT02030821|520323260|FG001|Overall Study|Physician Decision|2|||
144305377|NCT02030821|520323261|FG002|Overall Study|Physician Decision|5|||
144305378|NCT02030821|520323262|FG003|Overall Study|Physician Decision|2|||
144305379|NCT04422431|520323264|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
144305380|NCT04422431|520323264|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
144305381|NCT04422431|520323264|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
144305382|NCT04422431|520323264|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
144305383|NCT04422431|520323264|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
144305384|NCT04422431|520323264|FG000|Extension Period (48 Weeks)|Other than specified|2|||
144305385|NCT01174563|520323265|FG000|Overall Study|Progressive Disease|45|||
144305386|NCT01174563|520323265|FG000|Overall Study|Death|5|||
144305387|NCT01174563|520323265|FG000|Overall Study|Investigator's Discretion|5|||
144305388|NCT01174563|520323265|FG000|Overall Study|Participant Withdrew Consent|3|||
144305389|NCT01174563|520323265|FG000|Overall Study|Rash Adverse Event|1|||
144305390|NCT01174563|520323265|FG000|Overall Study|Sponsor's decision|1|||
144305391|NCT02015039|520323269|FG000|Overall Study|Not eligible|0|||
144305392|NCT02015039|520323270|FG001|Overall Study|Not eligible|1|||
144305393|NCT02317627|520323275|FG000|Overall Study|Withdrawal by Subject|0|||
144305394|NCT02317627|520323276|FG001|Overall Study|Withdrawal by Subject|1|||
144305395|NCT02317627|520323277|FG002|Overall Study|Withdrawal by Subject|1|||
144305396|NCT02317627|520323275|FG000|Overall Study|Lost to Follow-up|2|||
144305397|NCT02317627|520323276|FG001|Overall Study|Lost to Follow-up|0|||
144305398|NCT02317627|520323277|FG002|Overall Study|Lost to Follow-up|0|||
144305399|NCT02317627|520323275|FG000|Overall Study|Stopped by Investigator|0|||
144305400|NCT02317627|520323276|FG001|Overall Study|Stopped by Investigator|1|||
144305401|NCT02317627|520323277|FG002|Overall Study|Stopped by Investigator|0|||
144305402|NCT02317627|520323275|FG000|Overall Study|Adverse Event|0|||
144305403|NCT02317627|520323276|FG001|Overall Study|Adverse Event|2|||
144305404|NCT02317627|520323277|FG002|Overall Study|Adverse Event|3|||
144305405|NCT02317627|520323275|FG000|Overall Study|Non-compliance with study drug|0|||
144305406|NCT02317627|520323276|FG001|Overall Study|Non-compliance with study drug|1|||
144305407|NCT02317627|520323277|FG002|Overall Study|Non-compliance with study drug|0|||
144305408|NCT00279214|520323278|FG000|Overall Study|Physician Decision|3|||
144305409|NCT00279214|520323279|FG001|Overall Study|Physician Decision|2|||
144305410|NCT04749914|520323280|FG000|Period 1|Adverse Event|1|||
144305411|NCT04749914|520323281|FG001|Period 1|Adverse Event|0|||
144305412|NCT04749914|520323282|FG002|Period 1|Adverse Event|0|||
144305413|NCT04749914|520323283|FG003|Period 1|Adverse Event|0|||
144305414|NCT04749914|520323280|FG000|Period 1|Withdrawal by Subject|1|||
144305415|NCT04749914|520323281|FG001|Period 1|Withdrawal by Subject|0|||
144305416|NCT04749914|520323282|FG002|Period 1|Withdrawal by Subject|1|||
144305417|NCT04749914|520323283|FG003|Period 1|Withdrawal by Subject|0|||
144305418|NCT05414175|520323284|FG000|Overall Study|Withdrawal by Subject|1|||
144305419|NCT05414175|520323284|FG000|Overall Study|Other Reasons|1|||
144305420|NCT00457626|520323285|FG000|Overall Study|Adverse Event|3|||
144305421|NCT00457626|520323285|FG000|Overall Study|Administrative Problems|2|||
144305422|NCT00457626|520323285|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
144305423|NCT03247829|520325117|FG000|Overall Study|Death|3|||
144305424|NCT03247829|520325118|FG001|Overall Study|Death|4|||
144305425|NCT03247829|520325117|FG000|Overall Study|Enter Hospice Care|1|||
144305426|NCT03247829|520325118|FG001|Overall Study|Enter Hospice Care|0|||
144305427|NCT03247829|520325117|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
144305428|NCT03247829|520325118|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
144305429|NCT03247829|520325117|FG000|Overall Study|LVAD Explant|1|||
144305430|NCT03247829|520325118|FG001|Overall Study|LVAD Explant|1|||
144305431|NCT03247829|520325117|FG000|Overall Study|Transplant|1|||
144305432|NCT03247829|520325118|FG001|Overall Study|Transplant|1|||
144305433|NCT01856322|520325119|FG000|Overall Study|off study due to lack of accrual|0|||
144305434|NCT01856322|520325120|FG001|Overall Study|off study due to lack of accrual|0|||
144305435|NCT01856322|520325121|FG002|Overall Study|off study due to lack of accrual|3|||
144305436|NCT00427011|520325122|FG000|Overall Study|Adverse Event|10|||
144305437|NCT00427011|520325122|FG000|Overall Study|Withdrawal by Subject|1|||
144305438|NCT00427011|520325122|FG000|Overall Study|Lack of Efficacy|2|||
144305439|NCT00427011|520325122|FG000|Overall Study|Other|12|||
144305440|NCT00288015|520325123|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
144305441|NCT00288015|520325123|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
144305442|NCT00288015|520325123|FG000|First Response Assessment|Withdrawal by Subject|1|||
144305443|NCT00288015|520325123|FG000|First Response Assessment|Death|1|||
144305444|NCT00288015|520325123|FG000|First Response Assessment|Physician Decision|2|||
144305445|NCT00288015|520325123|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
144305446|NCT00288015|520325123|FG000|Follow up for Survival x 2 Years|Death|13|||
144305447|NCT00288015|520325123|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
144305448|NCT00288015|520325123|FG000|Follow up for Survival x 2 Years|Other|9|||
144305449|NCT00443703|520325124|FG000|Overall Study|Never Treated|3|||
144305450|NCT00443703|520325125|FG001|Overall Study|Never Treated|1|||
144305451|NCT00443703|520325124|FG000|Overall Study|Adverse Event|7|||
144305452|NCT00443703|520325125|FG001|Overall Study|Adverse Event|3|||
144305453|NCT00443703|520325124|FG000|Overall Study|Lack of Efficacy|3|||
144305454|NCT00443703|520325125|FG001|Overall Study|Lack of Efficacy|1|||
144305455|NCT00443703|520325124|FG000|Overall Study|Lost to Follow-up|0|||
144305456|NCT00443703|520325125|FG001|Overall Study|Lost to Follow-up|4|||
144305457|NCT00443703|520325124|FG000|Overall Study|Physician Decision|4|||
144305458|NCT00443703|520325125|FG001|Overall Study|Physician Decision|2|||
144305459|NCT00443703|520325124|FG000|Overall Study|Protocol Violation|1|||
144305460|NCT00443703|520325125|FG001|Overall Study|Protocol Violation|1|||
144305461|NCT00443703|520325124|FG000|Overall Study|Withdrawal by Subject|9|||
144305462|NCT00443703|520325125|FG001|Overall Study|Withdrawal by Subject|6|||
144305463|NCT00443703|520325124|FG000|Overall Study|Progressive Disease|1|||
144305464|NCT00443703|520325125|FG001|Overall Study|Progressive Disease|0|||
144305465|NCT01669902|520325130|FG000|Overall Study|Adverse Event|11|||
144305466|NCT01669902|520325130|FG000|Overall Study|Lack of Efficacy|10|||
144305467|NCT01669902|520325130|FG000|Overall Study|Other|8|||
144305468|NCT00457392|520325131|FG000|Overall Study|Objective Progression or Relapse|229|||
144305469|NCT00457392|520325132|FG001|Overall Study|Objective Progression or Relapse|296|||
144305470|NCT00457392|520325131|FG000|Overall Study|Death|106|||
144305471|NCT00457392|520325132|FG001|Overall Study|Death|106|||
144305472|NCT00457392|520325131|FG000|Overall Study|Adverse Event|84|||
144305473|NCT00457392|520325132|FG001|Overall Study|Adverse Event|41|||
144305474|NCT00457392|520325131|FG000|Overall Study|Global Deterioration of Health Status|22|||
144305475|NCT00457392|520325132|FG001|Overall Study|Global Deterioration of Health Status|8|||
144305476|NCT00457392|520325131|FG000|Overall Study|Withdrawal by Subject|14|||
144305477|NCT00457392|520325132|FG001|Overall Study|Withdrawal by Subject|8|||
144305478|NCT00457392|520325131|FG000|Overall Study|Lost to Follow-up|6|||
144305479|NCT00457392|520325132|FG001|Overall Study|Lost to Follow-up|7|||
144305480|NCT00457392|520325131|FG000|Overall Study|Protocol Violation|4|||
144305481|NCT00457392|520325132|FG001|Overall Study|Protocol Violation|3|||
144305482|NCT00457392|520325131|FG000|Overall Study|Other|7|||
144305483|NCT00457392|520325132|FG001|Overall Study|Other|4|||
144305484|NCT00457392|520325131|FG000|Overall Study|Study Terminated by Sponsor|1|||
144305485|NCT00457392|520325132|FG001|Overall Study|Study Terminated by Sponsor|4|||
144305486|NCT00457392|520325131|FG000|Overall Study|Randomized, Not Treated|7|||
144305487|NCT00457392|520325132|FG001|Overall Study|Randomized, Not Treated|3|||
144305488|NCT00980148|520325133|FG000|Overall Study|Discharged from facility|89|||
144305489|NCT00980148|520325134|FG001|Overall Study|Discharged from facility|96|||
144305490|NCT00980148|520325133|FG000|Overall Study|Received other antichlamydia treatment|20|||
144305491|NCT00980148|520325134|FG001|Overall Study|Received other antichlamydia treatment|14|||
144305492|NCT00980148|520325133|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
144305493|NCT00980148|520325134|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
144305494|NCT00980148|520325133|FG000|Overall Study|Various other reasons|8|||
144305495|NCT00980148|520325134|FG001|Overall Study|Various other reasons|9|||
144305496|NCT01462929|520325141|FG000|Overall Study|Adverse Event|3|||
144305497|NCT01462929|520325142|FG001|Overall Study|Adverse Event|3|||
144305498|NCT01462929|520325143|FG002|Overall Study|Adverse Event|4|||
144305499|NCT01462929|520325141|FG000|Overall Study|Withdrawal by Subject|2|||
144305500|NCT01462929|520325142|FG001|Overall Study|Withdrawal by Subject|1|||
144305501|NCT01462929|520325143|FG002|Overall Study|Withdrawal by Subject|0|||
144305502|NCT01462929|520325141|FG000|Overall Study|Lack of Efficacy|0|||
144305503|NCT01462929|520325142|FG001|Overall Study|Lack of Efficacy|0|||
144305504|NCT01462929|520325143|FG002|Overall Study|Lack of Efficacy|1|||
144305505|NCT01815424|520325146|FG000|Week 0 to 16|Adverse Event|1|||
144305506|NCT01815424|520325147|FG001|Week 0 to 16|Adverse Event|3|||
144305507|NCT01815424|520325148|FG002|Week 0 to 16|Adverse Event|3|||
144305508|NCT01815424|520325149|FG003|Week 0 to 16|Adverse Event|0|||
144305509|NCT01815424|520325150|FG004|Week 0 to 16|Adverse Event|0|||
144305510|NCT01815424|520325146|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
144305511|NCT01815424|520325147|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
144305512|NCT01815424|520325148|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
144305513|NCT01815424|520325149|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
144305514|NCT01815424|520325150|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
144305515|NCT01815424|520325146|FG000|Week 0 to 16|Lost to Follow-up|0|||
144305516|NCT01815424|520325147|FG001|Week 0 to 16|Lost to Follow-up|1|||
144305517|NCT01815424|520325148|FG002|Week 0 to 16|Lost to Follow-up|0|||
144305518|NCT01815424|520325149|FG003|Week 0 to 16|Lost to Follow-up|0|||
144305519|NCT01815424|520325150|FG004|Week 0 to 16|Lost to Follow-up|0|||
144305520|NCT01815424|520325146|FG000|Week 0 to 16|Withdrawal by Subject|0|||
144305521|NCT01815424|520325147|FG001|Week 0 to 16|Withdrawal by Subject|0|||
144305522|NCT01815424|520325148|FG002|Week 0 to 16|Withdrawal by Subject|1|||
144305523|NCT01815424|520325149|FG003|Week 0 to 16|Withdrawal by Subject|0|||
144305524|NCT01815424|520325150|FG004|Week 0 to 16|Withdrawal by Subject|0|||
144305525|NCT01815424|520325146|FG000|Week 0 to 16|Other|1|||
144305526|NCT01815424|520325147|FG001|Week 0 to 16|Other|0|||
144305527|NCT01815424|520325148|FG002|Week 0 to 16|Other|3|||
144305528|NCT01815424|520325149|FG003|Week 0 to 16|Other|0|||
144305529|NCT01815424|520325150|FG004|Week 0 to 16|Other|0|||
144305530|NCT01815424|520325146|FG000|Week 0 to 16|Protocol Violation|1|||
144305531|NCT01815424|520325147|FG001|Week 0 to 16|Protocol Violation|0|||
144305532|NCT01815424|520325148|FG002|Week 0 to 16|Protocol Violation|0|||
144305533|NCT01815424|520325149|FG003|Week 0 to 16|Protocol Violation|0|||
144305534|NCT01815424|520325150|FG004|Week 0 to 16|Protocol Violation|0|||
144305535|NCT01815424|520325146|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
144305536|NCT01815424|520325147|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
144305537|NCT01815424|520325148|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
144305538|NCT01815424|520325149|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
144305539|NCT01815424|520325150|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
144305540|NCT01815424|520325146|FG000|Week 16 to 52|Other|0|||
144305541|NCT01815424|520325147|FG001|Week 16 to 52|Other|1|||
144305542|NCT01815424|520325148|FG002|Week 16 to 52|Other|0|||
144305543|NCT01815424|520325149|FG003|Week 16 to 52|Other|0|||
144305544|NCT01815424|520325150|FG004|Week 16 to 52|Other|0|||
144305545|NCT01815424|520325146|FG000|Week 16 to 52|Adverse Event|0|||
144305546|NCT01815424|520325147|FG001|Week 16 to 52|Adverse Event|0|||
144305547|NCT01815424|520325148|FG002|Week 16 to 52|Adverse Event|0|||
144305548|NCT01815424|520325149|FG003|Week 16 to 52|Adverse Event|0|||
144305549|NCT01815424|520325150|FG004|Week 16 to 52|Adverse Event|1|||
144305550|NCT01815424|520325146|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
144305551|NCT01815424|520325147|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
144305552|NCT01815424|520325148|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
144305553|NCT01815424|520325149|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
144305554|NCT01815424|520325150|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
144305555|NCT01815424|520325146|FG000|Week 16 to 52|Lost to Follow-up|0|||
144305556|NCT01815424|520325147|FG001|Week 16 to 52|Lost to Follow-up|2|||
144305557|NCT01815424|520325148|FG002|Week 16 to 52|Lost to Follow-up|0|||
144305558|NCT01815424|520325149|FG003|Week 16 to 52|Lost to Follow-up|2|||
144305559|NCT01815424|520325150|FG004|Week 16 to 52|Lost to Follow-up|1|||
144305560|NCT01815424|520325146|FG000|Week 16 to 52|Withdrawal by Subject|1|||
144305561|NCT01815424|520325147|FG001|Week 16 to 52|Withdrawal by Subject|2|||
144305562|NCT01815424|520325148|FG002|Week 16 to 52|Withdrawal by Subject|0|||
144305563|NCT01815424|520325149|FG003|Week 16 to 52|Withdrawal by Subject|0|||
144305564|NCT01815424|520325150|FG004|Week 16 to 52|Withdrawal by Subject|0|||
144305565|NCT01309204|520325151|FG000|Overall Study|Adverse Event|48|||
144305566|NCT01309204|520325152|FG001|Overall Study|Adverse Event|58|||
144305567|NCT01309204|520325151|FG000|Overall Study|Lost to Follow-up|2|||
144305568|NCT01309204|520325152|FG001|Overall Study|Lost to Follow-up|2|||
144305569|NCT01309204|520325151|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
144305570|NCT01309204|520325152|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
144305571|NCT01309204|520325151|FG000|Overall Study|Inadequate control of IOP|4|||
144305572|NCT01309204|520325152|FG001|Overall Study|Inadequate control of IOP|4|||
144305573|NCT01309204|520325151|FG000|Overall Study|Other|4|||
144305574|NCT01309204|520325152|FG001|Overall Study|Other|1|||
144305575|NCT04723355|520325153|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
144305576|NCT04723355|520325153|FG000|Overall Study|Errors in the informed consent form|2|||
144305577|NCT03374358|520325154|FG000|Overall Study|Withdrawal by Subject|0|||
144305578|NCT03374358|520325155|FG001|Overall Study|Withdrawal by Subject|2|||
144305579|NCT01119443|520325162|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
144305580|NCT01119443|520325163|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
144305581|NCT02329743|520325166|FG000|Overall Study|Adverse Event|1|||
144305582|NCT02329743|520325167|FG001|Overall Study|Adverse Event|1|||
144305583|NCT02329743|520325168|FG002|Overall Study|Adverse Event|3|||
144305584|NCT02329743|520325166|FG000|Overall Study|Lost to Follow-up|1|||
144305585|NCT02329743|520325167|FG001|Overall Study|Lost to Follow-up|0|||
144305586|NCT02329743|520325168|FG002|Overall Study|Lost to Follow-up|1|||
144305587|NCT02329743|520325166|FG000|Overall Study|Withdrawal by Subject|4|||
144305588|NCT02329743|520325167|FG001|Overall Study|Withdrawal by Subject|4|||
144305589|NCT02329743|520325168|FG002|Overall Study|Withdrawal by Subject|1|||
144305590|NCT02329743|520325166|FG000|Overall Study|Other|0|||
144305591|NCT02329743|520325167|FG001|Overall Study|Other|2|||
144305592|NCT02329743|520325168|FG002|Overall Study|Other|3|||
144305593|NCT02216526|520325188|FG000|Overall Study|Adverse Event|1|||
144305594|NCT02216526|520325189|FG001|Overall Study|Adverse Event|1|||
144305595|NCT02216526|520325190|FG002|Overall Study|Adverse Event|0|||
144305596|NCT02216526|520325188|FG000|Overall Study|Death|0|||
144305597|NCT02216526|520325189|FG001|Overall Study|Death|1|||
144305598|NCT02216526|520325190|FG002|Overall Study|Death|3|||
144305599|NCT02216526|520325188|FG000|Overall Study|Protocol Violation|2|||
144305600|NCT02216526|520325189|FG001|Overall Study|Protocol Violation|0|||
144305601|NCT02216526|520325190|FG002|Overall Study|Protocol Violation|2|||
144305602|NCT02216526|520325188|FG000|Overall Study|Hospitalization|2|||
144305603|NCT02216526|520325189|FG001|Overall Study|Hospitalization|1|||
144305604|NCT02216526|520325190|FG002|Overall Study|Hospitalization|3|||
144305605|NCT00461708|520325191|FG000|Overall Study|Adverse Event|17|||
144305606|NCT00461708|520325192|FG001|Overall Study|Adverse Event|7|||
144305607|NCT00461708|520325191|FG000|Overall Study|Lack of Efficacy|68|||
144305608|NCT00461708|520325192|FG001|Overall Study|Lack of Efficacy|20|||
144305609|NCT00461708|520325191|FG000|Overall Study|Physician Decision|10|||
144305610|NCT00461708|520325192|FG001|Overall Study|Physician Decision|4|||
144305611|NCT00461708|520325191|FG000|Overall Study|Withdrawal by Subject|8|||
144305612|NCT00461708|520325192|FG001|Overall Study|Withdrawal by Subject|2|||
144305613|NCT00461708|520325191|FG000|Overall Study|Other|4|||
144305614|NCT00461708|520325192|FG001|Overall Study|Other|4|||
144305615|NCT00461708|520325191|FG000|Overall Study|Death|8|||
144305616|NCT00461708|520325192|FG001|Overall Study|Death|1|||
144305617|NCT02750514|520325193|FG000|Track 1|Disease progression|20|||
144305618|NCT02750514|520325194|FG001|Track 1|Disease progression|1|||
144305619|NCT02750514|520325195|FG002|Track 1|Disease progression|0|||
144305620|NCT02750514|520325196|FG003|Track 1|Disease progression|1|||
144305621|NCT02750514|520325197|FG004|Track 1|Disease progression|0|||
144305622|NCT02750514|520325193|FG000|Track 1|Adverse event unrelated to study drug|1|||
144305623|NCT02750514|520325194|FG001|Track 1|Adverse event unrelated to study drug|0|||
144305624|NCT02750514|520325195|FG002|Track 1|Adverse event unrelated to study drug|0|||
144305625|NCT02750514|520325196|FG003|Track 1|Adverse event unrelated to study drug|0|||
144305626|NCT02750514|520325197|FG004|Track 1|Adverse event unrelated to study drug|0|||
144305627|NCT02750514|520325193|FG000|Track 1|Study drug toxicity|4|||
144305628|NCT02750514|520325194|FG001|Track 1|Study drug toxicity|1|||
144305629|NCT02750514|520325195|FG002|Track 1|Study drug toxicity|0|||
144305630|NCT02750514|520325196|FG003|Track 1|Study drug toxicity|1|||
144305631|NCT02750514|520325197|FG004|Track 1|Study drug toxicity|0|||
144305632|NCT02750514|520325193|FG000|Track 1|Participant request to discontinue|1|||
144305633|NCT02750514|520325194|FG001|Track 1|Participant request to discontinue|0|||
144305634|NCT02750514|520325195|FG002|Track 1|Participant request to discontinue|0|||
144305635|NCT02750514|520325196|FG003|Track 1|Participant request to discontinue|0|||
144305636|NCT02750514|520325197|FG004|Track 1|Participant request to discontinue|0|||
144305637|NCT02750514|520325193|FG000|Track 1|Other reasons|1|||
144305638|NCT02750514|520325194|FG001|Track 1|Other reasons|0|||
144305639|NCT02750514|520325195|FG002|Track 1|Other reasons|0|||
144305640|NCT02750514|520325196|FG003|Track 1|Other reasons|0|||
144305641|NCT02750514|520325197|FG004|Track 1|Other reasons|0|||
144305642|NCT02750514|520325193|FG000|Track 2|Disease progression|4|||
144305643|NCT02750514|520325194|FG001|Track 2|Disease progression|5|||
144305644|NCT02750514|520325195|FG002|Track 2|Disease progression|2|||
144305645|NCT02750514|520325196|FG003|Track 2|Disease progression|5|||
144305646|NCT02750514|520325197|FG004|Track 2|Disease progression|0|||
144305647|NCT02750514|520325193|FG000|Track 2|Adverse event unrelated to study drug|1|||
144305648|NCT02750514|520325194|FG001|Track 2|Adverse event unrelated to study drug|0|||
144305649|NCT02750514|520325195|FG002|Track 2|Adverse event unrelated to study drug|0|||
144305650|NCT02750514|520325196|FG003|Track 2|Adverse event unrelated to study drug|0|||
144305651|NCT02750514|520325197|FG004|Track 2|Adverse event unrelated to study drug|0|||
144305652|NCT02750514|520325193|FG000|Track 2|Study drug toxicity|1|||
144305653|NCT02750514|520325194|FG001|Track 2|Study drug toxicity|2|||
144305654|NCT02750514|520325195|FG002|Track 2|Study drug toxicity|0|||
144305655|NCT02750514|520325196|FG003|Track 2|Study drug toxicity|2|||
144305656|NCT02750514|520325197|FG004|Track 2|Study drug toxicity|0|||
144305657|NCT02750514|520325193|FG000|Track 2|Participant withdrew consent|0|||
144305658|NCT02750514|520325194|FG001|Track 2|Participant withdrew consent|1|||
144305659|NCT02750514|520325195|FG002|Track 2|Participant withdrew consent|0|||
144305660|NCT02750514|520325196|FG003|Track 2|Participant withdrew consent|0|||
144305661|NCT02750514|520325197|FG004|Track 2|Participant withdrew consent|0|||
144305662|NCT02750514|520325193|FG000|Track 3|Disease progression|0|||
144305663|NCT02750514|520325194|FG001|Track 3|Disease progression|24|||
144305664|NCT02750514|520325195|FG002|Track 3|Disease progression|13|||
144305665|NCT02750514|520325196|FG003|Track 3|Disease progression|14|||
144305666|NCT02750514|520325197|FG004|Track 3|Disease progression|0|||
144305667|NCT02750514|520325193|FG000|Track 3|Adverse event unrelated to study drug|0|||
144305668|NCT02750514|520325194|FG001|Track 3|Adverse event unrelated to study drug|1|||
144305669|NCT02750514|520325195|FG002|Track 3|Adverse event unrelated to study drug|1|||
144305670|NCT02750514|520325196|FG003|Track 3|Adverse event unrelated to study drug|1|||
144305671|NCT02750514|520325197|FG004|Track 3|Adverse event unrelated to study drug|0|||
144305672|NCT02750514|520325193|FG000|Track 3|Study drug toxicity|0|||
144305673|NCT02750514|520325194|FG001|Track 3|Study drug toxicity|3|||
144305674|NCT02750514|520325195|FG002|Track 3|Study drug toxicity|0|||
144305675|NCT02750514|520325196|FG003|Track 3|Study drug toxicity|1|||
144305676|NCT02750514|520325197|FG004|Track 3|Study drug toxicity|0|||
144305677|NCT02750514|520325193|FG000|Track 3|Participant request to discontinue|0|||
144305678|NCT02750514|520325194|FG001|Track 3|Participant request to discontinue|2|||
144305679|NCT02750514|520325195|FG002|Track 3|Participant request to discontinue|0|||
144305680|NCT02750514|520325196|FG003|Track 3|Participant request to discontinue|0|||
144305681|NCT02750514|520325197|FG004|Track 3|Participant request to discontinue|0|||
144305682|NCT02750514|520325193|FG000|Track 3|Participant withdrew consent|0|||
144305683|NCT02750514|520325194|FG001|Track 3|Participant withdrew consent|3|||
144305684|NCT02750514|520325195|FG002|Track 3|Participant withdrew consent|1|||
144305685|NCT02750514|520325196|FG003|Track 3|Participant withdrew consent|0|||
144305686|NCT02750514|520325197|FG004|Track 3|Participant withdrew consent|0|||
144305687|NCT02750514|520325193|FG000|Track 3|Other reasons|0|||
144305688|NCT02750514|520325194|FG001|Track 3|Other reasons|3|||
144305689|NCT02750514|520325195|FG002|Track 3|Other reasons|0|||
144305690|NCT02750514|520325196|FG003|Track 3|Other reasons|0|||
144305691|NCT02750514|520325197|FG004|Track 3|Other reasons|0|||
144305692|NCT02750514|520325193|FG000|Track 4|Study drug toxicity|0|||
144305693|NCT02750514|520325194|FG001|Track 4|Study drug toxicity|6|||
144305694|NCT02750514|520325195|FG002|Track 4|Study drug toxicity|0|||
144305695|NCT02750514|520325196|FG003|Track 4|Study drug toxicity|5|||
144305696|NCT02750514|520325197|FG004|Track 4|Study drug toxicity|0|||
144305697|NCT02750514|520325193|FG000|Track 4|Participant request to discontinue|0|||
144305698|NCT02750514|520325194|FG001|Track 4|Participant request to discontinue|1|||
144305699|NCT02750514|520325195|FG002|Track 4|Participant request to discontinue|0|||
144305700|NCT02750514|520325196|FG003|Track 4|Participant request to discontinue|1|||
144305701|NCT02750514|520325197|FG004|Track 4|Participant request to discontinue|0|||
144305702|NCT02750514|520325193|FG000|Track 4|Participant withdrew consent|0|||
144305703|NCT02750514|520325194|FG001|Track 4|Participant withdrew consent|1|||
144305704|NCT02750514|520325195|FG002|Track 4|Participant withdrew consent|0|||
144305705|NCT02750514|520325196|FG003|Track 4|Participant withdrew consent|0|||
144305706|NCT02750514|520325197|FG004|Track 4|Participant withdrew consent|0|||
144305707|NCT02750514|520325193|FG000|Track 4|Other reasons|0|||
144305708|NCT02750514|520325194|FG001|Track 4|Other reasons|5|||
144305709|NCT02750514|520325195|FG002|Track 4|Other reasons|0|||
144305710|NCT02750514|520325196|FG003|Track 4|Other reasons|3|||
144305711|NCT02750514|520325197|FG004|Track 4|Other reasons|0|||
144305712|NCT02750514|520325193|FG000|Track 4|Disease progression|0|||
144305713|NCT02750514|520325194|FG001|Track 4|Disease progression|33|||
144305714|NCT02750514|520325195|FG002|Track 4|Disease progression|0|||
144305715|NCT02750514|520325196|FG003|Track 4|Disease progression|32|||
144305716|NCT02750514|520325197|FG004|Track 4|Disease progression|0|||
144305717|NCT02750514|520325193|FG000|Track 4|Adverse event unrelated to study drug|0|||
144305718|NCT02750514|520325194|FG001|Track 4|Adverse event unrelated to study drug|5|||
144305719|NCT02750514|520325195|FG002|Track 4|Adverse event unrelated to study drug|0|||
144305720|NCT02750514|520325196|FG003|Track 4|Adverse event unrelated to study drug|0|||
144305721|NCT02750514|520325197|FG004|Track 4|Adverse event unrelated to study drug|0|||
144305722|NCT02750514|520325193|FG000|Track 4|Death|0|||
144305723|NCT02750514|520325194|FG001|Track 4|Death|0|||
144305724|NCT02750514|520325195|FG002|Track 4|Death|0|||
144305725|NCT02750514|520325196|FG003|Track 4|Death|1|||
144305726|NCT02750514|520325197|FG004|Track 4|Death|0|||
144305727|NCT02750514|520325193|FG000|Track 5|Disease progression|0|||
144305728|NCT02750514|520325194|FG001|Track 5|Disease progression|0|||
144305729|NCT02750514|520325195|FG002|Track 5|Disease progression|0|||
144305730|NCT02750514|520325196|FG003|Track 5|Disease progression|0|||
144305731|NCT02750514|520325197|FG004|Track 5|Disease progression|34|||
144305732|NCT02750514|520325193|FG000|Track 5|Adverse event unrelated to study drug|0|||
144305733|NCT02750514|520325194|FG001|Track 5|Adverse event unrelated to study drug|0|||
144305734|NCT02750514|520325195|FG002|Track 5|Adverse event unrelated to study drug|0|||
144305735|NCT02750514|520325196|FG003|Track 5|Adverse event unrelated to study drug|0|||
144305736|NCT02750514|520325197|FG004|Track 5|Adverse event unrelated to study drug|2|||
144305737|NCT02750514|520325193|FG000|Track 5|Study drug toxicity|0|||
144305738|NCT02750514|520325194|FG001|Track 5|Study drug toxicity|0|||
144305739|NCT02750514|520325195|FG002|Track 5|Study drug toxicity|0|||
144305740|NCT02750514|520325196|FG003|Track 5|Study drug toxicity|0|||
144305741|NCT02750514|520325197|FG004|Track 5|Study drug toxicity|2|||
144305742|NCT02750514|520325193|FG000|Track 5|Participant request to discontinue|0|||
144305743|NCT02750514|520325194|FG001|Track 5|Participant request to discontinue|0|||
144305744|NCT02750514|520325195|FG002|Track 5|Participant request to discontinue|0|||
144305745|NCT02750514|520325196|FG003|Track 5|Participant request to discontinue|0|||
144305746|NCT02750514|520325197|FG004|Track 5|Participant request to discontinue|3|||
144305747|NCT02750514|520325193|FG000|Track 5|Other reasons|0|||
144305748|NCT02750514|520325194|FG001|Track 5|Other reasons|0|||
144305749|NCT02750514|520325195|FG002|Track 5|Other reasons|0|||
144305750|NCT02750514|520325196|FG003|Track 5|Other reasons|0|||
144305751|NCT02750514|520325197|FG004|Track 5|Other reasons|2|||
144305752|NCT01882465|520325198|FG000|Period 1|Lens Discomfort|0|||
144305753|NCT01882465|520325199|FG001|Period 1|Lens Discomfort|0|||
144305754|NCT01882465|520325200|FG002|Period 1|Lens Discomfort|0|||
144305755|NCT01882465|520325201|FG003|Period 1|Lens Discomfort|1|||
144305756|NCT01882465|520325202|FG004|Period 1|Lens Discomfort|0|||
144305757|NCT01882465|520325203|FG005|Period 1|Lens Discomfort|0|||
144305758|NCT01882465|520325204|FG006|Period 1|Lens Discomfort|0|||
144305759|NCT01882465|520325198|FG000|Period 1|Withdrawal by Subject|0|||
144305760|NCT01882465|520325199|FG001|Period 1|Withdrawal by Subject|0|||
144305761|NCT01882465|520325200|FG002|Period 1|Withdrawal by Subject|0|||
144305762|NCT01882465|520325201|FG003|Period 1|Withdrawal by Subject|0|||
144305763|NCT01882465|520325202|FG004|Period 1|Withdrawal by Subject|0|||
144305764|NCT01882465|520325203|FG005|Period 1|Withdrawal by Subject|0|||
144305765|NCT01882465|520325204|FG006|Period 1|Withdrawal by Subject|1|||
144305766|NCT01882465|520325198|FG000|Period 2|Protocol Violation|0|||
144305767|NCT01882465|520325199|FG001|Period 2|Protocol Violation|0|||
144305768|NCT01882465|520325200|FG002|Period 2|Protocol Violation|0|||
144305769|NCT01882465|520325201|FG003|Period 2|Protocol Violation|0|||
144305770|NCT01882465|520325202|FG004|Period 2|Protocol Violation|1|||
144305771|NCT01882465|520325203|FG005|Period 2|Protocol Violation|0|||
144305772|NCT01882465|520325204|FG006|Period 2|Protocol Violation|0|||
144305773|NCT01464879|520325205|FG000|Overall Study|Physician Decision|1|||
144305774|NCT01464879|520325205|FG000|Overall Study|Non-compliance|1|||
144305775|NCT00811720|520325206|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
144305776|NCT00811720|520325207|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
144305777|NCT00811720|520325206|FG000|All Treated Patients|Adverse Event|20|||
144305778|NCT00811720|520325207|FG001|All Treated Patients|Adverse Event|62|||
144305779|NCT00811720|520325206|FG000|All Treated Patients|Lack of Efficacy|22|||
144305780|NCT00811720|520325207|FG001|All Treated Patients|Lack of Efficacy|18|||
144305781|NCT00811720|520325206|FG000|All Treated Patients|Non-compliance|0|||
144305782|NCT00811720|520325207|FG001|All Treated Patients|Non-compliance|14|||
144305783|NCT00811720|520325206|FG000|All Treated Patients|Protocol Violation|9|||
144305784|NCT00811720|520325207|FG001|All Treated Patients|Protocol Violation|16|||
144305785|NCT00811720|520325206|FG000|All Treated Patients|Withdrawal by Subject|28|||
144305786|NCT00811720|520325207|FG001|All Treated Patients|Withdrawal by Subject|34|||
144305787|NCT00811720|520325206|FG000|All Treated Patients|Lost to Follow-up|10|||
144305788|NCT00811720|520325207|FG001|All Treated Patients|Lost to Follow-up|16|||
144305789|NCT00811720|520325206|FG000|All Treated Patients|Other Reason|7|||
144305790|NCT00811720|520325207|FG001|All Treated Patients|Other Reason|4|||
144305791|NCT03894891|520325208|FG000|Overall Study|Withdrawal by Subject|1|||
144305792|NCT03894891|520325208|FG000|Overall Study|Completed protocol treatment per protocol|5|||
144305793|NCT01824290|520325212|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
144305794|NCT01824290|520325213|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
144305795|NCT01824290|520325214|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
144305796|NCT01824290|520325215|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
144305797|NCT01824290|520325212|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
144305798|NCT01824290|520325213|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
144305799|NCT01824290|520325214|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
144305800|NCT01824290|520325215|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
144305801|NCT01824290|520325212|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
144305802|NCT01824290|520325213|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
144305803|NCT01824290|520325214|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
144305804|NCT01824290|520325215|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
144305805|NCT01824290|520325212|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
144305806|NCT01824290|520325213|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
144305807|NCT01824290|520325214|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
144305808|NCT01824290|520325215|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
144305809|NCT01824290|520325212|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
144305810|NCT01824290|520325213|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
144305811|NCT01824290|520325214|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
144305812|NCT01824290|520325215|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
144305813|NCT01824290|520325212|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
144305814|NCT01824290|520325213|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
144305815|NCT01824290|520325214|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
144305816|NCT01824290|520325215|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
144305817|NCT00800982|520325216|FG000|Overall Study|Lost to Follow-up|1|||
144305818|NCT00800982|520325217|FG001|Overall Study|Lost to Follow-up|2|||
144305819|NCT00800982|520325216|FG000|Overall Study|Withdrawal by Subject|0|||
144305820|NCT00800982|520325217|FG001|Overall Study|Withdrawal by Subject|1|||
144305821|NCT00800982|520325216|FG000|Overall Study|Patient moved out of state|1|||
144305822|NCT00800982|520325217|FG001|Overall Study|Patient moved out of state|0|||
144305823|NCT02779777|520325219|FG000|Overall Study|Disease Progression|1|||
144305824|NCT02779777|520325220|FG001|Overall Study|Disease Progression|0|||
144305825|NCT02779777|520325221|FG002|Overall Study|Disease Progression|0|||
144305826|NCT02779777|520325219|FG000|Overall Study|Adverse Event|3|||
144305827|NCT02779777|520325220|FG001|Overall Study|Adverse Event|1|||
144305828|NCT02779777|520325221|FG002|Overall Study|Adverse Event|0|||
144305829|NCT02779777|520325219|FG000|Overall Study|Physician Decision|9|||
144305830|NCT02779777|520325220|FG001|Overall Study|Physician Decision|0|||
144305831|NCT02779777|520325221|FG002|Overall Study|Physician Decision|1|||
144305832|NCT02779777|520325219|FG000|Overall Study|Withdrawal by Subject|1|||
144305833|NCT02779777|520325220|FG001|Overall Study|Withdrawal by Subject|0|||
144305834|NCT02779777|520325221|FG002|Overall Study|Withdrawal by Subject|0|||
144305835|NCT00539240|520325222|FG000|Overall Study|Withdrawal by Subject|0|||
144305836|NCT00539240|520325223|FG001|Overall Study|Withdrawal by Subject|2|||
144305837|NCT00539240|520325224|FG002|Overall Study|Withdrawal by Subject|0|||
144305838|NCT00539240|520325222|FG000|Overall Study|Protocol Violation|1|||
144305839|NCT00539240|520325223|FG001|Overall Study|Protocol Violation|1|||
144305840|NCT00539240|520325224|FG002|Overall Study|Protocol Violation|4|||
144305841|NCT00539240|520325222|FG000|Overall Study|Lost to Follow-up|2|||
144305842|NCT00539240|520325223|FG001|Overall Study|Lost to Follow-up|3|||
144305843|NCT00539240|520325224|FG002|Overall Study|Lost to Follow-up|1|||
144305844|NCT00539240|520325222|FG000|Overall Study|Adverse Event|3|||
144305845|NCT00539240|520325223|FG001|Overall Study|Adverse Event|1|||
144305846|NCT00539240|520325224|FG002|Overall Study|Adverse Event|10|||
144305847|NCT00716274|520325225|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
144305848|NCT00716274|520325226|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
144305849|NCT00716274|520325227|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
144305850|NCT00716274|520325228|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
144305851|NCT00716274|520325229|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
144305852|NCT00716274|520325230|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
144305853|NCT00716274|520325225|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
144305854|NCT00716274|520325226|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
144305855|NCT00716274|520325227|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
144305856|NCT00716274|520325228|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
144305857|NCT00716274|520325229|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
144305858|NCT00716274|520325230|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
144305859|NCT00716274|520325225|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
144305860|NCT00716274|520325226|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
144305861|NCT00716274|520325227|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
144305862|NCT00716274|520325228|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
144305863|NCT00716274|520325229|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
144305864|NCT00716274|520325230|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
144305865|NCT00716274|520325225|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
144305866|NCT00716274|520325226|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
144305867|NCT00716274|520325227|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
144305868|NCT00716274|520325228|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
144305869|NCT00716274|520325229|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
144305870|NCT00716274|520325230|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
144305871|NCT00716274|520325225|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
144305872|NCT00716274|520325226|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
144305873|NCT00716274|520325227|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
144305874|NCT00716274|520325228|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
144305875|NCT00716274|520325229|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
144305876|NCT00716274|520325230|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
144305877|NCT00716274|520325225|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
144305878|NCT00716274|520325226|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
144305879|NCT00716274|520325227|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
144305880|NCT00716274|520325228|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
144305881|NCT00716274|520325229|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
144305882|NCT00716274|520325230|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
144305883|NCT00716274|520325225|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
144305884|NCT00716274|520325226|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
144305885|NCT00716274|520325227|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
144305886|NCT00716274|520325228|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
144305887|NCT00716274|520325229|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
144305888|NCT00716274|520325230|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
144305889|NCT00716274|520325225|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
144305890|NCT00716274|520325226|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
144305891|NCT00716274|520325227|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
144305892|NCT00716274|520325228|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
144305893|NCT00716274|520325229|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
144305894|NCT00716274|520325230|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
144305895|NCT00716274|520325225|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
144305896|NCT00716274|520325226|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
144305897|NCT00716274|520325227|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
144305898|NCT00716274|520325228|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
144305899|NCT00716274|520325229|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
144305900|NCT00716274|520325230|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
144305901|NCT00716274|520325225|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
144305902|NCT00716274|520325226|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
144305903|NCT00716274|520325227|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
144305904|NCT00716274|520325228|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
144305905|NCT00716274|520325229|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
144305906|NCT00716274|520325230|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
144305907|NCT01171677|520325231|FG000|Overall Study|Withdrawal by Subject|0|||
144305908|NCT01171677|520325232|FG001|Overall Study|Withdrawal by Subject|3|||
144305909|NCT01171677|520325231|FG000|Overall Study|Adverse Event|1|||
144305910|NCT01171677|520325232|FG001|Overall Study|Adverse Event|0|||
144305911|NCT01171677|520325231|FG000|Overall Study|completed <70% IntenSati classes|5|||
144305912|NCT01171677|520325232|FG001|Overall Study|completed <70% IntenSati classes|0|||
144305913|NCT00444106|520325248|FG000|Overall Study|Lost to Follow-up|2|||
144305914|NCT00444106|520325249|FG001|Overall Study|Lost to Follow-up|1|||
144305915|NCT00444106|520325250|FG002|Overall Study|Lost to Follow-up|0|||
144305916|NCT00444106|520325248|FG000|Overall Study|Abnormal Test Procedure Results|0|||
144305917|NCT00444106|520325249|FG001|Overall Study|Abnormal Test Procedure Results|0|||
144305918|NCT00444106|520325250|FG002|Overall Study|Abnormal Test Procedure Results|1|||
144305919|NCT01085214|520325251|FG000|Overall Study|Alternate treatment required|1|||
144305920|NCT01634152|520325252|FG000|Overall Study|Adverse Event|2|||
144305921|NCT01634152|520325253|FG001|Overall Study|Adverse Event|0|||
144305922|NCT01634152|520325254|FG002|Overall Study|Adverse Event|2|||
144305923|NCT01634152|520325252|FG000|Overall Study|Consent withdrawn not due to AE|1|||
144305924|NCT01634152|520325253|FG001|Overall Study|Consent withdrawn not due to AE|0|||
144305925|NCT01634152|520325254|FG002|Overall Study|Consent withdrawn not due to AE|1|||
144305926|NCT01634152|520325252|FG000|Overall Study|Not treated|0|||
144305927|NCT01634152|520325253|FG001|Overall Study|Not treated|1|||
144305928|NCT01634152|520325254|FG002|Overall Study|Not treated|0|||
144305929|NCT01634152|520325252|FG000|Overall Study|Other reason not defined above|1|||
144305930|NCT01634152|520325253|FG001|Overall Study|Other reason not defined above|0|||
144305931|NCT01634152|520325254|FG002|Overall Study|Other reason not defined above|1|||
144305932|NCT01152437|520325255|FG000|Overall Study|Other Adverse Event|8|||
144305933|NCT01152437|520325256|FG001|Overall Study|Other Adverse Event|1|||
144305934|NCT01152437|520325257|FG002|Overall Study|Other Adverse Event|7|||
144305935|NCT01152437|520325255|FG000|Overall Study|Not treated|0|||
144305936|NCT01152437|520325256|FG001|Overall Study|Not treated|1|||
144305937|NCT01152437|520325257|FG002|Overall Study|Not treated|2|||
144305938|NCT01152437|520325255|FG000|Overall Study|Progressive disease|27|||
144305939|NCT01152437|520325256|FG001|Overall Study|Progressive disease|13|||
144305940|NCT01152437|520325257|FG002|Overall Study|Progressive disease|32|||
144305941|NCT01152437|520325255|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
144305942|NCT01152437|520325256|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
144305943|NCT01152437|520325257|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
144305944|NCT01900665|520325258|FG000|Placebo Controlled Period|Death|9|||
144305945|NCT01900665|520325259|FG001|Placebo Controlled Period|Death|16|||
144305946|NCT01900665|520325258|FG000|Placebo Controlled Period|Adverse Event|48|||
144305947|NCT01900665|520325259|FG001|Placebo Controlled Period|Adverse Event|39|||
144305948|NCT01900665|520325258|FG000|Placebo Controlled Period|Protocol Violation|1|||
144305949|NCT01900665|520325259|FG001|Placebo Controlled Period|Protocol Violation|7|||
144305950|NCT01900665|520325258|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
144305951|NCT01900665|520325259|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
144305952|NCT01900665|520325258|FG000|Placebo Controlled Period|Physician Decision|11|||
144305953|NCT01900665|520325259|FG001|Placebo Controlled Period|Physician Decision|7|||
144305954|NCT01900665|520325258|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
144305955|NCT01900665|520325259|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
144305956|NCT01900665|520325258|FG000|Placebo Controlled Period|Caregiver Decision|33|||
144305957|NCT01900665|520325259|FG001|Placebo Controlled Period|Caregiver Decision|41|||
144305958|NCT01900665|520325258|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
144305959|NCT01900665|520325259|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
144305960|NCT01900665|520325258|FG000|Open Label Period|Adverse Event|16|||
144305961|NCT01900665|520325259|FG001|Open Label Period|Adverse Event|20|||
144305962|NCT01900665|520325258|FG000|Open Label Period|Death|5|||
144305963|NCT01900665|520325259|FG001|Open Label Period|Death|6|||
144305964|NCT01900665|520325258|FG000|Open Label Period|Lost to Follow-up|1|||
144305965|NCT01900665|520325259|FG001|Open Label Period|Lost to Follow-up|1|||
144305966|NCT01900665|520325258|FG000|Open Label Period|Parent/Caregiver Decision|33|||
144305967|NCT01900665|520325259|FG001|Open Label Period|Parent/Caregiver Decision|34|||
144305968|NCT01900665|520325258|FG000|Open Label Period|Physician Decision|4|||
144305969|NCT01900665|520325259|FG001|Open Label Period|Physician Decision|4|||
144305970|NCT01900665|520325258|FG000|Open Label Period|Protocol Violation|0|||
144305971|NCT01900665|520325259|FG001|Open Label Period|Protocol Violation|1|||
144305972|NCT01900665|520325258|FG000|Open Label Period|Sponsor Decision|802|||
144305973|NCT01900665|520325259|FG001|Open Label Period|Sponsor Decision|765|||
144305974|NCT01900665|520325258|FG000|Open Label Period|Withdrawal by Subject|20|||
144305975|NCT01900665|520325259|FG001|Open Label Period|Withdrawal by Subject|28|||
144305976|NCT04046939|520325261|FG000|Primary Assessment Period|Adverse Event|1|||
144305977|NCT04046939|520325262|FG001|Primary Assessment Period|Adverse Event|0|||
144305978|NCT04046939|520325263|FG002|Primary Assessment Period|Adverse Event|0|||
144305979|NCT04046939|520325264|FG003|Primary Assessment Period|Adverse Event|0|||
144305980|NCT04046939|520325261|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
144305981|NCT04046939|520325262|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
144305982|NCT04046939|520325263|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
144305983|NCT04046939|520325264|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
144305984|NCT04046939|520325261|FG000|Primary Assessment Period|Physician Decision|0|||
144305985|NCT04046939|520325262|FG001|Primary Assessment Period|Physician Decision|0|||
144305986|NCT04046939|520325263|FG002|Primary Assessment Period|Physician Decision|1|||
144305987|NCT04046939|520325264|FG003|Primary Assessment Period|Physician Decision|0|||
144305988|NCT04046939|520325261|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
144305989|NCT04046939|520325262|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
144305990|NCT04046939|520325263|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
144305991|NCT04046939|520325264|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
144305992|NCT00403130|520325265|FG000|2 Years From Start of Treatment|Not Eligible|3|||
144305993|NCT00403130|520325265|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
144305994|NCT00403130|520325265|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
144305995|NCT00403130|520325265|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
144305996|NCT00806260|520325266|FG000|Period 1 (1 Day)|Adverse Event|0|||
144305997|NCT00806260|520325267|FG001|Period 1 (1 Day)|Adverse Event|0|||
144305998|NCT00806260|520325268|FG002|Period 1 (1 Day)|Adverse Event|0|||
144305999|NCT00806260|520325269|FG003|Period 1 (1 Day)|Adverse Event|0|||
144306000|NCT00806260|520325270|FG004|Period 1 (1 Day)|Adverse Event|3|||
144306001|NCT00806260|520325271|FG005|Period 1 (1 Day)|Adverse Event|0|||
144306002|NCT00806260|520325266|FG000|Period 2|Adverse Event|0|||
144306003|NCT00806260|520325267|FG001|Period 2|Adverse Event|0|||
144306004|NCT00806260|520325268|FG002|Period 2|Adverse Event|0|||
144306005|NCT00806260|520325269|FG003|Period 2|Adverse Event|1|||
144306006|NCT00806260|520325270|FG004|Period 2|Adverse Event|0|||
144306007|NCT00806260|520325271|FG005|Period 2|Adverse Event|0|||
144306008|NCT00806260|520325266|FG000|Period 2|Protocol Violation|1|||
144306009|NCT00806260|520325267|FG001|Period 2|Protocol Violation|0|||
144306010|NCT00806260|520325268|FG002|Period 2|Protocol Violation|1|||
144306011|NCT00806260|520325269|FG003|Period 2|Protocol Violation|0|||
144306012|NCT00806260|520325270|FG004|Period 2|Protocol Violation|0|||
144306013|NCT00806260|520325271|FG005|Period 2|Protocol Violation|0|||
144306014|NCT00806260|520325266|FG000|Period 2|Need to take concomitant medication|1|||
144306015|NCT00806260|520325267|FG001|Period 2|Need to take concomitant medication|0|||
144306016|NCT00806260|520325268|FG002|Period 2|Need to take concomitant medication|0|||
144306017|NCT00806260|520325269|FG003|Period 2|Need to take concomitant medication|0|||
144306018|NCT00806260|520325270|FG004|Period 2|Need to take concomitant medication|0|||
144306019|NCT00806260|520325271|FG005|Period 2|Need to take concomitant medication|0|||
144306020|NCT00806260|520325266|FG000|Period 2|sponsor request|0|||
144306021|NCT00806260|520325267|FG001|Period 2|sponsor request|0|||
144306022|NCT00806260|520325268|FG002|Period 2|sponsor request|1|||
144306023|NCT00806260|520325269|FG003|Period 2|sponsor request|1|||
144306024|NCT00806260|520325270|FG004|Period 2|sponsor request|0|||
144306025|NCT00806260|520325271|FG005|Period 2|sponsor request|0|||
144306026|NCT00806260|520325266|FG000|Period 3|Protocol Violation|0|||
144306027|NCT00806260|520325267|FG001|Period 3|Protocol Violation|1|||
144306028|NCT00806260|520325268|FG002|Period 3|Protocol Violation|1|||
144306029|NCT00806260|520325269|FG003|Period 3|Protocol Violation|0|||
144306030|NCT00806260|520325270|FG004|Period 3|Protocol Violation|0|||
144306031|NCT00806260|520325271|FG005|Period 3|Protocol Violation|0|||
144306032|NCT00806260|520325266|FG000|Period 3|Pregnancy|1|||
144306033|NCT00806260|520325267|FG001|Period 3|Pregnancy|0|||
144306034|NCT00806260|520325268|FG002|Period 3|Pregnancy|0|||
144306035|NCT00806260|520325269|FG003|Period 3|Pregnancy|0|||
144306036|NCT00806260|520325270|FG004|Period 3|Pregnancy|0|||
144306037|NCT00806260|520325271|FG005|Period 3|Pregnancy|0|||
144306038|NCT00237042|520325272|FG000|Treatment|Became ineligible post-randomization|0|||
144306039|NCT00237042|520325273|FG001|Treatment|Became ineligible post-randomization|1|||
144306040|NCT00237042|520325274|FG002|Treatment|Became ineligible post-randomization|16|||
144306041|NCT00237042|520325272|FG000|Treatment|Moved out of state|1|||
144306042|NCT00237042|520325273|FG001|Treatment|Moved out of state|1|||
144306043|NCT00237042|520325274|FG002|Treatment|Moved out of state|1|||
144306044|NCT00237042|520325272|FG000|Treatment|Completed no treatment|5|||
144306045|NCT00237042|520325273|FG001|Treatment|Completed no treatment|5|||
144306046|NCT00237042|520325274|FG002|Treatment|Completed no treatment|21|||
144306047|NCT00237042|520325272|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
144306048|NCT00237042|520325273|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
144306049|NCT00237042|520325274|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
144306050|NCT00237042|520325272|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
144306051|NCT00237042|520325273|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
144306052|NCT00237042|520325274|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
144306053|NCT01897532|520325276|FG000|Discontinuation From Treatment|Not Treated|7|||
144306054|NCT01897532|520325277|FG001|Discontinuation From Treatment|Not Treated|5|||
144306055|NCT01897532|520325276|FG000|Discontinuation From Treatment|Other reason than specified|196|||
144306056|NCT01897532|520325277|FG001|Discontinuation From Treatment|Other reason than specified|176|||
144306057|NCT01897532|520325276|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
144306058|NCT01897532|520325277|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
144306059|NCT01897532|520325276|FG000|Discontinuation From Treatment|Non compliance|24|||
144306060|NCT01897532|520325277|FG001|Discontinuation From Treatment|Non compliance|15|||
144306061|NCT01897532|520325276|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
144306062|NCT01897532|520325277|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
144306063|NCT01897532|520325276|FG000|Discontinuation From Trial|Not Treated|7|||
144306064|NCT01897532|520325277|FG001|Discontinuation From Trial|Not Treated|5|||
144306065|NCT01897532|520325276|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
144306066|NCT01897532|520325277|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
144306067|NCT01074931|520325279|FG000|Overall Study|Economic reasons|1|||
144306068|NCT01074931|520325279|FG000|Overall Study|Death|5|||
144306069|NCT03132467|520325280|FG000|Overall Study|Adverse Event|2|||
144306070|NCT03132467|520325280|FG000|Overall Study|Withdrawal by Subject|2|||
144306071|NCT00953706|520325283|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
144306072|NCT00953706|520325284|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
144306073|NCT00953706|520325285|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
144306074|NCT00953706|520325286|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
144306075|NCT00953706|520325283|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
144306076|NCT00953706|520325284|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
144306077|NCT00953706|520325285|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
144306078|NCT00953706|520325286|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
144306079|NCT00953706|520325283|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
144306080|NCT00953706|520325284|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
144306081|NCT00953706|520325285|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
144306082|NCT00953706|520325286|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
144306083|NCT00953706|520325283|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
144306084|NCT00953706|520325284|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
144306085|NCT00953706|520325285|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
144306086|NCT00953706|520325286|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
144306087|NCT00953706|520325283|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
144306088|NCT00953706|520325284|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
144306089|NCT00953706|520325285|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
144306090|NCT00953706|520325286|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
144306091|NCT00953706|520325283|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
144306092|NCT00953706|520325284|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
144306093|NCT00953706|520325285|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
144306094|NCT00953706|520325286|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
144306095|NCT00953706|520325283|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
144306096|NCT00953706|520325284|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
144306097|NCT00953706|520325285|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
144306098|NCT00953706|520325286|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
144306099|NCT00953706|520325283|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
144306100|NCT00953706|520325284|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
144306101|NCT00953706|520325285|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
144306102|NCT00953706|520325286|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
144306103|NCT00953706|520325283|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
144306104|NCT00953706|520325284|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
144306105|NCT00953706|520325285|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
144306106|NCT00953706|520325286|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
144306107|NCT00953706|520325283|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
144306108|NCT00953706|520325284|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
144306109|NCT00953706|520325285|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
144306110|NCT00953706|520325286|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
144306111|NCT00953706|520325283|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
144306112|NCT00953706|520325284|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
144306113|NCT00953706|520325285|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
144306114|NCT00953706|520325286|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
144306115|NCT05223673|520325287|FG000|Overall Study|Protocol Violation|1|||
144306116|NCT05223673|520325287|FG000|Overall Study|Study termination|6|||
144306117|NCT00027560|520325288|FG000|Overall Study|Withdrawal by Subject|1|||
144306118|NCT03559270|520325292|FG000|Overall Study|Adverse Event|6|||
144306119|NCT03559270|520325293|FG001|Overall Study|Adverse Event|5|||
144306120|NCT03559270|520325294|FG002|Overall Study|Adverse Event|3|||
144306121|NCT03559270|520325295|FG003|Overall Study|Adverse Event|0|||
144306122|NCT03559270|520325292|FG000|Overall Study|Lack of Efficacy|34|||
144306123|NCT03559270|520325293|FG001|Overall Study|Lack of Efficacy|52|||
144306124|NCT03559270|520325294|FG002|Overall Study|Lack of Efficacy|37|||
144306125|NCT03559270|520325295|FG003|Overall Study|Lack of Efficacy|2|||
144306126|NCT03559270|520325292|FG000|Overall Study|Death|0|||
144306127|NCT03559270|520325293|FG001|Overall Study|Death|2|||
144306128|NCT03559270|520325294|FG002|Overall Study|Death|0|||
144306129|NCT03559270|520325295|FG003|Overall Study|Death|0|||
144306130|NCT03559270|520325292|FG000|Overall Study|Lost to Follow-up|16|||
144306131|NCT03559270|520325293|FG001|Overall Study|Lost to Follow-up|4|||
144306132|NCT03559270|520325294|FG002|Overall Study|Lost to Follow-up|12|||
144306133|NCT03559270|520325295|FG003|Overall Study|Lost to Follow-up|3|||
144306134|NCT03559270|520325292|FG000|Overall Study|Sponsor Decision|38|||
144306135|NCT03559270|520325293|FG001|Overall Study|Sponsor Decision|31|||
144306136|NCT03559270|520325294|FG002|Overall Study|Sponsor Decision|35|||
144306137|NCT03559270|520325295|FG003|Overall Study|Sponsor Decision|18|||
144306138|NCT03559270|520325292|FG000|Overall Study|Withdrawal by Subject|19|||
144306139|NCT03559270|520325293|FG001|Overall Study|Withdrawal by Subject|21|||
144306140|NCT03559270|520325294|FG002|Overall Study|Withdrawal by Subject|18|||
144306141|NCT03559270|520325295|FG003|Overall Study|Withdrawal by Subject|7|||
144306142|NCT03559270|520325292|FG000|Overall Study|Physician Decision|3|||
144306143|NCT03559270|520325293|FG001|Overall Study|Physician Decision|2|||
144306144|NCT03559270|520325294|FG002|Overall Study|Physician Decision|1|||
144306145|NCT03559270|520325295|FG003|Overall Study|Physician Decision|0|||
144306146|NCT03559270|520325292|FG000|Overall Study|Pregnancy|0|||
144306147|NCT03559270|520325293|FG001|Overall Study|Pregnancy|1|||
144306148|NCT03559270|520325294|FG002|Overall Study|Pregnancy|0|||
144306149|NCT03559270|520325295|FG003|Overall Study|Pregnancy|0|||
144306150|NCT03559270|520325292|FG000|Overall Study|Protocol Violation|1|||
144306151|NCT03559270|520325293|FG001|Overall Study|Protocol Violation|0|||
144306152|NCT03559270|520325294|FG002|Overall Study|Protocol Violation|2|||
144306153|NCT03559270|520325295|FG003|Overall Study|Protocol Violation|0|||
144359544|NCT00001832|520522782|FG014|Treatment Period|Death during treatment|0|||
144359545|NCT00001832|520522768|FG000|Treatment Period|Not treated|0|||
144359546|NCT00001832|520522769|FG001|Treatment Period|Not treated|0|||
144359547|NCT00001832|520522770|FG002|Treatment Period|Not treated|0|||
144359548|NCT00001832|520522771|FG003|Treatment Period|Not treated|0|||
144359549|NCT00001832|520522772|FG004|Treatment Period|Not treated|0|||
144359550|NCT00001832|520522773|FG005|Treatment Period|Not treated|0|||
144359551|NCT00001832|520522774|FG006|Treatment Period|Not treated|0|||
144359552|NCT00001832|520522775|FG007|Treatment Period|Not treated|1|||
144359553|NCT00001832|520522776|FG008|Treatment Period|Not treated|0|||
144359554|NCT00001832|520522777|FG009|Treatment Period|Not treated|0|||
144359555|NCT00001832|520522778|FG010|Treatment Period|Not treated|0|||
144359556|NCT00001832|520522779|FG011|Treatment Period|Not treated|0|||
144359557|NCT00001832|520522780|FG012|Treatment Period|Not treated|0|||
144359558|NCT00001832|520522781|FG013|Treatment Period|Not treated|0|||
144359559|NCT00001832|520522782|FG014|Treatment Period|Not treated|0|||
144359560|NCT04529083|520522783|FG000|Overall Study|Withdrawal by Subject|3|||
144359561|NCT04196686|520522784|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
144359562|NCT04196686|520522785|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
144359563|NCT05106959|520522786|FG000|Overall Study|Lost to Follow-up|1|||
144359564|NCT00265564|520522789|FG000|Overall Study|Lost to Follow-up|5|||
144359565|NCT00265564|520522790|FG001|Overall Study|Lost to Follow-up|7|||
144359566|NCT00265564|520522789|FG000|Overall Study|met exclusion criteria|5|||
144359567|NCT00265564|520522790|FG001|Overall Study|met exclusion criteria|2|||
144359568|NCT03582215|520522793|FG000|Overall Study|Adverse Event|1|||
144359569|NCT03582215|520522794|FG001|Overall Study|Adverse Event|0|||
144359570|NCT03582215|520522795|FG002|Overall Study|Adverse Event|0|||
144359571|NCT03582215|520522796|FG003|Overall Study|Adverse Event|0|||
144359572|NCT03582215|520522797|FG004|Overall Study|Adverse Event|0|||
144359573|NCT03582215|520522798|FG005|Overall Study|Adverse Event|0|||
144359574|NCT03582215|520522799|FG006|Overall Study|Adverse Event|2|||
144359575|NCT03582215|520522800|FG007|Overall Study|Adverse Event|2|||
144359576|NCT00659061|520522801|FG000|Overall Study|Migration due to political unrest|21|||
144359577|NCT00659061|520522802|FG001|Overall Study|Migration due to political unrest|15|||
144359578|NCT03186209|520522805|FG000|Overall Study|Withdrawal by Subject|11|||
144359579|NCT03186209|520522806|FG001|Overall Study|Withdrawal by Subject|22|||
144359580|NCT03186209|520522805|FG000|Overall Study|Pregnancy|1|||
144359581|NCT03186209|520522806|FG001|Overall Study|Pregnancy|0|||
144359582|NCT03186209|520522805|FG000|Overall Study|Adverse Event|4|||
144359583|NCT03186209|520522806|FG001|Overall Study|Adverse Event|0|||
144359584|NCT03186209|520522805|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
144359585|NCT03186209|520522806|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
144359586|NCT03186209|520522805|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
144359587|NCT03186209|520522806|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
144359588|NCT03186209|520522805|FG000|Overall Study|Fail to meet randomization criteria|0|||
144359589|NCT03186209|520522806|FG001|Overall Study|Fail to meet randomization criteria|1|||
144359590|NCT03186209|520522805|FG000|Overall Study|Lost to Follow-up|0|||
144359591|NCT03186209|520522806|FG001|Overall Study|Lost to Follow-up|1|||
144359592|NCT01277744|520522807|FG000|Overall Study|Physician Decision|2|||
144359593|NCT00475670|520522810|FG000|Overall Study|Death|0|||
144359594|NCT00475670|520522811|FG001|Overall Study|Death|1|||
144359595|NCT00475670|520522810|FG000|Overall Study|Lack of Efficacy|3|||
144359596|NCT00475670|520522811|FG001|Overall Study|Lack of Efficacy|34|||
144359597|NCT00475670|520522810|FG000|Overall Study|Refused treatment|0|||
144359598|NCT00475670|520522811|FG001|Overall Study|Refused treatment|2|||
144359599|NCT00475670|520522810|FG000|Overall Study|Failure to Return|0|||
144359600|NCT00475670|520522811|FG001|Overall Study|Failure to Return|1|||
144359601|NCT00475670|520522810|FG000|Overall Study|Other|0|||
144359602|NCT00475670|520522811|FG001|Overall Study|Other|3|||
144359603|NCT05083351|520522817|FG000|Overall Study|Adverse Event|3|||
144359604|NCT05083351|520522817|FG000|Overall Study|Did not meet data inclusion criteria|8|||
144359605|NCT05083351|520522817|FG000|Overall Study|Did not meet eligibility criteria|19|||
144359606|NCT05083351|520522817|FG000|Overall Study|Study Staff Decision|19|||
144359607|NCT03416868|520522821|FG000|Overall Study|Withdrawal by Subject|2|||
144359608|NCT03416868|520522821|FG000|Overall Study|Lost to Follow-up|1|||
144359609|NCT03353675|520522823|FG000|Overall Study|Adverse Event|4|||
144359610|NCT03309020|520522824|FG000|Overall Study|Death|1|||
144359611|NCT03309020|520522825|FG001|Overall Study|Death|0|||
144359612|NCT03309020|520522824|FG000|Overall Study|Did not undergo surgery|2|||
144359613|NCT03309020|520522825|FG001|Overall Study|Did not undergo surgery|1|||
144359614|NCT00402168|520522826|FG000|Randomized|Lost to Follow-up|1|||
144359615|NCT00402168|520522827|FG001|Randomized|Lost to Follow-up|0|||
144359616|NCT00402168|520522826|FG000|Randomized|Withdrawal by Subject|0|||
144359617|NCT00402168|520522827|FG001|Randomized|Withdrawal by Subject|1|||
144306154|NCT01783444|520326866|FG000|Treatment Phase|Adverse Event|9|||
144306155|NCT01783444|520326867|FG001|Treatment Phase|Adverse Event|20|||
144306156|NCT01783444|520326868|FG002|Treatment Phase|Adverse Event|19|||
144306157|NCT01783444|520326866|FG000|Treatment Phase|Disease Progression|76|||
144306158|NCT01783444|520326867|FG001|Treatment Phase|Disease Progression|66|||
144306159|NCT01783444|520326868|FG002|Treatment Phase|Disease Progression|64|||
144306160|NCT01783444|520326866|FG000|Treatment Phase|Death|2|||
144306161|NCT01783444|520326867|FG001|Treatment Phase|Death|2|||
144306162|NCT01783444|520326868|FG002|Treatment Phase|Death|2|||
144306163|NCT01783444|520326866|FG000|Treatment Phase|Protocol Violation|1|||
144306164|NCT01783444|520326867|FG001|Treatment Phase|Protocol Violation|1|||
144306165|NCT01783444|520326868|FG002|Treatment Phase|Protocol Violation|2|||
144306166|NCT01783444|520326866|FG000|Treatment Phase|Withdrawal by Subject|6|||
144306167|NCT01783444|520326867|FG001|Treatment Phase|Withdrawal by Subject|8|||
144306168|NCT01783444|520326868|FG002|Treatment Phase|Withdrawal by Subject|9|||
144306169|NCT01783444|520326866|FG000|Treatment Phase|Administrative problems|2|||
144306170|NCT01783444|520326867|FG001|Treatment Phase|Administrative problems|0|||
144306171|NCT01783444|520326868|FG002|Treatment Phase|Administrative problems|1|||
144306172|NCT01783444|520326866|FG000|Treatment Phase|Physician Decision|8|||
144306173|NCT01783444|520326867|FG001|Treatment Phase|Physician Decision|6|||
144306174|NCT01783444|520326868|FG002|Treatment Phase|Physician Decision|5|||
144306175|NCT01783444|520326866|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
144306176|NCT01783444|520326867|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
144306177|NCT01783444|520326868|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
144306178|NCT01783444|520326866|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
144306179|NCT01783444|520326867|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
144306180|NCT01783444|520326868|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
144306181|NCT01783444|520326866|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
144306182|NCT01783444|520326867|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
144306183|NCT01783444|520326868|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
144306184|NCT01783444|520326866|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
144306185|NCT01783444|520326867|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
144306186|NCT01783444|520326868|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
144306187|NCT01783444|520326866|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
144306188|NCT01783444|520326867|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
144306189|NCT01783444|520326868|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
144306190|NCT01783444|520326866|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
144306191|NCT01783444|520326867|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
144306192|NCT01783444|520326868|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
144306193|NCT00552071|520326869|FG000|Overall Study|Adverse Event|1|||
144306194|NCT00552071|520326870|FG001|Overall Study|Adverse Event|0|||
144306195|NCT00552071|520326869|FG000|Overall Study|Lack of Efficacy|1|||
144306196|NCT00552071|520326870|FG001|Overall Study|Lack of Efficacy|0|||
144306197|NCT00552071|520326869|FG000|Overall Study|Physician Decision|1|||
144306198|NCT00552071|520326870|FG001|Overall Study|Physician Decision|0|||
144306199|NCT00552071|520326869|FG000|Overall Study|Pregnancy|1|||
144306200|NCT00552071|520326870|FG001|Overall Study|Pregnancy|0|||
144306201|NCT00552071|520326869|FG000|Overall Study|Death|0|||
144306202|NCT00552071|520326870|FG001|Overall Study|Death|1|||
144306203|NCT00552071|520326869|FG000|Overall Study|Withdrawal by Subject|0|||
144306204|NCT00552071|520326870|FG001|Overall Study|Withdrawal by Subject|1|||
144306205|NCT00937495|520326875|FG000|Overall Study|Protocol Violation|2|||
144306206|NCT00441272|520326876|FG000|Overall Study|Study terminated prior to enrollment|25|||
144306207|NCT00441272|520326877|FG001|Overall Study|Study terminated prior to enrollment|25|||
144306208|NCT01333722|520326878|FG000|Overall Study|Lack of Efficacy|0|||
144306209|NCT01333722|520326879|FG001|Overall Study|Lack of Efficacy|2|||
144306210|NCT01333722|520326878|FG000|Overall Study|Withdrawal by Subject|0|||
144306211|NCT01333722|520326879|FG001|Overall Study|Withdrawal by Subject|1|||
144306212|NCT04776161|520326882|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
144306213|NCT04776161|520326883|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
144306214|NCT04776161|520326884|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
144306215|NCT04776161|520326882|FG000|Overall Study|Withdrawal by Subject|1|||
144306216|NCT04776161|520326883|FG001|Overall Study|Withdrawal by Subject|0|||
144306217|NCT04776161|520326884|FG002|Overall Study|Withdrawal by Subject|1|||
144306218|NCT04776161|520326882|FG000|Overall Study|Adverse Event|0|||
144306219|NCT04776161|520326883|FG001|Overall Study|Adverse Event|1|||
144306220|NCT04776161|520326884|FG002|Overall Study|Adverse Event|1|||
144306221|NCT00342628|520326885|FG000|Overall Study|Withdrawal by Subject|19|||
144306222|NCT00342628|520326886|FG001|Overall Study|Withdrawal by Subject|19|||
144306223|NCT00342628|520326887|FG002|Overall Study|Withdrawal by Subject|18|||
144306224|NCT00342628|520326885|FG000|Overall Study|Death|1|||
144306225|NCT00342628|520326886|FG001|Overall Study|Death|1|||
144306226|NCT00342628|520326887|FG002|Overall Study|Death|0|||
144306227|NCT00342628|520326885|FG000|Overall Study|moved residence|0|||
144306228|NCT00342628|520326886|FG001|Overall Study|moved residence|1|||
144306229|NCT00342628|520326887|FG002|Overall Study|moved residence|1|||
144306230|NCT00954447|520326888|FG000|Overall Study|Adverse Event|33|||
144306231|NCT00954447|520326889|FG001|Overall Study|Adverse Event|25|||
144306232|NCT00954447|520326888|FG000|Overall Study|Lack of Efficacy|17|||
144306233|NCT00954447|520326889|FG001|Overall Study|Lack of Efficacy|3|||
144306234|NCT00954447|520326888|FG000|Overall Study|Protocol Violation|5|||
144306235|NCT00954447|520326889|FG001|Overall Study|Protocol Violation|7|||
144306236|NCT00954447|520326888|FG000|Overall Study|Lost to Follow-up|8|||
144306237|NCT00954447|520326889|FG001|Overall Study|Lost to Follow-up|14|||
144306238|NCT00954447|520326888|FG000|Overall Study|Withdrawal by Subject|26|||
144306239|NCT00954447|520326889|FG001|Overall Study|Withdrawal by Subject|21|||
144306240|NCT00954447|520326888|FG000|Overall Study|Other|21|||
144306241|NCT00954447|520326889|FG001|Overall Study|Other|18|||
144306242|NCT04592341|520326890|FG000|Overall Study|Physician Decision|5|||
144306243|NCT04592341|520326890|FG000|Overall Study|Study Terminated by Sponsor|5|||
144306244|NCT04592341|520326890|FG000|Overall Study|Withdrawal by Subject|53|||
144306245|NCT04592341|520326890|FG000|Overall Study|Lost to Follow-up|3|||
144306246|NCT04592341|520326890|FG000|Overall Study|Death|1|||
144306247|NCT04592341|520326890|FG000|Overall Study|Adverse Event|5|||
144306248|NCT04592341|520326890|FG000|Overall Study|other|4|||
144306249|NCT01944020|520326891|FG000|Overall Study|Withdrawal by Subject|5|||
144306250|NCT01944020|520326892|FG001|Overall Study|Withdrawal by Subject|0|||
144306251|NCT00692003|520326893|FG000|Overall Study|Sponsor Decision|5|||
144306252|NCT00692003|520326894|FG001|Overall Study|Sponsor Decision|1|||
144306253|NCT00661830|520326895|FG000|Overall Study|Death|37|||
144306254|NCT00661830|520326896|FG001|Overall Study|Death|33|||
144306255|NCT00661830|520326895|FG000|Overall Study|Lost to Follow-up|1|||
144306256|NCT00661830|520326896|FG001|Overall Study|Lost to Follow-up|3|||
144306257|NCT00661830|520326895|FG000|Overall Study|Withdrawal by Subject|1|||
144306258|NCT00661830|520326896|FG001|Overall Study|Withdrawal by Subject|1|||
144306259|NCT00661830|520326895|FG000|Overall Study|Other reason|1|||
144306260|NCT00661830|520326896|FG001|Overall Study|Other reason|5|||
144306261|NCT00488514|520326897|FG000|Overall Study|Adverse Event|41|||
144306262|NCT00488514|520326897|FG000|Overall Study|Lost to Follow-up|44|||
144306263|NCT00488514|520326897|FG000|Overall Study|Protocol Violation|32|||
144306264|NCT00488514|520326897|FG000|Overall Study|Withdrawal by Subject|106|||
144306265|NCT00488514|520326897|FG000|Overall Study|Lack of Efficacy|28|||
144306266|NCT00488514|520326897|FG000|Overall Study|Did not meet criteria for treatment|30|||
144306267|NCT00488514|520326897|FG000|Overall Study|Postive drug screen|1|||
144306268|NCT00488514|520326897|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
144306269|NCT00488514|520326897|FG000|Overall Study|Investigator decision|1|||
144306270|NCT00488514|520326897|FG000|Overall Study|Participant had too few migraines|5|||
144306271|NCT00488514|520326897|FG000|Overall Study|Increase in number of migraines|2|||
144306272|NCT00488514|520326897|FG000|Overall Study|Increased use of concomitant medication|1|||
144306273|NCT01535287|520326898|FG000|Overall Study|drug not prepared in time|5|||
144306274|NCT01535287|520326899|FG001|Overall Study|drug not prepared in time|6|||
144306275|NCT00517699|520326902|FG000|Overall Study|Withdrawal by Subject|1|||
144306276|NCT00517699|520326902|FG000|Overall Study|Lack of Efficacy|1|||
144306277|NCT00517699|520326902|FG000|Overall Study|Administrative error|1|||
144306278|NCT00517699|520326902|FG000|Overall Study|Study terminated by Sponsor|2|||
144306279|NCT00938912|520326907|FG000|Overall Study|Withdrawal by Subject|28|||
144306280|NCT00938912|520326907|FG000|Overall Study|Lost to Follow-up|4|||
144306281|NCT00938912|520326907|FG000|Overall Study|Lack of Efficacy|43|||
144306282|NCT00938912|520326907|FG000|Overall Study|Adverse event, non-fatal|24|||
144306283|NCT00938912|520326907|FG000|Overall Study|Adverse event, fatal|1|||
144306284|NCT00938912|520326907|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
144306285|NCT00938912|520326907|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
144306286|NCT00938912|520326907|FG000|Overall Study|Participant needed prohibit medication|1|||
144306287|NCT00938912|520326907|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
144306288|NCT00938912|520326907|FG000|Overall Study|Did not meet Eligibility criteria|1|||
144306289|NCT00938912|520326907|FG000|Overall Study|Participant relocated not related to AE|1|||
144306290|NCT00938912|520326907|FG000|Overall Study|Participant moved to another city|1|||
144306291|NCT00938912|520326907|FG000|Overall Study|Participant experienced break through seizures|1|||
144359618|NCT00402168|520522826|FG000|Treatment (up to 12 Months)|Death|0|||
144306292|NCT00938912|520326907|FG000|Overall Study|No longer wished to participate in the study|1|||
144306293|NCT00938912|520326907|FG000|Overall Study|Protocol Deviation|2|||
144306294|NCT03341637|520326908|FG000|Overall Study|Lost to Follow-up|1|||
144306295|NCT03341637|520326909|FG001|Overall Study|Lost to Follow-up|0|||
144306296|NCT03341637|520326908|FG000|Overall Study|Withdrawal by Subject|3|||
144306297|NCT03341637|520326909|FG001|Overall Study|Withdrawal by Subject|3|||
144306298|NCT03341637|520326908|FG000|Overall Study|Reason not Specified|1|||
144306299|NCT03341637|520326909|FG001|Overall Study|Reason not Specified|1|||
144306300|NCT00887159|520326910|FG000|Overall Study|Disease progression|6|||
144306301|NCT00887159|520326911|FG001|Overall Study|Disease progression|39|||
144306302|NCT00887159|520326912|FG002|Overall Study|Disease progression|33|||
144306303|NCT00887159|520326910|FG000|Overall Study|Adverse Event|3|||
144306304|NCT00887159|520326911|FG001|Overall Study|Adverse Event|4|||
144306305|NCT00887159|520326912|FG002|Overall Study|Adverse Event|17|||
144306306|NCT00887159|520326910|FG000|Overall Study|Death|2|||
144306307|NCT00887159|520326911|FG001|Overall Study|Death|2|||
144306308|NCT00887159|520326912|FG002|Overall Study|Death|0|||
144306309|NCT00887159|520326910|FG000|Overall Study|Withdrawal by Subject|4|||
144306310|NCT00887159|520326911|FG001|Overall Study|Withdrawal by Subject|4|||
144306311|NCT00887159|520326912|FG002|Overall Study|Withdrawal by Subject|2|||
144306312|NCT00887159|520326910|FG000|Overall Study|Alternative therapy|2|||
144306313|NCT00887159|520326911|FG001|Overall Study|Alternative therapy|0|||
144306314|NCT00887159|520326912|FG002|Overall Study|Alternative therapy|0|||
144306315|NCT00887159|520326910|FG000|Overall Study|Physician Decision|1|||
144306316|NCT00887159|520326911|FG001|Overall Study|Physician Decision|1|||
144306317|NCT00887159|520326912|FG002|Overall Study|Physician Decision|0|||
144306318|NCT00887159|520326910|FG000|Overall Study|Sympomatic deterioration|1|||
144306319|NCT00887159|520326911|FG001|Overall Study|Sympomatic deterioration|0|||
144306320|NCT00887159|520326912|FG002|Overall Study|Sympomatic deterioration|0|||
144306321|NCT00887159|520326910|FG000|Overall Study|Treatment delayed|1|||
144306322|NCT00887159|520326911|FG001|Overall Study|Treatment delayed|1|||
144306323|NCT00887159|520326912|FG002|Overall Study|Treatment delayed|0|||
144306324|NCT00887159|520326910|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
144306325|NCT00887159|520326911|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
144306326|NCT00887159|520326912|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
144306327|NCT00887159|520326910|FG000|Overall Study|Received more tx instead of observation|1|||
144306328|NCT00887159|520326911|FG001|Overall Study|Received more tx instead of observation|0|||
144306329|NCT00887159|520326912|FG002|Overall Study|Received more tx instead of observation|0|||
144306330|NCT00887159|520326910|FG000|Overall Study|Ineligible|5|||
144306331|NCT00887159|520326911|FG001|Overall Study|Ineligible|1|||
144306332|NCT00887159|520326912|FG002|Overall Study|Ineligible|0|||
144306333|NCT00887159|520326910|FG000|Overall Study|Never started assigned therapy|3|||
144306334|NCT00887159|520326911|FG001|Overall Study|Never started assigned therapy|3|||
144306335|NCT00887159|520326912|FG002|Overall Study|Never started assigned therapy|4|||
144306336|NCT00803738|520326918|FG000|Overall Study|Adverse Event|3|||
144306337|NCT00803738|520326919|FG001|Overall Study|Adverse Event|5|||
144306338|NCT00803738|520326918|FG000|Overall Study|Lost to Follow-up|4|||
144306339|NCT00803738|520326919|FG001|Overall Study|Lost to Follow-up|4|||
144306340|NCT00803738|520326918|FG000|Overall Study|Protocol Violation|18|||
144306341|NCT00803738|520326919|FG001|Overall Study|Protocol Violation|10|||
144306342|NCT00803738|520326918|FG000|Overall Study|Withdrawal by Subject|1|||
144306343|NCT00803738|520326919|FG001|Overall Study|Withdrawal by Subject|4|||
144306344|NCT00803738|520326918|FG000|Overall Study|Lack of Efficacy|10|||
144306345|NCT00803738|520326919|FG001|Overall Study|Lack of Efficacy|16|||
144306346|NCT00803738|520326918|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
144306347|NCT00803738|520326919|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
144306348|NCT00803738|520326918|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
144306349|NCT00803738|520326919|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
144306350|NCT06164691|520326920|FG000|Overall Study|Withdrawal by Subject|2|||
144306351|NCT06164691|520326921|FG001|Overall Study|Withdrawal by Subject|0|||
144306352|NCT06164691|520326922|FG002|Overall Study|Withdrawal by Subject|0|||
144306353|NCT00812955|520326923|FG000|Overall Study|Adverse Event|7|||
144306354|NCT00812955|520326924|FG001|Overall Study|Adverse Event|6|||
144306355|NCT00812955|520326925|FG002|Overall Study|Adverse Event|3|||
144306356|NCT00812955|520326926|FG003|Overall Study|Adverse Event|4|||
144306357|NCT00812955|520326923|FG000|Overall Study|Lost to Follow-up|2|||
144306358|NCT00812955|520326924|FG001|Overall Study|Lost to Follow-up|1|||
144306359|NCT00812955|520326925|FG002|Overall Study|Lost to Follow-up|1|||
144306360|NCT00812955|520326926|FG003|Overall Study|Lost to Follow-up|2|||
144306361|NCT00812955|520326923|FG000|Overall Study|Withdrawal by Subject|1|||
144306362|NCT00812955|520326924|FG001|Overall Study|Withdrawal by Subject|0|||
144306363|NCT00812955|520326925|FG002|Overall Study|Withdrawal by Subject|1|||
144306364|NCT00812955|520326926|FG003|Overall Study|Withdrawal by Subject|2|||
144306365|NCT00812955|520326923|FG000|Overall Study|randomized in error|0|||
144306366|NCT00812955|520326924|FG001|Overall Study|randomized in error|0|||
144306367|NCT00812955|520326925|FG002|Overall Study|randomized in error|1|||
144306368|NCT00812955|520326926|FG003|Overall Study|randomized in error|0|||
144306369|NCT01127633|520326928|FG000|Overall Study|Adverse Event|74|||
144306370|NCT01127633|520326929|FG001|Overall Study|Adverse Event|73|||
144306371|NCT01127633|520326928|FG000|Overall Study|Death|40|||
144306372|NCT01127633|520326929|FG001|Overall Study|Death|43|||
144306373|NCT01127633|520326928|FG000|Overall Study|Lost to Follow-up|4|||
144306374|NCT01127633|520326929|FG001|Overall Study|Lost to Follow-up|0|||
144306375|NCT01127633|520326928|FG000|Overall Study|Parent/Caregiver Decision|246|||
144306376|NCT01127633|520326929|FG001|Overall Study|Parent/Caregiver Decision|228|||
144306377|NCT01127633|520326928|FG000|Overall Study|Physician Decision|60|||
144306378|NCT01127633|520326929|FG001|Overall Study|Physician Decision|45|||
144306379|NCT01127633|520326928|FG000|Overall Study|Withdrawal by Subject|57|||
144306380|NCT01127633|520326929|FG001|Overall Study|Withdrawal by Subject|72|||
144306381|NCT01127633|520326928|FG000|Overall Study|Sponsor Decision|163|||
144306382|NCT01127633|520326929|FG001|Overall Study|Sponsor Decision|195|||
144306383|NCT01127633|520326928|FG000|Overall Study|Protocol Violation|8|||
144306384|NCT01127633|520326929|FG001|Overall Study|Protocol Violation|16|||
144306385|NCT01127633|520326928|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
144306386|NCT01127633|520326929|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
144306387|NCT01127633|520326928|FG000|Overall Study|Not treated|1|||
144306388|NCT01127633|520326929|FG001|Overall Study|Not treated|0|||
144306389|NCT02805790|520326932|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
144306390|NCT02805790|520326933|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
144306391|NCT02897115|520326938|FG000|Overall Study|Early termination of study by sponsor|11|||
144306392|NCT02897115|520326939|FG001|Overall Study|Early termination of study by sponsor|8|||
144306393|NCT00856323|520326941|FG000|Overall Study|Withdrawal by Subject|2|||
144306394|NCT01428219|520326945|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
144306395|NCT00775268|520326948|FG000|Baseline|Drug not synthesize dose|1|||
144306396|NCT00775268|520326949|FG001|Baseline|Drug not synthesize dose|0|||
144306397|NCT00775268|520326948|FG000|Baseline|Not treated-ineligible per CT|0|||
144306398|NCT00775268|520326949|FG001|Baseline|Not treated-ineligible per CT|1|||
144306399|NCT00775268|520326948|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
144306400|NCT00775268|520326949|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
144306401|NCT00775268|520326948|FG000|After Completion|Participant missed scan appointment|1|||
144306402|NCT00775268|520326949|FG001|After Completion|Participant missed scan appointment|0|||
144306403|NCT00825994|520326950|FG000|Overall Study|Withdrawal by Subject|2|||
144306404|NCT00825994|520326950|FG000|Overall Study|Lost to Follow-up|1|||
144306405|NCT00825994|520326950|FG000|Overall Study|Protocol Violation|1|||
144306406|NCT00825994|520326950|FG000|Overall Study|Placebo Responder at V2|1|||
144306407|NCT00616642|520326952|FG000|Overall Study|Withdrawal by Subject|0|||
144306408|NCT00616642|520326953|FG001|Overall Study|Withdrawal by Subject|1|||
144306409|NCT04232943|520326955|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
144306410|NCT04232943|520326956|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
144306411|NCT04232943|520326957|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
144306412|NCT04232943|520326955|FG000|Overall Study|Withdrawal by Subject|1|||
144306413|NCT04232943|520326956|FG001|Overall Study|Withdrawal by Subject|1|||
144306414|NCT04232943|520326957|FG002|Overall Study|Withdrawal by Subject|0|||
144306415|NCT01673646|520326966|FG000|Overall Study|Adverse Event|2|||
144306416|NCT01673646|520326967|FG001|Overall Study|Adverse Event|1|||
144306417|NCT01673646|520326968|FG002|Overall Study|Adverse Event|1|||
144306418|NCT01673646|520326966|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144306419|NCT01673646|520326967|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144306420|NCT01673646|520326968|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144306421|NCT01673646|520326966|FG000|Overall Study|Condition no longer requires study drug|0|||
144306422|NCT01673646|520326967|FG001|Overall Study|Condition no longer requires study drug|1|||
144306423|NCT01673646|520326968|FG002|Overall Study|Condition no longer requires study drug|0|||
144306424|NCT01673646|520326966|FG000|Overall Study|Withdrawal by Subject|0|||
144306425|NCT01673646|520326967|FG001|Overall Study|Withdrawal by Subject|2|||
144306426|NCT01673646|520326968|FG002|Overall Study|Withdrawal by Subject|2|||
144306427|NCT01673646|520326966|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
144306428|NCT01673646|520326967|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
144306429|NCT01673646|520326968|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
144306430|NCT01881009|520326969|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
144306431|NCT01881009|520326970|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
144306432|NCT01194245|520326971|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
144306433|NCT01194245|520326972|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
144306434|NCT01194245|520326973|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
144306435|NCT01194245|520326974|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
144306436|NCT01194245|520326975|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
144306437|NCT01194245|520326971|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
144306438|NCT01194245|520326972|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
144306439|NCT01194245|520326973|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
144306440|NCT01194245|520326974|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
144306441|NCT01194245|520326975|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
144306442|NCT01194245|520326971|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
144306443|NCT01194245|520326972|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
144306444|NCT01194245|520326973|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
144306445|NCT01194245|520326974|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
144306446|NCT01194245|520326975|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
144306447|NCT01194245|520326971|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
144306448|NCT01194245|520326972|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
144306449|NCT01194245|520326973|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
144306450|NCT01194245|520326974|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
144306451|NCT01194245|520326975|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
144306452|NCT01194245|520326971|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144306453|NCT01194245|520326972|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144306454|NCT01194245|520326973|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144306455|NCT01194245|520326974|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144306456|NCT01194245|520326975|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
144306457|NCT01194245|520326971|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144306458|NCT01194245|520326972|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144306459|NCT01194245|520326973|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
144306460|NCT01194245|520326974|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
144306461|NCT01194245|520326975|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
144306462|NCT03824392|520326976|FG000|Overall Study|Adverse Event|1|||
144306463|NCT03824392|520326977|FG001|Overall Study|Adverse Event|0|||
144306464|NCT03824392|520326978|FG002|Overall Study|Adverse Event|0|||
144306465|NCT03824392|520326979|FG003|Overall Study|Adverse Event|0|||
144306466|NCT03824392|520326976|FG000|Overall Study|Investigator Decision|0|||
144306467|NCT03824392|520326977|FG001|Overall Study|Investigator Decision|1|||
144306468|NCT03824392|520326978|FG002|Overall Study|Investigator Decision|0|||
144306469|NCT03824392|520326979|FG003|Overall Study|Investigator Decision|0|||
144306470|NCT03824392|520326976|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
144306471|NCT03824392|520326977|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
144306472|NCT03824392|520326978|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
144306473|NCT03824392|520326979|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
144306474|NCT00251693|520326990|FG000|Overall Study|Adverse Event|17|||
144306475|NCT00251693|520326991|FG001|Overall Study|Adverse Event|9|||
144306476|NCT00251693|520326992|FG002|Overall Study|Adverse Event|9|||
144306477|NCT00251693|520326990|FG000|Overall Study|Protocol Violation|2|||
144306478|NCT00251693|520326991|FG001|Overall Study|Protocol Violation|0|||
144306479|NCT00251693|520326992|FG002|Overall Study|Protocol Violation|2|||
144306480|NCT00251693|520326990|FG000|Overall Study|Lost to Follow-up|12|||
144306481|NCT00251693|520326991|FG001|Overall Study|Lost to Follow-up|7|||
144306482|NCT00251693|520326992|FG002|Overall Study|Lost to Follow-up|8|||
144306483|NCT00251693|520326990|FG000|Overall Study|Withdrawal by Subject|11|||
144306484|NCT00251693|520326991|FG001|Overall Study|Withdrawal by Subject|17|||
144306485|NCT00251693|520326992|FG002|Overall Study|Withdrawal by Subject|14|||
144306486|NCT00251693|520326990|FG000|Overall Study|Lack of Efficacy|0|||
144306487|NCT00251693|520326991|FG001|Overall Study|Lack of Efficacy|1|||
144306488|NCT00251693|520326992|FG002|Overall Study|Lack of Efficacy|0|||
144306489|NCT00251693|520326990|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
144306490|NCT00251693|520326991|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
144306491|NCT00251693|520326992|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
144306492|NCT00251693|520326990|FG000|Overall Study|Noncompliant|0|||
144306493|NCT00251693|520326991|FG001|Overall Study|Noncompliant|0|||
144306494|NCT00251693|520326992|FG002|Overall Study|Noncompliant|2|||
144306495|NCT00251693|520326990|FG000|Overall Study|Possible Barrett's esophagus|3|||
144306496|NCT00251693|520326991|FG001|Overall Study|Possible Barrett's esophagus|5|||
144306497|NCT00251693|520326992|FG002|Overall Study|Possible Barrett's esophagus|2|||
144306498|NCT00251693|520326990|FG000|Overall Study|Subject request/subject unavailable|1|||
144306499|NCT00251693|520326991|FG001|Overall Study|Subject request/subject unavailable|2|||
144306500|NCT00251693|520326992|FG002|Overall Study|Subject request/subject unavailable|0|||
144306501|NCT00251693|520326990|FG000|Overall Study|Abnormal laboratory findings|0|||
144306502|NCT00251693|520326991|FG001|Overall Study|Abnormal laboratory findings|0|||
144306503|NCT00251693|520326992|FG002|Overall Study|Abnormal laboratory findings|1|||
144306504|NCT01030822|520326993|FG000|Overall Study|Moved/migrated from study area|6|||
144306505|NCT01030822|520326994|FG001|Overall Study|Moved/migrated from study area|7|||
144359619|NCT00402168|520522827|FG001|Treatment (up to 12 Months)|Death|1|||
144306506|NCT01030822|520326995|FG002|Overall Study|Moved/migrated from study area|3|||
144306507|NCT01030822|520326993|FG000|Overall Study|Withdrawal by Subject|16|||
144306508|NCT01030822|520326994|FG001|Overall Study|Withdrawal by Subject|13|||
144306509|NCT01030822|520326995|FG002|Overall Study|Withdrawal by Subject|16|||
144306510|NCT01030822|520326993|FG000|Overall Study|Lost to Follow-up|9|||
144306511|NCT01030822|520326994|FG001|Overall Study|Lost to Follow-up|4|||
144306512|NCT01030822|520326995|FG002|Overall Study|Lost to Follow-up|7|||
144306513|NCT00401843|520326996|FG000|Overall Study|Achieved Complete Response|1|||
144306514|NCT00401843|520326997|FG001|Overall Study|Achieved Complete Response|5|||
144306515|NCT00401843|520326998|FG002|Overall Study|Achieved Complete Response|11|||
144306516|NCT00401843|520326996|FG000|Overall Study|Adverse Event|7|||
144306517|NCT00401843|520326997|FG001|Overall Study|Adverse Event|26|||
144306518|NCT00401843|520326998|FG002|Overall Study|Adverse Event|27|||
144306519|NCT00401843|520326996|FG000|Overall Study|Death|0|||
144306520|NCT00401843|520326997|FG001|Overall Study|Death|8|||
144306521|NCT00401843|520326998|FG002|Overall Study|Death|10|||
144306522|NCT00401843|520326996|FG000|Overall Study|Disease progression|10|||
144306523|NCT00401843|520326997|FG001|Overall Study|Disease progression|60|||
144306524|NCT00401843|520326998|FG002|Overall Study|Disease progression|49|||
144306525|NCT00401843|520326996|FG000|Overall Study|End of Study|1|||
144306526|NCT00401843|520326997|FG001|Overall Study|End of Study|1|||
144306527|NCT00401843|520326998|FG002|Overall Study|End of Study|2|||
144306528|NCT00401843|520326996|FG000|Overall Study|Lost to Follow-up|0|||
144306529|NCT00401843|520326997|FG001|Overall Study|Lost to Follow-up|0|||
144306530|NCT00401843|520326998|FG002|Overall Study|Lost to Follow-up|2|||
144306531|NCT00401843|520326996|FG000|Overall Study|Other Unspecified|0|||
144306532|NCT00401843|520326997|FG001|Overall Study|Other Unspecified|3|||
144306533|NCT00401843|520326998|FG002|Overall Study|Other Unspecified|5|||
144306534|NCT00401843|520326996|FG000|Overall Study|Physician Decision|0|||
144306535|NCT00401843|520326997|FG001|Overall Study|Physician Decision|16|||
144306536|NCT00401843|520326998|FG002|Overall Study|Physician Decision|10|||
144306537|NCT00401843|520326996|FG000|Overall Study|Protocol Violation|0|||
144306538|NCT00401843|520326997|FG001|Overall Study|Protocol Violation|0|||
144306539|NCT00401843|520326998|FG002|Overall Study|Protocol Violation|1|||
144306540|NCT00401843|520326996|FG000|Overall Study|Withdrawal by Subject|1|||
144306541|NCT00401843|520326997|FG001|Overall Study|Withdrawal by Subject|5|||
144306542|NCT00401843|520326998|FG002|Overall Study|Withdrawal by Subject|5|||
144306543|NCT00401843|520326996|FG000|Overall Study|Withdrawal of consent to study agent|1|||
144306544|NCT00401843|520326997|FG001|Overall Study|Withdrawal of consent to study agent|15|||
144306545|NCT00401843|520326998|FG002|Overall Study|Withdrawal of consent to study agent|17|||
144306546|NCT00401843|520326996|FG000|Overall Study|Randomized but not Treated|0|||
144306547|NCT00401843|520326997|FG001|Overall Study|Randomized but not Treated|2|||
144306548|NCT00401843|520326998|FG002|Overall Study|Randomized but not Treated|3|||
144306549|NCT00401843|520326996|FG000|Overall Study|Received incorrect treatment|0|||
144306550|NCT00401843|520326997|FG001|Overall Study|Received incorrect treatment|3|||
144306551|NCT00401843|520326998|FG002|Overall Study|Received incorrect treatment|0|||
144306552|NCT01932788|520327011|FG000|Overall Study|Protocol Violation|18|||
144306553|NCT01932788|520327012|FG001|Overall Study|Protocol Violation|0|||
144306554|NCT01932788|520327011|FG000|Overall Study|Lost to Follow-up|18|||
144306555|NCT01932788|520327012|FG001|Overall Study|Lost to Follow-up|46|||
144306556|NCT01932788|520327011|FG000|Overall Study|Lack of Efficacy|2|||
144306557|NCT01932788|520327012|FG001|Overall Study|Lack of Efficacy|0|||
144306558|NCT01932788|520327011|FG000|Overall Study|Withdrawal by Subject|0|||
144306559|NCT01932788|520327012|FG001|Overall Study|Withdrawal by Subject|5|||
144306560|NCT00833027|520327013|FG000|Overall Study|Adverse Event|33|||
144306561|NCT00833027|520327013|FG000|Overall Study|Death|1|||
144306562|NCT00833027|520327013|FG000|Overall Study|Lack of Efficacy|12|||
144306563|NCT00833027|520327013|FG000|Overall Study|Lost to Follow-up|24|||
144306564|NCT00833027|520327013|FG000|Overall Study|Protocol Violation|115|||
144306565|NCT00833027|520327013|FG000|Overall Study|Withdrawal by Subject|16|||
144306566|NCT00833027|520327013|FG000|Overall Study|Missing|10|||
144306567|NCT03069716|520327016|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
144306568|NCT03069716|520327017|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
144306569|NCT03069716|520327018|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
144306570|NCT03069716|520327016|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
144306571|NCT03069716|520327017|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
144306572|NCT03069716|520327018|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
144306573|NCT03069716|520327016|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
144306574|NCT03069716|520327017|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
144306575|NCT03069716|520327018|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
144306576|NCT03069716|520327016|FG000|Randomized Treatment|Withdrawal by Subject|0|||
144306577|NCT03069716|520327017|FG001|Randomized Treatment|Withdrawal by Subject|2|||
144306578|NCT03069716|520327018|FG002|Randomized Treatment|Withdrawal by Subject|0|||
144306579|NCT03092479|520327019|FG000|Overall Study|Lost to Follow-up|3|||
144306580|NCT03092479|520327020|FG001|Overall Study|Lost to Follow-up|2|||
144306581|NCT03092479|520327019|FG000|Overall Study|Withdrawal by Subject|4|||
144306582|NCT03092479|520327020|FG001|Overall Study|Withdrawal by Subject|0|||
144306583|NCT03913130|520327023|FG000|Overall Study|Sponsor Decision|1|||
144306584|NCT05653700|520327024|FG000|Overall Study|Non Responders|9|||
144306585|NCT05653700|520327025|FG001|Overall Study|Non Responders|0|||
144306586|NCT01985022|520327041|FG000|Overall Study|Lost to Follow-up|0|||
144306587|NCT01985022|520327042|FG001|Overall Study|Lost to Follow-up|1|||
144306588|NCT01985022|520327041|FG000|Overall Study|Protocol Violation|0|||
144306589|NCT01985022|520327042|FG001|Overall Study|Protocol Violation|1|||
144306590|NCT01985022|520327041|FG000|Overall Study|Withdrawal by Subject|4|||
144306591|NCT01985022|520327042|FG001|Overall Study|Withdrawal by Subject|1|||
144306592|NCT04790279|520328862|FG000|Overall Study|Did not meet medication start criteria|27|||
144306593|NCT04790279|520328863|FG001|Overall Study|Did not meet medication start criteria|15|||
144306594|NCT04790279|520328862|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
144306595|NCT04790279|520328863|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
144306596|NCT04790279|520328862|FG000|Overall Study|Protocol Violation|8|||
144306597|NCT04790279|520328863|FG001|Overall Study|Protocol Violation|3|||
144306598|NCT04790279|520328862|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
144306599|NCT04790279|520328863|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
144306600|NCT04472650|520328879|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
144306601|NCT04472650|520328880|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
144306602|NCT02549989|520328883|FG000|Overall Study|Adverse Event|4|||
144306603|NCT02549989|520328883|FG000|Overall Study|Death|1|||
144306604|NCT02549989|520328883|FG000|Overall Study|Lack of Efficacy|19|||
144306605|NCT02549989|520328883|FG000|Overall Study|Withdrawal by Subject|3|||
144306606|NCT00784368|520328887|FG000|Overall Study|Physician Decision|0|||
144306607|NCT00784368|520328888|FG001|Overall Study|Physician Decision|0|||
144306608|NCT00784368|520328889|FG002|Overall Study|Physician Decision|6|||
144306609|NCT00784368|520328887|FG000|Overall Study|Lack of Efficacy|2|||
144306610|NCT00784368|520328888|FG001|Overall Study|Lack of Efficacy|0|||
144306611|NCT00784368|520328889|FG002|Overall Study|Lack of Efficacy|1|||
144306612|NCT00784368|520328887|FG000|Overall Study|Adverse Event|6|||
144306613|NCT00784368|520328888|FG001|Overall Study|Adverse Event|9|||
144306614|NCT00784368|520328889|FG002|Overall Study|Adverse Event|2|||
144306615|NCT00784368|520328887|FG000|Overall Study|Diagnosis of fever|0|||
144306616|NCT00784368|520328888|FG001|Overall Study|Diagnosis of fever|0|||
144306617|NCT00784368|520328889|FG002|Overall Study|Diagnosis of fever|1|||
144306618|NCT00784368|520328887|FG000|Overall Study|Worsening of complications|0|||
144306619|NCT00784368|520328888|FG001|Overall Study|Worsening of complications|0|||
144306620|NCT00784368|520328889|FG002|Overall Study|Worsening of complications|1|||
144306621|NCT00784368|520328887|FG000|Overall Study|Worsening of symptoms|0|||
144306622|NCT00784368|520328888|FG001|Overall Study|Worsening of symptoms|1|||
144306623|NCT00784368|520328889|FG002|Overall Study|Worsening of symptoms|0|||
144306624|NCT00784368|520328887|FG000|Overall Study|Withdrawal of informed consent|0|||
144306625|NCT00784368|520328888|FG001|Overall Study|Withdrawal of informed consent|1|||
144306626|NCT00784368|520328889|FG002|Overall Study|Withdrawal of informed consent|0|||
144306627|NCT02079909|520328890|FG000|Overall Study|Adverse Event|23|||
144306628|NCT02079909|520328891|FG001|Overall Study|Adverse Event|23|||
144306629|NCT02079909|520328892|FG002|Overall Study|Adverse Event|7|||
144306630|NCT02079909|520328890|FG000|Overall Study|Withdrawal by Subject|9|||
144306631|NCT02079909|520328891|FG001|Overall Study|Withdrawal by Subject|17|||
144306632|NCT02079909|520328892|FG002|Overall Study|Withdrawal by Subject|4|||
144306633|NCT02079909|520328890|FG000|Overall Study|Lost to Follow-up|2|||
144306634|NCT02079909|520328891|FG001|Overall Study|Lost to Follow-up|3|||
144306635|NCT02079909|520328892|FG002|Overall Study|Lost to Follow-up|1|||
144306636|NCT02079909|520328890|FG000|Overall Study|Death|2|||
144306637|NCT02079909|520328891|FG001|Overall Study|Death|2|||
144306638|NCT02079909|520328892|FG002|Overall Study|Death|0|||
144306639|NCT02079909|520328890|FG000|Overall Study|Lack of Efficacy|0|||
144306640|NCT02079909|520328891|FG001|Overall Study|Lack of Efficacy|0|||
144306641|NCT02079909|520328892|FG002|Overall Study|Lack of Efficacy|1|||
144306642|NCT02079909|520328890|FG000|Overall Study|Protocol Violation|0|||
144306643|NCT02079909|520328891|FG001|Overall Study|Protocol Violation|1|||
144306644|NCT02079909|520328892|FG002|Overall Study|Protocol Violation|1|||
144306645|NCT02079909|520328890|FG000|Overall Study|Physician Decision|0|||
144306646|NCT02079909|520328891|FG001|Overall Study|Physician Decision|1|||
144306647|NCT02079909|520328892|FG002|Overall Study|Physician Decision|1|||
144306648|NCT02079909|520328890|FG000|Overall Study|Relocation etc.|2|||
144306649|NCT02079909|520328891|FG001|Overall Study|Relocation etc.|2|||
144306650|NCT02079909|520328892|FG002|Overall Study|Relocation etc.|3|||
144306651|NCT00720356|520328895|FG000|Registration to Study|Determined to have methylated MGMT|67|||
144306652|NCT00720356|520328895|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
144306653|NCT00720356|520328895|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
144306654|NCT00720356|520328895|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
144306655|NCT00720356|520328895|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
144306656|NCT00720356|520328895|FG000|Follow up Until Death|Withdrawal by Subject|1|||
144306657|NCT00720356|520328895|FG000|Follow up Until Death|Alive at last data collection|4|||
144306658|NCT02237001|520328898|FG000|Overall Study|Lost to Follow-up|2|||
144306659|NCT02237001|520328898|FG000|Overall Study|Withdrawal by Subject|1|||
144306660|NCT02237001|520328898|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
144306661|NCT02237001|520328898|FG000|Overall Study|Re-operation|4|||
144306662|NCT02237001|520328898|FG000|Overall Study|Incarceration|1|||
144306663|NCT01713582|520328899|FG000|Overall Study|Disease progression|3|||
144306664|NCT01713582|520328900|FG001|Overall Study|Disease progression|3|||
144306665|NCT01713582|520328901|FG002|Overall Study|Disease progression|3|||
144306666|NCT01713582|520328902|FG003|Overall Study|Disease progression|2|||
144306667|NCT01713582|520328903|FG004|Overall Study|Disease progression|3|||
144306668|NCT01713582|520328904|FG005|Overall Study|Disease progression|3|||
144306669|NCT01713582|520328905|FG006|Overall Study|Disease progression|3|||
144306670|NCT01713582|520328906|FG007|Overall Study|Disease progression|3|||
144306671|NCT01713582|520328907|FG008|Overall Study|Disease progression|3|||
144306672|NCT01713582|520328908|FG009|Overall Study|Disease progression|11|||
144306673|NCT01713582|520328909|FG010|Overall Study|Disease progression|10|||
144306674|NCT01713582|520328910|FG011|Overall Study|Disease progression|5|||
144306675|NCT01713582|520328911|FG012|Overall Study|Disease progression|3|||
144306676|NCT01713582|520328912|FG013|Overall Study|Disease progression|3|||
144306677|NCT01713582|520328913|FG014|Overall Study|Disease progression|6|||
144306678|NCT01713582|520328914|FG015|Overall Study|Disease progression|6|||
144306679|NCT01713582|520328915|FG016|Overall Study|Disease progression|5|||
144306680|NCT01713582|520328916|FG017|Overall Study|Disease progression|2|||
144306681|NCT01713582|520328917|FG018|Overall Study|Disease progression|3|||
144306682|NCT01713582|520328918|FG019|Overall Study|Disease progression|5|||
144306683|NCT01713582|520328919|FG020|Overall Study|Disease progression|15|||
144306684|NCT01713582|520328899|FG000|Overall Study|Death|0|||
144306685|NCT01713582|520328900|FG001|Overall Study|Death|0|||
144306686|NCT01713582|520328901|FG002|Overall Study|Death|0|||
144306687|NCT01713582|520328902|FG003|Overall Study|Death|1|||
144306688|NCT01713582|520328903|FG004|Overall Study|Death|1|||
144306689|NCT01713582|520328904|FG005|Overall Study|Death|3|||
144306690|NCT01713582|520328905|FG006|Overall Study|Death|3|||
144306691|NCT01713582|520328906|FG007|Overall Study|Death|2|||
144306692|NCT01713582|520328907|FG008|Overall Study|Death|3|||
144306693|NCT01713582|520328908|FG009|Overall Study|Death|4|||
144306694|NCT01713582|520328909|FG010|Overall Study|Death|3|||
144306695|NCT01713582|520328910|FG011|Overall Study|Death|0|||
144306696|NCT01713582|520328911|FG012|Overall Study|Death|0|||
144306697|NCT01713582|520328912|FG013|Overall Study|Death|0|||
144306698|NCT01713582|520328913|FG014|Overall Study|Death|0|||
144306699|NCT01713582|520328914|FG015|Overall Study|Death|0|||
144306700|NCT01713582|520328915|FG016|Overall Study|Death|0|||
144306701|NCT01713582|520328916|FG017|Overall Study|Death|0|||
144306702|NCT01713582|520328917|FG018|Overall Study|Death|0|||
144306703|NCT01713582|520328918|FG019|Overall Study|Death|0|||
144306704|NCT01713582|520328919|FG020|Overall Study|Death|0|||
144306705|NCT01713582|520328899|FG000|Overall Study|Adverse event-related|0|||
144306706|NCT01713582|520328900|FG001|Overall Study|Adverse event-related|0|||
144306707|NCT01713582|520328901|FG002|Overall Study|Adverse event-related|0|||
144306708|NCT01713582|520328902|FG003|Overall Study|Adverse event-related|0|||
144306709|NCT01713582|520328903|FG004|Overall Study|Adverse event-related|0|||
144306710|NCT01713582|520328904|FG005|Overall Study|Adverse event-related|0|||
144306711|NCT01713582|520328905|FG006|Overall Study|Adverse event-related|0|||
144306712|NCT01713582|520328906|FG007|Overall Study|Adverse event-related|0|||
144306713|NCT01713582|520328907|FG008|Overall Study|Adverse event-related|0|||
144306714|NCT01713582|520328908|FG009|Overall Study|Adverse event-related|1|||
144306715|NCT01713582|520328909|FG010|Overall Study|Adverse event-related|1|||
144306716|NCT01713582|520328910|FG011|Overall Study|Adverse event-related|0|||
144306717|NCT01713582|520328911|FG012|Overall Study|Adverse event-related|0|||
144306718|NCT01713582|520328912|FG013|Overall Study|Adverse event-related|0|||
144306719|NCT01713582|520328913|FG014|Overall Study|Adverse event-related|0|||
144306720|NCT01713582|520328914|FG015|Overall Study|Adverse event-related|0|||
144306721|NCT01713582|520328915|FG016|Overall Study|Adverse event-related|0|||
144306722|NCT01713582|520328916|FG017|Overall Study|Adverse event-related|0|||
144306723|NCT01713582|520328917|FG018|Overall Study|Adverse event-related|1|||
144306724|NCT01713582|520328918|FG019|Overall Study|Adverse event-related|0|||
144306725|NCT01713582|520328919|FG020|Overall Study|Adverse event-related|0|||
144306726|NCT01713582|520328899|FG000|Overall Study|Adverse event-unrelated|0|||
144306727|NCT01713582|520328900|FG001|Overall Study|Adverse event-unrelated|0|||
144306728|NCT01713582|520328901|FG002|Overall Study|Adverse event-unrelated|0|||
144306729|NCT01713582|520328902|FG003|Overall Study|Adverse event-unrelated|0|||
144306730|NCT01713582|520328903|FG004|Overall Study|Adverse event-unrelated|0|||
144306731|NCT01713582|520328904|FG005|Overall Study|Adverse event-unrelated|1|||
144306732|NCT01713582|520328905|FG006|Overall Study|Adverse event-unrelated|1|||
144306733|NCT01713582|520328906|FG007|Overall Study|Adverse event-unrelated|1|||
144306734|NCT01713582|520328907|FG008|Overall Study|Adverse event-unrelated|0|||
144306735|NCT01713582|520328908|FG009|Overall Study|Adverse event-unrelated|0|||
144306736|NCT01713582|520328909|FG010|Overall Study|Adverse event-unrelated|0|||
144306737|NCT01713582|520328910|FG011|Overall Study|Adverse event-unrelated|0|||
144306738|NCT01713582|520328911|FG012|Overall Study|Adverse event-unrelated|0|||
144306739|NCT01713582|520328912|FG013|Overall Study|Adverse event-unrelated|1|||
144306740|NCT01713582|520328913|FG014|Overall Study|Adverse event-unrelated|1|||
144306741|NCT01713582|520328914|FG015|Overall Study|Adverse event-unrelated|0|||
144306742|NCT01713582|520328915|FG016|Overall Study|Adverse event-unrelated|0|||
144306743|NCT01713582|520328916|FG017|Overall Study|Adverse event-unrelated|0|||
144306744|NCT01713582|520328917|FG018|Overall Study|Adverse event-unrelated|0|||
144306745|NCT01713582|520328918|FG019|Overall Study|Adverse event-unrelated|0|||
144306746|NCT01713582|520328919|FG020|Overall Study|Adverse event-unrelated|0|||
144306747|NCT01713582|520328899|FG000|Overall Study|Withdrawal of consent|0|||
144306748|NCT01713582|520328900|FG001|Overall Study|Withdrawal of consent|0|||
144306749|NCT01713582|520328901|FG002|Overall Study|Withdrawal of consent|1|||
144306750|NCT01713582|520328902|FG003|Overall Study|Withdrawal of consent|0|||
144306751|NCT01713582|520328903|FG004|Overall Study|Withdrawal of consent|0|||
144306752|NCT01713582|520328904|FG005|Overall Study|Withdrawal of consent|1|||
144306753|NCT01713582|520328905|FG006|Overall Study|Withdrawal of consent|0|||
144306754|NCT01713582|520328906|FG007|Overall Study|Withdrawal of consent|0|||
144306755|NCT01713582|520328907|FG008|Overall Study|Withdrawal of consent|0|||
144306756|NCT01713582|520328908|FG009|Overall Study|Withdrawal of consent|1|||
144306757|NCT01713582|520328909|FG010|Overall Study|Withdrawal of consent|0|||
144306758|NCT01713582|520328910|FG011|Overall Study|Withdrawal of consent|0|||
144306759|NCT01713582|520328911|FG012|Overall Study|Withdrawal of consent|0|||
144306760|NCT01713582|520328912|FG013|Overall Study|Withdrawal of consent|0|||
144306761|NCT01713582|520328913|FG014|Overall Study|Withdrawal of consent|0|||
144306762|NCT01713582|520328914|FG015|Overall Study|Withdrawal of consent|0|||
144306763|NCT01713582|520328915|FG016|Overall Study|Withdrawal of consent|0|||
144306764|NCT01713582|520328916|FG017|Overall Study|Withdrawal of consent|0|||
144306765|NCT01713582|520328917|FG018|Overall Study|Withdrawal of consent|1|||
144306766|NCT01713582|520328918|FG019|Overall Study|Withdrawal of consent|0|||
144306767|NCT01713582|520328919|FG020|Overall Study|Withdrawal of consent|0|||
144306768|NCT01713582|520328899|FG000|Overall Study|Lack of Efficacy|0|||
144306769|NCT01713582|520328900|FG001|Overall Study|Lack of Efficacy|0|||
144306770|NCT01713582|520328901|FG002|Overall Study|Lack of Efficacy|0|||
144306771|NCT01713582|520328902|FG003|Overall Study|Lack of Efficacy|0|||
144306772|NCT01713582|520328903|FG004|Overall Study|Lack of Efficacy|0|||
144306773|NCT01713582|520328904|FG005|Overall Study|Lack of Efficacy|0|||
144306774|NCT01713582|520328905|FG006|Overall Study|Lack of Efficacy|0|||
144306775|NCT01713582|520328906|FG007|Overall Study|Lack of Efficacy|0|||
144306776|NCT01713582|520328907|FG008|Overall Study|Lack of Efficacy|0|||
144306777|NCT01713582|520328908|FG009|Overall Study|Lack of Efficacy|1|||
144306778|NCT01713582|520328909|FG010|Overall Study|Lack of Efficacy|2|||
144306779|NCT01713582|520328910|FG011|Overall Study|Lack of Efficacy|0|||
144306780|NCT01713582|520328911|FG012|Overall Study|Lack of Efficacy|0|||
144306781|NCT01713582|520328912|FG013|Overall Study|Lack of Efficacy|0|||
144306782|NCT01713582|520328913|FG014|Overall Study|Lack of Efficacy|0|||
144306783|NCT01713582|520328914|FG015|Overall Study|Lack of Efficacy|0|||
144306784|NCT01713582|520328915|FG016|Overall Study|Lack of Efficacy|0|||
144306785|NCT01713582|520328916|FG017|Overall Study|Lack of Efficacy|0|||
144306786|NCT01713582|520328917|FG018|Overall Study|Lack of Efficacy|0|||
144306787|NCT01713582|520328918|FG019|Overall Study|Lack of Efficacy|0|||
144306788|NCT01713582|520328919|FG020|Overall Study|Lack of Efficacy|0|||
144306789|NCT01713582|520328899|FG000|Overall Study|Withdrawal by Subject|0|||
144306790|NCT01713582|520328900|FG001|Overall Study|Withdrawal by Subject|0|||
144306791|NCT01713582|520328901|FG002|Overall Study|Withdrawal by Subject|0|||
144306792|NCT01713582|520328902|FG003|Overall Study|Withdrawal by Subject|0|||
144306793|NCT01713582|520328903|FG004|Overall Study|Withdrawal by Subject|0|||
144306794|NCT01713582|520328904|FG005|Overall Study|Withdrawal by Subject|0|||
144306795|NCT01713582|520328905|FG006|Overall Study|Withdrawal by Subject|0|||
144306796|NCT01713582|520328906|FG007|Overall Study|Withdrawal by Subject|0|||
144306797|NCT01713582|520328907|FG008|Overall Study|Withdrawal by Subject|0|||
144306798|NCT01713582|520328908|FG009|Overall Study|Withdrawal by Subject|0|||
144306799|NCT01713582|520328909|FG010|Overall Study|Withdrawal by Subject|0|||
144306800|NCT01713582|520328910|FG011|Overall Study|Withdrawal by Subject|0|||
144306801|NCT01713582|520328911|FG012|Overall Study|Withdrawal by Subject|0|||
144306802|NCT01713582|520328912|FG013|Overall Study|Withdrawal by Subject|0|||
144306803|NCT01713582|520328913|FG014|Overall Study|Withdrawal by Subject|0|||
144306804|NCT01713582|520328914|FG015|Overall Study|Withdrawal by Subject|0|||
144306805|NCT01713582|520328915|FG016|Overall Study|Withdrawal by Subject|0|||
144306806|NCT01713582|520328916|FG017|Overall Study|Withdrawal by Subject|1|||
144306807|NCT01713582|520328917|FG018|Overall Study|Withdrawal by Subject|0|||
144306808|NCT01713582|520328918|FG019|Overall Study|Withdrawal by Subject|0|||
144306809|NCT01713582|520328919|FG020|Overall Study|Withdrawal by Subject|0|||
144306810|NCT01713582|520328899|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
144306811|NCT01713582|520328900|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
144306812|NCT01713582|520328901|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
144306813|NCT01713582|520328902|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
144306814|NCT01713582|520328903|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
144306815|NCT01713582|520328904|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
144306816|NCT01713582|520328905|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
144306817|NCT01713582|520328906|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
144306818|NCT01713582|520328907|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
144306819|NCT01713582|520328908|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
144306820|NCT01713582|520328909|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
144306821|NCT01713582|520328910|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
144306822|NCT01713582|520328911|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
144306823|NCT01713582|520328912|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
144306824|NCT01713582|520328913|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
144306825|NCT01713582|520328914|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
144306826|NCT01713582|520328915|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
144306827|NCT01713582|520328916|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
144306828|NCT01713582|520328917|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
144306829|NCT01713582|520328918|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
144306830|NCT01713582|520328919|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
144306831|NCT01713582|520328899|FG000|Overall Study|Disease progression and adverse event|0|||
144306832|NCT01713582|520328900|FG001|Overall Study|Disease progression and adverse event|0|||
144306833|NCT01713582|520328901|FG002|Overall Study|Disease progression and adverse event|0|||
144306834|NCT01713582|520328902|FG003|Overall Study|Disease progression and adverse event|0|||
144306835|NCT01713582|520328903|FG004|Overall Study|Disease progression and adverse event|0|||
144306836|NCT01713582|520328904|FG005|Overall Study|Disease progression and adverse event|0|||
144306837|NCT01713582|520328905|FG006|Overall Study|Disease progression and adverse event|0|||
144306838|NCT01713582|520328906|FG007|Overall Study|Disease progression and adverse event|0|||
144306839|NCT01713582|520328907|FG008|Overall Study|Disease progression and adverse event|0|||
144306840|NCT01713582|520328908|FG009|Overall Study|Disease progression and adverse event|0|||
144306841|NCT01713582|520328909|FG010|Overall Study|Disease progression and adverse event|0|||
144306842|NCT01713582|520328910|FG011|Overall Study|Disease progression and adverse event|0|||
144306843|NCT01713582|520328911|FG012|Overall Study|Disease progression and adverse event|0|||
144306844|NCT01713582|520328912|FG013|Overall Study|Disease progression and adverse event|0|||
144306845|NCT01713582|520328913|FG014|Overall Study|Disease progression and adverse event|0|||
144306846|NCT01713582|520328914|FG015|Overall Study|Disease progression and adverse event|0|||
144306847|NCT01713582|520328915|FG016|Overall Study|Disease progression and adverse event|1|||
144306848|NCT01713582|520328916|FG017|Overall Study|Disease progression and adverse event|0|||
144306849|NCT01713582|520328917|FG018|Overall Study|Disease progression and adverse event|0|||
144306850|NCT01713582|520328918|FG019|Overall Study|Disease progression and adverse event|0|||
144306851|NCT01713582|520328919|FG020|Overall Study|Disease progression and adverse event|0|||
144306852|NCT03427814|520328922|FG000|Overall Study|Withdrawal by Subject|4|||
144306853|NCT03427814|520328923|FG001|Overall Study|Withdrawal by Subject|4|||
144306854|NCT03427814|520328922|FG000|Overall Study|Lost to Follow-up|0|||
144306855|NCT03427814|520328923|FG001|Overall Study|Lost to Follow-up|2|||
144306856|NCT03427814|520328922|FG000|Overall Study|Death|42|||
144306857|NCT03427814|520328923|FG001|Overall Study|Death|31|||
144306858|NCT03427814|520328922|FG000|Overall Study|Sponsor's Decision|1|||
144306859|NCT03427814|520328923|FG001|Overall Study|Sponsor's Decision|0|||
144306860|NCT03427814|520328922|FG000|Overall Study|Investigator's Decision|1|||
144306861|NCT03427814|520328923|FG001|Overall Study|Investigator's Decision|2|||
144306862|NCT03427814|520328922|FG000|Overall Study|Disease progression|1|||
144306863|NCT03427814|520328923|FG001|Overall Study|Disease progression|0|||
144306864|NCT03427814|520328922|FG000|Overall Study|Treatment Completed|0|||
144306865|NCT03427814|520328923|FG001|Overall Study|Treatment Completed|1|||
144306866|NCT03427814|520328922|FG000|Overall Study|Sponsor's Decision to End study|21|||
144306867|NCT03427814|520328923|FG001|Overall Study|Sponsor's Decision to End study|25|||
144306868|NCT03427814|520328922|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
144306869|NCT03427814|520328923|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
144306870|NCT03846427|520328924|FG000|Overall Study|Death|13|||
144306871|NCT03846427|520328924|FG000|Overall Study|Withdrawal by Subject|3|||
144306872|NCT03846427|520328924|FG000|Overall Study|Physician Decision|1|||
144306873|NCT01334554|520328925|FG000|Overall Study|Adverse Event|4|||
144306874|NCT01334554|520328926|FG001|Overall Study|Adverse Event|2|||
144306875|NCT02393859|520328928|FG000|Overall Study|Decision by Sponsor|2|||
144306876|NCT02393859|520328929|FG001|Overall Study|Decision by Sponsor|4|||
144306877|NCT02393859|520328928|FG000|Overall Study|Withdrawal by Subject|11|||
144306878|NCT02393859|520328929|FG001|Overall Study|Withdrawal by Subject|6|||
144306879|NCT02393859|520328928|FG000|Overall Study|Death|27|||
144306880|NCT02393859|520328929|FG001|Overall Study|Death|10|||
144306881|NCT02393859|520328928|FG000|Overall Study|Lost to Follow-up|1|||
144306882|NCT02393859|520328929|FG001|Overall Study|Lost to Follow-up|1|||
144306883|NCT01979614|520328930|FG000|Overall Study|Adverse Event|1|||
144306884|NCT01979614|520328931|FG001|Overall Study|Adverse Event|1|||
144306885|NCT00756275|520328932|FG000|Overall Study|Lost to Follow-up|25|||
144306886|NCT00756275|520328933|FG001|Overall Study|Lost to Follow-up|21|||
144306887|NCT00756275|520328932|FG000|Overall Study|Withdrawal by Subject|4|||
144306888|NCT00756275|520328933|FG001|Overall Study|Withdrawal by Subject|7|||
144306889|NCT04971967|520328934|FG000|Overall Study|Lost to Follow-up|6|||
144306890|NCT04971967|520328935|FG001|Overall Study|Lost to Follow-up|7|||
144306891|NCT01475721|520328938|FG000|Overall Study|Death|3|||
144306892|NCT01475721|520328939|FG001|Overall Study|Death|6|||
144306893|NCT01475721|520328938|FG000|Overall Study|Withdrawal by Subject|8|||
144306894|NCT01475721|520328939|FG001|Overall Study|Withdrawal by Subject|8|||
144306895|NCT01048242|520328941|FG000|Overall Study|See study flow chart|4|||
144306896|NCT01048242|520328942|FG001|Overall Study|See study flow chart|2|||
144306897|NCT02364037|520328943|FG000|Overall Study|Withdrawal by Subject|7|||
144306898|NCT02364037|520328944|FG001|Overall Study|Withdrawal by Subject|4|||
144306899|NCT02364037|520328943|FG000|Overall Study|Lost to Follow-up|37|||
144306900|NCT02364037|520328944|FG001|Overall Study|Lost to Follow-up|49|||
144306901|NCT01772550|520328945|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
144306902|NCT01772550|520328946|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
144306903|NCT01772550|520328947|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
144306904|NCT01772550|520328945|FG000|Overall Study|Adverse Event|0|||
144306905|NCT01772550|520328946|FG001|Overall Study|Adverse Event|0|||
144306906|NCT01772550|520328947|FG002|Overall Study|Adverse Event|1|||
144306907|NCT00559104|520328948|FG000|Overall Study|Lack of Efficacy|9|||
144306908|NCT00559104|520328949|FG001|Overall Study|Lack of Efficacy|0|||
144306909|NCT00387088|520328950|FG000|Overall Study|Adverse Event|143|||
144306910|NCT00387088|520328951|FG001|Overall Study|Adverse Event|156|||
144306911|NCT00387088|520328950|FG000|Overall Study|Protocol Violation|47|||
144306912|NCT00387088|520328951|FG001|Overall Study|Protocol Violation|35|||
144306913|NCT00387088|520328950|FG000|Overall Study|Withdrawal by Subject|20|||
144306914|NCT00387088|520328951|FG001|Overall Study|Withdrawal by Subject|35|||
144306915|NCT00387088|520328950|FG000|Overall Study|Lack of Efficacy|28|||
144306916|NCT00387088|520328951|FG001|Overall Study|Lack of Efficacy|67|||
144306917|NCT00387088|520328950|FG000|Overall Study|Lost to Follow-up|22|||
144306918|NCT00387088|520328951|FG001|Overall Study|Lost to Follow-up|28|||
144306919|NCT00387088|520328950|FG000|Overall Study|Other|58|||
144306920|NCT00387088|520328951|FG001|Overall Study|Other|52|||
144306921|NCT01639469|520328952|FG000|Overall Study|Death|4|||
144306922|NCT01639469|520328953|FG001|Overall Study|Death|2|||
144306923|NCT01639469|520328952|FG000|Overall Study|Lost to Follow-up|1|||
144306924|NCT01639469|520328953|FG001|Overall Study|Lost to Follow-up|1|||
144306925|NCT00420381|520328954|FG000|Overall Study|Protocol Violation|1|||
144306926|NCT02071771|520328955|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
144306927|NCT02071771|520328956|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
144306928|NCT02071771|520328955|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
144306929|NCT02071771|520328956|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
144306930|NCT02078752|520328957|FG000|Overall Study|Death|0|||
144306931|NCT02078752|520328958|FG001|Overall Study|Death|3|||
144306932|NCT02078752|520328959|FG002|Overall Study|Death|0|||
144306933|NCT02078752|520328960|FG003|Overall Study|Death|0|||
144306934|NCT02078752|520328961|FG004|Overall Study|Death|0|||
144306935|NCT02078752|520328962|FG005|Overall Study|Death|1|||
144306936|NCT02078752|520328963|FG006|Overall Study|Death|0|||
144306937|NCT02078752|520328964|FG007|Overall Study|Death|1|||
144306938|NCT02078752|520328965|FG008|Overall Study|Death|0|||
144306939|NCT02078752|520328966|FG009|Overall Study|Death|4|||
144306940|NCT02078752|520328957|FG000|Overall Study|Lost to Follow-up|1|||
144306941|NCT02078752|520328958|FG001|Overall Study|Lost to Follow-up|0|||
144306942|NCT02078752|520328959|FG002|Overall Study|Lost to Follow-up|0|||
144306943|NCT02078752|520328960|FG003|Overall Study|Lost to Follow-up|1|||
144306944|NCT02078752|520328961|FG004|Overall Study|Lost to Follow-up|0|||
144306945|NCT02078752|520328962|FG005|Overall Study|Lost to Follow-up|0|||
144306946|NCT02078752|520328963|FG006|Overall Study|Lost to Follow-up|0|||
144306947|NCT02078752|520328964|FG007|Overall Study|Lost to Follow-up|0|||
144306948|NCT02078752|520328965|FG008|Overall Study|Lost to Follow-up|0|||
144306949|NCT02078752|520328966|FG009|Overall Study|Lost to Follow-up|0|||
144306950|NCT02078752|520328957|FG000|Overall Study|Withdrawal by Subject|1|||
144306951|NCT02078752|520328958|FG001|Overall Study|Withdrawal by Subject|1|||
144306952|NCT02078752|520328959|FG002|Overall Study|Withdrawal by Subject|1|||
144306953|NCT02078752|520328960|FG003|Overall Study|Withdrawal by Subject|1|||
144306954|NCT02078752|520328961|FG004|Overall Study|Withdrawal by Subject|0|||
144306955|NCT02078752|520328962|FG005|Overall Study|Withdrawal by Subject|3|||
144306956|NCT02078752|520328963|FG006|Overall Study|Withdrawal by Subject|2|||
144306957|NCT02078752|520328964|FG007|Overall Study|Withdrawal by Subject|1|||
144306958|NCT02078752|520328965|FG008|Overall Study|Withdrawal by Subject|0|||
144306959|NCT02078752|520328966|FG009|Overall Study|Withdrawal by Subject|1|||
144306960|NCT02078752|520328957|FG000|Overall Study|Other|0|||
144306961|NCT02078752|520328958|FG001|Overall Study|Other|3|||
144306962|NCT02078752|520328959|FG002|Overall Study|Other|0|||
144306963|NCT02078752|520328960|FG003|Overall Study|Other|0|||
144306964|NCT02078752|520328961|FG004|Overall Study|Other|1|||
144306965|NCT02078752|520328962|FG005|Overall Study|Other|0|||
144306966|NCT02078752|520328963|FG006|Overall Study|Other|0|||
144306967|NCT02078752|520328964|FG007|Overall Study|Other|1|||
144306968|NCT02078752|520328965|FG008|Overall Study|Other|0|||
144306969|NCT02078752|520328966|FG009|Overall Study|Other|0|||
144306970|NCT02078752|520328957|FG000|Overall Study|Study terminated by sponsor|0|||
144306971|NCT02078752|520328958|FG001|Overall Study|Study terminated by sponsor|0|||
144306972|NCT02078752|520328959|FG002|Overall Study|Study terminated by sponsor|0|||
144306973|NCT02078752|520328960|FG003|Overall Study|Study terminated by sponsor|0|||
144306974|NCT02078752|520328961|FG004|Overall Study|Study terminated by sponsor|0|||
144306975|NCT02078752|520328962|FG005|Overall Study|Study terminated by sponsor|0|||
144306976|NCT02078752|520328963|FG006|Overall Study|Study terminated by sponsor|0|||
144306977|NCT02078752|520328964|FG007|Overall Study|Study terminated by sponsor|0|||
144306978|NCT02078752|520328965|FG008|Overall Study|Study terminated by sponsor|0|||
144306979|NCT02078752|520328966|FG009|Overall Study|Study terminated by sponsor|5|||
144306994|NCT02383862|520328974|FG000|3 Month Follow up|Lost to Follow-up|23|||
144306995|NCT02383862|520328975|FG001|3 Month Follow up|Lost to Follow-up|21|||
144306996|NCT01833494|520328976|FG000|Overall Study|Adverse Event|24|||
144306997|NCT01833494|520328976|FG000|Overall Study|Physician Decision|6|||
144306998|NCT01833494|520328976|FG000|Overall Study|Withdrawal by Subject|6|||
144306999|NCT01833494|520328976|FG000|Overall Study|Decrease in serum phosphorus|4|||
144307000|NCT01833494|520328976|FG000|Overall Study|Decrease in serum calcium|4|||
144307001|NCT01833494|520328976|FG000|Overall Study|Increase in serum ferritin|1|||
144307002|NCT01694433|520328981|FG000|Overall Study|Adverse Event|7|||
144307003|NCT01694433|520328982|FG001|Overall Study|Adverse Event|0|||
144307004|NCT01694433|520328981|FG000|Overall Study|Physician Decision|1|||
144307005|NCT01694433|520328982|FG001|Overall Study|Physician Decision|0|||
144307006|NCT01694433|520328981|FG000|Overall Study|Withdrawal by Subject|3|||
144307007|NCT01694433|520328982|FG001|Overall Study|Withdrawal by Subject|4|||
144307008|NCT00374595|520328985|FG000|Overall Study|Death|23|||
144360016|NCT01601535|520525138|FG003|Phase 1|Started Another Treatment|0|||
144307009|NCT00374595|520328985|FG000|Overall Study|Withdrawal by Subject|39|||
144307010|NCT00374595|520328985|FG000|Overall Study|Lost to Follow-up|3|||
144307011|NCT00374595|520328985|FG000|Overall Study|too much time commitment|1|||
144307012|NCT00374595|520328985|FG000|Overall Study|transfer care to other clinical site|1|||
144307013|NCT00374595|520328985|FG000|Overall Study|relocation|3|||
144307014|NCT03745768|520328986|FG000|Overall Study|discontinued study|2|||
144307015|NCT03745768|520328987|FG001|Overall Study|discontinued study|0|||
144307016|NCT00443118|520328988|FG000|Overall Study|unknown primary outcome|3|||
144307017|NCT00443118|520328989|FG001|Overall Study|unknown primary outcome|1|||
144307018|NCT00443118|520328990|FG002|Overall Study|unknown primary outcome|0|||
144307019|NCT00443118|520328988|FG000|Overall Study|Withdrawal by Subject|1|||
144307020|NCT00443118|520328989|FG001|Overall Study|Withdrawal by Subject|0|||
144307021|NCT00443118|520328990|FG002|Overall Study|Withdrawal by Subject|0|||
144307022|NCT01664247|520328992|FG000|Overall Study|Adverse Event|5|||
144307023|NCT01664247|520328993|FG001|Overall Study|Adverse Event|3|||
144307024|NCT01664247|520328992|FG000|Overall Study|Protocol Violation|3|||
144307025|NCT01664247|520328993|FG001|Overall Study|Protocol Violation|5|||
144307026|NCT01664247|520328992|FG000|Overall Study|Withdrawal Criteria|1|||
144307027|NCT01664247|520328993|FG001|Overall Study|Withdrawal Criteria|4|||
144307028|NCT01664247|520328992|FG000|Overall Study|Unclassified|5|||
144307029|NCT01664247|520328993|FG001|Overall Study|Unclassified|29|||
144307030|NCT01023217|520328994|FG000|Overall Study|Withdrawal by Subject|1|||
144307031|NCT01023217|520328995|FG001|Overall Study|Withdrawal by Subject|0|||
144307032|NCT01106157|520328996|FG000|Overall Study|Withdrawal by Subject|1|||
144307033|NCT01106157|520328997|FG001|Overall Study|Withdrawal by Subject|0|||
144307034|NCT02298868|520328998|FG000|Overall Study|Adverse Event|1|||
144307035|NCT02298868|520328998|FG000|Overall Study|Death|1|||
144307036|NCT02298868|520328998|FG000|Overall Study|Patient underwent transplant|1|||
144307037|NCT01000506|520328999|FG000|Overall Study|Adverse Event|6|||
144307038|NCT01000506|520329000|FG001|Overall Study|Adverse Event|5|||
144307039|NCT01000506|520329001|FG002|Overall Study|Adverse Event|8|||
144307040|NCT01000506|520329002|FG003|Overall Study|Adverse Event|9|||
144307041|NCT01000506|520328999|FG000|Overall Study|Lack of Efficacy|8|||
144307042|NCT01000506|520329000|FG001|Overall Study|Lack of Efficacy|6|||
144307043|NCT01000506|520329001|FG002|Overall Study|Lack of Efficacy|4|||
144307044|NCT01000506|520329002|FG003|Overall Study|Lack of Efficacy|4|||
144307045|NCT01000506|520328999|FG000|Overall Study|Protocol Violation|1|||
144307046|NCT01000506|520329000|FG001|Overall Study|Protocol Violation|1|||
144307047|NCT01000506|520329001|FG002|Overall Study|Protocol Violation|0|||
144307048|NCT01000506|520329002|FG003|Overall Study|Protocol Violation|0|||
144307049|NCT01000506|520328999|FG000|Overall Study|Lost to Follow-up|1|||
144307050|NCT01000506|520329000|FG001|Overall Study|Lost to Follow-up|1|||
144307051|NCT01000506|520329001|FG002|Overall Study|Lost to Follow-up|4|||
144307052|NCT01000506|520329002|FG003|Overall Study|Lost to Follow-up|0|||
144307053|NCT01000506|520328999|FG000|Overall Study|Physician Decision|1|||
144307054|NCT01000506|520329000|FG001|Overall Study|Physician Decision|3|||
144307055|NCT01000506|520329001|FG002|Overall Study|Physician Decision|3|||
144307056|NCT01000506|520329002|FG003|Overall Study|Physician Decision|3|||
144307057|NCT01000506|520328999|FG000|Overall Study|Withdrawal by Subject|11|||
144307058|NCT01000506|520329000|FG001|Overall Study|Withdrawal by Subject|8|||
144307059|NCT01000506|520329001|FG002|Overall Study|Withdrawal by Subject|2|||
144307060|NCT01000506|520329002|FG003|Overall Study|Withdrawal by Subject|7|||
144307061|NCT03064074|520329003|FG000|Overall Study|Physician Decision|0|||
144307062|NCT03064074|520329004|FG001|Overall Study|Physician Decision|0|||
144307063|NCT03064074|520329005|FG002|Overall Study|Physician Decision|0|||
144307064|NCT03064074|520329006|FG003|Overall Study|Physician Decision|1|||
144307065|NCT03962855|520329009|FG000|Overall Study|Death|0|||
144307066|NCT03962855|520329010|FG001|Overall Study|Death|1|||
144307067|NCT03962855|520329009|FG000|Overall Study|Lost to Follow-up|0|||
144307068|NCT03962855|520329010|FG001|Overall Study|Lost to Follow-up|1|||
144307069|NCT03962855|520329009|FG000|Overall Study|Adverse Event|0|||
144307070|NCT03962855|520329010|FG001|Overall Study|Adverse Event|1|||
144307071|NCT03962855|520329009|FG000|Overall Study|Physician Decision|0|||
144307072|NCT03962855|520329010|FG001|Overall Study|Physician Decision|2|||
144307073|NCT00532844|520329012|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
144307074|NCT00532844|520329013|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
144307075|NCT00532844|520329012|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
144307076|NCT00532844|520329013|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
144307077|NCT00532844|520329012|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
144307078|NCT00532844|520329013|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
144307079|NCT00532844|520329012|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
144307080|NCT00532844|520329013|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
144307081|NCT00532844|520329012|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
144307082|NCT00532844|520329013|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
144307083|NCT04389866|520329015|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
144307084|NCT04389866|520329016|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
144307085|NCT04940130|520329019|FG000|Overall Study|Travel|1|||
144307086|NCT04940130|520329020|FG001|Overall Study|Travel|0|||
144307087|NCT04940130|520329021|FG002|Overall Study|Travel|2|||
144307088|NCT04940130|520329019|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
144307089|NCT04940130|520329020|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
144307090|NCT04940130|520329021|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
144307091|NCT04940130|520329019|FG000|Overall Study|Adverse Event|0|||
144307092|NCT04940130|520329020|FG001|Overall Study|Adverse Event|0|||
144307093|NCT04940130|520329021|FG002|Overall Study|Adverse Event|2|||
144307094|NCT04940130|520329019|FG000|Overall Study|Disease progression/treatment failure|0|||
144307095|NCT04940130|520329020|FG001|Overall Study|Disease progression/treatment failure|0|||
144307096|NCT04940130|520329021|FG002|Overall Study|Disease progression/treatment failure|1|||
144307097|NCT04940130|520329019|FG000|Overall Study|Participant refusal|0|||
144307098|NCT04940130|520329020|FG001|Overall Study|Participant refusal|0|||
144307099|NCT04940130|520329021|FG002|Overall Study|Participant refusal|1|||
144307100|NCT02240121|520329024|FG000|Overall Study|Protocol Violation|1|||
144307101|NCT02240121|520329025|FG001|Overall Study|Protocol Violation|2|||
144307102|NCT02240121|520329024|FG000|Overall Study|Physician Decision|0|||
144307103|NCT02240121|520329025|FG001|Overall Study|Physician Decision|1|||
144307104|NCT02240121|520329024|FG000|Overall Study|Change in protocol interpretation|1|||
144307105|NCT02240121|520329025|FG001|Overall Study|Change in protocol interpretation|0|||
144307106|NCT02240121|520329024|FG000|Overall Study|Lack of Efficacy|2|||
144307107|NCT02240121|520329025|FG001|Overall Study|Lack of Efficacy|3|||
144307108|NCT02240121|520329024|FG000|Overall Study|Site closed|1|||
144307109|NCT02240121|520329025|FG001|Overall Study|Site closed|1|||
144307110|NCT02240121|520329024|FG000|Overall Study|Pregnancy|1|||
144307111|NCT02240121|520329025|FG001|Overall Study|Pregnancy|0|||
144307112|NCT02240121|520329024|FG000|Overall Study|Adverse Event|2|||
144307113|NCT02240121|520329025|FG001|Overall Study|Adverse Event|4|||
144307114|NCT02240121|520329024|FG000|Overall Study|Withdrawal by Subject|6|||
144307115|NCT02240121|520329025|FG001|Overall Study|Withdrawal by Subject|2|||
144307116|NCT02240121|520329024|FG000|Overall Study|Lost to Follow-up|3|||
144307117|NCT02240121|520329025|FG001|Overall Study|Lost to Follow-up|4|||
144307118|NCT02240121|520329024|FG000|Overall Study|Other than specified|1|||
144307119|NCT02240121|520329025|FG001|Overall Study|Other than specified|3|||
144307120|NCT00600067|520329027|FG000|Overall Study|Adverse Event|0|||
144307121|NCT00600067|520329028|FG001|Overall Study|Adverse Event|1|||
144307122|NCT00600067|520329027|FG000|Overall Study|Lost to Follow-up|2|||
144307123|NCT00600067|520329028|FG001|Overall Study|Lost to Follow-up|3|||
144307124|NCT00600067|520329027|FG000|Overall Study|protocol non-compliance|0|||
144307125|NCT00600067|520329028|FG001|Overall Study|protocol non-compliance|3|||
144307126|NCT00600067|520329027|FG000|Overall Study|Lack of Efficacy|1|||
144307127|NCT00600067|520329028|FG001|Overall Study|Lack of Efficacy|0|||
144307128|NCT04571060|520329031|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
144307129|NCT04571060|520329032|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
144307130|NCT04571060|520329031|FG000|Overall Study|Never treated migraine|47|||
144307131|NCT04571060|520329032|FG001|Overall Study|Never treated migraine|36|||
144307132|NCT04571060|520329031|FG000|Overall Study|Protocol Violation|4|||
144307133|NCT04571060|520329032|FG001|Overall Study|Protocol Violation|2|||
144307134|NCT04571060|520329031|FG000|Overall Study|Withdrawal by Subject|6|||
144307135|NCT04571060|520329032|FG001|Overall Study|Withdrawal by Subject|2|||
144307136|NCT04571060|520329031|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
144307137|NCT04571060|520329032|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
144307138|NCT01508910|520329033|FG000|Treatment|Death|2|||
144307139|NCT01508910|520329034|FG001|Treatment|Death|3|||
144307140|NCT01508910|520329035|FG002|Treatment|Death|2|||
144307141|NCT01508910|520329036|FG003|Treatment|Death|0|||
144307142|NCT01508910|520329033|FG000|Treatment|Lost to Follow-up|0|||
144307143|NCT01508910|520329034|FG001|Treatment|Lost to Follow-up|0|||
144307144|NCT01508910|520329035|FG002|Treatment|Lost to Follow-up|2|||
144307145|NCT01508910|520329036|FG003|Treatment|Lost to Follow-up|1|||
144307146|NCT01508910|520329033|FG000|Treatment|Withdrawal by Subject|0|||
144307147|NCT01508910|520329034|FG001|Treatment|Withdrawal by Subject|1|||
144307148|NCT01508910|520329035|FG002|Treatment|Withdrawal by Subject|6|||
144307149|NCT01508910|520329036|FG003|Treatment|Withdrawal by Subject|1|||
144307150|NCT01508910|520329033|FG000|Treatment|Sponsor Decision|0|||
144307151|NCT01508910|520329034|FG001|Treatment|Sponsor Decision|0|||
144307152|NCT01508910|520329035|FG002|Treatment|Sponsor Decision|0|||
144307153|NCT01508910|520329036|FG003|Treatment|Sponsor Decision|1|||
144307154|NCT04819113|520329038|FG000|Overall Study|Withdrawal by parent/guardian|3|||
144307155|NCT04819113|520329038|FG000|Overall Study|Lost to Follow-up|1|||
144307156|NCT04819113|520329038|FG000|Overall Study|Withdrawn before vaccination|2|||
144307157|NCT01342094|520329041|FG000|Overall Study|Adverse Event|5|||
144307158|NCT01342094|520329042|FG001|Overall Study|Adverse Event|0|||
144307159|NCT01342094|520329041|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
144307160|NCT01342094|520329042|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
144307161|NCT01342094|520329041|FG000|Overall Study|Withdrawal by Subject|0|||
144307162|NCT01342094|520329042|FG001|Overall Study|Withdrawal by Subject|2|||
144307163|NCT00678288|520330908|FG000|Overall Study|Adverse Event|0|||
144307164|NCT00678288|520330909|FG001|Overall Study|Adverse Event|2|||
144307165|NCT00678288|520330908|FG000|Overall Study|Withdrawal by Subject|1|||
144307166|NCT00678288|520330909|FG001|Overall Study|Withdrawal by Subject|1|||
144307167|NCT00678288|520330908|FG000|Overall Study|Study terminated by the sponsor|2|||
144307168|NCT00678288|520330909|FG001|Overall Study|Study terminated by the sponsor|0|||
144307169|NCT00678288|520330908|FG000|Overall Study|Not compliant with study medication|0|||
144307170|NCT00678288|520330909|FG001|Overall Study|Not compliant with study medication|1|||
144307171|NCT00678288|520330908|FG000|Overall Study|Switch to commercial drug|0|||
144307172|NCT00678288|520330909|FG001|Overall Study|Switch to commercial drug|1|||
144307173|NCT00678288|520330908|FG000|Overall Study|Reason not reported|1|||
144307174|NCT00678288|520330909|FG001|Overall Study|Reason not reported|0|||
144307175|NCT00678288|520330908|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
144307176|NCT00678288|520330909|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
144307177|NCT02628444|520330912|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
144307178|NCT02628444|520330913|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307179|NCT02628444|520330914|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307180|NCT02628444|520330915|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307181|NCT02628444|520330916|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307182|NCT02628444|520330917|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307183|NCT02628444|520330918|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307184|NCT02628444|520330919|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307185|NCT02628444|520330920|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
144307186|NCT02628444|520330912|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307187|NCT02628444|520330913|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
144307188|NCT02628444|520330914|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
144307189|NCT02628444|520330915|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307190|NCT02628444|520330916|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307191|NCT02628444|520330917|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307192|NCT02628444|520330918|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307193|NCT02628444|520330919|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307194|NCT02628444|520330920|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
144307195|NCT02628444|520330912|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
144307196|NCT02628444|520330913|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
144307197|NCT02628444|520330914|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
144307198|NCT02628444|520330915|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307199|NCT02628444|520330916|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307200|NCT02628444|520330917|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307201|NCT02628444|520330918|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307202|NCT02628444|520330919|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307203|NCT02628444|520330920|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307204|NCT02628444|520330912|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
144307205|NCT02628444|520330913|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
144307206|NCT02628444|520330914|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
144307207|NCT02628444|520330915|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
144307208|NCT02628444|520330916|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
144307209|NCT02628444|520330917|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
144307210|NCT02628444|520330918|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
144307211|NCT02628444|520330919|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
144307212|NCT02628444|520330920|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
144307213|NCT02628444|520330912|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
144307214|NCT02628444|520330913|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
144307215|NCT02628444|520330914|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
144307216|NCT02628444|520330915|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
144307217|NCT02628444|520330916|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
144307218|NCT02628444|520330917|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
144307219|NCT02628444|520330918|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
144307220|NCT02628444|520330919|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
144307221|NCT02628444|520330920|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
144307222|NCT02628444|520330912|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307223|NCT02628444|520330913|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307224|NCT02628444|520330914|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307225|NCT02628444|520330915|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
144307226|NCT02628444|520330916|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307227|NCT02628444|520330917|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307228|NCT02628444|520330918|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307229|NCT02628444|520330919|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307230|NCT02628444|520330920|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
144307231|NCT02628444|520330912|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
144307232|NCT02628444|520330913|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
144307233|NCT02628444|520330914|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
144307234|NCT02628444|520330915|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
144307235|NCT02628444|520330916|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
144307236|NCT02628444|520330917|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
144307237|NCT02628444|520330918|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
144307238|NCT02628444|520330919|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
144307239|NCT02628444|520330920|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
144307240|NCT02628444|520330912|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307241|NCT02628444|520330913|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307242|NCT02628444|520330914|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
144307243|NCT02628444|520330915|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
144307244|NCT02628444|520330916|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
144307245|NCT02628444|520330917|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
144307246|NCT02628444|520330918|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
144307247|NCT02628444|520330919|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
144307248|NCT02628444|520330920|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
144307249|NCT02628444|520330912|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
144307250|NCT02628444|520330913|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
144307251|NCT02628444|520330914|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
144307252|NCT02628444|520330915|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
144307253|NCT02628444|520330916|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
144307254|NCT02628444|520330917|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
144307255|NCT02628444|520330918|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
144307256|NCT02628444|520330919|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
144307257|NCT02628444|520330920|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
144307258|NCT02628444|520330912|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
144307259|NCT02628444|520330913|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
144307260|NCT02628444|520330914|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
144307261|NCT02628444|520330915|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
144307262|NCT02628444|520330916|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
144307263|NCT02628444|520330917|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
144307264|NCT02628444|520330918|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
144307265|NCT02628444|520330919|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
144307266|NCT02628444|520330920|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
144307267|NCT00628446|520330923|FG000|Overall Study|Lost to Follow-up|3|||
144307268|NCT00628446|520330923|FG000|Overall Study|Withdrawal by Subject|1|||
144307269|NCT00628446|520330923|FG000|Overall Study|Protocol Violation|3|||
144307270|NCT00551031|520330924|FG000|Overall Study|Adverse Event|0|||
144307271|NCT00551031|520330925|FG001|Overall Study|Adverse Event|1|||
144307272|NCT00551031|520330926|FG002|Overall Study|Adverse Event|0|||
144307273|NCT00551031|520330927|FG003|Overall Study|Adverse Event|0|||
144307274|NCT00551031|520330928|FG004|Overall Study|Adverse Event|0|||
144307275|NCT00551031|520330924|FG000|Overall Study|Protocol Violation|1|||
144307276|NCT00551031|520330925|FG001|Overall Study|Protocol Violation|1|||
144307277|NCT00551031|520330926|FG002|Overall Study|Protocol Violation|0|||
144307278|NCT00551031|520330927|FG003|Overall Study|Protocol Violation|0|||
144307279|NCT00551031|520330928|FG004|Overall Study|Protocol Violation|0|||
144307280|NCT00551031|520330924|FG000|Overall Study|Lost to Follow-up|0|||
144307281|NCT00551031|520330925|FG001|Overall Study|Lost to Follow-up|1|||
144307282|NCT00551031|520330926|FG002|Overall Study|Lost to Follow-up|0|||
144307283|NCT00551031|520330927|FG003|Overall Study|Lost to Follow-up|1|||
144307284|NCT00551031|520330928|FG004|Overall Study|Lost to Follow-up|1|||
144307285|NCT00551031|520330924|FG000|Overall Study|Withdrawal by Subject|0|||
144307286|NCT00551031|520330925|FG001|Overall Study|Withdrawal by Subject|4|||
144307287|NCT00551031|520330926|FG002|Overall Study|Withdrawal by Subject|1|||
144307288|NCT00551031|520330927|FG003|Overall Study|Withdrawal by Subject|2|||
144307289|NCT00551031|520330928|FG004|Overall Study|Withdrawal by Subject|0|||
144307290|NCT00551031|520330924|FG000|Overall Study|Serious Adverse Event|0|||
144307291|NCT00551031|520330925|FG001|Overall Study|Serious Adverse Event|2|||
144307292|NCT00551031|520330926|FG002|Overall Study|Serious Adverse Event|1|||
144307293|NCT00551031|520330927|FG003|Overall Study|Serious Adverse Event|0|||
144307294|NCT00551031|520330928|FG004|Overall Study|Serious Adverse Event|0|||
144307295|NCT00551031|520330924|FG000|Overall Study|Did not receive vaccine|1|||
144307296|NCT00551031|520330925|FG001|Overall Study|Did not receive vaccine|2|||
144307297|NCT00551031|520330926|FG002|Overall Study|Did not receive vaccine|0|||
144307298|NCT00551031|520330927|FG003|Overall Study|Did not receive vaccine|0|||
144307299|NCT00551031|520330928|FG004|Overall Study|Did not receive vaccine|0|||
144307300|NCT00682929|520330933|FG000|Overall Study|Adverse Event|4|||
144307301|NCT00682929|520330934|FG001|Overall Study|Adverse Event|1|||
144307302|NCT00682929|520330935|FG002|Overall Study|Adverse Event|1|||
144307303|NCT00682929|520330933|FG000|Overall Study|Withdrawal by Subject|1|||
144307304|NCT00682929|520330934|FG001|Overall Study|Withdrawal by Subject|2|||
144307305|NCT00682929|520330935|FG002|Overall Study|Withdrawal by Subject|1|||
144307306|NCT00682929|520330933|FG000|Overall Study|dosing compliance < 80%|0|||
144307307|NCT00682929|520330934|FG001|Overall Study|dosing compliance < 80%|2|||
144307308|NCT00682929|520330935|FG002|Overall Study|dosing compliance < 80%|0|||
144307309|NCT00682929|520330933|FG000|Overall Study|lag in DEA renewal|1|||
144307310|NCT00682929|520330934|FG001|Overall Study|lag in DEA renewal|0|||
144307311|NCT00682929|520330935|FG002|Overall Study|lag in DEA renewal|0|||
144307312|NCT00456755|520330940|FG000|Overall Study|Lost to Follow-up|2|||
144307313|NCT00456755|520330941|FG001|Overall Study|Lost to Follow-up|1|||
144307314|NCT04072835|520330945|FG000|Overall Study|Overall trial ended|603|||
144307315|NCT04072835|520330945|FG000|Overall Study|Ablation|97|||
144307316|NCT04072835|520330945|FG000|Overall Study|Withdrawal of consent|66|||
144307317|NCT04072835|520330945|FG000|Overall Study|Physician Decision|50|||
144307318|NCT04072835|520330945|FG000|Overall Study|Lost to Follow-up|39|||
144307319|NCT04072835|520330945|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
144307320|NCT04072835|520330945|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
144307321|NCT04072835|520330945|FG000|Overall Study|Adverse Event|25|||
144307322|NCT04072835|520330945|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
144307323|NCT04072835|520330945|FG000|Overall Study|Death|11|||
144307324|NCT04072835|520330945|FG000|Overall Study|Participant felt the drug did not work|8|||
144307325|NCT04072835|520330945|FG000|Overall Study|Participant tolerability|5|||
144307326|NCT04072835|520330945|FG000|Overall Study|Missing|5|||
144307327|NCT04072835|520330945|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
144307328|NCT04072835|520330945|FG000|Overall Study|Pregnancy|3|||
144307329|NCT00399568|520330946|FG000|Overall Study|Adverse Event|1|||
144307330|NCT00399568|520330947|FG001|Overall Study|Adverse Event|2|||
144307331|NCT00399568|520330946|FG000|Overall Study|Withdrawal by Subject|7|||
144307332|NCT00399568|520330947|FG001|Overall Study|Withdrawal by Subject|3|||
144307333|NCT00399568|520330946|FG000|Overall Study|Protocol non-compliance|2|||
144307334|NCT00399568|520330947|FG001|Overall Study|Protocol non-compliance|2|||
144307335|NCT00399568|520330946|FG000|Overall Study|Lost to Follow-up|2|||
144307336|NCT00399568|520330947|FG001|Overall Study|Lost to Follow-up|2|||
144307337|NCT00841776|520330950|FG000|Overall Study|Lack of Efficacy|0|||
144307338|NCT00841776|520330951|FG001|Overall Study|Lack of Efficacy|1|||
144307339|NCT00841776|520330950|FG000|Overall Study|Lost to Follow-up|2|||
144307340|NCT00841776|520330951|FG001|Overall Study|Lost to Follow-up|1|||
144307341|NCT00841776|520330950|FG000|Overall Study|Withdrawal by Subject|0|||
144307342|NCT00841776|520330951|FG001|Overall Study|Withdrawal by Subject|1|||
144307343|NCT04567524|520330952|FG000|Overall Study|Adverse Event|1|||
144307344|NCT04567524|520330953|FG001|Overall Study|Adverse Event|1|||
144307345|NCT04567524|520330954|FG002|Overall Study|Adverse Event|0|||
144307346|NCT04567524|520330955|FG003|Overall Study|Adverse Event|0|||
144307347|NCT04567524|520330952|FG000|Overall Study|Withdrawal by Subject|2|||
144307348|NCT04567524|520330953|FG001|Overall Study|Withdrawal by Subject|0|||
144307349|NCT04567524|520330954|FG002|Overall Study|Withdrawal by Subject|0|||
144307350|NCT04567524|520330955|FG003|Overall Study|Withdrawal by Subject|1|||
144307351|NCT03432494|520330962|FG000|Overall Study|Death|1|||
144307352|NCT03432494|520330962|FG000|Overall Study|Noncompliance|1|||
144307353|NCT00592631|520330963|FG000|Overall Study|Lost to Follow-up|0|||
144307354|NCT00592631|520330964|FG001|Overall Study|Lost to Follow-up|2|||
144307355|NCT00856635|520330965|FG000|Overall Study|Lost to Follow-up|2|||
144307356|NCT00856635|520330966|FG001|Overall Study|Lost to Follow-up|5|||
144307357|NCT00856635|520330965|FG000|Overall Study|Pregnancy|1|||
144307358|NCT00856635|520330966|FG001|Overall Study|Pregnancy|0|||
144307359|NCT00856635|520330965|FG000|Overall Study|Withdrawal by Subject|3|||
144307360|NCT00856635|520330966|FG001|Overall Study|Withdrawal by Subject|1|||
144307361|NCT00856635|520330965|FG000|Overall Study|Serious Adverse Event|1|||
144307362|NCT00856635|520330966|FG001|Overall Study|Serious Adverse Event|0|||
144307363|NCT00856635|520330965|FG000|Overall Study|Other|1|||
144307364|NCT00856635|520330966|FG001|Overall Study|Other|0|||
144307365|NCT00856635|520330965|FG000|Overall Study|Discontinued at Randomization|2|||
144307366|NCT00856635|520330966|FG001|Overall Study|Discontinued at Randomization|2|||
144307367|NCT01244035|520330967|FG000|Part 1: Period 1|Adverse Event|0|||
144307368|NCT01244035|520330968|FG001|Part 1: Period 1|Adverse Event|0|||
144307369|NCT01244035|520330969|FG002|Part 1: Period 1|Adverse Event|0|||
144307370|NCT01244035|520330970|FG003|Part 1: Period 1|Adverse Event|0|||
144307371|NCT01244035|520330971|FG004|Part 1: Period 1|Adverse Event|0|||
144307372|NCT01244035|520330972|FG005|Part 1: Period 1|Adverse Event|1|||
144307373|NCT01244035|520330967|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
144307374|NCT01244035|520330968|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
144307375|NCT01244035|520330969|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
144307376|NCT01244035|520330970|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
144307377|NCT01244035|520330971|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
144307378|NCT01244035|520330972|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
144307379|NCT01244035|520330967|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
144307380|NCT01244035|520330968|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
144307381|NCT01244035|520330969|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
144307382|NCT01244035|520330970|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
144307383|NCT01244035|520330971|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
144307384|NCT01244035|520330972|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
144307385|NCT01244035|520330967|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
144307386|NCT01244035|520330968|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
144307387|NCT01244035|520330969|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
144307388|NCT01244035|520330970|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
144307389|NCT01244035|520330971|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
144307390|NCT01244035|520330972|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
144307391|NCT01244035|520330967|FG000|Part 1: Period 3|Adverse Event|0|||
144307392|NCT01244035|520330968|FG001|Part 1: Period 3|Adverse Event|0|||
144307393|NCT01244035|520330969|FG002|Part 1: Period 3|Adverse Event|0|||
144307394|NCT01244035|520330970|FG003|Part 1: Period 3|Adverse Event|0|||
144307395|NCT01244035|520330971|FG004|Part 1: Period 3|Adverse Event|0|||
144307396|NCT01244035|520330972|FG005|Part 1: Period 3|Adverse Event|1|||
144307397|NCT01244035|520330967|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
144307398|NCT01244035|520330968|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
144307399|NCT01244035|520330969|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
144307400|NCT01244035|520330970|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
144307401|NCT01244035|520330971|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
144307402|NCT01244035|520330972|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
144307403|NCT01244035|520330967|FG000|Part 1: Period 3|Protocol Deviation|0|||
144307404|NCT01244035|520330968|FG001|Part 1: Period 3|Protocol Deviation|1|||
144307405|NCT01244035|520330969|FG002|Part 1: Period 3|Protocol Deviation|0|||
144307406|NCT01244035|520330970|FG003|Part 1: Period 3|Protocol Deviation|0|||
144307407|NCT01244035|520330971|FG004|Part 1: Period 3|Protocol Deviation|0|||
144307408|NCT01244035|520330972|FG005|Part 1: Period 3|Protocol Deviation|0|||
144307409|NCT03688919|520330973|FG000|Overall Study|Lost to Follow-up|2|||
144307410|NCT03688919|520330974|FG001|Overall Study|Lost to Follow-up|1|||
144307411|NCT03688919|520330973|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
144307412|NCT03688919|520330974|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
144307413|NCT00347932|520330975|FG000|Overall Study|Adverse Event|4|||
144307414|NCT00347932|520330976|FG001|Overall Study|Adverse Event|5|||
144307415|NCT00347932|520330975|FG000|Overall Study|Lack of Efficacy|3|||
144307416|NCT00347932|520330976|FG001|Overall Study|Lack of Efficacy|14|||
144307417|NCT00347932|520330975|FG000|Overall Study|Lost to Follow-up|10|||
144307418|NCT00347932|520330976|FG001|Overall Study|Lost to Follow-up|9|||
144307419|NCT00347932|520330975|FG000|Overall Study|Withdrawal by Subject|10|||
144307420|NCT00347932|520330976|FG001|Overall Study|Withdrawal by Subject|16|||
144307421|NCT00347932|520330975|FG000|Overall Study|Did not meet inclusion criteria|4|||
144307422|NCT00347932|520330976|FG001|Overall Study|Did not meet inclusion criteria|8|||
144307423|NCT04512001|520330977|FG000|Week 0 to Week 24|Adverse Event|14|||
144307424|NCT04512001|520330978|FG001|Week 0 to Week 24|Adverse Event|10|||
144307425|NCT04512001|520330979|FG002|Week 0 to Week 24|Adverse Event|0|||
144307426|NCT04512001|520330980|FG003|Week 0 to Week 24|Adverse Event|0|||
144307427|NCT04512001|520330981|FG004|Week 0 to Week 24|Adverse Event|0|||
144307428|NCT04512001|520330977|FG000|Week 0 to Week 24|Death|0|||
144307429|NCT04512001|520330978|FG001|Week 0 to Week 24|Death|2|||
144307430|NCT04512001|520330979|FG002|Week 0 to Week 24|Death|0|||
144307431|NCT04512001|520330980|FG003|Week 0 to Week 24|Death|0|||
144307432|NCT04512001|520330981|FG004|Week 0 to Week 24|Death|0|||
144307433|NCT04512001|520330977|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
144307434|NCT04512001|520330978|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
144307435|NCT04512001|520330979|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
144307436|NCT04512001|520330980|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
144307437|NCT04512001|520330981|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
144307438|NCT04512001|520330977|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
144307439|NCT04512001|520330978|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
144307440|NCT04512001|520330979|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
144307441|NCT04512001|520330980|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
144307442|NCT04512001|520330981|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
144307443|NCT04512001|520330977|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
144307444|NCT04512001|520330978|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
144307445|NCT04512001|520330979|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
144307446|NCT04512001|520330980|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
144307447|NCT04512001|520330981|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
144307448|NCT04512001|520330977|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
144307449|NCT04512001|520330978|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
144307450|NCT04512001|520330979|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
144307451|NCT04512001|520330980|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
144307452|NCT04512001|520330981|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
144307453|NCT04512001|520330977|FG000|Week 24 to Week 63|Adverse Event|0|||
144307454|NCT04512001|520330978|FG001|Week 24 to Week 63|Adverse Event|0|||
144307455|NCT04512001|520330979|FG002|Week 24 to Week 63|Adverse Event|13|||
144307456|NCT04512001|520330980|FG003|Week 24 to Week 63|Adverse Event|8|||
144307457|NCT04512001|520330981|FG004|Week 24 to Week 63|Adverse Event|6|||
144307458|NCT04512001|520330977|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
144307459|NCT04512001|520330978|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
144307460|NCT04512001|520330979|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
144307461|NCT04512001|520330980|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
144307462|NCT04512001|520330981|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
144307463|NCT04512001|520330977|FG000|Week 24 to Week 63|Death|0|||
144307464|NCT04512001|520330978|FG001|Week 24 to Week 63|Death|0|||
144307465|NCT04512001|520330979|FG002|Week 24 to Week 63|Death|0|||
144307466|NCT04512001|520330980|FG003|Week 24 to Week 63|Death|1|||
144307467|NCT04512001|520330981|FG004|Week 24 to Week 63|Death|1|||
144307468|NCT04512001|520330977|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
144307469|NCT04512001|520330978|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
144307470|NCT04512001|520330979|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
144307471|NCT04512001|520330980|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
144307472|NCT04512001|520330981|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
144307473|NCT04512001|520330977|FG000|Week 24 to Week 63|Miscellaneous|0|||
144307474|NCT04512001|520330978|FG001|Week 24 to Week 63|Miscellaneous|0|||
144307475|NCT04512001|520330979|FG002|Week 24 to Week 63|Miscellaneous|3|||
144307476|NCT04512001|520330980|FG003|Week 24 to Week 63|Miscellaneous|2|||
144307477|NCT04512001|520330981|FG004|Week 24 to Week 63|Miscellaneous|1|||
144307478|NCT02776683|520330982|FG000|Pre-switch Period|Protocol Violation|1|||
144307479|NCT02776683|520330983|FG001|Pre-switch Period|Protocol Violation|0|||
144307480|NCT02776683|520330982|FG000|Pre-switch Period|Adverse Event|21|||
144307481|NCT02776683|520330983|FG001|Pre-switch Period|Adverse Event|0|||
144307482|NCT02776683|520330982|FG000|Pre-switch Period|Withdrawal by Subject|9|||
144307483|NCT02776683|520330983|FG001|Pre-switch Period|Withdrawal by Subject|0|||
144307484|NCT02776683|520330982|FG000|Pre-switch Period|Physician Decision|7|||
144307485|NCT02776683|520330983|FG001|Pre-switch Period|Physician Decision|0|||
144307486|NCT02776683|520330982|FG000|Pre-switch Period|Progressive disease|39|||
144307487|NCT02776683|520330983|FG001|Pre-switch Period|Progressive disease|0|||
144307488|NCT02776683|520330982|FG000|Pre-switch Period|Other than listed|3|||
144307489|NCT02776683|520330983|FG001|Pre-switch Period|Other than listed|0|||
144307490|NCT02776683|520330982|FG000|Post-switch Period|Adverse Event|0|||
144307491|NCT02776683|520330983|FG001|Post-switch Period|Adverse Event|3|||
144307492|NCT02776683|520330982|FG000|Post-switch Period|Withdrawal by Subject|0|||
144307493|NCT02776683|520330983|FG001|Post-switch Period|Withdrawal by Subject|2|||
144307494|NCT02776683|520330982|FG000|Post-switch Period|Physician Decision|0|||
144307495|NCT02776683|520330983|FG001|Post-switch Period|Physician Decision|3|||
144307496|NCT02776683|520330982|FG000|Post-switch Period|Progressive disease|0|||
144307497|NCT02776683|520330983|FG001|Post-switch Period|Progressive disease|20|||
144307498|NCT02776683|520330982|FG000|Post-switch Period|Other than listed|0|||
144307499|NCT02776683|520330983|FG001|Post-switch Period|Other than listed|15|||
144307500|NCT03389308|520330986|FG000|Overall Study|Withdrawal by Subject|5|||
144307501|NCT03389308|520330986|FG000|Overall Study|Lost to Follow-up|3|||
144307502|NCT03389308|520330986|FG000|Overall Study|Adverse Event|2|||
144307503|NCT03389308|520330986|FG000|Overall Study|Sponsor Request|2|||
144307504|NCT03198767|520330990|FG000|Overall Study|Protocol Violation|0|||
144307505|NCT03198767|520330991|FG001|Overall Study|Protocol Violation|0|||
144307506|NCT03198767|520330992|FG002|Overall Study|Protocol Violation|0|||
144307507|NCT03198767|520330993|FG003|Overall Study|Protocol Violation|6|||
144307508|NCT03198767|520330994|FG004|Overall Study|Protocol Violation|0|||
144307509|NCT03198767|520330995|FG005|Overall Study|Protocol Violation|0|||
144307510|NCT03198767|520330996|FG006|Overall Study|Protocol Violation|0|||
144307511|NCT00570323|520330997|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
144307512|NCT00570323|520330998|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
144307513|NCT00570323|520330997|FG000|Started Treatment After Randomization|Protocol Violation|1|||
144307514|NCT00570323|520330998|FG001|Started Treatment After Randomization|Protocol Violation|0|||
144307515|NCT00570323|520330997|FG000|Started Treatment After Randomization|Physician Decision|1|||
144307516|NCT00570323|520330998|FG001|Started Treatment After Randomization|Physician Decision|0|||
144307517|NCT00570323|520330997|FG000|Complete Study After Start|Lost to Follow-up|0|||
144307518|NCT00570323|520330998|FG001|Complete Study After Start|Lost to Follow-up|1|||
144307519|NCT00570323|520330997|FG000|Complete Study After Start|Withdrawal by Subject|2|||
144307520|NCT00570323|520330998|FG001|Complete Study After Start|Withdrawal by Subject|0|||
144307521|NCT00570323|520330997|FG000|Complete Study After Start|Physician Decision|1|||
144307522|NCT00570323|520330998|FG001|Complete Study After Start|Physician Decision|0|||
144307523|NCT02639247|520331001|FG000|Overall Study|Lost to Follow-up|2|||
144307524|NCT02639247|520331002|FG001|Overall Study|Lost to Follow-up|1|||
144307525|NCT02639247|520331001|FG000|Overall Study|Death|2|||
144307526|NCT02639247|520331002|FG001|Overall Study|Death|0|||
144307527|NCT02639247|520331001|FG000|Overall Study|Withdrew Consent|0|||
144307528|NCT02639247|520331002|FG001|Overall Study|Withdrew Consent|1|||
144307529|NCT02639247|520331001|FG000|Overall Study|Protocol Violation|1|||
144307530|NCT02639247|520331002|FG001|Overall Study|Protocol Violation|0|||
144307531|NCT00400517|520331005|FG000|Overall Study|Withdrawal by Subject|1|||
144307532|NCT00400517|520331005|FG000|Overall Study|Physician Decision|1|||
144307533|NCT02141672|520331009|FG000|Overall Study|Adverse Event|0|||
144307534|NCT02141672|520331010|FG001|Overall Study|Adverse Event|1|||
144307535|NCT02141672|520331011|FG002|Overall Study|Adverse Event|0|||
144307536|NCT02141672|520331009|FG000|Overall Study|Death|10|||
144307537|NCT02141672|520331010|FG001|Overall Study|Death|2|||
144307538|NCT02141672|520331011|FG002|Overall Study|Death|1|||
144307539|NCT02141672|520331009|FG000|Overall Study|Lack of Efficacy|0|||
144307540|NCT02141672|520331010|FG001|Overall Study|Lack of Efficacy|0|||
144307541|NCT02141672|520331011|FG002|Overall Study|Lack of Efficacy|2|||
144307542|NCT02141672|520331009|FG000|Overall Study|Lost to Follow-up|1|||
144307543|NCT02141672|520331010|FG001|Overall Study|Lost to Follow-up|1|||
144307544|NCT02141672|520331011|FG002|Overall Study|Lost to Follow-up|3|||
144307545|NCT02141672|520331009|FG000|Overall Study|Physician Decision|1|||
144307546|NCT02141672|520331010|FG001|Overall Study|Physician Decision|2|||
144307547|NCT02141672|520331011|FG002|Overall Study|Physician Decision|5|||
144307548|NCT02141672|520331009|FG000|Overall Study|Protocol Violation|0|||
144307549|NCT02141672|520331010|FG001|Overall Study|Protocol Violation|0|||
144307550|NCT02141672|520331011|FG002|Overall Study|Protocol Violation|1|||
144307551|NCT02141672|520331009|FG000|Overall Study|Withdrawal by Subject|3|||
144307552|NCT02141672|520331010|FG001|Overall Study|Withdrawal by Subject|2|||
144307553|NCT02141672|520331011|FG002|Overall Study|Withdrawal by Subject|5|||
144307554|NCT02141672|520331009|FG000|Overall Study|refused to follow-up|1|||
144307555|NCT02141672|520331010|FG001|Overall Study|refused to follow-up|0|||
144307556|NCT02141672|520331011|FG002|Overall Study|refused to follow-up|1|||
144307557|NCT01118780|520331012|FG000|Overall Study|Adverse Event|15|||
144307558|NCT01118780|520331013|FG001|Overall Study|Adverse Event|15|||
144307559|NCT01118780|520331012|FG000|Overall Study|Death|1|||
144307560|NCT01118780|520331013|FG001|Overall Study|Death|0|||
144307561|NCT01118780|520331012|FG000|Overall Study|Lack of Efficacy|2|||
144307562|NCT01118780|520331013|FG001|Overall Study|Lack of Efficacy|6|||
144307563|NCT01118780|520331012|FG000|Overall Study|Physician Decision|2|||
144307564|NCT01118780|520331013|FG001|Overall Study|Physician Decision|0|||
144307565|NCT01118780|520331012|FG000|Overall Study|Protocol Violation|3|||
144307566|NCT01118780|520331013|FG001|Overall Study|Protocol Violation|6|||
144307567|NCT01118780|520331012|FG000|Overall Study|Withdrawal by Subject|13|||
144307568|NCT01118780|520331013|FG001|Overall Study|Withdrawal by Subject|8|||
144307569|NCT02457247|520331016|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
144307570|NCT02457247|520331017|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
144307571|NCT02457247|520331018|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
144307572|NCT02457247|520331019|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
144307573|NCT02457247|520331016|FG000|Period 1|Significant Protocol Deviation|1|||
144307574|NCT02457247|520331017|FG001|Period 1|Significant Protocol Deviation|1|||
144307575|NCT02457247|520331018|FG002|Period 1|Significant Protocol Deviation|0|||
144307576|NCT02457247|520331019|FG003|Period 1|Significant Protocol Deviation|0|||
144307577|NCT02457247|520331016|FG000|Period 1|Voluntary Withdrawal|1|||
144307578|NCT02457247|520331017|FG001|Period 1|Voluntary Withdrawal|0|||
144307579|NCT02457247|520331018|FG002|Period 1|Voluntary Withdrawal|0|||
144307580|NCT02457247|520331019|FG003|Period 1|Voluntary Withdrawal|0|||
144307581|NCT02457247|520331016|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
144307582|NCT02457247|520331017|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
144307583|NCT02457247|520331018|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
144307584|NCT02457247|520331019|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
144307585|NCT02457247|520331016|FG000|Period 2|Significant Protocol Deviation|1|||
144307586|NCT02457247|520331017|FG001|Period 2|Significant Protocol Deviation|0|||
144307587|NCT02457247|520331018|FG002|Period 2|Significant Protocol Deviation|0|||
144307588|NCT02457247|520331019|FG003|Period 2|Significant Protocol Deviation|0|||
144307589|NCT02457247|520331016|FG000|Period 2|Lost to Follow-up|0|||
144307590|NCT02457247|520331017|FG001|Period 2|Lost to Follow-up|1|||
144307591|NCT02457247|520331018|FG002|Period 2|Lost to Follow-up|0|||
144307592|NCT02457247|520331019|FG003|Period 2|Lost to Follow-up|0|||
144307593|NCT02457247|520331016|FG000|Period 2|Voluntary Withdrawal|1|||
144307594|NCT02457247|520331017|FG001|Period 2|Voluntary Withdrawal|1|||
144307595|NCT02457247|520331018|FG002|Period 2|Voluntary Withdrawal|0|||
144307596|NCT02457247|520331019|FG003|Period 2|Voluntary Withdrawal|0|||
144307597|NCT02954887|520331020|FG000|Overall Study|Withdrawal by Subject|3|||
144307598|NCT02954887|520331020|FG000|Overall Study|Lack of Efficacy|3|||
144307599|NCT02954887|520331020|FG000|Overall Study|Other|1|||
144307600|NCT01061385|520331021|FG000|Overall Study|Lost to Follow-up|1|||
144307601|NCT01061385|520331022|FG001|Overall Study|Lost to Follow-up|0|||
144307602|NCT01061385|520331021|FG000|Overall Study|subject decision not related to AE|0|||
144307603|NCT01061385|520331022|FG001|Overall Study|subject decision not related to AE|1|||
144307604|NCT01492088|520331023|FG000|Overall Study|Withdrawal by Patient|0|||
144307605|NCT01492088|520331024|FG001|Overall Study|Withdrawal by Patient|2|||
144307606|NCT01492088|520331025|FG002|Overall Study|Withdrawal by Patient|0|||
144307607|NCT01492088|520331023|FG000|Overall Study|Death|1|||
144307608|NCT01492088|520331024|FG001|Overall Study|Death|6|||
144307609|NCT01492088|520331025|FG002|Overall Study|Death|2|||
144307610|NCT01492088|520331023|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
144307611|NCT01492088|520331024|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
144307612|NCT01492088|520331025|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
144307613|NCT01492088|520331023|FG000|Overall Study|Alive at Last Follow-up|0|||
144307614|NCT01492088|520331024|FG001|Overall Study|Alive at Last Follow-up|6|||
144307615|NCT01492088|520331025|FG002|Overall Study|Alive at Last Follow-up|11|||
144307616|NCT02803203|520331026|FG000|Overall Study|Adverse Event|4|||
144307617|NCT02803203|520331026|FG000|Overall Study|Death|4|||
144307618|NCT02803203|520331026|FG000|Overall Study|Progressive disease|29|||
144307619|NCT02803203|520331026|FG000|Overall Study|Withdrawal by Subject|8|||
144307620|NCT02803203|520331026|FG000|Overall Study|Complete resection of target disease|2|||
144307621|NCT02803203|520331026|FG000|Overall Study|Switched to commercial Osi|1|||
144307622|NCT02803203|520331026|FG000|Overall Study|Participant moved away|1|||
144307623|NCT02379052|520331027|FG000|Overall Study|Protocol Violation|0|||
144307624|NCT02379052|520331028|FG001|Overall Study|Protocol Violation|1|||
144307625|NCT02379052|520331027|FG000|Overall Study|Adverse Event|0|||
144307626|NCT02379052|520331028|FG001|Overall Study|Adverse Event|1|||
144307627|NCT02379052|520331027|FG000|Overall Study|Physician Decision|1|||
144307628|NCT02379052|520331028|FG001|Overall Study|Physician Decision|1|||
144307629|NCT02379052|520331027|FG000|Overall Study|Withdrawal by Subject|2|||
144307630|NCT02379052|520331028|FG001|Overall Study|Withdrawal by Subject|0|||
144307631|NCT02379052|520331027|FG000|Overall Study|Lost to Follow-up|2|||
144307632|NCT02379052|520331028|FG001|Overall Study|Lost to Follow-up|1|||
144307633|NCT02379052|520331027|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
144307634|NCT02379052|520331028|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
144307635|NCT02379052|520331027|FG000|Overall Study|Subject was Incarcerated|0|||
144307636|NCT02379052|520331028|FG001|Overall Study|Subject was Incarcerated|1|||
144307637|NCT00127855|520331029|FG000|Primary Vaccination Course|Adverse Event|0|||
144307638|NCT00127855|520331030|FG001|Primary Vaccination Course|Adverse Event|0|||
144307639|NCT00127855|520331031|FG002|Primary Vaccination Course|Adverse Event|1|||
144307640|NCT00127855|520331032|FG003|Primary Vaccination Course|Adverse Event|0|||
144307641|NCT00127855|520331033|FG004|Primary Vaccination Course|Adverse Event|0|||
144307642|NCT00127855|520331029|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
144307643|NCT00127855|520331030|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
144307644|NCT00127855|520331031|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
144307645|NCT00127855|520331032|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
144307646|NCT00127855|520331033|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
144307647|NCT00127855|520331029|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
144307648|NCT00127855|520331030|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
144307649|NCT00127855|520331031|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
144307650|NCT00127855|520331032|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
144307651|NCT00127855|520331033|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
144307652|NCT00127855|520331029|FG000|Primary Vaccination Course|Other|0|||
144307653|NCT00127855|520331030|FG001|Primary Vaccination Course|Other|0|||
144307654|NCT00127855|520331031|FG002|Primary Vaccination Course|Other|0|||
144307655|NCT00127855|520331032|FG003|Primary Vaccination Course|Other|0|||
144307656|NCT00127855|520331033|FG004|Primary Vaccination Course|Other|1|||
144307657|NCT02343302|520331034|FG000|Overall Study|Physician Decision|1|||
144307658|NCT02343302|520331035|FG001|Overall Study|Physician Decision|1|||
144307659|NCT03637491|520331036|FG000|Overall Study|Death|9|||
144307660|NCT03637491|520331037|FG001|Overall Study|Death|9|||
144307661|NCT03637491|520331038|FG002|Overall Study|Death|5|||
144307662|NCT03637491|520331039|FG003|Overall Study|Death|3|||
144307663|NCT03637491|520331036|FG000|Overall Study|Lost to Follow-up|0|||
144307664|NCT03637491|520331037|FG001|Overall Study|Lost to Follow-up|1|||
144307665|NCT03637491|520331038|FG002|Overall Study|Lost to Follow-up|0|||
144307666|NCT03637491|520331039|FG003|Overall Study|Lost to Follow-up|1|||
144307667|NCT03637491|520331036|FG000|Overall Study|Study Terminated By Sponsor|0|||
144307668|NCT03637491|520331037|FG001|Overall Study|Study Terminated By Sponsor|2|||
144307669|NCT03637491|520331038|FG002|Overall Study|Study Terminated By Sponsor|1|||
144307670|NCT03637491|520331039|FG003|Overall Study|Study Terminated By Sponsor|0|||
144307671|NCT03637491|520331036|FG000|Overall Study|Withdrawal by Subject|1|||
144307672|NCT03637491|520331037|FG001|Overall Study|Withdrawal by Subject|0|||
144307673|NCT03637491|520331038|FG002|Overall Study|Withdrawal by Subject|1|||
144307674|NCT03637491|520331039|FG003|Overall Study|Withdrawal by Subject|2|||
144307675|NCT02185534|520331042|FG000|First Period|Withdrawal by Subject|0|||
144307676|NCT02185534|520331043|FG001|First Period|Withdrawal by Subject|0|||
144307677|NCT02185534|520331044|FG002|First Period|Withdrawal by Subject|0|||
144307678|NCT02185534|520331045|FG003|First Period|Withdrawal by Subject|1|||
144307679|NCT02185534|520331046|FG004|First Period|Withdrawal by Subject|0|||
144307680|NCT02185534|520331047|FG005|First Period|Withdrawal by Subject|0|||
144307681|NCT02185534|520331042|FG000|First Washout Period|Withdrawal by Subject|1|||
144307682|NCT02185534|520331043|FG001|First Washout Period|Withdrawal by Subject|0|||
144307683|NCT02185534|520331044|FG002|First Washout Period|Withdrawal by Subject|0|||
144307684|NCT02185534|520331045|FG003|First Washout Period|Withdrawal by Subject|0|||
144307685|NCT02185534|520331046|FG004|First Washout Period|Withdrawal by Subject|1|||
144307686|NCT02185534|520331047|FG005|First Washout Period|Withdrawal by Subject|0|||
144307687|NCT02185534|520331042|FG000|First Washout Period|Protocol Violation|0|||
144307688|NCT02185534|520331043|FG001|First Washout Period|Protocol Violation|0|||
144307689|NCT02185534|520331044|FG002|First Washout Period|Protocol Violation|0|||
144307690|NCT02185534|520331045|FG003|First Washout Period|Protocol Violation|0|||
144307691|NCT02185534|520331046|FG004|First Washout Period|Protocol Violation|0|||
144307692|NCT02185534|520331047|FG005|First Washout Period|Protocol Violation|1|||
144307693|NCT01925768|520331050|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
144307694|NCT01925768|520331051|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
144307695|NCT01925768|520331050|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
144307696|NCT01925768|520331051|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
144307697|NCT01925768|520331050|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
144307698|NCT01925768|520331051|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
144307699|NCT01925768|520331050|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
144307700|NCT01925768|520331051|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
144307701|NCT01925768|520331050|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
144307702|NCT01925768|520331051|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
144307703|NCT01925768|520331050|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
144307704|NCT01925768|520331051|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
144307705|NCT01925768|520331050|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
144307706|NCT01925768|520331051|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
144307707|NCT01925768|520331050|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
144307708|NCT01925768|520331051|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
144307709|NCT01925768|520331050|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
144307710|NCT01925768|520331051|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
144307711|NCT01925768|520331050|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
144307712|NCT01925768|520331051|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
144307713|NCT01925768|520331050|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
144307714|NCT01925768|520331051|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
144307715|NCT02806414|520331070|FG000|Overall Study|Lost to Follow-up|2|||
144307716|NCT02573948|520331079|FG000|Longitudinal Cohort|Death|9|||
144307717|NCT02573948|520331079|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
144307718|NCT02573948|520331079|FG000|Longitudinal Cohort|Incarcerated|25|||
144307719|NCT01673126|520331080|FG000|Overall Study|change of diagnosis|4|||
144307720|NCT01673126|520331081|FG001|Overall Study|change of diagnosis|3|||
144307721|NCT01913327|520331086|FG000|Overall Study|Withdrawal by Subject|0|||
144307722|NCT01913327|520331087|FG001|Overall Study|Withdrawal by Subject|1|||
144307723|NCT02477527|520332873|FG000|Overall Study|Lost to Follow-up|2|||
144307724|NCT02477527|520332873|FG000|Overall Study|Withdrawal by Subject|1|||
144307725|NCT02477527|520332873|FG000|Overall Study|Screen Failure|3|||
144307726|NCT01147393|520332874|FG000|Dose Level 1|Dose limiting Toxicity|2|||
144307727|NCT01147393|520332874|FG000|Dose Level -1|Dose Limited Toxicity|1|||
144307728|NCT01891396|520332877|FG000|Overall Study|Withdrawal by Subject|4|||
144307729|NCT01891396|520332878|FG001|Overall Study|Withdrawal by Subject|4|||
144307730|NCT01891396|520332879|FG002|Overall Study|Withdrawal by Subject|3|||
144307731|NCT01891396|520332877|FG000|Overall Study|Lost to Follow-up|0|||
144307732|NCT01891396|520332878|FG001|Overall Study|Lost to Follow-up|1|||
144307733|NCT01891396|520332879|FG002|Overall Study|Lost to Follow-up|0|||
144307734|NCT03462758|520332880|FG000|Overall Study|Chose no or other method of contraception|20|||
144307735|NCT03462758|520332881|FG001|Overall Study|Chose no or other method of contraception|23|||
144307736|NCT03462758|520332880|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
144307737|NCT03462758|520332881|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
144307738|NCT03462758|520332880|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
144307739|NCT03462758|520332881|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
144307740|NCT03462758|520332880|FG000|Overall Study|Medical contraindication|2|||
144307741|NCT03462758|520332881|FG001|Overall Study|Medical contraindication|2|||
144307742|NCT03462758|520332880|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
144307743|NCT03462758|520332881|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
144307744|NCT02820844|520332883|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
144307745|NCT02820844|520332884|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
144307746|NCT02820844|520332885|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
144307747|NCT02820844|520332886|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
144307748|NCT02820844|520332887|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
144307749|NCT02820844|520332888|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
144307750|NCT02820844|520332883|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
144307751|NCT02820844|520332884|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
144307752|NCT02820844|520332885|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
144307753|NCT02820844|520332886|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
144307754|NCT02820844|520332887|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
144307755|NCT02820844|520332888|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
144307756|NCT02820844|520332883|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
144307757|NCT02820844|520332884|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
144307758|NCT02820844|520332885|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
144307759|NCT02820844|520332886|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
144307760|NCT02820844|520332887|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
144307761|NCT02820844|520332888|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
144307762|NCT02820844|520332883|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
144307763|NCT02820844|520332884|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
144307764|NCT02820844|520332885|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
144307765|NCT02820844|520332886|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
144307766|NCT02820844|520332887|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
144307767|NCT02820844|520332888|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
144307768|NCT02820844|520332883|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
144307769|NCT02820844|520332884|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
144307770|NCT02820844|520332885|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
144307771|NCT02820844|520332886|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
144307772|NCT02820844|520332887|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
144307773|NCT02820844|520332888|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
144307774|NCT02820844|520332883|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
144307775|NCT02820844|520332884|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
144307776|NCT02820844|520332885|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
144307777|NCT02820844|520332886|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
144307778|NCT02820844|520332887|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
144307779|NCT02820844|520332888|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
144307780|NCT02820844|520332883|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
144307781|NCT02820844|520332884|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
144307782|NCT02820844|520332885|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
144307783|NCT02820844|520332886|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
144307784|NCT02820844|520332887|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
144307785|NCT02820844|520332888|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
144307786|NCT02820844|520332883|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307787|NCT02820844|520332884|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307788|NCT02820844|520332885|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
144307789|NCT02820844|520332886|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
144307790|NCT02820844|520332887|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307791|NCT02820844|520332888|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307792|NCT02820844|520332883|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
144307793|NCT02820844|520332884|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
144307794|NCT02820844|520332885|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
144307795|NCT02820844|520332886|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
144307796|NCT02820844|520332887|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
144307797|NCT02820844|520332888|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
144307798|NCT02820844|520332883|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307799|NCT02820844|520332884|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307800|NCT02820844|520332885|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307801|NCT02820844|520332886|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307802|NCT02820844|520332887|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
144307803|NCT02820844|520332888|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
144307804|NCT02266147|520332889|FG000|PART 1: Dose Escalation|Physician Decision|0|||
144307805|NCT02266147|520332890|FG001|PART 1: Dose Escalation|Physician Decision|0|||
144307806|NCT02266147|520332891|FG002|PART 1: Dose Escalation|Physician Decision|1|||
144307807|NCT02266147|520332892|FG003|PART 1: Dose Escalation|Physician Decision|0|||
144307808|NCT02266147|520332889|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
144307809|NCT02266147|520332890|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
144307810|NCT02266147|520332891|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
144307811|NCT02266147|520332892|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
144307812|NCT02266147|520332889|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
144307813|NCT02266147|520332890|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
144307814|NCT02266147|520332891|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
144307815|NCT02266147|520332892|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
144307816|NCT02266147|520332889|FG000|PART 1: Dose Escalation|Other|1|||
144307817|NCT02266147|520332890|FG001|PART 1: Dose Escalation|Other|1|||
144307818|NCT02266147|520332891|FG002|PART 1: Dose Escalation|Other|0|||
144307819|NCT02266147|520332892|FG003|PART 1: Dose Escalation|Other|0|||
144307820|NCT02266147|520332889|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
144307821|NCT02266147|520332890|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
144307822|NCT02266147|520332891|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
144307823|NCT02266147|520332892|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
144307824|NCT02266147|520332889|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
144307825|NCT02266147|520332890|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
144307826|NCT02266147|520332891|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
144307827|NCT02266147|520332892|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
144307828|NCT00573391|520332893|FG000|Overall Study|study stopped|2|||
144307829|NCT00573391|520332894|FG001|Overall Study|study stopped|2|||
144307830|NCT00573391|520332893|FG000|Overall Study|Death|1|||
144307831|NCT00573391|520332894|FG001|Overall Study|Death|0|||
144307832|NCT00413660|520332897|FG000|Up To Week 12|Adverse Event|1|||
144307833|NCT00413660|520332898|FG001|Up To Week 12|Adverse Event|3|||
144307834|NCT00413660|520332899|FG002|Up To Week 12|Adverse Event|1|||
144307835|NCT00413660|520332900|FG003|Up To Week 12|Adverse Event|4|||
144307836|NCT00413660|520332901|FG004|Up To Week 12|Adverse Event|6|||
144307837|NCT00413660|520332902|FG005|Up To Week 12|Adverse Event|4|||
144307838|NCT00413660|520332903|FG006|Up To Week 12|Adverse Event|1|||
144307839|NCT00413660|520332904|FG007|Up To Week 12|Adverse Event|0|||
144307840|NCT00413660|520332905|FG008|Up To Week 12|Adverse Event|0|||
144307841|NCT00413660|520332906|FG009|Up To Week 12|Adverse Event|0|||
144307842|NCT00413660|520332907|FG010|Up To Week 12|Adverse Event|0|||
144307843|NCT00413660|520332897|FG000|Up To Week 12|Lack of Efficacy|2|||
144307844|NCT00413660|520332898|FG001|Up To Week 12|Lack of Efficacy|0|||
144307845|NCT00413660|520332899|FG002|Up To Week 12|Lack of Efficacy|0|||
144307846|NCT00413660|520332900|FG003|Up To Week 12|Lack of Efficacy|0|||
144307847|NCT00413660|520332901|FG004|Up To Week 12|Lack of Efficacy|0|||
144307848|NCT00413660|520332902|FG005|Up To Week 12|Lack of Efficacy|0|||
144307849|NCT00413660|520332903|FG006|Up To Week 12|Lack of Efficacy|5|||
144307850|NCT00413660|520332904|FG007|Up To Week 12|Lack of Efficacy|0|||
144307851|NCT00413660|520332905|FG008|Up To Week 12|Lack of Efficacy|0|||
144307852|NCT00413660|520332906|FG009|Up To Week 12|Lack of Efficacy|0|||
144307853|NCT00413660|520332907|FG010|Up To Week 12|Lack of Efficacy|0|||
144307854|NCT00413660|520332897|FG000|Up To Week 12|Lost to Follow-up|0|||
144307855|NCT00413660|520332898|FG001|Up To Week 12|Lost to Follow-up|1|||
144307856|NCT00413660|520332899|FG002|Up To Week 12|Lost to Follow-up|0|||
144307857|NCT00413660|520332900|FG003|Up To Week 12|Lost to Follow-up|0|||
144307858|NCT00413660|520332901|FG004|Up To Week 12|Lost to Follow-up|1|||
144307859|NCT00413660|520332902|FG005|Up To Week 12|Lost to Follow-up|0|||
144307860|NCT00413660|520332903|FG006|Up To Week 12|Lost to Follow-up|0|||
144307861|NCT00413660|520332904|FG007|Up To Week 12|Lost to Follow-up|0|||
144307862|NCT00413660|520332905|FG008|Up To Week 12|Lost to Follow-up|0|||
144307863|NCT00413660|520332906|FG009|Up To Week 12|Lost to Follow-up|0|||
144307864|NCT00413660|520332907|FG010|Up To Week 12|Lost to Follow-up|0|||
144307865|NCT00413660|520332897|FG000|Up To Week 12|Withdrawal by Subject|0|||
144307866|NCT00413660|520332898|FG001|Up To Week 12|Withdrawal by Subject|2|||
144307867|NCT00413660|520332899|FG002|Up To Week 12|Withdrawal by Subject|0|||
144307868|NCT00413660|520332900|FG003|Up To Week 12|Withdrawal by Subject|2|||
144307869|NCT00413660|520332901|FG004|Up To Week 12|Withdrawal by Subject|0|||
144307870|NCT00413660|520332902|FG005|Up To Week 12|Withdrawal by Subject|2|||
144307871|NCT00413660|520332903|FG006|Up To Week 12|Withdrawal by Subject|2|||
144307872|NCT00413660|520332904|FG007|Up To Week 12|Withdrawal by Subject|0|||
144307873|NCT00413660|520332905|FG008|Up To Week 12|Withdrawal by Subject|0|||
144307874|NCT00413660|520332906|FG009|Up To Week 12|Withdrawal by Subject|0|||
144307875|NCT00413660|520332907|FG010|Up To Week 12|Withdrawal by Subject|0|||
144307876|NCT00413660|520332897|FG000|Up To Week 12|Randomized, Not Treated|1|||
144307877|NCT00413660|520332898|FG001|Up To Week 12|Randomized, Not Treated|0|||
144307878|NCT00413660|520332899|FG002|Up To Week 12|Randomized, Not Treated|0|||
144307879|NCT00413660|520332900|FG003|Up To Week 12|Randomized, Not Treated|1|||
144307880|NCT00413660|520332901|FG004|Up To Week 12|Randomized, Not Treated|0|||
144307881|NCT00413660|520332902|FG005|Up To Week 12|Randomized, Not Treated|0|||
144307882|NCT00413660|520332903|FG006|Up To Week 12|Randomized, Not Treated|0|||
144307883|NCT00413660|520332904|FG007|Up To Week 12|Randomized, Not Treated|0|||
144307884|NCT00413660|520332905|FG008|Up To Week 12|Randomized, Not Treated|0|||
144307885|NCT00413660|520332906|FG009|Up To Week 12|Randomized, Not Treated|0|||
144307886|NCT00413660|520332907|FG010|Up To Week 12|Randomized, Not Treated|0|||
144307887|NCT00413660|520332897|FG000|Up To Week 12|Other|3|||
144307888|NCT00413660|520332898|FG001|Up To Week 12|Other|1|||
144307889|NCT00413660|520332899|FG002|Up To Week 12|Other|6|||
144307890|NCT00413660|520332900|FG003|Up To Week 12|Other|1|||
144307891|NCT00413660|520332901|FG004|Up To Week 12|Other|2|||
144307892|NCT00413660|520332902|FG005|Up To Week 12|Other|4|||
144307893|NCT00413660|520332903|FG006|Up To Week 12|Other|3|||
144307894|NCT00413660|520332904|FG007|Up To Week 12|Other|0|||
144307895|NCT00413660|520332905|FG008|Up To Week 12|Other|0|||
144307896|NCT00413660|520332906|FG009|Up To Week 12|Other|0|||
144307897|NCT00413660|520332907|FG010|Up To Week 12|Other|0|||
144307898|NCT00413660|520332897|FG000|Post Week 12|Adverse Event|2|||
144307899|NCT00413660|520332898|FG001|Post Week 12|Adverse Event|0|||
144307900|NCT00413660|520332899|FG002|Post Week 12|Adverse Event|2|||
144307901|NCT00413660|520332900|FG003|Post Week 12|Adverse Event|1|||
144307902|NCT00413660|520332901|FG004|Post Week 12|Adverse Event|4|||
144307903|NCT00413660|520332902|FG005|Post Week 12|Adverse Event|2|||
144307904|NCT00413660|520332903|FG006|Post Week 12|Adverse Event|2|||
144307905|NCT00413660|520332904|FG007|Post Week 12|Adverse Event|0|||
144307906|NCT00413660|520332905|FG008|Post Week 12|Adverse Event|0|||
144307907|NCT00413660|520332906|FG009|Post Week 12|Adverse Event|0|||
144307908|NCT00413660|520332907|FG010|Post Week 12|Adverse Event|0|||
144307909|NCT00413660|520332897|FG000|Post Week 12|Lack of Efficacy|0|||
144307910|NCT00413660|520332898|FG001|Post Week 12|Lack of Efficacy|0|||
144307911|NCT00413660|520332899|FG002|Post Week 12|Lack of Efficacy|1|||
144307912|NCT00413660|520332900|FG003|Post Week 12|Lack of Efficacy|0|||
144307913|NCT00413660|520332901|FG004|Post Week 12|Lack of Efficacy|0|||
144307914|NCT00413660|520332902|FG005|Post Week 12|Lack of Efficacy|0|||
144307915|NCT00413660|520332903|FG006|Post Week 12|Lack of Efficacy|0|||
144307916|NCT00413660|520332904|FG007|Post Week 12|Lack of Efficacy|0|||
144307917|NCT00413660|520332905|FG008|Post Week 12|Lack of Efficacy|0|||
144307918|NCT00413660|520332906|FG009|Post Week 12|Lack of Efficacy|1|||
144307919|NCT00413660|520332907|FG010|Post Week 12|Lack of Efficacy|0|||
144307920|NCT00413660|520332897|FG000|Post Week 12|Lost to Follow-up|0|||
144307921|NCT00413660|520332898|FG001|Post Week 12|Lost to Follow-up|1|||
144307922|NCT00413660|520332899|FG002|Post Week 12|Lost to Follow-up|1|||
144307923|NCT00413660|520332900|FG003|Post Week 12|Lost to Follow-up|0|||
144307924|NCT00413660|520332901|FG004|Post Week 12|Lost to Follow-up|0|||
144307925|NCT00413660|520332902|FG005|Post Week 12|Lost to Follow-up|0|||
144307926|NCT00413660|520332903|FG006|Post Week 12|Lost to Follow-up|0|||
144307927|NCT00413660|520332904|FG007|Post Week 12|Lost to Follow-up|0|||
144307928|NCT00413660|520332905|FG008|Post Week 12|Lost to Follow-up|0|||
144307929|NCT00413660|520332906|FG009|Post Week 12|Lost to Follow-up|0|||
144307930|NCT00413660|520332907|FG010|Post Week 12|Lost to Follow-up|0|||
144307931|NCT00413660|520332897|FG000|Post Week 12|Withdrawal by Subject|0|||
144307932|NCT00413660|520332898|FG001|Post Week 12|Withdrawal by Subject|1|||
144307933|NCT00413660|520332899|FG002|Post Week 12|Withdrawal by Subject|1|||
144307934|NCT00413660|520332900|FG003|Post Week 12|Withdrawal by Subject|0|||
144307935|NCT00413660|520332901|FG004|Post Week 12|Withdrawal by Subject|1|||
144307936|NCT00413660|520332902|FG005|Post Week 12|Withdrawal by Subject|0|||
144307937|NCT00413660|520332903|FG006|Post Week 12|Withdrawal by Subject|0|||
144307938|NCT00413660|520332904|FG007|Post Week 12|Withdrawal by Subject|0|||
144307939|NCT00413660|520332905|FG008|Post Week 12|Withdrawal by Subject|0|||
144307940|NCT00413660|520332906|FG009|Post Week 12|Withdrawal by Subject|0|||
144307941|NCT00413660|520332907|FG010|Post Week 12|Withdrawal by Subject|1|||
144307942|NCT00413660|520332897|FG000|Post Week 12|Other|1|||
144307943|NCT00413660|520332898|FG001|Post Week 12|Other|2|||
144307944|NCT00413660|520332899|FG002|Post Week 12|Other|3|||
144307945|NCT00413660|520332900|FG003|Post Week 12|Other|0|||
144307946|NCT00413660|520332901|FG004|Post Week 12|Other|1|||
144307947|NCT00413660|520332902|FG005|Post Week 12|Other|1|||
144307948|NCT00413660|520332903|FG006|Post Week 12|Other|1|||
144307949|NCT00413660|520332904|FG007|Post Week 12|Other|0|||
144307950|NCT00413660|520332905|FG008|Post Week 12|Other|0|||
144307951|NCT00413660|520332906|FG009|Post Week 12|Other|0|||
144307952|NCT00413660|520332907|FG010|Post Week 12|Other|0|||
144307953|NCT03896477|520332908|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
144307954|NCT03896477|520332909|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
144307955|NCT03896477|520332910|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
144307956|NCT03896477|520332908|FG000|Overall Study|Parent Requested Withdrawal|8|||
144307957|NCT03896477|520332909|FG001|Overall Study|Parent Requested Withdrawal|12|||
144307958|NCT03896477|520332910|FG002|Overall Study|Parent Requested Withdrawal|9|||
144307959|NCT03896477|520332908|FG000|Overall Study|Adverse Event|0|||
144307960|NCT03896477|520332909|FG001|Overall Study|Adverse Event|0|||
144307961|NCT03896477|520332910|FG002|Overall Study|Adverse Event|1|||
144307962|NCT03896477|520332908|FG000|Overall Study|Death|1|||
144307963|NCT03896477|520332909|FG001|Overall Study|Death|0|||
144307964|NCT03896477|520332910|FG002|Overall Study|Death|0|||
144307965|NCT03896477|520332908|FG000|Overall Study|Other|5|||
144307966|NCT03896477|520332909|FG001|Overall Study|Other|6|||
144307967|NCT03896477|520332910|FG002|Overall Study|Other|7|||
144307968|NCT03896477|520332908|FG000|Overall Study|Lost to Follow-up|2|||
144307969|NCT03896477|520332909|FG001|Overall Study|Lost to Follow-up|1|||
144307970|NCT03896477|520332910|FG002|Overall Study|Lost to Follow-up|1|||
144307971|NCT01791517|520332911|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
144307972|NCT01791517|520332912|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
144307973|NCT01791517|520332913|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
144307974|NCT01791517|520332914|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
144307975|NCT01791517|520332915|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
144307976|NCT01791517|520332916|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
144307977|NCT01791517|520332917|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
144307978|NCT01791517|520332918|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
144307979|NCT01791517|520332919|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
144307980|NCT01791517|520332920|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
144307981|NCT01791517|520332921|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
144307982|NCT01791517|520332922|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
144307983|NCT01791517|520332911|FG000|Phase I: Period 1|Adverse Event|0|||
144307984|NCT01791517|520332912|FG001|Phase I: Period 1|Adverse Event|0|||
144307985|NCT01791517|520332913|FG002|Phase I: Period 1|Adverse Event|1|||
144307986|NCT01791517|520332914|FG003|Phase I: Period 1|Adverse Event|1|||
144307987|NCT01791517|520332915|FG004|Phase I: Period 1|Adverse Event|0|||
144307988|NCT01791517|520332916|FG005|Phase I: Period 1|Adverse Event|0|||
144307989|NCT01791517|520332917|FG006|Phase I: Period 1|Adverse Event|0|||
144307990|NCT01791517|520332918|FG007|Phase I: Period 1|Adverse Event|0|||
144307991|NCT01791517|520332919|FG008|Phase I: Period 1|Adverse Event|0|||
144307992|NCT01791517|520332920|FG009|Phase I: Period 1|Adverse Event|0|||
144307993|NCT01791517|520332921|FG010|Phase I: Period 1|Adverse Event|0|||
144307994|NCT01791517|520332922|FG011|Phase I: Period 1|Adverse Event|0|||
144307995|NCT01791517|520332911|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
144307996|NCT01791517|520332912|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144307997|NCT01791517|520332913|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144307998|NCT01791517|520332914|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144307999|NCT01791517|520332915|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308000|NCT01791517|520332916|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308001|NCT01791517|520332917|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308002|NCT01791517|520332918|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308003|NCT01791517|520332919|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308004|NCT01791517|520332920|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308005|NCT01791517|520332921|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308006|NCT01791517|520332922|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
144308007|NCT01791517|520332911|FG000|Phase I: Period 1|Protocol Violation|0|||
144308008|NCT01791517|520332912|FG001|Phase I: Period 1|Protocol Violation|1|||
144308009|NCT01791517|520332913|FG002|Phase I: Period 1|Protocol Violation|0|||
144308010|NCT01791517|520332914|FG003|Phase I: Period 1|Protocol Violation|0|||
144308011|NCT01791517|520332915|FG004|Phase I: Period 1|Protocol Violation|0|||
144308012|NCT01791517|520332916|FG005|Phase I: Period 1|Protocol Violation|0|||
144308013|NCT01791517|520332917|FG006|Phase I: Period 1|Protocol Violation|0|||
144308014|NCT01791517|520332918|FG007|Phase I: Period 1|Protocol Violation|0|||
144308015|NCT01791517|520332919|FG008|Phase I: Period 1|Protocol Violation|0|||
144308016|NCT01791517|520332920|FG009|Phase I: Period 1|Protocol Violation|0|||
144308017|NCT01791517|520332921|FG010|Phase I: Period 1|Protocol Violation|0|||
144308018|NCT01791517|520332922|FG011|Phase I: Period 1|Protocol Violation|0|||
144308019|NCT01791517|520332911|FG000|Phase I: Period 1|Lost to Follow-up|0|||
144308020|NCT01791517|520332912|FG001|Phase I: Period 1|Lost to Follow-up|0|||
144308021|NCT01791517|520332913|FG002|Phase I: Period 1|Lost to Follow-up|0|||
144308022|NCT01791517|520332914|FG003|Phase I: Period 1|Lost to Follow-up|1|||
144308023|NCT01791517|520332915|FG004|Phase I: Period 1|Lost to Follow-up|0|||
144308024|NCT01791517|520332916|FG005|Phase I: Period 1|Lost to Follow-up|0|||
144308025|NCT01791517|520332917|FG006|Phase I: Period 1|Lost to Follow-up|1|||
144308026|NCT01791517|520332918|FG007|Phase I: Period 1|Lost to Follow-up|0|||
144308027|NCT01791517|520332919|FG008|Phase I: Period 1|Lost to Follow-up|1|||
144308028|NCT01791517|520332920|FG009|Phase I: Period 1|Lost to Follow-up|1|||
144308029|NCT01791517|520332921|FG010|Phase I: Period 1|Lost to Follow-up|0|||
144308030|NCT01791517|520332922|FG011|Phase I: Period 1|Lost to Follow-up|0|||
144308031|NCT01791517|520332911|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308032|NCT01791517|520332912|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308033|NCT01791517|520332913|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308034|NCT01791517|520332914|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308035|NCT01791517|520332915|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308036|NCT01791517|520332916|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308037|NCT01791517|520332917|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308038|NCT01791517|520332918|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308039|NCT01791517|520332919|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308040|NCT01791517|520332920|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308041|NCT01791517|520332921|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
144308042|NCT01791517|520332922|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
144308043|NCT01791517|520332911|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
144308044|NCT01791517|520332912|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308045|NCT01791517|520332913|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308046|NCT01791517|520332914|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308047|NCT01791517|520332915|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308048|NCT01791517|520332916|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308049|NCT01791517|520332917|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308050|NCT01791517|520332918|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308051|NCT01791517|520332919|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308052|NCT01791517|520332920|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308053|NCT01791517|520332921|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308054|NCT01791517|520332922|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
144308055|NCT01791517|520332911|FG000|Phase I: Period 2|Protocol Violation|0|||
144308056|NCT01791517|520332912|FG001|Phase I: Period 2|Protocol Violation|0|||
144308057|NCT01791517|520332913|FG002|Phase I: Period 2|Protocol Violation|0|||
144308058|NCT01791517|520332914|FG003|Phase I: Period 2|Protocol Violation|1|||
144308059|NCT01791517|520332915|FG004|Phase I: Period 2|Protocol Violation|0|||
144308060|NCT01791517|520332916|FG005|Phase I: Period 2|Protocol Violation|0|||
144308061|NCT01791517|520332917|FG006|Phase I: Period 2|Protocol Violation|0|||
144308062|NCT01791517|520332918|FG007|Phase I: Period 2|Protocol Violation|0|||
144308063|NCT01791517|520332919|FG008|Phase I: Period 2|Protocol Violation|0|||
144308064|NCT01791517|520332920|FG009|Phase I: Period 2|Protocol Violation|0|||
144308065|NCT01791517|520332921|FG010|Phase I: Period 2|Protocol Violation|0|||
144308066|NCT01791517|520332922|FG011|Phase I: Period 2|Protocol Violation|0|||
144308067|NCT01791517|520332911|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
144308068|NCT01791517|520332912|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
144308069|NCT01791517|520332913|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
144308070|NCT01791517|520332914|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
144308071|NCT01791517|520332915|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
144308072|NCT01791517|520332916|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
144308073|NCT01791517|520332917|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
144308074|NCT01791517|520332918|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
144308075|NCT01791517|520332919|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
144308076|NCT01791517|520332920|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
144308077|NCT01791517|520332921|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
144308078|NCT01791517|520332922|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
144308079|NCT01791517|520332911|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308080|NCT01791517|520332912|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308081|NCT01791517|520332913|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308082|NCT01791517|520332914|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308083|NCT01791517|520332915|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308084|NCT01791517|520332916|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308085|NCT01791517|520332917|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308086|NCT01791517|520332918|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308087|NCT01791517|520332919|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308088|NCT01791517|520332920|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308089|NCT01791517|520332921|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
144308090|NCT01791517|520332922|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
144308091|NCT01791517|520332911|FG000|Phase I: Period 2|Lens Discomfort|0|||
144308092|NCT01791517|520332912|FG001|Phase I: Period 2|Lens Discomfort|0|||
144308093|NCT01791517|520332913|FG002|Phase I: Period 2|Lens Discomfort|0|||
144308094|NCT01791517|520332914|FG003|Phase I: Period 2|Lens Discomfort|0|||
144308095|NCT01791517|520332915|FG004|Phase I: Period 2|Lens Discomfort|0|||
144308096|NCT01791517|520332916|FG005|Phase I: Period 2|Lens Discomfort|1|||
144308097|NCT01791517|520332917|FG006|Phase I: Period 2|Lens Discomfort|0|||
144308098|NCT01791517|520332918|FG007|Phase I: Period 2|Lens Discomfort|0|||
144308099|NCT01791517|520332919|FG008|Phase I: Period 2|Lens Discomfort|0|||
144308100|NCT01791517|520332920|FG009|Phase I: Period 2|Lens Discomfort|0|||
144308101|NCT01791517|520332921|FG010|Phase I: Period 2|Lens Discomfort|0|||
144308102|NCT01791517|520332922|FG011|Phase I: Period 2|Lens Discomfort|0|||
144308103|NCT01791517|520332911|FG000|Phase I: Period 2|Lost to Follow-up|0|||
144308104|NCT01791517|520332912|FG001|Phase I: Period 2|Lost to Follow-up|3|||
144308105|NCT01791517|520332913|FG002|Phase I: Period 2|Lost to Follow-up|2|||
144308106|NCT01791517|520332914|FG003|Phase I: Period 2|Lost to Follow-up|0|||
144308107|NCT01791517|520332915|FG004|Phase I: Period 2|Lost to Follow-up|0|||
144308108|NCT01791517|520332916|FG005|Phase I: Period 2|Lost to Follow-up|0|||
144308109|NCT01791517|520332917|FG006|Phase I: Period 2|Lost to Follow-up|0|||
144308110|NCT01791517|520332918|FG007|Phase I: Period 2|Lost to Follow-up|0|||
144308111|NCT01791517|520332919|FG008|Phase I: Period 2|Lost to Follow-up|0|||
144308112|NCT01791517|520332920|FG009|Phase I: Period 2|Lost to Follow-up|0|||
144308113|NCT01791517|520332921|FG010|Phase I: Period 2|Lost to Follow-up|0|||
144308114|NCT01791517|520332922|FG011|Phase I: Period 2|Lost to Follow-up|0|||
144308115|NCT01791517|520332911|FG000|Phase I: Period 3|Lens Discomfort|0|||
144308116|NCT01791517|520332912|FG001|Phase I: Period 3|Lens Discomfort|0|||
144308117|NCT01791517|520332913|FG002|Phase I: Period 3|Lens Discomfort|0|||
144308118|NCT01791517|520332914|FG003|Phase I: Period 3|Lens Discomfort|0|||
144308119|NCT01791517|520332915|FG004|Phase I: Period 3|Lens Discomfort|0|||
144308120|NCT01791517|520332916|FG005|Phase I: Period 3|Lens Discomfort|0|||
144308121|NCT01791517|520332917|FG006|Phase I: Period 3|Lens Discomfort|0|||
144308122|NCT01791517|520332918|FG007|Phase I: Period 3|Lens Discomfort|0|||
144308123|NCT01791517|520332919|FG008|Phase I: Period 3|Lens Discomfort|0|||
144308124|NCT01791517|520332920|FG009|Phase I: Period 3|Lens Discomfort|0|||
144308125|NCT01791517|520332921|FG010|Phase I: Period 3|Lens Discomfort|0|||
144308126|NCT01791517|520332922|FG011|Phase I: Period 3|Lens Discomfort|1|||
144308127|NCT01791517|520332911|FG000|Phase I: Period 3|Lost to Follow-up|0|||
144308128|NCT01791517|520332912|FG001|Phase I: Period 3|Lost to Follow-up|1|||
144308129|NCT01791517|520332913|FG002|Phase I: Period 3|Lost to Follow-up|0|||
144308130|NCT01791517|520332914|FG003|Phase I: Period 3|Lost to Follow-up|0|||
144308131|NCT01791517|520332915|FG004|Phase I: Period 3|Lost to Follow-up|1|||
144308132|NCT01791517|520332916|FG005|Phase I: Period 3|Lost to Follow-up|0|||
144308133|NCT01791517|520332917|FG006|Phase I: Period 3|Lost to Follow-up|0|||
144308134|NCT01791517|520332918|FG007|Phase I: Period 3|Lost to Follow-up|0|||
144308135|NCT01791517|520332919|FG008|Phase I: Period 3|Lost to Follow-up|0|||
144308136|NCT01791517|520332920|FG009|Phase I: Period 3|Lost to Follow-up|0|||
144308137|NCT01791517|520332921|FG010|Phase I: Period 3|Lost to Follow-up|0|||
144308138|NCT01791517|520332922|FG011|Phase I: Period 3|Lost to Follow-up|0|||
144308139|NCT01791517|520332911|FG000|Phase I: Period 3|Adverse Event|0|||
144308140|NCT01791517|520332912|FG001|Phase I: Period 3|Adverse Event|0|||
144308141|NCT01791517|520332913|FG002|Phase I: Period 3|Adverse Event|0|||
144308142|NCT01791517|520332914|FG003|Phase I: Period 3|Adverse Event|1|||
144308143|NCT01791517|520332915|FG004|Phase I: Period 3|Adverse Event|0|||
144308144|NCT01791517|520332916|FG005|Phase I: Period 3|Adverse Event|0|||
144308145|NCT01791517|520332917|FG006|Phase I: Period 3|Adverse Event|0|||
144308146|NCT01791517|520332918|FG007|Phase I: Period 3|Adverse Event|0|||
144308147|NCT01791517|520332919|FG008|Phase I: Period 3|Adverse Event|0|||
144308148|NCT01791517|520332920|FG009|Phase I: Period 3|Adverse Event|0|||
144308149|NCT01791517|520332921|FG010|Phase I: Period 3|Adverse Event|0|||
144308150|NCT01791517|520332922|FG011|Phase I: Period 3|Adverse Event|0|||
144308151|NCT01791517|520332911|FG000|Phase II|Lost to Follow-up|1|||
144308152|NCT01791517|520332912|FG001|Phase II|Lost to Follow-up|0|||
144308153|NCT01791517|520332913|FG002|Phase II|Lost to Follow-up|1|||
144308154|NCT01791517|520332914|FG003|Phase II|Lost to Follow-up|0|||
144308155|NCT01791517|520332915|FG004|Phase II|Lost to Follow-up|1|||
144308156|NCT01791517|520332916|FG005|Phase II|Lost to Follow-up|2|||
144308157|NCT01791517|520332917|FG006|Phase II|Lost to Follow-up|0|||
144308158|NCT01791517|520332918|FG007|Phase II|Lost to Follow-up|1|||
144308159|NCT01791517|520332919|FG008|Phase II|Lost to Follow-up|1|||
144308160|NCT01791517|520332920|FG009|Phase II|Lost to Follow-up|1|||
144308161|NCT01791517|520332921|FG010|Phase II|Lost to Follow-up|0|||
144308162|NCT01791517|520332922|FG011|Phase II|Lost to Follow-up|0|||
144308163|NCT01791517|520332911|FG000|Phase II|Withdrawal by Subject|1|||
144308164|NCT01791517|520332912|FG001|Phase II|Withdrawal by Subject|0|||
144308165|NCT01791517|520332913|FG002|Phase II|Withdrawal by Subject|0|||
144308166|NCT01791517|520332914|FG003|Phase II|Withdrawal by Subject|0|||
144308167|NCT01791517|520332915|FG004|Phase II|Withdrawal by Subject|0|||
144308168|NCT01791517|520332916|FG005|Phase II|Withdrawal by Subject|2|||
144308169|NCT01791517|520332917|FG006|Phase II|Withdrawal by Subject|0|||
144308170|NCT01791517|520332918|FG007|Phase II|Withdrawal by Subject|1|||
144308171|NCT01791517|520332919|FG008|Phase II|Withdrawal by Subject|0|||
144308172|NCT01791517|520332920|FG009|Phase II|Withdrawal by Subject|0|||
144308173|NCT01791517|520332921|FG010|Phase II|Withdrawal by Subject|1|||
144308174|NCT01791517|520332922|FG011|Phase II|Withdrawal by Subject|0|||
144308175|NCT01791517|520332911|FG000|Phase II|Lack of Efficacy|0|||
144308176|NCT01791517|520332912|FG001|Phase II|Lack of Efficacy|0|||
144308177|NCT01791517|520332913|FG002|Phase II|Lack of Efficacy|0|||
144308178|NCT01791517|520332914|FG003|Phase II|Lack of Efficacy|0|||
144308179|NCT01791517|520332915|FG004|Phase II|Lack of Efficacy|1|||
144308180|NCT01791517|520332916|FG005|Phase II|Lack of Efficacy|0|||
144308181|NCT01791517|520332917|FG006|Phase II|Lack of Efficacy|0|||
144308182|NCT01791517|520332918|FG007|Phase II|Lack of Efficacy|0|||
144308183|NCT01791517|520332919|FG008|Phase II|Lack of Efficacy|0|||
144308184|NCT01791517|520332920|FG009|Phase II|Lack of Efficacy|0|||
144308185|NCT01791517|520332921|FG010|Phase II|Lack of Efficacy|0|||
144308186|NCT01791517|520332922|FG011|Phase II|Lack of Efficacy|0|||
144308187|NCT01791517|520332911|FG000|Phase II|Adverse Event|0|||
144308188|NCT01791517|520332912|FG001|Phase II|Adverse Event|0|||
144308189|NCT01791517|520332913|FG002|Phase II|Adverse Event|0|||
144308190|NCT01791517|520332914|FG003|Phase II|Adverse Event|0|||
144308191|NCT01791517|520332915|FG004|Phase II|Adverse Event|0|||
144308192|NCT01791517|520332916|FG005|Phase II|Adverse Event|0|||
144308193|NCT01791517|520332917|FG006|Phase II|Adverse Event|2|||
144308194|NCT01791517|520332918|FG007|Phase II|Adverse Event|1|||
144308195|NCT01791517|520332919|FG008|Phase II|Adverse Event|0|||
144308196|NCT01791517|520332920|FG009|Phase II|Adverse Event|1|||
144308197|NCT01791517|520332921|FG010|Phase II|Adverse Event|0|||
144308198|NCT01791517|520332922|FG011|Phase II|Adverse Event|0|||
144308199|NCT01791517|520332911|FG000|Phase II|Lens Handling Difficulties|0|||
144308200|NCT01791517|520332912|FG001|Phase II|Lens Handling Difficulties|0|||
144308201|NCT01791517|520332913|FG002|Phase II|Lens Handling Difficulties|0|||
144308202|NCT01791517|520332914|FG003|Phase II|Lens Handling Difficulties|0|||
144308203|NCT01791517|520332915|FG004|Phase II|Lens Handling Difficulties|0|||
144308204|NCT01791517|520332916|FG005|Phase II|Lens Handling Difficulties|0|||
144308205|NCT01791517|520332917|FG006|Phase II|Lens Handling Difficulties|0|||
144308206|NCT01791517|520332918|FG007|Phase II|Lens Handling Difficulties|0|||
144308207|NCT01791517|520332919|FG008|Phase II|Lens Handling Difficulties|1|||
144308208|NCT01791517|520332920|FG009|Phase II|Lens Handling Difficulties|0|||
144308209|NCT01791517|520332921|FG010|Phase II|Lens Handling Difficulties|0|||
144308210|NCT01791517|520332922|FG011|Phase II|Lens Handling Difficulties|0|||
144308211|NCT01791517|520332911|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
144308212|NCT01791517|520332912|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
144308213|NCT01791517|520332913|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
144308214|NCT01791517|520332914|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
144308215|NCT01791517|520332915|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
144308216|NCT01791517|520332916|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
144308217|NCT01791517|520332917|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
144308218|NCT01791517|520332918|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
144308219|NCT01791517|520332919|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
144308220|NCT01791517|520332920|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
144308221|NCT01791517|520332921|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
144308222|NCT01791517|520332922|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
144308223|NCT01791517|520332911|FG000|Phase II|Pre-Existing Ocular Issue|0|||
144308224|NCT01791517|520332912|FG001|Phase II|Pre-Existing Ocular Issue|0|||
144308225|NCT01791517|520332913|FG002|Phase II|Pre-Existing Ocular Issue|0|||
144308226|NCT01791517|520332914|FG003|Phase II|Pre-Existing Ocular Issue|0|||
144308227|NCT01791517|520332915|FG004|Phase II|Pre-Existing Ocular Issue|0|||
144308228|NCT01791517|520332916|FG005|Phase II|Pre-Existing Ocular Issue|0|||
144308229|NCT01791517|520332917|FG006|Phase II|Pre-Existing Ocular Issue|0|||
144308230|NCT01791517|520332918|FG007|Phase II|Pre-Existing Ocular Issue|0|||
144308231|NCT01791517|520332919|FG008|Phase II|Pre-Existing Ocular Issue|0|||
144308232|NCT01791517|520332920|FG009|Phase II|Pre-Existing Ocular Issue|0|||
144308233|NCT01791517|520332921|FG010|Phase II|Pre-Existing Ocular Issue|0|||
144308234|NCT01791517|520332922|FG011|Phase II|Pre-Existing Ocular Issue|1|||
144308235|NCT03230318|520332926|FG000|Overall Study|Radiographic disease progression|72|||
144308236|NCT03230318|520332927|FG001|Overall Study|Radiographic disease progression|19|||
144308237|NCT03230318|520332926|FG000|Overall Study|Clinical progression|17|||
144308238|NCT03230318|520332927|FG001|Overall Study|Clinical progression|7|||
144308239|NCT03230318|520332926|FG000|Overall Study|Adverse Event|5|||
144308240|NCT03230318|520332927|FG001|Overall Study|Adverse Event|3|||
144308241|NCT03230318|520332926|FG000|Overall Study|Physician Decision|2|||
144308242|NCT03230318|520332927|FG001|Overall Study|Physician Decision|3|||
144308243|NCT03230318|520332926|FG000|Overall Study|Death|3|||
144308244|NCT03230318|520332927|FG001|Overall Study|Death|2|||
144308245|NCT03230318|520332926|FG000|Overall Study|Lost to Follow-up|1|||
144308246|NCT03230318|520332927|FG001|Overall Study|Lost to Follow-up|0|||
144308247|NCT03230318|520332926|FG000|Overall Study|Withdrawal by Subject|1|||
144308248|NCT03230318|520332927|FG001|Overall Study|Withdrawal by Subject|3|||
144308249|NCT03230318|520332926|FG000|Overall Study|Other|3|||
144308250|NCT03230318|520332927|FG001|Overall Study|Other|7|||
144308251|NCT04011735|520332929|FG000|Overall Study|Withdrawal by Subject|1|||
144308252|NCT04011735|520332930|FG001|Overall Study|Withdrawal by Subject|0|||
144308253|NCT04011735|520332931|FG002|Overall Study|Withdrawal by Subject|1|||
144308254|NCT04011735|520332929|FG000|Overall Study|Met exclusion criteria after study entry|0|||
144308255|NCT04011735|520332930|FG001|Overall Study|Met exclusion criteria after study entry|1|||
144308256|NCT04011735|520332931|FG002|Overall Study|Met exclusion criteria after study entry|0|||
144308257|NCT02651116|520332938|FG000|Overall Study|Adverse Event|0|||
144308258|NCT02651116|520332939|FG001|Overall Study|Adverse Event|1|||
144308259|NCT02651116|520332938|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
144308260|NCT02651116|520332939|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
144308261|NCT00041470|520332947|FG000|Overall Study|Loss of Funding|38|||
144308262|NCT00739310|520332948|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
144308263|NCT00739310|520332948|FG000|Overall Study|Withdrawal by Subject|1|||
144308264|NCT00739310|520332948|FG000|Overall Study|Lost to Follow-up|2|||
144308265|NCT01459666|520332949|FG000|Overall Study|PI left institution|5|||
144308266|NCT01459666|520332950|FG001|Overall Study|PI left institution|4|||
144308267|NCT00533429|520332951|FG000|Overall Study|Adverse Event|3|||
144308268|NCT00533429|520332952|FG001|Overall Study|Adverse Event|1|||
144308269|NCT00533429|520332951|FG000|Overall Study|Death|1|||
144308270|NCT00533429|520332952|FG001|Overall Study|Death|0|||
144308271|NCT00533429|520332951|FG000|Overall Study|Withdrawal by Subject|2|||
144308272|NCT00533429|520332952|FG001|Overall Study|Withdrawal by Subject|0|||
144308273|NCT00533429|520332951|FG000|Overall Study|Progressive Disease|12|||
144308274|NCT00533429|520332952|FG001|Overall Study|Progressive Disease|13|||
144308275|NCT00533429|520332951|FG000|Overall Study|Symptomatic deterioration|1|||
144308276|NCT00533429|520332952|FG001|Overall Study|Symptomatic deterioration|2|||
144308277|NCT01887717|520332959|FG000|Overall Study|Withdrawal by Subject|1|||
144308278|NCT01887717|520332960|FG001|Overall Study|Withdrawal by Subject|7|||
144308279|NCT01887717|520332959|FG000|Overall Study|Physician Decision|0|||
144308280|NCT01887717|520332960|FG001|Overall Study|Physician Decision|2|||
144308281|NCT01887717|520332959|FG000|Overall Study|Administrative reasons|5|||
144308282|NCT01887717|520332960|FG001|Overall Study|Administrative reasons|2|||
144308283|NCT02655887|520332961|FG000|Overall Study|Lost to Follow-up|3|||
144308284|NCT02655887|520332961|FG000|Overall Study|Death|4|||
144308285|NCT02655887|520332961|FG000|Overall Study|Withdrawal by Subject|3|||
144308286|NCT02655887|520332961|FG000|Overall Study|Missed 12-month follow-up visit|4|||
144308287|NCT02834819|520332962|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
144308288|NCT02834819|520332963|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
144308289|NCT04245709|520332964|FG000|Overall Study|Adverse Event|13|||
144308290|NCT04245709|520332964|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
144308291|NCT00889707|520332965|FG000|Overall Study|Adverse Event|1|||
144308292|NCT00889707|520332966|FG001|Overall Study|Adverse Event|0|||
144308293|NCT00889707|520332965|FG000|Overall Study|Withdrawal by Subject|4|||
144308294|NCT00889707|520332966|FG001|Overall Study|Withdrawal by Subject|3|||
144308295|NCT00889707|520332965|FG000|Overall Study|Lost to Follow-up|0|||
144308296|NCT00889707|520332966|FG001|Overall Study|Lost to Follow-up|2|||
144308297|NCT00889707|520332965|FG000|Overall Study|Lack of Efficacy|2|||
144308298|NCT00889707|520332966|FG001|Overall Study|Lack of Efficacy|5|||
144308299|NCT02389465|520332967|FG000|Overall Study|Lost to Follow-up|1|||
144308300|NCT02389465|520332968|FG001|Overall Study|Lost to Follow-up|3|||
144308301|NCT02389465|520332969|FG002|Overall Study|Lost to Follow-up|3|||
144308302|NCT02389465|520332970|FG003|Overall Study|Lost to Follow-up|0|||
144308303|NCT02389465|520332967|FG000|Overall Study|Physician Decision|0|||
144308304|NCT02389465|520332968|FG001|Overall Study|Physician Decision|0|||
144308305|NCT02389465|520332969|FG002|Overall Study|Physician Decision|0|||
144308306|NCT02389465|520332970|FG003|Overall Study|Physician Decision|1|||
144308307|NCT02389465|520332967|FG000|Overall Study|Withdrawal by Subject|0|||
144308308|NCT02389465|520332968|FG001|Overall Study|Withdrawal by Subject|1|||
144308309|NCT02389465|520332969|FG002|Overall Study|Withdrawal by Subject|2|||
144308310|NCT02389465|520332970|FG003|Overall Study|Withdrawal by Subject|2|||
144308311|NCT04419467|520332971|FG000|Overall Study|Not treated with IP|0|||
144308312|NCT04419467|520332972|FG001|Overall Study|Not treated with IP|0|||
144308313|NCT04419467|520332973|FG002|Overall Study|Not treated with IP|2|||
144308314|NCT04419467|520332971|FG000|Overall Study|Adverse Event|0|||
144308315|NCT04419467|520332972|FG001|Overall Study|Adverse Event|2|||
144308316|NCT04419467|520332973|FG002|Overall Study|Adverse Event|0|||
144308317|NCT04419467|520332971|FG000|Overall Study|Death|1|||
144308318|NCT04419467|520332972|FG001|Overall Study|Death|0|||
144308319|NCT04419467|520332973|FG002|Overall Study|Death|0|||
144308320|NCT04419467|520332971|FG000|Overall Study|Lost to Follow-up|0|||
144308321|NCT04419467|520332972|FG001|Overall Study|Lost to Follow-up|1|||
144308322|NCT04419467|520332973|FG002|Overall Study|Lost to Follow-up|2|||
144308323|NCT04419467|520332971|FG000|Overall Study|Withdrawal by Subject|0|||
144308324|NCT04419467|520332972|FG001|Overall Study|Withdrawal by Subject|0|||
144308325|NCT04419467|520332973|FG002|Overall Study|Withdrawal by Subject|4|||
144308326|NCT04419467|520332971|FG000|Overall Study|Pandemic related|0|||
144308327|NCT04419467|520332972|FG001|Overall Study|Pandemic related|0|||
144308328|NCT04419467|520332973|FG002|Overall Study|Pandemic related|1|||
144308329|NCT04419467|520332971|FG000|Overall Study|Reason not known|1|||
144308330|NCT04419467|520332972|FG001|Overall Study|Reason not known|0|||
144308331|NCT04419467|520332973|FG002|Overall Study|Reason not known|0|||
144308332|NCT00003631|520332975|FG000|Overall Study|Patient not treated|1|||
144308333|NCT00003631|520332976|FG001|Overall Study|Patient not treated|0|||
144308334|NCT00003631|520332977|FG002|Overall Study|Patient not treated|1|||
144308335|NCT00003631|520332975|FG000|Overall Study|Protocol Violation|1|||
144308336|NCT00003631|520332976|FG001|Overall Study|Protocol Violation|0|||
144308337|NCT00003631|520332977|FG002|Overall Study|Protocol Violation|0|||
144308338|NCT00003631|520332975|FG000|Overall Study|Adverse Event|1|||
144308339|NCT00003631|520332976|FG001|Overall Study|Adverse Event|1|||
144308340|NCT00003631|520332977|FG002|Overall Study|Adverse Event|5|||
144308341|NCT00003631|520332975|FG000|Overall Study|Death|0|||
144308342|NCT00003631|520332976|FG001|Overall Study|Death|0|||
144308343|NCT00003631|520332977|FG002|Overall Study|Death|1|||
144308344|NCT00003631|520332975|FG000|Overall Study|Evaluable for toxicity only|0|||
144308345|NCT00003631|520332976|FG001|Overall Study|Evaluable for toxicity only|0|||
144308346|NCT00003631|520332977|FG002|Overall Study|Evaluable for toxicity only|2|||
144308347|NCT00087698|520332983|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
144308348|NCT00087698|520332983|FG000|Overall Study|Death from Other Causes|3|||
144308349|NCT00087698|520332983|FG000|Overall Study|Adverse Event|4|||
144308350|NCT00087698|520332983|FG000|Overall Study|Withdrawal by Subject|4|||
144308351|NCT00087698|520332983|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
144308352|NCT00087698|520332983|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
144308353|NCT00087698|520332983|FG000|Overall Study|Clinical Relapse|1|||
144308354|NCT00087698|520332983|FG000|Overall Study|Death from Study Disease|2|||
144308355|NCT00087698|520332983|FG000|Overall Study|Death from Study Drug Toxicity|2|||
144308356|NCT00087698|520332983|FG000|Overall Study|Protocol Violation|1|||
144308357|NCT01220401|520332984|FG000|Overall Study|Withdrawal by Subject|2|||
144308358|NCT01220401|520332984|FG000|Overall Study|Protocol Violation|1|||
144308359|NCT04179305|520332988|FG000|Overall Study|Death|1|||
144308360|NCT04179305|520332989|FG001|Overall Study|Death|1|||
144308361|NCT04179305|520332990|FG002|Overall Study|Death|0|||
144308362|NCT04179305|520332991|FG003|Overall Study|Death|0|||
144308363|NCT04179305|520332988|FG000|Overall Study|Lost to Follow-up|1|||
144308364|NCT04179305|520332989|FG001|Overall Study|Lost to Follow-up|1|||
144308365|NCT04179305|520332990|FG002|Overall Study|Lost to Follow-up|0|||
144308366|NCT04179305|520332991|FG003|Overall Study|Lost to Follow-up|0|||
144308367|NCT04179305|520332988|FG000|Overall Study|Withdrawal by Subject|0|||
144308368|NCT04179305|520332989|FG001|Overall Study|Withdrawal by Subject|1|||
144308369|NCT04179305|520332990|FG002|Overall Study|Withdrawal by Subject|0|||
144308370|NCT04179305|520332991|FG003|Overall Study|Withdrawal by Subject|0|||
144308371|NCT04179305|520332988|FG000|Overall Study|Did not have scan|1|||
144308372|NCT04179305|520332989|FG001|Overall Study|Did not have scan|0|||
144308373|NCT04179305|520332990|FG002|Overall Study|Did not have scan|0|||
144308374|NCT04179305|520332991|FG003|Overall Study|Did not have scan|0|||
144308375|NCT04179305|520332988|FG000|Overall Study|In hospice care|3|||
144308376|NCT04179305|520332989|FG001|Overall Study|In hospice care|0|||
144308377|NCT04179305|520332990|FG002|Overall Study|In hospice care|0|||
144308378|NCT04179305|520332991|FG003|Overall Study|In hospice care|0|||
144308379|NCT03192137|520332994|FG000|Overall Study|Adverse Event|10|||
144308380|NCT03192137|520332995|FG001|Overall Study|Adverse Event|11|||
144308381|NCT03192137|520332994|FG000|Overall Study|Physician Decision|1|||
144308382|NCT03192137|520332995|FG001|Overall Study|Physician Decision|0|||
144308383|NCT03192137|520332994|FG000|Overall Study|Lack of Efficacy|20|||
144308384|NCT03192137|520332995|FG001|Overall Study|Lack of Efficacy|37|||
144308385|NCT03192137|520332994|FG000|Overall Study|Withdrawal by Subject|3|||
144308386|NCT03192137|520332995|FG001|Overall Study|Withdrawal by Subject|3|||
144308387|NCT03192137|520332994|FG000|Overall Study|Protocol Violation|4|||
144308388|NCT03192137|520332995|FG001|Overall Study|Protocol Violation|3|||
144308389|NCT03192137|520332994|FG000|Overall Study|Surgery Cancelled|4|||
144308390|NCT03192137|520332995|FG001|Overall Study|Surgery Cancelled|1|||
144308391|NCT03192137|520332994|FG000|Overall Study|Other - Various Administrative Reasons|8|||
144308392|NCT03192137|520332995|FG001|Overall Study|Other - Various Administrative Reasons|3|||
144308393|NCT02737501|520332998|FG000|Randomized Phase|Died|41|||
144308394|NCT02737501|520332999|FG001|Randomized Phase|Died|29|||
144308395|NCT02737501|520333000|FG002|Randomized Phase|Died|0|||
144308396|NCT02737501|520332998|FG000|Randomized Phase|Withdrawal by Subject|16|||
144308397|NCT02737501|520332999|FG001|Randomized Phase|Withdrawal by Subject|6|||
144308398|NCT02737501|520333000|FG002|Randomized Phase|Withdrawal by Subject|0|||
144308399|NCT02737501|520332998|FG000|Randomized Phase|Lost to Follow-up|0|||
144308400|NCT02737501|520332999|FG001|Randomized Phase|Lost to Follow-up|1|||
144308401|NCT02737501|520333000|FG002|Randomized Phase|Lost to Follow-up|0|||
144308402|NCT02737501|520332998|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
144308403|NCT02737501|520332999|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
144308404|NCT02737501|520333000|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
144308405|NCT02737501|520332998|FG000|Randomized Phase|Reason not Specified|1|||
144308406|NCT02737501|520332999|FG001|Randomized Phase|Reason not Specified|1|||
144308407|NCT02737501|520333000|FG002|Randomized Phase|Reason not Specified|0|||
144308408|NCT02737501|520332998|FG000|Randomized Phase|Never Treated|1|||
144308409|NCT02737501|520332999|FG001|Randomized Phase|Never Treated|1|||
144308410|NCT02737501|520333000|FG002|Randomized Phase|Never Treated|0|||
144308411|NCT02737501|520332998|FG000|Crossover Phase|Died|0|||
144308412|NCT02737501|520332999|FG001|Crossover Phase|Died|0|||
144308413|NCT02737501|520333000|FG002|Crossover Phase|Died|22|||
144308414|NCT02737501|520332998|FG000|Crossover Phase|Withdrew Consent|0|||
144308415|NCT02737501|520332999|FG001|Crossover Phase|Withdrew Consent|0|||
144308416|NCT02737501|520333000|FG002|Crossover Phase|Withdrew Consent|9|||
144308417|NCT02737501|520332998|FG000|Crossover Phase|Physician Decision|0|||
144308418|NCT02737501|520332999|FG001|Crossover Phase|Physician Decision|0|||
144308419|NCT02737501|520333000|FG002|Crossover Phase|Physician Decision|1|||
144308420|NCT02737501|520332998|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
144308421|NCT02737501|520332999|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
144308422|NCT02737501|520333000|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
144308423|NCT01261975|520333001|FG000|Overall Study|Surgical complication|1|||
144308424|NCT01070979|520333004|FG000|Overall Study|Adverse Event|2|||
144308425|NCT01070979|520333005|FG001|Overall Study|Adverse Event|3|||
144308426|NCT01070979|520333006|FG002|Overall Study|Adverse Event|3|||
144308427|NCT01070979|520333004|FG000|Overall Study|Lost to Follow-up|2|||
144308428|NCT01070979|520333005|FG001|Overall Study|Lost to Follow-up|1|||
144308429|NCT01070979|520333006|FG002|Overall Study|Lost to Follow-up|1|||
144308430|NCT01070979|520333004|FG000|Overall Study|Protocol Violation|0|||
144308431|NCT01070979|520333005|FG001|Overall Study|Protocol Violation|2|||
144308432|NCT01070979|520333006|FG002|Overall Study|Protocol Violation|6|||
144308433|NCT01070979|520333004|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
144308434|NCT01070979|520333005|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
144308435|NCT01070979|520333006|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
144308436|NCT01070979|520333004|FG000|Overall Study|Withdrawal by Subject|3|||
144308437|NCT01070979|520333005|FG001|Overall Study|Withdrawal by Subject|1|||
144308438|NCT01070979|520333006|FG002|Overall Study|Withdrawal by Subject|1|||
144308439|NCT01070979|520333004|FG000|Overall Study|No study drug taken|0|||
144308440|NCT01070979|520333005|FG001|Overall Study|No study drug taken|1|||
144308441|NCT01070979|520333006|FG002|Overall Study|No study drug taken|0|||
144308442|NCT00142792|520333007|FG000|Overall Study|Death|0|||
144308443|NCT00142792|520333008|FG001|Overall Study|Death|0|||
144308444|NCT00142792|520333009|FG002|Overall Study|Death|1|||
144308445|NCT00142792|520333007|FG000|Overall Study|Withdrawal by Subject|3|||
144308446|NCT00142792|520333008|FG001|Overall Study|Withdrawal by Subject|2|||
144308447|NCT00142792|520333009|FG002|Overall Study|Withdrawal by Subject|3|||
144308448|NCT00142792|520333007|FG000|Overall Study|Lost to Follow-up|8|||
144308449|NCT00142792|520333008|FG001|Overall Study|Lost to Follow-up|11|||
144308450|NCT00142792|520333009|FG002|Overall Study|Lost to Follow-up|7|||
144308451|NCT00142792|520333007|FG000|Overall Study|No category|1|||
144308452|NCT00142792|520333008|FG001|Overall Study|No category|2|||
144308453|NCT00142792|520333009|FG002|Overall Study|No category|1|||
144308454|NCT00437268|520333010|FG000|Overall Study|Adverse Event|1|||
144308455|NCT00437268|520333011|FG001|Overall Study|Adverse Event|1|||
144308456|NCT00437268|520333010|FG000|Overall Study|Withdrawal by Subject|2|||
144308457|NCT00437268|520333011|FG001|Overall Study|Withdrawal by Subject|2|||
144308458|NCT00437268|520333010|FG000|Overall Study|Progressive disease|9|||
144308459|NCT00437268|520333011|FG001|Overall Study|Progressive disease|9|||
144308460|NCT00437268|520333010|FG000|Overall Study|Physician Decision|1|||
144308461|NCT00437268|520333011|FG001|Overall Study|Physician Decision|0|||
144308462|NCT00437268|520333010|FG000|Overall Study|Death|0|||
144308463|NCT00437268|520333011|FG001|Overall Study|Death|1|||
144308464|NCT00444925|520333016|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
144308465|NCT00444925|520333017|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
144308466|NCT00444925|520333018|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
144308467|NCT00444925|520333016|FG000|Double-blind Treatment Period|Death|2|||
144308468|NCT00444925|520333017|FG001|Double-blind Treatment Period|Death|0|||
144308469|NCT00444925|520333018|FG002|Double-blind Treatment Period|Death|0|||
144308470|NCT00444925|520333016|FG000|Double-blind Treatment Period|Adverse Event|6|||
144308471|NCT00444925|520333017|FG001|Double-blind Treatment Period|Adverse Event|28|||
144308472|NCT00444925|520333018|FG002|Double-blind Treatment Period|Adverse Event|44|||
144308473|NCT00444925|520333016|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
144308474|NCT00444925|520333017|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
144308475|NCT00444925|520333018|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
144308476|NCT00444925|520333016|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
144308477|NCT00444925|520333017|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
144308478|NCT00444925|520333018|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
144308479|NCT00444925|520333016|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
144308480|NCT00444925|520333017|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
144308481|NCT00444925|520333018|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
144308482|NCT00444925|520333016|FG000|Double-blind Treatment Period|Other|7|||
144308483|NCT00444925|520333017|FG001|Double-blind Treatment Period|Other|7|||
144308484|NCT00444925|520333018|FG002|Double-blind Treatment Period|Other|12|||
144308485|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Death|2|||
144308486|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
144308487|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
144308488|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Physician Decision|1|||
144308489|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
144308490|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
144308491|NCT00786422|520333019|FG000|Rivaroxaban Treatment|Adverse Event|2|||
144308492|NCT00786422|520333019|FG000|Follow-up Period|Death|1|||
144308493|NCT00786422|520333019|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
144308494|NCT00810277|520334665|FG000|Overall Study|Adverse Event|1|||
144308495|NCT00532129|520334668|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
144308496|NCT00532129|520334668|FG000|Treatment Period|Physician Decision|15|||
144308497|NCT00532129|520334668|FG000|Treatment Period|Disease progression|3|||
144308498|NCT00532129|520334668|FG000|Treatment Period|Protocol Violation|1|||
144308499|NCT00532129|520334668|FG000|Treatment Period|Other|5|||
144308500|NCT00532129|520334668|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
144308501|NCT00532129|520334668|FG000|Follow-up Period|Disease progression|57|||
144308502|NCT00532129|520334668|FG000|Follow-up Period|Lost to Follow-up|1|||
144308503|NCT00532129|520334668|FG000|Follow-up Period|Other|6|||
144308504|NCT04551898|520334669|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
144308505|NCT04551898|520334670|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
144308506|NCT04551898|520334671|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
144308507|NCT04551898|520334672|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
144308508|NCT04551898|520334669|FG000|Overall Study|Withdrawal by Subject|5|||
144308509|NCT04551898|520334670|FG001|Overall Study|Withdrawal by Subject|1|||
144308510|NCT04551898|520334671|FG002|Overall Study|Withdrawal by Subject|2|||
144308511|NCT04551898|520334672|FG003|Overall Study|Withdrawal by Subject|2|||
144308512|NCT04551898|520334669|FG000|Overall Study|Lost to Follow-up|2|||
144308513|NCT04551898|520334670|FG001|Overall Study|Lost to Follow-up|1|||
144308514|NCT04551898|520334671|FG002|Overall Study|Lost to Follow-up|2|||
144308515|NCT04551898|520334672|FG003|Overall Study|Lost to Follow-up|2|||
144308516|NCT04551898|520334669|FG000|Overall Study|Death|1|||
144308517|NCT04551898|520334670|FG001|Overall Study|Death|0|||
144308518|NCT04551898|520334671|FG002|Overall Study|Death|0|||
144308519|NCT04551898|520334672|FG003|Overall Study|Death|0|||
144308520|NCT04551898|520334669|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
144308521|NCT04551898|520334670|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
144308522|NCT04551898|520334671|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
144308523|NCT04551898|520334672|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
144308524|NCT01396187|520334673|FG000|Overall Study|Adverse Event|0|||
144308525|NCT01396187|520334674|FG001|Overall Study|Adverse Event|1|||
144308526|NCT01396187|520334675|FG002|Overall Study|Adverse Event|0|||
144308527|NCT01396187|520334676|FG003|Overall Study|Adverse Event|0|||
144308528|NCT01396187|520334677|FG004|Overall Study|Adverse Event|0|||
144308529|NCT01396187|520334673|FG000|Overall Study|Withdrawal by Subject|0|||
144308530|NCT01396187|520334674|FG001|Overall Study|Withdrawal by Subject|1|||
144308531|NCT01396187|520334675|FG002|Overall Study|Withdrawal by Subject|1|||
144308532|NCT01396187|520334676|FG003|Overall Study|Withdrawal by Subject|0|||
144308533|NCT01396187|520334677|FG004|Overall Study|Withdrawal by Subject|0|||
144308534|NCT01396187|520334673|FG000|Overall Study|Other|1|||
144308535|NCT01396187|520334674|FG001|Overall Study|Other|1|||
144308536|NCT01396187|520334675|FG002|Overall Study|Other|0|||
144308537|NCT01396187|520334676|FG003|Overall Study|Other|0|||
144308538|NCT01396187|520334677|FG004|Overall Study|Other|1|||
144308539|NCT01336712|520334681|FG000|Overall Study|Death|2|||
144308540|NCT01336712|520334681|FG000|Overall Study|Lack of Efficacy|1|||
144308541|NCT04263766|520334689|FG000|Overall Study|Withdrawal by Subject|6|||
144308542|NCT04263766|520334690|FG001|Overall Study|Withdrawal by Subject|4|||
144308543|NCT04263766|520334689|FG000|Overall Study|Lack of Efficacy|1|||
144308544|NCT04263766|520334690|FG001|Overall Study|Lack of Efficacy|3|||
144308545|NCT00589797|520334694|FG000|Overall Study|Death|1|||
144308546|NCT00589797|520334695|FG001|Overall Study|Death|0|||
144308547|NCT00589797|520334694|FG000|Overall Study|Lost to Follow-up|12|||
144308548|NCT00589797|520334695|FG001|Overall Study|Lost to Follow-up|9|||
144308549|NCT00589797|520334694|FG000|Overall Study|Physician Decision|8|||
144308550|NCT00589797|520334695|FG001|Overall Study|Physician Decision|3|||
144308551|NCT00589797|520334694|FG000|Overall Study|Withdrawal by Subject|6|||
144308552|NCT00589797|520334695|FG001|Overall Study|Withdrawal by Subject|5|||
144308553|NCT00589797|520334694|FG000|Overall Study|Non-Randomized Training Subjects|46|||
144308554|NCT00589797|520334695|FG001|Overall Study|Non-Randomized Training Subjects|6|||
144308555|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
144308556|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
144308557|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
144308558|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
144308559|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
144308560|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
144308561|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
144308562|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
144308563|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
144308564|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
144308565|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
144308566|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
144308567|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
144308568|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
144308569|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
144308570|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
144308571|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
144308572|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
144308573|NCT02831855|520334697|FG000|Open Label Phase (24 Weeks)|Other|4|||
144308574|NCT02831855|520334698|FG001|Open Label Phase (24 Weeks)|Other|0|||
144308575|NCT02831855|520334699|FG002|Open Label Phase (24 Weeks)|Other|0|||
144308576|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
144308577|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
144308578|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
144308579|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Death|0|||
144308580|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Death|0|||
144308581|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Death|2|||
144308582|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
144308583|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
144308584|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
144308585|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
144308586|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
144308587|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
144308588|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
144308589|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
144308590|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
144308591|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Other|0|||
144308592|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Other|2|||
144308593|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Other|5|||
144308594|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
144308595|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
144308596|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
144308597|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
144308598|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
144308599|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
144308600|NCT02831855|520334697|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
144308601|NCT02831855|520334698|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
144308602|NCT02831855|520334699|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
144308603|NCT01057693|520334700|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
144308604|NCT01057693|520334701|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
144308605|NCT01057693|520334702|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
144308606|NCT01057693|520334700|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
144308607|NCT01057693|520334701|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
144308608|NCT01057693|520334702|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
144308609|NCT01057693|520334700|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
144308610|NCT01057693|520334701|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
144308611|NCT01057693|520334702|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
144308612|NCT01057693|520334700|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
144308613|NCT01057693|520334701|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
144308614|NCT01057693|520334702|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
144308615|NCT01057693|520334700|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
144308616|NCT01057693|520334701|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
144308617|NCT01057693|520334702|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
144308618|NCT01057693|520334700|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
144308619|NCT01057693|520334701|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
144308620|NCT01057693|520334702|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
144308621|NCT01057693|520334700|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
144308622|NCT01057693|520334701|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
144308623|NCT01057693|520334702|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
144308624|NCT01057693|520334700|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
144308625|NCT01057693|520334701|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
144308626|NCT01057693|520334702|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
144308627|NCT01057693|520334700|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
144308628|NCT01057693|520334701|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
144308629|NCT01057693|520334702|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
144308630|NCT01057693|520334700|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
144308631|NCT01057693|520334701|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
144308632|NCT01057693|520334702|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
144308633|NCT01057693|520334700|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
144308634|NCT01057693|520334701|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
144308635|NCT01057693|520334702|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
144308636|NCT01057693|520334700|FG000|Between Single-Blind and Double-Blind|Other|6|||
144308637|NCT01057693|520334701|FG001|Between Single-Blind and Double-Blind|Other|0|||
144308638|NCT01057693|520334702|FG002|Between Single-Blind and Double-Blind|Other|0|||
144308639|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
144308640|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
144308641|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
144308642|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
144308643|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
144308644|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
144308645|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
144308646|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
144308647|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
144308648|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
144308649|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
144308650|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
144308651|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
144308652|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
144308653|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
144308654|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
144308655|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
144308656|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
144308657|NCT01057693|520334700|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
144308658|NCT01057693|520334701|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
144308659|NCT01057693|520334702|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
144308660|NCT02236572|520334703|FG000|Overall Study|Withdrawal by Subject|1|||
144308661|NCT02236572|520334703|FG000|Overall Study|Protocol Violation|1|||
144308662|NCT02236572|520334703|FG000|Overall Study|Lost to Follow-up|1|||
144308663|NCT02413996|520334704|FG000|Overall Study|not comfortable with the intervention|9|||
144308664|NCT02413996|520334705|FG001|Overall Study|not comfortable with the intervention|2|||
144308665|NCT00920556|520334706|FG000|Overall Study|Adverse Event|16|||
144308666|NCT00920556|520334706|FG000|Overall Study|Physician Decision|7|||
144308667|NCT00920556|520334706|FG000|Overall Study|Withdrawal by Subject|1|||
144308668|NCT01299389|520334707|FG000|Double-blind|Adverse Event|45|||
144308669|NCT01299389|520334708|FG001|Double-blind|Adverse Event|27|||
144308670|NCT01299389|520334709|FG002|Double-blind|Adverse Event|0|||
144308671|NCT01299389|520334710|FG003|Double-blind|Adverse Event|0|||
144308672|NCT01299389|520334707|FG000|Double-blind|Lack of Efficacy|45|||
144308673|NCT01299389|520334708|FG001|Double-blind|Lack of Efficacy|21|||
144308674|NCT01299389|520334709|FG002|Double-blind|Lack of Efficacy|0|||
144308675|NCT01299389|520334710|FG003|Double-blind|Lack of Efficacy|0|||
144308676|NCT01299389|520334707|FG000|Double-blind|Lost to Follow-up|2|||
144308677|NCT01299389|520334708|FG001|Double-blind|Lost to Follow-up|1|||
144308678|NCT01299389|520334709|FG002|Double-blind|Lost to Follow-up|0|||
144308679|NCT01299389|520334710|FG003|Double-blind|Lost to Follow-up|0|||
144308680|NCT01299389|520334707|FG000|Double-blind|Withdrawal by Subject|16|||
144308681|NCT01299389|520334708|FG001|Double-blind|Withdrawal by Subject|13|||
144308682|NCT01299389|520334709|FG002|Double-blind|Withdrawal by Subject|0|||
144360017|NCT01601535|520525139|FG004|Phase 1|Started Another Treatment|0|||
144308683|NCT01299389|520334710|FG003|Double-blind|Withdrawal by Subject|0|||
144308684|NCT01299389|520334707|FG000|Double-blind|Other|1|||
144308685|NCT01299389|520334708|FG001|Double-blind|Other|1|||
144308686|NCT01299389|520334709|FG002|Double-blind|Other|0|||
144308687|NCT01299389|520334710|FG003|Double-blind|Other|0|||
144308688|NCT01299389|520334707|FG000|Double-blind|"fail to meet study population criteria"|0|||
144308689|NCT01299389|520334708|FG001|Double-blind|"fail to meet study population criteria"|1|||
144308690|NCT01299389|520334709|FG002|Double-blind|"fail to meet study population criteria"|0|||
144308691|NCT01299389|520334710|FG003|Double-blind|"fail to meet study population criteria"|0|||
144308692|NCT01299389|520334707|FG000|Post-observational|Other|0|||
144308693|NCT01299389|520334708|FG001|Post-observational|Other|0|||
144308694|NCT01299389|520334709|FG002|Post-observational|Other|12|||
144308695|NCT01299389|520334710|FG003|Post-observational|Other|6|||
144308696|NCT03465722|520334714|FG000|Overall Study|Withdrawal by Subject|21|||
144308697|NCT03465722|520334715|FG001|Overall Study|Withdrawal by Subject|14|||
144308698|NCT03465722|520334714|FG000|Overall Study|Death|89|||
144308699|NCT03465722|520334715|FG001|Overall Study|Death|87|||
144308700|NCT03465722|520334714|FG000|Overall Study|Lost to Follow-up|5|||
144308701|NCT03465722|520334715|FG001|Overall Study|Lost to Follow-up|3|||
144308702|NCT03465722|520334714|FG000|Overall Study|Administrative/Other|33|||
144308703|NCT03465722|520334715|FG001|Overall Study|Administrative/Other|32|||
144308704|NCT03465722|520334714|FG000|Overall Study|Not treated|1|||
144308705|NCT03465722|520334715|FG001|Overall Study|Not treated|2|||
144308706|NCT03465722|520334714|FG000|Overall Study|Sponsor decision|91|||
144308707|NCT03465722|520334715|FG001|Overall Study|Sponsor decision|98|||
144308708|NCT02948582|520334719|FG000|Washout Period 1|Adverse Event|0|||
144308709|NCT02948582|520334720|FG001|Washout Period 1|Adverse Event|2|||
144308710|NCT02948582|520334721|FG002|Washout Period 1|Adverse Event|0|||
144308711|NCT02948582|520334722|FG003|Washout Period 1|Adverse Event|0|||
144308712|NCT02948582|520334723|FG004|Washout Period 1|Adverse Event|0|||
144308713|NCT02948582|520334724|FG005|Washout Period 1|Adverse Event|0|||
144308714|NCT02948582|520334719|FG000|Washout Period 1|Protocol Violation|0|||
144308715|NCT02948582|520334720|FG001|Washout Period 1|Protocol Violation|0|||
144308716|NCT02948582|520334721|FG002|Washout Period 1|Protocol Violation|0|||
144308717|NCT02948582|520334722|FG003|Washout Period 1|Protocol Violation|0|||
144308718|NCT02948582|520334723|FG004|Washout Period 1|Protocol Violation|0|||
144308719|NCT02948582|520334724|FG005|Washout Period 1|Protocol Violation|1|||
144308720|NCT02948582|520334719|FG000|Washout Period 2|Adverse Event|0|||
144308721|NCT02948582|520334720|FG001|Washout Period 2|Adverse Event|1|||
144308722|NCT02948582|520334721|FG002|Washout Period 2|Adverse Event|0|||
144308723|NCT02948582|520334722|FG003|Washout Period 2|Adverse Event|0|||
144308724|NCT02948582|520334723|FG004|Washout Period 2|Adverse Event|0|||
144308725|NCT02948582|520334724|FG005|Washout Period 2|Adverse Event|0|||
144308726|NCT02948582|520334719|FG000|Washout Period 2|personal reasons|0|||
144308727|NCT02948582|520334720|FG001|Washout Period 2|personal reasons|0|||
144308728|NCT02948582|520334721|FG002|Washout Period 2|personal reasons|0|||
144308729|NCT02948582|520334722|FG003|Washout Period 2|personal reasons|1|||
144308730|NCT02948582|520334723|FG004|Washout Period 2|personal reasons|0|||
144308731|NCT02948582|520334724|FG005|Washout Period 2|personal reasons|0|||
144308732|NCT02948582|520334719|FG000|Washout Period 4|Adverse Event|1|||
144308733|NCT02948582|520334720|FG001|Washout Period 4|Adverse Event|0|||
144308734|NCT02948582|520334721|FG002|Washout Period 4|Adverse Event|1|||
144308735|NCT02948582|520334722|FG003|Washout Period 4|Adverse Event|0|||
144308736|NCT02948582|520334723|FG004|Washout Period 4|Adverse Event|0|||
144308737|NCT02948582|520334724|FG005|Washout Period 4|Adverse Event|0|||
144308738|NCT02041299|520334725|FG000|Overall Study|Adverse Event|9|||
144308739|NCT02041299|520334726|FG001|Overall Study|Adverse Event|3|||
144308740|NCT02041299|520334725|FG000|Overall Study|Lost to Follow-up|4|||
144308741|NCT02041299|520334726|FG001|Overall Study|Lost to Follow-up|1|||
144308742|NCT02041299|520334725|FG000|Overall Study|Physician Decision|1|||
144308743|NCT02041299|520334726|FG001|Overall Study|Physician Decision|1|||
144308744|NCT02041299|520334725|FG000|Overall Study|Withdrawal by Subject|13|||
144308745|NCT02041299|520334726|FG001|Overall Study|Withdrawal by Subject|7|||
144308746|NCT02041299|520334725|FG000|Overall Study|Protocol Violation|11|||
144308747|NCT02041299|520334726|FG001|Overall Study|Protocol Violation|4|||
144308748|NCT02041299|520334725|FG000|Overall Study|Termination of the study|7|||
144308749|NCT02041299|520334726|FG001|Overall Study|Termination of the study|3|||
144308750|NCT02041299|520334725|FG000|Overall Study|Required bone marrow transplant|0|||
144308751|NCT02041299|520334726|FG001|Overall Study|Required bone marrow transplant|1|||
144308752|NCT02041299|520334725|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
144308753|NCT02041299|520334726|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
144308754|NCT01635998|520334727|FG000|Overall Study|Death|1|||
144308755|NCT01635998|520334728|FG001|Overall Study|Death|1|||
144308756|NCT01635998|520334727|FG000|Overall Study|Lost to Follow-up|2|||
144308757|NCT01635998|520334728|FG001|Overall Study|Lost to Follow-up|1|||
144308758|NCT01635998|520334727|FG000|Overall Study|Withdrawal by Subject|1|||
144308759|NCT01635998|520334728|FG001|Overall Study|Withdrawal by Subject|5|||
144308760|NCT00846846|520334729|FG000|Overall Study|Death|56|||
144308761|NCT00846846|520334729|FG000|Overall Study|Withdrawal by Subject|19|||
144308762|NCT04339413|520334730|FG000|Overall Study|Reason Not Specified|2|||
144308763|NCT04339413|520334731|FG001|Overall Study|Reason Not Specified|7|||
144308764|NCT04339413|520334730|FG000|Overall Study|Study Terminated by Sponsor|30|||
144308765|NCT04339413|520334731|FG001|Overall Study|Study Terminated by Sponsor|33|||
144308766|NCT04339413|520334730|FG000|Overall Study|Progressive Disease|9|||
144308767|NCT04339413|520334731|FG001|Overall Study|Progressive Disease|6|||
144308768|NCT04339413|520334730|FG000|Overall Study|Withdrawal by Subject|9|||
144308769|NCT04339413|520334731|FG001|Overall Study|Withdrawal by Subject|10|||
144308770|NCT04339413|520334730|FG000|Overall Study|Physician Decision|3|||
144308771|NCT04339413|520334731|FG001|Overall Study|Physician Decision|1|||
144308772|NCT04339413|520334730|FG000|Overall Study|Death|2|||
144308773|NCT04339413|520334731|FG001|Overall Study|Death|0|||
144308774|NCT04339413|520334730|FG000|Overall Study|Adverse Event|3|||
144308775|NCT04339413|520334731|FG001|Overall Study|Adverse Event|0|||
144308776|NCT00442416|520334737|FG000|Overall Study|Adverse Event|4|||
144308777|NCT00442416|520334738|FG001|Overall Study|Adverse Event|1|||
144308778|NCT00442416|520334737|FG000|Overall Study|Death|1|||
144308779|NCT00442416|520334738|FG001|Overall Study|Death|0|||
144308780|NCT00442416|520334737|FG000|Overall Study|Lack of Efficacy|2|||
144308781|NCT00442416|520334738|FG001|Overall Study|Lack of Efficacy|0|||
144308782|NCT00442416|520334737|FG000|Overall Study|Protocol Violation|2|||
144308783|NCT00442416|520334738|FG001|Overall Study|Protocol Violation|3|||
144308784|NCT00442416|520334737|FG000|Overall Study|Withdrew consent|1|||
144308785|NCT00442416|520334738|FG001|Overall Study|Withdrew consent|2|||
144308786|NCT00442416|520334737|FG000|Overall Study|Administrative/Other|27|||
144308787|NCT00442416|520334738|FG001|Overall Study|Administrative/Other|33|||
144308788|NCT01853462|520334739|FG000|Overall Study|Withdrawal by Subject|1|||
144308789|NCT01853462|520334740|FG001|Overall Study|Withdrawal by Subject|1|||
144308790|NCT03943290|520334744|FG000|Overall Study|Sponsor Terminated Study|6|||
144308791|NCT03943290|520334745|FG001|Overall Study|Sponsor Terminated Study|1|||
144308792|NCT03943290|520334746|FG002|Overall Study|Sponsor Terminated Study|11|||
144308793|NCT03943290|520334747|FG003|Overall Study|Sponsor Terminated Study|6|||
144308794|NCT03943290|520334748|FG004|Overall Study|Sponsor Terminated Study|7|||
144308795|NCT03943290|520334749|FG005|Overall Study|Sponsor Terminated Study|6|||
144308796|NCT03943290|520334750|FG006|Overall Study|Sponsor Terminated Study|6|||
144308797|NCT03943290|520334751|FG007|Overall Study|Sponsor Terminated Study|7|||
144308798|NCT03943290|520334752|FG008|Overall Study|Sponsor Terminated Study|8|||
144308799|NCT03943290|520334744|FG000|Overall Study|Lost to Follow-up|1|||
144308800|NCT03943290|520334745|FG001|Overall Study|Lost to Follow-up|0|||
144308801|NCT03943290|520334746|FG002|Overall Study|Lost to Follow-up|1|||
144308802|NCT03943290|520334747|FG003|Overall Study|Lost to Follow-up|0|||
144308803|NCT03943290|520334748|FG004|Overall Study|Lost to Follow-up|0|||
144308804|NCT03943290|520334749|FG005|Overall Study|Lost to Follow-up|0|||
144308805|NCT03943290|520334750|FG006|Overall Study|Lost to Follow-up|0|||
144308806|NCT03943290|520334751|FG007|Overall Study|Lost to Follow-up|1|||
144308807|NCT03943290|520334752|FG008|Overall Study|Lost to Follow-up|0|||
144308808|NCT03943290|520334744|FG000|Overall Study|Withdrawal by Subject|0|||
144308809|NCT03943290|520334745|FG001|Overall Study|Withdrawal by Subject|0|||
144308810|NCT03943290|520334746|FG002|Overall Study|Withdrawal by Subject|1|||
144308811|NCT03943290|520334747|FG003|Overall Study|Withdrawal by Subject|0|||
144308812|NCT03943290|520334748|FG004|Overall Study|Withdrawal by Subject|0|||
144308813|NCT03943290|520334749|FG005|Overall Study|Withdrawal by Subject|0|||
144308814|NCT03943290|520334750|FG006|Overall Study|Withdrawal by Subject|0|||
144308815|NCT03943290|520334751|FG007|Overall Study|Withdrawal by Subject|0|||
144308816|NCT03943290|520334752|FG008|Overall Study|Withdrawal by Subject|0|||
144308817|NCT00003869|520334756|FG000|Overall Study|Adverse Event|14|||
144308818|NCT00003869|520334757|FG001|Overall Study|Adverse Event|3|||
144308819|NCT00003869|520334756|FG000|Overall Study|Withdrawal by Subject|21|||
144308820|NCT00003869|520334757|FG001|Overall Study|Withdrawal by Subject|3|||
144308821|NCT00003869|520334756|FG000|Overall Study|Death|1|||
144308822|NCT00003869|520334757|FG001|Overall Study|Death|2|||
144308823|NCT00003869|520334756|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
144308824|NCT00003869|520334757|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
144308825|NCT01964378|520334758|FG000|Overall Study|Disc. due to death before first dosing|0|||
144308826|NCT01964378|520334759|FG001|Overall Study|Disc. due to death before first dosing|1|||
144308827|NCT01964378|520334758|FG000|Overall Study|Disc. due to AE before first dosing|1|||
144308828|NCT01964378|520334759|FG001|Overall Study|Disc. due to AE before first dosing|0|||
144308829|NCT01964378|520334758|FG000|Overall Study|Death|3|||
144308830|NCT01964378|520334759|FG001|Overall Study|Death|2|||
144308831|NCT01964378|520334758|FG000|Overall Study|Adverse Event|12|||
144308832|NCT01964378|520334759|FG001|Overall Study|Adverse Event|5|||
144308833|NCT01964378|520334758|FG000|Overall Study|Lack of Efficacy|0|||
144308834|NCT01964378|520334759|FG001|Overall Study|Lack of Efficacy|1|||
144308835|NCT01964378|520334758|FG000|Overall Study|Protocol Violation|0|||
144308836|NCT01964378|520334759|FG001|Overall Study|Protocol Violation|1|||
144308837|NCT01964378|520334758|FG000|Overall Study|Lost to Follow-up|0|||
144308838|NCT01964378|520334759|FG001|Overall Study|Lost to Follow-up|1|||
144308839|NCT01964378|520334758|FG000|Overall Study|Withdrawal by Subject|7|||
144308840|NCT01964378|520334759|FG001|Overall Study|Withdrawal by Subject|5|||
144308841|NCT01964378|520334758|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
144308842|NCT01964378|520334759|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
144308843|NCT01964378|520334758|FG000|Overall Study|Other|1|||
144308844|NCT01964378|520334759|FG001|Overall Study|Other|2|||
144308845|NCT00326599|520334760|FG000|Overall Study|Withdrawal by Subject|1|||
144308846|NCT00326599|520334761|FG001|Overall Study|Withdrawal by Subject|0|||
144308847|NCT00326599|520334762|FG002|Overall Study|Withdrawal by Subject|5|||
144308848|NCT00326599|520334763|FG003|Overall Study|Withdrawal by Subject|2|||
144308849|NCT00326599|520334760|FG000|Overall Study|Adverse Event|1|||
144308850|NCT00326599|520334761|FG001|Overall Study|Adverse Event|0|||
144308851|NCT00326599|520334762|FG002|Overall Study|Adverse Event|32|||
144308852|NCT00326599|520334763|FG003|Overall Study|Adverse Event|3|||
144308853|NCT00326599|520334760|FG000|Overall Study|Disease Progression|3|||
144308854|NCT00326599|520334761|FG001|Overall Study|Disease Progression|1|||
144308855|NCT00326599|520334762|FG002|Overall Study|Disease Progression|13|||
144308856|NCT00326599|520334763|FG003|Overall Study|Disease Progression|11|||
144308857|NCT00326599|520334760|FG000|Overall Study|Alternate Treatment|1|||
144308858|NCT00326599|520334761|FG001|Overall Study|Alternate Treatment|0|||
144308859|NCT00326599|520334762|FG002|Overall Study|Alternate Treatment|0|||
144308860|NCT00326599|520334763|FG003|Overall Study|Alternate Treatment|0|||
144308861|NCT00326599|520334760|FG000|Overall Study|Death|0|||
144308862|NCT00326599|520334761|FG001|Overall Study|Death|0|||
144308863|NCT00326599|520334762|FG002|Overall Study|Death|1|||
144308864|NCT00326599|520334763|FG003|Overall Study|Death|2|||
144308865|NCT00326599|520334760|FG000|Overall Study|Other Unspecified Reason|0|||
144308866|NCT00326599|520334761|FG001|Overall Study|Other Unspecified Reason|0|||
144308867|NCT00326599|520334762|FG002|Overall Study|Other Unspecified Reason|2|||
144308868|NCT00326599|520334763|FG003|Overall Study|Other Unspecified Reason|1|||
144308869|NCT03364231|520334764|FG000|Overall Study|Adverse Event|1|||
144308870|NCT03364231|520334765|FG001|Overall Study|Adverse Event|4|||
144308871|NCT03364231|520334764|FG000|Overall Study|Death|1|||
144308872|NCT03364231|520334765|FG001|Overall Study|Death|0|||
144308873|NCT03364231|520334764|FG000|Overall Study|Investigator Decision|2|||
144308874|NCT03364231|520334765|FG001|Overall Study|Investigator Decision|2|||
144308875|NCT03364231|520334764|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
144308876|NCT03364231|520334765|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
144308877|NCT03364231|520334764|FG000|Overall Study|Withdrawal of Subject Consent|1|||
144308878|NCT03364231|520334765|FG001|Overall Study|Withdrawal of Subject Consent|0|||
144308879|NCT03364231|520334764|FG000|Overall Study|Reason Not Specified|1|||
144308880|NCT03364231|520334765|FG001|Overall Study|Reason Not Specified|0|||
144308881|NCT03364231|520334764|FG000|Overall Study|Disease Progression|0|||
144308882|NCT03364231|520334765|FG001|Overall Study|Disease Progression|6|||
144308883|NCT03386435|520334766|FG000|Overall Study|Protocol Violation|5|||
144308884|NCT03386435|520334767|FG001|Overall Study|Protocol Violation|7|||
144308885|NCT04068922|520334768|FG000|Overall Study|Lost to Follow-up|5|||
144308886|NCT04068922|520334768|FG000|Overall Study|Withdrawal by Subject|7|||
144308887|NCT04068922|520334768|FG000|Overall Study|Adverse Event|1|||
144308888|NCT00625586|520334769|FG000|Overall Study|Adverse Event|1|||
144308889|NCT00625586|520334769|FG000|Overall Study|Progressive disease|1|||
144308890|NCT03542266|520334770|FG000|Treatment Phase|Withdrawal by Subject|1|||
144308891|NCT03542266|520334770|FG000|Treatment Phase|Adverse Event|1|||
144308892|NCT03542266|520334770|FG000|Treatment Phase|PD|1|||
144308893|NCT01162473|520334782|FG000|Overall Study|Adverse Event|2|||
144308894|NCT01162473|520334783|FG001|Overall Study|Adverse Event|1|||
144308895|NCT01162473|520334782|FG000|Overall Study|Withdrawal by Subject|0|||
144308896|NCT01162473|520334783|FG001|Overall Study|Withdrawal by Subject|4|||
144308897|NCT00657267|520334790|FG000|Overall Study|Progressive disease|45|||
144308898|NCT00657267|520334790|FG000|Overall Study|Adverse Event|9|||
144308899|NCT03484429|520334794|FG000|Overall Study|Withdrawal by Subject|1|||
144308900|NCT03484429|520334795|FG001|Overall Study|Withdrawal by Subject|0|||
144308901|NCT03484429|520334794|FG000|Overall Study|Adverse Event|2|||
144308902|NCT03484429|520334795|FG001|Overall Study|Adverse Event|0|||
144308903|NCT04466384|520334796|FG000|First Phase|Protocol Violation|1|||
144308904|NCT04466384|520334797|FG001|First Phase|Protocol Violation|0|||
144308905|NCT04466384|520334796|FG000|First Phase|Missing data|1|||
144308906|NCT04466384|520334797|FG001|First Phase|Missing data|0|||
144308907|NCT04466384|520334796|FG000|Cross Over Phase|Physician Decision|1|||
144308908|NCT04466384|520334797|FG001|Cross Over Phase|Physician Decision|0|||
144308909|NCT04466384|520334796|FG000|Cross Over Phase|Withdrawal by Subject|0|||
144308910|NCT04466384|520334797|FG001|Cross Over Phase|Withdrawal by Subject|1|||
144308911|NCT02268383|520334798|FG000|Overall Study|Death|12|||
144308912|NCT02268383|520334798|FG000|Overall Study|Lost to Follow-up|2|||
144308913|NCT02268383|520334798|FG000|Overall Study|Withdrawal by Subject|9|||
144308914|NCT02268383|520334798|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
144308915|NCT02268383|520334798|FG000|Overall Study|Protocol deviation|3|||
144308916|NCT02268383|520334798|FG000|Overall Study|Sponsor decision|22|||
144308917|NCT02268383|520334798|FG000|Overall Study|Not reported|12|||
144308918|NCT04162470|520334799|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
144308919|NCT04570384|520334800|FG000|Overall Study|Adverse Event|2|||
144308920|NCT04570384|520334801|FG001|Overall Study|Adverse Event|1|||
144308921|NCT04570384|520334800|FG000|Overall Study|Death|2|||
144308922|NCT04570384|520334801|FG001|Overall Study|Death|5|||
144308923|NCT04570384|520334800|FG000|Overall Study|Lost to Follow-up|1|||
144308924|NCT04570384|520334801|FG001|Overall Study|Lost to Follow-up|0|||
144308925|NCT04570384|520334800|FG000|Overall Study|Other|1|||
144308926|NCT04570384|520334801|FG001|Overall Study|Other|0|||
144308927|NCT04570384|520334800|FG000|Overall Study|Protocol Violation|0|||
144308928|NCT04570384|520334801|FG001|Overall Study|Protocol Violation|1|||
144308929|NCT04570384|520334800|FG000|Overall Study|Sponsor Decision|1|||
144308930|NCT04570384|520334801|FG001|Overall Study|Sponsor Decision|0|||
144308931|NCT04570384|520334800|FG000|Overall Study|Withdrawal by Subject|4|||
144308932|NCT04570384|520334801|FG001|Overall Study|Withdrawal by Subject|2|||
144308933|NCT04749745|520334802|FG000|Overall Study|Withdrawal by Subject|1|||
144308934|NCT04749745|520334803|FG001|Overall Study|Withdrawal by Subject|0|||
144308935|NCT01365455|520334808|FG000|Induction Period|Adverse Event|5|||
144308936|NCT01365455|520334809|FG001|Induction Period|Adverse Event|3|||
144308937|NCT01365455|520334810|FG002|Induction Period|Adverse Event|4|||
144308938|NCT01365455|520334811|FG003|Induction Period|Adverse Event|0|||
144308939|NCT01365455|520334812|FG004|Induction Period|Adverse Event|0|||
144308940|NCT01365455|520334808|FG000|Induction Period|Lack of Efficacy|1|||
144308941|NCT01365455|520334809|FG001|Induction Period|Lack of Efficacy|1|||
144308942|NCT01365455|520334810|FG002|Induction Period|Lack of Efficacy|0|||
144308943|NCT01365455|520334811|FG003|Induction Period|Lack of Efficacy|0|||
144308944|NCT01365455|520334812|FG004|Induction Period|Lack of Efficacy|0|||
144308945|NCT01365455|520334808|FG000|Induction Period|Pregnancy|0|||
144308946|NCT01365455|520334809|FG001|Induction Period|Pregnancy|1|||
144308947|NCT01365455|520334810|FG002|Induction Period|Pregnancy|0|||
144308948|NCT01365455|520334811|FG003|Induction Period|Pregnancy|0|||
144308949|NCT01365455|520334812|FG004|Induction Period|Pregnancy|0|||
144308950|NCT01365455|520334808|FG000|Induction Period|Protocol deviation|0|||
144308951|NCT01365455|520334809|FG001|Induction Period|Protocol deviation|1|||
144308952|NCT01365455|520334810|FG002|Induction Period|Protocol deviation|1|||
144308953|NCT01365455|520334811|FG003|Induction Period|Protocol deviation|0|||
144308954|NCT01365455|520334812|FG004|Induction Period|Protocol deviation|0|||
144308955|NCT01365455|520334808|FG000|Induction Period|Subject/guardian decision|9|||
144308956|NCT01365455|520334809|FG001|Induction Period|Subject/guardian decision|1|||
144308957|NCT01365455|520334810|FG002|Induction Period|Subject/guardian decision|8|||
144308958|NCT01365455|520334811|FG003|Induction Period|Subject/guardian decision|0|||
144308959|NCT01365455|520334812|FG004|Induction Period|Subject/guardian decision|0|||
144308960|NCT01365455|520334808|FG000|Induction Period|Lost to Follow-up|0|||
144308961|NCT01365455|520334809|FG001|Induction Period|Lost to Follow-up|0|||
144308962|NCT01365455|520334810|FG002|Induction Period|Lost to Follow-up|3|||
144308963|NCT01365455|520334811|FG003|Induction Period|Lost to Follow-up|0|||
144308964|NCT01365455|520334812|FG004|Induction Period|Lost to Follow-up|0|||
144308965|NCT01365455|520334808|FG000|Maintenance Period|Adverse Event|12|||
144308966|NCT01365455|520334809|FG001|Maintenance Period|Adverse Event|5|||
144308967|NCT01365455|520334810|FG002|Maintenance Period|Adverse Event|1|||
144308968|NCT01365455|520334811|FG003|Maintenance Period|Adverse Event|2|||
144308969|NCT01365455|520334812|FG004|Maintenance Period|Adverse Event|4|||
144308970|NCT01365455|520334808|FG000|Maintenance Period|Lack of Efficacy|10|||
144308971|NCT01365455|520334809|FG001|Maintenance Period|Lack of Efficacy|2|||
144308972|NCT01365455|520334810|FG002|Maintenance Period|Lack of Efficacy|0|||
144308973|NCT01365455|520334811|FG003|Maintenance Period|Lack of Efficacy|2|||
144308974|NCT01365455|520334812|FG004|Maintenance Period|Lack of Efficacy|2|||
144308975|NCT01365455|520334808|FG000|Maintenance Period|Lost to Follow-up|2|||
144308976|NCT01365455|520334809|FG001|Maintenance Period|Lost to Follow-up|4|||
144308977|NCT01365455|520334810|FG002|Maintenance Period|Lost to Follow-up|0|||
144308978|NCT01365455|520334811|FG003|Maintenance Period|Lost to Follow-up|0|||
144308979|NCT01365455|520334812|FG004|Maintenance Period|Lost to Follow-up|3|||
144308980|NCT01365455|520334808|FG000|Maintenance Period|Non-compliance with study treatment|0|||
144308981|NCT01365455|520334809|FG001|Maintenance Period|Non-compliance with study treatment|0|||
144308982|NCT01365455|520334810|FG002|Maintenance Period|Non-compliance with study treatment|0|||
144308983|NCT01365455|520334811|FG003|Maintenance Period|Non-compliance with study treatment|1|||
144308984|NCT01365455|520334812|FG004|Maintenance Period|Non-compliance with study treatment|0|||
144308985|NCT01365455|520334808|FG000|Maintenance Period|Physician Decision|0|||
144308986|NCT01365455|520334809|FG001|Maintenance Period|Physician Decision|1|||
144308987|NCT01365455|520334810|FG002|Maintenance Period|Physician Decision|0|||
144308988|NCT01365455|520334811|FG003|Maintenance Period|Physician Decision|0|||
144308989|NCT01365455|520334812|FG004|Maintenance Period|Physician Decision|1|||
144308990|NCT01365455|520334808|FG000|Maintenance Period|Pregnancy|0|||
144308991|NCT01365455|520334809|FG001|Maintenance Period|Pregnancy|4|||
144308992|NCT01365455|520334810|FG002|Maintenance Period|Pregnancy|0|||
144308993|NCT01365455|520334811|FG003|Maintenance Period|Pregnancy|0|||
144308994|NCT01365455|520334812|FG004|Maintenance Period|Pregnancy|2|||
144308995|NCT01365455|520334808|FG000|Maintenance Period|Protocol deviation|1|||
144308996|NCT01365455|520334809|FG001|Maintenance Period|Protocol deviation|1|||
144308997|NCT01365455|520334810|FG002|Maintenance Period|Protocol deviation|0|||
144308998|NCT01365455|520334811|FG003|Maintenance Period|Protocol deviation|0|||
144308999|NCT01365455|520334812|FG004|Maintenance Period|Protocol deviation|0|||
144309000|NCT01365455|520334808|FG000|Maintenance Period|Subject/guardian decision|4|||
144309001|NCT01365455|520334809|FG001|Maintenance Period|Subject/guardian decision|6|||
144309002|NCT01365455|520334810|FG002|Maintenance Period|Subject/guardian decision|2|||
144309003|NCT01365455|520334811|FG003|Maintenance Period|Subject/guardian decision|4|||
144309004|NCT01365455|520334812|FG004|Maintenance Period|Subject/guardian decision|1|||
144309005|NCT03965403|520334813|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
144309006|NCT03718325|520335667|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
144309007|NCT03718325|520335668|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
144309008|NCT03718325|520335669|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
144309009|NCT03718325|520335667|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
144309010|NCT03718325|520335668|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
144309011|NCT03718325|520335669|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
144309012|NCT03145064|520335670|FG000|Overall Study|Death|24|||
144309013|NCT03145064|520335670|FG000|Overall Study|Lost to Follow-up|3|||
144309014|NCT03145064|520335670|FG000|Overall Study|Withdrawal by Subject|6|||
144309015|NCT03145064|520335670|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
144309016|NCT03145064|520335670|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
144309017|NCT01898286|520335671|FG000|Overall Study|Withdrawal by Subject|1|||
144309018|NCT01898286|520335671|FG000|Overall Study|Protocol Violation|1|||
144309019|NCT01898286|520335671|FG000|Overall Study|Lost to Follow-up|1|||
144309020|NCT02257242|520335672|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
144309021|NCT02257242|520335673|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309022|NCT02257242|520335674|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309023|NCT02257242|520335675|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309024|NCT02257242|520335676|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309025|NCT02257242|520335677|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309026|NCT02257242|520335678|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309027|NCT02257242|520335679|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309028|NCT02257242|520335680|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
144309029|NCT02964273|520335684|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
144309030|NCT02964273|520335685|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
144309031|NCT02964273|520335686|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
144309032|NCT02964273|520335687|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
144309033|NCT02964273|520335684|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
144309034|NCT02964273|520335685|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
144309035|NCT02964273|520335686|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
144309036|NCT02964273|520335687|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
144309037|NCT02964273|520335684|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
144309038|NCT02964273|520335685|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
144309039|NCT02964273|520335686|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
144309040|NCT02964273|520335687|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
144309041|NCT02964273|520335684|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
144309042|NCT02964273|520335685|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
144309043|NCT02964273|520335686|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
144309044|NCT02964273|520335687|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
144309045|NCT02964273|520335684|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
144309046|NCT02964273|520335685|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
144309047|NCT02964273|520335686|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
144309048|NCT02964273|520335687|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
144309049|NCT02964273|520335684|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
144309050|NCT02964273|520335685|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
144309051|NCT02964273|520335686|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
144309052|NCT02964273|520335687|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
144309053|NCT01453036|520335688|FG000|Overall Study|Lost to Follow-up|26|||
144309054|NCT01453036|520335689|FG001|Overall Study|Lost to Follow-up|115|||
144309055|NCT01453036|520335690|FG002|Overall Study|Lost to Follow-up|31|||
144309056|NCT04245449|520335691|FG000|Overall Study|COVID shutdown|7|||
144309057|NCT03073525|520335692|FG000|Overall Study|Withdrawal by Subject|0|||
144309058|NCT03073525|520335693|FG001|Overall Study|Withdrawal by Subject|0|||
144309059|NCT03073525|520335694|FG002|Overall Study|Withdrawal by Subject|3|||
144309060|NCT01976299|520335695|FG000|Overall Study|Withdrawal by Subject|3|||
144309061|NCT01976299|520335696|FG001|Overall Study|Withdrawal by Subject|1|||
144309062|NCT01976299|520335695|FG000|Overall Study|Death|4|||
144309063|NCT01976299|520335696|FG001|Overall Study|Death|2|||
144309064|NCT01976299|520335695|FG000|Overall Study|Lost to Follow-up|7|||
144309065|NCT01976299|520335696|FG001|Overall Study|Lost to Follow-up|1|||
144309066|NCT01976299|520335695|FG000|Overall Study|See clarification above in comments|9|||
144309067|NCT01976299|520335696|FG001|Overall Study|See clarification above in comments|2|||
144309068|NCT02848092|520335698|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
144309069|NCT02848092|520335699|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
144309070|NCT02848092|520335698|FG000|1-month Post-training Follow-up|Adverse Event|2|||
144309071|NCT02848092|520335699|FG001|1-month Post-training Follow-up|Adverse Event|1|||
144309072|NCT02848092|520335698|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
144309073|NCT02848092|520335699|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
144309074|NCT02848092|520335698|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
144309075|NCT02848092|520335699|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
144309076|NCT02848092|520335698|FG000|1-month Post-training Follow-up|fatigue|0|||
144309077|NCT02848092|520335699|FG001|1-month Post-training Follow-up|fatigue|1|||
144309078|NCT02848092|520335698|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
144309079|NCT02848092|520335699|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
144309080|NCT02848092|520335698|FG000|6-month Post-training Follow-up|Adverse Event|1|||
144309081|NCT02848092|520335699|FG001|6-month Post-training Follow-up|Adverse Event|1|||
144309082|NCT02848092|520335698|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
144309083|NCT02848092|520335699|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
144309084|NCT02848092|520335698|FG000|6-month Post-training Follow-up|frustrated with task|1|||
144309085|NCT02848092|520335699|FG001|6-month Post-training Follow-up|frustrated with task|0|||
144309086|NCT02848092|520335698|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
144309087|NCT02848092|520335699|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
144309088|NCT02848092|520335698|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
144309089|NCT02848092|520335699|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
144309090|NCT01484496|520335702|FG000|Period 1|Protocol Violation|3|||
144309091|NCT01484496|520335703|FG001|Period 1|Protocol Violation|4|||
144309092|NCT01484496|520335704|FG002|Period 1|Protocol Violation|0|||
144309093|NCT01484496|520335705|FG003|Period 1|Protocol Violation|0|||
144309094|NCT01484496|520335702|FG000|Period 1|Physician Decision|5|||
144309095|NCT01484496|520335703|FG001|Period 1|Physician Decision|1|||
144309096|NCT01484496|520335704|FG002|Period 1|Physician Decision|0|||
144309097|NCT01484496|520335705|FG003|Period 1|Physician Decision|0|||
144309098|NCT01484496|520335702|FG000|Period 1|Lack of Efficacy|10|||
144309099|NCT01484496|520335703|FG001|Period 1|Lack of Efficacy|15|||
144309100|NCT01484496|520335704|FG002|Period 1|Lack of Efficacy|0|||
144309101|NCT01484496|520335705|FG003|Period 1|Lack of Efficacy|0|||
144309102|NCT01484496|520335702|FG000|Period 1|Adverse Event|25|||
144309103|NCT01484496|520335703|FG001|Period 1|Adverse Event|40|||
144309104|NCT01484496|520335704|FG002|Period 1|Adverse Event|0|||
144309105|NCT01484496|520335705|FG003|Period 1|Adverse Event|0|||
144309106|NCT01484496|520335702|FG000|Period 1|Withdrawal by Subject|15|||
144309107|NCT01484496|520335703|FG001|Period 1|Withdrawal by Subject|12|||
144309108|NCT01484496|520335704|FG002|Period 1|Withdrawal by Subject|0|||
144309109|NCT01484496|520335705|FG003|Period 1|Withdrawal by Subject|0|||
144309110|NCT01484496|520335702|FG000|Period 1|Lost to Follow-up|2|||
144309111|NCT01484496|520335703|FG001|Period 1|Lost to Follow-up|6|||
144309112|NCT01484496|520335704|FG002|Period 1|Lost to Follow-up|0|||
144309113|NCT01484496|520335705|FG003|Period 1|Lost to Follow-up|0|||
144309114|NCT01484496|520335702|FG000|Period 1|Positive Pregnancy|1|||
144309115|NCT01484496|520335703|FG001|Period 1|Positive Pregnancy|6|||
144309116|NCT01484496|520335704|FG002|Period 1|Positive Pregnancy|0|||
144309117|NCT01484496|520335705|FG003|Period 1|Positive Pregnancy|0|||
144309118|NCT01484496|520335702|FG000|Period 1|Treatment Failure|3|||
144309119|NCT01484496|520335703|FG001|Period 1|Treatment Failure|6|||
144309120|NCT01484496|520335704|FG002|Period 1|Treatment Failure|0|||
144309121|NCT01484496|520335705|FG003|Period 1|Treatment Failure|0|||
144309122|NCT01484496|520335702|FG000|Period 1|Lack of Compliance|2|||
144309123|NCT01484496|520335703|FG001|Period 1|Lack of Compliance|1|||
144309124|NCT01484496|520335704|FG002|Period 1|Lack of Compliance|0|||
144309125|NCT01484496|520335705|FG003|Period 1|Lack of Compliance|0|||
144309126|NCT01484496|520335702|FG000|Period 1|Unable to Visit Site|0|||
144309127|NCT01484496|520335703|FG001|Period 1|Unable to Visit Site|2|||
144309128|NCT01484496|520335704|FG002|Period 1|Unable to Visit Site|0|||
144309129|NCT01484496|520335705|FG003|Period 1|Unable to Visit Site|0|||
144309130|NCT01484496|520335702|FG000|Period 2|Lack of Efficacy|0|||
144309131|NCT01484496|520335703|FG001|Period 2|Lack of Efficacy|0|||
144309132|NCT01484496|520335704|FG002|Period 2|Lack of Efficacy|1|||
144309133|NCT01484496|520335705|FG003|Period 2|Lack of Efficacy|3|||
144309134|NCT01484496|520335702|FG000|Period 2|Adverse Event|0|||
144309135|NCT01484496|520335703|FG001|Period 2|Adverse Event|0|||
144309136|NCT01484496|520335704|FG002|Period 2|Adverse Event|5|||
144309137|NCT01484496|520335705|FG003|Period 2|Adverse Event|13|||
144309138|NCT01484496|520335702|FG000|Period 2|Other|0|||
144309139|NCT01484496|520335703|FG001|Period 2|Other|0|||
144309140|NCT01484496|520335704|FG002|Period 2|Other|9|||
144309141|NCT01484496|520335705|FG003|Period 2|Other|6|||
144309142|NCT00506779|520335706|FG000|Overall Study|Withdrawal by Subject|1|||
144309143|NCT00506779|520335707|FG001|Overall Study|Withdrawal by Subject|0|||
144309144|NCT00506779|520335708|FG002|Overall Study|Withdrawal by Subject|1|||
144309145|NCT00506779|520335709|FG003|Overall Study|Withdrawal by Subject|0|||
144309146|NCT00506779|520335706|FG000|Overall Study|Adverse Event|0|||
144309147|NCT00506779|520335707|FG001|Overall Study|Adverse Event|1|||
144309148|NCT00506779|520335708|FG002|Overall Study|Adverse Event|1|||
144309149|NCT00506779|520335709|FG003|Overall Study|Adverse Event|1|||
144309150|NCT01645735|520335710|FG000|Overall Study|Physician Decision|2|||
144309151|NCT01645735|520335711|FG001|Overall Study|Physician Decision|0|||
144309152|NCT01645735|520335710|FG000|Overall Study|Withdrawal by Subject|1|||
144309153|NCT01645735|520335711|FG001|Overall Study|Withdrawal by Subject|0|||
144309154|NCT01645735|520335710|FG000|Overall Study|Protocol Violation|1|||
144309155|NCT01645735|520335711|FG001|Overall Study|Protocol Violation|0|||
144309156|NCT01645735|520335710|FG000|Overall Study|Adverse Event|0|||
144309157|NCT01645735|520335711|FG001|Overall Study|Adverse Event|1|||
144309158|NCT01456130|520335714|FG000|Overall Study|Adverse Event|4|||
144309159|NCT01456130|520335714|FG000|Overall Study|Voluntary Withdrawal|1|||
144309160|NCT01456130|520335714|FG000|Overall Study|Lack of Efficacy|4|||
144309161|NCT01456130|520335714|FG000|Overall Study|Other|1|||
144309162|NCT04908683|520335717|FG000|Overall Study|Failure to meet continuation criteria|34|||
144309163|NCT04908683|520335718|FG001|Overall Study|Failure to meet continuation criteria|22|||
144309164|NCT04908683|520335717|FG000|Overall Study|Initiated prohibited medication|3|||
144309165|NCT04908683|520335718|FG001|Overall Study|Initiated prohibited medication|0|||
144309166|NCT04908683|520335717|FG000|Overall Study|Randomized by mistake|1|||
144309167|NCT04908683|520335718|FG001|Overall Study|Randomized by mistake|0|||
144309168|NCT04908683|520335717|FG000|Overall Study|Lost to Follow-up|679|||
144309169|NCT04908683|520335718|FG001|Overall Study|Lost to Follow-up|341|||
144309170|NCT04908683|520335717|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
144309171|NCT04908683|520335718|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
144309172|NCT04908683|520335717|FG000|Overall Study|Physician Decision|44|||
144309173|NCT04908683|520335718|FG001|Overall Study|Physician Decision|35|||
144309174|NCT04908683|520335717|FG000|Overall Study|Technical problems|12|||
144309175|NCT04908683|520335718|FG001|Overall Study|Technical problems|9|||
144309176|NCT04908683|520335717|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
144309177|NCT04908683|520335718|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
144309178|NCT04908683|520335717|FG000|Overall Study|Protocol Violation|2|||
144309179|NCT04908683|520335718|FG001|Overall Study|Protocol Violation|0|||
144309180|NCT04908683|520335717|FG000|Overall Study|Withdrawal by Subject|1188|||
144309181|NCT04908683|520335718|FG001|Overall Study|Withdrawal by Subject|570|||
144309182|NCT04908683|520335717|FG000|Overall Study|Site Closure by Sponsor|6|||
144309183|NCT04908683|520335718|FG001|Overall Study|Site Closure by Sponsor|3|||
144309184|NCT04908683|520335717|FG000|Overall Study|Adverse Event|21|||
144309185|NCT04908683|520335718|FG001|Overall Study|Adverse Event|11|||
144309186|NCT04908683|520335717|FG000|Overall Study|Death|101|||
144309187|NCT04908683|520335718|FG001|Overall Study|Death|61|||
144309188|NCT04908683|520335717|FG000|Overall Study|Sponsor's decision|14398|||
144309189|NCT04908683|520335718|FG001|Overall Study|Sponsor's decision|7205|||
144309190|NCT04908683|520335717|FG000|Overall Study|Other|92|||
144309191|NCT04908683|520335718|FG001|Overall Study|Other|50|||
144309192|NCT04908683|520335717|FG000|Overall Study|Randomized not vaccinated|108|||
144309193|NCT04908683|520335718|FG001|Overall Study|Randomized not vaccinated|52|||
144309194|NCT01135459|520335719|FG000|Overall Study|Adverse Event|8|||
144309195|NCT01135459|520335720|FG001|Overall Study|Adverse Event|10|||
144309196|NCT01135459|520335719|FG000|Overall Study|Lack of Efficacy|3|||
144309197|NCT01135459|520335720|FG001|Overall Study|Lack of Efficacy|1|||
144309198|NCT01135459|520335719|FG000|Overall Study|Withdrawal by Subject|2|||
144309199|NCT01135459|520335720|FG001|Overall Study|Withdrawal by Subject|3|||
144309200|NCT01135459|520335719|FG000|Overall Study|Protocol Violation|5|||
144309201|NCT01135459|520335720|FG001|Overall Study|Protocol Violation|3|||
144309202|NCT01135459|520335719|FG000|Overall Study|Lost to Follow-up|2|||
144309203|NCT01135459|520335720|FG001|Overall Study|Lost to Follow-up|1|||
144309204|NCT01135459|520335719|FG000|Overall Study|Non-compliance to study procedures|0|||
144309205|NCT01135459|520335720|FG001|Overall Study|Non-compliance to study procedures|1|||
144309206|NCT01135459|520335719|FG000|Overall Study|Other than specified|1|||
144309207|NCT01135459|520335720|FG001|Overall Study|Other than specified|1|||
144309208|NCT00590967|520335724|FG000|Overall Study|Withdrawal by Subject|1|||
144309209|NCT00590967|520335725|FG001|Overall Study|Withdrawal by Subject|1|||
144309210|NCT00590967|520335724|FG000|Overall Study|Ineligible|1|||
144309211|NCT00590967|520335725|FG001|Overall Study|Ineligible|0|||
144309212|NCT00590967|520335724|FG000|Overall Study|Poor performance status|0|||
144309213|NCT00590967|520335725|FG001|Overall Study|Poor performance status|1|||
144309214|NCT00590967|520335724|FG000|Overall Study|Non-compliant|0|||
144309215|NCT00590967|520335725|FG001|Overall Study|Non-compliant|2|||
144309216|NCT00590967|520335724|FG000|Overall Study|Did not sign consent form|0|||
144309217|NCT00590967|520335725|FG001|Overall Study|Did not sign consent form|1|||
144309218|NCT00590967|520335724|FG000|Overall Study|Did not receive chemo per protocol|1|||
144309219|NCT00590967|520335725|FG001|Overall Study|Did not receive chemo per protocol|0|||
144309220|NCT01881789|520335726|FG000|Overall Study|Withdrawal by Subject|0|||
144309221|NCT01881789|520335727|FG001|Overall Study|Withdrawal by Subject|2|||
144309222|NCT01881789|520335728|FG002|Overall Study|Withdrawal by Subject|1|||
144309223|NCT01881789|520335729|FG003|Overall Study|Withdrawal by Subject|0|||
144309224|NCT01881789|520335730|FG004|Overall Study|Withdrawal by Subject|1|||
144309225|NCT01881789|520335731|FG005|Overall Study|Withdrawal by Subject|1|||
144309226|NCT01881789|520335726|FG000|Overall Study|Study Terminated by Sponsor|0|||
144309227|NCT01881789|520335727|FG001|Overall Study|Study Terminated by Sponsor|0|||
144309228|NCT01881789|520335728|FG002|Overall Study|Study Terminated by Sponsor|0|||
144309229|NCT01881789|520335729|FG003|Overall Study|Study Terminated by Sponsor|0|||
144309230|NCT01881789|520335730|FG004|Overall Study|Study Terminated by Sponsor|0|||
144309231|NCT01881789|520335731|FG005|Overall Study|Study Terminated by Sponsor|1|||
144309232|NCT01881789|520335726|FG000|Overall Study|Other|3|||
144309233|NCT01881789|520335727|FG001|Overall Study|Other|5|||
144309234|NCT01881789|520335728|FG002|Overall Study|Other|2|||
144309235|NCT01881789|520335729|FG003|Overall Study|Other|3|||
144309236|NCT01881789|520335730|FG004|Overall Study|Other|1|||
144309237|NCT01881789|520335731|FG005|Overall Study|Other|1|||
144309238|NCT00955474|520335738|FG000|Overall Study|Physician Decision|7|||
144309239|NCT00955474|520335739|FG001|Overall Study|Physician Decision|5|||
144309240|NCT02012218|520335743|FG000|Overall Study|Withdrawal by Subject|1|||
144309241|NCT02012218|520335744|FG001|Overall Study|Withdrawal by Subject|0|||
144309242|NCT02012218|520335745|FG002|Overall Study|Withdrawal by Subject|1|||
144309243|NCT02012218|520335746|FG003|Overall Study|Withdrawal by Subject|1|||
144309244|NCT02012218|520335747|FG004|Overall Study|Withdrawal by Subject|1|||
144309245|NCT02012218|520335743|FG000|Overall Study|Adverse Event|1|||
144309246|NCT02012218|520335744|FG001|Overall Study|Adverse Event|0|||
144309247|NCT02012218|520335745|FG002|Overall Study|Adverse Event|0|||
144309248|NCT02012218|520335746|FG003|Overall Study|Adverse Event|1|||
144309249|NCT02012218|520335747|FG004|Overall Study|Adverse Event|0|||
144309250|NCT02012218|520335743|FG000|Overall Study|Lost to Follow-up|0|||
144309251|NCT02012218|520335744|FG001|Overall Study|Lost to Follow-up|1|||
144309252|NCT02012218|520335745|FG002|Overall Study|Lost to Follow-up|1|||
144309253|NCT02012218|520335746|FG003|Overall Study|Lost to Follow-up|0|||
144309254|NCT02012218|520335747|FG004|Overall Study|Lost to Follow-up|0|||
144309255|NCT02012218|520335743|FG000|Overall Study|Protocol Specified|1|||
144309256|NCT02012218|520335744|FG001|Overall Study|Protocol Specified|0|||
144309257|NCT02012218|520335745|FG002|Overall Study|Protocol Specified|0|||
144309258|NCT02012218|520335746|FG003|Overall Study|Protocol Specified|0|||
144309259|NCT02012218|520335747|FG004|Overall Study|Protocol Specified|0|||
144309260|NCT02012218|520335743|FG000|Overall Study|Protocol Deviation|1|||
144309261|NCT02012218|520335744|FG001|Overall Study|Protocol Deviation|0|||
144309262|NCT02012218|520335745|FG002|Overall Study|Protocol Deviation|0|||
144309263|NCT02012218|520335746|FG003|Overall Study|Protocol Deviation|0|||
144309264|NCT02012218|520335747|FG004|Overall Study|Protocol Deviation|0|||
144309265|NCT04872569|520335748|FG000|Overall Study|Withdrawal by Subject|2|||
144309266|NCT02382991|520335749|FG000|Overall Study|Adverse Event|1|||
144309267|NCT02382991|520335750|FG001|Overall Study|Adverse Event|2|||
144309268|NCT02382991|520335749|FG000|Overall Study|Lost to Follow-up|1|||
144309269|NCT02382991|520335750|FG001|Overall Study|Lost to Follow-up|0|||
144309270|NCT02382991|520335749|FG000|Overall Study|Withdrawal by Subject|0|||
144309271|NCT02382991|520335750|FG001|Overall Study|Withdrawal by Subject|1|||
144309272|NCT03382912|520335754|FG000|Overall Study|Physician Decision|0|||
144309273|NCT03382912|520335755|FG001|Overall Study|Physician Decision|1|||
144309274|NCT03382912|520335754|FG000|Overall Study|Sponsor Decision|6|||
144309275|NCT03382912|520335755|FG001|Overall Study|Sponsor Decision|6|||
144309276|NCT03382912|520335754|FG000|Overall Study|Withdrawal by Subject|0|||
144309277|NCT03382912|520335755|FG001|Overall Study|Withdrawal by Subject|5|||
144309278|NCT00326001|520335756|FG000|Overall Study|Adverse Event|4|||
144309279|NCT00326001|520335757|FG001|Overall Study|Adverse Event|5|||
144309280|NCT00326001|520335756|FG000|Overall Study|Physician Decision|3|||
144309281|NCT00326001|520335757|FG001|Overall Study|Physician Decision|3|||
144309282|NCT03265145|520335758|FG000|Overall Study|Protocol Violation|2|||
144309283|NCT03265145|520335759|FG001|Overall Study|Protocol Violation|0|||
144309284|NCT03265145|520335758|FG000|Overall Study|Adverse Event|1|||
144309285|NCT03265145|520335759|FG001|Overall Study|Adverse Event|0|||
144309286|NCT03265145|520335758|FG000|Overall Study|Withdrawal by Subject|23|||
144309287|NCT03265145|520335759|FG001|Overall Study|Withdrawal by Subject|19|||
144309288|NCT03265145|520335758|FG000|Overall Study|Death|12|||
144309289|NCT03265145|520335759|FG001|Overall Study|Death|12|||
144309290|NCT03265145|520335758|FG000|Overall Study|Lost to Follow-up|13|||
144309291|NCT03265145|520335759|FG001|Overall Study|Lost to Follow-up|9|||
144309292|NCT03265145|520335758|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
144309293|NCT03265145|520335759|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
144309294|NCT03265145|520335758|FG000|Overall Study|Switched back to previous medication|1|||
144309295|NCT03265145|520335759|FG001|Overall Study|Switched back to previous medication|0|||
144309296|NCT03265145|520335758|FG000|Overall Study|Did not want to take medication|1|||
144309297|NCT03265145|520335759|FG001|Overall Study|Did not want to take medication|0|||
144309298|NCT03265145|520335758|FG000|Overall Study|Subject could not afford medication|0|||
144309299|NCT03265145|520335759|FG001|Overall Study|Subject could not afford medication|1|||
144309300|NCT03265145|520335758|FG000|Overall Study|Site closed|2|||
144309301|NCT03265145|520335759|FG001|Overall Study|Site closed|3|||
144309302|NCT03265145|520335758|FG000|Overall Study|Incorrectly randomized|16|||
144309303|NCT03265145|520335759|FG001|Overall Study|Incorrectly randomized|6|||
144309304|NCT03265145|520335758|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
144309305|NCT03265145|520335759|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
144309306|NCT03265145|520335758|FG000|Overall Study|Physician Decision|0|||
144309307|NCT03265145|520335759|FG001|Overall Study|Physician Decision|3|||
144309308|NCT03265145|520335758|FG000|Overall Study|Subject transferred to another facility|0|||
144309309|NCT03265145|520335759|FG001|Overall Study|Subject transferred to another facility|1|||
144309310|NCT05005273|520335760|FG000|Overall Study|Study Terminated|1|||
144309311|NCT05005273|520335761|FG001|Overall Study|Study Terminated|0|||
144309312|NCT04409834|520335762|FG000|Overall Study|Death|55|||
144309313|NCT04409834|520335763|FG001|Overall Study|Death|62|||
144309314|NCT02112656|520335764|FG000|Overall Study|Death|78|||
144309315|NCT02112656|520335765|FG001|Overall Study|Death|82|||
144309316|NCT02112656|520335764|FG000|Overall Study|Withdrawal by Subject|9|||
144309317|NCT02112656|520335765|FG001|Overall Study|Withdrawal by Subject|11|||
144309318|NCT02112656|520335764|FG000|Overall Study|Lost to Follow-up|2|||
144309319|NCT02112656|520335765|FG001|Overall Study|Lost to Follow-up|4|||
144309320|NCT02112656|520335764|FG000|Overall Study|Noncompliance|1|||
144309321|NCT02112656|520335765|FG001|Overall Study|Noncompliance|2|||
144309322|NCT03941483|520335766|FG000|Overall Study|Miscellaneous|2|||
144309323|NCT03941483|520335767|FG001|Overall Study|Miscellaneous|3|||
144309324|NCT03941483|520335768|FG002|Overall Study|Miscellaneous|0|||
144309325|NCT03941483|520335766|FG000|Overall Study|Study Terminated by Sponsor|1|||
144309326|NCT03941483|520335767|FG001|Overall Study|Study Terminated by Sponsor|0|||
144309327|NCT03941483|520335768|FG002|Overall Study|Study Terminated by Sponsor|0|||
144309328|NCT03941483|520335766|FG000|Overall Study|Withdrawal by Subject|1|||
144309329|NCT03941483|520335767|FG001|Overall Study|Withdrawal by Subject|4|||
144309330|NCT03941483|520335768|FG002|Overall Study|Withdrawal by Subject|1|||
144309331|NCT03941483|520335766|FG000|Overall Study|Lost to Follow-up|2|||
144309332|NCT03941483|520335767|FG001|Overall Study|Lost to Follow-up|1|||
144309333|NCT03941483|520335768|FG002|Overall Study|Lost to Follow-up|8|||
144309334|NCT03941483|520335766|FG000|Overall Study|Death|3|||
144309335|NCT03941483|520335767|FG001|Overall Study|Death|2|||
144309336|NCT03941483|520335768|FG002|Overall Study|Death|6|||
144309337|NCT03154476|520335769|FG000|Overall Study|Lost to Follow-up|4|||
144309338|NCT03154476|520335770|FG001|Overall Study|Lost to Follow-up|4|||
144309339|NCT03816176|520335771|FG000|Overall Study|Miscellaneous|5|||
144309340|NCT03816176|520335771|FG000|Overall Study|Lack of Efficacy|4|||
144309341|NCT03816176|520335771|FG000|Overall Study|Adverse Event|3|||
144309342|NCT03692403|520337796|FG000|Overall Study|Withdrawal by Subject|1|||
144309343|NCT03692403|520337797|FG001|Overall Study|Withdrawal by Subject|0|||
144309344|NCT03692403|520337798|FG002|Overall Study|Withdrawal by Subject|1|||
144309345|NCT03692403|520337799|FG003|Overall Study|Withdrawal by Subject|0|||
144309346|NCT03692403|520337796|FG000|Overall Study|Adverse Event|0|||
144309347|NCT03692403|520337797|FG001|Overall Study|Adverse Event|0|||
144309348|NCT03692403|520337798|FG002|Overall Study|Adverse Event|0|||
144309349|NCT03692403|520337799|FG003|Overall Study|Adverse Event|1|||
144309350|NCT03692403|520337796|FG000|Overall Study|Pregnancy|0|||
144309351|NCT03692403|520337797|FG001|Overall Study|Pregnancy|1|||
144309352|NCT03692403|520337798|FG002|Overall Study|Pregnancy|0|||
144309353|NCT03692403|520337799|FG003|Overall Study|Pregnancy|0|||
144309354|NCT03692403|520337796|FG000|Overall Study|Other|0|||
144309355|NCT03692403|520337797|FG001|Overall Study|Other|0|||
144309356|NCT03692403|520337798|FG002|Overall Study|Other|1|||
144309357|NCT03692403|520337799|FG003|Overall Study|Other|0|||
144309358|NCT01306643|520337800|FG000|Overall Study|Adverse Event|5|||
144309359|NCT01306643|520337800|FG000|Overall Study|Disease Progression|7|||
144309360|NCT01306643|520337800|FG000|Overall Study|Other: Change in Eligibility Status|1|||
144309361|NCT02479880|520337807|FG000|Overall Study|Study Terminated by Sponsor|13|||
144309362|NCT02479880|520337808|FG001|Overall Study|Study Terminated by Sponsor|12|||
144309363|NCT02479880|520337807|FG000|Overall Study|Pregnancy|0|||
144309364|NCT02479880|520337808|FG001|Overall Study|Pregnancy|1|||
144309365|NCT00355368|520337809|FG000|Overall Study|Protocol Violation|8|||
144309366|NCT00355368|520337810|FG001|Overall Study|Protocol Violation|7|||
144309367|NCT00355368|520337809|FG000|Overall Study|cardiac arrest prior to intubation|2|||
144309368|NCT00355368|520337810|FG001|Overall Study|cardiac arrest prior to intubation|2|||
144309369|NCT01349673|520337811|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
144309370|NCT01349673|520337811|FG000|Overall Study|No Longer Qualified For Study|1|||
144309371|NCT01349673|520337811|FG000|Overall Study|Site Closure|10|||
144309372|NCT01349673|520337811|FG000|Overall Study|Withdrawal by Subject|21|||
144309373|NCT01349673|520337811|FG000|Overall Study|Lost to Follow-up|6|||
144309374|NCT01349673|520337811|FG000|Overall Study|Adverse Event|17|||
144309375|NCT01349673|520337811|FG000|Overall Study|Study Terminated By Sponsor|50|||
144309376|NCT01349673|520337811|FG000|Overall Study|Lack of Efficacy|8|||
144309377|NCT01665911|520337814|FG000|Overall Study|Protocol Violation|4|||
144309378|NCT01665911|520337814|FG000|Overall Study|Withdrawal by Subject|1|||
144309379|NCT01665911|520337814|FG000|Overall Study|Adverse Event|1|||
144309380|NCT03801928|520337815|FG000|Overall Study|Adverse Event|1|||
144309381|NCT03801928|520337816|FG001|Overall Study|Adverse Event|0|||
144309382|NCT03801928|520337817|FG002|Overall Study|Adverse Event|1|||
144309383|NCT03801928|520337818|FG003|Overall Study|Adverse Event|2|||
144309384|NCT03801928|520337819|FG004|Overall Study|Adverse Event|0|||
144309385|NCT03801928|520337820|FG005|Overall Study|Adverse Event|2|||
144309386|NCT03801928|520337815|FG000|Overall Study|Lack of Efficacy|0|||
144309387|NCT03801928|520337816|FG001|Overall Study|Lack of Efficacy|0|||
144309388|NCT03801928|520337817|FG002|Overall Study|Lack of Efficacy|1|||
144309389|NCT03801928|520337818|FG003|Overall Study|Lack of Efficacy|0|||
144309390|NCT03801928|520337819|FG004|Overall Study|Lack of Efficacy|0|||
144309391|NCT03801928|520337820|FG005|Overall Study|Lack of Efficacy|0|||
144309392|NCT03801928|520337815|FG000|Overall Study|Lost to Follow-up|5|||
144309393|NCT03801928|520337816|FG001|Overall Study|Lost to Follow-up|1|||
144309394|NCT03801928|520337817|FG002|Overall Study|Lost to Follow-up|1|||
144309395|NCT03801928|520337818|FG003|Overall Study|Lost to Follow-up|4|||
144309396|NCT03801928|520337819|FG004|Overall Study|Lost to Follow-up|4|||
144309397|NCT03801928|520337820|FG005|Overall Study|Lost to Follow-up|2|||
144309398|NCT03801928|520337815|FG000|Overall Study|Withdrawal by Subject|0|||
144309399|NCT03801928|520337816|FG001|Overall Study|Withdrawal by Subject|0|||
144309400|NCT03801928|520337817|FG002|Overall Study|Withdrawal by Subject|2|||
144309401|NCT03801928|520337818|FG003|Overall Study|Withdrawal by Subject|1|||
144309402|NCT03801928|520337819|FG004|Overall Study|Withdrawal by Subject|0|||
144309403|NCT03801928|520337820|FG005|Overall Study|Withdrawal by Subject|0|||
144309404|NCT03801928|520337815|FG000|Overall Study|Other|0|||
144309405|NCT03801928|520337816|FG001|Overall Study|Other|2|||
144309406|NCT03801928|520337817|FG002|Overall Study|Other|0|||
144309407|NCT03801928|520337818|FG003|Overall Study|Other|1|||
144309408|NCT03801928|520337819|FG004|Overall Study|Other|0|||
144309409|NCT03801928|520337820|FG005|Overall Study|Other|1|||
144309410|NCT02370368|520337823|FG000|Overall Study|Adverse Event|1|||
144309411|NCT02370368|520337824|FG001|Overall Study|Adverse Event|2|||
144309412|NCT02370368|520337823|FG000|Overall Study|Withdrawal by Subject|5|||
144309413|NCT02370368|520337824|FG001|Overall Study|Withdrawal by Subject|4|||
144309414|NCT01724216|520337829|FG000|Overall Study|Scan was not completed|1|||
144309415|NCT00564733|520337830|FG000|Overall Study|Withdrawal by Subject|4|||
144309416|NCT00564733|520337830|FG000|Overall Study|Ineligible|5|||
144309417|NCT02688192|520337834|FG000|Overall Study|Lost to Follow-up|11|||
144309418|NCT02688192|520337835|FG001|Overall Study|Lost to Follow-up|5|||
144309419|NCT02688192|520337834|FG000|Overall Study|Physician Decision|1|||
144309420|NCT02688192|520337835|FG001|Overall Study|Physician Decision|0|||
144309421|NCT00075764|520337836|FG000|Overall Study|Adverse Event|5|||
144309422|NCT00075764|520337837|FG001|Overall Study|Adverse Event|12|||
144309423|NCT00075764|520337836|FG000|Overall Study|Death|4|||
144309424|NCT00075764|520337837|FG001|Overall Study|Death|8|||
144309425|NCT00075764|520337836|FG000|Overall Study|Withdrawal by Subject|28|||
144309426|NCT00075764|520337837|FG001|Overall Study|Withdrawal by Subject|18|||
144309427|NCT00075764|520337836|FG000|Overall Study|Progression|269|||
144309428|NCT00075764|520337837|FG001|Overall Study|Progression|274|||
144309429|NCT00075764|520337836|FG000|Overall Study|Still on treatment|8|||
144309430|NCT00075764|520337837|FG001|Overall Study|Still on treatment|15|||
144309431|NCT00075764|520337836|FG000|Overall Study|Delinquent|4|||
144309432|NCT00075764|520337837|FG001|Overall Study|Delinquent|2|||
144309433|NCT00075764|520337836|FG000|Overall Study|Not protocol specified|27|||
144309434|NCT00075764|520337837|FG001|Overall Study|Not protocol specified|19|||
144309435|NCT00075764|520337836|FG000|Overall Study|Under review|0|||
144309436|NCT00075764|520337837|FG001|Overall Study|Under review|1|||
144309437|NCT02817594|520337841|FG000|Overall Study|Withdrawal by Subject|1|||
144309438|NCT02817594|520337841|FG000|Overall Study|Other|1|||
144309439|NCT02817594|520337841|FG000|Overall Study|Did Not Receive Treatment|1|||
144309440|NCT02010593|520337842|FG000|Overall Study|Lost to Follow-up|1|||
144309441|NCT02010593|520337843|FG001|Overall Study|Lost to Follow-up|0|||
144309442|NCT02010593|520337842|FG000|Overall Study|Physician Decision|1|||
144309443|NCT02010593|520337843|FG001|Overall Study|Physician Decision|0|||
144309444|NCT02010593|520337842|FG000|Overall Study|Unable to adhere to visit schedule|0|||
144309445|NCT02010593|520337843|FG001|Overall Study|Unable to adhere to visit schedule|2|||
144309446|NCT01773967|520337844|FG000|Overall Study|Lost to Follow-up|15|||
144309447|NCT01773967|520337845|FG001|Overall Study|Lost to Follow-up|13|||
144309448|NCT01766037|520337846|FG000|Overall Study|Adverse Event|1|||
144309449|NCT01766037|520337847|FG001|Overall Study|Adverse Event|0|||
144309450|NCT01766037|520337846|FG000|Overall Study|Lack of Efficacy|1|||
144309451|NCT01766037|520337847|FG001|Overall Study|Lack of Efficacy|0|||
144309452|NCT01766037|520337846|FG000|Overall Study|Lost to Follow-up|0|||
144309453|NCT01766037|520337847|FG001|Overall Study|Lost to Follow-up|10|||
144309454|NCT01766037|520337846|FG000|Overall Study|Physician Decision|0|||
144309455|NCT01766037|520337847|FG001|Overall Study|Physician Decision|1|||
144309456|NCT01766037|520337846|FG000|Overall Study|Withdrawal by Subject|18|||
144309457|NCT01766037|520337847|FG001|Overall Study|Withdrawal by Subject|16|||
144309458|NCT01766037|520337846|FG000|Overall Study|Moved from area|5|||
144309459|NCT01766037|520337847|FG001|Overall Study|Moved from area|0|||
144309460|NCT01766037|520337846|FG000|Overall Study|medical - unrelated|1|||
144309461|NCT01766037|520337847|FG001|Overall Study|medical - unrelated|2|||
144309462|NCT01766037|520337846|FG000|Overall Study|nausea / discomfort|3|||
144309463|NCT01766037|520337847|FG001|Overall Study|nausea / discomfort|0|||
144309464|NCT00709319|520337850|FG000|Overall Study|Death|4|||
144309465|NCT00709319|520337850|FG000|Overall Study|Withdrawal by Subject|2|||
144309466|NCT00579553|520337854|FG000|Overall Study|Lost to Follow-up|16|||
144309467|NCT00579553|520337855|FG001|Overall Study|Lost to Follow-up|13|||
144309468|NCT00090779|520337856|FG000|Step 1|Withdrawal by Subject|4|||
144309469|NCT00090779|520337857|FG001|Step 1|Withdrawal by Subject|2|||
144309470|NCT00090779|520337856|FG000|Step 1|Lost to Follow-up|3|||
144309471|NCT00090779|520337857|FG001|Step 1|Lost to Follow-up|2|||
144309472|NCT00090779|520337856|FG000|Step 1|Death|0|||
144309473|NCT00090779|520337857|FG001|Step 1|Death|2|||
144309474|NCT00090779|520337856|FG000|Step 1|Physician Decision|1|||
144309475|NCT00090779|520337857|FG001|Step 1|Physician Decision|0|||
144309476|NCT00090779|520337856|FG000|Step 1|Pregnancy|1|||
144309477|NCT00090779|520337857|FG001|Step 1|Pregnancy|0|||
144309478|NCT00090779|520337856|FG000|Step 1|Non-compliance to study requirements|0|||
144309479|NCT00090779|520337857|FG001|Step 1|Non-compliance to study requirements|1|||
144309480|NCT00090779|520337856|FG000|Step 1|Subject relocated|2|||
144309481|NCT00090779|520337857|FG001|Step 1|Subject relocated|8|||
144309482|NCT00090779|520337856|FG000|Step 2|Off study per study closure|6|||
144309483|NCT00090779|520337857|FG001|Step 2|Off study per study closure|16|||
144309484|NCT00090779|520337856|FG000|Step 2|Subject relocated|0|||
144309485|NCT00090779|520337857|FG001|Step 2|Subject relocated|1|||
144309486|NCT00090779|520337856|FG000|Step 2|Non-compliance to study requirements|0|||
144309487|NCT00090779|520337857|FG001|Step 2|Non-compliance to study requirements|1|||
144309488|NCT00090779|520337856|FG000|Step 3|Initiation of ART and off extended study|3|||
144309489|NCT00090779|520337857|FG001|Step 3|Initiation of ART and off extended study|2|||
144309490|NCT00090779|520337856|FG000|Step 3|Off extended study due to study closure|4|||
144309491|NCT00090779|520337857|FG001|Step 3|Off extended study due to study closure|3|||
144309492|NCT04860869|520337864|FG000|Overall Study|Withdrawal by Subject|1|||
144309493|NCT04860869|520337865|FG001|Overall Study|Withdrawal by Subject|0|||
144309494|NCT03748641|520337866|FG000|Overall Study|Ongoing|155|||
144309495|NCT03748641|520337867|FG001|Overall Study|Ongoing|148|||
144309496|NCT03748641|520337868|FG002|Overall Study|Ongoing|66|||
144309497|NCT03748641|520337869|FG003|Overall Study|Ongoing|79|||
144309498|NCT03748641|520337870|FG004|Overall Study|Ongoing|84|||
144309499|NCT03748641|520337866|FG000|Overall Study|Death|54|||
144309500|NCT03748641|520337867|FG001|Overall Study|Death|59|||
144309501|NCT03748641|520337868|FG002|Overall Study|Death|51|||
144309502|NCT03748641|520337869|FG003|Overall Study|Death|42|||
144309503|NCT03748641|520337870|FG004|Overall Study|Death|9|||
144309504|NCT03748641|520337866|FG000|Overall Study|Lost to Follow-up|0|||
144309505|NCT03748641|520337867|FG001|Overall Study|Lost to Follow-up|2|||
144309506|NCT03748641|520337868|FG002|Overall Study|Lost to Follow-up|1|||
144309507|NCT03748641|520337869|FG003|Overall Study|Lost to Follow-up|0|||
144309508|NCT03748641|520337870|FG004|Overall Study|Lost to Follow-up|0|||
144309509|NCT03748641|520337866|FG000|Overall Study|Withdrawal by Subject|3|||
144309510|NCT03748641|520337867|FG001|Overall Study|Withdrawal by Subject|2|||
144309511|NCT03748641|520337868|FG002|Overall Study|Withdrawal by Subject|5|||
144309512|NCT03748641|520337869|FG003|Overall Study|Withdrawal by Subject|3|||
144309513|NCT03748641|520337870|FG004|Overall Study|Withdrawal by Subject|2|||
144309514|NCT04834726|520337871|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
144309515|NCT04834726|520337872|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
144309516|NCT04834726|520337873|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
144309517|NCT04834726|520337874|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
144309518|NCT04834726|520337875|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
144309519|NCT04834726|520337876|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
144309520|NCT04834726|520337877|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
144309521|NCT04834726|520337878|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
144309522|NCT04834726|520337879|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
144309523|NCT01151020|520337882|FG000|Overall Study|Death|25|||
144309524|NCT01151020|520337882|FG000|Overall Study|Conversion to open repair|1|||
144309525|NCT01151020|520337882|FG000|Overall Study|Lost to Follow-up|4|||
144309526|NCT01151020|520337882|FG000|Overall Study|Withdrawal by Subject|22|||
144309527|NCT01151020|520337882|FG000|Overall Study|Patients did not receive the device|2|||
144309528|NCT03606486|520337883|FG000|Overall Study|Unable to collect sample|5|||
144309529|NCT01737762|520337890|FG000|Overall Study|Adverse Event|2|||
144309530|NCT01737762|520337891|FG001|Overall Study|Adverse Event|2|||
144309531|NCT01737762|520337890|FG000|Overall Study|Lost to Follow-up|1|||
144309532|NCT01737762|520337891|FG001|Overall Study|Lost to Follow-up|0|||
144309533|NCT01737762|520337890|FG000|Overall Study|Withdrawal by Subject|2|||
144309534|NCT01737762|520337891|FG001|Overall Study|Withdrawal by Subject|2|||
144309535|NCT01737762|520337890|FG000|Overall Study|Progressive disease|1|||
144309536|NCT01737762|520337891|FG001|Overall Study|Progressive disease|2|||
144309537|NCT01737762|520337890|FG000|Overall Study|Physician Decision|1|||
144309538|NCT01737762|520337891|FG001|Overall Study|Physician Decision|1|||
144309539|NCT01737762|520337890|FG000|Overall Study|Moved from area|2|||
144309540|NCT01737762|520337891|FG001|Overall Study|Moved from area|1|||
144309541|NCT01737762|520337890|FG000|Overall Study|Trial termination|11|||
144309542|NCT01737762|520337891|FG001|Overall Study|Trial termination|9|||
144309543|NCT02148263|520337892|FG000|Overall Study|Withdrawal by Subject|3|||
144309544|NCT02148263|520337893|FG001|Overall Study|Withdrawal by Subject|2|||
144309545|NCT00503425|520337894|FG000|Overall Study|Participant files lost|6|||
144309546|NCT00503425|520337894|FG000|Overall Study|Adverse Event|5|||
144309547|NCT00503425|520337894|FG000|Overall Study|Lack of Efficacy|25|||
144309548|NCT00503425|520337894|FG000|Overall Study|Withdrawal by Subject|8|||
144309549|NCT00503425|520337894|FG000|Overall Study|Lost to Follow-up|3|||
144309550|NCT00503425|520337894|FG000|Overall Study|Death|3|||
144309551|NCT00503425|520337894|FG000|Overall Study|Missing Data/Unknown|4|||
144309552|NCT02503085|520337895|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
144309553|NCT02503085|520337896|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
144309554|NCT02503085|520337897|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
144309555|NCT02503085|520337898|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
144309556|NCT01144416|520337902|FG000|Intervention Period|Adverse Event|5|||
144309557|NCT01144416|520337903|FG001|Intervention Period|Adverse Event|6|||
144309558|NCT01144416|520337902|FG000|Intervention Period|Insufficient ovarian response|11|||
144309559|NCT01144416|520337903|FG001|Intervention Period|Insufficient ovarian response|17|||
144309560|NCT01144416|520337902|FG000|Intervention Period|Risk of OHSS|0|||
144309561|NCT01144416|520337903|FG001|Intervention Period|Risk of OHSS|1|||
144309562|NCT01144416|520337902|FG000|Intervention Period|Too high ovarian response|4|||
144309563|NCT01144416|520337903|FG001|Intervention Period|Too high ovarian response|2|||
144309564|NCT01144416|520337902|FG000|Intervention Period|No/too few/bad oocytes|7|||
144309565|NCT01144416|520337903|FG001|Intervention Period|No/too few/bad oocytes|5|||
144309566|NCT01144416|520337902|FG000|Intervention Period|No or abnormal fertilization|25|||
144309567|NCT01144416|520337903|FG001|Intervention Period|No or abnormal fertilization|10|||
144309568|NCT01144416|520337902|FG000|Intervention Period|No/too few/bad quality embryos|3|||
144309569|NCT01144416|520337903|FG001|Intervention Period|No/too few/bad quality embryos|3|||
144309570|NCT01144416|520337902|FG000|Intervention Period|Other|7|||
144309571|NCT01144416|520337903|FG001|Intervention Period|Other|5|||
144309572|NCT02534883|520337904|FG000|Overall Study|Early Termination|8|||
144309573|NCT02534883|520337905|FG001|Overall Study|Early Termination|3|||
144309574|NCT03328832|520337906|FG000|Overall Study|Lost to Follow-up|0|||
144309575|NCT03328832|520337907|FG001|Overall Study|Lost to Follow-up|1|||
144309576|NCT04417257|520337908|FG000|Pilot Phase 2|Adverse Event|2|||
144309577|NCT04417257|520337909|FG001|Pilot Phase 2|Adverse Event|0|||
144309578|NCT04417257|520337908|FG000|Pilot Phase 2|Death|14|||
144309579|NCT04417257|520337909|FG001|Pilot Phase 2|Death|11|||
144309580|NCT04417257|520337908|FG000|Pilot Phase 2|Lost to Follow-up|3|||
144309581|NCT04417257|520337909|FG001|Pilot Phase 2|Lost to Follow-up|5|||
144309582|NCT04417257|520337908|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
144309583|NCT04417257|520337909|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
144309584|NCT04417257|520337908|FG000|Pilot Phase 2|Hepatic impairment|1|||
144309585|NCT04417257|520337909|FG001|Pilot Phase 2|Hepatic impairment|0|||
144309586|NCT04417257|520337908|FG000|Pilot Phase 2|Unblinding|1|||
144309587|NCT04417257|520337909|FG001|Pilot Phase 2|Unblinding|0|||
144309588|NCT04417257|520337908|FG000|Pilot Phase 2|All other|0|||
144309589|NCT04417257|520337909|FG001|Pilot Phase 2|All other|2|||
144309590|NCT04417257|520337908|FG000|Phase 3 Extension|Death|3|||
144309591|NCT04417257|520337909|FG001|Phase 3 Extension|Death|1|||
144309592|NCT04417257|520337908|FG000|Phase 3 Extension|Lost to Follow-up|4|||
144309593|NCT04417257|520337909|FG001|Phase 3 Extension|Lost to Follow-up|2|||
144309594|NCT04417257|520337908|FG000|Phase 3 Extension|Patient withdrawal|2|||
144309595|NCT04417257|520337909|FG001|Phase 3 Extension|Patient withdrawal|2|||
144309596|NCT04417257|520337908|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
144309597|NCT04417257|520337909|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
144309598|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
144309599|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
144309600|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
144309601|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
144309602|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
144309603|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
144309604|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
144309605|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
144309606|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
144309607|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
144309608|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
144309609|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
144309610|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
144309611|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
144309612|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
144309613|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
144309614|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
144309615|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
144309616|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
144309617|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
144309618|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
144309619|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
144309620|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
144309621|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
144309622|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
144309623|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
144309624|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
144309625|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
144309626|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
144309627|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
144309628|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
144309629|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
144309630|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
144309631|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
144309632|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
144309633|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
144309634|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
144309635|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
144309636|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
144309637|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
144309638|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
144309639|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
144309640|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
144309641|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
144309642|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
144309643|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
144309644|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
144309645|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
144309646|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
144309647|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
144309648|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
144309649|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
144309650|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
144309651|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
144309652|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
144309653|NCT04951622|520337910|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
144309654|NCT04951622|520337911|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
144309655|NCT04951622|520337912|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
144309656|NCT04951622|520337913|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
144309657|NCT04951622|520337914|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
144309658|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
144309659|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
144309660|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
144309661|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
144309662|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
144309663|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
144309664|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
144309665|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
144309666|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
144309667|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
144309668|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
144309669|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
144309670|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
144309671|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
144309672|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
144309673|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
144309674|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
144309675|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
144309676|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
144309677|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
144309678|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
144309679|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
144309680|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
144309681|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
144309682|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
144309683|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
144309684|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
144309685|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
144309686|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
144309687|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
144309688|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
144309689|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
144309690|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
144309691|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
144309692|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
144309693|NCT04951622|520337910|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
144309694|NCT04951622|520337911|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
144309695|NCT04951622|520337912|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
144309696|NCT04951622|520337913|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
144309697|NCT04951622|520337914|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
144309698|NCT00943761|520337919|FG000|Overall Study|Lost to Follow-up|2|||
144309699|NCT00943761|520337920|FG001|Overall Study|Lost to Follow-up|0|||
144309700|NCT00943761|520337919|FG000|Overall Study|Withdrawal by Subject|2|||
144309701|NCT00943761|520337920|FG001|Overall Study|Withdrawal by Subject|1|||
144309702|NCT00714948|520337921|FG000|Overall Study|Adverse Event|2|||
144309703|NCT02708680|520337924|FG000|Overall Study|Withdrawal by Subject|4|||
144309704|NCT02708680|520337925|FG001|Overall Study|Withdrawal by Subject|12|||
144309705|NCT02708680|520337926|FG002|Overall Study|Withdrawal by Subject|12|||
144309706|NCT02708680|520337924|FG000|Overall Study|Death|4|||
144309707|NCT02708680|520337925|FG001|Overall Study|Death|19|||
144309708|NCT02708680|520337926|FG002|Overall Study|Death|21|||
144309709|NCT02708680|520337924|FG000|Overall Study|Lost to Follow-up|0|||
144309710|NCT02708680|520337925|FG001|Overall Study|Lost to Follow-up|3|||
144309711|NCT02708680|520337926|FG002|Overall Study|Lost to Follow-up|3|||
144309712|NCT02708680|520337924|FG000|Overall Study|Study Terminated By Sponsor|0|||
144309713|NCT02708680|520337925|FG001|Overall Study|Study Terminated By Sponsor|5|||
144309714|NCT02708680|520337926|FG002|Overall Study|Study Terminated By Sponsor|4|||
144309715|NCT02708680|520337924|FG000|Overall Study|Other than Specified|0|||
144309716|NCT02708680|520337925|FG001|Overall Study|Other than Specified|0|||
144309717|NCT02708680|520337926|FG002|Overall Study|Other than Specified|1|||
144309718|NCT02708680|520337924|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
144309719|NCT02708680|520337925|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
144309720|NCT02708680|520337926|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
144309721|NCT01342926|520337927|FG000|Overall Study|Adverse Event|5|||
144309722|NCT01342926|520337928|FG001|Overall Study|Adverse Event|8|||
144309723|NCT01342926|520337929|FG002|Overall Study|Adverse Event|10|||
144309724|NCT01342926|520337930|FG003|Overall Study|Adverse Event|7|||
144309725|NCT01342926|520337927|FG000|Overall Study|Lost to Follow-up|0|||
144309726|NCT01342926|520337928|FG001|Overall Study|Lost to Follow-up|1|||
144309727|NCT01342926|520337929|FG002|Overall Study|Lost to Follow-up|1|||
144309728|NCT01342926|520337930|FG003|Overall Study|Lost to Follow-up|0|||
144309729|NCT01342926|520337927|FG000|Overall Study|Investigator Discretion|2|||
144309730|NCT01342926|520337928|FG001|Overall Study|Investigator Discretion|2|||
144309731|NCT01342926|520337929|FG002|Overall Study|Investigator Discretion|0|||
144309732|NCT01342926|520337930|FG003|Overall Study|Investigator Discretion|0|||
144309733|NCT01342926|520337927|FG000|Overall Study|Withdrawal by Subject|2|||
144309734|NCT01342926|520337928|FG001|Overall Study|Withdrawal by Subject|4|||
144309735|NCT01342926|520337929|FG002|Overall Study|Withdrawal by Subject|3|||
144309736|NCT01342926|520337930|FG003|Overall Study|Withdrawal by Subject|5|||
144309737|NCT03654274|520337933|FG000|Overall Study|Adverse Event|19|||
144309738|NCT03654274|520337934|FG001|Overall Study|Adverse Event|23|||
144309739|NCT03654274|520337935|FG002|Overall Study|Adverse Event|24|||
144309740|NCT03654274|520337933|FG000|Overall Study|Protocol Deviation|0|||
144309741|NCT03654274|520337934|FG001|Overall Study|Protocol Deviation|2|||
144309742|NCT03654274|520337935|FG002|Overall Study|Protocol Deviation|0|||
144309743|NCT03654274|520337933|FG000|Overall Study|Lost to Follow-up|8|||
144309744|NCT03654274|520337934|FG001|Overall Study|Lost to Follow-up|6|||
144309745|NCT03654274|520337935|FG002|Overall Study|Lost to Follow-up|5|||
144309746|NCT03654274|520337933|FG000|Overall Study|Withdrawal by Subject|46|||
144309747|NCT03654274|520337934|FG001|Overall Study|Withdrawal by Subject|25|||
144309748|NCT03654274|520337935|FG002|Overall Study|Withdrawal by Subject|33|||
144309749|NCT03654274|520337933|FG000|Overall Study|Lack of Efficacy|4|||
144309750|NCT03654274|520337934|FG001|Overall Study|Lack of Efficacy|5|||
144309751|NCT03654274|520337935|FG002|Overall Study|Lack of Efficacy|7|||
144309752|NCT03654274|520337933|FG000|Overall Study|Pregnancy|2|||
144309753|NCT03654274|520337934|FG001|Overall Study|Pregnancy|2|||
144309754|NCT03654274|520337935|FG002|Overall Study|Pregnancy|1|||
144309755|NCT03654274|520337933|FG000|Overall Study|Other|27|||
144309756|NCT03654274|520337934|FG001|Overall Study|Other|29|||
144309757|NCT03654274|520337935|FG002|Overall Study|Other|32|||
144309758|NCT03654274|520337933|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
144309759|NCT03654274|520337934|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
144309760|NCT03654274|520337935|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
144309761|NCT01102491|520337938|FG000|Overall Study|Protocol Violation|11|||
144309762|NCT01102491|520337939|FG001|Overall Study|Protocol Violation|12|||
144309763|NCT01265992|520337940|FG000|Overall Study|Lost to Follow-up|1|||
144309764|NCT01265992|520337940|FG000|Overall Study|Withdrawal by Subject|1|||
144309765|NCT01265992|520337940|FG000|Overall Study|Adverse Event|1|||
144309766|NCT01265992|520337940|FG000|Overall Study|Administrative reasons|2|||
144309767|NCT01265992|520337940|FG000|Overall Study|Stopped treatment|3|||
144309768|NCT01265992|520337940|FG000|Overall Study|Did not receive treatment|1|||
144309769|NCT01837680|520337941|FG000|Overall Study|Lost to Follow-up|2|||
144309770|NCT01837680|520337942|FG001|Overall Study|Lost to Follow-up|2|||
144309771|NCT01837680|520337941|FG000|Overall Study|lack of insurance|0|||
144309772|NCT01837680|520337942|FG001|Overall Study|lack of insurance|2|||
144309773|NCT01837680|520337941|FG000|Overall Study|allergic reaction|6|||
144309774|NCT01837680|520337942|FG001|Overall Study|allergic reaction|0|||
144309775|NCT01837680|520337941|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
144309776|NCT01837680|520337942|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
144309777|NCT03008070|520337943|FG000|Overall Study|Adverse Event|3|||
144309778|NCT03008070|520337944|FG001|Overall Study|Adverse Event|3|||
144309779|NCT03008070|520337945|FG002|Overall Study|Adverse Event|3|||
144309780|NCT03008070|520337943|FG000|Overall Study|Lost to Follow-up|1|||
144309781|NCT03008070|520337944|FG001|Overall Study|Lost to Follow-up|1|||
144309782|NCT03008070|520337945|FG002|Overall Study|Lost to Follow-up|0|||
144309783|NCT03008070|520337943|FG000|Overall Study|Non compliance|0|||
144309784|NCT03008070|520337944|FG001|Overall Study|Non compliance|1|||
144309785|NCT03008070|520337945|FG002|Overall Study|Non compliance|1|||
144309786|NCT03008070|520337943|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
144309787|NCT03008070|520337944|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
144309788|NCT03008070|520337945|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
144309789|NCT03008070|520337943|FG000|Overall Study|Withdrawal by Subject|2|||
144309790|NCT03008070|520337944|FG001|Overall Study|Withdrawal by Subject|0|||
144309791|NCT03008070|520337945|FG002|Overall Study|Withdrawal by Subject|1|||
144309792|NCT03008070|520337943|FG000|Overall Study|Use of prohibited drug|0|||
144309793|NCT03008070|520337944|FG001|Overall Study|Use of prohibited drug|0|||
144309794|NCT03008070|520337945|FG002|Overall Study|Use of prohibited drug|2|||
144309795|NCT03960684|520337949|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
144309796|NCT02151786|520337950|FG000|Overall Study|Unavailability of Case Report Form|26|||
144309797|NCT02151786|520337950|FG000|Overall Study|Outside the Contract Period|1|||
144309798|NCT02151786|520337950|FG000|Overall Study|Randomized, not Treated|1|||
144309799|NCT02151786|520337950|FG000|Overall Study|Unavailability of Information|8|||
144309800|NCT03533660|520337951|FG000|Overall Study|Withdrawal by Subject|2|||
144309801|NCT03533660|520337952|FG001|Overall Study|Withdrawal by Subject|2|||
144309802|NCT03533660|520337951|FG000|Overall Study|Death|2|||
144309803|NCT03533660|520337952|FG001|Overall Study|Death|4|||
144309804|NCT03533660|520337951|FG000|Overall Study|Adverse Event|0|||
144309805|NCT03533660|520337952|FG001|Overall Study|Adverse Event|2|||
144309806|NCT03761056|520337956|FG000|Overall Study|Death|8|||
144309807|NCT03761056|520337956|FG000|Overall Study|Enrolled but never treated|2|||
144360018|NCT01601535|520525140|FG005|Phase 1|Started Another Treatment|0|||
144309808|NCT03761056|520337956|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
144309809|NCT03761056|520337956|FG000|Overall Study|Investigator decision|1|||
144309810|NCT00996658|520337957|FG000|Overall Study|Adverse Event|2|||
144309811|NCT00996658|520337958|FG001|Overall Study|Adverse Event|5|||
144309812|NCT00996658|520337957|FG000|Overall Study|Protocol Violation|0|||
144309813|NCT00996658|520337958|FG001|Overall Study|Protocol Violation|1|||
144309814|NCT00996658|520337957|FG000|Overall Study|Lost to Follow-up|2|||
144309815|NCT00996658|520337958|FG001|Overall Study|Lost to Follow-up|5|||
144309816|NCT00996658|520337957|FG000|Overall Study|Non-compliance issues|3|||
144309817|NCT00996658|520337958|FG001|Overall Study|Non-compliance issues|3|||
144309818|NCT00996658|520337957|FG000|Overall Study|Other|9|||
144309819|NCT00996658|520337958|FG001|Overall Study|Other|7|||
144309820|NCT02685826|520337961|FG000|Overall Study|Adverse Event|2|||
144309821|NCT02685826|520337962|FG001|Overall Study|Adverse Event|0|||
144309822|NCT02685826|520337963|FG002|Overall Study|Adverse Event|1|||
144309823|NCT02685826|520337961|FG000|Overall Study|Progressive Disease|2|||
144309824|NCT02685826|520337962|FG001|Overall Study|Progressive Disease|1|||
144309825|NCT02685826|520337963|FG002|Overall Study|Progressive Disease|0|||
144309826|NCT02685826|520337961|FG000|Overall Study|Withdrawal by Subject|2|||
144309827|NCT02685826|520337962|FG001|Overall Study|Withdrawal by Subject|0|||
144309828|NCT02685826|520337963|FG002|Overall Study|Withdrawal by Subject|0|||
144309829|NCT02685826|520337961|FG000|Overall Study|Full Clinical Hold by FDA|19|||
144309830|NCT02685826|520337962|FG001|Overall Study|Full Clinical Hold by FDA|9|||
144309831|NCT02685826|520337963|FG002|Overall Study|Full Clinical Hold by FDA|20|||
144309832|NCT04267926|520339432|FG000|Overall Study|abnormal labs. No longer eligible|0|||
144309833|NCT04267926|520339433|FG001|Overall Study|abnormal labs. No longer eligible|0|||
144309834|NCT04267926|520339434|FG002|Overall Study|abnormal labs. No longer eligible|1|||
144309835|NCT04267926|520339432|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
144309836|NCT04267926|520339433|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
144309837|NCT04267926|520339434|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
144309838|NCT00972023|520339437|FG000|Overall Study|Withdrawal by Subject|1|||
144309839|NCT02489318|520339438|FG000|Randomized|Withdrawal by Subject|0|||
144309840|NCT02489318|520339439|FG001|Randomized|Withdrawal by Subject|1|||
144309841|NCT02489318|520339438|FG000|Treated|Adverse Event|19|||
144309842|NCT02489318|520339439|FG001|Treated|Adverse Event|62|||
144309843|NCT02489318|520339438|FG000|Treated|Death|13|||
144309844|NCT02489318|520339439|FG001|Treated|Death|11|||
144309845|NCT02489318|520339438|FG000|Treated|Physician Decision|4|||
144309846|NCT02489318|520339439|FG001|Treated|Physician Decision|6|||
144309847|NCT02489318|520339438|FG000|Treated|Protocol Violation|1|||
144309848|NCT02489318|520339439|FG001|Treated|Protocol Violation|2|||
144309849|NCT02489318|520339438|FG000|Treated|Withdrawal by Subject|37|||
144309850|NCT02489318|520339439|FG001|Treated|Withdrawal by Subject|36|||
144309851|NCT02489318|520339438|FG000|Treated|Other: Progressive Disease|245|||
144309852|NCT02489318|520339439|FG001|Treated|Other: Progressive Disease|138|||
144309853|NCT02489318|520339438|FG000|Treated|Other|0|||
144309854|NCT02489318|520339439|FG001|Treated|Other|2|||
144309855|NCT02489318|520339438|FG000|Treated|Ongoing|0|||
144309856|NCT02489318|520339439|FG001|Treated|Ongoing|267|||
144309857|NCT02595879|520339440|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
144309858|NCT02595879|520339441|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
144309859|NCT05554146|520339442|FG000|Overall Study|Adverse Event|0|||
144309860|NCT05554146|520339443|FG001|Overall Study|Adverse Event|1|||
144309861|NCT05554146|520339444|FG002|Overall Study|Adverse Event|0|||
144309862|NCT05554146|520339445|FG003|Overall Study|Adverse Event|0|||
144309863|NCT05554146|520339442|FG000|Overall Study|Protocol Violation|0|||
144309864|NCT05554146|520339443|FG001|Overall Study|Protocol Violation|1|||
144309865|NCT05554146|520339444|FG002|Overall Study|Protocol Violation|0|||
144309866|NCT05554146|520339445|FG003|Overall Study|Protocol Violation|0|||
144309867|NCT05554146|520339442|FG000|Overall Study|No longer interested in participating|0|||
144309868|NCT05554146|520339443|FG001|Overall Study|No longer interested in participating|0|||
144309869|NCT05554146|520339444|FG002|Overall Study|No longer interested in participating|1|||
144309870|NCT05554146|520339445|FG003|Overall Study|No longer interested in participating|0|||
144309871|NCT05554146|520339442|FG000|Overall Study|Lost to Follow-up|1|||
144309872|NCT05554146|520339443|FG001|Overall Study|Lost to Follow-up|0|||
144309873|NCT05554146|520339444|FG002|Overall Study|Lost to Follow-up|0|||
144309874|NCT05554146|520339445|FG003|Overall Study|Lost to Follow-up|0|||
144309875|NCT04988295|520339446|FG000|Overall Study|Withdrawal by Subject|9|||
144309876|NCT04988295|520339447|FG001|Overall Study|Withdrawal by Subject|29|||
144309877|NCT04988295|520339448|FG002|Overall Study|Withdrawal by Subject|6|||
144309878|NCT04988295|520339449|FG003|Overall Study|Withdrawal by Subject|0|||
144309879|NCT04988295|520339446|FG000|Overall Study|Lost to Follow-up|1|||
144309880|NCT04988295|520339447|FG001|Overall Study|Lost to Follow-up|0|||
144309881|NCT04988295|520339448|FG002|Overall Study|Lost to Follow-up|0|||
144309882|NCT04988295|520339449|FG003|Overall Study|Lost to Follow-up|0|||
144309883|NCT04988295|520339446|FG000|Overall Study|Study participation ongoing|186|||
144309884|NCT04988295|520339447|FG001|Overall Study|Study participation ongoing|169|||
144309885|NCT04988295|520339448|FG002|Overall Study|Study participation ongoing|99|||
144309886|NCT04988295|520339449|FG003|Overall Study|Study participation ongoing|119|||
144309887|NCT02763059|520339456|FG000|Overall Study|Lost to Follow-up|4|||
144309888|NCT02763059|520339457|FG001|Overall Study|Lost to Follow-up|1|||
144309889|NCT02763059|520339458|FG002|Overall Study|Lost to Follow-up|6|||
144309890|NCT02763059|520339456|FG000|Overall Study|Withdrawal by Subject|1|||
144309891|NCT02763059|520339457|FG001|Overall Study|Withdrawal by Subject|0|||
144309892|NCT02763059|520339458|FG002|Overall Study|Withdrawal by Subject|3|||
144309893|NCT04024436|520339459|FG000|Overall Study|Death|10|||
144309894|NCT04024436|520339460|FG001|Overall Study|Death|14|||
144309895|NCT04024436|520339461|FG002|Overall Study|Death|2|||
144309896|NCT04024436|520339462|FG003|Overall Study|Death|7|||
144309897|NCT04024436|520339459|FG000|Overall Study|Loss to follow up|1|||
144309898|NCT04024436|520339460|FG001|Overall Study|Loss to follow up|0|||
144309899|NCT04024436|520339461|FG002|Overall Study|Loss to follow up|0|||
144309900|NCT04024436|520339462|FG003|Overall Study|Loss to follow up|1|||
144309901|NCT04024436|520339459|FG000|Overall Study|Withdrawal of consent|2|||
144309902|NCT04024436|520339460|FG001|Overall Study|Withdrawal of consent|0|||
144309903|NCT04024436|520339461|FG002|Overall Study|Withdrawal of consent|0|||
144309904|NCT04024436|520339462|FG003|Overall Study|Withdrawal of consent|1|||
144309905|NCT04024436|520339459|FG000|Overall Study|Study termination by sponsor|4|||
144309906|NCT04024436|520339460|FG001|Overall Study|Study termination by sponsor|6|||
144309907|NCT04024436|520339461|FG002|Overall Study|Study termination by sponsor|2|||
144309908|NCT04024436|520339462|FG003|Overall Study|Study termination by sponsor|11|||
144309909|NCT04024436|520339459|FG000|Overall Study|Reason Not Specified|0|||
144309910|NCT04024436|520339460|FG001|Overall Study|Reason Not Specified|1|||
144309911|NCT04024436|520339461|FG002|Overall Study|Reason Not Specified|0|||
144309912|NCT04024436|520339462|FG003|Overall Study|Reason Not Specified|2|||
144309913|NCT00540592|520339463|FG000|Overall Study|Adverse Event|0|||
144309914|NCT00540592|520339464|FG001|Overall Study|Adverse Event|1|||
144309915|NCT00540592|520339465|FG002|Overall Study|Adverse Event|0|||
144309916|NCT00540592|520339466|FG003|Overall Study|Adverse Event|0|||
144309917|NCT00540592|520339467|FG004|Overall Study|Adverse Event|1|||
144309918|NCT00540592|520339468|FG005|Overall Study|Adverse Event|0|||
144309919|NCT00540592|520339469|FG006|Overall Study|Adverse Event|0|||
144309920|NCT00540592|520339470|FG007|Overall Study|Adverse Event|1|||
144309921|NCT00540592|520339471|FG008|Overall Study|Adverse Event|1|||
144309922|NCT00540592|520339472|FG009|Overall Study|Adverse Event|2|||
144309923|NCT00540592|520339463|FG000|Overall Study|Lost to Follow-up|2|||
144309924|NCT00540592|520339464|FG001|Overall Study|Lost to Follow-up|0|||
144309925|NCT00540592|520339465|FG002|Overall Study|Lost to Follow-up|0|||
144309926|NCT00540592|520339466|FG003|Overall Study|Lost to Follow-up|0|||
144309927|NCT00540592|520339467|FG004|Overall Study|Lost to Follow-up|0|||
144309928|NCT00540592|520339468|FG005|Overall Study|Lost to Follow-up|0|||
144309929|NCT00540592|520339469|FG006|Overall Study|Lost to Follow-up|0|||
144309930|NCT00540592|520339470|FG007|Overall Study|Lost to Follow-up|0|||
144309931|NCT00540592|520339471|FG008|Overall Study|Lost to Follow-up|0|||
144309932|NCT00540592|520339472|FG009|Overall Study|Lost to Follow-up|0|||
144309933|NCT00540592|520339463|FG000|Overall Study|Withdrawal by Subject|0|||
144309934|NCT00540592|520339464|FG001|Overall Study|Withdrawal by Subject|0|||
144309935|NCT00540592|520339465|FG002|Overall Study|Withdrawal by Subject|1|||
144309936|NCT00540592|520339466|FG003|Overall Study|Withdrawal by Subject|1|||
144309937|NCT00540592|520339467|FG004|Overall Study|Withdrawal by Subject|0|||
144309938|NCT00540592|520339468|FG005|Overall Study|Withdrawal by Subject|0|||
144309939|NCT00540592|520339469|FG006|Overall Study|Withdrawal by Subject|0|||
144309940|NCT00540592|520339470|FG007|Overall Study|Withdrawal by Subject|0|||
144309941|NCT00540592|520339471|FG008|Overall Study|Withdrawal by Subject|0|||
144309942|NCT00540592|520339472|FG009|Overall Study|Withdrawal by Subject|0|||
144309943|NCT03369665|520339476|FG000|Overall Study|Adverse Event|3|||
144309944|NCT03369665|520339476|FG000|Overall Study|Lost to Follow-up|7|||
144309945|NCT03369665|520339476|FG000|Overall Study|Withdrawal by Subject|15|||
144309946|NCT03369665|520339476|FG000|Overall Study|Progression Disease|2|||
144309947|NCT03369665|520339476|FG000|Overall Study|Not classified|3|||
144309948|NCT05197049|520339477|FG000|Overall Study|Death|0|||
144309949|NCT05197049|520339478|FG001|Overall Study|Death|1|||
144309950|NCT05197049|520339479|FG002|Overall Study|Death|0|||
144309951|NCT05197049|520339477|FG000|Overall Study|Lost to Follow-up|3|||
144309952|NCT05197049|520339478|FG001|Overall Study|Lost to Follow-up|1|||
144309953|NCT05197049|520339479|FG002|Overall Study|Lost to Follow-up|0|||
144309954|NCT05197049|520339477|FG000|Overall Study|Withdrawal by Subject|15|||
144309955|NCT05197049|520339478|FG001|Overall Study|Withdrawal by Subject|3|||
144309956|NCT05197049|520339479|FG002|Overall Study|Withdrawal by Subject|1|||
144309957|NCT05197049|520339477|FG000|Overall Study|GCP non-compliance|1|||
144309958|NCT05197049|520339478|FG001|Overall Study|GCP non-compliance|2|||
144309959|NCT05197049|520339479|FG002|Overall Study|GCP non-compliance|0|||
144309960|NCT05384834|520339480|FG000|Overall Study|Lost to Follow-up|43|||
144309961|NCT05384834|520339480|FG000|Overall Study|Withdrawal by Subject|5|||
144309962|NCT01775553|520339481|FG000|Overall Study|Adverse Event|1|||
144309963|NCT01775553|520339481|FG000|Overall Study|Disease Progression|12|||
144309964|NCT03810014|520339482|FG000|Overall Study|Pregnancy|2|||
144309965|NCT03810014|520339483|FG001|Overall Study|Pregnancy|2|||
144309966|NCT03810014|520339484|FG002|Overall Study|Pregnancy|0|||
144309967|NCT03810014|520339485|FG003|Overall Study|Pregnancy|2|||
144309968|NCT00124072|520339500|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
144309969|NCT00124072|520339501|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
144309970|NCT00124072|520339502|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
144309971|NCT00124072|520339503|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
144309972|NCT00124072|520339500|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
144309973|NCT00124072|520339501|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
144309974|NCT00124072|520339502|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
144309975|NCT00124072|520339503|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
144309976|NCT00124072|520339500|FG000|Overall Study|Death|499|||
144309977|NCT00124072|520339501|FG001|Overall Study|Death|484|||
144309978|NCT00124072|520339502|FG002|Overall Study|Death|471|||
144309979|NCT00124072|520339503|FG003|Overall Study|Death|480|||
144309980|NCT00886769|520339504|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
144309981|NCT00886769|520339505|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
144309982|NCT00778336|520339508|FG000|Index Procedure-Discharge|Death|6|||
144309983|NCT00778336|520339509|FG001|Index Procedure-Discharge|Death|3|||
144309984|NCT00778336|520339510|FG002|Index Procedure-Discharge|Death|2|||
144309985|NCT00778336|520339511|FG003|Index Procedure-Discharge|Death|0|||
144309986|NCT00778336|520339508|FG000|3 Month Follow Up|Lost to Follow-up|15|||
144309987|NCT00778336|520339509|FG001|3 Month Follow Up|Lost to Follow-up|20|||
144309988|NCT00778336|520339510|FG002|3 Month Follow Up|Lost to Follow-up|3|||
144309989|NCT00778336|520339511|FG003|3 Month Follow Up|Lost to Follow-up|0|||
144309990|NCT00778336|520339508|FG000|3 Month Follow Up|Death|8|||
144309991|NCT00778336|520339509|FG001|3 Month Follow Up|Death|3|||
144309992|NCT00778336|520339510|FG002|3 Month Follow Up|Death|2|||
144309993|NCT00778336|520339511|FG003|3 Month Follow Up|Death|0|||
144309994|NCT00414076|520339512|FG000|Overall Study|Progression|1|||
144309995|NCT00414076|520339513|FG001|Overall Study|Progression|2|||
144309996|NCT00414076|520339512|FG000|Overall Study|Withdrawal by Subject|1|||
144309997|NCT00414076|520339513|FG001|Overall Study|Withdrawal by Subject|3|||
144309998|NCT00414076|520339512|FG000|Overall Study|Adverse Event|1|||
144309999|NCT00414076|520339513|FG001|Overall Study|Adverse Event|0|||
144310000|NCT04108208|520339514|FG000|Overall Study|Withdrawal by Subject|2|||
144310001|NCT04108208|520339515|FG001|Overall Study|Withdrawal by Subject|6|||
144310002|NCT04108208|520339514|FG000|Overall Study|other-ongoing|20|||
144310003|NCT04108208|520339515|FG001|Overall Study|other-ongoing|40|||
144310004|NCT04108208|520339514|FG000|Overall Study|Death|1|||
144310005|NCT04108208|520339515|FG001|Overall Study|Death|4|||
144310006|NCT04108208|520339514|FG000|Overall Study|Lost to Follow-up|2|||
144310007|NCT04108208|520339515|FG001|Overall Study|Lost to Follow-up|0|||
144310008|NCT03517436|520339516|FG000|Overall Study|Death|3|||
144310009|NCT03517436|520339516|FG000|Overall Study|Withdrawal by Subject|4|||
144310010|NCT03517436|520339516|FG000|Overall Study|Did not receive study valve.|1|||
144310011|NCT04181827|520339517|FG000|Overall Study|Ongoing|124|||
144310012|NCT04181827|520339518|FG001|Overall Study|Ongoing|157|||
144310013|NCT04181827|520339517|FG000|Overall Study|Death|82|||
144310014|NCT04181827|520339518|FG001|Overall Study|Death|50|||
144310015|NCT04181827|520339517|FG000|Overall Study|Lost to Follow-up|0|||
144310016|NCT04181827|520339518|FG001|Overall Study|Lost to Follow-up|1|||
144310017|NCT04181827|520339517|FG000|Overall Study|Withdrawal by Subject|5|||
144310018|NCT04181827|520339518|FG001|Overall Study|Withdrawal by Subject|0|||
144310019|NCT04538664|520339521|FG000|Overall Study|Withdrawal by Subject|5|||
144310020|NCT04538664|520339522|FG001|Overall Study|Withdrawal by Subject|9|||
144310021|NCT04538664|520339521|FG000|Overall Study|Lost to Follow-up|2|||
144310022|NCT04538664|520339522|FG001|Overall Study|Lost to Follow-up|1|||
144310023|NCT04538664|520339521|FG000|Overall Study|Ongoing|106|||
144310024|NCT04538664|520339522|FG001|Overall Study|Ongoing|115|||
144310025|NCT03390504|520339526|FG000|Overall Study|Lost to Follow-up|2|||
144310026|NCT03390504|520339527|FG001|Overall Study|Lost to Follow-up|4|||
144310027|NCT03390504|520339528|FG002|Overall Study|Lost to Follow-up|0|||
144310028|NCT03390504|520339529|FG003|Overall Study|Lost to Follow-up|1|||
144310029|NCT03390504|520339526|FG000|Overall Study|Withdrawal by Subject|3|||
144310030|NCT03390504|520339527|FG001|Overall Study|Withdrawal by Subject|15|||
144310031|NCT03390504|520339528|FG002|Overall Study|Withdrawal by Subject|5|||
144310032|NCT03390504|520339529|FG003|Overall Study|Withdrawal by Subject|2|||
144310033|NCT03390504|520339526|FG000|Overall Study|Other|1|||
144310034|NCT03390504|520339527|FG001|Overall Study|Other|2|||
144310035|NCT03390504|520339528|FG002|Overall Study|Other|2|||
144310036|NCT03390504|520339529|FG003|Overall Study|Other|6|||
144310037|NCT00980538|520339530|FG000|Overall Study|Lost to Follow-up|20|||
144310038|NCT00980538|520339530|FG000|Overall Study|Sponsor's Decision|4|||
144310039|NCT00980538|520339530|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
144310040|NCT00980538|520339530|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
144310041|NCT00980538|520339530|FG000|Overall Study|Switch to Commercially Available Medication|25|||
144310042|NCT00980538|520339530|FG000|Overall Study|Participant Non-Compliant|9|||
144359620|NCT00402168|520522826|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
144310043|NCT00980538|520339530|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
144310044|NCT00980538|520339530|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
144310045|NCT00980538|520339530|FG000|Overall Study|Other|60|||
144310046|NCT00980538|520339530|FG000|Overall Study|Other|1|||
144310047|NCT01544348|520339531|FG000|Overall Study|Lost to Follow-up|1|||
144310048|NCT01544348|520339532|FG001|Overall Study|Lost to Follow-up|0|||
144310049|NCT01544348|520339533|FG002|Overall Study|Lost to Follow-up|0|||
144310050|NCT01544348|520339534|FG003|Overall Study|Lost to Follow-up|0|||
144310051|NCT01544348|520339535|FG004|Overall Study|Lost to Follow-up|0|||
144310052|NCT01544348|520339536|FG005|Overall Study|Lost to Follow-up|0|||
144310053|NCT01544348|520339537|FG006|Overall Study|Lost to Follow-up|1|||
144310054|NCT01544348|520339538|FG007|Overall Study|Lost to Follow-up|0|||
144310055|NCT01544348|520339531|FG000|Overall Study|Withdrawal by Subject|1|||
144310056|NCT01544348|520339532|FG001|Overall Study|Withdrawal by Subject|0|||
144310057|NCT01544348|520339533|FG002|Overall Study|Withdrawal by Subject|0|||
144310058|NCT01544348|520339534|FG003|Overall Study|Withdrawal by Subject|0|||
144310059|NCT01544348|520339535|FG004|Overall Study|Withdrawal by Subject|1|||
144310060|NCT01544348|520339536|FG005|Overall Study|Withdrawal by Subject|2|||
144310061|NCT01544348|520339537|FG006|Overall Study|Withdrawal by Subject|1|||
144310062|NCT01544348|520339538|FG007|Overall Study|Withdrawal by Subject|0|||
144310063|NCT01544348|520339531|FG000|Overall Study|Physician Decision|0|||
144310064|NCT01544348|520339532|FG001|Overall Study|Physician Decision|0|||
144310065|NCT01544348|520339533|FG002|Overall Study|Physician Decision|0|||
144310066|NCT01544348|520339534|FG003|Overall Study|Physician Decision|0|||
144310067|NCT01544348|520339535|FG004|Overall Study|Physician Decision|0|||
144310068|NCT01544348|520339536|FG005|Overall Study|Physician Decision|1|||
144310069|NCT01544348|520339537|FG006|Overall Study|Physician Decision|0|||
144310070|NCT01544348|520339538|FG007|Overall Study|Physician Decision|0|||
144310071|NCT01445847|520339539|FG000|Overall Study|Protocol Violation|13|||
144310072|NCT01445847|520339540|FG001|Overall Study|Protocol Violation|14|||
144310073|NCT01445847|520339539|FG000|Overall Study|Missed Data|1|||
144310074|NCT01445847|520339540|FG001|Overall Study|Missed Data|0|||
144310075|NCT00707993|520339541|FG000|Overall Study|Adverse Event|16|||
144310076|NCT00707993|520339542|FG001|Overall Study|Adverse Event|20|||
144310077|NCT00707993|520339541|FG000|Overall Study|Protocol Violation|4|||
144310078|NCT00707993|520339542|FG001|Overall Study|Protocol Violation|7|||
144310079|NCT00707993|520339541|FG000|Overall Study|Lost to Follow-up|0|||
144310080|NCT00707993|520339542|FG001|Overall Study|Lost to Follow-up|4|||
144310081|NCT00707993|520339541|FG000|Overall Study|Withdrawal by Subject|12|||
144310082|NCT00707993|520339542|FG001|Overall Study|Withdrawal by Subject|16|||
144310083|NCT00707993|520339541|FG000|Overall Study|Hyperglycemic Rescue|55|||
144310084|NCT00707993|520339542|FG001|Overall Study|Hyperglycemic Rescue|47|||
144310085|NCT00707993|520339541|FG000|Overall Study|Other|2|||
144310086|NCT00707993|520339542|FG001|Overall Study|Other|0|||
144310087|NCT03381287|520339547|FG000|Overall Study|Withdrawal by Subject|0|||
144310088|NCT03381287|520339548|FG001|Overall Study|Withdrawal by Subject|1|||
144310089|NCT03381287|520339549|FG002|Overall Study|Withdrawal by Subject|0|||
144310090|NCT03381287|520339550|FG003|Overall Study|Withdrawal by Subject|0|||
144310091|NCT03381287|520339547|FG000|Overall Study|Adverse Event|0|||
144310092|NCT03381287|520339548|FG001|Overall Study|Adverse Event|0|||
144310093|NCT03381287|520339549|FG002|Overall Study|Adverse Event|0|||
144310094|NCT03381287|520339550|FG003|Overall Study|Adverse Event|1|||
144310095|NCT03381287|520339547|FG000|Overall Study|Physician Decision|0|||
144310096|NCT03381287|520339548|FG001|Overall Study|Physician Decision|0|||
144310097|NCT03381287|520339549|FG002|Overall Study|Physician Decision|0|||
144310098|NCT03381287|520339550|FG003|Overall Study|Physician Decision|1|||
144310099|NCT02137070|520339553|FG000|Overall Study|Adverse Event|12|||
144310100|NCT02137070|520339554|FG001|Overall Study|Adverse Event|3|||
144310101|NCT02137070|520339553|FG000|Overall Study|Death|2|||
144310102|NCT02137070|520339554|FG001|Overall Study|Death|0|||
144310103|NCT02137070|520339553|FG000|Overall Study|Lost to Follow-up|24|||
144310104|NCT02137070|520339554|FG001|Overall Study|Lost to Follow-up|9|||
144310105|NCT02137070|520339553|FG000|Overall Study|Physician Decision|0|||
144310106|NCT02137070|520339554|FG001|Overall Study|Physician Decision|1|||
144310107|NCT02137070|520339553|FG000|Overall Study|Protocol Violation|18|||
144310108|NCT02137070|520339554|FG001|Overall Study|Protocol Violation|4|||
144310109|NCT02137070|520339553|FG000|Overall Study|Withdrawal by Subject|18|||
144310110|NCT02137070|520339554|FG001|Overall Study|Withdrawal by Subject|1|||
144310111|NCT01444430|520339559|FG000|Overall Study|Withdrawal by Subject|53|||
144310112|NCT01444430|520339560|FG001|Overall Study|Withdrawal by Subject|72|||
144310113|NCT01444430|520339559|FG000|Overall Study|Death|6|||
144310114|NCT01444430|520339560|FG001|Overall Study|Death|8|||
144310115|NCT01444430|520339559|FG000|Overall Study|Lost to Follow-up|2|||
144310116|NCT01444430|520339560|FG001|Overall Study|Lost to Follow-up|0|||
144310117|NCT01444430|520339559|FG000|Overall Study|CRF termination module not completed.|0|||
144310118|NCT01444430|520339560|FG001|Overall Study|CRF termination module not completed.|1|||
144310119|NCT02842086|520339565|FG000|Overall Study|Randomized but Never Treated|6|||
144310120|NCT02842086|520339566|FG001|Overall Study|Randomized but Never Treated|6|||
144310121|NCT02842086|520339565|FG000|Overall Study|Still in Double-Blind Phase|7|||
144310122|NCT02842086|520339566|FG001|Overall Study|Still in Double-Blind Phase|3|||
144310123|NCT02842086|520339565|FG000|Overall Study|Adverse Event|18|||
144310124|NCT02842086|520339566|FG001|Overall Study|Adverse Event|20|||
144310125|NCT02842086|520339565|FG000|Overall Study|Death|3|||
144310126|NCT02842086|520339566|FG001|Overall Study|Death|3|||
144310127|NCT02842086|520339565|FG000|Overall Study|Investigator's Discretion|9|||
144310128|NCT02842086|520339566|FG001|Overall Study|Investigator's Discretion|13|||
144310129|NCT02842086|520339565|FG000|Overall Study|Non-Compliance with Study Drug|9|||
144310130|NCT02842086|520339566|FG001|Overall Study|Non-Compliance with Study Drug|8|||
144310131|NCT02842086|520339565|FG000|Overall Study|Protocol Violation|8|||
144310132|NCT02842086|520339566|FG001|Overall Study|Protocol Violation|4|||
144310133|NCT02842086|520339565|FG000|Overall Study|Withdrew Consent|205|||
144310134|NCT02842086|520339566|FG001|Overall Study|Withdrew Consent|194|||
144310135|NCT02842086|520339565|FG000|Overall Study|Lost to Follow-up|274|||
144310136|NCT02842086|520339566|FG001|Overall Study|Lost to Follow-up|236|||
144310137|NCT02842086|520339565|FG000|Overall Study|HIV-1 Infection|5|||
144310138|NCT02842086|520339566|FG001|Overall Study|HIV-1 Infection|6|||
144310139|NCT03451851|520339567|FG000|PCP: Week 0 -16|Adverse Event|1|||
144310140|NCT03451851|520339568|FG001|PCP: Week 0 -16|Adverse Event|0|||
144310141|NCT03451851|520339569|FG002|PCP: Week 0 -16|Adverse Event|0|||
144310142|NCT03451851|520339570|FG003|PCP: Week 0 -16|Adverse Event|0|||
144310143|NCT03451851|520339571|FG004|PCP: Week 0 -16|Adverse Event|0|||
144310144|NCT03451851|520339572|FG005|PCP: Week 0 -16|Adverse Event|0|||
144310145|NCT03451851|520339573|FG006|PCP: Week 0 -16|Adverse Event|1|||
144310146|NCT03451851|520339574|FG007|PCP: Week 0 -16|Adverse Event|0|||
144310147|NCT03451851|520339567|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310148|NCT03451851|520339568|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310149|NCT03451851|520339569|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
144310150|NCT03451851|520339570|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310151|NCT03451851|520339571|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310152|NCT03451851|520339572|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310153|NCT03451851|520339573|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310154|NCT03451851|520339574|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
144310155|NCT03451851|520339567|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310156|NCT03451851|520339568|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310157|NCT03451851|520339569|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
144310158|NCT03451851|520339570|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310159|NCT03451851|520339571|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310160|NCT03451851|520339572|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310161|NCT03451851|520339573|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310162|NCT03451851|520339574|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
144310163|NCT03451851|520339567|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
144310164|NCT03451851|520339568|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
144310165|NCT03451851|520339569|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
144310166|NCT03451851|520339570|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
144310167|NCT03451851|520339571|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
144310168|NCT03451851|520339572|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
144310169|NCT03451851|520339573|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
144310170|NCT03451851|520339574|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
144310171|NCT03451851|520339567|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310172|NCT03451851|520339568|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310173|NCT03451851|520339569|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310174|NCT03451851|520339570|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310175|NCT03451851|520339571|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
144310176|NCT03451851|520339572|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310177|NCT03451851|520339573|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310178|NCT03451851|520339574|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
144310179|NCT03451851|520339567|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310180|NCT03451851|520339568|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310181|NCT03451851|520339569|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310182|NCT03451851|520339570|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310183|NCT03451851|520339571|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
144310184|NCT03451851|520339572|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310185|NCT03451851|520339573|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310186|NCT03451851|520339574|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
144310187|NCT03581292|520339575|FG000|Overall Study|Physician Decision|9|||
144310188|NCT03581292|520339576|FG001|Overall Study|Physician Decision|5|||
144310189|NCT03581292|520339575|FG000|Overall Study|Withdrawal by Subject|3|||
144310190|NCT03581292|520339576|FG001|Overall Study|Withdrawal by Subject|0|||
144310191|NCT03581292|520339575|FG000|Overall Study|Withdrawal before Therapy Start|1|||
144310192|NCT03581292|520339576|FG001|Overall Study|Withdrawal before Therapy Start|0|||
144310193|NCT07214935|520339577|FG000|Overall Study|Adverse Event|1|||
144310194|NCT07214935|520339578|FG001|Overall Study|Adverse Event|1|||
144310195|NCT07214935|520339579|FG002|Overall Study|Adverse Event|1|||
144310196|NCT07214935|520339580|FG003|Overall Study|Adverse Event|0|||
144310197|NCT07214935|520339577|FG000|Overall Study|Lost to Follow-up|0|||
144310198|NCT07214935|520339578|FG001|Overall Study|Lost to Follow-up|1|||
144310199|NCT07214935|520339579|FG002|Overall Study|Lost to Follow-up|0|||
144310200|NCT07214935|520339580|FG003|Overall Study|Lost to Follow-up|0|||
144310201|NCT07214935|520339577|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
144310202|NCT07214935|520339578|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
144310203|NCT07214935|520339579|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
144310204|NCT07214935|520339580|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
144310205|NCT07214935|520339577|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
144310206|NCT07214935|520339578|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
144310207|NCT07214935|520339579|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
144310208|NCT07214935|520339580|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
144310209|NCT01650831|520340606|FG000|Overall Study|Screen failure|1|||
144310210|NCT02522429|520340607|FG000|Overall Study|Lost to Follow-up|8|||
144310211|NCT02522429|520340607|FG000|Overall Study|Adverse Event|2|||
144310212|NCT02522429|520340607|FG000|Overall Study|Death|1|||
144310213|NCT02522429|520340607|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
144310214|NCT00600106|520340608|FG000|Overall Study|Withdrawal by Subject|1|||
144310215|NCT00600106|520340609|FG001|Overall Study|Withdrawal by Subject|1|||
144310216|NCT01273038|520340614|FG000|Second Intervention (14 Days)|Adverse Event|0|||
144310217|NCT01273038|520340615|FG001|Second Intervention (14 Days)|Adverse Event|1|||
144310218|NCT01273038|520340614|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
144310219|NCT01273038|520340615|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
144310220|NCT00175916|520340618|FG000|Overall Study|Death|19|||
144310221|NCT00175916|520340618|FG000|Overall Study|Adverse Event|81|||
144310222|NCT00175916|520340618|FG000|Overall Study|Lack of Efficacy|354|||
144310223|NCT00175916|520340618|FG000|Overall Study|Lost to Follow-up|17|||
144310224|NCT00175916|520340618|FG000|Overall Study|Subject Choice|98|||
144310225|NCT00175916|520340618|FG000|Overall Study|Lack of compliance|8|||
144310226|NCT00175916|520340618|FG000|Overall Study|Patient cannot record seizures|1|||
144310227|NCT00175916|520340618|FG000|Overall Study|Sponsor decision|17|||
144310228|NCT00175916|520340618|FG000|Overall Study|Vigabatrin intake|1|||
144310229|NCT00175916|520340618|FG000|Overall Study|Suicidal behaviour|1|||
144310230|NCT00175916|520340618|FG000|Overall Study|Withdrawal by Subject|1|||
144310231|NCT00175916|520340618|FG000|Overall Study|Seizure - free|4|||
144310232|NCT00175916|520340618|FG000|Overall Study|Administrative reason|1|||
144310233|NCT00175916|520340618|FG000|Overall Study|Pregnancy|1|||
144310234|NCT00175916|520340618|FG000|Overall Study|Patient's request|2|||
144310235|NCT00175916|520340618|FG000|Overall Study|Treating physiciant's choice|1|||
144310236|NCT00175916|520340618|FG000|Overall Study|Moved overseas|1|||
144310237|NCT00175916|520340618|FG000|Overall Study|Loss of job and economic burden|1|||
144310238|NCT00175916|520340618|FG000|Overall Study|Site was closed|9|||
144310239|NCT00175916|520340618|FG000|Overall Study|Patient went to prison|1|||
144310240|NCT03901963|520340619|FG000|Overall Study|Lost to Follow-up|1|||
144310241|NCT03901963|520340620|FG001|Overall Study|Lost to Follow-up|1|||
144310242|NCT03901963|520340619|FG000|Overall Study|Physician Decision|1|||
144310243|NCT03901963|520340620|FG001|Overall Study|Physician Decision|2|||
144310244|NCT03901963|520340619|FG000|Overall Study|Protocol Violation|1|||
144310245|NCT03901963|520340620|FG001|Overall Study|Protocol Violation|1|||
144310246|NCT03901963|520340619|FG000|Overall Study|Withdrawal by Subject|4|||
144310247|NCT03901963|520340620|FG001|Overall Study|Withdrawal by Subject|11|||
144310248|NCT03901963|520340619|FG000|Overall Study|Ongoing|84|||
144310249|NCT03901963|520340620|FG001|Overall Study|Ongoing|73|||
144310250|NCT03901963|520340619|FG000|Overall Study|Randomized but not treated|3|||
144310251|NCT03901963|520340620|FG001|Overall Study|Randomized but not treated|3|||
144310252|NCT01206140|520340621|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
144310253|NCT01206140|520340622|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
144310254|NCT01803880|520340623|FG000|Overall Study|Adverse Event|1|||
144310255|NCT01803880|520340624|FG001|Overall Study|Adverse Event|0|||
144310256|NCT01803880|520340625|FG002|Overall Study|Adverse Event|0|||
144310257|NCT01803880|520340623|FG000|Overall Study|Withdrawal by Subject|1|||
144310258|NCT01803880|520340624|FG001|Overall Study|Withdrawal by Subject|1|||
144310259|NCT01803880|520340625|FG002|Overall Study|Withdrawal by Subject|4|||
144310260|NCT01803880|520340623|FG000|Overall Study|Physician Decision|0|||
144310261|NCT01803880|520340624|FG001|Overall Study|Physician Decision|0|||
144310262|NCT01803880|520340625|FG002|Overall Study|Physician Decision|1|||
144310263|NCT01803880|520340623|FG000|Overall Study|Unable to return for follow-up visits|0|||
144310264|NCT01803880|520340624|FG001|Overall Study|Unable to return for follow-up visits|1|||
144310265|NCT01803880|520340625|FG002|Overall Study|Unable to return for follow-up visits|2|||
144310266|NCT01803880|520340623|FG000|Overall Study|Lost to Follow-up|1|||
144310267|NCT01803880|520340624|FG001|Overall Study|Lost to Follow-up|2|||
144310268|NCT01803880|520340625|FG002|Overall Study|Lost to Follow-up|3|||
144310269|NCT01803880|520340623|FG000|Overall Study|Protocol Violation|1|||
144310270|NCT01803880|520340624|FG001|Overall Study|Protocol Violation|0|||
144310271|NCT01803880|520340625|FG002|Overall Study|Protocol Violation|0|||
144310272|NCT01803880|520340623|FG000|Overall Study|Early study termination|0|||
144310273|NCT01803880|520340624|FG001|Overall Study|Early study termination|6|||
144310274|NCT01803880|520340625|FG002|Overall Study|Early study termination|5|||
144310275|NCT01803880|520340623|FG000|Overall Study|Incomplete data entry by sites|2|||
144310276|NCT01803880|520340624|FG001|Overall Study|Incomplete data entry by sites|0|||
144310277|NCT01803880|520340625|FG002|Overall Study|Incomplete data entry by sites|0|||
144310278|NCT01081951|520340626|FG000|Overall Study|Death|54|||
144310279|NCT01081951|520340627|FG001|Overall Study|Death|47|||
144310280|NCT01081951|520340626|FG000|Overall Study|Withdrawal by Subject|2|||
144310281|NCT01081951|520340627|FG001|Overall Study|Withdrawal by Subject|6|||
144310282|NCT01081951|520340626|FG000|Overall Study|Allocated treatment but did not take it|0|||
144310283|NCT01081951|520340627|FG001|Overall Study|Allocated treatment but did not take it|1|||
144310284|NCT01081951|520340626|FG000|Overall Study|Lost to Follow-up|0|||
144310285|NCT01081951|520340627|FG001|Overall Study|Lost to Follow-up|1|||
144310286|NCT05226598|520340628|FG000|Overall Study|Death|186|||
144310287|NCT05226598|520340629|FG001|Overall Study|Death|191|||
144310288|NCT05226598|520340628|FG000|Overall Study|Withdrawal by Subject|6|||
144310289|NCT05226598|520340629|FG001|Overall Study|Withdrawal by Subject|6|||
144310290|NCT05226598|520340628|FG000|Overall Study|Ongoing|174|||
144310291|NCT05226598|520340629|FG001|Overall Study|Ongoing|176|||
144310292|NCT02959463|520340630|FG000|Overall Study|Adverse Event|1|||
144310293|NCT02959463|520340631|FG001|Overall Study|Adverse Event|1|||
144310294|NCT02959463|520340630|FG000|Overall Study|Death|1|||
144310295|NCT02959463|520340631|FG001|Overall Study|Death|0|||
144310296|NCT02959463|520340630|FG000|Overall Study|Withdrawal by Subject|1|||
144310297|NCT02959463|520340631|FG001|Overall Study|Withdrawal by Subject|0|||
144310298|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
144310299|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
144310300|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
144310301|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
144310302|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
144310303|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
144310304|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
144310305|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
144310306|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
144310307|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
144310308|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
144310309|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
144310310|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
144310311|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
144310312|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
144310313|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
144310314|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
144310315|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
144310316|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
144310317|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
144310318|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
144310319|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
144310320|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
144310321|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
144310322|NCT01672879|520340632|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
144310323|NCT01672879|520340633|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
144310324|NCT01672879|520340634|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
144310325|NCT01672879|520340632|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
144310326|NCT01672879|520340633|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
144310327|NCT01672879|520340634|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
144310328|NCT01672879|520340632|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
144310329|NCT01672879|520340633|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
144310330|NCT01672879|520340634|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
144310331|NCT01672879|520340632|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
144310332|NCT01672879|520340633|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
144360019|NCT01601535|520525135|FG000|Phase 2|Adverse Event|0|||
144310333|NCT01672879|520340634|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
144310334|NCT01672879|520340632|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
144310335|NCT01672879|520340633|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
144310336|NCT01672879|520340634|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
144310337|NCT02048813|520340639|FG000|Overall Study|Still on treatment|279|||
144310338|NCT02048813|520340640|FG001|Overall Study|Still on treatment|0|||
144310339|NCT02048813|520340639|FG000|Overall Study|Adverse Event|40|||
144310340|NCT02048813|520340640|FG001|Overall Study|Adverse Event|38|||
144310341|NCT02048813|520340639|FG000|Overall Study|Disease progression|13|||
144310342|NCT02048813|520340640|FG001|Overall Study|Disease progression|3|||
144310343|NCT02048813|520340639|FG000|Overall Study|Withdrawal by Subject|7|||
144310344|NCT02048813|520340640|FG001|Overall Study|Withdrawal by Subject|8|||
144310345|NCT02048813|520340639|FG000|Overall Study|Death|2|||
144310346|NCT02048813|520340640|FG001|Overall Study|Death|1|||
144310347|NCT02048813|520340639|FG000|Overall Study|Complication|2|||
144310348|NCT02048813|520340640|FG001|Overall Study|Complication|2|||
144310349|NCT02048813|520340639|FG000|Overall Study|Non-protocol therapy|0|||
144310350|NCT02048813|520340640|FG001|Overall Study|Non-protocol therapy|1|||
144310351|NCT02048813|520340639|FG000|Overall Study|Second primary cancer|2|||
144310352|NCT02048813|520340640|FG001|Overall Study|Second primary cancer|0|||
144310353|NCT02048813|520340639|FG000|Overall Study|Insurance|2|||
144310354|NCT02048813|520340640|FG001|Overall Study|Insurance|0|||
144310355|NCT02048813|520340639|FG000|Overall Study|Wound infection/healing|2|||
144310356|NCT02048813|520340640|FG001|Overall Study|Wound infection/healing|0|||
144310357|NCT02048813|520340639|FG000|Overall Study|Missed appointment|3|||
144310358|NCT02048813|520340640|FG001|Overall Study|Missed appointment|0|||
144310359|NCT02048813|520340639|FG000|Overall Study|Never started treatment|2|||
144310360|NCT02048813|520340640|FG001|Overall Study|Never started treatment|17|||
144310361|NCT04188509|520340641|FG000|Overall Study|Adverse Event|2|||
144310362|NCT04188509|520340641|FG000|Overall Study|Lost to Follow-up|1|||
144310363|NCT04188509|520340641|FG000|Overall Study|Withdrawal of Consent|1|||
144310364|NCT04188509|520340641|FG000|Overall Study|Discretion of Investigator|1|||
144310365|NCT04188509|520340641|FG000|Overall Study|Noncompliance|3|||
144310366|NCT04188509|520340641|FG000|Overall Study|Sponsor Decision|127|||
144310367|NCT04188509|520340641|FG000|Overall Study|Other|2|||
144310368|NCT01152788|520340643|FG000|Overall Study|Withdrawal by Subject|0|||
144310369|NCT01152788|520340644|FG001|Overall Study|Withdrawal by Subject|3|||
144310370|NCT01152788|520340643|FG000|Overall Study|No treatment|0|||
144310371|NCT01152788|520340644|FG001|Overall Study|No treatment|1|||
144310372|NCT01282866|520340653|FG000|Overall Study|Adverse Event|1|||
144310373|NCT01541865|520340655|FG000|Overall Study|Lost to Follow-up|11|||
144310374|NCT01541865|520340655|FG000|Overall Study|Withdrawal by Subject|9|||
144310375|NCT01541865|520340655|FG000|Overall Study|Adverse Event|1|||
144310376|NCT01541865|520340655|FG000|Overall Study|Protocol Violation|1|||
144310377|NCT01393899|520340660|FG000|Overall Study|Study terminated by sponsor|1|||
144310378|NCT01393899|520340661|FG001|Overall Study|Study terminated by sponsor|0|||
144310379|NCT01393899|520340662|FG002|Overall Study|Study terminated by sponsor|1|||
144310380|NCT01393899|520340660|FG000|Overall Study|Other|1|||
144310381|NCT01393899|520340661|FG001|Overall Study|Other|0|||
144310382|NCT01393899|520340662|FG002|Overall Study|Other|0|||
144310383|NCT01393899|520340660|FG000|Overall Study|Withdrawal by Subject|2|||
144310384|NCT01393899|520340661|FG001|Overall Study|Withdrawal by Subject|2|||
144310385|NCT01393899|520340662|FG002|Overall Study|Withdrawal by Subject|1|||
144310386|NCT01393899|520340660|FG000|Overall Study|Lost to Follow-up|0|||
144310387|NCT01393899|520340661|FG001|Overall Study|Lost to Follow-up|0|||
144310388|NCT01393899|520340662|FG002|Overall Study|Lost to Follow-up|1|||
144310389|NCT01393899|520340660|FG000|Overall Study|Does not meet entrance criteria|1|||
144310390|NCT01393899|520340661|FG001|Overall Study|Does not meet entrance criteria|0|||
144310391|NCT01393899|520340662|FG002|Overall Study|Does not meet entrance criteria|1|||
144310392|NCT01393899|520340660|FG000|Overall Study|Lack of Efficacy|26|||
144310393|NCT01393899|520340661|FG001|Overall Study|Lack of Efficacy|21|||
144310394|NCT01393899|520340662|FG002|Overall Study|Lack of Efficacy|16|||
144310395|NCT01393899|520340660|FG000|Overall Study|Adverse Event|1|||
144310396|NCT01393899|520340661|FG001|Overall Study|Adverse Event|5|||
144310397|NCT01393899|520340662|FG002|Overall Study|Adverse Event|3|||
144310398|NCT00049257|520340665|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
144310399|NCT00049257|520340665|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
144310400|NCT00049257|520340665|FG000|Carboplatin, Paclitaxel|Death|2|||
144310401|NCT00049257|520340665|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
144310402|NCT04721158|520340666|FG000|Overall Study|Lost to Follow-up|4|||
144310403|NCT04721158|520340666|FG000|Overall Study|Device did not connect|1|||
144310404|NCT03462719|520340672|FG000|Overall Study|Withdrawal by Subject|4|||
144310405|NCT03462719|520340673|FG001|Overall Study|Withdrawal by Subject|3|||
144310406|NCT03462719|520340672|FG000|Overall Study|Ongoing|87|||
144310407|NCT03462719|520340673|FG001|Overall Study|Ongoing|72|||
144310408|NCT03670355|520340674|FG000|Overall Study|Adverse Event|1|||
144310409|NCT03670355|520340675|FG001|Overall Study|Adverse Event|0|||
144310410|NCT03670355|520340674|FG000|Overall Study|Unable to comply with study procedures|0|||
144310411|NCT03670355|520340675|FG001|Overall Study|Unable to comply with study procedures|1|||
144310412|NCT03670355|520340674|FG000|Overall Study|Participant refused|0|||
144310413|NCT03670355|520340675|FG001|Overall Study|Participant refused|1|||
144310414|NCT04587869|520340678|FG000|Overall Study|Death|1|||
144310415|NCT04587869|520340679|FG001|Overall Study|Death|0|||
144310416|NCT04587869|520340678|FG000|Overall Study|Lost to Follow-up|27|||
144310417|NCT04587869|520340679|FG001|Overall Study|Lost to Follow-up|34|||
144310418|NCT04587869|520340678|FG000|Overall Study|Grant Termination|13|||
144310419|NCT04587869|520340679|FG001|Overall Study|Grant Termination|25|||
144310420|NCT04587869|520340678|FG000|Overall Study|too busy|2|||
144310421|NCT04587869|520340679|FG001|Overall Study|too busy|0|||
144310422|NCT04587869|520340678|FG000|Overall Study|Withdrawal by Subject|2|||
144310423|NCT04587869|520340679|FG001|Overall Study|Withdrawal by Subject|2|||
144310424|NCT04587869|520340678|FG000|Overall Study|Other|1|||
144310425|NCT04587869|520340679|FG001|Overall Study|Other|0|||
144310426|NCT02142803|520340683|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
144310427|NCT02142803|520340684|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
144310428|NCT02142803|520340685|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
144310429|NCT02142803|520340686|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
144310430|NCT03929913|520340687|FG000|Overall Study|Death|4|||
144310431|NCT03929913|520340687|FG000|Overall Study|Lost to Follow-up|1|||
144310432|NCT03929913|520340687|FG000|Overall Study|Failed Procedure|2|||
144310433|NCT00642707|520340688|FG000|Overall Study|Adverse Event|0|||
144310434|NCT00642707|520340689|FG001|Overall Study|Adverse Event|0|||
144310435|NCT00642707|520340690|FG002|Overall Study|Adverse Event|0|||
144310436|NCT00642707|520340691|FG003|Overall Study|Adverse Event|2|||
144310437|NCT00642707|520340688|FG000|Overall Study|Withdrawal by Subject|1|||
144310438|NCT00642707|520340689|FG001|Overall Study|Withdrawal by Subject|0|||
144310439|NCT00642707|520340690|FG002|Overall Study|Withdrawal by Subject|0|||
144310440|NCT00642707|520340691|FG003|Overall Study|Withdrawal by Subject|0|||
144310441|NCT03706430|520340692|FG000|Overall Study|No A-Line placed|5|||
144310442|NCT03706430|520340692|FG000|Overall Study|Subject had gel nail polish|1|||
144310443|NCT03706430|520340692|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
144310444|NCT03706430|520340692|FG000|Overall Study|Cancelled Case|6|||
144310445|NCT03706430|520340692|FG000|Overall Study|Physician Decision|2|||
144310446|NCT02891226|520340696|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
144310447|NCT02891226|520340697|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
144310448|NCT02891226|520340698|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
144310449|NCT02891226|520340699|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310450|NCT02891226|520340700|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310451|NCT02891226|520340701|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310452|NCT02891226|520340702|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310453|NCT02891226|520340703|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310454|NCT02891226|520340704|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310455|NCT02891226|520340705|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310456|NCT02891226|520340706|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310457|NCT02891226|520340707|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310458|NCT02891226|520340708|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310459|NCT02891226|520340709|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310460|NCT02891226|520340710|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310461|NCT02891226|520340711|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
144310462|NCT02891226|520340696|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
144310463|NCT02891226|520340697|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
144310464|NCT02891226|520340698|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310465|NCT02891226|520340699|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310466|NCT02891226|520340700|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310467|NCT02891226|520340701|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310468|NCT02891226|520340702|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310469|NCT02891226|520340703|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310470|NCT02891226|520340704|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310471|NCT02891226|520340705|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310472|NCT02891226|520340706|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310473|NCT02891226|520340707|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310474|NCT02891226|520340708|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310475|NCT02891226|520340709|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310476|NCT02891226|520340710|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310477|NCT02891226|520340711|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
144310478|NCT02891226|520340696|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310479|NCT02891226|520340697|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310480|NCT02891226|520340698|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310481|NCT02891226|520340699|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
144310482|NCT02891226|520340700|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310483|NCT02891226|520340701|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310484|NCT02891226|520340702|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310485|NCT02891226|520340703|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310486|NCT02891226|520340704|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310487|NCT02891226|520340705|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310488|NCT02891226|520340706|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310489|NCT02891226|520340707|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310490|NCT02891226|520340708|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310491|NCT02891226|520340709|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310492|NCT02891226|520340710|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310493|NCT02891226|520340711|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
144310494|NCT02891226|520340696|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310495|NCT02891226|520340697|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310496|NCT02891226|520340698|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
144310497|NCT02891226|520340699|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310498|NCT02891226|520340700|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310499|NCT02891226|520340701|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310500|NCT02891226|520340702|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310501|NCT02891226|520340703|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310502|NCT02891226|520340704|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310503|NCT02891226|520340705|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310504|NCT02891226|520340706|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310505|NCT02891226|520340707|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310506|NCT02891226|520340708|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310507|NCT02891226|520340709|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310508|NCT02891226|520340710|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310509|NCT02891226|520340711|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
144310510|NCT02891226|520340696|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310511|NCT02891226|520340697|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310512|NCT02891226|520340698|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310513|NCT02891226|520340699|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
144310514|NCT02891226|520340700|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310515|NCT02891226|520340701|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310516|NCT02891226|520340702|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310517|NCT02891226|520340703|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310518|NCT02891226|520340704|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310519|NCT02891226|520340705|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310520|NCT02891226|520340706|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310521|NCT02891226|520340707|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310522|NCT02891226|520340708|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310523|NCT02891226|520340709|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310524|NCT02891226|520340710|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310525|NCT02891226|520340711|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
144310526|NCT02891226|520340696|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310527|NCT02891226|520340697|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310528|NCT02891226|520340698|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310529|NCT02891226|520340699|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
144310530|NCT02891226|520340700|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310531|NCT02891226|520340701|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310532|NCT02891226|520340702|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310533|NCT02891226|520340703|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310534|NCT02891226|520340704|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310535|NCT02891226|520340705|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310536|NCT02891226|520340706|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310537|NCT02891226|520340707|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310538|NCT02891226|520340708|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310539|NCT02891226|520340709|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310540|NCT02891226|520340710|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310541|NCT02891226|520340711|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
144310542|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310543|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310544|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310545|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310546|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310547|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310548|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
144310549|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
144310550|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
144310551|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
144310552|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310553|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310554|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310555|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310556|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310557|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
144310558|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310559|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310560|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310561|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310562|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310563|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
144310564|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310565|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310566|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310567|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
144310568|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310569|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310570|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310571|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310572|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310573|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
144310574|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310575|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310576|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310577|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310578|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310579|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310580|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
144310581|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
144310582|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
144310583|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
144310584|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310585|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310586|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310587|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310588|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310589|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
144310590|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310591|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310592|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310593|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310594|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
144310595|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310596|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310597|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310598|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310599|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310600|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310601|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310602|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310603|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310604|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310605|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
144310606|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310607|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310608|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310609|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310610|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310611|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310612|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
144310613|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310614|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310615|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310616|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310617|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310618|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310619|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310620|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144310621|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
144360020|NCT01601535|520525136|FG001|Phase 2|Adverse Event|0|||
144310622|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310623|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310624|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310625|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310626|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310627|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310628|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310629|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
144310630|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
144310631|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
144310632|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310633|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310634|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310635|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310636|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310637|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
144310638|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310639|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310640|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310641|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310642|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310643|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310644|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310645|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
144310646|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310647|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310648|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310649|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310650|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310651|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310652|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310653|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
144310654|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310655|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310656|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310657|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310658|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310659|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310660|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310661|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310662|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
144310663|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310664|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310665|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310666|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310667|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310668|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310669|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
144310670|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310671|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310672|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310673|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310674|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310675|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310676|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310677|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310678|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310679|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
144310680|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310681|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310682|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310683|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310684|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310685|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
144310686|NCT02891226|520340696|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310687|NCT02891226|520340697|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310688|NCT02891226|520340698|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310689|NCT02891226|520340699|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310690|NCT02891226|520340700|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310691|NCT02891226|520340701|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310692|NCT02891226|520340702|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310693|NCT02891226|520340703|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310694|NCT02891226|520340704|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310695|NCT02891226|520340705|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
144310696|NCT02891226|520340706|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310697|NCT02891226|520340707|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310698|NCT02891226|520340708|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310699|NCT02891226|520340709|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310700|NCT02891226|520340710|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310701|NCT02891226|520340711|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
144310702|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310703|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310704|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310705|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310706|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310707|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310708|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310709|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310710|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310711|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310712|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
144310713|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310714|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310715|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310716|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310717|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
144310718|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310719|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310720|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310721|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310722|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310723|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310724|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310725|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310726|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310727|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310728|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
144310729|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310730|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310731|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310732|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310733|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
144310734|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310735|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310736|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310737|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310738|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310739|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310740|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310741|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310742|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310743|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310744|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
144310745|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310746|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310747|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310748|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310749|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
144310750|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310751|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310752|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310753|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310754|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310755|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310756|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310757|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310758|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310759|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310760|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
144310761|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310762|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310763|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310764|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310765|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
144310766|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310767|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310768|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310769|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310770|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310771|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310772|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310773|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310774|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310775|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310776|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
144310777|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310778|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310779|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310780|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310781|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
144310782|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310783|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310784|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310785|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310786|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310787|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310788|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310789|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310790|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310791|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310792|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
144310793|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310794|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310795|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310796|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310797|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
144310798|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310799|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310800|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310801|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310802|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310803|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310804|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310805|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310806|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310807|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310808|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
144310809|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310810|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310811|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144360021|NCT01601535|520525137|FG002|Phase 2|Adverse Event|0|||
144310812|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310813|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
144310814|NCT02891226|520340696|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310815|NCT02891226|520340697|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310816|NCT02891226|520340698|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310817|NCT02891226|520340699|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310818|NCT02891226|520340700|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310819|NCT02891226|520340701|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310820|NCT02891226|520340702|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310821|NCT02891226|520340703|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310822|NCT02891226|520340704|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310823|NCT02891226|520340705|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310824|NCT02891226|520340706|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
144310825|NCT02891226|520340707|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310826|NCT02891226|520340708|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310827|NCT02891226|520340709|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310828|NCT02891226|520340710|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310829|NCT02891226|520340711|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
144310830|NCT02891226|520340696|FG000|Follow-up Period|Withdrawal by Subject|0|||
144310831|NCT02891226|520340697|FG001|Follow-up Period|Withdrawal by Subject|0|||
144310832|NCT02891226|520340698|FG002|Follow-up Period|Withdrawal by Subject|0|||
144310833|NCT02891226|520340699|FG003|Follow-up Period|Withdrawal by Subject|0|||
144310834|NCT02891226|520340700|FG004|Follow-up Period|Withdrawal by Subject|0|||
144310835|NCT02891226|520340701|FG005|Follow-up Period|Withdrawal by Subject|0|||
144310836|NCT02891226|520340702|FG006|Follow-up Period|Withdrawal by Subject|0|||
144310837|NCT02891226|520340703|FG007|Follow-up Period|Withdrawal by Subject|0|||
144310838|NCT02891226|520340704|FG008|Follow-up Period|Withdrawal by Subject|0|||
144310839|NCT02891226|520340705|FG009|Follow-up Period|Withdrawal by Subject|0|||
144310840|NCT02891226|520340706|FG010|Follow-up Period|Withdrawal by Subject|0|||
144310841|NCT02891226|520340707|FG011|Follow-up Period|Withdrawal by Subject|1|||
144310842|NCT02891226|520340708|FG012|Follow-up Period|Withdrawal by Subject|0|||
144310843|NCT02891226|520340709|FG013|Follow-up Period|Withdrawal by Subject|0|||
144310844|NCT02891226|520340710|FG014|Follow-up Period|Withdrawal by Subject|1|||
144310845|NCT02891226|520340711|FG015|Follow-up Period|Withdrawal by Subject|1|||
144310846|NCT00145626|520340712|FG000|Overall Study|Did not have NK infusions|2|||
144310847|NCT00145626|520340712|FG000|Overall Study|Turned 2 years old before treatment|1|||
144310848|NCT00145626|520340712|FG000|Overall Study|Death|1|||
144310849|NCT00145626|520340712|FG000|Overall Study|Withdrawal by Subject|1|||
144310850|NCT02454530|520340715|FG000|Overall Study|Other|8|||
144310851|NCT02454530|520340716|FG001|Overall Study|Other|13|||
144310852|NCT02454530|520340715|FG000|Overall Study|Missing information|56|||
144310853|NCT02454530|520340716|FG001|Overall Study|Missing information|69|||
144310854|NCT02454530|520340715|FG000|Overall Study|Death|2|||
144310855|NCT02454530|520340716|FG001|Overall Study|Death|41|||
144310856|NCT02454530|520340715|FG000|Overall Study|Lost to Follow-up|4|||
144310857|NCT02454530|520340716|FG001|Overall Study|Lost to Follow-up|4|||
144310858|NCT04487080|520340723|FG000|Overall Study|Withdrawal by Subject|19|||
144310859|NCT04487080|520340724|FG001|Overall Study|Withdrawal by Subject|18|||
144310860|NCT04487080|520340725|FG002|Overall Study|Withdrawal by Subject|13|||
144310861|NCT04487080|520340723|FG000|Overall Study|Lost to Follow-up|3|||
144310862|NCT04487080|520340724|FG001|Overall Study|Lost to Follow-up|1|||
144310863|NCT04487080|520340725|FG002|Overall Study|Lost to Follow-up|0|||
144310864|NCT04487080|520340723|FG000|Overall Study|Ongoing|313|||
144310865|NCT04487080|520340724|FG001|Overall Study|Ongoing|297|||
144310866|NCT04487080|520340725|FG002|Overall Study|Ongoing|149|||
144310867|NCT00293813|520342111|FG000|Overall Study|Physician Decision|0|||
144310868|NCT00293813|520342112|FG001|Overall Study|Physician Decision|1|||
144310869|NCT00293813|520342113|FG002|Overall Study|Physician Decision|0|||
144310870|NCT00293813|520342111|FG000|Overall Study|Adverse Event|3|||
144310871|NCT00293813|520342112|FG001|Overall Study|Adverse Event|1|||
144310872|NCT00293813|520342113|FG002|Overall Study|Adverse Event|1|||
144310873|NCT00293813|520342111|FG000|Overall Study|Withdrawal by Subject|7|||
144310874|NCT00293813|520342112|FG001|Overall Study|Withdrawal by Subject|4|||
144310875|NCT00293813|520342113|FG002|Overall Study|Withdrawal by Subject|4|||
144310876|NCT00293813|520342111|FG000|Overall Study|Lost to Follow-up|3|||
144310877|NCT00293813|520342112|FG001|Overall Study|Lost to Follow-up|2|||
144310878|NCT00293813|520342113|FG002|Overall Study|Lost to Follow-up|3|||
144310879|NCT00293813|520342111|FG000|Overall Study|Noncompliance|0|||
144310880|NCT00293813|520342112|FG001|Overall Study|Noncompliance|1|||
144310881|NCT00293813|520342113|FG002|Overall Study|Noncompliance|0|||
144310882|NCT02197572|520342120|FG000|Overall Study|Progressive Disease|28|||
144310883|NCT02197572|520342120|FG000|Overall Study|Withdrawal by Subject|9|||
144310884|NCT02197572|520342120|FG000|Overall Study|Adverse Event|3|||
144310885|NCT02197572|520342120|FG000|Overall Study|Reason Not Specified|4|||
144310886|NCT01465386|520342122|FG000|Overall Study|Lack of Efficacy|3|||
144310887|NCT01465386|520342122|FG000|Overall Study|Adverse Event|1|||
144310888|NCT01279044|520342123|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
144310889|NCT01279044|520342124|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
144310890|NCT01279044|520342125|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
144310891|NCT01279044|520342123|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
144310892|NCT01279044|520342124|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
144310893|NCT01279044|520342125|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
144310894|NCT01279044|520342123|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
144310895|NCT01279044|520342124|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
144310896|NCT01279044|520342125|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
144310897|NCT01408277|520342127|FG000|Overall Study|Adverse Event|3|||
144310898|NCT01408277|520342128|FG001|Overall Study|Adverse Event|4|||
144310899|NCT01408277|520342127|FG000|Overall Study|Lost to Follow-up|1|||
144310900|NCT01408277|520342128|FG001|Overall Study|Lost to Follow-up|0|||
144310901|NCT01408277|520342127|FG000|Overall Study|Withdrawal by Subject|2|||
144310902|NCT01408277|520342128|FG001|Overall Study|Withdrawal by Subject|0|||
144310903|NCT01408277|520342127|FG000|Overall Study|Protocol Violation|2|||
144310904|NCT01408277|520342128|FG001|Overall Study|Protocol Violation|0|||
144310905|NCT02840253|520342129|FG000|Overall Study|Unsuccessful block|4|||
144310906|NCT03783962|520342130|FG000|Overall Study|Lost to Follow-up|3|||
144310907|NCT03783962|520342131|FG001|Overall Study|Lost to Follow-up|6|||
144310908|NCT03783962|520342130|FG000|Overall Study|Protocol Violation|0|||
144310909|NCT03783962|520342131|FG001|Overall Study|Protocol Violation|1|||
144310910|NCT03458325|520342132|FG000|Overall Study|Withdrawal by Subject|1|||
144310911|NCT00460655|520342137|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
144310912|NCT00460655|520342138|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144310913|NCT00460655|520342139|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144310914|NCT00460655|520342140|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
144310915|NCT00460655|520342137|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
144310916|NCT00460655|520342138|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144310917|NCT00460655|520342139|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144310918|NCT00460655|520342140|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
144310919|NCT00460655|520342137|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
144310920|NCT00460655|520342138|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
144310921|NCT00460655|520342139|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
144310922|NCT00460655|520342140|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
144310923|NCT00460655|520342137|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144310924|NCT00460655|520342138|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
144310925|NCT00460655|520342139|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
144310926|NCT00460655|520342140|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
144310927|NCT00460655|520342137|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144310928|NCT00460655|520342138|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
144310929|NCT00460655|520342139|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
144310930|NCT00460655|520342140|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
144310931|NCT00460655|520342137|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
144310932|NCT00460655|520342138|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
144310933|NCT00460655|520342139|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
144310934|NCT00460655|520342140|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
144310935|NCT03650413|520342141|FG000|Overall Study|Adverse Event|1|||
144310936|NCT03650413|520342141|FG000|Overall Study|Lack of Efficacy|17|||
144310937|NCT03650413|520342141|FG000|Overall Study|Other|9|||
144310938|NCT03650413|520342141|FG000|Overall Study|Physician Decision|2|||
144310939|NCT03650413|520342141|FG000|Overall Study|Study Terminated By Sponsor|16|||
144310940|NCT03650413|520342141|FG000|Overall Study|Withdrawal by Subject|16|||
144310941|NCT02168101|520342142|FG000|Overall Study|Death|2|||
144310942|NCT02168101|520342143|FG001|Overall Study|Death|2|||
144310943|NCT02168101|520342144|FG002|Overall Study|Death|1|||
144310944|NCT05507567|520342145|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
144310945|NCT05507567|520342146|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
144310946|NCT05507567|520342147|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
144310947|NCT05507567|520342145|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
144310948|NCT05507567|520342146|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
144310949|NCT05507567|520342147|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
144310950|NCT05507567|520342145|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
144310951|NCT05507567|520342146|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
144310952|NCT05507567|520342147|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
144310953|NCT05507567|520342145|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
144310954|NCT05507567|520342146|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
144310955|NCT05507567|520342147|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
144310956|NCT01722994|520342150|FG000|Overall Study|Missing data|25|||
144310957|NCT01722994|520342151|FG001|Overall Study|Missing data|17|||
144310958|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
144310959|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
144310960|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310961|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310962|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310963|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310964|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310965|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310966|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310967|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
144310968|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
144310969|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
144310970|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310971|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310972|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310973|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310974|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310975|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310976|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310977|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
144310978|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
144310979|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310980|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310981|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310982|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310983|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310984|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310985|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310986|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310987|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
144310988|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
144310989|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
144310990|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310991|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310992|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310993|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310994|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310995|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310996|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310997|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
144310998|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144310999|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
144311000|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311001|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311002|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311003|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311004|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311005|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311006|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311007|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
144311008|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
144311009|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
144311010|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311011|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311012|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311013|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311014|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311015|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311016|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311017|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
144311018|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
144311019|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
144311020|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311021|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311022|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311023|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311024|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311025|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311026|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311027|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
144311028|NCT01194219|520342157|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
144311029|NCT01194219|520342158|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
144311030|NCT01194219|520342159|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311031|NCT01194219|520342160|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311032|NCT01194219|520342161|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311033|NCT01194219|520342162|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311034|NCT01194219|520342163|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311035|NCT01194219|520342164|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311036|NCT01194219|520342165|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311037|NCT01194219|520342166|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
144311038|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311039|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311040|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
144311041|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
144311042|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311043|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311044|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311045|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311046|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311047|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
144311048|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311049|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311050|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
144311051|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
144311052|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311053|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311054|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311055|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311056|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311057|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
144311058|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311059|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311060|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
144311061|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
144311062|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311063|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311064|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311065|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311066|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311067|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
144311068|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311069|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311070|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
144311071|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
144311072|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311073|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311074|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311075|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311076|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311077|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
144311078|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311079|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311080|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
144311081|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311082|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311083|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311084|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311085|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311086|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311087|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
144311088|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311089|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311090|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311091|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
144311092|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311093|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311094|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311095|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311096|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311097|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
144311098|NCT01194219|520342157|FG000|Maintenance Phase Weeks16-32|Other|0|||
144311099|NCT01194219|520342158|FG001|Maintenance Phase Weeks16-32|Other|0|||
144311100|NCT01194219|520342159|FG002|Maintenance Phase Weeks16-32|Other|2|||
144311101|NCT01194219|520342160|FG003|Maintenance Phase Weeks16-32|Other|1|||
144311102|NCT01194219|520342161|FG004|Maintenance Phase Weeks16-32|Other|0|||
144311103|NCT01194219|520342162|FG005|Maintenance Phase Weeks16-32|Other|0|||
144311104|NCT01194219|520342163|FG006|Maintenance Phase Weeks16-32|Other|0|||
144311105|NCT01194219|520342164|FG007|Maintenance Phase Weeks16-32|Other|0|||
144311106|NCT01194219|520342165|FG008|Maintenance Phase Weeks16-32|Other|0|||
144311107|NCT01194219|520342166|FG009|Maintenance Phase Weeks16-32|Other|0|||
144311108|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311109|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311110|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311111|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311112|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311113|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
144311114|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
144311115|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
144311116|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311117|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
144311118|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
144311119|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
144311120|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
144311121|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
144311122|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
144311123|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
144311124|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
144311125|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
144311126|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
144311127|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
144311128|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311129|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311130|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311131|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311132|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
144311133|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311134|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
144311135|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311136|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311137|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
144311138|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311139|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311140|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311141|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311142|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
144311143|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311144|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
144311145|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
144311146|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311147|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
144311148|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311149|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311150|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311151|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311152|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
144360022|NCT01601535|520525138|FG003|Phase 2|Adverse Event|0|||
144311153|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
144311154|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
144311155|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311156|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311157|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
144311158|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311159|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311160|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311161|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311162|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311163|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311164|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311165|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
144311166|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311167|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
144311168|NCT01194219|520342157|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311169|NCT01194219|520342158|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311170|NCT01194219|520342159|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311171|NCT01194219|520342160|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311172|NCT01194219|520342161|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311173|NCT01194219|520342162|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311174|NCT01194219|520342163|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
144311175|NCT01194219|520342164|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311176|NCT01194219|520342165|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311177|NCT01194219|520342166|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
144311178|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311179|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311180|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311181|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311182|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311183|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311184|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311185|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
144311186|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
144311187|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
144311188|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311189|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311190|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311191|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311192|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311193|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311194|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311195|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
144311196|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
144311197|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
144311198|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311199|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311200|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311201|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311202|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311203|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311204|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311205|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
144311206|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
144311207|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
144311208|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311209|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311210|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311211|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311212|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311213|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311214|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311215|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
144311216|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
144311217|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
144311218|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
144311219|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
144311220|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
144311221|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
144311222|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
144311223|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
144311224|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
144311225|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
144311226|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
144311227|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
144311228|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311229|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311230|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311231|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311232|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311233|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311234|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311235|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
144311236|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
144311237|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
144311238|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311239|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311240|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311241|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311242|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311243|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311244|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311245|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311246|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
144311247|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
144311248|NCT01194219|520342157|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311249|NCT01194219|520342158|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311250|NCT01194219|520342159|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311251|NCT01194219|520342160|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311252|NCT01194219|520342161|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311253|NCT01194219|520342162|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311254|NCT01194219|520342163|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311255|NCT01194219|520342164|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
144311256|NCT01194219|520342165|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
144311257|NCT01194219|520342166|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
144311258|NCT03951766|520342167|FG000|Treatment Phase|Lost to Follow-up|1|||
144311259|NCT03951766|520342167|FG000|Follow-up Phase|Lost to Follow-up|10|||
144311260|NCT01871545|520342168|FG000|Overall Study|Death|2|||
144311261|NCT01871545|520342169|FG001|Overall Study|Death|0|||
144311262|NCT01871545|520342168|FG000|Overall Study|Lack of Efficacy|11|||
144311263|NCT01871545|520342169|FG001|Overall Study|Lack of Efficacy|2|||
144311264|NCT01871545|520342168|FG000|Overall Study|Physician Decision|4|||
144311265|NCT01871545|520342169|FG001|Overall Study|Physician Decision|0|||
144311266|NCT01871545|520342168|FG000|Overall Study|Withdrawal by Subject|0|||
144311267|NCT01871545|520342169|FG001|Overall Study|Withdrawal by Subject|1|||
144311268|NCT01523743|520342170|FG000|Period 1|Adverse Event|1|||
144311269|NCT01523743|520342171|FG001|Period 1|Adverse Event|0|||
144311270|NCT01523743|520342170|FG000|Period 1|Withdrawal by Subject|6|||
144311271|NCT01523743|520342171|FG001|Period 1|Withdrawal by Subject|2|||
144311272|NCT01523743|520342170|FG000|Period 1|Lost to Follow-up|1|||
144311273|NCT01523743|520342171|FG001|Period 1|Lost to Follow-up|0|||
144311274|NCT01523743|520342170|FG000|Period 1|Lack of Efficacy|1|||
144311275|NCT01523743|520342171|FG001|Period 1|Lack of Efficacy|0|||
144311276|NCT01523743|520342170|FG000|Period 1|Felt unable to empty bladder|1|||
144311277|NCT01523743|520342171|FG001|Period 1|Felt unable to empty bladder|0|||
144311278|NCT01523743|520342170|FG000|Period 2|Withdrawal by Subject|0|||
144311279|NCT01523743|520342171|FG001|Period 2|Withdrawal by Subject|2|||
144311280|NCT01523743|520342170|FG000|Period 2|Adverse Event|1|||
144311281|NCT01523743|520342171|FG001|Period 2|Adverse Event|0|||
144311282|NCT01071954|520342172|FG000|Overall Study|Noncompliance|4|||
144311283|NCT01071954|520342172|FG000|Overall Study|Adverse Event|1|||
144311284|NCT01071954|520342172|FG000|Overall Study|Withdrawal by Subject|11|||
144311285|NCT01071954|520342172|FG000|Overall Study|Requirement for Alternative Therapy|5|||
144311286|NCT01071954|520342172|FG000|Overall Study|Administrative Decision|5|||
144311287|NCT01071954|520342172|FG000|Overall Study|Protocol Specified Criteria|1|||
144311288|NCT03782064|520342173|FG000|Overall Study|Lack of Efficacy|2|||
144311289|NCT03782064|520342173|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
144311290|NCT00363142|520342174|FG000|Overall Study|Adverse Event|2|||
144311291|NCT00363142|520342175|FG001|Overall Study|Adverse Event|0|||
144311292|NCT00363142|520342174|FG000|Overall Study|Lack of Efficacy|0|||
144311293|NCT00363142|520342175|FG001|Overall Study|Lack of Efficacy|1|||
144311294|NCT00363142|520342174|FG000|Overall Study|Lost to Follow-up|1|||
144311295|NCT00363142|520342175|FG001|Overall Study|Lost to Follow-up|0|||
144311296|NCT00363142|520342174|FG000|Overall Study|Non-compliance|1|||
144311297|NCT00363142|520342175|FG001|Overall Study|Non-compliance|1|||
144311298|NCT00363142|520342174|FG000|Overall Study|Withdrawal by Subject|3|||
144311299|NCT00363142|520342175|FG001|Overall Study|Withdrawal by Subject|1|||
144311300|NCT00049322|520342179|FG000|Overall Study|disease burden|0|||
144311301|NCT00049322|520342180|FG001|Overall Study|disease burden|3|||
144311302|NCT00049322|520342179|FG000|Overall Study|Adverse Event|1|||
144311303|NCT00049322|520342180|FG001|Overall Study|Adverse Event|0|||
144311304|NCT00049322|520342179|FG000|Overall Study|refused angio|0|||
144311305|NCT00049322|520342180|FG001|Overall Study|refused angio|3|||
144311306|NCT00132301|520342181|FG000|Overall Study|Death|7|||
144311307|NCT00132301|520342182|FG001|Overall Study|Death|6|||
144311308|NCT00132301|520342181|FG000|Overall Study|Withdrawal by Subject|5|||
144311309|NCT00132301|520342182|FG001|Overall Study|Withdrawal by Subject|2|||
144311310|NCT00132301|520342181|FG000|Overall Study|Physician Decision|1|||
144311311|NCT00132301|520342182|FG001|Overall Study|Physician Decision|1|||
144311312|NCT00132301|520342181|FG000|Overall Study|Lost to Follow-up|5|||
144311313|NCT00132301|520342182|FG001|Overall Study|Lost to Follow-up|3|||
144311314|NCT00132301|520342181|FG000|Overall Study|Other|1|||
144311315|NCT00132301|520342182|FG001|Overall Study|Other|1|||
144311316|NCT00132301|520342181|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
144311317|NCT00132301|520342182|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
144311318|NCT01890265|520342186|FG000|Overall Study|Other (Unspecified reason)|0|||
144311319|NCT01890265|520342187|FG001|Overall Study|Other (Unspecified reason)|1|||
144311320|NCT01890265|520342188|FG002|Overall Study|Other (Unspecified reason)|0|||
144311321|NCT01890265|520342189|FG003|Overall Study|Other (Unspecified reason)|0|||
144311322|NCT01890265|520342190|FG004|Overall Study|Other (Unspecified reason)|0|||
144311323|NCT01890265|520342191|FG005|Overall Study|Other (Unspecified reason)|0|||
144311324|NCT01890265|520342186|FG000|Overall Study|Progressive disease|6|||
144311325|NCT01890265|520342187|FG001|Overall Study|Progressive disease|6|||
144311326|NCT01890265|520342188|FG002|Overall Study|Progressive disease|0|||
144311327|NCT01890265|520342189|FG003|Overall Study|Progressive disease|0|||
144311328|NCT01890265|520342190|FG004|Overall Study|Progressive disease|0|||
144311329|NCT01890265|520342191|FG005|Overall Study|Progressive disease|0|||
144311330|NCT01890265|520342186|FG000|Overall Study|Adverse Event|2|||
144311331|NCT01890265|520342187|FG001|Overall Study|Adverse Event|1|||
144311332|NCT01890265|520342188|FG002|Overall Study|Adverse Event|0|||
144311333|NCT01890265|520342189|FG003|Overall Study|Adverse Event|0|||
144311334|NCT01890265|520342190|FG004|Overall Study|Adverse Event|0|||
144311335|NCT01890265|520342191|FG005|Overall Study|Adverse Event|0|||
144311336|NCT01890265|520342186|FG000|Overall Study|Death|2|||
144311337|NCT01890265|520342187|FG001|Overall Study|Death|3|||
144311338|NCT01890265|520342188|FG002|Overall Study|Death|1|||
144311339|NCT01890265|520342189|FG003|Overall Study|Death|0|||
144311340|NCT01890265|520342190|FG004|Overall Study|Death|0|||
144311341|NCT01890265|520342191|FG005|Overall Study|Death|0|||
144311342|NCT01890265|520342186|FG000|Overall Study|Withdrawal by Subject|0|||
144311343|NCT01890265|520342187|FG001|Overall Study|Withdrawal by Subject|2|||
144311344|NCT01890265|520342188|FG002|Overall Study|Withdrawal by Subject|3|||
144311345|NCT01890265|520342189|FG003|Overall Study|Withdrawal by Subject|0|||
144311346|NCT01890265|520342190|FG004|Overall Study|Withdrawal by Subject|2|||
144311347|NCT01890265|520342191|FG005|Overall Study|Withdrawal by Subject|0|||
144311348|NCT00577707|520342195|FG000|Overall Study|Withdrawal by Subject|3|||
144311349|NCT03666988|520342196|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
144311350|NCT03666988|520342197|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
144311351|NCT03666988|520342198|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
144311352|NCT03666988|520342199|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
144311353|NCT03666988|520342200|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
144311354|NCT03666988|520342201|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
144311355|NCT03666988|520342196|FG000|Part 1 (Up to 28 Months)|Other|0|||
144311356|NCT03666988|520342197|FG001|Part 1 (Up to 28 Months)|Other|1|||
144311357|NCT03666988|520342198|FG002|Part 1 (Up to 28 Months)|Other|1|||
144311358|NCT03666988|520342199|FG003|Part 1 (Up to 28 Months)|Other|0|||
144311359|NCT03666988|520342200|FG004|Part 1 (Up to 28 Months)|Other|0|||
144311360|NCT03666988|520342201|FG005|Part 1 (Up to 28 Months)|Other|0|||
144311361|NCT03666988|520342196|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
144311362|NCT03666988|520342197|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
144311363|NCT03666988|520342198|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
144311364|NCT03666988|520342199|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
144311365|NCT03666988|520342200|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
144311366|NCT03666988|520342201|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
144311367|NCT03666988|520342196|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
144311368|NCT03666988|520342197|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
144311369|NCT03666988|520342198|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
144311370|NCT03666988|520342199|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
144311371|NCT03666988|520342200|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
144311372|NCT03666988|520342201|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
144311373|NCT03666988|520342196|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
144311374|NCT03666988|520342197|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
144311375|NCT03666988|520342198|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
144311376|NCT03666988|520342199|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
144311377|NCT03666988|520342200|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
144311378|NCT03666988|520342201|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
144311379|NCT05588440|520342208|FG000|Overall Study|Sponsor Decision|2|||
144311380|NCT05588440|520342209|FG001|Overall Study|Sponsor Decision|0|||
144311381|NCT05588440|520342210|FG002|Overall Study|Sponsor Decision|1|||
144311382|NCT05588440|520342208|FG000|Overall Study|Death|1|||
144311383|NCT05588440|520342209|FG001|Overall Study|Death|1|||
144311384|NCT05588440|520342210|FG002|Overall Study|Death|1|||
144311385|NCT05588440|520342208|FG000|Overall Study|Screen Fail|0|||
144311386|NCT05588440|520342209|FG001|Overall Study|Screen Fail|1|||
144311387|NCT05588440|520342210|FG002|Overall Study|Screen Fail|1|||
144311388|NCT05588440|520342208|FG000|Overall Study|Withdrawal by Subject|0|||
144311389|NCT05588440|520342209|FG001|Overall Study|Withdrawal by Subject|0|||
144311390|NCT05588440|520342210|FG002|Overall Study|Withdrawal by Subject|1|||
144311391|NCT01402869|520342211|FG000|Overall Study|Required Tooth Extraction|0|||
144311392|NCT01402869|520342212|FG001|Overall Study|Required Tooth Extraction|0|||
144311393|NCT01402869|520342213|FG002|Overall Study|Required Tooth Extraction|1|||
144311394|NCT01392573|520342214|FG000|Overall Study|Adverse Event|1|||
144311395|NCT01392573|520342215|FG001|Overall Study|Adverse Event|3|||
144311396|NCT01392573|520342214|FG000|Overall Study|Lack of Efficacy|1|||
144311397|NCT01392573|520342215|FG001|Overall Study|Lack of Efficacy|2|||
144311398|NCT01392573|520342214|FG000|Overall Study|Protocol Violation|0|||
144311399|NCT01392573|520342215|FG001|Overall Study|Protocol Violation|2|||
144311400|NCT01392573|520342214|FG000|Overall Study|Withdrawal Criteria|13|||
144311401|NCT01392573|520342215|FG001|Overall Study|Withdrawal Criteria|15|||
144311402|NCT01392573|520342214|FG000|Overall Study|Site closure|8|||
144311403|NCT01392573|520342215|FG001|Overall Study|Site closure|7|||
144311404|NCT01392573|520342214|FG000|Overall Study|Unclassified|9|||
144311405|NCT01392573|520342215|FG001|Overall Study|Unclassified|6|||
144311406|NCT00100802|520342216|FG000|Overall Study|Adverse Event|9|||
144311407|NCT00100802|520342216|FG000|Overall Study|Death|1|||
144311408|NCT00100802|520342216|FG000|Overall Study|Lack of Efficacy|47|||
144311409|NCT00100802|520342216|FG000|Overall Study|Physician Decision|5|||
144311410|NCT00100802|520342216|FG000|Overall Study|Protocol Violation|1|||
144311411|NCT00100802|520342216|FG000|Overall Study|Withdrawal by Subject|5|||
144311412|NCT00100802|520342216|FG000|Overall Study|Ineligible|12|||
144311413|NCT00436436|520342217|FG000|Overall Study|Progression|4|||
144311414|NCT00436436|520342217|FG000|Overall Study|Adverse Event|2|||
144311415|NCT00436436|520342217|FG000|Overall Study|Death|6|||
144311416|NCT02709720|520342218|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
144311417|NCT02709720|520342218|FG000|Overall Study|Protocol Violation|1|||
144311418|NCT02709720|520342218|FG000|Overall Study|Not take study medication|1|||
144311419|NCT00325130|520342250|FG000|Overall Study|Lost to Follow-up|6|||
144311420|NCT00325130|520342251|FG001|Overall Study|Lost to Follow-up|14|||
144311421|NCT00325130|520342250|FG000|Overall Study|Withdrawal by Subject|12|||
144311422|NCT00325130|520342251|FG001|Overall Study|Withdrawal by Subject|14|||
144311423|NCT00325130|520342250|FG000|Overall Study|Protocol Deviation|0|||
144311424|NCT00325130|520342251|FG001|Overall Study|Protocol Deviation|1|||
144311425|NCT00325130|520342250|FG000|Overall Study|Moved|0|||
144311426|NCT00325130|520342251|FG001|Overall Study|Moved|1|||
144311427|NCT00325130|520342250|FG000|Overall Study|Patient Discontinued for Other|1|||
144311428|NCT00325130|520342251|FG001|Overall Study|Patient Discontinued for Other|0|||
144311429|NCT00200967|520342252|FG000|First Treatment Period|Withdrawal by Subject|5|||
144311430|NCT00200967|520342253|FG001|First Treatment Period|Withdrawal by Subject|1|||
144311431|NCT00200967|520342252|FG000|First Treatment Period|Pregnancy|1|||
144311432|NCT00200967|520342253|FG001|First Treatment Period|Pregnancy|0|||
144311433|NCT00200967|520342252|FG000|Wash-out Period|Lost to Follow-up|0|||
144311434|NCT00200967|520342253|FG001|Wash-out Period|Lost to Follow-up|1|||
144311435|NCT00200967|520342252|FG000|Second Treatment Period|Withdrawal by Subject|1|||
144311436|NCT00200967|520342253|FG001|Second Treatment Period|Withdrawal by Subject|2|||
144311437|NCT00200967|520342252|FG000|Run-out Period|Lost to Follow-up|1|||
144311438|NCT00200967|520342253|FG001|Run-out Period|Lost to Follow-up|0|||
144311439|NCT00928187|520342257|FG000|Overall Study|Death|1|||
144311440|NCT00928187|520342258|FG001|Overall Study|Death|2|||
144311441|NCT00928187|520342259|FG002|Overall Study|Death|3|||
144311442|NCT00928187|520342257|FG000|Overall Study|Lost to Follow-up|1|||
144311443|NCT00928187|520342258|FG001|Overall Study|Lost to Follow-up|2|||
144311444|NCT00928187|520342259|FG002|Overall Study|Lost to Follow-up|1|||
144311445|NCT00928187|520342257|FG000|Overall Study|Withdrawal by Subject|0|||
144311446|NCT00928187|520342258|FG001|Overall Study|Withdrawal by Subject|1|||
144311447|NCT00928187|520342259|FG002|Overall Study|Withdrawal by Subject|1|||
144311448|NCT00928187|520342257|FG000|Overall Study|Protocol Violation|0|||
144311449|NCT00928187|520342258|FG001|Overall Study|Protocol Violation|1|||
144311450|NCT00928187|520342259|FG002|Overall Study|Protocol Violation|0|||
144311451|NCT02524145|520342263|FG000|Overall Study|Withdrawal by Subject|2|||
144311452|NCT02524145|520342264|FG001|Overall Study|Withdrawal by Subject|2|||
144311453|NCT02524145|520342265|FG002|Overall Study|Withdrawal by Subject|3|||
144311454|NCT00316706|520343906|FG000|Overall Study|Lost to Follow-up|38|||
144311455|NCT00316706|520343907|FG001|Overall Study|Lost to Follow-up|48|||
144311456|NCT01127607|520343913|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
144311457|NCT01127607|520343914|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
144311458|NCT01127607|520343913|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
144311459|NCT01127607|520343914|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
144311460|NCT03640325|520343915|FG000|Overall Study|Withdrawal by Subject|4|||
144311461|NCT03640325|520343916|FG001|Overall Study|Withdrawal by Subject|1|||
144311462|NCT03640325|520343917|FG002|Overall Study|Withdrawal by Subject|0|||
144311463|NCT03640325|520343915|FG000|Overall Study|Lost to Follow-up|4|||
144311464|NCT03640325|520343916|FG001|Overall Study|Lost to Follow-up|5|||
144311465|NCT03640325|520343917|FG002|Overall Study|Lost to Follow-up|21|||
144311466|NCT03640325|520343915|FG000|Overall Study|Death|5|||
144311467|NCT03640325|520343916|FG001|Overall Study|Death|5|||
144311468|NCT03640325|520343917|FG002|Overall Study|Death|0|||
144311469|NCT03493451|520343918|FG000|Overall Study|Death|11|||
144311470|NCT03493451|520343919|FG001|Overall Study|Death|26|||
144311471|NCT03493451|520343920|FG002|Overall Study|Death|3|||
144311472|NCT03493451|520343918|FG000|Overall Study|Lost to Follow-up|1|||
144311473|NCT03493451|520343919|FG001|Overall Study|Lost to Follow-up|4|||
144311474|NCT03493451|520343920|FG002|Overall Study|Lost to Follow-up|1|||
144311475|NCT03493451|520343918|FG000|Overall Study|Withdrawal by Subject|1|||
144311476|NCT03493451|520343919|FG001|Overall Study|Withdrawal by Subject|1|||
144311477|NCT03493451|520343920|FG002|Overall Study|Withdrawal by Subject|2|||
144311478|NCT03493451|520343918|FG000|Overall Study|Progressive Disease|1|||
144311479|NCT03493451|520343919|FG001|Overall Study|Progressive Disease|0|||
144311480|NCT03493451|520343920|FG002|Overall Study|Progressive Disease|0|||
144311481|NCT03493451|520343918|FG000|Overall Study|Transferred to long term extension study|8|||
144311482|NCT03493451|520343919|FG001|Overall Study|Transferred to long term extension study|13|||
144311483|NCT03493451|520343920|FG002|Overall Study|Transferred to long term extension study|5|||
144311484|NCT01133756|520343924|FG000|Overall Study|Adverse Event|1|||
144311485|NCT01133756|520343925|FG001|Overall Study|Adverse Event|2|||
144311486|NCT01133756|520343926|FG002|Overall Study|Adverse Event|1|||
144311487|NCT01133756|520343924|FG000|Overall Study|Investigator Decision|1|||
144311488|NCT01133756|520343925|FG001|Overall Study|Investigator Decision|0|||
144311489|NCT01133756|520343926|FG002|Overall Study|Investigator Decision|0|||
144311490|NCT01133756|520343924|FG000|Overall Study|Withdrawal by Subject|0|||
144311491|NCT01133756|520343925|FG001|Overall Study|Withdrawal by Subject|1|||
144311492|NCT01133756|520343926|FG002|Overall Study|Withdrawal by Subject|0|||
144311493|NCT01133756|520343924|FG000|Overall Study|Progression of Disease|0|||
144311494|NCT01133756|520343925|FG001|Overall Study|Progression of Disease|0|||
144311495|NCT01133756|520343926|FG002|Overall Study|Progression of Disease|1|||
144311496|NCT01566149|520343927|FG000|Overall Study|Adverse Event|0|||
144311497|NCT01566149|520343928|FG001|Overall Study|Adverse Event|1|||
144311498|NCT01566149|520343927|FG000|Overall Study|Non-compliance with study medication|2|||
144311499|NCT01566149|520343928|FG001|Overall Study|Non-compliance with study medication|0|||
144311500|NCT01566149|520343927|FG000|Overall Study|Protocol Violation|0|||
144311501|NCT01566149|520343928|FG001|Overall Study|Protocol Violation|1|||
144311502|NCT01566149|520343927|FG000|Overall Study|Withdrawal by Subject|1|||
144311503|NCT01566149|520343928|FG001|Overall Study|Withdrawal by Subject|0|||
144311504|NCT03941873|520343942|FG000|Overall Study|Death|0|||
144311505|NCT03941873|520343943|FG001|Overall Study|Death|12|||
144311506|NCT03941873|520343944|FG002|Overall Study|Death|2|||
144311507|NCT03941873|520343945|FG003|Overall Study|Death|53|||
144311508|NCT03941873|520343942|FG000|Overall Study|Withdrawal by Subject|1|||
144311509|NCT03941873|520343943|FG001|Overall Study|Withdrawal by Subject|1|||
144311510|NCT03941873|520343944|FG002|Overall Study|Withdrawal by Subject|0|||
144311511|NCT03941873|520343945|FG003|Overall Study|Withdrawal by Subject|5|||
144311512|NCT03941873|520343942|FG000|Overall Study|Lost to Follow-up|1|||
144311513|NCT03941873|520343943|FG001|Overall Study|Lost to Follow-up|2|||
144311514|NCT03941873|520343944|FG002|Overall Study|Lost to Follow-up|0|||
144311515|NCT03941873|520343945|FG003|Overall Study|Lost to Follow-up|0|||
144311516|NCT03941873|520343942|FG000|Overall Study|Sponsor Decision|0|||
144311517|NCT03941873|520343943|FG001|Overall Study|Sponsor Decision|6|||
144311518|NCT03941873|520343944|FG002|Overall Study|Sponsor Decision|0|||
144311519|NCT03941873|520343945|FG003|Overall Study|Sponsor Decision|15|||
144311520|NCT01693250|520343952|FG000|Overall Study|Lost to Follow-up|2|||
144311521|NCT01693250|520343953|FG001|Overall Study|Lost to Follow-up|2|||
144311522|NCT02297815|520343959|FG000|Overall Study|Lost to Follow-up|236|||
144311523|NCT02297815|520343960|FG001|Overall Study|Lost to Follow-up|140|||
144311524|NCT00662831|520343961|FG000|Overall Study|Death|4|||
144311525|NCT00662831|520343962|FG001|Overall Study|Death|1|||
144311526|NCT00662831|520343961|FG000|Overall Study|Lack of Efficacy|6|||
144311527|NCT00662831|520343962|FG001|Overall Study|Lack of Efficacy|6|||
144311528|NCT00662831|520343961|FG000|Overall Study|Lost to Follow-up|1|||
144311529|NCT00662831|520343962|FG001|Overall Study|Lost to Follow-up|0|||
144311530|NCT00662831|520343961|FG000|Overall Study|Withdrawal by Subject|2|||
144311531|NCT00662831|520343962|FG001|Overall Study|Withdrawal by Subject|1|||
144311532|NCT00662831|520343961|FG000|Overall Study|Other|62|||
144311533|NCT00662831|520343962|FG001|Overall Study|Other|31|||
144311534|NCT00662831|520343961|FG000|Overall Study|Protocol Violation|8|||
144311535|NCT00662831|520343962|FG001|Overall Study|Protocol Violation|4|||
144311536|NCT00662831|520343961|FG000|Overall Study|Adverse Event|23|||
144311537|NCT00662831|520343962|FG001|Overall Study|Adverse Event|16|||
144311538|NCT00620373|520343967|FG000|Overall Study|Unverified cancer status|33|||
144311539|NCT01897727|520343968|FG000|Overall Study|Exclusion: central sleep apnea|0|||
144311540|NCT01897727|520343969|FG001|Overall Study|Exclusion: central sleep apnea|1|||
144311541|NCT01061723|520343970|FG000|Overall Study|Adverse Event|0|||
144311542|NCT01061723|520343971|FG001|Overall Study|Adverse Event|2|||
144311543|NCT01061723|520343972|FG002|Overall Study|Adverse Event|5|||
144311544|NCT01061723|520343973|FG003|Overall Study|Adverse Event|5|||
144311545|NCT01061723|520343974|FG004|Overall Study|Adverse Event|2|||
144311546|NCT01061723|520343975|FG005|Overall Study|Adverse Event|6|||
144311547|NCT01061723|520343970|FG000|Overall Study|Lack of Efficacy|2|||
144311548|NCT01061723|520343971|FG001|Overall Study|Lack of Efficacy|3|||
144311549|NCT01061723|520343972|FG002|Overall Study|Lack of Efficacy|4|||
144311550|NCT01061723|520343973|FG003|Overall Study|Lack of Efficacy|2|||
144311551|NCT01061723|520343974|FG004|Overall Study|Lack of Efficacy|1|||
144311552|NCT01061723|520343975|FG005|Overall Study|Lack of Efficacy|1|||
144311553|NCT01061723|520343970|FG000|Overall Study|Randomized but not treated|0|||
144311554|NCT01061723|520343971|FG001|Overall Study|Randomized but not treated|0|||
144311555|NCT01061723|520343972|FG002|Overall Study|Randomized but not treated|0|||
144311556|NCT01061723|520343973|FG003|Overall Study|Randomized but not treated|0|||
144311557|NCT01061723|520343974|FG004|Overall Study|Randomized but not treated|0|||
144311558|NCT01061723|520343975|FG005|Overall Study|Randomized but not treated|1|||
144311559|NCT01061723|520343970|FG000|Overall Study|Other than specified above|2|||
144311560|NCT01061723|520343971|FG001|Overall Study|Other than specified above|1|||
144311561|NCT01061723|520343972|FG002|Overall Study|Other than specified above|1|||
144311562|NCT01061723|520343973|FG003|Overall Study|Other than specified above|1|||
144311563|NCT01061723|520343974|FG004|Overall Study|Other than specified above|0|||
144311564|NCT01061723|520343975|FG005|Overall Study|Other than specified above|1|||
144311565|NCT01734785|520343976|FG000|Open-Label Period|Adverse Event|0|||
144311566|NCT01734785|520343977|FG001|Open-Label Period|Adverse Event|0|||
144311567|NCT01734785|520343978|FG002|Open-Label Period|Adverse Event|0|||
144311568|NCT01734785|520343979|FG003|Open-Label Period|Adverse Event|9|||
144311569|NCT01734785|520343976|FG000|Open-Label Period|Lack of Efficacy|0|||
144311570|NCT01734785|520343977|FG001|Open-Label Period|Lack of Efficacy|0|||
144311571|NCT01734785|520343978|FG002|Open-Label Period|Lack of Efficacy|0|||
144311572|NCT01734785|520343979|FG003|Open-Label Period|Lack of Efficacy|1|||
144311573|NCT01734785|520343976|FG000|Open-Label Period|Protocol Violation|0|||
144311574|NCT01734785|520343977|FG001|Open-Label Period|Protocol Violation|0|||
144311575|NCT01734785|520343978|FG002|Open-Label Period|Protocol Violation|0|||
144311576|NCT01734785|520343979|FG003|Open-Label Period|Protocol Violation|13|||
144311577|NCT01734785|520343976|FG000|Open-Label Period|Lost to Follow-up|0|||
144311578|NCT01734785|520343977|FG001|Open-Label Period|Lost to Follow-up|0|||
144311579|NCT01734785|520343978|FG002|Open-Label Period|Lost to Follow-up|0|||
144311580|NCT01734785|520343979|FG003|Open-Label Period|Lost to Follow-up|14|||
144311581|NCT01734785|520343976|FG000|Open-Label Period|Withdrawal by Subject|0|||
144311582|NCT01734785|520343977|FG001|Open-Label Period|Withdrawal by Subject|0|||
144311583|NCT01734785|520343978|FG002|Open-Label Period|Withdrawal by Subject|0|||
144311584|NCT01734785|520343979|FG003|Open-Label Period|Withdrawal by Subject|12|||
144311585|NCT01734785|520343976|FG000|Open-Label Period|Other Reasons|0|||
144311586|NCT01734785|520343977|FG001|Open-Label Period|Other Reasons|0|||
144311587|NCT01734785|520343978|FG002|Open-Label Period|Other Reasons|0|||
144311588|NCT01734785|520343979|FG003|Open-Label Period|Other Reasons|224|||
144311589|NCT01734785|520343976|FG000|Double-Blind Period|Adverse Event|0|||
144311590|NCT01734785|520343977|FG001|Double-Blind Period|Adverse Event|3|||
144311591|NCT01734785|520343978|FG002|Double-Blind Period|Adverse Event|2|||
144311592|NCT01734785|520343979|FG003|Double-Blind Period|Adverse Event|0|||
144311593|NCT01734785|520343976|FG000|Double-Blind Period|Lack of Efficacy|0|||
144311594|NCT01734785|520343977|FG001|Double-Blind Period|Lack of Efficacy|1|||
144311595|NCT01734785|520343978|FG002|Double-Blind Period|Lack of Efficacy|0|||
144311596|NCT01734785|520343979|FG003|Double-Blind Period|Lack of Efficacy|0|||
144311597|NCT01734785|520343976|FG000|Double-Blind Period|Protocol Violation|0|||
144311598|NCT01734785|520343977|FG001|Double-Blind Period|Protocol Violation|1|||
144311599|NCT01734785|520343978|FG002|Double-Blind Period|Protocol Violation|1|||
144311600|NCT01734785|520343979|FG003|Double-Blind Period|Protocol Violation|0|||
144311601|NCT01734785|520343976|FG000|Double-Blind Period|Lost to Follow-up|2|||
144311602|NCT01734785|520343977|FG001|Double-Blind Period|Lost to Follow-up|4|||
144311603|NCT01734785|520343978|FG002|Double-Blind Period|Lost to Follow-up|2|||
144311604|NCT01734785|520343979|FG003|Double-Blind Period|Lost to Follow-up|0|||
144311605|NCT01734785|520343976|FG000|Double-Blind Period|Withdrawal by Subject|2|||
144311606|NCT01734785|520343977|FG001|Double-Blind Period|Withdrawal by Subject|0|||
144311607|NCT01734785|520343978|FG002|Double-Blind Period|Withdrawal by Subject|0|||
144311608|NCT01734785|520343979|FG003|Double-Blind Period|Withdrawal by Subject|0|||
144311609|NCT01734785|520343976|FG000|Double-Blind Period|Not treated|1|||
144311610|NCT01734785|520343977|FG001|Double-Blind Period|Not treated|0|||
144311611|NCT01734785|520343978|FG002|Double-Blind Period|Not treated|0|||
144311612|NCT01734785|520343979|FG003|Double-Blind Period|Not treated|0|||
144311613|NCT02013778|520343985|FG000|Overall Study|Death|4|||
144311614|NCT02013778|520343985|FG000|Overall Study|Withdrawal by Subject|1|||
144311615|NCT02013778|520343985|FG000|Overall Study|Physician Decision|1|||
144311616|NCT02013778|520343985|FG000|Overall Study|Adverse Event|1|||
144311617|NCT01961297|520343986|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
144311618|NCT01961297|520343987|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
144311619|NCT03592771|520343990|FG000|Overall Study|Adverse Event|2|||
144311620|NCT03592771|520343991|FG001|Overall Study|Adverse Event|0|||
144311621|NCT03592771|520343992|FG002|Overall Study|Adverse Event|1|||
144311622|NCT03592771|520343990|FG000|Overall Study|Death|0|||
144311623|NCT03592771|520343991|FG001|Overall Study|Death|1|||
144311624|NCT03592771|520343992|FG002|Overall Study|Death|1|||
144311625|NCT03592771|520343990|FG000|Overall Study|Lost to Follow-up|5|||
144311626|NCT03592771|520343991|FG001|Overall Study|Lost to Follow-up|11|||
144311627|NCT03592771|520343992|FG002|Overall Study|Lost to Follow-up|15|||
144311628|NCT03592771|520343990|FG000|Overall Study|Withdrawal by Subject|0|||
144311629|NCT03592771|520343991|FG001|Overall Study|Withdrawal by Subject|2|||
144311630|NCT03592771|520343992|FG002|Overall Study|Withdrawal by Subject|0|||
144311631|NCT00735553|520343993|FG000|Overall Study|Study prematurely terminated|77|||
144311632|NCT02705105|520343994|FG000|Treatment|Objective Disease Progression|1|||
144311633|NCT02705105|520343995|FG001|Treatment|Objective Disease Progression|50|||
144311634|NCT02705105|520343994|FG000|Treatment|Withdrawal by Subject|3|||
144311635|NCT02705105|520343995|FG001|Treatment|Withdrawal by Subject|5|||
144311636|NCT02705105|520343994|FG000|Treatment|Adverse Event|0|||
144311637|NCT02705105|520343995|FG001|Treatment|Adverse Event|17|||
144311638|NCT02705105|520343994|FG000|Treatment|Clinical Disease Progression|0|||
144311639|NCT02705105|520343995|FG001|Treatment|Clinical Disease Progression|32|||
144311640|NCT02705105|520343994|FG000|Treatment|Physician Decision|0|||
144311641|NCT02705105|520343995|FG001|Treatment|Physician Decision|3|||
144311642|NCT02705105|520343994|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
144311643|NCT02705105|520343995|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
144311644|NCT02705105|520343994|FG000|Follow-Up|Death|3|||
144311645|NCT02705105|520343995|FG001|Follow-Up|Death|68|||
144311646|NCT02705105|520343994|FG000|Follow-Up|Withdrawal by Subject|1|||
144311647|NCT02705105|520343995|FG001|Follow-Up|Withdrawal by Subject|14|||
144311648|NCT02705105|520343994|FG000|Follow-Up|Study Terminated|0|||
144311649|NCT02705105|520343995|FG001|Follow-Up|Study Terminated|26|||
144311650|NCT02705105|520343994|FG000|Follow-Up|Discontinued per Amendment 3|0|||
144311651|NCT02705105|520343995|FG001|Follow-Up|Discontinued per Amendment 3|2|||
144311652|NCT00310375|520343996|FG000|Primary Reporting Phase|Adverse Event|28|||
144311653|NCT00310375|520343997|FG001|Primary Reporting Phase|Adverse Event|22|||
144311654|NCT00310375|520343998|FG002|Primary Reporting Phase|Adverse Event|0|||
144311655|NCT00310375|520343996|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
144311656|NCT00310375|520343997|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
144311657|NCT00310375|520343998|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
144311658|NCT00310375|520343996|FG000|Primary Reporting Phase|Pregnancy|2|||
144311659|NCT00310375|520343997|FG001|Primary Reporting Phase|Pregnancy|2|||
144311660|NCT00310375|520343998|FG002|Primary Reporting Phase|Pregnancy|0|||
144311661|NCT00310375|520343996|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
144311662|NCT00310375|520343997|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
144311663|NCT00310375|520343998|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
144311664|NCT00310375|520343996|FG000|Primary Reporting Phase|Protocol Violation|8|||
144311665|NCT00310375|520343997|FG001|Primary Reporting Phase|Protocol Violation|5|||
144311666|NCT00310375|520343998|FG002|Primary Reporting Phase|Protocol Violation|0|||
144311667|NCT00310375|520343996|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
144311668|NCT00310375|520343997|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
144311669|NCT00310375|520343998|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
144311670|NCT00310375|520343996|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
144311671|NCT00310375|520343997|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
144311672|NCT00310375|520343998|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
144311673|NCT00310375|520343996|FG000|Primary Reporting Phase|Physician Decision|5|||
144311674|NCT00310375|520343997|FG001|Primary Reporting Phase|Physician Decision|3|||
144311675|NCT00310375|520343998|FG002|Primary Reporting Phase|Physician Decision|0|||
144311676|NCT00310375|520343996|FG000|Primary Reporting Phase|Request of the sponsor|2|||
144311677|NCT00310375|520343997|FG001|Primary Reporting Phase|Request of the sponsor|2|||
144311678|NCT00310375|520343998|FG002|Primary Reporting Phase|Request of the sponsor|0|||
144311679|NCT00310375|520343996|FG000|Primary Reporting Phase|Failed to return|1|||
144311680|NCT00310375|520343997|FG001|Primary Reporting Phase|Failed to return|3|||
144311681|NCT00310375|520343998|FG002|Primary Reporting Phase|Failed to return|0|||
144311682|NCT00310375|520343996|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
144311683|NCT00310375|520343997|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
144311684|NCT00310375|520343998|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
144311685|NCT00310375|520343996|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
144311686|NCT00310375|520343997|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
144311687|NCT00310375|520343998|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
144311688|NCT00310375|520343996|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
144311689|NCT00310375|520343997|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
144311690|NCT00310375|520343998|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
144311691|NCT00310375|520343996|FG000|Primary Reporting Phase|Site closure|3|||
144311692|NCT00310375|520343997|FG001|Primary Reporting Phase|Site closure|0|||
144311693|NCT00310375|520343998|FG002|Primary Reporting Phase|Site closure|0|||
144311694|NCT00310375|520343996|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
144311695|NCT00310375|520343997|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
144311696|NCT00310375|520343998|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
144311697|NCT00310375|520343996|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
144311698|NCT00310375|520343997|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
144311699|NCT00310375|520343998|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
144311700|NCT00310375|520343996|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
144311701|NCT00310375|520343997|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
144311702|NCT00310375|520343998|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
144311703|NCT00310375|520343996|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
144311704|NCT00310375|520343997|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
144311705|NCT00310375|520343998|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
144311706|NCT00910910|520343999|FG000|Overall Study|Adverse Event|63|||
144311707|NCT00910910|520344000|FG001|Overall Study|Adverse Event|35|||
144311708|NCT00910910|520343999|FG000|Overall Study|PD without histologic change|27|||
144311709|NCT00910910|520344000|FG001|Overall Study|PD without histologic change|23|||
144311710|NCT00910910|520343999|FG000|Overall Study|PD with histologic change|0|||
144311711|NCT00910910|520344000|FG001|Overall Study|PD with histologic change|2|||
144311712|NCT00910910|520343999|FG000|Overall Study|Withdrawal by Subject|7|||
144311713|NCT00910910|520344000|FG001|Overall Study|Withdrawal by Subject|5|||
144311714|NCT00910910|520343999|FG000|Overall Study|Lost to Follow-up|2|||
144311715|NCT00910910|520344000|FG001|Overall Study|Lost to Follow-up|2|||
144311716|NCT00910910|520343999|FG000|Overall Study|Death|9|||
144311717|NCT00910910|520344000|FG001|Overall Study|Death|3|||
144311718|NCT00910910|520343999|FG000|Overall Study|Protocol Violation|2|||
144311719|NCT00910910|520344000|FG001|Overall Study|Protocol Violation|2|||
144311720|NCT00910910|520343999|FG000|Overall Study|Completed 13 cycles of treatment|0|||
144311721|NCT00910910|520344000|FG001|Overall Study|Completed 13 cycles of treatment|118|||
144311722|NCT00910910|520343999|FG000|Overall Study|Other|114|||
144311723|NCT00910910|520344000|FG001|Overall Study|Other|32|||
144311724|NCT00910910|520343999|FG000|Overall Study|Untreated before cycle 1|1|||
144311725|NCT00910910|520344000|FG001|Overall Study|Untreated before cycle 1|2|||
144311726|NCT01973231|520344001|FG000|Overall Study|Protocol Violation|1|||
144311727|NCT01973231|520344002|FG001|Overall Study|Protocol Violation|1|||
144311728|NCT01973231|520344001|FG000|Overall Study|Lost to Follow-up|1|||
144311729|NCT01973231|520344002|FG001|Overall Study|Lost to Follow-up|1|||
144311730|NCT01973231|520344001|FG000|Overall Study|unclassified|2|||
144311731|NCT01973231|520344002|FG001|Overall Study|unclassified|1|||
144311732|NCT01973231|520344001|FG000|Overall Study|Withdrawal by Subject|7|||
144311733|NCT01973231|520344002|FG001|Overall Study|Withdrawal by Subject|9|||
144311734|NCT01643408|520344003|FG000|Overall Study|Adverse Event|12|||
144311735|NCT01643408|520344003|FG000|Overall Study|Other|2|||
144311736|NCT03726658|520344007|FG000|Overall Study|Lost to Follow-up|0|||
144311737|NCT03726658|520344008|FG001|Overall Study|Lost to Follow-up|0|||
144311738|NCT03726658|520344009|FG002|Overall Study|Lost to Follow-up|2|||
144311739|NCT03726658|520344010|FG003|Overall Study|Lost to Follow-up|0|||
144311740|NCT03726658|520344011|FG004|Overall Study|Lost to Follow-up|0|||
144311741|NCT03726658|520344012|FG005|Overall Study|Lost to Follow-up|1|||
144311742|NCT03726658|520344013|FG006|Overall Study|Lost to Follow-up|1|||
144311743|NCT03726658|520344007|FG000|Overall Study|Withdrawal by Subject|1|||
144311744|NCT03726658|520344008|FG001|Overall Study|Withdrawal by Subject|0|||
144311745|NCT03726658|520344009|FG002|Overall Study|Withdrawal by Subject|0|||
144311746|NCT03726658|520344010|FG003|Overall Study|Withdrawal by Subject|0|||
144311747|NCT03726658|520344011|FG004|Overall Study|Withdrawal by Subject|6|||
144311748|NCT03726658|520344012|FG005|Overall Study|Withdrawal by Subject|4|||
144311749|NCT03726658|520344013|FG006|Overall Study|Withdrawal by Subject|2|||
144311750|NCT03726658|520344007|FG000|Overall Study|Pregnancy|0|||
144311751|NCT03726658|520344008|FG001|Overall Study|Pregnancy|0|||
144311752|NCT03726658|520344009|FG002|Overall Study|Pregnancy|0|||
144311753|NCT03726658|520344010|FG003|Overall Study|Pregnancy|0|||
144311754|NCT03726658|520344011|FG004|Overall Study|Pregnancy|0|||
144311755|NCT03726658|520344012|FG005|Overall Study|Pregnancy|0|||
144311756|NCT03726658|520344013|FG006|Overall Study|Pregnancy|1|||
144311757|NCT03726658|520344007|FG000|Overall Study|Not Reported|0|||
144311758|NCT03726658|520344008|FG001|Overall Study|Not Reported|0|||
144311759|NCT03726658|520344009|FG002|Overall Study|Not Reported|0|||
144311760|NCT03726658|520344010|FG003|Overall Study|Not Reported|0|||
144311761|NCT03726658|520344011|FG004|Overall Study|Not Reported|0|||
144311762|NCT03726658|520344012|FG005|Overall Study|Not Reported|0|||
144311763|NCT03726658|520344013|FG006|Overall Study|Not Reported|1|||
144311764|NCT00412958|520344014|FG000|Overall Study|Withdrawal by Subject|3|||
144311765|NCT00412958|520344015|FG001|Overall Study|Withdrawal by Subject|0|||
144311766|NCT00412958|520344016|FG002|Overall Study|Withdrawal by Subject|0|||
144311767|NCT00412958|520344017|FG003|Overall Study|Withdrawal by Subject|1|||
144311768|NCT00412958|520344014|FG000|Overall Study|Adverse Event|0|||
144311769|NCT00412958|520344015|FG001|Overall Study|Adverse Event|1|||
144311770|NCT00412958|520344016|FG002|Overall Study|Adverse Event|0|||
144311771|NCT00412958|520344017|FG003|Overall Study|Adverse Event|0|||
144311772|NCT00412958|520344014|FG000|Overall Study|Lost to Follow-up|0|||
144311773|NCT00412958|520344015|FG001|Overall Study|Lost to Follow-up|1|||
144311774|NCT00412958|520344016|FG002|Overall Study|Lost to Follow-up|0|||
144311775|NCT00412958|520344017|FG003|Overall Study|Lost to Follow-up|0|||
144311776|NCT00412958|520344014|FG000|Overall Study|Death|0|||
144311777|NCT00412958|520344015|FG001|Overall Study|Death|1|||
144311778|NCT00412958|520344016|FG002|Overall Study|Death|0|||
144311779|NCT00412958|520344017|FG003|Overall Study|Death|0|||
144311780|NCT00412958|520344014|FG000|Overall Study|Transport issue|0|||
144311781|NCT00412958|520344015|FG001|Overall Study|Transport issue|1|||
144311782|NCT00412958|520344016|FG002|Overall Study|Transport issue|0|||
144311783|NCT00412958|520344017|FG003|Overall Study|Transport issue|0|||
144311784|NCT01318135|520344018|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
144311785|NCT01318135|520344019|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311786|NCT01318135|520344020|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311787|NCT01318135|520344021|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311788|NCT01318135|520344022|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311789|NCT01318135|520344023|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311790|NCT01318135|520344024|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311791|NCT01318135|520344025|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
144311792|NCT01318135|520344018|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
144311793|NCT01318135|520344019|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311794|NCT01318135|520344020|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311795|NCT01318135|520344021|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311796|NCT01318135|520344022|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311797|NCT01318135|520344023|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311798|NCT01318135|520344024|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311799|NCT01318135|520344025|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
144311800|NCT01318135|520344018|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
144311801|NCT01318135|520344019|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
144311802|NCT01318135|520344020|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
144311803|NCT01318135|520344021|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
144311804|NCT01318135|520344022|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
144311805|NCT01318135|520344023|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
144311806|NCT01318135|520344024|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
144311807|NCT01318135|520344025|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
144311808|NCT01318135|520344018|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
144311809|NCT01318135|520344019|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
144311810|NCT01318135|520344020|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
144311811|NCT01318135|520344021|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
144311812|NCT01318135|520344022|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
144311813|NCT01318135|520344023|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
144311814|NCT01318135|520344024|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
144311815|NCT01318135|520344025|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
144311816|NCT01318135|520344018|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144311817|NCT01318135|520344019|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144311818|NCT01318135|520344020|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144311819|NCT01318135|520344021|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144311820|NCT01318135|520344022|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
144311821|NCT01318135|520344023|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144311822|NCT01318135|520344024|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
144311823|NCT01318135|520344025|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
144311824|NCT01318135|520344018|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
144311825|NCT01318135|520344019|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
144311826|NCT01318135|520344020|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
144311827|NCT01318135|520344021|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
144311828|NCT01318135|520344022|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
144311829|NCT01318135|520344023|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
144311830|NCT01318135|520344024|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
144311831|NCT01318135|520344025|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
144311832|NCT01318135|520344018|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311833|NCT01318135|520344019|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311834|NCT01318135|520344020|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311835|NCT01318135|520344021|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311836|NCT01318135|520344022|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311837|NCT01318135|520344023|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311838|NCT01318135|520344024|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
144311839|NCT01318135|520344025|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
144311840|NCT03994211|520344030|FG000|Core Phase|Adverse Event|0|||
144311841|NCT03994211|520344031|FG001|Core Phase|Adverse Event|1|||
144311842|NCT03994211|520344032|FG002|Core Phase|Adverse Event|0|||
144311843|NCT03994211|520344030|FG000|Extension Phase|Adverse Event|0|||
144311844|NCT03994211|520344031|FG001|Extension Phase|Adverse Event|0|||
144311845|NCT03994211|520344032|FG002|Extension Phase|Adverse Event|1|||
144311846|NCT03994211|520344030|FG000|Extension Phase|Physician Decision|0|||
144311847|NCT03994211|520344031|FG001|Extension Phase|Physician Decision|0|||
144311848|NCT03994211|520344032|FG002|Extension Phase|Physician Decision|1|||
144311849|NCT03994211|520344030|FG000|Extension Phase|Progressive Disease|0|||
144311850|NCT03994211|520344031|FG001|Extension Phase|Progressive Disease|0|||
144311851|NCT03994211|520344032|FG002|Extension Phase|Progressive Disease|20|||
144311852|NCT03994211|520344030|FG000|Extension Phase|Withdrawal by Subject|0|||
144311853|NCT03994211|520344031|FG001|Extension Phase|Withdrawal by Subject|0|||
144311854|NCT03994211|520344032|FG002|Extension Phase|Withdrawal by Subject|2|||
144311855|NCT02625220|520344033|FG000|Overall Study|Adverse Event|2|||
144311856|NCT02625220|520344033|FG000|Overall Study|Lost to Follow-up|2|||
144311857|NCT02625220|520344033|FG000|Overall Study|Protocol Violation|1|||
144311858|NCT02625220|520344033|FG000|Overall Study|Study discontinued at site|2|||
144311859|NCT01140867|520344034|FG000|Overall Study|Adverse Event|22|||
144311860|NCT01140867|520344034|FG000|Overall Study|Lack of Efficacy|3|||
144311861|NCT01140867|520344034|FG000|Overall Study|Lost to Follow-up|2|||
144311862|NCT01140867|520344034|FG000|Overall Study|Withdrawal by Subject|1|||
144311863|NCT01140867|520344034|FG000|Overall Study|Protocol Violation|1|||
144311864|NCT01140867|520344034|FG000|Overall Study|Uncooperative patient|2|||
144311865|NCT01140867|520344034|FG000|Overall Study|Medication Noncompliance|2|||
144311866|NCT01926444|520344035|FG000|Overall Study|Colonoscopy not performed|0|||
144311867|NCT01926444|520344036|FG001|Overall Study|Colonoscopy not performed|0|||
144311868|NCT01926444|520344037|FG002|Overall Study|Colonoscopy not performed|4|||
144311869|NCT01926444|520344038|FG003|Overall Study|Colonoscopy not performed|2|||
144311870|NCT01637584|520344042|FG000|Overall Study|Withdrawal by Subject|1|||
144311871|NCT01637584|520344043|FG001|Overall Study|Withdrawal by Subject|3|||
144311872|NCT00995436|520344046|FG000|Overall Study|Withdrawal by Subject|2|||
144311873|NCT00995436|520344047|FG001|Overall Study|Withdrawal by Subject|5|||
144311874|NCT00995436|520344048|FG002|Overall Study|Withdrawal by Subject|0|||
144311875|NCT01232127|520344049|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
144311876|NCT01232127|520344050|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
144311877|NCT01232127|520344051|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
144311878|NCT03035864|520344054|FG000|Treatment Period|Adverse Event|1|||
144311879|NCT03035864|520344055|FG001|Treatment Period|Adverse Event|0|||
144311880|NCT03035864|520344054|FG000|Treatment Period|Other|3|||
144311881|NCT03035864|520344055|FG001|Treatment Period|Other|1|||
144311882|NCT03035864|520344054|FG000|Follow-up Period|Adverse Event|1|||
144311883|NCT03035864|520344055|FG001|Follow-up Period|Adverse Event|0|||
144311884|NCT03035864|520344054|FG000|Follow-up Period|Lost to Follow-up|6|||
144311885|NCT03035864|520344055|FG001|Follow-up Period|Lost to Follow-up|2|||
144311886|NCT03035864|520344054|FG000|Follow-up Period|Physician Decision|1|||
144311887|NCT03035864|520344055|FG001|Follow-up Period|Physician Decision|0|||
144311888|NCT03035864|520344054|FG000|Follow-up Period|Other|3|||
144311889|NCT03035864|520344055|FG001|Follow-up Period|Other|2|||
144311890|NCT02720523|520344056|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
144311891|NCT02720523|520344057|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
144311892|NCT02720523|520344058|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
144311893|NCT02720523|520344059|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
144311894|NCT02720523|520344060|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
144311895|NCT02720523|520344061|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
144311896|NCT02720523|520344062|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
144311897|NCT02720523|520344056|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
144311898|NCT02720523|520344057|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144311899|NCT02720523|520344058|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144311900|NCT02720523|520344059|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144311901|NCT02720523|520344060|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144311902|NCT02720523|520344061|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144311903|NCT02720523|520344062|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
144311904|NCT02720523|520344056|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
144311905|NCT02720523|520344057|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
144311906|NCT02720523|520344058|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
144311907|NCT02720523|520344059|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
144311908|NCT02720523|520344060|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
144311909|NCT02720523|520344061|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
144311910|NCT02720523|520344062|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
144311911|NCT02720523|520344056|FG000|Period 1: Placebo-controlled Period|Other|0|||
144311912|NCT02720523|520344057|FG001|Period 1: Placebo-controlled Period|Other|0|||
144311913|NCT02720523|520344058|FG002|Period 1: Placebo-controlled Period|Other|1|||
144311914|NCT02720523|520344059|FG003|Period 1: Placebo-controlled Period|Other|1|||
144311915|NCT02720523|520344060|FG004|Period 1: Placebo-controlled Period|Other|0|||
144311916|NCT02720523|520344061|FG005|Period 1: Placebo-controlled Period|Other|0|||
144311917|NCT02720523|520344062|FG006|Period 1: Placebo-controlled Period|Other|0|||
144311918|NCT02720523|520344056|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
144311919|NCT02720523|520344057|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
144311920|NCT02720523|520344058|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
144311921|NCT02720523|520344059|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
144311922|NCT02720523|520344060|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
144311923|NCT02720523|520344061|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
144311924|NCT02720523|520344062|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
144311925|NCT02720523|520344056|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
144311926|NCT02720523|520344057|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
144311927|NCT02720523|520344058|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
144311928|NCT02720523|520344059|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
144311929|NCT02720523|520344060|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
144311930|NCT02720523|520344061|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
144311931|NCT02720523|520344062|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
144311932|NCT02720523|520344056|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
144311933|NCT02720523|520344057|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
144311934|NCT02720523|520344058|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
144311935|NCT02720523|520344059|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
144311936|NCT02720523|520344060|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
144311937|NCT02720523|520344061|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
144311938|NCT02720523|520344062|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
144311939|NCT02720523|520344056|FG000|Period 2: Long-term Extension Period|Other|0|||
144311940|NCT02720523|520344057|FG001|Period 2: Long-term Extension Period|Other|0|||
144311941|NCT02720523|520344058|FG002|Period 2: Long-term Extension Period|Other|0|||
144311942|NCT02720523|520344059|FG003|Period 2: Long-term Extension Period|Other|0|||
144311943|NCT02720523|520344060|FG004|Period 2: Long-term Extension Period|Other|2|||
144311944|NCT02720523|520344061|FG005|Period 2: Long-term Extension Period|Other|0|||
144311945|NCT02720523|520344062|FG006|Period 2: Long-term Extension Period|Other|3|||
144311946|NCT03299244|520344067|FG000|Overall Study|Withdrawal by Subject|34|||
144311947|NCT03299244|520344068|FG001|Overall Study|Withdrawal by Subject|29|||
144311948|NCT03299244|520344067|FG000|Overall Study|Decision by Sponsor|4|||
144311949|NCT03299244|520344068|FG001|Overall Study|Decision by Sponsor|5|||
144311950|NCT03299244|520344067|FG000|Overall Study|Death|9|||
144311951|NCT03299244|520344068|FG001|Overall Study|Death|4|||
144311952|NCT03146663|520344071|FG000|Overall Study|Did not receive study treatment|1|||
144311953|NCT03146663|520344072|FG001|Overall Study|Did not receive study treatment|1|||
144311954|NCT01154452|520344073|FG000|Phase Ib|Not Treated|1|||
144311955|NCT01154452|520344074|FG001|Phase Ib|Not Treated|0|||
144311956|NCT01154452|520344075|FG002|Phase Ib|Not Treated|0|||
144311957|NCT01154452|520344076|FG003|Phase Ib|Not Treated|0|||
144311958|NCT01154452|520344073|FG000|Phase Ib|Adverse Event|2|||
144311959|NCT01154452|520344074|FG001|Phase Ib|Adverse Event|1|||
144311960|NCT01154452|520344075|FG002|Phase Ib|Adverse Event|0|||
144311961|NCT01154452|520344076|FG003|Phase Ib|Adverse Event|0|||
144311962|NCT01154452|520344073|FG000|Phase II|Withdrawal by Subject|0|||
144311963|NCT01154452|520344074|FG001|Phase II|Withdrawal by Subject|0|||
144311964|NCT01154452|520344075|FG002|Phase II|Withdrawal by Subject|1|||
144311965|NCT01154452|520344076|FG003|Phase II|Withdrawal by Subject|2|||
144311966|NCT01154452|520344073|FG000|Phase II|Adverse Event|0|||
144311967|NCT01154452|520344074|FG001|Phase II|Adverse Event|0|||
144311968|NCT01154452|520344075|FG002|Phase II|Adverse Event|4|||
144311969|NCT01154452|520344076|FG003|Phase II|Adverse Event|4|||
144311970|NCT00130039|520344081|FG000|Overall Study|Withdrawal by Subject|15|||
144311971|NCT00130039|520344082|FG001|Overall Study|Withdrawal by Subject|11|||
144311972|NCT00130039|520344081|FG000|Overall Study|Lost to Follow-up|3|||
144311973|NCT00130039|520344082|FG001|Overall Study|Lost to Follow-up|1|||
144311974|NCT00130039|520344081|FG000|Overall Study|Adverse Event|4|||
144311975|NCT00130039|520344082|FG001|Overall Study|Adverse Event|2|||
144311976|NCT00130039|520344081|FG000|Overall Study|Physician Decision|3|||
144311977|NCT00130039|520344082|FG001|Overall Study|Physician Decision|0|||
144311978|NCT00130039|520344081|FG000|Overall Study|clinical events without follow up MRI|5|||
144311979|NCT00130039|520344082|FG001|Overall Study|clinical events without follow up MRI|4|||
144311980|NCT01928433|520344083|FG000|Overall Study|Adverse Event|5|||
144311981|NCT01928433|520344084|FG001|Overall Study|Adverse Event|2|||
144311982|NCT01928433|520344085|FG002|Overall Study|Adverse Event|5|||
144311983|NCT01928433|520344083|FG000|Overall Study|Protocol Violation|0|||
144311984|NCT01928433|520344084|FG001|Overall Study|Protocol Violation|0|||
144311985|NCT01928433|520344085|FG002|Overall Study|Protocol Violation|2|||
144311986|NCT01928433|520344083|FG000|Overall Study|Lack of Efficacy|5|||
144311987|NCT01928433|520344084|FG001|Overall Study|Lack of Efficacy|4|||
144311988|NCT01928433|520344085|FG002|Overall Study|Lack of Efficacy|4|||
144311989|NCT01928433|520344083|FG000|Overall Study|Withdrawal by Subject|0|||
144311990|NCT01928433|520344084|FG001|Overall Study|Withdrawal by Subject|4|||
144311991|NCT01928433|520344085|FG002|Overall Study|Withdrawal by Subject|0|||
144311992|NCT01928433|520344083|FG000|Overall Study|Negative screening urine culture|7|||
144311993|NCT01928433|520344084|FG001|Overall Study|Negative screening urine culture|6|||
144311994|NCT01928433|520344085|FG002|Overall Study|Negative screening urine culture|10|||
144311995|NCT01928433|520344083|FG000|Overall Study|Lost to Follow-up|0|||
144311996|NCT01928433|520344084|FG001|Overall Study|Lost to Follow-up|2|||
144311997|NCT01928433|520344085|FG002|Overall Study|Lost to Follow-up|3|||
144311998|NCT01928433|520344083|FG000|Overall Study|Other reasons|3|||
144311999|NCT01928433|520344084|FG001|Overall Study|Other reasons|3|||
144312000|NCT01928433|520344085|FG002|Overall Study|Other reasons|4|||
144312001|NCT01016132|520344086|FG000|Overall Study|Discomfort|1|||
144312002|NCT01198574|520344087|FG000|Overall Study|Resigned from schools|4|||
144312003|NCT01198574|520344088|FG001|Overall Study|Resigned from schools|1|||
144312004|NCT01198574|520344089|FG002|Overall Study|Resigned from schools|1|||
144312005|NCT01198574|520344090|FG003|Overall Study|Resigned from schools|4|||
144312006|NCT02100423|520344091|FG000|Overall Study|Death|1|||
144312007|NCT02100423|520344091|FG000|Overall Study|Withdrawal by Subject|3|||
144312008|NCT02100423|520344091|FG000|Overall Study|Adverse Event|1|||
144312009|NCT02100423|520344091|FG000|Overall Study|Physician Decision|1|||
144312010|NCT00283803|520345793|FG000|Overall Study|Physician Decision|9|||
144312011|NCT00283803|520345793|FG000|Overall Study|Withdrawal by Subject|4|||
144312012|NCT03276728|520345794|FG000|Overall Study|Lost to Follow-up|0|||
144312013|NCT03276728|520345795|FG001|Overall Study|Lost to Follow-up|0|||
144312014|NCT03276728|520345796|FG002|Overall Study|Lost to Follow-up|2|||
144312015|NCT03276728|520345797|FG003|Overall Study|Lost to Follow-up|2|||
144312016|NCT03276728|520345798|FG004|Overall Study|Lost to Follow-up|0|||
144312017|NCT03276728|520345799|FG005|Overall Study|Lost to Follow-up|0|||
144312018|NCT03276728|520345800|FG006|Overall Study|Lost to Follow-up|0|||
144312019|NCT03276728|520345801|FG007|Overall Study|Lost to Follow-up|0|||
144312020|NCT03276728|520345794|FG000|Overall Study|Withdrawal by Subject|0|||
144312021|NCT03276728|520345795|FG001|Overall Study|Withdrawal by Subject|0|||
144312022|NCT03276728|520345796|FG002|Overall Study|Withdrawal by Subject|0|||
144312023|NCT03276728|520345797|FG003|Overall Study|Withdrawal by Subject|3|||
144312024|NCT03276728|520345798|FG004|Overall Study|Withdrawal by Subject|0|||
144312025|NCT03276728|520345799|FG005|Overall Study|Withdrawal by Subject|0|||
144312026|NCT03276728|520345800|FG006|Overall Study|Withdrawal by Subject|0|||
144312027|NCT03276728|520345801|FG007|Overall Study|Withdrawal by Subject|0|||
144312028|NCT03276728|520345794|FG000|Overall Study|Decision by sponsor|0|||
144312029|NCT03276728|520345795|FG001|Overall Study|Decision by sponsor|0|||
144312030|NCT03276728|520345796|FG002|Overall Study|Decision by sponsor|0|||
144312031|NCT03276728|520345797|FG003|Overall Study|Decision by sponsor|0|||
144312032|NCT03276728|520345798|FG004|Overall Study|Decision by sponsor|1|||
144312033|NCT03276728|520345799|FG005|Overall Study|Decision by sponsor|0|||
144312034|NCT03276728|520345800|FG006|Overall Study|Decision by sponsor|2|||
144312035|NCT03276728|520345801|FG007|Overall Study|Decision by sponsor|1|||
144312036|NCT02982772|520345802|FG000|Intervention|Lost to Follow-up|19|||
144312037|NCT02982772|520345803|FG001|Intervention|Lost to Follow-up|13|||
144312038|NCT02982772|520345802|FG000|1M Follow-Up|Lost to Follow-up|21|||
144312039|NCT02982772|520345803|FG001|1M Follow-Up|Lost to Follow-up|18|||
144312040|NCT02982772|520345802|FG000|3M Follow-Up|Lost to Follow-up|17|||
144312041|NCT02982772|520345803|FG001|3M Follow-Up|Lost to Follow-up|11|||
144312042|NCT02982772|520345802|FG000|6M Follow-Up|Lost to Follow-up|11|||
144312043|NCT02982772|520345803|FG001|6M Follow-Up|Lost to Follow-up|9|||
144312044|NCT02982772|520345802|FG000|12M Follow-Up|Lost to Follow-up|11|||
144312045|NCT02982772|520345803|FG001|12M Follow-Up|Lost to Follow-up|5|||
144312046|NCT01234480|520345804|FG000|Overall Study|Pregnancy|88|||
144312047|NCT01234480|520345804|FG000|Overall Study|>36/Normal History|50|||
144312048|NCT01234480|520345804|FG000|Overall Study|Age|3|||
144312049|NCT01234480|520345804|FG000|Overall Study|HPV Vaccine History|28|||
144312050|NCT01234480|520345804|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
144312051|NCT01234480|520345804|FG000|Overall Study|Hysterectomy|2|||
144312052|NCT01234480|520345804|FG000|Overall Study|Hysterectomy post enrollment|1|||
144312053|NCT01234480|520345804|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
144312054|NCT01234480|520345804|FG000|Overall Study|Informed Consent Form Violation|30|||
144312055|NCT01234480|520345804|FG000|Overall Study|Incorrect Visit|3|||
144312056|NCT01234480|520345804|FG000|Overall Study|No Florida Lab License|20|||
144312057|NCT01234480|520345804|FG000|Overall Study|Out of Window|42|||
144312058|NCT01234480|520345804|FG000|Overall Study|Sample Processing/Storage|92|||
144312059|NCT01234480|520345804|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
144312060|NCT01234480|520345804|FG000|Overall Study|Site/Subject non-compliance|44|||
144312061|NCT01234480|520345804|FG000|Overall Study|Missing Sample|9|||
144312062|NCT02974140|520345805|FG000|Overall Study|Adverse Event|2|||
144312063|NCT02974140|520345805|FG000|Overall Study|Lost to Follow-up|1|||
144312064|NCT02974140|520345805|FG000|Overall Study|Study Terminated by Sponsor|36|||
144312065|NCT00617084|520345806|FG000|Overall Study|Withdrawal by Subject|5|||
144312066|NCT00617084|520345807|FG001|Overall Study|Withdrawal by Subject|7|||
144312067|NCT00617084|520345806|FG000|Overall Study|Missed 12 Months visit|16|||
144312068|NCT00617084|520345807|FG001|Overall Study|Missed 12 Months visit|19|||
144312069|NCT03370419|520345808|FG000|Overall Study|Lost to Follow-up|16|||
144312070|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
144312071|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
144312072|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
144312073|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
144312074|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
144312075|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
144312076|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
144312077|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
144312078|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
144312079|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
144312080|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
144312081|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
144312082|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
144312083|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
144312084|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
144312085|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
144312086|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
144312087|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
144312088|NCT03308968|520345819|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
144312089|NCT03308968|520345820|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
144312090|NCT03308968|520345821|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
144312091|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
144312092|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
144312093|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
144312094|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
144312095|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
144312096|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
144312097|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
144312098|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
144312099|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
144312100|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
144312101|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
144312102|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
144312103|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
144312104|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
144312105|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
144312106|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
144312107|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
144312108|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
144312109|NCT03308968|520345819|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
144312110|NCT03308968|520345820|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
144360023|NCT01601535|520525139|FG004|Phase 2|Adverse Event|5|||
144312111|NCT03308968|520345821|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
144312112|NCT02482298|520345822|FG000|Overall Study|Withdrawal by Subject|2|||
144312113|NCT02482298|520345823|FG001|Overall Study|Withdrawal by Subject|1|||
144312114|NCT02482298|520345824|FG002|Overall Study|Withdrawal by Subject|2|||
144312115|NCT02482298|520345822|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
144312116|NCT02482298|520345823|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
144312117|NCT02482298|520345824|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
144312118|NCT02482298|520345822|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
144312119|NCT02482298|520345823|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
144312120|NCT02482298|520345824|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
144312121|NCT02482298|520345822|FG000|Overall Study|Lost to Follow-up|0|||
144312122|NCT02482298|520345823|FG001|Overall Study|Lost to Follow-up|1|||
144312123|NCT02482298|520345824|FG002|Overall Study|Lost to Follow-up|0|||
144312124|NCT01582009|520345825|FG000|Overall Study|Withdrawal by Subject|1|||
144312125|NCT01582009|520345825|FG000|Overall Study|Physician Decision|1|||
144312126|NCT01947283|520345828|FG000|Overall Study|Death|1|||
144312127|NCT01947283|520345829|FG001|Overall Study|Death|1|||
144312128|NCT01947283|520345830|FG002|Overall Study|Death|1|||
144312129|NCT01947283|520345831|FG003|Overall Study|Death|0|||
144312130|NCT01947283|520345832|FG004|Overall Study|Death|0|||
144312131|NCT01947283|520345833|FG005|Overall Study|Death|0|||
144312132|NCT01947283|520345834|FG006|Overall Study|Death|0|||
144312133|NCT01947283|520345828|FG000|Overall Study|Lost to Follow-up|4|||
144312134|NCT01947283|520345829|FG001|Overall Study|Lost to Follow-up|6|||
144312135|NCT01947283|520345830|FG002|Overall Study|Lost to Follow-up|5|||
144312136|NCT01947283|520345831|FG003|Overall Study|Lost to Follow-up|5|||
144312137|NCT01947283|520345832|FG004|Overall Study|Lost to Follow-up|0|||
144312138|NCT01947283|520345833|FG005|Overall Study|Lost to Follow-up|2|||
144312139|NCT01947283|520345834|FG006|Overall Study|Lost to Follow-up|5|||
144312140|NCT01947283|520345828|FG000|Overall Study|Withdrawal by Subject|10|||
144312141|NCT01947283|520345829|FG001|Overall Study|Withdrawal by Subject|8|||
144312142|NCT01947283|520345830|FG002|Overall Study|Withdrawal by Subject|4|||
144312143|NCT01947283|520345831|FG003|Overall Study|Withdrawal by Subject|1|||
144312144|NCT01947283|520345832|FG004|Overall Study|Withdrawal by Subject|0|||
144312145|NCT01947283|520345833|FG005|Overall Study|Withdrawal by Subject|0|||
144312146|NCT01947283|520345834|FG006|Overall Study|Withdrawal by Subject|2|||
144312147|NCT01947283|520345828|FG000|Overall Study|No Clinical Recording|12|||
144312148|NCT01947283|520345829|FG001|Overall Study|No Clinical Recording|6|||
144312149|NCT01947283|520345830|FG002|Overall Study|No Clinical Recording|8|||
144312150|NCT01947283|520345831|FG003|Overall Study|No Clinical Recording|10|||
144312151|NCT01947283|520345832|FG004|Overall Study|No Clinical Recording|0|||
144312152|NCT01947283|520345833|FG005|Overall Study|No Clinical Recording|0|||
144312153|NCT01947283|520345834|FG006|Overall Study|No Clinical Recording|0|||
144312154|NCT01947283|520345828|FG000|Overall Study|Non-coding Clinical Recording language|0|||
144312155|NCT01947283|520345829|FG001|Overall Study|Non-coding Clinical Recording language|0|||
144312156|NCT01947283|520345830|FG002|Overall Study|Non-coding Clinical Recording language|0|||
144312157|NCT01947283|520345831|FG003|Overall Study|Non-coding Clinical Recording language|1|||
144312158|NCT01947283|520345832|FG004|Overall Study|Non-coding Clinical Recording language|0|||
144312159|NCT01947283|520345833|FG005|Overall Study|Non-coding Clinical Recording language|0|||
144312160|NCT01947283|520345834|FG006|Overall Study|Non-coding Clinical Recording language|0|||
144312161|NCT01947283|520345828|FG000|Overall Study|Missing Follow-up Assessment|2|||
144312162|NCT01947283|520345829|FG001|Overall Study|Missing Follow-up Assessment|2|||
144312163|NCT01947283|520345830|FG002|Overall Study|Missing Follow-up Assessment|3|||
144312164|NCT01947283|520345831|FG003|Overall Study|Missing Follow-up Assessment|0|||
144312165|NCT01947283|520345832|FG004|Overall Study|Missing Follow-up Assessment|0|||
144312166|NCT01947283|520345833|FG005|Overall Study|Missing Follow-up Assessment|2|||
144312167|NCT01947283|520345834|FG006|Overall Study|Missing Follow-up Assessment|0|||
144312168|NCT01947283|520345828|FG000|Overall Study|No patients were enrolled in study|0|||
144312169|NCT01947283|520345829|FG001|Overall Study|No patients were enrolled in study|0|||
144312170|NCT01947283|520345830|FG002|Overall Study|No patients were enrolled in study|0|||
144312171|NCT01947283|520345831|FG003|Overall Study|No patients were enrolled in study|0|||
144312172|NCT01947283|520345832|FG004|Overall Study|No patients were enrolled in study|0|||
144312173|NCT01947283|520345833|FG005|Overall Study|No patients were enrolled in study|3|||
144312174|NCT01947283|520345834|FG006|Overall Study|No patients were enrolled in study|1|||
144312175|NCT00430989|520345835|FG000|Overall Study|Lost to Follow-up|2|||
144312176|NCT00430989|520345836|FG001|Overall Study|Lost to Follow-up|3|||
144312177|NCT00430989|520345835|FG000|Overall Study|Withdrawal by Subject|15|||
144312178|NCT00430989|520345836|FG001|Overall Study|Withdrawal by Subject|14|||
144312179|NCT00430989|520345835|FG000|Overall Study|Protocol Violation|30|||
144312180|NCT00430989|520345836|FG001|Overall Study|Protocol Violation|37|||
144312181|NCT00430989|520345835|FG000|Overall Study|Not eligible|13|||
144312182|NCT00430989|520345836|FG001|Overall Study|Not eligible|6|||
144312183|NCT03782259|520345837|FG000|Overall Study|Lost to Follow-up|1|||
144312184|NCT03782259|520345838|FG001|Overall Study|Lost to Follow-up|1|||
144312185|NCT03782259|520345837|FG000|Overall Study|Moved out of state|0|||
144312186|NCT03782259|520345838|FG001|Overall Study|Moved out of state|2|||
144312187|NCT03782259|520345837|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
144312188|NCT03782259|520345838|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
144312189|NCT03782259|520345837|FG000|Overall Study|Subject discontinued intervention|1|||
144312190|NCT03782259|520345838|FG001|Overall Study|Subject discontinued intervention|0|||
144312191|NCT03050450|520345839|FG000|Overall Study|Physician Decision|1|||
144312192|NCT03050450|520345840|FG001|Overall Study|Physician Decision|0|||
144312193|NCT03050450|520345841|FG002|Overall Study|Physician Decision|0|||
144312194|NCT03050450|520345842|FG003|Overall Study|Physician Decision|0|||
144312195|NCT03050450|520345843|FG004|Overall Study|Physician Decision|0|||
144312196|NCT05069597|520345844|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
144312197|NCT05069597|520345845|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
144312198|NCT01014767|520345847|FG000|Overall Study|PI left institution, data unavailable|12|||
144312199|NCT01014767|520345848|FG001|Overall Study|PI left institution, data unavailable|1|||
144312200|NCT01014767|520345849|FG002|Overall Study|PI left institution, data unavailable|4|||
144312201|NCT01014767|520345850|FG003|Overall Study|PI left institution, data unavailable|1|||
144312202|NCT04556591|520345854|FG000|Overall Study|Lost to Follow-up|1|||
144312203|NCT04556591|520345855|FG001|Overall Study|Lost to Follow-up|0|||
144312204|NCT04556591|520345854|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
144312205|NCT04556591|520345855|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
144312206|NCT03332173|520345856|FG000|Overall Study|Death|7|||
144312207|NCT03332173|520345856|FG000|Overall Study|Withdrawal by Subject|6|||
144312208|NCT03332173|520345856|FG000|Overall Study|Lost to Follow-up|2|||
144312209|NCT03332173|520345856|FG000|Overall Study|Transferred to long-term extension study|29|||
144312210|NCT02553928|520345857|FG000|Overall Study|Adverse Event|2|||
144312211|NCT02553928|520345858|FG001|Overall Study|Adverse Event|1|||
144312212|NCT02553928|520345857|FG000|Overall Study|Lost to Follow-up|0|||
144312213|NCT02553928|520345858|FG001|Overall Study|Lost to Follow-up|1|||
144312214|NCT02553928|520345857|FG000|Overall Study|Administrative reason(s)|0|||
144312215|NCT02553928|520345858|FG001|Overall Study|Administrative reason(s)|1|||
144312216|NCT00131352|520345859|FG000|Initial Treatment Period|Adverse Event|1|||
144312217|NCT00131352|520345860|FG001|Initial Treatment Period|Adverse Event|3|||
144312218|NCT00131352|520345859|FG000|Initial Treatment Period|Non-compliant|1|||
144312219|NCT00131352|520345860|FG001|Initial Treatment Period|Non-compliant|2|||
144312220|NCT00131352|520345859|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
144312221|NCT00131352|520345860|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
144312222|NCT00131352|520345859|FG000|Initial Treatment Period|Lack of Efficacy|6|||
144312223|NCT00131352|520345860|FG001|Initial Treatment Period|Lack of Efficacy|4|||
144312224|NCT00131352|520345859|FG000|Initial Treatment Period|Other|0|||
144312225|NCT00131352|520345860|FG001|Initial Treatment Period|Other|2|||
144312226|NCT00131352|520345859|FG000|Repeat Treatment Period|Adverse Event|1|||
144312227|NCT00131352|520345860|FG001|Repeat Treatment Period|Adverse Event|0|||
144312228|NCT00131352|520345859|FG000|Repeat Treatment Period|Other|1|||
144312229|NCT00131352|520345860|FG001|Repeat Treatment Period|Other|0|||
144312230|NCT01485796|520345863|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
144312231|NCT01485796|520345863|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
144312232|NCT01485796|520345863|FG000|Period 2: Epoch 2|Adverse Event|3|||
144312233|NCT01485796|520345863|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
144312234|NCT01485796|520345863|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
144312235|NCT01485796|520345863|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
144312236|NCT01485796|520345863|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
144312237|NCT01485796|520345863|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
144312238|NCT04830215|520345864|FG000|Overall Study|Adverse Event|6|||
144312239|NCT04830215|520345864|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
144312240|NCT04830215|520345864|FG000|Overall Study|Withdrawal by Subject|3|||
144312241|NCT04830215|520345864|FG000|Overall Study|Protocol Deviation|1|||
144312242|NCT00211172|520345867|FG000|Overall Study|Died or lost health plan eligibility|39|||
144312243|NCT00211172|520345868|FG001|Overall Study|Died or lost health plan eligibility|32|||
144312244|NCT00770562|520345871|FG000|Overall Study|Did not take treatment|1|||
144312245|NCT00770562|520345872|FG001|Overall Study|Did not take treatment|1|||
144312246|NCT00292045|520345876|FG000|Core Study (Through Week 13)|Adverse Event|1|||
144312247|NCT00292045|520345876|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
144312248|NCT04474197|520345877|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
144312249|NCT04474197|520345878|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
144312250|NCT04474197|520345879|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
144312251|NCT04474197|520345880|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
144312252|NCT00606411|520345881|FG000|Overall Study|Adverse Event|1|||
144312253|NCT00606411|520345882|FG001|Overall Study|Adverse Event|2|||
144312254|NCT00606411|520345881|FG000|Overall Study|Lack of Adherence|1|||
144312255|NCT00606411|520345882|FG001|Overall Study|Lack of Adherence|1|||
144312256|NCT00606411|520345881|FG000|Overall Study|Lack of Efficacy|1|||
144312257|NCT00606411|520345882|FG001|Overall Study|Lack of Efficacy|1|||
144312258|NCT00606411|520345881|FG000|Overall Study|Withdrawal by Subject|2|||
144312259|NCT00606411|520345882|FG001|Overall Study|Withdrawal by Subject|0|||
144312260|NCT00606411|520345881|FG000|Overall Study|Lost to Follow-up|1|||
144312261|NCT00606411|520345882|FG001|Overall Study|Lost to Follow-up|2|||
144312262|NCT00606411|520345881|FG000|Overall Study|Move out of state|0|||
144312263|NCT00606411|520345882|FG001|Overall Study|Move out of state|1|||
144312264|NCT02443337|520345884|FG000|Overall Study|Adverse Event|0|||
144312265|NCT02443337|520345885|FG001|Overall Study|Adverse Event|1|||
144312266|NCT02443337|520345884|FG000|Overall Study|Clinical Progressive Disease|3|||
144312267|NCT02443337|520345885|FG001|Overall Study|Clinical Progressive Disease|0|||
144312268|NCT02443337|520345884|FG000|Overall Study|Withdrawal by Subject|2|||
144312269|NCT02443337|520345885|FG001|Overall Study|Withdrawal by Subject|1|||
144312270|NCT00040742|520345886|FG000|Overall Study|Death|0|||
144312271|NCT00040742|520345887|FG001|Overall Study|Death|0|||
144312272|NCT00040742|520345888|FG002|Overall Study|Death|1|||
144312273|NCT00040742|520345889|FG003|Overall Study|Death|0|||
144312274|NCT00040742|520345886|FG000|Overall Study|Adverse Event|15|||
144312275|NCT00040742|520345887|FG001|Overall Study|Adverse Event|16|||
144312276|NCT00040742|520345888|FG002|Overall Study|Adverse Event|21|||
144312277|NCT00040742|520345889|FG003|Overall Study|Adverse Event|9|||
144312278|NCT00040742|520345886|FG000|Overall Study|Withdrawal by Subject|7|||
144312279|NCT00040742|520345887|FG001|Overall Study|Withdrawal by Subject|15|||
144312280|NCT00040742|520345888|FG002|Overall Study|Withdrawal by Subject|10|||
144312281|NCT00040742|520345889|FG003|Overall Study|Withdrawal by Subject|13|||
144312282|NCT00040742|520345886|FG000|Overall Study|Chemotoxicity|4|||
144312283|NCT00040742|520345887|FG001|Overall Study|Chemotoxicity|3|||
144312284|NCT00040742|520345888|FG002|Overall Study|Chemotoxicity|5|||
144312285|NCT00040742|520345889|FG003|Overall Study|Chemotoxicity|2|||
144312286|NCT00040742|520345886|FG000|Overall Study|Incomplete Forms|6|||
144312287|NCT00040742|520345887|FG001|Overall Study|Incomplete Forms|10|||
144312288|NCT00040742|520345888|FG002|Overall Study|Incomplete Forms|4|||
144312289|NCT00040742|520345889|FG003|Overall Study|Incomplete Forms|5|||
144312290|NCT00040742|520345886|FG000|Overall Study|Other medical|7|||
144312291|NCT00040742|520345887|FG001|Overall Study|Other medical|5|||
144312292|NCT00040742|520345888|FG002|Overall Study|Other medical|5|||
144312293|NCT00040742|520345889|FG003|Overall Study|Other medical|5|||
144312294|NCT00635349|520345890|FG000|Overall Study|Other|8|||
144312295|NCT00635349|520345891|FG001|Overall Study|Other|6|||
144312296|NCT00635349|520345890|FG000|Overall Study|Protocol Violation|18|||
144312297|NCT00635349|520345891|FG001|Overall Study|Protocol Violation|22|||
144312298|NCT00635349|520345890|FG000|Overall Study|Withdrawal by Subject|3|||
144312299|NCT00635349|520345891|FG001|Overall Study|Withdrawal by Subject|8|||
144312300|NCT00635349|520345890|FG000|Overall Study|Lost to Follow-up|4|||
144312301|NCT00635349|520345891|FG001|Overall Study|Lost to Follow-up|3|||
144312302|NCT00635349|520345890|FG000|Overall Study|Adverse Event|11|||
144312303|NCT00635349|520345891|FG001|Overall Study|Adverse Event|9|||
144312304|NCT00645840|520345893|FG000|Overall Study|Protocol Violation|3|||
144312305|NCT00402324|520345894|FG000|Overall Study|Lost to Follow-up|11|||
144312306|NCT00402324|520345895|FG001|Overall Study|Lost to Follow-up|11|||
144312307|NCT00402324|520345894|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
144312308|NCT00402324|520345895|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
144312309|NCT00402324|520345894|FG000|Overall Study|Protocol Violation|8|||
144312310|NCT00402324|520345895|FG001|Overall Study|Protocol Violation|7|||
144312311|NCT00402324|520345894|FG000|Overall Study|Withdrawal by Subject|5|||
144312312|NCT00402324|520345895|FG001|Overall Study|Withdrawal by Subject|2|||
144312313|NCT00402324|520345894|FG000|Overall Study|Physician Decision|2|||
144312314|NCT00402324|520345895|FG001|Overall Study|Physician Decision|4|||
144312315|NCT00402324|520345894|FG000|Overall Study|Sponsor Decision|4|||
144312316|NCT00402324|520345895|FG001|Overall Study|Sponsor Decision|5|||
144312317|NCT00402324|520345894|FG000|Overall Study|Lack of Efficacy|1|||
144312318|NCT00402324|520345895|FG001|Overall Study|Lack of Efficacy|4|||
144312319|NCT00402324|520345894|FG000|Overall Study|Adverse Event|6|||
144312320|NCT00402324|520345895|FG001|Overall Study|Adverse Event|4|||
144312321|NCT00402324|520345894|FG000|Overall Study|Death|1|||
144312322|NCT00402324|520345895|FG001|Overall Study|Death|0|||
144312323|NCT01340664|520345896|FG000|Overall Study|Adverse Event|0|||
144312324|NCT01340664|520345897|FG001|Overall Study|Adverse Event|1|||
144312325|NCT01340664|520345898|FG002|Overall Study|Adverse Event|7|||
144312326|NCT01340664|520345896|FG000|Overall Study|Lost to Follow-up|2|||
144312327|NCT01340664|520345897|FG001|Overall Study|Lost to Follow-up|0|||
144312328|NCT01340664|520345898|FG002|Overall Study|Lost to Follow-up|2|||
144312329|NCT01340664|520345896|FG000|Overall Study|Withdrawal by Subject|2|||
144312330|NCT01340664|520345897|FG001|Overall Study|Withdrawal by Subject|4|||
144312331|NCT01340664|520345898|FG002|Overall Study|Withdrawal by Subject|0|||
144312332|NCT01340664|520345896|FG000|Overall Study|Glycemic withdrawal criteria|2|||
144312333|NCT01340664|520345897|FG001|Overall Study|Glycemic withdrawal criteria|0|||
144312334|NCT01340664|520345898|FG002|Overall Study|Glycemic withdrawal criteria|0|||
144312335|NCT01340664|520345896|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
144312336|NCT01340664|520345897|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
144312337|NCT01340664|520345898|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
144312338|NCT01340664|520345896|FG000|Overall Study|Other|1|||
144312339|NCT01340664|520345897|FG001|Overall Study|Other|2|||
144312340|NCT01340664|520345898|FG002|Overall Study|Other|2|||
144312341|NCT02997865|520345900|FG000|Overall Study|Death|2|||
144312342|NCT02997865|520345901|FG001|Overall Study|Death|1|||
144312343|NCT02997865|520345900|FG000|Overall Study|Lost to Follow-up|6|||
144312344|NCT02997865|520345901|FG001|Overall Study|Lost to Follow-up|3|||
144312345|NCT02997865|520345900|FG000|Overall Study|Withdrawal by Subject|5|||
144312346|NCT02997865|520345901|FG001|Overall Study|Withdrawal by Subject|0|||
144312347|NCT01823198|520345902|FG000|Overall Study|Physician Decision|0|||
144312348|NCT01823198|520345903|FG001|Overall Study|Physician Decision|1|||
144312349|NCT01823198|520345904|FG002|Overall Study|Physician Decision|0|||
144312350|NCT01823198|520345905|FG003|Overall Study|Physician Decision|0|||
144312351|NCT01823198|520345906|FG004|Overall Study|Physician Decision|0|||
144312352|NCT01823198|520345907|FG005|Overall Study|Physician Decision|3|||
144312353|NCT01823198|520345908|FG006|Overall Study|Physician Decision|3|||
144312354|NCT01119066|520345909|FG000|Overall Study|Withdrawal by Subject|4|||
144312355|NCT01119066|520345910|FG001|Overall Study|Withdrawal by Subject|6|||
144312356|NCT01119066|520345911|FG002|Overall Study|Withdrawal by Subject|0|||
144312357|NCT01119066|520345912|FG003|Overall Study|Withdrawal by Subject|0|||
144312358|NCT01119066|520345909|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
144312359|NCT01119066|520345910|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
144312360|NCT01119066|520345911|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
144312361|NCT01119066|520345912|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
144312362|NCT01119066|520345909|FG000|Overall Study|Relapse identified before transplant|1|||
144312363|NCT01119066|520345910|FG001|Overall Study|Relapse identified before transplant|0|||
144312364|NCT01119066|520345911|FG002|Overall Study|Relapse identified before transplant|0|||
144312365|NCT01119066|520345912|FG003|Overall Study|Relapse identified before transplant|0|||
144312366|NCT01119066|520345909|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
144312367|NCT01119066|520345910|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
144312368|NCT01119066|520345911|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
144312369|NCT01119066|520345912|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
144312370|NCT01119066|520345909|FG000|Overall Study|Relapse identified before transplant|0|||
144312371|NCT01119066|520345910|FG001|Overall Study|Relapse identified before transplant|4|||
144312372|NCT01119066|520345911|FG002|Overall Study|Relapse identified before transplant|0|||
144312373|NCT01119066|520345912|FG003|Overall Study|Relapse identified before transplant|0|||
144312374|NCT02441101|520345915|FG000|Overall Study|Withdrawal by Subject|1|||
144312375|NCT02441101|520345916|FG001|Overall Study|Withdrawal by Subject|0|||
144312376|NCT02441101|520345915|FG000|Overall Study|Lost to Follow-up|1|||
144312377|NCT02441101|520345916|FG001|Overall Study|Lost to Follow-up|0|||
144312378|NCT02441101|520345915|FG000|Overall Study|PI relocated and study terminated|1|||
144312379|NCT02441101|520345916|FG001|Overall Study|PI relocated and study terminated|0|||
144312380|NCT02528942|520345917|FG000|Overall Study|Did not meet imaging criteria|9|||
144312381|NCT02528942|520345917|FG000|Overall Study|Lost to Follow-up|25|||
144312382|NCT04599803|520345918|FG000|Overall Study|Withdrawal by Subject|5|||
144312383|NCT04599803|520345918|FG000|Overall Study|Lost to Follow-up|26|||
144312384|NCT00881530|520345919|FG000|Overall Study|Adverse Event|5|||
144312385|NCT00881530|520345920|FG001|Overall Study|Adverse Event|1|||
144312386|NCT00881530|520345921|FG002|Overall Study|Adverse Event|1|||
144312387|NCT00881530|520345922|FG003|Overall Study|Adverse Event|4|||
144312388|NCT00881530|520345923|FG004|Overall Study|Adverse Event|10|||
144312389|NCT00881530|520345924|FG005|Overall Study|Adverse Event|2|||
144312390|NCT00881530|520345919|FG000|Overall Study|Lack of Efficacy|1|||
144312391|NCT00881530|520345920|FG001|Overall Study|Lack of Efficacy|0|||
144312392|NCT00881530|520345921|FG002|Overall Study|Lack of Efficacy|0|||
144312393|NCT00881530|520345922|FG003|Overall Study|Lack of Efficacy|0|||
144312394|NCT00881530|520345923|FG004|Overall Study|Lack of Efficacy|1|||
144312395|NCT00881530|520345924|FG005|Overall Study|Lack of Efficacy|1|||
144312396|NCT00881530|520345919|FG000|Overall Study|Not compliant with the protocol|0|||
144312397|NCT00881530|520345920|FG001|Overall Study|Not compliant with the protocol|0|||
144312398|NCT00881530|520345921|FG002|Overall Study|Not compliant with the protocol|0|||
144312399|NCT00881530|520345922|FG003|Overall Study|Not compliant with the protocol|0|||
144312400|NCT00881530|520345923|FG004|Overall Study|Not compliant with the protocol|2|||
144312401|NCT00881530|520345924|FG005|Overall Study|Not compliant with the protocol|0|||
144312402|NCT00881530|520345919|FG000|Overall Study|Lost to Follow-up|0|||
144312403|NCT00881530|520345920|FG001|Overall Study|Lost to Follow-up|1|||
144312404|NCT00881530|520345921|FG002|Overall Study|Lost to Follow-up|1|||
144312405|NCT00881530|520345922|FG003|Overall Study|Lost to Follow-up|3|||
144312406|NCT00881530|520345923|FG004|Overall Study|Lost to Follow-up|1|||
144312407|NCT00881530|520345924|FG005|Overall Study|Lost to Follow-up|0|||
144312408|NCT00881530|520345919|FG000|Overall Study|Refused to continue medication|7|||
144312409|NCT00881530|520345920|FG001|Overall Study|Refused to continue medication|2|||
144312410|NCT00881530|520345921|FG002|Overall Study|Refused to continue medication|1|||
144312411|NCT00881530|520345922|FG003|Overall Study|Refused to continue medication|2|||
144312412|NCT00881530|520345923|FG004|Overall Study|Refused to continue medication|0|||
144312413|NCT00881530|520345924|FG005|Overall Study|Refused to continue medication|0|||
144312414|NCT00881530|520345919|FG000|Overall Study|Other reason not defined above|1|||
144312415|NCT00881530|520345920|FG001|Overall Study|Other reason not defined above|1|||
144312416|NCT00881530|520345921|FG002|Overall Study|Other reason not defined above|2|||
144312417|NCT00881530|520345922|FG003|Overall Study|Other reason not defined above|0|||
144312418|NCT00881530|520345923|FG004|Overall Study|Other reason not defined above|0|||
144312419|NCT00881530|520345924|FG005|Overall Study|Other reason not defined above|2|||
144312420|NCT01509846|520345925|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
144312421|NCT01509846|520345926|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
144312422|NCT01509846|520345927|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
144312423|NCT01509846|520345928|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
144312424|NCT01509846|520345929|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
144312425|NCT01509846|520345925|FG000|Received Vaccination 2|Illness|0|||
144312426|NCT01509846|520345926|FG001|Received Vaccination 2|Illness|0|||
144312427|NCT01509846|520345927|FG002|Received Vaccination 2|Illness|0|||
144312428|NCT01509846|520345928|FG003|Received Vaccination 2|Illness|0|||
144312429|NCT01509846|520345929|FG004|Received Vaccination 2|Illness|1|||
144312430|NCT01509846|520345925|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
144312431|NCT01509846|520345926|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
144312432|NCT01509846|520345927|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
144312433|NCT01509846|520345928|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
144312434|NCT01509846|520345929|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
144312435|NCT01509846|520345925|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
144312436|NCT01509846|520345926|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
144312437|NCT01509846|520345927|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
144312438|NCT01509846|520345928|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
144312439|NCT01509846|520345929|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
144312440|NCT01509846|520345925|FG000|Received Vaccination 3|Pregnancy|0|||
144312441|NCT01509846|520345926|FG001|Received Vaccination 3|Pregnancy|0|||
144312442|NCT01509846|520345927|FG002|Received Vaccination 3|Pregnancy|0|||
144312443|NCT01509846|520345928|FG003|Received Vaccination 3|Pregnancy|1|||
144312444|NCT01509846|520345929|FG004|Received Vaccination 3|Pregnancy|0|||
144312445|NCT01509846|520345925|FG000|Received Vaccination 3|Lost to Follow-up|0|||
144312446|NCT01509846|520345926|FG001|Received Vaccination 3|Lost to Follow-up|0|||
144312447|NCT01509846|520345927|FG002|Received Vaccination 3|Lost to Follow-up|1|||
144312448|NCT01509846|520345928|FG003|Received Vaccination 3|Lost to Follow-up|0|||
144312449|NCT01509846|520345929|FG004|Received Vaccination 3|Lost to Follow-up|0|||
144312450|NCT00763256|520345930|FG000|Overall Study|Didn't return for appointments|7|||
144312451|NCT00763256|520345931|FG001|Overall Study|Didn't return for appointments|10|||
144312452|NCT04396795|520345934|FG000|Month 1|Lost to Follow-up|2|||
144312453|NCT04396795|520345935|FG001|Month 1|Lost to Follow-up|3|||
144312454|NCT04396795|520345934|FG000|Month 3|Lost to Follow-up|1|||
144312455|NCT04396795|520345935|FG001|Month 3|Lost to Follow-up|3|||
144312456|NCT04396795|520345934|FG000|Month 6|Lost to Follow-up|3|||
144312457|NCT04396795|520345935|FG001|Month 6|Lost to Follow-up|3|||
144312458|NCT02366923|520345936|FG000|Overall Study|Withdrawal by Subject|1|||
144312459|NCT02366923|520345936|FG000|Overall Study|Positive Slit Lamp Findings|2|||
144312460|NCT02366923|520345936|FG000|Overall Study|High Astigmatism|3|||
144312461|NCT02725476|520345938|FG000|Overall Study|Physician Decision|2|||
144312462|NCT02725476|520345939|FG001|Overall Study|Physician Decision|0|||
144312463|NCT02725476|520345938|FG000|Overall Study|Adverse Event|1|||
144312464|NCT02725476|520345939|FG001|Overall Study|Adverse Event|1|||
144312465|NCT02517398|520345954|FG000|Overall Study|Death|2|||
144312466|NCT02517398|520345955|FG001|Overall Study|Death|3|||
144312467|NCT02517398|520345956|FG002|Overall Study|Death|4|||
144312468|NCT02517398|520345957|FG003|Overall Study|Death|2|||
144312469|NCT02517398|520345958|FG004|Overall Study|Death|3|||
144312470|NCT02517398|520345959|FG005|Overall Study|Death|8|||
144312471|NCT02517398|520345960|FG006|Overall Study|Death|3|||
144312472|NCT02517398|520345961|FG007|Overall Study|Death|2|||
144312473|NCT02517398|520345962|FG008|Overall Study|Death|6|||
144312474|NCT02517398|520345963|FG009|Overall Study|Death|24|||
144312475|NCT02517398|520345964|FG010|Overall Study|Death|53|||
144312476|NCT02517398|520345965|FG011|Overall Study|Death|25|||
144312477|NCT02517398|520345966|FG012|Overall Study|Death|73|||
144312478|NCT02517398|520345967|FG013|Overall Study|Death|29|||
144312479|NCT02517398|520345968|FG014|Overall Study|Death|26|||
144312480|NCT02517398|520345969|FG015|Overall Study|Death|23|||
144312481|NCT02517398|520345970|FG016|Overall Study|Death|26|||
144312482|NCT02517398|520345971|FG017|Overall Study|Death|25|||
144312483|NCT02517398|520345972|FG018|Overall Study|Death|22|||
144312484|NCT02517398|520345973|FG019|Overall Study|Death|7|||
144312485|NCT02517398|520345974|FG020|Overall Study|Death|26|||
144312486|NCT02517398|520345975|FG021|Overall Study|Death|30|||
144312487|NCT02517398|520345976|FG022|Overall Study|Death|20|||
144312488|NCT02517398|520345954|FG000|Overall Study|Other|0|||
144312489|NCT02517398|520345955|FG001|Overall Study|Other|0|||
144312490|NCT02517398|520345956|FG002|Overall Study|Other|0|||
144312491|NCT02517398|520345957|FG003|Overall Study|Other|1|||
144312492|NCT02517398|520345958|FG004|Overall Study|Other|0|||
144312493|NCT02517398|520345959|FG005|Overall Study|Other|0|||
144312494|NCT02517398|520345960|FG006|Overall Study|Other|0|||
144312495|NCT02517398|520345961|FG007|Overall Study|Other|0|||
144312496|NCT02517398|520345962|FG008|Overall Study|Other|0|||
144312497|NCT02517398|520345963|FG009|Overall Study|Other|1|||
144312498|NCT02517398|520345964|FG010|Overall Study|Other|0|||
144312499|NCT02517398|520345965|FG011|Overall Study|Other|0|||
144312500|NCT02517398|520345966|FG012|Overall Study|Other|0|||
144312501|NCT02517398|520345967|FG013|Overall Study|Other|1|||
144312502|NCT02517398|520345968|FG014|Overall Study|Other|0|||
144312503|NCT02517398|520345969|FG015|Overall Study|Other|1|||
144312504|NCT02517398|520345970|FG016|Overall Study|Other|1|||
144312505|NCT02517398|520345971|FG017|Overall Study|Other|0|||
144312506|NCT02517398|520345972|FG018|Overall Study|Other|0|||
144312507|NCT02517398|520345973|FG019|Overall Study|Other|1|||
144312508|NCT02517398|520345974|FG020|Overall Study|Other|0|||
144312509|NCT02517398|520345975|FG021|Overall Study|Other|0|||
144312510|NCT02517398|520345976|FG022|Overall Study|Other|0|||
144312511|NCT02517398|520345954|FG000|Overall Study|Lost to Follow-up|0|||
144312512|NCT02517398|520345955|FG001|Overall Study|Lost to Follow-up|0|||
144312513|NCT02517398|520345956|FG002|Overall Study|Lost to Follow-up|0|||
144312514|NCT02517398|520345957|FG003|Overall Study|Lost to Follow-up|0|||
144312515|NCT02517398|520345958|FG004|Overall Study|Lost to Follow-up|0|||
144312516|NCT02517398|520345959|FG005|Overall Study|Lost to Follow-up|0|||
144312517|NCT02517398|520345960|FG006|Overall Study|Lost to Follow-up|0|||
144312518|NCT02517398|520345961|FG007|Overall Study|Lost to Follow-up|0|||
144312519|NCT02517398|520345962|FG008|Overall Study|Lost to Follow-up|0|||
144312520|NCT02517398|520345963|FG009|Overall Study|Lost to Follow-up|1|||
144312521|NCT02517398|520345964|FG010|Overall Study|Lost to Follow-up|0|||
144312522|NCT02517398|520345965|FG011|Overall Study|Lost to Follow-up|2|||
144312523|NCT02517398|520345966|FG012|Overall Study|Lost to Follow-up|2|||
144312524|NCT02517398|520345967|FG013|Overall Study|Lost to Follow-up|0|||
144312525|NCT02517398|520345968|FG014|Overall Study|Lost to Follow-up|1|||
144312526|NCT02517398|520345969|FG015|Overall Study|Lost to Follow-up|1|||
144312527|NCT02517398|520345970|FG016|Overall Study|Lost to Follow-up|0|||
144312528|NCT02517398|520345971|FG017|Overall Study|Lost to Follow-up|3|||
144312529|NCT02517398|520345972|FG018|Overall Study|Lost to Follow-up|1|||
144312530|NCT02517398|520345973|FG019|Overall Study|Lost to Follow-up|0|||
144312531|NCT02517398|520345974|FG020|Overall Study|Lost to Follow-up|1|||
144312532|NCT02517398|520345975|FG021|Overall Study|Lost to Follow-up|0|||
144312533|NCT02517398|520345976|FG022|Overall Study|Lost to Follow-up|2|||
144312534|NCT02517398|520345954|FG000|Overall Study|Withdrew Consent|0|||
144312535|NCT02517398|520345955|FG001|Overall Study|Withdrew Consent|0|||
144312536|NCT02517398|520345956|FG002|Overall Study|Withdrew Consent|0|||
144312537|NCT02517398|520345957|FG003|Overall Study|Withdrew Consent|0|||
144312538|NCT02517398|520345958|FG004|Overall Study|Withdrew Consent|0|||
144312539|NCT02517398|520345959|FG005|Overall Study|Withdrew Consent|0|||
144312540|NCT02517398|520345960|FG006|Overall Study|Withdrew Consent|1|||
144312541|NCT02517398|520345961|FG007|Overall Study|Withdrew Consent|0|||
144312542|NCT02517398|520345962|FG008|Overall Study|Withdrew Consent|0|||
144312543|NCT02517398|520345963|FG009|Overall Study|Withdrew Consent|2|||
144312544|NCT02517398|520345964|FG010|Overall Study|Withdrew Consent|7|||
144312545|NCT02517398|520345965|FG011|Overall Study|Withdrew Consent|1|||
144312546|NCT02517398|520345966|FG012|Overall Study|Withdrew Consent|5|||
144312547|NCT02517398|520345967|FG013|Overall Study|Withdrew Consent|4|||
144312548|NCT02517398|520345968|FG014|Overall Study|Withdrew Consent|2|||
144312549|NCT02517398|520345969|FG015|Overall Study|Withdrew Consent|5|||
144312550|NCT02517398|520345970|FG016|Overall Study|Withdrew Consent|4|||
144312551|NCT02517398|520345971|FG017|Overall Study|Withdrew Consent|2|||
144312552|NCT02517398|520345972|FG018|Overall Study|Withdrew Consent|3|||
144312553|NCT02517398|520345973|FG019|Overall Study|Withdrew Consent|2|||
144312554|NCT02517398|520345974|FG020|Overall Study|Withdrew Consent|9|||
144312555|NCT02517398|520345975|FG021|Overall Study|Withdrew Consent|3|||
144312556|NCT02517398|520345976|FG022|Overall Study|Withdrew Consent|1|||
144312557|NCT02131662|520345977|FG000|Overall Study|Protocol Violation|1|||
144312558|NCT02131662|520345978|FG001|Overall Study|Protocol Violation|0|||
144312559|NCT02131662|520345979|FG002|Overall Study|Protocol Violation|0|||
144312560|NCT02131662|520345980|FG003|Overall Study|Protocol Violation|0|||
144312561|NCT02131662|520345981|FG004|Overall Study|Protocol Violation|0|||
144312562|NCT02131662|520345977|FG000|Overall Study|Other|2|||
144312563|NCT02131662|520345978|FG001|Overall Study|Other|4|||
144312564|NCT02131662|520345979|FG002|Overall Study|Other|3|||
144312565|NCT02131662|520345980|FG003|Overall Study|Other|3|||
144312566|NCT02131662|520345981|FG004|Overall Study|Other|4|||
144312567|NCT02131662|520345977|FG000|Overall Study|Adverse Event|0|||
144312568|NCT02131662|520345978|FG001|Overall Study|Adverse Event|1|||
144312569|NCT02131662|520345979|FG002|Overall Study|Adverse Event|1|||
144312570|NCT02131662|520345980|FG003|Overall Study|Adverse Event|1|||
144312571|NCT02131662|520345981|FG004|Overall Study|Adverse Event|3|||
144312572|NCT02131662|520345977|FG000|Overall Study|Pregnancy|0|||
144312573|NCT02131662|520345978|FG001|Overall Study|Pregnancy|1|||
144312574|NCT02131662|520345979|FG002|Overall Study|Pregnancy|0|||
144312575|NCT02131662|520345980|FG003|Overall Study|Pregnancy|1|||
144312576|NCT02131662|520345981|FG004|Overall Study|Pregnancy|0|||
144312577|NCT02131662|520345977|FG000|Overall Study|Wish for pregnancy|0|||
144312578|NCT02131662|520345978|FG001|Overall Study|Wish for pregnancy|0|||
144312579|NCT02131662|520345979|FG002|Overall Study|Wish for pregnancy|0|||
144312580|NCT02131662|520345980|FG003|Overall Study|Wish for pregnancy|0|||
144312581|NCT02131662|520345981|FG004|Overall Study|Wish for pregnancy|1|||
144312582|NCT02131662|520345977|FG000|Overall Study|Lack of Efficacy|1|||
144312583|NCT02131662|520345978|FG001|Overall Study|Lack of Efficacy|0|||
144312584|NCT02131662|520345979|FG002|Overall Study|Lack of Efficacy|0|||
144312585|NCT02131662|520345980|FG003|Overall Study|Lack of Efficacy|0|||
144312586|NCT02131662|520345981|FG004|Overall Study|Lack of Efficacy|1|||
144312587|NCT02131662|520345977|FG000|Overall Study|Withdrawal by Subject|1|||
144312588|NCT02131662|520345978|FG001|Overall Study|Withdrawal by Subject|5|||
144312589|NCT02131662|520345979|FG002|Overall Study|Withdrawal by Subject|1|||
144312590|NCT02131662|520345980|FG003|Overall Study|Withdrawal by Subject|5|||
144312591|NCT02131662|520345981|FG004|Overall Study|Withdrawal by Subject|6|||
144312592|NCT02131662|520345977|FG000|Overall Study|Lost to Follow-up|1|||
144312593|NCT02131662|520345978|FG001|Overall Study|Lost to Follow-up|3|||
144312594|NCT02131662|520345979|FG002|Overall Study|Lost to Follow-up|0|||
144312595|NCT02131662|520345980|FG003|Overall Study|Lost to Follow-up|9|||
144312596|NCT02131662|520345981|FG004|Overall Study|Lost to Follow-up|0|||
144312597|NCT02131662|520345977|FG000|Overall Study|Not treated|2|||
144312598|NCT02131662|520345978|FG001|Overall Study|Not treated|0|||
144312599|NCT02131662|520345979|FG002|Overall Study|Not treated|2|||
144312600|NCT02131662|520345980|FG003|Overall Study|Not treated|2|||
144312601|NCT02131662|520345981|FG004|Overall Study|Not treated|3|||
144312602|NCT03554018|520345982|FG000|Overall Study|Lost to Follow-up|3|||
144312603|NCT03554018|520345983|FG001|Overall Study|Lost to Follow-up|7|||
144312604|NCT00556439|520345997|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
144312605|NCT00556439|520345998|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
144312606|NCT00556439|520345999|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
144312607|NCT00556439|520346000|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
144312608|NCT00556439|520345997|FG000|Study Entry to Week 12|Physician Decision|1|||
144312609|NCT00556439|520345998|FG001|Study Entry to Week 12|Physician Decision|0|||
144312610|NCT00556439|520345999|FG002|Study Entry to Week 12|Physician Decision|0|||
144312611|NCT00556439|520346000|FG003|Study Entry to Week 12|Physician Decision|0|||
144312612|NCT00556439|520345997|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
144312613|NCT00556439|520345998|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
144312614|NCT00556439|520345999|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
144312615|NCT00556439|520346000|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
144312616|NCT00556439|520345997|FG000|Study Entry to Week 12|Recurrent infection|1|||
144312617|NCT00556439|520345998|FG001|Study Entry to Week 12|Recurrent infection|0|||
144312618|NCT00556439|520345999|FG002|Study Entry to Week 12|Recurrent infection|0|||
144312619|NCT00556439|520346000|FG003|Study Entry to Week 12|Recurrent infection|0|||
144312620|NCT00556439|520345997|FG000|Study Entry to Week 12|Malignancy|0|||
144312621|NCT00556439|520345998|FG001|Study Entry to Week 12|Malignancy|0|||
144312622|NCT00556439|520345999|FG002|Study Entry to Week 12|Malignancy|1|||
144312623|NCT00556439|520346000|FG003|Study Entry to Week 12|Malignancy|0|||
144312624|NCT00556439|520345997|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
144312625|NCT00556439|520345998|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
144312626|NCT00556439|520345999|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
144312627|NCT00556439|520346000|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
144312628|NCT00556439|520345997|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
144312629|NCT00556439|520345998|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
144312630|NCT00556439|520345999|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
144312631|NCT00556439|520346000|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
144312632|NCT00556439|520345997|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
144312633|NCT00556439|520345998|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
144312634|NCT00556439|520345999|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
144312635|NCT00556439|520346000|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
144312636|NCT00556439|520345997|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
144312637|NCT00556439|520345998|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
144312638|NCT00556439|520345999|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
144312639|NCT00556439|520346000|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
144312640|NCT05823974|520347796|FG000|Overall Study|Lost to Follow-up|0|||
144312641|NCT05823974|520347797|FG001|Overall Study|Lost to Follow-up|3|||
144312642|NCT05823974|520347798|FG002|Overall Study|Lost to Follow-up|1|||
144312643|NCT05823974|520347799|FG003|Overall Study|Lost to Follow-up|0|||
144312644|NCT05823974|520347800|FG004|Overall Study|Lost to Follow-up|1|||
144312645|NCT05823974|520347801|FG005|Overall Study|Lost to Follow-up|0|||
144312646|NCT05823974|520347802|FG006|Overall Study|Lost to Follow-up|1|||
144312647|NCT05823974|520347803|FG007|Overall Study|Lost to Follow-up|0|||
144312648|NCT05823974|520347804|FG008|Overall Study|Lost to Follow-up|0|||
144312649|NCT05823974|520347805|FG009|Overall Study|Lost to Follow-up|1|||
144312650|NCT05823974|520347806|FG010|Overall Study|Lost to Follow-up|1|||
144312651|NCT05823974|520347807|FG011|Overall Study|Lost to Follow-up|0|||
144312652|NCT05823974|520347808|FG012|Overall Study|Lost to Follow-up|1|||
144312653|NCT05823974|520347809|FG013|Overall Study|Lost to Follow-up|2|||
144312654|NCT05823974|520347810|FG014|Overall Study|Lost to Follow-up|1|||
144312655|NCT05823974|520347811|FG015|Overall Study|Lost to Follow-up|1|||
144312656|NCT05823974|520347812|FG016|Overall Study|Lost to Follow-up|1|||
144312657|NCT05823974|520347813|FG017|Overall Study|Lost to Follow-up|0|||
144312658|NCT05823974|520347814|FG018|Overall Study|Lost to Follow-up|0|||
144312659|NCT05823974|520347815|FG019|Overall Study|Lost to Follow-up|2|||
144312660|NCT05823974|520347816|FG020|Overall Study|Lost to Follow-up|0|||
144312661|NCT05823974|520347796|FG000|Overall Study|Physician Decision|0|||
144312662|NCT05823974|520347797|FG001|Overall Study|Physician Decision|0|||
144312663|NCT05823974|520347798|FG002|Overall Study|Physician Decision|0|||
144312664|NCT05823974|520347799|FG003|Overall Study|Physician Decision|0|||
144312665|NCT05823974|520347800|FG004|Overall Study|Physician Decision|0|||
144312666|NCT05823974|520347801|FG005|Overall Study|Physician Decision|0|||
144312667|NCT05823974|520347802|FG006|Overall Study|Physician Decision|0|||
144312668|NCT05823974|520347803|FG007|Overall Study|Physician Decision|0|||
144312669|NCT05823974|520347804|FG008|Overall Study|Physician Decision|0|||
144312670|NCT05823974|520347805|FG009|Overall Study|Physician Decision|0|||
144312671|NCT05823974|520347806|FG010|Overall Study|Physician Decision|0|||
144312672|NCT05823974|520347807|FG011|Overall Study|Physician Decision|0|||
144312673|NCT05823974|520347808|FG012|Overall Study|Physician Decision|0|||
144312674|NCT05823974|520347809|FG013|Overall Study|Physician Decision|0|||
144312675|NCT05823974|520347810|FG014|Overall Study|Physician Decision|0|||
144312676|NCT05823974|520347811|FG015|Overall Study|Physician Decision|1|||
144312677|NCT05823974|520347812|FG016|Overall Study|Physician Decision|0|||
144312678|NCT05823974|520347813|FG017|Overall Study|Physician Decision|1|||
144312679|NCT05823974|520347814|FG018|Overall Study|Physician Decision|1|||
144312680|NCT05823974|520347815|FG019|Overall Study|Physician Decision|0|||
144312681|NCT05823974|520347816|FG020|Overall Study|Physician Decision|0|||
144312682|NCT05823974|520347796|FG000|Overall Study|Withdrawal by Subject|1|||
144312683|NCT05823974|520347797|FG001|Overall Study|Withdrawal by Subject|1|||
144312684|NCT05823974|520347798|FG002|Overall Study|Withdrawal by Subject|2|||
144312685|NCT05823974|520347799|FG003|Overall Study|Withdrawal by Subject|0|||
144312686|NCT05823974|520347800|FG004|Overall Study|Withdrawal by Subject|2|||
144312687|NCT05823974|520347801|FG005|Overall Study|Withdrawal by Subject|3|||
144312688|NCT05823974|520347802|FG006|Overall Study|Withdrawal by Subject|1|||
144312689|NCT05823974|520347803|FG007|Overall Study|Withdrawal by Subject|1|||
144312690|NCT05823974|520347804|FG008|Overall Study|Withdrawal by Subject|2|||
144312691|NCT05823974|520347805|FG009|Overall Study|Withdrawal by Subject|1|||
144312692|NCT05823974|520347806|FG010|Overall Study|Withdrawal by Subject|1|||
144312693|NCT05823974|520347807|FG011|Overall Study|Withdrawal by Subject|0|||
144312694|NCT05823974|520347808|FG012|Overall Study|Withdrawal by Subject|0|||
144312695|NCT05823974|520347809|FG013|Overall Study|Withdrawal by Subject|1|||
144312696|NCT05823974|520347810|FG014|Overall Study|Withdrawal by Subject|1|||
144312697|NCT05823974|520347811|FG015|Overall Study|Withdrawal by Subject|3|||
144312698|NCT05823974|520347812|FG016|Overall Study|Withdrawal by Subject|0|||
144312699|NCT05823974|520347813|FG017|Overall Study|Withdrawal by Subject|2|||
144312700|NCT05823974|520347814|FG018|Overall Study|Withdrawal by Subject|2|||
144312701|NCT05823974|520347815|FG019|Overall Study|Withdrawal by Subject|0|||
144312702|NCT05823974|520347816|FG020|Overall Study|Withdrawal by Subject|1|||
144312703|NCT05823974|520347796|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312704|NCT05823974|520347797|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312705|NCT05823974|520347798|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144312706|NCT05823974|520347799|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312707|NCT05823974|520347800|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312708|NCT05823974|520347801|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312709|NCT05823974|520347802|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312710|NCT05823974|520347803|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312711|NCT05823974|520347804|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312712|NCT05823974|520347805|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312713|NCT05823974|520347806|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312714|NCT05823974|520347807|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312715|NCT05823974|520347808|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312716|NCT05823974|520347809|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312717|NCT05823974|520347810|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
144312718|NCT05823974|520347811|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312719|NCT05823974|520347812|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312720|NCT05823974|520347813|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312721|NCT05823974|520347814|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312722|NCT05823974|520347815|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312723|NCT05823974|520347816|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
144312724|NCT05823974|520347796|FG000|Overall Study|Other|0|||
144312725|NCT05823974|520347797|FG001|Overall Study|Other|1|||
144312726|NCT05823974|520347798|FG002|Overall Study|Other|1|||
144312727|NCT05823974|520347799|FG003|Overall Study|Other|1|||
144312728|NCT05823974|520347800|FG004|Overall Study|Other|0|||
144312729|NCT05823974|520347801|FG005|Overall Study|Other|1|||
144312730|NCT05823974|520347802|FG006|Overall Study|Other|1|||
144312731|NCT05823974|520347803|FG007|Overall Study|Other|1|||
144312732|NCT05823974|520347804|FG008|Overall Study|Other|1|||
144312733|NCT05823974|520347805|FG009|Overall Study|Other|0|||
144312734|NCT05823974|520347806|FG010|Overall Study|Other|0|||
144312735|NCT05823974|520347807|FG011|Overall Study|Other|0|||
144312736|NCT05823974|520347808|FG012|Overall Study|Other|2|||
144312737|NCT05823974|520347809|FG013|Overall Study|Other|1|||
144312738|NCT05823974|520347810|FG014|Overall Study|Other|0|||
144312739|NCT05823974|520347811|FG015|Overall Study|Other|1|||
144312740|NCT05823974|520347812|FG016|Overall Study|Other|0|||
144312741|NCT05823974|520347813|FG017|Overall Study|Other|0|||
144312742|NCT05823974|520347814|FG018|Overall Study|Other|0|||
144312743|NCT05823974|520347815|FG019|Overall Study|Other|0|||
144312744|NCT05823974|520347816|FG020|Overall Study|Other|0|||
144312745|NCT01238991|520347821|FG000|Overall Study|Adverse Event|1|||
144312746|NCT01238991|520347822|FG001|Overall Study|Adverse Event|0|||
144312747|NCT01238991|520347823|FG002|Overall Study|Adverse Event|3|||
144312748|NCT01238991|520347824|FG003|Overall Study|Adverse Event|1|||
144312749|NCT01238991|520347825|FG004|Overall Study|Adverse Event|1|||
144312750|NCT01238991|520347826|FG005|Overall Study|Adverse Event|0|||
144312751|NCT01238991|520347827|FG006|Overall Study|Adverse Event|1|||
144312752|NCT01238991|520347828|FG007|Overall Study|Adverse Event|1|||
144312753|NCT01238991|520347829|FG008|Overall Study|Adverse Event|0|||
144312754|NCT01238991|520347830|FG009|Overall Study|Adverse Event|0|||
144312755|NCT01238991|520347821|FG000|Overall Study|Death|0|||
144312756|NCT01238991|520347822|FG001|Overall Study|Death|0|||
144312757|NCT01238991|520347823|FG002|Overall Study|Death|0|||
144312758|NCT01238991|520347824|FG003|Overall Study|Death|1|||
144312759|NCT01238991|520347825|FG004|Overall Study|Death|0|||
144312760|NCT01238991|520347826|FG005|Overall Study|Death|0|||
144312761|NCT01238991|520347827|FG006|Overall Study|Death|0|||
144312762|NCT01238991|520347828|FG007|Overall Study|Death|0|||
144312763|NCT01238991|520347829|FG008|Overall Study|Death|0|||
144312764|NCT01238991|520347830|FG009|Overall Study|Death|0|||
144312765|NCT01238991|520347821|FG000|Overall Study|Lack of Efficacy|0|||
144312766|NCT01238991|520347822|FG001|Overall Study|Lack of Efficacy|0|||
144312767|NCT01238991|520347823|FG002|Overall Study|Lack of Efficacy|1|||
144312768|NCT01238991|520347824|FG003|Overall Study|Lack of Efficacy|0|||
144312769|NCT01238991|520347825|FG004|Overall Study|Lack of Efficacy|0|||
144312770|NCT01238991|520347826|FG005|Overall Study|Lack of Efficacy|0|||
144312771|NCT01238991|520347827|FG006|Overall Study|Lack of Efficacy|0|||
144312772|NCT01238991|520347828|FG007|Overall Study|Lack of Efficacy|0|||
144312773|NCT01238991|520347829|FG008|Overall Study|Lack of Efficacy|1|||
144312774|NCT01238991|520347830|FG009|Overall Study|Lack of Efficacy|0|||
144312775|NCT01238991|520347821|FG000|Overall Study|Withdrawal by Subject|0|||
144312776|NCT01238991|520347822|FG001|Overall Study|Withdrawal by Subject|0|||
144312777|NCT01238991|520347823|FG002|Overall Study|Withdrawal by Subject|1|||
144312778|NCT01238991|520347824|FG003|Overall Study|Withdrawal by Subject|0|||
144312779|NCT01238991|520347825|FG004|Overall Study|Withdrawal by Subject|0|||
144312780|NCT01238991|520347826|FG005|Overall Study|Withdrawal by Subject|0|||
144312781|NCT01238991|520347827|FG006|Overall Study|Withdrawal by Subject|0|||
144312782|NCT01238991|520347828|FG007|Overall Study|Withdrawal by Subject|0|||
144312783|NCT01238991|520347829|FG008|Overall Study|Withdrawal by Subject|0|||
144312784|NCT01238991|520347830|FG009|Overall Study|Withdrawal by Subject|0|||
144312785|NCT01238991|520347821|FG000|Overall Study|Study Terminated by Sponsor|0|||
144312786|NCT01238991|520347822|FG001|Overall Study|Study Terminated by Sponsor|0|||
144312787|NCT01238991|520347823|FG002|Overall Study|Study Terminated by Sponsor|0|||
144312788|NCT01238991|520347824|FG003|Overall Study|Study Terminated by Sponsor|0|||
144312789|NCT01238991|520347825|FG004|Overall Study|Study Terminated by Sponsor|1|||
144312790|NCT01238991|520347826|FG005|Overall Study|Study Terminated by Sponsor|0|||
144312791|NCT01238991|520347827|FG006|Overall Study|Study Terminated by Sponsor|7|||
144312792|NCT01238991|520347828|FG007|Overall Study|Study Terminated by Sponsor|4|||
144312793|NCT01238991|520347829|FG008|Overall Study|Study Terminated by Sponsor|2|||
144312794|NCT01238991|520347830|FG009|Overall Study|Study Terminated by Sponsor|2|||
144312795|NCT01238991|520347821|FG000|Overall Study|Caregiver's request|0|||
144312796|NCT01238991|520347822|FG001|Overall Study|Caregiver's request|0|||
144312797|NCT01238991|520347823|FG002|Overall Study|Caregiver's request|0|||
144312798|NCT01238991|520347824|FG003|Overall Study|Caregiver's request|0|||
144312799|NCT01238991|520347825|FG004|Overall Study|Caregiver's request|0|||
144312800|NCT01238991|520347826|FG005|Overall Study|Caregiver's request|0|||
144312801|NCT01238991|520347827|FG006|Overall Study|Caregiver's request|0|||
144312802|NCT01238991|520347828|FG007|Overall Study|Caregiver's request|0|||
144312803|NCT01238991|520347829|FG008|Overall Study|Caregiver's request|1|||
144312804|NCT01238991|520347830|FG009|Overall Study|Caregiver's request|0|||
144312805|NCT01238991|520347821|FG000|Overall Study|Admission to a nursing home|1|||
144312806|NCT01238991|520347822|FG001|Overall Study|Admission to a nursing home|0|||
144312807|NCT01238991|520347823|FG002|Overall Study|Admission to a nursing home|1|||
144312808|NCT01238991|520347824|FG003|Overall Study|Admission to a nursing home|0|||
144312809|NCT01238991|520347825|FG004|Overall Study|Admission to a nursing home|0|||
144312810|NCT01238991|520347826|FG005|Overall Study|Admission to a nursing home|0|||
144312811|NCT01238991|520347827|FG006|Overall Study|Admission to a nursing home|0|||
144312812|NCT01238991|520347828|FG007|Overall Study|Admission to a nursing home|0|||
144312813|NCT01238991|520347829|FG008|Overall Study|Admission to a nursing home|0|||
144312814|NCT01238991|520347830|FG009|Overall Study|Admission to a nursing home|0|||
144312815|NCT02222688|520347834|FG000|Overall Study|Withdrawal by Subject|0|||
144312816|NCT02222688|520347835|FG001|Overall Study|Withdrawal by Subject|0|||
144312817|NCT02222688|520347836|FG002|Overall Study|Withdrawal by Subject|0|||
144312818|NCT02222688|520347837|FG003|Overall Study|Withdrawal by Subject|2|||
144312819|NCT02222688|520347838|FG004|Overall Study|Withdrawal by Subject|1|||
144312820|NCT02222688|520347839|FG005|Overall Study|Withdrawal by Subject|0|||
144312821|NCT02222688|520347840|FG006|Overall Study|Withdrawal by Subject|1|||
144312822|NCT02222688|520347834|FG000|Overall Study|Disease progression|1|||
144312823|NCT02222688|520347835|FG001|Overall Study|Disease progression|0|||
144312824|NCT02222688|520347836|FG002|Overall Study|Disease progression|0|||
144312825|NCT02222688|520347837|FG003|Overall Study|Disease progression|0|||
144312826|NCT02222688|520347838|FG004|Overall Study|Disease progression|0|||
144312827|NCT02222688|520347839|FG005|Overall Study|Disease progression|0|||
144312828|NCT02222688|520347840|FG006|Overall Study|Disease progression|0|||
144312829|NCT00294671|520347843|FG000|Overall Study|Lack of Efficacy|11|||
144312830|NCT00294671|520347844|FG001|Overall Study|Lack of Efficacy|23|||
144312831|NCT00294671|520347843|FG000|Overall Study|Liver transplant|7|||
144312832|NCT00294671|520347844|FG001|Overall Study|Liver transplant|9|||
144312833|NCT00294671|520347843|FG000|Overall Study|Drug related adverse event (AE)|4|||
144312834|NCT00294671|520347844|FG001|Overall Study|Drug related adverse event (AE)|2|||
144312835|NCT00294671|520347843|FG000|Overall Study|Non-drug related AE|3|||
144312836|NCT00294671|520347844|FG001|Overall Study|Non-drug related AE|2|||
144312837|NCT00294671|520347843|FG000|Overall Study|Lost to Follow-up|1|||
144312838|NCT00294671|520347844|FG001|Overall Study|Lost to Follow-up|3|||
144312839|NCT00294671|520347843|FG000|Overall Study|Non-compliance|1|||
144312840|NCT00294671|520347844|FG001|Overall Study|Non-compliance|0|||
144312841|NCT00294671|520347843|FG000|Overall Study|Death|0|||
144312842|NCT00294671|520347844|FG001|Overall Study|Death|1|||
144312843|NCT03015363|520347852|FG000|Overall Study|Physician Decision|14|||
144312844|NCT03015363|520347852|FG000|Overall Study|Withdrawal by Subject|3|||
144312845|NCT00958360|520347853|FG000|Overall Study|Withdrawal by Subject|3|||
144312846|NCT00958360|520347854|FG001|Overall Study|Withdrawal by Subject|1|||
144312847|NCT00958360|520347853|FG000|Overall Study|Death|6|||
144312848|NCT00958360|520347854|FG001|Overall Study|Death|7|||
144312849|NCT00958360|520347853|FG000|Overall Study|Physician Decision|2|||
144312850|NCT00958360|520347854|FG001|Overall Study|Physician Decision|1|||
144312851|NCT00958360|520347853|FG000|Overall Study|Lost to Follow-up|0|||
144312852|NCT00958360|520347854|FG001|Overall Study|Lost to Follow-up|1|||
144312853|NCT03107052|520347855|FG000|Overall Study|Adverse Event|6|||
144312854|NCT03107052|520347856|FG001|Overall Study|Adverse Event|1|||
144312855|NCT03107052|520347857|FG002|Overall Study|Adverse Event|2|||
144312856|NCT03107052|520347855|FG000|Overall Study|Withdrawal by Subject|9|||
144312857|NCT03107052|520347856|FG001|Overall Study|Withdrawal by Subject|5|||
144312858|NCT03107052|520347857|FG002|Overall Study|Withdrawal by Subject|8|||
144312859|NCT03107052|520347855|FG000|Overall Study|Protocol Violation|6|||
144312860|NCT03107052|520347856|FG001|Overall Study|Protocol Violation|0|||
144312861|NCT03107052|520347857|FG002|Overall Study|Protocol Violation|3|||
144312862|NCT03107052|520347855|FG000|Overall Study|Lost to Follow-up|4|||
144312863|NCT03107052|520347856|FG001|Overall Study|Lost to Follow-up|0|||
144312864|NCT03107052|520347857|FG002|Overall Study|Lost to Follow-up|1|||
144312865|NCT03107052|520347855|FG000|Overall Study|Lack of Efficacy|23|||
144312866|NCT03107052|520347856|FG001|Overall Study|Lack of Efficacy|7|||
144312867|NCT03107052|520347857|FG002|Overall Study|Lack of Efficacy|4|||
144312868|NCT03107052|520347855|FG000|Overall Study|Other than specified|4|||
144312869|NCT03107052|520347856|FG001|Overall Study|Other than specified|2|||
144312870|NCT03107052|520347857|FG002|Overall Study|Other than specified|0|||
144312871|NCT03107052|520347855|FG000|Overall Study|Study terminated due to futility|67|||
144312872|NCT03107052|520347856|FG001|Overall Study|Study terminated due to futility|31|||
144312873|NCT03107052|520347857|FG002|Overall Study|Study terminated due to futility|23|||
144312874|NCT00078806|520347858|FG000|Part 1A|Adverse Event|2|||
144312875|NCT00078806|520347859|FG001|Part 1A|Adverse Event|0|||
144312876|NCT00078806|520347860|FG002|Part 1A|Adverse Event|0|||
144312877|NCT00078806|520347861|FG003|Part 1A|Adverse Event|0|||
144312878|NCT00078806|520347858|FG000|Part 1A|Lack of Efficacy|7|||
144312879|NCT00078806|520347859|FG001|Part 1A|Lack of Efficacy|0|||
144312880|NCT00078806|520347860|FG002|Part 1A|Lack of Efficacy|0|||
144312881|NCT00078806|520347861|FG003|Part 1A|Lack of Efficacy|0|||
144312882|NCT00078806|520347858|FG000|Part 1A|Other|1|||
144312883|NCT00078806|520347859|FG001|Part 1A|Other|0|||
144312884|NCT00078806|520347860|FG002|Part 1A|Other|0|||
144312885|NCT00078806|520347861|FG003|Part 1A|Other|0|||
144312886|NCT00078806|520347858|FG000|Part 1B|Adverse Event|1|||
144312887|NCT00078806|520347859|FG001|Part 1B|Adverse Event|0|||
144312888|NCT00078806|520347860|FG002|Part 1B|Adverse Event|0|||
144312889|NCT00078806|520347861|FG003|Part 1B|Adverse Event|0|||
144312890|NCT00078806|520347858|FG000|Part 1B|Lack of Efficacy|7|||
144312891|NCT00078806|520347859|FG001|Part 1B|Lack of Efficacy|0|||
144312892|NCT00078806|520347860|FG002|Part 1B|Lack of Efficacy|0|||
144312893|NCT00078806|520347861|FG003|Part 1B|Lack of Efficacy|0|||
144312894|NCT00078806|520347858|FG000|Part 2|Adverse Event|0|||
144312895|NCT00078806|520347859|FG001|Part 2|Adverse Event|1|||
144312896|NCT00078806|520347860|FG002|Part 2|Adverse Event|0|||
144312897|NCT00078806|520347861|FG003|Part 2|Adverse Event|0|||
144312898|NCT03292874|520347864|FG000|Overall Study|Due to pandemic|5|||
144312899|NCT00336284|520347865|FG000|Overall Study|Death|52|||
144312900|NCT00336284|520347866|FG001|Overall Study|Death|26|||
144312901|NCT00336284|520347865|FG000|Overall Study|Lost to Follow-up|82|||
144312902|NCT00336284|520347866|FG001|Overall Study|Lost to Follow-up|61|||
144312903|NCT00336284|520347865|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
144312904|NCT00336284|520347866|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
144312905|NCT01188551|520347869|FG000|Overall Study|Pharmacy issues|1|||
144312906|NCT01188551|520347870|FG001|Overall Study|Pharmacy issues|0|||
144312907|NCT01188551|520347871|FG002|Overall Study|Pharmacy issues|0|||
144312908|NCT01188551|520347872|FG003|Overall Study|Pharmacy issues|0|||
144312909|NCT00391053|520347873|FG000|Overall Study|Serious Adverse Events|1|||
144312910|NCT00391053|520347874|FG001|Overall Study|Serious Adverse Events|0|||
144312911|NCT00391053|520347875|FG002|Overall Study|Serious Adverse Events|1|||
144312912|NCT00391053|520347876|FG003|Overall Study|Serious Adverse Events|4|||
144312913|NCT00391053|520347873|FG000|Overall Study|Protocol Violation|2|||
144312914|NCT00391053|520347874|FG001|Overall Study|Protocol Violation|0|||
144312915|NCT00391053|520347875|FG002|Overall Study|Protocol Violation|0|||
144312916|NCT00391053|520347876|FG003|Overall Study|Protocol Violation|0|||
144312917|NCT00391053|520347873|FG000|Overall Study|Lost to Follow-up|1|||
144312918|NCT00391053|520347874|FG001|Overall Study|Lost to Follow-up|0|||
144312919|NCT00391053|520347875|FG002|Overall Study|Lost to Follow-up|0|||
144312920|NCT00391053|520347876|FG003|Overall Study|Lost to Follow-up|5|||
144312921|NCT00391053|520347873|FG000|Overall Study|Withdrawal by Subject|5|||
144312922|NCT00391053|520347874|FG001|Overall Study|Withdrawal by Subject|1|||
144312923|NCT00391053|520347875|FG002|Overall Study|Withdrawal by Subject|1|||
144312924|NCT00391053|520347876|FG003|Overall Study|Withdrawal by Subject|1|||
144312925|NCT00473889|520347877|FG000|Overall Study|Did not receive study medication|1|||
144312926|NCT00473889|520347878|FG001|Overall Study|Did not receive study medication|4|||
144312927|NCT00473889|520347877|FG000|Overall Study|Adverse Event|30|||
144312928|NCT00473889|520347878|FG001|Overall Study|Adverse Event|17|||
144312929|NCT00473889|520347877|FG000|Overall Study|Protocol Violation|4|||
144312930|NCT00473889|520347878|FG001|Overall Study|Protocol Violation|2|||
144312931|NCT00473889|520347877|FG000|Overall Study|Lack of Efficacy|28|||
144312932|NCT00473889|520347878|FG001|Overall Study|Lack of Efficacy|29|||
144312933|NCT00473889|520347877|FG000|Overall Study|Lost to Follow-up|2|||
144312934|NCT00473889|520347878|FG001|Overall Study|Lost to Follow-up|1|||
144312935|NCT00473889|520347877|FG000|Overall Study|Physician Decision|10|||
144312936|NCT00473889|520347878|FG001|Overall Study|Physician Decision|5|||
144312937|NCT00473889|520347877|FG000|Overall Study|Trial Terminated|3|||
144312938|NCT00473889|520347878|FG001|Overall Study|Trial Terminated|6|||
144312939|NCT00473889|520347877|FG000|Overall Study|Withdrawal by Subject|5|||
144312940|NCT00473889|520347878|FG001|Overall Study|Withdrawal by Subject|0|||
144312941|NCT02140970|520347879|FG000|Overall Study|Lost to Follow-up|1|||
144312942|NCT02140970|520347880|FG001|Overall Study|Lost to Follow-up|2|||
144312943|NCT02140970|520347879|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
144312944|NCT02140970|520347880|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
144312945|NCT02140970|520347879|FG000|Overall Study|Did not meet inclusion criteria|0|||
144312946|NCT02140970|520347880|FG001|Overall Study|Did not meet inclusion criteria|1|||
144312947|NCT02526212|520347881|FG000|Overall Study|Incarceration|1|||
144312948|NCT02526212|520347882|FG001|Overall Study|Incarceration|0|||
144312949|NCT02526212|520347881|FG000|Overall Study|Lost to Follow-up|1|||
144312950|NCT02526212|520347882|FG001|Overall Study|Lost to Follow-up|0|||
144312951|NCT02526212|520347881|FG000|Overall Study|Death|0|||
144312952|NCT02526212|520347882|FG001|Overall Study|Death|1|||
144312953|NCT02096952|520347883|FG000|Overall Study|Adverse Event|1|||
144312954|NCT00624468|520347884|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
144312955|NCT00624468|520347885|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
144312956|NCT00624468|520347886|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
144312957|NCT00624468|520347887|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
144312958|NCT00624468|520347884|FG000|Double-blind Period|Withdrew Prematurely|1|||
144312959|NCT00624468|520347885|FG001|Double-blind Period|Withdrew Prematurely|1|||
144312960|NCT00624468|520347886|FG002|Double-blind Period|Withdrew Prematurely|0|||
144312961|NCT00624468|520347887|FG003|Double-blind Period|Withdrew Prematurely|0|||
144312962|NCT00624468|520347884|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
144312963|NCT00624468|520347885|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
144312964|NCT00624468|520347886|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
144312965|NCT00624468|520347887|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
144312966|NCT00624468|520347884|FG000|Safety Follow-up (SFU) Period|Other|0|||
144312967|NCT00624468|520347885|FG001|Safety Follow-up (SFU) Period|Other|0|||
144312968|NCT00624468|520347886|FG002|Safety Follow-up (SFU) Period|Other|1|||
144312969|NCT00624468|520347887|FG003|Safety Follow-up (SFU) Period|Other|1|||
144312970|NCT00988052|520347899|FG000|Overall Study|Missing|1|||
144312971|NCT00988052|520347900|FG001|Overall Study|Missing|0|||
144312972|NCT00988052|520347899|FG000|Overall Study|Teva requested subject withdrawal|3|||
144312973|NCT00988052|520347900|FG001|Overall Study|Teva requested subject withdrawal|1|||
144312974|NCT00988052|520347899|FG000|Overall Study|Death|1|||
144312975|NCT00988052|520347900|FG001|Overall Study|Death|3|||
144312976|NCT00988052|520347899|FG000|Overall Study|Protocol Violation|6|||
144312977|NCT00988052|520347900|FG001|Overall Study|Protocol Violation|5|||
144312978|NCT00988052|520347899|FG000|Overall Study|Pregnancy|6|||
144312979|NCT00988052|520347900|FG001|Overall Study|Pregnancy|6|||
144312980|NCT00988052|520347899|FG000|Overall Study|Lack of Efficacy|8|||
144312981|NCT00988052|520347900|FG001|Overall Study|Lack of Efficacy|7|||
144312982|NCT00988052|520347899|FG000|Overall Study|Lost to Follow-up|6|||
144312983|NCT00988052|520347900|FG001|Overall Study|Lost to Follow-up|11|||
144312984|NCT00988052|520347899|FG000|Overall Study|Physician Decision|27|||
144312985|NCT00988052|520347900|FG001|Overall Study|Physician Decision|28|||
144312986|NCT00988052|520347899|FG000|Overall Study|Adverse Event|35|||
144312987|NCT00988052|520347900|FG001|Overall Study|Adverse Event|28|||
144312988|NCT00988052|520347899|FG000|Overall Study|Withdrawal by Subject|90|||
144312989|NCT00988052|520347900|FG001|Overall Study|Withdrawal by Subject|91|||
144312990|NCT00988052|520347899|FG000|Overall Study|Study terminated by sponsor|240|||
144312991|NCT00988052|520347900|FG001|Overall Study|Study terminated by sponsor|236|||
144312992|NCT02569476|520347901|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
144312993|NCT02569476|520347901|FG000|Overall Study|Death|33|||
144312994|NCT02569476|520347901|FG000|Overall Study|Withdrawal by Subject|9|||
144312995|NCT02569476|520347901|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
144312996|NCT02569476|520347901|FG000|Overall Study|Palliative care|1|||
144312997|NCT02569476|520347901|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
144312998|NCT02569476|520347901|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
144312999|NCT01434654|520347902|FG000|Overall Study|Withdrawal by Subject|1|||
144313000|NCT01434654|520347903|FG001|Overall Study|Withdrawal by Subject|0|||
144313001|NCT01434654|520347902|FG000|Overall Study|Lost to Follow-up|1|||
144313002|NCT01434654|520347903|FG001|Overall Study|Lost to Follow-up|0|||
144313003|NCT00703963|520347905|FG000|Overall Study|Withdrawal by Subject|7|||
144313004|NCT00703963|520347906|FG001|Overall Study|Withdrawal by Subject|13|||
144313005|NCT00703963|520347905|FG000|Overall Study|Physician Decision|0|||
144313006|NCT00703963|520347906|FG001|Overall Study|Physician Decision|1|||
144313007|NCT03072043|520347909|FG000|Overall Study|Death|0|||
144313008|NCT03072043|520347910|FG001|Overall Study|Death|0|||
144313009|NCT03072043|520347911|FG002|Overall Study|Death|3|||
144313010|NCT03072043|520347909|FG000|Overall Study|Adverse Event|0|||
144313011|NCT03072043|520347910|FG001|Overall Study|Adverse Event|0|||
144313012|NCT03072043|520347911|FG002|Overall Study|Adverse Event|2|||
144313013|NCT03072043|520347909|FG000|Overall Study|Withdrawal by Subject|0|||
144313014|NCT03072043|520347910|FG001|Overall Study|Withdrawal by Subject|0|||
144313015|NCT03072043|520347911|FG002|Overall Study|Withdrawal by Subject|4|||
144313016|NCT01277822|520347912|FG000|Overall Study|Adverse Event|2|||
144313017|NCT01277822|520347913|FG001|Overall Study|Adverse Event|1|||
144313018|NCT01277822|520347912|FG000|Overall Study|Withdrawal by Subject|6|||
144313019|NCT01277822|520347913|FG001|Overall Study|Withdrawal by Subject|7|||
144313020|NCT01277822|520347912|FG000|Overall Study|Physician Decision|1|||
144313021|NCT01277822|520347913|FG001|Overall Study|Physician Decision|1|||
144313022|NCT01277822|520347912|FG000|Overall Study|Protocol Violation|1|||
144313023|NCT01277822|520347913|FG001|Overall Study|Protocol Violation|0|||
144313024|NCT01277822|520347912|FG000|Overall Study|Lost to Follow-up|2|||
144313025|NCT01277822|520347913|FG001|Overall Study|Lost to Follow-up|1|||
144313026|NCT01277822|520347912|FG000|Overall Study|Contraindicated medication used|2|||
144313027|NCT01277822|520347913|FG001|Overall Study|Contraindicated medication used|1|||
144313028|NCT01277822|520347912|FG000|Overall Study|Participant moved|1|||
144313029|NCT01277822|520347913|FG001|Overall Study|Participant moved|0|||
144313030|NCT02923531|520347914|FG000|Overall Study|Adverse Event|4|||
144313031|NCT02923531|520347914|FG000|Overall Study|Clinical Deterioration|1|||
144313032|NCT02923531|520347914|FG000|Overall Study|Disease Progression|3|||
144313033|NCT02923531|520347914|FG000|Overall Study|Study Termination|1|||
144313034|NCT00997984|520347915|FG000|Overall Study|Adverse Event|1|||
144313035|NCT00997984|520347916|FG001|Overall Study|Adverse Event|8|||
144313036|NCT00997984|520347917|FG002|Overall Study|Adverse Event|8|||
144313037|NCT00997984|520347915|FG000|Overall Study|Protocol Violation|1|||
144313038|NCT00997984|520347916|FG001|Overall Study|Protocol Violation|3|||
144313039|NCT00997984|520347917|FG002|Overall Study|Protocol Violation|0|||
144313040|NCT00997984|520347915|FG000|Overall Study|Withdrawal by Subject|6|||
144313041|NCT00997984|520347916|FG001|Overall Study|Withdrawal by Subject|9|||
144313042|NCT00997984|520347917|FG002|Overall Study|Withdrawal by Subject|5|||
144313043|NCT00997984|520347915|FG000|Overall Study|Lost to Follow-up|8|||
144313044|NCT00997984|520347916|FG001|Overall Study|Lost to Follow-up|5|||
144313045|NCT00997984|520347917|FG002|Overall Study|Lost to Follow-up|4|||
144313046|NCT00997984|520347915|FG000|Overall Study|Lack of Efficacy|20|||
144313047|NCT00997984|520347916|FG001|Overall Study|Lack of Efficacy|6|||
144313048|NCT00997984|520347917|FG002|Overall Study|Lack of Efficacy|3|||
144313049|NCT00997984|520347915|FG000|Overall Study|Met exclusion criteria|1|||
144313050|NCT00997984|520347916|FG001|Overall Study|Met exclusion criteria|0|||
144313051|NCT00997984|520347917|FG002|Overall Study|Met exclusion criteria|0|||
144313052|NCT00997984|520347915|FG000|Overall Study|non-compliance|0|||
144313053|NCT00997984|520347916|FG001|Overall Study|non-compliance|2|||
144313054|NCT00997984|520347917|FG002|Overall Study|non-compliance|3|||
144313055|NCT00997984|520347915|FG000|Overall Study|Wrong medication dispensed|0|||
144313056|NCT00997984|520347916|FG001|Overall Study|Wrong medication dispensed|1|||
144313057|NCT00997984|520347917|FG002|Overall Study|Wrong medication dispensed|0|||
144313058|NCT00997984|520347915|FG000|Overall Study|Suicidal ideation|0|||
144313059|NCT00997984|520347916|FG001|Overall Study|Suicidal ideation|0|||
144313060|NCT00997984|520347917|FG002|Overall Study|Suicidal ideation|1|||
144313061|NCT00997984|520347915|FG000|Overall Study|Work schedule|0|||
144313062|NCT00997984|520347916|FG001|Overall Study|Work schedule|0|||
144313063|NCT00997984|520347917|FG002|Overall Study|Work schedule|2|||
144313064|NCT00295646|520347925|FG000|Overall Study|Protocol Violation|18|||
144313065|NCT00295646|520347926|FG001|Overall Study|Protocol Violation|20|||
144313066|NCT00295646|520347927|FG002|Overall Study|Protocol Violation|20|||
144313067|NCT00295646|520347928|FG003|Overall Study|Protocol Violation|18|||
144313068|NCT00295646|520347925|FG000|Overall Study|Withdrawal by Subject|8|||
144313069|NCT00295646|520347926|FG001|Overall Study|Withdrawal by Subject|9|||
144313070|NCT00295646|520347927|FG002|Overall Study|Withdrawal by Subject|11|||
144313071|NCT00295646|520347928|FG003|Overall Study|Withdrawal by Subject|14|||
144313072|NCT00295646|520347925|FG000|Overall Study|Lost to Follow-up|0|||
144313073|NCT00295646|520347926|FG001|Overall Study|Lost to Follow-up|5|||
144313074|NCT00295646|520347927|FG002|Overall Study|Lost to Follow-up|1|||
144313075|NCT00295646|520347928|FG003|Overall Study|Lost to Follow-up|5|||
144313076|NCT00295646|520347925|FG000|Overall Study|Death|9|||
144313077|NCT00295646|520347926|FG001|Overall Study|Death|7|||
144313078|NCT00295646|520347927|FG002|Overall Study|Death|18|||
144313079|NCT00295646|520347928|FG003|Overall Study|Death|8|||
144313080|NCT02243371|520347929|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
144313081|NCT02243371|520347930|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
144313082|NCT02243371|520347929|FG000|Overall Study|Death (unrelated)|2|||
144313083|NCT02243371|520347930|FG001|Overall Study|Death (unrelated)|4|||
144313084|NCT02243371|520347929|FG000|Overall Study|Adverse Event (unrelated)|0|||
144313085|NCT02243371|520347930|FG001|Overall Study|Adverse Event (unrelated)|1|||
144313086|NCT02243371|520347929|FG000|Overall Study|Lack of Clinical Benefit|0|||
144313087|NCT02243371|520347930|FG001|Overall Study|Lack of Clinical Benefit|1|||
144313088|NCT02243371|520347929|FG000|Overall Study|Withdrawal by Subject|0|||
144313089|NCT02243371|520347930|FG001|Overall Study|Withdrawal by Subject|2|||
144313090|NCT01945996|520347932|FG000|Overall Study|Lost to Follow-up|3|||
144313091|NCT01945996|520347933|FG001|Overall Study|Lost to Follow-up|5|||
144313092|NCT00271856|520347934|FG000|Overall Study|Withdrawal by Subject|1|||
144313093|NCT00271856|520347935|FG001|Overall Study|Withdrawal by Subject|7|||
144313094|NCT00271856|520347934|FG000|Overall Study|Lost to Follow-up|10|||
144313095|NCT00271856|520347935|FG001|Overall Study|Lost to Follow-up|11|||
144313096|NCT03012828|520347936|FG000|Overall Study|Lost to Follow-up|1|||
144313097|NCT03012828|520347937|FG001|Overall Study|Lost to Follow-up|0|||
144313098|NCT03012828|520347938|FG002|Overall Study|Lost to Follow-up|1|||
144313099|NCT03012828|520347939|FG003|Overall Study|Lost to Follow-up|0|||
144313100|NCT03012828|520347940|FG004|Overall Study|Lost to Follow-up|1|||
144313101|NCT03012828|520347941|FG005|Overall Study|Lost to Follow-up|0|||
144313102|NCT03012828|520347936|FG000|Overall Study|Withdrawal by Subject|0|||
144313103|NCT03012828|520347937|FG001|Overall Study|Withdrawal by Subject|0|||
144313104|NCT03012828|520347938|FG002|Overall Study|Withdrawal by Subject|1|||
144313105|NCT03012828|520347939|FG003|Overall Study|Withdrawal by Subject|0|||
144313106|NCT03012828|520347940|FG004|Overall Study|Withdrawal by Subject|0|||
144313107|NCT03012828|520347941|FG005|Overall Study|Withdrawal by Subject|1|||
144313108|NCT03012828|520347936|FG000|Overall Study|Non-compliance with protocol|0|||
144313109|NCT03012828|520347937|FG001|Overall Study|Non-compliance with protocol|0|||
144313110|NCT03012828|520347938|FG002|Overall Study|Non-compliance with protocol|0|||
144313111|NCT03012828|520347939|FG003|Overall Study|Non-compliance with protocol|0|||
144313112|NCT03012828|520347940|FG004|Overall Study|Non-compliance with protocol|1|||
144313113|NCT03012828|520347941|FG005|Overall Study|Non-compliance with protocol|0|||
144313114|NCT03012828|520347936|FG000|Overall Study|Delay to last visit would delay DBL|0|||
144313115|NCT03012828|520347937|FG001|Overall Study|Delay to last visit would delay DBL|0|||
144313116|NCT03012828|520347938|FG002|Overall Study|Delay to last visit would delay DBL|0|||
144313117|NCT03012828|520347939|FG003|Overall Study|Delay to last visit would delay DBL|0|||
144313118|NCT03012828|520347940|FG004|Overall Study|Delay to last visit would delay DBL|0|||
144313119|NCT03012828|520347941|FG005|Overall Study|Delay to last visit would delay DBL|1|||
144313120|NCT02595866|520347943|FG000|Overall Study|Adverse Event|2|||
144313121|NCT02595866|520347944|FG001|Overall Study|Adverse Event|5|||
144313122|NCT02595866|520347943|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
144313123|NCT02595866|520347944|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
144313124|NCT02595866|520347943|FG000|Overall Study|Death|0|||
144313125|NCT02595866|520347944|FG001|Overall Study|Death|1|||
144313126|NCT02595866|520347943|FG000|Overall Study|Incarceration|1|||
144313127|NCT02595866|520347944|FG001|Overall Study|Incarceration|0|||
144313128|NCT02595866|520347943|FG000|Overall Study|Lack of Efficacy|17|||
144313129|NCT02595866|520347944|FG001|Overall Study|Lack of Efficacy|7|||
144313130|NCT02595866|520347943|FG000|Overall Study|Physician Decision|4|||
144313131|NCT02595866|520347944|FG001|Overall Study|Physician Decision|3|||
144313132|NCT02595866|520347943|FG000|Overall Study|Switched to Alternative Treatment|1|||
144313133|NCT02595866|520347944|FG001|Overall Study|Switched to Alternative Treatment|0|||
144313134|NCT02595866|520347943|FG000|Overall Study|Study Terminated|0|||
144313135|NCT02595866|520347944|FG001|Overall Study|Study Terminated|4|||
144313136|NCT02595866|520347943|FG000|Overall Study|Withdrawal by Subject|6|||
144313137|NCT02595866|520347944|FG001|Overall Study|Withdrawal by Subject|1|||
144313138|NCT00289289|520347945|FG000|Overall Study|Withdrawal by Subject|5|||
144313139|NCT00289289|520347946|FG001|Overall Study|Withdrawal by Subject|3|||
144313140|NCT00289289|520347947|FG002|Overall Study|Withdrawal by Subject|15|||
144313141|NCT00289289|520347945|FG000|Overall Study|Lost to Follow-up|1|||
144313142|NCT00289289|520347946|FG001|Overall Study|Lost to Follow-up|0|||
144313143|NCT00289289|520347947|FG002|Overall Study|Lost to Follow-up|1|||
144313144|NCT00289289|520347945|FG000|Overall Study|Death|4|||
144313145|NCT00289289|520347946|FG001|Overall Study|Death|2|||
144313146|NCT00289289|520347947|FG002|Overall Study|Death|5|||
144313147|NCT00289289|520347945|FG000|Overall Study|No implant attempted|0|||
144313148|NCT00289289|520347946|FG001|Overall Study|No implant attempted|0|||
144313149|NCT00289289|520347947|FG002|Overall Study|No implant attempted|1|||
144313150|NCT00289289|520347945|FG000|Overall Study|Physician Decision|1|||
144313151|NCT00289289|520347946|FG001|Overall Study|Physician Decision|0|||
144313152|NCT00289289|520347947|FG002|Overall Study|Physician Decision|6|||
144313153|NCT00289289|520347945|FG000|Overall Study|Non-study device implanted|2|||
144313154|NCT00289289|520347946|FG001|Overall Study|Non-study device implanted|1|||
144313155|NCT00289289|520347947|FG002|Overall Study|Non-study device implanted|3|||
144313156|NCT00289289|520347945|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
144313157|NCT00289289|520347946|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
144313158|NCT00289289|520347947|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
144313159|NCT00289289|520347945|FG000|Overall Study|Other Exit Reason|6|||
144313160|NCT00289289|520347946|FG001|Overall Study|Other Exit Reason|4|||
144313161|NCT00289289|520347947|FG002|Overall Study|Other Exit Reason|12|||
144313162|NCT01445613|520347948|FG000|30-day Follow-up|Withdrawal by Subject|6|||
144313163|NCT01445613|520347948|FG000|30-day Follow-up|Physician Decision|3|||
144313164|NCT01445613|520347948|FG000|30-day Follow-up|Missed visit|23|||
144313165|NCT01445613|520347948|FG000|30-day Follow-up|Death|3|||
144313166|NCT01445613|520347948|FG000|1-year Follow-up|Withdrawal by Subject|12|||
144313167|NCT01445613|520347948|FG000|1-year Follow-up|Missed visit|29|||
144313168|NCT01445613|520347948|FG000|1-year Follow-up|Lost to Follow-up|2|||
144313169|NCT01445613|520347948|FG000|1-year Follow-up|Death|30|||
144313170|NCT01445613|520347948|FG000|1-year Follow-up|Physician Decision|2|||
144313171|NCT01445613|520347948|FG000|1-year Follow-up|Received a non-study stent|2|||
144313172|NCT00407602|520347949|FG000|Overall Study|Death - unrelated to device|1|||
144313173|NCT00407602|520347949|FG000|Overall Study|Device explanted|5|||
144313174|NCT00407602|520347949|FG000|Overall Study|Withdrawal by Subject|1|||
144313175|NCT00431444|520347953|FG000|Overall Study|Protocol Violation|1|||
144313176|NCT00431444|520347954|FG001|Overall Study|Protocol Violation|4|||
144313177|NCT00431444|520347953|FG000|Overall Study|Adverse Event|2|||
144313178|NCT00431444|520347954|FG001|Overall Study|Adverse Event|1|||
144313179|NCT00431444|520347953|FG000|Overall Study|Withdrawal by Subject|1|||
144313180|NCT00431444|520347954|FG001|Overall Study|Withdrawal by Subject|1|||
144313181|NCT00431444|520347953|FG000|Overall Study|Lost to Follow-up|1|||
144313182|NCT00431444|520347954|FG001|Overall Study|Lost to Follow-up|0|||
144313183|NCT00431444|520347953|FG000|Overall Study|Administrative Problems|0|||
144313184|NCT00431444|520347954|FG001|Overall Study|Administrative Problems|1|||
144313185|NCT00809926|520347955|FG000|Overall Study|Adverse Event|18|||
144313186|NCT00809926|520347956|FG001|Overall Study|Adverse Event|10|||
144313187|NCT00809926|520347955|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
144313188|NCT00809926|520347956|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
144313189|NCT00809926|520347955|FG000|Overall Study|Patient withdrew consent|8|||
144313190|NCT00809926|520347956|FG001|Overall Study|Patient withdrew consent|6|||
144313191|NCT00809926|520347955|FG000|Overall Study|Lost to Follow-up|2|||
144313192|NCT00809926|520347956|FG001|Overall Study|Lost to Follow-up|1|||
144313193|NCT00809926|520347955|FG000|Overall Study|Administrative Problems|0|||
144313194|NCT00809926|520347956|FG001|Overall Study|Administrative Problems|1|||
144313195|NCT00809926|520347955|FG000|Overall Study|Protocol deviation|0|||
144313196|NCT00809926|520347956|FG001|Overall Study|Protocol deviation|2|||
144313197|NCT01740687|520347961|FG000|Overall Study|Lost to Follow-up|11|||
144313198|NCT01740687|520347961|FG000|Overall Study|Withdrawal by Subject|2|||
144313199|NCT01740687|520347961|FG000|Overall Study|other reason|22|||
144313200|NCT01740687|520347961|FG000|Overall Study|treatment not received|2|||
144313201|NCT01963767|520347963|FG000|Overall Study|Withdrawal by Subject|4|||
144313202|NCT01963767|520347964|FG001|Overall Study|Withdrawal by Subject|2|||
144313203|NCT01963767|520347963|FG000|Overall Study|Adverse Event|2|||
144313204|NCT01963767|520347964|FG001|Overall Study|Adverse Event|0|||
144313205|NCT01082081|520347967|FG000|Overall Study|Lost to Follow-up|0|||
144313206|NCT01082081|520347968|FG001|Overall Study|Lost to Follow-up|0|||
144313207|NCT01082081|520347969|FG002|Overall Study|Lost to Follow-up|1|||
144313208|NCT01082081|520347967|FG000|Overall Study|Withdrawal by Subject|0|||
144313209|NCT01082081|520347968|FG001|Overall Study|Withdrawal by Subject|0|||
144313210|NCT01082081|520347969|FG002|Overall Study|Withdrawal by Subject|1|||
144313211|NCT01082081|520347967|FG000|Overall Study|Other Reason|0|||
144313212|NCT01082081|520347968|FG001|Overall Study|Other Reason|1|||
144313213|NCT01082081|520347969|FG002|Overall Study|Other Reason|0|||
144313214|NCT00670930|520347970|FG000|Overall Study|Adminstrative Problem|0|||
144313215|NCT00670930|520347971|FG001|Overall Study|Adminstrative Problem|1|||
144313216|NCT00670930|520347970|FG000|Overall Study|Lost to Follow-up|1|||
144313217|NCT00670930|520347971|FG001|Overall Study|Lost to Follow-up|0|||
144313218|NCT03159468|520347973|FG000|Overall Study|Withdrawal by Subject|0|||
144313219|NCT03159468|520347974|FG001|Overall Study|Withdrawal by Subject|0|||
144313220|NCT03159468|520347975|FG002|Overall Study|Withdrawal by Subject|3|||
144313221|NCT03159468|520347976|FG003|Overall Study|Withdrawal by Subject|0|||
144313222|NCT03159468|520347977|FG004|Overall Study|Withdrawal by Subject|0|||
144313223|NCT03159468|520347978|FG005|Overall Study|Withdrawal by Subject|0|||
144313224|NCT03744910|520350483|FG000|Overall Study|Withdrew Consent|1|||
144313225|NCT03744910|520350484|FG001|Overall Study|Withdrew Consent|8|||
144313226|NCT03744910|520350483|FG000|Overall Study|Physician Decision|5|||
144313227|NCT03744910|520350484|FG001|Overall Study|Physician Decision|4|||
144313228|NCT03744910|520350483|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
144313229|NCT03744910|520350484|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
144313230|NCT03744910|520350483|FG000|Overall Study|Lost to Follow-up|0|||
144313231|NCT03744910|520350484|FG001|Overall Study|Lost to Follow-up|1|||
144313232|NCT03744910|520350483|FG000|Overall Study|Other-unspecified|4|||
144313233|NCT03744910|520350484|FG001|Overall Study|Other-unspecified|1|||
144313234|NCT02744612|520350485|FG000|Overall Study|Withdrawal by Subject|0|||
144313235|NCT02744612|520350486|FG001|Overall Study|Withdrawal by Subject|2|||
144313236|NCT02712983|520350488|FG000|Treatment Phase|Adverse Event|3|||
144313237|NCT02712983|520350489|FG001|Treatment Phase|Adverse Event|1|||
144313238|NCT02712983|520350490|FG002|Treatment Phase|Adverse Event|1|||
144313239|NCT02712983|520350491|FG003|Treatment Phase|Adverse Event|4|||
144313240|NCT02712983|520350492|FG004|Treatment Phase|Adverse Event|3|||
144313241|NCT02712983|520350493|FG005|Treatment Phase|Adverse Event|0|||
144313242|NCT02712983|520350494|FG006|Treatment Phase|Adverse Event|6|||
144313243|NCT02712983|520350495|FG007|Treatment Phase|Adverse Event|6|||
144313244|NCT02712983|520350496|FG008|Treatment Phase|Adverse Event|1|||
144313245|NCT02712983|520350488|FG000|Treatment Phase|Protocol Deviation|0|||
144313246|NCT02712983|520350489|FG001|Treatment Phase|Protocol Deviation|0|||
144313247|NCT02712983|520350490|FG002|Treatment Phase|Protocol Deviation|0|||
144313248|NCT02712983|520350491|FG003|Treatment Phase|Protocol Deviation|2|||
144313249|NCT02712983|520350492|FG004|Treatment Phase|Protocol Deviation|0|||
144313250|NCT02712983|520350493|FG005|Treatment Phase|Protocol Deviation|0|||
144313251|NCT02712983|520350494|FG006|Treatment Phase|Protocol Deviation|1|||
144313252|NCT02712983|520350495|FG007|Treatment Phase|Protocol Deviation|0|||
144313253|NCT02712983|520350496|FG008|Treatment Phase|Protocol Deviation|0|||
144313254|NCT02712983|520350488|FG000|Treatment Phase|Technical Problems|0|||
144313255|NCT02712983|520350489|FG001|Treatment Phase|Technical Problems|0|||
144313256|NCT02712983|520350490|FG002|Treatment Phase|Technical Problems|0|||
144313257|NCT02712983|520350491|FG003|Treatment Phase|Technical Problems|0|||
144313258|NCT02712983|520350492|FG004|Treatment Phase|Technical Problems|0|||
144313259|NCT02712983|520350493|FG005|Treatment Phase|Technical Problems|0|||
144313260|NCT02712983|520350494|FG006|Treatment Phase|Technical Problems|1|||
144313261|NCT02712983|520350495|FG007|Treatment Phase|Technical Problems|0|||
144313262|NCT02712983|520350496|FG008|Treatment Phase|Technical Problems|0|||
144313263|NCT02712983|520350488|FG000|Treatment Phase|Physician Decision|0|||
144313264|NCT02712983|520350489|FG001|Treatment Phase|Physician Decision|0|||
144313265|NCT02712983|520350490|FG002|Treatment Phase|Physician Decision|0|||
144313266|NCT02712983|520350491|FG003|Treatment Phase|Physician Decision|0|||
144313267|NCT02712983|520350492|FG004|Treatment Phase|Physician Decision|0|||
144313268|NCT02712983|520350493|FG005|Treatment Phase|Physician Decision|0|||
144313269|NCT02712983|520350494|FG006|Treatment Phase|Physician Decision|0|||
144313270|NCT02712983|520350495|FG007|Treatment Phase|Physician Decision|1|||
144313271|NCT02712983|520350496|FG008|Treatment Phase|Physician Decision|1|||
144313272|NCT02712983|520350488|FG000|Treatment Phase|Subject Decision|2|||
144313273|NCT02712983|520350489|FG001|Treatment Phase|Subject Decision|0|||
144313274|NCT02712983|520350490|FG002|Treatment Phase|Subject Decision|0|||
144313275|NCT02712983|520350491|FG003|Treatment Phase|Subject Decision|2|||
144313276|NCT02712983|520350492|FG004|Treatment Phase|Subject Decision|1|||
144313277|NCT02712983|520350493|FG005|Treatment Phase|Subject Decision|0|||
144313278|NCT02712983|520350494|FG006|Treatment Phase|Subject Decision|1|||
144313279|NCT02712983|520350495|FG007|Treatment Phase|Subject Decision|2|||
144313280|NCT02712983|520350496|FG008|Treatment Phase|Subject Decision|0|||
144313281|NCT02712983|520350488|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144313282|NCT02712983|520350489|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
144313283|NCT02712983|520350490|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144313284|NCT02712983|520350491|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144313285|NCT02712983|520350492|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144313286|NCT02712983|520350493|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144313287|NCT02712983|520350494|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
144313288|NCT02712983|520350495|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
144313289|NCT02712983|520350496|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
144313290|NCT02712983|520350488|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313291|NCT02712983|520350489|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313292|NCT02712983|520350490|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313293|NCT02712983|520350491|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
144313294|NCT02712983|520350492|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313295|NCT02712983|520350493|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313296|NCT02712983|520350494|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313297|NCT02712983|520350495|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313298|NCT02712983|520350496|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
144313299|NCT02712983|520350488|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
144313300|NCT02712983|520350489|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
144313301|NCT02712983|520350490|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
144313302|NCT02712983|520350491|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
144313303|NCT02712983|520350492|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
144313304|NCT02712983|520350493|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
144313305|NCT02712983|520350494|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
144313306|NCT02712983|520350495|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
144313307|NCT02712983|520350496|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
144313308|NCT02220855|520350497|FG000|Overall Study|Adverse Event|8|||
144313309|NCT02220855|520350497|FG000|Overall Study|Disease Progression|5|||
144313310|NCT02220855|520350497|FG000|Overall Study|Withdrawal by Subject|1|||
144313311|NCT03280303|520350498|FG000|Overall Study|Death|505|||
144313312|NCT03280303|520350498|FG000|Overall Study|Study terminated by sponsor|383|||
144313313|NCT03280303|520350498|FG000|Overall Study|Other|148|||
144313314|NCT03280303|520350498|FG000|Overall Study|No longer willing to participate in study|101|||
144313315|NCT03280303|520350498|FG000|Overall Study|Lost to follow up|39|||
144313316|NCT03280303|520350498|FG000|Overall Study|Adverse Event|20|||
144313317|NCT03419897|520350499|FG000|Overall Study|Death|180|||
144313318|NCT03419897|520350499|FG000|Overall Study|Lost to Follow-up|1|||
144313319|NCT03419897|520350499|FG000|Overall Study|Withdrawal by Subject|6|||
144313320|NCT03419897|520350499|FG000|Overall Study|Sponsor Decision|61|||
144313321|NCT03419897|520350499|FG000|Overall Study|Physician Decision|1|||
144313322|NCT01945216|520350502|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
144313323|NCT01945216|520350502|FG000|Overall Study|Protocol Violation|42|||
144313324|NCT01945216|520350502|FG000|Overall Study|CRF not assured by investigators|5|||
144313325|NCT01905943|520350506|FG000|Overall Study|Withdrawal of consent|90|||
144313326|NCT01905943|520350506|FG000|Overall Study|Lost to Follow-up|16|||
144313327|NCT01905943|520350506|FG000|Overall Study|Investigator discretion|7|||
144313328|NCT01905943|520350506|FG000|Overall Study|Death|186|||
144313329|NCT01905943|520350506|FG000|Overall Study|Adverse Event|3|||
144313330|NCT01905943|520350506|FG000|Overall Study|Other|12|||
144313331|NCT02574078|520350507|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313332|NCT02574078|520350508|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313333|NCT02574078|520350509|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313334|NCT02574078|520350510|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313335|NCT02574078|520350511|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313336|NCT02574078|520350512|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144313337|NCT02574078|520350513|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
144313338|NCT02574078|520350514|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313339|NCT02574078|520350515|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
144313340|NCT02574078|520350516|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313341|NCT02574078|520350517|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313342|NCT02574078|520350518|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313343|NCT02574078|520350519|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
144313344|NCT02574078|520350507|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
144313345|NCT02574078|520350508|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
144313346|NCT02574078|520350509|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
144313347|NCT02574078|520350510|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
144313348|NCT02574078|520350511|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
144313349|NCT02574078|520350512|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
144313350|NCT02574078|520350513|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
144313351|NCT02574078|520350514|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
144313352|NCT02574078|520350515|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
144313353|NCT02574078|520350516|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
144313354|NCT02574078|520350517|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
144313355|NCT02574078|520350518|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
144313356|NCT02574078|520350519|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
144313357|NCT02574078|520350507|FG000|Pre-Treatment Period|Other reasons|0|||
144313358|NCT02574078|520350508|FG001|Pre-Treatment Period|Other reasons|0|||
144313359|NCT02574078|520350509|FG002|Pre-Treatment Period|Other reasons|0|||
144313360|NCT02574078|520350510|FG003|Pre-Treatment Period|Other reasons|0|||
144313361|NCT02574078|520350511|FG004|Pre-Treatment Period|Other reasons|0|||
144313362|NCT02574078|520350512|FG005|Pre-Treatment Period|Other reasons|0|||
144313363|NCT02574078|520350513|FG006|Pre-Treatment Period|Other reasons|2|||
144313364|NCT02574078|520350514|FG007|Pre-Treatment Period|Other reasons|0|||
144313365|NCT02574078|520350515|FG008|Pre-Treatment Period|Other reasons|0|||
144313366|NCT02574078|520350516|FG009|Pre-Treatment Period|Other reasons|0|||
144313367|NCT02574078|520350517|FG010|Pre-Treatment Period|Other reasons|2|||
144313368|NCT02574078|520350518|FG011|Pre-Treatment Period|Other reasons|0|||
144313369|NCT02574078|520350519|FG012|Pre-Treatment Period|Other reasons|0|||
144313370|NCT02574078|520350507|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
144313371|NCT02574078|520350508|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
144313372|NCT02574078|520350509|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
144313373|NCT02574078|520350510|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
144313374|NCT02574078|520350511|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
144313375|NCT02574078|520350512|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
144313376|NCT02574078|520350513|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
144313377|NCT02574078|520350514|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
144313378|NCT02574078|520350515|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
144313379|NCT02574078|520350516|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
144313380|NCT02574078|520350517|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
144313381|NCT02574078|520350518|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
144313382|NCT02574078|520350519|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
144313383|NCT02574078|520350507|FG000|Treatment Period|Disease progression|6|||
144313384|NCT02574078|520350508|FG001|Treatment Period|Disease progression|4|||
144313385|NCT02574078|520350509|FG002|Treatment Period|Disease progression|7|||
144313386|NCT02574078|520350510|FG003|Treatment Period|Disease progression|18|||
144313387|NCT02574078|520350511|FG004|Treatment Period|Disease progression|16|||
144313388|NCT02574078|520350512|FG005|Treatment Period|Disease progression|26|||
144313389|NCT02574078|520350513|FG006|Treatment Period|Disease progression|5|||
144313390|NCT02574078|520350514|FG007|Treatment Period|Disease progression|9|||
144313391|NCT02574078|520350515|FG008|Treatment Period|Disease progression|8|||
144313392|NCT02574078|520350516|FG009|Treatment Period|Disease progression|5|||
144313393|NCT02574078|520350517|FG010|Treatment Period|Disease progression|20|||
144313394|NCT02574078|520350518|FG011|Treatment Period|Disease progression|29|||
144313395|NCT02574078|520350519|FG012|Treatment Period|Disease progression|2|||
144313396|NCT02574078|520350507|FG000|Treatment Period|Study drug toxicity|1|||
144313397|NCT02574078|520350508|FG001|Treatment Period|Study drug toxicity|1|||
144313398|NCT02574078|520350509|FG002|Treatment Period|Study drug toxicity|0|||
144313399|NCT02574078|520350510|FG003|Treatment Period|Study drug toxicity|5|||
144313400|NCT02574078|520350511|FG004|Treatment Period|Study drug toxicity|3|||
144313401|NCT02574078|520350512|FG005|Treatment Period|Study drug toxicity|1|||
144313402|NCT02574078|520350513|FG006|Treatment Period|Study drug toxicity|2|||
144313403|NCT02574078|520350514|FG007|Treatment Period|Study drug toxicity|0|||
144313404|NCT02574078|520350515|FG008|Treatment Period|Study drug toxicity|2|||
144313405|NCT02574078|520350516|FG009|Treatment Period|Study drug toxicity|1|||
144313406|NCT02574078|520350517|FG010|Treatment Period|Study drug toxicity|16|||
144313407|NCT02574078|520350518|FG011|Treatment Period|Study drug toxicity|2|||
144313408|NCT02574078|520350519|FG012|Treatment Period|Study drug toxicity|4|||
144313409|NCT02574078|520350507|FG000|Treatment Period|Death|2|||
144313410|NCT02574078|520350508|FG001|Treatment Period|Death|0|||
144313411|NCT02574078|520350509|FG002|Treatment Period|Death|0|||
144313412|NCT02574078|520350510|FG003|Treatment Period|Death|0|||
144313413|NCT02574078|520350511|FG004|Treatment Period|Death|1|||
144313414|NCT02574078|520350512|FG005|Treatment Period|Death|1|||
144313415|NCT02574078|520350513|FG006|Treatment Period|Death|1|||
144313416|NCT02574078|520350514|FG007|Treatment Period|Death|1|||
144313417|NCT02574078|520350515|FG008|Treatment Period|Death|7|||
144313418|NCT02574078|520350516|FG009|Treatment Period|Death|1|||
144313419|NCT02574078|520350517|FG010|Treatment Period|Death|0|||
144313420|NCT02574078|520350518|FG011|Treatment Period|Death|2|||
144313421|NCT02574078|520350519|FG012|Treatment Period|Death|1|||
144313422|NCT02574078|520350507|FG000|Treatment Period|Adverse event unrelated to drug|0|||
144313423|NCT02574078|520350508|FG001|Treatment Period|Adverse event unrelated to drug|0|||
144313424|NCT02574078|520350509|FG002|Treatment Period|Adverse event unrelated to drug|1|||
144313425|NCT02574078|520350510|FG003|Treatment Period|Adverse event unrelated to drug|0|||
144313426|NCT02574078|520350511|FG004|Treatment Period|Adverse event unrelated to drug|2|||
144313427|NCT02574078|520350512|FG005|Treatment Period|Adverse event unrelated to drug|3|||
144313428|NCT02574078|520350513|FG006|Treatment Period|Adverse event unrelated to drug|0|||
144313429|NCT02574078|520350514|FG007|Treatment Period|Adverse event unrelated to drug|0|||
144313430|NCT02574078|520350515|FG008|Treatment Period|Adverse event unrelated to drug|1|||
144313431|NCT02574078|520350516|FG009|Treatment Period|Adverse event unrelated to drug|2|||
144313432|NCT02574078|520350517|FG010|Treatment Period|Adverse event unrelated to drug|4|||
144313433|NCT02574078|520350518|FG011|Treatment Period|Adverse event unrelated to drug|1|||
144313434|NCT02574078|520350519|FG012|Treatment Period|Adverse event unrelated to drug|0|||
144313435|NCT02574078|520350507|FG000|Treatment Period|Administrative reason by Sponsor|0|||
144313436|NCT02574078|520350508|FG001|Treatment Period|Administrative reason by Sponsor|1|||
144313437|NCT02574078|520350509|FG002|Treatment Period|Administrative reason by Sponsor|0|||
144313438|NCT02574078|520350510|FG003|Treatment Period|Administrative reason by Sponsor|0|||
144313439|NCT02574078|520350511|FG004|Treatment Period|Administrative reason by Sponsor|0|||
144313440|NCT02574078|520350512|FG005|Treatment Period|Administrative reason by Sponsor|0|||
144313441|NCT02574078|520350513|FG006|Treatment Period|Administrative reason by Sponsor|1|||
144313442|NCT02574078|520350514|FG007|Treatment Period|Administrative reason by Sponsor|0|||
144313443|NCT02574078|520350515|FG008|Treatment Period|Administrative reason by Sponsor|0|||
144313444|NCT02574078|520350516|FG009|Treatment Period|Administrative reason by Sponsor|0|||
144313445|NCT02574078|520350517|FG010|Treatment Period|Administrative reason by Sponsor|0|||
144313446|NCT02574078|520350518|FG011|Treatment Period|Administrative reason by Sponsor|0|||
144313447|NCT02574078|520350519|FG012|Treatment Period|Administrative reason by Sponsor|3|||
144313448|NCT02574078|520350507|FG000|Treatment Period|Other reasons|1|||
144313449|NCT02574078|520350508|FG001|Treatment Period|Other reasons|0|||
144313450|NCT02574078|520350509|FG002|Treatment Period|Other reasons|1|||
144313451|NCT02574078|520350510|FG003|Treatment Period|Other reasons|3|||
144313452|NCT02574078|520350511|FG004|Treatment Period|Other reasons|3|||
144313453|NCT02574078|520350512|FG005|Treatment Period|Other reasons|1|||
144313454|NCT02574078|520350513|FG006|Treatment Period|Other reasons|2|||
144313455|NCT02574078|520350514|FG007|Treatment Period|Other reasons|1|||
144313456|NCT02574078|520350515|FG008|Treatment Period|Other reasons|3|||
144313457|NCT02574078|520350516|FG009|Treatment Period|Other reasons|1|||
144313458|NCT02574078|520350517|FG010|Treatment Period|Other reasons|1|||
144313459|NCT02574078|520350518|FG011|Treatment Period|Other reasons|3|||
144313460|NCT02574078|520350519|FG012|Treatment Period|Other reasons|1|||
144313461|NCT02574078|520350507|FG000|Treatment Period|Participant request to stop drug|0|||
144313462|NCT02574078|520350508|FG001|Treatment Period|Participant request to stop drug|0|||
144313463|NCT02574078|520350509|FG002|Treatment Period|Participant request to stop drug|0|||
144313464|NCT02574078|520350510|FG003|Treatment Period|Participant request to stop drug|2|||
144313465|NCT02574078|520350511|FG004|Treatment Period|Participant request to stop drug|4|||
144313466|NCT02574078|520350512|FG005|Treatment Period|Participant request to stop drug|0|||
144313467|NCT02574078|520350513|FG006|Treatment Period|Participant request to stop drug|1|||
144313468|NCT02574078|520350514|FG007|Treatment Period|Participant request to stop drug|0|||
144313469|NCT02574078|520350515|FG008|Treatment Period|Participant request to stop drug|3|||
144313470|NCT02574078|520350516|FG009|Treatment Period|Participant request to stop drug|2|||
144313471|NCT02574078|520350517|FG010|Treatment Period|Participant request to stop drug|2|||
144313472|NCT02574078|520350518|FG011|Treatment Period|Participant request to stop drug|4|||
144313473|NCT02574078|520350519|FG012|Treatment Period|Participant request to stop drug|1|||
144313474|NCT02574078|520350507|FG000|Treatment Period|Participant withdrew consent|0|||
144313475|NCT02574078|520350508|FG001|Treatment Period|Participant withdrew consent|0|||
144313476|NCT02574078|520350509|FG002|Treatment Period|Participant withdrew consent|0|||
144313477|NCT02574078|520350510|FG003|Treatment Period|Participant withdrew consent|0|||
144313478|NCT02574078|520350511|FG004|Treatment Period|Participant withdrew consent|1|||
144313479|NCT02574078|520350512|FG005|Treatment Period|Participant withdrew consent|1|||
144313480|NCT02574078|520350513|FG006|Treatment Period|Participant withdrew consent|0|||
144313481|NCT02574078|520350514|FG007|Treatment Period|Participant withdrew consent|1|||
144313482|NCT02574078|520350515|FG008|Treatment Period|Participant withdrew consent|0|||
144313483|NCT02574078|520350516|FG009|Treatment Period|Participant withdrew consent|2|||
144313484|NCT02574078|520350517|FG010|Treatment Period|Participant withdrew consent|1|||
144313485|NCT02574078|520350518|FG011|Treatment Period|Participant withdrew consent|4|||
144313486|NCT02574078|520350519|FG012|Treatment Period|Participant withdrew consent|1|||
144313487|NCT02574078|520350507|FG000|Treatment Period|Participant no longer meets criteria|0|||
144313488|NCT02574078|520350508|FG001|Treatment Period|Participant no longer meets criteria|0|||
144313489|NCT02574078|520350509|FG002|Treatment Period|Participant no longer meets criteria|0|||
144313490|NCT02574078|520350510|FG003|Treatment Period|Participant no longer meets criteria|0|||
144313491|NCT02574078|520350511|FG004|Treatment Period|Participant no longer meets criteria|1|||
144313492|NCT02574078|520350512|FG005|Treatment Period|Participant no longer meets criteria|0|||
144313493|NCT02574078|520350513|FG006|Treatment Period|Participant no longer meets criteria|0|||
144313494|NCT02574078|520350514|FG007|Treatment Period|Participant no longer meets criteria|0|||
144313495|NCT02574078|520350515|FG008|Treatment Period|Participant no longer meets criteria|0|||
144313496|NCT02574078|520350516|FG009|Treatment Period|Participant no longer meets criteria|1|||
144313497|NCT02574078|520350517|FG010|Treatment Period|Participant no longer meets criteria|1|||
144313498|NCT02574078|520350518|FG011|Treatment Period|Participant no longer meets criteria|1|||
144313499|NCT02574078|520350519|FG012|Treatment Period|Participant no longer meets criteria|0|||
144313500|NCT02574078|520350507|FG000|Treatment Period|Lost to Follow-up|0|||
144313501|NCT02574078|520350508|FG001|Treatment Period|Lost to Follow-up|0|||
144313502|NCT02574078|520350509|FG002|Treatment Period|Lost to Follow-up|0|||
144313503|NCT02574078|520350510|FG003|Treatment Period|Lost to Follow-up|0|||
144313504|NCT02574078|520350511|FG004|Treatment Period|Lost to Follow-up|0|||
144313505|NCT02574078|520350512|FG005|Treatment Period|Lost to Follow-up|0|||
144313506|NCT02574078|520350513|FG006|Treatment Period|Lost to Follow-up|0|||
144313507|NCT02574078|520350514|FG007|Treatment Period|Lost to Follow-up|0|||
144313508|NCT02574078|520350515|FG008|Treatment Period|Lost to Follow-up|0|||
144313509|NCT02574078|520350516|FG009|Treatment Period|Lost to Follow-up|1|||
144313510|NCT02574078|520350517|FG010|Treatment Period|Lost to Follow-up|0|||
144313511|NCT02574078|520350518|FG011|Treatment Period|Lost to Follow-up|1|||
144313512|NCT02574078|520350519|FG012|Treatment Period|Lost to Follow-up|0|||
144313513|NCT02574078|520350507|FG000|Treatment Period|Maximum clinical benefit|0|||
144313514|NCT02574078|520350508|FG001|Treatment Period|Maximum clinical benefit|0|||
144313515|NCT02574078|520350509|FG002|Treatment Period|Maximum clinical benefit|0|||
144313516|NCT02574078|520350510|FG003|Treatment Period|Maximum clinical benefit|0|||
144313517|NCT02574078|520350511|FG004|Treatment Period|Maximum clinical benefit|0|||
144313518|NCT02574078|520350512|FG005|Treatment Period|Maximum clinical benefit|0|||
144313519|NCT02574078|520350513|FG006|Treatment Period|Maximum clinical benefit|0|||
144313520|NCT02574078|520350514|FG007|Treatment Period|Maximum clinical benefit|0|||
144313521|NCT02574078|520350515|FG008|Treatment Period|Maximum clinical benefit|0|||
144313522|NCT02574078|520350516|FG009|Treatment Period|Maximum clinical benefit|1|||
144313523|NCT02574078|520350517|FG010|Treatment Period|Maximum clinical benefit|0|||
144313524|NCT02574078|520350518|FG011|Treatment Period|Maximum clinical benefit|0|||
144313525|NCT02574078|520350519|FG012|Treatment Period|Maximum clinical benefit|0|||
144313526|NCT05935878|520350520|FG000|Overall Study|Death|1|||
144313527|NCT05935878|520350521|FG001|Overall Study|Death|2|||
144313528|NCT05935878|520350520|FG000|Overall Study|Withdrawal by Subject|5|||
144313529|NCT05935878|520350521|FG001|Overall Study|Withdrawal by Subject|5|||
144313530|NCT05935878|520350520|FG000|Overall Study|Revision of implant|1|||
144313531|NCT05935878|520350521|FG001|Overall Study|Revision of implant|1|||
144313532|NCT05935878|520350520|FG000|Overall Study|Mobile bearing dislocation|0|||
144313533|NCT05935878|520350521|FG001|Overall Study|Mobile bearing dislocation|1|||
144313534|NCT00500357|520350528|FG000|Overall Study|Death|1|||
144313535|NCT02263326|520350529|FG000|Overall Study|Lost to Follow-up|1|||
144313536|NCT02263326|520350530|FG001|Overall Study|Lost to Follow-up|1|||
144313537|NCT01893411|520350531|FG000|Overall Study|Protocol Violation|1|||
144313538|NCT01893411|520350532|FG001|Overall Study|Protocol Violation|0|||
144313539|NCT01893411|520350533|FG002|Overall Study|Protocol Violation|0|||
144313540|NCT01893411|520350531|FG000|Overall Study|Physician Decision|1|||
144313541|NCT01893411|520350532|FG001|Overall Study|Physician Decision|1|||
144313542|NCT01893411|520350533|FG002|Overall Study|Physician Decision|2|||
144313543|NCT01893411|520350531|FG000|Overall Study|Lack of Efficacy|2|||
144313544|NCT01893411|520350532|FG001|Overall Study|Lack of Efficacy|1|||
144313545|NCT01893411|520350533|FG002|Overall Study|Lack of Efficacy|0|||
144313546|NCT01893411|520350531|FG000|Overall Study|Other|3|||
144313547|NCT01893411|520350532|FG001|Overall Study|Other|1|||
144313548|NCT01893411|520350533|FG002|Overall Study|Other|3|||
144313549|NCT01893411|520350531|FG000|Overall Study|Adverse Event|1|||
144313550|NCT01893411|520350532|FG001|Overall Study|Adverse Event|0|||
144313551|NCT01893411|520350533|FG002|Overall Study|Adverse Event|0|||
144313552|NCT01893411|520350531|FG000|Overall Study|Withdrawal by Subject|7|||
144313553|NCT01893411|520350532|FG001|Overall Study|Withdrawal by Subject|4|||
144313554|NCT01893411|520350533|FG002|Overall Study|Withdrawal by Subject|3|||
144313555|NCT01893411|520350531|FG000|Overall Study|Lost to Follow-up|2|||
144313556|NCT01893411|520350532|FG001|Overall Study|Lost to Follow-up|0|||
144313557|NCT01893411|520350533|FG002|Overall Study|Lost to Follow-up|1|||
144313558|NCT02397915|520350534|FG000|Period 1|Protocol Violation|0|||
144313559|NCT02397915|520350535|FG001|Period 1|Protocol Violation|1|||
144313560|NCT02397915|520350536|FG002|Period 1|Protocol Violation|0|||
144313561|NCT02397915|520350537|FG003|Period 1|Protocol Violation|0|||
144313562|NCT02397915|520350534|FG000|Period 1|Physician Decision|1|||
144313563|NCT02397915|520350535|FG001|Period 1|Physician Decision|0|||
144313564|NCT02397915|520350536|FG002|Period 1|Physician Decision|0|||
144313565|NCT02397915|520350537|FG003|Period 1|Physician Decision|0|||
144313566|NCT00368745|520350538|FG000|Double-blind Treatment Period|Adverse Event|6|||
144313567|NCT00368745|520350539|FG001|Double-blind Treatment Period|Adverse Event|6|||
144313568|NCT00368745|520350538|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
144313569|NCT00368745|520350539|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
144313570|NCT00368745|520350538|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
144313571|NCT00368745|520350539|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
144313572|NCT00368745|520350538|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
144313573|NCT00368745|520350539|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
144313574|NCT00368745|520350538|FG000|Double-blind Treatment Period|Other|7|||
144313575|NCT00368745|520350539|FG001|Double-blind Treatment Period|Other|6|||
144313576|NCT00566982|520350540|FG000|Overall Study|Adverse Event|6|||
144313577|NCT00566982|520350541|FG001|Overall Study|Adverse Event|48|||
144313578|NCT00566982|520350540|FG000|Overall Study|Withdrawal by Subject|1|||
144313579|NCT00566982|520350541|FG001|Overall Study|Withdrawal by Subject|14|||
144313580|NCT00566982|520350540|FG000|Overall Study|Protocol Violation|1|||
144313581|NCT00566982|520350541|FG001|Overall Study|Protocol Violation|4|||
144313582|NCT00566982|520350540|FG000|Overall Study|Lost to Follow-up|0|||
144313583|NCT00566982|520350541|FG001|Overall Study|Lost to Follow-up|1|||
144313584|NCT00566982|520350540|FG000|Overall Study|Other-family problems & doctor's request|0|||
144313585|NCT00566982|520350541|FG001|Overall Study|Other-family problems & doctor's request|2|||
144313586|NCT00161616|520350542|FG000|Overall Study|Withdrawal by Subject|6|||
144313587|NCT00161616|520350543|FG001|Overall Study|Withdrawal by Subject|5|||
144313588|NCT00161616|520350542|FG000|Overall Study|Physician Decision|1|||
144313589|NCT00161616|520350543|FG001|Overall Study|Physician Decision|0|||
144313590|NCT00161616|520350542|FG000|Overall Study|Death|1|||
144313591|NCT00161616|520350543|FG001|Overall Study|Death|1|||
144313592|NCT00161616|520350542|FG000|Overall Study|Lost to Follow-up|17|||
144313593|NCT00161616|520350543|FG001|Overall Study|Lost to Follow-up|13|||
144313594|NCT00161616|520350542|FG000|Overall Study|Protocol deviation|1|||
144313595|NCT00161616|520350543|FG001|Overall Study|Protocol deviation|0|||
144313596|NCT00933608|520350545|FG000|Overall Study|Adverse Event|4|||
144313597|NCT00933608|520350546|FG001|Overall Study|Adverse Event|2|||
144313598|NCT00933608|520350545|FG000|Overall Study|Physician Decision|1|||
144313599|NCT00933608|520350546|FG001|Overall Study|Physician Decision|0|||
144313600|NCT02719691|520350549|FG000|Overall Study|Physician Decision|0|||
144313601|NCT02719691|520350550|FG001|Overall Study|Physician Decision|0|||
144313602|NCT02719691|520350551|FG002|Overall Study|Physician Decision|1|||
144313603|NCT02719691|520350552|FG003|Overall Study|Physician Decision|0|||
144313604|NCT02719691|520350553|FG004|Overall Study|Physician Decision|0|||
144313605|NCT02719691|520350554|FG005|Overall Study|Physician Decision|0|||
144313606|NCT02719691|520350555|FG006|Overall Study|Physician Decision|0|||
144313607|NCT02719691|520350549|FG000|Overall Study|Withdrawal by Subject|0|||
144313608|NCT02719691|520350550|FG001|Overall Study|Withdrawal by Subject|0|||
144313609|NCT02719691|520350551|FG002|Overall Study|Withdrawal by Subject|0|||
144313610|NCT02719691|520350552|FG003|Overall Study|Withdrawal by Subject|0|||
144313611|NCT02719691|520350553|FG004|Overall Study|Withdrawal by Subject|0|||
144313612|NCT02719691|520350554|FG005|Overall Study|Withdrawal by Subject|1|||
144313613|NCT02719691|520350555|FG006|Overall Study|Withdrawal by Subject|0|||
144313614|NCT00861757|520350562|FG000|Overall Study|Adverse Event|1|||
144313615|NCT00861757|520350563|FG001|Overall Study|Adverse Event|5|||
144313616|NCT00861757|520350564|FG002|Overall Study|Adverse Event|7|||
144313617|NCT00861757|520350565|FG003|Overall Study|Adverse Event|2|||
144313618|NCT00861757|520350562|FG000|Overall Study|Entry Criteria Not Met|1|||
144313619|NCT00861757|520350563|FG001|Overall Study|Entry Criteria Not Met|2|||
144313620|NCT00861757|520350564|FG002|Overall Study|Entry Criteria Not Met|1|||
144313621|NCT00861757|520350565|FG003|Overall Study|Entry Criteria Not Met|1|||
144313622|NCT00861757|520350562|FG000|Overall Study|Lack of Efficacy|3|||
144313623|NCT00861757|520350563|FG001|Overall Study|Lack of Efficacy|1|||
144313624|NCT00861757|520350564|FG002|Overall Study|Lack of Efficacy|0|||
144313625|NCT00861757|520350565|FG003|Overall Study|Lack of Efficacy|1|||
144313626|NCT00861757|520350562|FG000|Overall Study|Lost to Follow-up|1|||
144313627|NCT00861757|520350563|FG001|Overall Study|Lost to Follow-up|0|||
144313628|NCT00861757|520350564|FG002|Overall Study|Lost to Follow-up|1|||
144313629|NCT00861757|520350565|FG003|Overall Study|Lost to Follow-up|1|||
144313630|NCT00861757|520350562|FG000|Overall Study|Physician Decision|0|||
144313631|NCT00861757|520350563|FG001|Overall Study|Physician Decision|0|||
144313632|NCT00861757|520350564|FG002|Overall Study|Physician Decision|0|||
144313633|NCT00861757|520350565|FG003|Overall Study|Physician Decision|1|||
144313634|NCT00861757|520350562|FG000|Overall Study|Protocol Violation|2|||
144313635|NCT00861757|520350563|FG001|Overall Study|Protocol Violation|2|||
144313636|NCT00861757|520350564|FG002|Overall Study|Protocol Violation|4|||
144313637|NCT00861757|520350565|FG003|Overall Study|Protocol Violation|1|||
144313638|NCT00861757|520350562|FG000|Overall Study|Withdrawal by Subject|1|||
144313639|NCT00861757|520350563|FG001|Overall Study|Withdrawal by Subject|5|||
144313640|NCT00861757|520350564|FG002|Overall Study|Withdrawal by Subject|5|||
144313641|NCT00861757|520350565|FG003|Overall Study|Withdrawal by Subject|2|||
144313642|NCT01521923|520350571|FG000|Overall Study|AE, serious fatal|1|||
144313643|NCT01521923|520350572|FG001|Overall Study|AE, serious fatal|0|||
144313644|NCT01521923|520350573|FG002|Overall Study|AE, serious fatal|0|||
144313645|NCT01521923|520350574|FG003|Overall Study|AE, serious fatal|0|||
144313646|NCT01521923|520350571|FG000|Overall Study|SAE, non-fatal|0|||
144313647|NCT01521923|520350572|FG001|Overall Study|SAE, non-fatal|2|||
144313648|NCT01521923|520350573|FG002|Overall Study|SAE, non-fatal|2|||
144313649|NCT01521923|520350574|FG003|Overall Study|SAE, non-fatal|0|||
144313650|NCT01521923|520350571|FG000|Overall Study|AE, non-serious, non-fatal|1|||
144313651|NCT01521923|520350572|FG001|Overall Study|AE, non-serious, non-fatal|3|||
144313652|NCT01521923|520350573|FG002|Overall Study|AE, non-serious, non-fatal|6|||
144313653|NCT01521923|520350574|FG003|Overall Study|AE, non-serious, non-fatal|2|||
144313654|NCT01521923|520350571|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
144313655|NCT01521923|520350572|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
144313656|NCT01521923|520350573|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
144313657|NCT01521923|520350574|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
144313658|NCT01521923|520350571|FG000|Overall Study|Lack of Efficacy|1|||
144313659|NCT01521923|520350572|FG001|Overall Study|Lack of Efficacy|1|||
144313660|NCT01521923|520350573|FG002|Overall Study|Lack of Efficacy|0|||
144313661|NCT01521923|520350574|FG003|Overall Study|Lack of Efficacy|0|||
144313662|NCT01521923|520350571|FG000|Overall Study|Protocol Violation|0|||
144313663|NCT01521923|520350572|FG001|Overall Study|Protocol Violation|0|||
144313664|NCT01521923|520350573|FG002|Overall Study|Protocol Violation|1|||
144313665|NCT01521923|520350574|FG003|Overall Study|Protocol Violation|0|||
144313666|NCT01521923|520350571|FG000|Overall Study|Lost to Follow-up|1|||
144313667|NCT01521923|520350572|FG001|Overall Study|Lost to Follow-up|0|||
144313668|NCT01521923|520350573|FG002|Overall Study|Lost to Follow-up|2|||
144313669|NCT01521923|520350574|FG003|Overall Study|Lost to Follow-up|1|||
144313670|NCT01521923|520350571|FG000|Overall Study|Withdrawal by Subject|1|||
144313671|NCT01521923|520350572|FG001|Overall Study|Withdrawal by Subject|1|||
144313672|NCT01521923|520350573|FG002|Overall Study|Withdrawal by Subject|1|||
144313673|NCT01521923|520350574|FG003|Overall Study|Withdrawal by Subject|2|||
144313674|NCT01521923|520350571|FG000|Overall Study|Other|2|||
144313675|NCT01521923|520350572|FG001|Overall Study|Other|1|||
144313676|NCT01521923|520350573|FG002|Overall Study|Other|3|||
144313677|NCT01521923|520350574|FG003|Overall Study|Other|6|||
144313678|NCT01521923|520350571|FG000|Overall Study|AE, captured in Period 1|0|||
144313679|NCT01521923|520350572|FG001|Overall Study|AE, captured in Period 1|1|||
144313680|NCT01521923|520350573|FG002|Overall Study|AE, captured in Period 1|0|||
144313681|NCT01521923|520350574|FG003|Overall Study|AE, captured in Period 1|1|||
144313682|NCT03037476|520350575|FG000|Overall Study|Lost to Follow-up|63|||
144313683|NCT03037476|520350576|FG001|Overall Study|Lost to Follow-up|46|||
144313684|NCT02141633|520350577|FG000|Overall Study|Physician Decision|1|||
144313685|NCT02141633|520350578|FG001|Overall Study|Physician Decision|0|||
144313686|NCT02403817|520350581|FG000|Overall Study|Withdrawal by Subject|5|||
144313687|NCT02403817|520350582|FG001|Overall Study|Withdrawal by Subject|0|||
144313688|NCT03053440|520350585|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
144313689|NCT03053440|520350586|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
144313690|NCT03053440|520350585|FG000|Overall Study|Death|18|||
144313691|NCT03053440|520350586|FG001|Overall Study|Death|14|||
144313692|NCT03053440|520350585|FG000|Overall Study|Withdrawal by Subject|9|||
144313693|NCT03053440|520350586|FG001|Overall Study|Withdrawal by Subject|8|||
144313694|NCT03053440|520350585|FG000|Overall Study|Lost to Follow-up|1|||
144313695|NCT03053440|520350586|FG001|Overall Study|Lost to Follow-up|0|||
144313696|NCT03053440|520350585|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
144313697|NCT03053440|520350586|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
144313698|NCT03053440|520350585|FG000|Overall Study|Physician Decision|2|||
144313699|NCT03053440|520350586|FG001|Overall Study|Physician Decision|1|||
144313700|NCT03053440|520350585|FG000|Overall Study|Participant Randomized but died before dosing|1|||
144313701|NCT03053440|520350586|FG001|Overall Study|Participant Randomized but died before dosing|0|||
144313702|NCT04908384|520350591|FG000|Overall Study|Lost to Follow-up|4|||
144313703|NCT04908384|520350592|FG001|Overall Study|Lost to Follow-up|4|||
144313704|NCT04908384|520350593|FG002|Overall Study|Lost to Follow-up|0|||
144313705|NCT04908384|520350594|FG003|Overall Study|Lost to Follow-up|0|||
144313706|NCT05002985|520350595|FG000|Overall Study|Withdrawal by Subject|1|||
144313707|NCT00833469|520350599|FG000|Overall Study|Withdrawal by Subject|1|||
144313708|NCT00833469|520350599|FG000|Overall Study|Lost to Follow-up|1|||
144313709|NCT00603941|520350600|FG000|Overall Study|Disease progression|6|||
144313710|NCT00603941|520350601|FG001|Overall Study|Disease progression|7|||
144313711|NCT00603941|520350602|FG002|Overall Study|Disease progression|1|||
144313712|NCT00603941|520350600|FG000|Overall Study|Adverse Event|1|||
144313713|NCT00603941|520350601|FG001|Overall Study|Adverse Event|0|||
144313714|NCT00603941|520350602|FG002|Overall Study|Adverse Event|1|||
144313715|NCT00603941|520350600|FG000|Overall Study|Physician Decision|0|||
144313716|NCT00603941|520350601|FG001|Overall Study|Physician Decision|1|||
144313717|NCT00603941|520350602|FG002|Overall Study|Physician Decision|0|||
144313718|NCT00603941|520350600|FG000|Overall Study|Withdrawal by Subject|0|||
144313719|NCT00603941|520350601|FG001|Overall Study|Withdrawal by Subject|2|||
144313720|NCT00603941|520350602|FG002|Overall Study|Withdrawal by Subject|0|||
144313721|NCT01642901|520350603|FG000|12-month Follow-up|Withdrawal by Subject|1|||
144313722|NCT01642901|520350604|FG001|12-month Follow-up|Withdrawal by Subject|0|||
144313723|NCT02943070|520350605|FG000|Overall Study|Physician Decision|1|||
144313724|NCT02943070|520350605|FG000|Overall Study|Adverse Event|2|||
144313725|NCT02943070|520350605|FG000|Overall Study|Death|2|||
144313726|NCT02943070|520350605|FG000|Overall Study|Withdrawal by Subject|3|||
144313727|NCT02943070|520350605|FG000|Overall Study|Lost to Follow-up|4|||
144313728|NCT02943070|520350605|FG000|Overall Study|Retreatment or TURP|13|||
144313729|NCT02943070|520350605|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
144313730|NCT00570778|520350606|FG000|Overall Study|Protocol deviation|2|||
144313731|NCT00570778|520350607|FG001|Overall Study|Protocol deviation|1|||
144313732|NCT00570778|520350608|FG002|Overall Study|Protocol deviation|2|||
144313733|NCT00570778|520350609|FG003|Overall Study|Protocol deviation|2|||
144313734|NCT00570778|520350606|FG000|Overall Study|Adverse Event|0|||
144313735|NCT00570778|520350607|FG001|Overall Study|Adverse Event|1|||
144313736|NCT00570778|520350608|FG002|Overall Study|Adverse Event|4|||
144313737|NCT00570778|520350609|FG003|Overall Study|Adverse Event|1|||
144313738|NCT00570778|520350606|FG000|Overall Study|Subject withdrew consent|0|||
144313739|NCT00570778|520350607|FG001|Overall Study|Subject withdrew consent|1|||
144313740|NCT00570778|520350608|FG002|Overall Study|Subject withdrew consent|0|||
144313741|NCT00570778|520350609|FG003|Overall Study|Subject withdrew consent|1|||
144313742|NCT00570778|520350606|FG000|Overall Study|Abnormal test procedure|1|||
144313743|NCT00570778|520350607|FG001|Overall Study|Abnormal test procedure|0|||
144313744|NCT00570778|520350608|FG002|Overall Study|Abnormal test procedure|0|||
144313745|NCT00570778|520350609|FG003|Overall Study|Abnormal test procedure|0|||
144313746|NCT00570778|520350606|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
144313747|NCT00570778|520350607|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144313748|NCT00570778|520350608|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144313749|NCT00570778|520350609|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
144313750|NCT00570778|520350606|FG000|Overall Study|Lost to Follow-up|0|||
144313751|NCT00570778|520350607|FG001|Overall Study|Lost to Follow-up|0|||
144313752|NCT00570778|520350608|FG002|Overall Study|Lost to Follow-up|1|||
144313753|NCT00570778|520350609|FG003|Overall Study|Lost to Follow-up|0|||
144313754|NCT00570778|520350606|FG000|Overall Study|Subject no longer requires study drug|0|||
144313755|NCT00570778|520350607|FG001|Overall Study|Subject no longer requires study drug|1|||
144313756|NCT00570778|520350608|FG002|Overall Study|Subject no longer requires study drug|0|||
144313757|NCT00570778|520350609|FG003|Overall Study|Subject no longer requires study drug|0|||
144313758|NCT03654040|520350610|FG000|Overall Study|Death|1|||
144313759|NCT03654040|520350611|FG001|Overall Study|Death|0|||
144313760|NCT03654040|520350610|FG000|Overall Study|Withdrawal by Subject|1|||
144313761|NCT03654040|520350611|FG001|Overall Study|Withdrawal by Subject|0|||
144313762|NCT03654040|520350610|FG000|Overall Study|Study terminated by sponsor|8|||
144313763|NCT03654040|520350611|FG001|Overall Study|Study terminated by sponsor|2|||
144313764|NCT03654040|520350610|FG000|Overall Study|Failure to initiate study therapy|2|||
144313765|NCT03654040|520350611|FG001|Overall Study|Failure to initiate study therapy|0|||
144313766|NCT03654040|520350610|FG000|Overall Study|Transplanted at another center|2|||
144313767|NCT03654040|520350611|FG001|Overall Study|Transplanted at another center|0|||
144313768|NCT03654040|520350610|FG000|Overall Study|Failure to meet eligibility criteria|14|||
144313769|NCT03654040|520350611|FG001|Overall Study|Failure to meet eligibility criteria|2|||
144313770|NCT03654040|520350610|FG000|Overall Study|No longer transplant candidate|1|||
144313771|NCT03654040|520350611|FG001|Overall Study|No longer transplant candidate|0|||
144313772|NCT03654040|520350610|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
144313773|NCT03654040|520350611|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
144313774|NCT03654040|520350610|FG000|Overall Study|Recipient ineligible|0|||
144313775|NCT03654040|520350611|FG001|Overall Study|Recipient ineligible|2|||
144313776|NCT03654040|520350610|FG000|Overall Study|Received deceased liver|0|||
144313777|NCT03654040|520350611|FG001|Overall Study|Received deceased liver|1|||
144313778|NCT00135330|520350612|FG000|Overall Study|Adverse Event|2|||
144313779|NCT00135330|520350613|FG001|Overall Study|Adverse Event|5|||
144313780|NCT00135330|520350614|FG002|Overall Study|Adverse Event|1|||
144313781|NCT00135330|520350612|FG000|Overall Study|Lost to Follow-up|0|||
144313782|NCT00135330|520350613|FG001|Overall Study|Lost to Follow-up|2|||
144313783|NCT00135330|520350614|FG002|Overall Study|Lost to Follow-up|3|||
144313784|NCT00135330|520350612|FG000|Overall Study|Physician Decision|1|||
144313785|NCT00135330|520350613|FG001|Overall Study|Physician Decision|1|||
144313786|NCT00135330|520350614|FG002|Overall Study|Physician Decision|0|||
144313787|NCT00135330|520350612|FG000|Overall Study|Protocol Violation|4|||
144313788|NCT00135330|520350613|FG001|Overall Study|Protocol Violation|3|||
144313789|NCT00135330|520350614|FG002|Overall Study|Protocol Violation|3|||
144313790|NCT00135330|520350612|FG000|Overall Study|Patient Decision|5|||
144313791|NCT00135330|520350613|FG001|Overall Study|Patient Decision|1|||
144313792|NCT00135330|520350614|FG002|Overall Study|Patient Decision|4|||
144313793|NCT00135330|520350612|FG000|Overall Study|Sponsor Decision|0|||
144313794|NCT00135330|520350613|FG001|Overall Study|Sponsor Decision|1|||
144313795|NCT00135330|520350614|FG002|Overall Study|Sponsor Decision|0|||
144313796|NCT01390298|520350615|FG000|Overall Study|Death|1|||
144313797|NCT01390298|520350615|FG000|Overall Study|long term ICU admission|1|||
144313798|NCT01390298|520350615|FG000|Overall Study|Withdrawal by Subject|14|||
144313799|NCT01390298|520350615|FG000|Overall Study|Lost to Follow-up|7|||
144313800|NCT01390298|520350615|FG000|Overall Study|Surgery cancelled|1|||
144313801|NCT00803361|520350616|FG000|Overall Study|Adverse Event|13|||
144313802|NCT00803361|520350617|FG001|Overall Study|Adverse Event|3|||
144313803|NCT00803361|520350616|FG000|Overall Study|Lack of Efficacy|4|||
144313804|NCT00803361|520350617|FG001|Overall Study|Lack of Efficacy|13|||
144313805|NCT00803361|520350616|FG000|Overall Study|Lost to Follow-up|1|||
144313806|NCT00803361|520350617|FG001|Overall Study|Lost to Follow-up|2|||
144313807|NCT00803361|520350616|FG000|Overall Study|Physician Decision|1|||
144313808|NCT00803361|520350617|FG001|Overall Study|Physician Decision|0|||
144313809|NCT00803361|520350616|FG000|Overall Study|Protocol Violation|2|||
144313810|NCT00803361|520350617|FG001|Overall Study|Protocol Violation|4|||
144313811|NCT00803361|520350616|FG000|Overall Study|Withdrawal by Subject|5|||
144313812|NCT00803361|520350617|FG001|Overall Study|Withdrawal by Subject|6|||
144313813|NCT02446769|520350618|FG000|Screening Period|Screen Failure|11|||
144313814|NCT02446769|520350619|FG001|Screening Period|Screen Failure|0|||
144313815|NCT02446769|520350620|FG002|Screening Period|Screen Failure|0|||
144313816|NCT02446769|520350618|FG000|Study Period|Randomized in Error|0|||
144313817|NCT02446769|520350619|FG001|Study Period|Randomized in Error|2|||
144313818|NCT02446769|520350620|FG002|Study Period|Randomized in Error|0|||
144313819|NCT04482439|520350621|FG000|Overall Study|Lost to Follow-up|1|||
144313820|NCT04482439|520350621|FG000|Overall Study|Unrelated illness|1|||
144313821|NCT03900728|520350622|FG000|Overall Study|No text responses|0|||
144313822|NCT03900728|520350623|FG001|Overall Study|No text responses|0|||
144313823|NCT03900728|520350624|FG002|Overall Study|No text responses|4|||
144313824|NCT02544750|520350625|FG000|Overall Study|Physician Decision|3|||
144313825|NCT02544750|520350626|FG001|Overall Study|Physician Decision|1|||
144313826|NCT02544750|520350625|FG000|Overall Study|Other reasons|69|||
144313827|NCT02544750|520350626|FG001|Overall Study|Other reasons|39|||
144313828|NCT02544750|520350625|FG000|Overall Study|Met withdrawal criteria|2|||
144313829|NCT02544750|520350626|FG001|Overall Study|Met withdrawal criteria|2|||
144313830|NCT02544750|520350625|FG000|Overall Study|Transition To Commercial Product|1|||
144313831|NCT02544750|520350626|FG001|Overall Study|Transition To Commercial Product|0|||
144313832|NCT02544750|520350625|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
144313833|NCT02544750|520350626|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
144313834|NCT02544750|520350625|FG000|Overall Study|Adverse Event|8|||
144313835|NCT02544750|520350626|FG001|Overall Study|Adverse Event|10|||
144313836|NCT02544750|520350625|FG000|Overall Study|Withdrawal by Subject|10|||
144313837|NCT02544750|520350626|FG001|Overall Study|Withdrawal by Subject|4|||
144313838|NCT02544750|520350625|FG000|Overall Study|Lost to Follow-up|1|||
144313839|NCT02544750|520350626|FG001|Overall Study|Lost to Follow-up|0|||
144313840|NCT02484443|520350627|FG000|Overall Study|Lack of Efficacy|28|||
144313841|NCT02484443|520350627|FG000|Overall Study|Physician Decision|2|||
144313842|NCT02484443|520350627|FG000|Overall Study|Ineligible|2|||
144313843|NCT04677543|520350628|FG000|Overall Study|Withdrawal by Subject|4|||
144313844|NCT04677543|520350629|FG001|Overall Study|Withdrawal by Subject|1|||
144313845|NCT04677543|520350628|FG000|Overall Study|Physician Decision|0|||
144313846|NCT04677543|520350629|FG001|Overall Study|Physician Decision|1|||
144313847|NCT04677543|520350628|FG000|Overall Study|Adverse Event|0|||
144313848|NCT04677543|520350629|FG001|Overall Study|Adverse Event|1|||
144313849|NCT02969915|520350630|FG000|Overall Study|Death|104|||
144313850|NCT02969915|520350631|FG001|Overall Study|Death|125|||
144313851|NCT02969915|520350630|FG000|Overall Study|Lost to Follow-up|108|||
144313852|NCT02969915|520350631|FG001|Overall Study|Lost to Follow-up|112|||
144313853|NCT02969915|520350630|FG000|Overall Study|Censored due to COVID-19|481|||
144313854|NCT02969915|520350631|FG001|Overall Study|Censored due to COVID-19|471|||
144313855|NCT02520388|520350632|FG000|Overall Study|Physician Decision|1|||
144313856|NCT02520388|520350633|FG001|Overall Study|Physician Decision|0|||
144313857|NCT02520388|520350632|FG000|Overall Study|Subject or parent/guardian request|0|||
144313858|NCT02520388|520350633|FG001|Overall Study|Subject or parent/guardian request|6|||
144313859|NCT02520388|520350632|FG000|Overall Study|Adverse Event|1|||
144313860|NCT02520388|520350633|FG001|Overall Study|Adverse Event|4|||
144313861|NCT02520388|520350632|FG000|Overall Study|Lost to Follow-up|3|||
144313862|NCT02520388|520350633|FG001|Overall Study|Lost to Follow-up|2|||
144313863|NCT02520388|520350632|FG000|Overall Study|Other (reason not defined)|4|||
144313864|NCT02520388|520350633|FG001|Overall Study|Other (reason not defined)|4|||
144313865|NCT01437111|520350634|FG000|Overall Study|Adverse Event|2|||
144313866|NCT01437111|520350634|FG000|Overall Study|Withdrawal by Subject|4|||
144313867|NCT01437111|520350634|FG000|Overall Study|Not reported|5|||
144313868|NCT01437111|520350634|FG000|Overall Study|Physician Decision|1|||
144313869|NCT01437111|520350634|FG000|Overall Study|Lost to Follow-up|5|||
144313870|NCT01437111|520350634|FG000|Overall Study|Protocol Violation|1|||
144313871|NCT02131311|520350636|FG000|Overall Study|Adverse Event|2|||
144313872|NCT02131311|520350636|FG000|Overall Study|Protocol Violation|1|||
144313873|NCT02131311|520350636|FG000|Overall Study|Lost to Follow-up|1|||
144313874|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
144313875|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
144313876|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
144313877|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
144313878|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
144313879|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
144313880|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
144313881|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
144313882|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
144313883|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
144313884|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
144313885|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
144313886|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
144313887|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
144313888|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
144313889|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
144313890|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
144313891|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
144313892|NCT03162796|520350638|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
144313893|NCT03162796|520350639|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
144313894|NCT03162796|520350640|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
144313895|NCT03162796|520350638|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
144313896|NCT03162796|520350639|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
144313897|NCT03162796|520350640|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
144313898|NCT03162796|520350638|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
144313899|NCT03162796|520350639|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
144313900|NCT03162796|520350640|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
144313901|NCT03162796|520350638|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
144313902|NCT03162796|520350639|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
144313903|NCT03162796|520350640|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
144313904|NCT03162796|520350638|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
144313905|NCT03162796|520350639|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
144313906|NCT03162796|520350640|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
144313907|NCT02473471|520350644|FG000|Overall Study|poor oral hygiene|2|||
144313908|NCT02473471|520350644|FG000|Overall Study|Lost to Follow-up|1|||
144313909|NCT02342288|520350645|FG000|Overall Study|no protocol anesthesiologist available|3|||
144313910|NCT02342288|520350646|FG001|Overall Study|no protocol anesthesiologist available|2|||
144313911|NCT02342288|520350645|FG000|Overall Study|anesthesia leak in system|1|||
144313912|NCT02342288|520350646|FG001|Overall Study|anesthesia leak in system|0|||
144313913|NCT02342288|520350645|FG000|Overall Study|Withdrawal by Subject|1|||
144313914|NCT02342288|520350646|FG001|Overall Study|Withdrawal by Subject|0|||
144313915|NCT02342288|520350645|FG000|Overall Study|coordinator contaminated with blood|0|||
144313916|NCT02342288|520350646|FG001|Overall Study|coordinator contaminated with blood|1|||
144313917|NCT02342288|520350645|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
144313918|NCT02342288|520350646|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
144313919|NCT02342288|520350645|FG000|Overall Study|coordinator not available|0|||
144313920|NCT02342288|520350646|FG001|Overall Study|coordinator not available|2|||
144313921|NCT02375373|520350652|FG000|Overall Study|Withdrawal by Subject|11|||
144313922|NCT00255723|520350653|FG000|Overall Study|Adverse Event|1|||
144313923|NCT00255723|520350654|FG001|Overall Study|Adverse Event|1|||
144313924|NCT00255723|520350653|FG000|Overall Study|Death|0|||
144313925|NCT00255723|520350654|FG001|Overall Study|Death|1|||
144313926|NCT00255723|520350653|FG000|Overall Study|Response Data Not Available|1|||
144313927|NCT00255723|520350654|FG001|Overall Study|Response Data Not Available|0|||
144313928|NCT00391430|520350656|FG000|Overall Study|Withdrawal by Subject|3|||
144313929|NCT00391430|520350657|FG001|Overall Study|Withdrawal by Subject|0|||
144313930|NCT00391430|520350658|FG002|Overall Study|Withdrawal by Subject|12|||
144313931|NCT02467192|520350659|FG000|Overall Study|Death|1|||
144313932|NCT02467192|520350659|FG000|Overall Study|revealed to have pneumonia before|2|||
144313933|NCT01603043|520350660|FG000|Overall Study|Study Futility|7|||
144313934|NCT01603043|520350661|FG001|Overall Study|Study Futility|3|||
144313935|NCT03089047|520350662|FG000|Overall Study|Lost to Follow-up|1|||
144313936|NCT03089047|520350663|FG001|Overall Study|Lost to Follow-up|0|||
144313937|NCT03599518|520350664|FG000|Overall Study|Clinical progression|0|||
144313938|NCT03599518|520350665|FG001|Overall Study|Clinical progression|0|||
144313939|NCT03599518|520350666|FG002|Overall Study|Clinical progression|0|||
144313940|NCT03599518|520350667|FG003|Overall Study|Clinical progression|0|||
144313941|NCT03599518|520350668|FG004|Overall Study|Clinical progression|1|||
144313942|NCT03599518|520350664|FG000|Overall Study|Adverse Event|0|||
144313943|NCT03599518|520350665|FG001|Overall Study|Adverse Event|0|||
144313944|NCT03599518|520350666|FG002|Overall Study|Adverse Event|0|||
144313945|NCT03599518|520350667|FG003|Overall Study|Adverse Event|0|||
144313946|NCT03599518|520350668|FG004|Overall Study|Adverse Event|1|||
144313947|NCT03599518|520350664|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
144313948|NCT03599518|520350665|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
144313949|NCT03599518|520350666|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
144313950|NCT03599518|520350667|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
144313951|NCT03599518|520350668|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
144313952|NCT03599518|520350664|FG000|Overall Study|Participant withdrawal from study treatment|0|||
144313953|NCT03599518|520350665|FG001|Overall Study|Participant withdrawal from study treatment|0|||
144313954|NCT03599518|520350666|FG002|Overall Study|Participant withdrawal from study treatment|1|||
144313955|NCT03599518|520350667|FG003|Overall Study|Participant withdrawal from study treatment|0|||
144313956|NCT03599518|520350668|FG004|Overall Study|Participant withdrawal from study treatment|0|||
144313957|NCT00912782|520350672|FG000|Overall Study|Death|2|||
144313958|NCT00912782|520350673|FG001|Overall Study|Death|1|||
144313959|NCT00912782|520350672|FG000|Overall Study|Lost to Follow-up|0|||
144313960|NCT00912782|520350673|FG001|Overall Study|Lost to Follow-up|1|||
144313961|NCT00912782|520350672|FG000|Overall Study|Did not receive vascular access type|1|||
144313962|NCT00912782|520350673|FG001|Overall Study|Did not receive vascular access type|2|||
144313963|NCT00912782|520350672|FG000|Overall Study|Relocated before study completion|0|||
144313964|NCT00912782|520350673|FG001|Overall Study|Relocated before study completion|1|||
144313965|NCT02707965|520352502|FG000|Overall Study|Withdrawal by Subject|0|||
144313966|NCT02707965|520352503|FG001|Overall Study|Withdrawal by Subject|0|||
144313967|NCT02707965|520352504|FG002|Overall Study|Withdrawal by Subject|1|||
144313968|NCT02707965|520352505|FG003|Overall Study|Withdrawal by Subject|0|||
144313969|NCT02707965|520352506|FG004|Overall Study|Withdrawal by Subject|0|||
144313970|NCT02707965|520352507|FG005|Overall Study|Withdrawal by Subject|0|||
144313971|NCT02707965|520352508|FG006|Overall Study|Withdrawal by Subject|0|||
144313972|NCT02707965|520352509|FG007|Overall Study|Withdrawal by Subject|2|||
144313973|NCT02707965|520352510|FG008|Overall Study|Withdrawal by Subject|0|||
144313974|NCT02707965|520352511|FG009|Overall Study|Withdrawal by Subject|0|||
144313975|NCT02707965|520352512|FG010|Overall Study|Withdrawal by Subject|0|||
144313976|NCT02707965|520352513|FG011|Overall Study|Withdrawal by Subject|0|||
144313977|NCT02707965|520352514|FG012|Overall Study|Withdrawal by Subject|0|||
144313978|NCT02707965|520352515|FG013|Overall Study|Withdrawal by Subject|0|||
144313979|NCT02707965|520352516|FG014|Overall Study|Withdrawal by Subject|0|||
144313980|NCT02707965|520352517|FG015|Overall Study|Withdrawal by Subject|0|||
144313981|NCT02707965|520352502|FG000|Overall Study|PI decisions|0|||
144313982|NCT02707965|520352503|FG001|Overall Study|PI decisions|0|||
144313983|NCT02707965|520352504|FG002|Overall Study|PI decisions|0|||
144313984|NCT02707965|520352505|FG003|Overall Study|PI decisions|0|||
144313985|NCT02707965|520352506|FG004|Overall Study|PI decisions|0|||
144313986|NCT02707965|520352507|FG005|Overall Study|PI decisions|0|||
144313987|NCT02707965|520352508|FG006|Overall Study|PI decisions|0|||
144313988|NCT02707965|520352509|FG007|Overall Study|PI decisions|0|||
144313989|NCT02707965|520352510|FG008|Overall Study|PI decisions|0|||
144313990|NCT02707965|520352511|FG009|Overall Study|PI decisions|0|||
144313991|NCT02707965|520352512|FG010|Overall Study|PI decisions|0|||
144313992|NCT02707965|520352513|FG011|Overall Study|PI decisions|0|||
144313993|NCT02707965|520352514|FG012|Overall Study|PI decisions|0|||
144313994|NCT02707965|520352515|FG013|Overall Study|PI decisions|0|||
144313995|NCT02707965|520352516|FG014|Overall Study|PI decisions|2|||
144313996|NCT02707965|520352517|FG015|Overall Study|PI decisions|0|||
144313997|NCT02707965|520352502|FG000|Overall Study|Protocol deviation|1|||
144313998|NCT02707965|520352503|FG001|Overall Study|Protocol deviation|1|||
144313999|NCT02707965|520352504|FG002|Overall Study|Protocol deviation|0|||
144314000|NCT02707965|520352505|FG003|Overall Study|Protocol deviation|0|||
144314001|NCT02707965|520352506|FG004|Overall Study|Protocol deviation|0|||
144314002|NCT02707965|520352507|FG005|Overall Study|Protocol deviation|0|||
144314003|NCT02707965|520352508|FG006|Overall Study|Protocol deviation|0|||
144314004|NCT02707965|520352509|FG007|Overall Study|Protocol deviation|1|||
144314005|NCT02707965|520352510|FG008|Overall Study|Protocol deviation|0|||
144314006|NCT02707965|520352511|FG009|Overall Study|Protocol deviation|0|||
144314007|NCT02707965|520352512|FG010|Overall Study|Protocol deviation|0|||
144314008|NCT02707965|520352513|FG011|Overall Study|Protocol deviation|0|||
144314009|NCT02707965|520352514|FG012|Overall Study|Protocol deviation|0|||
144314010|NCT02707965|520352515|FG013|Overall Study|Protocol deviation|0|||
144314011|NCT02707965|520352516|FG014|Overall Study|Protocol deviation|0|||
144314012|NCT02707965|520352517|FG015|Overall Study|Protocol deviation|0|||
144314013|NCT00711594|520352518|FG000|Overall Study|Progressive disease|2|||
144314014|NCT00711594|520352519|FG001|Overall Study|Progressive disease|2|||
144314015|NCT00711594|520352520|FG002|Overall Study|Progressive disease|6|||
144314016|NCT00711594|520352521|FG003|Overall Study|Progressive disease|44|||
144314017|NCT00711594|520352518|FG000|Overall Study|Other Adverse Event|1|||
144314018|NCT00711594|520352519|FG001|Overall Study|Other Adverse Event|0|||
144314019|NCT00711594|520352520|FG002|Overall Study|Other Adverse Event|0|||
144314020|NCT00711594|520352521|FG003|Overall Study|Other Adverse Event|16|||
144314021|NCT00711594|520352518|FG000|Overall Study|Withdrawal by Subject|0|||
144314022|NCT00711594|520352519|FG001|Overall Study|Withdrawal by Subject|1|||
144314023|NCT00711594|520352520|FG002|Overall Study|Withdrawal by Subject|0|||
144314024|NCT00711594|520352521|FG003|Overall Study|Withdrawal by Subject|2|||
144314025|NCT01709110|520352522|FG000|Overall Study|Adverse Event|56|||
144314026|NCT01709110|520352523|FG001|Overall Study|Adverse Event|48|||
144314027|NCT01709110|520352522|FG000|Overall Study|Death|14|||
144314028|NCT01709110|520352523|FG001|Overall Study|Death|6|||
144314029|NCT01709110|520352522|FG000|Overall Study|Lost to Follow-up|7|||
144314030|NCT01709110|520352523|FG001|Overall Study|Lost to Follow-up|5|||
144314031|NCT01709110|520352522|FG000|Overall Study|Protocol Violation|4|||
144314032|NCT01709110|520352523|FG001|Overall Study|Protocol Violation|6|||
144314033|NCT01709110|520352522|FG000|Overall Study|Withdrawal by Subject|96|||
144314034|NCT01709110|520352523|FG001|Overall Study|Withdrawal by Subject|89|||
144314035|NCT01709110|520352522|FG000|Overall Study|Physician Decision|4|||
144314036|NCT01709110|520352523|FG001|Overall Study|Physician Decision|10|||
144314037|NCT01709110|520352522|FG000|Overall Study|Sponsor Decision|2|||
144314038|NCT01709110|520352523|FG001|Overall Study|Sponsor Decision|2|||
144314039|NCT01709110|520352522|FG000|Overall Study|Lack of Efficacy|1|||
144314040|NCT01709110|520352523|FG001|Overall Study|Lack of Efficacy|1|||
144314041|NCT01709110|520352522|FG000|Overall Study|Caregiver Decision|1|||
144314042|NCT01709110|520352523|FG001|Overall Study|Caregiver Decision|1|||
144314043|NCT00485758|520352531|FG000|Overall Study|Adverse Event|102|||
144314044|NCT00485758|520352532|FG001|Overall Study|Adverse Event|31|||
144314045|NCT00485758|520352531|FG000|Overall Study|Death|0|||
144314046|NCT00485758|520352532|FG001|Overall Study|Death|1|||
144314047|NCT00485758|520352531|FG000|Overall Study|Lost to Follow-up|5|||
144314048|NCT00485758|520352532|FG001|Overall Study|Lost to Follow-up|1|||
144314049|NCT00485758|520352531|FG000|Overall Study|Physician Decision|3|||
144314050|NCT00485758|520352532|FG001|Overall Study|Physician Decision|3|||
144314051|NCT00485758|520352531|FG000|Overall Study|Protocol Violation|11|||
144314052|NCT00485758|520352532|FG001|Overall Study|Protocol Violation|2|||
144314053|NCT00485758|520352531|FG000|Overall Study|Withdrawal by Subject|32|||
144314054|NCT00485758|520352532|FG001|Overall Study|Withdrawal by Subject|27|||
144314055|NCT00485758|520352531|FG000|Overall Study|Study Terminated by Sponsor|3|||
144314056|NCT00485758|520352532|FG001|Overall Study|Study Terminated by Sponsor|0|||
144314057|NCT04123093|520352533|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
144314058|NCT04123093|520352534|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
144314059|NCT04123093|520352533|FG000|Phase 2|Physician Decision|0|||
144314060|NCT04123093|520352534|FG001|Phase 2|Physician Decision|1|||
144314061|NCT04123093|520352533|FG000|Phase 2|Withdrawal by Subject|0|||
144314062|NCT04123093|520352534|FG001|Phase 2|Withdrawal by Subject|1|||
144314063|NCT03379259|520352535|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
144314064|NCT03379259|520352536|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
144314065|NCT03379259|520352537|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
144314066|NCT03379259|520352538|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
144314067|NCT03379259|520352539|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
144314068|NCT03379259|520352540|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
144314069|NCT03379259|520352535|FG000|Overall Study|Death|0|||
144314070|NCT03379259|520352536|FG001|Overall Study|Death|1|||
144314071|NCT03379259|520352537|FG002|Overall Study|Death|2|||
144314072|NCT03379259|520352538|FG003|Overall Study|Death|1|||
144314073|NCT03379259|520352539|FG004|Overall Study|Death|4|||
144314074|NCT03379259|520352540|FG005|Overall Study|Death|2|||
144314075|NCT03379259|520352535|FG000|Overall Study|Withdrawal by Subject|0|||
144314076|NCT03379259|520352536|FG001|Overall Study|Withdrawal by Subject|0|||
144314077|NCT03379259|520352537|FG002|Overall Study|Withdrawal by Subject|1|||
144314078|NCT03379259|520352538|FG003|Overall Study|Withdrawal by Subject|0|||
144314079|NCT03379259|520352539|FG004|Overall Study|Withdrawal by Subject|2|||
144314080|NCT03379259|520352540|FG005|Overall Study|Withdrawal by Subject|0|||
144314081|NCT03379259|520352535|FG000|Overall Study|Study terminated by sponsor|0|||
144314082|NCT03379259|520352536|FG001|Overall Study|Study terminated by sponsor|0|||
144314083|NCT03379259|520352537|FG002|Overall Study|Study terminated by sponsor|0|||
144314084|NCT03379259|520352538|FG003|Overall Study|Study terminated by sponsor|1|||
144314085|NCT03379259|520352539|FG004|Overall Study|Study terminated by sponsor|1|||
144314086|NCT03379259|520352540|FG005|Overall Study|Study terminated by sponsor|4|||
144314087|NCT03379259|520352535|FG000|Overall Study|Disease progression|0|||
144314088|NCT03379259|520352536|FG001|Overall Study|Disease progression|0|||
144314089|NCT03379259|520352537|FG002|Overall Study|Disease progression|0|||
144314090|NCT03379259|520352538|FG003|Overall Study|Disease progression|1|||
144314091|NCT03379259|520352539|FG004|Overall Study|Disease progression|0|||
144314092|NCT03379259|520352540|FG005|Overall Study|Disease progression|1|||
144314093|NCT03379259|520352535|FG000|Overall Study|Lost to Follow-up|0|||
144314094|NCT03379259|520352536|FG001|Overall Study|Lost to Follow-up|0|||
144314095|NCT03379259|520352537|FG002|Overall Study|Lost to Follow-up|0|||
144314096|NCT03379259|520352538|FG003|Overall Study|Lost to Follow-up|0|||
144314097|NCT03379259|520352539|FG004|Overall Study|Lost to Follow-up|1|||
144314098|NCT03379259|520352540|FG005|Overall Study|Lost to Follow-up|0|||
144314099|NCT03379259|520352535|FG000|Overall Study|Deteriorating condition|0|||
144314100|NCT03379259|520352536|FG001|Overall Study|Deteriorating condition|0|||
144314101|NCT03379259|520352537|FG002|Overall Study|Deteriorating condition|0|||
144314102|NCT03379259|520352538|FG003|Overall Study|Deteriorating condition|0|||
144314103|NCT03379259|520352539|FG004|Overall Study|Deteriorating condition|1|||
144314104|NCT03379259|520352540|FG005|Overall Study|Deteriorating condition|0|||
144314105|NCT00984165|520352541|FG000|Overall Study|Death on study|2|||
144314106|NCT00984165|520352542|FG001|Overall Study|Death on study|0|||
144314107|NCT00984165|520352543|FG002|Overall Study|Death on study|0|||
144314108|NCT00984165|520352544|FG003|Overall Study|Death on study|0|||
144314109|NCT00984165|520352541|FG000|Overall Study|Disease progression on study|5|||
144314110|NCT00984165|520352542|FG001|Overall Study|Disease progression on study|1|||
144314111|NCT00984165|520352543|FG002|Overall Study|Disease progression on study|0|||
144314112|NCT00984165|520352544|FG003|Overall Study|Disease progression on study|0|||
144314113|NCT00984165|520352541|FG000|Overall Study|Death of recipient|0|||
144314114|NCT00984165|520352542|FG001|Overall Study|Death of recipient|0|||
144314115|NCT00984165|520352543|FG002|Overall Study|Death of recipient|0|||
144314116|NCT00984165|520352544|FG003|Overall Study|Death of recipient|1|||
144314117|NCT00984165|520352541|FG000|Overall Study|New protocol|0|||
144314118|NCT00984165|520352542|FG001|Overall Study|New protocol|0|||
144314119|NCT00984165|520352543|FG002|Overall Study|New protocol|0|||
144314120|NCT00984165|520352544|FG003|Overall Study|New protocol|1|||
144314121|NCT00984165|520352541|FG000|Overall Study|P+/donor pair removed from protocol|0|||
144314122|NCT00984165|520352542|FG001|Overall Study|P+/donor pair removed from protocol|0|||
144314123|NCT00984165|520352543|FG002|Overall Study|P+/donor pair removed from protocol|0|||
144314124|NCT00984165|520352544|FG003|Overall Study|P+/donor pair removed from protocol|1|||
144314125|NCT00984165|520352541|FG000|Overall Study|removed with a pair recipient|0|||
144314126|NCT00984165|520352542|FG001|Overall Study|removed with a pair recipient|0|||
144314127|NCT00984165|520352543|FG002|Overall Study|removed with a pair recipient|0|||
144314128|NCT00984165|520352544|FG003|Overall Study|removed with a pair recipient|1|||
144314129|NCT02229825|520352551|FG000|Overall Study|Personal Reasons|0|||
144314130|NCT02229825|520352552|FG001|Overall Study|Personal Reasons|1|||
144314131|NCT02229825|520352551|FG000|Overall Study|Refused continuing medication|7|||
144314132|NCT02229825|520352552|FG001|Overall Study|Refused continuing medication|6|||
144314133|NCT02229825|520352551|FG000|Overall Study|Lost to Follow-up|1|||
144314134|NCT02229825|520352552|FG001|Overall Study|Lost to Follow-up|2|||
144314135|NCT02229825|520352551|FG000|Overall Study|Protocol Violation|1|||
144314136|NCT02229825|520352552|FG001|Overall Study|Protocol Violation|1|||
144314137|NCT02229825|520352551|FG000|Overall Study|Lack of Efficacy|4|||
144314138|NCT02229825|520352552|FG001|Overall Study|Lack of Efficacy|10|||
144314139|NCT02229825|520352551|FG000|Overall Study|Adverse Event|11|||
144314140|NCT02229825|520352552|FG001|Overall Study|Adverse Event|9|||
144314141|NCT02229825|520352551|FG000|Overall Study|Not treated|0|||
144314142|NCT02229825|520352552|FG001|Overall Study|Not treated|1|||
144314143|NCT03520920|520352565|FG000|Overall Study|Death|13|||
144314144|NCT03520920|520352566|FG001|Overall Study|Death|1|||
144314145|NCT03520920|520352567|FG002|Overall Study|Death|0|||
144314146|NCT03520920|520352565|FG000|Overall Study|Withdrawal by Subject|2|||
144314147|NCT03520920|520352566|FG001|Overall Study|Withdrawal by Subject|1|||
144314148|NCT03520920|520352567|FG002|Overall Study|Withdrawal by Subject|0|||
144314149|NCT03520920|520352565|FG000|Overall Study|Study Terminated by the Sponsor|5|||
144314150|NCT03520920|520352566|FG001|Overall Study|Study Terminated by the Sponsor|14|||
144314151|NCT03520920|520352567|FG002|Overall Study|Study Terminated by the Sponsor|5|||
144314152|NCT00405392|520352568|FG000|Overall Study|Adverse Event|15|||
144314153|NCT00405392|520352569|FG001|Overall Study|Adverse Event|14|||
144314154|NCT00405392|520352568|FG000|Overall Study|Did not meet Eligibility criteria|7|||
144314155|NCT00405392|520352569|FG001|Overall Study|Did not meet Eligibility criteria|2|||
144314156|NCT00405392|520352568|FG000|Overall Study|Withdrawal by Subject|4|||
144314157|NCT00405392|520352569|FG001|Overall Study|Withdrawal by Subject|3|||
144314158|NCT00405392|520352568|FG000|Overall Study|Lost to Follow-up|1|||
144314159|NCT00405392|520352569|FG001|Overall Study|Lost to Follow-up|2|||
144314160|NCT00405392|520352568|FG000|Overall Study|Data missing|2|||
144314161|NCT00405392|520352569|FG001|Overall Study|Data missing|0|||
144314162|NCT00405392|520352568|FG000|Overall Study|Non-compliance|0|||
144314163|NCT00405392|520352569|FG001|Overall Study|Non-compliance|1|||
144314164|NCT00405392|520352568|FG000|Overall Study|Other|1|||
144314165|NCT00405392|520352569|FG001|Overall Study|Other|5|||
144314166|NCT05420961|520352572|FG000|Overall Study|Withdrawal by Subject|2|||
144314167|NCT05420961|520352573|FG001|Overall Study|Withdrawal by Subject|1|||
144314168|NCT05420961|520352574|FG002|Overall Study|Withdrawal by Subject|1|||
144314169|NCT05420961|520352575|FG003|Overall Study|Withdrawal by Subject|0|||
144314170|NCT05420961|520352576|FG004|Overall Study|Withdrawal by Subject|0|||
144314171|NCT05420961|520352572|FG000|Overall Study|Lost to Follow-up|0|||
144314172|NCT05420961|520352573|FG001|Overall Study|Lost to Follow-up|0|||
144314173|NCT05420961|520352574|FG002|Overall Study|Lost to Follow-up|1|||
144314174|NCT05420961|520352575|FG003|Overall Study|Lost to Follow-up|0|||
144314175|NCT05420961|520352576|FG004|Overall Study|Lost to Follow-up|0|||
144314176|NCT05420961|520352572|FG000|Overall Study|Randomized by mistake without study treatment|0|||
144314177|NCT05420961|520352573|FG001|Overall Study|Randomized by mistake without study treatment|0|||
144314178|NCT05420961|520352574|FG002|Overall Study|Randomized by mistake without study treatment|1|||
144314179|NCT05420961|520352575|FG003|Overall Study|Randomized by mistake without study treatment|0|||
144314180|NCT05420961|520352576|FG004|Overall Study|Randomized by mistake without study treatment|1|||
144314181|NCT03902392|520352578|FG000|Overall Study|Lost to Follow-up|7|||
144314182|NCT03902392|520352579|FG001|Overall Study|Lost to Follow-up|7|||
144314183|NCT00244725|520352580|FG000|Overall Study|Lost to Follow-up|3|||
144314184|NCT00244725|520352581|FG001|Overall Study|Lost to Follow-up|4|||
144314185|NCT00244725|520352582|FG002|Overall Study|Lost to Follow-up|9|||
144314186|NCT00244725|520352583|FG003|Overall Study|Lost to Follow-up|2|||
144314187|NCT00244725|520352580|FG000|Overall Study|Withdrawal by Subject|9|||
144314188|NCT00244725|520352581|FG001|Overall Study|Withdrawal by Subject|7|||
144314189|NCT00244725|520352582|FG002|Overall Study|Withdrawal by Subject|7|||
144314190|NCT00244725|520352583|FG003|Overall Study|Withdrawal by Subject|8|||
144314191|NCT00244725|520352580|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
144314192|NCT00244725|520352581|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
144314193|NCT00244725|520352582|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
144314194|NCT00244725|520352583|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
144314195|NCT00244725|520352580|FG000|Overall Study|Physician Decision|3|||
144314196|NCT00244725|520352581|FG001|Overall Study|Physician Decision|0|||
144314197|NCT00244725|520352582|FG002|Overall Study|Physician Decision|1|||
144314198|NCT00244725|520352583|FG003|Overall Study|Physician Decision|2|||
144314199|NCT00244725|520352580|FG000|Overall Study|Adverse Events|3|||
144314200|NCT00244725|520352581|FG001|Overall Study|Adverse Events|1|||
144314201|NCT00244725|520352582|FG002|Overall Study|Adverse Events|4|||
144314202|NCT00244725|520352583|FG003|Overall Study|Adverse Events|4|||
144314203|NCT00244725|520352580|FG000|Overall Study|Withdrwal by participant|1|||
144314204|NCT00244725|520352581|FG001|Overall Study|Withdrwal by participant|0|||
144314205|NCT00244725|520352582|FG002|Overall Study|Withdrwal by participant|0|||
144314206|NCT00244725|520352583|FG003|Overall Study|Withdrwal by participant|1|||
144314207|NCT00244725|520352580|FG000|Overall Study|Liver function test abnormality|2|||
144314208|NCT00244725|520352581|FG001|Overall Study|Liver function test abnormality|0|||
144314209|NCT00244725|520352582|FG002|Overall Study|Liver function test abnormality|0|||
144314210|NCT00244725|520352583|FG003|Overall Study|Liver function test abnormality|1|||
144314211|NCT00244725|520352580|FG000|Overall Study|Sponsor withdrew the participant|1|||
144314212|NCT00244725|520352581|FG001|Overall Study|Sponsor withdrew the participant|0|||
144314213|NCT00244725|520352582|FG002|Overall Study|Sponsor withdrew the participant|0|||
144314214|NCT00244725|520352583|FG003|Overall Study|Sponsor withdrew the participant|1|||
144314215|NCT00244725|520352580|FG000|Overall Study|Mediciation Error|0|||
144314216|NCT00244725|520352581|FG001|Overall Study|Mediciation Error|1|||
144314217|NCT00244725|520352582|FG002|Overall Study|Mediciation Error|0|||
144314218|NCT00244725|520352583|FG003|Overall Study|Mediciation Error|0|||
144314219|NCT00244725|520352580|FG000|Overall Study|Rehab Refused to allow participantion|0|||
144314220|NCT00244725|520352581|FG001|Overall Study|Rehab Refused to allow participantion|1|||
144314221|NCT00244725|520352582|FG002|Overall Study|Rehab Refused to allow participantion|0|||
144314222|NCT00244725|520352583|FG003|Overall Study|Rehab Refused to allow participantion|0|||
144314223|NCT00244725|520352580|FG000|Overall Study|Headache|0|||
144314224|NCT00244725|520352581|FG001|Overall Study|Headache|1|||
144314225|NCT00244725|520352582|FG002|Overall Study|Headache|0|||
144314226|NCT00244725|520352583|FG003|Overall Study|Headache|0|||
144314227|NCT00244725|520352580|FG000|Overall Study|Received prohibited medication|0|||
144314228|NCT00244725|520352581|FG001|Overall Study|Received prohibited medication|1|||
144314229|NCT00244725|520352582|FG002|Overall Study|Received prohibited medication|0|||
144314230|NCT00244725|520352583|FG003|Overall Study|Received prohibited medication|1|||
144314231|NCT00244725|520352580|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
144314232|NCT00244725|520352581|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
144314233|NCT00244725|520352582|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
144314234|NCT00244725|520352583|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
144314235|NCT00244725|520352580|FG000|Overall Study|Administrative reason|0|||
144314236|NCT00244725|520352581|FG001|Overall Study|Administrative reason|0|||
144314237|NCT00244725|520352582|FG002|Overall Study|Administrative reason|1|||
144314238|NCT00244725|520352583|FG003|Overall Study|Administrative reason|0|||
144314239|NCT00244725|520352580|FG000|Overall Study|Vomit|0|||
144314240|NCT00244725|520352581|FG001|Overall Study|Vomit|0|||
144314241|NCT00244725|520352582|FG002|Overall Study|Vomit|1|||
144314242|NCT00244725|520352583|FG003|Overall Study|Vomit|0|||
144314243|NCT00244725|520352580|FG000|Overall Study|Failed to follow-up|0|||
144314244|NCT00244725|520352581|FG001|Overall Study|Failed to follow-up|0|||
144314245|NCT00244725|520352582|FG002|Overall Study|Failed to follow-up|1|||
144314246|NCT00244725|520352583|FG003|Overall Study|Failed to follow-up|1|||
144314247|NCT03799952|520352584|FG000|Overall Study|Program was too easy, discontinued|1|||
144314248|NCT03799952|520352585|FG001|Overall Study|Program was too easy, discontinued|0|||
144314249|NCT03799952|520352584|FG000|Overall Study|Lost to Follow-up|0|||
144314250|NCT03799952|520352585|FG001|Overall Study|Lost to Follow-up|2|||
144314251|NCT03248167|520352586|FG000|Overall Study|Withdrawal by Subject|2|||
144314252|NCT03248167|520352587|FG001|Overall Study|Withdrawal by Subject|2|||
144314253|NCT03248167|520352586|FG000|Overall Study|Physician Decision|0|||
144314254|NCT03248167|520352587|FG001|Overall Study|Physician Decision|1|||
144314255|NCT03248167|520352586|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
144314256|NCT03248167|520352587|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
144314257|NCT03248167|520352586|FG000|Overall Study|Lost to Follow-up|1|||
144314258|NCT03248167|520352587|FG001|Overall Study|Lost to Follow-up|0|||
144314259|NCT02122146|520352588|FG000|Part 1: Dose Escalation|Death|0|||
144314260|NCT02122146|520352589|FG001|Part 1: Dose Escalation|Death|1|||
144314261|NCT02122146|520352590|FG002|Part 1: Dose Escalation|Death|1|||
144314262|NCT02122146|520352591|FG003|Part 1: Dose Escalation|Death|0|||
144314263|NCT02122146|520352592|FG004|Part 1: Dose Escalation|Death|0|||
144314264|NCT02122146|520352593|FG005|Part 1: Dose Escalation|Death|0|||
144314265|NCT02122146|520352594|FG006|Part 1: Dose Escalation|Death|0|||
144314266|NCT02122146|520352595|FG007|Part 1: Dose Escalation|Death|0|||
144314267|NCT02122146|520352588|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
144314268|NCT02122146|520352589|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
144314269|NCT02122146|520352590|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
144314270|NCT02122146|520352591|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
144314271|NCT02122146|520352592|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
144314272|NCT02122146|520352593|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
144314273|NCT02122146|520352594|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
144314274|NCT02122146|520352595|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
144314275|NCT02122146|520352588|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314276|NCT02122146|520352589|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314277|NCT02122146|520352590|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314278|NCT02122146|520352591|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
144314279|NCT02122146|520352592|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314280|NCT02122146|520352593|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314281|NCT02122146|520352594|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314282|NCT02122146|520352595|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
144314283|NCT02122146|520352588|FG000|Part 1: Dose Escalation|Other|1|||
144314284|NCT02122146|520352589|FG001|Part 1: Dose Escalation|Other|0|||
144314285|NCT02122146|520352590|FG002|Part 1: Dose Escalation|Other|0|||
144314286|NCT02122146|520352591|FG003|Part 1: Dose Escalation|Other|0|||
144314287|NCT02122146|520352592|FG004|Part 1: Dose Escalation|Other|0|||
144314288|NCT02122146|520352593|FG005|Part 1: Dose Escalation|Other|1|||
144314289|NCT02122146|520352594|FG006|Part 1: Dose Escalation|Other|1|||
144314290|NCT02122146|520352595|FG007|Part 1: Dose Escalation|Other|2|||
144314291|NCT03472495|520352596|FG000|Overall Study|Treatment no longer indicated|1|||
144314292|NCT03472495|520352597|FG001|Overall Study|Treatment no longer indicated|2|||
144314293|NCT03472495|520352596|FG000|Overall Study|Physician Decision|0|||
144314294|NCT03472495|520352597|FG001|Overall Study|Physician Decision|2|||
144314295|NCT02623205|520352601|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
144314296|NCT02623205|520352602|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
144314297|NCT03082677|520352603|FG000|Overall Study|Not Treated|2|||
144314298|NCT01667133|520352604|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
144314299|NCT01667133|520352605|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
144314300|NCT01667133|520352606|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
144314301|NCT01667133|520352607|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
144314302|NCT01667133|520352608|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
144314303|NCT01667133|520352609|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
144314304|NCT01667133|520352610|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
144314305|NCT01667133|520352611|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
144314306|NCT01667133|520352612|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
144314307|NCT01667133|520352613|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
144314308|NCT01667133|520352614|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
144314309|NCT01667133|520352615|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
144314310|NCT01667133|520352604|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314311|NCT01667133|520352605|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314312|NCT01667133|520352606|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
144314313|NCT01667133|520352607|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314314|NCT01667133|520352608|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314315|NCT01667133|520352609|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314316|NCT01667133|520352610|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314317|NCT01667133|520352611|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314318|NCT01667133|520352612|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314319|NCT01667133|520352613|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314320|NCT01667133|520352614|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314321|NCT01667133|520352615|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
144314322|NCT01667133|520352604|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
144314323|NCT01667133|520352605|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
144314324|NCT01667133|520352606|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
144314325|NCT01667133|520352607|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
144314326|NCT01667133|520352608|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
144314327|NCT01667133|520352609|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
144314328|NCT01667133|520352610|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
144314329|NCT01667133|520352611|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
144314330|NCT01667133|520352612|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
144314331|NCT01667133|520352613|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
144314332|NCT01667133|520352614|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
144314333|NCT01667133|520352615|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
144314334|NCT01667133|520352604|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314335|NCT01667133|520352605|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314336|NCT01667133|520352606|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314337|NCT01667133|520352607|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
144314338|NCT01667133|520352608|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314339|NCT01667133|520352609|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314340|NCT01667133|520352610|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314341|NCT01667133|520352611|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314342|NCT01667133|520352612|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314343|NCT01667133|520352613|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314344|NCT01667133|520352614|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314345|NCT01667133|520352615|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
144314346|NCT01667133|520352604|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
144314347|NCT01667133|520352605|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
144314348|NCT01667133|520352606|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
144314349|NCT01667133|520352607|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
144314350|NCT01667133|520352608|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
144314351|NCT01667133|520352609|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
144314352|NCT01667133|520352610|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
144314353|NCT01667133|520352611|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
144314354|NCT01667133|520352612|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
144314355|NCT01667133|520352613|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
144314356|NCT01667133|520352614|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
144314357|NCT01667133|520352615|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
144314358|NCT01667133|520352604|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314359|NCT01667133|520352605|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314360|NCT01667133|520352606|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314361|NCT01667133|520352607|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314362|NCT01667133|520352608|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314363|NCT01667133|520352609|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314364|NCT01667133|520352610|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314365|NCT01667133|520352611|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314366|NCT01667133|520352612|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314367|NCT01667133|520352613|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
144314368|NCT01667133|520352614|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314369|NCT01667133|520352615|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
144314370|NCT01667133|520352604|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
144314371|NCT01667133|520352605|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
144314372|NCT01667133|520352606|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
144314373|NCT01667133|520352607|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
144314374|NCT01667133|520352608|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
144314375|NCT01667133|520352609|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
144314376|NCT01667133|520352610|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
144314377|NCT01667133|520352611|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
144314378|NCT01667133|520352612|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
144314379|NCT01667133|520352613|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
144314380|NCT01667133|520352614|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
144314381|NCT01667133|520352615|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
144314382|NCT01667133|520352604|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314383|NCT01667133|520352605|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314384|NCT01667133|520352606|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314385|NCT01667133|520352607|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314386|NCT01667133|520352608|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314387|NCT01667133|520352609|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314388|NCT01667133|520352610|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314389|NCT01667133|520352611|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314390|NCT01667133|520352612|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314391|NCT01667133|520352613|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
144314392|NCT01667133|520352614|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314393|NCT01667133|520352615|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
144314394|NCT01667133|520352604|FG000|Phase 2: Dose-expansion|Death|0|||
144314395|NCT01667133|520352605|FG001|Phase 2: Dose-expansion|Death|0|||
144314396|NCT01667133|520352606|FG002|Phase 2: Dose-expansion|Death|0|||
144314397|NCT01667133|520352607|FG003|Phase 2: Dose-expansion|Death|0|||
144314398|NCT01667133|520352608|FG004|Phase 2: Dose-expansion|Death|0|||
144314399|NCT01667133|520352609|FG005|Phase 2: Dose-expansion|Death|0|||
144314400|NCT01667133|520352610|FG006|Phase 2: Dose-expansion|Death|0|||
144314401|NCT01667133|520352611|FG007|Phase 2: Dose-expansion|Death|0|||
144314402|NCT01667133|520352612|FG008|Phase 2: Dose-expansion|Death|0|||
144314403|NCT01667133|520352613|FG009|Phase 2: Dose-expansion|Death|1|||
144314404|NCT01667133|520352614|FG010|Phase 2: Dose-expansion|Death|0|||
144314405|NCT01667133|520352615|FG011|Phase 2: Dose-expansion|Death|0|||
144314406|NCT01667133|520352604|FG000|Phase 2: Dose-expansion|Other|0|||
144314407|NCT01667133|520352605|FG001|Phase 2: Dose-expansion|Other|0|||
144314408|NCT01667133|520352606|FG002|Phase 2: Dose-expansion|Other|0|||
144314409|NCT01667133|520352607|FG003|Phase 2: Dose-expansion|Other|0|||
144314410|NCT01667133|520352608|FG004|Phase 2: Dose-expansion|Other|0|||
144314411|NCT01667133|520352609|FG005|Phase 2: Dose-expansion|Other|0|||
144314412|NCT01667133|520352610|FG006|Phase 2: Dose-expansion|Other|0|||
144314413|NCT01667133|520352611|FG007|Phase 2: Dose-expansion|Other|0|||
144314414|NCT01667133|520352612|FG008|Phase 2: Dose-expansion|Other|0|||
144314415|NCT01667133|520352613|FG009|Phase 2: Dose-expansion|Other|0|||
144314416|NCT01667133|520352614|FG010|Phase 2: Dose-expansion|Other|0|||
144314417|NCT01667133|520352615|FG011|Phase 2: Dose-expansion|Other|1|||
144314418|NCT00191945|520352617|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
144314419|NCT00191945|520352618|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
144314420|NCT00191945|520352617|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
144314421|NCT00191945|520352618|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
144314422|NCT00191945|520352617|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
144314423|NCT00191945|520352618|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
144314424|NCT00191945|520352617|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
144314425|NCT00191945|520352618|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
144314426|NCT03711370|520352619|FG000|Overall Study|Lost to Follow-up|16|||
144314427|NCT03711370|520352620|FG001|Overall Study|Lost to Follow-up|10|||
144314428|NCT03711370|520352619|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
144314429|NCT03711370|520352620|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
144314430|NCT01169701|520352623|FG000|Overall Study|Lost to Follow-up|1|||
144314431|NCT01169701|520352624|FG001|Overall Study|Lost to Follow-up|1|||
144314432|NCT01169701|520352623|FG000|Overall Study|Withdrawal by Subject|1|||
144314433|NCT01169701|520352624|FG001|Overall Study|Withdrawal by Subject|3|||
144314434|NCT01169701|520352623|FG000|Overall Study|Adverse Event|1|||
144314435|NCT01169701|520352624|FG001|Overall Study|Adverse Event|2|||
144314436|NCT01169701|520352623|FG000|Overall Study|Exclusion criteria|2|||
144314437|NCT01169701|520352624|FG001|Overall Study|Exclusion criteria|0|||
144314438|NCT01169701|520352623|FG000|Overall Study|Death|0|||
144314439|NCT01169701|520352624|FG001|Overall Study|Death|1|||
144314440|NCT01169701|520352623|FG000|Overall Study|Administrative problems|0|||
144314441|NCT01169701|520352624|FG001|Overall Study|Administrative problems|1|||
144314442|NCT01169701|520352623|FG000|Overall Study|Serious adverse event|0|||
144314443|NCT01169701|520352624|FG001|Overall Study|Serious adverse event|1|||
144314444|NCT01169701|520352623|FG000|Overall Study|Sponsor decision|0|||
144314445|NCT01169701|520352624|FG001|Overall Study|Sponsor decision|1|||
144314446|NCT01536561|520352625|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
144314447|NCT01536561|520352625|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
144314448|NCT01536561|520352625|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
144314449|NCT01536561|520352625|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
144314450|NCT01536561|520352625|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
144314451|NCT01536561|520352625|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
144314452|NCT00553436|520352626|FG000|Overall Study|Conversion to another procedure|1|||
144314453|NCT04188834|520352627|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
144314454|NCT01030952|520352628|FG000|Overall Study|Protocol Violation|0|||
144314455|NCT01030952|520352629|FG001|Overall Study|Protocol Violation|1|||
144314456|NCT01030952|520352628|FG000|Overall Study|Informed consent withdrawal|1|||
144314457|NCT01030952|520352629|FG001|Overall Study|Informed consent withdrawal|0|||
144314458|NCT01030952|520352628|FG000|Overall Study|Lost to Follow-up|0|||
144314459|NCT01030952|520352629|FG001|Overall Study|Lost to Follow-up|1|||
144314460|NCT01030952|520352628|FG000|Overall Study|Unexplained|1|||
144314461|NCT01030952|520352629|FG001|Overall Study|Unexplained|1|||
144314462|NCT02455336|520352632|FG000|Overall Study|Withdrawal by Subject|0|||
144314463|NCT02455336|520352633|FG001|Overall Study|Withdrawal by Subject|2|||
144314464|NCT02455336|520352632|FG000|Overall Study|Adverse Event|3|||
144314465|NCT02455336|520352633|FG001|Overall Study|Adverse Event|0|||
144314466|NCT02455336|520352632|FG000|Overall Study|Non-responder to treatment|2|||
144314467|NCT02455336|520352633|FG001|Overall Study|Non-responder to treatment|0|||
144314468|NCT04532294|520352634|FG000|Overall Study|Withdrawal by Subject|0|||
144314469|NCT04532294|520352635|FG001|Overall Study|Withdrawal by Subject|0|||
144314470|NCT04532294|520352636|FG002|Overall Study|Withdrawal by Subject|1|||
144314471|NCT04532294|520352634|FG000|Overall Study|Participants Not Dosed|0|||
144314472|NCT04532294|520352635|FG001|Overall Study|Participants Not Dosed|0|||
144314473|NCT04532294|520352636|FG002|Overall Study|Participants Not Dosed|2|||
144314474|NCT03497039|520352637|FG000|Overall Study|Withdrawal by Subject|1|||
144314475|NCT03497039|520352638|FG001|Overall Study|Withdrawal by Subject|0|||
144314476|NCT03497039|520352637|FG000|Overall Study|Protocol Violation|0|||
144314477|NCT03497039|520352638|FG001|Overall Study|Protocol Violation|1|||
144314478|NCT01451749|520352642|FG000|Overall Study|Protocol Violation|14|||
144314479|NCT01451749|520352643|FG001|Overall Study|Protocol Violation|7|||
144314480|NCT01451749|520352642|FG000|Overall Study|Lost to Follow-up|15|||
144314481|NCT01451749|520352643|FG001|Overall Study|Lost to Follow-up|5|||
144314482|NCT01451749|520352642|FG000|Overall Study|Meet the exclusion criteria,and|1|||
144314483|NCT01451749|520352643|FG001|Overall Study|Meet the exclusion criteria,and|1|||
144314484|NCT01451749|520352642|FG000|Overall Study|Adverse Event|2|||
144314485|NCT01451749|520352643|FG001|Overall Study|Adverse Event|0|||
144314486|NCT01451749|520352642|FG000|Overall Study|Withdrawal by Subject|0|||
144314487|NCT01451749|520352643|FG001|Overall Study|Withdrawal by Subject|1|||
144314488|NCT02311881|520352646|FG000|Overall Study|Did not meet the study criteria|2|||
144314489|NCT02311881|520352647|FG001|Overall Study|Did not meet the study criteria|2|||
144314490|NCT02311881|520352648|FG002|Overall Study|Did not meet the study criteria|0|||
144314491|NCT02311881|520352646|FG000|Overall Study|Adverse Event|7|||
144314492|NCT02311881|520352647|FG001|Overall Study|Adverse Event|15|||
144314493|NCT02311881|520352648|FG002|Overall Study|Adverse Event|8|||
144314494|NCT02311881|520352646|FG000|Overall Study|Lost to Follow-up|3|||
144314495|NCT02311881|520352647|FG001|Overall Study|Lost to Follow-up|3|||
144314496|NCT02311881|520352648|FG002|Overall Study|Lost to Follow-up|2|||
144314497|NCT02311881|520352646|FG000|Overall Study|Protocol Violation|1|||
144314498|NCT02311881|520352647|FG001|Overall Study|Protocol Violation|2|||
144314499|NCT02311881|520352648|FG002|Overall Study|Protocol Violation|3|||
144314500|NCT02311881|520352646|FG000|Overall Study|Withdrawal of consent|14|||
144314501|NCT02311881|520352647|FG001|Overall Study|Withdrawal of consent|16|||
144314502|NCT02311881|520352648|FG002|Overall Study|Withdrawal of consent|17|||
144314503|NCT02311881|520352646|FG000|Overall Study|Other|0|||
144314504|NCT02311881|520352647|FG001|Overall Study|Other|0|||
144314505|NCT02311881|520352648|FG002|Overall Study|Other|1|||
144314506|NCT02311881|520352646|FG000|Overall Study|Lack of Efficacy|1|||
144314507|NCT02311881|520352647|FG001|Overall Study|Lack of Efficacy|2|||
144314508|NCT02311881|520352648|FG002|Overall Study|Lack of Efficacy|0|||
144314509|NCT02311881|520352646|FG000|Overall Study|Subject has border line pregnancy test|1|||
144314510|NCT02311881|520352647|FG001|Overall Study|Subject has border line pregnancy test|0|||
144314511|NCT02311881|520352648|FG002|Overall Study|Subject has border line pregnancy test|0|||
144314512|NCT02311881|520352646|FG000|Overall Study|Withdrawal by Subject|3|||
144314513|NCT02311881|520352647|FG001|Overall Study|Withdrawal by Subject|1|||
144314514|NCT02311881|520352648|FG002|Overall Study|Withdrawal by Subject|4|||
144314515|NCT02311881|520352646|FG000|Overall Study|Sponsor Decision|1|||
144314516|NCT02311881|520352647|FG001|Overall Study|Sponsor Decision|1|||
144314517|NCT02311881|520352648|FG002|Overall Study|Sponsor Decision|1|||
144314518|NCT02311881|520352646|FG000|Overall Study|Protocol Deviation|1|||
144314519|NCT02311881|520352647|FG001|Overall Study|Protocol Deviation|0|||
144314520|NCT02311881|520352648|FG002|Overall Study|Protocol Deviation|0|||
144314521|NCT02311881|520352646|FG000|Overall Study|Non-Compliance|1|||
144314522|NCT02311881|520352647|FG001|Overall Study|Non-Compliance|0|||
144314523|NCT02311881|520352648|FG002|Overall Study|Non-Compliance|2|||
144314524|NCT02311881|520352646|FG000|Overall Study|Physician Decision|0|||
144314525|NCT02311881|520352647|FG001|Overall Study|Physician Decision|0|||
144314526|NCT02311881|520352648|FG002|Overall Study|Physician Decision|1|||
144314527|NCT02311881|520352646|FG000|Overall Study|Medical Monitor Discretion|0|||
144314528|NCT02311881|520352647|FG001|Overall Study|Medical Monitor Discretion|0|||
144314529|NCT02311881|520352648|FG002|Overall Study|Medical Monitor Discretion|1|||
144314530|NCT02311881|520352646|FG000|Overall Study|Participant taking another medication|0|||
144314531|NCT02311881|520352647|FG001|Overall Study|Participant taking another medication|0|||
144314532|NCT02311881|520352648|FG002|Overall Study|Participant taking another medication|1|||
144314533|NCT02311881|520352646|FG000|Overall Study|Serious Adverse Event|0|||
144314534|NCT02311881|520352647|FG001|Overall Study|Serious Adverse Event|1|||
144314535|NCT02311881|520352648|FG002|Overall Study|Serious Adverse Event|0|||
144314536|NCT00790582|520352653|FG000|Overall Study|Death|14|||
144314537|NCT00790582|520352654|FG001|Overall Study|Death|32|||
144314538|NCT00790582|520352653|FG000|Overall Study|Physician Decision|7|||
144314539|NCT00790582|520352654|FG001|Overall Study|Physician Decision|1|||
144314540|NCT00790582|520352653|FG000|Overall Study|Lost to Follow-up|3|||
144314541|NCT00790582|520352654|FG001|Overall Study|Lost to Follow-up|3|||
144314542|NCT00790582|520352653|FG000|Overall Study|Withdrawal by Subject|7|||
144314543|NCT00790582|520352654|FG001|Overall Study|Withdrawal by Subject|51|||
144314544|NCT01597908|520352657|FG000|Randomized Phase|Death|217|||
144314545|NCT01597908|520352658|FG001|Randomized Phase|Death|238|||
144314546|NCT01597908|520352659|FG002|Randomized Phase|Death|0|||
144314547|NCT01597908|520352657|FG000|Randomized Phase|Sponsor Decision|93|||
144314548|NCT01597908|520352658|FG001|Randomized Phase|Sponsor Decision|39|||
144314549|NCT01597908|520352659|FG002|Randomized Phase|Sponsor Decision|0|||
144314550|NCT01597908|520352657|FG000|Randomized Phase|Lost to Follow-up|9|||
144314551|NCT01597908|520352658|FG001|Randomized Phase|Lost to Follow-up|16|||
144314552|NCT01597908|520352659|FG002|Randomized Phase|Lost to Follow-up|0|||
144314553|NCT01597908|520352657|FG000|Randomized Phase|Physician Decision|6|||
144314554|NCT01597908|520352658|FG001|Randomized Phase|Physician Decision|3|||
144314555|NCT01597908|520352659|FG002|Randomized Phase|Physician Decision|0|||
144314556|NCT01597908|520352657|FG000|Randomized Phase|Withdrawal by Subject|26|||
144314557|NCT01597908|520352658|FG001|Randomized Phase|Withdrawal by Subject|22|||
144314558|NCT01597908|520352659|FG002|Randomized Phase|Withdrawal by Subject|0|||
144314559|NCT01597908|520352657|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
144314560|NCT01597908|520352658|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
144314561|NCT01597908|520352659|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
144314562|NCT01597908|520352657|FG000|Crossover Phase|Death|0|||
144314563|NCT01597908|520352658|FG001|Crossover Phase|Death|0|||
144314564|NCT01597908|520352659|FG002|Crossover Phase|Death|11|||
144314565|NCT01597908|520352657|FG000|Crossover Phase|Withdrawal by Subject|0|||
144314566|NCT01597908|520352658|FG001|Crossover Phase|Withdrawal by Subject|0|||
144314567|NCT01597908|520352659|FG002|Crossover Phase|Withdrawal by Subject|3|||
144314568|NCT01597908|520352657|FG000|Crossover Phase|Sponsor Decision|0|||
144314569|NCT01597908|520352658|FG001|Crossover Phase|Sponsor Decision|0|||
144314570|NCT01597908|520352659|FG002|Crossover Phase|Sponsor Decision|20|||
144314571|NCT02949024|520352660|FG000|Overall Study|Withdrawal by Subject|0|||
144314572|NCT02949024|520352661|FG001|Overall Study|Withdrawal by Subject|1|||
144314573|NCT01027650|520352662|FG000|Overall Study|Personal Reasons|0|||
144314574|NCT01027650|520352663|FG001|Overall Study|Personal Reasons|0|||
144314575|NCT01027650|520352664|FG002|Overall Study|Personal Reasons|0|||
144314576|NCT01027650|520352665|FG003|Overall Study|Personal Reasons|0|||
144314577|NCT01027650|520352666|FG004|Overall Study|Personal Reasons|2|||
144314578|NCT01027650|520352667|FG005|Overall Study|Personal Reasons|1|||
144314579|NCT01027650|520352668|FG006|Overall Study|Personal Reasons|0|||
144314580|NCT01027650|520352669|FG007|Overall Study|Personal Reasons|0|||
144314581|NCT01027650|520352662|FG000|Overall Study|Lost to Follow-up|0|||
144314582|NCT01027650|520352663|FG001|Overall Study|Lost to Follow-up|0|||
144314583|NCT01027650|520352664|FG002|Overall Study|Lost to Follow-up|0|||
144314584|NCT01027650|520352665|FG003|Overall Study|Lost to Follow-up|0|||
144314585|NCT01027650|520352666|FG004|Overall Study|Lost to Follow-up|0|||
144314586|NCT01027650|520352667|FG005|Overall Study|Lost to Follow-up|0|||
144314587|NCT01027650|520352668|FG006|Overall Study|Lost to Follow-up|1|||
144314588|NCT01027650|520352669|FG007|Overall Study|Lost to Follow-up|0|||
144314589|NCT01027650|520352662|FG000|Overall Study|Lack of Efficacy|0|||
144314590|NCT01027650|520352663|FG001|Overall Study|Lack of Efficacy|0|||
144314591|NCT01027650|520352664|FG002|Overall Study|Lack of Efficacy|0|||
144314592|NCT01027650|520352665|FG003|Overall Study|Lack of Efficacy|0|||
144314593|NCT01027650|520352666|FG004|Overall Study|Lack of Efficacy|0|||
144314594|NCT01027650|520352667|FG005|Overall Study|Lack of Efficacy|1|||
144314595|NCT01027650|520352668|FG006|Overall Study|Lack of Efficacy|0|||
144314596|NCT01027650|520352669|FG007|Overall Study|Lack of Efficacy|0|||
144314597|NCT05360966|520354179|FG000|Overall Study|Adverse Event|5|||
144314598|NCT05360966|520354180|FG001|Overall Study|Adverse Event|5|||
144314599|NCT05360966|520354179|FG000|Overall Study|Withdrawal of Consent|5|||
144314600|NCT05360966|520354180|FG001|Overall Study|Withdrawal of Consent|3|||
144314601|NCT05360966|520354179|FG000|Overall Study|Noncompliance|2|||
144314602|NCT05360966|520354180|FG001|Overall Study|Noncompliance|1|||
144314603|NCT05360966|520354179|FG000|Overall Study|Lost to Follow-up|2|||
144314604|NCT05360966|520354180|FG001|Overall Study|Lost to Follow-up|3|||
144314605|NCT05360966|520354179|FG000|Overall Study|Protocol Deviation|2|||
144314606|NCT05360966|520354180|FG001|Overall Study|Protocol Deviation|1|||
144314607|NCT05360966|520354179|FG000|Overall Study|As specified in the Clinical Study Report|1|||
144314608|NCT05360966|520354180|FG001|Overall Study|As specified in the Clinical Study Report|3|||
144314609|NCT05258890|520354182|FG000|Overall Study|Patient withdrawal|6|||
144314610|NCT05258890|520354183|FG001|Overall Study|Patient withdrawal|7|||
144314611|NCT05258890|520354182|FG000|Overall Study|Patient lost to follow-up|10|||
144314612|NCT05258890|520354183|FG001|Overall Study|Patient lost to follow-up|3|||
144314613|NCT05258890|520354182|FG000|Overall Study|Social network member withdrawal|1|||
144314614|NCT05258890|520354183|FG001|Overall Study|Social network member withdrawal|0|||
144314615|NCT05258890|520354182|FG000|Overall Study|Social network member lost to follow-up|5|||
144314616|NCT05258890|520354183|FG001|Overall Study|Social network member lost to follow-up|0|||
144314617|NCT00854724|520354184|FG000|First Intervention|Withdrawal by Subject|1|||
144314618|NCT00854724|520354185|FG001|First Intervention|Withdrawal by Subject|1|||
144314619|NCT00854724|520354184|FG000|Washout|Protocol Violation|1|||
144314620|NCT00854724|520354185|FG001|Washout|Protocol Violation|0|||
144314621|NCT00854724|520354184|FG000|Washout|Withdrawal by Subject|0|||
144314622|NCT00854724|520354185|FG001|Washout|Withdrawal by Subject|1|||
144314623|NCT00854724|520354184|FG000|Second Intervention|Protocol Violation|1|||
144314624|NCT00854724|520354185|FG001|Second Intervention|Protocol Violation|0|||
144314625|NCT00854724|520354184|FG000|Second Intervention|Physician Decision|0|||
144314626|NCT00854724|520354185|FG001|Second Intervention|Physician Decision|1|||
144314627|NCT01498692|520354192|FG000|Overall Study|Death|4|||
144314628|NCT01498692|520354192|FG000|Overall Study|Withdrawal by Subject|1|||
144314629|NCT01498692|520354192|FG000|Overall Study|Missed 12-month visit|3|||
144314630|NCT04729972|520354193|FG000|Overall Study|Adverse Event|1|||
144314631|NCT00590122|520354194|FG000|Overall Study|swallowed oral dissolving dose|1|||
144314632|NCT00590122|520354195|FG001|Overall Study|swallowed oral dissolving dose|0|||
144314633|NCT01208324|520354196|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
144314634|NCT01208324|520354197|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
144314635|NCT01208324|520354198|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
144314636|NCT01208324|520354199|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
144314637|NCT01701362|520354200|FG000|Overall Study|Adverse events not related to study drug|1|||
144314638|NCT01701362|520354201|FG001|Overall Study|Adverse events not related to study drug|6|||
144314639|NCT01701362|520354200|FG000|Overall Study|Adverse events related to study drug|12|||
144314640|NCT01701362|520354201|FG001|Overall Study|Adverse events related to study drug|10|||
144314641|NCT01701362|520354200|FG000|Overall Study|Protocol Violation|5|||
144314642|NCT01701362|520354201|FG001|Overall Study|Protocol Violation|3|||
144314643|NCT01701362|520354200|FG000|Overall Study|No longer willing to participate|8|||
144314644|NCT01701362|520354201|FG001|Overall Study|No longer willing to participate|14|||
144314645|NCT01701362|520354200|FG000|Overall Study|Lost to Follow-up|6|||
144314646|NCT01701362|520354201|FG001|Overall Study|Lost to Follow-up|9|||
144314647|NCT01701362|520354200|FG000|Overall Study|Insufficient clinical response|6|||
144314648|NCT01701362|520354201|FG001|Overall Study|Insufficient clinical response|6|||
144314649|NCT01701362|520354200|FG000|Overall Study|Death|0|||
144314650|NCT01701362|520354201|FG001|Overall Study|Death|1|||
144314651|NCT01701362|520354200|FG000|Overall Study|Randomized but not treated|1|||
144314652|NCT01701362|520354201|FG001|Overall Study|Randomized but not treated|2|||
144314653|NCT01701362|520354200|FG000|Overall Study|Reasons other than those mentioned above|3|||
144314654|NCT01701362|520354201|FG001|Overall Study|Reasons other than those mentioned above|5|||
144314655|NCT00249808|520354204|FG000|Overall Study|Other|27|||
144314656|NCT00249808|520354204|FG000|Overall Study|Protocol Violation|3|||
144314657|NCT00249808|520354204|FG000|Overall Study|Lost to Follow-up|8|||
144314658|NCT00249808|520354204|FG000|Overall Study|Adverse Event|81|||
144314659|NCT00249808|520354204|FG000|Overall Study|Lack of Efficacy|52|||
144314660|NCT00249808|520354204|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
144314661|NCT00443872|520354205|FG000|Overall Study|Protocol Violation|7|||
144314662|NCT00443872|520354205|FG000|Overall Study|Lost to Follow-up|2|||
144314663|NCT00443872|520354205|FG000|Overall Study|Adverse Event|8|||
144314664|NCT02789345|520354206|FG000|Overall Study|Adverse Event|0|||
144314665|NCT02789345|520354207|FG001|Overall Study|Adverse Event|0|||
144314666|NCT02789345|520354208|FG002|Overall Study|Adverse Event|1|||
144314667|NCT02789345|520354206|FG000|Overall Study|Death|0|||
144314668|NCT02789345|520354207|FG001|Overall Study|Death|0|||
144314669|NCT02789345|520354208|FG002|Overall Study|Death|1|||
144314670|NCT02789345|520354206|FG000|Overall Study|Physician Decision|2|||
144314671|NCT02789345|520354207|FG001|Overall Study|Physician Decision|0|||
144314672|NCT02789345|520354208|FG002|Overall Study|Physician Decision|1|||
144314673|NCT02789345|520354206|FG000|Overall Study|Progressive Disease|1|||
144314674|NCT02789345|520354207|FG001|Overall Study|Progressive Disease|3|||
144314675|NCT02789345|520354208|FG002|Overall Study|Progressive Disease|14|||
144314676|NCT04551963|520354219|FG000|Overall Study|Physician Decision|1|||
144314677|NCT04551963|520354220|FG001|Overall Study|Physician Decision|1|||
144314678|NCT04551963|520354219|FG000|Overall Study|Death|1|||
144314679|NCT04551963|520354220|FG001|Overall Study|Death|0|||
144314680|NCT00700622|520354222|FG000|Overall Study|Adverse Event|4|||
144314681|NCT00700622|520354223|FG001|Overall Study|Adverse Event|0|||
144314682|NCT00700622|520354222|FG000|Overall Study|Lost to Follow-up|0|||
144314683|NCT00700622|520354223|FG001|Overall Study|Lost to Follow-up|1|||
144314684|NCT00700622|520354222|FG000|Overall Study|Physician Decision|2|||
144314685|NCT00700622|520354223|FG001|Overall Study|Physician Decision|1|||
144314686|NCT00700622|520354222|FG000|Overall Study|Protocol Violation|0|||
144314687|NCT00700622|520354223|FG001|Overall Study|Protocol Violation|1|||
144314688|NCT00700622|520354222|FG000|Overall Study|Withdrawal by Subject|4|||
144314689|NCT00700622|520354223|FG001|Overall Study|Withdrawal by Subject|1|||
144314690|NCT00700622|520354222|FG000|Overall Study|Other|3|||
144314691|NCT00700622|520354223|FG001|Overall Study|Other|1|||
144314692|NCT00383331|520354224|FG000|Overall Study|Protocol Violation|0|||
144314693|NCT00383331|520354225|FG001|Overall Study|Protocol Violation|1|||
144314694|NCT02253433|520354226|FG000|Overall Study|Unable to Contact|9|||
144314695|NCT02253433|520354227|FG001|Overall Study|Unable to Contact|16|||
144314696|NCT02253433|520354226|FG000|Overall Study|Death|1|||
144314697|NCT02253433|520354227|FG001|Overall Study|Death|1|||
144314698|NCT02253433|520354226|FG000|Overall Study|No Longer Interested|3|||
144314699|NCT02253433|520354227|FG001|Overall Study|No Longer Interested|15|||
144314700|NCT02253433|520354226|FG000|Overall Study|Out of Study Area|2|||
144314701|NCT02253433|520354227|FG001|Overall Study|Out of Study Area|7|||
144314702|NCT02253433|520354226|FG000|Overall Study|Uncomfortable with home visitors|0|||
144314703|NCT02253433|520354227|FG001|Overall Study|Uncomfortable with home visitors|3|||
144314704|NCT02253433|520354226|FG000|Overall Study|Unstable Housing/Homeless|0|||
144314705|NCT02253433|520354227|FG001|Overall Study|Unstable Housing/Homeless|7|||
144314706|NCT02253433|520354226|FG000|Overall Study|Too Busy|0|||
144314707|NCT02253433|520354227|FG001|Overall Study|Too Busy|4|||
144314708|NCT02253433|520354226|FG000|Overall Study|Medical or Other Concerns|1|||
144314709|NCT02253433|520354227|FG001|Overall Study|Medical or Other Concerns|2|||
144314710|NCT03850093|520354231|FG000|Overall Study|Withdrawal by Subject|1|||
144314711|NCT03850093|520354232|FG001|Overall Study|Withdrawal by Subject|0|||
144314712|NCT03850093|520354233|FG002|Overall Study|Withdrawal by Subject|2|||
144314713|NCT02836717|520354237|FG000|Test Phase|Lack of Efficacy|14|||
144314714|NCT02836717|520354238|FG001|Test Phase|Lack of Efficacy|8|||
144314715|NCT02836717|520354239|FG002|Test Phase|Lack of Efficacy|0|||
144314716|NCT02836717|520354237|FG000|Study Phase|Adverse Event|2|||
144314717|NCT02836717|520354238|FG001|Study Phase|Adverse Event|0|||
144314718|NCT02836717|520354239|FG002|Study Phase|Adverse Event|0|||
144314719|NCT02836717|520354237|FG000|Study Phase|Lack of Efficacy|8|||
144314720|NCT02836717|520354238|FG001|Study Phase|Lack of Efficacy|6|||
144314721|NCT02836717|520354239|FG002|Study Phase|Lack of Efficacy|1|||
144314722|NCT02836717|520354237|FG000|Study Phase|Withdrawal by Subject|1|||
144314723|NCT02836717|520354238|FG001|Study Phase|Withdrawal by Subject|0|||
144314724|NCT02836717|520354239|FG002|Study Phase|Withdrawal by Subject|0|||
144314725|NCT02836717|520354237|FG000|Study Phase|Death|1|||
144314726|NCT02836717|520354238|FG001|Study Phase|Death|0|||
144314727|NCT02836717|520354239|FG002|Study Phase|Death|0|||
144314728|NCT02836717|520354237|FG000|Study Phase|abdominal surgeries|2|||
144314729|NCT02836717|520354238|FG001|Study Phase|abdominal surgeries|1|||
144314730|NCT02836717|520354239|FG002|Study Phase|abdominal surgeries|0|||
144314731|NCT01309997|520354241|FG000|Overall Study|Adverse Event|1|||
144314732|NCT01309997|520354242|FG001|Overall Study|Adverse Event|0|||
144314733|NCT01309997|520354241|FG000|Overall Study|Death|1|||
144314734|NCT01309997|520354242|FG001|Overall Study|Death|3|||
144314735|NCT01309997|520354241|FG000|Overall Study|Lack of Efficacy|2|||
144314736|NCT01309997|520354242|FG001|Overall Study|Lack of Efficacy|2|||
144314737|NCT01309997|520354241|FG000|Overall Study|Withdrawal by Subject|1|||
144314738|NCT01309997|520354242|FG001|Overall Study|Withdrawal by Subject|1|||
144314739|NCT00282087|520354243|FG000|Overall Study|Death|1|||
144314740|NCT03226249|520354244|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
144314741|NCT03226249|520354244|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
144314742|NCT03226249|520354244|FG000|Survival Follow-up|Patients still in follow-up.|30|||
144314743|NCT01532921|520354245|FG000|Overall Study|Death|3|||
144314744|NCT01532921|520354245|FG000|Overall Study|Withdrawal by Subject|2|||
144314745|NCT01532921|520354245|FG000|Overall Study|Lost to Follow-up|3|||
144314746|NCT01532921|520354245|FG000|Overall Study|Physician Decision|7|||
144314747|NCT01532921|520354245|FG000|Overall Study|Device was explanted during procedure|1|||
144314748|NCT03462641|520354246|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
144314749|NCT03462641|520354247|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
144314750|NCT03462641|520354246|FG000|Visit 2|Withdrawal by Subject|0|||
144314751|NCT03462641|520354247|FG001|Visit 2|Withdrawal by Subject|1|||
144314752|NCT01804049|520354248|FG000|Overall Study|Adverse Event|2|||
144314753|NCT01804049|520354249|FG001|Overall Study|Adverse Event|10|||
144314754|NCT01804049|520354248|FG000|Overall Study|Lost to Follow-up|2|||
144314755|NCT01804049|520354249|FG001|Overall Study|Lost to Follow-up|1|||
144314756|NCT01804049|520354248|FG000|Overall Study|Decreased interest/personal|4|||
144314757|NCT01804049|520354249|FG001|Overall Study|Decreased interest/personal|5|||
144314758|NCT01804049|520354248|FG000|Overall Study|Other health concerns|2|||
144314759|NCT01804049|520354249|FG001|Overall Study|Other health concerns|7|||
144314760|NCT01804049|520354248|FG000|Overall Study|Moved out of area|0|||
144314761|NCT01804049|520354249|FG001|Overall Study|Moved out of area|7|||
144314762|NCT01804049|520354248|FG000|Overall Study|other MD recommended|1|||
144314763|NCT01804049|520354249|FG001|Overall Study|other MD recommended|1|||
144314764|NCT01804049|520354248|FG000|Overall Study|Enrollment in dual studies|0|||
144314765|NCT01804049|520354249|FG001|Overall Study|Enrollment in dual studies|1|||
144314766|NCT00372619|520354257|FG000|Overall Study|Ineligible|0|||
144314767|NCT00372619|520354258|FG001|Overall Study|Ineligible|0|||
144314768|NCT00372619|520354259|FG002|Overall Study|Ineligible|0|||
144314769|NCT00372619|520354260|FG003|Overall Study|Ineligible|0|||
144314770|NCT00372619|520354261|FG004|Overall Study|Ineligible|0|||
144314771|NCT00372619|520354262|FG005|Overall Study|Ineligible|2|||
144314772|NCT00372619|520354263|FG006|Overall Study|Ineligible|0|||
144314773|NCT00372619|520354257|FG000|Overall Study|Inevaluable|0|||
144314774|NCT00372619|520354258|FG001|Overall Study|Inevaluable|0|||
144314775|NCT00372619|520354259|FG002|Overall Study|Inevaluable|0|||
144314776|NCT00372619|520354260|FG003|Overall Study|Inevaluable|0|||
144314777|NCT00372619|520354261|FG004|Overall Study|Inevaluable|0|||
144314778|NCT00372619|520354262|FG005|Overall Study|Inevaluable|1|||
144314779|NCT00372619|520354263|FG006|Overall Study|Inevaluable|0|||
144314780|NCT00066222|520354264|FG000|Overall Study|No protocol treatment received|1|||
144314781|NCT01703091|520354276|FG000|Overall Study|Adverse Event|5|||
144314782|NCT01703091|520354277|FG001|Overall Study|Adverse Event|3|||
144314783|NCT01703091|520354276|FG000|Overall Study|Physician Decision|2|||
144314784|NCT01703091|520354277|FG001|Overall Study|Physician Decision|1|||
144314785|NCT01703091|520354276|FG000|Overall Study|Withdrawal by Subject|1|||
144314786|NCT01703091|520354277|FG001|Overall Study|Withdrawal by Subject|0|||
144314787|NCT01703091|520354276|FG000|Overall Study|Sponsor Decision|1|||
144314788|NCT01703091|520354277|FG001|Overall Study|Sponsor Decision|0|||
144314789|NCT01107392|520354280|FG000|Overall Study|Adverse Event|2|||
144314790|NCT01107392|520354281|FG001|Overall Study|Adverse Event|0|||
144314791|NCT01107392|520354280|FG000|Overall Study|Personal Reasons|2|||
144314792|NCT01107392|520354281|FG001|Overall Study|Personal Reasons|3|||
144314793|NCT01107392|520354280|FG000|Overall Study|Administrative decision|1|||
144314794|NCT01107392|520354281|FG001|Overall Study|Administrative decision|0|||
144314795|NCT02998671|520354282|FG000|Period 1|Study Terminated By Sponsor|2|||
144314796|NCT02998671|520354283|FG001|Period 1|Study Terminated By Sponsor|1|||
144314797|NCT02998671|520354284|FG002|Period 1|Study Terminated By Sponsor|0|||
144314798|NCT02998671|520354285|FG003|Period 1|Study Terminated By Sponsor|0|||
144314799|NCT02998671|520354286|FG004|Period 1|Study Terminated By Sponsor|1|||
144314800|NCT02998671|520354282|FG000|Period 1|Withdrawal by Subject|1|||
144314801|NCT02998671|520354283|FG001|Period 1|Withdrawal by Subject|2|||
144314802|NCT02998671|520354284|FG002|Period 1|Withdrawal by Subject|0|||
144314803|NCT02998671|520354285|FG003|Period 1|Withdrawal by Subject|0|||
144314804|NCT02998671|520354286|FG004|Period 1|Withdrawal by Subject|2|||
144314805|NCT02998671|520354282|FG000|Period 1|Pregnancy|1|||
144314806|NCT02998671|520354283|FG001|Period 1|Pregnancy|0|||
144314807|NCT02998671|520354284|FG002|Period 1|Pregnancy|0|||
144314808|NCT02998671|520354285|FG003|Period 1|Pregnancy|0|||
144314809|NCT02998671|520354286|FG004|Period 1|Pregnancy|0|||
144314810|NCT02998671|520354282|FG000|Period 1|Adverse Event|0|||
144314811|NCT02998671|520354283|FG001|Period 1|Adverse Event|0|||
144314812|NCT02998671|520354284|FG002|Period 1|Adverse Event|0|||
144314813|NCT02998671|520354285|FG003|Period 1|Adverse Event|0|||
144314814|NCT02998671|520354286|FG004|Period 1|Adverse Event|1|||
144314815|NCT02998671|520354282|FG000|Period 2|Adverse Event|0|||
144314816|NCT02998671|520354283|FG001|Period 2|Adverse Event|1|||
144314817|NCT02998671|520354284|FG002|Period 2|Adverse Event|0|||
144314818|NCT02998671|520354285|FG003|Period 2|Adverse Event|0|||
144314819|NCT02998671|520354286|FG004|Period 2|Adverse Event|0|||
144314820|NCT02998671|520354282|FG000|Period 2|Study Terminated By Sponsor|3|||
144314821|NCT02998671|520354283|FG001|Period 2|Study Terminated By Sponsor|5|||
144314822|NCT02998671|520354284|FG002|Period 2|Study Terminated By Sponsor|1|||
144314823|NCT02998671|520354285|FG003|Period 2|Study Terminated By Sponsor|3|||
144314824|NCT02998671|520354286|FG004|Period 2|Study Terminated By Sponsor|0|||
144314825|NCT02998671|520354282|FG000|Period 2|Withdrawal by Subject|0|||
144314826|NCT02998671|520354283|FG001|Period 2|Withdrawal by Subject|1|||
144314827|NCT02998671|520354284|FG002|Period 2|Withdrawal by Subject|0|||
144314828|NCT02998671|520354285|FG003|Period 2|Withdrawal by Subject|0|||
144314829|NCT02998671|520354286|FG004|Period 2|Withdrawal by Subject|0|||
144314830|NCT02998671|520354282|FG000|Period 2|Lost to Follow-up|0|||
144314831|NCT02998671|520354283|FG001|Period 2|Lost to Follow-up|0|||
144314832|NCT02998671|520354284|FG002|Period 2|Lost to Follow-up|0|||
144314833|NCT02998671|520354285|FG003|Period 2|Lost to Follow-up|1|||
144314834|NCT02998671|520354286|FG004|Period 2|Lost to Follow-up|0|||
144314835|NCT00771927|520354288|FG000|Overall Study|Adverse Event|100|||
144314836|NCT00771927|520354289|FG001|Overall Study|Adverse Event|105|||
144314837|NCT00771927|520354288|FG000|Overall Study|Lack of Efficacy|70|||
144314838|NCT00771927|520354289|FG001|Overall Study|Lack of Efficacy|42|||
144314839|NCT00771927|520354288|FG000|Overall Study|Lost to Follow-up|46|||
144314840|NCT00771927|520354289|FG001|Overall Study|Lost to Follow-up|46|||
144314841|NCT00771927|520354288|FG000|Overall Study|Withdrawal by Subject|16|||
144314842|NCT00771927|520354289|FG001|Overall Study|Withdrawal by Subject|17|||
144314843|NCT00771927|520354288|FG000|Overall Study|Other reason|23|||
144314844|NCT00771927|520354289|FG001|Overall Study|Other reason|27|||
144314845|NCT02063984|520354291|FG000|Overall Study|Lost to Follow-up|6|||
144314846|NCT02063984|520354292|FG001|Overall Study|Lost to Follow-up|5|||
144314847|NCT00958347|520354296|FG000|Overall Study|Death|43|||
144314848|NCT00958347|520354296|FG000|Overall Study|Withdrawal by Subject|23|||
144314849|NCT00958347|520354296|FG000|Overall Study|Lost to Follow-up|15|||
144314850|NCT00958347|520354296|FG000|Overall Study|revision/removal|10|||
144314851|NCT00958347|520354296|FG000|Overall Study|study termination|135|||
144314852|NCT00375505|520354297|FG000|Overall Study|Adverse Event|1|||
144314853|NCT00375505|520354298|FG001|Overall Study|Adverse Event|2|||
144314854|NCT00429182|520354301|FG000|Overall Study|Not evaluable, Disease Progression|2|||
144314855|NCT00429182|520354301|FG000|Overall Study|Not eligible|5|||
144314856|NCT00861692|520354303|FG000|Overall Study|Death|6|||
144314857|NCT03292640|520354304|FG000|Overall Study|Withdrawal by Subject|17|||
144314858|NCT03292640|520354305|FG001|Overall Study|Withdrawal by Subject|16|||
144314859|NCT03292640|520354304|FG000|Overall Study|Adverse Event|20|||
144314860|NCT03292640|520354305|FG001|Overall Study|Adverse Event|2|||
144314861|NCT03292640|520354304|FG000|Overall Study|Lost to Follow-up|24|||
144314862|NCT03292640|520354305|FG001|Overall Study|Lost to Follow-up|24|||
144314863|NCT05111002|520354310|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
144314864|NCT05111002|520354311|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
144314865|NCT05111002|520354310|FG000|Secondary Outcome|Lost to Follow-up|1|||
144314866|NCT05111002|520354311|FG001|Secondary Outcome|Lost to Follow-up|0|||
144314867|NCT04380753|520354312|FG000|Overall Study|Participants continuing study|4|||
144314868|NCT04380753|520354312|FG000|Overall Study|Death|2|||
144314869|NCT04776720|520354317|FG000|Overall Study|COVID Related|4|||
144314870|NCT04776720|520354318|FG001|Overall Study|COVID Related|2|||
144314871|NCT04776720|520354317|FG000|Overall Study|Adverse Event|2|||
144314872|NCT04776720|520354318|FG001|Overall Study|Adverse Event|0|||
144314873|NCT04776720|520354317|FG000|Overall Study|Serious Adverse Event|0|||
144314874|NCT04776720|520354318|FG001|Overall Study|Serious Adverse Event|1|||
144314875|NCT04776720|520354317|FG000|Overall Study|Too Busy|3|||
144314876|NCT04776720|520354318|FG001|Overall Study|Too Busy|1|||
144314877|NCT04776720|520354317|FG000|Overall Study|Lost to Follow-up|1|||
144314878|NCT04776720|520354318|FG001|Overall Study|Lost to Follow-up|2|||
144314879|NCT04776720|520354317|FG000|Overall Study|Family|2|||
144314880|NCT04776720|520354318|FG001|Overall Study|Family|2|||
144314881|NCT04776720|520354317|FG000|Overall Study|No remote technology access|0|||
144314882|NCT04776720|520354318|FG001|Overall Study|No remote technology access|1|||
144314883|NCT04776720|520354317|FG000|Overall Study|Withdrawal by Subject|1|||
144314884|NCT04776720|520354318|FG001|Overall Study|Withdrawal by Subject|0|||
144314885|NCT04776720|520354317|FG000|Overall Study|Cannot tolerate intervention|1|||
144314886|NCT04776720|520354318|FG001|Overall Study|Cannot tolerate intervention|0|||
144314887|NCT04776720|520354317|FG000|Overall Study|Incomplete outcome data|6|||
144314888|NCT04776720|520354318|FG001|Overall Study|Incomplete outcome data|1|||
144314889|NCT02712996|520354320|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
144314890|NCT02712996|520354321|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
144314891|NCT00972517|520354325|FG000|Overall Study|Adverse Event|0|||
144314892|NCT00972517|520354326|FG001|Overall Study|Adverse Event|0|||
144314893|NCT00972517|520354327|FG002|Overall Study|Adverse Event|0|||
144314894|NCT00972517|520354328|FG003|Overall Study|Adverse Event|1|||
144314895|NCT00972517|520354329|FG004|Overall Study|Adverse Event|0|||
144314896|NCT00972517|520354330|FG005|Overall Study|Adverse Event|0|||
144314897|NCT00972517|520354325|FG000|Overall Study|Withdrawal by Subject|0|||
144314898|NCT00972517|520354326|FG001|Overall Study|Withdrawal by Subject|1|||
144314899|NCT00972517|520354327|FG002|Overall Study|Withdrawal by Subject|0|||
144314900|NCT00972517|520354328|FG003|Overall Study|Withdrawal by Subject|2|||
144314901|NCT00972517|520354329|FG004|Overall Study|Withdrawal by Subject|1|||
144314902|NCT00972517|520354330|FG005|Overall Study|Withdrawal by Subject|0|||
144314903|NCT03306433|520354333|FG000|Overall Study|Lost to Follow-up|3|||
144314904|NCT03306433|520354333|FG000|Overall Study|Patient did not have teeth extracted|1|||
144314905|NCT03306433|520354333|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
144314906|NCT00819156|520354334|FG000|Overall Study|Adverse Event|1|||
144314907|NCT00819156|520354335|FG001|Overall Study|Adverse Event|4|||
144314908|NCT00819156|520354336|FG002|Overall Study|Adverse Event|2|||
144314909|NCT00819156|520354337|FG003|Overall Study|Adverse Event|1|||
144314910|NCT00819156|520354338|FG004|Overall Study|Adverse Event|2|||
144314911|NCT00819156|520354339|FG005|Overall Study|Adverse Event|3|||
144314912|NCT00819156|520354334|FG000|Overall Study|Withdrawal by Subject|0|||
144314913|NCT00819156|520354335|FG001|Overall Study|Withdrawal by Subject|3|||
144314914|NCT00819156|520354336|FG002|Overall Study|Withdrawal by Subject|2|||
144314915|NCT00819156|520354337|FG003|Overall Study|Withdrawal by Subject|0|||
144314916|NCT00819156|520354338|FG004|Overall Study|Withdrawal by Subject|1|||
144314917|NCT00819156|520354339|FG005|Overall Study|Withdrawal by Subject|0|||
144314918|NCT00819156|520354334|FG000|Overall Study|Protocol Violation|1|||
144314919|NCT00819156|520354335|FG001|Overall Study|Protocol Violation|0|||
144314920|NCT00819156|520354336|FG002|Overall Study|Protocol Violation|1|||
144314921|NCT00819156|520354337|FG003|Overall Study|Protocol Violation|0|||
144314922|NCT00819156|520354338|FG004|Overall Study|Protocol Violation|0|||
144314923|NCT00819156|520354339|FG005|Overall Study|Protocol Violation|1|||
144314924|NCT00819156|520354334|FG000|Overall Study|Lost to Follow-up|0|||
144314925|NCT00819156|520354335|FG001|Overall Study|Lost to Follow-up|1|||
144314926|NCT00819156|520354336|FG002|Overall Study|Lost to Follow-up|0|||
144314927|NCT00819156|520354337|FG003|Overall Study|Lost to Follow-up|0|||
144314928|NCT00819156|520354338|FG004|Overall Study|Lost to Follow-up|0|||
144314929|NCT00819156|520354339|FG005|Overall Study|Lost to Follow-up|2|||
144314930|NCT00819156|520354334|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
144314931|NCT00819156|520354335|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
144314932|NCT00819156|520354336|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
144314933|NCT00819156|520354337|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
144314934|NCT00819156|520354338|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
144314935|NCT00819156|520354339|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
144314936|NCT00819156|520354334|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
144314937|NCT00819156|520354335|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
144314938|NCT00819156|520354336|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
144314939|NCT00819156|520354337|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
144314940|NCT00819156|520354338|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
144314941|NCT00819156|520354339|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
144314942|NCT00819156|520354334|FG000|Overall Study|Prostate-specific antigen progression|0|||
144314943|NCT00819156|520354335|FG001|Overall Study|Prostate-specific antigen progression|0|||
144314944|NCT00819156|520354336|FG002|Overall Study|Prostate-specific antigen progression|0|||
144314945|NCT00819156|520354337|FG003|Overall Study|Prostate-specific antigen progression|0|||
144314946|NCT00819156|520354338|FG004|Overall Study|Prostate-specific antigen progression|1|||
144314947|NCT00819156|520354339|FG005|Overall Study|Prostate-specific antigen progression|0|||
144314948|NCT02195700|520354340|FG000|Overall Study|Protocol Violation|0|||
144314949|NCT02195700|520354341|FG001|Overall Study|Protocol Violation|2|||
144314950|NCT02195700|520354340|FG000|Overall Study|Noncompliance|1|||
144314951|NCT02195700|520354341|FG001|Overall Study|Noncompliance|0|||
144314952|NCT02195700|520354340|FG000|Overall Study|Adverse Event|1|||
144314953|NCT02195700|520354341|FG001|Overall Study|Adverse Event|2|||
144314954|NCT02195700|520354340|FG000|Overall Study|Withdrawal by Subject|3|||
144314955|NCT02195700|520354341|FG001|Overall Study|Withdrawal by Subject|2|||
144314956|NCT02195700|520354340|FG000|Overall Study|Lost to Follow-up|1|||
144314957|NCT02195700|520354341|FG001|Overall Study|Lost to Follow-up|1|||
144314958|NCT02931838|520354342|FG000|Overall Study|Reason not provided by investigator|1|||
144314959|NCT02931838|520354343|FG001|Overall Study|Reason not provided by investigator|0|||
144314960|NCT02931838|520354344|FG002|Overall Study|Reason not provided by investigator|1|||
144314961|NCT02931838|520354345|FG003|Overall Study|Reason not provided by investigator|0|||
144314962|NCT02931838|520354346|FG004|Overall Study|Reason not provided by investigator|0|||
144314963|NCT02931838|520354347|FG005|Overall Study|Reason not provided by investigator|0|||
144314964|NCT02931838|520354342|FG000|Overall Study|Poor/non-compliance|0|||
144314965|NCT02931838|520354343|FG001|Overall Study|Poor/non-compliance|0|||
144314966|NCT02931838|520354344|FG002|Overall Study|Poor/non-compliance|1|||
144314967|NCT02931838|520354345|FG003|Overall Study|Poor/non-compliance|0|||
144314968|NCT02931838|520354346|FG004|Overall Study|Poor/non-compliance|0|||
144314969|NCT02931838|520354347|FG005|Overall Study|Poor/non-compliance|0|||
144314970|NCT02931838|520354342|FG000|Overall Study|Lack of Efficacy|5|||
144314971|NCT02931838|520354343|FG001|Overall Study|Lack of Efficacy|4|||
144314972|NCT02931838|520354344|FG002|Overall Study|Lack of Efficacy|0|||
144314973|NCT02931838|520354345|FG003|Overall Study|Lack of Efficacy|0|||
144314974|NCT02931838|520354346|FG004|Overall Study|Lack of Efficacy|0|||
144314975|NCT02931838|520354347|FG005|Overall Study|Lack of Efficacy|1|||
144314976|NCT02931838|520354342|FG000|Overall Study|Lost to Follow-up|1|||
144314977|NCT02931838|520354343|FG001|Overall Study|Lost to Follow-up|0|||
144314978|NCT02931838|520354344|FG002|Overall Study|Lost to Follow-up|1|||
144314979|NCT02931838|520354345|FG003|Overall Study|Lost to Follow-up|1|||
144314980|NCT02931838|520354346|FG004|Overall Study|Lost to Follow-up|2|||
144314981|NCT02931838|520354347|FG005|Overall Study|Lost to Follow-up|0|||
144314982|NCT02931838|520354342|FG000|Overall Study|Subject request to discontinue treatment|4|||
144314983|NCT02931838|520354343|FG001|Overall Study|Subject request to discontinue treatment|3|||
144314984|NCT02931838|520354344|FG002|Overall Study|Subject request to discontinue treatment|3|||
144314985|NCT02931838|520354345|FG003|Overall Study|Subject request to discontinue treatment|0|||
144314986|NCT02931838|520354346|FG004|Overall Study|Subject request to discontinue treatment|1|||
144314987|NCT02931838|520354347|FG005|Overall Study|Subject request to discontinue treatment|0|||
144314988|NCT02931838|520354342|FG000|Overall Study|Withdrawal by Subject|1|||
144314989|NCT02931838|520354343|FG001|Overall Study|Withdrawal by Subject|2|||
144314990|NCT02931838|520354344|FG002|Overall Study|Withdrawal by Subject|0|||
144314991|NCT02931838|520354345|FG003|Overall Study|Withdrawal by Subject|1|||
144314992|NCT02931838|520354346|FG004|Overall Study|Withdrawal by Subject|0|||
144314993|NCT02931838|520354347|FG005|Overall Study|Withdrawal by Subject|0|||
144314994|NCT02931838|520354342|FG000|Overall Study|Adverse Event|2|||
144314995|NCT02931838|520354343|FG001|Overall Study|Adverse Event|1|||
144314996|NCT02931838|520354344|FG002|Overall Study|Adverse Event|2|||
144314997|NCT02931838|520354345|FG003|Overall Study|Adverse Event|1|||
144314998|NCT02931838|520354346|FG004|Overall Study|Adverse Event|3|||
144314999|NCT02931838|520354347|FG005|Overall Study|Adverse Event|1|||
144315000|NCT00104728|520354348|FG000|Overall Study|screen failures|19|||
144315001|NCT02709577|520354349|FG000|Overall Study|non-accommodating anatomy|0|||
144315002|NCT02709577|520354350|FG001|Overall Study|non-accommodating anatomy|1|||
144315003|NCT02709577|520354351|FG002|Overall Study|non-accommodating anatomy|0|||
144315004|NCT02709577|520354352|FG003|Overall Study|non-accommodating anatomy|0|||
144315005|NCT02709577|520354349|FG000|Overall Study|procedural complication|0|||
144315006|NCT02709577|520354350|FG001|Overall Study|procedural complication|1|||
144315007|NCT02709577|520354351|FG002|Overall Study|procedural complication|0|||
144315008|NCT02709577|520354352|FG003|Overall Study|procedural complication|0|||
144315009|NCT02709577|520354349|FG000|Overall Study|Withdrawal by Subject|2|||
144315010|NCT02709577|520354350|FG001|Overall Study|Withdrawal by Subject|3|||
144315011|NCT02709577|520354351|FG002|Overall Study|Withdrawal by Subject|2|||
144315012|NCT02709577|520354352|FG003|Overall Study|Withdrawal by Subject|0|||
144315013|NCT00064259|520356012|FG000|Overall Study|Adverse Event|1|||
144315014|NCT00064259|520356013|FG001|Overall Study|Adverse Event|0|||
144315015|NCT00064259|520356014|FG002|Overall Study|Adverse Event|0|||
144315016|NCT00064259|520356015|FG003|Overall Study|Adverse Event|1|||
144315017|NCT01132651|520356018|FG000|Overall Study|Lost to Follow-up|1|||
144315018|NCT01132651|520356019|FG001|Overall Study|Lost to Follow-up|1|||
144315019|NCT00948857|520356020|FG000|Overall Study|Lost to Follow-up|1|||
144315020|NCT00948857|520356021|FG001|Overall Study|Lost to Follow-up|0|||
144315021|NCT03430843|520356022|FG000|Overall Study|Death|233|||
144315022|NCT03430843|520356023|FG001|Overall Study|Death|233|||
144315023|NCT03430843|520356022|FG000|Overall Study|Sponsor Decision|17|||
144315024|NCT03430843|520356023|FG001|Overall Study|Sponsor Decision|6|||
144315025|NCT03430843|520356022|FG000|Overall Study|Withdrawal by Subject|5|||
144315026|NCT03430843|520356023|FG001|Overall Study|Withdrawal by Subject|14|||
144315027|NCT03430843|520356022|FG000|Overall Study|Lost to Follow-up|1|||
144315028|NCT03430843|520356023|FG001|Overall Study|Lost to Follow-up|3|||
144315029|NCT03062280|520356027|FG000|Overall Study|Adverse Event|1|||
144315030|NCT03062280|520356027|FG000|Overall Study|Death|1|||
144315031|NCT03062280|520356027|FG000|Overall Study|Fertility Treatment|2|||
144315032|NCT03062280|520356027|FG000|Overall Study|Physician Decision|2|||
144315033|NCT03062280|520356027|FG000|Overall Study|Pregnancy|5|||
144315034|NCT03062280|520356027|FG000|Overall Study|Withdrawal by Subject|11|||
144315035|NCT05959447|520356028|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
144315036|NCT05959447|520356029|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
144315037|NCT05959447|520356028|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
144315038|NCT05959447|520356029|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
144315039|NCT05959447|520356028|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
144315040|NCT05959447|520356029|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
144315041|NCT05959447|520356028|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
144315042|NCT05959447|520356029|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
144315043|NCT00070109|520356034|FG000|Overall Study|Death|1|||
144315044|NCT00070109|520356035|FG001|Overall Study|Death|1|||
144315045|NCT00070109|520356036|FG002|Overall Study|Death|0|||
144315046|NCT00070109|520356037|FG003|Overall Study|Death|0|||
144315047|NCT00070109|520356038|FG004|Overall Study|Death|1|||
144315048|NCT00070109|520356034|FG000|Overall Study|Lack of Efficacy|6|||
144315049|NCT00070109|520356035|FG001|Overall Study|Lack of Efficacy|4|||
144315050|NCT00070109|520356036|FG002|Overall Study|Lack of Efficacy|5|||
144315051|NCT00070109|520356037|FG003|Overall Study|Lack of Efficacy|15|||
144315052|NCT00070109|520356038|FG004|Overall Study|Lack of Efficacy|5|||
144315053|NCT00070109|520356034|FG000|Overall Study|Physician Decision|1|||
144315054|NCT00070109|520356035|FG001|Overall Study|Physician Decision|0|||
144315055|NCT00070109|520356036|FG002|Overall Study|Physician Decision|0|||
144315056|NCT00070109|520356037|FG003|Overall Study|Physician Decision|0|||
144315057|NCT00070109|520356038|FG004|Overall Study|Physician Decision|0|||
144315058|NCT00070109|520356034|FG000|Overall Study|Withdrawal by Subject|0|||
144315059|NCT00070109|520356035|FG001|Overall Study|Withdrawal by Subject|1|||
144315060|NCT00070109|520356036|FG002|Overall Study|Withdrawal by Subject|1|||
144315061|NCT00070109|520356037|FG003|Overall Study|Withdrawal by Subject|0|||
144315062|NCT00070109|520356038|FG004|Overall Study|Withdrawal by Subject|0|||
144315063|NCT00070109|520356034|FG000|Overall Study|Adverse Event|0|||
144315064|NCT00070109|520356035|FG001|Overall Study|Adverse Event|0|||
144315065|NCT00070109|520356036|FG002|Overall Study|Adverse Event|2|||
144315066|NCT00070109|520356037|FG003|Overall Study|Adverse Event|4|||
144315067|NCT00070109|520356038|FG004|Overall Study|Adverse Event|2|||
144315068|NCT00070109|520356034|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
144315069|NCT00070109|520356035|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
144315070|NCT00070109|520356036|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
144315071|NCT00070109|520356037|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
144315072|NCT00070109|520356038|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
144315073|NCT00588237|520356039|FG000|Overall Study|Evaluable for toxicity only|3|||
144315074|NCT00588237|520356039|FG000|Overall Study|Patien not treated|1|||
144315075|NCT00716482|520356049|FG000|Overall Study|Lost to Follow-up|6|||
144315076|NCT00716482|520356049|FG000|Overall Study|Inadequate acquisition or analysis|50|||
144315077|NCT00716482|520356049|FG000|Overall Study|no pathology obtained|10|||
144315078|NCT00716482|520356049|FG000|Overall Study|technical/machine error|28|||
144315079|NCT00716482|520356049|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
144315080|NCT03248531|520356050|FG000|Overall Study|Adverse Event|0|||
144315081|NCT03248531|520356051|FG001|Overall Study|Adverse Event|0|||
144315082|NCT03248531|520356052|FG002|Overall Study|Adverse Event|1|||
144315083|NCT03248531|520356050|FG000|Overall Study|Lost to Follow-up|1|||
144315084|NCT03248531|520356051|FG001|Overall Study|Lost to Follow-up|0|||
144315085|NCT03248531|520356052|FG002|Overall Study|Lost to Follow-up|5|||
144315086|NCT03248531|520356050|FG000|Overall Study|Withdrawal by Subject|3|||
144315087|NCT03248531|520356051|FG001|Overall Study|Withdrawal by Subject|3|||
144315088|NCT03248531|520356052|FG002|Overall Study|Withdrawal by Subject|2|||
144315089|NCT03248531|520356050|FG000|Overall Study|Sponsor Request|0|||
144315090|NCT03248531|520356051|FG001|Overall Study|Sponsor Request|2|||
144315091|NCT03248531|520356052|FG002|Overall Study|Sponsor Request|0|||
144315092|NCT04075513|520356053|FG000|Overall Study|Withdrawal by Subject|2|||
144315093|NCT04075513|520356054|FG001|Overall Study|Withdrawal by Subject|2|||
144315094|NCT04075513|520356053|FG000|Overall Study|Lack of Efficacy|1|||
144315095|NCT04075513|520356054|FG001|Overall Study|Lack of Efficacy|0|||
144315096|NCT04075513|520356053|FG000|Overall Study|Lost to Follow-up|4|||
144315097|NCT04075513|520356054|FG001|Overall Study|Lost to Follow-up|2|||
144315098|NCT04075513|520356053|FG000|Overall Study|Switch to insulin pump|1|||
144315099|NCT04075513|520356054|FG001|Overall Study|Switch to insulin pump|0|||
144315100|NCT02550288|520356055|FG000|Overall Study|Adverse Event|0|||
144315101|NCT02550288|520356056|FG001|Overall Study|Adverse Event|1|||
144315102|NCT02550288|520356057|FG002|Overall Study|Adverse Event|0|||
144315103|NCT02550288|520356058|FG003|Overall Study|Adverse Event|0|||
144315104|NCT02550288|520356059|FG004|Overall Study|Adverse Event|0|||
144315105|NCT02550288|520356055|FG000|Overall Study|Physician Decision|0|||
144315106|NCT02550288|520356056|FG001|Overall Study|Physician Decision|0|||
144315107|NCT02550288|520356057|FG002|Overall Study|Physician Decision|0|||
144315108|NCT02550288|520356058|FG003|Overall Study|Physician Decision|1|||
144315109|NCT02550288|520356059|FG004|Overall Study|Physician Decision|0|||
144315110|NCT02550288|520356055|FG000|Overall Study|Protocol Violation|2|||
144315111|NCT02550288|520356056|FG001|Overall Study|Protocol Violation|2|||
144315112|NCT02550288|520356057|FG002|Overall Study|Protocol Violation|1|||
144315113|NCT02550288|520356058|FG003|Overall Study|Protocol Violation|0|||
144315114|NCT02550288|520356059|FG004|Overall Study|Protocol Violation|3|||
144315115|NCT02550288|520356055|FG000|Overall Study|Participant moved|0|||
144315116|NCT02550288|520356056|FG001|Overall Study|Participant moved|0|||
144315117|NCT02550288|520356057|FG002|Overall Study|Participant moved|0|||
144315118|NCT02550288|520356058|FG003|Overall Study|Participant moved|1|||
144315119|NCT02550288|520356059|FG004|Overall Study|Participant moved|0|||
144315120|NCT02550288|520356055|FG000|Overall Study|Withdrawal by Subject|0|||
144315121|NCT02550288|520356056|FG001|Overall Study|Withdrawal by Subject|0|||
144315122|NCT02550288|520356057|FG002|Overall Study|Withdrawal by Subject|0|||
144315123|NCT02550288|520356058|FG003|Overall Study|Withdrawal by Subject|1|||
144315124|NCT02550288|520356059|FG004|Overall Study|Withdrawal by Subject|0|||
144315125|NCT01901614|520356061|FG000|Overall Study|Adverse Event|0|||
144315126|NCT01901614|520356062|FG001|Overall Study|Adverse Event|1|||
144315127|NCT01901614|520356061|FG000|Overall Study|Lost to Follow-up|1|||
144315128|NCT01901614|520356062|FG001|Overall Study|Lost to Follow-up|0|||
144315129|NCT01901614|520356061|FG000|Overall Study|Screen Fail|1|||
144315130|NCT01901614|520356062|FG001|Overall Study|Screen Fail|0|||
144315131|NCT02201329|520356063|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
144315132|NCT02201329|520356063|FG000|Overall Study|Withdrawal by Subject|2|||
144315133|NCT03629223|520356064|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
144315134|NCT03629223|520356065|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
144315135|NCT03629223|520356066|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
144315136|NCT03629223|520356067|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
144315137|NCT03629223|520356068|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
144315138|NCT03629223|520356069|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
144315139|NCT03629223|520356064|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
144315140|NCT03629223|520356065|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
144315141|NCT03629223|520356066|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
144315142|NCT03629223|520356067|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
144315143|NCT03629223|520356068|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
144315144|NCT03629223|520356069|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
144315145|NCT03629223|520356064|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
144360024|NCT01601535|520525140|FG005|Phase 2|Adverse Event|1|||
144315146|NCT03629223|520356065|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
144315147|NCT03629223|520356066|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
144315148|NCT03629223|520356067|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
144315149|NCT03629223|520356068|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
144315150|NCT03629223|520356069|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
144315151|NCT03629223|520356064|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
144315152|NCT03629223|520356065|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
144315153|NCT03629223|520356066|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
144315154|NCT03629223|520356067|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
144315155|NCT03629223|520356068|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
144315156|NCT03629223|520356069|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
144315157|NCT03629223|520356064|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
144315158|NCT03629223|520356065|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
144315159|NCT03629223|520356066|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
144315160|NCT03629223|520356067|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
144315161|NCT03629223|520356068|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
144315162|NCT03629223|520356069|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
144315163|NCT01262638|520356070|FG000|Overall Study|Adverse Event|3|||
144315164|NCT01262638|520356071|FG001|Overall Study|Adverse Event|4|||
144315165|NCT01262638|520356072|FG002|Overall Study|Adverse Event|3|||
144315166|NCT01262638|520356073|FG003|Overall Study|Adverse Event|4|||
144315167|NCT01262638|520356070|FG000|Overall Study|Protocol Violation|1|||
144315168|NCT01262638|520356071|FG001|Overall Study|Protocol Violation|0|||
144315169|NCT01262638|520356072|FG002|Overall Study|Protocol Violation|0|||
144315170|NCT01262638|520356073|FG003|Overall Study|Protocol Violation|1|||
144315171|NCT01262638|520356070|FG000|Overall Study|Withdrawal by Subject|2|||
144315172|NCT01262638|520356071|FG001|Overall Study|Withdrawal by Subject|1|||
144315173|NCT01262638|520356072|FG002|Overall Study|Withdrawal by Subject|0|||
144315174|NCT01262638|520356073|FG003|Overall Study|Withdrawal by Subject|1|||
144315175|NCT01262638|520356070|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
144315176|NCT01262638|520356071|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
144315177|NCT01262638|520356072|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
144315178|NCT01262638|520356073|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
144315179|NCT01262638|520356070|FG000|Overall Study|Lost to Follow-up|1|||
144315180|NCT01262638|520356071|FG001|Overall Study|Lost to Follow-up|1|||
144315181|NCT01262638|520356072|FG002|Overall Study|Lost to Follow-up|1|||
144315182|NCT01262638|520356073|FG003|Overall Study|Lost to Follow-up|1|||
144315183|NCT01262638|520356070|FG000|Overall Study|Participant Went Out of Town|0|||
144315184|NCT01262638|520356071|FG001|Overall Study|Participant Went Out of Town|0|||
144315185|NCT01262638|520356072|FG002|Overall Study|Participant Went Out of Town|1|||
144315186|NCT01262638|520356073|FG003|Overall Study|Participant Went Out of Town|0|||
144315187|NCT01369199|520356076|FG000|Overall Study|Withdrawal by Subject|1|||
144315188|NCT01369199|520356076|FG000|Overall Study|Lost to Follow-up|2|||
144315189|NCT01071252|520356077|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
144315190|NCT01071252|520356078|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
144315191|NCT01071252|520356079|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
144315192|NCT01071252|520356080|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
144315193|NCT01071252|520356081|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
144315194|NCT01071252|520356077|FG000|Overall Study|Withdrawal by Subject|8|||
144315195|NCT01071252|520356078|FG001|Overall Study|Withdrawal by Subject|2|||
144315196|NCT01071252|520356079|FG002|Overall Study|Withdrawal by Subject|1|||
144315197|NCT01071252|520356080|FG003|Overall Study|Withdrawal by Subject|2|||
144315198|NCT01071252|520356081|FG004|Overall Study|Withdrawal by Subject|3|||
144315199|NCT01071252|520356077|FG000|Overall Study|administrative problems|1|||
144315200|NCT01071252|520356078|FG001|Overall Study|administrative problems|1|||
144315201|NCT01071252|520356079|FG002|Overall Study|administrative problems|0|||
144315202|NCT01071252|520356080|FG003|Overall Study|administrative problems|2|||
144315203|NCT01071252|520356081|FG004|Overall Study|administrative problems|1|||
144315204|NCT01071252|520356077|FG000|Overall Study|Lost to Follow-up|1|||
144315205|NCT01071252|520356078|FG001|Overall Study|Lost to Follow-up|0|||
144315206|NCT01071252|520356079|FG002|Overall Study|Lost to Follow-up|1|||
144315207|NCT01071252|520356080|FG003|Overall Study|Lost to Follow-up|2|||
144315208|NCT01071252|520356081|FG004|Overall Study|Lost to Follow-up|0|||
144315209|NCT01071252|520356077|FG000|Overall Study|Adverse Event|1|||
144315210|NCT01071252|520356078|FG001|Overall Study|Adverse Event|1|||
144315211|NCT01071252|520356079|FG002|Overall Study|Adverse Event|0|||
144315212|NCT01071252|520356080|FG003|Overall Study|Adverse Event|1|||
144315213|NCT01071252|520356081|FG004|Overall Study|Adverse Event|0|||
144315214|NCT01071252|520356077|FG000|Overall Study|Death|0|||
144315215|NCT01071252|520356078|FG001|Overall Study|Death|0|||
144315216|NCT01071252|520356079|FG002|Overall Study|Death|0|||
144315217|NCT01071252|520356080|FG003|Overall Study|Death|0|||
144315218|NCT01071252|520356081|FG004|Overall Study|Death|1|||
144315219|NCT01066104|520356082|FG000|Overall Study|Adverse Event|1|||
144315220|NCT01066104|520356083|FG001|Overall Study|Adverse Event|1|||
144315221|NCT01066104|520356082|FG000|Overall Study|Protocol Violation|1|||
144315222|NCT01066104|520356083|FG001|Overall Study|Protocol Violation|0|||
144315223|NCT00470262|520356084|FG000|Overall Study|Withdrawal by Subject|2|||
144315224|NCT00470262|520356085|FG001|Overall Study|Withdrawal by Subject|0|||
144315225|NCT01970241|520356091|FG000|Overall Study|Withdrawal by Subject|2|||
144315226|NCT01970241|520356092|FG001|Overall Study|Withdrawal by Subject|0|||
144315227|NCT01970241|520356091|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
144315228|NCT01970241|520356092|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
144315229|NCT01001767|520356097|FG000|Overall Study|no baseline study performed|1|||
144315230|NCT01001767|520356098|FG001|Overall Study|no baseline study performed|0|||
144315231|NCT01001767|520356097|FG000|Overall Study|Protocol Violation|1|||
144315232|NCT01001767|520356098|FG001|Overall Study|Protocol Violation|0|||
144315233|NCT01001767|520356097|FG000|Overall Study|Lost to Follow-up|1|||
144315234|NCT01001767|520356098|FG001|Overall Study|Lost to Follow-up|0|||
144315235|NCT01001767|520356097|FG000|Overall Study|Physician Decision|1|||
144315236|NCT01001767|520356098|FG001|Overall Study|Physician Decision|0|||
144315237|NCT02584452|520356099|FG000|Overall Study|Physician Decision|1|||
144315238|NCT02584452|520356100|FG001|Overall Study|Physician Decision|1|||
144315239|NCT02584452|520356099|FG000|Overall Study|Lost to Follow-up|1|||
144315240|NCT02584452|520356100|FG001|Overall Study|Lost to Follow-up|1|||
144315241|NCT00851552|520356101|FG000|Overall Study|Death|2|||
144315242|NCT00851552|520356101|FG000|Overall Study|Adverse Event|1|||
144315243|NCT00851552|520356101|FG000|Overall Study|Disease Progression|4|||
144315244|NCT02689206|520356102|FG000|Overall Study|Adverse Event|0|||
144315245|NCT02689206|520356103|FG001|Overall Study|Adverse Event|0|||
144315246|NCT02689206|520356104|FG002|Overall Study|Adverse Event|1|||
144315247|NCT02689206|520356105|FG003|Overall Study|Adverse Event|0|||
144315248|NCT02689206|520356106|FG004|Overall Study|Adverse Event|2|||
144315249|NCT02689206|520356102|FG000|Overall Study|Protocol Violation|1|||
144315250|NCT02689206|520356103|FG001|Overall Study|Protocol Violation|0|||
144315251|NCT02689206|520356104|FG002|Overall Study|Protocol Violation|0|||
144315252|NCT02689206|520356105|FG003|Overall Study|Protocol Violation|1|||
144315253|NCT02689206|520356106|FG004|Overall Study|Protocol Violation|2|||
144315254|NCT02689206|520356102|FG000|Overall Study|Other: Reached stopping criteria|0|||
144315255|NCT02689206|520356103|FG001|Overall Study|Other: Reached stopping criteria|1|||
144315256|NCT02689206|520356104|FG002|Overall Study|Other: Reached stopping criteria|2|||
144315257|NCT02689206|520356105|FG003|Overall Study|Other: Reached stopping criteria|3|||
144315258|NCT02689206|520356106|FG004|Overall Study|Other: Reached stopping criteria|4|||
144315259|NCT02689206|520356102|FG000|Overall Study|Physician Decision|1|||
144315260|NCT02689206|520356103|FG001|Overall Study|Physician Decision|0|||
144315261|NCT02689206|520356104|FG002|Overall Study|Physician Decision|0|||
144315262|NCT02689206|520356105|FG003|Overall Study|Physician Decision|0|||
144315263|NCT02689206|520356106|FG004|Overall Study|Physician Decision|0|||
144315264|NCT02689206|520356102|FG000|Overall Study|Withdrawal by Subject|1|||
144315265|NCT02689206|520356103|FG001|Overall Study|Withdrawal by Subject|0|||
144315266|NCT02689206|520356104|FG002|Overall Study|Withdrawal by Subject|1|||
144315267|NCT02689206|520356105|FG003|Overall Study|Withdrawal by Subject|0|||
144315268|NCT02689206|520356106|FG004|Overall Study|Withdrawal by Subject|0|||
144315269|NCT00177294|520356107|FG000|Overall Study|Withdrawal by Subject|7|||
144315270|NCT00177294|520356108|FG001|Overall Study|Withdrawal by Subject|5|||
144315271|NCT02038946|520356109|FG000|Overall Study|Death|5|||
144315272|NCT02038946|520356109|FG000|Overall Study|Withdrawal by Subject|3|||
144315273|NCT02038946|520356109|FG000|Overall Study|Lost to Follow-up|2|||
144315274|NCT02038946|520356109|FG000|Overall Study|Other reasons|2|||
144315275|NCT01916824|520356113|FG000|Overall Study|Lost to Follow-up|3|||
144315276|NCT01916824|520356114|FG001|Overall Study|Lost to Follow-up|6|||
144315277|NCT01916824|520356113|FG000|Overall Study|Physician Decision|2|||
144315278|NCT01916824|520356114|FG001|Overall Study|Physician Decision|0|||
144315279|NCT01916824|520356113|FG000|Overall Study|Withdrawal by Subject|2|||
144315280|NCT01916824|520356114|FG001|Overall Study|Withdrawal by Subject|3|||
144315281|NCT03835481|520356115|FG000|Double-blind Period|Other not stated below|0|||
144315282|NCT03835481|520356116|FG001|Double-blind Period|Other not stated below|0|||
144315283|NCT03835481|520356117|FG002|Double-blind Period|Other not stated below|0|||
144315284|NCT03835481|520356118|FG003|Double-blind Period|Other not stated below|1|||
144315285|NCT03835481|520356119|FG004|Double-blind Period|Other not stated below|1|||
144315286|NCT03835481|520356115|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
144315287|NCT03835481|520356116|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
144315288|NCT03835481|520356117|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
144315289|NCT03835481|520356118|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
144315290|NCT03835481|520356119|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
144315291|NCT03835481|520356115|FG000|Double-blind Period|Withdrawal by Subject|0|||
144315292|NCT03835481|520356116|FG001|Double-blind Period|Withdrawal by Subject|0|||
144315293|NCT03835481|520356117|FG002|Double-blind Period|Withdrawal by Subject|1|||
144315294|NCT03835481|520356118|FG003|Double-blind Period|Withdrawal by Subject|0|||
144315295|NCT03835481|520356119|FG004|Double-blind Period|Withdrawal by Subject|5|||
144360025|NCT01601535|520525135|FG000|Phase 2|Withdrawal by Subject|0|||
144315296|NCT03835481|520356115|FG000|Double-blind Period|Lost to Follow-up|0|||
144315297|NCT03835481|520356116|FG001|Double-blind Period|Lost to Follow-up|0|||
144315298|NCT03835481|520356117|FG002|Double-blind Period|Lost to Follow-up|0|||
144315299|NCT03835481|520356118|FG003|Double-blind Period|Lost to Follow-up|1|||
144315300|NCT03835481|520356119|FG004|Double-blind Period|Lost to Follow-up|0|||
144315301|NCT03835481|520356115|FG000|Double-blind Period|Protocol Violation|0|||
144315302|NCT03835481|520356116|FG001|Double-blind Period|Protocol Violation|2|||
144315303|NCT03835481|520356117|FG002|Double-blind Period|Protocol Violation|0|||
144315304|NCT03835481|520356118|FG003|Double-blind Period|Protocol Violation|1|||
144315305|NCT03835481|520356119|FG004|Double-blind Period|Protocol Violation|0|||
144315306|NCT03835481|520356115|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
144315307|NCT03835481|520356116|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
144315308|NCT03835481|520356117|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
144315309|NCT03835481|520356118|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
144315310|NCT03835481|520356119|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
144315311|NCT03835481|520356115|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
144315312|NCT03835481|520356116|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
144315313|NCT03835481|520356117|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
144315314|NCT03835481|520356118|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
144315315|NCT03835481|520356119|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
144315316|NCT03835481|520356115|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
144315317|NCT03835481|520356116|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
144315318|NCT03835481|520356117|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
144315319|NCT03835481|520356118|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
144315320|NCT03835481|520356119|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
144315321|NCT03835481|520356115|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
144315322|NCT03835481|520356116|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
144315323|NCT03835481|520356117|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
144315324|NCT03835481|520356118|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
144315325|NCT03835481|520356119|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
144315326|NCT03835481|520356115|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
144315327|NCT03835481|520356116|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
144315328|NCT03835481|520356117|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
144315329|NCT03835481|520356118|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
144315330|NCT03835481|520356119|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
144315331|NCT03835481|520356115|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
144315332|NCT03835481|520356116|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
144315333|NCT03835481|520356117|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
144315334|NCT03835481|520356118|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
144315335|NCT03835481|520356119|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
144315336|NCT01221753|520356124|FG000|Overall Study|Adverse Event|1|||
144315337|NCT03335150|520356125|FG000|Overall Study|Withdrawal by Subject|10|||
144315338|NCT03335150|520356126|FG001|Overall Study|Withdrawal by Subject|4|||
144315339|NCT03335150|520356125|FG000|Overall Study|Adverse Event|0|||
144315340|NCT03335150|520356126|FG001|Overall Study|Adverse Event|1|||
144315341|NCT02218697|520356127|FG000|Overall Study|Adverse Event|0|||
144315342|NCT02218697|520356128|FG001|Overall Study|Adverse Event|2|||
144315343|NCT02218697|520356127|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
144315344|NCT02218697|520356128|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
144315345|NCT02218697|520356127|FG000|Overall Study|Withdrawal by Subject|2|||
144315346|NCT02218697|520356128|FG001|Overall Study|Withdrawal by Subject|3|||
144315347|NCT00803595|520356131|FG000|Overall Study|Adverse Event|3|||
144315348|NCT00803595|520356132|FG001|Overall Study|Adverse Event|4|||
144315349|NCT00803595|520356133|FG002|Overall Study|Adverse Event|1|||
144315350|NCT00803595|520356131|FG000|Overall Study|Protocol Violation|7|||
144315351|NCT00803595|520356132|FG001|Overall Study|Protocol Violation|2|||
144315352|NCT00803595|520356133|FG002|Overall Study|Protocol Violation|12|||
144315353|NCT00803595|520356131|FG000|Overall Study|Withdrawal by Subject|5|||
144315354|NCT00803595|520356132|FG001|Overall Study|Withdrawal by Subject|2|||
144315355|NCT00803595|520356133|FG002|Overall Study|Withdrawal by Subject|3|||
144315356|NCT02701764|520356134|FG000|Overall Study|Lost to Follow-up|0|||
144315357|NCT02701764|520356135|FG001|Overall Study|Lost to Follow-up|1|||
144315358|NCT03110029|520356136|FG000|Overall Study|Withdrawal by Subject|1|||
144315359|NCT03110029|520356137|FG001|Overall Study|Withdrawal by Subject|1|||
144315360|NCT03281629|520356138|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
144315361|NCT03281629|520356139|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
144315362|NCT03281629|520356138|FG000|Overall Study|Death|0|||
144315363|NCT03281629|520356139|FG001|Overall Study|Death|1|||
144315364|NCT03281629|520356138|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
144315365|NCT03281629|520356139|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
144315366|NCT02175277|520356140|FG000|Overall Study|Protocol-specified Criteria|1|||
144315367|NCT01042158|520356141|FG000|Overall Study|Physician Decision|1|||
144315368|NCT01575808|520356142|FG000|Overall Study|Death|2|||
144315369|NCT01575808|520356143|FG001|Overall Study|Death|0|||
144315370|NCT01575808|520356142|FG000|Overall Study|Withdrawal by Subject|1|||
144315371|NCT01575808|520356143|FG001|Overall Study|Withdrawal by Subject|0|||
144315372|NCT05396014|520358045|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
144315373|NCT05396014|520358046|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315374|NCT05396014|520358047|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315375|NCT05396014|520358048|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315376|NCT05396014|520358049|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315377|NCT05396014|520358050|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315378|NCT05396014|520358051|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315379|NCT05396014|520358052|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315380|NCT05396014|520358053|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315381|NCT05396014|520358054|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315382|NCT05396014|520358055|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315383|NCT05396014|520358056|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315384|NCT05396014|520358057|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315385|NCT05396014|520358058|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
144315386|NCT05396014|520358059|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315387|NCT05396014|520358060|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315388|NCT05396014|520358061|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315389|NCT05396014|520358062|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315390|NCT05396014|520358063|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315391|NCT05396014|520358064|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315392|NCT05396014|520358065|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315393|NCT05396014|520358066|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315394|NCT05396014|520358067|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315395|NCT05396014|520358068|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315396|NCT05396014|520358069|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315397|NCT05396014|520358070|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315398|NCT05396014|520358071|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
144315399|NCT05396014|520358072|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315400|NCT05396014|520358073|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315401|NCT05396014|520358074|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315402|NCT05396014|520358075|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315403|NCT05396014|520358076|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315404|NCT05396014|520358077|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315405|NCT05396014|520358078|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315406|NCT05396014|520358079|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315407|NCT05396014|520358080|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315408|NCT05396014|520358081|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315409|NCT05396014|520358082|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315410|NCT05396014|520358083|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315411|NCT05396014|520358084|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
144315412|NCT05396014|520358085|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315413|NCT05396014|520358086|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315414|NCT05396014|520358087|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
144315415|NCT05396014|520358045|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
144315416|NCT05396014|520358046|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315417|NCT05396014|520358047|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315418|NCT05396014|520358048|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315419|NCT05396014|520358049|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315420|NCT05396014|520358050|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315421|NCT05396014|520358051|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315422|NCT05396014|520358052|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315423|NCT05396014|520358053|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315424|NCT05396014|520358054|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315425|NCT05396014|520358055|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315426|NCT05396014|520358056|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315427|NCT05396014|520358057|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315428|NCT05396014|520358058|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
144315429|NCT05396014|520358059|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315430|NCT05396014|520358060|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315431|NCT05396014|520358061|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315432|NCT05396014|520358062|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315433|NCT05396014|520358063|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315434|NCT05396014|520358064|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315435|NCT05396014|520358065|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315436|NCT05396014|520358066|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315437|NCT05396014|520358067|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315438|NCT05396014|520358068|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315439|NCT05396014|520358069|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315440|NCT05396014|520358070|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315441|NCT05396014|520358071|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
144315442|NCT05396014|520358072|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315443|NCT05396014|520358073|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315444|NCT05396014|520358074|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315445|NCT05396014|520358075|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315446|NCT05396014|520358076|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315447|NCT05396014|520358077|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315448|NCT05396014|520358078|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315449|NCT05396014|520358079|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315450|NCT05396014|520358080|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315451|NCT05396014|520358081|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315452|NCT05396014|520358082|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315453|NCT05396014|520358083|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315454|NCT05396014|520358084|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
144315455|NCT05396014|520358085|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315456|NCT05396014|520358086|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315457|NCT05396014|520358087|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
144315458|NCT05396014|520358045|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
144315459|NCT05396014|520358046|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315460|NCT05396014|520358047|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315461|NCT05396014|520358048|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315462|NCT05396014|520358049|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315463|NCT05396014|520358050|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315464|NCT05396014|520358051|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315465|NCT05396014|520358052|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315466|NCT05396014|520358053|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315467|NCT05396014|520358054|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315468|NCT05396014|520358055|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315469|NCT05396014|520358056|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315470|NCT05396014|520358057|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315471|NCT05396014|520358058|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
144315472|NCT05396014|520358059|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315473|NCT05396014|520358060|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315474|NCT05396014|520358061|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315475|NCT05396014|520358062|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315476|NCT05396014|520358063|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315477|NCT05396014|520358064|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315478|NCT05396014|520358065|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315479|NCT05396014|520358066|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315480|NCT05396014|520358067|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315481|NCT05396014|520358068|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315482|NCT05396014|520358069|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315483|NCT05396014|520358070|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315484|NCT05396014|520358071|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
144315485|NCT05396014|520358072|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315486|NCT05396014|520358073|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315487|NCT05396014|520358074|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315488|NCT05396014|520358075|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315489|NCT05396014|520358076|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315490|NCT05396014|520358077|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315491|NCT05396014|520358078|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315492|NCT05396014|520358079|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315493|NCT05396014|520358080|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315494|NCT05396014|520358081|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315495|NCT05396014|520358082|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315496|NCT05396014|520358083|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315497|NCT05396014|520358084|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
144315498|NCT05396014|520358085|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315499|NCT05396014|520358086|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315500|NCT05396014|520358087|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
144315501|NCT05396014|520358045|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315502|NCT05396014|520358046|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315503|NCT05396014|520358047|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315504|NCT05396014|520358048|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315505|NCT05396014|520358049|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315506|NCT05396014|520358050|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315507|NCT05396014|520358051|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315508|NCT05396014|520358052|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315509|NCT05396014|520358053|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315510|NCT05396014|520358054|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315511|NCT05396014|520358055|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315512|NCT05396014|520358056|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315513|NCT05396014|520358057|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315514|NCT05396014|520358058|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315515|NCT05396014|520358059|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315516|NCT05396014|520358060|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315517|NCT05396014|520358061|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315518|NCT05396014|520358062|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315519|NCT05396014|520358063|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315520|NCT05396014|520358064|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315521|NCT05396014|520358065|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315522|NCT05396014|520358066|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315523|NCT05396014|520358067|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315524|NCT05396014|520358068|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315525|NCT05396014|520358069|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315526|NCT05396014|520358070|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315527|NCT05396014|520358071|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
144315528|NCT05396014|520358072|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315529|NCT05396014|520358073|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315530|NCT05396014|520358074|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315531|NCT05396014|520358075|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315532|NCT05396014|520358076|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315533|NCT05396014|520358077|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315534|NCT05396014|520358078|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315535|NCT05396014|520358079|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315536|NCT05396014|520358080|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315537|NCT05396014|520358081|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315538|NCT05396014|520358082|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315539|NCT05396014|520358083|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315540|NCT05396014|520358084|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
144315541|NCT05396014|520358085|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315542|NCT05396014|520358086|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315543|NCT05396014|520358087|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
144315544|NCT05396014|520358045|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315545|NCT05396014|520358046|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315546|NCT05396014|520358047|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315547|NCT05396014|520358048|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315548|NCT05396014|520358049|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315549|NCT05396014|520358050|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315550|NCT05396014|520358051|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315551|NCT05396014|520358052|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315552|NCT05396014|520358053|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315553|NCT05396014|520358054|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315554|NCT05396014|520358055|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315555|NCT05396014|520358056|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315556|NCT05396014|520358057|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315557|NCT05396014|520358058|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315558|NCT05396014|520358059|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315559|NCT05396014|520358060|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315560|NCT05396014|520358061|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144360026|NCT01601535|520525136|FG001|Phase 2|Withdrawal by Subject|0|||
144315561|NCT05396014|520358062|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315562|NCT05396014|520358063|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315563|NCT05396014|520358064|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315564|NCT05396014|520358065|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315565|NCT05396014|520358066|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315566|NCT05396014|520358067|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315567|NCT05396014|520358068|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315568|NCT05396014|520358069|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315569|NCT05396014|520358070|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315570|NCT05396014|520358071|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
144315571|NCT05396014|520358072|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315572|NCT05396014|520358073|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315573|NCT05396014|520358074|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315574|NCT05396014|520358075|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315575|NCT05396014|520358076|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315576|NCT05396014|520358077|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315577|NCT05396014|520358078|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315578|NCT05396014|520358079|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315579|NCT05396014|520358080|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315580|NCT05396014|520358081|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315581|NCT05396014|520358082|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315582|NCT05396014|520358083|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315583|NCT05396014|520358084|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315584|NCT05396014|520358085|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315585|NCT05396014|520358086|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315586|NCT05396014|520358087|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
144315587|NCT05396014|520358045|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315588|NCT05396014|520358046|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315589|NCT05396014|520358047|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315590|NCT05396014|520358048|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315591|NCT05396014|520358049|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315592|NCT05396014|520358050|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315593|NCT05396014|520358051|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315594|NCT05396014|520358052|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315595|NCT05396014|520358053|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315596|NCT05396014|520358054|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315597|NCT05396014|520358055|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315598|NCT05396014|520358056|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315599|NCT05396014|520358057|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315600|NCT05396014|520358058|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
144315601|NCT05396014|520358059|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315602|NCT05396014|520358060|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315603|NCT05396014|520358061|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315604|NCT05396014|520358062|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315605|NCT05396014|520358063|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315606|NCT05396014|520358064|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315607|NCT05396014|520358065|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315608|NCT05396014|520358066|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315609|NCT05396014|520358067|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315610|NCT05396014|520358068|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315611|NCT05396014|520358069|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315612|NCT05396014|520358070|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315613|NCT05396014|520358071|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315614|NCT05396014|520358072|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315615|NCT05396014|520358073|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315616|NCT05396014|520358074|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315617|NCT05396014|520358075|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315618|NCT05396014|520358076|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315619|NCT05396014|520358077|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315620|NCT05396014|520358078|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315621|NCT05396014|520358079|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315622|NCT05396014|520358080|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315623|NCT05396014|520358081|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315624|NCT05396014|520358082|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315625|NCT05396014|520358083|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315626|NCT05396014|520358084|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315627|NCT05396014|520358085|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315628|NCT05396014|520358086|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315629|NCT05396014|520358087|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
144315630|NCT05396014|520358045|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
144315631|NCT05396014|520358046|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315632|NCT05396014|520358047|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315633|NCT05396014|520358048|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315634|NCT05396014|520358049|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315635|NCT05396014|520358050|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315636|NCT05396014|520358051|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315637|NCT05396014|520358052|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315638|NCT05396014|520358053|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315639|NCT05396014|520358054|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315640|NCT05396014|520358055|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315641|NCT05396014|520358056|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315642|NCT05396014|520358057|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315643|NCT05396014|520358058|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
144315644|NCT05396014|520358059|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315645|NCT05396014|520358060|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315646|NCT05396014|520358061|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315647|NCT05396014|520358062|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315648|NCT05396014|520358063|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315649|NCT05396014|520358064|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315650|NCT05396014|520358065|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315651|NCT05396014|520358066|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315652|NCT05396014|520358067|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315653|NCT05396014|520358068|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315654|NCT05396014|520358069|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315655|NCT05396014|520358070|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315656|NCT05396014|520358071|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315657|NCT05396014|520358072|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315658|NCT05396014|520358073|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315659|NCT05396014|520358074|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315660|NCT05396014|520358075|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315661|NCT05396014|520358076|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315662|NCT05396014|520358077|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315663|NCT05396014|520358078|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315664|NCT05396014|520358079|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315665|NCT05396014|520358080|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315666|NCT05396014|520358081|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315667|NCT05396014|520358082|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315668|NCT05396014|520358083|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315669|NCT05396014|520358084|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
144315670|NCT05396014|520358085|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315671|NCT05396014|520358086|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315672|NCT05396014|520358087|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
144315673|NCT05396014|520358045|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
144315674|NCT05396014|520358046|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315675|NCT05396014|520358047|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315676|NCT05396014|520358048|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315677|NCT05396014|520358049|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315678|NCT05396014|520358050|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315679|NCT05396014|520358051|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315680|NCT05396014|520358052|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315681|NCT05396014|520358053|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315682|NCT05396014|520358054|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315683|NCT05396014|520358055|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315684|NCT05396014|520358056|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315685|NCT05396014|520358057|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315686|NCT05396014|520358058|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315687|NCT05396014|520358059|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315688|NCT05396014|520358060|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315689|NCT05396014|520358061|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315690|NCT05396014|520358062|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315691|NCT05396014|520358063|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315692|NCT05396014|520358064|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315693|NCT05396014|520358065|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315694|NCT05396014|520358066|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315695|NCT05396014|520358067|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315696|NCT05396014|520358068|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315697|NCT05396014|520358069|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315698|NCT05396014|520358070|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315699|NCT05396014|520358071|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
144315700|NCT05396014|520358072|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315701|NCT05396014|520358073|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315702|NCT05396014|520358074|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315703|NCT05396014|520358075|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315704|NCT05396014|520358076|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315705|NCT05396014|520358077|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315706|NCT05396014|520358078|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315707|NCT05396014|520358079|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315708|NCT05396014|520358080|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315709|NCT05396014|520358081|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315710|NCT05396014|520358082|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315711|NCT05396014|520358083|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315712|NCT05396014|520358084|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315713|NCT05396014|520358085|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315714|NCT05396014|520358086|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315715|NCT05396014|520358087|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
144315716|NCT05396014|520358045|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315717|NCT05396014|520358046|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315718|NCT05396014|520358047|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315719|NCT05396014|520358048|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315720|NCT05396014|520358049|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315721|NCT05396014|520358050|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315722|NCT05396014|520358051|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315723|NCT05396014|520358052|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315724|NCT05396014|520358053|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315725|NCT05396014|520358054|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315726|NCT05396014|520358055|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315727|NCT05396014|520358056|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315728|NCT05396014|520358057|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315729|NCT05396014|520358058|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
144315730|NCT05396014|520358059|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315731|NCT05396014|520358060|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315732|NCT05396014|520358061|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315733|NCT05396014|520358062|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315734|NCT05396014|520358063|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315735|NCT05396014|520358064|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315736|NCT05396014|520358065|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315737|NCT05396014|520358066|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315738|NCT05396014|520358067|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315739|NCT05396014|520358068|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315740|NCT05396014|520358069|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315741|NCT05396014|520358070|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315742|NCT05396014|520358071|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315743|NCT05396014|520358072|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315744|NCT05396014|520358073|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315745|NCT05396014|520358074|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315746|NCT05396014|520358075|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315747|NCT05396014|520358076|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315748|NCT05396014|520358077|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315749|NCT05396014|520358078|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315750|NCT05396014|520358079|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315751|NCT05396014|520358080|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315752|NCT05396014|520358081|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315753|NCT05396014|520358082|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315754|NCT05396014|520358083|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315755|NCT05396014|520358084|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315756|NCT05396014|520358085|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315757|NCT05396014|520358086|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315758|NCT05396014|520358087|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
144315759|NCT05396014|520358045|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315760|NCT05396014|520358046|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315761|NCT05396014|520358047|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315762|NCT05396014|520358048|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
144315763|NCT05396014|520358049|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315764|NCT05396014|520358050|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315765|NCT05396014|520358051|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315766|NCT05396014|520358052|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315767|NCT05396014|520358053|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
144315768|NCT05396014|520358054|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315769|NCT05396014|520358055|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315770|NCT05396014|520358056|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315771|NCT05396014|520358057|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315772|NCT05396014|520358058|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315773|NCT05396014|520358059|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315774|NCT05396014|520358060|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315775|NCT05396014|520358061|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315776|NCT05396014|520358062|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315777|NCT05396014|520358063|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315778|NCT05396014|520358064|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315779|NCT05396014|520358065|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315780|NCT05396014|520358066|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315781|NCT05396014|520358067|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315782|NCT05396014|520358068|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315783|NCT05396014|520358069|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315784|NCT05396014|520358070|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
144315785|NCT05396014|520358071|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315786|NCT05396014|520358072|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315787|NCT05396014|520358073|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315788|NCT05396014|520358074|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315789|NCT05396014|520358075|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315790|NCT05396014|520358076|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315791|NCT05396014|520358077|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315792|NCT05396014|520358078|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315793|NCT05396014|520358079|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315794|NCT05396014|520358080|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315795|NCT05396014|520358081|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315796|NCT05396014|520358082|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315797|NCT05396014|520358083|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144315798|NCT05396014|520358084|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
144360027|NCT01601535|520525137|FG002|Phase 2|Withdrawal by Subject|0|||
144315799|NCT05396014|520358085|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
144315800|NCT05396014|520358086|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
144315801|NCT05396014|520358087|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
144315802|NCT05396014|520358045|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315803|NCT05396014|520358046|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315804|NCT05396014|520358047|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315805|NCT05396014|520358048|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315806|NCT05396014|520358049|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315807|NCT05396014|520358050|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315808|NCT05396014|520358051|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315809|NCT05396014|520358052|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315810|NCT05396014|520358053|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
144315811|NCT05396014|520358054|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315812|NCT05396014|520358055|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315813|NCT05396014|520358056|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315814|NCT05396014|520358057|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315815|NCT05396014|520358058|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315816|NCT05396014|520358059|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315817|NCT05396014|520358060|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315818|NCT05396014|520358061|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315819|NCT05396014|520358062|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315820|NCT05396014|520358063|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315821|NCT05396014|520358064|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315822|NCT05396014|520358065|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315823|NCT05396014|520358066|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315824|NCT05396014|520358067|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
144315825|NCT05396014|520358068|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315826|NCT05396014|520358069|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315827|NCT05396014|520358070|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315828|NCT05396014|520358071|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315829|NCT05396014|520358072|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315830|NCT05396014|520358073|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315831|NCT05396014|520358074|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315832|NCT05396014|520358075|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315833|NCT05396014|520358076|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315834|NCT05396014|520358077|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315835|NCT05396014|520358078|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315836|NCT05396014|520358079|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315837|NCT05396014|520358080|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
144315838|NCT05396014|520358081|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315839|NCT05396014|520358082|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315840|NCT05396014|520358083|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315841|NCT05396014|520358084|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
144315842|NCT05396014|520358085|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315843|NCT05396014|520358086|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
144315844|NCT05396014|520358087|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
144315845|NCT05396014|520358045|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315846|NCT05396014|520358046|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315847|NCT05396014|520358047|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315848|NCT05396014|520358048|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315849|NCT05396014|520358049|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315850|NCT05396014|520358050|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315851|NCT05396014|520358051|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315852|NCT05396014|520358052|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315853|NCT05396014|520358053|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315854|NCT05396014|520358054|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315855|NCT05396014|520358055|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315856|NCT05396014|520358056|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315857|NCT05396014|520358057|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315858|NCT05396014|520358058|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
144315859|NCT05396014|520358059|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315860|NCT05396014|520358060|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315861|NCT05396014|520358061|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315862|NCT05396014|520358062|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315863|NCT05396014|520358063|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315864|NCT05396014|520358064|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315865|NCT05396014|520358065|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315866|NCT05396014|520358066|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315867|NCT05396014|520358067|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315868|NCT05396014|520358068|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315869|NCT05396014|520358069|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315870|NCT05396014|520358070|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315871|NCT05396014|520358071|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
144315872|NCT05396014|520358072|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315873|NCT05396014|520358073|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315874|NCT05396014|520358074|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315875|NCT05396014|520358075|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315876|NCT05396014|520358076|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315877|NCT05396014|520358077|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315878|NCT05396014|520358078|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315879|NCT05396014|520358079|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
144315880|NCT05396014|520358080|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315881|NCT05396014|520358081|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315882|NCT05396014|520358082|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315883|NCT05396014|520358083|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315884|NCT05396014|520358084|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315885|NCT05396014|520358085|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315886|NCT05396014|520358086|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
144315887|NCT05396014|520358087|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
144315888|NCT05396014|520358045|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315889|NCT05396014|520358046|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315890|NCT05396014|520358047|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315891|NCT05396014|520358048|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315892|NCT05396014|520358049|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315893|NCT05396014|520358050|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315894|NCT05396014|520358051|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315895|NCT05396014|520358052|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315896|NCT05396014|520358053|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315897|NCT05396014|520358054|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315898|NCT05396014|520358055|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315899|NCT05396014|520358056|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315900|NCT05396014|520358057|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315901|NCT05396014|520358058|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315902|NCT05396014|520358059|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315903|NCT05396014|520358060|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315904|NCT05396014|520358061|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315905|NCT05396014|520358062|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315906|NCT05396014|520358063|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315907|NCT05396014|520358064|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315908|NCT05396014|520358065|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315909|NCT05396014|520358066|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315910|NCT05396014|520358067|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315911|NCT05396014|520358068|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315912|NCT05396014|520358069|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315913|NCT05396014|520358070|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315914|NCT05396014|520358071|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
144315915|NCT05396014|520358072|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315916|NCT05396014|520358073|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315917|NCT05396014|520358074|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315918|NCT05396014|520358075|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315919|NCT05396014|520358076|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315920|NCT05396014|520358077|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315921|NCT05396014|520358078|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315922|NCT05396014|520358079|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315923|NCT05396014|520358080|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315924|NCT05396014|520358081|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315925|NCT05396014|520358082|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315926|NCT05396014|520358083|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315927|NCT05396014|520358084|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315928|NCT05396014|520358085|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315929|NCT05396014|520358086|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315930|NCT05396014|520358087|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
144315931|NCT04439539|520358090|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
144315932|NCT04439539|520358091|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
144315933|NCT04439539|520358092|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
144315934|NCT04439539|520358090|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
144315935|NCT04439539|520358091|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
144315936|NCT04439539|520358092|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
144315937|NCT04439539|520358090|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
144315938|NCT04439539|520358091|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
144315939|NCT04439539|520358092|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
144315940|NCT02482428|520358093|FG000|Overall Study|Lost to Follow-up|4|||
144315941|NCT02482428|520358094|FG001|Overall Study|Lost to Follow-up|9|||
144315942|NCT02482428|520358095|FG002|Overall Study|Lost to Follow-up|1|||
144315943|NCT02482428|520358096|FG003|Overall Study|Lost to Follow-up|2|||
144315944|NCT02482428|520358097|FG004|Overall Study|Lost to Follow-up|4|||
144315945|NCT02482428|520358093|FG000|Overall Study|Physician Decision|0|||
144315946|NCT02482428|520358094|FG001|Overall Study|Physician Decision|0|||
144315947|NCT02482428|520358095|FG002|Overall Study|Physician Decision|0|||
144315948|NCT02482428|520358096|FG003|Overall Study|Physician Decision|0|||
144315949|NCT02482428|520358097|FG004|Overall Study|Physician Decision|1|||
144315950|NCT02482428|520358093|FG000|Overall Study|protocol deviation|1|||
144315951|NCT02482428|520358094|FG001|Overall Study|protocol deviation|1|||
144315952|NCT02482428|520358095|FG002|Overall Study|protocol deviation|0|||
144315953|NCT02482428|520358096|FG003|Overall Study|protocol deviation|0|||
144315954|NCT02482428|520358097|FG004|Overall Study|protocol deviation|0|||
144315955|NCT02482428|520358093|FG000|Overall Study|subject/guardian decision|4|||
144315956|NCT02482428|520358094|FG001|Overall Study|subject/guardian decision|2|||
144315957|NCT02482428|520358095|FG002|Overall Study|subject/guardian decision|0|||
144315958|NCT02482428|520358096|FG003|Overall Study|subject/guardian decision|0|||
144315959|NCT02482428|520358097|FG004|Overall Study|subject/guardian decision|2|||
144315960|NCT00516893|520358099|FG000|Overall Study|Lost to Follow-up|4|||
144315961|NCT00516893|520358099|FG000|Overall Study|Adverse Event|3|||
144315962|NCT00516893|520358099|FG000|Overall Study|Withdrawal by Subject|2|||
144315963|NCT00516893|520358099|FG000|Overall Study|Noncompliance|2|||
144315964|NCT00516893|520358099|FG000|Overall Study|Death|1|||
144315965|NCT00516893|520358099|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
144315966|NCT00516893|520358099|FG000|Overall Study|Relocated|1|||
144315967|NCT00516893|520358099|FG000|Overall Study|Pregnancy|1|||
144315968|NCT00516893|520358099|FG000|Overall Study|Received Medication From Another Study|1|||
144315969|NCT00301262|520358107|FG000|Double Blind Phase (DB)|Adverse Event|1|||
144315970|NCT00301262|520358108|FG001|Double Blind Phase (DB)|Adverse Event|0|||
144315971|NCT00301262|520358107|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
144315972|NCT00301262|520358108|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
144315973|NCT00301262|520358107|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
144315974|NCT00301262|520358108|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
144315975|NCT00301262|520358107|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
144315976|NCT00301262|520358108|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
144315977|NCT00301262|520358107|FG000|Double Blind Phase (DB)|Other|1|||
144315978|NCT00301262|520358108|FG001|Double Blind Phase (DB)|Other|4|||
144315979|NCT00301262|520358107|FG000|Open Label Phase (OL)|Adverse Event|1|||
144315980|NCT00301262|520358108|FG001|Open Label Phase (OL)|Adverse Event|0|||
144315981|NCT00301262|520358107|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
144315982|NCT00301262|520358108|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
144315983|NCT00301262|520358107|FG000|Open Label Phase (OL)|Other|2|||
144315984|NCT00301262|520358108|FG001|Open Label Phase (OL)|Other|0|||
144315985|NCT01443364|520358109|FG000|Overall Study|Lack of Efficacy|14|||
144315986|NCT01443364|520358109|FG000|Overall Study|Lost to Follow-up|3|||
144315987|NCT01443364|520358109|FG000|Overall Study|Withdrawal by Subject|5|||
144315988|NCT01443364|520358109|FG000|Overall Study|Other Reason|4|||
144315989|NCT01443364|520358109|FG000|Overall Study|SAE, non-fatal|6|||
144315990|NCT01443364|520358109|FG000|Overall Study|AE, non-serious non-fatal|8|||
144315991|NCT01443364|520358109|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
144315992|NCT01519791|520358110|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
144315993|NCT01519791|520358111|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
144315994|NCT01519791|520358110|FG000|Overall Study|Protocol Violation|6|||
144315995|NCT01519791|520358111|FG001|Overall Study|Protocol Violation|19|||
144315996|NCT01519791|520358110|FG000|Overall Study|Other Reason|87|||
144315997|NCT01519791|520358111|FG001|Overall Study|Other Reason|222|||
144315998|NCT01519791|520358110|FG000|Overall Study|subjects randomized in error|2|||
144315999|NCT01519791|520358111|FG001|Overall Study|subjects randomized in error|0|||
144316000|NCT01519791|520358110|FG000|Overall Study|Lack of Efficacy|16|||
144316001|NCT01519791|520358111|FG001|Overall Study|Lack of Efficacy|20|||
144316002|NCT01519791|520358110|FG000|Overall Study|SAE, non-fatal|6|||
144316003|NCT01519791|520358111|FG001|Overall Study|SAE, non-fatal|22|||
144316004|NCT01519791|520358110|FG000|Overall Study|AE, serious fatal|0|||
144316005|NCT01519791|520358111|FG001|Overall Study|AE, serious fatal|1|||
144316006|NCT01519791|520358110|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
144316007|NCT01519791|520358111|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
144316008|NCT01519791|520358110|FG000|Overall Study|AE, non-serious non-fatal|12|||
144316009|NCT01519791|520358111|FG001|Overall Study|AE, non-serious non-fatal|31|||
144316010|NCT01519791|520358110|FG000|Overall Study|Withdrawal by Subject|15|||
144316011|NCT01519791|520358111|FG001|Overall Study|Withdrawal by Subject|37|||
144316012|NCT01519791|520358110|FG000|Overall Study|Lost to Follow-up|6|||
144316013|NCT01519791|520358111|FG001|Overall Study|Lost to Follow-up|14|||
144316014|NCT03206970|520358114|FG000|Overall Study|Death|21|||
144316015|NCT03206970|520358114|FG000|Overall Study|Withdrawal by Subject|13|||
144316016|NCT03206970|520358114|FG000|Overall Study|Lost to Follow-up|3|||
144316017|NCT03206970|520358114|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
144316018|NCT03645421|520358115|FG000|Overall Study|Adverse Event|0|||
144316019|NCT03645421|520358116|FG001|Overall Study|Adverse Event|0|||
144316020|NCT03645421|520358117|FG002|Overall Study|Adverse Event|4|||
144316021|NCT03645421|520358118|FG003|Overall Study|Adverse Event|1|||
144316022|NCT03645421|520358115|FG000|Overall Study|Withdrawal by patient|0|||
144316023|NCT03645421|520358116|FG001|Overall Study|Withdrawal by patient|0|||
144316024|NCT03645421|520358117|FG002|Overall Study|Withdrawal by patient|0|||
144316025|NCT03645421|520358118|FG003|Overall Study|Withdrawal by patient|3|||
144316026|NCT03645421|520358115|FG000|Overall Study|Study specific withdrawal criteria|0|||
144316027|NCT03645421|520358116|FG001|Overall Study|Study specific withdrawal criteria|0|||
144316028|NCT03645421|520358117|FG002|Overall Study|Study specific withdrawal criteria|1|||
144316029|NCT03645421|520358118|FG003|Overall Study|Study specific withdrawal criteria|0|||
144316030|NCT00375427|520358119|FG000|Overall Study|Adverse Event|21|||
144316031|NCT00375427|520358120|FG001|Overall Study|Adverse Event|27|||
144316032|NCT00375427|520358119|FG000|Overall Study|Abnormal test procedure result(s)|0|||
144316033|NCT00375427|520358120|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144316034|NCT00375427|520358119|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144316035|NCT00375427|520358120|FG001|Overall Study|Abnormal laboratory value(s)|2|||
144316036|NCT00375427|520358119|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
144316037|NCT00375427|520358120|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
144316038|NCT00375427|520358119|FG000|Overall Study|Patient no longer requires study drug|3|||
144316039|NCT00375427|520358120|FG001|Overall Study|Patient no longer requires study drug|7|||
144316040|NCT00375427|520358119|FG000|Overall Study|Protocol Violation|10|||
144316041|NCT00375427|520358120|FG001|Overall Study|Protocol Violation|8|||
144316042|NCT00375427|520358119|FG000|Overall Study|Withdrawal by Subject|9|||
144316043|NCT00375427|520358120|FG001|Overall Study|Withdrawal by Subject|13|||
144316044|NCT00375427|520358119|FG000|Overall Study|Lost to Follow-up|1|||
144316045|NCT00375427|520358120|FG001|Overall Study|Lost to Follow-up|1|||
144316046|NCT00375427|520358119|FG000|Overall Study|Administrative reasons|0|||
144316047|NCT00375427|520358120|FG001|Overall Study|Administrative reasons|1|||
144316048|NCT00375427|520358119|FG000|Overall Study|Death|11|||
144316049|NCT00375427|520358120|FG001|Overall Study|Death|10|||
144316050|NCT03636893|520358127|FG000|Overall Study|Death|0|||
144316051|NCT03636893|520358128|FG001|Overall Study|Death|1|||
144316052|NCT03636893|520358127|FG000|Overall Study|Protocol Violation|0|||
144316053|NCT03636893|520358128|FG001|Overall Study|Protocol Violation|3|||
144316054|NCT03636893|520358127|FG000|Overall Study|Withdrawal by Subject|1|||
144316055|NCT03636893|520358128|FG001|Overall Study|Withdrawal by Subject|2|||
144316056|NCT03636893|520358127|FG000|Overall Study|Refusal to surgery|4|||
144316057|NCT03636893|520358128|FG001|Overall Study|Refusal to surgery|3|||
144316058|NCT03636893|520358127|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
144316059|NCT03636893|520358128|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
144316060|NCT03636893|520358127|FG000|Overall Study|Adverse Event|1|||
144316061|NCT03636893|520358128|FG001|Overall Study|Adverse Event|1|||
144316062|NCT00224120|520358129|FG000|Overall Study|Adverse Event|10|||
144316063|NCT00224120|520358130|FG001|Overall Study|Adverse Event|4|||
144316064|NCT00224120|520358129|FG000|Overall Study|Protocol Violation|1|||
144316065|NCT00224120|520358130|FG001|Overall Study|Protocol Violation|0|||
144316066|NCT00224120|520358129|FG000|Overall Study|Withdrawal by Subject|5|||
144316067|NCT00224120|520358130|FG001|Overall Study|Withdrawal by Subject|10|||
144316068|NCT00224120|520358129|FG000|Overall Study|Lack of Efficacy|0|||
144316069|NCT00224120|520358130|FG001|Overall Study|Lack of Efficacy|2|||
144316070|NCT00224120|520358129|FG000|Overall Study|Lost to Follow-up|2|||
144316071|NCT00224120|520358130|FG001|Overall Study|Lost to Follow-up|3|||
144316072|NCT00224120|520358129|FG000|Overall Study|Other|4|||
144316073|NCT00224120|520358130|FG001|Overall Study|Other|5|||
144316074|NCT04560816|520358132|FG000|Overall Study|Withdrawal by Subject|1|||
144316075|NCT04560816|520358133|FG001|Overall Study|Withdrawal by Subject|1|||
144316076|NCT04560816|520358134|FG002|Overall Study|Withdrawal by Subject|1|||
144316077|NCT04560816|520358135|FG003|Overall Study|Withdrawal by Subject|0|||
144316078|NCT04560816|520358136|FG004|Overall Study|Withdrawal by Subject|3|||
144316079|NCT04560816|520358137|FG005|Overall Study|Withdrawal by Subject|0|||
144316080|NCT04560816|520358132|FG000|Overall Study|Lost to Follow-up|1|||
144316081|NCT04560816|520358133|FG001|Overall Study|Lost to Follow-up|0|||
144316082|NCT04560816|520358134|FG002|Overall Study|Lost to Follow-up|0|||
144316083|NCT04560816|520358135|FG003|Overall Study|Lost to Follow-up|0|||
144316084|NCT04560816|520358136|FG004|Overall Study|Lost to Follow-up|0|||
144316085|NCT04560816|520358137|FG005|Overall Study|Lost to Follow-up|0|||
144316086|NCT04560816|520358132|FG000|Overall Study|Protocol Violation|1|||
144316087|NCT04560816|520358133|FG001|Overall Study|Protocol Violation|0|||
144316088|NCT04560816|520358134|FG002|Overall Study|Protocol Violation|0|||
144316089|NCT04560816|520358135|FG003|Overall Study|Protocol Violation|0|||
144316090|NCT04560816|520358136|FG004|Overall Study|Protocol Violation|0|||
144316091|NCT04560816|520358137|FG005|Overall Study|Protocol Violation|0|||
144316092|NCT01524224|520358140|FG000|Overall Study|Progressive Disease|1|||
144316093|NCT01524224|520358141|FG001|Overall Study|Progressive Disease|0|||
144316094|NCT01524224|520358142|FG002|Overall Study|Progressive Disease|2|||
144316095|NCT01524224|520358143|FG003|Overall Study|Progressive Disease|1|||
144316096|NCT01524224|520358144|FG004|Overall Study|Progressive Disease|2|||
144316097|NCT01524224|520358145|FG005|Overall Study|Progressive Disease|1|||
144316098|NCT01524224|520358146|FG006|Overall Study|Progressive Disease|1|||
144316099|NCT01524224|520358147|FG007|Overall Study|Progressive Disease|5|||
144316100|NCT01524224|520358140|FG000|Overall Study|Withdrawal by Subject|2|||
144316101|NCT01524224|520358141|FG001|Overall Study|Withdrawal by Subject|0|||
144316102|NCT01524224|520358142|FG002|Overall Study|Withdrawal by Subject|0|||
144316103|NCT01524224|520358143|FG003|Overall Study|Withdrawal by Subject|0|||
144316104|NCT01524224|520358144|FG004|Overall Study|Withdrawal by Subject|0|||
144316105|NCT01524224|520358145|FG005|Overall Study|Withdrawal by Subject|0|||
144316106|NCT01524224|520358146|FG006|Overall Study|Withdrawal by Subject|2|||
144316107|NCT01524224|520358147|FG007|Overall Study|Withdrawal by Subject|0|||
144316108|NCT01524224|520358140|FG000|Overall Study|Adverse Event|0|||
144316109|NCT01524224|520358141|FG001|Overall Study|Adverse Event|1|||
144316110|NCT01524224|520358142|FG002|Overall Study|Adverse Event|0|||
144316111|NCT01524224|520358143|FG003|Overall Study|Adverse Event|0|||
144316112|NCT01524224|520358144|FG004|Overall Study|Adverse Event|0|||
144316113|NCT01524224|520358145|FG005|Overall Study|Adverse Event|1|||
144316114|NCT01524224|520358146|FG006|Overall Study|Adverse Event|0|||
144316115|NCT01524224|520358147|FG007|Overall Study|Adverse Event|0|||
144316116|NCT01524224|520358140|FG000|Overall Study|Physician Decision|0|||
144316117|NCT01524224|520358141|FG001|Overall Study|Physician Decision|0|||
144316118|NCT01524224|520358142|FG002|Overall Study|Physician Decision|0|||
144316119|NCT01524224|520358143|FG003|Overall Study|Physician Decision|1|||
144316120|NCT01524224|520358144|FG004|Overall Study|Physician Decision|1|||
144316121|NCT01524224|520358145|FG005|Overall Study|Physician Decision|0|||
144316122|NCT01524224|520358146|FG006|Overall Study|Physician Decision|0|||
144316123|NCT01524224|520358147|FG007|Overall Study|Physician Decision|1|||
144316124|NCT01524224|520358140|FG000|Overall Study|Sponsor Decision|0|||
144316125|NCT01524224|520358141|FG001|Overall Study|Sponsor Decision|0|||
144316126|NCT01524224|520358142|FG002|Overall Study|Sponsor Decision|0|||
144316127|NCT01524224|520358143|FG003|Overall Study|Sponsor Decision|0|||
144316128|NCT01524224|520358144|FG004|Overall Study|Sponsor Decision|1|||
144316129|NCT01524224|520358145|FG005|Overall Study|Sponsor Decision|0|||
144316130|NCT01524224|520358146|FG006|Overall Study|Sponsor Decision|0|||
144316131|NCT01524224|520358147|FG007|Overall Study|Sponsor Decision|0|||
144316132|NCT02702609|520358149|FG000|Overall Study|Lost to Follow-up|8|||
144316133|NCT02702609|520358150|FG001|Overall Study|Lost to Follow-up|4|||
144316134|NCT02702609|520358149|FG000|Overall Study|Physician Decision|1|||
144316135|NCT02702609|520358150|FG001|Overall Study|Physician Decision|0|||
144316136|NCT00935493|520358151|FG000|Overall Study|Lost to Follow-up|1|||
144316137|NCT00935493|520358152|FG001|Overall Study|Lost to Follow-up|1|||
144316138|NCT00935493|520358153|FG002|Overall Study|Lost to Follow-up|1|||
144316139|NCT00935493|520358151|FG000|Overall Study|Treatment Discontinued|0|||
144316140|NCT00935493|520358152|FG001|Overall Study|Treatment Discontinued|1|||
144316141|NCT00935493|520358153|FG002|Overall Study|Treatment Discontinued|0|||
144316142|NCT02674464|520358154|FG000|Overall Study|Death|10|||
144316143|NCT02674464|520358155|FG001|Overall Study|Death|21|||
144316144|NCT02674464|520358154|FG000|Overall Study|Withdrawal by Subject|24|||
144316145|NCT02674464|520358155|FG001|Overall Study|Withdrawal by Subject|44|||
144316146|NCT02674464|520358154|FG000|Overall Study|Lost to Follow-up|97|||
144316147|NCT02674464|520358155|FG001|Overall Study|Lost to Follow-up|92|||
144316148|NCT02674464|520358154|FG000|Overall Study|Outside survey window|6|||
144316149|NCT02674464|520358155|FG001|Overall Study|Outside survey window|3|||
144316150|NCT00783835|520358156|FG000|Overall Study|Adverse Event|3|||
144316151|NCT00783835|520358156|FG000|Overall Study|Medical Criteria|1|||
144316152|NCT00783835|520358156|FG000|Overall Study|Withdrawal by Subject|2|||
144316153|NCT00783835|520358156|FG000|Overall Study|Lost to Follow-up|1|||
144316154|NCT00783835|520358156|FG000|Overall Study|Participant not Adherent|3|||
144316155|NCT01555073|520358157|FG000|Overall Study|Lost to Follow-up|1|||
144316156|NCT01555073|520358158|FG001|Overall Study|Lost to Follow-up|2|||
144316157|NCT01555073|520358159|FG002|Overall Study|Lost to Follow-up|0|||
144316158|NCT01555073|520358160|FG003|Overall Study|Lost to Follow-up|5|||
144316159|NCT04004221|520358161|FG000|Overall Study|Death|89|||
144316160|NCT04004221|520358161|FG000|Overall Study|Withdrawal by Subject|5|||
144316161|NCT04004221|520358161|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
144316162|NCT04004221|520358161|FG000|Overall Study|Sponsor Decision|9|||
144360028|NCT01601535|520525138|FG003|Phase 2|Withdrawal by Subject|0|||
144316163|NCT04004221|520358161|FG000|Overall Study|Participant refused to enter LTE|1|||
144316164|NCT02036580|520358164|FG000|Overall Study|Withdrawal by Subject|0|||
144316165|NCT02036580|520358165|FG001|Overall Study|Withdrawal by Subject|1|||
144316166|NCT02036580|520358166|FG002|Overall Study|Withdrawal by Subject|0|||
144316167|NCT02036580|520358164|FG000|Overall Study|Adverse Event|1|||
144316168|NCT02036580|520358165|FG001|Overall Study|Adverse Event|0|||
144316169|NCT02036580|520358166|FG002|Overall Study|Adverse Event|0|||
144316170|NCT00992056|520358167|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
144316171|NCT00992056|520358168|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
144316172|NCT00992056|520358167|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
144316173|NCT00992056|520358168|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
144316174|NCT01558596|520358169|FG000|Overall Study|Withdrawal by Subject|1|||
144316175|NCT01558596|520358170|FG001|Overall Study|Withdrawal by Subject|0|||
144316176|NCT01558596|520358169|FG000|Overall Study|surgery elsewhere or cancelled|1|||
144316177|NCT01558596|520358170|FG001|Overall Study|surgery elsewhere or cancelled|1|||
144316178|NCT01558596|520358169|FG000|Overall Study|Protocol Violation|1|||
144316179|NCT01558596|520358170|FG001|Overall Study|Protocol Violation|0|||
144316180|NCT01479764|520358171|FG000|Randomized|Adverse Event|1|||
144316181|NCT01479764|520358172|FG001|Randomized|Adverse Event|1|||
144316182|NCT01479764|520358171|FG000|Randomized|Withdrawal by Subject|1|||
144316183|NCT01479764|520358172|FG001|Randomized|Withdrawal by Subject|0|||
144316184|NCT01479764|520358171|FG000|Treated|Lost to Follow-up|0|||
144316185|NCT01479764|520358172|FG001|Treated|Lost to Follow-up|2|||
144316186|NCT00260832|520358173|FG000|Overall Study|Adverse Event|26|||
144316187|NCT00260832|520358174|FG001|Overall Study|Adverse Event|19|||
144316188|NCT00260832|520358173|FG000|Overall Study|Progression|116|||
144316189|NCT00260832|520358174|FG001|Overall Study|Progression|96|||
144316190|NCT00260832|520358173|FG000|Overall Study|Withdrawal by Subject|15|||
144316191|NCT00260832|520358174|FG001|Overall Study|Withdrawal by Subject|17|||
144316192|NCT00260832|520358173|FG000|Overall Study|Physician Decision|15|||
144316193|NCT00260832|520358174|FG001|Overall Study|Physician Decision|9|||
144316194|NCT00260832|520358173|FG000|Overall Study|Death|43|||
144316195|NCT00260832|520358174|FG001|Overall Study|Death|62|||
144316196|NCT00260832|520358173|FG000|Overall Study|Other|10|||
144316197|NCT00260832|520358174|FG001|Overall Study|Other|7|||
144316198|NCT00260832|520358173|FG000|Overall Study|Protocol Violation|3|||
144316199|NCT00260832|520358174|FG001|Overall Study|Protocol Violation|1|||
144316200|NCT00902850|520358175|FG000|Overall Study|Physician Decision|2|||
144316201|NCT00902850|520358176|FG001|Overall Study|Physician Decision|2|||
144316202|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
144316203|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
144316204|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
144316205|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144316206|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144316207|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144316208|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
144316209|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
144316210|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144316211|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144316212|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144316213|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144316214|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144316215|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
144316216|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
144316217|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
144316218|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
144316219|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144316220|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144316221|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144316222|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
144316223|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
144316224|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
144316225|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144316226|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144316227|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144316228|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144316229|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
144316230|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
144316231|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
144316232|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
144316233|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
144316234|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
144316235|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
144316236|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
144316237|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144316238|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
144316239|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144316240|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144316241|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144316242|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144316243|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
144316244|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
144316245|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
144316246|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
144316247|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144316248|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144316249|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144316250|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
144316251|NCT03745638|520358179|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
144316252|NCT03745638|520358180|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
144316253|NCT03745638|520358181|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
144316254|NCT03745638|520358182|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
144316255|NCT03745638|520358183|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
144316256|NCT03745638|520358184|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
144316257|NCT03745638|520358185|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
144316258|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144316259|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144316260|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144316261|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144316262|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
144316263|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
144316264|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
144316265|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144316266|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144316267|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144316268|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
144316269|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
144316270|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
144316271|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
144316272|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144316273|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144316274|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
144316275|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
144316276|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
144316277|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
144316278|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
144316279|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144316280|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144316281|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144316282|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144316283|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
144316284|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
144316285|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
144316286|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144316287|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144316288|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144316289|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144316290|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144316291|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
144316292|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
144316293|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144316294|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144316295|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
144316296|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
144316297|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
144316298|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
144316299|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
144316300|NCT03745638|520358179|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
144316301|NCT03745638|520358180|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
144316302|NCT03745638|520358181|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
144316303|NCT03745638|520358182|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
144316304|NCT03745638|520358183|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
144316305|NCT03745638|520358184|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
144316306|NCT03745638|520358185|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
144316307|NCT01270880|520358196|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
144316308|NCT00976716|520358197|FG000|Overall Study|Adverse Event|1|||
144316309|NCT04222699|520358204|FG000|Overall Study|Lost to Follow-up|2|||
144316310|NCT04552288|520358210|FG000|Overall Study|Death|3|||
144316311|NCT04552288|520358210|FG000|Overall Study|Lost to Follow-up|6|||
144316312|NCT04552288|520358210|FG000|Overall Study|Physician Decision|3|||
144316313|NCT04552288|520358210|FG000|Overall Study|Protocol Violation|9|||
144316314|NCT04552288|520358210|FG000|Overall Study|Withdrawal by Subject|6|||
144316315|NCT04552288|520358210|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
144316316|NCT03583359|520358211|FG000|Overall Study|Withdrawal by Subject|15|||
144316317|NCT03583359|520358212|FG001|Overall Study|Withdrawal by Subject|6|||
144316318|NCT03583359|520358211|FG000|Overall Study|Lost to Follow-up|12|||
144316319|NCT03583359|520358212|FG001|Overall Study|Lost to Follow-up|3|||
144316320|NCT03583359|520358211|FG000|Overall Study|Adverse Event|0|||
144316321|NCT03583359|520358212|FG001|Overall Study|Adverse Event|1|||
144316322|NCT03583359|520358211|FG000|Overall Study|Protocol Violation|0|||
144316323|NCT03583359|520358212|FG001|Overall Study|Protocol Violation|1|||
144316324|NCT03583359|520358211|FG000|Overall Study|Other|2|||
144316325|NCT03583359|520358212|FG001|Overall Study|Other|1|||
144316326|NCT01831466|520358218|FG000|Overall Study|Protocol Violation|1|||
144316327|NCT01831466|520358219|FG001|Overall Study|Protocol Violation|1|||
144316328|NCT01831466|520358220|FG002|Overall Study|Protocol Violation|2|||
144316329|NCT01831466|520358221|FG003|Overall Study|Protocol Violation|0|||
144316330|NCT01831466|520358222|FG004|Overall Study|Protocol Violation|0|||
144316331|NCT01831466|520358223|FG005|Overall Study|Protocol Violation|1|||
144316332|NCT01831466|520358224|FG006|Overall Study|Protocol Violation|0|||
144316333|NCT01831466|520358225|FG007|Overall Study|Protocol Violation|0|||
144316334|NCT01831466|520358226|FG008|Overall Study|Protocol Violation|0|||
144316335|NCT01831466|520358227|FG009|Overall Study|Protocol Violation|0|||
144316336|NCT01831466|520358228|FG010|Overall Study|Protocol Violation|0|||
144316337|NCT01831466|520358229|FG011|Overall Study|Protocol Violation|0|||
144316338|NCT01831466|520358218|FG000|Overall Study|Other|2|||
144316339|NCT01831466|520358219|FG001|Overall Study|Other|3|||
144316340|NCT01831466|520358220|FG002|Overall Study|Other|2|||
144316341|NCT01831466|520358221|FG003|Overall Study|Other|2|||
144316342|NCT01831466|520358222|FG004|Overall Study|Other|2|||
144316343|NCT01831466|520358223|FG005|Overall Study|Other|1|||
144316344|NCT01831466|520358224|FG006|Overall Study|Other|0|||
144316345|NCT01831466|520358225|FG007|Overall Study|Other|0|||
144316346|NCT01831466|520358226|FG008|Overall Study|Other|0|||
144316347|NCT01831466|520358227|FG009|Overall Study|Other|0|||
144316348|NCT01831466|520358228|FG010|Overall Study|Other|0|||
144316349|NCT01831466|520358229|FG011|Overall Study|Other|0|||
144316350|NCT01831466|520358218|FG000|Overall Study|Non-compliance with study treatment|2|||
144316351|NCT01831466|520358219|FG001|Overall Study|Non-compliance with study treatment|1|||
144316352|NCT01831466|520358220|FG002|Overall Study|Non-compliance with study treatment|1|||
144316353|NCT01831466|520358221|FG003|Overall Study|Non-compliance with study treatment|0|||
144316354|NCT01831466|520358222|FG004|Overall Study|Non-compliance with study treatment|0|||
144316355|NCT01831466|520358223|FG005|Overall Study|Non-compliance with study treatment|1|||
144316356|NCT01831466|520358224|FG006|Overall Study|Non-compliance with study treatment|0|||
144316357|NCT01831466|520358225|FG007|Overall Study|Non-compliance with study treatment|0|||
144316358|NCT01831466|520358226|FG008|Overall Study|Non-compliance with study treatment|0|||
144316359|NCT01831466|520358227|FG009|Overall Study|Non-compliance with study treatment|0|||
144316360|NCT01831466|520358228|FG010|Overall Study|Non-compliance with study treatment|0|||
144316361|NCT01831466|520358229|FG011|Overall Study|Non-compliance with study treatment|0|||
144316362|NCT01831466|520358218|FG000|Overall Study|Death|0|||
144316363|NCT01831466|520358219|FG001|Overall Study|Death|1|||
144316364|NCT01831466|520358220|FG002|Overall Study|Death|0|||
144316365|NCT01831466|520358221|FG003|Overall Study|Death|0|||
144316366|NCT01831466|520358222|FG004|Overall Study|Death|0|||
144316367|NCT01831466|520358223|FG005|Overall Study|Death|0|||
144316368|NCT01831466|520358224|FG006|Overall Study|Death|0|||
144316369|NCT01831466|520358225|FG007|Overall Study|Death|0|||
144316370|NCT01831466|520358226|FG008|Overall Study|Death|0|||
144316371|NCT01831466|520358227|FG009|Overall Study|Death|0|||
144316372|NCT01831466|520358228|FG010|Overall Study|Death|0|||
144316373|NCT01831466|520358229|FG011|Overall Study|Death|0|||
144316374|NCT01831466|520358218|FG000|Overall Study|Withdrawal by Subject|6|||
144316375|NCT01831466|520358219|FG001|Overall Study|Withdrawal by Subject|3|||
144316376|NCT01831466|520358220|FG002|Overall Study|Withdrawal by Subject|3|||
144316377|NCT01831466|520358221|FG003|Overall Study|Withdrawal by Subject|3|||
144316378|NCT01831466|520358222|FG004|Overall Study|Withdrawal by Subject|3|||
144316379|NCT01831466|520358223|FG005|Overall Study|Withdrawal by Subject|5|||
144316380|NCT01831466|520358224|FG006|Overall Study|Withdrawal by Subject|0|||
144316381|NCT01831466|520358225|FG007|Overall Study|Withdrawal by Subject|0|||
144316382|NCT01831466|520358226|FG008|Overall Study|Withdrawal by Subject|0|||
144316383|NCT01831466|520358227|FG009|Overall Study|Withdrawal by Subject|1|||
144316384|NCT01831466|520358228|FG010|Overall Study|Withdrawal by Subject|0|||
144316385|NCT01831466|520358229|FG011|Overall Study|Withdrawal by Subject|1|||
144316386|NCT01831466|520358218|FG000|Overall Study|Lost to Follow-up|0|||
144316387|NCT01831466|520358219|FG001|Overall Study|Lost to Follow-up|1|||
144316388|NCT01831466|520358220|FG002|Overall Study|Lost to Follow-up|4|||
144316389|NCT01831466|520358221|FG003|Overall Study|Lost to Follow-up|2|||
144316390|NCT01831466|520358222|FG004|Overall Study|Lost to Follow-up|0|||
144316391|NCT01831466|520358223|FG005|Overall Study|Lost to Follow-up|3|||
144316392|NCT01831466|520358224|FG006|Overall Study|Lost to Follow-up|0|||
144316393|NCT01831466|520358225|FG007|Overall Study|Lost to Follow-up|0|||
144316394|NCT01831466|520358226|FG008|Overall Study|Lost to Follow-up|0|||
144316395|NCT01831466|520358227|FG009|Overall Study|Lost to Follow-up|1|||
144316396|NCT01831466|520358228|FG010|Overall Study|Lost to Follow-up|0|||
144316397|NCT01831466|520358229|FG011|Overall Study|Lost to Follow-up|1|||
144316398|NCT01831466|520358218|FG000|Overall Study|Lack of Efficacy|5|||
144316399|NCT01831466|520358219|FG001|Overall Study|Lack of Efficacy|8|||
144316400|NCT01831466|520358220|FG002|Overall Study|Lack of Efficacy|7|||
144316401|NCT01831466|520358221|FG003|Overall Study|Lack of Efficacy|6|||
144316402|NCT01831466|520358222|FG004|Overall Study|Lack of Efficacy|9|||
144316403|NCT01831466|520358223|FG005|Overall Study|Lack of Efficacy|8|||
144316404|NCT01831466|520358224|FG006|Overall Study|Lack of Efficacy|1|||
144316405|NCT01831466|520358225|FG007|Overall Study|Lack of Efficacy|1|||
144316406|NCT01831466|520358226|FG008|Overall Study|Lack of Efficacy|2|||
144316407|NCT01831466|520358227|FG009|Overall Study|Lack of Efficacy|2|||
144316408|NCT01831466|520358228|FG010|Overall Study|Lack of Efficacy|2|||
144316409|NCT01831466|520358229|FG011|Overall Study|Lack of Efficacy|0|||
144316410|NCT01831466|520358218|FG000|Overall Study|Adverse Event|0|||
144316411|NCT01831466|520358219|FG001|Overall Study|Adverse Event|0|||
144316412|NCT01831466|520358220|FG002|Overall Study|Adverse Event|4|||
144316413|NCT01831466|520358221|FG003|Overall Study|Adverse Event|6|||
144316414|NCT01831466|520358222|FG004|Overall Study|Adverse Event|3|||
144316415|NCT01831466|520358223|FG005|Overall Study|Adverse Event|7|||
144316416|NCT01831466|520358224|FG006|Overall Study|Adverse Event|0|||
144316417|NCT01831466|520358225|FG007|Overall Study|Adverse Event|1|||
144316418|NCT01831466|520358226|FG008|Overall Study|Adverse Event|1|||
144316419|NCT01831466|520358227|FG009|Overall Study|Adverse Event|1|||
144316420|NCT01831466|520358228|FG010|Overall Study|Adverse Event|0|||
144316421|NCT01831466|520358229|FG011|Overall Study|Adverse Event|2|||
144316422|NCT02798315|520358230|FG000|Overall Study|Failure to return|1|||
144316423|NCT00005947|520358231|FG000|Overall Study|Death|54|||
144316424|NCT00005947|520358232|FG001|Overall Study|Death|40|||
144316425|NCT00005947|520358231|FG000|Overall Study|Patient Refused to Continue|2|||
144316426|NCT00005947|520358232|FG001|Overall Study|Patient Refused to Continue|1|||
144316427|NCT00005947|520358231|FG000|Overall Study|Site Closure|1|||
144316428|NCT00005947|520358232|FG001|Overall Study|Site Closure|0|||
144316429|NCT02146131|520358234|FG000|Overall Study|Physician Decision|61|||
144316430|NCT02146131|520358235|FG001|Overall Study|Physician Decision|56|||
144316431|NCT02567799|520358236|FG000|Concurrent Chemoradiotherapy|Death|1|||
144316432|NCT02567799|520358237|FG001|Concurrent Chemoradiotherapy|Death|0|||
144316433|NCT02567799|520358238|FG002|Concurrent Chemoradiotherapy|Death|0|||
144316434|NCT02567799|520358236|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
144316435|NCT02567799|520358237|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
144316436|NCT02567799|520358238|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
144316437|NCT02567799|520358236|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
144316438|NCT02567799|520358237|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
144316439|NCT02567799|520358238|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
144316440|NCT02567799|520358236|FG000|Follow-up|Death|1|||
144316441|NCT02567799|520358237|FG001|Follow-up|Death|0|||
144316442|NCT02567799|520358238|FG002|Follow-up|Death|1|||
144316443|NCT02567799|520358236|FG000|Follow-up|Progressive Disease|1|||
144316444|NCT02567799|520358237|FG001|Follow-up|Progressive Disease|1|||
144316445|NCT02567799|520358238|FG002|Follow-up|Progressive Disease|3|||
144316446|NCT05356910|520358245|FG000|Overall Study|Lost to Follow-up|10|||
144316447|NCT05356910|520358246|FG001|Overall Study|Lost to Follow-up|19|||
144316448|NCT05356910|520358247|FG002|Overall Study|Lost to Follow-up|0|||
144316449|NCT05356910|520358248|FG003|Overall Study|Lost to Follow-up|0|||
144316450|NCT05356910|520358245|FG000|Overall Study|Withdrawal by Subject|4|||
144316451|NCT05356910|520358246|FG001|Overall Study|Withdrawal by Subject|2|||
144316452|NCT05356910|520358247|FG002|Overall Study|Withdrawal by Subject|0|||
144316453|NCT05356910|520358248|FG003|Overall Study|Withdrawal by Subject|0|||
144316454|NCT01659996|520358250|FG000|Overall Study|Protocol Violation|3|||
144316455|NCT01659996|520358251|FG001|Overall Study|Protocol Violation|3|||
144316456|NCT01659996|520358252|FG002|Overall Study|Protocol Violation|3|||
144316457|NCT01659996|520358250|FG000|Overall Study|Lost to Follow-up|1|||
144316458|NCT01659996|520358251|FG001|Overall Study|Lost to Follow-up|3|||
144316459|NCT01659996|520358252|FG002|Overall Study|Lost to Follow-up|2|||
144316460|NCT01659996|520358250|FG000|Overall Study|Adverse Event|0|||
144316461|NCT01659996|520358251|FG001|Overall Study|Adverse Event|0|||
144316462|NCT01659996|520358252|FG002|Overall Study|Adverse Event|1|||
144316463|NCT01659996|520358250|FG000|Overall Study|Withdrawal by Subject|4|||
144316464|NCT01659996|520358251|FG001|Overall Study|Withdrawal by Subject|1|||
144316465|NCT01659996|520358252|FG002|Overall Study|Withdrawal by Subject|5|||
144316466|NCT02547038|520359658|FG000|Overall Study|Lost to Follow-up|3|||
144316467|NCT02547038|520359659|FG001|Overall Study|Lost to Follow-up|2|||
144316468|NCT00623233|520359660|FG000|Overall Study|Adverse Event|10|||
144316469|NCT00623233|520359660|FG000|Overall Study|Physician Decision|10|||
144316470|NCT00623233|520359660|FG000|Overall Study|Lost to Follow-up|1|||
144316471|NCT00623233|520359660|FG000|Overall Study|Withdrawal by Subject|3|||
144316472|NCT00559845|520359661|FG000|Overall Study|Withdrew Consent|1|||
144316473|NCT00559845|520359661|FG000|Overall Study|Disease Progression|1|||
144316474|NCT00559845|520359661|FG000|Overall Study|Adverse Event|3|||
144316475|NCT00559845|520359661|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
144316476|NCT00559845|520359661|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
144316477|NCT00459875|520359662|FG000|Overall Study|Ineligible participant|1|||
144316478|NCT00459875|520359662|FG000|Overall Study|Adverse Event|2|||
144316479|NCT02150057|520359663|FG000|Overall Study|Lost to Follow-up|6|||
144316480|NCT02150057|520359664|FG001|Overall Study|Lost to Follow-up|4|||
144316481|NCT01558115|520359665|FG000|Overall Study|Withdrawal by Subject|3|||
144316482|NCT01558115|520359665|FG000|Overall Study|Study closed due to poor enrollment|4|||
144316483|NCT01696994|520359666|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
144316484|NCT01696994|520359667|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
144316485|NCT01696994|520359666|FG000|Overall Study|Died Before Randomization|1|||
144316486|NCT01696994|520359667|FG001|Overall Study|Died Before Randomization|2|||
144316487|NCT01696994|520359666|FG000|Overall Study|Died Before ASU (Control)|73|||
144316488|NCT01696994|520359667|FG001|Overall Study|Died Before ASU (Control)|0|||
144316489|NCT01696994|520359666|FG000|Overall Study|No Ovaries at Baseline|4807|||
144316490|NCT01696994|520359667|FG001|Overall Study|No Ovaries at Baseline|4851|||
144316491|NCT01696994|520359666|FG000|Overall Study|Refused ASU (Control)|311|||
144316492|NCT01696994|520359667|FG001|Overall Study|Refused ASU (Control)|0|||
144316493|NCT01696994|520359666|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
144316494|NCT01696994|520359667|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
144316495|NCT00576628|520359668|FG000|Overall Study|Adverse Event|11|||
144316496|NCT00576628|520359668|FG000|Overall Study|Death|2|||
144316497|NCT00576628|520359668|FG000|Overall Study|Failure to return|1|||
144316498|NCT00576628|520359668|FG000|Overall Study|Refused Treatment|8|||
144316499|NCT00576628|520359668|FG000|Overall Study|Pregnancy|1|||
144316500|NCT00576628|520359668|FG000|Overall Study|RBC transfusion|1|||
144316501|NCT00576628|520359668|FG000|Overall Study|Progression of Kidney Disease|1|||
144316502|NCT00576628|520359668|FG000|Overall Study|Progression of Renal Failure|1|||
144316503|NCT00576628|520359668|FG000|Overall Study|The patient move into other town|1|||
144316504|NCT00576628|520359668|FG000|Overall Study|Transplantation|1|||
144316505|NCT00576628|520359668|FG000|Overall Study|Dialysis|15|||
144316506|NCT02516982|520359669|FG000|Overall Study|Called in to antenatal appointment|32|||
144316507|NCT02516982|520359670|FG001|Overall Study|Called in to antenatal appointment|35|||
144316508|NCT02516982|520359671|FG002|Overall Study|Called in to antenatal appointment|0|||
144316509|NCT02516982|520359672|FG003|Overall Study|Called in to antenatal appointment|0|||
144316510|NCT02516982|520359669|FG000|Overall Study|Withdrawal by Subject|0|||
144316511|NCT02516982|520359670|FG001|Overall Study|Withdrawal by Subject|0|||
144316512|NCT02516982|520359671|FG002|Overall Study|Withdrawal by Subject|1|||
144316513|NCT02516982|520359672|FG003|Overall Study|Withdrawal by Subject|2|||
144316514|NCT02516982|520359669|FG000|Overall Study|Protocol Violation|0|||
144316515|NCT02516982|520359670|FG001|Overall Study|Protocol Violation|0|||
144316516|NCT02516982|520359671|FG002|Overall Study|Protocol Violation|1|||
144316517|NCT02516982|520359672|FG003|Overall Study|Protocol Violation|1|||
144316518|NCT02516982|520359669|FG000|Overall Study|Did not install the app|0|||
144316519|NCT02516982|520359670|FG001|Overall Study|Did not install the app|0|||
144316520|NCT02516982|520359671|FG002|Overall Study|Did not install the app|46|||
144316521|NCT02516982|520359672|FG003|Overall Study|Did not install the app|47|||
144316522|NCT01951586|520359675|FG000|Overall Study|Death|61|||
144316523|NCT01951586|520359676|FG001|Overall Study|Death|120|||
144316524|NCT01951586|520359675|FG000|Overall Study|Withdrawal by Subject|8|||
144316525|NCT01951586|520359676|FG001|Overall Study|Withdrawal by Subject|17|||
144316526|NCT01951586|520359675|FG000|Overall Study|Lost to Follow-up|0|||
144316527|NCT01951586|520359676|FG001|Overall Study|Lost to Follow-up|1|||
144316528|NCT01951586|520359675|FG000|Overall Study|Sponsor Decision|9|||
144316529|NCT01951586|520359676|FG001|Overall Study|Sponsor Decision|10|||
144316530|NCT00962741|520359677|FG000|Overall Study|Failed to return|3|||
144316531|NCT00962741|520359677|FG000|Overall Study|Lost to Follow-up|2|||
144316532|NCT00962741|520359677|FG000|Overall Study|Withdrawal by Subject|1|||
144316533|NCT00962741|520359677|FG000|Overall Study|Lack of Efficacy|1|||
144316534|NCT00962741|520359677|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
144316535|NCT01995526|520359680|FG000|Overall Study|Physician Decision|1|||
144316536|NCT01977729|520359681|FG000|Overall Study|Study terminated|1|||
144316537|NCT00104416|520359682|FG000|Double-Blind Phase|Adverse Event|2|||
144316538|NCT00104416|520359683|FG001|Double-Blind Phase|Adverse Event|1|||
144316539|NCT00104416|520359684|FG002|Double-Blind Phase|Adverse Event|0|||
144316540|NCT00104416|520359685|FG003|Double-Blind Phase|Adverse Event|0|||
144316541|NCT00104416|520359686|FG004|Double-Blind Phase|Adverse Event|0|||
144316542|NCT00104416|520359682|FG000|Double-Blind Phase|Lost to Follow-up|0|||
144316543|NCT00104416|520359683|FG001|Double-Blind Phase|Lost to Follow-up|1|||
144316544|NCT00104416|520359684|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144316545|NCT00104416|520359685|FG003|Double-Blind Phase|Lost to Follow-up|0|||
144316546|NCT00104416|520359686|FG004|Double-Blind Phase|Lost to Follow-up|0|||
144316547|NCT00104416|520359682|FG000|Double-Blind Phase|Protocol Violation|0|||
144316548|NCT00104416|520359683|FG001|Double-Blind Phase|Protocol Violation|1|||
144316549|NCT00104416|520359684|FG002|Double-Blind Phase|Protocol Violation|0|||
144316550|NCT00104416|520359685|FG003|Double-Blind Phase|Protocol Violation|0|||
144316551|NCT00104416|520359686|FG004|Double-Blind Phase|Protocol Violation|0|||
144316552|NCT00104416|520359682|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
144316553|NCT00104416|520359683|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
144316554|NCT00104416|520359684|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144316555|NCT00104416|520359685|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144316556|NCT00104416|520359686|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
144316557|NCT00104416|520359682|FG000|Double-Blind Phase|Pregnancy|1|||
144316558|NCT00104416|520359683|FG001|Double-Blind Phase|Pregnancy|0|||
144316559|NCT00104416|520359684|FG002|Double-Blind Phase|Pregnancy|0|||
144316560|NCT00104416|520359685|FG003|Double-Blind Phase|Pregnancy|0|||
144316561|NCT00104416|520359686|FG004|Double-Blind Phase|Pregnancy|0|||
144316562|NCT00104416|520359682|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
144316563|NCT00104416|520359683|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
144316564|NCT00104416|520359684|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
144316565|NCT00104416|520359685|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
144316566|NCT00104416|520359686|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
144316567|NCT00104416|520359682|FG000|Continuation Phase|Adverse Event|0|||
144316568|NCT00104416|520359683|FG001|Continuation Phase|Adverse Event|0|||
144316569|NCT00104416|520359684|FG002|Continuation Phase|Adverse Event|2|||
144316570|NCT00104416|520359685|FG003|Continuation Phase|Adverse Event|0|||
144316571|NCT00104416|520359686|FG004|Continuation Phase|Adverse Event|2|||
144316572|NCT00104416|520359682|FG000|Continuation Phase|Lost to Follow-up|0|||
144316573|NCT00104416|520359683|FG001|Continuation Phase|Lost to Follow-up|0|||
144316574|NCT00104416|520359684|FG002|Continuation Phase|Lost to Follow-up|1|||
144316575|NCT00104416|520359685|FG003|Continuation Phase|Lost to Follow-up|0|||
144316576|NCT00104416|520359686|FG004|Continuation Phase|Lost to Follow-up|1|||
144316577|NCT00104416|520359682|FG000|Continuation Phase|Withdrawal by Subject|0|||
144316578|NCT00104416|520359683|FG001|Continuation Phase|Withdrawal by Subject|0|||
144316579|NCT00104416|520359684|FG002|Continuation Phase|Withdrawal by Subject|2|||
144316580|NCT00104416|520359685|FG003|Continuation Phase|Withdrawal by Subject|1|||
144316581|NCT00104416|520359686|FG004|Continuation Phase|Withdrawal by Subject|1|||
144316582|NCT00104416|520359682|FG000|Continuation Phase|Pregnancy|0|||
144316583|NCT00104416|520359683|FG001|Continuation Phase|Pregnancy|0|||
144316584|NCT00104416|520359684|FG002|Continuation Phase|Pregnancy|1|||
144316585|NCT00104416|520359685|FG003|Continuation Phase|Pregnancy|1|||
144316586|NCT00104416|520359686|FG004|Continuation Phase|Pregnancy|0|||
144316587|NCT00104416|520359682|FG000|Continuation Phase|Non-compliance|0|||
144316588|NCT00104416|520359683|FG001|Continuation Phase|Non-compliance|0|||
144316589|NCT00104416|520359684|FG002|Continuation Phase|Non-compliance|0|||
144316590|NCT00104416|520359685|FG003|Continuation Phase|Non-compliance|0|||
144316591|NCT00104416|520359686|FG004|Continuation Phase|Non-compliance|1|||
144316592|NCT00438360|520359687|FG000|Overall Study|Adverse Event|6|||
144316593|NCT00438360|520359688|FG001|Overall Study|Adverse Event|1|||
144316594|NCT00438360|520359687|FG000|Overall Study|Lack of Efficacy|42|||
144316595|NCT00438360|520359688|FG001|Overall Study|Lack of Efficacy|27|||
144316596|NCT00438360|520359687|FG000|Overall Study|Other|24|||
144316597|NCT00438360|520359688|FG001|Overall Study|Other|15|||
144316598|NCT00758069|520359689|FG000|Overall Study|Lack of Efficacy|0|||
144316599|NCT00758069|520359690|FG001|Overall Study|Lack of Efficacy|0|||
144316600|NCT00758069|520359691|FG002|Overall Study|Lack of Efficacy|1|||
144316601|NCT00758069|520359689|FG000|Overall Study|Incorrect Study Drug|1|||
144316602|NCT00758069|520359690|FG001|Overall Study|Incorrect Study Drug|0|||
144316603|NCT00758069|520359691|FG002|Overall Study|Incorrect Study Drug|0|||
144316604|NCT02277691|520359692|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
144316605|NCT02277691|520359692|FG000|Overall Study|Voluntary Withdrawal|7|||
144316606|NCT02277691|520359692|FG000|Overall Study|Lack of Efficacy|5|||
144316607|NCT02277691|520359692|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
144316608|NCT01147250|520359693|FG000|Overall Study|Lost to Follow-up|14|||
144316609|NCT01147250|520359694|FG001|Overall Study|Lost to Follow-up|11|||
144316610|NCT01147250|520359693|FG000|Overall Study|Withdrawal by Subject|83|||
144316611|NCT01147250|520359694|FG001|Overall Study|Withdrawal by Subject|88|||
144316612|NCT01147250|520359693|FG000|Overall Study|Site termination by sponsor|13|||
144316613|NCT01147250|520359694|FG001|Overall Study|Site termination by sponsor|5|||
144316614|NCT01147250|520359693|FG000|Overall Study|Other than specified|0|||
144316615|NCT01147250|520359694|FG001|Overall Study|Other than specified|1|||
144316616|NCT02684617|520359695|FG000|Overall Study|Adverse Event|1|||
144316617|NCT02684617|520359696|FG001|Overall Study|Adverse Event|0|||
144316618|NCT02684617|520359697|FG002|Overall Study|Adverse Event|1|||
144316619|NCT02684617|520359695|FG000|Overall Study|Death|8|||
144316620|NCT02684617|520359696|FG001|Overall Study|Death|16|||
144316621|NCT02684617|520359697|FG002|Overall Study|Death|28|||
144316622|NCT02684617|520359695|FG000|Overall Study|Withdrawal by Subject|2|||
144316623|NCT02684617|520359696|FG001|Overall Study|Withdrawal by Subject|0|||
144316624|NCT02684617|520359697|FG002|Overall Study|Withdrawal by Subject|4|||
144316625|NCT02684617|520359695|FG000|Overall Study|Screen Failure|1|||
144316626|NCT02684617|520359696|FG001|Overall Study|Screen Failure|0|||
144316627|NCT02684617|520359697|FG002|Overall Study|Screen Failure|2|||
144316628|NCT02684617|520359695|FG000|Overall Study|Study Terminated by Sponsor|6|||
144316629|NCT02684617|520359696|FG001|Overall Study|Study Terminated by Sponsor|1|||
144316630|NCT02684617|520359697|FG002|Overall Study|Study Terminated by Sponsor|5|||
144316631|NCT01164891|520359698|FG000|Overall Study|Disease Progression|5|||
144316632|NCT01164891|520359698|FG000|Overall Study|Adverse Event|1|||
144316633|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
144316634|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
144316635|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
144316636|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
144316637|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
144316638|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
144316639|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
144316640|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
144316641|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144316642|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144316643|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144316644|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144316645|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
144316646|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
144316647|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144316648|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144316649|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144316650|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144316651|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
144316652|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
144316653|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
144316654|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
144316655|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
144316656|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
144316657|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144316658|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
144316659|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144316660|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144316661|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144316662|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144316663|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
144316664|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
144316665|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
144316666|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
144316667|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
144316668|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
144316669|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
144316670|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
144316671|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
144360029|NCT01601535|520525139|FG004|Phase 2|Withdrawal by Subject|8|||
144316672|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
144316673|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
144316674|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
144316675|NCT03985943|520359699|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
144316676|NCT03985943|520359700|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
144316677|NCT03985943|520359701|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
144316678|NCT03985943|520359702|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
144316679|NCT03985943|520359703|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
144316680|NCT03985943|520359704|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
144316681|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144316682|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144316683|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
144316684|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
144316685|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
144316686|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
144316687|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144316688|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144316689|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
144316690|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
144316691|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
144316692|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
144316693|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
144316694|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
144316695|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
144316696|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
144316697|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
144316698|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
144316699|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144316700|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144316701|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144316702|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
144316703|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
144316704|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
144316705|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
144316706|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
144316707|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
144316708|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
144316709|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
144316710|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
144316711|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
144316712|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
144316713|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
144316714|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
144316715|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
144316716|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
144316717|NCT03985943|520359699|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
144316718|NCT03985943|520359700|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
144316719|NCT03985943|520359701|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
144316720|NCT03985943|520359702|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
144316721|NCT03985943|520359703|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
144316722|NCT03985943|520359704|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
144316723|NCT00441142|520359705|FG000|Overall Study|Adverse Event|2|||
144316724|NCT00441142|520359706|FG001|Overall Study|Adverse Event|3|||
144316725|NCT00441142|520359707|FG002|Overall Study|Adverse Event|3|||
144316726|NCT00441142|520359708|FG003|Overall Study|Adverse Event|22|||
144316727|NCT00441142|520359705|FG000|Overall Study|Lack of Efficacy|3|||
144316728|NCT00441142|520359706|FG001|Overall Study|Lack of Efficacy|3|||
144316729|NCT00441142|520359707|FG002|Overall Study|Lack of Efficacy|17|||
144316730|NCT00441142|520359708|FG003|Overall Study|Lack of Efficacy|32|||
144316731|NCT00441142|520359705|FG000|Overall Study|Withdrawal by Subject|0|||
144316732|NCT00441142|520359706|FG001|Overall Study|Withdrawal by Subject|0|||
144316733|NCT00441142|520359707|FG002|Overall Study|Withdrawal by Subject|2|||
144316734|NCT00441142|520359708|FG003|Overall Study|Withdrawal by Subject|10|||
144316735|NCT00441142|520359705|FG000|Overall Study|Patient still receiving active study tx|1|||
144316736|NCT00441142|520359706|FG001|Overall Study|Patient still receiving active study tx|0|||
144316737|NCT00441142|520359707|FG002|Overall Study|Patient still receiving active study tx|0|||
144316738|NCT00441142|520359708|FG003|Overall Study|Patient still receiving active study tx|2|||
144316739|NCT00441142|520359705|FG000|Overall Study|Physician Decision|0|||
144316740|NCT00441142|520359706|FG001|Overall Study|Physician Decision|1|||
144316741|NCT00441142|520359707|FG002|Overall Study|Physician Decision|0|||
144316742|NCT00441142|520359708|FG003|Overall Study|Physician Decision|1|||
144316743|NCT00441142|520359705|FG000|Overall Study|Death|0|||
144316744|NCT00441142|520359706|FG001|Overall Study|Death|0|||
144316745|NCT00441142|520359707|FG002|Overall Study|Death|0|||
144316746|NCT00441142|520359708|FG003|Overall Study|Death|1|||
144316747|NCT00338286|520359709|FG000|Overall Study|Withdrawal by Subject|50|||
144316748|NCT00338286|520359710|FG001|Overall Study|Withdrawal by Subject|54|||
144316749|NCT00338286|520359709|FG000|Overall Study|Lost to Follow-up|80|||
144316750|NCT00338286|520359710|FG001|Overall Study|Lost to Follow-up|66|||
144316751|NCT00338286|520359709|FG000|Overall Study|Other|103|||
144316752|NCT00338286|520359710|FG001|Overall Study|Other|93|||
144316753|NCT01265563|520359711|FG000|Overall Study|Withdrawal by Subject|0|||
144316754|NCT01265563|520359712|FG001|Overall Study|Withdrawal by Subject|1|||
144316755|NCT01265563|520359713|FG002|Overall Study|Withdrawal by Subject|1|||
144316756|NCT01265563|520359714|FG003|Overall Study|Withdrawal by Subject|0|||
144316757|NCT01265563|520359715|FG004|Overall Study|Withdrawal by Subject|2|||
144316758|NCT03517371|520359718|FG000|Overall Study|Adverse Event|8|||
144316759|NCT03517371|520359719|FG001|Overall Study|Adverse Event|9|||
144316760|NCT03517371|520359718|FG000|Overall Study|Lost to Follow-up|1|||
144316761|NCT03517371|520359719|FG001|Overall Study|Lost to Follow-up|2|||
144316762|NCT03517371|520359718|FG000|Overall Study|Withdrawal by Subject|4|||
144316763|NCT03517371|520359719|FG001|Overall Study|Withdrawal by Subject|4|||
144316764|NCT03517371|520359718|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
144316765|NCT03517371|520359719|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
144316766|NCT03517371|520359718|FG000|Overall Study|COVID restrictions|2|||
144316767|NCT03517371|520359719|FG001|Overall Study|COVID restrictions|0|||
144316768|NCT03517371|520359718|FG000|Overall Study|Receiving DBS Surgery|0|||
144316769|NCT03517371|520359719|FG001|Overall Study|Receiving DBS Surgery|1|||
144316770|NCT05411822|520359720|FG000|Overall Study|Withdrawal by Subject|2|||
144316771|NCT05411822|520359721|FG001|Overall Study|Withdrawal by Subject|1|||
144316772|NCT05312697|520359722|FG000|Overall Study|Sponsor Terminated Trial|2|||
144316773|NCT04283656|520359723|FG000|Overall Study|Adverse Event|1|||
144316774|NCT04283656|520359724|FG001|Overall Study|Adverse Event|0|||
144316775|NCT04283656|520359723|FG000|Overall Study|Lost to Follow-up|0|||
144316776|NCT04283656|520359724|FG001|Overall Study|Lost to Follow-up|1|||
144316777|NCT02819297|520359725|FG000|Overall Study|Withdrawal by Subject|25|||
144316778|NCT02819297|520359726|FG001|Overall Study|Withdrawal by Subject|13|||
144316779|NCT02819297|520359725|FG000|Overall Study|Lost to Follow-up|12|||
144316780|NCT02819297|520359726|FG001|Overall Study|Lost to Follow-up|14|||
144316781|NCT02819297|520359725|FG000|Overall Study|Adverse Event|12|||
144316782|NCT02819297|520359726|FG001|Overall Study|Adverse Event|10|||
144316783|NCT02819297|520359725|FG000|Overall Study|Physician Decision|5|||
144316784|NCT02819297|520359726|FG001|Overall Study|Physician Decision|5|||
144316785|NCT02819297|520359725|FG000|Overall Study|Lack of Efficacy|5|||
144316786|NCT02819297|520359726|FG001|Overall Study|Lack of Efficacy|8|||
144316787|NCT02819297|520359725|FG000|Overall Study|Protocol Violation|1|||
144316788|NCT02819297|520359726|FG001|Overall Study|Protocol Violation|2|||
144316789|NCT02858440|520359727|FG000|Overall Study|Lost to Follow-up|3|||
144316790|NCT02858440|520359727|FG000|Overall Study|Protocol Violation|2|||
144316791|NCT02858440|520359727|FG000|Overall Study|Consent withdrawal|3|||
144316792|NCT02858440|520359727|FG000|Overall Study|Migrated/moved from study area|4|||
144316793|NCT01670279|520359728|FG000|Overall Study|Adverse Event|0|||
144316794|NCT01670279|520359729|FG001|Overall Study|Adverse Event|1|||
144316795|NCT01670279|520359730|FG002|Overall Study|Adverse Event|0|||
144316796|NCT01670279|520359731|FG003|Overall Study|Adverse Event|0|||
144316797|NCT01670279|520359728|FG000|Overall Study|Physician Decision|0|||
144316798|NCT01670279|520359729|FG001|Overall Study|Physician Decision|1|||
144316799|NCT01670279|520359730|FG002|Overall Study|Physician Decision|0|||
144316800|NCT01670279|520359731|FG003|Overall Study|Physician Decision|0|||
144316801|NCT01670279|520359728|FG000|Overall Study|Participant met withdrawal criteria|0|||
144316802|NCT01670279|520359729|FG001|Overall Study|Participant met withdrawal criteria|0|||
144316803|NCT01670279|520359730|FG002|Overall Study|Participant met withdrawal criteria|0|||
144316804|NCT01670279|520359731|FG003|Overall Study|Participant met withdrawal criteria|1|||
144316805|NCT02318368|520359732|FG000|Overall Study|Withdrawal by Subject|2|||
144316806|NCT02318368|520359733|FG001|Overall Study|Withdrawal by Subject|0|||
144316807|NCT02318368|520359732|FG000|Overall Study|Study terminated by the sponsor|5|||
144316808|NCT02318368|520359733|FG001|Overall Study|Study terminated by the sponsor|2|||
144316809|NCT02318368|520359732|FG000|Overall Study|Death|0|||
144316810|NCT02318368|520359733|FG001|Overall Study|Death|1|||
144316811|NCT01534351|520359734|FG000|Overall Study|Study Terminated Early|1|||
144316812|NCT01534351|520359735|FG001|Overall Study|Study Terminated Early|0|||
144316813|NCT01534351|520359736|FG002|Overall Study|Study Terminated Early|0|||
144316814|NCT04153981|520359737|FG000|Overall Study|Death|1|||
144316815|NCT04153981|520359737|FG000|Overall Study|Withdrawal by Subject|24|||
144316816|NCT04153981|520359737|FG000|Overall Study|Lost to Follow-up|1|||
144316817|NCT04153981|520359737|FG000|Overall Study|Physician Decision|1|||
144316818|NCT04153981|520359737|FG000|Overall Study|Due to Unavailable Glucometer|1|||
144316819|NCT04153981|520359737|FG000|Overall Study|Covid 19|52|||
144316820|NCT04153981|520359737|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
144316821|NCT04153981|520359737|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
144316822|NCT04660552|520359738|FG000|Overall Study|Withdrawal by Subject|3|||
144316823|NCT04660552|520359739|FG001|Overall Study|Withdrawal by Subject|1|||
144316824|NCT03928418|520359740|FG000|Overall Study|Lost to Follow-up|5|||
144316825|NCT03928418|520359741|FG001|Overall Study|Lost to Follow-up|3|||
144316826|NCT03928418|520359742|FG002|Overall Study|Lost to Follow-up|5|||
144316827|NCT03928418|520359740|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
144316828|NCT03928418|520359741|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
144316829|NCT03928418|520359742|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
144316830|NCT00964002|520359747|FG000|Overall Study|Protocol Violation|8|||
144316831|NCT03423238|520359757|FG000|Overall Study|Lost to Follow-up|1|||
144316832|NCT03423238|520359758|FG001|Overall Study|Lost to Follow-up|0|||
144316833|NCT03423238|520359757|FG000|Overall Study|Withdrawal by Subject|1|||
144316834|NCT03423238|520359758|FG001|Overall Study|Withdrawal by Subject|0|||
144316835|NCT00703846|520359761|FG000|Overall Study|Adverse Event|8|||
144316836|NCT00703846|520359761|FG000|Overall Study|Lost to Follow-up|55|||
144316837|NCT00703846|520359761|FG000|Overall Study|Lack of Efficacy|15|||
144316838|NCT00703846|520359761|FG000|Overall Study|Noncompliance with Study Treatment|2|||
144316839|NCT00703846|520359761|FG000|Overall Study|Withdrawal by Subject|40|||
144316840|NCT00703846|520359761|FG000|Overall Study|Death|1|||
144316841|NCT00703846|520359761|FG000|Overall Study|Other|14|||
144316842|NCT00703846|520359761|FG000|Overall Study|Did Not Receive Study Drug|2|||
144316843|NCT04601532|520359762|FG000|Overall Study|Lost to Follow-up|1|||
144316844|NCT04601532|520359763|FG001|Overall Study|Lost to Follow-up|2|||
144316845|NCT04601532|520359762|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
144316846|NCT04601532|520359763|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
144316847|NCT02566785|520359765|FG000|Overall Study|Lost to Follow-up|0|||
144316848|NCT02566785|520359766|FG001|Overall Study|Lost to Follow-up|2|||
144316849|NCT02566785|520359765|FG000|Overall Study|Worsening condition|1|||
144316850|NCT02566785|520359766|FG001|Overall Study|Worsening condition|1|||
144316851|NCT00837161|520359769|FG000|Overall Study|refused hysterectomy|2|||
144316852|NCT03206918|520359770|FG000|Overall Study|Death|11|||
144316853|NCT03206918|520359770|FG000|Overall Study|Withdrawal by Subject|5|||
144316854|NCT03206918|520359770|FG000|Overall Study|Study terminated by sponsor|12|||
144316855|NCT03206918|520359770|FG000|Overall Study|Lost to Follow-up|3|||
144316856|NCT03206918|520359770|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
144316857|NCT03823287|520359771|FG000|Overall Study|Withdrawal by Subject|25|||
144316858|NCT03823287|520359772|FG001|Overall Study|Withdrawal by Subject|17|||
144316859|NCT03823287|520359771|FG000|Overall Study|Death|13|||
144316860|NCT03823287|520359772|FG001|Overall Study|Death|7|||
144316861|NCT03823287|520359771|FG000|Overall Study|Lost to Follow-up|7|||
144316862|NCT03823287|520359772|FG001|Overall Study|Lost to Follow-up|8|||
144316863|NCT03823287|520359771|FG000|Overall Study|Adverse Event|6|||
144316864|NCT03823287|520359772|FG001|Overall Study|Adverse Event|8|||
144316865|NCT03823287|520359771|FG000|Overall Study|Physician Decision|5|||
144316866|NCT03823287|520359772|FG001|Overall Study|Physician Decision|2|||
144316867|NCT03823287|520359771|FG000|Overall Study|Lack of Efficacy|2|||
144316868|NCT03823287|520359772|FG001|Overall Study|Lack of Efficacy|0|||
144316869|NCT03823287|520359771|FG000|Overall Study|Other|2|||
144316870|NCT03823287|520359772|FG001|Overall Study|Other|4|||
144316871|NCT01059864|520359779|FG000|Open-Label Run-In Phase|Adverse Event|7|||
144316872|NCT01059864|520359780|FG001|Open-Label Run-In Phase|Adverse Event|0|||
144316873|NCT01059864|520359781|FG002|Open-Label Run-In Phase|Adverse Event|0|||
144316874|NCT01059864|520359779|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
144316875|NCT01059864|520359780|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
144316876|NCT01059864|520359781|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
144316877|NCT01059864|520359779|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
144316878|NCT01059864|520359780|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
144316879|NCT01059864|520359781|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
144316880|NCT01059864|520359779|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
144316881|NCT01059864|520359780|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
144316882|NCT01059864|520359781|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
144316883|NCT01059864|520359779|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
144316884|NCT01059864|520359780|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
144316885|NCT01059864|520359781|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
144316886|NCT01059864|520359779|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
144316887|NCT01059864|520359780|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
144316888|NCT01059864|520359781|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
144316889|NCT00451958|520359782|FG000|CS21A (NCT00451958)|Adverse Event|21|||
144316890|NCT00451958|520359783|FG001|CS21A (NCT00451958)|Adverse Event|34|||
144316891|NCT00451958|520359784|FG002|CS21A (NCT00451958)|Adverse Event|14|||
144316892|NCT00451958|520359785|FG003|CS21A (NCT00451958)|Adverse Event|17|||
144316893|NCT00451958|520359786|FG004|CS21A (NCT00451958)|Adverse Event|0|||
144316894|NCT00451958|520359782|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
144316895|NCT00451958|520359783|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
144316896|NCT00451958|520359784|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
144316897|NCT00451958|520359785|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
144316898|NCT00451958|520359786|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
144316899|NCT00451958|520359782|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
144316900|NCT00451958|520359783|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
144316901|NCT00451958|520359784|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
144316902|NCT00451958|520359785|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
144316903|NCT00451958|520359786|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
144316904|NCT00451958|520359782|FG000|CS21A (NCT00451958)|Physician Decision|2|||
144316905|NCT00451958|520359783|FG001|CS21A (NCT00451958)|Physician Decision|4|||
144316906|NCT00451958|520359784|FG002|CS21A (NCT00451958)|Physician Decision|4|||
144316907|NCT00451958|520359785|FG003|CS21A (NCT00451958)|Physician Decision|4|||
144316908|NCT00451958|520359786|FG004|CS21A (NCT00451958)|Physician Decision|0|||
144316909|NCT00451958|520359782|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
144316910|NCT00451958|520359783|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
144316911|NCT00451958|520359784|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
144316912|NCT00451958|520359785|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
144316913|NCT00451958|520359786|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
144316914|NCT00451958|520359782|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
144316915|NCT00451958|520359783|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
144316916|NCT00451958|520359784|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
144316917|NCT00451958|520359785|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
144316918|NCT00451958|520359786|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
144316919|NCT03108521|520359790|FG000|Overall Study|Lost to Follow-up|3|||
144316920|NCT03108521|520359791|FG001|Overall Study|Lost to Follow-up|0|||
144316921|NCT03108521|520359790|FG000|Overall Study|Lack of Efficacy|2|||
144316922|NCT03108521|520359791|FG001|Overall Study|Lack of Efficacy|0|||
144316923|NCT03108521|520359790|FG000|Overall Study|Physician Decision|4|||
144316924|NCT03108521|520359791|FG001|Overall Study|Physician Decision|0|||
144316925|NCT03108521|520359790|FG000|Overall Study|Adverse Event|3|||
144316926|NCT03108521|520359791|FG001|Overall Study|Adverse Event|0|||
144316927|NCT00375674|520359798|FG000|Overall Study|Other|26|||
144316928|NCT00375674|520359799|FG001|Overall Study|Other|18|||
144316929|NCT00375674|520359798|FG000|Overall Study|Death|67|||
144316930|NCT00375674|520359799|FG001|Overall Study|Death|76|||
144316931|NCT00375674|520359798|FG000|Overall Study|Participants refused further follow-up|31|||
144316932|NCT00375674|520359799|FG001|Overall Study|Participants refused further follow-up|30|||
144316933|NCT00375674|520359798|FG000|Overall Study|Lost to Follow-up|17|||
144316934|NCT00375674|520359799|FG001|Overall Study|Lost to Follow-up|15|||
144316935|NCT00375674|520359798|FG000|Overall Study|Enrolled but not treated|3|||
144316936|NCT00375674|520359799|FG001|Overall Study|Enrolled but not treated|2|||
144316937|NCT02908685|520361813|FG000|Part 1 OLE|Withdrawal by Subject|0|||
144316938|NCT02908685|520361814|FG001|Part 1 OLE|Withdrawal by Subject|0|||
144316939|NCT02908685|520361815|FG002|Part 1 OLE|Withdrawal by Subject|0|||
144316940|NCT02908685|520361816|FG003|Part 1 OLE|Withdrawal by Subject|0|||
144316941|NCT02908685|520361817|FG004|Part 1 OLE|Withdrawal by Subject|0|||
144316942|NCT02908685|520361818|FG005|Part 1 OLE|Withdrawal by Subject|0|||
144316943|NCT02908685|520361819|FG006|Part 1 OLE|Withdrawal by Subject|0|||
144316944|NCT02908685|520361820|FG007|Part 1 OLE|Withdrawal by Subject|0|||
144316945|NCT02908685|520361821|FG008|Part 1 OLE|Withdrawal by Subject|0|||
144316946|NCT02908685|520361822|FG009|Part 1 OLE|Withdrawal by Subject|0|||
144316947|NCT02908685|520361823|FG010|Part 1 OLE|Withdrawal by Subject|2|||
144316948|NCT02908685|520361824|FG011|Part 1 OLE|Withdrawal by Subject|1|||
144316949|NCT02908685|520361825|FG012|Part 1 OLE|Withdrawal by Subject|0|||
144316950|NCT02908685|520361826|FG013|Part 1 OLE|Withdrawal by Subject|0|||
144316951|NCT02908685|520361813|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316952|NCT02908685|520361814|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316953|NCT02908685|520361815|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316954|NCT02908685|520361816|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316955|NCT02908685|520361817|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316956|NCT02908685|520361818|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316957|NCT02908685|520361819|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316958|NCT02908685|520361820|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316959|NCT02908685|520361821|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316960|NCT02908685|520361822|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316961|NCT02908685|520361823|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316962|NCT02908685|520361824|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
144316963|NCT02908685|520361825|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
144316964|NCT02908685|520361826|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
144316965|NCT02908685|520361813|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316966|NCT02908685|520361814|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316967|NCT02908685|520361815|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316968|NCT02908685|520361816|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316969|NCT02908685|520361817|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316970|NCT02908685|520361818|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316971|NCT02908685|520361819|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316972|NCT02908685|520361820|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316973|NCT02908685|520361821|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316974|NCT02908685|520361822|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316975|NCT02908685|520361823|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316976|NCT02908685|520361824|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316977|NCT02908685|520361825|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
144316978|NCT02908685|520361826|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
144316979|NCT02908685|520361813|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316980|NCT02908685|520361814|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316981|NCT02908685|520361815|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316982|NCT02908685|520361816|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316983|NCT02908685|520361817|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316984|NCT02908685|520361818|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316985|NCT02908685|520361819|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316986|NCT02908685|520361820|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316987|NCT02908685|520361821|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316988|NCT02908685|520361822|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316989|NCT02908685|520361823|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316990|NCT02908685|520361824|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316991|NCT02908685|520361825|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
144316992|NCT02908685|520361826|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
144316993|NCT02908685|520361813|FG000|Part 2 OLE: > Month 24|Death|0|||
144316994|NCT02908685|520361814|FG001|Part 2 OLE: > Month 24|Death|0|||
144316995|NCT02908685|520361815|FG002|Part 2 OLE: > Month 24|Death|0|||
144316996|NCT02908685|520361816|FG003|Part 2 OLE: > Month 24|Death|0|||
144316997|NCT02908685|520361817|FG004|Part 2 OLE: > Month 24|Death|0|||
144316998|NCT02908685|520361818|FG005|Part 2 OLE: > Month 24|Death|0|||
144316999|NCT02908685|520361819|FG006|Part 2 OLE: > Month 24|Death|0|||
144317000|NCT02908685|520361820|FG007|Part 2 OLE: > Month 24|Death|0|||
144317001|NCT02908685|520361821|FG008|Part 2 OLE: > Month 24|Death|0|||
144317002|NCT02908685|520361822|FG009|Part 2 OLE: > Month 24|Death|0|||
144317003|NCT02908685|520361823|FG010|Part 2 OLE: > Month 24|Death|0|||
144317004|NCT02908685|520361824|FG011|Part 2 OLE: > Month 24|Death|0|||
144317005|NCT02908685|520361825|FG012|Part 2 OLE: > Month 24|Death|1|||
144317006|NCT02908685|520361826|FG013|Part 2 OLE: > Month 24|Death|0|||
144317007|NCT02908685|520361813|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
144317008|NCT02908685|520361814|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
144317009|NCT02908685|520361815|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
144317010|NCT02908685|520361816|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
144317011|NCT02908685|520361817|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
144317012|NCT02908685|520361818|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
144317013|NCT02908685|520361819|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
144317014|NCT02908685|520361820|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
144317015|NCT02908685|520361821|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
144317016|NCT02908685|520361822|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
144317017|NCT02908685|520361823|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
144317018|NCT02908685|520361824|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
144317019|NCT02908685|520361825|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
144317020|NCT02908685|520361826|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
144317021|NCT02908685|520361813|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317022|NCT02908685|520361814|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317023|NCT02908685|520361815|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317024|NCT02908685|520361816|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317025|NCT02908685|520361817|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317026|NCT02908685|520361818|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317027|NCT02908685|520361819|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317028|NCT02908685|520361820|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317029|NCT02908685|520361821|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317030|NCT02908685|520361822|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317031|NCT02908685|520361823|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317032|NCT02908685|520361824|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
144317033|NCT02908685|520361825|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
144317034|NCT02908685|520361826|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
144317035|NCT02954406|520361827|FG000|Overall Study|Adverse Event|0|||
144317036|NCT02954406|520361828|FG001|Overall Study|Adverse Event|1|||
144317037|NCT02954406|520361829|FG002|Overall Study|Adverse Event|0|||
144317038|NCT02954406|520361830|FG003|Overall Study|Adverse Event|0|||
144317039|NCT02954406|520361831|FG004|Overall Study|Adverse Event|1|||
144317040|NCT02954406|520361832|FG005|Overall Study|Adverse Event|0|||
144317041|NCT02954406|520361833|FG006|Overall Study|Adverse Event|0|||
144317042|NCT02954406|520361834|FG007|Overall Study|Adverse Event|0|||
144317043|NCT02954406|520361835|FG008|Overall Study|Adverse Event|1|||
144317044|NCT02954406|520361836|FG009|Overall Study|Adverse Event|1|||
144317045|NCT02954406|520361837|FG010|Overall Study|Adverse Event|0|||
144317046|NCT02954406|520361827|FG000|Overall Study|Progressive Disease|3|||
144317047|NCT02954406|520361828|FG001|Overall Study|Progressive Disease|4|||
144317048|NCT02954406|520361829|FG002|Overall Study|Progressive Disease|3|||
144317049|NCT02954406|520361830|FG003|Overall Study|Progressive Disease|4|||
144317050|NCT02954406|520361831|FG004|Overall Study|Progressive Disease|3|||
144317051|NCT02954406|520361832|FG005|Overall Study|Progressive Disease|3|||
144317052|NCT02954406|520361833|FG006|Overall Study|Progressive Disease|2|||
144317053|NCT02954406|520361834|FG007|Overall Study|Progressive Disease|2|||
144317054|NCT02954406|520361835|FG008|Overall Study|Progressive Disease|1|||
144317055|NCT02954406|520361836|FG009|Overall Study|Progressive Disease|1|||
144317056|NCT02954406|520361837|FG010|Overall Study|Progressive Disease|0|||
144317057|NCT02954406|520361827|FG000|Overall Study|Symptomatic Deterioration|0|||
144317058|NCT02954406|520361828|FG001|Overall Study|Symptomatic Deterioration|1|||
144317059|NCT02954406|520361829|FG002|Overall Study|Symptomatic Deterioration|0|||
144317060|NCT02954406|520361830|FG003|Overall Study|Symptomatic Deterioration|0|||
144317061|NCT02954406|520361831|FG004|Overall Study|Symptomatic Deterioration|0|||
144317062|NCT02954406|520361832|FG005|Overall Study|Symptomatic Deterioration|0|||
144317063|NCT02954406|520361833|FG006|Overall Study|Symptomatic Deterioration|0|||
144317064|NCT02954406|520361834|FG007|Overall Study|Symptomatic Deterioration|0|||
144317065|NCT02954406|520361835|FG008|Overall Study|Symptomatic Deterioration|0|||
144317066|NCT02954406|520361836|FG009|Overall Study|Symptomatic Deterioration|0|||
144317067|NCT02954406|520361837|FG010|Overall Study|Symptomatic Deterioration|0|||
144317068|NCT02954406|520361827|FG000|Overall Study|Death|0|||
144317069|NCT02954406|520361828|FG001|Overall Study|Death|0|||
144317070|NCT02954406|520361829|FG002|Overall Study|Death|0|||
144317071|NCT02954406|520361830|FG003|Overall Study|Death|0|||
144317072|NCT02954406|520361831|FG004|Overall Study|Death|1|||
144317073|NCT02954406|520361832|FG005|Overall Study|Death|0|||
144317074|NCT02954406|520361833|FG006|Overall Study|Death|0|||
144317075|NCT02954406|520361834|FG007|Overall Study|Death|0|||
144317076|NCT02954406|520361835|FG008|Overall Study|Death|1|||
144317077|NCT02954406|520361836|FG009|Overall Study|Death|1|||
144317078|NCT02954406|520361837|FG010|Overall Study|Death|0|||
144317079|NCT02954406|520361827|FG000|Overall Study|Reason Not Specified|0|||
144317080|NCT02954406|520361828|FG001|Overall Study|Reason Not Specified|0|||
144317081|NCT02954406|520361829|FG002|Overall Study|Reason Not Specified|3|||
144317082|NCT02954406|520361830|FG003|Overall Study|Reason Not Specified|2|||
144317083|NCT02954406|520361831|FG004|Overall Study|Reason Not Specified|2|||
144317084|NCT02954406|520361832|FG005|Overall Study|Reason Not Specified|0|||
144317085|NCT02954406|520361833|FG006|Overall Study|Reason Not Specified|1|||
144317086|NCT02954406|520361834|FG007|Overall Study|Reason Not Specified|0|||
144317087|NCT02954406|520361835|FG008|Overall Study|Reason Not Specified|1|||
144317088|NCT02954406|520361836|FG009|Overall Study|Reason Not Specified|0|||
144317089|NCT02954406|520361837|FG010|Overall Study|Reason Not Specified|0|||
144317090|NCT00782171|520361839|FG000|Overall Study|Lost to Follow-up|2|||
144317091|NCT00782171|520361840|FG001|Overall Study|Lost to Follow-up|2|||
144317092|NCT00782171|520361839|FG000|Overall Study|Withdrawal by Subject|2|||
144317093|NCT00782171|520361840|FG001|Overall Study|Withdrawal by Subject|1|||
144317094|NCT00782171|520361839|FG000|Overall Study|complications|3|||
144317095|NCT00782171|520361840|FG001|Overall Study|complications|1|||
144317096|NCT00782171|520361839|FG000|Overall Study|others|7|||
144317097|NCT00782171|520361840|FG001|Overall Study|others|9|||
144317098|NCT00782171|520361839|FG000|Overall Study|not eligible|8|||
144317099|NCT00782171|520361840|FG001|Overall Study|not eligible|6|||
144317100|NCT02120781|520361847|FG000|Overall Study|Physician Decision|2|||
144317101|NCT02120781|520361848|FG001|Overall Study|Physician Decision|0|||
144317102|NCT02120781|520361847|FG000|Overall Study|Completion not documented|2|||
144317103|NCT02120781|520361848|FG001|Overall Study|Completion not documented|1|||
144317104|NCT00654745|520361851|FG000|Overall Study|Adverse Event|12|||
144317105|NCT00654745|520361851|FG000|Overall Study|Lost to Follow-up|7|||
144317106|NCT00654745|520361851|FG000|Overall Study|Protocol Violation|11|||
144317107|NCT00654745|520361851|FG000|Overall Study|Withdrawal by Subject|10|||
144317108|NCT00654745|520361851|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
144317109|NCT00748618|520361852|FG000|Overall Study|Adverse Event|1|||
144317110|NCT00748618|520361853|FG001|Overall Study|Adverse Event|0|||
144317111|NCT00466947|520361854|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
144317112|NCT00466947|520361855|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
144317113|NCT00466947|520361854|FG000|Study End Analysis Period|Adverse Event|35|||
144317114|NCT00466947|520361855|FG001|Study End Analysis Period|Adverse Event|43|||
144317115|NCT00466947|520361854|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
144317116|NCT00466947|520361855|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
144317117|NCT00466947|520361854|FG000|Study End Analysis Period|Physician Decision|29|||
144317118|NCT00466947|520361855|FG001|Study End Analysis Period|Physician Decision|29|||
144317119|NCT00466947|520361854|FG000|Study End Analysis Period|Protocol Violation|9|||
144317120|NCT00466947|520361855|FG001|Study End Analysis Period|Protocol Violation|17|||
144317121|NCT00466947|520361854|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
144317122|NCT00466947|520361855|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
144317123|NCT00466947|520361854|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
144317124|NCT00466947|520361855|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
144317125|NCT00466947|520361854|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
144317126|NCT00466947|520361855|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
144317127|NCT00466947|520361854|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
144317128|NCT00466947|520361855|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
144317129|NCT03286543|520361858|FG000|Consented|Screen failure before randomization|2|||
144317130|NCT03286543|520361859|FG001|Consented|Screen failure before randomization|0|||
144317131|NCT03286543|520361860|FG002|Consented|Screen failure before randomization|0|||
144317132|NCT03286543|520361858|FG000|Consented|Screen failure before enrollment|4|||
144317133|NCT03286543|520361859|FG001|Consented|Screen failure before enrollment|0|||
144317134|NCT03286543|520361860|FG002|Consented|Screen failure before enrollment|0|||
144317135|NCT03286543|520361858|FG000|Consented|TKA cancelled after enrollment|1|||
144317136|NCT03286543|520361859|FG001|Consented|TKA cancelled after enrollment|0|||
144317137|NCT03286543|520361860|FG002|Consented|TKA cancelled after enrollment|0|||
144317138|NCT03286543|520361858|FG000|Consented|Withdrawn from study|12|||
144317139|NCT03286543|520361859|FG001|Consented|Withdrawn from study|0|||
144317140|NCT03286543|520361860|FG002|Consented|Withdrawn from study|0|||
144317141|NCT03286543|520361858|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
144317142|NCT03286543|520361859|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
144317143|NCT03286543|520361860|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
144317144|NCT03286543|520361858|FG000|Study Enrollment|Withdrawn from study|0|||
144317145|NCT03286543|520361859|FG001|Study Enrollment|Withdrawn from study|6|||
144317146|NCT03286543|520361860|FG002|Study Enrollment|Withdrawn from study|6|||
144317147|NCT04952597|520361864|FG000|Overall Study|Death|12|||
144317148|NCT04952597|520361865|FG001|Overall Study|Death|13|||
144317149|NCT04952597|520361866|FG002|Overall Study|Death|14|||
144317150|NCT04952597|520361864|FG000|Overall Study|Withdrawal by Subject|1|||
144317151|NCT04952597|520361865|FG001|Overall Study|Withdrawal by Subject|0|||
144317152|NCT04952597|520361866|FG002|Overall Study|Withdrawal by Subject|3|||
144317153|NCT04952597|520361864|FG000|Overall Study|Lost to Follow-up|0|||
144317154|NCT04952597|520361865|FG001|Overall Study|Lost to Follow-up|1|||
144317155|NCT04952597|520361866|FG002|Overall Study|Lost to Follow-up|1|||
144317156|NCT00022763|520361874|FG000|Overall Study|Adverse Event|1|||
144317157|NCT00022763|520361875|FG001|Overall Study|Adverse Event|2|||
144317158|NCT00022763|520361874|FG000|Overall Study|Injection Site Reactions|0|||
144317159|NCT00022763|520361875|FG001|Overall Study|Injection Site Reactions|2|||
144317160|NCT00022763|520361874|FG000|Overall Study|Death|0|||
144317161|NCT00022763|520361875|FG001|Overall Study|Death|1|||
144317162|NCT00022763|520361874|FG000|Overall Study|Lost to Follow-up|0|||
144317163|NCT00022763|520361875|FG001|Overall Study|Lost to Follow-up|3|||
144317164|NCT00022763|520361874|FG000|Overall Study|Withdrawal by Subject|4|||
144317165|NCT00022763|520361875|FG001|Overall Study|Withdrawal by Subject|7|||
144317166|NCT00022763|520361874|FG000|Overall Study|Insufficient Therapy|1|||
144317167|NCT00022763|520361875|FG001|Overall Study|Insufficient Therapy|0|||
144317168|NCT00022763|520361874|FG000|Overall Study|Admin|3|||
144317169|NCT00022763|520361875|FG001|Overall Study|Admin|2|||
144317170|NCT04908865|520361876|FG000|Overall Study|Adverse Event|2|||
144317171|NCT04908865|520361876|FG000|Overall Study|Lack of Efficacy|5|||
144317172|NCT04908865|520361876|FG000|Overall Study|Lost to Follow-up|1|||
144317173|NCT02141399|520361877|FG000|Overall Study|Adverse Event|158|||
144317174|NCT02141399|520361877|FG000|Overall Study|Lack of Efficacy|62|||
144317175|NCT02141399|520361877|FG000|Overall Study|Lost to Follow-up|151|||
144317176|NCT02141399|520361877|FG000|Overall Study|Non-compliance with study drug|18|||
144317177|NCT02141399|520361877|FG000|Overall Study|Other|45|||
144317178|NCT02141399|520361877|FG000|Overall Study|Physician Decision|17|||
144317179|NCT02141399|520361877|FG000|Overall Study|Pregnancy|3|||
144317180|NCT02141399|520361877|FG000|Overall Study|Protocol Violation|38|||
144317181|NCT02141399|520361877|FG000|Overall Study|Withdrawal by Subject|238|||
144317182|NCT02141399|520361877|FG000|Overall Study|Failure to meet eligibility criteria|14|||
144317183|NCT04445519|520361878|FG000|Overall Study|Due to adaptive design|3|||
144317184|NCT04445519|520361879|FG001|Overall Study|Due to adaptive design|0|||
144317185|NCT04445519|520361880|FG002|Overall Study|Due to adaptive design|0|||
144317186|NCT04445519|520361878|FG000|Overall Study|Lost to Follow-up|0|||
144317187|NCT04445519|520361879|FG001|Overall Study|Lost to Follow-up|1|||
144317188|NCT04445519|520361880|FG002|Overall Study|Lost to Follow-up|4|||
144317189|NCT04445519|520361878|FG000|Overall Study|Sponsor or IRB Decision|0|||
144317190|NCT04445519|520361879|FG001|Overall Study|Sponsor or IRB Decision|1|||
144317191|NCT04445519|520361880|FG002|Overall Study|Sponsor or IRB Decision|2|||
144317192|NCT04445519|520361878|FG000|Overall Study|Withdrawal by Subject|0|||
144317193|NCT04445519|520361879|FG001|Overall Study|Withdrawal by Subject|3|||
144317194|NCT04445519|520361880|FG002|Overall Study|Withdrawal by Subject|3|||
144317195|NCT04445519|520361878|FG000|Overall Study|Adverse Event|0|||
144317196|NCT04445519|520361879|FG001|Overall Study|Adverse Event|8|||
144317197|NCT04445519|520361880|FG002|Overall Study|Adverse Event|6|||
144317198|NCT04445519|520361878|FG000|Overall Study|Other Reason|0|||
144317199|NCT04445519|520361879|FG001|Overall Study|Other Reason|1|||
144317200|NCT04445519|520361880|FG002|Overall Study|Other Reason|1|||
144317201|NCT04445519|520361878|FG000|Overall Study|Protocol Violation|0|||
144317202|NCT04445519|520361879|FG001|Overall Study|Protocol Violation|0|||
144317203|NCT04445519|520361880|FG002|Overall Study|Protocol Violation|1|||
144317204|NCT01345929|520361881|FG000|Overall Study|Withdrawal by Subject|9|||
144317205|NCT01345929|520361882|FG001|Overall Study|Withdrawal by Subject|8|||
144317206|NCT01345929|520361881|FG000|Overall Study|Lost to Follow-up|9|||
144317207|NCT01345929|520361882|FG001|Overall Study|Lost to Follow-up|9|||
144317208|NCT01345929|520361881|FG000|Overall Study|Adverse Event|0|||
144317209|NCT01345929|520361882|FG001|Overall Study|Adverse Event|1|||
144317210|NCT01345929|520361881|FG000|Overall Study|Didn't meet eligibility criteria|2|||
144317211|NCT01345929|520361882|FG001|Overall Study|Didn't meet eligibility criteria|0|||
144317212|NCT01345929|520361881|FG000|Overall Study|40,000 CFU/ML|1|||
144317213|NCT01345929|520361882|FG001|Overall Study|40,000 CFU/ML|0|||
144317214|NCT01345929|520361881|FG000|Overall Study|Patient withdrawal|0|||
144317215|NCT01345929|520361882|FG001|Overall Study|Patient withdrawal|1|||
144317216|NCT02091362|520361891|FG000|Period 1|Protocol Violation|1|||
144317217|NCT02091362|520361892|FG001|Period 1|Protocol Violation|0|||
144317218|NCT02091362|520361891|FG000|Period 1|Withdrawal by Subject|2|||
144317219|NCT02091362|520361892|FG001|Period 1|Withdrawal by Subject|3|||
144317220|NCT02091362|520361891|FG000|Period 1|Lost to Follow-up|0|||
144317221|NCT02091362|520361892|FG001|Period 1|Lost to Follow-up|1|||
144317222|NCT02091362|520361891|FG000|Period 1|Adverse Event|2|||
144317223|NCT02091362|520361892|FG001|Period 1|Adverse Event|0|||
144317224|NCT02091362|520361891|FG000|Wash-out|Lost to Follow-up|1|||
144317225|NCT02091362|520361892|FG001|Wash-out|Lost to Follow-up|1|||
144317226|NCT02091362|520361891|FG000|Wash-out|Withdrawal by Subject|0|||
144317227|NCT02091362|520361892|FG001|Wash-out|Withdrawal by Subject|2|||
144317228|NCT02091362|520361891|FG000|Period 2|Adverse Event|1|||
144317229|NCT02091362|520361892|FG001|Period 2|Adverse Event|0|||
144317230|NCT02091362|520361891|FG000|Period 2|Lost to Follow-up|0|||
144317231|NCT02091362|520361892|FG001|Period 2|Lost to Follow-up|1|||
144317232|NCT02091362|520361891|FG000|Period 2|Withdrawal by Subject|1|||
144317233|NCT02091362|520361892|FG001|Period 2|Withdrawal by Subject|1|||
144317234|NCT00690430|520361893|FG000|Core Phase|Abnormal Laboratory value|0|||
144317235|NCT00690430|520361894|FG001|Core Phase|Abnormal Laboratory value|1|||
144317236|NCT00690430|520361895|FG002|Core Phase|Abnormal Laboratory value|0|||
144317237|NCT00690430|520361893|FG000|Core Phase|Adverse Event|5|||
144317238|NCT00690430|520361894|FG001|Core Phase|Adverse Event|1|||
144317239|NCT00690430|520361895|FG002|Core Phase|Adverse Event|0|||
144317240|NCT00690430|520361893|FG000|Core Phase|Death|0|||
144317241|NCT00690430|520361894|FG001|Core Phase|Death|2|||
144317242|NCT00690430|520361895|FG002|Core Phase|Death|0|||
144317243|NCT00690430|520361893|FG000|Core Phase|Protocol Violation|1|||
144317244|NCT00690430|520361894|FG001|Core Phase|Protocol Violation|0|||
144317245|NCT00690430|520361895|FG002|Core Phase|Protocol Violation|0|||
144317246|NCT00690430|520361893|FG000|Core Phase|Withdrawal by Subject|3|||
144317247|NCT00690430|520361894|FG001|Core Phase|Withdrawal by Subject|3|||
144317248|NCT00690430|520361895|FG002|Core Phase|Withdrawal by Subject|0|||
144317249|NCT00690430|520361893|FG000|Core Phase|Subject no longer requires study drug|1|||
144317250|NCT00690430|520361894|FG001|Core Phase|Subject no longer requires study drug|0|||
144317251|NCT00690430|520361895|FG002|Core Phase|Subject no longer requires study drug|0|||
144317252|NCT00690430|520361893|FG000|Core Phase|Lack of Efficacy|8|||
144317253|NCT00690430|520361894|FG001|Core Phase|Lack of Efficacy|10|||
144317254|NCT00690430|520361895|FG002|Core Phase|Lack of Efficacy|0|||
144317255|NCT00690430|520361893|FG000|Core Phase|Administrative Problems|0|||
144317256|NCT00690430|520361894|FG001|Core Phase|Administrative Problems|1|||
144317257|NCT00690430|520361895|FG002|Core Phase|Administrative Problems|0|||
144317258|NCT00690430|520361893|FG000|Core Phase|Early Termination|0|||
144317259|NCT00690430|520361894|FG001|Core Phase|Early Termination|5|||
144317260|NCT00690430|520361895|FG002|Core Phase|Early Termination|0|||
144317261|NCT00690430|520361893|FG000|Extension Phase|Lack of Efficacy|3|||
144317262|NCT00690430|520361894|FG001|Extension Phase|Lack of Efficacy|1|||
144317263|NCT00690430|520361895|FG002|Extension Phase|Lack of Efficacy|4|||
144317264|NCT00690430|520361893|FG000|Extension Phase|Abnormal Lab Values|1|||
144317265|NCT00690430|520361894|FG001|Extension Phase|Abnormal Lab Values|0|||
144317266|NCT00690430|520361895|FG002|Extension Phase|Abnormal Lab Values|0|||
144317267|NCT00690430|520361893|FG000|Extension Phase|Abnormal test procedure results|1|||
144317268|NCT00690430|520361894|FG001|Extension Phase|Abnormal test procedure results|0|||
144317269|NCT00690430|520361895|FG002|Extension Phase|Abnormal test procedure results|0|||
144317270|NCT00690430|520361893|FG000|Extension Phase|Administrative Problems|0|||
144317271|NCT00690430|520361894|FG001|Extension Phase|Administrative Problems|1|||
144317272|NCT00690430|520361895|FG002|Extension Phase|Administrative Problems|1|||
144317273|NCT00690430|520361893|FG000|Extension Phase|Adverse Event|2|||
144317274|NCT00690430|520361894|FG001|Extension Phase|Adverse Event|1|||
144317275|NCT00690430|520361895|FG002|Extension Phase|Adverse Event|2|||
144317276|NCT00690430|520361893|FG000|Extension Phase|Death|1|||
144317277|NCT00690430|520361894|FG001|Extension Phase|Death|1|||
144317278|NCT00690430|520361895|FG002|Extension Phase|Death|1|||
144317279|NCT00690430|520361893|FG000|Extension Phase|Withdrawal by Subject|0|||
144317280|NCT00690430|520361894|FG001|Extension Phase|Withdrawal by Subject|0|||
144317281|NCT00690430|520361895|FG002|Extension Phase|Withdrawal by Subject|2|||
144317282|NCT00690430|520361893|FG000|Extension Phase|Early Termination|10|||
144317283|NCT00690430|520361894|FG001|Extension Phase|Early Termination|1|||
144317284|NCT00690430|520361895|FG002|Extension Phase|Early Termination|3|||
144317285|NCT02125838|520361904|FG000|Overall Study|Lost to Follow-up|4|||
144317286|NCT02125838|520361905|FG001|Overall Study|Lost to Follow-up|4|||
144317287|NCT02565147|520361906|FG000|Overall Study|Withdrawal by Subject|5|||
144317288|NCT02565147|520361907|FG001|Overall Study|Withdrawal by Subject|1|||
144317289|NCT02565147|520361906|FG000|Overall Study|Lost to Follow-up|0|||
144317290|NCT02565147|520361907|FG001|Overall Study|Lost to Follow-up|1|||
144317291|NCT02565147|520361906|FG000|Overall Study|Death|1|||
144317292|NCT02565147|520361907|FG001|Overall Study|Death|1|||
144317293|NCT00787839|520361908|FG000|Overall Study|Failure to have the OGTT was most common|404|||
144317294|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
144317295|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
144317296|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
144317297|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
144317298|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Death|58|||
144317299|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Death|65|||
144317300|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Adverse Event|28|||
144317301|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Adverse Event|40|||
144317302|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Disease Progression|22|||
144317303|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Disease Progression|35|||
144317304|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Other|25|||
144317305|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Other|33|||
144317306|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
144317307|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
144317308|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Noncompliance|8|||
144317309|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Noncompliance|8|||
144317310|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
144317311|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
144317312|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
144317313|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
144317314|NCT00286091|520361915|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
144317315|NCT00286091|520361916|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
144317316|NCT00286091|520361915|FG000|Open-label Treatment Phase|Physician Decision|24|||
144317317|NCT00286091|520361916|FG001|Open-label Treatment Phase|Physician Decision|21|||
144317318|NCT00286091|520361915|FG000|Open-label Treatment Phase|Adverse Event|5|||
144317319|NCT00286091|520361916|FG001|Open-label Treatment Phase|Adverse Event|16|||
144317320|NCT00286091|520361915|FG000|Open-label Treatment Phase|Other|11|||
144317321|NCT00286091|520361916|FG001|Open-label Treatment Phase|Other|11|||
144317322|NCT00286091|520361915|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
144317323|NCT00286091|520361916|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
144317324|NCT00286091|520361915|FG000|Open-label Treatment Phase|Death|10|||
144317325|NCT00286091|520361916|FG001|Open-label Treatment Phase|Death|7|||
144317326|NCT00286091|520361915|FG000|Open-label Treatment Phase|Disease Progression|9|||
144317327|NCT00286091|520361916|FG001|Open-label Treatment Phase|Disease Progression|3|||
144317328|NCT00286091|520361915|FG000|Open-label Treatment Phase|Noncompliance|3|||
144317329|NCT00286091|520361916|FG001|Open-label Treatment Phase|Noncompliance|1|||
144317330|NCT00286091|520361915|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
144317331|NCT00286091|520361916|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
144317332|NCT00286091|520361915|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
144317333|NCT00286091|520361916|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
144317334|NCT00286091|520361915|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
144317335|NCT00286091|520361916|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
144317336|NCT02936869|520361919|FG000|Overall Study|Lost to Follow-up|1|||
144317337|NCT02936869|520361920|FG001|Overall Study|Lost to Follow-up|3|||
144317338|NCT02936869|520361919|FG000|Overall Study|Death|0|||
144317339|NCT02936869|520361920|FG001|Overall Study|Death|1|||
144317340|NCT02936869|520361919|FG000|Overall Study|Legal Case|0|||
144317341|NCT02936869|520361920|FG001|Overall Study|Legal Case|1|||
144317342|NCT02936869|520361919|FG000|Overall Study|Protocol Violation|1|||
144317343|NCT02936869|520361920|FG001|Overall Study|Protocol Violation|0|||
144317344|NCT00335738|520361921|FG000|Overall Study|Physician Decision|6|||
144317345|NCT00335738|520361922|FG001|Overall Study|Physician Decision|0|||
144317346|NCT00335738|520361921|FG000|Overall Study|Withdrawal by Subject|2|||
144317347|NCT00335738|520361922|FG001|Overall Study|Withdrawal by Subject|0|||
144317348|NCT00335738|520361921|FG000|Overall Study|Ineligible|3|||
144317349|NCT00335738|520361922|FG001|Overall Study|Ineligible|4|||
144317350|NCT00506454|520361927|FG000|Overall Study|Withdrawal by Subject|1|||
144317351|NCT00506454|520361928|FG001|Overall Study|Withdrawal by Subject|1|||
144317352|NCT03098433|520361931|FG000|Overall Study|Withdrawal by Subject|10|||
144317353|NCT04470050|520361932|FG000|Double-blind Treatment Phase|Adverse Event|0|||
144317354|NCT04470050|520361933|FG001|Double-blind Treatment Phase|Adverse Event|0|||
144317355|NCT04470050|520361934|FG002|Double-blind Treatment Phase|Adverse Event|0|||
144317356|NCT04470050|520361935|FG003|Double-blind Treatment Phase|Adverse Event|1|||
144317357|NCT04470050|520361936|FG004|Double-blind Treatment Phase|Adverse Event|0|||
144317358|NCT04470050|520361937|FG005|Double-blind Treatment Phase|Adverse Event|0|||
144317359|NCT04470050|520361938|FG006|Double-blind Treatment Phase|Adverse Event|0|||
144317360|NCT04470050|520361932|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
144317361|NCT04470050|520361933|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
144317362|NCT04470050|520361934|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
144317363|NCT04470050|520361935|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
144317364|NCT04470050|520361936|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
144317365|NCT04470050|520361937|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
144317366|NCT04470050|520361938|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
144317367|NCT04470050|520361932|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
144317368|NCT04470050|520361933|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
144317369|NCT04470050|520361934|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
144317370|NCT04470050|520361935|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
144317371|NCT04470050|520361936|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
144317372|NCT04470050|520361937|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
144317373|NCT04470050|520361938|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
144317374|NCT01104545|520361939|FG000|Overall Study|Adverse Event|0|||
144317375|NCT01104545|520361940|FG001|Overall Study|Adverse Event|1|||
144317376|NCT01104545|520361941|FG002|Overall Study|Adverse Event|2|||
144317377|NCT03640507|520361942|FG000|Overall Study|Withdrawal by Subject|0|||
144317378|NCT03640507|520361943|FG001|Overall Study|Withdrawal by Subject|0|||
144317379|NCT03640507|520361944|FG002|Overall Study|Withdrawal by Subject|1|||
144317380|NCT03604172|520361945|FG000|Overall Study|Lost to Follow-up|1|||
144317381|NCT03604172|520361946|FG001|Overall Study|Lost to Follow-up|2|||
144317382|NCT02676895|520361947|FG000|Overall Study|Administrative reason|1|||
144317383|NCT02676895|520361948|FG001|Overall Study|Administrative reason|0|||
144317384|NCT02676895|520361949|FG002|Overall Study|Administrative reason|0|||
144317385|NCT02676895|520361947|FG000|Overall Study|Protocol Violation|1|||
144317386|NCT02676895|520361948|FG001|Overall Study|Protocol Violation|0|||
144317387|NCT02676895|520361949|FG002|Overall Study|Protocol Violation|0|||
144317388|NCT02676895|520361947|FG000|Overall Study|Adverse Event|0|||
144317389|NCT02676895|520361948|FG001|Overall Study|Adverse Event|3|||
144317390|NCT02676895|520361949|FG002|Overall Study|Adverse Event|1|||
144317391|NCT02676895|520361947|FG000|Overall Study|Lost to Follow-up|0|||
144317392|NCT02676895|520361948|FG001|Overall Study|Lost to Follow-up|0|||
144317393|NCT02676895|520361949|FG002|Overall Study|Lost to Follow-up|1|||
144317394|NCT02676895|520361947|FG000|Overall Study|Withdrawal by Subject|0|||
144317395|NCT02676895|520361948|FG001|Overall Study|Withdrawal by Subject|0|||
144317396|NCT02676895|520361949|FG002|Overall Study|Withdrawal by Subject|1|||
144317397|NCT00923351|520361953|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
144317398|NCT00923351|520361954|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
144317399|NCT00923351|520361955|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
144317400|NCT00395486|520361960|FG000|Overall Study|Adverse Event|1|||
144317401|NCT00395486|520361961|FG001|Overall Study|Adverse Event|2|||
144317402|NCT00395486|520361960|FG000|Overall Study|Withdrawal by Subject|5|||
144317403|NCT00395486|520361961|FG001|Overall Study|Withdrawal by Subject|2|||
144317404|NCT00395486|520361960|FG000|Overall Study|Lost to Follow-up|0|||
144317405|NCT00395486|520361961|FG001|Overall Study|Lost to Follow-up|1|||
144317406|NCT01076205|520361962|FG000|Overall Study|Adverse Drug Reaction|299|||
144317407|NCT01076205|520361962|FG000|Overall Study|Lack of Effectiveness|1423|||
144317408|NCT01076205|520361962|FG000|Overall Study|Other Reason|1075|||
144317409|NCT01076205|520361962|FG000|Overall Study|Unknown Reason|71|||
144317410|NCT01076205|520361962|FG000|Overall Study|Lost to Follow-up|3151|||
144317411|NCT02993822|520361969|FG000|Overall Study|Lack of Efficacy|1|||
144317412|NCT02993822|520361970|FG001|Overall Study|Lack of Efficacy|1|||
144317413|NCT02993822|520361971|FG002|Overall Study|Lack of Efficacy|0|||
144317414|NCT02993822|520361972|FG003|Overall Study|Lack of Efficacy|0|||
144317415|NCT02993822|520361969|FG000|Overall Study|Protocol Violation|1|||
144317416|NCT02993822|520361970|FG001|Overall Study|Protocol Violation|0|||
144317417|NCT02993822|520361971|FG002|Overall Study|Protocol Violation|0|||
144317418|NCT02993822|520361972|FG003|Overall Study|Protocol Violation|0|||
144317419|NCT02993822|520361969|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
144317420|NCT02993822|520361970|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
144317421|NCT02993822|520361971|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
144317422|NCT02993822|520361972|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
144317423|NCT02993822|520361969|FG000|Overall Study|Adverse Event|3|||
144317424|NCT02993822|520361970|FG001|Overall Study|Adverse Event|1|||
144317425|NCT02993822|520361971|FG002|Overall Study|Adverse Event|7|||
144317426|NCT02993822|520361972|FG003|Overall Study|Adverse Event|0|||
144317427|NCT02993822|520361969|FG000|Overall Study|Withdrawal by Subject|4|||
144317428|NCT02993822|520361970|FG001|Overall Study|Withdrawal by Subject|2|||
144317429|NCT02993822|520361971|FG002|Overall Study|Withdrawal by Subject|2|||
144317430|NCT02993822|520361972|FG003|Overall Study|Withdrawal by Subject|3|||
144317431|NCT02993822|520361969|FG000|Overall Study|Lost to Follow-up|1|||
144317432|NCT02993822|520361970|FG001|Overall Study|Lost to Follow-up|0|||
144317433|NCT02993822|520361971|FG002|Overall Study|Lost to Follow-up|1|||
144317434|NCT02993822|520361972|FG003|Overall Study|Lost to Follow-up|0|||
144317435|NCT01814046|520361976|FG000|Drug Administration|Death due to complications of RSV|1|||
144317436|NCT01814046|520361977|FG001|Drug Administration|Death due to complications of RSV|0|||
144317437|NCT01814046|520361978|FG002|Drug Administration|Death due to complications of RSV|0|||
144317438|NCT00564902|520361979|FG000|Overall Study|Withdrawal by Subject|0|||
144317439|NCT00564902|520361980|FG001|Overall Study|Withdrawal by Subject|3|||
144317440|NCT00564902|520361981|FG002|Overall Study|Withdrawal by Subject|4|||
144317441|NCT00564902|520361979|FG000|Overall Study|Death|1|||
144317442|NCT00564902|520361980|FG001|Overall Study|Death|1|||
144317443|NCT00564902|520361981|FG002|Overall Study|Death|0|||
144317444|NCT02097719|520361985|FG000|Overall Study|Subject Withdrew Consent|1|||
144317445|NCT02097719|520361986|FG001|Overall Study|Subject Withdrew Consent|0|||
144317446|NCT02097719|520361985|FG000|Overall Study|Lost to Follow-up|0|||
144317447|NCT02097719|520361986|FG001|Overall Study|Lost to Follow-up|1|||
144317448|NCT02097719|520361985|FG000|Overall Study|Adverse Event|2|||
144317449|NCT02097719|520361986|FG001|Overall Study|Adverse Event|0|||
144317450|NCT01854775|520361989|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
144317451|NCT01854775|520361990|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
144317452|NCT01854775|520361991|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
144317453|NCT01854775|520361989|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
144317454|NCT01854775|520361990|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
144317455|NCT01854775|520361991|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
144317456|NCT01854775|520361989|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
144317457|NCT01854775|520361990|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
144317458|NCT01854775|520361991|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
144317459|NCT01854775|520361989|FG000|Extension Phase|Pregnancy|3|||
144317460|NCT01854775|520361990|FG001|Extension Phase|Pregnancy|0|||
144317461|NCT01854775|520361991|FG002|Extension Phase|Pregnancy|0|||
144317462|NCT01854775|520361989|FG000|Extension Phase|Investigator's Discretion|1|||
144317463|NCT01854775|520361990|FG001|Extension Phase|Investigator's Discretion|0|||
144317464|NCT01854775|520361991|FG002|Extension Phase|Investigator's Discretion|0|||
144317465|NCT01854775|520361989|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
144317466|NCT01854775|520361990|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
144317467|NCT01854775|520361991|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
144317468|NCT01854775|520361989|FG000|Extension Phase|Lost to Follow-up|2|||
144317469|NCT01854775|520361990|FG001|Extension Phase|Lost to Follow-up|0|||
144317470|NCT01854775|520361991|FG002|Extension Phase|Lost to Follow-up|0|||
144317471|NCT01854775|520361989|FG000|Extension Phase|Still on Study|32|||
144317472|NCT01854775|520361990|FG001|Extension Phase|Still on Study|47|||
144317473|NCT01854775|520361991|FG002|Extension Phase|Still on Study|18|||
144317474|NCT00984594|520361993|FG000|Overall Study|Lost to Follow-up|1|||
144317475|NCT00984594|520361994|FG001|Overall Study|Lost to Follow-up|0|||
144317476|NCT00984594|520361993|FG000|Overall Study|Withdrawal by Subject|0|||
144317477|NCT00984594|520361994|FG001|Overall Study|Withdrawal by Subject|1|||
144317478|NCT03135431|520361995|FG000|Overall Study|Study Surgeon not available|2|||
144317479|NCT03135431|520361996|FG001|Overall Study|Study Surgeon not available|0|||
144317480|NCT02597452|520361997|FG000|Overall Study|testing incomplete|30|||
144317481|NCT03122145|520362000|FG000|Overall Study|Concurrent respiratory disease|3|||
144317482|NCT03122145|520362001|FG001|Overall Study|Concurrent respiratory disease|0|||
144317483|NCT00281099|520362006|FG000|Overall Study|Death|46|||
144317484|NCT00281099|520362007|FG001|Overall Study|Death|57|||
144317485|NCT00281099|520362006|FG000|Overall Study|Lost to Follow-up|10|||
144317486|NCT00281099|520362007|FG001|Overall Study|Lost to Follow-up|19|||
144317487|NCT00281099|520362006|FG000|Overall Study|Withdrawal by Subject|65|||
144317488|NCT00281099|520362007|FG001|Overall Study|Withdrawal by Subject|70|||
144317489|NCT00281099|520362006|FG000|Overall Study|Physician Decision|79|||
144317490|NCT00281099|520362007|FG001|Overall Study|Physician Decision|72|||
144317491|NCT00281099|520362006|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
144317492|NCT00281099|520362007|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
144317493|NCT01170273|520362008|FG000|Overall Study|Lost to Follow-up|6|||
144317494|NCT01170273|520362009|FG001|Overall Study|Lost to Follow-up|8|||
144317495|NCT01170273|520362008|FG000|Overall Study|Protocol Violation|1|||
144317496|NCT01170273|520362009|FG001|Overall Study|Protocol Violation|0|||
144317497|NCT01170273|520362008|FG000|Overall Study|Death|1|||
144317498|NCT01170273|520362009|FG001|Overall Study|Death|0|||
144317499|NCT01170273|520362008|FG000|Overall Study|Adverse Event|0|||
144317500|NCT01170273|520362009|FG001|Overall Study|Adverse Event|1|||
144317501|NCT00334737|520362010|FG000|Hospital Phase|Death|1|||
144317502|NCT00334737|520362011|FG001|Hospital Phase|Death|2|||
144317503|NCT00334737|520362012|FG002|Hospital Phase|Death|3|||
144317504|NCT00334737|520362010|FG000|Hospital Phase|Withdrawal by Subject|0|||
144317505|NCT00334737|520362011|FG001|Hospital Phase|Withdrawal by Subject|0|||
144317506|NCT00334737|520362012|FG002|Hospital Phase|Withdrawal by Subject|1|||
144317507|NCT00334737|520362010|FG000|Hospital Phase|Did not receive study drug|1|||
144317508|NCT00334737|520362011|FG001|Hospital Phase|Did not receive study drug|0|||
144317509|NCT00334737|520362012|FG002|Hospital Phase|Did not receive study drug|0|||
144317510|NCT00334737|520362010|FG000|Follow up Phase|Lost to Follow-up|5|||
144317511|NCT00334737|520362011|FG001|Follow up Phase|Lost to Follow-up|3|||
144317512|NCT00334737|520362012|FG002|Follow up Phase|Lost to Follow-up|6|||
144317513|NCT00875485|520363908|FG000|Challenge Dose Epoch|Pregnancy|1|||
144317514|NCT00875485|520363909|FG001|Challenge Dose Epoch|Pregnancy|0|||
144317515|NCT01271010|520363910|FG000|Overall Study|Reason not specified|11|||
144317516|NCT01271010|520363910|FG000|Overall Study|Start of new CLL therapy|1|||
144317517|NCT01271010|520363910|FG000|Overall Study|Protocol Violation|1|||
144317518|NCT01271010|520363910|FG000|Overall Study|Death|2|||
144317519|NCT01271010|520363910|FG000|Overall Study|Progression and relapse of disease|1|||
144317520|NCT01271010|520363910|FG000|Overall Study|Withdrawal by Subject|18|||
144317521|NCT01271010|520363910|FG000|Overall Study|Disease progression|27|||
144317522|NCT01631747|520363911|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
144317523|NCT01631747|520363912|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
144317524|NCT01631747|520363911|FG000|Live Birth|Pregnancy Termination|1|||
144317525|NCT01631747|520363912|FG001|Live Birth|Pregnancy Termination|0|||
144317526|NCT01631747|520363911|FG000|Live Birth|MIscarriage|2|||
144317527|NCT01631747|520363912|FG001|Live Birth|MIscarriage|0|||
144317528|NCT01631747|520363911|FG000|Live Birth|Stillbirth|1|||
144317529|NCT01631747|520363912|FG001|Live Birth|Stillbirth|1|||
144317530|NCT01631747|520363911|FG000|One Year Infant Outcomes|Patient Refused|13|||
144317531|NCT01631747|520363912|FG001|One Year Infant Outcomes|Patient Refused|9|||
144317532|NCT01456195|520363913|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
144317533|NCT01456195|520363914|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
144317534|NCT01456195|520363915|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
144317535|NCT01456195|520363913|FG000|Overall Study|Lost to Follow-up|3|||
144317536|NCT01456195|520363914|FG001|Overall Study|Lost to Follow-up|1|||
144317537|NCT01456195|520363915|FG002|Overall Study|Lost to Follow-up|3|||
144317538|NCT01456195|520363913|FG000|Overall Study|Voluntary Withdrawal|5|||
144317539|NCT01456195|520363914|FG001|Overall Study|Voluntary Withdrawal|3|||
144317540|NCT01456195|520363915|FG002|Overall Study|Voluntary Withdrawal|7|||
144317541|NCT01456195|520363913|FG000|Overall Study|Lack of Efficacy|0|||
144317542|NCT01456195|520363914|FG001|Overall Study|Lack of Efficacy|1|||
144317543|NCT01456195|520363915|FG002|Overall Study|Lack of Efficacy|0|||
144317544|NCT01456195|520363913|FG000|Overall Study|Other Reasons|2|||
144317545|NCT01456195|520363914|FG001|Overall Study|Other Reasons|1|||
144317546|NCT01456195|520363915|FG002|Overall Study|Other Reasons|3|||
144317547|NCT02109432|520363916|FG000|Overall Study|Withdrawal by Subject|1|||
144317548|NCT01691014|520363923|FG000|Overall Study|Premature Termination|1|||
144317549|NCT01691014|520363924|FG001|Overall Study|Premature Termination|6|||
144317550|NCT01691014|520363925|FG002|Overall Study|Premature Termination|0|||
144317551|NCT01691014|520363926|FG003|Overall Study|Premature Termination|3|||
144317552|NCT01691014|520363923|FG000|Overall Study|Other|0|||
144317553|NCT01691014|520363924|FG001|Overall Study|Other|0|||
144317554|NCT01691014|520363925|FG002|Overall Study|Other|2|||
144317555|NCT01691014|520363926|FG003|Overall Study|Other|0|||
144317556|NCT01691014|520363923|FG000|Overall Study|Withdrawal by Subject|0|||
144317557|NCT01691014|520363924|FG001|Overall Study|Withdrawal by Subject|1|||
144317558|NCT01691014|520363925|FG002|Overall Study|Withdrawal by Subject|1|||
144317559|NCT01691014|520363926|FG003|Overall Study|Withdrawal by Subject|1|||
144317560|NCT01691014|520363923|FG000|Overall Study|Adverse Event|0|||
144317561|NCT01691014|520363924|FG001|Overall Study|Adverse Event|5|||
144317562|NCT01691014|520363925|FG002|Overall Study|Adverse Event|1|||
144317563|NCT01691014|520363926|FG003|Overall Study|Adverse Event|1|||
144317564|NCT01691014|520363923|FG000|Overall Study|Lack of Efficacy|2|||
144317565|NCT01691014|520363924|FG001|Overall Study|Lack of Efficacy|3|||
144317566|NCT01691014|520363925|FG002|Overall Study|Lack of Efficacy|7|||
144317567|NCT01691014|520363926|FG003|Overall Study|Lack of Efficacy|0|||
144317568|NCT03372551|520363927|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
144317569|NCT03372551|520363928|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
144317570|NCT03522246|520363935|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
144317571|NCT03522246|520363936|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
144317572|NCT03522246|520363937|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
144317573|NCT03522246|520363938|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
144317574|NCT03522246|520363939|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
144317575|NCT04683029|520363940|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
144317576|NCT04683029|520363941|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
144317577|NCT04683029|520363942|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
144317578|NCT04683029|520363943|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
144317579|NCT04683029|520363940|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
144317580|NCT04683029|520363941|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
144317581|NCT04683029|520363942|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
144317582|NCT04683029|520363943|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
144317583|NCT04683029|520363940|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
144317584|NCT04683029|520363941|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
144317585|NCT04683029|520363942|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
144317586|NCT04683029|520363943|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
144317587|NCT04299308|520363944|FG000|Overall Study|Withdrawal by Subject|1|||
144317588|NCT04299308|520363945|FG001|Overall Study|Withdrawal by Subject|0|||
144317589|NCT04299308|520363944|FG000|Overall Study|issue with PET image (1)|1|||
144317590|NCT04299308|520363945|FG001|Overall Study|issue with PET image (1)|0|||
144317591|NCT00814580|520363946|FG000|Overall Study|Adverse Event|6|||
144317592|NCT00814580|520363947|FG001|Overall Study|Adverse Event|15|||
144317593|NCT00814580|520363946|FG000|Overall Study|Lack of Efficacy|18|||
144317594|NCT00814580|520363947|FG001|Overall Study|Lack of Efficacy|25|||
144317595|NCT00814580|520363946|FG000|Overall Study|Protocol Violation|2|||
144317596|NCT00814580|520363947|FG001|Overall Study|Protocol Violation|0|||
144317597|NCT00814580|520363946|FG000|Overall Study|Withdrawal by Subject|2|||
144317598|NCT00814580|520363947|FG001|Overall Study|Withdrawal by Subject|2|||
144317599|NCT00814580|520363946|FG000|Overall Study|Other|1|||
144317600|NCT00814580|520363947|FG001|Overall Study|Other|3|||
144317601|NCT00814580|520363946|FG000|Overall Study|Did Not Take Drug|2|||
144317602|NCT00814580|520363947|FG001|Overall Study|Did Not Take Drug|2|||
144317603|NCT02920528|520363952|FG000|Overall Study|Incomplete Data|1|||
144317604|NCT02920528|520363953|FG001|Overall Study|Incomplete Data|1|||
144317605|NCT02920528|520363954|FG002|Overall Study|Incomplete Data|1|||
144317606|NCT02920528|520363952|FG000|Overall Study|Adverse Event|0|||
144317607|NCT02920528|520363953|FG001|Overall Study|Adverse Event|0|||
144317608|NCT02920528|520363954|FG002|Overall Study|Adverse Event|3|||
144317609|NCT02920528|520363952|FG000|Overall Study|Did not meet inclusion criteria|2|||
144317610|NCT02920528|520363953|FG001|Overall Study|Did not meet inclusion criteria|0|||
144317611|NCT02920528|520363954|FG002|Overall Study|Did not meet inclusion criteria|1|||
144317612|NCT01340625|520363955|FG000|First Intervention|Adverse Event|1|||
144317613|NCT01340625|520363956|FG001|First Intervention|Adverse Event|0|||
144317614|NCT01340625|520363955|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
144317615|NCT01340625|520363956|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
144317616|NCT00066703|520363957|FG000|Overall Study|Adverse Event|80|||
144317617|NCT00066703|520363958|FG001|Overall Study|Adverse Event|111|||
144317618|NCT00066703|520363957|FG000|Overall Study|Death|3|||
144317619|NCT00066703|520363958|FG001|Overall Study|Death|0|||
144317620|NCT00066703|520363957|FG000|Overall Study|Lack of Efficacy|114|||
144317621|NCT00066703|520363958|FG001|Overall Study|Lack of Efficacy|69|||
144317622|NCT00066703|520363957|FG000|Overall Study|Lost to Follow-up|31|||
144317623|NCT00066703|520363958|FG001|Overall Study|Lost to Follow-up|28|||
144317624|NCT00066703|520363957|FG000|Overall Study|Withdrawal by Subject|38|||
144317625|NCT00066703|520363958|FG001|Overall Study|Withdrawal by Subject|63|||
144317626|NCT00066703|520363957|FG000|Overall Study|Treatment ongoing|346|||
144317627|NCT00066703|520363958|FG001|Overall Study|Treatment ongoing|311|||
144317628|NCT01696968|520363959|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
144317629|NCT01696968|520363960|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
144317630|NCT01696968|520363959|FG000|Overall Study|Died Before Randomization|3|||
144317631|NCT01696968|520363960|FG001|Overall Study|Died Before Randomization|8|||
144317632|NCT01696968|520363959|FG000|Overall Study|Died Before ASU (Control)|278|||
144317633|NCT01696968|520363960|FG001|Overall Study|Died Before ASU (Control)|0|||
144317634|NCT01696968|520363959|FG000|Overall Study|Refused ASU (Control)|920|||
144317635|NCT01696968|520363960|FG001|Overall Study|Refused ASU (Control)|0|||
144317636|NCT01696968|520363959|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
144317637|NCT01696968|520363960|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
144317638|NCT03727646|520363961|FG000|Overall Study|Adverse Event|1|||
144317639|NCT03727646|520363962|FG001|Overall Study|Adverse Event|0|||
144317640|NCT04753658|520363965|FG000|Overall Study|Progressive disease|7|||
144317641|NCT04753658|520363965|FG000|Overall Study|Other|7|||
144317642|NCT04753658|520363965|FG000|Overall Study|Adverse Event|1|||
144317643|NCT05659719|520363966|FG000|Overall Study|At sponsor's request|0|||
144317644|NCT05659719|520363967|FG001|Overall Study|At sponsor's request|0|||
144317645|NCT05659719|520363968|FG002|Overall Study|At sponsor's request|0|||
144317646|NCT05659719|520363969|FG003|Overall Study|At sponsor's request|95|||
144317647|NCT05659719|520363966|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
144317648|NCT05659719|520363967|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
144317649|NCT05659719|520363968|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
144317650|NCT05659719|520363969|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
144317651|NCT05659719|520363966|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
144317652|NCT05659719|520363967|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
144317653|NCT05659719|520363968|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
144317654|NCT05659719|520363969|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
144317655|NCT05659719|520363966|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
144317656|NCT05659719|520363967|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
144317657|NCT05659719|520363968|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
144317658|NCT05659719|520363969|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
144317659|NCT05659719|520363966|FG000|Overall Study|Lost to Follow-up|0|||
144317660|NCT05659719|520363967|FG001|Overall Study|Lost to Follow-up|0|||
144317661|NCT05659719|520363968|FG002|Overall Study|Lost to Follow-up|0|||
144317662|NCT05659719|520363969|FG003|Overall Study|Lost to Follow-up|2|||
144317663|NCT05659719|520363966|FG000|Overall Study|Moved to another observational study|0|||
144317664|NCT05659719|520363967|FG001|Overall Study|Moved to another observational study|0|||
144317665|NCT05659719|520363968|FG002|Overall Study|Moved to another observational study|0|||
144317666|NCT05659719|520363969|FG003|Overall Study|Moved to another observational study|1|||
144317667|NCT05659719|520363966|FG000|Overall Study|The child was enrolled in an interventional study|0|||
144317668|NCT05659719|520363967|FG001|Overall Study|The child was enrolled in an interventional study|0|||
144317669|NCT05659719|520363968|FG002|Overall Study|The child was enrolled in an interventional study|0|||
144317670|NCT05659719|520363969|FG003|Overall Study|The child was enrolled in an interventional study|55|||
144317671|NCT05659719|520363966|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
144317672|NCT05659719|520363967|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
144317673|NCT05659719|520363968|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
144317674|NCT05659719|520363969|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
144317675|NCT05659719|520363966|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
144317676|NCT05659719|520363967|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
144317677|NCT05659719|520363968|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
144317678|NCT05659719|520363969|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
144317679|NCT05924165|520363970|FG000|Overall Study|Physician Decision|2|||
144317680|NCT05924165|520363971|FG001|Overall Study|Physician Decision|3|||
144317681|NCT05160415|520363972|FG000|Overall Study|Withdrawal by Subject|3|||
144317682|NCT04308239|520363979|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
144317683|NCT04308239|520363980|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
144317684|NCT04308239|520363979|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
144317685|NCT04308239|520363980|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
144317686|NCT04308239|520363979|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
144317687|NCT04308239|520363980|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
144317688|NCT04308239|520363979|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
144317689|NCT04308239|520363980|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
144317690|NCT01986231|520363981|FG000|Overall Study|Adverse Event|1|||
144317691|NCT00489424|520363984|FG000|Overall Study|Adverse Event|3|||
144317692|NCT00489424|520363985|FG001|Overall Study|Adverse Event|3|||
144317693|NCT00489424|520363986|FG002|Overall Study|Adverse Event|4|||
144317694|NCT00489424|520363984|FG000|Overall Study|Lack of Efficacy|1|||
144317695|NCT00489424|520363985|FG001|Overall Study|Lack of Efficacy|0|||
144317696|NCT00489424|520363986|FG002|Overall Study|Lack of Efficacy|0|||
144317697|NCT00489424|520363984|FG000|Overall Study|Administrative problems|0|||
144317698|NCT00489424|520363985|FG001|Overall Study|Administrative problems|2|||
144317699|NCT00489424|520363986|FG002|Overall Study|Administrative problems|1|||
144317700|NCT01436656|520363987|FG000|Dose Escalation|Death|1|||
144317701|NCT01436656|520363988|FG001|Dose Escalation|Death|3|||
144317702|NCT01436656|520363989|FG002|Dose Escalation|Death|1|||
144317703|NCT01436656|520363990|FG003|Dose Escalation|Death|0|||
144317704|NCT01436656|520363991|FG004|Dose Escalation|Death|2|||
144317705|NCT01436656|520363992|FG005|Dose Escalation|Death|1|||
144317706|NCT01436656|520363993|FG006|Dose Escalation|Death|1|||
144317707|NCT01436656|520363994|FG007|Dose Escalation|Death|1|||
144317708|NCT01436656|520363995|FG008|Dose Escalation|Death|1|||
144317709|NCT01436656|520363996|FG009|Dose Escalation|Death|0|||
144317710|NCT01436656|520363997|FG010|Dose Escalation|Death|0|||
144317711|NCT01436656|520363998|FG011|Dose Escalation|Death|0|||
144317712|NCT01436656|520363999|FG012|Dose Escalation|Death|0|||
144317713|NCT01436656|520364000|FG013|Dose Escalation|Death|0|||
144317714|NCT01436656|520364001|FG014|Dose Escalation|Death|0|||
144317715|NCT01436656|520364002|FG015|Dose Escalation|Death|0|||
144317716|NCT01436656|520364003|FG016|Dose Escalation|Death|0|||
144317717|NCT01436656|520364004|FG017|Dose Escalation|Death|0|||
144317718|NCT01436656|520363987|FG000|Dose Escalation|Protocol Violation|0|||
144317719|NCT01436656|520363988|FG001|Dose Escalation|Protocol Violation|0|||
144317720|NCT01436656|520363989|FG002|Dose Escalation|Protocol Violation|0|||
144317721|NCT01436656|520363990|FG003|Dose Escalation|Protocol Violation|0|||
144317722|NCT01436656|520363991|FG004|Dose Escalation|Protocol Violation|0|||
144317723|NCT01436656|520363992|FG005|Dose Escalation|Protocol Violation|1|||
144317724|NCT01436656|520363993|FG006|Dose Escalation|Protocol Violation|0|||
144317725|NCT01436656|520363994|FG007|Dose Escalation|Protocol Violation|0|||
144317726|NCT01436656|520363995|FG008|Dose Escalation|Protocol Violation|0|||
144317727|NCT01436656|520363996|FG009|Dose Escalation|Protocol Violation|0|||
144317728|NCT01436656|520363997|FG010|Dose Escalation|Protocol Violation|0|||
144317729|NCT01436656|520363998|FG011|Dose Escalation|Protocol Violation|0|||
144317730|NCT01436656|520363999|FG012|Dose Escalation|Protocol Violation|0|||
144317731|NCT01436656|520364000|FG013|Dose Escalation|Protocol Violation|0|||
144317732|NCT01436656|520364001|FG014|Dose Escalation|Protocol Violation|0|||
144317733|NCT01436656|520364002|FG015|Dose Escalation|Protocol Violation|0|||
144317734|NCT01436656|520364003|FG016|Dose Escalation|Protocol Violation|0|||
144317735|NCT01436656|520364004|FG017|Dose Escalation|Protocol Violation|0|||
144317736|NCT01436656|520363987|FG000|Dose Escalation|Withdrawal by Subject|0|||
144317737|NCT01436656|520363988|FG001|Dose Escalation|Withdrawal by Subject|0|||
144317738|NCT01436656|520363989|FG002|Dose Escalation|Withdrawal by Subject|0|||
144317739|NCT01436656|520363990|FG003|Dose Escalation|Withdrawal by Subject|0|||
144317740|NCT01436656|520363991|FG004|Dose Escalation|Withdrawal by Subject|1|||
144317741|NCT01436656|520363992|FG005|Dose Escalation|Withdrawal by Subject|0|||
144317742|NCT01436656|520363993|FG006|Dose Escalation|Withdrawal by Subject|0|||
144317743|NCT01436656|520363994|FG007|Dose Escalation|Withdrawal by Subject|2|||
144317744|NCT01436656|520363995|FG008|Dose Escalation|Withdrawal by Subject|0|||
144317745|NCT01436656|520363996|FG009|Dose Escalation|Withdrawal by Subject|1|||
144317746|NCT01436656|520363997|FG010|Dose Escalation|Withdrawal by Subject|1|||
144317747|NCT01436656|520363998|FG011|Dose Escalation|Withdrawal by Subject|0|||
144317748|NCT01436656|520363999|FG012|Dose Escalation|Withdrawal by Subject|0|||
144317749|NCT01436656|520364000|FG013|Dose Escalation|Withdrawal by Subject|0|||
144317750|NCT01436656|520364001|FG014|Dose Escalation|Withdrawal by Subject|0|||
144317751|NCT01436656|520364002|FG015|Dose Escalation|Withdrawal by Subject|0|||
144317752|NCT01436656|520364003|FG016|Dose Escalation|Withdrawal by Subject|0|||
144317753|NCT01436656|520364004|FG017|Dose Escalation|Withdrawal by Subject|0|||
144317754|NCT01436656|520363987|FG000|Dose Escalation|Administrative problems|0|||
144317755|NCT01436656|520363988|FG001|Dose Escalation|Administrative problems|1|||
144317756|NCT01436656|520363989|FG002|Dose Escalation|Administrative problems|0|||
144317757|NCT01436656|520363990|FG003|Dose Escalation|Administrative problems|0|||
144317758|NCT01436656|520363991|FG004|Dose Escalation|Administrative problems|0|||
144317759|NCT01436656|520363992|FG005|Dose Escalation|Administrative problems|0|||
144317760|NCT01436656|520363993|FG006|Dose Escalation|Administrative problems|0|||
144317761|NCT01436656|520363994|FG007|Dose Escalation|Administrative problems|0|||
144317762|NCT01436656|520363995|FG008|Dose Escalation|Administrative problems|0|||
144317763|NCT01436656|520363996|FG009|Dose Escalation|Administrative problems|0|||
144317764|NCT01436656|520363997|FG010|Dose Escalation|Administrative problems|0|||
144317765|NCT01436656|520363998|FG011|Dose Escalation|Administrative problems|0|||
144317766|NCT01436656|520363999|FG012|Dose Escalation|Administrative problems|0|||
144317767|NCT01436656|520364000|FG013|Dose Escalation|Administrative problems|0|||
144317768|NCT01436656|520364001|FG014|Dose Escalation|Administrative problems|0|||
144317769|NCT01436656|520364002|FG015|Dose Escalation|Administrative problems|0|||
144317770|NCT01436656|520364003|FG016|Dose Escalation|Administrative problems|0|||
144317771|NCT01436656|520364004|FG017|Dose Escalation|Administrative problems|0|||
144317772|NCT01436656|520363987|FG000|Dose Escalation|Lost to Follow-up|1|||
144317773|NCT01436656|520363988|FG001|Dose Escalation|Lost to Follow-up|0|||
144317774|NCT01436656|520363989|FG002|Dose Escalation|Lost to Follow-up|0|||
144317775|NCT01436656|520363990|FG003|Dose Escalation|Lost to Follow-up|0|||
144317776|NCT01436656|520363991|FG004|Dose Escalation|Lost to Follow-up|1|||
144317777|NCT01436656|520363992|FG005|Dose Escalation|Lost to Follow-up|0|||
144317778|NCT01436656|520363993|FG006|Dose Escalation|Lost to Follow-up|0|||
144317779|NCT01436656|520363994|FG007|Dose Escalation|Lost to Follow-up|0|||
144317780|NCT01436656|520363995|FG008|Dose Escalation|Lost to Follow-up|0|||
144317781|NCT01436656|520363996|FG009|Dose Escalation|Lost to Follow-up|0|||
144317782|NCT01436656|520363997|FG010|Dose Escalation|Lost to Follow-up|0|||
144317783|NCT01436656|520363998|FG011|Dose Escalation|Lost to Follow-up|0|||
144317784|NCT01436656|520363999|FG012|Dose Escalation|Lost to Follow-up|0|||
144317785|NCT01436656|520364000|FG013|Dose Escalation|Lost to Follow-up|0|||
144317786|NCT01436656|520364001|FG014|Dose Escalation|Lost to Follow-up|0|||
144317787|NCT01436656|520364002|FG015|Dose Escalation|Lost to Follow-up|0|||
144317788|NCT01436656|520364003|FG016|Dose Escalation|Lost to Follow-up|0|||
144317789|NCT01436656|520364004|FG017|Dose Escalation|Lost to Follow-up|0|||
144317790|NCT01436656|520363987|FG000|Dose Escalation|New anti-cancer therapy|1|||
144317791|NCT01436656|520363988|FG001|Dose Escalation|New anti-cancer therapy|0|||
144317792|NCT01436656|520363989|FG002|Dose Escalation|New anti-cancer therapy|0|||
144317793|NCT01436656|520363990|FG003|Dose Escalation|New anti-cancer therapy|0|||
144317794|NCT01436656|520363991|FG004|Dose Escalation|New anti-cancer therapy|0|||
144317795|NCT01436656|520363992|FG005|Dose Escalation|New anti-cancer therapy|0|||
144317796|NCT01436656|520363993|FG006|Dose Escalation|New anti-cancer therapy|0|||
144317797|NCT01436656|520363994|FG007|Dose Escalation|New anti-cancer therapy|0|||
144317798|NCT01436656|520363995|FG008|Dose Escalation|New anti-cancer therapy|1|||
144317799|NCT01436656|520363996|FG009|Dose Escalation|New anti-cancer therapy|1|||
144317800|NCT01436656|520363997|FG010|Dose Escalation|New anti-cancer therapy|0|||
144317801|NCT01436656|520363998|FG011|Dose Escalation|New anti-cancer therapy|0|||
144317802|NCT01436656|520363999|FG012|Dose Escalation|New anti-cancer therapy|0|||
144317803|NCT01436656|520364000|FG013|Dose Escalation|New anti-cancer therapy|0|||
144317804|NCT01436656|520364001|FG014|Dose Escalation|New anti-cancer therapy|0|||
144317805|NCT01436656|520364002|FG015|Dose Escalation|New anti-cancer therapy|0|||
144317806|NCT01436656|520364003|FG016|Dose Escalation|New anti-cancer therapy|0|||
144317807|NCT01436656|520364004|FG017|Dose Escalation|New anti-cancer therapy|0|||
144317808|NCT01436656|520363987|FG000|Dose Expansion|Adverse Event|0|||
144317809|NCT01436656|520363988|FG001|Dose Expansion|Adverse Event|0|||
144317810|NCT01436656|520363989|FG002|Dose Expansion|Adverse Event|0|||
144317811|NCT01436656|520363990|FG003|Dose Expansion|Adverse Event|0|||
144317812|NCT01436656|520363991|FG004|Dose Expansion|Adverse Event|0|||
144317813|NCT01436656|520363992|FG005|Dose Expansion|Adverse Event|0|||
144317814|NCT01436656|520363993|FG006|Dose Expansion|Adverse Event|0|||
144317815|NCT01436656|520363994|FG007|Dose Expansion|Adverse Event|0|||
144317816|NCT01436656|520363995|FG008|Dose Expansion|Adverse Event|0|||
144317817|NCT01436656|520363996|FG009|Dose Expansion|Adverse Event|0|||
144317818|NCT01436656|520363997|FG010|Dose Expansion|Adverse Event|0|||
144317819|NCT01436656|520363998|FG011|Dose Expansion|Adverse Event|1|||
144317820|NCT01436656|520363999|FG012|Dose Expansion|Adverse Event|0|||
144317821|NCT01436656|520364000|FG013|Dose Expansion|Adverse Event|0|||
144317822|NCT01436656|520364001|FG014|Dose Expansion|Adverse Event|0|||
144317823|NCT01436656|520364002|FG015|Dose Expansion|Adverse Event|0|||
144317824|NCT01436656|520364003|FG016|Dose Expansion|Adverse Event|0|||
144317825|NCT01436656|520364004|FG017|Dose Expansion|Adverse Event|0|||
144317826|NCT01436656|520363987|FG000|Dose Expansion|Withdrawal by Subject|0|||
144317827|NCT01436656|520363988|FG001|Dose Expansion|Withdrawal by Subject|0|||
144317828|NCT01436656|520363989|FG002|Dose Expansion|Withdrawal by Subject|0|||
144317829|NCT01436656|520363990|FG003|Dose Expansion|Withdrawal by Subject|0|||
144317830|NCT01436656|520363991|FG004|Dose Expansion|Withdrawal by Subject|0|||
144317831|NCT01436656|520363992|FG005|Dose Expansion|Withdrawal by Subject|0|||
144317832|NCT01436656|520363993|FG006|Dose Expansion|Withdrawal by Subject|0|||
144317833|NCT01436656|520363994|FG007|Dose Expansion|Withdrawal by Subject|0|||
144317834|NCT01436656|520363995|FG008|Dose Expansion|Withdrawal by Subject|0|||
144317835|NCT01436656|520363996|FG009|Dose Expansion|Withdrawal by Subject|0|||
144317836|NCT01436656|520363997|FG010|Dose Expansion|Withdrawal by Subject|0|||
144317837|NCT01436656|520363998|FG011|Dose Expansion|Withdrawal by Subject|1|||
144317838|NCT01436656|520363999|FG012|Dose Expansion|Withdrawal by Subject|3|||
144317839|NCT01436656|520364000|FG013|Dose Expansion|Withdrawal by Subject|1|||
144317840|NCT01436656|520364001|FG014|Dose Expansion|Withdrawal by Subject|2|||
144317841|NCT01436656|520364002|FG015|Dose Expansion|Withdrawal by Subject|0|||
144317842|NCT01436656|520364003|FG016|Dose Expansion|Withdrawal by Subject|1|||
144317843|NCT01436656|520364004|FG017|Dose Expansion|Withdrawal by Subject|1|||
144317844|NCT01436656|520363987|FG000|Dose Expansion|Death|0|||
144317845|NCT01436656|520363988|FG001|Dose Expansion|Death|0|||
144317846|NCT01436656|520363989|FG002|Dose Expansion|Death|0|||
144317847|NCT01436656|520363990|FG003|Dose Expansion|Death|0|||
144317848|NCT01436656|520363991|FG004|Dose Expansion|Death|0|||
144317849|NCT01436656|520363992|FG005|Dose Expansion|Death|0|||
144317850|NCT01436656|520363993|FG006|Dose Expansion|Death|0|||
144317851|NCT01436656|520363994|FG007|Dose Expansion|Death|0|||
144317852|NCT01436656|520363995|FG008|Dose Expansion|Death|0|||
144317853|NCT01436656|520363996|FG009|Dose Expansion|Death|0|||
144317854|NCT01436656|520363997|FG010|Dose Expansion|Death|0|||
144317855|NCT01436656|520363998|FG011|Dose Expansion|Death|0|||
144317856|NCT01436656|520363999|FG012|Dose Expansion|Death|1|||
144317857|NCT01436656|520364000|FG013|Dose Expansion|Death|0|||
144317858|NCT01436656|520364001|FG014|Dose Expansion|Death|3|||
144317859|NCT01436656|520364002|FG015|Dose Expansion|Death|0|||
144317860|NCT01436656|520364003|FG016|Dose Expansion|Death|3|||
144317861|NCT01436656|520364004|FG017|Dose Expansion|Death|3|||
144317862|NCT01436656|520363987|FG000|Dose Expansion|Lost to Follow-up|0|||
144317863|NCT01436656|520363988|FG001|Dose Expansion|Lost to Follow-up|0|||
144317864|NCT01436656|520363989|FG002|Dose Expansion|Lost to Follow-up|0|||
144317865|NCT01436656|520363990|FG003|Dose Expansion|Lost to Follow-up|0|||
144317866|NCT01436656|520363991|FG004|Dose Expansion|Lost to Follow-up|0|||
144317867|NCT01436656|520363992|FG005|Dose Expansion|Lost to Follow-up|0|||
144317868|NCT01436656|520363993|FG006|Dose Expansion|Lost to Follow-up|0|||
144317869|NCT01436656|520363994|FG007|Dose Expansion|Lost to Follow-up|0|||
144317870|NCT01436656|520363995|FG008|Dose Expansion|Lost to Follow-up|0|||
144317871|NCT01436656|520363996|FG009|Dose Expansion|Lost to Follow-up|0|||
144317872|NCT01436656|520363997|FG010|Dose Expansion|Lost to Follow-up|0|||
144317873|NCT01436656|520363998|FG011|Dose Expansion|Lost to Follow-up|0|||
144317874|NCT01436656|520363999|FG012|Dose Expansion|Lost to Follow-up|0|||
144317875|NCT01436656|520364000|FG013|Dose Expansion|Lost to Follow-up|0|||
144317876|NCT01436656|520364001|FG014|Dose Expansion|Lost to Follow-up|0|||
144317877|NCT01436656|520364002|FG015|Dose Expansion|Lost to Follow-up|0|||
144317878|NCT01436656|520364003|FG016|Dose Expansion|Lost to Follow-up|0|||
144317879|NCT01436656|520364004|FG017|Dose Expansion|Lost to Follow-up|3|||
144317880|NCT01436656|520363987|FG000|Dose Expansion|Disease progression|0|||
144317881|NCT01436656|520363988|FG001|Dose Expansion|Disease progression|0|||
144317882|NCT01436656|520363989|FG002|Dose Expansion|Disease progression|0|||
144317883|NCT01436656|520363990|FG003|Dose Expansion|Disease progression|0|||
144317884|NCT01436656|520363991|FG004|Dose Expansion|Disease progression|0|||
144317885|NCT01436656|520363992|FG005|Dose Expansion|Disease progression|0|||
144317886|NCT01436656|520363993|FG006|Dose Expansion|Disease progression|0|||
144317887|NCT01436656|520363994|FG007|Dose Expansion|Disease progression|0|||
144317888|NCT01436656|520363995|FG008|Dose Expansion|Disease progression|0|||
144317889|NCT01436656|520363996|FG009|Dose Expansion|Disease progression|0|||
144317890|NCT01436656|520363997|FG010|Dose Expansion|Disease progression|0|||
144317891|NCT01436656|520363998|FG011|Dose Expansion|Disease progression|3|||
144317892|NCT01436656|520363999|FG012|Dose Expansion|Disease progression|1|||
144317893|NCT01436656|520364000|FG013|Dose Expansion|Disease progression|0|||
144317894|NCT01436656|520364001|FG014|Dose Expansion|Disease progression|1|||
144317895|NCT01436656|520364002|FG015|Dose Expansion|Disease progression|0|||
144317896|NCT01436656|520364003|FG016|Dose Expansion|Disease progression|0|||
144317897|NCT01436656|520364004|FG017|Dose Expansion|Disease progression|1|||
144317898|NCT01436656|520363987|FG000|Dose Expansion|New cancer therapy|0|||
144317899|NCT01436656|520363988|FG001|Dose Expansion|New cancer therapy|0|||
144317900|NCT01436656|520363989|FG002|Dose Expansion|New cancer therapy|0|||
144317901|NCT01436656|520363990|FG003|Dose Expansion|New cancer therapy|0|||
144317902|NCT01436656|520363991|FG004|Dose Expansion|New cancer therapy|0|||
144317903|NCT01436656|520363992|FG005|Dose Expansion|New cancer therapy|0|||
144317904|NCT01436656|520363993|FG006|Dose Expansion|New cancer therapy|0|||
144317905|NCT01436656|520363994|FG007|Dose Expansion|New cancer therapy|0|||
144317906|NCT01436656|520363995|FG008|Dose Expansion|New cancer therapy|0|||
144317907|NCT01436656|520363996|FG009|Dose Expansion|New cancer therapy|0|||
144317908|NCT01436656|520363997|FG010|Dose Expansion|New cancer therapy|0|||
144317909|NCT01436656|520363998|FG011|Dose Expansion|New cancer therapy|1|||
144317910|NCT01436656|520363999|FG012|Dose Expansion|New cancer therapy|1|||
144317911|NCT01436656|520364000|FG013|Dose Expansion|New cancer therapy|0|||
144317912|NCT01436656|520364001|FG014|Dose Expansion|New cancer therapy|2|||
144317913|NCT01436656|520364002|FG015|Dose Expansion|New cancer therapy|0|||
144317914|NCT01436656|520364003|FG016|Dose Expansion|New cancer therapy|0|||
144317915|NCT01436656|520364004|FG017|Dose Expansion|New cancer therapy|0|||
144317916|NCT00880269|520364005|FG000|Overall Study|Protocol Violation|1|||
144317917|NCT00880269|520364006|FG001|Overall Study|Protocol Violation|0|||
144317918|NCT00880269|520364005|FG000|Overall Study|Disease Progression|13|||
144317919|NCT00880269|520364006|FG001|Overall Study|Disease Progression|11|||
144317920|NCT00880269|520364005|FG000|Overall Study|New Cancer Therapy|1|||
144317921|NCT00880269|520364006|FG001|Overall Study|New Cancer Therapy|0|||
144317922|NCT00880269|520364005|FG000|Overall Study|Death|4|||
144317923|NCT00880269|520364006|FG001|Overall Study|Death|2|||
144317924|NCT00880269|520364005|FG000|Overall Study|Lost to Follow-up|0|||
144317925|NCT00880269|520364006|FG001|Overall Study|Lost to Follow-up|1|||
144317926|NCT00880269|520364005|FG000|Overall Study|Withdrawal by Subject|3|||
144317927|NCT00880269|520364006|FG001|Overall Study|Withdrawal by Subject|4|||
144317928|NCT00880269|520364005|FG000|Overall Study|Adverse Event|10|||
144317929|NCT00880269|520364006|FG001|Overall Study|Adverse Event|9|||
144317930|NCT00842153|520364014|FG000|Overall Study|Adverse Event|0|||
144317931|NCT00842153|520364015|FG001|Overall Study|Adverse Event|1|||
144317932|NCT00842153|520364014|FG000|Overall Study|Lost to Follow-up|1|||
144317933|NCT00842153|520364015|FG001|Overall Study|Lost to Follow-up|2|||
144317934|NCT01355679|520364017|FG000|Overall Study|benign tumor types found at biopsy|2|||
144317935|NCT02027311|520364018|FG000|Overall Study|Protocol Violation|3|||
144317936|NCT02027311|520364019|FG001|Overall Study|Protocol Violation|2|||
144317937|NCT05319600|520364020|FG000|Overall Study|Withdrawal by Subject|1|||
144317938|NCT05319600|520364021|FG001|Overall Study|Withdrawal by Subject|0|||
144317939|NCT05319600|520364020|FG000|Overall Study|Lost to Follow-up|0|||
144317940|NCT05319600|520364021|FG001|Overall Study|Lost to Follow-up|4|||
144317941|NCT03028129|520364028|FG000|Overall Study|Adverse Event|13|||
144317942|NCT03028129|520364029|FG001|Overall Study|Adverse Event|2|||
144317943|NCT03028129|520364028|FG000|Overall Study|Lost to Follow-up|50|||
144317944|NCT03028129|520364029|FG001|Overall Study|Lost to Follow-up|38|||
144317945|NCT03028129|520364028|FG000|Overall Study|Physician Decision|0|||
144317946|NCT03028129|520364029|FG001|Overall Study|Physician Decision|1|||
144317947|NCT03028129|520364028|FG000|Overall Study|Protocol Violation|1|||
144317948|NCT03028129|520364029|FG001|Overall Study|Protocol Violation|1|||
144317949|NCT03028129|520364028|FG000|Overall Study|Withdrawal by Subject|62|||
144317950|NCT03028129|520364029|FG001|Overall Study|Withdrawal by Subject|45|||
144317951|NCT00182078|520364030|FG000|Overall Study|Withdrawal by Subject|1|||
144317952|NCT00182078|520364031|FG001|Overall Study|Withdrawal by Subject|0|||
144317953|NCT01939977|520364032|FG000|Overall Study|Adverse Event|4|||
144317954|NCT01939977|520364033|FG001|Overall Study|Adverse Event|3|||
144317955|NCT01939977|520364032|FG000|Overall Study|Lack of Efficacy|3|||
144317956|NCT01939977|520364033|FG001|Overall Study|Lack of Efficacy|0|||
144317957|NCT01939977|520364032|FG000|Overall Study|Physician Decision|1|||
144317958|NCT01939977|520364033|FG001|Overall Study|Physician Decision|1|||
144317959|NCT01939977|520364032|FG000|Overall Study|Withdrawal by Subject|0|||
144317960|NCT01939977|520364033|FG001|Overall Study|Withdrawal by Subject|2|||
144317961|NCT01939977|520364032|FG000|Overall Study|Did not meet inclusion criteria|1|||
144317962|NCT01939977|520364033|FG001|Overall Study|Did not meet inclusion criteria|0|||
144317963|NCT01939977|520364032|FG000|Overall Study|Did not receive study medication|0|||
144317964|NCT01939977|520364033|FG001|Overall Study|Did not receive study medication|1|||
144317965|NCT01262560|520364045|FG000|Overall Study|Protocol Violation|0|||
144317966|NCT01262560|520364046|FG001|Overall Study|Protocol Violation|1|||
144317967|NCT01262560|520364047|FG002|Overall Study|Protocol Violation|2|||
144317968|NCT02443116|520364052|FG000|Part 1|Adverse Event|2|||
144317969|NCT02443116|520364053|FG001|Part 1|Adverse Event|3|||
144317970|NCT02443116|520364054|FG002|Part 1|Adverse Event|0|||
144317971|NCT02443116|520364055|FG003|Part 1|Adverse Event|0|||
144317972|NCT02443116|520364056|FG004|Part 1|Adverse Event|0|||
144317973|NCT02443116|520364057|FG005|Part 1|Adverse Event|0|||
144317974|NCT02443116|520364058|FG006|Part 1|Adverse Event|0|||
144317975|NCT02443116|520364059|FG007|Part 1|Adverse Event|0|||
144317976|NCT02443116|520364060|FG008|Part 1|Adverse Event|0|||
144317977|NCT02443116|520364052|FG000|Part 1|Withdrew informed consent|0|||
144317978|NCT02443116|520364053|FG001|Part 1|Withdrew informed consent|1|||
144317979|NCT02443116|520364054|FG002|Part 1|Withdrew informed consent|0|||
144317980|NCT02443116|520364055|FG003|Part 1|Withdrew informed consent|0|||
144317981|NCT02443116|520364056|FG004|Part 1|Withdrew informed consent|0|||
144317982|NCT02443116|520364057|FG005|Part 1|Withdrew informed consent|0|||
144317983|NCT02443116|520364058|FG006|Part 1|Withdrew informed consent|0|||
144317984|NCT02443116|520364059|FG007|Part 1|Withdrew informed consent|0|||
144317985|NCT02443116|520364060|FG008|Part 1|Withdrew informed consent|0|||
144317986|NCT02443116|520364052|FG000|Part 1|Lost to Follow-up|0|||
144317987|NCT02443116|520364053|FG001|Part 1|Lost to Follow-up|0|||
144317988|NCT02443116|520364054|FG002|Part 1|Lost to Follow-up|2|||
144317989|NCT02443116|520364055|FG003|Part 1|Lost to Follow-up|0|||
144317990|NCT02443116|520364056|FG004|Part 1|Lost to Follow-up|0|||
144317991|NCT02443116|520364057|FG005|Part 1|Lost to Follow-up|0|||
144317992|NCT02443116|520364058|FG006|Part 1|Lost to Follow-up|0|||
144317993|NCT02443116|520364059|FG007|Part 1|Lost to Follow-up|0|||
144317994|NCT02443116|520364060|FG008|Part 1|Lost to Follow-up|0|||
144317995|NCT02443116|520364052|FG000|Part 1|Participant moved out of state|0|||
144317996|NCT02443116|520364053|FG001|Part 1|Participant moved out of state|0|||
144317997|NCT02443116|520364054|FG002|Part 1|Participant moved out of state|1|||
144317998|NCT02443116|520364055|FG003|Part 1|Participant moved out of state|0|||
144317999|NCT02443116|520364056|FG004|Part 1|Participant moved out of state|0|||
144318000|NCT02443116|520364057|FG005|Part 1|Participant moved out of state|0|||
144318001|NCT02443116|520364058|FG006|Part 1|Participant moved out of state|0|||
144318002|NCT02443116|520364059|FG007|Part 1|Participant moved out of state|0|||
144318003|NCT02443116|520364060|FG008|Part 1|Participant moved out of state|0|||
144318004|NCT02443116|520364052|FG000|Part 1|Participant enrolled in another clinical trial|0|||
144318005|NCT02443116|520364053|FG001|Part 1|Participant enrolled in another clinical trial|0|||
144318006|NCT02443116|520364054|FG002|Part 1|Participant enrolled in another clinical trial|1|||
144318007|NCT02443116|520364055|FG003|Part 1|Participant enrolled in another clinical trial|0|||
144318008|NCT02443116|520364056|FG004|Part 1|Participant enrolled in another clinical trial|0|||
144318009|NCT02443116|520364057|FG005|Part 1|Participant enrolled in another clinical trial|0|||
144318010|NCT02443116|520364058|FG006|Part 1|Participant enrolled in another clinical trial|0|||
144318011|NCT02443116|520364059|FG007|Part 1|Participant enrolled in another clinical trial|0|||
144318012|NCT02443116|520364060|FG008|Part 1|Participant enrolled in another clinical trial|0|||
144318013|NCT02443116|520364052|FG000|Part 2|Adverse Event|0|||
144318014|NCT02443116|520364053|FG001|Part 2|Adverse Event|0|||
144318015|NCT02443116|520364054|FG002|Part 2|Adverse Event|0|||
144318016|NCT02443116|520364055|FG003|Part 2|Adverse Event|0|||
144318017|NCT02443116|520364056|FG004|Part 2|Adverse Event|1|||
144318018|NCT02443116|520364057|FG005|Part 2|Adverse Event|1|||
144318019|NCT02443116|520364058|FG006|Part 2|Adverse Event|2|||
144318020|NCT02443116|520364059|FG007|Part 2|Adverse Event|0|||
144318021|NCT02443116|520364060|FG008|Part 2|Adverse Event|0|||
144318022|NCT02443116|520364052|FG000|Part 2|Withdrew informed consent|0|||
144318023|NCT02443116|520364053|FG001|Part 2|Withdrew informed consent|0|||
144318024|NCT02443116|520364054|FG002|Part 2|Withdrew informed consent|0|||
144318025|NCT02443116|520364055|FG003|Part 2|Withdrew informed consent|0|||
144318026|NCT02443116|520364056|FG004|Part 2|Withdrew informed consent|0|||
144318027|NCT02443116|520364057|FG005|Part 2|Withdrew informed consent|1|||
144318028|NCT02443116|520364058|FG006|Part 2|Withdrew informed consent|1|||
144318029|NCT02443116|520364059|FG007|Part 2|Withdrew informed consent|0|||
144318030|NCT02443116|520364060|FG008|Part 2|Withdrew informed consent|0|||
144318031|NCT02443116|520364052|FG000|Part 2|Inability to comply with protocol|0|||
144318032|NCT02443116|520364053|FG001|Part 2|Inability to comply with protocol|0|||
144318033|NCT02443116|520364054|FG002|Part 2|Inability to comply with protocol|0|||
144318034|NCT02443116|520364055|FG003|Part 2|Inability to comply with protocol|1|||
144318035|NCT02443116|520364056|FG004|Part 2|Inability to comply with protocol|0|||
144318036|NCT02443116|520364057|FG005|Part 2|Inability to comply with protocol|0|||
144318037|NCT02443116|520364058|FG006|Part 2|Inability to comply with protocol|0|||
144318038|NCT02443116|520364059|FG007|Part 2|Inability to comply with protocol|0|||
144318039|NCT02443116|520364060|FG008|Part 2|Inability to comply with protocol|0|||
144318040|NCT02443116|520364052|FG000|Part 2|Lost to Follow-up|0|||
144318041|NCT02443116|520364053|FG001|Part 2|Lost to Follow-up|0|||
144318042|NCT02443116|520364054|FG002|Part 2|Lost to Follow-up|0|||
144318043|NCT02443116|520364055|FG003|Part 2|Lost to Follow-up|1|||
144318044|NCT02443116|520364056|FG004|Part 2|Lost to Follow-up|0|||
144318045|NCT02443116|520364057|FG005|Part 2|Lost to Follow-up|0|||
144318046|NCT02443116|520364058|FG006|Part 2|Lost to Follow-up|0|||
144318047|NCT02443116|520364059|FG007|Part 2|Lost to Follow-up|0|||
144318048|NCT02443116|520364060|FG008|Part 2|Lost to Follow-up|0|||
144318049|NCT02443116|520364052|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318050|NCT02443116|520364053|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318051|NCT02443116|520364054|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318052|NCT02443116|520364055|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318053|NCT02443116|520364056|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318054|NCT02443116|520364057|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
144318055|NCT02443116|520364058|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318056|NCT02443116|520364059|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318057|NCT02443116|520364060|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
144318058|NCT02443116|520364052|FG000|Part 3|Adverse Event|0|||
144318059|NCT02443116|520364053|FG001|Part 3|Adverse Event|0|||
144318060|NCT02443116|520364054|FG002|Part 3|Adverse Event|0|||
144318061|NCT02443116|520364055|FG003|Part 3|Adverse Event|0|||
144318062|NCT02443116|520364056|FG004|Part 3|Adverse Event|0|||
144318063|NCT02443116|520364057|FG005|Part 3|Adverse Event|0|||
144318064|NCT02443116|520364058|FG006|Part 3|Adverse Event|0|||
144318065|NCT02443116|520364059|FG007|Part 3|Adverse Event|0|||
144318066|NCT02443116|520364060|FG008|Part 3|Adverse Event|1|||
144318067|NCT02443116|520364052|FG000|Part 3|Withdrew informed consent|0|||
144318068|NCT02443116|520364053|FG001|Part 3|Withdrew informed consent|0|||
144318069|NCT02443116|520364054|FG002|Part 3|Withdrew informed consent|0|||
144318070|NCT02443116|520364055|FG003|Part 3|Withdrew informed consent|0|||
144318071|NCT02443116|520364056|FG004|Part 3|Withdrew informed consent|0|||
144318072|NCT02443116|520364057|FG005|Part 3|Withdrew informed consent|0|||
144318073|NCT02443116|520364058|FG006|Part 3|Withdrew informed consent|0|||
144318074|NCT02443116|520364059|FG007|Part 3|Withdrew informed consent|3|||
144318075|NCT02443116|520364060|FG008|Part 3|Withdrew informed consent|2|||
144318076|NCT02443116|520364052|FG000|Part 3|Lost to Follow-up|0|||
144318077|NCT02443116|520364053|FG001|Part 3|Lost to Follow-up|0|||
144318078|NCT02443116|520364054|FG002|Part 3|Lost to Follow-up|0|||
144318079|NCT02443116|520364055|FG003|Part 3|Lost to Follow-up|0|||
144318080|NCT02443116|520364056|FG004|Part 3|Lost to Follow-up|0|||
144318081|NCT02443116|520364057|FG005|Part 3|Lost to Follow-up|0|||
144318082|NCT02443116|520364058|FG006|Part 3|Lost to Follow-up|0|||
144318083|NCT02443116|520364059|FG007|Part 3|Lost to Follow-up|1|||
144318084|NCT02443116|520364060|FG008|Part 3|Lost to Follow-up|2|||
144318085|NCT04295759|520364061|FG000|Overall Study|Lack of Efficacy|9|||
144318086|NCT04295759|520364061|FG000|Overall Study|Death|1|||
144318087|NCT04295759|520364061|FG000|Overall Study|Withdrawal by Subject|2|||
144318088|NCT04295759|520364061|FG000|Overall Study|Deemed ineligible|1|||
144318089|NCT01696981|520364062|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
144318090|NCT01696981|520364063|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
144318091|NCT01696981|520364062|FG000|Overall Study|Died Before Randomization|3|||
144318092|NCT01696981|520364063|FG001|Overall Study|Died Before Randomization|8|||
144318093|NCT01696981|520364062|FG000|Overall Study|Died Before ASU (Control)|278|||
144318094|NCT01696981|520364063|FG001|Overall Study|Died Before ASU (Control)|0|||
144318095|NCT01696981|520364062|FG000|Overall Study|Refused ASU (Control)|920|||
144318096|NCT01696981|520364063|FG001|Overall Study|Refused ASU (Control)|0|||
144318097|NCT01696981|520364062|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
144318098|NCT01696981|520364063|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
144318099|NCT00465972|520364066|FG000|Overall Study|Withdrawal by Subject|2|||
144318100|NCT00465972|520364067|FG001|Overall Study|Withdrawal by Subject|1|||
144318101|NCT02095873|520364068|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
144318102|NCT02095873|520364069|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
144318103|NCT02095873|520364068|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
144318104|NCT02095873|520364069|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
144318105|NCT02095873|520364068|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
144318106|NCT02095873|520364069|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
144318107|NCT00851890|520364070|FG000|Overall Study|Lost to Follow-up|0|||
144318108|NCT00851890|520364071|FG001|Overall Study|Lost to Follow-up|1|||
144318109|NCT00851890|520364072|FG002|Overall Study|Lost to Follow-up|0|||
144318110|NCT00851890|520364073|FG003|Overall Study|Lost to Follow-up|1|||
144318111|NCT00792740|520364074|FG000|Overall Study|Disease Worsening|3|||
144318112|NCT00792740|520364075|FG001|Overall Study|Disease Worsening|2|||
144318113|NCT00792740|520364074|FG000|Overall Study|Personal Reason|1|||
144318114|NCT00792740|520364075|FG001|Overall Study|Personal Reason|0|||
144318115|NCT00792740|520364074|FG000|Overall Study|Adverse Event|1|||
144318116|NCT00792740|520364075|FG001|Overall Study|Adverse Event|3|||
144318117|NCT00792740|520364074|FG000|Overall Study|Patient's withdrawal of consent|0|||
144318118|NCT00792740|520364075|FG001|Overall Study|Patient's withdrawal of consent|1|||
144318119|NCT00792740|520364074|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
144318120|NCT00792740|520364075|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
144318121|NCT00792740|520364074|FG000|Overall Study|Other reasons|0|||
144318122|NCT00792740|520364075|FG001|Overall Study|Other reasons|1|||
144318123|NCT01352221|520364076|FG000|Double-blind Phase|Adverse Event|6|||
144318124|NCT01352221|520364077|FG001|Double-blind Phase|Adverse Event|4|||
144318125|NCT01352221|520364078|FG002|Double-blind Phase|Adverse Event|0|||
144318126|NCT01352221|520364079|FG003|Double-blind Phase|Adverse Event|0|||
144318127|NCT01352221|520364076|FG000|Double-blind Phase|Withdrawal by Subject|3|||
144318128|NCT01352221|520364077|FG001|Double-blind Phase|Withdrawal by Subject|5|||
144318129|NCT01352221|520364078|FG002|Double-blind Phase|Withdrawal by Subject|0|||
144318130|NCT01352221|520364079|FG003|Double-blind Phase|Withdrawal by Subject|0|||
144318131|NCT01352221|520364076|FG000|Double-blind Phase|Lost to Follow-up|0|||
144318132|NCT01352221|520364077|FG001|Double-blind Phase|Lost to Follow-up|1|||
144318133|NCT01352221|520364078|FG002|Double-blind Phase|Lost to Follow-up|0|||
144318134|NCT01352221|520364079|FG003|Double-blind Phase|Lost to Follow-up|0|||
144318135|NCT01352221|520364076|FG000|Double-blind Phase|Protocol Violation|0|||
144318136|NCT01352221|520364077|FG001|Double-blind Phase|Protocol Violation|1|||
144318137|NCT01352221|520364078|FG002|Double-blind Phase|Protocol Violation|0|||
144318138|NCT01352221|520364079|FG003|Double-blind Phase|Protocol Violation|0|||
144318139|NCT01352221|520364076|FG000|Open-label Phase|Physician Decision|0|||
144318140|NCT01352221|520364077|FG001|Open-label Phase|Physician Decision|0|||
144318141|NCT01352221|520364078|FG002|Open-label Phase|Physician Decision|2|||
144318142|NCT01352221|520364079|FG003|Open-label Phase|Physician Decision|1|||
144318143|NCT01352221|520364076|FG000|Open-label Phase|Pregnancy|0|||
144318144|NCT01352221|520364077|FG001|Open-label Phase|Pregnancy|0|||
144318145|NCT01352221|520364078|FG002|Open-label Phase|Pregnancy|1|||
144318146|NCT01352221|520364079|FG003|Open-label Phase|Pregnancy|0|||
144318147|NCT01352221|520364076|FG000|Open-label Phase|Adverse Event|0|||
144318148|NCT01352221|520364077|FG001|Open-label Phase|Adverse Event|0|||
144318149|NCT01352221|520364078|FG002|Open-label Phase|Adverse Event|8|||
144318150|NCT01352221|520364079|FG003|Open-label Phase|Adverse Event|4|||
144318151|NCT01352221|520364076|FG000|Open-label Phase|Withdrawal by Subject|0|||
144318152|NCT01352221|520364077|FG001|Open-label Phase|Withdrawal by Subject|0|||
144318153|NCT01352221|520364078|FG002|Open-label Phase|Withdrawal by Subject|1|||
144318154|NCT01352221|520364079|FG003|Open-label Phase|Withdrawal by Subject|6|||
144318155|NCT01352221|520364076|FG000|Open-label Phase|Worsening of IBD|0|||
144318156|NCT01352221|520364077|FG001|Open-label Phase|Worsening of IBD|0|||
144318157|NCT01352221|520364078|FG002|Open-label Phase|Worsening of IBD|1|||
144318158|NCT01352221|520364079|FG003|Open-label Phase|Worsening of IBD|0|||
144318159|NCT06899737|520364086|FG000|Overall Study|Lost to Follow-up|19|||
144318160|NCT06899737|520364087|FG001|Overall Study|Lost to Follow-up|7|||
144318161|NCT02316353|520364089|FG000|Overall Study|Pregnancy|1|||
144318162|NCT02316353|520364090|FG001|Overall Study|Pregnancy|3|||
144318163|NCT02316353|520364089|FG000|Overall Study|Adverse Event|1|||
144318164|NCT02316353|520364090|FG001|Overall Study|Adverse Event|3|||
144318165|NCT02316353|520364089|FG000|Overall Study|Withdrawal by Subject|6|||
144318166|NCT02316353|520364090|FG001|Overall Study|Withdrawal by Subject|2|||
144318167|NCT01681186|520365732|FG000|Washout Period From Second Intervention|Adverse Event|0|||
144318168|NCT01681186|520365733|FG001|Washout Period From Second Intervention|Adverse Event|0|||
144318169|NCT01681186|520365734|FG002|Washout Period From Second Intervention|Adverse Event|0|||
144318170|NCT01681186|520365735|FG003|Washout Period From Second Intervention|Adverse Event|0|||
144318171|NCT01681186|520365736|FG004|Washout Period From Second Intervention|Adverse Event|0|||
144318172|NCT01681186|520365737|FG005|Washout Period From Second Intervention|Adverse Event|0|||
144318173|NCT01681186|520365738|FG006|Washout Period From Second Intervention|Adverse Event|1|||
144318174|NCT01681186|520365739|FG007|Washout Period From Second Intervention|Adverse Event|0|||
144318175|NCT01681186|520365732|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
144318176|NCT01681186|520365733|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
144318177|NCT01681186|520365734|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
144318178|NCT01681186|520365735|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
144318179|NCT01681186|520365736|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
144318180|NCT01681186|520365737|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
144318181|NCT01681186|520365738|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
144318182|NCT01681186|520365739|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
144318183|NCT01681186|520365732|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318184|NCT01681186|520365733|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318185|NCT01681186|520365734|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318186|NCT01681186|520365735|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318187|NCT01681186|520365736|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318188|NCT01681186|520365737|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318189|NCT01681186|520365738|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
144318190|NCT01681186|520365739|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
144318191|NCT01681186|520365732|FG000|Fourth Intervention|Protocol Violation|0|||
144318192|NCT01681186|520365733|FG001|Fourth Intervention|Protocol Violation|0|||
144318193|NCT01681186|520365734|FG002|Fourth Intervention|Protocol Violation|0|||
144318194|NCT01681186|520365735|FG003|Fourth Intervention|Protocol Violation|0|||
144318195|NCT01681186|520365736|FG004|Fourth Intervention|Protocol Violation|0|||
144318196|NCT01681186|520365737|FG005|Fourth Intervention|Protocol Violation|0|||
144318197|NCT01681186|520365738|FG006|Fourth Intervention|Protocol Violation|0|||
144318198|NCT01681186|520365739|FG007|Fourth Intervention|Protocol Violation|1|||
144318199|NCT04848220|520365748|FG000|Overall Study|Unable to proceed to study procedure|0|||
144318200|NCT04848220|520365749|FG001|Overall Study|Unable to proceed to study procedure|1|||
144318201|NCT04848220|520365750|FG002|Overall Study|Unable to proceed to study procedure|0|||
144318202|NCT04848220|520365748|FG000|Overall Study|Fractional flow not significant|0|||
144318203|NCT04848220|520365749|FG001|Overall Study|Fractional flow not significant|1|||
144318204|NCT04848220|520365750|FG002|Overall Study|Fractional flow not significant|0|||
144318205|NCT02923830|520365751|FG000|Overall Study|Physician Decision|13|||
144318206|NCT02923830|520365752|FG001|Overall Study|Physician Decision|15|||
144318207|NCT00394251|520365770|FG000|Overall Study|Adverse Event|7|||
144318208|NCT00394251|520365771|FG001|Overall Study|Adverse Event|5|||
144318209|NCT00394251|520365770|FG000|Overall Study|Unacceptable Toxicity|20|||
144318210|NCT00394251|520365771|FG001|Overall Study|Unacceptable Toxicity|18|||
144318211|NCT00394251|520365770|FG000|Overall Study|Physician Decision|1|||
144318212|NCT00394251|520365771|FG001|Overall Study|Physician Decision|1|||
144318213|NCT00394251|520365770|FG000|Overall Study|Protocol Violation|0|||
144318214|NCT00394251|520365771|FG001|Overall Study|Protocol Violation|1|||
144318215|NCT00394251|520365770|FG000|Overall Study|Withdrawal by Subject|7|||
144318216|NCT00394251|520365771|FG001|Overall Study|Withdrawal by Subject|11|||
144318217|NCT00394251|520365770|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
144318218|NCT00394251|520365771|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
144318219|NCT05791565|520365772|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
144318220|NCT05791565|520365773|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
144318221|NCT04644276|520365774|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
144318222|NCT04644276|520365775|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
144318223|NCT04644276|520365776|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
144318224|NCT00705250|520365777|FG000|Overall Study|Withdrawal by Subject|1|||
144318225|NCT00705250|520365777|FG000|Overall Study|Patient died in car accident|1|||
144318226|NCT01406938|520365778|FG000|Induction Period|Subject/guardian decision|6|||
144318227|NCT01406938|520365779|FG001|Induction Period|Subject/guardian decision|8|||
144318228|NCT01406938|520365780|FG002|Induction Period|Subject/guardian decision|0|||
144318229|NCT01406938|520365781|FG003|Induction Period|Subject/guardian decision|0|||
144318230|NCT01406938|520365782|FG004|Induction Period|Subject/guardian decision|0|||
144318231|NCT01406938|520365783|FG005|Induction Period|Subject/guardian decision|0|||
144318232|NCT01406938|520365778|FG000|Induction Period|Protocol deviation|1|||
144318233|NCT01406938|520365779|FG001|Induction Period|Protocol deviation|0|||
144318234|NCT01406938|520365780|FG002|Induction Period|Protocol deviation|0|||
144318235|NCT01406938|520365781|FG003|Induction Period|Protocol deviation|0|||
144318236|NCT01406938|520365782|FG004|Induction Period|Protocol deviation|0|||
144318237|NCT01406938|520365783|FG005|Induction Period|Protocol deviation|0|||
144318238|NCT01406938|520365778|FG000|Induction Period|Adverse Event|8|||
144318239|NCT01406938|520365779|FG001|Induction Period|Adverse Event|9|||
144318240|NCT01406938|520365780|FG002|Induction Period|Adverse Event|0|||
144318241|NCT01406938|520365781|FG003|Induction Period|Adverse Event|0|||
144318242|NCT01406938|520365782|FG004|Induction Period|Adverse Event|0|||
144318243|NCT01406938|520365783|FG005|Induction Period|Adverse Event|0|||
144318244|NCT01406938|520365778|FG000|Induction Period|Lack of Efficacy|1|||
144318245|NCT01406938|520365779|FG001|Induction Period|Lack of Efficacy|0|||
144318246|NCT01406938|520365780|FG002|Induction Period|Lack of Efficacy|0|||
144318247|NCT01406938|520365781|FG003|Induction Period|Lack of Efficacy|0|||
144318248|NCT01406938|520365782|FG004|Induction Period|Lack of Efficacy|0|||
144318249|NCT01406938|520365783|FG005|Induction Period|Lack of Efficacy|0|||
144318250|NCT01406938|520365778|FG000|Induction Period|Lost to Follow-up|2|||
144318251|NCT01406938|520365779|FG001|Induction Period|Lost to Follow-up|3|||
144318252|NCT01406938|520365780|FG002|Induction Period|Lost to Follow-up|0|||
144318253|NCT01406938|520365781|FG003|Induction Period|Lost to Follow-up|0|||
144318254|NCT01406938|520365782|FG004|Induction Period|Lost to Follow-up|0|||
144318255|NCT01406938|520365783|FG005|Induction Period|Lost to Follow-up|0|||
144318256|NCT01406938|520365778|FG000|Maintenance Period|Adverse Event|0|||
144318257|NCT01406938|520365779|FG001|Maintenance Period|Adverse Event|0|||
144318258|NCT01406938|520365780|FG002|Maintenance Period|Adverse Event|2|||
144318259|NCT01406938|520365781|FG003|Maintenance Period|Adverse Event|8|||
144318260|NCT01406938|520365782|FG004|Maintenance Period|Adverse Event|4|||
144318261|NCT01406938|520365783|FG005|Maintenance Period|Adverse Event|2|||
144318262|NCT01406938|520365778|FG000|Maintenance Period|Death|0|||
144318263|NCT01406938|520365779|FG001|Maintenance Period|Death|0|||
144318264|NCT01406938|520365780|FG002|Maintenance Period|Death|0|||
144318265|NCT01406938|520365781|FG003|Maintenance Period|Death|0|||
144318266|NCT01406938|520365782|FG004|Maintenance Period|Death|1|||
144318267|NCT01406938|520365783|FG005|Maintenance Period|Death|0|||
144318268|NCT01406938|520365778|FG000|Maintenance Period|Subject/guardian decision|0|||
144318269|NCT01406938|520365779|FG001|Maintenance Period|Subject/guardian decision|0|||
144318270|NCT01406938|520365780|FG002|Maintenance Period|Subject/guardian decision|11|||
144318271|NCT01406938|520365781|FG003|Maintenance Period|Subject/guardian decision|7|||
144318272|NCT01406938|520365782|FG004|Maintenance Period|Subject/guardian decision|10|||
144318273|NCT01406938|520365783|FG005|Maintenance Period|Subject/guardian decision|7|||
144318274|NCT01406938|520365778|FG000|Maintenance Period|Protocol Violation|0|||
144318275|NCT01406938|520365779|FG001|Maintenance Period|Protocol Violation|0|||
144318276|NCT01406938|520365780|FG002|Maintenance Period|Protocol Violation|2|||
144318277|NCT01406938|520365781|FG003|Maintenance Period|Protocol Violation|2|||
144318278|NCT01406938|520365782|FG004|Maintenance Period|Protocol Violation|2|||
144318279|NCT01406938|520365783|FG005|Maintenance Period|Protocol Violation|2|||
144318280|NCT01406938|520365778|FG000|Maintenance Period|Pregnancy|0|||
144318281|NCT01406938|520365779|FG001|Maintenance Period|Pregnancy|0|||
144318282|NCT01406938|520365780|FG002|Maintenance Period|Pregnancy|0|||
144318283|NCT01406938|520365781|FG003|Maintenance Period|Pregnancy|0|||
144318284|NCT01406938|520365782|FG004|Maintenance Period|Pregnancy|1|||
144318285|NCT01406938|520365783|FG005|Maintenance Period|Pregnancy|0|||
144318286|NCT01406938|520365778|FG000|Maintenance Period|Lost to Follow-up|0|||
144318287|NCT01406938|520365779|FG001|Maintenance Period|Lost to Follow-up|0|||
144318288|NCT01406938|520365780|FG002|Maintenance Period|Lost to Follow-up|0|||
144318289|NCT01406938|520365781|FG003|Maintenance Period|Lost to Follow-up|0|||
144318290|NCT01406938|520365782|FG004|Maintenance Period|Lost to Follow-up|4|||
144318291|NCT01406938|520365783|FG005|Maintenance Period|Lost to Follow-up|0|||
144318292|NCT01406938|520365778|FG000|Maintenance Period|Lack of Efficacy|0|||
144318293|NCT01406938|520365779|FG001|Maintenance Period|Lack of Efficacy|0|||
144318294|NCT01406938|520365780|FG002|Maintenance Period|Lack of Efficacy|2|||
144318295|NCT01406938|520365781|FG003|Maintenance Period|Lack of Efficacy|1|||
144318296|NCT01406938|520365782|FG004|Maintenance Period|Lack of Efficacy|3|||
144318297|NCT01406938|520365783|FG005|Maintenance Period|Lack of Efficacy|5|||
144318298|NCT01406938|520365778|FG000|Follow up|Lack of Efficacy|3|||
144318299|NCT01406938|520365779|FG001|Follow up|Lack of Efficacy|2|||
144318300|NCT01406938|520365780|FG002|Follow up|Lack of Efficacy|1|||
144318301|NCT01406938|520365781|FG003|Follow up|Lack of Efficacy|0|||
144318302|NCT01406938|520365782|FG004|Follow up|Lack of Efficacy|0|||
144318303|NCT01406938|520365783|FG005|Follow up|Lack of Efficacy|0|||
144318304|NCT01406938|520365778|FG000|Follow up|Patient/guardian decision|4|||
144318305|NCT01406938|520365779|FG001|Follow up|Patient/guardian decision|2|||
144318306|NCT01406938|520365780|FG002|Follow up|Patient/guardian decision|4|||
144318307|NCT01406938|520365781|FG003|Follow up|Patient/guardian decision|2|||
144318308|NCT01406938|520365782|FG004|Follow up|Patient/guardian decision|4|||
144318309|NCT01406938|520365783|FG005|Follow up|Patient/guardian decision|1|||
144318310|NCT01406938|520365778|FG000|Follow up|Protocol Violation|0|||
144318311|NCT01406938|520365779|FG001|Follow up|Protocol Violation|0|||
144318312|NCT01406938|520365780|FG002|Follow up|Protocol Violation|1|||
144318313|NCT01406938|520365781|FG003|Follow up|Protocol Violation|0|||
144318314|NCT01406938|520365782|FG004|Follow up|Protocol Violation|0|||
144318315|NCT01406938|520365783|FG005|Follow up|Protocol Violation|0|||
144318316|NCT01406938|520365778|FG000|Follow up|Physician Decision|0|||
144318317|NCT01406938|520365779|FG001|Follow up|Physician Decision|0|||
144318318|NCT01406938|520365780|FG002|Follow up|Physician Decision|2|||
144318319|NCT01406938|520365781|FG003|Follow up|Physician Decision|0|||
144318320|NCT01406938|520365782|FG004|Follow up|Physician Decision|3|||
144318321|NCT01406938|520365783|FG005|Follow up|Physician Decision|1|||
144318322|NCT01406938|520365778|FG000|Follow up|Lost to Follow-up|1|||
144318323|NCT01406938|520365779|FG001|Follow up|Lost to Follow-up|1|||
144318324|NCT01406938|520365780|FG002|Follow up|Lost to Follow-up|0|||
144318325|NCT01406938|520365781|FG003|Follow up|Lost to Follow-up|1|||
144318326|NCT01406938|520365782|FG004|Follow up|Lost to Follow-up|2|||
144318327|NCT01406938|520365783|FG005|Follow up|Lost to Follow-up|1|||
144318328|NCT01576146|520365784|FG000|Extension Period 1|Adverse Event|2|||
144318329|NCT01576146|520365784|FG000|Extension Period 1|Death|2|||
144318330|NCT01576146|520365784|FG000|Extension Period 1|Physician Decision|2|||
144318331|NCT01576146|520365784|FG000|Extension Period 1|Withdrawal by Subject|1|||
144318332|NCT01576146|520365784|FG000|Extension Period 1|Lost to Follow-up|1|||
144318333|NCT01576146|520365784|FG000|Extension Period 1|Parathyroidectomy|1|||
144318334|NCT01576146|520365784|FG000|Extension Period 1|Renal Transplant|1|||
144318335|NCT01576146|520365784|FG000|Extension Period 2|Sponsor Decision|13|||
144318336|NCT01576146|520365784|FG000|Extension Period 2|Death|1|||
144318337|NCT01576146|520365784|FG000|Extension Period 2|Adverse Event|1|||
144318338|NCT01576146|520365784|FG000|Extension Period 2|Renal Transplant|1|||
144318339|NCT01576146|520365784|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
144318340|NCT01667224|520365787|FG000|Overall Study|Withdrawal by Subject|3|||
144318341|NCT01667224|520365788|FG001|Overall Study|Withdrawal by Subject|1|||
144318342|NCT01667224|520365787|FG000|Overall Study|Protocol Violation|1|||
144318343|NCT01667224|520365788|FG001|Overall Study|Protocol Violation|1|||
144318344|NCT00316225|520365791|FG000|Overall Study|Adverse Event|2|||
144318345|NCT00316225|520365791|FG000|Overall Study|Physician Decision|3|||
144318346|NCT00316225|520365791|FG000|Overall Study|Progressive Disease|15|||
144318347|NCT00316225|520365791|FG000|Overall Study|Withdrawal by Subject|3|||
144318348|NCT00316225|520365791|FG000|Overall Study|Death|2|||
144318349|NCT01814878|520365792|FG000|Overall Study|Adverse Event|16|||
144318350|NCT01814878|520365793|FG001|Overall Study|Adverse Event|5|||
144318351|NCT01814878|520365792|FG000|Overall Study|Withdrawal by Subject|20|||
144318352|NCT01814878|520365793|FG001|Overall Study|Withdrawal by Subject|16|||
144318353|NCT01814878|520365792|FG000|Overall Study|Protocol Violation|5|||
144318354|NCT01814878|520365793|FG001|Overall Study|Protocol Violation|5|||
144318355|NCT01814878|520365792|FG000|Overall Study|Physician Decision|3|||
144318356|NCT01814878|520365793|FG001|Overall Study|Physician Decision|1|||
144318357|NCT01814878|520365792|FG000|Overall Study|Screening failure (drop-out)|0|||
144318358|NCT01814878|520365793|FG001|Overall Study|Screening failure (drop-out)|3|||
144318359|NCT01814878|520365792|FG000|Overall Study|Other|2|||
144318360|NCT01814878|520365793|FG001|Overall Study|Other|0|||
144318361|NCT01811485|520365794|FG000|Overall Study|Adverse Event|1|||
144318362|NCT01811485|520365795|FG001|Overall Study|Adverse Event|3|||
144318363|NCT01811485|520365796|FG002|Overall Study|Adverse Event|2|||
144318364|NCT01811485|520365794|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144318365|NCT01811485|520365795|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144318366|NCT01811485|520365796|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
144318367|NCT01811485|520365794|FG000|Overall Study|Administrative problems|1|||
144318368|NCT01811485|520365795|FG001|Overall Study|Administrative problems|0|||
144318369|NCT01811485|520365796|FG002|Overall Study|Administrative problems|0|||
144318370|NCT01811485|520365794|FG000|Overall Study|Protocol Deviation|0|||
144318371|NCT01811485|520365795|FG001|Overall Study|Protocol Deviation|1|||
144318372|NCT01811485|520365796|FG002|Overall Study|Protocol Deviation|0|||
144318373|NCT01545934|520365797|FG000|Overall Study|Withdrawal by Subject|4|||
144318374|NCT01545934|520365798|FG001|Overall Study|Withdrawal by Subject|3|||
144318375|NCT01545934|520365797|FG000|Overall Study|Lost to Follow-up|1|||
144318376|NCT01545934|520365798|FG001|Overall Study|Lost to Follow-up|0|||
144318377|NCT03654404|520365799|FG000|Overall Study|Death|1|||
144318378|NCT03654404|520365799|FG000|Overall Study|Lost to Follow-up|2|||
144318379|NCT03654404|520365799|FG000|Overall Study|Withdrawal by Subject|5|||
144318380|NCT02003638|520365804|FG000|Overall Study|Withdrawal by Subject|1|||
144318381|NCT02003638|520365805|FG001|Overall Study|Withdrawal by Subject|0|||
144318382|NCT03299881|520365806|FG000|Overall Study|Study Termination|17|||
144318383|NCT03299881|520365807|FG001|Overall Study|Study Termination|13|||
144318384|NCT00878254|520365808|FG000|Overall Study|Physician Decision|1|||
144318385|NCT00878254|520365808|FG000|Overall Study|Death|1|||
144318386|NCT00878254|520365808|FG000|Overall Study|Withdrawal by Subject|1|||
144318387|NCT00194077|520365812|FG000|Overall Study|Lack of Efficacy|22|||
144318388|NCT00194077|520365813|FG001|Overall Study|Lack of Efficacy|29|||
144318389|NCT00194077|520365812|FG000|Overall Study|Study nonadherence|1|||
144318390|NCT00194077|520365813|FG001|Overall Study|Study nonadherence|0|||
144318391|NCT00194077|520365812|FG000|Overall Study|Withdrawal by Subject|1|||
144318392|NCT00194077|520365813|FG001|Overall Study|Withdrawal by Subject|1|||
144318393|NCT03470194|520365816|FG000|Overall Study|Lost to Follow-up|11|||
144318394|NCT03470194|520365817|FG001|Overall Study|Lost to Follow-up|17|||
144318395|NCT01822899|520365818|FG000|Overall Study|Adverse Event|6|||
144318396|NCT01822899|520365819|FG001|Overall Study|Adverse Event|5|||
144318397|NCT01822899|520365818|FG000|Overall Study|Lack of Efficacy|6|||
144318398|NCT01822899|520365819|FG001|Overall Study|Lack of Efficacy|3|||
144318399|NCT01822899|520365818|FG000|Overall Study|Protocol Violation|6|||
144318400|NCT01822899|520365819|FG001|Overall Study|Protocol Violation|3|||
144318401|NCT01822899|520365818|FG000|Overall Study|Lost to Follow-up|1|||
144318402|NCT01822899|520365819|FG001|Overall Study|Lost to Follow-up|0|||
144318403|NCT01822899|520365818|FG000|Overall Study|Withdrawal by Subject|5|||
144318404|NCT01822899|520365819|FG001|Overall Study|Withdrawal by Subject|7|||
144318405|NCT05332392|520365820|FG000|Overall Study|Did not meet inclusion criteria|25|||
144318406|NCT05332392|520365820|FG000|Overall Study|Principal Investigator's decision|17|||
144318407|NCT05332392|520365820|FG000|Overall Study|Adverse Event|1|||
144318408|NCT05332392|520365820|FG000|Overall Study|Subject's decision|1|||
144318409|NCT01268046|520365821|FG000|Overall Study|Withdrawal by Subject|1|||
144318410|NCT01268046|520365822|FG001|Overall Study|Withdrawal by Subject|0|||
144318411|NCT01268046|520365823|FG002|Overall Study|Withdrawal by Subject|0|||
144318412|NCT01268046|520365824|FG003|Overall Study|Withdrawal by Subject|1|||
144318413|NCT01268046|520365821|FG000|Overall Study|Lost to Follow-up|0|||
144318414|NCT01268046|520365822|FG001|Overall Study|Lost to Follow-up|0|||
144318415|NCT01268046|520365823|FG002|Overall Study|Lost to Follow-up|1|||
144318416|NCT01268046|520365824|FG003|Overall Study|Lost to Follow-up|0|||
144318417|NCT02314156|520365826|FG000|Overall Study|Adverse Event|1|||
144318418|NCT02314156|520365827|FG001|Overall Study|Adverse Event|0|||
144318419|NCT02314156|520365826|FG000|Overall Study|Withdrawal by Subject|1|||
144318420|NCT02314156|520365827|FG001|Overall Study|Withdrawal by Subject|0|||
144318421|NCT01450696|520365828|FG000|Overall Study|Never Treated|1|||
144318422|NCT01450696|520365829|FG001|Overall Study|Never Treated|1|||
144318423|NCT01450696|520365828|FG000|Overall Study|Death|77|||
144318424|NCT01450696|520365829|FG001|Overall Study|Death|84|||
144318425|NCT01450696|520365828|FG000|Overall Study|Lost to Follow-up|3|||
144318426|NCT01450696|520365829|FG001|Overall Study|Lost to Follow-up|3|||
144318427|NCT01450696|520365828|FG000|Overall Study|Non-Compliance|1|||
144318428|NCT01450696|520365829|FG001|Overall Study|Non-Compliance|0|||
144318429|NCT01450696|520365828|FG000|Overall Study|Withdrawal by Subject|13|||
144318430|NCT01450696|520365829|FG001|Overall Study|Withdrawal by Subject|2|||
144318431|NCT01450696|520365828|FG000|Overall Study|Study Terminated by Sponsor|53|||
144318432|NCT01450696|520365829|FG001|Overall Study|Study Terminated by Sponsor|58|||
144318433|NCT03818607|520365830|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
144318434|NCT03818607|520365831|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
144318435|NCT03818607|520365830|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
144318436|NCT03818607|520365831|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
144318437|NCT03818607|520365830|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
144318438|NCT03818607|520365831|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
144318439|NCT05059301|520365834|FG000|Overall Study|Adverse Event|0|||
144318440|NCT05059301|520365835|FG001|Overall Study|Adverse Event|2|||
144318441|NCT05059301|520365836|FG002|Overall Study|Adverse Event|2|||
144318442|NCT05059301|520365834|FG000|Overall Study|Lost to Follow-up|2|||
144318443|NCT05059301|520365835|FG001|Overall Study|Lost to Follow-up|3|||
144318444|NCT05059301|520365836|FG002|Overall Study|Lost to Follow-up|3|||
144318445|NCT00853242|520365837|FG000|Overall Study|Adverse Event|0|||
144318446|NCT00853242|520365838|FG001|Overall Study|Adverse Event|1|||
144318447|NCT00853242|520365839|FG002|Overall Study|Adverse Event|1|||
144318448|NCT00853242|520365840|FG003|Overall Study|Adverse Event|0|||
144318449|NCT00853242|520365841|FG004|Overall Study|Adverse Event|3|||
144318450|NCT00853242|520365842|FG005|Overall Study|Adverse Event|1|||
144318451|NCT00853242|520365843|FG006|Overall Study|Adverse Event|1|||
144318452|NCT00853242|520365837|FG000|Overall Study|Noncompliant|0|||
144318453|NCT00853242|520365838|FG001|Overall Study|Noncompliant|0|||
144318454|NCT00853242|520365839|FG002|Overall Study|Noncompliant|0|||
144318455|NCT00853242|520365840|FG003|Overall Study|Noncompliant|0|||
144318456|NCT00853242|520365841|FG004|Overall Study|Noncompliant|1|||
144318457|NCT00853242|520365842|FG005|Overall Study|Noncompliant|0|||
144318458|NCT00853242|520365843|FG006|Overall Study|Noncompliant|0|||
144318459|NCT00853242|520365837|FG000|Overall Study|Withdrawal by Subject|1|||
144318460|NCT00853242|520365838|FG001|Overall Study|Withdrawal by Subject|2|||
144318461|NCT00853242|520365839|FG002|Overall Study|Withdrawal by Subject|0|||
144318462|NCT00853242|520365840|FG003|Overall Study|Withdrawal by Subject|4|||
144318463|NCT00853242|520365841|FG004|Overall Study|Withdrawal by Subject|0|||
144318464|NCT00853242|520365842|FG005|Overall Study|Withdrawal by Subject|0|||
144318465|NCT00853242|520365843|FG006|Overall Study|Withdrawal by Subject|2|||
144318466|NCT00853242|520365837|FG000|Overall Study|Other|2|||
144318467|NCT00853242|520365838|FG001|Overall Study|Other|0|||
144318468|NCT00853242|520365839|FG002|Overall Study|Other|2|||
144318469|NCT00853242|520365840|FG003|Overall Study|Other|0|||
144318470|NCT00853242|520365841|FG004|Overall Study|Other|0|||
144318471|NCT00853242|520365842|FG005|Overall Study|Other|1|||
144318472|NCT00853242|520365843|FG006|Overall Study|Other|2|||
144318473|NCT05730335|520365844|FG000|Overall Study|Lost to Follow-up|8|||
144318474|NCT05730335|520365844|FG000|Overall Study|Withdrawal by Subject|6|||
144318475|NCT03249909|520365851|FG000|Overall Study|Withdrawal by Subject|3|||
144318476|NCT03249909|520365852|FG001|Overall Study|Withdrawal by Subject|0|||
144318477|NCT03249909|520365853|FG002|Overall Study|Withdrawal by Subject|0|||
144318478|NCT03249909|520365851|FG000|Overall Study|Adverse Event|3|||
144318479|NCT03249909|520365852|FG001|Overall Study|Adverse Event|0|||
144318480|NCT03249909|520365853|FG002|Overall Study|Adverse Event|0|||
144318481|NCT03249909|520365851|FG000|Overall Study|Lost to Follow-up|0|||
144318482|NCT03249909|520365852|FG001|Overall Study|Lost to Follow-up|1|||
144318483|NCT03249909|520365853|FG002|Overall Study|Lost to Follow-up|0|||
144318484|NCT00606034|520365854|FG000|Overall Study|incarceration|1|||
144318485|NCT05286658|520365856|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
144318486|NCT05286658|520365856|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
144318487|NCT01205061|520365859|FG000|Overall Study|Adverse Event|4|||
144318488|NCT01205061|520365859|FG000|Overall Study|Withdrawal by Subject|11|||
144318489|NCT01205061|520365859|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
144318490|NCT01205061|520365859|FG000|Overall Study|Lost to Follow-up|9|||
144318491|NCT01205061|520365859|FG000|Overall Study|Other|1|||
144318492|NCT04026009|520365860|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144318493|NCT04026009|520365861|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144318494|NCT04026009|520365862|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
144318495|NCT04026009|520365863|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
144318496|NCT04026009|520365864|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
144318497|NCT04026009|520365860|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
144318498|NCT04026009|520365861|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
144318499|NCT04026009|520365862|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
144318500|NCT04026009|520365863|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
144318501|NCT04026009|520365864|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
144318502|NCT00615719|520365867|FG000|Overall Study|Physician Decision|5|||
144318503|NCT03748706|520365868|FG000|Overall Study|Lost to Follow-up|1|||
144318504|NCT05141175|520365869|FG000|Overall Study|Withdrawal by Subject|1|||
144318505|NCT02470585|520365870|FG000|Overall Study|Death|224|||
144318506|NCT02470585|520365871|FG001|Overall Study|Death|227|||
144318507|NCT02470585|520365872|FG002|Overall Study|Death|199|||
144318508|NCT02470585|520365870|FG000|Overall Study|Withdrew consent|21|||
144318509|NCT02470585|520365871|FG001|Overall Study|Withdrew consent|22|||
144318510|NCT02470585|520365872|FG002|Overall Study|Withdrew consent|31|||
144318511|NCT02470585|520365870|FG000|Overall Study|Lost to Follow-up|8|||
144318512|NCT02470585|520365871|FG001|Overall Study|Lost to Follow-up|15|||
144318513|NCT02470585|520365872|FG002|Overall Study|Lost to Follow-up|13|||
144318514|NCT02470585|520365870|FG000|Overall Study|Sponsor discontinued study|117|||
144318515|NCT02470585|520365871|FG001|Overall Study|Sponsor discontinued study|110|||
144318516|NCT02470585|520365872|FG002|Overall Study|Sponsor discontinued study|122|||
144318517|NCT02470585|520365870|FG000|Overall Study|Other, not specified|5|||
144318518|NCT02470585|520365871|FG001|Overall Study|Other, not specified|7|||
144318519|NCT02470585|520365872|FG002|Overall Study|Other, not specified|14|||
144318520|NCT02470585|520365870|FG000|Overall Study|Missing due to site non-compliance|0|||
144318521|NCT02470585|520365871|FG001|Overall Study|Missing due to site non-compliance|2|||
144318522|NCT02470585|520365872|FG002|Overall Study|Missing due to site non-compliance|3|||
144318523|NCT00349349|520365873|FG000|Overall Study|Adverse Event|5|||
144318524|NCT00349349|520365874|FG001|Overall Study|Adverse Event|6|||
144318525|NCT00349349|520365875|FG002|Overall Study|Adverse Event|2|||
144318526|NCT00349349|520365873|FG000|Overall Study|Withdrawal by Subject|5|||
144318527|NCT00349349|520365874|FG001|Overall Study|Withdrawal by Subject|2|||
144318528|NCT00349349|520365875|FG002|Overall Study|Withdrawal by Subject|1|||
144318529|NCT00349349|520365873|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
144318530|NCT00349349|520365874|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
144318531|NCT00349349|520365875|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
144318532|NCT00349349|520365873|FG000|Overall Study|Death|13|||
144318533|NCT00349349|520365874|FG001|Overall Study|Death|10|||
144318534|NCT00349349|520365875|FG002|Overall Study|Death|1|||
144318535|NCT00349349|520365873|FG000|Overall Study|Other Treatment Selected|2|||
144318536|NCT00349349|520365874|FG001|Overall Study|Other Treatment Selected|0|||
144318537|NCT00349349|520365875|FG002|Overall Study|Other Treatment Selected|0|||
144318538|NCT00349349|520365873|FG000|Overall Study|Participant Reduced General Condition|0|||
144318539|NCT00349349|520365874|FG001|Overall Study|Participant Reduced General Condition|1|||
144318540|NCT00349349|520365875|FG002|Overall Study|Participant Reduced General Condition|0|||
144318541|NCT00349349|520365873|FG000|Overall Study|Physician Decision|1|||
144318542|NCT00349349|520365874|FG001|Overall Study|Physician Decision|2|||
144318543|NCT00349349|520365875|FG002|Overall Study|Physician Decision|1|||
144318544|NCT00349349|520365873|FG000|Overall Study|No Response|0|||
144318545|NCT00349349|520365874|FG001|Overall Study|No Response|3|||
144318546|NCT00349349|520365875|FG002|Overall Study|No Response|0|||
144318547|NCT00349349|520365873|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
144318548|NCT00349349|520365874|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
144318549|NCT00349349|520365875|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
144318550|NCT01063062|520365883|FG000|Overall Study|Patient withdrew consent|0|||
144318551|NCT01063062|520365884|FG001|Overall Study|Patient withdrew consent|1|||
144318552|NCT01063062|520365883|FG000|Overall Study|Adverse Event|2|||
144318553|NCT01063062|520365884|FG001|Overall Study|Adverse Event|4|||
144318554|NCT01063062|520365883|FG000|Overall Study|Protocol Violation|5|||
144318555|NCT01063062|520365884|FG001|Overall Study|Protocol Violation|4|||
144318556|NCT01063062|520365883|FG000|Overall Study|Investigator's request|1|||
144318557|NCT01063062|520365884|FG001|Overall Study|Investigator's request|0|||
144318558|NCT01063062|520365883|FG000|Overall Study|Lost to Follow-up|0|||
144318559|NCT01063062|520365884|FG001|Overall Study|Lost to Follow-up|2|||
144318560|NCT01063062|520365883|FG000|Overall Study|Miscellaneous reason|0|||
144318561|NCT01063062|520365884|FG001|Overall Study|Miscellaneous reason|1|||
144318562|NCT02015481|520365885|FG000|Overall Study|Death|1|||
144318563|NCT02016716|520365886|FG000|Overall Study|Withdrawal by Subject|5|||
144318564|NCT02016716|520365887|FG001|Overall Study|Withdrawal by Subject|5|||
144318565|NCT02016716|520365888|FG002|Overall Study|Withdrawal by Subject|5|||
144318566|NCT02016716|520365886|FG000|Overall Study|Protocol-specified Criteria|0|||
144318567|NCT02016716|520365887|FG001|Overall Study|Protocol-specified Criteria|1|||
144318568|NCT02016716|520365888|FG002|Overall Study|Protocol-specified Criteria|0|||
144318569|NCT02016716|520365886|FG000|Overall Study|Lost to Follow-up|1|||
144318570|NCT02016716|520365887|FG001|Overall Study|Lost to Follow-up|2|||
144318571|NCT02016716|520365888|FG002|Overall Study|Lost to Follow-up|1|||
144318572|NCT00107900|520365891|FG000|Overall Study|Adverse Event|3|||
144318573|NCT00107900|520365892|FG001|Overall Study|Adverse Event|2|||
144318574|NCT00107900|520365893|FG002|Overall Study|Adverse Event|10|||
144318575|NCT00107900|520365894|FG003|Overall Study|Adverse Event|3|||
144318576|NCT00107900|520365895|FG004|Overall Study|Adverse Event|5|||
144318577|NCT00107900|520365896|FG005|Overall Study|Adverse Event|3|||
144318578|NCT00107900|520365891|FG000|Overall Study|Death|0|||
144318579|NCT00107900|520365892|FG001|Overall Study|Death|0|||
144318580|NCT00107900|520365893|FG002|Overall Study|Death|0|||
144318581|NCT00107900|520365894|FG003|Overall Study|Death|0|||
144318582|NCT00107900|520365895|FG004|Overall Study|Death|1|||
144318583|NCT00107900|520365896|FG005|Overall Study|Death|0|||
144318584|NCT00107900|520365891|FG000|Overall Study|Lost to Follow-up|4|||
144318585|NCT00107900|520365892|FG001|Overall Study|Lost to Follow-up|1|||
144318586|NCT00107900|520365893|FG002|Overall Study|Lost to Follow-up|3|||
144318587|NCT00107900|520365894|FG003|Overall Study|Lost to Follow-up|2|||
144318588|NCT00107900|520365895|FG004|Overall Study|Lost to Follow-up|5|||
144318589|NCT00107900|520365896|FG005|Overall Study|Lost to Follow-up|5|||
144318590|NCT00107900|520365891|FG000|Overall Study|Protocol Violation|1|||
144318591|NCT00107900|520365892|FG001|Overall Study|Protocol Violation|0|||
144318592|NCT00107900|520365893|FG002|Overall Study|Protocol Violation|5|||
144318593|NCT00107900|520365894|FG003|Overall Study|Protocol Violation|5|||
144318594|NCT00107900|520365895|FG004|Overall Study|Protocol Violation|7|||
144318595|NCT00107900|520365896|FG005|Overall Study|Protocol Violation|0|||
144318596|NCT00107900|520365891|FG000|Overall Study|Withdrawal by Subject|1|||
144318597|NCT00107900|520365892|FG001|Overall Study|Withdrawal by Subject|0|||
144318598|NCT00107900|520365893|FG002|Overall Study|Withdrawal by Subject|5|||
144318599|NCT00107900|520365894|FG003|Overall Study|Withdrawal by Subject|0|||
144318600|NCT00107900|520365895|FG004|Overall Study|Withdrawal by Subject|1|||
144318601|NCT00107900|520365896|FG005|Overall Study|Withdrawal by Subject|1|||
144318602|NCT00107900|520365891|FG000|Overall Study|Administrative Reasons|1|||
144318603|NCT00107900|520365892|FG001|Overall Study|Administrative Reasons|0|||
144318604|NCT00107900|520365893|FG002|Overall Study|Administrative Reasons|2|||
144318605|NCT00107900|520365894|FG003|Overall Study|Administrative Reasons|2|||
144318606|NCT00107900|520365895|FG004|Overall Study|Administrative Reasons|2|||
144318607|NCT00107900|520365896|FG005|Overall Study|Administrative Reasons|0|||
144318608|NCT02147197|520365900|FG000|Overall Study|Adverse Event|1|||
144318609|NCT02147197|520365901|FG001|Overall Study|Adverse Event|0|||
144318610|NCT02147197|520365902|FG002|Overall Study|Adverse Event|0|||
144318611|NCT02147197|520365900|FG000|Overall Study|Withdrawal of Consent|4|||
144318612|NCT02147197|520365901|FG001|Overall Study|Withdrawal of Consent|3|||
144318613|NCT02147197|520365902|FG002|Overall Study|Withdrawal of Consent|2|||
144318614|NCT02147197|520365900|FG000|Overall Study|Lost to Follow-up|2|||
144318615|NCT02147197|520365901|FG001|Overall Study|Lost to Follow-up|3|||
144318616|NCT02147197|520365902|FG002|Overall Study|Lost to Follow-up|1|||
144318617|NCT02147197|520365900|FG000|Overall Study|Protocol Violation|1|||
144318618|NCT02147197|520365901|FG001|Overall Study|Protocol Violation|0|||
144318619|NCT02147197|520365902|FG002|Overall Study|Protocol Violation|3|||
144318620|NCT02147197|520365900|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144318621|NCT02147197|520365901|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144318622|NCT02147197|520365902|FG002|Overall Study|Other Miscellaneous Reasons|3|||
144318623|NCT02582814|520368251|FG000|Overall Study|Study-specific withdrawal criteria|1|||
144318624|NCT02582814|520368252|FG001|Overall Study|Study-specific withdrawal criteria|0|||
144318625|NCT02582814|520368251|FG000|Overall Study|Withdrawal by Subject|4|||
144318626|NCT02582814|520368252|FG001|Overall Study|Withdrawal by Subject|3|||
144318627|NCT02582814|520368251|FG000|Overall Study|Adverse Event|4|||
144318628|NCT02582814|520368252|FG001|Overall Study|Adverse Event|4|||
144318629|NCT03530995|520368253|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
144318630|NCT03530995|520368254|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
144318631|NCT03530995|520368253|FG000|Part 1 Period 3|Protocol Violation|1|||
144318632|NCT03530995|520368254|FG001|Part 1 Period 3|Protocol Violation|0|||
144318633|NCT03530995|520368253|FG000|Part 1 Period 4|Physician Decision|1|||
144318634|NCT03530995|520368254|FG001|Part 1 Period 4|Physician Decision|0|||
144318635|NCT03530995|520368253|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
144318636|NCT03530995|520368254|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
144318637|NCT01751906|520368258|FG000|Overall Study|Lost to Follow-up|151|||
144318638|NCT01751906|520368259|FG001|Overall Study|Lost to Follow-up|68|||
144318639|NCT01751906|520368258|FG000|Overall Study|Withdrawal by Subject|22|||
144318640|NCT01751906|520368259|FG001|Overall Study|Withdrawal by Subject|18|||
144318641|NCT01751906|520368258|FG000|Overall Study|Physician Decision|5|||
144318642|NCT01751906|520368259|FG001|Overall Study|Physician Decision|2|||
144318643|NCT01751906|520368258|FG000|Overall Study|Death|84|||
144318644|NCT01751906|520368259|FG001|Overall Study|Death|43|||
144318645|NCT01751906|520368258|FG000|Overall Study|Denied on premises for follow-up by law|1|||
144318646|NCT01751906|520368259|FG001|Overall Study|Denied on premises for follow-up by law|0|||
144318647|NCT02557100|520368260|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
144318648|NCT02557100|520368261|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
144318649|NCT02557100|520368262|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
144318650|NCT02557100|520368260|FG000|Single Blind Treatment Period|Death|0|||
144318651|NCT02557100|520368261|FG001|Single Blind Treatment Period|Death|1|||
144318652|NCT02557100|520368262|FG002|Single Blind Treatment Period|Death|0|||
144318653|NCT02557100|520368260|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
144318654|NCT02557100|520368261|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
144318655|NCT02557100|520368262|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
144318656|NCT02557100|520368260|FG000|Single Blind Treatment Period|Adverse Event|0|||
144318657|NCT02557100|520368261|FG001|Single Blind Treatment Period|Adverse Event|1|||
144318658|NCT02557100|520368262|FG002|Single Blind Treatment Period|Adverse Event|0|||
144318659|NCT02557100|520368260|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
144318660|NCT02557100|520368261|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
144318661|NCT02557100|520368262|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
144318662|NCT02557100|520368260|FG000|Cumulative Abatacept Period|Other Reasons|0|||
144318663|NCT02557100|520368261|FG001|Cumulative Abatacept Period|Other Reasons|0|||
144318664|NCT02557100|520368262|FG002|Cumulative Abatacept Period|Other Reasons|1|||
144318665|NCT02557100|520368260|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
144318666|NCT02557100|520368261|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
144318667|NCT02557100|520368262|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
144318668|NCT02557100|520368260|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
144318669|NCT02557100|520368261|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
144318670|NCT02557100|520368262|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
144318671|NCT00510718|520368263|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
144318672|NCT00510718|520368264|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
144318673|NCT00510718|520368263|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
144318674|NCT00510718|520368264|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
144318675|NCT00510718|520368263|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
144318676|NCT00510718|520368264|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
144318677|NCT00510718|520368263|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
144318678|NCT00510718|520368264|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
144318679|NCT00510718|520368263|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
144318680|NCT00510718|520368264|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
144318681|NCT00510718|520368263|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
144318682|NCT00510718|520368264|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
144318683|NCT02388165|520368265|FG000|Overall Study|Study terminated by sponsor|5|||
144318684|NCT02388165|520368266|FG001|Overall Study|Study terminated by sponsor|5|||
144318685|NCT02388165|520368265|FG000|Overall Study|Other|11|||
144318686|NCT02388165|520368266|FG001|Overall Study|Other|13|||
144318687|NCT02388165|520368265|FG000|Overall Study|No longer meet eligibility criteria|40|||
144318688|NCT02388165|520368266|FG001|Overall Study|No longer meet eligibility criteria|43|||
144318689|NCT02388165|520368265|FG000|Overall Study|Withdrawal of consent|31|||
144318690|NCT02388165|520368266|FG001|Overall Study|Withdrawal of consent|32|||
144318691|NCT02388165|520368265|FG000|Overall Study|Lost to Follow-up|19|||
144318692|NCT02388165|520368266|FG001|Overall Study|Lost to Follow-up|20|||
144318693|NCT02388165|520368265|FG000|Overall Study|Death|13|||
144318694|NCT02388165|520368266|FG001|Overall Study|Death|10|||
144318695|NCT02388165|520368265|FG000|Overall Study|Adverse Event|3|||
144318696|NCT02388165|520368266|FG001|Overall Study|Adverse Event|5|||
144318697|NCT02388165|520368265|FG000|Overall Study|Did not meet entrance criteria|5|||
144318698|NCT02388165|520368266|FG001|Overall Study|Did not meet entrance criteria|2|||
144318699|NCT01474772|520368271|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
144318700|NCT01474772|520368272|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
144318701|NCT01474772|520368271|FG000|Period 1|AE not Related to Study Drug|1|||
144318702|NCT01474772|520368272|FG001|Period 1|AE not Related to Study Drug|0|||
144318703|NCT01474772|520368271|FG000|Period 1|Withdrawal by Subject|3|||
144318704|NCT01474772|520368272|FG001|Period 1|Withdrawal by Subject|1|||
144318705|NCT01474772|520368271|FG000|Period 1|Lost to Follow-up|1|||
144318706|NCT01474772|520368272|FG001|Period 1|Lost to Follow-up|0|||
144318707|NCT01474772|520368271|FG000|Period 1|Reason not Specified|1|||
144318708|NCT01474772|520368272|FG001|Period 1|Reason not Specified|1|||
144318709|NCT01474772|520368271|FG000|Washout|AE not Related to Study Drug|2|||
144318710|NCT01474772|520368272|FG001|Washout|AE not Related to Study Drug|0|||
144318711|NCT01474772|520368271|FG000|Washout|Withdrawal by Subject|1|||
144318712|NCT01474772|520368272|FG001|Washout|Withdrawal by Subject|0|||
144318713|NCT01474772|520368271|FG000|Washout|Lost to Follow-up|0|||
144318714|NCT01474772|520368272|FG001|Washout|Lost to Follow-up|1|||
144318715|NCT01474772|520368271|FG000|Washout|Reason not Specified|0|||
144318716|NCT01474772|520368272|FG001|Washout|Reason not Specified|1|||
144318717|NCT01474772|520368271|FG000|Period 2|Death|0|||
144318718|NCT01474772|520368272|FG001|Period 2|Death|1|||
144318719|NCT01474772|520368271|FG000|Period 2|AE Related to Study Drug|0|||
144318720|NCT01474772|520368272|FG001|Period 2|AE Related to Study Drug|1|||
144318721|NCT01474772|520368271|FG000|Period 2|AE not Related to Study Drug|4|||
144318722|NCT01474772|520368272|FG001|Period 2|AE not Related to Study Drug|1|||
144318723|NCT01474772|520368271|FG000|Period 2|Lack of Efficacy|1|||
144318724|NCT01474772|520368272|FG001|Period 2|Lack of Efficacy|0|||
144318725|NCT01474772|520368271|FG000|Period 2|Withdrawal by Subject|3|||
144318726|NCT01474772|520368272|FG001|Period 2|Withdrawal by Subject|4|||
144318727|NCT01474772|520368271|FG000|Period 2|Lost to Follow-up|1|||
144318728|NCT01474772|520368272|FG001|Period 2|Lost to Follow-up|1|||
144318729|NCT01474772|520368271|FG000|Period 2|Reason not Specified|0|||
144318730|NCT01474772|520368272|FG001|Period 2|Reason not Specified|2|||
144318731|NCT01474772|520368271|FG000|Follow-up|AE not Related to Study Drug|0|||
144318732|NCT01474772|520368272|FG001|Follow-up|AE not Related to Study Drug|1|||
144318733|NCT03195660|520368273|FG000|Overall Study|The study was terminated|2|||
144318734|NCT03367403|520368274|FG000|Overall Study|Adverse Event|20|||
144318735|NCT03367403|520368275|FG001|Overall Study|Adverse Event|6|||
144318736|NCT03367403|520368276|FG002|Overall Study|Adverse Event|2|||
144318737|NCT03367403|520368274|FG000|Overall Study|Withdrawal by Subject|12|||
144318738|NCT03367403|520368275|FG001|Overall Study|Withdrawal by Subject|13|||
144318739|NCT03367403|520368276|FG002|Overall Study|Withdrawal by Subject|1|||
144318740|NCT03367403|520368274|FG000|Overall Study|Death|1|||
144318741|NCT03367403|520368275|FG001|Overall Study|Death|2|||
144318742|NCT03367403|520368276|FG002|Overall Study|Death|0|||
144318743|NCT03367403|520368274|FG000|Overall Study|Physician Decision|0|||
144318744|NCT03367403|520368275|FG001|Overall Study|Physician Decision|1|||
144318745|NCT03367403|520368276|FG002|Overall Study|Physician Decision|0|||
144318746|NCT03367403|520368274|FG000|Overall Study|Protocol Violation|1|||
144318747|NCT03367403|520368275|FG001|Overall Study|Protocol Violation|1|||
144318748|NCT03367403|520368276|FG002|Overall Study|Protocol Violation|0|||
144318749|NCT03367403|520368274|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
144318750|NCT03367403|520368275|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
144318751|NCT03367403|520368276|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
144318752|NCT03367403|520368274|FG000|Overall Study|COVID-19|3|||
144318753|NCT03367403|520368275|FG001|Overall Study|COVID-19|6|||
144318754|NCT03367403|520368276|FG002|Overall Study|COVID-19|0|||
144318755|NCT03367403|520368274|FG000|Overall Study|Abuse of Alcohol Intake|0|||
144318756|NCT03367403|520368275|FG001|Overall Study|Abuse of Alcohol Intake|1|||
144318757|NCT03367403|520368276|FG002|Overall Study|Abuse of Alcohol Intake|0|||
144318758|NCT03367403|520368274|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
144318759|NCT03367403|520368275|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
144318760|NCT03367403|520368276|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
144318761|NCT00759876|520368277|FG000|Overall Study|Sponsor terminated study early|36|||
144318762|NCT02957747|520368279|FG000|Overall Study|Withdrawal by Subject|0|||
144318763|NCT02957747|520368280|FG001|Overall Study|Withdrawal by Subject|3|||
144318764|NCT02957747|520368279|FG000|Overall Study|Lost to Follow-up|10|||
144318765|NCT02957747|520368280|FG001|Overall Study|Lost to Follow-up|5|||
144318766|NCT01035463|520368283|FG000|Overall Study|Adverse Event|0|||
144318767|NCT01035463|520368284|FG001|Overall Study|Adverse Event|0|||
144318768|NCT01035463|520368285|FG002|Overall Study|Adverse Event|4|||
144318769|NCT01035463|520368286|FG003|Overall Study|Adverse Event|1|||
144318770|NCT01035463|520368287|FG004|Overall Study|Adverse Event|5|||
144318771|NCT01035463|520368288|FG005|Overall Study|Adverse Event|7|||
144318772|NCT01035463|520368283|FG000|Overall Study|Withdrawal by Subject|0|||
144318773|NCT01035463|520368284|FG001|Overall Study|Withdrawal by Subject|2|||
144318774|NCT01035463|520368285|FG002|Overall Study|Withdrawal by Subject|1|||
144318775|NCT01035463|520368286|FG003|Overall Study|Withdrawal by Subject|0|||
144318776|NCT01035463|520368287|FG004|Overall Study|Withdrawal by Subject|1|||
144318777|NCT01035463|520368288|FG005|Overall Study|Withdrawal by Subject|4|||
144318778|NCT01035463|520368283|FG000|Overall Study|Disease progression|0|||
144318779|NCT01035463|520368284|FG001|Overall Study|Disease progression|0|||
144318780|NCT01035463|520368285|FG002|Overall Study|Disease progression|0|||
144318781|NCT01035463|520368286|FG003|Overall Study|Disease progression|0|||
144318782|NCT01035463|520368287|FG004|Overall Study|Disease progression|0|||
144318783|NCT01035463|520368288|FG005|Overall Study|Disease progression|3|||
144318784|NCT01035463|520368283|FG000|Overall Study|Other Malignancy|0|||
144318785|NCT01035463|520368284|FG001|Overall Study|Other Malignancy|0|||
144318786|NCT01035463|520368285|FG002|Overall Study|Other Malignancy|0|||
144318787|NCT01035463|520368286|FG003|Overall Study|Other Malignancy|0|||
144318788|NCT01035463|520368287|FG004|Overall Study|Other Malignancy|0|||
144318789|NCT01035463|520368288|FG005|Overall Study|Other Malignancy|2|||
144318790|NCT01035463|520368283|FG000|Overall Study|Other|0|||
144318791|NCT01035463|520368284|FG001|Overall Study|Other|0|||
144318792|NCT01035463|520368285|FG002|Overall Study|Other|0|||
144318793|NCT01035463|520368286|FG003|Overall Study|Other|1|||
144318794|NCT01035463|520368287|FG004|Overall Study|Other|0|||
144318795|NCT01035463|520368288|FG005|Overall Study|Other|2|||
144318796|NCT01257230|520368289|FG000|Overall Study|Not Treated|0|||
144318797|NCT01257230|520368290|FG001|Overall Study|Not Treated|0|||
144318798|NCT01257230|520368291|FG002|Overall Study|Not Treated|1|||
144318799|NCT01257230|520368289|FG000|Overall Study|Adverse Event|2|||
144318800|NCT01257230|520368290|FG001|Overall Study|Adverse Event|0|||
144318801|NCT01257230|520368291|FG002|Overall Study|Adverse Event|0|||
144318802|NCT01257230|520368289|FG000|Overall Study|Lack of Efficacy|0|||
144318803|NCT01257230|520368290|FG001|Overall Study|Lack of Efficacy|1|||
144318804|NCT01257230|520368291|FG002|Overall Study|Lack of Efficacy|0|||
144318805|NCT01257230|520368289|FG000|Overall Study|Protocol Violation|3|||
144318806|NCT01257230|520368290|FG001|Overall Study|Protocol Violation|0|||
144318807|NCT01257230|520368291|FG002|Overall Study|Protocol Violation|1|||
144318808|NCT01257230|520368289|FG000|Overall Study|Withdrawal by Subject|0|||
144318809|NCT01257230|520368290|FG001|Overall Study|Withdrawal by Subject|4|||
144318810|NCT01257230|520368291|FG002|Overall Study|Withdrawal by Subject|1|||
144318811|NCT01257230|520368289|FG000|Overall Study|Other reason not defined above|1|||
144318812|NCT01257230|520368290|FG001|Overall Study|Other reason not defined above|5|||
144318813|NCT01257230|520368291|FG002|Overall Study|Other reason not defined above|3|||
144318814|NCT00765037|520368294|FG000|Overall Study|Lost to Follow-up|5|||
144318815|NCT00765037|520368294|FG000|Overall Study|Adverse Event|1|||
144318816|NCT01988662|520368299|FG000|Overall Study|Subject/guardian decision|1|||
144318817|NCT01988662|520368300|FG001|Overall Study|Subject/guardian decision|1|||
144318818|NCT01988662|520368299|FG000|Overall Study|Adverse Event|3|||
144318819|NCT01988662|520368300|FG001|Overall Study|Adverse Event|1|||
144318820|NCT00002540|520368302|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
144318821|NCT00002540|520368303|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
144318822|NCT00002540|520368302|FG000|Overall Study|Died Before Randomization|2|||
144318823|NCT00002540|520368303|FG001|Overall Study|Died Before Randomization|6|||
144318824|NCT00002540|520368302|FG000|Overall Study|Died Before ASU (Control)|202|||
144318825|NCT00002540|520368303|FG001|Overall Study|Died Before ASU (Control)|0|||
144318826|NCT00002540|520368302|FG000|Overall Study|Refused ASU (Control)|597|||
144318827|NCT00002540|520368303|FG001|Overall Study|Refused ASU (Control)|0|||
144318828|NCT00002540|520368302|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
144318829|NCT00002540|520368303|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
144318830|NCT01864148|520368304|FG000|Overall Study|Other|2|||
144318831|NCT01864148|520368305|FG001|Overall Study|Other|1|||
144318832|NCT01864148|520368306|FG002|Overall Study|Other|1|||
144318833|NCT01864148|520368307|FG003|Overall Study|Other|3|||
144318834|NCT01864148|520368308|FG004|Overall Study|Other|1|||
144318835|NCT01864148|520368304|FG000|Overall Study|Death|0|||
144318836|NCT01864148|520368305|FG001|Overall Study|Death|0|||
144318837|NCT01864148|520368306|FG002|Overall Study|Death|0|||
144318838|NCT01864148|520368307|FG003|Overall Study|Death|1|||
144318839|NCT01864148|520368308|FG004|Overall Study|Death|0|||
144318840|NCT01864148|520368304|FG000|Overall Study|Investigator Decision|5|||
144318841|NCT01864148|520368305|FG001|Overall Study|Investigator Decision|0|||
144318842|NCT01864148|520368306|FG002|Overall Study|Investigator Decision|0|||
144318843|NCT01864148|520368307|FG003|Overall Study|Investigator Decision|4|||
144318844|NCT01864148|520368308|FG004|Overall Study|Investigator Decision|6|||
144318845|NCT01864148|520368304|FG000|Overall Study|Withdrawal by Subject|9|||
144318846|NCT01864148|520368305|FG001|Overall Study|Withdrawal by Subject|2|||
144318847|NCT01864148|520368306|FG002|Overall Study|Withdrawal by Subject|6|||
144318848|NCT01864148|520368307|FG003|Overall Study|Withdrawal by Subject|8|||
144318849|NCT01864148|520368308|FG004|Overall Study|Withdrawal by Subject|8|||
144318850|NCT01864148|520368304|FG000|Overall Study|Lost to Follow-up|0|||
144318851|NCT01864148|520368305|FG001|Overall Study|Lost to Follow-up|0|||
144318852|NCT01864148|520368306|FG002|Overall Study|Lost to Follow-up|0|||
144318853|NCT01864148|520368307|FG003|Overall Study|Lost to Follow-up|2|||
144318854|NCT01864148|520368308|FG004|Overall Study|Lost to Follow-up|1|||
144318855|NCT01864148|520368304|FG000|Overall Study|Adverse Event|4|||
144318856|NCT01864148|520368305|FG001|Overall Study|Adverse Event|2|||
144318857|NCT01864148|520368306|FG002|Overall Study|Adverse Event|4|||
144318858|NCT01864148|520368307|FG003|Overall Study|Adverse Event|7|||
144318859|NCT01864148|520368308|FG004|Overall Study|Adverse Event|7|||
144318860|NCT01864148|520368304|FG000|Overall Study|Not Dosed|0|||
144318861|NCT01864148|520368305|FG001|Overall Study|Not Dosed|0|||
144318862|NCT01864148|520368306|FG002|Overall Study|Not Dosed|0|||
144318863|NCT01864148|520368307|FG003|Overall Study|Not Dosed|1|||
144318864|NCT01864148|520368308|FG004|Overall Study|Not Dosed|0|||
144318865|NCT00778375|520368309|FG000|Overall Study|Ineligible|3|||
144318866|NCT03490292|520368310|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
144318867|NCT03490292|520368311|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
144318868|NCT03490292|520368310|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
144318869|NCT03490292|520368311|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
144318870|NCT03490292|520368310|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
144318871|NCT03490292|520368311|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
144318872|NCT03490292|520368310|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
144318873|NCT03490292|520368311|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
144318874|NCT03490292|520368310|FG000|1 Year Follow Up Post Last Dose|Death|1|||
144318875|NCT03490292|520368311|FG001|1 Year Follow Up Post Last Dose|Death|1|||
144318876|NCT02466425|520368315|FG000|Overall Study|Adverse Event|3|||
144318877|NCT02466425|520368316|FG001|Overall Study|Adverse Event|11|||
144318878|NCT02466425|520368315|FG000|Overall Study|Lack of Efficacy|4|||
144318879|NCT02466425|520368316|FG001|Overall Study|Lack of Efficacy|1|||
144318880|NCT02466425|520368315|FG000|Overall Study|Lost to Follow-up|3|||
144318881|NCT02466425|520368316|FG001|Overall Study|Lost to Follow-up|0|||
144318882|NCT02466425|520368315|FG000|Overall Study|Protocol Violation|1|||
144318883|NCT02466425|520368316|FG001|Overall Study|Protocol Violation|0|||
144318884|NCT02466425|520368315|FG000|Overall Study|Withdrawal by Subject|0|||
144318885|NCT02466425|520368316|FG001|Overall Study|Withdrawal by Subject|1|||
144318886|NCT02466425|520368315|FG000|Overall Study|Other|1|||
144318887|NCT02466425|520368316|FG001|Overall Study|Other|3|||
144318888|NCT02466425|520368315|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
144318889|NCT02466425|520368316|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144318890|NCT01721486|520368321|FG000|Overall Study|Protocol Violation|1|||
144318891|NCT01721486|520368322|FG001|Overall Study|Protocol Violation|0|||
144318892|NCT01721486|520368321|FG000|Overall Study|Physician Decision|0|||
144318893|NCT01721486|520368322|FG001|Overall Study|Physician Decision|1|||
144318894|NCT00582712|520368323|FG000|Overall Study|Adverse Event|1|||
144318895|NCT00582712|520368323|FG000|Overall Study|Lack of Efficacy|1|||
144318896|NCT00582712|520368323|FG000|Overall Study|Withdrawal by Subject|1|||
144318897|NCT00582712|520368323|FG000|Overall Study|Complicating disease requiring treatment|1|||
144318898|NCT01901289|520368324|FG000|Overall Study|Death|32|||
144318899|NCT01901289|520368324|FG000|Overall Study|Lost to Follow-up|16|||
144318900|NCT01901289|520368324|FG000|Overall Study|Withdrawal by Subject|35|||
144318901|NCT01901289|520368324|FG000|Overall Study|Other type of endpoint met|2|||
144318902|NCT01813058|520368329|FG000|Overall Study|Withdrawal by Subject|5|||
144318903|NCT01813058|520368330|FG001|Overall Study|Withdrawal by Subject|4|||
144318904|NCT03585764|520368331|FG000|Overall Study|Death|3|||
144318905|NCT03585764|520368332|FG001|Overall Study|Death|2|||
144318906|NCT03585764|520368333|FG002|Overall Study|Death|3|||
144318907|NCT03585764|520368334|FG003|Overall Study|Death|0|||
144318908|NCT03585764|520368331|FG000|Overall Study|Lost to Follow-up|0|||
144318909|NCT03585764|520368332|FG001|Overall Study|Lost to Follow-up|1|||
144318910|NCT03585764|520368333|FG002|Overall Study|Lost to Follow-up|0|||
144318911|NCT03585764|520368334|FG003|Overall Study|Lost to Follow-up|0|||
144318912|NCT03585764|520368331|FG000|Overall Study|Physician Decision|0|||
144318913|NCT03585764|520368332|FG001|Overall Study|Physician Decision|0|||
144318914|NCT03585764|520368333|FG002|Overall Study|Physician Decision|2|||
144318915|NCT03585764|520368334|FG003|Overall Study|Physician Decision|0|||
144318916|NCT01581021|520368335|FG000|Overall Study|Lost to Follow-up|4|||
144318917|NCT01581021|520368336|FG001|Overall Study|Lost to Follow-up|6|||
144318918|NCT01581021|520368335|FG000|Overall Study|More than 2 hooks in thoracic|3|||
144318919|NCT01581021|520368336|FG001|Overall Study|More than 2 hooks in thoracic|0|||
144318920|NCT01581021|520368335|FG000|Overall Study|Neuromuscular|2|||
144318921|NCT01581021|520368336|FG001|Overall Study|Neuromuscular|1|||
144318922|NCT01581021|520368335|FG000|Overall Study|Not Randomized|1|||
144318923|NCT01581021|520368336|FG001|Overall Study|Not Randomized|2|||
144318924|NCT01581021|520368335|FG000|Overall Study|Lenke 6 Classification|0|||
144318925|NCT01581021|520368336|FG001|Overall Study|Lenke 6 Classification|1|||
144318926|NCT01581021|520368335|FG000|Overall Study|Lack of Efficacy|0|||
144318927|NCT01581021|520368336|FG001|Overall Study|Lack of Efficacy|1|||
144318928|NCT00054327|520368342|FG000|Overall Study|Engraftment failure|1|||
144318929|NCT00054327|520368343|FG001|Overall Study|Engraftment failure|0|||
144318930|NCT00054327|520368344|FG002|Overall Study|Engraftment failure|0|||
144318931|NCT00054327|520368345|FG003|Overall Study|Engraftment failure|0|||
144318932|NCT00054327|520368346|FG004|Overall Study|Engraftment failure|0|||
144318933|NCT00054327|520368347|FG005|Overall Study|Engraftment failure|0|||
144318934|NCT00613327|520368348|FG000|Overall Study|Adverse Event|38|||
144318935|NCT00613327|520368348|FG000|Overall Study|Lost to Follow-up|8|||
144318936|NCT00613327|520368348|FG000|Overall Study|Withdrawal by Subject|6|||
144318937|NCT00613327|520368348|FG000|Overall Study|Protocol Violation|2|||
144318938|NCT00613327|520368348|FG000|Overall Study|Other|47|||
144318939|NCT00344318|520368349|FG000|Overall Study|Adverse Event|0|||
144318940|NCT00344318|520368350|FG001|Overall Study|Adverse Event|3|||
144318941|NCT00344318|520368351|FG002|Overall Study|Adverse Event|0|||
144318942|NCT00344318|520368352|FG003|Overall Study|Adverse Event|1|||
144318943|NCT00344318|520368349|FG000|Overall Study|Withdrawal by Subject|2|||
144318944|NCT00344318|520368350|FG001|Overall Study|Withdrawal by Subject|2|||
144318945|NCT00344318|520368351|FG002|Overall Study|Withdrawal by Subject|0|||
144318946|NCT00344318|520368352|FG003|Overall Study|Withdrawal by Subject|2|||
144318947|NCT00344318|520368349|FG000|Overall Study|Lost to Follow-up|2|||
144318948|NCT00344318|520368350|FG001|Overall Study|Lost to Follow-up|0|||
144318949|NCT00344318|520368351|FG002|Overall Study|Lost to Follow-up|1|||
144318950|NCT00344318|520368352|FG003|Overall Study|Lost to Follow-up|0|||
144318951|NCT01606176|520368361|FG000|Overall Study|Adverse Event|2|||
144318952|NCT01606176|520368362|FG001|Overall Study|Adverse Event|3|||
144318953|NCT01606176|520368361|FG000|Overall Study|Disease progression|1|||
144318954|NCT01606176|520368362|FG001|Overall Study|Disease progression|0|||
144318955|NCT01606176|520368361|FG000|Overall Study|Withdrawal by Subject|1|||
144318956|NCT01606176|520368362|FG001|Overall Study|Withdrawal by Subject|0|||
144318957|NCT00361231|520368364|FG000|Overall Study|Physician Decision|3|||
144318958|NCT00361231|520368364|FG000|Overall Study|Symptomatic deterioration|5|||
144360030|NCT01601535|520525140|FG005|Phase 2|Withdrawal by Subject|2|||
144318959|NCT00361231|520368364|FG000|Overall Study|Radiographic disease progression|16|||
144318960|NCT00361231|520368364|FG000|Overall Study|Withdrawal by Subject|4|||
144318961|NCT00361231|520368364|FG000|Overall Study|Adverse Event|6|||
144318962|NCT01814397|520368365|FG000|Overall Study|Adverse Event|7|||
144318963|NCT01814397|520368365|FG000|Overall Study|Withdrawal by Subject|7|||
144318964|NCT01732510|520368366|FG000|Overall Study|Adverse Event|0|||
144318965|NCT01732510|520368367|FG001|Overall Study|Adverse Event|1|||
144318966|NCT01732510|520368368|FG002|Overall Study|Adverse Event|1|||
144318967|NCT01732510|520368369|FG003|Overall Study|Adverse Event|0|||
144318968|NCT01732510|520368370|FG004|Overall Study|Adverse Event|0|||
144318969|NCT01732510|520368371|FG005|Overall Study|Adverse Event|0|||
144318970|NCT01732510|520368372|FG006|Overall Study|Adverse Event|1|||
144318971|NCT01732510|520368366|FG000|Overall Study|Protocol Violation|0|||
144318972|NCT01732510|520368367|FG001|Overall Study|Protocol Violation|0|||
144318973|NCT01732510|520368368|FG002|Overall Study|Protocol Violation|0|||
144318974|NCT01732510|520368369|FG003|Overall Study|Protocol Violation|1|||
144318975|NCT01732510|520368370|FG004|Overall Study|Protocol Violation|0|||
144318976|NCT01732510|520368371|FG005|Overall Study|Protocol Violation|0|||
144318977|NCT01732510|520368372|FG006|Overall Study|Protocol Violation|0|||
144318978|NCT01732510|520368366|FG000|Overall Study|Withdrawal by Subject|1|||
144318979|NCT01732510|520368367|FG001|Overall Study|Withdrawal by Subject|3|||
144318980|NCT01732510|520368368|FG002|Overall Study|Withdrawal by Subject|2|||
144318981|NCT01732510|520368369|FG003|Overall Study|Withdrawal by Subject|1|||
144318982|NCT01732510|520368370|FG004|Overall Study|Withdrawal by Subject|5|||
144318983|NCT01732510|520368371|FG005|Overall Study|Withdrawal by Subject|0|||
144318984|NCT01732510|520368372|FG006|Overall Study|Withdrawal by Subject|1|||
144318985|NCT01732510|520368366|FG000|Overall Study|Lost to Follow-up|0|||
144318986|NCT01732510|520368367|FG001|Overall Study|Lost to Follow-up|0|||
144318987|NCT01732510|520368368|FG002|Overall Study|Lost to Follow-up|1|||
144318988|NCT01732510|520368369|FG003|Overall Study|Lost to Follow-up|1|||
144318989|NCT01732510|520368370|FG004|Overall Study|Lost to Follow-up|0|||
144318990|NCT01732510|520368371|FG005|Overall Study|Lost to Follow-up|1|||
144318991|NCT01732510|520368372|FG006|Overall Study|Lost to Follow-up|0|||
144318992|NCT01732510|520368366|FG000|Overall Study|Physician Decision|0|||
144318993|NCT01732510|520368367|FG001|Overall Study|Physician Decision|1|||
144318994|NCT01732510|520368368|FG002|Overall Study|Physician Decision|0|||
144318995|NCT01732510|520368369|FG003|Overall Study|Physician Decision|0|||
144318996|NCT01732510|520368370|FG004|Overall Study|Physician Decision|0|||
144318997|NCT01732510|520368371|FG005|Overall Study|Physician Decision|0|||
144318998|NCT01732510|520368372|FG006|Overall Study|Physician Decision|0|||
144318999|NCT01732510|520368366|FG000|Overall Study|Pregnancy|0|||
144319000|NCT01732510|520368367|FG001|Overall Study|Pregnancy|0|||
144319001|NCT01732510|520368368|FG002|Overall Study|Pregnancy|0|||
144319002|NCT01732510|520368369|FG003|Overall Study|Pregnancy|1|||
144319003|NCT01732510|520368370|FG004|Overall Study|Pregnancy|0|||
144319004|NCT01732510|520368371|FG005|Overall Study|Pregnancy|0|||
144319005|NCT01732510|520368372|FG006|Overall Study|Pregnancy|0|||
144319006|NCT01732510|520368366|FG000|Overall Study|Study Terminated By Sponsor|0|||
144319007|NCT01732510|520368367|FG001|Overall Study|Study Terminated By Sponsor|0|||
144319008|NCT01732510|520368368|FG002|Overall Study|Study Terminated By Sponsor|0|||
144319009|NCT01732510|520368369|FG003|Overall Study|Study Terminated By Sponsor|1|||
144319010|NCT01732510|520368370|FG004|Overall Study|Study Terminated By Sponsor|0|||
144319011|NCT01732510|520368371|FG005|Overall Study|Study Terminated By Sponsor|12|||
144319012|NCT01732510|520368372|FG006|Overall Study|Study Terminated By Sponsor|6|||
144319013|NCT00244933|520368374|FG000|Overall Study|Not response evaluable|2|||
144319014|NCT03403361|520368376|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
144319015|NCT03213938|520368377|FG000|Overall Study|Lost to Follow-up|4|||
144319016|NCT03213938|520368378|FG001|Overall Study|Lost to Follow-up|3|||
144319017|NCT03213938|520368377|FG000|Overall Study|Lack of Efficacy|1|||
144319018|NCT03213938|520368378|FG001|Overall Study|Lack of Efficacy|0|||
144319019|NCT03213938|520368377|FG000|Overall Study|Decline to participate|5|||
144319020|NCT03213938|520368378|FG001|Overall Study|Decline to participate|4|||
144319021|NCT03213938|520368377|FG000|Overall Study|Without reason|4|||
144319022|NCT03213938|520368378|FG001|Overall Study|Without reason|5|||
144319023|NCT04238481|520368379|FG000|Overall Study|Miscellaneous|0|||
144319024|NCT04238481|520368380|FG001|Overall Study|Miscellaneous|1|||
144319025|NCT04238481|520368381|FG002|Overall Study|Miscellaneous|0|||
144319026|NCT04238481|520368382|FG003|Overall Study|Miscellaneous|0|||
144319027|NCT00350870|520368383|FG000|Overall Study|Withdrawal by Subject|21|||
144319028|NCT00350870|520368384|FG001|Overall Study|Withdrawal by Subject|17|||
144319029|NCT00350870|520368385|FG002|Overall Study|Withdrawal by Subject|15|||
144319030|NCT00350870|520368386|FG003|Overall Study|Withdrawal by Subject|14|||
144319031|NCT00350870|520368383|FG000|Overall Study|Physician Decision|1|||
144319032|NCT00350870|520368384|FG001|Overall Study|Physician Decision|0|||
144319033|NCT00350870|520368385|FG002|Overall Study|Physician Decision|1|||
144319034|NCT00350870|520368386|FG003|Overall Study|Physician Decision|1|||
144319035|NCT00349921|520368387|FG000|First Spinal Injection|Physician Decision|1|||
144319036|NCT00349921|520368388|FG001|First Spinal Injection|Physician Decision|0|||
144319037|NCT00349921|520368389|FG002|First Spinal Injection|Physician Decision|0|||
144319038|NCT00349921|520368390|FG003|First Spinal Injection|Physician Decision|0|||
144319039|NCT00349921|520368387|FG000|First Spinal Injection|Adverse Event|0|||
144319040|NCT00349921|520368388|FG001|First Spinal Injection|Adverse Event|0|||
144319041|NCT00349921|520368389|FG002|First Spinal Injection|Adverse Event|1|||
144319042|NCT00349921|520368390|FG003|First Spinal Injection|Adverse Event|0|||
144319043|NCT01932372|520368391|FG000|Overall Study|Not meeting eligibility criteria|33|||
144319044|NCT01932372|520368392|FG001|Overall Study|Not meeting eligibility criteria|179|||
144319045|NCT01917929|520368397|FG000|Overall Study|Death|8|||
144319046|NCT01917929|520368397|FG000|Overall Study|Lost to Follow-up|19|||
144319047|NCT01917929|520368397|FG000|Overall Study|Withdrawal by Subject|33|||
144319048|NCT01917929|520368397|FG000|Overall Study|Adverse Event|6|||
144319049|NCT01917929|520368397|FG000|Overall Study|Investigative Site Terminated|35|||
144319050|NCT01917929|520368397|FG000|Overall Study|Censored because study device not implanted|6|||
144319051|NCT01917929|520368397|FG000|Overall Study|Censored because surgery not performed|3|||
144319052|NCT01917929|520368397|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
144319053|NCT01917929|520368397|FG000|Overall Study|Sponsor terminated study|175|||
144319054|NCT00673231|520368398|FG000|Overall Study|Withdrawal by Subject|14|||
144319055|NCT00673231|520368399|FG001|Overall Study|Withdrawal by Subject|10|||
144319056|NCT00673231|520368400|FG002|Overall Study|Withdrawal by Subject|8|||
144319057|NCT00673231|520368401|FG003|Overall Study|Withdrawal by Subject|6|||
144319058|NCT00673231|520368398|FG000|Overall Study|Adverse Event|6|||
144319059|NCT00673231|520368399|FG001|Overall Study|Adverse Event|5|||
144319060|NCT00673231|520368400|FG002|Overall Study|Adverse Event|9|||
144319061|NCT00673231|520368401|FG003|Overall Study|Adverse Event|6|||
144319062|NCT00673231|520368398|FG000|Overall Study|Lost to Follow-up|1|||
144319063|NCT00673231|520368399|FG001|Overall Study|Lost to Follow-up|2|||
144319064|NCT00673231|520368400|FG002|Overall Study|Lost to Follow-up|1|||
144319065|NCT00673231|520368401|FG003|Overall Study|Lost to Follow-up|2|||
144319066|NCT00673231|520368398|FG000|Overall Study|Death|0|||
144319067|NCT00673231|520368399|FG001|Overall Study|Death|0|||
144319068|NCT00673231|520368400|FG002|Overall Study|Death|1|||
144319069|NCT00673231|520368401|FG003|Overall Study|Death|0|||
144319070|NCT00673231|520368398|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
144319071|NCT00673231|520368399|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
144319072|NCT00673231|520368400|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
144319073|NCT00673231|520368401|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
144319074|NCT03594747|520368405|FG000|Overall Study|Death|78|||
144319075|NCT03594747|520368406|FG001|Overall Study|Death|86|||
144319076|NCT03594747|520368407|FG002|Overall Study|Death|87|||
144319077|NCT03594747|520368405|FG000|Overall Study|Withdrawal by Subject|5|||
144319078|NCT03594747|520368406|FG001|Overall Study|Withdrawal by Subject|2|||
144319079|NCT03594747|520368407|FG002|Overall Study|Withdrawal by Subject|11|||
144319080|NCT03594747|520368405|FG000|Overall Study|Lost to Follow-up|4|||
144319081|NCT03594747|520368406|FG001|Overall Study|Lost to Follow-up|1|||
144319082|NCT03594747|520368407|FG002|Overall Study|Lost to Follow-up|1|||
144319083|NCT03594747|520368405|FG000|Overall Study|Physician Decision|0|||
144319084|NCT03594747|520368406|FG001|Overall Study|Physician Decision|1|||
144319085|NCT03594747|520368407|FG002|Overall Study|Physician Decision|0|||
144319086|NCT03594747|520368405|FG000|Overall Study|Sponsor decision|23|||
144319087|NCT03594747|520368406|FG001|Overall Study|Sponsor decision|17|||
144319088|NCT03594747|520368407|FG002|Overall Study|Sponsor decision|16|||
144319089|NCT03594747|520368405|FG000|Overall Study|Did not meet inclusion criteria|0|||
144319090|NCT03594747|520368406|FG001|Overall Study|Did not meet inclusion criteria|0|||
144319091|NCT03594747|520368407|FG002|Overall Study|Did not meet inclusion criteria|1|||
144319092|NCT03594747|520368405|FG000|Overall Study|Transfer to long term extension study|10|||
144319093|NCT03594747|520368406|FG001|Overall Study|Transfer to long term extension study|12|||
144319094|NCT03594747|520368407|FG002|Overall Study|Transfer to long term extension study|5|||
144319095|NCT03028415|520368408|FG000|Overall Study|Lost to Follow-up|6|||
144319096|NCT03028415|520368409|FG001|Overall Study|Lost to Follow-up|3|||
144319097|NCT03028415|520368408|FG000|Overall Study|Withdrawal by Subject|1|||
144319098|NCT03028415|520368409|FG001|Overall Study|Withdrawal by Subject|0|||
144319099|NCT03028415|520368408|FG000|Overall Study|Discontinued due to COVID-19|1|||
144319100|NCT03028415|520368409|FG001|Overall Study|Discontinued due to COVID-19|0|||
144319101|NCT02907216|520368410|FG000|Overall Study|No benefit to be obtained by continuing|0|||
144319102|NCT02907216|520368411|FG001|Overall Study|No benefit to be obtained by continuing|1|||
144319103|NCT02907216|520368410|FG000|Overall Study|Withdrawal by Subject|1|||
144319104|NCT02907216|520368411|FG001|Overall Study|Withdrawal by Subject|0|||
144319105|NCT01108731|520368413|FG000|Overall Study|Withdrawal by Subject|1|||
144319106|NCT01108731|520368414|FG001|Overall Study|Withdrawal by Subject|1|||
144319107|NCT01108731|520368413|FG000|Overall Study|Adverse Event|3|||
144319108|NCT01108731|520368414|FG001|Overall Study|Adverse Event|3|||
144319109|NCT02485639|520368419|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
144319110|NCT02485639|520368419|FG000|Overall Study|Early termination|4|||
144319111|NCT02485639|520368419|FG000|Overall Study|Withdrawal by Subject|4|||
144319112|NCT03479541|520368420|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
144319113|NCT03479541|520368421|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
144319114|NCT03479541|520368422|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
144319115|NCT03479541|520368423|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
144319116|NCT03479541|520368420|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
144319117|NCT03479541|520368421|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
144319118|NCT03479541|520368422|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
144319119|NCT03479541|520368423|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
144319120|NCT03479541|520368420|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
144319121|NCT03479541|520368421|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
144319122|NCT03479541|520368422|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
144319123|NCT03479541|520368423|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
144319124|NCT03479541|520368420|FG000|Home Monitoring|Lost to Follow-up|0|||
144319125|NCT03479541|520368421|FG001|Home Monitoring|Lost to Follow-up|0|||
144319126|NCT03479541|520368422|FG002|Home Monitoring|Lost to Follow-up|8|||
144319127|NCT03479541|520368423|FG003|Home Monitoring|Lost to Follow-up|12|||
144319128|NCT03479541|520368420|FG000|Home Monitoring|Withdrawal by Subject|0|||
144319129|NCT03479541|520368421|FG001|Home Monitoring|Withdrawal by Subject|0|||
144319130|NCT03479541|520368422|FG002|Home Monitoring|Withdrawal by Subject|17|||
144319131|NCT03479541|520368423|FG003|Home Monitoring|Withdrawal by Subject|30|||
144319132|NCT03479541|520368420|FG000|Home Monitoring|Early Termination - PI Decision|0|||
144319133|NCT03479541|520368421|FG001|Home Monitoring|Early Termination - PI Decision|0|||
144319134|NCT03479541|520368422|FG002|Home Monitoring|Early Termination - PI Decision|4|||
144319135|NCT03479541|520368423|FG003|Home Monitoring|Early Termination - PI Decision|6|||
144319136|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
144319137|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
144319138|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
144319139|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
144319140|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
144319141|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
144319142|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
144319143|NCT01673854|520368425|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
144319144|NCT01673854|520368425|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
144319145|NCT01673854|520368425|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
144319146|NCT01673854|520368425|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
144319147|NCT01673854|520368425|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
144319148|NCT01700959|520368428|FG000|Overall Study|Adverse Event|0|||
144319149|NCT01700959|520368429|FG001|Overall Study|Adverse Event|1|||
144319150|NCT01700959|520368430|FG002|Overall Study|Adverse Event|1|||
144319151|NCT01700959|520368431|FG003|Overall Study|Adverse Event|2|||
144319152|NCT01700959|520368432|FG004|Overall Study|Adverse Event|0|||
144319153|NCT01700959|520368433|FG005|Overall Study|Adverse Event|2|||
144319154|NCT01700959|520368428|FG000|Overall Study|Withdrawal by Subject|15|||
144319155|NCT01700959|520368429|FG001|Overall Study|Withdrawal by Subject|9|||
144319156|NCT01700959|520368430|FG002|Overall Study|Withdrawal by Subject|12|||
144319157|NCT01700959|520368431|FG003|Overall Study|Withdrawal by Subject|11|||
144319158|NCT01700959|520368432|FG004|Overall Study|Withdrawal by Subject|8|||
144319159|NCT01700959|520368433|FG005|Overall Study|Withdrawal by Subject|12|||
144319160|NCT01700959|520368428|FG000|Overall Study|Ineligible|2|||
144319161|NCT01700959|520368429|FG001|Overall Study|Ineligible|1|||
144319162|NCT01700959|520368430|FG002|Overall Study|Ineligible|2|||
144319163|NCT01700959|520368431|FG003|Overall Study|Ineligible|0|||
144319164|NCT01700959|520368432|FG004|Overall Study|Ineligible|0|||
144319165|NCT01700959|520368433|FG005|Overall Study|Ineligible|1|||
144319166|NCT01700959|520368428|FG000|Overall Study|Noncompliant|9|||
144319167|NCT01700959|520368429|FG001|Overall Study|Noncompliant|9|||
144319168|NCT01700959|520368430|FG002|Overall Study|Noncompliant|17|||
144319169|NCT01700959|520368431|FG003|Overall Study|Noncompliant|18|||
144319170|NCT01700959|520368432|FG004|Overall Study|Noncompliant|15|||
144319171|NCT01700959|520368433|FG005|Overall Study|Noncompliant|9|||
144319172|NCT01700959|520368428|FG000|Overall Study|Side effects|1|||
144319173|NCT01700959|520368429|FG001|Overall Study|Side effects|4|||
144319174|NCT01700959|520368430|FG002|Overall Study|Side effects|8|||
144319175|NCT01700959|520368431|FG003|Overall Study|Side effects|4|||
144319176|NCT01700959|520368432|FG004|Overall Study|Side effects|4|||
144319177|NCT01700959|520368433|FG005|Overall Study|Side effects|1|||
144319178|NCT00830375|520368434|FG000|Overall Study|Lost to Follow-up|1|||
144319179|NCT05897242|520370454|FG000|Overall Study|Lost to Follow-up|6|||
144319180|NCT05897242|520370455|FG001|Overall Study|Lost to Follow-up|1|||
144319181|NCT05897242|520370454|FG000|Overall Study|Incomplete|1|||
144319182|NCT05897242|520370455|FG001|Overall Study|Incomplete|0|||
144319183|NCT05897242|520370454|FG000|Overall Study|Withdrawal by Subject|1|||
144319184|NCT05897242|520370455|FG001|Overall Study|Withdrawal by Subject|0|||
144319185|NCT00809835|520370456|FG000|Overall Study|Lost to Follow-up|7|||
144319186|NCT00809835|520370457|FG001|Overall Study|Lost to Follow-up|6|||
144319187|NCT00809835|520370458|FG002|Overall Study|Lost to Follow-up|10|||
144319188|NCT00809835|520370459|FG003|Overall Study|Lost to Follow-up|2|||
144319189|NCT00809835|520370456|FG000|Overall Study|Withdrawal by Subject|1|||
144319190|NCT00809835|520370457|FG001|Overall Study|Withdrawal by Subject|1|||
144319191|NCT00809835|520370458|FG002|Overall Study|Withdrawal by Subject|1|||
144319192|NCT00809835|520370459|FG003|Overall Study|Withdrawal by Subject|0|||
144319193|NCT01110330|520370460|FG000|Overall Study|Adverse Event|0|||
144319194|NCT01110330|520370461|FG001|Overall Study|Adverse Event|4|||
144319195|NCT01110330|520370462|FG002|Overall Study|Adverse Event|3|||
144319196|NCT01110330|520370460|FG000|Overall Study|Lack of Efficacy|3|||
144319197|NCT01110330|520370461|FG001|Overall Study|Lack of Efficacy|1|||
144319198|NCT01110330|520370462|FG002|Overall Study|Lack of Efficacy|1|||
144319199|NCT01110330|520370460|FG000|Overall Study|Lost to Follow-up|9|||
144319200|NCT01110330|520370461|FG001|Overall Study|Lost to Follow-up|10|||
144319201|NCT01110330|520370462|FG002|Overall Study|Lost to Follow-up|15|||
144319202|NCT01110330|520370460|FG000|Overall Study|Physician Decision|0|||
144319203|NCT01110330|520370461|FG001|Overall Study|Physician Decision|1|||
144319204|NCT01110330|520370462|FG002|Overall Study|Physician Decision|0|||
144319205|NCT01110330|520370460|FG000|Overall Study|Protocol Violation|2|||
144319206|NCT01110330|520370461|FG001|Overall Study|Protocol Violation|0|||
144319207|NCT01110330|520370462|FG002|Overall Study|Protocol Violation|4|||
144319208|NCT01110330|520370460|FG000|Overall Study|Withdrawal by Subject|0|||
144319209|NCT01110330|520370461|FG001|Overall Study|Withdrawal by Subject|6|||
144319210|NCT01110330|520370462|FG002|Overall Study|Withdrawal by Subject|2|||
144319211|NCT01110330|520370460|FG000|Overall Study|Other|1|||
144319212|NCT01110330|520370461|FG001|Overall Study|Other|1|||
144319213|NCT01110330|520370462|FG002|Overall Study|Other|1|||
144319214|NCT04115748|520370465|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
144319215|NCT04115748|520370466|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
144319216|NCT04115748|520370467|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
144319217|NCT04115748|520370468|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
144319218|NCT04115748|520370469|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
144319219|NCT04115748|520370470|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
144319220|NCT04115748|520370471|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
144319221|NCT04115748|520370472|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
144319222|NCT04115748|520370473|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
144319223|NCT04115748|520370474|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
144319224|NCT04115748|520370465|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319225|NCT04115748|520370466|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319226|NCT04115748|520370467|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319227|NCT04115748|520370468|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
144319228|NCT04115748|520370469|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319229|NCT04115748|520370470|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319230|NCT04115748|520370471|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319231|NCT04115748|520370472|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319232|NCT04115748|520370473|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319233|NCT04115748|520370474|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
144319234|NCT04115748|520370465|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
144319235|NCT04115748|520370466|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
144319236|NCT04115748|520370467|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
144319237|NCT04115748|520370468|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
144319238|NCT04115748|520370469|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
144319239|NCT04115748|520370470|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
144319240|NCT04115748|520370471|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
144319241|NCT04115748|520370472|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
144319242|NCT04115748|520370473|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
144319243|NCT04115748|520370474|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
144319244|NCT04115748|520370465|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319245|NCT04115748|520370466|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319246|NCT04115748|520370467|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319247|NCT04115748|520370468|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319248|NCT04115748|520370469|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319249|NCT04115748|520370470|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319250|NCT04115748|520370471|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319251|NCT04115748|520370472|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319252|NCT04115748|520370473|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
144319253|NCT04115748|520370474|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
144319254|NCT00713349|520370475|FG000|Overall Study|Protocol Violation|1|||
144319255|NCT03764631|520370476|FG000|Overall Study|Personal Reasons|3|||
144319256|NCT03764631|520370477|FG001|Overall Study|Personal Reasons|2|||
144319257|NCT03764631|520370476|FG000|Overall Study|Switching Therapy|3|||
144319258|NCT03764631|520370477|FG001|Overall Study|Switching Therapy|3|||
144319259|NCT03764631|520370476|FG000|Overall Study|Adverse Event|0|||
144319260|NCT03764631|520370477|FG001|Overall Study|Adverse Event|1|||
144319261|NCT03764631|520370476|FG000|Overall Study|Lost to Follow-up|33|||
144319262|NCT03764631|520370477|FG001|Overall Study|Lost to Follow-up|41|||
144319263|NCT03764631|520370476|FG000|Overall Study|No data as study site was closed|2|||
144319264|NCT03764631|520370477|FG001|Overall Study|No data as study site was closed|6|||
144319265|NCT01200407|520370478|FG000|Overall Study|Lost to Follow-up|56|||
144319266|NCT01200407|520370478|FG000|Overall Study|Adverse Event|3|||
144319267|NCT01200407|520370478|FG000|Overall Study|Withdrawal by Subject|4|||
144319268|NCT01200407|520370478|FG000|Overall Study|Other|19|||
144319269|NCT02752633|520370481|FG000|Overall Study|Withdrawal by Subject|1|||
144319270|NCT02846389|520370482|FG000|Overall Study|Withdrawal by Subject|1|||
144319271|NCT02846389|520370483|FG001|Overall Study|Withdrawal by Subject|1|||
144319272|NCT02321319|520370484|FG000|Overall Study|Product discontinued|5|||
144319273|NCT02249091|520370485|FG000|Overall Study|Lack of Efficacy|8|||
144319274|NCT02249091|520370486|FG001|Overall Study|Lack of Efficacy|3|||
144319275|NCT02249091|520370485|FG000|Overall Study|Physician Decision|4|||
144319276|NCT02249091|520370486|FG001|Overall Study|Physician Decision|1|||
144319277|NCT02249091|520370485|FG000|Overall Study|Withdrawal by Subject|2|||
144319278|NCT02249091|520370486|FG001|Overall Study|Withdrawal by Subject|2|||
144319279|NCT02249091|520370485|FG000|Overall Study|Death|3|||
144319280|NCT02249091|520370486|FG001|Overall Study|Death|4|||
144319281|NCT02249091|520370485|FG000|Overall Study|Adverse Event|1|||
144319282|NCT02249091|520370486|FG001|Overall Study|Adverse Event|0|||
144319283|NCT02249091|520370485|FG000|Overall Study|Stable disease with following SCT|0|||
144319284|NCT02249091|520370486|FG001|Overall Study|Stable disease with following SCT|1|||
144319285|NCT02249091|520370485|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
144319286|NCT02249091|520370486|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
144319287|NCT02249091|520370485|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
144319288|NCT02249091|520370486|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
144319289|NCT02249091|520370485|FG000|Overall Study|Refractory AML|1|||
144319290|NCT02249091|520370486|FG001|Overall Study|Refractory AML|1|||
144319291|NCT03275246|520370487|FG000|Overall Study|Protocol Violation|5|||
144319292|NCT03275246|520370487|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
144319293|NCT00433966|520370490|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
144319294|NCT00433966|520370491|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
144319295|NCT00433966|520370492|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
144319296|NCT00433966|520370493|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
144319297|NCT00433966|520370490|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
144319298|NCT00433966|520370491|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
144319299|NCT00433966|520370492|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
144319300|NCT00433966|520370493|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
144319301|NCT00433966|520370490|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
144319302|NCT00433966|520370491|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
144319303|NCT00433966|520370492|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
144319304|NCT00433966|520370493|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
144319305|NCT00433966|520370490|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
144319306|NCT00433966|520370491|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
144319307|NCT00433966|520370492|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
144319308|NCT00433966|520370493|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
144319309|NCT00433966|520370490|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
144319310|NCT00433966|520370491|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
144319311|NCT00433966|520370492|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
144319312|NCT00433966|520370493|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
144319313|NCT03497975|520370494|FG000|Overall Study|Withdrew Consent|34|||
144319314|NCT03497975|520370495|FG001|Overall Study|Withdrew Consent|35|||
144319315|NCT03497975|520370494|FG000|Overall Study|Lost to Follow-up|7|||
144319316|NCT03497975|520370495|FG001|Overall Study|Lost to Follow-up|7|||
144319317|NCT03497975|520370494|FG000|Overall Study|Physician Decision|4|||
144319318|NCT03497975|520370495|FG001|Overall Study|Physician Decision|5|||
144319319|NCT03497975|520370494|FG000|Overall Study|Discontinued|42|||
144319320|NCT03497975|520370495|FG001|Overall Study|Discontinued|39|||
144319321|NCT03497975|520370494|FG000|Overall Study|Reason Not Specified|15|||
144319322|NCT03497975|520370495|FG001|Overall Study|Reason Not Specified|14|||
144319323|NCT01296711|520370496|FG000|Overall Study|Adverse Event|3|||
144319324|NCT01296711|520370497|FG001|Overall Study|Adverse Event|1|||
144319325|NCT01296711|520370498|FG002|Overall Study|Adverse Event|4|||
144319326|NCT01296711|520370499|FG003|Overall Study|Adverse Event|3|||
144319327|NCT01296711|520370500|FG004|Overall Study|Adverse Event|1|||
144319328|NCT01296711|520370501|FG005|Overall Study|Adverse Event|6|||
144319329|NCT01296711|520370502|FG006|Overall Study|Adverse Event|11|||
144319330|NCT01296711|520370503|FG007|Overall Study|Adverse Event|3|||
144319331|NCT01296711|520370496|FG000|Overall Study|Lack of Efficacy|1|||
144319332|NCT01296711|520370497|FG001|Overall Study|Lack of Efficacy|4|||
144319333|NCT01296711|520370498|FG002|Overall Study|Lack of Efficacy|1|||
144319334|NCT01296711|520370499|FG003|Overall Study|Lack of Efficacy|1|||
144319335|NCT01296711|520370500|FG004|Overall Study|Lack of Efficacy|1|||
144319336|NCT01296711|520370501|FG005|Overall Study|Lack of Efficacy|0|||
144319337|NCT01296711|520370502|FG006|Overall Study|Lack of Efficacy|2|||
144319338|NCT01296711|520370503|FG007|Overall Study|Lack of Efficacy|3|||
144319339|NCT01296711|520370496|FG000|Overall Study|Lost to Follow-up|0|||
144319340|NCT01296711|520370497|FG001|Overall Study|Lost to Follow-up|0|||
144319341|NCT01296711|520370498|FG002|Overall Study|Lost to Follow-up|1|||
144319342|NCT01296711|520370499|FG003|Overall Study|Lost to Follow-up|1|||
144319343|NCT01296711|520370500|FG004|Overall Study|Lost to Follow-up|2|||
144319344|NCT01296711|520370501|FG005|Overall Study|Lost to Follow-up|0|||
144319345|NCT01296711|520370502|FG006|Overall Study|Lost to Follow-up|4|||
144319346|NCT01296711|520370503|FG007|Overall Study|Lost to Follow-up|2|||
144319347|NCT01296711|520370496|FG000|Overall Study|Protocol Violation|0|||
144319348|NCT01296711|520370497|FG001|Overall Study|Protocol Violation|0|||
144319349|NCT01296711|520370498|FG002|Overall Study|Protocol Violation|0|||
144319350|NCT01296711|520370499|FG003|Overall Study|Protocol Violation|1|||
144319351|NCT01296711|520370500|FG004|Overall Study|Protocol Violation|1|||
144319352|NCT01296711|520370501|FG005|Overall Study|Protocol Violation|0|||
144319353|NCT01296711|520370502|FG006|Overall Study|Protocol Violation|0|||
144319354|NCT01296711|520370503|FG007|Overall Study|Protocol Violation|0|||
144319355|NCT01296711|520370496|FG000|Overall Study|Withdrawal by Subject|4|||
144319356|NCT01296711|520370497|FG001|Overall Study|Withdrawal by Subject|2|||
144319357|NCT01296711|520370498|FG002|Overall Study|Withdrawal by Subject|2|||
144319358|NCT01296711|520370499|FG003|Overall Study|Withdrawal by Subject|1|||
144319359|NCT01296711|520370500|FG004|Overall Study|Withdrawal by Subject|1|||
144319360|NCT01296711|520370501|FG005|Overall Study|Withdrawal by Subject|1|||
144319361|NCT01296711|520370502|FG006|Overall Study|Withdrawal by Subject|2|||
144319362|NCT01296711|520370503|FG007|Overall Study|Withdrawal by Subject|1|||
144319363|NCT01296711|520370496|FG000|Overall Study|Study termination|8|||
144319364|NCT01296711|520370497|FG001|Overall Study|Study termination|1|||
144319365|NCT01296711|520370498|FG002|Overall Study|Study termination|5|||
144319366|NCT01296711|520370499|FG003|Overall Study|Study termination|4|||
144319367|NCT01296711|520370500|FG004|Overall Study|Study termination|4|||
144319368|NCT01296711|520370501|FG005|Overall Study|Study termination|4|||
144319369|NCT01296711|520370502|FG006|Overall Study|Study termination|8|||
144319370|NCT01296711|520370503|FG007|Overall Study|Study termination|10|||
144319371|NCT01296711|520370496|FG000|Overall Study|Continued elevated liver enzymes|0|||
144319372|NCT01296711|520370497|FG001|Overall Study|Continued elevated liver enzymes|0|||
144319373|NCT01296711|520370498|FG002|Overall Study|Continued elevated liver enzymes|0|||
144319374|NCT01296711|520370499|FG003|Overall Study|Continued elevated liver enzymes|1|||
144319375|NCT01296711|520370500|FG004|Overall Study|Continued elevated liver enzymes|0|||
144319376|NCT01296711|520370501|FG005|Overall Study|Continued elevated liver enzymes|0|||
144319377|NCT01296711|520370502|FG006|Overall Study|Continued elevated liver enzymes|0|||
144319378|NCT01296711|520370503|FG007|Overall Study|Continued elevated liver enzymes|0|||
144319379|NCT01296711|520370496|FG000|Overall Study|Methotrexate discontinued|0|||
144319380|NCT01296711|520370497|FG001|Overall Study|Methotrexate discontinued|0|||
144319381|NCT01296711|520370498|FG002|Overall Study|Methotrexate discontinued|0|||
144319382|NCT01296711|520370499|FG003|Overall Study|Methotrexate discontinued|1|||
144319383|NCT01296711|520370500|FG004|Overall Study|Methotrexate discontinued|0|||
144319384|NCT01296711|520370501|FG005|Overall Study|Methotrexate discontinued|0|||
144319385|NCT01296711|520370502|FG006|Overall Study|Methotrexate discontinued|0|||
144319386|NCT01296711|520370503|FG007|Overall Study|Methotrexate discontinued|0|||
144319387|NCT01296711|520370496|FG000|Overall Study|Investigator discretion|0|||
144319388|NCT01296711|520370497|FG001|Overall Study|Investigator discretion|0|||
144319389|NCT01296711|520370498|FG002|Overall Study|Investigator discretion|0|||
144319390|NCT01296711|520370499|FG003|Overall Study|Investigator discretion|0|||
144319391|NCT01296711|520370500|FG004|Overall Study|Investigator discretion|0|||
144319392|NCT01296711|520370501|FG005|Overall Study|Investigator discretion|0|||
144319393|NCT01296711|520370502|FG006|Overall Study|Investigator discretion|1|||
144319394|NCT01296711|520370503|FG007|Overall Study|Investigator discretion|0|||
144319395|NCT01296711|520370496|FG000|Overall Study|Other|0|||
144319396|NCT01296711|520370497|FG001|Overall Study|Other|0|||
144319397|NCT01296711|520370498|FG002|Overall Study|Other|0|||
144319398|NCT01296711|520370499|FG003|Overall Study|Other|0|||
144319399|NCT01296711|520370500|FG004|Overall Study|Other|0|||
144319400|NCT01296711|520370501|FG005|Overall Study|Other|0|||
144319401|NCT01296711|520370502|FG006|Overall Study|Other|1|||
144319402|NCT01296711|520370503|FG007|Overall Study|Other|0|||
144319403|NCT01296711|520370496|FG000|Overall Study|Required restricted steroid injections|0|||
144319404|NCT01296711|520370497|FG001|Overall Study|Required restricted steroid injections|0|||
144319405|NCT01296711|520370498|FG002|Overall Study|Required restricted steroid injections|0|||
144319406|NCT01296711|520370499|FG003|Overall Study|Required restricted steroid injections|0|||
144319407|NCT01296711|520370500|FG004|Overall Study|Required restricted steroid injections|0|||
144319408|NCT01296711|520370501|FG005|Overall Study|Required restricted steroid injections|0|||
144319409|NCT01296711|520370502|FG006|Overall Study|Required restricted steroid injections|1|||
144319410|NCT01296711|520370503|FG007|Overall Study|Required restricted steroid injections|0|||
144319411|NCT01296711|520370496|FG000|Overall Study|Ongoing missed appointments|0|||
144319412|NCT01296711|520370497|FG001|Overall Study|Ongoing missed appointments|0|||
144319413|NCT01296711|520370498|FG002|Overall Study|Ongoing missed appointments|0|||
144319414|NCT01296711|520370499|FG003|Overall Study|Ongoing missed appointments|0|||
144319415|NCT01296711|520370500|FG004|Overall Study|Ongoing missed appointments|0|||
144319416|NCT01296711|520370501|FG005|Overall Study|Ongoing missed appointments|0|||
144319417|NCT01296711|520370502|FG006|Overall Study|Ongoing missed appointments|1|||
144319418|NCT01296711|520370503|FG007|Overall Study|Ongoing missed appointments|0|||
144319419|NCT01296711|520370496|FG000|Overall Study|Failure to comply with visits|0|||
144319420|NCT01296711|520370497|FG001|Overall Study|Failure to comply with visits|0|||
144319421|NCT01296711|520370498|FG002|Overall Study|Failure to comply with visits|0|||
144319422|NCT01296711|520370499|FG003|Overall Study|Failure to comply with visits|0|||
144319423|NCT01296711|520370500|FG004|Overall Study|Failure to comply with visits|0|||
144319424|NCT01296711|520370501|FG005|Overall Study|Failure to comply with visits|0|||
144319425|NCT01296711|520370502|FG006|Overall Study|Failure to comply with visits|0|||
144319426|NCT01296711|520370503|FG007|Overall Study|Failure to comply with visits|1|||
144319427|NCT01296711|520370496|FG000|Overall Study|Patient decision due to transport|0|||
144319428|NCT01296711|520370497|FG001|Overall Study|Patient decision due to transport|0|||
144319429|NCT01296711|520370498|FG002|Overall Study|Patient decision due to transport|0|||
144319430|NCT01296711|520370499|FG003|Overall Study|Patient decision due to transport|0|||
144319431|NCT01296711|520370500|FG004|Overall Study|Patient decision due to transport|0|||
144319432|NCT01296711|520370501|FG005|Overall Study|Patient decision due to transport|0|||
144319433|NCT01296711|520370502|FG006|Overall Study|Patient decision due to transport|0|||
144319434|NCT01296711|520370503|FG007|Overall Study|Patient decision due to transport|1|||
144319435|NCT00923975|520370507|FG000|Overall Study|Did not meet inclusion criteria|1|||
144319436|NCT01005316|520370510|FG000|Overall Study|Adverse Event|0|||
144319437|NCT01005316|520370511|FG001|Overall Study|Adverse Event|0|||
144319438|NCT01005316|520370512|FG002|Overall Study|Adverse Event|0|||
144319439|NCT01005316|520370513|FG003|Overall Study|Adverse Event|1|||
144319440|NCT01005316|520370510|FG000|Overall Study|Death|20|||
144319441|NCT01005316|520370511|FG001|Overall Study|Death|5|||
144319442|NCT01005316|520370512|FG002|Overall Study|Death|1|||
144319443|NCT01005316|520370513|FG003|Overall Study|Death|15|||
144319444|NCT01005316|520370510|FG000|Overall Study|Study Termination|5|||
144319445|NCT01005316|520370511|FG001|Overall Study|Study Termination|63|||
144319446|NCT01005316|520370512|FG002|Overall Study|Study Termination|9|||
144319447|NCT01005316|520370513|FG003|Overall Study|Study Termination|85|||
144319448|NCT01005316|520370510|FG000|Overall Study|Lost to Follow-up|1|||
144319449|NCT01005316|520370511|FG001|Overall Study|Lost to Follow-up|3|||
144319450|NCT01005316|520370512|FG002|Overall Study|Lost to Follow-up|0|||
144319451|NCT01005316|520370513|FG003|Overall Study|Lost to Follow-up|2|||
144319452|NCT01005316|520370510|FG000|Overall Study|Physician Decision|6|||
144319453|NCT01005316|520370511|FG001|Overall Study|Physician Decision|0|||
144319454|NCT01005316|520370512|FG002|Overall Study|Physician Decision|0|||
144319455|NCT01005316|520370513|FG003|Overall Study|Physician Decision|0|||
144319456|NCT01005316|520370510|FG000|Overall Study|Sponsor Decision|6|||
144319457|NCT01005316|520370511|FG001|Overall Study|Sponsor Decision|3|||
144319458|NCT01005316|520370512|FG002|Overall Study|Sponsor Decision|0|||
144319459|NCT01005316|520370513|FG003|Overall Study|Sponsor Decision|0|||
144319460|NCT01005316|520370510|FG000|Overall Study|Withdrawal by Subject|1|||
144319461|NCT01005316|520370511|FG001|Overall Study|Withdrawal by Subject|1|||
144319462|NCT01005316|520370512|FG002|Overall Study|Withdrawal by Subject|0|||
144319463|NCT01005316|520370513|FG003|Overall Study|Withdrawal by Subject|2|||
144319464|NCT01005316|520370510|FG000|Overall Study|Consented to Another Study|2|||
144319465|NCT01005316|520370511|FG001|Overall Study|Consented to Another Study|0|||
144319466|NCT01005316|520370512|FG002|Overall Study|Consented to Another Study|0|||
144319467|NCT01005316|520370513|FG003|Overall Study|Consented to Another Study|0|||
144319468|NCT01005316|520370510|FG000|Overall Study|Delisted|8|||
144319469|NCT01005316|520370511|FG001|Overall Study|Delisted|0|||
144319470|NCT01005316|520370512|FG002|Overall Study|Delisted|0|||
144319471|NCT01005316|520370513|FG003|Overall Study|Delisted|0|||
144319472|NCT01005316|520370510|FG000|Overall Study|Transferred Care|1|||
144319473|NCT01005316|520370511|FG001|Overall Study|Transferred Care|0|||
144319474|NCT01005316|520370512|FG002|Overall Study|Transferred Care|1|||
144319475|NCT01005316|520370513|FG003|Overall Study|Transferred Care|3|||
144319476|NCT01005316|520370510|FG000|Overall Study|Retransplanted|0|||
144319477|NCT01005316|520370511|FG001|Overall Study|Retransplanted|1|||
144319478|NCT01005316|520370512|FG002|Overall Study|Retransplanted|0|||
144319479|NCT01005316|520370513|FG003|Overall Study|Retransplanted|0|||
144319480|NCT00632827|520370514|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
144319481|NCT00632827|520370514|FG000|Overall Study|Death|2|||
144319482|NCT00632827|520370514|FG000|Overall Study|Adverse Event|5|||
144319483|NCT00632827|520370514|FG000|Overall Study|Lost to Follow-up|1|||
144319484|NCT02516098|520370517|FG000|Period 1|Protocol Violation|1|||
144319485|NCT02516098|520370518|FG001|Period 1|Protocol Violation|0|||
144319486|NCT02516098|520370517|FG000|Washout After Period 1|Adverse Event|0|||
144319487|NCT02516098|520370518|FG001|Washout After Period 1|Adverse Event|1|||
144319488|NCT02516098|520370517|FG000|Period 2|Withdrawal by Subject|0|||
144319489|NCT02516098|520370518|FG001|Period 2|Withdrawal by Subject|1|||
144319490|NCT01734395|520370519|FG000|Overall Study|Other|65|||
144319491|NCT01734395|520370519|FG000|Overall Study|Lost to Follow-up|287|||
144319492|NCT01734395|520370519|FG000|Overall Study|Lack of Efficacy|5|||
144319493|NCT01734395|520370519|FG000|Overall Study|Adverse Event|40|||
144319494|NCT01734395|520370519|FG000|Overall Study|Withdrawal by Subject|10|||
144319495|NCT01734395|520370519|FG000|Overall Study|Missing the reasons for not completed|3|||
144319496|NCT01092780|520370520|FG000|Washout Period 1|Adverse Event|0|||
144319497|NCT01092780|520370521|FG001|Washout Period 1|Adverse Event|1|||
144319498|NCT01092780|520370522|FG002|Washout Period 1|Adverse Event|0|||
144319499|NCT01092780|520370523|FG003|Washout Period 1|Adverse Event|0|||
144319500|NCT01092780|520370520|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
144319501|NCT01092780|520370521|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
144319502|NCT01092780|520370522|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
144319503|NCT01092780|520370523|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
144319504|NCT01092780|520370520|FG000|Washout Period 2|Adverse Event|0|||
144319505|NCT01092780|520370521|FG001|Washout Period 2|Adverse Event|1|||
144319506|NCT01092780|520370522|FG002|Washout Period 2|Adverse Event|1|||
144319507|NCT01092780|520370523|FG003|Washout Period 2|Adverse Event|0|||
144319508|NCT01126268|520370527|FG000|Overall Study|Adverse Event|1|||
144319509|NCT03425006|520370528|FG000|Overall Study|Withdrawal by Subject|1|||
144319510|NCT03425006|520370528|FG000|Overall Study|Physician Decision|1|||
144319511|NCT03425006|520370528|FG000|Overall Study|Death|1|||
144319512|NCT02300558|520370536|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
144319513|NCT02300558|520370536|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
144319514|NCT02300558|520370536|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
144319515|NCT02300558|520370536|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
144319516|NCT00610857|520370540|FG000|Overall Study|Not evaluable for response|2|||
144319517|NCT01626118|520370543|FG000|Overall Study|Lack of Efficacy|1|||
144319518|NCT01626118|520370544|FG001|Overall Study|Lack of Efficacy|0|||
144319519|NCT01626118|520370545|FG002|Overall Study|Lack of Efficacy|1|||
144319520|NCT01626118|520370546|FG003|Overall Study|Lack of Efficacy|3|||
144319521|NCT01626118|520370543|FG000|Overall Study|Lost to Follow-up|1|||
144319522|NCT01626118|520370544|FG001|Overall Study|Lost to Follow-up|0|||
144319523|NCT01626118|520370545|FG002|Overall Study|Lost to Follow-up|0|||
144319524|NCT01626118|520370546|FG003|Overall Study|Lost to Follow-up|0|||
144319525|NCT01626118|520370543|FG000|Overall Study|Adverse Event|0|||
144319526|NCT01626118|520370544|FG001|Overall Study|Adverse Event|1|||
144319527|NCT01626118|520370545|FG002|Overall Study|Adverse Event|1|||
144319528|NCT01626118|520370546|FG003|Overall Study|Adverse Event|0|||
144319529|NCT01626118|520370543|FG000|Overall Study|Investigator Decision|0|||
144319530|NCT01626118|520370544|FG001|Overall Study|Investigator Decision|1|||
144319531|NCT01626118|520370545|FG002|Overall Study|Investigator Decision|0|||
144319532|NCT01626118|520370546|FG003|Overall Study|Investigator Decision|0|||
144319533|NCT00888329|520370547|FG000|Overall Study|Physician Decision|6|||
144319534|NCT00888329|520370548|FG001|Overall Study|Physician Decision|9|||
144319535|NCT04826094|520370549|FG000|Overall Study|Lost to Follow-up|2|||
144319536|NCT04826094|520370550|FG001|Overall Study|Lost to Follow-up|1|||
144319537|NCT04826094|520370551|FG002|Overall Study|Lost to Follow-up|0|||
144319538|NCT04826094|520370552|FG003|Overall Study|Lost to Follow-up|0|||
144319539|NCT04826094|520370553|FG004|Overall Study|Lost to Follow-up|1|||
144319540|NCT04826094|520370554|FG005|Overall Study|Lost to Follow-up|3|||
144319541|NCT04826094|520370555|FG006|Overall Study|Lost to Follow-up|1|||
144319542|NCT04826094|520370556|FG007|Overall Study|Lost to Follow-up|1|||
144319543|NCT04826094|520370549|FG000|Overall Study|Participant withdrew consent|1|||
144319544|NCT04826094|520370550|FG001|Overall Study|Participant withdrew consent|0|||
144319545|NCT04826094|520370551|FG002|Overall Study|Participant withdrew consent|0|||
144319546|NCT04826094|520370552|FG003|Overall Study|Participant withdrew consent|1|||
144319547|NCT04826094|520370553|FG004|Overall Study|Participant withdrew consent|1|||
144319548|NCT04826094|520370554|FG005|Overall Study|Participant withdrew consent|1|||
144319549|NCT04826094|520370555|FG006|Overall Study|Participant withdrew consent|0|||
144319550|NCT04826094|520370556|FG007|Overall Study|Participant withdrew consent|1|||
144319551|NCT04826094|520370549|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
144319552|NCT04826094|520370550|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
144319553|NCT04826094|520370551|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
144319554|NCT04826094|520370552|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
144319555|NCT04826094|520370553|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
144319556|NCT04826094|520370554|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
144319557|NCT04826094|520370555|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
144319558|NCT04826094|520370556|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
144319559|NCT04826094|520370549|FG000|Overall Study|Withdrawn by Investigator|0|||
144319560|NCT04826094|520370550|FG001|Overall Study|Withdrawn by Investigator|0|||
144319561|NCT04826094|520370551|FG002|Overall Study|Withdrawn by Investigator|0|||
144319562|NCT04826094|520370552|FG003|Overall Study|Withdrawn by Investigator|0|||
144319563|NCT04826094|520370553|FG004|Overall Study|Withdrawn by Investigator|0|||
144319564|NCT04826094|520370554|FG005|Overall Study|Withdrawn by Investigator|1|||
144319565|NCT04826094|520370555|FG006|Overall Study|Withdrawn by Investigator|0|||
144319566|NCT04826094|520370556|FG007|Overall Study|Withdrawn by Investigator|1|||
144319567|NCT04826094|520370549|FG000|Overall Study|Other: Moved from area|1|||
144319568|NCT04826094|520370550|FG001|Overall Study|Other: Moved from area|1|||
144319569|NCT04826094|520370551|FG002|Overall Study|Other: Moved from area|1|||
144319570|NCT04826094|520370552|FG003|Overall Study|Other: Moved from area|0|||
144319571|NCT04826094|520370553|FG004|Overall Study|Other: Moved from area|0|||
144319572|NCT04826094|520370554|FG005|Overall Study|Other: Moved from area|0|||
144319573|NCT04826094|520370555|FG006|Overall Study|Other: Moved from area|0|||
144319574|NCT04826094|520370556|FG007|Overall Study|Other: Moved from area|0|||
144319575|NCT04826094|520370549|FG000|Overall Study|Other: Declined|0|||
144319576|NCT04826094|520370550|FG001|Overall Study|Other: Declined|0|||
144319577|NCT04826094|520370551|FG002|Overall Study|Other: Declined|0|||
144319578|NCT04826094|520370552|FG003|Overall Study|Other: Declined|0|||
144319579|NCT04826094|520370553|FG004|Overall Study|Other: Declined|1|||
144319580|NCT04826094|520370554|FG005|Overall Study|Other: Declined|0|||
144319581|NCT04826094|520370555|FG006|Overall Study|Other: Declined|0|||
144319582|NCT04826094|520370556|FG007|Overall Study|Other: Declined|0|||
144319583|NCT04826094|520370549|FG000|Overall Study|Other: Vaccine not administered|0|||
144319584|NCT04826094|520370550|FG001|Overall Study|Other: Vaccine not administered|0|||
144319585|NCT04826094|520370551|FG002|Overall Study|Other: Vaccine not administered|1|||
144319586|NCT04826094|520370552|FG003|Overall Study|Other: Vaccine not administered|0|||
144319587|NCT04826094|520370553|FG004|Overall Study|Other: Vaccine not administered|0|||
144319588|NCT04826094|520370554|FG005|Overall Study|Other: Vaccine not administered|1|||
144319589|NCT04826094|520370555|FG006|Overall Study|Other: Vaccine not administered|1|||
144319590|NCT04826094|520370556|FG007|Overall Study|Other: Vaccine not administered|3|||
144319591|NCT02151903|520370557|FG000|Overall Study|Withdrawal by Subject|1|||
144319592|NCT02151903|520370558|FG001|Overall Study|Withdrawal by Subject|0|||
144319593|NCT02151903|520370557|FG000|Overall Study|Progressive disease|2|||
144319594|NCT02151903|520370558|FG001|Overall Study|Progressive disease|1|||
144319595|NCT01500252|520370559|FG000|Overall Study|Death|4|||
144319596|NCT01500252|520370560|FG001|Overall Study|Death|2|||
144319597|NCT01500252|520370559|FG000|Overall Study|Lost to Follow-up|5|||
144319598|NCT01500252|520370560|FG001|Overall Study|Lost to Follow-up|4|||
144319599|NCT01421303|520370562|FG000|Overall Study|Lost to Follow-up|13|||
144319600|NCT01421303|520370562|FG000|Overall Study|Non compliance with study procedure|1|||
144319601|NCT01421303|520370562|FG000|Overall Study|Other|7|||
144319602|NCT01421303|520370562|FG000|Overall Study|Withdrawal by Subject|1|||
144319603|NCT06003777|520370563|FG000|Period 1|Adverse Event|0|||
144319604|NCT06003777|520370564|FG001|Period 1|Adverse Event|0|||
144319605|NCT06003777|520370565|FG002|Period 1|Adverse Event|1|||
144319606|NCT06003777|520370566|FG003|Period 1|Adverse Event|0|||
144319607|NCT06003777|520370567|FG004|Period 1|Adverse Event|0|||
144319608|NCT06003777|520370568|FG005|Period 1|Adverse Event|0|||
144319609|NCT06003777|520370569|FG006|Period 1|Adverse Event|0|||
144319610|NCT06003777|520370570|FG007|Period 1|Adverse Event|0|||
144319611|NCT06003777|520370571|FG008|Period 1|Adverse Event|0|||
144319612|NCT06003777|520370572|FG009|Period 1|Adverse Event|0|||
144319613|NCT06003777|520370573|FG010|Period 1|Adverse Event|0|||
144319614|NCT06003777|520370574|FG011|Period 1|Adverse Event|0|||
144319615|NCT06003777|520370563|FG000|Period 1|Withdrawal by Subject|0|||
144319616|NCT06003777|520370564|FG001|Period 1|Withdrawal by Subject|0|||
144319617|NCT06003777|520370565|FG002|Period 1|Withdrawal by Subject|0|||
144319618|NCT06003777|520370566|FG003|Period 1|Withdrawal by Subject|0|||
144319619|NCT06003777|520370567|FG004|Period 1|Withdrawal by Subject|1|||
144319620|NCT06003777|520370568|FG005|Period 1|Withdrawal by Subject|0|||
144319621|NCT06003777|520370569|FG006|Period 1|Withdrawal by Subject|0|||
144319622|NCT06003777|520370570|FG007|Period 1|Withdrawal by Subject|0|||
144319623|NCT06003777|520370571|FG008|Period 1|Withdrawal by Subject|0|||
144319624|NCT06003777|520370572|FG009|Period 1|Withdrawal by Subject|0|||
144319625|NCT06003777|520370573|FG010|Period 1|Withdrawal by Subject|0|||
144319626|NCT06003777|520370574|FG011|Period 1|Withdrawal by Subject|0|||
144319627|NCT06003777|520370563|FG000|Period 2|Withdrawal by Subject|0|||
144319628|NCT06003777|520370564|FG001|Period 2|Withdrawal by Subject|0|||
144319629|NCT06003777|520370565|FG002|Period 2|Withdrawal by Subject|0|||
144319630|NCT06003777|520370566|FG003|Period 2|Withdrawal by Subject|0|||
144319631|NCT06003777|520370567|FG004|Period 2|Withdrawal by Subject|0|||
144319632|NCT06003777|520370568|FG005|Period 2|Withdrawal by Subject|0|||
144319633|NCT06003777|520370569|FG006|Period 2|Withdrawal by Subject|0|||
144319634|NCT06003777|520370570|FG007|Period 2|Withdrawal by Subject|0|||
144319635|NCT06003777|520370571|FG008|Period 2|Withdrawal by Subject|1|||
144319636|NCT06003777|520370572|FG009|Period 2|Withdrawal by Subject|0|||
144319637|NCT06003777|520370573|FG010|Period 2|Withdrawal by Subject|0|||
144319638|NCT06003777|520370574|FG011|Period 2|Withdrawal by Subject|0|||
144319639|NCT06003777|520370563|FG000|Period 3|Adverse Event|0|||
144319640|NCT06003777|520370564|FG001|Period 3|Adverse Event|0|||
144319641|NCT06003777|520370565|FG002|Period 3|Adverse Event|0|||
144319642|NCT06003777|520370566|FG003|Period 3|Adverse Event|0|||
144319643|NCT06003777|520370567|FG004|Period 3|Adverse Event|0|||
144319644|NCT06003777|520370568|FG005|Period 3|Adverse Event|0|||
144319645|NCT06003777|520370569|FG006|Period 3|Adverse Event|1|||
144319646|NCT06003777|520370570|FG007|Period 3|Adverse Event|0|||
144319647|NCT06003777|520370571|FG008|Period 3|Adverse Event|0|||
144319648|NCT06003777|520370572|FG009|Period 3|Adverse Event|0|||
144319649|NCT06003777|520370573|FG010|Period 3|Adverse Event|0|||
144319650|NCT06003777|520370574|FG011|Period 3|Adverse Event|0|||
144319651|NCT06003777|520370563|FG000|Period 4|No longer met eligibility criteria|0|||
144319652|NCT06003777|520370564|FG001|Period 4|No longer met eligibility criteria|0|||
144319653|NCT06003777|520370565|FG002|Period 4|No longer met eligibility criteria|1|||
144319654|NCT06003777|520370566|FG003|Period 4|No longer met eligibility criteria|0|||
144319655|NCT06003777|520370567|FG004|Period 4|No longer met eligibility criteria|0|||
144319656|NCT06003777|520370568|FG005|Period 4|No longer met eligibility criteria|0|||
144319657|NCT06003777|520370569|FG006|Period 4|No longer met eligibility criteria|0|||
144319658|NCT06003777|520370570|FG007|Period 4|No longer met eligibility criteria|0|||
144319659|NCT06003777|520370571|FG008|Period 4|No longer met eligibility criteria|0|||
144319660|NCT06003777|520370572|FG009|Period 4|No longer met eligibility criteria|0|||
144319661|NCT06003777|520370573|FG010|Period 4|No longer met eligibility criteria|0|||
144319662|NCT06003777|520370574|FG011|Period 4|No longer met eligibility criteria|0|||
144319663|NCT06003777|520370563|FG000|Period 4|Withdrawal by Subject|0|||
144319664|NCT06003777|520370564|FG001|Period 4|Withdrawal by Subject|1|||
144319665|NCT06003777|520370565|FG002|Period 4|Withdrawal by Subject|0|||
144319666|NCT06003777|520370566|FG003|Period 4|Withdrawal by Subject|0|||
144319667|NCT06003777|520370567|FG004|Period 4|Withdrawal by Subject|0|||
144319668|NCT06003777|520370568|FG005|Period 4|Withdrawal by Subject|0|||
144319669|NCT06003777|520370569|FG006|Period 4|Withdrawal by Subject|0|||
144319670|NCT06003777|520370570|FG007|Period 4|Withdrawal by Subject|0|||
144319671|NCT06003777|520370571|FG008|Period 4|Withdrawal by Subject|0|||
144319672|NCT06003777|520370572|FG009|Period 4|Withdrawal by Subject|0|||
144319673|NCT06003777|520370573|FG010|Period 4|Withdrawal by Subject|0|||
144319674|NCT06003777|520370574|FG011|Period 4|Withdrawal by Subject|0|||
144319675|NCT00904670|520370575|FG000|Open Label Phase|Withdrawal by Subject|2|||
144319676|NCT00904670|520370576|FG001|Open Label Phase|Withdrawal by Subject|0|||
144319677|NCT00904670|520370575|FG000|Open Label Phase|Adverse Event|2|||
144319678|NCT00904670|520370576|FG001|Open Label Phase|Adverse Event|0|||
144319679|NCT00904670|520370575|FG000|Open Label Phase|Lack of Efficacy|1|||
144319680|NCT00904670|520370576|FG001|Open Label Phase|Lack of Efficacy|0|||
144319681|NCT00904670|520370575|FG000|Open Label Phase|Lost to Follow-up|1|||
144319682|NCT00904670|520370576|FG001|Open Label Phase|Lost to Follow-up|0|||
144319683|NCT02120300|520370579|FG000|Overall Study|Enrolled but Never Treated|2|||
144319684|NCT02120300|520370580|FG001|Overall Study|Enrolled but Never Treated|0|||
144319685|NCT02120300|520370581|FG002|Overall Study|Enrolled but Never Treated|0|||
144319686|NCT02120300|520370582|FG003|Overall Study|Enrolled but Never Treated|0|||
144319687|NCT02120300|520370579|FG000|Overall Study|Lack of Efficacy|0|||
144319688|NCT02120300|520370580|FG001|Overall Study|Lack of Efficacy|0|||
144319689|NCT02120300|520370581|FG002|Overall Study|Lack of Efficacy|0|||
144319690|NCT02120300|520370582|FG003|Overall Study|Lack of Efficacy|1|||
144319691|NCT02120300|520370579|FG000|Overall Study|Lost to Follow-up|1|||
144319692|NCT02120300|520370580|FG001|Overall Study|Lost to Follow-up|0|||
144319693|NCT02120300|520370581|FG002|Overall Study|Lost to Follow-up|0|||
144319694|NCT02120300|520370582|FG003|Overall Study|Lost to Follow-up|0|||
144319695|NCT00700882|520370583|FG000|Overall Study|Never received treatment|6|||
144319696|NCT00700882|520370583|FG000|Overall Study|Ineligible|2|||
144319697|NCT00700882|520370583|FG000|Overall Study|No KIT mutation|51|||
144319698|NCT01832493|520370584|FG000|Overall Study|Physician Decision|2|||
144319699|NCT01832493|520370584|FG000|Overall Study|Protocol Violation|4|||
144319700|NCT01832493|520370584|FG000|Overall Study|Unable to place LV lead|2|||
144319701|NCT00313144|520370587|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
144319702|NCT00313144|520370587|FG000|Overall Study|Death|7|||
144319703|NCT00313144|520370587|FG000|Overall Study|Lost to Follow-up|5|||
144319704|NCT00313144|520370587|FG000|Overall Study|Withdrawal by Subject|4|||
144319705|NCT00313144|520370587|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
144319706|NCT00313144|520370587|FG000|Overall Study|Physician Decision|4|||
144319707|NCT00313144|520370587|FG000|Overall Study|Adverse event - transient|5|||
144319708|NCT00313144|520370587|FG000|Overall Study|Liver transplant|1|||
144319709|NCT00313144|520370587|FG000|Overall Study|Insurance (homecare provider) change|1|||
144319710|NCT00313144|520370587|FG000|Overall Study|Change to different product|1|||
144319711|NCT00313144|520370587|FG000|Overall Study|Due to termination of the study|66|||
144319712|NCT04731298|520370590|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
144319713|NCT04731298|520370591|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
144319714|NCT01208961|520370592|FG000|High-Fat Period III|Protocol Violation|1|||
144319715|NCT01208961|520370593|FG001|High-Fat Period III|Protocol Violation|0|||
144360031|NCT01601535|520525135|FG000|Phase 2|Progressive Disease|0|||
144319716|NCT02487654|520370595|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
144319717|NCT02487654|520370596|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
144319718|NCT02487654|520370595|FG000|Overall Study|Withdrawal by Subject|3|||
144319719|NCT02487654|520370596|FG001|Overall Study|Withdrawal by Subject|7|||
144319720|NCT02152371|520370597|FG000|Overall Study|Adverse Event|6|||
144319721|NCT02152371|520370598|FG001|Overall Study|Adverse Event|2|||
144319722|NCT02152371|520370597|FG000|Overall Study|Withdrawal by Subject|3|||
144319723|NCT02152371|520370598|FG001|Overall Study|Withdrawal by Subject|7|||
144319724|NCT02152371|520370597|FG000|Overall Study|Protocol Violation|2|||
144319725|NCT02152371|520370598|FG001|Overall Study|Protocol Violation|3|||
144319726|NCT02152371|520370597|FG000|Overall Study|Lost to Follow-up|1|||
144319727|NCT02152371|520370598|FG001|Overall Study|Lost to Follow-up|0|||
144319728|NCT02152371|520370597|FG000|Overall Study|Lack of Efficacy|0|||
144319729|NCT02152371|520370598|FG001|Overall Study|Lack of Efficacy|1|||
144319730|NCT02152371|520370597|FG000|Overall Study|Physician Decision|0|||
144319731|NCT02152371|520370598|FG001|Overall Study|Physician Decision|2|||
144319732|NCT02152371|520370597|FG000|Overall Study|Reason Not Given|0|||
144319733|NCT02152371|520370598|FG001|Overall Study|Reason Not Given|1|||
144319734|NCT05285644|520370599|FG000|Overall Study|Adverse Event|3|||
144319735|NCT05285644|520370600|FG001|Overall Study|Adverse Event|3|||
144319736|NCT05285644|520370599|FG000|Overall Study|Withdrawal of Consent|2|||
144319737|NCT05285644|520370600|FG001|Overall Study|Withdrawal of Consent|5|||
144319738|NCT05285644|520370599|FG000|Overall Study|Noncompliance|0|||
144319739|NCT05285644|520370600|FG001|Overall Study|Noncompliance|4|||
144319740|NCT05285644|520370599|FG000|Overall Study|Lost to Follow-up|4|||
144319741|NCT05285644|520370600|FG001|Overall Study|Lost to Follow-up|6|||
144319742|NCT05285644|520370599|FG000|Overall Study|Disallowed Concurrent Medication|1|||
144319743|NCT05285644|520370600|FG001|Overall Study|Disallowed Concurrent Medication|1|||
144319744|NCT05285644|520370599|FG000|Overall Study|Investigator Decision|2|||
144319745|NCT05285644|520370600|FG001|Overall Study|Investigator Decision|0|||
144319746|NCT05285644|520370599|FG000|Overall Study|Protocol Deviation|1|||
144319747|NCT05285644|520370600|FG001|Overall Study|Protocol Deviation|0|||
144319748|NCT05285644|520370599|FG000|Overall Study|As specified in the Clinical Study Report|7|||
144319749|NCT05285644|520370600|FG001|Overall Study|As specified in the Clinical Study Report|3|||
144319750|NCT02952313|520370601|FG000|Primary Endpoint|Lost to Follow-up|4|||
144319751|NCT02952313|520370601|FG000|Primary Endpoint|Withdrawal by Subject|1|||
144319752|NCT02952313|520370601|FG000|Primary Endpoint|Lack of Efficacy|1|||
144319753|NCT02952313|520370601|FG000|Primary Endpoint|Missed visit|1|||
144319754|NCT02952313|520370601|FG000|Long-term Follow-up|Lost to Follow-up|12|||
144319755|NCT02952313|520370601|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
144319756|NCT02952313|520370601|FG000|Long-term Follow-up|Lack of Efficacy|6|||
144319757|NCT02952313|520370601|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
144319758|NCT02952313|520370601|FG000|Long-term Follow-up|Physician Decision|1|||
144319759|NCT02952313|520370601|FG000|Long-term Follow-up|Death|1|||
144319760|NCT04382586|520370602|FG000|Overall Study|Death|3|||
144319761|NCT04382586|520370603|FG001|Overall Study|Death|4|||
144319762|NCT04382586|520370602|FG000|Overall Study|Lost to Follow-up|11|||
144319763|NCT04382586|520370603|FG001|Overall Study|Lost to Follow-up|8|||
144319764|NCT04382586|520370602|FG000|Overall Study|Withdrawal by Subject|3|||
144319765|NCT04382586|520370603|FG001|Overall Study|Withdrawal by Subject|1|||
144319766|NCT04382586|520370602|FG000|Overall Study|Physician Decision|0|||
144319767|NCT04382586|520370603|FG001|Overall Study|Physician Decision|3|||
144319768|NCT00079391|520370604|FG000|Overall Study|Withdrawal by Subject|1|||
144319769|NCT00583752|520370605|FG000|Overall Study|Lost to Follow-up|5|||
144319770|NCT00583752|520370606|FG001|Overall Study|Lost to Follow-up|5|||
144319771|NCT01331837|520370607|FG000|Overall Study|Death|30|||
144319772|NCT01331837|520370608|FG001|Overall Study|Death|34|||
144319773|NCT01331837|520370607|FG000|Overall Study|Lost to Follow-up|3|||
144319774|NCT01331837|520370608|FG001|Overall Study|Lost to Follow-up|1|||
144319775|NCT01331837|520370607|FG000|Overall Study|Info not recorded|10|||
144319776|NCT01331837|520370608|FG001|Overall Study|Info not recorded|16|||
144319777|NCT01331837|520370607|FG000|Overall Study|Withdrawal by Subject|13|||
144319778|NCT01331837|520370608|FG001|Overall Study|Withdrawal by Subject|16|||
144319779|NCT02640625|520373143|FG000|Overall Study|Adverse Event|1|||
144319780|NCT00511433|520373144|FG000|Overall Study|Adverse Event|5|||
144319781|NCT00511433|520373145|FG001|Overall Study|Adverse Event|0|||
144319782|NCT00511433|520373144|FG000|Overall Study|Other Reason|1|||
144319783|NCT00511433|520373145|FG001|Overall Study|Other Reason|1|||
144319784|NCT01380535|520373146|FG000|Overall Study|Adverse Event|3|||
144319785|NCT01380535|520373147|FG001|Overall Study|Adverse Event|3|||
144319786|NCT01380535|520373146|FG000|Overall Study|Death|3|||
144319787|NCT01380535|520373147|FG001|Overall Study|Death|0|||
144319788|NCT01380535|520373146|FG000|Overall Study|Study site closed|0|||
144319789|NCT01380535|520373147|FG001|Overall Study|Study site closed|5|||
144319790|NCT01380535|520373146|FG000|Overall Study|Withdrawal by Subject|1|||
144319791|NCT01380535|520373147|FG001|Overall Study|Withdrawal by Subject|2|||
144319792|NCT01380535|520373146|FG000|Overall Study|Protocol Violation|0|||
144319793|NCT01380535|520373147|FG001|Overall Study|Protocol Violation|2|||
144319794|NCT01380535|520373146|FG000|Overall Study|Lack of Efficacy|0|||
144319795|NCT01380535|520373147|FG001|Overall Study|Lack of Efficacy|3|||
144319796|NCT02370537|520373148|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
144319797|NCT02370537|520373149|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
144319798|NCT02370537|520373150|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
144319799|NCT02370537|520373148|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
144319800|NCT02370537|520373149|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
144319801|NCT02370537|520373150|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
144319802|NCT02370537|520373148|FG000|Part B|Not randomised to receive treatment|1|||
144319803|NCT02370537|520373149|FG001|Part B|Not randomised to receive treatment|2|||
144319804|NCT02370537|520373150|FG002|Part B|Not randomised to receive treatment|259|||
144319805|NCT02370537|520373148|FG000|Part B|Withdrawal by Subject|0|||
144319806|NCT02370537|520373149|FG001|Part B|Withdrawal by Subject|1|||
144319807|NCT02370537|520373150|FG002|Part B|Withdrawal by Subject|0|||
144319808|NCT03100539|520373157|FG000|Overall Study|Lost to Follow-up|60|||
144319809|NCT03100539|520373158|FG001|Overall Study|Lost to Follow-up|54|||
144319810|NCT03100539|520373159|FG002|Overall Study|Lost to Follow-up|17|||
144319811|NCT03100539|520373157|FG000|Overall Study|Uncollected|8|||
144319812|NCT03100539|520373158|FG001|Overall Study|Uncollected|8|||
144319813|NCT03100539|520373159|FG002|Overall Study|Uncollected|0|||
144319814|NCT03100539|520373157|FG000|Overall Study|Ally Health|0|||
144319815|NCT03100539|520373158|FG001|Overall Study|Ally Health|0|||
144319816|NCT03100539|520373159|FG002|Overall Study|Ally Health|3|||
144319817|NCT03100539|520373157|FG000|Overall Study|Disinterest|0|||
144319818|NCT03100539|520373158|FG001|Overall Study|Disinterest|0|||
144319819|NCT03100539|520373159|FG002|Overall Study|Disinterest|22|||
144319820|NCT03100539|520373157|FG000|Overall Study|Veteran Health|0|||
144319821|NCT03100539|520373158|FG001|Overall Study|Veteran Health|0|||
144319822|NCT03100539|520373159|FG002|Overall Study|Veteran Health|8|||
144319823|NCT03100539|520373157|FG000|Overall Study|Moved|0|||
144319824|NCT03100539|520373158|FG001|Overall Study|Moved|0|||
144319825|NCT03100539|520373159|FG002|Overall Study|Moved|1|||
144319826|NCT03100539|520373157|FG000|Overall Study|Scheduling Conflicts|0|||
144319827|NCT03100539|520373158|FG001|Overall Study|Scheduling Conflicts|0|||
144319828|NCT03100539|520373159|FG002|Overall Study|Scheduling Conflicts|12|||
144319829|NCT00837265|520373166|FG000|Pilot Phase|Withdrawal by Subject|0|||
144319830|NCT00837265|520373167|FG001|Pilot Phase|Withdrawal by Subject|2|||
144319831|NCT00837265|520373168|FG002|Pilot Phase|Withdrawal by Subject|3|||
144319832|NCT00837265|520373169|FG003|Pilot Phase|Withdrawal by Subject|2|||
144319833|NCT00837265|520373170|FG004|Pilot Phase|Withdrawal by Subject|0|||
144319834|NCT00837265|520373171|FG005|Pilot Phase|Withdrawal by Subject|0|||
144319835|NCT00837265|520373172|FG006|Pilot Phase|Withdrawal by Subject|0|||
144319836|NCT00837265|520373166|FG000|Pilot Phase|Decision of the investigator|2|||
144319837|NCT00837265|520373167|FG001|Pilot Phase|Decision of the investigator|1|||
144319838|NCT00837265|520373168|FG002|Pilot Phase|Decision of the investigator|0|||
144319839|NCT00837265|520373169|FG003|Pilot Phase|Decision of the investigator|0|||
144319840|NCT00837265|520373170|FG004|Pilot Phase|Decision of the investigator|0|||
144319841|NCT00837265|520373171|FG005|Pilot Phase|Decision of the investigator|0|||
144319842|NCT00837265|520373172|FG006|Pilot Phase|Decision of the investigator|0|||
144319843|NCT00837265|520373166|FG000|Pilot Phase|Adverse Event|1|||
144319844|NCT00837265|520373167|FG001|Pilot Phase|Adverse Event|0|||
144319845|NCT00837265|520373168|FG002|Pilot Phase|Adverse Event|0|||
144319846|NCT00837265|520373169|FG003|Pilot Phase|Adverse Event|0|||
144319847|NCT00837265|520373170|FG004|Pilot Phase|Adverse Event|0|||
144319848|NCT00837265|520373171|FG005|Pilot Phase|Adverse Event|0|||
144319849|NCT00837265|520373172|FG006|Pilot Phase|Adverse Event|0|||
144319850|NCT00837265|520373166|FG000|Pilot Phase|Disease progression|0|||
144319851|NCT00837265|520373167|FG001|Pilot Phase|Disease progression|0|||
144319852|NCT00837265|520373168|FG002|Pilot Phase|Disease progression|0|||
144319853|NCT00837265|520373169|FG003|Pilot Phase|Disease progression|1|||
144319854|NCT00837265|520373170|FG004|Pilot Phase|Disease progression|0|||
144319855|NCT00837265|520373171|FG005|Pilot Phase|Disease progression|0|||
144319856|NCT00837265|520373172|FG006|Pilot Phase|Disease progression|0|||
144319857|NCT00837265|520373166|FG000|Pilot Phase|Participant left the city|0|||
144319858|NCT00837265|520373167|FG001|Pilot Phase|Participant left the city|0|||
144319859|NCT00837265|520373168|FG002|Pilot Phase|Participant left the city|0|||
144319860|NCT00837265|520373169|FG003|Pilot Phase|Participant left the city|1|||
144319861|NCT00837265|520373170|FG004|Pilot Phase|Participant left the city|0|||
144319862|NCT00837265|520373171|FG005|Pilot Phase|Participant left the city|0|||
144319863|NCT00837265|520373172|FG006|Pilot Phase|Participant left the city|0|||
144319864|NCT00837265|520373166|FG000|Main Phase|Withdrawal by Subject|0|||
144319865|NCT00837265|520373167|FG001|Main Phase|Withdrawal by Subject|0|||
144319866|NCT00837265|520373168|FG002|Main Phase|Withdrawal by Subject|0|||
144319867|NCT00837265|520373169|FG003|Main Phase|Withdrawal by Subject|0|||
144319868|NCT00837265|520373170|FG004|Main Phase|Withdrawal by Subject|4|||
144319869|NCT00837265|520373171|FG005|Main Phase|Withdrawal by Subject|2|||
144319870|NCT00837265|520373172|FG006|Main Phase|Withdrawal by Subject|1|||
144319871|NCT00837265|520373166|FG000|Main Phase|Decision of the investigator|0|||
144319872|NCT00837265|520373167|FG001|Main Phase|Decision of the investigator|0|||
144319873|NCT00837265|520373168|FG002|Main Phase|Decision of the investigator|0|||
144319874|NCT00837265|520373169|FG003|Main Phase|Decision of the investigator|0|||
144319875|NCT00837265|520373170|FG004|Main Phase|Decision of the investigator|0|||
144319876|NCT00837265|520373171|FG005|Main Phase|Decision of the investigator|2|||
144319877|NCT00837265|520373172|FG006|Main Phase|Decision of the investigator|1|||
144319878|NCT00837265|520373166|FG000|Main Phase|Adverse Event|0|||
144319879|NCT00837265|520373167|FG001|Main Phase|Adverse Event|0|||
144319880|NCT00837265|520373168|FG002|Main Phase|Adverse Event|0|||
144319881|NCT00837265|520373169|FG003|Main Phase|Adverse Event|0|||
144319882|NCT00837265|520373170|FG004|Main Phase|Adverse Event|0|||
144319883|NCT00837265|520373171|FG005|Main Phase|Adverse Event|1|||
144319884|NCT00837265|520373172|FG006|Main Phase|Adverse Event|0|||
144319885|NCT00837265|520373166|FG000|Main Phase|Death|0|||
144319886|NCT00837265|520373167|FG001|Main Phase|Death|0|||
144319887|NCT00837265|520373168|FG002|Main Phase|Death|0|||
144319888|NCT00837265|520373169|FG003|Main Phase|Death|0|||
144319889|NCT00837265|520373170|FG004|Main Phase|Death|2|||
144319890|NCT00837265|520373171|FG005|Main Phase|Death|0|||
144319891|NCT00837265|520373172|FG006|Main Phase|Death|1|||
144319892|NCT00837265|520373166|FG000|Main Phase|Lost to Follow-up|0|||
144319893|NCT00837265|520373167|FG001|Main Phase|Lost to Follow-up|0|||
144319894|NCT00837265|520373168|FG002|Main Phase|Lost to Follow-up|0|||
144319895|NCT00837265|520373169|FG003|Main Phase|Lost to Follow-up|0|||
144319896|NCT00837265|520373170|FG004|Main Phase|Lost to Follow-up|1|||
144319897|NCT00837265|520373171|FG005|Main Phase|Lost to Follow-up|0|||
144319898|NCT00837265|520373172|FG006|Main Phase|Lost to Follow-up|0|||
144319899|NCT00837265|520373166|FG000|Main Phase|Principal investigator resignation|0|||
144319900|NCT00837265|520373167|FG001|Main Phase|Principal investigator resignation|0|||
144319901|NCT00837265|520373168|FG002|Main Phase|Principal investigator resignation|0|||
144319902|NCT00837265|520373169|FG003|Main Phase|Principal investigator resignation|0|||
144319903|NCT00837265|520373170|FG004|Main Phase|Principal investigator resignation|2|||
144319904|NCT00837265|520373171|FG005|Main Phase|Principal investigator resignation|0|||
144319905|NCT00837265|520373172|FG006|Main Phase|Principal investigator resignation|0|||
144319906|NCT00837265|520373166|FG000|Main Phase|Participant's personal reason|0|||
144319907|NCT00837265|520373167|FG001|Main Phase|Participant's personal reason|0|||
144319908|NCT00837265|520373168|FG002|Main Phase|Participant's personal reason|0|||
144319909|NCT00837265|520373169|FG003|Main Phase|Participant's personal reason|0|||
144319910|NCT00837265|520373170|FG004|Main Phase|Participant's personal reason|1|||
144319911|NCT00837265|520373171|FG005|Main Phase|Participant's personal reason|0|||
144319912|NCT00837265|520373172|FG006|Main Phase|Participant's personal reason|0|||
144319913|NCT02242435|520373186|FG000|Overall Study|Lost to Follow-up|3|||
144319914|NCT02242435|520373187|FG001|Overall Study|Lost to Follow-up|4|||
144319915|NCT02242435|520373186|FG000|Overall Study|Adverse Event|3|||
144319916|NCT02242435|520373187|FG001|Overall Study|Adverse Event|2|||
144319917|NCT02242435|520373186|FG000|Overall Study|Withdrawal by Subject|13|||
144319918|NCT02242435|520373187|FG001|Overall Study|Withdrawal by Subject|8|||
144319919|NCT02242435|520373186|FG000|Overall Study|Death|0|||
144319920|NCT02242435|520373187|FG001|Overall Study|Death|1|||
144319921|NCT02242435|520373186|FG000|Overall Study|Protocol Violation|1|||
144319922|NCT02242435|520373187|FG001|Overall Study|Protocol Violation|0|||
144319923|NCT02242435|520373186|FG000|Overall Study|Physician Decision|0|||
144319924|NCT02242435|520373187|FG001|Overall Study|Physician Decision|1|||
144319925|NCT03895086|520373189|FG000|Overall Study|Early termination study|1|||
144319926|NCT03895086|520373190|FG001|Overall Study|Early termination study|0|||
144319927|NCT02513485|520373200|FG000|Overall Study|Adverse Event|1|||
144319928|NCT02513485|520373201|FG001|Overall Study|Adverse Event|0|||
144319929|NCT00420004|520373211|FG000|Overall Study|Adverse Event|4|||
144319930|NCT00420004|520373212|FG001|Overall Study|Adverse Event|1|||
144319931|NCT00420004|520373213|FG002|Overall Study|Adverse Event|1|||
144319932|NCT00420004|520373211|FG000|Overall Study|Lack of Efficacy|5|||
144319933|NCT00420004|520373212|FG001|Overall Study|Lack of Efficacy|4|||
144319934|NCT00420004|520373213|FG002|Overall Study|Lack of Efficacy|1|||
144319935|NCT00420004|520373211|FG000|Overall Study|Lost to Follow-up|31|||
144319936|NCT00420004|520373212|FG001|Overall Study|Lost to Follow-up|12|||
144319937|NCT00420004|520373213|FG002|Overall Study|Lost to Follow-up|10|||
144319938|NCT00420004|520373211|FG000|Overall Study|Entry Criteria Not Met|0|||
144319939|NCT00420004|520373212|FG001|Overall Study|Entry Criteria Not Met|1|||
144319940|NCT00420004|520373213|FG002|Overall Study|Entry Criteria Not Met|0|||
144319941|NCT00420004|520373211|FG000|Overall Study|Physician Decision|14|||
144319942|NCT00420004|520373212|FG001|Overall Study|Physician Decision|4|||
144319943|NCT00420004|520373213|FG002|Overall Study|Physician Decision|2|||
144319944|NCT00420004|520373211|FG000|Overall Study|Protocol Violation|5|||
144319945|NCT00420004|520373212|FG001|Overall Study|Protocol Violation|4|||
144319946|NCT00420004|520373213|FG002|Overall Study|Protocol Violation|3|||
144319947|NCT00420004|520373211|FG000|Overall Study|Withdrawal by Subject|67|||
144319948|NCT00420004|520373212|FG001|Overall Study|Withdrawal by Subject|42|||
144319949|NCT00420004|520373213|FG002|Overall Study|Withdrawal by Subject|14|||
144319950|NCT00420004|520373211|FG000|Overall Study|Sponsor Decision|3|||
144319951|NCT00420004|520373212|FG001|Overall Study|Sponsor Decision|3|||
144319952|NCT00420004|520373213|FG002|Overall Study|Sponsor Decision|1|||
144319953|NCT03215758|520373219|FG000|Overall Study|Technical Problems|1|||
144319954|NCT03215758|520373220|FG001|Overall Study|Technical Problems|0|||
144319955|NCT03215758|520373219|FG000|Overall Study|Protocol deviation|0|||
144319956|NCT03215758|520373220|FG001|Overall Study|Protocol deviation|1|||
144319957|NCT03215758|520373219|FG000|Overall Study|Physician Decision|0|||
144319958|NCT03215758|520373220|FG001|Overall Study|Physician Decision|1|||
144319959|NCT03215758|520373219|FG000|Overall Study|Death|0|||
144319960|NCT03215758|520373220|FG001|Overall Study|Death|1|||
144319961|NCT03215758|520373219|FG000|Overall Study|Adverse Event|1|||
144319962|NCT03215758|520373220|FG001|Overall Study|Adverse Event|2|||
144319963|NCT03215758|520373219|FG000|Overall Study|Subject/Guardian Decision|3|||
144319964|NCT03215758|520373220|FG001|Overall Study|Subject/Guardian Decision|3|||
144319965|NCT01843673|520373221|FG000|Overall Study|Lack of Efficacy|2|||
144319966|NCT01843673|520373221|FG000|Overall Study|Withdrawal by Subject|4|||
144319967|NCT01177553|520373223|FG000|Overall Study|babies not yet 6 months of age|1|||
144319968|NCT01177553|520373224|FG001|Overall Study|babies not yet 6 months of age|0|||
144319969|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
144319970|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
144319971|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
144319972|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
144319973|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
144319974|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
144319975|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
144319976|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
144319977|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
144319978|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
144319979|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
144319980|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
144319981|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
144319982|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
144319983|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
144319984|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
144319985|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
144319986|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319987|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319988|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319989|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319990|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319991|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319992|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319993|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319994|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319995|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319996|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319997|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319998|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
144319999|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
144320000|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
144320001|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
144320002|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
144320003|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
144320004|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
144320005|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
144320006|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
144320007|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
144320008|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
144320009|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
144320010|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
144320011|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
144320012|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
144320013|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
144320014|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
144320015|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
144320016|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
144320017|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
144320018|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
144320019|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
144320020|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
144320021|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
144320022|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
144320023|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
144320024|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
144320025|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
144320026|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
144320027|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
144320028|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
144320029|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
144320030|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
144320031|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
144320032|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
144320033|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320034|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320035|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320036|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320037|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320038|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320039|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320040|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320041|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320042|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320043|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
144320044|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
144320045|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
144320046|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
144320047|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
144320048|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320049|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320050|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320051|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320052|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320053|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320054|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320055|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320056|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320057|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320058|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
144320059|NCT03831191|520373228|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320060|NCT03831191|520373229|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320061|NCT03831191|520373230|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320062|NCT03831191|520373231|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
144320063|NCT03831191|520373232|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320064|NCT03831191|520373233|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320065|NCT03831191|520373234|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320066|NCT03831191|520373235|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320067|NCT03831191|520373236|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320068|NCT03831191|520373237|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320069|NCT03831191|520373238|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320070|NCT03831191|520373239|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320071|NCT03831191|520373240|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320072|NCT03831191|520373241|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320073|NCT03831191|520373242|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
144320074|NCT03831191|520373228|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
144320075|NCT03831191|520373229|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
144320076|NCT03831191|520373230|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
144320077|NCT03831191|520373231|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
144320078|NCT03831191|520373232|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
144320079|NCT03831191|520373233|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
144320080|NCT03831191|520373234|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
144320081|NCT03831191|520373235|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
144320082|NCT03831191|520373236|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
144320083|NCT03831191|520373237|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
144320084|NCT03831191|520373238|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
144320085|NCT03831191|520373239|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
144320086|NCT03831191|520373240|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
144320087|NCT03831191|520373241|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
144320088|NCT03831191|520373242|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
144320089|NCT03831191|520373228|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320090|NCT03831191|520373229|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320091|NCT03831191|520373230|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320092|NCT03831191|520373231|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320093|NCT03831191|520373232|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320094|NCT03831191|520373233|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320095|NCT03831191|520373234|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320096|NCT03831191|520373235|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320097|NCT03831191|520373236|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320098|NCT03831191|520373237|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320099|NCT03831191|520373238|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320100|NCT03831191|520373239|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320101|NCT03831191|520373240|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320102|NCT03831191|520373241|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144320103|NCT03831191|520373242|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
144320104|NCT03831191|520373228|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320105|NCT03831191|520373229|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320106|NCT03831191|520373230|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320107|NCT03831191|520373231|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320108|NCT03831191|520373232|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320109|NCT03831191|520373233|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320110|NCT03831191|520373234|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320111|NCT03831191|520373235|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320112|NCT03831191|520373236|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320113|NCT03831191|520373237|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320114|NCT03831191|520373238|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320115|NCT03831191|520373239|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320116|NCT03831191|520373240|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320117|NCT03831191|520373241|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144320118|NCT03831191|520373242|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
144320119|NCT03070171|520373245|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
144320120|NCT03070171|520373246|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
144320121|NCT03070171|520373245|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
144320122|NCT03070171|520373246|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
144320123|NCT01471028|520373247|FG000|VTI-208|Adverse Event|39|||
144320124|NCT01471028|520373248|FG001|VTI-208|Adverse Event|41|||
144320125|NCT01471028|520373247|FG000|VTI-208|Withdrawal by Subject|0|||
144320126|NCT01471028|520373248|FG001|VTI-208|Withdrawal by Subject|2|||
144320127|NCT01471028|520373247|FG000|VTI-208|Lost to Follow-up|1|||
144320128|NCT01471028|520373248|FG001|VTI-208|Lost to Follow-up|1|||
144320129|NCT01471028|520373247|FG000|VTI-208E|Death|7|||
144320130|NCT01471028|520373248|FG001|VTI-208E|Death|10|||
144320131|NCT01471028|520373247|FG000|VTI-208E|Withdrawal by Subject|1|||
144320132|NCT01471028|520373248|FG001|VTI-208E|Withdrawal by Subject|0|||
144320133|NCT01471028|520373247|FG000|VTI-208E|Lost to Follow-up|0|||
144320134|NCT01471028|520373248|FG001|VTI-208E|Lost to Follow-up|2|||
144320135|NCT00695955|520373249|FG000|Cohort 1|Adverse Event|26|||
144320136|NCT00695955|520373249|FG000|Cohort 1|Protocol Violation|2|||
144320137|NCT00695955|520373249|FG000|Cohort 1|Lost to Follow-up|30|||
144320138|NCT00695955|520373249|FG000|Cohort 1|Withdrawal by Subject|25|||
144320139|NCT00695955|520373249|FG000|Cohort 1|Lack of Efficacy|3|||
144320140|NCT00695955|520373249|FG000|Cohort 1|Other|16|||
144320141|NCT00695955|520373249|FG000|Cohort 2|Adverse Event|24|||
144320142|NCT00695955|520373249|FG000|Cohort 2|Protocol Violation|5|||
144320143|NCT00695955|520373249|FG000|Cohort 2|Lost to Follow-up|38|||
144320144|NCT00695955|520373249|FG000|Cohort 2|Withdrawal by Subject|28|||
144320145|NCT00695955|520373249|FG000|Cohort 2|Lack of Efficacy|4|||
144320146|NCT00695955|520373249|FG000|Cohort 2|Other|5|||
144320147|NCT01106651|520373255|FG000|Overall Study|Adverse Event|17|||
144320148|NCT01106651|520373256|FG001|Overall Study|Adverse Event|9|||
144320149|NCT01106651|520373257|FG002|Overall Study|Adverse Event|23|||
144320150|NCT01106651|520373255|FG000|Overall Study|Lost to Follow-up|8|||
144320151|NCT01106651|520373256|FG001|Overall Study|Lost to Follow-up|2|||
144320152|NCT01106651|520373257|FG002|Overall Study|Lost to Follow-up|6|||
144320153|NCT01106651|520373255|FG000|Overall Study|Physician Decision|4|||
144320154|NCT01106651|520373256|FG001|Overall Study|Physician Decision|3|||
144320155|NCT01106651|520373257|FG002|Overall Study|Physician Decision|1|||
144320156|NCT01106651|520373255|FG000|Overall Study|Protocol Violation|1|||
144320157|NCT01106651|520373256|FG001|Overall Study|Protocol Violation|2|||
144320158|NCT01106651|520373257|FG002|Overall Study|Protocol Violation|1|||
144320159|NCT01106651|520373255|FG000|Overall Study|Withdrawal by Subject|14|||
144320160|NCT01106651|520373256|FG001|Overall Study|Withdrawal by Subject|7|||
144320161|NCT01106651|520373257|FG002|Overall Study|Withdrawal by Subject|4|||
144320162|NCT01106651|520373255|FG000|Overall Study|Noncompliance with study drug|1|||
144320163|NCT01106651|520373256|FG001|Overall Study|Noncompliance with study drug|0|||
144320164|NCT01106651|520373257|FG002|Overall Study|Noncompliance with study drug|2|||
144320165|NCT01106651|520373255|FG000|Overall Study|Other|34|||
144320166|NCT01106651|520373256|FG001|Overall Study|Other|31|||
144320167|NCT01106651|520373257|FG002|Overall Study|Other|21|||
144320168|NCT01106651|520373255|FG000|Overall Study|Death|0|||
144320169|NCT01106651|520373256|FG001|Overall Study|Death|3|||
144320170|NCT01106651|520373257|FG002|Overall Study|Death|0|||
144320171|NCT03768089|520373258|FG000|Part A|Lost to Follow-up|0|||
144320172|NCT03768089|520373259|FG001|Part A|Lost to Follow-up|0|||
144320173|NCT03768089|520373260|FG002|Part A|Lost to Follow-up|0|||
144320174|NCT03768089|520373261|FG003|Part A|Lost to Follow-up|0|||
144320175|NCT03768089|520373262|FG004|Part A|Lost to Follow-up|1|||
144320176|NCT03768089|520373263|FG005|Part A|Lost to Follow-up|0|||
144320177|NCT03768089|520373264|FG006|Part A|Lost to Follow-up|0|||
144320178|NCT03768089|520373265|FG007|Part A|Lost to Follow-up|0|||
144320179|NCT03768089|520373266|FG008|Part A|Lost to Follow-up|0|||
144320180|NCT03768089|520373267|FG009|Part A|Lost to Follow-up|0|||
144320181|NCT03768089|520373268|FG010|Part A|Lost to Follow-up|0|||
144320182|NCT03768089|520373269|FG011|Part A|Lost to Follow-up|0|||
144320183|NCT03768089|520373270|FG012|Part A|Lost to Follow-up|0|||
144320184|NCT03768089|520373271|FG013|Part A|Lost to Follow-up|0|||
144320185|NCT03768089|520373272|FG014|Part A|Lost to Follow-up|0|||
144320186|NCT03768089|520373273|FG015|Part A|Lost to Follow-up|0|||
144320187|NCT03768089|520373274|FG016|Part A|Lost to Follow-up|0|||
144320188|NCT03768089|520373275|FG017|Part A|Lost to Follow-up|0|||
144320189|NCT03768089|520373258|FG000|Part C|Randomized, Never Dosed|0|||
144320190|NCT03768089|520373259|FG001|Part C|Randomized, Never Dosed|0|||
144320191|NCT03768089|520373260|FG002|Part C|Randomized, Never Dosed|0|||
144320192|NCT03768089|520373261|FG003|Part C|Randomized, Never Dosed|0|||
144320193|NCT03768089|520373262|FG004|Part C|Randomized, Never Dosed|0|||
144320194|NCT03768089|520373263|FG005|Part C|Randomized, Never Dosed|0|||
144320195|NCT03768089|520373264|FG006|Part C|Randomized, Never Dosed|0|||
144320196|NCT03768089|520373265|FG007|Part C|Randomized, Never Dosed|0|||
144320197|NCT03768089|520373266|FG008|Part C|Randomized, Never Dosed|0|||
144320198|NCT03768089|520373267|FG009|Part C|Randomized, Never Dosed|0|||
144320199|NCT03768089|520373268|FG010|Part C|Randomized, Never Dosed|0|||
144320200|NCT03768089|520373269|FG011|Part C|Randomized, Never Dosed|0|||
144320201|NCT03768089|520373270|FG012|Part C|Randomized, Never Dosed|0|||
144320202|NCT03768089|520373271|FG013|Part C|Randomized, Never Dosed|0|||
144320203|NCT03768089|520373272|FG014|Part C|Randomized, Never Dosed|1|||
144320204|NCT03768089|520373273|FG015|Part C|Randomized, Never Dosed|0|||
144320205|NCT03768089|520373274|FG016|Part C|Randomized, Never Dosed|0|||
144320206|NCT03768089|520373275|FG017|Part C|Randomized, Never Dosed|0|||
144320207|NCT00656058|520373276|FG000|Overall Study|Withdrawal by Subject|2|||
144320208|NCT00656058|520373276|FG000|Overall Study|Withdrawal by Subject|4|||
144320209|NCT00404755|520373277|FG000|Phase I (Bupropion)|Adverse Event|3|||
144320210|NCT00404755|520373277|FG000|Phase I (Bupropion)|Other|1|||
144320211|NCT00404755|520373277|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
144320212|NCT04700540|520373278|FG000|Overall Study|Withdrawal by Subject|12|||
144320213|NCT04700540|520373279|FG001|Overall Study|Withdrawal by Subject|8|||
144320214|NCT04700540|520373278|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
144320215|NCT04700540|520373279|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
144320216|NCT02265536|520373280|FG000|Overall Study|Adverse Event|1|||
144320217|NCT02265536|520373281|FG001|Overall Study|Adverse Event|0|||
144320218|NCT02265536|520373282|FG002|Overall Study|Adverse Event|0|||
144320219|NCT02265536|520373283|FG003|Overall Study|Adverse Event|0|||
144320220|NCT02265536|520373284|FG004|Overall Study|Adverse Event|1|||
144320221|NCT02265536|520373285|FG005|Overall Study|Adverse Event|0|||
144320222|NCT02265536|520373280|FG000|Overall Study|Physician Decision|0|||
144320223|NCT02265536|520373281|FG001|Overall Study|Physician Decision|0|||
144320224|NCT02265536|520373282|FG002|Overall Study|Physician Decision|0|||
144320225|NCT02265536|520373283|FG003|Overall Study|Physician Decision|0|||
144320226|NCT02265536|520373284|FG004|Overall Study|Physician Decision|2|||
144320227|NCT02265536|520373285|FG005|Overall Study|Physician Decision|0|||
144320228|NCT02265536|520373280|FG000|Overall Study|Withdrawal by Subject|0|||
144320229|NCT02265536|520373281|FG001|Overall Study|Withdrawal by Subject|3|||
144320230|NCT02265536|520373282|FG002|Overall Study|Withdrawal by Subject|0|||
144320231|NCT02265536|520373283|FG003|Overall Study|Withdrawal by Subject|0|||
144320232|NCT02265536|520373284|FG004|Overall Study|Withdrawal by Subject|0|||
144320233|NCT02265536|520373285|FG005|Overall Study|Withdrawal by Subject|0|||
144320234|NCT02241733|520373288|FG000|Overall Study|Lost to Follow-up|9|||
144320235|NCT02241733|520373289|FG001|Overall Study|Lost to Follow-up|4|||
144320236|NCT02241733|520373288|FG000|Overall Study|Physician Decision|6|||
144320237|NCT02241733|520373289|FG001|Overall Study|Physician Decision|2|||
144320238|NCT02241733|520373288|FG000|Overall Study|Withdrawal by Subject|0|||
144320239|NCT02241733|520373289|FG001|Overall Study|Withdrawal by Subject|2|||
144320240|NCT02241733|520373288|FG000|Overall Study|Death|0|||
144320241|NCT02241733|520373289|FG001|Overall Study|Death|2|||
144320242|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
144320243|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
144320244|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
144320245|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
144320246|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
144320247|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
144360032|NCT01601535|520525136|FG001|Phase 2|Progressive Disease|0|||
144320248|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
144320249|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
144320250|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
144320251|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
144320252|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
144320253|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
144320254|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
144320255|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
144320256|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
144320257|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
144320258|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
144320259|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
144320260|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
144320261|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
144320262|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
144320263|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
144320264|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
144320265|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
144320266|NCT01866111|520373290|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
144320267|NCT01866111|520373291|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
144320268|NCT01866111|520373292|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
144320269|NCT01866111|520373293|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
144320270|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
144320271|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
144320272|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
144320273|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
144320274|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
144320275|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
144320276|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
144320277|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
144320278|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
144320279|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
144320280|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
144320281|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
144320282|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
144320283|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
144320284|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
144320285|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
144320286|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Death|1|||
144320287|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Death|1|||
144320288|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Death|3|||
144320289|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Death|2|||
144320290|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
144320291|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
144320292|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
144320293|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
144320294|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
144320295|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
144320296|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
144320297|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
144320298|NCT01866111|520373290|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
144320299|NCT01866111|520373291|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
144320300|NCT01866111|520373292|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
144320301|NCT01866111|520373293|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
144320302|NCT00157196|520373294|FG000|Overall Study|Ongoing at data cut-off|9|||
144320303|NCT01252186|520373297|FG000|Overall Study|Adverse Event|9|||
144320304|NCT01252186|520373298|FG001|Overall Study|Adverse Event|6|||
144320305|NCT01252186|520373299|FG002|Overall Study|Adverse Event|8|||
144320306|NCT01252186|520373297|FG000|Overall Study|Withdrawal by Subject|2|||
144320307|NCT01252186|520373298|FG001|Overall Study|Withdrawal by Subject|5|||
144320308|NCT01252186|520373299|FG002|Overall Study|Withdrawal by Subject|2|||
144320309|NCT01252186|520373297|FG000|Overall Study|Physician Decision|0|||
144320310|NCT01252186|520373298|FG001|Overall Study|Physician Decision|0|||
144320311|NCT01252186|520373299|FG002|Overall Study|Physician Decision|1|||
144320312|NCT01252186|520373297|FG000|Overall Study|Non-compliance|0|||
144320313|NCT01252186|520373298|FG001|Overall Study|Non-compliance|3|||
144320314|NCT01252186|520373299|FG002|Overall Study|Non-compliance|4|||
144320315|NCT01252186|520373297|FG000|Overall Study|Protocol Violation|0|||
144320316|NCT01252186|520373298|FG001|Overall Study|Protocol Violation|0|||
144320317|NCT01252186|520373299|FG002|Overall Study|Protocol Violation|1|||
144320318|NCT01252186|520373297|FG000|Overall Study|Pregnancy|2|||
144320319|NCT01252186|520373298|FG001|Overall Study|Pregnancy|2|||
144320320|NCT01252186|520373299|FG002|Overall Study|Pregnancy|0|||
144320321|NCT01252186|520373297|FG000|Overall Study|Sponsor Request|2|||
144320322|NCT01252186|520373298|FG001|Overall Study|Sponsor Request|1|||
144320323|NCT01252186|520373299|FG002|Overall Study|Sponsor Request|0|||
144320324|NCT01252186|520373297|FG000|Overall Study|Lost to Follow-up|10|||
144320325|NCT01252186|520373298|FG001|Overall Study|Lost to Follow-up|10|||
144320326|NCT01252186|520373299|FG002|Overall Study|Lost to Follow-up|11|||
144320327|NCT01252186|520373297|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
144320328|NCT01252186|520373298|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
144320329|NCT01252186|520373299|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
144320330|NCT02791516|520373300|FG000|Overall Study|Withdrawal by Subject|1|||
144320331|NCT02791516|520373301|FG001|Overall Study|Withdrawal by Subject|1|||
144320332|NCT02524275|520373302|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
144320333|NCT01439971|520373303|FG000|Overall Study|Required number in cohort dosed|0|||
144320334|NCT01439971|520373304|FG001|Overall Study|Required number in cohort dosed|1|||
144320335|NCT01439971|520373305|FG002|Overall Study|Required number in cohort dosed|2|||
144320336|NCT01439971|520373306|FG003|Overall Study|Required number in cohort dosed|0|||
144320337|NCT01439971|520373307|FG004|Overall Study|Required number in cohort dosed|1|||
144320338|NCT02628600|520373308|FG000|Overall Study|Death|2|||
144320339|NCT02628600|520373309|FG001|Overall Study|Death|1|||
144320340|NCT02628600|520373308|FG000|Overall Study|Adverse Event|3|||
144320341|NCT02628600|520373309|FG001|Overall Study|Adverse Event|20|||
144320342|NCT02628600|520373308|FG000|Overall Study|Protocol Violation|0|||
144320343|NCT02628600|520373309|FG001|Overall Study|Protocol Violation|1|||
144320344|NCT02628600|520373308|FG000|Overall Study|Lack of Efficacy|2|||
144320345|NCT02628600|520373309|FG001|Overall Study|Lack of Efficacy|0|||
144320346|NCT02628600|520373308|FG000|Overall Study|Withdrawal by Subject|13|||
144320347|NCT02628600|520373309|FG001|Overall Study|Withdrawal by Subject|8|||
144320348|NCT02628600|520373308|FG000|Overall Study|Lost to Follow-up|1|||
144320349|NCT02628600|520373309|FG001|Overall Study|Lost to Follow-up|0|||
144320350|NCT02628600|520373308|FG000|Overall Study|Physician Decision|2|||
144320351|NCT02628600|520373309|FG001|Overall Study|Physician Decision|2|||
144320352|NCT02628600|520373308|FG000|Overall Study|Other not specified|1|||
144320353|NCT02628600|520373309|FG001|Overall Study|Other not specified|0|||
144320354|NCT04283994|520373316|FG000|Overall Study|Death|11|||
144320355|NCT04283994|520373317|FG001|Overall Study|Death|20|||
144320356|NCT04283994|520373318|FG002|Overall Study|Death|11|||
144320357|NCT04283994|520373319|FG003|Overall Study|Death|0|||
144320358|NCT04283994|520373320|FG004|Overall Study|Death|0|||
144320359|NCT04283994|520373321|FG005|Overall Study|Death|0|||
144320360|NCT04283994|520373322|FG006|Overall Study|Death|0|||
144320361|NCT04283994|520373316|FG000|Overall Study|Withdrawal by Subject|16|||
144320362|NCT04283994|520373317|FG001|Overall Study|Withdrawal by Subject|4|||
144320363|NCT04283994|520373318|FG002|Overall Study|Withdrawal by Subject|6|||
144320364|NCT04283994|520373319|FG003|Overall Study|Withdrawal by Subject|1|||
144320365|NCT04283994|520373320|FG004|Overall Study|Withdrawal by Subject|0|||
144320366|NCT04283994|520373321|FG005|Overall Study|Withdrawal by Subject|1|||
144320367|NCT04283994|520373322|FG006|Overall Study|Withdrawal by Subject|0|||
144320368|NCT03763656|520373323|FG000|Overall Study|Physician Decision|1|||
144320369|NCT03763656|520373323|FG000|Overall Study|Protocol Violation|1|||
144320370|NCT03763656|520373323|FG000|Overall Study|Withdrawal by Subject|7|||
144320371|NCT00780143|520373324|FG000|Overall Study|Progressive disease|1|||
144320372|NCT00780143|520373324|FG000|Overall Study|Toxicity|1|||
144320373|NCT00780143|520373324|FG000|Overall Study|Adverse Event|1|||
144320374|NCT00197145|520375084|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
144320375|NCT00197145|520375085|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
144320376|NCT00197145|520375084|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
144320377|NCT00197145|520375085|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
144320378|NCT00197145|520375084|FG000|Period 1: Randomized Treatment Phase|Other|2|||
144320379|NCT00197145|520375085|FG001|Period 1: Randomized Treatment Phase|Other|2|||
144320380|NCT00197145|520375084|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
144320381|NCT00197145|520375085|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
144320382|NCT00197145|520375084|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
144320383|NCT00197145|520375085|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
144320384|NCT00197145|520375084|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
144320385|NCT00197145|520375085|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
144320386|NCT00197145|520375084|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
144320387|NCT00197145|520375085|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
144320388|NCT00197145|520375084|FG000|Period 2 : Open Label Phase|Other|1|||
144320389|NCT00197145|520375085|FG001|Period 2 : Open Label Phase|Other|0|||
144320390|NCT00882583|520375088|FG000|Overall Study|Physician Decision|1|||
144320391|NCT00882583|520375089|FG001|Overall Study|Physician Decision|0|||
144320392|NCT00882583|520375088|FG000|Overall Study|Adverse Event|0|||
144320393|NCT00882583|520375089|FG001|Overall Study|Adverse Event|1|||
144320394|NCT02596958|520375090|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
144320395|NCT02596958|520375090|FG000|Overall Study|Cancer Progression|441|||
144320396|NCT02596958|520375090|FG000|Overall Study|Death From Cancer|112|||
144320397|NCT02596958|520375090|FG000|Overall Study|Death From Other Cause|33|||
144320398|NCT02596958|520375090|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
144320399|NCT02596958|520375090|FG000|Overall Study|Administrative Reasons/Other|231|||
144320400|NCT02596958|520375090|FG000|Overall Study|Lost to Follow-up|33|||
144320401|NCT02596958|520375090|FG000|Overall Study|Missing|32|||
144320402|NCT02596958|520375090|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
144320403|NCT03596047|520375091|FG000|Overall Study|Withdrawal by Subject|7|||
144320404|NCT03596047|520375092|FG001|Overall Study|Withdrawal by Subject|4|||
144320405|NCT03596047|520375091|FG000|Overall Study|Lost to Follow-up|0|||
144320406|NCT03596047|520375092|FG001|Overall Study|Lost to Follow-up|2|||
144320407|NCT00176488|520375095|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
144320408|NCT00327015|520375096|FG000|Overall Study|Lack of Efficacy|18|||
144320409|NCT00327015|520375097|FG001|Overall Study|Lack of Efficacy|18|||
144320410|NCT00327015|520375098|FG002|Overall Study|Lack of Efficacy|35|||
144320411|NCT00327015|520375099|FG003|Overall Study|Lack of Efficacy|29|||
144320412|NCT00327015|520375096|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
144320413|NCT00327015|520375097|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
144320414|NCT00327015|520375098|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
144320415|NCT00327015|520375099|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
144320416|NCT00327015|520375096|FG000|Overall Study|Lost to Follow-up|22|||
144320417|NCT00327015|520375097|FG001|Overall Study|Lost to Follow-up|23|||
144320418|NCT00327015|520375098|FG002|Overall Study|Lost to Follow-up|29|||
144320419|NCT00327015|520375099|FG003|Overall Study|Lost to Follow-up|22|||
144320420|NCT00327015|520375096|FG000|Overall Study|Adverse Event|14|||
144320421|NCT00327015|520375097|FG001|Overall Study|Adverse Event|10|||
144320422|NCT00327015|520375098|FG002|Overall Study|Adverse Event|14|||
144320423|NCT00327015|520375099|FG003|Overall Study|Adverse Event|14|||
144320424|NCT00327015|520375096|FG000|Overall Study|Subject no longer meets study criteria|4|||
144320425|NCT00327015|520375097|FG001|Overall Study|Subject no longer meets study criteria|2|||
144320426|NCT00327015|520375098|FG002|Overall Study|Subject no longer meets study criteria|8|||
144320427|NCT00327015|520375099|FG003|Overall Study|Subject no longer meets study criteria|7|||
144320428|NCT00327015|520375096|FG000|Overall Study|Poor/Noncompliance|11|||
144320429|NCT00327015|520375097|FG001|Overall Study|Poor/Noncompliance|8|||
144320430|NCT00327015|520375098|FG002|Overall Study|Poor/Noncompliance|4|||
144320431|NCT00327015|520375099|FG003|Overall Study|Poor/Noncompliance|5|||
144320432|NCT00327015|520375096|FG000|Overall Study|Physician Decision|0|||
144320433|NCT00327015|520375097|FG001|Overall Study|Physician Decision|1|||
144320434|NCT00327015|520375098|FG002|Overall Study|Physician Decision|3|||
144320435|NCT00327015|520375099|FG003|Overall Study|Physician Decision|2|||
144320436|NCT00327015|520375096|FG000|Overall Study|Death|1|||
144320437|NCT00327015|520375097|FG001|Overall Study|Death|2|||
144320438|NCT00327015|520375098|FG002|Overall Study|Death|2|||
144320439|NCT00327015|520375099|FG003|Overall Study|Death|3|||
144320440|NCT00327015|520375096|FG000|Overall Study|Pregnancy|0|||
144320441|NCT00327015|520375097|FG001|Overall Study|Pregnancy|2|||
144320442|NCT00327015|520375098|FG002|Overall Study|Pregnancy|1|||
144320443|NCT00327015|520375099|FG003|Overall Study|Pregnancy|1|||
144320444|NCT00327015|520375096|FG000|Overall Study|Administrative Reason by Sponsor|1|||
144320445|NCT00327015|520375097|FG001|Overall Study|Administrative Reason by Sponsor|2|||
144320446|NCT00327015|520375098|FG002|Overall Study|Administrative Reason by Sponsor|2|||
144320447|NCT00327015|520375099|FG003|Overall Study|Administrative Reason by Sponsor|1|||
144320448|NCT00733291|520375100|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
144320449|NCT00733291|520375101|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
144320450|NCT00733291|520375102|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
144320451|NCT00733291|520375103|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
144320452|NCT02759107|520375104|FG000|Overall Study|Adverse Event|0|||
144320453|NCT02759107|520375105|FG001|Overall Study|Adverse Event|0|||
144320454|NCT02759107|520375106|FG002|Overall Study|Adverse Event|0|||
144320455|NCT02759107|520375107|FG003|Overall Study|Adverse Event|0|||
144320456|NCT02759107|520375108|FG004|Overall Study|Adverse Event|0|||
144320457|NCT02759107|520375109|FG005|Overall Study|Adverse Event|0|||
144320458|NCT02759107|520375110|FG006|Overall Study|Adverse Event|0|||
144320459|NCT02759107|520375111|FG007|Overall Study|Adverse Event|0|||
144320460|NCT02759107|520375112|FG008|Overall Study|Adverse Event|0|||
144320461|NCT02759107|520375113|FG009|Overall Study|Adverse Event|0|||
144320462|NCT02759107|520375114|FG010|Overall Study|Adverse Event|0|||
144320463|NCT02759107|520375115|FG011|Overall Study|Adverse Event|0|||
144320464|NCT02759107|520375116|FG012|Overall Study|Adverse Event|2|||
144320465|NCT02759107|520375117|FG013|Overall Study|Adverse Event|0|||
144320466|NCT02759107|520375118|FG014|Overall Study|Adverse Event|0|||
144320467|NCT02759107|520375119|FG015|Overall Study|Adverse Event|1|||
144320468|NCT02759107|520375120|FG016|Overall Study|Adverse Event|0|||
144320469|NCT02759107|520375121|FG017|Overall Study|Adverse Event|2|||
144320470|NCT02759107|520375104|FG000|Overall Study|Scheduling Conflict|0|||
144320471|NCT02759107|520375105|FG001|Overall Study|Scheduling Conflict|0|||
144320472|NCT02759107|520375106|FG002|Overall Study|Scheduling Conflict|0|||
144320473|NCT02759107|520375107|FG003|Overall Study|Scheduling Conflict|0|||
144320474|NCT02759107|520375108|FG004|Overall Study|Scheduling Conflict|0|||
144320475|NCT02759107|520375109|FG005|Overall Study|Scheduling Conflict|0|||
144320476|NCT02759107|520375110|FG006|Overall Study|Scheduling Conflict|0|||
144320477|NCT02759107|520375111|FG007|Overall Study|Scheduling Conflict|0|||
144320478|NCT02759107|520375112|FG008|Overall Study|Scheduling Conflict|0|||
144320479|NCT02759107|520375113|FG009|Overall Study|Scheduling Conflict|1|||
144320480|NCT02759107|520375114|FG010|Overall Study|Scheduling Conflict|0|||
144320481|NCT02759107|520375115|FG011|Overall Study|Scheduling Conflict|0|||
144320482|NCT02759107|520375116|FG012|Overall Study|Scheduling Conflict|0|||
144320483|NCT02759107|520375117|FG013|Overall Study|Scheduling Conflict|0|||
144320484|NCT02759107|520375118|FG014|Overall Study|Scheduling Conflict|0|||
144320485|NCT02759107|520375119|FG015|Overall Study|Scheduling Conflict|0|||
144320486|NCT02759107|520375120|FG016|Overall Study|Scheduling Conflict|0|||
144320487|NCT02759107|520375121|FG017|Overall Study|Scheduling Conflict|0|||
144320488|NCT01089413|520375122|FG000|Overall Study|Lost to Follow-up|1|||
144320489|NCT01089413|520375122|FG000|Overall Study|Progressive Disease|93|||
144320490|NCT01089413|520375122|FG000|Overall Study|Participant Withdrew Consent|1|||
144320491|NCT01089413|520375122|FG000|Overall Study|Unacceptable Toxicity|12|||
144320492|NCT01089413|520375122|FG000|Overall Study|Death|10|||
144320493|NCT01089413|520375122|FG000|Overall Study|Metastasectomy|13|||
144320494|NCT01089413|520375122|FG000|Overall Study|Other|71|||
144320495|NCT03350035|520375125|FG000|Overall Study|Lack of Efficacy|2|||
144320496|NCT03350035|520375126|FG001|Overall Study|Lack of Efficacy|0|||
144320497|NCT03350035|520375127|FG002|Overall Study|Lack of Efficacy|0|||
144320498|NCT03350035|520375125|FG000|Overall Study|Subject discharged to hospice|0|||
144320499|NCT03350035|520375126|FG001|Overall Study|Subject discharged to hospice|0|||
144320500|NCT03350035|520375127|FG002|Overall Study|Subject discharged to hospice|1|||
144320501|NCT01289353|520375128|FG000|Overall Study|Lost to Follow-up|2|||
144320502|NCT01549886|520375129|FG000|Overall Study|Sponsor's decision|2|||
144320503|NCT01549886|520375130|FG001|Overall Study|Sponsor's decision|3|||
144320504|NCT02226562|520375131|FG000|Overall Study|Lost to Follow-up|0|||
144320505|NCT02226562|520375132|FG001|Overall Study|Lost to Follow-up|1|||
144320506|NCT02974855|520375133|FG000|Overall Study|Adverse Event|0|||
144320507|NCT02974855|520375134|FG001|Overall Study|Adverse Event|1|||
144320508|NCT02974855|520375135|FG002|Overall Study|Adverse Event|0|||
144320509|NCT02974855|520375136|FG003|Overall Study|Adverse Event|1|||
144320510|NCT00633074|520375141|FG000|Overall Study|Adverse Event|1|||
144320511|NCT00633074|520375142|FG001|Overall Study|Adverse Event|0|||
144320512|NCT02570152|520375144|FG000|Overall Study|Protocol Violation|2|||
144320513|NCT02570152|520375144|FG000|Overall Study|Migrated/moved from study area|13|||
144320514|NCT00758264|520375147|FG000|Active Phase|Withdrawal by Subject|0|||
144320515|NCT00758264|520375148|FG001|Active Phase|Withdrawal by Subject|0|||
144320516|NCT00758264|520375149|FG002|Active Phase|Withdrawal by Subject|1|||
144320517|NCT00758264|520375147|FG000|Active Phase|Lost to Follow-up|1|||
144320518|NCT00758264|520375148|FG001|Active Phase|Lost to Follow-up|0|||
144320519|NCT00758264|520375149|FG002|Active Phase|Lost to Follow-up|0|||
144320520|NCT00758264|520375147|FG000|Active Phase|Other|0|||
144320521|NCT00758264|520375148|FG001|Active Phase|Other|0|||
144320522|NCT00758264|520375149|FG002|Active Phase|Other|4|||
144320523|NCT02135029|520375150|FG000|Overall Study|Adverse Event|2|||
144320524|NCT02135029|520375151|FG001|Overall Study|Adverse Event|2|||
144320525|NCT02135029|520375152|FG002|Overall Study|Adverse Event|2|||
144320526|NCT02135029|520375150|FG000|Overall Study|Lost to Follow-up|0|||
144320527|NCT02135029|520375151|FG001|Overall Study|Lost to Follow-up|1|||
144320528|NCT02135029|520375152|FG002|Overall Study|Lost to Follow-up|0|||
144320529|NCT02135029|520375150|FG000|Overall Study|Withdrawal by Subject|2|||
144320530|NCT02135029|520375151|FG001|Overall Study|Withdrawal by Subject|0|||
144320531|NCT02135029|520375152|FG002|Overall Study|Withdrawal by Subject|1|||
144320532|NCT02135029|520375150|FG000|Overall Study|Other|0|||
144320533|NCT02135029|520375151|FG001|Overall Study|Other|1|||
144320534|NCT02135029|520375152|FG002|Overall Study|Other|0|||
144320535|NCT02135029|520375150|FG000|Overall Study|Death|0|||
144320536|NCT02135029|520375151|FG001|Overall Study|Death|1|||
144320537|NCT02135029|520375152|FG002|Overall Study|Death|0|||
144320538|NCT00712725|520375155|FG000|Overall Study|Adverse Event|1|||
144320539|NCT00712725|520375156|FG001|Overall Study|Adverse Event|0|||
144320540|NCT00712725|520375157|FG002|Overall Study|Adverse Event|0|||
144320541|NCT00712725|520375158|FG003|Overall Study|Adverse Event|1|||
144320542|NCT00712725|520375159|FG004|Overall Study|Adverse Event|0|||
144320543|NCT00712725|520375160|FG005|Overall Study|Adverse Event|0|||
144320544|NCT00712725|520375161|FG006|Overall Study|Adverse Event|0|||
144320545|NCT00712725|520375162|FG007|Overall Study|Adverse Event|0|||
144320546|NCT00712725|520375155|FG000|Overall Study|Lost to Follow-up|3|||
144320547|NCT00712725|520375156|FG001|Overall Study|Lost to Follow-up|2|||
144320548|NCT00712725|520375157|FG002|Overall Study|Lost to Follow-up|1|||
144320549|NCT00712725|520375158|FG003|Overall Study|Lost to Follow-up|1|||
144320550|NCT00712725|520375159|FG004|Overall Study|Lost to Follow-up|2|||
144320551|NCT00712725|520375160|FG005|Overall Study|Lost to Follow-up|2|||
144320552|NCT00712725|520375161|FG006|Overall Study|Lost to Follow-up|3|||
144320553|NCT00712725|520375162|FG007|Overall Study|Lost to Follow-up|1|||
144320554|NCT00712725|520375155|FG000|Overall Study|Physician Decision|2|||
144320555|NCT00712725|520375156|FG001|Overall Study|Physician Decision|0|||
144320556|NCT00712725|520375157|FG002|Overall Study|Physician Decision|0|||
144320557|NCT00712725|520375158|FG003|Overall Study|Physician Decision|0|||
144320558|NCT00712725|520375159|FG004|Overall Study|Physician Decision|1|||
144320559|NCT00712725|520375160|FG005|Overall Study|Physician Decision|0|||
144320560|NCT00712725|520375161|FG006|Overall Study|Physician Decision|2|||
144320561|NCT00712725|520375162|FG007|Overall Study|Physician Decision|0|||
144320562|NCT00712725|520375155|FG000|Overall Study|Pregnancy|0|||
144320563|NCT00712725|520375156|FG001|Overall Study|Pregnancy|1|||
144320564|NCT00712725|520375157|FG002|Overall Study|Pregnancy|0|||
144320565|NCT00712725|520375158|FG003|Overall Study|Pregnancy|0|||
144320566|NCT00712725|520375159|FG004|Overall Study|Pregnancy|1|||
144320567|NCT00712725|520375160|FG005|Overall Study|Pregnancy|0|||
144320568|NCT00712725|520375161|FG006|Overall Study|Pregnancy|2|||
144320569|NCT00712725|520375162|FG007|Overall Study|Pregnancy|0|||
144320570|NCT00712725|520375155|FG000|Overall Study|Protocol Violation|2|||
144320571|NCT00712725|520375156|FG001|Overall Study|Protocol Violation|0|||
144320572|NCT00712725|520375157|FG002|Overall Study|Protocol Violation|1|||
144320573|NCT00712725|520375158|FG003|Overall Study|Protocol Violation|3|||
144320574|NCT00712725|520375159|FG004|Overall Study|Protocol Violation|2|||
144320575|NCT00712725|520375160|FG005|Overall Study|Protocol Violation|0|||
144320576|NCT00712725|520375161|FG006|Overall Study|Protocol Violation|1|||
144320577|NCT00712725|520375162|FG007|Overall Study|Protocol Violation|1|||
144320578|NCT00712725|520375155|FG000|Overall Study|Withdrawal by Subject|2|||
144320579|NCT00712725|520375156|FG001|Overall Study|Withdrawal by Subject|1|||
144320580|NCT00712725|520375157|FG002|Overall Study|Withdrawal by Subject|1|||
144320581|NCT00712725|520375158|FG003|Overall Study|Withdrawal by Subject|2|||
144320582|NCT00712725|520375159|FG004|Overall Study|Withdrawal by Subject|1|||
144320583|NCT00712725|520375160|FG005|Overall Study|Withdrawal by Subject|1|||
144320584|NCT00712725|520375161|FG006|Overall Study|Withdrawal by Subject|1|||
144320585|NCT00712725|520375162|FG007|Overall Study|Withdrawal by Subject|2|||
144320586|NCT00712725|520375155|FG000|Overall Study|Lack of Qualifying Event|16|||
144320587|NCT00712725|520375156|FG001|Overall Study|Lack of Qualifying Event|2|||
144320588|NCT00712725|520375157|FG002|Overall Study|Lack of Qualifying Event|6|||
144320589|NCT00712725|520375158|FG003|Overall Study|Lack of Qualifying Event|8|||
144320590|NCT00712725|520375159|FG004|Overall Study|Lack of Qualifying Event|11|||
144320591|NCT00712725|520375160|FG005|Overall Study|Lack of Qualifying Event|13|||
144320592|NCT00712725|520375161|FG006|Overall Study|Lack of Qualifying Event|11|||
144320593|NCT00712725|520375162|FG007|Overall Study|Lack of Qualifying Event|6|||
144320594|NCT00712725|520375155|FG000|Overall Study|Protocol Specified Criteria|3|||
144320595|NCT00712725|520375156|FG001|Overall Study|Protocol Specified Criteria|0|||
144320596|NCT00712725|520375157|FG002|Overall Study|Protocol Specified Criteria|1|||
144320597|NCT00712725|520375158|FG003|Overall Study|Protocol Specified Criteria|2|||
144320598|NCT00712725|520375159|FG004|Overall Study|Protocol Specified Criteria|1|||
144320599|NCT00712725|520375160|FG005|Overall Study|Protocol Specified Criteria|0|||
144320600|NCT00712725|520375161|FG006|Overall Study|Protocol Specified Criteria|2|||
144320601|NCT00712725|520375162|FG007|Overall Study|Protocol Specified Criteria|1|||
144320602|NCT03466099|520375163|FG000|Overall Study|Adverse Event|1|||
144320603|NCT03466099|520375164|FG001|Overall Study|Adverse Event|1|||
144320604|NCT03466099|520375165|FG002|Overall Study|Adverse Event|1|||
144320605|NCT03466099|520375163|FG000|Overall Study|Withdrawal by Subject|2|||
144320606|NCT03466099|520375164|FG001|Overall Study|Withdrawal by Subject|3|||
144320607|NCT03466099|520375165|FG002|Overall Study|Withdrawal by Subject|1|||
144320608|NCT03466099|520375163|FG000|Overall Study|Use of rescue medication|8|||
144320609|NCT03466099|520375164|FG001|Overall Study|Use of rescue medication|9|||
144320610|NCT03466099|520375165|FG002|Overall Study|Use of rescue medication|13|||
144320611|NCT03466099|520375163|FG000|Overall Study|Rescued without meeting criteria|4|||
144320612|NCT03466099|520375164|FG001|Overall Study|Rescued without meeting criteria|1|||
144320613|NCT03466099|520375165|FG002|Overall Study|Rescued without meeting criteria|1|||
144320614|NCT03466099|520375163|FG000|Overall Study|Subject compliance|2|||
144320615|NCT03466099|520375164|FG001|Overall Study|Subject compliance|0|||
144320616|NCT03466099|520375165|FG002|Overall Study|Subject compliance|0|||
144320617|NCT03466099|520375163|FG000|Overall Study|Worsening disease|0|||
144320618|NCT03466099|520375164|FG001|Overall Study|Worsening disease|0|||
144320619|NCT03466099|520375165|FG002|Overall Study|Worsening disease|1|||
144320620|NCT04590404|520375168|FG000|Overall Study|Death|16|||
144320621|NCT04590404|520375169|FG001|Overall Study|Death|17|||
144320622|NCT04590404|520375168|FG000|Overall Study|Withdrawal by Subject|7|||
144320623|NCT04590404|520375169|FG001|Overall Study|Withdrawal by Subject|2|||
144320624|NCT04154605|520375170|FG000|Overall Study|Procedure Canceled|1|||
144320625|NCT04154605|520375171|FG001|Overall Study|Procedure Canceled|1|||
144320626|NCT04154605|520375170|FG000|Overall Study|Missed follow up|1|||
144320627|NCT04154605|520375171|FG001|Overall Study|Missed follow up|1|||
144320628|NCT04154605|520375170|FG000|Overall Study|Withdrawal by Subject|1|||
144320629|NCT04154605|520375171|FG001|Overall Study|Withdrawal by Subject|0|||
144320630|NCT00675441|520375174|FG000|Overall Study|Withdrawal by Subject|2|||
144320631|NCT00675441|520375174|FG000|Overall Study|Death|1|||
144320632|NCT03525600|520375175|FG000|Overall Study|Adverse Event|9|||
144320633|NCT03525600|520375176|FG001|Overall Study|Adverse Event|6|||
144320634|NCT03525600|520375177|FG002|Overall Study|Adverse Event|5|||
144320635|NCT03525600|520375178|FG003|Overall Study|Adverse Event|3|||
144320636|NCT03525600|520375175|FG000|Overall Study|Lost to Follow-up|2|||
144320637|NCT03525600|520375176|FG001|Overall Study|Lost to Follow-up|4|||
144320638|NCT03525600|520375177|FG002|Overall Study|Lost to Follow-up|4|||
144320639|NCT03525600|520375178|FG003|Overall Study|Lost to Follow-up|0|||
144320640|NCT03525600|520375175|FG000|Overall Study|Physician Decision|1|||
144320641|NCT03525600|520375176|FG001|Overall Study|Physician Decision|0|||
144320642|NCT03525600|520375177|FG002|Overall Study|Physician Decision|2|||
144320643|NCT03525600|520375178|FG003|Overall Study|Physician Decision|0|||
144320644|NCT03525600|520375175|FG000|Overall Study|Consent withdrawal|36|||
144320645|NCT03525600|520375176|FG001|Overall Study|Consent withdrawal|20|||
144320646|NCT03525600|520375177|FG002|Overall Study|Consent withdrawal|6|||
144320647|NCT03525600|520375178|FG003|Overall Study|Consent withdrawal|13|||
144320648|NCT03525600|520375175|FG000|Overall Study|Death|7|||
144320649|NCT03525600|520375176|FG001|Overall Study|Death|6|||
144320650|NCT03525600|520375177|FG002|Overall Study|Death|4|||
144320651|NCT03525600|520375178|FG003|Overall Study|Death|3|||
144320652|NCT03525600|520375175|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
144320653|NCT03525600|520375176|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
144320654|NCT03525600|520375177|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
144320655|NCT03525600|520375178|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
144320656|NCT03525600|520375175|FG000|Overall Study|Other|0|||
144320657|NCT03525600|520375176|FG001|Overall Study|Other|1|||
144320658|NCT03525600|520375177|FG002|Overall Study|Other|0|||
144320659|NCT03525600|520375178|FG003|Overall Study|Other|0|||
144320660|NCT01923363|520375181|FG000|Overall Study|Protocol Violation|1|||
144320661|NCT00290771|520375184|FG000|Overall Study|Disease progression|95|||
144320662|NCT00290771|520375185|FG001|Overall Study|Disease progression|73|||
144320663|NCT00290771|520375184|FG000|Overall Study|Death|11|||
144320664|NCT00290771|520375185|FG001|Overall Study|Death|10|||
144320665|NCT00290771|520375184|FG000|Overall Study|Adverse Event|12|||
144320666|NCT00290771|520375185|FG001|Overall Study|Adverse Event|6|||
144320667|NCT00290771|520375184|FG000|Overall Study|Withdrawal by Subject|5|||
144320668|NCT00290771|520375185|FG001|Overall Study|Withdrawal by Subject|6|||
144320669|NCT00290771|520375184|FG000|Overall Study|Administrative problems|2|||
144320670|NCT00290771|520375185|FG001|Overall Study|Administrative problems|1|||
144320671|NCT00290771|520375184|FG000|Overall Study|Protocol Violation|2|||
144320672|NCT00290771|520375185|FG001|Overall Study|Protocol Violation|0|||
144320673|NCT00290771|520375184|FG000|Overall Study|Lost to Follow-up|0|||
144320674|NCT00290771|520375185|FG001|Overall Study|Lost to Follow-up|1|||
144320675|NCT04154293|520375188|FG000|Overall Study|Withdrawal by Subject|2|||
144320676|NCT04154293|520375189|FG001|Overall Study|Withdrawal by Subject|3|||
144320677|NCT04154293|520375190|FG002|Overall Study|Withdrawal by Subject|1|||
144320678|NCT04154293|520375188|FG000|Overall Study|Physician Decision|0|||
144320679|NCT04154293|520375189|FG001|Overall Study|Physician Decision|0|||
144320680|NCT04154293|520375190|FG002|Overall Study|Physician Decision|1|||
144320681|NCT01818258|520375192|FG000|Overall Study|Death|3|||
144320682|NCT01818258|520375193|FG001|Overall Study|Death|0|||
144320683|NCT01818258|520375192|FG000|Overall Study|Withdrawal by Subject|0|||
144320684|NCT01818258|520375193|FG001|Overall Study|Withdrawal by Subject|1|||
144320685|NCT01818258|520375192|FG000|Overall Study|Lost to Follow-up|0|||
144320686|NCT01818258|520375193|FG001|Overall Study|Lost to Follow-up|1|||
144320687|NCT01818258|520375192|FG000|Overall Study|Unable to Travel to Clinic|0|||
144320688|NCT01818258|520375193|FG001|Overall Study|Unable to Travel to Clinic|1|||
144320689|NCT02099344|520375194|FG000|Overall Study|Physician Decision|1|||
144320690|NCT02099344|520375195|FG001|Overall Study|Physician Decision|0|||
144320691|NCT05145322|520375200|FG000|Overall Study|Lost to Follow-up|4|||
144320692|NCT05145322|520375201|FG001|Overall Study|Lost to Follow-up|5|||
144320693|NCT06359028|520375202|FG000|Overall Study|Adverse Event|1|||
144320694|NCT06359028|520375203|FG001|Overall Study|Adverse Event|0|||
144320695|NCT06359028|520375202|FG000|Overall Study|Withdrawal by Subject|1|||
144320696|NCT06359028|520375203|FG001|Overall Study|Withdrawal by Subject|0|||
144320697|NCT03194568|520375204|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
144320698|NCT03515551|520375207|FG000|Overall Study|Death|4|||
144320699|NCT03515551|520375208|FG001|Overall Study|Death|1|||
144320700|NCT03515551|520375209|FG002|Overall Study|Death|2|||
144320701|NCT03515551|520375210|FG003|Overall Study|Death|2|||
144320702|NCT03515551|520375211|FG004|Overall Study|Death|2|||
144320703|NCT03515551|520375212|FG005|Overall Study|Death|4|||
144320704|NCT03515551|520375213|FG006|Overall Study|Death|1|||
144320705|NCT03515551|520375207|FG000|Overall Study|Lost to Follow-up|0|||
144320706|NCT03515551|520375208|FG001|Overall Study|Lost to Follow-up|0|||
144320707|NCT03515551|520375209|FG002|Overall Study|Lost to Follow-up|1|||
144320708|NCT03515551|520375210|FG003|Overall Study|Lost to Follow-up|0|||
144320709|NCT03515551|520375211|FG004|Overall Study|Lost to Follow-up|0|||
144320710|NCT03515551|520375212|FG005|Overall Study|Lost to Follow-up|0|||
144320711|NCT03515551|520375213|FG006|Overall Study|Lost to Follow-up|0|||
144320712|NCT03515551|520375207|FG000|Overall Study|Withdrawal by Subject|0|||
144320713|NCT03515551|520375208|FG001|Overall Study|Withdrawal by Subject|1|||
144320714|NCT03515551|520375209|FG002|Overall Study|Withdrawal by Subject|0|||
144320715|NCT03515551|520375210|FG003|Overall Study|Withdrawal by Subject|0|||
144320716|NCT03515551|520375211|FG004|Overall Study|Withdrawal by Subject|0|||
144320717|NCT03515551|520375212|FG005|Overall Study|Withdrawal by Subject|0|||
144320718|NCT03515551|520375213|FG006|Overall Study|Withdrawal by Subject|1|||
144320719|NCT03515551|520375207|FG000|Overall Study|Study ended by sponsor|0|||
144320720|NCT03515551|520375208|FG001|Overall Study|Study ended by sponsor|0|||
144320721|NCT03515551|520375209|FG002|Overall Study|Study ended by sponsor|2|||
144320722|NCT03515551|520375210|FG003|Overall Study|Study ended by sponsor|1|||
144320723|NCT03515551|520375211|FG004|Overall Study|Study ended by sponsor|3|||
144320724|NCT03515551|520375212|FG005|Overall Study|Study ended by sponsor|0|||
144320725|NCT03515551|520375213|FG006|Overall Study|Study ended by sponsor|3|||
144320726|NCT03515551|520375207|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
144320727|NCT03515551|520375208|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
144320728|NCT03515551|520375209|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
144320729|NCT03515551|520375210|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
144320730|NCT03515551|520375211|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
144320731|NCT03515551|520375212|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
144320732|NCT03515551|520375213|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
144320733|NCT00920387|520375221|FG000|Stage 1|Adverse Event|1|||
144320734|NCT00920387|520375222|FG001|Stage 1|Adverse Event|0|||
144320735|NCT00920387|520375223|FG002|Stage 1|Adverse Event|0|||
144320736|NCT04113018|520375240|FG000|Overall Study|Death|2|||
144320737|NCT04113018|520375240|FG000|Overall Study|Lost to Follow-up|1|||
144320738|NCT04113018|520375240|FG000|Overall Study|Still On Study (on study treatment)|24|||
144320739|NCT04113018|520375240|FG000|Overall Study|Still On Study (in follow up)|12|||
144320740|NCT03802630|520375241|FG000|Overall Study|Study terminated by sponsor|130|||
144320741|NCT03802630|520375242|FG001|Overall Study|Study terminated by sponsor|134|||
144320742|NCT03802630|520375241|FG000|Overall Study|Subject decision|16|||
144320743|NCT03802630|520375242|FG001|Overall Study|Subject decision|9|||
144320744|NCT03802630|520375241|FG000|Overall Study|Adverse Event|3|||
144320745|NCT03802630|520375242|FG001|Overall Study|Adverse Event|1|||
144320746|NCT03802630|520375241|FG000|Overall Study|Lost to Follow-up|2|||
144320747|NCT03802630|520375242|FG001|Overall Study|Lost to Follow-up|2|||
144320748|NCT03802630|520375241|FG000|Overall Study|Physician Decision|2|||
144320749|NCT03802630|520375242|FG001|Overall Study|Physician Decision|0|||
144320750|NCT03802630|520375241|FG000|Overall Study|Death|0|||
144320751|NCT03802630|520375242|FG001|Overall Study|Death|2|||
144320752|NCT05005013|520375243|FG000|Overall Study|Withdrawal by Subject|5|||
144320753|NCT05005013|520375244|FG001|Overall Study|Withdrawal by Subject|1|||
144320754|NCT05005013|520375243|FG000|Overall Study|Lost to Follow-up|3|||
144320755|NCT05005013|520375244|FG001|Overall Study|Lost to Follow-up|1|||
144320756|NCT05005013|520375243|FG000|Overall Study|Ineligibility|1|||
144320757|NCT05005013|520375244|FG001|Overall Study|Ineligibility|1|||
144320758|NCT02059499|520375245|FG000|Upto Week 20|Lost to Follow-up|2|||
144320759|NCT02059499|520375246|FG001|Upto Week 20|Lost to Follow-up|6|||
144320760|NCT02059499|520375247|FG002|Upto Week 20|Lost to Follow-up|0|||
144320761|NCT02059499|520375245|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
144320762|NCT02059499|520375246|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
144320763|NCT02059499|520375247|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
144320764|NCT02059499|520375245|FG000|Upto Week 20|Withdrawal by Subject|1|||
144320765|NCT02059499|520375246|FG001|Upto Week 20|Withdrawal by Subject|1|||
144320766|NCT02059499|520375247|FG002|Upto Week 20|Withdrawal by Subject|0|||
144320767|NCT02059499|520375245|FG000|Upto Week 20|No treatment per protocol criteria|0|||
144320768|NCT02059499|520375246|FG001|Upto Week 20|No treatment per protocol criteria|0|||
144320769|NCT02059499|520375247|FG002|Upto Week 20|No treatment per protocol criteria|5|||
144320770|NCT02059499|520375245|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
144320771|NCT02059499|520375246|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
144320772|NCT02059499|520375247|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
144320773|NCT02059499|520375245|FG000|Post-week 20|Lost to Follow-up|0|||
144320774|NCT02059499|520375246|FG001|Post-week 20|Lost to Follow-up|2|||
144320775|NCT02059499|520375247|FG002|Post-week 20|Lost to Follow-up|0|||
144320776|NCT02059499|520375245|FG000|Post-week 20|Withdrawal by Subject|0|||
144320777|NCT02059499|520375246|FG001|Post-week 20|Withdrawal by Subject|1|||
144320778|NCT02059499|520375247|FG002|Post-week 20|Withdrawal by Subject|0|||
144320779|NCT02059499|520375245|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
144320780|NCT02059499|520375246|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
144320781|NCT02059499|520375247|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
144320782|NCT04210245|520375248|FG000|Overall Study|Adverse Event|0|||
144320783|NCT04210245|520375249|FG001|Overall Study|Adverse Event|3|||
144320784|NCT04210245|520375250|FG002|Overall Study|Adverse Event|6|||
144320785|NCT04210245|520375251|FG003|Overall Study|Adverse Event|0|||
144320786|NCT04210245|520375248|FG000|Overall Study|Withdrawal by Subject|0|||
144320787|NCT04210245|520375249|FG001|Overall Study|Withdrawal by Subject|1|||
144320788|NCT04210245|520375250|FG002|Overall Study|Withdrawal by Subject|4|||
144320789|NCT04210245|520375251|FG003|Overall Study|Withdrawal by Subject|4|||
144320790|NCT04210245|520375248|FG000|Overall Study|Lost to Follow-up|0|||
144320791|NCT04210245|520375249|FG001|Overall Study|Lost to Follow-up|1|||
144320792|NCT04210245|520375250|FG002|Overall Study|Lost to Follow-up|1|||
144320793|NCT04210245|520375251|FG003|Overall Study|Lost to Follow-up|1|||
144320794|NCT04210245|520375248|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
144320795|NCT04210245|520375249|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
144320796|NCT04210245|520375250|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
144320797|NCT04210245|520375251|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
144320798|NCT02248649|520375252|FG000|Overall Study|Death|7|||
144320799|NCT02248649|520375253|FG001|Overall Study|Death|11|||
144320800|NCT02248649|520375252|FG000|Overall Study|Lost to Follow-up|14|||
144320801|NCT02248649|520375253|FG001|Overall Study|Lost to Follow-up|10|||
144320802|NCT01221623|520375257|FG000|Overall Study|Withdrawal by Subject|19|||
144320803|NCT01221623|520375258|FG001|Overall Study|Withdrawal by Subject|8|||
144320804|NCT01221623|520375257|FG000|Overall Study|Lost to Follow-up|7|||
144320805|NCT01221623|520375258|FG001|Overall Study|Lost to Follow-up|1|||
144320806|NCT01221623|520375257|FG000|Overall Study|Adverse Event|6|||
144320807|NCT01221623|520375258|FG001|Overall Study|Adverse Event|3|||
144320808|NCT01221623|520375257|FG000|Overall Study|Death|1|||
144320809|NCT01221623|520375258|FG001|Overall Study|Death|0|||
144320810|NCT01221623|520375257|FG000|Overall Study|Other|5|||
144320811|NCT01221623|520375258|FG001|Overall Study|Other|2|||
144320812|NCT04091581|520375259|FG000|Overall Study|Lost to Follow-up|0|||
144320813|NCT04091581|520375260|FG001|Overall Study|Lost to Follow-up|1|||
144320814|NCT02438384|520375261|FG000|Overall Study|Lost to Follow-up|8|||
144320815|NCT02438384|520375262|FG001|Overall Study|Lost to Follow-up|6|||
144320816|NCT02438384|520375263|FG002|Overall Study|Lost to Follow-up|4|||
144320817|NCT03315793|520375264|FG000|Overall Study|Adverse Event|4|||
144320818|NCT03315793|520375265|FG001|Overall Study|Adverse Event|2|||
144320819|NCT03315793|520375264|FG000|Overall Study|Protocol Deviation|1|||
144320820|NCT03315793|520375265|FG001|Overall Study|Protocol Deviation|0|||
144320821|NCT03315793|520375264|FG000|Overall Study|Difficult for regular visit|0|||
144320822|NCT03315793|520375265|FG001|Overall Study|Difficult for regular visit|1|||
144320823|NCT03724981|520376633|FG000|First Device|Protocol Violation|1|||
144320824|NCT03724981|520376634|FG001|First Device|Protocol Violation|1|||
144320825|NCT00790868|520376635|FG000|Overall Study|Withdrawal by Subject|4|||
144320826|NCT00790868|520376636|FG001|Overall Study|Withdrawal by Subject|5|||
144320827|NCT00790868|520376635|FG000|Overall Study|Lost to Follow-up|2|||
144320828|NCT00790868|520376636|FG001|Overall Study|Lost to Follow-up|12|||
144320829|NCT02578680|520376639|FG000|Overall Study|Death|329|||
144320830|NCT02578680|520376640|FG001|Overall Study|Death|181|||
144320831|NCT02578680|520376639|FG000|Overall Study|Lost to Follow-up|3|||
144320832|NCT02578680|520376640|FG001|Overall Study|Lost to Follow-up|1|||
144320833|NCT02578680|520376639|FG000|Overall Study|Physician Decision|0|||
144320834|NCT02578680|520376640|FG001|Overall Study|Physician Decision|1|||
144320835|NCT02578680|520376639|FG000|Overall Study|Protocol Violation|1|||
144320836|NCT02578680|520376640|FG001|Overall Study|Protocol Violation|1|||
144320837|NCT02578680|520376639|FG000|Overall Study|Sponsor Decision|64|||
144320838|NCT02578680|520376640|FG001|Overall Study|Sponsor Decision|13|||
144320839|NCT02578680|520376639|FG000|Overall Study|Withdrawal by Subject|13|||
144320840|NCT02578680|520376640|FG001|Overall Study|Withdrawal by Subject|9|||
144320841|NCT00306293|520376642|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
144320842|NCT00306293|520376643|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
144320843|NCT00306293|520376642|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
144320844|NCT00306293|520376643|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
144320845|NCT00306293|520376642|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
144320846|NCT00306293|520376643|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
144320847|NCT00306293|520376642|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
144320848|NCT00306293|520376643|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
144320849|NCT00306293|520376642|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
144320850|NCT00306293|520376643|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
144320851|NCT00306293|520376642|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
144320852|NCT00306293|520376643|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
144320853|NCT00306293|520376642|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
144320854|NCT00306293|520376643|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
144320855|NCT00306293|520376642|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
144320856|NCT00306293|520376643|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
144320857|NCT02589665|520376646|FG000|Induction Period|Did not receive drug|0|||
144320858|NCT02589665|520376647|FG001|Induction Period|Did not receive drug|0|||
144320859|NCT02589665|520376648|FG002|Induction Period|Did not receive drug|0|||
144320860|NCT02589665|520376649|FG003|Induction Period|Did not receive drug|1|||
144320861|NCT02589665|520376650|FG004|Induction Period|Did not receive drug|0|||
144320862|NCT02589665|520376651|FG005|Induction Period|Did not receive drug|0|||
144320863|NCT02589665|520376652|FG006|Induction Period|Did not receive drug|0|||
144320864|NCT02589665|520376653|FG007|Induction Period|Did not receive drug|0|||
144320865|NCT02589665|520376654|FG008|Induction Period|Did not receive drug|0|||
144320866|NCT02589665|520376655|FG009|Induction Period|Did not receive drug|0|||
144320867|NCT02589665|520376646|FG000|Induction Period|Adverse Event|3|||
144320868|NCT02589665|520376647|FG001|Induction Period|Adverse Event|0|||
144320869|NCT02589665|520376648|FG002|Induction Period|Adverse Event|2|||
144320870|NCT02589665|520376649|FG003|Induction Period|Adverse Event|2|||
144320871|NCT02589665|520376650|FG004|Induction Period|Adverse Event|0|||
144320872|NCT02589665|520376651|FG005|Induction Period|Adverse Event|0|||
144320873|NCT02589665|520376652|FG006|Induction Period|Adverse Event|0|||
144320874|NCT02589665|520376653|FG007|Induction Period|Adverse Event|0|||
144320875|NCT02589665|520376654|FG008|Induction Period|Adverse Event|0|||
144320876|NCT02589665|520376655|FG009|Induction Period|Adverse Event|0|||
144320877|NCT02589665|520376646|FG000|Induction Period|Withdrawal by Subject|0|||
144320878|NCT02589665|520376647|FG001|Induction Period|Withdrawal by Subject|1|||
144320879|NCT02589665|520376648|FG002|Induction Period|Withdrawal by Subject|0|||
144320880|NCT02589665|520376649|FG003|Induction Period|Withdrawal by Subject|1|||
144320881|NCT02589665|520376650|FG004|Induction Period|Withdrawal by Subject|0|||
144320882|NCT02589665|520376651|FG005|Induction Period|Withdrawal by Subject|0|||
144320883|NCT02589665|520376652|FG006|Induction Period|Withdrawal by Subject|0|||
144320884|NCT02589665|520376653|FG007|Induction Period|Withdrawal by Subject|0|||
144320885|NCT02589665|520376654|FG008|Induction Period|Withdrawal by Subject|0|||
144320886|NCT02589665|520376655|FG009|Induction Period|Withdrawal by Subject|0|||
144320887|NCT02589665|520376646|FG000|Induction Period|Protocol Violation|0|||
144320888|NCT02589665|520376647|FG001|Induction Period|Protocol Violation|1|||
144320889|NCT02589665|520376648|FG002|Induction Period|Protocol Violation|0|||
144320890|NCT02589665|520376649|FG003|Induction Period|Protocol Violation|0|||
144320891|NCT02589665|520376650|FG004|Induction Period|Protocol Violation|0|||
144320892|NCT02589665|520376651|FG005|Induction Period|Protocol Violation|0|||
144320893|NCT02589665|520376652|FG006|Induction Period|Protocol Violation|0|||
144320894|NCT02589665|520376653|FG007|Induction Period|Protocol Violation|0|||
144320895|NCT02589665|520376654|FG008|Induction Period|Protocol Violation|0|||
144320896|NCT02589665|520376655|FG009|Induction Period|Protocol Violation|0|||
144320897|NCT02589665|520376646|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320898|NCT02589665|520376647|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320899|NCT02589665|520376648|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320900|NCT02589665|520376649|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320901|NCT02589665|520376650|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
144320902|NCT02589665|520376651|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
144320903|NCT02589665|520376652|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
144320904|NCT02589665|520376653|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320905|NCT02589665|520376654|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320906|NCT02589665|520376655|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144320907|NCT02589665|520376646|FG000|Maintenance Period|Withdrawal by Subject|0|||
144320908|NCT02589665|520376647|FG001|Maintenance Period|Withdrawal by Subject|0|||
144320909|NCT02589665|520376648|FG002|Maintenance Period|Withdrawal by Subject|0|||
144320910|NCT02589665|520376649|FG003|Maintenance Period|Withdrawal by Subject|0|||
144320911|NCT02589665|520376650|FG004|Maintenance Period|Withdrawal by Subject|4|||
144320912|NCT02589665|520376651|FG005|Maintenance Period|Withdrawal by Subject|2|||
144320913|NCT02589665|520376652|FG006|Maintenance Period|Withdrawal by Subject|4|||
144320914|NCT02589665|520376653|FG007|Maintenance Period|Withdrawal by Subject|0|||
144320915|NCT02589665|520376654|FG008|Maintenance Period|Withdrawal by Subject|0|||
144320916|NCT02589665|520376655|FG009|Maintenance Period|Withdrawal by Subject|0|||
144320917|NCT02589665|520376646|FG000|Maintenance Period|Lack of Efficacy|0|||
144320918|NCT02589665|520376647|FG001|Maintenance Period|Lack of Efficacy|0|||
144320919|NCT02589665|520376648|FG002|Maintenance Period|Lack of Efficacy|0|||
144320920|NCT02589665|520376649|FG003|Maintenance Period|Lack of Efficacy|0|||
144320921|NCT02589665|520376650|FG004|Maintenance Period|Lack of Efficacy|2|||
144320922|NCT02589665|520376651|FG005|Maintenance Period|Lack of Efficacy|1|||
144320923|NCT02589665|520376652|FG006|Maintenance Period|Lack of Efficacy|0|||
144320924|NCT02589665|520376653|FG007|Maintenance Period|Lack of Efficacy|0|||
144320925|NCT02589665|520376654|FG008|Maintenance Period|Lack of Efficacy|0|||
144320926|NCT02589665|520376655|FG009|Maintenance Period|Lack of Efficacy|0|||
144320927|NCT02589665|520376646|FG000|Maintenance Period|Adverse Event|0|||
144320928|NCT02589665|520376647|FG001|Maintenance Period|Adverse Event|0|||
144320929|NCT02589665|520376648|FG002|Maintenance Period|Adverse Event|0|||
144320930|NCT02589665|520376649|FG003|Maintenance Period|Adverse Event|0|||
144320931|NCT02589665|520376650|FG004|Maintenance Period|Adverse Event|0|||
144320932|NCT02589665|520376651|FG005|Maintenance Period|Adverse Event|0|||
144320933|NCT02589665|520376652|FG006|Maintenance Period|Adverse Event|2|||
144320934|NCT02589665|520376653|FG007|Maintenance Period|Adverse Event|0|||
144320935|NCT02589665|520376654|FG008|Maintenance Period|Adverse Event|0|||
144320936|NCT02589665|520376655|FG009|Maintenance Period|Adverse Event|0|||
144320937|NCT02589665|520376646|FG000|Maintenance Period|Lost to Follow-up|0|||
144320938|NCT02589665|520376647|FG001|Maintenance Period|Lost to Follow-up|0|||
144320939|NCT02589665|520376648|FG002|Maintenance Period|Lost to Follow-up|0|||
144320940|NCT02589665|520376649|FG003|Maintenance Period|Lost to Follow-up|0|||
144320941|NCT02589665|520376650|FG004|Maintenance Period|Lost to Follow-up|0|||
144320942|NCT02589665|520376651|FG005|Maintenance Period|Lost to Follow-up|1|||
144320943|NCT02589665|520376652|FG006|Maintenance Period|Lost to Follow-up|0|||
144320944|NCT02589665|520376653|FG007|Maintenance Period|Lost to Follow-up|0|||
144320945|NCT02589665|520376654|FG008|Maintenance Period|Lost to Follow-up|0|||
144320946|NCT02589665|520376655|FG009|Maintenance Period|Lost to Follow-up|0|||
144320947|NCT02589665|520376646|FG000|Maintenance Period|Physician Decision|0|||
144320948|NCT02589665|520376647|FG001|Maintenance Period|Physician Decision|0|||
144320949|NCT02589665|520376648|FG002|Maintenance Period|Physician Decision|0|||
144320950|NCT02589665|520376649|FG003|Maintenance Period|Physician Decision|0|||
144320951|NCT02589665|520376650|FG004|Maintenance Period|Physician Decision|0|||
144320952|NCT02589665|520376651|FG005|Maintenance Period|Physician Decision|1|||
144320953|NCT02589665|520376652|FG006|Maintenance Period|Physician Decision|0|||
144320954|NCT02589665|520376653|FG007|Maintenance Period|Physician Decision|0|||
144320955|NCT02589665|520376654|FG008|Maintenance Period|Physician Decision|0|||
144320956|NCT02589665|520376655|FG009|Maintenance Period|Physician Decision|0|||
144320957|NCT02589665|520376646|FG000|Maintenance Period|Reason Not Collected|0|||
144320958|NCT02589665|520376647|FG001|Maintenance Period|Reason Not Collected|0|||
144320959|NCT02589665|520376648|FG002|Maintenance Period|Reason Not Collected|0|||
144320960|NCT02589665|520376649|FG003|Maintenance Period|Reason Not Collected|0|||
144320961|NCT02589665|520376650|FG004|Maintenance Period|Reason Not Collected|0|||
144320962|NCT02589665|520376651|FG005|Maintenance Period|Reason Not Collected|1|||
144320963|NCT02589665|520376652|FG006|Maintenance Period|Reason Not Collected|1|||
144320964|NCT02589665|520376653|FG007|Maintenance Period|Reason Not Collected|0|||
144320965|NCT02589665|520376654|FG008|Maintenance Period|Reason Not Collected|0|||
144320966|NCT02589665|520376655|FG009|Maintenance Period|Reason Not Collected|0|||
144320967|NCT02589665|520376646|FG000|Induction Extension Period|Adverse Event|0|||
144320968|NCT02589665|520376647|FG001|Induction Extension Period|Adverse Event|0|||
144320969|NCT02589665|520376648|FG002|Induction Extension Period|Adverse Event|0|||
144320970|NCT02589665|520376649|FG003|Induction Extension Period|Adverse Event|0|||
144320971|NCT02589665|520376650|FG004|Induction Extension Period|Adverse Event|0|||
144320972|NCT02589665|520376651|FG005|Induction Extension Period|Adverse Event|0|||
144320973|NCT02589665|520376652|FG006|Induction Extension Period|Adverse Event|0|||
144320974|NCT02589665|520376653|FG007|Induction Extension Period|Adverse Event|0|||
144320975|NCT02589665|520376654|FG008|Induction Extension Period|Adverse Event|4|||
144320976|NCT02589665|520376655|FG009|Induction Extension Period|Adverse Event|0|||
144320977|NCT02589665|520376646|FG000|Induction Extension Period|Lack of Efficacy|0|||
144320978|NCT02589665|520376647|FG001|Induction Extension Period|Lack of Efficacy|0|||
144320979|NCT02589665|520376648|FG002|Induction Extension Period|Lack of Efficacy|0|||
144320980|NCT02589665|520376649|FG003|Induction Extension Period|Lack of Efficacy|0|||
144320981|NCT02589665|520376650|FG004|Induction Extension Period|Lack of Efficacy|0|||
144320982|NCT02589665|520376651|FG005|Induction Extension Period|Lack of Efficacy|0|||
144320983|NCT02589665|520376652|FG006|Induction Extension Period|Lack of Efficacy|0|||
144320984|NCT02589665|520376653|FG007|Induction Extension Period|Lack of Efficacy|0|||
144320985|NCT02589665|520376654|FG008|Induction Extension Period|Lack of Efficacy|3|||
144320986|NCT02589665|520376655|FG009|Induction Extension Period|Lack of Efficacy|0|||
144320987|NCT02589665|520376646|FG000|Induction Extension Period|Withdrawal by Subject|0|||
144320988|NCT02589665|520376647|FG001|Induction Extension Period|Withdrawal by Subject|0|||
144320989|NCT02589665|520376648|FG002|Induction Extension Period|Withdrawal by Subject|0|||
144320990|NCT02589665|520376649|FG003|Induction Extension Period|Withdrawal by Subject|0|||
144320991|NCT02589665|520376650|FG004|Induction Extension Period|Withdrawal by Subject|0|||
144320992|NCT02589665|520376651|FG005|Induction Extension Period|Withdrawal by Subject|0|||
144320993|NCT02589665|520376652|FG006|Induction Extension Period|Withdrawal by Subject|0|||
144320994|NCT02589665|520376653|FG007|Induction Extension Period|Withdrawal by Subject|2|||
144320995|NCT02589665|520376654|FG008|Induction Extension Period|Withdrawal by Subject|3|||
144320996|NCT02589665|520376655|FG009|Induction Extension Period|Withdrawal by Subject|0|||
144320997|NCT02589665|520376646|FG000|Induction Extension Period|Physician Decision|0|||
144320998|NCT02589665|520376647|FG001|Induction Extension Period|Physician Decision|0|||
144320999|NCT02589665|520376648|FG002|Induction Extension Period|Physician Decision|0|||
144321000|NCT02589665|520376649|FG003|Induction Extension Period|Physician Decision|0|||
144321001|NCT02589665|520376650|FG004|Induction Extension Period|Physician Decision|0|||
144321002|NCT02589665|520376651|FG005|Induction Extension Period|Physician Decision|0|||
144321003|NCT02589665|520376652|FG006|Induction Extension Period|Physician Decision|0|||
144321004|NCT02589665|520376653|FG007|Induction Extension Period|Physician Decision|0|||
144321005|NCT02589665|520376654|FG008|Induction Extension Period|Physician Decision|1|||
144321006|NCT02589665|520376655|FG009|Induction Extension Period|Physician Decision|0|||
144321007|NCT02589665|520376646|FG000|Induction Extension Period|Reason Not Collected|0|||
144321008|NCT02589665|520376647|FG001|Induction Extension Period|Reason Not Collected|0|||
144321009|NCT02589665|520376648|FG002|Induction Extension Period|Reason Not Collected|0|||
144321010|NCT02589665|520376649|FG003|Induction Extension Period|Reason Not Collected|0|||
144321011|NCT02589665|520376650|FG004|Induction Extension Period|Reason Not Collected|0|||
144321012|NCT02589665|520376651|FG005|Induction Extension Period|Reason Not Collected|0|||
144321013|NCT02589665|520376652|FG006|Induction Extension Period|Reason Not Collected|0|||
144321014|NCT02589665|520376653|FG007|Induction Extension Period|Reason Not Collected|0|||
144321015|NCT02589665|520376654|FG008|Induction Extension Period|Reason Not Collected|1|||
144321016|NCT02589665|520376655|FG009|Induction Extension Period|Reason Not Collected|0|||
144321017|NCT02589665|520376646|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321018|NCT02589665|520376647|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321019|NCT02589665|520376648|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321020|NCT02589665|520376649|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321021|NCT02589665|520376650|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321022|NCT02589665|520376651|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321023|NCT02589665|520376652|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321024|NCT02589665|520376653|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321025|NCT02589665|520376654|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
144321026|NCT02589665|520376655|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
144321027|NCT02589665|520376646|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
144321028|NCT02589665|520376647|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
144321029|NCT02589665|520376648|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
144321030|NCT02589665|520376649|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
144321031|NCT02589665|520376650|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
144321032|NCT02589665|520376651|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
144321033|NCT02589665|520376652|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
144321034|NCT02589665|520376653|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
144321035|NCT02589665|520376654|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
144321036|NCT02589665|520376655|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
144321037|NCT02589665|520376646|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
144321038|NCT02589665|520376647|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
144321039|NCT02589665|520376648|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
144321040|NCT02589665|520376649|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
144321041|NCT02589665|520376650|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
144321042|NCT02589665|520376651|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
144321043|NCT02589665|520376652|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
144321044|NCT02589665|520376653|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
144321045|NCT02589665|520376654|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
144321046|NCT02589665|520376655|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
144321047|NCT02589665|520376646|FG000|Maintenance Extension Period|Adverse Event|0|||
144321048|NCT02589665|520376647|FG001|Maintenance Extension Period|Adverse Event|0|||
144321049|NCT02589665|520376648|FG002|Maintenance Extension Period|Adverse Event|0|||
144321050|NCT02589665|520376649|FG003|Maintenance Extension Period|Adverse Event|0|||
144321051|NCT02589665|520376650|FG004|Maintenance Extension Period|Adverse Event|0|||
144321052|NCT02589665|520376651|FG005|Maintenance Extension Period|Adverse Event|0|||
144321053|NCT02589665|520376652|FG006|Maintenance Extension Period|Adverse Event|0|||
144321054|NCT02589665|520376653|FG007|Maintenance Extension Period|Adverse Event|0|||
144321055|NCT02589665|520376654|FG008|Maintenance Extension Period|Adverse Event|0|||
144321056|NCT02589665|520376655|FG009|Maintenance Extension Period|Adverse Event|2|||
144321057|NCT02589665|520376646|FG000|Maintenance Extension Period|Non-responder|0|||
144321058|NCT02589665|520376647|FG001|Maintenance Extension Period|Non-responder|0|||
144321059|NCT02589665|520376648|FG002|Maintenance Extension Period|Non-responder|0|||
144321060|NCT02589665|520376649|FG003|Maintenance Extension Period|Non-responder|0|||
144321061|NCT02589665|520376650|FG004|Maintenance Extension Period|Non-responder|0|||
144321062|NCT02589665|520376651|FG005|Maintenance Extension Period|Non-responder|0|||
144321063|NCT02589665|520376652|FG006|Maintenance Extension Period|Non-responder|0|||
144321064|NCT02589665|520376653|FG007|Maintenance Extension Period|Non-responder|0|||
144321065|NCT02589665|520376654|FG008|Maintenance Extension Period|Non-responder|0|||
144321066|NCT02589665|520376655|FG009|Maintenance Extension Period|Non-responder|1|||
144321067|NCT00978380|520376656|FG000|Overall Study|Protocol Violation|2|||
144321068|NCT00978380|520376656|FG000|Overall Study|Withdrawal criteria|9|||
144321069|NCT00978380|520376656|FG000|Overall Study|Unclassified|8|||
144321070|NCT02199314|520376657|FG000|Overall Study|Withdrawal by Subject|6|||
144321071|NCT02199314|520376657|FG000|Overall Study|Physician Decision|10|||
144321072|NCT02650804|520376658|FG000|Overall Study|Adverse Event|3|||
144321073|NCT02650804|520376659|FG001|Overall Study|Adverse Event|2|||
144321074|NCT02650804|520376658|FG000|Overall Study|Death|1|||
144321075|NCT02650804|520376659|FG001|Overall Study|Death|2|||
144321076|NCT02650804|520376658|FG000|Overall Study|Progressive Disease|7|||
144321077|NCT02650804|520376659|FG001|Overall Study|Progressive Disease|10|||
144321078|NCT02650804|520376658|FG000|Overall Study|Physician Decision|0|||
144321079|NCT02650804|520376659|FG001|Overall Study|Physician Decision|2|||
144321080|NCT02650804|520376658|FG000|Overall Study|Withdrawal by Subject|1|||
144321081|NCT02650804|520376659|FG001|Overall Study|Withdrawal by Subject|4|||
144321082|NCT02650804|520376658|FG000|Overall Study|Symptomatic deterioration|5|||
144321083|NCT02650804|520376659|FG001|Overall Study|Symptomatic deterioration|7|||
144321084|NCT02650804|520376658|FG000|Overall Study|Protocol Violation|0|||
144321085|NCT02650804|520376659|FG001|Overall Study|Protocol Violation|1|||
144321086|NCT01159171|520376660|FG000|Overall Study|Adverse Event|11|||
144321087|NCT01159171|520376660|FG000|Overall Study|Progression of Disease|28|||
144321088|NCT01159171|520376660|FG000|Overall Study|Protocol Violation|1|||
144321089|NCT01159171|520376660|FG000|Overall Study|Need for Surgery|5|||
144321090|NCT01159171|520376660|FG000|Overall Study|Medical Decision|4|||
144321091|NCT01159171|520376660|FG000|Overall Study|Death|1|||
144321092|NCT01892436|520376663|FG000|Overall Study|Withdrawal by Subject|8|||
144321093|NCT01892436|520376664|FG001|Overall Study|Withdrawal by Subject|15|||
144321094|NCT01892436|520376665|FG002|Overall Study|Withdrawal by Subject|4|||
144321095|NCT01892436|520376666|FG003|Overall Study|Withdrawal by Subject|4|||
144321096|NCT01892436|520376663|FG000|Overall Study|Death|1|||
144321097|NCT01892436|520376664|FG001|Overall Study|Death|1|||
144321098|NCT01892436|520376665|FG002|Overall Study|Death|0|||
144321099|NCT01892436|520376666|FG003|Overall Study|Death|0|||
144321100|NCT01892436|520376663|FG000|Overall Study|Physician Decision|2|||
144321101|NCT01892436|520376664|FG001|Overall Study|Physician Decision|1|||
144321102|NCT01892436|520376665|FG002|Overall Study|Physician Decision|0|||
144321103|NCT01892436|520376666|FG003|Overall Study|Physician Decision|1|||
144321104|NCT01892436|520376663|FG000|Overall Study|Pregnancy|0|||
144321105|NCT01892436|520376664|FG001|Overall Study|Pregnancy|2|||
144321106|NCT01892436|520376665|FG002|Overall Study|Pregnancy|1|||
144321107|NCT01892436|520376666|FG003|Overall Study|Pregnancy|0|||
144321108|NCT01892436|520376663|FG000|Overall Study|Technical problems|2|||
144321109|NCT01892436|520376664|FG001|Overall Study|Technical problems|1|||
144321110|NCT01892436|520376665|FG002|Overall Study|Technical problems|1|||
144321111|NCT01892436|520376666|FG003|Overall Study|Technical problems|1|||
144321112|NCT01892436|520376663|FG000|Overall Study|Lack of Efficacy|1|||
144321113|NCT01892436|520376664|FG001|Overall Study|Lack of Efficacy|2|||
144321114|NCT01892436|520376665|FG002|Overall Study|Lack of Efficacy|2|||
144321115|NCT01892436|520376666|FG003|Overall Study|Lack of Efficacy|2|||
144321116|NCT01892436|520376663|FG000|Overall Study|Lost to Follow-up|1|||
144321117|NCT01892436|520376664|FG001|Overall Study|Lost to Follow-up|1|||
144321118|NCT01892436|520376665|FG002|Overall Study|Lost to Follow-up|1|||
144321119|NCT01892436|520376666|FG003|Overall Study|Lost to Follow-up|3|||
144321120|NCT01892436|520376663|FG000|Overall Study|non-compliance with treatment|1|||
144321121|NCT01892436|520376664|FG001|Overall Study|non-compliance with treatment|0|||
144321122|NCT01892436|520376665|FG002|Overall Study|non-compliance with treatment|0|||
144321123|NCT01892436|520376666|FG003|Overall Study|non-compliance with treatment|0|||
144321124|NCT01892436|520376663|FG000|Overall Study|Adverse Event|7|||
144321125|NCT01892436|520376664|FG001|Overall Study|Adverse Event|6|||
144321126|NCT01892436|520376665|FG002|Overall Study|Adverse Event|2|||
144321127|NCT01892436|520376666|FG003|Overall Study|Adverse Event|3|||
144321128|NCT02526524|520376673|FG000|Overall Study|Withdrawal by Subject|3|||
144321129|NCT02526524|520376674|FG001|Overall Study|Withdrawal by Subject|3|||
144321130|NCT02526524|520376675|FG002|Overall Study|Withdrawal by Subject|6|||
144321131|NCT02526524|520376676|FG003|Overall Study|Withdrawal by Subject|1|||
144321132|NCT02526524|520376677|FG004|Overall Study|Withdrawal by Subject|9|||
144321133|NCT02526524|520376678|FG005|Overall Study|Withdrawal by Subject|5|||
144321134|NCT02526524|520376673|FG000|Overall Study|Adverse Event|3|||
144321135|NCT02526524|520376674|FG001|Overall Study|Adverse Event|2|||
144321136|NCT02526524|520376675|FG002|Overall Study|Adverse Event|4|||
144321137|NCT02526524|520376676|FG003|Overall Study|Adverse Event|2|||
144321138|NCT02526524|520376677|FG004|Overall Study|Adverse Event|6|||
144321139|NCT02526524|520376678|FG005|Overall Study|Adverse Event|8|||
144321140|NCT02526524|520376673|FG000|Overall Study|Lost to Follow-up|2|||
144321141|NCT02526524|520376674|FG001|Overall Study|Lost to Follow-up|3|||
144321142|NCT02526524|520376675|FG002|Overall Study|Lost to Follow-up|8|||
144321143|NCT02526524|520376676|FG003|Overall Study|Lost to Follow-up|1|||
144321144|NCT02526524|520376677|FG004|Overall Study|Lost to Follow-up|2|||
144321145|NCT02526524|520376678|FG005|Overall Study|Lost to Follow-up|5|||
144321146|NCT02526524|520376673|FG000|Overall Study|Protocol Violation|3|||
144321147|NCT02526524|520376674|FG001|Overall Study|Protocol Violation|1|||
144321148|NCT02526524|520376675|FG002|Overall Study|Protocol Violation|5|||
144321149|NCT02526524|520376676|FG003|Overall Study|Protocol Violation|3|||
144321150|NCT02526524|520376677|FG004|Overall Study|Protocol Violation|4|||
144321151|NCT02526524|520376678|FG005|Overall Study|Protocol Violation|3|||
144321152|NCT02526524|520376673|FG000|Overall Study|Loss of Glucose Control|0|||
144321153|NCT02526524|520376674|FG001|Overall Study|Loss of Glucose Control|0|||
144321154|NCT02526524|520376675|FG002|Overall Study|Loss of Glucose Control|3|||
144321155|NCT02526524|520376676|FG003|Overall Study|Loss of Glucose Control|0|||
144321156|NCT02526524|520376677|FG004|Overall Study|Loss of Glucose Control|2|||
144321157|NCT02526524|520376678|FG005|Overall Study|Loss of Glucose Control|0|||
144321158|NCT02526524|520376673|FG000|Overall Study|Physician Decision|0|||
144321159|NCT02526524|520376674|FG001|Overall Study|Physician Decision|0|||
144321160|NCT02526524|520376675|FG002|Overall Study|Physician Decision|0|||
144321161|NCT02526524|520376676|FG003|Overall Study|Physician Decision|0|||
144321162|NCT02526524|520376677|FG004|Overall Study|Physician Decision|1|||
144321163|NCT02526524|520376678|FG005|Overall Study|Physician Decision|0|||
144321164|NCT02526524|520376673|FG000|Overall Study|Sponsor Decision|1|||
144321165|NCT02526524|520376674|FG001|Overall Study|Sponsor Decision|0|||
144321166|NCT02526524|520376675|FG002|Overall Study|Sponsor Decision|0|||
144321167|NCT02526524|520376676|FG003|Overall Study|Sponsor Decision|0|||
144321168|NCT02526524|520376677|FG004|Overall Study|Sponsor Decision|0|||
144321169|NCT02526524|520376678|FG005|Overall Study|Sponsor Decision|0|||
144321170|NCT00470093|520376680|FG000|Overall Study|Adverse Event|2|||
144321171|NCT00664560|520376681|FG000|Overall Study|Adverse Event|19|||
144321172|NCT00664560|520376682|FG001|Overall Study|Adverse Event|16|||
144321173|NCT00664560|520376683|FG002|Overall Study|Adverse Event|7|||
144321174|NCT00664560|520376681|FG000|Overall Study|Withdrawal by Subject|9|||
144321175|NCT00664560|520376682|FG001|Overall Study|Withdrawal by Subject|13|||
144321176|NCT00664560|520376683|FG002|Overall Study|Withdrawal by Subject|7|||
144321177|NCT00664560|520376681|FG000|Overall Study|Lost to Follow-up|0|||
144321178|NCT00664560|520376682|FG001|Overall Study|Lost to Follow-up|2|||
144321179|NCT00664560|520376683|FG002|Overall Study|Lost to Follow-up|0|||
144321180|NCT00664560|520376681|FG000|Overall Study|Other|11|||
144321181|NCT00664560|520376682|FG001|Overall Study|Other|4|||
144321182|NCT00664560|520376683|FG002|Overall Study|Other|5|||
144321183|NCT01610557|520376686|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
144321184|NCT01610557|520376687|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
144321185|NCT01610557|520376688|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
144321186|NCT01610557|520376689|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
144321187|NCT01610557|520376690|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
144321188|NCT01610557|520376686|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
144321189|NCT01610557|520376687|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
144321190|NCT01610557|520376688|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
144321191|NCT01610557|520376689|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
144321192|NCT01610557|520376690|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
144321193|NCT00473668|520376691|FG000|Overall Study|Withdrawal by Subject|0|||
144321194|NCT00473668|520376692|FG001|Overall Study|Withdrawal by Subject|2|||
144321195|NCT00473668|520376693|FG002|Overall Study|Withdrawal by Subject|0|||
144321196|NCT00473668|520376691|FG000|Overall Study|Migrated/moved from study area|3|||
144321197|NCT00473668|520376692|FG001|Overall Study|Migrated/moved from study area|2|||
144321198|NCT00473668|520376693|FG002|Overall Study|Migrated/moved from study area|0|||
144321199|NCT00473668|520376691|FG000|Overall Study|Lost to Follow-up|0|||
144321200|NCT00473668|520376692|FG001|Overall Study|Lost to Follow-up|4|||
144321201|NCT00473668|520376693|FG002|Overall Study|Lost to Follow-up|6|||
144321202|NCT00473668|520376691|FG000|Overall Study|Other|2|||
144321203|NCT00473668|520376692|FG001|Overall Study|Other|3|||
144321204|NCT00473668|520376693|FG002|Overall Study|Other|4|||
144321205|NCT02039219|520376694|FG000|Treatment|Withdrawal by Subject|1|||
144321206|NCT02039219|520376695|FG001|Treatment|Withdrawal by Subject|0|||
144321207|NCT02039219|520376694|FG000|Treatment|Adverse Event|0|||
144321208|NCT02039219|520376695|FG001|Treatment|Adverse Event|1|||
144321209|NCT02039219|520376694|FG000|Treatment|Physician Decision|1|||
144321210|NCT02039219|520376695|FG001|Treatment|Physician Decision|0|||
144321211|NCT02039219|520376694|FG000|Treatment|Lost to Follow-up|0|||
144321212|NCT02039219|520376695|FG001|Treatment|Lost to Follow-up|1|||
144321213|NCT02039219|520376694|FG000|Treatment|Protocol Violation|1|||
144321214|NCT02039219|520376695|FG001|Treatment|Protocol Violation|0|||
144321215|NCT02039219|520376694|FG000|Treatment|Death|1|||
144321216|NCT02039219|520376695|FG001|Treatment|Death|0|||
144321217|NCT02039219|520376694|FG000|Follow up|Adverse Event|0|||
144321218|NCT02039219|520376695|FG001|Follow up|Adverse Event|1|||
144321219|NCT04569136|520376696|FG000|Overall Study|Lost to Follow-up|2|||
144321220|NCT04569136|520376697|FG001|Overall Study|Lost to Follow-up|0|||
144321221|NCT04569136|520376698|FG002|Overall Study|Lost to Follow-up|1|||
144321222|NCT00129701|520376700|FG000|Overall Study|Withdrawal by Subject|33|||
144321223|NCT01466660|520376701|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
144321224|NCT01466660|520376702|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
144321225|NCT01466660|520376701|FG000|Overall Study|Worsening of underlying cancer disease|5|||
144321226|NCT01466660|520376702|FG001|Overall Study|Worsening of underlying cancer disease|2|||
144321227|NCT01466660|520376701|FG000|Overall Study|Other adverse event|19|||
144321228|NCT01466660|520376702|FG001|Overall Study|Other adverse event|18|||
144321229|NCT01466660|520376701|FG000|Overall Study|Protocol Violation|2|||
144321230|NCT01466660|520376702|FG001|Overall Study|Protocol Violation|1|||
144321231|NCT01466660|520376701|FG000|Overall Study|Refused continuation of trial medication|4|||
144321232|NCT01466660|520376702|FG001|Overall Study|Refused continuation of trial medication|3|||
144321233|NCT01466660|520376701|FG000|Overall Study|Other reason not defined above|10|||
144321234|NCT01466660|520376702|FG001|Overall Study|Other reason not defined above|8|||
144321235|NCT02750345|520376703|FG000|Intervention 1|Adverse Event|0|||
144321236|NCT02750345|520376704|FG001|Intervention 1|Adverse Event|0|||
144321237|NCT02750345|520376705|FG002|Intervention 1|Adverse Event|0|||
144321238|NCT02750345|520376706|FG003|Intervention 1|Adverse Event|0|||
144321239|NCT02750345|520376707|FG004|Intervention 1|Adverse Event|1|||
144321240|NCT02750345|520376708|FG005|Intervention 1|Adverse Event|0|||
144321241|NCT00006164|520376709|FG000|Overall Study|Withdrew or lost to follow-up|70|||
144321242|NCT00006164|520376710|FG001|Overall Study|Withdrew or lost to follow-up|81|||
144321243|NCT00223808|520376711|FG000|Overall Study|<5 hrs therapy before discharge|3|||
144321244|NCT00223808|520376712|FG001|Overall Study|<5 hrs therapy before discharge|5|||
144321245|NCT00223808|520376713|FG002|Overall Study|<5 hrs therapy before discharge|5|||
144321246|NCT00365105|520376714|FG000|Overall Study|Protocol Violation|5|||
144321247|NCT00365105|520376715|FG001|Overall Study|Protocol Violation|8|||
144321248|NCT00191724|520376718|FG000|Overall Study|Adverse Event|0|||
144321249|NCT00191724|520376719|FG001|Overall Study|Adverse Event|0|||
144321250|NCT00191724|520376720|FG002|Overall Study|Adverse Event|1|||
144321251|NCT00191724|520376721|FG003|Overall Study|Adverse Event|0|||
144321252|NCT00191724|520376722|FG004|Overall Study|Adverse Event|0|||
144321253|NCT00191724|520376718|FG000|Overall Study|Lost to Follow-up|1|||
144321254|NCT00191724|520376719|FG001|Overall Study|Lost to Follow-up|1|||
144321255|NCT00191724|520376720|FG002|Overall Study|Lost to Follow-up|0|||
144321256|NCT00191724|520376721|FG003|Overall Study|Lost to Follow-up|2|||
144321257|NCT00191724|520376722|FG004|Overall Study|Lost to Follow-up|3|||
144321258|NCT00191724|520376718|FG000|Overall Study|Withdrawal by Subject|0|||
144321259|NCT00191724|520376719|FG001|Overall Study|Withdrawal by Subject|0|||
144321260|NCT00191724|520376720|FG002|Overall Study|Withdrawal by Subject|0|||
144321261|NCT00191724|520376721|FG003|Overall Study|Withdrawal by Subject|1|||
144321262|NCT00191724|520376722|FG004|Overall Study|Withdrawal by Subject|0|||
144321263|NCT00608023|520376723|FG000|Overall Study|Withdrawal by Subject|8|||
144321264|NCT00608023|520376724|FG001|Overall Study|Withdrawal by Subject|10|||
144321265|NCT00608023|520376725|FG002|Overall Study|Withdrawal by Subject|7|||
144321266|NCT00608023|520376723|FG000|Overall Study|Adverse Event|1|||
144321267|NCT00608023|520376724|FG001|Overall Study|Adverse Event|4|||
144321268|NCT00608023|520376725|FG002|Overall Study|Adverse Event|5|||
144321269|NCT00608023|520376723|FG000|Overall Study|Lost to Follow-up|2|||
144321270|NCT00608023|520376724|FG001|Overall Study|Lost to Follow-up|2|||
144321271|NCT00608023|520376725|FG002|Overall Study|Lost to Follow-up|1|||
144321272|NCT00608023|520376723|FG000|Overall Study|Protocol Violation|1|||
144321273|NCT00608023|520376724|FG001|Overall Study|Protocol Violation|3|||
144321274|NCT00608023|520376725|FG002|Overall Study|Protocol Violation|1|||
144321275|NCT00608023|520376723|FG000|Overall Study|Unknown reason|0|||
144321276|NCT00608023|520376724|FG001|Overall Study|Unknown reason|3|||
144321277|NCT00608023|520376725|FG002|Overall Study|Unknown reason|0|||
144321278|NCT05260073|520376726|FG000|Overall Study|Physician Decision|1|||
144321279|NCT05260073|520376726|FG000|Overall Study|Withdrawal by Subject|6|||
144321280|NCT05260073|520376726|FG000|Overall Study|Lost to Follow-up|14|||
144321281|NCT03458910|520376727|FG000|Overall Study|Withdrawal by Subject|7|||
144321282|NCT03458910|520376728|FG001|Overall Study|Withdrawal by Subject|8|||
144321283|NCT03458910|520376729|FG002|Overall Study|Withdrawal by Subject|6|||
144321284|NCT03458910|520376730|FG003|Overall Study|Withdrawal by Subject|4|||
144321285|NCT03458910|520376727|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
144321286|NCT03458910|520376728|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
144321287|NCT03458910|520376729|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
144321288|NCT03458910|520376730|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
144321289|NCT03931382|520376742|FG000|Overall Study|Equipment malfunction|2|||
144321290|NCT03931382|520376743|FG001|Overall Study|Equipment malfunction|0|||
144321291|NCT03931382|520376744|FG002|Overall Study|Equipment malfunction|2|||
144321292|NCT03931382|520376742|FG000|Overall Study|Withdrawal by Subject|0|||
144321293|NCT03931382|520376743|FG001|Overall Study|Withdrawal by Subject|1|||
144321294|NCT03931382|520376744|FG002|Overall Study|Withdrawal by Subject|0|||
144321295|NCT01054560|520376747|FG000|Overall Study|Death|10|||
144321296|NCT01054560|520376748|FG001|Overall Study|Death|21|||
144321297|NCT01054560|520376747|FG000|Overall Study|Lost to Follow-up|2|||
144321298|NCT01054560|520376748|FG001|Overall Study|Lost to Follow-up|5|||
144321299|NCT01054560|520376747|FG000|Overall Study|Withdrawal by Subject|0|||
144321300|NCT01054560|520376748|FG001|Overall Study|Withdrawal by Subject|2|||
144321301|NCT01054560|520376747|FG000|Overall Study|Physician Decision|1|||
144321302|NCT01054560|520376748|FG001|Overall Study|Physician Decision|0|||
144321303|NCT03703817|520376753|FG000|Overall Study|Not meeting eligibility criteria|7|||
144321304|NCT03703817|520376754|FG001|Overall Study|Not meeting eligibility criteria|4|||
144321305|NCT05129449|520376755|FG000|Overall Study|Protocol Violation|1|||
144321306|NCT00616018|520376762|FG000|Overall Study|Protocol Violation|3|||
144321307|NCT03718884|520376763|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
144321308|NCT03718884|520376764|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
144321309|NCT03718884|520376763|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
144321310|NCT03718884|520376764|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
144321311|NCT02839720|520376765|FG000|Overall Study|Adverse Event|2|||
144321312|NCT02839720|520376765|FG000|Overall Study|Non-compliance|2|||
144321313|NCT02839720|520376765|FG000|Overall Study|Intercurrent Illness|1|||
144321314|NCT02839720|520376765|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
144321315|NCT06099223|520376766|FG000|Overall Study|Preoperative surveys missed|0|||
144321316|NCT06099223|520376767|FG001|Overall Study|Preoperative surveys missed|1|||
144321317|NCT04621240|520376773|FG000|Overall Study|Withdrawal by Subject|36|||
144321318|NCT00661726|520376775|FG000|Overall Study|Adverse Event|1|||
144321319|NCT02644096|520376776|FG000|Overall Study|Withdrawal by Subject|28|||
144321320|NCT02644096|520376777|FG001|Overall Study|Withdrawal by Subject|25|||
144321321|NCT00322452|520376778|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
144321322|NCT00322452|520376779|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144321323|NCT00322452|520376778|FG000|Overall Study|Lost to Follow-up|5|||
144321324|NCT00322452|520376779|FG001|Overall Study|Lost to Follow-up|2|||
144321325|NCT00322452|520376778|FG000|Overall Study|Withdrawal by Subject|19|||
144321326|NCT00322452|520376779|FG001|Overall Study|Withdrawal by Subject|46|||
144321327|NCT00322452|520376778|FG000|Overall Study|Death|223|||
144321328|NCT00322452|520376779|FG001|Overall Study|Death|227|||
144321329|NCT00526656|520376780|FG000|Overall Study|Death|1|||
144321330|NCT00526656|520376780|FG000|Overall Study|Refused surgery|1|||
144321331|NCT03319953|520376781|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
144321332|NCT03319953|520376782|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
144321333|NCT03319953|520376783|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
144321334|NCT03319953|520376784|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
144321335|NCT03319953|520376781|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
144321336|NCT03319953|520376782|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
144321337|NCT03319953|520376783|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
144321338|NCT03319953|520376784|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
144321339|NCT01795495|520376786|FG000|Overall Study|Protocol Violation|1|||
144321340|NCT01795495|520376787|FG001|Overall Study|Protocol Violation|0|||
144321341|NCT01795495|520376788|FG002|Overall Study|Protocol Violation|1|||
144321342|NCT01795495|520376786|FG000|Overall Study|Physician Decision|0|||
144321343|NCT01795495|520376787|FG001|Overall Study|Physician Decision|0|||
144321344|NCT01795495|520376788|FG002|Overall Study|Physician Decision|1|||
144321345|NCT02650128|520376789|FG000|Overall Study|Death|2|||
144321346|NCT01579565|520378181|FG000|Randomized|Adverse Event|1|||
144321347|NCT01579565|520378182|FG001|Randomized|Adverse Event|3|||
144321348|NCT01579565|520378181|FG000|Randomized|Withdrawal by Subject|3|||
144321349|NCT01579565|520378182|FG001|Randomized|Withdrawal by Subject|0|||
144321350|NCT01579565|520378181|FG000|Randomized|inadequate preoperative pupil dilation|0|||
144321351|NCT01579565|520378182|FG001|Randomized|inadequate preoperative pupil dilation|1|||
144321352|NCT01579565|520378181|FG000|Randomized|prohibited preoperative eating|1|||
144321353|NCT01579565|520378182|FG001|Randomized|prohibited preoperative eating|0|||
144321354|NCT01579565|520378181|FG000|Randomized|prohibited preoperative medication|0|||
144321355|NCT01579565|520378182|FG001|Randomized|prohibited preoperative medication|1|||
144321356|NCT01579565|520378181|FG000|Treated|Physician Decision|0|||
144321357|NCT01579565|520378182|FG001|Treated|Physician Decision|1|||
144321358|NCT01579565|520378181|FG000|Treated|Lost to Follow-up|2|||
144321359|NCT01579565|520378182|FG001|Treated|Lost to Follow-up|1|||
144321360|NCT01579565|520378181|FG000|Treated|declined to return for final visit|0|||
144321361|NCT01579565|520378182|FG001|Treated|declined to return for final visit|1|||
144321362|NCT02791191|520378185|FG000|Overall Study|Adverse Event|2|||
144321363|NCT02791191|520378186|FG001|Overall Study|Adverse Event|4|||
144321364|NCT02791191|520378187|FG002|Overall Study|Adverse Event|5|||
144321365|NCT02791191|520378185|FG000|Overall Study|Lack of Efficacy|0|||
144321366|NCT02791191|520378186|FG001|Overall Study|Lack of Efficacy|1|||
144321367|NCT02791191|520378187|FG002|Overall Study|Lack of Efficacy|0|||
144321368|NCT02791191|520378185|FG000|Overall Study|Study Drug Non-Compliance|0|||
144321369|NCT02791191|520378186|FG001|Overall Study|Study Drug Non-Compliance|2|||
144321370|NCT02791191|520378187|FG002|Overall Study|Study Drug Non-Compliance|0|||
144321371|NCT02791191|520378185|FG000|Overall Study|Site Closed by Sponsor|1|||
144321372|NCT02791191|520378186|FG001|Overall Study|Site Closed by Sponsor|1|||
144321373|NCT02791191|520378187|FG002|Overall Study|Site Closed by Sponsor|3|||
144321374|NCT02791191|520378185|FG000|Overall Study|Progressive Disease|1|||
144321375|NCT02791191|520378186|FG001|Overall Study|Progressive Disease|0|||
144321376|NCT02791191|520378187|FG002|Overall Study|Progressive Disease|0|||
144321377|NCT02791191|520378185|FG000|Overall Study|Study Terminated by Sponsor|29|||
144321378|NCT02791191|520378186|FG001|Overall Study|Study Terminated by Sponsor|101|||
144321379|NCT02791191|520378187|FG002|Overall Study|Study Terminated by Sponsor|109|||
144321380|NCT02791191|520378185|FG000|Overall Study|Withdrawal by Subject|3|||
144321381|NCT02791191|520378186|FG001|Overall Study|Withdrawal by Subject|1|||
144321382|NCT02791191|520378187|FG002|Overall Study|Withdrawal by Subject|3|||
144321383|NCT02791191|520378185|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
144321384|NCT02791191|520378186|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
144321385|NCT02791191|520378187|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
144321386|NCT02290691|520378189|FG000|Overall Study|Noncompliance|0|||
144321387|NCT02290691|520378190|FG001|Overall Study|Noncompliance|1|||
144321388|NCT02290691|520378189|FG000|Overall Study|Withdrawal by Subject|1|||
144321389|NCT02290691|520378190|FG001|Overall Study|Withdrawal by Subject|1|||
144321390|NCT02290691|520378189|FG000|Overall Study|Lost to Follow-up|7|||
144321391|NCT02290691|520378190|FG001|Overall Study|Lost to Follow-up|7|||
144321392|NCT00185380|520378191|FG000|Overall Study|Adverse Event|41|||
144321393|NCT00185380|520378192|FG001|Overall Study|Adverse Event|43|||
144321394|NCT00185380|520378193|FG002|Overall Study|Adverse Event|48|||
144321395|NCT00185380|520378191|FG000|Overall Study|Lost to Follow-up|0|||
144321396|NCT00185380|520378192|FG001|Overall Study|Lost to Follow-up|4|||
144321397|NCT00185380|520378193|FG002|Overall Study|Lost to Follow-up|3|||
144321398|NCT00185380|520378191|FG000|Overall Study|Pregnancy|1|||
144321399|NCT00185380|520378192|FG001|Overall Study|Pregnancy|4|||
144321400|NCT00185380|520378193|FG002|Overall Study|Pregnancy|0|||
144321401|NCT00185380|520378191|FG000|Overall Study|Protocol Violation|2|||
144321402|NCT00185380|520378192|FG001|Overall Study|Protocol Violation|2|||
144321403|NCT00185380|520378193|FG002|Overall Study|Protocol Violation|1|||
144321404|NCT00185380|520378191|FG000|Overall Study|Withdrawal by Subject|1|||
144321405|NCT00185380|520378192|FG001|Overall Study|Withdrawal by Subject|2|||
144321406|NCT00185380|520378193|FG002|Overall Study|Withdrawal by Subject|0|||
144321407|NCT00185380|520378191|FG000|Overall Study|Failed insertion|1|||
144321408|NCT00185380|520378192|FG001|Overall Study|Failed insertion|1|||
144321409|NCT00185380|520378193|FG002|Overall Study|Failed insertion|2|||
144321410|NCT00185380|520378191|FG000|Overall Study|Planned pregnancy|9|||
144321411|NCT00185380|520378192|FG001|Overall Study|Planned pregnancy|12|||
144321412|NCT00185380|520378193|FG002|Overall Study|Planned pregnancy|12|||
144321413|NCT00185380|520378191|FG000|Overall Study|No need for contraception|3|||
144321414|NCT00185380|520378192|FG001|Overall Study|No need for contraception|3|||
144321415|NCT00185380|520378193|FG002|Overall Study|No need for contraception|3|||
144321416|NCT00185380|520378191|FG000|Overall Study|Could not attend visits|2|||
144321417|NCT00185380|520378192|FG001|Overall Study|Could not attend visits|0|||
144321418|NCT00185380|520378193|FG002|Overall Study|Could not attend visits|4|||
144321419|NCT00185380|520378191|FG000|Overall Study|personal reason|6|||
144321420|NCT00185380|520378192|FG001|Overall Study|personal reason|1|||
144321421|NCT00185380|520378193|FG002|Overall Study|personal reason|1|||
144321422|NCT00218634|520378195|FG000|Overall Study|Lost to Follow-up|8|||
144321423|NCT00218634|520378196|FG001|Overall Study|Lost to Follow-up|15|||
144321424|NCT00734604|520378197|FG000|Overall Study|Adverse Event|0|||
144321425|NCT00734604|520378198|FG001|Overall Study|Adverse Event|2|||
144321426|NCT00734604|520378199|FG002|Overall Study|Adverse Event|0|||
144321427|NCT00734604|520378200|FG003|Overall Study|Adverse Event|2|||
144321428|NCT00734604|520378201|FG004|Overall Study|Adverse Event|1|||
144321429|NCT00734604|520378202|FG005|Overall Study|Adverse Event|1|||
144321430|NCT00734604|520378197|FG000|Overall Study|Serious Adverse Event|1|||
144321431|NCT00734604|520378198|FG001|Overall Study|Serious Adverse Event|0|||
144321432|NCT00734604|520378199|FG002|Overall Study|Serious Adverse Event|1|||
144321433|NCT00734604|520378200|FG003|Overall Study|Serious Adverse Event|2|||
144321434|NCT00734604|520378201|FG004|Overall Study|Serious Adverse Event|0|||
144321435|NCT00734604|520378202|FG005|Overall Study|Serious Adverse Event|1|||
144321436|NCT00734604|520378197|FG000|Overall Study|Lost to Follow-up|1|||
144321437|NCT00734604|520378198|FG001|Overall Study|Lost to Follow-up|2|||
144321438|NCT00734604|520378199|FG002|Overall Study|Lost to Follow-up|2|||
144321439|NCT00734604|520378200|FG003|Overall Study|Lost to Follow-up|4|||
144321440|NCT00734604|520378201|FG004|Overall Study|Lost to Follow-up|2|||
144321441|NCT00734604|520378202|FG005|Overall Study|Lost to Follow-up|3|||
144321442|NCT00734604|520378197|FG000|Overall Study|Physician Decision|0|||
144321443|NCT00734604|520378198|FG001|Overall Study|Physician Decision|1|||
144321444|NCT00734604|520378199|FG002|Overall Study|Physician Decision|1|||
144321445|NCT00734604|520378200|FG003|Overall Study|Physician Decision|0|||
144321446|NCT00734604|520378201|FG004|Overall Study|Physician Decision|0|||
144321447|NCT00734604|520378202|FG005|Overall Study|Physician Decision|0|||
144321448|NCT00734604|520378197|FG000|Overall Study|Protocol Violation|0|||
144321449|NCT00734604|520378198|FG001|Overall Study|Protocol Violation|2|||
144321450|NCT00734604|520378199|FG002|Overall Study|Protocol Violation|0|||
144321451|NCT00734604|520378200|FG003|Overall Study|Protocol Violation|0|||
144321452|NCT00734604|520378201|FG004|Overall Study|Protocol Violation|1|||
144321453|NCT00734604|520378202|FG005|Overall Study|Protocol Violation|0|||
144321454|NCT00734604|520378197|FG000|Overall Study|Sponsor Decision|1|||
144321455|NCT00734604|520378198|FG001|Overall Study|Sponsor Decision|2|||
144321456|NCT00734604|520378199|FG002|Overall Study|Sponsor Decision|1|||
144321457|NCT00734604|520378200|FG003|Overall Study|Sponsor Decision|0|||
144321458|NCT00734604|520378201|FG004|Overall Study|Sponsor Decision|2|||
144321459|NCT00734604|520378202|FG005|Overall Study|Sponsor Decision|0|||
144321460|NCT00734604|520378197|FG000|Overall Study|Withdrawal by Subject|0|||
144321461|NCT00734604|520378198|FG001|Overall Study|Withdrawal by Subject|2|||
144321462|NCT00734604|520378199|FG002|Overall Study|Withdrawal by Subject|0|||
144321463|NCT00734604|520378200|FG003|Overall Study|Withdrawal by Subject|1|||
144321464|NCT00734604|520378201|FG004|Overall Study|Withdrawal by Subject|2|||
144321465|NCT00734604|520378202|FG005|Overall Study|Withdrawal by Subject|1|||
144321466|NCT00734604|520378197|FG000|Overall Study|Lack of Efficacy|0|||
144321467|NCT00734604|520378198|FG001|Overall Study|Lack of Efficacy|1|||
144321468|NCT00734604|520378199|FG002|Overall Study|Lack of Efficacy|1|||
144321469|NCT00734604|520378200|FG003|Overall Study|Lack of Efficacy|0|||
144321470|NCT00734604|520378201|FG004|Overall Study|Lack of Efficacy|0|||
144321471|NCT00734604|520378202|FG005|Overall Study|Lack of Efficacy|0|||
144321472|NCT01044745|520378203|FG000|Overall Study|Ineiligible|2|||
144321473|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Adverse Event|76|||
144321474|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Adverse Event|0|||
144321475|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Adverse Event|0|||
144321476|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Death|3|||
144321477|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Death|0|||
144321478|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Death|0|||
144321479|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
144321480|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
144321481|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
144321482|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Physician Decision|9|||
144321483|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Physician Decision|0|||
144321484|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Physician Decision|0|||
144321485|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
144321486|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
144321487|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
144321488|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Disease progression|45|||
144321489|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Disease progression|0|||
144321490|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Disease progression|0|||
144321491|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
144321492|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
144321493|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
144321494|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
144321495|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
144321496|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
144321497|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
144321498|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
144321499|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
144321500|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
144321501|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
144321502|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
144321503|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
144321504|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
144321505|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
144321506|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
144321507|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
144321508|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
144321509|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
144321510|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
144321511|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
144321512|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
144321513|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
144321514|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
144321515|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
144321516|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
144321517|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
144321518|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Promotor request|1|||
144321519|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Promotor request|0|||
144321520|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Promotor request|0|||
144321521|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
144321522|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
144321523|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
144321524|NCT01461928|520378206|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
144321525|NCT01461928|520378207|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
144321526|NCT01461928|520378208|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
144321527|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Death|3|||
144321528|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Death|0|||
144321529|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Death|0|||
144321530|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
144321531|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
144321532|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
144321533|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
144321534|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
144321535|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
144321536|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Diseases progression|91|||
144321537|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Diseases progression|0|||
144321538|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Diseases progression|0|||
144321539|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Adverse Event|70|||
144321540|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Adverse Event|0|||
144321541|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Adverse Event|0|||
144321542|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Physician Decision|9|||
144321543|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Physician Decision|0|||
144321544|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Physician Decision|0|||
144321545|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
144321546|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
144321547|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
144321548|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
144321549|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
144321550|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
144321551|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
144321552|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
144321553|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
144321554|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Not compliant|1|||
144321555|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Not compliant|0|||
144321556|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Not compliant|0|||
144321557|NCT01461928|520378206|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
144321558|NCT01461928|520378207|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
144321559|NCT01461928|520378208|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
144321560|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Adverse Event|0|||
144321561|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Adverse Event|2|||
144321562|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Adverse Event|0|||
144321563|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Death|0|||
144321564|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Death|10|||
144321565|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Death|8|||
144321566|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Physician Decision|0|||
144321567|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Physician Decision|0|||
144321568|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Physician Decision|4|||
144321569|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
144321570|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
144321571|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
144321572|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Moved to another town|0|||
144321573|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Moved to another town|1|||
144321574|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Moved to another town|0|||
144321575|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Disease progression|0|||
144321576|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Disease progression|0|||
144321577|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Disease progression|3|||
144321578|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
144321579|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
144321580|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
144321581|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
144321582|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
144321583|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
144321584|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
144321585|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
144321586|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
144321587|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
144321588|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
144321589|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
144321590|NCT01461928|520378206|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
144321591|NCT01461928|520378207|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
144321592|NCT01461928|520378208|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
144321593|NCT00152477|520378209|FG000|Chemotherapy Period|Adverse Event|9|||
144321594|NCT00152477|520378210|FG001|Chemotherapy Period|Adverse Event|4|||
144321595|NCT00152477|520378211|FG002|Chemotherapy Period|Adverse Event|5|||
144321596|NCT00152477|520378209|FG000|Chemotherapy Period|Death|1|||
144321597|NCT00152477|520378210|FG001|Chemotherapy Period|Death|3|||
144321598|NCT00152477|520378211|FG002|Chemotherapy Period|Death|3|||
144321599|NCT00152477|520378209|FG000|Chemotherapy Period|Lack of Efficacy|4|||
144321600|NCT00152477|520378210|FG001|Chemotherapy Period|Lack of Efficacy|5|||
144321601|NCT00152477|520378211|FG002|Chemotherapy Period|Lack of Efficacy|6|||
144321602|NCT00152477|520378209|FG000|Chemotherapy Period|Lost to Follow-up|1|||
144321603|NCT00152477|520378210|FG001|Chemotherapy Period|Lost to Follow-up|0|||
144321604|NCT00152477|520378211|FG002|Chemotherapy Period|Lost to Follow-up|1|||
144321605|NCT00152477|520378209|FG000|Chemotherapy Period|Protocol Violation|1|||
144321606|NCT00152477|520378210|FG001|Chemotherapy Period|Protocol Violation|1|||
144321607|NCT00152477|520378211|FG002|Chemotherapy Period|Protocol Violation|0|||
144321608|NCT00152477|520378209|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
144321609|NCT00152477|520378210|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
144321610|NCT00152477|520378211|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
144321611|NCT00152477|520378209|FG000|Chemotherapy Period|Progression of Disease|6|||
144321612|NCT00152477|520378210|FG001|Chemotherapy Period|Progression of Disease|8|||
144321613|NCT00152477|520378211|FG002|Chemotherapy Period|Progression of Disease|4|||
144321614|NCT00152477|520378209|FG000|Chemotherapy Period|Investigator decision|0|||
144321615|NCT00152477|520378210|FG001|Chemotherapy Period|Investigator decision|0|||
144321616|NCT00152477|520378211|FG002|Chemotherapy Period|Investigator decision|1|||
144321617|NCT00152477|520378209|FG000|Chemotherapy Period|Patient condition worsened|1|||
144321618|NCT00152477|520378210|FG001|Chemotherapy Period|Patient condition worsened|0|||
144321619|NCT00152477|520378211|FG002|Chemotherapy Period|Patient condition worsened|0|||
144321620|NCT00152477|520378209|FG000|Monotherapy Period|Adverse Event|1|||
144321621|NCT00152477|520378210|FG001|Monotherapy Period|Adverse Event|0|||
144321622|NCT00152477|520378211|FG002|Monotherapy Period|Adverse Event|5|||
144321623|NCT00152477|520378209|FG000|Monotherapy Period|Death|2|||
144321624|NCT00152477|520378210|FG001|Monotherapy Period|Death|0|||
144321625|NCT00152477|520378211|FG002|Monotherapy Period|Death|1|||
144321626|NCT00152477|520378209|FG000|Monotherapy Period|Lack of Efficacy|7|||
144321627|NCT00152477|520378210|FG001|Monotherapy Period|Lack of Efficacy|16|||
144321628|NCT00152477|520378211|FG002|Monotherapy Period|Lack of Efficacy|10|||
144321629|NCT00152477|520378209|FG000|Monotherapy Period|Protocol Violation|0|||
144321630|NCT00152477|520378210|FG001|Monotherapy Period|Protocol Violation|1|||
144321631|NCT00152477|520378211|FG002|Monotherapy Period|Protocol Violation|0|||
144321632|NCT00152477|520378209|FG000|Monotherapy Period|Withdrawal by Subject|0|||
144321633|NCT00152477|520378210|FG001|Monotherapy Period|Withdrawal by Subject|0|||
144321634|NCT00152477|520378211|FG002|Monotherapy Period|Withdrawal by Subject|4|||
144321635|NCT00152477|520378209|FG000|Monotherapy Period|Progression of Disease|5|||
144321636|NCT00152477|520378210|FG001|Monotherapy Period|Progression of Disease|11|||
144321637|NCT00152477|520378211|FG002|Monotherapy Period|Progression of Disease|12|||
144321638|NCT00152477|520378209|FG000|Monotherapy Period|Patient decision|0|||
144321639|NCT00152477|520378210|FG001|Monotherapy Period|Patient decision|1|||
144321640|NCT00152477|520378211|FG002|Monotherapy Period|Patient decision|1|||
144321641|NCT00152477|520378209|FG000|Monotherapy Period|Study personel decision|0|||
144321642|NCT00152477|520378210|FG001|Monotherapy Period|Study personel decision|0|||
144321643|NCT00152477|520378211|FG002|Monotherapy Period|Study personel decision|1|||
144321644|NCT00425698|520378212|FG000|Overall Study|Adverse Event|3|||
144321645|NCT00425698|520378213|FG001|Overall Study|Adverse Event|1|||
144321646|NCT00425698|520378212|FG000|Overall Study|Withdrawal by Subject|0|||
144321647|NCT00425698|520378213|FG001|Overall Study|Withdrawal by Subject|1|||
144321648|NCT03905265|520378221|FG000|Overall Study|Withdrawal by Subject|1|||
144321649|NCT03905265|520378222|FG001|Overall Study|Withdrawal by Subject|1|||
144321650|NCT03905265|520378223|FG002|Overall Study|Withdrawal by Subject|0|||
144321651|NCT03905265|520378224|FG003|Overall Study|Withdrawal by Subject|0|||
144321652|NCT01328535|520378225|FG000|Overall Study|Ineligible|1|||
144321653|NCT00960011|520378226|FG000|Overall Study|Death|5|||
144321654|NCT00960011|520378227|FG001|Overall Study|Death|0|||
144321655|NCT00960011|520378226|FG000|Overall Study|Lost to Follow-up|6|||
144321656|NCT00960011|520378227|FG001|Overall Study|Lost to Follow-up|2|||
144321657|NCT01082874|520378228|FG000|Overall Study|Lost to Follow-up|10|||
144321658|NCT01082874|520378229|FG001|Overall Study|Lost to Follow-up|10|||
144321659|NCT01082874|520378230|FG002|Overall Study|Lost to Follow-up|6|||
144321660|NCT01082874|520378231|FG003|Overall Study|Lost to Follow-up|10|||
144321661|NCT01082874|520378228|FG000|Overall Study|Withdrawal by Subject|1|||
144321662|NCT01082874|520378229|FG001|Overall Study|Withdrawal by Subject|2|||
144321663|NCT01082874|520378230|FG002|Overall Study|Withdrawal by Subject|5|||
144321664|NCT01082874|520378231|FG003|Overall Study|Withdrawal by Subject|3|||
144321665|NCT03655054|520378237|FG000|Overall Study|Lost to Follow-up|1|||
144321666|NCT03888235|520378241|FG000|Overall Study|Lost to Follow-up|1|||
144321667|NCT03888235|520378242|FG001|Overall Study|Lost to Follow-up|1|||
144321668|NCT03888235|520378243|FG002|Overall Study|Lost to Follow-up|0|||
144321669|NCT00939029|520378247|FG000|Overall Study|Withdrawal by Subject|3|||
144321670|NCT00939029|520378248|FG001|Overall Study|Withdrawal by Subject|7|||
144321671|NCT00939029|520378247|FG000|Overall Study|Lost to Follow-up|3|||
144321672|NCT00939029|520378248|FG001|Overall Study|Lost to Follow-up|4|||
144321673|NCT00939029|520378247|FG000|Overall Study|Adverse Event|0|||
144321674|NCT00939029|520378248|FG001|Overall Study|Adverse Event|1|||
144321675|NCT00889603|520378249|FG000|Overall Study|Adverse Event|7|||
144321676|NCT00889603|520378249|FG000|Overall Study|Death|3|||
144321677|NCT00889603|520378249|FG000|Overall Study|Lost to Follow-up|19|||
144321678|NCT00889603|520378249|FG000|Overall Study|No longer willing to participant in stud|4|||
144321679|NCT00889603|520378249|FG000|Overall Study|Other|4|||
144321680|NCT02231892|520378250|FG000|Overall Study|Lost to Follow-up|1|||
144321681|NCT02231892|520378251|FG001|Overall Study|Lost to Follow-up|0|||
144321682|NCT02231892|520378252|FG002|Overall Study|Lost to Follow-up|3|||
144321683|NCT02231892|520378250|FG000|Overall Study|Withdrawal by Subject|4|||
144321684|NCT02231892|520378251|FG001|Overall Study|Withdrawal by Subject|3|||
144321685|NCT02231892|520378252|FG002|Overall Study|Withdrawal by Subject|15|||
144321686|NCT02231892|520378250|FG000|Overall Study|Physician Decision|0|||
144321687|NCT02231892|520378251|FG001|Overall Study|Physician Decision|2|||
144321688|NCT02231892|520378252|FG002|Overall Study|Physician Decision|4|||
144321689|NCT02231892|520378250|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
144321690|NCT02231892|520378251|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
144321691|NCT02231892|520378252|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
144321692|NCT02231892|520378250|FG000|Overall Study|Participant motor threshold was >83%|0|||
144321693|NCT02231892|520378251|FG001|Overall Study|Participant motor threshold was >83%|0|||
144321694|NCT02231892|520378252|FG002|Overall Study|Participant motor threshold was >83%|9|||
144321695|NCT02231892|520378250|FG000|Overall Study|Could not find motor threshold|2|||
144321696|NCT02231892|520378251|FG001|Overall Study|Could not find motor threshold|0|||
144321697|NCT02231892|520378252|FG002|Overall Study|Could not find motor threshold|1|||
144321698|NCT02231892|520378250|FG000|Overall Study|Could not find reliable motor hotspot|0|||
144321699|NCT02231892|520378251|FG001|Overall Study|Could not find reliable motor hotspot|0|||
144321700|NCT02231892|520378252|FG002|Overall Study|Could not find reliable motor hotspot|1|||
144321701|NCT03832322|520378253|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
144321702|NCT03832322|520378254|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
144321703|NCT02247011|520378266|FG000|Overall Study|Poor quality of radiological results|125|||
144321704|NCT02901054|520378268|FG000|Overall Study|Physician Decision|1|||
144321705|NCT02901054|520378268|FG000|Overall Study|Withdrawal by Subject|3|||
144321706|NCT05248997|520378272|FG000|Overall Study|Lost to Follow-up|1|||
144321707|NCT05248997|520378273|FG001|Overall Study|Lost to Follow-up|1|||
144321708|NCT05248997|520378272|FG000|Overall Study|Randomized but not treated|32|||
144321709|NCT05248997|520378273|FG001|Overall Study|Randomized but not treated|25|||
144321710|NCT01974206|520378274|FG000|Overall Study|Did Not Take Study Drug|0|||
144321711|NCT01974206|520378275|FG001|Overall Study|Did Not Take Study Drug|1|||
144321712|NCT01974206|520378274|FG000|Overall Study|Physician Decision|1|||
144321713|NCT01974206|520378275|FG001|Overall Study|Physician Decision|0|||
144321714|NCT01974206|520378274|FG000|Overall Study|Withdrawal by Subject|3|||
144321715|NCT01974206|520378275|FG001|Overall Study|Withdrawal by Subject|0|||
144321716|NCT01974206|520378274|FG000|Overall Study|Lost to Follow-up|1|||
144321717|NCT01974206|520378275|FG001|Overall Study|Lost to Follow-up|0|||
144321718|NCT01974206|520378274|FG000|Overall Study|Death|1|||
144321719|NCT01974206|520378275|FG001|Overall Study|Death|0|||
144321720|NCT03255967|520378278|FG000|Overall Study|Adverse Event|26|||
144321721|NCT03255967|520378279|FG001|Overall Study|Adverse Event|30|||
144321722|NCT03255967|520378278|FG000|Overall Study|Withdrawal by Subject|6|||
144321723|NCT03255967|520378279|FG001|Overall Study|Withdrawal by Subject|6|||
144321724|NCT03255967|520378278|FG000|Overall Study|Schedule conflict|6|||
144321725|NCT03255967|520378279|FG001|Overall Study|Schedule conflict|4|||
144321726|NCT03255967|520378278|FG000|Overall Study|POA did not sign consent form|2|||
144321727|NCT03255967|520378279|FG001|Overall Study|POA did not sign consent form|0|||
144321728|NCT01202188|520378282|FG000|Overall Study|Protocol deviation|14|||
144321729|NCT01202188|520378283|FG001|Overall Study|Protocol deviation|8|||
144321730|NCT01202188|520378284|FG002|Overall Study|Protocol deviation|12|||
144321731|NCT01202188|520378285|FG003|Overall Study|Protocol deviation|10|||
144321732|NCT01202188|520378286|FG004|Overall Study|Protocol deviation|11|||
144321733|NCT01202188|520378282|FG000|Overall Study|Subject withdrew consent|12|||
144321734|NCT01202188|520378283|FG001|Overall Study|Subject withdrew consent|13|||
144321735|NCT01202188|520378284|FG002|Overall Study|Subject withdrew consent|22|||
144321736|NCT01202188|520378285|FG003|Overall Study|Subject withdrew consent|11|||
144321737|NCT01202188|520378286|FG004|Overall Study|Subject withdrew consent|13|||
144321738|NCT01202188|520378282|FG000|Overall Study|Adverse Event|5|||
144321739|NCT01202188|520378283|FG001|Overall Study|Adverse Event|23|||
144321740|NCT01202188|520378284|FG002|Overall Study|Adverse Event|13|||
144321741|NCT01202188|520378285|FG003|Overall Study|Adverse Event|10|||
144321742|NCT01202188|520378286|FG004|Overall Study|Adverse Event|10|||
144321743|NCT01202188|520378282|FG000|Overall Study|Administrative problems|3|||
144321744|NCT01202188|520378283|FG001|Overall Study|Administrative problems|2|||
144321745|NCT01202188|520378284|FG002|Overall Study|Administrative problems|1|||
144321746|NCT01202188|520378285|FG003|Overall Study|Administrative problems|1|||
144321747|NCT01202188|520378286|FG004|Overall Study|Administrative problems|2|||
144321748|NCT01202188|520378282|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
144321749|NCT01202188|520378283|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
144321750|NCT01202188|520378284|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144321751|NCT01202188|520378285|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
144321752|NCT01202188|520378286|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
144321753|NCT01202188|520378282|FG000|Overall Study|Lost to Follow-up|1|||
144321754|NCT01202188|520378283|FG001|Overall Study|Lost to Follow-up|1|||
144321755|NCT01202188|520378284|FG002|Overall Study|Lost to Follow-up|0|||
144321756|NCT01202188|520378285|FG003|Overall Study|Lost to Follow-up|4|||
144321757|NCT01202188|520378286|FG004|Overall Study|Lost to Follow-up|1|||
144321758|NCT01202188|520378282|FG000|Overall Study|Death|1|||
144321759|NCT01202188|520378283|FG001|Overall Study|Death|1|||
144321760|NCT01202188|520378284|FG002|Overall Study|Death|1|||
144321761|NCT01202188|520378285|FG003|Overall Study|Death|1|||
144321762|NCT01202188|520378286|FG004|Overall Study|Death|0|||
144321763|NCT01202188|520378282|FG000|Overall Study|Abnormal test procedure result (s)|0|||
144321764|NCT01202188|520378283|FG001|Overall Study|Abnormal test procedure result (s)|0|||
144321765|NCT01202188|520378284|FG002|Overall Study|Abnormal test procedure result (s)|2|||
144321766|NCT01202188|520378285|FG003|Overall Study|Abnormal test procedure result (s)|0|||
144321767|NCT01202188|520378286|FG004|Overall Study|Abnormal test procedure result (s)|0|||
144321768|NCT00487942|520378289|FG000|Overall Study|Adverse Event|1|||
144321769|NCT00487942|520378290|FG001|Overall Study|Adverse Event|1|||
144321770|NCT00487942|520378291|FG002|Overall Study|Adverse Event|1|||
144321771|NCT00487942|520378292|FG003|Overall Study|Adverse Event|1|||
144321772|NCT00487942|520378289|FG000|Overall Study|Lost to Follow-up|1|||
144321773|NCT00487942|520378290|FG001|Overall Study|Lost to Follow-up|0|||
144321774|NCT00487942|520378291|FG002|Overall Study|Lost to Follow-up|0|||
144321775|NCT00487942|520378292|FG003|Overall Study|Lost to Follow-up|1|||
144321776|NCT00487942|520378289|FG000|Overall Study|Protocol Violation|1|||
144321777|NCT00487942|520378290|FG001|Overall Study|Protocol Violation|1|||
144321778|NCT00487942|520378291|FG002|Overall Study|Protocol Violation|0|||
144321779|NCT00487942|520378292|FG003|Overall Study|Protocol Violation|0|||
144321780|NCT00487942|520378289|FG000|Overall Study|Withdrawal by Subject|0|||
144321781|NCT00487942|520378290|FG001|Overall Study|Withdrawal by Subject|1|||
144321782|NCT00487942|520378291|FG002|Overall Study|Withdrawal by Subject|2|||
144321783|NCT00487942|520378292|FG003|Overall Study|Withdrawal by Subject|0|||
144321784|NCT00211757|520378293|FG000|Overall Study|Withdrawal by Subject|1|||
144321785|NCT00211757|520378294|FG001|Overall Study|Withdrawal by Subject|1|||
144321786|NCT00211757|520378293|FG000|Overall Study|Lack of Efficacy|0|||
144321787|NCT00211757|520378294|FG001|Overall Study|Lack of Efficacy|1|||
144321788|NCT00082368|520378300|FG000|Overall Study|Not treated-pt had poor IV access|1|||
144321789|NCT01457014|520378301|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
144321790|NCT01457014|520378302|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
144321791|NCT01457014|520378303|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
144321792|NCT01457014|520378304|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
144321793|NCT01457014|520378301|FG000|First Night|Withdrawal by Subject|3|||
144321794|NCT01457014|520378302|FG001|First Night|Withdrawal by Subject|0|||
144321795|NCT01457014|520378303|FG002|First Night|Withdrawal by Subject|0|||
144321796|NCT01457014|520378304|FG003|First Night|Withdrawal by Subject|0|||
144321797|NCT02461290|520378305|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
144321798|NCT02461290|520378305|FG000|Overall Study|Lost to Follow-up|3|||
144321799|NCT04027049|520378306|FG000|Overall Study|Withdrawn by family|1|||
144321800|NCT04027049|520378307|FG001|Overall Study|Withdrawn by family|0|||
144321801|NCT04027049|520378306|FG000|Overall Study|Participant safety|1|||
144321802|NCT04027049|520378307|FG001|Overall Study|Participant safety|0|||
144321803|NCT02013206|520380591|FG000|Overall Study|Progressive disease (PD)|14|||
144321804|NCT02013206|520380592|FG001|Overall Study|Progressive disease (PD)|17|||
144321805|NCT02013206|520380591|FG000|Overall Study|Symptomatic deterioration|3|||
144321806|NCT02013206|520380592|FG001|Overall Study|Symptomatic deterioration|1|||
144321807|NCT02013206|520380591|FG000|Overall Study|Adverse Event|1|||
144321808|NCT02013206|520380592|FG001|Overall Study|Adverse Event|0|||
144321809|NCT02013206|520380591|FG000|Overall Study|Patient refusal|2|||
144321810|NCT02013206|520380592|FG001|Overall Study|Patient refusal|0|||
144321811|NCT02013206|520380591|FG000|Overall Study|Patient non-compliance|1|||
144321812|NCT02013206|520380592|FG001|Overall Study|Patient non-compliance|0|||
144321813|NCT02013206|520380591|FG000|Overall Study|Death|1|||
144321814|NCT02013206|520380592|FG001|Overall Study|Death|2|||
144321815|NCT02013206|520380591|FG000|Overall Study|Other reasons off treatment|5|||
144321816|NCT02013206|520380592|FG001|Overall Study|Other reasons off treatment|2|||
144321817|NCT02867813|520380593|FG000|Overall Study|Withdrawal by Subject|57|||
144321818|NCT02867813|520380594|FG001|Overall Study|Withdrawal by Subject|56|||
144321819|NCT02867813|520380593|FG000|Overall Study|Decision by Sponsor|7|||
144321820|NCT02867813|520380594|FG001|Overall Study|Decision by Sponsor|7|||
144321821|NCT02867813|520380593|FG000|Overall Study|Lost to Follow-up|91|||
144321822|NCT02867813|520380594|FG001|Overall Study|Lost to Follow-up|78|||
144321823|NCT02867813|520380593|FG000|Overall Study|Missing|2|||
144321824|NCT02867813|520380594|FG001|Overall Study|Missing|1|||
144321825|NCT02867813|520380593|FG000|Overall Study|Death|294|||
144321826|NCT02867813|520380594|FG001|Overall Study|Death|268|||
144321827|NCT01952665|520380595|FG000|Overall Study|Physician Decision|3|||
144321828|NCT01952665|520380596|FG001|Overall Study|Physician Decision|2|||
144321829|NCT01952665|520380595|FG000|Overall Study|Lost to Follow-up|1|||
144321830|NCT01952665|520380596|FG001|Overall Study|Lost to Follow-up|2|||
144321831|NCT01952665|520380595|FG000|Overall Study|Adverse Event|2|||
144321832|NCT01952665|520380596|FG001|Overall Study|Adverse Event|1|||
144321833|NCT01952665|520380595|FG000|Overall Study|Protocol Violation|0|||
144321834|NCT01952665|520380596|FG001|Overall Study|Protocol Violation|1|||
144321835|NCT01537081|520380597|FG000|Overall Study|Adverse Event|5|||
144321836|NCT01537081|520380598|FG001|Overall Study|Adverse Event|2|||
144321837|NCT01537081|520380599|FG002|Overall Study|Adverse Event|2|||
144321838|NCT01537081|520380597|FG000|Overall Study|Lack of Efficacy|2|||
144321839|NCT01537081|520380598|FG001|Overall Study|Lack of Efficacy|1|||
144321840|NCT01537081|520380599|FG002|Overall Study|Lack of Efficacy|0|||
144321841|NCT01537081|520380597|FG000|Overall Study|Lost to Follow-up|17|||
144321842|NCT01537081|520380598|FG001|Overall Study|Lost to Follow-up|15|||
144321843|NCT01537081|520380599|FG002|Overall Study|Lost to Follow-up|9|||
144321844|NCT01537081|520380597|FG000|Overall Study|Protocol Violation|3|||
144321845|NCT01537081|520380598|FG001|Overall Study|Protocol Violation|2|||
144321846|NCT01537081|520380599|FG002|Overall Study|Protocol Violation|2|||
144321847|NCT01537081|520380597|FG000|Overall Study|Withdrawal by Subject|6|||
144321848|NCT01537081|520380598|FG001|Overall Study|Withdrawal by Subject|11|||
144321849|NCT01537081|520380599|FG002|Overall Study|Withdrawal by Subject|3|||
144321850|NCT01537081|520380597|FG000|Overall Study|Physician Decision|5|||
144321851|NCT01537081|520380598|FG001|Overall Study|Physician Decision|6|||
144321852|NCT01537081|520380599|FG002|Overall Study|Physician Decision|0|||
144321853|NCT01537081|520380597|FG000|Overall Study|Sponsor decision|0|||
144321854|NCT01537081|520380598|FG001|Overall Study|Sponsor decision|1|||
144321855|NCT01537081|520380599|FG002|Overall Study|Sponsor decision|0|||
144321856|NCT01537081|520380597|FG000|Overall Study|Assigned but never dosed|1|||
144321857|NCT01537081|520380598|FG001|Overall Study|Assigned but never dosed|0|||
144321858|NCT01537081|520380599|FG002|Overall Study|Assigned but never dosed|0|||
144321859|NCT01463111|520380602|FG000|Overall Study|Withdrawal by Subject|2|||
144321860|NCT01463111|520380602|FG000|Overall Study|Lost to Follow-up|5|||
144321861|NCT01463111|520380602|FG000|Overall Study|Physician Decision|2|||
144321862|NCT00591149|520380610|FG000|Overall Study|Adverse Event|4|||
144321863|NCT00591149|520380610|FG000|Overall Study|Withdrawal by Subject|1|||
144321864|NCT02456636|520380611|FG000|Overall Study|Death|0|||
144321865|NCT02456636|520380612|FG001|Overall Study|Death|3|||
144321866|NCT02456636|520380613|FG002|Overall Study|Death|0|||
144321867|NCT02456636|520380611|FG000|Overall Study|Pregnancy|1|||
144321868|NCT02456636|520380612|FG001|Overall Study|Pregnancy|3|||
144321869|NCT02456636|520380613|FG002|Overall Study|Pregnancy|5|||
144321870|NCT02456636|520380611|FG000|Overall Study|Physician Decision|4|||
144321871|NCT02456636|520380612|FG001|Overall Study|Physician Decision|5|||
144321872|NCT02456636|520380613|FG002|Overall Study|Physician Decision|4|||
144321873|NCT02456636|520380611|FG000|Overall Study|Withdrawal by Subject|13|||
144321874|NCT02456636|520380612|FG001|Overall Study|Withdrawal by Subject|14|||
144321875|NCT02456636|520380613|FG002|Overall Study|Withdrawal by Subject|16|||
144321876|NCT02456636|520380611|FG000|Overall Study|Lost to Follow-up|50|||
144321877|NCT02456636|520380612|FG001|Overall Study|Lost to Follow-up|44|||
144321878|NCT02456636|520380613|FG002|Overall Study|Lost to Follow-up|50|||
144321879|NCT02379221|520380614|FG000|Overall Study|Lost to Follow-up|1|||
144321880|NCT02019108|520380615|FG000|Overall Study|Lost to Follow-up|5|||
144321881|NCT02019108|520380616|FG001|Overall Study|Lost to Follow-up|7|||
144321882|NCT00519376|520380617|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321883|NCT00519376|520380618|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321884|NCT00519376|520380619|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321885|NCT00519376|520380620|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321886|NCT00519376|520380621|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321887|NCT00519376|520380622|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321888|NCT00519376|520380623|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321889|NCT00519376|520380624|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321890|NCT00519376|520380625|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321891|NCT00519376|520380626|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321892|NCT00519376|520380627|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321893|NCT00519376|520380628|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321894|NCT00519376|520380629|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
144321895|NCT00519376|520380630|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321896|NCT00519376|520380631|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321897|NCT00519376|520380632|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
144321898|NCT00519376|520380617|FG000|Treatment Period 4|Lost to Follow-up|0|||
144321899|NCT00519376|520380618|FG001|Treatment Period 4|Lost to Follow-up|0|||
144321900|NCT00519376|520380619|FG002|Treatment Period 4|Lost to Follow-up|1|||
144321901|NCT00519376|520380620|FG003|Treatment Period 4|Lost to Follow-up|0|||
144321902|NCT00519376|520380621|FG004|Treatment Period 4|Lost to Follow-up|0|||
144321903|NCT00519376|520380622|FG005|Treatment Period 4|Lost to Follow-up|0|||
144321904|NCT00519376|520380623|FG006|Treatment Period 4|Lost to Follow-up|0|||
144321905|NCT00519376|520380624|FG007|Treatment Period 4|Lost to Follow-up|0|||
144321906|NCT00519376|520380625|FG008|Treatment Period 4|Lost to Follow-up|0|||
144321907|NCT00519376|520380626|FG009|Treatment Period 4|Lost to Follow-up|0|||
144321908|NCT00519376|520380627|FG010|Treatment Period 4|Lost to Follow-up|0|||
144321909|NCT00519376|520380628|FG011|Treatment Period 4|Lost to Follow-up|0|||
144321910|NCT00519376|520380629|FG012|Treatment Period 4|Lost to Follow-up|0|||
144321911|NCT00519376|520380630|FG013|Treatment Period 4|Lost to Follow-up|0|||
144321912|NCT00519376|520380631|FG014|Treatment Period 4|Lost to Follow-up|0|||
144321913|NCT00519376|520380632|FG015|Treatment Period 4|Lost to Follow-up|0|||
144321914|NCT03576066|520380640|FG000|Overall Study|Noncompliance with study drug|0|||
144321915|NCT03576066|520380641|FG001|Overall Study|Noncompliance with study drug|1|||
144321916|NCT06422364|520380644|FG000|Overall Study|Withdrawn due to study closure|0|||
144321917|NCT06422364|520380645|FG001|Overall Study|Withdrawn due to study closure|2|||
144321918|NCT05275010|520380647|FG000|Overall Study|Reason Not Specified|4|||
144321919|NCT05275010|520380648|FG001|Overall Study|Reason Not Specified|1|||
144321920|NCT05275010|520380647|FG000|Overall Study|Withdrawal by Subject|1|||
144321921|NCT05275010|520380648|FG001|Overall Study|Withdrawal by Subject|0|||
144321922|NCT05275010|520380647|FG000|Overall Study|Lost to Follow-up|0|||
144321923|NCT05275010|520380648|FG001|Overall Study|Lost to Follow-up|1|||
144321924|NCT06004895|520380651|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
144321925|NCT06004895|520380651|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
144321926|NCT04484649|520380652|FG000|Overall Study|Lost to Follow-up|2|||
144321927|NCT04484649|520380653|FG001|Overall Study|Lost to Follow-up|1|||
144321928|NCT04484649|520380652|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
144321929|NCT04484649|520380653|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
144321930|NCT01463696|520380657|FG000|Overall Study|Adverse Event|0|||
144321931|NCT01463696|520380658|FG001|Overall Study|Adverse Event|1|||
144321932|NCT01463696|520380659|FG002|Overall Study|Adverse Event|0|||
144321933|NCT01463696|520380660|FG003|Overall Study|Adverse Event|2|||
144321934|NCT01463696|520380661|FG004|Overall Study|Adverse Event|0|||
144321935|NCT01463696|520380662|FG005|Overall Study|Adverse Event|1|||
144321936|NCT01463696|520380663|FG006|Overall Study|Adverse Event|3|||
144321937|NCT01463696|520380664|FG007|Overall Study|Adverse Event|2|||
144321938|NCT01463696|520380657|FG000|Overall Study|Lost to Follow-up|0|||
144321939|NCT01463696|520380658|FG001|Overall Study|Lost to Follow-up|0|||
144321940|NCT01463696|520380659|FG002|Overall Study|Lost to Follow-up|1|||
144321941|NCT01463696|520380660|FG003|Overall Study|Lost to Follow-up|0|||
144321942|NCT01463696|520380661|FG004|Overall Study|Lost to Follow-up|0|||
144321943|NCT01463696|520380662|FG005|Overall Study|Lost to Follow-up|0|||
144321944|NCT01463696|520380663|FG006|Overall Study|Lost to Follow-up|0|||
144321945|NCT01463696|520380664|FG007|Overall Study|Lost to Follow-up|0|||
144321946|NCT01463696|520380657|FG000|Overall Study|Progressive Disease|0|||
144321947|NCT01463696|520380658|FG001|Overall Study|Progressive Disease|1|||
144321948|NCT01463696|520380659|FG002|Overall Study|Progressive Disease|0|||
144321949|NCT01463696|520380660|FG003|Overall Study|Progressive Disease|1|||
144321950|NCT01463696|520380661|FG004|Overall Study|Progressive Disease|0|||
144321951|NCT01463696|520380662|FG005|Overall Study|Progressive Disease|1|||
144321952|NCT01463696|520380663|FG006|Overall Study|Progressive Disease|4|||
144321953|NCT01463696|520380664|FG007|Overall Study|Progressive Disease|2|||
144321954|NCT01463696|520380657|FG000|Overall Study|Withdrawal by Subject|0|||
144321955|NCT01463696|520380658|FG001|Overall Study|Withdrawal by Subject|0|||
144321956|NCT01463696|520380659|FG002|Overall Study|Withdrawal by Subject|0|||
144321957|NCT01463696|520380660|FG003|Overall Study|Withdrawal by Subject|1|||
144321958|NCT01463696|520380661|FG004|Overall Study|Withdrawal by Subject|1|||
144321959|NCT01463696|520380662|FG005|Overall Study|Withdrawal by Subject|1|||
144321960|NCT01463696|520380663|FG006|Overall Study|Withdrawal by Subject|2|||
144321961|NCT01463696|520380664|FG007|Overall Study|Withdrawal by Subject|0|||
144321962|NCT01463696|520380657|FG000|Overall Study|Not Treated|0|||
144321963|NCT01463696|520380658|FG001|Overall Study|Not Treated|0|||
144321964|NCT01463696|520380659|FG002|Overall Study|Not Treated|0|||
144321965|NCT01463696|520380660|FG003|Overall Study|Not Treated|0|||
144321966|NCT01463696|520380661|FG004|Overall Study|Not Treated|0|||
144321967|NCT01463696|520380662|FG005|Overall Study|Not Treated|0|||
144321968|NCT01463696|520380663|FG006|Overall Study|Not Treated|1|||
144321969|NCT01463696|520380664|FG007|Overall Study|Not Treated|0|||
144321970|NCT00967694|520380670|FG000|Overall Study|Withdrawal by Subject|6|||
144321971|NCT04417218|520380671|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
144321972|NCT04417218|520380672|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
144321973|NCT00873041|520380673|FG000|Core Study|Adverse Event|2|||
144321974|NCT00873041|520380674|FG001|Core Study|Adverse Event|3|||
144321975|NCT00873041|520380675|FG002|Core Study|Adverse Event|1|||
144321976|NCT00873041|520380673|FG000|Core Study|Withdrawal by Subject|1|||
144321977|NCT00873041|520380674|FG001|Core Study|Withdrawal by Subject|2|||
144321978|NCT00873041|520380675|FG002|Core Study|Withdrawal by Subject|2|||
144321979|NCT00873041|520380673|FG000|Core Study|Lost to Follow-up|3|||
144321980|NCT00873041|520380674|FG001|Core Study|Lost to Follow-up|1|||
144321981|NCT00873041|520380675|FG002|Core Study|Lost to Follow-up|0|||
144321982|NCT00873041|520380673|FG000|Core Study|Abnormal laboratory value|0|||
144321983|NCT00873041|520380674|FG001|Core Study|Abnormal laboratory value|0|||
144321984|NCT00873041|520380675|FG002|Core Study|Abnormal laboratory value|1|||
144321985|NCT00873041|520380673|FG000|Core Study|Protocol deviation|1|||
144321986|NCT00873041|520380674|FG001|Core Study|Protocol deviation|0|||
144321987|NCT00873041|520380675|FG002|Core Study|Protocol deviation|1|||
144321988|NCT00873041|520380673|FG000|Extension Study|Adverse Event|1|||
144321989|NCT00873041|520380674|FG001|Extension Study|Adverse Event|0|||
144321990|NCT00873041|520380675|FG002|Extension Study|Adverse Event|1|||
144321991|NCT00873041|520380673|FG000|Extension Study|Administrative reasons|0|||
144321992|NCT00873041|520380674|FG001|Extension Study|Administrative reasons|0|||
144321993|NCT00873041|520380675|FG002|Extension Study|Administrative reasons|1|||
144321994|NCT00313313|520380678|FG000|Overall Study|Lack of Efficacy|14|||
144321995|NCT00313313|520380679|FG001|Overall Study|Lack of Efficacy|9|||
144321996|NCT00313313|520380680|FG002|Overall Study|Lack of Efficacy|20|||
144321997|NCT00313313|520380678|FG000|Overall Study|Withdrawal of consent by subject|18|||
144321998|NCT00313313|520380679|FG001|Overall Study|Withdrawal of consent by subject|17|||
144321999|NCT00313313|520380680|FG002|Overall Study|Withdrawal of consent by subject|31|||
144322000|NCT00313313|520380678|FG000|Overall Study|Lost to Follow-up|10|||
144322001|NCT00313313|520380679|FG001|Overall Study|Lost to Follow-up|7|||
144322002|NCT00313313|520380680|FG002|Overall Study|Lost to Follow-up|9|||
144322003|NCT00313313|520380678|FG000|Overall Study|Adverse Event|15|||
144322004|NCT00313313|520380679|FG001|Overall Study|Adverse Event|16|||
144322005|NCT00313313|520380680|FG002|Overall Study|Adverse Event|12|||
144322006|NCT00313313|520380678|FG000|Overall Study|Physician Decision|2|||
144322007|NCT00313313|520380679|FG001|Overall Study|Physician Decision|6|||
144322008|NCT00313313|520380680|FG002|Overall Study|Physician Decision|4|||
144322009|NCT00313313|520380678|FG000|Overall Study|Poor/Noncompliance|3|||
144322010|NCT00313313|520380679|FG001|Overall Study|Poor/Noncompliance|6|||
144322011|NCT00313313|520380680|FG002|Overall Study|Poor/Noncompliance|2|||
144322012|NCT00313313|520380678|FG000|Overall Study|Pregnancy|1|||
144322013|NCT00313313|520380679|FG001|Overall Study|Pregnancy|2|||
144322014|NCT00313313|520380680|FG002|Overall Study|Pregnancy|0|||
144322015|NCT00313313|520380678|FG000|Overall Study|Death|0|||
144322016|NCT00313313|520380679|FG001|Overall Study|Death|0|||
144322017|NCT00313313|520380680|FG002|Overall Study|Death|2|||
144322018|NCT00313313|520380678|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
144322019|NCT00313313|520380679|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
144322020|NCT00313313|520380680|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
144322021|NCT03305419|520380695|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322022|NCT03305419|520380696|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
144322023|NCT03305419|520380697|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322024|NCT03305419|520380698|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322025|NCT03305419|520380699|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322026|NCT03305419|520380700|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322027|NCT03305419|520380701|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322028|NCT03305419|520380702|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
144322029|NCT03305419|520380695|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
144322030|NCT03305419|520380696|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322031|NCT03305419|520380697|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322032|NCT03305419|520380698|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322033|NCT03305419|520380699|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322034|NCT03305419|520380700|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322035|NCT03305419|520380701|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322036|NCT03305419|520380702|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
144322037|NCT03305419|520380695|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
144322038|NCT03305419|520380696|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144322039|NCT03305419|520380697|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144322040|NCT03305419|520380698|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144322041|NCT03305419|520380699|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144322042|NCT03305419|520380700|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144322043|NCT03305419|520380701|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144360033|NCT01601535|520525137|FG002|Phase 2|Progressive Disease|0|||
144322044|NCT03305419|520380702|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
144322045|NCT03305419|520380695|FG000|Part B (14 Days)|Adverse Event|0|||
144322046|NCT03305419|520380696|FG001|Part B (14 Days)|Adverse Event|0|||
144322047|NCT03305419|520380697|FG002|Part B (14 Days)|Adverse Event|0|||
144322048|NCT03305419|520380698|FG003|Part B (14 Days)|Adverse Event|0|||
144322049|NCT03305419|520380699|FG004|Part B (14 Days)|Adverse Event|1|||
144322050|NCT03305419|520380700|FG005|Part B (14 Days)|Adverse Event|2|||
144322051|NCT03305419|520380701|FG006|Part B (14 Days)|Adverse Event|4|||
144322052|NCT03305419|520380702|FG007|Part B (14 Days)|Adverse Event|0|||
144322053|NCT03305419|520380695|FG000|Part B (14 Days)|Physician Decision|0|||
144322054|NCT03305419|520380696|FG001|Part B (14 Days)|Physician Decision|0|||
144322055|NCT03305419|520380697|FG002|Part B (14 Days)|Physician Decision|0|||
144322056|NCT03305419|520380698|FG003|Part B (14 Days)|Physician Decision|0|||
144322057|NCT03305419|520380699|FG004|Part B (14 Days)|Physician Decision|2|||
144322058|NCT03305419|520380700|FG005|Part B (14 Days)|Physician Decision|8|||
144322059|NCT03305419|520380701|FG006|Part B (14 Days)|Physician Decision|1|||
144322060|NCT03305419|520380702|FG007|Part B (14 Days)|Physician Decision|0|||
144322061|NCT02210689|520380703|FG000|Overall Study|Withdrawal by Subject|7|||
144322062|NCT02210689|520380704|FG001|Overall Study|Withdrawal by Subject|4|||
144322063|NCT02210689|520380705|FG002|Overall Study|Withdrawal by Subject|2|||
144322064|NCT02210689|520380703|FG000|Overall Study|Adverse Event|0|||
144322065|NCT02210689|520380704|FG001|Overall Study|Adverse Event|1|||
144322066|NCT02210689|520380705|FG002|Overall Study|Adverse Event|0|||
144322067|NCT02210689|520380703|FG000|Overall Study|Protocol Violation|1|||
144322068|NCT02210689|520380704|FG001|Overall Study|Protocol Violation|0|||
144322069|NCT02210689|520380705|FG002|Overall Study|Protocol Violation|0|||
144322070|NCT02210689|520380703|FG000|Overall Study|Lost to Follow-up|11|||
144322071|NCT02210689|520380704|FG001|Overall Study|Lost to Follow-up|9|||
144322072|NCT02210689|520380705|FG002|Overall Study|Lost to Follow-up|5|||
144322073|NCT02210689|520380703|FG000|Overall Study|Pregnancy|0|||
144322074|NCT02210689|520380704|FG001|Overall Study|Pregnancy|1|||
144322075|NCT02210689|520380705|FG002|Overall Study|Pregnancy|0|||
144322076|NCT02210689|520380703|FG000|Overall Study|Lack of Efficacy|0|||
144322077|NCT02210689|520380704|FG001|Overall Study|Lack of Efficacy|1|||
144322078|NCT02210689|520380705|FG002|Overall Study|Lack of Efficacy|5|||
144322079|NCT02210689|520380703|FG000|Overall Study|Prohibited medication|2|||
144322080|NCT02210689|520380704|FG001|Overall Study|Prohibited medication|8|||
144322081|NCT02210689|520380705|FG002|Overall Study|Prohibited medication|1|||
144322082|NCT02210689|520380703|FG000|Overall Study|Negative Nugent score at baseline|6|||
144322083|NCT02210689|520380704|FG001|Overall Study|Negative Nugent score at baseline|2|||
144322084|NCT02210689|520380705|FG002|Overall Study|Negative Nugent score at baseline|2|||
144322085|NCT02210689|520380703|FG000|Overall Study|Other|25|||
144322086|NCT02210689|520380704|FG001|Overall Study|Other|21|||
144322087|NCT02210689|520380705|FG002|Overall Study|Other|8|||
144322088|NCT00075946|520380706|FG000|Overall Study|Path ineligible: undetermined histology|0|||
144322089|NCT00075946|520380707|FG001|Overall Study|Path ineligible: undetermined histology|0|||
144322090|NCT00075946|520380708|FG002|Overall Study|Path ineligible: undetermined histology|0|||
144322091|NCT00075946|520380709|FG003|Overall Study|Path ineligible: undetermined histology|0|||
144322092|NCT00075946|520380710|FG004|Overall Study|Path ineligible: undetermined histology|6|||
144322093|NCT00075946|520380706|FG000|Overall Study|Did not achieve response after induction|0|||
144322094|NCT00075946|520380707|FG001|Overall Study|Did not achieve response after induction|0|||
144322095|NCT00075946|520380708|FG002|Overall Study|Did not achieve response after induction|0|||
144322096|NCT00075946|520380709|FG003|Overall Study|Did not achieve response after induction|0|||
144322097|NCT00075946|520380710|FG004|Overall Study|Did not achieve response after induction|182|||
144322098|NCT00075946|520380706|FG000|Overall Study|Incorrectly randomized (no response)|5|||
144322099|NCT00075946|520380707|FG001|Overall Study|Incorrectly randomized (no response)|5|||
144322100|NCT00075946|520380708|FG002|Overall Study|Incorrectly randomized (no response)|5|||
144322101|NCT00075946|520380709|FG003|Overall Study|Incorrectly randomized (no response)|1|||
144322102|NCT00075946|520380710|FG004|Overall Study|Incorrectly randomized (no response)|0|||
144322103|NCT00075946|520380706|FG000|Overall Study|Adverse Event|2|||
144322104|NCT00075946|520380707|FG001|Overall Study|Adverse Event|10|||
144322105|NCT00075946|520380708|FG002|Overall Study|Adverse Event|0|||
144322106|NCT00075946|520380709|FG003|Overall Study|Adverse Event|2|||
144322107|NCT00075946|520380710|FG004|Overall Study|Adverse Event|0|||
144322108|NCT00075946|520380706|FG000|Overall Study|Death|0|||
144322109|NCT00075946|520380707|FG001|Overall Study|Death|1|||
144322110|NCT00075946|520380708|FG002|Overall Study|Death|0|||
144322111|NCT00075946|520380709|FG003|Overall Study|Death|0|||
144322112|NCT00075946|520380710|FG004|Overall Study|Death|0|||
144322113|NCT00075946|520380706|FG000|Overall Study|Withdrawal by Subject|23|||
144322114|NCT00075946|520380707|FG001|Overall Study|Withdrawal by Subject|58|||
144322115|NCT00075946|520380708|FG002|Overall Study|Withdrawal by Subject|4|||
144322116|NCT00075946|520380709|FG003|Overall Study|Withdrawal by Subject|9|||
144322117|NCT00075946|520380710|FG004|Overall Study|Withdrawal by Subject|0|||
144322118|NCT00075946|520380706|FG000|Overall Study|Alternative therapy|16|||
144322119|NCT00075946|520380707|FG001|Overall Study|Alternative therapy|2|||
144322120|NCT00075946|520380708|FG002|Overall Study|Alternative therapy|5|||
144322121|NCT00075946|520380709|FG003|Overall Study|Alternative therapy|0|||
144322122|NCT00075946|520380710|FG004|Overall Study|Alternative therapy|0|||
144322123|NCT00075946|520380706|FG000|Overall Study|Other complicating disease|7|||
144322124|NCT00075946|520380707|FG001|Overall Study|Other complicating disease|13|||
144322125|NCT00075946|520380708|FG002|Overall Study|Other complicating disease|1|||
144322126|NCT00075946|520380709|FG003|Overall Study|Other complicating disease|4|||
144322127|NCT00075946|520380710|FG004|Overall Study|Other complicating disease|0|||
144322128|NCT00075946|520380706|FG000|Overall Study|No response to retreatment|23|||
144322129|NCT00075946|520380707|FG001|Overall Study|No response to retreatment|0|||
144322130|NCT00075946|520380708|FG002|Overall Study|No response to retreatment|2|||
144322131|NCT00075946|520380709|FG003|Overall Study|No response to retreatment|0|||
144322132|NCT00075946|520380710|FG004|Overall Study|No response to retreatment|0|||
144322133|NCT00075946|520380706|FG000|Overall Study|Time to progression less than 6 months|15|||
144322134|NCT00075946|520380707|FG001|Overall Study|Time to progression less than 6 months|30|||
144322135|NCT00075946|520380708|FG002|Overall Study|Time to progression less than 6 months|8|||
144322136|NCT00075946|520380709|FG003|Overall Study|Time to progression less than 6 months|3|||
144322137|NCT00075946|520380710|FG004|Overall Study|Time to progression less than 6 months|0|||
144322138|NCT00075946|520380706|FG000|Overall Study|Other|57|||
144322139|NCT00075946|520380707|FG001|Overall Study|Other|32|||
144322140|NCT00075946|520380708|FG002|Overall Study|Other|3|||
144322141|NCT00075946|520380709|FG003|Overall Study|Other|11|||
144322142|NCT00075946|520380710|FG004|Overall Study|Other|0|||
144322143|NCT02186652|520380712|FG000|Overall Study|Lost to Follow-up|2|||
144322144|NCT02186652|520380713|FG001|Overall Study|Lost to Follow-up|0|||
144322145|NCT00503776|520380714|FG000|Overall Study|Withdrawal by Subject|1|||
144322146|NCT00503776|520380715|FG001|Overall Study|Withdrawal by Subject|0|||
144322147|NCT00503776|520380716|FG002|Overall Study|Withdrawal by Subject|1|||
144322148|NCT00503776|520380717|FG003|Overall Study|Withdrawal by Subject|1|||
144322149|NCT00503776|520380714|FG000|Overall Study|Physician Decision|0|||
144322150|NCT00503776|520380715|FG001|Overall Study|Physician Decision|0|||
144322151|NCT00503776|520380716|FG002|Overall Study|Physician Decision|1|||
144322152|NCT00503776|520380717|FG003|Overall Study|Physician Decision|1|||
144322153|NCT01453205|520380722|FG000|Overall Study|Lost to Follow-up|3|||
144322154|NCT01453205|520380723|FG001|Overall Study|Lost to Follow-up|0|||
144322155|NCT01453205|520380724|FG002|Overall Study|Lost to Follow-up|1|||
144322156|NCT01453205|520380722|FG000|Overall Study|Withdrawal by Subject|8|||
144322157|NCT01453205|520380723|FG001|Overall Study|Withdrawal by Subject|3|||
144322158|NCT01453205|520380724|FG002|Overall Study|Withdrawal by Subject|0|||
144322159|NCT01453205|520380722|FG000|Overall Study|Death|24|||
144322160|NCT01453205|520380723|FG001|Overall Study|Death|22|||
144322161|NCT01453205|520380724|FG002|Overall Study|Death|18|||
144322162|NCT01453205|520380722|FG000|Overall Study|Other|45|||
144322163|NCT01453205|520380723|FG001|Overall Study|Other|27|||
144322164|NCT01453205|520380724|FG002|Overall Study|Other|35|||
144322165|NCT05593913|520380725|FG000|Overall Study|Insufficient image quality|39|||
144322166|NCT02602275|520380730|FG000|Day 1|Physician Decision|0|||
144322167|NCT02602275|520380731|FG001|Day 1|Physician Decision|1|||
144322168|NCT05596734|520380732|FG000|Substudy A|Withdrawal by Subject|1|||
144322169|NCT05596734|520380733|FG001|Substudy A|Withdrawal by Subject|0|||
144322170|NCT05596734|520380734|FG002|Substudy A|Withdrawal by Subject|0|||
144322171|NCT05596734|520380735|FG003|Substudy A|Withdrawal by Subject|0|||
144322172|NCT05596734|520380736|FG004|Substudy A|Withdrawal by Subject|0|||
144322173|NCT05596734|520380737|FG005|Substudy A|Withdrawal by Subject|0|||
144322174|NCT05596734|520380738|FG006|Substudy A|Withdrawal by Subject|1|||
144322175|NCT05596734|520380739|FG007|Substudy A|Withdrawal by Subject|0|||
144322176|NCT05596734|520380740|FG008|Substudy A|Withdrawal by Subject|0|||
144322177|NCT05596734|520380741|FG009|Substudy A|Withdrawal by Subject|0|||
144322178|NCT05596734|520380742|FG010|Substudy A|Withdrawal by Subject|0|||
144322179|NCT05596734|520380743|FG011|Substudy A|Withdrawal by Subject|0|||
144322180|NCT05596734|520380744|FG012|Substudy A|Withdrawal by Subject|0|||
144322181|NCT05596734|520380745|FG013|Substudy A|Withdrawal by Subject|0|||
144322182|NCT05596734|520380746|FG014|Substudy A|Withdrawal by Subject|0|||
144322183|NCT05596734|520380747|FG015|Substudy A|Withdrawal by Subject|0|||
144322184|NCT05596734|520380748|FG016|Substudy A|Withdrawal by Subject|0|||
144322185|NCT05596734|520380749|FG017|Substudy A|Withdrawal by Subject|0|||
144322186|NCT05596734|520380750|FG018|Substudy A|Withdrawal by Subject|0|||
144322187|NCT05596734|520380751|FG019|Substudy A|Withdrawal by Subject|0|||
144322188|NCT05596734|520380752|FG020|Substudy A|Withdrawal by Subject|0|||
144322189|NCT05596734|520380753|FG021|Substudy A|Withdrawal by Subject|0|||
144322190|NCT05596734|520380754|FG022|Substudy A|Withdrawal by Subject|0|||
144322191|NCT05596734|520380755|FG023|Substudy A|Withdrawal by Subject|0|||
144322192|NCT05596734|520380732|FG000|Substudy A|Lost to Follow-up|1|||
144322193|NCT05596734|520380733|FG001|Substudy A|Lost to Follow-up|0|||
144322194|NCT05596734|520380734|FG002|Substudy A|Lost to Follow-up|1|||
144322195|NCT05596734|520380735|FG003|Substudy A|Lost to Follow-up|0|||
144322196|NCT05596734|520380736|FG004|Substudy A|Lost to Follow-up|0|||
144322197|NCT05596734|520380737|FG005|Substudy A|Lost to Follow-up|0|||
144322198|NCT05596734|520380738|FG006|Substudy A|Lost to Follow-up|0|||
144322199|NCT05596734|520380739|FG007|Substudy A|Lost to Follow-up|0|||
144322200|NCT05596734|520380740|FG008|Substudy A|Lost to Follow-up|0|||
144322201|NCT05596734|520380741|FG009|Substudy A|Lost to Follow-up|0|||
144322202|NCT05596734|520380742|FG010|Substudy A|Lost to Follow-up|0|||
144322203|NCT05596734|520380743|FG011|Substudy A|Lost to Follow-up|0|||
144322204|NCT05596734|520380744|FG012|Substudy A|Lost to Follow-up|0|||
144322205|NCT05596734|520380745|FG013|Substudy A|Lost to Follow-up|0|||
144322206|NCT05596734|520380746|FG014|Substudy A|Lost to Follow-up|0|||
144322207|NCT05596734|520380747|FG015|Substudy A|Lost to Follow-up|0|||
144322208|NCT05596734|520380748|FG016|Substudy A|Lost to Follow-up|0|||
144322209|NCT05596734|520380749|FG017|Substudy A|Lost to Follow-up|0|||
144322210|NCT05596734|520380750|FG018|Substudy A|Lost to Follow-up|0|||
144322211|NCT05596734|520380751|FG019|Substudy A|Lost to Follow-up|0|||
144322212|NCT05596734|520380752|FG020|Substudy A|Lost to Follow-up|0|||
144322213|NCT05596734|520380753|FG021|Substudy A|Lost to Follow-up|0|||
144322214|NCT05596734|520380754|FG022|Substudy A|Lost to Follow-up|0|||
144322215|NCT05596734|520380755|FG023|Substudy A|Lost to Follow-up|0|||
144322216|NCT05596734|520380732|FG000|Substudy B|Withdrawal by Subject|0|||
144322217|NCT05596734|520380733|FG001|Substudy B|Withdrawal by Subject|0|||
144322218|NCT05596734|520380734|FG002|Substudy B|Withdrawal by Subject|0|||
144322219|NCT05596734|520380735|FG003|Substudy B|Withdrawal by Subject|0|||
144322220|NCT05596734|520380736|FG004|Substudy B|Withdrawal by Subject|0|||
144322221|NCT05596734|520380737|FG005|Substudy B|Withdrawal by Subject|0|||
144322222|NCT05596734|520380738|FG006|Substudy B|Withdrawal by Subject|0|||
144322223|NCT05596734|520380739|FG007|Substudy B|Withdrawal by Subject|0|||
144322224|NCT05596734|520380740|FG008|Substudy B|Withdrawal by Subject|0|||
144322225|NCT05596734|520380741|FG009|Substudy B|Withdrawal by Subject|0|||
144322226|NCT05596734|520380742|FG010|Substudy B|Withdrawal by Subject|0|||
144322227|NCT05596734|520380743|FG011|Substudy B|Withdrawal by Subject|0|||
144322228|NCT05596734|520380744|FG012|Substudy B|Withdrawal by Subject|1|||
144322229|NCT05596734|520380745|FG013|Substudy B|Withdrawal by Subject|0|||
144322230|NCT05596734|520380746|FG014|Substudy B|Withdrawal by Subject|1|||
144322231|NCT05596734|520380747|FG015|Substudy B|Withdrawal by Subject|2|||
144322232|NCT05596734|520380748|FG016|Substudy B|Withdrawal by Subject|2|||
144322233|NCT05596734|520380749|FG017|Substudy B|Withdrawal by Subject|1|||
144322234|NCT05596734|520380750|FG018|Substudy B|Withdrawal by Subject|2|||
144322235|NCT05596734|520380751|FG019|Substudy B|Withdrawal by Subject|0|||
144322236|NCT05596734|520380752|FG020|Substudy B|Withdrawal by Subject|0|||
144322237|NCT05596734|520380753|FG021|Substudy B|Withdrawal by Subject|0|||
144322238|NCT05596734|520380754|FG022|Substudy B|Withdrawal by Subject|0|||
144322239|NCT05596734|520380755|FG023|Substudy B|Withdrawal by Subject|1|||
144322240|NCT05596734|520380732|FG000|Substudy B|Physician Decision|0|||
144322241|NCT05596734|520380733|FG001|Substudy B|Physician Decision|0|||
144322242|NCT05596734|520380734|FG002|Substudy B|Physician Decision|0|||
144322243|NCT05596734|520380735|FG003|Substudy B|Physician Decision|0|||
144322244|NCT05596734|520380736|FG004|Substudy B|Physician Decision|0|||
144322245|NCT05596734|520380737|FG005|Substudy B|Physician Decision|0|||
144322246|NCT05596734|520380738|FG006|Substudy B|Physician Decision|0|||
144322247|NCT05596734|520380739|FG007|Substudy B|Physician Decision|0|||
144322248|NCT05596734|520380740|FG008|Substudy B|Physician Decision|0|||
144322249|NCT05596734|520380741|FG009|Substudy B|Physician Decision|0|||
144322250|NCT05596734|520380742|FG010|Substudy B|Physician Decision|0|||
144322251|NCT05596734|520380743|FG011|Substudy B|Physician Decision|0|||
144322252|NCT05596734|520380744|FG012|Substudy B|Physician Decision|0|||
144322253|NCT05596734|520380745|FG013|Substudy B|Physician Decision|0|||
144322254|NCT05596734|520380746|FG014|Substudy B|Physician Decision|0|||
144322255|NCT05596734|520380747|FG015|Substudy B|Physician Decision|1|||
144322256|NCT05596734|520380748|FG016|Substudy B|Physician Decision|0|||
144322257|NCT05596734|520380749|FG017|Substudy B|Physician Decision|0|||
144322258|NCT05596734|520380750|FG018|Substudy B|Physician Decision|0|||
144322259|NCT05596734|520380751|FG019|Substudy B|Physician Decision|0|||
144322260|NCT05596734|520380752|FG020|Substudy B|Physician Decision|0|||
144322261|NCT05596734|520380753|FG021|Substudy B|Physician Decision|0|||
144322262|NCT05596734|520380754|FG022|Substudy B|Physician Decision|0|||
144322263|NCT05596734|520380755|FG023|Substudy B|Physician Decision|0|||
144322264|NCT05596734|520380732|FG000|Substudy B|Lost to Follow-up|0|||
144322265|NCT05596734|520380733|FG001|Substudy B|Lost to Follow-up|0|||
144322266|NCT05596734|520380734|FG002|Substudy B|Lost to Follow-up|0|||
144322267|NCT05596734|520380735|FG003|Substudy B|Lost to Follow-up|0|||
144322268|NCT05596734|520380736|FG004|Substudy B|Lost to Follow-up|0|||
144322269|NCT05596734|520380737|FG005|Substudy B|Lost to Follow-up|0|||
144322270|NCT05596734|520380738|FG006|Substudy B|Lost to Follow-up|0|||
144322271|NCT05596734|520380739|FG007|Substudy B|Lost to Follow-up|0|||
144322272|NCT05596734|520380740|FG008|Substudy B|Lost to Follow-up|0|||
144322273|NCT05596734|520380741|FG009|Substudy B|Lost to Follow-up|0|||
144322274|NCT05596734|520380742|FG010|Substudy B|Lost to Follow-up|0|||
144322275|NCT05596734|520380743|FG011|Substudy B|Lost to Follow-up|0|||
144322276|NCT05596734|520380744|FG012|Substudy B|Lost to Follow-up|1|||
144322277|NCT05596734|520380745|FG013|Substudy B|Lost to Follow-up|0|||
144322278|NCT05596734|520380746|FG014|Substudy B|Lost to Follow-up|1|||
144322279|NCT05596734|520380747|FG015|Substudy B|Lost to Follow-up|1|||
144322280|NCT05596734|520380748|FG016|Substudy B|Lost to Follow-up|0|||
144322281|NCT05596734|520380749|FG017|Substudy B|Lost to Follow-up|0|||
144322282|NCT05596734|520380750|FG018|Substudy B|Lost to Follow-up|0|||
144322283|NCT05596734|520380751|FG019|Substudy B|Lost to Follow-up|0|||
144322284|NCT05596734|520380752|FG020|Substudy B|Lost to Follow-up|0|||
144322285|NCT05596734|520380753|FG021|Substudy B|Lost to Follow-up|0|||
144322286|NCT05596734|520380754|FG022|Substudy B|Lost to Follow-up|0|||
144322287|NCT05596734|520380755|FG023|Substudy B|Lost to Follow-up|0|||
144322288|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
144322289|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144322290|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144322291|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144322292|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144322293|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
144322294|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
144322295|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
144322296|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144322297|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144322298|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144322299|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
144322300|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
144322301|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
144322302|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
144322303|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
144322304|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
144322305|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
144322306|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
144322307|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
144322308|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144322309|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144322310|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144322311|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
144322312|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
144322313|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
144322314|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
144322315|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
144322316|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
144322317|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
144322318|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
144322319|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
144322320|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
144322321|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
144322322|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
144322323|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
144322324|NCT03989349|520380760|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
144322325|NCT03989349|520380761|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
144322326|NCT03989349|520380762|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
144322327|NCT03989349|520380763|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
144322328|NCT03989349|520380764|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
144322329|NCT03989349|520380765|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
144322330|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144322331|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
144322332|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
144322333|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
144322334|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
144322335|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
144322336|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144322337|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
144322338|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
144322339|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
144322340|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
144322341|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
144322342|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
144322343|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
144322344|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
144322345|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
144322346|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
144322347|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
144322348|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144322349|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144322350|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
144322351|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144322352|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
144322353|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
144322354|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
144322355|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
144322356|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
144322357|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
144322358|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
144322359|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
144322360|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
144322361|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
144322362|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
144322363|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
144322364|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
144322365|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
144322366|NCT03989349|520380760|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
144322367|NCT03989349|520380761|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
144322368|NCT03989349|520380762|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
144322369|NCT03989349|520380763|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
144322370|NCT03989349|520380764|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
144322371|NCT03989349|520380765|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
144322372|NCT03219034|520380766|FG000|Overall Study|Lost to Follow-up|9|||
144322373|NCT03219034|520380767|FG001|Overall Study|Lost to Follow-up|13|||
144322374|NCT03219034|520380766|FG000|Overall Study|Additional dental work needed|1|||
144322375|NCT03219034|520380767|FG001|Overall Study|Additional dental work needed|0|||
144322376|NCT03219034|520380766|FG000|Overall Study|UPPP Surgery|1|||
144322377|NCT03219034|520380767|FG001|Overall Study|UPPP Surgery|0|||
144322378|NCT03219034|520380766|FG000|Overall Study|Dental sensitivity|0|||
144322379|NCT03219034|520380767|FG001|Overall Study|Dental sensitivity|1|||
144322380|NCT03219034|520380766|FG000|Overall Study|Death in family|0|||
144322381|NCT03219034|520380767|FG001|Overall Study|Death in family|1|||
144322382|NCT01802580|520380768|FG000|Overall Study|Physician Decision|1|||
144322383|NCT01802580|520380769|FG001|Overall Study|Physician Decision|0|||
144322384|NCT01802580|520380768|FG000|Overall Study|Protocol Violation|2|||
144322385|NCT01802580|520380769|FG001|Overall Study|Protocol Violation|0|||
144322386|NCT01802580|520380768|FG000|Overall Study|Withdrawal by Subject|5|||
144322387|NCT01802580|520380769|FG001|Overall Study|Withdrawal by Subject|6|||
144322388|NCT01802580|520380768|FG000|Overall Study|Other|1|||
144322389|NCT01802580|520380769|FG001|Overall Study|Other|3|||
144322390|NCT01802580|520380768|FG000|Overall Study|Lack of Efficacy|0|||
144322391|NCT01802580|520380769|FG001|Overall Study|Lack of Efficacy|2|||
144322392|NCT00778258|520380770|FG000|Overall Study|Adverse Event|1|||
144322393|NCT00778258|520380771|FG001|Overall Study|Adverse Event|0|||
144322394|NCT00778258|520380772|FG002|Overall Study|Adverse Event|0|||
144322395|NCT00778258|520380773|FG003|Overall Study|Adverse Event|0|||
144322396|NCT00778258|520380774|FG004|Overall Study|Adverse Event|0|||
144322397|NCT00778258|520380775|FG005|Overall Study|Adverse Event|1|||
144322398|NCT00778258|520380776|FG006|Overall Study|Adverse Event|0|||
144322399|NCT00778258|520380777|FG007|Overall Study|Adverse Event|0|||
144322400|NCT00778258|520380778|FG008|Overall Study|Adverse Event|0|||
144322401|NCT00778258|520380770|FG000|Overall Study|Lost to Follow-up|0|||
144322402|NCT00778258|520380771|FG001|Overall Study|Lost to Follow-up|0|||
144322403|NCT00778258|520380772|FG002|Overall Study|Lost to Follow-up|2|||
144322404|NCT00778258|520380773|FG003|Overall Study|Lost to Follow-up|0|||
144322405|NCT00778258|520380774|FG004|Overall Study|Lost to Follow-up|0|||
144322406|NCT00778258|520380775|FG005|Overall Study|Lost to Follow-up|3|||
144322407|NCT00778258|520380776|FG006|Overall Study|Lost to Follow-up|2|||
144322408|NCT00778258|520380777|FG007|Overall Study|Lost to Follow-up|2|||
144322409|NCT00778258|520380778|FG008|Overall Study|Lost to Follow-up|0|||
144322410|NCT00778258|520380770|FG000|Overall Study|Withdrawal by Subject|6|||
144322411|NCT00778258|520380771|FG001|Overall Study|Withdrawal by Subject|2|||
144322412|NCT00778258|520380772|FG002|Overall Study|Withdrawal by Subject|8|||
144322413|NCT00778258|520380773|FG003|Overall Study|Withdrawal by Subject|2|||
144322414|NCT00778258|520380774|FG004|Overall Study|Withdrawal by Subject|0|||
144322415|NCT00778258|520380775|FG005|Overall Study|Withdrawal by Subject|6|||
144322416|NCT00778258|520380776|FG006|Overall Study|Withdrawal by Subject|12|||
144322417|NCT00778258|520380777|FG007|Overall Study|Withdrawal by Subject|12|||
144322418|NCT00778258|520380778|FG008|Overall Study|Withdrawal by Subject|4|||
144322419|NCT00778258|520380770|FG000|Overall Study|New Contraindication|0|||
144322420|NCT00778258|520380771|FG001|Overall Study|New Contraindication|0|||
144322421|NCT00778258|520380772|FG002|Overall Study|New Contraindication|0|||
144322422|NCT00778258|520380773|FG003|Overall Study|New Contraindication|0|||
144322423|NCT00778258|520380774|FG004|Overall Study|New Contraindication|0|||
144322424|NCT00778258|520380775|FG005|Overall Study|New Contraindication|0|||
144322425|NCT00778258|520380776|FG006|Overall Study|New Contraindication|0|||
144322426|NCT00778258|520380777|FG007|Overall Study|New Contraindication|1|||
144322427|NCT00778258|520380778|FG008|Overall Study|New Contraindication|0|||
144322428|NCT00778258|520380770|FG000|Overall Study|Non-compliance|0|||
144322429|NCT00778258|520380771|FG001|Overall Study|Non-compliance|0|||
144322430|NCT00778258|520380772|FG002|Overall Study|Non-compliance|0|||
144322431|NCT00778258|520380773|FG003|Overall Study|Non-compliance|1|||
144322432|NCT00778258|520380774|FG004|Overall Study|Non-compliance|0|||
144322433|NCT00778258|520380775|FG005|Overall Study|Non-compliance|0|||
144322434|NCT00778258|520380776|FG006|Overall Study|Non-compliance|0|||
144322435|NCT00778258|520380777|FG007|Overall Study|Non-compliance|0|||
144322436|NCT00778258|520380778|FG008|Overall Study|Non-compliance|0|||
144322437|NCT00778258|520380770|FG000|Overall Study|Other|0|||
144322438|NCT00778258|520380771|FG001|Overall Study|Other|0|||
144322439|NCT00778258|520380772|FG002|Overall Study|Other|0|||
144322440|NCT00778258|520380773|FG003|Overall Study|Other|0|||
144322441|NCT00778258|520380774|FG004|Overall Study|Other|0|||
144322442|NCT00778258|520380775|FG005|Overall Study|Other|0|||
144322443|NCT00778258|520380776|FG006|Overall Study|Other|1|||
144322444|NCT00778258|520380777|FG007|Overall Study|Other|0|||
144322445|NCT00778258|520380778|FG008|Overall Study|Other|0|||
144322446|NCT02438683|520380779|FG000|Overall Study|Adverse Event|1|||
144322447|NCT02438683|520380780|FG001|Overall Study|Adverse Event|0|||
144322448|NCT02438683|520380781|FG002|Overall Study|Adverse Event|0|||
144322449|NCT02438683|520380782|FG003|Overall Study|Adverse Event|0|||
144322450|NCT02438683|520380783|FG004|Overall Study|Adverse Event|0|||
144322451|NCT02438683|520380784|FG005|Overall Study|Adverse Event|0|||
144322452|NCT02136680|520380787|FG000|Overall Study|No Longer Interested|1|||
144322453|NCT02136680|520380788|FG001|Overall Study|No Longer Interested|1|||
144322454|NCT02136680|520380787|FG000|Overall Study|No longer receiving care at clinic|3|||
144322455|NCT02136680|520380788|FG001|Overall Study|No longer receiving care at clinic|5|||
144322456|NCT02136680|520380787|FG000|Overall Study|Moved away|5|||
144322457|NCT02136680|520380788|FG001|Overall Study|Moved away|4|||
144322458|NCT02136680|520380787|FG000|Overall Study|Unable to schedule|17|||
144322459|NCT02136680|520380788|FG001|Overall Study|Unable to schedule|16|||
144322460|NCT02136680|520380787|FG000|Overall Study|Study ended before interview due|6|||
144322461|NCT02136680|520380788|FG001|Overall Study|Study ended before interview due|3|||
144322462|NCT01846299|520380793|FG000|Overall Study|Physician Decision|4|||
144322463|NCT01846299|520380794|FG001|Overall Study|Physician Decision|2|||
144322464|NCT01846299|520380793|FG000|Overall Study|Protocol deviation|1|||
144322465|NCT01846299|520380794|FG001|Overall Study|Protocol deviation|0|||
144322466|NCT01846299|520380793|FG000|Overall Study|Death|1|||
144322467|NCT01846299|520380794|FG001|Overall Study|Death|2|||
144322468|NCT01846299|520380793|FG000|Overall Study|Lost to Follow-up|3|||
144322469|NCT01846299|520380794|FG001|Overall Study|Lost to Follow-up|0|||
144322470|NCT01846299|520380793|FG000|Overall Study|Withdrawal by Subject|1|||
144322471|NCT01846299|520380794|FG001|Overall Study|Withdrawal by Subject|6|||
144322472|NCT01846299|520380793|FG000|Overall Study|Adverse Event|2|||
144322473|NCT01846299|520380794|FG001|Overall Study|Adverse Event|0|||
144322474|NCT03559517|520380795|FG000|Overall Study|Withdrawal by Subject|1|||
144322475|NCT03559517|520380796|FG001|Overall Study|Withdrawal by Subject|0|||
144322476|NCT03559517|520380797|FG002|Overall Study|Withdrawal by Subject|0|||
144322477|NCT03285958|520382652|FG000|Overall Study|Lost to Follow-up|1|||
144322478|NCT03285958|520382653|FG001|Overall Study|Lost to Follow-up|1|||
144322479|NCT03285958|520382652|FG000|Overall Study|Withdrawal by Subject|1|||
144322480|NCT03285958|520382653|FG001|Overall Study|Withdrawal by Subject|0|||
144322481|NCT03285958|520382652|FG000|Overall Study|Not able to attend required orientation|3|||
144322482|NCT03285958|520382653|FG001|Overall Study|Not able to attend required orientation|0|||
144322483|NCT03116828|520382656|FG000|Overall Study|Adverse Event|1|||
144322484|NCT03116828|520382657|FG001|Overall Study|Adverse Event|10|||
144322485|NCT03116828|520382656|FG000|Overall Study|Withdrawal by Subject|4|||
144322486|NCT03116828|520382657|FG001|Overall Study|Withdrawal by Subject|8|||
144322487|NCT03116828|520382656|FG000|Overall Study|OTHER|3|||
144322488|NCT03116828|520382657|FG001|Overall Study|OTHER|3|||
144322489|NCT01559259|520382665|FG000|Overall Study|Withdrawal by Subject|0|||
144322490|NCT01559259|520382666|FG001|Overall Study|Withdrawal by Subject|0|||
144322491|NCT01559259|520382667|FG002|Overall Study|Withdrawal by Subject|0|||
144322492|NCT01559259|520382668|FG003|Overall Study|Withdrawal by Subject|1|||
144322493|NCT01559259|520382669|FG004|Overall Study|Withdrawal by Subject|0|||
144322494|NCT01559259|520382665|FG000|Overall Study|Adverse Event|0|||
144322495|NCT01559259|520382666|FG001|Overall Study|Adverse Event|1|||
144322496|NCT01559259|520382667|FG002|Overall Study|Adverse Event|1|||
144322497|NCT01559259|520382668|FG003|Overall Study|Adverse Event|0|||
144322498|NCT01559259|520382669|FG004|Overall Study|Adverse Event|0|||
144322499|NCT01995669|520382670|FG000|Overall Study|Progression|2|||
144322500|NCT01995669|520382671|FG001|Overall Study|Progression|1|||
144322501|NCT01995669|520382672|FG002|Overall Study|Progression|1|||
144322502|NCT01995669|520382673|FG003|Overall Study|Progression|13|||
144322503|NCT01995669|520382670|FG000|Overall Study|Adverse Event|0|||
144322504|NCT01995669|520382671|FG001|Overall Study|Adverse Event|0|||
144322505|NCT01995669|520382672|FG002|Overall Study|Adverse Event|0|||
144322506|NCT01995669|520382673|FG003|Overall Study|Adverse Event|3|||
144322507|NCT01995669|520382670|FG000|Overall Study|Death|0|||
144322508|NCT01995669|520382671|FG001|Overall Study|Death|0|||
144322509|NCT01995669|520382672|FG002|Overall Study|Death|0|||
144322510|NCT01995669|520382673|FG003|Overall Study|Death|6|||
144322511|NCT01995669|520382670|FG000|Overall Study|Withdrawal by Subject|0|||
144322512|NCT01995669|520382671|FG001|Overall Study|Withdrawal by Subject|0|||
144322513|NCT01995669|520382672|FG002|Overall Study|Withdrawal by Subject|0|||
144322514|NCT01995669|520382673|FG003|Overall Study|Withdrawal by Subject|6|||
144322515|NCT01995669|520382670|FG000|Overall Study|Insurance Expired|0|||
144322516|NCT01995669|520382671|FG001|Overall Study|Insurance Expired|0|||
144322517|NCT01995669|520382672|FG002|Overall Study|Insurance Expired|0|||
144322518|NCT01995669|520382673|FG003|Overall Study|Insurance Expired|1|||
144322519|NCT05425732|520382674|FG000|Overall Study|Death|4|||
144322520|NCT05425732|520382675|FG001|Overall Study|Death|2|||
144322521|NCT05425732|520382676|FG002|Overall Study|Death|0|||
144322522|NCT05425732|520382677|FG003|Overall Study|Death|0|||
144322523|NCT05425732|520382674|FG000|Overall Study|Lost to Follow-up|10|||
144322524|NCT05425732|520382675|FG001|Overall Study|Lost to Follow-up|15|||
144322525|NCT05425732|520382676|FG002|Overall Study|Lost to Follow-up|5|||
144322526|NCT05425732|520382677|FG003|Overall Study|Lost to Follow-up|3|||
144322527|NCT05425732|520382674|FG000|Overall Study|Physician Decision|0|||
144322528|NCT05425732|520382675|FG001|Overall Study|Physician Decision|2|||
144322529|NCT05425732|520382676|FG002|Overall Study|Physician Decision|0|||
144322530|NCT05425732|520382677|FG003|Overall Study|Physician Decision|0|||
144322531|NCT05425732|520382674|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
144322532|NCT05425732|520382675|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
144322533|NCT05425732|520382676|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144322534|NCT05425732|520382677|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
144322535|NCT05425732|520382674|FG000|Overall Study|Withdrawal by Subject|4|||
144322536|NCT05425732|520382675|FG001|Overall Study|Withdrawal by Subject|8|||
144322537|NCT05425732|520382676|FG002|Overall Study|Withdrawal by Subject|1|||
144322538|NCT05425732|520382677|FG003|Overall Study|Withdrawal by Subject|1|||
144322539|NCT05425732|520382674|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
144322540|NCT05425732|520382675|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
144322541|NCT05425732|520382676|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
144322542|NCT05425732|520382677|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
144322543|NCT00539513|520382678|FG000|Overall Study|Withdrawal by Subject|2|||
144322544|NCT00539513|520382679|FG001|Overall Study|Withdrawal by Subject|1|||
144322545|NCT00539513|520382678|FG000|Overall Study|Lost to Follow-up|0|||
144322546|NCT00539513|520382679|FG001|Overall Study|Lost to Follow-up|1|||
144322547|NCT01328041|520382680|FG000|Overall Study|Adverse Event|7|||
144322548|NCT01328041|520382680|FG000|Overall Study|Lack of Efficacy|27|||
144322549|NCT01328041|520382680|FG000|Overall Study|Protocol Violation|7|||
144322550|NCT01328041|520382680|FG000|Overall Study|Lost to Follow-up|7|||
144322551|NCT01328041|520382680|FG000|Overall Study|Physician Decision|2|||
144322552|NCT01328041|520382680|FG000|Overall Study|Withdrawal by Subject|7|||
144322553|NCT00711113|520382681|FG000|Overall Study|Lost to Follow-up|9|||
144322554|NCT00711113|520382681|FG000|Overall Study|Implant lost|2|||
144322555|NCT02688088|520382686|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
144322556|NCT02688088|520382687|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
144322557|NCT02688088|520382688|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
144322558|NCT02688088|520382689|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
144322559|NCT02688088|520382690|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
144322560|NCT02688088|520382686|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
144322561|NCT02688088|520382687|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
144322562|NCT02688088|520382688|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
144322563|NCT02688088|520382689|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
144322564|NCT02688088|520382690|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
144322565|NCT02688088|520382686|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
144322566|NCT02688088|520382687|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
144322567|NCT02688088|520382688|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
144322568|NCT02688088|520382689|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
144322569|NCT02688088|520382690|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
144322570|NCT02688088|520382686|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
144322571|NCT02688088|520382687|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
144322572|NCT02688088|520382688|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
144322573|NCT02688088|520382689|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
144322574|NCT02688088|520382690|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
144322575|NCT02688088|520382686|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
144322576|NCT02688088|520382687|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
144322577|NCT02688088|520382688|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
144322578|NCT02688088|520382689|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
144322579|NCT02688088|520382690|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
144322580|NCT02688088|520382686|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
144322581|NCT02688088|520382687|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
144322582|NCT02688088|520382688|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
144322583|NCT02688088|520382689|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
144322584|NCT02688088|520382690|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
144322585|NCT02688088|520382686|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
144322586|NCT02688088|520382687|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
144322587|NCT02688088|520382688|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
144322588|NCT02688088|520382689|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
144322589|NCT02688088|520382690|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
144322590|NCT02688088|520382686|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
144322591|NCT02688088|520382687|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
144322592|NCT02688088|520382688|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
144322593|NCT02688088|520382689|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
144322594|NCT02688088|520382690|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
144322595|NCT02688088|520382686|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
144322596|NCT02688088|520382687|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
144322597|NCT02688088|520382688|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
144322598|NCT02688088|520382689|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
144322599|NCT02688088|520382690|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
144322600|NCT01231321|520382694|FG000|Overall Study|Adverse Event|3|||
144322601|NCT01231321|520382694|FG000|Overall Study|Lack of Efficacy|2|||
144322602|NCT04021524|520382695|FG000|Overall Study|Change in surgical intervention|0|||
144322603|NCT04021524|520382696|FG001|Overall Study|Change in surgical intervention|1|||
144322604|NCT01681069|520382697|FG000|Overall Study|Withdrawal by Subject|4|||
144322605|NCT01681069|520382698|FG001|Overall Study|Withdrawal by Subject|5|||
144322606|NCT01681069|520382697|FG000|Overall Study|Protocol Violation|1|||
144322607|NCT01681069|520382698|FG001|Overall Study|Protocol Violation|1|||
144322608|NCT01681069|520382697|FG000|Overall Study|Adverse Event|0|||
144322609|NCT01681069|520382698|FG001|Overall Study|Adverse Event|1|||
144322610|NCT03883165|520382699|FG000|Overall Study|Withdrawal by Subject|4|||
144322611|NCT03883165|520382700|FG001|Overall Study|Withdrawal by Subject|3|||
144322612|NCT00245050|520382702|FG000|Overall Study|Adverse Event|3|||
144322613|NCT00245050|520382703|FG001|Overall Study|Adverse Event|2|||
144322614|NCT00730041|520382708|FG000|Overall Study|Lost to Follow-up|0|||
144322615|NCT00730041|520382709|FG001|Overall Study|Lost to Follow-up|2|||
144322616|NCT02301546|520382710|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
144322617|NCT02301546|520382711|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
144322618|NCT02301546|520382710|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
144322619|NCT02301546|520382711|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
144322620|NCT02301546|520382710|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
144322621|NCT02301546|520382711|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
144322622|NCT02301546|520382710|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
144322623|NCT02301546|520382711|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
144322624|NCT02301546|520382710|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
144322625|NCT02301546|520382711|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
144322626|NCT02301546|520382710|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
144322627|NCT02301546|520382711|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
144322628|NCT02301546|520382710|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
144322629|NCT02301546|520382711|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
144322630|NCT05526781|520382714|FG000|Overall Study|Lost to Follow-up|1|||
144322631|NCT01801436|520382717|FG000|Overall Study|Withdrawal by Subject|3|||
144322632|NCT01801436|520382717|FG000|Overall Study|Adverse Event|2|||
144322633|NCT01801436|520382717|FG000|Overall Study|Progressive disease|4|||
144322634|NCT04085458|520382718|FG000|Overall Study|Other|1|||
144322635|NCT04085458|520382718|FG000|Overall Study|Withdrawal by Subject|2|||
144322636|NCT04085458|520382718|FG000|Overall Study|Adverse Event|2|||
144322637|NCT02447250|520382719|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
144322638|NCT02447250|520382719|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
144322639|NCT02447250|520382719|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
144322640|NCT03632993|520382720|FG000|Overall Study|Withdrawal by Subject|1|||
144322641|NCT03632993|520382721|FG001|Overall Study|Withdrawal by Subject|0|||
144322642|NCT03632993|520382722|FG002|Overall Study|Withdrawal by Subject|0|||
144322643|NCT03632993|520382723|FG003|Overall Study|Withdrawal by Subject|0|||
144322644|NCT03632993|520382724|FG004|Overall Study|Withdrawal by Subject|0|||
144322645|NCT03632993|520382725|FG005|Overall Study|Withdrawal by Subject|0|||
144322646|NCT03632993|520382726|FG006|Overall Study|Withdrawal by Subject|0|||
144322647|NCT03632993|520382727|FG007|Overall Study|Withdrawal by Subject|0|||
144322648|NCT03632993|520382728|FG008|Overall Study|Withdrawal by Subject|0|||
144322649|NCT03632993|520382729|FG009|Overall Study|Withdrawal by Subject|1|||
144322650|NCT03632993|520382720|FG000|Overall Study|Protocol Non-compliance|0|||
144322651|NCT03632993|520382721|FG001|Overall Study|Protocol Non-compliance|1|||
144322652|NCT03632993|520382722|FG002|Overall Study|Protocol Non-compliance|0|||
144322653|NCT03632993|520382723|FG003|Overall Study|Protocol Non-compliance|0|||
144322654|NCT03632993|520382724|FG004|Overall Study|Protocol Non-compliance|0|||
144322655|NCT03632993|520382725|FG005|Overall Study|Protocol Non-compliance|0|||
144322656|NCT03632993|520382726|FG006|Overall Study|Protocol Non-compliance|0|||
144322657|NCT03632993|520382727|FG007|Overall Study|Protocol Non-compliance|0|||
144322658|NCT03632993|520382728|FG008|Overall Study|Protocol Non-compliance|0|||
144322659|NCT03632993|520382729|FG009|Overall Study|Protocol Non-compliance|0|||
144322660|NCT03632993|520382720|FG000|Overall Study|Lost to Follow-up|0|||
144322661|NCT03632993|520382721|FG001|Overall Study|Lost to Follow-up|0|||
144322662|NCT03632993|520382722|FG002|Overall Study|Lost to Follow-up|0|||
144322663|NCT03632993|520382723|FG003|Overall Study|Lost to Follow-up|0|||
144322664|NCT03632993|520382724|FG004|Overall Study|Lost to Follow-up|0|||
144322665|NCT03632993|520382725|FG005|Overall Study|Lost to Follow-up|1|||
144322666|NCT03632993|520382726|FG006|Overall Study|Lost to Follow-up|0|||
144322667|NCT03632993|520382727|FG007|Overall Study|Lost to Follow-up|1|||
144322668|NCT03632993|520382728|FG008|Overall Study|Lost to Follow-up|0|||
144322669|NCT03632993|520382729|FG009|Overall Study|Lost to Follow-up|0|||
144322670|NCT03632993|520382720|FG000|Overall Study|Adverse Event|0|||
144322671|NCT03632993|520382721|FG001|Overall Study|Adverse Event|0|||
144322672|NCT03632993|520382722|FG002|Overall Study|Adverse Event|0|||
144322673|NCT03632993|520382723|FG003|Overall Study|Adverse Event|0|||
144322674|NCT03632993|520382724|FG004|Overall Study|Adverse Event|0|||
144322675|NCT03632993|520382725|FG005|Overall Study|Adverse Event|1|||
144322676|NCT03632993|520382726|FG006|Overall Study|Adverse Event|0|||
144322677|NCT03632993|520382727|FG007|Overall Study|Adverse Event|1|||
144322678|NCT03632993|520382728|FG008|Overall Study|Adverse Event|0|||
144322679|NCT03632993|520382729|FG009|Overall Study|Adverse Event|0|||
144322680|NCT00368836|520382732|FG000|Phase II|Screen Failure|1|||
144322681|NCT00368836|520382732|FG000|Phase II|Withdrawal by Subject|1|||
144322682|NCT00368836|520382732|FG000|Phase II|unable to collect blood and/or breath|17|||
144322683|NCT00368836|520382732|FG000|Phase II|Protocol Violation|2|||
144322684|NCT01345591|520382737|FG000|Overall Study|Lost to Follow-up|1|||
144322685|NCT00090142|520382738|FG000|Treatment Period I|Lost to Follow-up|1|||
144322686|NCT00090142|520382739|FG001|Treatment Period I|Lost to Follow-up|2|||
144322687|NCT00090142|520382738|FG000|Treatment Period I|Protocol Violation|2|||
144322688|NCT00090142|520382739|FG001|Treatment Period I|Protocol Violation|0|||
144322689|NCT00090142|520382738|FG000|Treatment Period I|Withdrawal by Subject|2|||
144322690|NCT00090142|520382739|FG001|Treatment Period I|Withdrawal by Subject|0|||
144322691|NCT00090142|520382738|FG000|Treatment Period I|Other|0|||
144322692|NCT00090142|520382739|FG001|Treatment Period I|Other|1|||
144322693|NCT00090142|520382738|FG000|Treatment Period II|Other|1|||
144322694|NCT00090142|520382739|FG001|Treatment Period II|Other|0|||
144322695|NCT02442310|520382740|FG000|Overall Study|Adverse Event|2|||
144322696|NCT02442310|520382740|FG000|Overall Study|Withdrawal by Subject|1|||
144322697|NCT01126437|520382741|FG000|Overall Study|Not treated|11|||
144322698|NCT01126437|520382742|FG001|Overall Study|Not treated|18|||
144322699|NCT01126437|520382743|FG002|Overall Study|Not treated|19|||
144322700|NCT01126437|520382741|FG000|Overall Study|Sites with data irregularities/fraud|6|||
144322701|NCT01126437|520382742|FG001|Overall Study|Sites with data irregularities/fraud|6|||
144322702|NCT01126437|520382743|FG002|Overall Study|Sites with data irregularities/fraud|7|||
144322703|NCT01126437|520382741|FG000|Overall Study|Adverse Event|602|||
144322704|NCT01126437|520382742|FG001|Overall Study|Adverse Event|606|||
144322705|NCT01126437|520382743|FG002|Overall Study|Adverse Event|635|||
144322706|NCT01126437|520382741|FG000|Overall Study|Lack of Efficacy|65|||
144322707|NCT01126437|520382742|FG001|Overall Study|Lack of Efficacy|60|||
144322708|NCT01126437|520382743|FG002|Overall Study|Lack of Efficacy|59|||
144322709|NCT01126437|520382741|FG000|Overall Study|Protocol Violation|64|||
144322710|NCT01126437|520382742|FG001|Overall Study|Protocol Violation|66|||
144322711|NCT01126437|520382743|FG002|Overall Study|Protocol Violation|41|||
144322712|NCT01126437|520382741|FG000|Overall Study|Lost to Follow-up|52|||
144322713|NCT01126437|520382742|FG001|Overall Study|Lost to Follow-up|63|||
144322714|NCT01126437|520382743|FG002|Overall Study|Lost to Follow-up|55|||
144322715|NCT01126437|520382741|FG000|Overall Study|Withdrawal by Subject|331|||
144322716|NCT01126437|520382742|FG001|Overall Study|Withdrawal by Subject|335|||
144322717|NCT01126437|520382743|FG002|Overall Study|Withdrawal by Subject|319|||
144322718|NCT01126437|520382741|FG000|Overall Study|Other reason not specified|210|||
144322719|NCT01126437|520382742|FG001|Overall Study|Other reason not specified|176|||
144322720|NCT01126437|520382743|FG002|Overall Study|Other reason not specified|178|||
144322721|NCT00006046|520382755|FG000|Overall Study|Adverse Event|3|||
144322722|NCT00006046|520382756|FG001|Overall Study|Adverse Event|0|||
144322723|NCT00006046|520382757|FG002|Overall Study|Adverse Event|0|||
144322724|NCT00006046|520382758|FG003|Overall Study|Adverse Event|0|||
144322725|NCT00006046|520382759|FG004|Overall Study|Adverse Event|0|||
144322726|NCT00006046|520382755|FG000|Overall Study|Disease Progression|2|||
144322727|NCT00006046|520382756|FG001|Overall Study|Disease Progression|0|||
144322728|NCT00006046|520382757|FG002|Overall Study|Disease Progression|0|||
144322729|NCT00006046|520382758|FG003|Overall Study|Disease Progression|0|||
144322730|NCT00006046|520382759|FG004|Overall Study|Disease Progression|0|||
144322731|NCT01972308|520382760|FG000|Overall Study|Withdrawal by Subject|0|||
144322732|NCT01972308|520382761|FG001|Overall Study|Withdrawal by Subject|1|||
144322733|NCT01972308|520382760|FG000|Overall Study|Lost to Follow-up|4|||
144322734|NCT01972308|520382761|FG001|Overall Study|Lost to Follow-up|6|||
144322735|NCT01972308|520382760|FG000|Overall Study|Death|4|||
144322736|NCT01972308|520382761|FG001|Overall Study|Death|1|||
144322737|NCT00596154|520382762|FG000|Overall Study|Not Evaluable|2|||
144322738|NCT01846663|520382767|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
144322739|NCT01846663|520382768|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
144322740|NCT01846663|520382767|FG000|Overall Study|Withdrawal by Subject|1|||
144322741|NCT01846663|520382768|FG001|Overall Study|Withdrawal by Subject|0|||
144322742|NCT01846663|520382767|FG000|Overall Study|Adverse Event|1|||
144322743|NCT01846663|520382768|FG001|Overall Study|Adverse Event|2|||
144322744|NCT02851797|520382776|FG000|Overall Study|Withdrawal by Subject|4|||
144322745|NCT02851797|520382777|FG001|Overall Study|Withdrawal by Subject|2|||
144322746|NCT02851797|520382776|FG000|Overall Study|Adverse Event|3|||
144322747|NCT02851797|520382777|FG001|Overall Study|Adverse Event|0|||
144322748|NCT00813865|520382778|FG000|Overall Study|Failure to Respond|3|||
144322749|NCT00813865|520382778|FG000|Overall Study|Lost to Follow-up|3|||
144322750|NCT00813865|520382778|FG000|Overall Study|Withdrawal by Subject|1|||
144322751|NCT00624585|520382789|FG000|Overall Study|Death|3|||
144322752|NCT00624585|520382789|FG000|Overall Study|Disease Progression|6|||
144322753|NCT00624585|520382789|FG000|Overall Study|Adverse Event|3|||
144322754|NCT02256384|520382790|FG000|Overall Study|Withdrawal by Subject|12|||
144322755|NCT02256384|520382790|FG000|Overall Study|Equipment not capturing data|2|||
144322756|NCT01425359|520382797|FG000|Overall Study|Randomized but Not Treated|2|||
144322757|NCT01425359|520382798|FG001|Overall Study|Randomized but Not Treated|3|||
144322758|NCT01425359|520382797|FG000|Overall Study|Adverse Event|9|||
144322759|NCT01425359|520382798|FG001|Overall Study|Adverse Event|8|||
144322760|NCT01425359|520382797|FG000|Overall Study|Revascularization|0|||
144322761|NCT01425359|520382798|FG001|Overall Study|Revascularization|1|||
144322762|NCT01425359|520382797|FG000|Overall Study|Death|0|||
144322763|NCT01425359|520382798|FG001|Overall Study|Death|1|||
144322764|NCT01425359|520382797|FG000|Overall Study|Unsatisfactory Response|1|||
144322765|NCT01425359|520382798|FG001|Overall Study|Unsatisfactory Response|0|||
144322766|NCT01425359|520382797|FG000|Overall Study|Protocol Violation|1|||
144322767|NCT01425359|520382798|FG001|Overall Study|Protocol Violation|2|||
144322768|NCT01425359|520382797|FG000|Overall Study|Subject Withdrew Consent|1|||
144322769|NCT01425359|520382798|FG001|Overall Study|Subject Withdrew Consent|2|||
144322770|NCT01425359|520382797|FG000|Overall Study|Investigator's Discretion|2|||
144322771|NCT01425359|520382798|FG001|Overall Study|Investigator's Discretion|0|||
144322772|NCT01425359|520382797|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
144322773|NCT01425359|520382798|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
144322774|NCT01229254|520382809|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
144322775|NCT01229254|520382810|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
144322776|NCT01229254|520382811|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
144322777|NCT01229254|520382809|FG000|Overall Study|Adverse Event|4|||
144322778|NCT01229254|520382810|FG001|Overall Study|Adverse Event|5|||
144322779|NCT01229254|520382811|FG002|Overall Study|Adverse Event|3|||
144322780|NCT01229254|520382809|FG000|Overall Study|Lost to Follow-up|3|||
144322781|NCT01229254|520382810|FG001|Overall Study|Lost to Follow-up|0|||
144322782|NCT01229254|520382811|FG002|Overall Study|Lost to Follow-up|1|||
144322783|NCT01229254|520382809|FG000|Overall Study|Physician Decision|0|||
144322784|NCT01229254|520382810|FG001|Overall Study|Physician Decision|3|||
144322785|NCT01229254|520382811|FG002|Overall Study|Physician Decision|0|||
144322786|NCT01229254|520382809|FG000|Overall Study|Protocol Violation|4|||
144322787|NCT01229254|520382810|FG001|Overall Study|Protocol Violation|6|||
144322788|NCT01229254|520382811|FG002|Overall Study|Protocol Violation|5|||
144322789|NCT01229254|520382809|FG000|Overall Study|Withdrawal by Subject|1|||
144322790|NCT01229254|520382810|FG001|Overall Study|Withdrawal by Subject|0|||
144322791|NCT01229254|520382811|FG002|Overall Study|Withdrawal by Subject|1|||
144322792|NCT01229254|520382809|FG000|Overall Study|Non-compliance with Study Drug|0|||
144322793|NCT01229254|520382810|FG001|Overall Study|Non-compliance with Study Drug|1|||
144322794|NCT01229254|520382811|FG002|Overall Study|Non-compliance with Study Drug|1|||
144322795|NCT05427539|520382814|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
144322796|NCT05427539|520382815|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
144322797|NCT05427539|520382814|FG000|Period 1|Withdrawal by Subject|1|||
144322798|NCT05427539|520382815|FG001|Period 1|Withdrawal by Subject|0|||
144322799|NCT00223977|520382816|FG000|Overall Study|Adverse Event|7|||
144322800|NCT00223977|520382817|FG001|Overall Study|Adverse Event|10|||
144322801|NCT00223977|520382818|FG002|Overall Study|Adverse Event|0|||
144322802|NCT00223977|520382816|FG000|Overall Study|Protocol Violation|0|||
144322803|NCT00223977|520382817|FG001|Overall Study|Protocol Violation|0|||
144322804|NCT00223977|520382818|FG002|Overall Study|Protocol Violation|1|||
144322805|NCT00223977|520382816|FG000|Overall Study|Withdrawal by Subject|1|||
144322806|NCT00223977|520382817|FG001|Overall Study|Withdrawal by Subject|1|||
144322807|NCT00223977|520382818|FG002|Overall Study|Withdrawal by Subject|2|||
144322808|NCT00223977|520382816|FG000|Overall Study|Other|1|||
144322809|NCT00223977|520382817|FG001|Overall Study|Other|0|||
144322810|NCT00223977|520382818|FG002|Overall Study|Other|0|||
144322811|NCT03359785|520382819|FG000|Overall Study|Protocol Violation|0|||
144322812|NCT03359785|520382820|FG001|Overall Study|Protocol Violation|1|||
144322813|NCT03359785|520382821|FG002|Overall Study|Protocol Violation|0|||
144322814|NCT03359785|520382822|FG003|Overall Study|Protocol Violation|0|||
144322815|NCT03359785|520382819|FG000|Overall Study|Early study termination due to study pause|0|||
144322816|NCT03359785|520382820|FG001|Overall Study|Early study termination due to study pause|0|||
144322817|NCT03359785|520382821|FG002|Overall Study|Early study termination due to study pause|2|||
144322818|NCT03359785|520382822|FG003|Overall Study|Early study termination due to study pause|0|||
144322819|NCT03359785|520382819|FG000|Overall Study|Withdrawal by Subject|2|||
144322820|NCT03359785|520382820|FG001|Overall Study|Withdrawal by Subject|2|||
144322821|NCT03359785|520382821|FG002|Overall Study|Withdrawal by Subject|0|||
144322822|NCT03359785|520382822|FG003|Overall Study|Withdrawal by Subject|0|||
144322823|NCT01895543|520382823|FG000|Overall Study|Withdrawal by Subject|43|||
144322824|NCT01895543|520382823|FG000|Overall Study|Lost to Follow-up|25|||
144322825|NCT01895543|520382823|FG000|Overall Study|Adverse Event|28|||
144322826|NCT01895543|520382823|FG000|Overall Study|Subject's substantial non-compliance|6|||
144322827|NCT01895543|520382823|FG000|Overall Study|Protocol Violation|1|||
144322828|NCT01895543|520382823|FG000|Overall Study|Physician Decision|2|||
144322829|NCT01895543|520382823|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
144322830|NCT02649218|520382829|FG000|Overall Study|Adverse Event|8|||
144322831|NCT02649218|520382829|FG000|Overall Study|Lack of Efficacy|8|||
144322832|NCT02649218|520382829|FG000|Overall Study|Pregnancy|3|||
144322833|NCT02649218|520382829|FG000|Overall Study|Protocol Violation|3|||
144322834|NCT02649218|520382829|FG000|Overall Study|Physician Decision|1|||
144322835|NCT02649218|520382829|FG000|Overall Study|Withdrawal by Subject|2|||
144322836|NCT04470908|520382830|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
144322837|NCT04376684|520382831|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
144322838|NCT04376684|520382832|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
144322839|NCT04376684|520382833|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
144322840|NCT04376684|520382834|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
144322841|NCT04376684|520382831|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
144322842|NCT04376684|520382832|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
144322843|NCT04376684|520382833|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
144322844|NCT04376684|520382834|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
144322845|NCT04376684|520382831|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
144322846|NCT04376684|520382832|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
144322847|NCT04376684|520382833|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
144322848|NCT04376684|520382834|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
144322849|NCT04376684|520382831|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
144322850|NCT04376684|520382832|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
144322851|NCT04376684|520382833|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
144322852|NCT04376684|520382834|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
144322853|NCT04376684|520382831|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
144322854|NCT04376684|520382832|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
144322855|NCT04376684|520382833|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
144322856|NCT04376684|520382834|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
144322857|NCT04376684|520382831|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
144322858|NCT04376684|520382832|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
144322859|NCT04376684|520382833|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
144322860|NCT04376684|520382834|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
144322861|NCT04376684|520382831|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
144322862|NCT04376684|520382832|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
144322863|NCT04376684|520382833|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
144322864|NCT04376684|520382834|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
144322865|NCT01301066|520382840|FG000|Overall Study|Lost to Follow-up|5|||
144322866|NCT01301066|520382841|FG001|Overall Study|Lost to Follow-up|11|||
144322867|NCT01301066|520382840|FG000|Overall Study|Protocol Violation|8|||
144322868|NCT01301066|520382841|FG001|Overall Study|Protocol Violation|7|||
144322869|NCT01301066|520382840|FG000|Overall Study|Withdrawal by Subject|4|||
144322870|NCT01301066|520382841|FG001|Overall Study|Withdrawal by Subject|9|||
144322871|NCT01301066|520382840|FG000|Overall Study|Adverse Event|6|||
144322872|NCT01301066|520382841|FG001|Overall Study|Adverse Event|6|||
144322873|NCT01301066|520382840|FG000|Overall Study|Sponsor Decision|2|||
144322874|NCT01301066|520382841|FG001|Overall Study|Sponsor Decision|1|||
144322875|NCT01301066|520382840|FG000|Overall Study|Physician Decision|0|||
144322876|NCT01301066|520382841|FG001|Overall Study|Physician Decision|1|||
144322877|NCT01301066|520382840|FG000|Overall Study|Other|2|||
144322878|NCT01301066|520382841|FG001|Overall Study|Other|0|||
144322879|NCT01330628|520382846|FG000|Overall Study|Death|2|||
144322880|NCT01330628|520382847|FG001|Overall Study|Death|3|||
144322881|NCT01330628|520382846|FG000|Overall Study|Lost to Follow-up|5|||
144322882|NCT01330628|520382847|FG001|Overall Study|Lost to Follow-up|6|||
144322883|NCT01330628|520382846|FG000|Overall Study|Adverse Event|44|||
144322884|NCT01330628|520382847|FG001|Overall Study|Adverse Event|25|||
144322885|NCT01330628|520382846|FG000|Overall Study|Withdrawn|18|||
144322886|NCT01330628|520382847|FG001|Overall Study|Withdrawn|6|||
144322887|NCT01330628|520382846|FG000|Overall Study|Didn't receive study treatment|1|||
144322888|NCT01330628|520382847|FG001|Overall Study|Didn't receive study treatment|0|||
144322889|NCT01740089|520384782|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
144322890|NCT01740089|520384783|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
144322891|NCT01740089|520384784|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
144322892|NCT01740089|520384782|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
144322893|NCT01740089|520384783|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
144322894|NCT01740089|520384784|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
144322895|NCT01740089|520384782|FG000|After 12 Weeks|Lack of Efficacy|3|||
144322896|NCT01740089|520384783|FG001|After 12 Weeks|Lack of Efficacy|1|||
144322897|NCT01740089|520384784|FG002|After 12 Weeks|Lack of Efficacy|4|||
144322898|NCT01740089|520384782|FG000|After 12 Weeks|Adverse Event|2|||
144322899|NCT01740089|520384783|FG001|After 12 Weeks|Adverse Event|0|||
144322900|NCT01740089|520384784|FG002|After 12 Weeks|Adverse Event|5|||
144322901|NCT01740089|520384782|FG000|After 12 Weeks|Protocol Violation|1|||
144322902|NCT01740089|520384783|FG001|After 12 Weeks|Protocol Violation|1|||
144322903|NCT01740089|520384784|FG002|After 12 Weeks|Protocol Violation|1|||
144322904|NCT01740089|520384782|FG000|After 12 Weeks|Withdrawal by Subject|1|||
144322905|NCT01740089|520384783|FG001|After 12 Weeks|Withdrawal by Subject|1|||
144322906|NCT01740089|520384784|FG002|After 12 Weeks|Withdrawal by Subject|1|||
144322907|NCT01448824|520384787|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322908|NCT01448824|520384788|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322909|NCT01448824|520384789|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322910|NCT01448824|520384790|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322911|NCT01448824|520384791|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322912|NCT01448824|520384792|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322913|NCT01448824|520384793|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
144322914|NCT01448824|520384794|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
144322915|NCT01448824|520384787|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
144322916|NCT01448824|520384788|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
144322917|NCT01448824|520384789|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
144322918|NCT01448824|520384790|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
144322919|NCT01448824|520384791|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
144322920|NCT01448824|520384792|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
144322921|NCT01448824|520384793|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
144322922|NCT01448824|520384794|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
144322923|NCT01448824|520384787|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322924|NCT01448824|520384788|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322925|NCT01448824|520384789|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322926|NCT01448824|520384790|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322927|NCT01448824|520384791|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322928|NCT01448824|520384792|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
144322929|NCT01448824|520384793|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322930|NCT01448824|520384794|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
144322931|NCT01448824|520384787|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
144322932|NCT01448824|520384788|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
144322933|NCT01448824|520384789|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
144322934|NCT01448824|520384790|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
144322935|NCT01448824|520384791|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
144322936|NCT01448824|520384792|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
144322937|NCT01448824|520384793|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
144322938|NCT01448824|520384794|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
144322939|NCT01448824|520384787|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322940|NCT01448824|520384788|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322941|NCT01448824|520384789|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322942|NCT01448824|520384790|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322943|NCT01448824|520384791|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322944|NCT01448824|520384792|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322945|NCT01448824|520384793|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
144322946|NCT01448824|520384794|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
144322947|NCT01448824|520384787|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322948|NCT01448824|520384788|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322949|NCT01448824|520384789|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322950|NCT01448824|520384790|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322951|NCT01448824|520384791|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322952|NCT01448824|520384792|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322953|NCT01448824|520384793|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
144322954|NCT01448824|520384794|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
144322955|NCT01448824|520384787|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322956|NCT01448824|520384788|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322957|NCT01448824|520384789|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322958|NCT01448824|520384790|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322959|NCT01448824|520384791|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322960|NCT01448824|520384792|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322961|NCT01448824|520384793|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
144322962|NCT01448824|520384794|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
144322963|NCT01448824|520384787|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322964|NCT01448824|520384788|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322965|NCT01448824|520384789|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322966|NCT01448824|520384790|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322967|NCT01448824|520384791|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322968|NCT01448824|520384792|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322969|NCT01448824|520384793|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
144322970|NCT01448824|520384794|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
144322971|NCT05243745|520384798|FG000|Overall Study|Withdrawal by Subject|0|||
144322972|NCT05243745|520384799|FG001|Overall Study|Withdrawal by Subject|0|||
144322973|NCT05243745|520384800|FG002|Overall Study|Withdrawal by Subject|0|||
144322974|NCT05243745|520384801|FG003|Overall Study|Withdrawal by Subject|1|||
144322975|NCT05243745|520384798|FG000|Overall Study|Unable to Attend Visit 6|0|||
144322976|NCT05243745|520384799|FG001|Overall Study|Unable to Attend Visit 6|0|||
144322977|NCT05243745|520384800|FG002|Overall Study|Unable to Attend Visit 6|1|||
144322978|NCT05243745|520384801|FG003|Overall Study|Unable to Attend Visit 6|0|||
144322979|NCT02998203|520384802|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
144322980|NCT02998203|520384803|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
144322981|NCT02998203|520384802|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
144322982|NCT02998203|520384803|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
144322983|NCT03842969|520384814|FG000|Overall Study|Participant declined follow-up visit|0|||
144322984|NCT03842969|520384815|FG001|Overall Study|Participant declined follow-up visit|1|||
144322985|NCT03842969|520384816|FG002|Overall Study|Participant declined follow-up visit|0|||
144322986|NCT03842969|520384814|FG000|Overall Study|Sponsor's decision|12|||
144322987|NCT03842969|520384815|FG001|Overall Study|Sponsor's decision|99|||
144322988|NCT03842969|520384816|FG002|Overall Study|Sponsor's decision|61|||
144322989|NCT03842969|520384814|FG000|Overall Study|Pregnancy|0|||
144322990|NCT03842969|520384815|FG001|Overall Study|Pregnancy|0|||
144322991|NCT03842969|520384816|FG002|Overall Study|Pregnancy|1|||
144322992|NCT03842969|520384814|FG000|Overall Study|Death|1|||
144322993|NCT03842969|520384815|FG001|Overall Study|Death|0|||
144322994|NCT03842969|520384816|FG002|Overall Study|Death|1|||
144322995|NCT03842969|520384814|FG000|Overall Study|Withdrawal by Subject|3|||
144322996|NCT03842969|520384815|FG001|Overall Study|Withdrawal by Subject|30|||
144322997|NCT03842969|520384816|FG002|Overall Study|Withdrawal by Subject|18|||
144322998|NCT03842969|520384814|FG000|Overall Study|Protocol Violation|1|||
144322999|NCT03842969|520384815|FG001|Overall Study|Protocol Violation|1|||
144323000|NCT03842969|520384816|FG002|Overall Study|Protocol Violation|0|||
144323001|NCT03842969|520384814|FG000|Overall Study|Physician Decision|0|||
144323002|NCT03842969|520384815|FG001|Overall Study|Physician Decision|3|||
144323003|NCT03842969|520384816|FG002|Overall Study|Physician Decision|0|||
144323004|NCT03842969|520384814|FG000|Overall Study|Lost to Follow-up|0|||
144323005|NCT03842969|520384815|FG001|Overall Study|Lost to Follow-up|2|||
144323006|NCT03842969|520384816|FG002|Overall Study|Lost to Follow-up|0|||
144323007|NCT03842969|520384814|FG000|Overall Study|Adverse Event|0|||
144323008|NCT03842969|520384815|FG001|Overall Study|Adverse Event|2|||
144323009|NCT03842969|520384816|FG002|Overall Study|Adverse Event|0|||
144323010|NCT04187144|520384817|FG000|Overall Study|Lost to Follow-up|12|||
144323011|NCT04187144|520384818|FG001|Overall Study|Lost to Follow-up|11|||
144323012|NCT04187144|520384817|FG000|Overall Study|Withdrawal by Subject|20|||
144323013|NCT04187144|520384818|FG001|Overall Study|Withdrawal by Subject|18|||
144323014|NCT04187144|520384817|FG000|Overall Study|Adverse Event|19|||
144323015|NCT04187144|520384818|FG001|Overall Study|Adverse Event|4|||
144323016|NCT04187144|520384817|FG000|Overall Study|Physician Decision|5|||
144323017|NCT04187144|520384818|FG001|Overall Study|Physician Decision|3|||
144323018|NCT04187144|520384817|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
144323019|NCT04187144|520384818|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
144323020|NCT04187144|520384817|FG000|Overall Study|Protocol Deviation|1|||
144323021|NCT04187144|520384818|FG001|Overall Study|Protocol Deviation|4|||
144323022|NCT01468207|520384821|FG000|Treatment Period 1|Adverse Event|1|||
144323023|NCT01468207|520384822|FG001|Treatment Period 1|Adverse Event|0|||
144323024|NCT01468207|520384823|FG002|Treatment Period 1|Adverse Event|0|||
144323025|NCT01468207|520384824|FG003|Treatment Period 1|Adverse Event|0|||
144323026|NCT01468207|520384825|FG004|Treatment Period 1|Adverse Event|0|||
144323027|NCT01468207|520384826|FG005|Treatment Period 1|Adverse Event|0|||
144323028|NCT01468207|520384821|FG000|Treatment Period 1|Protocol Violation|1|||
144323029|NCT01468207|520384822|FG001|Treatment Period 1|Protocol Violation|1|||
144323030|NCT01468207|520384823|FG002|Treatment Period 1|Protocol Violation|0|||
144323031|NCT01468207|520384824|FG003|Treatment Period 1|Protocol Violation|0|||
144323032|NCT01468207|520384825|FG004|Treatment Period 1|Protocol Violation|0|||
144323033|NCT01468207|520384826|FG005|Treatment Period 1|Protocol Violation|0|||
144323034|NCT01468207|520384821|FG000|Treatment Period 1|Withdrawal by Subject|5|||
144323035|NCT01468207|520384822|FG001|Treatment Period 1|Withdrawal by Subject|4|||
144323036|NCT01468207|520384823|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144323037|NCT01468207|520384824|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144323038|NCT01468207|520384825|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144323039|NCT01468207|520384826|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144323040|NCT01468207|520384821|FG000|Treatment Period 1|Lost to Follow-up|2|||
144323041|NCT01468207|520384822|FG001|Treatment Period 1|Lost to Follow-up|1|||
144323042|NCT01468207|520384823|FG002|Treatment Period 1|Lost to Follow-up|0|||
144323043|NCT01468207|520384824|FG003|Treatment Period 1|Lost to Follow-up|0|||
144323044|NCT01468207|520384825|FG004|Treatment Period 1|Lost to Follow-up|0|||
144323045|NCT01468207|520384826|FG005|Treatment Period 1|Lost to Follow-up|0|||
144323046|NCT01468207|520384821|FG000|Treatment Period 1|Other|0|||
144323047|NCT01468207|520384822|FG001|Treatment Period 1|Other|2|||
144323048|NCT01468207|520384823|FG002|Treatment Period 1|Other|0|||
144323049|NCT01468207|520384824|FG003|Treatment Period 1|Other|0|||
144323050|NCT01468207|520384825|FG004|Treatment Period 1|Other|0|||
144323051|NCT01468207|520384826|FG005|Treatment Period 1|Other|0|||
144323052|NCT01468207|520384821|FG000|Treatment Period 2|Adverse Event|0|||
144323053|NCT01468207|520384822|FG001|Treatment Period 2|Adverse Event|0|||
144323054|NCT01468207|520384823|FG002|Treatment Period 2|Adverse Event|6|||
144323055|NCT01468207|520384824|FG003|Treatment Period 2|Adverse Event|1|||
144323056|NCT01468207|520384825|FG004|Treatment Period 2|Adverse Event|2|||
144323057|NCT01468207|520384826|FG005|Treatment Period 2|Adverse Event|1|||
144323058|NCT01468207|520384821|FG000|Treatment Period 2|Lack of Efficacy|0|||
144323059|NCT01468207|520384822|FG001|Treatment Period 2|Lack of Efficacy|0|||
144323060|NCT01468207|520384823|FG002|Treatment Period 2|Lack of Efficacy|1|||
144323061|NCT01468207|520384824|FG003|Treatment Period 2|Lack of Efficacy|1|||
144323062|NCT01468207|520384825|FG004|Treatment Period 2|Lack of Efficacy|0|||
144323063|NCT01468207|520384826|FG005|Treatment Period 2|Lack of Efficacy|2|||
144323064|NCT01468207|520384821|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144323065|NCT01468207|520384822|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144323066|NCT01468207|520384823|FG002|Treatment Period 2|Withdrawal by Subject|5|||
144323067|NCT01468207|520384824|FG003|Treatment Period 2|Withdrawal by Subject|0|||
144323068|NCT01468207|520384825|FG004|Treatment Period 2|Withdrawal by Subject|0|||
144323069|NCT01468207|520384826|FG005|Treatment Period 2|Withdrawal by Subject|2|||
144323070|NCT01468207|520384821|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
144323071|NCT01468207|520384822|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
144323072|NCT01468207|520384823|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
144323073|NCT01468207|520384824|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
144323074|NCT01468207|520384825|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
144323075|NCT01468207|520384826|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
144323076|NCT01468207|520384821|FG000|Treatment Period 2|Lost to Follow-up|0|||
144323077|NCT01468207|520384822|FG001|Treatment Period 2|Lost to Follow-up|0|||
144323078|NCT01468207|520384823|FG002|Treatment Period 2|Lost to Follow-up|5|||
144323079|NCT01468207|520384824|FG003|Treatment Period 2|Lost to Follow-up|1|||
144323080|NCT01468207|520384825|FG004|Treatment Period 2|Lost to Follow-up|0|||
144323081|NCT01468207|520384826|FG005|Treatment Period 2|Lost to Follow-up|0|||
144323082|NCT01468207|520384821|FG000|Treatment Period 2|Other|0|||
144323083|NCT01468207|520384822|FG001|Treatment Period 2|Other|0|||
144323084|NCT01468207|520384823|FG002|Treatment Period 2|Other|5|||
144323085|NCT01468207|520384824|FG003|Treatment Period 2|Other|1|||
144323086|NCT01468207|520384825|FG004|Treatment Period 2|Other|1|||
144323087|NCT01468207|520384826|FG005|Treatment Period 2|Other|2|||
144323088|NCT03002818|520384827|FG000|Overall Study|Decision of the investigator|1|||
144323089|NCT01606787|520384829|FG000|Overall Study|Withdrawal by Subject|4|||
144323090|NCT01606787|520384830|FG001|Overall Study|Withdrawal by Subject|5|||
144323091|NCT01606787|520384829|FG000|Overall Study|Surgery canceled|0|||
144323092|NCT01606787|520384830|FG001|Overall Study|Surgery canceled|2|||
144323093|NCT05312632|520384833|FG000|Overall Study|Adverse Event|12|||
144323094|NCT05312632|520384833|FG000|Overall Study|Withdrawal by Subject|10|||
144323095|NCT05312632|520384833|FG000|Overall Study|Lack of Efficacy|4|||
144323096|NCT05312632|520384833|FG000|Overall Study|Non-compliance with study procedures|9|||
144323097|NCT05312632|520384833|FG000|Overall Study|Other|4|||
144323098|NCT02743949|520384837|FG000|Overall Study|Adverse Event|0|||
144323099|NCT02743949|520384838|FG001|Overall Study|Adverse Event|0|||
144323100|NCT02743949|520384839|FG002|Overall Study|Adverse Event|2|||
144323101|NCT02743949|520384837|FG000|Overall Study|Significant Protocol Deviation|2|||
144323102|NCT02743949|520384838|FG001|Overall Study|Significant Protocol Deviation|0|||
144323103|NCT02743949|520384839|FG002|Overall Study|Significant Protocol Deviation|1|||
144323104|NCT02743949|520384837|FG000|Overall Study|Voluntary Withdrawal|2|||
144323105|NCT02743949|520384838|FG001|Overall Study|Voluntary Withdrawal|1|||
144323106|NCT02743949|520384839|FG002|Overall Study|Voluntary Withdrawal|0|||
144323107|NCT01921218|520384840|FG000|Overall Study|Death|2|||
144323108|NCT01921218|520384841|FG001|Overall Study|Death|1|||
144323109|NCT01921218|520384840|FG000|Overall Study|Withdrawal by Subject|0|||
144323110|NCT01921218|520384841|FG001|Overall Study|Withdrawal by Subject|2|||
144323111|NCT01921218|520384840|FG000|Overall Study|Kidney transplant|1|||
144323112|NCT01921218|520384841|FG001|Overall Study|Kidney transplant|1|||
144323113|NCT03389555|520384842|FG000|Overall Study|Protocol Violation|1|||
144323114|NCT03389555|520384843|FG001|Overall Study|Protocol Violation|3|||
144323115|NCT03389555|520384842|FG000|Overall Study|Death|1|||
144323116|NCT03389555|520384843|FG001|Overall Study|Death|0|||
144323117|NCT01885208|520384844|FG000|Overall Study|Unclassified|32|||
144323118|NCT01885208|520384845|FG001|Overall Study|Unclassified|38|||
144323119|NCT00920218|520384846|FG000|Overall Study|Serious Adverse Event|2|||
144323120|NCT00920218|520384847|FG001|Overall Study|Serious Adverse Event|0|||
144323121|NCT00920218|520384848|FG002|Overall Study|Serious Adverse Event|2|||
144323122|NCT00920218|520384849|FG003|Overall Study|Serious Adverse Event|1|||
144323123|NCT00920218|520384846|FG000|Overall Study|Withdrawal by Subject|0|||
144323124|NCT00920218|520384847|FG001|Overall Study|Withdrawal by Subject|3|||
144323125|NCT00920218|520384848|FG002|Overall Study|Withdrawal by Subject|2|||
144323126|NCT00920218|520384849|FG003|Overall Study|Withdrawal by Subject|0|||
144323127|NCT00920218|520384846|FG000|Overall Study|Migrated/moved from study area|0|||
144323128|NCT00920218|520384847|FG001|Overall Study|Migrated/moved from study area|0|||
144323129|NCT00920218|520384848|FG002|Overall Study|Migrated/moved from study area|1|||
144323130|NCT00920218|520384849|FG003|Overall Study|Migrated/moved from study area|0|||
144323131|NCT00920218|520384846|FG000|Overall Study|Lost to Follow-up|0|||
144323132|NCT00920218|520384847|FG001|Overall Study|Lost to Follow-up|1|||
144323133|NCT00920218|520384848|FG002|Overall Study|Lost to Follow-up|0|||
144323134|NCT00920218|520384849|FG003|Overall Study|Lost to Follow-up|3|||
144323135|NCT00920218|520384846|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
144323136|NCT00920218|520384847|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
144323137|NCT00920218|520384848|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
144323138|NCT00920218|520384849|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
144323139|NCT00920218|520384846|FG000|Overall Study|Other|0|||
144323140|NCT00920218|520384847|FG001|Overall Study|Other|0|||
144323141|NCT00920218|520384848|FG002|Overall Study|Other|1|||
144323142|NCT00920218|520384849|FG003|Overall Study|Other|0|||
144323143|NCT03224507|520384853|FG000|Overall Study|Death|3|||
144323144|NCT03224507|520384854|FG001|Overall Study|Death|0|||
144323145|NCT03224507|520384853|FG000|Overall Study|Lack of Efficacy|6|||
144323146|NCT03224507|520384854|FG001|Overall Study|Lack of Efficacy|0|||
144323147|NCT03224507|520384853|FG000|Overall Study|Withdrawal by Subject|6|||
144323148|NCT03224507|520384854|FG001|Overall Study|Withdrawal by Subject|0|||
144323149|NCT01032291|520384855|FG000|Safety Lead-in|Adverse Event|1|||
144323150|NCT01032291|520384856|FG001|Safety Lead-in|Adverse Event|0|||
144323151|NCT01032291|520384857|FG002|Safety Lead-in|Adverse Event|0|||
144323152|NCT01032291|520384855|FG000|Safety Lead-in|Death|1|||
144323153|NCT01032291|520384856|FG001|Safety Lead-in|Death|0|||
144323154|NCT01032291|520384857|FG002|Safety Lead-in|Death|0|||
144323155|NCT01032291|520384855|FG000|Proof of Concept|Adverse Event|0|||
144323156|NCT01032291|520384856|FG001|Proof of Concept|Adverse Event|5|||
144323157|NCT01032291|520384857|FG002|Proof of Concept|Adverse Event|1|||
144323158|NCT01032291|520384855|FG000|Proof of Concept|Death|0|||
144323159|NCT01032291|520384856|FG001|Proof of Concept|Death|1|||
144323160|NCT01032291|520384857|FG002|Proof of Concept|Death|2|||
144323161|NCT01032291|520384855|FG000|Proof of Concept|Lack of Efficacy|0|||
144323162|NCT01032291|520384856|FG001|Proof of Concept|Lack of Efficacy|1|||
144323163|NCT01032291|520384857|FG002|Proof of Concept|Lack of Efficacy|0|||
144323164|NCT01032291|520384855|FG000|Proof of Concept|Never Received Study Drug|0|||
144323165|NCT01032291|520384856|FG001|Proof of Concept|Never Received Study Drug|1|||
144323166|NCT01032291|520384857|FG002|Proof of Concept|Never Received Study Drug|0|||
144323167|NCT02449889|520384858|FG000|Overall Study|Adverse Event|1|||
144323168|NCT02449889|520384859|FG001|Overall Study|Adverse Event|2|||
144323169|NCT02449889|520384860|FG002|Overall Study|Adverse Event|0|||
144323170|NCT02449889|520384858|FG000|Overall Study|Protocol Violation|0|||
144323171|NCT02449889|520384859|FG001|Overall Study|Protocol Violation|4|||
144323172|NCT02449889|520384860|FG002|Overall Study|Protocol Violation|1|||
144323173|NCT01973387|520384861|FG000|Overall Study|Adverse Event|14|||
144323174|NCT01973387|520384862|FG001|Overall Study|Adverse Event|4|||
144323175|NCT01973387|520384861|FG000|Overall Study|Withdrawal by Subject|7|||
144323176|NCT01973387|520384862|FG001|Overall Study|Withdrawal by Subject|4|||
144323177|NCT01973387|520384861|FG000|Overall Study|Study terminated by sponsor|63|||
144323178|NCT01973387|520384862|FG001|Overall Study|Study terminated by sponsor|0|||
144323179|NCT01973387|520384861|FG000|Overall Study|Progressive disease or relapse|16|||
144323180|NCT01973387|520384862|FG001|Overall Study|Progressive disease or relapse|5|||
144323181|NCT01973387|520384861|FG000|Overall Study|Death|4|||
144323182|NCT01973387|520384862|FG001|Overall Study|Death|3|||
144323183|NCT01973387|520384861|FG000|Overall Study|Randomized, not treated|2|||
144323184|NCT01973387|520384862|FG001|Overall Study|Randomized, not treated|2|||
144323185|NCT03327220|520384863|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
144323186|NCT03327220|520384864|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
144323187|NCT03327220|520384863|FG000|Overall Study|Investigator Decision|2|||
144323188|NCT03327220|520384864|FG001|Overall Study|Investigator Decision|0|||
144323189|NCT03327220|520384863|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
144323190|NCT03327220|520384864|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
144323191|NCT03327220|520384863|FG000|Overall Study|Fungal infection|1|||
144323192|NCT03327220|520384864|FG001|Overall Study|Fungal infection|0|||
144323193|NCT03327220|520384863|FG000|Overall Study|Discharged to Rehabilitation|0|||
144323194|NCT03327220|520384864|FG001|Overall Study|Discharged to Rehabilitation|1|||
144323195|NCT03327220|520384863|FG000|Overall Study|Missing|1|||
144323196|NCT03327220|520384864|FG001|Overall Study|Missing|0|||
144323197|NCT01498575|520384865|FG000|Overall Sample|Withdrawal by Subject|60|||
144323198|NCT01498575|520384866|FG001|Overall Sample|Withdrawal by Subject|14|||
144323199|NCT01498575|520384865|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
144323200|NCT01498575|520384866|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
144323201|NCT01498575|520384865|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
144323202|NCT01498575|520384866|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
144323203|NCT00693017|520384868|FG000|Overall Study|Sponsor Decision|2|||
144323204|NCT00693017|520384869|FG001|Overall Study|Sponsor Decision|1|||
144323205|NCT00693017|520384868|FG000|Overall Study|Death|0|||
144323206|NCT00693017|520384869|FG001|Overall Study|Death|1|||
144323207|NCT00688324|520384871|FG000|Overall Study|Withdrawal by Subject|2|||
144323208|NCT00688324|520384871|FG000|Overall Study|Physician Decision|5|||
144323209|NCT00688324|520384871|FG000|Overall Study|Lost to Follow-up|1|||
144323210|NCT03176472|520384874|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
144323211|NCT03176472|520384875|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
144323212|NCT03176472|520384874|FG000|Double Blind Treatment Period|Adverse Event|0|||
144323213|NCT03176472|520384875|FG001|Double Blind Treatment Period|Adverse Event|5|||
144323214|NCT03176472|520384874|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
144323215|NCT03176472|520384875|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
144323216|NCT03176472|520384874|FG000|Double Blind Treatment Period|Physician Decision|0|||
144323217|NCT03176472|520384875|FG001|Double Blind Treatment Period|Physician Decision|1|||
144323218|NCT03176472|520384874|FG000|Double Blind Treatment Period|Protocol Violation|1|||
144323219|NCT03176472|520384875|FG001|Double Blind Treatment Period|Protocol Violation|0|||
144323220|NCT03176472|520384874|FG000|Double Blind Treatment Period|Not Provided|1|||
144323221|NCT03176472|520384875|FG001|Double Blind Treatment Period|Not Provided|0|||
144323222|NCT03176472|520384874|FG000|Open Label Extension|Withdrawal by Subject|3|||
144323223|NCT03176472|520384875|FG001|Open Label Extension|Withdrawal by Subject|4|||
144323224|NCT03176472|520384874|FG000|Open Label Extension|Adverse Event|2|||
144323225|NCT03176472|520384875|FG001|Open Label Extension|Adverse Event|4|||
144323226|NCT03176472|520384874|FG000|Open Label Extension|Lost to Follow-up|1|||
144323227|NCT03176472|520384875|FG001|Open Label Extension|Lost to Follow-up|2|||
144323228|NCT03176472|520384874|FG000|Open Label Extension|Protocol Violation|0|||
144323229|NCT03176472|520384875|FG001|Open Label Extension|Protocol Violation|1|||
144323230|NCT03176472|520384874|FG000|Open Label Extension|Not Provided|2|||
144323231|NCT03176472|520384875|FG001|Open Label Extension|Not Provided|1|||
144323232|NCT03272828|520384876|FG000|Overall Study|Lost to Follow-up|7|||
144323233|NCT03272828|520384877|FG001|Overall Study|Lost to Follow-up|7|||
144323234|NCT03272828|520384876|FG000|Overall Study|Withdrawal by Subject|2|||
144323235|NCT03272828|520384877|FG001|Overall Study|Withdrawal by Subject|0|||
144323236|NCT03272828|520384876|FG000|Overall Study|Deceased|1|||
144323237|NCT03272828|520384877|FG001|Overall Study|Deceased|1|||
144323238|NCT03272828|520384876|FG000|Overall Study|Failed implant|1|||
144323239|NCT03272828|520384877|FG001|Overall Study|Failed implant|2|||
144323240|NCT00642369|520384878|FG000|Overall Study|Adverse Event|2|||
144323241|NCT00642369|520384879|FG001|Overall Study|Adverse Event|3|||
144323242|NCT00642369|520384878|FG000|Overall Study|Withdrawal by Subject|1|||
144323243|NCT00642369|520384879|FG001|Overall Study|Withdrawal by Subject|0|||
144323244|NCT00642369|520384878|FG000|Overall Study|misdiagnosis|0|||
144323245|NCT00642369|520384879|FG001|Overall Study|misdiagnosis|1|||
144323246|NCT00642369|520384878|FG000|Overall Study|Lack of Efficacy|2|||
144323247|NCT00642369|520384879|FG001|Overall Study|Lack of Efficacy|2|||
144323248|NCT00847665|520384880|FG000|Overall Study|Withdrawal by Subject|1|||
144323249|NCT00847665|520384881|FG001|Overall Study|Withdrawal by Subject|0|||
144323250|NCT00585546|520384888|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
144323251|NCT00585546|520384888|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
144323252|NCT01562314|520384889|FG000|Overall Study|Adverse Event|10|||
144323253|NCT01562314|520384890|FG001|Overall Study|Adverse Event|5|||
144323254|NCT01562314|520384889|FG000|Overall Study|Met Withdrawal Criteria|3|||
144323255|NCT01562314|520384890|FG001|Overall Study|Met Withdrawal Criteria|2|||
144323256|NCT01562314|520384889|FG000|Overall Study|Withdrawal by Subject|0|||
144323257|NCT01562314|520384890|FG001|Overall Study|Withdrawal by Subject|1|||
144323258|NCT04295681|520384891|FG000|Overall Study|Eligibility error|1|||
144323259|NCT04295681|520384892|FG001|Overall Study|Eligibility error|3|||
144323260|NCT01535599|520384893|FG000|Overall Study|Adverse Event|6|||
144323261|NCT01535599|520384894|FG001|Overall Study|Adverse Event|15|||
144323262|NCT01535599|520384893|FG000|Overall Study|Lost to Follow-up|3|||
144323263|NCT01535599|520384894|FG001|Overall Study|Lost to Follow-up|4|||
144323264|NCT01535599|520384893|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
144323265|NCT01535599|520384894|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
144323266|NCT01535599|520384893|FG000|Overall Study|Treatment Failure|33|||
144323267|NCT01535599|520384894|FG001|Overall Study|Treatment Failure|66|||
144323268|NCT01535599|520384893|FG000|Overall Study|BL Culture + for Group A Strep|0|||
144323269|NCT01535599|520384894|FG001|Overall Study|BL Culture + for Group A Strep|1|||
144323270|NCT01535599|520384893|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
144323271|NCT01535599|520384894|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
144323272|NCT01535599|520384893|FG000|Overall Study|Randomized in Error|2|||
144323273|NCT01535599|520384894|FG001|Overall Study|Randomized in Error|4|||
144323274|NCT01535599|520384893|FG000|Overall Study|Did not use product|1|||
144323275|NCT01535599|520384894|FG001|Overall Study|Did not use product|0|||
144323276|NCT01535599|520384893|FG000|Overall Study|Other|1|||
144323277|NCT01535599|520384894|FG001|Overall Study|Other|0|||
144323278|NCT01535599|520384893|FG000|Overall Study|Stopped medication|0|||
144323279|NCT01535599|520384894|FG001|Overall Study|Stopped medication|1|||
144323280|NCT01535599|520384893|FG000|Overall Study|Noncompliance|0|||
144323281|NCT01535599|520384894|FG001|Overall Study|Noncompliance|1|||
144323282|NCT03172325|520384895|FG000|Overall Study|Adverse Event|2|||
144323283|NCT03172325|520384896|FG001|Overall Study|Adverse Event|3|||
144323284|NCT03172325|520384895|FG000|Overall Study|Positive PPD|1|||
144323285|NCT03172325|520384896|FG001|Overall Study|Positive PPD|0|||
144323286|NCT03172325|520384895|FG000|Overall Study|Poor Compliance|1|||
144323287|NCT03172325|520384896|FG001|Overall Study|Poor Compliance|1|||
144323288|NCT01694121|520384898|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
144323289|NCT01694121|520384899|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
144323290|NCT00744978|520384900|FG000|Period 1|Lost to Follow-up|1|||
144323291|NCT00744978|520384901|FG001|Period 1|Lost to Follow-up|0|||
144323292|NCT00744978|520384900|FG000|Period 1|Withdrawal by Subject|0|||
144323293|NCT00744978|520384901|FG001|Period 1|Withdrawal by Subject|2|||
144323294|NCT00744978|520384900|FG000|Period 1|Other|0|||
144323295|NCT00744978|520384901|FG001|Period 1|Other|2|||
144323296|NCT00744978|520384900|FG000|Period 1|Adverse Event|4|||
144323297|NCT00744978|520384901|FG001|Period 1|Adverse Event|0|||
144323298|NCT00744978|520384900|FG000|Period 1|Randomized but not Treated|1|||
144323299|NCT00744978|520384901|FG001|Period 1|Randomized but not Treated|1|||
144323300|NCT00744978|520384900|FG000|Period 2|Adverse Event|0|||
144323301|NCT00744978|520384901|FG001|Period 2|Adverse Event|1|||
144323302|NCT03773133|520384902|FG000|Overall Study|Screen Failure|8|||
144323303|NCT00866047|520384903|FG000|Treatment Period|Progressive disease|13|||
144323304|NCT00866047|520384903|FG000|Treatment Period|Adverse Event|16|||
144323305|NCT00866047|520384903|FG000|Treatment Period|Physician Decision|14|||
144323306|NCT00866047|520384903|FG000|Treatment Period|Withdrawal by Subject|5|||
144323307|NCT00866047|520384903|FG000|Follow-up Period|Lost to Follow-up|5|||
144323308|NCT02928029|520384904|FG000|Overall Study|Withdrawal by Subject|0|||
144323309|NCT02928029|520384905|FG001|Overall Study|Withdrawal by Subject|1|||
144323310|NCT02928029|520384904|FG000|Overall Study|Radiological progression|1|||
144323311|NCT02928029|520384905|FG001|Overall Study|Radiological progression|0|||
144323312|NCT02928029|520384904|FG000|Overall Study|Clinical progression|1|||
144323313|NCT02928029|520384905|FG001|Overall Study|Clinical progression|2|||
144323314|NCT02928029|520384904|FG000|Overall Study|AE not related to clinical progression|1|||
144323315|NCT02928029|520384905|FG001|Overall Study|AE not related to clinical progression|1|||
144323316|NCT04659174|520384916|FG000|Overall Study|Sponsor decision to discontinue study|0|||
144323317|NCT04659174|520384917|FG001|Overall Study|Sponsor decision to discontinue study|2|||
144323318|NCT04659174|520384916|FG000|Overall Study|Lost to Follow-up|9|||
144323319|NCT04659174|520384917|FG001|Overall Study|Lost to Follow-up|11|||
144323320|NCT04659174|520384916|FG000|Overall Study|Adverse Event|8|||
144323321|NCT04659174|520384917|FG001|Overall Study|Adverse Event|5|||
144323322|NCT04659174|520384916|FG000|Overall Study|Withdrawal by Subject|17|||
144323323|NCT04659174|520384917|FG001|Overall Study|Withdrawal by Subject|33|||
144323324|NCT04659174|520384916|FG000|Overall Study|Progressive disease|0|||
144323325|NCT04659174|520384917|FG001|Overall Study|Progressive disease|2|||
144323326|NCT04659174|520384916|FG000|Overall Study|Other reasons|0|||
144323327|NCT04659174|520384917|FG001|Overall Study|Other reasons|2|||
144323328|NCT04659174|520384916|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
144323329|NCT04659174|520384917|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
144323330|NCT04659174|520384916|FG000|Overall Study|Alcohol or illegal drug use|0|||
144323331|NCT04659174|520384917|FG001|Overall Study|Alcohol or illegal drug use|3|||
144323332|NCT04659174|520384916|FG000|Overall Study|Violation of entry criteria|1|||
144323333|NCT04659174|520384917|FG001|Overall Study|Violation of entry criteria|0|||
144323334|NCT04659174|520384916|FG000|Overall Study|Death|0|||
144323335|NCT04659174|520384917|FG001|Overall Study|Death|1|||
144323336|NCT03276026|520384920|FG000|Overall Study|Protocol Violation|1|||
144323337|NCT03276026|520384921|FG001|Overall Study|Protocol Violation|0|||
144323338|NCT03650803|520384923|FG000|Overall Study|Lost to Follow-up|6|||
144323339|NCT01534260|520384924|FG000|Overall Study|Adverse Event|1|||
144323340|NCT01534260|520384925|FG001|Overall Study|Adverse Event|8|||
144323341|NCT01534260|520384924|FG000|Overall Study|Death|2|||
144323342|NCT01534260|520384925|FG001|Overall Study|Death|0|||
144323343|NCT01534260|520384924|FG000|Overall Study|Lack of Efficacy|1|||
144323344|NCT01534260|520384925|FG001|Overall Study|Lack of Efficacy|1|||
144323345|NCT01534260|520384924|FG000|Overall Study|Withdrawal by Subject|1|||
144323346|NCT01534260|520384925|FG001|Overall Study|Withdrawal by Subject|3|||
144323347|NCT01534260|520384924|FG000|Overall Study|Disease Progression|8|||
144323348|NCT01534260|520384925|FG001|Overall Study|Disease Progression|6|||
144323349|NCT01534260|520384924|FG000|Overall Study|Physician Decision|3|||
144323350|NCT01534260|520384925|FG001|Overall Study|Physician Decision|1|||
144323351|NCT01534260|520384924|FG000|Overall Study|No treatment, per protocol|0|||
144323352|NCT01534260|520384925|FG001|Overall Study|No treatment, per protocol|1|||
144323353|NCT02359045|520384926|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
144323354|NCT02359045|520384927|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
144323355|NCT02359045|520384926|FG000|Overall Study|Lost to Follow-up|1|||
144323356|NCT02359045|520384927|FG001|Overall Study|Lost to Follow-up|1|||
144323357|NCT02359045|520384926|FG000|Overall Study|Adverse Event|0|||
144323358|NCT02359045|520384927|FG001|Overall Study|Adverse Event|1|||
144323359|NCT02825420|520384930|FG000|Overall Study|Death|30|||
144323360|NCT02825420|520384931|FG001|Overall Study|Death|12|||
144323361|NCT02825420|520384930|FG000|Overall Study|Progressive disease|6|||
144323362|NCT02825420|520384931|FG001|Overall Study|Progressive disease|1|||
144323363|NCT02825420|520384930|FG000|Overall Study|Lost to Follow-up|2|||
144323364|NCT02825420|520384931|FG001|Overall Study|Lost to Follow-up|2|||
144323365|NCT02825420|520384930|FG000|Overall Study|Withdrawal by Subject|1|||
144323366|NCT02825420|520384931|FG001|Overall Study|Withdrawal by Subject|1|||
144323367|NCT02825420|520384930|FG000|Overall Study|Protocol amendment not signed|1|||
144323368|NCT02825420|520384931|FG001|Overall Study|Protocol amendment not signed|1|||
144323369|NCT02825420|520384930|FG000|Overall Study|Physician Decision|1|||
144323370|NCT02825420|520384931|FG001|Overall Study|Physician Decision|0|||
144323371|NCT02825420|520384930|FG000|Overall Study|Did not receive PLD|2|||
144323372|NCT02825420|520384931|FG001|Overall Study|Did not receive PLD|0|||
144323373|NCT02264665|520386392|FG000|Overall Study|Other|0|||
144323374|NCT02264665|520386393|FG001|Overall Study|Other|0|||
144323375|NCT02264665|520386394|FG002|Overall Study|Other|3|||
144323376|NCT02264665|520386395|FG003|Overall Study|Other|0|||
144323377|NCT02264665|520386396|FG004|Overall Study|Other|0|||
144323378|NCT02264665|520386397|FG005|Overall Study|Other|0|||
144323379|NCT02264665|520386398|FG006|Overall Study|Other|0|||
144323380|NCT02264665|520386392|FG000|Overall Study|Death|9|||
144323381|NCT02264665|520386393|FG001|Overall Study|Death|8|||
144323382|NCT02264665|520386394|FG002|Overall Study|Death|13|||
144323383|NCT02264665|520386395|FG003|Overall Study|Death|5|||
144323384|NCT02264665|520386396|FG004|Overall Study|Death|0|||
144323385|NCT02264665|520386397|FG005|Overall Study|Death|0|||
144323386|NCT02264665|520386398|FG006|Overall Study|Death|1|||
144323387|NCT02264665|520386392|FG000|Overall Study|Lost to Follow-up|1|||
144323388|NCT02264665|520386393|FG001|Overall Study|Lost to Follow-up|0|||
144323389|NCT02264665|520386394|FG002|Overall Study|Lost to Follow-up|2|||
144323390|NCT02264665|520386395|FG003|Overall Study|Lost to Follow-up|1|||
144323391|NCT02264665|520386396|FG004|Overall Study|Lost to Follow-up|0|||
144323392|NCT02264665|520386397|FG005|Overall Study|Lost to Follow-up|0|||
144323393|NCT02264665|520386398|FG006|Overall Study|Lost to Follow-up|0|||
144323394|NCT02264665|520386392|FG000|Overall Study|Participant decision|0|||
144323395|NCT02264665|520386393|FG001|Overall Study|Participant decision|0|||
144323396|NCT02264665|520386394|FG002|Overall Study|Participant decision|0|||
144323397|NCT02264665|520386395|FG003|Overall Study|Participant decision|1|||
144323398|NCT02264665|520386396|FG004|Overall Study|Participant decision|0|||
144323399|NCT02264665|520386397|FG005|Overall Study|Participant decision|0|||
144323400|NCT02264665|520386398|FG006|Overall Study|Participant decision|0|||
144323401|NCT02264665|520386392|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
144323402|NCT02264665|520386393|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
144323403|NCT02264665|520386394|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
144323404|NCT02264665|520386395|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
144323405|NCT02264665|520386396|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
144323406|NCT02264665|520386397|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
144323407|NCT02264665|520386398|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
144323408|NCT02264665|520386392|FG000|Overall Study|Data Missing|0|||
144323409|NCT02264665|520386393|FG001|Overall Study|Data Missing|0|||
144323410|NCT02264665|520386394|FG002|Overall Study|Data Missing|1|||
144323411|NCT02264665|520386395|FG003|Overall Study|Data Missing|0|||
144323412|NCT02264665|520386396|FG004|Overall Study|Data Missing|0|||
144323413|NCT02264665|520386397|FG005|Overall Study|Data Missing|0|||
144323414|NCT02264665|520386398|FG006|Overall Study|Data Missing|0|||
144323415|NCT00789581|520386399|FG000|AC Therapy|Adverse Event|2|||
144323416|NCT00789581|520386400|FG001|AC Therapy|Adverse Event|3|||
144323417|NCT00789581|520386399|FG000|AC Therapy|Withdrawal by Subject|4|||
144323418|NCT00789581|520386400|FG001|AC Therapy|Withdrawal by Subject|7|||
144323419|NCT00789581|520386399|FG000|AC Therapy|Disease recurrence|3|||
144323420|NCT00789581|520386400|FG001|AC Therapy|Disease recurrence|1|||
144323421|NCT00789581|520386399|FG000|AC Therapy|Intercurrent Illness|1|||
144323422|NCT00789581|520386400|FG001|AC Therapy|Intercurrent Illness|0|||
144323423|NCT00789581|520386399|FG000|AC Therapy|Never Treated|1|||
144323424|NCT00789581|520386400|FG001|AC Therapy|Never Treated|4|||
144323425|NCT00789581|520386399|FG000|AC Therapy|Other|0|||
144323426|NCT00789581|520386400|FG001|AC Therapy|Other|2|||
144323427|NCT00789581|520386399|FG000|Adjuvant Therapy|Never treated|2|||
144323428|NCT00789581|520386400|FG001|Adjuvant Therapy|Never treated|2|||
144323429|NCT00789581|520386399|FG000|Adjuvant Therapy|Adverse Event|20|||
144323430|NCT00789581|520386400|FG001|Adjuvant Therapy|Adverse Event|44|||
144323431|NCT00789581|520386399|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
144323432|NCT00789581|520386400|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
144323433|NCT00789581|520386399|FG000|Adjuvant Therapy|Disease recurrence|2|||
144323434|NCT00789581|520386400|FG001|Adjuvant Therapy|Disease recurrence|1|||
144323435|NCT00789581|520386399|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
144323436|NCT00789581|520386400|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
144323437|NCT00789581|520386399|FG000|Adjuvant Therapy|Protocol Violation|1|||
144323438|NCT00789581|520386400|FG001|Adjuvant Therapy|Protocol Violation|1|||
144323439|NCT00789581|520386399|FG000|Adjuvant Therapy|Other|0|||
144323440|NCT00789581|520386400|FG001|Adjuvant Therapy|Other|1|||
144323441|NCT00489736|520386407|FG000|Overall Study|Lack of Efficacy|53|||
144323442|NCT00489736|520386408|FG001|Overall Study|Lack of Efficacy|14|||
144323443|NCT00489736|520386407|FG000|Overall Study|Adverse Event|32|||
144323444|NCT00489736|520386408|FG001|Overall Study|Adverse Event|45|||
144323445|NCT00489736|520386407|FG000|Overall Study|Poor compliance|6|||
144323446|NCT00489736|520386408|FG001|Overall Study|Poor compliance|2|||
144323447|NCT00489736|520386407|FG000|Overall Study|Not coded/ Not pre-specified|5|||
144360034|NCT01601535|520525138|FG003|Phase 2|Progressive Disease|0|||
144323448|NCT00489736|520386408|FG001|Overall Study|Not coded/ Not pre-specified|8|||
144323449|NCT03077438|520386415|FG000|Overall Study|Protocol Violation|3|||
144323450|NCT03077438|520386416|FG001|Overall Study|Protocol Violation|5|||
144323451|NCT03077438|520386415|FG000|Overall Study|Withdrawal by Subject|3|||
144323452|NCT03077438|520386416|FG001|Overall Study|Withdrawal by Subject|6|||
144323453|NCT03077438|520386415|FG000|Overall Study|Lost to Follow-up|6|||
144323454|NCT03077438|520386416|FG001|Overall Study|Lost to Follow-up|3|||
144323455|NCT04154345|520386421|FG000|Overall Study|Covid-19 pandemic|4|||
144323456|NCT04686084|520386423|FG000|Overall Study|Lost to Follow-up|1|||
144323457|NCT01779856|520386425|FG000|Overall Study|Withdrawal by Subject|15|||
144323458|NCT01779856|520386425|FG000|Overall Study|Death|3|||
144323459|NCT01779856|520386425|FG000|Overall Study|Physician Decision|1|||
144323460|NCT01779856|520386425|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
144323461|NCT01779856|520386425|FG000|Overall Study|Delays in scheduling implant|1|||
144323462|NCT01779856|520386425|FG000|Overall Study|Subject ineligible for Implant|2|||
144323463|NCT00676520|520386429|FG000|Overall Study|Withdrawal by Subject|163|||
144323464|NCT00676520|520386429|FG000|Overall Study|Lost to Follow-up|162|||
144323465|NCT00676520|520386429|FG000|Overall Study|Death|159|||
144323466|NCT00676520|520386429|FG000|Overall Study|Physician Decision|20|||
144323467|NCT00676520|520386429|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
144323468|NCT00676520|520386429|FG000|Overall Study|Other Reason|18|||
144323469|NCT00385944|520386430|FG000|1st Maintenance Dose Period|Physician Decision|1|||
144323470|NCT00385944|520386431|FG001|1st Maintenance Dose Period|Physician Decision|0|||
144323471|NCT00385944|520386432|FG002|1st Maintenance Dose Period|Physician Decision|0|||
144323472|NCT00385944|520386430|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
144323473|NCT00385944|520386431|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
144323474|NCT00385944|520386432|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
144323475|NCT00385944|520386430|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
144323476|NCT00385944|520386431|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
144323477|NCT00385944|520386432|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
144323478|NCT00385944|520386430|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
144323479|NCT00385944|520386431|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
144323480|NCT00385944|520386432|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
144323481|NCT01778049|520386438|FG000|Open Label Treatment Period|Adverse Event|5|||
144323482|NCT01778049|520386439|FG001|Open Label Treatment Period|Adverse Event|15|||
144323483|NCT01778049|520386440|FG002|Open Label Treatment Period|Adverse Event|0|||
144323484|NCT01778049|520386441|FG003|Open Label Treatment Period|Adverse Event|0|||
144323485|NCT01778049|520386442|FG004|Open Label Treatment Period|Adverse Event|0|||
144323486|NCT01778049|520386443|FG005|Open Label Treatment Period|Adverse Event|0|||
144323487|NCT01778049|520386438|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
144323488|NCT01778049|520386439|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
144323489|NCT01778049|520386440|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
144323490|NCT01778049|520386441|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
144323491|NCT01778049|520386442|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
144323492|NCT01778049|520386443|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
144323493|NCT01778049|520386438|FG000|Open Label Treatment Period|Protocol Violation|5|||
144323494|NCT01778049|520386439|FG001|Open Label Treatment Period|Protocol Violation|5|||
144323495|NCT01778049|520386440|FG002|Open Label Treatment Period|Protocol Violation|0|||
144323496|NCT01778049|520386441|FG003|Open Label Treatment Period|Protocol Violation|0|||
144323497|NCT01778049|520386442|FG004|Open Label Treatment Period|Protocol Violation|0|||
144323498|NCT01778049|520386443|FG005|Open Label Treatment Period|Protocol Violation|0|||
144323499|NCT01778049|520386438|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
144323500|NCT01778049|520386439|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
144323501|NCT01778049|520386440|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
144323502|NCT01778049|520386441|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
144323503|NCT01778049|520386442|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
144323504|NCT01778049|520386443|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
144323505|NCT01778049|520386438|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
144323506|NCT01778049|520386439|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
144323507|NCT01778049|520386440|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
144323508|NCT01778049|520386441|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
144323509|NCT01778049|520386442|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
144323510|NCT01778049|520386443|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
144323511|NCT01778049|520386438|FG000|Open Label Treatment Period|Not treated|2|||
144323512|NCT01778049|520386439|FG001|Open Label Treatment Period|Not treated|1|||
144323513|NCT01778049|520386440|FG002|Open Label Treatment Period|Not treated|0|||
144323514|NCT01778049|520386441|FG003|Open Label Treatment Period|Not treated|0|||
144323515|NCT01778049|520386442|FG004|Open Label Treatment Period|Not treated|0|||
144323516|NCT01778049|520386443|FG005|Open Label Treatment Period|Not treated|0|||
144323517|NCT01778049|520386438|FG000|Open Label Treatment Period|Other reason not defined above|77|||
144323518|NCT01778049|520386439|FG001|Open Label Treatment Period|Other reason not defined above|94|||
144323519|NCT01778049|520386440|FG002|Open Label Treatment Period|Other reason not defined above|0|||
144323520|NCT01778049|520386441|FG003|Open Label Treatment Period|Other reason not defined above|0|||
144323521|NCT01778049|520386442|FG004|Open Label Treatment Period|Other reason not defined above|0|||
144323522|NCT01778049|520386443|FG005|Open Label Treatment Period|Other reason not defined above|0|||
144323523|NCT01778049|520386438|FG000|Double Blind Treatment Period|Adverse Event|0|||
144323524|NCT01778049|520386439|FG001|Double Blind Treatment Period|Adverse Event|0|||
144323525|NCT01778049|520386440|FG002|Double Blind Treatment Period|Adverse Event|4|||
144323526|NCT01778049|520386441|FG003|Double Blind Treatment Period|Adverse Event|5|||
144323527|NCT01778049|520386442|FG004|Double Blind Treatment Period|Adverse Event|3|||
144323528|NCT01778049|520386443|FG005|Double Blind Treatment Period|Adverse Event|2|||
144323529|NCT01778049|520386438|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
144323530|NCT01778049|520386439|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
144323531|NCT01778049|520386440|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
144323532|NCT01778049|520386441|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
144323533|NCT01778049|520386442|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
144323534|NCT01778049|520386443|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
144323535|NCT01778049|520386438|FG000|Double Blind Treatment Period|Protocol Violation|0|||
144323536|NCT01778049|520386439|FG001|Double Blind Treatment Period|Protocol Violation|0|||
144323537|NCT01778049|520386440|FG002|Double Blind Treatment Period|Protocol Violation|2|||
144323538|NCT01778049|520386441|FG003|Double Blind Treatment Period|Protocol Violation|0|||
144323539|NCT01778049|520386442|FG004|Double Blind Treatment Period|Protocol Violation|0|||
144323540|NCT01778049|520386443|FG005|Double Blind Treatment Period|Protocol Violation|0|||
144323541|NCT01778049|520386438|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
144323542|NCT01778049|520386439|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
144323543|NCT01778049|520386440|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
144323544|NCT01778049|520386441|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
144323545|NCT01778049|520386442|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
144323546|NCT01778049|520386443|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
144323547|NCT01778049|520386438|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
144323548|NCT01778049|520386439|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
144323549|NCT01778049|520386440|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
144323550|NCT01778049|520386441|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
144323551|NCT01778049|520386442|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
144323552|NCT01778049|520386443|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
144323553|NCT01778049|520386438|FG000|Double Blind Treatment Period|Not treated|0|||
144323554|NCT01778049|520386439|FG001|Double Blind Treatment Period|Not treated|0|||
144323555|NCT01778049|520386440|FG002|Double Blind Treatment Period|Not treated|0|||
144323556|NCT01778049|520386441|FG003|Double Blind Treatment Period|Not treated|2|||
144323557|NCT01778049|520386442|FG004|Double Blind Treatment Period|Not treated|2|||
144323558|NCT01778049|520386443|FG005|Double Blind Treatment Period|Not treated|0|||
144323559|NCT01778049|520386438|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
144323560|NCT01778049|520386439|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
144323561|NCT01778049|520386440|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
144323562|NCT01778049|520386441|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
144323563|NCT01778049|520386442|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
144323564|NCT01778049|520386443|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
144323565|NCT00515294|520386447|FG000|Overall Study|Lost to Follow-up|3|||
144323566|NCT00515294|520386448|FG001|Overall Study|Lost to Follow-up|2|||
144323567|NCT00515294|520386449|FG002|Overall Study|Lost to Follow-up|3|||
144323568|NCT00515294|520386450|FG003|Overall Study|Lost to Follow-up|1|||
144323569|NCT00515294|520386447|FG000|Overall Study|Driver simulator problems|1|||
144323570|NCT00515294|520386448|FG001|Overall Study|Driver simulator problems|1|||
144323571|NCT00515294|520386449|FG002|Overall Study|Driver simulator problems|1|||
144323572|NCT00515294|520386450|FG003|Overall Study|Driver simulator problems|3|||
144323573|NCT00515294|520386447|FG000|Overall Study|Caffeine amount inaccurate|5|||
144323574|NCT00515294|520386448|FG001|Overall Study|Caffeine amount inaccurate|0|||
144323575|NCT00515294|520386449|FG002|Overall Study|Caffeine amount inaccurate|7|||
144323576|NCT00515294|520386450|FG003|Overall Study|Caffeine amount inaccurate|0|||
144323577|NCT03943550|520386454|FG000|Overall Study|Adverse Event|0|||
144323578|NCT03943550|520386455|FG001|Overall Study|Adverse Event|0|||
144323579|NCT03943550|520386456|FG002|Overall Study|Adverse Event|1|||
144323580|NCT03943550|520386454|FG000|Overall Study|Lost to Follow-up|0|||
144323581|NCT03943550|520386455|FG001|Overall Study|Lost to Follow-up|0|||
144323582|NCT03943550|520386456|FG002|Overall Study|Lost to Follow-up|1|||
144323583|NCT03943550|520386454|FG000|Overall Study|Progressive Disease|0|||
144323584|NCT03943550|520386455|FG001|Overall Study|Progressive Disease|0|||
144323585|NCT03943550|520386456|FG002|Overall Study|Progressive Disease|2|||
144323586|NCT03943550|520386454|FG000|Overall Study|Participant Moved Out of the Country|0|||
144323587|NCT03943550|520386455|FG001|Overall Study|Participant Moved Out of the Country|1|||
144323588|NCT03943550|520386456|FG002|Overall Study|Participant Moved Out of the Country|0|||
144323589|NCT01639339|520386459|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
144323590|NCT01639339|520386460|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
144323591|NCT01639339|520386459|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
144323592|NCT01639339|520386460|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
144323593|NCT01639339|520386459|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
144323594|NCT01639339|520386460|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
144323595|NCT01639339|520386459|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
144323596|NCT01639339|520386460|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
144323597|NCT01639339|520386459|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
144323598|NCT01639339|520386460|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
144323599|NCT01639339|520386459|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
144323600|NCT01639339|520386460|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
144323601|NCT01639339|520386459|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
144323602|NCT01639339|520386460|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
144323603|NCT01639339|520386459|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
144323604|NCT01639339|520386460|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
144323605|NCT01639339|520386459|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
144323606|NCT01639339|520386460|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
144323607|NCT01639339|520386459|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
144323608|NCT01639339|520386460|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
144323609|NCT00367744|520386461|FG000|Overall Study|Lost to Follow-up|4|||
144323610|NCT00367744|520386462|FG001|Overall Study|Lost to Follow-up|5|||
144323611|NCT00503581|520386469|FG000|Overall Study|Study closed|3|||
144323612|NCT00503581|520386470|FG001|Overall Study|Study closed|4|||
144323613|NCT00503581|520386471|FG002|Overall Study|Study closed|2|||
144323614|NCT00096226|520386472|FG000|Overall Study|Ineligible|2|||
144323615|NCT00096226|520386472|FG000|Overall Study|Protocol treatment not started|1|||
144323616|NCT01666119|520386473|FG000|Overall Study|Adverse Event|6|||
144323617|NCT01666119|520386473|FG000|Overall Study|Withdrawal by Subject|16|||
144323618|NCT01666119|520386473|FG000|Overall Study|Lost to Follow-up|7|||
144323619|NCT01666119|520386473|FG000|Overall Study|non compliance with study medication, pa|18|||
144323620|NCT01666119|520386473|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
144323621|NCT04262882|520386476|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
144323622|NCT04262882|520386477|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
144323623|NCT04262882|520386476|FG000|Overall Study|Lost to Follow-up|1|||
144323624|NCT04262882|520386477|FG001|Overall Study|Lost to Follow-up|0|||
144323625|NCT02979093|520386486|FG000|First Scan Session|Scanning data problems|1|||
144323626|NCT02979093|520386487|FG001|First Scan Session|Scanning data problems|2|||
144323627|NCT02979093|520386488|FG002|First Scan Session|Scanning data problems|2|||
144323628|NCT02979093|520386489|FG003|First Scan Session|Scanning data problems|0|||
144323629|NCT02979093|520386486|FG000|Second Scan Session|Scanning data problems|3|||
144323630|NCT02979093|520386487|FG001|Second Scan Session|Scanning data problems|0|||
144323631|NCT02979093|520386488|FG002|Second Scan Session|Scanning data problems|1|||
144323632|NCT02979093|520386489|FG003|Second Scan Session|Scanning data problems|3|||
144323633|NCT06107803|520386490|FG000|Overall Study|Adverse Event|1|||
144323634|NCT06107803|520386490|FG000|Overall Study|Withdrawal by Subject|2|||
144323635|NCT06107803|520386490|FG000|Overall Study|Protocol Violation|1|||
144323636|NCT04730635|520386492|FG000|Overall Study|Lost to Follow-up|1|||
144323637|NCT04730635|520386493|FG001|Overall Study|Lost to Follow-up|0|||
144323638|NCT04730635|520386492|FG000|Overall Study|Withdrawal by Subject|0|||
144323639|NCT04730635|520386493|FG001|Overall Study|Withdrawal by Subject|1|||
144323640|NCT03070223|520386494|FG000|Overall Study|Lost to Follow-up|34|||
144323641|NCT03070223|520386495|FG001|Overall Study|Lost to Follow-up|27|||
144323642|NCT03070223|520386494|FG000|Overall Study|Withdrawal by Subject|12|||
144323643|NCT03070223|520386495|FG001|Overall Study|Withdrawal by Subject|22|||
144323644|NCT03070223|520386494|FG000|Overall Study|Protocol Violation|0|||
144323645|NCT03070223|520386495|FG001|Overall Study|Protocol Violation|1|||
144323646|NCT04934800|520386496|FG000|Overall Study|Other|1|||
144323647|NCT04934800|520386496|FG000|Overall Study|Withdrawal by Subject|5|||
144323648|NCT04934800|520386496|FG000|Overall Study|Lack of Efficacy|1|||
144323649|NCT04934800|520386496|FG000|Overall Study|Adverse Event|9|||
144323650|NCT04934800|520386496|FG000|Overall Study|Lost to Follow-up|5|||
144323651|NCT04934800|520386496|FG000|Overall Study|Enrolled but not treated|1|||
144323652|NCT00516906|520386497|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
144323653|NCT00516906|520386498|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
144323654|NCT02684058|520386506|FG000|Treatment Period|Progressive disease|4|||
144323655|NCT02684058|520386507|FG001|Treatment Period|Progressive disease|10|||
144323656|NCT02684058|520386508|FG002|Treatment Period|Progressive disease|19|||
144323657|NCT02684058|520386506|FG000|Treatment Period|Adverse Event|3|||
144323658|NCT02684058|520386507|FG001|Treatment Period|Adverse Event|8|||
144323659|NCT02684058|520386508|FG002|Treatment Period|Adverse Event|1|||
144323660|NCT02684058|520386506|FG000|Treatment Period|Physician Decision|5|||
144323661|NCT02684058|520386507|FG001|Treatment Period|Physician Decision|1|||
144323662|NCT02684058|520386508|FG002|Treatment Period|Physician Decision|2|||
144323663|NCT02684058|520386506|FG000|Treatment Period|New therapy for study indication|1|||
144323664|NCT02684058|520386507|FG001|Treatment Period|New therapy for study indication|0|||
144323665|NCT02684058|520386508|FG002|Treatment Period|New therapy for study indication|0|||
144323666|NCT02684058|520386506|FG000|Treatment Period|Protocol deviation|0|||
144323667|NCT02684058|520386507|FG001|Treatment Period|Protocol deviation|1|||
144323668|NCT02684058|520386508|FG002|Treatment Period|Protocol deviation|0|||
144323669|NCT02684058|520386506|FG000|Treatment Period|Subject/guardian decision|4|||
144323670|NCT02684058|520386507|FG001|Treatment Period|Subject/guardian decision|3|||
144323671|NCT02684058|520386508|FG002|Treatment Period|Subject/guardian decision|0|||
144323672|NCT02684058|520386506|FG000|Treatment Period|Death|0|||
144323673|NCT02684058|520386507|FG001|Treatment Period|Death|0|||
144323674|NCT02684058|520386508|FG002|Treatment Period|Death|2|||
144323675|NCT02684058|520386506|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
144323676|NCT02684058|520386507|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
144323677|NCT02684058|520386508|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
144323678|NCT02684058|520386506|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
144323679|NCT02684058|520386507|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
144323680|NCT02684058|520386508|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
144323681|NCT02684058|520386506|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
144323682|NCT02684058|520386507|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
144323683|NCT02684058|520386508|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
144323684|NCT02684058|520386506|FG000|Post-treatment Efficacy Follow-up|Death|0|||
144323685|NCT02684058|520386507|FG001|Post-treatment Efficacy Follow-up|Death|0|||
144323686|NCT02684058|520386508|FG002|Post-treatment Efficacy Follow-up|Death|3|||
144323687|NCT02684058|520386506|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
144323688|NCT02684058|520386507|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
144323689|NCT02684058|520386508|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
144323690|NCT02684058|520386506|FG000|Post-treatment Survival Follow-up|Death|0|||
144323691|NCT02684058|520386507|FG001|Post-treatment Survival Follow-up|Death|0|||
144323692|NCT02684058|520386508|FG002|Post-treatment Survival Follow-up|Death|7|||
144323693|NCT02684058|520386506|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
144323694|NCT02684058|520386507|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
144323695|NCT02684058|520386508|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
144323696|NCT02684058|520386506|FG000|Crossover Treatment Period|Progressive disease|0|||
144323697|NCT02684058|520386507|FG001|Crossover Treatment Period|Progressive disease|1|||
144323698|NCT02684058|520386508|FG002|Crossover Treatment Period|Progressive disease|0|||
144323699|NCT01327053|520386509|FG000|Overall Study|Adverse Event|23|||
144323700|NCT01327053|520386510|FG001|Overall Study|Adverse Event|57|||
144323701|NCT01327053|520386509|FG000|Overall Study|Patient/guardian decision|11|||
144323702|NCT01327053|520386510|FG001|Overall Study|Patient/guardian decision|35|||
144323703|NCT01327053|520386509|FG000|Overall Study|Physician Decision|10|||
144323704|NCT01327053|520386510|FG001|Overall Study|Physician Decision|14|||
144323705|NCT01327053|520386509|FG000|Overall Study|Death|1|||
144323706|NCT01327053|520386510|FG001|Overall Study|Death|5|||
144323707|NCT01327053|520386509|FG000|Overall Study|Lost to Follow-up|2|||
144323708|NCT01327053|520386510|FG001|Overall Study|Lost to Follow-up|4|||
144323709|NCT01327053|520386509|FG000|Overall Study|Non-compliance with study treatment|0|||
144323710|NCT01327053|520386510|FG001|Overall Study|Non-compliance with study treatment|5|||
144323711|NCT01327053|520386509|FG000|Overall Study|Study terminated by Sponsor|1|||
144323712|NCT01327053|520386510|FG001|Overall Study|Study terminated by Sponsor|3|||
144323713|NCT01327053|520386509|FG000|Overall Study|Progressive disease|31|||
144323714|NCT01327053|520386510|FG001|Overall Study|Progressive disease|26|||
144323715|NCT01327053|520386509|FG000|Overall Study|Protocol Violation|0|||
144323716|NCT01327053|520386510|FG001|Overall Study|Protocol Violation|1|||
144323717|NCT01327053|520386509|FG000|Overall Study|Untreated|0|||
144323718|NCT01327053|520386510|FG001|Overall Study|Untreated|1|||
144323719|NCT00721578|520386511|FG000|Overall Study|Death|1|||
144323720|NCT00721578|520386512|FG001|Overall Study|Death|1|||
144323721|NCT00721578|520386511|FG000|Overall Study|Withdrawal by Subject|1|||
144323722|NCT00721578|520386512|FG001|Overall Study|Withdrawal by Subject|1|||
144323723|NCT05032690|520386521|FG000|Period 1|Adverse Event|0|||
144323724|NCT05032690|520386522|FG001|Period 1|Adverse Event|1|||
144323725|NCT05032690|520386523|FG002|Period 1|Adverse Event|0|||
144323726|NCT05032690|520386524|FG003|Period 1|Adverse Event|0|||
144323727|NCT05032690|520386521|FG000|Period 1|Withdrawal by Subject|1|||
144323728|NCT05032690|520386522|FG001|Period 1|Withdrawal by Subject|0|||
144323729|NCT05032690|520386523|FG002|Period 1|Withdrawal by Subject|0|||
144323730|NCT05032690|520386524|FG003|Period 1|Withdrawal by Subject|0|||
144323731|NCT05032690|520386521|FG000|Period 1|No longer meets eligibility criteria|0|||
144323732|NCT05032690|520386522|FG001|Period 1|No longer meets eligibility criteria|1|||
144323733|NCT05032690|520386523|FG002|Period 1|No longer meets eligibility criteria|0|||
144323734|NCT05032690|520386524|FG003|Period 1|No longer meets eligibility criteria|0|||
144323735|NCT05032690|520386521|FG000|Period 2|Adverse Event|1|||
144323736|NCT05032690|520386522|FG001|Period 2|Adverse Event|0|||
144323737|NCT05032690|520386523|FG002|Period 2|Adverse Event|0|||
144323738|NCT05032690|520386524|FG003|Period 2|Adverse Event|0|||
144323739|NCT05032690|520386521|FG000|Period 2|Withdrawal by Subject|0|||
144323740|NCT05032690|520386522|FG001|Period 2|Withdrawal by Subject|1|||
144323741|NCT05032690|520386523|FG002|Period 2|Withdrawal by Subject|0|||
144323742|NCT05032690|520386524|FG003|Period 2|Withdrawal by Subject|0|||
144323743|NCT05032690|520386521|FG000|Period 2|No longer meets eligibility criteria|0|||
144323744|NCT05032690|520386522|FG001|Period 2|No longer meets eligibility criteria|1|||
144323745|NCT05032690|520386523|FG002|Period 2|No longer meets eligibility criteria|0|||
144323746|NCT05032690|520386524|FG003|Period 2|No longer meets eligibility criteria|0|||
144323747|NCT05032690|520386521|FG000|Period 3|Adverse Event|0|||
144323748|NCT05032690|520386522|FG001|Period 3|Adverse Event|1|||
144323749|NCT05032690|520386523|FG002|Period 3|Adverse Event|0|||
144323750|NCT05032690|520386524|FG003|Period 3|Adverse Event|0|||
144323751|NCT05151445|520386525|FG000|Overall Study|Withdrawal by Subject|3|||
144323752|NCT02298179|520386526|FG000|Overall Study|Lost to Follow-up|0|||
144323753|NCT02298179|520386527|FG001|Overall Study|Lost to Follow-up|0|||
144323754|NCT02298179|520386528|FG002|Overall Study|Lost to Follow-up|1|||
144323755|NCT02298179|520386529|FG003|Overall Study|Lost to Follow-up|0|||
144323756|NCT02298179|520386530|FG004|Overall Study|Lost to Follow-up|0|||
144323757|NCT02298179|520386531|FG005|Overall Study|Lost to Follow-up|0|||
144323758|NCT02298179|520386532|FG006|Overall Study|Lost to Follow-up|0|||
144323759|NCT02298179|520386533|FG007|Overall Study|Lost to Follow-up|1|||
144323760|NCT02298179|520386534|FG008|Overall Study|Lost to Follow-up|0|||
144323761|NCT02298179|520386535|FG009|Overall Study|Lost to Follow-up|0|||
144323762|NCT02298179|520386536|FG010|Overall Study|Lost to Follow-up|0|||
144323763|NCT02298179|520386537|FG011|Overall Study|Lost to Follow-up|0|||
144323764|NCT00840060|520388918|FG000|Overall Study|Withdrawal by Subject|1|||
144323765|NCT00840060|520388919|FG001|Overall Study|Withdrawal by Subject|0|||
144323766|NCT00840060|520388918|FG000|Overall Study|Change in emotional/behavioral status|0|||
144323767|NCT00840060|520388919|FG001|Overall Study|Change in emotional/behavioral status|1|||
144323768|NCT00871923|520388920|FG000|Overall Study|Death|1|||
144323769|NCT00871923|520388920|FG000|Overall Study|Withdrawal by Subject|1|||
144323770|NCT01263015|520388925|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
144323771|NCT01263015|520388926|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
144323772|NCT01263015|520388925|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
144323773|NCT01263015|520388926|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
144323774|NCT01263015|520388925|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
144323775|NCT01263015|520388926|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
144323776|NCT01263015|520388925|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
144323777|NCT01263015|520388926|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
144323778|NCT01263015|520388925|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
144323779|NCT01263015|520388926|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
144323780|NCT01263015|520388925|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
144323781|NCT01263015|520388926|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
144323782|NCT01263015|520388925|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
144323783|NCT01263015|520388926|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
144323784|NCT01263015|520388925|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
144323785|NCT01263015|520388926|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
144323786|NCT01263015|520388925|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
144323787|NCT01263015|520388926|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
144323788|NCT01263015|520388925|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
144323789|NCT01263015|520388926|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
144323790|NCT01263015|520388925|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
144323791|NCT01263015|520388926|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
144323792|NCT01263015|520388925|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
144323793|NCT01263015|520388926|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
144323794|NCT05599451|520388927|FG000|Overall Study|Not randomized|11|||
144323795|NCT05599451|520388928|FG001|Overall Study|Not randomized|0|||
144323796|NCT05599451|520388929|FG002|Overall Study|Not randomized|0|||
144323797|NCT05599451|520388930|FG003|Overall Study|Not randomized|0|||
144323798|NCT05599451|520388931|FG004|Overall Study|Not randomized|0|||
144323799|NCT05599451|520388927|FG000|Overall Study|Physician Decision|0|||
144323800|NCT05599451|520388928|FG001|Overall Study|Physician Decision|0|||
144323801|NCT05599451|520388929|FG002|Overall Study|Physician Decision|0|||
144323802|NCT05599451|520388930|FG003|Overall Study|Physician Decision|1|||
144323803|NCT05599451|520388931|FG004|Overall Study|Physician Decision|0|||
144323804|NCT00983515|520388935|FG000|Ritonavir Alone|liver panel out of range|6|||
144323805|NCT00983515|520388935|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
144323806|NCT04143217|520388936|FG000|Overall Study|Withdrawal by Subject|42|||
144323807|NCT04143217|520388936|FG000|Overall Study|Adverse Event|29|||
144323808|NCT04143217|520388936|FG000|Overall Study|Lost to Follow-up|29|||
144323809|NCT04143217|520388936|FG000|Overall Study|Lack of Efficacy|15|||
144323810|NCT04143217|520388936|FG000|Overall Study|Physician Decision|1|||
144323811|NCT04143217|520388936|FG000|Overall Study|Non-Compliance With Study Drug|6|||
144323812|NCT04143217|520388936|FG000|Overall Study|Other, Multiple Categories|11|||
144323813|NCT01962987|520388937|FG000|Overall Study|Adverse Event|4|||
144323814|NCT01962987|520388938|FG001|Overall Study|Adverse Event|4|||
144323815|NCT01962987|520388939|FG002|Overall Study|Adverse Event|0|||
144323816|NCT01962987|520388937|FG000|Overall Study|Lost to Follow-up|0|||
144323817|NCT01962987|520388938|FG001|Overall Study|Lost to Follow-up|0|||
144323818|NCT01962987|520388939|FG002|Overall Study|Lost to Follow-up|1|||
144323819|NCT01962987|520388937|FG000|Overall Study|Non compliance with dosing requirements|4|||
144323820|NCT01962987|520388938|FG001|Overall Study|Non compliance with dosing requirements|2|||
144323821|NCT01962987|520388939|FG002|Overall Study|Non compliance with dosing requirements|0|||
144323822|NCT01962987|520388937|FG000|Overall Study|Miscellaneous|1|||
144323823|NCT01962987|520388938|FG001|Overall Study|Miscellaneous|9|||
144323824|NCT01962987|520388939|FG002|Overall Study|Miscellaneous|2|||
144323825|NCT01962987|520388937|FG000|Overall Study|Restricted medication|5|||
144323826|NCT01962987|520388938|FG001|Overall Study|Restricted medication|1|||
144323827|NCT01962987|520388939|FG002|Overall Study|Restricted medication|1|||
144323828|NCT01962987|520388937|FG000|Overall Study|Serious Adverse Event|1|||
144323829|NCT01962987|520388938|FG001|Overall Study|Serious Adverse Event|0|||
144323830|NCT01962987|520388939|FG002|Overall Study|Serious Adverse Event|0|||
144323831|NCT01962987|520388937|FG000|Overall Study|Withdrawal by Subject|11|||
144323832|NCT01962987|520388938|FG001|Overall Study|Withdrawal by Subject|10|||
144323833|NCT01962987|520388939|FG002|Overall Study|Withdrawal by Subject|6|||
144323834|NCT01962987|520388937|FG000|Overall Study|Randomized in Error|4|||
144323835|NCT01962987|520388938|FG001|Overall Study|Randomized in Error|2|||
144323836|NCT01962987|520388939|FG002|Overall Study|Randomized in Error|2|||
144323837|NCT00316693|520388940|FG000|Overall Study|Adverse Event|6|||
144323838|NCT00316693|520388941|FG001|Overall Study|Adverse Event|1|||
144323839|NCT00316693|520388940|FG000|Overall Study|Protocol Violation|1|||
144323840|NCT00316693|520388941|FG001|Overall Study|Protocol Violation|0|||
144323841|NCT00316693|520388940|FG000|Overall Study|Withdrawal by Subject|6|||
144323842|NCT00316693|520388941|FG001|Overall Study|Withdrawal by Subject|6|||
144323843|NCT00316693|520388940|FG000|Overall Study|Lost to Follow-up|26|||
144323844|NCT00316693|520388941|FG001|Overall Study|Lost to Follow-up|34|||
144323845|NCT00316693|520388940|FG000|Overall Study|Other|38|||
144323846|NCT00316693|520388941|FG001|Overall Study|Other|44|||
144323847|NCT01967823|520388942|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
144323848|NCT00413894|520388950|FG000|Overall Study|Withdrawal by Subject|10|||
144323849|NCT00413894|520388950|FG000|Overall Study|Administrative Reasons|1|||
144323850|NCT00413894|520388950|FG000|Overall Study|Hb <10 grams/deciliter|12|||
144323851|NCT00413894|520388950|FG000|Overall Study|Adverse Event|28|||
144323852|NCT00413894|520388950|FG000|Overall Study|Protocol Violation|11|||
144323853|NCT00413894|520388950|FG000|Overall Study|Other|18|||
144323854|NCT04225676|520388951|FG000|Overall Study|Physician Decision|1|||
144323855|NCT04225676|520388951|FG000|Overall Study|Lack of Efficacy|1|||
144323856|NCT04225676|520388951|FG000|Overall Study|Study terminated by sponsor|3|||
144323857|NCT01942161|520388952|FG000|Overall Study|Adverse Event|1|||
144323858|NCT01942161|520388953|FG001|Overall Study|Adverse Event|2|||
144323859|NCT01942161|520388954|FG002|Overall Study|Adverse Event|5|||
144323860|NCT01942161|520388952|FG000|Overall Study|Physician Decision|3|||
144323861|NCT01942161|520388953|FG001|Overall Study|Physician Decision|1|||
144323862|NCT01942161|520388954|FG002|Overall Study|Physician Decision|0|||
144323863|NCT01942161|520388952|FG000|Overall Study|Protocol Violation|1|||
144323864|NCT01942161|520388953|FG001|Overall Study|Protocol Violation|0|||
144323865|NCT01942161|520388954|FG002|Overall Study|Protocol Violation|0|||
144323866|NCT01942161|520388952|FG000|Overall Study|Withdrawal by Subject|3|||
144323867|NCT01942161|520388953|FG001|Overall Study|Withdrawal by Subject|3|||
144323868|NCT01942161|520388954|FG002|Overall Study|Withdrawal by Subject|1|||
144323869|NCT05289271|520388957|FG000|Overall Study|Mistakenly allocated, untreated|1|||
144323870|NCT05289271|520388958|FG001|Overall Study|Mistakenly allocated, untreated|0|||
144323871|NCT01257568|520388959|FG000|Overall Study|Lost to Follow-up|2|||
144323872|NCT01257568|520388959|FG000|Overall Study|Withdrawal by Subject|6|||
144323873|NCT01257568|520388959|FG000|Overall Study|Terminated|1|||
144323874|NCT01257568|520388959|FG000|Overall Study|Component Revision|24|||
144323875|NCT03392883|520388960|FG000|Overall Study|Lost to Follow-up|122|||
144323876|NCT03392883|520388961|FG001|Overall Study|Lost to Follow-up|13|||
144323877|NCT03392883|520388962|FG002|Overall Study|Lost to Follow-up|9|||
144323878|NCT03392883|520388960|FG000|Overall Study|Death|4|||
144323879|NCT03392883|520388961|FG001|Overall Study|Death|0|||
144323880|NCT03392883|520388962|FG002|Overall Study|Death|0|||
144323881|NCT03392883|520388960|FG000|Overall Study|Lack of Efficacy|29|||
144323882|NCT03392883|520388961|FG001|Overall Study|Lack of Efficacy|0|||
144323883|NCT03392883|520388962|FG002|Overall Study|Lack of Efficacy|0|||
144323884|NCT03392883|520388960|FG000|Overall Study|Withdrawal by Subject|180|||
144323885|NCT03392883|520388961|FG001|Overall Study|Withdrawal by Subject|0|||
144323886|NCT03392883|520388962|FG002|Overall Study|Withdrawal by Subject|0|||
144323887|NCT03392883|520388960|FG000|Overall Study|Adverse Event|1|||
144323888|NCT03392883|520388961|FG001|Overall Study|Adverse Event|0|||
144323889|NCT03392883|520388962|FG002|Overall Study|Adverse Event|0|||
144323890|NCT01739933|520388972|FG000|Overall Study|Death|89|||
144323891|NCT01739933|520388973|FG001|Overall Study|Death|86|||
144323892|NCT01739933|520388972|FG000|Overall Study|Withdrawal by Subject|10|||
144323893|NCT01739933|520388973|FG001|Overall Study|Withdrawal by Subject|8|||
144323894|NCT01739933|520388972|FG000|Overall Study|Lost to Follow-up|3|||
144323895|NCT01739933|520388973|FG001|Overall Study|Lost to Follow-up|10|||
144323896|NCT01739933|520388972|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
144323897|NCT01739933|520388973|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
144323898|NCT03356977|520388974|FG000|Overall Study|Lost to Follow-up|3|||
144323899|NCT03356977|520388974|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144323900|NCT00908115|520388980|FG000|Overall Study|Other|14|||
144323901|NCT01728077|520388981|FG000|Overall Study|Lack of Efficacy|3|||
144323902|NCT01728077|520388982|FG001|Overall Study|Lack of Efficacy|1|||
144323903|NCT01728077|520388981|FG000|Overall Study|Lost to Follow-up|1|||
144323904|NCT01728077|520388982|FG001|Overall Study|Lost to Follow-up|0|||
144323905|NCT01728077|520388981|FG000|Overall Study|Subject choice|2|||
144323906|NCT01728077|520388982|FG001|Overall Study|Subject choice|3|||
144323907|NCT01728077|520388981|FG000|Overall Study|Death|0|||
144323908|NCT01728077|520388982|FG001|Overall Study|Death|1|||
144323909|NCT01728077|520388981|FG000|Overall Study|Patient moving|1|||
144323910|NCT01728077|520388982|FG001|Overall Study|Patient moving|0|||
144323911|NCT01728077|520388981|FG000|Overall Study|Non compliance|1|||
144323912|NCT01728077|520388982|FG001|Overall Study|Non compliance|0|||
144323913|NCT00416715|520388986|FG000|Overall Study|Not evaluable for joint aches|7|||
144323914|NCT00416715|520388986|FG000|Overall Study|Vitamin D levels not evaluable|8|||
144323915|NCT03812185|520388990|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
144323916|NCT01007435|520388993|FG000|Overall Study|Adverse Event|16|||
144323917|NCT01007435|520388994|FG001|Overall Study|Adverse Event|25|||
144323918|NCT01007435|520388995|FG002|Overall Study|Adverse Event|47|||
144323919|NCT01007435|520388996|FG003|Overall Study|Adverse Event|31|||
144323920|NCT01007435|520388993|FG000|Overall Study|Death|2|||
144323921|NCT01007435|520388994|FG001|Overall Study|Death|4|||
144323922|NCT01007435|520388995|FG002|Overall Study|Death|2|||
144323923|NCT01007435|520388996|FG003|Overall Study|Death|1|||
144323924|NCT01007435|520388993|FG000|Overall Study|Insufficient Therapeutic Response|21|||
144323925|NCT01007435|520388994|FG001|Overall Study|Insufficient Therapeutic Response|7|||
144323926|NCT01007435|520388995|FG002|Overall Study|Insufficient Therapeutic Response|2|||
144323927|NCT01007435|520388996|FG003|Overall Study|Insufficient Therapeutic Response|9|||
144323928|NCT01007435|520388993|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
144323929|NCT01007435|520388994|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
144323930|NCT01007435|520388995|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
144323931|NCT01007435|520388996|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
144323932|NCT01007435|520388993|FG000|Overall Study|Other Protocol Violation|2|||
144323933|NCT01007435|520388994|FG001|Overall Study|Other Protocol Violation|0|||
144323934|NCT01007435|520388995|FG002|Overall Study|Other Protocol Violation|1|||
144323935|NCT01007435|520388996|FG003|Overall Study|Other Protocol Violation|0|||
144323936|NCT01007435|520388993|FG000|Overall Study|Refused Treatment|13|||
144323937|NCT01007435|520388994|FG001|Overall Study|Refused Treatment|13|||
144323938|NCT01007435|520388995|FG002|Overall Study|Refused Treatment|5|||
144323939|NCT01007435|520388996|FG003|Overall Study|Refused Treatment|8|||
144323940|NCT01007435|520388993|FG000|Overall Study|Failure to Return|5|||
144323941|NCT01007435|520388994|FG001|Overall Study|Failure to Return|4|||
144323942|NCT01007435|520388995|FG002|Overall Study|Failure to Return|3|||
144323943|NCT01007435|520388996|FG003|Overall Study|Failure to Return|6|||
144323944|NCT01007435|520388993|FG000|Overall Study|Reason not Specified|1|||
144323945|NCT01007435|520388994|FG001|Overall Study|Reason not Specified|1|||
144323946|NCT01007435|520388995|FG002|Overall Study|Reason not Specified|2|||
144323947|NCT01007435|520388996|FG003|Overall Study|Reason not Specified|1|||
144323948|NCT00347438|520388997|FG000|Overall Study|Withdrawal by Subject|1|||
144323949|NCT00347438|520388997|FG000|Overall Study|Physician Decision|1|||
144323950|NCT02545517|520388998|FG000|Overall Study|Death|2|||
144323951|NCT02545517|520388999|FG001|Overall Study|Death|2|||
144323952|NCT02545517|520389000|FG002|Overall Study|Death|1|||
144323953|NCT02545517|520388998|FG000|Overall Study|Lost to Follow-up|14|||
144323954|NCT02545517|520388999|FG001|Overall Study|Lost to Follow-up|13|||
144323955|NCT02545517|520389000|FG002|Overall Study|Lost to Follow-up|17|||
144323956|NCT02545517|520388998|FG000|Overall Study|Protocol Violation|0|||
144323957|NCT02545517|520388999|FG001|Overall Study|Protocol Violation|1|||
144323958|NCT02545517|520389000|FG002|Overall Study|Protocol Violation|1|||
144323959|NCT02545517|520388998|FG000|Overall Study|Withdrawal by Subject|5|||
144323960|NCT02545517|520388999|FG001|Overall Study|Withdrawal by Subject|8|||
144323961|NCT02545517|520389000|FG002|Overall Study|Withdrawal by Subject|9|||
144323962|NCT02545517|520388998|FG000|Overall Study|Administrative reason|5|||
144323963|NCT02545517|520388999|FG001|Overall Study|Administrative reason|6|||
144323964|NCT02545517|520389000|FG002|Overall Study|Administrative reason|10|||
144323965|NCT02545517|520388998|FG000|Overall Study|Other|2|||
144323966|NCT02545517|520388999|FG001|Overall Study|Other|4|||
144323967|NCT02545517|520389000|FG002|Overall Study|Other|3|||
144323968|NCT01529515|520389001|FG000|TRANSITION PHASE|Adverse Event|16|||
144323969|NCT01529515|520389002|FG001|TRANSITION PHASE|Adverse Event|0|||
144323970|NCT01529515|520389003|FG002|TRANSITION PHASE|Adverse Event|0|||
144323971|NCT01529515|520389004|FG003|TRANSITION PHASE|Adverse Event|0|||
144323972|NCT01529515|520389001|FG000|TRANSITION PHASE|Death|1|||
144323973|NCT01529515|520389002|FG001|TRANSITION PHASE|Death|0|||
144323974|NCT01529515|520389003|FG002|TRANSITION PHASE|Death|0|||
144323975|NCT01529515|520389004|FG003|TRANSITION PHASE|Death|0|||
144323976|NCT01529515|520389001|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
144323977|NCT01529515|520389002|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
144323978|NCT01529515|520389003|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
144323979|NCT01529515|520389004|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
144323980|NCT01529515|520389001|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
144323981|NCT01529515|520389002|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
144323982|NCT01529515|520389003|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
144323983|NCT01529515|520389004|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
144323984|NCT01529515|520389001|FG000|TRANSITION PHASE|Protocol Violation|4|||
144323985|NCT01529515|520389002|FG001|TRANSITION PHASE|Protocol Violation|0|||
144323986|NCT01529515|520389003|FG002|TRANSITION PHASE|Protocol Violation|0|||
144323987|NCT01529515|520389004|FG003|TRANSITION PHASE|Protocol Violation|0|||
144323988|NCT01529515|520389001|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
144323989|NCT01529515|520389002|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
144323990|NCT01529515|520389003|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
144323991|NCT01529515|520389004|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
144323992|NCT01529515|520389001|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
144323993|NCT01529515|520389002|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
144323994|NCT01529515|520389003|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
144323995|NCT01529515|520389004|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
144323996|NCT01529515|520389001|FG000|TRANSITION PHASE|Other|9|||
144323997|NCT01529515|520389002|FG001|TRANSITION PHASE|Other|0|||
144323998|NCT01529515|520389003|FG002|TRANSITION PHASE|Other|0|||
144323999|NCT01529515|520389004|FG003|TRANSITION PHASE|Other|0|||
144324000|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Adverse Event|0|||
144324001|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Adverse Event|10|||
144324002|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Adverse Event|0|||
144324003|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Adverse Event|0|||
144324004|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
144324005|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
144324006|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
144324007|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
144324008|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
144324009|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
144324010|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
144324011|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
144324012|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
144324013|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
144324014|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
144324015|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
144324016|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
144324017|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
144324018|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
144324019|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
144324020|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
144324021|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
144324022|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
144324023|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
144324024|NCT01529515|520389001|FG000|MAINTENANCE PHASE|Other|0|||
144324025|NCT01529515|520389002|FG001|MAINTENANCE PHASE|Other|10|||
144324026|NCT01529515|520389003|FG002|MAINTENANCE PHASE|Other|0|||
144324027|NCT01529515|520389004|FG003|MAINTENANCE PHASE|Other|0|||
144324028|NCT01529515|520389001|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
144324029|NCT01529515|520389002|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
144324030|NCT01529515|520389003|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
144324031|NCT01529515|520389004|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
144324032|NCT01529515|520389001|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
144324033|NCT01529515|520389002|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
144324034|NCT01529515|520389003|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
144324035|NCT01529515|520389004|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
144324036|NCT01529515|520389001|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
144324037|NCT01529515|520389002|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
144324038|NCT01529515|520389003|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
144324039|NCT01529515|520389004|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
144324040|NCT01529515|520389001|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
144324041|NCT01529515|520389002|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
144324042|NCT01529515|520389003|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
144324043|NCT01529515|520389004|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
144324044|NCT01529515|520389001|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
144324045|NCT01529515|520389002|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
144324046|NCT01529515|520389003|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
144324047|NCT01529515|520389004|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
144324048|NCT01529515|520389001|FG000|DOUBLE BLIND PHASE|Other|0|||
144324049|NCT01529515|520389002|FG001|DOUBLE BLIND PHASE|Other|0|||
144324050|NCT01529515|520389003|FG002|DOUBLE BLIND PHASE|Other|9|||
144324051|NCT01529515|520389004|FG003|DOUBLE BLIND PHASE|Other|2|||
144324052|NCT03334851|520389006|FG000|Overall Study|Other|0|||
144324053|NCT03334851|520389007|FG001|Overall Study|Other|0|||
144324054|NCT03334851|520389008|FG002|Overall Study|Other|0|||
144324055|NCT03334851|520389009|FG003|Overall Study|Other|0|||
144324056|NCT03334851|520389010|FG004|Overall Study|Other|0|||
144324057|NCT03334851|520389011|FG005|Overall Study|Other|0|||
144324058|NCT03334851|520389012|FG006|Overall Study|Other|0|||
144324059|NCT03334851|520389013|FG007|Overall Study|Other|1|||
144324060|NCT03334851|520389014|FG008|Overall Study|Other|0|||
144324061|NCT03334851|520389015|FG009|Overall Study|Other|0|||
144324062|NCT03334851|520389016|FG010|Overall Study|Other|0|||
144324063|NCT03334851|520389017|FG011|Overall Study|Other|0|||
144324064|NCT03334851|520389018|FG012|Overall Study|Other|0|||
144324065|NCT03334851|520389006|FG000|Overall Study|Adverse Event|0|||
144324066|NCT03334851|520389007|FG001|Overall Study|Adverse Event|0|||
144324067|NCT03334851|520389008|FG002|Overall Study|Adverse Event|0|||
144324068|NCT03334851|520389009|FG003|Overall Study|Adverse Event|0|||
144324069|NCT03334851|520389010|FG004|Overall Study|Adverse Event|0|||
144324070|NCT03334851|520389011|FG005|Overall Study|Adverse Event|0|||
144324071|NCT03334851|520389012|FG006|Overall Study|Adverse Event|0|||
144324072|NCT03334851|520389013|FG007|Overall Study|Adverse Event|1|||
144324073|NCT03334851|520389014|FG008|Overall Study|Adverse Event|0|||
144324074|NCT03334851|520389015|FG009|Overall Study|Adverse Event|0|||
144324075|NCT03334851|520389016|FG010|Overall Study|Adverse Event|0|||
144324076|NCT03334851|520389017|FG011|Overall Study|Adverse Event|0|||
144324077|NCT03334851|520389018|FG012|Overall Study|Adverse Event|0|||
144324078|NCT03334851|520389006|FG000|Overall Study|Withdrawal by Subject|0|||
144324079|NCT03334851|520389007|FG001|Overall Study|Withdrawal by Subject|0|||
144324080|NCT03334851|520389008|FG002|Overall Study|Withdrawal by Subject|0|||
144324081|NCT03334851|520389009|FG003|Overall Study|Withdrawal by Subject|0|||
144324082|NCT03334851|520389010|FG004|Overall Study|Withdrawal by Subject|0|||
144324083|NCT03334851|520389011|FG005|Overall Study|Withdrawal by Subject|0|||
144324084|NCT03334851|520389012|FG006|Overall Study|Withdrawal by Subject|0|||
144324085|NCT03334851|520389013|FG007|Overall Study|Withdrawal by Subject|0|||
144324086|NCT03334851|520389014|FG008|Overall Study|Withdrawal by Subject|0|||
144324087|NCT03334851|520389015|FG009|Overall Study|Withdrawal by Subject|0|||
144324088|NCT03334851|520389016|FG010|Overall Study|Withdrawal by Subject|1|||
144324089|NCT03334851|520389017|FG011|Overall Study|Withdrawal by Subject|0|||
144324090|NCT03334851|520389018|FG012|Overall Study|Withdrawal by Subject|1|||
144324091|NCT03334851|520389006|FG000|Overall Study|Lost to Follow-up|0|||
144324092|NCT03334851|520389007|FG001|Overall Study|Lost to Follow-up|0|||
144324093|NCT03334851|520389008|FG002|Overall Study|Lost to Follow-up|0|||
144324094|NCT03334851|520389009|FG003|Overall Study|Lost to Follow-up|0|||
144324095|NCT03334851|520389010|FG004|Overall Study|Lost to Follow-up|0|||
144324096|NCT03334851|520389011|FG005|Overall Study|Lost to Follow-up|0|||
144324097|NCT03334851|520389012|FG006|Overall Study|Lost to Follow-up|0|||
144324098|NCT03334851|520389013|FG007|Overall Study|Lost to Follow-up|0|||
144324099|NCT03334851|520389014|FG008|Overall Study|Lost to Follow-up|0|||
144324100|NCT03334851|520389015|FG009|Overall Study|Lost to Follow-up|0|||
144324101|NCT03334851|520389016|FG010|Overall Study|Lost to Follow-up|2|||
144324102|NCT03334851|520389017|FG011|Overall Study|Lost to Follow-up|1|||
144324103|NCT03334851|520389018|FG012|Overall Study|Lost to Follow-up|0|||
144324104|NCT00523705|520389019|FG000|Overall Study|No time for study.|0|||
144324105|NCT00523705|520389020|FG001|Overall Study|No time for study.|1|||
144324106|NCT00543803|520389022|FG000|Overall Study|Adverse Event|14|||
144324107|NCT00543803|520389022|FG000|Overall Study|Lack of Efficacy|22|||
144324108|NCT00543803|520389022|FG000|Overall Study|Lost to Follow-up|20|||
144324109|NCT00543803|520389022|FG000|Overall Study|Other|86|||
144324110|NCT01190475|520389023|FG000|Overall Study|Withdrawal by Subject|0|||
144324111|NCT01190475|520389024|FG001|Overall Study|Withdrawal by Subject|0|||
144324112|NCT01190475|520389025|FG002|Overall Study|Withdrawal by Subject|1|||
144324113|NCT00666588|520389028|FG000|Overall Study|ineligible|2|||
144324114|NCT00666588|520389029|FG001|Overall Study|ineligible|0|||
144324115|NCT00666588|520389030|FG002|Overall Study|ineligible|0|||
144324116|NCT00666588|520389031|FG003|Overall Study|ineligible|2|||
144324117|NCT00666588|520389028|FG000|Overall Study|inevaluable|2|||
144324118|NCT00666588|520389029|FG001|Overall Study|inevaluable|0|||
144324119|NCT00666588|520389030|FG002|Overall Study|inevaluable|0|||
144324120|NCT00666588|520389031|FG003|Overall Study|inevaluable|0|||
144324121|NCT04043234|520389032|FG000|Overall Study|Lost to Follow-up|1|||
144324122|NCT04043234|520389032|FG000|Overall Study|Withdrawal by Subject|1|||
144324123|NCT03622112|520389036|FG000|Overall Study|Withdrawal by Subject|6|||
144324124|NCT03622112|520389037|FG001|Overall Study|Withdrawal by Subject|2|||
144324125|NCT03622112|520389038|FG002|Overall Study|Withdrawal by Subject|4|||
144324126|NCT03622112|520389039|FG003|Overall Study|Withdrawal by Subject|2|||
144324127|NCT03622112|520389040|FG004|Overall Study|Withdrawal by Subject|1|||
144324128|NCT03622112|520389041|FG005|Overall Study|Withdrawal by Subject|2|||
144324129|NCT03622112|520389042|FG006|Overall Study|Withdrawal by Subject|2|||
144324130|NCT03622112|520389036|FG000|Overall Study|Death|0|||
144324131|NCT03622112|520389037|FG001|Overall Study|Death|0|||
144324132|NCT03622112|520389038|FG002|Overall Study|Death|0|||
144324133|NCT03622112|520389039|FG003|Overall Study|Death|1|||
144324134|NCT03622112|520389040|FG004|Overall Study|Death|0|||
144324135|NCT03622112|520389041|FG005|Overall Study|Death|0|||
144324136|NCT03622112|520389042|FG006|Overall Study|Death|0|||
144324137|NCT03622112|520389036|FG000|Overall Study|Lost to Follow-up|1|||
144324138|NCT03622112|520389037|FG001|Overall Study|Lost to Follow-up|1|||
144324139|NCT03622112|520389038|FG002|Overall Study|Lost to Follow-up|0|||
144324140|NCT03622112|520389039|FG003|Overall Study|Lost to Follow-up|0|||
144324141|NCT03622112|520389040|FG004|Overall Study|Lost to Follow-up|0|||
144324142|NCT03622112|520389041|FG005|Overall Study|Lost to Follow-up|0|||
144324143|NCT03622112|520389042|FG006|Overall Study|Lost to Follow-up|0|||
144324144|NCT03622112|520389036|FG000|Overall Study|Study-specific withdrawal criteria|10|||
144324145|NCT03622112|520389037|FG001|Overall Study|Study-specific withdrawal criteria|8|||
144324146|NCT03622112|520389038|FG002|Overall Study|Study-specific withdrawal criteria|7|||
144324147|NCT03622112|520389039|FG003|Overall Study|Study-specific withdrawal criteria|6|||
144324148|NCT03622112|520389040|FG004|Overall Study|Study-specific withdrawal criteria|4|||
144324149|NCT03622112|520389041|FG005|Overall Study|Study-specific withdrawal criteria|18|||
144324150|NCT03622112|520389042|FG006|Overall Study|Study-specific withdrawal criteria|4|||
144324151|NCT03622112|520389036|FG000|Overall Study|Protocol Violation|2|||
144324152|NCT03622112|520389037|FG001|Overall Study|Protocol Violation|0|||
144324153|NCT03622112|520389038|FG002|Overall Study|Protocol Violation|1|||
144324154|NCT03622112|520389039|FG003|Overall Study|Protocol Violation|1|||
144324155|NCT03622112|520389040|FG004|Overall Study|Protocol Violation|0|||
144324156|NCT03622112|520389041|FG005|Overall Study|Protocol Violation|0|||
144324157|NCT03622112|520389042|FG006|Overall Study|Protocol Violation|0|||
144324158|NCT03622112|520389036|FG000|Overall Study|Adverse Event|6|||
144324159|NCT03622112|520389037|FG001|Overall Study|Adverse Event|8|||
144324160|NCT03622112|520389038|FG002|Overall Study|Adverse Event|4|||
144324161|NCT03622112|520389039|FG003|Overall Study|Adverse Event|11|||
144324162|NCT03622112|520389040|FG004|Overall Study|Adverse Event|4|||
144324163|NCT03622112|520389041|FG005|Overall Study|Adverse Event|20|||
144324164|NCT03622112|520389042|FG006|Overall Study|Adverse Event|2|||
144324165|NCT03622112|520389036|FG000|Overall Study|Reason not specified|0|||
144324166|NCT03622112|520389037|FG001|Overall Study|Reason not specified|1|||
144324167|NCT03622112|520389038|FG002|Overall Study|Reason not specified|0|||
144324168|NCT03622112|520389039|FG003|Overall Study|Reason not specified|1|||
144324169|NCT03622112|520389040|FG004|Overall Study|Reason not specified|1|||
144324170|NCT03622112|520389041|FG005|Overall Study|Reason not specified|2|||
144324171|NCT03622112|520389042|FG006|Overall Study|Reason not specified|1|||
144324172|NCT01165320|520389043|FG000|Overall Study|Clinical adverse experience|2|||
144324173|NCT01165320|520389044|FG001|Overall Study|Clinical adverse experience|1|||
144324174|NCT01165320|520389045|FG002|Overall Study|Clinical adverse experience|0|||
144324175|NCT01165320|520389043|FG000|Overall Study|Laboratory adverse experience|1|||
144324176|NCT01165320|520389044|FG001|Overall Study|Laboratory adverse experience|0|||
144324177|NCT01165320|520389045|FG002|Overall Study|Laboratory adverse experience|0|||
144324178|NCT01165320|520389043|FG000|Overall Study|Lack of Efficacy|0|||
144324179|NCT01165320|520389044|FG001|Overall Study|Lack of Efficacy|2|||
144324180|NCT01165320|520389045|FG002|Overall Study|Lack of Efficacy|0|||
144324181|NCT01165320|520389043|FG000|Overall Study|Reason unknown|0|||
144324182|NCT01165320|520389044|FG001|Overall Study|Reason unknown|1|||
144324183|NCT01165320|520389045|FG002|Overall Study|Reason unknown|0|||
144324184|NCT01155466|520389046|FG000|Overall Study|Adverse Event|13|||
144324185|NCT01155466|520389047|FG001|Overall Study|Adverse Event|15|||
144324186|NCT01155466|520389048|FG002|Overall Study|Adverse Event|6|||
144324187|NCT01155466|520389049|FG003|Overall Study|Adverse Event|17|||
144324188|NCT01155466|520389050|FG004|Overall Study|Adverse Event|18|||
144324189|NCT01155466|520389046|FG000|Overall Study|Lost to Follow-up|0|||
144324190|NCT01155466|520389047|FG001|Overall Study|Lost to Follow-up|0|||
144324191|NCT01155466|520389048|FG002|Overall Study|Lost to Follow-up|0|||
144324192|NCT01155466|520389049|FG003|Overall Study|Lost to Follow-up|0|||
144324193|NCT01155466|520389050|FG004|Overall Study|Lost to Follow-up|2|||
144324194|NCT01155466|520389046|FG000|Overall Study|Withdrawal by Subject|7|||
144324195|NCT01155466|520389047|FG001|Overall Study|Withdrawal by Subject|5|||
144324196|NCT01155466|520389048|FG002|Overall Study|Withdrawal by Subject|9|||
144324197|NCT01155466|520389049|FG003|Overall Study|Withdrawal by Subject|4|||
144324198|NCT01155466|520389050|FG004|Overall Study|Withdrawal by Subject|4|||
144324199|NCT01155466|520389046|FG000|Overall Study|Protocol Violation|0|||
144324200|NCT01155466|520389047|FG001|Overall Study|Protocol Violation|0|||
144324201|NCT01155466|520389048|FG002|Overall Study|Protocol Violation|2|||
144324202|NCT01155466|520389049|FG003|Overall Study|Protocol Violation|0|||
144324203|NCT01155466|520389050|FG004|Overall Study|Protocol Violation|1|||
144324204|NCT01155466|520389046|FG000|Overall Study|Administrative|0|||
144324205|NCT01155466|520389047|FG001|Overall Study|Administrative|3|||
144324206|NCT01155466|520389048|FG002|Overall Study|Administrative|0|||
144324207|NCT01155466|520389049|FG003|Overall Study|Administrative|0|||
144324208|NCT01155466|520389050|FG004|Overall Study|Administrative|0|||
144324209|NCT01155466|520389046|FG000|Overall Study|Randomized not treated|2|||
144324210|NCT01155466|520389047|FG001|Overall Study|Randomized not treated|2|||
144324211|NCT01155466|520389048|FG002|Overall Study|Randomized not treated|3|||
144324212|NCT01155466|520389049|FG003|Overall Study|Randomized not treated|0|||
144324213|NCT01155466|520389050|FG004|Overall Study|Randomized not treated|2|||
144324214|NCT00590824|520389051|FG000|Overall Study|Disease could not be resected|0|||
144324215|NCT00590824|520389052|FG001|Overall Study|Disease could not be resected|2|||
144324216|NCT00590824|520389053|FG002|Overall Study|Disease could not be resected|1|||
144324217|NCT00590824|520389054|FG003|Overall Study|Disease could not be resected|0|||
144324218|NCT00590824|520389051|FG000|Overall Study|Adverse Event|0|||
144324219|NCT00590824|520389052|FG001|Overall Study|Adverse Event|0|||
144324220|NCT00590824|520389053|FG002|Overall Study|Adverse Event|0|||
144324221|NCT00590824|520389054|FG003|Overall Study|Adverse Event|1|||
144324222|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
144324223|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
144324224|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
144324225|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
144324226|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
144324227|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
144324228|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
144324229|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
144324230|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
144324231|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
144324232|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Other|1|||
144324233|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Other|1|||
144324234|NCT02075047|520389055|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
144324235|NCT02075047|520389056|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
144324236|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
144324237|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
144324238|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
144324239|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
144324240|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
144324241|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
144324242|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
144324243|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
144324244|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
144324245|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
144324246|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Other|1|||
144324247|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Other|2|||
144324248|NCT02075047|520389055|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
144324249|NCT02075047|520389056|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
144324250|NCT02680041|520389060|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
144324251|NCT02680041|520389060|FG000|Overall Study|Lost to Follow-up|2|||
144324252|NCT00521599|520389061|FG000|Overall Study|Adverse Event|5|||
144324253|NCT00521599|520389062|FG001|Overall Study|Adverse Event|7|||
144324254|NCT00521599|520389063|FG002|Overall Study|Adverse Event|6|||
144324255|NCT00521599|520389061|FG000|Overall Study|Treatment Failure|8|||
144324256|NCT00521599|520389062|FG001|Overall Study|Treatment Failure|9|||
144324257|NCT00521599|520389063|FG002|Overall Study|Treatment Failure|22|||
144324258|NCT00521599|520389061|FG000|Overall Study|Lost to Follow-up|2|||
144324259|NCT00521599|520389062|FG001|Overall Study|Lost to Follow-up|1|||
144324260|NCT00521599|520389063|FG002|Overall Study|Lost to Follow-up|2|||
144324261|NCT00521599|520389061|FG000|Overall Study|Withdrawal by Subject|3|||
144324262|NCT00521599|520389062|FG001|Overall Study|Withdrawal by Subject|5|||
144324263|NCT00521599|520389063|FG002|Overall Study|Withdrawal by Subject|1|||
144324264|NCT00521599|520389061|FG000|Overall Study|Withdrawal by subject treatment related|3|||
144324265|NCT00521599|520389062|FG001|Overall Study|Withdrawal by subject treatment related|1|||
144324266|NCT00521599|520389063|FG002|Overall Study|Withdrawal by subject treatment related|2|||
144324267|NCT00521599|520389061|FG000|Overall Study|Protocol Violation|2|||
144324268|NCT00521599|520389062|FG001|Overall Study|Protocol Violation|4|||
144324269|NCT00521599|520389063|FG002|Overall Study|Protocol Violation|2|||
144324270|NCT00521599|520389061|FG000|Overall Study|Did not meet protocol eligibility|2|||
144324271|NCT00521599|520389062|FG001|Overall Study|Did not meet protocol eligibility|2|||
144324272|NCT00521599|520389063|FG002|Overall Study|Did not meet protocol eligibility|1|||
144324273|NCT01610713|520389066|FG000|Overall Study|Adverse Event|3|||
144324274|NCT01610713|520389067|FG001|Overall Study|Adverse Event|0|||
144324275|NCT01610713|520389066|FG000|Overall Study|Lack of Efficacy|1|||
144324276|NCT01610713|520389067|FG001|Overall Study|Lack of Efficacy|0|||
144324277|NCT01610713|520389066|FG000|Overall Study|low mood and poor motivation|1|||
144324278|NCT01610713|520389067|FG001|Overall Study|low mood and poor motivation|0|||
144324279|NCT01610713|520389066|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
144324280|NCT01610713|520389067|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
144324281|NCT01610713|520389066|FG000|Overall Study|Lost to Follow-up|0|||
144324282|NCT01610713|520389067|FG001|Overall Study|Lost to Follow-up|1|||
144324283|NCT03770728|520389070|FG000|Overall Study|Adverse Event|1|||
144324284|NCT03770728|520389071|FG001|Overall Study|Adverse Event|0|||
144324285|NCT03770728|520389072|FG002|Overall Study|Adverse Event|1|||
144324286|NCT03770728|520389073|FG003|Overall Study|Adverse Event|0|||
144324287|NCT03770728|520389070|FG000|Overall Study|Poor compliance to protocol|0|||
144324288|NCT03770728|520389071|FG001|Overall Study|Poor compliance to protocol|0|||
144324289|NCT03770728|520389072|FG002|Overall Study|Poor compliance to protocol|1|||
144324290|NCT03770728|520389073|FG003|Overall Study|Poor compliance to protocol|0|||
144324291|NCT03770728|520389070|FG000|Overall Study|Withdrawal by Subject|13|||
144324292|NCT03770728|520389071|FG001|Overall Study|Withdrawal by Subject|8|||
144324293|NCT03770728|520389072|FG002|Overall Study|Withdrawal by Subject|9|||
144324294|NCT03770728|520389073|FG003|Overall Study|Withdrawal by Subject|13|||
144324295|NCT03770728|520389070|FG000|Overall Study|Other than specified|24|||
144324296|NCT03770728|520389071|FG001|Overall Study|Other than specified|23|||
144324297|NCT03770728|520389072|FG002|Overall Study|Other than specified|21|||
144324298|NCT03770728|520389073|FG003|Overall Study|Other than specified|22|||
144324299|NCT02778555|520389074|FG000|Overall Study|Withdrawal by Subject|55|||
144324300|NCT02778555|520389075|FG001|Overall Study|Withdrawal by Subject|32|||
144324301|NCT02778555|520389076|FG002|Overall Study|Withdrawal by Subject|107|||
144324302|NCT02379988|520389077|FG000|Overall Study|Not eligible|1|||
144324303|NCT00107315|520389078|FG000|Overall Study|Disease Progression|9|||
144324304|NCT00107315|520389078|FG000|Overall Study|Adverse Event|4|||
144324305|NCT00107315|520389078|FG000|Overall Study|Withdrawal by Subject|2|||
144324306|NCT02509039|520389081|FG000|Overall Study|Adverse Event|0|||
144324307|NCT02509039|520389082|FG001|Overall Study|Adverse Event|1|||
144324308|NCT02509039|520389083|FG002|Overall Study|Adverse Event|1|||
144324309|NCT02509039|520389084|FG003|Overall Study|Adverse Event|1|||
144324310|NCT02509039|520389081|FG000|Overall Study|Withdrawal by Subject|0|||
144324311|NCT02509039|520389082|FG001|Overall Study|Withdrawal by Subject|0|||
144324312|NCT02509039|520389083|FG002|Overall Study|Withdrawal by Subject|1|||
144324313|NCT02509039|520389084|FG003|Overall Study|Withdrawal by Subject|0|||
144324314|NCT02509039|520389081|FG000|Overall Study|Progressive disease|2|||
144324315|NCT02509039|520389082|FG001|Overall Study|Progressive disease|2|||
144324316|NCT02509039|520389083|FG002|Overall Study|Progressive disease|1|||
144324317|NCT02509039|520389084|FG003|Overall Study|Progressive disease|5|||
144324318|NCT02509039|520389081|FG000|Overall Study|Study terminated by Sponsor|1|||
144324319|NCT02509039|520389082|FG001|Overall Study|Study terminated by Sponsor|0|||
144324320|NCT02509039|520389083|FG002|Overall Study|Study terminated by Sponsor|0|||
144324321|NCT02509039|520389084|FG003|Overall Study|Study terminated by Sponsor|0|||
144324322|NCT00557310|520389087|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
144324323|NCT00557310|520389087|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
144324324|NCT00557310|520389087|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
144324325|NCT00557310|520389087|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
144324326|NCT00557310|520389087|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
144324327|NCT00557310|520389087|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
144324328|NCT01638013|520389092|FG000|Overall Study|Adverse Event|36|||
144324329|NCT01638013|520389093|FG001|Overall Study|Adverse Event|29|||
144324330|NCT01638013|520389094|FG002|Overall Study|Adverse Event|48|||
144324331|NCT01638013|520389092|FG000|Overall Study|Lack of Efficacy|39|||
144324332|NCT01638013|520389093|FG001|Overall Study|Lack of Efficacy|11|||
144324333|NCT01638013|520389094|FG002|Overall Study|Lack of Efficacy|14|||
144324334|NCT01638013|520389092|FG000|Overall Study|Protocol Violation|10|||
144324335|NCT01638013|520389093|FG001|Overall Study|Protocol Violation|7|||
144324336|NCT01638013|520389094|FG002|Overall Study|Protocol Violation|11|||
144324337|NCT01638013|520389092|FG000|Overall Study|Met discontinuation criteria|4|||
144324338|NCT01638013|520389093|FG001|Overall Study|Met discontinuation criteria|0|||
144324339|NCT01638013|520389094|FG002|Overall Study|Met discontinuation criteria|7|||
144324340|NCT01638013|520389092|FG000|Overall Study|Subject Lost to Follow up|1|||
144324341|NCT01638013|520389093|FG001|Overall Study|Subject Lost to Follow up|0|||
144324342|NCT01638013|520389094|FG002|Overall Study|Subject Lost to Follow up|1|||
144324343|NCT01638013|520389092|FG000|Overall Study|Miscellaneous|25|||
144324344|NCT01638013|520389093|FG001|Overall Study|Miscellaneous|19|||
144324345|NCT01638013|520389094|FG002|Overall Study|Miscellaneous|23|||
144324346|NCT01638013|520389092|FG000|Overall Study|Withdrawal of Consent|16|||
144324347|NCT01638013|520389093|FG001|Overall Study|Withdrawal of Consent|12|||
144324348|NCT01638013|520389094|FG002|Overall Study|Withdrawal of Consent|16|||
144324349|NCT01638013|520389092|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
144324350|NCT01638013|520389093|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
144324351|NCT01638013|520389094|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
144324352|NCT05463744|520389096|FG000|Treatment Period|Withdrawal by Subject|19|||
144324353|NCT05463744|520389097|FG001|Treatment Period|Withdrawal by Subject|16|||
144324354|NCT05463744|520389096|FG000|Treatment Period|Adverse Event|4|||
144324355|NCT05463744|520389097|FG001|Treatment Period|Adverse Event|4|||
144324356|NCT05463744|520389096|FG000|Treatment Period|Pregnancy|0|||
144324357|NCT05463744|520389097|FG001|Treatment Period|Pregnancy|3|||
144324358|NCT05463744|520389096|FG000|Treatment Period|Lost to Follow-up|1|||
144324359|NCT05463744|520389097|FG001|Treatment Period|Lost to Follow-up|3|||
144324360|NCT05463744|520389096|FG000|Treatment Period|Inadvertent enrollment|2|||
144324361|NCT05463744|520389097|FG001|Treatment Period|Inadvertent enrollment|1|||
144324362|NCT05463744|520389096|FG000|Treatment Period|Death|0|||
144324363|NCT05463744|520389097|FG001|Treatment Period|Death|1|||
144324364|NCT05463744|520389096|FG000|Treatment Period|Non-compliance with Study Drug|1|||
144324365|NCT05463744|520389097|FG001|Treatment Period|Non-compliance with Study Drug|0|||
144324366|NCT05463744|520389096|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
144324367|NCT05463744|520389097|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
144324368|NCT05463744|520389096|FG000|Treatment Period|Physician Decision|0|||
144324369|NCT05463744|520389097|FG001|Treatment Period|Physician Decision|1|||
144324370|NCT05463744|520389096|FG000|Follow-Up Period|Withdrawal by Subject|3|||
144324371|NCT05463744|520389097|FG001|Follow-Up Period|Withdrawal by Subject|1|||
144324372|NCT05463744|520389096|FG000|Follow-Up Period|Lost to Follow-up|1|||
144324373|NCT05463744|520389097|FG001|Follow-Up Period|Lost to Follow-up|1|||
144324374|NCT02226198|520391226|FG000|Lead-in Phase|Protocol Violation|1|||
144324375|NCT02226198|520391227|FG001|Lead-in Phase|Protocol Violation|0|||
144324376|NCT02226198|520391228|FG002|Lead-in Phase|Protocol Violation|0|||
144324377|NCT02226198|520391226|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
144324378|NCT02226198|520391227|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
144324379|NCT02226198|520391228|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
144324380|NCT01440517|520391231|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
144324381|NCT01288612|520391232|FG000|Overall Study|Unable to contact|11|||
144324382|NCT01288612|520391233|FG001|Overall Study|Unable to contact|16|||
144324383|NCT01288612|520391234|FG002|Overall Study|Unable to contact|20|||
144324384|NCT01288612|520391232|FG000|Overall Study|Declined|78|||
144324385|NCT01288612|520391233|FG001|Overall Study|Declined|63|||
144324386|NCT01288612|520391234|FG002|Overall Study|Declined|62|||
144324387|NCT01288612|520391232|FG000|Overall Study|Unable to intubate|0|||
144324388|NCT01288612|520391233|FG001|Overall Study|Unable to intubate|3|||
144324389|NCT01288612|520391234|FG002|Overall Study|Unable to intubate|0|||
144324390|NCT02723006|520391235|FG000|Overall Study|Withdrawal by Subject|0|||
144324391|NCT02723006|520391236|FG001|Overall Study|Withdrawal by Subject|1|||
144324392|NCT02723006|520391237|FG002|Overall Study|Withdrawal by Subject|1|||
144324393|NCT02723006|520391235|FG000|Overall Study|Study Terminated by Sponsor|1|||
144324394|NCT02723006|520391236|FG001|Overall Study|Study Terminated by Sponsor|6|||
144324395|NCT02723006|520391237|FG002|Overall Study|Study Terminated by Sponsor|6|||
144324396|NCT00303446|520391238|FG000|Overall Study|Withdrawal by Subject|2|||
144324397|NCT00303446|520391239|FG001|Overall Study|Withdrawal by Subject|2|||
144324398|NCT00303446|520391238|FG000|Overall Study|Death|0|||
144324399|NCT00303446|520391239|FG001|Overall Study|Death|1|||
144324400|NCT00303446|520391238|FG000|Overall Study|Physician Decision|0|||
144324401|NCT00303446|520391239|FG001|Overall Study|Physician Decision|1|||
144324402|NCT04258995|520391240|FG000|Overall Study|Lost to Follow-up|1|||
144324403|NCT04258995|520391241|FG001|Overall Study|Lost to Follow-up|1|||
144324404|NCT00642174|520391252|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
144324405|NCT00642174|520391253|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
144324406|NCT01730339|520391254|FG000|Overall Study|Withdrawal by Subject|3|||
144324407|NCT01730339|520391255|FG001|Overall Study|Withdrawal by Subject|2|||
144324408|NCT01730339|520391254|FG000|Overall Study|Lost to Follow-up|1|||
144324409|NCT01730339|520391255|FG001|Overall Study|Lost to Follow-up|1|||
144324410|NCT01730339|520391254|FG000|Overall Study|Un-specified|1|||
144324411|NCT01730339|520391255|FG001|Overall Study|Un-specified|0|||
144324412|NCT00113399|520391256|FG000|Overall Study|Death|1|||
144324413|NCT00113399|520391257|FG001|Overall Study|Death|1|||
144324414|NCT00113399|520391256|FG000|Overall Study|Withdrawal by Subject|1|||
144324415|NCT00113399|520391257|FG001|Overall Study|Withdrawal by Subject|2|||
144324416|NCT00113399|520391256|FG000|Overall Study|Complete Response|0|||
144324417|NCT00113399|520391257|FG001|Overall Study|Complete Response|1|||
144324418|NCT00113399|520391256|FG000|Overall Study|Other|0|||
144324419|NCT00113399|520391257|FG001|Overall Study|Other|1|||
144324420|NCT01774097|520391260|FG000|Overall Study|Withdrawal by Subject|1|||
144324421|NCT01774097|520391261|FG001|Overall Study|Withdrawal by Subject|1|||
144324422|NCT01774097|520391260|FG000|Overall Study|Adverse Event|1|||
144324423|NCT01774097|520391261|FG001|Overall Study|Adverse Event|1|||
144324424|NCT03447314|520391264|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
144324425|NCT03447314|520391265|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
144324426|NCT03447314|520391266|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
144324427|NCT03447314|520391267|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
144324428|NCT03447314|520391268|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
144324429|NCT03447314|520391269|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
144324430|NCT03447314|520391270|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
144324431|NCT03447314|520391271|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324432|NCT03447314|520391272|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324433|NCT03447314|520391273|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324434|NCT03447314|520391274|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
144324435|NCT03447314|520391275|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
144324436|NCT03447314|520391276|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324437|NCT03447314|520391277|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324438|NCT03447314|520391278|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324439|NCT03447314|520391279|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324440|NCT03447314|520391280|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324441|NCT03447314|520391281|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
144324442|NCT03447314|520391264|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
144324443|NCT03447314|520391265|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324444|NCT03447314|520391266|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
144324445|NCT03447314|520391267|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324446|NCT03447314|520391268|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324447|NCT03447314|520391269|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
144324448|NCT03447314|520391270|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
144324449|NCT03447314|520391271|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324450|NCT03447314|520391272|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324451|NCT03447314|520391273|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324452|NCT03447314|520391274|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324453|NCT03447314|520391275|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324454|NCT03447314|520391276|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324455|NCT03447314|520391277|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324456|NCT03447314|520391278|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324457|NCT03447314|520391279|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324458|NCT03447314|520391280|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324459|NCT03447314|520391281|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
144324460|NCT03447314|520391264|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324461|NCT03447314|520391265|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324462|NCT03447314|520391266|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
144324463|NCT03447314|520391267|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324464|NCT03447314|520391268|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324465|NCT03447314|520391269|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324466|NCT03447314|520391270|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324467|NCT03447314|520391271|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324468|NCT03447314|520391272|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324469|NCT03447314|520391273|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324470|NCT03447314|520391274|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324471|NCT03447314|520391275|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324472|NCT03447314|520391276|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324473|NCT03447314|520391277|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324474|NCT03447314|520391278|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324475|NCT03447314|520391279|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324476|NCT03447314|520391280|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324477|NCT03447314|520391281|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
144324478|NCT03447314|520391264|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324479|NCT03447314|520391265|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324480|NCT03447314|520391266|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
144324481|NCT03447314|520391267|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324482|NCT03447314|520391268|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324483|NCT03447314|520391269|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324484|NCT03447314|520391270|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324485|NCT03447314|520391271|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324486|NCT03447314|520391272|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324487|NCT03447314|520391273|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324488|NCT03447314|520391274|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324489|NCT03447314|520391275|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324490|NCT03447314|520391276|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324491|NCT03447314|520391277|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324492|NCT03447314|520391278|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324493|NCT03447314|520391279|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324494|NCT03447314|520391280|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324495|NCT03447314|520391281|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
144324496|NCT03447314|520391264|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324497|NCT03447314|520391265|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324498|NCT03447314|520391266|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324499|NCT03447314|520391267|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324500|NCT03447314|520391268|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324501|NCT03447314|520391269|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324502|NCT03447314|520391270|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324503|NCT03447314|520391271|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324504|NCT03447314|520391272|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324505|NCT03447314|520391273|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324506|NCT03447314|520391274|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
144324507|NCT03447314|520391275|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324508|NCT03447314|520391276|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324509|NCT03447314|520391277|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324510|NCT03447314|520391278|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324511|NCT03447314|520391279|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324512|NCT03447314|520391280|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324513|NCT03447314|520391281|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
144324514|NCT03447314|520391264|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324515|NCT03447314|520391265|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324516|NCT03447314|520391266|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324517|NCT03447314|520391267|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
144324518|NCT03447314|520391268|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324519|NCT03447314|520391269|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
144324520|NCT03447314|520391270|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324521|NCT03447314|520391271|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324522|NCT03447314|520391272|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324523|NCT03447314|520391273|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324524|NCT03447314|520391274|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324525|NCT03447314|520391275|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324526|NCT03447314|520391276|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324527|NCT03447314|520391277|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324528|NCT03447314|520391278|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324529|NCT03447314|520391279|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324530|NCT03447314|520391280|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324531|NCT03447314|520391281|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
144324532|NCT01703208|520391284|FG000|Overall Study|Death|61|||
144324533|NCT01703208|520391285|FG001|Overall Study|Death|48|||
144324534|NCT01703208|520391284|FG000|Overall Study|Lack of Efficacy|1|||
144324535|NCT01703208|520391285|FG001|Overall Study|Lack of Efficacy|2|||
144324536|NCT01703208|520391284|FG000|Overall Study|Lost to Follow-up|68|||
144324537|NCT01703208|520391285|FG001|Overall Study|Lost to Follow-up|62|||
144324538|NCT01703208|520391284|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144324539|NCT01703208|520391285|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144324540|NCT01703208|520391284|FG000|Overall Study|Excluded Medication|1|||
144324541|NCT01703208|520391285|FG001|Overall Study|Excluded Medication|2|||
144324542|NCT01703208|520391284|FG000|Overall Study|Site Discontinued Study Participation|23|||
144324543|NCT01703208|520391285|FG001|Overall Study|Site Discontinued Study Participation|27|||
144324544|NCT01703208|520391284|FG000|Overall Study|Physician Decision|11|||
144324545|NCT01703208|520391285|FG001|Overall Study|Physician Decision|13|||
144324546|NCT01703208|520391284|FG000|Overall Study|Progressive disease|2|||
144324547|NCT01703208|520391285|FG001|Overall Study|Progressive disease|2|||
144324548|NCT01703208|520391284|FG000|Overall Study|Protocol Violation|1|||
144324549|NCT01703208|520391285|FG001|Overall Study|Protocol Violation|1|||
144324550|NCT01703208|520391284|FG000|Overall Study|Study Terminated by Sponsor|1710|||
144324551|NCT01703208|520391285|FG001|Overall Study|Study Terminated by Sponsor|1716|||
144324552|NCT01703208|520391284|FG000|Overall Study|Withdrawal by Subject|205|||
144324553|NCT01703208|520391285|FG001|Overall Study|Withdrawal by Subject|209|||
144324554|NCT01703208|520391284|FG000|Overall Study|Adverse Event|14|||
144324555|NCT01703208|520391285|FG001|Overall Study|Adverse Event|19|||
144324556|NCT01703208|520391284|FG000|Overall Study|Technical Problems|0|||
144324557|NCT01703208|520391285|FG001|Overall Study|Technical Problems|1|||
144324558|NCT01703208|520391284|FG000|Overall Study|Protocol Deviation|2|||
144324559|NCT01703208|520391285|FG001|Overall Study|Protocol Deviation|0|||
144324560|NCT01271712|520391290|FG000|Double Blind Treatment|Death|2|||
144324561|NCT01271712|520391291|FG001|Double Blind Treatment|Death|0|||
144324562|NCT01271712|520391290|FG000|Double Blind Treatment|Lack of Efficacy|1|||
144324563|NCT01271712|520391291|FG001|Double Blind Treatment|Lack of Efficacy|0|||
144324564|NCT01271712|520391290|FG000|Double Blind Treatment|Adverse Event|9|||
144324565|NCT01271712|520391291|FG001|Double Blind Treatment|Adverse Event|4|||
144324566|NCT01271712|520391290|FG000|Double Blind Treatment|Progressive disease|23|||
144324567|NCT01271712|520391291|FG001|Double Blind Treatment|Progressive disease|3|||
144324568|NCT01271712|520391290|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
144324569|NCT01271712|520391291|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
144324570|NCT01271712|520391290|FG000|Double Blind Treatment|Non compliance with study drug|2|||
144324571|NCT01271712|520391291|FG001|Double Blind Treatment|Non compliance with study drug|0|||
144324572|NCT01271712|520391290|FG000|Double Blind Treatment|receive no study drug|1|||
144324573|NCT01271712|520391291|FG001|Double Blind Treatment|receive no study drug|0|||
144324574|NCT01271712|520391290|FG000|Open Label Treatment|Death|6|||
144324575|NCT01271712|520391291|FG001|Open Label Treatment|Death|5|||
144324576|NCT01271712|520391290|FG000|Open Label Treatment|Withdrawal by Subject|6|||
144324577|NCT01271712|520391291|FG001|Open Label Treatment|Withdrawal by Subject|11|||
144324578|NCT01271712|520391290|FG000|Open Label Treatment|Physician Decision|2|||
144324579|NCT01271712|520391291|FG001|Open Label Treatment|Physician Decision|0|||
144324580|NCT01271712|520391290|FG000|Open Label Treatment|Adverse Event|14|||
144324581|NCT01271712|520391291|FG001|Open Label Treatment|Adverse Event|8|||
144324582|NCT01271712|520391290|FG000|Open Label Treatment|Progressive disease|59|||
144324583|NCT01271712|520391291|FG001|Open Label Treatment|Progressive disease|32|||
144324584|NCT01271712|520391290|FG000|Open Label Treatment|transferred to rollover study|1|||
144324585|NCT01271712|520391291|FG001|Open Label Treatment|transferred to rollover study|0|||
144324586|NCT01271712|520391290|FG000|Open Label Treatment|Non-compliance with study drug|1|||
144324587|NCT01271712|520391291|FG001|Open Label Treatment|Non-compliance with study drug|0|||
144324588|NCT01271712|520391290|FG000|Open Label Treatment|Protocol Violation|0|||
144324589|NCT01271712|520391291|FG001|Open Label Treatment|Protocol Violation|1|||
144324590|NCT01271712|520391290|FG000|Open Label Treatment|Switching to other therapy|2|||
144324591|NCT01271712|520391291|FG001|Open Label Treatment|Switching to other therapy|1|||
144324592|NCT01271712|520391290|FG000|Safety Follow-up|Death|11|||
144324593|NCT01271712|520391291|FG001|Safety Follow-up|Death|7|||
144324594|NCT01271712|520391290|FG000|Safety Follow-up|Withdrawal by Subject|4|||
144324595|NCT01271712|520391291|FG001|Safety Follow-up|Withdrawal by Subject|2|||
144324596|NCT01271712|520391290|FG000|Safety Follow-up|Protocol Violation|1|||
144324597|NCT01271712|520391291|FG001|Safety Follow-up|Protocol Violation|1|||
144324598|NCT01271712|520391290|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
144324599|NCT01271712|520391291|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
144324600|NCT01271712|520391290|FG000|Safety Follow-up|No follow-up|1|||
144324601|NCT01271712|520391291|FG001|Safety Follow-up|No follow-up|1|||
144324602|NCT01271712|520391290|FG000|Safety Follow-up|Progressive disease|1|||
144324603|NCT01271712|520391291|FG001|Safety Follow-up|Progressive disease|0|||
144324604|NCT01271712|520391290|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
144324605|NCT01271712|520391291|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
144324606|NCT04003207|520391295|FG000|Overall Study|Protocol Violation|1|||
144324607|NCT03099174|520391296|FG000|Overall Study|Withdrawal by Subject|0|||
144324608|NCT03099174|520391297|FG001|Overall Study|Withdrawal by Subject|0|||
144324609|NCT03099174|520391298|FG002|Overall Study|Withdrawal by Subject|1|||
144324610|NCT03099174|520391299|FG003|Overall Study|Withdrawal by Subject|0|||
144324611|NCT03099174|520391300|FG004|Overall Study|Withdrawal by Subject|2|||
144324612|NCT03099174|520391301|FG005|Overall Study|Withdrawal by Subject|2|||
144324613|NCT03099174|520391302|FG006|Overall Study|Withdrawal by Subject|1|||
144324614|NCT03099174|520391303|FG007|Overall Study|Withdrawal by Subject|4|||
144324615|NCT03099174|520391296|FG000|Overall Study|Adverse Event|0|||
144324616|NCT03099174|520391297|FG001|Overall Study|Adverse Event|1|||
144324617|NCT03099174|520391298|FG002|Overall Study|Adverse Event|1|||
144324618|NCT03099174|520391299|FG003|Overall Study|Adverse Event|2|||
144324619|NCT03099174|520391300|FG004|Overall Study|Adverse Event|5|||
144324620|NCT03099174|520391301|FG005|Overall Study|Adverse Event|3|||
144324621|NCT03099174|520391302|FG006|Overall Study|Adverse Event|6|||
144324622|NCT03099174|520391303|FG007|Overall Study|Adverse Event|4|||
144324623|NCT03099174|520391296|FG000|Overall Study|Other than listed|6|||
144324624|NCT03099174|520391297|FG001|Overall Study|Other than listed|6|||
144324625|NCT03099174|520391298|FG002|Overall Study|Other than listed|5|||
144324626|NCT03099174|520391299|FG003|Overall Study|Other than listed|6|||
144324627|NCT03099174|520391300|FG004|Overall Study|Other than listed|19|||
144324628|NCT03099174|520391301|FG005|Overall Study|Other than listed|10|||
144324629|NCT03099174|520391302|FG006|Overall Study|Other than listed|26|||
144324630|NCT03099174|520391303|FG007|Overall Study|Other than listed|23|||
144324631|NCT04173260|520391304|FG000|Overall Study|Early termination|4|||
144324632|NCT02308163|520391305|FG000|Overall Study|Not fulfill eligible criteria|1|||
144324633|NCT02308163|520391306|FG001|Overall Study|Not fulfill eligible criteria|2|||
144324634|NCT02308163|520391307|FG002|Overall Study|Not fulfill eligible criteria|0|||
144324635|NCT02308163|520391308|FG003|Overall Study|Not fulfill eligible criteria|1|||
144324636|NCT02308163|520391309|FG004|Overall Study|Not fulfill eligible criteria|1|||
144324637|NCT02308163|520391305|FG000|Overall Study|Adverse Event|9|||
144324638|NCT02308163|520391306|FG001|Overall Study|Adverse Event|5|||
144324639|NCT02308163|520391307|FG002|Overall Study|Adverse Event|2|||
144324640|NCT02308163|520391308|FG003|Overall Study|Adverse Event|2|||
144324641|NCT02308163|520391309|FG004|Overall Study|Adverse Event|11|||
144324642|NCT02308163|520391305|FG000|Overall Study|Lack of Efficacy|11|||
144324643|NCT02308163|520391306|FG001|Overall Study|Lack of Efficacy|3|||
144324644|NCT02308163|520391307|FG002|Overall Study|Lack of Efficacy|8|||
144324645|NCT02308163|520391308|FG003|Overall Study|Lack of Efficacy|4|||
144324646|NCT02308163|520391309|FG004|Overall Study|Lack of Efficacy|6|||
144324647|NCT02308163|520391305|FG000|Overall Study|Withdrawal of consent|2|||
144324648|NCT02308163|520391306|FG001|Overall Study|Withdrawal of consent|3|||
144324649|NCT02308163|520391307|FG002|Overall Study|Withdrawal of consent|0|||
144324650|NCT02308163|520391308|FG003|Overall Study|Withdrawal of consent|2|||
144324651|NCT02308163|520391309|FG004|Overall Study|Withdrawal of consent|6|||
144324652|NCT02308163|520391305|FG000|Overall Study|Protocol Violation|3|||
144324653|NCT02308163|520391306|FG001|Overall Study|Protocol Violation|3|||
144324654|NCT02308163|520391307|FG002|Overall Study|Protocol Violation|3|||
144324655|NCT02308163|520391308|FG003|Overall Study|Protocol Violation|2|||
144324656|NCT02308163|520391309|FG004|Overall Study|Protocol Violation|5|||
144324657|NCT02308163|520391305|FG000|Overall Study|Lab data met discontinuation criteria|3|||
144324658|NCT02308163|520391306|FG001|Overall Study|Lab data met discontinuation criteria|0|||
144324659|NCT02308163|520391307|FG002|Overall Study|Lab data met discontinuation criteria|0|||
144324660|NCT02308163|520391308|FG003|Overall Study|Lab data met discontinuation criteria|2|||
144324661|NCT02308163|520391309|FG004|Overall Study|Lab data met discontinuation criteria|0|||
144324662|NCT02308163|520391305|FG000|Overall Study|Miscellaneous|2|||
144324663|NCT02308163|520391306|FG001|Overall Study|Miscellaneous|2|||
144324664|NCT02308163|520391307|FG002|Overall Study|Miscellaneous|1|||
144324665|NCT02308163|520391308|FG003|Overall Study|Miscellaneous|0|||
144324666|NCT02308163|520391309|FG004|Overall Study|Miscellaneous|5|||
144324667|NCT02118766|520391315|FG000|Overall Study|Adverse Event|7|||
144324668|NCT02118766|520391316|FG001|Overall Study|Adverse Event|2|||
144324669|NCT02118766|520391315|FG000|Overall Study|Withdrawal by Subject|3|||
144324670|NCT02118766|520391316|FG001|Overall Study|Withdrawal by Subject|6|||
144324671|NCT02118766|520391315|FG000|Overall Study|Lost to Follow-up|5|||
144324672|NCT02118766|520391316|FG001|Overall Study|Lost to Follow-up|4|||
144324673|NCT02118766|520391315|FG000|Overall Study|Withdrawal by parent/guardian|12|||
144324674|NCT02118766|520391316|FG001|Overall Study|Withdrawal by parent/guardian|18|||
144324675|NCT02118766|520391315|FG000|Overall Study|Other|3|||
144324676|NCT02118766|520391316|FG001|Overall Study|Other|1|||
144324677|NCT03941964|520391317|FG000|Overall Study|Adverse Event|1|||
144324678|NCT03941964|520391318|FG001|Overall Study|Adverse Event|8|||
144324679|NCT03941964|520391317|FG000|Overall Study|Progressive disease|7|||
144324680|NCT03941964|520391318|FG001|Overall Study|Progressive disease|3|||
144324681|NCT03941964|520391317|FG000|Overall Study|Lack of Efficacy|0|||
144324682|NCT03941964|520391318|FG001|Overall Study|Lack of Efficacy|1|||
144324683|NCT03941964|520391317|FG000|Overall Study|Death|3|||
144324684|NCT03941964|520391318|FG001|Overall Study|Death|1|||
144324685|NCT03941964|520391317|FG000|Overall Study|Withdrew consent|1|||
144324686|NCT03941964|520391318|FG001|Overall Study|Withdrew consent|3|||
144324687|NCT03941964|520391317|FG000|Overall Study|Physician Decision|9|||
144324688|NCT03941964|520391318|FG001|Overall Study|Physician Decision|2|||
144324689|NCT03941964|520391317|FG000|Overall Study|Other, not specified|2|||
144324690|NCT03941964|520391318|FG001|Overall Study|Other, not specified|1|||
144324691|NCT00118846|520391320|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
144324692|NCT00118846|520391321|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
144324693|NCT00118846|520391320|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
144324694|NCT00118846|520391321|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
144324695|NCT00118846|520391320|FG000|Overall Study|Physician Decision|1|||
144324696|NCT00118846|520391321|FG001|Overall Study|Physician Decision|0|||
144324697|NCT00118846|520391320|FG000|Overall Study|Medical condition|2|||
144324698|NCT00118846|520391321|FG001|Overall Study|Medical condition|2|||
144324699|NCT00118846|520391320|FG000|Overall Study|Lost to Follow-up|0|||
144324700|NCT00118846|520391321|FG001|Overall Study|Lost to Follow-up|2|||
144324701|NCT00118846|520391320|FG000|Overall Study|Personal reason|4|||
144324702|NCT00118846|520391321|FG001|Overall Study|Personal reason|5|||
144324703|NCT00443053|520391325|FG000|Overall Study|Adverse Event|2|||
144324704|NCT00443053|520391326|FG001|Overall Study|Adverse Event|1|||
144324705|NCT00443053|520391325|FG000|Overall Study|Withdrawal by Subject|9|||
144324706|NCT00443053|520391326|FG001|Overall Study|Withdrawal by Subject|18|||
144324707|NCT00443053|520391325|FG000|Overall Study|Lost to Follow-up|4|||
144324708|NCT00443053|520391326|FG001|Overall Study|Lost to Follow-up|5|||
144324709|NCT00443053|520391325|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
144324710|NCT00443053|520391326|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
144324711|NCT00443053|520391325|FG000|Overall Study|Noncompliance|2|||
144324712|NCT00443053|520391326|FG001|Overall Study|Noncompliance|1|||
144324713|NCT00443053|520391325|FG000|Overall Study|Other|3|||
144324714|NCT00443053|520391326|FG001|Overall Study|Other|4|||
144324715|NCT00443053|520391325|FG000|Overall Study|Physician Decision|0|||
144324716|NCT00443053|520391326|FG001|Overall Study|Physician Decision|4|||
144324717|NCT00541866|520391327|FG000|Overall Study|Adverse Event|3|||
144324718|NCT00541866|520391328|FG001|Overall Study|Adverse Event|0|||
144324719|NCT00541866|520391329|FG002|Overall Study|Adverse Event|0|||
144324720|NCT00541866|520391330|FG003|Overall Study|Adverse Event|0|||
144324721|NCT00541866|520391331|FG004|Overall Study|Adverse Event|0|||
144324722|NCT00541866|520391327|FG000|Overall Study|Death|1|||
144324723|NCT00541866|520391328|FG001|Overall Study|Death|0|||
144324724|NCT00541866|520391329|FG002|Overall Study|Death|0|||
144324725|NCT00541866|520391330|FG003|Overall Study|Death|0|||
144324726|NCT00541866|520391331|FG004|Overall Study|Death|0|||
144324727|NCT00541866|520391327|FG000|Overall Study|Lack of Efficacy|19|||
144324728|NCT00541866|520391328|FG001|Overall Study|Lack of Efficacy|15|||
144324729|NCT00541866|520391329|FG002|Overall Study|Lack of Efficacy|10|||
144324730|NCT00541866|520391330|FG003|Overall Study|Lack of Efficacy|12|||
144324731|NCT00541866|520391331|FG004|Overall Study|Lack of Efficacy|14|||
144324732|NCT00541866|520391327|FG000|Overall Study|Not Reported or Other|11|||
144324733|NCT00541866|520391328|FG001|Overall Study|Not Reported or Other|3|||
144324734|NCT00541866|520391329|FG002|Overall Study|Not Reported or Other|3|||
144324735|NCT00541866|520391330|FG003|Overall Study|Not Reported or Other|3|||
144324736|NCT00541866|520391331|FG004|Overall Study|Not Reported or Other|1|||
144324737|NCT00541866|520391327|FG000|Overall Study|Physician Decision|0|||
144324738|NCT00541866|520391328|FG001|Overall Study|Physician Decision|0|||
144324739|NCT00541866|520391329|FG002|Overall Study|Physician Decision|2|||
144324740|NCT00541866|520391330|FG003|Overall Study|Physician Decision|1|||
144324741|NCT00541866|520391331|FG004|Overall Study|Physician Decision|0|||
144324742|NCT00522418|520391332|FG000|Overall Study|Local IRB Consent Violation|5|||
144324743|NCT00522418|520391333|FG001|Overall Study|Local IRB Consent Violation|5|||
144324744|NCT00522418|520391332|FG000|Overall Study|Early Study Termination|46|||
144324745|NCT00522418|520391333|FG001|Overall Study|Early Study Termination|47|||
144324746|NCT00522418|520391332|FG000|Overall Study|Noncompliance|2|||
144324747|NCT00522418|520391333|FG001|Overall Study|Noncompliance|2|||
144324748|NCT00522418|520391332|FG000|Overall Study|Reason Not Specified|3|||
144324749|NCT00522418|520391333|FG001|Overall Study|Reason Not Specified|1|||
144324750|NCT00522418|520391332|FG000|Overall Study|Consent Withdraw|1|||
144324751|NCT00522418|520391333|FG001|Overall Study|Consent Withdraw|2|||
144324752|NCT00522418|520391332|FG000|Overall Study|Lack of Efficacy|0|||
144324753|NCT00522418|520391333|FG001|Overall Study|Lack of Efficacy|1|||
144324754|NCT01574157|520391334|FG000|Overall Study|Withdrawal by Subject|4|||
144324755|NCT01574157|520391335|FG001|Overall Study|Withdrawal by Subject|5|||
144324756|NCT01574157|520391334|FG000|Overall Study|Lost to Follow-up|0|||
144324757|NCT01574157|520391335|FG001|Overall Study|Lost to Follow-up|3|||
144324758|NCT00578877|520391338|FG000|Overall Study|Lost to Follow-up|8|||
144324759|NCT00578877|520391339|FG001|Overall Study|Lost to Follow-up|10|||
144324760|NCT00578877|520391338|FG000|Overall Study|early discontinue|61|||
144324761|NCT00578877|520391339|FG001|Overall Study|early discontinue|101|||
144324762|NCT00578877|520391338|FG000|Overall Study|did not provide follow-up data|12|||
144324763|NCT00578877|520391339|FG001|Overall Study|did not provide follow-up data|17|||
144324764|NCT01944098|520391344|FG000|Overall Study|Physician Decision|1|||
144324765|NCT01944098|520391345|FG001|Overall Study|Physician Decision|0|||
144324766|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
144324767|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
144324768|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
144324769|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
144324770|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
144324771|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
144324772|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
144324773|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
144324774|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
144324775|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
144324776|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
144324777|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
144324778|NCT01632241|520391346|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
144324779|NCT01632241|520391347|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
144324780|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
144324781|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
144324782|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
144324783|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
144324784|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
144324785|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
144324786|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
144324787|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
144324788|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
144324789|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
144324790|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
144324791|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
144324792|NCT01632241|520391346|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
144324793|NCT01632241|520391347|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
144324794|NCT04669262|520391348|FG000|Overall Study|Withdrawal by Subject|0|||
144324795|NCT04669262|520391349|FG001|Overall Study|Withdrawal by Subject|0|||
144324796|NCT04669262|520391350|FG002|Overall Study|Withdrawal by Subject|0|||
144324797|NCT04669262|520391351|FG003|Overall Study|Withdrawal by Subject|1|||
144324798|NCT04669262|520391348|FG000|Overall Study|Randomized but Not Treated|0|||
144324799|NCT04669262|520391349|FG001|Overall Study|Randomized but Not Treated|1|||
144324800|NCT04669262|520391350|FG002|Overall Study|Randomized but Not Treated|0|||
144324801|NCT04669262|520391351|FG003|Overall Study|Randomized but Not Treated|0|||
144324802|NCT00350272|520391352|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
144324803|NCT00350272|520391353|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
144324804|NCT00350272|520391352|FG000|Blinded 12-Week Treatment|Death|1|||
144324805|NCT00350272|520391353|FG001|Blinded 12-Week Treatment|Death|0|||
144324806|NCT00350272|520391352|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
144324807|NCT00350272|520391353|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
144324808|NCT00350272|520391352|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
144324809|NCT00350272|520391353|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
144324810|NCT00350272|520391352|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
144324811|NCT00350272|520391353|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
144324812|NCT00350272|520391352|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
144324813|NCT00350272|520391353|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
144324814|NCT00350272|520391352|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
144324815|NCT00350272|520391353|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
144324816|NCT00350272|520391352|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
144324817|NCT00350272|520391353|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
144324818|NCT00350272|520391352|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
144324819|NCT00350272|520391353|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
144324820|NCT00350272|520391352|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
144324821|NCT00350272|520391353|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
144324822|NCT00350272|520391352|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
144324823|NCT00350272|520391353|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
144324824|NCT00098748|520391355|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
144324825|NCT00098748|520391356|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
144324826|NCT00098748|520391357|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
144324827|NCT00098748|520391355|FG000|Received Study Treatment|Death|2|||
144324828|NCT00098748|520391356|FG001|Received Study Treatment|Death|1|||
144324829|NCT00098748|520391357|FG002|Received Study Treatment|Death|2|||
144324830|NCT00098748|520391355|FG000|Received Study Treatment|Adverse Event|1|||
144324831|NCT00098748|520391356|FG001|Received Study Treatment|Adverse Event|2|||
144324832|NCT00098748|520391357|FG002|Received Study Treatment|Adverse Event|5|||
144324833|NCT00098748|520391355|FG000|Received Study Treatment|Lack of Efficacy|40|||
144324834|NCT00098748|520391356|FG001|Received Study Treatment|Lack of Efficacy|27|||
144324835|NCT00098748|520391357|FG002|Received Study Treatment|Lack of Efficacy|27|||
144324836|NCT00098748|520391355|FG000|Received Study Treatment|Other|2|||
144324837|NCT00098748|520391356|FG001|Received Study Treatment|Other|2|||
144324838|NCT00098748|520391357|FG002|Received Study Treatment|Other|6|||
144324839|NCT00098748|520391355|FG000|Received Study Treatment|Subject defaulted|3|||
144324840|NCT00098748|520391356|FG001|Received Study Treatment|Subject defaulted|4|||
144324841|NCT00098748|520391357|FG002|Received Study Treatment|Subject defaulted|4|||
144324842|NCT00098748|520391355|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
144324843|NCT00098748|520391356|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
144324844|NCT00098748|520391357|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
144324845|NCT00098748|520391355|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
144324846|NCT00098748|520391356|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
144324847|NCT00098748|520391357|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
144324848|NCT00098748|520391355|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
144324849|NCT00098748|520391356|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
144324850|NCT00098748|520391357|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
144324851|NCT00098748|520391355|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
144324852|NCT00098748|520391356|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
144324853|NCT00098748|520391357|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
144324854|NCT00098748|520391355|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
144324855|NCT00098748|520391356|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
144324856|NCT00098748|520391357|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
144324857|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
144324858|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
144324859|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Death|0|||
144324860|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Death|0|||
144324861|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
144324862|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
144324863|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
144324864|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
144324865|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
144324866|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
144324867|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
144324868|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
144324869|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
144324870|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
144324871|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
144324872|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
144324873|NCT00433160|520391362|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
144324874|NCT00433160|520391363|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
144324875|NCT00433160|520391362|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
144324876|NCT00433160|520391363|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
144324877|NCT00433160|520391362|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
144324878|NCT00433160|520391363|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
144324879|NCT00433160|520391362|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
144324880|NCT00433160|520391363|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
144324881|NCT00433160|520391362|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
144324882|NCT00433160|520391363|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
144324883|NCT00433160|520391362|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
144324884|NCT00433160|520391363|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
144324885|NCT00433160|520391362|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
144324886|NCT00433160|520391363|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
144324887|NCT00433160|520391362|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
144324888|NCT00433160|520391363|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
144324889|NCT03222973|520391372|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
144324890|NCT03222973|520391373|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
144324891|NCT03222973|520391374|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
144324892|NCT03222973|520391375|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
144324893|NCT03222973|520391372|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
144324894|NCT03222973|520391373|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
144324895|NCT03222973|520391374|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
144324896|NCT03222973|520391375|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
144324897|NCT03222973|520391372|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
144324898|NCT03222973|520391373|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
144324899|NCT03222973|520391374|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
144324900|NCT03222973|520391375|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
144324901|NCT03222973|520391372|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
144324902|NCT03222973|520391373|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
144324903|NCT03222973|520391374|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
144324904|NCT03222973|520391375|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
144324905|NCT03222973|520391372|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
144324906|NCT03222973|520391373|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
144324907|NCT03222973|520391374|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
144324908|NCT03222973|520391375|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
144324909|NCT03222973|520391372|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
144324910|NCT03222973|520391373|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
144324911|NCT03222973|520391374|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
144324912|NCT03222973|520391375|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
144324913|NCT03222973|520391372|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
144324914|NCT03222973|520391373|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
144324915|NCT03222973|520391374|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
144324916|NCT03222973|520391375|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
144324917|NCT03222973|520391372|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
144324918|NCT03222973|520391373|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
144324919|NCT03222973|520391374|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
144324920|NCT03222973|520391375|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
144324921|NCT03222973|520391372|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
144324922|NCT03222973|520391373|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
144324923|NCT03222973|520391374|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
144324924|NCT03222973|520391375|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
144324925|NCT03222973|520391372|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
144324926|NCT03222973|520391373|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
144324927|NCT03222973|520391374|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
144324928|NCT03222973|520391375|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
144324929|NCT03222973|520391372|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
144324930|NCT03222973|520391373|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
144324931|NCT03222973|520391374|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
144324932|NCT03222973|520391375|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
144324933|NCT03222973|520391372|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
144324934|NCT03222973|520391373|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
144324935|NCT03222973|520391374|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
144324936|NCT03222973|520391375|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
144324937|NCT02080481|520391376|FG000|Overall Study|Never received a block.|1|||
144324938|NCT02080481|520391377|FG001|Overall Study|Never received a block.|0|||
144324939|NCT03551665|520391378|FG000|Overall Study|Lost to Follow-up|11|||
144324940|NCT03551665|520391379|FG001|Overall Study|Lost to Follow-up|2|||
144324941|NCT00896363|520392872|FG000|Overall Study|Adverse Event|3|||
144324942|NCT00896363|520392873|FG001|Overall Study|Adverse Event|4|||
144324943|NCT00896363|520392874|FG002|Overall Study|Adverse Event|2|||
144324944|NCT00896363|520392872|FG000|Overall Study|Lack of Efficacy|0|||
144324945|NCT00896363|520392873|FG001|Overall Study|Lack of Efficacy|2|||
144324946|NCT00896363|520392874|FG002|Overall Study|Lack of Efficacy|1|||
144324947|NCT00896363|520392872|FG000|Overall Study|Withdrawal by Subject|3|||
144324948|NCT00896363|520392873|FG001|Overall Study|Withdrawal by Subject|5|||
144324949|NCT00896363|520392874|FG002|Overall Study|Withdrawal by Subject|5|||
144324950|NCT01145352|520392879|FG000|Overall Study|Found to have been registered twice|6|||
144324951|NCT01145352|520392879|FG000|Overall Study|Treated before marketing approval|4|||
144324952|NCT01145352|520392879|FG000|Overall Study|Syringe formulation was used|1|||
144324953|NCT03095027|520392880|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
144324954|NCT03095027|520392881|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
144324955|NCT02982018|520392882|FG000|Overall Study|Incorrect Lens Dispensed|1|||
144324956|NCT02982018|520392883|FG001|Overall Study|Incorrect Lens Dispensed|0|||
144324957|NCT02982018|520392882|FG000|Overall Study|Protocol Violation|1|||
144324958|NCT02982018|520392883|FG001|Overall Study|Protocol Violation|1|||
144324959|NCT02982018|520392882|FG000|Overall Study|Adverse Event|1|||
144324960|NCT02982018|520392883|FG001|Overall Study|Adverse Event|1|||
144324961|NCT02982018|520392882|FG000|Overall Study|Lens Discomfort|2|||
144324962|NCT02982018|520392883|FG001|Overall Study|Lens Discomfort|0|||
144324963|NCT02982018|520392882|FG000|Overall Study|Withdrawal by Subject|0|||
144324964|NCT02982018|520392883|FG001|Overall Study|Withdrawal by Subject|1|||
144324965|NCT04098367|520392887|FG000|Overall Study|Adverse Event|0|||
144324966|NCT04098367|520392888|FG001|Overall Study|Adverse Event|0|||
144324967|NCT04098367|520392889|FG002|Overall Study|Adverse Event|1|||
144324968|NCT04098367|520392887|FG000|Overall Study|Lost to Follow-up|1|||
144324969|NCT04098367|520392888|FG001|Overall Study|Lost to Follow-up|5|||
144324970|NCT04098367|520392889|FG002|Overall Study|Lost to Follow-up|2|||
144324971|NCT04098367|520392887|FG000|Overall Study|Withdrawal by Subject|0|||
144324972|NCT04098367|520392888|FG001|Overall Study|Withdrawal by Subject|0|||
144324973|NCT04098367|520392889|FG002|Overall Study|Withdrawal by Subject|1|||
144324974|NCT04098367|520392887|FG000|Overall Study|Sick . Could not attend visit|1|||
144324975|NCT04098367|520392888|FG001|Overall Study|Sick . Could not attend visit|0|||
144324976|NCT04098367|520392889|FG002|Overall Study|Sick . Could not attend visit|0|||
144324977|NCT02251717|520392890|FG000|Overall Study|Adverse Event|0|||
144324978|NCT02251717|520392891|FG001|Overall Study|Adverse Event|1|||
144324979|NCT02251717|520392890|FG000|Overall Study|Withdrew Consent|1|||
144324980|NCT02251717|520392891|FG001|Overall Study|Withdrew Consent|0|||
144324981|NCT00445939|520392894|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
144324982|NCT00445939|520392895|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
144324983|NCT00445939|520392896|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
144324984|NCT00445939|520392897|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
144324985|NCT00445939|520392894|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
144324986|NCT00445939|520392895|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
144324987|NCT00445939|520392896|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
144324988|NCT00445939|520392897|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
144324989|NCT00378599|520392901|FG000|Overall Study|Adverse Event|38|||
144324990|NCT00378599|520392901|FG000|Overall Study|Protocol Violation|2|||
144324991|NCT00378599|520392901|FG000|Overall Study|Treatment failure|7|||
144324992|NCT00378599|520392901|FG000|Overall Study|Withdrawal by Subject|5|||
144324993|NCT02576535|520392914|FG000|Overall Study|Withdrawal by Subject|2|||
144324994|NCT00322023|520392917|FG000|Overall Study|various|0|||
144324995|NCT00322023|520392918|FG001|Overall Study|various|2|||
144324996|NCT00322023|520392919|FG002|Overall Study|various|6|||
144324997|NCT03920293|520392920|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
144324998|NCT03920293|520392921|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
144324999|NCT03920293|520392920|FG000|Randomized-Controlled Period|Physician Decision|1|||
144325000|NCT03920293|520392921|FG001|Randomized-Controlled Period|Physician Decision|2|||
144325001|NCT03920293|520392920|FG000|Randomized-Controlled Period|Adverse Event|0|||
144325002|NCT03920293|520392921|FG001|Randomized-Controlled Period|Adverse Event|2|||
144325003|NCT03920293|520392920|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
144325004|NCT03920293|520392921|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
144325005|NCT03920293|520392920|FG000|Randomized-Controlled Period|Death|2|||
144325006|NCT03920293|520392921|FG001|Randomized-Controlled Period|Death|0|||
144325007|NCT03920293|520392920|FG000|Randomized-Controlled Period|Protocol Violation|1|||
144325008|NCT03920293|520392921|FG001|Randomized-Controlled Period|Protocol Violation|0|||
144325009|NCT03920293|520392920|FG000|Randomized-Controlled Period|Noncompliance|1|||
144325010|NCT03920293|520392921|FG001|Randomized-Controlled Period|Noncompliance|0|||
144325011|NCT03920293|520392920|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
144325012|NCT03920293|520392921|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
144325013|NCT03920293|520392920|FG000|Open- Label Extension Period|Death|3|||
144325014|NCT03920293|520392921|FG001|Open- Label Extension Period|Death|3|||
144325015|NCT03920293|520392920|FG000|Open- Label Extension Period|Physician Decision|5|||
144325016|NCT03920293|520392921|FG001|Open- Label Extension Period|Physician Decision|3|||
144325017|NCT03920293|520392920|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
144325018|NCT03920293|520392921|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
144325019|NCT01691885|520392927|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
144325020|NCT01691885|520392928|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
144325021|NCT01691885|520392927|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
144325022|NCT01691885|520392928|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
144325023|NCT00996281|520392930|FG000|Overall Study|Adverse Event|75|||
144325024|NCT00996281|520392931|FG001|Overall Study|Adverse Event|37|||
144325025|NCT00996281|520392930|FG000|Overall Study|Major Protocol Deviation|6|||
144325026|NCT00996281|520392931|FG001|Overall Study|Major Protocol Deviation|7|||
144325027|NCT00996281|520392930|FG000|Overall Study|Lost to Follow-up|14|||
144325028|NCT00996281|520392931|FG001|Overall Study|Lost to Follow-up|16|||
144325029|NCT00996281|520392930|FG000|Overall Study|Withdrawal by Subject|31|||
144325030|NCT00996281|520392931|FG001|Overall Study|Withdrawal by Subject|20|||
144325031|NCT00996281|520392930|FG000|Overall Study|Lack of Efficacy|0|||
144325032|NCT00996281|520392931|FG001|Overall Study|Lack of Efficacy|2|||
144325033|NCT00996281|520392930|FG000|Overall Study|Other|5|||
144325034|NCT00996281|520392931|FG001|Overall Study|Other|7|||
144325035|NCT03505788|520392934|FG000|Overall Study|Lost to Follow-up|2|||
144325036|NCT03505788|520392935|FG001|Overall Study|Lost to Follow-up|1|||
144325037|NCT03505788|520392934|FG000|Overall Study|Withdrawal by Subject|1|||
144325038|NCT03505788|520392935|FG001|Overall Study|Withdrawal by Subject|3|||
144325039|NCT03505788|520392934|FG000|Overall Study|Physician Decision|0|||
144325040|NCT03505788|520392935|FG001|Overall Study|Physician Decision|1|||
144325041|NCT03575065|520392936|FG000|Overall Study|Death|31|||
144325042|NCT03575065|520392937|FG001|Overall Study|Death|12|||
144325043|NCT03575065|520392936|FG000|Overall Study|Sponsor's Decision|28|||
144325044|NCT03575065|520392937|FG001|Overall Study|Sponsor's Decision|13|||
144325045|NCT03575065|520392936|FG000|Overall Study|Withdrawal by Subject|2|||
144325046|NCT03575065|520392937|FG001|Overall Study|Withdrawal by Subject|1|||
144325047|NCT03575065|520392936|FG000|Overall Study|Lost to Follow-up|1|||
144325048|NCT03575065|520392937|FG001|Overall Study|Lost to Follow-up|0|||
144325049|NCT03344549|520392942|FG000|Overall Study|Withdrawal by Subject|3|||
144325050|NCT03344549|520392943|FG001|Overall Study|Withdrawal by Subject|2|||
144325051|NCT03344549|520392942|FG000|Overall Study|Dialysis|2|||
144325052|NCT03344549|520392943|FG001|Overall Study|Dialysis|0|||
144325053|NCT03344549|520392942|FG000|Overall Study|Cancer|1|||
144325054|NCT03344549|520392943|FG001|Overall Study|Cancer|0|||
144325055|NCT03344549|520392942|FG000|Overall Study|Lack of electronic device|1|||
144325056|NCT03344549|520392943|FG001|Overall Study|Lack of electronic device|0|||
144325057|NCT03344549|520392942|FG000|Overall Study|Transportation difficulty|0|||
144325058|NCT03344549|520392943|FG001|Overall Study|Transportation difficulty|13|||
144325059|NCT00396136|520392944|FG000|Overall Study|Death|43|||
144325060|NCT00396136|520392944|FG000|Overall Study|Withdrawal by Subject|59|||
144325061|NCT00396136|520392944|FG000|Overall Study|Lost to Follow-up|15|||
144325062|NCT00396136|520392944|FG000|Overall Study|Study device explanted|8|||
144325063|NCT00543296|520392949|FG000|Overall Study|Physician Decision|7|||
144325064|NCT00934947|520392950|FG000|Overall Study|Adverse Event|0|||
144325065|NCT00934947|520392951|FG001|Overall Study|Adverse Event|2|||
144325066|NCT01920568|520392952|FG000|Overall Study|Adverse Event|27|||
144325067|NCT01920568|520392953|FG001|Overall Study|Adverse Event|8|||
144325068|NCT01920568|520392952|FG000|Overall Study|Protocol Violation|5|||
144325069|NCT01920568|520392953|FG001|Overall Study|Protocol Violation|3|||
144325070|NCT01920568|520392952|FG000|Overall Study|Lost to Follow-up|2|||
144325071|NCT01920568|520392953|FG001|Overall Study|Lost to Follow-up|2|||
144325072|NCT01920568|520392952|FG000|Overall Study|Physician Decision|13|||
144325073|NCT01920568|520392953|FG001|Overall Study|Physician Decision|4|||
144325074|NCT01920568|520392952|FG000|Overall Study|Withdrawal by Subject|79|||
144325075|NCT01920568|520392953|FG001|Overall Study|Withdrawal by Subject|55|||
144325076|NCT01920568|520392952|FG000|Overall Study|Death due to disease progression|25|||
144325077|NCT01920568|520392953|FG001|Overall Study|Death due to disease progression|12|||
144325078|NCT00252694|520392957|FG000|Overall Study|Withdrawal by Subject|83|||
144325079|NCT00252694|520392958|FG001|Overall Study|Withdrawal by Subject|91|||
144325080|NCT00252694|520392957|FG000|Overall Study|Death|36|||
144325081|NCT00252694|520392958|FG001|Overall Study|Death|34|||
144325082|NCT00252694|520392957|FG000|Overall Study|Mostly Lost to Follow Up|8|||
144325083|NCT00252694|520392958|FG001|Overall Study|Mostly Lost to Follow Up|13|||
144325084|NCT00252694|520392957|FG000|Overall Study|Patient Moving|17|||
144325085|NCT00252694|520392958|FG001|Overall Study|Patient Moving|16|||
144325086|NCT03664674|520392960|FG000|Overall Study|Adverse Event|1|||
144325087|NCT03664674|520392961|FG001|Overall Study|Adverse Event|1|||
144325088|NCT03664674|520392960|FG000|Overall Study|Physician Decision|0|||
144325089|NCT03664674|520392961|FG001|Overall Study|Physician Decision|1|||
144325090|NCT03664674|520392960|FG000|Overall Study|Withdrawal by Subject|2|||
144325091|NCT03664674|520392961|FG001|Overall Study|Withdrawal by Subject|0|||
144325092|NCT03022097|520392962|FG000|Overall Study|Adverse Event|3|||
144325093|NCT03022097|520392963|FG001|Overall Study|Adverse Event|4|||
144325094|NCT03022097|520392964|FG002|Overall Study|Adverse Event|1|||
144325095|NCT03022097|520392965|FG003|Overall Study|Adverse Event|3|||
144325096|NCT03022097|520392962|FG000|Overall Study|Progressive Disease|2|||
144325097|NCT03022097|520392963|FG001|Overall Study|Progressive Disease|0|||
144325098|NCT03022097|520392964|FG002|Overall Study|Progressive Disease|5|||
144325099|NCT03022097|520392965|FG003|Overall Study|Progressive Disease|2|||
144325100|NCT03022097|520392962|FG000|Overall Study|Lack of Efficacy|0|||
144325101|NCT03022097|520392963|FG001|Overall Study|Lack of Efficacy|0|||
144325102|NCT03022097|520392964|FG002|Overall Study|Lack of Efficacy|3|||
144325103|NCT03022097|520392965|FG003|Overall Study|Lack of Efficacy|3|||
144325104|NCT03022097|520392962|FG000|Overall Study|Protocol Violation|1|||
144325105|NCT03022097|520392963|FG001|Overall Study|Protocol Violation|0|||
144325106|NCT03022097|520392964|FG002|Overall Study|Protocol Violation|1|||
144325107|NCT03022097|520392965|FG003|Overall Study|Protocol Violation|0|||
144325108|NCT03022097|520392962|FG000|Overall Study|Withdrawal by Subject|11|||
144325109|NCT03022097|520392963|FG001|Overall Study|Withdrawal by Subject|13|||
144325110|NCT03022097|520392964|FG002|Overall Study|Withdrawal by Subject|15|||
144325111|NCT03022097|520392965|FG003|Overall Study|Withdrawal by Subject|21|||
144325112|NCT03022097|520392962|FG000|Overall Study|Lost to Follow-up|0|||
144325113|NCT03022097|520392963|FG001|Overall Study|Lost to Follow-up|0|||
144325114|NCT03022097|520392964|FG002|Overall Study|Lost to Follow-up|1|||
144325115|NCT03022097|520392965|FG003|Overall Study|Lost to Follow-up|1|||
144325116|NCT03022097|520392962|FG000|Overall Study|Other|4|||
144325117|NCT03022097|520392963|FG001|Overall Study|Other|1|||
144325118|NCT03022097|520392964|FG002|Overall Study|Other|6|||
144325119|NCT03022097|520392965|FG003|Overall Study|Other|4|||
144325120|NCT03022097|520392962|FG000|Overall Study|Due to COVID-19 pandemic|0|||
144325121|NCT03022097|520392963|FG001|Overall Study|Due to COVID-19 pandemic|1|||
144325122|NCT03022097|520392964|FG002|Overall Study|Due to COVID-19 pandemic|0|||
144325123|NCT03022097|520392965|FG003|Overall Study|Due to COVID-19 pandemic|0|||
144325124|NCT01451931|520392966|FG000|Overall Study|Lost to Follow-up|17|||
144325125|NCT01451931|520392967|FG001|Overall Study|Lost to Follow-up|36|||
144325126|NCT01451931|520392968|FG002|Overall Study|Lost to Follow-up|21|||
144325127|NCT01451931|520392966|FG000|Overall Study|Withdrawal by Subject|16|||
144325128|NCT01451931|520392967|FG001|Overall Study|Withdrawal by Subject|22|||
144325129|NCT01451931|520392968|FG002|Overall Study|Withdrawal by Subject|22|||
144325130|NCT00855933|520392972|FG000|Overall Study|Withdrawal by Subject|0|||
144325131|NCT00855933|520392973|FG001|Overall Study|Withdrawal by Subject|1|||
144325132|NCT00951080|520392974|FG000|Overall Study|Adverse Event|3|||
144325133|NCT00951080|520392975|FG001|Overall Study|Adverse Event|3|||
144325134|NCT00951080|520392974|FG000|Overall Study|Lost to Follow-up|0|||
144325135|NCT00951080|520392975|FG001|Overall Study|Lost to Follow-up|1|||
144325136|NCT00951080|520392974|FG000|Overall Study|Physician Decision|4|||
144325137|NCT00951080|520392975|FG001|Overall Study|Physician Decision|1|||
144325138|NCT00951080|520392974|FG000|Overall Study|Other|19|||
144325139|NCT00951080|520392975|FG001|Overall Study|Other|22|||
144325140|NCT01904149|520392978|FG000|Overall Study|Adverse Event|3|||
144325141|NCT01904149|520392979|FG001|Overall Study|Adverse Event|4|||
144325142|NCT01904149|520392980|FG002|Overall Study|Adverse Event|0|||
144325143|NCT01904149|520392981|FG003|Overall Study|Adverse Event|1|||
144325144|NCT01904149|520392982|FG004|Overall Study|Adverse Event|1|||
144325145|NCT01904149|520392983|FG005|Overall Study|Adverse Event|2|||
144325146|NCT01904149|520392978|FG000|Overall Study|Lack of Efficacy|0|||
144325147|NCT01904149|520392979|FG001|Overall Study|Lack of Efficacy|3|||
144325148|NCT01904149|520392980|FG002|Overall Study|Lack of Efficacy|1|||
144325149|NCT01904149|520392981|FG003|Overall Study|Lack of Efficacy|3|||
144325150|NCT01904149|520392982|FG004|Overall Study|Lack of Efficacy|3|||
144325151|NCT01904149|520392983|FG005|Overall Study|Lack of Efficacy|1|||
144325152|NCT01904149|520392978|FG000|Overall Study|Withdrawal by Subject|1|||
144325153|NCT01904149|520392979|FG001|Overall Study|Withdrawal by Subject|3|||
144325154|NCT01904149|520392980|FG002|Overall Study|Withdrawal by Subject|1|||
144325155|NCT01904149|520392981|FG003|Overall Study|Withdrawal by Subject|0|||
144325156|NCT01904149|520392982|FG004|Overall Study|Withdrawal by Subject|1|||
144325157|NCT01904149|520392983|FG005|Overall Study|Withdrawal by Subject|0|||
144325158|NCT01904149|520392978|FG000|Overall Study|Protocol Violation|0|||
144325159|NCT01904149|520392979|FG001|Overall Study|Protocol Violation|1|||
144325160|NCT01904149|520392980|FG002|Overall Study|Protocol Violation|0|||
144325161|NCT01904149|520392981|FG003|Overall Study|Protocol Violation|0|||
144325162|NCT01904149|520392982|FG004|Overall Study|Protocol Violation|0|||
144325163|NCT01904149|520392983|FG005|Overall Study|Protocol Violation|0|||
144325164|NCT01904149|520392978|FG000|Overall Study|non compliance with study drug|1|||
144325165|NCT01904149|520392979|FG001|Overall Study|non compliance with study drug|0|||
144325166|NCT01904149|520392980|FG002|Overall Study|non compliance with study drug|0|||
144325167|NCT01904149|520392981|FG003|Overall Study|non compliance with study drug|0|||
144325168|NCT01904149|520392982|FG004|Overall Study|non compliance with study drug|0|||
144325169|NCT01904149|520392983|FG005|Overall Study|non compliance with study drug|0|||
144325170|NCT00068250|520392984|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
144325171|NCT00068250|520392985|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
144325172|NCT00068250|520392986|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
144325173|NCT00068250|520392987|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
144325174|NCT01357161|520392988|FG000|Part 1 (Open Label Run-in)|Death|5|||
144325175|NCT01357161|520392989|FG001|Part 1 (Open Label Run-in)|Death|0|||
144325176|NCT01357161|520392990|FG002|Part 1 (Open Label Run-in)|Death|0|||
144325177|NCT01357161|520392988|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
144325178|NCT01357161|520392989|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
144325179|NCT01357161|520392990|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
144325180|NCT01357161|520392988|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
144325181|NCT01357161|520392989|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
144325182|NCT01357161|520392990|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
144325183|NCT01357161|520392988|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
144325184|NCT01357161|520392989|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
144325185|NCT01357161|520392990|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
144325186|NCT01357161|520392988|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
144325187|NCT01357161|520392989|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
144325188|NCT01357161|520392990|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
144325189|NCT01357161|520392988|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
144325190|NCT01357161|520392989|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
144325191|NCT01357161|520392990|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
144325192|NCT01357161|520392988|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
144325193|NCT01357161|520392989|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
144325194|NCT01357161|520392990|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
144325195|NCT01357161|520392988|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
144325196|NCT01357161|520392989|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
144325197|NCT01357161|520392990|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
144325198|NCT01357161|520392988|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
144325199|NCT01357161|520392989|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
144325200|NCT01357161|520392990|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
144325201|NCT01357161|520392988|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
144325202|NCT01357161|520392989|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
144325203|NCT01357161|520392990|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
144325204|NCT01357161|520392988|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
144325205|NCT01357161|520392989|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
144325206|NCT01357161|520392990|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
144325207|NCT01824823|520392991|FG000|Overall Study|Lack of Efficacy|1|||
144325208|NCT01824823|520392992|FG001|Overall Study|Lack of Efficacy|1|||
144325209|NCT01824823|520392991|FG000|Overall Study|Off-treatment reason not submitted|1|||
144325210|NCT01824823|520392992|FG001|Overall Study|Off-treatment reason not submitted|0|||
144325211|NCT03349645|520392995|FG000|Overall Study|Sponsor Terminated Study|75|||
144325212|NCT03349645|520392995|FG000|Overall Study|Withdrawal by Subject|4|||
144325213|NCT03349645|520392995|FG000|Overall Study|Protocol Violation|1|||
144325214|NCT03349645|520392995|FG000|Overall Study|Other|2|||
144325215|NCT00580034|520393007|FG000|Overall Study|Toxicity|10|||
144325216|NCT00580034|520393008|FG001|Overall Study|Toxicity|0|||
144325217|NCT01939002|520393009|FG000|Overall Study|Adverse Event|13|||
144325218|NCT01939002|520393010|FG001|Overall Study|Adverse Event|13|||
144325219|NCT01939002|520393009|FG000|Overall Study|Withdrawal by Subject|5|||
144325220|NCT01939002|520393010|FG001|Overall Study|Withdrawal by Subject|3|||
144325221|NCT01939002|520393009|FG000|Overall Study|Other|1|||
144325222|NCT01939002|520393010|FG001|Overall Study|Other|2|||
144325223|NCT02910401|520393013|FG000|Overall Study|Study closure Study closure|0|||
144325224|NCT02910401|520393014|FG001|Overall Study|Study closure Study closure|0|||
144325225|NCT02910401|520393015|FG002|Overall Study|Study closure Study closure|2|||
144325226|NCT02910401|520393013|FG000|Overall Study|Physician Decision|1|||
144325227|NCT02910401|520393014|FG001|Overall Study|Physician Decision|0|||
144325228|NCT02910401|520393015|FG002|Overall Study|Physician Decision|0|||
144325229|NCT01774253|520393017|FG000|Overall Study|Lack of Efficacy|4|||
144325230|NCT01774253|520393017|FG000|Overall Study|Physician Decision|2|||
144325231|NCT01774253|520393017|FG000|Overall Study|Withdrawal by Subject|2|||
144325232|NCT01774253|520393017|FG000|Overall Study|Death|1|||
144325233|NCT00772369|520393018|FG000|Overall Study|Did not return record release form|1|||
144325234|NCT02240368|520393019|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
144325235|NCT02240368|520393020|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
144325236|NCT02240368|520393021|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
144325237|NCT02240368|520393019|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
144325238|NCT02240368|520393020|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
144325239|NCT02240368|520393021|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
144325240|NCT03372460|520393022|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
144325241|NCT03372460|520393023|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
144325242|NCT02499900|520393024|FG000|Core Study Period|Other|1|||
144325243|NCT02499900|520393025|FG001|Core Study Period|Other|4|||
144325244|NCT02499900|520393024|FG000|Core Study Period|Lost to Follow-up|1|||
144325245|NCT02499900|520393025|FG001|Core Study Period|Lost to Follow-up|2|||
144325246|NCT02499900|520393024|FG000|Core Study Period|Per sponsor request|0|||
144325247|NCT02499900|520393025|FG001|Core Study Period|Per sponsor request|1|||
144325248|NCT02499900|520393024|FG000|Core Study Period|Pregnancy|1|||
144325249|NCT02499900|520393025|FG001|Core Study Period|Pregnancy|0|||
144325250|NCT02499900|520393024|FG000|Core Study Period|Protocol Violation|3|||
144325251|NCT02499900|520393025|FG001|Core Study Period|Protocol Violation|0|||
144325252|NCT02499900|520393024|FG000|Core Study Period|Withdrawal by Subject|11|||
144325253|NCT02499900|520393025|FG001|Core Study Period|Withdrawal by Subject|10|||
144325254|NCT02499900|520393024|FG000|Core Study Period|Adverse Event|18|||
144325255|NCT02499900|520393025|FG001|Core Study Period|Adverse Event|14|||
144325256|NCT02499900|520393024|FG000|Core Study Period|Death|0|||
144325257|NCT02499900|520393025|FG001|Core Study Period|Death|1|||
144325258|NCT02499900|520393024|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
144325259|NCT02499900|520393025|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
144325260|NCT02499900|520393024|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
144325261|NCT02499900|520393025|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
144325262|NCT02499900|520393024|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
144325263|NCT02499900|520393025|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
144325264|NCT02499900|520393024|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
144325265|NCT02499900|520393025|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
144325266|NCT02499900|520393024|FG000|Extension Study Period|Adverse Event|2|||
144325267|NCT02499900|520393025|FG001|Extension Study Period|Adverse Event|4|||
144325268|NCT02499900|520393024|FG000|Extension Study Period|Withdrawal by Subject|5|||
144325269|NCT02499900|520393025|FG001|Extension Study Period|Withdrawal by Subject|2|||
144325270|NCT02499900|520393024|FG000|Extension Study Period|Physician Decision|2|||
144325271|NCT02499900|520393025|FG001|Extension Study Period|Physician Decision|5|||
144325272|NCT02499900|520393024|FG000|Extension Study Period|Pregnancy|1|||
144325273|NCT02499900|520393025|FG001|Extension Study Period|Pregnancy|2|||
144325274|NCT02499900|520393024|FG000|Extension Study Period|Lost to Follow-up|2|||
144325275|NCT02499900|520393025|FG001|Extension Study Period|Lost to Follow-up|5|||
144325276|NCT02499900|520393024|FG000|Extension Study Period|Other|0|||
144325277|NCT02499900|520393025|FG001|Extension Study Period|Other|2|||
144325278|NCT00871117|520393026|FG000|Overall Study|Lost to Follow-up|5|||
144325279|NCT00871117|520393027|FG001|Overall Study|Lost to Follow-up|6|||
144325280|NCT00871117|520393026|FG000|Overall Study|Other|0|||
144325281|NCT00871117|520393027|FG001|Overall Study|Other|4|||
144325282|NCT00916058|520393028|FG000|Phase 1|Screen Failure|0|||
144325283|NCT00916058|520393029|FG001|Phase 1|Screen Failure|0|||
144325284|NCT00916058|520393030|FG002|Phase 1|Screen Failure|0|||
144325285|NCT00916058|520393031|FG003|Phase 1|Screen Failure|0|||
144325286|NCT00916058|520393032|FG004|Phase 1|Screen Failure|0|||
144325287|NCT00916058|520393033|FG005|Phase 1|Screen Failure|1|||
144325288|NCT00916058|520393034|FG006|Phase 1|Screen Failure|0|||
144325289|NCT00916058|520393028|FG000|Phase 2|Screen Failure|0|||
144325290|NCT00916058|520393029|FG001|Phase 2|Screen Failure|0|||
144325291|NCT00916058|520393030|FG002|Phase 2|Screen Failure|0|||
144325292|NCT00916058|520393031|FG003|Phase 2|Screen Failure|0|||
144325293|NCT00916058|520393032|FG004|Phase 2|Screen Failure|0|||
144325294|NCT00916058|520393033|FG005|Phase 2|Screen Failure|0|||
144325295|NCT00916058|520393034|FG006|Phase 2|Screen Failure|3|||
144325296|NCT02439450|520393035|FG000|Overall Study|Adverse Event|4|||
144325297|NCT02439450|520393036|FG001|Overall Study|Adverse Event|1|||
144325298|NCT02439450|520393037|FG002|Overall Study|Adverse Event|0|||
144325299|NCT02439450|520393038|FG003|Overall Study|Adverse Event|0|||
144325300|NCT02439450|520393035|FG000|Overall Study|Withdrawal by Subject|1|||
144325301|NCT02439450|520393036|FG001|Overall Study|Withdrawal by Subject|2|||
144325302|NCT02439450|520393037|FG002|Overall Study|Withdrawal by Subject|0|||
144325303|NCT02439450|520393038|FG003|Overall Study|Withdrawal by Subject|0|||
144325304|NCT02439450|520393035|FG000|Overall Study|Death|3|||
144325305|NCT02439450|520393036|FG001|Overall Study|Death|0|||
144325306|NCT02439450|520393037|FG002|Overall Study|Death|0|||
144325307|NCT02439450|520393038|FG003|Overall Study|Death|1|||
144325308|NCT02439450|520393035|FG000|Overall Study|Progressive Disease|18|||
144325309|NCT02439450|520393036|FG001|Overall Study|Progressive Disease|41|||
144325310|NCT02439450|520393037|FG002|Overall Study|Progressive Disease|2|||
144325311|NCT02439450|520393038|FG003|Overall Study|Progressive Disease|3|||
144325312|NCT01170065|520393041|FG000|Overall Study|Adverse Event|17|||
144325313|NCT01170065|520393042|FG001|Overall Study|Adverse Event|50|||
144325314|NCT01170065|520393043|FG002|Overall Study|Adverse Event|10|||
144325315|NCT01170065|520393041|FG000|Overall Study|Lost to Follow-up|1|||
144325316|NCT01170065|520393042|FG001|Overall Study|Lost to Follow-up|4|||
144325317|NCT01170065|520393043|FG002|Overall Study|Lost to Follow-up|1|||
144325318|NCT01170065|520393041|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
144325319|NCT01170065|520393042|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
144325320|NCT01170065|520393043|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
144325321|NCT01170065|520393041|FG000|Overall Study|Reason other than specified|3|||
144325322|NCT01170065|520393042|FG001|Overall Study|Reason other than specified|8|||
144325323|NCT01170065|520393043|FG002|Overall Study|Reason other than specified|3|||
144325324|NCT01170065|520393041|FG000|Overall Study|Ongoing after planned observation time|5|||
144325325|NCT01170065|520393042|FG001|Overall Study|Ongoing after planned observation time|26|||
144325326|NCT01170065|520393043|FG002|Overall Study|Ongoing after planned observation time|10|||
144325327|NCT01444027|520393044|FG000|Overall Study|Withdrawal by Subject|4|||
144325328|NCT01444027|520393045|FG001|Overall Study|Withdrawal by Subject|10|||
144325329|NCT01444027|520393046|FG002|Overall Study|Withdrawal by Subject|24|||
144325330|NCT01444027|520393044|FG000|Overall Study|Lost to Follow-up|26|||
144325331|NCT01444027|520393045|FG001|Overall Study|Lost to Follow-up|20|||
144325332|NCT01444027|520393046|FG002|Overall Study|Lost to Follow-up|14|||
144325333|NCT00496483|520394373|FG000|Overall Study|Not dosed|9|||
144325334|NCT00496483|520394373|FG000|Overall Study|Adverse Event|2|||
144325335|NCT00496483|520394373|FG000|Overall Study|Lack of Efficacy|1|||
144325336|NCT00428220|520394374|FG000|Overall Study|Participant died|8|||
144325337|NCT00428220|520394374|FG000|Overall Study|Global deterioration of health status|7|||
144325338|NCT00428220|520394374|FG000|Overall Study|Lost to Follow-up|4|||
144325339|NCT00428220|520394374|FG000|Overall Study|Objective progression or relapse|123|||
144325340|NCT00428220|520394374|FG000|Overall Study|Participant refused continued treatment|7|||
144325341|NCT00428220|520394374|FG000|Overall Study|Adverse Event|51|||
144325342|NCT00428220|520394374|FG000|Overall Study|Other|23|||
144325343|NCT03245736|520394375|FG000|Overall Study|Adverse Event|1|||
144325344|NCT03245736|520394375|FG000|Overall Study|Progressive Disease|4|||
144325345|NCT00132691|520394377|FG000|Overall Study|Lost to Follow-up|5|||
144325346|NCT00132691|520394378|FG001|Overall Study|Lost to Follow-up|8|||
144325347|NCT00132691|520394377|FG000|Overall Study|Missed 2-year visit|4|||
144325348|NCT00132691|520394378|FG001|Overall Study|Missed 2-year visit|4|||
144325349|NCT00132691|520394377|FG000|Overall Study|Death|2|||
144325350|NCT00132691|520394378|FG001|Overall Study|Death|0|||
144325351|NCT03555981|520394379|FG000|Overall Study|Lost to Follow-up|0|||
144325352|NCT03555981|520394380|FG001|Overall Study|Lost to Follow-up|2|||
144325353|NCT00354107|520394381|FG000|Overall Study|Adverse Event|2|||
144325354|NCT00354107|520394381|FG000|Overall Study|Physician Decision|2|||
144325355|NCT00354107|520394381|FG000|Overall Study|Withdrawal by Subject|1|||
144325356|NCT04035564|520394383|FG000|Overall Study|Protocol Violation|1|||
144325357|NCT04035564|520394384|FG001|Overall Study|Protocol Violation|2|||
144325358|NCT04035564|520394383|FG000|Overall Study|No laboratory available|2|||
144325359|NCT04035564|520394384|FG001|Overall Study|No laboratory available|2|||
144325360|NCT04035564|520394383|FG000|Overall Study|Guardian declined consent|1|||
144325361|NCT04035564|520394384|FG001|Overall Study|Guardian declined consent|2|||
144325362|NCT03361189|520394387|FG000|Overall Study|Received heart transplant|1|||
144325363|NCT03361189|520394388|FG001|Overall Study|Received heart transplant|0|||
144325364|NCT03361189|520394387|FG000|Overall Study|Pacemake replacement|0|||
144325365|NCT03361189|520394388|FG001|Overall Study|Pacemake replacement|1|||
144325366|NCT02323126|520394389|FG000|Overall Study|Patient / guardian decision|0|||
144325367|NCT02323126|520394390|FG001|Overall Study|Patient / guardian decision|1|||
144325368|NCT02323126|520394391|FG002|Overall Study|Patient / guardian decision|2|||
144325369|NCT02323126|520394389|FG000|Overall Study|Progressive disease|14|||
144325370|NCT02323126|520394390|FG001|Overall Study|Progressive disease|8|||
144325371|NCT02323126|520394391|FG002|Overall Study|Progressive disease|14|||
144325372|NCT02323126|520394389|FG000|Overall Study|Physician Decision|0|||
144325373|NCT02323126|520394390|FG001|Overall Study|Physician Decision|1|||
144325374|NCT02323126|520394391|FG002|Overall Study|Physician Decision|3|||
144325375|NCT02323126|520394389|FG000|Overall Study|Death|1|||
144325376|NCT02323126|520394390|FG001|Overall Study|Death|1|||
144325377|NCT02323126|520394391|FG002|Overall Study|Death|4|||
144325378|NCT02323126|520394389|FG000|Overall Study|Adverse Event|3|||
144325379|NCT02323126|520394390|FG001|Overall Study|Adverse Event|5|||
144325380|NCT02323126|520394391|FG002|Overall Study|Adverse Event|7|||
144325381|NCT03333252|520394392|FG000|Overall Study|Adverse Event|10|||
144325382|NCT03333252|520394393|FG001|Overall Study|Adverse Event|6|||
144325383|NCT03333252|520394394|FG002|Overall Study|Adverse Event|5|||
144325384|NCT03333252|520394395|FG003|Overall Study|Adverse Event|2|||
144325385|NCT03333252|520394392|FG000|Overall Study|Death|1|||
144325386|NCT03333252|520394393|FG001|Overall Study|Death|3|||
144325387|NCT03333252|520394394|FG002|Overall Study|Death|0|||
144325388|NCT03333252|520394395|FG003|Overall Study|Death|0|||
144325389|NCT03333252|520394392|FG000|Overall Study|Lack of Efficacy|8|||
144325390|NCT03333252|520394393|FG001|Overall Study|Lack of Efficacy|4|||
144325391|NCT03333252|520394394|FG002|Overall Study|Lack of Efficacy|0|||
144325392|NCT03333252|520394395|FG003|Overall Study|Lack of Efficacy|7|||
144325393|NCT03333252|520394392|FG000|Overall Study|Lost to Follow-up|0|||
144325394|NCT03333252|520394393|FG001|Overall Study|Lost to Follow-up|5|||
144325395|NCT03333252|520394394|FG002|Overall Study|Lost to Follow-up|9|||
144325396|NCT03333252|520394395|FG003|Overall Study|Lost to Follow-up|3|||
144325397|NCT03333252|520394392|FG000|Overall Study|Withdrawal by Subject|14|||
144325398|NCT03333252|520394393|FG001|Overall Study|Withdrawal by Subject|24|||
144325399|NCT03333252|520394394|FG002|Overall Study|Withdrawal by Subject|11|||
144325400|NCT03333252|520394395|FG003|Overall Study|Withdrawal by Subject|17|||
144325401|NCT01685801|520394401|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
144325402|NCT01685801|520394402|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
144325403|NCT01685801|520394403|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
144325404|NCT01685801|520394404|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
144325405|NCT01685801|520394401|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
144325406|NCT01685801|520394402|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
144325407|NCT01685801|520394403|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
144325408|NCT01685801|520394404|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
144325409|NCT03350256|520394405|FG000|Overall Study|Inclusion/exclusion violation|4|||
144325410|NCT03350256|520394405|FG000|Overall Study|Recommended for other therapies|2|||
144325411|NCT03350256|520394405|FG000|Overall Study|Protocol Violation|3|||
144325412|NCT03350256|520394405|FG000|Overall Study|Non compliance|2|||
144325413|NCT03350256|520394405|FG000|Overall Study|Denial by insurance|1|||
144325414|NCT03350256|520394405|FG000|Overall Study|Adverse Event|2|||
144325415|NCT03350256|520394405|FG000|Overall Study|Trial failure|12|||
144325416|NCT03350256|520394405|FG000|Overall Study|Did not proceed to permanent implant|3|||
144325417|NCT03350256|520394405|FG000|Overall Study|Withdrawal by Subject|3|||
144325418|NCT03350256|520394405|FG000|Overall Study|Subject moving out of state|1|||
144325419|NCT03350256|520394405|FG000|Overall Study|Lost to Follow-up|1|||
144325420|NCT03350256|520394405|FG000|Overall Study|Lack of Efficacy|2|||
144325421|NCT03960580|520394406|FG000|Overall Study|Adverse Event|2|||
144325422|NCT03960580|520394407|FG001|Overall Study|Adverse Event|1|||
144325423|NCT03960580|520394408|FG002|Overall Study|Adverse Event|1|||
144325424|NCT03960580|520394406|FG000|Overall Study|Lost to Follow-up|1|||
144325425|NCT03960580|520394407|FG001|Overall Study|Lost to Follow-up|0|||
144325426|NCT03960580|520394408|FG002|Overall Study|Lost to Follow-up|0|||
144325427|NCT03960580|520394406|FG000|Overall Study|Lack of Efficacy|2|||
144325428|NCT03960580|520394407|FG001|Overall Study|Lack of Efficacy|1|||
144325429|NCT03960580|520394408|FG002|Overall Study|Lack of Efficacy|0|||
144325430|NCT03960580|520394406|FG000|Overall Study|Protocol Violation|0|||
144325431|NCT03960580|520394407|FG001|Overall Study|Protocol Violation|0|||
144325432|NCT03960580|520394408|FG002|Overall Study|Protocol Violation|1|||
144325433|NCT03960580|520394406|FG000|Overall Study|Withdrawal by Subject|1|||
144325434|NCT03960580|520394407|FG001|Overall Study|Withdrawal by Subject|1|||
144325435|NCT03960580|520394408|FG002|Overall Study|Withdrawal by Subject|1|||
144325436|NCT03960580|520394406|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
144325437|NCT03960580|520394407|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
144325438|NCT03960580|520394408|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
144325439|NCT00791479|520394414|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
144325440|NCT00791479|520394415|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
144325441|NCT00791479|520394416|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
144325442|NCT00791479|520394417|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
144325443|NCT00791479|520394418|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
144325444|NCT00791479|520394419|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
144325445|NCT00791479|520394414|FG000|Overall Study|Adverse Event|0|||
144325446|NCT00791479|520394415|FG001|Overall Study|Adverse Event|1|||
144325447|NCT00791479|520394416|FG002|Overall Study|Adverse Event|0|||
144325448|NCT00791479|520394417|FG003|Overall Study|Adverse Event|2|||
144325449|NCT00791479|520394418|FG004|Overall Study|Adverse Event|0|||
144325450|NCT00791479|520394419|FG005|Overall Study|Adverse Event|1|||
144325451|NCT00791479|520394414|FG000|Overall Study|Lost to Follow-up|0|||
144325452|NCT00791479|520394415|FG001|Overall Study|Lost to Follow-up|1|||
144325453|NCT00791479|520394416|FG002|Overall Study|Lost to Follow-up|0|||
144325454|NCT00791479|520394417|FG003|Overall Study|Lost to Follow-up|0|||
144325455|NCT00791479|520394418|FG004|Overall Study|Lost to Follow-up|0|||
144325456|NCT00791479|520394419|FG005|Overall Study|Lost to Follow-up|1|||
144325457|NCT00791479|520394414|FG000|Overall Study|Protocol Violation|2|||
144325458|NCT00791479|520394415|FG001|Overall Study|Protocol Violation|1|||
144325459|NCT00791479|520394416|FG002|Overall Study|Protocol Violation|0|||
144325460|NCT00791479|520394417|FG003|Overall Study|Protocol Violation|1|||
144325461|NCT00791479|520394418|FG004|Overall Study|Protocol Violation|0|||
144325462|NCT00791479|520394419|FG005|Overall Study|Protocol Violation|0|||
144325463|NCT00791479|520394414|FG000|Overall Study|Withdrawal by Subject|0|||
144325464|NCT00791479|520394415|FG001|Overall Study|Withdrawal by Subject|0|||
144325465|NCT00791479|520394416|FG002|Overall Study|Withdrawal by Subject|0|||
144325466|NCT00791479|520394417|FG003|Overall Study|Withdrawal by Subject|1|||
144325467|NCT00791479|520394418|FG004|Overall Study|Withdrawal by Subject|0|||
144325468|NCT00791479|520394419|FG005|Overall Study|Withdrawal by Subject|1|||
144325469|NCT04600076|520394422|FG000|Overall Study|Lost to Follow-up|3|||
144325470|NCT01342965|520394423|FG000|Overall Study|Death|58|||
144325471|NCT01342965|520394424|FG001|Overall Study|Death|57|||
144325472|NCT01342965|520394423|FG000|Overall Study|Lost to Follow-up|5|||
144325473|NCT01342965|520394424|FG001|Overall Study|Lost to Follow-up|3|||
144325474|NCT01342965|520394423|FG000|Overall Study|Other Reasons- Unspecified|44|||
144325475|NCT01342965|520394424|FG001|Overall Study|Other Reasons- Unspecified|38|||
144325476|NCT01342965|520394423|FG000|Overall Study|Withdrawal by Subject|2|||
144325477|NCT01342965|520394424|FG001|Overall Study|Withdrawal by Subject|9|||
144325478|NCT01170598|520394425|FG000|Overall Study|Withdrawal by Subject|1|||
144325479|NCT01170598|520394425|FG000|Overall Study|Death|3|||
144325480|NCT01170598|520394425|FG000|Overall Study|Lost to Follow-up|1|||
144325481|NCT01170598|520394425|FG000|Overall Study|Refused|1|||
144325482|NCT02780856|520394428|FG000|Overall Study|Lost to Follow-up|1|||
144325483|NCT05479097|520394429|FG000|Overall Study|Withdrawal by Subject|2|||
144325484|NCT03894969|520394432|FG000|Overall Study|Adverse Event|0|||
144325485|NCT03894969|520394433|FG001|Overall Study|Adverse Event|2|||
144325486|NCT03894969|520394434|FG002|Overall Study|Adverse Event|0|||
144325487|NCT03894969|520394435|FG003|Overall Study|Adverse Event|1|||
144325488|NCT03894969|520394436|FG004|Overall Study|Adverse Event|2|||
144325489|NCT03894969|520394432|FG000|Overall Study|Lost to Follow-up|3|||
144325490|NCT03894969|520394433|FG001|Overall Study|Lost to Follow-up|1|||
144325491|NCT03894969|520394434|FG002|Overall Study|Lost to Follow-up|1|||
144325492|NCT03894969|520394435|FG003|Overall Study|Lost to Follow-up|0|||
144325493|NCT03894969|520394436|FG004|Overall Study|Lost to Follow-up|0|||
144325494|NCT03894969|520394432|FG000|Overall Study|Withdrawal by Subject|2|||
144325495|NCT03894969|520394433|FG001|Overall Study|Withdrawal by Subject|1|||
144325496|NCT03894969|520394434|FG002|Overall Study|Withdrawal by Subject|3|||
144325497|NCT03894969|520394435|FG003|Overall Study|Withdrawal by Subject|4|||
144325498|NCT03894969|520394436|FG004|Overall Study|Withdrawal by Subject|8|||
144325499|NCT03894969|520394432|FG000|Overall Study|Other|0|||
144325500|NCT03894969|520394433|FG001|Overall Study|Other|0|||
144325501|NCT03894969|520394434|FG002|Overall Study|Other|0|||
144325502|NCT03894969|520394435|FG003|Overall Study|Other|0|||
144325503|NCT03894969|520394436|FG004|Overall Study|Other|3|||
144325504|NCT03894969|520394432|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
144325505|NCT03894969|520394433|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
144325506|NCT03894969|520394434|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
144325507|NCT03894969|520394435|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
144325508|NCT03894969|520394436|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
144325509|NCT03894969|520394432|FG000|Overall Study|Solicited Adverse Event|0|||
144325510|NCT03894969|520394433|FG001|Overall Study|Solicited Adverse Event|1|||
144325511|NCT03894969|520394434|FG002|Overall Study|Solicited Adverse Event|0|||
144325512|NCT03894969|520394435|FG003|Overall Study|Solicited Adverse Event|0|||
144325513|NCT03894969|520394436|FG004|Overall Study|Solicited Adverse Event|0|||
144325514|NCT00468676|520394438|FG000|Overall Study|Lost to Follow-up|14|||
144325515|NCT00468676|520394439|FG001|Overall Study|Lost to Follow-up|11|||
144325516|NCT00468676|520394438|FG000|Overall Study|Death|2|||
144325517|NCT00468676|520394439|FG001|Overall Study|Death|1|||
144325518|NCT02378298|520394440|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
144325519|NCT02378298|520394441|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
144325520|NCT02378298|520394442|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
144325521|NCT02378298|520394440|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
144325522|NCT02378298|520394441|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
144325523|NCT02378298|520394442|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
144325524|NCT02378298|520394440|FG000|Surveillance (19-68 Weeks)|Death|1|||
144325525|NCT02378298|520394441|FG001|Surveillance (19-68 Weeks)|Death|0|||
144325526|NCT02378298|520394442|FG002|Surveillance (19-68 Weeks)|Death|0|||
144325527|NCT01779869|520394445|FG000|Overall Study|Physician Decision|2|||
144325528|NCT02437409|520394448|FG000|Overall Study|Withdrawal by Subject|3|||
144325529|NCT02437409|520394448|FG000|Overall Study|Screening failure|12|||
144325530|NCT00737568|520394455|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
144325531|NCT00737568|520394456|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
144325532|NCT00737568|520394455|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
144325533|NCT00737568|520394456|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
144325534|NCT00737568|520394455|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
144325535|NCT00737568|520394456|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
144325536|NCT00737568|520394455|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
144325537|NCT00737568|520394456|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
144325538|NCT00737568|520394455|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
144325539|NCT00737568|520394456|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
144325540|NCT00737568|520394455|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
144325541|NCT00737568|520394456|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
144325542|NCT00737568|520394455|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
144325543|NCT00737568|520394456|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
144325544|NCT00737568|520394455|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
144325545|NCT00737568|520394456|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
144325546|NCT00737568|520394455|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
144325547|NCT00737568|520394456|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
144325548|NCT01960998|520394457|FG000|Overall Study|Lost to Follow-up|3|||
144325549|NCT01960998|520394458|FG001|Overall Study|Lost to Follow-up|7|||
144325550|NCT01960998|520394457|FG000|Overall Study|Death|0|||
144325551|NCT01960998|520394458|FG001|Overall Study|Death|1|||
144325552|NCT01960998|520394457|FG000|Overall Study|Withdrawal by Subject|8|||
144325553|NCT01960998|520394458|FG001|Overall Study|Withdrawal by Subject|2|||
144325554|NCT01960998|520394457|FG000|Overall Study|lost computer access|0|||
144325555|NCT01960998|520394458|FG001|Overall Study|lost computer access|1|||
144325556|NCT00759356|520394459|FG000|Overall Study|Adverse Event|0|||
144325557|NCT00759356|520394460|FG001|Overall Study|Adverse Event|1|||
144325558|NCT00759356|520394459|FG000|Overall Study|Withdrawal by Subject|0|||
144325559|NCT00759356|520394460|FG001|Overall Study|Withdrawal by Subject|2|||
144325560|NCT00759356|520394459|FG000|Overall Study|Subject was unable to return|1|||
144325561|NCT00759356|520394460|FG001|Overall Study|Subject was unable to return|0|||
144325562|NCT01713283|520394461|FG000|Overall Study|Lack of Efficacy|10|||
144325563|NCT01713283|520394462|FG001|Overall Study|Lack of Efficacy|2|||
144325564|NCT01713283|520394461|FG000|Overall Study|Lost to Follow-up|1|||
144325565|NCT01713283|520394462|FG001|Overall Study|Lost to Follow-up|1|||
144325566|NCT00835640|520394463|FG000|Second Intervention|Protocol Violation|1|||
144325567|NCT00835640|520394464|FG001|Second Intervention|Protocol Violation|0|||
144325568|NCT00812006|520394465|FG000|Overall Study|Lost to Follow-up|0|||
144325569|NCT00812006|520394466|FG001|Overall Study|Lost to Follow-up|0|||
144325570|NCT00812006|520394467|FG002|Overall Study|Lost to Follow-up|2|||
144325571|NCT00812006|520394465|FG000|Overall Study|Physician Decision|0|||
144325572|NCT00812006|520394466|FG001|Overall Study|Physician Decision|0|||
144325573|NCT00812006|520394467|FG002|Overall Study|Physician Decision|1|||
144325574|NCT00812006|520394465|FG000|Overall Study|Withdrawal by Subject|2|||
144325575|NCT00812006|520394466|FG001|Overall Study|Withdrawal by Subject|1|||
144325576|NCT00812006|520394467|FG002|Overall Study|Withdrawal by Subject|1|||
144325577|NCT00812006|520394465|FG000|Overall Study|Lack of Qualifying Event|4|||
144325578|NCT00812006|520394466|FG001|Overall Study|Lack of Qualifying Event|2|||
144325579|NCT00812006|520394467|FG002|Overall Study|Lack of Qualifying Event|2|||
144325580|NCT00235391|520394469|FG000|Overall Study|Adverse Event|4|||
144325581|NCT00235391|520394470|FG001|Overall Study|Adverse Event|5|||
144325582|NCT00235391|520394471|FG002|Overall Study|Adverse Event|10|||
144325583|NCT00235391|520394472|FG003|Overall Study|Adverse Event|72|||
144325584|NCT00235391|520394473|FG004|Overall Study|Adverse Event|5|||
144325585|NCT00235391|520394474|FG005|Overall Study|Adverse Event|2|||
144325586|NCT00235391|520394469|FG000|Overall Study|Abnormal laboratory value(s)|3|||
144325587|NCT00235391|520394470|FG001|Overall Study|Abnormal laboratory value(s)|5|||
144325588|NCT00235391|520394471|FG002|Overall Study|Abnormal laboratory value(s)|4|||
144325589|NCT00235391|520394472|FG003|Overall Study|Abnormal laboratory value(s)|27|||
144325590|NCT00235391|520394473|FG004|Overall Study|Abnormal laboratory value(s)|1|||
144325591|NCT00235391|520394474|FG005|Overall Study|Abnormal laboratory value(s)|2|||
144325592|NCT00235391|520394469|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144325593|NCT00235391|520394470|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
144325594|NCT00235391|520394471|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
144325595|NCT00235391|520394472|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
144325596|NCT00235391|520394473|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
144325597|NCT00235391|520394474|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
144325598|NCT00235391|520394469|FG000|Overall Study|Condition no longer requires treatment|3|||
144325599|NCT00235391|520394470|FG001|Overall Study|Condition no longer requires treatment|0|||
144325600|NCT00235391|520394471|FG002|Overall Study|Condition no longer requires treatment|0|||
144325601|NCT00235391|520394472|FG003|Overall Study|Condition no longer requires treatment|11|||
144325602|NCT00235391|520394473|FG004|Overall Study|Condition no longer requires treatment|1|||
144325603|NCT00235391|520394474|FG005|Overall Study|Condition no longer requires treatment|0|||
144325604|NCT00235391|520394469|FG000|Overall Study|Protocol deviation|0|||
144325605|NCT00235391|520394470|FG001|Overall Study|Protocol deviation|0|||
144325606|NCT00235391|520394471|FG002|Overall Study|Protocol deviation|1|||
144325607|NCT00235391|520394472|FG003|Overall Study|Protocol deviation|11|||
144325608|NCT00235391|520394473|FG004|Overall Study|Protocol deviation|0|||
144325609|NCT00235391|520394474|FG005|Overall Study|Protocol deviation|0|||
144325610|NCT00235391|520394469|FG000|Overall Study|Withdrawal by Subject|2|||
144325611|NCT00235391|520394470|FG001|Overall Study|Withdrawal by Subject|3|||
144325612|NCT00235391|520394471|FG002|Overall Study|Withdrawal by Subject|3|||
144325613|NCT00235391|520394472|FG003|Overall Study|Withdrawal by Subject|61|||
144325614|NCT00235391|520394473|FG004|Overall Study|Withdrawal by Subject|5|||
144325615|NCT00235391|520394474|FG005|Overall Study|Withdrawal by Subject|0|||
144325616|NCT00235391|520394469|FG000|Overall Study|Lost to Follow-up|0|||
144325617|NCT00235391|520394470|FG001|Overall Study|Lost to Follow-up|3|||
144325618|NCT00235391|520394471|FG002|Overall Study|Lost to Follow-up|3|||
144325619|NCT00235391|520394472|FG003|Overall Study|Lost to Follow-up|16|||
144325620|NCT00235391|520394473|FG004|Overall Study|Lost to Follow-up|0|||
144325621|NCT00235391|520394474|FG005|Overall Study|Lost to Follow-up|0|||
144325622|NCT00235391|520394469|FG000|Overall Study|Administrative problems|0|||
144325623|NCT00235391|520394470|FG001|Overall Study|Administrative problems|0|||
144325624|NCT00235391|520394471|FG002|Overall Study|Administrative problems|0|||
144325625|NCT00235391|520394472|FG003|Overall Study|Administrative problems|1|||
144325626|NCT00235391|520394473|FG004|Overall Study|Administrative problems|0|||
144325627|NCT00235391|520394474|FG005|Overall Study|Administrative problems|0|||
144325628|NCT00235391|520394469|FG000|Overall Study|Death|0|||
144325629|NCT00235391|520394470|FG001|Overall Study|Death|0|||
144325630|NCT00235391|520394471|FG002|Overall Study|Death|1|||
144325631|NCT00235391|520394472|FG003|Overall Study|Death|4|||
144325632|NCT00235391|520394473|FG004|Overall Study|Death|0|||
144325633|NCT00235391|520394474|FG005|Overall Study|Death|0|||
144325634|NCT02927925|520394479|FG000|Overall Study|Death|16|||
144325635|NCT02927925|520394479|FG000|Overall Study|Physician Decision|1|||
144325636|NCT02927925|520394479|FG000|Overall Study|Withdrawal by Subject|11|||
144325637|NCT02927925|520394479|FG000|Overall Study|Other|3|||
144325638|NCT02927925|520394479|FG000|Overall Study|Disease progression at clinical cutoff|1|||
144325639|NCT01071200|520394480|FG000|Overall Study|Lack of ovarian response|1|||
144325640|NCT01071200|520394481|FG001|Overall Study|Lack of ovarian response|1|||
144325641|NCT01071200|520394480|FG000|Overall Study|No fertilization|4|||
144325642|NCT01071200|520394481|FG001|Overall Study|No fertilization|0|||
144325643|NCT01071200|520394480|FG000|Overall Study|No oocytes retrieved|1|||
144325644|NCT01071200|520394481|FG001|Overall Study|No oocytes retrieved|1|||
144325645|NCT01071200|520394480|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
144325646|NCT01071200|520394481|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
144325647|NCT01071200|520394480|FG000|Overall Study|No viable embryos|0|||
144325648|NCT01071200|520394481|FG001|Overall Study|No viable embryos|1|||
144325649|NCT01646645|520394488|FG000|Overall Study|No Treated|1|||
144325650|NCT01646645|520394488|FG000|Overall Study|Inevaluable Donor|29|||
144325651|NCT00717522|520394489|FG000|Overall Study|Disease Progression|5|||
144325652|NCT00717522|520394489|FG000|Overall Study|Adverse Event|1|||
144325653|NCT00717522|520394489|FG000|Overall Study|Death|1|||
144325654|NCT00509093|520396192|FG000|Overall Study|Adverse Event|10|||
144325655|NCT00509093|520396192|FG000|Overall Study|Disease Progression|9|||
144325656|NCT00509093|520396192|FG000|Overall Study|Transformed into MDS|1|||
144325657|NCT00509093|520396192|FG000|Overall Study|Withdrawal by Subject|3|||
144325658|NCT00509093|520396192|FG000|Overall Study|Physician Decision|1|||
144325659|NCT03136497|520396193|FG000|Overall Study|Screen Failure|1|||
144325660|NCT03136497|520396194|FG001|Overall Study|Screen Failure|0|||
144325661|NCT03136497|520396195|FG002|Overall Study|Screen Failure|0|||
144325662|NCT04049266|520396200|FG000|Overall Study|Adverse Event|16|||
144325663|NCT04049266|520396201|FG001|Overall Study|Adverse Event|9|||
144325664|NCT04049266|520396200|FG000|Overall Study|Non-compliance with study drug|0|||
144325665|NCT04049266|520396201|FG001|Overall Study|Non-compliance with study drug|3|||
144325666|NCT04049266|520396200|FG000|Overall Study|Withdrawal by Subject|6|||
144325667|NCT04049266|520396201|FG001|Overall Study|Withdrawal by Subject|10|||
144325668|NCT04049266|520396200|FG000|Overall Study|Lost to Follow-up|2|||
144325669|NCT04049266|520396201|FG001|Overall Study|Lost to Follow-up|2|||
144325670|NCT04049266|520396200|FG000|Overall Study|Progressive disease|11|||
144325671|NCT04049266|520396201|FG001|Overall Study|Progressive disease|2|||
144325672|NCT04049266|520396200|FG000|Overall Study|Physician Decision|1|||
144325673|NCT04049266|520396201|FG001|Overall Study|Physician Decision|0|||
144325674|NCT04049266|520396200|FG000|Overall Study|Patient moved out of state|1|||
144325675|NCT04049266|520396201|FG001|Overall Study|Patient moved out of state|0|||
144325676|NCT02891681|520396202|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
144325677|NCT02891681|520396203|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
144325678|NCT02891681|520396204|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
144325679|NCT02891681|520396202|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
144325680|NCT02891681|520396203|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
144325681|NCT02891681|520396204|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
144325682|NCT02891681|520396202|FG000|Overall Study|Taken off study after first imaging appointment|1|||
144325683|NCT02891681|520396203|FG001|Overall Study|Taken off study after first imaging appointment|0|||
144325684|NCT02891681|520396204|FG002|Overall Study|Taken off study after first imaging appointment|0|||
144325685|NCT02174523|520396205|FG000|Overall Study|Withdrawal by Subject|1|||
144325686|NCT02174523|520396206|FG001|Overall Study|Withdrawal by Subject|0|||
144325687|NCT00794365|520396207|FG000|Overall Study|Lost to Follow-up|38|||
144325688|NCT00794365|520396207|FG000|Overall Study|Other|17|||
144325689|NCT00794365|520396207|FG000|Overall Study|Poor Compliance|11|||
144325690|NCT00794365|520396207|FG000|Overall Study|Adverse Event|10|||
144325691|NCT00794365|520396207|FG000|Overall Study|Lack of Efficacy|3|||
144325692|NCT00856206|520396210|FG000|Overall Study|Protocol Violation|6|||
144325693|NCT00856206|520396211|FG001|Overall Study|Protocol Violation|18|||
144325694|NCT00856206|520396210|FG000|Overall Study|Adverse Event|10|||
144325695|NCT00856206|520396211|FG001|Overall Study|Adverse Event|46|||
144325696|NCT00856206|520396210|FG000|Overall Study|Lack of Efficacy|1|||
144325697|NCT00856206|520396211|FG001|Overall Study|Lack of Efficacy|2|||
144325698|NCT00856206|520396210|FG000|Overall Study|Withdrawal by Subject|15|||
144325699|NCT00856206|520396211|FG001|Overall Study|Withdrawal by Subject|36|||
144325700|NCT00856206|520396210|FG000|Overall Study|Lost to Follow-up|13|||
144325701|NCT00856206|520396211|FG001|Overall Study|Lost to Follow-up|39|||
144325702|NCT00856206|520396210|FG000|Overall Study|Death|2|||
144325703|NCT00856206|520396211|FG001|Overall Study|Death|2|||
144325704|NCT00856206|520396210|FG000|Overall Study|Decision by the Sponsor|4|||
144325705|NCT00856206|520396211|FG001|Overall Study|Decision by the Sponsor|8|||
144325706|NCT00856206|520396210|FG000|Overall Study|Other than specified above|3|||
144325707|NCT00856206|520396211|FG001|Overall Study|Other than specified above|10|||
144325708|NCT03538444|520396215|FG000|Overall Study|opioid withdrawal|1|||
144325709|NCT03538444|520396216|FG001|Overall Study|opioid withdrawal|0|||
144325710|NCT03006458|520396227|FG000|First Intervention|Unsatisfied Vision|0|||
144325711|NCT03006458|520396228|FG001|First Intervention|Unsatisfied Vision|3|||
144325712|NCT00957944|520396229|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
144325713|NCT00957944|520396230|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
144325714|NCT01468233|520396232|FG000|Treatment Period 1|Adverse Event|5|||
144325715|NCT01468233|520396233|FG001|Treatment Period 1|Adverse Event|3|||
144325716|NCT01468233|520396234|FG002|Treatment Period 1|Adverse Event|0|||
144325717|NCT01468233|520396235|FG003|Treatment Period 1|Adverse Event|0|||
144325718|NCT01468233|520396236|FG004|Treatment Period 1|Adverse Event|0|||
144325719|NCT01468233|520396237|FG005|Treatment Period 1|Adverse Event|0|||
144325720|NCT01468233|520396232|FG000|Treatment Period 1|Withdrawal by Subject|3|||
144325721|NCT01468233|520396233|FG001|Treatment Period 1|Withdrawal by Subject|4|||
144325722|NCT01468233|520396234|FG002|Treatment Period 1|Withdrawal by Subject|0|||
144325723|NCT01468233|520396235|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144325724|NCT01468233|520396236|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144325725|NCT01468233|520396237|FG005|Treatment Period 1|Withdrawal by Subject|0|||
144325726|NCT01468233|520396232|FG000|Treatment Period 1|Lost to Follow-up|3|||
144325727|NCT01468233|520396233|FG001|Treatment Period 1|Lost to Follow-up|0|||
144325728|NCT01468233|520396234|FG002|Treatment Period 1|Lost to Follow-up|0|||
144325729|NCT01468233|520396235|FG003|Treatment Period 1|Lost to Follow-up|0|||
144325730|NCT01468233|520396236|FG004|Treatment Period 1|Lost to Follow-up|0|||
144325731|NCT01468233|520396237|FG005|Treatment Period 1|Lost to Follow-up|0|||
144325732|NCT01468233|520396232|FG000|Treatment Period 1|Other|1|||
144325733|NCT01468233|520396233|FG001|Treatment Period 1|Other|1|||
144325734|NCT01468233|520396234|FG002|Treatment Period 1|Other|0|||
144325735|NCT01468233|520396235|FG003|Treatment Period 1|Other|0|||
144325736|NCT01468233|520396236|FG004|Treatment Period 1|Other|0|||
144325737|NCT01468233|520396237|FG005|Treatment Period 1|Other|0|||
144325738|NCT01468233|520396232|FG000|Treatment Period 2|Adverse Event|0|||
144325739|NCT01468233|520396233|FG001|Treatment Period 2|Adverse Event|0|||
144325740|NCT01468233|520396234|FG002|Treatment Period 2|Adverse Event|3|||
144325741|NCT01468233|520396235|FG003|Treatment Period 2|Adverse Event|0|||
144325742|NCT01468233|520396236|FG004|Treatment Period 2|Adverse Event|2|||
144325743|NCT01468233|520396237|FG005|Treatment Period 2|Adverse Event|1|||
144325744|NCT01468233|520396232|FG000|Treatment Period 2|Lack of Efficacy|0|||
144325745|NCT01468233|520396233|FG001|Treatment Period 2|Lack of Efficacy|0|||
144325746|NCT01468233|520396234|FG002|Treatment Period 2|Lack of Efficacy|9|||
144325747|NCT01468233|520396235|FG003|Treatment Period 2|Lack of Efficacy|2|||
144325748|NCT01468233|520396236|FG004|Treatment Period 2|Lack of Efficacy|0|||
144325749|NCT01468233|520396237|FG005|Treatment Period 2|Lack of Efficacy|1|||
144325750|NCT01468233|520396232|FG000|Treatment Period 2|Withdrawal by Subject|0|||
144325751|NCT01468233|520396233|FG001|Treatment Period 2|Withdrawal by Subject|0|||
144325752|NCT01468233|520396234|FG002|Treatment Period 2|Withdrawal by Subject|9|||
144325753|NCT01468233|520396235|FG003|Treatment Period 2|Withdrawal by Subject|1|||
144325754|NCT01468233|520396236|FG004|Treatment Period 2|Withdrawal by Subject|1|||
144325755|NCT01468233|520396237|FG005|Treatment Period 2|Withdrawal by Subject|1|||
144325756|NCT01468233|520396232|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
144325757|NCT01468233|520396233|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
144325758|NCT01468233|520396234|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
144325759|NCT01468233|520396235|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
144325760|NCT01468233|520396236|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
144325761|NCT01468233|520396237|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
144325762|NCT01468233|520396232|FG000|Treatment Period 2|Lost to Follow-up|0|||
144325763|NCT01468233|520396233|FG001|Treatment Period 2|Lost to Follow-up|0|||
144325764|NCT01468233|520396234|FG002|Treatment Period 2|Lost to Follow-up|3|||
144325765|NCT01468233|520396235|FG003|Treatment Period 2|Lost to Follow-up|0|||
144325766|NCT01468233|520396236|FG004|Treatment Period 2|Lost to Follow-up|2|||
144325767|NCT01468233|520396237|FG005|Treatment Period 2|Lost to Follow-up|0|||
144325768|NCT01468233|520396232|FG000|Treatment Period 2|Other|0|||
144325769|NCT01468233|520396233|FG001|Treatment Period 2|Other|0|||
144325770|NCT01468233|520396234|FG002|Treatment Period 2|Other|3|||
144325771|NCT01468233|520396235|FG003|Treatment Period 2|Other|0|||
144325772|NCT01468233|520396236|FG004|Treatment Period 2|Other|1|||
144325773|NCT01468233|520396237|FG005|Treatment Period 2|Other|0|||
144325774|NCT01482169|520396238|FG000|Overall Study|Physician Decision|2|||
144325775|NCT00457821|520396244|FG000|Part 2|Withdrawal by Subject|0|||
144325776|NCT00457821|520396245|FG001|Part 2|Withdrawal by Subject|0|||
144325777|NCT00457821|520396246|FG002|Part 2|Withdrawal by Subject|0|||
144325778|NCT00457821|520396247|FG003|Part 2|Withdrawal by Subject|0|||
144325779|NCT00457821|520396248|FG004|Part 2|Withdrawal by Subject|0|||
144325780|NCT00457821|520396249|FG005|Part 2|Withdrawal by Subject|0|||
144325781|NCT00457821|520396250|FG006|Part 2|Withdrawal by Subject|0|||
144325782|NCT00457821|520396251|FG007|Part 2|Withdrawal by Subject|1|||
144325783|NCT01369680|520396262|FG000|Overall Study|Lost to Follow-up|0|||
144325784|NCT01369680|520396263|FG001|Overall Study|Lost to Follow-up|0|||
144325785|NCT01369680|520396264|FG002|Overall Study|Lost to Follow-up|1|||
144325786|NCT01369680|520396265|FG003|Overall Study|Lost to Follow-up|2|||
144325787|NCT03549871|520396266|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
144325788|NCT03549871|520396267|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
144325789|NCT03549871|520396266|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
144325790|NCT03549871|520396267|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
144325791|NCT03549871|520396266|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
144325792|NCT03549871|520396267|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
144325793|NCT03549871|520396266|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
144325794|NCT03549871|520396267|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
144325795|NCT03549871|520396266|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
144325796|NCT03549871|520396267|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
144325797|NCT03549871|520396266|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
144325798|NCT03549871|520396267|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
144325799|NCT03549871|520396266|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
144325800|NCT03549871|520396267|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
144325801|NCT03549871|520396266|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
144325802|NCT03549871|520396267|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
144325803|NCT03549871|520396266|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
144325804|NCT03549871|520396267|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
144325805|NCT03549871|520396266|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
144325806|NCT03549871|520396267|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
144325807|NCT03549871|520396266|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
144325808|NCT03549871|520396267|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
144325809|NCT01133626|520396272|FG000|Overall Study|Adverse Event|0|||
144325810|NCT01133626|520396273|FG001|Overall Study|Adverse Event|1|||
144325811|NCT01133626|520396274|FG002|Overall Study|Adverse Event|0|||
144325812|NCT01133626|520396272|FG000|Overall Study|Withdrawal by Subject|1|||
144325813|NCT01133626|520396273|FG001|Overall Study|Withdrawal by Subject|2|||
144325814|NCT01133626|520396274|FG002|Overall Study|Withdrawal by Subject|2|||
144325815|NCT01133626|520396272|FG000|Overall Study|Other|0|||
144325816|NCT01133626|520396273|FG001|Overall Study|Other|2|||
144325817|NCT01133626|520396274|FG002|Overall Study|Other|0|||
144325818|NCT02851407|520396275|FG000|Overall Study|Withdrawal by parent/guardian|2|||
144325819|NCT02851407|520396276|FG001|Overall Study|Withdrawal by parent/guardian|7|||
144325820|NCT02851407|520396275|FG000|Overall Study|Protocol deviation|0|||
144325821|NCT02851407|520396276|FG001|Overall Study|Protocol deviation|1|||
144325822|NCT02851407|520396275|FG000|Overall Study|Transferred to another hospital to continue|1|||
144325823|NCT02851407|520396276|FG001|Overall Study|Transferred to another hospital to continue|0|||
144325824|NCT02851407|520396275|FG000|Overall Study|Other Death|30|||
144325825|NCT02851407|520396276|FG001|Overall Study|Other Death|20|||
144325826|NCT02851407|520396275|FG000|Overall Study|Adverse event, serious fatal|6|||
144325827|NCT02851407|520396276|FG001|Overall Study|Adverse event, serious fatal|8|||
144325828|NCT02851407|520396275|FG000|Overall Study|Consent withdrawn by participant|5|||
144325829|NCT02851407|520396276|FG001|Overall Study|Consent withdrawn by participant|3|||
144325830|NCT02851407|520396275|FG000|Overall Study|Screen failure|2|||
144325831|NCT02851407|520396276|FG001|Overall Study|Screen failure|1|||
144325832|NCT02851407|520396275|FG000|Overall Study|Disease relapse|9|||
144325833|NCT02851407|520396276|FG001|Overall Study|Disease relapse|6|||
144325834|NCT02851407|520396275|FG000|Overall Study|Physician Decision|7|||
144325835|NCT02851407|520396276|FG001|Overall Study|Physician Decision|6|||
144325836|NCT02851407|520396275|FG000|Overall Study|Transferred to hospital closer to home|0|||
144325837|NCT02851407|520396276|FG001|Overall Study|Transferred to hospital closer to home|1|||
144325838|NCT02851407|520396275|FG000|Overall Study|Enrolled in an investigational study|0|||
144325839|NCT02851407|520396276|FG001|Overall Study|Enrolled in an investigational study|1|||
144325840|NCT02851407|520396275|FG000|Overall Study|Early recovery|1|||
144325841|NCT02851407|520396276|FG001|Overall Study|Early recovery|0|||
144325842|NCT02851407|520396275|FG000|Overall Study|Adverse event, non-fatal|7|||
144325843|NCT02851407|520396276|FG001|Overall Study|Adverse event, non-fatal|5|||
144325844|NCT02851407|520396275|FG000|Overall Study|Lost to Follow-up|0|||
144325845|NCT02851407|520396276|FG001|Overall Study|Lost to Follow-up|2|||
144325846|NCT01080768|520396280|FG000|Overall Study|Protocol Deviation|2|||
144325847|NCT01080768|520396281|FG001|Overall Study|Protocol Deviation|1|||
144325848|NCT03385265|520396282|FG000|Overall Study|Withdrawal by Subject|5|||
144325849|NCT03385265|520396283|FG001|Overall Study|Withdrawal by Subject|2|||
144325850|NCT03385265|520396284|FG002|Overall Study|Withdrawal by Subject|5|||
144325851|NCT03385265|520396285|FG003|Overall Study|Withdrawal by Subject|2|||
144325852|NCT02437305|520396287|FG000|Overall Study|Lost to Follow-up|18|||
144325853|NCT02437305|520396288|FG001|Overall Study|Lost to Follow-up|12|||
144325854|NCT03730961|520396312|FG000|Overall Study|Adverse Event|0|||
144325855|NCT03730961|520396313|FG001|Overall Study|Adverse Event|1|||
144325856|NCT04508751|520396316|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
144325857|NCT04508751|520396317|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
144325858|NCT04508751|520396318|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
144325859|NCT02752958|520396319|FG000|Overall Study|Adverse Event|3|||
144325860|NCT02752958|520396319|FG000|Overall Study|Lost to Follow-up|1|||
144325861|NCT02752958|520396319|FG000|Overall Study|Protocol Violation|1|||
144325862|NCT02752958|520396319|FG000|Overall Study|Withdrawal by Subject|2|||
144325863|NCT02752958|520396319|FG000|Overall Study|Other (Reason not specified)|2|||
144325864|NCT00853125|520396320|FG000|Overall Study|Study participant's donor was CMV +|1|||
144325865|NCT03023826|520396322|FG000|Period 1|Withdrawal by Subject|0|||
144325866|NCT03023826|520396323|FG001|Period 1|Withdrawal by Subject|0|||
144325867|NCT03023826|520396324|FG002|Period 1|Withdrawal by Subject|0|||
144325868|NCT03023826|520396325|FG003|Period 1|Withdrawal by Subject|0|||
144325869|NCT03023826|520396326|FG004|Period 1|Withdrawal by Subject|1|||
144325870|NCT03023826|520396327|FG005|Period 1|Withdrawal by Subject|0|||
144325871|NCT03746600|520396328|FG000|Overall Study|Withdrawal by Subject|3|||
144325872|NCT03746600|520396329|FG001|Overall Study|Withdrawal by Subject|3|||
144325873|NCT03746600|520396328|FG000|Overall Study|dismissed from study|1|||
144325874|NCT03746600|520396329|FG001|Overall Study|dismissed from study|0|||
144325875|NCT03746600|520396328|FG000|Overall Study|Lost to Follow-up|1|||
144325876|NCT03746600|520396329|FG001|Overall Study|Lost to Follow-up|0|||
144325877|NCT00072293|520396330|FG000|Overall Study|Lost to Follow-up|1|||
144325878|NCT00072293|520396331|FG001|Overall Study|Lost to Follow-up|1|||
144325879|NCT00072293|520396330|FG000|Overall Study|Withdrawal by Subject|0|||
144325880|NCT00072293|520396331|FG001|Overall Study|Withdrawal by Subject|1|||
144325881|NCT04209114|520396332|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
144325882|NCT04209114|520396333|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
144325883|NCT04209114|520396334|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
144325884|NCT04209114|520396332|FG000|Pre-Treatment Phase|Other reasons|0|||
144325885|NCT04209114|520396333|FG001|Pre-Treatment Phase|Other reasons|0|||
144325886|NCT04209114|520396334|FG002|Pre-Treatment Phase|Other reasons|1|||
144325887|NCT04209114|520396332|FG000|Pre-Treatment Phase|Death|0|||
144325888|NCT04209114|520396333|FG001|Pre-Treatment Phase|Death|0|||
144325889|NCT04209114|520396334|FG002|Pre-Treatment Phase|Death|1|||
144325890|NCT04209114|520396332|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
144325891|NCT04209114|520396333|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
144325892|NCT04209114|520396334|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
144325893|NCT04209114|520396332|FG000|Treatment Phase|Other reasons|5|||
144325894|NCT04209114|520396333|FG001|Treatment Phase|Other reasons|3|||
144325895|NCT04209114|520396334|FG002|Treatment Phase|Other reasons|0|||
144325896|NCT04209114|520396332|FG000|Treatment Phase|Lost to Follow-up|1|||
144325897|NCT04209114|520396333|FG001|Treatment Phase|Lost to Follow-up|0|||
144325898|NCT04209114|520396334|FG002|Treatment Phase|Lost to Follow-up|0|||
144325899|NCT04209114|520396332|FG000|Treatment Phase|Participant withdrew consent|1|||
144325900|NCT04209114|520396333|FG001|Treatment Phase|Participant withdrew consent|0|||
144325901|NCT04209114|520396334|FG002|Treatment Phase|Participant withdrew consent|0|||
144325902|NCT04209114|520396332|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
144325903|NCT04209114|520396333|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
144325904|NCT04209114|520396334|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
144325905|NCT04209114|520396332|FG000|Treatment Phase|Death|4|||
144325906|NCT04209114|520396333|FG001|Treatment Phase|Death|1|||
144325907|NCT04209114|520396334|FG002|Treatment Phase|Death|0|||
144325908|NCT04209114|520396332|FG000|Treatment Phase|Study drug toxicity|4|||
144325909|NCT04209114|520396333|FG001|Treatment Phase|Study drug toxicity|6|||
144325910|NCT04209114|520396334|FG002|Treatment Phase|Study drug toxicity|0|||
144325911|NCT04209114|520396332|FG000|Treatment Phase|Disease progression|6|||
144325912|NCT04209114|520396333|FG001|Treatment Phase|Disease progression|9|||
144325913|NCT04209114|520396334|FG002|Treatment Phase|Disease progression|0|||
144325914|NCT00405964|520396339|FG000|Overall Study|Treatment Failure|17|||
144325915|NCT00405964|520396340|FG001|Overall Study|Treatment Failure|45|||
144325916|NCT00405964|520396339|FG000|Overall Study|Adverse Event|7|||
144325917|NCT00405964|520396340|FG001|Overall Study|Adverse Event|16|||
144325918|NCT00405964|520396339|FG000|Overall Study|Lost to Follow-up|5|||
144325919|NCT00405964|520396340|FG001|Overall Study|Lost to Follow-up|5|||
144325920|NCT00405964|520396339|FG000|Overall Study|Withdrawal by Subject|19|||
144325921|NCT00405964|520396340|FG001|Overall Study|Withdrawal by Subject|23|||
144325922|NCT00405964|520396339|FG000|Overall Study|Protocol Violation|11|||
144325923|NCT00405964|520396340|FG001|Overall Study|Protocol Violation|6|||
144325924|NCT02981407|520396342|FG000|Overall Study|Withdrawal by Subject|2|||
144325925|NCT02981407|520396343|FG001|Overall Study|Withdrawal by Subject|0|||
144325926|NCT00468845|520396350|FG000|Overall Study|Adverse Event|9|||
144325927|NCT00468845|520396351|FG001|Overall Study|Adverse Event|14|||
144325928|NCT00468845|520396352|FG002|Overall Study|Adverse Event|11|||
144325929|NCT00468845|520396350|FG000|Overall Study|Lost to Follow-up|2|||
144325930|NCT00468845|520396351|FG001|Overall Study|Lost to Follow-up|1|||
144325931|NCT00468845|520396352|FG002|Overall Study|Lost to Follow-up|2|||
144325932|NCT00468845|520396350|FG000|Overall Study|Other|4|||
144325933|NCT00468845|520396351|FG001|Overall Study|Other|9|||
144325934|NCT00468845|520396352|FG002|Overall Study|Other|5|||
144325935|NCT00468845|520396350|FG000|Overall Study|No longer willing to participate|5|||
144325936|NCT00468845|520396351|FG001|Overall Study|No longer willing to participate|6|||
144325937|NCT00468845|520396352|FG002|Overall Study|No longer willing to participate|10|||
144325938|NCT00468845|520396350|FG000|Overall Study|Randomized, not treated|1|||
144325939|NCT00468845|520396351|FG001|Overall Study|Randomized, not treated|4|||
144325940|NCT00468845|520396352|FG002|Overall Study|Randomized, not treated|2|||
144325941|NCT01896271|520396353|FG000|Overall Study|Physician Decision|10|||
144325942|NCT00953680|520396354|FG000|Period 1|Withdrawal by Subject|0|||
144325943|NCT00953680|520396355|FG001|Period 1|Withdrawal by Subject|1|||
144325944|NCT01514240|520397826|FG000|Overall Study|Adverse Event|4|||
144325945|NCT01514240|520397827|FG001|Overall Study|Adverse Event|4|||
144325946|NCT01514240|520397826|FG000|Overall Study|Subject Decision|2|||
144325947|NCT01514240|520397827|FG001|Overall Study|Subject Decision|7|||
144325948|NCT01103063|520397828|FG000|Overall Study|Adverse Event|3|||
144325949|NCT01103063|520397829|FG001|Overall Study|Adverse Event|1|||
144325950|NCT01103063|520397828|FG000|Overall Study|Lost to Follow-up|68|||
144325951|NCT01103063|520397829|FG001|Overall Study|Lost to Follow-up|51|||
144325952|NCT01103063|520397828|FG000|Overall Study|Withdrawal by Subject|60|||
144325953|NCT01103063|520397829|FG001|Overall Study|Withdrawal by Subject|15|||
144325954|NCT01103063|520397828|FG000|Overall Study|Other|16|||
144325955|NCT01103063|520397829|FG001|Overall Study|Other|11|||
144325956|NCT01103063|520397828|FG000|Overall Study|Protocol Violation|1|||
144325957|NCT01103063|520397829|FG001|Overall Study|Protocol Violation|0|||
144325958|NCT01103063|520397828|FG000|Overall Study|Study terminated by Sponsor|326|||
144325959|NCT01103063|520397829|FG001|Overall Study|Study terminated by Sponsor|342|||
144325960|NCT01103063|520397828|FG000|Overall Study|Death|3|||
144325961|NCT01103063|520397829|FG001|Overall Study|Death|1|||
144325962|NCT05320393|520397830|FG000|Overall Study|Withdrawal by Subject|1|||
144325963|NCT05320393|520397831|FG001|Overall Study|Withdrawal by Subject|0|||
144325964|NCT05320393|520397832|FG002|Overall Study|Withdrawal by Subject|2|||
144325965|NCT05320393|520397830|FG000|Overall Study|Lost to Follow-up|1|||
144325966|NCT05320393|520397831|FG001|Overall Study|Lost to Follow-up|2|||
144325967|NCT05320393|520397832|FG002|Overall Study|Lost to Follow-up|1|||
144325968|NCT05320393|520397830|FG000|Overall Study|Moved; too much driving|0|||
144325969|NCT05320393|520397831|FG001|Overall Study|Moved; too much driving|0|||
144325970|NCT05320393|520397832|FG002|Overall Study|Moved; too much driving|2|||
144325971|NCT05320393|520397830|FG000|Overall Study|Did not receive treatment|0|||
144325972|NCT05320393|520397831|FG001|Overall Study|Did not receive treatment|0|||
144325973|NCT05320393|520397832|FG002|Overall Study|Did not receive treatment|1|||
144325974|NCT03283098|520397833|FG000|Overall Study|Withdrawal by Subject|0|||
144325975|NCT03283098|520397834|FG001|Overall Study|Withdrawal by Subject|1|||
144325976|NCT00798317|520397835|FG000|Overall Study|Physician Decision|0|||
144325977|NCT00798317|520397836|FG001|Overall Study|Physician Decision|1|||
144325978|NCT00798317|520397835|FG000|Overall Study|Withdrawal by Subject|5|||
144325979|NCT00798317|520397836|FG001|Overall Study|Withdrawal by Subject|4|||
144325980|NCT00798317|520397835|FG000|Overall Study|Lost to Follow-up|2|||
144325981|NCT00798317|520397836|FG001|Overall Study|Lost to Follow-up|2|||
144325982|NCT00798317|520397835|FG000|Overall Study|Adverse Event|2|||
144325983|NCT00798317|520397836|FG001|Overall Study|Adverse Event|0|||
144325984|NCT00798317|520397835|FG000|Overall Study|Death|1|||
144325985|NCT00798317|520397836|FG001|Overall Study|Death|0|||
144325986|NCT01069861|520397838|FG000|Overall Study|Death|1|||
144325987|NCT01069861|520397838|FG000|Overall Study|Adverse Event|1|||
144325988|NCT01069861|520397838|FG000|Overall Study|Did not meet entrance criteria|1|||
144325989|NCT01187446|520397839|FG000|Overall Study|Patient started non-protocol therapy|0|||
144325990|NCT01187446|520397840|FG001|Overall Study|Patient started non-protocol therapy|1|||
144325991|NCT00823212|520397841|FG000|Overall Study|Death|8|||
144325992|NCT00823212|520397842|FG001|Overall Study|Death|10|||
144325993|NCT00823212|520397841|FG000|Overall Study|Withdrawal by Subject|6|||
144325994|NCT00823212|520397842|FG001|Overall Study|Withdrawal by Subject|1|||
144325995|NCT00823212|520397841|FG000|Overall Study|Incarcerated|0|||
144325996|NCT00823212|520397842|FG001|Overall Study|Incarcerated|1|||
144325997|NCT00823212|520397841|FG000|Overall Study|Missed 12-month visit|21|||
144325998|NCT00823212|520397842|FG001|Overall Study|Missed 12-month visit|21|||
144325999|NCT00496197|520397843|FG000|Overall Study|Discontinued study due to death|43|||
144326000|NCT00496197|520397843|FG000|Overall Study|Adverse Event|13|||
144326001|NCT00496197|520397843|FG000|Overall Study|Does not meet entrance criteria|5|||
144326002|NCT00496197|520397843|FG000|Overall Study|Insufficient clinical response|3|||
144326003|NCT00496197|520397843|FG000|Overall Study|Insufficient bacteriological response|10|||
144326004|NCT00496197|520397843|FG000|Overall Study|Lost to Follow-up|11|||
144326005|NCT00496197|520397843|FG000|Overall Study|Withdrawal by Subject|11|||
144326006|NCT00496197|520397843|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
144326007|NCT00496197|520397843|FG000|Overall Study|Other|14|||
144326008|NCT00496197|520397843|FG000|Overall Study|Protocol Violation|8|||
144326009|NCT04431713|520397844|FG000|Overall Study|Withdrawal by Subject|2|||
144326010|NCT04431713|520397845|FG001|Overall Study|Withdrawal by Subject|0|||
144326011|NCT04431713|520397844|FG000|Overall Study|Death|2|||
144326012|NCT04431713|520397845|FG001|Overall Study|Death|2|||
144326013|NCT00149994|520397846|FG000|Overall Study|Administrative problems:|1|||
144326014|NCT00149994|520397847|FG001|Overall Study|Administrative problems:|0|||
144326015|NCT00149994|520397846|FG000|Overall Study|Protocol Violation|0|||
144326016|NCT00149994|520397847|FG001|Overall Study|Protocol Violation|1|||
144326017|NCT01344538|520397848|FG000|Overall Study|Adverse Event|1|||
144326018|NCT01344538|520397849|FG001|Overall Study|Adverse Event|1|||
144326019|NCT01344538|520397848|FG000|Overall Study|Lost to Follow-up|1|||
144326020|NCT01344538|520397849|FG001|Overall Study|Lost to Follow-up|0|||
144326021|NCT01655381|520397852|FG000|Overall Study|Investigator Decision|1|||
144326022|NCT01655381|520397852|FG000|Overall Study|Moved to Another City|1|||
144326023|NCT01655381|520397852|FG000|Overall Study|Insufficient Treatment Response|1|||
144326024|NCT02324205|520397853|FG000|Overall Study|Withdrawal by Subject|37|||
144326025|NCT04195438|520397854|FG000|Overall Study|Withdrawal by Subject|1|||
144326026|NCT00613925|520397855|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
144326027|NCT00613925|520397856|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
144326028|NCT04584346|520397865|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
144326029|NCT04584346|520397866|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
144326030|NCT03640052|520397869|FG000|Overall Study|Lost to Follow-up|0|||
144326031|NCT03640052|520397870|FG001|Overall Study|Lost to Follow-up|1|||
144326032|NCT03640052|520397871|FG002|Overall Study|Lost to Follow-up|0|||
144326033|NCT03640052|520397872|FG003|Overall Study|Lost to Follow-up|0|||
144326034|NCT03640052|520397873|FG004|Overall Study|Lost to Follow-up|0|||
144326035|NCT04239222|520397874|FG000|Baseline|Withdrawal by Subject|0|||
144326036|NCT04239222|520397875|FG001|Baseline|Withdrawal by Subject|0|||
144326037|NCT04239222|520397876|FG002|Baseline|Withdrawal by Subject|1|||
144326038|NCT04239222|520397877|FG003|Baseline|Withdrawal by Subject|1|||
144326039|NCT04239222|520397874|FG000|First Foot Assignment|Withdrawal by Subject|0|||
144326040|NCT04239222|520397875|FG001|First Foot Assignment|Withdrawal by Subject|0|||
144326041|NCT04239222|520397876|FG002|First Foot Assignment|Withdrawal by Subject|1|||
144326042|NCT04239222|520397877|FG003|First Foot Assignment|Withdrawal by Subject|0|||
144326043|NCT04239222|520397874|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
144326044|NCT04239222|520397875|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
144326045|NCT04239222|520397876|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
144326046|NCT04239222|520397877|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
144326047|NCT00445848|520397886|FG000|Overall Study|Adverse Event|14|||
144326048|NCT00445848|520397886|FG000|Overall Study|Withdrawal by Subject|4|||
144326049|NCT00445848|520397886|FG000|Overall Study|Progression|62|||
144326050|NCT00445848|520397886|FG000|Overall Study|Other-Not protocol specified|5|||
144326051|NCT00790647|520397889|FG000|Overall Study|Adverse Event|1|||
144326052|NCT00027378|520397890|FG000|Overall Study|Physician Decision|0|||
144326053|NCT00027378|520397891|FG001|Overall Study|Physician Decision|3|||
144326054|NCT02403635|520397897|FG000|Overall Study|Not eligible|9|||
144326055|NCT03263923|520397901|FG000|Overall Study|Withdrawal by Subject|10|||
144326056|NCT03263923|520397902|FG001|Overall Study|Withdrawal by Subject|8|||
144326057|NCT03263923|520397901|FG000|Overall Study|Lost to Follow-up|15|||
144326058|NCT03263923|520397902|FG001|Overall Study|Lost to Follow-up|13|||
144326059|NCT02098369|520397903|FG000|Overall Study|Withdrawal by Subject|1|||
144326060|NCT02098369|520397904|FG001|Overall Study|Withdrawal by Subject|5|||
144326061|NCT02098369|520397905|FG002|Overall Study|Withdrawal by Subject|0|||
144326062|NCT02098369|520397903|FG000|Overall Study|Lost to Follow-up|5|||
144326063|NCT02098369|520397904|FG001|Overall Study|Lost to Follow-up|1|||
144326064|NCT02098369|520397905|FG002|Overall Study|Lost to Follow-up|3|||
144326065|NCT02098369|520397903|FG000|Overall Study|Death|1|||
144326066|NCT02098369|520397904|FG001|Overall Study|Death|1|||
144326067|NCT02098369|520397905|FG002|Overall Study|Death|1|||
144326068|NCT02098369|520397903|FG000|Overall Study|Other|0|||
144326069|NCT02098369|520397904|FG001|Overall Study|Other|2|||
144326070|NCT02098369|520397905|FG002|Overall Study|Other|1|||
144326071|NCT03362931|520397907|FG000|Overall Study|Adverse Event|1|||
144326072|NCT03362931|520397907|FG000|Overall Study|Death|2|||
144326073|NCT01323270|520397908|FG000|Overall Study|Withdrawal by Subject|19|||
144326074|NCT01323270|520397909|FG001|Overall Study|Withdrawal by Subject|10|||
144326075|NCT01323270|520397908|FG000|Overall Study|Protocol Violation|9|||
144326076|NCT01323270|520397909|FG001|Overall Study|Protocol Violation|7|||
144326077|NCT01323270|520397908|FG000|Overall Study|Lost to Follow-up|4|||
144326078|NCT01323270|520397909|FG001|Overall Study|Lost to Follow-up|6|||
144326079|NCT01323270|520397908|FG000|Overall Study|Adverse Event|8|||
144326080|NCT01323270|520397909|FG001|Overall Study|Adverse Event|0|||
144326081|NCT01323270|520397908|FG000|Overall Study|Other|0|||
144326082|NCT01323270|520397909|FG001|Overall Study|Other|3|||
144326083|NCT01323270|520397908|FG000|Overall Study|Physician Decision|0|||
144326084|NCT01323270|520397909|FG001|Overall Study|Physician Decision|2|||
144326085|NCT01323270|520397908|FG000|Overall Study|Not eligible|1|||
144326086|NCT01323270|520397909|FG001|Overall Study|Not eligible|1|||
144326087|NCT01323270|520397908|FG000|Overall Study|Death|1|||
144326088|NCT01323270|520397909|FG001|Overall Study|Death|0|||
144326089|NCT01323270|520397908|FG000|Overall Study|Randomized, but not vaccinated|1|||
144326090|NCT01323270|520397909|FG001|Overall Study|Randomized, but not vaccinated|0|||
144326091|NCT03761394|520397910|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
144326092|NCT03761394|520397911|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
144326093|NCT03761394|520397912|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
144326094|NCT03761394|520397913|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
144326095|NCT03761394|520397910|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
144326096|NCT03761394|520397911|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
144326097|NCT03761394|520397912|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
144326098|NCT03761394|520397913|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
144326099|NCT03761394|520397910|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
144326100|NCT03761394|520397911|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
144326101|NCT03761394|520397912|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
144326102|NCT03761394|520397913|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
144326103|NCT03761394|520397910|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
144326104|NCT03761394|520397911|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
144326105|NCT03761394|520397912|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
144326106|NCT03761394|520397913|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
144326107|NCT03054350|520397915|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
144326108|NCT03054350|520397916|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
144326109|NCT03054350|520397917|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
144326110|NCT03054350|520397918|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
144326111|NCT03054350|520397919|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
144326112|NCT03054350|520397920|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
144326113|NCT03054350|520397915|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
144326114|NCT03054350|520397916|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
144326115|NCT03054350|520397917|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
144326116|NCT03054350|520397918|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
144326117|NCT03054350|520397919|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
144326118|NCT03054350|520397920|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
144326119|NCT03054350|520397915|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
144326120|NCT03054350|520397916|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
144326121|NCT03054350|520397917|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
144326122|NCT03054350|520397918|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
144326123|NCT03054350|520397919|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
144326124|NCT03054350|520397920|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
144326125|NCT03054350|520397915|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
144326126|NCT03054350|520397916|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
144326127|NCT03054350|520397917|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
144326128|NCT03054350|520397918|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
144326129|NCT03054350|520397919|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
144326130|NCT03054350|520397920|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
144326131|NCT03510468|520397922|FG000|Overall Study|Lost to Follow-up|1|||
144326132|NCT03510468|520397922|FG000|Overall Study|Adverse Event|5|||
144326133|NCT03510468|520397922|FG000|Overall Study|Physician Decision|1|||
144326134|NCT03510468|520397922|FG000|Overall Study|non-compliant with treatment|2|||
144326135|NCT03510468|520397922|FG000|Overall Study|Missed visit|1|||
144326136|NCT04677660|520397923|FG000|Overall Study|Lost to Follow-up|0|||
144326137|NCT04677660|520397924|FG001|Overall Study|Lost to Follow-up|2|||
144326138|NCT04677660|520397923|FG000|Overall Study|Withdrawal by Subject|0|||
144360035|NCT01601535|520525139|FG004|Phase 2|Progressive Disease|5|||
144326139|NCT04677660|520397924|FG001|Overall Study|Withdrawal by Subject|1|||
144326140|NCT04677660|520397923|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
144326141|NCT04677660|520397924|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
144326142|NCT01560637|520397926|FG000|Overall Study|Adverse Event|63|||
144326143|NCT01560637|520397926|FG000|Overall Study|Death|69|||
144326144|NCT01560637|520397926|FG000|Overall Study|Lost to Follow-up|8|||
144326145|NCT01560637|520397926|FG000|Overall Study|Protocol Violation|8|||
144326146|NCT01560637|520397926|FG000|Overall Study|Withdrawal by Subject|24|||
144326147|NCT01560637|520397926|FG000|Overall Study|Progressive Disease|20|||
144326148|NCT01560637|520397926|FG000|Overall Study|Other Reason Not Specified|6|||
144326149|NCT03220581|520397927|FG000|Overall Study|Withdrawal by Subject|0|||
144326150|NCT03220581|520397928|FG001|Overall Study|Withdrawal by Subject|1|||
144326151|NCT03220581|520397927|FG000|Overall Study|Lost to Follow-up|3|||
144326152|NCT03220581|520397928|FG001|Overall Study|Lost to Follow-up|6|||
144326153|NCT00919867|520397929|FG000|First Intervention|Withdrawal by Subject|0|||
144326154|NCT00919867|520397930|FG001|First Intervention|Withdrawal by Subject|0|||
144326155|NCT00919867|520397931|FG002|First Intervention|Withdrawal by Subject|1|||
144326156|NCT00919867|520397932|FG003|First Intervention|Withdrawal by Subject|0|||
144326157|NCT00919867|520397933|FG004|First Intervention|Withdrawal by Subject|0|||
144326158|NCT00919867|520397934|FG005|First Intervention|Withdrawal by Subject|0|||
144326159|NCT00919867|520397929|FG000|First Intervention|Physician Decision|0|||
144326160|NCT00919867|520397930|FG001|First Intervention|Physician Decision|0|||
144326161|NCT00919867|520397931|FG002|First Intervention|Physician Decision|0|||
144326162|NCT00919867|520397932|FG003|First Intervention|Physician Decision|0|||
144326163|NCT00919867|520397933|FG004|First Intervention|Physician Decision|0|||
144326164|NCT00919867|520397934|FG005|First Intervention|Physician Decision|1|||
144326165|NCT01185964|520397935|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
144326166|NCT01185964|520397936|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
144326167|NCT01185964|520397937|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
144326168|NCT01185964|520397938|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
144326169|NCT01185964|520397935|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
144326170|NCT01185964|520397936|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
144326171|NCT01185964|520397937|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
144326172|NCT01185964|520397938|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
144326173|NCT01185964|520397935|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
144326174|NCT01185964|520397936|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
144326175|NCT01185964|520397937|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
144326176|NCT01185964|520397938|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
144326177|NCT01185964|520397935|FG000|Phase 1b and Phase 2|Adverse Event|1|||
144326178|NCT01185964|520397936|FG001|Phase 1b and Phase 2|Adverse Event|0|||
144326179|NCT01185964|520397937|FG002|Phase 1b and Phase 2|Adverse Event|2|||
144326180|NCT01185964|520397938|FG003|Phase 1b and Phase 2|Adverse Event|0|||
144326181|NCT01185964|520397935|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
144326182|NCT01185964|520397936|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
144326183|NCT01185964|520397937|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
144326184|NCT01185964|520397938|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
144326185|NCT01185964|520397935|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
144326186|NCT01185964|520397936|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
144326187|NCT01185964|520397937|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
144326188|NCT01185964|520397938|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
144326189|NCT01185964|520397935|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
144326190|NCT01185964|520397936|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
144326191|NCT01185964|520397937|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
144326192|NCT01185964|520397938|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
144326193|NCT01185964|520397935|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
144326194|NCT01185964|520397936|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
144326195|NCT01185964|520397937|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
144326196|NCT01185964|520397938|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
144326197|NCT01920893|520397939|FG000|Overall Study|Adverse Event|5|||
144326198|NCT01920893|520397940|FG001|Overall Study|Adverse Event|2|||
144326199|NCT01920893|520397939|FG000|Overall Study|Lack of Efficacy|2|||
144326200|NCT01920893|520397940|FG001|Overall Study|Lack of Efficacy|0|||
144326201|NCT02323204|520397944|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
144326202|NCT02323204|520397945|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
144326203|NCT02323204|520397946|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
144326204|NCT02323204|520397947|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
144326205|NCT02323204|520397944|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
144326206|NCT02323204|520397945|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
144326207|NCT02323204|520397946|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
144326208|NCT02323204|520397947|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
144326209|NCT02323204|520397944|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
144326210|NCT02323204|520397945|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
144326211|NCT02323204|520397946|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
144326212|NCT02323204|520397947|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
144326213|NCT02323204|520397944|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
144326214|NCT02323204|520397945|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
144326215|NCT02323204|520397946|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
144326216|NCT02323204|520397947|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
144326217|NCT02323204|520397944|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
144326218|NCT02323204|520397945|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
144326219|NCT02323204|520397946|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
144326220|NCT02323204|520397947|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
144326221|NCT02323204|520397944|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
144326222|NCT02323204|520397945|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
144326223|NCT02323204|520397946|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
144326224|NCT02323204|520397947|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
144326225|NCT02323204|520397944|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
144326226|NCT02323204|520397945|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
144326227|NCT02323204|520397946|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
144326228|NCT02323204|520397947|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
144326229|NCT02323204|520397944|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
144326230|NCT02323204|520397945|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
144326231|NCT02323204|520397946|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
144326232|NCT02323204|520397947|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
144326233|NCT02323204|520397944|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
144326234|NCT02323204|520397945|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
144326235|NCT02323204|520397946|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
144326236|NCT02323204|520397947|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
144326237|NCT01396265|520397959|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
144326238|NCT01767493|520397960|FG000|Overall Study|screen failures|3|||
144326239|NCT00884039|520397961|FG000|Overall Study|Withdrawal by Subject|0|||
144326240|NCT00884039|520397962|FG001|Overall Study|Withdrawal by Subject|1|||
144326241|NCT00884039|520397961|FG000|Overall Study|Lack of Efficacy|2|||
144326242|NCT00884039|520397962|FG001|Overall Study|Lack of Efficacy|0|||
144326243|NCT02182440|520397965|FG000|Overall Study|Adverse Event|0|||
144326244|NCT02182440|520397966|FG001|Overall Study|Adverse Event|1|||
144326245|NCT02182440|520397967|FG002|Overall Study|Adverse Event|0|||
144326246|NCT02182440|520397968|FG003|Overall Study|Adverse Event|0|||
144326247|NCT02182440|520397965|FG000|Overall Study|Death|31|||
144326248|NCT02182440|520397966|FG001|Overall Study|Death|8|||
144326249|NCT02182440|520397967|FG002|Overall Study|Death|5|||
144326250|NCT02182440|520397968|FG003|Overall Study|Death|16|||
144326251|NCT02182440|520397965|FG000|Overall Study|Protocol Violation|0|||
144326252|NCT02182440|520397966|FG001|Overall Study|Protocol Violation|1|||
144326253|NCT02182440|520397967|FG002|Overall Study|Protocol Violation|0|||
144326254|NCT02182440|520397968|FG003|Overall Study|Protocol Violation|0|||
144326255|NCT02182440|520397965|FG000|Overall Study|Physician Decision|1|||
144326256|NCT02182440|520397966|FG001|Overall Study|Physician Decision|0|||
144326257|NCT02182440|520397967|FG002|Overall Study|Physician Decision|0|||
144326258|NCT02182440|520397968|FG003|Overall Study|Physician Decision|0|||
144326259|NCT02182440|520397965|FG000|Overall Study|Withdrawal by Subject|1|||
144326260|NCT02182440|520397966|FG001|Overall Study|Withdrawal by Subject|1|||
144326261|NCT02182440|520397967|FG002|Overall Study|Withdrawal by Subject|3|||
144326262|NCT02182440|520397968|FG003|Overall Study|Withdrawal by Subject|4|||
144326263|NCT02182440|520397965|FG000|Overall Study|different, e.g adm other hospital|12|||
144326264|NCT02182440|520397966|FG001|Overall Study|different, e.g adm other hospital|3|||
144326265|NCT02182440|520397967|FG002|Overall Study|different, e.g adm other hospital|3|||
144326266|NCT02182440|520397968|FG003|Overall Study|different, e.g adm other hospital|10|||
144326267|NCT02653495|520397970|FG000|Overall Study|Lost to Follow-up|2|||
144326268|NCT02653495|520397971|FG001|Overall Study|Lost to Follow-up|0|||
144326269|NCT02653495|520397970|FG000|Overall Study|Screening Failure|10|||
144326270|NCT02653495|520397971|FG001|Overall Study|Screening Failure|0|||
144326271|NCT00549900|520400508|FG000|Overall Study|Adverse Event|1|||
144326272|NCT02210832|520400510|FG000|Overall Study|Pregnancy termination .|3|||
144326273|NCT02210832|520400511|FG001|Overall Study|Pregnancy termination .|4|||
144326274|NCT02210832|520400512|FG002|Overall Study|Pregnancy termination .|1|||
144326275|NCT02210832|520400510|FG000|Overall Study|Lost to Follow-up|26|||
144326276|NCT02210832|520400511|FG001|Overall Study|Lost to Follow-up|32|||
144326277|NCT02210832|520400512|FG002|Overall Study|Lost to Follow-up|17|||
144326278|NCT02754141|520400517|FG000|Overall Study|Disease progression|11|||
144326279|NCT02754141|520400518|FG001|Overall Study|Disease progression|7|||
144326280|NCT02754141|520400519|FG002|Overall Study|Disease progression|8|||
144326281|NCT02754141|520400520|FG003|Overall Study|Disease progression|5|||
144326282|NCT02754141|520400521|FG004|Overall Study|Disease progression|7|||
144326283|NCT02754141|520400522|FG005|Overall Study|Disease progression|7|||
144326284|NCT02754141|520400523|FG006|Overall Study|Disease progression|7|||
144326285|NCT02754141|520400524|FG007|Overall Study|Disease progression|6|||
144326286|NCT02754141|520400525|FG008|Overall Study|Disease progression|11|||
144326287|NCT02754141|520400526|FG009|Overall Study|Disease progression|16|||
144326288|NCT02754141|520400527|FG010|Overall Study|Disease progression|18|||
144326289|NCT02754141|520400528|FG011|Overall Study|Disease progression|13|||
144326290|NCT02754141|520400529|FG012|Overall Study|Disease progression|10|||
144326291|NCT02754141|520400530|FG013|Overall Study|Disease progression|12|||
144326292|NCT02754141|520400531|FG014|Overall Study|Disease progression|12|||
144326293|NCT02754141|520400532|FG015|Overall Study|Disease progression|14|||
144326294|NCT02754141|520400533|FG016|Overall Study|Disease progression|0|||
144326295|NCT02754141|520400534|FG017|Overall Study|Disease progression|1|||
144326296|NCT02754141|520400517|FG000|Overall Study|Study drug toxicity|1|||
144326297|NCT02754141|520400518|FG001|Overall Study|Study drug toxicity|1|||
144326298|NCT02754141|520400519|FG002|Overall Study|Study drug toxicity|0|||
144326299|NCT02754141|520400520|FG003|Overall Study|Study drug toxicity|0|||
144326300|NCT02754141|520400521|FG004|Overall Study|Study drug toxicity|0|||
144326301|NCT02754141|520400522|FG005|Overall Study|Study drug toxicity|0|||
144326302|NCT02754141|520400523|FG006|Overall Study|Study drug toxicity|0|||
144326303|NCT02754141|520400524|FG007|Overall Study|Study drug toxicity|0|||
144326304|NCT02754141|520400525|FG008|Overall Study|Study drug toxicity|0|||
144326305|NCT02754141|520400526|FG009|Overall Study|Study drug toxicity|0|||
144326306|NCT02754141|520400527|FG010|Overall Study|Study drug toxicity|2|||
144326307|NCT02754141|520400528|FG011|Overall Study|Study drug toxicity|1|||
144326308|NCT02754141|520400529|FG012|Overall Study|Study drug toxicity|1|||
144326309|NCT02754141|520400530|FG013|Overall Study|Study drug toxicity|0|||
144326310|NCT02754141|520400531|FG014|Overall Study|Study drug toxicity|0|||
144326311|NCT02754141|520400532|FG015|Overall Study|Study drug toxicity|0|||
144326312|NCT02754141|520400533|FG016|Overall Study|Study drug toxicity|0|||
144326313|NCT02754141|520400534|FG017|Overall Study|Study drug toxicity|0|||
144326314|NCT02754141|520400517|FG000|Overall Study|AE unrelated to study drug|1|||
144326315|NCT02754141|520400518|FG001|Overall Study|AE unrelated to study drug|1|||
144326316|NCT02754141|520400519|FG002|Overall Study|AE unrelated to study drug|0|||
144326317|NCT02754141|520400520|FG003|Overall Study|AE unrelated to study drug|1|||
144326318|NCT02754141|520400521|FG004|Overall Study|AE unrelated to study drug|3|||
144326319|NCT02754141|520400522|FG005|Overall Study|AE unrelated to study drug|2|||
144326320|NCT02754141|520400523|FG006|Overall Study|AE unrelated to study drug|1|||
144326321|NCT02754141|520400524|FG007|Overall Study|AE unrelated to study drug|0|||
144326322|NCT02754141|520400525|FG008|Overall Study|AE unrelated to study drug|0|||
144326323|NCT02754141|520400526|FG009|Overall Study|AE unrelated to study drug|0|||
144326324|NCT02754141|520400527|FG010|Overall Study|AE unrelated to study drug|0|||
144326325|NCT02754141|520400528|FG011|Overall Study|AE unrelated to study drug|0|||
144326326|NCT02754141|520400529|FG012|Overall Study|AE unrelated to study drug|0|||
144326327|NCT02754141|520400530|FG013|Overall Study|AE unrelated to study drug|0|||
144326328|NCT02754141|520400531|FG014|Overall Study|AE unrelated to study drug|0|||
144326329|NCT02754141|520400532|FG015|Overall Study|AE unrelated to study drug|0|||
144326330|NCT02754141|520400533|FG016|Overall Study|AE unrelated to study drug|0|||
144326331|NCT02754141|520400534|FG017|Overall Study|AE unrelated to study drug|0|||
144326332|NCT02754141|520400517|FG000|Overall Study|Request to discontinue|0|||
144326333|NCT02754141|520400518|FG001|Overall Study|Request to discontinue|0|||
144326334|NCT02754141|520400519|FG002|Overall Study|Request to discontinue|0|||
144326335|NCT02754141|520400520|FG003|Overall Study|Request to discontinue|0|||
144326336|NCT02754141|520400521|FG004|Overall Study|Request to discontinue|0|||
144326337|NCT02754141|520400522|FG005|Overall Study|Request to discontinue|0|||
144326338|NCT02754141|520400523|FG006|Overall Study|Request to discontinue|0|||
144326339|NCT02754141|520400524|FG007|Overall Study|Request to discontinue|0|||
144326340|NCT02754141|520400525|FG008|Overall Study|Request to discontinue|1|||
144326341|NCT02754141|520400526|FG009|Overall Study|Request to discontinue|0|||
144326342|NCT02754141|520400527|FG010|Overall Study|Request to discontinue|0|||
144326343|NCT02754141|520400528|FG011|Overall Study|Request to discontinue|0|||
144326344|NCT02754141|520400529|FG012|Overall Study|Request to discontinue|0|||
144326345|NCT02754141|520400530|FG013|Overall Study|Request to discontinue|1|||
144326346|NCT02754141|520400531|FG014|Overall Study|Request to discontinue|1|||
144326347|NCT02754141|520400532|FG015|Overall Study|Request to discontinue|0|||
144326348|NCT02754141|520400533|FG016|Overall Study|Request to discontinue|0|||
144326349|NCT02754141|520400534|FG017|Overall Study|Request to discontinue|0|||
144326350|NCT02754141|520400517|FG000|Overall Study|Withdrew consent|0|||
144326351|NCT02754141|520400518|FG001|Overall Study|Withdrew consent|0|||
144326352|NCT02754141|520400519|FG002|Overall Study|Withdrew consent|0|||
144326353|NCT02754141|520400520|FG003|Overall Study|Withdrew consent|0|||
144326354|NCT02754141|520400521|FG004|Overall Study|Withdrew consent|0|||
144326355|NCT02754141|520400522|FG005|Overall Study|Withdrew consent|0|||
144326356|NCT02754141|520400523|FG006|Overall Study|Withdrew consent|0|||
144326357|NCT02754141|520400524|FG007|Overall Study|Withdrew consent|0|||
144326358|NCT02754141|520400525|FG008|Overall Study|Withdrew consent|0|||
144326359|NCT02754141|520400526|FG009|Overall Study|Withdrew consent|1|||
144326360|NCT02754141|520400527|FG010|Overall Study|Withdrew consent|0|||
144326361|NCT02754141|520400528|FG011|Overall Study|Withdrew consent|0|||
144326362|NCT02754141|520400529|FG012|Overall Study|Withdrew consent|0|||
144326363|NCT02754141|520400530|FG013|Overall Study|Withdrew consent|0|||
144326364|NCT02754141|520400531|FG014|Overall Study|Withdrew consent|0|||
144326365|NCT02754141|520400532|FG015|Overall Study|Withdrew consent|0|||
144326366|NCT02754141|520400533|FG016|Overall Study|Withdrew consent|0|||
144326367|NCT02754141|520400534|FG017|Overall Study|Withdrew consent|0|||
144326368|NCT02754141|520400517|FG000|Overall Study|Maximum clinical benefit|0|||
144326369|NCT02754141|520400518|FG001|Overall Study|Maximum clinical benefit|0|||
144326370|NCT02754141|520400519|FG002|Overall Study|Maximum clinical benefit|0|||
144326371|NCT02754141|520400520|FG003|Overall Study|Maximum clinical benefit|1|||
144326372|NCT02754141|520400521|FG004|Overall Study|Maximum clinical benefit|0|||
144326373|NCT02754141|520400522|FG005|Overall Study|Maximum clinical benefit|0|||
144326374|NCT02754141|520400523|FG006|Overall Study|Maximum clinical benefit|0|||
144326375|NCT02754141|520400524|FG007|Overall Study|Maximum clinical benefit|0|||
144326376|NCT02754141|520400525|FG008|Overall Study|Maximum clinical benefit|0|||
144326377|NCT02754141|520400526|FG009|Overall Study|Maximum clinical benefit|0|||
144326378|NCT02754141|520400527|FG010|Overall Study|Maximum clinical benefit|0|||
144326379|NCT02754141|520400528|FG011|Overall Study|Maximum clinical benefit|0|||
144326380|NCT02754141|520400529|FG012|Overall Study|Maximum clinical benefit|0|||
144326381|NCT02754141|520400530|FG013|Overall Study|Maximum clinical benefit|0|||
144326382|NCT02754141|520400531|FG014|Overall Study|Maximum clinical benefit|0|||
144326383|NCT02754141|520400532|FG015|Overall Study|Maximum clinical benefit|0|||
144326384|NCT02754141|520400533|FG016|Overall Study|Maximum clinical benefit|0|||
144326385|NCT02754141|520400534|FG017|Overall Study|Maximum clinical benefit|0|||
144326386|NCT02754141|520400517|FG000|Overall Study|No longer meets study criteria|0|||
144326387|NCT02754141|520400518|FG001|Overall Study|No longer meets study criteria|0|||
144326388|NCT02754141|520400519|FG002|Overall Study|No longer meets study criteria|0|||
144326389|NCT02754141|520400520|FG003|Overall Study|No longer meets study criteria|1|||
144326390|NCT02754141|520400521|FG004|Overall Study|No longer meets study criteria|0|||
144326391|NCT02754141|520400522|FG005|Overall Study|No longer meets study criteria|0|||
144326392|NCT02754141|520400523|FG006|Overall Study|No longer meets study criteria|0|||
144326393|NCT02754141|520400524|FG007|Overall Study|No longer meets study criteria|0|||
144326394|NCT02754141|520400525|FG008|Overall Study|No longer meets study criteria|0|||
144326395|NCT02754141|520400526|FG009|Overall Study|No longer meets study criteria|0|||
144326396|NCT02754141|520400527|FG010|Overall Study|No longer meets study criteria|0|||
144326397|NCT02754141|520400528|FG011|Overall Study|No longer meets study criteria|0|||
144326398|NCT02754141|520400529|FG012|Overall Study|No longer meets study criteria|0|||
144326399|NCT02754141|520400530|FG013|Overall Study|No longer meets study criteria|0|||
144326400|NCT02754141|520400531|FG014|Overall Study|No longer meets study criteria|0|||
144326401|NCT02754141|520400532|FG015|Overall Study|No longer meets study criteria|0|||
144326402|NCT02754141|520400533|FG016|Overall Study|No longer meets study criteria|0|||
144326403|NCT02754141|520400534|FG017|Overall Study|No longer meets study criteria|0|||
144326404|NCT02754141|520400517|FG000|Overall Study|Other reasons|0|||
144326405|NCT02754141|520400518|FG001|Overall Study|Other reasons|0|||
144326406|NCT02754141|520400519|FG002|Overall Study|Other reasons|0|||
144326407|NCT02754141|520400520|FG003|Overall Study|Other reasons|0|||
144326408|NCT02754141|520400521|FG004|Overall Study|Other reasons|0|||
144326409|NCT02754141|520400522|FG005|Overall Study|Other reasons|0|||
144326410|NCT02754141|520400523|FG006|Overall Study|Other reasons|0|||
144326411|NCT02754141|520400524|FG007|Overall Study|Other reasons|1|||
144326412|NCT02754141|520400525|FG008|Overall Study|Other reasons|0|||
144326413|NCT02754141|520400526|FG009|Overall Study|Other reasons|0|||
144326414|NCT02754141|520400527|FG010|Overall Study|Other reasons|0|||
144326415|NCT02754141|520400528|FG011|Overall Study|Other reasons|0|||
144326416|NCT02754141|520400529|FG012|Overall Study|Other reasons|2|||
144326417|NCT02754141|520400530|FG013|Overall Study|Other reasons|0|||
144326418|NCT02754141|520400531|FG014|Overall Study|Other reasons|0|||
144326419|NCT02754141|520400532|FG015|Overall Study|Other reasons|0|||
144326420|NCT02754141|520400533|FG016|Overall Study|Other reasons|0|||
144326421|NCT02754141|520400534|FG017|Overall Study|Other reasons|0|||
144326422|NCT02754141|520400517|FG000|Overall Study|Completed treatment as per protocol|0|||
144326423|NCT02754141|520400518|FG001|Overall Study|Completed treatment as per protocol|1|||
144326424|NCT02754141|520400519|FG002|Overall Study|Completed treatment as per protocol|0|||
144326425|NCT02754141|520400520|FG003|Overall Study|Completed treatment as per protocol|0|||
144326426|NCT02754141|520400521|FG004|Overall Study|Completed treatment as per protocol|0|||
144326427|NCT02754141|520400522|FG005|Overall Study|Completed treatment as per protocol|0|||
144326428|NCT02754141|520400523|FG006|Overall Study|Completed treatment as per protocol|0|||
144326429|NCT02754141|520400524|FG007|Overall Study|Completed treatment as per protocol|0|||
144326430|NCT02754141|520400525|FG008|Overall Study|Completed treatment as per protocol|0|||
144326431|NCT02754141|520400526|FG009|Overall Study|Completed treatment as per protocol|0|||
144326432|NCT02754141|520400527|FG010|Overall Study|Completed treatment as per protocol|0|||
144326433|NCT02754141|520400528|FG011|Overall Study|Completed treatment as per protocol|0|||
144326434|NCT02754141|520400529|FG012|Overall Study|Completed treatment as per protocol|1|||
144326435|NCT02754141|520400530|FG013|Overall Study|Completed treatment as per protocol|0|||
144326436|NCT02754141|520400531|FG014|Overall Study|Completed treatment as per protocol|0|||
144326437|NCT02754141|520400532|FG015|Overall Study|Completed treatment as per protocol|0|||
144326438|NCT02754141|520400533|FG016|Overall Study|Completed treatment as per protocol|0|||
144326439|NCT02754141|520400534|FG017|Overall Study|Completed treatment as per protocol|0|||
144326440|NCT02754141|520400517|FG000|Overall Study|Not completing monotherapy|0|||
144326441|NCT02754141|520400518|FG001|Overall Study|Not completing monotherapy|0|||
144326442|NCT02754141|520400519|FG002|Overall Study|Not completing monotherapy|0|||
144326443|NCT02754141|520400520|FG003|Overall Study|Not completing monotherapy|0|||
144326444|NCT02754141|520400521|FG004|Overall Study|Not completing monotherapy|0|||
144326445|NCT02754141|520400522|FG005|Overall Study|Not completing monotherapy|0|||
144326446|NCT02754141|520400523|FG006|Overall Study|Not completing monotherapy|0|||
144326447|NCT02754141|520400524|FG007|Overall Study|Not completing monotherapy|0|||
144326448|NCT02754141|520400525|FG008|Overall Study|Not completing monotherapy|0|||
144326449|NCT02754141|520400526|FG009|Overall Study|Not completing monotherapy|0|||
144326450|NCT02754141|520400527|FG010|Overall Study|Not completing monotherapy|0|||
144326451|NCT02754141|520400528|FG011|Overall Study|Not completing monotherapy|0|||
144326452|NCT02754141|520400529|FG012|Overall Study|Not completing monotherapy|0|||
144326453|NCT02754141|520400530|FG013|Overall Study|Not completing monotherapy|1|||
144326454|NCT02754141|520400531|FG014|Overall Study|Not completing monotherapy|0|||
144326455|NCT02754141|520400532|FG015|Overall Study|Not completing monotherapy|0|||
144326456|NCT02754141|520400533|FG016|Overall Study|Not completing monotherapy|0|||
144326457|NCT02754141|520400534|FG017|Overall Study|Not completing monotherapy|0|||
144326458|NCT00623545|520400543|FG000|Overall Study|Adverse Event|6|||
144326459|NCT00623545|520400543|FG000|Overall Study|Withdrawal by Subject|4|||
144326460|NCT03500172|520400549|FG000|Period 1: Baseline Randomization|Death|0|||
144326461|NCT03500172|520400550|FG001|Period 1: Baseline Randomization|Death|0|||
144326462|NCT03500172|520400551|FG002|Period 1: Baseline Randomization|Death|0|||
144326463|NCT03500172|520400552|FG003|Period 1: Baseline Randomization|Death|0|||
144326464|NCT03500172|520400553|FG004|Period 1: Baseline Randomization|Death|0|||
144326465|NCT03500172|520400554|FG005|Period 1: Baseline Randomization|Death|0|||
144326466|NCT03500172|520400555|FG006|Period 1: Baseline Randomization|Death|0|||
144326467|NCT03500172|520400556|FG007|Period 1: Baseline Randomization|Death|0|||
144326468|NCT03500172|520400557|FG008|Period 1: Baseline Randomization|Death|0|||
144326469|NCT03500172|520400558|FG009|Period 1: Baseline Randomization|Death|2|||
144326470|NCT03500172|520400559|FG010|Period 1: Baseline Randomization|Death|0|||
144326471|NCT03500172|520400549|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
144326472|NCT03500172|520400550|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
144326473|NCT03500172|520400551|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
144326474|NCT03500172|520400552|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
144326475|NCT03500172|520400553|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
144326476|NCT03500172|520400554|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
144326477|NCT03500172|520400555|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
144326478|NCT03500172|520400556|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
144326479|NCT03500172|520400557|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
144326480|NCT03500172|520400558|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
144326481|NCT03500172|520400559|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
144326482|NCT03500172|520400549|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
144326483|NCT03500172|520400550|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
144326484|NCT03500172|520400551|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
144326485|NCT03500172|520400552|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
144326486|NCT03500172|520400553|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
144326487|NCT03500172|520400554|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
144326488|NCT03500172|520400555|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
144326489|NCT03500172|520400556|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
144326490|NCT03500172|520400557|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
144326491|NCT03500172|520400558|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
144326492|NCT03500172|520400559|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
144326493|NCT03500172|520400549|FG000|Period 2: Re-Randomization|Death|0|||
144326494|NCT03500172|520400550|FG001|Period 2: Re-Randomization|Death|0|||
144326495|NCT03500172|520400551|FG002|Period 2: Re-Randomization|Death|0|||
144326496|NCT03500172|520400552|FG003|Period 2: Re-Randomization|Death|4|||
144326497|NCT03500172|520400553|FG004|Period 2: Re-Randomization|Death|2|||
144326498|NCT03500172|520400554|FG005|Period 2: Re-Randomization|Death|0|||
144326499|NCT03500172|520400555|FG006|Period 2: Re-Randomization|Death|5|||
144326500|NCT03500172|520400556|FG007|Period 2: Re-Randomization|Death|2|||
144326501|NCT03500172|520400557|FG008|Period 2: Re-Randomization|Death|0|||
144326502|NCT03500172|520400558|FG009|Period 2: Re-Randomization|Death|0|||
144326503|NCT03500172|520400559|FG010|Period 2: Re-Randomization|Death|0|||
144326504|NCT00937404|520400560|FG000|Overall Study|Protocol Violation|1|||
144326505|NCT00937404|520400560|FG000|Overall Study|Withdrawal by Subject|1|||
144326506|NCT00230282|520400562|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
144326507|NCT00230282|520400562|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
144326508|NCT00230282|520400562|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
144326509|NCT00230282|520400562|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
144326510|NCT00090233|520400563|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
144326511|NCT00090233|520400564|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
144326512|NCT00090233|520400563|FG000|Overall Study|Adverse Event|214|||
144326513|NCT00090233|520400564|FG001|Overall Study|Adverse Event|198|||
144326514|NCT00090233|520400563|FG000|Overall Study|Lost to Follow-up|68|||
144326515|NCT00090233|520400564|FG001|Overall Study|Lost to Follow-up|95|||
144326516|NCT00090233|520400563|FG000|Overall Study|Protocol Violation|960|||
144326517|NCT00090233|520400564|FG001|Overall Study|Protocol Violation|1022|||
144326518|NCT00090233|520400563|FG000|Overall Study|Withdrawal by Subject|182|||
144326519|NCT00090233|520400564|FG001|Overall Study|Withdrawal by Subject|211|||
144326520|NCT00090233|520400563|FG000|Overall Study|Moved|203|||
144326521|NCT00090233|520400564|FG001|Overall Study|Moved|189|||
144326522|NCT00090233|520400563|FG000|Overall Study|Other|1211|||
144326523|NCT00090233|520400564|FG001|Overall Study|Other|1160|||
144326524|NCT00090233|520400563|FG000|Overall Study|Data not available at data cut-off point|1552|||
144326525|NCT00090233|520400564|FG001|Overall Study|Data not available at data cut-off point|1563|||
144326526|NCT05605691|520400568|FG000|Overall Study|Lost to Follow-up|1|||
144326527|NCT02701777|520400569|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
144326528|NCT02701777|520400570|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
144326529|NCT02701777|520400571|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
144326530|NCT02701777|520400572|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
144326531|NCT02701777|520400569|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
144326532|NCT02701777|520400570|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
144326533|NCT02701777|520400571|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
144326534|NCT02701777|520400572|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
144326535|NCT03199053|520400573|FG000|ST Period|Withdrawal by Subject|2|||
144326536|NCT03199053|520400574|FG001|ST Period|Withdrawal by Subject|4|||
144326537|NCT03199053|520400575|FG002|ST Period|Withdrawal by Subject|6|||
144326538|NCT03199053|520400573|FG000|ST Period|Withdrawal by parent/guardian|1|||
144326539|NCT03199053|520400574|FG001|ST Period|Withdrawal by parent/guardian|1|||
144326540|NCT03199053|520400575|FG002|ST Period|Withdrawal by parent/guardian|1|||
144326541|NCT03199053|520400573|FG000|ST Period|Lost to Follow-up|2|||
144326542|NCT03199053|520400574|FG001|ST Period|Lost to Follow-up|0|||
144326543|NCT03199053|520400575|FG002|ST Period|Lost to Follow-up|1|||
144326544|NCT03199053|520400573|FG000|LT Period|Withdrawal by Subject|1|||
144326545|NCT03199053|520400574|FG001|LT Period|Withdrawal by Subject|3|||
144326546|NCT03199053|520400575|FG002|LT Period|Withdrawal by Subject|3|||
144326547|NCT03199053|520400573|FG000|LT Period|Withdrawal by parent/guardian|0|||
144326548|NCT03199053|520400574|FG001|LT Period|Withdrawal by parent/guardian|0|||
144326549|NCT03199053|520400575|FG002|LT Period|Withdrawal by parent/guardian|1|||
144326550|NCT03199053|520400573|FG000|LT Period|Lost to Follow-up|0|||
144326551|NCT03199053|520400574|FG001|LT Period|Lost to Follow-up|1|||
144326552|NCT03199053|520400575|FG002|LT Period|Lost to Follow-up|1|||
144326553|NCT03199053|520400573|FG000|LT Period|Miscellaneous|0|||
144326554|NCT03199053|520400574|FG001|LT Period|Miscellaneous|0|||
144326555|NCT03199053|520400575|FG002|LT Period|Miscellaneous|2|||
144326556|NCT03199053|520400573|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
144326557|NCT03199053|520400574|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
144326558|NCT03199053|520400575|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
144326559|NCT03199053|520400573|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
144326560|NCT03199053|520400574|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
144326561|NCT03199053|520400575|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
144326562|NCT03199053|520400573|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
144326563|NCT03199053|520400574|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
144326564|NCT03199053|520400575|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
144326565|NCT03199053|520400573|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
144326566|NCT03199053|520400574|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
144326567|NCT03199053|520400575|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
144326568|NCT03298984|520400578|FG000|Overall Study|Physician Decision|1|||
144326569|NCT03298984|520400579|FG001|Overall Study|Physician Decision|0|||
144326570|NCT03298984|520400580|FG002|Overall Study|Physician Decision|0|||
144326571|NCT03298984|520400581|FG003|Overall Study|Physician Decision|6|||
144326572|NCT03298984|520400578|FG000|Overall Study|Lack of Efficacy|0|||
144326573|NCT03298984|520400579|FG001|Overall Study|Lack of Efficacy|1|||
144326574|NCT03298984|520400580|FG002|Overall Study|Lack of Efficacy|1|||
144326575|NCT03298984|520400581|FG003|Overall Study|Lack of Efficacy|4|||
144326576|NCT03298984|520400578|FG000|Overall Study|Relapsed disease (following remission)|0|||
144326577|NCT03298984|520400579|FG001|Overall Study|Relapsed disease (following remission)|0|||
144326578|NCT03298984|520400580|FG002|Overall Study|Relapsed disease (following remission)|1|||
144326579|NCT03298984|520400581|FG003|Overall Study|Relapsed disease (following remission)|1|||
144326580|NCT03298984|520400578|FG000|Overall Study|Adverse Event|0|||
144326581|NCT03298984|520400579|FG001|Overall Study|Adverse Event|0|||
144326582|NCT03298984|520400580|FG002|Overall Study|Adverse Event|0|||
144326583|NCT03298984|520400581|FG003|Overall Study|Adverse Event|1|||
144326584|NCT03298984|520400578|FG000|Overall Study|Death|0|||
144326585|NCT03298984|520400579|FG001|Overall Study|Death|0|||
144326586|NCT03298984|520400580|FG002|Overall Study|Death|0|||
144326587|NCT03298984|520400581|FG003|Overall Study|Death|2|||
144326588|NCT03298984|520400578|FG000|Overall Study|Insurance Company Decision|0|||
144326589|NCT03298984|520400579|FG001|Overall Study|Insurance Company Decision|0|||
144326590|NCT03298984|520400580|FG002|Overall Study|Insurance Company Decision|0|||
144326591|NCT03298984|520400581|FG003|Overall Study|Insurance Company Decision|1|||
144326592|NCT02509052|520400584|FG000|Overall Study|Non compliance|0|||
144326593|NCT02509052|520400585|FG001|Overall Study|Non compliance|0|||
144326594|NCT02509052|520400586|FG002|Overall Study|Non compliance|1|||
144326595|NCT00585221|520400587|FG000|Overall Study|Protocol Violation|8|||
144326596|NCT02585830|520400588|FG000|Overall Study|Withdrawal by Subject|3|||
144326597|NCT02229214|520400598|FG000|Overall Study|Adverse Event|2|||
144326598|NCT02229214|520400599|FG001|Overall Study|Adverse Event|0|||
144326599|NCT02229214|520400598|FG000|Overall Study|Withdrawal by Subject|4|||
144326600|NCT02229214|520400599|FG001|Overall Study|Withdrawal by Subject|0|||
144326601|NCT00246025|520400607|FG000|Overall Study|Adverse Event|7|||
144326602|NCT00246025|520400608|FG001|Overall Study|Adverse Event|9|||
144326603|NCT00246025|520400609|FG002|Overall Study|Adverse Event|9|||
144326604|NCT00246025|520400610|FG003|Overall Study|Adverse Event|10|||
144326605|NCT00246025|520400607|FG000|Overall Study|Withdrawal by Subject|3|||
144326606|NCT00246025|520400608|FG001|Overall Study|Withdrawal by Subject|0|||
144326607|NCT00246025|520400609|FG002|Overall Study|Withdrawal by Subject|1|||
144326608|NCT00246025|520400610|FG003|Overall Study|Withdrawal by Subject|2|||
144326609|NCT00246025|520400607|FG000|Overall Study|unsuitable medical history was found|0|||
144326610|NCT00246025|520400608|FG001|Overall Study|unsuitable medical history was found|0|||
144326611|NCT00246025|520400609|FG002|Overall Study|unsuitable medical history was found|0|||
144326612|NCT00246025|520400610|FG003|Overall Study|unsuitable medical history was found|1|||
144326613|NCT00931723|520400613|FG000|Overall Study|Withdrawal by Subject|11|||
144326614|NCT00931723|520400614|FG001|Overall Study|Withdrawal by Subject|13|||
144326615|NCT00931723|520400613|FG000|Overall Study|Adverse Event|6|||
144326616|NCT00931723|520400614|FG001|Overall Study|Adverse Event|13|||
144326617|NCT00931723|520400613|FG000|Overall Study|Lithium found in blood|0|||
144326618|NCT00931723|520400614|FG001|Overall Study|Lithium found in blood|1|||
144326619|NCT00931723|520400613|FG000|Overall Study|Condition under investigation worsened|1|||
144326620|NCT00931723|520400614|FG001|Overall Study|Condition under investigation worsened|2|||
144326621|NCT00931723|520400613|FG000|Overall Study|Lost to Follow-up|1|||
144326622|NCT00931723|520400614|FG001|Overall Study|Lost to Follow-up|2|||
144326623|NCT00931723|520400613|FG000|Overall Study|Study-specific discontinuation criteria|1|||
144326624|NCT00931723|520400614|FG001|Overall Study|Study-specific discontinuation criteria|1|||
144326625|NCT00931723|520400613|FG000|Overall Study|Severe non-compliance to protocol|2|||
144326626|NCT00931723|520400614|FG001|Overall Study|Severe non-compliance to protocol|0|||
144326627|NCT00931723|520400613|FG000|Overall Study|Safety reasons|0|||
144326628|NCT00931723|520400614|FG001|Overall Study|Safety reasons|1|||
144326629|NCT00931723|520400613|FG000|Overall Study|Took prohibited concomitant medication|0|||
144326630|NCT00931723|520400614|FG001|Overall Study|Took prohibited concomitant medication|1|||
144326631|NCT00931723|520400613|FG000|Overall Study|Lack or insufficient theraputic response|2|||
144326632|NCT00931723|520400614|FG001|Overall Study|Lack or insufficient theraputic response|5|||
144326633|NCT00931723|520400613|FG000|Overall Study|Sponsor decision|1|||
144326634|NCT00931723|520400614|FG001|Overall Study|Sponsor decision|0|||
144326635|NCT00931723|520400613|FG000|Overall Study|Late hospital discharge|1|||
144326636|NCT00931723|520400614|FG001|Overall Study|Late hospital discharge|0|||
144326637|NCT01643850|520400615|FG000|Overall Study|Withdrawal by Subject|0|||
144326638|NCT01643850|520400616|FG001|Overall Study|Withdrawal by Subject|0|||
144326639|NCT01643850|520400617|FG002|Overall Study|Withdrawal by Subject|0|||
144326640|NCT01643850|520400618|FG003|Overall Study|Withdrawal by Subject|0|||
144326641|NCT01643850|520400619|FG004|Overall Study|Withdrawal by Subject|1|||
144326642|NCT01643850|520400620|FG005|Overall Study|Withdrawal by Subject|0|||
144326643|NCT01643850|520400621|FG006|Overall Study|Withdrawal by Subject|0|||
144326644|NCT01643850|520400622|FG007|Overall Study|Withdrawal by Subject|0|||
144326645|NCT01643850|520400623|FG008|Overall Study|Withdrawal by Subject|0|||
144326646|NCT01643850|520400615|FG000|Overall Study|Lost to Follow-up|0|||
144326647|NCT01643850|520400616|FG001|Overall Study|Lost to Follow-up|0|||
144326648|NCT01643850|520400617|FG002|Overall Study|Lost to Follow-up|0|||
144326649|NCT01643850|520400618|FG003|Overall Study|Lost to Follow-up|0|||
144326650|NCT01643850|520400619|FG004|Overall Study|Lost to Follow-up|0|||
144326651|NCT01643850|520400620|FG005|Overall Study|Lost to Follow-up|0|||
144326652|NCT01643850|520400621|FG006|Overall Study|Lost to Follow-up|1|||
144326653|NCT01643850|520400622|FG007|Overall Study|Lost to Follow-up|0|||
144326654|NCT01643850|520400623|FG008|Overall Study|Lost to Follow-up|1|||
144326655|NCT01643850|520400615|FG000|Overall Study|Adverse Event|0|||
144326656|NCT01643850|520400616|FG001|Overall Study|Adverse Event|0|||
144326657|NCT01643850|520400617|FG002|Overall Study|Adverse Event|0|||
144326658|NCT01643850|520400618|FG003|Overall Study|Adverse Event|0|||
144326659|NCT01643850|520400619|FG004|Overall Study|Adverse Event|1|||
144326660|NCT01643850|520400620|FG005|Overall Study|Adverse Event|0|||
144326661|NCT01643850|520400621|FG006|Overall Study|Adverse Event|0|||
144326662|NCT01643850|520400622|FG007|Overall Study|Adverse Event|0|||
144326663|NCT01643850|520400623|FG008|Overall Study|Adverse Event|0|||
144326664|NCT01643850|520400615|FG000|Overall Study|Administrative Problems|0|||
144326665|NCT01643850|520400616|FG001|Overall Study|Administrative Problems|0|||
144326666|NCT01643850|520400617|FG002|Overall Study|Administrative Problems|1|||
144326667|NCT01643850|520400618|FG003|Overall Study|Administrative Problems|0|||
144326668|NCT01643850|520400619|FG004|Overall Study|Administrative Problems|1|||
144326669|NCT01643850|520400620|FG005|Overall Study|Administrative Problems|0|||
144326670|NCT01643850|520400621|FG006|Overall Study|Administrative Problems|0|||
144326671|NCT01643850|520400622|FG007|Overall Study|Administrative Problems|0|||
144326672|NCT01643850|520400623|FG008|Overall Study|Administrative Problems|0|||
144326673|NCT03300024|520400624|FG000|Overall Study|Physician Decision|4|||
144326674|NCT03300024|520400625|FG001|Overall Study|Physician Decision|6|||
144326675|NCT03305081|520400626|FG000|Overall Study|Lost to Follow-up|10|||
144326676|NCT03305081|520400627|FG001|Overall Study|Lost to Follow-up|15|||
144326677|NCT00570037|520400628|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
144326678|NCT00570037|520400629|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
144326679|NCT00554619|520400630|FG000|Overall Study|Adverse Event|1|||
144326680|NCT00554619|520400630|FG000|Overall Study|Physician Decision|1|||
144326681|NCT00554619|520400630|FG000|Overall Study|Liver Function Test Abnormality|1|||
144326682|NCT01571284|520400631|FG000|Overall Study|Participant's decision|84|||
144326683|NCT01571284|520400631|FG000|Overall Study|Lost to Follow-up|3|||
144326684|NCT01571284|520400631|FG000|Overall Study|Enrolled but not treated|2|||
144326685|NCT01571284|520400631|FG000|Overall Study|Other than specified above|80|||
144326686|NCT00075725|520400632|FG000|Overall Study|Adverse Event|6|||
144326687|NCT00075725|520400633|FG001|Overall Study|Adverse Event|6|||
144326688|NCT00075725|520400634|FG002|Overall Study|Adverse Event|20|||
144326689|NCT00075725|520400635|FG003|Overall Study|Adverse Event|8|||
144326690|NCT00075725|520400636|FG004|Overall Study|Adverse Event|4|||
144326691|NCT00075725|520400637|FG005|Overall Study|Adverse Event|38|||
144326692|NCT00075725|520400638|FG006|Overall Study|Adverse Event|3|||
144326693|NCT00075725|520400639|FG007|Overall Study|Adverse Event|51|||
144326694|NCT00075725|520400640|FG008|Overall Study|Adverse Event|15|||
144326695|NCT00075725|520400641|FG009|Overall Study|Adverse Event|4|||
144326696|NCT00075725|520400642|FG010|Overall Study|Adverse Event|2|||
144326697|NCT00075725|520400643|FG011|Overall Study|Adverse Event|2|||
144326698|NCT00075725|520400632|FG000|Overall Study|Death|3|||
144326699|NCT00075725|520400633|FG001|Overall Study|Death|5|||
144326700|NCT00075725|520400634|FG002|Overall Study|Death|10|||
144326701|NCT00075725|520400635|FG003|Overall Study|Death|2|||
144326702|NCT00075725|520400636|FG004|Overall Study|Death|3|||
144326703|NCT00075725|520400637|FG005|Overall Study|Death|25|||
144326704|NCT00075725|520400638|FG006|Overall Study|Death|4|||
144326705|NCT00075725|520400639|FG007|Overall Study|Death|22|||
144326706|NCT00075725|520400640|FG008|Overall Study|Death|14|||
144326707|NCT00075725|520400641|FG009|Overall Study|Death|4|||
144326708|NCT00075725|520400642|FG010|Overall Study|Death|3|||
144326709|NCT00075725|520400643|FG011|Overall Study|Death|0|||
144326710|NCT00075725|520400632|FG000|Overall Study|Lost to Follow-up|1|||
144326711|NCT00075725|520400633|FG001|Overall Study|Lost to Follow-up|1|||
144326712|NCT00075725|520400634|FG002|Overall Study|Lost to Follow-up|4|||
144326713|NCT00075725|520400635|FG003|Overall Study|Lost to Follow-up|1|||
144326714|NCT00075725|520400636|FG004|Overall Study|Lost to Follow-up|0|||
144326715|NCT00075725|520400637|FG005|Overall Study|Lost to Follow-up|13|||
144326716|NCT00075725|520400638|FG006|Overall Study|Lost to Follow-up|2|||
144326717|NCT00075725|520400639|FG007|Overall Study|Lost to Follow-up|4|||
144326718|NCT00075725|520400640|FG008|Overall Study|Lost to Follow-up|1|||
144326719|NCT00075725|520400641|FG009|Overall Study|Lost to Follow-up|0|||
144326720|NCT00075725|520400642|FG010|Overall Study|Lost to Follow-up|0|||
144326721|NCT00075725|520400643|FG011|Overall Study|Lost to Follow-up|0|||
144326722|NCT00075725|520400632|FG000|Overall Study|Physician Decision|2|||
144326723|NCT00075725|520400633|FG001|Overall Study|Physician Decision|6|||
144326724|NCT00075725|520400634|FG002|Overall Study|Physician Decision|5|||
144326725|NCT00075725|520400635|FG003|Overall Study|Physician Decision|8|||
144326726|NCT00075725|520400636|FG004|Overall Study|Physician Decision|4|||
144326727|NCT00075725|520400637|FG005|Overall Study|Physician Decision|19|||
144326728|NCT00075725|520400638|FG006|Overall Study|Physician Decision|3|||
144326729|NCT00075725|520400639|FG007|Overall Study|Physician Decision|17|||
144326730|NCT00075725|520400640|FG008|Overall Study|Physician Decision|5|||
144326731|NCT00075725|520400641|FG009|Overall Study|Physician Decision|0|||
144326732|NCT00075725|520400642|FG010|Overall Study|Physician Decision|1|||
144326733|NCT00075725|520400643|FG011|Overall Study|Physician Decision|0|||
144326734|NCT00075725|520400632|FG000|Overall Study|Pregnancy|0|||
144326735|NCT00075725|520400633|FG001|Overall Study|Pregnancy|0|||
144326736|NCT00075725|520400634|FG002|Overall Study|Pregnancy|0|||
144326737|NCT00075725|520400635|FG003|Overall Study|Pregnancy|0|||
144326738|NCT00075725|520400636|FG004|Overall Study|Pregnancy|0|||
144326739|NCT00075725|520400637|FG005|Overall Study|Pregnancy|1|||
144326740|NCT00075725|520400638|FG006|Overall Study|Pregnancy|0|||
144326741|NCT00075725|520400639|FG007|Overall Study|Pregnancy|1|||
144326742|NCT00075725|520400640|FG008|Overall Study|Pregnancy|0|||
144326743|NCT00075725|520400641|FG009|Overall Study|Pregnancy|0|||
144326744|NCT00075725|520400642|FG010|Overall Study|Pregnancy|0|||
144326745|NCT00075725|520400643|FG011|Overall Study|Pregnancy|0|||
144326746|NCT00075725|520400632|FG000|Overall Study|Protocol Violation|1|||
144326747|NCT00075725|520400633|FG001|Overall Study|Protocol Violation|1|||
144326748|NCT00075725|520400634|FG002|Overall Study|Protocol Violation|0|||
144326749|NCT00075725|520400635|FG003|Overall Study|Protocol Violation|3|||
144326750|NCT00075725|520400636|FG004|Overall Study|Protocol Violation|3|||
144326751|NCT00075725|520400637|FG005|Overall Study|Protocol Violation|2|||
144326752|NCT00075725|520400638|FG006|Overall Study|Protocol Violation|1|||
144326753|NCT00075725|520400639|FG007|Overall Study|Protocol Violation|2|||
144326754|NCT00075725|520400640|FG008|Overall Study|Protocol Violation|3|||
144326755|NCT00075725|520400641|FG009|Overall Study|Protocol Violation|0|||
144326756|NCT00075725|520400642|FG010|Overall Study|Protocol Violation|0|||
144326757|NCT00075725|520400643|FG011|Overall Study|Protocol Violation|1|||
144326758|NCT00075725|520400632|FG000|Overall Study|Withdrawal by Subject|12|||
144326759|NCT00075725|520400633|FG001|Overall Study|Withdrawal by Subject|3|||
144326760|NCT00075725|520400634|FG002|Overall Study|Withdrawal by Subject|6|||
144326761|NCT00075725|520400635|FG003|Overall Study|Withdrawal by Subject|10|||
144326762|NCT00075725|520400636|FG004|Overall Study|Withdrawal by Subject|6|||
144326763|NCT00075725|520400637|FG005|Overall Study|Withdrawal by Subject|27|||
144326764|NCT00075725|520400638|FG006|Overall Study|Withdrawal by Subject|7|||
144326765|NCT00075725|520400639|FG007|Overall Study|Withdrawal by Subject|31|||
144326766|NCT00075725|520400640|FG008|Overall Study|Withdrawal by Subject|10|||
144326767|NCT00075725|520400641|FG009|Overall Study|Withdrawal by Subject|2|||
144326768|NCT00075725|520400642|FG010|Overall Study|Withdrawal by Subject|0|||
144326769|NCT00075725|520400643|FG011|Overall Study|Withdrawal by Subject|0|||
144326770|NCT00075725|520400632|FG000|Overall Study|Disease Progression, all other reasons|17|||
144326771|NCT00075725|520400633|FG001|Overall Study|Disease Progression, all other reasons|5|||
144326772|NCT00075725|520400634|FG002|Overall Study|Disease Progression, all other reasons|33|||
144326773|NCT00075725|520400635|FG003|Overall Study|Disease Progression, all other reasons|6|||
144326774|NCT00075725|520400636|FG004|Overall Study|Disease Progression, all other reasons|21|||
144326775|NCT00075725|520400637|FG005|Overall Study|Disease Progression, all other reasons|59|||
144326776|NCT00075725|520400638|FG006|Overall Study|Disease Progression, all other reasons|20|||
144326777|NCT00075725|520400639|FG007|Overall Study|Disease Progression, all other reasons|46|||
144326778|NCT00075725|520400640|FG008|Overall Study|Disease Progression, all other reasons|21|||
144326779|NCT00075725|520400641|FG009|Overall Study|Disease Progression, all other reasons|4|||
144326780|NCT00075725|520400642|FG010|Overall Study|Disease Progression, all other reasons|0|||
144326781|NCT00075725|520400643|FG011|Overall Study|Disease Progression, all other reasons|5|||
144326782|NCT00075725|520400632|FG000|Overall Study|Patient off treatment|0|||
144326783|NCT00075725|520400633|FG001|Overall Study|Patient off treatment|0|||
144326784|NCT00075725|520400634|FG002|Overall Study|Patient off treatment|1|||
144326785|NCT00075725|520400635|FG003|Overall Study|Patient off treatment|2|||
144326786|NCT00075725|520400636|FG004|Overall Study|Patient off treatment|1|||
144326787|NCT00075725|520400637|FG005|Overall Study|Patient off treatment|0|||
144326788|NCT00075725|520400638|FG006|Overall Study|Patient off treatment|0|||
144326789|NCT00075725|520400639|FG007|Overall Study|Patient off treatment|2|||
144326790|NCT00075725|520400640|FG008|Overall Study|Patient off treatment|1|||
144326791|NCT00075725|520400641|FG009|Overall Study|Patient off treatment|0|||
144326792|NCT00075725|520400642|FG010|Overall Study|Patient off treatment|0|||
144326793|NCT00075725|520400643|FG011|Overall Study|Patient off treatment|0|||
144326794|NCT00075725|520400632|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
144326795|NCT00075725|520400633|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
144326796|NCT00075725|520400634|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
144326797|NCT00075725|520400635|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
144326798|NCT00075725|520400636|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
144326799|NCT00075725|520400637|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
144326800|NCT00075725|520400638|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
144326801|NCT00075725|520400639|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
144326802|NCT00075725|520400640|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
144326803|NCT00075725|520400641|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
144326804|NCT00075725|520400642|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
144326805|NCT00075725|520400643|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
144326806|NCT00075725|520400632|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
144326807|NCT00075725|520400633|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
144326808|NCT00075725|520400634|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
144326809|NCT00075725|520400635|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
144326810|NCT00075725|520400636|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
144326811|NCT00075725|520400637|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
144326812|NCT00075725|520400638|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
144326813|NCT00075725|520400639|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
144360036|NCT01601535|520525140|FG005|Phase 2|Progressive Disease|7|||
144326814|NCT00075725|520400640|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
144326815|NCT00075725|520400641|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
144326816|NCT00075725|520400642|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
144326817|NCT00075725|520400643|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
144326818|NCT00075725|520400632|FG000|Overall Study|Pt non compliant with therapy|2|||
144326819|NCT00075725|520400633|FG001|Overall Study|Pt non compliant with therapy|1|||
144326820|NCT00075725|520400634|FG002|Overall Study|Pt non compliant with therapy|1|||
144326821|NCT00075725|520400635|FG003|Overall Study|Pt non compliant with therapy|0|||
144326822|NCT00075725|520400636|FG004|Overall Study|Pt non compliant with therapy|2|||
144326823|NCT00075725|520400637|FG005|Overall Study|Pt non compliant with therapy|14|||
144326824|NCT00075725|520400638|FG006|Overall Study|Pt non compliant with therapy|2|||
144326825|NCT00075725|520400639|FG007|Overall Study|Pt non compliant with therapy|5|||
144326826|NCT00075725|520400640|FG008|Overall Study|Pt non compliant with therapy|3|||
144326827|NCT00075725|520400641|FG009|Overall Study|Pt non compliant with therapy|0|||
144326828|NCT00075725|520400642|FG010|Overall Study|Pt non compliant with therapy|0|||
144326829|NCT00075725|520400643|FG011|Overall Study|Pt non compliant with therapy|0|||
144326830|NCT00075725|520400632|FG000|Overall Study|Pt age out of range for treatment|0|||
144326831|NCT00075725|520400633|FG001|Overall Study|Pt age out of range for treatment|1|||
144326832|NCT00075725|520400634|FG002|Overall Study|Pt age out of range for treatment|0|||
144326833|NCT00075725|520400635|FG003|Overall Study|Pt age out of range for treatment|0|||
144326834|NCT00075725|520400636|FG004|Overall Study|Pt age out of range for treatment|0|||
144326835|NCT00075725|520400637|FG005|Overall Study|Pt age out of range for treatment|1|||
144326836|NCT00075725|520400638|FG006|Overall Study|Pt age out of range for treatment|0|||
144326837|NCT00075725|520400639|FG007|Overall Study|Pt age out of range for treatment|1|||
144326838|NCT00075725|520400640|FG008|Overall Study|Pt age out of range for treatment|0|||
144326839|NCT00075725|520400641|FG009|Overall Study|Pt age out of range for treatment|0|||
144326840|NCT00075725|520400642|FG010|Overall Study|Pt age out of range for treatment|0|||
144326841|NCT00075725|520400643|FG011|Overall Study|Pt age out of range for treatment|0|||
144326842|NCT00075725|520400632|FG000|Overall Study|Insurance issues|0|||
144326843|NCT00075725|520400633|FG001|Overall Study|Insurance issues|1|||
144326844|NCT00075725|520400634|FG002|Overall Study|Insurance issues|0|||
144326845|NCT00075725|520400635|FG003|Overall Study|Insurance issues|1|||
144326846|NCT00075725|520400636|FG004|Overall Study|Insurance issues|1|||
144326847|NCT00075725|520400637|FG005|Overall Study|Insurance issues|1|||
144326848|NCT00075725|520400638|FG006|Overall Study|Insurance issues|0|||
144326849|NCT00075725|520400639|FG007|Overall Study|Insurance issues|1|||
144326850|NCT00075725|520400640|FG008|Overall Study|Insurance issues|0|||
144326851|NCT00075725|520400641|FG009|Overall Study|Insurance issues|0|||
144326852|NCT00075725|520400642|FG010|Overall Study|Insurance issues|0|||
144326853|NCT00075725|520400643|FG011|Overall Study|Insurance issues|0|||
144326854|NCT00075725|520400632|FG000|Overall Study|MRD positive after extended ind|0|||
144326855|NCT00075725|520400633|FG001|Overall Study|MRD positive after extended ind|1|||
144326856|NCT00075725|520400634|FG002|Overall Study|MRD positive after extended ind|1|||
144326857|NCT00075725|520400635|FG003|Overall Study|MRD positive after extended ind|0|||
144326858|NCT00075725|520400636|FG004|Overall Study|MRD positive after extended ind|1|||
144326859|NCT00075725|520400637|FG005|Overall Study|MRD positive after extended ind|2|||
144326860|NCT00075725|520400638|FG006|Overall Study|MRD positive after extended ind|0|||
144326861|NCT00075725|520400639|FG007|Overall Study|MRD positive after extended ind|1|||
144326862|NCT00075725|520400640|FG008|Overall Study|MRD positive after extended ind|0|||
144326863|NCT00075725|520400641|FG009|Overall Study|MRD positive after extended ind|0|||
144326864|NCT00075725|520400642|FG010|Overall Study|MRD positive after extended ind|0|||
144326865|NCT00075725|520400643|FG011|Overall Study|MRD positive after extended ind|0|||
144326866|NCT00075725|520400632|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
144326867|NCT00075725|520400633|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
144326868|NCT00075725|520400634|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
144326869|NCT00075725|520400635|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
144326870|NCT00075725|520400636|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
144326871|NCT00075725|520400637|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
144326872|NCT00075725|520400638|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
144326873|NCT00075725|520400639|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
144326874|NCT00075725|520400640|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
144326875|NCT00075725|520400641|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
144326876|NCT00075725|520400642|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
144326877|NCT00075725|520400643|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
144326878|NCT00075725|520400632|FG000|Overall Study|Inevaluable|1|||
144326879|NCT00075725|520400633|FG001|Overall Study|Inevaluable|1|||
144326880|NCT00075725|520400634|FG002|Overall Study|Inevaluable|4|||
144326881|NCT00075725|520400635|FG003|Overall Study|Inevaluable|2|||
144326882|NCT00075725|520400636|FG004|Overall Study|Inevaluable|2|||
144326883|NCT00075725|520400637|FG005|Overall Study|Inevaluable|9|||
144326884|NCT00075725|520400638|FG006|Overall Study|Inevaluable|1|||
144326885|NCT00075725|520400639|FG007|Overall Study|Inevaluable|11|||
144326886|NCT00075725|520400640|FG008|Overall Study|Inevaluable|2|||
144326887|NCT00075725|520400641|FG009|Overall Study|Inevaluable|0|||
144326888|NCT00075725|520400642|FG010|Overall Study|Inevaluable|1|||
144326889|NCT00075725|520400643|FG011|Overall Study|Inevaluable|0|||
144326890|NCT00075725|520400632|FG000|Overall Study|Other|4|||
144326891|NCT00075725|520400633|FG001|Overall Study|Other|2|||
144326892|NCT00075725|520400634|FG002|Overall Study|Other|1|||
144326893|NCT00075725|520400635|FG003|Overall Study|Other|1|||
144326894|NCT00075725|520400636|FG004|Overall Study|Other|1|||
144326895|NCT00075725|520400637|FG005|Overall Study|Other|4|||
144326896|NCT00075725|520400638|FG006|Overall Study|Other|2|||
144326897|NCT00075725|520400639|FG007|Overall Study|Other|9|||
144326898|NCT00075725|520400640|FG008|Overall Study|Other|2|||
144326899|NCT00075725|520400641|FG009|Overall Study|Other|1|||
144326900|NCT00075725|520400642|FG010|Overall Study|Other|0|||
144326901|NCT00075725|520400643|FG011|Overall Study|Other|3|||
144326902|NCT00075725|520400632|FG000|Overall Study|Pt trying to find a BM donor|0|||
144326903|NCT00075725|520400633|FG001|Overall Study|Pt trying to find a BM donor|1|||
144326904|NCT00075725|520400634|FG002|Overall Study|Pt trying to find a BM donor|0|||
144326905|NCT00075725|520400635|FG003|Overall Study|Pt trying to find a BM donor|0|||
144326906|NCT00075725|520400636|FG004|Overall Study|Pt trying to find a BM donor|0|||
144326907|NCT00075725|520400637|FG005|Overall Study|Pt trying to find a BM donor|0|||
144326908|NCT00075725|520400638|FG006|Overall Study|Pt trying to find a BM donor|0|||
144326909|NCT00075725|520400639|FG007|Overall Study|Pt trying to find a BM donor|0|||
144326910|NCT00075725|520400640|FG008|Overall Study|Pt trying to find a BM donor|0|||
144326911|NCT00075725|520400641|FG009|Overall Study|Pt trying to find a BM donor|0|||
144326912|NCT00075725|520400642|FG010|Overall Study|Pt trying to find a BM donor|0|||
144326913|NCT00075725|520400643|FG011|Overall Study|Pt trying to find a BM donor|0|||
144326914|NCT00075725|520400632|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
144326915|NCT00075725|520400633|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
144326916|NCT00075725|520400634|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
144326917|NCT00075725|520400635|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
144326918|NCT00075725|520400636|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
144326919|NCT00075725|520400637|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
144326920|NCT00075725|520400638|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
144326921|NCT00075725|520400639|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
144326922|NCT00075725|520400640|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
144326923|NCT00075725|520400641|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
144326924|NCT00075725|520400642|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
144326925|NCT00075725|520400643|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
144326926|NCT00075725|520400632|FG000|Overall Study|Unsuccessful institutional transfer|0|||
144326927|NCT00075725|520400633|FG001|Overall Study|Unsuccessful institutional transfer|0|||
144326928|NCT00075725|520400634|FG002|Overall Study|Unsuccessful institutional transfer|2|||
144326929|NCT00075725|520400635|FG003|Overall Study|Unsuccessful institutional transfer|0|||
144326930|NCT00075725|520400636|FG004|Overall Study|Unsuccessful institutional transfer|0|||
144326931|NCT00075725|520400637|FG005|Overall Study|Unsuccessful institutional transfer|0|||
144326932|NCT00075725|520400638|FG006|Overall Study|Unsuccessful institutional transfer|0|||
144326933|NCT00075725|520400639|FG007|Overall Study|Unsuccessful institutional transfer|0|||
144326934|NCT00075725|520400640|FG008|Overall Study|Unsuccessful institutional transfer|0|||
144326935|NCT00075725|520400641|FG009|Overall Study|Unsuccessful institutional transfer|1|||
144326936|NCT00075725|520400642|FG010|Overall Study|Unsuccessful institutional transfer|0|||
144326937|NCT00075725|520400643|FG011|Overall Study|Unsuccessful institutional transfer|0|||
144326938|NCT00075725|520400632|FG000|Overall Study|specimen(s) not submitted|0|||
144326939|NCT00075725|520400633|FG001|Overall Study|specimen(s) not submitted|0|||
144326940|NCT00075725|520400634|FG002|Overall Study|specimen(s) not submitted|2|||
144326941|NCT00075725|520400635|FG003|Overall Study|specimen(s) not submitted|0|||
144326942|NCT00075725|520400636|FG004|Overall Study|specimen(s) not submitted|0|||
144326943|NCT00075725|520400637|FG005|Overall Study|specimen(s) not submitted|0|||
144326944|NCT00075725|520400638|FG006|Overall Study|specimen(s) not submitted|0|||
144326945|NCT00075725|520400639|FG007|Overall Study|specimen(s) not submitted|0|||
144326946|NCT00075725|520400640|FG008|Overall Study|specimen(s) not submitted|0|||
144326947|NCT00075725|520400641|FG009|Overall Study|specimen(s) not submitted|0|||
144326948|NCT00075725|520400642|FG010|Overall Study|specimen(s) not submitted|0|||
144326949|NCT00075725|520400643|FG011|Overall Study|specimen(s) not submitted|0|||
144326950|NCT00075725|520400632|FG000|Overall Study|Pt went to transplant|0|||
144326951|NCT00075725|520400633|FG001|Overall Study|Pt went to transplant|0|||
144326952|NCT00075725|520400634|FG002|Overall Study|Pt went to transplant|0|||
144326953|NCT00075725|520400635|FG003|Overall Study|Pt went to transplant|1|||
144326954|NCT00075725|520400636|FG004|Overall Study|Pt went to transplant|0|||
144326955|NCT00075725|520400637|FG005|Overall Study|Pt went to transplant|1|||
144326956|NCT00075725|520400638|FG006|Overall Study|Pt went to transplant|0|||
144326957|NCT00075725|520400639|FG007|Overall Study|Pt went to transplant|0|||
144326958|NCT00075725|520400640|FG008|Overall Study|Pt went to transplant|0|||
144326959|NCT00075725|520400641|FG009|Overall Study|Pt went to transplant|0|||
144326960|NCT00075725|520400642|FG010|Overall Study|Pt went to transplant|0|||
144326961|NCT00075725|520400643|FG011|Overall Study|Pt went to transplant|0|||
144326962|NCT00075725|520400632|FG000|Overall Study|Pt received additional steroids|0|||
144326963|NCT00075725|520400633|FG001|Overall Study|Pt received additional steroids|0|||
144326964|NCT00075725|520400634|FG002|Overall Study|Pt received additional steroids|0|||
144326965|NCT00075725|520400635|FG003|Overall Study|Pt received additional steroids|1|||
144326966|NCT00075725|520400636|FG004|Overall Study|Pt received additional steroids|0|||
144326967|NCT00075725|520400637|FG005|Overall Study|Pt received additional steroids|0|||
144326968|NCT00075725|520400638|FG006|Overall Study|Pt received additional steroids|0|||
144326969|NCT00075725|520400639|FG007|Overall Study|Pt received additional steroids|0|||
144326970|NCT00075725|520400640|FG008|Overall Study|Pt received additional steroids|0|||
144326971|NCT00075725|520400641|FG009|Overall Study|Pt received additional steroids|0|||
144326972|NCT00075725|520400642|FG010|Overall Study|Pt received additional steroids|0|||
144326973|NCT00075725|520400643|FG011|Overall Study|Pt received additional steroids|0|||
144326974|NCT00075725|520400632|FG000|Overall Study|Pt relocated|0|||
144326975|NCT00075725|520400633|FG001|Overall Study|Pt relocated|0|||
144326976|NCT00075725|520400634|FG002|Overall Study|Pt relocated|0|||
144326977|NCT00075725|520400635|FG003|Overall Study|Pt relocated|2|||
144326978|NCT00075725|520400636|FG004|Overall Study|Pt relocated|0|||
144326979|NCT00075725|520400637|FG005|Overall Study|Pt relocated|1|||
144326980|NCT00075725|520400638|FG006|Overall Study|Pt relocated|1|||
144326981|NCT00075725|520400639|FG007|Overall Study|Pt relocated|2|||
144326982|NCT00075725|520400640|FG008|Overall Study|Pt relocated|1|||
144326983|NCT00075725|520400641|FG009|Overall Study|Pt relocated|0|||
144326984|NCT00075725|520400642|FG010|Overall Study|Pt relocated|0|||
144326985|NCT00075725|520400643|FG011|Overall Study|Pt relocated|0|||
144326986|NCT00075725|520400632|FG000|Overall Study|Institution Terminated|0|||
144326987|NCT00075725|520400633|FG001|Overall Study|Institution Terminated|0|||
144326988|NCT00075725|520400634|FG002|Overall Study|Institution Terminated|0|||
144326989|NCT00075725|520400635|FG003|Overall Study|Institution Terminated|0|||
144326990|NCT00075725|520400636|FG004|Overall Study|Institution Terminated|1|||
144326991|NCT00075725|520400637|FG005|Overall Study|Institution Terminated|0|||
144326992|NCT00075725|520400638|FG006|Overall Study|Institution Terminated|0|||
144326993|NCT00075725|520400639|FG007|Overall Study|Institution Terminated|3|||
144326994|NCT00075725|520400640|FG008|Overall Study|Institution Terminated|0|||
144326995|NCT00075725|520400641|FG009|Overall Study|Institution Terminated|0|||
144326996|NCT00075725|520400642|FG010|Overall Study|Institution Terminated|0|||
144326997|NCT00075725|520400643|FG011|Overall Study|Institution Terminated|0|||
144326998|NCT00075725|520400632|FG000|Overall Study|Study Closure|1|||
144326999|NCT00075725|520400633|FG001|Overall Study|Study Closure|0|||
144327000|NCT00075725|520400634|FG002|Overall Study|Study Closure|0|||
144327001|NCT00075725|520400635|FG003|Overall Study|Study Closure|0|||
144327002|NCT00075725|520400636|FG004|Overall Study|Study Closure|1|||
144327003|NCT00075725|520400637|FG005|Overall Study|Study Closure|3|||
144327004|NCT00075725|520400638|FG006|Overall Study|Study Closure|0|||
144327005|NCT00075725|520400639|FG007|Overall Study|Study Closure|1|||
144327006|NCT00075725|520400640|FG008|Overall Study|Study Closure|0|||
144327007|NCT00075725|520400641|FG009|Overall Study|Study Closure|0|||
144327008|NCT00075725|520400642|FG010|Overall Study|Study Closure|0|||
144327009|NCT00075725|520400643|FG011|Overall Study|Study Closure|0|||
144327010|NCT00075725|520400632|FG000|Overall Study|Other complications|0|||
144327011|NCT00075725|520400633|FG001|Overall Study|Other complications|0|||
144327012|NCT00075725|520400634|FG002|Overall Study|Other complications|0|||
144327013|NCT00075725|520400635|FG003|Overall Study|Other complications|0|||
144327014|NCT00075725|520400636|FG004|Overall Study|Other complications|0|||
144327015|NCT00075725|520400637|FG005|Overall Study|Other complications|1|||
144327016|NCT00075725|520400638|FG006|Overall Study|Other complications|0|||
144327017|NCT00075725|520400639|FG007|Overall Study|Other complications|0|||
144327018|NCT00075725|520400640|FG008|Overall Study|Other complications|0|||
144327019|NCT00075725|520400641|FG009|Overall Study|Other complications|0|||
144327020|NCT00075725|520400642|FG010|Overall Study|Other complications|0|||
144327021|NCT00075725|520400643|FG011|Overall Study|Other complications|0|||
144327022|NCT00075725|520400632|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
144327023|NCT00075725|520400633|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
144327024|NCT00075725|520400634|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
144327025|NCT00075725|520400635|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
144327026|NCT00075725|520400636|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
144327027|NCT00075725|520400637|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
144327028|NCT00075725|520400638|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
144327029|NCT00075725|520400639|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
144327030|NCT00075725|520400640|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
144327031|NCT00075725|520400641|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
144327032|NCT00075725|520400642|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
144327033|NCT00075725|520400643|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
144327034|NCT00075725|520400632|FG000|Overall Study|Pt incarcerated|0|||
144327035|NCT00075725|520400633|FG001|Overall Study|Pt incarcerated|0|||
144327036|NCT00075725|520400634|FG002|Overall Study|Pt incarcerated|0|||
144327037|NCT00075725|520400635|FG003|Overall Study|Pt incarcerated|0|||
144327038|NCT00075725|520400636|FG004|Overall Study|Pt incarcerated|0|||
144327039|NCT00075725|520400637|FG005|Overall Study|Pt incarcerated|0|||
144327040|NCT00075725|520400638|FG006|Overall Study|Pt incarcerated|0|||
144327041|NCT00075725|520400639|FG007|Overall Study|Pt incarcerated|1|||
144327042|NCT00075725|520400640|FG008|Overall Study|Pt incarcerated|0|||
144327043|NCT00075725|520400641|FG009|Overall Study|Pt incarcerated|0|||
144327044|NCT00075725|520400642|FG010|Overall Study|Pt incarcerated|0|||
144327045|NCT00075725|520400643|FG011|Overall Study|Pt incarcerated|0|||
144327046|NCT03242772|520400644|FG000|Overall Study|Lost to Follow-up|2|||
144327047|NCT03242772|520400645|FG001|Overall Study|Lost to Follow-up|0|||
144327048|NCT03242772|520400644|FG000|Overall Study|Physician Decision|0|||
144327049|NCT03242772|520400645|FG001|Overall Study|Physician Decision|1|||
144327050|NCT03242772|520400644|FG000|Overall Study|Withdrawal by Subject|1|||
144327051|NCT03242772|520400645|FG001|Overall Study|Withdrawal by Subject|0|||
144327052|NCT04065074|520400648|FG000|Overall Study|Adverse Event|1|||
144327053|NCT04065074|520400648|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
144327054|NCT02434354|520400649|FG000|Overall Study|screen fail|3|||
144327055|NCT04465877|520400650|FG000|Overall Study|Noncompliant with study requirements|0|||
144327056|NCT04465877|520400651|FG001|Overall Study|Noncompliant with study requirements|0|||
144327057|NCT04465877|520400652|FG002|Overall Study|Noncompliant with study requirements|1|||
144327058|NCT04465877|520400653|FG003|Overall Study|Noncompliant with study requirements|0|||
144327059|NCT03440918|520400659|FG000|Overall Study|Protocol Violation|0|||
144327060|NCT03440918|520400660|FG001|Overall Study|Protocol Violation|16|||
144327061|NCT03576755|520400661|FG000|Overall Study|Withdrawal by Subject|1|||
144327062|NCT03576755|520400662|FG001|Overall Study|Withdrawal by Subject|0|||
144327063|NCT03576755|520400663|FG002|Overall Study|Withdrawal by Subject|0|||
144327064|NCT03576755|520400664|FG003|Overall Study|Withdrawal by Subject|0|||
144327065|NCT03444766|520400667|FG000|Overall Study|Other Reasons|2|||
144327066|NCT03444766|520400667|FG000|Overall Study|Participant Withdrew Consent|5|||
144327067|NCT03444766|520400667|FG000|Overall Study|Lost to Follow-up|2|||
144327068|NCT03444766|520400667|FG000|Overall Study|Death|2|||
144327069|NCT03444766|520400667|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
144327070|NCT03444766|520400667|FG000|Overall Study|Disease Progression|49|||
144327071|NCT04346108|520400668|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
144327072|NCT04346108|520400669|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
144327073|NCT04346108|520400670|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
144327074|NCT04346108|520400668|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
144327075|NCT04346108|520400669|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
144327076|NCT04346108|520400670|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
144327077|NCT01598753|520400671|FG000|Overall Study|Adverse Event|1|||
144327078|NCT01598753|520400672|FG001|Overall Study|Adverse Event|9|||
144327079|NCT01598753|520400673|FG002|Overall Study|Adverse Event|1|||
144327080|NCT01598753|520400674|FG003|Overall Study|Adverse Event|7|||
144327081|NCT01598753|520400671|FG000|Overall Study|Lost to Follow-up|4|||
144327082|NCT01598753|520400672|FG001|Overall Study|Lost to Follow-up|3|||
144327083|NCT01598753|520400673|FG002|Overall Study|Lost to Follow-up|7|||
144327084|NCT01598753|520400674|FG003|Overall Study|Lost to Follow-up|5|||
144327085|NCT01598753|520400671|FG000|Overall Study|Physician Decision|0|||
144327086|NCT01598753|520400672|FG001|Overall Study|Physician Decision|1|||
144327087|NCT01598753|520400673|FG002|Overall Study|Physician Decision|0|||
144327088|NCT01598753|520400674|FG003|Overall Study|Physician Decision|2|||
144327089|NCT01598753|520400671|FG000|Overall Study|Withdrawal by Subject|7|||
144327090|NCT01598753|520400672|FG001|Overall Study|Withdrawal by Subject|2|||
144327091|NCT01598753|520400673|FG002|Overall Study|Withdrawal by Subject|0|||
144327092|NCT01598753|520400674|FG003|Overall Study|Withdrawal by Subject|1|||
144327093|NCT02275117|520400675|FG000|Overall Study|Adverse Event|0|||
144327094|NCT02275117|520400676|FG001|Overall Study|Adverse Event|0|||
144327095|NCT02275117|520400677|FG002|Overall Study|Adverse Event|0|||
144327096|NCT02275117|520400678|FG003|Overall Study|Adverse Event|0|||
144327097|NCT02275117|520400679|FG004|Overall Study|Adverse Event|1|||
144327098|NCT02275117|520400675|FG000|Overall Study|Lack of Efficacy|6|||
144327099|NCT02275117|520400676|FG001|Overall Study|Lack of Efficacy|7|||
144327100|NCT02275117|520400677|FG002|Overall Study|Lack of Efficacy|5|||
144327101|NCT02275117|520400678|FG003|Overall Study|Lack of Efficacy|2|||
144327102|NCT02275117|520400679|FG004|Overall Study|Lack of Efficacy|10|||
144327103|NCT02275117|520400675|FG000|Overall Study|Lost to Follow-up|11|||
144327104|NCT02275117|520400676|FG001|Overall Study|Lost to Follow-up|16|||
144327105|NCT02275117|520400677|FG002|Overall Study|Lost to Follow-up|15|||
144327106|NCT02275117|520400678|FG003|Overall Study|Lost to Follow-up|16|||
144327107|NCT02275117|520400679|FG004|Overall Study|Lost to Follow-up|8|||
144327108|NCT02275117|520400675|FG000|Overall Study|Physician Decision|0|||
144327109|NCT02275117|520400676|FG001|Overall Study|Physician Decision|1|||
144327110|NCT02275117|520400677|FG002|Overall Study|Physician Decision|1|||
144327111|NCT02275117|520400678|FG003|Overall Study|Physician Decision|0|||
144327112|NCT02275117|520400679|FG004|Overall Study|Physician Decision|1|||
144327113|NCT02275117|520400675|FG000|Overall Study|Protocol Violation|1|||
144327114|NCT02275117|520400676|FG001|Overall Study|Protocol Violation|0|||
144327115|NCT02275117|520400677|FG002|Overall Study|Protocol Violation|1|||
144327116|NCT02275117|520400678|FG003|Overall Study|Protocol Violation|1|||
144327117|NCT02275117|520400679|FG004|Overall Study|Protocol Violation|0|||
144327118|NCT02275117|520400675|FG000|Overall Study|Withdrawal by Subject|6|||
144327119|NCT02275117|520400676|FG001|Overall Study|Withdrawal by Subject|4|||
144327120|NCT02275117|520400677|FG002|Overall Study|Withdrawal by Subject|7|||
144327121|NCT02275117|520400678|FG003|Overall Study|Withdrawal by Subject|3|||
144327122|NCT02275117|520400679|FG004|Overall Study|Withdrawal by Subject|3|||
144327123|NCT02275117|520400675|FG000|Overall Study|Terminated by Sponsor|4|||
144327124|NCT02275117|520400676|FG001|Overall Study|Terminated by Sponsor|4|||
144327125|NCT02275117|520400677|FG002|Overall Study|Terminated by Sponsor|4|||
144327126|NCT02275117|520400678|FG003|Overall Study|Terminated by Sponsor|6|||
144327127|NCT02275117|520400679|FG004|Overall Study|Terminated by Sponsor|4|||
144327128|NCT02275117|520400675|FG000|Overall Study|Worsening of Study Indication|0|||
144327129|NCT02275117|520400676|FG001|Overall Study|Worsening of Study Indication|1|||
144327130|NCT02275117|520400677|FG002|Overall Study|Worsening of Study Indication|2|||
144327131|NCT02275117|520400678|FG003|Overall Study|Worsening of Study Indication|0|||
144327132|NCT02275117|520400679|FG004|Overall Study|Worsening of Study Indication|0|||
144327133|NCT02275117|520400675|FG000|Overall Study|Study Burden|5|||
144327134|NCT02275117|520400676|FG001|Overall Study|Study Burden|4|||
144327135|NCT02275117|520400677|FG002|Overall Study|Study Burden|7|||
144327136|NCT02275117|520400678|FG003|Overall Study|Study Burden|5|||
144327137|NCT02275117|520400679|FG004|Overall Study|Study Burden|7|||
144327138|NCT02275117|520400675|FG000|Overall Study|Other|1|||
144327139|NCT02275117|520400676|FG001|Overall Study|Other|0|||
144327140|NCT02275117|520400677|FG002|Overall Study|Other|0|||
144327141|NCT02275117|520400678|FG003|Overall Study|Other|0|||
144327142|NCT02275117|520400679|FG004|Overall Study|Other|2|||
144327143|NCT01081301|520400680|FG000|Overall Study|Bereaved|3|||
144327144|NCT01081301|520400680|FG000|Overall Study|Too busy|5|||
144327145|NCT01081301|520400680|FG000|Overall Study|Patient too ill|2|||
144327146|NCT01081301|520400680|FG000|Overall Study|Lost to Follow-up|4|||
144327147|NCT00724854|520400681|FG000|Overall Study|Lack of Efficacy|187|||
144327148|NCT00724854|520400682|FG001|Overall Study|Lack of Efficacy|13|||
144327149|NCT00724854|520400681|FG000|Overall Study|Lost to Follow-up|87|||
144327150|NCT00724854|520400682|FG001|Overall Study|Lost to Follow-up|10|||
144327151|NCT00724854|520400681|FG000|Overall Study|Adverse Event|62|||
144327152|NCT00724854|520400682|FG001|Overall Study|Adverse Event|4|||
144327153|NCT00724854|520400681|FG000|Overall Study|Other|42|||
144327154|NCT00724854|520400682|FG001|Overall Study|Other|3|||
144327155|NCT00724854|520400681|FG000|Overall Study|Death|11|||
144327156|NCT00724854|520400682|FG001|Overall Study|Death|0|||
144327157|NCT00724854|520400681|FG000|Overall Study|Change of treatment|7|||
144327158|NCT00724854|520400682|FG001|Overall Study|Change of treatment|0|||
144327159|NCT00724854|520400681|FG000|Overall Study|Withdrawal by Subject|5|||
144327160|NCT00724854|520400682|FG001|Overall Study|Withdrawal by Subject|0|||
144327161|NCT00724854|520400681|FG000|Overall Study|Adverse event + lack of efficacy|2|||
144327162|NCT00724854|520400682|FG001|Overall Study|Adverse event + lack of efficacy|1|||
144327163|NCT01865812|520400683|FG000|Primary Treatment Phase|Adverse Event|2|||
144327164|NCT01865812|520400684|FG001|Primary Treatment Phase|Adverse Event|0|||
144327165|NCT01865812|520400683|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
144327166|NCT01865812|520400684|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
144327167|NCT01865812|520400683|FG000|Long-term Safety Extension Phase|Pruritus|0|||
144327168|NCT01865812|520400684|FG001|Long-term Safety Extension Phase|Pruritus|3|||
144327169|NCT01865812|520400683|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
144327170|NCT01865812|520400684|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
144327171|NCT01865812|520400683|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
144327172|NCT01865812|520400684|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
144327173|NCT01095653|520400685|FG000|Overall Study|Lack of Efficacy|3|||
144327174|NCT01095653|520400686|FG001|Overall Study|Lack of Efficacy|0|||
144327175|NCT01095653|520400687|FG002|Overall Study|Lack of Efficacy|0|||
144327176|NCT01095653|520400685|FG000|Overall Study|Adverse Event|1|||
144327177|NCT01095653|520400686|FG001|Overall Study|Adverse Event|4|||
144327178|NCT01095653|520400687|FG002|Overall Study|Adverse Event|4|||
144327179|NCT01095653|520400685|FG000|Overall Study|Lost to Follow-up|1|||
144327180|NCT01095653|520400686|FG001|Overall Study|Lost to Follow-up|0|||
144327181|NCT01095653|520400687|FG002|Overall Study|Lost to Follow-up|4|||
144327182|NCT01095653|520400685|FG000|Overall Study|Withdrawal by Subject|4|||
144327183|NCT01095653|520400686|FG001|Overall Study|Withdrawal by Subject|5|||
144327184|NCT01095653|520400687|FG002|Overall Study|Withdrawal by Subject|3|||
144327185|NCT01095653|520400685|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
144327186|NCT01095653|520400686|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
144327187|NCT01095653|520400687|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
144327188|NCT02046226|520400688|FG000|Overall Study|Lost to Follow-up|7|||
144327189|NCT00171925|520400689|FG000|Overall Study|Adverse Event|10|||
144327190|NCT00171925|520400690|FG001|Overall Study|Adverse Event|6|||
144327191|NCT00171925|520400689|FG000|Overall Study|Protocol Violation|1|||
144327192|NCT00171925|520400690|FG001|Overall Study|Protocol Violation|1|||
144327193|NCT00171925|520400689|FG000|Overall Study|Withdrawal by Subject|6|||
144327194|NCT00171925|520400690|FG001|Overall Study|Withdrawal by Subject|9|||
144327195|NCT00171925|520400689|FG000|Overall Study|Lost to Follow-up|2|||
144327196|NCT00171925|520400690|FG001|Overall Study|Lost to Follow-up|2|||
144327197|NCT00171925|520400689|FG000|Overall Study|Administrative problems|10|||
144327198|NCT00171925|520400690|FG001|Overall Study|Administrative problems|11|||
144327199|NCT00171925|520400689|FG000|Overall Study|Death|1|||
144327200|NCT00171925|520400690|FG001|Overall Study|Death|2|||
144327201|NCT02142283|520400693|FG000|Overall Study|Death|20|||
144327202|NCT02142283|520400694|FG001|Overall Study|Death|18|||
144327203|NCT02142283|520400693|FG000|Overall Study|Withdrawal by Subject|1|||
144327204|NCT02142283|520400694|FG001|Overall Study|Withdrawal by Subject|3|||
144327205|NCT00747344|520400697|FG000|Controlled Period|Adverse Event|3|||
144327206|NCT00747344|520400698|FG001|Controlled Period|Adverse Event|0|||
144327207|NCT00747344|520400699|FG002|Controlled Period|Adverse Event|0|||
144327208|NCT00747344|520400700|FG003|Controlled Period|Adverse Event|0|||
144327209|NCT00747344|520400697|FG000|Controlled Period|Lack of Efficacy|2|||
144327210|NCT00747344|520400698|FG001|Controlled Period|Lack of Efficacy|1|||
144327211|NCT00747344|520400699|FG002|Controlled Period|Lack of Efficacy|0|||
144327212|NCT00747344|520400700|FG003|Controlled Period|Lack of Efficacy|0|||
144327213|NCT00747344|520400697|FG000|Controlled Period|Other|0|||
144327214|NCT00747344|520400698|FG001|Controlled Period|Other|3|||
144327215|NCT00747344|520400699|FG002|Controlled Period|Other|0|||
144327216|NCT00747344|520400700|FG003|Controlled Period|Other|0|||
144327217|NCT00747344|520400697|FG000|After Controlled Period|Adverse Event|0|||
144327218|NCT00747344|520400698|FG001|After Controlled Period|Adverse Event|0|||
144327219|NCT00747344|520400699|FG002|After Controlled Period|Adverse Event|0|||
144327220|NCT00747344|520400700|FG003|After Controlled Period|Adverse Event|1|||
144327221|NCT02374814|520400701|FG000|Overall Study|Lost to Follow-up|1|||
144327222|NCT02374814|520400702|FG001|Overall Study|Lost to Follow-up|1|||
144327223|NCT02374814|520400703|FG002|Overall Study|Lost to Follow-up|0|||
144327224|NCT02374814|520400704|FG003|Overall Study|Lost to Follow-up|1|||
144327225|NCT02374814|520400705|FG004|Overall Study|Lost to Follow-up|0|||
144327226|NCT02374814|520400706|FG005|Overall Study|Lost to Follow-up|0|||
144327227|NCT02374814|520400701|FG000|Overall Study|Withdrawal by Subject|0|||
144327228|NCT02374814|520400702|FG001|Overall Study|Withdrawal by Subject|0|||
144327229|NCT02374814|520400703|FG002|Overall Study|Withdrawal by Subject|1|||
144327230|NCT02374814|520400704|FG003|Overall Study|Withdrawal by Subject|1|||
144327231|NCT02374814|520400705|FG004|Overall Study|Withdrawal by Subject|0|||
144327232|NCT02374814|520400706|FG005|Overall Study|Withdrawal by Subject|0|||
144327233|NCT03754582|520400709|FG000|Treatment Phase|Adverse Event|0|||
144327234|NCT03754582|520400710|FG001|Treatment Phase|Adverse Event|1|||
144327235|NCT03754582|520400711|FG002|Treatment Phase|Adverse Event|0|||
144327236|NCT03754582|520400709|FG000|Follow-up Phase|Other|0|||
144327237|NCT03754582|520400710|FG001|Follow-up Phase|Other|0|||
144327238|NCT03754582|520400711|FG002|Follow-up Phase|Other|1|||
144327239|NCT01799239|520400712|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
144327240|NCT01799239|520400713|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
144327241|NCT01799239|520400712|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
144327242|NCT01799239|520400713|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
144327243|NCT01799239|520400712|FG000|Period 1 (7 Days)|Protocol Violation|0|||
144327244|NCT01799239|520400713|FG001|Period 1 (7 Days)|Protocol Violation|1|||
144327245|NCT01799239|520400712|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
144327246|NCT01799239|520400713|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
144327247|NCT01799239|520400712|FG000|Period 2 (7 Days)|Protocol Violation|1|||
144327248|NCT01799239|520400713|FG001|Period 2 (7 Days)|Protocol Violation|0|||
144327249|NCT01561755|520400714|FG000|Overall Study|Lost to Follow-up|0|||
144327250|NCT01561755|520400715|FG001|Overall Study|Lost to Follow-up|1|||
144327251|NCT01166958|520400716|FG000|Overall Study|Withdrawal by Subject|1|||
144327252|NCT01166958|520400717|FG001|Overall Study|Withdrawal by Subject|0|||
144327253|NCT02680574|520400718|FG000|Overall Study|Death|137|||
144327254|NCT02680574|520400719|FG001|Overall Study|Death|137|||
144327255|NCT02680574|520400718|FG000|Overall Study|Withdrawal by Subject|17|||
144327256|NCT02680574|520400719|FG001|Overall Study|Withdrawal by Subject|9|||
144327257|NCT02680574|520400718|FG000|Overall Study|Lost to Follow-up|4|||
144327258|NCT02680574|520400719|FG001|Overall Study|Lost to Follow-up|6|||
144327259|NCT01286987|520400721|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
144327260|NCT01286987|520400722|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
144327261|NCT01286987|520400723|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
144327262|NCT01286987|520400724|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
144327263|NCT01286987|520400725|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
144327264|NCT01286987|520400726|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
144327265|NCT01286987|520400727|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
144327266|NCT01286987|520400728|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
144327267|NCT01286987|520400729|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
144327268|NCT01286987|520400730|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
144327269|NCT01286987|520400731|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
144327270|NCT01286987|520400732|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
144327271|NCT01286987|520400733|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
144327272|NCT01286987|520400734|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
144327273|NCT01286987|520400735|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
144327274|NCT01286987|520400721|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
144327275|NCT01286987|520400722|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
144327276|NCT01286987|520400723|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
144327277|NCT01286987|520400724|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
144327278|NCT01286987|520400725|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
144327279|NCT01286987|520400726|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
144327280|NCT01286987|520400727|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
144327281|NCT01286987|520400728|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
144327282|NCT01286987|520400729|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
144327283|NCT01286987|520400730|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
144327284|NCT01286987|520400731|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
144327285|NCT01286987|520400732|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
144327286|NCT01286987|520400733|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
144327287|NCT01286987|520400734|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
144327288|NCT01286987|520400735|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
144327289|NCT01286987|520400721|FG000|Part 1: Dose Escalation|Physician Decision|0|||
144327290|NCT01286987|520400722|FG001|Part 1: Dose Escalation|Physician Decision|0|||
144327291|NCT01286987|520400723|FG002|Part 1: Dose Escalation|Physician Decision|0|||
144327292|NCT01286987|520400724|FG003|Part 1: Dose Escalation|Physician Decision|0|||
144327293|NCT01286987|520400725|FG004|Part 1: Dose Escalation|Physician Decision|1|||
144327294|NCT01286987|520400726|FG005|Part 1: Dose Escalation|Physician Decision|0|||
144327295|NCT01286987|520400727|FG006|Part 1: Dose Escalation|Physician Decision|0|||
144327296|NCT01286987|520400728|FG007|Part 1: Dose Escalation|Physician Decision|0|||
144327297|NCT01286987|520400729|FG008|Part 1: Dose Escalation|Physician Decision|0|||
144327298|NCT01286987|520400730|FG009|Part 1: Dose Escalation|Physician Decision|0|||
144327299|NCT01286987|520400731|FG010|Part 1: Dose Escalation|Physician Decision|0|||
144327300|NCT01286987|520400732|FG011|Part 1: Dose Escalation|Physician Decision|0|||
144327301|NCT01286987|520400733|FG012|Part 1: Dose Escalation|Physician Decision|0|||
144327302|NCT01286987|520400734|FG013|Part 1: Dose Escalation|Physician Decision|0|||
144327303|NCT01286987|520400735|FG014|Part 1: Dose Escalation|Physician Decision|0|||
144327304|NCT01286987|520400721|FG000|Part 2: Dose Expansion|Death|0|||
144327305|NCT01286987|520400722|FG001|Part 2: Dose Expansion|Death|0|||
144327306|NCT01286987|520400723|FG002|Part 2: Dose Expansion|Death|0|||
144327307|NCT01286987|520400724|FG003|Part 2: Dose Expansion|Death|0|||
144327308|NCT01286987|520400725|FG004|Part 2: Dose Expansion|Death|0|||
144327309|NCT01286987|520400726|FG005|Part 2: Dose Expansion|Death|0|||
144327310|NCT01286987|520400727|FG006|Part 2: Dose Expansion|Death|0|||
144327311|NCT01286987|520400728|FG007|Part 2: Dose Expansion|Death|0|||
144327312|NCT01286987|520400729|FG008|Part 2: Dose Expansion|Death|0|||
144327313|NCT01286987|520400730|FG009|Part 2: Dose Expansion|Death|0|||
144327314|NCT01286987|520400731|FG010|Part 2: Dose Expansion|Death|0|||
144327315|NCT01286987|520400732|FG011|Part 2: Dose Expansion|Death|0|||
144327316|NCT01286987|520400733|FG012|Part 2: Dose Expansion|Death|1|||
144327317|NCT01286987|520400734|FG013|Part 2: Dose Expansion|Death|1|||
144327318|NCT01286987|520400735|FG014|Part 2: Dose Expansion|Death|0|||
144327319|NCT01286987|520400721|FG000|Part 2: Dose Expansion|Physician Decision|0|||
144327320|NCT01286987|520400722|FG001|Part 2: Dose Expansion|Physician Decision|0|||
144327321|NCT01286987|520400723|FG002|Part 2: Dose Expansion|Physician Decision|0|||
144327322|NCT01286987|520400724|FG003|Part 2: Dose Expansion|Physician Decision|0|||
144327323|NCT01286987|520400725|FG004|Part 2: Dose Expansion|Physician Decision|0|||
144327324|NCT01286987|520400726|FG005|Part 2: Dose Expansion|Physician Decision|0|||
144327325|NCT01286987|520400727|FG006|Part 2: Dose Expansion|Physician Decision|0|||
144327326|NCT01286987|520400728|FG007|Part 2: Dose Expansion|Physician Decision|0|||
144327327|NCT01286987|520400729|FG008|Part 2: Dose Expansion|Physician Decision|0|||
144327328|NCT01286987|520400730|FG009|Part 2: Dose Expansion|Physician Decision|0|||
144327329|NCT01286987|520400731|FG010|Part 2: Dose Expansion|Physician Decision|1|||
144327330|NCT01286987|520400732|FG011|Part 2: Dose Expansion|Physician Decision|1|||
144327331|NCT01286987|520400733|FG012|Part 2: Dose Expansion|Physician Decision|0|||
144327332|NCT01286987|520400734|FG013|Part 2: Dose Expansion|Physician Decision|1|||
144327333|NCT01286987|520400735|FG014|Part 2: Dose Expansion|Physician Decision|0|||
144327334|NCT01286987|520400721|FG000|Part 2: Dose Expansion|Other|0|||
144327335|NCT01286987|520400722|FG001|Part 2: Dose Expansion|Other|0|||
144327336|NCT01286987|520400723|FG002|Part 2: Dose Expansion|Other|0|||
144327337|NCT01286987|520400724|FG003|Part 2: Dose Expansion|Other|0|||
144327338|NCT01286987|520400725|FG004|Part 2: Dose Expansion|Other|0|||
144327339|NCT01286987|520400726|FG005|Part 2: Dose Expansion|Other|0|||
144327340|NCT01286987|520400727|FG006|Part 2: Dose Expansion|Other|0|||
144327341|NCT01286987|520400728|FG007|Part 2: Dose Expansion|Other|0|||
144327342|NCT01286987|520400729|FG008|Part 2: Dose Expansion|Other|0|||
144327343|NCT01286987|520400730|FG009|Part 2: Dose Expansion|Other|0|||
144327344|NCT01286987|520400731|FG010|Part 2: Dose Expansion|Other|0|||
144327345|NCT01286987|520400732|FG011|Part 2: Dose Expansion|Other|0|||
144327346|NCT01286987|520400733|FG012|Part 2: Dose Expansion|Other|0|||
144327347|NCT01286987|520400734|FG013|Part 2: Dose Expansion|Other|1|||
144327348|NCT01286987|520400735|FG014|Part 2: Dose Expansion|Other|0|||
144327349|NCT01286987|520400721|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
144327350|NCT01286987|520400722|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
144327351|NCT01286987|520400723|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
144327352|NCT01286987|520400724|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
144327353|NCT01286987|520400725|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
144327354|NCT01286987|520400726|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
144327355|NCT01286987|520400727|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
144327356|NCT01286987|520400728|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
144327357|NCT01286987|520400729|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
144327358|NCT01286987|520400730|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
144327359|NCT01286987|520400731|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
144327360|NCT01286987|520400732|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
144327361|NCT01286987|520400733|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
144327362|NCT01286987|520400734|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
144327363|NCT01286987|520400735|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
144327364|NCT01286987|520400721|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
144327365|NCT01286987|520400722|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
144327366|NCT01286987|520400723|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
144327367|NCT01286987|520400724|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
144327368|NCT01286987|520400725|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
144327369|NCT01286987|520400726|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
144327370|NCT01286987|520400727|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
144327371|NCT01286987|520400728|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
144327372|NCT01286987|520400729|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
144327373|NCT01286987|520400730|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
144327374|NCT01286987|520400731|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
144327375|NCT01286987|520400732|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
144327376|NCT01286987|520400733|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
144327377|NCT01286987|520400734|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
144327378|NCT01286987|520400735|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
144327379|NCT01286987|520400721|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327380|NCT01286987|520400722|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327381|NCT01286987|520400723|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327382|NCT01286987|520400724|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327383|NCT01286987|520400725|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327384|NCT01286987|520400726|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327385|NCT01286987|520400727|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327386|NCT01286987|520400728|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327387|NCT01286987|520400729|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327388|NCT01286987|520400730|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327389|NCT01286987|520400731|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
144327390|NCT01286987|520400732|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327391|NCT01286987|520400733|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327392|NCT01286987|520400734|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327393|NCT01286987|520400735|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
144327394|NCT00392808|520400736|FG000|Overall Study|Lost to Follow-up|3|||
144327395|NCT00392808|520400737|FG001|Overall Study|Lost to Follow-up|2|||
144327396|NCT00392808|520400738|FG002|Overall Study|Lost to Follow-up|1|||
144327397|NCT00392808|520400739|FG003|Overall Study|Lost to Follow-up|2|||
144327398|NCT00392808|520400736|FG000|Overall Study|Unable to withdraw blood|3|||
144327399|NCT00392808|520400737|FG001|Overall Study|Unable to withdraw blood|1|||
144327400|NCT00392808|520400738|FG002|Overall Study|Unable to withdraw blood|1|||
144327401|NCT00392808|520400739|FG003|Overall Study|Unable to withdraw blood|2|||
144327402|NCT02649855|520400740|FG000|Overall Study|Refused further treatment|2|||
144327403|NCT02649855|520400741|FG001|Overall Study|Refused further treatment|1|||
144327404|NCT02649855|520400742|FG002|Overall Study|Refused further treatment|1|||
144327405|NCT02649855|520400740|FG000|Overall Study|Withdrew consent|0|||
144327406|NCT02649855|520400741|FG001|Overall Study|Withdrew consent|1|||
144327407|NCT02649855|520400742|FG002|Overall Study|Withdrew consent|0|||
144327408|NCT02649855|520400740|FG000|Overall Study|Switched to alternative treatment|0|||
144327409|NCT02649855|520400741|FG001|Overall Study|Switched to alternative treatment|1|||
144327410|NCT02649855|520400742|FG002|Overall Study|Switched to alternative treatment|1|||
144327411|NCT02649855|520400740|FG000|Overall Study|Principal investigator discretion|0|||
144327412|NCT02649855|520400741|FG001|Overall Study|Principal investigator discretion|1|||
144327413|NCT02649855|520400742|FG002|Overall Study|Principal investigator discretion|1|||
144327414|NCT02649855|520400740|FG000|Overall Study|No treatment, per protocol|1|||
144327415|NCT02649855|520400741|FG001|Overall Study|No treatment, per protocol|0|||
144327416|NCT02649855|520400742|FG002|Overall Study|No treatment, per protocol|0|||
144327417|NCT02649855|520400740|FG000|Overall Study|Initiate new treatment|1|||
144327418|NCT02649855|520400741|FG001|Overall Study|Initiate new treatment|0|||
144327419|NCT02649855|520400742|FG002|Overall Study|Initiate new treatment|0|||
144327420|NCT01300819|520400743|FG000|Overall Study|Adverse Event|9|||
144327421|NCT01300819|520400744|FG001|Overall Study|Adverse Event|27|||
144327422|NCT01300819|520400743|FG000|Overall Study|Lack of Efficacy|2|||
144327423|NCT01300819|520400744|FG001|Overall Study|Lack of Efficacy|1|||
144327424|NCT01300819|520400743|FG000|Overall Study|Withdrawal by Subject|10|||
144327425|NCT01300819|520400744|FG001|Overall Study|Withdrawal by Subject|12|||
144327426|NCT01300819|520400743|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
144327427|NCT01300819|520400744|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
144327428|NCT01300819|520400743|FG000|Overall Study|Refusal to down titrate study drug|0|||
144327429|NCT01300819|520400744|FG001|Overall Study|Refusal to down titrate study drug|1|||
144327430|NCT01300819|520400743|FG000|Overall Study|Administrative reason|0|||
144327431|NCT01300819|520400744|FG001|Overall Study|Administrative reason|1|||
144327432|NCT01300819|520400743|FG000|Overall Study|Safety follow up not done by mistake|0|||
144327433|NCT01300819|520400744|FG001|Overall Study|Safety follow up not done by mistake|1|||
144327434|NCT01300819|520400743|FG000|Overall Study|Follow up call was not done|1|||
144327435|NCT01300819|520400744|FG001|Overall Study|Follow up call was not done|0|||
144327436|NCT02818036|520400745|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
144327437|NCT02818036|520400746|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
144327438|NCT02818036|520400745|FG000|Overall Study|Withdrawal by Subject|1|||
144327439|NCT02818036|520400746|FG001|Overall Study|Withdrawal by Subject|0|||
144327440|NCT01319721|520400752|FG000|Overall Study|Lost to Follow-up|1|||
144327441|NCT01319721|520400753|FG001|Overall Study|Lost to Follow-up|6|||
144327442|NCT00461305|520400757|FG000|Treatment|Adverse Event|26|||
144327443|NCT00461305|520400758|FG001|Treatment|Adverse Event|3|||
144327444|NCT00461305|520400757|FG000|Treatment|Lost to Follow-up|4|||
144327445|NCT00461305|520400758|FG001|Treatment|Lost to Follow-up|2|||
144327446|NCT00461305|520400757|FG000|Treatment|Protocol Violation|13|||
144327447|NCT00461305|520400758|FG001|Treatment|Protocol Violation|2|||
144327448|NCT00461305|520400757|FG000|Treatment|Withdrawal by Subject|48|||
144327449|NCT00461305|520400758|FG001|Treatment|Withdrawal by Subject|2|||
144327450|NCT00461305|520400757|FG000|Treatment|Never dispensed|5|||
144327451|NCT00461305|520400758|FG001|Treatment|Never dispensed|0|||
144327452|NCT00461305|520400757|FG000|Treatment|Study drug not taken|1|||
144327453|NCT00461305|520400758|FG001|Treatment|Study drug not taken|0|||
144327454|NCT00461305|520400757|FG000|Treatment|Partially missing diary|2|||
144327455|NCT00461305|520400758|FG001|Treatment|Partially missing diary|0|||
144327456|NCT00461305|520400757|FG000|Treatment|Other (missing drug etc)|2|||
144327457|NCT00461305|520400758|FG001|Treatment|Other (missing drug etc)|0|||
144327458|NCT00461305|520400757|FG000|Continued Treatment|Adverse Event|26|||
144327459|NCT00461305|520400758|FG001|Continued Treatment|Adverse Event|0|||
144327460|NCT00461305|520400757|FG000|Continued Treatment|Lost to Follow-up|4|||
144327461|NCT00461305|520400758|FG001|Continued Treatment|Lost to Follow-up|0|||
144327462|NCT00461305|520400757|FG000|Continued Treatment|Protocol Violation|13|||
144327463|NCT00461305|520400758|FG001|Continued Treatment|Protocol Violation|0|||
144327464|NCT00461305|520400757|FG000|Continued Treatment|Withdrawal by Subject|48|||
144327465|NCT00461305|520400758|FG001|Continued Treatment|Withdrawal by Subject|0|||
144327466|NCT00461305|520400757|FG000|Continued Treatment|Partially missing diary|2|||
144327467|NCT00461305|520400758|FG001|Continued Treatment|Partially missing diary|0|||
144327468|NCT00461305|520400757|FG000|Continued Treatment|Other (missing drug etc)|2|||
144327469|NCT00461305|520400758|FG001|Continued Treatment|Other (missing drug etc)|0|||
144327470|NCT01007123|520403503|FG000|Overall Study|Adverse Event|3|||
144327471|NCT01007123|520403504|FG001|Overall Study|Adverse Event|4|||
144327472|NCT01007123|520403505|FG002|Overall Study|Adverse Event|7|||
144327473|NCT01007123|520403506|FG003|Overall Study|Adverse Event|1|||
144327474|NCT01007123|520403503|FG000|Overall Study|Lack of Efficacy|1|||
144327475|NCT01007123|520403504|FG001|Overall Study|Lack of Efficacy|0|||
144327476|NCT01007123|520403505|FG002|Overall Study|Lack of Efficacy|1|||
144327477|NCT01007123|520403506|FG003|Overall Study|Lack of Efficacy|4|||
144327478|NCT01007123|520403503|FG000|Overall Study|Protocol Violation|1|||
144327479|NCT01007123|520403504|FG001|Overall Study|Protocol Violation|1|||
144327480|NCT01007123|520403505|FG002|Overall Study|Protocol Violation|2|||
144327481|NCT01007123|520403506|FG003|Overall Study|Protocol Violation|1|||
144327482|NCT01007123|520403503|FG000|Overall Study|Withdrawal by Subject|1|||
144327483|NCT01007123|520403504|FG001|Overall Study|Withdrawal by Subject|0|||
144327484|NCT01007123|520403505|FG002|Overall Study|Withdrawal by Subject|1|||
144327485|NCT01007123|520403506|FG003|Overall Study|Withdrawal by Subject|0|||
144327486|NCT01007123|520403503|FG000|Overall Study|Lost to Follow-up|0|||
144327487|NCT01007123|520403504|FG001|Overall Study|Lost to Follow-up|1|||
144327488|NCT01007123|520403505|FG002|Overall Study|Lost to Follow-up|0|||
144327489|NCT01007123|520403506|FG003|Overall Study|Lost to Follow-up|0|||
144327490|NCT02838901|520403507|FG000|Overall Study|Withdrawal by Subject|1|||
144327491|NCT02838901|520403508|FG001|Overall Study|Withdrawal by Subject|1|||
144327492|NCT02838901|520403507|FG000|Overall Study|Lost to Follow-up|1|||
144327493|NCT02838901|520403508|FG001|Overall Study|Lost to Follow-up|1|||
144327494|NCT00320255|520403509|FG000|Overall Study|Lack of Efficacy|1|||
144327495|NCT00320255|520403510|FG001|Overall Study|Lack of Efficacy|0|||
144327496|NCT00320255|520403511|FG002|Overall Study|Lack of Efficacy|0|||
144327497|NCT00320255|520403512|FG003|Overall Study|Lack of Efficacy|0|||
144327498|NCT00320255|520403513|FG004|Overall Study|Lack of Efficacy|0|||
144327499|NCT00320255|520403514|FG005|Overall Study|Lack of Efficacy|0|||
144327500|NCT00320255|520403509|FG000|Overall Study|Adverse Event|5|||
144327501|NCT00320255|520403510|FG001|Overall Study|Adverse Event|2|||
144327502|NCT00320255|520403511|FG002|Overall Study|Adverse Event|3|||
144327503|NCT00320255|520403512|FG003|Overall Study|Adverse Event|2|||
144327504|NCT00320255|520403513|FG004|Overall Study|Adverse Event|0|||
144327505|NCT00320255|520403514|FG005|Overall Study|Adverse Event|0|||
144327506|NCT00320255|520403509|FG000|Overall Study|Withdrawal by Subject|1|||
144327507|NCT00320255|520403510|FG001|Overall Study|Withdrawal by Subject|2|||
144327508|NCT00320255|520403511|FG002|Overall Study|Withdrawal by Subject|2|||
144327509|NCT00320255|520403512|FG003|Overall Study|Withdrawal by Subject|4|||
144327510|NCT00320255|520403513|FG004|Overall Study|Withdrawal by Subject|0|||
144327511|NCT00320255|520403514|FG005|Overall Study|Withdrawal by Subject|0|||
144327512|NCT00320255|520403509|FG000|Overall Study|Poor compliance/noncompliance|1|||
144327513|NCT00320255|520403510|FG001|Overall Study|Poor compliance/noncompliance|1|||
144327514|NCT00320255|520403511|FG002|Overall Study|Poor compliance/noncompliance|0|||
144327515|NCT00320255|520403512|FG003|Overall Study|Poor compliance/noncompliance|1|||
144327516|NCT00320255|520403513|FG004|Overall Study|Poor compliance/noncompliance|0|||
144327517|NCT00320255|520403514|FG005|Overall Study|Poor compliance/noncompliance|0|||
144327518|NCT00320255|520403509|FG000|Overall Study|No longer meets study criteria|0|||
144327519|NCT00320255|520403510|FG001|Overall Study|No longer meets study criteria|0|||
144327520|NCT00320255|520403511|FG002|Overall Study|No longer meets study criteria|0|||
144327521|NCT00320255|520403512|FG003|Overall Study|No longer meets study criteria|1|||
144327522|NCT00320255|520403513|FG004|Overall Study|No longer meets study criteria|0|||
144327523|NCT00320255|520403514|FG005|Overall Study|No longer meets study criteria|0|||
144327524|NCT00320255|520403509|FG000|Overall Study|Other|3|||
144327525|NCT00320255|520403510|FG001|Overall Study|Other|2|||
144327526|NCT00320255|520403511|FG002|Overall Study|Other|1|||
144327527|NCT00320255|520403512|FG003|Overall Study|Other|0|||
144327528|NCT00320255|520403513|FG004|Overall Study|Other|0|||
144327529|NCT00320255|520403514|FG005|Overall Study|Other|0|||
144327530|NCT03405935|520403516|FG000|Overall Study|Adverse Event|3|||
144327531|NCT03405935|520403516|FG000|Overall Study|Death|2|||
144327532|NCT03405935|520403516|FG000|Overall Study|Withdrawal by Subject|1|||
144327533|NCT03405935|520403516|FG000|Overall Study|Lost to Follow-up|2|||
144327534|NCT02781792|520403524|FG000|Overall Study|Adverse Event|1|||
144327535|NCT02781792|520403525|FG001|Overall Study|Adverse Event|2|||
144327536|NCT02781792|520403524|FG000|Overall Study|Withdrawal by Subject|3|||
144327537|NCT02781792|520403525|FG001|Overall Study|Withdrawal by Subject|1|||
144327538|NCT02781792|520403524|FG000|Overall Study|Lack of Efficacy|1|||
144327539|NCT02781792|520403525|FG001|Overall Study|Lack of Efficacy|1|||
144327540|NCT02781792|520403524|FG000|Overall Study|Hospice|0|||
144327541|NCT02781792|520403525|FG001|Overall Study|Hospice|1|||
144327542|NCT00683917|520403533|FG000|Overall Study|Study prematurely terminated|10|||
144327543|NCT04422561|520403537|FG000|Overall Study|Lost to Follow-up|25|||
144327544|NCT04422561|520403538|FG001|Overall Study|Lost to Follow-up|11|||
144327545|NCT02685748|520403539|FG000|Overall Study|Withdrawal by Subject|3|||
144327546|NCT02685748|520403540|FG001|Overall Study|Withdrawal by Subject|2|||
144327547|NCT04863248|520403542|FG000|Overall Study|Sponsor Terminated|4|||
144327548|NCT04863248|520403543|FG001|Overall Study|Sponsor Terminated|1|||
144327549|NCT04863248|520403542|FG000|Overall Study|Death|0|||
144327550|NCT04863248|520403543|FG001|Overall Study|Death|1|||
144327551|NCT04863248|520403542|FG000|Overall Study|Withdrawal by Subject|0|||
144327552|NCT04863248|520403543|FG001|Overall Study|Withdrawal by Subject|1|||
144327553|NCT01691105|520403544|FG000|1 Month Follow-up|Lost to Follow-up|41|||
144327554|NCT01691105|520403545|FG001|1 Month Follow-up|Lost to Follow-up|38|||
144327555|NCT01691105|520403544|FG000|1 Month Follow-up|Death|2|||
144327556|NCT01691105|520403545|FG001|1 Month Follow-up|Death|3|||
144327557|NCT01691105|520403544|FG000|6 Month Follow-up|Lost to Follow-up|39|||
144327558|NCT01691105|520403545|FG001|6 Month Follow-up|Lost to Follow-up|58|||
144327559|NCT01691105|520403544|FG000|6 Month Follow-up|Death|13|||
144327560|NCT01691105|520403545|FG001|6 Month Follow-up|Death|13|||
144327561|NCT01691105|520403544|FG000|12 Month Follow-up|Lost to Follow-up|50|||
144327562|NCT01691105|520403545|FG001|12 Month Follow-up|Lost to Follow-up|71|||
144327563|NCT01691105|520403544|FG000|12 Month Follow-up|Death|22|||
144327564|NCT01691105|520403545|FG001|12 Month Follow-up|Death|30|||
144327565|NCT01691105|520403544|FG000|12 Month Biochemical Verification|Death|22|||
144327566|NCT01691105|520403545|FG001|12 Month Biochemical Verification|Death|30|||
144327567|NCT01691105|520403544|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
144327568|NCT01691105|520403545|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
144327569|NCT01691105|520403544|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
144327570|NCT01691105|520403545|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
144327571|NCT02233738|520403546|FG000|Overall Study|Lost to Follow-up|5|||
144327572|NCT02233738|520403547|FG001|Overall Study|Lost to Follow-up|12|||
144327573|NCT02233738|520403546|FG000|Overall Study|Death|0|||
144327574|NCT02233738|520403547|FG001|Overall Study|Death|1|||
144327575|NCT02233738|520403546|FG000|Overall Study|Withdrawal by Subject|0|||
144327576|NCT02233738|520403547|FG001|Overall Study|Withdrawal by Subject|1|||
144327577|NCT02233738|520403546|FG000|Overall Study|Did not return after Baseline|3|||
144327578|NCT02233738|520403547|FG001|Overall Study|Did not return after Baseline|2|||
144327579|NCT01777542|520403550|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
144327580|NCT01777542|520403551|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
144327581|NCT02279719|520403552|FG000|Overall Study|Patients randomized but never treated|0|||
144327582|NCT02279719|520403553|FG001|Overall Study|Patients randomized but never treated|0|||
144327583|NCT02279719|520403554|FG002|Overall Study|Patients randomized but never treated|0|||
144327584|NCT02279719|520403555|FG003|Overall Study|Patients randomized but never treated|0|||
144327585|NCT02279719|520403556|FG004|Overall Study|Patients randomized but never treated|3|||
144327586|NCT02279719|520403557|FG005|Overall Study|Patients randomized but never treated|0|||
144327587|NCT02279719|520403558|FG006|Overall Study|Patients randomized but never treated|3|||
144327588|NCT04706273|520403559|FG000|Overall Study|Withdrawal by Subject|27|||
144327589|NCT04706273|520403559|FG000|Overall Study|Physician Decision|1|||
144327590|NCT04706273|520403559|FG000|Overall Study|Lost to Follow-up|42|||
144327591|NCT04706273|520403559|FG000|Overall Study|Death|85|||
144327592|NCT04706273|520403559|FG000|Overall Study|Amputation that removes study device|2|||
144327593|NCT04706273|520403559|FG000|Overall Study|Surgical bypass|3|||
144327594|NCT04706273|520403559|FG000|Overall Study|Changing hospital|23|||
144327595|NCT04706273|520403559|FG000|Overall Study|Unable to attend hospital|2|||
144327596|NCT03541187|520403560|FG000|Overall Study|Lost to Follow-up|2|||
144327597|NCT03541187|520403561|FG001|Overall Study|Lost to Follow-up|6|||
144327598|NCT03541187|520403560|FG000|Overall Study|Pregnancy|0|||
144327599|NCT03541187|520403561|FG001|Overall Study|Pregnancy|1|||
144327600|NCT03541187|520403560|FG000|Overall Study|Withdrawal by Subject|6|||
144327601|NCT03541187|520403561|FG001|Overall Study|Withdrawal by Subject|2|||
144327602|NCT03541187|520403560|FG000|Overall Study|Moved out of town|1|||
144327603|NCT03541187|520403561|FG001|Overall Study|Moved out of town|0|||
144327604|NCT03541187|520403560|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
144327605|NCT03541187|520403561|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
144327606|NCT03541187|520403560|FG000|Overall Study|Did not meet randomization criteria|1|||
144327607|NCT03541187|520403561|FG001|Overall Study|Did not meet randomization criteria|1|||
144327608|NCT03541187|520403560|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
144327609|NCT03541187|520403561|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
144327610|NCT03541187|520403560|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
144327611|NCT03541187|520403561|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
144327612|NCT00869050|520403562|FG000|Overall Study|Screen Failure|3|||
144327613|NCT00294645|520403567|FG000|Overall Study|Death|10|||
144327614|NCT00294645|520403568|FG001|Overall Study|Death|18|||
144327615|NCT00294645|520403567|FG000|Overall Study|Lost to Follow-up|1|||
144327616|NCT00294645|520403568|FG001|Overall Study|Lost to Follow-up|10|||
144327617|NCT00294645|520403567|FG000|Overall Study|Withdrawal by Subject|18|||
144327618|NCT00294645|520403568|FG001|Overall Study|Withdrawal by Subject|34|||
144327619|NCT00294645|520403567|FG000|Overall Study|Physician Decision|15|||
144327620|NCT00294645|520403568|FG001|Overall Study|Physician Decision|20|||
144327621|NCT00294645|520403567|FG000|Overall Study|Other|4|||
144327622|NCT00294645|520403568|FG001|Overall Study|Other|10|||
144327623|NCT02419131|520403571|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
144327624|NCT02419131|520403572|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
144327625|NCT02419131|520403573|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
144327626|NCT02419131|520403571|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
144327627|NCT02419131|520403572|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
144327628|NCT02419131|520403573|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
144327629|NCT05426031|520403574|FG000|Overall Study|Circulatory Arrest|3|||
144327630|NCT05426031|520403575|FG001|Overall Study|Circulatory Arrest|2|||
144327631|NCT01118520|520403576|FG000|Overall Study|AAA repair|9|||
144327632|NCT01118520|520403577|FG001|Overall Study|AAA repair|7|||
144327633|NCT01118520|520403578|FG002|Overall Study|AAA repair|9|||
144327634|NCT01118520|520403576|FG000|Overall Study|Adverse Event|3|||
144327635|NCT01118520|520403577|FG001|Overall Study|Adverse Event|3|||
144327636|NCT01118520|520403578|FG002|Overall Study|Adverse Event|3|||
144327637|NCT01118520|520403576|FG000|Overall Study|Withdrawal by Subject|8|||
144327638|NCT01118520|520403577|FG001|Overall Study|Withdrawal by Subject|13|||
144327639|NCT01118520|520403578|FG002|Overall Study|Withdrawal by Subject|8|||
144327640|NCT04962230|520403579|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
144327641|NCT04962230|520403579|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
144327642|NCT03958656|520403580|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
144327643|NCT03958656|520403581|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
144327644|NCT03958656|520403582|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
144327645|NCT03958656|520403583|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
144327646|NCT03958656|520403580|FG000|Overall Study|No longer meets eligibility criteria|0|||
144327647|NCT03958656|520403581|FG001|Overall Study|No longer meets eligibility criteria|0|||
144327648|NCT03958656|520403582|FG002|Overall Study|No longer meets eligibility criteria|1|||
144327649|NCT03958656|520403583|FG003|Overall Study|No longer meets eligibility criteria|0|||
144327650|NCT03958656|520403580|FG000|Overall Study|Started anti-cancer treatment|0|||
144327651|NCT03958656|520403581|FG001|Overall Study|Started anti-cancer treatment|0|||
144327652|NCT03958656|520403582|FG002|Overall Study|Started anti-cancer treatment|1|||
144327653|NCT03958656|520403583|FG003|Overall Study|Started anti-cancer treatment|0|||
144327654|NCT03831880|520403586|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
144327655|NCT03831880|520403587|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
144327656|NCT03831880|520403586|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
144327657|NCT03831880|520403587|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
144327658|NCT02014480|520403590|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
144327659|NCT02014480|520403591|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
144327660|NCT02014480|520403592|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
144327661|NCT02014480|520403593|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
144327662|NCT02014480|520403594|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
144327663|NCT02014480|520403595|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
144327664|NCT02014480|520403590|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144327665|NCT02014480|520403591|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144327666|NCT02014480|520403592|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144327667|NCT02014480|520403593|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
144327668|NCT02014480|520403594|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
144327669|NCT02014480|520403595|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
144327670|NCT02014480|520403590|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144327671|NCT02014480|520403591|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144327672|NCT02014480|520403592|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
144327673|NCT02014480|520403593|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144327674|NCT02014480|520403594|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144327675|NCT02014480|520403595|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
144327676|NCT02014480|520403590|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
144327677|NCT02014480|520403591|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
144327678|NCT02014480|520403592|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
144327679|NCT02014480|520403593|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
144327680|NCT02014480|520403594|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144327681|NCT02014480|520403595|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
144327682|NCT02014480|520403590|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144327683|NCT02014480|520403591|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
144327684|NCT02014480|520403592|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144327685|NCT02014480|520403593|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144327686|NCT02014480|520403594|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144327687|NCT02014480|520403595|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
144327688|NCT02014480|520403590|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
144327689|NCT02014480|520403591|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
144327690|NCT02014480|520403592|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
144327691|NCT02014480|520403593|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
144327692|NCT02014480|520403594|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
144327693|NCT02014480|520403595|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
144327694|NCT02014480|520403590|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144327695|NCT02014480|520403591|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144327696|NCT02014480|520403592|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144327697|NCT02014480|520403593|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144327698|NCT02014480|520403594|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
144327699|NCT02014480|520403595|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
144327700|NCT02692040|520403596|FG000|Overall Study|Protocol Violation|0|||
144327701|NCT02692040|520403597|FG001|Overall Study|Protocol Violation|0|||
144327702|NCT02692040|520403598|FG002|Overall Study|Protocol Violation|0|||
144327703|NCT02692040|520403599|FG003|Overall Study|Protocol Violation|0|||
144327704|NCT02692040|520403600|FG004|Overall Study|Protocol Violation|0|||
144327705|NCT02692040|520403601|FG005|Overall Study|Protocol Violation|0|||
144327706|NCT02692040|520403602|FG006|Overall Study|Protocol Violation|0|||
144327707|NCT02692040|520403603|FG007|Overall Study|Protocol Violation|0|||
144327708|NCT02692040|520403604|FG008|Overall Study|Protocol Violation|0|||
144327709|NCT02692040|520403605|FG009|Overall Study|Protocol Violation|0|||
144327710|NCT02692040|520403606|FG010|Overall Study|Protocol Violation|0|||
144327711|NCT02692040|520403607|FG011|Overall Study|Protocol Violation|0|||
144327712|NCT02692040|520403608|FG012|Overall Study|Protocol Violation|1|||
144327713|NCT02692040|520403609|FG013|Overall Study|Protocol Violation|0|||
144327714|NCT02692040|520403610|FG014|Overall Study|Protocol Violation|0|||
144327715|NCT02692040|520403611|FG015|Overall Study|Protocol Violation|0|||
144327716|NCT02692040|520403612|FG016|Overall Study|Protocol Violation|0|||
144327717|NCT02692040|520403596|FG000|Overall Study|Adverse Event|0|||
144327718|NCT02692040|520403597|FG001|Overall Study|Adverse Event|0|||
144327719|NCT02692040|520403598|FG002|Overall Study|Adverse Event|0|||
144327720|NCT02692040|520403599|FG003|Overall Study|Adverse Event|0|||
144327721|NCT02692040|520403600|FG004|Overall Study|Adverse Event|0|||
144327722|NCT02692040|520403601|FG005|Overall Study|Adverse Event|0|||
144327723|NCT02692040|520403602|FG006|Overall Study|Adverse Event|0|||
144327724|NCT02692040|520403603|FG007|Overall Study|Adverse Event|0|||
144327725|NCT02692040|520403604|FG008|Overall Study|Adverse Event|0|||
144327726|NCT02692040|520403605|FG009|Overall Study|Adverse Event|0|||
144327727|NCT02692040|520403606|FG010|Overall Study|Adverse Event|0|||
144327728|NCT02692040|520403607|FG011|Overall Study|Adverse Event|0|||
144327729|NCT02692040|520403608|FG012|Overall Study|Adverse Event|0|||
144327730|NCT02692040|520403609|FG013|Overall Study|Adverse Event|3|||
144327731|NCT02692040|520403610|FG014|Overall Study|Adverse Event|1|||
144327732|NCT02692040|520403611|FG015|Overall Study|Adverse Event|1|||
144327733|NCT02692040|520403612|FG016|Overall Study|Adverse Event|0|||
144327734|NCT00435162|520403616|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
144327735|NCT00435162|520403617|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
144327736|NCT00435162|520403618|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
144327737|NCT00435162|520403619|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
144327738|NCT00435162|520403620|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
144327739|NCT00435162|520403621|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
144327740|NCT01819129|520403622|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
144327741|NCT01819129|520403623|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
144327742|NCT01819129|520403622|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
144327743|NCT01819129|520403623|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
144327744|NCT01819129|520403622|FG000|Overall Study|Other, Subject moved out of the country|0|||
144327745|NCT01819129|520403623|FG001|Overall Study|Other, Subject moved out of the country|1|||
144327746|NCT01819129|520403622|FG000|Overall Study|Withdrawal by Subject|15|||
144327747|NCT01819129|520403623|FG001|Overall Study|Withdrawal by Subject|15|||
144327748|NCT01819129|520403622|FG000|Overall Study|Lost to Follow-up|5|||
144327749|NCT01819129|520403623|FG001|Overall Study|Lost to Follow-up|2|||
144327750|NCT01819129|520403622|FG000|Overall Study|Lack of Efficacy|0|||
144327751|NCT01819129|520403623|FG001|Overall Study|Lack of Efficacy|1|||
144327752|NCT01819129|520403622|FG000|Overall Study|Adverse Event|1|||
144327753|NCT01819129|520403623|FG001|Overall Study|Adverse Event|4|||
144327754|NCT01819129|520403622|FG000|Overall Study|Death|1|||
144327755|NCT01819129|520403623|FG001|Overall Study|Death|1|||
144327756|NCT01819129|520403622|FG000|Overall Study|Withdrawal Criteria|20|||
144327757|NCT01819129|520403623|FG001|Overall Study|Withdrawal Criteria|15|||
144327758|NCT02836873|520403627|FG000|Overall Study|Protocol Violation|0|||
144327759|NCT02836873|520403628|FG001|Overall Study|Protocol Violation|1|||
144327760|NCT02836873|520403627|FG000|Overall Study|Adverse Event|1|||
144327761|NCT02836873|520403628|FG001|Overall Study|Adverse Event|4|||
144327762|NCT02836873|520403627|FG000|Overall Study|Withdrawal by Subject|2|||
144327763|NCT02836873|520403628|FG001|Overall Study|Withdrawal by Subject|2|||
144327764|NCT02836873|520403627|FG000|Overall Study|Lost to Follow-up|1|||
144327765|NCT02836873|520403628|FG001|Overall Study|Lost to Follow-up|3|||
144327766|NCT02836873|520403627|FG000|Overall Study|Physician Decision|0|||
144327767|NCT02836873|520403628|FG001|Overall Study|Physician Decision|1|||
144327768|NCT02836873|520403627|FG000|Overall Study|Other|1|||
144327769|NCT02836873|520403628|FG001|Overall Study|Other|0|||
144327770|NCT02914548|520403634|FG000|Overall Study|Adverse Event|15|||
144327771|NCT02914548|520403635|FG001|Overall Study|Adverse Event|7|||
144327772|NCT02914548|520403636|FG002|Overall Study|Adverse Event|15|||
144327773|NCT02914548|520403634|FG000|Overall Study|Physician Decision|2|||
144327774|NCT02914548|520403635|FG001|Overall Study|Physician Decision|2|||
144327775|NCT02914548|520403636|FG002|Overall Study|Physician Decision|0|||
144327776|NCT02914548|520403634|FG000|Overall Study|Protocol Violation|1|||
144327777|NCT02914548|520403635|FG001|Overall Study|Protocol Violation|0|||
144327778|NCT02914548|520403636|FG002|Overall Study|Protocol Violation|0|||
144327779|NCT02914548|520403634|FG000|Overall Study|Withdrawal by Subject|3|||
144327780|NCT02914548|520403635|FG001|Overall Study|Withdrawal by Subject|4|||
144327781|NCT02914548|520403636|FG002|Overall Study|Withdrawal by Subject|4|||
144327782|NCT02914548|520403634|FG000|Overall Study|>40% of body surface area|0|||
144327783|NCT02914548|520403635|FG001|Overall Study|>40% of body surface area|1|||
144327784|NCT02914548|520403636|FG002|Overall Study|>40% of body surface area|1|||
144327785|NCT00977938|520403646|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
144327786|NCT00977938|520403647|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
144327787|NCT00977938|520403648|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
144327788|NCT00977938|520403649|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
144327789|NCT00977938|520403646|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
144327790|NCT00977938|520403647|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
144327791|NCT00977938|520403648|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
144327792|NCT00977938|520403649|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
144327793|NCT00977938|520403646|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
144327794|NCT00977938|520403647|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
144327795|NCT00977938|520403648|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
144327796|NCT00977938|520403649|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
144327797|NCT00977938|520403646|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
144327798|NCT00977938|520403647|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
144327799|NCT00977938|520403648|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
144327800|NCT00977938|520403649|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
144327801|NCT00977938|520403646|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
144327802|NCT00977938|520403647|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
144327803|NCT00977938|520403648|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
144327804|NCT00977938|520403649|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
144327805|NCT00977938|520403646|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
144327806|NCT00977938|520403647|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
144327807|NCT00977938|520403648|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
144327808|NCT00977938|520403649|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
144327809|NCT02460783|520403653|FG000|Overall Study|Withdrawal by Subject|1|||
144327810|NCT02460783|520403654|FG001|Overall Study|Withdrawal by Subject|3|||
144327811|NCT02460783|520403653|FG000|Overall Study|Lost to Follow-up|1|||
144327812|NCT02460783|520403654|FG001|Overall Study|Lost to Follow-up|1|||
144327813|NCT02214225|520403660|FG000|Overall Study|Lost to Follow-up|46|||
144327814|NCT02214225|520403661|FG001|Overall Study|Lost to Follow-up|18|||
144327815|NCT02214225|520403662|FG002|Overall Study|Lost to Follow-up|18|||
144327816|NCT02214225|520403660|FG000|Overall Study|Withdrawal by Subject|2|||
144327817|NCT02214225|520403661|FG001|Overall Study|Withdrawal by Subject|0|||
144327818|NCT02214225|520403662|FG002|Overall Study|Withdrawal by Subject|2|||
144327819|NCT02214225|520403660|FG000|Overall Study|Death|5|||
144327820|NCT02214225|520403661|FG001|Overall Study|Death|0|||
144327821|NCT02214225|520403662|FG002|Overall Study|Death|1|||
144327822|NCT02214225|520403660|FG000|Overall Study|randomized in error, not vaccinated|2|||
144327823|NCT02214225|520403661|FG001|Overall Study|randomized in error, not vaccinated|1|||
144327824|NCT02214225|520403662|FG002|Overall Study|randomized in error, not vaccinated|1|||
144327825|NCT02847858|520403663|FG000|Overall Study|Lost to Follow-up|401|||
144327826|NCT02847858|520403664|FG001|Overall Study|Lost to Follow-up|269|||
144327827|NCT00624819|520403665|FG000|Follow-up Period: Year 4|Parents decision|0|||
144327828|NCT00624819|520403666|FG001|Follow-up Period: Year 4|Parents decision|0|||
144327829|NCT00624819|520403667|FG002|Follow-up Period: Year 4|Parents decision|1|||
144327830|NCT00624819|520403668|FG003|Follow-up Period: Year 4|Parents decision|0|||
144327831|NCT00624819|520403665|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
144327832|NCT00624819|520403666|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
144327833|NCT00624819|520403667|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
144327834|NCT00624819|520403668|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
144327835|NCT00681564|520403671|FG000|Overall Study|Lost to Follow-up|6|||
144327836|NCT00681564|520403672|FG001|Overall Study|Lost to Follow-up|6|||
144327837|NCT00681564|520403671|FG000|Overall Study|Withdrawal by Subject|0|||
144327838|NCT00681564|520403672|FG001|Overall Study|Withdrawal by Subject|1|||
144327839|NCT00681564|520403671|FG000|Overall Study|Death|0|||
144327840|NCT00681564|520403672|FG001|Overall Study|Death|1|||
144327841|NCT02826421|520403675|FG000|Overall Study|Adverse Event|1|||
144327842|NCT02826421|520403676|FG001|Overall Study|Adverse Event|0|||
144327843|NCT02826421|520403677|FG002|Overall Study|Adverse Event|0|||
144327844|NCT02826421|520403678|FG003|Overall Study|Adverse Event|1|||
144327845|NCT02826421|520403675|FG000|Overall Study|Withdrawal by Subject|1|||
144327846|NCT02826421|520403676|FG001|Overall Study|Withdrawal by Subject|3|||
144327847|NCT02826421|520403677|FG002|Overall Study|Withdrawal by Subject|1|||
144327848|NCT02826421|520403678|FG003|Overall Study|Withdrawal by Subject|1|||
144327849|NCT02826421|520403675|FG000|Overall Study|Reason not given|1|||
144327850|NCT02826421|520403676|FG001|Overall Study|Reason not given|0|||
144327851|NCT02826421|520403677|FG002|Overall Study|Reason not given|1|||
144327852|NCT02826421|520403678|FG003|Overall Study|Reason not given|0|||
144327853|NCT02210221|520403683|FG000|Overall Study|Lack of Efficacy|7|||
144327854|NCT02210221|520403683|FG000|Overall Study|Withdrawal by Subject|43|||
144327855|NCT02185014|520403686|FG000|Overall Study|Adverse Event|18|||
144327856|NCT02185014|520403686|FG000|Overall Study|Withdrew Consent|8|||
144327857|NCT02185014|520403686|FG000|Overall Study|Lost to Follow-up|4|||
144327858|NCT02185014|520403686|FG000|Overall Study|Lack of Efficacy|14|||
144327859|NCT02185014|520403686|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
144327860|NCT02185014|520403686|FG000|Overall Study|Subject Noncompliance|1|||
144327861|NCT02185014|520403686|FG000|Overall Study|Other|4|||
144327862|NCT03093974|520403687|FG000|Overall Study|Withdrawal by Subject|32|||
144327863|NCT03093974|520403688|FG001|Overall Study|Withdrawal by Subject|27|||
144327864|NCT03093974|520403687|FG000|Overall Study|Adverse Event|17|||
144327865|NCT03093974|520403688|FG001|Overall Study|Adverse Event|24|||
144327866|NCT03093974|520403687|FG000|Overall Study|Death|0|||
144327867|NCT03093974|520403688|FG001|Overall Study|Death|1|||
144327868|NCT03093974|520403687|FG000|Overall Study|Non-Compliance with Study Drug|1|||
144327869|NCT03093974|520403688|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144327870|NCT03093974|520403687|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
144327871|NCT03093974|520403688|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
144327872|NCT03093974|520403687|FG000|Overall Study|Lost to Follow-up|0|||
144327873|NCT03093974|520403688|FG001|Overall Study|Lost to Follow-up|1|||
144327874|NCT03093974|520403687|FG000|Overall Study|Other|1|||
144327875|NCT03093974|520403688|FG001|Overall Study|Other|2|||
144327876|NCT02141490|520403689|FG000|Overall Study|Screening failures|4|||
144327877|NCT02141490|520403690|FG001|Overall Study|Screening failures|0|||
144327878|NCT02141490|520403691|FG002|Overall Study|Screening failures|0|||
144327879|NCT00033540|520403694|FG000|Overall Study|Adverse Event|14|||
144327880|NCT00033540|520403694|FG000|Overall Study|Death|1|||
144327881|NCT00033540|520403694|FG000|Overall Study|Progression|26|||
144327882|NCT00033540|520403694|FG000|Overall Study|Withdrawal by Subject|6|||
144327883|NCT00033540|520403694|FG000|Overall Study|Other|5|||
144327884|NCT00033540|520403694|FG000|Overall Study|Ineligible|3|||
144327885|NCT00033540|520403694|FG000|Overall Study|Never received treatment|2|||
144327886|NCT01253265|520403697|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
144327887|NCT01253265|520403698|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
144327888|NCT01253265|520403699|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
144327889|NCT01253265|520403700|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
144327890|NCT01253265|520403701|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
144327891|NCT01253265|520403697|FG000|Overall Study|Withdrawal by Subject|0|||
144327892|NCT01253265|520403698|FG001|Overall Study|Withdrawal by Subject|0|||
144327893|NCT01253265|520403699|FG002|Overall Study|Withdrawal by Subject|0|||
144327894|NCT01253265|520403700|FG003|Overall Study|Withdrawal by Subject|0|||
144327895|NCT01253265|520403701|FG004|Overall Study|Withdrawal by Subject|1|||
144327896|NCT03271047|520403703|FG000|Phase 1b: Dose Finding Period|Death|8|||
144327897|NCT03271047|520403704|FG001|Phase 1b: Dose Finding Period|Death|8|||
144327898|NCT03271047|520403705|FG002|Phase 1b: Dose Finding Period|Death|0|||
144327899|NCT03271047|520403706|FG003|Phase 1b: Dose Finding Period|Death|0|||
144327900|NCT03271047|520403703|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
144327901|NCT03271047|520403704|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
144327902|NCT03271047|520403705|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
144327903|NCT03271047|520403706|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
144327904|NCT03271047|520403703|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
144327905|NCT03271047|520403704|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
144327906|NCT03271047|520403705|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
144327907|NCT03271047|520403706|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
144327908|NCT03271047|520403703|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
144327909|NCT03271047|520403704|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
144327910|NCT03271047|520403705|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
144327911|NCT03271047|520403706|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
144327912|NCT03271047|520403703|FG000|Randomized Phase 2 Period|Other|0|||
144327913|NCT03271047|520403704|FG001|Randomized Phase 2 Period|Other|0|||
144327914|NCT03271047|520403705|FG002|Randomized Phase 2 Period|Other|0|||
144327915|NCT03271047|520403706|FG003|Randomized Phase 2 Period|Other|1|||
144327916|NCT03271047|520403703|FG000|Randomized Phase 2 Period|Death|0|||
144327917|NCT03271047|520403704|FG001|Randomized Phase 2 Period|Death|0|||
144327918|NCT03271047|520403705|FG002|Randomized Phase 2 Period|Death|20|||
144327919|NCT03271047|520403706|FG003|Randomized Phase 2 Period|Death|21|||
144327920|NCT03271047|520403703|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
144327921|NCT03271047|520403704|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
144327922|NCT03271047|520403705|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
144327923|NCT03271047|520403706|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
144327924|NCT03271047|520403703|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
144327925|NCT03271047|520403704|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
144327926|NCT03271047|520403705|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
144327927|NCT03271047|520403706|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
144327928|NCT03271047|520403703|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
144327929|NCT03271047|520403704|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
144327930|NCT03271047|520403705|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
144327931|NCT03271047|520403706|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
144327932|NCT00434759|520403708|FG000|Overall Study|Lack of Efficacy|5|||
144327933|NCT00434759|520403709|FG001|Overall Study|Lack of Efficacy|4|||
144327934|NCT00434759|520403708|FG000|Overall Study|Withdrawal by Subject|17|||
144327935|NCT00434759|520403709|FG001|Overall Study|Withdrawal by Subject|1|||
144327936|NCT00434759|520403708|FG000|Overall Study|family affairs|2|||
144327937|NCT00434759|520403709|FG001|Overall Study|family affairs|0|||
144327938|NCT00495521|520403710|FG000|Overall Study|Physician Decision|0|||
144327939|NCT00495521|520403711|FG001|Overall Study|Physician Decision|1|||
144327940|NCT02410824|520403712|FG000|First Intervention (One Week)|Headache|0|||
144327941|NCT02410824|520403713|FG001|First Intervention (One Week)|Headache|1|||
144327942|NCT02782325|520403714|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
144327943|NCT02782325|520403715|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
144327944|NCT02782325|520403716|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
144327945|NCT02782325|520403714|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
144327946|NCT02782325|520403715|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
144327947|NCT02782325|520403716|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
144327948|NCT01038713|520403717|FG000|Overall Study|Patient to hospice|1|||
144327949|NCT01038713|520403718|FG001|Overall Study|Patient to hospice|1|||
144327950|NCT01038713|520403719|FG002|Overall Study|Patient to hospice|1|||
144327951|NCT01038713|520403717|FG000|Overall Study|Lost to Follow-up|3|||
144327952|NCT01038713|520403718|FG001|Overall Study|Lost to Follow-up|0|||
144327953|NCT01038713|520403719|FG002|Overall Study|Lost to Follow-up|0|||
144327954|NCT01038713|520403717|FG000|Overall Study|Neuroendocrine Tumor|0|||
144327955|NCT01038713|520403718|FG001|Overall Study|Neuroendocrine Tumor|1|||
144327956|NCT01038713|520403719|FG002|Overall Study|Neuroendocrine Tumor|0|||
144327957|NCT01038713|520403717|FG000|Overall Study|died from PEP|0|||
144327958|NCT01038713|520403718|FG001|Overall Study|died from PEP|1|||
144327959|NCT01038713|520403719|FG002|Overall Study|died from PEP|0|||
144327960|NCT01038713|520403717|FG000|Overall Study|Autoimmune Pancreatitis|1|||
144327961|NCT01038713|520403718|FG001|Overall Study|Autoimmune Pancreatitis|0|||
144327962|NCT01038713|520403719|FG002|Overall Study|Autoimmune Pancreatitis|0|||
144327963|NCT03777917|520403720|FG000|Overall Study|Withdrawal by Subject|1|||
144327964|NCT03777917|520403721|FG001|Overall Study|Withdrawal by Subject|0|||
144327965|NCT03777917|520403720|FG000|Overall Study|Physician Decision|1|||
144327966|NCT03777917|520403721|FG001|Overall Study|Physician Decision|0|||
144327967|NCT03777917|520403720|FG000|Overall Study|Lost to Follow-up|6|||
144327968|NCT03777917|520403721|FG001|Overall Study|Lost to Follow-up|2|||
144327969|NCT03777917|520403720|FG000|Overall Study|Other|1|||
144327970|NCT03777917|520403721|FG001|Overall Study|Other|0|||
144327971|NCT00042432|520403722|FG000|Overall Study|Adverse Event|4|||
144327972|NCT00042432|520403723|FG001|Overall Study|Adverse Event|1|||
144327973|NCT00042432|520403722|FG000|Overall Study|Withdrawal by Subject|1|||
144327974|NCT00042432|520403723|FG001|Overall Study|Withdrawal by Subject|3|||
144327975|NCT00042432|520403722|FG000|Overall Study|Death|0|||
144327976|NCT00042432|520403723|FG001|Overall Study|Death|2|||
144327977|NCT00042432|520403722|FG000|Overall Study|Ineligibility determined|1|||
144327978|NCT00042432|520403723|FG001|Overall Study|Ineligibility determined|0|||
144327979|NCT00042432|520403722|FG000|Overall Study|Initiation of maintenance dialysis|1|||
144327980|NCT00042432|520403723|FG001|Overall Study|Initiation of maintenance dialysis|1|||
144327981|NCT00042432|520403722|FG000|Overall Study|Other|2|||
144327982|NCT00042432|520403723|FG001|Overall Study|Other|0|||
144327983|NCT00930969|520403724|FG000|Overall Study|Death|5|||
144327984|NCT00930969|520403724|FG000|Overall Study|Lost to Follow-up|1|||
144327985|NCT00930969|520403724|FG000|Overall Study|Physician Decision|13|||
144327986|NCT00930969|520403724|FG000|Overall Study|Withdrawal by Subject|19|||
144327987|NCT00657150|520403725|FG000|Overall Study|Adverse Event|19|||
144327988|NCT00657150|520403726|FG001|Overall Study|Adverse Event|10|||
144327989|NCT00657150|520403725|FG000|Overall Study|Non-compliant with protocol|5|||
144327990|NCT00657150|520403726|FG001|Overall Study|Non-compliant with protocol|9|||
144327991|NCT00657150|520403725|FG000|Overall Study|Lost to Follow-up|2|||
144327992|NCT00657150|520403726|FG001|Overall Study|Lost to Follow-up|0|||
144327993|NCT00657150|520403725|FG000|Overall Study|Withdrawal by Subject|51|||
144327994|NCT00657150|520403726|FG001|Overall Study|Withdrawal by Subject|36|||
144327995|NCT00657150|520403725|FG000|Overall Study|Other|38|||
144327996|NCT00657150|520403726|FG001|Overall Study|Other|38|||
144327997|NCT00657150|520403725|FG000|Treatment|Adverse Event|60|||
144327998|NCT00657150|520403726|FG001|Treatment|Adverse Event|53|||
144327999|NCT00657150|520403725|FG000|Treatment|Non-compliant with protocol|10|||
144328000|NCT00657150|520403726|FG001|Treatment|Non-compliant with protocol|9|||
144328001|NCT00657150|520403725|FG000|Treatment|Lost to Follow-up|1|||
144328002|NCT00657150|520403726|FG001|Treatment|Lost to Follow-up|0|||
144328003|NCT00657150|520403725|FG000|Treatment|Withdrawal by Subject|23|||
144328004|NCT00657150|520403726|FG001|Treatment|Withdrawal by Subject|20|||
144328005|NCT00657150|520403725|FG000|Treatment|Other|13|||
144328006|NCT00657150|520403726|FG001|Treatment|Other|15|||
144328007|NCT02966795|520403727|FG000|Overall Study|Patient Left the Country|0|||
144328008|NCT02966795|520403728|FG001|Overall Study|Patient Left the Country|1|||
144328009|NCT00432744|520403729|FG000|Months 0-6|Withdrawal by Subject|4|||
144328010|NCT00432744|520403730|FG001|Months 0-6|Withdrawal by Subject|4|||
144328011|NCT00432744|520403729|FG000|Months 0-6|Too disabled to score|1|||
144328012|NCT00432744|520403730|FG001|Months 0-6|Too disabled to score|0|||
144328013|NCT00432744|520403729|FG000|Months 7 - 12|Withdrawal by Subject|1|||
144328014|NCT00432744|520403730|FG001|Months 7 - 12|Withdrawal by Subject|0|||
144328015|NCT00432744|520403729|FG000|Months 7 - 12|Too disabled to score|0|||
144328016|NCT00432744|520403730|FG001|Months 7 - 12|Too disabled to score|1|||
144328017|NCT01416441|520403731|FG000|Overall Study|Lost to Follow-up|5|||
144328018|NCT01416441|520403731|FG000|Overall Study|Adverse Event|6|||
144328019|NCT01416441|520403731|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
144328020|NCT01416441|520403731|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
144328021|NCT01416441|520403731|FG000|Overall Study|Investigator Withdrew Subject|2|||
144328022|NCT01416441|520403731|FG000|Overall Study|Subject Withdrew Consent|12|||
144328023|NCT01416441|520403731|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
144328024|NCT04070326|520403739|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
144328025|NCT04070326|520403740|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
144328026|NCT04030247|520405403|FG000|Overall Study|Withdrawal by Subject|4|||
144328027|NCT04030247|520405403|FG000|Overall Study|Lost to Follow-up|13|||
144328028|NCT03966885|520405404|FG000|Overall Study|Death|1|||
144328029|NCT03966885|520405405|FG001|Overall Study|Death|0|||
144328030|NCT03966885|520405404|FG000|Overall Study|Lost to Follow-up|1|||
144328031|NCT03966885|520405405|FG001|Overall Study|Lost to Follow-up|2|||
144328032|NCT03966885|520405404|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
144328033|NCT03966885|520405405|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
144328034|NCT03966885|520405404|FG000|Overall Study|Moved from study area.|0|||
144328035|NCT03966885|520405405|FG001|Overall Study|Moved from study area.|2|||
144328036|NCT03187834|520405406|FG000|Overall Study|Lost to Follow-up|0|||
144328037|NCT03187834|520405407|FG001|Overall Study|Lost to Follow-up|1|||
144328038|NCT03187834|520405408|FG002|Overall Study|Lost to Follow-up|2|||
144328039|NCT03187834|520405409|FG003|Overall Study|Lost to Follow-up|2|||
144328040|NCT03187834|520405406|FG000|Overall Study|Had invalid anthropometric measurements|5|||
144328041|NCT03187834|520405407|FG001|Overall Study|Had invalid anthropometric measurements|3|||
144328042|NCT03187834|520405408|FG002|Overall Study|Had invalid anthropometric measurements|4|||
144328043|NCT03187834|520405409|FG003|Overall Study|Had invalid anthropometric measurements|2|||
144328044|NCT01930890|520405410|FG000|Overall Study|Study Termination|14|||
144328045|NCT01930890|520405411|FG001|Overall Study|Study Termination|28|||
144328046|NCT01930890|520405412|FG002|Overall Study|Study Termination|13|||
144328047|NCT01930890|520405413|FG003|Overall Study|Study Termination|25|||
144328048|NCT01930890|520405410|FG000|Overall Study|Death|0|||
144328049|NCT01930890|520405411|FG001|Overall Study|Death|0|||
144328050|NCT01930890|520405412|FG002|Overall Study|Death|0|||
144328051|NCT01930890|520405413|FG003|Overall Study|Death|1|||
144328052|NCT01930890|520405410|FG000|Overall Study|Investigator Decision|0|||
144328053|NCT01930890|520405411|FG001|Overall Study|Investigator Decision|1|||
144328054|NCT01930890|520405412|FG002|Overall Study|Investigator Decision|0|||
144328055|NCT01930890|520405413|FG003|Overall Study|Investigator Decision|0|||
144328056|NCT01930890|520405410|FG000|Overall Study|Consent Withdrawn|0|||
144328057|NCT01930890|520405411|FG001|Overall Study|Consent Withdrawn|3|||
144328058|NCT01930890|520405412|FG002|Overall Study|Consent Withdrawn|0|||
144328059|NCT01930890|520405413|FG003|Overall Study|Consent Withdrawn|1|||
144328060|NCT01930890|520405410|FG000|Overall Study|Adverse Event|0|||
144328061|NCT01930890|520405411|FG001|Overall Study|Adverse Event|1|||
144328062|NCT01930890|520405412|FG002|Overall Study|Adverse Event|0|||
144328063|NCT01930890|520405413|FG003|Overall Study|Adverse Event|0|||
144328064|NCT03710876|520405414|FG000|Overall Study|Death|0|||
144328065|NCT03710876|520405415|FG001|Overall Study|Death|2|||
144328066|NCT03710876|520405414|FG000|Overall Study|Withdrawal by Subject|0|||
144328067|NCT03710876|520405415|FG001|Overall Study|Withdrawal by Subject|2|||
144328068|NCT04979897|520405419|FG000|Overall Study|Death|1|||
144328069|NCT04979897|520405420|FG001|Overall Study|Death|8|||
144328070|NCT04979897|520405419|FG000|Overall Study|Lost to Follow-up|111|||
144328071|NCT04979897|520405420|FG001|Overall Study|Lost to Follow-up|56|||
144328072|NCT04979897|520405419|FG000|Overall Study|Withdrawal by Subject|7|||
144328073|NCT04979897|520405420|FG001|Overall Study|Withdrawal by Subject|2|||
144328074|NCT03383783|520405422|FG000|Overall Study|Withdrawal by Subject|2|||
144328075|NCT01224821|520405424|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
144328076|NCT01224821|520405424|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
144328077|NCT01224821|520405424|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
144328078|NCT01224821|520405424|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
144328079|NCT01224821|520405424|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
144328080|NCT01224821|520405424|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
144328081|NCT01224821|520405424|FG000|Long-Term Follow-Up|Death|2|||
144328082|NCT01224821|520405424|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
144328083|NCT00350623|520405427|FG000|Overall Study|Lost to Follow-up|8|||
144328084|NCT00350623|520405428|FG001|Overall Study|Lost to Follow-up|3|||
144328085|NCT00350623|520405429|FG002|Overall Study|Lost to Follow-up|4|||
144328086|NCT00350623|520405427|FG000|Overall Study|Withdrawal by Subject|0|||
144328087|NCT00350623|520405428|FG001|Overall Study|Withdrawal by Subject|1|||
144328088|NCT00350623|520405429|FG002|Overall Study|Withdrawal by Subject|1|||
144328089|NCT00350623|520405427|FG000|Overall Study|patient traveling outside the country|0|||
144328090|NCT00350623|520405428|FG001|Overall Study|patient traveling outside the country|0|||
144328091|NCT00350623|520405429|FG002|Overall Study|patient traveling outside the country|1|||
144328092|NCT04126564|520405435|FG000|Overall Study|Withdrawal by Subject|0|||
144328093|NCT04126564|520405436|FG001|Overall Study|Withdrawal by Subject|2|||
144328094|NCT04126564|520405435|FG000|Overall Study|Lost to Follow-up|0|||
144328095|NCT04126564|520405436|FG001|Overall Study|Lost to Follow-up|1|||
144328096|NCT04599166|520405437|FG000|Overall Study|Technological failure connecting to study app|80|||
144328097|NCT02317809|520405438|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
144328098|NCT02317809|520405439|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
144328099|NCT02317809|520405438|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
144328100|NCT02317809|520405439|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
144328101|NCT01974752|520405440|FG000|Overall Study|Death|33|||
144328102|NCT01974752|520405441|FG001|Overall Study|Death|11|||
144328103|NCT01974752|520405440|FG000|Overall Study|Lost to Follow-up|2|||
144328104|NCT01974752|520405441|FG001|Overall Study|Lost to Follow-up|0|||
144328105|NCT01974752|520405440|FG000|Overall Study|Withdrawal by Subject|2|||
144328106|NCT01974752|520405441|FG001|Overall Study|Withdrawal by Subject|3|||
144328107|NCT01974752|520405440|FG000|Overall Study|Other Eligibility Criteria|0|||
144328108|NCT01974752|520405441|FG001|Overall Study|Other Eligibility Criteria|1|||
144328109|NCT02536300|520405442|FG000|Overall Study|Investigator's Discretion|17|||
144328110|NCT02536300|520405443|FG001|Overall Study|Investigator's Discretion|11|||
144328111|NCT02536300|520405444|FG002|Overall Study|Investigator's Discretion|2|||
144328112|NCT02536300|520405442|FG000|Overall Study|Progressive Disease|11|||
144328113|NCT02536300|520405443|FG001|Overall Study|Progressive Disease|7|||
144328114|NCT02536300|520405444|FG002|Overall Study|Progressive Disease|6|||
144328115|NCT02536300|520405442|FG000|Overall Study|Study Terminated by Sponsor|6|||
144328116|NCT02536300|520405443|FG001|Overall Study|Study Terminated by Sponsor|4|||
144328117|NCT02536300|520405444|FG002|Overall Study|Study Terminated by Sponsor|7|||
144328118|NCT02536300|520405442|FG000|Overall Study|Death|7|||
144328119|NCT02536300|520405443|FG001|Overall Study|Death|0|||
144328120|NCT02536300|520405444|FG002|Overall Study|Death|5|||
144328121|NCT02536300|520405442|FG000|Overall Study|Withdrew Consent|4|||
144328122|NCT02536300|520405443|FG001|Overall Study|Withdrew Consent|2|||
144328123|NCT02536300|520405444|FG002|Overall Study|Withdrew Consent|0|||
144328124|NCT02536300|520405442|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
144328125|NCT02536300|520405443|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
144328126|NCT02536300|520405444|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
144328127|NCT02536300|520405442|FG000|Overall Study|Enrolled but Never Treated|0|||
144328128|NCT02536300|520405443|FG001|Overall Study|Enrolled but Never Treated|0|||
144328129|NCT02536300|520405444|FG002|Overall Study|Enrolled but Never Treated|1|||
144328130|NCT02536300|520405442|FG000|Overall Study|Non-compliance With Study Drug|1|||
144328131|NCT02536300|520405443|FG001|Overall Study|Non-compliance With Study Drug|0|||
144328132|NCT02536300|520405444|FG002|Overall Study|Non-compliance With Study Drug|0|||
144328133|NCT02536300|520405442|FG000|Overall Study|Protocol Violation|0|||
144328134|NCT02536300|520405443|FG001|Overall Study|Protocol Violation|1|||
144328135|NCT02536300|520405444|FG002|Overall Study|Protocol Violation|0|||
144328136|NCT00096174|520405452|FG000|Overall Study|Lack of Efficacy|9|||
144328137|NCT00096174|520405452|FG000|Overall Study|Adverse Event|15|||
144328138|NCT00096174|520405452|FG000|Overall Study|Death|6|||
144328139|NCT00096174|520405452|FG000|Overall Study|Withdrawal by Subject|15|||
144328140|NCT00096174|520405452|FG000|Overall Study|Not started protocol therapy|3|||
144328141|NCT00096174|520405452|FG000|Overall Study|Ineligible|6|||
144328142|NCT00096174|520405452|FG000|Overall Study|other reason|8|||
144328143|NCT00330928|520405453|FG000|Overall Study|Lost to Follow-up|6|||
144328144|NCT00330928|520405453|FG000|Overall Study|Physician Decision|9|||
144328145|NCT00330928|520405453|FG000|Overall Study|Death|1|||
144328146|NCT00330928|520405453|FG000|Overall Study|IVUS could not be performed.|1|||
144328147|NCT03028480|520405456|FG000|Overall Study|No revisit after the first prescription date|2|||
144328148|NCT03028480|520405456|FG000|Overall Study|Did not use the drug|1|||
144328149|NCT03028480|520405456|FG000|Overall Study|Violation of the enrollment deadline|10|||
144328150|NCT03028480|520405456|FG000|Overall Study|Case report forms were not collected|21|||
144328151|NCT03554772|520405460|FG000|Overall Study|Lost to Follow-up|0|||
144328152|NCT03554772|520405461|FG001|Overall Study|Lost to Follow-up|0|||
144328153|NCT03554772|520405462|FG002|Overall Study|Lost to Follow-up|0|||
144328154|NCT03554772|520405463|FG003|Overall Study|Lost to Follow-up|2|||
144328155|NCT01133405|520405468|FG000|Period 1|Withdrawal by Subject|0|||
144328156|NCT01133405|520405469|FG001|Period 1|Withdrawal by Subject|1|||
144328157|NCT01133405|520405470|FG002|Period 1|Withdrawal by Subject|0|||
144328158|NCT01133405|520405471|FG003|Period 1|Withdrawal by Subject|1|||
144328159|NCT01133405|520405472|FG004|Period 1|Withdrawal by Subject|0|||
144328160|NCT01133405|520405473|FG005|Period 1|Withdrawal by Subject|1|||
144328161|NCT01133405|520405474|FG006|Period 1|Withdrawal by Subject|0|||
144328162|NCT01133405|520405475|FG007|Period 1|Withdrawal by Subject|0|||
144328163|NCT01133405|520405476|FG008|Period 1|Withdrawal by Subject|0|||
144328164|NCT01133405|520405477|FG009|Period 1|Withdrawal by Subject|0|||
144328165|NCT01133405|520405468|FG000|Period 1|Physician Decision|0|||
144328166|NCT01133405|520405469|FG001|Period 1|Physician Decision|0|||
144328167|NCT01133405|520405470|FG002|Period 1|Physician Decision|0|||
144328168|NCT01133405|520405471|FG003|Period 1|Physician Decision|1|||
144328169|NCT01133405|520405472|FG004|Period 1|Physician Decision|0|||
144328170|NCT01133405|520405473|FG005|Period 1|Physician Decision|0|||
144328171|NCT01133405|520405474|FG006|Period 1|Physician Decision|0|||
144328172|NCT01133405|520405475|FG007|Period 1|Physician Decision|0|||
144328173|NCT01133405|520405476|FG008|Period 1|Physician Decision|0|||
144328174|NCT01133405|520405477|FG009|Period 1|Physician Decision|0|||
144328175|NCT01133405|520405468|FG000|Period 1|Discontinued after randomization|1|||
144328176|NCT01133405|520405469|FG001|Period 1|Discontinued after randomization|0|||
144328177|NCT01133405|520405470|FG002|Period 1|Discontinued after randomization|0|||
144328178|NCT01133405|520405471|FG003|Period 1|Discontinued after randomization|0|||
144328179|NCT01133405|520405472|FG004|Period 1|Discontinued after randomization|0|||
144328180|NCT01133405|520405473|FG005|Period 1|Discontinued after randomization|0|||
144328181|NCT01133405|520405474|FG006|Period 1|Discontinued after randomization|1|||
144328182|NCT01133405|520405475|FG007|Period 1|Discontinued after randomization|0|||
144328183|NCT01133405|520405476|FG008|Period 1|Discontinued after randomization|0|||
144328184|NCT01133405|520405477|FG009|Period 1|Discontinued after randomization|0|||
144328185|NCT01133405|520405468|FG000|Period 1|Received drug only in period 2|0|||
144328186|NCT01133405|520405469|FG001|Period 1|Received drug only in period 2|1|||
144328187|NCT01133405|520405470|FG002|Period 1|Received drug only in period 2|0|||
144328188|NCT01133405|520405471|FG003|Period 1|Received drug only in period 2|2|||
144328189|NCT01133405|520405472|FG004|Period 1|Received drug only in period 2|0|||
144328190|NCT01133405|520405473|FG005|Period 1|Received drug only in period 2|1|||
144328191|NCT01133405|520405474|FG006|Period 1|Received drug only in period 2|0|||
144328192|NCT01133405|520405475|FG007|Period 1|Received drug only in period 2|0|||
144328193|NCT01133405|520405476|FG008|Period 1|Received drug only in period 2|0|||
144328194|NCT01133405|520405477|FG009|Period 1|Received drug only in period 2|0|||
144328195|NCT01133405|520405468|FG000|Period 1|Received drug only in period 3|0|||
144328196|NCT01133405|520405469|FG001|Period 1|Received drug only in period 3|1|||
144328197|NCT01133405|520405470|FG002|Period 1|Received drug only in period 3|1|||
144328198|NCT01133405|520405471|FG003|Period 1|Received drug only in period 3|0|||
144328199|NCT01133405|520405472|FG004|Period 1|Received drug only in period 3|0|||
144328200|NCT01133405|520405473|FG005|Period 1|Received drug only in period 3|0|||
144328201|NCT01133405|520405474|FG006|Period 1|Received drug only in period 3|0|||
144328202|NCT01133405|520405475|FG007|Period 1|Received drug only in period 3|0|||
144328203|NCT01133405|520405476|FG008|Period 1|Received drug only in period 3|0|||
144328204|NCT01133405|520405477|FG009|Period 1|Received drug only in period 3|0|||
144328205|NCT01133405|520405468|FG000|Period 2|Adverse Event|0|||
144328206|NCT01133405|520405469|FG001|Period 2|Adverse Event|0|||
144328207|NCT01133405|520405470|FG002|Period 2|Adverse Event|1|||
144328208|NCT01133405|520405471|FG003|Period 2|Adverse Event|0|||
144328209|NCT01133405|520405472|FG004|Period 2|Adverse Event|0|||
144328210|NCT01133405|520405473|FG005|Period 2|Adverse Event|0|||
144328211|NCT01133405|520405474|FG006|Period 2|Adverse Event|0|||
144328212|NCT01133405|520405475|FG007|Period 2|Adverse Event|0|||
144328213|NCT01133405|520405476|FG008|Period 2|Adverse Event|0|||
144328214|NCT01133405|520405477|FG009|Period 2|Adverse Event|0|||
144328215|NCT01133405|520405468|FG000|Period 2|Withdrawal by Subject|0|||
144328216|NCT01133405|520405469|FG001|Period 2|Withdrawal by Subject|0|||
144328217|NCT01133405|520405470|FG002|Period 2|Withdrawal by Subject|0|||
144328218|NCT01133405|520405471|FG003|Period 2|Withdrawal by Subject|1|||
144328219|NCT01133405|520405472|FG004|Period 2|Withdrawal by Subject|0|||
144328220|NCT01133405|520405473|FG005|Period 2|Withdrawal by Subject|1|||
144328221|NCT01133405|520405474|FG006|Period 2|Withdrawal by Subject|0|||
144328222|NCT01133405|520405475|FG007|Period 2|Withdrawal by Subject|0|||
144328223|NCT01133405|520405476|FG008|Period 2|Withdrawal by Subject|0|||
144328224|NCT01133405|520405477|FG009|Period 2|Withdrawal by Subject|0|||
144328225|NCT01133405|520405468|FG000|Period 2|Entry Criteria Not Met|0|||
144328226|NCT01133405|520405469|FG001|Period 2|Entry Criteria Not Met|1|||
144328227|NCT01133405|520405470|FG002|Period 2|Entry Criteria Not Met|0|||
144328228|NCT01133405|520405471|FG003|Period 2|Entry Criteria Not Met|0|||
144328229|NCT01133405|520405472|FG004|Period 2|Entry Criteria Not Met|0|||
144328230|NCT01133405|520405473|FG005|Period 2|Entry Criteria Not Met|0|||
144328231|NCT01133405|520405474|FG006|Period 2|Entry Criteria Not Met|0|||
144328232|NCT01133405|520405475|FG007|Period 2|Entry Criteria Not Met|0|||
144328233|NCT01133405|520405476|FG008|Period 2|Entry Criteria Not Met|0|||
144328234|NCT01133405|520405477|FG009|Period 2|Entry Criteria Not Met|0|||
144328235|NCT01133405|520405468|FG000|Period 2|Physician Decision|0|||
144328236|NCT01133405|520405469|FG001|Period 2|Physician Decision|0|||
144328237|NCT01133405|520405470|FG002|Period 2|Physician Decision|0|||
144328238|NCT01133405|520405471|FG003|Period 2|Physician Decision|0|||
144328239|NCT01133405|520405472|FG004|Period 2|Physician Decision|0|||
144328240|NCT01133405|520405473|FG005|Period 2|Physician Decision|1|||
144328241|NCT01133405|520405474|FG006|Period 2|Physician Decision|0|||
144328242|NCT01133405|520405475|FG007|Period 2|Physician Decision|0|||
144328243|NCT01133405|520405476|FG008|Period 2|Physician Decision|0|||
144328244|NCT01133405|520405477|FG009|Period 2|Physician Decision|0|||
144328245|NCT01238835|520405486|FG000|Overall Study|Death|124|||
144328246|NCT01238835|520405486|FG000|Overall Study|Withdrawal by Subject|9|||
144328247|NCT01238835|520405486|FG000|Overall Study|Lost to Follow-up|1|||
144328248|NCT01238835|520405486|FG000|Overall Study|Site early discontinuation|2|||
144328249|NCT00907803|520405488|FG000|Overall Study|Withdrawal of consent - long commute|1|||
144328250|NCT00907803|520405489|FG001|Overall Study|Withdrawal of consent - long commute|0|||
144328251|NCT00907803|520405490|FG002|Overall Study|Withdrawal of consent - long commute|0|||
144328252|NCT00907803|520405488|FG000|Overall Study|Adverse Event|2|||
144328253|NCT00907803|520405489|FG001|Overall Study|Adverse Event|0|||
144328254|NCT00907803|520405490|FG002|Overall Study|Adverse Event|0|||
144328255|NCT00907803|520405488|FG000|Overall Study|Withdrawal by Subject|0|||
144328256|NCT00907803|520405489|FG001|Overall Study|Withdrawal by Subject|1|||
144328257|NCT00907803|520405490|FG002|Overall Study|Withdrawal by Subject|0|||
144328258|NCT00907803|520405488|FG000|Overall Study|Lost to Follow-up|0|||
144328259|NCT00907803|520405489|FG001|Overall Study|Lost to Follow-up|1|||
144328260|NCT00907803|520405490|FG002|Overall Study|Lost to Follow-up|0|||
144328261|NCT00907803|520405488|FG000|Overall Study|Protocol Violation|0|||
144328262|NCT00907803|520405489|FG001|Overall Study|Protocol Violation|1|||
144328263|NCT00907803|520405490|FG002|Overall Study|Protocol Violation|0|||
144328264|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Death|1|||
144328265|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Death|1|||
144328266|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Death|0|||
144328267|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Death|0|||
144328268|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Death|1|||
144328269|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Death|0|||
144328270|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Death|0|||
144328271|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Death|0|||
144328272|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Death|0|||
144328273|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Death|0|||
144328274|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
144328275|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
144328276|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
144328277|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
144328278|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
144328279|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
144328280|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
144328281|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
144328282|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
144328283|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
144328284|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328285|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328286|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328287|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328288|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
144328289|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328290|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328291|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328292|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328293|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
144328294|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
144328295|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328296|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328297|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328298|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328299|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328300|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328301|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328302|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328303|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
144328304|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
144328305|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328306|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328307|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
144328308|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
144328309|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328310|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328311|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328312|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328313|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
144328314|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
144328315|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328316|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328317|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
144328318|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328319|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328320|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328321|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328322|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328323|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
144328324|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
144328325|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
144328326|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
144328327|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
144328328|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
144328329|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
144328330|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
144328331|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
144328332|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
144328333|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
144328334|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
144328335|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
144328336|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
144328337|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328338|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
144328339|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328340|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328341|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328342|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328343|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328344|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
144328345|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328346|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328347|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
144328348|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
144328349|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328350|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328351|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328352|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328353|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
144328354|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328355|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328356|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328357|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328358|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328359|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328360|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328361|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328362|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328363|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328364|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328365|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328366|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
144328367|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328368|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
144328369|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328370|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328371|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328372|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328373|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328374|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
144328375|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
144328376|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
144328377|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
144328378|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
144328379|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
144328380|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
144328381|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
144328382|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
144328383|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
144328384|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328385|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328386|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328387|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
144328388|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
144328389|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328390|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328391|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328392|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328393|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328394|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
144328395|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328396|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
144328397|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
144328398|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
144328399|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328400|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328401|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328402|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328403|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328404|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
144328405|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328406|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328407|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328408|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
144328409|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328410|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328411|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328412|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328413|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
144328414|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328415|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328416|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328417|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144359621|NCT00402168|520522827|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
144328418|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
144328419|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328420|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328421|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328422|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328423|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328424|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328425|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
144328426|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328427|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328428|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
144328429|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328430|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328431|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328432|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328433|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
144328434|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
144328435|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328436|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328437|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328438|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
144328439|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328440|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328441|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328442|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328443|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
144328444|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
144328445|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328446|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
144328447|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328448|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
144328449|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328450|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328451|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328452|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328453|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
144328454|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Other|5|||
144328455|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Other|1|||
144328456|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Other|0|||
144328457|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Other|3|||
144328458|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Other|0|||
144328459|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Other|0|||
144328460|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Other|0|||
144328461|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Other|0|||
144328462|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Other|0|||
144328463|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Other|0|||
144328464|NCT03352557|520405491|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328465|NCT03352557|520405492|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328466|NCT03352557|520405493|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328467|NCT03352557|520405494|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328468|NCT03352557|520405495|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
144328469|NCT03352557|520405496|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328470|NCT03352557|520405497|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328471|NCT03352557|520405498|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328472|NCT03352557|520405499|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328473|NCT03352557|520405500|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
144328474|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Death|0|||
144328475|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Death|0|||
144328476|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Death|0|||
144328477|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Death|0|||
144328478|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Death|0|||
144328479|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Death|1|||
144328480|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Death|0|||
144328481|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Death|1|||
144328482|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Death|1|||
144328483|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Death|1|||
144328484|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328485|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328486|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328487|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328488|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328489|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
144328490|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328491|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328492|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328493|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
144328494|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328495|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328496|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328497|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328498|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328499|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328500|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328501|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328502|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
144328503|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
144328504|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
144328505|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
144328506|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
144328507|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
144328508|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
144328509|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
144328510|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
144328511|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
144328512|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
144328513|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
144328514|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328515|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328516|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328517|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328518|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328519|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
144328520|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
144328521|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
144328522|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
144328523|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
144328524|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328525|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328526|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328527|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328528|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328529|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328530|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328531|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328532|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
144328533|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
144328534|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
144328535|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
144328536|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
144328537|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
144328538|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
144328539|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
144328540|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
144328541|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
144328542|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
144328543|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
144328544|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328545|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328546|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328547|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328548|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328549|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328550|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328551|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
144328552|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
144328553|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
144328554|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328555|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328556|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328557|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328558|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328559|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328560|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328561|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
144328562|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328563|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
144328564|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328565|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328566|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328567|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328568|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328569|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328570|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328571|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
144328572|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328573|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
144328574|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328575|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328576|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328577|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328578|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328579|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328580|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328581|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
144328582|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
144328583|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
144328584|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328585|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328586|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328587|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328588|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328589|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
144328590|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328591|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328592|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
144328593|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
144328594|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328595|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328596|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328597|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328598|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328599|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328600|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328601|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328602|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
144328603|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
144328604|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328605|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328606|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328607|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328608|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328609|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328610|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328611|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
144328612|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
144328613|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
144328614|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328615|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328616|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328617|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328618|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328619|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328620|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328621|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
144328622|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
144328623|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
144328624|NCT03352557|520405491|FG000|LTE Period: Week 80 to Week 173|Other|0|||
144328625|NCT03352557|520405492|FG001|LTE Period: Week 80 to Week 173|Other|0|||
144328626|NCT03352557|520405493|FG002|LTE Period: Week 80 to Week 173|Other|0|||
144328627|NCT03352557|520405494|FG003|LTE Period: Week 80 to Week 173|Other|0|||
144328628|NCT03352557|520405495|FG004|LTE Period: Week 80 to Week 173|Other|0|||
144328629|NCT03352557|520405496|FG005|LTE Period: Week 80 to Week 173|Other|0|||
144328630|NCT03352557|520405497|FG006|LTE Period: Week 80 to Week 173|Other|0|||
144328631|NCT03352557|520405498|FG007|LTE Period: Week 80 to Week 173|Other|1|||
144328632|NCT03352557|520405499|FG008|LTE Period: Week 80 to Week 173|Other|0|||
144328633|NCT03352557|520405500|FG009|LTE Period: Week 80 to Week 173|Other|0|||
144328634|NCT04612842|520405501|FG000|Overall Study|Lost to Follow-up|20|||
144328635|NCT04612842|520405502|FG001|Overall Study|Lost to Follow-up|11|||
144328636|NCT04612842|520405501|FG000|Overall Study|Withdrawal by Subject|26|||
144328637|NCT04612842|520405502|FG001|Overall Study|Withdrawal by Subject|15|||
144328638|NCT04612842|520405501|FG000|Overall Study|Death|2|||
144328639|NCT04612842|520405502|FG001|Overall Study|Death|2|||
144328640|NCT03060512|520405503|FG000|Overall Study|Adverse Event|4|||
144328641|NCT03060512|520405504|FG001|Overall Study|Adverse Event|6|||
144328642|NCT03060512|520405503|FG000|Overall Study|Lost to Follow-up|1|||
144328643|NCT03060512|520405504|FG001|Overall Study|Lost to Follow-up|1|||
144328644|NCT03060512|520405503|FG000|Overall Study|Withdrawal by Subject|1|||
144328645|NCT03060512|520405504|FG001|Overall Study|Withdrawal by Subject|0|||
144328646|NCT03060512|520405503|FG000|Overall Study|Non-compliance with study medication|1|||
144328647|NCT03060512|520405504|FG001|Overall Study|Non-compliance with study medication|2|||
144328648|NCT01218100|520405507|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
144328649|NCT01218100|520405508|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
144328650|NCT01218100|520405509|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
144328651|NCT01218100|520405510|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
144328652|NCT01218100|520405507|FG000|Overall Study|Adverse Event|4|||
144328653|NCT01218100|520405508|FG001|Overall Study|Adverse Event|6|||
144328654|NCT01218100|520405509|FG002|Overall Study|Adverse Event|6|||
144328655|NCT01218100|520405510|FG003|Overall Study|Adverse Event|7|||
144328656|NCT01218100|520405507|FG000|Overall Study|Lack of Efficacy|9|||
144328657|NCT01218100|520405508|FG001|Overall Study|Lack of Efficacy|6|||
144328658|NCT01218100|520405509|FG002|Overall Study|Lack of Efficacy|5|||
144328659|NCT01218100|520405510|FG003|Overall Study|Lack of Efficacy|12|||
144328660|NCT01218100|520405507|FG000|Overall Study|Protocol Violation|0|||
144328661|NCT01218100|520405508|FG001|Overall Study|Protocol Violation|0|||
144328662|NCT01218100|520405509|FG002|Overall Study|Protocol Violation|1|||
144328663|NCT01218100|520405510|FG003|Overall Study|Protocol Violation|1|||
144328664|NCT01218100|520405507|FG000|Overall Study|Withdrawal by Subject|5|||
144328665|NCT01218100|520405508|FG001|Overall Study|Withdrawal by Subject|2|||
144328666|NCT01218100|520405509|FG002|Overall Study|Withdrawal by Subject|6|||
144328667|NCT01218100|520405510|FG003|Overall Study|Withdrawal by Subject|7|||
144328668|NCT01218100|520405507|FG000|Overall Study|Lost to Follow-up|3|||
144328669|NCT01218100|520405508|FG001|Overall Study|Lost to Follow-up|8|||
144328670|NCT01218100|520405509|FG002|Overall Study|Lost to Follow-up|2|||
144328671|NCT01218100|520405510|FG003|Overall Study|Lost to Follow-up|1|||
144328672|NCT01218100|520405507|FG000|Overall Study|Other Reason|2|||
144328673|NCT01218100|520405508|FG001|Overall Study|Other Reason|2|||
144328674|NCT01218100|520405509|FG002|Overall Study|Other Reason|6|||
144328675|NCT01218100|520405510|FG003|Overall Study|Other Reason|4|||
144328676|NCT00241631|520405511|FG000|Run in (2 Weeks)|Physician Decision|3|||
144328677|NCT00241631|520405512|FG001|Run in (2 Weeks)|Physician Decision|3|||
144328678|NCT00241631|520405511|FG000|Phase 1 (4 Weeks)|sore throat|1|||
144328679|NCT00241631|520405512|FG001|Phase 1 (4 Weeks)|sore throat|0|||
144328680|NCT00241631|520405511|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
144328681|NCT00241631|520405512|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
144328682|NCT00241631|520405511|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
144328683|NCT00241631|520405512|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
144328684|NCT00241631|520405511|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
144328685|NCT00241631|520405512|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
144328686|NCT01089023|520405518|FG000|Overall Study|Lost to Follow-up|3|||
144328687|NCT01089023|520405518|FG000|Overall Study|Adverse Event|1|||
144328688|NCT01089023|520405518|FG000|Overall Study|Withdrawal by Subject|1|||
144328689|NCT01089023|520405518|FG000|Overall Study|Protocol Violation|1|||
144328690|NCT01089023|520405518|FG000|Overall Study|Lack of Efficacy|1|||
144328691|NCT00413920|520405520|FG000|Overall Study|Adverse Event|9|||
144328692|NCT00413920|520405521|FG001|Overall Study|Adverse Event|11|||
144328693|NCT00413920|520405520|FG000|Overall Study|Lack of Efficacy|11|||
144328694|NCT00413920|520405521|FG001|Overall Study|Lack of Efficacy|9|||
144328695|NCT00413920|520405520|FG000|Overall Study|Death|3|||
144328696|NCT00413920|520405521|FG001|Overall Study|Death|5|||
144328697|NCT00413920|520405520|FG000|Overall Study|Graft Loss|5|||
144328698|NCT00413920|520405521|FG001|Overall Study|Graft Loss|3|||
144328699|NCT03883113|520405523|FG000|Overall Study|Physician Decision|4|||
144328700|NCT03883113|520405524|FG001|Overall Study|Physician Decision|2|||
144328701|NCT03883113|520405523|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
144328702|NCT03883113|520405524|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
144328703|NCT03883113|520405523|FG000|Overall Study|Pregnancy|1|||
144328704|NCT03883113|520405524|FG001|Overall Study|Pregnancy|0|||
144328705|NCT03883113|520405523|FG000|Overall Study|Adverse Event|0|||
144328706|NCT03883113|520405524|FG001|Overall Study|Adverse Event|1|||
144328707|NCT03883113|520405523|FG000|Overall Study|Withdrawal by Subject|1|||
144328708|NCT03883113|520405524|FG001|Overall Study|Withdrawal by Subject|2|||
144328709|NCT03883113|520405523|FG000|Overall Study|Lost to Follow-up|1|||
144328710|NCT03883113|520405524|FG001|Overall Study|Lost to Follow-up|0|||
144328711|NCT03158012|520405525|FG000|Overall Study|Withdrawal by Subject|0|||
144328712|NCT03158012|520405526|FG001|Overall Study|Withdrawal by Subject|1|||
144328713|NCT02788201|520405527|FG000|Overall Study|Death|1|||
144328714|NCT02788201|520405528|FG001|Overall Study|Death|1|||
144328715|NCT02788201|520405529|FG002|Overall Study|Death|1|||
144328716|NCT02788201|520405530|FG003|Overall Study|Death|1|||
144328717|NCT02788201|520405531|FG004|Overall Study|Death|0|||
144328718|NCT02788201|520405532|FG005|Overall Study|Death|1|||
144328719|NCT02788201|520405527|FG000|Overall Study|Ineligible|0|||
144328720|NCT02788201|520405528|FG001|Overall Study|Ineligible|0|||
144328721|NCT02788201|520405529|FG002|Overall Study|Ineligible|0|||
144328722|NCT02788201|520405530|FG003|Overall Study|Ineligible|0|||
144328723|NCT02788201|520405531|FG004|Overall Study|Ineligible|0|||
144328724|NCT02788201|520405532|FG005|Overall Study|Ineligible|1|||
144328725|NCT02788201|520405527|FG000|Overall Study|Withdrawal by Subject|0|||
144328726|NCT02788201|520405528|FG001|Overall Study|Withdrawal by Subject|0|||
144328727|NCT02788201|520405529|FG002|Overall Study|Withdrawal by Subject|0|||
144328728|NCT02788201|520405530|FG003|Overall Study|Withdrawal by Subject|0|||
144328729|NCT02788201|520405531|FG004|Overall Study|Withdrawal by Subject|0|||
144328730|NCT02788201|520405532|FG005|Overall Study|Withdrawal by Subject|1|||
144328731|NCT01852825|520405533|FG000|Overall Study|Withdrawal by Subject|2|||
144328732|NCT01852825|520405534|FG001|Overall Study|Withdrawal by Subject|0|||
144328733|NCT01852825|520405535|FG002|Overall Study|Withdrawal by Subject|0|||
144328734|NCT02446418|520405541|FG000|Overall Study|Adverse Event|4|||
144328735|NCT02446418|520405542|FG001|Overall Study|Adverse Event|8|||
144328736|NCT02446418|520405541|FG000|Overall Study|Physician Decision|5|||
144328737|NCT02446418|520405542|FG001|Overall Study|Physician Decision|1|||
144328738|NCT02446418|520405541|FG000|Overall Study|Withdrawal by Subject|3|||
144328739|NCT02446418|520405542|FG001|Overall Study|Withdrawal by Subject|3|||
144328740|NCT02446418|520405541|FG000|Overall Study|Lost to Follow-up|2|||
144328741|NCT02446418|520405542|FG001|Overall Study|Lost to Follow-up|2|||
144328742|NCT02446418|520405541|FG000|Overall Study|Protocol Violation|1|||
144328743|NCT02446418|520405542|FG001|Overall Study|Protocol Violation|2|||
144328744|NCT02446418|520405541|FG000|Overall Study|Lack of Efficacy|2|||
144328745|NCT02446418|520405542|FG001|Overall Study|Lack of Efficacy|0|||
144328746|NCT02446418|520405541|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
144328747|NCT02446418|520405542|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
144328748|NCT01338610|520405543|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
144328749|NCT01338610|520405544|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
144328750|NCT01338610|520405545|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
144328751|NCT01338610|520405543|FG000|Overall Study|Protocol Violation|1|||
144328752|NCT01338610|520405544|FG001|Overall Study|Protocol Violation|0|||
144328753|NCT01338610|520405545|FG002|Overall Study|Protocol Violation|1|||
144328754|NCT01338610|520405543|FG000|Overall Study|Adverse Event|3|||
144328755|NCT01338610|520405544|FG001|Overall Study|Adverse Event|0|||
144328756|NCT01338610|520405545|FG002|Overall Study|Adverse Event|0|||
144328757|NCT03421743|520405548|FG000|Overall Study|Lack of Efficacy|1|||
144328758|NCT03421743|520405549|FG001|Overall Study|Lack of Efficacy|0|||
144328759|NCT03421743|520405548|FG000|Overall Study|Adverse Event|2|||
144328760|NCT03421743|520405549|FG001|Overall Study|Adverse Event|1|||
144328761|NCT03421743|520405548|FG000|Overall Study|Withdrawal by Subject|0|||
144328762|NCT03421743|520405549|FG001|Overall Study|Withdrawal by Subject|1|||
144328763|NCT01765426|520405550|FG000|Overall Study|Lost to Follow-up|0|||
144328764|NCT01765426|520405551|FG001|Overall Study|Lost to Follow-up|1|||
144328765|NCT01765426|520405552|FG002|Overall Study|Lost to Follow-up|0|||
144328766|NCT01765426|520405553|FG003|Overall Study|Lost to Follow-up|0|||
144328767|NCT00054691|520405554|FG000|Overall Study|Unmeasurable Disease|2|||
144328768|NCT00054691|520405554|FG000|Overall Study|Noncompliant|1|||
144328769|NCT00694096|520405561|FG000|Overall Study|Withdrawal by Subject|5|||
144328770|NCT01484834|520405564|FG000|Overall Study|Lost to Follow-up|5|||
144328771|NCT01484834|520405565|FG001|Overall Study|Lost to Follow-up|8|||
144328772|NCT01484834|520405566|FG002|Overall Study|Lost to Follow-up|1|||
144328773|NCT01484834|520405567|FG003|Overall Study|Lost to Follow-up|4|||
144328774|NCT01371643|520405568|FG000|Overall Study|Withdrawal by Subject|3|||
144328775|NCT01371643|520405569|FG001|Overall Study|Withdrawal by Subject|0|||
144328776|NCT03987932|520405571|FG000|Overall Study|Lost to Follow-up|2|||
144328777|NCT03987932|520405572|FG001|Overall Study|Lost to Follow-up|1|||
144328778|NCT03987932|520405573|FG002|Overall Study|Lost to Follow-up|1|||
144328779|NCT03987932|520405571|FG000|Overall Study|Non-study related elective surgery|0|||
144328780|NCT03987932|520405572|FG001|Overall Study|Non-study related elective surgery|0|||
144328781|NCT03987932|520405573|FG002|Overall Study|Non-study related elective surgery|1|||
144328782|NCT01605227|520405577|FG000|Overall Study|Did not receive study treatment|2|||
144328783|NCT01605227|520405578|FG001|Overall Study|Did not receive study treatment|3|||
144328784|NCT01605227|520405577|FG000|Overall Study|Adverse Event|228|||
144328785|NCT01605227|520405578|FG001|Overall Study|Adverse Event|42|||
144328786|NCT01605227|520405577|FG000|Overall Study|Progressive Disease|132|||
144328787|NCT01605227|520405578|FG001|Overall Study|Progressive Disease|128|||
144328788|NCT01605227|520405577|FG000|Overall Study|Clinical Deterioration|227|||
144328789|NCT01605227|520405578|FG001|Overall Study|Clinical Deterioration|133|||
144328790|NCT01605227|520405577|FG000|Overall Study|Lost to Follow-up|1|||
144328791|NCT01605227|520405578|FG001|Overall Study|Lost to Follow-up|0|||
144328792|NCT01605227|520405577|FG000|Overall Study|Protocol Violation|1|||
144328793|NCT01605227|520405578|FG001|Overall Study|Protocol Violation|0|||
144328794|NCT01605227|520405577|FG000|Overall Study|Physician Decision|9|||
144328795|NCT01605227|520405578|FG001|Overall Study|Physician Decision|7|||
144328796|NCT01605227|520405577|FG000|Overall Study|Withdrawal by Subject|18|||
144328797|NCT01605227|520405578|FG001|Overall Study|Withdrawal by Subject|14|||
144328798|NCT01605227|520405577|FG000|Overall Study|Sponsor Decision|2|||
144328799|NCT01605227|520405578|FG001|Overall Study|Sponsor Decision|0|||
144328800|NCT01605227|520405577|FG000|Overall Study|Started New Therapy|1|||
144328801|NCT01605227|520405578|FG001|Overall Study|Started New Therapy|0|||
144328802|NCT01605227|520405577|FG000|Overall Study|Subject Decision|0|||
144328803|NCT01605227|520405578|FG001|Overall Study|Subject Decision|1|||
144328804|NCT01605227|520405577|FG000|Overall Study|Dose Held >6 weeks|0|||
144328805|NCT01605227|520405578|FG001|Overall Study|Dose Held >6 weeks|1|||
144328806|NCT02387164|520405580|FG000|Overall Study|Lost to Follow-up|2|||
144328807|NCT02387164|520405581|FG001|Overall Study|Lost to Follow-up|0|||
144328808|NCT02387164|520405580|FG000|Overall Study|Diagnosed|1|||
144328809|NCT02387164|520405581|FG001|Overall Study|Diagnosed|2|||
144328810|NCT02370641|520405582|FG000|Overall Study|dropped study|4|||
144328811|NCT02370641|520405583|FG001|Overall Study|dropped study|2|||
144328812|NCT02436408|520405591|FG000|Overall Study|Death|1|||
144328813|NCT00526110|520405595|FG000|Overall Study|Adverse Event|2|||
144328814|NCT00526110|520405596|FG001|Overall Study|Adverse Event|9|||
144328815|NCT00526110|520405595|FG000|Overall Study|Disease Progression|0|||
144328816|NCT00526110|520405596|FG001|Overall Study|Disease Progression|19|||
144328817|NCT00526110|520405595|FG000|Overall Study|Maximal Response|0|||
144328818|NCT00526110|520405596|FG001|Overall Study|Maximal Response|6|||
144328819|NCT00526110|520405595|FG000|Overall Study|Withdrawal by Subject|0|||
144328820|NCT00526110|520405596|FG001|Overall Study|Withdrawal by Subject|2|||
144328821|NCT00526110|520405595|FG000|Overall Study|Poor Tolerance|0|||
144328822|NCT00526110|520405596|FG001|Overall Study|Poor Tolerance|5|||
144328823|NCT01400243|520405597|FG000|Overall Study|Protocol Violation|8|||
144328824|NCT01400243|520405598|FG001|Overall Study|Protocol Violation|11|||
144328825|NCT02193087|520405600|FG000|Overall Study|Adverse Event|2|||
144328826|NCT02193087|520405601|FG001|Overall Study|Adverse Event|0|||
144328827|NCT02193087|520405602|FG002|Overall Study|Adverse Event|0|||
144328828|NCT02193087|520405603|FG003|Overall Study|Adverse Event|11|||
144328829|NCT02193087|520405600|FG000|Overall Study|Lost to Follow-up|14|||
144328830|NCT02193087|520405601|FG001|Overall Study|Lost to Follow-up|6|||
144328831|NCT02193087|520405602|FG002|Overall Study|Lost to Follow-up|4|||
144328832|NCT02193087|520405603|FG003|Overall Study|Lost to Follow-up|37|||
144328833|NCT02193087|520405600|FG000|Overall Study|Protocol Violation|2|||
144328834|NCT02193087|520405601|FG001|Overall Study|Protocol Violation|0|||
144328835|NCT02193087|520405602|FG002|Overall Study|Protocol Violation|1|||
144328836|NCT02193087|520405603|FG003|Overall Study|Protocol Violation|2|||
144328837|NCT02193087|520405600|FG000|Overall Study|Withdrawal by Subject|10|||
144328838|NCT02193087|520405601|FG001|Overall Study|Withdrawal by Subject|3|||
144328839|NCT02193087|520405602|FG002|Overall Study|Withdrawal by Subject|1|||
144328840|NCT02193087|520405603|FG003|Overall Study|Withdrawal by Subject|19|||
144328841|NCT02193087|520405600|FG000|Overall Study|Other Reason Not Specified|7|||
144328842|NCT02193087|520405601|FG001|Overall Study|Other Reason Not Specified|2|||
144328843|NCT02193087|520405602|FG002|Overall Study|Other Reason Not Specified|1|||
144328844|NCT02193087|520405603|FG003|Overall Study|Other Reason Not Specified|9|||
144328845|NCT02193087|520405600|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
144328846|NCT02193087|520405601|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
144328847|NCT02193087|520405602|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
144328848|NCT02193087|520405603|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
144328849|NCT02278614|520405606|FG000|Overall Study|Withdrawal by Subject|3|||
144328850|NCT02278614|520405607|FG001|Overall Study|Withdrawal by Subject|5|||
144328851|NCT02278614|520405606|FG000|Overall Study|Adverse Event|1|||
144328852|NCT02278614|520405607|FG001|Overall Study|Adverse Event|0|||
144328853|NCT02278614|520405606|FG000|Overall Study|left eye was not eligible|1|||
144328854|NCT02278614|520405607|FG001|Overall Study|left eye was not eligible|0|||
144328855|NCT03762616|520405609|FG000|Overall Study|Protocol Violation|2|||
144328856|NCT03959982|520408669|FG000|Overall Study|Withdrawal by Subject|1|||
144328857|NCT03959982|520408670|FG001|Overall Study|Withdrawal by Subject|0|||
144328858|NCT03959982|520408669|FG000|Overall Study|Physician Decision|2|||
144328859|NCT03959982|520408670|FG001|Overall Study|Physician Decision|0|||
144328860|NCT03959982|520408669|FG000|Overall Study|Lost to Follow-up|1|||
144328861|NCT03959982|520408670|FG001|Overall Study|Lost to Follow-up|0|||
144328862|NCT00262847|520408671|FG000|Overall Study|Disease Progression|309|||
144328863|NCT00262847|520408672|FG001|Overall Study|Disease Progression|274|||
144328864|NCT00262847|520408673|FG002|Overall Study|Disease Progression|195|||
144328865|NCT00262847|520408671|FG000|Overall Study|Patient Refusal|41|||
144328866|NCT00262847|520408672|FG001|Overall Study|Patient Refusal|52|||
144328867|NCT00262847|520408673|FG002|Overall Study|Patient Refusal|47|||
144328868|NCT00262847|520408671|FG000|Overall Study|Adverse Event|74|||
144328869|NCT00262847|520408672|FG001|Overall Study|Adverse Event|88|||
144328870|NCT00262847|520408673|FG002|Overall Study|Adverse Event|108|||
144328871|NCT00262847|520408671|FG000|Overall Study|Death|8|||
144328872|NCT00262847|520408672|FG001|Overall Study|Death|8|||
144328873|NCT00262847|520408673|FG002|Overall Study|Death|11|||
144328874|NCT00262847|520408671|FG000|Overall Study|Concomitant disease|3|||
144328875|NCT00262847|520408672|FG001|Overall Study|Concomitant disease|2|||
144328876|NCT00262847|520408673|FG002|Overall Study|Concomitant disease|4|||
144328877|NCT00262847|520408671|FG000|Overall Study|Other Reasons|79|||
144328878|NCT00262847|520408672|FG001|Overall Study|Other Reasons|88|||
144328879|NCT00262847|520408673|FG002|Overall Study|Other Reasons|27|||
144328880|NCT00262847|520408671|FG000|Overall Study|Did not receive study treatment|4|||
144328881|NCT00262847|520408672|FG001|Overall Study|Did not receive study treatment|1|||
144328882|NCT00262847|520408673|FG002|Overall Study|Did not receive study treatment|4|||
144328883|NCT00758589|520408674|FG000|Overall Study|Adverse Event|3|||
144328884|NCT00758589|520408675|FG001|Overall Study|Adverse Event|2|||
144328885|NCT00758589|520408676|FG002|Overall Study|Adverse Event|5|||
144328886|NCT00758589|520408677|FG003|Overall Study|Adverse Event|4|||
144328887|NCT00758589|520408674|FG000|Overall Study|Withdrawal by Subject|0|||
144328888|NCT00758589|520408675|FG001|Overall Study|Withdrawal by Subject|1|||
144328889|NCT00758589|520408676|FG002|Overall Study|Withdrawal by Subject|1|||
144328890|NCT00758589|520408677|FG003|Overall Study|Withdrawal by Subject|1|||
144328891|NCT00758589|520408674|FG000|Overall Study|Palm stopped to work|0|||
144328892|NCT00758589|520408675|FG001|Overall Study|Palm stopped to work|0|||
144328893|NCT00758589|520408676|FG002|Overall Study|Palm stopped to work|0|||
144328894|NCT00758589|520408677|FG003|Overall Study|Palm stopped to work|1|||
144328895|NCT03559699|520408694|FG000|Overall Study|Withdrawal by Subject|6|||
144328896|NCT03559699|520408694|FG000|Overall Study|Lost to Follow-up|1|||
144328897|NCT00471887|520408701|FG000|Overall Study|Adverse Event|9|||
144328898|NCT05438602|520408702|FG000|Treatment (15 Days)|Adverse Event|2|||
144328899|NCT05438602|520408703|FG001|Treatment (15 Days)|Adverse Event|1|||
144328900|NCT05438602|520408704|FG002|Treatment (15 Days)|Adverse Event|3|||
144328901|NCT05438602|520408702|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
144328902|NCT05438602|520408703|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
144328903|NCT05438602|520408704|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
144328904|NCT05438602|520408702|FG000|Treatment (15 Days)|Other|0|||
144328905|NCT05438602|520408703|FG001|Treatment (15 Days)|Other|0|||
144328906|NCT05438602|520408704|FG002|Treatment (15 Days)|Other|1|||
144328907|NCT05438602|520408702|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
144328908|NCT05438602|520408703|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
144328909|NCT05438602|520408704|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
144328910|NCT05438602|520408702|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
144328911|NCT05438602|520408703|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
144328912|NCT05438602|520408704|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
144328913|NCT05438602|520408702|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
144328914|NCT05438602|520408703|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
144328915|NCT05438602|520408704|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
144328916|NCT05438602|520408702|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
144328917|NCT05438602|520408703|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
144328918|NCT05438602|520408704|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
144328919|NCT05438602|520408702|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
144328920|NCT05438602|520408703|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
144328921|NCT05438602|520408704|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
144328922|NCT05438602|520408702|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
144328923|NCT05438602|520408703|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
144328924|NCT05438602|520408704|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
144328925|NCT05438602|520408702|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
144328926|NCT05438602|520408703|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
144328927|NCT05438602|520408704|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
144328928|NCT02091284|520408705|FG000|Overall Study|Withdrawal by Subject|2|||
144328929|NCT02091284|520408706|FG001|Overall Study|Withdrawal by Subject|1|||
144328930|NCT02091284|520408705|FG000|Overall Study|unreliable data|1|||
144328931|NCT02091284|520408706|FG001|Overall Study|unreliable data|0|||
144328932|NCT01278407|520408707|FG000|Confirmatory Phase|Adverse Event|5|||
144328933|NCT01278407|520408708|FG001|Confirmatory Phase|Adverse Event|10|||
144328934|NCT01278407|520408709|FG002|Confirmatory Phase|Adverse Event|1|||
144328935|NCT01278407|520408710|FG003|Confirmatory Phase|Adverse Event|0|||
144328936|NCT01278407|520408711|FG004|Confirmatory Phase|Adverse Event|0|||
144328937|NCT01278407|520408707|FG000|Confirmatory Phase|Participant's Choice|3|||
144328938|NCT01278407|520408708|FG001|Confirmatory Phase|Participant's Choice|5|||
144328939|NCT01278407|520408709|FG002|Confirmatory Phase|Participant's Choice|3|||
144328940|NCT01278407|520408710|FG003|Confirmatory Phase|Participant's Choice|0|||
144328941|NCT01278407|520408711|FG004|Confirmatory Phase|Participant's Choice|0|||
144328942|NCT01278407|520408707|FG000|Confirmatory Phase|Other|1|||
144328943|NCT01278407|520408708|FG001|Confirmatory Phase|Other|1|||
144328944|NCT01278407|520408709|FG002|Confirmatory Phase|Other|2|||
144328945|NCT01278407|520408710|FG003|Confirmatory Phase|Other|0|||
144328946|NCT01278407|520408711|FG004|Confirmatory Phase|Other|0|||
144328947|NCT01278407|520408707|FG000|Extension Phase|Adverse Event|0|||
144328948|NCT01278407|520408708|FG001|Extension Phase|Adverse Event|0|||
144328949|NCT01278407|520408709|FG002|Extension Phase|Adverse Event|0|||
144328950|NCT01278407|520408710|FG003|Extension Phase|Adverse Event|7|||
144328951|NCT01278407|520408711|FG004|Extension Phase|Adverse Event|16|||
144328952|NCT01278407|520408707|FG000|Extension Phase|Participant's Choice|0|||
144328953|NCT01278407|520408708|FG001|Extension Phase|Participant's Choice|0|||
144328954|NCT01278407|520408709|FG002|Extension Phase|Participant's Choice|0|||
144328955|NCT01278407|520408710|FG003|Extension Phase|Participant's Choice|4|||
144328956|NCT01278407|520408711|FG004|Extension Phase|Participant's Choice|11|||
144328957|NCT01278407|520408707|FG000|Extension Phase|Other|0|||
144328958|NCT01278407|520408708|FG001|Extension Phase|Other|0|||
144328959|NCT01278407|520408709|FG002|Extension Phase|Other|0|||
144328960|NCT01278407|520408710|FG003|Extension Phase|Other|1|||
144328961|NCT01278407|520408711|FG004|Extension Phase|Other|3|||
144328962|NCT02534935|520408712|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
144328963|NCT02534935|520408713|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
144328964|NCT02534935|520408714|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
144328965|NCT02534935|520408712|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
144328966|NCT02534935|520408713|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
144360037|NCT01601535|520525135|FG000|Phase 2|Started Another Treatment|0|||
144328967|NCT02534935|520408714|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
144328968|NCT02534935|520408712|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
144328969|NCT02534935|520408713|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
144328970|NCT02534935|520408714|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
144328971|NCT02534935|520408712|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
144328972|NCT02534935|520408713|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
144328973|NCT02534935|520408714|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
144328974|NCT02534935|520408712|FG000|Stage 1: 24 Months|Adverse Event|0|||
144328975|NCT02534935|520408713|FG001|Stage 1: 24 Months|Adverse Event|2|||
144328976|NCT02534935|520408714|FG002|Stage 1: 24 Months|Adverse Event|0|||
144328977|NCT02534935|520408712|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
144328978|NCT02534935|520408713|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
144328979|NCT02534935|520408714|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
144328980|NCT02534935|520408712|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
144328981|NCT02534935|520408713|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
144328982|NCT02534935|520408714|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
144328983|NCT01596335|520408715|FG000|Overall Study|exacerbation of primary disease|5|||
144328984|NCT01596335|520408716|FG001|Overall Study|exacerbation of primary disease|9|||
144328985|NCT01460719|520408717|FG000|Overall Study|Adverse Event|1|||
144328986|NCT01460719|520408717|FG000|Overall Study|Withdrawal by Subject|1|||
144328987|NCT04524455|520408724|FG000|Overall Study|Death|3|||
144328988|NCT04524455|520408725|FG001|Overall Study|Death|3|||
144328989|NCT04524455|520408724|FG000|Overall Study|Decision by Sponsor|0|||
144328990|NCT04524455|520408725|FG001|Overall Study|Decision by Sponsor|2|||
144328991|NCT04524455|520408724|FG000|Overall Study|Withdrawal of Consent From Study|1|||
144328992|NCT04524455|520408725|FG001|Overall Study|Withdrawal of Consent From Study|0|||
144328993|NCT04524455|520408724|FG000|Overall Study|Lost to Follow-up|0|||
144328994|NCT04524455|520408725|FG001|Overall Study|Lost to Follow-up|1|||
144328995|NCT01176565|520408730|FG000|Overall Study|Lost to Follow-up|12|||
144328996|NCT01176565|520408731|FG001|Overall Study|Lost to Follow-up|16|||
144328997|NCT01176565|520408730|FG000|Overall Study|Withdrawal by Subject|7|||
144328998|NCT01176565|520408731|FG001|Overall Study|Withdrawal by Subject|1|||
144328999|NCT01176565|520408730|FG000|Overall Study|Not Analyzed (any other reason)|1|||
144329000|NCT01176565|520408731|FG001|Overall Study|Not Analyzed (any other reason)|2|||
144329001|NCT03602885|520408733|FG000|Overall Study|Lost to Follow-up|3|||
144329002|NCT03602885|520408734|FG001|Overall Study|Lost to Follow-up|0|||
144329003|NCT02285114|520408736|FG000|Main Phase|Investigator's Discretion|0|||
144329004|NCT02285114|520408737|FG001|Main Phase|Investigator's Discretion|2|||
144329005|NCT02285114|520408738|FG002|Main Phase|Investigator's Discretion|0|||
144329006|NCT02285114|520408739|FG003|Main Phase|Investigator's Discretion|0|||
144329007|NCT02285114|520408740|FG004|Main Phase|Investigator's Discretion|0|||
144329008|NCT02285114|520408741|FG005|Main Phase|Investigator's Discretion|0|||
144329009|NCT02285114|520408736|FG000|Main Phase|Enrolled but Never Treated|1|||
144329010|NCT02285114|520408737|FG001|Main Phase|Enrolled but Never Treated|0|||
144329011|NCT02285114|520408738|FG002|Main Phase|Enrolled but Never Treated|0|||
144329012|NCT02285114|520408739|FG003|Main Phase|Enrolled but Never Treated|0|||
144329013|NCT02285114|520408740|FG004|Main Phase|Enrolled but Never Treated|0|||
144329014|NCT02285114|520408741|FG005|Main Phase|Enrolled but Never Treated|0|||
144329015|NCT02285114|520408736|FG000|Main Phase|Withdrew Consent|0|||
144329016|NCT02285114|520408737|FG001|Main Phase|Withdrew Consent|0|||
144329017|NCT02285114|520408738|FG002|Main Phase|Withdrew Consent|1|||
144329018|NCT02285114|520408739|FG003|Main Phase|Withdrew Consent|0|||
144329019|NCT02285114|520408740|FG004|Main Phase|Withdrew Consent|0|||
144329020|NCT02285114|520408741|FG005|Main Phase|Withdrew Consent|0|||
144329021|NCT02285114|520408736|FG000|Extension Phase|Investigator's Discretion|0|||
144329022|NCT02285114|520408737|FG001|Extension Phase|Investigator's Discretion|0|||
144329023|NCT02285114|520408738|FG002|Extension Phase|Investigator's Discretion|0|||
144329024|NCT02285114|520408739|FG003|Extension Phase|Investigator's Discretion|14|||
144329025|NCT02285114|520408740|FG004|Extension Phase|Investigator's Discretion|1|||
144329026|NCT02285114|520408741|FG005|Extension Phase|Investigator's Discretion|0|||
144329027|NCT02285114|520408736|FG000|Extension Phase|Lost to Follow-up|0|||
144329028|NCT02285114|520408737|FG001|Extension Phase|Lost to Follow-up|0|||
144329029|NCT02285114|520408738|FG002|Extension Phase|Lost to Follow-up|0|||
144329030|NCT02285114|520408739|FG003|Extension Phase|Lost to Follow-up|1|||
144329031|NCT02285114|520408740|FG004|Extension Phase|Lost to Follow-up|1|||
144329032|NCT02285114|520408741|FG005|Extension Phase|Lost to Follow-up|0|||
144329033|NCT02285114|520408736|FG000|Extension Phase|Non-compliance with Study Drug|0|||
144329034|NCT02285114|520408737|FG001|Extension Phase|Non-compliance with Study Drug|0|||
144329035|NCT02285114|520408738|FG002|Extension Phase|Non-compliance with Study Drug|0|||
144329036|NCT02285114|520408739|FG003|Extension Phase|Non-compliance with Study Drug|2|||
144329037|NCT02285114|520408740|FG004|Extension Phase|Non-compliance with Study Drug|0|||
144329038|NCT02285114|520408741|FG005|Extension Phase|Non-compliance with Study Drug|0|||
144329039|NCT02285114|520408736|FG000|Extension Phase|Pregnancy|0|||
144329040|NCT02285114|520408737|FG001|Extension Phase|Pregnancy|0|||
144329041|NCT02285114|520408738|FG002|Extension Phase|Pregnancy|0|||
144329042|NCT02285114|520408739|FG003|Extension Phase|Pregnancy|1|||
144329043|NCT02285114|520408740|FG004|Extension Phase|Pregnancy|0|||
144329044|NCT02285114|520408741|FG005|Extension Phase|Pregnancy|0|||
144329045|NCT01156389|520408742|FG000|Overall Study|Elevated liver enzymes|4|||
144329046|NCT01156389|520408743|FG001|Overall Study|Elevated liver enzymes|0|||
144329047|NCT01156389|520408742|FG000|Overall Study|Vomiting|0|||
144329048|NCT01156389|520408743|FG001|Overall Study|Vomiting|1|||
144329049|NCT02351349|520408749|FG000|Overall Study|Withdrawal by Subject|2|||
144329050|NCT02351349|520408750|FG001|Overall Study|Withdrawal by Subject|3|||
144329051|NCT01703117|520408751|FG000|Overall Study|Adverse Event|4|||
144329052|NCT01703117|520408752|FG001|Overall Study|Adverse Event|3|||
144329053|NCT01703117|520408751|FG000|Overall Study|Withdrawal by Subject|0|||
144329054|NCT01703117|520408752|FG001|Overall Study|Withdrawal by Subject|1|||
144329055|NCT01340937|520408754|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
144329056|NCT01340937|520408755|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
144329057|NCT01340937|520408756|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
144329058|NCT01340937|520408757|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
144329059|NCT01340937|520408754|FG000|Period 1: Infant Series|Adverse Event|0|||
144329060|NCT01340937|520408755|FG001|Period 1: Infant Series|Adverse Event|1|||
144329061|NCT01340937|520408756|FG002|Period 1: Infant Series|Adverse Event|4|||
144329062|NCT01340937|520408757|FG003|Period 1: Infant Series|Adverse Event|0|||
144329063|NCT01340937|520408754|FG000|Period 1: Infant Series|Death|2|||
144329064|NCT01340937|520408755|FG001|Period 1: Infant Series|Death|0|||
144329065|NCT01340937|520408756|FG002|Period 1: Infant Series|Death|2|||
144329066|NCT01340937|520408757|FG003|Period 1: Infant Series|Death|0|||
144329067|NCT01340937|520408754|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
144329068|NCT01340937|520408755|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
144329069|NCT01340937|520408756|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
144329070|NCT01340937|520408757|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
144329071|NCT01340937|520408754|FG000|Period 1: Infant Series|Physician Decision|2|||
144329072|NCT01340937|520408755|FG001|Period 1: Infant Series|Physician Decision|3|||
144329073|NCT01340937|520408756|FG002|Period 1: Infant Series|Physician Decision|1|||
144329074|NCT01340937|520408757|FG003|Period 1: Infant Series|Physician Decision|0|||
144329075|NCT01340937|520408754|FG000|Period 1: Infant Series|Protocol Violation|1|||
144329076|NCT01340937|520408755|FG001|Period 1: Infant Series|Protocol Violation|4|||
144329077|NCT01340937|520408756|FG002|Period 1: Infant Series|Protocol Violation|4|||
144329078|NCT01340937|520408757|FG003|Period 1: Infant Series|Protocol Violation|3|||
144329079|NCT01340937|520408754|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
144329080|NCT01340937|520408755|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
144329081|NCT01340937|520408756|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
144329082|NCT01340937|520408757|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
144329083|NCT01340937|520408754|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
144329084|NCT01340937|520408755|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
144329085|NCT01340937|520408756|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
144329086|NCT01340937|520408757|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
144329087|NCT01340937|520408754|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
144329088|NCT01340937|520408755|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
144329089|NCT01340937|520408756|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
144329090|NCT01340937|520408757|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
144329091|NCT01340937|520408754|FG000|Period 2: Interim Period|Adverse Event|1|||
144329092|NCT01340937|520408755|FG001|Period 2: Interim Period|Adverse Event|0|||
144329093|NCT01340937|520408756|FG002|Period 2: Interim Period|Adverse Event|1|||
144329094|NCT01340937|520408757|FG003|Period 2: Interim Period|Adverse Event|0|||
144329095|NCT01340937|520408754|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
144329096|NCT01340937|520408755|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
144329097|NCT01340937|520408756|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
144329098|NCT01340937|520408757|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
144329099|NCT01340937|520408754|FG000|Period 2: Interim Period|Physician Decision|0|||
144329100|NCT01340937|520408755|FG001|Period 2: Interim Period|Physician Decision|1|||
144329101|NCT01340937|520408756|FG002|Period 2: Interim Period|Physician Decision|1|||
144329102|NCT01340937|520408757|FG003|Period 2: Interim Period|Physician Decision|0|||
144329103|NCT01340937|520408754|FG000|Period 2: Interim Period|Protocol Violation|5|||
144329104|NCT01340937|520408755|FG001|Period 2: Interim Period|Protocol Violation|3|||
144329105|NCT01340937|520408756|FG002|Period 2: Interim Period|Protocol Violation|6|||
144329106|NCT01340937|520408757|FG003|Period 2: Interim Period|Protocol Violation|3|||
144329107|NCT01340937|520408754|FG000|Period 2: Interim Period|Technical problems|4|||
144329108|NCT01340937|520408755|FG001|Period 2: Interim Period|Technical problems|4|||
144329109|NCT01340937|520408756|FG002|Period 2: Interim Period|Technical problems|6|||
144329110|NCT01340937|520408757|FG003|Period 2: Interim Period|Technical problems|3|||
144329111|NCT01340937|520408754|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
144329112|NCT01340937|520408755|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
144329113|NCT01340937|520408756|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
144329114|NCT01340937|520408757|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
144329115|NCT01340937|520408754|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
144329116|NCT01340937|520408755|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
144329117|NCT01340937|520408756|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
144329118|NCT01340937|520408757|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
144329119|NCT01340937|520408754|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
144329120|NCT01340937|520408755|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
144329121|NCT01340937|520408756|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
144329122|NCT01340937|520408757|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
144329123|NCT01340937|520408754|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
144329124|NCT01340937|520408755|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
144329125|NCT01340937|520408756|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
144329126|NCT01340937|520408757|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
144329127|NCT00440310|520408758|FG000|Overall Study|Lost to Follow-up|4|||
144329128|NCT00440310|520408759|FG001|Overall Study|Lost to Follow-up|5|||
144329129|NCT00440310|520408758|FG000|Overall Study|Protocol Violation|0|||
144329130|NCT00440310|520408759|FG001|Overall Study|Protocol Violation|1|||
144329131|NCT00440310|520408758|FG000|Overall Study|Withdrawal by Subject|15|||
144329132|NCT00440310|520408759|FG001|Overall Study|Withdrawal by Subject|14|||
144329133|NCT00440310|520408758|FG000|Overall Study|No Reply at EOS|7|||
144329134|NCT00440310|520408759|FG001|Overall Study|No Reply at EOS|7|||
144329135|NCT00440310|520408758|FG000|Overall Study|Other|1|||
144329136|NCT00440310|520408759|FG001|Overall Study|Other|0|||
144329137|NCT00440310|520408758|FG000|Overall Study|Status Unknown|1|||
144329138|NCT00440310|520408759|FG001|Overall Study|Status Unknown|3|||
144329139|NCT02119156|520408760|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
144329140|NCT02119156|520408761|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
144329141|NCT02119156|520408762|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
144329142|NCT02119156|520408760|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
144329143|NCT02119156|520408761|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
144329144|NCT02119156|520408762|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
144329145|NCT02119156|520408760|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
144329146|NCT02119156|520408761|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
144329147|NCT02119156|520408762|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
144329148|NCT02119156|520408760|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
144329149|NCT02119156|520408761|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
144329150|NCT02119156|520408762|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
144329151|NCT02119156|520408760|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
144329152|NCT02119156|520408761|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
144329153|NCT02119156|520408762|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
144329154|NCT02469415|520408763|FG000|Overall Study|Withdrawal by Subject|1|||
144329155|NCT02469415|520408763|FG000|Overall Study|Investigational agent placed on hold|2|||
144329156|NCT01519674|520408767|FG000|Overall Study|Adverse Event|3|||
144329157|NCT01519674|520408768|FG001|Overall Study|Adverse Event|3|||
144329158|NCT01519674|520408769|FG002|Overall Study|Adverse Event|0|||
144329159|NCT01519674|520408767|FG000|Overall Study|Lack of Efficacy|1|||
144329160|NCT01519674|520408768|FG001|Overall Study|Lack of Efficacy|1|||
144329161|NCT01519674|520408769|FG002|Overall Study|Lack of Efficacy|1|||
144329162|NCT01519674|520408767|FG000|Overall Study|Protocol Violation|0|||
144329163|NCT01519674|520408768|FG001|Overall Study|Protocol Violation|3|||
144329164|NCT01519674|520408769|FG002|Overall Study|Protocol Violation|1|||
144329165|NCT01519674|520408767|FG000|Overall Study|Withdrawal Criteria|7|||
144329166|NCT01519674|520408768|FG001|Overall Study|Withdrawal Criteria|2|||
144329167|NCT01519674|520408769|FG002|Overall Study|Withdrawal Criteria|7|||
144329168|NCT01519674|520408767|FG000|Overall Study|Unsclassified|10|||
144329169|NCT01519674|520408768|FG001|Overall Study|Unsclassified|4|||
144329170|NCT01519674|520408769|FG002|Overall Study|Unsclassified|3|||
144329171|NCT01610596|520408772|FG000|Overall Study|Lost to Follow-up|0|||
144329172|NCT01610596|520408773|FG001|Overall Study|Lost to Follow-up|1|||
144329173|NCT02435680|520408780|FG000|Overall Study|Physician Decision|3|||
144329174|NCT02435680|520408781|FG001|Overall Study|Physician Decision|0|||
144329175|NCT02435680|520408782|FG002|Overall Study|Physician Decision|0|||
144329176|NCT02435680|520408780|FG000|Overall Study|subject / guardian decision|0|||
144329177|NCT02435680|520408781|FG001|Overall Study|subject / guardian decision|3|||
144329178|NCT02435680|520408782|FG002|Overall Study|subject / guardian decision|2|||
144329179|NCT02435680|520408780|FG000|Overall Study|Adverse Event|8|||
144329180|NCT02435680|520408781|FG001|Overall Study|Adverse Event|3|||
144329181|NCT02435680|520408782|FG002|Overall Study|Adverse Event|2|||
144329182|NCT02435680|520408780|FG000|Overall Study|progressive disease|10|||
144329183|NCT02435680|520408781|FG001|Overall Study|progressive disease|7|||
144329184|NCT02435680|520408782|FG002|Overall Study|progressive disease|11|||
144329185|NCT02435680|520408780|FG000|Overall Study|not treated|0|||
144329186|NCT02435680|520408781|FG001|Overall Study|not treated|0|||
144329187|NCT02435680|520408782|FG002|Overall Study|not treated|1|||
144329188|NCT01030874|520408783|FG000|Overall Study|Withdrawal by Subject|1|||
144329189|NCT01030874|520408784|FG001|Overall Study|Withdrawal by Subject|0|||
144329190|NCT01030874|520408783|FG000|Overall Study|Discharged in first 2 weeks|17|||
144329191|NCT01030874|520408784|FG001|Overall Study|Discharged in first 2 weeks|16|||
144329192|NCT00953524|520408785|FG000|Overall Study|Adverse Event|2|||
144329193|NCT00953524|520408786|FG001|Overall Study|Adverse Event|0|||
144329194|NCT00953524|520408787|FG002|Overall Study|Adverse Event|1|||
144329195|NCT00953524|520408788|FG003|Overall Study|Adverse Event|2|||
144329196|NCT00953524|520408785|FG000|Overall Study|Protocol Violation|18|||
144329197|NCT00953524|520408786|FG001|Overall Study|Protocol Violation|10|||
144329198|NCT00953524|520408787|FG002|Overall Study|Protocol Violation|11|||
144329199|NCT00953524|520408788|FG003|Overall Study|Protocol Violation|6|||
144329200|NCT00953524|520408785|FG000|Overall Study|Lost to Follow-up|0|||
144329201|NCT00953524|520408786|FG001|Overall Study|Lost to Follow-up|1|||
144329202|NCT00953524|520408787|FG002|Overall Study|Lost to Follow-up|1|||
144329203|NCT00953524|520408788|FG003|Overall Study|Lost to Follow-up|0|||
144329204|NCT00953524|520408785|FG000|Overall Study|Withdrawal by Subject|2|||
144329205|NCT00953524|520408786|FG001|Overall Study|Withdrawal by Subject|4|||
144329206|NCT00953524|520408787|FG002|Overall Study|Withdrawal by Subject|1|||
144329207|NCT00953524|520408788|FG003|Overall Study|Withdrawal by Subject|0|||
144329208|NCT00089986|520408795|FG000|Overall Study|Adverse Event|6|||
144329209|NCT00089986|520408796|FG001|Overall Study|Adverse Event|9|||
144329210|NCT00089986|520408797|FG002|Overall Study|Adverse Event|6|||
144329211|NCT00089986|520408795|FG000|Overall Study|Lost to Follow-up|3|||
144329212|NCT00089986|520408796|FG001|Overall Study|Lost to Follow-up|1|||
144329213|NCT00089986|520408797|FG002|Overall Study|Lost to Follow-up|1|||
144329214|NCT00089986|520408795|FG000|Overall Study|Protocol Violation|0|||
144329215|NCT00089986|520408796|FG001|Overall Study|Protocol Violation|1|||
144329216|NCT00089986|520408797|FG002|Overall Study|Protocol Violation|0|||
144329217|NCT00089986|520408795|FG000|Overall Study|Patient transferred to another hospital|2|||
144329218|NCT00089986|520408796|FG001|Overall Study|Patient transferred to another hospital|1|||
144329219|NCT00089986|520408797|FG002|Overall Study|Patient transferred to another hospital|0|||
144329220|NCT00089986|520408795|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
144329221|NCT00089986|520408796|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
144329222|NCT00089986|520408797|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
144329223|NCT00089986|520408795|FG000|Overall Study|Hemohlobin stopping rule|0|||
144329224|NCT00089986|520408796|FG001|Overall Study|Hemohlobin stopping rule|1|||
144329225|NCT00089986|520408797|FG002|Overall Study|Hemohlobin stopping rule|0|||
144329226|NCT00089986|520408795|FG000|Overall Study|Investigator decision to withdrew|0|||
144329227|NCT00089986|520408796|FG001|Overall Study|Investigator decision to withdrew|1|||
144329228|NCT00089986|520408797|FG002|Overall Study|Investigator decision to withdrew|0|||
144329229|NCT00089986|520408795|FG000|Overall Study|Enrollment in another study|0|||
144329230|NCT00089986|520408796|FG001|Overall Study|Enrollment in another study|1|||
144329231|NCT00089986|520408797|FG002|Overall Study|Enrollment in another study|0|||
144329232|NCT00089986|520408795|FG000|Overall Study|Family decision|0|||
144329233|NCT00089986|520408796|FG001|Overall Study|Family decision|1|||
144329234|NCT00089986|520408797|FG002|Overall Study|Family decision|0|||
144329235|NCT00089986|520408795|FG000|Overall Study|Do not resuscitate (DNR)|0|||
144329236|NCT00089986|520408796|FG001|Overall Study|Do not resuscitate (DNR)|0|||
144329237|NCT00089986|520408797|FG002|Overall Study|Do not resuscitate (DNR)|1|||
144329238|NCT00089986|520408795|FG000|Overall Study|Withdrawal by Subject|3|||
144329239|NCT00089986|520408796|FG001|Overall Study|Withdrawal by Subject|6|||
144329240|NCT00089986|520408797|FG002|Overall Study|Withdrawal by Subject|2|||
144329241|NCT03946124|520408798|FG000|Overall Study|Withdrawal by Subject|19|||
144329242|NCT01414205|520408805|FG000|Overall Study|Death|5|||
144329243|NCT01414205|520408806|FG001|Overall Study|Death|1|||
144329244|NCT01414205|520408805|FG000|Overall Study|Lost to Follow-up|1|||
144329245|NCT01414205|520408806|FG001|Overall Study|Lost to Follow-up|4|||
144329246|NCT01414205|520408805|FG000|Overall Study|Physician Decision|0|||
144329247|NCT01414205|520408806|FG001|Overall Study|Physician Decision|1|||
144329248|NCT01414205|520408805|FG000|Overall Study|Randomized but not Treated|1|||
144329249|NCT01414205|520408806|FG001|Overall Study|Randomized but not Treated|1|||
144329250|NCT01457950|520408807|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
144329251|NCT01457950|520408808|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
144329252|NCT01457950|520408809|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
144329253|NCT01457950|520408810|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
144329254|NCT01457950|520408807|FG000|Double-Blind Phase|Protocol Violation|2|||
144329255|NCT01457950|520408808|FG001|Double-Blind Phase|Protocol Violation|1|||
144329256|NCT01457950|520408809|FG002|Double-Blind Phase|Protocol Violation|0|||
144329257|NCT01457950|520408810|FG003|Double-Blind Phase|Protocol Violation|0|||
144329258|NCT01457950|520408807|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
144329259|NCT01457950|520408808|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
144329260|NCT01457950|520408809|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144360038|NCT01601535|520525136|FG001|Phase 2|Started Another Treatment|0|||
144329261|NCT01457950|520408810|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144329262|NCT01457950|520408807|FG000|Open-Label Phase|Adverse Event|0|||
144329263|NCT01457950|520408808|FG001|Open-Label Phase|Adverse Event|0|||
144329264|NCT01457950|520408809|FG002|Open-Label Phase|Adverse Event|0|||
144329265|NCT01457950|520408810|FG003|Open-Label Phase|Adverse Event|1|||
144329266|NCT01457950|520408807|FG000|Open-Label Phase|Protocol Violation|0|||
144329267|NCT01457950|520408808|FG001|Open-Label Phase|Protocol Violation|0|||
144329268|NCT01457950|520408809|FG002|Open-Label Phase|Protocol Violation|0|||
144329269|NCT01457950|520408810|FG003|Open-Label Phase|Protocol Violation|1|||
144329270|NCT01457950|520408807|FG000|Open-Label Phase|Withdrawal by Subject|0|||
144329271|NCT01457950|520408808|FG001|Open-Label Phase|Withdrawal by Subject|0|||
144329272|NCT01457950|520408809|FG002|Open-Label Phase|Withdrawal by Subject|2|||
144329273|NCT01457950|520408810|FG003|Open-Label Phase|Withdrawal by Subject|0|||
144329274|NCT01166373|520408811|FG000|Overall Study|Lost to Follow-up|3|||
144329275|NCT01166373|520408812|FG001|Overall Study|Lost to Follow-up|2|||
144329276|NCT01166373|520408813|FG002|Overall Study|Lost to Follow-up|2|||
144329277|NCT01166373|520408814|FG003|Overall Study|Lost to Follow-up|2|||
144329278|NCT01166373|520408811|FG000|Overall Study|Withdrawal by Subject|1|||
144329279|NCT01166373|520408812|FG001|Overall Study|Withdrawal by Subject|2|||
144329280|NCT01166373|520408813|FG002|Overall Study|Withdrawal by Subject|2|||
144329281|NCT01166373|520408814|FG003|Overall Study|Withdrawal by Subject|3|||
144329282|NCT01166373|520408811|FG000|Overall Study|Physician Decision|1|||
144329283|NCT01166373|520408812|FG001|Overall Study|Physician Decision|0|||
144329284|NCT01166373|520408813|FG002|Overall Study|Physician Decision|0|||
144329285|NCT01166373|520408814|FG003|Overall Study|Physician Decision|0|||
144329286|NCT01510184|520408815|FG000|Overall Study|Sponsor discretion|28|||
144329287|NCT01510184|520408816|FG001|Overall Study|Sponsor discretion|28|||
144329288|NCT01510184|520408815|FG000|Overall Study|Death|1|||
144329289|NCT01510184|520408816|FG001|Overall Study|Death|2|||
144329290|NCT01510184|520408815|FG000|Overall Study|Withdrawal by Subject|1|||
144329291|NCT01510184|520408816|FG001|Overall Study|Withdrawal by Subject|4|||
144329292|NCT01510184|520408815|FG000|Overall Study|Other|0|||
144329293|NCT01510184|520408816|FG001|Overall Study|Other|1|||
144329294|NCT02078102|520408820|FG000|Overall Study|Adverse Event|1|||
144329295|NCT02078102|520408821|FG001|Overall Study|Adverse Event|0|||
144329296|NCT02078102|520408820|FG000|Overall Study|Withdrawal by Subject|1|||
144329297|NCT02078102|520408821|FG001|Overall Study|Withdrawal by Subject|0|||
144329298|NCT02078102|520408820|FG000|Overall Study|Physician Decision|0|||
144329299|NCT02078102|520408821|FG001|Overall Study|Physician Decision|1|||
144329300|NCT05291936|520408824|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
144329301|NCT05291936|520408825|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
144329302|NCT05291936|520408824|FG000|Period 1|Withdrew Consent during study|1|||
144329303|NCT05291936|520408825|FG001|Period 1|Withdrew Consent during study|0|||
144329304|NCT05291936|520408824|FG000|Period 2|Adverse Event|0|||
144329305|NCT05291936|520408825|FG001|Period 2|Adverse Event|1|||
144329306|NCT05291936|520408824|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
144329307|NCT05291936|520408825|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144329308|NCT02370095|520408826|FG000|Overall Study|Withdrawal by Subject|0|||
144329309|NCT02370095|520408827|FG001|Overall Study|Withdrawal by Subject|1|||
144329310|NCT01667562|520408828|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
144329311|NCT01667562|520408829|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
144329312|NCT01667562|520408828|FG000|Erlotinib Phase|Lost to Follow-up|0|||
144329313|NCT01667562|520408829|FG001|Erlotinib Phase|Lost to Follow-up|1|||
144329314|NCT01667562|520408828|FG000|Erlotinib Phase|Adverse Event|0|||
144329315|NCT01667562|520408829|FG001|Erlotinib Phase|Adverse Event|1|||
144329316|NCT01667562|520408828|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
144329317|NCT01667562|520408829|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
144329318|NCT02130986|520408830|FG000|Overall Study|Withdrawal by Subject|4|||
144329319|NCT02130986|520408831|FG001|Overall Study|Withdrawal by Subject|4|||
144329320|NCT02130986|520408830|FG000|Overall Study|Lost to Follow-up|151|||
144329321|NCT02130986|520408831|FG001|Overall Study|Lost to Follow-up|160|||
144329322|NCT01129882|520408832|FG000|Overall Study|Adverse Event|39|||
144329323|NCT01129882|520408832|FG000|Overall Study|Death|6|||
144329324|NCT01129882|520408832|FG000|Overall Study|Lack of Efficacy|5|||
144329325|NCT01129882|520408832|FG000|Overall Study|Lost to Follow-up|13|||
144329326|NCT01129882|520408832|FG000|Overall Study|Physician Decision|27|||
144329327|NCT01129882|520408832|FG000|Overall Study|Protocol Deviation|3|||
144329328|NCT01129882|520408832|FG000|Overall Study|Withdrawal Criteria Met|19|||
144329329|NCT01129882|520408832|FG000|Overall Study|Trial Termination by Sponsor|6|||
144329330|NCT01129882|520408832|FG000|Overall Study|Withdrawal by Subject|160|||
144329331|NCT02305849|520408833|FG000|Overall Study|Adverse Event|10|||
144329332|NCT02305849|520408834|FG001|Overall Study|Adverse Event|12|||
144329333|NCT02305849|520408835|FG002|Overall Study|Adverse Event|7|||
144329334|NCT02305849|520408836|FG003|Overall Study|Adverse Event|3|||
144329335|NCT02305849|520408833|FG000|Overall Study|Lack of Efficacy|10|||
144329336|NCT02305849|520408834|FG001|Overall Study|Lack of Efficacy|6|||
144329337|NCT02305849|520408835|FG002|Overall Study|Lack of Efficacy|3|||
144329338|NCT02305849|520408836|FG003|Overall Study|Lack of Efficacy|9|||
144329339|NCT02305849|520408833|FG000|Overall Study|Withdrawal by Subject|2|||
144329340|NCT02305849|520408834|FG001|Overall Study|Withdrawal by Subject|2|||
144329341|NCT02305849|520408835|FG002|Overall Study|Withdrawal by Subject|1|||
144329342|NCT02305849|520408836|FG003|Overall Study|Withdrawal by Subject|4|||
144329343|NCT02305849|520408833|FG000|Overall Study|Lost to Follow-up|0|||
144329344|NCT02305849|520408834|FG001|Overall Study|Lost to Follow-up|2|||
144329345|NCT02305849|520408835|FG002|Overall Study|Lost to Follow-up|0|||
144329346|NCT02305849|520408836|FG003|Overall Study|Lost to Follow-up|0|||
144329347|NCT02305849|520408833|FG000|Overall Study|Protocol Violation|3|||
144329348|NCT02305849|520408834|FG001|Overall Study|Protocol Violation|2|||
144329349|NCT02305849|520408835|FG002|Overall Study|Protocol Violation|1|||
144329350|NCT02305849|520408836|FG003|Overall Study|Protocol Violation|1|||
144329351|NCT02305849|520408833|FG000|Overall Study|Lab data met discontinuation criteria|0|||
144329352|NCT02305849|520408834|FG001|Overall Study|Lab data met discontinuation criteria|1|||
144329353|NCT02305849|520408835|FG002|Overall Study|Lab data met discontinuation criteria|2|||
144329354|NCT02305849|520408836|FG003|Overall Study|Lab data met discontinuation criteria|1|||
144329355|NCT02305849|520408833|FG000|Overall Study|Miscellaneous|1|||
144329356|NCT02305849|520408834|FG001|Overall Study|Miscellaneous|2|||
144329357|NCT02305849|520408835|FG002|Overall Study|Miscellaneous|4|||
144329358|NCT02305849|520408836|FG003|Overall Study|Miscellaneous|1|||
144329359|NCT02305849|520408833|FG000|Overall Study|Not fulfill eligibility criteria|1|||
144329360|NCT02305849|520408834|FG001|Overall Study|Not fulfill eligibility criteria|1|||
144329361|NCT02305849|520408835|FG002|Overall Study|Not fulfill eligibility criteria|0|||
144329362|NCT02305849|520408836|FG003|Overall Study|Not fulfill eligibility criteria|0|||
144329363|NCT00355342|520408837|FG000|Overall Study|Adverse Event|13|||
144329364|NCT00355342|520408838|FG001|Overall Study|Adverse Event|15|||
144329365|NCT00355342|520408837|FG000|Overall Study|Lost to Follow-up|4|||
144329366|NCT00355342|520408838|FG001|Overall Study|Lost to Follow-up|2|||
144329367|NCT00355342|520408837|FG000|Overall Study|Withdrawal by Subject|14|||
144329368|NCT00355342|520408838|FG001|Overall Study|Withdrawal by Subject|11|||
144329369|NCT00355342|520408837|FG000|Overall Study|Sponsor terminated study|2|||
144329370|NCT00355342|520408838|FG001|Overall Study|Sponsor terminated study|2|||
144329371|NCT00355342|520408837|FG000|Overall Study|Overcompliant-PI discretion|1|||
144329372|NCT00355342|520408838|FG001|Overall Study|Overcompliant-PI discretion|0|||
144329373|NCT00355342|520408837|FG000|Overall Study|Use of prohibited medication|1|||
144329374|NCT00355342|520408838|FG001|Overall Study|Use of prohibited medication|0|||
144329375|NCT00355342|520408837|FG000|Overall Study|COPD exacerbation|1|||
144329376|NCT00355342|520408838|FG001|Overall Study|COPD exacerbation|1|||
144329377|NCT00355342|520408837|FG000|Overall Study|Dispensed wrong study drug kit|1|||
144329378|NCT00355342|520408838|FG001|Overall Study|Dispensed wrong study drug kit|0|||
144329379|NCT00355342|520408837|FG000|Overall Study|Non-compliance with Dexa scans|1|||
144329380|NCT00355342|520408838|FG001|Overall Study|Non-compliance with Dexa scans|0|||
144329381|NCT00355342|520408837|FG000|Overall Study|Withdrawal by participant and physician|1|||
144329382|NCT00355342|520408838|FG001|Overall Study|Withdrawal by participant and physician|0|||
144329383|NCT00355342|520408837|FG000|Overall Study|Participant relocated|0|||
144329384|NCT00355342|520408838|FG001|Overall Study|Participant relocated|1|||
144329385|NCT00355342|520408837|FG000|Overall Study|Participant discontinued study drug|0|||
144329386|NCT00355342|520408838|FG001|Overall Study|Participant discontinued study drug|1|||
144329387|NCT00355342|520408837|FG000|Overall Study|Study management|0|||
144329388|NCT00355342|520408838|FG001|Overall Study|Study management|1|||
144329389|NCT00355342|520408837|FG000|Overall Study|Protocol Violation|0|||
144329390|NCT00355342|520408838|FG001|Overall Study|Protocol Violation|1|||
144329391|NCT00355342|520408837|FG000|Overall Study|Use of protocol excluded medication|0|||
144329392|NCT00355342|520408838|FG001|Overall Study|Use of protocol excluded medication|1|||
144329393|NCT00536874|520408839|FG000|Overall Study|Adverse Event|1|||
144329394|NCT00536874|520408839|FG000|Overall Study|Death|2|||
144329395|NCT00536874|520408839|FG000|Overall Study|Withdrawal by Subject|1|||
144329396|NCT01287221|520408841|FG000|Overall Study|Lack of Perceived Benefit|1|||
144329397|NCT01287221|520408842|FG001|Overall Study|Lack of Perceived Benefit|1|||
144329398|NCT01287221|520408841|FG000|Overall Study|Adverse Event|3|||
144329399|NCT01287221|520408842|FG001|Overall Study|Adverse Event|3|||
144329400|NCT01287221|520408841|FG000|Overall Study|Withdrawal by Subject|0|||
144329401|NCT01287221|520408842|FG001|Overall Study|Withdrawal by Subject|1|||
144329402|NCT02761694|520408853|FG000|Overall Study|Lack of Efficacy|0|||
144329403|NCT02761694|520408854|FG001|Overall Study|Lack of Efficacy|0|||
144329404|NCT02761694|520408855|FG002|Overall Study|Lack of Efficacy|0|||
144329405|NCT02761694|520408856|FG003|Overall Study|Lack of Efficacy|0|||
144329406|NCT02761694|520408857|FG004|Overall Study|Lack of Efficacy|0|||
144329407|NCT02761694|520408858|FG005|Overall Study|Lack of Efficacy|0|||
144329408|NCT02761694|520408859|FG006|Overall Study|Lack of Efficacy|6|||
144329409|NCT02761694|520408860|FG007|Overall Study|Lack of Efficacy|0|||
144329410|NCT02761694|520408861|FG008|Overall Study|Lack of Efficacy|0|||
144329411|NCT02761694|520408862|FG009|Overall Study|Lack of Efficacy|1|||
144329412|NCT02761694|520408863|FG010|Overall Study|Lack of Efficacy|1|||
144329413|NCT02761694|520408864|FG011|Overall Study|Lack of Efficacy|4|||
144329414|NCT02761694|520408853|FG000|Overall Study|Death|0|||
144329415|NCT02761694|520408854|FG001|Overall Study|Death|0|||
144329416|NCT02761694|520408855|FG002|Overall Study|Death|0|||
144329417|NCT02761694|520408856|FG003|Overall Study|Death|0|||
144329418|NCT02761694|520408857|FG004|Overall Study|Death|0|||
144329419|NCT02761694|520408858|FG005|Overall Study|Death|0|||
144329420|NCT02761694|520408859|FG006|Overall Study|Death|2|||
144329421|NCT02761694|520408860|FG007|Overall Study|Death|0|||
144329422|NCT02761694|520408861|FG008|Overall Study|Death|2|||
144329423|NCT02761694|520408862|FG009|Overall Study|Death|2|||
144329424|NCT02761694|520408863|FG010|Overall Study|Death|1|||
144329425|NCT02761694|520408864|FG011|Overall Study|Death|0|||
144329426|NCT02761694|520408853|FG000|Overall Study|Physician Decision|0|||
144329427|NCT02761694|520408854|FG001|Overall Study|Physician Decision|0|||
144329428|NCT02761694|520408855|FG002|Overall Study|Physician Decision|0|||
144329429|NCT02761694|520408856|FG003|Overall Study|Physician Decision|0|||
144329430|NCT02761694|520408857|FG004|Overall Study|Physician Decision|0|||
144329431|NCT02761694|520408858|FG005|Overall Study|Physician Decision|0|||
144329432|NCT02761694|520408859|FG006|Overall Study|Physician Decision|1|||
144329433|NCT02761694|520408860|FG007|Overall Study|Physician Decision|0|||
144329434|NCT02761694|520408861|FG008|Overall Study|Physician Decision|0|||
144329435|NCT02761694|520408862|FG009|Overall Study|Physician Decision|0|||
144329436|NCT02761694|520408863|FG010|Overall Study|Physician Decision|0|||
144329437|NCT02761694|520408864|FG011|Overall Study|Physician Decision|0|||
144329438|NCT02761694|520408853|FG000|Overall Study|Withdrawal by Subject|0|||
144329439|NCT02761694|520408854|FG001|Overall Study|Withdrawal by Subject|0|||
144329440|NCT02761694|520408855|FG002|Overall Study|Withdrawal by Subject|0|||
144329441|NCT02761694|520408856|FG003|Overall Study|Withdrawal by Subject|1|||
144329442|NCT02761694|520408857|FG004|Overall Study|Withdrawal by Subject|0|||
144329443|NCT02761694|520408858|FG005|Overall Study|Withdrawal by Subject|0|||
144329444|NCT02761694|520408859|FG006|Overall Study|Withdrawal by Subject|4|||
144329445|NCT02761694|520408860|FG007|Overall Study|Withdrawal by Subject|0|||
144329446|NCT02761694|520408861|FG008|Overall Study|Withdrawal by Subject|2|||
144329447|NCT02761694|520408862|FG009|Overall Study|Withdrawal by Subject|1|||
144329448|NCT02761694|520408863|FG010|Overall Study|Withdrawal by Subject|0|||
144329449|NCT02761694|520408864|FG011|Overall Study|Withdrawal by Subject|0|||
144329450|NCT02761694|520408853|FG000|Overall Study|Lost to Follow-up|0|||
144329451|NCT02761694|520408854|FG001|Overall Study|Lost to Follow-up|0|||
144329452|NCT02761694|520408855|FG002|Overall Study|Lost to Follow-up|0|||
144329453|NCT02761694|520408856|FG003|Overall Study|Lost to Follow-up|0|||
144329454|NCT02761694|520408857|FG004|Overall Study|Lost to Follow-up|0|||
144329455|NCT02761694|520408858|FG005|Overall Study|Lost to Follow-up|0|||
144329456|NCT02761694|520408859|FG006|Overall Study|Lost to Follow-up|1|||
144329457|NCT02761694|520408860|FG007|Overall Study|Lost to Follow-up|0|||
144329458|NCT02761694|520408861|FG008|Overall Study|Lost to Follow-up|0|||
144329459|NCT02761694|520408862|FG009|Overall Study|Lost to Follow-up|0|||
144329460|NCT02761694|520408863|FG010|Overall Study|Lost to Follow-up|0|||
144329461|NCT02761694|520408864|FG011|Overall Study|Lost to Follow-up|1|||
144329462|NCT02761694|520408853|FG000|Overall Study|Adverse Event|0|||
144329463|NCT02761694|520408854|FG001|Overall Study|Adverse Event|0|||
144329464|NCT02761694|520408855|FG002|Overall Study|Adverse Event|0|||
144329465|NCT02761694|520408856|FG003|Overall Study|Adverse Event|0|||
144329466|NCT02761694|520408857|FG004|Overall Study|Adverse Event|0|||
144329467|NCT02761694|520408858|FG005|Overall Study|Adverse Event|0|||
144329468|NCT02761694|520408859|FG006|Overall Study|Adverse Event|1|||
144329469|NCT02761694|520408860|FG007|Overall Study|Adverse Event|0|||
144329470|NCT02761694|520408861|FG008|Overall Study|Adverse Event|1|||
144329471|NCT02761694|520408862|FG009|Overall Study|Adverse Event|0|||
144329472|NCT02761694|520408863|FG010|Overall Study|Adverse Event|0|||
144329473|NCT02761694|520408864|FG011|Overall Study|Adverse Event|1|||
144329474|NCT02761694|520408853|FG000|Overall Study|Other|4|||
144329475|NCT02761694|520408854|FG001|Overall Study|Other|4|||
144329476|NCT02761694|520408855|FG002|Overall Study|Other|1|||
144329477|NCT02761694|520408856|FG003|Overall Study|Other|2|||
144329478|NCT02761694|520408857|FG004|Overall Study|Other|3|||
144329479|NCT02761694|520408858|FG005|Overall Study|Other|3|||
144329480|NCT02761694|520408859|FG006|Overall Study|Other|18|||
144329481|NCT02761694|520408860|FG007|Overall Study|Other|8|||
144329482|NCT02761694|520408861|FG008|Overall Study|Other|0|||
144329483|NCT02761694|520408862|FG009|Overall Study|Other|1|||
144329484|NCT02761694|520408863|FG010|Overall Study|Other|1|||
144329485|NCT02761694|520408864|FG011|Overall Study|Other|0|||
144329486|NCT00787930|520408865|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
144329487|NCT02395055|520408866|FG000|Overall Study|Withdrawal by Subject|7|||
144329488|NCT02395055|520408867|FG001|Overall Study|Withdrawal by Subject|3|||
144329489|NCT02513823|520408868|FG000|Overall Study|Lost to Follow-up|4|||
144329490|NCT02513823|520408868|FG000|Overall Study|Physician Decision|1|||
144329491|NCT01294462|520408870|FG000|Overall Study|Lost to Follow-up|1|||
144329492|NCT01294462|520408871|FG001|Overall Study|Lost to Follow-up|0|||
144329493|NCT01294462|520408870|FG000|Overall Study|Withdrawal by Subject|65|||
144329494|NCT01294462|520408871|FG001|Overall Study|Withdrawal by Subject|63|||
144329495|NCT02743780|520408872|FG000|Part 3 (7 Days)|Adverse Event|0|||
144329496|NCT02743780|520408873|FG001|Part 3 (7 Days)|Adverse Event|0|||
144329497|NCT02743780|520408874|FG002|Part 3 (7 Days)|Adverse Event|1|||
144329498|NCT02743780|520408875|FG003|Part 3 (7 Days)|Adverse Event|0|||
144329499|NCT02743780|520408876|FG004|Part 3 (7 Days)|Adverse Event|0|||
144329500|NCT04342689|520408882|FG000|Overall Study|Withdrawal by Subject|32|||
144329501|NCT04342689|520408883|FG001|Overall Study|Withdrawal by Subject|33|||
144329502|NCT04342689|520408882|FG000|Overall Study|Lost to Follow-up|10|||
144329503|NCT04342689|520408883|FG001|Overall Study|Lost to Follow-up|12|||
144329504|NCT01460407|520408886|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
144329505|NCT01460407|520408887|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
144329506|NCT01367704|520408890|FG000|Overall Study|Lost to Follow-up|47|||
144329507|NCT01367704|520408891|FG001|Overall Study|Lost to Follow-up|161|||
144329508|NCT01510145|520408892|FG000|Overall Study|Adverse Event|6|||
144329509|NCT01510145|520408892|FG000|Overall Study|Lost to Follow-up|5|||
144329510|NCT01510145|520408892|FG000|Overall Study|Withdrawal by Subject|6|||
144329511|NCT01510145|520408892|FG000|Overall Study|Relative reported subject withdrew|1|||
144329512|NCT02279498|520408896|FG000|Overall Study|Adverse Event|3|||
144329513|NCT02279498|520408897|FG001|Overall Study|Adverse Event|0|||
144329514|NCT02279498|520408896|FG000|Overall Study|Lack of Efficacy|4|||
144329515|NCT02279498|520408897|FG001|Overall Study|Lack of Efficacy|0|||
144329516|NCT02279498|520408896|FG000|Overall Study|Lost to Follow-up|0|||
144329517|NCT02279498|520408897|FG001|Overall Study|Lost to Follow-up|1|||
144329518|NCT02279498|520408896|FG000|Overall Study|Withdrawal by Subject|9|||
144329519|NCT02279498|520408897|FG001|Overall Study|Withdrawal by Subject|2|||
144329520|NCT02279498|520408896|FG000|Overall Study|Undefined|2|||
144329521|NCT02279498|520408897|FG001|Overall Study|Undefined|1|||
144329522|NCT00737711|520408898|FG000|Overall Study|Adverse Event|2|||
144329523|NCT00737711|520408898|FG000|Overall Study|Death|8|||
144329524|NCT00737711|520408898|FG000|Overall Study|Failure to return|4|||
144329525|NCT00737711|520408898|FG000|Overall Study|Protocol Violation|1|||
144329526|NCT00737711|520408898|FG000|Overall Study|Withdrawal by Subject|5|||
144329527|NCT00737711|520408898|FG000|Overall Study|Blood transfusion|6|||
144329528|NCT00737711|520408898|FG000|Overall Study|Other|5|||
144329529|NCT00624780|520408902|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
144329530|NCT00624780|520408903|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
144329531|NCT00624780|520408904|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
144329532|NCT00624780|520408905|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
144329533|NCT00624780|520408906|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
144329534|NCT00624780|520408907|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
144329535|NCT00624780|520408902|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
144329536|NCT00624780|520408903|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
144329537|NCT00624780|520408904|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
144329538|NCT00624780|520408905|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
144329539|NCT00624780|520408906|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
144329540|NCT00624780|520408907|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
144329541|NCT00624780|520408902|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
144329542|NCT00624780|520408903|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
144329543|NCT00624780|520408904|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
144329544|NCT00624780|520408905|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
144329545|NCT00624780|520408906|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
144329546|NCT00624780|520408907|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
144329547|NCT00624780|520408902|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
144329548|NCT00624780|520408903|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
144329549|NCT00624780|520408904|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
144329550|NCT00624780|520408905|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
144329551|NCT00624780|520408906|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
144329552|NCT00624780|520408907|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
144329553|NCT00624780|520408902|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
144329554|NCT00624780|520408903|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
144329555|NCT00624780|520408904|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
144329556|NCT00624780|520408905|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
144329557|NCT00624780|520408906|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
144329558|NCT00624780|520408907|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
144329559|NCT00624780|520408902|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
144329560|NCT00624780|520408903|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
144329561|NCT00624780|520408904|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
144329562|NCT00624780|520408905|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
144329563|NCT00624780|520408906|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
144329564|NCT00624780|520408907|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
144329565|NCT00624780|520408902|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
144329566|NCT00624780|520408903|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
144329567|NCT00624780|520408904|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
144329568|NCT00624780|520408905|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
144329569|NCT00624780|520408906|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
144329570|NCT00624780|520408907|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
144329571|NCT00624780|520408902|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
144329572|NCT00624780|520408903|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
144329573|NCT00624780|520408904|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
144329574|NCT00624780|520408905|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
144329575|NCT00624780|520408906|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
144329576|NCT00624780|520408907|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
144329577|NCT00624780|520408902|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
144329578|NCT00624780|520408903|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
144329579|NCT00624780|520408904|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
144329580|NCT00624780|520408905|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
144329581|NCT00624780|520408906|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
144329582|NCT00624780|520408907|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
144329583|NCT00624780|520408902|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
144329584|NCT00624780|520408903|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
144329585|NCT00624780|520408904|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
144329586|NCT00624780|520408905|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
144329587|NCT00624780|520408906|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
144329588|NCT00624780|520408907|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
144329589|NCT00624780|520408902|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
144329590|NCT00624780|520408903|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
144329591|NCT00624780|520408904|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
144329592|NCT00624780|520408905|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
144329593|NCT00624780|520408906|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
144329594|NCT00624780|520408907|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
144329595|NCT00624780|520408902|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
144329596|NCT00624780|520408903|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
144329597|NCT00624780|520408904|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
144329598|NCT00624780|520408905|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
144329599|NCT00624780|520408906|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
144329600|NCT00624780|520408907|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
144329601|NCT00624780|520408902|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
144329602|NCT00624780|520408903|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
144329603|NCT00624780|520408904|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
144329604|NCT00624780|520408905|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
144329605|NCT00624780|520408906|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
144329606|NCT00624780|520408907|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
144329607|NCT00624780|520408902|FG000|Follow-up (Week 26)|Death|0|||
144329608|NCT00624780|520408903|FG001|Follow-up (Week 26)|Death|0|||
144329609|NCT00624780|520408904|FG002|Follow-up (Week 26)|Death|1|||
144329610|NCT00624780|520408905|FG003|Follow-up (Week 26)|Death|0|||
144329611|NCT00624780|520408906|FG004|Follow-up (Week 26)|Death|0|||
144329612|NCT00624780|520408907|FG005|Follow-up (Week 26)|Death|0|||
144329613|NCT00624780|520408902|FG000|Follow-up (Week 26)|Adverse Event|0|||
144329614|NCT00624780|520408903|FG001|Follow-up (Week 26)|Adverse Event|0|||
144329615|NCT00624780|520408904|FG002|Follow-up (Week 26)|Adverse Event|0|||
144329616|NCT00624780|520408905|FG003|Follow-up (Week 26)|Adverse Event|0|||
144329617|NCT00624780|520408906|FG004|Follow-up (Week 26)|Adverse Event|1|||
144329618|NCT00624780|520408907|FG005|Follow-up (Week 26)|Adverse Event|0|||
144329619|NCT00624780|520408902|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
144329620|NCT00624780|520408903|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
144329621|NCT00624780|520408904|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
144329622|NCT00624780|520408905|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
144329623|NCT00624780|520408906|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
144329624|NCT00624780|520408907|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
144329625|NCT00624780|520408902|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
144329626|NCT00624780|520408903|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
144329627|NCT00624780|520408904|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
144329628|NCT00624780|520408905|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
144329629|NCT00624780|520408906|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
144329630|NCT00624780|520408907|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
144329631|NCT00624780|520408902|FG000|Follow-up (Week 26)|Other|1|||
144329632|NCT00624780|520408903|FG001|Follow-up (Week 26)|Other|1|||
144329633|NCT00624780|520408904|FG002|Follow-up (Week 26)|Other|0|||
144329634|NCT00624780|520408905|FG003|Follow-up (Week 26)|Other|0|||
144329635|NCT00624780|520408906|FG004|Follow-up (Week 26)|Other|0|||
144329636|NCT00624780|520408907|FG005|Follow-up (Week 26)|Other|0|||
144329637|NCT04068519|520408908|FG000|Dose Verification|Death|15|||
144329638|NCT04068519|520408908|FG000|Dose Verification|Withdrawal by Subject|1|||
144329639|NCT04068519|520408908|FG000|Pharmacokinetic Sub-study|Death|35|||
144329640|NCT04068519|520408908|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
144329641|NCT04068519|520408908|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
144329642|NCT04068519|520408908|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
144329643|NCT04068519|520408908|FG000|Indication Expansion|Death|152|||
144329644|NCT04068519|520408908|FG000|Indication Expansion|Withdrawal by Subject|10|||
144329645|NCT04068519|520408908|FG000|Indication Expansion|Lost to Follow-up|7|||
144329646|NCT00969761|520408909|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
144329647|NCT00969761|520408910|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329648|NCT00969761|520408911|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329649|NCT00969761|520408912|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
144329650|NCT00969761|520408913|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329651|NCT00969761|520408914|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329652|NCT00969761|520408915|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329653|NCT00969761|520408916|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329654|NCT00969761|520408917|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
144329655|NCT00969761|520408918|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
144329656|NCT00969761|520408919|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329657|NCT00969761|520408920|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
144329658|NCT00969761|520408909|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329659|NCT00969761|520408910|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329660|NCT00969761|520408911|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
144329661|NCT00969761|520408912|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329662|NCT00969761|520408913|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329663|NCT00969761|520408914|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329664|NCT00969761|520408915|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329665|NCT00969761|520408916|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329666|NCT00969761|520408917|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329667|NCT00969761|520408918|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329668|NCT00969761|520408919|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329669|NCT00969761|520408920|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
144329670|NCT00969761|520408909|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329671|NCT00969761|520408910|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329672|NCT00969761|520408911|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
144329673|NCT00969761|520408912|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329674|NCT00969761|520408913|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329675|NCT00969761|520408914|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329676|NCT00969761|520408915|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329677|NCT00969761|520408916|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329678|NCT00969761|520408917|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329679|NCT00969761|520408918|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329680|NCT00969761|520408919|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329681|NCT00969761|520408920|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
144329682|NCT00969761|520408909|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329683|NCT00969761|520408910|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329684|NCT00969761|520408911|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329685|NCT00969761|520408912|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329686|NCT00969761|520408913|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329687|NCT00969761|520408914|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329688|NCT00969761|520408915|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329689|NCT00969761|520408916|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329690|NCT00969761|520408917|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
144329691|NCT00969761|520408918|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329692|NCT00969761|520408919|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329693|NCT00969761|520408920|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
144329694|NCT00969761|520408909|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
144329695|NCT00969761|520408910|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
144329696|NCT00969761|520408911|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
144329697|NCT00969761|520408912|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
144329698|NCT00969761|520408913|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
144329699|NCT00969761|520408914|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
144329700|NCT00969761|520408915|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
144329701|NCT00969761|520408916|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
144329702|NCT00969761|520408917|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
144329703|NCT00969761|520408918|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
144329704|NCT00969761|520408919|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
144329705|NCT00969761|520408920|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
144329706|NCT00969761|520408909|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329707|NCT00969761|520408910|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329708|NCT00969761|520408911|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329709|NCT00969761|520408912|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
144329710|NCT00969761|520408913|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
144329711|NCT00969761|520408914|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329712|NCT00969761|520408915|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329713|NCT00969761|520408916|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329714|NCT00969761|520408917|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
144329715|NCT00969761|520408918|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329716|NCT00969761|520408919|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329717|NCT00969761|520408920|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
144329718|NCT05013424|520410258|FG000|Overall Study|Lost to Follow-up|1|||
144329719|NCT05013424|520410259|FG001|Overall Study|Lost to Follow-up|1|||
144329720|NCT05013424|520410260|FG002|Overall Study|Lost to Follow-up|1|||
144329721|NCT05013424|520410258|FG000|Overall Study|Withdrawal by Subject|0|||
144329722|NCT05013424|520410259|FG001|Overall Study|Withdrawal by Subject|1|||
144329723|NCT05013424|520410260|FG002|Overall Study|Withdrawal by Subject|0|||
144329724|NCT04411420|520410261|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
144329725|NCT04411420|520410262|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
144329726|NCT04411420|520410261|FG000|Survey Subset|Lost to Follow-up|134|||
144329727|NCT04411420|520410262|FG001|Survey Subset|Lost to Follow-up|120|||
144329728|NCT03899064|520410263|FG000|Overall Study|Lost to Follow-up|1|||
144329729|NCT03899064|520410263|FG000|Overall Study|Protocol Violation|2|||
144329730|NCT03899064|520410263|FG000|Overall Study|Withdrawal by Subject|2|||
144329731|NCT03899064|520410263|FG000|Overall Study|Other|2|||
144329732|NCT00031460|520410266|FG000|Overall Study|Lost to Follow-up|0|||
144329733|NCT00031460|520410267|FG001|Overall Study|Lost to Follow-up|1|||
144329734|NCT00031460|520410266|FG000|Overall Study|Withdrawal by Subject|1|||
144329735|NCT00031460|520410267|FG001|Overall Study|Withdrawal by Subject|1|||
144329736|NCT00031460|520410266|FG000|Overall Study|Non-Compliant|1|||
144329737|NCT00031460|520410267|FG001|Overall Study|Non-Compliant|1|||
144329738|NCT00031460|520410266|FG000|Overall Study|Death|0|||
144329739|NCT00031460|520410267|FG001|Overall Study|Death|1|||
144329740|NCT00031460|520410266|FG000|Overall Study|Reactivation of Disease|5|||
144329741|NCT00031460|520410267|FG001|Overall Study|Reactivation of Disease|9|||
144329742|NCT00031460|520410266|FG000|Overall Study|Disruption of blinded drug supply|2|||
144329743|NCT00031460|520410267|FG001|Overall Study|Disruption of blinded drug supply|0|||
144329744|NCT00031460|520410266|FG000|Overall Study|Confirmed unevaluable|0|||
144329745|NCT00031460|520410267|FG001|Overall Study|Confirmed unevaluable|1|||
144329746|NCT00076336|520410279|FG000|Overall Study|Death|13|||
144329747|NCT00076336|520410280|FG001|Overall Study|Death|17|||
144329748|NCT00076336|520410279|FG000|Overall Study|Adverse Event|4|||
144329749|NCT00076336|520410280|FG001|Overall Study|Adverse Event|4|||
144329750|NCT00076336|520410279|FG000|Overall Study|Lost to Follow-up|4|||
144329751|NCT00076336|520410280|FG001|Overall Study|Lost to Follow-up|4|||
144329752|NCT00076336|520410279|FG000|Overall Study|Non-Compliance|2|||
144329753|NCT00076336|520410280|FG001|Overall Study|Non-Compliance|0|||
144329754|NCT00076336|520410279|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
144329755|NCT00076336|520410280|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
144329756|NCT00076336|520410279|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
144329757|NCT00076336|520410280|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
144329758|NCT00076336|520410279|FG000|Overall Study|Liver Transplantation|3|||
144329759|NCT00076336|520410280|FG001|Overall Study|Liver Transplantation|3|||
144329760|NCT00076336|520410279|FG000|Overall Study|Virologic Breakthrough|14|||
144329761|NCT00076336|520410280|FG001|Overall Study|Virologic Breakthrough|16|||
144329762|NCT00076336|520410279|FG000|Overall Study|Treatment failure|4|||
144329763|NCT00076336|520410280|FG001|Overall Study|Treatment failure|5|||
144329764|NCT00524589|520410281|FG000|Overall Study|Withdrawal by Subject|2|||
144329765|NCT00524589|520410281|FG000|Overall Study|Disease Progression|16|||
144329766|NCT00098722|520410287|FG000|Double Blind Phase|Adverse Event|7|||
144329767|NCT00098722|520410288|FG001|Double Blind Phase|Adverse Event|7|||
144329768|NCT00098722|520410289|FG002|Double Blind Phase|Adverse Event|3|||
144329769|NCT00098722|520410290|FG003|Double Blind Phase|Adverse Event|0|||
144329770|NCT00098722|520410291|FG004|Double Blind Phase|Adverse Event|0|||
144329771|NCT00098722|520410292|FG005|Double Blind Phase|Adverse Event|0|||
144329772|NCT00098722|520410293|FG006|Double Blind Phase|Adverse Event|0|||
144329773|NCT00098722|520410287|FG000|Double Blind Phase|Death|2|||
144329774|NCT00098722|520410288|FG001|Double Blind Phase|Death|5|||
144329775|NCT00098722|520410289|FG002|Double Blind Phase|Death|0|||
144329776|NCT00098722|520410290|FG003|Double Blind Phase|Death|0|||
144329777|NCT00098722|520410291|FG004|Double Blind Phase|Death|0|||
144329778|NCT00098722|520410292|FG005|Double Blind Phase|Death|0|||
144329779|NCT00098722|520410293|FG006|Double Blind Phase|Death|0|||
144329780|NCT00098722|520410287|FG000|Double Blind Phase|Lack of Efficacy|21|||
144329781|NCT00098722|520410288|FG001|Double Blind Phase|Lack of Efficacy|23|||
144329782|NCT00098722|520410289|FG002|Double Blind Phase|Lack of Efficacy|15|||
144329783|NCT00098722|520410290|FG003|Double Blind Phase|Lack of Efficacy|0|||
144329784|NCT00098722|520410291|FG004|Double Blind Phase|Lack of Efficacy|0|||
144329785|NCT00098722|520410292|FG005|Double Blind Phase|Lack of Efficacy|0|||
144329786|NCT00098722|520410293|FG006|Double Blind Phase|Lack of Efficacy|0|||
144329787|NCT00098722|520410287|FG000|Double Blind Phase|Participant defaulted|16|||
144329788|NCT00098722|520410288|FG001|Double Blind Phase|Participant defaulted|11|||
144329789|NCT00098722|520410289|FG002|Double Blind Phase|Participant defaulted|9|||
144329790|NCT00098722|520410290|FG003|Double Blind Phase|Participant defaulted|0|||
144329791|NCT00098722|520410291|FG004|Double Blind Phase|Participant defaulted|0|||
144329792|NCT00098722|520410292|FG005|Double Blind Phase|Participant defaulted|0|||
144329793|NCT00098722|520410293|FG006|Double Blind Phase|Participant defaulted|0|||
144329794|NCT00098722|520410287|FG000|Double Blind Phase|Pregnancy|1|||
144329795|NCT00098722|520410288|FG001|Double Blind Phase|Pregnancy|0|||
144329796|NCT00098722|520410289|FG002|Double Blind Phase|Pregnancy|0|||
144329797|NCT00098722|520410290|FG003|Double Blind Phase|Pregnancy|0|||
144329798|NCT00098722|520410291|FG004|Double Blind Phase|Pregnancy|0|||
144329799|NCT00098722|520410292|FG005|Double Blind Phase|Pregnancy|0|||
144329800|NCT00098722|520410293|FG006|Double Blind Phase|Pregnancy|0|||
144329801|NCT00098722|520410287|FG000|Double Blind Phase|Randomized, not treated|4|||
144329802|NCT00098722|520410288|FG001|Double Blind Phase|Randomized, not treated|3|||
144329803|NCT00098722|520410289|FG002|Double Blind Phase|Randomized, not treated|3|||
144329804|NCT00098722|520410290|FG003|Double Blind Phase|Randomized, not treated|0|||
144329805|NCT00098722|520410291|FG004|Double Blind Phase|Randomized, not treated|0|||
144329806|NCT00098722|520410292|FG005|Double Blind Phase|Randomized, not treated|0|||
144329807|NCT00098722|520410293|FG006|Double Blind Phase|Randomized, not treated|0|||
144329808|NCT00098722|520410287|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
144329809|NCT00098722|520410288|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
144329810|NCT00098722|520410289|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
144329811|NCT00098722|520410290|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
144329812|NCT00098722|520410291|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
144329813|NCT00098722|520410292|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
144329814|NCT00098722|520410293|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
144329815|NCT00098722|520410287|FG000|Double Blind Phase|Other|7|||
144329816|NCT00098722|520410288|FG001|Double Blind Phase|Other|8|||
144329817|NCT00098722|520410289|FG002|Double Blind Phase|Other|7|||
144329818|NCT00098722|520410290|FG003|Double Blind Phase|Other|0|||
144329819|NCT00098722|520410291|FG004|Double Blind Phase|Other|0|||
144329820|NCT00098722|520410292|FG005|Double Blind Phase|Other|0|||
144329821|NCT00098722|520410293|FG006|Double Blind Phase|Other|0|||
144329822|NCT00098722|520410287|FG000|Open Label Phase|Adverse Event|0|||
144329823|NCT00098722|520410288|FG001|Open Label Phase|Adverse Event|0|||
144329824|NCT00098722|520410289|FG002|Open Label Phase|Adverse Event|0|||
144329825|NCT00098722|520410290|FG003|Open Label Phase|Adverse Event|5|||
144329826|NCT00098722|520410291|FG004|Open Label Phase|Adverse Event|0|||
144329827|NCT00098722|520410292|FG005|Open Label Phase|Adverse Event|0|||
144329828|NCT00098722|520410293|FG006|Open Label Phase|Adverse Event|0|||
144329829|NCT00098722|520410287|FG000|Open Label Phase|Death|0|||
144329830|NCT00098722|520410288|FG001|Open Label Phase|Death|0|||
144329831|NCT00098722|520410289|FG002|Open Label Phase|Death|0|||
144329832|NCT00098722|520410290|FG003|Open Label Phase|Death|2|||
144329833|NCT00098722|520410291|FG004|Open Label Phase|Death|0|||
144329834|NCT00098722|520410292|FG005|Open Label Phase|Death|0|||
144329835|NCT00098722|520410293|FG006|Open Label Phase|Death|0|||
144329836|NCT00098722|520410287|FG000|Open Label Phase|Lack of Efficacy|0|||
144329837|NCT00098722|520410288|FG001|Open Label Phase|Lack of Efficacy|0|||
144329838|NCT00098722|520410289|FG002|Open Label Phase|Lack of Efficacy|0|||
144329839|NCT00098722|520410290|FG003|Open Label Phase|Lack of Efficacy|8|||
144329840|NCT00098722|520410291|FG004|Open Label Phase|Lack of Efficacy|0|||
144329841|NCT00098722|520410292|FG005|Open Label Phase|Lack of Efficacy|0|||
144329842|NCT00098722|520410293|FG006|Open Label Phase|Lack of Efficacy|0|||
144329843|NCT00098722|520410287|FG000|Open Label Phase|Pregnancy|0|||
144329844|NCT00098722|520410288|FG001|Open Label Phase|Pregnancy|0|||
144329845|NCT00098722|520410289|FG002|Open Label Phase|Pregnancy|0|||
144329846|NCT00098722|520410290|FG003|Open Label Phase|Pregnancy|1|||
144329847|NCT00098722|520410291|FG004|Open Label Phase|Pregnancy|0|||
144329848|NCT00098722|520410292|FG005|Open Label Phase|Pregnancy|0|||
144329849|NCT00098722|520410293|FG006|Open Label Phase|Pregnancy|0|||
144329850|NCT00098722|520410287|FG000|Open Label Phase|Participant defaulted|0|||
144329851|NCT00098722|520410288|FG001|Open Label Phase|Participant defaulted|0|||
144329852|NCT00098722|520410289|FG002|Open Label Phase|Participant defaulted|0|||
144329853|NCT00098722|520410290|FG003|Open Label Phase|Participant defaulted|18|||
144329854|NCT00098722|520410291|FG004|Open Label Phase|Participant defaulted|0|||
144329855|NCT00098722|520410292|FG005|Open Label Phase|Participant defaulted|0|||
144329856|NCT00098722|520410293|FG006|Open Label Phase|Participant defaulted|0|||
144329857|NCT00098722|520410287|FG000|Open Label Phase|Ongoing at cut-off date|0|||
144329858|NCT00098722|520410288|FG001|Open Label Phase|Ongoing at cut-off date|0|||
144329859|NCT00098722|520410289|FG002|Open Label Phase|Ongoing at cut-off date|0|||
144329860|NCT00098722|520410290|FG003|Open Label Phase|Ongoing at cut-off date|220|||
144329861|NCT00098722|520410291|FG004|Open Label Phase|Ongoing at cut-off date|50|||
144329862|NCT00098722|520410292|FG005|Open Label Phase|Ongoing at cut-off date|0|||
144329863|NCT00098722|520410293|FG006|Open Label Phase|Ongoing at cut-off date|0|||
144329864|NCT00098722|520410287|FG000|Open Label Phase|Other|0|||
144329865|NCT00098722|520410288|FG001|Open Label Phase|Other|0|||
144329866|NCT00098722|520410289|FG002|Open Label Phase|Other|0|||
144329867|NCT00098722|520410290|FG003|Open Label Phase|Other|18|||
144329868|NCT00098722|520410291|FG004|Open Label Phase|Other|0|||
144329869|NCT00098722|520410292|FG005|Open Label Phase|Other|0|||
144329870|NCT00098722|520410293|FG006|Open Label Phase|Other|0|||
144329871|NCT00098722|520410287|FG000|Observation Phase|Death|0|||
144329872|NCT00098722|520410288|FG001|Observation Phase|Death|0|||
144329873|NCT00098722|520410289|FG002|Observation Phase|Death|0|||
144329874|NCT00098722|520410290|FG003|Observation Phase|Death|0|||
144329875|NCT00098722|520410291|FG004|Observation Phase|Death|0|||
144329876|NCT00098722|520410292|FG005|Observation Phase|Death|5|||
144329877|NCT00098722|520410293|FG006|Observation Phase|Death|3|||
144329878|NCT00098722|520410287|FG000|Observation Phase|Lack of Efficacy|0|||
144329879|NCT00098722|520410288|FG001|Observation Phase|Lack of Efficacy|0|||
144329880|NCT00098722|520410289|FG002|Observation Phase|Lack of Efficacy|0|||
144329881|NCT00098722|520410290|FG003|Observation Phase|Lack of Efficacy|0|||
144329882|NCT00098722|520410291|FG004|Observation Phase|Lack of Efficacy|0|||
144329883|NCT00098722|520410292|FG005|Observation Phase|Lack of Efficacy|2|||
144329884|NCT00098722|520410293|FG006|Observation Phase|Lack of Efficacy|0|||
144329885|NCT00098722|520410287|FG000|Observation Phase|Participant defaulted|0|||
144329886|NCT00098722|520410288|FG001|Observation Phase|Participant defaulted|0|||
144329887|NCT00098722|520410289|FG002|Observation Phase|Participant defaulted|0|||
144329888|NCT00098722|520410290|FG003|Observation Phase|Participant defaulted|0|||
144329889|NCT00098722|520410291|FG004|Observation Phase|Participant defaulted|0|||
144329890|NCT00098722|520410292|FG005|Observation Phase|Participant defaulted|17|||
144329891|NCT00098722|520410293|FG006|Observation Phase|Participant defaulted|4|||
144329892|NCT00098722|520410287|FG000|Observation Phase|Other|0|||
144329893|NCT00098722|520410288|FG001|Observation Phase|Other|0|||
144329894|NCT00098722|520410289|FG002|Observation Phase|Other|0|||
144329895|NCT00098722|520410290|FG003|Observation Phase|Other|0|||
144329896|NCT00098722|520410291|FG004|Observation Phase|Other|0|||
144329897|NCT00098722|520410292|FG005|Observation Phase|Other|21|||
144329898|NCT00098722|520410293|FG006|Observation Phase|Other|10|||
144329899|NCT00799591|520410294|FG000|Overall Study|De-escalation of doses|20|||
144329900|NCT00799591|520410294|FG000|Overall Study|Death|14|||
144329901|NCT00799591|520410294|FG000|Overall Study|Technical failure|12|||
144329902|NCT00799591|520410294|FG000|Overall Study|Resistant germ|11|||
144329903|NCT00799591|520410294|FG000|Overall Study|New infection|4|||
144329904|NCT00799591|520410294|FG000|Overall Study|Resistance germ and technical failure|2|||
144329905|NCT00799591|520410294|FG000|Overall Study|Persistance of fever undetermined origin|1|||
144329906|NCT00799591|520410294|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
144329907|NCT00799591|520410294|FG000|Overall Study|Infectious origin not probable|1|||
144329908|NCT01998893|520410303|FG000|Overall Study|Adverse Event|2|||
144329909|NCT01998893|520410303|FG000|Overall Study|Death|1|||
144329910|NCT01998893|520410303|FG000|Overall Study|Lost to Follow-up|8|||
144329911|NCT01998893|520410303|FG000|Overall Study|Physician Decision|2|||
144329912|NCT01998893|520410303|FG000|Overall Study|Protocol Violation|2|||
144329913|NCT01998893|520410303|FG000|Overall Study|Withdrawal by Subject|1|||
144329914|NCT01998893|520410303|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
144329915|NCT03276052|520410304|FG000|Overall Study|Withdrawal by Subject|5|||
144329916|NCT03276052|520410304|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
144329917|NCT01994863|520410305|FG000|Period 1|Adverse Event|4|||
144329918|NCT01994863|520410306|FG001|Period 1|Adverse Event|0|||
144329919|NCT01994863|520410305|FG000|Period 1|Withdrawal by Subject|1|||
144329920|NCT01994863|520410306|FG001|Period 1|Withdrawal by Subject|0|||
144329921|NCT01994863|520410305|FG000|Period 1|Trial stopped by sponsor|1|||
144329922|NCT01994863|520410306|FG001|Period 1|Trial stopped by sponsor|3|||
144329923|NCT01994863|520410305|FG000|Period 1|Lack of Efficacy|1|||
144329924|NCT01994863|520410306|FG001|Period 1|Lack of Efficacy|0|||
144329925|NCT01994863|520410305|FG000|Period 2|Adverse Event|0|||
144329926|NCT01994863|520410306|FG001|Period 2|Adverse Event|1|||
144329927|NCT01994863|520410305|FG000|Period 2|Lack of Efficacy|0|||
144329928|NCT01994863|520410306|FG001|Period 2|Lack of Efficacy|2|||
144329929|NCT01994863|520410305|FG000|Period 2|Withdrawal by Subject|1|||
144329930|NCT01994863|520410306|FG001|Period 2|Withdrawal by Subject|1|||
144329931|NCT05136898|520410307|FG000|Overall Study|Adverse Event|2|||
144329932|NCT03784846|520410308|FG000|Pre-COVID Study|Lost to Follow-up|3|||
144329933|NCT03784846|520410309|FG001|Pre-COVID Study|Lost to Follow-up|3|||
144329934|NCT03784846|520410310|FG002|Pre-COVID Study|Lost to Follow-up|2|||
144329935|NCT03784846|520410308|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
144329936|NCT03784846|520410309|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
144329937|NCT03784846|520410310|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
144329938|NCT03784846|520410308|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
144329939|NCT03784846|520410309|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
144329940|NCT03784846|520410310|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
144329941|NCT03784846|520410308|FG000|Post-COVID Study|Lost to Follow-up|3|||
144329942|NCT03784846|520410309|FG001|Post-COVID Study|Lost to Follow-up|5|||
144329943|NCT03784846|520410310|FG002|Post-COVID Study|Lost to Follow-up|1|||
144329944|NCT03784846|520410308|FG000|Post-COVID Study|Withdrawal by Subject|1|||
144329945|NCT03784846|520410309|FG001|Post-COVID Study|Withdrawal by Subject|2|||
144329946|NCT03784846|520410310|FG002|Post-COVID Study|Withdrawal by Subject|0|||
144329947|NCT00867087|520410311|FG000|Overall Study|Other|1|||
144329948|NCT00867087|520410311|FG000|Overall Study|Withdrawal by Subject|4|||
144329949|NCT00867087|520410311|FG000|Overall Study|Death|37|||
144329950|NCT02334683|520410312|FG000|First 12 Week Period|Lost to Follow-up|1|||
144329951|NCT02334683|520410313|FG001|First 12 Week Period|Lost to Follow-up|0|||
144329952|NCT02334683|520410312|FG000|Second 12 Week Period|Adverse Event|0|||
144329953|NCT02334683|520410313|FG001|Second 12 Week Period|Adverse Event|1|||
144329954|NCT01891344|520410314|FG000|Overall Study|Ongoing|6|||
144329955|NCT01891344|520410315|FG001|Overall Study|Ongoing|2|||
144329956|NCT01891344|520410316|FG002|Overall Study|Ongoing|0|||
144329957|NCT01891344|520410317|FG003|Overall Study|Ongoing|1|||
144329958|NCT01891344|520410318|FG004|Overall Study|Ongoing|4|||
144329959|NCT01891344|520410319|FG005|Overall Study|Ongoing|1|||
144329960|NCT01891344|520410320|FG006|Overall Study|Ongoing|0|||
144329961|NCT01891344|520410321|FG007|Overall Study|Ongoing|0|||
144329962|NCT02310230|520410327|FG000|Overall Study|Physician Decision|1|||
144329963|NCT02310230|520410328|FG001|Overall Study|Physician Decision|3|||
144329964|NCT02310230|520410327|FG000|Overall Study|monitor baseline taken after induction|2|||
144329965|NCT02310230|520410328|FG001|Overall Study|monitor baseline taken after induction|7|||
144329966|NCT02310230|520410327|FG000|Overall Study|Poor signal quality|5|||
144329967|NCT02310230|520410328|FG001|Overall Study|Poor signal quality|8|||
144329968|NCT02310230|520410327|FG000|Overall Study|Case cancelled|1|||
144329969|NCT02310230|520410328|FG001|Overall Study|Case cancelled|0|||
144329970|NCT02231762|520410329|FG000|Combination Phase|Adverse Event|10|||
144329971|NCT02231762|520410330|FG001|Combination Phase|Adverse Event|0|||
144329972|NCT02231762|520410331|FG002|Combination Phase|Adverse Event|0|||
144329973|NCT02231762|520410332|FG003|Combination Phase|Adverse Event|0|||
144329974|NCT02231762|520410329|FG000|Combination Phase|Withdrawal by Subject|2|||
144329975|NCT02231762|520410330|FG001|Combination Phase|Withdrawal by Subject|0|||
144329976|NCT02231762|520410331|FG002|Combination Phase|Withdrawal by Subject|0|||
144329977|NCT02231762|520410332|FG003|Combination Phase|Withdrawal by Subject|0|||
144329978|NCT02231762|520410329|FG000|Combination Phase|Disease Progression|6|||
144329979|NCT02231762|520410330|FG001|Combination Phase|Disease Progression|0|||
144329980|NCT02231762|520410331|FG002|Combination Phase|Disease Progression|0|||
144329981|NCT02231762|520410332|FG003|Combination Phase|Disease Progression|0|||
144329982|NCT02231762|520410329|FG000|Combination Phase|Did not meet inclusion criteria|1|||
144329983|NCT02231762|520410330|FG001|Combination Phase|Did not meet inclusion criteria|0|||
144329984|NCT02231762|520410331|FG002|Combination Phase|Did not meet inclusion criteria|0|||
144329985|NCT02231762|520410332|FG003|Combination Phase|Did not meet inclusion criteria|0|||
144329986|NCT02231762|520410329|FG000|Combination Phase|Protocol Violation|1|||
144329987|NCT02231762|520410330|FG001|Combination Phase|Protocol Violation|0|||
144329988|NCT02231762|520410331|FG002|Combination Phase|Protocol Violation|0|||
144329989|NCT02231762|520410332|FG003|Combination Phase|Protocol Violation|0|||
144329990|NCT02231762|520410329|FG000|Maintenance Phase|Disease progression|0|||
144329991|NCT02231762|520410330|FG001|Maintenance Phase|Disease progression|3|||
144329992|NCT02231762|520410331|FG002|Maintenance Phase|Disease progression|4|||
144329993|NCT02231762|520410332|FG003|Maintenance Phase|Disease progression|3|||
144329994|NCT02231762|520410329|FG000|Maintenance Phase|Adverse Event|0|||
144329995|NCT02231762|520410330|FG001|Maintenance Phase|Adverse Event|0|||
144329996|NCT02231762|520410331|FG002|Maintenance Phase|Adverse Event|1|||
144329997|NCT02231762|520410332|FG003|Maintenance Phase|Adverse Event|2|||
144329998|NCT03249935|520410337|FG000|Overall Study|Discharged from facility early|36|||
144329999|NCT03249935|520410337|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
144330000|NCT03249935|520410337|FG000|Overall Study|Protocol Violation|5|||
144330001|NCT03593681|520410338|FG000|Overall Study|Inadequate sample collected|12|||
144330002|NCT03593681|520410338|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
144330003|NCT03593681|520410338|FG000|Overall Study|Protocol Violation|3|||
144330004|NCT03593681|520410338|FG000|Overall Study|Withdrawal by Subject|3|||
144330005|NCT03593681|520410338|FG000|Overall Study|Procedure not attempted|3|||
144330006|NCT03593681|520410338|FG000|Overall Study|Adverse Event|2|||
144330007|NCT03593681|520410338|FG000|Overall Study|Physician Decision|1|||
144330008|NCT01669421|520410341|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
144330009|NCT01669421|520410341|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
144330010|NCT01149486|520410345|FG000|First Intervention|Adverse Event|0|||
144330011|NCT01149486|520410346|FG001|First Intervention|Adverse Event|1|||
144330012|NCT00541099|520410351|FG000|Overall Study|Ineligible|3|||
144330013|NCT00066469|520410352|FG000|Overall Study|Death|3|||
144330014|NCT00066469|520410352|FG000|Overall Study|Lack of Efficacy|9|||
144330015|NCT00066469|520410352|FG000|Overall Study|Lost to Follow-up|1|||
144330016|NCT00066469|520410352|FG000|Overall Study|Physician Decision|1|||
144330017|NCT00066469|520410352|FG000|Overall Study|Withdrawal by Subject|1|||
144330018|NCT00066469|520410352|FG000|Overall Study|ineligible|1|||
144330019|NCT00711802|520410353|FG000|Overall Study|Not treated (no further detail)|2|||
144330020|NCT00711802|520410354|FG001|Overall Study|Not treated (no further detail)|1|||
144330021|NCT00711802|520410355|FG002|Overall Study|Not treated (no further detail)|2|||
144330022|NCT00711802|520410356|FG003|Overall Study|Not treated (no further detail)|0|||
144330023|NCT00711802|520410357|FG004|Overall Study|Not treated (no further detail)|2|||
144330024|NCT00711802|520410358|FG005|Overall Study|Not treated (no further detail)|0|||
144330025|NCT00711802|520410359|FG006|Overall Study|Not treated (no further detail)|0|||
144330026|NCT00711802|520410360|FG007|Overall Study|Not treated (no further detail)|0|||
144330027|NCT00711802|520410353|FG000|Overall Study|Adverse Event|0|||
144330028|NCT00711802|520410354|FG001|Overall Study|Adverse Event|0|||
144330029|NCT00711802|520410355|FG002|Overall Study|Adverse Event|0|||
144330030|NCT00711802|520410356|FG003|Overall Study|Adverse Event|0|||
144330031|NCT00711802|520410357|FG004|Overall Study|Adverse Event|1|||
144330032|NCT00711802|520410358|FG005|Overall Study|Adverse Event|1|||
144330033|NCT00711802|520410359|FG006|Overall Study|Adverse Event|0|||
144330034|NCT00711802|520410360|FG007|Overall Study|Adverse Event|0|||
144330035|NCT00711802|520410353|FG000|Overall Study|Microbiological failure|0|||
144330036|NCT00711802|520410354|FG001|Overall Study|Microbiological failure|1|||
144330037|NCT00711802|520410355|FG002|Overall Study|Microbiological failure|0|||
144330038|NCT00711802|520410356|FG003|Overall Study|Microbiological failure|0|||
144330039|NCT00711802|520410357|FG004|Overall Study|Microbiological failure|0|||
144330040|NCT00711802|520410358|FG005|Overall Study|Microbiological failure|1|||
144330041|NCT00711802|520410359|FG006|Overall Study|Microbiological failure|0|||
144330042|NCT00711802|520410360|FG007|Overall Study|Microbiological failure|0|||
144330043|NCT00711802|520410353|FG000|Overall Study|Protocol Violation|0|||
144330044|NCT00711802|520410354|FG001|Overall Study|Protocol Violation|0|||
144330045|NCT00711802|520410355|FG002|Overall Study|Protocol Violation|0|||
144330046|NCT00711802|520410356|FG003|Overall Study|Protocol Violation|1|||
144330047|NCT00711802|520410357|FG004|Overall Study|Protocol Violation|0|||
144330048|NCT00711802|520410358|FG005|Overall Study|Protocol Violation|0|||
144330049|NCT00711802|520410359|FG006|Overall Study|Protocol Violation|0|||
144330050|NCT00711802|520410360|FG007|Overall Study|Protocol Violation|0|||
144330051|NCT00711802|520410353|FG000|Overall Study|Physician Decision|0|||
144330052|NCT00711802|520410354|FG001|Overall Study|Physician Decision|2|||
144330053|NCT00711802|520410355|FG002|Overall Study|Physician Decision|0|||
144330054|NCT00711802|520410356|FG003|Overall Study|Physician Decision|0|||
144330055|NCT00711802|520410357|FG004|Overall Study|Physician Decision|0|||
144330056|NCT00711802|520410358|FG005|Overall Study|Physician Decision|0|||
144330057|NCT00711802|520410359|FG006|Overall Study|Physician Decision|0|||
144330058|NCT00711802|520410360|FG007|Overall Study|Physician Decision|0|||
144330059|NCT00711802|520410353|FG000|Overall Study|Withdrawal by Subject|0|||
144330060|NCT00711802|520410354|FG001|Overall Study|Withdrawal by Subject|1|||
144330061|NCT00711802|520410355|FG002|Overall Study|Withdrawal by Subject|0|||
144330062|NCT00711802|520410356|FG003|Overall Study|Withdrawal by Subject|1|||
144330063|NCT00711802|520410357|FG004|Overall Study|Withdrawal by Subject|0|||
144330064|NCT00711802|520410358|FG005|Overall Study|Withdrawal by Subject|0|||
144330065|NCT00711802|520410359|FG006|Overall Study|Withdrawal by Subject|0|||
144330066|NCT00711802|520410360|FG007|Overall Study|Withdrawal by Subject|0|||
144330067|NCT00711802|520410353|FG000|Overall Study|Lost to Follow-up|0|||
144330068|NCT00711802|520410354|FG001|Overall Study|Lost to Follow-up|0|||
144330069|NCT00711802|520410355|FG002|Overall Study|Lost to Follow-up|3|||
144330070|NCT00711802|520410356|FG003|Overall Study|Lost to Follow-up|1|||
144330071|NCT00711802|520410357|FG004|Overall Study|Lost to Follow-up|10|||
144330072|NCT00711802|520410358|FG005|Overall Study|Lost to Follow-up|6|||
144330073|NCT00711802|520410359|FG006|Overall Study|Lost to Follow-up|4|||
144330074|NCT00711802|520410360|FG007|Overall Study|Lost to Follow-up|2|||
144330075|NCT00711802|520410353|FG000|Overall Study|Reason not reported|0|||
144330076|NCT00711802|520410354|FG001|Overall Study|Reason not reported|1|||
144330077|NCT00711802|520410355|FG002|Overall Study|Reason not reported|1|||
144330078|NCT00711802|520410356|FG003|Overall Study|Reason not reported|0|||
144330079|NCT00711802|520410357|FG004|Overall Study|Reason not reported|1|||
144330080|NCT00711802|520410358|FG005|Overall Study|Reason not reported|0|||
144330081|NCT00711802|520410359|FG006|Overall Study|Reason not reported|1|||
144330082|NCT00711802|520410360|FG007|Overall Study|Reason not reported|0|||
144330083|NCT00581828|520410361|FG000|Overall Study|Protocol Violation|1|||
144330084|NCT00391391|520410362|FG000|Overall Study|Adverse Event|0|||
144330085|NCT00391391|520410363|FG001|Overall Study|Adverse Event|0|||
144330086|NCT00391391|520410364|FG002|Overall Study|Adverse Event|0|||
144330087|NCT00391391|520410365|FG003|Overall Study|Adverse Event|1|||
144330088|NCT00391391|520410362|FG000|Overall Study|Lost to Follow-up|1|||
144330089|NCT00391391|520410363|FG001|Overall Study|Lost to Follow-up|3|||
144330090|NCT00391391|520410364|FG002|Overall Study|Lost to Follow-up|7|||
144330091|NCT00391391|520410365|FG003|Overall Study|Lost to Follow-up|4|||
144330092|NCT00391391|520410362|FG000|Overall Study|Protocol Violation|2|||
144330093|NCT00391391|520410363|FG001|Overall Study|Protocol Violation|3|||
144330094|NCT00391391|520410364|FG002|Overall Study|Protocol Violation|6|||
144330095|NCT00391391|520410365|FG003|Overall Study|Protocol Violation|7|||
144330096|NCT00391391|520410362|FG000|Overall Study|Withdrawal by Subject|6|||
144330097|NCT00391391|520410363|FG001|Overall Study|Withdrawal by Subject|4|||
144330098|NCT00391391|520410364|FG002|Overall Study|Withdrawal by Subject|10|||
144330099|NCT00391391|520410365|FG003|Overall Study|Withdrawal by Subject|7|||
144330100|NCT02084238|520410366|FG000|Overall Study|Lost to Follow-up|2|||
144330101|NCT01154283|520410367|FG000|0-6 Weeks|Withdrawal by Subject|7|||
144330102|NCT01154283|520410368|FG001|0-6 Weeks|Withdrawal by Subject|2|||
144330103|NCT01154283|520410367|FG000|0-6 Weeks|Death|0|||
144330104|NCT01154283|520410368|FG001|0-6 Weeks|Death|1|||
144330105|NCT01154283|520410367|FG000|7-12 Weeks|Death|1|||
144330106|NCT01154283|520410368|FG001|7-12 Weeks|Death|0|||
144330107|NCT01154283|520410367|FG000|7-12 Weeks|Withdrawal by Subject|0|||
144330108|NCT01154283|520410368|FG001|7-12 Weeks|Withdrawal by Subject|1|||
144330109|NCT00320372|520410369|FG000|Overall Study|Physician Decision|4|||
144330110|NCT00320372|520410370|FG001|Overall Study|Physician Decision|7|||
144330111|NCT00320372|520410369|FG000|Overall Study|Death|7|||
144330112|NCT00320372|520410370|FG001|Overall Study|Death|8|||
144330113|NCT00320372|520410369|FG000|Overall Study|Withdrawal by Subject|55|||
144330114|NCT00320372|520410370|FG001|Overall Study|Withdrawal by Subject|37|||
144330115|NCT00320372|520410369|FG000|Overall Study|Non-Compliance|40|||
144330116|NCT00320372|520410370|FG001|Overall Study|Non-Compliance|39|||
144330117|NCT00320372|520410369|FG000|Overall Study|Did not Meet (I/E)|3|||
144330118|NCT00320372|520410370|FG001|Overall Study|Did not Meet (I/E)|1|||
144330119|NCT00320372|520410369|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
144330120|NCT00320372|520410370|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
144330121|NCT01853072|520410371|FG000|Overall Study|Adverse event prior to treatment|0|||
144330122|NCT01853072|520410372|FG001|Overall Study|Adverse event prior to treatment|1|||
144330123|NCT01853072|520410371|FG000|Overall Study|Adverse Event|0|||
144330124|NCT01853072|520410372|FG001|Overall Study|Adverse Event|3|||
144330125|NCT01853072|520410371|FG000|Overall Study|Death|1|||
144330126|NCT01853072|520410372|FG001|Overall Study|Death|4|||
144330127|NCT01853072|520410371|FG000|Overall Study|Lost to Follow-up|0|||
144330128|NCT01853072|520410372|FG001|Overall Study|Lost to Follow-up|3|||
144330129|NCT01853072|520410371|FG000|Overall Study|Non-compliance with study drug|0|||
144330130|NCT01853072|520410372|FG001|Overall Study|Non-compliance with study drug|1|||
144330131|NCT01853072|520410371|FG000|Overall Study|Physician Decision|1|||
144330132|NCT01853072|520410372|FG001|Overall Study|Physician Decision|1|||
144330133|NCT01853072|520410371|FG000|Overall Study|Withdrawal by Subject|1|||
144330134|NCT01853072|520410372|FG001|Overall Study|Withdrawal by Subject|2|||
144330135|NCT01853072|520410371|FG000|Overall Study|Reason not specified|9|||
144330136|NCT01853072|520410372|FG001|Overall Study|Reason not specified|6|||
144330137|NCT03412604|520410373|FG000|Overall Study|Withdrawal by Subject|1|||
144330138|NCT03464422|520410375|FG000|Overall Study|Lost to Follow-up|2|||
144330139|NCT03464422|520410375|FG000|Overall Study|Withdrawal by Subject|2|||
144330140|NCT00475865|520410379|FG000|Overall Study|Adverse Event|0|||
144330141|NCT00475865|520410380|FG001|Overall Study|Adverse Event|3|||
144330142|NCT00475865|520410381|FG002|Overall Study|Adverse Event|4|||
144330143|NCT00475865|520410379|FG000|Overall Study|Lack of Efficacy|1|||
144330144|NCT00475865|520410380|FG001|Overall Study|Lack of Efficacy|0|||
144330145|NCT00475865|520410381|FG002|Overall Study|Lack of Efficacy|0|||
144330146|NCT00475865|520410379|FG000|Overall Study|Progressive disease|0|||
144330147|NCT00475865|520410380|FG001|Overall Study|Progressive disease|1|||
144330148|NCT00475865|520410381|FG002|Overall Study|Progressive disease|2|||
144330149|NCT00475865|520410379|FG000|Overall Study|Participant did not wish to continue|1|||
144330150|NCT00475865|520410380|FG001|Overall Study|Participant did not wish to continue|0|||
144330151|NCT00475865|520410381|FG002|Overall Study|Participant did not wish to continue|0|||
144330152|NCT00475865|520410379|FG000|Overall Study|Other than above|0|||
144330153|NCT00475865|520410380|FG001|Overall Study|Other than above|1|||
144330154|NCT00475865|520410381|FG002|Overall Study|Other than above|0|||
144330155|NCT01360398|520410385|FG000|Overall Study|Withdrawal by Subject|14|||
144330156|NCT01360398|520410385|FG000|Overall Study|Other|7|||
144330157|NCT01360398|520410385|FG000|Overall Study|Migrated/moved from study area|1|||
144330158|NCT00846040|520410386|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
144330159|NCT00846040|520410387|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
144330160|NCT00846040|520410388|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
144330161|NCT00846040|520410386|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
144330162|NCT00846040|520410387|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
144330163|NCT00846040|520410388|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
144330164|NCT03158272|520410391|FG000|Overall Study|Disease progression|3|||
144330165|NCT03158272|520410392|FG001|Overall Study|Disease progression|3|||
144330166|NCT03158272|520410393|FG002|Overall Study|Disease progression|4|||
144330167|NCT03158272|520410394|FG003|Overall Study|Disease progression|6|||
144330168|NCT03158272|520410391|FG000|Overall Study|Death|0|||
144330169|NCT03158272|520410392|FG001|Overall Study|Death|0|||
144330170|NCT03158272|520410393|FG002|Overall Study|Death|1|||
144330171|NCT03158272|520410394|FG003|Overall Study|Death|0|||
144330172|NCT03158272|520410391|FG000|Overall Study|Other reasons|0|||
144330173|NCT03158272|520410392|FG001|Overall Study|Other reasons|0|||
144330174|NCT03158272|520410393|FG002|Overall Study|Other reasons|1|||
144330175|NCT03158272|520410394|FG003|Overall Study|Other reasons|0|||
144330176|NCT03158272|520410391|FG000|Overall Study|Adverse event unrelated to the drug|0|||
144330177|NCT03158272|520410392|FG001|Overall Study|Adverse event unrelated to the drug|1|||
144330178|NCT03158272|520410393|FG002|Overall Study|Adverse event unrelated to the drug|0|||
144330179|NCT03158272|520410394|FG003|Overall Study|Adverse event unrelated to the drug|0|||
144330180|NCT01822535|520410395|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
144330181|NCT01822535|520410396|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
144330182|NCT01822535|520410395|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
144330183|NCT01822535|520410396|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
144330184|NCT01822535|520410395|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
144330185|NCT01822535|520410396|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
144330186|NCT01048866|520410397|FG000|Overall Study|Adverse Event|1|||
144330187|NCT01048866|520410398|FG001|Overall Study|Adverse Event|0|||
144330188|NCT01048866|520410397|FG000|Overall Study|Protocol Violation|1|||
144330189|NCT01048866|520410398|FG001|Overall Study|Protocol Violation|0|||
144330190|NCT01048866|520410397|FG000|Overall Study|Physician Decision|1|||
144330191|NCT01048866|520410398|FG001|Overall Study|Physician Decision|0|||
144330192|NCT01048866|520410397|FG000|Overall Study|Withdrawal by Subject|0|||
144330193|NCT01048866|520410398|FG001|Overall Study|Withdrawal by Subject|2|||
144330194|NCT01048866|520410397|FG000|Overall Study|Lost to Follow-up|0|||
144330195|NCT01048866|520410398|FG001|Overall Study|Lost to Follow-up|2|||
144330196|NCT01048866|520410397|FG000|Overall Study|Other|1|||
144330197|NCT01048866|520410398|FG001|Overall Study|Other|1|||
144330198|NCT03582813|520410399|FG000|Overall Study|Lost to Follow-up|18|||
144330199|NCT03582813|520410400|FG001|Overall Study|Lost to Follow-up|21|||
144330200|NCT03582813|520410399|FG000|Overall Study|Withdrawal by Subject|1|||
144330201|NCT03582813|520410400|FG001|Overall Study|Withdrawal by Subject|0|||
144330202|NCT02230683|520410401|FG000|Overall Study|Adverse Event|1|||
144330203|NCT03081858|520411700|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
144330204|NCT03081858|520411701|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
144330205|NCT03081858|520411702|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
144330206|NCT03081858|520411703|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
144330207|NCT00387647|520411708|FG000|Overall Study|Death|18|||
144330208|NCT02032407|520411709|FG000|Overall Study|Lost to Follow-up|2|||
144330209|NCT02032407|520411709|FG000|Overall Study|Pregnancy|1|||
144330210|NCT02032407|520411709|FG000|Overall Study|Other Miscellaneous Reasons|2|||
144330211|NCT01309269|520411710|FG000|Overall Study|Adverse Event|56|||
144330212|NCT01309269|520411710|FG000|Overall Study|Withdrawal by Subject|25|||
144330213|NCT01309269|520411710|FG000|Overall Study|Lack of Acceptance|15|||
144330214|NCT01309269|520411710|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
144330215|NCT01309269|520411710|FG000|Overall Study|Kidney Transplant|25|||
144330216|NCT01309269|520411710|FG000|Overall Study|Administrative Problems|141|||
144330217|NCT01309269|520411710|FG000|Overall Study|Other|256|||
144330218|NCT01309269|520411710|FG000|Overall Study|Other|1|||
144330219|NCT01309269|520411710|FG000|Overall Study|Study Completion Data Not Recorded|95|||
144330220|NCT01309269|520411710|FG000|Overall Study|Enrolled but not Treated|107|||
144330221|NCT01062841|520411721|FG000|Overall Study|Indwelling Device Removed|41|||
144330222|NCT01062841|520411722|FG001|Overall Study|Indwelling Device Removed|48|||
144330223|NCT01062841|520411721|FG000|Overall Study|Death|3|||
144330224|NCT01062841|520411722|FG001|Overall Study|Death|5|||
144330225|NCT01062841|520411721|FG000|Overall Study|Withdrawal by Subject|2|||
144330226|NCT01062841|520411722|FG001|Overall Study|Withdrawal by Subject|0|||
144330227|NCT01062841|520411721|FG000|Overall Study|Withdrawal by Study|3|||
144330228|NCT01062841|520411722|FG001|Overall Study|Withdrawal by Study|0|||
144330229|NCT02046174|520411723|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
144330230|NCT02046174|520411724|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
144330231|NCT02969590|520411726|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
144330232|NCT02969590|520411727|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
144330233|NCT02969590|520411728|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
144330234|NCT03294135|520411729|FG000|Overall Study|Serious Adverse Event|1|||
144330235|NCT03294135|520411730|FG001|Overall Study|Serious Adverse Event|0|||
144330236|NCT03294135|520411731|FG002|Overall Study|Serious Adverse Event|0|||
144330237|NCT03294135|520411729|FG000|Overall Study|Lost to Follow-up|1|||
144330238|NCT03294135|520411730|FG001|Overall Study|Lost to Follow-up|0|||
144330239|NCT03294135|520411731|FG002|Overall Study|Lost to Follow-up|1|||
144330240|NCT03294135|520411729|FG000|Overall Study|Withdrawal by Subject|0|||
144330241|NCT03294135|520411730|FG001|Overall Study|Withdrawal by Subject|0|||
144330242|NCT03294135|520411731|FG002|Overall Study|Withdrawal by Subject|1|||
144330243|NCT03294135|520411729|FG000|Overall Study|Other|2|||
144330244|NCT03294135|520411730|FG001|Overall Study|Other|0|||
144330245|NCT03294135|520411731|FG002|Overall Study|Other|0|||
144330246|NCT00186537|520411732|FG000|Overall Study|Withdrawal by Subject|4|||
144330247|NCT00186537|520411733|FG001|Overall Study|Withdrawal by Subject|0|||
144330248|NCT00186537|520411734|FG002|Overall Study|Withdrawal by Subject|3|||
144330249|NCT00186537|520411732|FG000|Overall Study|ALT > 1.5 x ULN|3|||
144330250|NCT00186537|520411733|FG001|Overall Study|ALT > 1.5 x ULN|0|||
144330251|NCT00186537|520411734|FG002|Overall Study|ALT > 1.5 x ULN|0|||
144330252|NCT02763254|520411735|FG000|Overall Study|Adverse Event|1|||
144330253|NCT01143051|520411737|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
144330254|NCT01143051|520411738|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
144330255|NCT01143051|520411739|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
144330256|NCT01143051|520411740|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
144330257|NCT01143051|520411741|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
144330258|NCT01143051|520411742|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
144330259|NCT01143051|520411737|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
144330260|NCT01143051|520411738|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
144330261|NCT01143051|520411739|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
144330262|NCT01143051|520411740|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
144330263|NCT01143051|520411741|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
144330264|NCT01143051|520411742|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
144330265|NCT02498067|520411743|FG000|Overall Study|Lost to Follow-up|22|||
144330266|NCT02498067|520411743|FG000|Overall Study|Did not meet inclusion criteria|11|||
144330267|NCT00765882|520411744|FG000|Overall Study|Adverse Event|10|||
144330268|NCT00765882|520411745|FG001|Overall Study|Adverse Event|21|||
144330269|NCT00765882|520411746|FG002|Overall Study|Adverse Event|20|||
144330270|NCT00765882|520411744|FG000|Overall Study|Lack of Efficacy|4|||
144330271|NCT00765882|520411745|FG001|Overall Study|Lack of Efficacy|0|||
144330272|NCT00765882|520411746|FG002|Overall Study|Lack of Efficacy|1|||
144330273|NCT00765882|520411744|FG000|Overall Study|Protocol Violation|4|||
144330274|NCT00765882|520411745|FG001|Overall Study|Protocol Violation|3|||
144330275|NCT00765882|520411746|FG002|Overall Study|Protocol Violation|1|||
144330276|NCT00765882|520411744|FG000|Overall Study|Withdrawal by Subject|2|||
144330277|NCT00765882|520411745|FG001|Overall Study|Withdrawal by Subject|6|||
144330278|NCT00765882|520411746|FG002|Overall Study|Withdrawal by Subject|6|||
144330279|NCT00765882|520411744|FG000|Overall Study|Lost to Follow-up|1|||
144330280|NCT00765882|520411745|FG001|Overall Study|Lost to Follow-up|9|||
144330281|NCT00765882|520411746|FG002|Overall Study|Lost to Follow-up|6|||
144330282|NCT00765882|520411744|FG000|Overall Study|Other Reason|3|||
144330283|NCT00765882|520411745|FG001|Overall Study|Other Reason|1|||
144330284|NCT00765882|520411746|FG002|Overall Study|Other Reason|2|||
144330285|NCT01874275|520411750|FG000|Overall Study|Lost to Follow-up|1|||
144330286|NCT01874275|520411751|FG001|Overall Study|Lost to Follow-up|0|||
144330287|NCT03351114|520411752|FG000|Overall Study|Withdrawal by Subject|1|||
144330288|NCT01665430|520411755|FG000|Overall Study|Adverse Event|1|||
144330289|NCT01665430|520411755|FG000|Overall Study|Withdrawal by Subject|6|||
144330290|NCT01665430|520411755|FG000|Overall Study|Other Unspecified|2|||
144330291|NCT00989235|520411756|FG000|Overall Study|Death|0|||
144330292|NCT00989235|520411757|FG001|Overall Study|Death|1|||
144330293|NCT00989235|520411756|FG000|Overall Study|Adverse Event|0|||
144330294|NCT00989235|520411757|FG001|Overall Study|Adverse Event|1|||
144330295|NCT00989235|520411756|FG000|Overall Study|Lack of Efficacy|1|||
144330296|NCT00989235|520411757|FG001|Overall Study|Lack of Efficacy|0|||
144330297|NCT00989235|520411756|FG000|Overall Study|Withdrawal of Consent|1|||
144330298|NCT00989235|520411757|FG001|Overall Study|Withdrawal of Consent|1|||
144330299|NCT00989235|520411756|FG000|Overall Study|Desire to Become Pregnant|1|||
144330300|NCT00989235|520411757|FG001|Overall Study|Desire to Become Pregnant|0|||
144330301|NCT00989235|520411756|FG000|Overall Study|Randomized by Mistake|0|||
144330302|NCT00989235|520411757|FG001|Overall Study|Randomized by Mistake|2|||
144330303|NCT00989235|520411756|FG000|Overall Study|Lost to Follow-up|0|||
144330304|NCT00989235|520411757|FG001|Overall Study|Lost to Follow-up|1|||
144330305|NCT02961790|520411762|FG000|Overall Study|Canceled|4|||
144330306|NCT02961790|520411763|FG001|Overall Study|Canceled|5|||
144330307|NCT02961790|520411764|FG002|Overall Study|Canceled|1|||
144330308|NCT02961790|520411765|FG003|Overall Study|Canceled|4|||
144330309|NCT02961790|520411762|FG000|Overall Study|without baseline data|4|||
144330310|NCT02961790|520411763|FG001|Overall Study|without baseline data|0|||
144330311|NCT02961790|520411764|FG002|Overall Study|without baseline data|1|||
144330312|NCT02961790|520411765|FG003|Overall Study|without baseline data|0|||
144330313|NCT02961790|520411762|FG000|Overall Study|without post baseline data|7|||
144330314|NCT02961790|520411763|FG001|Overall Study|without post baseline data|6|||
144330315|NCT02961790|520411764|FG002|Overall Study|without post baseline data|4|||
144330316|NCT02961790|520411765|FG003|Overall Study|without post baseline data|1|||
144330317|NCT01135914|520411768|FG000|Overall Study|Withdrawal by Subject|1|||
144330318|NCT01135914|520411769|FG001|Overall Study|Withdrawal by Subject|3|||
144330319|NCT01135914|520411770|FG002|Overall Study|Withdrawal by Subject|6|||
144330320|NCT01135914|520411768|FG000|Overall Study|Lost to Follow-up|1|||
144330321|NCT01135914|520411769|FG001|Overall Study|Lost to Follow-up|0|||
144330322|NCT01135914|520411770|FG002|Overall Study|Lost to Follow-up|1|||
144330323|NCT01135914|520411768|FG000|Overall Study|Protocol Violation|0|||
144330324|NCT01135914|520411769|FG001|Overall Study|Protocol Violation|0|||
144330325|NCT01135914|520411770|FG002|Overall Study|Protocol Violation|3|||
144330326|NCT01135914|520411768|FG000|Overall Study|Lack of Efficacy|2|||
144330327|NCT01135914|520411769|FG001|Overall Study|Lack of Efficacy|1|||
144330328|NCT01135914|520411770|FG002|Overall Study|Lack of Efficacy|10|||
144330329|NCT01135914|520411768|FG000|Overall Study|Adverse Event|0|||
144330330|NCT01135914|520411769|FG001|Overall Study|Adverse Event|1|||
144330331|NCT01135914|520411770|FG002|Overall Study|Adverse Event|2|||
144330332|NCT02594098|520411771|FG000|Overall Study|Lack of Efficacy|17|||
144330333|NCT02594098|520411772|FG001|Overall Study|Lack of Efficacy|6|||
144330334|NCT02594098|520411771|FG000|Overall Study|Withdrawal by Subject|1|||
144330335|NCT02594098|520411772|FG001|Overall Study|Withdrawal by Subject|3|||
144330336|NCT02594098|520411771|FG000|Overall Study|Terminated participation|6|||
144330337|NCT02594098|520411772|FG001|Overall Study|Terminated participation|2|||
144330338|NCT02594098|520411771|FG000|Overall Study|Seek alternative treatment|2|||
144330339|NCT02594098|520411772|FG001|Overall Study|Seek alternative treatment|1|||
144330340|NCT02594098|520411771|FG000|Overall Study|Other|0|||
144330341|NCT02594098|520411772|FG001|Overall Study|Other|1|||
144330342|NCT01479595|520411776|FG000|Overall Study|Protocol deviation|0|||
144330343|NCT01479595|520411777|FG001|Overall Study|Protocol deviation|1|||
144330344|NCT01479595|520411776|FG000|Overall Study|Adverse Event|2|||
144330345|NCT01479595|520411777|FG001|Overall Study|Adverse Event|1|||
144330346|NCT02133664|520411778|FG000|Overall Study|Lost to Follow-up|2|||
144330347|NCT02133664|520411779|FG001|Overall Study|Lost to Follow-up|1|||
144330348|NCT02133664|520411778|FG000|Overall Study|Adverse Event|3|||
144330349|NCT02133664|520411779|FG001|Overall Study|Adverse Event|6|||
144330350|NCT00810901|520411780|FG000|Overall Study|Lost to Follow-up|88|||
144330351|NCT00810901|520411781|FG001|Overall Study|Lost to Follow-up|58|||
144330352|NCT01009346|520411782|FG000|Overall Study|Adverse Event|4|||
144330353|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
144330354|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
144330355|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
144330356|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
144330357|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
144330358|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
144330359|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
144330360|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
144330361|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
144330362|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
144330363|NCT03906656|520411785|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
144330364|NCT03906656|520411786|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
144330365|NCT03906656|520411785|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
144330366|NCT03906656|520411786|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
144330367|NCT03906656|520411785|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
144330368|NCT03906656|520411786|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
144330369|NCT03906656|520411785|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
144330370|NCT03906656|520411786|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
144330371|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
144330372|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
144330373|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
144330374|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
144330375|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
144330376|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
144330377|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
144330378|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
144330379|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
144330380|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
144330381|NCT03906656|520411785|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
144330382|NCT03906656|520411786|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
144330383|NCT03906656|520411785|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
144330384|NCT03906656|520411786|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
144330385|NCT03906656|520411785|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
144330386|NCT03906656|520411786|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
144330387|NCT03906656|520411785|FG000|Home Use 2 (3 Months)|Death|2|||
144330388|NCT03906656|520411786|FG001|Home Use 2 (3 Months)|Death|0|||
144330389|NCT03906656|520411785|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
144330390|NCT03906656|520411786|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
144330391|NCT03906656|520411785|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
144330392|NCT03906656|520411786|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
144330393|NCT03366103|520411787|FG000|Overall Study|Disease Progression|3|||
144330394|NCT03366103|520411788|FG001|Overall Study|Disease Progression|1|||
144330395|NCT03366103|520411789|FG002|Overall Study|Disease Progression|0|||
144330396|NCT03366103|520411787|FG000|Overall Study|Adverse Event|0|||
144330397|NCT03366103|520411788|FG001|Overall Study|Adverse Event|1|||
144330398|NCT03366103|520411789|FG002|Overall Study|Adverse Event|0|||
144330399|NCT05590000|520411795|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
144330400|NCT00762996|520411796|FG000|Period One|Protocol Violation|0|||
144330401|NCT00762996|520411797|FG001|Period One|Protocol Violation|0|||
144330402|NCT00762996|520411798|FG002|Period One|Protocol Violation|1|||
144330403|NCT00762996|520411799|FG003|Period One|Protocol Violation|0|||
144330404|NCT00762996|520411796|FG000|Period One|ineligible|0|||
144330405|NCT00762996|520411797|FG001|Period One|ineligible|0|||
144330406|NCT00762996|520411798|FG002|Period One|ineligible|1|||
144330407|NCT00762996|520411799|FG003|Period One|ineligible|1|||
144330408|NCT00762996|520411796|FG000|Period One|Adverse Event|0|||
144330409|NCT00762996|520411797|FG001|Period One|Adverse Event|0|||
144330410|NCT00762996|520411798|FG002|Period One|Adverse Event|1|||
144330411|NCT00762996|520411799|FG003|Period One|Adverse Event|0|||
144330412|NCT00762996|520411796|FG000|Period One|Withdrawal by Subject|0|||
144330413|NCT00762996|520411797|FG001|Period One|Withdrawal by Subject|0|||
144330414|NCT00762996|520411798|FG002|Period One|Withdrawal by Subject|1|||
144330415|NCT00762996|520411799|FG003|Period One|Withdrawal by Subject|0|||
144330416|NCT02689076|520411802|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
144330417|NCT02689076|520411803|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
144330418|NCT02689076|520411804|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
144330419|NCT02689076|520411802|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
144330420|NCT02689076|520411803|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
144330421|NCT02689076|520411804|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
144330422|NCT02689076|520411802|FG000|Overall Study|Did not have an HIE match|2|||
144330423|NCT02689076|520411803|FG001|Overall Study|Did not have an HIE match|0|||
144330424|NCT02689076|520411804|FG002|Overall Study|Did not have an HIE match|0|||
144330425|NCT02689076|520411802|FG000|Overall Study|Death during non-VA encounter|2|||
144330426|NCT02689076|520411803|FG001|Overall Study|Death during non-VA encounter|5|||
144330427|NCT02689076|520411804|FG002|Overall Study|Death during non-VA encounter|0|||
144330428|NCT02689076|520411802|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
144330429|NCT02689076|520411803|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
144330430|NCT02689076|520411804|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
144330431|NCT02689076|520411802|FG000|Overall Study|Participant no longer active in VA system|1|||
144330432|NCT02689076|520411803|FG001|Overall Study|Participant no longer active in VA system|0|||
144330433|NCT02689076|520411804|FG002|Overall Study|Participant no longer active in VA system|0|||
144330434|NCT02689076|520411802|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
144330435|NCT02689076|520411803|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
144330436|NCT02689076|520411804|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
144330437|NCT01816906|520411810|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
144330438|NCT01816906|520411811|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
144330439|NCT01816906|520411810|FG000|Six Months|Lost to Follow-up|14|||
144330440|NCT01816906|520411811|FG001|Six Months|Lost to Follow-up|16|||
144330441|NCT01816906|520411810|FG000|12 Months|Adverse Event|2|||
144330442|NCT01816906|520411811|FG001|12 Months|Adverse Event|2|||
144330443|NCT01816906|520411810|FG000|12 Months|Death|0|||
144330444|NCT01816906|520411811|FG001|12 Months|Death|2|||
144330445|NCT01816906|520411810|FG000|12 Months|Lost to Follow-up|2|||
144330446|NCT01816906|520411811|FG001|12 Months|Lost to Follow-up|1|||
144330447|NCT00746733|520411812|FG000|Second Intervention|Adverse Event|1|||
144330448|NCT00746733|520411813|FG001|Second Intervention|Adverse Event|0|||
144330449|NCT00746733|520411812|FG000|Third Intervention|Withdrawal by Subject|1|||
144330450|NCT00746733|520411813|FG001|Third Intervention|Withdrawal by Subject|1|||
144330451|NCT00993499|520411816|FG000|Run-in Period (8 Days)|Adverse Event|0|||
144330452|NCT00993499|520411817|FG001|Run-in Period (8 Days)|Adverse Event|1|||
144330453|NCT00993499|520411818|FG002|Run-in Period (8 Days)|Adverse Event|0|||
144330454|NCT00993499|520411819|FG003|Run-in Period (8 Days)|Adverse Event|0|||
144330455|NCT00993499|520411820|FG004|Run-in Period (8 Days)|Adverse Event|0|||
144330456|NCT00993499|520411821|FG005|Run-in Period (8 Days)|Adverse Event|0|||
144330457|NCT00993499|520411816|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
144330458|NCT00993499|520411817|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
144330459|NCT00993499|520411818|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
144330460|NCT00993499|520411819|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
144330461|NCT00993499|520411820|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
144330462|NCT00993499|520411821|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
144330463|NCT00993499|520411816|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
144330464|NCT00993499|520411817|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
144330465|NCT00993499|520411818|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
144330466|NCT00993499|520411819|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
144330467|NCT00993499|520411820|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
144330468|NCT00993499|520411821|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
144330469|NCT00993499|520411816|FG000|Run-in Period (8 Days)|Progressive disease|0|||
144330470|NCT00993499|520411817|FG001|Run-in Period (8 Days)|Progressive disease|1|||
144330471|NCT00993499|520411818|FG002|Run-in Period (8 Days)|Progressive disease|1|||
144330472|NCT00993499|520411819|FG003|Run-in Period (8 Days)|Progressive disease|0|||
144330473|NCT00993499|520411820|FG004|Run-in Period (8 Days)|Progressive disease|0|||
144330474|NCT00993499|520411821|FG005|Run-in Period (8 Days)|Progressive disease|0|||
144330475|NCT00993499|520411816|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
144330476|NCT00993499|520411817|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
144330477|NCT00993499|520411818|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
144330478|NCT00993499|520411819|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
144330479|NCT00993499|520411820|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
144330480|NCT00993499|520411821|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
144330481|NCT00993499|520411816|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
144330482|NCT00993499|520411817|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
144330483|NCT00993499|520411818|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
144330484|NCT00993499|520411819|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
144330485|NCT00993499|520411820|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
144330486|NCT00993499|520411821|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
144330487|NCT00993499|520411816|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
144330488|NCT00993499|520411817|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
144330489|NCT00993499|520411818|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
144330490|NCT00993499|520411819|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
144330491|NCT00993499|520411820|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
144330492|NCT00993499|520411821|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
144330493|NCT00993499|520411816|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
144330494|NCT00993499|520411817|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
144330495|NCT00993499|520411818|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
144330496|NCT00993499|520411819|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
144330497|NCT00993499|520411820|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
144330498|NCT00993499|520411821|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
144330499|NCT00993499|520411816|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
144330500|NCT00993499|520411817|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
144330501|NCT00993499|520411818|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
144330502|NCT00993499|520411819|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
144330503|NCT00993499|520411820|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
144330504|NCT00993499|520411821|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
144330505|NCT00993499|520411816|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
144330506|NCT00993499|520411817|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
144330507|NCT00993499|520411818|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
144330508|NCT00993499|520411819|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
144330509|NCT00993499|520411820|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
144330510|NCT00993499|520411821|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
144330511|NCT00993499|520411816|FG000|Discontinued After Starting Course 3|DLT|1|||
144330512|NCT00993499|520411817|FG001|Discontinued After Starting Course 3|DLT|0|||
144330513|NCT00993499|520411818|FG002|Discontinued After Starting Course 3|DLT|2|||
144330514|NCT00993499|520411819|FG003|Discontinued After Starting Course 3|DLT|1|||
144330515|NCT00993499|520411820|FG004|Discontinued After Starting Course 3|DLT|0|||
144330516|NCT00993499|520411821|FG005|Discontinued After Starting Course 3|DLT|0|||
144330517|NCT00993499|520411816|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
144330518|NCT00993499|520411817|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
144330519|NCT00993499|520411818|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
144330520|NCT00993499|520411819|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
144330521|NCT00993499|520411820|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
144330522|NCT00993499|520411821|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
144330523|NCT01945775|520411822|FG000|Overall Study|Death|214|||
144330524|NCT01945775|520411823|FG001|Overall Study|Death|98|||
144330525|NCT01945775|520411822|FG000|Overall Study|Lost to Follow-up|12|||
144330526|NCT01945775|520411823|FG001|Overall Study|Lost to Follow-up|7|||
144330527|NCT01945775|520411822|FG000|Overall Study|Withdrawal by Subject|11|||
144330528|NCT01945775|520411823|FG001|Overall Study|Withdrawal by Subject|21|||
144330529|NCT01945775|520411822|FG000|Overall Study|Other|50|||
144330530|NCT01945775|520411823|FG001|Overall Study|Other|18|||
144330531|NCT02876328|520411824|FG000|Overall Study|Death|2|||
144330532|NCT02876328|520411825|FG001|Overall Study|Death|1|||
144330533|NCT02876328|520411826|FG002|Overall Study|Death|3|||
144330534|NCT02876328|520411827|FG003|Overall Study|Death|0|||
144330535|NCT02876328|520411828|FG004|Overall Study|Death|0|||
144330536|NCT02876328|520411829|FG005|Overall Study|Death|0|||
144330537|NCT02876328|520411830|FG006|Overall Study|Death|1|||
144330538|NCT02876328|520411831|FG007|Overall Study|Death|3|||
144330539|NCT02876328|520411832|FG008|Overall Study|Death|0|||
144330540|NCT02876328|520411833|FG009|Overall Study|Death|1|||
144330541|NCT02876328|520411834|FG010|Overall Study|Death|1|||
144330542|NCT02876328|520411835|FG011|Overall Study|Death|0|||
144330543|NCT02876328|520411836|FG012|Overall Study|Death|0|||
144330544|NCT02876328|520411837|FG013|Overall Study|Death|0|||
144330545|NCT02876328|520411838|FG014|Overall Study|Death|0|||
144330546|NCT02876328|520411839|FG015|Overall Study|Death|0|||
144330547|NCT02876328|520411840|FG016|Overall Study|Death|1|||
144330548|NCT02876328|520411841|FG017|Overall Study|Death|1|||
144330549|NCT02876328|520411842|FG018|Overall Study|Death|0|||
144330550|NCT02876328|520411843|FG019|Overall Study|Death|0|||
144330551|NCT02876328|520411844|FG020|Overall Study|Death|0|||
144330552|NCT02876328|520411845|FG021|Overall Study|Death|1|||
144330553|NCT02876328|520411846|FG022|Overall Study|Death|0|||
144330554|NCT02876328|520411847|FG023|Overall Study|Death|0|||
144330555|NCT02876328|520411824|FG000|Overall Study|Withdrawal by Subject|0|||
144330556|NCT02876328|520411825|FG001|Overall Study|Withdrawal by Subject|2|||
144330557|NCT02876328|520411826|FG002|Overall Study|Withdrawal by Subject|3|||
144330558|NCT02876328|520411827|FG003|Overall Study|Withdrawal by Subject|3|||
144330559|NCT02876328|520411828|FG004|Overall Study|Withdrawal by Subject|0|||
144330560|NCT02876328|520411829|FG005|Overall Study|Withdrawal by Subject|1|||
144330561|NCT02876328|520411830|FG006|Overall Study|Withdrawal by Subject|0|||
144330562|NCT02876328|520411831|FG007|Overall Study|Withdrawal by Subject|1|||
144330563|NCT02876328|520411832|FG008|Overall Study|Withdrawal by Subject|1|||
144330564|NCT02876328|520411833|FG009|Overall Study|Withdrawal by Subject|2|||
144330565|NCT02876328|520411834|FG010|Overall Study|Withdrawal by Subject|0|||
144330566|NCT02876328|520411835|FG011|Overall Study|Withdrawal by Subject|0|||
144330567|NCT02876328|520411836|FG012|Overall Study|Withdrawal by Subject|0|||
144330568|NCT02876328|520411837|FG013|Overall Study|Withdrawal by Subject|0|||
144330569|NCT02876328|520411838|FG014|Overall Study|Withdrawal by Subject|0|||
144330570|NCT02876328|520411839|FG015|Overall Study|Withdrawal by Subject|0|||
144330571|NCT02876328|520411840|FG016|Overall Study|Withdrawal by Subject|1|||
144330572|NCT02876328|520411841|FG017|Overall Study|Withdrawal by Subject|3|||
144330573|NCT02876328|520411842|FG018|Overall Study|Withdrawal by Subject|0|||
144330574|NCT02876328|520411843|FG019|Overall Study|Withdrawal by Subject|0|||
144330575|NCT02876328|520411844|FG020|Overall Study|Withdrawal by Subject|1|||
144330576|NCT02876328|520411845|FG021|Overall Study|Withdrawal by Subject|0|||
144360039|NCT01601535|520525137|FG002|Phase 2|Started Another Treatment|0|||
144330577|NCT02876328|520411846|FG022|Overall Study|Withdrawal by Subject|0|||
144330578|NCT02876328|520411847|FG023|Overall Study|Withdrawal by Subject|0|||
144330579|NCT02876328|520411824|FG000|Overall Study|Missed 12 Month Visit|15|||
144330580|NCT02876328|520411825|FG001|Overall Study|Missed 12 Month Visit|10|||
144330581|NCT02876328|520411826|FG002|Overall Study|Missed 12 Month Visit|11|||
144330582|NCT02876328|520411827|FG003|Overall Study|Missed 12 Month Visit|6|||
144330583|NCT02876328|520411828|FG004|Overall Study|Missed 12 Month Visit|10|||
144330584|NCT02876328|520411829|FG005|Overall Study|Missed 12 Month Visit|14|||
144330585|NCT02876328|520411830|FG006|Overall Study|Missed 12 Month Visit|3|||
144330586|NCT02876328|520411831|FG007|Overall Study|Missed 12 Month Visit|8|||
144330587|NCT02876328|520411832|FG008|Overall Study|Missed 12 Month Visit|9|||
144330588|NCT02876328|520411833|FG009|Overall Study|Missed 12 Month Visit|5|||
144330589|NCT02876328|520411834|FG010|Overall Study|Missed 12 Month Visit|4|||
144330590|NCT02876328|520411835|FG011|Overall Study|Missed 12 Month Visit|1|||
144330591|NCT02876328|520411836|FG012|Overall Study|Missed 12 Month Visit|5|||
144330592|NCT02876328|520411837|FG013|Overall Study|Missed 12 Month Visit|4|||
144330593|NCT02876328|520411838|FG014|Overall Study|Missed 12 Month Visit|4|||
144330594|NCT02876328|520411839|FG015|Overall Study|Missed 12 Month Visit|4|||
144330595|NCT02876328|520411840|FG016|Overall Study|Missed 12 Month Visit|3|||
144330596|NCT02876328|520411841|FG017|Overall Study|Missed 12 Month Visit|6|||
144330597|NCT02876328|520411842|FG018|Overall Study|Missed 12 Month Visit|2|||
144330598|NCT02876328|520411843|FG019|Overall Study|Missed 12 Month Visit|2|||
144330599|NCT02876328|520411844|FG020|Overall Study|Missed 12 Month Visit|11|||
144330600|NCT02876328|520411845|FG021|Overall Study|Missed 12 Month Visit|7|||
144330601|NCT02876328|520411846|FG022|Overall Study|Missed 12 Month Visit|1|||
144330602|NCT02876328|520411847|FG023|Overall Study|Missed 12 Month Visit|0|||
144330603|NCT00844805|520411849|FG000|Treatment Phase|Adverse Event|5|||
144330604|NCT00844805|520411850|FG001|Treatment Phase|Adverse Event|1|||
144330605|NCT00844805|520411851|FG002|Treatment Phase|Adverse Event|0|||
144330606|NCT00844805|520411852|FG003|Treatment Phase|Adverse Event|0|||
144330607|NCT00844805|520411849|FG000|Treatment Phase|Withdrawal by Subject|3|||
144330608|NCT00844805|520411850|FG001|Treatment Phase|Withdrawal by Subject|4|||
144330609|NCT00844805|520411851|FG002|Treatment Phase|Withdrawal by Subject|0|||
144330610|NCT00844805|520411852|FG003|Treatment Phase|Withdrawal by Subject|0|||
144330611|NCT00844805|520411849|FG000|Treatment Phase|Noncompliance With Protocol|1|||
144330612|NCT00844805|520411850|FG001|Treatment Phase|Noncompliance With Protocol|0|||
144330613|NCT00844805|520411851|FG002|Treatment Phase|Noncompliance With Protocol|0|||
144330614|NCT00844805|520411852|FG003|Treatment Phase|Noncompliance With Protocol|0|||
144330615|NCT00844805|520411849|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
144330616|NCT00844805|520411850|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
144330617|NCT00844805|520411851|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
144330618|NCT00844805|520411852|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
144330619|NCT00844805|520411849|FG000|Follow-Up Phase|Adverse Event|0|||
144330620|NCT00844805|520411850|FG001|Follow-Up Phase|Adverse Event|0|||
144330621|NCT00844805|520411851|FG002|Follow-Up Phase|Adverse Event|1|||
144330622|NCT00844805|520411852|FG003|Follow-Up Phase|Adverse Event|0|||
144330623|NCT00844805|520411849|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
144330624|NCT00844805|520411850|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
144330625|NCT00844805|520411851|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
144330626|NCT00844805|520411852|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
144330627|NCT00844805|520411849|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
144330628|NCT00844805|520411850|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
144330629|NCT00844805|520411851|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
144330630|NCT00844805|520411852|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
144330631|NCT00844805|520411849|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
144330632|NCT00844805|520411850|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
144330633|NCT00844805|520411851|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
144330634|NCT00844805|520411852|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
144330635|NCT00844805|520411849|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
144330636|NCT00844805|520411850|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
144330637|NCT00844805|520411851|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
144330638|NCT00844805|520411852|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
144330639|NCT04096820|520411853|FG000|Overall Study|Did not return for intervention|2|||
144330640|NCT04096820|520411853|FG000|Overall Study|Death|1|||
144330641|NCT02726880|520411854|FG000|Overall Study|Withdrawal by Subject|2|||
144330642|NCT02726880|520411855|FG001|Overall Study|Withdrawal by Subject|0|||
144330643|NCT02726880|520411854|FG000|Overall Study|Lost to Follow-up|1|||
144330644|NCT02726880|520411855|FG001|Overall Study|Lost to Follow-up|3|||
144330645|NCT04316741|520411856|FG000|Baseline Enrollment|Lost to Follow-up|1|||
144330646|NCT04316741|520411857|FG001|Baseline Enrollment|Lost to Follow-up|1|||
144330647|NCT04316741|520411856|FG000|Immediate Post-Test|Lost to Follow-up|5|||
144330648|NCT04316741|520411857|FG001|Immediate Post-Test|Lost to Follow-up|1|||
144330649|NCT04316741|520411856|FG000|1-month Post-test|Lost to Follow-up|7|||
144330650|NCT04316741|520411857|FG001|1-month Post-test|Lost to Follow-up|2|||
144330651|NCT04316741|520411856|FG000|3-month Follow-up|Lost to Follow-up|10|||
144330652|NCT04316741|520411857|FG001|3-month Follow-up|Lost to Follow-up|2|||
144330653|NCT00787202|520411858|FG000|Overall Study|Adverse Event|3|||
144330654|NCT00787202|520411859|FG001|Overall Study|Adverse Event|2|||
144330655|NCT00787202|520411860|FG002|Overall Study|Adverse Event|0|||
144330656|NCT00787202|520411861|FG003|Overall Study|Adverse Event|0|||
144330657|NCT00787202|520411862|FG004|Overall Study|Adverse Event|2|||
144330658|NCT00787202|520411858|FG000|Overall Study|Lack of Efficacy|5|||
144330659|NCT00787202|520411859|FG001|Overall Study|Lack of Efficacy|6|||
144330660|NCT00787202|520411860|FG002|Overall Study|Lack of Efficacy|5|||
144330661|NCT00787202|520411861|FG003|Overall Study|Lack of Efficacy|2|||
144330662|NCT00787202|520411862|FG004|Overall Study|Lack of Efficacy|1|||
144330663|NCT00787202|520411858|FG000|Overall Study|Lost to Follow-up|1|||
144330664|NCT00787202|520411859|FG001|Overall Study|Lost to Follow-up|0|||
144330665|NCT00787202|520411860|FG002|Overall Study|Lost to Follow-up|0|||
144330666|NCT00787202|520411861|FG003|Overall Study|Lost to Follow-up|0|||
144330667|NCT00787202|520411862|FG004|Overall Study|Lost to Follow-up|0|||
144330668|NCT00787202|520411858|FG000|Overall Study|Withdrawal by Subject|2|||
144330669|NCT00787202|520411859|FG001|Overall Study|Withdrawal by Subject|2|||
144330670|NCT00787202|520411860|FG002|Overall Study|Withdrawal by Subject|2|||
144330671|NCT00787202|520411861|FG003|Overall Study|Withdrawal by Subject|0|||
144330672|NCT00787202|520411862|FG004|Overall Study|Withdrawal by Subject|0|||
144330673|NCT00787202|520411858|FG000|Overall Study|Protocol Violation|2|||
144330674|NCT00787202|520411859|FG001|Overall Study|Protocol Violation|1|||
144330675|NCT00787202|520411860|FG002|Overall Study|Protocol Violation|0|||
144330676|NCT00787202|520411861|FG003|Overall Study|Protocol Violation|0|||
144330677|NCT00787202|520411862|FG004|Overall Study|Protocol Violation|1|||
144330678|NCT00787202|520411858|FG000|Overall Study|Randomized, not treated|1|||
144330679|NCT00787202|520411859|FG001|Overall Study|Randomized, not treated|0|||
144330680|NCT00787202|520411860|FG002|Overall Study|Randomized, not treated|0|||
144330681|NCT00787202|520411861|FG003|Overall Study|Randomized, not treated|0|||
144330682|NCT00787202|520411862|FG004|Overall Study|Randomized, not treated|0|||
144330683|NCT01453946|520411863|FG000|Overall Study|Did not receive drug for the taper phase|1|||
144330684|NCT01453946|520411863|FG000|Overall Study|Protocol Violation|2|||
144330685|NCT01453946|520411863|FG000|Overall Study|Lack of Efficacy|3|||
144330686|NCT01453946|520411863|FG000|Overall Study|Adverse Event|3|||
144330687|NCT03697993|520411865|FG000|Overall Study|Became Ineligible after Enrollment|1|||
144330688|NCT03697993|520411866|FG001|Overall Study|Became Ineligible after Enrollment|3|||
144330689|NCT03697993|520411865|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
144330690|NCT03697993|520411866|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
144330691|NCT03697993|520411865|FG000|Overall Study|Lost to Follow-up|3|||
144330692|NCT03697993|520411866|FG001|Overall Study|Lost to Follow-up|0|||
144330693|NCT03697993|520411865|FG000|Overall Study|Physician Decision|4|||
144330694|NCT03697993|520411866|FG001|Overall Study|Physician Decision|0|||
144330695|NCT03697993|520411865|FG000|Overall Study|Initial Urine Culture Negative|0|||
144330696|NCT03697993|520411866|FG001|Overall Study|Initial Urine Culture Negative|1|||
144330697|NCT02191605|520413261|FG000|Overall Study|Lost to Follow-up|9|||
144330698|NCT02191605|520413262|FG001|Overall Study|Lost to Follow-up|4|||
144330699|NCT02191605|520413263|FG002|Overall Study|Lost to Follow-up|7|||
144330700|NCT02191605|520413264|FG003|Overall Study|Lost to Follow-up|3|||
144330701|NCT02191605|520413265|FG004|Overall Study|Lost to Follow-up|4|||
144330702|NCT00734071|520413266|FG000|Overall Study|Adverse Event|4|||
144330703|NCT00734071|520413267|FG001|Overall Study|Adverse Event|3|||
144330704|NCT00734071|520413266|FG000|Overall Study|Lack of Efficacy|3|||
144330705|NCT00734071|520413267|FG001|Overall Study|Lack of Efficacy|1|||
144330706|NCT00734071|520413266|FG000|Overall Study|Noncompliance|2|||
144330707|NCT00734071|520413267|FG001|Overall Study|Noncompliance|2|||
144330708|NCT00734071|520413266|FG000|Overall Study|Protocol Deviations|3|||
144330709|NCT00734071|520413267|FG001|Overall Study|Protocol Deviations|4|||
144330710|NCT00734071|520413266|FG000|Overall Study|Voluntary Withdrawal|9|||
144330711|NCT00734071|520413267|FG001|Overall Study|Voluntary Withdrawal|7|||
144330712|NCT00734071|520413266|FG000|Overall Study|Lost to Follow-up|16|||
144330713|NCT00734071|520413267|FG001|Overall Study|Lost to Follow-up|8|||
144330714|NCT00734071|520413266|FG000|Overall Study|Other|1|||
144330715|NCT00734071|520413267|FG001|Overall Study|Other|2|||
144330716|NCT00583791|520413268|FG000|Overall Study|Other|67|||
144330717|NCT00583791|520413268|FG000|Overall Study|Death|6|||
144330718|NCT00203021|520413269|FG000|Overall Study|Death|4|||
144330719|NCT00203021|520413270|FG001|Overall Study|Death|1|||
144330720|NCT00203021|520413269|FG000|Overall Study|Adverse Event|10|||
144330721|NCT00203021|520413270|FG001|Overall Study|Adverse Event|5|||
144330722|NCT00203021|520413269|FG000|Overall Study|Withdrawal by Subject|45|||
144330723|NCT00203021|520413270|FG001|Overall Study|Withdrawal by Subject|48|||
144330724|NCT00203021|520413269|FG000|Overall Study|Lost to Follow-up|9|||
144330725|NCT00203021|520413270|FG001|Overall Study|Lost to Follow-up|7|||
144330726|NCT00203021|520413269|FG000|Overall Study|Other than specified|11|||
144330727|NCT00203021|520413270|FG001|Overall Study|Other than specified|16|||
144330728|NCT01062061|520413275|FG000|Overall Study|Enrolled more than once|2|||
144330729|NCT01062061|520413275|FG000|Overall Study|Investigated before study start|13|||
144330730|NCT01062061|520413275|FG000|Overall Study|Outside chief indications|10|||
144330731|NCT01062061|520413275|FG000|Overall Study|Failed to meet inclusion criteria|2|||
144330732|NCT00046930|520413276|FG000|Overall Study|Ineligible|12|||
144330733|NCT00046930|520413277|FG001|Overall Study|Ineligible|4|||
144330734|NCT01145053|520413279|FG000|Overall Study|Adverse Event|22|||
144330735|NCT01145053|520413279|FG000|Overall Study|Lost to Follow-up|28|||
144330736|NCT01145053|520413279|FG000|Overall Study|Withdrawal by Subject|25|||
144330737|NCT01145053|520413279|FG000|Overall Study|Other|18|||
144330738|NCT02088073|520413281|FG000|Acute Phase|Withdrawal by Subject|5|||
144330739|NCT02088073|520413282|FG001|Acute Phase|Withdrawal by Subject|0|||
144330740|NCT02088073|520413283|FG002|Acute Phase|Withdrawal by Subject|0|||
144330741|NCT02088073|520413284|FG003|Acute Phase|Withdrawal by Subject|0|||
144330742|NCT02088073|520413285|FG004|Acute Phase|Withdrawal by Subject|0|||
144330743|NCT02088073|520413281|FG000|Acute Phase|Hyperkalemia|2|||
144330744|NCT02088073|520413282|FG001|Acute Phase|Hyperkalemia|0|||
144330745|NCT02088073|520413283|FG002|Acute Phase|Hyperkalemia|0|||
144330746|NCT02088073|520413284|FG003|Acute Phase|Hyperkalemia|0|||
144330747|NCT02088073|520413285|FG004|Acute Phase|Hyperkalemia|0|||
144330748|NCT02088073|520413281|FG000|Maintanance Phase|Withdrawal by Subject|0|||
144330749|NCT02088073|520413282|FG001|Maintanance Phase|Withdrawal by Subject|2|||
144330750|NCT02088073|520413283|FG002|Maintanance Phase|Withdrawal by Subject|0|||
144330751|NCT02088073|520413284|FG003|Maintanance Phase|Withdrawal by Subject|0|||
144330752|NCT02088073|520413285|FG004|Maintanance Phase|Withdrawal by Subject|0|||
144330753|NCT02088073|520413281|FG000|Maintanance Phase|Adverse Event|0|||
144330754|NCT02088073|520413282|FG001|Maintanance Phase|Adverse Event|0|||
144330755|NCT02088073|520413283|FG002|Maintanance Phase|Adverse Event|3|||
144330756|NCT02088073|520413284|FG003|Maintanance Phase|Adverse Event|0|||
144330757|NCT02088073|520413285|FG004|Maintanance Phase|Adverse Event|1|||
144330758|NCT02088073|520413281|FG000|Maintanance Phase|Physician Decision|0|||
144330759|NCT02088073|520413282|FG001|Maintanance Phase|Physician Decision|0|||
144330760|NCT02088073|520413283|FG002|Maintanance Phase|Physician Decision|0|||
144330761|NCT02088073|520413284|FG003|Maintanance Phase|Physician Decision|0|||
144330762|NCT02088073|520413285|FG004|Maintanance Phase|Physician Decision|1|||
144330763|NCT02088073|520413281|FG000|Maintanance Phase|Sponsor's decision|0|||
144330764|NCT02088073|520413282|FG001|Maintanance Phase|Sponsor's decision|2|||
144330765|NCT02088073|520413283|FG002|Maintanance Phase|Sponsor's decision|0|||
144330766|NCT02088073|520413284|FG003|Maintanance Phase|Sponsor's decision|2|||
144330767|NCT02088073|520413285|FG004|Maintanance Phase|Sponsor's decision|1|||
144330768|NCT02088073|520413281|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
144330769|NCT02088073|520413282|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
144330770|NCT02088073|520413283|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
144330771|NCT02088073|520413284|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
144330772|NCT02088073|520413285|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
144330773|NCT02088073|520413281|FG000|Maintanance Phase|Miscellaneous|0|||
144330774|NCT02088073|520413282|FG001|Maintanance Phase|Miscellaneous|2|||
144330775|NCT02088073|520413283|FG002|Maintanance Phase|Miscellaneous|1|||
144330776|NCT02088073|520413284|FG003|Maintanance Phase|Miscellaneous|2|||
144330777|NCT02088073|520413285|FG004|Maintanance Phase|Miscellaneous|1|||
144330778|NCT02088073|520413281|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
144330779|NCT02088073|520413282|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
144330780|NCT02088073|520413283|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
144330781|NCT02088073|520413284|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
144330782|NCT02088073|520413285|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
144330783|NCT02088073|520413281|FG000|Maintanance Phase|Subject compliance|0|||
144330784|NCT02088073|520413282|FG001|Maintanance Phase|Subject compliance|1|||
144330785|NCT02088073|520413283|FG002|Maintanance Phase|Subject compliance|0|||
144330786|NCT02088073|520413284|FG003|Maintanance Phase|Subject compliance|0|||
144330787|NCT02088073|520413285|FG004|Maintanance Phase|Subject compliance|0|||
144330788|NCT00520013|520413286|FG000|Overall Study|Withdrawal by Subject|0|||
144330789|NCT00520013|520413287|FG001|Overall Study|Withdrawal by Subject|0|||
144330790|NCT00520013|520413288|FG002|Overall Study|Withdrawal by Subject|1|||
144330791|NCT00520013|520413286|FG000|Overall Study|Adverse Event|2|||
144330792|NCT00520013|520413287|FG001|Overall Study|Adverse Event|10|||
144330793|NCT00520013|520413288|FG002|Overall Study|Adverse Event|7|||
144330794|NCT00520013|520413286|FG000|Overall Study|Progressive Disease|7|||
144330795|NCT00520013|520413287|FG001|Overall Study|Progressive Disease|3|||
144330796|NCT00520013|520413288|FG002|Overall Study|Progressive Disease|0|||
144330797|NCT00520013|520413286|FG000|Overall Study|Clinical Progression|3|||
144330798|NCT00520013|520413287|FG001|Overall Study|Clinical Progression|1|||
144330799|NCT00520013|520413288|FG002|Overall Study|Clinical Progression|0|||
144330800|NCT00520013|520413286|FG000|Overall Study|Death|0|||
144330801|NCT00520013|520413287|FG001|Overall Study|Death|1|||
144330802|NCT00520013|520413288|FG002|Overall Study|Death|0|||
144330803|NCT00520013|520413286|FG000|Overall Study|Physician Decision|0|||
144330804|NCT00520013|520413287|FG001|Overall Study|Physician Decision|0|||
144330805|NCT00520013|520413288|FG002|Overall Study|Physician Decision|3|||
144330806|NCT03684304|520413289|FG000|Overall Study|Lost to Follow-up|19|||
144330807|NCT03684304|520413290|FG001|Overall Study|Lost to Follow-up|17|||
144330808|NCT02813668|520413291|FG000|Overall Study|Death|4|||
144330809|NCT02813668|520413291|FG000|Overall Study|Lost to Follow-up|509|||
144330810|NCT02813668|520413291|FG000|Overall Study|Withdrawal by Subject|148|||
144330811|NCT02813668|520413291|FG000|Overall Study|No longer at worksite|85|||
144330812|NCT02813668|520413291|FG000|Overall Study|Medical reasons not related to the study|4|||
144330813|NCT04662073|520413292|FG000|Overall Study|Withdrawal by Subject|1|||
144330814|NCT04662073|520413293|FG001|Overall Study|Withdrawal by Subject|0|||
144330815|NCT00598078|520413298|FG000|Period 2 (Day 2)|Adverse Event|1|||
144330816|NCT00598078|520413299|FG001|Period 2 (Day 2)|Adverse Event|0|||
144330817|NCT01813721|520413300|FG000|Overall Study|Ineligibility determined|63|||
144330818|NCT01813721|520413300|FG000|Overall Study|Withdrawal by Subject|1|||
144330819|NCT01036529|520413303|FG000|Overall Study|Adverse Event|0|||
144330820|NCT01036529|520413304|FG001|Overall Study|Adverse Event|1|||
144330821|NCT01036529|520413303|FG000|Overall Study|Lost to Follow-up|0|||
144330822|NCT01036529|520413304|FG001|Overall Study|Lost to Follow-up|1|||
144330823|NCT01036529|520413303|FG000|Overall Study|Physician Decision|1|||
144330824|NCT01036529|520413304|FG001|Overall Study|Physician Decision|0|||
144330825|NCT01036529|520413303|FG000|Overall Study|Withdrawal by Subject|1|||
144330826|NCT01036529|520413304|FG001|Overall Study|Withdrawal by Subject|1|||
144330827|NCT01036529|520413303|FG000|Overall Study|Sponsor study termination|11|||
144330828|NCT01036529|520413304|FG001|Overall Study|Sponsor study termination|12|||
144330829|NCT02120365|520413311|FG000|Overall Study|Withdrawal by Subject|0|||
144330830|NCT02120365|520413312|FG001|Overall Study|Withdrawal by Subject|0|||
144330831|NCT02120365|520413313|FG002|Overall Study|Withdrawal by Subject|2|||
144330832|NCT02120365|520413314|FG003|Overall Study|Withdrawal by Subject|4|||
144330833|NCT02120365|520413315|FG004|Overall Study|Withdrawal by Subject|0|||
144330834|NCT02120365|520413316|FG005|Overall Study|Withdrawal by Subject|2|||
144330835|NCT00343915|520413317|FG000|Primary Study|Withdrawal by Subject|1|||
144330836|NCT00343915|520413318|FG001|Primary Study|Withdrawal by Subject|0|||
144330837|NCT00343915|520413317|FG000|Primary Study|Lost to Follow-up|2|||
144330838|NCT00343915|520413318|FG001|Primary Study|Lost to Follow-up|3|||
144330839|NCT00343915|520413317|FG000|Primary Study|Other|1|||
144330840|NCT00343915|520413318|FG001|Primary Study|Other|0|||
144330841|NCT01719003|520413324|FG000|Overall Study|Non compliant with protocol|1|||
144330842|NCT01719003|520413325|FG001|Overall Study|Non compliant with protocol|1|||
144330843|NCT01719003|520413326|FG002|Overall Study|Non compliant with protocol|0|||
144330844|NCT01719003|520413327|FG003|Overall Study|Non compliant with protocol|1|||
144330845|NCT01719003|520413328|FG004|Overall Study|Non compliant with protocol|2|||
144330846|NCT01719003|520413329|FG005|Overall Study|Non compliant with protocol|1|||
144330847|NCT01719003|520413330|FG006|Overall Study|Non compliant with protocol|2|||
144330848|NCT01719003|520413331|FG007|Overall Study|Non compliant with protocol|3|||
144330849|NCT01719003|520413332|FG008|Overall Study|Non compliant with protocol|0|||
144330850|NCT01719003|520413324|FG000|Overall Study|Adverse Event|6|||
144330851|NCT01719003|520413325|FG001|Overall Study|Adverse Event|5|||
144330852|NCT01719003|520413326|FG002|Overall Study|Adverse Event|4|||
144330853|NCT01719003|520413327|FG003|Overall Study|Adverse Event|3|||
144330854|NCT01719003|520413328|FG004|Overall Study|Adverse Event|4|||
144330855|NCT01719003|520413329|FG005|Overall Study|Adverse Event|3|||
144330856|NCT01719003|520413330|FG006|Overall Study|Adverse Event|6|||
144330857|NCT01719003|520413331|FG007|Overall Study|Adverse Event|5|||
144330858|NCT01719003|520413332|FG008|Overall Study|Adverse Event|0|||
144330859|NCT01719003|520413324|FG000|Overall Study|Lost to Follow-up|0|||
144330860|NCT01719003|520413325|FG001|Overall Study|Lost to Follow-up|6|||
144330861|NCT01719003|520413326|FG002|Overall Study|Lost to Follow-up|7|||
144330862|NCT01719003|520413327|FG003|Overall Study|Lost to Follow-up|2|||
144330863|NCT01719003|520413328|FG004|Overall Study|Lost to Follow-up|3|||
144330864|NCT01719003|520413329|FG005|Overall Study|Lost to Follow-up|4|||
144330865|NCT01719003|520413330|FG006|Overall Study|Lost to Follow-up|3|||
144330866|NCT01719003|520413331|FG007|Overall Study|Lost to Follow-up|2|||
144330867|NCT01719003|520413332|FG008|Overall Study|Lost to Follow-up|2|||
144330868|NCT01719003|520413324|FG000|Overall Study|Refusal to continue, not due to AE|2|||
144330869|NCT01719003|520413325|FG001|Overall Study|Refusal to continue, not due to AE|5|||
144330870|NCT01719003|520413326|FG002|Overall Study|Refusal to continue, not due to AE|4|||
144330871|NCT01719003|520413327|FG003|Overall Study|Refusal to continue, not due to AE|4|||
144330872|NCT01719003|520413328|FG004|Overall Study|Refusal to continue, not due to AE|4|||
144330873|NCT01719003|520413329|FG005|Overall Study|Refusal to continue, not due to AE|3|||
144330874|NCT01719003|520413330|FG006|Overall Study|Refusal to continue, not due to AE|8|||
144330875|NCT01719003|520413331|FG007|Overall Study|Refusal to continue, not due to AE|7|||
144330876|NCT01719003|520413332|FG008|Overall Study|Refusal to continue, not due to AE|1|||
144330877|NCT01719003|520413324|FG000|Overall Study|Reason other than those specified|0|||
144330878|NCT01719003|520413325|FG001|Overall Study|Reason other than those specified|0|||
144330879|NCT01719003|520413326|FG002|Overall Study|Reason other than those specified|2|||
144330880|NCT01719003|520413327|FG003|Overall Study|Reason other than those specified|3|||
144330881|NCT01719003|520413328|FG004|Overall Study|Reason other than those specified|4|||
144330882|NCT01719003|520413329|FG005|Overall Study|Reason other than those specified|1|||
144330883|NCT01719003|520413330|FG006|Overall Study|Reason other than those specified|0|||
144330884|NCT01719003|520413331|FG007|Overall Study|Reason other than those specified|3|||
144330885|NCT01719003|520413332|FG008|Overall Study|Reason other than those specified|1|||
144330886|NCT01719003|520413324|FG000|Overall Study|Lack of Efficacy|0|||
144330887|NCT01719003|520413325|FG001|Overall Study|Lack of Efficacy|0|||
144330888|NCT01719003|520413326|FG002|Overall Study|Lack of Efficacy|0|||
144330889|NCT01719003|520413327|FG003|Overall Study|Lack of Efficacy|0|||
144330890|NCT01719003|520413328|FG004|Overall Study|Lack of Efficacy|0|||
144330891|NCT01719003|520413329|FG005|Overall Study|Lack of Efficacy|0|||
144330892|NCT01719003|520413330|FG006|Overall Study|Lack of Efficacy|1|||
144330893|NCT01719003|520413331|FG007|Overall Study|Lack of Efficacy|0|||
144330894|NCT01719003|520413332|FG008|Overall Study|Lack of Efficacy|0|||
144330895|NCT00882908|520413333|FG000|Overall Study|Adverse Event|0|||
144330896|NCT00882908|520413334|FG001|Overall Study|Adverse Event|0|||
144330897|NCT00882908|520413335|FG002|Overall Study|Adverse Event|1|||
144330898|NCT00882908|520413336|FG003|Overall Study|Adverse Event|0|||
144330899|NCT00882908|520413337|FG004|Overall Study|Adverse Event|1|||
144330900|NCT00882908|520413333|FG000|Overall Study|Lost to Follow-up|3|||
144330901|NCT00882908|520413334|FG001|Overall Study|Lost to Follow-up|5|||
144330902|NCT00882908|520413335|FG002|Overall Study|Lost to Follow-up|3|||
144330903|NCT00882908|520413336|FG003|Overall Study|Lost to Follow-up|1|||
144330904|NCT00882908|520413337|FG004|Overall Study|Lost to Follow-up|2|||
144330905|NCT00882908|520413333|FG000|Overall Study|Protocol Violation|0|||
144330906|NCT00882908|520413334|FG001|Overall Study|Protocol Violation|1|||
144330907|NCT00882908|520413335|FG002|Overall Study|Protocol Violation|0|||
144330908|NCT00882908|520413336|FG003|Overall Study|Protocol Violation|0|||
144330909|NCT00882908|520413337|FG004|Overall Study|Protocol Violation|0|||
144330910|NCT00882908|520413333|FG000|Overall Study|Withdrawal by Subject|0|||
144330911|NCT00882908|520413334|FG001|Overall Study|Withdrawal by Subject|0|||
144330912|NCT00882908|520413335|FG002|Overall Study|Withdrawal by Subject|3|||
144330913|NCT00882908|520413336|FG003|Overall Study|Withdrawal by Subject|5|||
144330914|NCT00882908|520413337|FG004|Overall Study|Withdrawal by Subject|2|||
144330915|NCT00882908|520413333|FG000|Overall Study|Subject reached a virologic endpoint|0|||
144330916|NCT00882908|520413334|FG001|Overall Study|Subject reached a virologic endpoint|0|||
144330917|NCT00882908|520413335|FG002|Overall Study|Subject reached a virologic endpoint|0|||
144330918|NCT00882908|520413336|FG003|Overall Study|Subject reached a virologic endpoint|0|||
144330919|NCT00882908|520413337|FG004|Overall Study|Subject reached a virologic endpoint|1|||
144330920|NCT00882908|520413333|FG000|Overall Study|Study terminated in error|0|||
144330921|NCT00882908|520413334|FG001|Overall Study|Study terminated in error|0|||
144330922|NCT00882908|520413335|FG002|Overall Study|Study terminated in error|0|||
144330923|NCT00882908|520413336|FG003|Overall Study|Study terminated in error|1|||
144330924|NCT00882908|520413337|FG004|Overall Study|Study terminated in error|0|||
144330925|NCT01344629|520413339|FG000|Crossover Period 2|Withdrawal by Subject|0|||
144330926|NCT01344629|520413340|FG001|Crossover Period 2|Withdrawal by Subject|1|||
144330927|NCT00693472|520413341|FG000|Part 1|Adverse Event|1|||
144330928|NCT00693472|520413342|FG001|Part 1|Adverse Event|1|||
144330929|NCT00693472|520413343|FG002|Part 1|Adverse Event|0|||
144330930|NCT00693472|520413344|FG003|Part 1|Adverse Event|0|||
144330931|NCT00693472|520413341|FG000|Part 1|Lost to Follow-up|0|||
144330932|NCT00693472|520413342|FG001|Part 1|Lost to Follow-up|1|||
144330933|NCT00693472|520413343|FG002|Part 1|Lost to Follow-up|0|||
144330934|NCT00693472|520413344|FG003|Part 1|Lost to Follow-up|0|||
144330935|NCT00693472|520413341|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
144330936|NCT00693472|520413342|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
144330937|NCT00693472|520413343|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
144330938|NCT00693472|520413344|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
144330939|NCT00693472|520413341|FG000|Part 2|Adverse Event|0|||
144330940|NCT00693472|520413342|FG001|Part 2|Adverse Event|0|||
144330941|NCT00693472|520413343|FG002|Part 2|Adverse Event|1|||
144330942|NCT00693472|520413344|FG003|Part 2|Adverse Event|0|||
144330943|NCT00693472|520413341|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
144330944|NCT00693472|520413342|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
144330945|NCT00693472|520413343|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
144330946|NCT00693472|520413344|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
144330947|NCT04063787|520413345|FG000|Overall Study|Inadequate Doppler data|4|||
144330948|NCT04063787|520413345|FG000|Overall Study|Lost to Follow-up|2|||
144330949|NCT04063787|520413345|FG000|Overall Study|Death|3|||
144330950|NCT01527383|520413346|FG000|Overall Study|Adverse Event|5|||
144330951|NCT01527383|520413347|FG001|Overall Study|Adverse Event|0|||
144330952|NCT01527383|520413346|FG000|Overall Study|Lost to Follow-up|3|||
144330953|NCT01527383|520413347|FG001|Overall Study|Lost to Follow-up|0|||
144330954|NCT01527383|520413346|FG000|Overall Study|Physician Decision|2|||
144330955|NCT01527383|520413347|FG001|Overall Study|Physician Decision|0|||
144330956|NCT01527383|520413346|FG000|Overall Study|Pregnancy|1|||
144330957|NCT01527383|520413347|FG001|Overall Study|Pregnancy|0|||
144330958|NCT01527383|520413346|FG000|Overall Study|Protocol Violation|1|||
144330959|NCT01527383|520413347|FG001|Overall Study|Protocol Violation|0|||
144330960|NCT01527383|520413346|FG000|Overall Study|Screen failure|1|||
144330961|NCT01527383|520413347|FG001|Overall Study|Screen failure|0|||
144330962|NCT01527383|520413346|FG000|Overall Study|Participant moved|0|||
144330963|NCT01527383|520413347|FG001|Overall Study|Participant moved|1|||
144330964|NCT01527383|520413346|FG000|Overall Study|Withdrawal by Subject|2|||
144330965|NCT01527383|520413347|FG001|Overall Study|Withdrawal by Subject|3|||
144330966|NCT03515941|520413360|FG000|Overall Study|Adverse Event|1|||
144330967|NCT03515941|520413361|FG001|Overall Study|Adverse Event|0|||
144330968|NCT01406015|520413362|FG000|Overall Study|Withdrawal by Subject|3|||
144330969|NCT01406015|520413363|FG001|Overall Study|Withdrawal by Subject|3|||
144330970|NCT00787137|520413364|FG000|Overall Study|Study Termination|0|||
144330971|NCT00787137|520413365|FG001|Overall Study|Study Termination|0|||
144330972|NCT00787137|520413366|FG002|Overall Study|Study Termination|1|||
144330973|NCT01628367|520413374|FG000|Overall Study|Adverse Event|1|||
144330974|NCT01628367|520413375|FG001|Overall Study|Adverse Event|0|||
144330975|NCT03688555|520413376|FG000|Treatment Period|Adverse Event|0|||
144330976|NCT03688555|520413377|FG001|Treatment Period|Adverse Event|0|||
144330977|NCT03688555|520413378|FG002|Treatment Period|Adverse Event|1|||
144330978|NCT02639338|520413384|FG000|Overall Study|Lost to Follow-up|2|||
144330979|NCT02639338|520413385|FG001|Overall Study|Lost to Follow-up|2|||
144330980|NCT02639338|520413384|FG000|Overall Study|Withdrew Consent|1|||
144330981|NCT02639338|520413385|FG001|Overall Study|Withdrew Consent|2|||
144330982|NCT02639338|520413384|FG000|Overall Study|Death|1|||
144330983|NCT02639338|520413385|FG001|Overall Study|Death|0|||
144330984|NCT02639338|520413384|FG000|Overall Study|Randomized but Not Treated|0|||
144330985|NCT02639338|520413385|FG001|Overall Study|Randomized but Not Treated|1|||
144330986|NCT00613080|520413389|FG000|Overall Study|Ineligible / no protocol treatment|11|||
144330987|NCT02153346|520413390|FG000|Overall Study|Lost to Follow-up|11|||
144330988|NCT01522404|520413393|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
144330989|NCT01522404|520413394|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
144330990|NCT01522404|520413393|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
144330991|NCT01522404|520413394|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
144330992|NCT01522404|520413393|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
144330993|NCT01522404|520413394|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
144330994|NCT01591863|520413395|FG000|Overall Study|Adverse Event|3|||
144330995|NCT01591863|520413395|FG000|Overall Study|Withdrawal by Subject|1|||
144330996|NCT01591863|520413395|FG000|Overall Study|recurrence|9|||
144330997|NCT01591863|520413395|FG000|Overall Study|Lack of Efficacy|1|||
144330998|NCT02366767|520413398|FG000|Overall Study|left for home after 1 day at camp|1|||
144330999|NCT02366767|520413399|FG001|Overall Study|left for home after 1 day at camp|0|||
144331000|NCT02558400|520413402|FG000|Overall Study|Adverse Event|47|||
144331001|NCT02558400|520413403|FG001|Overall Study|Adverse Event|53|||
144331002|NCT02558400|520413404|FG002|Overall Study|Adverse Event|4|||
144331003|NCT02558400|520413402|FG000|Overall Study|Withdrawal by Subject|13|||
144331004|NCT02558400|520413403|FG001|Overall Study|Withdrawal by Subject|9|||
144331005|NCT02558400|520413404|FG002|Overall Study|Withdrawal by Subject|8|||
144331006|NCT02558400|520413402|FG000|Overall Study|Non-Compliant|0|||
144331007|NCT02558400|520413403|FG001|Overall Study|Non-Compliant|1|||
144331008|NCT02558400|520413404|FG002|Overall Study|Non-Compliant|3|||
144331009|NCT02558400|520413402|FG000|Overall Study|Lost to Follow-up|5|||
144331010|NCT02558400|520413403|FG001|Overall Study|Lost to Follow-up|5|||
144331011|NCT02558400|520413404|FG002|Overall Study|Lost to Follow-up|4|||
144331012|NCT02558400|520413402|FG000|Overall Study|Lack of Efficacy|0|||
144331013|NCT02558400|520413403|FG001|Overall Study|Lack of Efficacy|13|||
144331014|NCT02558400|520413404|FG002|Overall Study|Lack of Efficacy|1|||
144331015|NCT02558400|520413402|FG000|Overall Study|Disallowed Concurrent Medication|6|||
144331016|NCT02558400|520413403|FG001|Overall Study|Disallowed Concurrent Medication|7|||
144331017|NCT02558400|520413404|FG002|Overall Study|Disallowed Concurrent Medication|5|||
144331018|NCT02558400|520413402|FG000|Overall Study|Physician Decision|2|||
144331019|NCT02558400|520413403|FG001|Overall Study|Physician Decision|2|||
144331020|NCT02558400|520413404|FG002|Overall Study|Physician Decision|0|||
144331021|NCT02558400|520413402|FG000|Overall Study|Protocol Violation|6|||
144331022|NCT02558400|520413403|FG001|Overall Study|Protocol Violation|3|||
144331023|NCT02558400|520413404|FG002|Overall Study|Protocol Violation|8|||
144331024|NCT02558400|520413402|FG000|Overall Study|Death|0|||
144331025|NCT02558400|520413403|FG001|Overall Study|Death|1|||
144331026|NCT02558400|520413404|FG002|Overall Study|Death|0|||
144331027|NCT02558400|520413402|FG000|Overall Study|Ineligible for the study|0|||
144331028|NCT02558400|520413403|FG001|Overall Study|Ineligible for the study|2|||
144331029|NCT02558400|520413404|FG002|Overall Study|Ineligible for the study|0|||
144331030|NCT00456599|520413405|FG000|Overall Study|Non-compliance|1|||
144331031|NCT00456599|520413405|FG000|Overall Study|Withdrawal by Subject|2|||
144331032|NCT00260065|520413406|FG000|Overall Study|Progressive Disease|22|||
144331033|NCT00260065|520413406|FG000|Overall Study|Adverse Event|17|||
144331034|NCT00260065|520413406|FG000|Overall Study|Death|13|||
144331035|NCT00260065|520413406|FG000|Overall Study|Withdrawal by Subject|13|||
144331036|NCT00260065|520413406|FG000|Overall Study|Physician Decision|19|||
144331037|NCT00260065|520413406|FG000|Overall Study|Not otherwise specified|8|||
144331038|NCT00260065|520413406|FG000|Overall Study|Medication Noncompliance|1|||
144331039|NCT00240110|520415805|FG000|Overall Study|Lost to Follow-up|6|||
144331040|NCT00240110|520415806|FG001|Overall Study|Lost to Follow-up|7|||
144331041|NCT02080260|520415807|FG000|Overall Study|Death|18|||
144331042|NCT02080260|520415807|FG000|Overall Study|Withdrawal by Subject|1|||
144331043|NCT03769311|520415808|FG000|Overall Study|Withdrawal by Subject|1|||
144331044|NCT02853435|520415809|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
144331045|NCT02853435|520415810|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
144331046|NCT02853435|520415811|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
144331047|NCT02853435|520415812|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
144331048|NCT02853435|520415813|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
144331049|NCT02853435|520415814|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
144331050|NCT03747120|520415815|FG000|Overall Study|treatment related toxicity|3|||
144331051|NCT03747120|520415816|FG001|Overall Study|treatment related toxicity|0|||
144331052|NCT03747120|520415817|FG002|Overall Study|treatment related toxicity|0|||
144331053|NCT03747120|520415815|FG000|Overall Study|Withdrawal by Subject|0|||
144331054|NCT03747120|520415816|FG001|Overall Study|Withdrawal by Subject|1|||
144331055|NCT03747120|520415817|FG002|Overall Study|Withdrawal by Subject|2|||
144331056|NCT03627065|520415818|FG000|Overall Study|Study Terminated by sponsor|1|||
144331057|NCT03627065|520415818|FG000|Overall Study|Withdrawal by Subject|2|||
144331058|NCT00289198|520415819|FG000|Overall Study|Adverse Event|0|||
144331059|NCT00289198|520415820|FG001|Overall Study|Adverse Event|2|||
144331060|NCT00289198|520415819|FG000|Overall Study|Protocol Violation|2|||
144331061|NCT00289198|520415820|FG001|Overall Study|Protocol Violation|1|||
144331062|NCT00289198|520415819|FG000|Overall Study|Withdrawal by Subject|4|||
144331063|NCT00289198|520415820|FG001|Overall Study|Withdrawal by Subject|1|||
144331064|NCT00289198|520415819|FG000|Overall Study|Lack of Efficacy|2|||
144331065|NCT00289198|520415820|FG001|Overall Study|Lack of Efficacy|0|||
144331066|NCT00289198|520415819|FG000|Overall Study|Other: Low compliance|0|||
144331067|NCT00289198|520415820|FG001|Overall Study|Other: Low compliance|1|||
144331068|NCT00289198|520415819|FG000|Overall Study|Other: Physician's decision|0|||
144331069|NCT00289198|520415820|FG001|Overall Study|Other: Physician's decision|1|||
144331070|NCT00289198|520415819|FG000|Overall Study|Other: Unable to attend on schedule|2|||
144331071|NCT00289198|520415820|FG001|Overall Study|Other: Unable to attend on schedule|1|||
144331072|NCT00289198|520415819|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
144331073|NCT00289198|520415820|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
144331074|NCT00289198|520415819|FG000|Overall Study|Other: Impossible to come on visit|0|||
144331075|NCT00289198|520415820|FG001|Overall Study|Other: Impossible to come on visit|1|||
144331076|NCT01266317|520415821|FG000|Overall Study|Withdrawal by Subject|2|||
144331077|NCT00490776|520415822|FG000|Overall Study|Withdrawal by Subject|1|||
144331078|NCT00490776|520415822|FG000|Overall Study|Administrative Problems|1|||
144331079|NCT00490776|520415822|FG000|Overall Study|Death|1|||
144331080|NCT00490776|520415822|FG000|Overall Study|New Cancer Therapy|1|||
144331081|NCT00490776|520415822|FG000|Overall Study|Disease Progression|5|||
144331082|NCT01657760|520415823|FG000|Overall Study|Withdrawal by Subject|0|||
144331083|NCT01657760|520415824|FG001|Overall Study|Withdrawal by Subject|0|||
144331084|NCT01657760|520415825|FG002|Overall Study|Withdrawal by Subject|0|||
144331085|NCT01657760|520415826|FG003|Overall Study|Withdrawal by Subject|1|||
144331086|NCT01657760|520415823|FG000|Overall Study|Physician Decision|1|||
144331087|NCT01657760|520415824|FG001|Overall Study|Physician Decision|1|||
144331088|NCT01657760|520415825|FG002|Overall Study|Physician Decision|1|||
144331089|NCT01657760|520415826|FG003|Overall Study|Physician Decision|2|||
144331090|NCT04912895|520415833|FG000|Overall Study|Unable to provide specimen|2|||
144331091|NCT04912895|520415834|FG001|Overall Study|Unable to provide specimen|0|||
144331092|NCT04912895|520415835|FG002|Overall Study|Unable to provide specimen|0|||
144331093|NCT02255565|520415836|FG000|Overall Study|Withdrawal by Subject|0|||
144331094|NCT02255565|520415837|FG001|Overall Study|Withdrawal by Subject|1|||
144331095|NCT02255565|520415838|FG002|Overall Study|Withdrawal by Subject|0|||
144331096|NCT00900146|520415841|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
144331097|NCT00900146|520415842|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
144331098|NCT00900146|520415843|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
144331099|NCT00900146|520415844|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
144331100|NCT00900146|520415845|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
144331101|NCT00900146|520415841|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
144331102|NCT00900146|520415842|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
144331103|NCT00900146|520415843|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
144331104|NCT00900146|520415844|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
144331105|NCT00900146|520415845|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
144331106|NCT00900146|520415841|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
144331107|NCT00900146|520415842|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
144331108|NCT00900146|520415843|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
144331109|NCT00900146|520415844|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
144331110|NCT00900146|520415845|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
144331111|NCT00900146|520415841|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
144331112|NCT00900146|520415842|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
144331113|NCT00900146|520415843|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
144331114|NCT00900146|520415844|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
144331115|NCT00900146|520415845|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
144331116|NCT00900146|520415841|FG000|Intermediate: Period III|Lost to Follow-up|2|||
144331117|NCT00900146|520415842|FG001|Intermediate: Period III|Lost to Follow-up|0|||
144331118|NCT00900146|520415843|FG002|Intermediate: Period III|Lost to Follow-up|0|||
144331119|NCT00900146|520415844|FG003|Intermediate: Period III|Lost to Follow-up|0|||
144331120|NCT00900146|520415845|FG004|Intermediate: Period III|Lost to Follow-up|1|||
144331121|NCT00900146|520415841|FG000|Intermediate: Period III|Administrative problems|85|||
144331122|NCT00900146|520415842|FG001|Intermediate: Period III|Administrative problems|92|||
144331123|NCT00900146|520415843|FG002|Intermediate: Period III|Administrative problems|84|||
144331124|NCT00900146|520415844|FG003|Intermediate: Period III|Administrative problems|90|||
144331125|NCT00900146|520415845|FG004|Intermediate: Period III|Administrative problems|163|||
144331126|NCT00700102|520415846|FG000|Overall Study|Died|394|||
144331127|NCT00700102|520415847|FG001|Overall Study|Died|385|||
144331128|NCT00700102|520415846|FG000|Overall Study|Lost to Follow-up|8|||
144331129|NCT00700102|520415847|FG001|Overall Study|Lost to Follow-up|10|||
144331130|NCT02525939|520415852|FG000|Overall Study|Lost to Follow-up|27|||
144331131|NCT02525939|520415853|FG001|Overall Study|Lost to Follow-up|24|||
144331132|NCT02525939|520415852|FG000|Overall Study|Physician Decision|0|||
144331133|NCT02525939|520415853|FG001|Overall Study|Physician Decision|1|||
144331134|NCT02525939|520415852|FG000|Overall Study|Withdrawal by Subject|24|||
144331135|NCT02525939|520415853|FG001|Overall Study|Withdrawal by Subject|39|||
144331136|NCT02525939|520415852|FG000|Overall Study|Death|180|||
144331137|NCT02525939|520415853|FG001|Overall Study|Death|179|||
144331138|NCT01635764|520415854|FG000|Overall Study|Adverse Event|46|||
144331139|NCT01635764|520415854|FG000|Overall Study|Lack of Efficacy|76|||
144331140|NCT01635764|520415854|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
144331141|NCT01635764|520415854|FG000|Overall Study|Protocol Deviation|1|||
144331142|NCT01635764|520415854|FG000|Overall Study|Withdrew Consent|67|||
144331143|NCT01635764|520415854|FG000|Overall Study|Lost to Follow-up|53|||
144331144|NCT01635764|520415854|FG000|Overall Study|Other|28|||
144331145|NCT01174004|520415855|FG000|Overall Study|Adverse Event|2|||
144331146|NCT01174004|520415856|FG001|Overall Study|Adverse Event|10|||
144331147|NCT01174004|520415855|FG000|Overall Study|Withdrawal by Subject|2|||
144331148|NCT01174004|520415856|FG001|Overall Study|Withdrawal by Subject|3|||
144331149|NCT01174004|520415855|FG000|Overall Study|At Discretion of Sponsor|2|||
144331150|NCT01174004|520415856|FG001|Overall Study|At Discretion of Sponsor|2|||
144331151|NCT01174004|520415855|FG000|Overall Study|Protocol Violation|0|||
144331152|NCT01174004|520415856|FG001|Overall Study|Protocol Violation|1|||
144331153|NCT01174004|520415855|FG000|Overall Study|Physician Decision|1|||
144331154|NCT01174004|520415856|FG001|Overall Study|Physician Decision|0|||
144331155|NCT00933244|520415857|FG000|Overall Study|Withdrawal by Subject|5|||
144331156|NCT00933244|520415858|FG001|Overall Study|Withdrawal by Subject|1|||
144331157|NCT00933244|520415859|FG002|Overall Study|Withdrawal by Subject|3|||
144331158|NCT02266875|520415861|FG000|Overall Study|Withdrawal by Subject|9|||
144331159|NCT02266875|520415862|FG001|Overall Study|Withdrawal by Subject|0|||
144331160|NCT02266875|520415861|FG000|Overall Study|Lost to Follow-up|2|||
144331161|NCT02266875|520415862|FG001|Overall Study|Lost to Follow-up|0|||
144331162|NCT02956850|520415864|FG000|Overall Study|Withdrawal by Subject|0|||
144331163|NCT02956850|520415865|FG001|Overall Study|Withdrawal by Subject|0|||
144331164|NCT02956850|520415866|FG002|Overall Study|Withdrawal by Subject|0|||
144331165|NCT02956850|520415867|FG003|Overall Study|Withdrawal by Subject|0|||
144331166|NCT02956850|520415868|FG004|Overall Study|Withdrawal by Subject|0|||
144331167|NCT02956850|520415869|FG005|Overall Study|Withdrawal by Subject|0|||
144331168|NCT02956850|520415870|FG006|Overall Study|Withdrawal by Subject|0|||
144331169|NCT02956850|520415871|FG007|Overall Study|Withdrawal by Subject|0|||
144331170|NCT02956850|520415872|FG008|Overall Study|Withdrawal by Subject|0|||
144331171|NCT02956850|520415873|FG009|Overall Study|Withdrawal by Subject|0|||
144331172|NCT02956850|520415874|FG010|Overall Study|Withdrawal by Subject|0|||
144331173|NCT02956850|520415875|FG011|Overall Study|Withdrawal by Subject|0|||
144331174|NCT02956850|520415876|FG012|Overall Study|Withdrawal by Subject|0|||
144331175|NCT02956850|520415877|FG013|Overall Study|Withdrawal by Subject|0|||
144331176|NCT02956850|520415878|FG014|Overall Study|Withdrawal by Subject|0|||
144331177|NCT02956850|520415879|FG015|Overall Study|Withdrawal by Subject|0|||
144331178|NCT02956850|520415880|FG016|Overall Study|Withdrawal by Subject|0|||
144331179|NCT02956850|520415881|FG017|Overall Study|Withdrawal by Subject|1|||
144331180|NCT01920152|520415882|FG000|Overall Study|Withdrawal by Subject|1|||
144331181|NCT01920152|520415883|FG001|Overall Study|Withdrawal by Subject|2|||
144331182|NCT00849875|520415886|FG000|Overall Study|Death|28|||
144331183|NCT00849875|520415886|FG000|Overall Study|Ongoing (unknown completion status)|11|||
144331184|NCT00849875|520415886|FG000|Overall Study|Others|6|||
144331185|NCT00849875|520415886|FG000|Overall Study|Lost to Follow-up|2|||
144331186|NCT01304329|520415888|FG000|Third Intervention (3 Days)|Adverse Event|0|||
144331187|NCT01304329|520415889|FG001|Third Intervention (3 Days)|Adverse Event|1|||
144331188|NCT01304329|520415890|FG002|Third Intervention (3 Days)|Adverse Event|0|||
144331189|NCT01304329|520415891|FG003|Third Intervention (3 Days)|Adverse Event|0|||
144331190|NCT01304329|520415892|FG004|Third Intervention (3 Days)|Adverse Event|0|||
144331191|NCT01304329|520415893|FG005|Third Intervention (3 Days)|Adverse Event|0|||
144331192|NCT00276094|520415899|FG000|Overall Study|Adverse Event|15|||
144331193|NCT00276094|520415900|FG001|Overall Study|Adverse Event|13|||
144331194|NCT00276094|520415901|FG002|Overall Study|Adverse Event|11|||
144331195|NCT00276094|520415899|FG000|Overall Study|Withdrawal by Subject|14|||
144331196|NCT00276094|520415900|FG001|Overall Study|Withdrawal by Subject|14|||
144331197|NCT00276094|520415901|FG002|Overall Study|Withdrawal by Subject|12|||
144331198|NCT00276094|520415899|FG000|Overall Study|Protocol Violation|16|||
144331199|NCT00276094|520415900|FG001|Overall Study|Protocol Violation|7|||
144331200|NCT00276094|520415901|FG002|Overall Study|Protocol Violation|10|||
144331201|NCT00276094|520415899|FG000|Overall Study|Lost to Follow-up|8|||
144331202|NCT00276094|520415900|FG001|Overall Study|Lost to Follow-up|6|||
144331203|NCT00276094|520415901|FG002|Overall Study|Lost to Follow-up|4|||
144331204|NCT00276094|520415899|FG000|Overall Study|Other-Subject moved out of country|1|||
144331205|NCT00276094|520415900|FG001|Overall Study|Other-Subject moved out of country|0|||
144331206|NCT00276094|520415901|FG002|Overall Study|Other-Subject moved out of country|0|||
144331207|NCT00276094|520415899|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
144331208|NCT00276094|520415900|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
144331209|NCT00276094|520415901|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
144331210|NCT00276094|520415899|FG000|Overall Study|Other-Lack of efficacy|1|||
144331211|NCT00276094|520415900|FG001|Overall Study|Other-Lack of efficacy|0|||
144331212|NCT00276094|520415901|FG002|Overall Study|Other-Lack of efficacy|0|||
144331213|NCT00276094|520415899|FG000|Overall Study|Other-Refused follow-up visit|1|||
144331214|NCT00276094|520415900|FG001|Overall Study|Other-Refused follow-up visit|0|||
144331215|NCT00276094|520415901|FG002|Overall Study|Other-Refused follow-up visit|0|||
144331216|NCT00276094|520415899|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
144331217|NCT00276094|520415900|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
144331218|NCT00276094|520415901|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
144331219|NCT00276094|520415899|FG000|Overall Study|Other-Relocation|0|||
144331220|NCT00276094|520415900|FG001|Overall Study|Other-Relocation|1|||
144331221|NCT00276094|520415901|FG002|Overall Study|Other-Relocation|0|||
144331222|NCT00276094|520415899|FG000|Overall Study|Other-Study medication lost|0|||
144331223|NCT00276094|520415900|FG001|Overall Study|Other-Study medication lost|0|||
144331224|NCT00276094|520415901|FG002|Overall Study|Other-Study medication lost|1|||
144331225|NCT02759315|520415902|FG000|Overall Study|Adverse Event|0|||
144331226|NCT02759315|520415903|FG001|Overall Study|Adverse Event|0|||
144331227|NCT02759315|520415904|FG002|Overall Study|Adverse Event|0|||
144331228|NCT02759315|520415905|FG003|Overall Study|Adverse Event|1|||
144331229|NCT02759315|520415906|FG004|Overall Study|Adverse Event|0|||
144331230|NCT02759315|520415902|FG000|Overall Study|Death|0|||
144331231|NCT02759315|520415903|FG001|Overall Study|Death|0|||
144331232|NCT02759315|520415904|FG002|Overall Study|Death|1|||
144331233|NCT02759315|520415905|FG003|Overall Study|Death|0|||
144331234|NCT02759315|520415906|FG004|Overall Study|Death|0|||
144331235|NCT02759315|520415902|FG000|Overall Study|Lost to Follow-up|2|||
144331236|NCT02759315|520415903|FG001|Overall Study|Lost to Follow-up|0|||
144331237|NCT02759315|520415904|FG002|Overall Study|Lost to Follow-up|4|||
144331238|NCT02759315|520415905|FG003|Overall Study|Lost to Follow-up|0|||
144331239|NCT02759315|520415906|FG004|Overall Study|Lost to Follow-up|0|||
144331240|NCT02759315|520415902|FG000|Overall Study|Protocol Violation|0|||
144331241|NCT02759315|520415903|FG001|Overall Study|Protocol Violation|1|||
144331242|NCT02759315|520415904|FG002|Overall Study|Protocol Violation|0|||
144331243|NCT02759315|520415905|FG003|Overall Study|Protocol Violation|0|||
144331244|NCT02759315|520415906|FG004|Overall Study|Protocol Violation|0|||
144331245|NCT02759315|520415902|FG000|Overall Study|Study terminated prior to completion|2|||
144331246|NCT02759315|520415903|FG001|Overall Study|Study terminated prior to completion|0|||
144331247|NCT02759315|520415904|FG002|Overall Study|Study terminated prior to completion|5|||
144331248|NCT02759315|520415905|FG003|Overall Study|Study terminated prior to completion|0|||
144331249|NCT02759315|520415906|FG004|Overall Study|Study terminated prior to completion|1|||
144331250|NCT00554099|520415911|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
144331251|NCT00554099|520415912|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
144331252|NCT00554099|520415913|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
144331253|NCT00554099|520415911|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
144331254|NCT00554099|520415912|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
144331255|NCT00554099|520415913|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
144331256|NCT00554099|520415911|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
144331257|NCT00554099|520415912|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
144331258|NCT00554099|520415913|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
144331259|NCT00554099|520415911|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
144331260|NCT00554099|520415912|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
144331261|NCT00554099|520415913|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
144331262|NCT00554099|520415911|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
144331263|NCT00554099|520415912|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
144331264|NCT00554099|520415913|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
144331265|NCT00554099|520415911|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
144331266|NCT00554099|520415912|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
144331267|NCT00554099|520415913|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
144331268|NCT00554099|520415911|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
144331269|NCT00554099|520415912|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
144331270|NCT00554099|520415913|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
144331271|NCT00554099|520415911|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
144331272|NCT00554099|520415912|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
144331273|NCT00554099|520415913|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
144331274|NCT00554099|520415911|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
144331275|NCT00554099|520415912|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
144331276|NCT00554099|520415913|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
144331277|NCT02075632|520415914|FG000|Overall Study|Adverse Event|1|||
144331278|NCT02075632|520415915|FG001|Overall Study|Adverse Event|1|||
144331279|NCT02075632|520415914|FG000|Overall Study|Lost to Follow-up|0|||
144331280|NCT02075632|520415915|FG001|Overall Study|Lost to Follow-up|3|||
144331281|NCT02075632|520415914|FG000|Overall Study|Withdrawal by Subject|0|||
144331282|NCT02075632|520415915|FG001|Overall Study|Withdrawal by Subject|1|||
144331283|NCT03353922|520415920|FG000|Overall Study|Withdrawal by Subject|1|||
144331284|NCT03353922|520415921|FG001|Overall Study|Withdrawal by Subject|0|||
144331285|NCT03353922|520415922|FG002|Overall Study|Withdrawal by Subject|1|||
144331286|NCT03353922|520415923|FG003|Overall Study|Withdrawal by Subject|1|||
144331287|NCT03353922|520415924|FG004|Overall Study|Withdrawal by Subject|0|||
144331288|NCT03353922|520415925|FG005|Overall Study|Withdrawal by Subject|0|||
144331289|NCT03353922|520415920|FG000|Overall Study|Adverse Event|0|||
144331290|NCT03353922|520415921|FG001|Overall Study|Adverse Event|1|||
144331291|NCT03353922|520415922|FG002|Overall Study|Adverse Event|0|||
144331292|NCT03353922|520415923|FG003|Overall Study|Adverse Event|0|||
144331293|NCT03353922|520415924|FG004|Overall Study|Adverse Event|0|||
144331294|NCT03353922|520415925|FG005|Overall Study|Adverse Event|0|||
144331295|NCT00740714|520415926|FG000|Overall Study|Withdrawal by Subject|17|||
144331296|NCT00740714|520415927|FG001|Overall Study|Withdrawal by Subject|19|||
144331297|NCT00740714|520415928|FG002|Overall Study|Withdrawal by Subject|29|||
144331298|NCT00886119|520415929|FG000|Period 1|Did not meet inclusion criteria|1|||
144331299|NCT00886119|520415930|FG001|Period 1|Did not meet inclusion criteria|0|||
144331300|NCT00394901|520415931|FG000|Baseline Phase|Protocol Violation|0|||
144331301|NCT00394901|520415932|FG001|Baseline Phase|Protocol Violation|0|||
144331302|NCT00394901|520415933|FG002|Baseline Phase|Protocol Violation|1|||
144331303|NCT00394901|520415934|FG003|Baseline Phase|Protocol Violation|0|||
144331304|NCT00394901|520415931|FG000|Double-blind Phase|Adverse Event|5|||
144331305|NCT00394901|520415932|FG001|Double-blind Phase|Adverse Event|7|||
144331306|NCT00394901|520415933|FG002|Double-blind Phase|Adverse Event|16|||
144331307|NCT00394901|520415934|FG003|Double-blind Phase|Adverse Event|20|||
144331308|NCT00394901|520415931|FG000|Double-blind Phase|Lack of Efficacy|6|||
144331309|NCT00394901|520415932|FG001|Double-blind Phase|Lack of Efficacy|4|||
144331310|NCT00394901|520415933|FG002|Double-blind Phase|Lack of Efficacy|1|||
144331311|NCT00394901|520415934|FG003|Double-blind Phase|Lack of Efficacy|3|||
144331312|NCT00394901|520415931|FG000|Double-blind Phase|Withdrawal by Subject|2|||
144331313|NCT00394901|520415932|FG001|Double-blind Phase|Withdrawal by Subject|0|||
144331314|NCT00394901|520415933|FG002|Double-blind Phase|Withdrawal by Subject|0|||
144331315|NCT00394901|520415934|FG003|Double-blind Phase|Withdrawal by Subject|0|||
144331316|NCT00394901|520415931|FG000|Double-blind Phase|Lost to Follow-up|0|||
144331317|NCT00394901|520415932|FG001|Double-blind Phase|Lost to Follow-up|0|||
144331318|NCT00394901|520415933|FG002|Double-blind Phase|Lost to Follow-up|0|||
144331319|NCT00394901|520415934|FG003|Double-blind Phase|Lost to Follow-up|1|||
144331320|NCT00394901|520415931|FG000|Double-blind Phase|Protocol Violation|0|||
144331321|NCT00394901|520415932|FG001|Double-blind Phase|Protocol Violation|0|||
144331322|NCT00394901|520415933|FG002|Double-blind Phase|Protocol Violation|0|||
144331323|NCT00394901|520415934|FG003|Double-blind Phase|Protocol Violation|1|||
144331324|NCT00394901|520415931|FG000|Double-blind Phase|Death|1|||
144331325|NCT00394901|520415932|FG001|Double-blind Phase|Death|0|||
144331326|NCT00394901|520415933|FG002|Double-blind Phase|Death|0|||
144331327|NCT00394901|520415934|FG003|Double-blind Phase|Death|0|||
144331328|NCT00394901|520415931|FG000|Double-blind Phase|Subject's Personal Reason|1|||
144331329|NCT00394901|520415932|FG001|Double-blind Phase|Subject's Personal Reason|0|||
144331330|NCT00394901|520415933|FG002|Double-blind Phase|Subject's Personal Reason|0|||
144331331|NCT00394901|520415934|FG003|Double-blind Phase|Subject's Personal Reason|1|||
144331332|NCT00394901|520415931|FG000|Double-blind Phase|Lack of Compliance|0|||
144331333|NCT00394901|520415932|FG001|Double-blind Phase|Lack of Compliance|3|||
144331334|NCT00394901|520415933|FG002|Double-blind Phase|Lack of Compliance|0|||
144331335|NCT00394901|520415934|FG003|Double-blind Phase|Lack of Compliance|0|||
144331336|NCT00394901|520415931|FG000|Double-blind Phase|Entry into another study was found|0|||
144331337|NCT00394901|520415932|FG001|Double-blind Phase|Entry into another study was found|0|||
144331338|NCT00394901|520415933|FG002|Double-blind Phase|Entry into another study was found|1|||
144331339|NCT00394901|520415934|FG003|Double-blind Phase|Entry into another study was found|0|||
144331340|NCT00394901|520415931|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
144331341|NCT00394901|520415932|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
144331342|NCT00394901|520415933|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
144331343|NCT00394901|520415934|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
144331344|NCT03002623|520415935|FG000|Overall Study|Lost to Follow-up|1|||
144331345|NCT03002623|520415936|FG001|Overall Study|Lost to Follow-up|0|||
144331346|NCT03002623|520415935|FG000|Overall Study|Physician Decision|1|||
144331347|NCT03002623|520415936|FG001|Overall Study|Physician Decision|1|||
144331348|NCT02256267|520415937|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
144331349|NCT02256267|520415937|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
144331350|NCT01352741|520415942|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
144331351|NCT01352741|520415943|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
144331352|NCT01352741|520415942|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
144331353|NCT01352741|520415943|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
144331354|NCT01352741|520415942|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
144331355|NCT01352741|520415943|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
144331356|NCT01352741|520415942|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
144331357|NCT01352741|520415943|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
144331358|NCT01352741|520415942|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
144331359|NCT01352741|520415943|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
144331360|NCT01352741|520415942|FG000|Open-label Tapentadol Titration Period|Other|4|||
144331361|NCT01352741|520415943|FG001|Open-label Tapentadol Titration Period|Other|0|||
144331362|NCT01352741|520415942|FG000|Double-blind Comparative Period|Protocol Violation|2|||
144331363|NCT01352741|520415943|FG001|Double-blind Comparative Period|Protocol Violation|0|||
144331364|NCT01352741|520415942|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
144331365|NCT01352741|520415943|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
144331366|NCT01352741|520415942|FG000|Double-blind Comparative Period|Adverse Event|16|||
144331367|NCT01352741|520415943|FG001|Double-blind Comparative Period|Adverse Event|17|||
144331368|NCT01352741|520415942|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
144331369|NCT01352741|520415943|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
144331370|NCT01352741|520415942|FG000|Double-blind Comparative Period|Death|0|||
144331371|NCT01352741|520415943|FG001|Double-blind Comparative Period|Death|1|||
144331372|NCT01352741|520415942|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
144331373|NCT01352741|520415943|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
144331374|NCT01352741|520415942|FG000|Double-blind Comparative Period|Other|1|||
144331375|NCT01352741|520415943|FG001|Double-blind Comparative Period|Other|2|||
144331376|NCT01352741|520415942|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
144331377|NCT01352741|520415943|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
144331378|NCT01352741|520415942|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
144331379|NCT01352741|520415943|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
144331380|NCT01352741|520415942|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
144331381|NCT01352741|520415943|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
144331382|NCT01352741|520415942|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
144331383|NCT01352741|520415943|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
144331384|NCT00259298|520415944|FG000|Overall Study|Withdrawal by Subject|1|||
144331385|NCT00259298|520415944|FG000|Overall Study|Physician Decision|2|||
144331386|NCT00645528|520415945|FG000|Overall Study|Did not show up for Visit 2|7|||
144331387|NCT03618628|520415951|FG000|Overall Study|Death|1|||
144331388|NCT03618628|520415951|FG000|Overall Study|Lost to Follow-up|1|||
144331389|NCT01969500|520415952|FG000|Overall Study|Death|0|||
144331390|NCT01969500|520415953|FG001|Overall Study|Death|1|||
144331391|NCT01969500|520415952|FG000|Overall Study|extended hospitalization|1|||
144331392|NCT01969500|520415953|FG001|Overall Study|extended hospitalization|1|||
144331393|NCT02463032|520415954|FG000|Overall Study|Lack of Efficacy|61|||
144331394|NCT02463032|520415955|FG001|Overall Study|Lack of Efficacy|50|||
144331395|NCT02463032|520415954|FG000|Overall Study|Death|8|||
144331396|NCT02463032|520415955|FG001|Overall Study|Death|8|||
144331397|NCT02463032|520415954|FG000|Overall Study|Adverse Event|2|||
144331398|NCT02463032|520415955|FG001|Overall Study|Adverse Event|6|||
144331399|NCT01741532|520415956|FG000|Overall Study|Adverse Event|4|||
144331400|NCT01741532|520415957|FG001|Overall Study|Adverse Event|0|||
144331401|NCT01741532|520415956|FG000|Overall Study|Withdrawal by Subject|1|||
144331402|NCT01741532|520415957|FG001|Overall Study|Withdrawal by Subject|1|||
144331403|NCT01741532|520415956|FG000|Overall Study|Protocol Violation|0|||
144331404|NCT01741532|520415957|FG001|Overall Study|Protocol Violation|1|||
144331405|NCT01741532|520415956|FG000|Overall Study|Worsening of the disease|3|||
144331406|NCT01741532|520415957|FG001|Overall Study|Worsening of the disease|1|||
144331407|NCT01741532|520415956|FG000|Overall Study|Sponsor decision|1|||
144331408|NCT01741532|520415957|FG001|Overall Study|Sponsor decision|0|||
144331409|NCT01741532|520415956|FG000|Overall Study|Medical event|1|||
144331410|NCT01741532|520415957|FG001|Overall Study|Medical event|0|||
144331411|NCT02360293|520415958|FG000|Overall Study|Lost to Follow-up|73|||
144331412|NCT02360293|520415959|FG001|Overall Study|Lost to Follow-up|95|||
144331413|NCT02360293|520415958|FG000|Overall Study|Withdrawal by Subject|2|||
144331414|NCT02360293|520415959|FG001|Overall Study|Withdrawal by Subject|1|||
144331415|NCT02360293|520415958|FG000|Overall Study|Excluded|1|||
144331416|NCT02360293|520415959|FG001|Overall Study|Excluded|0|||
144331417|NCT02226549|520415960|FG000|Overall Study|Randomized but Never Treated|1|||
144331418|NCT02226549|520415961|FG001|Overall Study|Randomized but Never Treated|0|||
144331419|NCT02226549|520415960|FG000|Overall Study|Lost to Follow-up|0|||
144331420|NCT02226549|520415961|FG001|Overall Study|Lost to Follow-up|1|||
144331421|NCT00612508|520415963|FG000|Overall Study|Withdrawal by Subject|3|||
144331422|NCT00612508|520415964|FG001|Overall Study|Withdrawal by Subject|4|||
144331423|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
144331424|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
144331425|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
144331426|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
144331427|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
144331428|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
144331429|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
144331430|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
144331431|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
144331432|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
144331433|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
144331434|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
144331435|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
144331436|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
144331437|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
144331438|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
144331439|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
144331440|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
144331441|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
144331442|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
144331443|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
144331444|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
144331445|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
144331446|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
144331447|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
144331448|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
144331449|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
144331450|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
144331451|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
144331452|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
144331453|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
144331454|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
144331455|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
144331456|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
144331457|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
144331458|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
144331459|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
144331460|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
144331461|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
144331462|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
144331463|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
144331464|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
144331465|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
144331466|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
144331467|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
144331468|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
144331469|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
144331470|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
144331471|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
144331472|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
144331473|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
144331474|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
144331475|NCT02008357|520415965|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
144331476|NCT02008357|520415966|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
144331477|NCT02008357|520415965|FG000|Open-label Extension Period|Adverse Event|8|||
144331478|NCT02008357|520415966|FG001|Open-label Extension Period|Adverse Event|7|||
144331479|NCT02008357|520415965|FG000|Open-label Extension Period|Death|7|||
144331480|NCT02008357|520415966|FG001|Open-label Extension Period|Death|4|||
144331481|NCT02008357|520415965|FG000|Open-label Extension Period|Lack of Efficacy|9|||
144331482|NCT02008357|520415966|FG001|Open-label Extension Period|Lack of Efficacy|5|||
144331483|NCT02008357|520415965|FG000|Open-label Extension Period|Lost to Follow-up|2|||
144331484|NCT02008357|520415966|FG001|Open-label Extension Period|Lost to Follow-up|2|||
144331485|NCT02008357|520415965|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
144331486|NCT02008357|520415966|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
144331487|NCT02008357|520415965|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
144331488|NCT02008357|520415966|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
144331489|NCT02008357|520415965|FG000|Open-label Extension Period|Safety Risk|2|||
144331490|NCT02008357|520415966|FG001|Open-label Extension Period|Safety Risk|1|||
144331491|NCT02008357|520415965|FG000|Open-label Extension Period|Non-Compliance|0|||
144331492|NCT02008357|520415966|FG001|Open-label Extension Period|Non-Compliance|1|||
144331493|NCT02008357|520415965|FG000|Open-label Extension Period|Investigator Recommendation|0|||
144331494|NCT02008357|520415966|FG001|Open-label Extension Period|Investigator Recommendation|1|||
144331495|NCT02008357|520415965|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
144331496|NCT02008357|520415966|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
144331497|NCT02008357|520415965|FG000|Open-label Extension Period|Coordinating Center Request|2|||
144331498|NCT02008357|520415966|FG001|Open-label Extension Period|Coordinating Center Request|4|||
144331499|NCT02008357|520415965|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
144331500|NCT02008357|520415966|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
144331501|NCT02008357|520415965|FG000|Open-label Extension Period|Study Ended|20|||
144331502|NCT02008357|520415966|FG001|Open-label Extension Period|Study Ended|25|||
144331503|NCT02008357|520415965|FG000|Open-label Extension Period|Personal Reasons|0|||
144331504|NCT02008357|520415966|FG001|Open-label Extension Period|Personal Reasons|1|||
144331505|NCT02008357|520415965|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
144331506|NCT02008357|520415966|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
144331507|NCT02008357|520415965|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
144331508|NCT02008357|520415966|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
144331509|NCT02008357|520415965|FG000|Open-label Extension Period|Other|2|||
144331510|NCT02008357|520415966|FG001|Open-label Extension Period|Other|0|||
144331511|NCT01442064|520415967|FG000|Overall Study|Adverse Event|2|||
144331512|NCT01442064|520415968|FG001|Overall Study|Adverse Event|2|||
144331513|NCT01442064|520415969|FG002|Overall Study|Adverse Event|2|||
144331514|NCT01442064|520415970|FG003|Overall Study|Adverse Event|1|||
144331515|NCT01442064|520415971|FG004|Overall Study|Adverse Event|2|||
144331516|NCT01442064|520415972|FG005|Overall Study|Adverse Event|0|||
144331517|NCT01442064|520415967|FG000|Overall Study|Death|0|||
144331518|NCT01442064|520415968|FG001|Overall Study|Death|1|||
144331519|NCT01442064|520415969|FG002|Overall Study|Death|3|||
144331520|NCT01442064|520415970|FG003|Overall Study|Death|3|||
144331521|NCT01442064|520415971|FG004|Overall Study|Death|1|||
144331522|NCT01442064|520415972|FG005|Overall Study|Death|3|||
144331523|NCT01442064|520415967|FG000|Overall Study|Lost to Follow-up|5|||
144331524|NCT01442064|520415968|FG001|Overall Study|Lost to Follow-up|5|||
144331525|NCT01442064|520415969|FG002|Overall Study|Lost to Follow-up|1|||
144331526|NCT01442064|520415970|FG003|Overall Study|Lost to Follow-up|1|||
144331527|NCT01442064|520415971|FG004|Overall Study|Lost to Follow-up|3|||
144331528|NCT01442064|520415972|FG005|Overall Study|Lost to Follow-up|3|||
144331529|NCT01442064|520415967|FG000|Overall Study|Physician Decision|1|||
144331530|NCT01442064|520415968|FG001|Overall Study|Physician Decision|1|||
144331531|NCT01442064|520415969|FG002|Overall Study|Physician Decision|2|||
144331532|NCT01442064|520415970|FG003|Overall Study|Physician Decision|3|||
144331533|NCT01442064|520415971|FG004|Overall Study|Physician Decision|3|||
144331534|NCT01442064|520415972|FG005|Overall Study|Physician Decision|1|||
144331535|NCT01442064|520415967|FG000|Overall Study|Withdrawal by Subject|6|||
144331536|NCT01442064|520415968|FG001|Overall Study|Withdrawal by Subject|3|||
144331537|NCT01442064|520415969|FG002|Overall Study|Withdrawal by Subject|2|||
144331538|NCT01442064|520415970|FG003|Overall Study|Withdrawal by Subject|2|||
144331539|NCT01442064|520415971|FG004|Overall Study|Withdrawal by Subject|2|||
144331540|NCT01442064|520415972|FG005|Overall Study|Withdrawal by Subject|1|||
144331541|NCT01442064|520415967|FG000|Overall Study|Sponsor decision|82|||
144331542|NCT01442064|520415968|FG001|Overall Study|Sponsor decision|88|||
144331543|NCT01442064|520415969|FG002|Overall Study|Sponsor decision|92|||
144331544|NCT01442064|520415970|FG003|Overall Study|Sponsor decision|88|||
144331545|NCT01442064|520415971|FG004|Overall Study|Sponsor decision|95|||
144331546|NCT01442064|520415972|FG005|Overall Study|Sponsor decision|87|||
144331547|NCT01442064|520415967|FG000|Overall Study|Subject non-compliance|0|||
144331548|NCT01442064|520415968|FG001|Overall Study|Subject non-compliance|0|||
144331549|NCT01442064|520415969|FG002|Overall Study|Subject non-compliance|0|||
144331550|NCT01442064|520415970|FG003|Overall Study|Subject non-compliance|0|||
144331551|NCT01442064|520415971|FG004|Overall Study|Subject non-compliance|0|||
144331552|NCT01442064|520415972|FG005|Overall Study|Subject non-compliance|2|||
144331553|NCT01442064|520415967|FG000|Overall Study|Condition mandated other intervention|1|||
144331554|NCT01442064|520415968|FG001|Overall Study|Condition mandated other intervention|1|||
144331555|NCT01442064|520415969|FG002|Overall Study|Condition mandated other intervention|2|||
144331556|NCT01442064|520415970|FG003|Overall Study|Condition mandated other intervention|0|||
144331557|NCT01442064|520415971|FG004|Overall Study|Condition mandated other intervention|0|||
144331558|NCT01442064|520415972|FG005|Overall Study|Condition mandated other intervention|2|||
144331559|NCT02312219|520415973|FG000|Overall Study|Withdrawal by Subject|1|||
144331560|NCT02312219|520415974|FG001|Overall Study|Withdrawal by Subject|2|||
144331561|NCT02312219|520415973|FG000|Overall Study|could not schedule imaging in time|0|||
144331562|NCT02312219|520415974|FG001|Overall Study|could not schedule imaging in time|2|||
144331563|NCT02312219|520415973|FG000|Overall Study|Other|0|||
144331564|NCT02312219|520415974|FG001|Overall Study|Other|1|||
144331565|NCT02312219|520415973|FG000|Overall Study|Not randomized. Ineligible|0|||
144331566|NCT02312219|520415974|FG001|Overall Study|Not randomized. Ineligible|1|||
144331567|NCT01269385|520415975|FG000|Overall Study|Adverse Event|1|||
144331568|NCT01269385|520415976|FG001|Overall Study|Adverse Event|1|||
144331569|NCT01269385|520415977|FG002|Overall Study|Adverse Event|0|||
144331570|NCT01269385|520415978|FG003|Overall Study|Adverse Event|0|||
144331571|NCT02741570|520415980|FG000|Pre-Treatment Period|Other reasons|0|||
144331572|NCT02741570|520415981|FG001|Pre-Treatment Period|Other reasons|3|||
144331573|NCT02741570|520415980|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
144331574|NCT02741570|520415981|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
144331575|NCT02741570|520415980|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
144331576|NCT02741570|520415981|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
144331577|NCT02741570|520415980|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
144331578|NCT02741570|520415981|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
144331579|NCT02741570|520415980|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
144331580|NCT02741570|520415981|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
144331581|NCT02741570|520415980|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
144331582|NCT02741570|520415981|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
144331583|NCT02741570|520415980|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
144331584|NCT02741570|520415981|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
144331585|NCT02741570|520415980|FG000|Pre-Treatment Period|Death|0|||
144331586|NCT02741570|520415981|FG001|Pre-Treatment Period|Death|1|||
144331587|NCT02741570|520415980|FG000|Pre-Treatment Period|Disease progression|0|||
144331588|NCT02741570|520415981|FG001|Pre-Treatment Period|Disease progression|1|||
144331589|NCT02741570|520415980|FG000|Treatment Period|Other reasons|47|||
144331590|NCT02741570|520415981|FG001|Treatment Period|Other reasons|12|||
144331591|NCT02741570|520415980|FG000|Treatment Period|Poor/non-compliance|0|||
144331592|NCT02741570|520415981|FG001|Treatment Period|Poor/non-compliance|2|||
144331593|NCT02741570|520415980|FG000|Treatment Period|Maximum clinical benefit|4|||
144331594|NCT02741570|520415981|FG001|Treatment Period|Maximum clinical benefit|6|||
144331595|NCT02741570|520415980|FG000|Treatment Period|Lost to Follow-up|1|||
144331596|NCT02741570|520415981|FG001|Treatment Period|Lost to Follow-up|3|||
144331597|NCT02741570|520415980|FG000|Treatment Period|Participant withdrew consent|9|||
144331598|NCT02741570|520415981|FG001|Treatment Period|Participant withdrew consent|13|||
144331599|NCT02741570|520415980|FG000|Treatment Period|Participant request to discontinue treatment|8|||
144331600|NCT02741570|520415981|FG001|Treatment Period|Participant request to discontinue treatment|23|||
144331601|NCT02741570|520415980|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
144331602|NCT02741570|520415981|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
144331603|NCT02741570|520415980|FG000|Treatment Period|Death|9|||
144331604|NCT02741570|520415981|FG001|Treatment Period|Death|7|||
144331605|NCT02741570|520415980|FG000|Treatment Period|Study drug toxicity|55|||
144331606|NCT02741570|520415981|FG001|Treatment Period|Study drug toxicity|47|||
144331607|NCT02741570|520415980|FG000|Treatment Period|Disease progression|294|||
144331608|NCT02741570|520415981|FG001|Treatment Period|Disease progression|301|||
144331609|NCT02741570|520415980|FG000|Treatment Period|Administrative reason by sponsor|0|||
144331610|NCT02741570|520415981|FG001|Treatment Period|Administrative reason by sponsor|1|||
144331611|NCT01498185|520415982|FG000|Overall Study|Adverse Event|0|||
144331612|NCT01498185|520415983|FG001|Overall Study|Adverse Event|0|||
144331613|NCT01498185|520415984|FG002|Overall Study|Adverse Event|0|||
144331614|NCT01498185|520415985|FG003|Overall Study|Adverse Event|1|||
144331615|NCT01498185|520415986|FG004|Overall Study|Adverse Event|0|||
144331616|NCT01498185|520415982|FG000|Overall Study|Withdrawal by Subject|1|||
144331617|NCT01498185|520415983|FG001|Overall Study|Withdrawal by Subject|1|||
144331618|NCT01498185|520415984|FG002|Overall Study|Withdrawal by Subject|0|||
144331619|NCT01498185|520415985|FG003|Overall Study|Withdrawal by Subject|2|||
144331620|NCT01498185|520415986|FG004|Overall Study|Withdrawal by Subject|1|||
144331621|NCT01498185|520415982|FG000|Overall Study|No longer met criteria, etc|0|||
144331622|NCT01498185|520415983|FG001|Overall Study|No longer met criteria, etc|0|||
144331623|NCT01498185|520415984|FG002|Overall Study|No longer met criteria, etc|0|||
144331624|NCT01498185|520415985|FG003|Overall Study|No longer met criteria, etc|0|||
144331625|NCT01498185|520415986|FG004|Overall Study|No longer met criteria, etc|2|||
144331626|NCT00946322|520415987|FG000|Pre-treatment|participant failure to follow up|1|||
144331627|NCT00946322|520415987|FG000|Post-treatment|participant failure to follow up|2|||
144331628|NCT04384107|520415993|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
144331629|NCT04384107|520415994|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
144331630|NCT04384107|520415993|FG000|Overall Study|Lost to Follow-up|1|||
144331631|NCT04384107|520415994|FG001|Overall Study|Lost to Follow-up|0|||
144331632|NCT00276614|520415997|FG000|Overall Study|Progression of disease under study|3|||
144331633|NCT02198235|520416004|FG000|Overall Study|Lost to Follow-up|3|||
144331634|NCT02198235|520416005|FG001|Overall Study|Lost to Follow-up|2|||
144331635|NCT02198235|520416006|FG002|Overall Study|Lost to Follow-up|2|||
144331636|NCT04573881|520416008|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
144331637|NCT01999218|520416009|FG000|Overall Study|Hyperglycemia|18|||
144331638|NCT01999218|520416010|FG001|Overall Study|Hyperglycemia|17|||
144331639|NCT01999218|520416011|FG002|Overall Study|Hyperglycemia|17|||
144331640|NCT01999218|520416009|FG000|Overall Study|Lack of Efficacy|1|||
144331641|NCT01999218|520416010|FG001|Overall Study|Lack of Efficacy|0|||
144331642|NCT01999218|520416011|FG002|Overall Study|Lack of Efficacy|1|||
144331643|NCT01999218|520416009|FG000|Overall Study|Lost to Follow-up|22|||
144331644|NCT01999218|520416010|FG001|Overall Study|Lost to Follow-up|17|||
144331645|NCT01999218|520416011|FG002|Overall Study|Lost to Follow-up|18|||
144331646|NCT01999218|520416009|FG000|Overall Study|Non-Compliance With Study Drug|6|||
144331647|NCT01999218|520416010|FG001|Overall Study|Non-Compliance With Study Drug|4|||
144331648|NCT01999218|520416011|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144331649|NCT01999218|520416009|FG000|Overall Study|Physician Decision|1|||
144331650|NCT01999218|520416010|FG001|Overall Study|Physician Decision|4|||
144331651|NCT01999218|520416011|FG002|Overall Study|Physician Decision|6|||
144331652|NCT01999218|520416009|FG000|Overall Study|Protocol Violation|4|||
144331653|NCT01999218|520416010|FG001|Overall Study|Protocol Violation|5|||
144331654|NCT01999218|520416011|FG002|Overall Study|Protocol Violation|4|||
144331655|NCT01999218|520416009|FG000|Overall Study|Screen failure|0|||
144331656|NCT01999218|520416010|FG001|Overall Study|Screen failure|1|||
144331657|NCT01999218|520416011|FG002|Overall Study|Screen failure|0|||
144331658|NCT01999218|520416009|FG000|Overall Study|Study Terminated By Sponsor|7|||
144331659|NCT01999218|520416010|FG001|Overall Study|Study Terminated By Sponsor|5|||
144331660|NCT01999218|520416011|FG002|Overall Study|Study Terminated By Sponsor|12|||
144331661|NCT01999218|520416009|FG000|Overall Study|Participant moves|2|||
144331662|NCT01999218|520416010|FG001|Overall Study|Participant moves|5|||
144331663|NCT01999218|520416011|FG002|Overall Study|Participant moves|3|||
144331664|NCT01999218|520416009|FG000|Overall Study|Withdrawal by Subject|28|||
144331665|NCT01999218|520416010|FG001|Overall Study|Withdrawal by Subject|29|||
144331666|NCT01999218|520416011|FG002|Overall Study|Withdrawal by Subject|34|||
144331667|NCT01999218|520416009|FG000|Overall Study|Creatinine/eGFR|0|||
144331668|NCT01999218|520416010|FG001|Overall Study|Creatinine/eGFR|0|||
144331669|NCT01999218|520416011|FG002|Overall Study|Creatinine/eGFR|1|||
144331670|NCT01999218|520416009|FG000|Overall Study|Death|7|||
144331671|NCT01999218|520416010|FG001|Overall Study|Death|1|||
144331672|NCT01999218|520416011|FG002|Overall Study|Death|2|||
144331673|NCT01999218|520416009|FG000|Overall Study|Excluded Medication|1|||
144331674|NCT01999218|520416010|FG001|Overall Study|Excluded Medication|1|||
144331675|NCT01999218|520416011|FG002|Overall Study|Excluded Medication|2|||
144331676|NCT01999218|520416009|FG000|Overall Study|Adverse Event|9|||
144331677|NCT01999218|520416010|FG001|Overall Study|Adverse Event|7|||
144331678|NCT01999218|520416011|FG002|Overall Study|Adverse Event|7|||
144331679|NCT01999218|520416009|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
144331680|NCT01999218|520416010|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
144331681|NCT01999218|520416011|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
144331682|NCT00664326|520417895|FG000|Overall Study|Adverse Event|14|||
144331683|NCT00664326|520417895|FG000|Overall Study|Noncompliance with study medication|3|||
144331684|NCT00664326|520417895|FG000|Overall Study|Withdrawal by Subject|1|||
144331685|NCT00664326|520417895|FG000|Overall Study|Physician Decision|1|||
144331686|NCT00664326|520417895|FG000|Overall Study|Other Reasons|3|||
144331687|NCT00664326|520417895|FG000|Overall Study|Death|2|||
144331688|NCT00664326|520417895|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
144331689|NCT05079477|520417898|FG000|Overall Study|Lost to Follow-up|2|||
144331690|NCT05079477|520417899|FG001|Overall Study|Lost to Follow-up|0|||
144331691|NCT05079477|520417898|FG000|Overall Study|Withdrawal by Subject|1|||
144331692|NCT05079477|520417899|FG001|Overall Study|Withdrawal by Subject|0|||
144331693|NCT05079477|520417898|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
144331694|NCT05079477|520417899|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
144331695|NCT05079477|520417898|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
144331696|NCT05079477|520417899|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
144331697|NCT03131596|520417902|FG000|Overall Study|Protocol Violation|3|||
144331698|NCT03131596|520417903|FG001|Overall Study|Protocol Violation|3|||
144331699|NCT03131596|520417902|FG000|Overall Study|Lost to Follow-up|3|||
144331700|NCT03131596|520417903|FG001|Overall Study|Lost to Follow-up|0|||
144331701|NCT03654885|520417906|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
144331702|NCT03654885|520417907|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
144331703|NCT03654885|520417906|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
144331704|NCT03654885|520417907|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
144331705|NCT03654885|520417906|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
144331706|NCT03654885|520417907|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
144331707|NCT03654885|520417906|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
144331708|NCT03654885|520417907|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
144331709|NCT03654885|520417906|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
144331710|NCT03654885|520417907|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
144331711|NCT03654885|520417906|FG000|Overall Study|Adverse Event in Study Eye|3|||
144331712|NCT03654885|520417907|FG001|Overall Study|Adverse Event in Study Eye|0|||
144331713|NCT03654885|520417906|FG000|Overall Study|Consent Withdrawn|1|||
144331714|NCT03654885|520417907|FG001|Overall Study|Consent Withdrawn|0|||
144331715|NCT03654885|520417906|FG000|Overall Study|Death|3|||
144331716|NCT03654885|520417907|FG001|Overall Study|Death|1|||
144331717|NCT03654885|520417906|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
144331718|NCT03654885|520417907|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
144331719|NCT03654885|520417906|FG000|Overall Study|Lost to Follow-up|3|||
144331720|NCT03654885|520417907|FG001|Overall Study|Lost to Follow-up|3|||
144331721|NCT05275582|520417908|FG000|Overall Study|Lost to Follow-up|1|||
144331722|NCT05275582|520417909|FG001|Overall Study|Lost to Follow-up|0|||
144331723|NCT05275582|520417908|FG000|Overall Study|Withdrawal by Subject|0|||
144331724|NCT05275582|520417909|FG001|Overall Study|Withdrawal by Subject|2|||
144331725|NCT05275582|520417908|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
144331726|NCT05275582|520417909|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
144331727|NCT05275582|520417908|FG000|Overall Study|Death|1|||
144331728|NCT05275582|520417909|FG001|Overall Study|Death|0|||
144331729|NCT05275582|520417908|FG000|Overall Study|Protocol Violation|1|||
144331730|NCT05275582|520417909|FG001|Overall Study|Protocol Violation|0|||
144331731|NCT03204890|520417914|FG000|Overall Study|Withdrawal by Subject|1|||
144331732|NCT00996801|520417915|FG000|Overall Study|Adverse Event|6|||
144331733|NCT00996801|520417916|FG001|Overall Study|Adverse Event|4|||
144331734|NCT00996801|520417917|FG002|Overall Study|Adverse Event|12|||
144331735|NCT00996801|520417918|FG003|Overall Study|Adverse Event|17|||
144331736|NCT00996801|520417919|FG004|Overall Study|Adverse Event|31|||
144331737|NCT00996801|520417920|FG005|Overall Study|Adverse Event|3|||
144331738|NCT00996801|520417915|FG000|Overall Study|Lack of Efficacy|3|||
144331739|NCT00996801|520417916|FG001|Overall Study|Lack of Efficacy|0|||
144331740|NCT00996801|520417917|FG002|Overall Study|Lack of Efficacy|1|||
144331741|NCT00996801|520417918|FG003|Overall Study|Lack of Efficacy|3|||
144331742|NCT00996801|520417919|FG004|Overall Study|Lack of Efficacy|0|||
144331743|NCT00996801|520417920|FG005|Overall Study|Lack of Efficacy|1|||
144331744|NCT00996801|520417915|FG000|Overall Study|Lost to Follow-up|0|||
144331745|NCT00996801|520417916|FG001|Overall Study|Lost to Follow-up|0|||
144331746|NCT00996801|520417917|FG002|Overall Study|Lost to Follow-up|0|||
144331747|NCT00996801|520417918|FG003|Overall Study|Lost to Follow-up|3|||
144331748|NCT00996801|520417919|FG004|Overall Study|Lost to Follow-up|3|||
144331749|NCT00996801|520417920|FG005|Overall Study|Lost to Follow-up|2|||
144331750|NCT00996801|520417915|FG000|Overall Study|Physician Decision|0|||
144331751|NCT00996801|520417916|FG001|Overall Study|Physician Decision|0|||
144331752|NCT00996801|520417917|FG002|Overall Study|Physician Decision|0|||
144331753|NCT00996801|520417918|FG003|Overall Study|Physician Decision|1|||
144331754|NCT00996801|520417919|FG004|Overall Study|Physician Decision|0|||
144331755|NCT00996801|520417920|FG005|Overall Study|Physician Decision|0|||
144331756|NCT00996801|520417915|FG000|Overall Study|Progressive Disease|0|||
144331757|NCT00996801|520417916|FG001|Overall Study|Progressive Disease|1|||
144331758|NCT00996801|520417917|FG002|Overall Study|Progressive Disease|0|||
144331759|NCT00996801|520417918|FG003|Overall Study|Progressive Disease|0|||
144331760|NCT00996801|520417919|FG004|Overall Study|Progressive Disease|0|||
144331761|NCT00996801|520417920|FG005|Overall Study|Progressive Disease|0|||
144331762|NCT00996801|520417915|FG000|Overall Study|Protocol Violation|3|||
144331763|NCT00996801|520417916|FG001|Overall Study|Protocol Violation|4|||
144331764|NCT00996801|520417917|FG002|Overall Study|Protocol Violation|1|||
144331765|NCT00996801|520417918|FG003|Overall Study|Protocol Violation|2|||
144331766|NCT00996801|520417919|FG004|Overall Study|Protocol Violation|3|||
144331767|NCT00996801|520417920|FG005|Overall Study|Protocol Violation|4|||
144331768|NCT00996801|520417915|FG000|Overall Study|Study Terminated by Sponsor|0|||
144331769|NCT00996801|520417916|FG001|Overall Study|Study Terminated by Sponsor|1|||
144331770|NCT00996801|520417917|FG002|Overall Study|Study Terminated by Sponsor|0|||
144331771|NCT00996801|520417918|FG003|Overall Study|Study Terminated by Sponsor|0|||
144331772|NCT00996801|520417919|FG004|Overall Study|Study Terminated by Sponsor|46|||
144331773|NCT00996801|520417920|FG005|Overall Study|Study Terminated by Sponsor|0|||
144331774|NCT00996801|520417915|FG000|Overall Study|Withdrawal by Subject|8|||
144331775|NCT00996801|520417916|FG001|Overall Study|Withdrawal by Subject|6|||
144331776|NCT00996801|520417917|FG002|Overall Study|Withdrawal by Subject|9|||
144331777|NCT00996801|520417918|FG003|Overall Study|Withdrawal by Subject|5|||
144331778|NCT00996801|520417919|FG004|Overall Study|Withdrawal by Subject|5|||
144331779|NCT00996801|520417920|FG005|Overall Study|Withdrawal by Subject|9|||
144331780|NCT01688739|520417921|FG000|Overall Study|Administrative Decision|1|||
144331781|NCT01688739|520417922|FG001|Overall Study|Administrative Decision|0|||
144331782|NCT01688739|520417923|FG002|Overall Study|Administrative Decision|0|||
144331783|NCT01688739|520417924|FG003|Overall Study|Administrative Decision|0|||
144331784|NCT01688739|520417925|FG004|Overall Study|Administrative Decision|0|||
144331785|NCT01688739|520417926|FG005|Overall Study|Administrative Decision|0|||
144331786|NCT01688739|520417927|FG006|Overall Study|Administrative Decision|0|||
144331787|NCT01688739|520417928|FG007|Overall Study|Administrative Decision|0|||
144331788|NCT01688739|520417929|FG008|Overall Study|Administrative Decision|0|||
144331789|NCT01688739|520417930|FG009|Overall Study|Administrative Decision|0|||
144331790|NCT03369431|520417932|FG000|Overall Study|Lost to Follow-up|1|||
144331791|NCT03369431|520417933|FG001|Overall Study|Lost to Follow-up|3|||
144331792|NCT03369431|520417932|FG000|Overall Study|Withdrawal by Subject|2|||
144331793|NCT03369431|520417933|FG001|Overall Study|Withdrawal by Subject|3|||
144331794|NCT03369431|520417932|FG000|Overall Study|Protocol Violation|1|||
144331795|NCT03369431|520417933|FG001|Overall Study|Protocol Violation|1|||
144331796|NCT01113580|520417936|FG000|Overall Study|Protocol Violation|1|||
144331797|NCT01113580|520417937|FG001|Overall Study|Protocol Violation|0|||
144331798|NCT00293709|520417945|FG000|Overall Study|Other|47|||
144331799|NCT02785458|520417946|FG000|1 Month|Withdrawal by Subject|2|||
144331800|NCT02785458|520417947|FG001|1 Month|Withdrawal by Subject|1|||
144331801|NCT02785458|520417946|FG000|1 Month|Lost to Follow-up|38|||
144331802|NCT02785458|520417947|FG001|1 Month|Lost to Follow-up|31|||
144331803|NCT02785458|520417946|FG000|1 Month|Deemed Ineligible|1|||
144331804|NCT02785458|520417947|FG001|1 Month|Deemed Ineligible|0|||
144331805|NCT02785458|520417946|FG000|1 Month|Completed Evaluation by Baseline|42|||
144331806|NCT02785458|520417947|FG001|1 Month|Completed Evaluation by Baseline|39|||
144331807|NCT02785458|520417946|FG000|1 Month|Partial Interview|0|||
144331808|NCT02785458|520417947|FG001|1 Month|Partial Interview|4|||
144331809|NCT02785458|520417946|FG000|3 Months|Withdrawal by Subject|3|||
144331810|NCT02785458|520417947|FG001|3 Months|Withdrawal by Subject|1|||
144331811|NCT02785458|520417946|FG000|3 Months|Lost to Follow-up|25|||
144331812|NCT02785458|520417947|FG001|3 Months|Lost to Follow-up|21|||
144331813|NCT02785458|520417946|FG000|3 Months|Completed Evaluation at 1 Month|100|||
144331814|NCT02785458|520417947|FG001|3 Months|Completed Evaluation at 1 Month|89|||
144331815|NCT01146652|520417948|FG000|Overall Study|Adverse Event|506|||
144331816|NCT01146652|520417949|FG001|Overall Study|Adverse Event|15|||
144331817|NCT01146652|520417948|FG000|Overall Study|Lack of Efficacy|91|||
144331818|NCT01146652|520417949|FG001|Overall Study|Lack of Efficacy|7|||
144331819|NCT01146652|520417948|FG000|Overall Study|Poor compliance to protocol|38|||
144331820|NCT01146652|520417949|FG001|Overall Study|Poor compliance to protocol|1|||
144331821|NCT01146652|520417948|FG000|Overall Study|Other unspecified reasons|314|||
144331822|NCT01146652|520417949|FG001|Overall Study|Other unspecified reasons|22|||
144331823|NCT01146652|520417948|FG000|Overall Study|Enrolled but not treated|2|||
144331824|NCT01146652|520417949|FG001|Overall Study|Enrolled but not treated|0|||
144331825|NCT02118597|520417951|FG000|Overall Study|Sponsor terminated the study|14|||
144331826|NCT02118597|520417951|FG000|Overall Study|Serious Adverse Event|1|||
144331827|NCT02118597|520417951|FG000|Overall Study|Investigator's decision|1|||
144331828|NCT02590562|520417956|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
144331829|NCT00824005|520417957|FG000|Overall Study|Death|0|||
144331830|NCT00824005|520417958|FG001|Overall Study|Death|1|||
144331831|NCT00824005|520417957|FG000|Overall Study|Lost to Follow-up|0|||
144331832|NCT00824005|520417958|FG001|Overall Study|Lost to Follow-up|1|||
144331833|NCT01866423|520417959|FG000|Overall Study|Lack of Efficacy|3|||
144331834|NCT01866423|520417959|FG000|Overall Study|Sponsor Decision|1|||
144331835|NCT02699450|520417960|FG000|Overall Study|Death|2|||
144331836|NCT02699450|520417961|FG001|Overall Study|Death|1|||
144331837|NCT02699450|520417962|FG002|Overall Study|Death|2|||
144331838|NCT02699450|520417960|FG000|Overall Study|Met Criteria for Study Exit|0|||
144331839|NCT02699450|520417961|FG001|Overall Study|Met Criteria for Study Exit|0|||
144331840|NCT02699450|520417962|FG002|Overall Study|Met Criteria for Study Exit|1|||
144331841|NCT02699450|520417960|FG000|Overall Study|Protocol Violation|4|||
144331842|NCT02699450|520417961|FG001|Overall Study|Protocol Violation|3|||
144331843|NCT02699450|520417962|FG002|Overall Study|Protocol Violation|5|||
144331844|NCT02699450|520417960|FG000|Overall Study|Lost to Follow-up|3|||
144331845|NCT02699450|520417961|FG001|Overall Study|Lost to Follow-up|0|||
144331846|NCT02699450|520417962|FG002|Overall Study|Lost to Follow-up|5|||
144331847|NCT02699450|520417960|FG000|Overall Study|Physician Decision|2|||
144331848|NCT02699450|520417961|FG001|Overall Study|Physician Decision|0|||
144331849|NCT02699450|520417962|FG002|Overall Study|Physician Decision|0|||
144331850|NCT02699450|520417960|FG000|Overall Study|Withdrawal by Subject|3|||
144331851|NCT02699450|520417961|FG001|Overall Study|Withdrawal by Subject|1|||
144331852|NCT02699450|520417962|FG002|Overall Study|Withdrawal by Subject|2|||
144331853|NCT02699450|520417960|FG000|Overall Study|Adverse Event|1|||
144331854|NCT02699450|520417961|FG001|Overall Study|Adverse Event|0|||
144331855|NCT02699450|520417962|FG002|Overall Study|Adverse Event|0|||
144331856|NCT01995552|520417963|FG000|Overall Study|Protocol Violation|1|||
144331857|NCT01995552|520417963|FG000|Overall Study|Lack of Efficacy|15|||
144331858|NCT01995552|520417963|FG000|Overall Study|Death|1|||
144331859|NCT02068118|520417967|FG000|18-month Comparative Study Period|Death|90|||
144331860|NCT02068118|520417968|FG001|18-month Comparative Study Period|Death|97|||
144331861|NCT02068118|520417967|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
144331862|NCT02068118|520417968|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
144331863|NCT02068118|520417967|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
144331864|NCT02068118|520417968|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
144331865|NCT02068118|520417967|FG000|18-month Comparative Study Period|Heart transplant|9|||
144331866|NCT02068118|520417968|FG001|18-month Comparative Study Period|Heart transplant|15|||
144331867|NCT02068118|520417967|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
144331868|NCT02068118|520417968|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
144331869|NCT02068118|520417967|FG000|18-month Comparative Study Period|Hemiplegia|0|||
144331870|NCT02068118|520417968|FG001|18-month Comparative Study Period|Hemiplegia|1|||
144331871|NCT02068118|520417967|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
144331872|NCT02068118|520417968|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
144331873|NCT02068118|520417967|FG000|18-month Comparative Study Period|Move|0|||
144331874|NCT02068118|520417968|FG001|18-month Comparative Study Period|Move|1|||
144331875|NCT02068118|520417967|FG000|18-month Comparative Study Period|Hearing loss|0|||
144331876|NCT02068118|520417968|FG001|18-month Comparative Study Period|Hearing loss|1|||
144331877|NCT02068118|520417967|FG000|Extension Period|Death|0|||
144331878|NCT02068118|520417968|FG001|Extension Period|Death|2|||
144331879|NCT02068118|520417967|FG000|Extension Period|Withdrawal by Subject|1|||
144331880|NCT02068118|520417968|FG001|Extension Period|Withdrawal by Subject|0|||
144331881|NCT02068118|520417967|FG000|Extension Period|Heart transplant|1|||
144331882|NCT02068118|520417968|FG001|Extension Period|Heart transplant|0|||
144331883|NCT02068118|520417967|FG000|Extension Period|Wrong device use|0|||
144331884|NCT02068118|520417968|FG001|Extension Period|Wrong device use|1|||
144331885|NCT00334282|520417969|FG000|Overall Study|Lost to Follow-up|11|||
144331886|NCT00334282|520417970|FG001|Overall Study|Lost to Follow-up|5|||
144331887|NCT00334282|520417969|FG000|Overall Study|Withdrawal by Subject|17|||
144331888|NCT00334282|520417970|FG001|Overall Study|Withdrawal by Subject|3|||
144331889|NCT00334282|520417969|FG000|Overall Study|Death|194|||
144331890|NCT00334282|520417970|FG001|Overall Study|Death|100|||
144331891|NCT00283868|520417971|FG000|Overall Study|Lost to Follow-up|7|||
144331892|NCT00283868|520417972|FG001|Overall Study|Lost to Follow-up|8|||
144331893|NCT01515475|520417973|FG000|Overall Study|Lost to Follow-up|20|||
144331894|NCT01515475|520417974|FG001|Overall Study|Lost to Follow-up|15|||
144331895|NCT01515475|520417975|FG002|Overall Study|Lost to Follow-up|12|||
144331896|NCT01515475|520417976|FG003|Overall Study|Lost to Follow-up|12|||
144331897|NCT01420627|520417978|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
144331898|NCT01996592|520417986|FG000|Overall Study|no response to text/no diary entry|32|||
144331899|NCT01996592|520417986|FG000|Overall Study|change in surgical date|4|||
144331900|NCT01996592|520417986|FG000|Overall Study|Withdrawal by Subject|5|||
144331901|NCT01996592|520417986|FG000|Overall Study|change in mode of delivery|4|||
144331902|NCT01886690|520417994|FG000|Overall Study|Protocol Violation|0|||
144331903|NCT01886690|520417995|FG001|Overall Study|Protocol Violation|1|||
144331904|NCT01886690|520417994|FG000|Overall Study|Personal Reasons|0|||
144331905|NCT01886690|520417995|FG001|Overall Study|Personal Reasons|1|||
144331906|NCT03077698|520417996|FG000|Progestin Monotherapy|Stable Disease|8|||
144331907|NCT03077698|520417997|FG001|Progestin Monotherapy|Stable Disease|0|||
144331908|NCT03077698|520417996|FG000|Progestin Monotherapy|Adverse Event|1|||
144331909|NCT03077698|520417997|FG001|Progestin Monotherapy|Adverse Event|0|||
144331910|NCT03077698|520417996|FG000|Progestin Monotherapy|Death|1|||
144331911|NCT03077698|520417997|FG001|Progestin Monotherapy|Death|0|||
144331912|NCT03077698|520417996|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
144331913|NCT03077698|520417997|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
144331914|NCT03077698|520417996|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
144331915|NCT03077698|520417997|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
144331916|NCT03077698|520417996|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
144331917|NCT03077698|520417997|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
144331918|NCT03077698|520417996|FG000|Safety Follow Up|Withdrawal by Subject|2|||
144331919|NCT03077698|520417997|FG001|Safety Follow Up|Withdrawal by Subject|1|||
144331920|NCT03077698|520417996|FG000|Safety Follow Up|Transfer of care to hospice|1|||
144331921|NCT03077698|520417997|FG001|Safety Follow Up|Transfer of care to hospice|0|||
144331922|NCT01873729|520418002|FG000|Overall Study|Withdrawal by Subject|1|||
144331923|NCT01066780|520418003|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
144331924|NCT01066780|520418004|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
144331925|NCT01827332|520418006|FG000|Overall Study|Lost to Follow-up|2|||
144331926|NCT01827332|520418007|FG001|Overall Study|Lost to Follow-up|1|||
144331927|NCT03352453|520418010|FG000|Overall Study|Miscellaneous Reasons|1|||
144331928|NCT03352453|520418011|FG001|Overall Study|Miscellaneous Reasons|2|||
144331929|NCT03352453|520418010|FG000|Overall Study|Lack of Efficacy|1|||
144331930|NCT03352453|520418011|FG001|Overall Study|Lack of Efficacy|0|||
144331931|NCT03352453|520418010|FG000|Overall Study|Withdrawal by Subject|8|||
144331932|NCT03352453|520418011|FG001|Overall Study|Withdrawal by Subject|14|||
144331933|NCT03352453|520418010|FG000|Overall Study|Study Terminated by Sponsor|2|||
144331934|NCT03352453|520418011|FG001|Overall Study|Study Terminated by Sponsor|1|||
144331935|NCT03352453|520418010|FG000|Overall Study|Protocol Deviation|1|||
144331936|NCT03352453|520418011|FG001|Overall Study|Protocol Deviation|0|||
144331937|NCT03352453|520418010|FG000|Overall Study|Lost to Follow-up|7|||
144331938|NCT03352453|520418011|FG001|Overall Study|Lost to Follow-up|6|||
144331939|NCT03352453|520418010|FG000|Overall Study|Adverse Event|2|||
144331940|NCT03352453|520418011|FG001|Overall Study|Adverse Event|9|||
144331941|NCT01241760|520418012|FG000|Overall Study|Adverse Event|1|||
144331942|NCT01241760|520418013|FG001|Overall Study|Adverse Event|0|||
144331943|NCT01241760|520418012|FG000|Overall Study|Lost to Follow-up|18|||
144331944|NCT01241760|520418013|FG001|Overall Study|Lost to Follow-up|22|||
144331945|NCT01241760|520418012|FG000|Overall Study|Withdrawal by Subject|13|||
144331946|NCT01241760|520418013|FG001|Overall Study|Withdrawal by Subject|13|||
144331947|NCT01241760|520418012|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
144331948|NCT01241760|520418013|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
144331949|NCT01241760|520418012|FG000|Overall Study|Other|1|||
144331950|NCT01241760|520418013|FG001|Overall Study|Other|1|||
144331951|NCT00514020|520418014|FG000|Overall Study|Adverse Event|6|||
144331952|NCT00514020|520418014|FG000|Overall Study|Withdrawal by Subject|3|||
144331953|NCT00514020|520418014|FG000|Overall Study|Physician Decision|1|||
144331954|NCT00514020|520418014|FG000|Overall Study|disease progression|9|||
144331955|NCT00514020|520418014|FG000|Overall Study|other complicating disease|2|||
144331956|NCT00514020|520418014|FG000|Overall Study|patient went to radiation treatment|1|||
144331957|NCT00514020|520418014|FG000|Overall Study|"patients moved to the no tx group"|6|||
144331958|NCT02725593|520418015|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
144331959|NCT02725593|520418016|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
144331960|NCT02725593|520418015|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
144331961|NCT02725593|520418016|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
144331962|NCT02725593|520418015|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
144331963|NCT02725593|520418016|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
144331964|NCT02725593|520418015|FG000|Long Term Extension|Withdrawal by Subject|1|||
144331965|NCT02725593|520418016|FG001|Long Term Extension|Withdrawal by Subject|3|||
144331966|NCT01688921|520418017|FG000|Overall Study|Lost to Follow-up|7|||
144331967|NCT01688921|520418018|FG001|Overall Study|Lost to Follow-up|13|||
144331968|NCT01688921|520418017|FG000|Overall Study|Physician Decision|6|||
144331969|NCT01688921|520418018|FG001|Overall Study|Physician Decision|1|||
144331970|NCT01688921|520418017|FG000|Overall Study|Protocol Violation|0|||
144331971|NCT01688921|520418018|FG001|Overall Study|Protocol Violation|1|||
144331972|NCT01688921|520418017|FG000|Overall Study|informed consent|3|||
144331973|NCT01688921|520418018|FG001|Overall Study|informed consent|0|||
144331974|NCT00459537|520418032|FG000|Overall Study|Adverse Event|1|||
144331975|NCT00459537|520418033|FG001|Overall Study|Adverse Event|6|||
144331976|NCT00459537|520418032|FG000|Overall Study|Lack of Efficacy|10|||
144331977|NCT00459537|520418033|FG001|Overall Study|Lack of Efficacy|11|||
144331978|NCT00459537|520418032|FG000|Overall Study|Withdrawal by Subject|20|||
144331979|NCT00459537|520418033|FG001|Overall Study|Withdrawal by Subject|26|||
144331980|NCT00459537|520418032|FG000|Overall Study|Lost to Follow-up|27|||
144331981|NCT00459537|520418033|FG001|Overall Study|Lost to Follow-up|30|||
144331982|NCT00459537|520418032|FG000|Overall Study|Administrative problems|3|||
144331983|NCT00459537|520418033|FG001|Overall Study|Administrative problems|0|||
144331984|NCT00459537|520418032|FG000|Overall Study|Protocol Violation|4|||
144331985|NCT00459537|520418033|FG001|Overall Study|Protocol Violation|3|||
144331986|NCT00459537|520418032|FG000|Overall Study|Missing|1|||
144331987|NCT00459537|520418033|FG001|Overall Study|Missing|0|||
144331988|NCT01831817|520418034|FG000|Overall Study|Lost to Follow-up|1|||
144331989|NCT01831817|520418035|FG001|Overall Study|Lost to Follow-up|0|||
144331990|NCT01831817|520418036|FG002|Overall Study|Lost to Follow-up|0|||
144331991|NCT01831817|520418037|FG003|Overall Study|Lost to Follow-up|0|||
144331992|NCT01831817|520418034|FG000|Overall Study|Withdrawl of Consent|3|||
144331993|NCT01831817|520418035|FG001|Overall Study|Withdrawl of Consent|0|||
144331994|NCT01831817|520418036|FG002|Overall Study|Withdrawl of Consent|0|||
144331995|NCT01831817|520418037|FG003|Overall Study|Withdrawl of Consent|0|||
144331996|NCT03159104|520418038|FG000|Overall Study|Violation of inclusion criteria|1|||
144331997|NCT03159104|520418039|FG001|Overall Study|Violation of inclusion criteria|2|||
144331998|NCT00958217|520418040|FG000|Overall Study|Death|2|||
144331999|NCT00958217|520418041|FG001|Overall Study|Death|1|||
144332000|NCT00958217|520418040|FG000|Overall Study|Withdrawal by Subject|4|||
144332001|NCT00958217|520418041|FG001|Overall Study|Withdrawal by Subject|3|||
144332002|NCT00958217|520418040|FG000|Overall Study|Lost to Follow-up|17|||
144332003|NCT00958217|520418041|FG001|Overall Study|Lost to Follow-up|19|||
144332004|NCT00958217|520418040|FG000|Overall Study|Moved out of area|1|||
144332005|NCT00958217|520418041|FG001|Overall Study|Moved out of area|1|||
144332006|NCT00958217|520418040|FG000|Overall Study|Inpatient hospitalization|0|||
144332007|NCT00958217|520418041|FG001|Overall Study|Inpatient hospitalization|1|||
144332008|NCT03647267|520419613|FG000|Overall Study|Lost to Follow-up|1|||
144332009|NCT03647267|520419614|FG001|Overall Study|Lost to Follow-up|0|||
144332010|NCT00004445|520419615|FG000|Overall Study|Physician Decision|2|||
144332011|NCT00004445|520419615|FG000|Overall Study|Withdrawal by Subject|1|||
144332012|NCT02753127|520419616|FG000|Overall Study|Lost to Follow-up|13|||
144332013|NCT02753127|520419617|FG001|Overall Study|Lost to Follow-up|11|||
144332014|NCT02753127|520419616|FG000|Overall Study|Withdrawal by Subject|37|||
144332015|NCT02753127|520419617|FG001|Overall Study|Withdrawal by Subject|47|||
144332016|NCT02753127|520419616|FG000|Overall Study|Other|3|||
144332017|NCT02753127|520419617|FG001|Overall Study|Other|8|||
144332018|NCT02753127|520419616|FG000|Overall Study|Hospice|0|||
144332019|NCT02753127|520419617|FG001|Overall Study|Hospice|2|||
144332020|NCT02677844|520419620|FG000|Period 3|Withdrawal by Subject|0|||
144332021|NCT02677844|520419621|FG001|Period 3|Withdrawal by Subject|0|||
144332022|NCT02677844|520419622|FG002|Period 3|Withdrawal by Subject|0|||
144332023|NCT02677844|520419623|FG003|Period 3|Withdrawal by Subject|1|||
144332024|NCT02677844|520419624|FG004|Period 3|Withdrawal by Subject|0|||
144332025|NCT02677844|520419625|FG005|Period 3|Withdrawal by Subject|0|||
144332026|NCT02677844|520419626|FG006|Period 3|Withdrawal by Subject|0|||
144332027|NCT03458702|520419627|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
144332028|NCT03458702|520419628|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
144332029|NCT03458702|520419627|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
144332030|NCT03458702|520419628|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
144332031|NCT01390779|520419629|FG000|Overall Study|Physician Decision|1|||
144332032|NCT01697462|520419630|FG000|Overall Study|Disease Progression|1|||
144332033|NCT01697462|520419630|FG000|Overall Study|Adverse Event|6|||
144332034|NCT01697462|520419630|FG000|Overall Study|Lost to Follow-up|21|||
144332035|NCT01697462|520419630|FG000|Overall Study|Withdrawal by Subject|12|||
144332036|NCT01697462|520419630|FG000|Overall Study|Investigator Decision|21|||
144332037|NCT01697462|520419630|FG000|Overall Study|Death|1|||
144332038|NCT01697462|520419630|FG000|Overall Study|Other|10|||
144332039|NCT01697462|520419630|FG000|Overall Study|Missing|5|||
144332040|NCT00168103|520419631|FG000|Overall Study|Withdrawal by Subject|1|||
144332041|NCT00168103|520419632|FG001|Overall Study|Withdrawal by Subject|2|||
144332042|NCT00168103|520419633|FG002|Overall Study|Withdrawal by Subject|1|||
144332043|NCT00168103|520419634|FG003|Overall Study|Withdrawal by Subject|0|||
144332044|NCT00168103|520419631|FG000|Overall Study|Lost to Follow-up|1|||
144332045|NCT00168103|520419632|FG001|Overall Study|Lost to Follow-up|3|||
144332046|NCT00168103|520419633|FG002|Overall Study|Lost to Follow-up|0|||
144332047|NCT00168103|520419634|FG003|Overall Study|Lost to Follow-up|0|||
144332048|NCT00545532|520419635|FG000|Overall Study|Withdrawal by Subject|1|||
144332049|NCT00545532|520419636|FG001|Overall Study|Withdrawal by Subject|3|||
144332050|NCT00545532|520419635|FG000|Overall Study|Lost to Follow-up|5|||
144332051|NCT00545532|520419636|FG001|Overall Study|Lost to Follow-up|6|||
144332052|NCT00545532|520419635|FG000|Overall Study|Death|0|||
144332053|NCT00545532|520419636|FG001|Overall Study|Death|1|||
144332054|NCT03630302|520419637|FG000|Surgery|hardware issue prevented LFP recordings|1|||
144332055|NCT03630302|520419637|FG000|3 Month Visit|Adverse Event|2|||
144332056|NCT03630302|520419637|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
144332057|NCT03532932|520419641|FG000|Overall Study|Protocol Deviation|33|||
144332058|NCT03532932|520419642|FG001|Overall Study|Protocol Deviation|31|||
144332059|NCT03532932|520419641|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
144332060|NCT03532932|520419642|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
144332061|NCT03532932|520419641|FG000|Overall Study|Withdrawal by Subject|2|||
144332062|NCT03532932|520419642|FG001|Overall Study|Withdrawal by Subject|0|||
144332063|NCT03532932|520419641|FG000|Overall Study|Lost to Follow-up|15|||
144332064|NCT03532932|520419642|FG001|Overall Study|Lost to Follow-up|9|||
144332065|NCT03532932|520419641|FG000|Overall Study|Adverse Event|4|||
144332066|NCT03532932|520419642|FG001|Overall Study|Adverse Event|3|||
144332067|NCT03532932|520419641|FG000|Overall Study|Death|0|||
144332068|NCT03532932|520419642|FG001|Overall Study|Death|2|||
144332069|NCT03532932|520419641|FG000|Overall Study|Other|11|||
144332070|NCT03532932|520419642|FG001|Overall Study|Other|16|||
144332071|NCT00931801|520419646|FG000|Overall Study|Adverse Event|0|||
144332072|NCT00931801|520419647|FG001|Overall Study|Adverse Event|0|||
144332073|NCT00931801|520419648|FG002|Overall Study|Adverse Event|1|||
144332074|NCT00931801|520419646|FG000|Overall Study|Lost to Follow-up|0|||
144332075|NCT00931801|520419647|FG001|Overall Study|Lost to Follow-up|1|||
144332076|NCT00931801|520419648|FG002|Overall Study|Lost to Follow-up|0|||
144332077|NCT00931801|520419646|FG000|Overall Study|Withdrawal by Subject|1|||
144332078|NCT00931801|520419647|FG001|Overall Study|Withdrawal by Subject|0|||
144332079|NCT00931801|520419648|FG002|Overall Study|Withdrawal by Subject|0|||
144332080|NCT00931801|520419646|FG000|Overall Study|Confirmed Virologic Failure|0|||
144332081|NCT00931801|520419647|FG001|Overall Study|Confirmed Virologic Failure|0|||
144332082|NCT00931801|520419648|FG002|Overall Study|Confirmed Virologic Failure|3|||
144332083|NCT03283150|520419649|FG000|Overall Study|Withdrawal by Subject|6|||
144332084|NCT03283150|520419650|FG001|Overall Study|Withdrawal by Subject|0|||
144332085|NCT03283150|520419651|FG002|Overall Study|Withdrawal by Subject|0|||
144332086|NCT01133275|520419652|FG000|Overall Study|Withdrawal by Subject|1|||
144332087|NCT01133275|520419652|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
144332088|NCT01028716|520419653|FG000|Overall Study|Physician Decision|1|||
144332089|NCT01143896|520419654|FG000|Overall Study|Did not complete Baseline Interview|5|||
144332090|NCT01143896|520419655|FG001|Overall Study|Did not complete Baseline Interview|4|||
144332091|NCT01143896|520419654|FG000|Overall Study|Lost to Follow-up|18|||
144332092|NCT01143896|520419655|FG001|Overall Study|Lost to Follow-up|13|||
144332093|NCT01143896|520419654|FG000|Overall Study|Withdrawal by Subject|13|||
144332094|NCT01143896|520419655|FG001|Overall Study|Withdrawal by Subject|5|||
144332095|NCT01143896|520419654|FG000|Overall Study|Death|6|||
144332096|NCT01143896|520419655|FG001|Overall Study|Death|3|||
144332097|NCT04375397|520419658|FG000|Overall Study|Death|1|||
144332098|NCT04375397|520419659|FG001|Overall Study|Death|1|||
144332099|NCT04375397|520419658|FG000|Overall Study|Withdrew consent|2|||
144332100|NCT04375397|520419659|FG001|Overall Study|Withdrew consent|0|||
144332101|NCT04375397|520419658|FG000|Overall Study|Lost to Follow-up|6|||
144332102|NCT04375397|520419659|FG001|Overall Study|Lost to Follow-up|4|||
144332103|NCT04375397|520419658|FG000|Overall Study|Other, not specified|0|||
144332104|NCT04375397|520419659|FG001|Overall Study|Other, not specified|1|||
144332105|NCT00086502|520419660|FG000|Overall Study|Adverse Event|11|||
144332106|NCT00086502|520419661|FG001|Overall Study|Adverse Event|2|||
144332107|NCT00086502|520419660|FG000|Overall Study|Lack of Efficacy|0|||
144332108|NCT00086502|520419661|FG001|Overall Study|Lack of Efficacy|2|||
144332109|NCT00086502|520419660|FG000|Overall Study|Lost to Follow-up|3|||
144332110|NCT00086502|520419661|FG001|Overall Study|Lost to Follow-up|1|||
144332111|NCT00086502|520419660|FG000|Overall Study|Physician Decision|1|||
144332112|NCT00086502|520419661|FG001|Overall Study|Physician Decision|1|||
144332113|NCT00086502|520419660|FG000|Overall Study|Pregnancy|0|||
144332114|NCT00086502|520419661|FG001|Overall Study|Pregnancy|1|||
144332115|NCT00086502|520419660|FG000|Overall Study|Protocol Violation|3|||
144332116|NCT00086502|520419661|FG001|Overall Study|Protocol Violation|3|||
144332117|NCT00086502|520419660|FG000|Overall Study|Withdrawal by Subject|5|||
144332118|NCT00086502|520419661|FG001|Overall Study|Withdrawal by Subject|6|||
144332119|NCT00086502|520419660|FG000|Overall Study|Patient Moved|1|||
144332120|NCT00086502|520419661|FG001|Overall Study|Patient Moved|1|||
144332121|NCT00086502|520419660|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
144332122|NCT00086502|520419661|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
144332123|NCT00086502|520419660|FG000|Overall Study|Patient Accidentally Unblinded|1|||
144332124|NCT00086502|520419661|FG001|Overall Study|Patient Accidentally Unblinded|0|||
144332125|NCT05545644|520419663|FG000|Overall Study|Lost to Follow-up|4|||
144332126|NCT05545644|520419664|FG001|Overall Study|Lost to Follow-up|3|||
144332127|NCT00610441|520419665|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
144332128|NCT00610441|520419666|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
144332129|NCT00610441|520419667|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
144332130|NCT00610441|520419668|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
144332131|NCT00610441|520419665|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
144332132|NCT00610441|520419666|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
144332133|NCT00610441|520419667|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
144332134|NCT00610441|520419668|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
144332135|NCT00610441|520419665|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
144332136|NCT00610441|520419666|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
144332137|NCT00610441|520419667|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
144332138|NCT00610441|520419668|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
144332139|NCT00610441|520419665|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
144332140|NCT00610441|520419666|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
144332141|NCT00610441|520419667|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
144332142|NCT00610441|520419668|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
144332143|NCT00610441|520419665|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
144332144|NCT00610441|520419666|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
144332145|NCT00610441|520419667|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
144332146|NCT00610441|520419668|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
144332147|NCT00610441|520419665|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
144332148|NCT00610441|520419666|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
144332149|NCT00610441|520419667|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
144332150|NCT00610441|520419668|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
144332151|NCT00610441|520419665|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
144332152|NCT00610441|520419666|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
144332153|NCT00610441|520419667|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
144332154|NCT00610441|520419668|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
144332155|NCT00610441|520419665|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
144332156|NCT00610441|520419666|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
144332157|NCT00610441|520419667|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
144332158|NCT00610441|520419668|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
144332159|NCT00610441|520419665|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
144332160|NCT00610441|520419666|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
144332161|NCT00610441|520419667|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
144332162|NCT00610441|520419668|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
144332163|NCT01842581|520419674|FG000|Overall Study|Adverse Event|6|||
144332164|NCT01842581|520419675|FG001|Overall Study|Adverse Event|4|||
144332165|NCT01842581|520419674|FG000|Overall Study|HE breakthrough|26|||
144332166|NCT01842581|520419675|FG001|Overall Study|HE breakthrough|13|||
144332167|NCT01842581|520419674|FG000|Overall Study|Liver transplant|2|||
144332168|NCT01842581|520419675|FG001|Overall Study|Liver transplant|0|||
144332169|NCT01842581|520419674|FG000|Overall Study|Lost to Follow-up|2|||
144332170|NCT01842581|520419675|FG001|Overall Study|Lost to Follow-up|5|||
144332171|NCT01842581|520419674|FG000|Overall Study|Withdrawal by Subject|5|||
144332172|NCT01842581|520419675|FG001|Overall Study|Withdrawal by Subject|7|||
144332173|NCT01842581|520419674|FG000|Overall Study|Other than specified|3|||
144332174|NCT01842581|520419675|FG001|Overall Study|Other than specified|1|||
144332175|NCT01287195|520419678|FG000|Overall Study|Withdrawal by Subject|2|||
144332176|NCT00837876|520419679|FG000|Overall Study|Death|2|||
144332177|NCT00837876|520419679|FG000|Overall Study|Adverse Event|7|||
144332178|NCT00837876|520419679|FG000|Overall Study|Physician Decision|1|||
144332179|NCT00837876|520419679|FG000|Overall Study|Withdrawal by Subject|3|||
144332180|NCT00837876|520419679|FG000|Overall Study|disease progression|24|||
144332181|NCT00453973|520419681|FG000|Overall Study|Adverse Event|4|||
144332182|NCT00453973|520419682|FG001|Overall Study|Adverse Event|9|||
144332183|NCT00453973|520419681|FG000|Overall Study|Withdrawal by Subject|7|||
144332184|NCT00453973|520419682|FG001|Overall Study|Withdrawal by Subject|6|||
144332185|NCT00453973|520419681|FG000|Overall Study|PI Decision|0|||
144332186|NCT00453973|520419682|FG001|Overall Study|PI Decision|2|||
144332187|NCT00453973|520419681|FG000|Overall Study|Relocation|1|||
144332188|NCT00453973|520419682|FG001|Overall Study|Relocation|0|||
144332189|NCT00453973|520419681|FG000|Overall Study|Renal transplant|1|||
144332190|NCT00453973|520419682|FG001|Overall Study|Renal transplant|1|||
144332191|NCT00453973|520419681|FG000|Overall Study|Site closed by sponsor|3|||
144332192|NCT00453973|520419682|FG001|Overall Study|Site closed by sponsor|0|||
144332193|NCT00453973|520419681|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
144332194|NCT00453973|520419682|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
144332195|NCT00870194|520419683|FG000|Overall Study|Adverse Event|10|||
144332196|NCT00870194|520419684|FG001|Overall Study|Adverse Event|5|||
144332197|NCT00870194|520419683|FG000|Overall Study|Lack of Efficacy|0|||
144332198|NCT00870194|520419684|FG001|Overall Study|Lack of Efficacy|1|||
144332199|NCT00870194|520419683|FG000|Overall Study|Lost to Follow-up|2|||
144332200|NCT00870194|520419684|FG001|Overall Study|Lost to Follow-up|0|||
144332201|NCT00870194|520419683|FG000|Overall Study|Physician Decision|3|||
144332202|NCT00870194|520419684|FG001|Overall Study|Physician Decision|1|||
144332203|NCT00870194|520419683|FG000|Overall Study|Protocol Violation|3|||
144332204|NCT00870194|520419684|FG001|Overall Study|Protocol Violation|3|||
144332205|NCT00870194|520419683|FG000|Overall Study|Entry Criteria Not Met|1|||
144332206|NCT00870194|520419684|FG001|Overall Study|Entry Criteria Not Met|2|||
144332207|NCT00870194|520419683|FG000|Overall Study|Subject Decision|7|||
144332208|NCT00870194|520419684|FG001|Overall Study|Subject Decision|2|||
144332209|NCT04957758|520419685|FG000|Overall Study|Adverse Event|1|||
144332210|NCT04957758|520419686|FG001|Overall Study|Adverse Event|0|||
144332211|NCT04957758|520419685|FG000|Overall Study|Lost to Follow-up|0|||
144332212|NCT04957758|520419686|FG001|Overall Study|Lost to Follow-up|2|||
144332213|NCT04957758|520419685|FG000|Overall Study|Withdrawal by Subject|4|||
144332214|NCT04957758|520419686|FG001|Overall Study|Withdrawal by Subject|2|||
144332215|NCT04957758|520419685|FG000|Overall Study|Protocol Violation|0|||
144332216|NCT04957758|520419686|FG001|Overall Study|Protocol Violation|1|||
144332217|NCT00707746|520419687|FG000|Treatment Period|Adverse Event|2|||
144332218|NCT00707746|520419688|FG001|Treatment Period|Adverse Event|4|||
144332219|NCT00707746|520419687|FG000|Treatment Period|Ineligibility|0|||
144332220|NCT00707746|520419688|FG001|Treatment Period|Ineligibility|1|||
144332221|NCT01685983|520419690|FG000|Overall Study|Adverse Event|7|||
144332222|NCT01685983|520419690|FG000|Overall Study|Death|1|||
144332223|NCT01685983|520419690|FG000|Overall Study|Withdrawal by Subject|19|||
144332224|NCT01685983|520419690|FG000|Overall Study|Protocol Violation|2|||
144332225|NCT01685983|520419690|FG000|Overall Study|Physician Decision|13|||
144332226|NCT01685983|520419690|FG000|Overall Study|Other|7|||
144332227|NCT01685983|520419690|FG000|Overall Study|Progressive Disease|32|||
144332228|NCT01685983|520419690|FG000|Overall Study|Noncompliance with Study Drug|1|||
144332229|NCT00364533|520419691|FG000|Overall Study|Adverse Event|8|||
144332230|NCT00364533|520419692|FG001|Overall Study|Adverse Event|7|||
144332231|NCT00364533|520419693|FG002|Overall Study|Adverse Event|15|||
144332232|NCT00364533|520419694|FG003|Overall Study|Adverse Event|5|||
144332233|NCT00364533|520419695|FG004|Overall Study|Adverse Event|2|||
144332234|NCT00364533|520419691|FG000|Overall Study|Withdrawal by Subject|4|||
144332235|NCT00364533|520419692|FG001|Overall Study|Withdrawal by Subject|8|||
144332236|NCT00364533|520419693|FG002|Overall Study|Withdrawal by Subject|6|||
144332237|NCT00364533|520419694|FG003|Overall Study|Withdrawal by Subject|6|||
144332238|NCT00364533|520419695|FG004|Overall Study|Withdrawal by Subject|6|||
144332239|NCT00364533|520419691|FG000|Overall Study|Lack of Efficacy|22|||
144332240|NCT00364533|520419692|FG001|Overall Study|Lack of Efficacy|22|||
144332241|NCT00364533|520419693|FG002|Overall Study|Lack of Efficacy|21|||
144332242|NCT00364533|520419694|FG003|Overall Study|Lack of Efficacy|17|||
144332243|NCT00364533|520419695|FG004|Overall Study|Lack of Efficacy|42|||
144332244|NCT00364533|520419691|FG000|Overall Study|Subject discharged from hospital|4|||
144332245|NCT00364533|520419692|FG001|Overall Study|Subject discharged from hospital|1|||
144332246|NCT00364533|520419693|FG002|Overall Study|Subject discharged from hospital|2|||
144332247|NCT00364533|520419694|FG003|Overall Study|Subject discharged from hospital|3|||
144332248|NCT00364533|520419695|FG004|Overall Study|Subject discharged from hospital|1|||
144332249|NCT00364533|520419691|FG000|Overall Study|Variations in drug compliance|2|||
144332250|NCT00364533|520419692|FG001|Overall Study|Variations in drug compliance|1|||
144332251|NCT00364533|520419693|FG002|Overall Study|Variations in drug compliance|1|||
144332252|NCT00364533|520419694|FG003|Overall Study|Variations in drug compliance|0|||
144332253|NCT00364533|520419695|FG004|Overall Study|Variations in drug compliance|0|||
144332254|NCT00364533|520419691|FG000|Overall Study|Non-compliance|1|||
144332255|NCT00364533|520419692|FG001|Overall Study|Non-compliance|0|||
144332256|NCT00364533|520419693|FG002|Overall Study|Non-compliance|0|||
144332257|NCT00364533|520419694|FG003|Overall Study|Non-compliance|0|||
144332258|NCT00364533|520419695|FG004|Overall Study|Non-compliance|0|||
144332259|NCT00364533|520419691|FG000|Overall Study|Protocol Violation|1|||
144332260|NCT00364533|520419692|FG001|Overall Study|Protocol Violation|1|||
144332261|NCT00364533|520419693|FG002|Overall Study|Protocol Violation|0|||
144332262|NCT00364533|520419694|FG003|Overall Study|Protocol Violation|0|||
144332263|NCT00364533|520419695|FG004|Overall Study|Protocol Violation|0|||
144332264|NCT00582738|520419696|FG000|Overall Study|Administrative Problems|7|||
144332265|NCT00582738|520419697|FG001|Overall Study|Administrative Problems|8|||
144332266|NCT00582738|520419696|FG000|Overall Study|Adverse Event|0|||
144332267|NCT00582738|520419697|FG001|Overall Study|Adverse Event|5|||
144332268|NCT00582738|520419696|FG000|Overall Study|Graft Lost|0|||
144332269|NCT00582738|520419697|FG001|Overall Study|Graft Lost|1|||
144332270|NCT00582738|520419696|FG000|Overall Study|Other|1|||
144332271|NCT00582738|520419697|FG001|Overall Study|Other|0|||
144332272|NCT00582738|520419696|FG000|Overall Study|Protocol Violation|1|||
144332273|NCT00582738|520419697|FG001|Overall Study|Protocol Violation|1|||
144332274|NCT00582738|520419696|FG000|Overall Study|Withdrawal by Subject|0|||
144332275|NCT00582738|520419697|FG001|Overall Study|Withdrawal by Subject|3|||
144332276|NCT02758301|520419698|FG000|Overall Study|Death|12|||
144332277|NCT02758301|520419699|FG001|Overall Study|Death|0|||
144332278|NCT02758301|520419698|FG000|Overall Study|Physician Decision|10|||
144332279|NCT02758301|520419699|FG001|Overall Study|Physician Decision|1|||
144332280|NCT02758301|520419698|FG000|Overall Study|Withdrawal by Subject|5|||
144332281|NCT02758301|520419699|FG001|Overall Study|Withdrawal by Subject|6|||
144332282|NCT02758301|520419698|FG000|Overall Study|Lost to Follow-up|7|||
144332283|NCT02758301|520419699|FG001|Overall Study|Lost to Follow-up|0|||
144332284|NCT02758301|520419698|FG000|Overall Study|Protocol Violation|0|||
144332285|NCT02758301|520419699|FG001|Overall Study|Protocol Violation|1|||
144332286|NCT02642965|520419701|FG000|Overall Study|Lack of Efficacy|4|||
144332287|NCT02642965|520419701|FG000|Overall Study|Physician Decision|9|||
144332288|NCT01167907|520419703|FG000|Overall Study|Protocol Violation|1|||
144332289|NCT01167907|520419704|FG001|Overall Study|Protocol Violation|0|||
144332290|NCT01167907|520419703|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
144332291|NCT01167907|520419704|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
144332292|NCT01011933|520419705|FG000|Overall Study|Wrong cell type|1|||
144332293|NCT01011933|520419705|FG000|Overall Study|Improper pre-protocol Rx|1|||
144332294|NCT01011933|520419705|FG000|Overall Study|Inadequate pathology|1|||
144332295|NCT01011933|520419705|FG000|Overall Study|Never treated|1|||
144332296|NCT03461406|520419706|FG000|Overall Study|Death|1|||
144332297|NCT03461406|520419707|FG001|Overall Study|Death|2|||
144332298|NCT03461406|520419706|FG000|Overall Study|Consent Withdrawn by Participant|0|||
144332299|NCT03461406|520419707|FG001|Overall Study|Consent Withdrawn by Participant|1|||
144332300|NCT03461406|520419706|FG000|Overall Study|Screen Failure|3|||
144332301|NCT03461406|520419707|FG001|Overall Study|Screen Failure|1|||
144332302|NCT03461406|520419706|FG000|Overall Study|Reason not Specified|1|||
144332303|NCT03461406|520419707|FG001|Overall Study|Reason not Specified|3|||
144332304|NCT03461406|520419706|FG000|Overall Study|Lost to Follow-up|3|||
144332305|NCT03461406|520419707|FG001|Overall Study|Lost to Follow-up|0|||
144332306|NCT01439074|520419708|FG000|Overall Study|Lost to Follow-up|3|||
144332307|NCT01439074|520419709|FG001|Overall Study|Lost to Follow-up|4|||
144332308|NCT01439074|520419708|FG000|Overall Study|Subject shedding|1|||
144332309|NCT01439074|520419709|FG001|Overall Study|Subject shedding|0|||
144332310|NCT01439074|520419708|FG000|Overall Study|Withdrawal by Subject|1|||
144332311|NCT01439074|520419709|FG001|Overall Study|Withdrawal by Subject|5|||
144332312|NCT01439074|520419708|FG000|Overall Study|Other|4|||
144332313|NCT01439074|520419709|FG001|Overall Study|Other|4|||
144332314|NCT01140568|520419710|FG000|Overall Study|disease progression|31|||
144332315|NCT01140568|520419710|FG000|Overall Study|Withdrawal by Subject|1|||
144332316|NCT01140568|520419710|FG000|Overall Study|Screen Fail|4|||
144332317|NCT00815191|520419711|FG000|Overall Study|Protocol Violation|1|||
144332318|NCT00815191|520419712|FG001|Overall Study|Protocol Violation|1|||
144332319|NCT00493636|520419713|FG000|Overall Study|Withdrawal by Subject|1|||
144332320|NCT00493636|520419714|FG001|Overall Study|Withdrawal by Subject|0|||
144332321|NCT00493636|520419713|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
144332322|NCT00493636|520419714|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
144332323|NCT00493636|520419713|FG000|Overall Study|Mis-randomization|1|||
144332324|NCT00493636|520419714|FG001|Overall Study|Mis-randomization|1|||
144332325|NCT02012686|520419715|FG000|Overall Study|muscle contraction|0|||
144332326|NCT02012686|520419716|FG001|Overall Study|muscle contraction|1|||
144332327|NCT02012686|520419715|FG000|Overall Study|electrocardiography monitoring noise|0|||
144332328|NCT02012686|520419716|FG001|Overall Study|electrocardiography monitoring noise|1|||
144332329|NCT03099148|520419717|FG000|Wash-out|scheduling conflict|0|||
144332330|NCT03099148|520419718|FG001|Wash-out|scheduling conflict|1|||
144332331|NCT03099148|520419719|FG002|Wash-out|scheduling conflict|0|||
144332332|NCT03099148|520419720|FG003|Wash-out|scheduling conflict|0|||
144332333|NCT03099148|520419717|FG000|Wash-out|Adverse Event|0|||
144332334|NCT03099148|520419718|FG001|Wash-out|Adverse Event|1|||
144332335|NCT03099148|520419719|FG002|Wash-out|Adverse Event|0|||
144332336|NCT03099148|520419720|FG003|Wash-out|Adverse Event|0|||
144332337|NCT00966719|520419721|FG000|Overall Study|Lost to Follow-up|6|||
144332338|NCT00966719|520419722|FG001|Overall Study|Lost to Follow-up|11|||
144332339|NCT03089944|520419725|FG000|Overall Study|Lost to Follow-up|8|||
144332340|NCT03089944|520419725|FG000|Overall Study|Withdrew Consent|2|||
144332341|NCT03089944|520419725|FG000|Overall Study|Adverse Event|1|||
144332342|NCT03089944|520419725|FG000|Overall Study|Other|1|||
144332343|NCT01636713|520419726|FG000|Overall Study|Adverse Event|16|||
144332344|NCT01636713|520419727|FG001|Overall Study|Adverse Event|16|||
144332345|NCT01636713|520419728|FG002|Overall Study|Adverse Event|7|||
144332346|NCT01636713|520419726|FG000|Overall Study|Lack of Efficacy|6|||
144332347|NCT01636713|520419727|FG001|Overall Study|Lack of Efficacy|6|||
144332348|NCT01636713|520419728|FG002|Overall Study|Lack of Efficacy|2|||
144332349|NCT01636713|520419726|FG000|Overall Study|Protocol Violation|3|||
144332350|NCT01636713|520419727|FG001|Overall Study|Protocol Violation|0|||
144332351|NCT01636713|520419728|FG002|Overall Study|Protocol Violation|1|||
144332352|NCT01636713|520419726|FG000|Overall Study|Lost to Follow-up|0|||
144332353|NCT01636713|520419727|FG001|Overall Study|Lost to Follow-up|0|||
144332354|NCT01636713|520419728|FG002|Overall Study|Lost to Follow-up|1|||
144332355|NCT01636713|520419726|FG000|Overall Study|Withdrawal by Subject|5|||
144332356|NCT01636713|520419727|FG001|Overall Study|Withdrawal by Subject|4|||
144332357|NCT01636713|520419728|FG002|Overall Study|Withdrawal by Subject|8|||
144332358|NCT01636713|520419726|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
144332359|NCT01636713|520419727|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
144332360|NCT01636713|520419728|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
144332361|NCT03689244|520419729|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
144332362|NCT03689244|520419730|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
144332363|NCT03689244|520419731|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
144332364|NCT03689244|520419732|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
144332365|NCT03689244|520419729|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
144332366|NCT03689244|520419730|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
144332367|NCT03689244|520419731|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
144332368|NCT03689244|520419732|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
144332369|NCT03689244|520419729|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
144332370|NCT03689244|520419730|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
144332371|NCT03689244|520419731|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
144332372|NCT03689244|520419732|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
144332373|NCT03689244|520419729|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
144332374|NCT03689244|520419730|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
144332375|NCT03689244|520419731|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
144332376|NCT03689244|520419732|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
144332377|NCT03689244|520419729|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
144332378|NCT03689244|520419730|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
144332379|NCT03689244|520419731|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
144332380|NCT03689244|520419732|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
144332381|NCT03689244|520419729|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
144332382|NCT03689244|520419730|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
144332383|NCT03689244|520419731|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
144332384|NCT03689244|520419732|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
144332385|NCT03689244|520419729|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
144332386|NCT03689244|520419730|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
144332387|NCT03689244|520419731|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
144332388|NCT03689244|520419732|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
144332389|NCT03689244|520419729|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
144332390|NCT03689244|520419730|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
144332391|NCT03689244|520419731|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
144332392|NCT03689244|520419732|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
144332393|NCT01490294|520419740|FG000|Overall Study|Prematurely discontinuation|4|||
144332394|NCT01490294|520419741|FG001|Overall Study|Prematurely discontinuation|0|||
144332395|NCT01490294|520419742|FG002|Overall Study|Prematurely discontinuation|1|||
144332396|NCT01490294|520419743|FG003|Overall Study|Prematurely discontinuation|1|||
144332397|NCT01490294|520419740|FG000|Overall Study|Adverse Event|1|||
144332398|NCT01490294|520419741|FG001|Overall Study|Adverse Event|0|||
144332399|NCT01490294|520419742|FG002|Overall Study|Adverse Event|0|||
144332400|NCT01490294|520419743|FG003|Overall Study|Adverse Event|0|||
144332401|NCT01751776|520419746|FG000|Overall Study|Adverse Event|0|||
144332402|NCT01751776|520419747|FG001|Overall Study|Adverse Event|0|||
144332403|NCT01751776|520419748|FG002|Overall Study|Adverse Event|0|||
144332404|NCT01751776|520419749|FG003|Overall Study|Adverse Event|0|||
144332405|NCT01751776|520419750|FG004|Overall Study|Adverse Event|0|||
144332406|NCT01751776|520419751|FG005|Overall Study|Adverse Event|0|||
144332407|NCT01751776|520419752|FG006|Overall Study|Adverse Event|4|||
144332408|NCT01751776|520419753|FG007|Overall Study|Adverse Event|2|||
144332409|NCT01751776|520419746|FG000|Overall Study|Consent withdrawn|0|||
144332410|NCT01751776|520419747|FG001|Overall Study|Consent withdrawn|0|||
144332411|NCT01751776|520419748|FG002|Overall Study|Consent withdrawn|0|||
144332412|NCT01751776|520419749|FG003|Overall Study|Consent withdrawn|0|||
144332413|NCT01751776|520419750|FG004|Overall Study|Consent withdrawn|0|||
144332414|NCT01751776|520419751|FG005|Overall Study|Consent withdrawn|0|||
144332415|NCT01751776|520419752|FG006|Overall Study|Consent withdrawn|0|||
144332416|NCT01751776|520419753|FG007|Overall Study|Consent withdrawn|1|||
144332417|NCT01751776|520419746|FG000|Overall Study|Other reason not specified above|0|||
144332418|NCT01751776|520419747|FG001|Overall Study|Other reason not specified above|0|||
144332419|NCT01751776|520419748|FG002|Overall Study|Other reason not specified above|0|||
144332420|NCT01751776|520419749|FG003|Overall Study|Other reason not specified above|0|||
144332421|NCT01751776|520419750|FG004|Overall Study|Other reason not specified above|0|||
144332422|NCT01751776|520419751|FG005|Overall Study|Other reason not specified above|0|||
144332423|NCT01751776|520419752|FG006|Overall Study|Other reason not specified above|0|||
144332424|NCT01751776|520419753|FG007|Overall Study|Other reason not specified above|1|||
144332425|NCT00160654|520419754|FG000|Overall Study|Adverse Event|14|||
144332426|NCT00160654|520419754|FG000|Overall Study|Lack of Efficacy|4|||
144332427|NCT00160654|520419754|FG000|Overall Study|Lost to Follow-up|2|||
144332428|NCT00160654|520419754|FG000|Overall Study|Intake of expired drug|7|||
144332429|NCT00160654|520419754|FG000|Overall Study|Psychological trauma|1|||
144332430|NCT00160654|520419754|FG000|Overall Study|Sponsor decision|1|||
144332431|NCT00160654|520419754|FG000|Overall Study|Patient met exclusion criteria|1|||
144332432|NCT00160654|520419754|FG000|Overall Study|Patient decision|1|||
144332433|NCT00160654|520419754|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
144332434|NCT00160654|520419754|FG000|Overall Study|Met exclusion criteria|1|||
144332435|NCT02644356|520419755|FG000|Overall Study|Withdrawal by Subject|2|||
144332436|NCT02210091|520419757|FG000|Overall Study|Physician Decision|0|||
144332437|NCT02210091|520419758|FG001|Overall Study|Physician Decision|1|||
144332438|NCT02210091|520419757|FG000|Overall Study|Withdrawal by Sponsor|0|||
144332439|NCT02210091|520419758|FG001|Overall Study|Withdrawal by Sponsor|1|||
144332440|NCT01711866|520419759|FG000|Overall Study|Noncompliant|3|||
144332441|NCT01711866|520419759|FG000|Overall Study|Withdrawal by Subject|3|||
144332442|NCT01711866|520419759|FG000|Overall Study|Adverse Event|2|||
144332443|NCT00897390|520419760|FG000|Overall Study|Adverse Event|2|||
144332444|NCT00897390|520419760|FG000|Overall Study|No Longer Met Study Criteria|1|||
144332445|NCT00897390|520419760|FG000|Overall Study|Personal Reasons|1|||
144332446|NCT00897390|520419760|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
144332447|NCT00546260|520419765|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
144332448|NCT00546260|520419766|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
144332449|NCT03780959|520419767|FG000|Part 1|Adverse Event|1|||
144332450|NCT03780959|520419768|FG001|Part 1|Adverse Event|0|||
144332451|NCT03780959|520419769|FG002|Part 1|Adverse Event|0|||
144332452|NCT03780959|520419767|FG000|Part 1|Withdrawal by Subject|1|||
144332453|NCT03780959|520419768|FG001|Part 1|Withdrawal by Subject|0|||
144332454|NCT03780959|520419769|FG002|Part 1|Withdrawal by Subject|0|||
144332455|NCT03780959|520419767|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
144332456|NCT03780959|520419768|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
144332457|NCT03780959|520419769|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
144332458|NCT03780959|520419767|FG000|Part 1|Response Status|2|||
144332459|NCT03780959|520419768|FG001|Part 1|Response Status|0|||
144332460|NCT03780959|520419769|FG002|Part 1|Response Status|0|||
144332461|NCT03780959|520419767|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
144332462|NCT03780959|520419768|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
144332463|NCT03780959|520419769|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
144332464|NCT03780959|520419767|FG000|Part 2|Response Status|0|||
144332465|NCT03780959|520419768|FG001|Part 2|Response Status|18|||
144332466|NCT03780959|520419769|FG002|Part 2|Response Status|6|||
144332467|NCT04938037|520421390|FG000|Overall Study|Lost to Follow-up|4|||
144332468|NCT04938037|520421391|FG001|Overall Study|Lost to Follow-up|3|||
144332469|NCT03323736|520421392|FG000|Overall Study|Screen Failure|14|||
144332470|NCT03323736|520421393|FG001|Overall Study|Screen Failure|9|||
144332471|NCT03323736|520421394|FG002|Overall Study|Screen Failure|1|||
144332472|NCT03323736|520421392|FG000|Overall Study|Withdrawal Before Treatment|3|||
144332473|NCT03323736|520421393|FG001|Overall Study|Withdrawal Before Treatment|1|||
144332474|NCT03323736|520421394|FG002|Overall Study|Withdrawal Before Treatment|1|||
144332475|NCT03323736|520421392|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
144332476|NCT03323736|520421393|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
144332477|NCT03323736|520421394|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
144332478|NCT01549873|520421396|FG000|Overall Study|Physician Decision|0|||
144332479|NCT01549873|520421397|FG001|Overall Study|Physician Decision|1|||
144332480|NCT02804750|520421409|FG000|Period 1|Adverse Event|0|||
144332481|NCT02804750|520421410|FG001|Period 1|Adverse Event|2|||
144332482|NCT02804750|520421409|FG000|Period 1|Withdrawal by Subject|0|||
144332483|NCT02804750|520421410|FG001|Period 1|Withdrawal by Subject|1|||
144332484|NCT02804750|520421409|FG000|Period 2|Adverse Event|1|||
144332485|NCT02804750|520421410|FG001|Period 2|Adverse Event|0|||
144332486|NCT02804750|520421409|FG000|Period 3|Adverse Event|0|||
144332487|NCT02804750|520421410|FG001|Period 3|Adverse Event|2|||
144332488|NCT02804750|520421409|FG000|Period 4|Adverse Event|0|||
144332489|NCT02804750|520421410|FG001|Period 4|Adverse Event|5|||
144332490|NCT02559414|520421411|FG000|Overall Study|Lost to Follow-up|0|||
144332491|NCT02559414|520421412|FG001|Overall Study|Lost to Follow-up|1|||
144332492|NCT02559414|520421413|FG002|Overall Study|Lost to Follow-up|0|||
144332493|NCT02559414|520421411|FG000|Overall Study|Withdrawal by Subject|1|||
144332494|NCT02559414|520421412|FG001|Overall Study|Withdrawal by Subject|0|||
144332495|NCT02559414|520421413|FG002|Overall Study|Withdrawal by Subject|1|||
144332496|NCT02559414|520421411|FG000|Overall Study|Other|0|||
144332497|NCT02559414|520421412|FG001|Overall Study|Other|1|||
144332498|NCT02559414|520421413|FG002|Overall Study|Other|1|||
144332499|NCT00940485|520421421|FG000|Overall Study|HBeAb positive at Baseline|3|||
144332500|NCT00940485|520421422|FG001|Overall Study|HBeAb positive at Baseline|2|||
144332501|NCT00940485|520421421|FG000|Overall Study|Lost to Follow-up|2|||
144332502|NCT00940485|520421422|FG001|Overall Study|Lost to Follow-up|3|||
144332503|NCT00940485|520421421|FG000|Overall Study|Adverse Event|8|||
144332504|NCT00940485|520421422|FG001|Overall Study|Adverse Event|0|||
144332505|NCT00940485|520421421|FG000|Overall Study|Withdrawal by Subject|1|||
144332506|NCT00940485|520421422|FG001|Overall Study|Withdrawal by Subject|1|||
144332507|NCT00940485|520421421|FG000|Overall Study|Others|1|||
144332508|NCT00940485|520421422|FG001|Overall Study|Others|1|||
144332509|NCT04271475|520421423|FG000|DB Period: Day 1 up to EODBT|Death|1|||
144332510|NCT04271475|520421424|FG001|DB Period: Day 1 up to EODBT|Death|0|||
144332511|NCT04271475|520421425|FG002|DB Period: Day 1 up to EODBT|Death|0|||
144332512|NCT04271475|520421426|FG003|DB Period: Day 1 up to EODBT|Death|0|||
144332513|NCT04271475|520421423|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
144332514|NCT04271475|520421424|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
144332515|NCT04271475|520421425|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
144332516|NCT04271475|520421426|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
144332517|NCT04271475|520421423|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
144332518|NCT04271475|520421424|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
144332519|NCT04271475|520421425|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
144332520|NCT04271475|520421426|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
144332521|NCT04271475|520421423|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
144332522|NCT04271475|520421424|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
144332523|NCT04271475|520421425|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
144332524|NCT04271475|520421426|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
144332525|NCT04271475|520421423|FG000|DB Period: Day 1 up to EODBT|Other|8|||
144332526|NCT04271475|520421424|FG001|DB Period: Day 1 up to EODBT|Other|5|||
144332527|NCT04271475|520421425|FG002|DB Period: Day 1 up to EODBT|Other|0|||
144332528|NCT04271475|520421426|FG003|DB Period: Day 1 up to EODBT|Other|0|||
144332529|NCT04271475|520421423|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
144332530|NCT04271475|520421424|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
144332531|NCT04271475|520421425|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
144332532|NCT04271475|520421426|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
144332533|NCT04271475|520421423|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
144332534|NCT04271475|520421424|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
144332535|NCT04271475|520421425|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
144332536|NCT04271475|520421426|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
144332537|NCT06250738|520421427|FG000|Overall Study|Lost to Follow-up|1|||
144332538|NCT02936284|520421429|FG000|Overall Study|Withdrawal by Subject|3|||
144332539|NCT02936284|520421430|FG001|Overall Study|Withdrawal by Subject|1|||
144332540|NCT02936284|520421429|FG000|Overall Study|Lost to Follow-up|7|||
144332541|NCT02936284|520421430|FG001|Overall Study|Lost to Follow-up|8|||
144332542|NCT04619004|520421433|FG000|Overall Study|Death|114|||
144332543|NCT04619004|520421434|FG001|Overall Study|Death|28|||
144332544|NCT04619004|520421433|FG000|Overall Study|Lost to Follow-up|1|||
144332545|NCT04619004|520421434|FG001|Overall Study|Lost to Follow-up|1|||
144332546|NCT04619004|520421433|FG000|Overall Study|Withdrawal by Subject|24|||
144332547|NCT04619004|520421434|FG001|Overall Study|Withdrawal by Subject|7|||
144332548|NCT04619004|520421433|FG000|Overall Study|Other - Not specified|0|||
144332549|NCT04619004|520421434|FG001|Overall Study|Other - Not specified|1|||
144332550|NCT01114360|520421442|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
144332551|NCT01114360|520421443|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
144332552|NCT03106415|520421444|FG000|Phase 1|Withdrawal by Subject|1|||
144332553|NCT03106415|520421445|FG001|Phase 1|Withdrawal by Subject|0|||
144332554|NCT03106415|520421446|FG002|Phase 1|Withdrawal by Subject|0|||
144332555|NCT03106415|520421444|FG000|Phase 1|Adverse Event|1|||
144332556|NCT03106415|520421445|FG001|Phase 1|Adverse Event|1|||
144332557|NCT03106415|520421446|FG002|Phase 1|Adverse Event|0|||
144332558|NCT03106415|520421444|FG000|Phase 1|Protocol Violation|0|||
144332559|NCT03106415|520421445|FG001|Phase 1|Protocol Violation|1|||
144332560|NCT03106415|520421446|FG002|Phase 1|Protocol Violation|0|||
144332561|NCT01804582|520421451|FG000|Overall Study|Lost to Follow-up|47|||
144332562|NCT01804582|520421452|FG001|Overall Study|Lost to Follow-up|56|||
144332563|NCT01804582|520421451|FG000|Overall Study|Physician Decision|2|||
144332564|NCT01804582|520421452|FG001|Overall Study|Physician Decision|0|||
144332565|NCT02981524|520421453|FG000|Overall Study|Progressive Disease|14|||
144332566|NCT02981524|520421453|FG000|Overall Study|Death (unrelated)|1|||
144332567|NCT02981524|520421453|FG000|Overall Study|Treatment Related Toxicity|1|||
144332568|NCT02981524|520421453|FG000|Overall Study|Withdrawal by Subject|1|||
144332569|NCT00159913|520421457|FG000|Overall Study|Adverse Event|1|||
144332570|NCT00159913|520421458|FG001|Overall Study|Adverse Event|0|||
144332571|NCT00159913|520421459|FG002|Overall Study|Adverse Event|1|||
144332572|NCT00159913|520421460|FG003|Overall Study|Adverse Event|0|||
144332573|NCT00159913|520421457|FG000|Overall Study|Withdrawal by Subject|0|||
144332574|NCT00159913|520421458|FG001|Overall Study|Withdrawal by Subject|0|||
144332575|NCT00159913|520421459|FG002|Overall Study|Withdrawal by Subject|0|||
144332576|NCT00159913|520421460|FG003|Overall Study|Withdrawal by Subject|1|||
144332577|NCT00159913|520421457|FG000|Overall Study|Lost to Follow-up|0|||
144332578|NCT00159913|520421458|FG001|Overall Study|Lost to Follow-up|0|||
144332579|NCT00159913|520421459|FG002|Overall Study|Lost to Follow-up|0|||
144332580|NCT00159913|520421460|FG003|Overall Study|Lost to Follow-up|1|||
144332581|NCT00159913|520421457|FG000|Overall Study|Protocol Violation|1|||
144332582|NCT00159913|520421458|FG001|Overall Study|Protocol Violation|0|||
144332583|NCT00159913|520421459|FG002|Overall Study|Protocol Violation|1|||
144332584|NCT00159913|520421460|FG003|Overall Study|Protocol Violation|0|||
144332585|NCT01146288|520421461|FG000|First Intervention(1 Day)|Adverse Event|0|||
144332586|NCT01146288|520421462|FG001|First Intervention(1 Day)|Adverse Event|1|||
144332587|NCT00385723|520421463|FG000|Overall Study|Lost to Follow-up|1|||
144332588|NCT00385723|520421464|FG001|Overall Study|Lost to Follow-up|1|||
144332589|NCT00385723|520421465|FG002|Overall Study|Lost to Follow-up|0|||
144332590|NCT00385723|520421463|FG000|Overall Study|Withdrawal by Subject|1|||
144332591|NCT00385723|520421464|FG001|Overall Study|Withdrawal by Subject|0|||
144332592|NCT00385723|520421465|FG002|Overall Study|Withdrawal by Subject|2|||
144332593|NCT03455829|520421466|FG000|Overall Study|Death|2|||
144332594|NCT03455829|520421467|FG001|Overall Study|Death|3|||
144332595|NCT03455829|520421468|FG002|Overall Study|Death|2|||
144332596|NCT03455829|520421469|FG003|Overall Study|Death|4|||
144332597|NCT03455829|520421470|FG004|Overall Study|Death|2|||
144332598|NCT03455829|520421466|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
144332599|NCT03455829|520421467|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
144332600|NCT03455829|520421468|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
144332601|NCT03455829|520421469|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
144332602|NCT03455829|520421470|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
144332603|NCT03455829|520421466|FG000|Overall Study|Disease progression|0|||
144332604|NCT03455829|520421467|FG001|Overall Study|Disease progression|0|||
144332605|NCT03455829|520421468|FG002|Overall Study|Disease progression|0|||
144332606|NCT03455829|520421469|FG003|Overall Study|Disease progression|1|||
144332607|NCT03455829|520421470|FG004|Overall Study|Disease progression|1|||
144332608|NCT00875056|520421473|FG000|Overall Study|Adverse Event|6|||
144332609|NCT00875056|520421474|FG001|Overall Study|Adverse Event|1|||
144332610|NCT00875056|520421475|FG002|Overall Study|Adverse Event|2|||
144332611|NCT00875056|520421473|FG000|Overall Study|Progressive Disease|14|||
144332612|NCT00875056|520421474|FG001|Overall Study|Progressive Disease|8|||
144332613|NCT00875056|520421475|FG002|Overall Study|Progressive Disease|3|||
144332614|NCT00875056|520421473|FG000|Overall Study|Withdrawal by Subject|3|||
144332615|NCT00875056|520421474|FG001|Overall Study|Withdrawal by Subject|0|||
144332616|NCT00875056|520421475|FG002|Overall Study|Withdrawal by Subject|1|||
144332617|NCT01318070|520421476|FG000|Overall Study|Adverse Event|1|||
144332618|NCT01318070|520421477|FG001|Overall Study|Adverse Event|1|||
144332619|NCT01318070|520421478|FG002|Overall Study|Adverse Event|5|||
144332620|NCT01318070|520421476|FG000|Overall Study|Withdrawal by Subject|0|||
144332621|NCT01318070|520421477|FG001|Overall Study|Withdrawal by Subject|1|||
144332622|NCT01318070|520421478|FG002|Overall Study|Withdrawal by Subject|1|||
144332623|NCT01318070|520421476|FG000|Overall Study|Lack of Efficacy|0|||
144332624|NCT01318070|520421477|FG001|Overall Study|Lack of Efficacy|0|||
144332625|NCT01318070|520421478|FG002|Overall Study|Lack of Efficacy|1|||
144332626|NCT01318070|520421476|FG000|Overall Study|Principal Investigator Discretion|1|||
144332627|NCT01318070|520421477|FG001|Overall Study|Principal Investigator Discretion|0|||
144332628|NCT01318070|520421478|FG002|Overall Study|Principal Investigator Discretion|0|||
144332629|NCT01443130|520421479|FG000|Overall Study|Lost to Follow-up|44|||
144332630|NCT01443130|520421480|FG001|Overall Study|Lost to Follow-up|42|||
144332631|NCT01443130|520421481|FG002|Overall Study|Lost to Follow-up|50|||
144332632|NCT01443130|520421482|FG003|Overall Study|Lost to Follow-up|23|||
144332633|NCT01443130|520421483|FG004|Overall Study|Lost to Follow-up|25|||
144332634|NCT01443130|520421484|FG005|Overall Study|Lost to Follow-up|21|||
144332635|NCT01443130|520421479|FG000|Overall Study|Death|0|||
144332636|NCT01443130|520421480|FG001|Overall Study|Death|1|||
144332637|NCT01443130|520421481|FG002|Overall Study|Death|0|||
144332638|NCT01443130|520421482|FG003|Overall Study|Death|7|||
144332639|NCT01443130|520421483|FG004|Overall Study|Death|10|||
144332640|NCT01443130|520421484|FG005|Overall Study|Death|8|||
144332641|NCT01443130|520421479|FG000|Overall Study|Adverse Event|2|||
144332642|NCT01443130|520421480|FG001|Overall Study|Adverse Event|1|||
144332643|NCT01443130|520421481|FG002|Overall Study|Adverse Event|1|||
144332644|NCT01443130|520421482|FG003|Overall Study|Adverse Event|0|||
144332645|NCT01443130|520421483|FG004|Overall Study|Adverse Event|0|||
144332646|NCT01443130|520421484|FG005|Overall Study|Adverse Event|0|||
144332647|NCT01443130|520421479|FG000|Overall Study|Protocol Violation|2|||
144332648|NCT01443130|520421480|FG001|Overall Study|Protocol Violation|1|||
144332649|NCT01443130|520421481|FG002|Overall Study|Protocol Violation|3|||
144332650|NCT01443130|520421482|FG003|Overall Study|Protocol Violation|2|||
144332651|NCT01443130|520421483|FG004|Overall Study|Protocol Violation|2|||
144332652|NCT01443130|520421484|FG005|Overall Study|Protocol Violation|3|||
144332653|NCT01443130|520421479|FG000|Overall Study|Withdrawal by Subject|15|||
144332654|NCT01443130|520421480|FG001|Overall Study|Withdrawal by Subject|14|||
144332655|NCT01443130|520421481|FG002|Overall Study|Withdrawal by Subject|12|||
144332656|NCT01443130|520421482|FG003|Overall Study|Withdrawal by Subject|7|||
144332657|NCT01443130|520421483|FG004|Overall Study|Withdrawal by Subject|7|||
144332658|NCT01443130|520421484|FG005|Overall Study|Withdrawal by Subject|2|||
144332659|NCT01443130|520421479|FG000|Overall Study|Death of Subject's Infant|5|||
144332660|NCT01443130|520421480|FG001|Overall Study|Death of Subject's Infant|10|||
144332661|NCT01443130|520421481|FG002|Overall Study|Death of Subject's Infant|11|||
144332662|NCT01443130|520421482|FG003|Overall Study|Death of Subject's Infant|0|||
144332663|NCT01443130|520421483|FG004|Overall Study|Death of Subject's Infant|0|||
144332664|NCT01443130|520421484|FG005|Overall Study|Death of Subject's Infant|0|||
144332665|NCT02900170|520421489|FG000|Overall Study|Lost to Follow-up|8|||
144332666|NCT03553498|520421494|FG000|Overall Study|Missing primary outcome|1|||
144332667|NCT03553498|520421495|FG001|Overall Study|Missing primary outcome|2|||
144332668|NCT04941807|520421496|FG000|Overall Study|Lost to Follow-up|1|||
144332669|NCT04941807|520421497|FG001|Overall Study|Lost to Follow-up|1|||
144332670|NCT01703065|520421498|FG000|Overall Study|Lack of Efficacy|1|||
144332671|NCT01703065|520421499|FG001|Overall Study|Lack of Efficacy|0|||
144332672|NCT01100567|520421500|FG000|Overall Study|Withdrawal by Subject|5|||
144332673|NCT01100567|520421501|FG001|Overall Study|Withdrawal by Subject|8|||
144332674|NCT01100567|520421500|FG000|Overall Study|Early Hospital Discharge|6|||
144332675|NCT01100567|520421501|FG001|Overall Study|Early Hospital Discharge|4|||
144332676|NCT01100567|520421500|FG000|Overall Study|Lost to Follow-up|1|||
144332677|NCT01100567|520421501|FG001|Overall Study|Lost to Follow-up|2|||
144332678|NCT01100567|520421500|FG000|Overall Study|Physician Decision|0|||
144332679|NCT01100567|520421501|FG001|Overall Study|Physician Decision|1|||
144332680|NCT01100567|520421500|FG000|Overall Study|Deemed ineligible after consent|0|||
144332681|NCT01100567|520421501|FG001|Overall Study|Deemed ineligible after consent|1|||
144332682|NCT00160199|520421504|FG000|Overall Study|Adverse Event|5|||
144332683|NCT00160199|520421505|FG001|Overall Study|Adverse Event|14|||
144332684|NCT00160199|520421504|FG000|Overall Study|Lack of Efficacy|0|||
144332685|NCT00160199|520421505|FG001|Overall Study|Lack of Efficacy|1|||
144332686|NCT00160199|520421504|FG000|Overall Study|Lost to Follow-up|7|||
144332687|NCT00160199|520421505|FG001|Overall Study|Lost to Follow-up|7|||
144332688|NCT00160199|520421504|FG000|Overall Study|Withdrawal by Subject|4|||
144332689|NCT00160199|520421505|FG001|Overall Study|Withdrawal by Subject|6|||
144332690|NCT00160199|520421504|FG000|Overall Study|Administrative|0|||
144332691|NCT00160199|520421505|FG001|Overall Study|Administrative|1|||
144332692|NCT00160199|520421504|FG000|Overall Study|Protocol Violation|8|||
144332693|NCT00160199|520421505|FG001|Overall Study|Protocol Violation|8|||
144332694|NCT01710527|520421508|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
144332695|NCT01710527|520421509|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
144332696|NCT02124772|520421510|FG000|Overall Study|Lack of Efficacy|2|||
144332697|NCT02124772|520421511|FG001|Overall Study|Lack of Efficacy|0|||
144332698|NCT02124772|520421512|FG002|Overall Study|Lack of Efficacy|0|||
144332699|NCT02124772|520421513|FG003|Overall Study|Lack of Efficacy|1|||
144332700|NCT02124772|520421514|FG004|Overall Study|Lack of Efficacy|2|||
144332701|NCT02124772|520421515|FG005|Overall Study|Lack of Efficacy|3|||
144332702|NCT02124772|520421516|FG006|Overall Study|Lack of Efficacy|0|||
144332703|NCT02124772|520421517|FG007|Overall Study|Lack of Efficacy|2|||
144332704|NCT02124772|520421518|FG008|Overall Study|Lack of Efficacy|0|||
144332705|NCT02124772|520421519|FG009|Overall Study|Lack of Efficacy|1|||
144332706|NCT02124772|520421520|FG010|Overall Study|Lack of Efficacy|0|||
144332707|NCT02124772|520421521|FG011|Overall Study|Lack of Efficacy|0|||
144332708|NCT02124772|520421522|FG012|Overall Study|Lack of Efficacy|1|||
144332709|NCT02124772|520421510|FG000|Overall Study|Adverse Event|1|||
144332710|NCT02124772|520421511|FG001|Overall Study|Adverse Event|4|||
144332711|NCT02124772|520421512|FG002|Overall Study|Adverse Event|1|||
144332712|NCT02124772|520421513|FG003|Overall Study|Adverse Event|5|||
144332713|NCT02124772|520421514|FG004|Overall Study|Adverse Event|2|||
144332714|NCT02124772|520421515|FG005|Overall Study|Adverse Event|1|||
144332715|NCT02124772|520421516|FG006|Overall Study|Adverse Event|1|||
144332716|NCT02124772|520421517|FG007|Overall Study|Adverse Event|5|||
144332717|NCT02124772|520421518|FG008|Overall Study|Adverse Event|0|||
144332718|NCT02124772|520421519|FG009|Overall Study|Adverse Event|3|||
144332719|NCT02124772|520421520|FG010|Overall Study|Adverse Event|1|||
144332720|NCT02124772|520421521|FG011|Overall Study|Adverse Event|3|||
144332721|NCT02124772|520421522|FG012|Overall Study|Adverse Event|1|||
144332722|NCT02124772|520421510|FG000|Overall Study|Withdrawal consent|0|||
144332723|NCT02124772|520421511|FG001|Overall Study|Withdrawal consent|1|||
144332724|NCT02124772|520421512|FG002|Overall Study|Withdrawal consent|1|||
144332725|NCT02124772|520421513|FG003|Overall Study|Withdrawal consent|1|||
144332726|NCT02124772|520421514|FG004|Overall Study|Withdrawal consent|0|||
144332727|NCT02124772|520421515|FG005|Overall Study|Withdrawal consent|1|||
144332728|NCT02124772|520421516|FG006|Overall Study|Withdrawal consent|1|||
144332729|NCT02124772|520421517|FG007|Overall Study|Withdrawal consent|0|||
144332730|NCT02124772|520421518|FG008|Overall Study|Withdrawal consent|0|||
144332731|NCT02124772|520421519|FG009|Overall Study|Withdrawal consent|1|||
144332732|NCT02124772|520421520|FG010|Overall Study|Withdrawal consent|0|||
144332733|NCT02124772|520421521|FG011|Overall Study|Withdrawal consent|1|||
144332734|NCT02124772|520421522|FG012|Overall Study|Withdrawal consent|0|||
144332735|NCT02124772|520421510|FG000|Overall Study|Investigator discretion|0|||
144332736|NCT02124772|520421511|FG001|Overall Study|Investigator discretion|2|||
144332737|NCT02124772|520421512|FG002|Overall Study|Investigator discretion|2|||
144332738|NCT02124772|520421513|FG003|Overall Study|Investigator discretion|1|||
144332739|NCT02124772|520421514|FG004|Overall Study|Investigator discretion|1|||
144332740|NCT02124772|520421515|FG005|Overall Study|Investigator discretion|0|||
144332741|NCT02124772|520421516|FG006|Overall Study|Investigator discretion|1|||
144332742|NCT02124772|520421517|FG007|Overall Study|Investigator discretion|0|||
144332743|NCT02124772|520421518|FG008|Overall Study|Investigator discretion|0|||
144332744|NCT02124772|520421519|FG009|Overall Study|Investigator discretion|1|||
144332745|NCT02124772|520421520|FG010|Overall Study|Investigator discretion|0|||
144332746|NCT02124772|520421521|FG011|Overall Study|Investigator discretion|1|||
144332747|NCT02124772|520421522|FG012|Overall Study|Investigator discretion|0|||
144332748|NCT02124772|520421510|FG000|Overall Study|Progressive disease|0|||
144332749|NCT02124772|520421511|FG001|Overall Study|Progressive disease|0|||
144332750|NCT02124772|520421512|FG002|Overall Study|Progressive disease|0|||
144332751|NCT02124772|520421513|FG003|Overall Study|Progressive disease|0|||
144332752|NCT02124772|520421514|FG004|Overall Study|Progressive disease|0|||
144332753|NCT02124772|520421515|FG005|Overall Study|Progressive disease|0|||
144332754|NCT02124772|520421516|FG006|Overall Study|Progressive disease|1|||
144332755|NCT02124772|520421517|FG007|Overall Study|Progressive disease|1|||
144332756|NCT02124772|520421518|FG008|Overall Study|Progressive disease|0|||
144332757|NCT02124772|520421519|FG009|Overall Study|Progressive disease|0|||
144332758|NCT02124772|520421520|FG010|Overall Study|Progressive disease|0|||
144332759|NCT02124772|520421521|FG011|Overall Study|Progressive disease|0|||
144332760|NCT02124772|520421522|FG012|Overall Study|Progressive disease|0|||
144332761|NCT02124772|520421510|FG000|Overall Study|Other|0|||
144332762|NCT02124772|520421511|FG001|Overall Study|Other|7|||
144332763|NCT02124772|520421512|FG002|Overall Study|Other|2|||
144332764|NCT02124772|520421513|FG003|Overall Study|Other|5|||
144332765|NCT02124772|520421514|FG004|Overall Study|Other|4|||
144332766|NCT02124772|520421515|FG005|Overall Study|Other|3|||
144332767|NCT02124772|520421516|FG006|Overall Study|Other|4|||
144332768|NCT02124772|520421517|FG007|Overall Study|Other|1|||
144332769|NCT02124772|520421518|FG008|Overall Study|Other|1|||
144332770|NCT02124772|520421519|FG009|Overall Study|Other|1|||
144332771|NCT02124772|520421520|FG010|Overall Study|Other|1|||
144332772|NCT02124772|520421521|FG011|Overall Study|Other|1|||
144332773|NCT02124772|520421522|FG012|Overall Study|Other|0|||
144332774|NCT02827500|520421523|FG000|Overall Study|Death|7|||
144332775|NCT02827500|520421524|FG001|Overall Study|Death|3|||
144332776|NCT02827500|520421523|FG000|Overall Study|Lost to Follow-up|1|||
144332777|NCT02827500|520421524|FG001|Overall Study|Lost to Follow-up|1|||
144332778|NCT02827500|520421523|FG000|Overall Study|Withdrawal by Subject|3|||
144332779|NCT02827500|520421524|FG001|Overall Study|Withdrawal by Subject|1|||
144332780|NCT02827500|520421523|FG000|Overall Study|Missing primary endpoint data|3|||
144332781|NCT02827500|520421524|FG001|Overall Study|Missing primary endpoint data|1|||
144332782|NCT02827500|520421523|FG000|Overall Study|Other|5|||
144332783|NCT02827500|520421524|FG001|Overall Study|Other|1|||
144332784|NCT02308488|520421525|FG000|Overall Study|Withdrawal by Subject|2|||
144332785|NCT01541917|520421526|FG000|Overall Study|Lost to Follow-up|2|||
144332786|NCT01541917|520421527|FG001|Overall Study|Lost to Follow-up|2|||
144332787|NCT01541917|520421526|FG000|Overall Study|Withdrawal by Subject|13|||
144332788|NCT01541917|520421527|FG001|Overall Study|Withdrawal by Subject|7|||
144332789|NCT01739803|520421528|FG000|Overall Study|Lost to Follow-up|9|||
144332790|NCT01739803|520421529|FG001|Overall Study|Lost to Follow-up|6|||
144332791|NCT03759041|520421537|FG000|Overall Study|Withdrawal by Subject|4|||
144332792|NCT03759041|520421538|FG001|Overall Study|Withdrawal by Subject|10|||
144332793|NCT03759041|520421539|FG002|Overall Study|Withdrawal by Subject|10|||
144332794|NCT03759041|520421537|FG000|Overall Study|Adverse Event|1|||
144332795|NCT03759041|520421538|FG001|Overall Study|Adverse Event|3|||
144332796|NCT03759041|520421539|FG002|Overall Study|Adverse Event|4|||
144332797|NCT03759041|520421537|FG000|Overall Study|Lack of Efficacy|0|||
144332798|NCT03759041|520421538|FG001|Overall Study|Lack of Efficacy|0|||
144332799|NCT03759041|520421539|FG002|Overall Study|Lack of Efficacy|1|||
144332800|NCT03759041|520421537|FG000|Overall Study|Study Terminated by Sponsor|15|||
144332801|NCT03759041|520421538|FG001|Overall Study|Study Terminated by Sponsor|16|||
144332802|NCT03759041|520421539|FG002|Overall Study|Study Terminated by Sponsor|10|||
144332803|NCT03759041|520421537|FG000|Overall Study|Other reason for discontinuation|0|||
144332804|NCT03759041|520421538|FG001|Overall Study|Other reason for discontinuation|2|||
144332805|NCT03759041|520421539|FG002|Overall Study|Other reason for discontinuation|1|||
144332806|NCT03759041|520421537|FG000|Overall Study|Lost to Follow-up|7|||
144332807|NCT03759041|520421538|FG001|Overall Study|Lost to Follow-up|2|||
144332808|NCT03759041|520421539|FG002|Overall Study|Lost to Follow-up|2|||
144332809|NCT03759041|520421537|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
144332810|NCT03759041|520421538|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
144332811|NCT03759041|520421539|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
144332812|NCT00525824|520421545|FG000|Overall Study|Adverse Event|7|||
144332813|NCT00525824|520421546|FG001|Overall Study|Adverse Event|11|||
144332814|NCT00525824|520421547|FG002|Overall Study|Adverse Event|6|||
144332815|NCT00525824|520421548|FG003|Overall Study|Adverse Event|7|||
144332816|NCT00525824|520421545|FG000|Overall Study|Withdrawal by Subject|5|||
144332817|NCT00525824|520421546|FG001|Overall Study|Withdrawal by Subject|9|||
144332818|NCT00525824|520421547|FG002|Overall Study|Withdrawal by Subject|3|||
144332819|NCT00525824|520421548|FG003|Overall Study|Withdrawal by Subject|4|||
144332820|NCT00525824|520421545|FG000|Overall Study|Lost to Follow-up|4|||
144332821|NCT00525824|520421546|FG001|Overall Study|Lost to Follow-up|2|||
144332822|NCT00525824|520421547|FG002|Overall Study|Lost to Follow-up|4|||
144332823|NCT00525824|520421548|FG003|Overall Study|Lost to Follow-up|0|||
144332824|NCT00525824|520421545|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
144332825|NCT00525824|520421546|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
144332826|NCT00525824|520421547|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
144332827|NCT00525824|520421548|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
144332828|NCT00525824|520421545|FG000|Overall Study|Severe non-compliance|0|||
144332829|NCT00525824|520421546|FG001|Overall Study|Severe non-compliance|1|||
144332830|NCT00525824|520421547|FG002|Overall Study|Severe non-compliance|1|||
144332831|NCT00525824|520421548|FG003|Overall Study|Severe non-compliance|1|||
144332832|NCT00525824|520421545|FG000|Overall Study|Safety reasons|1|||
144332833|NCT00525824|520421546|FG001|Overall Study|Safety reasons|0|||
144332834|NCT00525824|520421547|FG002|Overall Study|Safety reasons|1|||
144332835|NCT00525824|520421548|FG003|Overall Study|Safety reasons|0|||
144332836|NCT00525824|520421545|FG000|Overall Study|Other|1|||
144332837|NCT00525824|520421546|FG001|Overall Study|Other|3|||
144332838|NCT00525824|520421547|FG002|Overall Study|Other|3|||
144332839|NCT00525824|520421548|FG003|Overall Study|Other|1|||
144332840|NCT02242981|520421552|FG000|Overall Study|Withdrawal by Subject|1|||
144332841|NCT03474081|520421553|FG000|Overall Study|Adverse Event|6|||
144332842|NCT03474081|520421554|FG001|Overall Study|Adverse Event|3|||
144332843|NCT03474081|520421553|FG000|Overall Study|Lost to Follow-up|2|||
144332844|NCT03474081|520421554|FG001|Overall Study|Lost to Follow-up|1|||
144332845|NCT03474081|520421553|FG000|Overall Study|Physician Decision|3|||
144332846|NCT03474081|520421554|FG001|Overall Study|Physician Decision|2|||
144332847|NCT03474081|520421553|FG000|Overall Study|Withdrawal by Subject|5|||
144332848|NCT03474081|520421554|FG001|Overall Study|Withdrawal by Subject|7|||
144332849|NCT03474081|520421553|FG000|Overall Study|Investigator site closed|1|||
144332850|NCT03474081|520421554|FG001|Overall Study|Investigator site closed|0|||
144332851|NCT02290938|520421560|FG000|Overall Study|Lost to Follow-up|14|||
144332852|NCT02290938|520421561|FG001|Overall Study|Lost to Follow-up|43|||
144332853|NCT00701805|520422574|FG000|Overall Study|Withdrawal by Subject|3|||
144332854|NCT00701805|520422575|FG001|Overall Study|Withdrawal by Subject|1|||
144332855|NCT00701805|520422576|FG002|Overall Study|Withdrawal by Subject|4|||
144332856|NCT00701805|520422577|FG003|Overall Study|Withdrawal by Subject|3|||
144332857|NCT00701805|520422574|FG000|Overall Study|Adverse Event|0|||
144332858|NCT00701805|520422575|FG001|Overall Study|Adverse Event|1|||
144332859|NCT00701805|520422576|FG002|Overall Study|Adverse Event|1|||
144332860|NCT00701805|520422577|FG003|Overall Study|Adverse Event|0|||
144332861|NCT00701805|520422574|FG000|Overall Study|Missed 7 consecutive doses|0|||
144332862|NCT00701805|520422575|FG001|Overall Study|Missed 7 consecutive doses|1|||
144332863|NCT00701805|520422576|FG002|Overall Study|Missed 7 consecutive doses|0|||
144332864|NCT00701805|520422577|FG003|Overall Study|Missed 7 consecutive doses|0|||
144332865|NCT00701805|520422574|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
144332866|NCT00701805|520422575|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
144332867|NCT00701805|520422576|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
144332868|NCT00701805|520422577|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
144332869|NCT00701805|520422574|FG000|Overall Study|Physician decision, change of therapy|0|||
144332870|NCT00701805|520422575|FG001|Overall Study|Physician decision, change of therapy|0|||
144332871|NCT00701805|520422576|FG002|Overall Study|Physician decision, change of therapy|0|||
144332872|NCT00701805|520422577|FG003|Overall Study|Physician decision, change of therapy|1|||
144332873|NCT00701805|520422574|FG000|Overall Study|Difficult to travel to dialysis site|0|||
144332874|NCT00701805|520422575|FG001|Overall Study|Difficult to travel to dialysis site|0|||
144332875|NCT00701805|520422576|FG002|Overall Study|Difficult to travel to dialysis site|1|||
144332876|NCT00701805|520422577|FG003|Overall Study|Difficult to travel to dialysis site|0|||
144332877|NCT00701805|520422574|FG000|Overall Study|Resumption criteria were not met|0|||
144332878|NCT00701805|520422575|FG001|Overall Study|Resumption criteria were not met|1|||
144332879|NCT00701805|520422576|FG002|Overall Study|Resumption criteria were not met|0|||
144332880|NCT00701805|520422577|FG003|Overall Study|Resumption criteria were not met|0|||
144332881|NCT01818284|520422583|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
144332882|NCT01818284|520422584|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
144332883|NCT01818284|520422583|FG000|Overall Study|Death|0|||
144332884|NCT01818284|520422584|FG001|Overall Study|Death|2|||
144332885|NCT03681678|520422585|FG000|Overall Study|Lost to Follow-up|20|||
144332886|NCT00096018|520422595|FG000|Overall Study|Became Ineligible (not treated)|0|||
144332887|NCT00096018|520422596|FG001|Overall Study|Became Ineligible (not treated)|3|||
144332888|NCT00096018|520422595|FG000|Overall Study|Miscellaneous (not treated)|0|||
144332889|NCT00096018|520422596|FG001|Overall Study|Miscellaneous (not treated)|2|||
144332890|NCT00096018|520422595|FG000|Overall Study|Adverse Event|0|||
144332891|NCT00096018|520422596|FG001|Overall Study|Adverse Event|5|||
144332892|NCT00096018|520422595|FG000|Overall Study|Death|0|||
144332893|NCT00096018|520422596|FG001|Overall Study|Death|1|||
144332894|NCT00096018|520422595|FG000|Overall Study|Withdrawal by Subject|0|||
144332895|NCT00096018|520422596|FG001|Overall Study|Withdrawal by Subject|2|||
144332896|NCT00096018|520422595|FG000|Overall Study|Miscellaneous|2|||
144332897|NCT00096018|520422596|FG001|Overall Study|Miscellaneous|1|||
144332898|NCT03689712|520422597|FG000|Overall Study|Adverse Event|1|||
144332899|NCT03689712|520422598|FG001|Overall Study|Adverse Event|0|||
144332900|NCT03689712|520422597|FG000|Overall Study|Death|20|||
144332901|NCT03689712|520422598|FG001|Overall Study|Death|10|||
144332902|NCT03689712|520422597|FG000|Overall Study|Lost to Follow-up|6|||
144332903|NCT03689712|520422598|FG001|Overall Study|Lost to Follow-up|6|||
144332904|NCT03689712|520422597|FG000|Overall Study|Other|1|||
144332905|NCT03689712|520422598|FG001|Overall Study|Other|0|||
144332906|NCT03689712|520422597|FG000|Overall Study|Patient Non-Compliance|0|||
144332907|NCT03689712|520422598|FG001|Overall Study|Patient Non-Compliance|1|||
144332908|NCT03689712|520422597|FG000|Overall Study|Withdrawal by Subject|20|||
144332909|NCT03689712|520422598|FG001|Overall Study|Withdrawal by Subject|4|||
144332910|NCT03689712|520422597|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
144332911|NCT03689712|520422598|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
144332912|NCT03689712|520422597|FG000|Overall Study|Randomized but not Treated|13|||
144332913|NCT03689712|520422598|FG001|Overall Study|Randomized but not Treated|7|||
144332914|NCT03689712|520422597|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
144332915|NCT03689712|520422598|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
144332916|NCT00689793|520422599|FG000|Overall Study|Lost to Follow-up|4|||
144332917|NCT00689793|520422600|FG001|Overall Study|Lost to Follow-up|5|||
144332918|NCT00791557|520422606|FG000|Overall Study|Adverse Event|1|||
144332919|NCT02066129|520422609|FG000|Overall Study|Lost to Follow-up|13|||
144332920|NCT02066129|520422610|FG001|Overall Study|Lost to Follow-up|12|||
144332921|NCT02066129|520422609|FG000|Overall Study|Withdrawal by Subject|7|||
144332922|NCT02066129|520422610|FG001|Overall Study|Withdrawal by Subject|10|||
144332923|NCT02066129|520422609|FG000|Overall Study|Lack of Efficacy|8|||
144332924|NCT02066129|520422610|FG001|Overall Study|Lack of Efficacy|10|||
144332925|NCT02066129|520422609|FG000|Overall Study|Physician Decision|1|||
144332926|NCT02066129|520422610|FG001|Overall Study|Physician Decision|1|||
144332927|NCT02322190|520422611|FG000|Overall Study|Death on study|1|||
144332928|NCT02322190|520422612|FG001|Overall Study|Death on study|0|||
144332929|NCT00357656|520422613|FG000|Overall Study|Other, No surgery performed|0|||
144332930|NCT00357656|520422614|FG001|Overall Study|Other, No surgery performed|3|||
144332931|NCT02573246|520422618|FG000|Overall Study|Lost to Follow-up|2|||
144332932|NCT02573246|520422619|FG001|Overall Study|Lost to Follow-up|0|||
144332933|NCT02573246|520422620|FG002|Overall Study|Lost to Follow-up|0|||
144332934|NCT02573246|520422621|FG003|Overall Study|Lost to Follow-up|0|||
144332935|NCT02573246|520422622|FG004|Overall Study|Lost to Follow-up|1|||
144332936|NCT02573246|520422618|FG000|Overall Study|Withdrawal by Subject|0|||
144332937|NCT02573246|520422619|FG001|Overall Study|Withdrawal by Subject|0|||
144332938|NCT02573246|520422620|FG002|Overall Study|Withdrawal by Subject|0|||
144332939|NCT02573246|520422621|FG003|Overall Study|Withdrawal by Subject|0|||
144332940|NCT02573246|520422622|FG004|Overall Study|Withdrawal by Subject|1|||
144332941|NCT02573246|520422618|FG000|Overall Study|Physician Decision|1|||
144332942|NCT02573246|520422619|FG001|Overall Study|Physician Decision|1|||
144332943|NCT02573246|520422620|FG002|Overall Study|Physician Decision|3|||
144332944|NCT02573246|520422621|FG003|Overall Study|Physician Decision|2|||
144332945|NCT02573246|520422622|FG004|Overall Study|Physician Decision|2|||
144332946|NCT01219933|520422624|FG000|Overall Study|Adverse Event|8|||
144332947|NCT01219933|520422624|FG000|Overall Study|No LDA reached|5|||
144332948|NCT01219933|520422624|FG000|Overall Study|No LDA maintained|7|||
144332949|NCT01219933|520422624|FG000|Overall Study|Lost to Follow-up|3|||
144332950|NCT01219933|520422624|FG000|Overall Study|GC free|1|||
144332951|NCT01219933|520422624|FG000|Overall Study|Withdrawal by Subject|5|||
144332952|NCT01219933|520422624|FG000|Overall Study|Protocol Violation|8|||
144332953|NCT01219933|520422624|FG000|Overall Study|Lack of Efficacy|1|||
144332954|NCT01902888|520422625|FG000|Overall Study|Study Terminated|3|||
144332955|NCT03149003|520422626|FG000|Overall Study|Randomized but not treated|0|||
144332956|NCT03149003|520422627|FG001|Overall Study|Randomized but not treated|1|||
144332957|NCT03149003|520422628|FG002|Overall Study|Randomized but not treated|18|||
144332958|NCT00685373|520422630|FG000|Overall Study|Adverse Event|3|||
144332959|NCT00685373|520422630|FG000|Overall Study|Withdrawal by Subject|5|||
144332960|NCT00685373|520422630|FG000|Overall Study|Lack of Efficacy|3|||
144332961|NCT00685373|520422630|FG000|Overall Study|Condition no longer requires study drug|1|||
144332962|NCT00685373|520422630|FG000|Overall Study|Lost to Follow-up|2|||
144332963|NCT00685373|520422630|FG000|Overall Study|Protocol Violation|1|||
144332964|NCT01814670|520422632|FG000|Overall Study|Protocol Violation|12|||
144332965|NCT00973102|520422633|FG000|Overall Study|Protocol Violation|1|||
144332966|NCT00973102|520422634|FG001|Overall Study|Protocol Violation|0|||
144332967|NCT00973102|520422633|FG000|Overall Study|Prisoner|0|||
144332968|NCT00973102|520422634|FG001|Overall Study|Prisoner|1|||
144332969|NCT01565564|520422638|FG000|Overall Study|Lost to Follow-up|5|||
144332970|NCT01565564|520422639|FG001|Overall Study|Lost to Follow-up|1|||
144332971|NCT02449018|520422640|FG000|Overall Study|Abnormal laboratory value|0|||
144332972|NCT02449018|520422641|FG001|Overall Study|Abnormal laboratory value|1|||
144332973|NCT02449018|520422640|FG000|Overall Study|Administrative problems|1|||
144332974|NCT02449018|520422641|FG001|Overall Study|Administrative problems|0|||
144332975|NCT02449018|520422640|FG000|Overall Study|Adverse Event|5|||
144332976|NCT02449018|520422641|FG001|Overall Study|Adverse Event|1|||
144332977|NCT02449018|520422640|FG000|Overall Study|Protocol deviation|4|||
144332978|NCT02449018|520422641|FG001|Overall Study|Protocol deviation|0|||
144332979|NCT02449018|520422640|FG000|Overall Study|Patient decision|2|||
144332980|NCT02449018|520422641|FG001|Overall Study|Patient decision|0|||
144332981|NCT03995355|520422642|FG000|Overall Study|Adverse Event|1|||
144332982|NCT03995355|520422643|FG001|Overall Study|Adverse Event|0|||
144332983|NCT03995355|520422642|FG000|Overall Study|Withdrawal by Subject|1|||
144332984|NCT03995355|520422643|FG001|Overall Study|Withdrawal by Subject|0|||
144332985|NCT03995355|520422642|FG000|Overall Study|Scheduling Issues|0|||
144332986|NCT03995355|520422643|FG001|Overall Study|Scheduling Issues|1|||
144332987|NCT00094107|520422644|FG000|Overall Study|Lack of Efficacy|23|||
144332988|NCT00094107|520422644|FG000|Overall Study|Death|5|||
144332989|NCT00094107|520422644|FG000|Overall Study|Adverse Event|3|||
144332990|NCT00094107|520422644|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
144332991|NCT02698371|520422672|FG000|All Participants Flow|Lost to Follow-up|3|||
144332992|NCT02698371|520422672|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
144332993|NCT02698371|520422672|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
144332994|NCT02698371|520422672|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
144332995|NCT02698371|520422672|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
144332996|NCT02698371|520422672|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
144332997|NCT02698371|520422672|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
144332998|NCT02525094|520422673|FG000|Overall Study|Lost to Follow-up|2|||
144332999|NCT02525094|520422674|FG001|Overall Study|Lost to Follow-up|1|||
144333000|NCT02525094|520422673|FG000|Overall Study|Withdrawal by Subject|5|||
144333001|NCT02525094|520422674|FG001|Overall Study|Withdrawal by Subject|6|||
144333002|NCT02525094|520422673|FG000|Overall Study|Not Treated|1|||
144333003|NCT02525094|520422674|FG001|Overall Study|Not Treated|1|||
144333004|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
144333005|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
144333006|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
144333007|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
144333008|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
144333009|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
144333010|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
144333011|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
144333012|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
144333013|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
144333014|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
144333015|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
144333016|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
144333017|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
144333018|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
144333019|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
144333020|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
144333021|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
144333022|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
144333023|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
144333024|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
144333025|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
144333026|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
144333027|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
144333028|NCT01672866|520422677|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
144333029|NCT01672866|520422678|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
144333030|NCT01672866|520422679|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
144333031|NCT01672866|520422677|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
144333032|NCT01672866|520422678|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
144333033|NCT01672866|520422679|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
144333034|NCT01672866|520422677|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
144333035|NCT01672866|520422678|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
144333036|NCT01672866|520422679|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
144333037|NCT01672866|520422677|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
144333038|NCT01672866|520422678|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
144333039|NCT01672866|520422679|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
144333040|NCT01672866|520422677|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
144333041|NCT01672866|520422678|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
144333042|NCT01672866|520422679|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
144333043|NCT00831701|520422682|FG000|Overall Study|Withdrawal by Subject|2|||
144333044|NCT00831701|520422683|FG001|Overall Study|Withdrawal by Subject|0|||
144333045|NCT00831701|520422682|FG000|Overall Study|Stone expulsion before first medication|2|||
144333046|NCT00831701|520422683|FG001|Overall Study|Stone expulsion before first medication|2|||
144333047|NCT00831701|520422682|FG000|Overall Study|Lost to Follow-up|1|||
144333048|NCT00831701|520422683|FG001|Overall Study|Lost to Follow-up|3|||
144333049|NCT01440881|520422684|FG000|Overall Study|Death|0|||
144333050|NCT01440881|520422685|FG001|Overall Study|Death|1|||
144333051|NCT02739321|520422686|FG000|Overall Study|Lack of Efficacy|1|||
144333052|NCT02739321|520422687|FG001|Overall Study|Lack of Efficacy|1|||
144333053|NCT02739321|520422686|FG000|Overall Study|Lost to Follow-up|1|||
144333054|NCT02739321|520422687|FG001|Overall Study|Lost to Follow-up|1|||
144333055|NCT02739321|520422686|FG000|Overall Study|Withdrawal by Subject|1|||
144333056|NCT02739321|520422687|FG001|Overall Study|Withdrawal by Subject|2|||
144333057|NCT00528996|520424297|FG000|Overall Study|Other reasons than listing|6|||
144333058|NCT00528996|520424298|FG001|Overall Study|Other reasons than listing|7|||
144333059|NCT00528996|520424299|FG002|Overall Study|Other reasons than listing|14|||
144333060|NCT00528996|520424300|FG003|Overall Study|Other reasons than listing|11|||
144333061|NCT00528996|520424301|FG004|Overall Study|Other reasons than listing|5|||
144333062|NCT00528996|520424297|FG000|Overall Study|Refused continue medication|16|||
144333063|NCT00528996|520424298|FG001|Overall Study|Refused continue medication|0|||
144333064|NCT00528996|520424299|FG002|Overall Study|Refused continue medication|3|||
144333065|NCT00528996|520424300|FG003|Overall Study|Refused continue medication|3|||
144333066|NCT00528996|520424301|FG004|Overall Study|Refused continue medication|6|||
144333067|NCT00528996|520424297|FG000|Overall Study|Lost to Follow-up|2|||
144333068|NCT00528996|520424298|FG001|Overall Study|Lost to Follow-up|0|||
144333069|NCT00528996|520424299|FG002|Overall Study|Lost to Follow-up|4|||
144333070|NCT00528996|520424300|FG003|Overall Study|Lost to Follow-up|1|||
144333071|NCT00528996|520424301|FG004|Overall Study|Lost to Follow-up|3|||
144333072|NCT00528996|520424297|FG000|Overall Study|Protocol Violation|1|||
144333073|NCT00528996|520424298|FG001|Overall Study|Protocol Violation|2|||
144333074|NCT00528996|520424299|FG002|Overall Study|Protocol Violation|3|||
144333075|NCT00528996|520424300|FG003|Overall Study|Protocol Violation|3|||
144333076|NCT00528996|520424301|FG004|Overall Study|Protocol Violation|2|||
144333077|NCT00528996|520424297|FG000|Overall Study|Lack of Efficacy|7|||
144333078|NCT00528996|520424298|FG001|Overall Study|Lack of Efficacy|2|||
144333079|NCT00528996|520424299|FG002|Overall Study|Lack of Efficacy|1|||
144333080|NCT00528996|520424300|FG003|Overall Study|Lack of Efficacy|3|||
144333081|NCT00528996|520424301|FG004|Overall Study|Lack of Efficacy|3|||
144333082|NCT00528996|520424297|FG000|Overall Study|Adverse Event|32|||
144333083|NCT00528996|520424298|FG001|Overall Study|Adverse Event|13|||
144333084|NCT00528996|520424299|FG002|Overall Study|Adverse Event|18|||
144333085|NCT00528996|520424300|FG003|Overall Study|Adverse Event|29|||
144333086|NCT00528996|520424301|FG004|Overall Study|Adverse Event|18|||
144333087|NCT02831933|520424302|FG000|Overall Study|Physician Decision|11|||
144333088|NCT05065190|520424309|FG000|Overall Study|Other than listed|2|||
144333089|NCT05065190|520424310|FG001|Overall Study|Other than listed|12|||
144333090|NCT05065190|520424309|FG000|Overall Study|Lack of Efficacy|4|||
144333091|NCT05065190|520424310|FG001|Overall Study|Lack of Efficacy|0|||
144333092|NCT05065190|520424309|FG000|Overall Study|Adverse Event|1|||
144333093|NCT05065190|520424310|FG001|Overall Study|Adverse Event|10|||
144333094|NCT01350115|520424311|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
144333095|NCT01350115|520424312|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
144333096|NCT01350115|520424311|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
144333097|NCT01350115|520424312|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
144333098|NCT01350115|520424311|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
144333099|NCT01350115|520424312|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
144333100|NCT05565937|520424313|FG000|Overall Study|Adverse Event|0|||
144333101|NCT05565937|520424314|FG001|Overall Study|Adverse Event|1|||
144333102|NCT05565937|520424313|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
144333103|NCT05565937|520424314|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
144333104|NCT05565937|520424313|FG000|Overall Study|Lost to Follow-up|2|||
144333105|NCT05565937|520424314|FG001|Overall Study|Lost to Follow-up|0|||
144333106|NCT05565937|520424313|FG000|Overall Study|Pregnancy|0|||
144333107|NCT05565937|520424314|FG001|Overall Study|Pregnancy|2|||
144333108|NCT05565937|520424313|FG000|Overall Study|Anisometropia|0|||
144333109|NCT05565937|520424314|FG001|Overall Study|Anisometropia|1|||
144333110|NCT04544683|520424315|FG000|Overall Study|Lost to Follow-up|2|||
144333111|NCT04544683|520424315|FG000|Overall Study|Underwent cervical spine surgery|6|||
144333112|NCT04732949|520424316|FG000|Overall Study|Withdrawal by Subject|23|||
144333113|NCT04732949|520424317|FG001|Overall Study|Withdrawal by Subject|27|||
144333114|NCT04732949|520424316|FG000|Overall Study|Protocol Violation|0|||
144333115|NCT04732949|520424317|FG001|Overall Study|Protocol Violation|1|||
144333116|NCT04732949|520424316|FG000|Overall Study|Non-compliance|0|||
144333117|NCT04732949|520424317|FG001|Overall Study|Non-compliance|2|||
144333118|NCT04732949|520424316|FG000|Overall Study|Physician Decision|2|||
144333119|NCT04732949|520424317|FG001|Overall Study|Physician Decision|1|||
144333120|NCT04732949|520424316|FG000|Overall Study|Serious adverse event (Fatal)|16|||
144333121|NCT04732949|520424317|FG001|Overall Study|Serious adverse event (Fatal)|18|||
144333122|NCT04732949|520424316|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
144333123|NCT04732949|520424317|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
144333124|NCT04732949|520424316|FG000|Overall Study|Non-serious adverse event|1|||
144333125|NCT04732949|520424317|FG001|Overall Study|Non-serious adverse event|3|||
144333126|NCT04732949|520424316|FG000|Overall Study|Lost to Follow-up|26|||
144333127|NCT04732949|520424317|FG001|Overall Study|Lost to Follow-up|27|||
144333128|NCT04732949|520424316|FG000|Overall Study|Other|6|||
144333129|NCT04732949|520424317|FG001|Overall Study|Other|3|||
144333130|NCT05160766|520424322|FG000|Overall Study|Adverse Event|0|||
144333131|NCT05160766|520424323|FG001|Overall Study|Adverse Event|1|||
144333132|NCT05160766|520424324|FG002|Overall Study|Adverse Event|0|||
144333133|NCT05160766|520424325|FG003|Overall Study|Adverse Event|0|||
144333134|NCT05160766|520424322|FG000|Overall Study|COVID-19 infection|0|||
144333135|NCT05160766|520424323|FG001|Overall Study|COVID-19 infection|1|||
144333136|NCT05160766|520424324|FG002|Overall Study|COVID-19 infection|0|||
144333137|NCT05160766|520424325|FG003|Overall Study|COVID-19 infection|0|||
144333138|NCT05160766|520424322|FG000|Overall Study|travel time|1|||
144333139|NCT05160766|520424323|FG001|Overall Study|travel time|0|||
144333140|NCT05160766|520424324|FG002|Overall Study|travel time|0|||
144333141|NCT05160766|520424325|FG003|Overall Study|travel time|1|||
144333142|NCT05160766|520424322|FG000|Overall Study|Withdrawal by Subject|3|||
144333143|NCT05160766|520424323|FG001|Overall Study|Withdrawal by Subject|5|||
144333144|NCT05160766|520424324|FG002|Overall Study|Withdrawal by Subject|4|||
144333145|NCT05160766|520424325|FG003|Overall Study|Withdrawal by Subject|2|||
144333146|NCT05160766|520424322|FG000|Overall Study|Death|0|||
144333147|NCT05160766|520424323|FG001|Overall Study|Death|0|||
144333148|NCT05160766|520424324|FG002|Overall Study|Death|2|||
144333149|NCT05160766|520424325|FG003|Overall Study|Death|5|||
144333150|NCT05160766|520424322|FG000|Overall Study|Lost to Follow-up|0|||
144333151|NCT05160766|520424323|FG001|Overall Study|Lost to Follow-up|0|||
144333152|NCT05160766|520424324|FG002|Overall Study|Lost to Follow-up|1|||
144333153|NCT05160766|520424325|FG003|Overall Study|Lost to Follow-up|2|||
144333154|NCT05160766|520424322|FG000|Overall Study|No show|0|||
144333155|NCT05160766|520424323|FG001|Overall Study|No show|0|||
144333156|NCT05160766|520424324|FG002|Overall Study|No show|1|||
144333157|NCT05160766|520424325|FG003|Overall Study|No show|1|||
144333158|NCT05160766|520424322|FG000|Overall Study|Physician Decision|0|||
144333159|NCT05160766|520424323|FG001|Overall Study|Physician Decision|0|||
144333160|NCT05160766|520424324|FG002|Overall Study|Physician Decision|0|||
144333161|NCT05160766|520424325|FG003|Overall Study|Physician Decision|1|||
144333162|NCT05160766|520424322|FG000|Overall Study|Protocol Violation|0|||
144333163|NCT05160766|520424323|FG001|Overall Study|Protocol Violation|0|||
144333164|NCT05160766|520424324|FG002|Overall Study|Protocol Violation|1|||
144333165|NCT05160766|520424325|FG003|Overall Study|Protocol Violation|0|||
144333166|NCT01282294|520424328|FG000|Overall Study|Lost to Follow-up|14|||
144333167|NCT01282294|520424328|FG000|Overall Study|Screening failure|1|||
144333168|NCT01282294|520424328|FG000|Overall Study|Adverse Event|1|||
144333169|NCT01282294|520424328|FG000|Overall Study|Patient non-compliance|2|||
144333170|NCT01282294|520424328|FG000|Overall Study|Physician Decision|1|||
144333171|NCT02654236|520424329|FG000|Overall Study|Withdrawal by Subject|0|||
144333172|NCT02654236|520424330|FG001|Overall Study|Withdrawal by Subject|0|||
144333173|NCT02654236|520424331|FG002|Overall Study|Withdrawal by Subject|2|||
144333174|NCT02943915|520424332|FG000|Overall Study|Withdrawal by Subject|2|||
144333175|NCT02943915|520424333|FG001|Overall Study|Withdrawal by Subject|1|||
144333176|NCT02943915|520424334|FG002|Overall Study|Withdrawal by Subject|0|||
144333177|NCT02943915|520424335|FG003|Overall Study|Withdrawal by Subject|0|||
144333178|NCT02943915|520424332|FG000|Overall Study|Lost to Follow-up|3|||
144333179|NCT02943915|520424333|FG001|Overall Study|Lost to Follow-up|1|||
144333180|NCT02943915|520424334|FG002|Overall Study|Lost to Follow-up|0|||
144333181|NCT02943915|520424335|FG003|Overall Study|Lost to Follow-up|0|||
144333182|NCT02943915|520424332|FG000|Overall Study|excluded|0|||
144333183|NCT02943915|520424333|FG001|Overall Study|excluded|1|||
144333184|NCT02943915|520424334|FG002|Overall Study|excluded|0|||
144333185|NCT02943915|520424335|FG003|Overall Study|excluded|0|||
144333186|NCT04692077|520424338|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
144333187|NCT05149313|520424339|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
144333188|NCT05149313|520424340|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
144333189|NCT05149313|520424341|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
144333190|NCT05149313|520424342|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
144333191|NCT05149313|520424339|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
144333192|NCT05149313|520424340|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
144333193|NCT05149313|520424341|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
144333194|NCT05149313|520424342|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
144333195|NCT05149313|520424339|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
144333196|NCT05149313|520424340|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
144333197|NCT05149313|520424341|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
144333198|NCT05149313|520424342|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
144333199|NCT05149313|520424339|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
144333200|NCT05149313|520424340|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
144333201|NCT05149313|520424341|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
144333202|NCT05149313|520424342|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
144333203|NCT05149313|520424339|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
144333204|NCT05149313|520424340|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
144333205|NCT05149313|520424341|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
144333206|NCT05149313|520424342|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
144333207|NCT05149313|520424339|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
144333208|NCT05149313|520424340|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
144333209|NCT05149313|520424341|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
144333210|NCT05149313|520424342|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
144333211|NCT05149313|520424339|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
144333212|NCT05149313|520424340|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
144333213|NCT05149313|520424341|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
144333214|NCT05149313|520424342|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
144333215|NCT05149313|520424339|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144333216|NCT05149313|520424340|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
144333217|NCT05149313|520424341|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
144333218|NCT05149313|520424342|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
144333219|NCT05149313|520424339|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
144333220|NCT05149313|520424340|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
144333221|NCT05149313|520424341|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
144333222|NCT05149313|520424342|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
144333223|NCT05149313|520424339|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144333224|NCT05149313|520424340|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144333225|NCT05149313|520424341|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
144333226|NCT05149313|520424342|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
144333227|NCT05149313|520424339|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
144333228|NCT05149313|520424340|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
144333229|NCT05149313|520424341|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
144333230|NCT05149313|520424342|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
144333231|NCT03199391|520424347|FG000|Overall Study|Death|1|||
144333232|NCT03199391|520424347|FG000|Overall Study|Lost to Follow-up|3|||
144333233|NCT03199391|520424347|FG000|Overall Study|Adverse Event|2|||
144333234|NCT03199391|520424347|FG000|Overall Study|Withdrawal by Subject|10|||
144333235|NCT01867086|520424348|FG000|Overall Study|Disease Progression|1|||
144333236|NCT03826342|520424358|FG000|Overall Study|Withdrawal by Subject|8|||
144333237|NCT03826342|520424359|FG001|Overall Study|Withdrawal by Subject|1|||
144333238|NCT03826342|520424358|FG000|Overall Study|Lost to Follow-up|7|||
144333239|NCT03826342|520424359|FG001|Overall Study|Lost to Follow-up|7|||
144333240|NCT03826342|520424358|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
144333241|NCT03826342|520424359|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
144333242|NCT02046070|520424366|FG000|Overall Study|Progressive Disease|18|||
144333243|NCT02046070|520424367|FG001|Overall Study|Progressive Disease|11|||
144333244|NCT02046070|520424368|FG002|Overall Study|Progressive Disease|40|||
144333245|NCT02046070|520424366|FG000|Overall Study|Adverse Event|8|||
144333246|NCT02046070|520424367|FG001|Overall Study|Adverse Event|10|||
144333247|NCT02046070|520424368|FG002|Overall Study|Adverse Event|17|||
144333248|NCT02046070|520424366|FG000|Overall Study|Withdrawal by Subject|1|||
144333249|NCT02046070|520424367|FG001|Overall Study|Withdrawal by Subject|2|||
144333250|NCT02046070|520424368|FG002|Overall Study|Withdrawal by Subject|6|||
144333251|NCT02046070|520424366|FG000|Overall Study|Study Terminated by Sponsor|1|||
144333252|NCT02046070|520424367|FG001|Overall Study|Study Terminated by Sponsor|1|||
144333253|NCT02046070|520424368|FG002|Overall Study|Study Terminated by Sponsor|1|||
144333254|NCT02046070|520424366|FG000|Overall Study|Reason not Specified|4|||
144333255|NCT02046070|520424367|FG001|Overall Study|Reason not Specified|4|||
144333256|NCT02046070|520424368|FG002|Overall Study|Reason not Specified|6|||
144333257|NCT04030962|520424369|FG000|Stage 2|Adverse Event|0|||
144333258|NCT04030962|520424370|FG001|Stage 2|Adverse Event|0|||
144333259|NCT04030962|520424371|FG002|Stage 2|Adverse Event|0|||
144333260|NCT04030962|520424372|FG003|Stage 2|Adverse Event|0|||
144333261|NCT04030962|520424373|FG004|Stage 2|Adverse Event|0|||
144333262|NCT04030962|520424374|FG005|Stage 2|Adverse Event|0|||
144333263|NCT04030962|520424375|FG006|Stage 2|Adverse Event|0|||
144333264|NCT04030962|520424376|FG007|Stage 2|Adverse Event|0|||
144333265|NCT04030962|520424377|FG008|Stage 2|Adverse Event|1|||
144333266|NCT04030962|520424378|FG009|Stage 2|Adverse Event|0|||
144333267|NCT04030962|520424379|FG010|Stage 2|Adverse Event|1|||
144333268|NCT04030962|520424380|FG011|Stage 2|Adverse Event|1|||
144333269|NCT04030962|520424381|FG012|Stage 2|Adverse Event|1|||
144333270|NCT04030962|520424369|FG000|Stage 2|Withdrawal by Subject|0|||
144333271|NCT04030962|520424370|FG001|Stage 2|Withdrawal by Subject|0|||
144333272|NCT04030962|520424371|FG002|Stage 2|Withdrawal by Subject|0|||
144333273|NCT04030962|520424372|FG003|Stage 2|Withdrawal by Subject|0|||
144333274|NCT04030962|520424373|FG004|Stage 2|Withdrawal by Subject|0|||
144333275|NCT04030962|520424374|FG005|Stage 2|Withdrawal by Subject|0|||
144333276|NCT04030962|520424375|FG006|Stage 2|Withdrawal by Subject|0|||
144333277|NCT04030962|520424376|FG007|Stage 2|Withdrawal by Subject|0|||
144333278|NCT04030962|520424377|FG008|Stage 2|Withdrawal by Subject|1|||
144333279|NCT04030962|520424378|FG009|Stage 2|Withdrawal by Subject|0|||
144333280|NCT04030962|520424379|FG010|Stage 2|Withdrawal by Subject|0|||
144333281|NCT04030962|520424380|FG011|Stage 2|Withdrawal by Subject|2|||
144333282|NCT04030962|520424381|FG012|Stage 2|Withdrawal by Subject|1|||
144333283|NCT04030962|520424369|FG000|Stage 2|Lost to Follow-up|0|||
144333284|NCT04030962|520424370|FG001|Stage 2|Lost to Follow-up|0|||
144333285|NCT04030962|520424371|FG002|Stage 2|Lost to Follow-up|0|||
144333286|NCT04030962|520424372|FG003|Stage 2|Lost to Follow-up|0|||
144333287|NCT04030962|520424373|FG004|Stage 2|Lost to Follow-up|0|||
144333288|NCT04030962|520424374|FG005|Stage 2|Lost to Follow-up|0|||
144333289|NCT04030962|520424375|FG006|Stage 2|Lost to Follow-up|0|||
144333290|NCT04030962|520424376|FG007|Stage 2|Lost to Follow-up|0|||
144333291|NCT04030962|520424377|FG008|Stage 2|Lost to Follow-up|1|||
144333292|NCT04030962|520424378|FG009|Stage 2|Lost to Follow-up|0|||
144333293|NCT04030962|520424379|FG010|Stage 2|Lost to Follow-up|0|||
144333294|NCT04030962|520424380|FG011|Stage 2|Lost to Follow-up|0|||
144333295|NCT04030962|520424381|FG012|Stage 2|Lost to Follow-up|0|||
144333296|NCT04030962|520424369|FG000|Stage 2|Technical Problems|0|||
144333297|NCT04030962|520424370|FG001|Stage 2|Technical Problems|0|||
144333298|NCT04030962|520424371|FG002|Stage 2|Technical Problems|0|||
144333299|NCT04030962|520424372|FG003|Stage 2|Technical Problems|0|||
144333300|NCT04030962|520424373|FG004|Stage 2|Technical Problems|0|||
144333301|NCT04030962|520424374|FG005|Stage 2|Technical Problems|0|||
144333302|NCT04030962|520424375|FG006|Stage 2|Technical Problems|0|||
144333303|NCT04030962|520424376|FG007|Stage 2|Technical Problems|0|||
144333304|NCT04030962|520424377|FG008|Stage 2|Technical Problems|0|||
144333305|NCT04030962|520424378|FG009|Stage 2|Technical Problems|0|||
144333306|NCT04030962|520424379|FG010|Stage 2|Technical Problems|0|||
144333307|NCT04030962|520424380|FG011|Stage 2|Technical Problems|1|||
144333308|NCT04030962|520424381|FG012|Stage 2|Technical Problems|0|||
144333309|NCT04284813|520424384|FG000|Overall Study|Withdrawal by Subject|1|||
144333310|NCT03921554|520424385|FG000|Overall Study|Adverse Event|2|||
144333311|NCT03921554|520424385|FG000|Overall Study|Withdrawal by Subject|1|||
144333312|NCT03921554|520424385|FG000|Overall Study|Death|3|||
144333313|NCT05824936|520424386|FG000|Overall Study|Lost to Follow-up|1|||
144333314|NCT00673881|520424387|FG000|Overall Study|Withdrawal by Subject|1|||
144333315|NCT00895661|520424396|FG000|Overall Study|Death|1|||
144333316|NCT00895661|520424396|FG000|Overall Study|reason unknown|2|||
144333317|NCT02006069|520424397|FG000|Overall Study|MPP other programming|239|||
144333318|NCT02006069|520424398|FG001|Overall Study|MPP other programming|0|||
144333319|NCT02006069|520424397|FG000|Overall Study|RV only pacing|0|||
144333320|NCT02006069|520424398|FG001|Overall Study|RV only pacing|3|||
144333321|NCT00316888|520424399|FG000|Overall Study|Adverse Event|4|||
144333322|NCT00316888|520424400|FG001|Overall Study|Adverse Event|5|||
144333323|NCT00316888|520424399|FG000|Overall Study|Withdrawal by Subject|2|||
144333324|NCT00316888|520424400|FG001|Overall Study|Withdrawal by Subject|2|||
144333325|NCT00316888|520424399|FG000|Overall Study|Not start protocol therapy|0|||
144333326|NCT00316888|520424400|FG001|Overall Study|Not start protocol therapy|1|||
144333327|NCT03757130|520424404|FG000|Overall Study|Lost to Follow-up|0|||
144333328|NCT03757130|520424405|FG001|Overall Study|Lost to Follow-up|0|||
144333329|NCT03757130|520424406|FG002|Overall Study|Lost to Follow-up|0|||
144333330|NCT03757130|520424407|FG003|Overall Study|Lost to Follow-up|1|||
144333331|NCT03757130|520424408|FG004|Overall Study|Lost to Follow-up|0|||
144333332|NCT03757130|520424409|FG005|Overall Study|Lost to Follow-up|0|||
144333333|NCT03757130|520424410|FG006|Overall Study|Lost to Follow-up|0|||
144333334|NCT03757130|520424411|FG007|Overall Study|Lost to Follow-up|1|||
144333335|NCT03757130|520424404|FG000|Overall Study|Withdrawal by Subject|0|||
144333336|NCT03757130|520424405|FG001|Overall Study|Withdrawal by Subject|0|||
144333337|NCT03757130|520424406|FG002|Overall Study|Withdrawal by Subject|0|||
144333338|NCT03757130|520424407|FG003|Overall Study|Withdrawal by Subject|0|||
144333339|NCT03757130|520424408|FG004|Overall Study|Withdrawal by Subject|0|||
144333340|NCT03757130|520424409|FG005|Overall Study|Withdrawal by Subject|0|||
144333341|NCT03757130|520424410|FG006|Overall Study|Withdrawal by Subject|1|||
144333342|NCT03757130|520424411|FG007|Overall Study|Withdrawal by Subject|0|||
144333343|NCT01439126|520424414|FG000|Overall Study|Adverse Event|2|||
144333344|NCT01439126|520424415|FG001|Overall Study|Adverse Event|0|||
144333345|NCT01439126|520424414|FG000|Overall Study|Withdrawal by Subject|5|||
144333346|NCT01439126|520424415|FG001|Overall Study|Withdrawal by Subject|21|||
144333347|NCT01439126|520424414|FG000|Overall Study|Protocol Violation|6|||
144333348|NCT01439126|520424415|FG001|Overall Study|Protocol Violation|4|||
144333349|NCT01439126|520424414|FG000|Overall Study|Lost to Follow-up|6|||
144333350|NCT01439126|520424415|FG001|Overall Study|Lost to Follow-up|3|||
144333351|NCT01439126|520424414|FG000|Overall Study|Other-Use of prohibited treatment|0|||
144333352|NCT01439126|520424415|FG001|Overall Study|Other-Use of prohibited treatment|2|||
144333353|NCT01439126|520424414|FG000|Overall Study|Other-Miscellaneous|12|||
144333354|NCT01439126|520424415|FG001|Overall Study|Other-Miscellaneous|12|||
144333355|NCT00687609|520424416|FG000|Overall Study|Physician Decision|1|||
144333356|NCT00687609|520424416|FG000|Overall Study|Withdrawal by Subject|2|||
144333357|NCT02635347|520424419|FG000|Overall Study|Failed screening|20|||
144333358|NCT02635347|520424420|FG001|Overall Study|Failed screening|7|||
144333359|NCT01617447|520424422|FG000|Overall Study|Adverse Event|0|||
144333360|NCT01617447|520424423|FG001|Overall Study|Adverse Event|1|||
144333361|NCT01617447|520424422|FG000|Overall Study|Physician Decision|0|||
144333362|NCT01617447|520424423|FG001|Overall Study|Physician Decision|2|||
144333363|NCT03443427|520424424|FG000|Overall Study|Adverse Event|2|||
144333364|NCT03443427|520424425|FG001|Overall Study|Adverse Event|3|||
144333365|NCT03443427|520424424|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
144333366|NCT03443427|520424425|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
144333367|NCT03443427|520424424|FG000|Overall Study|Other|4|||
144333368|NCT03443427|520424425|FG001|Overall Study|Other|6|||
144333369|NCT02713529|520424426|FG000|Overall Study|Withdrawal by Subject|3|||
144333370|NCT02713529|520424427|FG001|Overall Study|Withdrawal by Subject|1|||
144333371|NCT02713529|520424428|FG002|Overall Study|Withdrawal by Subject|4|||
144333372|NCT02713529|520424429|FG003|Overall Study|Withdrawal by Subject|2|||
144333373|NCT02713529|520424430|FG004|Overall Study|Withdrawal by Subject|0|||
144333374|NCT02713529|520424431|FG005|Overall Study|Withdrawal by Subject|1|||
144333375|NCT02713529|520424432|FG006|Overall Study|Withdrawal by Subject|1|||
144333376|NCT02713529|520424426|FG000|Overall Study|Lost to Follow-up|1|||
144333377|NCT02713529|520424427|FG001|Overall Study|Lost to Follow-up|0|||
144333378|NCT02713529|520424428|FG002|Overall Study|Lost to Follow-up|1|||
144333379|NCT02713529|520424429|FG003|Overall Study|Lost to Follow-up|0|||
144333380|NCT02713529|520424430|FG004|Overall Study|Lost to Follow-up|0|||
144333381|NCT02713529|520424431|FG005|Overall Study|Lost to Follow-up|0|||
144333382|NCT02713529|520424432|FG006|Overall Study|Lost to Follow-up|0|||
144333383|NCT02713529|520424426|FG000|Overall Study|Death|3|||
144333384|NCT02713529|520424427|FG001|Overall Study|Death|3|||
144333385|NCT02713529|520424428|FG002|Overall Study|Death|26|||
144333386|NCT02713529|520424429|FG003|Overall Study|Death|27|||
144333387|NCT02713529|520424430|FG004|Overall Study|Death|3|||
144333388|NCT02713529|520424431|FG005|Overall Study|Death|13|||
144333389|NCT02713529|520424432|FG006|Overall Study|Death|3|||
144333390|NCT00780273|520424433|FG000|Overall Study|Death|1|||
144333391|NCT00780273|520424433|FG000|Overall Study|Lost to Follow-up|1|||
144333392|NCT00969436|520424443|FG000|Overall Study|Protocol Violation|1|||
144333393|NCT00969436|520424444|FG001|Overall Study|Protocol Violation|3|||
144333394|NCT00969436|520424445|FG002|Overall Study|Protocol Violation|0|||
144333395|NCT00969436|520424443|FG000|Overall Study|Migrated/moved from study area|12|||
144333396|NCT00969436|520424444|FG001|Overall Study|Migrated/moved from study area|10|||
144333397|NCT00969436|520424445|FG002|Overall Study|Migrated/moved from study area|2|||
144333398|NCT00969436|520424443|FG000|Overall Study|Father - serious health problem|0|||
144333399|NCT00969436|520424444|FG001|Overall Study|Father - serious health problem|0|||
144333400|NCT00969436|520424445|FG002|Overall Study|Father - serious health problem|1|||
144333401|NCT00969436|520424443|FG000|Overall Study|Parents personal problem|0|||
144333402|NCT00969436|520424444|FG001|Overall Study|Parents personal problem|0|||
144333403|NCT00969436|520424445|FG002|Overall Study|Parents personal problem|1|||
144333404|NCT00969436|520424443|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
144333405|NCT00969436|520424444|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
144333406|NCT00969436|520424445|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
144333407|NCT00969436|520424443|FG000|Overall Study|Withdrawal by Subject|3|||
144333408|NCT00969436|520424444|FG001|Overall Study|Withdrawal by Subject|0|||
144333409|NCT00969436|520424445|FG002|Overall Study|Withdrawal by Subject|2|||
144333410|NCT00969436|520424443|FG000|Overall Study|Lost to Follow-up|8|||
144333411|NCT00969436|520424444|FG001|Overall Study|Lost to Follow-up|8|||
144333412|NCT00969436|520424445|FG002|Overall Study|Lost to Follow-up|5|||
144333413|NCT02117349|520424449|FG000|Overall Study|Withdrawal by Subject|1|||
144333414|NCT02117349|520424450|FG001|Overall Study|Withdrawal by Subject|0|||
144333415|NCT02117349|520424449|FG000|Overall Study|Lost to Follow-up|1|||
144333416|NCT02117349|520424450|FG001|Overall Study|Lost to Follow-up|1|||
144333417|NCT02117349|520424449|FG000|Overall Study|Death|1|||
144333418|NCT02117349|520424450|FG001|Overall Study|Death|0|||
144333419|NCT02535416|520424453|FG000|Overall Study|Family bereavement overseas|1|||
144333420|NCT02535416|520424454|FG001|Overall Study|Family bereavement overseas|0|||
144333421|NCT02535416|520424455|FG002|Overall Study|Family bereavement overseas|0|||
144333422|NCT02535416|520424456|FG003|Overall Study|Family bereavement overseas|0|||
144333423|NCT02535416|520424457|FG004|Overall Study|Family bereavement overseas|0|||
144333424|NCT02535416|520424458|FG005|Overall Study|Family bereavement overseas|0|||
144333425|NCT02535416|520424459|FG006|Overall Study|Family bereavement overseas|0|||
144333426|NCT02535416|520424460|FG007|Overall Study|Family bereavement overseas|0|||
144333427|NCT02535416|520424461|FG008|Overall Study|Family bereavement overseas|0|||
144333428|NCT01977690|520424462|FG000|Overall Study|Withdrawal by Subject|0|||
144333429|NCT01977690|520424463|FG001|Overall Study|Withdrawal by Subject|4|||
144333430|NCT02440789|520424466|FG000|Overall Study|Withdrawal by Subject|3|||
144333431|NCT02440789|520424466|FG000|Overall Study|Not willing to adhere to reqs|1|||
144333432|NCT03172130|520425906|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
144333433|NCT03172130|520425907|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
144333434|NCT01825941|520425910|FG000|Overall Study|Lost to Follow-up|4|||
144333435|NCT01825941|520425911|FG001|Overall Study|Lost to Follow-up|1|||
144333436|NCT02769962|520425918|FG000|Overall Study|Physician Decision|0|||
144333437|NCT02769962|520425919|FG001|Overall Study|Physician Decision|0|||
144333438|NCT02769962|520425920|FG002|Overall Study|Physician Decision|0|||
144333439|NCT02769962|520425921|FG003|Overall Study|Physician Decision|0|||
144333440|NCT02769962|520425922|FG004|Overall Study|Physician Decision|0|||
144333441|NCT02769962|520425923|FG005|Overall Study|Physician Decision|1|||
144333442|NCT02769962|520425924|FG006|Overall Study|Physician Decision|0|||
144333443|NCT02769962|520425925|FG007|Overall Study|Physician Decision|1|||
144333444|NCT02769962|520425918|FG000|Overall Study|Refused further treatment|0|||
144333445|NCT02769962|520425919|FG001|Overall Study|Refused further treatment|0|||
144333446|NCT02769962|520425920|FG002|Overall Study|Refused further treatment|0|||
144333447|NCT02769962|520425921|FG003|Overall Study|Refused further treatment|0|||
144333448|NCT02769962|520425922|FG004|Overall Study|Refused further treatment|0|||
144333449|NCT02769962|520425923|FG005|Overall Study|Refused further treatment|1|||
144333450|NCT02769962|520425924|FG006|Overall Study|Refused further treatment|1|||
144333451|NCT02769962|520425925|FG007|Overall Study|Refused further treatment|0|||
144333452|NCT00151372|520425926|FG000|Overall Study|Death|12|||
144333453|NCT00151372|520425927|FG001|Overall Study|Death|11|||
144333454|NCT00151372|520425926|FG000|Overall Study|Lost to Follow-up|5|||
144333455|NCT00151372|520425927|FG001|Overall Study|Lost to Follow-up|5|||
144333456|NCT00151372|520425926|FG000|Overall Study|Too sick medically to continue|5|||
144333457|NCT00151372|520425927|FG001|Overall Study|Too sick medically to continue|6|||
144333458|NCT00151372|520425926|FG000|Overall Study|Withdrawal by Subject|7|||
144333459|NCT00151372|520425927|FG001|Overall Study|Withdrawal by Subject|7|||
144333460|NCT02783170|520425930|FG000|Overall Study|Randomized but not Vaccinated|1|||
144333461|NCT02783170|520425931|FG001|Overall Study|Randomized but not Vaccinated|0|||
144333462|NCT00541346|520425932|FG000|Follow-up|Adverse Event|1|||
144333463|NCT02008773|520425933|FG000|Overall Study|Adverse Event|3|||
144333464|NCT02008773|520425934|FG001|Overall Study|Adverse Event|3|||
144333465|NCT02008773|520425935|FG002|Overall Study|Adverse Event|1|||
144333466|NCT02008773|520425936|FG003|Overall Study|Adverse Event|2|||
144333467|NCT02008773|520425933|FG000|Overall Study|Medication Non-compliance|2|||
144333468|NCT02008773|520425934|FG001|Overall Study|Medication Non-compliance|1|||
144333469|NCT02008773|520425935|FG002|Overall Study|Medication Non-compliance|3|||
144333470|NCT02008773|520425936|FG003|Overall Study|Medication Non-compliance|2|||
144333471|NCT02008773|520425933|FG000|Overall Study|Withdrawal by Subject|8|||
144333472|NCT02008773|520425934|FG001|Overall Study|Withdrawal by Subject|4|||
144333473|NCT02008773|520425935|FG002|Overall Study|Withdrawal by Subject|7|||
144333474|NCT02008773|520425936|FG003|Overall Study|Withdrawal by Subject|6|||
144333475|NCT02008773|520425933|FG000|Overall Study|Lost to Follow-up|0|||
144333476|NCT02008773|520425934|FG001|Overall Study|Lost to Follow-up|1|||
144333477|NCT02008773|520425935|FG002|Overall Study|Lost to Follow-up|3|||
144333478|NCT02008773|520425936|FG003|Overall Study|Lost to Follow-up|2|||
144333479|NCT01806064|520425939|FG000|Overall Study|Randomized Not Enrolled|0|||
144333480|NCT01806064|520425940|FG001|Overall Study|Randomized Not Enrolled|0|||
144333481|NCT01806064|520425941|FG002|Overall Study|Randomized Not Enrolled|0|||
144333482|NCT01806064|520425942|FG003|Overall Study|Randomized Not Enrolled|1|||
144333483|NCT01806064|520425943|FG004|Overall Study|Randomized Not Enrolled|2|||
144333484|NCT01286077|520425944|FG000|Overall Study|Adverse Event|2|||
144333485|NCT01286077|520425945|FG001|Overall Study|Adverse Event|0|||
144333486|NCT01286077|520425944|FG000|Overall Study|Death|1|||
144333487|NCT01286077|520425945|FG001|Overall Study|Death|0|||
144333488|NCT01286077|520425944|FG000|Overall Study|Protocol Violation|1|||
144333489|NCT01286077|520425945|FG001|Overall Study|Protocol Violation|1|||
144333490|NCT01286077|520425944|FG000|Overall Study|Withdrawal by Subject|0|||
144333491|NCT01286077|520425945|FG001|Overall Study|Withdrawal by Subject|2|||
144333492|NCT01286077|520425944|FG000|Overall Study|Intercurrent illness|1|||
144333493|NCT01286077|520425945|FG001|Overall Study|Intercurrent illness|0|||
144333494|NCT01286077|520425944|FG000|Overall Study|Non-compliance|1|||
144333495|NCT01286077|520425945|FG001|Overall Study|Non-compliance|0|||
144333496|NCT01286077|520425944|FG000|Overall Study|The subject starts with alternative MMY|0|||
144333497|NCT01286077|520425945|FG001|Overall Study|The subject starts with alternative MMY|3|||
144333498|NCT01286077|520425944|FG000|Overall Study|Patient's decision to stop treatment|3|||
144333499|NCT01286077|520425945|FG001|Overall Study|Patient's decision to stop treatment|0|||
144333500|NCT01286077|520425944|FG000|Overall Study|Progression of disease|0|||
144333501|NCT01286077|520425945|FG001|Overall Study|Progression of disease|1|||
144333502|NCT01286077|520425944|FG000|Overall Study|refill medication not received in time|1|||
144333503|NCT01286077|520425945|FG001|Overall Study|refill medication not received in time|0|||
144333504|NCT02408523|520425946|FG000|Overall Study|Adverse Event|4|||
144333505|NCT02408523|520425947|FG001|Overall Study|Adverse Event|10|||
144333506|NCT02408523|520425946|FG000|Overall Study|Lack of Efficacy|0|||
144333507|NCT02408523|520425947|FG001|Overall Study|Lack of Efficacy|1|||
144333508|NCT02408523|520425946|FG000|Overall Study|Protocol Violation|1|||
144333509|NCT02408523|520425947|FG001|Overall Study|Protocol Violation|2|||
144333510|NCT02408523|520425946|FG000|Overall Study|Lost to Follow-up|2|||
144333511|NCT02408523|520425947|FG001|Overall Study|Lost to Follow-up|3|||
144333512|NCT02408523|520425946|FG000|Overall Study|Withdrawal by Subject|3|||
144333513|NCT02408523|520425947|FG001|Overall Study|Withdrawal by Subject|1|||
144333514|NCT02408523|520425946|FG000|Overall Study|Sponsor request|1|||
144333515|NCT02408523|520425947|FG001|Overall Study|Sponsor request|0|||
144333516|NCT02408523|520425946|FG000|Overall Study|Did not satisfy extension conditions|0|||
144333517|NCT02408523|520425947|FG001|Overall Study|Did not satisfy extension conditions|1|||
144333518|NCT04256512|520425948|FG000|Overall Study|Withdrawal by Subject|1|||
144333519|NCT02212678|520425956|FG000|Overall Study|Adverse Event|1|||
144333520|NCT02337634|520425957|FG000|Overall Study|Protocol Violation|3|||
144333521|NCT02337634|520425958|FG001|Overall Study|Protocol Violation|1|||
144333522|NCT02337634|520425957|FG000|Overall Study|Lost to Follow-up|1|||
144333523|NCT02337634|520425958|FG001|Overall Study|Lost to Follow-up|0|||
144333524|NCT04068610|520425959|FG000|Overall Study|Death|4|||
144333525|NCT04068610|520425960|FG001|Overall Study|Death|8|||
144333526|NCT04068610|520425961|FG002|Overall Study|Death|13|||
144333527|NCT04068610|520425959|FG000|Overall Study|Lost to Follow-up|0|||
144333528|NCT04068610|520425960|FG001|Overall Study|Lost to Follow-up|2|||
144333529|NCT04068610|520425961|FG002|Overall Study|Lost to Follow-up|0|||
144333530|NCT04068610|520425959|FG000|Overall Study|Withdrawal by Subject|0|||
144333531|NCT04068610|520425960|FG001|Overall Study|Withdrawal by Subject|4|||
144333532|NCT04068610|520425961|FG002|Overall Study|Withdrawal by Subject|2|||
144333533|NCT04068610|520425959|FG000|Overall Study|Other|3|||
144333534|NCT04068610|520425960|FG001|Overall Study|Other|12|||
144333535|NCT04068610|520425961|FG002|Overall Study|Other|11|||
144333536|NCT05601102|520425963|FG000|Overall Study|Death|1|||
144333537|NCT05601102|520425964|FG001|Overall Study|Death|2|||
144333538|NCT05601102|520425963|FG000|Overall Study|Withdrawal by Subject|1|||
144333539|NCT05601102|520425964|FG001|Overall Study|Withdrawal by Subject|1|||
144333540|NCT05601102|520425963|FG000|Overall Study|Lost to Follow-up|0|||
144333541|NCT05601102|520425964|FG001|Overall Study|Lost to Follow-up|2|||
144333542|NCT05288166|520425965|FG000|Overall Study|Adverse Event|1|||
144333543|NCT05288166|520425966|FG001|Overall Study|Adverse Event|0|||
144333544|NCT05288166|520425965|FG000|Overall Study|Lost to Follow-up|2|||
144333545|NCT05288166|520425966|FG001|Overall Study|Lost to Follow-up|0|||
144333546|NCT05288166|520425965|FG000|Overall Study|Physician Decision|0|||
144333547|NCT05288166|520425966|FG001|Overall Study|Physician Decision|2|||
144333548|NCT05288166|520425965|FG000|Overall Study|Screen Failure|1|||
144333549|NCT05288166|520425966|FG001|Overall Study|Screen Failure|1|||
144333550|NCT05288166|520425965|FG000|Overall Study|Withdrawal by Subject|4|||
144333551|NCT05288166|520425966|FG001|Overall Study|Withdrawal by Subject|2|||
144333552|NCT05288166|520425965|FG000|Overall Study|On Study Treatment|408|||
144333553|NCT05288166|520425966|FG001|Overall Study|On Study Treatment|418|||
144333554|NCT03007745|520425967|FG000|Overall Study|Sleep test negative for OSA|53|||
144333555|NCT03007745|520425968|FG001|Overall Study|Sleep test negative for OSA|49|||
144333556|NCT03007745|520425967|FG000|Overall Study|Physician Decision|6|||
144333557|NCT03007745|520425968|FG001|Overall Study|Physician Decision|9|||
144333558|NCT03007745|520425967|FG000|Overall Study|Withdrawal by Subject|38|||
144333559|NCT03007745|520425968|FG001|Overall Study|Withdrawal by Subject|16|||
144333560|NCT03007745|520425967|FG000|Overall Study|Lost to Follow-up|19|||
144333561|NCT03007745|520425968|FG001|Overall Study|Lost to Follow-up|25|||
144333562|NCT03007745|520425967|FG000|Overall Study|Unable to login to website|17|||
144333563|NCT03007745|520425968|FG001|Overall Study|Unable to login to website|4|||
144333564|NCT00431951|520425970|FG000|Overall Study|Inability to follow study procedures|1|||
144333565|NCT00431951|520425971|FG001|Overall Study|Inability to follow study procedures|0|||
144333566|NCT00431951|520425972|FG002|Overall Study|Inability to follow study procedures|1|||
144333567|NCT00431951|520425973|FG003|Overall Study|Inability to follow study procedures|2|||
144333568|NCT00431951|520425970|FG000|Overall Study|Lost to Follow-up|0|||
144333569|NCT00431951|520425971|FG001|Overall Study|Lost to Follow-up|1|||
144333570|NCT00431951|520425972|FG002|Overall Study|Lost to Follow-up|0|||
144333571|NCT00431951|520425973|FG003|Overall Study|Lost to Follow-up|0|||
144333572|NCT00431951|520425970|FG000|Overall Study|Withdrawal by Subject|0|||
144333573|NCT00431951|520425971|FG001|Overall Study|Withdrawal by Subject|1|||
144333574|NCT00431951|520425972|FG002|Overall Study|Withdrawal by Subject|0|||
144333575|NCT00431951|520425973|FG003|Overall Study|Withdrawal by Subject|0|||
144333576|NCT00431951|520425970|FG000|Overall Study|Adverse Event|0|||
144333577|NCT00431951|520425971|FG001|Overall Study|Adverse Event|0|||
144333578|NCT00431951|520425972|FG002|Overall Study|Adverse Event|1|||
144333579|NCT00431951|520425973|FG003|Overall Study|Adverse Event|0|||
144333580|NCT03968159|520425976|FG000|Overall Study|Adverse Event|4|||
144333581|NCT03968159|520425977|FG001|Overall Study|Adverse Event|4|||
144333582|NCT03968159|520425976|FG000|Overall Study|Lost to Follow-up|1|||
144333583|NCT03968159|520425977|FG001|Overall Study|Lost to Follow-up|1|||
144333584|NCT03968159|520425976|FG000|Overall Study|Use of prohibited medication|0|||
144333585|NCT03968159|520425977|FG001|Overall Study|Use of prohibited medication|1|||
144333586|NCT03968159|520425976|FG000|Overall Study|Protocol Violation|2|||
144333587|NCT03968159|520425977|FG001|Overall Study|Protocol Violation|2|||
144333588|NCT03968159|520425976|FG000|Overall Study|Withdrawal by Subject|4|||
144333589|NCT03968159|520425977|FG001|Overall Study|Withdrawal by Subject|6|||
144333590|NCT03968159|520425976|FG000|Overall Study|Lack of Efficacy|0|||
144333591|NCT03968159|520425977|FG001|Overall Study|Lack of Efficacy|1|||
144333592|NCT03968159|520425976|FG000|Overall Study|Not further specified|2|||
144333593|NCT03968159|520425977|FG001|Overall Study|Not further specified|0|||
144333594|NCT01299571|520425984|FG000|Overall Study|Protocol Violation|107|||
144333595|NCT00413010|520425985|FG000|Overall Study|Adverse Event|8|||
144333596|NCT00413010|520425986|FG001|Overall Study|Adverse Event|4|||
144333597|NCT00413010|520425985|FG000|Overall Study|Laboratory abnormality|0|||
144333598|NCT00413010|520425986|FG001|Overall Study|Laboratory abnormality|2|||
144333599|NCT00413010|520425985|FG000|Overall Study|Lack of Efficacy|0|||
144333600|NCT00413010|520425986|FG001|Overall Study|Lack of Efficacy|3|||
144333601|NCT00413010|520425985|FG000|Overall Study|Lost to Follow-up|3|||
144333602|NCT00413010|520425986|FG001|Overall Study|Lost to Follow-up|0|||
144333603|NCT00413010|520425985|FG000|Overall Study|Withdrawal by Subject|7|||
144333604|NCT00413010|520425986|FG001|Overall Study|Withdrawal by Subject|2|||
144333605|NCT00413010|520425985|FG000|Overall Study|Due to termination of the study|54|||
144333606|NCT00413010|520425986|FG001|Overall Study|Due to termination of the study|52|||
144333607|NCT00708734|520425987|FG000|Overall Study|scheduling conflict|2|||
144333608|NCT00708734|520425987|FG000|Overall Study|moved|1|||
144333609|NCT00708734|520425987|FG000|Overall Study|leg injury|1|||
144333610|NCT00708734|520425987|FG000|Overall Study|knee replacement|1|||
144333611|NCT00708734|520425987|FG000|Overall Study|vertigo|1|||
144333612|NCT00708734|520425987|FG000|Overall Study|leg fracture|1|||
144333613|NCT01533922|520425988|FG000|Overall Study|Adverse Event|5|||
144333614|NCT01533922|520425989|FG001|Overall Study|Adverse Event|8|||
144333615|NCT01533922|520425990|FG002|Overall Study|Adverse Event|6|||
144333616|NCT01533922|520425991|FG003|Overall Study|Adverse Event|3|||
144333617|NCT01533922|520425992|FG004|Overall Study|Adverse Event|4|||
144333618|NCT01533922|520425988|FG000|Overall Study|Lack of Efficacy|0|||
144333619|NCT01533922|520425989|FG001|Overall Study|Lack of Efficacy|0|||
144333620|NCT01533922|520425990|FG002|Overall Study|Lack of Efficacy|1|||
144333621|NCT01533922|520425991|FG003|Overall Study|Lack of Efficacy|0|||
144333622|NCT01533922|520425992|FG004|Overall Study|Lack of Efficacy|0|||
144333623|NCT01533922|520425988|FG000|Overall Study|Protocol Violation|0|||
144333624|NCT01533922|520425989|FG001|Overall Study|Protocol Violation|3|||
144333625|NCT01533922|520425990|FG002|Overall Study|Protocol Violation|0|||
144333626|NCT01533922|520425991|FG003|Overall Study|Protocol Violation|0|||
144333627|NCT01533922|520425992|FG004|Overall Study|Protocol Violation|1|||
144333628|NCT01533922|520425988|FG000|Overall Study|Withdrawal by Subject|3|||
144333629|NCT01533922|520425989|FG001|Overall Study|Withdrawal by Subject|1|||
144333630|NCT01533922|520425990|FG002|Overall Study|Withdrawal by Subject|2|||
144333631|NCT01533922|520425991|FG003|Overall Study|Withdrawal by Subject|2|||
144333632|NCT01533922|520425992|FG004|Overall Study|Withdrawal by Subject|1|||
144333633|NCT01533922|520425988|FG000|Overall Study|Other reason not defined above|2|||
144333634|NCT01533922|520425989|FG001|Overall Study|Other reason not defined above|0|||
144333635|NCT01533922|520425990|FG002|Overall Study|Other reason not defined above|1|||
144333636|NCT01533922|520425991|FG003|Overall Study|Other reason not defined above|0|||
144333637|NCT01533922|520425992|FG004|Overall Study|Other reason not defined above|0|||
144333638|NCT02634606|520425993|FG000|Overall Study|unable to obtain the drug at start|13|||
144333639|NCT05432167|520425996|FG000|Overall Study|Adverse Event|0|||
144333640|NCT05432167|520425997|FG001|Overall Study|Adverse Event|2|||
144333641|NCT05432167|520425998|FG002|Overall Study|Adverse Event|1|||
144333642|NCT05432167|520425996|FG000|Overall Study|Lost to Follow-up|3|||
144333643|NCT05432167|520425997|FG001|Overall Study|Lost to Follow-up|3|||
144333644|NCT05432167|520425998|FG002|Overall Study|Lost to Follow-up|2|||
144333645|NCT05432167|520425996|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
144333646|NCT05432167|520425997|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
144333647|NCT05432167|520425998|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
144333648|NCT05432167|520425996|FG000|Overall Study|Physician Decision|1|||
144333649|NCT05432167|520425997|FG001|Overall Study|Physician Decision|0|||
144333650|NCT05432167|520425998|FG002|Overall Study|Physician Decision|0|||
144333651|NCT05432167|520425996|FG000|Overall Study|Withdrawal by Subject|7|||
144333652|NCT05432167|520425997|FG001|Overall Study|Withdrawal by Subject|4|||
144333653|NCT05432167|520425998|FG002|Overall Study|Withdrawal by Subject|11|||
144333654|NCT05432167|520425996|FG000|Overall Study|Other|0|||
144333655|NCT05432167|520425997|FG001|Overall Study|Other|0|||
144333656|NCT05432167|520425998|FG002|Overall Study|Other|1|||
144333657|NCT01267175|520425999|FG000|Overall Study|Withdrawal by Subject|1|||
144333658|NCT01267175|520425999|FG000|Overall Study|Lost to Follow-up|1|||
144333659|NCT00353873|520426001|FG000|Overall Study|Protocol Violation|1|||
144333660|NCT00353873|520426002|FG001|Overall Study|Protocol Violation|2|||
144333661|NCT00353873|520426001|FG000|Overall Study|Exacerbation|1|||
144333662|NCT00353873|520426002|FG001|Overall Study|Exacerbation|0|||
144333663|NCT00353873|520426001|FG000|Overall Study|Adverse Event|1|||
144333664|NCT00353873|520426002|FG001|Overall Study|Adverse Event|0|||
144333665|NCT00353873|520426001|FG000|Overall Study|Physician Decision|2|||
144333666|NCT00353873|520426002|FG001|Overall Study|Physician Decision|0|||
144333667|NCT00353873|520426001|FG000|Overall Study|Withdrawal by Subject|1|||
144333668|NCT00353873|520426002|FG001|Overall Study|Withdrawal by Subject|1|||
144333669|NCT00286221|520426005|FG000|Overall Study|Protocol Violation|2|||
144333670|NCT00286221|520426006|FG001|Overall Study|Protocol Violation|1|||
144333671|NCT00286221|520426007|FG002|Overall Study|Protocol Violation|6|||
144333672|NCT00286221|520426008|FG003|Overall Study|Protocol Violation|4|||
144333673|NCT00286221|520426005|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
144333674|NCT00286221|520426006|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
144333675|NCT00286221|520426007|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
144333676|NCT00286221|520426008|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
144333677|NCT00286221|520426005|FG000|Overall Study|Inability to trigger PCA|2|||
144333678|NCT00286221|520426006|FG001|Overall Study|Inability to trigger PCA|0|||
144333679|NCT00286221|520426007|FG002|Overall Study|Inability to trigger PCA|0|||
144333680|NCT00286221|520426008|FG003|Overall Study|Inability to trigger PCA|0|||
144333681|NCT00286221|520426005|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
144333682|NCT00286221|520426006|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
144333683|NCT00286221|520426007|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
144333684|NCT00286221|520426008|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
144333685|NCT02690649|520426009|FG000|Overall Study|Withdrawal by Subject|1|||
144333686|NCT02690649|520426010|FG001|Overall Study|Withdrawal by Subject|1|||
144333687|NCT02690649|520426009|FG000|Overall Study|Protocol Violation|0|||
144333688|NCT02690649|520426010|FG001|Overall Study|Protocol Violation|3|||
144333689|NCT02276547|520426011|FG000|Overall Study|Death|2|||
144333690|NCT02276547|520426011|FG000|Overall Study|Explant|2|||
144333691|NCT00530920|520426012|FG000|Overall Study|Randomized but not treated|0|||
144333692|NCT00530920|520426013|FG001|Overall Study|Randomized but not treated|2|||
144333693|NCT00530920|520426014|FG002|Overall Study|Randomized but not treated|0|||
144333694|NCT00530920|520426012|FG000|Overall Study|Adverse Event|0|||
144333695|NCT00530920|520426013|FG001|Overall Study|Adverse Event|0|||
144333696|NCT00530920|520426014|FG002|Overall Study|Adverse Event|3|||
144333697|NCT00530920|520426012|FG000|Overall Study|Withdrawal by Subject|0|||
144333698|NCT00530920|520426013|FG001|Overall Study|Withdrawal by Subject|0|||
144333699|NCT00530920|520426014|FG002|Overall Study|Withdrawal by Subject|1|||
144333700|NCT02616393|520426019|FG000|Overall Study|Death|5|||
144333701|NCT02616393|520426020|FG001|Overall Study|Death|12|||
144333702|NCT02616393|520426021|FG002|Overall Study|Death|1|||
144333703|NCT02616393|520426019|FG000|Overall Study|Termination by Sponsor|4|||
144333704|NCT02616393|520426020|FG001|Overall Study|Termination by Sponsor|5|||
144333705|NCT02616393|520426021|FG002|Overall Study|Termination by Sponsor|2|||
144333706|NCT02616393|520426019|FG000|Overall Study|Other|3|||
144333707|NCT02616393|520426020|FG001|Overall Study|Other|0|||
144333708|NCT02616393|520426021|FG002|Overall Study|Other|0|||
144333709|NCT02616393|520426019|FG000|Overall Study|Withdrawal by Subject|1|||
144333710|NCT02616393|520426020|FG001|Overall Study|Withdrawal by Subject|1|||
144333711|NCT02616393|520426021|FG002|Overall Study|Withdrawal by Subject|0|||
144333712|NCT02616393|520426019|FG000|Overall Study|Lost to Follow-up|0|||
144333713|NCT02616393|520426020|FG001|Overall Study|Lost to Follow-up|2|||
144333714|NCT02616393|520426021|FG002|Overall Study|Lost to Follow-up|0|||
144333715|NCT02713867|520426022|FG000|Randomization|Other Reason|2|||
144333716|NCT02713867|520426023|FG001|Randomization|Other Reason|1|||
144333717|NCT02713867|520426022|FG000|Randomization|Participant Withdrew consent|0|||
144333718|NCT02713867|520426023|FG001|Randomization|Participant Withdrew consent|2|||
144333719|NCT02713867|520426022|FG000|Treatment Period|Other Reasons|22|||
144333720|NCT02713867|520426023|FG001|Treatment Period|Other Reasons|28|||
144333721|NCT02713867|520426022|FG000|Treatment Period|Administrative reason by sponsor|21|||
144333722|NCT02713867|520426023|FG001|Treatment Period|Administrative reason by sponsor|16|||
144333723|NCT02713867|520426022|FG000|Treatment Period|No longer meets study criteria|2|||
144333724|NCT02713867|520426023|FG001|Treatment Period|No longer meets study criteria|1|||
144333725|NCT02713867|520426022|FG000|Treatment Period|Poor/Non Compliance|1|||
144333726|NCT02713867|520426023|FG001|Treatment Period|Poor/Non Compliance|0|||
144333727|NCT02713867|520426022|FG000|Treatment Period|Maximum Clinical Benefit|5|||
144333728|NCT02713867|520426023|FG001|Treatment Period|Maximum Clinical Benefit|6|||
144333729|NCT02713867|520426022|FG000|Treatment Period|Withdrew consent|3|||
144333730|NCT02713867|520426023|FG001|Treatment Period|Withdrew consent|6|||
144333731|NCT02713867|520426022|FG000|Treatment Period|Requested to Discontinue|8|||
144333732|NCT02713867|520426023|FG001|Treatment Period|Requested to Discontinue|8|||
144333733|NCT02713867|520426022|FG000|Treatment Period|AE unrelated to Study Drug|11|||
144333734|NCT02713867|520426023|FG001|Treatment Period|AE unrelated to Study Drug|10|||
144333735|NCT02713867|520426022|FG000|Treatment Period|Death|7|||
144333736|NCT02713867|520426023|FG001|Treatment Period|Death|3|||
144333737|NCT02713867|520426022|FG000|Treatment Period|Study Drug Toxicity|16|||
144333738|NCT02713867|520426023|FG001|Treatment Period|Study Drug Toxicity|19|||
144333739|NCT02713867|520426022|FG000|Treatment Period|Disease Progression|82|||
144333740|NCT02713867|520426023|FG001|Treatment Period|Disease Progression|83|||
144333741|NCT03242018|520426027|FG000|Overall Study|Adverse Event|7|||
144333742|NCT03242018|520426028|FG001|Overall Study|Adverse Event|7|||
144333743|NCT03242018|520426029|FG002|Overall Study|Adverse Event|6|||
144333744|NCT03242018|520426027|FG000|Overall Study|Lost to Follow-up|2|||
144333745|NCT03242018|520426028|FG001|Overall Study|Lost to Follow-up|2|||
144333746|NCT03242018|520426029|FG002|Overall Study|Lost to Follow-up|2|||
144333747|NCT03242018|520426027|FG000|Overall Study|At the Participant's Own Request|5|||
144333748|NCT03242018|520426028|FG001|Overall Study|At the Participant's Own Request|1|||
144333749|NCT03242018|520426029|FG002|Overall Study|At the Participant's Own Request|4|||
144333750|NCT03242018|520426027|FG000|Overall Study|Reason Not Specified|3|||
144333751|NCT03242018|520426028|FG001|Overall Study|Reason Not Specified|4|||
144333752|NCT03242018|520426029|FG002|Overall Study|Reason Not Specified|1|||
144333753|NCT03242018|520426027|FG000|Overall Study|Study Terminated by Sponsor|1|||
144333754|NCT03242018|520426028|FG001|Overall Study|Study Terminated by Sponsor|0|||
144333755|NCT03242018|520426029|FG002|Overall Study|Study Terminated by Sponsor|1|||
144333756|NCT00249613|520426030|FG000|12 Month Follow-up|Death|1|||
144333757|NCT00249613|520426031|FG001|12 Month Follow-up|Death|1|||
144333758|NCT00249613|520426030|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
144333759|NCT00249613|520426031|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
144333760|NCT00249613|520426030|FG000|12 Month Follow-up|Lost to Follow-up|10|||
144333761|NCT00249613|520426031|FG001|12 Month Follow-up|Lost to Follow-up|8|||
144333762|NCT00806442|520426033|FG000|Overall Study|Lost to Follow-up|3|||
144333763|NCT00806442|520426034|FG001|Overall Study|Lost to Follow-up|2|||
144333764|NCT00806442|520426033|FG000|Overall Study|Withdrawal by Subject|1|||
144333765|NCT00806442|520426034|FG001|Overall Study|Withdrawal by Subject|5|||
144333766|NCT02544373|520426036|FG000|Overall Study|Lost to Follow-up|5|||
144333767|NCT02544373|520426037|FG001|Overall Study|Lost to Follow-up|3|||
144333768|NCT02544373|520426036|FG000|Overall Study|Withdrawal by Subject|8|||
144333769|NCT02544373|520426037|FG001|Overall Study|Withdrawal by Subject|2|||
144333770|NCT02404649|520426038|FG000|Overall Study|Adverse Event|1|||
144333771|NCT02404649|520426039|FG001|Overall Study|Adverse Event|2|||
144333772|NCT00162266|520426043|FG000|Double-Blind Period|Adverse Event|5|||
144333773|NCT00162266|520426044|FG001|Double-Blind Period|Adverse Event|9|||
144333774|NCT00162266|520426045|FG002|Double-Blind Period|Adverse Event|11|||
144333775|NCT00162266|520426046|FG003|Double-Blind Period|Adverse Event|0|||
144333776|NCT00162266|520426043|FG000|Double-Blind Period|Death|0|||
144333777|NCT00162266|520426044|FG001|Double-Blind Period|Death|1|||
144333778|NCT00162266|520426045|FG002|Double-Blind Period|Death|0|||
144333779|NCT00162266|520426046|FG003|Double-Blind Period|Death|0|||
144333780|NCT00162266|520426043|FG000|Double-Blind Period|Lost to Follow-up|1|||
144333781|NCT00162266|520426044|FG001|Double-Blind Period|Lost to Follow-up|2|||
144333782|NCT00162266|520426045|FG002|Double-Blind Period|Lost to Follow-up|0|||
144333783|NCT00162266|520426046|FG003|Double-Blind Period|Lost to Follow-up|0|||
144333784|NCT00162266|520426043|FG000|Double-Blind Period|Other Reason|1|||
144333785|NCT00162266|520426044|FG001|Double-Blind Period|Other Reason|0|||
144333786|NCT00162266|520426045|FG002|Double-Blind Period|Other Reason|1|||
144333787|NCT00162266|520426046|FG003|Double-Blind Period|Other Reason|0|||
144333788|NCT00162266|520426043|FG000|Double-Blind Period|Lack of Efficacy|13|||
144333789|NCT00162266|520426044|FG001|Double-Blind Period|Lack of Efficacy|17|||
144333790|NCT00162266|520426045|FG002|Double-Blind Period|Lack of Efficacy|30|||
144333791|NCT00162266|520426046|FG003|Double-Blind Period|Lack of Efficacy|0|||
144333792|NCT00162266|520426043|FG000|Double-Blind Period|Withdrawal by Subject|5|||
144333793|NCT00162266|520426044|FG001|Double-Blind Period|Withdrawal by Subject|2|||
144333794|NCT00162266|520426045|FG002|Double-Blind Period|Withdrawal by Subject|6|||
144333795|NCT00162266|520426046|FG003|Double-Blind Period|Withdrawal by Subject|0|||
144333796|NCT00162266|520426043|FG000|Open-Label Period|Death|0|||
144333797|NCT00162266|520426044|FG001|Open-Label Period|Death|0|||
144333798|NCT00162266|520426045|FG002|Open-Label Period|Death|0|||
144333799|NCT00162266|520426046|FG003|Open-Label Period|Death|7|||
144333800|NCT00162266|520426043|FG000|Open-Label Period|Adverse Event|0|||
144333801|NCT00162266|520426044|FG001|Open-Label Period|Adverse Event|0|||
144333802|NCT00162266|520426045|FG002|Open-Label Period|Adverse Event|0|||
144333803|NCT00162266|520426046|FG003|Open-Label Period|Adverse Event|46|||
144333804|NCT00162266|520426043|FG000|Open-Label Period|Lack of Efficacy|0|||
144333805|NCT00162266|520426044|FG001|Open-Label Period|Lack of Efficacy|0|||
144333806|NCT00162266|520426045|FG002|Open-Label Period|Lack of Efficacy|0|||
144333807|NCT00162266|520426046|FG003|Open-Label Period|Lack of Efficacy|26|||
144333808|NCT00162266|520426043|FG000|Open-Label Period|Lost to Follow-up|0|||
144333809|NCT00162266|520426044|FG001|Open-Label Period|Lost to Follow-up|0|||
144333810|NCT00162266|520426045|FG002|Open-Label Period|Lost to Follow-up|0|||
144333811|NCT00162266|520426046|FG003|Open-Label Period|Lost to Follow-up|3|||
144333812|NCT00162266|520426043|FG000|Open-Label Period|Withdrawal by Subject|0|||
144333813|NCT00162266|520426044|FG001|Open-Label Period|Withdrawal by Subject|0|||
144333814|NCT00162266|520426045|FG002|Open-Label Period|Withdrawal by Subject|0|||
144333815|NCT00162266|520426046|FG003|Open-Label Period|Withdrawal by Subject|31|||
144333816|NCT00162266|520426043|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
144333817|NCT00162266|520426044|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
144333818|NCT00162266|520426045|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
144333819|NCT00162266|520426046|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
144333820|NCT00162266|520426043|FG000|Open-Label Period|Other Reasons|0|||
144333821|NCT00162266|520426044|FG001|Open-Label Period|Other Reasons|0|||
144333822|NCT00162266|520426045|FG002|Open-Label Period|Other Reasons|0|||
144333823|NCT00162266|520426046|FG003|Open-Label Period|Other Reasons|15|||
144333824|NCT04208087|520426047|FG000|Overall Study|Adverse Event|1|||
144333825|NCT04208087|520426048|FG001|Overall Study|Adverse Event|0|||
144333826|NCT04208087|520426049|FG002|Overall Study|Adverse Event|0|||
144333827|NCT04208087|520426050|FG003|Overall Study|Adverse Event|0|||
144333828|NCT04208087|520426051|FG004|Overall Study|Adverse Event|0|||
144333829|NCT04208087|520426047|FG000|Overall Study|Withdrawal by Subject|0|||
144333830|NCT04208087|520426048|FG001|Overall Study|Withdrawal by Subject|0|||
144333831|NCT04208087|520426049|FG002|Overall Study|Withdrawal by Subject|1|||
144333832|NCT04208087|520426050|FG003|Overall Study|Withdrawal by Subject|0|||
144333833|NCT04208087|520426051|FG004|Overall Study|Withdrawal by Subject|0|||
144333834|NCT04208087|520426047|FG000|Overall Study|Other|0|||
144333835|NCT04208087|520426048|FG001|Overall Study|Other|0|||
144333836|NCT04208087|520426049|FG002|Overall Study|Other|0|||
144333837|NCT04208087|520426050|FG003|Overall Study|Other|0|||
144333838|NCT04208087|520426051|FG004|Overall Study|Other|1|||
144333839|NCT01839656|520426052|FG000|Overall Study|Withdrawal by Subject|1|||
144333840|NCT01839656|520426053|FG001|Overall Study|Withdrawal by Subject|1|||
144333841|NCT01839656|520426052|FG000|Overall Study|Adverse event, serious fatal|1|||
144333842|NCT01839656|520426053|FG001|Overall Study|Adverse event, serious fatal|4|||
144333843|NCT01839656|520426052|FG000|Overall Study|Early study closure|0|||
144333844|NCT01839656|520426053|FG001|Overall Study|Early study closure|11|||
144333845|NCT01839656|520426052|FG000|Overall Study|Adverse Event|1|||
144333846|NCT01839656|520426053|FG001|Overall Study|Adverse Event|0|||
144333847|NCT03938324|520427402|FG000|Overall Study|Lost to Follow-up|42|||
144333848|NCT03938324|520427403|FG001|Overall Study|Lost to Follow-up|21|||
144333849|NCT03938324|520427402|FG000|Overall Study|Withdrawal by Subject|6|||
144333850|NCT03938324|520427403|FG001|Overall Study|Withdrawal by Subject|1|||
144333851|NCT01073930|520427405|FG000|Overall Study|Withdrawal by Subject|3|||
144333852|NCT01073930|520427406|FG001|Overall Study|Withdrawal by Subject|2|||
144333853|NCT01073930|520427405|FG000|Overall Study|Lost to Follow-up|0|||
144333854|NCT01073930|520427406|FG001|Overall Study|Lost to Follow-up|1|||
144333855|NCT01073930|520427405|FG000|Overall Study|Adverse Event|0|||
144333856|NCT01073930|520427406|FG001|Overall Study|Adverse Event|1|||
144333857|NCT01073930|520427405|FG000|Overall Study|Noncompliance with study drug|0|||
144333858|NCT01073930|520427406|FG001|Overall Study|Noncompliance with study drug|1|||
144333859|NCT01073930|520427405|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
144333860|NCT01073930|520427406|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
144333861|NCT01266590|520427407|FG000|Overall Study|Adverse Event|3|||
144333862|NCT01266590|520427407|FG000|Overall Study|Lost to Follow-up|1|||
144333863|NCT01266590|520427407|FG000|Overall Study|Withdrawal by Subject|1|||
144333864|NCT01266590|520427407|FG000|Overall Study|Physician Decision|1|||
144333865|NCT00720343|520427410|FG000|Overall Study|Lost to Follow-up|1|||
144333866|NCT00720343|520427411|FG001|Overall Study|Lost to Follow-up|0|||
144333867|NCT00720343|520427410|FG000|Overall Study|Protocol Violation|0|||
144333868|NCT00720343|520427411|FG001|Overall Study|Protocol Violation|2|||
144333869|NCT04435600|520427412|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333870|NCT04435600|520427413|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333871|NCT04435600|520427414|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
144333872|NCT04435600|520427415|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333873|NCT04435600|520427416|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333874|NCT04435600|520427417|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333875|NCT04435600|520427418|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333876|NCT04435600|520427419|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333877|NCT04435600|520427420|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333878|NCT04435600|520427421|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
144333879|NCT04435600|520427412|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333880|NCT04435600|520427413|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333881|NCT04435600|520427414|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333882|NCT04435600|520427415|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333883|NCT04435600|520427416|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333884|NCT04435600|520427417|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333885|NCT04435600|520427418|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333886|NCT04435600|520427419|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333887|NCT04435600|520427420|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
144333888|NCT04435600|520427421|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
144333889|NCT04435600|520427412|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333890|NCT04435600|520427413|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333891|NCT04435600|520427414|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333892|NCT04435600|520427415|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333893|NCT04435600|520427416|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333894|NCT04435600|520427417|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333895|NCT04435600|520427418|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333896|NCT04435600|520427419|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333897|NCT04435600|520427420|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
144333898|NCT04435600|520427421|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
144333899|NCT04435600|520427412|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333900|NCT04435600|520427413|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333901|NCT04435600|520427414|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333902|NCT04435600|520427415|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333903|NCT04435600|520427416|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333904|NCT04435600|520427417|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333905|NCT04435600|520427418|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333906|NCT04435600|520427419|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333907|NCT04435600|520427420|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
144333908|NCT04435600|520427421|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
144333909|NCT02797184|520427424|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
144333910|NCT02797184|520427425|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
144333911|NCT01300351|520427428|FG000|Overall Study|Did not receive treatment|2|||
144333912|NCT01300351|520427429|FG001|Overall Study|Did not receive treatment|0|||
144333913|NCT01300351|520427428|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
144333914|NCT01300351|520427429|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
144333915|NCT01300351|520427428|FG000|Overall Study|Lost to Follow-up|0|||
144333916|NCT01300351|520427429|FG001|Overall Study|Lost to Follow-up|1|||
144333917|NCT01300351|520427428|FG000|Overall Study|Adverse Event|0|||
144333918|NCT01300351|520427429|FG001|Overall Study|Adverse Event|4|||
144333919|NCT01300351|520427428|FG000|Overall Study|Withdrawal by Subject|7|||
144333920|NCT01300351|520427429|FG001|Overall Study|Withdrawal by Subject|10|||
144333921|NCT02258529|520427431|FG000|Overall Study|Study Terminated by Sponsor|9|||
144333922|NCT02258529|520427431|FG000|Overall Study|Adverse Event|1|||
144333923|NCT00443781|520427432|FG000|Overall Study|Lost to Follow-up|10|||
144333924|NCT00443781|520427432|FG000|Overall Study|Physician Decision|2|||
144333925|NCT00443781|520427432|FG000|Overall Study|Protocol Violation|1|||
144333926|NCT00443781|520427432|FG000|Overall Study|Withdrawal by Subject|6|||
144333927|NCT00443781|520427432|FG000|Overall Study|Unable to comply with study follow up|2|||
144333928|NCT00443781|520427432|FG000|Overall Study|Investigator terminated participation|1|||
144333929|NCT00443781|520427432|FG000|Overall Study|Insurance not covered|2|||
144333930|NCT00443781|520427432|FG000|Overall Study|PD/FAD not done|1|||
144333931|NCT02066415|520427433|FG000|Overall Study|Decision by Sponsor|5|||
144333932|NCT02066415|520427434|FG001|Overall Study|Decision by Sponsor|4|||
144333933|NCT02066415|520427435|FG002|Overall Study|Decision by Sponsor|2|||
144333934|NCT02066415|520427433|FG000|Overall Study|Withdrawal by Subject|9|||
144333935|NCT02066415|520427434|FG001|Overall Study|Withdrawal by Subject|1|||
144333936|NCT02066415|520427435|FG002|Overall Study|Withdrawal by Subject|4|||
144333937|NCT02066415|520427433|FG000|Overall Study|Lost to Follow-up|7|||
144333938|NCT02066415|520427434|FG001|Overall Study|Lost to Follow-up|2|||
144333939|NCT02066415|520427435|FG002|Overall Study|Lost to Follow-up|2|||
144333940|NCT00430937|520427436|FG000|Overall Study|Adverse Event|3|||
144333941|NCT00430937|520427437|FG001|Overall Study|Adverse Event|8|||
144333942|NCT00430937|520427436|FG000|Overall Study|Death|0|||
144333943|NCT00430937|520427437|FG001|Overall Study|Death|1|||
144333944|NCT00430937|520427436|FG000|Overall Study|Lost to Follow-up|6|||
144333945|NCT00430937|520427437|FG001|Overall Study|Lost to Follow-up|6|||
144333946|NCT00430937|520427436|FG000|Overall Study|Withdrawal by Subject|5|||
144333947|NCT00430937|520427437|FG001|Overall Study|Withdrawal by Subject|2|||
144333948|NCT00430937|520427436|FG000|Overall Study|Protocol Violation|3|||
144333949|NCT00430937|520427437|FG001|Overall Study|Protocol Violation|2|||
144333950|NCT00430937|520427436|FG000|Overall Study|Lack of Efficacy|6|||
144333951|NCT00430937|520427437|FG001|Overall Study|Lack of Efficacy|5|||
144333952|NCT00430937|520427436|FG000|Overall Study|Inappropriate enrollment|2|||
144333953|NCT00430937|520427437|FG001|Overall Study|Inappropriate enrollment|1|||
144333954|NCT00430937|520427436|FG000|Overall Study|Administrative reasons|1|||
144333955|NCT00430937|520427437|FG001|Overall Study|Administrative reasons|0|||
144333956|NCT00430937|520427436|FG000|Overall Study|Protocol discontinuation criteria met|1|||
144333957|NCT00430937|520427437|FG001|Overall Study|Protocol discontinuation criteria met|2|||
144333958|NCT00430937|520427436|FG000|Overall Study|Unable to classify|0|||
144333959|NCT00430937|520427437|FG001|Overall Study|Unable to classify|1|||
144333960|NCT03743064|520427438|FG000|Overall Study|Adverse Event|7|||
144333961|NCT03743064|520427439|FG001|Overall Study|Adverse Event|9|||
144333962|NCT03743064|520427438|FG000|Overall Study|Death|25|||
144333963|NCT03743064|520427439|FG001|Overall Study|Death|28|||
144333964|NCT03743064|520427438|FG000|Overall Study|Lost to Follow-up|3|||
144333965|NCT03743064|520427439|FG001|Overall Study|Lost to Follow-up|6|||
144333966|NCT03743064|520427438|FG000|Overall Study|Withdrawal by Subject|28|||
144333967|NCT03743064|520427439|FG001|Overall Study|Withdrawal by Subject|25|||
144333968|NCT03743064|520427438|FG000|Overall Study|Physician Decision|2|||
144333969|NCT03743064|520427439|FG001|Overall Study|Physician Decision|4|||
144333970|NCT03743064|520427438|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
144333971|NCT03743064|520427439|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
144333972|NCT02553538|520427445|FG000|Overall Study|Could Not Reach by Telephone|133|||
144333973|NCT02553538|520427446|FG001|Overall Study|Could Not Reach by Telephone|0|||
144333974|NCT02553538|520427445|FG000|Overall Study|Died or Left Network|54|||
144333975|NCT02553538|520427446|FG001|Overall Study|Died or Left Network|56|||
144333976|NCT02648217|520427447|FG000|Overall Study|Adverse Event|0|||
144333977|NCT02648217|520427448|FG001|Overall Study|Adverse Event|1|||
144333978|NCT02648217|520427447|FG000|Overall Study|Lost to Follow-up|1|||
144333979|NCT02648217|520427448|FG001|Overall Study|Lost to Follow-up|1|||
144333980|NCT02648217|520427447|FG000|Overall Study|Withdrawal by Subject|4|||
144333981|NCT02648217|520427448|FG001|Overall Study|Withdrawal by Subject|3|||
144333982|NCT02648217|520427447|FG000|Overall Study|Unclassified|5|||
144333983|NCT02648217|520427448|FG001|Overall Study|Unclassified|0|||
144333984|NCT04094584|520427449|FG000|Overall Study|No interest in study|88|||
144333985|NCT04094584|520427449|FG000|Overall Study|Unwilling to undergo screening tests|36|||
144333986|NCT04094584|520427449|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
144333987|NCT04094584|520427449|FG000|Overall Study|Opioid use|7|||
144333988|NCT04094584|520427449|FG000|Overall Study|Need for major surgery in study period|4|||
144333989|NCT04094584|520427449|FG000|Overall Study|eligible but declined enrollment|4|||
144333990|NCT04094584|520427449|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
144333991|NCT04094584|520427449|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
144333992|NCT04094584|520427449|FG000|Overall Study|Lost to Follow-up|3|||
144333993|NCT04094584|520427449|FG000|Overall Study|Withdrawal by Subject|2|||
144333994|NCT00106691|520427450|FG000|Overall Study|Adverse Event|60|||
144333995|NCT00106691|520427451|FG001|Overall Study|Adverse Event|64|||
144333996|NCT00106691|520427450|FG000|Overall Study|Lost to Follow-up|23|||
144333997|NCT00106691|520427451|FG001|Overall Study|Lost to Follow-up|18|||
144333998|NCT00106691|520427450|FG000|Overall Study|Physician Decision|18|||
144333999|NCT00106691|520427451|FG001|Overall Study|Physician Decision|21|||
144334000|NCT00106691|520427450|FG000|Overall Study|Protocol Violation|13|||
144334001|NCT00106691|520427451|FG001|Overall Study|Protocol Violation|18|||
144334002|NCT00106691|520427450|FG000|Overall Study|Withdrawal by Subject|75|||
144334003|NCT00106691|520427451|FG001|Overall Study|Withdrawal by Subject|70|||
144334004|NCT00106691|520427450|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
144334005|NCT00106691|520427451|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
144334006|NCT00106691|520427450|FG000|Overall Study|QTc>480|3|||
144334007|NCT00106691|520427451|FG001|Overall Study|QTc>480|1|||
144334008|NCT00106691|520427450|FG000|Overall Study|mililtary deployment|2|||
144334009|NCT00106691|520427451|FG001|Overall Study|mililtary deployment|0|||
144334010|NCT00106691|520427450|FG000|Overall Study|Study Site Closing/PI Moved|1|||
144334011|NCT00106691|520427451|FG001|Overall Study|Study Site Closing/PI Moved|2|||
144334012|NCT00106691|520427450|FG000|Overall Study|Cardiologist recommendation|1|||
144334013|NCT00106691|520427451|FG001|Overall Study|Cardiologist recommendation|0|||
144334014|NCT00106691|520427450|FG000|Overall Study|Pt. moved to another state|1|||
144334015|NCT00106691|520427451|FG001|Overall Study|Pt. moved to another state|0|||
144334016|NCT00106691|520427450|FG000|Overall Study|Taking exclusionary avodart|1|||
144334017|NCT00106691|520427451|FG001|Overall Study|Taking exclusionary avodart|0|||
144334018|NCT00106691|520427450|FG000|Overall Study|Not able to discontinue plavix|0|||
144334019|NCT00106691|520427451|FG001|Overall Study|Not able to discontinue plavix|1|||
144334020|NCT00907296|520427452|FG000|Overall Study|Ineligibility Determined|1|||
144334021|NCT00907296|520427453|FG001|Overall Study|Ineligibility Determined|0|||
144334022|NCT00907296|520427454|FG002|Overall Study|Ineligibility Determined|0|||
144334023|NCT00907296|520427455|FG003|Overall Study|Ineligibility Determined|1|||
144334024|NCT00907296|520427456|FG004|Overall Study|Ineligibility Determined|0|||
144334025|NCT00907296|520427457|FG005|Overall Study|Ineligibility Determined|0|||
144334026|NCT00907296|520427458|FG006|Overall Study|Ineligibility Determined|0|||
144334027|NCT00907296|520427459|FG007|Overall Study|Ineligibility Determined|1|||
144334028|NCT00907296|520427460|FG008|Overall Study|Ineligibility Determined|0|||
144334029|NCT00907296|520427461|FG009|Overall Study|Ineligibility Determined|0|||
144334030|NCT00907296|520427452|FG000|Overall Study|Protocol Deviation|0|||
144334031|NCT00907296|520427453|FG001|Overall Study|Protocol Deviation|1|||
144334032|NCT00907296|520427454|FG002|Overall Study|Protocol Deviation|0|||
144334033|NCT00907296|520427455|FG003|Overall Study|Protocol Deviation|0|||
144334034|NCT00907296|520427456|FG004|Overall Study|Protocol Deviation|0|||
144334035|NCT00907296|520427457|FG005|Overall Study|Protocol Deviation|0|||
144334036|NCT00907296|520427458|FG006|Overall Study|Protocol Deviation|0|||
144334037|NCT00907296|520427459|FG007|Overall Study|Protocol Deviation|0|||
144334038|NCT00907296|520427460|FG008|Overall Study|Protocol Deviation|0|||
144334039|NCT00907296|520427461|FG009|Overall Study|Protocol Deviation|0|||
144334040|NCT00907296|520427452|FG000|Overall Study|Noncompliance|1|||
144334041|NCT00907296|520427453|FG001|Overall Study|Noncompliance|1|||
144334042|NCT00907296|520427454|FG002|Overall Study|Noncompliance|1|||
144334043|NCT00907296|520427455|FG003|Overall Study|Noncompliance|0|||
144334044|NCT00907296|520427456|FG004|Overall Study|Noncompliance|0|||
144334045|NCT00907296|520427457|FG005|Overall Study|Noncompliance|1|||
144334046|NCT00907296|520427458|FG006|Overall Study|Noncompliance|0|||
144334047|NCT00907296|520427459|FG007|Overall Study|Noncompliance|2|||
144334048|NCT00907296|520427460|FG008|Overall Study|Noncompliance|0|||
144334049|NCT00907296|520427461|FG009|Overall Study|Noncompliance|0|||
144334050|NCT00907296|520427452|FG000|Overall Study|Adverse Event|2|||
144334051|NCT00907296|520427453|FG001|Overall Study|Adverse Event|0|||
144334052|NCT00907296|520427454|FG002|Overall Study|Adverse Event|0|||
144334053|NCT00907296|520427455|FG003|Overall Study|Adverse Event|0|||
144334054|NCT00907296|520427456|FG004|Overall Study|Adverse Event|0|||
144334055|NCT00907296|520427457|FG005|Overall Study|Adverse Event|0|||
144334056|NCT00907296|520427458|FG006|Overall Study|Adverse Event|1|||
144334057|NCT00907296|520427459|FG007|Overall Study|Adverse Event|0|||
144334058|NCT00907296|520427460|FG008|Overall Study|Adverse Event|0|||
144334059|NCT00907296|520427461|FG009|Overall Study|Adverse Event|1|||
144334060|NCT00907296|520427452|FG000|Overall Study|Withdrawal by Subject|7|||
144334061|NCT00907296|520427453|FG001|Overall Study|Withdrawal by Subject|2|||
144334062|NCT00907296|520427454|FG002|Overall Study|Withdrawal by Subject|1|||
144334063|NCT00907296|520427455|FG003|Overall Study|Withdrawal by Subject|1|||
144334064|NCT00907296|520427456|FG004|Overall Study|Withdrawal by Subject|1|||
144334065|NCT00907296|520427457|FG005|Overall Study|Withdrawal by Subject|5|||
144334066|NCT00907296|520427458|FG006|Overall Study|Withdrawal by Subject|3|||
144334067|NCT00907296|520427459|FG007|Overall Study|Withdrawal by Subject|2|||
144334068|NCT00907296|520427460|FG008|Overall Study|Withdrawal by Subject|4|||
144334069|NCT00907296|520427461|FG009|Overall Study|Withdrawal by Subject|2|||
144334070|NCT00907296|520427452|FG000|Overall Study|Lost to Follow-up|9|||
144334071|NCT00907296|520427453|FG001|Overall Study|Lost to Follow-up|1|||
144334072|NCT00907296|520427454|FG002|Overall Study|Lost to Follow-up|0|||
144334073|NCT00907296|520427455|FG003|Overall Study|Lost to Follow-up|2|||
144334074|NCT00907296|520427456|FG004|Overall Study|Lost to Follow-up|0|||
144334075|NCT00907296|520427457|FG005|Overall Study|Lost to Follow-up|3|||
144334076|NCT00907296|520427458|FG006|Overall Study|Lost to Follow-up|2|||
144334077|NCT00907296|520427459|FG007|Overall Study|Lost to Follow-up|2|||
144334078|NCT00907296|520427460|FG008|Overall Study|Lost to Follow-up|0|||
144334079|NCT00907296|520427461|FG009|Overall Study|Lost to Follow-up|4|||
144334080|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
144334081|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
144334082|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
144334083|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
144334084|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
144334085|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
144334086|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
144334087|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
144334088|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
144334089|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
144334090|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
144334091|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
144334092|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
144334093|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
144334094|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
144334095|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
144334096|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
144334097|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
144334098|NCT01302054|520427467|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
144334099|NCT01302054|520427468|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
144334100|NCT01302054|520427469|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
144334101|NCT01302054|520427467|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
144334102|NCT01302054|520427468|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
144334103|NCT01302054|520427469|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
144334104|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
144334105|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
144334106|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
144334107|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
144334108|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
144334109|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
144334110|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
144334111|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
144334112|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
144334113|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
144334114|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
144334115|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
144334116|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
144334117|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
144334118|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
144334119|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
144334120|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
144334121|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
144334122|NCT01302054|520427467|FG000|Double-Blind Treatment Phase|Other|0|||
144334123|NCT01302054|520427468|FG001|Double-Blind Treatment Phase|Other|4|||
144334124|NCT01302054|520427469|FG002|Double-Blind Treatment Phase|Other|9|||
144334125|NCT00857948|520427470|FG000|Overall Study|Withdrawal by Subject|2|||
144334126|NCT00857948|520427471|FG001|Overall Study|Withdrawal by Subject|0|||
144334127|NCT00857948|520427472|FG002|Overall Study|Withdrawal by Subject|0|||
144334128|NCT00857948|520427473|FG003|Overall Study|Withdrawal by Subject|0|||
144334129|NCT00857948|520427470|FG000|Overall Study|Protocol Violation|1|||
144334130|NCT00857948|520427471|FG001|Overall Study|Protocol Violation|0|||
144334131|NCT00857948|520427472|FG002|Overall Study|Protocol Violation|1|||
144334132|NCT00857948|520427473|FG003|Overall Study|Protocol Violation|0|||
144334133|NCT04135859|520427475|FG000|Overall Study|Withdrawal by Subject|1|||
144334134|NCT04135859|520427476|FG001|Overall Study|Withdrawal by Subject|0|||
144334135|NCT04135859|520427475|FG000|Overall Study|Withdrawal due to screening failure|1|||
144334136|NCT04135859|520427476|FG001|Overall Study|Withdrawal due to screening failure|2|||
144334137|NCT04135859|520427475|FG000|Overall Study|Did not complete stress test|3|||
144334138|NCT04135859|520427476|FG001|Overall Study|Did not complete stress test|3|||
144334139|NCT04135859|520427475|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
144334140|NCT04135859|520427476|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
144334141|NCT03629912|520427477|FG000|Overall Study|Lost to Follow-up|19|||
144334142|NCT03629912|520427478|FG001|Overall Study|Lost to Follow-up|7|||
144334143|NCT03629912|520427479|FG002|Overall Study|Lost to Follow-up|5|||
144334144|NCT03629912|520427480|FG003|Overall Study|Lost to Follow-up|1|||
144334145|NCT03629912|520427477|FG000|Overall Study|Withdrawal by Subject|6|||
144334146|NCT03629912|520427478|FG001|Overall Study|Withdrawal by Subject|0|||
144334147|NCT03629912|520427479|FG002|Overall Study|Withdrawal by Subject|1|||
144334148|NCT03629912|520427480|FG003|Overall Study|Withdrawal by Subject|2|||
144334149|NCT03629912|520427477|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
144334150|NCT03629912|520427478|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
144334151|NCT03629912|520427479|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
144334152|NCT03629912|520427480|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
144334153|NCT03629912|520427477|FG000|Overall Study|Death|1|||
144334154|NCT03629912|520427478|FG001|Overall Study|Death|0|||
144334155|NCT03629912|520427479|FG002|Overall Study|Death|0|||
144334156|NCT03629912|520427480|FG003|Overall Study|Death|0|||
144334157|NCT03262116|520427481|FG000|Overall Study|Physician Decision|0|||
144334158|NCT03262116|520427482|FG001|Overall Study|Physician Decision|2|||
144334159|NCT03262116|520427483|FG002|Overall Study|Physician Decision|1|||
144334160|NCT03262116|520427484|FG003|Overall Study|Physician Decision|1|||
144334161|NCT03262116|520427485|FG004|Overall Study|Physician Decision|1|||
144334162|NCT03262116|520427486|FG005|Overall Study|Physician Decision|2|||
144334163|NCT02365285|520427487|FG000|Overall Study|Physician Decision|0|||
144334164|NCT02365285|520427488|FG001|Overall Study|Physician Decision|1|||
144334165|NCT02365285|520427489|FG002|Overall Study|Physician Decision|1|||
144334166|NCT02365285|520427490|FG003|Overall Study|Physician Decision|0|||
144334167|NCT02365285|520427487|FG000|Overall Study|Adverse Event|0|||
144334168|NCT02365285|520427488|FG001|Overall Study|Adverse Event|0|||
144334169|NCT02365285|520427489|FG002|Overall Study|Adverse Event|0|||
144334170|NCT02365285|520427490|FG003|Overall Study|Adverse Event|2|||
144334171|NCT02608450|520427491|FG000|Overall Study|Lost to Follow-up|39|||
144334172|NCT02608450|520427492|FG001|Overall Study|Lost to Follow-up|32|||
144334173|NCT02608450|520427491|FG000|Overall Study|Withdrawal by Subject|21|||
144334174|NCT02608450|520427492|FG001|Overall Study|Withdrawal by Subject|15|||
144334175|NCT02608450|520427491|FG000|Overall Study|Adverse Event|3|||
144334176|NCT02608450|520427492|FG001|Overall Study|Adverse Event|6|||
144334177|NCT02608450|520427491|FG000|Overall Study|Withdrawal by parent|2|||
144334178|NCT02608450|520427492|FG001|Overall Study|Withdrawal by parent|3|||
144334179|NCT02608450|520427491|FG000|Overall Study|Lack of Efficacy|0|||
144334180|NCT02608450|520427492|FG001|Overall Study|Lack of Efficacy|3|||
144334181|NCT02608450|520427491|FG000|Overall Study|Noncompliance with study drug|0|||
144334182|NCT02608450|520427492|FG001|Overall Study|Noncompliance with study drug|2|||
144334183|NCT02608450|520427491|FG000|Overall Study|Physician Decision|0|||
144334184|NCT02608450|520427492|FG001|Overall Study|Physician Decision|1|||
144334185|NCT02608450|520427491|FG000|Overall Study|Pregnancy|0|||
144334186|NCT02608450|520427492|FG001|Overall Study|Pregnancy|1|||
144334187|NCT02608450|520427491|FG000|Overall Study|Progressive disease|1|||
144334188|NCT02608450|520427492|FG001|Overall Study|Progressive disease|0|||
144334189|NCT02608450|520427491|FG000|Overall Study|Multiple reasons|0|||
144334190|NCT02608450|520427492|FG001|Overall Study|Multiple reasons|2|||
144334191|NCT00635089|520427493|FG000|Overall Study|Adverse Event|7|||
144334192|NCT00635089|520427493|FG000|Overall Study|Lack of Efficacy|28|||
144334193|NCT00635089|520427493|FG000|Overall Study|Protocol Deviation|4|||
144334194|NCT00635089|520427493|FG000|Overall Study|Lost to Follow-up|8|||
144334195|NCT00635089|520427493|FG000|Overall Study|Other|31|||
144334196|NCT01283542|520427495|FG000|Main Phase|Acute or progressive vision loss|1|||
144334197|NCT01283542|520427495|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
144334198|NCT01283542|520427495|FG000|Main Phase|abnormal laboratory values|5|||
144334199|NCT01283542|520427495|FG000|Extension Phase|Physician Decision|1|||
144334200|NCT01283542|520427495|FG000|Extension Phase|Adverse Event|1|||
144334201|NCT01283542|520427495|FG000|Extension Phase|Administrative problems|1|||
144334202|NCT02636946|520427496|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
144334203|NCT02636946|520427497|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
144334204|NCT02636946|520427496|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
144334205|NCT02636946|520427497|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
144334206|NCT02636946|520427496|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
144334207|NCT02636946|520427497|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
144334208|NCT02636946|520427496|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
144334209|NCT02636946|520427497|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
144334210|NCT02636946|520427496|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
144334211|NCT02636946|520427497|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
144334212|NCT02636946|520427496|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
144334213|NCT02636946|520427497|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
144334214|NCT05059977|520427498|FG000|Overall Study|Withdrawal by Subject|0|||
144334215|NCT05059977|520427499|FG001|Overall Study|Withdrawal by Subject|0|||
144334216|NCT05059977|520427500|FG002|Overall Study|Withdrawal by Subject|1|||
144334217|NCT02576860|520427501|FG000|Overall Study|Adverse Event|6|||
144334218|NCT02576860|520427502|FG001|Overall Study|Adverse Event|6|||
144334219|NCT02576860|520427501|FG000|Overall Study|Lost to Follow-up|5|||
144334220|NCT02576860|520427502|FG001|Overall Study|Lost to Follow-up|7|||
144334221|NCT02576860|520427501|FG000|Overall Study|Physician Decision|0|||
144334222|NCT02576860|520427502|FG001|Overall Study|Physician Decision|1|||
144334223|NCT02576860|520427501|FG000|Overall Study|Protocol Violation|0|||
144334224|NCT02576860|520427502|FG001|Overall Study|Protocol Violation|2|||
144334225|NCT02576860|520427501|FG000|Overall Study|Withdrawal by Subject|13|||
144334226|NCT02576860|520427502|FG001|Overall Study|Withdrawal by Subject|8|||
144334227|NCT02576860|520427501|FG000|Overall Study|Disallowed medication|1|||
144334228|NCT02576860|520427502|FG001|Overall Study|Disallowed medication|0|||
144334229|NCT00477269|520427503|FG000|Core Study|Adverse Event|6|||
144334230|NCT00477269|520427504|FG001|Core Study|Adverse Event|4|||
144334231|NCT00477269|520427505|FG002|Core Study|Adverse Event|0|||
144334232|NCT00477269|520427503|FG000|Core Study|Death|3|||
144334233|NCT00477269|520427504|FG001|Core Study|Death|3|||
144334234|NCT00477269|520427505|FG002|Core Study|Death|0|||
144334235|NCT00477269|520427503|FG000|Core Study|Withdrawn Consent|0|||
144334236|NCT00477269|520427504|FG001|Core Study|Withdrawn Consent|1|||
144334237|NCT00477269|520427505|FG002|Core Study|Withdrawn Consent|0|||
144334238|NCT00477269|520427503|FG000|Open Label Extension|Adverse Event|0|||
144334239|NCT00477269|520427504|FG001|Open Label Extension|Adverse Event|0|||
144334240|NCT00477269|520427505|FG002|Open Label Extension|Adverse Event|4|||
144334241|NCT00477269|520427503|FG000|Open Label Extension|Abnormal laboratory values|0|||
144334242|NCT00477269|520427504|FG001|Open Label Extension|Abnormal laboratory values|0|||
144334243|NCT00477269|520427505|FG002|Open Label Extension|Abnormal laboratory values|1|||
144334244|NCT00477269|520427503|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
144334245|NCT00477269|520427504|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
144334246|NCT00477269|520427505|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
144334247|NCT00477269|520427503|FG000|Open Label Extension|Adminiatrative problems|0|||
144334248|NCT00477269|520427504|FG001|Open Label Extension|Adminiatrative problems|0|||
144334249|NCT00477269|520427505|FG002|Open Label Extension|Adminiatrative problems|2|||
144334250|NCT00477269|520427503|FG000|Open Label Extension|Death|0|||
144334251|NCT00477269|520427504|FG001|Open Label Extension|Death|0|||
144334252|NCT00477269|520427505|FG002|Open Label Extension|Death|4|||
144334253|NCT02358044|520427506|FG000|Overall Study|Adverse Event|0|||
144334254|NCT02358044|520427507|FG001|Overall Study|Adverse Event|1|||
144334255|NCT02358044|520427506|FG000|Overall Study|Lost to Follow-up|2|||
144334256|NCT02358044|520427507|FG001|Overall Study|Lost to Follow-up|1|||
144334257|NCT02358044|520427506|FG000|Overall Study|Physician Decision|0|||
144334258|NCT02358044|520427507|FG001|Overall Study|Physician Decision|1|||
144334259|NCT02358044|520427506|FG000|Overall Study|Withdrawal by Subject|0|||
144334260|NCT02358044|520427507|FG001|Overall Study|Withdrawal by Subject|4|||
144334261|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
144334262|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
144334263|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
144334264|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
144334265|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
144334266|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
144334267|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
144334268|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
144334269|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
144334270|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
144334271|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
144334272|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
144334273|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
144334274|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
144334275|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
144334276|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
144334277|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
144334278|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
144334279|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
144334280|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
144334281|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
144334282|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
144334283|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
144334284|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
144334285|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
144334286|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
144334287|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
144334288|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
144334289|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
144334290|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
144334291|NCT00121641|520427510|FG000|24-week Short-term Treatment Period|Other Reason|1|||
144334292|NCT00121641|520427511|FG001|24-week Short-term Treatment Period|Other Reason|0|||
144334293|NCT00121641|520427512|FG002|24-week Short-term Treatment Period|Other Reason|0|||
144334294|NCT00121641|520427513|FG003|24-week Short-term Treatment Period|Other Reason|0|||
144334295|NCT00121641|520427514|FG004|24-week Short-term Treatment Period|Other Reason|0|||
144334296|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
144334297|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
144334298|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
144334299|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
144334300|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
144334301|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
144334302|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
144334303|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
144334304|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
144334305|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
144334306|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
144334307|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
144334308|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
144334309|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
144334310|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
144334311|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
144334312|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
144334313|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
144334314|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
144334315|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
144334316|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
144334317|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
144334318|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
144334319|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
144334320|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
144334321|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
144334322|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
144334323|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
144334324|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
144334325|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
144334326|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
144334327|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
144334328|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
144334329|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
144334330|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
144334331|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
144334332|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
144334333|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
144334334|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
144334335|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
144334336|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Death|0|||
144334337|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Death|0|||
144334338|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Death|0|||
144334339|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Death|1|||
144334340|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Death|0|||
144334341|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Missing|0|||
144334342|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Missing|0|||
144334343|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Missing|1|||
144334344|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Missing|0|||
144334345|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Missing|0|||
144334346|NCT00121641|520427510|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
144334347|NCT00121641|520427511|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
144334348|NCT00121641|520427512|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
144334349|NCT00121641|520427513|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
144334350|NCT00121641|520427514|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
144334351|NCT03263780|520427515|FG000|Overall Study|Withdrawal by Subject|3|||
144334352|NCT03263780|520427515|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
144334353|NCT00424190|520427523|FG000|Overall Study|Withdrew consent|3|||
144334354|NCT00424190|520427524|FG001|Overall Study|Withdrew consent|4|||
144334355|NCT00424190|520427523|FG000|Overall Study|Death|3|||
144334356|NCT00424190|520427524|FG001|Overall Study|Death|0|||
144334357|NCT00424190|520427523|FG000|Overall Study|Noncompliance|1|||
144334358|NCT00424190|520427524|FG001|Overall Study|Noncompliance|2|||
144334359|NCT00424190|520427523|FG000|Overall Study|Request of sponsor or investigator|0|||
144334360|NCT00424190|520427524|FG001|Overall Study|Request of sponsor or investigator|2|||
144334361|NCT00424190|520427523|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
144334362|NCT00424190|520427524|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
144334363|NCT00424190|520427523|FG000|Overall Study|Other|15|||
144334364|NCT00424190|520427524|FG001|Overall Study|Other|21|||
144334365|NCT01378429|520427526|FG000|Overall Study|Noncompliance with study drug|1|||
144334366|NCT01378429|520427527|FG001|Overall Study|Noncompliance with study drug|0|||
144334367|NCT02241187|520427528|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
144334368|NCT00619489|520427529|FG000|Overall Study|Adverse Event|0|||
144334369|NCT00619489|520427530|FG001|Overall Study|Adverse Event|7|||
144334370|NCT00619489|520427529|FG000|Overall Study|Withdrawal by Subject|1|||
144334371|NCT00619489|520427530|FG001|Overall Study|Withdrawal by Subject|1|||
144334372|NCT00619489|520427529|FG000|Overall Study|Lack of Efficacy|0|||
144334373|NCT00619489|520427530|FG001|Overall Study|Lack of Efficacy|11|||
144334374|NCT00619489|520427529|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
144334375|NCT00619489|520427530|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
144334376|NCT02356887|520427531|FG000|Overall Study|poor compliance|2|||
144334377|NCT02621073|520427534|FG000|Overall Study|Lost to Follow-up|0|||
144334378|NCT02621073|520427535|FG001|Overall Study|Lost to Follow-up|1|||
144334379|NCT02621073|520427534|FG000|Overall Study|Physician Decision|3|||
144334380|NCT02621073|520427535|FG001|Overall Study|Physician Decision|2|||
144334381|NCT01595581|520427536|FG000|Overall Study|Withdrawal by Subject|1|||
144334382|NCT01595581|520427537|FG001|Overall Study|Withdrawal by Subject|0|||
144334383|NCT02273960|520427541|FG000|Short Term Period|Lost to Follow-up|1|||
144334384|NCT02273960|520427542|FG001|Short Term Period|Lost to Follow-up|0|||
144334385|NCT02273960|520427543|FG002|Short Term Period|Lost to Follow-up|0|||
144334386|NCT02273960|520427544|FG003|Short Term Period|Lost to Follow-up|0|||
144334387|NCT02273960|520427541|FG000|Short Term Period|Lack of Efficacy|0|||
144334388|NCT02273960|520427542|FG001|Short Term Period|Lack of Efficacy|0|||
144334389|NCT02273960|520427543|FG002|Short Term Period|Lack of Efficacy|0|||
144334390|NCT02273960|520427544|FG003|Short Term Period|Lack of Efficacy|1|||
144334391|NCT02273960|520427541|FG000|Short Term Period|ST complete, not entering LTE|4|||
144334392|NCT02273960|520427542|FG001|Short Term Period|ST complete, not entering LTE|6|||
144334393|NCT02273960|520427543|FG002|Short Term Period|ST complete, not entering LTE|4|||
144334394|NCT02273960|520427544|FG003|Short Term Period|ST complete, not entering LTE|5|||
144334395|NCT02273960|520427541|FG000|Long Term Extension|Death|0|||
144334396|NCT02273960|520427542|FG001|Long Term Extension|Death|0|||
144334397|NCT02273960|520427543|FG002|Long Term Extension|Death|0|||
144334398|NCT02273960|520427544|FG003|Long Term Extension|Death|1|||
144334399|NCT00495755|520427545|FG000|Overall Study|Adverse Event|3|||
144334400|NCT01012323|520427546|FG000|Overall Study|Investigator Judgment|1|||
144334401|NCT01789606|520427547|FG000|Overall Study|Participant not Purchased the Product|0|||
144334402|NCT01789606|520427548|FG001|Overall Study|Participant not Purchased the Product|20|||
144334403|NCT01789606|520427547|FG000|Overall Study|Withdrawal by Subject|0|||
144334404|NCT01789606|520427548|FG001|Overall Study|Withdrawal by Subject|1|||
144334405|NCT01789606|520427547|FG000|Overall Study|Ineligible|6|||
144334406|NCT01789606|520427548|FG001|Overall Study|Ineligible|2|||
144334407|NCT01789606|520427547|FG000|Overall Study|Administrative Reasons|17|||
144334408|NCT01789606|520427548|FG001|Overall Study|Administrative Reasons|6|||
144334409|NCT01789606|520427547|FG000|Overall Study|No Study Medication Taken|0|||
144334410|NCT01789606|520427548|FG001|Overall Study|No Study Medication Taken|1|||
144334411|NCT01789606|520427547|FG000|Overall Study|Protocol Violation|0|||
144334412|NCT01789606|520427548|FG001|Overall Study|Protocol Violation|55|||
144334413|NCT01789606|520427547|FG000|Overall Study|Adverse Event|0|||
144334414|NCT01789606|520427548|FG001|Overall Study|Adverse Event|3|||
144334415|NCT01789606|520427547|FG000|Overall Study|Lost to Follow-up|0|||
144334416|NCT01789606|520427548|FG001|Overall Study|Lost to Follow-up|14|||
144334417|NCT01789606|520427547|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
144334418|NCT01789606|520427548|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
144334419|NCT01105377|520427552|FG000|Overall Study|Withdrawal by Subject|0|||
144334420|NCT01105377|520427553|FG001|Overall Study|Withdrawal by Subject|1|||
144359622|NCT00402168|520522826|FG000|Treatment (up to 12 Months)|non-specified|0|||
144359623|NCT00402168|520522827|FG001|Treatment (up to 12 Months)|non-specified|1|||
144359624|NCT00402168|520522826|FG000|Long Term (LT)|Adverse Event|1|||
144359625|NCT00402168|520522827|FG001|Long Term (LT)|Adverse Event|5|||
144359626|NCT00402168|520522826|FG000|Long Term (LT)|Withdrawal by Subject|4|||
144359627|NCT00402168|520522827|FG001|Long Term (LT)|Withdrawal by Subject|7|||
144359628|NCT00402168|520522826|FG000|Long Term (LT)|Pregnancy|0|||
144359629|NCT00402168|520522827|FG001|Long Term (LT)|Pregnancy|1|||
144359630|NCT00402168|520522826|FG000|Long Term (LT)|Lost to Follow-up|1|||
144359631|NCT00402168|520522827|FG001|Long Term (LT)|Lost to Follow-up|0|||
144359632|NCT00402168|520522826|FG000|Long Term (LT)|Death|4|||
144359633|NCT00402168|520522827|FG001|Long Term (LT)|Death|0|||
144359634|NCT00402168|520522826|FG000|Long Term (LT)|Lack of Efficacy|0|||
144359635|NCT00402168|520522827|FG001|Long Term (LT)|Lack of Efficacy|2|||
144359636|NCT00402168|520522826|FG000|Long Term (LT)|non-specified|1|||
144359637|NCT00402168|520522827|FG001|Long Term (LT)|non-specified|2|||
144359638|NCT00402168|520522826|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
144359639|NCT00402168|520522827|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
144359640|NCT00402168|520522826|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
144359641|NCT00402168|520522827|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
144359642|NCT00601835|520522831|FG000|Overall Study|Withdrawal by Subject|9|||
144359643|NCT00601835|520522832|FG001|Overall Study|Withdrawal by Subject|6|||
144359644|NCT00601835|520522831|FG000|Overall Study|Physician Decision|1|||
144359645|NCT00601835|520522832|FG001|Overall Study|Physician Decision|0|||
144359646|NCT00601835|520522831|FG000|Overall Study|Lost to Follow-up|37|||
144359647|NCT00601835|520522832|FG001|Overall Study|Lost to Follow-up|5|||
144359648|NCT00601835|520522831|FG000|Overall Study|Adverse Event|1|||
144359649|NCT00601835|520522832|FG001|Overall Study|Adverse Event|1|||
144359650|NCT00601835|520522831|FG000|Overall Study|Relocate|12|||
144359651|NCT00601835|520522832|FG001|Overall Study|Relocate|2|||
144359652|NCT04199351|520524975|FG000|Overall Study|Decision by sponsor|0|||
144359653|NCT04199351|520524976|FG001|Overall Study|Decision by sponsor|0|||
144359654|NCT04199351|520524977|FG002|Overall Study|Decision by sponsor|0|||
144359655|NCT04199351|520524978|FG003|Overall Study|Decision by sponsor|2|||
144359656|NCT04199351|520524979|FG004|Overall Study|Decision by sponsor|0|||
144359657|NCT04199351|520524980|FG005|Overall Study|Decision by sponsor|0|||
144359658|NCT04199351|520524981|FG006|Overall Study|Decision by sponsor|0|||
144359659|NCT04199351|520524982|FG007|Overall Study|Decision by sponsor|0|||
144359660|NCT04199351|520524983|FG008|Overall Study|Decision by sponsor|0|||
144359661|NCT04199351|520524984|FG009|Overall Study|Decision by sponsor|6|||
144359662|NCT04199351|520524975|FG000|Overall Study|Lost to Follow-up|0|||
144359663|NCT04199351|520524976|FG001|Overall Study|Lost to Follow-up|0|||
144359664|NCT04199351|520524977|FG002|Overall Study|Lost to Follow-up|1|||
144359665|NCT04199351|520524978|FG003|Overall Study|Lost to Follow-up|0|||
144359666|NCT04199351|520524979|FG004|Overall Study|Lost to Follow-up|0|||
144359667|NCT04199351|520524980|FG005|Overall Study|Lost to Follow-up|1|||
144359668|NCT04199351|520524981|FG006|Overall Study|Lost to Follow-up|0|||
144359669|NCT04199351|520524982|FG007|Overall Study|Lost to Follow-up|0|||
144359670|NCT04199351|520524983|FG008|Overall Study|Lost to Follow-up|0|||
144359671|NCT04199351|520524984|FG009|Overall Study|Lost to Follow-up|0|||
144359672|NCT04199351|520524975|FG000|Overall Study|Withdrawal by Subject|0|||
144359673|NCT04199351|520524976|FG001|Overall Study|Withdrawal by Subject|1|||
144359674|NCT04199351|520524977|FG002|Overall Study|Withdrawal by Subject|0|||
144359675|NCT04199351|520524978|FG003|Overall Study|Withdrawal by Subject|0|||
144359676|NCT04199351|520524979|FG004|Overall Study|Withdrawal by Subject|1|||
144359677|NCT04199351|520524980|FG005|Overall Study|Withdrawal by Subject|4|||
144359678|NCT04199351|520524981|FG006|Overall Study|Withdrawal by Subject|2|||
144359679|NCT04199351|520524982|FG007|Overall Study|Withdrawal by Subject|0|||
144359680|NCT04199351|520524983|FG008|Overall Study|Withdrawal by Subject|3|||
144359681|NCT04199351|520524984|FG009|Overall Study|Withdrawal by Subject|0|||
144359682|NCT03623243|520524985|FG000|Overall Study|Adverse Event|15|||
144359683|NCT03623243|520524985|FG000|Overall Study|Guardian Decision|1|||
144359684|NCT03623243|520524985|FG000|Overall Study|New Therapy for Study Indication|1|||
144359685|NCT03623243|520524985|FG000|Overall Study|Protocol Deviation|3|||
144334421|NCT03495102|520429209|FG000|Overall Study|Adverse Event|5|||
144334422|NCT03495102|520429210|FG001|Overall Study|Adverse Event|7|||
144334423|NCT03495102|520429211|FG002|Overall Study|Adverse Event|10|||
144334424|NCT03495102|520429209|FG000|Overall Study|Death|3|||
144334425|NCT03495102|520429210|FG001|Overall Study|Death|4|||
144334426|NCT03495102|520429211|FG002|Overall Study|Death|4|||
144334427|NCT03495102|520429209|FG000|Overall Study|Lost to Follow-up|15|||
144334428|NCT03495102|520429210|FG001|Overall Study|Lost to Follow-up|16|||
144334429|NCT03495102|520429211|FG002|Overall Study|Lost to Follow-up|17|||
144334430|NCT03495102|520429209|FG000|Overall Study|Physician Decision|2|||
144334431|NCT03495102|520429210|FG001|Overall Study|Physician Decision|0|||
144334432|NCT03495102|520429211|FG002|Overall Study|Physician Decision|2|||
144334433|NCT03495102|520429209|FG000|Overall Study|Withdrawal by Subject|25|||
144334434|NCT03495102|520429210|FG001|Overall Study|Withdrawal by Subject|36|||
144334435|NCT03495102|520429211|FG002|Overall Study|Withdrawal by Subject|18|||
144334436|NCT03495102|520429209|FG000|Overall Study|Protocol Violation|1|||
144334437|NCT03495102|520429210|FG001|Overall Study|Protocol Violation|1|||
144334438|NCT03495102|520429211|FG002|Overall Study|Protocol Violation|0|||
144334439|NCT03495102|520429209|FG000|Overall Study|Site Closure|3|||
144334440|NCT03495102|520429210|FG001|Overall Study|Site Closure|1|||
144334441|NCT03495102|520429211|FG002|Overall Study|Site Closure|2|||
144334442|NCT03495102|520429209|FG000|Overall Study|Non-compliance|1|||
144334443|NCT03495102|520429210|FG001|Overall Study|Non-compliance|0|||
144334444|NCT03495102|520429211|FG002|Overall Study|Non-compliance|0|||
144334445|NCT03495102|520429209|FG000|Overall Study|Participant Duplicated at Another Site|0|||
144334446|NCT03495102|520429210|FG001|Overall Study|Participant Duplicated at Another Site|0|||
144334447|NCT03495102|520429211|FG002|Overall Study|Participant Duplicated at Another Site|1|||
144334448|NCT03495102|520429209|FG000|Overall Study|Primary Care Physician Recommendation|0|||
144334449|NCT03495102|520429210|FG001|Overall Study|Primary Care Physician Recommendation|1|||
144334450|NCT03495102|520429211|FG002|Overall Study|Primary Care Physician Recommendation|0|||
144334451|NCT03495102|520429209|FG000|Overall Study|Relocated to Another Country|0|||
144334452|NCT03495102|520429210|FG001|Overall Study|Relocated to Another Country|1|||
144334453|NCT03495102|520429211|FG002|Overall Study|Relocated to Another Country|0|||
144334454|NCT03495102|520429209|FG000|Overall Study|Participant was in Rehabilitation|1|||
144334455|NCT03495102|520429210|FG001|Overall Study|Participant was in Rehabilitation|0|||
144334456|NCT03495102|520429211|FG002|Overall Study|Participant was in Rehabilitation|0|||
144334457|NCT01161537|520429212|FG000|Part B|Withdrawal by Subject|2|||
144334458|NCT00358436|520429215|FG000|Overall Study|Adverse Event|29|||
144334459|NCT00358436|520429216|FG001|Overall Study|Adverse Event|13|||
144334460|NCT00358436|520429215|FG000|Overall Study|Lack of Efficacy|34|||
144334461|NCT00358436|520429216|FG001|Overall Study|Lack of Efficacy|36|||
144334462|NCT00358436|520429215|FG000|Overall Study|Lost to Follow-up|11|||
144334463|NCT00358436|520429216|FG001|Overall Study|Lost to Follow-up|6|||
144334464|NCT00358436|520429215|FG000|Overall Study|Protocol Violation|8|||
144334465|NCT00358436|520429216|FG001|Overall Study|Protocol Violation|3|||
144334466|NCT00358436|520429215|FG000|Overall Study|Withdrawal by Subject|40|||
144334467|NCT00358436|520429216|FG001|Overall Study|Withdrawal by Subject|17|||
144334468|NCT00358436|520429215|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
144334469|NCT00358436|520429216|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
144334470|NCT00358436|520429215|FG000|Overall Study|COPD exacerbation|22|||
144334471|NCT00358436|520429216|FG001|Overall Study|COPD exacerbation|10|||
144334472|NCT00358436|520429215|FG000|Overall Study|Other|6|||
144334473|NCT00358436|520429216|FG001|Overall Study|Other|1|||
144334474|NCT04327024|520429217|FG000|Overall Study|Death|1|||
144334475|NCT04327024|520429218|FG001|Overall Study|Death|2|||
144334476|NCT04327024|520429219|FG002|Overall Study|Death|1|||
144334477|NCT04327024|520429217|FG000|Overall Study|Non-compliance with study drug|0|||
144334478|NCT04327024|520429218|FG001|Overall Study|Non-compliance with study drug|1|||
144334479|NCT04327024|520429219|FG002|Overall Study|Non-compliance with study drug|0|||
144334480|NCT04327024|520429217|FG000|Overall Study|Withdrawal by Subject|1|||
144334481|NCT04327024|520429218|FG001|Overall Study|Withdrawal by Subject|1|||
144334482|NCT04327024|520429219|FG002|Overall Study|Withdrawal by Subject|2|||
144334483|NCT00837759|520429220|FG000|Overall Study|Protocol Violation|3|||
144334484|NCT00837759|520429220|FG000|Overall Study|Lost to Follow-up|1|||
144334485|NCT01022424|520429221|FG000|Overall Study|Adverse Event|1|||
144334486|NCT01022424|520429221|FG000|Overall Study|Physician Decision|1|||
144334487|NCT01022424|520429221|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
144334488|NCT02100969|520429222|FG000|Overall Study|Did not pass screening phase|1|||
144334489|NCT03459365|520429223|FG000|Overall Study|Withdrawal by Subject|6|||
144334490|NCT03459365|520429223|FG000|Overall Study|Protocol Violation|8|||
144334491|NCT04037254|520429224|FG000|Overall Study|Protocol Violation|1|||
144334492|NCT04037254|520429225|FG001|Overall Study|Protocol Violation|0|||
144334493|NCT04037254|520429226|FG002|Overall Study|Protocol Violation|0|||
144334494|NCT04037254|520429227|FG003|Overall Study|Protocol Violation|0|||
144334495|NCT04037254|520429228|FG004|Overall Study|Protocol Violation|0|||
144334496|NCT04037254|520429224|FG000|Overall Study|Withdrawal by Subject|0|||
144334497|NCT04037254|520429225|FG001|Overall Study|Withdrawal by Subject|0|||
144334498|NCT04037254|520429226|FG002|Overall Study|Withdrawal by Subject|1|||
144334499|NCT04037254|520429227|FG003|Overall Study|Withdrawal by Subject|0|||
144334500|NCT04037254|520429228|FG004|Overall Study|Withdrawal by Subject|0|||
144334501|NCT04037254|520429224|FG000|Overall Study|Delayed or incomplete treatment|0|||
144334502|NCT04037254|520429225|FG001|Overall Study|Delayed or incomplete treatment|2|||
144334503|NCT04037254|520429226|FG002|Overall Study|Delayed or incomplete treatment|1|||
144334504|NCT04037254|520429227|FG003|Overall Study|Delayed or incomplete treatment|0|||
144334505|NCT04037254|520429228|FG004|Overall Study|Delayed or incomplete treatment|0|||
144334506|NCT03320330|520429229|FG000|Overall Study|Lack of Efficacy|5|||
144334507|NCT03320330|520429230|FG001|Overall Study|Lack of Efficacy|5|||
144334508|NCT03320330|520429231|FG002|Overall Study|Lack of Efficacy|14|||
144334509|NCT03320330|520429229|FG000|Overall Study|Physician Decision|1|||
144334510|NCT03320330|520429230|FG001|Overall Study|Physician Decision|0|||
144334511|NCT03320330|520429231|FG002|Overall Study|Physician Decision|0|||
144334512|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
144334513|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
144334514|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
144334515|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
144334516|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
144334517|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
144334518|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
144334519|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
144334520|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
144334521|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
144334522|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
144334523|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
144334524|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
144334525|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
144334526|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
144334527|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
144334528|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
144334529|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
144334530|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
144334531|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
144334532|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
144334533|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
144334534|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
144334535|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
144334536|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
144334537|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
144334538|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
144334539|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
144334540|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
144334541|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
144334542|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
144334543|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
144334544|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
144334545|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
144334546|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
144334547|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
144334548|NCT02198794|520429232|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
144334549|NCT02198794|520429233|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
144334550|NCT02198794|520429234|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
144334551|NCT02198794|520429235|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
144334552|NCT02198794|520429232|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
144334553|NCT02198794|520429233|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
144334554|NCT02198794|520429234|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
144334555|NCT02198794|520429235|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
144334556|NCT02198794|520429232|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
144334557|NCT02198794|520429233|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
144334558|NCT02198794|520429234|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
144334559|NCT02198794|520429235|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
144334560|NCT02198794|520429232|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
144334561|NCT02198794|520429233|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
144334562|NCT02198794|520429234|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
144334563|NCT02198794|520429235|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
144334564|NCT02198794|520429232|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
144334565|NCT02198794|520429233|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
144334566|NCT02198794|520429234|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
144334567|NCT02198794|520429235|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
144334568|NCT02198794|520429232|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
144334569|NCT02198794|520429233|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
144334570|NCT02198794|520429234|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
144334571|NCT02198794|520429235|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
144334572|NCT01918332|520429237|FG000|Overall Study|Adverse Event|0|||
144334573|NCT01918332|520429238|FG001|Overall Study|Adverse Event|0|||
144334574|NCT01918332|520429239|FG002|Overall Study|Adverse Event|0|||
144334575|NCT01918332|520429240|FG003|Overall Study|Adverse Event|1|||
144334576|NCT01918332|520429237|FG000|Overall Study|Withdrawal by Subject|2|||
144334577|NCT01918332|520429238|FG001|Overall Study|Withdrawal by Subject|3|||
144334578|NCT01918332|520429239|FG002|Overall Study|Withdrawal by Subject|2|||
144334579|NCT01918332|520429240|FG003|Overall Study|Withdrawal by Subject|3|||
144334580|NCT01918332|520429237|FG000|Overall Study|Protocol Violation|6|||
144334581|NCT01918332|520429238|FG001|Overall Study|Protocol Violation|2|||
144334582|NCT01918332|520429239|FG002|Overall Study|Protocol Violation|6|||
144334583|NCT01918332|520429240|FG003|Overall Study|Protocol Violation|3|||
144334584|NCT01918332|520429237|FG000|Overall Study|lipid result by central lab did not meet|0|||
144334585|NCT01918332|520429238|FG001|Overall Study|lipid result by central lab did not meet|0|||
144334586|NCT01918332|520429239|FG002|Overall Study|lipid result by central lab did not meet|1|||
144334587|NCT01918332|520429240|FG003|Overall Study|lipid result by central lab did not meet|0|||
144334588|NCT03779503|520429241|FG000|First Intervention|Adverse Event|0|||
144334589|NCT03779503|520429242|FG001|First Intervention|Adverse Event|1|||
144334590|NCT03779503|520429241|FG000|First Intervention|Withdrawal by Subject|1|||
144334591|NCT03779503|520429242|FG001|First Intervention|Withdrawal by Subject|0|||
144334592|NCT00864851|520429243|FG000|Overall Study|Withdrawal by Subject|0|||
144334593|NCT00864851|520429244|FG001|Overall Study|Withdrawal by Subject|1|||
144334594|NCT00864851|520429245|FG002|Overall Study|Withdrawal by Subject|0|||
144334595|NCT00864851|520429243|FG000|Overall Study|Physician Decision|1|||
144334596|NCT00864851|520429244|FG001|Overall Study|Physician Decision|0|||
144334597|NCT00864851|520429245|FG002|Overall Study|Physician Decision|0|||
144334598|NCT00864851|520429243|FG000|Overall Study|Death|1|||
144334599|NCT00864851|520429244|FG001|Overall Study|Death|0|||
144334600|NCT00864851|520429245|FG002|Overall Study|Death|0|||
144334601|NCT00864851|520429243|FG000|Overall Study|Patient uncooperative|1|||
144334602|NCT00864851|520429244|FG001|Overall Study|Patient uncooperative|0|||
144334603|NCT00864851|520429245|FG002|Overall Study|Patient uncooperative|0|||
144334604|NCT01116427|520429246|FG000|Core Phase|Adverse Event|0|||
144334605|NCT01116427|520429247|FG001|Core Phase|Adverse Event|1|||
144334606|NCT01116427|520429246|FG000|Core Phase|Lost to Follow-up|1|||
144334607|NCT01116427|520429247|FG001|Core Phase|Lost to Follow-up|0|||
144334608|NCT01116427|520429246|FG000|Core Phase|Withdrawal by Subject|3|||
144334609|NCT01116427|520429247|FG001|Core Phase|Withdrawal by Subject|0|||
144334610|NCT01116427|520429246|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
144334611|NCT01116427|520429247|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
144334612|NCT01116427|520429246|FG000|Extension Phase|Adverse Event|1|||
144334613|NCT01116427|520429247|FG001|Extension Phase|Adverse Event|1|||
144334614|NCT01116427|520429246|FG000|Extension Phase|Lost to Follow-up|2|||
144334615|NCT01116427|520429247|FG001|Extension Phase|Lost to Follow-up|0|||
144334616|NCT01116427|520429246|FG000|Extension Phase|Withdrawal by Subject|5|||
144334617|NCT01116427|520429247|FG001|Extension Phase|Withdrawal by Subject|1|||
144334618|NCT01116427|520429246|FG000|Extension Phase|Not using appropriate birth control|1|||
144334619|NCT01116427|520429247|FG001|Extension Phase|Not using appropriate birth control|0|||
144334620|NCT02989805|520429248|FG000|Overall Study|invalid consent|6|||
144334621|NCT02989805|520429249|FG001|Overall Study|invalid consent|4|||
144334622|NCT02771626|520429250|FG000|Overall Study|Adverse Event|1|||
144334623|NCT02771626|520429251|FG001|Overall Study|Adverse Event|5|||
144334624|NCT02771626|520429252|FG002|Overall Study|Adverse Event|3|||
144334625|NCT02771626|520429253|FG003|Overall Study|Adverse Event|0|||
144334626|NCT02771626|520429254|FG004|Overall Study|Adverse Event|1|||
144334627|NCT02771626|520429255|FG005|Overall Study|Adverse Event|1|||
144334628|NCT02771626|520429250|FG000|Overall Study|Radiologic Disease Progression|6|||
144334629|NCT02771626|520429251|FG001|Overall Study|Radiologic Disease Progression|13|||
144334630|NCT02771626|520429252|FG002|Overall Study|Radiologic Disease Progression|10|||
144334631|NCT02771626|520429253|FG003|Overall Study|Radiologic Disease Progression|7|||
144334632|NCT02771626|520429254|FG004|Overall Study|Radiologic Disease Progression|28|||
144334633|NCT02771626|520429255|FG005|Overall Study|Radiologic Disease Progression|15|||
144334634|NCT02771626|520429250|FG000|Overall Study|Symptomatic Deterioration|0|||
144334635|NCT02771626|520429251|FG001|Overall Study|Symptomatic Deterioration|4|||
144334636|NCT02771626|520429252|FG002|Overall Study|Symptomatic Deterioration|2|||
144334637|NCT02771626|520429253|FG003|Overall Study|Symptomatic Deterioration|0|||
144334638|NCT02771626|520429254|FG004|Overall Study|Symptomatic Deterioration|5|||
144334639|NCT02771626|520429255|FG005|Overall Study|Symptomatic Deterioration|2|||
144334640|NCT02771626|520429250|FG000|Overall Study|Participant Request|0|||
144334641|NCT02771626|520429251|FG001|Overall Study|Participant Request|1|||
144334642|NCT02771626|520429252|FG002|Overall Study|Participant Request|0|||
144334643|NCT02771626|520429253|FG003|Overall Study|Participant Request|2|||
144334644|NCT02771626|520429254|FG004|Overall Study|Participant Request|0|||
144334645|NCT02771626|520429255|FG005|Overall Study|Participant Request|1|||
144334646|NCT02771626|520429250|FG000|Overall Study|Investigator Decision|0|||
144334647|NCT02771626|520429251|FG001|Overall Study|Investigator Decision|1|||
144334648|NCT02771626|520429252|FG002|Overall Study|Investigator Decision|0|||
144334649|NCT02771626|520429253|FG003|Overall Study|Investigator Decision|0|||
144334650|NCT02771626|520429254|FG004|Overall Study|Investigator Decision|1|||
144334651|NCT02771626|520429255|FG005|Overall Study|Investigator Decision|0|||
144334652|NCT02771626|520429250|FG000|Overall Study|Study Termination by Sponsor|0|||
144334653|NCT02771626|520429251|FG001|Overall Study|Study Termination by Sponsor|2|||
144334654|NCT02771626|520429252|FG002|Overall Study|Study Termination by Sponsor|1|||
144334655|NCT02771626|520429253|FG003|Overall Study|Study Termination by Sponsor|0|||
144334656|NCT02771626|520429254|FG004|Overall Study|Study Termination by Sponsor|1|||
144334657|NCT02771626|520429255|FG005|Overall Study|Study Termination by Sponsor|0|||
144334658|NCT02771626|520429250|FG000|Overall Study|Informed Consent Withdrawn|0|||
144334659|NCT02771626|520429251|FG001|Overall Study|Informed Consent Withdrawn|0|||
144334660|NCT02771626|520429252|FG002|Overall Study|Informed Consent Withdrawn|1|||
144334661|NCT02771626|520429253|FG003|Overall Study|Informed Consent Withdrawn|0|||
144334662|NCT02771626|520429254|FG004|Overall Study|Informed Consent Withdrawn|1|||
144334663|NCT02771626|520429255|FG005|Overall Study|Informed Consent Withdrawn|1|||
144334664|NCT02771626|520429250|FG000|Overall Study|Other, Not Specified|1|||
144334665|NCT02771626|520429251|FG001|Overall Study|Other, Not Specified|0|||
144334666|NCT02771626|520429252|FG002|Overall Study|Other, Not Specified|0|||
144334667|NCT02771626|520429253|FG003|Overall Study|Other, Not Specified|0|||
144334668|NCT02771626|520429254|FG004|Overall Study|Other, Not Specified|0|||
144334669|NCT02771626|520429255|FG005|Overall Study|Other, Not Specified|1|||
144334670|NCT01754194|520429256|FG000|Overall Study|Lost to Follow-up|39|||
144334671|NCT01754194|520429257|FG001|Overall Study|Lost to Follow-up|14|||
144334672|NCT01754194|520429256|FG000|Overall Study|Withdrawal by Subject|4|||
144334673|NCT01754194|520429257|FG001|Overall Study|Withdrawal by Subject|5|||
144334674|NCT01754194|520429256|FG000|Overall Study|Other|9|||
144334675|NCT01754194|520429257|FG001|Overall Study|Other|8|||
144334676|NCT02392403|520429258|FG000|Overall Study|Adverse Event|1|||
144334677|NCT02392403|520429258|FG000|Overall Study|Death|1|||
144334678|NCT02392403|520429258|FG000|Overall Study|Withdrawal by Subject|1|||
144334679|NCT02776033|520429259|FG000|Overall Study|Withdrawal by Subject|0|||
144334680|NCT02776033|520429260|FG001|Overall Study|Withdrawal by Subject|0|||
144334681|NCT02776033|520429261|FG002|Overall Study|Withdrawal by Subject|2|||
144334682|NCT02776033|520429259|FG000|Overall Study|Physician Decision|2|||
144334683|NCT02776033|520429260|FG001|Overall Study|Physician Decision|0|||
144334684|NCT02776033|520429261|FG002|Overall Study|Physician Decision|0|||
144334685|NCT02776033|520429259|FG000|Overall Study|Lost to Follow-up|1|||
144334686|NCT02776033|520429260|FG001|Overall Study|Lost to Follow-up|0|||
144334687|NCT02776033|520429261|FG002|Overall Study|Lost to Follow-up|0|||
144334688|NCT02776033|520429259|FG000|Overall Study|Adverse Event|1|||
144334689|NCT02776033|520429260|FG001|Overall Study|Adverse Event|2|||
144334690|NCT02776033|520429261|FG002|Overall Study|Adverse Event|0|||
144334691|NCT00657371|520429265|FG000|Overall Study|Poor bowel preparation|15|||
144334692|NCT00657371|520429265|FG000|Overall Study|Unable to intubate the cecum|5|||
144334693|NCT00657371|520429265|FG000|Overall Study|Protocol Violation|2|||
144334694|NCT00657371|520429265|FG000|Overall Study|Device- related reasons|13|||
144334695|NCT00657371|520429265|FG000|Overall Study|Pre-existing medical condition|4|||
144334696|NCT00652899|520429271|FG000|Overall Study|Death|1|||
144334697|NCT00652899|520429271|FG000|Overall Study|Treating physician decision|1|||
144334698|NCT00551291|520429272|FG000|Overall Study|Physician Decision|1|||
144334699|NCT04047420|520429275|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
144334700|NCT04047420|520429275|FG000|Washout Period|Refused Participation|2|||
144334701|NCT03230292|520429276|FG000|Overall Study|Adverse Event|1|||
144334702|NCT03230292|520429276|FG000|Overall Study|Protocol Violation|1|||
144334703|NCT03230292|520429276|FG000|Overall Study|Lost to Follow-up|1|||
144334704|NCT03230292|520429276|FG000|Overall Study|Withdrawal by Subject|3|||
144334705|NCT01639755|520429277|FG000|Overall Study|Study Ongoing|15|||
144334706|NCT01639755|520429277|FG000|Overall Study|Patient had device explantation|4|||
144334707|NCT04405245|520429286|FG000|Overall Study|Adverse Event|0|||
144334708|NCT04405245|520429287|FG001|Overall Study|Adverse Event|1|||
144334709|NCT04405245|520429288|FG002|Overall Study|Adverse Event|0|||
144334710|NCT00576472|520429289|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334711|NCT00576472|520429290|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334712|NCT00576472|520429291|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334713|NCT00576472|520429292|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
144334714|NCT00576472|520429293|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334715|NCT00576472|520429294|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334716|NCT00576472|520429295|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334717|NCT00576472|520429296|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334718|NCT00576472|520429297|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334719|NCT00576472|520429298|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334720|NCT00576472|520429299|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334721|NCT00576472|520429300|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334722|NCT00576472|520429301|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334723|NCT00576472|520429302|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334724|NCT00576472|520429303|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
144334725|NCT00576472|520429289|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
144334726|NCT00576472|520429290|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
144334727|NCT00576472|520429291|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
144334728|NCT00576472|520429292|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
144334729|NCT00576472|520429293|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
144334730|NCT00576472|520429294|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
144334731|NCT00576472|520429295|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
144334732|NCT00576472|520429296|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
144334733|NCT00576472|520429297|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
144334734|NCT00576472|520429298|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
144334735|NCT00576472|520429299|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
144334736|NCT00576472|520429300|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
144334737|NCT00576472|520429301|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
144334738|NCT00576472|520429302|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
144334739|NCT00576472|520429303|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
144334740|NCT00576472|520429289|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334741|NCT00576472|520429290|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334742|NCT00576472|520429291|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334743|NCT00576472|520429292|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
144334744|NCT00576472|520429293|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334745|NCT00576472|520429294|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334746|NCT00576472|520429295|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334747|NCT00576472|520429296|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334748|NCT00576472|520429297|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334749|NCT00576472|520429298|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334750|NCT00576472|520429299|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334751|NCT00576472|520429300|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334752|NCT00576472|520429301|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334753|NCT00576472|520429302|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334754|NCT00576472|520429303|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
144334755|NCT00576472|520429289|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
144334756|NCT00576472|520429290|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
144334757|NCT00576472|520429291|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
144334758|NCT00576472|520429292|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
144334759|NCT00576472|520429293|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
144334760|NCT00576472|520429294|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
144334761|NCT00576472|520429295|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
144334762|NCT00576472|520429296|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
144334763|NCT00576472|520429297|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
144334764|NCT00576472|520429298|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
144334765|NCT00576472|520429299|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
144334766|NCT00576472|520429300|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
144334767|NCT00576472|520429301|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
144334768|NCT00576472|520429302|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
144334769|NCT00576472|520429303|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
144334770|NCT00576472|520429289|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334771|NCT00576472|520429290|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334772|NCT00576472|520429291|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334773|NCT00576472|520429292|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
144334774|NCT00576472|520429293|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334775|NCT00576472|520429294|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334776|NCT00576472|520429295|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334777|NCT00576472|520429296|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334778|NCT00576472|520429297|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334779|NCT00576472|520429298|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334780|NCT00576472|520429299|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334781|NCT00576472|520429300|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334782|NCT00576472|520429301|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334783|NCT00576472|520429302|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334784|NCT00576472|520429303|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
144334785|NCT00576472|520429289|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334786|NCT00576472|520429290|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334787|NCT00576472|520429291|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334788|NCT00576472|520429292|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334789|NCT00576472|520429293|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334790|NCT00576472|520429294|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334791|NCT00576472|520429295|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
144334792|NCT00576472|520429296|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334793|NCT00576472|520429297|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334794|NCT00576472|520429298|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334795|NCT00576472|520429299|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334796|NCT00576472|520429300|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334797|NCT00576472|520429301|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334798|NCT00576472|520429302|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334799|NCT00576472|520429303|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
144334800|NCT00576472|520429289|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
144334801|NCT00576472|520429290|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
144334802|NCT00576472|520429291|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
144334803|NCT00576472|520429292|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
144334804|NCT00576472|520429293|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
144334805|NCT00576472|520429294|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
144334806|NCT00576472|520429295|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
144334807|NCT00576472|520429296|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
144334808|NCT00576472|520429297|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
144334809|NCT00576472|520429298|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
144334810|NCT00576472|520429299|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
144334811|NCT00576472|520429300|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
144334812|NCT00576472|520429301|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
144334813|NCT00576472|520429302|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
144334814|NCT00576472|520429303|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
144334815|NCT00576472|520429289|FG000|MPH Cross Over Phase|Physician Decision|0|||
144334816|NCT00576472|520429290|FG001|MPH Cross Over Phase|Physician Decision|0|||
144334817|NCT00576472|520429291|FG002|MPH Cross Over Phase|Physician Decision|0|||
144334818|NCT00576472|520429292|FG003|MPH Cross Over Phase|Physician Decision|0|||
144334819|NCT00576472|520429293|FG004|MPH Cross Over Phase|Physician Decision|0|||
144334820|NCT00576472|520429294|FG005|MPH Cross Over Phase|Physician Decision|0|||
144334821|NCT00576472|520429295|FG006|MPH Cross Over Phase|Physician Decision|4|||
144334822|NCT00576472|520429296|FG007|MPH Cross Over Phase|Physician Decision|0|||
144334823|NCT00576472|520429297|FG008|MPH Cross Over Phase|Physician Decision|0|||
144334824|NCT00576472|520429298|FG009|MPH Cross Over Phase|Physician Decision|0|||
144334825|NCT00576472|520429299|FG010|MPH Cross Over Phase|Physician Decision|0|||
144334826|NCT00576472|520429300|FG011|MPH Cross Over Phase|Physician Decision|0|||
144334827|NCT00576472|520429301|FG012|MPH Cross Over Phase|Physician Decision|0|||
144334828|NCT00576472|520429302|FG013|MPH Cross Over Phase|Physician Decision|0|||
144334829|NCT00576472|520429303|FG014|MPH Cross Over Phase|Physician Decision|0|||
144334830|NCT00576472|520429289|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334831|NCT00576472|520429290|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334832|NCT00576472|520429291|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334833|NCT00576472|520429292|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334834|NCT00576472|520429293|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334835|NCT00576472|520429294|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334836|NCT00576472|520429295|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334837|NCT00576472|520429296|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334838|NCT00576472|520429297|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
144334839|NCT00576472|520429298|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334840|NCT00576472|520429299|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
144334841|NCT00576472|520429300|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
144334842|NCT00576472|520429301|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334843|NCT00576472|520429302|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334844|NCT00576472|520429303|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
144334845|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334846|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334847|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334848|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334849|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334850|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334851|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334852|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334853|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334854|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334855|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334856|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334857|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334858|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
144334859|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
144334860|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
144334861|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
144334862|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
144334863|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
144334864|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
144334865|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
144334866|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
144334867|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
144334868|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
144334869|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
144334870|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
144334871|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
144334872|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
144334873|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
144334874|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
144334875|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
144334876|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
144334877|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
144334878|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
144334879|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
144334880|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
144334881|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
144334882|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
144334883|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
144334884|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
144334885|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
144334886|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
144334887|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
144334888|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
144334889|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
144334890|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Side effects|0|||
144334891|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Side effects|0|||
144334892|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Side effects|0|||
144334893|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Side effects|0|||
144334894|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Side effects|0|||
144334895|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Side effects|0|||
144334896|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Side effects|0|||
144334897|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Side effects|0|||
144334898|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Side effects|0|||
144334899|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Side effects|0|||
144334900|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Side effects|0|||
144334901|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Side effects|0|||
144334902|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Side effects|0|||
144334903|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Side effects|0|||
144334904|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Side effects|8|||
144334905|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334906|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334907|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334908|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334909|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334910|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334911|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334912|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334913|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334914|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334915|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334916|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334917|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334918|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
144334919|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
144334920|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
144334921|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
144334922|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
144334923|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
144334924|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
144334925|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
144334926|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
144334927|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
144334928|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
144334929|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
144334930|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
144334931|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
144334932|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
144334933|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
144334934|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
144334935|NCT00576472|520429289|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334936|NCT00576472|520429290|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334937|NCT00576472|520429291|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334938|NCT00576472|520429292|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334939|NCT00576472|520429293|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334940|NCT00576472|520429294|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334941|NCT00576472|520429295|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334942|NCT00576472|520429296|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334943|NCT00576472|520429297|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334944|NCT00576472|520429298|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334945|NCT00576472|520429299|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334946|NCT00576472|520429300|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334947|NCT00576472|520429301|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334948|NCT00576472|520429302|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
144334949|NCT00576472|520429303|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
144334950|NCT00351273|520429315|FG000|Overall Study|Lost to Follow-up|1|||
144334951|NCT00351273|520429316|FG001|Overall Study|Lost to Follow-up|2|||
144334952|NCT00351273|520429317|FG002|Overall Study|Lost to Follow-up|5|||
144334953|NCT00199888|520429320|FG000|Overall Study|Lost to Follow-up|1|||
144334954|NCT05219669|520429321|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
144334955|NCT05219669|520429322|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
144334956|NCT05219669|520429323|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
144334957|NCT05219669|520429324|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
144334958|NCT05219669|520429325|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
144334959|NCT05219669|520429326|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
144334960|NCT00330668|520429329|FG000|BID Dosing Period|Adverse Event|1|||
144334961|NCT00330668|520429329|FG000|BID Dosing Period|Lost to Follow-up|7|||
144334962|NCT00330668|520429329|FG000|BID Dosing Period|Non-Compliance|5|||
144334963|NCT00330668|520429329|FG000|BID Dosing Period|Withdrawal by Subject|19|||
144334964|NCT00330668|520429329|FG000|BID Dosing Period|Sponsor's decision|1|||
144334965|NCT00330668|520429329|FG000|BID Dosing Period|Other|3|||
144334966|NCT00330668|520429329|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
144334967|NCT00330668|520429329|FG000|QD Dosing Period|Other|1|||
144334968|NCT00330668|520429329|FG000|QD Dosing Period|Withdrawal by Subject|1|||
144334969|NCT00330668|520429329|FG000|QD Dosing Period|Lost to Follow-up|2|||
144334970|NCT02265796|520429330|FG000|Overall Study|Death|1|||
144334971|NCT02265796|520429331|FG001|Overall Study|Death|0|||
144334972|NCT02265796|520429330|FG000|Overall Study|started on excluded medication|1|||
144334973|NCT02265796|520429331|FG001|Overall Study|started on excluded medication|0|||
144334974|NCT02265796|520429330|FG000|Overall Study|Withdrawal by Subject|1|||
144334975|NCT02265796|520429331|FG001|Overall Study|Withdrawal by Subject|1|||
144334976|NCT00558272|520429332|FG000|Overall Study|Adverse Event|10|||
144334977|NCT00558272|520429333|FG001|Overall Study|Adverse Event|0|||
144334978|NCT00558272|520429332|FG000|Overall Study|Death|1|||
144334979|NCT00558272|520429333|FG001|Overall Study|Death|0|||
144334980|NCT00558272|520429332|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
144334981|NCT00558272|520429333|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
144334982|NCT00558272|520429332|FG000|Overall Study|AZ study team decision|0|||
144334983|NCT00558272|520429333|FG001|Overall Study|AZ study team decision|1|||
144334984|NCT00558272|520429332|FG000|Overall Study|Incorrectly enrolled|1|||
144334985|NCT00558272|520429333|FG001|Overall Study|Incorrectly enrolled|0|||
144334986|NCT00558272|520429332|FG000|Overall Study|Withdrawal by Subject|0|||
144334987|NCT00558272|520429333|FG001|Overall Study|Withdrawal by Subject|1|||
144334988|NCT02920957|520429334|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
144334989|NCT02920957|520429335|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
144334990|NCT02920957|520429334|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
144334991|NCT02920957|520429335|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
144334992|NCT02920957|520429334|FG000|First Intervention : 1 Month|Adverse Event|1|||
144334993|NCT02920957|520429335|FG001|First Intervention : 1 Month|Adverse Event|0|||
144334994|NCT02920957|520429334|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
144334995|NCT02920957|520429335|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
144334996|NCT02745535|520429342|FG000|Overall Study|Death|1|||
144334997|NCT02745535|520429342|FG000|Overall Study|Adverse Event|3|||
144334998|NCT02745535|520429342|FG000|Overall Study|Lost to Follow-up|2|||
144334999|NCT01345682|520429346|FG000|Overall Study|Progressive disease per RECIST|226|||
144335000|NCT01345682|520429347|FG001|Overall Study|Progressive disease per RECIST|93|||
144335001|NCT01345682|520429346|FG000|Overall Study|Worsening of underlying cancer disease|23|||
144335002|NCT01345682|520429347|FG001|Overall Study|Worsening of underlying cancer disease|12|||
144335003|NCT01345682|520429346|FG000|Overall Study|Adverse Event|51|||
144335004|NCT01345682|520429347|FG001|Overall Study|Adverse Event|41|||
144335005|NCT01345682|520429346|FG000|Overall Study|Non-compliance with protocol|0|||
144335006|NCT01345682|520429347|FG001|Overall Study|Non-compliance with protocol|1|||
144335007|NCT01345682|520429346|FG000|Overall Study|Lost to Follow-up|0|||
144335008|NCT01345682|520429347|FG001|Overall Study|Lost to Follow-up|1|||
144335009|NCT01345682|520429346|FG000|Overall Study|Refused to continue trial medication|16|||
144335010|NCT01345682|520429347|FG001|Overall Study|Refused to continue trial medication|9|||
144335011|NCT01345682|520429346|FG000|Overall Study|Not treated|2|||
144335012|NCT01345682|520429347|FG001|Overall Study|Not treated|1|||
144335013|NCT01345682|520429346|FG000|Overall Study|Reason other than those specified above|4|||
144335014|NCT01345682|520429347|FG001|Overall Study|Reason other than those specified above|3|||
144335015|NCT01075984|520429348|FG000|Treatment Phase|Adverse Event|0|||
144335016|NCT01075984|520429349|FG001|Treatment Phase|Adverse Event|1|||
144335017|NCT01075984|520429350|FG002|Treatment Phase|Adverse Event|3|||
144335018|NCT01075984|520429351|FG003|Treatment Phase|Adverse Event|7|||
144335019|NCT01075984|520429352|FG004|Treatment Phase|Adverse Event|35|||
144335020|NCT01075984|520429348|FG000|Treatment Phase|Protocol Violation|0|||
144335021|NCT01075984|520429349|FG001|Treatment Phase|Protocol Violation|0|||
144335022|NCT01075984|520429350|FG002|Treatment Phase|Protocol Violation|1|||
144335023|NCT01075984|520429351|FG003|Treatment Phase|Protocol Violation|0|||
144335024|NCT01075984|520429352|FG004|Treatment Phase|Protocol Violation|3|||
144335025|NCT01075984|520429348|FG000|Treatment Phase|Withdrawal by Subject|0|||
144335026|NCT01075984|520429349|FG001|Treatment Phase|Withdrawal by Subject|0|||
144335027|NCT01075984|520429350|FG002|Treatment Phase|Withdrawal by Subject|2|||
144335028|NCT01075984|520429351|FG003|Treatment Phase|Withdrawal by Subject|0|||
144335029|NCT01075984|520429352|FG004|Treatment Phase|Withdrawal by Subject|15|||
144335030|NCT01075984|520429348|FG000|Treatment Phase|Treatment Failure|0|||
144335031|NCT01075984|520429349|FG001|Treatment Phase|Treatment Failure|0|||
144335032|NCT01075984|520429350|FG002|Treatment Phase|Treatment Failure|1|||
144335033|NCT01075984|520429351|FG003|Treatment Phase|Treatment Failure|0|||
144335034|NCT01075984|520429352|FG004|Treatment Phase|Treatment Failure|5|||
144335035|NCT01075984|520429348|FG000|Treatment Phase|Progression of disease|0|||
144335036|NCT01075984|520429349|FG001|Treatment Phase|Progression of disease|0|||
144335037|NCT01075984|520429350|FG002|Treatment Phase|Progression of disease|0|||
144335038|NCT01075984|520429351|FG003|Treatment Phase|Progression of disease|0|||
144335039|NCT01075984|520429352|FG004|Treatment Phase|Progression of disease|2|||
144335040|NCT01075984|520429348|FG000|Follow-up Phase|Protocol Violation|0|||
144335041|NCT01075984|520429349|FG001|Follow-up Phase|Protocol Violation|0|||
144335042|NCT01075984|520429350|FG002|Follow-up Phase|Protocol Violation|1|||
144335043|NCT01075984|520429351|FG003|Follow-up Phase|Protocol Violation|0|||
144335044|NCT01075984|520429352|FG004|Follow-up Phase|Protocol Violation|3|||
144335045|NCT01075984|520429348|FG000|Follow-up Phase|Adverse Event|0|||
144335046|NCT01075984|520429349|FG001|Follow-up Phase|Adverse Event|0|||
144335047|NCT01075984|520429350|FG002|Follow-up Phase|Adverse Event|0|||
144335048|NCT01075984|520429351|FG003|Follow-up Phase|Adverse Event|2|||
144335049|NCT01075984|520429352|FG004|Follow-up Phase|Adverse Event|27|||
144335050|NCT01075984|520429348|FG000|Follow-up Phase|Administrative|0|||
144335051|NCT01075984|520429349|FG001|Follow-up Phase|Administrative|0|||
144335052|NCT01075984|520429350|FG002|Follow-up Phase|Administrative|0|||
144335053|NCT01075984|520429351|FG003|Follow-up Phase|Administrative|0|||
144335054|NCT01075984|520429352|FG004|Follow-up Phase|Administrative|1|||
144335055|NCT01075984|520429348|FG000|Follow-up Phase|Withdrawal by Subject|0|||
144335056|NCT01075984|520429349|FG001|Follow-up Phase|Withdrawal by Subject|0|||
144335057|NCT01075984|520429350|FG002|Follow-up Phase|Withdrawal by Subject|0|||
144335058|NCT01075984|520429351|FG003|Follow-up Phase|Withdrawal by Subject|0|||
144335059|NCT01075984|520429352|FG004|Follow-up Phase|Withdrawal by Subject|10|||
144335060|NCT01075984|520429348|FG000|Follow-up Phase|Progression of disease|0|||
144335061|NCT01075984|520429349|FG001|Follow-up Phase|Progression of disease|0|||
144335062|NCT01075984|520429350|FG002|Follow-up Phase|Progression of disease|0|||
144335063|NCT01075984|520429351|FG003|Follow-up Phase|Progression of disease|0|||
144335064|NCT01075984|520429352|FG004|Follow-up Phase|Progression of disease|2|||
144335065|NCT01075984|520429348|FG000|Follow-up Phase|Treatment failure|0|||
144335066|NCT01075984|520429349|FG001|Follow-up Phase|Treatment failure|0|||
144335067|NCT01075984|520429350|FG002|Follow-up Phase|Treatment failure|0|||
144335068|NCT01075984|520429351|FG003|Follow-up Phase|Treatment failure|0|||
144335069|NCT01075984|520429352|FG004|Follow-up Phase|Treatment failure|4|||
144335070|NCT00483002|520429360|FG000|Overall Study|Adverse Event|68|||
144335071|NCT00483002|520429360|FG000|Overall Study|Lack of Efficacy|555|||
144335072|NCT00483002|520429360|FG000|Overall Study|Lost to Follow-up|962|||
144335073|NCT00483002|520429360|FG000|Overall Study|Other|2|||
144335074|NCT00483002|520429360|FG000|Overall Study|Other|967|||
144335075|NCT02014584|520429361|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144335076|NCT02014584|520429362|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
144335077|NCT02014584|520429363|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144335078|NCT02014584|520429364|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144335079|NCT02014584|520429365|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144335080|NCT02014584|520429366|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
144335081|NCT02014584|520429361|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
144335082|NCT02014584|520429362|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
144335083|NCT02014584|520429363|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144335084|NCT02014584|520429364|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144335085|NCT02014584|520429365|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144335086|NCT02014584|520429366|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
144335087|NCT02014584|520429361|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
144335088|NCT02014584|520429362|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
144335089|NCT02014584|520429363|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
144335090|NCT02014584|520429364|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
144335091|NCT02014584|520429365|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
144335092|NCT02014584|520429366|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
144335093|NCT02014584|520429361|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
144335094|NCT02014584|520429362|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
144335095|NCT02014584|520429363|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
144335096|NCT02014584|520429364|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
144335097|NCT02014584|520429365|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
144335098|NCT02014584|520429366|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
144335099|NCT02014584|520429361|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
144335100|NCT02014584|520429362|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
144335101|NCT02014584|520429363|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
144335102|NCT02014584|520429364|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
144335103|NCT02014584|520429365|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
144335104|NCT02014584|520429366|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
144335105|NCT03442296|520429367|FG000|3 Month Follow-up|Death|3|||
144335106|NCT03442296|520429368|FG001|3 Month Follow-up|Death|1|||
144335107|NCT03442296|520429367|FG000|3 Month Follow-up|Lost to Follow-up|1|||
144335108|NCT03442296|520429368|FG001|3 Month Follow-up|Lost to Follow-up|1|||
144335109|NCT03442296|520429367|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
144335110|NCT03442296|520429368|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
144335111|NCT03442296|520429367|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
144335112|NCT03442296|520429368|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
144335113|NCT03442296|520429367|FG000|12 Month Follow-up|Incomplete measurement|1|||
144335114|NCT03442296|520429368|FG001|12 Month Follow-up|Incomplete measurement|1|||
144335115|NCT03684694|520429369|FG000|Phase 1|Withdrawal by Subject|1|||
144335116|NCT03684694|520429370|FG001|Phase 1|Withdrawal by Subject|0|||
144335117|NCT03684694|520429371|FG002|Phase 1|Withdrawal by Subject|0|||
144335118|NCT03684694|520429372|FG003|Phase 1|Withdrawal by Subject|0|||
144335119|NCT03684694|520429373|FG004|Phase 1|Withdrawal by Subject|0|||
144335120|NCT03684694|520429374|FG005|Phase 1|Withdrawal by Subject|0|||
144335121|NCT03684694|520429369|FG000|Phase 1|Investigator/Sponsor Decision|12|||
144335122|NCT03684694|520429370|FG001|Phase 1|Investigator/Sponsor Decision|2|||
144335123|NCT03684694|520429371|FG002|Phase 1|Investigator/Sponsor Decision|1|||
144335124|NCT03684694|520429372|FG003|Phase 1|Investigator/Sponsor Decision|0|||
144335125|NCT03684694|520429373|FG004|Phase 1|Investigator/Sponsor Decision|0|||
144335126|NCT03684694|520429374|FG005|Phase 1|Investigator/Sponsor Decision|0|||
144335127|NCT03684694|520429369|FG000|Phase 1|Death|24|||
144335128|NCT03684694|520429370|FG001|Phase 1|Death|0|||
144335129|NCT03684694|520429371|FG002|Phase 1|Death|3|||
144335130|NCT03684694|520429372|FG003|Phase 1|Death|0|||
144335131|NCT03684694|520429373|FG004|Phase 1|Death|0|||
144335132|NCT03684694|520429374|FG005|Phase 1|Death|0|||
144335133|NCT03684694|520429369|FG000|Phase 1|Lost to Follow-up|0|||
144335134|NCT03684694|520429370|FG001|Phase 1|Lost to Follow-up|0|||
144335135|NCT03684694|520429371|FG002|Phase 1|Lost to Follow-up|1|||
144335136|NCT03684694|520429372|FG003|Phase 1|Lost to Follow-up|0|||
144335137|NCT03684694|520429373|FG004|Phase 1|Lost to Follow-up|0|||
144335138|NCT03684694|520429374|FG005|Phase 1|Lost to Follow-up|0|||
144335139|NCT03684694|520429369|FG000|Phase 1|Miscellaneous|0|||
144335140|NCT03684694|520429370|FG001|Phase 1|Miscellaneous|1|||
144335141|NCT03684694|520429371|FG002|Phase 1|Miscellaneous|0|||
144335142|NCT03684694|520429372|FG003|Phase 1|Miscellaneous|0|||
144335143|NCT03684694|520429373|FG004|Phase 1|Miscellaneous|0|||
144335144|NCT03684694|520429374|FG005|Phase 1|Miscellaneous|0|||
144335145|NCT03684694|520429369|FG000|Phase 2|Withdrawal by Subject|0|||
144335146|NCT03684694|520429370|FG001|Phase 2|Withdrawal by Subject|0|||
144335147|NCT03684694|520429371|FG002|Phase 2|Withdrawal by Subject|0|||
144335148|NCT03684694|520429372|FG003|Phase 2|Withdrawal by Subject|0|||
144335149|NCT03684694|520429373|FG004|Phase 2|Withdrawal by Subject|0|||
144335150|NCT03684694|520429374|FG005|Phase 2|Withdrawal by Subject|1|||
144335151|NCT03684694|520429369|FG000|Phase 2|Investigator/Sponsor Decision|0|||
144335152|NCT03684694|520429370|FG001|Phase 2|Investigator/Sponsor Decision|0|||
144335153|NCT03684694|520429371|FG002|Phase 2|Investigator/Sponsor Decision|0|||
144335154|NCT03684694|520429372|FG003|Phase 2|Investigator/Sponsor Decision|17|||
144335155|NCT03684694|520429373|FG004|Phase 2|Investigator/Sponsor Decision|16|||
144335156|NCT03684694|520429374|FG005|Phase 2|Investigator/Sponsor Decision|6|||
144335157|NCT03684694|520429369|FG000|Phase 2|Death|0|||
144335158|NCT03684694|520429370|FG001|Phase 2|Death|0|||
144335159|NCT03684694|520429371|FG002|Phase 2|Death|0|||
144335160|NCT03684694|520429372|FG003|Phase 2|Death|28|||
144335161|NCT03684694|520429373|FG004|Phase 2|Death|14|||
144335162|NCT03684694|520429374|FG005|Phase 2|Death|3|||
144335163|NCT03684694|520429369|FG000|Phase 2|Lost to Follow-up|0|||
144335164|NCT03684694|520429370|FG001|Phase 2|Lost to Follow-up|0|||
144335165|NCT03684694|520429371|FG002|Phase 2|Lost to Follow-up|0|||
144335166|NCT03684694|520429372|FG003|Phase 2|Lost to Follow-up|1|||
144335167|NCT03684694|520429373|FG004|Phase 2|Lost to Follow-up|0|||
144335168|NCT03684694|520429374|FG005|Phase 2|Lost to Follow-up|0|||
144335169|NCT03684694|520429369|FG000|Phase 2|Miscellaneous|0|||
144335170|NCT03684694|520429370|FG001|Phase 2|Miscellaneous|0|||
144335171|NCT03684694|520429371|FG002|Phase 2|Miscellaneous|0|||
144335172|NCT03684694|520429372|FG003|Phase 2|Miscellaneous|3|||
144335173|NCT03684694|520429373|FG004|Phase 2|Miscellaneous|0|||
144335174|NCT03684694|520429374|FG005|Phase 2|Miscellaneous|0|||
144335175|NCT05063539|520430582|FG000|Overall Study|Adverse Event|1|||
144335176|NCT05063539|520430583|FG001|Overall Study|Adverse Event|2|||
144335177|NCT05063539|520430584|FG002|Overall Study|Adverse Event|1|||
144335178|NCT05063539|520430582|FG000|Overall Study|Death|0|||
144335179|NCT05063539|520430583|FG001|Overall Study|Death|1|||
144335180|NCT05063539|520430584|FG002|Overall Study|Death|1|||
144335181|NCT05063539|520430582|FG000|Overall Study|Lost to Follow-up|0|||
144335182|NCT05063539|520430583|FG001|Overall Study|Lost to Follow-up|1|||
144335183|NCT05063539|520430584|FG002|Overall Study|Lost to Follow-up|0|||
144335184|NCT05063539|520430582|FG000|Overall Study|Physician Decision|4|||
144335185|NCT05063539|520430583|FG001|Overall Study|Physician Decision|3|||
144335186|NCT05063539|520430584|FG002|Overall Study|Physician Decision|1|||
144335187|NCT05063539|520430582|FG000|Overall Study|Progressive Disease|0|||
144335188|NCT05063539|520430583|FG001|Overall Study|Progressive Disease|2|||
144335189|NCT05063539|520430584|FG002|Overall Study|Progressive Disease|0|||
144335190|NCT05063539|520430582|FG000|Overall Study|Withdrawal by Subject|17|||
144335191|NCT05063539|520430583|FG001|Overall Study|Withdrawal by Subject|26|||
144335192|NCT05063539|520430584|FG002|Overall Study|Withdrawal by Subject|14|||
144335193|NCT05063539|520430582|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
144335194|NCT05063539|520430583|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
144335195|NCT05063539|520430584|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
144335196|NCT05063539|520430582|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
144335197|NCT05063539|520430583|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
144335198|NCT05063539|520430584|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
144335199|NCT05063539|520430582|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
144335200|NCT05063539|520430583|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
144335201|NCT05063539|520430584|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
144335202|NCT05063539|520430582|FG000|Overall Study|Discontinued due to Common Close Design|0|||
144335203|NCT05063539|520430583|FG001|Overall Study|Discontinued due to Common Close Design|1|||
144335204|NCT05063539|520430584|FG002|Overall Study|Discontinued due to Common Close Design|0|||
144335205|NCT05063539|520430582|FG000|Overall Study|Participant not co-operative|0|||
144335206|NCT05063539|520430583|FG001|Overall Study|Participant not co-operative|1|||
144335207|NCT05063539|520430584|FG002|Overall Study|Participant not co-operative|0|||
144335208|NCT05063539|520430582|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
144335209|NCT05063539|520430583|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
144335210|NCT05063539|520430584|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
144335211|NCT05063539|520430582|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
144335212|NCT05063539|520430583|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
144335213|NCT05063539|520430584|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
144335214|NCT00527319|520430585|FG000|Overall Study|Withdrawal by Subject|5|||
144335215|NCT00527319|520430586|FG001|Overall Study|Withdrawal by Subject|0|||
144335216|NCT00527319|520430587|FG002|Overall Study|Withdrawal by Subject|1|||
144335217|NCT00527319|520430585|FG000|Overall Study|Lost to Follow-up|1|||
144335218|NCT00527319|520430586|FG001|Overall Study|Lost to Follow-up|0|||
144335219|NCT00527319|520430587|FG002|Overall Study|Lost to Follow-up|0|||
144335220|NCT00527319|520430585|FG000|Overall Study|Death|0|||
144335221|NCT00527319|520430586|FG001|Overall Study|Death|3|||
144335222|NCT00527319|520430587|FG002|Overall Study|Death|1|||
144335223|NCT00527319|520430585|FG000|Overall Study|Intercurrent Medical Illness|0|||
144335224|NCT00527319|520430586|FG001|Overall Study|Intercurrent Medical Illness|1|||
144335225|NCT00527319|520430587|FG002|Overall Study|Intercurrent Medical Illness|3|||
144335226|NCT00527319|520430585|FG000|Overall Study|Adverse Event|0|||
144335227|NCT00527319|520430586|FG001|Overall Study|Adverse Event|0|||
144335228|NCT00527319|520430587|FG002|Overall Study|Adverse Event|1|||
144335229|NCT03344172|520430591|FG000|Overall Study|Received <1 dose of treatment|1|||
144335230|NCT03344172|520430592|FG001|Overall Study|Received <1 dose of treatment|0|||
144335231|NCT00680368|520430593|FG000|Overall Study|not supervised, not eligible|15|||
144335232|NCT00483041|520430594|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
144335233|NCT00483041|520430595|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
144335234|NCT03242252|520430597|FG000|Overall Study|At the Participant's own Request|18|||
144335235|NCT03242252|520430598|FG001|Overall Study|At the Participant's own Request|10|||
144335236|NCT03242252|520430599|FG002|Overall Study|At the Participant's own Request|15|||
144335237|NCT03242252|520430597|FG000|Overall Study|Adverse Event|8|||
144335238|NCT03242252|520430598|FG001|Overall Study|Adverse Event|6|||
144335239|NCT03242252|520430599|FG002|Overall Study|Adverse Event|9|||
144335240|NCT03242252|520430597|FG000|Overall Study|Poor Compliance to Protocol|0|||
144335241|NCT03242252|520430598|FG001|Overall Study|Poor Compliance to Protocol|2|||
144335242|NCT03242252|520430599|FG002|Overall Study|Poor Compliance to Protocol|3|||
144335243|NCT03242252|520430597|FG000|Overall Study|Study Terminated by Sponsor|1|||
144335244|NCT03242252|520430598|FG001|Overall Study|Study Terminated by Sponsor|0|||
144335245|NCT03242252|520430599|FG002|Overall Study|Study Terminated by Sponsor|0|||
144335246|NCT03242252|520430597|FG000|Overall Study|Reason not Specified|4|||
144335247|NCT03242252|520430598|FG001|Overall Study|Reason not Specified|4|||
144335248|NCT03242252|520430599|FG002|Overall Study|Reason not Specified|1|||
144335249|NCT03242252|520430597|FG000|Overall Study|Lost to Follow-up|5|||
144335250|NCT03242252|520430598|FG001|Overall Study|Lost to Follow-up|1|||
144335251|NCT03242252|520430599|FG002|Overall Study|Lost to Follow-up|4|||
144335252|NCT02211313|520430600|FG000|Overall Study|Treatment Failure|5|||
144335253|NCT02211313|520430601|FG001|Overall Study|Treatment Failure|2|||
144335254|NCT02211313|520430600|FG000|Overall Study|No Follow up Questionnaires|1|||
144335255|NCT02211313|520430601|FG001|Overall Study|No Follow up Questionnaires|1|||
144335256|NCT02717130|520430602|FG000|Overall Study|Withdrawal by Subject|1|||
144335257|NCT02717130|520430602|FG000|Overall Study|Adverse Event|1|||
144335258|NCT02717130|520430602|FG000|Overall Study|Physician Decision|1|||
144335259|NCT02717130|520430602|FG000|Overall Study|Study Closure|4|||
144335260|NCT03344640|520430603|FG000|Overall Study|Adverse Event|1|||
144335261|NCT03344640|520430604|FG001|Overall Study|Adverse Event|0|||
144335262|NCT03344640|520430603|FG000|Overall Study|Physician Decision|1|||
144335263|NCT03344640|520430604|FG001|Overall Study|Physician Decision|1|||
144335264|NCT03344640|520430603|FG000|Overall Study|Withdrawal by Subject|1|||
144335265|NCT03344640|520430604|FG001|Overall Study|Withdrawal by Subject|2|||
144335266|NCT03344640|520430603|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
144335267|NCT03344640|520430604|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
144335268|NCT01943552|520430605|FG000|Overall Study|Adverse Event|3|||
144335269|NCT01943552|520430606|FG001|Overall Study|Adverse Event|2|||
144335270|NCT01943552|520430605|FG000|Overall Study|Withdrawal by Subject|6|||
144335271|NCT01943552|520430606|FG001|Overall Study|Withdrawal by Subject|6|||
144335272|NCT01943552|520430605|FG000|Overall Study|Other Reasons|16|||
144335273|NCT01943552|520430606|FG001|Overall Study|Other Reasons|17|||
144335274|NCT01600053|520430607|FG000|Overall Study|Adverse Event|2|||
144335275|NCT01600053|520430607|FG000|Overall Study|trial will not meet the interim endpoint|9|||
144335276|NCT02715726|520430608|FG000|Overall Study|Adverse Event|2|||
144335277|NCT02715726|520430609|FG001|Overall Study|Adverse Event|6|||
144335278|NCT02715726|520430608|FG000|Overall Study|Protocol Violation|1|||
144335279|NCT02715726|520430609|FG001|Overall Study|Protocol Violation|0|||
144335280|NCT02715726|520430608|FG000|Overall Study|Death|2|||
144335281|NCT02715726|520430609|FG001|Overall Study|Death|1|||
144335282|NCT02715726|520430608|FG000|Overall Study|Participant moved|1|||
144335283|NCT02715726|520430609|FG001|Overall Study|Participant moved|3|||
144335284|NCT02715726|520430608|FG000|Overall Study|Other than specified above|11|||
144335285|NCT02715726|520430609|FG001|Overall Study|Other than specified above|15|||
144335286|NCT02715726|520430608|FG000|Overall Study|Randomized but not treated|1|||
144335287|NCT02715726|520430609|FG001|Overall Study|Randomized but not treated|2|||
144335288|NCT01177969|520430610|FG000|Overall Study|Protocol Violation|2|||
144335289|NCT01177969|520430611|FG001|Overall Study|Protocol Violation|1|||
144335290|NCT01177969|520430610|FG000|Overall Study|Withdrawal by Subject|1|||
144335291|NCT01177969|520430611|FG001|Overall Study|Withdrawal by Subject|2|||
144335292|NCT02445573|520430612|FG000|Overall Study|Withdrawal by Subject|1|||
144335293|NCT02445573|520430613|FG001|Overall Study|Withdrawal by Subject|1|||
144335294|NCT02445573|520430612|FG000|Overall Study|Lost to Follow-up|0|||
144335295|NCT02445573|520430613|FG001|Overall Study|Lost to Follow-up|1|||
144335296|NCT01565941|520430614|FG000|Overall Study|Withdrawn by parent/guardian|3|||
144335297|NCT01565941|520430615|FG001|Overall Study|Withdrawn by parent/guardian|2|||
144335298|NCT01565941|520430614|FG000|Overall Study|Randomized; did not receive intevention|8|||
144335299|NCT01565941|520430615|FG001|Overall Study|Randomized; did not receive intevention|2|||
144335300|NCT02855944|520430616|FG000|Period 1: Treatment|Ongoing|14|||
144335301|NCT02855944|520430617|FG001|Period 1: Treatment|Ongoing|0|||
144335302|NCT02855944|520430616|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
144335303|NCT02855944|520430617|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
144335304|NCT02855944|520430616|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
144335305|NCT02855944|520430617|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
144335306|NCT01475162|520430622|FG000|Overall Study|Physician Decision|1|||
144335307|NCT01475162|520430622|FG000|Overall Study|Death|10|||
144335308|NCT01475162|520430622|FG000|Overall Study|Study closed for safety|3|||
144335309|NCT00490022|520430623|FG000|Overall Study|Adverse Event|0|||
144335310|NCT00490022|520430624|FG001|Overall Study|Adverse Event|2|||
144335311|NCT00490022|520430623|FG000|Overall Study|Withdrawal by Subject|1|||
144335312|NCT00490022|520430624|FG001|Overall Study|Withdrawal by Subject|0|||
144335313|NCT00490022|520430623|FG000|Overall Study|Subject failed to disclose concommitant|0|||
144335314|NCT00490022|520430624|FG001|Overall Study|Subject failed to disclose concommitant|1|||
144335315|NCT02391961|520430628|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
144335316|NCT02391961|520430629|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
144335317|NCT02391961|520430628|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
144335318|NCT02391961|520430629|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
144335319|NCT02391961|520430628|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144335320|NCT02391961|520430629|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
144335321|NCT01792518|520430632|FG000|Overall Study|Adverse Event|3|||
144335322|NCT01792518|520430633|FG001|Overall Study|Adverse Event|4|||
144335323|NCT01792518|520430632|FG000|Overall Study|Protocol Violation|0|||
144335324|NCT01792518|520430633|FG001|Overall Study|Protocol Violation|1|||
144335325|NCT01792518|520430632|FG000|Overall Study|Lost to Follow-up|3|||
144335326|NCT01792518|520430633|FG001|Overall Study|Lost to Follow-up|1|||
144335327|NCT01792518|520430632|FG000|Overall Study|Withdrawal by Subject|2|||
144335328|NCT01792518|520430633|FG001|Overall Study|Withdrawal by Subject|0|||
144335329|NCT01792518|520430632|FG000|Overall Study|Other Reason|0|||
144335330|NCT01792518|520430633|FG001|Overall Study|Other Reason|1|||
144335331|NCT01264770|520430636|FG000|Overall Study|Not reported|0|||
144335332|NCT01264770|520430637|FG001|Overall Study|Not reported|0|||
144335333|NCT01264770|520430638|FG002|Overall Study|Not reported|1|||
144335334|NCT01264770|520430639|FG003|Overall Study|Not reported|0|||
144335335|NCT01264770|520430640|FG004|Overall Study|Not reported|0|||
144335336|NCT01264770|520430641|FG005|Overall Study|Not reported|0|||
144335337|NCT01264770|520430636|FG000|Overall Study|e.g., change in circumstances|8|||
144335338|NCT01264770|520430637|FG001|Overall Study|e.g., change in circumstances|3|||
144335339|NCT01264770|520430638|FG002|Overall Study|e.g., change in circumstances|3|||
144335340|NCT01264770|520430639|FG003|Overall Study|e.g., change in circumstances|3|||
144335341|NCT01264770|520430640|FG004|Overall Study|e.g., change in circumstances|4|||
144335342|NCT01264770|520430641|FG005|Overall Study|e.g., change in circumstances|4|||
144335343|NCT01264770|520430636|FG000|Overall Study|Severe non-compliance to protocol|0|||
144335344|NCT01264770|520430637|FG001|Overall Study|Severe non-compliance to protocol|0|||
144335345|NCT01264770|520430638|FG002|Overall Study|Severe non-compliance to protocol|1|||
144335346|NCT01264770|520430639|FG003|Overall Study|Severe non-compliance to protocol|1|||
144335347|NCT01264770|520430640|FG004|Overall Study|Severe non-compliance to protocol|0|||
144335348|NCT01264770|520430641|FG005|Overall Study|Severe non-compliance to protocol|0|||
144335349|NCT01264770|520430636|FG000|Overall Study|Lack of therapeutic response|1|||
144335350|NCT01264770|520430637|FG001|Overall Study|Lack of therapeutic response|0|||
144335351|NCT01264770|520430638|FG002|Overall Study|Lack of therapeutic response|2|||
144335352|NCT01264770|520430639|FG003|Overall Study|Lack of therapeutic response|1|||
144335353|NCT01264770|520430640|FG004|Overall Study|Lack of therapeutic response|1|||
144335354|NCT01264770|520430641|FG005|Overall Study|Lack of therapeutic response|0|||
144335355|NCT01264770|520430636|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
144335356|NCT01264770|520430637|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
144335357|NCT01264770|520430638|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
144335358|NCT01264770|520430639|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
144335359|NCT01264770|520430640|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
144335360|NCT01264770|520430641|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
144335361|NCT01264770|520430636|FG000|Overall Study|Lost to Follow-up|0|||
144335362|NCT01264770|520430637|FG001|Overall Study|Lost to Follow-up|0|||
144335363|NCT01264770|520430638|FG002|Overall Study|Lost to Follow-up|1|||
144335364|NCT01264770|520430639|FG003|Overall Study|Lost to Follow-up|1|||
144335365|NCT01264770|520430640|FG004|Overall Study|Lost to Follow-up|0|||
144335366|NCT01264770|520430641|FG005|Overall Study|Lost to Follow-up|0|||
144335367|NCT01264770|520430636|FG000|Overall Study|Adverse Event|7|||
144335368|NCT01264770|520430637|FG001|Overall Study|Adverse Event|7|||
144335369|NCT01264770|520430638|FG002|Overall Study|Adverse Event|8|||
144335370|NCT01264770|520430639|FG003|Overall Study|Adverse Event|0|||
144335371|NCT01264770|520430640|FG004|Overall Study|Adverse Event|2|||
144335372|NCT01264770|520430641|FG005|Overall Study|Adverse Event|1|||
144335373|NCT01455220|520430643|FG000|Overall Study|screen fail|30|||
144335374|NCT00267150|520430644|FG000|Overall Study|Adverse Event|1|||
144335375|NCT04881747|520430645|FG000|Period 2 Washout|Adverse Event|1|||
144335376|NCT04881747|520430646|FG001|Period 2 Washout|Adverse Event|0|||
144335377|NCT04881747|520430647|FG002|Period 2 Washout|Adverse Event|0|||
144335378|NCT04881747|520430648|FG003|Period 2 Washout|Adverse Event|0|||
144335379|NCT04881747|520430649|FG004|Period 2 Washout|Adverse Event|1|||
144335380|NCT04881747|520430650|FG005|Period 2 Washout|Adverse Event|0|||
144335381|NCT04881747|520430645|FG000|Period 2 Washout|Withdrawal by Subject|1|||
144335382|NCT04881747|520430646|FG001|Period 2 Washout|Withdrawal by Subject|0|||
144335383|NCT04881747|520430647|FG002|Period 2 Washout|Withdrawal by Subject|0|||
144335384|NCT04881747|520430648|FG003|Period 2 Washout|Withdrawal by Subject|1|||
144335385|NCT04881747|520430649|FG004|Period 2 Washout|Withdrawal by Subject|0|||
144335386|NCT04881747|520430650|FG005|Period 2 Washout|Withdrawal by Subject|0|||
144335387|NCT00521222|520430652|FG000|Overall Study|Lost to Follow-up|0|||
144335388|NCT00521222|520430653|FG001|Overall Study|Lost to Follow-up|0|||
144335389|NCT00521222|520430654|FG002|Overall Study|Lost to Follow-up|1|||
144335390|NCT00521222|520430655|FG003|Overall Study|Lost to Follow-up|1|||
144335391|NCT00521222|520430652|FG000|Overall Study|Withdrawal by Subject|0|||
144335392|NCT00521222|520430653|FG001|Overall Study|Withdrawal by Subject|0|||
144335393|NCT00521222|520430654|FG002|Overall Study|Withdrawal by Subject|2|||
144335394|NCT00521222|520430655|FG003|Overall Study|Withdrawal by Subject|0|||
144335395|NCT00521222|520430652|FG000|Overall Study|Physician Decision|0|||
144335396|NCT00521222|520430653|FG001|Overall Study|Physician Decision|1|||
144335397|NCT00521222|520430654|FG002|Overall Study|Physician Decision|0|||
144335398|NCT00521222|520430655|FG003|Overall Study|Physician Decision|1|||
144335399|NCT02477553|520430656|FG000|Overall Study|Screening up-to-date|12|||
144335400|NCT02477553|520430657|FG001|Overall Study|Screening up-to-date|13|||
144335401|NCT02477553|520430656|FG000|Overall Study|No MD visit|1|||
144335402|NCT02477553|520430657|FG001|Overall Study|No MD visit|1|||
144335403|NCT02477553|520430656|FG000|Overall Study|Workup consistent w/CRC|1|||
144335404|NCT02477553|520430657|FG001|Overall Study|Workup consistent w/CRC|1|||
144335405|NCT02477553|520430656|FG000|Overall Study|Technical issues with intervention|2|||
144335406|NCT02477553|520430657|FG001|Overall Study|Technical issues with intervention|0|||
144335407|NCT02477553|520430656|FG000|Overall Study|Elevated risk for CRC|2|||
144335408|NCT02477553|520430657|FG001|Overall Study|Elevated risk for CRC|2|||
144335409|NCT02477553|520430656|FG000|Overall Study|MD advised against screening|1|||
144335410|NCT02477553|520430657|FG001|Overall Study|MD advised against screening|3|||
144335411|NCT02477553|520430656|FG000|Overall Study|patient deceased|1|||
144335412|NCT02477553|520430657|FG001|Overall Study|patient deceased|0|||
144335413|NCT00637572|520430658|FG000|Overall Study|Adverse Event|1|||
144335414|NCT00637572|520430659|FG001|Overall Study|Adverse Event|2|||
144335415|NCT00637572|520430658|FG000|Overall Study|Death|0|||
144335416|NCT00637572|520430659|FG001|Overall Study|Death|1|||
144335417|NCT00637572|520430658|FG000|Overall Study|Lost to Follow-up|0|||
144335418|NCT00637572|520430659|FG001|Overall Study|Lost to Follow-up|1|||
144335419|NCT00637572|520430658|FG000|Overall Study|Physician Decision|1|||
144335420|NCT00637572|520430659|FG001|Overall Study|Physician Decision|1|||
144335421|NCT00637572|520430658|FG000|Overall Study|Withdrawal by Subject|0|||
144335422|NCT00637572|520430659|FG001|Overall Study|Withdrawal by Subject|2|||
144335423|NCT00637572|520430658|FG000|Overall Study|Illicit Drug Use|1|||
144335424|NCT00637572|520430659|FG001|Overall Study|Illicit Drug Use|0|||
144335425|NCT03652675|520430661|FG000|Overall Study|Lost to Follow-up|4|||
144335426|NCT03652675|520430662|FG001|Overall Study|Lost to Follow-up|4|||
144335427|NCT01638559|520430663|FG000|Overall Study|Lost to Follow-up|1|||
144335428|NCT01638559|520430663|FG000|Overall Study|Withdrawal by Subject|1|||
144335429|NCT01638559|520430663|FG000|Overall Study|Subject declined to travel for biopsy|1|||
144335430|NCT01403116|520430667|FG000|Overall Study|Adverse Event|7|||
144335431|NCT01403116|520430668|FG001|Overall Study|Adverse Event|4|||
144335432|NCT01403116|520430667|FG000|Overall Study|Lost to Follow-up|7|||
144335433|NCT01403116|520430668|FG001|Overall Study|Lost to Follow-up|5|||
144335434|NCT01403116|520430667|FG000|Overall Study|Withdrawal by Subject|12|||
144335435|NCT01403116|520430668|FG001|Overall Study|Withdrawal by Subject|15|||
144335436|NCT01403116|520430667|FG000|Overall Study|Non-compliance of study drug|3|||
144335437|NCT01403116|520430668|FG001|Overall Study|Non-compliance of study drug|0|||
144335438|NCT01403116|520430667|FG000|Overall Study|Protocol Violation|0|||
144335439|NCT01403116|520430668|FG001|Overall Study|Protocol Violation|1|||
144335440|NCT01403116|520430667|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
144335441|NCT01403116|520430668|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
144335442|NCT01403116|520430667|FG000|Overall Study|Hct >54%|2|||
144335443|NCT01403116|520430668|FG001|Overall Study|Hct >54%|0|||
144335444|NCT01403116|520430667|FG000|Overall Study|unable to keep appointments|0|||
144335445|NCT01403116|520430668|FG001|Overall Study|unable to keep appointments|2|||
144335446|NCT00752726|520430669|FG000|Overall Study|Lost to Follow-up|2|||
144335447|NCT00752726|520430670|FG001|Overall Study|Lost to Follow-up|1|||
144335448|NCT00752726|520430669|FG000|Overall Study|Adverse Event|3|||
144335449|NCT00752726|520430670|FG001|Overall Study|Adverse Event|0|||
144335450|NCT00752726|520430669|FG000|Overall Study|Withdrawal by Subject|5|||
144335451|NCT00752726|520430670|FG001|Overall Study|Withdrawal by Subject|10|||
144335452|NCT00752726|520430669|FG000|Overall Study|Other Reason|1|||
144335453|NCT00752726|520430670|FG001|Overall Study|Other Reason|2|||
144335454|NCT01895309|520430671|FG000|Overall Study|Adverse Event|13|||
144335455|NCT01895309|520430672|FG001|Overall Study|Adverse Event|17|||
144335456|NCT01895309|520430671|FG000|Overall Study|Protocol Violation|1|||
144335457|NCT01895309|520430672|FG001|Overall Study|Protocol Violation|0|||
144335458|NCT01895309|520430671|FG000|Overall Study|Lack of Efficacy|1|||
144335459|NCT01895309|520430672|FG001|Overall Study|Lack of Efficacy|3|||
144335460|NCT01895309|520430671|FG000|Overall Study|Lost to Follow-up|1|||
144335461|NCT01895309|520430672|FG001|Overall Study|Lost to Follow-up|3|||
144335462|NCT01895309|520430671|FG000|Overall Study|Physician Decision|15|||
144335463|NCT01895309|520430672|FG001|Overall Study|Physician Decision|10|||
144335464|NCT01895309|520430671|FG000|Overall Study|Withdrawal by Subject|9|||
144335465|NCT01895309|520430672|FG001|Overall Study|Withdrawal by Subject|18|||
144335466|NCT00042666|520430673|FG000|Overall Study|Adverse Event|2|||
144335467|NCT00042666|520430673|FG000|Overall Study|Death|4|||
144335468|NCT00042666|520430673|FG000|Overall Study|Protocol Violation|1|||
144335469|NCT00042666|520430673|FG000|Overall Study|Participant/Physician Perception|1|||
144335470|NCT00042666|520430673|FG000|Overall Study|Progressive Disease|41|||
144335471|NCT00042666|520430673|FG000|Overall Study|Other|1|||
144335472|NCT00042666|520430673|FG000|Overall Study|Other|4|||
144335473|NCT04232215|520430674|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
144335474|NCT04232215|520430675|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
144335475|NCT00447122|520430676|FG000|Overall Study|worsening medical condition -came off|0|||
144335476|NCT00447122|520430677|FG001|Overall Study|worsening medical condition -came off|1|||
144335477|NCT00447122|520430678|FG002|Overall Study|worsening medical condition -came off|0|||
144335478|NCT00447122|520430679|FG003|Overall Study|worsening medical condition -came off|0|||
144335479|NCT02409342|520430680|FG000|Overall Study|Death|211|||
144335480|NCT02409342|520430681|FG001|Overall Study|Death|201|||
144335481|NCT02409342|520430680|FG000|Overall Study|Withdrawal by Subject|24|||
144335482|NCT02409342|520430681|FG001|Overall Study|Withdrawal by Subject|17|||
144335483|NCT02409342|520430680|FG000|Overall Study|Study Terminated By Sponsor|48|||
144335484|NCT02409342|520430681|FG001|Overall Study|Study Terminated By Sponsor|59|||
144335485|NCT02409342|520430680|FG000|Overall Study|Lost to Follow-up|3|||
144335486|NCT02409342|520430681|FG001|Overall Study|Lost to Follow-up|5|||
144335487|NCT02409342|520430680|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
144335488|NCT02409342|520430681|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
144335489|NCT02409342|520430680|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
144335490|NCT02409342|520430681|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
144335491|NCT02409342|520430680|FG000|Overall Study|Sponsor Decision|1|||
144335492|NCT02409342|520430681|FG001|Overall Study|Sponsor Decision|0|||
144335493|NCT00279812|520430682|FG000|Overall Study|Protocol Violation|1|||
144335494|NCT00279812|520430683|FG001|Overall Study|Protocol Violation|1|||
144335495|NCT00279812|520430684|FG002|Overall Study|Protocol Violation|0|||
144335496|NCT00279812|520430685|FG003|Overall Study|Protocol Violation|0|||
144335497|NCT00279812|520430686|FG004|Overall Study|Protocol Violation|1|||
144335498|NCT00279812|520430687|FG005|Overall Study|Protocol Violation|0|||
144335499|NCT00279812|520430682|FG000|Overall Study|Withdrawal by Subject|0|||
144335500|NCT00279812|520430683|FG001|Overall Study|Withdrawal by Subject|4|||
144335501|NCT00279812|520430684|FG002|Overall Study|Withdrawal by Subject|2|||
144335502|NCT00279812|520430685|FG003|Overall Study|Withdrawal by Subject|0|||
144335503|NCT00279812|520430686|FG004|Overall Study|Withdrawal by Subject|0|||
144335504|NCT00279812|520430687|FG005|Overall Study|Withdrawal by Subject|0|||
144335505|NCT00279812|520430682|FG000|Overall Study|Adverse Event|0|||
144335506|NCT00279812|520430683|FG001|Overall Study|Adverse Event|1|||
144335507|NCT00279812|520430684|FG002|Overall Study|Adverse Event|1|||
144335508|NCT00279812|520430685|FG003|Overall Study|Adverse Event|0|||
144335509|NCT00279812|520430686|FG004|Overall Study|Adverse Event|2|||
144335510|NCT00279812|520430687|FG005|Overall Study|Adverse Event|1|||
144335511|NCT01274429|520430688|FG000|Overall Study|Study closed do to lack of funding|5|||
144335512|NCT01439373|520430694|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
144335513|NCT01439373|520430695|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
144335514|NCT01439373|520430694|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
144335515|NCT01439373|520430695|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
144335516|NCT04046250|520430698|FG000|Overall Study|Death|0|||
144335517|NCT04046250|520430699|FG001|Overall Study|Death|1|||
144335518|NCT04046250|520430698|FG000|Overall Study|Withdrawal by Subject|3|||
144335519|NCT04046250|520430699|FG001|Overall Study|Withdrawal by Subject|3|||
144335520|NCT04576897|520430706|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
144335521|NCT03834220|520430707|FG000|Overall Study|Adverse Event|1|||
144335522|NCT03834220|520430708|FG001|Overall Study|Adverse Event|0|||
144335523|NCT03834220|520430709|FG002|Overall Study|Adverse Event|0|||
144335524|NCT03834220|520430707|FG000|Overall Study|Death|8|||
144335525|NCT03834220|520430708|FG001|Overall Study|Death|1|||
144335526|NCT03834220|520430709|FG002|Overall Study|Death|17|||
144335527|NCT03834220|520430707|FG000|Overall Study|Reason not Specified|9|||
144335528|NCT03834220|520430708|FG001|Overall Study|Reason not Specified|0|||
144335529|NCT03834220|520430709|FG002|Overall Study|Reason not Specified|6|||
144335530|NCT03834220|520430707|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
144335531|NCT03834220|520430708|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
144335532|NCT03834220|520430709|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
144335533|NCT03834220|520430707|FG000|Overall Study|Withdrawal of Consent|2|||
144335534|NCT03834220|520430708|FG001|Overall Study|Withdrawal of Consent|2|||
144335535|NCT03834220|520430709|FG002|Overall Study|Withdrawal of Consent|2|||
144335536|NCT02593318|520430712|FG000|Overall Study|Withdrawal by Subject|1|||
144335537|NCT02593318|520430713|FG001|Overall Study|Withdrawal by Subject|1|||
144335538|NCT01174173|520430715|FG000|Overall Study|drug-drug interaction|1|||
144335539|NCT00527332|520430719|FG000|Overall Study|Protocol Violation|4|||
144335540|NCT00527332|520430720|FG001|Overall Study|Protocol Violation|8|||
144335541|NCT00527332|520430719|FG000|Overall Study|Withdrew consent|5|||
144335542|NCT00527332|520430720|FG001|Overall Study|Withdrew consent|1|||
144335543|NCT05011513|520432582|FG000|Overall Study|Death|0|||
144335544|NCT05011513|520432583|FG001|Overall Study|Death|1|||
144335545|NCT05011513|520432582|FG000|Overall Study|Lost to Follow-up|4|||
144335546|NCT05011513|520432583|FG001|Overall Study|Lost to Follow-up|0|||
144335547|NCT05011513|520432582|FG000|Overall Study|Withdrawal by Subject|18|||
144335548|NCT05011513|520432583|FG001|Overall Study|Withdrawal by Subject|17|||
144335549|NCT05011513|520432582|FG000|Overall Study|Other|4|||
144335550|NCT05011513|520432583|FG001|Overall Study|Other|2|||
144335551|NCT03667690|520432584|FG000|Overall Study|Adverse Event|0|||
144335552|NCT03667690|520432585|FG001|Overall Study|Adverse Event|3|||
144335553|NCT03667690|520432584|FG000|Overall Study|Death|22|||
144335554|NCT03667690|520432585|FG001|Overall Study|Death|21|||
144335555|NCT03667690|520432584|FG000|Overall Study|Lost to Follow-up|4|||
144335556|NCT03667690|520432585|FG001|Overall Study|Lost to Follow-up|5|||
144335557|NCT03667690|520432584|FG000|Overall Study|Withdrawal by Subject|7|||
144335558|NCT03667690|520432585|FG001|Overall Study|Withdrawal by Subject|8|||
144335559|NCT03667690|520432584|FG000|Overall Study|Subject could not return for additional investigational product|1|||
144335560|NCT03667690|520432585|FG001|Overall Study|Subject could not return for additional investigational product|0|||
144335561|NCT03667690|520432584|FG000|Overall Study|Subject discharged to hospice care|2|||
144335562|NCT03667690|520432585|FG001|Overall Study|Subject discharged to hospice care|0|||
144335563|NCT03667690|520432584|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
144335564|NCT03667690|520432585|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
144335565|NCT03667690|520432584|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
144335566|NCT03667690|520432585|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
144335567|NCT03667690|520432584|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
144335568|NCT03667690|520432585|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
144335569|NCT03667690|520432584|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
144335570|NCT03667690|520432585|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
144335571|NCT03667690|520432584|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
144335572|NCT03667690|520432585|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
144335573|NCT01597635|520432594|FG000|Part A|Adverse Event|3|||
144335574|NCT01597635|520432595|FG001|Part A|Adverse Event|0|||
144335575|NCT01597635|520432596|FG002|Part A|Adverse Event|0|||
144335576|NCT01597635|520432594|FG000|Part B|Adverse Event|0|||
144335577|NCT01597635|520432595|FG001|Part B|Adverse Event|0|||
144335578|NCT01597635|520432596|FG002|Part B|Adverse Event|1|||
144335579|NCT01597635|520432594|FG000|Part B|Protocol Violation|0|||
144335580|NCT01597635|520432595|FG001|Part B|Protocol Violation|1|||
144335581|NCT01597635|520432596|FG002|Part B|Protocol Violation|0|||
144335582|NCT01597635|520432594|FG000|Part B|Protocol-defined stopping criteria|0|||
144335583|NCT01597635|520432595|FG001|Part B|Protocol-defined stopping criteria|4|||
144335584|NCT01597635|520432596|FG002|Part B|Protocol-defined stopping criteria|3|||
144335585|NCT01597635|520432594|FG000|Part B|Withdrawal by Subject|0|||
144335586|NCT01597635|520432595|FG001|Part B|Withdrawal by Subject|1|||
144335587|NCT01597635|520432596|FG002|Part B|Withdrawal by Subject|0|||
144335588|NCT00652951|520432597|FG000|Booster Phase|Adverse event, non-fatal|0|||
144335589|NCT00652951|520432598|FG001|Booster Phase|Adverse event, non-fatal|1|||
144335590|NCT00652951|520432599|FG002|Booster Phase|Adverse event, non-fatal|0|||
144335591|NCT00652951|520432597|FG000|Booster Phase|Other|1|||
144335592|NCT00652951|520432598|FG001|Booster Phase|Other|0|||
144335593|NCT00652951|520432599|FG002|Booster Phase|Other|0|||
144335594|NCT01192568|520432600|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
144335595|NCT01192568|520432601|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
144335596|NCT01192568|520432602|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
144335597|NCT01192568|520432603|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
144335598|NCT01192568|520432600|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
144335599|NCT01192568|520432601|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
144335600|NCT01192568|520432602|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
144335601|NCT01192568|520432603|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
144335602|NCT02593825|520432604|FG000|Intervention|Lost to Follow-up|10|||
144335603|NCT02593825|520432605|FG001|Intervention|Lost to Follow-up|12|||
144335604|NCT06359080|520432606|FG000|Overall Study|Withdrawal by Subject|3|||
144335605|NCT00511134|520432607|FG000|Overall Study|Withdrawal by Subject|0|||
144335606|NCT00511134|520432608|FG001|Overall Study|Withdrawal by Subject|2|||
144335607|NCT01949090|520432609|FG000|Overall Study|Serious Adverse Event|0|||
144335608|NCT01949090|520432610|FG001|Overall Study|Serious Adverse Event|1|||
144335609|NCT01949090|520432611|FG002|Overall Study|Serious Adverse Event|2|||
144335610|NCT01949090|520432612|FG003|Overall Study|Serious Adverse Event|0|||
144335611|NCT01949090|520432613|FG004|Overall Study|Serious Adverse Event|1|||
144335612|NCT01949090|520432609|FG000|Overall Study|Withdrawal by Subject|2|||
144335613|NCT01949090|520432610|FG001|Overall Study|Withdrawal by Subject|0|||
144335614|NCT01949090|520432611|FG002|Overall Study|Withdrawal by Subject|0|||
144335615|NCT01949090|520432612|FG003|Overall Study|Withdrawal by Subject|0|||
144335616|NCT01949090|520432613|FG004|Overall Study|Withdrawal by Subject|1|||
144335617|NCT01949090|520432609|FG000|Overall Study|Protocol non-compliance|0|||
144335618|NCT01949090|520432610|FG001|Overall Study|Protocol non-compliance|0|||
144335619|NCT01949090|520432611|FG002|Overall Study|Protocol non-compliance|0|||
144335620|NCT01949090|520432612|FG003|Overall Study|Protocol non-compliance|0|||
144335621|NCT01949090|520432613|FG004|Overall Study|Protocol non-compliance|1|||
144335622|NCT01949090|520432609|FG000|Overall Study|Lost to Follow-up|2|||
144335623|NCT01949090|520432610|FG001|Overall Study|Lost to Follow-up|1|||
144335624|NCT01949090|520432611|FG002|Overall Study|Lost to Follow-up|0|||
144335625|NCT01949090|520432612|FG003|Overall Study|Lost to Follow-up|1|||
144335626|NCT01949090|520432613|FG004|Overall Study|Lost to Follow-up|1|||
144335627|NCT00599755|520432614|FG000|Overall Study|Adverse Event|11|||
144335628|NCT00599755|520432614|FG000|Overall Study|Withdrawal by Subject|2|||
144335629|NCT00599755|520432614|FG000|Overall Study|Progression of Disease|3|||
144335630|NCT00599755|520432614|FG000|Overall Study|Other Reason|2|||
144335631|NCT00599755|520432614|FG000|Overall Study|No data available|1|||
144335632|NCT01306656|520432615|FG000|Overall Study|Lost to Follow-up|1|||
144335633|NCT01306656|520432616|FG001|Overall Study|Lost to Follow-up|0|||
144335634|NCT00417963|520432622|FG000|Overall Study|Lost to Follow-up|3|||
144335635|NCT00417963|520432622|FG000|Overall Study|Withdrawal by Subject|18|||
144335636|NCT00417963|520432622|FG000|Overall Study|Death|17|||
144335637|NCT00417963|520432622|FG000|Overall Study|Study device could not be deployed|3|||
144335638|NCT00477152|520432623|FG000|Overall Study|Parent withdrew consent|2|||
144335639|NCT00477152|520432623|FG000|Overall Study|Adverse Event|1|||
144335640|NCT01023672|520432624|FG000|Overall Study|Worsening disease|2|||
144335641|NCT01023672|520432624|FG000|Overall Study|Death|1|||
144335642|NCT02504580|520432625|FG000|Overall Study|Other|1|||
144335643|NCT02504580|520432626|FG001|Overall Study|Other|0|||
144335644|NCT02504580|520432627|FG002|Overall Study|Other|0|||
144335645|NCT02504580|520432628|FG003|Overall Study|Other|2|||
144335646|NCT02504580|520432629|FG004|Overall Study|Other|1|||
144335647|NCT02504580|520432630|FG005|Overall Study|Other|1|||
144335648|NCT02504580|520432631|FG006|Overall Study|Other|1|||
144335649|NCT02504580|520432632|FG007|Overall Study|Other|2|||
144335650|NCT02504580|520432633|FG008|Overall Study|Other|0|||
144335651|NCT02504580|520432634|FG009|Overall Study|Other|0|||
144335652|NCT02504580|520432635|FG010|Overall Study|Other|0|||
144335653|NCT02504580|520432636|FG011|Overall Study|Other|2|||
144335654|NCT02504580|520432625|FG000|Overall Study|Subject refusal to continue|0|||
144335655|NCT02504580|520432626|FG001|Overall Study|Subject refusal to continue|1|||
144335656|NCT02504580|520432627|FG002|Overall Study|Subject refusal to continue|0|||
144335657|NCT02504580|520432628|FG003|Overall Study|Subject refusal to continue|0|||
144335658|NCT02504580|520432629|FG004|Overall Study|Subject refusal to continue|0|||
144335659|NCT02504580|520432630|FG005|Overall Study|Subject refusal to continue|0|||
144335660|NCT02504580|520432631|FG006|Overall Study|Subject refusal to continue|0|||
144335661|NCT02504580|520432632|FG007|Overall Study|Subject refusal to continue|0|||
144335662|NCT02504580|520432633|FG008|Overall Study|Subject refusal to continue|0|||
144335663|NCT02504580|520432634|FG009|Overall Study|Subject refusal to continue|0|||
144335664|NCT02504580|520432635|FG010|Overall Study|Subject refusal to continue|0|||
144335665|NCT02504580|520432636|FG011|Overall Study|Subject refusal to continue|0|||
144335666|NCT00448747|520432638|FG000|Overall Study|collapsed veins|1|||
144335667|NCT00448747|520432639|FG001|Overall Study|collapsed veins|0|||
144335668|NCT02905006|520432641|FG000|Overall Study|Adverse Event|1|||
144335669|NCT02905006|520432642|FG001|Overall Study|Adverse Event|1|||
144335670|NCT02905006|520432643|FG002|Overall Study|Adverse Event|1|||
144335671|NCT02905006|520432644|FG003|Overall Study|Adverse Event|1|||
144335672|NCT02905006|520432645|FG004|Overall Study|Adverse Event|0|||
144335673|NCT02905006|520432646|FG005|Overall Study|Adverse Event|1|||
144335674|NCT02905006|520432641|FG000|Overall Study|Lack of Efficacy|1|||
144335675|NCT02905006|520432642|FG001|Overall Study|Lack of Efficacy|0|||
144335676|NCT02905006|520432643|FG002|Overall Study|Lack of Efficacy|0|||
144335677|NCT02905006|520432644|FG003|Overall Study|Lack of Efficacy|0|||
144335678|NCT02905006|520432645|FG004|Overall Study|Lack of Efficacy|0|||
144335679|NCT02905006|520432646|FG005|Overall Study|Lack of Efficacy|0|||
144335680|NCT02905006|520432641|FG000|Overall Study|Protocol Violation|2|||
144335681|NCT02905006|520432642|FG001|Overall Study|Protocol Violation|0|||
144335682|NCT02905006|520432643|FG002|Overall Study|Protocol Violation|0|||
144335683|NCT02905006|520432644|FG003|Overall Study|Protocol Violation|0|||
144335684|NCT02905006|520432645|FG004|Overall Study|Protocol Violation|0|||
144335685|NCT02905006|520432646|FG005|Overall Study|Protocol Violation|0|||
144335686|NCT02905006|520432641|FG000|Overall Study|Lost to Follow-up|0|||
144335687|NCT02905006|520432642|FG001|Overall Study|Lost to Follow-up|0|||
144335688|NCT02905006|520432643|FG002|Overall Study|Lost to Follow-up|0|||
144335689|NCT02905006|520432644|FG003|Overall Study|Lost to Follow-up|1|||
144335690|NCT02905006|520432645|FG004|Overall Study|Lost to Follow-up|1|||
144335691|NCT02905006|520432646|FG005|Overall Study|Lost to Follow-up|0|||
144335692|NCT02905006|520432641|FG000|Overall Study|Withdrawal by Subject|0|||
144335693|NCT02905006|520432642|FG001|Overall Study|Withdrawal by Subject|0|||
144335694|NCT02905006|520432643|FG002|Overall Study|Withdrawal by Subject|1|||
144335695|NCT02905006|520432644|FG003|Overall Study|Withdrawal by Subject|1|||
144335696|NCT02905006|520432645|FG004|Overall Study|Withdrawal by Subject|0|||
144335697|NCT02905006|520432646|FG005|Overall Study|Withdrawal by Subject|1|||
144335698|NCT02905006|520432641|FG000|Overall Study|Screening exclusion criteria met|1|||
144335699|NCT02905006|520432642|FG001|Overall Study|Screening exclusion criteria met|0|||
144335700|NCT02905006|520432643|FG002|Overall Study|Screening exclusion criteria met|0|||
144335701|NCT02905006|520432644|FG003|Overall Study|Screening exclusion criteria met|0|||
144335702|NCT02905006|520432645|FG004|Overall Study|Screening exclusion criteria met|0|||
144335703|NCT02905006|520432646|FG005|Overall Study|Screening exclusion criteria met|0|||
144335704|NCT02905006|520432641|FG000|Overall Study|Lab withdrawal criterion met|0|||
144335705|NCT02905006|520432642|FG001|Overall Study|Lab withdrawal criterion met|1|||
144335706|NCT02905006|520432643|FG002|Overall Study|Lab withdrawal criterion met|2|||
144335707|NCT02905006|520432644|FG003|Overall Study|Lab withdrawal criterion met|2|||
144335708|NCT02905006|520432645|FG004|Overall Study|Lab withdrawal criterion met|2|||
144335709|NCT02905006|520432646|FG005|Overall Study|Lab withdrawal criterion met|1|||
144335710|NCT02905006|520432641|FG000|Overall Study|Positive for Tuberculosis|0|||
144335711|NCT02905006|520432642|FG001|Overall Study|Positive for Tuberculosis|1|||
144335712|NCT02905006|520432643|FG002|Overall Study|Positive for Tuberculosis|0|||
144335713|NCT02905006|520432644|FG003|Overall Study|Positive for Tuberculosis|0|||
144335714|NCT02905006|520432645|FG004|Overall Study|Positive for Tuberculosis|0|||
144335715|NCT02905006|520432646|FG005|Overall Study|Positive for Tuberculosis|0|||
144335716|NCT02905006|520432641|FG000|Overall Study|Subject positive for Hep B|0|||
144335717|NCT02905006|520432642|FG001|Overall Study|Subject positive for Hep B|0|||
144335718|NCT02905006|520432643|FG002|Overall Study|Subject positive for Hep B|1|||
144335719|NCT02905006|520432644|FG003|Overall Study|Subject positive for Hep B|0|||
144335720|NCT02905006|520432645|FG004|Overall Study|Subject positive for Hep B|0|||
144335721|NCT02905006|520432646|FG005|Overall Study|Subject positive for Hep B|0|||
144335722|NCT02905006|520432641|FG000|Overall Study|Patient moved abroad|0|||
144335723|NCT02905006|520432642|FG001|Overall Study|Patient moved abroad|0|||
144335724|NCT02905006|520432643|FG002|Overall Study|Patient moved abroad|0|||
144335725|NCT02905006|520432644|FG003|Overall Study|Patient moved abroad|1|||
144335726|NCT02905006|520432645|FG004|Overall Study|Patient moved abroad|0|||
144335727|NCT02905006|520432646|FG005|Overall Study|Patient moved abroad|0|||
144335728|NCT02905006|520432641|FG000|Overall Study|Patient randomized by mistake|0|||
144335729|NCT02905006|520432642|FG001|Overall Study|Patient randomized by mistake|0|||
144335730|NCT02905006|520432643|FG002|Overall Study|Patient randomized by mistake|0|||
144335731|NCT02905006|520432644|FG003|Overall Study|Patient randomized by mistake|0|||
144335732|NCT02905006|520432645|FG004|Overall Study|Patient randomized by mistake|0|||
144335733|NCT02905006|520432646|FG005|Overall Study|Patient randomized by mistake|1|||
144335734|NCT02252965|520432651|FG000|Overall Study|Adverse Event|9|||
144335735|NCT02252965|520432652|FG001|Overall Study|Adverse Event|14|||
144335736|NCT02252965|520432651|FG000|Overall Study|Lost to Follow-up|16|||
144335737|NCT02252965|520432652|FG001|Overall Study|Lost to Follow-up|8|||
144335738|NCT02252965|520432651|FG000|Overall Study|Protocol Violation|4|||
144335739|NCT02252965|520432652|FG001|Overall Study|Protocol Violation|5|||
144335740|NCT02252965|520432651|FG000|Overall Study|Lack of Efficacy|0|||
144335741|NCT02252965|520432652|FG001|Overall Study|Lack of Efficacy|2|||
144335742|NCT02252965|520432651|FG000|Overall Study|Withdrawal by Subject|7|||
144335743|NCT02252965|520432652|FG001|Overall Study|Withdrawal by Subject|9|||
144335744|NCT02252965|520432651|FG000|Overall Study|Other|4|||
144335745|NCT02252965|520432652|FG001|Overall Study|Other|5|||
144335746|NCT02017522|520432653|FG000|Overall Study|Withdrawal by Subject|1|||
144335747|NCT05856227|520432654|FG000|Overall Study|Adverse Event|0|||
144335748|NCT05856227|520432655|FG001|Overall Study|Adverse Event|1|||
144335749|NCT05856227|520432654|FG000|Overall Study|Due to Investigator absence|1|||
144335750|NCT05856227|520432655|FG001|Overall Study|Due to Investigator absence|0|||
144335751|NCT05856227|520432654|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
144335752|NCT05856227|520432655|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
144335753|NCT01751139|520432656|FG000|Overall Study|Other|135|||
144335754|NCT01751139|520432656|FG000|Overall Study|Sponsor study termination|1609|||
144335755|NCT01751139|520432656|FG000|Overall Study|Lost to Follow-up|240|||
144335756|NCT01751139|520432656|FG000|Overall Study|Withdrawal by Subject|251|||
144335757|NCT01751139|520432656|FG000|Overall Study|Adverse Event|1|||
144335758|NCT01751139|520432656|FG000|Overall Study|Death|31|||
144335759|NCT04736628|520432657|FG000|Overall Study|Not treated|0|||
144335760|NCT04736628|520432658|FG001|Overall Study|Not treated|0|||
144335761|NCT04736628|520432659|FG002|Overall Study|Not treated|0|||
144335762|NCT04736628|520432660|FG003|Overall Study|Not treated|2|||
144335763|NCT04736628|520432657|FG000|Overall Study|Other reason than listed|1|||
144335764|NCT04736628|520432658|FG001|Overall Study|Other reason than listed|2|||
144335765|NCT04736628|520432659|FG002|Overall Study|Other reason than listed|2|||
144335766|NCT04736628|520432660|FG003|Overall Study|Other reason than listed|3|||
144335767|NCT04736628|520432657|FG000|Overall Study|Protocol deviation|0|||
144335768|NCT04736628|520432658|FG001|Overall Study|Protocol deviation|0|||
144335769|NCT04736628|520432659|FG002|Overall Study|Protocol deviation|0|||
144335770|NCT04736628|520432660|FG003|Overall Study|Protocol deviation|1|||
144335771|NCT04736628|520432657|FG000|Overall Study|Burden of study procedures|1|||
144335772|NCT04736628|520432658|FG001|Overall Study|Burden of study procedures|0|||
144335773|NCT04736628|520432659|FG002|Overall Study|Burden of study procedures|0|||
144335774|NCT04736628|520432660|FG003|Overall Study|Burden of study procedures|1|||
144335775|NCT04736628|520432657|FG000|Overall Study|Change of residence|0|||
144335776|NCT04736628|520432658|FG001|Overall Study|Change of residence|1|||
144335777|NCT04736628|520432659|FG002|Overall Study|Change of residence|0|||
144335778|NCT04736628|520432660|FG003|Overall Study|Change of residence|0|||
144335779|NCT04736628|520432657|FG000|Overall Study|Perceived lack of efficacy|1|||
144335780|NCT04736628|520432658|FG001|Overall Study|Perceived lack of efficacy|0|||
144335781|NCT04736628|520432659|FG002|Overall Study|Perceived lack of efficacy|0|||
144335782|NCT04736628|520432660|FG003|Overall Study|Perceived lack of efficacy|1|||
144335783|NCT04736628|520432657|FG000|Overall Study|Adverse Event|3|||
144335784|NCT04736628|520432658|FG001|Overall Study|Adverse Event|2|||
144335785|NCT04736628|520432659|FG002|Overall Study|Adverse Event|4|||
144335786|NCT04736628|520432660|FG003|Overall Study|Adverse Event|3|||
144335787|NCT02704689|520432661|FG000|Overall Study|Physician Decision|1|||
144335788|NCT02704689|520432661|FG000|Overall Study|Study device not implanted|2|||
144335789|NCT02428205|520432664|FG000|Overall Study|Lack of Efficacy|1|||
144335790|NCT02428205|520432665|FG001|Overall Study|Lack of Efficacy|0|||
144335791|NCT02428205|520432664|FG000|Overall Study|Lost to Follow-up|1|||
144335792|NCT02428205|520432665|FG001|Overall Study|Lost to Follow-up|1|||
144335793|NCT02428205|520432664|FG000|Overall Study|Worse behavior|0|||
144335794|NCT02428205|520432665|FG001|Overall Study|Worse behavior|1|||
144335795|NCT01646203|520432666|FG000|Overall Study|Adverse Event|2|||
144335796|NCT01646203|520432667|FG001|Overall Study|Adverse Event|0|||
144335797|NCT01646203|520432668|FG002|Overall Study|Adverse Event|1|||
144335798|NCT01646203|520432666|FG000|Overall Study|Withdrawal by Subject|0|||
144335799|NCT01646203|520432667|FG001|Overall Study|Withdrawal by Subject|1|||
144335800|NCT01646203|520432668|FG002|Overall Study|Withdrawal by Subject|0|||
144335801|NCT01646203|520432666|FG000|Overall Study|Physician's Decision|0|||
144335802|NCT01646203|520432667|FG001|Overall Study|Physician's Decision|1|||
144335803|NCT01646203|520432668|FG002|Overall Study|Physician's Decision|0|||
144335804|NCT01100528|520432672|FG000|Overall Study|Death|1|||
144335805|NCT01100528|520432672|FG000|Overall Study|Withdrawal by Subject|2|||
144335806|NCT01504204|520432677|FG000|Overall Study|Lost to Follow-up|1|||
144335807|NCT01504204|520432678|FG001|Overall Study|Lost to Follow-up|1|||
144335808|NCT00903331|520432679|FG000|Overall Study|Death|4|||
144335809|NCT00903331|520432680|FG001|Overall Study|Death|8|||
144335810|NCT00903331|520432679|FG000|Overall Study|Withdrawal of consent|1|||
144335811|NCT00903331|520432680|FG001|Overall Study|Withdrawal of consent|8|||
144335812|NCT00903331|520432679|FG000|Overall Study|Lung transplant|0|||
144335813|NCT00903331|520432680|FG001|Overall Study|Lung transplant|2|||
144335814|NCT00257660|520432681|FG000|Overall Study|Lack of Efficacy|5|||
144335815|NCT00257660|520432682|FG001|Overall Study|Lack of Efficacy|23|||
144335816|NCT00257660|520432681|FG000|Overall Study|Withdrawal by Subject|2|||
144335817|NCT00257660|520432682|FG001|Overall Study|Withdrawal by Subject|0|||
144335818|NCT00257660|520432681|FG000|Overall Study|Lost to Follow-up|1|||
144335819|NCT00257660|520432682|FG001|Overall Study|Lost to Follow-up|0|||
144335820|NCT00257660|520432681|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
144335821|NCT00257660|520432682|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
144335822|NCT00257660|520432681|FG000|Overall Study|No longer wanted to do blood draws|1|||
144335823|NCT00257660|520432682|FG001|Overall Study|No longer wanted to do blood draws|0|||
144335824|NCT03426631|520432685|FG000|Overall Study|Lost to Follow-up|0|||
144335825|NCT03426631|520432686|FG001|Overall Study|Lost to Follow-up|1|||
144335826|NCT00654004|520432689|FG000|Overall Study|Lost to Follow-up|1|||
144335827|NCT00654004|520432690|FG001|Overall Study|Lost to Follow-up|0|||
144335828|NCT00444067|520432691|FG000|Overall Study|Lost to Follow-up|0|||
144335829|NCT00444067|520432692|FG001|Overall Study|Lost to Follow-up|1|||
144335830|NCT00710385|520432697|FG000|Overall Study|Did not qualify|1|||
144335831|NCT00710385|520432697|FG000|Overall Study|Withdrawal by Subject|1|||
144335832|NCT00710385|520432697|FG000|Overall Study|Undisclosed back pain|1|||
144335833|NCT00710385|520432697|FG000|Overall Study|Physician Decision|1|||
144335834|NCT00710385|520432697|FG000|Overall Study|Undisclosed excessive methadone use|1|||
144335835|NCT03134183|520432701|FG000|Overall Study|Withdrawal by Subject|1|||
144335836|NCT03134183|520432702|FG001|Overall Study|Withdrawal by Subject|1|||
144335837|NCT02299076|520432703|FG000|Overall Study|Fraudulent Entries|20|||
144335838|NCT02299076|520432704|FG001|Overall Study|Fraudulent Entries|14|||
144335839|NCT00499746|520432710|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
144335840|NCT00499746|520432710|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
144335841|NCT00499746|520432710|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
144335842|NCT00499746|520432710|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
144335843|NCT02228096|520432711|FG000|Overall Study|Study terminated by Sponsor|24|||
144335844|NCT02228096|520432711|FG000|Overall Study|Lack of Efficacy|18|||
144335845|NCT02228096|520432711|FG000|Overall Study|Death|12|||
144335846|NCT02228096|520432711|FG000|Overall Study|Physician Decision|3|||
144335847|NCT02228096|520432711|FG000|Overall Study|Subject/guardian decision|2|||
144335848|NCT02228096|520432711|FG000|Overall Study|New therapy for study indication|1|||
144335849|NCT02228096|520432711|FG000|Overall Study|Enrolled, not infused|11|||
144335850|NCT01969721|520432712|FG000|Overall Study|Adverse Event|3|||
144335851|NCT01969721|520432713|FG001|Overall Study|Adverse Event|8|||
144335852|NCT01969721|520432714|FG002|Overall Study|Adverse Event|3|||
144335853|NCT01969721|520432715|FG003|Overall Study|Adverse Event|2|||
144335854|NCT01969721|520432712|FG000|Overall Study|Lack of Efficacy|0|||
144335855|NCT01969721|520432713|FG001|Overall Study|Lack of Efficacy|0|||
144335856|NCT01969721|520432714|FG002|Overall Study|Lack of Efficacy|1|||
144335857|NCT01969721|520432715|FG003|Overall Study|Lack of Efficacy|0|||
144335858|NCT01969721|520432712|FG000|Overall Study|Non compliant with protocol|1|||
144335859|NCT01969721|520432713|FG001|Overall Study|Non compliant with protocol|1|||
144335860|NCT01969721|520432714|FG002|Overall Study|Non compliant with protocol|0|||
144335861|NCT01969721|520432715|FG003|Overall Study|Non compliant with protocol|2|||
144335862|NCT01969721|520432712|FG000|Overall Study|Other not defined above|0|||
144335863|NCT01969721|520432713|FG001|Overall Study|Other not defined above|2|||
144335864|NCT01969721|520432714|FG002|Overall Study|Other not defined above|0|||
144335865|NCT01969721|520432715|FG003|Overall Study|Other not defined above|0|||
144335866|NCT01969721|520432712|FG000|Overall Study|Discontinued during washout periods.|0|||
144335867|NCT01969721|520432713|FG001|Overall Study|Discontinued during washout periods.|1|||
144335868|NCT01969721|520432714|FG002|Overall Study|Discontinued during washout periods.|1|||
144335869|NCT01969721|520432715|FG003|Overall Study|Discontinued during washout periods.|2|||
144335870|NCT02383433|520432716|FG000|Overall Study|Disease progression|2|||
144335871|NCT04023682|520432718|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
144335872|NCT01291277|520432719|FG000|Overall Study|Death|2|||
144335873|NCT01291277|520432720|FG001|Overall Study|Death|2|||
144335874|NCT01291277|520432719|FG000|Overall Study|Lost to Follow-up|3|||
144335875|NCT01291277|520432720|FG001|Overall Study|Lost to Follow-up|1|||
144335876|NCT00849108|520432721|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
144335877|NCT00849108|520432722|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
144335878|NCT00849108|520432721|FG000|Cohort 2 Efficacy|Adverse Event|0|||
144335879|NCT00849108|520432722|FG001|Cohort 2 Efficacy|Adverse Event|1|||
144335880|NCT00849108|520432721|FG000|Cohort 2 Efficacy|Other|0|||
144335881|NCT00849108|520432722|FG001|Cohort 2 Efficacy|Other|9|||
144335882|NCT02963701|520432723|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
144335883|NCT02963701|520432724|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
144335884|NCT03480009|520432727|FG000|Overall Study|Lost to Follow-up|4|||
144335885|NCT03480009|520432728|FG001|Overall Study|Lost to Follow-up|5|||
144335886|NCT03480009|520432729|FG002|Overall Study|Lost to Follow-up|4|||
144335887|NCT03480009|520432730|FG003|Overall Study|Lost to Follow-up|0|||
144335888|NCT00896649|520432731|FG000|Overall Study|Physician Decision|1|||
144335889|NCT00896649|520432731|FG000|Overall Study|Pregnancy|1|||
144335890|NCT00896649|520432731|FG000|Overall Study|missing documentation|1|||
144335891|NCT00896649|520432731|FG000|Overall Study|technical difficulties|2|||
144335892|NCT01563172|520432734|FG000|Overall Study|Adverse Event|5|||
144335893|NCT01563172|520432734|FG000|Overall Study|Lost to Follow-up|2|||
144335894|NCT01563172|520432734|FG000|Overall Study|Other (Protocol deviation)|5|||
144335895|NCT01563172|520432734|FG000|Overall Study|Other (Not specified)|1|||
144335896|NCT05327361|520432744|FG000|Overall Study|Lost to Follow-up|4|||
144335897|NCT03268941|520434842|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
144335898|NCT03268941|520434843|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
144335899|NCT03268941|520434844|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
144335900|NCT03268941|520434845|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
144335901|NCT03268941|520434846|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
144335902|NCT03268941|520434847|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
144335903|NCT03268941|520434848|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
144335904|NCT03268941|520434842|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
144335905|NCT03268941|520434843|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
144335906|NCT03268941|520434844|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
144335907|NCT03268941|520434845|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
144335908|NCT03268941|520434846|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
144335909|NCT03268941|520434847|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
144335910|NCT03268941|520434848|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
144335911|NCT03268941|520434842|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
144335912|NCT03268941|520434843|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
144335913|NCT03268941|520434844|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
144335914|NCT03268941|520434845|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
144335915|NCT03268941|520434846|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
144335916|NCT03268941|520434847|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
144335917|NCT03268941|520434848|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
144335918|NCT03268941|520434842|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
144335919|NCT03268941|520434843|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
144335920|NCT03268941|520434844|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
144335921|NCT03268941|520434845|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
144335922|NCT03268941|520434846|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
144335923|NCT03268941|520434847|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
144335924|NCT03268941|520434848|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
144335925|NCT03268941|520434842|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
144335926|NCT03268941|520434843|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
144335927|NCT03268941|520434844|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
144335928|NCT03268941|520434845|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
144335929|NCT03268941|520434846|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
144335930|NCT03268941|520434847|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
144335931|NCT03268941|520434848|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
144335932|NCT01216683|520434853|FG000|Induction|Never started treatment|0|||
144335933|NCT01216683|520434854|FG001|Induction|Never started treatment|6|||
144335934|NCT01216683|520434855|FG002|Induction|Never started treatment|3|||
144335935|NCT01216683|520434853|FG000|Induction|Lack of Efficacy|4|||
144335936|NCT01216683|520434854|FG001|Induction|Lack of Efficacy|3|||
144335937|NCT01216683|520434855|FG002|Induction|Lack of Efficacy|7|||
144335938|NCT01216683|520434853|FG000|Induction|Adverse Event|0|||
144335939|NCT01216683|520434854|FG001|Induction|Adverse Event|5|||
144335940|NCT01216683|520434855|FG002|Induction|Adverse Event|5|||
144335941|NCT01216683|520434853|FG000|Induction|Death|0|||
144335942|NCT01216683|520434854|FG001|Induction|Death|0|||
144335943|NCT01216683|520434855|FG002|Induction|Death|2|||
144335944|NCT01216683|520434853|FG000|Induction|Withdrawal by Subject|0|||
144335945|NCT01216683|520434854|FG001|Induction|Withdrawal by Subject|4|||
144335946|NCT01216683|520434855|FG002|Induction|Withdrawal by Subject|2|||
144335947|NCT01216683|520434853|FG000|Induction|Other disease|0|||
144335948|NCT01216683|520434854|FG001|Induction|Other disease|1|||
144335949|NCT01216683|520434855|FG002|Induction|Other disease|2|||
144335950|NCT01216683|520434853|FG000|Continuation|Lack of Efficacy|3|||
144335951|NCT01216683|520434854|FG001|Continuation|Lack of Efficacy|2|||
144335952|NCT01216683|520434855|FG002|Continuation|Lack of Efficacy|7|||
144335953|NCT01216683|520434853|FG000|Continuation|Adverse Event|5|||
144335954|NCT01216683|520434854|FG001|Continuation|Adverse Event|3|||
144335955|NCT01216683|520434855|FG002|Continuation|Adverse Event|16|||
144335956|NCT01216683|520434853|FG000|Continuation|Death|1|||
144335957|NCT01216683|520434854|FG001|Continuation|Death|0|||
144335958|NCT01216683|520434855|FG002|Continuation|Death|2|||
144335959|NCT01216683|520434853|FG000|Continuation|Withdrawal by Subject|4|||
144335960|NCT01216683|520434854|FG001|Continuation|Withdrawal by Subject|5|||
144335961|NCT01216683|520434855|FG002|Continuation|Withdrawal by Subject|9|||
144335962|NCT01216683|520434853|FG000|Continuation|Other diseases|0|||
144335963|NCT01216683|520434854|FG001|Continuation|Other diseases|2|||
144335964|NCT01216683|520434855|FG002|Continuation|Other diseases|1|||
144335965|NCT01216683|520434853|FG000|Continuation|Physician Decision|1|||
144335966|NCT01216683|520434854|FG001|Continuation|Physician Decision|0|||
144335967|NCT01216683|520434855|FG002|Continuation|Physician Decision|1|||
144335968|NCT01216683|520434853|FG000|Continuation|Non-compliance|1|||
144335969|NCT01216683|520434854|FG001|Continuation|Non-compliance|0|||
144335970|NCT01216683|520434855|FG002|Continuation|Non-compliance|1|||
144335971|NCT01216683|520434853|FG000|Continuation|Insurance change|0|||
144335972|NCT01216683|520434854|FG001|Continuation|Insurance change|1|||
144335973|NCT01216683|520434855|FG002|Continuation|Insurance change|0|||
144335974|NCT01216683|520434853|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
144335975|NCT01216683|520434854|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
144335976|NCT01216683|520434855|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
144335977|NCT01216683|520434853|FG000|Continuation|Not reported|0|||
144335978|NCT01216683|520434854|FG001|Continuation|Not reported|0|||
144335979|NCT01216683|520434855|FG002|Continuation|Not reported|1|||
144335980|NCT01216683|520434853|FG000|Continuation|Never started treatment|0|||
144335981|NCT01216683|520434854|FG001|Continuation|Never started treatment|1|||
144335982|NCT01216683|520434855|FG002|Continuation|Never started treatment|5|||
144335983|NCT02720692|520434856|FG000|Overall Study|Withdrawal by Subject|3|||
144335984|NCT02720692|520434857|FG001|Overall Study|Withdrawal by Subject|0|||
144335985|NCT02720692|520434856|FG000|Overall Study|Physician Decision|1|||
144335986|NCT02720692|520434857|FG001|Overall Study|Physician Decision|0|||
144335987|NCT02720692|520434856|FG000|Overall Study|Lost to Follow-up|8|||
144335988|NCT02720692|520434857|FG001|Overall Study|Lost to Follow-up|3|||
144335989|NCT02720692|520434856|FG000|Overall Study|Subject unable to return for visit|1|||
144335990|NCT02720692|520434857|FG001|Overall Study|Subject unable to return for visit|0|||
144335991|NCT02503501|520434858|FG000|Overall Study|Physician Decision|1|||
144335992|NCT02503501|520434859|FG001|Overall Study|Physician Decision|0|||
144335993|NCT02503501|520434858|FG000|Overall Study|Protocol Violation|0|||
144335994|NCT02503501|520434859|FG001|Overall Study|Protocol Violation|1|||
144335995|NCT02503501|520434858|FG000|Overall Study|Withdrawal by Subject|0|||
144335996|NCT02503501|520434859|FG001|Overall Study|Withdrawal by Subject|2|||
144335997|NCT03878758|520434860|FG000|Overall Study|Withdrawal by Subject|1|||
144335998|NCT03878758|520434860|FG000|Overall Study|Protocol defined|2|||
144335999|NCT03878758|520434860|FG000|Overall Study|Improper consent documentation|1|||
144336000|NCT00765063|520434861|FG000|Overall Study|Lack of Efficacy|5|||
144336001|NCT00765063|520434861|FG000|Overall Study|Withdrawal by Subject|1|||
144336002|NCT00765063|520434861|FG000|Overall Study|Other|16|||
144336003|NCT00765063|520434861|FG000|Overall Study|Protocol Violation|6|||
144336004|NCT00765063|520434861|FG000|Overall Study|Adverse Event|4|||
144336005|NCT03614325|520434862|FG000|Overall Study|Withdrawal by Subject|0|||
144336006|NCT03614325|520434863|FG001|Overall Study|Withdrawal by Subject|2|||
144336007|NCT03614325|520434862|FG000|Overall Study|Surgery Cancelled|2|||
144336008|NCT03614325|520434863|FG001|Overall Study|Surgery Cancelled|1|||
144336009|NCT03614325|520434862|FG000|Overall Study|Lost to Follow-up|2|||
144336010|NCT03614325|520434863|FG001|Overall Study|Lost to Follow-up|1|||
144336011|NCT03614325|520434862|FG000|Overall Study|Surgery never scheduled|1|||
144336012|NCT03614325|520434863|FG001|Overall Study|Surgery never scheduled|0|||
144336013|NCT00321464|520434864|FG000|Overall Study|Death|169|||
144336014|NCT00321464|520434865|FG001|Overall Study|Death|174|||
144336015|NCT00321464|520434864|FG000|Overall Study|Disease progression|124|||
144336016|NCT00321464|520434865|FG001|Overall Study|Disease progression|124|||
144336017|NCT00321464|520434864|FG000|Overall Study|Withdrawal by Subject|117|||
144336018|NCT00321464|520434865|FG001|Overall Study|Withdrawal by Subject|118|||
144336019|NCT00321464|520434864|FG000|Overall Study|Participant request|57|||
144336020|NCT00321464|520434865|FG001|Overall Study|Participant request|61|||
144336021|NCT00321464|520434864|FG000|Overall Study|Adverse Event|43|||
144336022|NCT00321464|520434865|FG001|Overall Study|Adverse Event|28|||
144336023|NCT00321464|520434864|FG000|Overall Study|Physician Decision|15|||
144336024|NCT00321464|520434865|FG001|Overall Study|Physician Decision|14|||
144336025|NCT00321464|520434864|FG000|Overall Study|Noncompliance|4|||
144336026|NCT00321464|520434865|FG001|Overall Study|Noncompliance|10|||
144336027|NCT00321464|520434864|FG000|Overall Study|Lost to Follow-up|7|||
144336028|NCT00321464|520434865|FG001|Overall Study|Lost to Follow-up|8|||
144336029|NCT00321464|520434864|FG000|Overall Study|Protocol deviation|0|||
144336030|NCT00321464|520434865|FG001|Overall Study|Protocol deviation|2|||
144336031|NCT00321464|520434864|FG000|Overall Study|Ineligibility determined|2|||
144336032|NCT00321464|520434865|FG001|Overall Study|Ineligibility determined|1|||
144336033|NCT00321464|520434864|FG000|Overall Study|Other|21|||
144336034|NCT00321464|520434865|FG001|Overall Study|Other|18|||
144336035|NCT02081599|520434866|FG000|Period 1：Double-blind Period|Adverse Event|3|||
144336036|NCT02081599|520434867|FG001|Period 1：Double-blind Period|Adverse Event|0|||
144336037|NCT02081599|520434866|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
144336038|NCT02081599|520434867|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
144336039|NCT02081599|520434866|FG000|Period 1：Double-blind Period|Physician Decision|1|||
144336040|NCT02081599|520434867|FG001|Period 1：Double-blind Period|Physician Decision|0|||
144336041|NCT02081599|520434866|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
144336042|NCT02081599|520434867|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
144336043|NCT02081599|520434866|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
144336044|NCT02081599|520434867|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
144336045|NCT02081599|520434866|FG000|Period 1：Double-blind Period|stopping criteria|1|||
144336046|NCT02081599|520434867|FG001|Period 1：Double-blind Period|stopping criteria|0|||
144336047|NCT02081599|520434866|FG000|Period 2：Open-label Period|Adverse Event|1|||
144336048|NCT02081599|520434867|FG001|Period 2：Open-label Period|Adverse Event|0|||
144336049|NCT02081599|520434866|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
144336050|NCT02081599|520434867|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
144336051|NCT02081599|520434866|FG000|Period 2：Open-label Period|Physician Decision|1|||
144336052|NCT02081599|520434867|FG001|Period 2：Open-label Period|Physician Decision|0|||
144336053|NCT02081599|520434866|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
144336054|NCT02081599|520434867|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
144336055|NCT01629953|520434868|FG000|Overall Study|Death|3|||
144336056|NCT01629953|520434869|FG001|Overall Study|Death|1|||
144336057|NCT01629953|520434868|FG000|Overall Study|Lost to Follow-up|10|||
144336058|NCT01629953|520434869|FG001|Overall Study|Lost to Follow-up|14|||
144336059|NCT00707954|520434874|FG000|Overall Study|Physician Decision|0|||
144336060|NCT00707954|520434875|FG001|Overall Study|Physician Decision|0|||
144336061|NCT00707954|520434876|FG002|Overall Study|Physician Decision|0|||
144336062|NCT00707954|520434877|FG003|Overall Study|Physician Decision|0|||
144336063|NCT00707954|520434878|FG004|Overall Study|Physician Decision|1|||
144336064|NCT00306527|520434880|FG000|Overall Study|Lost to Follow-up|3|||
144336065|NCT00306527|520434881|FG001|Overall Study|Lost to Follow-up|4|||
144336066|NCT00306527|520434882|FG002|Overall Study|Lost to Follow-up|3|||
144336067|NCT00306527|520434883|FG003|Overall Study|Lost to Follow-up|0|||
144336068|NCT00306527|520434880|FG000|Overall Study|Withdrawal by Subject|2|||
144336069|NCT00306527|520434881|FG001|Overall Study|Withdrawal by Subject|3|||
144336070|NCT00306527|520434882|FG002|Overall Study|Withdrawal by Subject|0|||
144336071|NCT00306527|520434883|FG003|Overall Study|Withdrawal by Subject|3|||
144336072|NCT00306527|520434880|FG000|Overall Study|Adverse Event|0|||
144336073|NCT00306527|520434881|FG001|Overall Study|Adverse Event|0|||
144336074|NCT00306527|520434882|FG002|Overall Study|Adverse Event|1|||
144336075|NCT00306527|520434883|FG003|Overall Study|Adverse Event|1|||
144336076|NCT00306527|520434880|FG000|Overall Study|Death|1|||
144336077|NCT00306527|520434881|FG001|Overall Study|Death|0|||
144336078|NCT00306527|520434882|FG002|Overall Study|Death|1|||
144336079|NCT00306527|520434883|FG003|Overall Study|Death|2|||
144336080|NCT00785980|520434884|FG000|7 Day Washout Period|Protocol Violation|3|||
144336081|NCT00528801|520434885|FG000|Overall Study|Withdrawal by Subject|1|||
144336082|NCT00528801|520434886|FG001|Overall Study|Withdrawal by Subject|1|||
144336083|NCT00528801|520434885|FG000|Overall Study|Protocol Violation|11|||
144336084|NCT00528801|520434886|FG001|Overall Study|Protocol Violation|5|||
144336085|NCT00528801|520434885|FG000|Overall Study|Lost to Follow-up|15|||
144336086|NCT00528801|520434886|FG001|Overall Study|Lost to Follow-up|4|||
144336087|NCT00528801|520434885|FG000|Overall Study|Administrative Reasons|0|||
144336088|NCT00528801|520434886|FG001|Overall Study|Administrative Reasons|1|||
144336089|NCT00344500|520434887|FG000|Overall Study|Adverse Event|6|||
144336090|NCT00344500|520434888|FG001|Overall Study|Adverse Event|2|||
144336091|NCT00344500|520434889|FG002|Overall Study|Adverse Event|0|||
144336092|NCT00344500|520434887|FG000|Overall Study|Lost to Follow-up|5|||
144336093|NCT00344500|520434888|FG001|Overall Study|Lost to Follow-up|13|||
144336094|NCT00344500|520434889|FG002|Overall Study|Lost to Follow-up|1|||
144336095|NCT00344500|520434887|FG000|Overall Study|Withdrawal by Subject|7|||
144336096|NCT00344500|520434888|FG001|Overall Study|Withdrawal by Subject|10|||
144336097|NCT00344500|520434889|FG002|Overall Study|Withdrawal by Subject|0|||
144336098|NCT00344500|520434887|FG000|Overall Study|Protocol Violation|4|||
144336099|NCT00344500|520434888|FG001|Overall Study|Protocol Violation|7|||
144336100|NCT00344500|520434889|FG002|Overall Study|Protocol Violation|1|||
144336101|NCT00344500|520434887|FG000|Overall Study|Not Noted|1|||
144336102|NCT00344500|520434888|FG001|Overall Study|Not Noted|3|||
144336103|NCT00344500|520434889|FG002|Overall Study|Not Noted|0|||
144336104|NCT02207491|520434890|FG000|Overall Study|Adverse Event|20|||
144336105|NCT02207491|520434891|FG001|Overall Study|Adverse Event|4|||
144336106|NCT02207491|520434890|FG000|Overall Study|Withdrawal by Subject|3|||
144336107|NCT02207491|520434891|FG001|Overall Study|Withdrawal by Subject|2|||
144336108|NCT02207491|520434890|FG000|Overall Study|Non-compliant|0|||
144336109|NCT02207491|520434891|FG001|Overall Study|Non-compliant|1|||
144336110|NCT02207491|520434890|FG000|Overall Study|Lost to Follow-up|0|||
144336111|NCT02207491|520434891|FG001|Overall Study|Lost to Follow-up|1|||
144336112|NCT02207491|520434890|FG000|Overall Study|Lack of Efficacy|3|||
144336113|NCT02207491|520434891|FG001|Overall Study|Lack of Efficacy|0|||
144336114|NCT02207491|520434890|FG000|Overall Study|Physician Decision|2|||
144336115|NCT02207491|520434891|FG001|Overall Study|Physician Decision|0|||
144336116|NCT02207491|520434890|FG000|Overall Study|Protocol Violation|3|||
144336117|NCT02207491|520434891|FG001|Overall Study|Protocol Violation|5|||
144336118|NCT02615691|520434894|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
144336119|NCT02615691|520434894|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
144336120|NCT02615691|520434894|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
144336121|NCT02615691|520434894|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
144336122|NCT04201093|520434895|FG000|Overall Study|Adverse Event|6|||
144336123|NCT04201093|520434896|FG001|Overall Study|Adverse Event|29|||
144336124|NCT04201093|520434897|FG002|Overall Study|Adverse Event|35|||
144336125|NCT04201093|520434895|FG000|Overall Study|Death|2|||
144336126|NCT04201093|520434896|FG001|Overall Study|Death|1|||
144336127|NCT04201093|520434897|FG002|Overall Study|Death|0|||
144336128|NCT04201093|520434895|FG000|Overall Study|Lack of Efficacy|5|||
144336129|NCT04201093|520434896|FG001|Overall Study|Lack of Efficacy|1|||
144336130|NCT04201093|520434897|FG002|Overall Study|Lack of Efficacy|2|||
144336131|NCT04201093|520434895|FG000|Overall Study|Lost to Follow-up|0|||
144336132|NCT04201093|520434896|FG001|Overall Study|Lost to Follow-up|0|||
144336133|NCT04201093|520434897|FG002|Overall Study|Lost to Follow-up|1|||
144336134|NCT04201093|520434895|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
144336135|NCT04201093|520434896|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
144336136|NCT04201093|520434897|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
144336137|NCT04201093|520434895|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
144336138|NCT04201093|520434896|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
144336139|NCT04201093|520434897|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
144336140|NCT04201093|520434895|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
144336141|NCT04201093|520434896|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
144336142|NCT04201093|520434897|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
144336143|NCT04201093|520434895|FG000|Overall Study|Physician Decision|1|||
144336144|NCT04201093|520434896|FG001|Overall Study|Physician Decision|0|||
144336145|NCT04201093|520434897|FG002|Overall Study|Physician Decision|0|||
144336146|NCT04201093|520434895|FG000|Overall Study|Protocol Deviation|1|||
144336147|NCT04201093|520434896|FG001|Overall Study|Protocol Deviation|0|||
144336148|NCT04201093|520434897|FG002|Overall Study|Protocol Deviation|0|||
144336149|NCT04201093|520434895|FG000|Overall Study|Site Terminated by Sponsor|5|||
144336150|NCT04201093|520434896|FG001|Overall Study|Site Terminated by Sponsor|3|||
144336151|NCT04201093|520434897|FG002|Overall Study|Site Terminated by Sponsor|1|||
144336152|NCT04201093|520434895|FG000|Overall Study|Withdrawal by Subject|7|||
144336153|NCT04201093|520434896|FG001|Overall Study|Withdrawal by Subject|8|||
144336154|NCT04201093|520434897|FG002|Overall Study|Withdrawal by Subject|15|||
144336155|NCT04201093|520434895|FG000|Overall Study|Other|0|||
144336156|NCT04201093|520434896|FG001|Overall Study|Other|1|||
144336157|NCT04201093|520434897|FG002|Overall Study|Other|2|||
144336158|NCT00007020|520434898|FG000|Overall Study|Death|16|||
144336159|NCT00007020|520434898|FG000|Overall Study|Lost to Follow-up|13|||
144336160|NCT00007020|520434898|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
144336161|NCT00007020|520434898|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
144336162|NCT00007020|520434898|FG000|Overall Study|Pt cared for by outside physician|4|||
144336163|NCT00007020|520434898|FG000|Overall Study|No evidence of treatment|6|||
144336164|NCT00881504|520434899|FG000|Overall Study|Withdrawal by Subject|1|||
144336165|NCT01276223|520434900|FG000|Overall Study|Adverse Event|7|||
144336166|NCT01276223|520434901|FG001|Overall Study|Adverse Event|4|||
144336167|NCT01276223|520434902|FG002|Overall Study|Adverse Event|1|||
144336168|NCT01276223|520434900|FG000|Overall Study|Lost to Follow-up|0|||
144336169|NCT01276223|520434901|FG001|Overall Study|Lost to Follow-up|0|||
144336170|NCT01276223|520434902|FG002|Overall Study|Lost to Follow-up|1|||
144336171|NCT01276223|520434900|FG000|Overall Study|Other|0|||
144336172|NCT01276223|520434901|FG001|Overall Study|Other|0|||
144336173|NCT01276223|520434902|FG002|Overall Study|Other|1|||
144336174|NCT01276223|520434900|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
144336175|NCT01276223|520434901|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
144336176|NCT01276223|520434902|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
144336177|NCT01276223|520434900|FG000|Overall Study|Protocol Violation|1|||
144336178|NCT01276223|520434901|FG001|Overall Study|Protocol Violation|0|||
144336179|NCT01276223|520434902|FG002|Overall Study|Protocol Violation|0|||
144336180|NCT04279613|520434904|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
144336181|NCT04279613|520434905|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
144336182|NCT04279613|520434906|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
144336183|NCT04279613|520434907|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
144336184|NCT04279613|520434908|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
144336185|NCT04279613|520434904|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
144336186|NCT04279613|520434905|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
144336187|NCT04279613|520434906|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
144336188|NCT04279613|520434907|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
144336189|NCT04279613|520434908|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
144336190|NCT04279613|520434904|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
144336191|NCT04279613|520434905|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
144336192|NCT04279613|520434906|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
144336193|NCT04279613|520434907|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
144336194|NCT04279613|520434908|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
144336195|NCT04279613|520434904|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
144336196|NCT04279613|520434905|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
144336197|NCT04279613|520434906|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
144336198|NCT04279613|520434907|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
144336199|NCT04279613|520434908|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
144336200|NCT04279613|520434904|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
144336201|NCT04279613|520434905|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
144336202|NCT04279613|520434906|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
144336203|NCT04279613|520434907|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
144336204|NCT04279613|520434908|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
144336205|NCT02478164|520434909|FG000|Overall Study|Lack of Efficacy|13|||
144336206|NCT02478164|520434909|FG000|Overall Study|Adverse Event|1|||
144336207|NCT02478164|520434909|FG000|Overall Study|Withdrawal by Subject|1|||
144336208|NCT00320424|520434910|FG000|Overall Study|Adverse Event|3|||
144336209|NCT00320424|520434910|FG000|Overall Study|Other|3|||
144336210|NCT04051827|520434912|FG000|Overall Study|Death|1|||
144336211|NCT04051827|520434912|FG000|Overall Study|Withdrawal by Subject|4|||
144336212|NCT04051827|520434912|FG000|Overall Study|Progressive disease|16|||
144336213|NCT04051827|520434912|FG000|Overall Study|Physician Decision|1|||
144336214|NCT04051827|520434912|FG000|Overall Study|Other|4|||
144336215|NCT02888743|520434913|FG000|Overall Study|Withdrawal by Subject|1|||
144336216|NCT02888743|520434914|FG001|Overall Study|Withdrawal by Subject|2|||
144336217|NCT02888743|520434915|FG002|Overall Study|Withdrawal by Subject|2|||
144336218|NCT02888743|520434916|FG003|Overall Study|Withdrawal by Subject|0|||
144336219|NCT02888743|520434917|FG004|Overall Study|Withdrawal by Subject|1|||
144336220|NCT02888743|520434913|FG000|Overall Study|Disease progression before treatment|2|||
144336221|NCT02888743|520434914|FG001|Overall Study|Disease progression before treatment|0|||
144336222|NCT02888743|520434915|FG002|Overall Study|Disease progression before treatment|2|||
144336223|NCT02888743|520434916|FG003|Overall Study|Disease progression before treatment|0|||
144336224|NCT02888743|520434917|FG004|Overall Study|Disease progression before treatment|0|||
144336225|NCT02888743|520434913|FG000|Overall Study|Patient ineligible|1|||
144336226|NCT02888743|520434914|FG001|Overall Study|Patient ineligible|2|||
144336227|NCT02888743|520434915|FG002|Overall Study|Patient ineligible|0|||
144336228|NCT02888743|520434916|FG003|Overall Study|Patient ineligible|0|||
144336229|NCT02888743|520434917|FG004|Overall Study|Patient ineligible|0|||
144336230|NCT01424566|520434918|FG000|Single-blind Treatment|Adverse Event|71|||
144336231|NCT01424566|520434919|FG001|Single-blind Treatment|Adverse Event|0|||
144336232|NCT01424566|520434920|FG002|Single-blind Treatment|Adverse Event|0|||
144336233|NCT01424566|520434918|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
144336234|NCT01424566|520434919|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
144336235|NCT01424566|520434920|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
144336236|NCT01424566|520434918|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
144336237|NCT01424566|520434919|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
144336238|NCT01424566|520434920|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
144336239|NCT01424566|520434918|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
144336240|NCT01424566|520434919|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
144336241|NCT01424566|520434920|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
144336242|NCT01424566|520434918|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
144336243|NCT01424566|520434919|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
144336244|NCT01424566|520434920|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
144336245|NCT01424566|520434918|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
144336246|NCT01424566|520434919|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
144336247|NCT01424566|520434920|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
144336248|NCT01424566|520434918|FG000|Double-blind Treatment|Adverse Event|0|||
144336249|NCT01424566|520434919|FG001|Double-blind Treatment|Adverse Event|21|||
144336250|NCT01424566|520434920|FG002|Double-blind Treatment|Adverse Event|13|||
144336251|NCT01424566|520434918|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
144336252|NCT01424566|520434919|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
144336253|NCT01424566|520434920|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
144336254|NCT01424566|520434918|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
144336255|NCT01424566|520434919|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
144336256|NCT01424566|520434920|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
144336257|NCT01424566|520434918|FG000|Double-blind Treatment|Lack of Efficacy|0|||
144336258|NCT01424566|520434919|FG001|Double-blind Treatment|Lack of Efficacy|1|||
144336259|NCT01424566|520434920|FG002|Double-blind Treatment|Lack of Efficacy|1|||
144336260|NCT01659255|520434921|FG000|Overall Study|Adverse Event|0|||
144336261|NCT01659255|520434922|FG001|Overall Study|Adverse Event|0|||
144336262|NCT01659255|520434923|FG002|Overall Study|Adverse Event|0|||
144336263|NCT01659255|520434924|FG003|Overall Study|Adverse Event|0|||
144336264|NCT01659255|520434925|FG004|Overall Study|Adverse Event|0|||
144336265|NCT01659255|520434926|FG005|Overall Study|Adverse Event|1|||
144336266|NCT01659255|520434927|FG006|Overall Study|Adverse Event|1|||
144336267|NCT01659255|520434928|FG007|Overall Study|Adverse Event|0|||
144336268|NCT01659255|520434929|FG008|Overall Study|Adverse Event|0|||
144336269|NCT01659255|520434930|FG009|Overall Study|Adverse Event|1|||
144336270|NCT01659255|520434931|FG010|Overall Study|Adverse Event|0|||
144336271|NCT01659255|520434932|FG011|Overall Study|Adverse Event|1|||
144336272|NCT01659255|520434933|FG012|Overall Study|Adverse Event|0|||
144336273|NCT01659255|520434934|FG013|Overall Study|Adverse Event|2|||
144336274|NCT01659255|520434935|FG014|Overall Study|Adverse Event|0|||
144336275|NCT01659255|520434936|FG015|Overall Study|Adverse Event|1|||
144336276|NCT01659255|520434937|FG016|Overall Study|Adverse Event|0|||
144336277|NCT01659255|520434921|FG000|Overall Study|Death|0|||
144336278|NCT01659255|520434922|FG001|Overall Study|Death|1|||
144336279|NCT01659255|520434923|FG002|Overall Study|Death|0|||
144336280|NCT01659255|520434924|FG003|Overall Study|Death|0|||
144336281|NCT01659255|520434925|FG004|Overall Study|Death|0|||
144336282|NCT01659255|520434926|FG005|Overall Study|Death|0|||
144336283|NCT01659255|520434927|FG006|Overall Study|Death|0|||
144336284|NCT01659255|520434928|FG007|Overall Study|Death|1|||
144336285|NCT01659255|520434929|FG008|Overall Study|Death|1|||
144336286|NCT01659255|520434930|FG009|Overall Study|Death|0|||
144336287|NCT01659255|520434931|FG010|Overall Study|Death|0|||
144336288|NCT01659255|520434932|FG011|Overall Study|Death|0|||
144336289|NCT01659255|520434933|FG012|Overall Study|Death|1|||
144336290|NCT01659255|520434934|FG013|Overall Study|Death|1|||
144336291|NCT01659255|520434935|FG014|Overall Study|Death|2|||
144336292|NCT01659255|520434936|FG015|Overall Study|Death|1|||
144336293|NCT01659255|520434937|FG016|Overall Study|Death|0|||
144336294|NCT01659255|520434921|FG000|Overall Study|Progressive Disease|2|||
144336295|NCT01659255|520434922|FG001|Overall Study|Progressive Disease|0|||
144336296|NCT01659255|520434923|FG002|Overall Study|Progressive Disease|0|||
144336297|NCT01659255|520434924|FG003|Overall Study|Progressive Disease|0|||
144336298|NCT01659255|520434925|FG004|Overall Study|Progressive Disease|0|||
144336299|NCT01659255|520434926|FG005|Overall Study|Progressive Disease|0|||
144336300|NCT01659255|520434927|FG006|Overall Study|Progressive Disease|0|||
144336301|NCT01659255|520434928|FG007|Overall Study|Progressive Disease|1|||
144336302|NCT01659255|520434929|FG008|Overall Study|Progressive Disease|0|||
144336303|NCT01659255|520434930|FG009|Overall Study|Progressive Disease|2|||
144336304|NCT01659255|520434931|FG010|Overall Study|Progressive Disease|2|||
144336305|NCT01659255|520434932|FG011|Overall Study|Progressive Disease|3|||
144336306|NCT01659255|520434933|FG012|Overall Study|Progressive Disease|5|||
144336307|NCT01659255|520434934|FG013|Overall Study|Progressive Disease|13|||
144336308|NCT01659255|520434935|FG014|Overall Study|Progressive Disease|6|||
144336309|NCT01659255|520434936|FG015|Overall Study|Progressive Disease|2|||
144336310|NCT01659255|520434937|FG016|Overall Study|Progressive Disease|3|||
144336311|NCT01659255|520434921|FG000|Overall Study|Withdrew Consent|0|||
144336312|NCT01659255|520434922|FG001|Overall Study|Withdrew Consent|0|||
144336313|NCT01659255|520434923|FG002|Overall Study|Withdrew Consent|0|||
144336314|NCT01659255|520434924|FG003|Overall Study|Withdrew Consent|0|||
144336315|NCT01659255|520434925|FG004|Overall Study|Withdrew Consent|0|||
144336316|NCT01659255|520434926|FG005|Overall Study|Withdrew Consent|0|||
144336317|NCT01659255|520434927|FG006|Overall Study|Withdrew Consent|0|||
144336318|NCT01659255|520434928|FG007|Overall Study|Withdrew Consent|0|||
144336319|NCT01659255|520434929|FG008|Overall Study|Withdrew Consent|0|||
144336320|NCT01659255|520434930|FG009|Overall Study|Withdrew Consent|0|||
144336321|NCT01659255|520434931|FG010|Overall Study|Withdrew Consent|1|||
144336322|NCT01659255|520434932|FG011|Overall Study|Withdrew Consent|0|||
144336323|NCT01659255|520434933|FG012|Overall Study|Withdrew Consent|0|||
144336324|NCT01659255|520434934|FG013|Overall Study|Withdrew Consent|1|||
144336325|NCT01659255|520434935|FG014|Overall Study|Withdrew Consent|0|||
144336326|NCT01659255|520434936|FG015|Overall Study|Withdrew Consent|0|||
144336327|NCT01659255|520434937|FG016|Overall Study|Withdrew Consent|0|||
144336328|NCT01659255|520434921|FG000|Overall Study|Investigator Decision|0|||
144336329|NCT01659255|520434922|FG001|Overall Study|Investigator Decision|0|||
144336330|NCT01659255|520434923|FG002|Overall Study|Investigator Decision|0|||
144336331|NCT01659255|520434924|FG003|Overall Study|Investigator Decision|0|||
144336332|NCT01659255|520434925|FG004|Overall Study|Investigator Decision|0|||
144336333|NCT01659255|520434926|FG005|Overall Study|Investigator Decision|0|||
144336334|NCT01659255|520434927|FG006|Overall Study|Investigator Decision|0|||
144336335|NCT01659255|520434928|FG007|Overall Study|Investigator Decision|0|||
144336336|NCT01659255|520434929|FG008|Overall Study|Investigator Decision|0|||
144336337|NCT01659255|520434930|FG009|Overall Study|Investigator Decision|0|||
144336338|NCT01659255|520434931|FG010|Overall Study|Investigator Decision|0|||
144336339|NCT01659255|520434932|FG011|Overall Study|Investigator Decision|0|||
144336340|NCT01659255|520434933|FG012|Overall Study|Investigator Decision|1|||
144336341|NCT01659255|520434934|FG013|Overall Study|Investigator Decision|1|||
144336342|NCT01659255|520434935|FG014|Overall Study|Investigator Decision|0|||
144336343|NCT01659255|520434936|FG015|Overall Study|Investigator Decision|0|||
144336344|NCT01659255|520434937|FG016|Overall Study|Investigator Decision|0|||
144336345|NCT01659255|520434921|FG000|Overall Study|Sponsor's Decision|0|||
144336346|NCT01659255|520434922|FG001|Overall Study|Sponsor's Decision|0|||
144336347|NCT01659255|520434923|FG002|Overall Study|Sponsor's Decision|0|||
144336348|NCT01659255|520434924|FG003|Overall Study|Sponsor's Decision|0|||
144336349|NCT01659255|520434925|FG004|Overall Study|Sponsor's Decision|0|||
144336350|NCT01659255|520434926|FG005|Overall Study|Sponsor's Decision|0|||
144336351|NCT01659255|520434927|FG006|Overall Study|Sponsor's Decision|1|||
144336352|NCT01659255|520434928|FG007|Overall Study|Sponsor's Decision|0|||
144336353|NCT01659255|520434929|FG008|Overall Study|Sponsor's Decision|0|||
144336354|NCT01659255|520434930|FG009|Overall Study|Sponsor's Decision|0|||
144336355|NCT01659255|520434931|FG010|Overall Study|Sponsor's Decision|0|||
144336356|NCT01659255|520434932|FG011|Overall Study|Sponsor's Decision|0|||
144336357|NCT01659255|520434933|FG012|Overall Study|Sponsor's Decision|0|||
144336358|NCT01659255|520434934|FG013|Overall Study|Sponsor's Decision|0|||
144336359|NCT01659255|520434935|FG014|Overall Study|Sponsor's Decision|0|||
144336360|NCT01659255|520434936|FG015|Overall Study|Sponsor's Decision|0|||
144336361|NCT01659255|520434937|FG016|Overall Study|Sponsor's Decision|0|||
144336362|NCT01659255|520434921|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336363|NCT01659255|520434922|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336364|NCT01659255|520434923|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336365|NCT01659255|520434924|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336366|NCT01659255|520434925|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336367|NCT01659255|520434926|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336368|NCT01659255|520434927|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336369|NCT01659255|520434928|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336370|NCT01659255|520434929|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336371|NCT01659255|520434930|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336372|NCT01659255|520434931|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336373|NCT01659255|520434932|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336374|NCT01659255|520434933|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336375|NCT01659255|520434934|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336376|NCT01659255|520434935|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336377|NCT01659255|520434936|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
144336378|NCT01659255|520434937|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
144336379|NCT01659255|520434921|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
144336380|NCT01659255|520434922|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
144336381|NCT01659255|520434923|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
144336382|NCT01659255|520434924|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
144336383|NCT01659255|520434925|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
144336384|NCT01659255|520434926|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
144336385|NCT01659255|520434927|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
144336386|NCT01659255|520434928|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
144336387|NCT01659255|520434929|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
144336388|NCT01659255|520434930|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
144336389|NCT01659255|520434931|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
144336390|NCT01659255|520434932|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
144336391|NCT01659255|520434933|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
144336392|NCT01659255|520434934|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
144336393|NCT01659255|520434935|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
144336394|NCT01659255|520434936|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
144336395|NCT01659255|520434937|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
144336396|NCT01079936|520434938|FG000|Phase I: MTD|First Remission Status|2|||
144336397|NCT01079936|520434939|FG001|Phase I: MTD|First Remission Status|0|||
144336398|NCT01079936|520434940|FG002|Phase I: MTD|First Remission Status|0|||
144336399|NCT01079936|520434941|FG003|Phase I: MTD|First Remission Status|0|||
144336400|NCT01079936|520434942|FG004|Phase I: MTD|First Remission Status|0|||
144336401|NCT01079936|520434938|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
144336402|NCT01079936|520434939|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
144336403|NCT01079936|520434940|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
144336404|NCT01079936|520434941|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
144336405|NCT01079936|520434942|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
144336406|NCT01079936|520434938|FG000|Phase II|Adverse Event|0|||
144336407|NCT01079936|520434939|FG001|Phase II|Adverse Event|0|||
144336408|NCT01079936|520434940|FG002|Phase II|Adverse Event|1|||
144336409|NCT01079936|520434941|FG003|Phase II|Adverse Event|0|||
144336410|NCT01079936|520434942|FG004|Phase II|Adverse Event|0|||
144336411|NCT01079936|520434938|FG000|Phase II|Insurance Issue|0|||
144336412|NCT01079936|520434939|FG001|Phase II|Insurance Issue|0|||
144336413|NCT01079936|520434940|FG002|Phase II|Insurance Issue|0|||
144336414|NCT01079936|520434941|FG003|Phase II|Insurance Issue|0|||
144336415|NCT01079936|520434942|FG004|Phase II|Insurance Issue|1|||
144336416|NCT02335424|520434943|FG000|Overall Study|Withdrawal by Subject|19|||
144336417|NCT02335424|520434943|FG000|Overall Study|Adverse Event|25|||
144336418|NCT02335424|520434943|FG000|Overall Study|Death|273|||
144336419|NCT02335424|520434943|FG000|Overall Study|Lost to Follow-up|3|||
144336420|NCT02335424|520434943|FG000|Overall Study|Physician Decision|13|||
144336421|NCT02335424|520434943|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
144336422|NCT02335424|520434943|FG000|Overall Study|Protocol Violation|1|||
144336423|NCT02335424|520434943|FG000|Overall Study|Screen failure|1|||
144336424|NCT02712424|520434944|FG000|Overall Study|Lost to Follow-up|34|||
144336425|NCT02712424|520434945|FG001|Overall Study|Lost to Follow-up|32|||
144336426|NCT02809053|520434946|FG000|Overall Study|Death|0|||
144336427|NCT02809053|520434947|FG001|Overall Study|Death|1|||
144336428|NCT02809053|520434946|FG000|Overall Study|Lost to Follow-up|3|||
144336429|NCT02809053|520434947|FG001|Overall Study|Lost to Follow-up|1|||
144336430|NCT02809053|520434946|FG000|Overall Study|Withdrawal by Subject|2|||
144336431|NCT02809053|520434947|FG001|Overall Study|Withdrawal by Subject|3|||
144336432|NCT02809053|520434946|FG000|Overall Study|Disease Progression|2|||
144336433|NCT02809053|520434947|FG001|Overall Study|Disease Progression|1|||
144336434|NCT02565810|520434950|FG000|Overall Study|Withdrawal by Subject|1|||
144336435|NCT02723175|520434951|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
144336436|NCT02723175|520434952|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
144336437|NCT02723175|520434951|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
144336438|NCT02723175|520434952|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
144336439|NCT02049138|520434953|FG000|Overall Study|Adverse Event|46|||
144336440|NCT02049138|520434954|FG001|Overall Study|Adverse Event|25|||
144336441|NCT02049138|520434955|FG002|Overall Study|Adverse Event|1|||
144336442|NCT02049138|520434953|FG000|Overall Study|Withdrawal by Subject|57|||
144336443|NCT02049138|520434954|FG001|Overall Study|Withdrawal by Subject|21|||
144336444|NCT02049138|520434955|FG002|Overall Study|Withdrawal by Subject|5|||
144336445|NCT02049138|520434953|FG000|Overall Study|Lost to Follow-up|18|||
144336446|NCT02049138|520434954|FG001|Overall Study|Lost to Follow-up|5|||
144336447|NCT02049138|520434955|FG002|Overall Study|Lost to Follow-up|1|||
144336448|NCT02049138|520434953|FG000|Overall Study|Lack of Efficacy|10|||
144336449|NCT02049138|520434954|FG001|Overall Study|Lack of Efficacy|26|||
144336450|NCT02049138|520434955|FG002|Overall Study|Lack of Efficacy|1|||
144336451|NCT02049138|520434953|FG000|Overall Study|Non-Compliance|15|||
144336452|NCT02049138|520434954|FG001|Overall Study|Non-Compliance|6|||
144336453|NCT02049138|520434955|FG002|Overall Study|Non-Compliance|0|||
144336454|NCT02049138|520434953|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
144336455|NCT02049138|520434954|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
144336456|NCT02049138|520434955|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
144336457|NCT02049138|520434953|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
144336458|NCT02049138|520434954|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
144336459|NCT02049138|520434955|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
144336460|NCT02049138|520434953|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
144336461|NCT02049138|520434954|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
144336462|NCT02049138|520434955|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
144336463|NCT02049138|520434953|FG000|Overall Study|Other|15|||
144336464|NCT02049138|520434954|FG001|Overall Study|Other|13|||
144336465|NCT02049138|520434955|FG002|Overall Study|Other|0|||
144336466|NCT02049138|520434953|FG000|Overall Study|Missing|0|||
144336467|NCT02049138|520434954|FG001|Overall Study|Missing|1|||
144336468|NCT02049138|520434955|FG002|Overall Study|Missing|0|||
144336469|NCT04109976|520434956|FG000|Overall Study|Withdrawal by Subject|1|||
144336470|NCT04109976|520434957|FG001|Overall Study|Withdrawal by Subject|0|||
144336471|NCT00491608|520434958|FG000|Overall Study|Death|2|||
144336472|NCT00491608|520434958|FG000|Overall Study|Withdrawal by Subject|1|||
144336473|NCT05086510|520434959|FG000|Overall Study|Lost to Follow-up|0|||
144336474|NCT05086510|520434960|FG001|Overall Study|Lost to Follow-up|2|||
144336475|NCT05086510|520434959|FG000|Overall Study|Death|0|||
144336476|NCT05086510|520434960|FG001|Overall Study|Death|2|||
144336477|NCT00413374|520434961|FG000|Overall Study|Ineligible due to screening criteria.|3|||
144336478|NCT00413374|520434962|FG001|Overall Study|Ineligible due to screening criteria.|0|||
144336479|NCT00413374|520434961|FG000|Overall Study|Adverse Event|1|||
144336480|NCT00413374|520434962|FG001|Overall Study|Adverse Event|0|||
144336481|NCT00413374|520434961|FG000|Overall Study|Lost to Follow-up|1|||
144336482|NCT00413374|520434962|FG001|Overall Study|Lost to Follow-up|0|||
144336483|NCT00413374|520434961|FG000|Overall Study|Surgery|1|||
144336484|NCT00413374|520434962|FG001|Overall Study|Surgery|0|||
144336485|NCT00552760|520434963|FG000|Overall Study|Adverse Event|3|||
144336486|NCT00552760|520434964|FG001|Overall Study|Adverse Event|5|||
144336487|NCT00552760|520434963|FG000|Overall Study|Relapsed- Depressed Event|10|||
144336488|NCT00552760|520434964|FG001|Overall Study|Relapsed- Depressed Event|16|||
144336489|NCT00552760|520434963|FG000|Overall Study|Relapse- Manic Event|3|||
144336490|NCT00552760|520434964|FG001|Overall Study|Relapse- Manic Event|3|||
144336491|NCT00552760|520434963|FG000|Overall Study|Relapsed- Mixed Event|3|||
144336492|NCT00552760|520434964|FG001|Overall Study|Relapsed- Mixed Event|5|||
144336493|NCT00552760|520434963|FG000|Overall Study|Protocol Violation|0|||
144336494|NCT00552760|520434964|FG001|Overall Study|Protocol Violation|1|||
144336495|NCT00552760|520434963|FG000|Overall Study|Lost to Follow-up|1|||
144336496|NCT00552760|520434964|FG001|Overall Study|Lost to Follow-up|1|||
144336497|NCT00552760|520434963|FG000|Overall Study|Non-compliance|1|||
144336498|NCT00552760|520434964|FG001|Overall Study|Non-compliance|1|||
144336499|NCT00552760|520434963|FG000|Overall Study|Medical Condition|1|||
144336500|NCT00552760|520434964|FG001|Overall Study|Medical Condition|1|||
144336501|NCT00552760|520434963|FG000|Overall Study|Withdrawal by Subject|3|||
144336502|NCT00552760|520434964|FG001|Overall Study|Withdrawal by Subject|0|||
144336503|NCT00552760|520434963|FG000|Overall Study|Medication Change|1|||
144336504|NCT00552760|520434964|FG001|Overall Study|Medication Change|0|||
144336505|NCT03022981|520434965|FG000|Overall Study|Adverse Event|0|||
144336506|NCT03022981|520434966|FG001|Overall Study|Adverse Event|1|||
144336507|NCT03022981|520434967|FG002|Overall Study|Adverse Event|0|||
144336508|NCT03022981|520434965|FG000|Overall Study|Investigator's Discretion|0|||
144336509|NCT03022981|520434966|FG001|Overall Study|Investigator's Discretion|1|||
144336510|NCT03022981|520434967|FG002|Overall Study|Investigator's Discretion|2|||
144336511|NCT03022981|520434965|FG000|Overall Study|Lost to Follow-up|6|||
144336512|NCT03022981|520434966|FG001|Overall Study|Lost to Follow-up|2|||
144336513|NCT03022981|520434967|FG002|Overall Study|Lost to Follow-up|1|||
144336514|NCT03022981|520434965|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144336515|NCT03022981|520434966|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144336516|NCT03022981|520434967|FG002|Overall Study|Non-Compliance With Study Drug|2|||
144336517|NCT03022981|520434965|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
144336518|NCT03022981|520434966|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
144336519|NCT03022981|520434967|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
144336520|NCT03615066|520434970|FG000|Main Study|Withdrew Consent|0|||
144336521|NCT03615066|520434971|FG001|Main Study|Withdrew Consent|1|||
144336522|NCT03615066|520434972|FG002|Main Study|Withdrew Consent|1|||
144336523|NCT03615066|520434970|FG000|Main Study|Lost to Follow-up|0|||
144336524|NCT03615066|520434971|FG001|Main Study|Lost to Follow-up|0|||
144336525|NCT03615066|520434972|FG002|Main Study|Lost to Follow-up|1|||
144336526|NCT03615066|520434970|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
144336527|NCT03615066|520434971|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
144336528|NCT03615066|520434972|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
144336529|NCT03615066|520434970|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
144336530|NCT03615066|520434971|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
144336531|NCT03615066|520434972|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
144336532|NCT03615066|520434970|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
144336533|NCT03615066|520434971|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
144336534|NCT03615066|520434972|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
144336535|NCT00924404|520434973|FG000|Overall Study|Lost to Follow-up|6|||
144336536|NCT00924404|520434974|FG001|Overall Study|Lost to Follow-up|4|||
144336537|NCT03691779|520434977|FG000|Part B (24 Weeks)|Adverse Event|0|||
144336538|NCT03691779|520434978|FG001|Part B (24 Weeks)|Adverse Event|1|||
144336539|NCT03691779|520434977|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
144336540|NCT03691779|520434978|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
144336541|NCT02528357|520434979|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336542|NCT02528357|520434980|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
144336543|NCT02528357|520434981|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336544|NCT02528357|520434982|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336545|NCT02528357|520434983|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336546|NCT02528357|520434984|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336547|NCT02528357|520434985|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336548|NCT02528357|520434986|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336549|NCT02528357|520434987|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336550|NCT02528357|520434988|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336551|NCT02528357|520434989|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336552|NCT02528357|520434990|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336553|NCT02528357|520434991|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336554|NCT02528357|520434992|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336555|NCT02528357|520434993|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336556|NCT02528357|520434994|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336557|NCT02528357|520434995|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336558|NCT02528357|520434996|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336559|NCT02528357|520434997|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
144336560|NCT02528357|520434979|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336561|NCT02528357|520434980|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336562|NCT02528357|520434981|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336563|NCT02528357|520434982|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
144336564|NCT02528357|520434983|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336565|NCT02528357|520434984|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
144336566|NCT02528357|520434985|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336567|NCT02528357|520434986|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
144336568|NCT02528357|520434987|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336569|NCT02528357|520434988|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336570|NCT02528357|520434989|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336571|NCT02528357|520434990|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336572|NCT02528357|520434991|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336573|NCT02528357|520434992|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336574|NCT02528357|520434993|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336575|NCT02528357|520434994|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336576|NCT02528357|520434995|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336577|NCT02528357|520434996|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336578|NCT02528357|520434997|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
144336579|NCT02528357|520434979|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336580|NCT02528357|520434980|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336581|NCT02528357|520434981|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
144336582|NCT02528357|520434982|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336583|NCT02528357|520434983|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
144336584|NCT02528357|520434984|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336585|NCT02528357|520434985|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
144336586|NCT02528357|520434986|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
144336587|NCT02528357|520434987|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336588|NCT02528357|520434988|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336589|NCT02528357|520434989|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336590|NCT02528357|520434990|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336591|NCT02528357|520434991|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336592|NCT02528357|520434992|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336593|NCT02528357|520434993|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336594|NCT02528357|520434994|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336595|NCT02528357|520434995|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336596|NCT02528357|520434996|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336597|NCT02528357|520434997|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
144336598|NCT02528357|520434979|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336599|NCT02528357|520434980|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336600|NCT02528357|520434981|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336601|NCT02528357|520434982|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336602|NCT02528357|520434983|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
144336603|NCT02528357|520434984|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336604|NCT02528357|520434985|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336605|NCT02528357|520434986|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336606|NCT02528357|520434987|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336607|NCT02528357|520434988|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336608|NCT02528357|520434989|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336609|NCT02528357|520434990|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336610|NCT02528357|520434991|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336611|NCT02528357|520434992|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336612|NCT02528357|520434993|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336613|NCT02528357|520434994|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336614|NCT02528357|520434995|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336615|NCT02528357|520434996|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336616|NCT02528357|520434997|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336617|NCT02528357|520434979|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336618|NCT02528357|520434980|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336619|NCT02528357|520434981|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336620|NCT02528357|520434982|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336621|NCT02528357|520434983|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336622|NCT02528357|520434984|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336623|NCT02528357|520434985|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336624|NCT02528357|520434986|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336625|NCT02528357|520434987|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336626|NCT02528357|520434988|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336627|NCT02528357|520434989|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336628|NCT02528357|520434990|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336629|NCT02528357|520434991|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336630|NCT02528357|520434992|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
144336631|NCT02528357|520434993|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
144336632|NCT02528357|520434994|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336633|NCT02528357|520434995|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336634|NCT02528357|520434996|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336635|NCT02528357|520434997|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
144336636|NCT02528357|520434979|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336637|NCT02528357|520434980|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336638|NCT02528357|520434981|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336639|NCT02528357|520434982|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336640|NCT02528357|520434983|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336641|NCT02528357|520434984|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336642|NCT02528357|520434985|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336643|NCT02528357|520434986|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336644|NCT02528357|520434987|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336645|NCT02528357|520434988|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336646|NCT02528357|520434989|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336647|NCT02528357|520434990|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336648|NCT02528357|520434991|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336649|NCT02528357|520434992|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
144336650|NCT02528357|520434993|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336651|NCT02528357|520434994|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336652|NCT02528357|520434995|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336653|NCT02528357|520434996|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336654|NCT02528357|520434997|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
144336655|NCT02528357|520434979|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336656|NCT02528357|520434980|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336657|NCT02528357|520434981|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336658|NCT02528357|520434982|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336659|NCT02528357|520434983|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336660|NCT02528357|520434984|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336661|NCT02528357|520434985|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336662|NCT02528357|520434986|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336663|NCT02528357|520434987|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336664|NCT02528357|520434988|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336665|NCT02528357|520434989|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
144336666|NCT02528357|520434990|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336667|NCT02528357|520434991|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
144336668|NCT02528357|520434992|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
144336669|NCT02528357|520434993|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
144336670|NCT02528357|520434994|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336671|NCT02528357|520434995|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336672|NCT02528357|520434996|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336673|NCT02528357|520434997|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
144336674|NCT02528357|520434979|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336675|NCT02528357|520434980|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336676|NCT02528357|520434981|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336677|NCT02528357|520434982|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336678|NCT02528357|520434983|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336679|NCT02528357|520434984|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336680|NCT02528357|520434985|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336681|NCT02528357|520434986|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336682|NCT02528357|520434987|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
144336683|NCT02528357|520434988|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
144336684|NCT02528357|520434989|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336685|NCT02528357|520434990|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
144336686|NCT02528357|520434991|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
144336687|NCT02528357|520434992|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
144336688|NCT02528357|520434993|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
144336689|NCT02528357|520434994|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336690|NCT02528357|520434995|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336691|NCT02528357|520434996|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336692|NCT02528357|520434997|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336693|NCT02528357|520434979|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336694|NCT02528357|520434980|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336695|NCT02528357|520434981|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336696|NCT02528357|520434982|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336697|NCT02528357|520434983|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336698|NCT02528357|520434984|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336699|NCT02528357|520434985|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336700|NCT02528357|520434986|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336701|NCT02528357|520434987|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336702|NCT02528357|520434988|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336703|NCT02528357|520434989|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336704|NCT02528357|520434990|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336705|NCT02528357|520434991|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336706|NCT02528357|520434992|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336707|NCT02528357|520434993|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336708|NCT02528357|520434994|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336709|NCT02528357|520434995|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
144336710|NCT02528357|520434996|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336711|NCT02528357|520434997|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
144336712|NCT02528357|520434979|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336713|NCT02528357|520434980|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336714|NCT02528357|520434981|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336715|NCT02528357|520434982|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336716|NCT02528357|520434983|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336717|NCT02528357|520434984|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336718|NCT02528357|520434985|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336719|NCT02528357|520434986|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336720|NCT02528357|520434987|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336721|NCT02528357|520434988|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336722|NCT02528357|520434989|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336723|NCT02528357|520434990|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336724|NCT02528357|520434991|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336725|NCT02528357|520434992|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336726|NCT02528357|520434993|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336727|NCT02528357|520434994|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
144336728|NCT02528357|520434995|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
144336729|NCT02528357|520434996|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
144336730|NCT02528357|520434997|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
144336731|NCT01561963|520434998|FG000|Overall Study|Adverse Event|1|||
144336732|NCT03869333|520435005|FG000|Overall Study|Lost to Follow-up|1|||
144336733|NCT03869333|520435006|FG001|Overall Study|Lost to Follow-up|0|||
144336734|NCT03869333|520435007|FG002|Overall Study|Lost to Follow-up|0|||
144336735|NCT03869333|520435008|FG003|Overall Study|Lost to Follow-up|0|||
144336736|NCT03869333|520435005|FG000|Overall Study|Pregnancy|1|||
144336737|NCT03869333|520435006|FG001|Overall Study|Pregnancy|0|||
144336738|NCT03869333|520435007|FG002|Overall Study|Pregnancy|0|||
144336739|NCT03869333|520435008|FG003|Overall Study|Pregnancy|0|||
144336740|NCT03869333|520435005|FG000|Overall Study|Physician Decision|0|||
144336741|NCT03869333|520435006|FG001|Overall Study|Physician Decision|1|||
144336742|NCT03869333|520435007|FG002|Overall Study|Physician Decision|0|||
144336743|NCT03869333|520435008|FG003|Overall Study|Physician Decision|0|||
144336744|NCT01927055|520435009|FG000|Open-label|Adverse Event|6|||
144336745|NCT01927055|520435010|FG001|Open-label|Adverse Event|0|||
144336746|NCT01927055|520435011|FG002|Open-label|Adverse Event|0|||
144336747|NCT01927055|520435009|FG000|Open-label|Withdrawal by Subject|1|||
144336748|NCT01927055|520435010|FG001|Open-label|Withdrawal by Subject|0|||
144336749|NCT01927055|520435011|FG002|Open-label|Withdrawal by Subject|0|||
144336750|NCT01927055|520435009|FG000|Open-label|Study Stopped|4|||
144336751|NCT01927055|520435010|FG001|Open-label|Study Stopped|0|||
144336752|NCT01927055|520435011|FG002|Open-label|Study Stopped|0|||
144336753|NCT01927055|520435009|FG000|Open-label|Supine Hypertension|4|||
144336754|NCT01927055|520435010|FG001|Open-label|Supine Hypertension|0|||
144336755|NCT01927055|520435011|FG002|Open-label|Supine Hypertension|0|||
144336756|NCT01927055|520435009|FG000|Open-label|Difficulty attending study visits|1|||
144336757|NCT01927055|520435010|FG001|Open-label|Difficulty attending study visits|0|||
144336758|NCT01927055|520435011|FG002|Open-label|Difficulty attending study visits|0|||
144336759|NCT01927055|520435009|FG000|Double-Blind|Adverse Event|0|||
144336760|NCT01927055|520435010|FG001|Double-Blind|Adverse Event|1|||
144336761|NCT01927055|520435011|FG002|Double-Blind|Adverse Event|1|||
144336762|NCT01927055|520435009|FG000|Double-Blind|Protocol Violation|0|||
144336763|NCT01927055|520435010|FG001|Double-Blind|Protocol Violation|0|||
144336764|NCT01927055|520435011|FG002|Double-Blind|Protocol Violation|1|||
144359686|NCT03623243|520524985|FG000|Overall Study|Physician Decision|4|||
144336765|NCT01927055|520435009|FG000|Double-Blind|Withdrawal by Subject|0|||
144336766|NCT01927055|520435010|FG001|Double-Blind|Withdrawal by Subject|2|||
144336767|NCT01927055|520435011|FG002|Double-Blind|Withdrawal by Subject|3|||
144336768|NCT01927055|520435009|FG000|Double-Blind|Study Stopped|0|||
144336769|NCT01927055|520435010|FG001|Double-Blind|Study Stopped|7|||
144336770|NCT01927055|520435011|FG002|Double-Blind|Study Stopped|7|||
144336771|NCT01927055|520435009|FG000|Double-Blind|Supine Hypertension|0|||
144336772|NCT01927055|520435010|FG001|Double-Blind|Supine Hypertension|0|||
144336773|NCT01927055|520435011|FG002|Double-Blind|Supine Hypertension|1|||
144336774|NCT01927055|520435009|FG000|Double-Blind|Extended Vacation|0|||
144336775|NCT01927055|520435010|FG001|Double-Blind|Extended Vacation|1|||
144336776|NCT01927055|520435011|FG002|Double-Blind|Extended Vacation|0|||
144336777|NCT02598128|520435012|FG000|Period A: Days -7 to -1|Adverse Event|1|||
144336778|NCT02598128|520435013|FG001|Period A: Days -7 to -1|Adverse Event|0|||
144336779|NCT02598128|520435014|FG002|Period A: Days -7 to -1|Adverse Event|0|||
144336780|NCT02598128|520435015|FG003|Period A: Days -7 to -1|Adverse Event|0|||
144336781|NCT01459913|520435016|FG000|Overall Study|Adverse Event|0|||
144336782|NCT01459913|520435017|FG001|Overall Study|Adverse Event|0|||
144336783|NCT01459913|520435018|FG002|Overall Study|Adverse Event|0|||
144336784|NCT01459913|520435019|FG003|Overall Study|Adverse Event|3|||
144336785|NCT01459913|520435016|FG000|Overall Study|Withdrawal by Subject|4|||
144336786|NCT01459913|520435017|FG001|Overall Study|Withdrawal by Subject|0|||
144336787|NCT01459913|520435018|FG002|Overall Study|Withdrawal by Subject|0|||
144336788|NCT01459913|520435019|FG003|Overall Study|Withdrawal by Subject|5|||
144336789|NCT01459913|520435016|FG000|Overall Study|Lost to Follow-up|7|||
144336790|NCT01459913|520435017|FG001|Overall Study|Lost to Follow-up|4|||
144336791|NCT01459913|520435018|FG002|Overall Study|Lost to Follow-up|1|||
144336792|NCT01459913|520435019|FG003|Overall Study|Lost to Follow-up|8|||
144336793|NCT01459913|520435016|FG000|Overall Study|Death|0|||
144336794|NCT01459913|520435017|FG001|Overall Study|Death|0|||
144336795|NCT01459913|520435018|FG002|Overall Study|Death|0|||
144336796|NCT01459913|520435019|FG003|Overall Study|Death|1|||
144336797|NCT01459913|520435016|FG000|Overall Study|Non- Compliance|0|||
144336798|NCT01459913|520435017|FG001|Overall Study|Non- Compliance|0|||
144336799|NCT01459913|520435018|FG002|Overall Study|Non- Compliance|0|||
144336800|NCT01459913|520435019|FG003|Overall Study|Non- Compliance|3|||
144336801|NCT01459913|520435016|FG000|Overall Study|Physician Decision|0|||
144336802|NCT01459913|520435017|FG001|Overall Study|Physician Decision|1|||
144336803|NCT01459913|520435018|FG002|Overall Study|Physician Decision|0|||
144336804|NCT01459913|520435019|FG003|Overall Study|Physician Decision|0|||
144336805|NCT01459913|520435016|FG000|Overall Study|Study Terminated by Sponsor|30|||
144336806|NCT01459913|520435017|FG001|Overall Study|Study Terminated by Sponsor|15|||
144336807|NCT01459913|520435018|FG002|Overall Study|Study Terminated by Sponsor|9|||
144336808|NCT01459913|520435019|FG003|Overall Study|Study Terminated by Sponsor|11|||
144336809|NCT01459913|520435016|FG000|Overall Study|Other|0|||
144336810|NCT01459913|520435017|FG001|Overall Study|Other|0|||
144336811|NCT01459913|520435018|FG002|Overall Study|Other|3|||
144336812|NCT01459913|520435019|FG003|Overall Study|Other|1|||
144336813|NCT01459913|520435016|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
144336814|NCT01459913|520435017|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
144336815|NCT01459913|520435018|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
144336816|NCT01459913|520435019|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
144336817|NCT01555125|520435026|FG000|Induction Period|Lost to Follow-up|0|||
144336818|NCT01555125|520435027|FG001|Induction Period|Lost to Follow-up|2|||
144336819|NCT01555125|520435028|FG002|Induction Period|Lost to Follow-up|0|||
144336820|NCT01555125|520435029|FG003|Induction Period|Lost to Follow-up|0|||
144336821|NCT01555125|520435030|FG004|Induction Period|Lost to Follow-up|0|||
144336822|NCT01555125|520435026|FG000|Induction Period|Adverse Event|0|||
144336823|NCT01555125|520435027|FG001|Induction Period|Adverse Event|1|||
144336824|NCT01555125|520435028|FG002|Induction Period|Adverse Event|0|||
144336825|NCT01555125|520435029|FG003|Induction Period|Adverse Event|0|||
144336826|NCT01555125|520435030|FG004|Induction Period|Adverse Event|1|||
144336827|NCT01555125|520435026|FG000|Induction Period|Subject / guardian decision|0|||
144336828|NCT01555125|520435027|FG001|Induction Period|Subject / guardian decision|0|||
144336829|NCT01555125|520435028|FG002|Induction Period|Subject / guardian decision|0|||
144336830|NCT01555125|520435029|FG003|Induction Period|Subject / guardian decision|0|||
144336831|NCT01555125|520435030|FG004|Induction Period|Subject / guardian decision|2|||
144336832|NCT01555125|520435026|FG000|Induction Period|Death|1|||
144336833|NCT01555125|520435027|FG001|Induction Period|Death|0|||
144336834|NCT01555125|520435028|FG002|Induction Period|Death|0|||
144336835|NCT01555125|520435029|FG003|Induction Period|Death|0|||
144336836|NCT01555125|520435030|FG004|Induction Period|Death|0|||
144336837|NCT01555125|520435026|FG000|Maintenance Period|Adverse Event|1|||
144336838|NCT01555125|520435027|FG001|Maintenance Period|Adverse Event|1|||
144336839|NCT01555125|520435028|FG002|Maintenance Period|Adverse Event|0|||
144336840|NCT01555125|520435029|FG003|Maintenance Period|Adverse Event|0|||
144336841|NCT01555125|520435030|FG004|Maintenance Period|Adverse Event|0|||
144336842|NCT01555125|520435026|FG000|Maintenance Period|Subject / guardian decision|1|||
144336843|NCT01555125|520435027|FG001|Maintenance Period|Subject / guardian decision|2|||
144336844|NCT01555125|520435028|FG002|Maintenance Period|Subject / guardian decision|0|||
144336845|NCT01555125|520435029|FG003|Maintenance Period|Subject / guardian decision|0|||
144336846|NCT01555125|520435030|FG004|Maintenance Period|Subject / guardian decision|0|||
144336847|NCT01555125|520435026|FG000|Maintenance Period|Lost to Follow-up|2|||
144336848|NCT01555125|520435027|FG001|Maintenance Period|Lost to Follow-up|0|||
144336849|NCT01555125|520435028|FG002|Maintenance Period|Lost to Follow-up|0|||
144336850|NCT01555125|520435029|FG003|Maintenance Period|Lost to Follow-up|1|||
144336851|NCT01555125|520435030|FG004|Maintenance Period|Lost to Follow-up|0|||
144336852|NCT01555125|520435026|FG000|Maintenance Period|Lack of Efficacy|6|||
144336853|NCT01555125|520435027|FG001|Maintenance Period|Lack of Efficacy|1|||
144336854|NCT01555125|520435028|FG002|Maintenance Period|Lack of Efficacy|3|||
144336855|NCT01555125|520435029|FG003|Maintenance Period|Lack of Efficacy|0|||
144336856|NCT01555125|520435030|FG004|Maintenance Period|Lack of Efficacy|0|||
144336857|NCT01555125|520435026|FG000|Maintenance Period|Physician Decision|0|||
144336858|NCT01555125|520435027|FG001|Maintenance Period|Physician Decision|0|||
144336859|NCT01555125|520435028|FG002|Maintenance Period|Physician Decision|1|||
144336860|NCT01555125|520435029|FG003|Maintenance Period|Physician Decision|0|||
144336861|NCT01555125|520435030|FG004|Maintenance Period|Physician Decision|0|||
144336862|NCT01555125|520435026|FG000|Maintenance Period|Death|0|||
144336863|NCT01555125|520435027|FG001|Maintenance Period|Death|0|||
144336864|NCT01555125|520435028|FG002|Maintenance Period|Death|0|||
144336865|NCT01555125|520435029|FG003|Maintenance Period|Death|1|||
144336866|NCT01555125|520435030|FG004|Maintenance Period|Death|0|||
144336867|NCT01555125|520435026|FG000|Extension|Adverse Event|1|||
144336868|NCT01555125|520435027|FG001|Extension|Adverse Event|2|||
144336869|NCT01555125|520435028|FG002|Extension|Adverse Event|1|||
144336870|NCT01555125|520435029|FG003|Extension|Adverse Event|1|||
144336871|NCT01555125|520435030|FG004|Extension|Adverse Event|0|||
144336872|NCT01555125|520435026|FG000|Extension|Protocol deviation|1|||
144336873|NCT01555125|520435027|FG001|Extension|Protocol deviation|0|||
144336874|NCT01555125|520435028|FG002|Extension|Protocol deviation|0|||
144336875|NCT01555125|520435029|FG003|Extension|Protocol deviation|0|||
144336876|NCT01555125|520435030|FG004|Extension|Protocol deviation|0|||
144336877|NCT01555125|520435026|FG000|Extension|Lack of Efficacy|7|||
144336878|NCT01555125|520435027|FG001|Extension|Lack of Efficacy|6|||
144336879|NCT01555125|520435028|FG002|Extension|Lack of Efficacy|3|||
144336880|NCT01555125|520435029|FG003|Extension|Lack of Efficacy|0|||
144336881|NCT01555125|520435030|FG004|Extension|Lack of Efficacy|0|||
144336882|NCT01555125|520435026|FG000|Extension|Lost to Follow-up|2|||
144336883|NCT01555125|520435027|FG001|Extension|Lost to Follow-up|1|||
144336884|NCT01555125|520435028|FG002|Extension|Lost to Follow-up|2|||
144336885|NCT01555125|520435029|FG003|Extension|Lost to Follow-up|0|||
144336886|NCT01555125|520435030|FG004|Extension|Lost to Follow-up|0|||
144336887|NCT01555125|520435026|FG000|Extension|Study terminated by sponsor|32|||
144336888|NCT01555125|520435027|FG001|Extension|Study terminated by sponsor|33|||
144336889|NCT01555125|520435028|FG002|Extension|Study terminated by sponsor|16|||
144336890|NCT01555125|520435029|FG003|Extension|Study terminated by sponsor|20|||
144336891|NCT01555125|520435030|FG004|Extension|Study terminated by sponsor|0|||
144336892|NCT01555125|520435026|FG000|Extension|Subject/guardian decision|1|||
144336893|NCT01555125|520435027|FG001|Extension|Subject/guardian decision|9|||
144336894|NCT01555125|520435028|FG002|Extension|Subject/guardian decision|1|||
144336895|NCT01555125|520435029|FG003|Extension|Subject/guardian decision|0|||
144336896|NCT01555125|520435030|FG004|Extension|Subject/guardian decision|0|||
144336897|NCT01555125|520435026|FG000|Extension|Technical Problems|1|||
144336898|NCT01555125|520435027|FG001|Extension|Technical Problems|0|||
144336899|NCT01555125|520435028|FG002|Extension|Technical Problems|0|||
144336900|NCT01555125|520435029|FG003|Extension|Technical Problems|1|||
144336901|NCT01555125|520435030|FG004|Extension|Technical Problems|0|||
144336902|NCT01555125|520435026|FG000|Follow-Up Period|Lost to Follow-up|1|||
144336903|NCT01555125|520435027|FG001|Follow-Up Period|Lost to Follow-up|0|||
144336904|NCT01555125|520435028|FG002|Follow-Up Period|Lost to Follow-up|0|||
144336905|NCT01555125|520435029|FG003|Follow-Up Period|Lost to Follow-up|0|||
144336906|NCT01555125|520435030|FG004|Follow-Up Period|Lost to Follow-up|0|||
144336907|NCT01555125|520435026|FG000|Follow-Up Period|Subject / guardian decision|3|||
144336908|NCT01555125|520435027|FG001|Follow-Up Period|Subject / guardian decision|1|||
144336909|NCT01555125|520435028|FG002|Follow-Up Period|Subject / guardian decision|1|||
144336910|NCT01555125|520435029|FG003|Follow-Up Period|Subject / guardian decision|1|||
144336911|NCT01555125|520435030|FG004|Follow-Up Period|Subject / guardian decision|0|||
144336912|NCT02651220|520435031|FG000|Overall Study|Adverse Event|1|||
144336913|NCT02651220|520435032|FG001|Overall Study|Adverse Event|5|||
144336914|NCT02651220|520435033|FG002|Overall Study|Adverse Event|1|||
144336915|NCT02651220|520435031|FG000|Overall Study|Lost to Follow-up|8|||
144336916|NCT02651220|520435032|FG001|Overall Study|Lost to Follow-up|14|||
144336917|NCT02651220|520435033|FG002|Overall Study|Lost to Follow-up|14|||
144336918|NCT02651220|520435031|FG000|Overall Study|Non-Compliance with Study Drug|4|||
144336919|NCT02651220|520435032|FG001|Overall Study|Non-Compliance with Study Drug|0|||
144336920|NCT02651220|520435033|FG002|Overall Study|Non-Compliance with Study Drug|1|||
144336921|NCT02651220|520435031|FG000|Overall Study|Pregnancy|1|||
144336922|NCT02651220|520435032|FG001|Overall Study|Pregnancy|0|||
144336923|NCT02651220|520435033|FG002|Overall Study|Pregnancy|1|||
144336924|NCT02651220|520435031|FG000|Overall Study|Protocol Violation|0|||
144336925|NCT02651220|520435032|FG001|Overall Study|Protocol Violation|0|||
144336926|NCT02651220|520435033|FG002|Overall Study|Protocol Violation|1|||
144336927|NCT02651220|520435031|FG000|Overall Study|Withdrawal by Subject|5|||
144336928|NCT02651220|520435032|FG001|Overall Study|Withdrawal by Subject|6|||
144336929|NCT02651220|520435033|FG002|Overall Study|Withdrawal by Subject|8|||
144336930|NCT02651220|520435031|FG000|Overall Study|Miscellaneous|4|||
144336931|NCT02651220|520435032|FG001|Overall Study|Miscellaneous|1|||
144336932|NCT02651220|520435033|FG002|Overall Study|Miscellaneous|2|||
144336933|NCT02651220|520435031|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144336934|NCT02651220|520435032|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
144336935|NCT02651220|520435033|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
144336936|NCT04268745|520435034|FG000|Overall Study|Lost to Follow-up|2|||
144336937|NCT04268745|520435035|FG001|Overall Study|Lost to Follow-up|3|||
144336938|NCT04268745|520435034|FG000|Overall Study|Withdrawal by Subject|4|||
144336939|NCT04268745|520435035|FG001|Overall Study|Withdrawal by Subject|2|||
144336940|NCT04268745|520435034|FG000|Overall Study|Death in the family|1|||
144336941|NCT04268745|520435035|FG001|Overall Study|Death in the family|0|||
144336942|NCT02666105|520435039|FG000|Overall Study|Death|1|||
144336943|NCT02429791|520437345|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
144336944|NCT02429791|520437346|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
144336945|NCT02429791|520437345|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
144336946|NCT02429791|520437346|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
144336947|NCT02429791|520437345|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
144336948|NCT02429791|520437346|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
144336949|NCT02429791|520437345|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
144336950|NCT02429791|520437346|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
144336951|NCT02429791|520437345|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
144336952|NCT02429791|520437346|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
144336953|NCT02429791|520437345|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
144336954|NCT02429791|520437346|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
144336955|NCT02429791|520437345|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
144336956|NCT02429791|520437346|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
144336957|NCT02429791|520437345|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
144336958|NCT02429791|520437346|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
144336959|NCT02429791|520437345|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
144336960|NCT02429791|520437346|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
144336961|NCT02429791|520437345|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
144336962|NCT02429791|520437346|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
144336963|NCT02429791|520437345|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
144336964|NCT02429791|520437346|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
144336965|NCT02429791|520437345|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
144336966|NCT02429791|520437346|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
144336967|NCT02429791|520437345|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
144336968|NCT02429791|520437346|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
144336969|NCT02429791|520437345|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
144336970|NCT02429791|520437346|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
144336971|NCT02429791|520437345|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
144336972|NCT02429791|520437346|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
144336973|NCT02429791|520437345|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
144336974|NCT02429791|520437346|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
144336975|NCT02429791|520437345|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
144336976|NCT02429791|520437346|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
144336977|NCT02429791|520437345|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
144336978|NCT02429791|520437346|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
144336979|NCT05194267|520437347|FG000|Overall Study|Withdrawal by Subject|2|||
144336980|NCT00802893|520437348|FG000|Overall Study|study terminated|3|||
144336981|NCT02868229|520437349|FG000|Overall Study|Adverse Event|1|||
144336982|NCT02868229|520437350|FG001|Overall Study|Adverse Event|0|||
144336983|NCT02868229|520437351|FG002|Overall Study|Adverse Event|0|||
144336984|NCT02868229|520437352|FG003|Overall Study|Adverse Event|1|||
144336985|NCT02868229|520437349|FG000|Overall Study|Death|0|||
144336986|NCT02868229|520437350|FG001|Overall Study|Death|0|||
144336987|NCT02868229|520437351|FG002|Overall Study|Death|1|||
144336988|NCT02868229|520437352|FG003|Overall Study|Death|1|||
144336989|NCT02868229|520437349|FG000|Overall Study|Missed dose|0|||
144336990|NCT02868229|520437350|FG001|Overall Study|Missed dose|0|||
144336991|NCT02868229|520437351|FG002|Overall Study|Missed dose|0|||
144336992|NCT02868229|520437352|FG003|Overall Study|Missed dose|3|||
144359687|NCT03623243|520524985|FG000|Overall Study|Patient Decision|15|||
144336993|NCT05779007|520437354|FG000|Overall Study|not meeting eligibility criteria|3517|||
144336994|NCT05779007|520437355|FG001|Overall Study|not meeting eligibility criteria|2009|||
144336995|NCT05147662|520437364|FG000|Overall Study|Withdrawal by parent/guardian|3|||
144336996|NCT05147662|520437364|FG000|Overall Study|Assigned to treatment but never treated|1|||
144336997|NCT00231413|520437367|FG000|Overall Study|Non-serious AE|0|||
144336998|NCT00231413|520437368|FG001|Overall Study|Non-serious AE|0|||
144336999|NCT00231413|520437369|FG002|Overall Study|Non-serious AE|1|||
144337000|NCT00231413|520437370|FG003|Overall Study|Non-serious AE|0|||
144337001|NCT00231413|520437371|FG004|Overall Study|Non-serious AE|0|||
144337002|NCT00231413|520437372|FG005|Overall Study|Non-serious AE|0|||
144337003|NCT00231413|520437373|FG006|Overall Study|Non-serious AE|1|||
144337004|NCT00231413|520437367|FG000|Overall Study|Withdrawal by Subject|3|||
144337005|NCT00231413|520437368|FG001|Overall Study|Withdrawal by Subject|1|||
144337006|NCT00231413|520437369|FG002|Overall Study|Withdrawal by Subject|4|||
144337007|NCT00231413|520437370|FG003|Overall Study|Withdrawal by Subject|2|||
144337008|NCT00231413|520437371|FG004|Overall Study|Withdrawal by Subject|2|||
144337009|NCT00231413|520437372|FG005|Overall Study|Withdrawal by Subject|0|||
144337010|NCT00231413|520437373|FG006|Overall Study|Withdrawal by Subject|3|||
144337011|NCT00231413|520437367|FG000|Overall Study|Migrated/moved from study area|0|||
144337012|NCT00231413|520437368|FG001|Overall Study|Migrated/moved from study area|0|||
144337013|NCT00231413|520437369|FG002|Overall Study|Migrated/moved from study area|1|||
144337014|NCT00231413|520437370|FG003|Overall Study|Migrated/moved from study area|0|||
144337015|NCT00231413|520437371|FG004|Overall Study|Migrated/moved from study area|0|||
144337016|NCT00231413|520437372|FG005|Overall Study|Migrated/moved from study area|1|||
144337017|NCT00231413|520437373|FG006|Overall Study|Migrated/moved from study area|0|||
144337018|NCT00231413|520437367|FG000|Overall Study|Lost to Follow-up|4|||
144337019|NCT00231413|520437368|FG001|Overall Study|Lost to Follow-up|4|||
144337020|NCT00231413|520437369|FG002|Overall Study|Lost to Follow-up|1|||
144337021|NCT00231413|520437370|FG003|Overall Study|Lost to Follow-up|1|||
144337022|NCT00231413|520437371|FG004|Overall Study|Lost to Follow-up|1|||
144337023|NCT00231413|520437372|FG005|Overall Study|Lost to Follow-up|4|||
144337024|NCT00231413|520437373|FG006|Overall Study|Lost to Follow-up|0|||
144337025|NCT00231413|520437367|FG000|Overall Study|Pregnancy|1|||
144337026|NCT00231413|520437368|FG001|Overall Study|Pregnancy|0|||
144337027|NCT00231413|520437369|FG002|Overall Study|Pregnancy|0|||
144337028|NCT00231413|520437370|FG003|Overall Study|Pregnancy|0|||
144337029|NCT00231413|520437371|FG004|Overall Study|Pregnancy|0|||
144337030|NCT00231413|520437372|FG005|Overall Study|Pregnancy|0|||
144337031|NCT00231413|520437373|FG006|Overall Study|Pregnancy|0|||
144337032|NCT04676867|520437374|FG000|Overall Study|Screen failure|0|||
144337033|NCT04676867|520437375|FG001|Overall Study|Screen failure|0|||
144337034|NCT04676867|520437376|FG002|Overall Study|Screen failure|6|||
144337035|NCT04676867|520437377|FG003|Overall Study|Screen failure|2|||
144337036|NCT04676867|520437374|FG000|Overall Study|Death|0|||
144337037|NCT04676867|520437375|FG001|Overall Study|Death|0|||
144337038|NCT04676867|520437376|FG002|Overall Study|Death|1|||
144337039|NCT04676867|520437377|FG003|Overall Study|Death|0|||
144337040|NCT04676867|520437374|FG000|Overall Study|Withdrawal by Subject|2|||
144337041|NCT04676867|520437375|FG001|Overall Study|Withdrawal by Subject|2|||
144337042|NCT04676867|520437376|FG002|Overall Study|Withdrawal by Subject|4|||
144337043|NCT04676867|520437377|FG003|Overall Study|Withdrawal by Subject|4|||
144337044|NCT04676867|520437374|FG000|Overall Study|Lost to Follow-up|1|||
144337045|NCT04676867|520437375|FG001|Overall Study|Lost to Follow-up|0|||
144337046|NCT04676867|520437376|FG002|Overall Study|Lost to Follow-up|0|||
144337047|NCT04676867|520437377|FG003|Overall Study|Lost to Follow-up|0|||
144337048|NCT03316950|520437378|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
144337049|NCT03316950|520437379|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
144337050|NCT03316950|520437380|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
144337051|NCT03316950|520437381|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
144337052|NCT03316950|520437378|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
144337053|NCT03316950|520437379|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
144337054|NCT03316950|520437380|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
144337055|NCT03316950|520437381|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
144337056|NCT03316950|520437378|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
144337057|NCT03316950|520437379|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
144337058|NCT03316950|520437380|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
144337059|NCT03316950|520437381|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
144337060|NCT00549770|520437382|FG000|Overall Study|Protocol deviation|1|||
144337061|NCT00549770|520437383|FG001|Overall Study|Protocol deviation|1|||
144337062|NCT00549770|520437384|FG002|Overall Study|Protocol deviation|1|||
144337063|NCT00549770|520437385|FG003|Overall Study|Protocol deviation|2|||
144337064|NCT00549770|520437386|FG004|Overall Study|Protocol deviation|2|||
144337065|NCT00549770|520437387|FG005|Overall Study|Protocol deviation|2|||
144337066|NCT00549770|520437388|FG006|Overall Study|Protocol deviation|1|||
144337067|NCT00549770|520437389|FG007|Overall Study|Protocol deviation|2|||
144337068|NCT00549770|520437382|FG000|Overall Study|Administrative problems|0|||
144337069|NCT00549770|520437383|FG001|Overall Study|Administrative problems|1|||
144337070|NCT00549770|520437384|FG002|Overall Study|Administrative problems|0|||
144337071|NCT00549770|520437385|FG003|Overall Study|Administrative problems|0|||
144337072|NCT00549770|520437386|FG004|Overall Study|Administrative problems|0|||
144337073|NCT00549770|520437387|FG005|Overall Study|Administrative problems|0|||
144337074|NCT00549770|520437388|FG006|Overall Study|Administrative problems|0|||
144337075|NCT00549770|520437389|FG007|Overall Study|Administrative problems|1|||
144337076|NCT00549770|520437382|FG000|Overall Study|Lost to Follow-up|0|||
144337077|NCT00549770|520437383|FG001|Overall Study|Lost to Follow-up|0|||
144337078|NCT00549770|520437384|FG002|Overall Study|Lost to Follow-up|2|||
144337079|NCT00549770|520437385|FG003|Overall Study|Lost to Follow-up|2|||
144337080|NCT00549770|520437386|FG004|Overall Study|Lost to Follow-up|3|||
144337081|NCT00549770|520437387|FG005|Overall Study|Lost to Follow-up|2|||
144337082|NCT00549770|520437388|FG006|Overall Study|Lost to Follow-up|0|||
144337083|NCT00549770|520437389|FG007|Overall Study|Lost to Follow-up|0|||
144337084|NCT00549770|520437382|FG000|Overall Study|Withdrawal by Subject|4|||
144337085|NCT00549770|520437383|FG001|Overall Study|Withdrawal by Subject|6|||
144337086|NCT00549770|520437384|FG002|Overall Study|Withdrawal by Subject|4|||
144337087|NCT00549770|520437385|FG003|Overall Study|Withdrawal by Subject|5|||
144337088|NCT00549770|520437386|FG004|Overall Study|Withdrawal by Subject|6|||
144337089|NCT00549770|520437387|FG005|Overall Study|Withdrawal by Subject|6|||
144337090|NCT00549770|520437388|FG006|Overall Study|Withdrawal by Subject|4|||
144337091|NCT00549770|520437389|FG007|Overall Study|Withdrawal by Subject|9|||
144337092|NCT00549770|520437382|FG000|Overall Study|Lack of Efficacy|1|||
144337093|NCT00549770|520437383|FG001|Overall Study|Lack of Efficacy|0|||
144337094|NCT00549770|520437384|FG002|Overall Study|Lack of Efficacy|2|||
144337095|NCT00549770|520437385|FG003|Overall Study|Lack of Efficacy|3|||
144337096|NCT00549770|520437386|FG004|Overall Study|Lack of Efficacy|5|||
144337097|NCT00549770|520437387|FG005|Overall Study|Lack of Efficacy|1|||
144337098|NCT00549770|520437388|FG006|Overall Study|Lack of Efficacy|3|||
144337099|NCT00549770|520437389|FG007|Overall Study|Lack of Efficacy|8|||
144337100|NCT00549770|520437382|FG000|Overall Study|Abnormal test procedure results|0|||
144337101|NCT00549770|520437383|FG001|Overall Study|Abnormal test procedure results|0|||
144337102|NCT00549770|520437384|FG002|Overall Study|Abnormal test procedure results|0|||
144337103|NCT00549770|520437385|FG003|Overall Study|Abnormal test procedure results|2|||
144337104|NCT00549770|520437386|FG004|Overall Study|Abnormal test procedure results|0|||
144337105|NCT00549770|520437387|FG005|Overall Study|Abnormal test procedure results|1|||
144337106|NCT00549770|520437388|FG006|Overall Study|Abnormal test procedure results|1|||
144337107|NCT00549770|520437389|FG007|Overall Study|Abnormal test procedure results|1|||
144337108|NCT00549770|520437382|FG000|Overall Study|Abnormal laboratory values|0|||
144337109|NCT00549770|520437383|FG001|Overall Study|Abnormal laboratory values|0|||
144337110|NCT00549770|520437384|FG002|Overall Study|Abnormal laboratory values|0|||
144337111|NCT00549770|520437385|FG003|Overall Study|Abnormal laboratory values|0|||
144337112|NCT00549770|520437386|FG004|Overall Study|Abnormal laboratory values|0|||
144337113|NCT00549770|520437387|FG005|Overall Study|Abnormal laboratory values|1|||
144337114|NCT00549770|520437388|FG006|Overall Study|Abnormal laboratory values|0|||
144337115|NCT00549770|520437389|FG007|Overall Study|Abnormal laboratory values|0|||
144337116|NCT00549770|520437382|FG000|Overall Study|Adverse Event|1|||
144337117|NCT00549770|520437383|FG001|Overall Study|Adverse Event|3|||
144337118|NCT00549770|520437384|FG002|Overall Study|Adverse Event|1|||
144337119|NCT00549770|520437385|FG003|Overall Study|Adverse Event|2|||
144337120|NCT00549770|520437386|FG004|Overall Study|Adverse Event|1|||
144337121|NCT00549770|520437387|FG005|Overall Study|Adverse Event|0|||
144337122|NCT00549770|520437388|FG006|Overall Study|Adverse Event|5|||
144337123|NCT00549770|520437389|FG007|Overall Study|Adverse Event|4|||
144337124|NCT00908037|520437390|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337125|NCT00908037|520437391|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337126|NCT00908037|520437392|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337127|NCT00908037|520437393|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337128|NCT00908037|520437394|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
144337129|NCT00908037|520437395|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337130|NCT00908037|520437396|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
144337131|NCT00908037|520437397|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337132|NCT00908037|520437398|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
144337133|NCT00908037|520437399|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337134|NCT00908037|520437400|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337135|NCT00908037|520437401|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
144337136|NCT00908037|520437390|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337137|NCT00908037|520437391|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337138|NCT00908037|520437392|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337139|NCT00908037|520437393|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337140|NCT00908037|520437394|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
144337141|NCT00908037|520437395|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337142|NCT00908037|520437396|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337143|NCT00908037|520437397|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337144|NCT00908037|520437398|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
144337145|NCT00908037|520437399|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337146|NCT00908037|520437400|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337147|NCT00908037|520437401|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
144337148|NCT00908037|520437390|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337149|NCT00908037|520437391|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337150|NCT00908037|520437392|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337151|NCT00908037|520437393|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
144337152|NCT00908037|520437394|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337153|NCT00908037|520437395|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337154|NCT00908037|520437396|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
144337155|NCT00908037|520437397|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337156|NCT00908037|520437398|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337157|NCT00908037|520437399|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337158|NCT00908037|520437400|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337159|NCT00908037|520437401|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
144337160|NCT00908037|520437390|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337161|NCT00908037|520437391|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337162|NCT00908037|520437392|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337163|NCT00908037|520437393|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337164|NCT00908037|520437394|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337165|NCT00908037|520437395|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337166|NCT00908037|520437396|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337167|NCT00908037|520437397|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337168|NCT00908037|520437398|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337169|NCT00908037|520437399|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337170|NCT00908037|520437400|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
144337171|NCT00908037|520437401|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
144337172|NCT00908037|520437390|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337173|NCT00908037|520437391|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337174|NCT00908037|520437392|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337175|NCT00908037|520437393|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337176|NCT00908037|520437394|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337177|NCT00908037|520437395|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337178|NCT00908037|520437396|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337179|NCT00908037|520437397|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337180|NCT00908037|520437398|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337181|NCT00908037|520437399|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
144337182|NCT00908037|520437400|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
144337183|NCT00908037|520437401|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
144337184|NCT00908037|520437390|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337185|NCT00908037|520437391|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337186|NCT00908037|520437392|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337187|NCT00908037|520437393|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337188|NCT00908037|520437394|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337189|NCT00908037|520437395|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337190|NCT00908037|520437396|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337191|NCT00908037|520437397|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337192|NCT00908037|520437398|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337193|NCT00908037|520437399|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
144337194|NCT00908037|520437400|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337195|NCT00908037|520437401|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
144337196|NCT00908037|520437390|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337197|NCT00908037|520437391|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337198|NCT00908037|520437392|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337199|NCT00908037|520437393|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337200|NCT00908037|520437394|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337201|NCT00908037|520437395|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337202|NCT00908037|520437396|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337203|NCT00908037|520437397|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337204|NCT00908037|520437398|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337205|NCT00908037|520437399|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337206|NCT00908037|520437400|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
144337207|NCT00908037|520437401|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
144337208|NCT00908037|520437390|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337209|NCT00908037|520437391|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337210|NCT00908037|520437392|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337211|NCT00908037|520437393|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337212|NCT00908037|520437394|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337213|NCT00908037|520437395|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337214|NCT00908037|520437396|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337215|NCT00908037|520437397|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337216|NCT00908037|520437398|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337217|NCT00908037|520437399|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
144337218|NCT00908037|520437400|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337219|NCT00908037|520437401|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
144337220|NCT00908037|520437390|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337221|NCT00908037|520437391|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337222|NCT00908037|520437392|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337223|NCT00908037|520437393|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337224|NCT00908037|520437394|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337225|NCT00908037|520437395|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337226|NCT00908037|520437396|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337227|NCT00908037|520437397|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337228|NCT00908037|520437398|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337229|NCT00908037|520437399|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337230|NCT00908037|520437400|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
144337231|NCT00908037|520437401|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
144337232|NCT00494507|520437406|FG000|Double-Blind Phase|Adverse Event|2|||
144337233|NCT00494507|520437407|FG001|Double-Blind Phase|Adverse Event|0|||
144337234|NCT00494507|520437408|FG002|Double-Blind Phase|Adverse Event|1|||
144337235|NCT00494507|520437409|FG003|Double-Blind Phase|Adverse Event|0|||
144337236|NCT00494507|520437406|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
144337237|NCT00494507|520437407|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
144337238|NCT00494507|520437408|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144337239|NCT00494507|520437409|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144337240|NCT00494507|520437406|FG000|Double-Blind Phase|Subject Non-compliance|0|||
144337241|NCT00494507|520437407|FG001|Double-Blind Phase|Subject Non-compliance|0|||
144337242|NCT00494507|520437408|FG002|Double-Blind Phase|Subject Non-compliance|1|||
144337243|NCT00494507|520437409|FG003|Double-Blind Phase|Subject Non-compliance|0|||
144337244|NCT00494507|520437406|FG000|Double-Blind Phase|Negative DNA test|0|||
144337245|NCT00494507|520437407|FG001|Double-Blind Phase|Negative DNA test|0|||
144337246|NCT00494507|520437408|FG002|Double-Blind Phase|Negative DNA test|0|||
144337247|NCT00494507|520437409|FG003|Double-Blind Phase|Negative DNA test|1|||
144337248|NCT00494507|520437406|FG000|Open-Label Phase|Adverse Event|0|||
144337249|NCT00494507|520437407|FG001|Open-Label Phase|Adverse Event|1|||
144337250|NCT00494507|520437408|FG002|Open-Label Phase|Adverse Event|5|||
144337251|NCT00494507|520437409|FG003|Open-Label Phase|Adverse Event|3|||
144337252|NCT00494507|520437406|FG000|Open-Label Phase|Worsening Disease|0|||
144337253|NCT00494507|520437407|FG001|Open-Label Phase|Worsening Disease|0|||
144337254|NCT00494507|520437408|FG002|Open-Label Phase|Worsening Disease|0|||
144337255|NCT00494507|520437409|FG003|Open-Label Phase|Worsening Disease|2|||
144337256|NCT02437084|520437410|FG000|Overall Study|Withdrawal by Subject|2|||
144337257|NCT02437084|520437410|FG000|Overall Study|Physician Decision|1|||
144337258|NCT00109577|520437411|FG000|Overall Study|Withdrawal by Subject|3|||
144337259|NCT00109577|520437412|FG001|Overall Study|Withdrawal by Subject|3|||
144337260|NCT02613169|520437413|FG000|Overall Study|Withdrawal by Subject|4|||
144337261|NCT02613169|520437414|FG001|Overall Study|Withdrawal by Subject|1|||
144337262|NCT02613169|520437413|FG000|Overall Study|Lost to Follow-up|0|||
144337263|NCT02613169|520437414|FG001|Overall Study|Lost to Follow-up|5|||
144337264|NCT02613169|520437413|FG000|Overall Study|HIV|0|||
144337265|NCT02613169|520437414|FG001|Overall Study|HIV|2|||
144337266|NCT02613169|520437413|FG000|Overall Study|No TB infection endpoint|14|||
144337267|NCT02613169|520437414|FG001|Overall Study|No TB infection endpoint|9|||
144337268|NCT01064687|520437416|FG000|Overall Study|Adverse Event|9|||
144337269|NCT01064687|520437417|FG001|Overall Study|Adverse Event|4|||
144337270|NCT01064687|520437418|FG002|Overall Study|Adverse Event|10|||
144337271|NCT01064687|520437419|FG003|Overall Study|Adverse Event|3|||
144337272|NCT01064687|520437416|FG000|Overall Study|Death|1|||
144337273|NCT01064687|520437417|FG001|Overall Study|Death|1|||
144337274|NCT01064687|520437418|FG002|Overall Study|Death|0|||
144337275|NCT01064687|520437419|FG003|Overall Study|Death|0|||
144337276|NCT01064687|520437416|FG000|Overall Study|Entry Criteria Not Met|3|||
144337277|NCT01064687|520437417|FG001|Overall Study|Entry Criteria Not Met|0|||
144337278|NCT01064687|520437418|FG002|Overall Study|Entry Criteria Not Met|0|||
144337279|NCT01064687|520437419|FG003|Overall Study|Entry Criteria Not Met|0|||
144337280|NCT01064687|520437416|FG000|Overall Study|Lack of Efficacy|1|||
144337281|NCT01064687|520437417|FG001|Overall Study|Lack of Efficacy|0|||
144337282|NCT01064687|520437418|FG002|Overall Study|Lack of Efficacy|2|||
144337283|NCT01064687|520437419|FG003|Overall Study|Lack of Efficacy|3|||
144337284|NCT01064687|520437416|FG000|Overall Study|Lost to Follow-up|7|||
144337285|NCT01064687|520437417|FG001|Overall Study|Lost to Follow-up|10|||
144337286|NCT01064687|520437418|FG002|Overall Study|Lost to Follow-up|13|||
144337287|NCT01064687|520437419|FG003|Overall Study|Lost to Follow-up|5|||
144337288|NCT01064687|520437416|FG000|Overall Study|Physician Decision|2|||
144337289|NCT01064687|520437417|FG001|Overall Study|Physician Decision|2|||
144337290|NCT01064687|520437418|FG002|Overall Study|Physician Decision|0|||
144337291|NCT01064687|520437419|FG003|Overall Study|Physician Decision|0|||
144337292|NCT01064687|520437416|FG000|Overall Study|Protocol Violation|1|||
144337293|NCT01064687|520437417|FG001|Overall Study|Protocol Violation|1|||
144337294|NCT01064687|520437418|FG002|Overall Study|Protocol Violation|0|||
144337295|NCT01064687|520437419|FG003|Overall Study|Protocol Violation|1|||
144337296|NCT01064687|520437416|FG000|Overall Study|Sponsor Decision|0|||
144337297|NCT01064687|520437417|FG001|Overall Study|Sponsor Decision|0|||
144337298|NCT01064687|520437418|FG002|Overall Study|Sponsor Decision|3|||
144337299|NCT01064687|520437419|FG003|Overall Study|Sponsor Decision|0|||
144337300|NCT01064687|520437416|FG000|Overall Study|Withdrawal by Subject|9|||
144337301|NCT01064687|520437417|FG001|Overall Study|Withdrawal by Subject|7|||
144337302|NCT01064687|520437418|FG002|Overall Study|Withdrawal by Subject|12|||
144337303|NCT01064687|520437419|FG003|Overall Study|Withdrawal by Subject|5|||
144337304|NCT01064687|520437416|FG000|Overall Study|Treatment Noncompliance|1|||
144337305|NCT01064687|520437417|FG001|Overall Study|Treatment Noncompliance|1|||
144337306|NCT01064687|520437418|FG002|Overall Study|Treatment Noncompliance|1|||
144337307|NCT01064687|520437419|FG003|Overall Study|Treatment Noncompliance|0|||
144337308|NCT01183468|520437422|FG000|Overall Study|Lost to Follow-up|2|||
144337309|NCT01183468|520437423|FG001|Overall Study|Lost to Follow-up|1|||
144337310|NCT01183468|520437424|FG002|Overall Study|Lost to Follow-up|0|||
144337311|NCT01183468|520437425|FG003|Overall Study|Lost to Follow-up|0|||
144337312|NCT01183468|520437422|FG000|Overall Study|Physician Decision|1|||
144337313|NCT01183468|520437423|FG001|Overall Study|Physician Decision|0|||
144337314|NCT01183468|520437424|FG002|Overall Study|Physician Decision|0|||
144337315|NCT01183468|520437425|FG003|Overall Study|Physician Decision|0|||
144337316|NCT01183468|520437422|FG000|Overall Study|Withdrawal by Subject|0|||
144337317|NCT01183468|520437423|FG001|Overall Study|Withdrawal by Subject|1|||
144337318|NCT01183468|520437424|FG002|Overall Study|Withdrawal by Subject|0|||
144337319|NCT01183468|520437425|FG003|Overall Study|Withdrawal by Subject|0|||
144337320|NCT00845065|520437426|FG000|Overall Study|Adverse Event|3|||
144337321|NCT00845065|520437427|FG001|Overall Study|Adverse Event|23|||
144337322|NCT00845065|520437426|FG000|Overall Study|Lack of Efficacy|43|||
144337323|NCT00845065|520437427|FG001|Overall Study|Lack of Efficacy|21|||
144337324|NCT00845065|520437426|FG000|Overall Study|Non-Medical Reasons|1|||
144337325|NCT00845065|520437427|FG001|Overall Study|Non-Medical Reasons|11|||
144337326|NCT01198509|520437428|FG000|Overall Study|Withdrawal by Subject|1|||
144337327|NCT01198509|520437429|FG001|Overall Study|Withdrawal by Subject|0|||
144337328|NCT01198509|520437430|FG002|Overall Study|Withdrawal by Subject|0|||
144337329|NCT01198509|520437431|FG003|Overall Study|Withdrawal by Subject|0|||
144337330|NCT01198509|520437432|FG004|Overall Study|Withdrawal by Subject|0|||
144337331|NCT01198509|520437433|FG005|Overall Study|Withdrawal by Subject|0|||
144337332|NCT00952614|520437441|FG000|Overall Study|Death|3|||
144337333|NCT00952614|520437441|FG000|Overall Study|Lost to Follow-up|3|||
144337334|NCT00952614|520437441|FG000|Overall Study|other reason|1|||
144337335|NCT04311463|520437442|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
144337336|NCT04311463|520437443|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
144337337|NCT04311463|520437442|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
144337338|NCT04311463|520437443|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
144337339|NCT04311463|520437442|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
144337340|NCT04311463|520437443|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
144337341|NCT03180307|520437454|FG000|Overall Study|Lost to Follow-up|2|||
144337342|NCT03180307|520437455|FG001|Overall Study|Lost to Follow-up|0|||
144337343|NCT03180307|520437454|FG000|Overall Study|Death|1|||
144337344|NCT03180307|520437455|FG001|Overall Study|Death|0|||
144337345|NCT03180307|520437454|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
144337346|NCT03180307|520437455|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
144337347|NCT02986854|520437457|FG000|Overall Study|Withdrawal by Subject|0|||
144337348|NCT02986854|520437458|FG001|Overall Study|Withdrawal by Subject|1|||
144337349|NCT02986854|520437459|FG002|Overall Study|Withdrawal by Subject|1|||
144337350|NCT02986854|520437457|FG000|Overall Study|Lost to Follow-up|3|||
144337351|NCT02986854|520437458|FG001|Overall Study|Lost to Follow-up|11|||
144337352|NCT02986854|520437459|FG002|Overall Study|Lost to Follow-up|2|||
144337353|NCT00718770|520437460|FG000|Overall Study|Adverse Event|1|||
144337354|NCT00718770|520437460|FG000|Overall Study|Lack of Efficacy|1|||
144337355|NCT00718770|520437460|FG000|Overall Study|Lack of Efficacy|1|||
144337356|NCT00718770|520437460|FG000|Overall Study|Adverse Event|1|||
144337357|NCT00718770|520437460|FG000|Overall Study|Lack of Efficacy|1|||
144337358|NCT00718770|520437460|FG000|Overall Study|Adverse Event|1|||
144337359|NCT00718770|520437460|FG000|Overall Study|Lack of Efficacy|1|||
144337360|NCT00718770|520437460|FG000|Overall Study|Adverse Event|1|||
144337361|NCT01624090|520437464|FG000|Overall Study|DLT, taken off therapy|0|||
144337362|NCT01624090|520437465|FG001|Overall Study|DLT, taken off therapy|1|||
144337363|NCT01624090|520437466|FG002|Overall Study|DLT, taken off therapy|0|||
144337364|NCT01624090|520437467|FG003|Overall Study|DLT, taken off therapy|0|||
144337365|NCT01624090|520437464|FG000|Overall Study|Withdrew prior to treatment|0|||
144337366|NCT01624090|520437465|FG001|Overall Study|Withdrew prior to treatment|1|||
144337367|NCT01624090|520437466|FG002|Overall Study|Withdrew prior to treatment|0|||
144337368|NCT01624090|520437467|FG003|Overall Study|Withdrew prior to treatment|0|||
144337369|NCT01624090|520437464|FG000|Overall Study|Died on study|0|||
144337370|NCT01624090|520437465|FG001|Overall Study|Died on study|0|||
144337371|NCT01624090|520437466|FG002|Overall Study|Died on study|2|||
144337372|NCT01624090|520437467|FG003|Overall Study|Died on study|0|||
144337373|NCT01624090|520437464|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
144337374|NCT01624090|520437465|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
144337375|NCT01624090|520437466|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
144337376|NCT01624090|520437467|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
144337377|NCT01624090|520437464|FG000|Overall Study|Dose escalated|0|||
144337378|NCT01624090|520437465|FG001|Overall Study|Dose escalated|0|||
144337379|NCT01624090|520437466|FG002|Overall Study|Dose escalated|3|||
144337380|NCT01624090|520437467|FG003|Overall Study|Dose escalated|0|||
144337381|NCT00772109|520437468|FG000|Overall Study|Serious adverse event|1|||
144337382|NCT00772109|520437469|FG001|Overall Study|Serious adverse event|0|||
144337383|NCT00772109|520437470|FG002|Overall Study|Serious adverse event|1|||
144337384|NCT00772109|520437471|FG003|Overall Study|Serious adverse event|0|||
144337385|NCT00772109|520437468|FG000|Overall Study|Protocol Violation|5|||
144337386|NCT00772109|520437469|FG001|Overall Study|Protocol Violation|8|||
144337387|NCT00772109|520437470|FG002|Overall Study|Protocol Violation|7|||
144337388|NCT00772109|520437471|FG003|Overall Study|Protocol Violation|6|||
144337389|NCT00772109|520437468|FG000|Overall Study|Lost to Follow-up|7|||
144337390|NCT00772109|520437469|FG001|Overall Study|Lost to Follow-up|3|||
144337391|NCT00772109|520437470|FG002|Overall Study|Lost to Follow-up|5|||
144337392|NCT00772109|520437471|FG003|Overall Study|Lost to Follow-up|9|||
144337393|NCT00772109|520437468|FG000|Overall Study|Withdrawal by Subject|8|||
144337394|NCT00772109|520437469|FG001|Overall Study|Withdrawal by Subject|8|||
144337395|NCT00772109|520437470|FG002|Overall Study|Withdrawal by Subject|6|||
144337396|NCT00772109|520437471|FG003|Overall Study|Withdrawal by Subject|16|||
144337397|NCT02039856|520437472|FG000|Overall Study|Death|5|||
144337398|NCT02039856|520437473|FG001|Overall Study|Death|3|||
144337399|NCT02039856|520437472|FG000|Overall Study|Partial survey completion|61|||
144337400|NCT02039856|520437473|FG001|Overall Study|Partial survey completion|26|||
144337401|NCT02039856|520437472|FG000|Overall Study|Lost to Follow-up|388|||
144337402|NCT02039856|520437473|FG001|Overall Study|Lost to Follow-up|206|||
144337403|NCT02039856|520437472|FG000|Overall Study|Withdrawal by Subject|1573|||
144337404|NCT02039856|520437473|FG001|Overall Study|Withdrawal by Subject|618|||
144337405|NCT02540291|520437474|FG000|Overall Study|Death|7|||
144337406|NCT02540291|520437475|FG001|Overall Study|Death|7|||
144337407|NCT02540291|520437476|FG002|Overall Study|Death|5|||
144337408|NCT02540291|520437477|FG003|Overall Study|Death|7|||
144337409|NCT02540291|520437474|FG000|Overall Study|Lost to Follow-up|0|||
144337410|NCT02540291|520437475|FG001|Overall Study|Lost to Follow-up|0|||
144337411|NCT02540291|520437476|FG002|Overall Study|Lost to Follow-up|1|||
144337412|NCT02540291|520437477|FG003|Overall Study|Lost to Follow-up|0|||
144337413|NCT02540291|520437474|FG000|Overall Study|Withdrawal Of Consent|0|||
144337414|NCT02540291|520437475|FG001|Overall Study|Withdrawal Of Consent|1|||
144337415|NCT02540291|520437476|FG002|Overall Study|Withdrawal Of Consent|0|||
144337416|NCT02540291|520437477|FG003|Overall Study|Withdrawal Of Consent|0|||
144337417|NCT02540291|520437474|FG000|Overall Study|Study Terminated By Sponsor|1|||
144337418|NCT02540291|520437475|FG001|Overall Study|Study Terminated By Sponsor|0|||
144337419|NCT02540291|520437476|FG002|Overall Study|Study Terminated By Sponsor|0|||
144337420|NCT02540291|520437477|FG003|Overall Study|Study Terminated By Sponsor|0|||
144337421|NCT02540291|520437474|FG000|Overall Study|Other|0|||
144337422|NCT02540291|520437475|FG001|Overall Study|Other|0|||
144337423|NCT02540291|520437476|FG002|Overall Study|Other|1|||
144337424|NCT02540291|520437477|FG003|Overall Study|Other|0|||
144337425|NCT01879072|520437486|FG000|Overall Study|Withdrawal by Subject|121|||
144337426|NCT01879072|520437486|FG000|Overall Study|Not Transplanted|30|||
144337427|NCT00626405|520437494|FG000|Overall Study|Deemed Ineligible|1|||
144337428|NCT00626405|520437495|FG001|Overall Study|Deemed Ineligible|0|||
144337429|NCT00626405|520437494|FG000|Overall Study|Withdrawal by Subject|0|||
144337430|NCT00626405|520437495|FG001|Overall Study|Withdrawal by Subject|1|||
144337431|NCT01078168|520437496|FG000|Overall Study|Physician Decision|0|||
144337432|NCT01078168|520437497|FG001|Overall Study|Physician Decision|1|||
144337433|NCT01264419|520437501|FG000|Overall Study|Lost to Follow-up|3|||
144337434|NCT01740401|520439337|FG000|Overall Study|Progression of disease|6|||
144337435|NCT01740401|520439337|FG000|Overall Study|Adverse Event|2|||
144337436|NCT01740401|520439337|FG000|Overall Study|Did not reach primary endpoint|2|||
144337437|NCT02806960|520439338|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
144337438|NCT02806960|520439339|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
144337439|NCT02806960|520439340|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
144337440|NCT02806960|520439341|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
144337441|NCT01769196|520439342|FG000|Overall Study|Adverse Event|24|||
144337442|NCT01769196|520439343|FG001|Overall Study|Adverse Event|20|||
144337443|NCT01769196|520439342|FG000|Overall Study|Death|21|||
144337444|NCT01769196|520439343|FG001|Overall Study|Death|26|||
144337445|NCT01769196|520439342|FG000|Overall Study|Investigator Discretion|7|||
144337446|NCT01769196|520439343|FG001|Overall Study|Investigator Discretion|3|||
144337447|NCT01769196|520439342|FG000|Overall Study|Lack of Efficacy|3|||
144337448|NCT01769196|520439343|FG001|Overall Study|Lack of Efficacy|2|||
144337449|NCT01769196|520439342|FG000|Overall Study|Progressive disease|11|||
144337450|NCT01769196|520439343|FG001|Overall Study|Progressive disease|6|||
144337451|NCT01769196|520439342|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
144337452|NCT01769196|520439343|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
144337453|NCT01769196|520439342|FG000|Overall Study|Protocol Violation|0|||
144337454|NCT01769196|520439343|FG001|Overall Study|Protocol Violation|3|||
144337455|NCT01769196|520439342|FG000|Overall Study|Study terminated by sponsor|160|||
144337456|NCT01769196|520439343|FG001|Overall Study|Study terminated by sponsor|161|||
144337457|NCT01769196|520439342|FG000|Overall Study|Participant never dosed with study drug|1|||
144337458|NCT01769196|520439343|FG001|Overall Study|Participant never dosed with study drug|0|||
144337459|NCT01769196|520439342|FG000|Overall Study|Withdrew consent|36|||
144337460|NCT01769196|520439343|FG001|Overall Study|Withdrew consent|40|||
144337461|NCT01673620|520439344|FG000|Overall Study|Adverse Event|1|||
144337462|NCT01673620|520439345|FG001|Overall Study|Adverse Event|0|||
144337463|NCT01206582|520439346|FG000|Overall Study|Withdrew prior to study|1|||
144337464|NCT01206582|520439347|FG001|Overall Study|Withdrew prior to study|0|||
144337465|NCT01206582|520439346|FG000|Overall Study|Discontinued intervention before week 8|1|||
144337466|NCT01206582|520439347|FG001|Overall Study|Discontinued intervention before week 8|2|||
144337467|NCT02522325|520439348|FG000|Overall Study|Adverse Event|0|||
144337468|NCT02522325|520439349|FG001|Overall Study|Adverse Event|1|||
144337469|NCT00126776|520439352|FG000|Overall Study|follow up complete on all patients|0|||
144337470|NCT00126776|520439353|FG001|Overall Study|follow up complete on all patients|0|||
144337471|NCT00387725|520439365|FG000|Overall Study|Adverse Event|0|||
144337472|NCT00387725|520439366|FG001|Overall Study|Adverse Event|0|||
144337473|NCT00387725|520439367|FG002|Overall Study|Adverse Event|0|||
144337474|NCT00387725|520439368|FG003|Overall Study|Adverse Event|1|||
144337475|NCT00387725|520439365|FG000|Overall Study|Protocol Violation|0|||
144337476|NCT00387725|520439366|FG001|Overall Study|Protocol Violation|1|||
144337477|NCT00387725|520439367|FG002|Overall Study|Protocol Violation|0|||
144337478|NCT00387725|520439368|FG003|Overall Study|Protocol Violation|0|||
144337479|NCT00387725|520439365|FG000|Overall Study|Withdrawal by Subject|1|||
144337480|NCT00387725|520439366|FG001|Overall Study|Withdrawal by Subject|0|||
144337481|NCT00387725|520439367|FG002|Overall Study|Withdrawal by Subject|1|||
144337482|NCT00387725|520439368|FG003|Overall Study|Withdrawal by Subject|0|||
144337483|NCT00387725|520439365|FG000|Overall Study|Parent/legal guardian request|0|||
144337484|NCT00387725|520439366|FG001|Overall Study|Parent/legal guardian request|0|||
144337485|NCT00387725|520439367|FG002|Overall Study|Parent/legal guardian request|1|||
144337486|NCT00387725|520439368|FG003|Overall Study|Parent/legal guardian request|1|||
144337487|NCT01939366|520439369|FG000|Overall Study|Adverse Event|8|||
144337488|NCT01939366|520439370|FG001|Overall Study|Adverse Event|17|||
144337489|NCT01939366|520439371|FG002|Overall Study|Adverse Event|30|||
144337490|NCT01939366|520439372|FG003|Overall Study|Adverse Event|8|||
144337491|NCT01939366|520439373|FG004|Overall Study|Adverse Event|5|||
144337492|NCT01939366|520439369|FG000|Overall Study|Lack of Efficacy|2|||
144337493|NCT01939366|520439370|FG001|Overall Study|Lack of Efficacy|1|||
144337494|NCT01939366|520439371|FG002|Overall Study|Lack of Efficacy|1|||
144337495|NCT01939366|520439372|FG003|Overall Study|Lack of Efficacy|1|||
144337496|NCT01939366|520439373|FG004|Overall Study|Lack of Efficacy|3|||
144337497|NCT01939366|520439369|FG000|Overall Study|Lost to Follow-up|1|||
144337498|NCT01939366|520439370|FG001|Overall Study|Lost to Follow-up|1|||
144337499|NCT01939366|520439371|FG002|Overall Study|Lost to Follow-up|0|||
144337500|NCT01939366|520439372|FG003|Overall Study|Lost to Follow-up|0|||
144337501|NCT01939366|520439373|FG004|Overall Study|Lost to Follow-up|0|||
144337502|NCT01939366|520439369|FG000|Overall Study|Withdrawal by Subject|1|||
144337503|NCT01939366|520439370|FG001|Overall Study|Withdrawal by Subject|0|||
144337504|NCT01939366|520439371|FG002|Overall Study|Withdrawal by Subject|2|||
144337505|NCT01939366|520439372|FG003|Overall Study|Withdrawal by Subject|2|||
144337506|NCT01939366|520439373|FG004|Overall Study|Withdrawal by Subject|3|||
144337507|NCT01939366|520439369|FG000|Overall Study|Inclusion criteria not met|0|||
144337508|NCT01939366|520439370|FG001|Overall Study|Inclusion criteria not met|1|||
144337509|NCT01939366|520439371|FG002|Overall Study|Inclusion criteria not met|1|||
144337510|NCT01939366|520439372|FG003|Overall Study|Inclusion criteria not met|0|||
144337511|NCT01939366|520439373|FG004|Overall Study|Inclusion criteria not met|1|||
144337512|NCT01939366|520439369|FG000|Overall Study|Other|0|||
144337513|NCT01939366|520439370|FG001|Overall Study|Other|0|||
144337514|NCT01939366|520439371|FG002|Overall Study|Other|2|||
144337515|NCT01939366|520439372|FG003|Overall Study|Other|2|||
144337516|NCT01939366|520439373|FG004|Overall Study|Other|1|||
144337517|NCT01939366|520439369|FG000|Overall Study|Protocol Violation|0|||
144337518|NCT01939366|520439370|FG001|Overall Study|Protocol Violation|0|||
144337519|NCT01939366|520439371|FG002|Overall Study|Protocol Violation|0|||
144337520|NCT01939366|520439372|FG003|Overall Study|Protocol Violation|1|||
144337521|NCT01939366|520439373|FG004|Overall Study|Protocol Violation|0|||
144337522|NCT01939366|520439369|FG000|Overall Study|Sponsor decision|0|||
144337523|NCT01939366|520439370|FG001|Overall Study|Sponsor decision|0|||
144337524|NCT01939366|520439371|FG002|Overall Study|Sponsor decision|0|||
144337525|NCT01939366|520439372|FG003|Overall Study|Sponsor decision|0|||
144337526|NCT01939366|520439373|FG004|Overall Study|Sponsor decision|2|||
144337527|NCT01939366|520439369|FG000|Overall Study|GCP non-compliance at site|2|||
144337528|NCT01939366|520439370|FG001|Overall Study|GCP non-compliance at site|3|||
144337529|NCT01939366|520439371|FG002|Overall Study|GCP non-compliance at site|2|||
144337530|NCT01939366|520439372|FG003|Overall Study|GCP non-compliance at site|3|||
144337531|NCT01939366|520439373|FG004|Overall Study|GCP non-compliance at site|3|||
144337532|NCT05011058|520439374|FG000|Overall Study|Sponsor Decision|2|||
144337533|NCT05011058|520439375|FG001|Overall Study|Sponsor Decision|0|||
144337534|NCT05011058|520439376|FG002|Overall Study|Sponsor Decision|14|||
144337535|NCT05011058|520439377|FG003|Overall Study|Sponsor Decision|0|||
144337536|NCT05011058|520439378|FG004|Overall Study|Sponsor Decision|0|||
144337537|NCT05011058|520439379|FG005|Overall Study|Sponsor Decision|1|||
144337538|NCT05011058|520439380|FG006|Overall Study|Sponsor Decision|0|||
144337539|NCT05011058|520439381|FG007|Overall Study|Sponsor Decision|5|||
144337540|NCT02596230|520439382|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
144337541|NCT02596230|520439383|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
144337542|NCT02596230|520439384|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
144337543|NCT02596230|520439385|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
144337544|NCT02596230|520439386|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
144337545|NCT02596230|520439382|FG000|Objective 2, One Year|Lost to Follow-up|0|||
144337546|NCT02596230|520439383|FG001|Objective 2, One Year|Lost to Follow-up|41|||
144337547|NCT02596230|520439384|FG002|Objective 2, One Year|Lost to Follow-up|41|||
144337548|NCT02596230|520439385|FG003|Objective 2, One Year|Lost to Follow-up|32|||
144337549|NCT02596230|520439386|FG004|Objective 2, One Year|Lost to Follow-up|46|||
144337550|NCT02596230|520439382|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
144337551|NCT02596230|520439383|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
144337552|NCT02596230|520439384|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
144337553|NCT02596230|520439385|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
144337554|NCT02596230|520439386|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
144337555|NCT02596230|520439382|FG000|Objective 2, One Year|Adverse drug reaction|0|||
144337556|NCT02596230|520439383|FG001|Objective 2, One Year|Adverse drug reaction|1|||
144337557|NCT02596230|520439384|FG002|Objective 2, One Year|Adverse drug reaction|0|||
144337558|NCT02596230|520439385|FG003|Objective 2, One Year|Adverse drug reaction|0|||
144337559|NCT02596230|520439386|FG004|Objective 2, One Year|Adverse drug reaction|0|||
144337560|NCT02596230|520439382|FG000|Objective 2, One Year|Death|0|||
144337561|NCT02596230|520439383|FG001|Objective 2, One Year|Death|12|||
144337562|NCT02596230|520439384|FG002|Objective 2, One Year|Death|41|||
144337563|NCT02596230|520439385|FG003|Objective 2, One Year|Death|21|||
144337564|NCT02596230|520439386|FG004|Objective 2, One Year|Death|30|||
144337565|NCT02596230|520439382|FG000|Objective 2, One Year|Other|0|||
144337566|NCT02596230|520439383|FG001|Objective 2, One Year|Other|3|||
144337567|NCT02596230|520439384|FG002|Objective 2, One Year|Other|2|||
144337568|NCT02596230|520439385|FG003|Objective 2, One Year|Other|0|||
144337569|NCT02596230|520439386|FG004|Objective 2, One Year|Other|0|||
144337570|NCT01272869|520439387|FG000|Period 2 (14 Days)|Adverse Event|1|||
144337571|NCT01272869|520439388|FG001|Period 2 (14 Days)|Adverse Event|0|||
144337572|NCT01571232|520439389|FG000|Overall Study|Lost to Follow-up|0|||
144337573|NCT01571232|520439390|FG001|Overall Study|Lost to Follow-up|1|||
144337574|NCT01571232|520439389|FG000|Overall Study|Withdrawal by Subject|1|||
144337575|NCT01571232|520439390|FG001|Overall Study|Withdrawal by Subject|0|||
144337576|NCT00771615|520439391|FG000|Overall Study|Withdrawal by Subject|0|||
144337577|NCT00771615|520439392|FG001|Overall Study|Withdrawal by Subject|1|||
144337578|NCT00771615|520439393|FG002|Overall Study|Withdrawal by Subject|0|||
144337579|NCT00771615|520439394|FG003|Overall Study|Withdrawal by Subject|0|||
144337580|NCT00771615|520439395|FG004|Overall Study|Withdrawal by Subject|0|||
144337581|NCT00771615|520439396|FG005|Overall Study|Withdrawal by Subject|0|||
144337582|NCT00771615|520439397|FG006|Overall Study|Withdrawal by Subject|0|||
144337583|NCT00771615|520439398|FG007|Overall Study|Withdrawal by Subject|1|||
144337584|NCT00771615|520439399|FG008|Overall Study|Withdrawal by Subject|0|||
144337585|NCT00771615|520439391|FG000|Overall Study|Lost to Follow-up|1|||
144337586|NCT00771615|520439392|FG001|Overall Study|Lost to Follow-up|1|||
144337587|NCT00771615|520439393|FG002|Overall Study|Lost to Follow-up|1|||
144337588|NCT00771615|520439394|FG003|Overall Study|Lost to Follow-up|1|||
144337589|NCT00771615|520439395|FG004|Overall Study|Lost to Follow-up|0|||
144337590|NCT00771615|520439396|FG005|Overall Study|Lost to Follow-up|1|||
144337591|NCT00771615|520439397|FG006|Overall Study|Lost to Follow-up|1|||
144337592|NCT00771615|520439398|FG007|Overall Study|Lost to Follow-up|0|||
144337593|NCT00771615|520439399|FG008|Overall Study|Lost to Follow-up|0|||
144337594|NCT02455076|520439400|FG000|Inpatient|Withdrawal by Subject|1|||
144337595|NCT02455076|520439401|FG001|Inpatient|Withdrawal by Subject|0|||
144337596|NCT02455076|520439402|FG002|Inpatient|Withdrawal by Subject|0|||
144337597|NCT02455076|520439403|FG003|Inpatient|Withdrawal by Subject|0|||
144337598|NCT02455076|520439404|FG004|Inpatient|Withdrawal by Subject|0|||
144337599|NCT02455076|520439400|FG000|Inpatient|Discharged <24 h after admission|0|||
144337600|NCT02455076|520439401|FG001|Inpatient|Discharged <24 h after admission|1|||
144337601|NCT02455076|520439402|FG002|Inpatient|Discharged <24 h after admission|0|||
144337602|NCT02455076|520439403|FG003|Inpatient|Discharged <24 h after admission|0|||
144337603|NCT02455076|520439404|FG004|Inpatient|Discharged <24 h after admission|0|||
144337604|NCT02455076|520439400|FG000|Inpatient|Adverse Event|3|||
144337605|NCT02455076|520439401|FG001|Inpatient|Adverse Event|0|||
144337606|NCT02455076|520439402|FG002|Inpatient|Adverse Event|0|||
144337607|NCT02455076|520439403|FG003|Inpatient|Adverse Event|0|||
144337608|NCT02455076|520439404|FG004|Inpatient|Adverse Event|0|||
144337609|NCT02455076|520439400|FG000|Outpatient|Adverse Event|0|||
144337610|NCT02455076|520439401|FG001|Outpatient|Adverse Event|0|||
144337611|NCT02455076|520439402|FG002|Outpatient|Adverse Event|0|||
144337612|NCT02455076|520439403|FG003|Outpatient|Adverse Event|5|||
144337613|NCT02455076|520439404|FG004|Outpatient|Adverse Event|0|||
144337614|NCT02455076|520439400|FG000|Outpatient|Lost to Follow-up|0|||
144337615|NCT02455076|520439401|FG001|Outpatient|Lost to Follow-up|0|||
144337616|NCT02455076|520439402|FG002|Outpatient|Lost to Follow-up|0|||
144337617|NCT02455076|520439403|FG003|Outpatient|Lost to Follow-up|1|||
144337618|NCT02455076|520439404|FG004|Outpatient|Lost to Follow-up|12|||
144337619|NCT00859937|520439405|FG000|Overall Study|Protocol Violation|1|||
144337620|NCT00859937|520439406|FG001|Overall Study|Protocol Violation|0|||
144337621|NCT03908476|520439407|FG000|Overall Study|Death|3|||
144337622|NCT03908476|520439408|FG001|Overall Study|Death|0|||
144337623|NCT03908476|520439407|FG000|Overall Study|Lost to Follow-up|3|||
144337624|NCT03908476|520439408|FG001|Overall Study|Lost to Follow-up|1|||
144337625|NCT03908476|520439407|FG000|Overall Study|Withdrawal by Subject|7|||
144337626|NCT03908476|520439408|FG001|Overall Study|Withdrawal by Subject|1|||
144337627|NCT03908476|520439407|FG000|Overall Study|Physician Decision|2|||
144337628|NCT03908476|520439408|FG001|Overall Study|Physician Decision|0|||
144337629|NCT03908476|520439407|FG000|Overall Study|System Explanted and not Replaced|4|||
144337630|NCT03908476|520439408|FG001|Overall Study|System Explanted and not Replaced|0|||
144337631|NCT03908476|520439407|FG000|Overall Study|Intrathecal Pump|1|||
144337632|NCT03908476|520439408|FG001|Overall Study|Intrathecal Pump|0|||
144337633|NCT03908476|520439407|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
144337634|NCT03908476|520439408|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
144337635|NCT03270891|520439411|FG000|Overall Study|Lost to Follow-up|3|||
144337636|NCT03270891|520439412|FG001|Overall Study|Lost to Follow-up|6|||
144337637|NCT03270891|520439413|FG002|Overall Study|Lost to Follow-up|0|||
144337638|NCT03270891|520439411|FG000|Overall Study|Withdrawal by Subject|1|||
144337639|NCT03270891|520439412|FG001|Overall Study|Withdrawal by Subject|0|||
144337640|NCT03270891|520439413|FG002|Overall Study|Withdrawal by Subject|0|||
144337641|NCT03270891|520439411|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
144337642|NCT03270891|520439412|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
144337643|NCT03270891|520439413|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
144337644|NCT02540668|520439414|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
144337645|NCT02540668|520439415|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
144337646|NCT02294734|520439416|FG000|Overall Study|Adverse Event|5|||
144337647|NCT02294734|520439417|FG001|Overall Study|Adverse Event|5|||
144337648|NCT02294734|520439416|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
144337649|NCT02294734|520439417|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
144337650|NCT02294734|520439416|FG000|Overall Study|Lost to Follow-up|2|||
144337651|NCT02294734|520439417|FG001|Overall Study|Lost to Follow-up|0|||
144337652|NCT02294734|520439416|FG000|Overall Study|Physician Decision|2|||
144337653|NCT02294734|520439417|FG001|Overall Study|Physician Decision|1|||
144337654|NCT02294734|520439416|FG000|Overall Study|Withdrawal by Subject|4|||
144337655|NCT02294734|520439417|FG001|Overall Study|Withdrawal by Subject|2|||
144337656|NCT00548717|520439418|FG000|Overall Study|Death|5|||
144337657|NCT00548717|520439419|FG001|Overall Study|Death|2|||
144337658|NCT00548717|520439418|FG000|Overall Study|Relapse|3|||
144337659|NCT00548717|520439419|FG001|Overall Study|Relapse|0|||
144337660|NCT00548717|520439418|FG000|Overall Study|Alternative treatment for GVHD|1|||
144337661|NCT00548717|520439419|FG001|Overall Study|Alternative treatment for GVHD|0|||
144337662|NCT00082381|520439428|FG000|Overall Study|Adverse Event|27|||
144337663|NCT00082381|520439429|FG001|Overall Study|Adverse Event|2|||
144337664|NCT00082381|520439428|FG000|Overall Study|Lost to Follow-up|5|||
144337665|NCT00082381|520439429|FG001|Overall Study|Lost to Follow-up|7|||
144337666|NCT00082381|520439428|FG000|Overall Study|Patient Decision|8|||
144337667|NCT00082381|520439429|FG001|Overall Study|Patient Decision|4|||
144337668|NCT00082381|520439428|FG000|Overall Study|Physician Decision|1|||
144337669|NCT00082381|520439429|FG001|Overall Study|Physician Decision|2|||
144337670|NCT00082381|520439428|FG000|Overall Study|Protocol Violation|10|||
144337671|NCT00082381|520439429|FG001|Overall Study|Protocol Violation|11|||
144337672|NCT00082381|520439428|FG000|Overall Study|Loss of Glucose Control|4|||
144337673|NCT00082381|520439429|FG001|Overall Study|Loss of Glucose Control|0|||
144337674|NCT02925741|520439430|FG000|Overall Study|Withdrawal by Subject|11|||
144337675|NCT02925741|520439431|FG001|Overall Study|Withdrawal by Subject|0|||
144337676|NCT00025155|520439432|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
144337677|NCT00025155|520439432|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
144337678|NCT00343382|520439435|FG000|Overall Study|Adverse Event|2|||
144337679|NCT00343382|520439436|FG001|Overall Study|Adverse Event|10|||
144337680|NCT00343382|520439437|FG002|Overall Study|Adverse Event|7|||
144337681|NCT00343382|520439435|FG000|Overall Study|Withdrawal by Subject|1|||
144337682|NCT00343382|520439436|FG001|Overall Study|Withdrawal by Subject|2|||
144337683|NCT00343382|520439437|FG002|Overall Study|Withdrawal by Subject|6|||
144337684|NCT00343382|520439435|FG000|Overall Study|Other Reason Not Specified|1|||
144337685|NCT00343382|520439436|FG001|Overall Study|Other Reason Not Specified|2|||
144337686|NCT00343382|520439437|FG002|Overall Study|Other Reason Not Specified|4|||
144337687|NCT03729245|520439438|FG000|Overall Study|Lost to Follow-up|5|||
144337688|NCT03729245|520439439|FG001|Overall Study|Lost to Follow-up|6|||
144337689|NCT03729245|520439438|FG000|Overall Study|Withdrawal by Subject|16|||
144337690|NCT03729245|520439439|FG001|Overall Study|Withdrawal by Subject|19|||
144337691|NCT03729245|520439438|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
144337692|NCT03729245|520439439|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
144337693|NCT03322423|520439444|FG000|Period 1|Subject no longer eligible|0|||
144337694|NCT03322423|520439445|FG001|Period 1|Subject no longer eligible|1|||
144337695|NCT03322423|520439444|FG000|Period 1|Withdrawal by Subject|0|||
144337696|NCT03322423|520439445|FG001|Period 1|Withdrawal by Subject|1|||
144337697|NCT03322423|520439444|FG000|Period 1|Incorrect Lens Dispensed|1|||
144337698|NCT03322423|520439445|FG001|Period 1|Incorrect Lens Dispensed|0|||
144337699|NCT03322423|520439444|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
144337700|NCT03322423|520439445|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
144337701|NCT03322423|520439444|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
144337702|NCT03322423|520439445|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
144337703|NCT03322423|520439444|FG000|Period 2|Protocol Violation|1|||
144337704|NCT03322423|520439445|FG001|Period 2|Protocol Violation|0|||
144337705|NCT03322423|520439444|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
144337706|NCT03322423|520439445|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
144337707|NCT04891107|520439447|FG000|Overall Study|Physician Decision|1|||
144337708|NCT04891107|520439447|FG000|Overall Study|Withdrawal by Subject|1|||
144337709|NCT04891107|520439447|FG000|Overall Study|Screen failure after consent|1|||
144337710|NCT01571453|520439448|FG000|Overall Study|Adverse Event|14|||
144337711|NCT01571453|520439449|FG001|Overall Study|Adverse Event|32|||
144337712|NCT01571453|520439448|FG000|Overall Study|Lack of Efficacy|8|||
144337713|NCT01571453|520439449|FG001|Overall Study|Lack of Efficacy|3|||
144337714|NCT01571453|520439448|FG000|Overall Study|Non-compliance|2|||
144337715|NCT01571453|520439449|FG001|Overall Study|Non-compliance|4|||
144337716|NCT01571453|520439448|FG000|Overall Study|Protocol Violation|1|||
144337717|NCT01571453|520439449|FG001|Overall Study|Protocol Violation|5|||
144337718|NCT01571453|520439448|FG000|Overall Study|Withdrawal of consent|5|||
144337719|NCT01571453|520439449|FG001|Overall Study|Withdrawal of consent|13|||
144337720|NCT01571453|520439448|FG000|Overall Study|Lost to Follow-up|4|||
144337721|NCT01571453|520439449|FG001|Overall Study|Lost to Follow-up|2|||
144337722|NCT01571453|520439448|FG000|Overall Study|Administrative or other reason(s)|4|||
144337723|NCT01571453|520439449|FG001|Overall Study|Administrative or other reason(s)|3|||
144337724|NCT00500760|520439456|FG000|Overall Study|Death|32|||
144337725|NCT00500760|520439457|FG001|Overall Study|Death|15|||
144337726|NCT00500760|520439456|FG000|Overall Study|Withdrawal by Subject|5|||
144337727|NCT00500760|520439457|FG001|Overall Study|Withdrawal by Subject|7|||
144337728|NCT00500760|520439456|FG000|Overall Study|Administrative decision|2|||
144337729|NCT00500760|520439457|FG001|Overall Study|Administrative decision|0|||
144337730|NCT00500760|520439456|FG000|Overall Study|Lost to Follow-up|3|||
144337731|NCT00500760|520439457|FG001|Overall Study|Lost to Follow-up|0|||
144337732|NCT00500760|520439456|FG000|Overall Study|Other|1|||
144337733|NCT00500760|520439457|FG001|Overall Study|Other|2|||
144337734|NCT00129961|520439459|FG000|Overall Study|Adverse Event|1|||
144337735|NCT00129961|520439460|FG001|Overall Study|Adverse Event|0|||
144337736|NCT00129961|520439459|FG000|Overall Study|Death|1|||
144337737|NCT00129961|520439460|FG001|Overall Study|Death|1|||
144337738|NCT00129961|520439459|FG000|Overall Study|Withdrawal by Sponsor|14|||
144337739|NCT00129961|520439460|FG001|Overall Study|Withdrawal by Sponsor|20|||
144337740|NCT00129961|520439459|FG000|Overall Study|Physician Decision|1|||
144337741|NCT00129961|520439460|FG001|Overall Study|Physician Decision|0|||
144337742|NCT00129961|520439459|FG000|Overall Study|Withdrawal by Subject|2|||
144337743|NCT00129961|520439460|FG001|Overall Study|Withdrawal by Subject|1|||
144337744|NCT00129961|520439459|FG000|Overall Study|Missing Record|0|||
144337745|NCT00129961|520439460|FG001|Overall Study|Missing Record|1|||
144337746|NCT01985360|520439461|FG000|Overall Study|Withdrawal by Subject|4|||
144337747|NCT01985360|520439462|FG001|Overall Study|Withdrawal by Subject|0|||
144337748|NCT01985360|520439461|FG000|Overall Study|Lost to Follow-up|5|||
144337749|NCT01985360|520439462|FG001|Overall Study|Lost to Follow-up|3|||
144337750|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
144337751|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
144337752|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
144337753|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
144337754|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
144337755|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
144337756|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
144337757|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
144337758|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
144337759|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
144337760|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
144337761|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
144337762|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
144337763|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
144337764|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
144337765|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
144337766|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
144337767|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
144337768|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
144337769|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
144337770|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
144337771|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
144337772|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
144337773|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
144337774|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
144337775|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
144337776|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
144337777|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
144337778|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
144337779|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
144337780|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
144337781|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
144337782|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
144337783|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
144337784|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
144337785|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
144337786|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
144337787|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
144337788|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
144337789|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
144337790|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
144337791|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
144337792|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
144337793|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
144337794|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337795|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337796|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
144337797|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337798|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337799|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
144337800|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337801|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337802|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337803|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144337804|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
144360040|NCT01601535|520525138|FG003|Phase 2|Started Another Treatment|0|||
144337805|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
144337806|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337807|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337808|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337809|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337810|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337811|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337812|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337813|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337814|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337815|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
144337816|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337817|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337818|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
144337819|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337820|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337821|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337822|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337823|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337824|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337825|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337826|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
144337827|NCT02914561|520439463|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
144337828|NCT02914561|520439464|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
144337829|NCT02914561|520439465|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
144337830|NCT02914561|520439466|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
144337831|NCT02914561|520439467|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
144337832|NCT02914561|520439468|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
144337833|NCT02914561|520439469|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
144337834|NCT02914561|520439470|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
144337835|NCT02914561|520439471|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
144337836|NCT02914561|520439472|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
144337837|NCT02914561|520439473|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
144337838|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
144337839|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
144337840|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
144337841|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
144337842|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
144337843|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
144337844|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
144337845|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
144337846|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
144337847|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
144337848|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
144337849|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
144337850|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
144337851|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
144337852|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
144337853|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
144337854|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
144337855|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
144337856|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
144337857|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
144337858|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
144337859|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
144337860|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
144337861|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
144337862|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
144337863|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
144337864|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
144337865|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
144337866|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
144337867|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
144337868|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
144337869|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
144337870|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
144337871|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337872|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337873|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337874|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337875|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337876|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337877|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
144337878|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337879|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
144337880|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
144337881|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
144337882|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337883|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337884|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337885|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337886|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337887|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337888|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
144337889|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
144337890|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
144337891|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
144337892|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
144337893|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337894|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337895|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337896|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337897|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337898|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337899|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
144337900|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337901|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
144337902|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337903|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
144337904|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337905|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337906|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337907|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337908|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337909|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337910|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337911|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337912|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
144337913|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337914|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
144337915|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337916|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337917|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337918|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337919|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337920|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337921|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
144337922|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337923|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337924|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337925|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
144337926|NCT02914561|520439463|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337927|NCT02914561|520439464|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337928|NCT02914561|520439465|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337929|NCT02914561|520439466|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337930|NCT02914561|520439467|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337931|NCT02914561|520439468|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337932|NCT02914561|520439469|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337933|NCT02914561|520439470|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
144337934|NCT02914561|520439471|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
144337935|NCT02914561|520439472|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
144337936|NCT02914561|520439473|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
144337937|NCT01300455|520439474|FG000|Washout|Withdrawal by Subject|1|||
144337938|NCT01300455|520439475|FG001|Washout|Withdrawal by Subject|0|||
144337939|NCT00084487|520439476|FG000|Overall Study|Death|1|||
144337940|NCT03332160|520439481|FG000|Overall Study|Withdrawal by Subject|1|||
144337941|NCT03332160|520439482|FG001|Overall Study|Withdrawal by Subject|1|||
144337942|NCT03332160|520439481|FG000|Overall Study|Adverse Event|0|||
144337943|NCT03332160|520439482|FG001|Overall Study|Adverse Event|1|||
144337944|NCT03332160|520439481|FG000|Overall Study|Developed Exclusion Criteria|0|||
144337945|NCT03332160|520439482|FG001|Overall Study|Developed Exclusion Criteria|1|||
144337946|NCT03332160|520439481|FG000|Overall Study|Non-adherence to treatment|0|||
144337947|NCT03332160|520439482|FG001|Overall Study|Non-adherence to treatment|2|||
144337948|NCT04598269|520439483|FG000|Overall Study|Adverse Event|0|||
144337949|NCT04598269|520439484|FG001|Overall Study|Adverse Event|3|||
144337950|NCT04598269|520439483|FG000|Overall Study|Withdrawal by Subject|1|||
144337951|NCT04598269|520439484|FG001|Overall Study|Withdrawal by Subject|4|||
144337952|NCT04598269|520439483|FG000|Overall Study|Lost to Follow-up|1|||
144337953|NCT04598269|520439484|FG001|Overall Study|Lost to Follow-up|0|||
144337954|NCT04598269|520439483|FG000|Overall Study|Not Treated|2|||
144337955|NCT04598269|520439484|FG001|Overall Study|Not Treated|0|||
144337956|NCT02966015|520439485|FG000|Inclusion Visit|did not answer questionnaire|8|||
144337957|NCT02966015|520439486|FG001|Inclusion Visit|did not answer questionnaire|3|||
144337958|NCT03040986|520439489|FG000|Overall Study|Hospice|1|||
144337959|NCT03040986|520439490|FG001|Overall Study|Hospice|0|||
144337960|NCT03040986|520439489|FG000|Overall Study|Adverse Event|2|||
144337961|NCT03040986|520439490|FG001|Overall Study|Adverse Event|1|||
144337962|NCT03040986|520439489|FG000|Overall Study|Disease progression on study|3|||
144337963|NCT03040986|520439490|FG001|Overall Study|Disease progression on study|1|||
144337964|NCT02879578|520439491|FG000|Overall Study|Adverse Event|1|||
144337965|NCT02879578|520439492|FG001|Overall Study|Adverse Event|2|||
144337966|NCT02879578|520439493|FG002|Overall Study|Adverse Event|14|||
144337967|NCT02879578|520439491|FG000|Overall Study|Protocol Violation|0|||
144337968|NCT02879578|520439492|FG001|Overall Study|Protocol Violation|1|||
144337969|NCT02879578|520439493|FG002|Overall Study|Protocol Violation|1|||
144337970|NCT02879578|520439491|FG000|Overall Study|Withdrawal by Subject|8|||
144337971|NCT02879578|520439492|FG001|Overall Study|Withdrawal by Subject|6|||
144337972|NCT02879578|520439493|FG002|Overall Study|Withdrawal by Subject|9|||
144337973|NCT02879578|520439491|FG000|Overall Study|Lost to Follow-up|1|||
144337974|NCT02879578|520439492|FG001|Overall Study|Lost to Follow-up|0|||
144337975|NCT02879578|520439493|FG002|Overall Study|Lost to Follow-up|4|||
144337976|NCT02879578|520439491|FG000|Overall Study|Physician Decision|0|||
144337977|NCT02879578|520439492|FG001|Overall Study|Physician Decision|0|||
144337978|NCT02879578|520439493|FG002|Overall Study|Physician Decision|4|||
144337979|NCT00454649|520439499|FG000|Overall Study|Lack of Efficacy|2|||
144337980|NCT00454649|520439500|FG001|Overall Study|Lack of Efficacy|2|||
144337981|NCT00454649|520439501|FG002|Overall Study|Lack of Efficacy|10|||
144337982|NCT00454649|520439502|FG003|Overall Study|Lack of Efficacy|3|||
144337983|NCT00454649|520439503|FG004|Overall Study|Lack of Efficacy|0|||
144337984|NCT00454649|520439504|FG005|Overall Study|Lack of Efficacy|4|||
144337985|NCT00454649|520439505|FG006|Overall Study|Lack of Efficacy|5|||
144337986|NCT00454649|520439506|FG007|Overall Study|Lack of Efficacy|13|||
144337987|NCT00454649|520439507|FG008|Overall Study|Lack of Efficacy|10|||
144337988|NCT00454649|520439508|FG009|Overall Study|Lack of Efficacy|2|||
144337989|NCT00454649|520439499|FG000|Overall Study|Adverse Event|0|||
144337990|NCT00454649|520439500|FG001|Overall Study|Adverse Event|1|||
144337991|NCT00454649|520439501|FG002|Overall Study|Adverse Event|3|||
144337992|NCT00454649|520439502|FG003|Overall Study|Adverse Event|0|||
144337993|NCT00454649|520439503|FG004|Overall Study|Adverse Event|1|||
144337994|NCT00454649|520439504|FG005|Overall Study|Adverse Event|2|||
144337995|NCT00454649|520439505|FG006|Overall Study|Adverse Event|3|||
144337996|NCT00454649|520439506|FG007|Overall Study|Adverse Event|4|||
144337997|NCT00454649|520439507|FG008|Overall Study|Adverse Event|6|||
144337998|NCT00454649|520439508|FG009|Overall Study|Adverse Event|2|||
144337999|NCT00454649|520439499|FG000|Overall Study|Lost to Follow-up|0|||
144338000|NCT00454649|520439500|FG001|Overall Study|Lost to Follow-up|0|||
144338001|NCT00454649|520439501|FG002|Overall Study|Lost to Follow-up|1|||
144338002|NCT00454649|520439502|FG003|Overall Study|Lost to Follow-up|0|||
144338003|NCT00454649|520439503|FG004|Overall Study|Lost to Follow-up|0|||
144338004|NCT00454649|520439504|FG005|Overall Study|Lost to Follow-up|0|||
144338005|NCT00454649|520439505|FG006|Overall Study|Lost to Follow-up|1|||
144338006|NCT00454649|520439506|FG007|Overall Study|Lost to Follow-up|0|||
144338007|NCT00454649|520439507|FG008|Overall Study|Lost to Follow-up|0|||
144338008|NCT00454649|520439508|FG009|Overall Study|Lost to Follow-up|0|||
144338009|NCT00454649|520439499|FG000|Overall Study|Other|1|||
144338010|NCT00454649|520439500|FG001|Overall Study|Other|1|||
144338011|NCT00454649|520439501|FG002|Overall Study|Other|5|||
144338012|NCT00454649|520439502|FG003|Overall Study|Other|3|||
144338013|NCT00454649|520439503|FG004|Overall Study|Other|0|||
144338014|NCT00454649|520439504|FG005|Overall Study|Other|0|||
144338015|NCT00454649|520439505|FG006|Overall Study|Other|0|||
144338016|NCT00454649|520439506|FG007|Overall Study|Other|0|||
144338017|NCT00454649|520439507|FG008|Overall Study|Other|3|||
144338018|NCT00454649|520439508|FG009|Overall Study|Other|1|||
144338019|NCT00454649|520439499|FG000|Overall Study|Withdrawal by Subject|0|||
144338020|NCT00454649|520439500|FG001|Overall Study|Withdrawal by Subject|0|||
144338021|NCT00454649|520439501|FG002|Overall Study|Withdrawal by Subject|0|||
144338022|NCT00454649|520439502|FG003|Overall Study|Withdrawal by Subject|0|||
144338023|NCT00454649|520439503|FG004|Overall Study|Withdrawal by Subject|0|||
144338024|NCT00454649|520439504|FG005|Overall Study|Withdrawal by Subject|1|||
144338025|NCT00454649|520439505|FG006|Overall Study|Withdrawal by Subject|0|||
144338026|NCT00454649|520439506|FG007|Overall Study|Withdrawal by Subject|2|||
144338027|NCT00454649|520439507|FG008|Overall Study|Withdrawal by Subject|1|||
144338028|NCT00454649|520439508|FG009|Overall Study|Withdrawal by Subject|0|||
144338029|NCT00737633|520439509|FG000|Overall Study|Study terminated by sponsor|44|||
144338030|NCT00737633|520439510|FG001|Overall Study|Study terminated by sponsor|55|||
144338031|NCT00737633|520439509|FG000|Overall Study|Lost to Follow-up|0|||
144338032|NCT00737633|520439510|FG001|Overall Study|Lost to Follow-up|1|||
144338033|NCT00737633|520439509|FG000|Overall Study|protocol non-compliance|0|||
144338034|NCT00737633|520439510|FG001|Overall Study|protocol non-compliance|1|||
144338035|NCT00377364|520439511|FG000|Overall Study|Lost to Follow-up|1|||
144338036|NCT00377364|520439512|FG001|Overall Study|Lost to Follow-up|0|||
144338037|NCT00377364|520439511|FG000|Overall Study|Withdrawal by Subject|1|||
144338038|NCT00377364|520439512|FG001|Overall Study|Withdrawal by Subject|0|||
144338039|NCT02925728|520439513|FG000|Overall Study|Death|3|||
144338040|NCT02925728|520439514|FG001|Overall Study|Death|5|||
144338041|NCT02925728|520439513|FG000|Overall Study|Physician Decision|1|||
144338042|NCT02925728|520439514|FG001|Overall Study|Physician Decision|0|||
144338043|NCT02925728|520439513|FG000|Overall Study|Withdrawal by Subject|1|||
144338044|NCT02925728|520439514|FG001|Overall Study|Withdrawal by Subject|0|||
144338045|NCT05098509|520439515|FG000|Overall Study|Withdrawal by Subject|0|||
144338046|NCT05098509|520439516|FG001|Overall Study|Withdrawal by Subject|0|||
144338047|NCT05098509|520439517|FG002|Overall Study|Withdrawal by Subject|1|||
144338048|NCT05098509|520439518|FG003|Overall Study|Withdrawal by Subject|0|||
144338049|NCT05098509|520439515|FG000|Overall Study|Early study termination|1|||
144338050|NCT05098509|520439516|FG001|Overall Study|Early study termination|1|||
144338051|NCT05098509|520439517|FG002|Overall Study|Early study termination|1|||
144338052|NCT05098509|520439518|FG003|Overall Study|Early study termination|0|||
144338053|NCT03101085|520439519|FG000|Overall Study|Lost to Follow-up|0|||
144338054|NCT03101085|520439520|FG001|Overall Study|Lost to Follow-up|1|||
144338055|NCT01972789|520439523|FG000|Overall Study|Adverse Event|11|||
144338056|NCT01972789|520439524|FG001|Overall Study|Adverse Event|4|||
144338057|NCT01972789|520439523|FG000|Overall Study|Subject withdrew consent|14|||
144338058|NCT01972789|520439524|FG001|Overall Study|Subject withdrew consent|12|||
144338059|NCT01972789|520439523|FG000|Overall Study|Lost to Follow-up|4|||
144338060|NCT01972789|520439524|FG001|Overall Study|Lost to Follow-up|7|||
144338061|NCT01972789|520439523|FG000|Overall Study|Death|7|||
144338062|NCT01972789|520439524|FG001|Overall Study|Death|5|||
144338063|NCT01972789|520439523|FG000|Overall Study|Protocol deviation|1|||
144338064|NCT01972789|520439524|FG001|Overall Study|Protocol deviation|0|||
144338065|NCT01972789|520439523|FG000|Overall Study|Physician Decision|3|||
144338066|NCT01972789|520439524|FG001|Overall Study|Physician Decision|2|||
144338067|NCT00086411|520439530|FG000|Overall Study|Lost to Follow-up|11|||
144338068|NCT00086411|520439531|FG001|Overall Study|Lost to Follow-up|11|||
144338069|NCT00086411|520439532|FG002|Overall Study|Lost to Follow-up|13|||
144338070|NCT00086411|520439533|FG003|Overall Study|Lost to Follow-up|12|||
144338071|NCT00695864|520439534|FG000|Placebo|Withdrawal by Subject|1|||
144338072|NCT00695864|520439534|FG000|Placebo|Physician Decision|4|||
144338073|NCT02100475|520441172|FG000|Overall Study|Unclassified|1|||
144338074|NCT02100475|520441173|FG001|Overall Study|Unclassified|2|||
144338075|NCT02100475|520441172|FG000|Overall Study|Withdrawal criteria|1|||
144338076|NCT02100475|520441173|FG001|Overall Study|Withdrawal criteria|0|||
144338077|NCT02315560|520441174|FG000|Overall Study|noncompliance by subjects|3|||
144338078|NCT01041287|520441175|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
144338079|NCT01041287|520441176|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
144338080|NCT01041287|520441175|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
144338081|NCT01041287|520441176|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
144338082|NCT00495625|520441182|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
144338083|NCT03464019|520441184|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
144338084|NCT03464019|520441185|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
144338085|NCT03464019|520441186|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
144338086|NCT03464019|520441184|FG000|NODE-301 Part 1|Ablation|0|||
144338087|NCT03464019|520441185|FG001|NODE-301 Part 1|Ablation|0|||
144338088|NCT03464019|520441186|FG002|NODE-301 Part 1|Ablation|16|||
144338089|NCT03464019|520441184|FG000|NODE-301 Part 1|Test Dose Failure|0|||
144338090|NCT03464019|520441185|FG001|NODE-301 Part 1|Test Dose Failure|0|||
144338091|NCT03464019|520441186|FG002|NODE-301 Part 1|Test Dose Failure|8|||
144338092|NCT03464019|520441184|FG000|NODE-301 Part 1|Adverse Event|0|||
144338093|NCT03464019|520441185|FG001|NODE-301 Part 1|Adverse Event|0|||
144338094|NCT03464019|520441186|FG002|NODE-301 Part 1|Adverse Event|5|||
144338095|NCT03464019|520441184|FG000|NODE-301 Part 1|Physician Decision|0|||
144338096|NCT03464019|520441185|FG001|NODE-301 Part 1|Physician Decision|0|||
144338097|NCT03464019|520441186|FG002|NODE-301 Part 1|Physician Decision|4|||
144338098|NCT03464019|520441184|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
144338099|NCT03464019|520441185|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
144338100|NCT03464019|520441186|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
144338101|NCT03464019|520441184|FG000|NODE-301 Part 1|Protocol Violation|0|||
144338102|NCT03464019|520441185|FG001|NODE-301 Part 1|Protocol Violation|0|||
144338103|NCT03464019|520441186|FG002|NODE-301 Part 1|Protocol Violation|2|||
144338104|NCT03464019|520441184|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
144338105|NCT03464019|520441185|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
144338106|NCT03464019|520441186|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
144338107|NCT03464019|520441184|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
144338108|NCT03464019|520441185|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
144338109|NCT03464019|520441186|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
144338110|NCT03464019|520441184|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
144338111|NCT03464019|520441185|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
144338112|NCT03464019|520441186|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
144338113|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
144338114|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
144338115|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
144338116|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
144338117|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
144338118|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
144338119|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
144338120|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
144338121|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
144338122|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
144338123|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
144338124|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
144338125|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
144338126|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
144338127|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
144338128|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
144338129|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
144338130|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
144338131|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
144338132|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
144338133|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
144338134|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
144338135|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
144338136|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
144338137|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
144338138|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
144338139|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
144338140|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
144338141|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
144338142|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
144338143|NCT03464019|520441184|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
144338144|NCT03464019|520441185|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
144338145|NCT03464019|520441186|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
144338146|NCT00767806|520441187|FG000|Overall Study|Adverse Event|30|||
144338147|NCT00767806|520441188|FG001|Overall Study|Adverse Event|11|||
144338148|NCT00767806|520441187|FG000|Overall Study|Withdrawal by Subject|8|||
144338149|NCT00767806|520441188|FG001|Overall Study|Withdrawal by Subject|13|||
144338150|NCT00767806|520441187|FG000|Overall Study|Protocol Violation|6|||
144338151|NCT00767806|520441188|FG001|Overall Study|Protocol Violation|5|||
144338152|NCT00767806|520441187|FG000|Overall Study|Lack of Efficacy|1|||
144338153|NCT00767806|520441188|FG001|Overall Study|Lack of Efficacy|9|||
144338154|NCT00767806|520441187|FG000|Overall Study|Physician Decision|4|||
144338155|NCT00767806|520441188|FG001|Overall Study|Physician Decision|3|||
144338156|NCT00767806|520441187|FG000|Overall Study|Lost to Follow-up|1|||
144338157|NCT00767806|520441188|FG001|Overall Study|Lost to Follow-up|4|||
144338158|NCT00767806|520441187|FG000|Overall Study|Entry Criteria Not Met|1|||
144338159|NCT00767806|520441188|FG001|Overall Study|Entry Criteria Not Met|1|||
144338160|NCT00767806|520441187|FG000|Overall Study|Sponsor Decision|0|||
144338161|NCT00767806|520441188|FG001|Overall Study|Sponsor Decision|1|||
144338162|NCT00527982|520441190|FG000|Overall Study|Physician Decision|1|||
144338163|NCT00527982|520441191|FG001|Overall Study|Physician Decision|0|||
144338164|NCT04680975|520441196|FG000|Overall Study|Adverse Event|3|||
144338165|NCT04680975|520441196|FG000|Overall Study|Death|1|||
144338166|NCT04680975|520441196|FG000|Overall Study|Progressive Disease|1|||
144338167|NCT04680975|520441196|FG000|Overall Study|Withdrawal by Subject|1|||
144338168|NCT03909152|520441197|FG000|Overall Study|Adverse Event|14|||
144338169|NCT03909152|520441198|FG001|Overall Study|Adverse Event|5|||
144338170|NCT03909152|520441199|FG002|Overall Study|Adverse Event|1|||
144338171|NCT03909152|520441200|FG003|Overall Study|Adverse Event|14|||
144338172|NCT02271945|520441204|FG000|Overall Study|Death|3|||
144338173|NCT02271945|520441205|FG001|Overall Study|Death|3|||
144338174|NCT02271945|520441204|FG000|Overall Study|Withdrawal by Subject|1|||
144338175|NCT02271945|520441205|FG001|Overall Study|Withdrawal by Subject|1|||
144338176|NCT02271945|520441204|FG000|Overall Study|Other|1|||
144338177|NCT02271945|520441205|FG001|Overall Study|Other|1|||
144338178|NCT01192412|520441206|FG000|Overall Study|Lost to Follow-up|2|||
144338179|NCT01192412|520441207|FG001|Overall Study|Lost to Follow-up|1|||
144338180|NCT01192412|520441206|FG000|Overall Study|Withdrawal by Subject|2|||
144338181|NCT01192412|520441207|FG001|Overall Study|Withdrawal by Subject|1|||
144338182|NCT00151476|520441208|FG000|FAP Identified Subjects|Protocol Violation|0|||
144338183|NCT00151476|520441209|FG001|FAP Identified Subjects|Protocol Violation|1|||
144338184|NCT00151476|520441208|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
144338185|NCT00151476|520441209|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
144338186|NCT00151476|520441208|FG000|FAP Analyzed Subjects|Other study participation|0|||
144338187|NCT00151476|520441209|FG001|FAP Analyzed Subjects|Other study participation|1|||
144338188|NCT03446456|520441210|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
144338189|NCT03446456|520441211|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
144338190|NCT03446456|520441210|FG000|Overall Study|Lost to Follow-up|1|||
144338191|NCT03446456|520441211|FG001|Overall Study|Lost to Follow-up|3|||
144338192|NCT03446456|520441210|FG000|Overall Study|Participant failed the toxicology test|1|||
144338193|NCT03446456|520441211|FG001|Overall Study|Participant failed the toxicology test|0|||
144338194|NCT03446456|520441210|FG000|Overall Study|Break down of the experimental equipment|1|||
144338195|NCT03446456|520441211|FG001|Overall Study|Break down of the experimental equipment|0|||
144338196|NCT04099511|520441215|FG000|Overall Study|Lost to Follow-up|2|||
144338197|NCT04099511|520441216|FG001|Overall Study|Lost to Follow-up|2|||
144338198|NCT04099511|520441215|FG000|Overall Study|Withdrawal by Subject|8|||
144338199|NCT04099511|520441216|FG001|Overall Study|Withdrawal by Subject|4|||
144338200|NCT06151288|520441217|FG000|Overall Study|Lost to Follow-up|4|||
144338201|NCT06151288|520441218|FG001|Overall Study|Lost to Follow-up|2|||
144338202|NCT06151288|520441219|FG002|Overall Study|Lost to Follow-up|4|||
144338203|NCT06151288|520441220|FG003|Overall Study|Lost to Follow-up|3|||
144338204|NCT06151288|520441217|FG000|Overall Study|Withdrawal by Subject|4|||
144338205|NCT06151288|520441218|FG001|Overall Study|Withdrawal by Subject|5|||
144338206|NCT06151288|520441219|FG002|Overall Study|Withdrawal by Subject|1|||
144338207|NCT06151288|520441220|FG003|Overall Study|Withdrawal by Subject|1|||
144338208|NCT01240200|520441222|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
144338209|NCT01240200|520441223|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
144338210|NCT04588389|520441224|FG000|Overall Study|Issues with anesthesia during surgery|2|||
144338211|NCT04588389|520441225|FG001|Overall Study|Issues with anesthesia during surgery|0|||
144338212|NCT04588389|520441226|FG002|Overall Study|Issues with anesthesia during surgery|0|||
144338213|NCT00719680|520441229|FG000|Overall Study|Adverse Event|1|||
144338214|NCT00719680|520441229|FG000|Overall Study|Lost to Follow-up|1|||
144338215|NCT00719680|520441229|FG000|Overall Study|Withdrawal by Subject|3|||
144338216|NCT00658814|520441230|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
144338217|NCT00658814|520441231|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
144338218|NCT00658814|520441230|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
144338219|NCT00658814|520441231|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
144338220|NCT00658814|520441230|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
144338221|NCT00658814|520441231|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
144338222|NCT00658814|520441230|FG000|Remission Induction Chemotherapy|Death|1|||
144338223|NCT00658814|520441231|FG001|Remission Induction Chemotherapy|Death|4|||
144338224|NCT00658814|520441230|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
144338225|NCT00658814|520441231|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
144338226|NCT00658814|520441230|FG000|Remission Induction Chemotherapy|Not eligible|1|||
144338227|NCT00658814|520441231|FG001|Remission Induction Chemotherapy|Not eligible|2|||
144338228|NCT00658814|520441230|FG000|Consolidation Therapy|Not protocol specified|0|||
144338229|NCT00658814|520441231|FG001|Consolidation Therapy|Not protocol specified|1|||
144338230|NCT00658814|520441230|FG000|Consolidation Therapy|Not eligible|2|||
144338231|NCT00658814|520441231|FG001|Consolidation Therapy|Not eligible|2|||
144338232|NCT00658814|520441230|FG000|Maintenance Therapy|Adverse Event|1|||
144338233|NCT00658814|520441231|FG001|Maintenance Therapy|Adverse Event|1|||
144338234|NCT00658814|520441230|FG000|Maintenance Therapy|Not protocol specified|1|||
144338235|NCT00658814|520441231|FG001|Maintenance Therapy|Not protocol specified|0|||
144338236|NCT00658814|520441230|FG000|Maintenance Therapy|Not eligible|1|||
144338237|NCT00658814|520441231|FG001|Maintenance Therapy|Not eligible|0|||
144338238|NCT02911142|520441232|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
144338239|NCT02911142|520441232|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
144338240|NCT02911142|520441232|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
144338241|NCT02911142|520441232|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
144338242|NCT03194438|520441233|FG000|Overall Study|Withdrawal by Subject|2|||
144338243|NCT02708485|520441234|FG000|Overall Study|Withdrawal by Subject|3|||
144338244|NCT02708485|520441235|FG001|Overall Study|Withdrawal by Subject|2|||
144338245|NCT03157583|520441242|FG000|Overall Study|Other (did not meet study criteria)|1|||
144338246|NCT01141478|520441243|FG000|Overall Study|Withdrawal by Subject|1|||
144338247|NCT01141478|520441244|FG001|Overall Study|Withdrawal by Subject|1|||
144338248|NCT01581619|520441247|FG000|Overall Study|Withdrawal by Subject|1|||
144338249|NCT01581619|520441247|FG000|Overall Study|Lost to Follow-up|1|||
144338250|NCT00290498|520441248|FG000|Overall Study|Death|2|||
144338251|NCT00290498|520441249|FG001|Overall Study|Death|0|||
144338252|NCT00290498|520441248|FG000|Overall Study|Physician Decision|1|||
144338253|NCT00290498|520441249|FG001|Overall Study|Physician Decision|0|||
144338254|NCT00290498|520441248|FG000|Overall Study|Withdrawal by Subject|1|||
144338255|NCT00290498|520441249|FG001|Overall Study|Withdrawal by Subject|0|||
144338256|NCT00290498|520441248|FG000|Overall Study|Ineligible|3|||
144338257|NCT00290498|520441249|FG001|Overall Study|Ineligible|0|||
144338258|NCT00290498|520441248|FG000|Overall Study|Non-Compliance|1|||
144338259|NCT00290498|520441249|FG001|Overall Study|Non-Compliance|0|||
144338260|NCT02250664|520441252|FG000|Overall Study|Lost to Follow-up|18|||
144338261|NCT02250664|520441253|FG001|Overall Study|Lost to Follow-up|28|||
144338262|NCT02250664|520441254|FG002|Overall Study|Lost to Follow-up|33|||
144338263|NCT02250664|520441252|FG000|Overall Study|Personal Reasons|7|||
144338264|NCT02250664|520441253|FG001|Overall Study|Personal Reasons|8|||
144338265|NCT02250664|520441254|FG002|Overall Study|Personal Reasons|14|||
144338266|NCT02250664|520441252|FG000|Overall Study|Adverse Event|6|||
144338267|NCT02250664|520441253|FG001|Overall Study|Adverse Event|3|||
144338268|NCT02250664|520441254|FG002|Overall Study|Adverse Event|8|||
144338269|NCT02250664|520441252|FG000|Overall Study|Incarcerated|2|||
144338270|NCT02250664|520441253|FG001|Overall Study|Incarcerated|1|||
144338271|NCT02250664|520441254|FG002|Overall Study|Incarcerated|2|||
144338272|NCT02250664|520441252|FG000|Overall Study|Withdrawal by Subject|0|||
144338273|NCT02250664|520441253|FG001|Overall Study|Withdrawal by Subject|1|||
144338274|NCT02250664|520441254|FG002|Overall Study|Withdrawal by Subject|2|||
144338275|NCT02250664|520441252|FG000|Overall Study|Death|0|||
144338276|NCT02250664|520441253|FG001|Overall Study|Death|1|||
144338277|NCT02250664|520441254|FG002|Overall Study|Death|1|||
144338278|NCT02250664|520441252|FG000|Overall Study|Physician Decision|1|||
144338279|NCT02250664|520441253|FG001|Overall Study|Physician Decision|3|||
144338280|NCT02250664|520441254|FG002|Overall Study|Physician Decision|1|||
144338281|NCT02250664|520441252|FG000|Overall Study|Protocol Violation|1|||
144338282|NCT02250664|520441253|FG001|Overall Study|Protocol Violation|0|||
144338283|NCT02250664|520441254|FG002|Overall Study|Protocol Violation|1|||
144338284|NCT02250664|520441252|FG000|Overall Study|Reason unknown|1|||
144338285|NCT02250664|520441253|FG001|Overall Study|Reason unknown|0|||
144338286|NCT02250664|520441254|FG002|Overall Study|Reason unknown|0|||
144338287|NCT03847909|520441256|FG000|Overall Study|Withdrawal by Subject|1|||
144338288|NCT03847909|520441257|FG001|Overall Study|Withdrawal by Subject|1|||
144338289|NCT04268173|520441262|FG000|Overall Study|Lost to Follow-up|75|||
144338290|NCT04268173|520441263|FG001|Overall Study|Lost to Follow-up|108|||
144338291|NCT00869401|520441264|FG000|Overall Study|Withdrawal by Subject|0|||
144338292|NCT00869401|520441265|FG001|Overall Study|Withdrawal by Subject|0|||
144338293|NCT00869401|520441266|FG002|Overall Study|Withdrawal by Subject|0|||
144338294|NCT00869401|520441267|FG003|Overall Study|Withdrawal by Subject|5|||
144338295|NCT00869401|520441268|FG004|Overall Study|Withdrawal by Subject|3|||
144338296|NCT01147900|520441269|FG000|At Year 10|Lost to Follow-up|0|||
144338297|NCT01147900|520441270|FG001|At Year 10|Lost to Follow-up|1|||
144338298|NCT01147900|520441271|FG002|At Year 10|Lost to Follow-up|0|||
144338299|NCT00975143|520441272|FG000|Overall Study|Adverse Event|19|||
144338300|NCT00975143|520441273|FG001|Overall Study|Adverse Event|15|||
144338301|NCT00975143|520441272|FG000|Overall Study|Withdrawal by Subject|15|||
144338302|NCT00975143|520441273|FG001|Overall Study|Withdrawal by Subject|15|||
144338303|NCT00975143|520441272|FG000|Overall Study|Lost to Follow-up|20|||
144338304|NCT00975143|520441273|FG001|Overall Study|Lost to Follow-up|16|||
144338305|NCT00975143|520441272|FG000|Overall Study|Non-compliance|5|||
144338306|NCT00975143|520441273|FG001|Overall Study|Non-compliance|8|||
144338307|NCT00975143|520441272|FG000|Overall Study|Physician Decision|1|||
144338308|NCT00975143|520441273|FG001|Overall Study|Physician Decision|2|||
144338309|NCT00975143|520441272|FG000|Overall Study|Details not available|10|||
144338310|NCT00975143|520441273|FG001|Overall Study|Details not available|4|||
144338311|NCT01375608|520441274|FG000|Overall Study|Withdrawal by Subject|2|||
144338312|NCT00581360|520441275|FG000|Overall Study|Withdrawal by Subject|1|||
144338313|NCT03129360|520441276|FG000|Overall Study|Did not meet entry criteria|0|||
144338314|NCT03129360|520441277|FG001|Overall Study|Did not meet entry criteria|2|||
144338315|NCT03129360|520441278|FG002|Overall Study|Did not meet entry criteria|1|||
144338316|NCT03129360|520441276|FG000|Overall Study|Excluded due to motion in scanner|1|||
144338317|NCT03129360|520441277|FG001|Overall Study|Excluded due to motion in scanner|0|||
144338318|NCT03129360|520441278|FG002|Overall Study|Excluded due to motion in scanner|0|||
144338319|NCT00545103|520441279|FG000|Overall Study|Lack of Efficacy|48|||
144338320|NCT00545103|520441280|FG001|Overall Study|Lack of Efficacy|45|||
144338321|NCT00545103|520441281|FG002|Overall Study|Lack of Efficacy|31|||
144338322|NCT00545103|520441282|FG003|Overall Study|Lack of Efficacy|27|||
144338323|NCT00545103|520441279|FG000|Overall Study|Withdrawal by Subject|6|||
144338324|NCT00545103|520441280|FG001|Overall Study|Withdrawal by Subject|10|||
144338325|NCT00545103|520441281|FG002|Overall Study|Withdrawal by Subject|18|||
144338326|NCT00545103|520441282|FG003|Overall Study|Withdrawal by Subject|22|||
144338327|NCT00545103|520441279|FG000|Overall Study|Adverse Event|11|||
144338328|NCT00545103|520441280|FG001|Overall Study|Adverse Event|12|||
144338329|NCT00545103|520441281|FG002|Overall Study|Adverse Event|17|||
144338330|NCT00545103|520441282|FG003|Overall Study|Adverse Event|10|||
144338331|NCT00545103|520441279|FG000|Overall Study|Lost to Follow-up|4|||
144338332|NCT00545103|520441280|FG001|Overall Study|Lost to Follow-up|6|||
144338333|NCT00545103|520441281|FG002|Overall Study|Lost to Follow-up|3|||
144338334|NCT00545103|520441282|FG003|Overall Study|Lost to Follow-up|4|||
144338335|NCT00545103|520441279|FG000|Overall Study|Protocol Violation|1|||
144338336|NCT00545103|520441280|FG001|Overall Study|Protocol Violation|2|||
144338337|NCT00545103|520441281|FG002|Overall Study|Protocol Violation|3|||
144338338|NCT00545103|520441282|FG003|Overall Study|Protocol Violation|0|||
144338339|NCT00545103|520441279|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
144338340|NCT00545103|520441280|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
144338341|NCT00545103|520441281|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
144338342|NCT00545103|520441282|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
144338343|NCT00545103|520441279|FG000|Overall Study|Difficult to open package|0|||
144338344|NCT00545103|520441280|FG001|Overall Study|Difficult to open package|0|||
144338345|NCT00545103|520441281|FG002|Overall Study|Difficult to open package|0|||
144338346|NCT00545103|520441282|FG003|Overall Study|Difficult to open package|1|||
144338347|NCT00545103|520441279|FG000|Overall Study|Investigational product not taken|1|||
144338348|NCT00545103|520441280|FG001|Overall Study|Investigational product not taken|0|||
144338349|NCT00545103|520441281|FG002|Overall Study|Investigational product not taken|0|||
144338350|NCT00545103|520441282|FG003|Overall Study|Investigational product not taken|1|||
144338351|NCT00545103|520441279|FG000|Overall Study|Wish to start a family|0|||
144338352|NCT00545103|520441280|FG001|Overall Study|Wish to start a family|0|||
144338353|NCT00545103|520441281|FG002|Overall Study|Wish to start a family|0|||
144338354|NCT00545103|520441282|FG003|Overall Study|Wish to start a family|1|||
144338355|NCT00545103|520441279|FG000|Overall Study|Diverticulitis crisis|0|||
144338356|NCT00545103|520441280|FG001|Overall Study|Diverticulitis crisis|0|||
144338357|NCT00545103|520441281|FG002|Overall Study|Diverticulitis crisis|0|||
144338358|NCT00545103|520441282|FG003|Overall Study|Diverticulitis crisis|1|||
144338359|NCT00545103|520441279|FG000|Overall Study|Personal reasons|1|||
144338360|NCT00545103|520441280|FG001|Overall Study|Personal reasons|0|||
144338361|NCT00545103|520441281|FG002|Overall Study|Personal reasons|0|||
144338362|NCT00545103|520441282|FG003|Overall Study|Personal reasons|0|||
144338363|NCT00545103|520441279|FG000|Overall Study|Subject's decision|1|||
144338364|NCT00545103|520441280|FG001|Overall Study|Subject's decision|0|||
144338365|NCT00545103|520441281|FG002|Overall Study|Subject's decision|0|||
144338366|NCT00545103|520441282|FG003|Overall Study|Subject's decision|0|||
144338367|NCT00545103|520441279|FG000|Overall Study|Noncompliance|0|||
144338368|NCT00545103|520441280|FG001|Overall Study|Noncompliance|1|||
144338369|NCT00545103|520441281|FG002|Overall Study|Noncompliance|0|||
144338370|NCT00545103|520441282|FG003|Overall Study|Noncompliance|0|||
144338371|NCT00545103|520441279|FG000|Overall Study|Investigator decision|0|||
144338372|NCT00545103|520441280|FG001|Overall Study|Investigator decision|0|||
144338373|NCT00545103|520441281|FG002|Overall Study|Investigator decision|1|||
144338374|NCT00545103|520441282|FG003|Overall Study|Investigator decision|0|||
144338375|NCT00545103|520441279|FG000|Overall Study|Subject moved|0|||
144338376|NCT00545103|520441280|FG001|Overall Study|Subject moved|1|||
144338377|NCT00545103|520441281|FG002|Overall Study|Subject moved|0|||
144338378|NCT00545103|520441282|FG003|Overall Study|Subject moved|0|||
144338379|NCT00545103|520441279|FG000|Overall Study|Use of prohibited medication|0|||
144338380|NCT00545103|520441280|FG001|Overall Study|Use of prohibited medication|0|||
144338381|NCT00545103|520441281|FG002|Overall Study|Use of prohibited medication|1|||
144338382|NCT00545103|520441282|FG003|Overall Study|Use of prohibited medication|0|||
144338383|NCT00545103|520441279|FG000|Overall Study|Does not want to take study drug anymore|1|||
144338384|NCT00545103|520441280|FG001|Overall Study|Does not want to take study drug anymore|0|||
144338385|NCT00545103|520441281|FG002|Overall Study|Does not want to take study drug anymore|1|||
144338386|NCT00545103|520441282|FG003|Overall Study|Does not want to take study drug anymore|0|||
144338387|NCT00545103|520441279|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
144338388|NCT00545103|520441280|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
144338389|NCT00545103|520441281|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
144338390|NCT00545103|520441282|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
144338391|NCT00545103|520441279|FG000|Overall Study|Death|0|||
144338392|NCT00545103|520441280|FG001|Overall Study|Death|1|||
144338393|NCT00545103|520441281|FG002|Overall Study|Death|0|||
144338394|NCT00545103|520441282|FG003|Overall Study|Death|0|||
144338395|NCT01353911|520441283|FG000|Overall Study|Lost to Follow-up|2|||
144338396|NCT01353911|520441284|FG001|Overall Study|Lost to Follow-up|6|||
144338397|NCT01353911|520441285|FG002|Overall Study|Lost to Follow-up|4|||
144338398|NCT01353911|520441286|FG003|Overall Study|Lost to Follow-up|0|||
144338399|NCT01353911|520441287|FG004|Overall Study|Lost to Follow-up|4|||
144338400|NCT01353911|520441288|FG005|Overall Study|Lost to Follow-up|4|||
144338401|NCT01353911|520441289|FG006|Overall Study|Lost to Follow-up|3|||
144338402|NCT01353911|520441290|FG007|Overall Study|Lost to Follow-up|6|||
144338403|NCT01353911|520441283|FG000|Overall Study|Withdrawal by Subject|2|||
144338404|NCT01353911|520441284|FG001|Overall Study|Withdrawal by Subject|3|||
144338405|NCT01353911|520441285|FG002|Overall Study|Withdrawal by Subject|4|||
144338406|NCT01353911|520441286|FG003|Overall Study|Withdrawal by Subject|2|||
144338407|NCT01353911|520441287|FG004|Overall Study|Withdrawal by Subject|2|||
144338408|NCT01353911|520441288|FG005|Overall Study|Withdrawal by Subject|3|||
144338409|NCT01353911|520441289|FG006|Overall Study|Withdrawal by Subject|3|||
144338410|NCT01353911|520441290|FG007|Overall Study|Withdrawal by Subject|9|||
144338411|NCT01353911|520441283|FG000|Overall Study|Status Not Recorded|4|||
144338412|NCT01353911|520441284|FG001|Overall Study|Status Not Recorded|0|||
144338413|NCT01353911|520441285|FG002|Overall Study|Status Not Recorded|1|||
144338414|NCT01353911|520441286|FG003|Overall Study|Status Not Recorded|0|||
144338415|NCT01353911|520441287|FG004|Overall Study|Status Not Recorded|0|||
144338416|NCT01353911|520441288|FG005|Overall Study|Status Not Recorded|0|||
144338417|NCT01353911|520441289|FG006|Overall Study|Status Not Recorded|0|||
144338418|NCT01353911|520441290|FG007|Overall Study|Status Not Recorded|0|||
144338419|NCT03831945|520441292|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
144338420|NCT03831945|520441293|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
144338421|NCT03831945|520441292|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
144338422|NCT03831945|520441293|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
144338423|NCT03831945|520441292|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
144338424|NCT03831945|520441293|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
144338425|NCT00295932|520441294|FG000|Overall Study|Not Treated|0|||
144338426|NCT00295932|520441295|FG001|Overall Study|Not Treated|0|||
144338427|NCT00295932|520441296|FG002|Overall Study|Not Treated|0|||
144338428|NCT00295932|520441297|FG003|Overall Study|Not Treated|0|||
144338429|NCT00295932|520441298|FG004|Overall Study|Not Treated|0|||
144338430|NCT00295932|520441299|FG005|Overall Study|Not Treated|0|||
144338431|NCT00295932|520441300|FG006|Overall Study|Not Treated|0|||
144338432|NCT00295932|520441301|FG007|Overall Study|Not Treated|0|||
144338433|NCT00295932|520441302|FG008|Overall Study|Not Treated|0|||
144338434|NCT00295932|520441303|FG009|Overall Study|Not Treated|0|||
144338435|NCT00295932|520441304|FG010|Overall Study|Not Treated|1|||
144338436|NCT00587847|520441305|FG000|Overall Study|Lack of Efficacy|5|||
144338437|NCT00587847|520441305|FG000|Overall Study|Adverse Event|2|||
144338438|NCT04032080|520441306|FG000|Overall Study|Death|6|||
144338439|NCT00884832|520441307|FG000|Overall Study|Withdrawal by Subject|0|||
144338440|NCT00884832|520441308|FG001|Overall Study|Withdrawal by Subject|1|||
144338441|NCT02337725|520441309|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
144338442|NCT02337725|520441310|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
144338443|NCT02337725|520441309|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
144338444|NCT02337725|520441310|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
144338445|NCT02337725|520441309|FG000|Overall Study|Major Protocol Deviation|0|||
144338446|NCT02337725|520441310|FG001|Overall Study|Major Protocol Deviation|1|||
144338447|NCT02337725|520441309|FG000|Overall Study|Voluntary Withdrawal|14|||
144338448|NCT02337725|520441310|FG001|Overall Study|Voluntary Withdrawal|3|||
144338449|NCT02337725|520441309|FG000|Overall Study|Lack of Efficacy|4|||
144338450|NCT02337725|520441310|FG001|Overall Study|Lack of Efficacy|0|||
144338451|NCT02096263|520441311|FG000|Overall Study|Adverse Event|1|||
144338452|NCT02096263|520441312|FG001|Overall Study|Adverse Event|0|||
144338453|NCT02096263|520441313|FG002|Overall Study|Adverse Event|1|||
144338454|NCT02096263|520441311|FG000|Overall Study|Lost to Follow-up|14|||
144338455|NCT02096263|520441312|FG001|Overall Study|Lost to Follow-up|18|||
144338456|NCT02096263|520441313|FG002|Overall Study|Lost to Follow-up|15|||
144338457|NCT02096263|520441311|FG000|Overall Study|Other|7|||
144338458|NCT02096263|520441312|FG001|Overall Study|Other|9|||
144338459|NCT02096263|520441313|FG002|Overall Study|Other|6|||
144338460|NCT02096263|520441311|FG000|Overall Study|Sponsor study termination|0|||
144338461|NCT02096263|520441312|FG001|Overall Study|Sponsor study termination|0|||
144338462|NCT02096263|520441313|FG002|Overall Study|Sponsor study termination|1|||
144338463|NCT02096263|520441311|FG000|Overall Study|Protocol Violation|7|||
144338464|NCT02096263|520441312|FG001|Overall Study|Protocol Violation|2|||
144338465|NCT02096263|520441313|FG002|Overall Study|Protocol Violation|8|||
144338466|NCT02096263|520441311|FG000|Overall Study|Withdrawal by Subject|5|||
144338467|NCT02096263|520441312|FG001|Overall Study|Withdrawal by Subject|7|||
144338468|NCT02096263|520441313|FG002|Overall Study|Withdrawal by Subject|8|||
144338469|NCT01270256|520441324|FG000|Overall Study|Withdrawal by Subject|1|||
144338470|NCT01270256|520441325|FG001|Overall Study|Withdrawal by Subject|0|||
144338471|NCT02177838|520441326|FG000|Overall Study|Withdrawal by Subject|1|||
144338472|NCT02177838|520441326|FG000|Overall Study|Physician Decision|1|||
144338473|NCT02177838|520441326|FG000|Overall Study|Death|1|||
144338474|NCT03517566|520441329|FG000|Overall Study|Adverse Event|5|||
144338475|NCT03517566|520441330|FG001|Overall Study|Adverse Event|2|||
144338476|NCT03517566|520441331|FG002|Overall Study|Adverse Event|2|||
144338477|NCT03517566|520441332|FG003|Overall Study|Adverse Event|8|||
144338478|NCT03517566|520441333|FG004|Overall Study|Adverse Event|7|||
144338479|NCT03517566|520441329|FG000|Overall Study|Lack of Efficacy|3|||
144338480|NCT03517566|520441330|FG001|Overall Study|Lack of Efficacy|2|||
144338481|NCT03517566|520441331|FG002|Overall Study|Lack of Efficacy|1|||
144338482|NCT03517566|520441332|FG003|Overall Study|Lack of Efficacy|1|||
144338483|NCT03517566|520441333|FG004|Overall Study|Lack of Efficacy|4|||
144338484|NCT03517566|520441329|FG000|Overall Study|Lost to Follow-up|3|||
144338485|NCT03517566|520441330|FG001|Overall Study|Lost to Follow-up|1|||
144338486|NCT03517566|520441331|FG002|Overall Study|Lost to Follow-up|1|||
144338487|NCT03517566|520441332|FG003|Overall Study|Lost to Follow-up|1|||
144338488|NCT03517566|520441333|FG004|Overall Study|Lost to Follow-up|0|||
144338489|NCT03517566|520441329|FG000|Overall Study|Physician Decision|1|||
144338490|NCT03517566|520441330|FG001|Overall Study|Physician Decision|1|||
144338491|NCT03517566|520441331|FG002|Overall Study|Physician Decision|0|||
144338492|NCT03517566|520441332|FG003|Overall Study|Physician Decision|1|||
144338493|NCT03517566|520441333|FG004|Overall Study|Physician Decision|0|||
144338494|NCT03517566|520441329|FG000|Overall Study|Pregnancy|0|||
144338495|NCT03517566|520441330|FG001|Overall Study|Pregnancy|1|||
144338496|NCT03517566|520441331|FG002|Overall Study|Pregnancy|0|||
144338497|NCT03517566|520441332|FG003|Overall Study|Pregnancy|0|||
144338498|NCT03517566|520441333|FG004|Overall Study|Pregnancy|0|||
144338499|NCT03517566|520441329|FG000|Overall Study|Protocol Deviation|0|||
144338500|NCT03517566|520441330|FG001|Overall Study|Protocol Deviation|1|||
144338501|NCT03517566|520441331|FG002|Overall Study|Protocol Deviation|0|||
144338502|NCT03517566|520441332|FG003|Overall Study|Protocol Deviation|1|||
144338503|NCT03517566|520441333|FG004|Overall Study|Protocol Deviation|1|||
144338504|NCT03517566|520441329|FG000|Overall Study|Study terminated by Sponsor|11|||
144338505|NCT03517566|520441330|FG001|Overall Study|Study terminated by Sponsor|5|||
144338506|NCT03517566|520441331|FG002|Overall Study|Study terminated by Sponsor|6|||
144338507|NCT03517566|520441332|FG003|Overall Study|Study terminated by Sponsor|14|||
144338508|NCT03517566|520441333|FG004|Overall Study|Study terminated by Sponsor|12|||
144338509|NCT03517566|520441329|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
144338510|NCT03517566|520441330|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
144338511|NCT03517566|520441331|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
144338512|NCT03517566|520441332|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
144338513|NCT03517566|520441333|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
144338514|NCT03109184|520443321|FG000|Overall Study|Lost to Follow-up|6|||
144338515|NCT03109184|520443322|FG001|Overall Study|Lost to Follow-up|6|||
144338516|NCT03109184|520443321|FG000|Overall Study|Withdrawal by Subject|1|||
144338517|NCT03109184|520443322|FG001|Overall Study|Withdrawal by Subject|1|||
144338518|NCT00602420|520443323|FG000|Overall Study|Death|1|||
144338519|NCT00602420|520443324|FG001|Overall Study|Death|4|||
144338520|NCT00602420|520443323|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
144338521|NCT00602420|520443324|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
144338522|NCT00602420|520443323|FG000|Overall Study|Withdrawal by Subject|18|||
144338523|NCT00602420|520443324|FG001|Overall Study|Withdrawal by Subject|17|||
144338524|NCT00602420|520443323|FG000|Overall Study|Adverse Event|1|||
144338525|NCT00602420|520443324|FG001|Overall Study|Adverse Event|0|||
144338526|NCT01209078|520443327|FG000|Overall Study|Adverse Event|5|||
144338527|NCT01209078|520443328|FG001|Overall Study|Adverse Event|0|||
144338528|NCT01209078|520443327|FG000|Overall Study|Lost to Follow-up|4|||
144338529|NCT01209078|520443328|FG001|Overall Study|Lost to Follow-up|0|||
144338530|NCT01209078|520443327|FG000|Overall Study|Physician Decision|5|||
144338531|NCT01209078|520443328|FG001|Overall Study|Physician Decision|2|||
144338532|NCT01209078|520443327|FG000|Overall Study|Withdrawal by Subject|2|||
144338533|NCT01209078|520443328|FG001|Overall Study|Withdrawal by Subject|1|||
144338534|NCT00924508|520443329|FG000|Overall Study|Withdrawal by Subject|3|||
144338535|NCT00704288|520443330|FG000|Overall Treatment Period|Adverse Event|11|||
144338536|NCT00704288|520443331|FG001|Overall Treatment Period|Adverse Event|8|||
144338537|NCT00704288|520443332|FG002|Overall Treatment Period|Adverse Event|22|||
144338538|NCT00704288|520443330|FG000|Overall Treatment Period|Death|0|||
144338539|NCT00704288|520443331|FG001|Overall Treatment Period|Death|0|||
144338540|NCT00704288|520443332|FG002|Overall Treatment Period|Death|1|||
144338541|NCT00704288|520443330|FG000|Overall Treatment Period|Physician Decision|0|||
144338542|NCT00704288|520443331|FG001|Overall Treatment Period|Physician Decision|2|||
144338543|NCT00704288|520443332|FG002|Overall Treatment Period|Physician Decision|0|||
144338544|NCT00704288|520443330|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
144338545|NCT00704288|520443331|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
144338546|NCT00704288|520443332|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
144338547|NCT00704288|520443330|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
144338548|NCT00704288|520443331|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
144338549|NCT00704288|520443332|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
144338550|NCT00704288|520443330|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
144338551|NCT00704288|520443331|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
144338552|NCT00704288|520443332|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
144338553|NCT00704288|520443330|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
144338554|NCT00704288|520443331|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
144338555|NCT00704288|520443332|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
144338556|NCT00704288|520443330|FG000|Overall Treatment Period|Roll-over to another study|1|||
144338557|NCT00704288|520443331|FG001|Overall Treatment Period|Roll-over to another study|0|||
144338558|NCT00704288|520443332|FG002|Overall Treatment Period|Roll-over to another study|4|||
144338559|NCT00704288|520443330|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
144338560|NCT00704288|520443331|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
144338561|NCT00704288|520443332|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
144338562|NCT00704288|520443330|FG000|Extended Post Treatment Follow Up Period|Death|41|||
144338563|NCT00704288|520443331|FG001|Extended Post Treatment Follow Up Period|Death|50|||
144338564|NCT00704288|520443332|FG002|Extended Post Treatment Follow Up Period|Death|93|||
144338565|NCT00704288|520443330|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
144338566|NCT00704288|520443331|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
144338567|NCT00704288|520443332|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
144338568|NCT00704288|520443330|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
144338569|NCT00704288|520443331|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
144338570|NCT00704288|520443332|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
144338571|NCT00704288|520443330|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
144338572|NCT00704288|520443331|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
144338573|NCT00704288|520443332|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
144338574|NCT01055314|520443333|FG000|Overall Study|Adverse Event|7|||
144338575|NCT01055314|520443334|FG001|Overall Study|Adverse Event|4|||
144338576|NCT01055314|520443333|FG000|Overall Study|Death|2|||
144338577|NCT01055314|520443334|FG001|Overall Study|Death|1|||
144338578|NCT01055314|520443333|FG000|Overall Study|Lack of Efficacy|11|||
144338579|NCT01055314|520443334|FG001|Overall Study|Lack of Efficacy|19|||
144338580|NCT01055314|520443333|FG000|Overall Study|Physician Decision|10|||
144338581|NCT01055314|520443334|FG001|Overall Study|Physician Decision|5|||
144338582|NCT01055314|520443333|FG000|Overall Study|Withdrawal by Subject|1|||
144338583|NCT01055314|520443334|FG001|Overall Study|Withdrawal by Subject|0|||
144338584|NCT01055314|520443333|FG000|Overall Study|Ineligible|3|||
144338585|NCT01055314|520443334|FG001|Overall Study|Ineligible|5|||
144338586|NCT01055314|520443333|FG000|Overall Study|Refusal of further protocol therapy|10|||
144338587|NCT01055314|520443334|FG001|Overall Study|Refusal of further protocol therapy|4|||
144338588|NCT01055314|520443333|FG000|Overall Study|No treatment|1|||
144338589|NCT01055314|520443334|FG001|Overall Study|No treatment|0|||
144338590|NCT00568126|520443335|FG000|Overall Study|Adverse Event|3|||
144338591|NCT00568126|520443336|FG001|Overall Study|Adverse Event|0|||
144338592|NCT00568126|520443335|FG000|Overall Study|Withdrawal by Subject|2|||
144338593|NCT00568126|520443336|FG001|Overall Study|Withdrawal by Subject|3|||
144338594|NCT00568126|520443335|FG000|Overall Study|Lost to Follow-up|4|||
144338595|NCT00568126|520443336|FG001|Overall Study|Lost to Follow-up|3|||
144338596|NCT00568126|520443335|FG000|Overall Study|Lack of Efficacy|0|||
144338597|NCT00568126|520443336|FG001|Overall Study|Lack of Efficacy|1|||
144338598|NCT00568126|520443335|FG000|Overall Study|Physician Decision|2|||
144338599|NCT00568126|520443336|FG001|Overall Study|Physician Decision|2|||
144338600|NCT04512976|520443337|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
144338601|NCT04512976|520443338|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
144338602|NCT04512976|520443339|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
144338603|NCT04512976|520443340|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
144338604|NCT04512976|520443341|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
144338605|NCT04512976|520443342|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
144338606|NCT02702414|520443345|FG000|Overall Study|Death|96|||
144338607|NCT02702414|520443346|FG001|Overall Study|Death|42|||
144338608|NCT02702414|520443345|FG000|Overall Study|Lost to Follow-up|0|||
144338609|NCT02702414|520443346|FG001|Overall Study|Lost to Follow-up|1|||
144338610|NCT02702414|520443345|FG000|Overall Study|Withdrawal by Subject|0|||
144338611|NCT02702414|520443346|FG001|Overall Study|Withdrawal by Subject|1|||
144338612|NCT02702414|520443345|FG000|Overall Study|Protocol Violation|1|||
144338613|NCT02702414|520443346|FG001|Overall Study|Protocol Violation|0|||
144338614|NCT02702414|520443345|FG000|Overall Study|Sponsor Decision|8|||
144338615|NCT02702414|520443346|FG001|Overall Study|Sponsor Decision|7|||
144338616|NCT04541628|520443347|FG000|Overall Study|Study Terminated|1|||
144338617|NCT04541628|520443348|FG001|Overall Study|Study Terminated|1|||
144338618|NCT04541628|520443349|FG002|Overall Study|Study Terminated|1|||
144338619|NCT01359943|520443354|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
144338620|NCT01359943|520443355|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
144338621|NCT01359943|520443356|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
144338622|NCT01359943|520443354|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
144338623|NCT01359943|520443355|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
144338624|NCT01359943|520443356|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
144338625|NCT01359943|520443354|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
144338626|NCT01359943|520443355|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
144338627|NCT01359943|520443356|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
144338628|NCT01359943|520443354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
144338629|NCT01359943|520443355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
144338630|NCT01359943|520443356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
144338631|NCT01359943|520443354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
144338632|NCT01359943|520443355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
144338633|NCT01359943|520443356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
144338634|NCT01359943|520443354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
144338635|NCT01359943|520443355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
144338636|NCT01359943|520443356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
144338637|NCT01359943|520443354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
144338638|NCT01359943|520443355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
144338639|NCT01359943|520443356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
144338640|NCT01359943|520443354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
144338641|NCT01359943|520443355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
144338642|NCT01359943|520443356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
144338643|NCT01359943|520443354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
144338644|NCT01359943|520443355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
144338645|NCT01359943|520443356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
144338646|NCT01359943|520443354|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
144338647|NCT01359943|520443355|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
144338648|NCT01359943|520443356|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
144338649|NCT01359943|520443354|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
144338650|NCT01359943|520443355|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
144338651|NCT01359943|520443356|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
144338652|NCT01359943|520443354|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
144338653|NCT01359943|520443355|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
144338654|NCT01359943|520443356|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
144338655|NCT01359943|520443354|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
144338656|NCT01359943|520443355|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
144338657|NCT01359943|520443356|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
144338658|NCT01359943|520443354|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
144338659|NCT01359943|520443355|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
144338660|NCT01359943|520443356|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
144338661|NCT01359943|520443354|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
144338662|NCT01359943|520443355|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
144338663|NCT01359943|520443356|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
144338664|NCT04369950|520443367|FG000|Overall Study|Protocol Violation|2|||
144338665|NCT04369950|520443368|FG001|Overall Study|Protocol Violation|2|||
144338666|NCT00989963|520443369|FG000|Overall Study|Adverse Event|1|||
144338667|NCT00989963|520443370|FG001|Overall Study|Adverse Event|1|||
144338668|NCT00989963|520443371|FG002|Overall Study|Adverse Event|1|||
144338669|NCT01529034|520443380|FG000|Overall Study|Discontinued prior to study treatment|14|||
144338670|NCT01529034|520443380|FG000|Overall Study|Site closure|62|||
144338671|NCT01529034|520443380|FG000|Overall Study|Study termination|29|||
144338672|NCT01529034|520443380|FG000|Overall Study|Withdrawal by Subject|25|||
144338673|NCT01529034|520443380|FG000|Overall Study|No treated SCs within protocol window|13|||
144338674|NCT01529034|520443380|FG000|Overall Study|Noncompliance|8|||
144338675|NCT01529034|520443380|FG000|Overall Study|Caregiver no longer available|7|||
144338676|NCT01529034|520443380|FG000|Overall Study|Adverse Event|4|||
144338677|NCT01529034|520443380|FG000|Overall Study|Protocol Violation|4|||
144338678|NCT01529034|520443380|FG000|Overall Study|Lack of Efficacy|4|||
144338679|NCT01529034|520443380|FG000|Overall Study|Investigator no longer available|2|||
144338680|NCT01529034|520443380|FG000|Overall Study|Study drug not available|2|||
144338681|NCT02649894|520443381|FG000|Overall Study|Adverse Event|1|||
144338682|NCT02649894|520443382|FG001|Overall Study|Adverse Event|0|||
144338683|NCT02649894|520443381|FG000|Overall Study|Physician Decision|0|||
144338684|NCT02649894|520443382|FG001|Overall Study|Physician Decision|1|||
144338685|NCT02649894|520443381|FG000|Overall Study|Withdrawal by Subject|5|||
144338686|NCT02649894|520443382|FG001|Overall Study|Withdrawal by Subject|2|||
144338687|NCT02649894|520443381|FG000|Overall Study|Lost to Follow-up|2|||
144338688|NCT02649894|520443382|FG001|Overall Study|Lost to Follow-up|1|||
144338689|NCT02649894|520443381|FG000|Overall Study|Death|30|||
144338690|NCT02649894|520443382|FG001|Overall Study|Death|7|||
144338691|NCT02649894|520443381|FG000|Overall Study|Other, not specified|6|||
144338692|NCT02649894|520443382|FG001|Overall Study|Other, not specified|0|||
144338693|NCT01554514|520443385|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
144338694|NCT01554514|520443385|FG000|Overall Study|Physician Decision|1|||
144338695|NCT01423916|520443386|FG000|Overall Study|Adverse Event|5|||
144338696|NCT01423916|520443387|FG001|Overall Study|Adverse Event|9|||
144338697|NCT01423916|520443388|FG002|Overall Study|Adverse Event|2|||
144338698|NCT01423916|520443386|FG000|Overall Study|Met Withdrawal Criteria|1|||
144338699|NCT01423916|520443387|FG001|Overall Study|Met Withdrawal Criteria|1|||
144338700|NCT01423916|520443388|FG002|Overall Study|Met Withdrawal Criteria|1|||
144338701|NCT01423916|520443386|FG000|Overall Study|Physician Decision|1|||
144338702|NCT01423916|520443387|FG001|Overall Study|Physician Decision|0|||
144338703|NCT01423916|520443388|FG002|Overall Study|Physician Decision|1|||
144338704|NCT01423916|520443386|FG000|Overall Study|Withdrawal by Subject|3|||
144338705|NCT01423916|520443387|FG001|Overall Study|Withdrawal by Subject|10|||
144338706|NCT01423916|520443388|FG002|Overall Study|Withdrawal by Subject|3|||
144338707|NCT01423916|520443386|FG000|Overall Study|Protocol Deviation|1|||
144338708|NCT01423916|520443387|FG001|Overall Study|Protocol Deviation|0|||
144338709|NCT01423916|520443388|FG002|Overall Study|Protocol Deviation|0|||
144338710|NCT00847015|520443391|FG000|Overall Study|Withdrawal by Subject|1|||
144338711|NCT00847015|520443391|FG000|Overall Study|declined any surgery|1|||
144338712|NCT00847015|520443391|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
144338713|NCT01953913|520443392|FG000|Overall Study|Disease Progression|349|||
144338714|NCT01953913|520443392|FG000|Overall Study|Worsening of underlying cancer|22|||
144338715|NCT01953913|520443392|FG000|Overall Study|Adverse Event|20|||
144338716|NCT01953913|520443392|FG000|Overall Study|Protocol Violation|6|||
144338717|NCT01953913|520443392|FG000|Overall Study|Lost to Follow-up|4|||
144338718|NCT01953913|520443392|FG000|Overall Study|Withdrawal by Subject|32|||
144338719|NCT01953913|520443392|FG000|Overall Study|Other than listed|108|||
144338720|NCT01953913|520443392|FG000|Overall Study|Not Treated|1|||
144338721|NCT05026853|520443393|FG000|Overall Study|Cancelled appointment|1|||
144338722|NCT05026853|520443394|FG001|Overall Study|Cancelled appointment|0|||
144338723|NCT05026853|520443393|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
144338724|NCT05026853|520443394|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
144338725|NCT05026853|520443393|FG000|Overall Study|Did not complete 12-week survey|16|||
144338726|NCT05026853|520443394|FG001|Overall Study|Did not complete 12-week survey|16|||
144338727|NCT03836677|520443395|FG000|Period 1|Adverse Event|0|||
144338728|NCT03836677|520443396|FG001|Period 1|Adverse Event|1|||
144338729|NCT03836677|520443395|FG000|Period 2|Severe non-compliance to protocol|1|||
144338730|NCT03836677|520443396|FG001|Period 2|Severe non-compliance to protocol|0|||
144338731|NCT02895945|520443397|FG000|Overall Study|Physician Decision|2|||
144338732|NCT02895945|520443398|FG001|Overall Study|Physician Decision|1|||
144338733|NCT01732913|520443399|FG000|Overall Study|Study Terminated by Sponsor|105|||
144338734|NCT01732913|520443400|FG001|Overall Study|Study Terminated by Sponsor|55|||
144338735|NCT01732913|520443399|FG000|Overall Study|Withdrawal by Subject|27|||
144338736|NCT01732913|520443400|FG001|Overall Study|Withdrawal by Subject|4|||
144338737|NCT01732913|520443399|FG000|Overall Study|Physician Decision|14|||
144338738|NCT01732913|520443400|FG001|Overall Study|Physician Decision|7|||
144338739|NCT01732913|520443399|FG000|Overall Study|Other|7|||
144338740|NCT01732913|520443400|FG001|Overall Study|Other|1|||
144338741|NCT01732913|520443399|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
144338742|NCT01732913|520443400|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
144338743|NCT03233438|520443405|FG000|Overall Study|Lost to Follow-up|4|||
144338744|NCT03233438|520443406|FG001|Overall Study|Lost to Follow-up|9|||
144338745|NCT03233438|520443405|FG000|Overall Study|Withdrawal by Subject|2|||
144338746|NCT03233438|520443406|FG001|Overall Study|Withdrawal by Subject|1|||
144338747|NCT03233438|520443405|FG000|Overall Study|No recording of dalbavancin|0|||
144338748|NCT03233438|520443406|FG001|Overall Study|No recording of dalbavancin|1|||
144338749|NCT03429543|520443407|FG000|Overall Study|Adverse Event|1|||
144338750|NCT03429543|520443408|FG001|Overall Study|Adverse Event|1|||
144338751|NCT03429543|520443409|FG002|Overall Study|Adverse Event|0|||
144338752|NCT03429543|520443410|FG003|Overall Study|Adverse Event|0|||
144338753|NCT03429543|520443411|FG004|Overall Study|Adverse Event|0|||
144338754|NCT03429543|520443412|FG005|Overall Study|Adverse Event|2|||
144338755|NCT03429543|520443413|FG006|Overall Study|Adverse Event|0|||
144338756|NCT03429543|520443407|FG000|Overall Study|Lost to Follow-up|1|||
144338757|NCT03429543|520443408|FG001|Overall Study|Lost to Follow-up|0|||
144338758|NCT03429543|520443409|FG002|Overall Study|Lost to Follow-up|0|||
144338759|NCT03429543|520443410|FG003|Overall Study|Lost to Follow-up|0|||
144338760|NCT03429543|520443411|FG004|Overall Study|Lost to Follow-up|1|||
144338761|NCT03429543|520443412|FG005|Overall Study|Lost to Follow-up|0|||
144338762|NCT03429543|520443413|FG006|Overall Study|Lost to Follow-up|0|||
144338763|NCT03429543|520443407|FG000|Overall Study|Withdrawal by Subject|5|||
144338764|NCT03429543|520443408|FG001|Overall Study|Withdrawal by Subject|0|||
144338765|NCT03429543|520443409|FG002|Overall Study|Withdrawal by Subject|1|||
144338766|NCT03429543|520443410|FG003|Overall Study|Withdrawal by Subject|2|||
144338767|NCT03429543|520443411|FG004|Overall Study|Withdrawal by Subject|6|||
144338768|NCT03429543|520443412|FG005|Overall Study|Withdrawal by Subject|3|||
144338769|NCT03429543|520443413|FG006|Overall Study|Withdrawal by Subject|1|||
144338770|NCT03429543|520443407|FG000|Overall Study|Other reason than listed|0|||
144338771|NCT03429543|520443408|FG001|Overall Study|Other reason than listed|1|||
144338772|NCT03429543|520443409|FG002|Overall Study|Other reason than listed|0|||
144338773|NCT03429543|520443410|FG003|Overall Study|Other reason than listed|0|||
144338774|NCT03429543|520443411|FG004|Overall Study|Other reason than listed|4|||
144338775|NCT03429543|520443412|FG005|Overall Study|Other reason than listed|4|||
144338776|NCT03429543|520443413|FG006|Overall Study|Other reason than listed|0|||
144338777|NCT03429543|520443407|FG000|Overall Study|Not treated|0|||
144338778|NCT03429543|520443408|FG001|Overall Study|Not treated|0|||
144338779|NCT03429543|520443409|FG002|Overall Study|Not treated|0|||
144338780|NCT03429543|520443410|FG003|Overall Study|Not treated|0|||
144338781|NCT03429543|520443411|FG004|Overall Study|Not treated|1|||
144338782|NCT03429543|520443412|FG005|Overall Study|Not treated|0|||
144338783|NCT03429543|520443413|FG006|Overall Study|Not treated|0|||
144338784|NCT01818492|520443414|FG000|Overall Study|Adverse Event|2|||
144338785|NCT01818492|520443414|FG000|Overall Study|Death|3|||
144338786|NCT01818492|520443414|FG000|Overall Study|Withdrawal by Subject|1|||
144338787|NCT01818492|520443414|FG000|Overall Study|Additional therapy when not allowed PP|4|||
144338788|NCT02345330|520443415|FG000|Overall Study|Death|1|||
144338789|NCT02345330|520443415|FG000|Overall Study|Progressive Disease|2|||
144338790|NCT03178669|520443419|FG000|Overall Study|Adverse Event|4|||
144338791|NCT03178669|520443420|FG001|Overall Study|Adverse Event|1|||
144338792|NCT03178669|520443421|FG002|Overall Study|Adverse Event|4|||
144338793|NCT03178669|520443422|FG003|Overall Study|Adverse Event|2|||
144338794|NCT03178669|520443423|FG004|Overall Study|Adverse Event|2|||
144338795|NCT03178669|520443419|FG000|Overall Study|Lack of Efficacy|0|||
144338796|NCT03178669|520443420|FG001|Overall Study|Lack of Efficacy|0|||
144338797|NCT03178669|520443421|FG002|Overall Study|Lack of Efficacy|2|||
144338798|NCT03178669|520443422|FG003|Overall Study|Lack of Efficacy|0|||
144338799|NCT03178669|520443423|FG004|Overall Study|Lack of Efficacy|1|||
144338800|NCT03178669|520443419|FG000|Overall Study|Physician Decision|0|||
144338801|NCT03178669|520443420|FG001|Overall Study|Physician Decision|0|||
144338802|NCT03178669|520443421|FG002|Overall Study|Physician Decision|0|||
144338803|NCT03178669|520443422|FG003|Overall Study|Physician Decision|0|||
144338804|NCT03178669|520443423|FG004|Overall Study|Physician Decision|1|||
144338805|NCT03178669|520443419|FG000|Overall Study|Withdrawal by Subject|1|||
144338806|NCT03178669|520443420|FG001|Overall Study|Withdrawal by Subject|0|||
144338807|NCT03178669|520443421|FG002|Overall Study|Withdrawal by Subject|1|||
144338808|NCT03178669|520443422|FG003|Overall Study|Withdrawal by Subject|1|||
144338809|NCT03178669|520443423|FG004|Overall Study|Withdrawal by Subject|0|||
144338810|NCT03178669|520443419|FG000|Overall Study|Lost to Follow-up|0|||
144338811|NCT03178669|520443420|FG001|Overall Study|Lost to Follow-up|0|||
144338812|NCT03178669|520443421|FG002|Overall Study|Lost to Follow-up|0|||
144338813|NCT03178669|520443422|FG003|Overall Study|Lost to Follow-up|1|||
144338814|NCT03178669|520443423|FG004|Overall Study|Lost to Follow-up|0|||
144338815|NCT01600092|520443424|FG000|Overall Study|Adverse Event|2|||
144338816|NCT01600092|520443425|FG001|Overall Study|Adverse Event|0|||
144338817|NCT01600092|520443424|FG000|Overall Study|Lost to Follow-up|4|||
144338818|NCT01600092|520443425|FG001|Overall Study|Lost to Follow-up|6|||
144338819|NCT01600092|520443424|FG000|Overall Study|Withdrawal by parent/guardian|8|||
144338820|NCT01600092|520443425|FG001|Overall Study|Withdrawal by parent/guardian|6|||
144338821|NCT01600092|520443424|FG000|Overall Study|Physician Decision|1|||
144338822|NCT01600092|520443425|FG001|Overall Study|Physician Decision|1|||
144338823|NCT01600092|520443424|FG000|Overall Study|Randomized but not vaccinated|3|||
144338824|NCT01600092|520443425|FG001|Overall Study|Randomized but not vaccinated|3|||
144338825|NCT02976103|520443427|FG000|Overall Study|Withdrawal by Subject|1|||
144338826|NCT02976103|520443428|FG001|Overall Study|Withdrawal by Subject|0|||
144338827|NCT02976103|520443427|FG000|Overall Study|Lost to Follow-up|12|||
144338828|NCT02976103|520443428|FG001|Overall Study|Lost to Follow-up|8|||
144338829|NCT00565136|520443429|FG000|Overall Study|Lost to Follow-up|1|||
144338830|NCT00565136|520443429|FG000|Overall Study|Withdrawal by Subject|1|||
144338831|NCT00565136|520443429|FG000|Overall Study|Protocol Violation|1|||
144338832|NCT02438813|520443438|FG000|Overall Study|Patient Decision|59|||
144338833|NCT02438813|520443438|FG000|Overall Study|Patient Lost to Follow-Up|137|||
144338834|NCT02438813|520443438|FG000|Overall Study|Study Ended by Sponsor|80|||
144338835|NCT02438813|520443438|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
144338836|NCT00694304|520443439|FG000|Overall Study|Adverse Event|42|||
144338837|NCT00694304|520443439|FG000|Overall Study|Lack of Efficacy|35|||
144338838|NCT00694304|520443439|FG000|Overall Study|Non-compliance With Study Product|16|||
144338839|NCT00694304|520443439|FG000|Overall Study|Protocol Violation|6|||
144338840|NCT00694304|520443439|FG000|Overall Study|Withdrawal of Consent|61|||
144338841|NCT00694304|520443439|FG000|Overall Study|Lost to Follow-up|15|||
144338842|NCT00694304|520443439|FG000|Overall Study|Administrative or Other Reasons|32|||
144338843|NCT00576576|520443442|FG000|Overall Study|Lost to Follow-up|6|||
144338844|NCT00576576|520443442|FG000|Overall Study|Protocol Violation|1|||
144338845|NCT03135210|520443443|FG000|Overall Study|Death|0|||
144338846|NCT03135210|520443444|FG001|Overall Study|Death|1|||
144338847|NCT01805037|520443445|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
144338848|NCT01805037|520443446|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
144338849|NCT01805037|520443445|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
144338850|NCT01805037|520443446|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
144338851|NCT01805037|520443445|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
144338852|NCT01805037|520443446|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
144338853|NCT01805037|520443445|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
144338854|NCT01805037|520443446|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
144338855|NCT01805037|520443445|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
144338856|NCT01805037|520443446|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
144338857|NCT01805037|520443445|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
144338858|NCT01805037|520443446|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
144338859|NCT01805037|520443445|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
144338860|NCT01805037|520443446|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
144338861|NCT01805037|520443445|FG000|Follow Up (up to 3 Years)|Death|0|||
144338862|NCT01805037|520443446|FG001|Follow Up (up to 3 Years)|Death|2|||
144338863|NCT01805037|520443445|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
144338864|NCT01805037|520443446|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
144338865|NCT01805037|520443445|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
144338866|NCT01805037|520443446|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
144338867|NCT04566692|520443447|FG000|Overall Study|Adverse Event|2|||
144338868|NCT04566692|520443448|FG001|Overall Study|Adverse Event|0|||
144338869|NCT04566692|520443447|FG000|Overall Study|Withdrawal by Subject|1|||
144338870|NCT04566692|520443448|FG001|Overall Study|Withdrawal by Subject|1|||
144338871|NCT00671437|520443449|FG000|Overall Study|Progressive disease before C1 week 8|8|||
144338872|NCT00671437|520443449|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
144338873|NCT00671437|520443449|FG000|Overall Study|Adverse Event|3|||
144338874|NCT00671437|520443449|FG000|Overall Study|Ineligible post-hoc|1|||
144338875|NCT03927404|520443450|FG000|Overall Study|Withdrawal by Subject|1|||
144338876|NCT01229449|520443451|FG000|Overall Study|Withdrawal by Subject|0|||
144338877|NCT01229449|520443452|FG001|Overall Study|Withdrawal by Subject|3|||
144338878|NCT01229449|520443453|FG002|Overall Study|Withdrawal by Subject|0|||
144338879|NCT01229449|520443454|FG003|Overall Study|Withdrawal by Subject|1|||
144338880|NCT01229449|520443455|FG004|Overall Study|Withdrawal by Subject|1|||
144338881|NCT01229449|520443451|FG000|Overall Study|Lost to Follow-up|1|||
144338882|NCT01229449|520443452|FG001|Overall Study|Lost to Follow-up|1|||
144338883|NCT01229449|520443453|FG002|Overall Study|Lost to Follow-up|1|||
144338884|NCT01229449|520443454|FG003|Overall Study|Lost to Follow-up|0|||
144338885|NCT01229449|520443455|FG004|Overall Study|Lost to Follow-up|0|||
144338886|NCT01229449|520443451|FG000|Overall Study|Physician Decision|0|||
144338887|NCT01229449|520443452|FG001|Overall Study|Physician Decision|0|||
144338888|NCT01229449|520443453|FG002|Overall Study|Physician Decision|1|||
144338889|NCT01229449|520443454|FG003|Overall Study|Physician Decision|0|||
144338890|NCT01229449|520443455|FG004|Overall Study|Physician Decision|0|||
144338891|NCT03203291|520443458|FG000|Overall Study|Withdrawal by Subject|1|||
144338892|NCT04033068|520443459|FG000|Overall Study|Withdrawal by Subject|0|||
144338893|NCT04033068|520443460|FG001|Overall Study|Withdrawal by Subject|0|||
144338894|NCT04033068|520443461|FG002|Overall Study|Withdrawal by Subject|1|||
144338895|NCT04033068|520443462|FG003|Overall Study|Withdrawal by Subject|0|||
144338896|NCT04033068|520443459|FG000|Overall Study|Lost to Follow-up|0|||
144338897|NCT04033068|520443460|FG001|Overall Study|Lost to Follow-up|1|||
144338898|NCT04033068|520443461|FG002|Overall Study|Lost to Follow-up|0|||
144338899|NCT04033068|520443462|FG003|Overall Study|Lost to Follow-up|0|||
144338900|NCT04033068|520443459|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
144338901|NCT04033068|520443460|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
144338902|NCT04033068|520443461|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
144338903|NCT04033068|520443462|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
144338904|NCT02540265|520443466|FG000|Overall Study|Lost to Follow-up|0|||
144338905|NCT02540265|520443467|FG001|Overall Study|Lost to Follow-up|0|||
144338906|NCT02540265|520443468|FG002|Overall Study|Lost to Follow-up|1|||
144338907|NCT00324233|520443469|FG000|First Period|unable to insert catheter|1|||
144338908|NCT00324233|520443470|FG001|First Period|unable to insert catheter|0|||
144338909|NCT00324233|520443469|FG000|Second Period|unable to insert catheter|1|||
144338910|NCT00324233|520443470|FG001|Second Period|unable to insert catheter|1|||
144338911|NCT00324233|520443469|FG000|Second Period|Protocol Violation|4|||
144338912|NCT00324233|520443470|FG001|Second Period|Protocol Violation|6|||
144338913|NCT01704456|520443475|FG000|Overall Study|Lost to Follow-up|8|||
144338914|NCT01704456|520443476|FG001|Overall Study|Lost to Follow-up|14|||
144338915|NCT00498355|520443477|FG000|Overall Study|Lost to Follow-up|1|||
144338916|NCT00410605|520443478|FG000|Overall Study|Adverse Event|12|||
144338917|NCT00410605|520443478|FG000|Overall Study|Physician Decision|3|||
144338918|NCT00410605|520443478|FG000|Overall Study|Withdrawal by Subject|5|||
144338919|NCT00410605|520443478|FG000|Overall Study|Started Non-Protocol Therapy|3|||
144338920|NCT00410605|520443478|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
144338921|NCT00410605|520443478|FG000|Overall Study|Transferred to another Institution|1|||
144338922|NCT04583956|520443479|FG000|Overall Study|Death|9|||
144338923|NCT04583956|520443480|FG001|Overall Study|Death|11|||
144338924|NCT04583956|520443479|FG000|Overall Study|Lost to Follow-up|7|||
144338925|NCT04583956|520443480|FG001|Overall Study|Lost to Follow-up|9|||
144338926|NCT04583956|520443479|FG000|Overall Study|Protocol Violation|2|||
144338927|NCT04583956|520443480|FG001|Overall Study|Protocol Violation|0|||
144338928|NCT04583956|520443479|FG000|Overall Study|Withdrawal by Subject|0|||
144338929|NCT04583956|520443480|FG001|Overall Study|Withdrawal by Subject|2|||
144338930|NCT04583956|520443479|FG000|Overall Study|Randomized but not dosed|2|||
144338931|NCT04583956|520443480|FG001|Overall Study|Randomized but not dosed|3|||
144338932|NCT04583956|520443479|FG000|Overall Study|Withdrawal of consent before product administration|1|||
144338933|NCT04583956|520443480|FG001|Overall Study|Withdrawal of consent before product administration|0|||
144338934|NCT00649428|520444821|FG000|Overall Study|Adverse Event|2|||
144338935|NCT00649428|520444822|FG001|Overall Study|Adverse Event|2|||
144338936|NCT00649428|520444821|FG000|Overall Study|Withdrawal by Subject|6|||
144338937|NCT00649428|520444822|FG001|Overall Study|Withdrawal by Subject|6|||
144338938|NCT00649428|520444821|FG000|Overall Study|Lost to Follow-up|1|||
144338939|NCT00649428|520444822|FG001|Overall Study|Lost to Follow-up|3|||
144338940|NCT00649428|520444821|FG000|Overall Study|Insufficient manufacturing yield|5|||
144338941|NCT00649428|520444822|FG001|Overall Study|Insufficient manufacturing yield|1|||
144338942|NCT00649428|520444821|FG000|Overall Study|Protocol Violation|6|||
144338943|NCT00649428|520444822|FG001|Overall Study|Protocol Violation|2|||
144338944|NCT00649428|520444821|FG000|Overall Study|Physician Decision|0|||
144338945|NCT00649428|520444822|FG001|Overall Study|Physician Decision|1|||
144338946|NCT04599465|520444823|FG000|Overall Study|Physician Decision|1|||
144338947|NCT04599465|520444823|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
144338948|NCT00965575|520444826|FG000|Overall Study|subject unwillingness to swallow study c|1|||
144338949|NCT00965575|520444827|FG001|Overall Study|subject unwillingness to swallow study c|0|||
144338950|NCT02814175|520444830|FG000|Part 1|Adverse Event|2|||
144338951|NCT02814175|520444831|FG001|Part 1|Adverse Event|3|||
144338952|NCT02814175|520444832|FG002|Part 1|Adverse Event|0|||
144338953|NCT02814175|520444833|FG003|Part 1|Adverse Event|0|||
144338954|NCT02814175|520444834|FG004|Part 1|Adverse Event|0|||
144338955|NCT02814175|520444835|FG005|Part 1|Adverse Event|0|||
144338956|NCT02814175|520444830|FG000|Part 1|Withdrawal Consent|8|||
144338957|NCT02814175|520444831|FG001|Part 1|Withdrawal Consent|1|||
144338958|NCT02814175|520444832|FG002|Part 1|Withdrawal Consent|0|||
144338959|NCT02814175|520444833|FG003|Part 1|Withdrawal Consent|0|||
144338960|NCT02814175|520444834|FG004|Part 1|Withdrawal Consent|0|||
144338961|NCT02814175|520444835|FG005|Part 1|Withdrawal Consent|0|||
144338962|NCT02814175|520444830|FG000|Part 1|Lost to Follow-up|1|||
144338963|NCT02814175|520444831|FG001|Part 1|Lost to Follow-up|0|||
144338964|NCT02814175|520444832|FG002|Part 1|Lost to Follow-up|0|||
144338965|NCT02814175|520444833|FG003|Part 1|Lost to Follow-up|0|||
144338966|NCT02814175|520444834|FG004|Part 1|Lost to Follow-up|0|||
144338967|NCT02814175|520444835|FG005|Part 1|Lost to Follow-up|0|||
144338968|NCT02814175|520444830|FG000|Part 1|Lack of Efficacy|1|||
144338969|NCT02814175|520444831|FG001|Part 1|Lack of Efficacy|2|||
144338970|NCT02814175|520444832|FG002|Part 1|Lack of Efficacy|0|||
144338971|NCT02814175|520444833|FG003|Part 1|Lack of Efficacy|0|||
144338972|NCT02814175|520444834|FG004|Part 1|Lack of Efficacy|0|||
144338973|NCT02814175|520444835|FG005|Part 1|Lack of Efficacy|0|||
144338974|NCT02814175|520444830|FG000|Part 2|Adverse Event|0|||
144338975|NCT02814175|520444831|FG001|Part 2|Adverse Event|0|||
144338976|NCT02814175|520444832|FG002|Part 2|Adverse Event|0|||
144338977|NCT02814175|520444833|FG003|Part 2|Adverse Event|1|||
144338978|NCT02814175|520444834|FG004|Part 2|Adverse Event|1|||
144338979|NCT02814175|520444835|FG005|Part 2|Adverse Event|2|||
144338980|NCT02814175|520444830|FG000|Part 2|Withdrawal Consent|0|||
144338981|NCT02814175|520444831|FG001|Part 2|Withdrawal Consent|0|||
144338982|NCT02814175|520444832|FG002|Part 2|Withdrawal Consent|0|||
144338983|NCT02814175|520444833|FG003|Part 2|Withdrawal Consent|2|||
144338984|NCT02814175|520444834|FG004|Part 2|Withdrawal Consent|1|||
144338985|NCT02814175|520444835|FG005|Part 2|Withdrawal Consent|1|||
144338986|NCT02814175|520444830|FG000|Part 2|Lost to Follow-up|0|||
144338987|NCT02814175|520444831|FG001|Part 2|Lost to Follow-up|0|||
144338988|NCT02814175|520444832|FG002|Part 2|Lost to Follow-up|0|||
144338989|NCT02814175|520444833|FG003|Part 2|Lost to Follow-up|1|||
144338990|NCT02814175|520444834|FG004|Part 2|Lost to Follow-up|0|||
144338991|NCT02814175|520444835|FG005|Part 2|Lost to Follow-up|0|||
144338992|NCT02814175|520444830|FG000|Part 2|Lack of Efficacy|0|||
144338993|NCT02814175|520444831|FG001|Part 2|Lack of Efficacy|0|||
144338994|NCT02814175|520444832|FG002|Part 2|Lack of Efficacy|0|||
144338995|NCT02814175|520444833|FG003|Part 2|Lack of Efficacy|0|||
144338996|NCT02814175|520444834|FG004|Part 2|Lack of Efficacy|0|||
144338997|NCT02814175|520444835|FG005|Part 2|Lack of Efficacy|3|||
144338998|NCT01912339|520444836|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
144338999|NCT01912339|520444837|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
144339000|NCT01912339|520444838|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
144339001|NCT01912339|520444836|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
144339002|NCT01912339|520444837|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
144339003|NCT01912339|520444838|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
144339004|NCT01912339|520444836|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
144339005|NCT01912339|520444837|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
144339006|NCT01912339|520444838|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
144339007|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
144339008|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
144339009|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
144339010|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
144339011|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
144339012|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
144339013|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
144339014|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
144339015|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
144339016|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
144339017|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
144339018|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
144339019|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
144339020|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
144339021|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
144339022|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
144339023|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
144339024|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
144339025|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
144339026|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
144339027|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
144339028|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
144339029|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
144339030|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
144339031|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
144339032|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
144339033|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
144339034|NCT01912339|520444836|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
144339035|NCT01912339|520444837|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
144339036|NCT01912339|520444838|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
144339037|NCT01754493|520444839|FG000|Overall Study|Adverse Event|1|||
144339038|NCT01754493|520444839|FG000|Overall Study|Lost to Follow-up|3|||
144339039|NCT01754493|520444839|FG000|Overall Study|Withdrawal by Subject|1|||
144339040|NCT01754493|520444839|FG000|Overall Study|Moved out of town|1|||
144339041|NCT01754493|520444839|FG000|Overall Study|Scheduling conflict|1|||
144339042|NCT02489942|520444840|FG000|Overall Study|Request by patient|602|||
144339043|NCT02489942|520444840|FG000|Overall Study|Improvement/remission|157|||
144339044|NCT02489942|520444840|FG000|Overall Study|No change/Progressive disease|263|||
144339045|NCT02489942|520444840|FG000|Overall Study|Adverse Event|522|||
144339046|NCT02489942|520444840|FG000|Overall Study|Other personal reasons|1218|||
144339047|NCT02489942|520444840|FG000|Overall Study|Lost to Follow-up|456|||
144339048|NCT02489942|520444840|FG000|Overall Study|Not continuously investigated|7|||
144339049|NCT02489942|520444840|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
144339050|NCT02489942|520444840|FG000|Overall Study|Multiple registration|1|||
144339051|NCT02489942|520444840|FG000|Overall Study|No patient visit after entry|100|||
144339052|NCT02489942|520444840|FG000|Overall Study|No treatment with Jardiance|2|||
144339053|NCT02489942|520444840|FG000|Overall Study|Patient received Jardiance before registration|1|||
144339054|NCT02489942|520444840|FG000|Overall Study|No CRF collected|86|||
144339055|NCT01272635|520444841|FG000|Overall Study|Lost to Follow-up|31|||
144339056|NCT01272635|520444842|FG001|Overall Study|Lost to Follow-up|20|||
144339057|NCT01272635|520444843|FG002|Overall Study|Lost to Follow-up|31|||
144339058|NCT01272635|520444844|FG003|Overall Study|Lost to Follow-up|23|||
144339059|NCT01543776|520444847|FG000|Overall Study|Withdrawal by Subject|2|||
144339060|NCT01543776|520444848|FG001|Overall Study|Withdrawal by Subject|2|||
144339061|NCT02702180|520444849|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
144339062|NCT02702180|520444850|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
144339063|NCT02702180|520444851|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
144339064|NCT02702180|520444849|FG000|Double-blind Treatment Period|Adverse Event|0|||
144339065|NCT02702180|520444850|FG001|Double-blind Treatment Period|Adverse Event|0|||
144339066|NCT02702180|520444851|FG002|Double-blind Treatment Period|Adverse Event|1|||
144339067|NCT02702180|520444849|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
144339068|NCT02702180|520444850|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
144339069|NCT02702180|520444851|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
144339070|NCT02702180|520444849|FG000|Double-blind Treatment Period|Protocol Violation|0|||
144339071|NCT02702180|520444850|FG001|Double-blind Treatment Period|Protocol Violation|0|||
144339072|NCT02702180|520444851|FG002|Double-blind Treatment Period|Protocol Violation|2|||
144339073|NCT02702180|520444849|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
144339074|NCT02702180|520444850|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
144339075|NCT02702180|520444851|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
144339076|NCT02702180|520444849|FG000|Open-label Treatment Period|Withdrawn in error|0|||
144339077|NCT02702180|520444850|FG001|Open-label Treatment Period|Withdrawn in error|0|||
144339078|NCT02702180|520444851|FG002|Open-label Treatment Period|Withdrawn in error|1|||
144339079|NCT00372697|520444852|FG000|Overall Study|Protocol Violation|1|||
144339080|NCT00372697|520444853|FG001|Overall Study|Protocol Violation|1|||
144339081|NCT01815840|520444854|FG000|Overall Study|Missing|1|||
144339082|NCT01815840|520444855|FG001|Overall Study|Missing|0|||
144339083|NCT01815840|520444854|FG000|Overall Study|Withdrew Consent|31|||
144339084|NCT01815840|520444855|FG001|Overall Study|Withdrew Consent|30|||
144339085|NCT01815840|520444854|FG000|Overall Study|Administrative/Other|1|||
144339086|NCT01815840|520444855|FG001|Overall Study|Administrative/Other|3|||
144339087|NCT01815840|520444854|FG000|Overall Study|Adverse Event|10|||
144339088|NCT01815840|520444855|FG001|Overall Study|Adverse Event|16|||
144339089|NCT01815840|520444854|FG000|Overall Study|Death|2|||
144339090|NCT01815840|520444855|FG001|Overall Study|Death|2|||
144339091|NCT01815840|520444854|FG000|Overall Study|Disease progression|3|||
144339092|NCT01815840|520444855|FG001|Overall Study|Disease progression|2|||
144339093|NCT01815840|520444854|FG000|Overall Study|Investigators Decision|2|||
144339094|NCT01815840|520444855|FG001|Overall Study|Investigators Decision|3|||
144339095|NCT01815840|520444854|FG000|Overall Study|Lost to Follow-up|3|||
144339096|NCT01815840|520444855|FG001|Overall Study|Lost to Follow-up|6|||
144339097|NCT01815840|520444854|FG000|Overall Study|Refused Treatment|5|||
144339098|NCT01815840|520444855|FG001|Overall Study|Refused Treatment|1|||
144339099|NCT01815840|520444854|FG000|Overall Study|Sponsor Termination Treatment|1|||
144339100|NCT01815840|520444855|FG001|Overall Study|Sponsor Termination Treatment|0|||
144339101|NCT03221842|520444857|FG000|Period 1 (Open-label)|Adverse Event|4|||
144339102|NCT03221842|520444858|FG001|Period 1 (Open-label)|Adverse Event|0|||
144339103|NCT03221842|520444857|FG000|Period 1 (Open-label)|Physician Decision|2|||
144339104|NCT03221842|520444858|FG001|Period 1 (Open-label)|Physician Decision|0|||
144339105|NCT03221842|520444857|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
144339106|NCT03221842|520444858|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
144339107|NCT03221842|520444857|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
144339108|NCT03221842|520444858|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
144339109|NCT03221842|520444857|FG000|Period 1 (Open-label)|Other|2|||
144339110|NCT03221842|520444858|FG001|Period 1 (Open-label)|Other|0|||
144339111|NCT03221842|520444857|FG000|Period 2 (Randomized, Blinded)|Death|0|||
144339112|NCT03221842|520444858|FG001|Period 2 (Randomized, Blinded)|Death|1|||
144339113|NCT03221842|520444857|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
144339114|NCT03221842|520444858|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
144339115|NCT04395690|520444859|FG000|Overall Study|Lost to Follow-up|1|||
144339116|NCT04395690|520444860|FG001|Overall Study|Lost to Follow-up|1|||
144339117|NCT00753454|520444861|FG000|Overall Study|Adverse Event|4|||
144339118|NCT00753454|520444861|FG000|Overall Study|Lack of Efficacy|1|||
144339119|NCT00753454|520444861|FG000|Overall Study|Lost to Follow-up|3|||
144339120|NCT00753454|520444861|FG000|Overall Study|Withdrawal by Subject|5|||
144339121|NCT00753454|520444861|FG000|Overall Study|Investigator Decision|1|||
144339122|NCT05249569|520444862|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
144339123|NCT03927144|520444863|FG000|Core Phase|Adverse Event|9|||
144339124|NCT03927144|520444864|FG001|Core Phase|Adverse Event|5|||
144339125|NCT03927144|520444863|FG000|Core Phase|Lost to Follow-up|3|||
144339126|NCT03927144|520444864|FG001|Core Phase|Lost to Follow-up|2|||
144339127|NCT03927144|520444863|FG000|Core Phase|New Therapy for Study Indication|0|||
144339128|NCT03927144|520444864|FG001|Core Phase|New Therapy for Study Indication|1|||
144339129|NCT03927144|520444863|FG000|Core Phase|No Longer Clinically Benefiting|4|||
144339130|NCT03927144|520444864|FG001|Core Phase|No Longer Clinically Benefiting|4|||
144339131|NCT03927144|520444863|FG000|Core Phase|Physician Decision|2|||
144339132|NCT03927144|520444864|FG001|Core Phase|Physician Decision|8|||
144339133|NCT03927144|520444863|FG000|Core Phase|Protocol Violation|2|||
144339134|NCT03927144|520444864|FG001|Core Phase|Protocol Violation|2|||
144339135|NCT03927144|520444863|FG000|Core Phase|Withdrawal by Subject|16|||
144339136|NCT03927144|520444864|FG001|Core Phase|Withdrawal by Subject|40|||
144339137|NCT03927144|520444863|FG000|Extension Phase|Adverse Event|2|||
144339138|NCT03927144|520444864|FG001|Extension Phase|Adverse Event|1|||
144339139|NCT03927144|520444863|FG000|Extension Phase|No longer clinically benefiting|4|||
144339140|NCT03927144|520444864|FG001|Extension Phase|No longer clinically benefiting|5|||
144339141|NCT03927144|520444863|FG000|Extension Phase|Pregnancy|1|||
144339142|NCT03927144|520444864|FG001|Extension Phase|Pregnancy|0|||
144339143|NCT03927144|520444863|FG000|Extension Phase|Protocol Violation|0|||
144339144|NCT03927144|520444864|FG001|Extension Phase|Protocol Violation|1|||
144339145|NCT03927144|520444863|FG000|Extension Phase|Withdrawal by Subject|8|||
144339146|NCT03927144|520444864|FG001|Extension Phase|Withdrawal by Subject|3|||
144339147|NCT01452919|520444865|FG000|Open-Label Treatment|Adverse Event|5|||
144339148|NCT01452919|520444866|FG001|Open-Label Treatment|Adverse Event|0|||
144339149|NCT01452919|520444867|FG002|Open-Label Treatment|Adverse Event|0|||
144339150|NCT01452919|520444865|FG000|Open-Label Treatment|Lost to Follow-up|4|||
144339151|NCT01452919|520444866|FG001|Open-Label Treatment|Lost to Follow-up|0|||
144339152|NCT01452919|520444867|FG002|Open-Label Treatment|Lost to Follow-up|0|||
144339153|NCT01452919|520444865|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
144339154|NCT01452919|520444866|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
144339155|NCT01452919|520444867|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
144339156|NCT01452919|520444865|FG000|Open-Label Treatment|Protocol Violation|4|||
144339157|NCT01452919|520444866|FG001|Open-Label Treatment|Protocol Violation|0|||
144339158|NCT01452919|520444867|FG002|Open-Label Treatment|Protocol Violation|0|||
144339159|NCT01452919|520444865|FG000|Open-Label Treatment|Sponsor Decision|1|||
144339160|NCT01452919|520444866|FG001|Open-Label Treatment|Sponsor Decision|0|||
144339161|NCT01452919|520444867|FG002|Open-Label Treatment|Sponsor Decision|0|||
144339162|NCT01452919|520444865|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
144339163|NCT01452919|520444866|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
144339164|NCT01452919|520444867|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
144339165|NCT01452919|520444865|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
144339166|NCT01452919|520444866|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
144339167|NCT01452919|520444867|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
144339168|NCT01452919|520444865|FG000|Randomization Treatment|Adverse Event|0|||
144339169|NCT01452919|520444866|FG001|Randomization Treatment|Adverse Event|0|||
144339170|NCT01452919|520444867|FG002|Randomization Treatment|Adverse Event|2|||
144339171|NCT01452919|520444865|FG000|Randomization Treatment|Sponsor Decision|0|||
144339172|NCT01452919|520444866|FG001|Randomization Treatment|Sponsor Decision|1|||
144339173|NCT01452919|520444867|FG002|Randomization Treatment|Sponsor Decision|0|||
144339174|NCT01452919|520444865|FG000|Randomization Treatment|Withdrawal by Subject|0|||
144339175|NCT01452919|520444866|FG001|Randomization Treatment|Withdrawal by Subject|1|||
144339176|NCT01452919|520444867|FG002|Randomization Treatment|Withdrawal by Subject|0|||
144339177|NCT01452919|520444865|FG000|Randomization Treatment|Subject is moving or has moved|0|||
144339178|NCT01452919|520444866|FG001|Randomization Treatment|Subject is moving or has moved|1|||
144339179|NCT01452919|520444867|FG002|Randomization Treatment|Subject is moving or has moved|0|||
144339180|NCT02421588|520444868|FG000|Overall Study|Non-treatment-related AE|8|||
144339181|NCT02421588|520444869|FG001|Overall Study|Non-treatment-related AE|8|||
144339182|NCT02421588|520444868|FG000|Overall Study|Progressive disease|152|||
144339183|NCT02421588|520444869|FG001|Overall Study|Progressive disease|135|||
144339184|NCT02421588|520444868|FG000|Overall Study|Death|11|||
144339185|NCT02421588|520444869|FG001|Overall Study|Death|3|||
144339186|NCT02421588|520444868|FG000|Overall Study|Physician Decision|8|||
144339187|NCT02421588|520444869|FG001|Overall Study|Physician Decision|17|||
144339188|NCT02421588|520444868|FG000|Overall Study|Other reason not specified|3|||
144339189|NCT02421588|520444869|FG001|Overall Study|Other reason not specified|1|||
144339190|NCT02421588|520444868|FG000|Overall Study|Symptomatic deterioration|13|||
144339191|NCT02421588|520444869|FG001|Overall Study|Symptomatic deterioration|19|||
144339192|NCT02421588|520444868|FG000|Overall Study|Treatment-related AE|10|||
144339193|NCT02421588|520444869|FG001|Overall Study|Treatment-related AE|14|||
144339194|NCT02421588|520444868|FG000|Overall Study|Withdrawal by Subject|14|||
144339195|NCT02421588|520444869|FG001|Overall Study|Withdrawal by Subject|16|||
144339196|NCT02421588|520444868|FG000|Overall Study|Not treated|2|||
144339197|NCT02421588|520444869|FG001|Overall Study|Not treated|8|||
144339198|NCT00615030|520444870|FG000|Period I|Administrative problem|0|||
144339199|NCT00615030|520444871|FG001|Period I|Administrative problem|0|||
144339200|NCT00615030|520444872|FG002|Period I|Administrative problem|0|||
144339201|NCT00615030|520444873|FG003|Period I|Administrative problem|0|||
144339202|NCT00615030|520444874|FG004|Period I|Administrative problem|1|||
144339203|NCT00615030|520444875|FG005|Period I|Administrative problem|0|||
144339204|NCT00615030|520444876|FG006|Period I|Administrative problem|0|||
144339205|NCT00615030|520444877|FG007|Period I|Administrative problem|0|||
144339206|NCT00615030|520444878|FG008|Period I|Administrative problem|0|||
144339207|NCT00615030|520444879|FG009|Period I|Administrative problem|0|||
144339208|NCT00615030|520444880|FG010|Period I|Administrative problem|0|||
144339209|NCT00615030|520444881|FG011|Period I|Administrative problem|0|||
144339210|NCT00615030|520444870|FG000|Period I|Protocol deviation|1|||
144339211|NCT00615030|520444871|FG001|Period I|Protocol deviation|0|||
144339212|NCT00615030|520444872|FG002|Period I|Protocol deviation|0|||
144339213|NCT00615030|520444873|FG003|Period I|Protocol deviation|0|||
144339214|NCT00615030|520444874|FG004|Period I|Protocol deviation|0|||
144339215|NCT00615030|520444875|FG005|Period I|Protocol deviation|0|||
144339216|NCT00615030|520444876|FG006|Period I|Protocol deviation|0|||
144339217|NCT00615030|520444877|FG007|Period I|Protocol deviation|0|||
144339218|NCT00615030|520444878|FG008|Period I|Protocol deviation|0|||
144339219|NCT00615030|520444879|FG009|Period I|Protocol deviation|0|||
144339220|NCT00615030|520444880|FG010|Period I|Protocol deviation|0|||
144339221|NCT00615030|520444881|FG011|Period I|Protocol deviation|0|||
144339222|NCT00615030|520444870|FG000|Period I|Subject withdrew consent|0|||
144339223|NCT00615030|520444871|FG001|Period I|Subject withdrew consent|0|||
144339224|NCT00615030|520444872|FG002|Period I|Subject withdrew consent|0|||
144339225|NCT00615030|520444873|FG003|Period I|Subject withdrew consent|0|||
144339226|NCT00615030|520444874|FG004|Period I|Subject withdrew consent|0|||
144339227|NCT00615030|520444875|FG005|Period I|Subject withdrew consent|0|||
144339228|NCT00615030|520444876|FG006|Period I|Subject withdrew consent|0|||
144339229|NCT00615030|520444877|FG007|Period I|Subject withdrew consent|0|||
144339230|NCT00615030|520444878|FG008|Period I|Subject withdrew consent|1|||
144339231|NCT00615030|520444879|FG009|Period I|Subject withdrew consent|0|||
144339232|NCT00615030|520444880|FG010|Period I|Subject withdrew consent|1|||
144339233|NCT00615030|520444881|FG011|Period I|Subject withdrew consent|1|||
144339234|NCT00615030|520444870|FG000|Period I|Abnormal laboratory value(s)|0|||
144339235|NCT00615030|520444871|FG001|Period I|Abnormal laboratory value(s)|0|||
144339236|NCT00615030|520444872|FG002|Period I|Abnormal laboratory value(s)|0|||
144339237|NCT00615030|520444873|FG003|Period I|Abnormal laboratory value(s)|0|||
144339238|NCT00615030|520444874|FG004|Period I|Abnormal laboratory value(s)|0|||
144339239|NCT00615030|520444875|FG005|Period I|Abnormal laboratory value(s)|1|||
144339240|NCT00615030|520444876|FG006|Period I|Abnormal laboratory value(s)|0|||
144339241|NCT00615030|520444877|FG007|Period I|Abnormal laboratory value(s)|0|||
144339242|NCT00615030|520444878|FG008|Period I|Abnormal laboratory value(s)|0|||
144339243|NCT00615030|520444879|FG009|Period I|Abnormal laboratory value(s)|0|||
144339244|NCT00615030|520444880|FG010|Period I|Abnormal laboratory value(s)|0|||
144339245|NCT00615030|520444881|FG011|Period I|Abnormal laboratory value(s)|0|||
144339246|NCT00615030|520444870|FG000|Period II|Adverse Event|0|||
144339247|NCT00615030|520444871|FG001|Period II|Adverse Event|0|||
144339248|NCT00615030|520444872|FG002|Period II|Adverse Event|1|||
144339249|NCT00615030|520444873|FG003|Period II|Adverse Event|0|||
144339250|NCT00615030|520444874|FG004|Period II|Adverse Event|0|||
144339251|NCT00615030|520444875|FG005|Period II|Adverse Event|0|||
144339252|NCT00615030|520444876|FG006|Period II|Adverse Event|0|||
144339253|NCT00615030|520444877|FG007|Period II|Adverse Event|0|||
144339254|NCT00615030|520444878|FG008|Period II|Adverse Event|1|||
144339255|NCT00615030|520444879|FG009|Period II|Adverse Event|0|||
144339256|NCT00615030|520444880|FG010|Period II|Adverse Event|0|||
144339257|NCT00615030|520444881|FG011|Period II|Adverse Event|0|||
144339258|NCT00615030|520444870|FG000|Period II|Subject withdrew consent|0|||
144339259|NCT00615030|520444871|FG001|Period II|Subject withdrew consent|0|||
144339260|NCT00615030|520444872|FG002|Period II|Subject withdrew consent|0|||
144339261|NCT00615030|520444873|FG003|Period II|Subject withdrew consent|1|||
144339262|NCT00615030|520444874|FG004|Period II|Subject withdrew consent|0|||
144339263|NCT00615030|520444875|FG005|Period II|Subject withdrew consent|0|||
144339264|NCT00615030|520444876|FG006|Period II|Subject withdrew consent|1|||
144339265|NCT00615030|520444877|FG007|Period II|Subject withdrew consent|0|||
144339266|NCT00615030|520444878|FG008|Period II|Subject withdrew consent|0|||
144339267|NCT00615030|520444879|FG009|Period II|Subject withdrew consent|0|||
144339268|NCT00615030|520444880|FG010|Period II|Subject withdrew consent|0|||
144339269|NCT00615030|520444881|FG011|Period II|Subject withdrew consent|0|||
144339270|NCT00615030|520444870|FG000|Period III|Administrative problems|1|||
144339271|NCT00615030|520444871|FG001|Period III|Administrative problems|0|||
144339272|NCT00615030|520444872|FG002|Period III|Administrative problems|0|||
144339273|NCT00615030|520444873|FG003|Period III|Administrative problems|1|||
144339274|NCT00615030|520444874|FG004|Period III|Administrative problems|0|||
144339275|NCT00615030|520444875|FG005|Period III|Administrative problems|0|||
144339276|NCT00615030|520444876|FG006|Period III|Administrative problems|0|||
144339277|NCT00615030|520444877|FG007|Period III|Administrative problems|0|||
144339278|NCT00615030|520444878|FG008|Period III|Administrative problems|0|||
144339279|NCT00615030|520444879|FG009|Period III|Administrative problems|0|||
144339280|NCT00615030|520444880|FG010|Period III|Administrative problems|0|||
144339281|NCT00615030|520444881|FG011|Period III|Administrative problems|0|||
144339282|NCT00308074|520444884|FG000|Overall Study|Withdrawal by Subject|1|||
144339283|NCT03002311|520444885|FG000|Overall Study|Lost to Follow-up|13|||
144339284|NCT03002311|520444886|FG001|Overall Study|Lost to Follow-up|26|||
144339285|NCT03002311|520444885|FG000|Overall Study|Referral provider called to schedule app|3|||
144339286|NCT03002311|520444886|FG001|Overall Study|Referral provider called to schedule app|3|||
144339287|NCT03002311|520444885|FG000|Overall Study|Physician Decision|3|||
144339288|NCT03002311|520444886|FG001|Overall Study|Physician Decision|1|||
144339289|NCT03722524|520444889|FG000|Overall Study|Protocol Violation|86|||
144339290|NCT03722524|520444889|FG000|Overall Study|Adverse Event|7|||
144339291|NCT03722524|520444889|FG000|Overall Study|Lost to Follow-up|1|||
144339292|NCT03722524|520444889|FG000|Overall Study|Reason is not stated|1|||
144339293|NCT03722524|520444889|FG000|Overall Study|Physician Decision|1|||
144339294|NCT03722524|520444889|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
144339295|NCT01178099|520444890|FG000|Overall Study|Physician Decision|0|||
144339296|NCT01178099|520444891|FG001|Overall Study|Physician Decision|1|||
144339297|NCT02473367|520444892|FG000|Wait 1|Withdrawal by Subject|1|||
144339298|NCT02473367|520444892|FG000|Period 4|Lost to Follow-up|1|||
144339299|NCT04816721|520444893|FG000|Overall Study|Withdrawal by Subject|0|||
144339300|NCT04816721|520444894|FG001|Overall Study|Withdrawal by Subject|2|||
144339301|NCT04816721|520444895|FG002|Overall Study|Withdrawal by Subject|0|||
144339302|NCT04816721|520444896|FG003|Overall Study|Withdrawal by Subject|1|||
144339303|NCT04816721|520444897|FG004|Overall Study|Withdrawal by Subject|1|||
144339304|NCT04816721|520444898|FG005|Overall Study|Withdrawal by Subject|0|||
144339305|NCT04816721|520444899|FG006|Overall Study|Withdrawal by Subject|0|||
144339306|NCT04816721|520444900|FG007|Overall Study|Withdrawal by Subject|0|||
144339307|NCT04816721|520444893|FG000|Overall Study|Miscellaneous|0|||
144339308|NCT04816721|520444894|FG001|Overall Study|Miscellaneous|0|||
144339309|NCT04816721|520444895|FG002|Overall Study|Miscellaneous|0|||
144339310|NCT04816721|520444896|FG003|Overall Study|Miscellaneous|0|||
144339311|NCT04816721|520444897|FG004|Overall Study|Miscellaneous|0|||
144339312|NCT04816721|520444898|FG005|Overall Study|Miscellaneous|1|||
144339313|NCT04816721|520444899|FG006|Overall Study|Miscellaneous|0|||
144339314|NCT04816721|520444900|FG007|Overall Study|Miscellaneous|0|||
144339315|NCT04816721|520444893|FG000|Overall Study|Lost to Follow-up|0|||
144339316|NCT04816721|520444894|FG001|Overall Study|Lost to Follow-up|0|||
144339317|NCT04816721|520444895|FG002|Overall Study|Lost to Follow-up|0|||
144339318|NCT04816721|520444896|FG003|Overall Study|Lost to Follow-up|1|||
144339319|NCT04816721|520444897|FG004|Overall Study|Lost to Follow-up|0|||
144339320|NCT04816721|520444898|FG005|Overall Study|Lost to Follow-up|0|||
144339321|NCT04816721|520444899|FG006|Overall Study|Lost to Follow-up|0|||
144339322|NCT04816721|520444900|FG007|Overall Study|Lost to Follow-up|0|||
144339323|NCT00902174|520444905|FG000|Overall Study|Adverse Event|27|||
144339324|NCT00902174|520444906|FG001|Overall Study|Adverse Event|7|||
144339325|NCT00902174|520444905|FG000|Overall Study|Lack of Efficacy|1|||
144339326|NCT00902174|520444906|FG001|Overall Study|Lack of Efficacy|5|||
144339327|NCT00902174|520444905|FG000|Overall Study|Death|2|||
144339328|NCT00902174|520444906|FG001|Overall Study|Death|2|||
144339329|NCT00902174|520444905|FG000|Overall Study|Withdrawal by Subject|2|||
144339330|NCT00902174|520444906|FG001|Overall Study|Withdrawal by Subject|1|||
144339331|NCT00902174|520444905|FG000|Overall Study|Abnormal labs|1|||
144339332|NCT00902174|520444906|FG001|Overall Study|Abnormal labs|1|||
144339333|NCT00902174|520444905|FG000|Overall Study|Protocol Violation|1|||
144339334|NCT00902174|520444906|FG001|Overall Study|Protocol Violation|1|||
144339335|NCT00902174|520444905|FG000|Overall Study|Administration problem|0|||
144339336|NCT00902174|520444906|FG001|Overall Study|Administration problem|1|||
144339337|NCT00454584|520444907|FG000|Controlled Period|Adverse Event|5|||
144339338|NCT00454584|520444908|FG001|Controlled Period|Adverse Event|2|||
144339339|NCT00454584|520444909|FG002|Controlled Period|Adverse Event|1|||
144339340|NCT00454584|520444910|FG003|Controlled Period|Adverse Event|0|||
144339341|NCT00454584|520444911|FG004|Controlled Period|Adverse Event|0|||
144339342|NCT00454584|520444912|FG005|Controlled Period|Adverse Event|0|||
144339343|NCT00454584|520444907|FG000|Controlled Period|Lost to Follow-up|1|||
144339344|NCT00454584|520444908|FG001|Controlled Period|Lost to Follow-up|2|||
144339345|NCT00454584|520444909|FG002|Controlled Period|Lost to Follow-up|2|||
144339346|NCT00454584|520444910|FG003|Controlled Period|Lost to Follow-up|0|||
144339347|NCT00454584|520444911|FG004|Controlled Period|Lost to Follow-up|0|||
144339348|NCT00454584|520444912|FG005|Controlled Period|Lost to Follow-up|0|||
144339349|NCT00454584|520444907|FG000|Controlled Period|Other|5|||
144339350|NCT00454584|520444908|FG001|Controlled Period|Other|4|||
144339351|NCT00454584|520444909|FG002|Controlled Period|Other|2|||
144339352|NCT00454584|520444910|FG003|Controlled Period|Other|0|||
144339353|NCT00454584|520444911|FG004|Controlled Period|Other|0|||
144339354|NCT00454584|520444912|FG005|Controlled Period|Other|0|||
144339355|NCT00454584|520444907|FG000|After Controlled Period|Adverse Event|0|||
144339356|NCT00454584|520444908|FG001|After Controlled Period|Adverse Event|0|||
144339357|NCT00454584|520444909|FG002|After Controlled Period|Adverse Event|0|||
144339358|NCT00454584|520444910|FG003|After Controlled Period|Adverse Event|9|||
144339359|NCT00454584|520444911|FG004|After Controlled Period|Adverse Event|3|||
144339360|NCT00454584|520444912|FG005|After Controlled Period|Adverse Event|9|||
144339361|NCT00454584|520444907|FG000|After Controlled Period|Lack of Efficacy|0|||
144339362|NCT00454584|520444908|FG001|After Controlled Period|Lack of Efficacy|0|||
144339363|NCT00454584|520444909|FG002|After Controlled Period|Lack of Efficacy|0|||
144339364|NCT00454584|520444910|FG003|After Controlled Period|Lack of Efficacy|1|||
144339365|NCT00454584|520444911|FG004|After Controlled Period|Lack of Efficacy|0|||
144339366|NCT00454584|520444912|FG005|After Controlled Period|Lack of Efficacy|0|||
144339367|NCT00454584|520444907|FG000|After Controlled Period|Lost to Follow-up|0|||
144339368|NCT00454584|520444908|FG001|After Controlled Period|Lost to Follow-up|0|||
144339369|NCT00454584|520444909|FG002|After Controlled Period|Lost to Follow-up|0|||
144339370|NCT00454584|520444910|FG003|After Controlled Period|Lost to Follow-up|2|||
144339371|NCT00454584|520444911|FG004|After Controlled Period|Lost to Follow-up|4|||
144339372|NCT00454584|520444912|FG005|After Controlled Period|Lost to Follow-up|6|||
144339373|NCT00454584|520444907|FG000|After Controlled Period|Other|0|||
144339374|NCT00454584|520444908|FG001|After Controlled Period|Other|0|||
144339375|NCT00454584|520444909|FG002|After Controlled Period|Other|0|||
144339376|NCT00454584|520444910|FG003|After Controlled Period|Other|1|||
144339377|NCT00454584|520444911|FG004|After Controlled Period|Other|0|||
144339378|NCT00454584|520444912|FG005|After Controlled Period|Other|0|||
144339379|NCT00454584|520444907|FG000|After Controlled Period|Other|0|||
144339380|NCT00454584|520444908|FG001|After Controlled Period|Other|0|||
144339381|NCT00454584|520444909|FG002|After Controlled Period|Other|0|||
144339382|NCT00454584|520444910|FG003|After Controlled Period|Other|13|||
144339383|NCT00454584|520444911|FG004|After Controlled Period|Other|5|||
144339384|NCT00454584|520444912|FG005|After Controlled Period|Other|17|||
144339385|NCT01716104|520444915|FG000|Overall Study|Do not meet inclusion criteria|6|||
144339386|NCT01716104|520444916|FG001|Overall Study|Do not meet inclusion criteria|7|||
144339387|NCT00599638|520444919|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
144339388|NCT00599638|520444920|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
144339389|NCT00599638|520444921|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
144339390|NCT00599638|520444922|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
144339391|NCT00599638|520444919|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
144339392|NCT00599638|520444920|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
144339393|NCT00599638|520444921|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
144339394|NCT00599638|520444922|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
144339395|NCT00599638|520444919|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
144339396|NCT00599638|520444920|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
144339397|NCT00599638|520444921|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
144339398|NCT00599638|520444922|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
144339399|NCT00599638|520444919|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
144339400|NCT00599638|520444920|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
144339401|NCT00599638|520444921|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
144339402|NCT00599638|520444922|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
144339403|NCT00599638|520444919|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
144339404|NCT00599638|520444920|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
144339405|NCT00599638|520444921|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
144339406|NCT00599638|520444922|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
144339407|NCT00599638|520444919|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
144339408|NCT00599638|520444920|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
144339409|NCT00599638|520444921|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
144339410|NCT00599638|520444922|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
144339411|NCT00599638|520444919|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
144339412|NCT00599638|520444920|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
144339413|NCT00599638|520444921|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
144339414|NCT00599638|520444922|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
144339415|NCT00599638|520444919|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
144339416|NCT00599638|520444920|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
144339417|NCT00599638|520444921|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
144339418|NCT00599638|520444922|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
144339419|NCT00599638|520444919|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
144339420|NCT00599638|520444920|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
144339421|NCT00599638|520444921|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
144339422|NCT00599638|520444922|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
144339423|NCT03006887|520444924|FG000|Overall Study|Adverse Event|1|||
144339424|NCT00462748|520444925|FG000|Overall Study|Adverse Event|7|||
144339425|NCT00462748|520444926|FG001|Overall Study|Adverse Event|5|||
144339426|NCT00462748|520444927|FG002|Overall Study|Adverse Event|9|||
144339427|NCT00462748|520444925|FG000|Overall Study|Protocol Violation|0|||
144339428|NCT00462748|520444926|FG001|Overall Study|Protocol Violation|2|||
144339429|NCT00462748|520444927|FG002|Overall Study|Protocol Violation|1|||
144339430|NCT00462748|520444925|FG000|Overall Study|Withdrew consent|3|||
144339431|NCT00462748|520444926|FG001|Overall Study|Withdrew consent|3|||
144339432|NCT00462748|520444927|FG002|Overall Study|Withdrew consent|0|||
144339433|NCT00462748|520444925|FG000|Overall Study|Lost to Follow-up|1|||
144339434|NCT00462748|520444926|FG001|Overall Study|Lost to Follow-up|1|||
144339435|NCT00462748|520444927|FG002|Overall Study|Lost to Follow-up|1|||
144339436|NCT00462748|520444925|FG000|Overall Study|Discontinued after 41 days Rx|1|||
144339437|NCT00462748|520444926|FG001|Overall Study|Discontinued after 41 days Rx|0|||
144339438|NCT00462748|520444927|FG002|Overall Study|Discontinued after 41 days Rx|0|||
144339439|NCT01729208|520444928|FG000|Baseline|Physician Decision|5|||
144339440|NCT01729208|520444929|FG001|Baseline|Physician Decision|4|||
144339441|NCT01729208|520444928|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
144339442|NCT01729208|520444929|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
144339443|NCT01729208|520444928|FG000|12 Months Follow-up|Lost to Follow-up|3|||
144339444|NCT01729208|520444929|FG001|12 Months Follow-up|Lost to Follow-up|3|||
144339445|NCT01729208|520444928|FG000|24 Months Follow-up|Lost to Follow-up|3|||
144339446|NCT01729208|520444929|FG001|24 Months Follow-up|Lost to Follow-up|0|||
144339447|NCT01729208|520444928|FG000|36 Months Follow-up|Physician Decision|1|||
144339448|NCT01729208|520444929|FG001|36 Months Follow-up|Physician Decision|0|||
144339449|NCT01729208|520444928|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
144339450|NCT01729208|520444929|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
144339451|NCT02428413|520444930|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
144339452|NCT02428413|520444931|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
144339453|NCT02428413|520444930|FG000|Overall Study|Protocol Violation|1|||
144339454|NCT02428413|520444931|FG001|Overall Study|Protocol Violation|2|||
144339455|NCT02428413|520444930|FG000|Overall Study|Case Cancelled|2|||
144339456|NCT02428413|520444931|FG001|Overall Study|Case Cancelled|0|||
144339457|NCT02428413|520444930|FG000|Overall Study|Missed Cases|1|||
144339458|NCT02428413|520444931|FG001|Overall Study|Missed Cases|2|||
144339459|NCT02428413|520444930|FG000|Overall Study|Nurse Refusal|1|||
144339460|NCT02428413|520444931|FG001|Overall Study|Nurse Refusal|0|||
144339461|NCT00454181|520444937|FG000|Overall Study|Adverse Event|1|||
144339462|NCT00454181|520444938|FG001|Overall Study|Adverse Event|1|||
144339463|NCT00454181|520444937|FG000|Overall Study|Lost to Follow-up|11|||
144339464|NCT00454181|520444938|FG001|Overall Study|Lost to Follow-up|1|||
144339465|NCT00454181|520444937|FG000|Overall Study|Protocol Violation|1|||
144339466|NCT00454181|520444938|FG001|Overall Study|Protocol Violation|1|||
144339467|NCT00454181|520444937|FG000|Overall Study|Withdrawal by Subject|2|||
144339468|NCT00454181|520444938|FG001|Overall Study|Withdrawal by Subject|0|||
144339469|NCT00079677|520444939|FG000|Overall Study|Adverse Event|5|||
144339470|NCT00079677|520444940|FG001|Overall Study|Adverse Event|6|||
144339471|NCT00079677|520444939|FG000|Overall Study|Lack of Efficacy|1|||
144339472|NCT00079677|520444940|FG001|Overall Study|Lack of Efficacy|0|||
144339473|NCT00079677|520444939|FG000|Overall Study|Lost to Follow-up|2|||
144339474|NCT00079677|520444940|FG001|Overall Study|Lost to Follow-up|2|||
144339475|NCT00079677|520444939|FG000|Overall Study|Physician Decision|3|||
144339476|NCT00079677|520444940|FG001|Overall Study|Physician Decision|0|||
144339477|NCT00079677|520444939|FG000|Overall Study|Protocol Violation|2|||
144339478|NCT00079677|520444940|FG001|Overall Study|Protocol Violation|3|||
144339479|NCT00079677|520444939|FG000|Overall Study|Withdrawal by Subject|5|||
144339480|NCT00079677|520444940|FG001|Overall Study|Withdrawal by Subject|3|||
144339481|NCT00079677|520444939|FG000|Overall Study|Miscellaneous|2|||
144339482|NCT00079677|520444940|FG001|Overall Study|Miscellaneous|0|||
144339483|NCT00989781|520444943|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
144339484|NCT00989781|520444944|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
144339485|NCT00409344|520444945|FG000|Overall Study|no enrollment|0|||
144339486|NCT00409344|520444946|FG001|Overall Study|no enrollment|0|||
144339487|NCT05096312|520444947|FG000|Overall Study|Lost to Follow-up|2|||
144339488|NCT05096312|520444948|FG001|Overall Study|Lost to Follow-up|4|||
144339489|NCT05096312|520444947|FG000|Overall Study|Adverse Event|1|||
144339490|NCT05096312|520444948|FG001|Overall Study|Adverse Event|0|||
144339491|NCT03157037|520444949|FG000|Overall Study|Death|1|||
144339492|NCT02102399|520444950|FG000|Overall Study|Withdrawal by Subject|6|||
144339493|NCT02102399|520444951|FG001|Overall Study|Withdrawal by Subject|4|||
144339494|NCT04349033|520444952|FG000|Overall Study|Lost to Follow-up|3|||
144339495|NCT04349033|520444953|FG001|Overall Study|Lost to Follow-up|1|||
144339496|NCT04349033|520444954|FG002|Overall Study|Lost to Follow-up|1|||
144339497|NCT01887353|520444963|FG000|Overall Study|Study stopped early|4|||
144339498|NCT01887353|520444964|FG001|Overall Study|Study stopped early|3|||
144339499|NCT04407234|520444966|FG000|Overall Study|Adverse Event|3|||
144339500|NCT04407234|520444967|FG001|Overall Study|Adverse Event|3|||
144339501|NCT03908970|520444968|FG000|Overall Study|Adverse Event|7|||
144339502|NCT03908970|520444969|FG001|Overall Study|Adverse Event|21|||
144339503|NCT03908970|520444968|FG000|Overall Study|Physician Decision|1|||
144339504|NCT03908970|520444969|FG001|Overall Study|Physician Decision|4|||
144339505|NCT03908970|520444968|FG000|Overall Study|Withdrawal by Subject|9|||
144339506|NCT03908970|520444969|FG001|Overall Study|Withdrawal by Subject|22|||
144339507|NCT00605345|520444971|FG000|Overall Study|Withdrawal by Subject|1|||
144339508|NCT00605345|520444972|FG001|Overall Study|Withdrawal by Subject|0|||
144339509|NCT00605345|520444971|FG000|Overall Study|Adverse Event|0|||
144339510|NCT00605345|520444972|FG001|Overall Study|Adverse Event|1|||
144339511|NCT00605345|520444971|FG000|Overall Study|Protocol Violation|0|||
144339512|NCT00605345|520444972|FG001|Overall Study|Protocol Violation|2|||
144339513|NCT00761527|520444975|FG000|Overall Study|Adverse Event|3|||
144339514|NCT00761527|520444975|FG000|Overall Study|Poor Compliance|8|||
144339515|NCT00761527|520444975|FG000|Overall Study|Lost to Follow-up|9|||
144339516|NCT00761527|520444975|FG000|Overall Study|Unknown reason|2|||
144339517|NCT02008227|520446719|FG000|Overall Study|Lost to Follow-up|7|||
144339518|NCT02008227|520446720|FG001|Overall Study|Lost to Follow-up|9|||
144339519|NCT02008227|520446719|FG000|Overall Study|Death|494|||
144339520|NCT02008227|520446720|FG001|Overall Study|Death|485|||
144339521|NCT02008227|520446719|FG000|Overall Study|Withdrawal by Subject|67|||
144339522|NCT02008227|520446720|FG001|Overall Study|Withdrawal by Subject|36|||
144339523|NCT02008227|520446719|FG000|Overall Study|Study Terminated By Sponsor|44|||
144339524|NCT02008227|520446720|FG001|Overall Study|Study Terminated By Sponsor|83|||
144339525|NCT00742417|520446721|FG000|Randomized|Withdrawal by legal representative|0|||
144339526|NCT00742417|520446722|FG001|Randomized|Withdrawal by legal representative|1|||
144339527|NCT00742417|520446721|FG000|Randomized|Withdrawal by Subject|1|||
144339528|NCT00742417|520446722|FG001|Randomized|Withdrawal by Subject|0|||
144339529|NCT00742417|520446721|FG000|Randomized|Physician Decision|1|||
144339530|NCT00742417|520446722|FG001|Randomized|Physician Decision|0|||
144339531|NCT00742417|520446721|FG000|Intensive Period|Withdrawal by Subject|1|||
144339532|NCT00742417|520446722|FG001|Intensive Period|Withdrawal by Subject|1|||
144339533|NCT00742417|520446721|FG000|Intensive Period|Adverse Event|2|||
144339534|NCT00742417|520446722|FG001|Intensive Period|Adverse Event|0|||
144339535|NCT04566601|520446725|FG000|Overall Study|Other than listed|13|||
144339536|NCT04566601|520446726|FG001|Overall Study|Other than listed|4|||
144339537|NCT04566601|520446727|FG002|Overall Study|Other than listed|2|||
144339538|NCT04566601|520446728|FG003|Overall Study|Other than listed|1|||
144339539|NCT04566601|520446729|FG004|Overall Study|Other than listed|4|||
144339540|NCT04566601|520446725|FG000|Overall Study|Protocol deviation|3|||
144339541|NCT04566601|520446726|FG001|Overall Study|Protocol deviation|0|||
144339542|NCT04566601|520446727|FG002|Overall Study|Protocol deviation|1|||
144339543|NCT04566601|520446728|FG003|Overall Study|Protocol deviation|1|||
144339544|NCT04566601|520446729|FG004|Overall Study|Protocol deviation|1|||
144339545|NCT04566601|520446725|FG000|Overall Study|Technical problems|0|||
144339546|NCT04566601|520446726|FG001|Overall Study|Technical problems|0|||
144339547|NCT04566601|520446727|FG002|Overall Study|Technical problems|1|||
144339548|NCT04566601|520446728|FG003|Overall Study|Technical problems|0|||
144339549|NCT04566601|520446729|FG004|Overall Study|Technical problems|0|||
144339550|NCT04566601|520446725|FG000|Overall Study|No reason available|3|||
144339551|NCT04566601|520446726|FG001|Overall Study|No reason available|2|||
144339552|NCT04566601|520446727|FG002|Overall Study|No reason available|7|||
144339553|NCT04566601|520446728|FG003|Overall Study|No reason available|1|||
144339554|NCT04566601|520446729|FG004|Overall Study|No reason available|5|||
144339555|NCT04566601|520446725|FG000|Overall Study|Burden of study procedures|3|||
144339556|NCT04566601|520446726|FG001|Overall Study|Burden of study procedures|0|||
144339557|NCT04566601|520446727|FG002|Overall Study|Burden of study procedures|0|||
144339558|NCT04566601|520446728|FG003|Overall Study|Burden of study procedures|3|||
144339559|NCT04566601|520446729|FG004|Overall Study|Burden of study procedures|1|||
144339560|NCT04566601|520446725|FG000|Overall Study|Change of residence|2|||
144339561|NCT04566601|520446726|FG001|Overall Study|Change of residence|2|||
144339562|NCT04566601|520446727|FG002|Overall Study|Change of residence|0|||
144339563|NCT04566601|520446728|FG003|Overall Study|Change of residence|1|||
144339564|NCT04566601|520446729|FG004|Overall Study|Change of residence|2|||
144339565|NCT04566601|520446725|FG000|Overall Study|Perceived lack of efficacy|2|||
144339566|NCT04566601|520446726|FG001|Overall Study|Perceived lack of efficacy|0|||
144339567|NCT04566601|520446727|FG002|Overall Study|Perceived lack of efficacy|1|||
144339568|NCT04566601|520446728|FG003|Overall Study|Perceived lack of efficacy|1|||
144339569|NCT04566601|520446729|FG004|Overall Study|Perceived lack of efficacy|2|||
144339570|NCT04566601|520446725|FG000|Overall Study|Adverse Event|7|||
144339571|NCT04566601|520446726|FG001|Overall Study|Adverse Event|4|||
144339572|NCT04566601|520446727|FG002|Overall Study|Adverse Event|6|||
144339573|NCT04566601|520446728|FG003|Overall Study|Adverse Event|5|||
144339574|NCT04566601|520446729|FG004|Overall Study|Adverse Event|12|||
144339575|NCT00567359|520446731|FG000|Overall Study|Withdrawal by Subject|1|||
144339576|NCT02397057|520446732|FG000|Overall Study|Withdrawal by Subject|6|||
144339577|NCT02397057|520446733|FG001|Overall Study|Withdrawal by Subject|7|||
144339578|NCT02397057|520446732|FG000|Overall Study|Lost to Follow-up|4|||
144339579|NCT02397057|520446733|FG001|Overall Study|Lost to Follow-up|3|||
144339580|NCT02397057|520446732|FG000|Overall Study|Death|1|||
144339581|NCT02397057|520446733|FG001|Overall Study|Death|0|||
144339582|NCT02397057|520446732|FG000|Overall Study|Adverse Event|0|||
144339583|NCT02397057|520446733|FG001|Overall Study|Adverse Event|1|||
144339584|NCT02397057|520446732|FG000|Overall Study|Physician Decision|0|||
144339585|NCT02397057|520446733|FG001|Overall Study|Physician Decision|1|||
144339586|NCT02397057|520446732|FG000|Overall Study|Subject did not receive study drug|0|||
144339587|NCT02397057|520446733|FG001|Overall Study|Subject did not receive study drug|1|||
144339588|NCT03626545|520446737|FG000|Overall Study|Progressive disease|3|||
144339589|NCT03626545|520446738|FG001|Overall Study|Progressive disease|82|||
144339590|NCT03626545|520446739|FG002|Overall Study|Progressive disease|85|||
144339591|NCT03626545|520446737|FG000|Overall Study|Adverse Event|3|||
144339592|NCT03626545|520446738|FG001|Overall Study|Adverse Event|13|||
144339593|NCT03626545|520446739|FG002|Overall Study|Adverse Event|10|||
144339594|NCT03626545|520446737|FG000|Overall Study|Physician Decision|1|||
144339595|NCT03626545|520446738|FG001|Overall Study|Physician Decision|18|||
144339596|NCT03626545|520446739|FG002|Overall Study|Physician Decision|14|||
144339597|NCT03626545|520446737|FG000|Overall Study|Subject Decision|0|||
144339598|NCT03626545|520446738|FG001|Overall Study|Subject Decision|5|||
144339599|NCT03626545|520446739|FG002|Overall Study|Subject Decision|5|||
144339600|NCT03626545|520446737|FG000|Overall Study|Death|1|||
144339601|NCT03626545|520446738|FG001|Overall Study|Death|1|||
144339602|NCT03626545|520446739|FG002|Overall Study|Death|1|||
144339603|NCT03626545|520446737|FG000|Overall Study|Protocol Deviation|0|||
144339604|NCT03626545|520446738|FG001|Overall Study|Protocol Deviation|1|||
144339605|NCT03626545|520446739|FG002|Overall Study|Protocol Deviation|1|||
144339606|NCT03626545|520446737|FG000|Overall Study|Guardian Decision|0|||
144339607|NCT03626545|520446738|FG001|Overall Study|Guardian Decision|0|||
144339608|NCT03626545|520446739|FG002|Overall Study|Guardian Decision|1|||
144339609|NCT00679172|520446740|FG000|Overall Study|Non-compliance|1|||
144339610|NCT00679172|520446741|FG001|Overall Study|Non-compliance|1|||
144339611|NCT00679172|520446742|FG002|Overall Study|Non-compliance|0|||
144339612|NCT00679172|520446743|FG003|Overall Study|Non-compliance|1|||
144339613|NCT00679172|520446744|FG004|Overall Study|Non-compliance|0|||
144339614|NCT00679172|520446740|FG000|Overall Study|Other not specified|0|||
144339615|NCT00679172|520446741|FG001|Overall Study|Other not specified|0|||
144339616|NCT00679172|520446742|FG002|Overall Study|Other not specified|1|||
144339617|NCT00679172|520446743|FG003|Overall Study|Other not specified|0|||
144339618|NCT00679172|520446744|FG004|Overall Study|Other not specified|0|||
144339619|NCT00793325|520446747|FG000|Overall Study|Protocol Violation|18|||
144339620|NCT00793325|520446747|FG000|Overall Study|Lost to Follow-up|1|||
144339621|NCT03387020|520446748|FG000|Overall Study|Adverse Event|0|||
144339622|NCT03387020|520446749|FG001|Overall Study|Adverse Event|2|||
144339623|NCT03387020|520446750|FG002|Overall Study|Adverse Event|0|||
144339624|NCT03387020|520446748|FG000|Overall Study|Withdrawal by Subject|2|||
144339625|NCT03387020|520446749|FG001|Overall Study|Withdrawal by Subject|0|||
144339626|NCT03387020|520446750|FG002|Overall Study|Withdrawal by Subject|0|||
144339627|NCT00434642|520446751|FG000|Blinded Treatment Phase|Adverse Event|12|||
144339628|NCT00434642|520446752|FG001|Blinded Treatment Phase|Adverse Event|58|||
144339629|NCT00434642|520446751|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
144339630|NCT00434642|520446752|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
144339631|NCT00434642|520446751|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
144339632|NCT00434642|520446752|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
144339633|NCT00434642|520446751|FG000|Blinded Treatment Phase|Physician Decision|19|||
144339634|NCT00434642|520446752|FG001|Blinded Treatment Phase|Physician Decision|27|||
144339635|NCT00434642|520446751|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
144339636|NCT00434642|520446752|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
144339637|NCT00434642|520446751|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
144339638|NCT00434642|520446752|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
144339639|NCT00434642|520446751|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
144339640|NCT00434642|520446752|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
144339641|NCT00434642|520446751|FG000|Open-label Treatment Phase|Adverse Event|0|||
144339642|NCT00434642|520446752|FG001|Open-label Treatment Phase|Adverse Event|5|||
144339643|NCT00434642|520446751|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
144339644|NCT00434642|520446752|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
144339645|NCT02241343|520446755|FG000|Overall Study|Adverse Event|1|||
144339646|NCT01329939|520446760|FG000|Overall Study|Lost to Follow-up|3|||
144339647|NCT01329939|520446761|FG001|Overall Study|Lost to Follow-up|0|||
144339648|NCT01329939|520446762|FG002|Overall Study|Lost to Follow-up|1|||
144339649|NCT01329939|520446763|FG003|Overall Study|Lost to Follow-up|2|||
144339650|NCT01329939|520446760|FG000|Overall Study|Withdrawal by Subject|0|||
144339651|NCT01329939|520446761|FG001|Overall Study|Withdrawal by Subject|1|||
144339652|NCT01329939|520446762|FG002|Overall Study|Withdrawal by Subject|0|||
144339653|NCT01329939|520446763|FG003|Overall Study|Withdrawal by Subject|0|||
144339654|NCT01329939|520446760|FG000|Overall Study|Adverse Event|0|||
144339655|NCT01329939|520446761|FG001|Overall Study|Adverse Event|0|||
144339656|NCT01329939|520446762|FG002|Overall Study|Adverse Event|0|||
144339657|NCT01329939|520446763|FG003|Overall Study|Adverse Event|3|||
144339658|NCT02942485|520446764|FG000|Overall Study|Lost to Follow-up|1|||
144339659|NCT02942485|520446765|FG001|Overall Study|Lost to Follow-up|0|||
144339660|NCT04071158|520446767|FG000|Overall Study|Lost to Follow-up|1|||
144339661|NCT04071158|520446768|FG001|Overall Study|Lost to Follow-up|2|||
144339662|NCT04071158|520446769|FG002|Overall Study|Lost to Follow-up|3|||
144339663|NCT04071158|520446770|FG003|Overall Study|Lost to Follow-up|3|||
144339664|NCT04071158|520446771|FG004|Overall Study|Lost to Follow-up|5|||
144339665|NCT04071158|520446767|FG000|Overall Study|Randomized but not treated|2|||
144339666|NCT04071158|520446768|FG001|Overall Study|Randomized but not treated|2|||
144339667|NCT04071158|520446769|FG002|Overall Study|Randomized but not treated|0|||
144339668|NCT04071158|520446770|FG003|Overall Study|Randomized but not treated|0|||
144339669|NCT04071158|520446771|FG004|Overall Study|Randomized but not treated|0|||
144339670|NCT01286740|520446772|FG000|Overall Study|Enrolled but not treated|1|||
144339671|NCT01286740|520446772|FG000|Overall Study|Protocol Violation|1|||
144339672|NCT02678923|520446773|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
144339673|NCT02678923|520446774|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
144339674|NCT02678923|520446773|FG000|Overall Study|Withdrawal by Subject|3|||
144339675|NCT02678923|520446774|FG001|Overall Study|Withdrawal by Subject|2|||
144339676|NCT02678923|520446773|FG000|Overall Study|Lost to Follow-up|1|||
144339677|NCT02678923|520446774|FG001|Overall Study|Lost to Follow-up|0|||
144339678|NCT02678923|520446773|FG000|Overall Study|Did Not Return for Study Visits|1|||
144339679|NCT02678923|520446774|FG001|Overall Study|Did Not Return for Study Visits|0|||
144339680|NCT00455143|520446775|FG000|Overall Study|Physician Decision|1|||
144339681|NCT00455143|520446775|FG000|Overall Study|Withdrawal by Subject|1|||
144339682|NCT00455143|520446775|FG000|Overall Study|Staff was not avail to follow patient|2|||
144339683|NCT00455143|520446775|FG000|Overall Study|No longer met Inclusion Criteria|1|||
144339684|NCT00455143|520446775|FG000|Overall Study|Surgical time, staff not available|1|||
144339685|NCT03266172|520446776|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
144339686|NCT03266172|520446777|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
144339687|NCT03266172|520446778|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
144339688|NCT03266172|520446776|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
144339689|NCT03266172|520446777|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
144339690|NCT03266172|520446778|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
144339691|NCT03266172|520446776|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
144339692|NCT03266172|520446777|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
144339693|NCT03266172|520446778|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
144339694|NCT03266172|520446776|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
144339695|NCT03266172|520446777|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
144339696|NCT03266172|520446778|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
144339697|NCT03266172|520446776|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
144339698|NCT03266172|520446777|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
144339699|NCT03266172|520446778|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
144339700|NCT03266172|520446776|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
144339701|NCT03266172|520446777|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
144339702|NCT03266172|520446778|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
144339703|NCT00300365|520446780|FG000|Overall Study|Lost to Follow-up|1|||
144339704|NCT00300365|520446781|FG001|Overall Study|Lost to Follow-up|0|||
144339705|NCT00300365|520446780|FG000|Overall Study|Physician Decision|2|||
144339706|NCT00300365|520446781|FG001|Overall Study|Physician Decision|0|||
144339707|NCT00300365|520446780|FG000|Overall Study|Withdrawal by Subject|1|||
144339708|NCT00300365|520446781|FG001|Overall Study|Withdrawal by Subject|0|||
144339709|NCT00300365|520446780|FG000|Overall Study|Adverse Event|0|||
144339710|NCT00300365|520446781|FG001|Overall Study|Adverse Event|2|||
144339711|NCT01374178|520446784|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
144339712|NCT01374178|520446785|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
144339713|NCT01374178|520446784|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
144339714|NCT01374178|520446785|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
144339715|NCT04856904|520446786|FG000|Overall Study|Physician Decision|1|||
144339716|NCT04856904|520446787|FG001|Overall Study|Physician Decision|1|||
144339717|NCT04856904|520446786|FG000|Overall Study|Withdrawal by Subject|13|||
144339718|NCT04856904|520446787|FG001|Overall Study|Withdrawal by Subject|13|||
144339719|NCT04856904|520446786|FG000|Overall Study|Adverse Event|1|||
144339720|NCT04856904|520446787|FG001|Overall Study|Adverse Event|1|||
144339721|NCT04856904|520446786|FG000|Overall Study|Non-compliance with study drug|1|||
144339722|NCT04856904|520446787|FG001|Overall Study|Non-compliance with study drug|1|||
144339723|NCT04856904|520446786|FG000|Overall Study|Lost to Follow-up|4|||
144339724|NCT04856904|520446787|FG001|Overall Study|Lost to Follow-up|4|||
144339725|NCT04856904|520446786|FG000|Overall Study|Withdrawal by Subject|1|||
144339726|NCT04856904|520446787|FG001|Overall Study|Withdrawal by Subject|1|||
144339727|NCT04856904|520446786|FG000|Overall Study|Protocol Violation|1|||
144339728|NCT04856904|520446787|FG001|Overall Study|Protocol Violation|1|||
144339729|NCT01422824|520446788|FG000|Overall Study|Case record form not evaluated|1|||
144339730|NCT01422824|520446788|FG000|Overall Study|Lost to Follow-up|37|||
144339731|NCT01641822|520446789|FG000|Run-in Phase|Noncompliance with study drug|1|||
144339732|NCT01641822|520446790|FG001|Run-in Phase|Noncompliance with study drug|0|||
144339733|NCT01641822|520446791|FG002|Run-in Phase|Noncompliance with study drug|0|||
144339734|NCT01641822|520446789|FG000|Run-in Phase|Adverse Event|3|||
144339735|NCT01641822|520446790|FG001|Run-in Phase|Adverse Event|0|||
144339736|NCT01641822|520446791|FG002|Run-in Phase|Adverse Event|0|||
144339737|NCT01641822|520446789|FG000|Run-in Phase|Withdrew consent|1|||
144339738|NCT01641822|520446790|FG001|Run-in Phase|Withdrew consent|0|||
144339739|NCT01641822|520446791|FG002|Run-in Phase|Withdrew consent|0|||
144339740|NCT01641822|520446789|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
144339741|NCT01641822|520446790|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
144339742|NCT01641822|520446791|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
144339743|NCT01641822|520446789|FG000|Comparative Phase|Noncompliance with study drug|0|||
144339744|NCT01641822|520446790|FG001|Comparative Phase|Noncompliance with study drug|1|||
144339745|NCT01641822|520446791|FG002|Comparative Phase|Noncompliance with study drug|0|||
144339746|NCT01641822|520446789|FG000|Comparative Phase|Investigator's discretion|0|||
144339747|NCT01641822|520446790|FG001|Comparative Phase|Investigator's discretion|0|||
144339748|NCT01641822|520446791|FG002|Comparative Phase|Investigator's discretion|1|||
144339749|NCT01641822|520446789|FG000|Comparative Phase|Pregnancy|0|||
144339750|NCT01641822|520446790|FG001|Comparative Phase|Pregnancy|0|||
144339751|NCT01641822|520446791|FG002|Comparative Phase|Pregnancy|1|||
144339752|NCT01641822|520446789|FG000|Comparative Phase|Adverse event, serious fatal|0|||
144339753|NCT01641822|520446790|FG001|Comparative Phase|Adverse event, serious fatal|1|||
144360041|NCT01601535|520525139|FG004|Phase 2|Started Another Treatment|1|||
144339754|NCT01641822|520446791|FG002|Comparative Phase|Adverse event, serious fatal|0|||
144339755|NCT01641822|520446789|FG000|Comparative Phase|Withdrew consent|0|||
144339756|NCT01641822|520446790|FG001|Comparative Phase|Withdrew consent|3|||
144339757|NCT01641822|520446791|FG002|Comparative Phase|Withdrew consent|7|||
144339758|NCT01641822|520446789|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
144339759|NCT01641822|520446790|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
144339760|NCT01641822|520446791|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
144339761|NCT02760810|520446792|FG000|Overall Study|Protocol Violation|1|||
144339762|NCT02421601|520446793|FG000|Overall Study|Adverse Event|4|||
144339763|NCT02421601|520446793|FG000|Overall Study|Lack of Efficacy|5|||
144339764|NCT02421601|520446793|FG000|Overall Study|Physician Decision|1|||
144339765|NCT02421601|520446793|FG000|Overall Study|Withdrawal by Subject|31|||
144339766|NCT02421601|520446793|FG000|Overall Study|Others|41|||
144339767|NCT00117793|520446794|FG000|Overall Study|Withdrawal by Subject|12|||
144339768|NCT00470418|520446795|FG000|Overall Study|Withdrawal by Subject|1|||
144339769|NCT00470418|520446796|FG001|Overall Study|Withdrawal by Subject|0|||
144339770|NCT02453555|520446800|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
144339771|NCT02453555|520446801|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
144339772|NCT02453555|520446802|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
144339773|NCT02453555|520446803|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
144339774|NCT02453555|520446804|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
144339775|NCT02453555|520446805|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
144339776|NCT02453555|520446800|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
144339777|NCT02453555|520446801|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
144339778|NCT02453555|520446802|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
144339779|NCT02453555|520446803|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
144339780|NCT02453555|520446804|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
144339781|NCT02453555|520446805|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
144339782|NCT02453555|520446800|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
144339783|NCT02453555|520446801|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
144339784|NCT02453555|520446802|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144339785|NCT02453555|520446803|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144339786|NCT02453555|520446804|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144339787|NCT02453555|520446805|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
144339788|NCT02453555|520446800|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
144339789|NCT02453555|520446801|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
144339790|NCT02453555|520446802|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
144339791|NCT02453555|520446803|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
144339792|NCT02453555|520446804|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
144339793|NCT02453555|520446805|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
144339794|NCT02453555|520446800|FG000|Extension Period|Adverse Event|0|||
144339795|NCT02453555|520446801|FG001|Extension Period|Adverse Event|0|||
144339796|NCT02453555|520446802|FG002|Extension Period|Adverse Event|1|||
144339797|NCT02453555|520446803|FG003|Extension Period|Adverse Event|2|||
144339798|NCT02453555|520446804|FG004|Extension Period|Adverse Event|1|||
144339799|NCT02453555|520446805|FG005|Extension Period|Adverse Event|1|||
144339800|NCT02453555|520446800|FG000|Extension Period|Protocol Violation|0|||
144339801|NCT02453555|520446801|FG001|Extension Period|Protocol Violation|0|||
144339802|NCT02453555|520446802|FG002|Extension Period|Protocol Violation|1|||
144339803|NCT02453555|520446803|FG003|Extension Period|Protocol Violation|0|||
144339804|NCT02453555|520446804|FG004|Extension Period|Protocol Violation|0|||
144339805|NCT02453555|520446805|FG005|Extension Period|Protocol Violation|0|||
144339806|NCT02453555|520446800|FG000|Extension Period|Withdrawal by Subject|0|||
144339807|NCT02453555|520446801|FG001|Extension Period|Withdrawal by Subject|0|||
144339808|NCT02453555|520446802|FG002|Extension Period|Withdrawal by Subject|1|||
144339809|NCT02453555|520446803|FG003|Extension Period|Withdrawal by Subject|0|||
144339810|NCT02453555|520446804|FG004|Extension Period|Withdrawal by Subject|0|||
144339811|NCT02453555|520446805|FG005|Extension Period|Withdrawal by Subject|0|||
144339812|NCT03689855|520446810|FG000|Overall Study|Adverse Event|3|||
144339813|NCT03689855|520446810|FG000|Overall Study|Withdrawal by Subject|1|||
144339814|NCT01438177|520446811|FG000|Overall Study|Withdrawal by Subject|1|||
144339815|NCT01438177|520446811|FG000|Overall Study|Initiation of new therapy|1|||
144339816|NCT00619099|520446812|FG000|Overall Study|Progressive Disease|7|||
144339817|NCT00619099|520446813|FG001|Overall Study|Progressive Disease|5|||
144339818|NCT00619099|520446812|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
144339819|NCT00619099|520446813|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
144339820|NCT00619099|520446812|FG000|Overall Study|Adverse Event|4|||
144339821|NCT00619099|520446813|FG001|Overall Study|Adverse Event|3|||
144339822|NCT00619099|520446812|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
144339823|NCT00619099|520446813|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
144339824|NCT00619099|520446812|FG000|Overall Study|Withdrawal by Subject|10|||
144339825|NCT00619099|520446813|FG001|Overall Study|Withdrawal by Subject|2|||
144339826|NCT00619099|520446812|FG000|Overall Study|Physician Decision|9|||
144339827|NCT00619099|520446813|FG001|Overall Study|Physician Decision|6|||
144339828|NCT00885482|520446814|FG000|Overall Study|Pregnancy|1|||
144339829|NCT00885482|520446814|FG000|Overall Study|Lack of Efficacy|1|||
144339830|NCT00885482|520446814|FG000|Overall Study|Death|1|||
144339831|NCT00885482|520446814|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
144339832|NCT02772978|520446815|FG000|Overall Study|Withdrawal by Subject|1|||
144339833|NCT02772978|520446816|FG001|Overall Study|Withdrawal by Subject|1|||
144339834|NCT01026220|520446817|FG000|Induction|Death|1|||
144339835|NCT01026220|520446818|FG001|Induction|Death|0|||
144339836|NCT01026220|520446819|FG002|Induction|Death|0|||
144339837|NCT01026220|520446817|FG000|Induction|Lack of Efficacy|2|||
144339838|NCT01026220|520446818|FG001|Induction|Lack of Efficacy|0|||
144339839|NCT01026220|520446819|FG002|Induction|Lack of Efficacy|0|||
144339840|NCT01026220|520446817|FG000|Induction|Physician Decision|12|||
144339841|NCT01026220|520446818|FG001|Induction|Physician Decision|0|||
144339842|NCT01026220|520446819|FG002|Induction|Physician Decision|0|||
144339843|NCT01026220|520446817|FG000|Induction|Withdrawal by Subject|9|||
144339844|NCT01026220|520446818|FG001|Induction|Withdrawal by Subject|0|||
144339845|NCT01026220|520446819|FG002|Induction|Withdrawal by Subject|0|||
144339846|NCT01026220|520446817|FG000|Induction|Ineligible|1|||
144339847|NCT01026220|520446818|FG001|Induction|Ineligible|0|||
144339848|NCT01026220|520446819|FG002|Induction|Ineligible|0|||
144339849|NCT01026220|520446817|FG000|Consolidation Maintenance|Death|0|||
144339850|NCT01026220|520446818|FG001|Consolidation Maintenance|Death|1|||
144339851|NCT01026220|520446819|FG002|Consolidation Maintenance|Death|0|||
144339852|NCT01026220|520446817|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
144339853|NCT01026220|520446818|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
144339854|NCT01026220|520446819|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
144339855|NCT01026220|520446817|FG000|Consolidation Maintenance|Physician Decision|0|||
144339856|NCT01026220|520446818|FG001|Consolidation Maintenance|Physician Decision|2|||
144339857|NCT01026220|520446819|FG002|Consolidation Maintenance|Physician Decision|7|||
144339858|NCT01026220|520446817|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
144339859|NCT01026220|520446818|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
144339860|NCT01026220|520446819|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
144339861|NCT01009086|520446824|FG000|Overall Study|Lack of Efficacy|16|||
144339862|NCT01009086|520446825|FG001|Overall Study|Lack of Efficacy|15|||
144339863|NCT01009086|520446826|FG002|Overall Study|Lack of Efficacy|9|||
144339864|NCT01009086|520446824|FG000|Overall Study|Lost to Follow-up|4|||
144339865|NCT01009086|520446825|FG001|Overall Study|Lost to Follow-up|5|||
144339866|NCT01009086|520446826|FG002|Overall Study|Lost to Follow-up|3|||
144339867|NCT01009086|520446824|FG000|Overall Study|Adverse Event|12|||
144339868|NCT01009086|520446825|FG001|Overall Study|Adverse Event|11|||
144339869|NCT01009086|520446826|FG002|Overall Study|Adverse Event|8|||
144339870|NCT01009086|520446824|FG000|Overall Study|Withdrawal by Subject|9|||
144339871|NCT01009086|520446825|FG001|Overall Study|Withdrawal by Subject|11|||
144339872|NCT01009086|520446826|FG002|Overall Study|Withdrawal by Subject|13|||
144339873|NCT01009086|520446824|FG000|Overall Study|Other|3|||
144339874|NCT01009086|520446825|FG001|Overall Study|Other|5|||
144339875|NCT01009086|520446826|FG002|Overall Study|Other|1|||
144339876|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
144339877|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
144339878|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
144339879|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
144339880|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
144339881|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
144339882|NCT01389323|520446827|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
144339883|NCT01389323|520446827|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
144339884|NCT01389323|520446827|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
144339885|NCT01389323|520446827|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
144339886|NCT01389323|520446827|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
144339887|NCT00559988|520446829|FG000|Overall Study|Death|147|||
144339888|NCT00559988|520446830|FG001|Overall Study|Death|140|||
144339889|NCT00559988|520446829|FG000|Overall Study|Withdrawal by Subject|152|||
144339890|NCT00559988|520446830|FG001|Overall Study|Withdrawal by Subject|139|||
144339891|NCT00559988|520446829|FG000|Overall Study|Lost to Follow-up|42|||
144339892|NCT00559988|520446830|FG001|Overall Study|Lost to Follow-up|56|||
144339893|NCT00559988|520446829|FG000|Overall Study|ICD device explanted|10|||
144339894|NCT00559988|520446830|FG001|Overall Study|ICD device explanted|17|||
144339895|NCT00788710|520446831|FG000|Overall Study|Adverse Event|1|||
144339896|NCT00788710|520446832|FG001|Overall Study|Adverse Event|3|||
144339897|NCT00788710|520446833|FG002|Overall Study|Adverse Event|4|||
144339898|NCT00788710|520446831|FG000|Overall Study|Lack of Efficacy|0|||
144339899|NCT00788710|520446832|FG001|Overall Study|Lack of Efficacy|0|||
144339900|NCT00788710|520446833|FG002|Overall Study|Lack of Efficacy|1|||
144339901|NCT00788710|520446831|FG000|Overall Study|Lost to Follow-up|0|||
144339902|NCT00788710|520446832|FG001|Overall Study|Lost to Follow-up|1|||
144339903|NCT00788710|520446833|FG002|Overall Study|Lost to Follow-up|0|||
144339904|NCT00788710|520446831|FG000|Overall Study|Physician Decision|2|||
144339905|NCT00788710|520446832|FG001|Overall Study|Physician Decision|1|||
144339906|NCT00788710|520446833|FG002|Overall Study|Physician Decision|0|||
144339907|NCT00788710|520446831|FG000|Overall Study|Protocol Violation|0|||
144339908|NCT00788710|520446832|FG001|Overall Study|Protocol Violation|1|||
144339909|NCT00788710|520446833|FG002|Overall Study|Protocol Violation|1|||
144339910|NCT00788710|520446831|FG000|Overall Study|Withdrawal by Subject|2|||
144339911|NCT00788710|520446832|FG001|Overall Study|Withdrawal by Subject|2|||
144339912|NCT00788710|520446833|FG002|Overall Study|Withdrawal by Subject|0|||
144339913|NCT00727558|520446841|FG000|Overall Study|Lens issue|0|||
144339914|NCT00727558|520446842|FG001|Overall Study|Lens issue|1|||
144339915|NCT00727558|520446841|FG000|Overall Study|Adverse Event|0|||
144339916|NCT00727558|520446842|FG001|Overall Study|Adverse Event|1|||
144339917|NCT00727558|520446841|FG000|Overall Study|Subject unable to return for follow-up|1|||
144339918|NCT00727558|520446842|FG001|Overall Study|Subject unable to return for follow-up|1|||
144339919|NCT00727558|520446841|FG000|Overall Study|Lost to Follow-up|1|||
144339920|NCT00727558|520446842|FG001|Overall Study|Lost to Follow-up|0|||
144339921|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
144339922|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
144339923|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
144339924|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
144339925|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
144339926|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
144339927|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
144339928|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
144339929|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Death|0|||
144339930|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Death|1|||
144339931|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
144339932|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
144339933|NCT03281304|520446848|FG000|Treatment Phase (up to 42 Months)|Other|0|||
144339934|NCT03281304|520446849|FG001|Treatment Phase (up to 42 Months)|Other|2|||
144339935|NCT03281304|520446848|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
144339936|NCT03281304|520446849|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
144339937|NCT01114438|520446850|FG000|Overall Study|Adverse Event|10|||
144339938|NCT01114438|520446850|FG000|Overall Study|concomitant medication|1|||
144339939|NCT01114438|520446850|FG000|Overall Study|Physician Decision|1|||
144339940|NCT01114438|520446850|FG000|Overall Study|Withdrawal by Subject|2|||
144339941|NCT00428844|520446853|FG000|Completed Study Drug Treatment|Adverse Event|2|||
144339942|NCT00428844|520446854|FG001|Completed Study Drug Treatment|Adverse Event|4|||
144339943|NCT00428844|520446855|FG002|Completed Study Drug Treatment|Adverse Event|4|||
144339944|NCT00428844|520446853|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
144339945|NCT00428844|520446854|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
144339946|NCT00428844|520446855|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
144339947|NCT00428844|520446853|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
144339948|NCT00428844|520446854|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
144339949|NCT00428844|520446855|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
144339950|NCT00428844|520446853|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
144339951|NCT00428844|520446854|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
144339952|NCT00428844|520446855|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
144339953|NCT00428844|520446853|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
144339954|NCT00428844|520446854|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
144339955|NCT00428844|520446855|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
144339956|NCT00428844|520446853|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
144339957|NCT00428844|520446854|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
144339958|NCT00428844|520446855|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
144339959|NCT00428844|520446853|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
144339960|NCT00428844|520446854|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
144339961|NCT00428844|520446855|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
144339962|NCT00428844|520446853|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
144339963|NCT00428844|520446854|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
144339964|NCT00428844|520446855|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
144339965|NCT00428844|520446853|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
144339966|NCT00428844|520446854|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
144339967|NCT00428844|520446855|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
144339968|NCT00488826|520446856|FG000|Overall Study|Withdrawal by Subject|40|||
144339969|NCT00488826|520446857|FG001|Overall Study|Withdrawal by Subject|35|||
144339970|NCT00488826|520446858|FG002|Overall Study|Withdrawal by Subject|19|||
144339971|NCT00488826|520446856|FG000|Overall Study|Protocol Violation|0|||
144339972|NCT00488826|520446857|FG001|Overall Study|Protocol Violation|0|||
144339973|NCT00488826|520446858|FG002|Overall Study|Protocol Violation|2|||
144339974|NCT00488826|520446856|FG000|Overall Study|Adverse Event|9|||
144339975|NCT00488826|520446857|FG001|Overall Study|Adverse Event|15|||
144339976|NCT00488826|520446858|FG002|Overall Study|Adverse Event|4|||
144339977|NCT00488826|520446856|FG000|Overall Study|Lost to Follow-up|5|||
144339978|NCT00488826|520446857|FG001|Overall Study|Lost to Follow-up|1|||
144339979|NCT00488826|520446858|FG002|Overall Study|Lost to Follow-up|0|||
144339980|NCT00488826|520446856|FG000|Overall Study|Protocol Deviations|2|||
144339981|NCT00488826|520446857|FG001|Overall Study|Protocol Deviations|1|||
144339982|NCT00488826|520446858|FG002|Overall Study|Protocol Deviations|1|||
144339983|NCT04667104|520446866|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
144339984|NCT04667104|520446867|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
144339985|NCT04667104|520446868|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
144339986|NCT03208088|520446869|FG000|Period 2|Withdrawal by Subject|0|||
144339987|NCT03208088|520446870|FG001|Period 2|Withdrawal by Subject|0|||
144339988|NCT03208088|520446871|FG002|Period 2|Withdrawal by Subject|0|||
144339989|NCT03208088|520446872|FG003|Period 2|Withdrawal by Subject|0|||
144339990|NCT03208088|520446873|FG004|Period 2|Withdrawal by Subject|0|||
144339991|NCT03208088|520446874|FG005|Period 2|Withdrawal by Subject|0|||
144339992|NCT03208088|520446875|FG006|Period 2|Withdrawal by Subject|0|||
144339993|NCT03208088|520446876|FG007|Period 2|Withdrawal by Subject|0|||
144339994|NCT03208088|520446877|FG008|Period 2|Withdrawal by Subject|1|||
144339995|NCT03208088|520446878|FG009|Period 2|Withdrawal by Subject|0|||
144339996|NCT03208088|520446869|FG000|Period 3|Unsatisfactory Test Article|0|||
144339997|NCT03208088|520446870|FG001|Period 3|Unsatisfactory Test Article|0|||
144339998|NCT03208088|520446871|FG002|Period 3|Unsatisfactory Test Article|0|||
144339999|NCT03208088|520446872|FG003|Period 3|Unsatisfactory Test Article|1|||
144340000|NCT03208088|520446873|FG004|Period 3|Unsatisfactory Test Article|0|||
144340001|NCT03208088|520446874|FG005|Period 3|Unsatisfactory Test Article|0|||
144340002|NCT03208088|520446875|FG006|Period 3|Unsatisfactory Test Article|0|||
144340003|NCT03208088|520446876|FG007|Period 3|Unsatisfactory Test Article|0|||
144340004|NCT03208088|520446877|FG008|Period 3|Unsatisfactory Test Article|0|||
144340005|NCT03208088|520446878|FG009|Period 3|Unsatisfactory Test Article|0|||
144340006|NCT03208088|520446869|FG000|Period 4|Unsatisfactory Test Article|0|||
144340007|NCT03208088|520446870|FG001|Period 4|Unsatisfactory Test Article|0|||
144340008|NCT03208088|520446871|FG002|Period 4|Unsatisfactory Test Article|0|||
144340009|NCT03208088|520446872|FG003|Period 4|Unsatisfactory Test Article|1|||
144340010|NCT03208088|520446873|FG004|Period 4|Unsatisfactory Test Article|0|||
144340011|NCT03208088|520446874|FG005|Period 4|Unsatisfactory Test Article|0|||
144340012|NCT03208088|520446875|FG006|Period 4|Unsatisfactory Test Article|0|||
144340013|NCT03208088|520446876|FG007|Period 4|Unsatisfactory Test Article|0|||
144340014|NCT03208088|520446877|FG008|Period 4|Unsatisfactory Test Article|0|||
144340015|NCT03208088|520446878|FG009|Period 4|Unsatisfactory Test Article|0|||
144340016|NCT02577016|520446883|FG000|Overall Study|Adverse Event|2|||
144340017|NCT02577016|520446884|FG001|Overall Study|Adverse Event|1|||
144340018|NCT02577016|520446883|FG000|Overall Study|Physician Decision|0|||
144340019|NCT02577016|520446884|FG001|Overall Study|Physician Decision|1|||
144340020|NCT02126839|520446885|FG000|Overall Study|Adverse Event|0|||
144340021|NCT02126839|520446886|FG001|Overall Study|Adverse Event|1|||
144340022|NCT02126839|520446885|FG000|Overall Study|Withdrawal by Subject|1|||
144340023|NCT02126839|520446886|FG001|Overall Study|Withdrawal by Subject|0|||
144340024|NCT02126839|520446885|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144340025|NCT02126839|520446886|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144340026|NCT02126839|520446885|FG000|Overall Study|Protocol Violation|2|||
144340027|NCT02126839|520446886|FG001|Overall Study|Protocol Violation|3|||
144340028|NCT02126839|520446885|FG000|Overall Study|Sponsor request|0|||
144340029|NCT02126839|520446886|FG001|Overall Study|Sponsor request|1|||
144340030|NCT02126839|520446885|FG000|Overall Study|Lost to Follow-up|1|||
144340031|NCT02126839|520446886|FG001|Overall Study|Lost to Follow-up|4|||
144340032|NCT02126839|520446885|FG000|Overall Study|Other|5|||
144340033|NCT02126839|520446886|FG001|Overall Study|Other|5|||
144340034|NCT00422383|520446887|FG000|Overall Study|Adverse Event|5|||
144340035|NCT00422383|520446888|FG001|Overall Study|Adverse Event|3|||
144340036|NCT00422383|520446889|FG002|Overall Study|Adverse Event|1|||
144340037|NCT00422383|520446890|FG003|Overall Study|Adverse Event|1|||
144340038|NCT00422383|520446891|FG004|Overall Study|Adverse Event|0|||
144340039|NCT00422383|520446887|FG000|Overall Study|Lack of Efficacy|4|||
144340040|NCT00422383|520446888|FG001|Overall Study|Lack of Efficacy|4|||
144340041|NCT00422383|520446889|FG002|Overall Study|Lack of Efficacy|2|||
144340042|NCT00422383|520446890|FG003|Overall Study|Lack of Efficacy|1|||
144340043|NCT00422383|520446891|FG004|Overall Study|Lack of Efficacy|1|||
144340044|NCT00422383|520446887|FG000|Overall Study|Lost to Follow-up|0|||
144340045|NCT00422383|520446888|FG001|Overall Study|Lost to Follow-up|1|||
144340046|NCT00422383|520446889|FG002|Overall Study|Lost to Follow-up|0|||
144340047|NCT00422383|520446890|FG003|Overall Study|Lost to Follow-up|0|||
144340048|NCT00422383|520446891|FG004|Overall Study|Lost to Follow-up|1|||
144340049|NCT00422383|520446887|FG000|Overall Study|Protocol Violation|1|||
144340050|NCT00422383|520446888|FG001|Overall Study|Protocol Violation|1|||
144340051|NCT00422383|520446889|FG002|Overall Study|Protocol Violation|1|||
144340052|NCT00422383|520446890|FG003|Overall Study|Protocol Violation|0|||
144340053|NCT00422383|520446891|FG004|Overall Study|Protocol Violation|0|||
144340054|NCT00422383|520446887|FG000|Overall Study|Withdrawal by Subject|5|||
144340055|NCT00422383|520446888|FG001|Overall Study|Withdrawal by Subject|5|||
144340056|NCT00422383|520446889|FG002|Overall Study|Withdrawal by Subject|0|||
144340057|NCT00422383|520446890|FG003|Overall Study|Withdrawal by Subject|0|||
144340058|NCT00422383|520446891|FG004|Overall Study|Withdrawal by Subject|1|||
144340059|NCT00411632|520446892|FG000|Overall Study|Death|1|||
144340060|NCT00566254|520446893|FG000|Overall Study|Adverse Event|3|||
144340061|NCT00566254|520446894|FG001|Overall Study|Adverse Event|1|||
144340062|NCT00566254|520446893|FG000|Overall Study|Protocol Violation|1|||
144340063|NCT00566254|520446894|FG001|Overall Study|Protocol Violation|3|||
144340064|NCT00566254|520446893|FG000|Overall Study|Withdrawal by Subject|1|||
144340065|NCT00566254|520446894|FG001|Overall Study|Withdrawal by Subject|2|||
144340066|NCT00566254|520446893|FG000|Overall Study|Lack of Efficacy|5|||
144340067|NCT00566254|520446894|FG001|Overall Study|Lack of Efficacy|6|||
144340068|NCT00566254|520446893|FG000|Overall Study|Other|0|||
144340069|NCT00566254|520446894|FG001|Overall Study|Other|2|||
144340070|NCT01108523|520446895|FG000|Overall Study|Protocol Violation|4|||
144340071|NCT00703924|520449088|FG000|Overall Study|Withdrawal by Subject|1|||
144340072|NCT00703924|520449089|FG001|Overall Study|Withdrawal by Subject|1|||
144340073|NCT03047031|520449090|FG000|Overall Study|Other than listed|1|||
144340074|NCT03047031|520449091|FG001|Overall Study|Other than listed|0|||
144340075|NCT03047031|520449092|FG002|Overall Study|Other than listed|0|||
144340076|NCT03047031|520449090|FG000|Overall Study|Lost to Follow-up|4|||
144340077|NCT03047031|520449091|FG001|Overall Study|Lost to Follow-up|0|||
144340078|NCT03047031|520449092|FG002|Overall Study|Lost to Follow-up|0|||
144340079|NCT03047031|520449090|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
144340080|NCT03047031|520449091|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
144340081|NCT03047031|520449092|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
144340082|NCT03047031|520449090|FG000|Overall Study|Adverse Event|1|||
144340083|NCT03047031|520449091|FG001|Overall Study|Adverse Event|0|||
144340084|NCT03047031|520449092|FG002|Overall Study|Adverse Event|0|||
144340085|NCT03047031|520449090|FG000|Overall Study|Withdrawal by Subject|2|||
144340086|NCT03047031|520449091|FG001|Overall Study|Withdrawal by Subject|0|||
144340087|NCT03047031|520449092|FG002|Overall Study|Withdrawal by Subject|0|||
144340088|NCT03047031|520449090|FG000|Overall Study|Change to other medication|2|||
144340089|NCT03047031|520449091|FG001|Overall Study|Change to other medication|0|||
144340090|NCT03047031|520449092|FG002|Overall Study|Change to other medication|0|||
144340091|NCT03047031|520449090|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
144340092|NCT03047031|520449091|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
144340093|NCT03047031|520449092|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
144340094|NCT01450098|520449093|FG000|Period 3|Protocol Violation|0|||
144340095|NCT01450098|520449094|FG001|Period 3|Protocol Violation|1|||
144340096|NCT01450098|520449093|FG000|Period 3|Withdrawal by Subject|0|||
144340097|NCT01450098|520449094|FG001|Period 3|Withdrawal by Subject|2|||
144340098|NCT03229109|520449096|FG000|Overall Study|Withdrawal by Subject|0|||
144340099|NCT03229109|520449097|FG001|Overall Study|Withdrawal by Subject|0|||
144340100|NCT03229109|520449098|FG002|Overall Study|Withdrawal by Subject|0|||
144340101|NCT03229109|520449099|FG003|Overall Study|Withdrawal by Subject|1|||
144340102|NCT04207749|520449100|FG000|Overall Study|Lost to Follow-up|0|||
144340103|NCT04207749|520449101|FG001|Overall Study|Lost to Follow-up|2|||
144340104|NCT04207749|520449100|FG000|Overall Study|Protocol Violation|0|||
144340105|NCT04207749|520449101|FG001|Overall Study|Protocol Violation|1|||
144340106|NCT04207749|520449100|FG000|Overall Study|Withdrawal by Subject|3|||
144340107|NCT04207749|520449101|FG001|Overall Study|Withdrawal by Subject|0|||
144340108|NCT04207749|520449100|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
144340109|NCT04207749|520449101|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
144340110|NCT03416127|520449104|FG000|Overall Study|Withdrawal by Subject|0|||
144340111|NCT03416127|520449105|FG001|Overall Study|Withdrawal by Subject|1|||
144340112|NCT03416127|520449106|FG002|Overall Study|Withdrawal by Subject|1|||
144340113|NCT01971008|520449107|FG000|Overall Study|Protocol Violation|2|||
144340114|NCT01971008|520449108|FG001|Overall Study|Protocol Violation|1|||
144340115|NCT03775512|520449109|FG000|Overall Study|Death|1|||
144340116|NCT03775512|520449110|FG001|Overall Study|Death|1|||
144340117|NCT03775512|520449109|FG000|Overall Study|Withdrawal by Subject|7|||
144340118|NCT03775512|520449110|FG001|Overall Study|Withdrawal by Subject|4|||
144340119|NCT03775512|520449109|FG000|Overall Study|Lost to Follow-up|5|||
144340120|NCT03775512|520449110|FG001|Overall Study|Lost to Follow-up|5|||
144340121|NCT03775512|520449109|FG000|Overall Study|Excluded before Catheter insertion|14|||
144340122|NCT03775512|520449110|FG001|Overall Study|Excluded before Catheter insertion|5|||
144340123|NCT03775512|520449109|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
144340124|NCT03775512|520449110|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
144340125|NCT03775512|520449109|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
144340126|NCT03775512|520449110|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
144340127|NCT01959139|520449113|FG000|Phase II|Disease progression|0|||
144340128|NCT01959139|520449114|FG001|Phase II|Disease progression|0|||
144340129|NCT01959139|520449115|FG002|Phase II|Disease progression|26|||
144340130|NCT01959139|520449116|FG003|Phase II|Disease progression|34|||
144340131|NCT01959139|520449113|FG000|Phase II|Adverse Event|0|||
144340132|NCT01959139|520449114|FG001|Phase II|Adverse Event|0|||
144340133|NCT01959139|520449115|FG002|Phase II|Adverse Event|10|||
144340134|NCT01959139|520449116|FG003|Phase II|Adverse Event|11|||
144340135|NCT01959139|520449113|FG000|Phase II|Patient Refusal|0|||
144340136|NCT01959139|520449114|FG001|Phase II|Patient Refusal|0|||
144340137|NCT01959139|520449115|FG002|Phase II|Patient Refusal|5|||
144340138|NCT01959139|520449116|FG003|Phase II|Patient Refusal|4|||
144340139|NCT01959139|520449113|FG000|Phase II|Death|0|||
144340140|NCT01959139|520449114|FG001|Phase II|Death|0|||
144340141|NCT01959139|520449115|FG002|Phase II|Death|3|||
144340142|NCT01959139|520449116|FG003|Phase II|Death|1|||
144340143|NCT01959139|520449113|FG000|Phase II|Other/Unknown|0|||
144340144|NCT01959139|520449114|FG001|Phase II|Other/Unknown|0|||
144340145|NCT01959139|520449115|FG002|Phase II|Other/Unknown|8|||
144340146|NCT01959139|520449116|FG003|Phase II|Other/Unknown|5|||
144340147|NCT01959139|520449113|FG000|Phase II|On treatment|0|||
144340148|NCT01959139|520449114|FG001|Phase II|On treatment|0|||
144340149|NCT01959139|520449115|FG002|Phase II|On treatment|4|||
144340150|NCT01959139|520449116|FG003|Phase II|On treatment|0|||
144340151|NCT00858208|520449117|FG000|Overall Study|Adverse Event|3|||
144340152|NCT00858208|520449117|FG000|Overall Study|Lost to Follow-up|26|||
144340153|NCT00858208|520449117|FG000|Overall Study|Participant refused|40|||
144340154|NCT00858208|520449117|FG000|Overall Study|Other|10|||
144340155|NCT02516592|520449124|FG000|Overall Study|Patient withdrew consent|5|||
144340156|NCT02516592|520449125|FG001|Overall Study|Patient withdrew consent|2|||
144340157|NCT02516592|520449124|FG000|Overall Study|Protocol deviation|4|||
144340158|NCT02516592|520449125|FG001|Overall Study|Protocol deviation|4|||
144340159|NCT02516592|520449124|FG000|Overall Study|Lost to Follow-up|2|||
144340160|NCT02516592|520449125|FG001|Overall Study|Lost to Follow-up|3|||
144340161|NCT02516592|520449124|FG000|Overall Study|Patient/guardian decision|2|||
144340162|NCT02516592|520449125|FG001|Overall Study|Patient/guardian decision|1|||
144340163|NCT02516592|520449124|FG000|Overall Study|Adverse Event|1|||
144340164|NCT02516592|520449125|FG001|Overall Study|Adverse Event|2|||
144340165|NCT02516592|520449124|FG000|Overall Study|Abnormal test procedure result|1|||
144340166|NCT02516592|520449125|FG001|Overall Study|Abnormal test procedure result|0|||
144340167|NCT02516592|520449124|FG000|Overall Study|Death|1|||
144340168|NCT02516592|520449125|FG001|Overall Study|Death|1|||
144340169|NCT01110382|520449137|FG000|Overall Study|Withdrawal by Subject|0|||
144340170|NCT01110382|520449138|FG001|Overall Study|Withdrawal by Subject|1|||
144340171|NCT01110382|520449137|FG000|Overall Study|Protocol Violation|0|||
144340172|NCT01110382|520449138|FG001|Overall Study|Protocol Violation|1|||
144340173|NCT00098306|520449141|FG000|Double Blind|Randomized, not treated|9|||
144340174|NCT00098306|520449142|FG001|Double Blind|Randomized, not treated|5|||
144340175|NCT00098306|520449143|FG002|Double Blind|Randomized, not treated|2|||
144340176|NCT00098306|520449144|FG003|Double Blind|Randomized, not treated|0|||
144340177|NCT00098306|520449145|FG004|Double Blind|Randomized, not treated|0|||
144340178|NCT00098306|520449146|FG005|Double Blind|Randomized, not treated|0|||
144340179|NCT00098306|520449147|FG006|Double Blind|Randomized, not treated|0|||
144340180|NCT00098306|520449141|FG000|Double Blind|Ongoing at cut-off date|151|||
144340181|NCT00098306|520449142|FG001|Double Blind|Ongoing at cut-off date|166|||
144340182|NCT00098306|520449143|FG002|Double Blind|Ongoing at cut-off date|72|||
144340183|NCT00098306|520449144|FG003|Double Blind|Ongoing at cut-off date|0|||
144340184|NCT00098306|520449145|FG004|Double Blind|Ongoing at cut-off date|0|||
144340185|NCT00098306|520449146|FG005|Double Blind|Ongoing at cut-off date|0|||
144340186|NCT00098306|520449147|FG006|Double Blind|Ongoing at cut-off date|0|||
144340187|NCT00098306|520449141|FG000|Double Blind|Adverse Event|11|||
144340188|NCT00098306|520449142|FG001|Double Blind|Adverse Event|10|||
144340189|NCT00098306|520449143|FG002|Double Blind|Adverse Event|6|||
144340190|NCT00098306|520449144|FG003|Double Blind|Adverse Event|0|||
144340191|NCT00098306|520449145|FG004|Double Blind|Adverse Event|0|||
144340192|NCT00098306|520449146|FG005|Double Blind|Adverse Event|0|||
144340193|NCT00098306|520449147|FG006|Double Blind|Adverse Event|0|||
144340194|NCT00098306|520449141|FG000|Double Blind|Lack of Efficacy|43|||
144340195|NCT00098306|520449142|FG001|Double Blind|Lack of Efficacy|34|||
144340196|NCT00098306|520449143|FG002|Double Blind|Lack of Efficacy|17|||
144340197|NCT00098306|520449144|FG003|Double Blind|Lack of Efficacy|0|||
144340198|NCT00098306|520449145|FG004|Double Blind|Lack of Efficacy|0|||
144340199|NCT00098306|520449146|FG005|Double Blind|Lack of Efficacy|0|||
144340200|NCT00098306|520449147|FG006|Double Blind|Lack of Efficacy|0|||
144340201|NCT00098306|520449141|FG000|Double Blind|Death|1|||
144340202|NCT00098306|520449142|FG001|Double Blind|Death|4|||
144340203|NCT00098306|520449143|FG002|Double Blind|Death|1|||
144340204|NCT00098306|520449144|FG003|Double Blind|Death|0|||
144340205|NCT00098306|520449145|FG004|Double Blind|Death|0|||
144340206|NCT00098306|520449146|FG005|Double Blind|Death|0|||
144340207|NCT00098306|520449147|FG006|Double Blind|Death|0|||
144340208|NCT00098306|520449141|FG000|Double Blind|Participant defaulted|19|||
144340209|NCT00098306|520449142|FG001|Double Blind|Participant defaulted|18|||
144340210|NCT00098306|520449143|FG002|Double Blind|Participant defaulted|11|||
144340211|NCT00098306|520449144|FG003|Double Blind|Participant defaulted|0|||
144340212|NCT00098306|520449145|FG004|Double Blind|Participant defaulted|0|||
144340213|NCT00098306|520449146|FG005|Double Blind|Participant defaulted|0|||
144340214|NCT00098306|520449147|FG006|Double Blind|Participant defaulted|0|||
144340215|NCT00098306|520449141|FG000|Double Blind|Un-specified|7|||
144340216|NCT00098306|520449142|FG001|Double Blind|Un-specified|3|||
144340217|NCT00098306|520449143|FG002|Double Blind|Un-specified|11|||
144340218|NCT00098306|520449144|FG003|Double Blind|Un-specified|0|||
144340219|NCT00098306|520449145|FG004|Double Blind|Un-specified|0|||
144340220|NCT00098306|520449146|FG005|Double Blind|Un-specified|0|||
144340221|NCT00098306|520449147|FG006|Double Blind|Un-specified|0|||
144340222|NCT00098306|520449141|FG000|Open Label|Lack of Efficacy|0|||
144340223|NCT00098306|520449142|FG001|Open Label|Lack of Efficacy|0|||
144340224|NCT00098306|520449143|FG002|Open Label|Lack of Efficacy|0|||
144340225|NCT00098306|520449144|FG003|Open Label|Lack of Efficacy|13|||
144340226|NCT00098306|520449145|FG004|Open Label|Lack of Efficacy|0|||
144340227|NCT00098306|520449146|FG005|Open Label|Lack of Efficacy|0|||
144340228|NCT00098306|520449147|FG006|Open Label|Lack of Efficacy|0|||
144340229|NCT00098306|520449141|FG000|Open Label|Adverse Event|0|||
144340230|NCT00098306|520449142|FG001|Open Label|Adverse Event|0|||
144340231|NCT00098306|520449143|FG002|Open Label|Adverse Event|0|||
144340232|NCT00098306|520449144|FG003|Open Label|Adverse Event|2|||
144340233|NCT00098306|520449145|FG004|Open Label|Adverse Event|0|||
144340234|NCT00098306|520449146|FG005|Open Label|Adverse Event|0|||
144340235|NCT00098306|520449147|FG006|Open Label|Adverse Event|0|||
144340236|NCT00098306|520449141|FG000|Open Label|Death|0|||
144340237|NCT00098306|520449142|FG001|Open Label|Death|0|||
144340238|NCT00098306|520449143|FG002|Open Label|Death|0|||
144340239|NCT00098306|520449144|FG003|Open Label|Death|4|||
144340240|NCT00098306|520449145|FG004|Open Label|Death|0|||
144340241|NCT00098306|520449146|FG005|Open Label|Death|0|||
144340242|NCT00098306|520449147|FG006|Open Label|Death|0|||
144340243|NCT00098306|520449141|FG000|Open Label|Participant defaulted|0|||
144340244|NCT00098306|520449142|FG001|Open Label|Participant defaulted|0|||
144340245|NCT00098306|520449143|FG002|Open Label|Participant defaulted|0|||
144340246|NCT00098306|520449144|FG003|Open Label|Participant defaulted|24|||
144340247|NCT00098306|520449145|FG004|Open Label|Participant defaulted|0|||
144340248|NCT00098306|520449146|FG005|Open Label|Participant defaulted|0|||
144340249|NCT00098306|520449147|FG006|Open Label|Participant defaulted|0|||
144340250|NCT00098306|520449141|FG000|Open Label|Un-specified|0|||
144340251|NCT00098306|520449142|FG001|Open Label|Un-specified|0|||
144340252|NCT00098306|520449143|FG002|Open Label|Un-specified|0|||
144340253|NCT00098306|520449144|FG003|Open Label|Un-specified|15|||
144340254|NCT00098306|520449145|FG004|Open Label|Un-specified|0|||
144340255|NCT00098306|520449146|FG005|Open Label|Un-specified|0|||
144340256|NCT00098306|520449147|FG006|Open Label|Un-specified|0|||
144340257|NCT00098306|520449141|FG000|Open Label|Ongoing at cut-off date|0|||
144340258|NCT00098306|520449142|FG001|Open Label|Ongoing at cut-off date|0|||
144340259|NCT00098306|520449143|FG002|Open Label|Ongoing at cut-off date|0|||
144340260|NCT00098306|520449144|FG003|Open Label|Ongoing at cut-off date|269|||
144340261|NCT00098306|520449145|FG004|Open Label|Ongoing at cut-off date|62|||
144340262|NCT00098306|520449146|FG005|Open Label|Ongoing at cut-off date|0|||
144340263|NCT00098306|520449147|FG006|Open Label|Ongoing at cut-off date|0|||
144340264|NCT00098306|520449141|FG000|Observational Phase|Death|0|||
144340265|NCT00098306|520449142|FG001|Observational Phase|Death|0|||
144340266|NCT00098306|520449143|FG002|Observational Phase|Death|0|||
144340267|NCT00098306|520449144|FG003|Observational Phase|Death|0|||
144340268|NCT00098306|520449145|FG004|Observational Phase|Death|0|||
144340269|NCT00098306|520449146|FG005|Observational Phase|Death|5|||
144340270|NCT00098306|520449147|FG006|Observational Phase|Death|4|||
144340271|NCT00098306|520449141|FG000|Observational Phase|Participant defaulted|0|||
144340272|NCT00098306|520449142|FG001|Observational Phase|Participant defaulted|0|||
144340273|NCT00098306|520449143|FG002|Observational Phase|Participant defaulted|0|||
144340274|NCT00098306|520449144|FG003|Observational Phase|Participant defaulted|0|||
144340275|NCT00098306|520449145|FG004|Observational Phase|Participant defaulted|0|||
144340276|NCT00098306|520449146|FG005|Observational Phase|Participant defaulted|34|||
144340277|NCT00098306|520449147|FG006|Observational Phase|Participant defaulted|18|||
144340278|NCT00098306|520449141|FG000|Observational Phase|Un-specified|0|||
144340279|NCT00098306|520449142|FG001|Observational Phase|Un-specified|0|||
144340280|NCT00098306|520449143|FG002|Observational Phase|Un-specified|0|||
144340281|NCT00098306|520449144|FG003|Observational Phase|Un-specified|0|||
144340282|NCT00098306|520449145|FG004|Observational Phase|Un-specified|0|||
144340283|NCT00098306|520449146|FG005|Observational Phase|Un-specified|7|||
144340284|NCT00098306|520449147|FG006|Observational Phase|Un-specified|4|||
144340285|NCT05222555|520449148|FG000|Overall Study|Ongoing|2|||
144340286|NCT05222555|520449149|FG001|Overall Study|Ongoing|18|||
144340287|NCT05222555|520449148|FG000|Overall Study|Adverse Event|1|||
144340288|NCT05222555|520449149|FG001|Overall Study|Adverse Event|1|||
144340289|NCT05222555|520449148|FG000|Overall Study|Death|0|||
144340290|NCT05222555|520449149|FG001|Overall Study|Death|6|||
144340291|NCT05222555|520449148|FG000|Overall Study|Withdrawal by Subject|0|||
144340292|NCT05222555|520449149|FG001|Overall Study|Withdrawal by Subject|11|||
144340293|NCT01966445|520449150|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
144340294|NCT01966445|520449151|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
144340295|NCT01966445|520449152|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
144340296|NCT01966445|520449153|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
144340297|NCT01966445|520449154|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
144340298|NCT01966445|520449155|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
144340299|NCT01966445|520449156|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
144340300|NCT01966445|520449150|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
144340301|NCT01966445|520449151|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
144340302|NCT01966445|520449152|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
144340303|NCT01966445|520449153|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
144340304|NCT01966445|520449154|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
144340305|NCT01966445|520449155|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
144340306|NCT01966445|520449156|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
144340307|NCT01966445|520449150|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
144340308|NCT01966445|520449151|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
144340309|NCT01966445|520449152|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
144340310|NCT01966445|520449153|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
144340311|NCT01966445|520449154|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
144340312|NCT01966445|520449155|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
144340313|NCT01966445|520449156|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
144340314|NCT01966445|520449150|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
144340315|NCT01966445|520449151|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
144340316|NCT01966445|520449152|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
144340317|NCT01966445|520449153|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
144340318|NCT01966445|520449154|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
144340319|NCT01966445|520449155|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
144340320|NCT01966445|520449156|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
144340321|NCT01966445|520449150|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
144340322|NCT01966445|520449151|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
144340323|NCT01966445|520449152|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
144340324|NCT01966445|520449153|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
144340325|NCT01966445|520449154|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
144340326|NCT01966445|520449155|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
144340327|NCT01966445|520449156|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
144340328|NCT00077649|520449159|FG000|Overall Study|Adverse Event|5|||
144340329|NCT00077649|520449160|FG001|Overall Study|Adverse Event|1|||
144340330|NCT00077649|520449161|FG002|Overall Study|Adverse Event|7|||
144340331|NCT00077649|520449162|FG003|Overall Study|Adverse Event|9|||
144340332|NCT00077649|520449159|FG000|Overall Study|Lack of Efficacy|5|||
144340333|NCT00077649|520449160|FG001|Overall Study|Lack of Efficacy|3|||
144340334|NCT00077649|520449161|FG002|Overall Study|Lack of Efficacy|3|||
144340335|NCT00077649|520449162|FG003|Overall Study|Lack of Efficacy|2|||
144340336|NCT00077649|520449159|FG000|Overall Study|Withdrawal by Subject|0|||
144340337|NCT00077649|520449160|FG001|Overall Study|Withdrawal by Subject|1|||
144340338|NCT00077649|520449161|FG002|Overall Study|Withdrawal by Subject|1|||
144340339|NCT00077649|520449162|FG003|Overall Study|Withdrawal by Subject|2|||
144340340|NCT00077649|520449159|FG000|Overall Study|Lost to Follow-up|2|||
144340341|NCT00077649|520449160|FG001|Overall Study|Lost to Follow-up|2|||
144340342|NCT00077649|520449161|FG002|Overall Study|Lost to Follow-up|3|||
144340343|NCT00077649|520449162|FG003|Overall Study|Lost to Follow-up|2|||
144340344|NCT00077649|520449159|FG000|Overall Study|Abnormality of Laboratory Test|1|||
144340345|NCT00077649|520449160|FG001|Overall Study|Abnormality of Laboratory Test|2|||
144340346|NCT00077649|520449161|FG002|Overall Study|Abnormality of Laboratory Test|1|||
144340347|NCT00077649|520449162|FG003|Overall Study|Abnormality of Laboratory Test|2|||
144340348|NCT00077649|520449159|FG000|Overall Study|Randomized but never dosed|1|||
144340349|NCT00077649|520449160|FG001|Overall Study|Randomized but never dosed|0|||
144340350|NCT00077649|520449161|FG002|Overall Study|Randomized but never dosed|0|||
144340351|NCT00077649|520449162|FG003|Overall Study|Randomized but never dosed|0|||
144340352|NCT01753401|520449163|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
144340353|NCT01753401|520449164|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
144340354|NCT01753401|520449165|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
144340355|NCT01753401|520449166|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
144340356|NCT01753401|520449163|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
144340357|NCT01753401|520449164|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
144340358|NCT01753401|520449165|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
144340359|NCT01753401|520449166|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
144340360|NCT01753401|520449163|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
144340361|NCT01753401|520449164|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
144340362|NCT01753401|520449165|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
144340363|NCT01753401|520449166|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
144340364|NCT01753401|520449163|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
144340365|NCT01753401|520449164|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
144340366|NCT01753401|520449165|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
144340367|NCT01753401|520449166|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
144340368|NCT01753401|520449163|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
144340369|NCT01753401|520449164|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
144340370|NCT01753401|520449165|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
144340371|NCT01753401|520449166|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
144340372|NCT01753401|520449163|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
144340373|NCT01753401|520449164|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
144340374|NCT01753401|520449165|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
144340375|NCT01753401|520449166|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
144340376|NCT01753401|520449163|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
144340377|NCT01753401|520449164|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
144340378|NCT01753401|520449165|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
144340379|NCT01753401|520449166|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
144340380|NCT03688100|520449167|FG000|Overall Study|Lost to Follow-up|21|||
144340381|NCT03688100|520449168|FG001|Overall Study|Lost to Follow-up|15|||
144340382|NCT03688100|520449169|FG002|Overall Study|Lost to Follow-up|15|||
144340383|NCT03688100|520449170|FG003|Overall Study|Lost to Follow-up|18|||
144340384|NCT03688100|520449167|FG000|Overall Study|Withdrawal by Subject|19|||
144340385|NCT03688100|520449168|FG001|Overall Study|Withdrawal by Subject|16|||
144340386|NCT03688100|520449169|FG002|Overall Study|Withdrawal by Subject|0|||
144340387|NCT03688100|520449170|FG003|Overall Study|Withdrawal by Subject|0|||
144340388|NCT03688100|520449167|FG000|Overall Study|Death|36|||
144340389|NCT03688100|520449168|FG001|Overall Study|Death|27|||
144340390|NCT03688100|520449169|FG002|Overall Study|Death|0|||
144340391|NCT03688100|520449170|FG003|Overall Study|Death|0|||
144340392|NCT02409719|520449178|FG000|Overall Study|Lost to Follow-up|3|||
144340393|NCT02409719|520449179|FG001|Overall Study|Lost to Follow-up|3|||
144340394|NCT02479139|520449180|FG000|Overall Study|Lost to Follow-up|2|||
144340395|NCT02479139|520449181|FG001|Overall Study|Lost to Follow-up|4|||
144340396|NCT02479139|520449182|FG002|Overall Study|Lost to Follow-up|4|||
144340397|NCT02479139|520449183|FG003|Overall Study|Lost to Follow-up|2|||
144340398|NCT02479139|520449184|FG004|Overall Study|Lost to Follow-up|3|||
144340399|NCT02479139|520449185|FG005|Overall Study|Lost to Follow-up|5|||
144340400|NCT02479139|520449180|FG000|Overall Study|Withdrew Consent|5|||
144340401|NCT02479139|520449181|FG001|Overall Study|Withdrew Consent|6|||
144340402|NCT02479139|520449182|FG002|Overall Study|Withdrew Consent|1|||
144340403|NCT02479139|520449183|FG003|Overall Study|Withdrew Consent|4|||
144340404|NCT02479139|520449184|FG004|Overall Study|Withdrew Consent|1|||
144340405|NCT02479139|520449185|FG005|Overall Study|Withdrew Consent|1|||
144340406|NCT02479139|520449180|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
144340407|NCT02479139|520449181|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
144340408|NCT02479139|520449182|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
144340409|NCT02479139|520449183|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
144340410|NCT02479139|520449184|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
144340411|NCT02479139|520449185|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
144340412|NCT02479139|520449180|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144340413|NCT02479139|520449181|FG001|Overall Study|Other Miscellaneous Reasons|0|||
144340414|NCT02479139|520449182|FG002|Overall Study|Other Miscellaneous Reasons|1|||
144340415|NCT02479139|520449183|FG003|Overall Study|Other Miscellaneous Reasons|1|||
144340416|NCT02479139|520449184|FG004|Overall Study|Other Miscellaneous Reasons|1|||
144340417|NCT02479139|520449185|FG005|Overall Study|Other Miscellaneous Reasons|0|||
144340418|NCT00764673|520449186|FG000|Overall Study|Death|1|||
144340419|NCT00764673|520449186|FG000|Overall Study|Lost to Follow-up|3|||
144340420|NCT00764673|520449186|FG000|Overall Study|Withdrawal by Subject|6|||
144340421|NCT00764673|520449186|FG000|Overall Study|Revision of Device|2|||
144340422|NCT01727336|520449187|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
144340423|NCT01727336|520449188|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
144340424|NCT01727336|520449189|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
144340425|NCT01727336|520449190|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
144340426|NCT01727336|520449191|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
144340427|NCT01727336|520449192|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
144340428|NCT01727336|520449187|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
144340429|NCT01727336|520449188|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
144340430|NCT01727336|520449189|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
144340431|NCT01727336|520449190|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
144340432|NCT01727336|520449191|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
144340433|NCT01727336|520449192|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
144340434|NCT01727336|520449187|FG000|Part 2 Blinded|Death|0|||
144340435|NCT01727336|520449188|FG001|Part 2 Blinded|Death|0|||
144340436|NCT01727336|520449189|FG002|Part 2 Blinded|Death|0|||
144340437|NCT01727336|520449190|FG003|Part 2 Blinded|Death|0|||
144340438|NCT01727336|520449191|FG004|Part 2 Blinded|Death|20|||
144340439|NCT01727336|520449192|FG005|Part 2 Blinded|Death|16|||
144340440|NCT01727336|520449187|FG000|Part 2 Blinded|Lack of Efficacy|0|||
144340441|NCT01727336|520449188|FG001|Part 2 Blinded|Lack of Efficacy|0|||
144340442|NCT01727336|520449189|FG002|Part 2 Blinded|Lack of Efficacy|0|||
144340443|NCT01727336|520449190|FG003|Part 2 Blinded|Lack of Efficacy|0|||
144340444|NCT01727336|520449191|FG004|Part 2 Blinded|Lack of Efficacy|42|||
144340445|NCT01727336|520449192|FG005|Part 2 Blinded|Lack of Efficacy|44|||
144340446|NCT01727336|520449187|FG000|Part 2 Blinded|Lost to Follow-up|0|||
144340447|NCT01727336|520449188|FG001|Part 2 Blinded|Lost to Follow-up|0|||
144340448|NCT01727336|520449189|FG002|Part 2 Blinded|Lost to Follow-up|0|||
144340449|NCT01727336|520449190|FG003|Part 2 Blinded|Lost to Follow-up|0|||
144340450|NCT01727336|520449191|FG004|Part 2 Blinded|Lost to Follow-up|0|||
144340451|NCT01727336|520449192|FG005|Part 2 Blinded|Lost to Follow-up|1|||
144340452|NCT01727336|520449187|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
144340453|NCT01727336|520449188|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
144340454|NCT01727336|520449189|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
144340455|NCT01727336|520449190|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
144340456|NCT01727336|520449191|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
144340457|NCT01727336|520449192|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
144340458|NCT01727336|520449187|FG000|Part 2 Blinded|use of prohibited medications|0|||
144340459|NCT01727336|520449188|FG001|Part 2 Blinded|use of prohibited medications|0|||
144340460|NCT01727336|520449189|FG002|Part 2 Blinded|use of prohibited medications|0|||
144340461|NCT01727336|520449190|FG003|Part 2 Blinded|use of prohibited medications|0|||
144340462|NCT01727336|520449191|FG004|Part 2 Blinded|use of prohibited medications|1|||
144340463|NCT01727336|520449192|FG005|Part 2 Blinded|use of prohibited medications|3|||
144340464|NCT00084656|520449195|FG000|Overall Study|Other reasons|0|||
144340465|NCT00084656|520449196|FG001|Overall Study|Other reasons|12|||
144340466|NCT00084656|520449197|FG002|Overall Study|Other reasons|11|||
144340467|NCT00084656|520449195|FG000|Overall Study|Withdrawal by Subject|15|||
144340468|NCT00084656|520449196|FG001|Overall Study|Withdrawal by Subject|4|||
144340469|NCT00084656|520449197|FG002|Overall Study|Withdrawal by Subject|4|||
144340470|NCT00084656|520449195|FG000|Overall Study|Disease relapse|0|||
144340471|NCT00084656|520449196|FG001|Overall Study|Disease relapse|9|||
144340472|NCT00084656|520449197|FG002|Overall Study|Disease relapse|10|||
144340473|NCT00084656|520449195|FG000|Overall Study|Disease progression|9|||
144340474|NCT00084656|520449196|FG001|Overall Study|Disease progression|0|||
144340475|NCT00084656|520449197|FG002|Overall Study|Disease progression|0|||
144340476|NCT00084656|520449195|FG000|Overall Study|Lost to Follow-up|1|||
144340477|NCT00084656|520449196|FG001|Overall Study|Lost to Follow-up|0|||
144340478|NCT00084656|520449197|FG002|Overall Study|Lost to Follow-up|1|||
144340479|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
144340480|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
144340481|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
144340482|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
144340483|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
144340484|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
144340485|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
144340486|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
144340487|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
144340488|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
144340489|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
144340490|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
144340491|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
144340492|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
144340493|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
144340494|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
144340495|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
144340496|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
144340497|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
144340498|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
144340499|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
144340500|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
144340501|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
144340502|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
144340503|NCT01532869|520449198|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
144340504|NCT01532869|520449199|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
144340505|NCT01532869|520449198|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
144340506|NCT01532869|520449199|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
144340507|NCT01532869|520449198|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
144340508|NCT01532869|520449199|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
144340509|NCT01532869|520449198|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
144340510|NCT01532869|520449199|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
144340511|NCT01532869|520449198|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
144340512|NCT01532869|520449199|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
144340513|NCT00778895|520449200|FG000|Active Phase|Adverse Event|3|||
144340514|NCT00778895|520449201|FG001|Active Phase|Adverse Event|1|||
144340515|NCT00778895|520449202|FG002|Active Phase|Adverse Event|0|||
144340516|NCT00778895|520449200|FG000|Active Phase|Withdrawal by Subject|1|||
144340517|NCT00778895|520449201|FG001|Active Phase|Withdrawal by Subject|4|||
144340518|NCT00778895|520449202|FG002|Active Phase|Withdrawal by Subject|0|||
144340519|NCT00778895|520449200|FG000|Active Phase|Lost to Follow-up|1|||
144340520|NCT00778895|520449201|FG001|Active Phase|Lost to Follow-up|1|||
144340521|NCT00778895|520449202|FG002|Active Phase|Lost to Follow-up|0|||
144340522|NCT00778895|520449200|FG000|Active Phase|Other|2|||
144340523|NCT00778895|520449201|FG001|Active Phase|Other|0|||
144340524|NCT00778895|520449202|FG002|Active Phase|Other|0|||
144340525|NCT00778895|520449200|FG000|ESFU Phase|Adverse Event|2|||
144340526|NCT00778895|520449201|FG001|ESFU Phase|Adverse Event|1|||
144340527|NCT00778895|520449202|FG002|ESFU Phase|Adverse Event|0|||
144340528|NCT00778895|520449200|FG000|ESFU Phase|Withdrawal by Subject|1|||
144340529|NCT00778895|520449201|FG001|ESFU Phase|Withdrawal by Subject|4|||
144340530|NCT00778895|520449202|FG002|ESFU Phase|Withdrawal by Subject|0|||
144340531|NCT00778895|520449200|FG000|ESFU Phase|Lost to Follow-up|6|||
144340532|NCT00778895|520449201|FG001|ESFU Phase|Lost to Follow-up|7|||
144340533|NCT00778895|520449202|FG002|ESFU Phase|Lost to Follow-up|2|||
144340534|NCT00778895|520449200|FG000|ESFU Phase|Other|2|||
144340535|NCT00778895|520449201|FG001|ESFU Phase|Other|0|||
144340536|NCT00778895|520449202|FG002|ESFU Phase|Other|0|||
144340537|NCT01424228|520449207|FG000|Overall Study|Withdrawal by Subject|27|||
144340538|NCT01424228|520449208|FG001|Overall Study|Withdrawal by Subject|11|||
144340539|NCT01424228|520449207|FG000|Overall Study|Adverse Event|10|||
144340540|NCT01424228|520449208|FG001|Overall Study|Adverse Event|14|||
144340541|NCT01424228|520449207|FG000|Overall Study|Sponsor's decision|9|||
144340542|NCT01424228|520449208|FG001|Overall Study|Sponsor's decision|12|||
144340543|NCT01424228|520449207|FG000|Overall Study|Lack of Efficacy|5|||
144340544|NCT01424228|520449208|FG001|Overall Study|Lack of Efficacy|7|||
144340545|NCT01424228|520449207|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
144340546|NCT01424228|520449208|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
144340547|NCT01424228|520449207|FG000|Overall Study|Non-compliance|2|||
144340548|NCT01424228|520449208|FG001|Overall Study|Non-compliance|0|||
144340549|NCT01424228|520449207|FG000|Overall Study|Worsening of symptoms|1|||
144340550|NCT01424228|520449208|FG001|Overall Study|Worsening of symptoms|0|||
144340551|NCT01424228|520449207|FG000|Overall Study|Unplanned journey|0|||
144340552|NCT01424228|520449208|FG001|Overall Study|Unplanned journey|1|||
144340553|NCT00590577|520449213|FG000|Overall Study|Lack of Efficacy|31|||
144340554|NCT00590577|520449214|FG001|Overall Study|Lack of Efficacy|28|||
144340555|NCT00590577|520449215|FG002|Overall Study|Lack of Efficacy|23|||
144340556|NCT00590577|520449216|FG003|Overall Study|Lack of Efficacy|45|||
144340557|NCT00590577|520449213|FG000|Overall Study|Withdrawal by Subject|23|||
144340558|NCT00590577|520449214|FG001|Overall Study|Withdrawal by Subject|28|||
144340559|NCT00590577|520449215|FG002|Overall Study|Withdrawal by Subject|30|||
144340560|NCT00590577|520449216|FG003|Overall Study|Withdrawal by Subject|26|||
144340561|NCT00590577|520449213|FG000|Overall Study|Adverse Event|10|||
144340562|NCT00590577|520449214|FG001|Overall Study|Adverse Event|10|||
144340563|NCT00590577|520449215|FG002|Overall Study|Adverse Event|13|||
144340564|NCT00590577|520449216|FG003|Overall Study|Adverse Event|11|||
144340565|NCT00590577|520449213|FG000|Overall Study|Lost to Follow-up|12|||
144340566|NCT00590577|520449214|FG001|Overall Study|Lost to Follow-up|6|||
144340567|NCT00590577|520449215|FG002|Overall Study|Lost to Follow-up|6|||
144340568|NCT00590577|520449216|FG003|Overall Study|Lost to Follow-up|9|||
144340569|NCT00590577|520449213|FG000|Overall Study|Pregnancy|0|||
144340570|NCT00590577|520449214|FG001|Overall Study|Pregnancy|1|||
144340571|NCT00590577|520449215|FG002|Overall Study|Pregnancy|0|||
144340572|NCT00590577|520449216|FG003|Overall Study|Pregnancy|0|||
144340573|NCT00590577|520449213|FG000|Overall Study|Various reasons|1|||
144340574|NCT00590577|520449214|FG001|Overall Study|Various reasons|3|||
144340575|NCT00590577|520449215|FG002|Overall Study|Various reasons|1|||
144340576|NCT00590577|520449216|FG003|Overall Study|Various reasons|2|||
144340577|NCT01300260|520449217|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
144340578|NCT01300260|520449218|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
144360042|NCT01601535|520525140|FG005|Phase 2|Started Another Treatment|2|||
144340579|NCT01300260|520449217|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
144340580|NCT01300260|520449218|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
144340581|NCT01300260|520449217|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
144340582|NCT01300260|520449218|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
144340583|NCT00293020|520449224|FG000|Overall Study|Withdrawal by Subject|34|||
144340584|NCT00293020|520449224|FG000|Overall Study|Adverse Event|30|||
144340585|NCT00293020|520449224|FG000|Overall Study|Death|32|||
144340586|NCT00293020|520449224|FG000|Overall Study|Lack of Efficacy|12|||
144340587|NCT00293020|520449224|FG000|Overall Study|Lost to Follow-up|4|||
144340588|NCT00293020|520449224|FG000|Overall Study|Protocol Violation|6|||
144340589|NCT00293020|520449224|FG000|Overall Study|Physician Decision|21|||
144340590|NCT00293020|520449224|FG000|Overall Study|Other Reason|22|||
144340591|NCT00293020|520449224|FG000|Overall Study|No dose taken|1|||
144340592|NCT01147848|520449225|FG000|Run-in Period|Screen Failure|623|||
144340593|NCT01147848|520449226|FG001|Run-in Period|Screen Failure|0|||
144340594|NCT01147848|520449227|FG002|Run-in Period|Screen Failure|0|||
144340595|NCT01147848|520449225|FG000|Run-in Period|Run-in Failure|135|||
144340596|NCT01147848|520449226|FG001|Run-in Period|Run-in Failure|0|||
144340597|NCT01147848|520449227|FG002|Run-in Period|Run-in Failure|0|||
144340598|NCT01147848|520449225|FG000|Randomized Phase|Adverse Event|0|||
144340599|NCT01147848|520449226|FG001|Randomized Phase|Adverse Event|6|||
144340600|NCT01147848|520449227|FG002|Randomized Phase|Adverse Event|8|||
144340601|NCT01147848|520449225|FG000|Randomized Phase|Lack of Efficacy|0|||
144340602|NCT01147848|520449226|FG001|Randomized Phase|Lack of Efficacy|20|||
144340603|NCT01147848|520449227|FG002|Randomized Phase|Lack of Efficacy|11|||
144340604|NCT01147848|520449225|FG000|Randomized Phase|Protocol Violation|0|||
144340605|NCT01147848|520449226|FG001|Randomized Phase|Protocol Violation|7|||
144340606|NCT01147848|520449227|FG002|Randomized Phase|Protocol Violation|10|||
144340607|NCT01147848|520449225|FG000|Randomized Phase|Lost to Follow-up|0|||
144340608|NCT01147848|520449226|FG001|Randomized Phase|Lost to Follow-up|5|||
144340609|NCT01147848|520449227|FG002|Randomized Phase|Lost to Follow-up|7|||
144340610|NCT01147848|520449225|FG000|Randomized Phase|Physician Decision|0|||
144340611|NCT01147848|520449226|FG001|Randomized Phase|Physician Decision|0|||
144340612|NCT01147848|520449227|FG002|Randomized Phase|Physician Decision|1|||
144340613|NCT01147848|520449225|FG000|Randomized Phase|Withdrawal by Subject|0|||
144340614|NCT01147848|520449226|FG001|Randomized Phase|Withdrawal by Subject|7|||
144340615|NCT01147848|520449227|FG002|Randomized Phase|Withdrawal by Subject|9|||
144340616|NCT03596450|520449242|FG000|Overall Study|Death|9|||
144340617|NCT03596450|520449243|FG001|Overall Study|Death|9|||
144340618|NCT03596450|520449242|FG000|Overall Study|Protocol Violation|18|||
144340619|NCT03596450|520449243|FG001|Overall Study|Protocol Violation|26|||
144340620|NCT03596450|520449242|FG000|Overall Study|Lost to Follow-up|50|||
144340621|NCT03596450|520449243|FG001|Overall Study|Lost to Follow-up|56|||
144340622|NCT03596450|520449242|FG000|Overall Study|Adverse Event|14|||
144340623|NCT03596450|520449243|FG001|Overall Study|Adverse Event|7|||
144340624|NCT03596450|520449242|FG000|Overall Study|Withdrawal by Subject|38|||
144340625|NCT03596450|520449243|FG001|Overall Study|Withdrawal by Subject|36|||
144340626|NCT03596450|520449242|FG000|Overall Study|Accidentally Randomized|2|||
144340627|NCT03596450|520449243|FG001|Overall Study|Accidentally Randomized|0|||
144340628|NCT03596450|520449242|FG000|Overall Study|Other reasons|48|||
144340629|NCT03596450|520449243|FG001|Overall Study|Other reasons|53|||
144340630|NCT03596450|520449242|FG000|Overall Study|Pregnancy|2|||
144340631|NCT03596450|520449243|FG001|Overall Study|Pregnancy|0|||
144340632|NCT04058886|520449246|FG000|Overall Study|Withdrawal by Subject|4|||
144340633|NCT04058886|520449246|FG000|Overall Study|Inadequate deafness interpreter service|1|||
144340634|NCT01069705|520449247|FG000|Overall Study|Adverse Event|1|||
144340635|NCT01069705|520449247|FG000|Overall Study|Withdrawal by Subject|2|||
144340636|NCT03624127|520449248|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
144340637|NCT03624127|520449249|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
144340638|NCT03624127|520449250|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
144340639|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
144340640|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
144340641|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
144340642|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Death|0|||
144340643|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Death|1|||
144340644|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Death|0|||
144340645|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
144340646|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
144340647|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
144340648|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
144340649|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
144340650|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
144340651|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
144340652|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
144340653|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
144340654|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
144340655|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
144340656|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
144340657|NCT03624127|520449248|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
144340658|NCT03624127|520449249|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
144340659|NCT03624127|520449250|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
144340660|NCT03624127|520449248|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
144340661|NCT03624127|520449249|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
144340662|NCT03624127|520449250|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
144340663|NCT03624127|520449248|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
144340664|NCT03624127|520449249|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
144340665|NCT03624127|520449250|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
144340666|NCT03624127|520449248|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
144340667|NCT03624127|520449249|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
144340668|NCT03624127|520449250|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
144340669|NCT03624127|520449248|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
144340670|NCT03624127|520449249|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
144340671|NCT03624127|520449250|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
144340672|NCT03624127|520449248|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
144340673|NCT03624127|520449249|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
144340674|NCT03624127|520449250|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
144340675|NCT03624127|520449248|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
144340676|NCT03624127|520449249|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
144340677|NCT03624127|520449250|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
144340678|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
144340679|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
144340680|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
144340681|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
144340682|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
144340683|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
144340684|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
144340685|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
144340686|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
144340687|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
144340688|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
144340689|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
144340690|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
144340691|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
144340692|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
144340693|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
144340694|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
144340695|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
144340696|NCT03624127|520449248|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
144340697|NCT03624127|520449249|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
144340698|NCT03624127|520449250|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
144340699|NCT00915551|520449251|FG000|Overall Study|Withdrawal by Subject|0|||
144340700|NCT00915551|520449252|FG001|Overall Study|Withdrawal by Subject|1|||
144340701|NCT00235716|520449253|FG000|Overall Study|Death|26|||
144340702|NCT00235716|520449254|FG001|Overall Study|Death|39|||
144340703|NCT00235716|520449255|FG002|Overall Study|Death|32|||
144340704|NCT00235716|520449256|FG003|Overall Study|Death|31|||
144340705|NCT00235716|520449253|FG000|Overall Study|Withdrawal by Subject|23|||
144340706|NCT00235716|520449254|FG001|Overall Study|Withdrawal by Subject|19|||
144340707|NCT00235716|520449255|FG002|Overall Study|Withdrawal by Subject|17|||
144340708|NCT00235716|520449256|FG003|Overall Study|Withdrawal by Subject|18|||
144340709|NCT00235716|520449253|FG000|Overall Study|Lost to Follow-up|12|||
144340710|NCT00235716|520449254|FG001|Overall Study|Lost to Follow-up|7|||
144340711|NCT00235716|520449255|FG002|Overall Study|Lost to Follow-up|14|||
144340712|NCT00235716|520449256|FG003|Overall Study|Lost to Follow-up|10|||
144340713|NCT00235716|520449253|FG000|Overall Study|Adverse Event|1|||
144340714|NCT00235716|520449254|FG001|Overall Study|Adverse Event|1|||
144340715|NCT00235716|520449255|FG002|Overall Study|Adverse Event|1|||
144340716|NCT00235716|520449256|FG003|Overall Study|Adverse Event|0|||
144340717|NCT00235716|520449253|FG000|Overall Study|Physician Decision|0|||
144340718|NCT00235716|520449254|FG001|Overall Study|Physician Decision|1|||
144340719|NCT00235716|520449255|FG002|Overall Study|Physician Decision|1|||
144340720|NCT00235716|520449256|FG003|Overall Study|Physician Decision|3|||
144340721|NCT04390841|520449257|FG000|Overall Study|Withdrawal by Subject|2|||
144340722|NCT02999633|520449258|FG000|Overall Study|Adverse Event|2|||
144340723|NCT02999633|520449258|FG000|Overall Study|Progressive disease|12|||
144340724|NCT03262441|520449259|FG000|Overall Study|Withdrawal by Subject|1|||
144340725|NCT01545050|520449260|FG000|Overall Study|Lack of Efficacy|0|||
144340726|NCT01545050|520449261|FG001|Overall Study|Lack of Efficacy|0|||
144340727|NCT01545050|520449262|FG002|Overall Study|Lack of Efficacy|0|||
144340728|NCT01545050|520449263|FG003|Overall Study|Lack of Efficacy|3|||
144340729|NCT01545050|520449264|FG004|Overall Study|Lack of Efficacy|2|||
144340730|NCT01545050|520449260|FG000|Overall Study|Adverse Event|1|||
144340731|NCT01545050|520449261|FG001|Overall Study|Adverse Event|1|||
144340732|NCT01545050|520449262|FG002|Overall Study|Adverse Event|2|||
144340733|NCT01545050|520449263|FG003|Overall Study|Adverse Event|2|||
144340734|NCT01545050|520449264|FG004|Overall Study|Adverse Event|0|||
144340735|NCT01545050|520449260|FG000|Overall Study|Discontinued study treatment|1|||
144340736|NCT01545050|520449261|FG001|Overall Study|Discontinued study treatment|0|||
144340737|NCT01545050|520449262|FG002|Overall Study|Discontinued study treatment|0|||
144340738|NCT01545050|520449263|FG003|Overall Study|Discontinued study treatment|0|||
144340739|NCT01545050|520449264|FG004|Overall Study|Discontinued study treatment|0|||
144340740|NCT01545050|520449260|FG000|Overall Study|Withdrawal by Subject|1|||
144340741|NCT01545050|520449261|FG001|Overall Study|Withdrawal by Subject|0|||
144340742|NCT01545050|520449262|FG002|Overall Study|Withdrawal by Subject|0|||
144340743|NCT01545050|520449263|FG003|Overall Study|Withdrawal by Subject|2|||
144340744|NCT01545050|520449264|FG004|Overall Study|Withdrawal by Subject|1|||
144340745|NCT01545050|520449260|FG000|Overall Study|Participant no longer meets study criteria|0|||
144340746|NCT01545050|520449261|FG001|Overall Study|Participant no longer meets study criteria|2|||
144340747|NCT01545050|520449262|FG002|Overall Study|Participant no longer meets study criteria|0|||
144340748|NCT01545050|520449263|FG003|Overall Study|Participant no longer meets study criteria|0|||
144340749|NCT01545050|520449264|FG004|Overall Study|Participant no longer meets study criteria|1|||
144340750|NCT01545050|520449260|FG000|Overall Study|Administrative reason by sponsor|4|||
144340751|NCT01545050|520449261|FG001|Overall Study|Administrative reason by sponsor|2|||
144340752|NCT01545050|520449262|FG002|Overall Study|Administrative reason by sponsor|3|||
144340753|NCT01545050|520449263|FG003|Overall Study|Administrative reason by sponsor|5|||
144340754|NCT01545050|520449264|FG004|Overall Study|Administrative reason by sponsor|5|||
144340755|NCT02607228|520449265|FG000|Overall Study|Progressive Disease|4|||
144340756|NCT02607228|520449266|FG001|Overall Study|Progressive Disease|3|||
144340757|NCT02607228|520449267|FG002|Overall Study|Progressive Disease|1|||
144340758|NCT02607228|520449268|FG003|Overall Study|Progressive Disease|5|||
144340759|NCT02607228|520449269|FG004|Overall Study|Progressive Disease|4|||
144340760|NCT02607228|520449270|FG005|Overall Study|Progressive Disease|3|||
144340761|NCT02607228|520449271|FG006|Overall Study|Progressive Disease|1|||
144340762|NCT02607228|520449265|FG000|Overall Study|Adverse Event|1|||
144340763|NCT02607228|520449266|FG001|Overall Study|Adverse Event|0|||
144340764|NCT02607228|520449267|FG002|Overall Study|Adverse Event|1|||
144340765|NCT02607228|520449268|FG003|Overall Study|Adverse Event|0|||
144340766|NCT02607228|520449269|FG004|Overall Study|Adverse Event|1|||
144340767|NCT02607228|520449270|FG005|Overall Study|Adverse Event|1|||
144340768|NCT02607228|520449271|FG006|Overall Study|Adverse Event|1|||
144340769|NCT02607228|520449265|FG000|Overall Study|Investigator's Discretion|0|||
144340770|NCT02607228|520449266|FG001|Overall Study|Investigator's Discretion|0|||
144340771|NCT02607228|520449267|FG002|Overall Study|Investigator's Discretion|1|||
144340772|NCT02607228|520449268|FG003|Overall Study|Investigator's Discretion|0|||
144340773|NCT02607228|520449269|FG004|Overall Study|Investigator's Discretion|0|||
144340774|NCT02607228|520449270|FG005|Overall Study|Investigator's Discretion|1|||
144340775|NCT02607228|520449271|FG006|Overall Study|Investigator's Discretion|0|||
144340776|NCT02607228|520449265|FG000|Overall Study|Withdrew Consent|0|||
144340777|NCT02607228|520449266|FG001|Overall Study|Withdrew Consent|1|||
144340778|NCT02607228|520449267|FG002|Overall Study|Withdrew Consent|0|||
144340779|NCT02607228|520449268|FG003|Overall Study|Withdrew Consent|0|||
144340780|NCT02607228|520449269|FG004|Overall Study|Withdrew Consent|0|||
144340781|NCT02607228|520449270|FG005|Overall Study|Withdrew Consent|1|||
144340782|NCT02607228|520449271|FG006|Overall Study|Withdrew Consent|0|||
144340783|NCT02607228|520449265|FG000|Overall Study|Study Terminated by Sponsor|0|||
144340784|NCT02607228|520449266|FG001|Overall Study|Study Terminated by Sponsor|0|||
144340785|NCT02607228|520449267|FG002|Overall Study|Study Terminated by Sponsor|0|||
144340786|NCT02607228|520449268|FG003|Overall Study|Study Terminated by Sponsor|1|||
144340787|NCT02607228|520449269|FG004|Overall Study|Study Terminated by Sponsor|0|||
144340788|NCT02607228|520449270|FG005|Overall Study|Study Terminated by Sponsor|0|||
144340789|NCT02607228|520449271|FG006|Overall Study|Study Terminated by Sponsor|0|||
144340790|NCT03235089|520449278|FG000|Overall Study|Lost to Follow-up|1|||
144340791|NCT03235089|520449279|FG001|Overall Study|Lost to Follow-up|1|||
144340792|NCT03235089|520449278|FG000|Overall Study|Physician Decision|2|||
144340793|NCT03235089|520449279|FG001|Overall Study|Physician Decision|2|||
144340794|NCT03238924|520449282|FG000|Overall Study|Withdrawal by Subject|2|||
144340795|NCT03238924|520449283|FG001|Overall Study|Withdrawal by Subject|2|||
144340796|NCT02516228|520449285|FG000|Overall Study|Lost to Follow-up|1|||
144340797|NCT02516228|520449285|FG000|Overall Study|Withdrawal by Subject|1|||
144340798|NCT02516228|520449285|FG000|Overall Study|Physician Decision|1|||
144340799|NCT03916484|520449286|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144340800|NCT03916484|520449287|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
144340801|NCT03916484|520449288|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144340802|NCT03916484|520449289|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
144340803|NCT03916484|520449286|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
144340804|NCT03916484|520449287|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
144340805|NCT03916484|520449288|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
144340806|NCT03916484|520449289|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
144340807|NCT01196416|520449290|FG000|Overall Study|Withdrawal by Subject|2|||
144340808|NCT01717326|520449291|FG000|Overall Study|Death|0|||
144340809|NCT01717326|520449292|FG001|Overall Study|Death|0|||
144340810|NCT01717326|520449293|FG002|Overall Study|Death|0|||
144340811|NCT01717326|520449294|FG003|Overall Study|Death|0|||
144340812|NCT01717326|520449295|FG004|Overall Study|Death|0|||
144340813|NCT01717326|520449296|FG005|Overall Study|Death|0|||
144340814|NCT01717326|520449297|FG006|Overall Study|Death|0|||
144340815|NCT01717326|520449298|FG007|Overall Study|Death|0|||
144340816|NCT01717326|520449299|FG008|Overall Study|Death|0|||
144340817|NCT01717326|520449300|FG009|Overall Study|Death|0|||
144340818|NCT01717326|520449301|FG010|Overall Study|Death|1|||
144340819|NCT01717326|520449302|FG011|Overall Study|Death|0|||
144340820|NCT01717326|520449303|FG012|Overall Study|Death|0|||
144340821|NCT01717326|520449304|FG013|Overall Study|Death|0|||
144340822|NCT01717326|520449305|FG014|Overall Study|Death|0|||
144340823|NCT01717326|520449306|FG015|Overall Study|Death|0|||
144340824|NCT01717326|520449307|FG016|Overall Study|Death|0|||
144340825|NCT01717326|520449308|FG017|Overall Study|Death|0|||
144340826|NCT01717326|520449309|FG018|Overall Study|Death|0|||
144340827|NCT01717326|520449310|FG019|Overall Study|Death|0|||
144340828|NCT01717326|520449291|FG000|Overall Study|Lost to Follow-up|3|||
144340829|NCT01717326|520449292|FG001|Overall Study|Lost to Follow-up|0|||
144340830|NCT01717326|520449293|FG002|Overall Study|Lost to Follow-up|0|||
144340831|NCT01717326|520449294|FG003|Overall Study|Lost to Follow-up|2|||
144340832|NCT01717326|520449295|FG004|Overall Study|Lost to Follow-up|1|||
144340833|NCT01717326|520449296|FG005|Overall Study|Lost to Follow-up|0|||
144340834|NCT01717326|520449297|FG006|Overall Study|Lost to Follow-up|1|||
144340835|NCT01717326|520449298|FG007|Overall Study|Lost to Follow-up|0|||
144340836|NCT01717326|520449299|FG008|Overall Study|Lost to Follow-up|0|||
144340837|NCT01717326|520449300|FG009|Overall Study|Lost to Follow-up|0|||
144340838|NCT01717326|520449301|FG010|Overall Study|Lost to Follow-up|1|||
144340839|NCT01717326|520449302|FG011|Overall Study|Lost to Follow-up|0|||
144340840|NCT01717326|520449303|FG012|Overall Study|Lost to Follow-up|0|||
144340841|NCT01717326|520449304|FG013|Overall Study|Lost to Follow-up|0|||
144340842|NCT01717326|520449305|FG014|Overall Study|Lost to Follow-up|0|||
144340843|NCT01717326|520449306|FG015|Overall Study|Lost to Follow-up|2|||
144340844|NCT01717326|520449307|FG016|Overall Study|Lost to Follow-up|1|||
144340845|NCT01717326|520449308|FG017|Overall Study|Lost to Follow-up|0|||
144340846|NCT01717326|520449309|FG018|Overall Study|Lost to Follow-up|2|||
144340847|NCT01717326|520449310|FG019|Overall Study|Lost to Follow-up|3|||
144340848|NCT01717326|520449291|FG000|Overall Study|Physician Decision|0|||
144340849|NCT01717326|520449292|FG001|Overall Study|Physician Decision|0|||
144340850|NCT01717326|520449293|FG002|Overall Study|Physician Decision|0|||
144340851|NCT01717326|520449294|FG003|Overall Study|Physician Decision|0|||
144340852|NCT01717326|520449295|FG004|Overall Study|Physician Decision|0|||
144340853|NCT01717326|520449296|FG005|Overall Study|Physician Decision|0|||
144340854|NCT01717326|520449297|FG006|Overall Study|Physician Decision|0|||
144340855|NCT01717326|520449298|FG007|Overall Study|Physician Decision|0|||
144340856|NCT01717326|520449299|FG008|Overall Study|Physician Decision|0|||
144340857|NCT01717326|520449300|FG009|Overall Study|Physician Decision|1|||
144340858|NCT01717326|520449301|FG010|Overall Study|Physician Decision|0|||
144340859|NCT01717326|520449302|FG011|Overall Study|Physician Decision|0|||
144340860|NCT01717326|520449303|FG012|Overall Study|Physician Decision|0|||
144340861|NCT01717326|520449304|FG013|Overall Study|Physician Decision|0|||
144340862|NCT01717326|520449305|FG014|Overall Study|Physician Decision|0|||
144340863|NCT01717326|520449306|FG015|Overall Study|Physician Decision|0|||
144340864|NCT01717326|520449307|FG016|Overall Study|Physician Decision|0|||
144340865|NCT01717326|520449308|FG017|Overall Study|Physician Decision|0|||
144340866|NCT01717326|520449309|FG018|Overall Study|Physician Decision|0|||
144340867|NCT01717326|520449310|FG019|Overall Study|Physician Decision|0|||
144340868|NCT01717326|520449291|FG000|Overall Study|Protocol Violation|0|||
144340869|NCT01717326|520449292|FG001|Overall Study|Protocol Violation|0|||
144340870|NCT01717326|520449293|FG002|Overall Study|Protocol Violation|0|||
144340871|NCT01717326|520449294|FG003|Overall Study|Protocol Violation|0|||
144340872|NCT01717326|520449295|FG004|Overall Study|Protocol Violation|1|||
144340873|NCT01717326|520449296|FG005|Overall Study|Protocol Violation|0|||
144340874|NCT01717326|520449297|FG006|Overall Study|Protocol Violation|0|||
144340875|NCT01717326|520449298|FG007|Overall Study|Protocol Violation|0|||
144340876|NCT01717326|520449299|FG008|Overall Study|Protocol Violation|0|||
144340877|NCT01717326|520449300|FG009|Overall Study|Protocol Violation|0|||
144340878|NCT01717326|520449301|FG010|Overall Study|Protocol Violation|0|||
144340879|NCT01717326|520449302|FG011|Overall Study|Protocol Violation|0|||
144340880|NCT01717326|520449303|FG012|Overall Study|Protocol Violation|0|||
144340881|NCT01717326|520449304|FG013|Overall Study|Protocol Violation|0|||
144340882|NCT01717326|520449305|FG014|Overall Study|Protocol Violation|0|||
144340883|NCT01717326|520449306|FG015|Overall Study|Protocol Violation|0|||
144340884|NCT01717326|520449307|FG016|Overall Study|Protocol Violation|0|||
144340885|NCT01717326|520449308|FG017|Overall Study|Protocol Violation|0|||
144340886|NCT01717326|520449309|FG018|Overall Study|Protocol Violation|0|||
144340887|NCT01717326|520449310|FG019|Overall Study|Protocol Violation|0|||
144340888|NCT01717326|520449291|FG000|Overall Study|Withdrawal by Subject|0|||
144340889|NCT01717326|520449292|FG001|Overall Study|Withdrawal by Subject|1|||
144340890|NCT01717326|520449293|FG002|Overall Study|Withdrawal by Subject|0|||
144340891|NCT01717326|520449294|FG003|Overall Study|Withdrawal by Subject|0|||
144340892|NCT01717326|520449295|FG004|Overall Study|Withdrawal by Subject|0|||
144340893|NCT01717326|520449296|FG005|Overall Study|Withdrawal by Subject|0|||
144340894|NCT01717326|520449297|FG006|Overall Study|Withdrawal by Subject|0|||
144340895|NCT01717326|520449298|FG007|Overall Study|Withdrawal by Subject|0|||
144340896|NCT01717326|520449299|FG008|Overall Study|Withdrawal by Subject|0|||
144340897|NCT01717326|520449300|FG009|Overall Study|Withdrawal by Subject|1|||
144340898|NCT01717326|520449301|FG010|Overall Study|Withdrawal by Subject|0|||
144340899|NCT01717326|520449302|FG011|Overall Study|Withdrawal by Subject|0|||
144340900|NCT01717326|520449303|FG012|Overall Study|Withdrawal by Subject|1|||
144340901|NCT01717326|520449304|FG013|Overall Study|Withdrawal by Subject|0|||
144340902|NCT01717326|520449305|FG014|Overall Study|Withdrawal by Subject|0|||
144340903|NCT01717326|520449306|FG015|Overall Study|Withdrawal by Subject|1|||
144340904|NCT01717326|520449307|FG016|Overall Study|Withdrawal by Subject|0|||
144340905|NCT01717326|520449308|FG017|Overall Study|Withdrawal by Subject|0|||
144340906|NCT01717326|520449309|FG018|Overall Study|Withdrawal by Subject|2|||
144340907|NCT01717326|520449310|FG019|Overall Study|Withdrawal by Subject|3|||
144340908|NCT01123707|520449311|FG000|Overall Study|Lost to Follow-up|3|||
144340909|NCT01123707|520449312|FG001|Overall Study|Lost to Follow-up|1|||
144340910|NCT01123707|520449313|FG002|Overall Study|Lost to Follow-up|3|||
144340911|NCT01123707|520449314|FG003|Overall Study|Lost to Follow-up|2|||
144340912|NCT01123707|520449311|FG000|Overall Study|Adverse Event|5|||
144340913|NCT01123707|520449312|FG001|Overall Study|Adverse Event|7|||
144340914|NCT01123707|520449313|FG002|Overall Study|Adverse Event|5|||
144340915|NCT01123707|520449314|FG003|Overall Study|Adverse Event|3|||
144340916|NCT01123707|520449311|FG000|Overall Study|Sponsor Discontinued Study|30|||
144340917|NCT01123707|520449312|FG001|Overall Study|Sponsor Discontinued Study|24|||
144340918|NCT01123707|520449313|FG002|Overall Study|Sponsor Discontinued Study|25|||
144340919|NCT01123707|520449314|FG003|Overall Study|Sponsor Discontinued Study|40|||
144340920|NCT01123707|520449311|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
144340921|NCT01123707|520449312|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
144340922|NCT01123707|520449313|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
144340923|NCT01123707|520449314|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
144340924|NCT01123707|520449311|FG000|Overall Study|Investigator Withdrew Participant|0|||
144340925|NCT01123707|520449312|FG001|Overall Study|Investigator Withdrew Participant|1|||
144340926|NCT01123707|520449313|FG002|Overall Study|Investigator Withdrew Participant|1|||
144340927|NCT01123707|520449314|FG003|Overall Study|Investigator Withdrew Participant|1|||
144340928|NCT01123707|520449311|FG000|Overall Study|Subject Withdrew Consent|4|||
144340929|NCT01123707|520449312|FG001|Overall Study|Subject Withdrew Consent|5|||
144340930|NCT01123707|520449313|FG002|Overall Study|Subject Withdrew Consent|1|||
144340931|NCT01123707|520449314|FG003|Overall Study|Subject Withdrew Consent|2|||
144340932|NCT01123707|520449311|FG000|Overall Study|Lack of Efficacy|1|||
144340933|NCT01123707|520449312|FG001|Overall Study|Lack of Efficacy|2|||
144340934|NCT01123707|520449313|FG002|Overall Study|Lack of Efficacy|1|||
144340935|NCT01123707|520449314|FG003|Overall Study|Lack of Efficacy|0|||
144340936|NCT01123707|520449311|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
144340937|NCT01123707|520449312|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
144340938|NCT01123707|520449313|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
144340939|NCT01123707|520449314|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
144340940|NCT03210961|520451596|FG000|Overall Study|Adverse Event|0|||
144340941|NCT03210961|520451597|FG001|Overall Study|Adverse Event|0|||
144340942|NCT03210961|520451598|FG002|Overall Study|Adverse Event|0|||
144340943|NCT03210961|520451599|FG003|Overall Study|Adverse Event|0|||
144340944|NCT03210961|520451600|FG004|Overall Study|Adverse Event|0|||
144340945|NCT03210961|520451601|FG005|Overall Study|Adverse Event|0|||
144340946|NCT03210961|520451602|FG006|Overall Study|Adverse Event|0|||
144340947|NCT03210961|520451603|FG007|Overall Study|Adverse Event|0|||
144340948|NCT03210961|520451604|FG008|Overall Study|Adverse Event|0|||
144340949|NCT03210961|520451605|FG009|Overall Study|Adverse Event|0|||
144340950|NCT03210961|520451606|FG010|Overall Study|Adverse Event|0|||
144340951|NCT03210961|520451607|FG011|Overall Study|Adverse Event|0|||
144340952|NCT03210961|520451608|FG012|Overall Study|Adverse Event|0|||
144340953|NCT03210961|520451609|FG013|Overall Study|Adverse Event|1|||
144340954|NCT03210961|520451610|FG014|Overall Study|Adverse Event|0|||
144340955|NCT03210961|520451596|FG000|Overall Study|Lost to Follow-up|0|||
144340956|NCT03210961|520451597|FG001|Overall Study|Lost to Follow-up|0|||
144340957|NCT03210961|520451598|FG002|Overall Study|Lost to Follow-up|0|||
144340958|NCT03210961|520451599|FG003|Overall Study|Lost to Follow-up|0|||
144340959|NCT03210961|520451600|FG004|Overall Study|Lost to Follow-up|0|||
144340960|NCT03210961|520451601|FG005|Overall Study|Lost to Follow-up|0|||
144340961|NCT03210961|520451602|FG006|Overall Study|Lost to Follow-up|0|||
144340962|NCT03210961|520451603|FG007|Overall Study|Lost to Follow-up|0|||
144340963|NCT03210961|520451604|FG008|Overall Study|Lost to Follow-up|0|||
144340964|NCT03210961|520451605|FG009|Overall Study|Lost to Follow-up|0|||
144340965|NCT03210961|520451606|FG010|Overall Study|Lost to Follow-up|0|||
144340966|NCT03210961|520451607|FG011|Overall Study|Lost to Follow-up|0|||
144340967|NCT03210961|520451608|FG012|Overall Study|Lost to Follow-up|0|||
144340968|NCT03210961|520451609|FG013|Overall Study|Lost to Follow-up|0|||
144340969|NCT03210961|520451610|FG014|Overall Study|Lost to Follow-up|1|||
144340970|NCT03210961|520451596|FG000|Overall Study|Withdrawal by Subject|0|||
144340971|NCT03210961|520451597|FG001|Overall Study|Withdrawal by Subject|0|||
144340972|NCT03210961|520451598|FG002|Overall Study|Withdrawal by Subject|0|||
144340973|NCT03210961|520451599|FG003|Overall Study|Withdrawal by Subject|0|||
144340974|NCT03210961|520451600|FG004|Overall Study|Withdrawal by Subject|0|||
144340975|NCT03210961|520451601|FG005|Overall Study|Withdrawal by Subject|0|||
144340976|NCT03210961|520451602|FG006|Overall Study|Withdrawal by Subject|0|||
144340977|NCT03210961|520451603|FG007|Overall Study|Withdrawal by Subject|0|||
144340978|NCT03210961|520451604|FG008|Overall Study|Withdrawal by Subject|0|||
144340979|NCT03210961|520451605|FG009|Overall Study|Withdrawal by Subject|0|||
144340980|NCT03210961|520451606|FG010|Overall Study|Withdrawal by Subject|0|||
144340981|NCT03210961|520451607|FG011|Overall Study|Withdrawal by Subject|0|||
144340982|NCT03210961|520451608|FG012|Overall Study|Withdrawal by Subject|0|||
144340983|NCT03210961|520451609|FG013|Overall Study|Withdrawal by Subject|0|||
144340984|NCT03210961|520451610|FG014|Overall Study|Withdrawal by Subject|1|||
144340985|NCT03210961|520451596|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340986|NCT03210961|520451597|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340987|NCT03210961|520451598|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340988|NCT03210961|520451599|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340989|NCT03210961|520451600|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340990|NCT03210961|520451601|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340991|NCT03210961|520451602|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340992|NCT03210961|520451603|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340993|NCT03210961|520451604|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340994|NCT03210961|520451605|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340995|NCT03210961|520451606|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340996|NCT03210961|520451607|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340997|NCT03210961|520451608|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
144340998|NCT03210961|520451609|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
144340999|NCT03210961|520451610|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
144341000|NCT03210961|520451596|FG000|Overall Study|Other|0|||
144341001|NCT03210961|520451597|FG001|Overall Study|Other|0|||
144341002|NCT03210961|520451598|FG002|Overall Study|Other|0|||
144341003|NCT03210961|520451599|FG003|Overall Study|Other|1|||
144341004|NCT03210961|520451600|FG004|Overall Study|Other|0|||
144341005|NCT03210961|520451601|FG005|Overall Study|Other|0|||
144341006|NCT03210961|520451602|FG006|Overall Study|Other|1|||
144341007|NCT03210961|520451603|FG007|Overall Study|Other|0|||
144341008|NCT03210961|520451604|FG008|Overall Study|Other|0|||
144341009|NCT03210961|520451605|FG009|Overall Study|Other|0|||
144341010|NCT03210961|520451606|FG010|Overall Study|Other|1|||
144341011|NCT03210961|520451607|FG011|Overall Study|Other|0|||
144341012|NCT03210961|520451608|FG012|Overall Study|Other|2|||
144341013|NCT03210961|520451609|FG013|Overall Study|Other|2|||
144341014|NCT03210961|520451610|FG014|Overall Study|Other|0|||
144341015|NCT02467582|520451611|FG000|Allocation|Withdrawal by Subject|1|||
144341016|NCT02467582|520451612|FG001|Allocation|Withdrawal by Subject|0|||
144341017|NCT02467582|520451611|FG000|Follow-up|Death|5|||
144341018|NCT02467582|520451612|FG001|Follow-up|Death|4|||
144341019|NCT02467582|520451611|FG000|Follow-up|Lost to Follow-up|6|||
144341020|NCT02467582|520451612|FG001|Follow-up|Lost to Follow-up|5|||
144341021|NCT01031979|520451615|FG000|Overall Study|Lost to Follow-up|5|||
144341022|NCT01031979|520451616|FG001|Overall Study|Lost to Follow-up|4|||
144341023|NCT03592368|520451618|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
144341024|NCT03592368|520451619|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
144341025|NCT03592368|520451620|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
144341026|NCT03592368|520451621|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
144341027|NCT03592368|520451618|FG000|Overall Study|Adverse Event|0|||
144341028|NCT03592368|520451619|FG001|Overall Study|Adverse Event|0|||
144341029|NCT03592368|520451620|FG002|Overall Study|Adverse Event|0|||
144341030|NCT03592368|520451621|FG003|Overall Study|Adverse Event|1|||
144341031|NCT03592368|520451618|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
144341032|NCT03592368|520451619|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
144341033|NCT03592368|520451620|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
144341034|NCT03592368|520451621|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
144341035|NCT03831100|520451622|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
144341036|NCT03831100|520451623|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
144341037|NCT02454478|520451630|FG000|Overall Study|Incomplete DLT Evaluation|1|||
144341038|NCT03354273|520451648|FG000|Overall Study|Adverse Event|5|||
144341039|NCT03354273|520451648|FG000|Overall Study|Screen Failure|21|||
144341040|NCT03354273|520451648|FG000|Overall Study|Withdrawal by Subject|34|||
144341041|NCT03354273|520451648|FG000|Overall Study|Technical Problems|30|||
144341042|NCT03354273|520451648|FG000|Overall Study|Lost to Follow-up|4|||
144341043|NCT03354273|520451648|FG000|Overall Study|Investigator Decision|3|||
144341044|NCT03354273|520451648|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
144341045|NCT03354273|520451648|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
144341046|NCT03354273|520451648|FG000|Overall Study|COVID-19 Restrictions|9|||
144341047|NCT03354273|520451648|FG000|Overall Study|Other|5|||
144341048|NCT00705367|520451649|FG000|Long-term Extension Period|Adverse Event|2|||
144341049|NCT00705367|520451650|FG001|Long-term Extension Period|Adverse Event|0|||
144341050|NCT00705367|520451649|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
144341051|NCT00705367|520451650|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
144341052|NCT00705367|520451649|FG000|Long-term Extension Period|Lack of Efficacy|1|||
144341053|NCT00705367|520451650|FG001|Long-term Extension Period|Lack of Efficacy|0|||
144341054|NCT00705367|520451649|FG000|Long-term Extension Period|No longer met study criteria|1|||
144341055|NCT00705367|520451650|FG001|Long-term Extension Period|No longer met study criteria|0|||
144341056|NCT00705367|520451649|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
144341057|NCT00705367|520451650|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
144341058|NCT02629822|520451654|FG000|Base Study|Lost to Follow-up|2|||
144341059|NCT02629822|520451654|FG000|Base Study|Non-Compliance With Study Drug|1|||
144341060|NCT02629822|520451654|FG000|Extension Study|Adverse Event|1|||
144341061|NCT02629822|520451654|FG000|Extension Study|Lost to Follow-up|1|||
144341062|NCT03679624|520451655|FG000|Overall Study|Adverse Event|1|||
144341063|NCT03679624|520451656|FG001|Overall Study|Adverse Event|0|||
144341064|NCT00741013|520451657|FG000|Overall Study|Adverse Event|1|||
144341065|NCT00741013|520451658|FG001|Overall Study|Adverse Event|0|||
144341066|NCT00741013|520451659|FG002|Overall Study|Adverse Event|0|||
144341067|NCT00741013|520451657|FG000|Overall Study|Withdrawal by Subject|0|||
144341068|NCT00741013|520451658|FG001|Overall Study|Withdrawal by Subject|0|||
144341069|NCT00741013|520451659|FG002|Overall Study|Withdrawal by Subject|1|||
144341070|NCT00741013|520451657|FG000|Overall Study|Discovered failed screen after enrolled|0|||
144341071|NCT00741013|520451658|FG001|Overall Study|Discovered failed screen after enrolled|2|||
144341072|NCT00741013|520451659|FG002|Overall Study|Discovered failed screen after enrolled|0|||
144341073|NCT00082407|520451660|FG000|Overall Study|Adverse Event|20|||
144341074|NCT00082407|520451661|FG001|Overall Study|Adverse Event|0|||
144341075|NCT00082407|520451660|FG000|Overall Study|Protocol Violation|14|||
144341076|NCT00082407|520451661|FG001|Overall Study|Protocol Violation|12|||
144341077|NCT00082407|520451660|FG000|Overall Study|Patient Decision|13|||
144341078|NCT00082407|520451661|FG001|Overall Study|Patient Decision|6|||
144341079|NCT00082407|520451660|FG000|Overall Study|Physician Decision|5|||
144341080|NCT00082407|520451661|FG001|Overall Study|Physician Decision|3|||
144341081|NCT00082407|520451660|FG000|Overall Study|Loss of Glucose Control|2|||
144341082|NCT00082407|520451661|FG001|Overall Study|Loss of Glucose Control|2|||
144341083|NCT00082407|520451660|FG000|Overall Study|Death|2|||
144341084|NCT00082407|520451661|FG001|Overall Study|Death|1|||
144341085|NCT00082407|520451660|FG000|Overall Study|Lost to Follow-up|0|||
144341086|NCT00082407|520451661|FG001|Overall Study|Lost to Follow-up|3|||
144341087|NCT02352753|520451662|FG000|6-Month Dosing Period|Decision by sponsor|2|||
144341088|NCT02352753|520451662|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
144341089|NCT02352753|520451662|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
144341090|NCT02352753|520451662|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
144341091|NCT02352753|520451662|FG000|3-Month Dosing Period|Decision by sponsor|14|||
144341092|NCT02352753|520451662|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
144341093|NCT00539305|520451663|FG000|Overall Study|Adverse Event|1|||
144341094|NCT00539305|520451664|FG001|Overall Study|Adverse Event|0|||
144341095|NCT00539305|520451663|FG000|Overall Study|Substance Use|0|||
144341096|NCT00539305|520451664|FG001|Overall Study|Substance Use|1|||
144341097|NCT00539305|520451663|FG000|Overall Study|Withdrawal by Subject|0|||
144341098|NCT00539305|520451664|FG001|Overall Study|Withdrawal by Subject|1|||
144341099|NCT01393639|520451668|FG000|Overall Study|Protocol Violation|0|||
144341100|NCT01393639|520451669|FG001|Overall Study|Protocol Violation|0|||
144341101|NCT01393639|520451670|FG002|Overall Study|Protocol Violation|0|||
144341102|NCT01393639|520451671|FG003|Overall Study|Protocol Violation|1|||
144341103|NCT01393639|520451672|FG004|Overall Study|Protocol Violation|0|||
144341104|NCT01393639|520451673|FG005|Overall Study|Protocol Violation|0|||
144341105|NCT01393639|520451674|FG006|Overall Study|Protocol Violation|0|||
144341106|NCT01393639|520451668|FG000|Overall Study|Other|0|||
144341107|NCT01393639|520451669|FG001|Overall Study|Other|2|||
144341108|NCT01393639|520451670|FG002|Overall Study|Other|0|||
144341109|NCT01393639|520451671|FG003|Overall Study|Other|2|||
144341110|NCT01393639|520451672|FG004|Overall Study|Other|1|||
144341111|NCT01393639|520451673|FG005|Overall Study|Other|0|||
144341112|NCT01393639|520451674|FG006|Overall Study|Other|1|||
144341113|NCT01393639|520451668|FG000|Overall Study|Withdrawal by Subject|1|||
144341114|NCT01393639|520451669|FG001|Overall Study|Withdrawal by Subject|1|||
144341115|NCT01393639|520451670|FG002|Overall Study|Withdrawal by Subject|0|||
144341116|NCT01393639|520451671|FG003|Overall Study|Withdrawal by Subject|0|||
144341117|NCT01393639|520451672|FG004|Overall Study|Withdrawal by Subject|0|||
144341118|NCT01393639|520451673|FG005|Overall Study|Withdrawal by Subject|0|||
144341119|NCT01393639|520451674|FG006|Overall Study|Withdrawal by Subject|1|||
144341120|NCT01393639|520451668|FG000|Overall Study|Medication error without associated AE|0|||
144341121|NCT01393639|520451669|FG001|Overall Study|Medication error without associated AE|0|||
144341122|NCT01393639|520451670|FG002|Overall Study|Medication error without associated AE|0|||
144341123|NCT01393639|520451671|FG003|Overall Study|Medication error without associated AE|0|||
144341124|NCT01393639|520451672|FG004|Overall Study|Medication error without associated AE|0|||
144341125|NCT01393639|520451673|FG005|Overall Study|Medication error without associated AE|0|||
144341126|NCT01393639|520451674|FG006|Overall Study|Medication error without associated AE|1|||
144341127|NCT01393639|520451668|FG000|Overall Study|Lost to Follow-up|0|||
144341128|NCT01393639|520451669|FG001|Overall Study|Lost to Follow-up|1|||
144341129|NCT01393639|520451670|FG002|Overall Study|Lost to Follow-up|0|||
144341130|NCT01393639|520451671|FG003|Overall Study|Lost to Follow-up|0|||
144341131|NCT01393639|520451672|FG004|Overall Study|Lost to Follow-up|0|||
144341132|NCT01393639|520451673|FG005|Overall Study|Lost to Follow-up|0|||
144341133|NCT01393639|520451674|FG006|Overall Study|Lost to Follow-up|1|||
144341134|NCT01393639|520451668|FG000|Overall Study|Lack of Efficacy|0|||
144341135|NCT01393639|520451669|FG001|Overall Study|Lack of Efficacy|0|||
144341136|NCT01393639|520451670|FG002|Overall Study|Lack of Efficacy|0|||
144341137|NCT01393639|520451671|FG003|Overall Study|Lack of Efficacy|0|||
144341138|NCT01393639|520451672|FG004|Overall Study|Lack of Efficacy|0|||
144341139|NCT01393639|520451673|FG005|Overall Study|Lack of Efficacy|0|||
144341140|NCT01393639|520451674|FG006|Overall Study|Lack of Efficacy|1|||
144341141|NCT01393639|520451668|FG000|Overall Study|Adverse Event|2|||
144341142|NCT01393639|520451669|FG001|Overall Study|Adverse Event|3|||
144341143|NCT01393639|520451670|FG002|Overall Study|Adverse Event|1|||
144341144|NCT01393639|520451671|FG003|Overall Study|Adverse Event|2|||
144341145|NCT01393639|520451672|FG004|Overall Study|Adverse Event|0|||
144341146|NCT01393639|520451673|FG005|Overall Study|Adverse Event|2|||
144341147|NCT01393639|520451674|FG006|Overall Study|Adverse Event|3|||
144341148|NCT01440816|520451675|FG000|Overall Study|Disease Progression|0|||
144341149|NCT01440816|520451676|FG001|Overall Study|Disease Progression|9|||
144341150|NCT01440816|520451675|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
144341151|NCT01440816|520451676|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
144341152|NCT03576716|520451683|FG000|Overall Study|Withdrawal by Subject|0|||
144341153|NCT03576716|520451684|FG001|Overall Study|Withdrawal by Subject|1|||
144341154|NCT02891382|520451685|FG000|Overall Study|Lost to Follow-up|3|||
144341155|NCT02891382|520451686|FG001|Overall Study|Lost to Follow-up|4|||
144341156|NCT02891382|520451687|FG002|Overall Study|Lost to Follow-up|5|||
144341157|NCT02891382|520451688|FG003|Overall Study|Lost to Follow-up|3|||
144341158|NCT02891382|520451689|FG004|Overall Study|Lost to Follow-up|4|||
144341159|NCT01455194|520451690|FG000|Overall Study|Screen Failure|20|||
144341160|NCT01455194|520451691|FG001|Overall Study|Screen Failure|0|||
144341161|NCT01455194|520451692|FG002|Overall Study|Screen Failure|0|||
144341162|NCT01455194|520451693|FG003|Overall Study|Screen Failure|0|||
144341163|NCT01455194|520451690|FG000|Overall Study|Randomisation Failure|90|||
144341164|NCT01455194|520451691|FG001|Overall Study|Randomisation Failure|0|||
144341165|NCT01455194|520451692|FG002|Overall Study|Randomisation Failure|0|||
144341166|NCT01455194|520451693|FG003|Overall Study|Randomisation Failure|0|||
144341167|NCT01455194|520451690|FG000|Overall Study|Deterioration in asthma|12|||
144341168|NCT01455194|520451691|FG001|Overall Study|Deterioration in asthma|6|||
144341169|NCT01455194|520451692|FG002|Overall Study|Deterioration in asthma|14|||
144341170|NCT01455194|520451693|FG003|Overall Study|Deterioration in asthma|9|||
144341171|NCT01455194|520451690|FG000|Overall Study|Adverse Event|1|||
144341172|NCT01455194|520451691|FG001|Overall Study|Adverse Event|1|||
144341173|NCT01455194|520451692|FG002|Overall Study|Adverse Event|1|||
144341174|NCT01455194|520451693|FG003|Overall Study|Adverse Event|3|||
144341175|NCT01455194|520451690|FG000|Overall Study|Withdrawal by Subject|21|||
144341176|NCT01455194|520451691|FG001|Overall Study|Withdrawal by Subject|16|||
144341177|NCT01455194|520451692|FG002|Overall Study|Withdrawal by Subject|12|||
144341178|NCT01455194|520451693|FG003|Overall Study|Withdrawal by Subject|9|||
144341179|NCT01455194|520451690|FG000|Overall Study|Lost to Follow-up|2|||
144341180|NCT01455194|520451691|FG001|Overall Study|Lost to Follow-up|0|||
144341181|NCT01455194|520451692|FG002|Overall Study|Lost to Follow-up|1|||
144341182|NCT01455194|520451693|FG003|Overall Study|Lost to Follow-up|1|||
144341183|NCT01455194|520451690|FG000|Overall Study|Pregnancy|0|||
144341184|NCT01455194|520451691|FG001|Overall Study|Pregnancy|1|||
144341185|NCT01455194|520451692|FG002|Overall Study|Pregnancy|1|||
144341186|NCT01455194|520451693|FG003|Overall Study|Pregnancy|0|||
144341187|NCT01455194|520451690|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
144341188|NCT01455194|520451691|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
144341189|NCT01455194|520451692|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
144341190|NCT01455194|520451693|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
144341191|NCT01455194|520451690|FG000|Overall Study|Miscellaneous|4|||
144341192|NCT01455194|520451691|FG001|Overall Study|Miscellaneous|5|||
144341193|NCT01455194|520451692|FG002|Overall Study|Miscellaneous|1|||
144341194|NCT01455194|520451693|FG003|Overall Study|Miscellaneous|4|||
144341195|NCT02249182|520451694|FG000|Treatment Phase|Lost to Follow-up|4|||
144341196|NCT02249182|520451695|FG001|Treatment Phase|Lost to Follow-up|0|||
144341197|NCT02249182|520451696|FG002|Treatment Phase|Lost to Follow-up|0|||
144341198|NCT02249182|520451697|FG003|Treatment Phase|Lost to Follow-up|0|||
144341199|NCT02249182|520451698|FG004|Treatment Phase|Lost to Follow-up|0|||
144341200|NCT00148941|520451705|FG000|Overall Study|Lost to Follow-up|17|||
144341201|NCT00148941|520451706|FG001|Overall Study|Lost to Follow-up|24|||
144341202|NCT00148941|520451707|FG002|Overall Study|Lost to Follow-up|18|||
144341203|NCT00148941|520451708|FG003|Overall Study|Lost to Follow-up|22|||
144341204|NCT00148941|520451705|FG000|Overall Study|Withdrawal by Subject|1|||
144341205|NCT00148941|520451706|FG001|Overall Study|Withdrawal by Subject|0|||
144341206|NCT00148941|520451707|FG002|Overall Study|Withdrawal by Subject|1|||
144341207|NCT00148941|520451708|FG003|Overall Study|Withdrawal by Subject|0|||
144341208|NCT00148941|520451705|FG000|Overall Study|Other|0|||
144341209|NCT00148941|520451706|FG001|Overall Study|Other|0|||
144341210|NCT00148941|520451707|FG002|Overall Study|Other|1|||
144341211|NCT00148941|520451708|FG003|Overall Study|Other|2|||
144341212|NCT03244826|520451709|FG000|Overall Study|Withdrawal by Subject|2|||
144341213|NCT03244826|520451710|FG001|Overall Study|Withdrawal by Subject|0|||
144341214|NCT03244826|520451709|FG000|Overall Study|Transplant delayed or withdrawn|12|||
144341215|NCT03244826|520451710|FG001|Overall Study|Transplant delayed or withdrawn|10|||
144341216|NCT02673684|520451713|FG000|Overall Study|Study not completed d/t loss of funding|9|||
144341217|NCT02673684|520451714|FG001|Overall Study|Study not completed d/t loss of funding|8|||
144341218|NCT04356040|520451715|FG000|Overall Study|Death|2|||
144341219|NCT04356040|520451716|FG001|Overall Study|Death|0|||
144341220|NCT04356040|520451715|FG000|Overall Study|Lost to Follow-up|1|||
144341221|NCT04356040|520451716|FG001|Overall Study|Lost to Follow-up|0|||
144341222|NCT04356040|520451715|FG000|Overall Study|Physician Decision|0|||
144341223|NCT04356040|520451716|FG001|Overall Study|Physician Decision|1|||
144341224|NCT04356040|520451715|FG000|Overall Study|Withdrawal by Subject|13|||
144341225|NCT04356040|520451716|FG001|Overall Study|Withdrawal by Subject|1|||
144341226|NCT04356040|520451715|FG000|Overall Study|Enrollment Pause|10|||
144341227|NCT04356040|520451716|FG001|Overall Study|Enrollment Pause|0|||
144341228|NCT04356040|520451715|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
144341229|NCT04356040|520451716|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
144341230|NCT04356040|520451715|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
144341231|NCT04356040|520451716|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
144341232|NCT04356040|520451715|FG000|Overall Study|PI left institution|3|||
144341233|NCT04356040|520451716|FG001|Overall Study|PI left institution|0|||
144341234|NCT01092663|520451717|FG000|Overall Study|Withdrawal by Subject|3|||
144341235|NCT01092663|520451718|FG001|Overall Study|Withdrawal by Subject|2|||
144341236|NCT01092663|520451717|FG000|Overall Study|Glucose >300mg/dL|1|||
144341237|NCT01092663|520451718|FG001|Overall Study|Glucose >300mg/dL|0|||
144341238|NCT01092663|520451717|FG000|Overall Study|High fasting triglyceride|2|||
144341239|NCT01092663|520451718|FG001|Overall Study|High fasting triglyceride|0|||
144341240|NCT01092663|520451717|FG000|Overall Study|Adverse Event|1|||
144341241|NCT01092663|520451718|FG001|Overall Study|Adverse Event|1|||
144341242|NCT01092663|520451717|FG000|Overall Study|Protocol Violation|0|||
144341243|NCT01092663|520451718|FG001|Overall Study|Protocol Violation|1|||
144341244|NCT01990859|520451719|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
144341245|NCT01990859|520451719|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
144341246|NCT02262754|520451720|FG000|Overall Study|Adverse Event|3|||
144341247|NCT02262754|520451721|FG001|Overall Study|Adverse Event|4|||
144341248|NCT02262754|520451722|FG002|Overall Study|Adverse Event|0|||
144341249|NCT02262754|520451720|FG000|Overall Study|Lack of Efficacy|2|||
144341250|NCT02262754|520451721|FG001|Overall Study|Lack of Efficacy|0|||
144341251|NCT02262754|520451722|FG002|Overall Study|Lack of Efficacy|1|||
144341252|NCT02262754|520451720|FG000|Overall Study|Lost to Follow-up|0|||
144341253|NCT02262754|520451721|FG001|Overall Study|Lost to Follow-up|0|||
144341254|NCT02262754|520451722|FG002|Overall Study|Lost to Follow-up|1|||
144341255|NCT02262754|520451720|FG000|Overall Study|No longer meets eligibility criteria|0|||
144341256|NCT02262754|520451721|FG001|Overall Study|No longer meets eligibility criteria|1|||
144341257|NCT02262754|520451722|FG002|Overall Study|No longer meets eligibility criteria|0|||
144341258|NCT02262754|520451720|FG000|Overall Study|Study terminated by sponsor|5|||
144341259|NCT02262754|520451721|FG001|Overall Study|Study terminated by sponsor|4|||
144341260|NCT02262754|520451722|FG002|Overall Study|Study terminated by sponsor|4|||
144341261|NCT02262754|520451720|FG000|Overall Study|Protocol Violation|1|||
144341262|NCT02262754|520451721|FG001|Overall Study|Protocol Violation|0|||
144341263|NCT02262754|520451722|FG002|Overall Study|Protocol Violation|0|||
144341264|NCT02262754|520451720|FG000|Overall Study|Withdrawal by Subject|1|||
144341265|NCT02262754|520451721|FG001|Overall Study|Withdrawal by Subject|0|||
144341266|NCT02262754|520451722|FG002|Overall Study|Withdrawal by Subject|1|||
144341267|NCT02262754|520451720|FG000|Overall Study|Other|4|||
144341268|NCT02262754|520451721|FG001|Overall Study|Other|0|||
144341269|NCT02262754|520451722|FG002|Overall Study|Other|2|||
144341270|NCT01067469|520451723|FG000|Overall Study|Withdrawal by Subject|0|||
144341271|NCT01067469|520451724|FG001|Overall Study|Withdrawal by Subject|1|||
144341272|NCT01067469|520451723|FG000|Overall Study|Disease Progression|0|||
144341273|NCT01067469|520451724|FG001|Overall Study|Disease Progression|1|||
144341274|NCT04079114|520451726|FG000|Overall Study|Study prematuely terminated.|166|||
144341275|NCT01959243|520451731|FG000|Overall Study|Investigator Decision|3|||
144341276|NCT01959243|520451732|FG001|Overall Study|Investigator Decision|0|||
144341277|NCT01959243|520451731|FG000|Overall Study|Adverse Event|5|||
144341278|NCT01959243|520451732|FG001|Overall Study|Adverse Event|2|||
144341279|NCT01959243|520451731|FG000|Overall Study|Administrative reasons|2|||
144341280|NCT01959243|520451732|FG001|Overall Study|Administrative reasons|1|||
144341281|NCT01959243|520451731|FG000|Overall Study|Lost to Follow-up|3|||
144341282|NCT01959243|520451732|FG001|Overall Study|Lost to Follow-up|1|||
144341283|NCT00629798|520451735|FG000|Overall Study|Not Treated|4|||
144341284|NCT02554981|520451736|FG000|Overall Study|Adverse Event|1|||
144341285|NCT02554981|520451736|FG000|Overall Study|Administrative Reasons|1|||
144341286|NCT02554981|520451736|FG000|Overall Study|Other Miscellaneous Reasons|3|||
144341287|NCT02292706|520451739|FG000|Overall Study|Lost to Follow-up|20|||
144341288|NCT02292706|520451740|FG001|Overall Study|Lost to Follow-up|44|||
144341289|NCT02292706|520451741|FG002|Overall Study|Lost to Follow-up|24|||
144341290|NCT02292706|520451742|FG003|Overall Study|Lost to Follow-up|61|||
144341291|NCT02292706|520451743|FG004|Overall Study|Lost to Follow-up|21|||
144341292|NCT02292706|520451744|FG005|Overall Study|Lost to Follow-up|52|||
144341293|NCT02292706|520451745|FG006|Overall Study|Lost to Follow-up|25|||
144341294|NCT02292706|520451746|FG007|Overall Study|Lost to Follow-up|0|||
144341295|NCT02292706|520451739|FG000|Overall Study|Withdrew consent|15|||
144341296|NCT02292706|520451740|FG001|Overall Study|Withdrew consent|56|||
144341297|NCT02292706|520451741|FG002|Overall Study|Withdrew consent|43|||
144341298|NCT02292706|520451742|FG003|Overall Study|Withdrew consent|36|||
144341299|NCT02292706|520451743|FG004|Overall Study|Withdrew consent|13|||
144341300|NCT02292706|520451744|FG005|Overall Study|Withdrew consent|51|||
144341301|NCT02292706|520451745|FG006|Overall Study|Withdrew consent|20|||
144341302|NCT02292706|520451746|FG007|Overall Study|Withdrew consent|0|||
144341303|NCT02292706|520451739|FG000|Overall Study|Death|3|||
144341304|NCT02292706|520451740|FG001|Overall Study|Death|11|||
144341305|NCT02292706|520451741|FG002|Overall Study|Death|16|||
144341306|NCT02292706|520451742|FG003|Overall Study|Death|22|||
144341307|NCT02292706|520451743|FG004|Overall Study|Death|8|||
144341308|NCT02292706|520451744|FG005|Overall Study|Death|17|||
144341309|NCT02292706|520451745|FG006|Overall Study|Death|3|||
144341310|NCT02292706|520451746|FG007|Overall Study|Death|0|||
144341311|NCT02292706|520451739|FG000|Overall Study|Study terminated by sponsor|0|||
144341312|NCT02292706|520451740|FG001|Overall Study|Study terminated by sponsor|9|||
144341313|NCT02292706|520451741|FG002|Overall Study|Study terminated by sponsor|4|||
144341314|NCT02292706|520451742|FG003|Overall Study|Study terminated by sponsor|21|||
144341315|NCT02292706|520451743|FG004|Overall Study|Study terminated by sponsor|11|||
144341316|NCT02292706|520451744|FG005|Overall Study|Study terminated by sponsor|13|||
144341317|NCT02292706|520451745|FG006|Overall Study|Study terminated by sponsor|3|||
144341318|NCT02292706|520451746|FG007|Overall Study|Study terminated by sponsor|0|||
144341319|NCT02292706|520451739|FG000|Overall Study|Investigator's discretion|4|||
144341320|NCT02292706|520451740|FG001|Overall Study|Investigator's discretion|9|||
144341321|NCT02292706|520451741|FG002|Overall Study|Investigator's discretion|7|||
144341322|NCT02292706|520451742|FG003|Overall Study|Investigator's discretion|11|||
144341323|NCT02292706|520451743|FG004|Overall Study|Investigator's discretion|4|||
144341324|NCT02292706|520451744|FG005|Overall Study|Investigator's discretion|10|||
144341325|NCT02292706|520451745|FG006|Overall Study|Investigator's discretion|1|||
144341326|NCT02292706|520451746|FG007|Overall Study|Investigator's discretion|0|||
144341327|NCT02292706|520451739|FG000|Overall Study|Liver transplant|1|||
144341328|NCT02292706|520451740|FG001|Overall Study|Liver transplant|1|||
144341329|NCT02292706|520451741|FG002|Overall Study|Liver transplant|11|||
144341330|NCT02292706|520451742|FG003|Overall Study|Liver transplant|16|||
144341331|NCT02292706|520451743|FG004|Overall Study|Liver transplant|5|||
144341332|NCT02292706|520451744|FG005|Overall Study|Liver transplant|6|||
144341333|NCT02292706|520451745|FG006|Overall Study|Liver transplant|5|||
144341334|NCT02292706|520451746|FG007|Overall Study|Liver transplant|0|||
144341335|NCT02292706|520451739|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
144341336|NCT02292706|520451740|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
144341337|NCT02292706|520451741|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
144341338|NCT02292706|520451742|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
144341339|NCT02292706|520451743|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
144341340|NCT02292706|520451744|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
144341341|NCT02292706|520451745|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
144341342|NCT02292706|520451746|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
144341343|NCT02292706|520451739|FG000|Overall Study|Subject terminated by sponsor|1|||
144341344|NCT02292706|520451740|FG001|Overall Study|Subject terminated by sponsor|0|||
144341345|NCT02292706|520451741|FG002|Overall Study|Subject terminated by sponsor|0|||
144341346|NCT02292706|520451742|FG003|Overall Study|Subject terminated by sponsor|2|||
144341347|NCT02292706|520451743|FG004|Overall Study|Subject terminated by sponsor|1|||
144341348|NCT02292706|520451744|FG005|Overall Study|Subject terminated by sponsor|0|||
144341349|NCT02292706|520451745|FG006|Overall Study|Subject terminated by sponsor|0|||
144341350|NCT02292706|520451746|FG007|Overall Study|Subject terminated by sponsor|0|||
144341351|NCT02292706|520451739|FG000|Overall Study|Missing|0|||
144341352|NCT02292706|520451740|FG001|Overall Study|Missing|0|||
144341353|NCT02292706|520451741|FG002|Overall Study|Missing|1|||
144341354|NCT02292706|520451742|FG003|Overall Study|Missing|1|||
144341355|NCT02292706|520451743|FG004|Overall Study|Missing|0|||
144341356|NCT02292706|520451744|FG005|Overall Study|Missing|1|||
144341357|NCT02292706|520451745|FG006|Overall Study|Missing|0|||
144341358|NCT02292706|520451746|FG007|Overall Study|Missing|0|||
144341359|NCT02292706|520451739|FG000|Overall Study|Virologic relapse or reinfection|1|||
144341360|NCT02292706|520451740|FG001|Overall Study|Virologic relapse or reinfection|0|||
144341361|NCT02292706|520451741|FG002|Overall Study|Virologic relapse or reinfection|0|||
144341362|NCT02292706|520451742|FG003|Overall Study|Virologic relapse or reinfection|1|||
144341363|NCT02292706|520451743|FG004|Overall Study|Virologic relapse or reinfection|0|||
144341364|NCT02292706|520451744|FG005|Overall Study|Virologic relapse or reinfection|1|||
144341365|NCT02292706|520451745|FG006|Overall Study|Virologic relapse or reinfection|0|||
144341366|NCT02292706|520451746|FG007|Overall Study|Virologic relapse or reinfection|0|||
144341367|NCT01990612|520451749|FG000|Overall Study|Lost to Follow-up|2|||
144341368|NCT01990612|520451750|FG001|Overall Study|Lost to Follow-up|1|||
144341369|NCT01990612|520451749|FG000|Overall Study|Withdrawal by Subject|5|||
144341370|NCT01990612|520451750|FG001|Overall Study|Withdrawal by Subject|2|||
144341371|NCT02725866|520451751|FG000|Overall Study|Failure to return|6|||
144341372|NCT02725866|520451751|FG000|Overall Study|Withdrew consent|3|||
144341373|NCT02725866|520451751|FG000|Overall Study|Insufficient virological response|1|||
144341374|NCT02725866|520451751|FG000|Overall Study|Other, not specified|4|||
144341375|NCT02188849|520451754|FG000|Overall Study|Lost to Follow-up|3|||
144341376|NCT02188849|520451755|FG001|Overall Study|Lost to Follow-up|8|||
144341377|NCT00812565|520451761|FG000|Overall Study|Did Not Receive Study Medication|1|||
144341378|NCT00812565|520451762|FG001|Overall Study|Did Not Receive Study Medication|1|||
144341379|NCT00812565|520451763|FG002|Overall Study|Did Not Receive Study Medication|0|||
144341380|NCT00812565|520451764|FG003|Overall Study|Did Not Receive Study Medication|0|||
144341381|NCT00812565|520451765|FG004|Overall Study|Did Not Receive Study Medication|0|||
144341382|NCT00812565|520451766|FG005|Overall Study|Did Not Receive Study Medication|0|||
144341383|NCT00812565|520451767|FG006|Overall Study|Did Not Receive Study Medication|0|||
144341384|NCT00812565|520451768|FG007|Overall Study|Did Not Receive Study Medication|0|||
144341385|NCT00812565|520451761|FG000|Overall Study|Adverse Event|0|||
144341386|NCT00812565|520451762|FG001|Overall Study|Adverse Event|0|||
144341387|NCT00812565|520451763|FG002|Overall Study|Adverse Event|0|||
144341388|NCT00812565|520451764|FG003|Overall Study|Adverse Event|2|||
144341389|NCT00812565|520451765|FG004|Overall Study|Adverse Event|0|||
144341390|NCT00812565|520451766|FG005|Overall Study|Adverse Event|0|||
144341391|NCT00812565|520451767|FG006|Overall Study|Adverse Event|0|||
144341392|NCT00812565|520451768|FG007|Overall Study|Adverse Event|1|||
144341393|NCT00812565|520451761|FG000|Overall Study|Did Not Come to Study Visit|1|||
144341394|NCT00812565|520451762|FG001|Overall Study|Did Not Come to Study Visit|0|||
144341395|NCT00812565|520451763|FG002|Overall Study|Did Not Come to Study Visit|0|||
144341396|NCT00812565|520451764|FG003|Overall Study|Did Not Come to Study Visit|0|||
144341397|NCT00812565|520451765|FG004|Overall Study|Did Not Come to Study Visit|0|||
144341398|NCT00812565|520451766|FG005|Overall Study|Did Not Come to Study Visit|0|||
144341399|NCT00812565|520451767|FG006|Overall Study|Did Not Come to Study Visit|0|||
144341400|NCT00812565|520451768|FG007|Overall Study|Did Not Come to Study Visit|0|||
144341401|NCT00812565|520451761|FG000|Overall Study|Withdrawal of Consent|1|||
144341402|NCT00812565|520451762|FG001|Overall Study|Withdrawal of Consent|0|||
144341403|NCT00812565|520451763|FG002|Overall Study|Withdrawal of Consent|0|||
144341404|NCT00812565|520451764|FG003|Overall Study|Withdrawal of Consent|0|||
144341405|NCT00812565|520451765|FG004|Overall Study|Withdrawal of Consent|1|||
144341406|NCT00812565|520451766|FG005|Overall Study|Withdrawal of Consent|0|||
144341407|NCT00812565|520451767|FG006|Overall Study|Withdrawal of Consent|0|||
144341408|NCT00812565|520451768|FG007|Overall Study|Withdrawal of Consent|0|||
144341409|NCT00812565|520451761|FG000|Overall Study|Reason Not Specified|0|||
144341410|NCT00812565|520451762|FG001|Overall Study|Reason Not Specified|0|||
144341411|NCT00812565|520451763|FG002|Overall Study|Reason Not Specified|0|||
144341412|NCT00812565|520451764|FG003|Overall Study|Reason Not Specified|0|||
144341413|NCT00812565|520451765|FG004|Overall Study|Reason Not Specified|0|||
144341414|NCT00812565|520451766|FG005|Overall Study|Reason Not Specified|1|||
144341415|NCT00812565|520451767|FG006|Overall Study|Reason Not Specified|0|||
144341416|NCT00812565|520451768|FG007|Overall Study|Reason Not Specified|0|||
144341417|NCT00238238|520451773|FG000|Overall Study|Withdrawal by Subject|0|||
144341418|NCT00238238|520451774|FG001|Overall Study|Withdrawal by Subject|3|||
144341419|NCT00238238|520451775|FG002|Overall Study|Withdrawal by Subject|0|||
144341420|NCT01345669|520451778|FG000|Overall Study|Primary tumour recurrence|53|||
144341421|NCT01345669|520451779|FG001|Overall Study|Primary tumour recurrence|32|||
144341422|NCT01345669|520451778|FG000|Overall Study|Second primary tumour|4|||
144341423|NCT01345669|520451779|FG001|Overall Study|Second primary tumour|3|||
144341424|NCT01345669|520451778|FG000|Overall Study|Adverse Event|63|||
144341425|NCT01345669|520451779|FG001|Overall Study|Adverse Event|9|||
144341426|NCT01345669|520451778|FG000|Overall Study|Protocol Violation|3|||
144341427|NCT01345669|520451779|FG001|Overall Study|Protocol Violation|1|||
144341428|NCT01345669|520451778|FG000|Overall Study|Lost to Follow-up|1|||
144341429|NCT01345669|520451779|FG001|Overall Study|Lost to Follow-up|1|||
144341430|NCT01345669|520451778|FG000|Overall Study|Withdrawal by Subject|52|||
144341431|NCT01345669|520451779|FG001|Overall Study|Withdrawal by Subject|13|||
144341432|NCT01345669|520451778|FG000|Overall Study|Other Reasons|111|||
144341433|NCT01345669|520451779|FG001|Overall Study|Other Reasons|60|||
144341434|NCT01793883|520451780|FG000|Overall Study|Withdrawal by Subject|3|||
144341435|NCT01793883|520451781|FG001|Overall Study|Withdrawal by Subject|7|||
144341436|NCT01793883|520451782|FG002|Overall Study|Withdrawal by Subject|3|||
144341437|NCT01793883|520451780|FG000|Overall Study|Subject noncompliance|0|||
144341438|NCT01793883|520451781|FG001|Overall Study|Subject noncompliance|1|||
144341439|NCT01793883|520451782|FG002|Overall Study|Subject noncompliance|1|||
144341440|NCT01793883|520451780|FG000|Overall Study|Lost to Follow-up|5|||
144341441|NCT01793883|520451781|FG001|Overall Study|Lost to Follow-up|1|||
144341442|NCT01793883|520451782|FG002|Overall Study|Lost to Follow-up|3|||
144341443|NCT01793883|520451780|FG000|Overall Study|Randomized in error|1|||
144341444|NCT01793883|520451781|FG001|Overall Study|Randomized in error|0|||
144341445|NCT01793883|520451782|FG002|Overall Study|Randomized in error|0|||
144341446|NCT01793883|520451780|FG000|Overall Study|Unable to complete spriometry|1|||
144341447|NCT01793883|520451781|FG001|Overall Study|Unable to complete spriometry|0|||
144341448|NCT01793883|520451782|FG002|Overall Study|Unable to complete spriometry|0|||
144341449|NCT01793883|520451780|FG000|Overall Study|Unable to complete measurements|1|||
144341450|NCT01793883|520451781|FG001|Overall Study|Unable to complete measurements|0|||
144341451|NCT01793883|520451782|FG002|Overall Study|Unable to complete measurements|0|||
144341452|NCT01793883|520451780|FG000|Overall Study|Met exclusion criteria|1|||
144341453|NCT01793883|520451781|FG001|Overall Study|Met exclusion criteria|0|||
144341454|NCT01793883|520451782|FG002|Overall Study|Met exclusion criteria|0|||
144341455|NCT01793883|520451780|FG000|Overall Study|Dosing error|0|||
144341456|NCT01793883|520451781|FG001|Overall Study|Dosing error|1|||
144341457|NCT01793883|520451782|FG002|Overall Study|Dosing error|0|||
144341458|NCT01793883|520451780|FG000|Overall Study|Respiratory distress during spirometry|0|||
144341459|NCT01793883|520451781|FG001|Overall Study|Respiratory distress during spirometry|0|||
144341460|NCT01793883|520451782|FG002|Overall Study|Respiratory distress during spirometry|1|||
144341461|NCT02478255|520451784|FG000|Overall Study|Physician Decision|6|||
144341462|NCT02478255|520451785|FG001|Overall Study|Physician Decision|0|||
144341463|NCT02478255|520451784|FG000|Overall Study|Withdrawal by Subject|2|||
144341464|NCT02478255|520451785|FG001|Overall Study|Withdrawal by Subject|0|||
144341465|NCT00687531|520451788|FG000|Overall Study|Did not meet protocol eligibility|104|||
144341466|NCT00687531|520451788|FG000|Overall Study|Adverse Event|5|||
144341467|NCT00687531|520451788|FG000|Overall Study|Lost to Follow-up|26|||
144341468|NCT02353728|520451789|FG000|Overall Study|Subject non-compliance|1|||
144341469|NCT02301624|520451790|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
144341470|NCT02301624|520451791|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
144341471|NCT02301624|520451790|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
144341472|NCT02301624|520451791|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
144341473|NCT02301624|520451790|FG000|Open-label Maintenance Phase|Adverse Event|2|||
144341474|NCT02301624|520451791|FG001|Open-label Maintenance Phase|Adverse Event|5|||
144341475|NCT02301624|520451790|FG000|Open-label Maintenance Phase|Physician Decision|3|||
144341476|NCT02301624|520451791|FG001|Open-label Maintenance Phase|Physician Decision|3|||
144341477|NCT02301624|520451790|FG000|Open-label Maintenance Phase|Death|2|||
144341478|NCT02301624|520451791|FG001|Open-label Maintenance Phase|Death|1|||
144341479|NCT02301624|520451790|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
144341480|NCT02301624|520451791|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
144341481|NCT00895310|520451792|FG000|Overall Study|Withdrawal by Subject|1|||
144341482|NCT00659230|520451793|FG000|Overall Study|Lost to Follow-up|2|||
144341483|NCT00659230|520451794|FG001|Overall Study|Lost to Follow-up|5|||
144341484|NCT00659230|520451793|FG000|Overall Study|Lost source documentation|5|||
144341485|NCT00659230|520451794|FG001|Overall Study|Lost source documentation|4|||
144341486|NCT00659230|520451793|FG000|Overall Study|Did not return post-randomization|2|||
144341487|NCT00659230|520451794|FG001|Overall Study|Did not return post-randomization|3|||
144341488|NCT00547521|520451795|FG000|Short Term Study (4 Months)|Adverse Event|1|||
144341489|NCT00547521|520451796|FG001|Short Term Study (4 Months)|Adverse Event|0|||
144360107|NCT02081677|520527399|FG001|Overall Study|Adverse Event|0|||
144341490|NCT00547521|520451795|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
144341491|NCT00547521|520451796|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
144341492|NCT00547521|520451795|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
144341493|NCT00547521|520451796|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
144341494|NCT00547521|520451795|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
144341495|NCT00547521|520451796|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
144341496|NCT00547521|520451795|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
144341497|NCT00547521|520451796|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
144341498|NCT00547521|520451795|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
144341499|NCT00547521|520451796|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
144341500|NCT00547521|520451795|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
144341501|NCT00547521|520451796|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
144341502|NCT00547521|520451795|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
144341503|NCT00547521|520451796|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
144341504|NCT00547521|520451795|FG000|Long Term Extension (LTE) Study|Other|0|||
144341505|NCT00547521|520451796|FG001|Long Term Extension (LTE) Study|Other|2|||
144341506|NCT00547521|520451795|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
144341507|NCT00547521|520451796|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
144341508|NCT05066165|520453312|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
144341509|NCT05066165|520453313|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
144341510|NCT05066165|520453312|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
144341511|NCT05066165|520453313|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
144341512|NCT01487265|520453315|FG000|Overall Study|Adverse Event|8|||
144341513|NCT01487265|520453315|FG000|Overall Study|Withdrawal by Subject|5|||
144341514|NCT01487265|520453315|FG000|Overall Study|Disease Progression|21|||
144341515|NCT01487265|520453315|FG000|Overall Study|Death|2|||
144341516|NCT01487265|520453315|FG000|Overall Study|Still on Treatment|1|||
144341517|NCT01618695|520453316|FG000|Core Phase|Adverse Event|4|||
144341518|NCT01618695|520453317|FG001|Core Phase|Adverse Event|5|||
144341519|NCT01618695|520453318|FG002|Core Phase|Adverse Event|15|||
144341520|NCT01618695|520453319|FG003|Core Phase|Adverse Event|20|||
144341521|NCT01618695|520453316|FG000|Core Phase|Lost to Follow-up|0|||
144341522|NCT01618695|520453317|FG001|Core Phase|Lost to Follow-up|0|||
144341523|NCT01618695|520453318|FG002|Core Phase|Lost to Follow-up|1|||
144341524|NCT01618695|520453319|FG003|Core Phase|Lost to Follow-up|0|||
144341525|NCT01618695|520453316|FG000|Core Phase|Withdrawal by Subject|16|||
144341526|NCT01618695|520453317|FG001|Core Phase|Withdrawal by Subject|11|||
144341527|NCT01618695|520453318|FG002|Core Phase|Withdrawal by Subject|9|||
144341528|NCT01618695|520453319|FG003|Core Phase|Withdrawal by Subject|13|||
144341529|NCT01618695|520453316|FG000|Core Phase|Pregnancy|2|||
144341530|NCT01618695|520453317|FG001|Core Phase|Pregnancy|0|||
144341531|NCT01618695|520453318|FG002|Core Phase|Pregnancy|0|||
144341532|NCT01618695|520453319|FG003|Core Phase|Pregnancy|0|||
144341533|NCT01618695|520453316|FG000|Core Phase|Lack of Efficacy|1|||
144341534|NCT01618695|520453317|FG001|Core Phase|Lack of Efficacy|2|||
144341535|NCT01618695|520453318|FG002|Core Phase|Lack of Efficacy|1|||
144341536|NCT01618695|520453319|FG003|Core Phase|Lack of Efficacy|1|||
144341537|NCT01618695|520453316|FG000|Core Phase|Other than specified|1|||
144341538|NCT01618695|520453317|FG001|Core Phase|Other than specified|2|||
144341539|NCT01618695|520453318|FG002|Core Phase|Other than specified|2|||
144341540|NCT01618695|520453319|FG003|Core Phase|Other than specified|2|||
144341541|NCT01618695|520453316|FG000|Core Phase|Not treated|1|||
144341542|NCT01618695|520453317|FG001|Core Phase|Not treated|0|||
144341543|NCT01618695|520453318|FG002|Core Phase|Not treated|2|||
144341544|NCT01618695|520453319|FG003|Core Phase|Not treated|0|||
144341545|NCT01618695|520453316|FG000|Extension Phase|Lack of Efficacy|17|||
144341546|NCT01618695|520453317|FG001|Extension Phase|Lack of Efficacy|33|||
144341547|NCT01618695|520453318|FG002|Extension Phase|Lack of Efficacy|26|||
144341548|NCT01618695|520453319|FG003|Extension Phase|Lack of Efficacy|24|||
144341549|NCT01618695|520453316|FG000|Extension Phase|Pregnancy|2|||
144341550|NCT01618695|520453317|FG001|Extension Phase|Pregnancy|0|||
144341551|NCT01618695|520453318|FG002|Extension Phase|Pregnancy|1|||
144341552|NCT01618695|520453319|FG003|Extension Phase|Pregnancy|1|||
144341553|NCT01618695|520453316|FG000|Extension Phase|Withdrawal by Subject|43|||
144341554|NCT01618695|520453317|FG001|Extension Phase|Withdrawal by Subject|48|||
144341555|NCT01618695|520453318|FG002|Extension Phase|Withdrawal by Subject|42|||
144341556|NCT01618695|520453319|FG003|Extension Phase|Withdrawal by Subject|33|||
144341557|NCT01618695|520453316|FG000|Extension Phase|Adverse Event|18|||
144341558|NCT01618695|520453317|FG001|Extension Phase|Adverse Event|16|||
144341559|NCT01618695|520453318|FG002|Extension Phase|Adverse Event|9|||
144341560|NCT01618695|520453319|FG003|Extension Phase|Adverse Event|20|||
144341561|NCT01618695|520453316|FG000|Extension Phase|Lost to Follow-up|2|||
144341562|NCT01618695|520453317|FG001|Extension Phase|Lost to Follow-up|1|||
144341563|NCT01618695|520453318|FG002|Extension Phase|Lost to Follow-up|1|||
144341564|NCT01618695|520453319|FG003|Extension Phase|Lost to Follow-up|1|||
144341565|NCT01618695|520453316|FG000|Extension Phase|Other than specified|13|||
144341566|NCT01618695|520453317|FG001|Extension Phase|Other than specified|18|||
144341567|NCT01618695|520453318|FG002|Extension Phase|Other than specified|13|||
144341568|NCT01618695|520453319|FG003|Extension Phase|Other than specified|18|||
144341569|NCT01732770|520453320|FG000|Overall Study|Lost to Follow-up|2|||
144341570|NCT01732770|520453321|FG001|Overall Study|Lost to Follow-up|3|||
144341571|NCT01732770|520453320|FG000|Overall Study|Withdrawal by Subject|5|||
144341572|NCT01732770|520453321|FG001|Overall Study|Withdrawal by Subject|3|||
144341573|NCT01732770|520453320|FG000|Overall Study|Decision by Sponsor|2|||
144341574|NCT01732770|520453321|FG001|Overall Study|Decision by Sponsor|2|||
144341575|NCT01732770|520453320|FG000|Overall Study|Death|1|||
144341576|NCT01732770|520453321|FG001|Overall Study|Death|0|||
144341577|NCT00780416|520453322|FG000|Overall Study|Physician Decision|3|||
144341578|NCT00780416|520453323|FG001|Overall Study|Physician Decision|3|||
144341579|NCT00780416|520453322|FG000|Overall Study|Protocol Violation|1|||
144341580|NCT00780416|520453323|FG001|Overall Study|Protocol Violation|0|||
144341581|NCT00780416|520453322|FG000|Overall Study|Withdrawal by Subject|8|||
144341582|NCT00780416|520453323|FG001|Overall Study|Withdrawal by Subject|6|||
144341583|NCT00666224|520453326|FG000|Double-Blind|Adverse Event|15|||
144341584|NCT00666224|520453327|FG001|Double-Blind|Adverse Event|5|||
144341585|NCT00666224|520453326|FG000|Double-Blind|Lost to Follow-up|2|||
144341586|NCT00666224|520453327|FG001|Double-Blind|Lost to Follow-up|2|||
144341587|NCT00666224|520453326|FG000|Double-Blind|Withdrawal by Subject|18|||
144341588|NCT00666224|520453327|FG001|Double-Blind|Withdrawal by Subject|14|||
144341589|NCT00666224|520453326|FG000|Double-Blind|Physician Decision|0|||
144341590|NCT00666224|520453327|FG001|Double-Blind|Physician Decision|3|||
144341591|NCT00666224|520453326|FG000|Double-Blind|Sponsor decision|1|||
144341592|NCT00666224|520453327|FG001|Double-Blind|Sponsor decision|0|||
144341593|NCT00666224|520453326|FG000|Double-Blind|Pregnancy|3|||
144341594|NCT00666224|520453327|FG001|Double-Blind|Pregnancy|2|||
144341595|NCT00666224|520453326|FG000|Double-Blind|Noncompliance|1|||
144341596|NCT00666224|520453327|FG001|Double-Blind|Noncompliance|0|||
144341597|NCT00666224|520453326|FG000|Double-Blind|Death|1|||
144341598|NCT00666224|520453327|FG001|Double-Blind|Death|0|||
144341599|NCT00666224|520453326|FG000|Double-Blind|Undefined/Unknown|4|||
144341600|NCT00666224|520453327|FG001|Double-Blind|Undefined/Unknown|1|||
144341601|NCT00666224|520453326|FG000|Open-Label|Adverse Event|8|||
144341602|NCT00666224|520453327|FG001|Open-Label|Adverse Event|43|||
144341603|NCT00666224|520453326|FG000|Open-Label|Lost to Follow-up|4|||
144341604|NCT00666224|520453327|FG001|Open-Label|Lost to Follow-up|5|||
144341605|NCT00666224|520453326|FG000|Open-Label|Withdrawal by Subject|12|||
144341606|NCT00666224|520453327|FG001|Open-Label|Withdrawal by Subject|25|||
144341607|NCT00666224|520453326|FG000|Open-Label|Physician Decision|7|||
144341608|NCT00666224|520453327|FG001|Open-Label|Physician Decision|5|||
144341609|NCT00666224|520453326|FG000|Open-Label|Pregnancy|1|||
144341610|NCT00666224|520453327|FG001|Open-Label|Pregnancy|5|||
144341611|NCT00666224|520453326|FG000|Open-Label|Noncompliance|2|||
144341612|NCT00666224|520453327|FG001|Open-Label|Noncompliance|1|||
144341613|NCT00666224|520453326|FG000|Open-Label|Undefined/Unknown|1|||
144341614|NCT00666224|520453327|FG001|Open-Label|Undefined/Unknown|1|||
144341615|NCT03521141|520453328|FG000|Overall Study|Death|1|||
144341616|NCT03521141|520453329|FG001|Overall Study|Death|0|||
144341617|NCT03521141|520453330|FG002|Overall Study|Death|1|||
144341618|NCT00655629|520453334|FG000|Overall Study|Adverse Event|4|||
144341619|NCT00655629|520453335|FG001|Overall Study|Adverse Event|1|||
144341620|NCT00655629|520453334|FG000|Overall Study|Lack of Efficacy|2|||
144341621|NCT00655629|520453335|FG001|Overall Study|Lack of Efficacy|12|||
144341622|NCT00655629|520453334|FG000|Overall Study|Lost to Follow-up|4|||
144341623|NCT00655629|520453335|FG001|Overall Study|Lost to Follow-up|3|||
144341624|NCT00655629|520453334|FG000|Overall Study|Protocol Violation|5|||
144341625|NCT00655629|520453335|FG001|Overall Study|Protocol Violation|3|||
144341626|NCT00655629|520453334|FG000|Overall Study|consent withdrawn|6|||
144341627|NCT00655629|520453335|FG001|Overall Study|consent withdrawn|4|||
144341628|NCT01610336|520453336|FG000|Overall Study|Progressive Disease|4|||
144341629|NCT01610336|520453337|FG001|Overall Study|Progressive Disease|6|||
144341630|NCT01610336|520453338|FG002|Overall Study|Progressive Disease|6|||
144341631|NCT01610336|520453339|FG003|Overall Study|Progressive Disease|5|||
144341632|NCT01610336|520453340|FG004|Overall Study|Progressive Disease|3|||
144341633|NCT01610336|520453341|FG005|Overall Study|Progressive Disease|10|||
144341634|NCT01610336|520453342|FG006|Overall Study|Progressive Disease|1|||
144341635|NCT01610336|520453343|FG007|Overall Study|Progressive Disease|6|||
144341636|NCT01610336|520453344|FG008|Overall Study|Progressive Disease|6|||
144341637|NCT01610336|520453345|FG009|Overall Study|Progressive Disease|40|||
144341638|NCT01610336|520453346|FG010|Overall Study|Progressive Disease|36|||
144341639|NCT01610336|520453336|FG000|Overall Study|Adverse Event|0|||
144341640|NCT01610336|520453337|FG001|Overall Study|Adverse Event|0|||
144341641|NCT01610336|520453338|FG002|Overall Study|Adverse Event|0|||
144341642|NCT01610336|520453339|FG003|Overall Study|Adverse Event|1|||
144341643|NCT01610336|520453340|FG004|Overall Study|Adverse Event|1|||
144341644|NCT01610336|520453341|FG005|Overall Study|Adverse Event|1|||
144341645|NCT01610336|520453342|FG006|Overall Study|Adverse Event|0|||
144341646|NCT01610336|520453343|FG007|Overall Study|Adverse Event|0|||
144341647|NCT01610336|520453344|FG008|Overall Study|Adverse Event|2|||
144341648|NCT01610336|520453345|FG009|Overall Study|Adverse Event|8|||
144341649|NCT01610336|520453346|FG010|Overall Study|Adverse Event|6|||
144341650|NCT01610336|520453336|FG000|Overall Study|Subject/Guardian decision|1|||
144341651|NCT01610336|520453337|FG001|Overall Study|Subject/Guardian decision|1|||
144341652|NCT01610336|520453338|FG002|Overall Study|Subject/Guardian decision|0|||
144341653|NCT01610336|520453339|FG003|Overall Study|Subject/Guardian decision|1|||
144341654|NCT01610336|520453340|FG004|Overall Study|Subject/Guardian decision|0|||
144341655|NCT01610336|520453341|FG005|Overall Study|Subject/Guardian decision|0|||
144341656|NCT01610336|520453342|FG006|Overall Study|Subject/Guardian decision|0|||
144341657|NCT01610336|520453343|FG007|Overall Study|Subject/Guardian decision|1|||
144341658|NCT01610336|520453344|FG008|Overall Study|Subject/Guardian decision|0|||
144341659|NCT01610336|520453345|FG009|Overall Study|Subject/Guardian decision|2|||
144341660|NCT01610336|520453346|FG010|Overall Study|Subject/Guardian decision|2|||
144341661|NCT01610336|520453336|FG000|Overall Study|Death|0|||
144341662|NCT01610336|520453337|FG001|Overall Study|Death|0|||
144341663|NCT01610336|520453338|FG002|Overall Study|Death|0|||
144341664|NCT01610336|520453339|FG003|Overall Study|Death|0|||
144341665|NCT01610336|520453340|FG004|Overall Study|Death|0|||
144341666|NCT01610336|520453341|FG005|Overall Study|Death|1|||
144341667|NCT01610336|520453342|FG006|Overall Study|Death|3|||
144341668|NCT01610336|520453343|FG007|Overall Study|Death|0|||
144341669|NCT01610336|520453344|FG008|Overall Study|Death|0|||
144341670|NCT01610336|520453345|FG009|Overall Study|Death|1|||
144341671|NCT01610336|520453346|FG010|Overall Study|Death|2|||
144341672|NCT01610336|520453336|FG000|Overall Study|Non-Compliance with study treatment|0|||
144341673|NCT01610336|520453337|FG001|Overall Study|Non-Compliance with study treatment|0|||
144341674|NCT01610336|520453338|FG002|Overall Study|Non-Compliance with study treatment|0|||
144341675|NCT01610336|520453339|FG003|Overall Study|Non-Compliance with study treatment|0|||
144341676|NCT01610336|520453340|FG004|Overall Study|Non-Compliance with study treatment|0|||
144341677|NCT01610336|520453341|FG005|Overall Study|Non-Compliance with study treatment|0|||
144341678|NCT01610336|520453342|FG006|Overall Study|Non-Compliance with study treatment|0|||
144341679|NCT01610336|520453343|FG007|Overall Study|Non-Compliance with study treatment|0|||
144341680|NCT01610336|520453344|FG008|Overall Study|Non-Compliance with study treatment|0|||
144341681|NCT01610336|520453345|FG009|Overall Study|Non-Compliance with study treatment|1|||
144341682|NCT01610336|520453346|FG010|Overall Study|Non-Compliance with study treatment|0|||
144341683|NCT01610336|520453336|FG000|Overall Study|Physician Decision|0|||
144341684|NCT01610336|520453337|FG001|Overall Study|Physician Decision|0|||
144341685|NCT01610336|520453338|FG002|Overall Study|Physician Decision|0|||
144341686|NCT01610336|520453339|FG003|Overall Study|Physician Decision|0|||
144341687|NCT01610336|520453340|FG004|Overall Study|Physician Decision|0|||
144341688|NCT01610336|520453341|FG005|Overall Study|Physician Decision|0|||
144341689|NCT01610336|520453342|FG006|Overall Study|Physician Decision|1|||
144341690|NCT01610336|520453343|FG007|Overall Study|Physician Decision|0|||
144341691|NCT01610336|520453344|FG008|Overall Study|Physician Decision|0|||
144341692|NCT01610336|520453345|FG009|Overall Study|Physician Decision|0|||
144341693|NCT01610336|520453346|FG010|Overall Study|Physician Decision|0|||
144341694|NCT01610336|520453336|FG000|Overall Study|Protocol Deviation|0|||
144341695|NCT01610336|520453337|FG001|Overall Study|Protocol Deviation|0|||
144341696|NCT01610336|520453338|FG002|Overall Study|Protocol Deviation|0|||
144341697|NCT01610336|520453339|FG003|Overall Study|Protocol Deviation|0|||
144341698|NCT01610336|520453340|FG004|Overall Study|Protocol Deviation|0|||
144341699|NCT01610336|520453341|FG005|Overall Study|Protocol Deviation|0|||
144341700|NCT01610336|520453342|FG006|Overall Study|Protocol Deviation|0|||
144341701|NCT01610336|520453343|FG007|Overall Study|Protocol Deviation|0|||
144341702|NCT01610336|520453344|FG008|Overall Study|Protocol Deviation|0|||
144341703|NCT01610336|520453345|FG009|Overall Study|Protocol Deviation|1|||
144341704|NCT01610336|520453346|FG010|Overall Study|Protocol Deviation|0|||
144341705|NCT01610336|520453336|FG000|Overall Study|Transfer to another trial|0|||
144341706|NCT01610336|520453337|FG001|Overall Study|Transfer to another trial|0|||
144341707|NCT01610336|520453338|FG002|Overall Study|Transfer to another trial|0|||
144341708|NCT01610336|520453339|FG003|Overall Study|Transfer to another trial|0|||
144341709|NCT01610336|520453340|FG004|Overall Study|Transfer to another trial|0|||
144341710|NCT01610336|520453341|FG005|Overall Study|Transfer to another trial|0|||
144341711|NCT01610336|520453342|FG006|Overall Study|Transfer to another trial|0|||
144341712|NCT01610336|520453343|FG007|Overall Study|Transfer to another trial|0|||
144341713|NCT01610336|520453344|FG008|Overall Study|Transfer to another trial|0|||
144341714|NCT01610336|520453345|FG009|Overall Study|Transfer to another trial|0|||
144341715|NCT01610336|520453346|FG010|Overall Study|Transfer to another trial|1|||
144341716|NCT00193180|520453351|FG000|Overall Study|Lack of Efficacy|1|||
144341717|NCT00193180|520453351|FG000|Overall Study|Adverse Event|8|||
144341718|NCT00193180|520453351|FG000|Overall Study|Protocol Violation|1|||
144341719|NCT01832155|520453352|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
144341720|NCT01832155|520453353|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
144341721|NCT01832155|520453352|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
144341722|NCT01832155|520453353|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
144341723|NCT01279616|520453354|FG000|Overall Study|donor could not be located|5|||
144341724|NCT01279616|520453354|FG000|Overall Study|no signs of sickle cell disease|2|||
144341725|NCT02462720|520453355|FG000|Part 2|Withdrawal by Subject|1|||
144341726|NCT02462720|520453356|FG001|Part 2|Withdrawal by Subject|0|||
144341727|NCT02462720|520453355|FG000|Part 2|Protocol Violation|0|||
144341728|NCT02462720|520453356|FG001|Part 2|Protocol Violation|1|||
144341729|NCT00413036|520453357|FG000|Overall Study|Adverse Event|44|||
144341730|NCT00413036|520453357|FG000|Overall Study|Lack of Efficacy|129|||
144341731|NCT00413036|520453357|FG000|Overall Study|Withdrawal by Subject|7|||
144341732|NCT00413036|520453357|FG000|Overall Study|Death|9|||
144341733|NCT00413036|520453357|FG000|Overall Study|Other|26|||
144341734|NCT00413036|520453357|FG000|Overall Study|Missing|2|||
144341735|NCT00183625|520453362|FG000|Overall Study|Withdrawal by Subject|18|||
144341736|NCT00183625|520453363|FG001|Overall Study|Withdrawal by Subject|18|||
144341737|NCT00183625|520453364|FG002|Overall Study|Withdrawal by Subject|19|||
144341738|NCT00183625|520453365|FG003|Overall Study|Withdrawal by Subject|14|||
144341739|NCT01369641|520453370|FG000|Overall Study|Withdrawal by Subject|1|||
144341740|NCT00842543|520453371|FG000|Overall Study|Withdrawal by Subject|2|||
144341741|NCT00842543|520453372|FG001|Overall Study|Withdrawal by Subject|0|||
144341742|NCT00842543|520453373|FG002|Overall Study|Withdrawal by Subject|3|||
144341743|NCT00842543|520453374|FG003|Overall Study|Withdrawal by Subject|4|||
144341744|NCT01483183|520453379|FG000|Overall Study|Physician Decision|0|||
144341745|NCT01483183|520453380|FG001|Overall Study|Physician Decision|0|||
144341746|NCT01483183|520453381|FG002|Overall Study|Physician Decision|0|||
144341747|NCT01483183|520453382|FG003|Overall Study|Physician Decision|0|||
144341748|NCT01483183|520453383|FG004|Overall Study|Physician Decision|0|||
144341749|NCT01483183|520453384|FG005|Overall Study|Physician Decision|0|||
144341750|NCT01483183|520453385|FG006|Overall Study|Physician Decision|2|||
144341751|NCT01483183|520453386|FG007|Overall Study|Physician Decision|0|||
144341752|NCT01483183|520453387|FG008|Overall Study|Physician Decision|0|||
144341753|NCT01483183|520453388|FG009|Overall Study|Physician Decision|0|||
144341754|NCT01483183|520453379|FG000|Overall Study|Withdrawal by Subject|0|||
144341755|NCT01483183|520453380|FG001|Overall Study|Withdrawal by Subject|0|||
144341756|NCT01483183|520453381|FG002|Overall Study|Withdrawal by Subject|0|||
144341757|NCT01483183|520453382|FG003|Overall Study|Withdrawal by Subject|0|||
144341758|NCT01483183|520453383|FG004|Overall Study|Withdrawal by Subject|0|||
144341759|NCT01483183|520453384|FG005|Overall Study|Withdrawal by Subject|0|||
144341760|NCT01483183|520453385|FG006|Overall Study|Withdrawal by Subject|0|||
144341761|NCT01483183|520453386|FG007|Overall Study|Withdrawal by Subject|0|||
144341762|NCT01483183|520453387|FG008|Overall Study|Withdrawal by Subject|0|||
144341763|NCT01483183|520453388|FG009|Overall Study|Withdrawal by Subject|1|||
144341764|NCT00239928|520453389|FG000|Overall Study|Lack of Efficacy|1|||
144341765|NCT00239928|520453389|FG000|Overall Study|Adverse Event|4|||
144341766|NCT00239928|520453389|FG000|Overall Study|Not need to continue study|3|||
144341767|NCT00239928|520453389|FG000|Overall Study|Withdrawal by Subject|2|||
144341768|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341769|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341770|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
144341771|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
144341772|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
144341773|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341774|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
144341775|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
144341776|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
144341777|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341778|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341779|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341780|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
144341781|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
144341782|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
144341783|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
144341784|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
144341785|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
144341786|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
144341787|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
144341788|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
144341789|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
144341790|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
144341791|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
144341792|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
144341793|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
144341794|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341795|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
144341796|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
144341797|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341798|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341799|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
144341800|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
144341801|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341802|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341803|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341804|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341805|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341806|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
144341807|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341808|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
144341809|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
144341810|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341811|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341812|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341813|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
144341814|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341815|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
144341816|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341817|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341818|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341819|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
144341820|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341821|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341822|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341823|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
144341824|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341825|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341826|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341827|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
144341828|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341829|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341830|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341831|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341832|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
144341833|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341834|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341835|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341836|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
144341837|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341838|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341839|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
144341840|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341841|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341842|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341843|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341844|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341845|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
144341846|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341847|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
144341848|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341849|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341850|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341851|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341852|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341853|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341854|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341855|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341856|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341857|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341858|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
144341859|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
144341860|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341861|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341862|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341863|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341864|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341865|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341866|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341867|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341868|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341869|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341870|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341871|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
144341872|NCT03100058|520453391|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341873|NCT03100058|520453392|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341874|NCT03100058|520453393|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341875|NCT03100058|520453394|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341876|NCT03100058|520453395|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341877|NCT03100058|520453396|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341878|NCT03100058|520453397|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
144341879|NCT03100058|520453398|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341880|NCT03100058|520453399|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341881|NCT03100058|520453400|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341882|NCT03100058|520453401|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341883|NCT03100058|520453402|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341884|NCT03100058|520453403|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
144341885|NCT03100058|520453391|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341886|NCT03100058|520453392|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341887|NCT03100058|520453393|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341888|NCT03100058|520453394|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341889|NCT03100058|520453395|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341890|NCT03100058|520453396|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341891|NCT03100058|520453397|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341892|NCT03100058|520453398|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341893|NCT03100058|520453399|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341894|NCT03100058|520453400|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
144341895|NCT03100058|520453401|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
144341896|NCT03100058|520453402|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
144341897|NCT03100058|520453403|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
144341898|NCT03100058|520453391|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341899|NCT03100058|520453392|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341900|NCT03100058|520453393|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341901|NCT03100058|520453394|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341902|NCT03100058|520453395|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341903|NCT03100058|520453396|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341904|NCT03100058|520453397|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341905|NCT03100058|520453398|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341906|NCT03100058|520453399|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341907|NCT03100058|520453400|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341908|NCT03100058|520453401|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
144341909|NCT03100058|520453402|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
144341910|NCT03100058|520453403|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
144341911|NCT03100058|520453391|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341912|NCT03100058|520453392|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341913|NCT03100058|520453393|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341914|NCT03100058|520453394|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341915|NCT03100058|520453395|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341916|NCT03100058|520453396|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341917|NCT03100058|520453397|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341918|NCT03100058|520453398|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341919|NCT03100058|520453399|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341920|NCT03100058|520453400|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
144341921|NCT03100058|520453401|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
144341922|NCT03100058|520453402|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
144341923|NCT03100058|520453403|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
144341924|NCT03100058|520453391|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341925|NCT03100058|520453392|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341926|NCT03100058|520453393|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341927|NCT03100058|520453394|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341928|NCT03100058|520453395|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341929|NCT03100058|520453396|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341930|NCT03100058|520453397|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341931|NCT03100058|520453398|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341932|NCT03100058|520453399|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341933|NCT03100058|520453400|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341934|NCT03100058|520453401|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
144341935|NCT03100058|520453402|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341936|NCT03100058|520453403|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
144341937|NCT03100058|520453391|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341938|NCT03100058|520453392|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341939|NCT03100058|520453393|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341940|NCT03100058|520453394|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341941|NCT03100058|520453395|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341942|NCT03100058|520453396|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341943|NCT03100058|520453397|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341944|NCT03100058|520453398|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341945|NCT03100058|520453399|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341946|NCT03100058|520453400|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341947|NCT03100058|520453401|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341948|NCT03100058|520453402|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
144341949|NCT03100058|520453403|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
144341950|NCT03100058|520453391|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341951|NCT03100058|520453392|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341952|NCT03100058|520453393|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341953|NCT03100058|520453394|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341954|NCT03100058|520453395|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341955|NCT03100058|520453396|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341956|NCT03100058|520453397|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341957|NCT03100058|520453398|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341958|NCT03100058|520453399|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341959|NCT03100058|520453400|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
144341960|NCT03100058|520453401|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341961|NCT03100058|520453402|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341962|NCT03100058|520453403|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
144341963|NCT02718716|520453405|FG000|Overall Study|Lack of Efficacy|1|||
144341964|NCT02718716|520453406|FG001|Overall Study|Lack of Efficacy|0|||
144341965|NCT02718716|520453407|FG002|Overall Study|Lack of Efficacy|0|||
144341966|NCT02718716|520453408|FG003|Overall Study|Lack of Efficacy|0|||
144341967|NCT02718716|520453409|FG004|Overall Study|Lack of Efficacy|0|||
144341968|NCT03194646|520453416|FG000|Overall Study|Adverse Event|24|||
144341969|NCT03194646|520453417|FG001|Overall Study|Adverse Event|25|||
144341970|NCT03194646|520453418|FG002|Overall Study|Adverse Event|14|||
144341971|NCT03194646|520453419|FG003|Overall Study|Adverse Event|17|||
144341972|NCT03194646|520453416|FG000|Overall Study|Lack of Efficacy|4|||
144341973|NCT03194646|520453417|FG001|Overall Study|Lack of Efficacy|2|||
144341974|NCT03194646|520453418|FG002|Overall Study|Lack of Efficacy|2|||
144341975|NCT03194646|520453419|FG003|Overall Study|Lack of Efficacy|12|||
144341976|NCT03194646|520453416|FG000|Overall Study|Lost to Follow-up|30|||
144341977|NCT03194646|520453417|FG001|Overall Study|Lost to Follow-up|22|||
144341978|NCT03194646|520453418|FG002|Overall Study|Lost to Follow-up|12|||
144341979|NCT03194646|520453419|FG003|Overall Study|Lost to Follow-up|35|||
144341980|NCT03194646|520453416|FG000|Overall Study|Non-compliance with study drug|4|||
144341981|NCT03194646|520453417|FG001|Overall Study|Non-compliance with study drug|0|||
144341982|NCT03194646|520453418|FG002|Overall Study|Non-compliance with study drug|1|||
144341983|NCT03194646|520453419|FG003|Overall Study|Non-compliance with study drug|1|||
144341984|NCT03194646|520453416|FG000|Overall Study|Other|89|||
144341985|NCT03194646|520453417|FG001|Overall Study|Other|68|||
144341986|NCT03194646|520453418|FG002|Overall Study|Other|34|||
144341987|NCT03194646|520453419|FG003|Overall Study|Other|31|||
144341988|NCT03194646|520453416|FG000|Overall Study|Physician Decision|7|||
144341989|NCT03194646|520453417|FG001|Overall Study|Physician Decision|9|||
144341990|NCT03194646|520453418|FG002|Overall Study|Physician Decision|5|||
144341991|NCT03194646|520453419|FG003|Overall Study|Physician Decision|4|||
144341992|NCT03194646|520453416|FG000|Overall Study|Pregnancy|4|||
144341993|NCT03194646|520453417|FG001|Overall Study|Pregnancy|5|||
144341994|NCT03194646|520453418|FG002|Overall Study|Pregnancy|1|||
144341995|NCT03194646|520453419|FG003|Overall Study|Pregnancy|2|||
144341996|NCT03194646|520453416|FG000|Overall Study|Protocol Violation|4|||
144341997|NCT03194646|520453417|FG001|Overall Study|Protocol Violation|2|||
144341998|NCT03194646|520453418|FG002|Overall Study|Protocol Violation|1|||
144341999|NCT03194646|520453419|FG003|Overall Study|Protocol Violation|1|||
144342000|NCT03194646|520453416|FG000|Overall Study|Site terminated by sponsor|0|||
144342001|NCT03194646|520453417|FG001|Overall Study|Site terminated by sponsor|0|||
144342002|NCT03194646|520453418|FG002|Overall Study|Site terminated by sponsor|2|||
144342003|NCT03194646|520453419|FG003|Overall Study|Site terminated by sponsor|0|||
144342004|NCT03194646|520453416|FG000|Overall Study|Study terminated by sponsor|62|||
144342005|NCT03194646|520453417|FG001|Overall Study|Study terminated by sponsor|61|||
144342006|NCT03194646|520453418|FG002|Overall Study|Study terminated by sponsor|30|||
144342007|NCT03194646|520453419|FG003|Overall Study|Study terminated by sponsor|34|||
144342008|NCT03194646|520453416|FG000|Overall Study|Withdrawal by Subject|75|||
144342009|NCT03194646|520453417|FG001|Overall Study|Withdrawal by Subject|74|||
144342010|NCT03194646|520453418|FG002|Overall Study|Withdrawal by Subject|36|||
144342011|NCT03194646|520453419|FG003|Overall Study|Withdrawal by Subject|131|||
144342012|NCT03194646|520453416|FG000|Overall Study|Missing|1|||
144342013|NCT03194646|520453417|FG001|Overall Study|Missing|0|||
144342014|NCT03194646|520453418|FG002|Overall Study|Missing|1|||
144342015|NCT03194646|520453419|FG003|Overall Study|Missing|12|||
144342016|NCT04869358|520453420|FG000|Overall Study|Wish to have children.|1|||
144342017|NCT04869358|520453421|FG001|Overall Study|Wish to have children.|0|||
144342018|NCT04869358|520453422|FG002|Overall Study|Wish to have children.|0|||
144342019|NCT04869358|520453423|FG003|Overall Study|Wish to have children.|0|||
144342020|NCT02141360|520453424|FG000|Overall Study|Withdrawal by Subject|6|||
144342021|NCT02141360|520453425|FG001|Overall Study|Withdrawal by Subject|0|||
144342022|NCT02141360|520453426|FG002|Overall Study|Withdrawal by Subject|0|||
144342023|NCT02141360|520453424|FG000|Overall Study|Study Terminated before Visit|1|||
144342024|NCT02141360|520453425|FG001|Overall Study|Study Terminated before Visit|0|||
144342025|NCT02141360|520453426|FG002|Overall Study|Study Terminated before Visit|0|||
144342026|NCT00646399|520453427|FG000|Overall Study|Death|63|||
144342027|NCT00646399|520453428|FG001|Overall Study|Death|53|||
144342028|NCT00646399|520453427|FG000|Overall Study|Withdrawal by Subject|9|||
144342029|NCT00646399|520453428|FG001|Overall Study|Withdrawal by Subject|10|||
144342030|NCT00646399|520453427|FG000|Overall Study|Other Reason|11|||
144342031|NCT00646399|520453428|FG001|Overall Study|Other Reason|11|||
144342032|NCT04302545|520453431|FG000|Overall Study|Lost to Follow-up|3|||
144342033|NCT04302545|520453432|FG001|Overall Study|Lost to Follow-up|4|||
144342034|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
144342035|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
144342036|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
144342037|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
144342038|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Death|2|||
144342039|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Death|2|||
144342040|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Death|0|||
144342041|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Death|0|||
144342042|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
144342043|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
144342044|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
144342045|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
144342046|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
144342047|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
144342048|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
144342049|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
144342050|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
144342051|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
144342052|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
144342053|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
144342054|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
144342055|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
144342056|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
144342057|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
144342058|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
144342059|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
144342060|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
144342061|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
144342062|NCT03068754|520453433|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
144342063|NCT03068754|520453434|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
144342064|NCT03068754|520453435|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
144342065|NCT03068754|520453436|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
144342066|NCT03068754|520453433|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
144342067|NCT03068754|520453434|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
144342068|NCT03068754|520453435|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
144342069|NCT03068754|520453436|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
144342070|NCT03068754|520453433|FG000|Open Label Extension Period (OLE)|Death|0|||
144342071|NCT03068754|520453434|FG001|Open Label Extension Period (OLE)|Death|0|||
144342072|NCT03068754|520453435|FG002|Open Label Extension Period (OLE)|Death|0|||
144342073|NCT03068754|520453436|FG003|Open Label Extension Period (OLE)|Death|1|||
144342074|NCT03068754|520453433|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
144342075|NCT03068754|520453434|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
144342076|NCT03068754|520453435|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
144342077|NCT03068754|520453436|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
144342078|NCT03068754|520453433|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
144342079|NCT03068754|520453434|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
144342080|NCT03068754|520453435|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
144342081|NCT03068754|520453436|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
144342082|NCT03068754|520453433|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
144342083|NCT03068754|520453434|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
144342084|NCT03068754|520453435|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
144342085|NCT03068754|520453436|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
144342086|NCT03068754|520453433|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
144342087|NCT03068754|520453434|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
144342088|NCT03068754|520453435|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
144342089|NCT03068754|520453436|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
144342090|NCT00129467|520453437|FG000|Received Intervention|Death|1|||
144342091|NCT00129467|520453438|FG001|Received Intervention|Death|1|||
144342092|NCT00129467|520453437|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
144342093|NCT00129467|520453438|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
144342094|NCT00129467|520453437|FG000|Received Intervention|Delirium|2|||
144342095|NCT00129467|520453438|FG001|Received Intervention|Delirium|0|||
144342096|NCT00129467|520453437|FG000|Received Intervention|Withdrawal by Subject|1|||
144342097|NCT00129467|520453438|FG001|Received Intervention|Withdrawal by Subject|0|||
144342098|NCT00129467|520453437|FG000|Received Intervention|Nausea|1|||
144342099|NCT00129467|520453438|FG001|Received Intervention|Nausea|0|||
144342100|NCT00129467|520453437|FG000|Received Intervention|Intolerance to citalopram|0|||
144342101|NCT00129467|520453438|FG001|Received Intervention|Intolerance to citalopram|1|||
144342102|NCT00129467|520453437|FG000|Received Intervention|Dizzyness, fatigue|0|||
144342103|NCT00129467|520453438|FG001|Received Intervention|Dizzyness, fatigue|1|||
144342104|NCT00129467|520453437|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
144342105|NCT00129467|520453438|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
144342106|NCT00129467|520453437|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
144342107|NCT00129467|520453438|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
144342108|NCT01331291|520453439|FG000|Overall Study|Lack of Efficacy|2|||
144342109|NCT01331291|520453440|FG001|Overall Study|Lack of Efficacy|8|||
144342110|NCT01331291|520453439|FG000|Overall Study|Death|0|||
144342111|NCT01331291|520453440|FG001|Overall Study|Death|1|||
144342112|NCT03550404|520453441|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
144342113|NCT03550404|520453442|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
144342114|NCT03550404|520453443|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
144342115|NCT03550404|520453441|FG000|Phase 2|Vacated position|1|||
144342116|NCT03550404|520453442|FG001|Phase 2|Vacated position|0|||
144342117|NCT03550404|520453443|FG002|Phase 2|Vacated position|0|||
144342118|NCT00932165|520453444|FG000|Overall Study|Lost to Follow-up|1|||
144342119|NCT02690714|520453445|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
144342120|NCT02690714|520453445|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
144342121|NCT00666965|520453446|FG000|Overall Study|Adverse Event|0|||
144342122|NCT00666965|520453447|FG001|Overall Study|Adverse Event|2|||
144342123|NCT00666965|520453448|FG002|Overall Study|Adverse Event|1|||
144342124|NCT00666965|520453449|FG003|Overall Study|Adverse Event|9|||
144342125|NCT00666965|520453446|FG000|Overall Study|Lack of Efficacy|1|||
144342126|NCT00666965|520453447|FG001|Overall Study|Lack of Efficacy|1|||
144342127|NCT00666965|520453448|FG002|Overall Study|Lack of Efficacy|0|||
144342128|NCT00666965|520453449|FG003|Overall Study|Lack of Efficacy|0|||
144342129|NCT00666965|520453446|FG000|Overall Study|Protocol Violation|0|||
144342130|NCT00666965|520453447|FG001|Overall Study|Protocol Violation|0|||
144342131|NCT00666965|520453448|FG002|Overall Study|Protocol Violation|0|||
144342132|NCT00666965|520453449|FG003|Overall Study|Protocol Violation|2|||
144342133|NCT00666965|520453446|FG000|Overall Study|Discontinuation criteria|2|||
144342134|NCT00666965|520453447|FG001|Overall Study|Discontinuation criteria|1|||
144342135|NCT00666965|520453448|FG002|Overall Study|Discontinuation criteria|1|||
144342136|NCT00666965|520453449|FG003|Overall Study|Discontinuation criteria|2|||
144342137|NCT00666965|520453446|FG000|Overall Study|Withdrawal by Subject|0|||
144342138|NCT00666965|520453447|FG001|Overall Study|Withdrawal by Subject|0|||
144342139|NCT00666965|520453448|FG002|Overall Study|Withdrawal by Subject|0|||
144342140|NCT00666965|520453449|FG003|Overall Study|Withdrawal by Subject|2|||
144342141|NCT05090852|520453450|FG000|Overall Study|Physician Decision|5|||
144342142|NCT00504894|520453451|FG000|Overall Study|fMRI technical problems|1|||
144342143|NCT00504894|520453452|FG001|Overall Study|fMRI technical problems|1|||
144342144|NCT00504894|520453453|FG002|Overall Study|fMRI technical problems|0|||
144342145|NCT00504894|520453451|FG000|Overall Study|Withdrawal by Subject|0|||
144342146|NCT00504894|520453452|FG001|Overall Study|Withdrawal by Subject|1|||
144360108|NCT02081677|520527400|FG002|Overall Study|Adverse Event|1|||
144342147|NCT00504894|520453453|FG002|Overall Study|Withdrawal by Subject|0|||
144342148|NCT00504894|520453451|FG000|Overall Study|Infusion technical problems|0|||
144342149|NCT00504894|520453452|FG001|Overall Study|Infusion technical problems|1|||
144342150|NCT00504894|520453453|FG002|Overall Study|Infusion technical problems|0|||
144342151|NCT00504894|520453451|FG000|Overall Study|poor subject data|2|||
144342152|NCT00504894|520453452|FG001|Overall Study|poor subject data|0|||
144342153|NCT00504894|520453453|FG002|Overall Study|poor subject data|0|||
144342154|NCT00360568|520453454|FG000|Overall Study|Adverse Event|1|||
144342155|NCT00360568|520453455|FG001|Overall Study|Adverse Event|2|||
144342156|NCT00360568|520453454|FG000|Overall Study|Lack of Efficacy|1|||
144342157|NCT00360568|520453455|FG001|Overall Study|Lack of Efficacy|0|||
144342158|NCT00360568|520453454|FG000|Overall Study|Withdrawal by Subject|0|||
144342159|NCT00360568|520453455|FG001|Overall Study|Withdrawal by Subject|3|||
144342160|NCT01008449|520453458|FG000|Overall Study|Lost to Follow-up|29|||
144342161|NCT01008449|520453459|FG001|Overall Study|Lost to Follow-up|19|||
144342162|NCT01220180|520453460|FG000|Overall Study|Lost to Follow-up|76|||
144342163|NCT01220180|520453460|FG000|Overall Study|Other|72|||
144342164|NCT01220180|520453460|FG000|Overall Study|Adverse Event|35|||
144342165|NCT01220180|520453460|FG000|Overall Study|Lack of Efficacy|22|||
144342166|NCT01220180|520453460|FG000|Overall Study|Death|1|||
144342167|NCT01220180|520453460|FG000|Overall Study|Randomized but not treated|1|||
144342168|NCT01534195|520453462|FG000|Overall Study|Withdrawal by Subject|1|||
144342169|NCT01534195|520453463|FG001|Overall Study|Withdrawal by Subject|1|||
144342170|NCT01368081|520453466|FG000|Overall Study|Adverse Event|4|||
144342171|NCT01368081|520453467|FG001|Overall Study|Adverse Event|4|||
144342172|NCT01368081|520453468|FG002|Overall Study|Adverse Event|3|||
144342173|NCT01368081|520453469|FG003|Overall Study|Adverse Event|2|||
144342174|NCT01368081|520453470|FG004|Overall Study|Adverse Event|2|||
144342175|NCT01368081|520453471|FG005|Overall Study|Adverse Event|5|||
144342176|NCT01368081|520453472|FG006|Overall Study|Adverse Event|6|||
144342177|NCT01368081|520453473|FG007|Overall Study|Adverse Event|2|||
144342178|NCT01368081|520453474|FG008|Overall Study|Adverse Event|3|||
144342179|NCT01368081|520453475|FG009|Overall Study|Adverse Event|5|||
144342180|NCT01368081|520453476|FG010|Overall Study|Adverse Event|6|||
144342181|NCT01368081|520453477|FG011|Overall Study|Adverse Event|1|||
144342182|NCT01368081|520453478|FG012|Overall Study|Adverse Event|3|||
144342183|NCT01368081|520453466|FG000|Overall Study|Lack of Efficacy|0|||
144342184|NCT01368081|520453467|FG001|Overall Study|Lack of Efficacy|1|||
144342185|NCT01368081|520453468|FG002|Overall Study|Lack of Efficacy|0|||
144342186|NCT01368081|520453469|FG003|Overall Study|Lack of Efficacy|1|||
144342187|NCT01368081|520453470|FG004|Overall Study|Lack of Efficacy|0|||
144342188|NCT01368081|520453471|FG005|Overall Study|Lack of Efficacy|0|||
144342189|NCT01368081|520453472|FG006|Overall Study|Lack of Efficacy|0|||
144342190|NCT01368081|520453473|FG007|Overall Study|Lack of Efficacy|2|||
144342191|NCT01368081|520453474|FG008|Overall Study|Lack of Efficacy|0|||
144342192|NCT01368081|520453475|FG009|Overall Study|Lack of Efficacy|0|||
144342193|NCT01368081|520453476|FG010|Overall Study|Lack of Efficacy|0|||
144342194|NCT01368081|520453477|FG011|Overall Study|Lack of Efficacy|0|||
144342195|NCT01368081|520453478|FG012|Overall Study|Lack of Efficacy|0|||
144342196|NCT01368081|520453466|FG000|Overall Study|Protocol Violation|0|||
144342197|NCT01368081|520453467|FG001|Overall Study|Protocol Violation|0|||
144342198|NCT01368081|520453468|FG002|Overall Study|Protocol Violation|0|||
144342199|NCT01368081|520453469|FG003|Overall Study|Protocol Violation|0|||
144342200|NCT01368081|520453470|FG004|Overall Study|Protocol Violation|0|||
144342201|NCT01368081|520453471|FG005|Overall Study|Protocol Violation|1|||
144342202|NCT01368081|520453472|FG006|Overall Study|Protocol Violation|0|||
144342203|NCT01368081|520453473|FG007|Overall Study|Protocol Violation|1|||
144342204|NCT01368081|520453474|FG008|Overall Study|Protocol Violation|0|||
144342205|NCT01368081|520453475|FG009|Overall Study|Protocol Violation|0|||
144342206|NCT01368081|520453476|FG010|Overall Study|Protocol Violation|0|||
144342207|NCT01368081|520453477|FG011|Overall Study|Protocol Violation|0|||
144342208|NCT01368081|520453478|FG012|Overall Study|Protocol Violation|0|||
144342209|NCT01368081|520453466|FG000|Overall Study|Lost to Follow-up|0|||
144342210|NCT01368081|520453467|FG001|Overall Study|Lost to Follow-up|0|||
144342211|NCT01368081|520453468|FG002|Overall Study|Lost to Follow-up|0|||
144342212|NCT01368081|520453469|FG003|Overall Study|Lost to Follow-up|0|||
144342213|NCT01368081|520453470|FG004|Overall Study|Lost to Follow-up|0|||
144342214|NCT01368081|520453471|FG005|Overall Study|Lost to Follow-up|0|||
144342215|NCT01368081|520453472|FG006|Overall Study|Lost to Follow-up|0|||
144342216|NCT01368081|520453473|FG007|Overall Study|Lost to Follow-up|0|||
144342217|NCT01368081|520453474|FG008|Overall Study|Lost to Follow-up|0|||
144342218|NCT01368081|520453475|FG009|Overall Study|Lost to Follow-up|0|||
144342219|NCT01368081|520453476|FG010|Overall Study|Lost to Follow-up|0|||
144342220|NCT01368081|520453477|FG011|Overall Study|Lost to Follow-up|0|||
144342221|NCT01368081|520453478|FG012|Overall Study|Lost to Follow-up|1|||
144342222|NCT01368081|520453466|FG000|Overall Study|Withdrawal by Subject|4|||
144342223|NCT01368081|520453467|FG001|Overall Study|Withdrawal by Subject|4|||
144342224|NCT01368081|520453468|FG002|Overall Study|Withdrawal by Subject|1|||
144342225|NCT01368081|520453469|FG003|Overall Study|Withdrawal by Subject|1|||
144342226|NCT01368081|520453470|FG004|Overall Study|Withdrawal by Subject|0|||
144342227|NCT01368081|520453471|FG005|Overall Study|Withdrawal by Subject|3|||
144342228|NCT01368081|520453472|FG006|Overall Study|Withdrawal by Subject|4|||
144342229|NCT01368081|520453473|FG007|Overall Study|Withdrawal by Subject|2|||
144342230|NCT01368081|520453474|FG008|Overall Study|Withdrawal by Subject|5|||
144342231|NCT01368081|520453475|FG009|Overall Study|Withdrawal by Subject|4|||
144342232|NCT01368081|520453476|FG010|Overall Study|Withdrawal by Subject|3|||
144342233|NCT01368081|520453477|FG011|Overall Study|Withdrawal by Subject|2|||
144342234|NCT01368081|520453478|FG012|Overall Study|Withdrawal by Subject|0|||
144342235|NCT01368081|520453466|FG000|Overall Study|Other reason not defined above|2|||
144342236|NCT01368081|520453467|FG001|Overall Study|Other reason not defined above|0|||
144342237|NCT01368081|520453468|FG002|Overall Study|Other reason not defined above|0|||
144342238|NCT01368081|520453469|FG003|Overall Study|Other reason not defined above|1|||
144342239|NCT01368081|520453470|FG004|Overall Study|Other reason not defined above|0|||
144342240|NCT01368081|520453471|FG005|Overall Study|Other reason not defined above|1|||
144342241|NCT01368081|520453472|FG006|Overall Study|Other reason not defined above|2|||
144342242|NCT01368081|520453473|FG007|Overall Study|Other reason not defined above|0|||
144342243|NCT01368081|520453474|FG008|Overall Study|Other reason not defined above|0|||
144342244|NCT01368081|520453475|FG009|Overall Study|Other reason not defined above|1|||
144342245|NCT01368081|520453476|FG010|Overall Study|Other reason not defined above|0|||
144342246|NCT01368081|520453477|FG011|Overall Study|Other reason not defined above|0|||
144342247|NCT01368081|520453478|FG012|Overall Study|Other reason not defined above|3|||
144342248|NCT02277119|520453480|FG000|Overall Study|Lack of Efficacy|1|||
144342249|NCT02277119|520453481|FG001|Overall Study|Lack of Efficacy|1|||
144342250|NCT02277119|520453482|FG002|Overall Study|Lack of Efficacy|1|||
144342251|NCT02277119|520453480|FG000|Overall Study|Protocol Violation|2|||
144342252|NCT02277119|520453481|FG001|Overall Study|Protocol Violation|3|||
144342253|NCT02277119|520453482|FG002|Overall Study|Protocol Violation|7|||
144342254|NCT03068767|520453488|FG000|Overall Study|Lost to Follow-up|7|||
144342255|NCT03068767|520453489|FG001|Overall Study|Lost to Follow-up|3|||
144342256|NCT03068767|520453488|FG000|Overall Study|Protocol Violation|3|||
144342257|NCT03068767|520453489|FG001|Overall Study|Protocol Violation|0|||
144342258|NCT01730586|520453490|FG000|Overall Study|Progressive Disease|2|||
144342259|NCT01730586|520453490|FG000|Overall Study|Inadequate Trial|8|||
144342260|NCT01730586|520453490|FG000|Overall Study|Adverse Event|2|||
144342261|NCT01730586|520453490|FG000|Overall Study|Hospice|1|||
144342262|NCT00061633|520453491|FG000|Overall Study|Adverse Event|1|||
144342263|NCT00061633|520453492|FG001|Overall Study|Adverse Event|2|||
144342264|NCT00061633|520453491|FG000|Overall Study|Withdrawal by Subject|2|||
144342265|NCT00061633|520453492|FG001|Overall Study|Withdrawal by Subject|2|||
144342266|NCT00061633|520453491|FG000|Overall Study|Lost to Follow-up|1|||
144342267|NCT00061633|520453492|FG001|Overall Study|Lost to Follow-up|4|||
144342268|NCT00061633|520453491|FG000|Overall Study|Other|1|||
144342269|NCT00061633|520453492|FG001|Overall Study|Other|1|||
144342270|NCT00061633|520453491|FG000|Overall Study|Never received study treatment|0|||
144342271|NCT00061633|520453492|FG001|Overall Study|Never received study treatment|2|||
144342272|NCT01431963|520453493|FG000|Overall Study|Adverse Event|18|||
144342273|NCT01431963|520453493|FG000|Overall Study|Lack of Efficacy|7|||
144342274|NCT01431963|520453493|FG000|Overall Study|Protocol Violation|1|||
144342275|NCT01431963|520453493|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
144342276|NCT01431963|520453493|FG000|Overall Study|Physician Decision|4|||
144342277|NCT01431963|520453493|FG000|Overall Study|Withdrawal by Subject|3|||
144342278|NCT01370265|520455782|FG000|First Intervention|Adverse Event|1|||
144342279|NCT01370265|520455783|FG001|First Intervention|Adverse Event|1|||
144342280|NCT03343626|520455784|FG000|Overall Study|Lost to Follow-up|4|||
144342281|NCT03343626|520455785|FG001|Overall Study|Lost to Follow-up|3|||
144342282|NCT03343626|520455786|FG002|Overall Study|Lost to Follow-up|2|||
144342283|NCT03343626|520455787|FG003|Overall Study|Lost to Follow-up|5|||
144342284|NCT03343626|520455788|FG004|Overall Study|Lost to Follow-up|4|||
144342285|NCT03343626|520455789|FG005|Overall Study|Lost to Follow-up|4|||
144342286|NCT03343626|520455790|FG006|Overall Study|Lost to Follow-up|4|||
144342287|NCT03343626|520455791|FG007|Overall Study|Lost to Follow-up|7|||
144342288|NCT03343626|520455784|FG000|Overall Study|Withdrawal of Consent|2|||
144342289|NCT03343626|520455785|FG001|Overall Study|Withdrawal of Consent|1|||
144342290|NCT03343626|520455786|FG002|Overall Study|Withdrawal of Consent|0|||
144342291|NCT03343626|520455787|FG003|Overall Study|Withdrawal of Consent|3|||
144342292|NCT03343626|520455788|FG004|Overall Study|Withdrawal of Consent|3|||
144342293|NCT03343626|520455789|FG005|Overall Study|Withdrawal of Consent|1|||
144342294|NCT03343626|520455790|FG006|Overall Study|Withdrawal of Consent|1|||
144342295|NCT03343626|520455791|FG007|Overall Study|Withdrawal of Consent|2|||
144342296|NCT03343626|520455784|FG000|Overall Study|Reason not Specified|0|||
144342297|NCT03343626|520455785|FG001|Overall Study|Reason not Specified|1|||
144342298|NCT03343626|520455786|FG002|Overall Study|Reason not Specified|0|||
144342299|NCT03343626|520455787|FG003|Overall Study|Reason not Specified|0|||
144342300|NCT03343626|520455788|FG004|Overall Study|Reason not Specified|0|||
144342301|NCT03343626|520455789|FG005|Overall Study|Reason not Specified|0|||
144342302|NCT03343626|520455790|FG006|Overall Study|Reason not Specified|0|||
144342303|NCT03343626|520455791|FG007|Overall Study|Reason not Specified|1|||
144342304|NCT03343626|520455784|FG000|Overall Study|Data Entry Error|0|||
144342305|NCT03343626|520455785|FG001|Overall Study|Data Entry Error|0|||
144342306|NCT03343626|520455786|FG002|Overall Study|Data Entry Error|0|||
144342307|NCT03343626|520455787|FG003|Overall Study|Data Entry Error|0|||
144342308|NCT03343626|520455788|FG004|Overall Study|Data Entry Error|0|||
144342309|NCT03343626|520455789|FG005|Overall Study|Data Entry Error|0|||
144342310|NCT03343626|520455790|FG006|Overall Study|Data Entry Error|0|||
144342311|NCT03343626|520455791|FG007|Overall Study|Data Entry Error|1|||
144342312|NCT02611817|520455792|FG000|Open-label Induction Phase|Reason not Specified|9|||
144342313|NCT02611817|520455793|FG001|Open-label Induction Phase|Reason not Specified|0|||
144342314|NCT02611817|520455794|FG002|Open-label Induction Phase|Reason not Specified|0|||
144342315|NCT02611817|520455792|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
144342316|NCT02611817|520455793|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
144342317|NCT02611817|520455794|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
144342318|NCT02611817|520455792|FG000|Open-label Induction Phase|Pregnancy|1|||
144342319|NCT02611817|520455793|FG001|Open-label Induction Phase|Pregnancy|0|||
144342320|NCT02611817|520455794|FG002|Open-label Induction Phase|Pregnancy|0|||
144342321|NCT02611817|520455792|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
144342322|NCT02611817|520455793|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
144342323|NCT02611817|520455794|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
144342324|NCT02611817|520455792|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
144342325|NCT02611817|520455793|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
144342326|NCT02611817|520455794|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
144342327|NCT02611817|520455792|FG000|Open-label Induction Phase|Protocol Violation|5|||
144342328|NCT02611817|520455793|FG001|Open-label Induction Phase|Protocol Violation|0|||
144342329|NCT02611817|520455794|FG002|Open-label Induction Phase|Protocol Violation|0|||
144342330|NCT02611817|520455792|FG000|Open-label Induction Phase|Adverse Event|16|||
144342331|NCT02611817|520455793|FG001|Open-label Induction Phase|Adverse Event|0|||
144342332|NCT02611817|520455794|FG002|Open-label Induction Phase|Adverse Event|0|||
144342333|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
144342334|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
144342335|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
144342336|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
144342337|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
144342338|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
144342339|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
144342340|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
144342341|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
144342342|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
144342343|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
144342344|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
144342345|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
144342346|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
144342347|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
144342348|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
144342349|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
144342350|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
144342351|NCT02611817|520455792|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
144342352|NCT02611817|520455793|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
144342353|NCT02611817|520455794|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
144342354|NCT03077919|520455795|FG000|Overall Study|Lost to Follow-up|4|||
144342355|NCT03077919|520455796|FG001|Overall Study|Lost to Follow-up|1|||
144342356|NCT03738618|520455797|FG000|Overall Study|Protocol deviation|23|||
144342357|NCT03738618|520455798|FG001|Overall Study|Protocol deviation|0|||
144342358|NCT03738618|520455797|FG000|Overall Study|Adverse Event|4|||
144342359|NCT03738618|520455798|FG001|Overall Study|Adverse Event|0|||
144342360|NCT03738618|520455797|FG000|Overall Study|Lost to Follow-up|2|||
144342361|NCT03738618|520455798|FG001|Overall Study|Lost to Follow-up|0|||
144342362|NCT03738618|520455797|FG000|Overall Study|Randomization failure|1|||
144342363|NCT03738618|520455798|FG001|Overall Study|Randomization failure|0|||
144342364|NCT03738618|520455797|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
144342365|NCT03738618|520455798|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
144342366|NCT03738618|520455797|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
144342367|NCT03738618|520455798|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
144342368|NCT00826618|520455799|FG000|Overall Study|Withdrawal by Subject|1|||
144342369|NCT03499314|520455802|FG000|Overall Study|Time Commitment|1|||
144342370|NCT03499314|520455803|FG001|Overall Study|Time Commitment|2|||
144342371|NCT03499314|520455802|FG000|Overall Study|Medical issue unrelated to research study|1|||
144342372|NCT03499314|520455803|FG001|Overall Study|Medical issue unrelated to research study|1|||
144342373|NCT02291419|520455804|FG000|Overall Study|Early study termination|1|||
144342374|NCT02291419|520455805|FG001|Overall Study|Early study termination|5|||
144342375|NCT01959841|520455810|FG000|Overall Study|Adverse Event|1|||
144342376|NCT01959841|520455811|FG001|Overall Study|Adverse Event|3|||
144342377|NCT01959841|520455812|FG002|Overall Study|Adverse Event|2|||
144342378|NCT01959841|520455810|FG000|Overall Study|Lack of Efficacy|5|||
144342379|NCT01959841|520455811|FG001|Overall Study|Lack of Efficacy|0|||
144342380|NCT01959841|520455812|FG002|Overall Study|Lack of Efficacy|0|||
144342381|NCT01959841|520455810|FG000|Overall Study|Lost to Follow-up|1|||
144342382|NCT01959841|520455811|FG001|Overall Study|Lost to Follow-up|1|||
144342383|NCT01959841|520455812|FG002|Overall Study|Lost to Follow-up|0|||
144342384|NCT01959841|520455810|FG000|Overall Study|Physician Decision|0|||
144342385|NCT01959841|520455811|FG001|Overall Study|Physician Decision|2|||
144342386|NCT01959841|520455812|FG002|Overall Study|Physician Decision|3|||
144342387|NCT01959841|520455810|FG000|Overall Study|Protocol Violation|16|||
144342388|NCT01959841|520455811|FG001|Overall Study|Protocol Violation|23|||
144342389|NCT01959841|520455812|FG002|Overall Study|Protocol Violation|16|||
144342390|NCT01959841|520455810|FG000|Overall Study|Withdrawal by Subject|7|||
144342391|NCT01959841|520455811|FG001|Overall Study|Withdrawal by Subject|7|||
144342392|NCT01959841|520455812|FG002|Overall Study|Withdrawal by Subject|5|||
144342393|NCT01959841|520455810|FG000|Overall Study|Clinical laboratory value|2|||
144342394|NCT01959841|520455811|FG001|Overall Study|Clinical laboratory value|6|||
144342395|NCT01959841|520455812|FG002|Overall Study|Clinical laboratory value|6|||
144342396|NCT01959841|520455810|FG000|Overall Study|Platelet count below on day1 or 4|11|||
144342397|NCT01959841|520455811|FG001|Overall Study|Platelet count below on day1 or 4|15|||
144342398|NCT01959841|520455812|FG002|Overall Study|Platelet count below on day1 or 4|11|||
144342399|NCT03828617|520455825|FG000|Overall Study|Lost to Follow-up|22|||
144342400|NCT03828617|520455826|FG001|Overall Study|Lost to Follow-up|12|||
144342401|NCT03828617|520455827|FG002|Overall Study|Lost to Follow-up|23|||
144342402|NCT03828617|520455828|FG003|Overall Study|Lost to Follow-up|7|||
144342403|NCT03828617|520455825|FG000|Overall Study|No longer met eligibility criteria|0|||
144342404|NCT03828617|520455826|FG001|Overall Study|No longer met eligibility criteria|1|||
144342405|NCT03828617|520455827|FG002|Overall Study|No longer met eligibility criteria|1|||
144342406|NCT03828617|520455828|FG003|Overall Study|No longer met eligibility criteria|3|||
144342407|NCT03828617|520455825|FG000|Overall Study|Protocol Violation|0|||
144342408|NCT03828617|520455826|FG001|Overall Study|Protocol Violation|2|||
144342409|NCT03828617|520455827|FG002|Overall Study|Protocol Violation|0|||
144342410|NCT03828617|520455828|FG003|Overall Study|Protocol Violation|0|||
144342411|NCT03828617|520455825|FG000|Overall Study|Withdrawal by Subject|2|||
144342412|NCT03828617|520455826|FG001|Overall Study|Withdrawal by Subject|0|||
144342413|NCT03828617|520455827|FG002|Overall Study|Withdrawal by Subject|2|||
144342414|NCT03828617|520455828|FG003|Overall Study|Withdrawal by Subject|0|||
144342415|NCT01271725|520455829|FG000|Part A|Progressive disease according to RECIST|8|||
144342416|NCT01271725|520455830|FG001|Part A|Progressive disease according to RECIST|0|||
144342417|NCT01271725|520455829|FG000|Part A|Clinical signs/symptoms of progression|2|||
144342418|NCT01271725|520455830|FG001|Part A|Clinical signs/symptoms of progression|0|||
144342419|NCT01271725|520455829|FG000|Part A|Other Adverse Event|8|||
144342420|NCT01271725|520455830|FG001|Part A|Other Adverse Event|0|||
144342421|NCT01271725|520455829|FG000|Part A|Lost to Follow-up|1|||
144342422|NCT01271725|520455830|FG001|Part A|Lost to Follow-up|0|||
144342423|NCT01271725|520455829|FG000|Part A|Withdrawal by Subject|12|||
144342424|NCT01271725|520455830|FG001|Part A|Withdrawal by Subject|0|||
144342425|NCT01271725|520455829|FG000|Part A|Other than specified|3|||
144342426|NCT01271725|520455830|FG001|Part A|Other than specified|0|||
144342427|NCT01271725|520455829|FG000|Part A|Protocol Violation|1|||
144342428|NCT01271725|520455830|FG001|Part A|Protocol Violation|0|||
144342429|NCT01271725|520455829|FG000|Part B|Other than specified|0|||
144342430|NCT01271725|520455830|FG001|Part B|Other than specified|2|||
144342431|NCT01271725|520455829|FG000|Part B|Clinical signs/symptoms of progression|0|||
144342432|NCT01271725|520455830|FG001|Part B|Clinical signs/symptoms of progression|2|||
144342433|NCT01271725|520455829|FG000|Part B|Other Adverse Event|0|||
144342434|NCT01271725|520455830|FG001|Part B|Other Adverse Event|1|||
144342435|NCT01271725|520455829|FG000|Part B|Protocol Violation|0|||
144342436|NCT01271725|520455830|FG001|Part B|Protocol Violation|1|||
144342437|NCT01271725|520455829|FG000|Part B|Withdrawal by Subject|0|||
144342438|NCT01271725|520455830|FG001|Part B|Withdrawal by Subject|6|||
144342439|NCT02950480|520455833|FG000|Overall Study|Withdrawal by Subject|1|||
144342440|NCT02950480|520455834|FG001|Overall Study|Withdrawal by Subject|0|||
144342441|NCT01363661|520455841|FG000|Overall Study|Adverse Event|9|||
144342442|NCT01363661|520455842|FG001|Overall Study|Adverse Event|2|||
144342443|NCT01363661|520455841|FG000|Overall Study|Withdrawal by Subject|1|||
144342444|NCT01363661|520455842|FG001|Overall Study|Withdrawal by Subject|1|||
144342445|NCT01363661|520455841|FG000|Overall Study|Protocol Violation|1|||
144342446|NCT01363661|520455842|FG001|Overall Study|Protocol Violation|0|||
144342447|NCT01363661|520455841|FG000|Overall Study|Lost to Follow-up|3|||
144342448|NCT01363661|520455842|FG001|Overall Study|Lost to Follow-up|1|||
144342449|NCT01835223|520455843|FG000|Overall Study|Adverse Event|1|||
144342450|NCT01835223|520455844|FG001|Overall Study|Adverse Event|0|||
144342451|NCT01835223|520455843|FG000|Overall Study|Withdrawal by Subject|2|||
144342452|NCT01835223|520455844|FG001|Overall Study|Withdrawal by Subject|0|||
144342453|NCT01835223|520455843|FG000|Overall Study|Disease progression|2|||
144342454|NCT01835223|520455844|FG001|Overall Study|Disease progression|1|||
144342455|NCT01835223|520455843|FG000|Overall Study|Became Inelligible|4|||
144342456|NCT01835223|520455844|FG001|Overall Study|Became Inelligible|0|||
144342457|NCT03149055|520455849|FG000|Overall Study|Not treated|4|||
144342458|NCT01378325|520455853|FG000|Overall Study|Protocol Violation|0|||
144342459|NCT01378325|520455854|FG001|Overall Study|Protocol Violation|1|||
144342460|NCT01559675|520455855|FG000|Overall Study|Protocol Violation|1|||
144342461|NCT01559675|520455856|FG001|Overall Study|Protocol Violation|2|||
144342462|NCT01559675|520455855|FG000|Overall Study|2nd operation on same patient excluded|14|||
144342463|NCT01559675|520455856|FG001|Overall Study|2nd operation on same patient excluded|12|||
144342464|NCT01357551|520455857|FG000|Overall Study|Withdrawal by Subject|6|||
144342465|NCT01357551|520455858|FG001|Overall Study|Withdrawal by Subject|4|||
144342466|NCT01357551|520455857|FG000|Overall Study|Death|0|||
144342467|NCT01357551|520455858|FG001|Overall Study|Death|1|||
144342468|NCT01357551|520455857|FG000|Overall Study|Lost to Follow-up|16|||
144342469|NCT01357551|520455858|FG001|Overall Study|Lost to Follow-up|6|||
144342470|NCT00891228|520455859|FG000|Overall Study|Adverse Event|0|||
144342471|NCT00891228|520455860|FG001|Overall Study|Adverse Event|2|||
144342472|NCT00891228|520455861|FG002|Overall Study|Adverse Event|3|||
144342473|NCT00891228|520455859|FG000|Overall Study|Withdrawal by Subject|2|||
144342474|NCT00891228|520455860|FG001|Overall Study|Withdrawal by Subject|4|||
144342475|NCT00891228|520455861|FG002|Overall Study|Withdrawal by Subject|5|||
144342476|NCT00891228|520455859|FG000|Overall Study|Protocol Violation|3|||
144342477|NCT00891228|520455860|FG001|Overall Study|Protocol Violation|1|||
144342478|NCT00891228|520455861|FG002|Overall Study|Protocol Violation|2|||
144342479|NCT00891228|520455859|FG000|Overall Study|Physician Decision|2|||
144342480|NCT00891228|520455860|FG001|Overall Study|Physician Decision|1|||
144342481|NCT00891228|520455861|FG002|Overall Study|Physician Decision|0|||
144342482|NCT00891228|520455859|FG000|Overall Study|Lost to Follow-up|4|||
144342483|NCT00891228|520455860|FG001|Overall Study|Lost to Follow-up|4|||
144342484|NCT00891228|520455861|FG002|Overall Study|Lost to Follow-up|5|||
144342485|NCT00891228|520455859|FG000|Overall Study|Pregnancy|0|||
144342486|NCT00891228|520455860|FG001|Overall Study|Pregnancy|1|||
144342487|NCT00891228|520455861|FG002|Overall Study|Pregnancy|0|||
144342488|NCT03704688|520455862|FG000|Overall Study|Adverse Event|0|||
144342489|NCT03704688|520455863|FG001|Overall Study|Adverse Event|0|||
144342490|NCT03704688|520455864|FG002|Overall Study|Adverse Event|0|||
144342491|NCT03704688|520455865|FG003|Overall Study|Adverse Event|4|||
144342492|NCT03704688|520455866|FG004|Overall Study|Adverse Event|1|||
144342493|NCT03704688|520455867|FG005|Overall Study|Adverse Event|0|||
144342494|NCT03704688|520455862|FG000|Overall Study|Disease Progression|0|||
144342495|NCT03704688|520455863|FG001|Overall Study|Disease Progression|0|||
144342496|NCT03704688|520455864|FG002|Overall Study|Disease Progression|0|||
144342497|NCT03704688|520455865|FG003|Overall Study|Disease Progression|3|||
144342498|NCT03704688|520455866|FG004|Overall Study|Disease Progression|1|||
144342499|NCT03704688|520455867|FG005|Overall Study|Disease Progression|0|||
144342500|NCT03704688|520455862|FG000|Overall Study|Death|0|||
144342501|NCT03704688|520455863|FG001|Overall Study|Death|0|||
144342502|NCT03704688|520455864|FG002|Overall Study|Death|0|||
144342503|NCT03704688|520455865|FG003|Overall Study|Death|0|||
144342504|NCT03704688|520455866|FG004|Overall Study|Death|3|||
144342505|NCT03704688|520455867|FG005|Overall Study|Death|0|||
144342506|NCT00787189|520455868|FG000|Overall Study|Lost to Follow-up|2|||
144342507|NCT00787189|520455869|FG001|Overall Study|Lost to Follow-up|2|||
144342508|NCT00596830|520455870|FG000|Overall Study|Death|258|||
144342509|NCT00596830|520455871|FG001|Overall Study|Death|247|||
144342510|NCT00596830|520455870|FG000|Overall Study|Lost to Follow-up|7|||
144342511|NCT00596830|520455871|FG001|Overall Study|Lost to Follow-up|11|||
144342512|NCT00596830|520455870|FG000|Overall Study|Withdrawal by Subject|22|||
144342513|NCT00596830|520455871|FG001|Overall Study|Withdrawal by Subject|12|||
144342514|NCT00596830|520455870|FG000|Overall Study|Study terminated by sponsor|51|||
144342515|NCT00596830|520455871|FG001|Overall Study|Study terminated by sponsor|62|||
144342516|NCT00596830|520455870|FG000|Overall Study|Follow-up was discontinued|1|||
144342517|NCT00596830|520455871|FG001|Overall Study|Follow-up was discontinued|0|||
144342518|NCT00596830|520455870|FG000|Overall Study|Randomized but not treated|3|||
144342519|NCT00596830|520455871|FG001|Overall Study|Randomized but not treated|7|||
144342520|NCT00887926|520455872|FG000|Overall Study|Withdrawal by Subject|0|||
144342521|NCT00887926|520455873|FG001|Overall Study|Withdrawal by Subject|1|||
144342522|NCT00887926|520455874|FG002|Overall Study|Withdrawal by Subject|0|||
144342523|NCT00887926|520455875|FG003|Overall Study|Withdrawal by Subject|0|||
144342524|NCT02097030|520455876|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
144342525|NCT02097030|520455877|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
144342526|NCT02097030|520455876|FG000|First Intervention (3 Days)|Visual Acuity|0|||
144342527|NCT02097030|520455877|FG001|First Intervention (3 Days)|Visual Acuity|1|||
144342528|NCT00774800|520455878|FG000|Intervention 4|Withdrawal by Subject|1|||
144342529|NCT01973998|520455883|FG000|Overall Study|Death|2|||
144342530|NCT01973998|520455884|FG001|Overall Study|Death|2|||
144342531|NCT02540993|520455890|FG000|Overall Study|Lost to Follow-up|5|||
144342532|NCT02540993|520455891|FG001|Overall Study|Lost to Follow-up|3|||
144342533|NCT02540993|520455890|FG000|Overall Study|Withdrawal by Subject|4|||
144342534|NCT02540993|520455891|FG001|Overall Study|Withdrawal by Subject|6|||
144342535|NCT02540993|520455890|FG000|Overall Study|GCP violations|33|||
144342536|NCT02540993|520455891|FG001|Overall Study|GCP violations|27|||
144342537|NCT00820222|520455892|FG000|Overall Study|Lost to Follow-up|10|||
144342538|NCT00820222|520455893|FG001|Overall Study|Lost to Follow-up|9|||
144342539|NCT00820222|520455892|FG000|Overall Study|Withdrawal by Subject|19|||
144342540|NCT00820222|520455893|FG001|Overall Study|Withdrawal by Subject|21|||
144342541|NCT00820222|520455892|FG000|Overall Study|Physician Decision|93|||
144342542|NCT00820222|520455893|FG001|Overall Study|Physician Decision|88|||
144342543|NCT00820222|520455892|FG000|Overall Study|Sponsor Terminated Study|43|||
144342544|NCT00820222|520455893|FG001|Overall Study|Sponsor Terminated Study|65|||
144342545|NCT00820222|520455892|FG000|Overall Study|Unkown|11|||
144342546|NCT00820222|520455893|FG001|Overall Study|Unkown|7|||
144342547|NCT00844558|520455894|FG000|Overall Study|Withdrawal by Subject|9|||
144342548|NCT00844558|520455895|FG001|Overall Study|Withdrawal by Subject|2|||
144342549|NCT00844558|520455894|FG000|Overall Study|Death|1|||
144342550|NCT00844558|520455895|FG001|Overall Study|Death|0|||
144342551|NCT00844558|520455894|FG000|Overall Study|Protocol Violation|1|||
144342552|NCT00844558|520455895|FG001|Overall Study|Protocol Violation|1|||
144342553|NCT00844558|520455894|FG000|Overall Study|Lost to Follow-up|0|||
144342554|NCT00844558|520455895|FG001|Overall Study|Lost to Follow-up|1|||
144342555|NCT00844558|520455894|FG000|Overall Study|Physician Decision|1|||
144342556|NCT00844558|520455895|FG001|Overall Study|Physician Decision|0|||
144342557|NCT00588094|520455896|FG000|Overall Study|Adverse Event|3|||
144342558|NCT00588094|520455896|FG000|Overall Study|Progression of Disease|2|||
144342559|NCT01336023|520455897|FG000|Week 0 to Week 26|Adverse Event|8|||
144342560|NCT01336023|520455898|FG001|Week 0 to Week 26|Adverse Event|10|||
144342561|NCT01336023|520455899|FG002|Week 0 to Week 26|Adverse Event|24|||
144342562|NCT01336023|520455897|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
144342563|NCT01336023|520455898|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
144342564|NCT01336023|520455899|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
144342565|NCT01336023|520455897|FG000|Week 0 to Week 26|Protocol Violation|1|||
144342566|NCT01336023|520455898|FG001|Week 0 to Week 26|Protocol Violation|2|||
144342567|NCT01336023|520455899|FG002|Week 0 to Week 26|Protocol Violation|0|||
144342568|NCT01336023|520455897|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
144342569|NCT01336023|520455898|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
144342570|NCT01336023|520455899|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
144342571|NCT01336023|520455897|FG000|Week 0 to Week 26|Unclassified|5|||
144342572|NCT01336023|520455898|FG001|Week 0 to Week 26|Unclassified|16|||
144342573|NCT01336023|520455899|FG002|Week 0 to Week 26|Unclassified|9|||
144342574|NCT01336023|520455897|FG000|Week 27 to 52|Adverse Event|1|||
144342575|NCT01336023|520455898|FG001|Week 27 to 52|Adverse Event|5|||
144342576|NCT01336023|520455899|FG002|Week 27 to 52|Adverse Event|2|||
144342577|NCT01336023|520455897|FG000|Week 27 to 52|Protocol Violation|0|||
144342578|NCT01336023|520455898|FG001|Week 27 to 52|Protocol Violation|2|||
144342579|NCT01336023|520455899|FG002|Week 27 to 52|Protocol Violation|1|||
144342580|NCT01336023|520455897|FG000|Week 27 to 52|Withdrawal Criteria|14|||
144342581|NCT01336023|520455898|FG001|Week 27 to 52|Withdrawal Criteria|19|||
144342582|NCT01336023|520455899|FG002|Week 27 to 52|Withdrawal Criteria|16|||
144342583|NCT01336023|520455897|FG000|Week 27 to 52|Unclassified|13|||
144342584|NCT01336023|520455898|FG001|Week 27 to 52|Unclassified|18|||
144342585|NCT01336023|520455899|FG002|Week 27 to 52|Unclassified|9|||
144342586|NCT01894022|520455905|FG000|Overall Study|Death|1|||
144342587|NCT01894022|520455906|FG001|Overall Study|Death|0|||
144342588|NCT01894022|520455905|FG000|Overall Study|Adverse Event, non-fatal|1|||
144342589|NCT01894022|520455906|FG001|Overall Study|Adverse Event, non-fatal|0|||
144342590|NCT01894022|520455905|FG000|Overall Study|Study Closed/terminated|7|||
144342591|NCT01894022|520455906|FG001|Overall Study|Study Closed/terminated|10|||
144342592|NCT04496453|520455908|FG000|Overall Study|Lost to Follow-up|6|||
144342593|NCT01361178|520455909|FG000|Overall Study|Death|13|||
144342594|NCT01361178|520455910|FG001|Overall Study|Death|0|||
144342595|NCT05392803|520455913|FG000|Overall Study|Lost to Follow-up|0|||
144342596|NCT05392803|520455914|FG001|Overall Study|Lost to Follow-up|2|||
144342597|NCT03688620|520455917|FG000|Overall Study|Other|0|||
144342598|NCT03688620|520455918|FG001|Overall Study|Other|0|||
144342599|NCT03688620|520455919|FG002|Overall Study|Other|1|||
144342600|NCT03688620|520455917|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
144342601|NCT03688620|520455918|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
144342602|NCT03688620|520455919|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
144342603|NCT03688620|520455917|FG000|Overall Study|Lost to Follow-up|16|||
144342604|NCT03688620|520455918|FG001|Overall Study|Lost to Follow-up|0|||
144342605|NCT03688620|520455919|FG002|Overall Study|Lost to Follow-up|1|||
144342606|NCT03688620|520455917|FG000|Overall Study|Withdrawal by Subject|0|||
144342607|NCT03688620|520455918|FG001|Overall Study|Withdrawal by Subject|0|||
144342608|NCT03688620|520455919|FG002|Overall Study|Withdrawal by Subject|6|||
144342609|NCT02828020|520455920|FG000|Treatment Period|Adverse Event|3|||
144342610|NCT02828020|520455921|FG001|Treatment Period|Adverse Event|1|||
144342611|NCT02828020|520455922|FG002|Treatment Period|Adverse Event|1|||
144342612|NCT02828020|520455920|FG000|Treatment Period|Withdrawal of Consent|10|||
144342613|NCT02828020|520455921|FG001|Treatment Period|Withdrawal of Consent|14|||
144342614|NCT02828020|520455922|FG002|Treatment Period|Withdrawal of Consent|9|||
144342615|NCT02828020|520455920|FG000|Treatment Period|Lost to Follow-up|21|||
144342616|NCT02828020|520455921|FG001|Treatment Period|Lost to Follow-up|24|||
144342617|NCT02828020|520455922|FG002|Treatment Period|Lost to Follow-up|18|||
144342618|NCT02828020|520455920|FG000|Treatment Period|Lack of Qualifying Event|44|||
144342619|NCT02828020|520455921|FG001|Treatment Period|Lack of Qualifying Event|53|||
144342620|NCT02828020|520455922|FG002|Treatment Period|Lack of Qualifying Event|43|||
144342621|NCT02828020|520455920|FG000|Treatment Period|Pregnancy|0|||
144342622|NCT02828020|520455921|FG001|Treatment Period|Pregnancy|2|||
144342623|NCT02828020|520455922|FG002|Treatment Period|Pregnancy|0|||
144342624|NCT02828020|520455920|FG000|Treatment Period|Protocol Violation|2|||
144342625|NCT02828020|520455921|FG001|Treatment Period|Protocol Violation|4|||
144342626|NCT02828020|520455922|FG002|Treatment Period|Protocol Violation|7|||
144342627|NCT02828020|520455920|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
144342628|NCT02828020|520455921|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
144342629|NCT02828020|520455922|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
144342630|NCT02828020|520455920|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
144342631|NCT02828020|520455921|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
144342632|NCT02828020|520455922|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
144342633|NCT02828020|520455920|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
144342634|NCT02828020|520455921|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
144342635|NCT02828020|520455922|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
144342636|NCT02828020|520455920|FG000|Safety Follow-up Period|Protocol Violation|0|||
144342637|NCT02828020|520455921|FG001|Safety Follow-up Period|Protocol Violation|2|||
144342638|NCT02828020|520455922|FG002|Safety Follow-up Period|Protocol Violation|1|||
144342639|NCT02828020|520455920|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
144342640|NCT02828020|520455921|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
144342641|NCT02828020|520455922|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
144342642|NCT01008904|520455923|FG000|Overall Study|Lost to Follow-up|1|||
144342643|NCT01008904|520455923|FG000|Overall Study|Adverse Event|2|||
144342644|NCT01008904|520455923|FG000|Overall Study|unexpected unrelated surgery|1|||
144342645|NCT01364389|520455930|FG000|Overall Study|Withdrawal by Subject|0|||
144342646|NCT01364389|520455931|FG001|Overall Study|Withdrawal by Subject|1|||
144342647|NCT01364389|520455932|FG002|Overall Study|Withdrawal by Subject|0|||
144342648|NCT01364389|520455930|FG000|Overall Study|Protocol deviation|0|||
144342649|NCT01364389|520455931|FG001|Overall Study|Protocol deviation|0|||
144342650|NCT01364389|520455932|FG002|Overall Study|Protocol deviation|1|||
144342651|NCT01364389|520455930|FG000|Overall Study|Administrative problems|1|||
144342652|NCT01364389|520455931|FG001|Overall Study|Administrative problems|0|||
144342653|NCT01364389|520455932|FG002|Overall Study|Administrative problems|0|||
144342654|NCT01364389|520455930|FG000|Overall Study|Adverse Event|1|||
144342655|NCT01364389|520455931|FG001|Overall Study|Adverse Event|0|||
144342656|NCT01364389|520455932|FG002|Overall Study|Adverse Event|0|||
144342657|NCT03043651|520455937|FG000|Overall Study|Death|1|||
144342658|NCT03043651|520455937|FG000|Overall Study|Progressive Disease|2|||
144342659|NCT03043651|520455937|FG000|Overall Study|Adverse Event|2|||
144342660|NCT03043651|520455937|FG000|Overall Study|Withdrawal by Subject|4|||
144342661|NCT03043651|520455937|FG000|Overall Study|Study Terminated by Sponsor|39|||
144342662|NCT01630889|520455938|FG000|Overall Study|Death|2|||
144342663|NCT01630889|520455938|FG000|Overall Study|Withdrawal by Subject|1|||
144342664|NCT01630889|520455938|FG000|Overall Study|Other than Specified|2|||
144342665|NCT01630889|520455938|FG000|Overall Study|Lost to Follow-up|4|||
144342666|NCT01630889|520455938|FG000|Overall Study|Other|1|||
144342667|NCT02974842|520455939|FG000|Overall Study|Withdrawal by Subject|4|||
144342668|NCT02974842|520455939|FG000|Overall Study|Screen failures|4|||
144342669|NCT01068158|520455945|FG000|Overall Study|Withdrawal by Subject|1|||
144342670|NCT01068158|520455946|FG001|Overall Study|Withdrawal by Subject|2|||
144342671|NCT01068158|520455945|FG000|Overall Study|Lost to Follow-up|7|||
144342672|NCT01068158|520455946|FG001|Overall Study|Lost to Follow-up|0|||
144342673|NCT01068158|520455945|FG000|Overall Study|Protocol Violation|0|||
144342674|NCT01068158|520455946|FG001|Overall Study|Protocol Violation|2|||
144342675|NCT00872599|520457282|FG000|Second Washout Period|Adverse Event|1|||
144342676|NCT00872599|520457283|FG001|Second Washout Period|Adverse Event|1|||
144342677|NCT04794270|520457284|FG000|Period 1|Non Compliance|1|||
144342678|NCT04794270|520457285|FG001|Period 1|Non Compliance|0|||
144342679|NCT04794270|520457284|FG000|Period 1|Adverse Event|1|||
144342680|NCT04794270|520457285|FG001|Period 1|Adverse Event|0|||
144342681|NCT04794270|520457284|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
144342682|NCT04794270|520457285|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
144342683|NCT02510001|520457288|FG000|Overall Study|Early disease progression|0|||
144342684|NCT02510001|520457289|FG001|Overall Study|Early disease progression|0|||
144342685|NCT02510001|520457290|FG002|Overall Study|Early disease progression|0|||
144342686|NCT02510001|520457291|FG003|Overall Study|Early disease progression|1|||
144342687|NCT02510001|520457292|FG004|Overall Study|Early disease progression|1|||
144342688|NCT02510001|520457293|FG005|Overall Study|Early disease progression|1|||
144342689|NCT02510001|520457294|FG006|Overall Study|Early disease progression|0|||
144342690|NCT02510001|520457295|FG007|Overall Study|Early disease progression|0|||
144342691|NCT02510001|520457288|FG000|Overall Study|Adverse Event|0|||
144342692|NCT02510001|520457289|FG001|Overall Study|Adverse Event|0|||
144342693|NCT02510001|520457290|FG002|Overall Study|Adverse Event|0|||
144342694|NCT02510001|520457291|FG003|Overall Study|Adverse Event|1|||
144342695|NCT02510001|520457292|FG004|Overall Study|Adverse Event|2|||
144342696|NCT02510001|520457293|FG005|Overall Study|Adverse Event|1|||
144342697|NCT02510001|520457294|FG006|Overall Study|Adverse Event|2|||
144342698|NCT02510001|520457295|FG007|Overall Study|Adverse Event|5|||
144342699|NCT02510001|520457288|FG000|Overall Study|Physician Decision|0|||
144342700|NCT02510001|520457289|FG001|Overall Study|Physician Decision|0|||
144342701|NCT02510001|520457290|FG002|Overall Study|Physician Decision|0|||
144342702|NCT02510001|520457291|FG003|Overall Study|Physician Decision|0|||
144342703|NCT02510001|520457292|FG004|Overall Study|Physician Decision|1|||
144342704|NCT02510001|520457293|FG005|Overall Study|Physician Decision|0|||
144342705|NCT02510001|520457294|FG006|Overall Study|Physician Decision|0|||
144342706|NCT02510001|520457295|FG007|Overall Study|Physician Decision|0|||
144342707|NCT02510001|520457288|FG000|Overall Study|Withdrawal by Subject|0|||
144342708|NCT02510001|520457289|FG001|Overall Study|Withdrawal by Subject|0|||
144342709|NCT02510001|520457290|FG002|Overall Study|Withdrawal by Subject|0|||
144342710|NCT02510001|520457291|FG003|Overall Study|Withdrawal by Subject|0|||
144342711|NCT02510001|520457292|FG004|Overall Study|Withdrawal by Subject|0|||
144342712|NCT02510001|520457293|FG005|Overall Study|Withdrawal by Subject|0|||
144342713|NCT02510001|520457294|FG006|Overall Study|Withdrawal by Subject|0|||
144342714|NCT02510001|520457295|FG007|Overall Study|Withdrawal by Subject|2|||
144342715|NCT00303485|520457309|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
144342716|NCT00303485|520457310|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
144342717|NCT00303485|520457309|FG000|Overall Study|Failure to return|0|||
144342718|NCT00303485|520457310|FG001|Overall Study|Failure to return|1|||
144342719|NCT00303485|520457309|FG000|Overall Study|Withdrawal by Subject|1|||
144342720|NCT00303485|520457310|FG001|Overall Study|Withdrawal by Subject|0|||
144342721|NCT01504841|520457311|FG000|Overall Study|Withdrawal by Subject|1|||
144342722|NCT01504841|520457312|FG001|Overall Study|Withdrawal by Subject|1|||
144342723|NCT01504841|520457313|FG002|Overall Study|Withdrawal by Subject|0|||
144342724|NCT01496469|520457318|FG000|Overall Study|Adverse Event|1|||
144342725|NCT01496469|520457319|FG001|Overall Study|Adverse Event|0|||
144342726|NCT01496469|520457318|FG000|Overall Study|Protocol Violation|2|||
144342727|NCT01496469|520457319|FG001|Overall Study|Protocol Violation|0|||
144342728|NCT01496469|520457318|FG000|Overall Study|Lost to Follow-up|1|||
144342729|NCT01496469|520457319|FG001|Overall Study|Lost to Follow-up|1|||
144342730|NCT01496469|520457318|FG000|Overall Study|Withdrawal by Subject|4|||
144342731|NCT01496469|520457319|FG001|Overall Study|Withdrawal by Subject|4|||
144342732|NCT01496469|520457318|FG000|Overall Study|BP exceeds protocol limits|1|||
144342733|NCT01496469|520457319|FG001|Overall Study|BP exceeds protocol limits|2|||
144342734|NCT01496469|520457318|FG000|Overall Study|Other|1|||
144342735|NCT01496469|520457319|FG001|Overall Study|Other|1|||
144342736|NCT00630344|520457321|FG000|Overall Study|Adverse Event|5|||
144342737|NCT00630344|520457321|FG000|Overall Study|Progressive Disease|19|||
144342738|NCT00630344|520457321|FG000|Overall Study|Physician Decision|9|||
144342739|NCT00630344|520457321|FG000|Overall Study|Withdrawal by Subject|1|||
144342740|NCT00630344|520457321|FG000|Overall Study|Intercurrent Illness|1|||
144342741|NCT00630344|520457321|FG000|Overall Study|Other|1|||
144342742|NCT01726582|520457330|FG000|Overall Study|Physician Decision|99|||
144342743|NCT01726582|520457330|FG000|Overall Study|Death|85|||
144342744|NCT01235234|520457331|FG000|Overall Study|Adverse Event|2|||
144342745|NCT01235234|520457332|FG001|Overall Study|Adverse Event|2|||
144342746|NCT01235234|520457333|FG002|Overall Study|Adverse Event|1|||
144342747|NCT03671304|520457342|FG000|Overall Study|study terminated|7|||
144342748|NCT00773747|520457345|FG000|Overall Study|Lack of Efficacy|112|||
144342749|NCT00773747|520457346|FG001|Overall Study|Lack of Efficacy|144|||
144342750|NCT00773747|520457345|FG000|Overall Study|Physician Decision|26|||
144342751|NCT00773747|520457346|FG001|Overall Study|Physician Decision|18|||
144342752|NCT00773747|520457345|FG000|Overall Study|Lost to Follow-up|0|||
144342753|NCT00773747|520457346|FG001|Overall Study|Lost to Follow-up|1|||
144342754|NCT00773747|520457345|FG000|Overall Study|Protocol Violation|2|||
144342755|NCT00773747|520457346|FG001|Overall Study|Protocol Violation|2|||
144342756|NCT00773747|520457345|FG000|Overall Study|Withdrawal by Subject|89|||
144342757|NCT00773747|520457346|FG001|Overall Study|Withdrawal by Subject|61|||
144342758|NCT00773747|520457345|FG000|Overall Study|Adverse Event|61|||
144342759|NCT00773747|520457346|FG001|Overall Study|Adverse Event|62|||
144342760|NCT00773747|520457345|FG000|Overall Study|Death|5|||
144342761|NCT00773747|520457346|FG001|Overall Study|Death|8|||
144342762|NCT00773747|520457345|FG000|Overall Study|Not Treated|2|||
144342763|NCT00773747|520457346|FG001|Overall Study|Not Treated|0|||
144342764|NCT02202538|520457354|FG000|Overall Study|Withdrawal by Subject|5|||
144342765|NCT02202538|520457354|FG000|Overall Study|Did not meet all inclusion criteria|2|||
144342766|NCT02202538|520457354|FG000|Overall Study|Investigator Decision|1|||
144342767|NCT01457846|520457356|FG000|Overall Study|Death before treatment|1|||
144342768|NCT01457846|520457357|FG001|Overall Study|Death before treatment|2|||
144342769|NCT01457846|520457356|FG000|Overall Study|Did not receive treatment|0|||
144342770|NCT01457846|520457357|FG001|Overall Study|Did not receive treatment|1|||
144342771|NCT01457846|520457356|FG000|Overall Study|Death|27|||
144342772|NCT01457846|520457357|FG001|Overall Study|Death|16|||
144342773|NCT01457846|520457356|FG000|Overall Study|Unclassified reason for not completed|11|||
144342774|NCT01457846|520457357|FG001|Overall Study|Unclassified reason for not completed|10|||
144342775|NCT01457846|520457356|FG000|Overall Study|Withdrawal by Subject|1|||
144342776|NCT01457846|520457357|FG001|Overall Study|Withdrawal by Subject|1|||
144342777|NCT01457846|520457356|FG000|Overall Study|Lost to Follow-up|1|||
144342778|NCT01457846|520457357|FG001|Overall Study|Lost to Follow-up|0|||
144342779|NCT01846741|520457358|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
144342780|NCT01853878|520457359|FG000|Overall Study|Recurrence|2|||
144342781|NCT01853878|520457360|FG001|Overall Study|Recurrence|0|||
144342782|NCT01853878|520457359|FG000|Overall Study|Adverse Event|2|||
144342783|NCT01853878|520457360|FG001|Overall Study|Adverse Event|0|||
144342784|NCT01853878|520457359|FG000|Overall Study|Withdrawal by Subject|3|||
144342785|NCT01853878|520457360|FG001|Overall Study|Withdrawal by Subject|1|||
144342786|NCT01853878|520457359|FG000|Overall Study|Migrated/moved from the study area|1|||
144342787|NCT01853878|520457360|FG001|Overall Study|Migrated/moved from the study area|0|||
144342788|NCT01853878|520457359|FG000|Overall Study|Other|55|||
144342789|NCT01853878|520457360|FG001|Overall Study|Other|43|||
144342790|NCT02161757|520457361|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
144342791|NCT02161757|520457362|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
144342792|NCT02161757|520457363|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
144342793|NCT02161757|520457361|FG000|Treatment Through Study Completion|Adverse Event|1|||
144342794|NCT02161757|520457362|FG001|Treatment Through Study Completion|Adverse Event|1|||
144342795|NCT02161757|520457363|FG002|Treatment Through Study Completion|Adverse Event|0|||
144342796|NCT02161757|520457361|FG000|Treatment Through Study Completion|Protocol Violation|0|||
144342797|NCT02161757|520457362|FG001|Treatment Through Study Completion|Protocol Violation|1|||
144342798|NCT02161757|520457363|FG002|Treatment Through Study Completion|Protocol Violation|2|||
144342799|NCT02161757|520457361|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
144342800|NCT02161757|520457362|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
144342801|NCT02161757|520457363|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
144342802|NCT02161757|520457361|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
144342803|NCT02161757|520457362|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
144342804|NCT02161757|520457363|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
144342805|NCT02161757|520457361|FG000|Treatment Through Study Completion|Other|20|||
144342806|NCT02161757|520457362|FG001|Treatment Through Study Completion|Other|19|||
144342807|NCT02161757|520457363|FG002|Treatment Through Study Completion|Other|12|||
144342808|NCT02161757|520457361|FG000|Treatment Through Study Completion|Death|2|||
144342809|NCT02161757|520457362|FG001|Treatment Through Study Completion|Death|1|||
144342810|NCT02161757|520457363|FG002|Treatment Through Study Completion|Death|1|||
144342811|NCT03997825|520457364|FG000|Overall Study|Death|3|||
144342812|NCT03997825|520457364|FG000|Overall Study|Lost to Follow-up|10|||
144342813|NCT03997825|520457364|FG000|Overall Study|Withdrawal by Subject|3|||
144342814|NCT03997825|520457364|FG000|Overall Study|Refused participation|1|||
144342815|NCT01153698|520457365|FG000|Overall Study|Adverse Event|12|||
144342816|NCT01153698|520457365|FG000|Overall Study|Lost to Follow-up|4|||
144342817|NCT01153698|520457365|FG000|Overall Study|Withdrawal by Subject|2|||
144342818|NCT01153698|520457365|FG000|Overall Study|Switch to other anticoagulants|4|||
144342819|NCT01153698|520457365|FG000|Overall Study|Other|2|||
144342820|NCT01153698|520457365|FG000|Overall Study|Not treated with Pradaxa|5|||
144342821|NCT04294147|520457373|FG000|Overall Study|Protocol Violation|2|||
144342822|NCT04294147|520457374|FG001|Overall Study|Protocol Violation|0|||
144342823|NCT02332291|520457375|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
144342824|NCT02332291|520457376|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
144342825|NCT02332291|520457375|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
144342826|NCT02332291|520457376|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
144342827|NCT02332291|520457375|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
144342828|NCT02332291|520457376|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
144342829|NCT02332291|520457375|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
144342830|NCT02332291|520457376|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
144342831|NCT02332291|520457375|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
144342832|NCT02332291|520457376|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
144342833|NCT02332291|520457375|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
144342834|NCT02332291|520457376|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
144342835|NCT00465647|520457383|FG000|Overall Study|Administrative|2|||
144342836|NCT00465647|520457384|FG001|Overall Study|Administrative|2|||
144342837|NCT00465647|520457385|FG002|Overall Study|Administrative|3|||
144342838|NCT00465647|520457386|FG003|Overall Study|Administrative|2|||
144342839|NCT00465647|520457383|FG000|Overall Study|Adverse Event|2|||
144342840|NCT00465647|520457384|FG001|Overall Study|Adverse Event|0|||
144342841|NCT00465647|520457385|FG002|Overall Study|Adverse Event|3|||
144342842|NCT00465647|520457386|FG003|Overall Study|Adverse Event|2|||
144342843|NCT00465647|520457383|FG000|Overall Study|Withdrawal by Subject|1|||
144342844|NCT00465647|520457384|FG001|Overall Study|Withdrawal by Subject|2|||
144342845|NCT00465647|520457385|FG002|Overall Study|Withdrawal by Subject|2|||
144342846|NCT00465647|520457386|FG003|Overall Study|Withdrawal by Subject|7|||
144342847|NCT00465647|520457383|FG000|Overall Study|"The other reasons included loss of IV"|8|||
144342848|NCT00465647|520457384|FG001|Overall Study|"The other reasons included loss of IV"|4|||
144342849|NCT00465647|520457385|FG002|Overall Study|"The other reasons included loss of IV"|3|||
144342850|NCT00465647|520457386|FG003|Overall Study|"The other reasons included loss of IV"|2|||
144342851|NCT03916081|520457387|FG000|Overall Study|Adverse Event|1|||
144342852|NCT03916081|520457388|FG001|Overall Study|Adverse Event|0|||
144342853|NCT03916081|520457389|FG002|Overall Study|Adverse Event|0|||
144342854|NCT03916081|520457387|FG000|Overall Study|Physician Decision|0|||
144342855|NCT03916081|520457388|FG001|Overall Study|Physician Decision|0|||
144342856|NCT03916081|520457389|FG002|Overall Study|Physician Decision|1|||
144342857|NCT03916081|520457387|FG000|Overall Study|Lost to Follow-up|0|||
144342858|NCT03916081|520457388|FG001|Overall Study|Lost to Follow-up|1|||
144342859|NCT03916081|520457389|FG002|Overall Study|Lost to Follow-up|0|||
144342860|NCT03916081|520457387|FG000|Overall Study|Withdrawal by Subject|3|||
144342861|NCT03916081|520457388|FG001|Overall Study|Withdrawal by Subject|0|||
144342862|NCT03916081|520457389|FG002|Overall Study|Withdrawal by Subject|1|||
144342863|NCT03916081|520457387|FG000|Overall Study|Worsening of AD|0|||
144342864|NCT03916081|520457388|FG001|Overall Study|Worsening of AD|0|||
144342865|NCT03916081|520457389|FG002|Overall Study|Worsening of AD|1|||
144342866|NCT01240135|520457390|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
144342867|NCT01240135|520457391|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
144342868|NCT01240135|520457390|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
144342869|NCT01240135|520457391|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
144342870|NCT00699335|520457395|FG000|Overall Study|Combination of multiple reasons|176|||
144342871|NCT00699335|520457395|FG000|Overall Study|Missing data|52|||
144342872|NCT00416455|520457399|FG000|Overall Study|PET / CT not done|3|||
144342873|NCT00416455|520457400|FG001|Overall Study|PET / CT not done|5|||
144342874|NCT00416455|520457399|FG000|Overall Study|PET / CT poor quality|2|||
144342875|NCT00416455|520457400|FG001|Overall Study|PET / CT poor quality|1|||
144342876|NCT00416455|520457399|FG000|Overall Study|Inadequate pathology|11|||
144342877|NCT00416455|520457400|FG001|Overall Study|Inadequate pathology|2|||
144342878|NCT02456857|520457401|FG000|Overall Study|Disease Progression|4|||
144342879|NCT00781859|520457402|FG000|Overall Study|Adverse Event|2|||
144342880|NCT00781859|520457403|FG001|Overall Study|Adverse Event|2|||
144342881|NCT00781859|520457402|FG000|Overall Study|Withdrawal by Subject|8|||
144342882|NCT00781859|520457403|FG001|Overall Study|Withdrawal by Subject|4|||
144342883|NCT00781859|520457402|FG000|Overall Study|Lost to Follow-up|6|||
144342884|NCT00781859|520457403|FG001|Overall Study|Lost to Follow-up|3|||
144342885|NCT00781859|520457402|FG000|Overall Study|Death|3|||
144342886|NCT00781859|520457403|FG001|Overall Study|Death|0|||
144342887|NCT01983774|520457407|FG000|Overall Study|Lung Transplant|0|||
144342888|NCT01983774|520457408|FG001|Overall Study|Lung Transplant|1|||
144342889|NCT01983774|520457407|FG000|Overall Study|Lost to Follow-up|1|||
144342890|NCT01983774|520457408|FG001|Overall Study|Lost to Follow-up|0|||
144342891|NCT01339897|520457409|FG000|Overall Study|Adverse Event|1|||
144342892|NCT01339897|520457410|FG001|Overall Study|Adverse Event|0|||
144342893|NCT01339897|520457411|FG002|Overall Study|Adverse Event|0|||
144342894|NCT01339897|520457412|FG003|Overall Study|Adverse Event|1|||
144342895|NCT02980133|520457414|FG000|Overall Study|Other than specified|1|||
144342896|NCT02980133|520457415|FG001|Overall Study|Other than specified|1|||
144342897|NCT02980133|520457416|FG002|Overall Study|Other than specified|2|||
144342898|NCT02980133|520457417|FG003|Overall Study|Other than specified|2|||
144342899|NCT02980133|520457414|FG000|Overall Study|Lost to Follow-up|0|||
144342900|NCT02980133|520457415|FG001|Overall Study|Lost to Follow-up|0|||
144342901|NCT02980133|520457416|FG002|Overall Study|Lost to Follow-up|1|||
144342902|NCT02980133|520457417|FG003|Overall Study|Lost to Follow-up|3|||
144342903|NCT02980133|520457414|FG000|Overall Study|Protocol Violation|0|||
144342904|NCT02980133|520457415|FG001|Overall Study|Protocol Violation|1|||
144342905|NCT02980133|520457416|FG002|Overall Study|Protocol Violation|0|||
144342906|NCT02980133|520457417|FG003|Overall Study|Protocol Violation|0|||
144342907|NCT02980133|520457414|FG000|Overall Study|Withdrawal by parent/guardian|6|||
144342908|NCT02980133|520457415|FG001|Overall Study|Withdrawal by parent/guardian|3|||
144342909|NCT02980133|520457416|FG002|Overall Study|Withdrawal by parent/guardian|3|||
144342910|NCT02980133|520457417|FG003|Overall Study|Withdrawal by parent/guardian|1|||
144342911|NCT02980133|520457414|FG000|Overall Study|Withdrawal by Subject|0|||
144342912|NCT02980133|520457415|FG001|Overall Study|Withdrawal by Subject|0|||
144342913|NCT02980133|520457416|FG002|Overall Study|Withdrawal by Subject|1|||
144342914|NCT02980133|520457417|FG003|Overall Study|Withdrawal by Subject|0|||
144342915|NCT00825812|520457419|FG000|Overall Study|Never entered follow up|0|||
144342916|NCT00825812|520457420|FG001|Overall Study|Never entered follow up|0|||
144342917|NCT00825812|520457421|FG002|Overall Study|Never entered follow up|0|||
144342918|NCT00825812|520457422|FG003|Overall Study|Never entered follow up|1|||
144342919|NCT00825812|520457419|FG000|Overall Study|Adverse Event|0|||
144342920|NCT00825812|520457420|FG001|Overall Study|Adverse Event|0|||
144342921|NCT00825812|520457421|FG002|Overall Study|Adverse Event|0|||
144342922|NCT00825812|520457422|FG003|Overall Study|Adverse Event|1|||
144342923|NCT00825812|520457419|FG000|Overall Study|Subject withdrew consent|0|||
144342924|NCT00825812|520457420|FG001|Overall Study|Subject withdrew consent|0|||
144342925|NCT00825812|520457421|FG002|Overall Study|Subject withdrew consent|3|||
144342926|NCT00825812|520457422|FG003|Overall Study|Subject withdrew consent|2|||
144342927|NCT00825812|520457419|FG000|Overall Study|Non-compliance with protocol|0|||
144342928|NCT00825812|520457420|FG001|Overall Study|Non-compliance with protocol|0|||
144342929|NCT00825812|520457421|FG002|Overall Study|Non-compliance with protocol|0|||
144342930|NCT00825812|520457422|FG003|Overall Study|Non-compliance with protocol|1|||
144342931|NCT00825812|520457419|FG000|Overall Study|Administrative|0|||
144342932|NCT00825812|520457420|FG001|Overall Study|Administrative|1|||
144342933|NCT00825812|520457421|FG002|Overall Study|Administrative|3|||
144342934|NCT00825812|520457422|FG003|Overall Study|Administrative|5|||
144342935|NCT00991406|520457423|FG000|Overall Study|One participant did not respond to FES.|1|||
144342936|NCT03824587|520457424|FG000|Run-in Period|Screen Failure|0|||
144342937|NCT03824587|520457425|FG001|Run-in Period|Screen Failure|275|||
144342938|NCT03824587|520457424|FG000|Treatment Period|Adverse Event|4|||
144342939|NCT03824587|520457425|FG001|Treatment Period|Adverse Event|1|||
144342940|NCT03824587|520457424|FG000|Treatment Period|Withdrawal by Subject|0|||
144342941|NCT03824587|520457425|FG001|Treatment Period|Withdrawal by Subject|1|||
144342942|NCT03824587|520457424|FG000|Treatment Period|Kidney Transplant|1|||
144342943|NCT03824587|520457425|FG001|Treatment Period|Kidney Transplant|1|||
144342944|NCT01300572|520457426|FG000|Overall Study|HAMA + post dosimetry|1|||
144342945|NCT00986362|520457427|FG000|Overall Study|Death|2|||
144342946|NCT00986362|520457428|FG001|Overall Study|Death|0|||
144342947|NCT00986362|520457427|FG000|Overall Study|Lost to Follow-up|0|||
144342948|NCT00986362|520457428|FG001|Overall Study|Lost to Follow-up|1|||
144342949|NCT02160145|520457429|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
144342950|NCT02160145|520457430|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
144342951|NCT02160145|520457431|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
144342952|NCT02160145|520457429|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
144342953|NCT02160145|520457430|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
144342954|NCT02160145|520457431|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
144342955|NCT02160145|520457429|FG000|Randomized Double-blind Period|Subject decision|0|||
144342956|NCT02160145|520457430|FG001|Randomized Double-blind Period|Subject decision|21|||
144342957|NCT02160145|520457431|FG002|Randomized Double-blind Period|Subject decision|20|||
144342958|NCT02160145|520457429|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
144342959|NCT02160145|520457430|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
144342960|NCT02160145|520457431|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
144342961|NCT02160145|520457429|FG000|Randomized Double-blind Period|Physician Decision|0|||
144342962|NCT02160145|520457430|FG001|Randomized Double-blind Period|Physician Decision|7|||
144342963|NCT02160145|520457431|FG002|Randomized Double-blind Period|Physician Decision|5|||
144342964|NCT03597061|520457432|FG000|Overall Study|Lost to Follow-up|1|||
144342965|NCT03597061|520457433|FG001|Overall Study|Lost to Follow-up|0|||
144342966|NCT03597061|520457432|FG000|Overall Study|Protocol Violation|0|||
144342967|NCT03597061|520457433|FG001|Overall Study|Protocol Violation|1|||
144342968|NCT02006979|520457434|FG000|Overall Study|Withdrawal by Subject|1|||
144342969|NCT02006979|520457435|FG001|Overall Study|Withdrawal by Subject|1|||
144342970|NCT02006979|520457434|FG000|Overall Study|Protocol Violation|0|||
144342971|NCT02006979|520457435|FG001|Overall Study|Protocol Violation|1|||
144342972|NCT00375518|520457436|FG000|Overall Study|Withdrawal by Subject|2|||
144342973|NCT00375518|520457437|FG001|Overall Study|Withdrawal by Subject|10|||
144342974|NCT00375518|520457436|FG000|Overall Study|Patient Not Treated|6|||
144342975|NCT00375518|520457437|FG001|Overall Study|Patient Not Treated|6|||
144342976|NCT00375518|520457436|FG000|Overall Study|Death|0|||
144342977|NCT00375518|520457437|FG001|Overall Study|Death|1|||
144342978|NCT02596945|520457438|FG000|Overall Study|No documentation of study drug dosing|3|||
144342979|NCT02596945|520457438|FG000|Overall Study|Other|32|||
144342980|NCT02596945|520457438|FG000|Overall Study|Change to hemodialysis|15|||
144342981|NCT02596945|520457438|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
144342982|NCT02596945|520457438|FG000|Overall Study|Withdrawal by Subject|1|||
144342983|NCT02596945|520457438|FG000|Overall Study|Missing|1|||
144342984|NCT01007838|520457439|FG000|Overall Study|Withdrawal by Subject|1|||
144342985|NCT01007838|520457440|FG001|Overall Study|Withdrawal by Subject|0|||
144342986|NCT01007838|520457441|FG002|Overall Study|Withdrawal by Subject|0|||
144342987|NCT01007838|520457442|FG003|Overall Study|Withdrawal by Subject|0|||
144342988|NCT01007838|520457439|FG000|Overall Study|Physician Decision|1|||
144342989|NCT01007838|520457440|FG001|Overall Study|Physician Decision|0|||
144342990|NCT01007838|520457441|FG002|Overall Study|Physician Decision|0|||
144342991|NCT01007838|520457442|FG003|Overall Study|Physician Decision|0|||
144342992|NCT01007838|520457439|FG000|Overall Study|Started home haemodialysis|1|||
144342993|NCT01007838|520457440|FG001|Overall Study|Started home haemodialysis|0|||
144342994|NCT01007838|520457441|FG002|Overall Study|Started home haemodialysis|0|||
144342995|NCT01007838|520457442|FG003|Overall Study|Started home haemodialysis|0|||
144342996|NCT04699461|520457446|FG000|Overall Study|Withdrawal by Subject|1|||
144342997|NCT04699461|520457447|FG001|Overall Study|Withdrawal by Subject|0|||
144342998|NCT04699461|520457446|FG000|Overall Study|Study termination by sponsor|2|||
144342999|NCT04699461|520457447|FG001|Overall Study|Study termination by sponsor|1|||
144343000|NCT04699461|520457446|FG000|Overall Study|Death|1|||
144343001|NCT04699461|520457447|FG001|Overall Study|Death|0|||
144343002|NCT04699461|520457446|FG000|Overall Study|Radiographic progression|0|||
144343003|NCT04699461|520457447|FG001|Overall Study|Radiographic progression|1|||
144343004|NCT00931606|520460193|FG000|Overall Study|Death|1|||
144343005|NCT00931606|520460194|FG001|Overall Study|Death|3|||
144343006|NCT00931606|520460195|FG002|Overall Study|Death|2|||
144343007|NCT00931606|520460196|FG003|Overall Study|Death|0|||
144343008|NCT00931606|520460193|FG000|Overall Study|Lost to Follow-up|0|||
144343009|NCT00931606|520460194|FG001|Overall Study|Lost to Follow-up|1|||
144343010|NCT00931606|520460195|FG002|Overall Study|Lost to Follow-up|0|||
144343011|NCT00931606|520460196|FG003|Overall Study|Lost to Follow-up|0|||
144343012|NCT00931606|520460193|FG000|Overall Study|Physician Decision|0|||
144343013|NCT00931606|520460194|FG001|Overall Study|Physician Decision|0|||
144343014|NCT00931606|520460195|FG002|Overall Study|Physician Decision|3|||
144343015|NCT00931606|520460196|FG003|Overall Study|Physician Decision|0|||
144343016|NCT00931606|520460193|FG000|Overall Study|Sponsor Decision|1|||
144343017|NCT00931606|520460194|FG001|Overall Study|Sponsor Decision|4|||
144343018|NCT00931606|520460195|FG002|Overall Study|Sponsor Decision|0|||
144343019|NCT00931606|520460196|FG003|Overall Study|Sponsor Decision|2|||
144343020|NCT00931606|520460193|FG000|Overall Study|Withdrawal by Subject|3|||
144343021|NCT00931606|520460194|FG001|Overall Study|Withdrawal by Subject|1|||
144343022|NCT00931606|520460195|FG002|Overall Study|Withdrawal by Subject|1|||
144343023|NCT00931606|520460196|FG003|Overall Study|Withdrawal by Subject|1|||
144343024|NCT00871338|520460197|FG000|Prior to Booster|Withdrawal by Subject|1|||
144343025|NCT00871338|520460198|FG001|Prior to Booster|Withdrawal by Subject|3|||
144343026|NCT00871338|520460197|FG000|Prior to Booster|Lost to Follow-up|1|||
144343027|NCT00871338|520460198|FG001|Prior to Booster|Lost to Follow-up|0|||
144343028|NCT02391363|520460199|FG000|Overall Study|Lost to Follow-up|5|||
144343029|NCT02391363|520460200|FG001|Overall Study|Lost to Follow-up|5|||
144343030|NCT02391363|520460199|FG000|Overall Study|Withdrawal by Subject|6|||
144343031|NCT02391363|520460200|FG001|Overall Study|Withdrawal by Subject|3|||
144343032|NCT01702025|520460203|FG000|Overall Study|Equipment failure|1|||
144343033|NCT01702025|520460204|FG001|Overall Study|Equipment failure|0|||
144343034|NCT01702025|520460205|FG002|Overall Study|Equipment failure|0|||
144343035|NCT01702025|520460206|FG003|Overall Study|Equipment failure|0|||
144343036|NCT01702025|520460203|FG000|Overall Study|Adverse Event|1|||
144343037|NCT01702025|520460204|FG001|Overall Study|Adverse Event|1|||
144343038|NCT01702025|520460205|FG002|Overall Study|Adverse Event|1|||
144343039|NCT01702025|520460206|FG003|Overall Study|Adverse Event|0|||
144343040|NCT00265317|520460209|FG000|Lead-In|Objective progression or relapse|6|||
144343041|NCT00265317|520460210|FG001|Lead-In|Objective progression or relapse|11|||
144343042|NCT00265317|520460211|FG002|Lead-In|Objective progression or relapse|0|||
144343043|NCT00265317|520460212|FG003|Lead-In|Objective progression or relapse|0|||
144343044|NCT00265317|520460209|FG000|Lead-In|Adverse Event|2|||
144343045|NCT00265317|520460210|FG001|Lead-In|Adverse Event|1|||
144343046|NCT00265317|520460211|FG002|Lead-In|Adverse Event|0|||
144343047|NCT00265317|520460212|FG003|Lead-In|Adverse Event|0|||
144343048|NCT00265317|520460209|FG000|Lead-In|Death|3|||
144343049|NCT00265317|520460210|FG001|Lead-In|Death|5|||
144343050|NCT00265317|520460211|FG002|Lead-In|Death|0|||
144343051|NCT00265317|520460212|FG003|Lead-In|Death|0|||
144343052|NCT00265317|520460209|FG000|Lead-In|Withdrawal/other than adverse event|1|||
144343053|NCT00265317|520460210|FG001|Lead-In|Withdrawal/other than adverse event|0|||
144343054|NCT00265317|520460211|FG002|Lead-In|Withdrawal/other than adverse event|0|||
144343055|NCT00265317|520460212|FG003|Lead-In|Withdrawal/other than adverse event|0|||
144343056|NCT00265317|520460209|FG000|Phase 2|Objective progression or relapse|0|||
144343057|NCT00265317|520460210|FG001|Phase 2|Objective progression or relapse|0|||
144343058|NCT00265317|520460211|FG002|Phase 2|Objective progression or relapse|37|||
144343059|NCT00265317|520460212|FG003|Phase 2|Objective progression or relapse|38|||
144343060|NCT00265317|520460209|FG000|Phase 2|Global deterioration of health status|0|||
144343061|NCT00265317|520460210|FG001|Phase 2|Global deterioration of health status|0|||
144343062|NCT00265317|520460211|FG002|Phase 2|Global deterioration of health status|3|||
144343063|NCT00265317|520460212|FG003|Phase 2|Global deterioration of health status|0|||
144343064|NCT00265317|520460209|FG000|Phase 2|Adverse Event|0|||
144343065|NCT00265317|520460210|FG001|Phase 2|Adverse Event|0|||
144343066|NCT00265317|520460211|FG002|Phase 2|Adverse Event|7|||
144343067|NCT00265317|520460212|FG003|Phase 2|Adverse Event|5|||
144343068|NCT00265317|520460209|FG000|Phase 2|Death|0|||
144343069|NCT00265317|520460210|FG001|Phase 2|Death|0|||
144343070|NCT00265317|520460211|FG002|Phase 2|Death|12|||
144343071|NCT00265317|520460212|FG003|Phase 2|Death|15|||
144343072|NCT00265317|520460209|FG000|Phase 2|Protocol Violation|0|||
144343073|NCT00265317|520460210|FG001|Phase 2|Protocol Violation|0|||
144343074|NCT00265317|520460211|FG002|Phase 2|Protocol Violation|1|||
144343075|NCT00265317|520460212|FG003|Phase 2|Protocol Violation|4|||
144343076|NCT00265317|520460209|FG000|Phase 2|Lost to Follow-up|0|||
144343077|NCT00265317|520460210|FG001|Phase 2|Lost to Follow-up|0|||
144343078|NCT00265317|520460211|FG002|Phase 2|Lost to Follow-up|0|||
144343079|NCT00265317|520460212|FG003|Phase 2|Lost to Follow-up|1|||
144343080|NCT00265317|520460209|FG000|Phase 2|Withdrawal/other than adverse event|0|||
144343081|NCT00265317|520460210|FG001|Phase 2|Withdrawal/other than adverse event|0|||
144343082|NCT00265317|520460211|FG002|Phase 2|Withdrawal/other than adverse event|2|||
144343083|NCT00265317|520460212|FG003|Phase 2|Withdrawal/other than adverse event|1|||
144343084|NCT00265317|520460209|FG000|Phase 2|Study terminated by sponsor|0|||
144343085|NCT00265317|520460210|FG001|Phase 2|Study terminated by sponsor|0|||
144343086|NCT00265317|520460211|FG002|Phase 2|Study terminated by sponsor|1|||
144343087|NCT00265317|520460212|FG003|Phase 2|Study terminated by sponsor|0|||
144343088|NCT00265317|520460209|FG000|Phase 2|Other|0|||
144343089|NCT00265317|520460210|FG001|Phase 2|Other|0|||
144343090|NCT00265317|520460211|FG002|Phase 2|Other|1|||
144343091|NCT00265317|520460212|FG003|Phase 2|Other|1|||
144343092|NCT00801229|520460213|FG000|Signed Consent|Withdrawal by Subject|2|||
144343093|NCT00801229|520460214|FG001|Signed Consent|Withdrawal by Subject|2|||
144343094|NCT00801229|520460213|FG000|Signed Consent|Found Ineligible|1|||
144343095|NCT00801229|520460214|FG001|Signed Consent|Found Ineligible|1|||
144343096|NCT00801229|520460213|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
144343097|NCT00801229|520460214|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
144343098|NCT00801229|520460213|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
144343099|NCT00801229|520460214|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
144343100|NCT00801229|520460213|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
144343101|NCT00801229|520460214|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
144343102|NCT00801229|520460213|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
144343103|NCT00801229|520460214|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
144343104|NCT00801229|520460213|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
144343105|NCT00801229|520460214|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
144343106|NCT00801229|520460213|FG000|Received Study Drug/Placebo|Adverse Event|1|||
144343107|NCT00801229|520460214|FG001|Received Study Drug/Placebo|Adverse Event|1|||
144343108|NCT00732875|520460215|FG000|Overall Study|Adverse Event|16|||
144343109|NCT00732875|520460215|FG000|Overall Study|Withdrawal by Subject|6|||
144343110|NCT00732875|520460215|FG000|Overall Study|Lack of Efficacy|13|||
144343111|NCT03826186|520460218|FG000|Overall Study|Protocol Violation|2|||
144343112|NCT03826186|520460219|FG001|Overall Study|Protocol Violation|0|||
144343113|NCT03826186|520460218|FG000|Overall Study|Withdrawal by Subject|1|||
144343114|NCT03826186|520460219|FG001|Overall Study|Withdrawal by Subject|0|||
144343115|NCT02300259|520460220|FG000|Period 1|Adverse Event|0|||
144343116|NCT02300259|520460221|FG001|Period 1|Adverse Event|0|||
144343117|NCT02300259|520460222|FG002|Period 1|Adverse Event|1|||
144343118|NCT02300259|520460220|FG000|Period 1|Withdrawal by Subject|0|||
144343119|NCT02300259|520460221|FG001|Period 1|Withdrawal by Subject|0|||
144343120|NCT02300259|520460222|FG002|Period 1|Withdrawal by Subject|1|||
144343121|NCT02300259|520460220|FG000|Period 2|Adverse Event|1|||
144343122|NCT02300259|520460221|FG001|Period 2|Adverse Event|0|||
144343123|NCT02300259|520460222|FG002|Period 2|Adverse Event|0|||
144343124|NCT02300259|520460220|FG000|Period 2|Withdrawal by Subject|0|||
144343125|NCT02300259|520460221|FG001|Period 2|Withdrawal by Subject|0|||
144343126|NCT02300259|520460222|FG002|Period 2|Withdrawal by Subject|1|||
144343127|NCT02737475|520460223|FG000|Overall Study|Other reasons|0|||
144343128|NCT02737475|520460224|FG001|Overall Study|Other reasons|0|||
144343129|NCT02737475|520460225|FG002|Overall Study|Other reasons|0|||
144343130|NCT02737475|520460226|FG003|Overall Study|Other reasons|0|||
144343131|NCT02737475|520460227|FG004|Overall Study|Other reasons|1|||
144343132|NCT02737475|520460228|FG005|Overall Study|Other reasons|1|||
144343133|NCT02737475|520460229|FG006|Overall Study|Other reasons|0|||
144343134|NCT02737475|520460230|FG007|Overall Study|Other reasons|0|||
144343135|NCT02737475|520460231|FG008|Overall Study|Other reasons|1|||
144343136|NCT02737475|520460232|FG009|Overall Study|Other reasons|0|||
144343137|NCT02737475|520460233|FG010|Overall Study|Other reasons|1|||
144343138|NCT02737475|520460234|FG011|Overall Study|Other reasons|0|||
144343139|NCT02737475|520460235|FG012|Overall Study|Other reasons|0|||
144343140|NCT02737475|520460236|FG013|Overall Study|Other reasons|0|||
144343141|NCT02737475|520460237|FG014|Overall Study|Other reasons|0|||
144343142|NCT02737475|520460238|FG015|Overall Study|Other reasons|0|||
144343143|NCT02737475|520460239|FG016|Overall Study|Other reasons|0|||
144343144|NCT02737475|520460240|FG017|Overall Study|Other reasons|0|||
144343145|NCT02737475|520460241|FG018|Overall Study|Other reasons|0|||
144343146|NCT02737475|520460242|FG019|Overall Study|Other reasons|0|||
144343147|NCT02737475|520460243|FG020|Overall Study|Other reasons|0|||
144343148|NCT02737475|520460244|FG021|Overall Study|Other reasons|1|||
144343149|NCT02737475|520460245|FG022|Overall Study|Other reasons|0|||
144343150|NCT02737475|520460246|FG023|Overall Study|Other reasons|1|||
144343151|NCT02737475|520460247|FG024|Overall Study|Other reasons|1|||
144343152|NCT02737475|520460248|FG025|Overall Study|Other reasons|1|||
144343153|NCT02737475|520460249|FG026|Overall Study|Other reasons|0|||
144343154|NCT02737475|520460223|FG000|Overall Study|Death|1|||
144343155|NCT02737475|520460224|FG001|Overall Study|Death|0|||
144343156|NCT02737475|520460225|FG002|Overall Study|Death|0|||
144343157|NCT02737475|520460226|FG003|Overall Study|Death|1|||
144343158|NCT02737475|520460227|FG004|Overall Study|Death|0|||
144343159|NCT02737475|520460228|FG005|Overall Study|Death|0|||
144343160|NCT02737475|520460229|FG006|Overall Study|Death|0|||
144343161|NCT02737475|520460230|FG007|Overall Study|Death|2|||
144343162|NCT02737475|520460231|FG008|Overall Study|Death|0|||
144343163|NCT02737475|520460232|FG009|Overall Study|Death|0|||
144343164|NCT02737475|520460233|FG010|Overall Study|Death|0|||
144343165|NCT02737475|520460234|FG011|Overall Study|Death|4|||
144343166|NCT02737475|520460235|FG012|Overall Study|Death|2|||
144343167|NCT02737475|520460236|FG013|Overall Study|Death|2|||
144343168|NCT02737475|520460237|FG014|Overall Study|Death|0|||
144343169|NCT02737475|520460238|FG015|Overall Study|Death|2|||
144343170|NCT02737475|520460239|FG016|Overall Study|Death|2|||
144343171|NCT02737475|520460240|FG017|Overall Study|Death|2|||
144343172|NCT02737475|520460241|FG018|Overall Study|Death|1|||
144343173|NCT02737475|520460242|FG019|Overall Study|Death|0|||
144343174|NCT02737475|520460243|FG020|Overall Study|Death|0|||
144343175|NCT02737475|520460244|FG021|Overall Study|Death|0|||
144343176|NCT02737475|520460245|FG022|Overall Study|Death|0|||
144343177|NCT02737475|520460246|FG023|Overall Study|Death|0|||
144343178|NCT02737475|520460247|FG024|Overall Study|Death|0|||
144343179|NCT02737475|520460248|FG025|Overall Study|Death|0|||
144343180|NCT02737475|520460249|FG026|Overall Study|Death|0|||
144343181|NCT02737475|520460223|FG000|Overall Study|Participant withdrew consent|0|||
144343182|NCT02737475|520460224|FG001|Overall Study|Participant withdrew consent|0|||
144343183|NCT02737475|520460225|FG002|Overall Study|Participant withdrew consent|0|||
144343184|NCT02737475|520460226|FG003|Overall Study|Participant withdrew consent|0|||
144343185|NCT02737475|520460227|FG004|Overall Study|Participant withdrew consent|0|||
144343186|NCT02737475|520460228|FG005|Overall Study|Participant withdrew consent|2|||
144343187|NCT02737475|520460229|FG006|Overall Study|Participant withdrew consent|0|||
144343188|NCT02737475|520460230|FG007|Overall Study|Participant withdrew consent|0|||
144343189|NCT02737475|520460231|FG008|Overall Study|Participant withdrew consent|0|||
144343190|NCT02737475|520460232|FG009|Overall Study|Participant withdrew consent|0|||
144343191|NCT02737475|520460233|FG010|Overall Study|Participant withdrew consent|0|||
144343192|NCT02737475|520460234|FG011|Overall Study|Participant withdrew consent|0|||
144343193|NCT02737475|520460235|FG012|Overall Study|Participant withdrew consent|0|||
144343194|NCT02737475|520460236|FG013|Overall Study|Participant withdrew consent|0|||
144343195|NCT02737475|520460237|FG014|Overall Study|Participant withdrew consent|1|||
144343196|NCT02737475|520460238|FG015|Overall Study|Participant withdrew consent|0|||
144343197|NCT02737475|520460239|FG016|Overall Study|Participant withdrew consent|0|||
144343198|NCT02737475|520460240|FG017|Overall Study|Participant withdrew consent|2|||
144343199|NCT02737475|520460241|FG018|Overall Study|Participant withdrew consent|1|||
144343200|NCT02737475|520460242|FG019|Overall Study|Participant withdrew consent|0|||
144343201|NCT02737475|520460243|FG020|Overall Study|Participant withdrew consent|2|||
144343202|NCT02737475|520460244|FG021|Overall Study|Participant withdrew consent|0|||
144343203|NCT02737475|520460245|FG022|Overall Study|Participant withdrew consent|0|||
144343204|NCT02737475|520460246|FG023|Overall Study|Participant withdrew consent|0|||
144343205|NCT02737475|520460247|FG024|Overall Study|Participant withdrew consent|0|||
144343206|NCT02737475|520460248|FG025|Overall Study|Participant withdrew consent|0|||
144343207|NCT02737475|520460249|FG026|Overall Study|Participant withdrew consent|0|||
144343208|NCT02737475|520460223|FG000|Overall Study|Lost to Follow-up|0|||
144343209|NCT02737475|520460224|FG001|Overall Study|Lost to Follow-up|0|||
144343210|NCT02737475|520460225|FG002|Overall Study|Lost to Follow-up|0|||
144343211|NCT02737475|520460226|FG003|Overall Study|Lost to Follow-up|0|||
144343212|NCT02737475|520460227|FG004|Overall Study|Lost to Follow-up|0|||
144343213|NCT02737475|520460228|FG005|Overall Study|Lost to Follow-up|0|||
144343214|NCT02737475|520460229|FG006|Overall Study|Lost to Follow-up|0|||
144343215|NCT02737475|520460230|FG007|Overall Study|Lost to Follow-up|0|||
144343216|NCT02737475|520460231|FG008|Overall Study|Lost to Follow-up|0|||
144343217|NCT02737475|520460232|FG009|Overall Study|Lost to Follow-up|0|||
144343218|NCT02737475|520460233|FG010|Overall Study|Lost to Follow-up|0|||
144343219|NCT02737475|520460234|FG011|Overall Study|Lost to Follow-up|0|||
144343220|NCT02737475|520460235|FG012|Overall Study|Lost to Follow-up|0|||
144343221|NCT02737475|520460236|FG013|Overall Study|Lost to Follow-up|0|||
144343222|NCT02737475|520460237|FG014|Overall Study|Lost to Follow-up|0|||
144343223|NCT02737475|520460238|FG015|Overall Study|Lost to Follow-up|1|||
144343224|NCT02737475|520460239|FG016|Overall Study|Lost to Follow-up|0|||
144343225|NCT02737475|520460240|FG017|Overall Study|Lost to Follow-up|0|||
144343226|NCT02737475|520460241|FG018|Overall Study|Lost to Follow-up|0|||
144343227|NCT02737475|520460242|FG019|Overall Study|Lost to Follow-up|0|||
144343228|NCT02737475|520460243|FG020|Overall Study|Lost to Follow-up|0|||
144343229|NCT02737475|520460244|FG021|Overall Study|Lost to Follow-up|0|||
144343230|NCT02737475|520460245|FG022|Overall Study|Lost to Follow-up|0|||
144343231|NCT02737475|520460246|FG023|Overall Study|Lost to Follow-up|0|||
144343232|NCT02737475|520460247|FG024|Overall Study|Lost to Follow-up|0|||
144343233|NCT02737475|520460248|FG025|Overall Study|Lost to Follow-up|0|||
144343234|NCT02737475|520460249|FG026|Overall Study|Lost to Follow-up|0|||
144343235|NCT02737475|520460223|FG000|Overall Study|Disease Progression|0|||
144343236|NCT02737475|520460224|FG001|Overall Study|Disease Progression|0|||
144343237|NCT02737475|520460225|FG002|Overall Study|Disease Progression|0|||
144343238|NCT02737475|520460226|FG003|Overall Study|Disease Progression|0|||
144343239|NCT02737475|520460227|FG004|Overall Study|Disease Progression|0|||
144343240|NCT02737475|520460228|FG005|Overall Study|Disease Progression|0|||
144343241|NCT02737475|520460229|FG006|Overall Study|Disease Progression|0|||
144343242|NCT02737475|520460230|FG007|Overall Study|Disease Progression|0|||
144343243|NCT02737475|520460231|FG008|Overall Study|Disease Progression|0|||
144343244|NCT02737475|520460232|FG009|Overall Study|Disease Progression|0|||
144343245|NCT02737475|520460233|FG010|Overall Study|Disease Progression|0|||
144343246|NCT02737475|520460234|FG011|Overall Study|Disease Progression|0|||
144343247|NCT02737475|520460235|FG012|Overall Study|Disease Progression|0|||
144343248|NCT02737475|520460236|FG013|Overall Study|Disease Progression|0|||
144343249|NCT02737475|520460237|FG014|Overall Study|Disease Progression|0|||
144343250|NCT02737475|520460238|FG015|Overall Study|Disease Progression|0|||
144343251|NCT02737475|520460239|FG016|Overall Study|Disease Progression|0|||
144343252|NCT02737475|520460240|FG017|Overall Study|Disease Progression|0|||
144343253|NCT02737475|520460241|FG018|Overall Study|Disease Progression|0|||
144343254|NCT02737475|520460242|FG019|Overall Study|Disease Progression|0|||
144343255|NCT02737475|520460243|FG020|Overall Study|Disease Progression|0|||
144343256|NCT02737475|520460244|FG021|Overall Study|Disease Progression|0|||
144343257|NCT02737475|520460245|FG022|Overall Study|Disease Progression|0|||
144343258|NCT02737475|520460246|FG023|Overall Study|Disease Progression|0|||
144343259|NCT02737475|520460247|FG024|Overall Study|Disease Progression|0|||
144343260|NCT02737475|520460248|FG025|Overall Study|Disease Progression|0|||
144343261|NCT02737475|520460249|FG026|Overall Study|Disease Progression|1|||
144343262|NCT00291018|520460256|FG000|Overall Study|Not Consented or Declined PAS|12|||
144343263|NCT00291018|520460257|FG001|Overall Study|Not Consented or Declined PAS|15|||
144343264|NCT00291018|520460258|FG002|Overall Study|Not Consented or Declined PAS|15|||
144343265|NCT00291018|520460256|FG000|Overall Study|Death|3|||
144343266|NCT00291018|520460257|FG001|Overall Study|Death|3|||
144343267|NCT00291018|520460258|FG002|Overall Study|Death|4|||
144343268|NCT00291018|520460256|FG000|Overall Study|Withdrawal by Subject|2|||
144343269|NCT00291018|520460257|FG001|Overall Study|Withdrawal by Subject|8|||
144343270|NCT00291018|520460258|FG002|Overall Study|Withdrawal by Subject|1|||
144343271|NCT00291018|520460256|FG000|Overall Study|Failures|5|||
144343272|NCT00291018|520460257|FG001|Overall Study|Failures|12|||
144343273|NCT00291018|520460258|FG002|Overall Study|Failures|5|||
144343274|NCT00291018|520460256|FG000|Overall Study|Lost to Follow-up|3|||
144343275|NCT00291018|520460257|FG001|Overall Study|Lost to Follow-up|4|||
144343276|NCT00291018|520460258|FG002|Overall Study|Lost to Follow-up|18|||
144343277|NCT05362058|520460260|FG000|Treatment Period|Adverse Event|3|||
144343278|NCT05362058|520460261|FG001|Treatment Period|Adverse Event|3|||
144343279|NCT05362058|520460260|FG000|Treatment Period|Assigned treatment by mistake|3|||
144343280|NCT05362058|520460261|FG001|Treatment Period|Assigned treatment by mistake|4|||
144343281|NCT05362058|520460260|FG000|Treatment Period|Death|1|||
144343282|NCT05362058|520460261|FG001|Treatment Period|Death|1|||
144343283|NCT05362058|520460260|FG000|Treatment Period|Lost to Follow-up|6|||
144343284|NCT05362058|520460261|FG001|Treatment Period|Lost to Follow-up|3|||
144343285|NCT05362058|520460260|FG000|Treatment Period|Non-compliance with study drug|0|||
144343286|NCT05362058|520460261|FG001|Treatment Period|Non-compliance with study drug|1|||
144343287|NCT05362058|520460260|FG000|Treatment Period|Physician Decision|1|||
144343288|NCT05362058|520460261|FG001|Treatment Period|Physician Decision|0|||
144343289|NCT05362058|520460260|FG000|Treatment Period|Protocol deviation|1|||
144343290|NCT05362058|520460261|FG001|Treatment Period|Protocol deviation|0|||
144343291|NCT05362058|520460260|FG000|Treatment Period|Withdrawal by Subject|10|||
144343292|NCT05362058|520460261|FG001|Treatment Period|Withdrawal by Subject|11|||
144343293|NCT05362058|520460260|FG000|Follow-Up Period|Death|1|||
144343294|NCT05362058|520460261|FG001|Follow-Up Period|Death|0|||
144343295|NCT05362058|520460260|FG000|Follow-Up Period|Lost to Follow-up|2|||
144343296|NCT05362058|520460261|FG001|Follow-Up Period|Lost to Follow-up|1|||
144343297|NCT05362058|520460260|FG000|Follow-Up Period|Protocol deviation|1|||
144343298|NCT05362058|520460261|FG001|Follow-Up Period|Protocol deviation|1|||
144343299|NCT05362058|520460260|FG000|Follow-Up Period|Withdrawal by Subject|0|||
144343300|NCT05362058|520460261|FG001|Follow-Up Period|Withdrawal by Subject|3|||
144343301|NCT02688985|520460264|FG000|Overall Study|Adverse Event|1|||
144343302|NCT02688985|520460265|FG001|Overall Study|Adverse Event|2|||
144343303|NCT02688985|520460266|FG002|Overall Study|Adverse Event|2|||
144343304|NCT02688985|520460267|FG003|Overall Study|Adverse Event|0|||
144343305|NCT02688985|520460268|FG004|Overall Study|Adverse Event|0|||
144343306|NCT02688985|520460264|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
144343307|NCT02688985|520460265|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
144343308|NCT02688985|520460266|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
144360109|NCT02081677|520527401|FG003|Overall Study|Adverse Event|0|||
144343309|NCT02688985|520460267|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
144343310|NCT02688985|520460268|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
144343311|NCT02688985|520460264|FG000|Overall Study|Death|0|||
144343312|NCT02688985|520460265|FG001|Overall Study|Death|0|||
144343313|NCT02688985|520460266|FG002|Overall Study|Death|0|||
144343314|NCT02688985|520460267|FG003|Overall Study|Death|0|||
144343315|NCT02688985|520460268|FG004|Overall Study|Death|1|||
144343316|NCT02688985|520460264|FG000|Overall Study|Lack of Efficacy|0|||
144343317|NCT02688985|520460265|FG001|Overall Study|Lack of Efficacy|0|||
144343318|NCT02688985|520460266|FG002|Overall Study|Lack of Efficacy|0|||
144343319|NCT02688985|520460267|FG003|Overall Study|Lack of Efficacy|0|||
144343320|NCT02688985|520460268|FG004|Overall Study|Lack of Efficacy|1|||
144343321|NCT02688985|520460264|FG000|Overall Study|Lost to Follow-up|2|||
144343322|NCT02688985|520460265|FG001|Overall Study|Lost to Follow-up|0|||
144343323|NCT02688985|520460266|FG002|Overall Study|Lost to Follow-up|1|||
144343324|NCT02688985|520460267|FG003|Overall Study|Lost to Follow-up|1|||
144343325|NCT02688985|520460268|FG004|Overall Study|Lost to Follow-up|1|||
144343326|NCT02688985|520460264|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144343327|NCT02688985|520460265|FG001|Overall Study|Non-Compliance With Study Drug|3|||
144343328|NCT02688985|520460266|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144343329|NCT02688985|520460267|FG003|Overall Study|Non-Compliance With Study Drug|0|||
144343330|NCT02688985|520460268|FG004|Overall Study|Non-Compliance With Study Drug|1|||
144343331|NCT02688985|520460264|FG000|Overall Study|Other|3|||
144343332|NCT02688985|520460265|FG001|Overall Study|Other|4|||
144343333|NCT02688985|520460266|FG002|Overall Study|Other|1|||
144343334|NCT02688985|520460267|FG003|Overall Study|Other|0|||
144343335|NCT02688985|520460268|FG004|Overall Study|Other|0|||
144343336|NCT02688985|520460264|FG000|Overall Study|Physician Decision|2|||
144343337|NCT02688985|520460265|FG001|Overall Study|Physician Decision|2|||
144343338|NCT02688985|520460266|FG002|Overall Study|Physician Decision|0|||
144343339|NCT02688985|520460267|FG003|Overall Study|Physician Decision|0|||
144343340|NCT02688985|520460268|FG004|Overall Study|Physician Decision|1|||
144343341|NCT02688985|520460264|FG000|Overall Study|Pregnancy|0|||
144343342|NCT02688985|520460265|FG001|Overall Study|Pregnancy|0|||
144343343|NCT02688985|520460266|FG002|Overall Study|Pregnancy|2|||
144343344|NCT02688985|520460267|FG003|Overall Study|Pregnancy|1|||
144343345|NCT02688985|520460268|FG004|Overall Study|Pregnancy|0|||
144343346|NCT02688985|520460264|FG000|Overall Study|Study Terminated By Sponsor|0|||
144343347|NCT02688985|520460265|FG001|Overall Study|Study Terminated By Sponsor|0|||
144343348|NCT02688985|520460266|FG002|Overall Study|Study Terminated By Sponsor|0|||
144343349|NCT02688985|520460267|FG003|Overall Study|Study Terminated By Sponsor|1|||
144343350|NCT02688985|520460268|FG004|Overall Study|Study Terminated By Sponsor|0|||
144343351|NCT02688985|520460264|FG000|Overall Study|Withdrawal by Subject|2|||
144343352|NCT02688985|520460265|FG001|Overall Study|Withdrawal by Subject|8|||
144343353|NCT02688985|520460266|FG002|Overall Study|Withdrawal by Subject|7|||
144343354|NCT02688985|520460267|FG003|Overall Study|Withdrawal by Subject|1|||
144343355|NCT02688985|520460268|FG004|Overall Study|Withdrawal by Subject|4|||
144343356|NCT01964963|520460271|FG000|Overall Study|Case Report Forms Uncollected|888|||
144343357|NCT01964963|520460271|FG000|Overall Study|Protocol Deviation|50|||
144343358|NCT01964963|520460271|FG000|Overall Study|Data Reliability was not Assured|5|||
144343359|NCT00930553|520460272|FG000|Overall Study|Adverse Event|1|||
144343360|NCT00930553|520460272|FG000|Overall Study|Lack of Efficacy|7|||
144343361|NCT00930553|520460272|FG000|Overall Study|Physician Decision|39|||
144343362|NCT00930553|520460272|FG000|Overall Study|Protocol Violation|1|||
144343363|NCT00930553|520460272|FG000|Overall Study|Pregnancy|1|||
144343364|NCT00930553|520460272|FG000|Overall Study|Withdrawal by Subject|88|||
144343365|NCT00930553|520460272|FG000|Overall Study|Lost to Follow-up|25|||
144343366|NCT00930553|520460272|FG000|Overall Study|Death|9|||
144343367|NCT00930553|520460272|FG000|Overall Study|Study terminated by sponsor|24|||
144343368|NCT00930553|520460272|FG000|Overall Study|Other than specified above|28|||
144343369|NCT02630472|520460273|FG000|Overall Study|Physician Decision|10|||
144343370|NCT02630472|520460274|FG001|Overall Study|Physician Decision|0|||
144343371|NCT03250182|520460275|FG000|Overall Study|Withdrawal by Subject|1|||
144343372|NCT01858740|520460276|FG000|Overall Study|Death|4|||
144343373|NCT01068769|520460277|FG000|Overall Study|Ineligible|1|||
144343374|NCT02524158|520460278|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
144343375|NCT02524158|520460279|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
144343376|NCT02524158|520460278|FG000|12-weeks Assessment|Lost to Follow-up|18|||
144343377|NCT02524158|520460279|FG001|12-weeks Assessment|Lost to Follow-up|12|||
144343378|NCT02524158|520460278|FG000|6-month Assessment|Withdrawal by Subject|1|||
144343379|NCT02524158|520460279|FG001|6-month Assessment|Withdrawal by Subject|1|||
144343380|NCT02524158|520460278|FG000|6-month Assessment|Lost to Follow-up|21|||
144343381|NCT02524158|520460279|FG001|6-month Assessment|Lost to Follow-up|20|||
144343382|NCT00391625|520460284|FG000|Month 14|Withdrawal by Subject|1|||
144343383|NCT00391625|520460284|FG000|Month 50|Physician Decision|1|||
144343384|NCT03664765|520460285|FG000|Overall Study|Withdrawal by Subject|4|||
144343385|NCT03664765|520460286|FG001|Overall Study|Withdrawal by Subject|1|||
144343386|NCT03664765|520460285|FG000|Overall Study|Lost to Follow-up|0|||
144343387|NCT03664765|520460286|FG001|Overall Study|Lost to Follow-up|1|||
144343388|NCT00383162|520460287|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
144343389|NCT00383162|520460288|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
144343390|NCT00383162|520460287|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
144343391|NCT00383162|520460288|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
144343392|NCT00383162|520460287|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
144343393|NCT00383162|520460288|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
144343394|NCT00383162|520460287|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
144343395|NCT00383162|520460288|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
144343396|NCT00383162|520460287|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
144343397|NCT00383162|520460288|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
144343398|NCT00383162|520460287|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
144343399|NCT00383162|520460288|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
144343400|NCT00383162|520460287|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
144343401|NCT00383162|520460288|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
144343402|NCT00383162|520460287|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
144343403|NCT00383162|520460288|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
144343404|NCT00383162|520460287|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
144343405|NCT00383162|520460288|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
144343406|NCT01371305|520460290|FG000|Overall Study|Adverse Event|0|||
144343407|NCT01371305|520460291|FG001|Overall Study|Adverse Event|0|||
144343408|NCT01371305|520460292|FG002|Overall Study|Adverse Event|0|||
144343409|NCT01371305|520460293|FG003|Overall Study|Adverse Event|2|||
144343410|NCT01371305|520460294|FG004|Overall Study|Adverse Event|1|||
144343411|NCT01371305|520460295|FG005|Overall Study|Adverse Event|0|||
144343412|NCT01371305|520460290|FG000|Overall Study|Study terminated by sponsor|0|||
144343413|NCT01371305|520460291|FG001|Overall Study|Study terminated by sponsor|0|||
144343414|NCT01371305|520460292|FG002|Overall Study|Study terminated by sponsor|0|||
144343415|NCT01371305|520460293|FG003|Overall Study|Study terminated by sponsor|0|||
144343416|NCT01371305|520460294|FG004|Overall Study|Study terminated by sponsor|3|||
144343417|NCT01371305|520460295|FG005|Overall Study|Study terminated by sponsor|1|||
144343418|NCT01371305|520460290|FG000|Overall Study|Subject request|0|||
144343419|NCT01371305|520460291|FG001|Overall Study|Subject request|0|||
144343420|NCT01371305|520460292|FG002|Overall Study|Subject request|0|||
144343421|NCT01371305|520460293|FG003|Overall Study|Subject request|0|||
144343422|NCT01371305|520460294|FG004|Overall Study|Subject request|0|||
144343423|NCT01371305|520460295|FG005|Overall Study|Subject request|1|||
144343424|NCT04038567|520460296|FG000|Overall Study|Lost to Follow-up|6|||
144343425|NCT04038567|520460297|FG001|Overall Study|Lost to Follow-up|4|||
144343426|NCT04038567|520460298|FG002|Overall Study|Lost to Follow-up|5|||
144343427|NCT04038567|520460299|FG003|Overall Study|Lost to Follow-up|4|||
144343428|NCT04038567|520460300|FG004|Overall Study|Lost to Follow-up|6|||
144343429|NCT04038567|520460301|FG005|Overall Study|Lost to Follow-up|4|||
144343430|NCT04038567|520460302|FG006|Overall Study|Lost to Follow-up|4|||
144343431|NCT04038567|520460303|FG007|Overall Study|Lost to Follow-up|1|||
144343432|NCT04038567|520460296|FG000|Overall Study|Withdrawal by Subject|2|||
144343433|NCT04038567|520460297|FG001|Overall Study|Withdrawal by Subject|1|||
144343434|NCT04038567|520460298|FG002|Overall Study|Withdrawal by Subject|1|||
144343435|NCT04038567|520460299|FG003|Overall Study|Withdrawal by Subject|1|||
144343436|NCT04038567|520460300|FG004|Overall Study|Withdrawal by Subject|4|||
144343437|NCT04038567|520460301|FG005|Overall Study|Withdrawal by Subject|1|||
144343438|NCT04038567|520460302|FG006|Overall Study|Withdrawal by Subject|1|||
144343439|NCT04038567|520460303|FG007|Overall Study|Withdrawal by Subject|1|||
144343440|NCT04038567|520460296|FG000|Overall Study|missed survey window|1|||
144343441|NCT04038567|520460297|FG001|Overall Study|missed survey window|2|||
144343442|NCT04038567|520460298|FG002|Overall Study|missed survey window|0|||
144343443|NCT04038567|520460299|FG003|Overall Study|missed survey window|0|||
144343444|NCT04038567|520460300|FG004|Overall Study|missed survey window|1|||
144343445|NCT04038567|520460301|FG005|Overall Study|missed survey window|1|||
144343446|NCT04038567|520460302|FG006|Overall Study|missed survey window|2|||
144343447|NCT04038567|520460303|FG007|Overall Study|missed survey window|2|||
144343448|NCT04038567|520460296|FG000|Overall Study|technical issues|0|||
144343449|NCT04038567|520460297|FG001|Overall Study|technical issues|0|||
144343450|NCT04038567|520460298|FG002|Overall Study|technical issues|0|||
144343451|NCT04038567|520460299|FG003|Overall Study|technical issues|0|||
144343452|NCT04038567|520460300|FG004|Overall Study|technical issues|0|||
144343453|NCT04038567|520460301|FG005|Overall Study|technical issues|0|||
144343454|NCT04038567|520460302|FG006|Overall Study|technical issues|1|||
144343455|NCT04038567|520460303|FG007|Overall Study|technical issues|0|||
144343456|NCT04038567|520460296|FG000|Overall Study|Medical issues (i.e., illness)|0|||
144343457|NCT04038567|520460297|FG001|Overall Study|Medical issues (i.e., illness)|1|||
144343458|NCT04038567|520460298|FG002|Overall Study|Medical issues (i.e., illness)|2|||
144343459|NCT04038567|520460299|FG003|Overall Study|Medical issues (i.e., illness)|1|||
144343460|NCT04038567|520460300|FG004|Overall Study|Medical issues (i.e., illness)|1|||
144343461|NCT04038567|520460301|FG005|Overall Study|Medical issues (i.e., illness)|1|||
144343462|NCT04038567|520460302|FG006|Overall Study|Medical issues (i.e., illness)|0|||
144343463|NCT04038567|520460303|FG007|Overall Study|Medical issues (i.e., illness)|0|||
144343464|NCT04038567|520460296|FG000|Overall Study|Death|0|||
144343465|NCT04038567|520460297|FG001|Overall Study|Death|0|||
144343466|NCT04038567|520460298|FG002|Overall Study|Death|0|||
144343467|NCT04038567|520460299|FG003|Overall Study|Death|1|||
144343468|NCT04038567|520460300|FG004|Overall Study|Death|1|||
144343469|NCT04038567|520460301|FG005|Overall Study|Death|0|||
144343470|NCT04038567|520460302|FG006|Overall Study|Death|0|||
144343471|NCT04038567|520460303|FG007|Overall Study|Death|1|||
144343472|NCT02220712|520460304|FG000|Overall Study|Adverse Event|1|||
144343473|NCT02220712|520460304|FG000|Overall Study|Withdrawal by Subject|2|||
144343474|NCT02220712|520460304|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
144343475|NCT00760838|520460308|FG000|Overall Study|Adverse Event|1|||
144343476|NCT00760838|520460309|FG001|Overall Study|Adverse Event|1|||
144343477|NCT00760838|520460308|FG000|Overall Study|Lack of Efficacy|1|||
144343478|NCT00760838|520460309|FG001|Overall Study|Lack of Efficacy|0|||
144343479|NCT00760838|520460308|FG000|Overall Study|Lost to Follow-up|2|||
144343480|NCT00760838|520460309|FG001|Overall Study|Lost to Follow-up|0|||
144343481|NCT00760838|520460308|FG000|Overall Study|Withdrawal by Subject|1|||
144343482|NCT00760838|520460309|FG001|Overall Study|Withdrawal by Subject|1|||
144343483|NCT02726022|520460310|FG000|Overall Study|Adverse Event|14|||
144343484|NCT02726022|520460310|FG000|Overall Study|Treatment Failure|8|||
144343485|NCT02726022|520460310|FG000|Overall Study|Poor Compliance|13|||
144343486|NCT02726022|520460310|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
144343487|NCT01817959|520460311|FG000|Overall Study|Graft loss|1|||
144343488|NCT01817959|520460312|FG001|Overall Study|Graft loss|1|||
144343489|NCT01817959|520460311|FG000|Overall Study|forbidden medication|1|||
144343490|NCT01817959|520460312|FG001|Overall Study|forbidden medication|1|||
144343491|NCT01817959|520460311|FG000|Overall Study|Adverse Event|1|||
144343492|NCT01817959|520460312|FG001|Overall Study|Adverse Event|0|||
144343493|NCT01817959|520460311|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
144343494|NCT01817959|520460312|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
144343495|NCT01183065|520460322|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
144343496|NCT03657095|520460324|FG000|Overall Study|Withdrawal by Subject|1|||
144343497|NCT03657095|520460325|FG001|Overall Study|Withdrawal by Subject|1|||
144343498|NCT03657095|520460324|FG000|Overall Study|Adverse Event|0|||
144343499|NCT03657095|520460325|FG001|Overall Study|Adverse Event|3|||
144343500|NCT03657095|520460324|FG000|Overall Study|Study Terminated by Sponsor|58|||
144343501|NCT03657095|520460325|FG001|Overall Study|Study Terminated by Sponsor|49|||
144343502|NCT00622388|520460328|FG000|Overall Study|Disease Progression|47|||
144343503|NCT00622388|520460328|FG000|Overall Study|Adverse Event|6|||
144343504|NCT00622388|520460328|FG000|Overall Study|Protocol Violation|3|||
144343505|NCT00622388|520460328|FG000|Overall Study|Participant Refusal|1|||
144343506|NCT00622388|520460328|FG000|Overall Study|Death|3|||
144343507|NCT00622388|520460328|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
144343508|NCT00622388|520460328|FG000|Overall Study|Took Prohibited Medication|2|||
144343509|NCT00622388|520460328|FG000|Overall Study|Withdrew Consent|1|||
144343510|NCT00622388|520460328|FG000|Overall Study|Insurance Expired|1|||
144343511|NCT00348309|520460329|FG000|Overall Study|Adverse Event|56|||
144343512|NCT00348309|520460330|FG001|Overall Study|Adverse Event|28|||
144343513|NCT00348309|520460331|FG002|Overall Study|Adverse Event|63|||
144343514|NCT00348309|520460329|FG000|Overall Study|Lost to Follow-up|6|||
144343515|NCT00348309|520460330|FG001|Overall Study|Lost to Follow-up|7|||
144343516|NCT00348309|520460331|FG002|Overall Study|Lost to Follow-up|4|||
144343517|NCT00348309|520460329|FG000|Overall Study|Protocol Violation|7|||
144343518|NCT00348309|520460330|FG001|Overall Study|Protocol Violation|12|||
144343519|NCT00348309|520460331|FG002|Overall Study|Protocol Violation|7|||
144343520|NCT00348309|520460329|FG000|Overall Study|Withdrawal by Subject|33|||
144343521|NCT00348309|520460330|FG001|Overall Study|Withdrawal by Subject|37|||
144343522|NCT00348309|520460331|FG002|Overall Study|Withdrawal by Subject|40|||
144343523|NCT00348309|520460329|FG000|Overall Study|Non-compliance|8|||
144343524|NCT00348309|520460330|FG001|Overall Study|Non-compliance|6|||
144343525|NCT00348309|520460331|FG002|Overall Study|Non-compliance|8|||
144343526|NCT00348309|520460329|FG000|Overall Study|Death of caregiver|1|||
144343527|NCT00348309|520460330|FG001|Overall Study|Death of caregiver|0|||
144343528|NCT00348309|520460331|FG002|Overall Study|Death of caregiver|1|||
144343529|NCT00348309|520460329|FG000|Overall Study|Lack of insight, dementia|1|||
144343530|NCT00348309|520460330|FG001|Overall Study|Lack of insight, dementia|0|||
144343531|NCT00348309|520460331|FG002|Overall Study|Lack of insight, dementia|0|||
144343532|NCT00348309|520460329|FG000|Overall Study|Wrong bottle allocated|1|||
144343533|NCT00348309|520460330|FG001|Overall Study|Wrong bottle allocated|0|||
144343534|NCT00348309|520460331|FG002|Overall Study|Wrong bottle allocated|0|||
144343535|NCT00348309|520460329|FG000|Overall Study|Caregiver sick|1|||
144343536|NCT00348309|520460330|FG001|Overall Study|Caregiver sick|0|||
144343537|NCT00348309|520460331|FG002|Overall Study|Caregiver sick|0|||
144360188|NCT03037385|520527408|FG000|Overall Study|Progressive Disease|0|||
144343538|NCT00348309|520460329|FG000|Overall Study|Use of prohibited medication|5|||
144343539|NCT00348309|520460330|FG001|Overall Study|Use of prohibited medication|2|||
144343540|NCT00348309|520460331|FG002|Overall Study|Use of prohibited medication|2|||
144343541|NCT00348309|520460329|FG000|Overall Study|Caregiver withdrawal|3|||
144343542|NCT00348309|520460330|FG001|Overall Study|Caregiver withdrawal|0|||
144343543|NCT00348309|520460331|FG002|Overall Study|Caregiver withdrawal|7|||
144343544|NCT00348309|520460329|FG000|Overall Study|Unable to complete ET visit|1|||
144343545|NCT00348309|520460330|FG001|Overall Study|Unable to complete ET visit|0|||
144343546|NCT00348309|520460331|FG002|Overall Study|Unable to complete ET visit|0|||
144343547|NCT00348309|520460329|FG000|Overall Study|PI closing medical practice|1|||
144343548|NCT00348309|520460330|FG001|Overall Study|PI closing medical practice|0|||
144343549|NCT00348309|520460331|FG002|Overall Study|PI closing medical practice|0|||
144343550|NCT00348309|520460329|FG000|Overall Study|Principal investigator's decision|1|||
144343551|NCT00348309|520460330|FG001|Overall Study|Principal investigator's decision|0|||
144343552|NCT00348309|520460331|FG002|Overall Study|Principal investigator's decision|0|||
144343553|NCT00348309|520460329|FG000|Overall Study|No disponibility of medication|1|||
144343554|NCT00348309|520460330|FG001|Overall Study|No disponibility of medication|0|||
144343555|NCT00348309|520460331|FG002|Overall Study|No disponibility of medication|0|||
144343556|NCT00348309|520460329|FG000|Overall Study|Worsened neurodegenerative disease|1|||
144343557|NCT00348309|520460330|FG001|Overall Study|Worsened neurodegenerative disease|0|||
144343558|NCT00348309|520460331|FG002|Overall Study|Worsened neurodegenerative disease|0|||
144343559|NCT00348309|520460329|FG000|Overall Study|Cognitive and behaviour worsening|2|||
144343560|NCT00348309|520460330|FG001|Overall Study|Cognitive and behaviour worsening|0|||
144343561|NCT00348309|520460331|FG002|Overall Study|Cognitive and behaviour worsening|0|||
144343562|NCT00348309|520460329|FG000|Overall Study|Worsening of alzheimer|1|||
144343563|NCT00348309|520460330|FG001|Overall Study|Worsening of alzheimer|0|||
144343564|NCT00348309|520460331|FG002|Overall Study|Worsening of alzheimer|1|||
144343565|NCT00348309|520460329|FG000|Overall Study|Did not appear in time for Visit 3|1|||
144343566|NCT00348309|520460330|FG001|Overall Study|Did not appear in time for Visit 3|0|||
144343567|NCT00348309|520460331|FG002|Overall Study|Did not appear in time for Visit 3|0|||
144343568|NCT00348309|520460329|FG000|Overall Study|Participant died|2|||
144343569|NCT00348309|520460330|FG001|Overall Study|Participant died|1|||
144343570|NCT00348309|520460331|FG002|Overall Study|Participant died|1|||
144343571|NCT00348309|520460329|FG000|Overall Study|Decision of sponsor|1|||
144343572|NCT00348309|520460330|FG001|Overall Study|Decision of sponsor|0|||
144343573|NCT00348309|520460331|FG002|Overall Study|Decision of sponsor|0|||
144343574|NCT00348309|520460329|FG000|Overall Study|Ineffectiveness of treatment|0|||
144343575|NCT00348309|520460330|FG001|Overall Study|Ineffectiveness of treatment|1|||
144343576|NCT00348309|520460331|FG002|Overall Study|Ineffectiveness of treatment|0|||
144343577|NCT00348309|520460329|FG000|Overall Study|A foul of exclusion criteria|0|||
144343578|NCT00348309|520460330|FG001|Overall Study|A foul of exclusion criteria|1|||
144343579|NCT00348309|520460331|FG002|Overall Study|A foul of exclusion criteria|0|||
144343580|NCT00348309|520460329|FG000|Overall Study|Participant was hospitalized|0|||
144343581|NCT00348309|520460330|FG001|Overall Study|Participant was hospitalized|1|||
144343582|NCT00348309|520460331|FG002|Overall Study|Participant was hospitalized|0|||
144343583|NCT00348309|520460329|FG000|Overall Study|Sponsor refuseal|0|||
144343584|NCT00348309|520460330|FG001|Overall Study|Sponsor refuseal|1|||
144343585|NCT00348309|520460331|FG002|Overall Study|Sponsor refuseal|1|||
144343586|NCT00348309|520460329|FG000|Overall Study|Forgot often medication|0|||
144343587|NCT00348309|520460330|FG001|Overall Study|Forgot often medication|1|||
144343588|NCT00348309|520460331|FG002|Overall Study|Forgot often medication|0|||
144343589|NCT00348309|520460329|FG000|Overall Study|Medical Monitor decision|0|||
144343590|NCT00348309|520460330|FG001|Overall Study|Medical Monitor decision|0|||
144343591|NCT00348309|520460331|FG002|Overall Study|Medical Monitor decision|1|||
144343592|NCT00348309|520460329|FG000|Overall Study|Increased dose of Aricept|0|||
144343593|NCT00348309|520460330|FG001|Overall Study|Increased dose of Aricept|0|||
144343594|NCT00348309|520460331|FG002|Overall Study|Increased dose of Aricept|1|||
144343595|NCT00348309|520460329|FG000|Overall Study|Site closure|0|||
144343596|NCT00348309|520460330|FG001|Overall Study|Site closure|0|||
144343597|NCT00348309|520460331|FG002|Overall Study|Site closure|1|||
144343598|NCT00348309|520460329|FG000|Overall Study|Adverse event not attended|0|||
144343599|NCT00348309|520460330|FG001|Overall Study|Adverse event not attended|0|||
144343600|NCT00348309|520460331|FG002|Overall Study|Adverse event not attended|1|||
144343601|NCT00348309|520460329|FG000|Overall Study|ECG abnormal|0|||
144343602|NCT00348309|520460330|FG001|Overall Study|ECG abnormal|0|||
144343603|NCT00348309|520460331|FG002|Overall Study|ECG abnormal|2|||
144343604|NCT00348309|520460329|FG000|Overall Study|Cardiologist recommendations|0|||
144343605|NCT00348309|520460330|FG001|Overall Study|Cardiologist recommendations|0|||
144343606|NCT00348309|520460331|FG002|Overall Study|Cardiologist recommendations|1|||
144343607|NCT00348309|520460329|FG000|Overall Study|HCV career|0|||
144343608|NCT00348309|520460330|FG001|Overall Study|HCV career|0|||
144343609|NCT00348309|520460331|FG002|Overall Study|HCV career|1|||
144343610|NCT01894243|520460332|FG000|Overall Study|Adverse Event|0|||
144343611|NCT01894243|520460333|FG001|Overall Study|Adverse Event|1|||
144343612|NCT01894243|520460334|FG002|Overall Study|Adverse Event|2|||
144343613|NCT01894243|520460332|FG000|Overall Study|Death|0|||
144343614|NCT01894243|520460333|FG001|Overall Study|Death|0|||
144343615|NCT01894243|520460334|FG002|Overall Study|Death|3|||
144343616|NCT01894243|520460332|FG000|Overall Study|Lack of Efficacy|3|||
144343617|NCT01894243|520460333|FG001|Overall Study|Lack of Efficacy|3|||
144343618|NCT01894243|520460334|FG002|Overall Study|Lack of Efficacy|1|||
144343619|NCT01894243|520460332|FG000|Overall Study|Condition under investigation worsened|8|||
144343620|NCT01894243|520460333|FG001|Overall Study|Condition under investigation worsened|6|||
144343621|NCT01894243|520460334|FG002|Overall Study|Condition under investigation worsened|2|||
144343622|NCT01894243|520460332|FG000|Overall Study|Subject decision|1|||
144343623|NCT01894243|520460333|FG001|Overall Study|Subject decision|0|||
144343624|NCT01894243|520460334|FG002|Overall Study|Subject decision|0|||
144343625|NCT01894243|520460332|FG000|Overall Study|Other|1|||
144343626|NCT01894243|520460333|FG001|Overall Study|Other|0|||
144343627|NCT01894243|520460334|FG002|Overall Study|Other|0|||
144343628|NCT01743040|520460335|FG000|Overall Study|Death|1|||
144343629|NCT01743040|520460335|FG000|Overall Study|Lost to Follow-up|66|||
144343630|NCT01743040|520460335|FG000|Overall Study|Physician Decision|40|||
144343631|NCT01743040|520460335|FG000|Overall Study|Protocol Violation|1|||
144343632|NCT01743040|520460335|FG000|Overall Study|Withdrawal by Subject|121|||
144343633|NCT00828750|520460336|FG000|Overall Study|Lack of Efficacy|3|||
144343634|NCT00828750|520460336|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
144343635|NCT04006392|520460338|FG000|Overall Study|Lost to Follow-up|0|||
144343636|NCT04006392|520460339|FG001|Overall Study|Lost to Follow-up|1|||
144343637|NCT01299116|520460340|FG000|Overall Study|Lost to Follow-up|65|||
144343638|NCT01299116|520460341|FG001|Overall Study|Lost to Follow-up|9|||
144343639|NCT01299116|520460342|FG002|Overall Study|Lost to Follow-up|11|||
144343640|NCT01620944|520460343|FG000|Overall Study|Early termination of Study|2|||
144343641|NCT01620944|520460344|FG001|Overall Study|Early termination of Study|1|||
144343642|NCT04378114|520460345|FG000|Overall Study|Withdrawal by Subject|5|||
144343643|NCT00830180|520460346|FG000|Overall Study|Adverse Event|6|||
144343644|NCT00830180|520460346|FG000|Overall Study|Death|11|||
144343645|NCT00830180|520460346|FG000|Overall Study|Insufficient clinical response|1|||
144343646|NCT00830180|520460346|FG000|Overall Study|Withdrawal by Subject|5|||
144343647|NCT00830180|520460346|FG000|Overall Study|Progressive disease|2|||
144343648|NCT00830180|520460346|FG000|Overall Study|Other - Unspecified|1|||
144343649|NCT01832532|520460347|FG000|Overall Study|Withdrawal by Subject|5|||
144343650|NCT01832532|520460348|FG001|Overall Study|Withdrawal by Subject|2|||
144343651|NCT00392990|520460349|FG000|Treatment on Study|Adverse Event|3|||
144343652|NCT00392990|520460350|FG001|Treatment on Study|Adverse Event|1|||
144343653|NCT00392990|520460349|FG000|Follow up for 2 Years|Death|4|||
144343654|NCT00392990|520460350|FG001|Follow up for 2 Years|Death|0|||
144343655|NCT03170193|520460353|FG000|Overall Study|Withdrawal by Subject|0|||
144343656|NCT03170193|520460354|FG001|Overall Study|Withdrawal by Subject|0|||
144343657|NCT03170193|520460355|FG002|Overall Study|Withdrawal by Subject|0|||
144343658|NCT03170193|520460356|FG003|Overall Study|Withdrawal by Subject|1|||
144343659|NCT03170193|520460357|FG004|Overall Study|Withdrawal by Subject|0|||
144343660|NCT03170193|520460358|FG005|Overall Study|Withdrawal by Subject|0|||
144343661|NCT03170193|520460359|FG006|Overall Study|Withdrawal by Subject|0|||
144343662|NCT03170193|520460353|FG000|Overall Study|Lost to Follow-up|1|||
144343663|NCT03170193|520460354|FG001|Overall Study|Lost to Follow-up|1|||
144343664|NCT03170193|520460355|FG002|Overall Study|Lost to Follow-up|0|||
144343665|NCT03170193|520460356|FG003|Overall Study|Lost to Follow-up|0|||
144343666|NCT03170193|520460357|FG004|Overall Study|Lost to Follow-up|0|||
144343667|NCT03170193|520460358|FG005|Overall Study|Lost to Follow-up|0|||
144343668|NCT03170193|520460359|FG006|Overall Study|Lost to Follow-up|0|||
144343669|NCT03052816|520460360|FG000|Overall Study|Withdrawal by Subject|1|||
144343670|NCT03052816|520460361|FG001|Overall Study|Withdrawal by Subject|0|||
144343671|NCT03052816|520460360|FG000|Overall Study|Desired opioids|2|||
144343672|NCT03052816|520460361|FG001|Overall Study|Desired opioids|0|||
144343673|NCT03755661|520460364|FG000|Overall Study|Lost to Follow-up|1|||
144343674|NCT03755661|520460365|FG001|Overall Study|Lost to Follow-up|0|||
144343675|NCT00895453|520460366|FG000|Overall Study|Lost to Follow-up|25|||
144343676|NCT00895453|520460367|FG001|Overall Study|Lost to Follow-up|25|||
144343677|NCT00895453|520460368|FG002|Overall Study|Lost to Follow-up|23|||
144343678|NCT01736618|520460371|FG000|Overall Study|Death|294|||
144343679|NCT01736618|520460371|FG000|Overall Study|Lost to Follow-up|193|||
144343680|NCT01736618|520460371|FG000|Overall Study|Withdrawal by Subject|54|||
144343681|NCT01736618|520460371|FG000|Overall Study|Subject unable to be followed at study location|223|||
144343682|NCT01736618|520460371|FG000|Overall Study|Physician Decision|33|||
144343683|NCT01736618|520460371|FG000|Overall Study|Transplant or removal of target organ|19|||
144343684|NCT01736618|520460371|FG000|Overall Study|Change in indication or condition|78|||
144343685|NCT01736618|520460371|FG000|Overall Study|Study device explant|103|||
144343686|NCT01736618|520460371|FG000|Overall Study|Unable to complete implant|2|||
144343687|NCT04167137|520460372|FG000|Overall Study|Disease progression|1|||
144343688|NCT04167137|520460373|FG001|Overall Study|Disease progression|1|||
144343689|NCT04167137|520460374|FG002|Overall Study|Disease progression|3|||
144343690|NCT04167137|520460375|FG003|Overall Study|Disease progression|3|||
144343691|NCT04167137|520460376|FG004|Overall Study|Disease progression|2|||
144343692|NCT04167137|520460377|FG005|Overall Study|Disease progression|3|||
144343693|NCT04167137|520460378|FG006|Overall Study|Disease progression|2|||
144343694|NCT04167137|520460379|FG007|Overall Study|Disease progression|2|||
144343695|NCT04167137|520460372|FG000|Overall Study|Withdrawal by Subject|1|||
144343696|NCT04167137|520460373|FG001|Overall Study|Withdrawal by Subject|0|||
144343697|NCT04167137|520460374|FG002|Overall Study|Withdrawal by Subject|0|||
144343698|NCT04167137|520460375|FG003|Overall Study|Withdrawal by Subject|1|||
144343699|NCT04167137|520460376|FG004|Overall Study|Withdrawal by Subject|0|||
144343700|NCT04167137|520460377|FG005|Overall Study|Withdrawal by Subject|2|||
144343701|NCT04167137|520460378|FG006|Overall Study|Withdrawal by Subject|1|||
144343702|NCT04167137|520460379|FG007|Overall Study|Withdrawal by Subject|0|||
144343703|NCT04167137|520460372|FG000|Overall Study|Adverse Event|0|||
144343704|NCT04167137|520460373|FG001|Overall Study|Adverse Event|0|||
144343705|NCT04167137|520460374|FG002|Overall Study|Adverse Event|0|||
144343706|NCT04167137|520460375|FG003|Overall Study|Adverse Event|0|||
144343707|NCT04167137|520460376|FG004|Overall Study|Adverse Event|0|||
144343708|NCT04167137|520460377|FG005|Overall Study|Adverse Event|1|||
144343709|NCT04167137|520460378|FG006|Overall Study|Adverse Event|0|||
144343710|NCT04167137|520460379|FG007|Overall Study|Adverse Event|1|||
144343711|NCT04167137|520460372|FG000|Overall Study|Physician Decision|0|||
144343712|NCT04167137|520460373|FG001|Overall Study|Physician Decision|0|||
144343713|NCT04167137|520460374|FG002|Overall Study|Physician Decision|0|||
144343714|NCT04167137|520460375|FG003|Overall Study|Physician Decision|1|||
144343715|NCT04167137|520460376|FG004|Overall Study|Physician Decision|0|||
144343716|NCT04167137|520460377|FG005|Overall Study|Physician Decision|0|||
144343717|NCT04167137|520460378|FG006|Overall Study|Physician Decision|1|||
144343718|NCT04167137|520460379|FG007|Overall Study|Physician Decision|0|||
144343719|NCT04167137|520460372|FG000|Overall Study|Death|0|||
144343720|NCT04167137|520460373|FG001|Overall Study|Death|1|||
144343721|NCT04167137|520460374|FG002|Overall Study|Death|0|||
144343722|NCT04167137|520460375|FG003|Overall Study|Death|0|||
144343723|NCT04167137|520460376|FG004|Overall Study|Death|0|||
144343724|NCT04167137|520460377|FG005|Overall Study|Death|0|||
144343725|NCT04167137|520460378|FG006|Overall Study|Death|0|||
144343726|NCT04167137|520460379|FG007|Overall Study|Death|0|||
144343727|NCT04167137|520460372|FG000|Overall Study|Study terminated by Sponsor|0|||
144343728|NCT04167137|520460373|FG001|Overall Study|Study terminated by Sponsor|0|||
144343729|NCT04167137|520460374|FG002|Overall Study|Study terminated by Sponsor|0|||
144343730|NCT04167137|520460375|FG003|Overall Study|Study terminated by Sponsor|0|||
144343731|NCT04167137|520460376|FG004|Overall Study|Study terminated by Sponsor|0|||
144343732|NCT04167137|520460377|FG005|Overall Study|Study terminated by Sponsor|0|||
144343733|NCT04167137|520460378|FG006|Overall Study|Study terminated by Sponsor|0|||
144343734|NCT04167137|520460379|FG007|Overall Study|Study terminated by Sponsor|1|||
144343735|NCT00400569|520460383|FG000|Overall Study|Death|1|||
144343736|NCT01748825|520460384|FG000|Dose Escalation|Refused further treatment|2|||
144343737|NCT01748825|520460385|FG001|Dose Escalation|Refused further treatment|2|||
144343738|NCT01748825|520460386|FG002|Dose Escalation|Refused further treatment|0|||
144343739|NCT01748825|520460387|FG003|Dose Escalation|Refused further treatment|0|||
144343740|NCT01748825|520460388|FG004|Dose Escalation|Refused further treatment|1|||
144343741|NCT01748825|520460389|FG005|Dose Escalation|Refused further treatment|2|||
144343742|NCT01748825|520460390|FG006|Dose Escalation|Refused further treatment|0|||
144343743|NCT01748825|520460391|FG007|Dose Escalation|Refused further treatment|0|||
144343744|NCT01748825|520460392|FG008|Dose Escalation|Refused further treatment|0|||
144343745|NCT01748825|520460393|FG009|Dose Escalation|Refused further treatment|0|||
144343746|NCT01748825|520460384|FG000|Dose Escalation|Switched to alternative treatment|0|||
144343747|NCT01748825|520460385|FG001|Dose Escalation|Switched to alternative treatment|0|||
144343748|NCT01748825|520460386|FG002|Dose Escalation|Switched to alternative treatment|0|||
144343749|NCT01748825|520460387|FG003|Dose Escalation|Switched to alternative treatment|1|||
144343750|NCT01748825|520460388|FG004|Dose Escalation|Switched to alternative treatment|0|||
144343751|NCT01748825|520460389|FG005|Dose Escalation|Switched to alternative treatment|0|||
144343752|NCT01748825|520460390|FG006|Dose Escalation|Switched to alternative treatment|0|||
144343753|NCT01748825|520460391|FG007|Dose Escalation|Switched to alternative treatment|0|||
144343754|NCT01748825|520460392|FG008|Dose Escalation|Switched to alternative treatment|0|||
144343755|NCT01748825|520460393|FG009|Dose Escalation|Switched to alternative treatment|0|||
144343756|NCT01748825|520460384|FG000|Dose Escalation|Adverse Event|0|||
144343757|NCT01748825|520460385|FG001|Dose Escalation|Adverse Event|0|||
144343758|NCT01748825|520460386|FG002|Dose Escalation|Adverse Event|0|||
144343759|NCT01748825|520460387|FG003|Dose Escalation|Adverse Event|0|||
144343760|NCT01748825|520460388|FG004|Dose Escalation|Adverse Event|0|||
144343761|NCT01748825|520460389|FG005|Dose Escalation|Adverse Event|0|||
144343762|NCT01748825|520460390|FG006|Dose Escalation|Adverse Event|1|||
144343763|NCT01748825|520460391|FG007|Dose Escalation|Adverse Event|0|||
144343764|NCT01748825|520460392|FG008|Dose Escalation|Adverse Event|0|||
144343765|NCT01748825|520460393|FG009|Dose Escalation|Adverse Event|0|||
144343766|NCT01748825|520460384|FG000|Dose Expansion|Refused further treatment|0|||
144343767|NCT01748825|520460385|FG001|Dose Expansion|Refused further treatment|0|||
144343768|NCT01748825|520460386|FG002|Dose Expansion|Refused further treatment|0|||
144343769|NCT01748825|520460387|FG003|Dose Expansion|Refused further treatment|0|||
144343770|NCT01748825|520460388|FG004|Dose Expansion|Refused further treatment|0|||
144343771|NCT01748825|520460389|FG005|Dose Expansion|Refused further treatment|0|||
144343772|NCT01748825|520460390|FG006|Dose Expansion|Refused further treatment|0|||
144343773|NCT01748825|520460391|FG007|Dose Expansion|Refused further treatment|0|||
144343774|NCT01748825|520460392|FG008|Dose Expansion|Refused further treatment|1|||
144343775|NCT01748825|520460393|FG009|Dose Expansion|Refused further treatment|1|||
144343776|NCT01748825|520460384|FG000|Dose Expansion|Switched to alternative treatment|0|||
144343777|NCT01748825|520460385|FG001|Dose Expansion|Switched to alternative treatment|0|||
144343778|NCT01748825|520460386|FG002|Dose Expansion|Switched to alternative treatment|0|||
144343779|NCT01748825|520460387|FG003|Dose Expansion|Switched to alternative treatment|0|||
144343780|NCT01748825|520460388|FG004|Dose Expansion|Switched to alternative treatment|0|||
144343781|NCT01748825|520460389|FG005|Dose Expansion|Switched to alternative treatment|0|||
144343782|NCT01748825|520460390|FG006|Dose Expansion|Switched to alternative treatment|0|||
144343783|NCT01748825|520460391|FG007|Dose Expansion|Switched to alternative treatment|0|||
144343784|NCT01748825|520460392|FG008|Dose Expansion|Switched to alternative treatment|0|||
144343785|NCT01748825|520460393|FG009|Dose Expansion|Switched to alternative treatment|1|||
144343786|NCT01748825|520460384|FG000|Dose Expansion|Adverse Event|0|||
144343787|NCT01748825|520460385|FG001|Dose Expansion|Adverse Event|0|||
144343788|NCT01748825|520460386|FG002|Dose Expansion|Adverse Event|0|||
144343789|NCT01748825|520460387|FG003|Dose Expansion|Adverse Event|0|||
144343790|NCT01748825|520460388|FG004|Dose Expansion|Adverse Event|0|||
144343791|NCT01748825|520460389|FG005|Dose Expansion|Adverse Event|0|||
144343792|NCT01748825|520460390|FG006|Dose Expansion|Adverse Event|0|||
144343793|NCT01748825|520460391|FG007|Dose Expansion|Adverse Event|0|||
144343794|NCT01748825|520460392|FG008|Dose Expansion|Adverse Event|0|||
144343795|NCT01748825|520460393|FG009|Dose Expansion|Adverse Event|3|||
144343796|NCT01748825|520460384|FG000|Dose Expansion|Physician Decision|0|||
144343797|NCT01748825|520460385|FG001|Dose Expansion|Physician Decision|0|||
144343798|NCT01748825|520460386|FG002|Dose Expansion|Physician Decision|0|||
144343799|NCT01748825|520460387|FG003|Dose Expansion|Physician Decision|0|||
144343800|NCT01748825|520460388|FG004|Dose Expansion|Physician Decision|0|||
144343801|NCT01748825|520460389|FG005|Dose Expansion|Physician Decision|0|||
144343802|NCT01748825|520460390|FG006|Dose Expansion|Physician Decision|0|||
144343803|NCT01748825|520460391|FG007|Dose Expansion|Physician Decision|0|||
144343804|NCT01748825|520460392|FG008|Dose Expansion|Physician Decision|1|||
144343805|NCT01748825|520460393|FG009|Dose Expansion|Physician Decision|0|||
144343806|NCT02921087|520460397|FG000|Overall Study|Withdrawal by Subject|0|||
144343807|NCT02921087|520460398|FG001|Overall Study|Withdrawal by Subject|1|||
144343808|NCT03848949|520460399|FG000|Overall Study|Lost to Follow-up|5|||
144343809|NCT03848949|520460400|FG001|Overall Study|Lost to Follow-up|7|||
144343810|NCT01865448|520462262|FG000|Overall Study|Adverse Event|1|||
144343811|NCT01865448|520462263|FG001|Overall Study|Adverse Event|1|||
144343812|NCT01865448|520462262|FG000|Overall Study|Pregnancy|0|||
144343813|NCT01865448|520462263|FG001|Overall Study|Pregnancy|1|||
144343814|NCT01865448|520462262|FG000|Overall Study|dropout unrelated to study|1|||
144343815|NCT01865448|520462263|FG001|Overall Study|dropout unrelated to study|1|||
144343816|NCT00799266|520462270|FG000|Overall Study|Adverse Event|0|||
144343817|NCT00799266|520462271|FG001|Overall Study|Adverse Event|1|||
144343818|NCT00799266|520462270|FG000|Overall Study|Subject withdrew consent|3|||
144343819|NCT00799266|520462271|FG001|Overall Study|Subject withdrew consent|0|||
144343820|NCT01016600|520462272|FG000|Overall Study|Did not start treatment|1|||
144343821|NCT01016600|520462273|FG001|Overall Study|Did not start treatment|0|||
144343822|NCT01016600|520462274|FG002|Overall Study|Did not start treatment|0|||
144343823|NCT01016600|520462275|FG003|Overall Study|Did not start treatment|0|||
144343824|NCT04440813|520462279|FG000|Overall Study|Lost to Follow-up|5|||
144343825|NCT04440813|520462280|FG001|Overall Study|Lost to Follow-up|5|||
144343826|NCT02255461|520462281|FG000|Overall Study|Adverse Event|0|||
144343827|NCT02255461|520462282|FG001|Overall Study|Adverse Event|1|||
144343828|NCT02255461|520462283|FG002|Overall Study|Adverse Event|0|||
144343829|NCT02255461|520462284|FG003|Overall Study|Adverse Event|0|||
144343830|NCT02255461|520462285|FG004|Overall Study|Adverse Event|1|||
144343831|NCT02255461|520462281|FG000|Overall Study|Withdrawal by Subject|0|||
144343832|NCT02255461|520462282|FG001|Overall Study|Withdrawal by Subject|0|||
144343833|NCT02255461|520462283|FG002|Overall Study|Withdrawal by Subject|1|||
144343834|NCT02255461|520462284|FG003|Overall Study|Withdrawal by Subject|0|||
144343835|NCT02255461|520462285|FG004|Overall Study|Withdrawal by Subject|1|||
144343836|NCT02255461|520462281|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
144343837|NCT02255461|520462282|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
144343838|NCT02255461|520462283|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
144343839|NCT02255461|520462284|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
144343840|NCT02255461|520462285|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
144343841|NCT02219334|520462286|FG000|Overall Study|Withdrawal by Subject|1|||
144343842|NCT02219334|520462287|FG001|Overall Study|Withdrawal by Subject|0|||
144343843|NCT02219334|520462286|FG000|Overall Study|Protocol Violation|7|||
144343844|NCT02219334|520462287|FG001|Overall Study|Protocol Violation|3|||
144343845|NCT00711971|520462288|FG000|Overall Study|Lost to Follow-up|3|||
144343846|NCT00711971|520462289|FG001|Overall Study|Lost to Follow-up|4|||
144343847|NCT00711971|520462290|FG002|Overall Study|Lost to Follow-up|1|||
144343848|NCT04878211|520462294|FG000|Overall Study|Lost to Follow-up|0|||
144343849|NCT04878211|520462295|FG001|Overall Study|Lost to Follow-up|0|||
144343850|NCT04878211|520462296|FG002|Overall Study|Lost to Follow-up|0|||
144343851|NCT04878211|520462297|FG003|Overall Study|Lost to Follow-up|1|||
144343852|NCT04878211|520462298|FG004|Overall Study|Lost to Follow-up|0|||
144343853|NCT04878211|520462299|FG005|Overall Study|Lost to Follow-up|1|||
144343854|NCT04878211|520462294|FG000|Overall Study|Protocol deviation|1|||
144343855|NCT04878211|520462295|FG001|Overall Study|Protocol deviation|0|||
144343856|NCT04878211|520462296|FG002|Overall Study|Protocol deviation|0|||
144343857|NCT04878211|520462297|FG003|Overall Study|Protocol deviation|0|||
144343858|NCT04878211|520462298|FG004|Overall Study|Protocol deviation|0|||
144343859|NCT04878211|520462299|FG005|Overall Study|Protocol deviation|0|||
144343860|NCT04878211|520462294|FG000|Overall Study|Study terminated by sponsor|0|||
144343861|NCT04878211|520462295|FG001|Overall Study|Study terminated by sponsor|0|||
144343862|NCT04878211|520462296|FG002|Overall Study|Study terminated by sponsor|0|||
144343863|NCT04878211|520462297|FG003|Overall Study|Study terminated by sponsor|0|||
144343864|NCT04878211|520462298|FG004|Overall Study|Study terminated by sponsor|9|||
144343865|NCT04878211|520462299|FG005|Overall Study|Study terminated by sponsor|4|||
144343866|NCT04878211|520462294|FG000|Overall Study|Subject decision|0|||
144343867|NCT04878211|520462295|FG001|Overall Study|Subject decision|0|||
144343868|NCT04878211|520462296|FG002|Overall Study|Subject decision|0|||
144343869|NCT04878211|520462297|FG003|Overall Study|Subject decision|0|||
144343870|NCT04878211|520462298|FG004|Overall Study|Subject decision|1|||
144343871|NCT04878211|520462299|FG005|Overall Study|Subject decision|0|||
144343872|NCT04774926|520462306|FG000|Overall Study|Adverse Event|15|||
144343873|NCT04774926|520462306|FG000|Overall Study|Lost to Follow-up|3|||
144343874|NCT04774926|520462306|FG000|Overall Study|Physician Decision|6|||
144343875|NCT04774926|520462306|FG000|Overall Study|Withdrawal by Subject|3|||
144343876|NCT04774926|520462306|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
144343877|NCT00847886|520462309|FG000|Overall Study|Adverse Event|0|||
144343878|NCT00847886|520462310|FG001|Overall Study|Adverse Event|1|||
144343879|NCT01687101|520462311|FG000|Overall Study|Lost to Follow-up|7|||
144343880|NCT03668613|520462313|FG000|Overall Study|Adverse Event|1|||
144343881|NCT03668613|520462314|FG001|Overall Study|Adverse Event|2|||
144343882|NCT03668613|520462313|FG000|Overall Study|Lack of Efficacy|5|||
144343883|NCT03668613|520462314|FG001|Overall Study|Lack of Efficacy|1|||
144343884|NCT03668613|520462313|FG000|Overall Study|Pregnancy|0|||
144343885|NCT03668613|520462314|FG001|Overall Study|Pregnancy|2|||
144343886|NCT03668613|520462313|FG000|Overall Study|Protocol Violation|1|||
144343887|NCT03668613|520462314|FG001|Overall Study|Protocol Violation|0|||
144343888|NCT03668613|520462313|FG000|Overall Study|Physician Decision|1|||
144343889|NCT03668613|520462314|FG001|Overall Study|Physician Decision|0|||
144343890|NCT03668613|520462313|FG000|Overall Study|Withdrawal by Subject|2|||
144343891|NCT03668613|520462314|FG001|Overall Study|Withdrawal by Subject|1|||
144343892|NCT03668613|520462313|FG000|Overall Study|Guardian decision|1|||
144343893|NCT03668613|520462314|FG001|Overall Study|Guardian decision|0|||
144343894|NCT03386487|520462317|FG000|Overall Study|Lost to Follow-up|5|||
144343895|NCT03386487|520462318|FG001|Overall Study|Lost to Follow-up|6|||
144343896|NCT03386487|520462317|FG000|Overall Study|Withdrawal by Subject|11|||
144343897|NCT03386487|520462318|FG001|Overall Study|Withdrawal by Subject|7|||
144343898|NCT03386487|520462317|FG000|Overall Study|Physician Decision|11|||
144343899|NCT03386487|520462318|FG001|Overall Study|Physician Decision|8|||
144343900|NCT04042909|520462319|FG000|Overall Study|Withdrawal by Subject|1|||
144343901|NCT04042909|520462320|FG001|Overall Study|Withdrawal by Subject|0|||
144343902|NCT04042909|520462321|FG002|Overall Study|Withdrawal by Subject|0|||
144343903|NCT04042909|520462319|FG000|Overall Study|duplicate cases|2|||
144343904|NCT04042909|520462320|FG001|Overall Study|duplicate cases|0|||
144343905|NCT04042909|520462321|FG002|Overall Study|duplicate cases|0|||
144343906|NCT04042909|520462319|FG000|Overall Study|technical problem|0|||
144343907|NCT04042909|520462320|FG001|Overall Study|technical problem|1|||
144343908|NCT04042909|520462321|FG002|Overall Study|technical problem|0|||
144343909|NCT04207060|520462324|FG000|Overall Study|Lost to Follow-up|2|||
144343910|NCT04207060|520462325|FG001|Overall Study|Lost to Follow-up|0|||
144343911|NCT01067144|520462326|FG000|Treatment|Did not receive allocated intervention|4|||
144343912|NCT01067144|520462327|FG001|Treatment|Did not receive allocated intervention|7|||
144343913|NCT01067144|520462326|FG000|Follow-up|Lost to Follow-up|22|||
144343914|NCT01067144|520462327|FG001|Follow-up|Lost to Follow-up|12|||
144343915|NCT01067144|520462326|FG000|Follow-up|Censored owing to second surgery|19|||
144343916|NCT01067144|520462327|FG001|Follow-up|Censored owing to second surgery|28|||
144343917|NCT01067144|520462326|FG000|Follow-up|Withdrawal by Subject|18|||
144343918|NCT01067144|520462327|FG001|Follow-up|Withdrawal by Subject|14|||
144343919|NCT01067144|520462326|FG000|Follow-up|Surgery cancelled|0|||
144343920|NCT01067144|520462327|FG001|Follow-up|Surgery cancelled|1|||
144343921|NCT01067144|520462326|FG000|Follow-up|Death|0|||
144343922|NCT01067144|520462327|FG001|Follow-up|Death|1|||
144343923|NCT01835158|520462330|FG000|Overall Study|Withdrawal by Subject|1|||
144343924|NCT01835158|520462331|FG001|Overall Study|Withdrawal by Subject|6|||
144343925|NCT00296140|520462332|FG000|Overall Study|Lost to Follow-up|1|||
144343926|NCT00296140|520462333|FG001|Overall Study|Lost to Follow-up|0|||
144343927|NCT00296140|520462332|FG000|Overall Study|Withdrawal by Subject|1|||
144343928|NCT00296140|520462333|FG001|Overall Study|Withdrawal by Subject|0|||
144343929|NCT00296140|520462332|FG000|Overall Study|Discharge to Nursing Home|1|||
144343930|NCT00296140|520462333|FG001|Overall Study|Discharge to Nursing Home|0|||
144343931|NCT01856582|520462334|FG000|Overall Study|Died prior to Boost infusion|1|||
144343932|NCT00880191|520462335|FG000|Overall Study|Refused further treatment|4|||
144343933|NCT00880191|520462336|FG001|Overall Study|Refused further treatment|1|||
144343934|NCT00880191|520462335|FG000|Overall Study|Adverse Event|8|||
144343935|NCT00880191|520462336|FG001|Overall Study|Adverse Event|6|||
144343936|NCT00880191|520462335|FG000|Overall Study|Hospitalization/efficacy|1|||
144343937|NCT00880191|520462336|FG001|Overall Study|Hospitalization/efficacy|1|||
144343938|NCT01919801|520462339|FG000|Overall Study|Withdrawal by Subject|1|||
144343939|NCT01919801|520462340|FG001|Overall Study|Withdrawal by Subject|0|||
144343940|NCT01919801|520462339|FG000|Overall Study|Physician Decision|0|||
144343941|NCT01919801|520462340|FG001|Overall Study|Physician Decision|1|||
144343942|NCT01919801|520462339|FG000|Overall Study|Lost to Follow-up|0|||
144343943|NCT01919801|520462340|FG001|Overall Study|Lost to Follow-up|1|||
144343944|NCT01919801|520462339|FG000|Overall Study|Other|0|||
144343945|NCT01919801|520462340|FG001|Overall Study|Other|1|||
144343946|NCT01843062|520462341|FG000|Overall Study|Protocol Violation|1|||
144343947|NCT01843062|520462342|FG001|Overall Study|Protocol Violation|0|||
144343948|NCT01843062|520462341|FG000|Overall Study|New treatment following progression|2|||
144343949|NCT01843062|520462342|FG001|Overall Study|New treatment following progression|0|||
144343950|NCT01843062|520462341|FG000|Overall Study|Pregnancy|1|||
144343951|NCT01843062|520462342|FG001|Overall Study|Pregnancy|0|||
144343952|NCT01843062|520462341|FG000|Overall Study|Adverse Event|2|||
144343953|NCT01843062|520462342|FG001|Overall Study|Adverse Event|0|||
144343954|NCT01843062|520462341|FG000|Overall Study|Incorrect randomisation|1|||
144343955|NCT01843062|520462342|FG001|Overall Study|Incorrect randomisation|0|||
144343956|NCT01843062|520462341|FG000|Overall Study|Withdrawal by Subject|12|||
144343957|NCT01843062|520462342|FG001|Overall Study|Withdrawal by Subject|3|||
144343958|NCT01843062|520462341|FG000|Overall Study|Death|1|||
144343959|NCT01843062|520462342|FG001|Overall Study|Death|2|||
144343960|NCT01843062|520462341|FG000|Overall Study|Lost to Follow-up|2|||
144343961|NCT01843062|520462342|FG001|Overall Study|Lost to Follow-up|4|||
144343962|NCT01677858|520462343|FG000|Overall Study|Adverse Event|0|||
144343963|NCT01677858|520462344|FG001|Overall Study|Adverse Event|0|||
144343964|NCT01677858|520462345|FG002|Overall Study|Adverse Event|2|||
144343965|NCT01677858|520462346|FG003|Overall Study|Adverse Event|3|||
144343966|NCT01677858|520462347|FG004|Overall Study|Adverse Event|13|||
144343967|NCT01677858|520462343|FG000|Overall Study|Death|0|||
144343968|NCT01677858|520462344|FG001|Overall Study|Death|0|||
144343969|NCT01677858|520462345|FG002|Overall Study|Death|0|||
144343970|NCT01677858|520462346|FG003|Overall Study|Death|0|||
144343971|NCT01677858|520462347|FG004|Overall Study|Death|1|||
144343972|NCT01677858|520462343|FG000|Overall Study|Physician Decision|1|||
144343973|NCT01677858|520462344|FG001|Overall Study|Physician Decision|0|||
144343974|NCT01677858|520462345|FG002|Overall Study|Physician Decision|2|||
144343975|NCT01677858|520462346|FG003|Overall Study|Physician Decision|0|||
144343976|NCT01677858|520462347|FG004|Overall Study|Physician Decision|12|||
144343977|NCT01677858|520462343|FG000|Overall Study|Progressive Disease|2|||
144343978|NCT01677858|520462344|FG001|Overall Study|Progressive Disease|1|||
144343979|NCT01677858|520462345|FG002|Overall Study|Progressive Disease|9|||
144343980|NCT01677858|520462346|FG003|Overall Study|Progressive Disease|3|||
144343981|NCT01677858|520462347|FG004|Overall Study|Progressive Disease|43|||
144343982|NCT01677858|520462343|FG000|Overall Study|Withdrawal by Subject|0|||
144343983|NCT01677858|520462344|FG001|Overall Study|Withdrawal by Subject|1|||
144343984|NCT01677858|520462345|FG002|Overall Study|Withdrawal by Subject|1|||
144343985|NCT01677858|520462346|FG003|Overall Study|Withdrawal by Subject|0|||
144343986|NCT01677858|520462347|FG004|Overall Study|Withdrawal by Subject|15|||
144343987|NCT01677858|520462343|FG000|Overall Study|Lost to Follow-up|0|||
144343988|NCT01677858|520462344|FG001|Overall Study|Lost to Follow-up|0|||
144343989|NCT01677858|520462345|FG002|Overall Study|Lost to Follow-up|0|||
144343990|NCT01677858|520462346|FG003|Overall Study|Lost to Follow-up|0|||
144343991|NCT01677858|520462347|FG004|Overall Study|Lost to Follow-up|1|||
144343992|NCT01331109|520462348|FG000|Overall Study|Adverse Event|6|||
144343993|NCT01331109|520462348|FG000|Overall Study|Lack of Efficacy|2|||
144343994|NCT01331109|520462348|FG000|Overall Study|Protocol Violation|3|||
144343995|NCT01331109|520462348|FG000|Overall Study|Withdrawal by Subject|7|||
144343996|NCT01331109|520462348|FG000|Overall Study|Lost to Follow-up|1|||
144343997|NCT01331109|520462348|FG000|Overall Study|Study Terminated by Sponsor|38|||
144343998|NCT00988091|520462352|FG000|Double-blind Period|Withdrawal by Subject|15|||
144343999|NCT00988091|520462353|FG001|Double-blind Period|Withdrawal by Subject|13|||
144344000|NCT00988091|520462352|FG000|Double-blind Period|Lost to Follow-up|12|||
144344001|NCT00988091|520462353|FG001|Double-blind Period|Lost to Follow-up|14|||
144344002|NCT00988091|520462352|FG000|Double-blind Period|Other|8|||
144344003|NCT00988091|520462353|FG001|Double-blind Period|Other|8|||
144344004|NCT00988091|520462352|FG000|Double-blind Period|Adverse Event|6|||
144344005|NCT00988091|520462353|FG001|Double-blind Period|Adverse Event|9|||
144344006|NCT00988091|520462352|FG000|Double-blind Period|Use of exclusionary medication|2|||
144344007|NCT00988091|520462353|FG001|Double-blind Period|Use of exclusionary medication|3|||
144344008|NCT00988091|520462352|FG000|Open-label Period|Adverse Event|4|||
144344009|NCT00988091|520462353|FG001|Open-label Period|Adverse Event|7|||
144344010|NCT00988091|520462352|FG000|Open-label Period|Use of exclusionary medication|1|||
144344011|NCT00988091|520462353|FG001|Open-label Period|Use of exclusionary medication|1|||
144344012|NCT00988091|520462352|FG000|Open-label Period|Protocol Violation|1|||
144344013|NCT00988091|520462353|FG001|Open-label Period|Protocol Violation|1|||
144344014|NCT00988091|520462352|FG000|Open-label Period|Withdrawal by Subject|10|||
144344015|NCT00988091|520462353|FG001|Open-label Period|Withdrawal by Subject|16|||
144344016|NCT00988091|520462352|FG000|Open-label Period|Lost to Follow-up|3|||
144344017|NCT00988091|520462353|FG001|Open-label Period|Lost to Follow-up|5|||
144344018|NCT00988091|520462352|FG000|Open-label Period|Other|2|||
144344019|NCT00988091|520462353|FG001|Open-label Period|Other|3|||
144344020|NCT02669212|520462356|FG000|Overall Study|Lost to Follow-up|1|||
144344021|NCT02669212|520462357|FG001|Overall Study|Lost to Follow-up|0|||
144344022|NCT02669212|520462356|FG000|Overall Study|Medical Condition|3|||
144344023|NCT02669212|520462357|FG001|Overall Study|Medical Condition|4|||
144344024|NCT02669212|520462356|FG000|Overall Study|Withdrawal by Subject|0|||
144344025|NCT02669212|520462357|FG001|Overall Study|Withdrawal by Subject|2|||
144344026|NCT02669212|520462356|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
144344027|NCT02669212|520462357|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
144344028|NCT03549104|520462358|FG000|Overall Study|Withdrawal by Subject|5|||
144344029|NCT03549104|520462359|FG001|Overall Study|Withdrawal by Subject|2|||
144344030|NCT03549104|520462358|FG000|Overall Study|Covid shelter in place|1|||
144344031|NCT03549104|520462359|FG001|Overall Study|Covid shelter in place|2|||
144344032|NCT03078855|520462363|FG000|Overall Study|Lack of Efficacy|62|||
144344033|NCT03078855|520462364|FG001|Overall Study|Lack of Efficacy|31|||
144344034|NCT03078855|520462363|FG000|Overall Study|Death|1|||
144344035|NCT03078855|520462364|FG001|Overall Study|Death|0|||
144344036|NCT03078855|520462363|FG000|Overall Study|Withdrawal by Subject|12|||
144344037|NCT03078855|520462364|FG001|Overall Study|Withdrawal by Subject|6|||
144344038|NCT03078855|520462363|FG000|Overall Study|Physician Decision|3|||
144344039|NCT03078855|520462364|FG001|Overall Study|Physician Decision|2|||
144344040|NCT03078855|520462363|FG000|Overall Study|Second Malignancy|4|||
144344041|NCT03078855|520462364|FG001|Overall Study|Second Malignancy|0|||
144344042|NCT03078855|520462363|FG000|Overall Study|Ineligible|2|||
144344043|NCT03078855|520462364|FG001|Overall Study|Ineligible|0|||
144344044|NCT03078855|520462363|FG000|Overall Study|Withdrew before day 1 treatment|2|||
144344045|NCT03078855|520462364|FG001|Overall Study|Withdrew before day 1 treatment|1|||
144344046|NCT00391027|520462365|FG000|Overall Study|Adverse Event|8|||
144344047|NCT00391027|520462366|FG001|Overall Study|Adverse Event|8|||
144344048|NCT00391027|520462365|FG000|Overall Study|Lack of Efficacy|3|||
144344049|NCT00391027|520462366|FG001|Overall Study|Lack of Efficacy|0|||
144344050|NCT00391027|520462365|FG000|Overall Study|Withdrawal by Subject|10|||
144344051|NCT00391027|520462366|FG001|Overall Study|Withdrawal by Subject|1|||
144344052|NCT00391027|520462365|FG000|Overall Study|Other|4|||
144344053|NCT00391027|520462366|FG001|Overall Study|Other|3|||
144344054|NCT00479856|520462367|FG000|Overall Study|Adverse Event|1|||
144344055|NCT00479856|520462367|FG000|Overall Study|Withdrawal by Subject|1|||
144344056|NCT00479856|520462367|FG000|Overall Study|Physician Decision|1|||
144344057|NCT04164732|520462371|FG000|Treatment run-in Period|Adverse Event|4|||
144344058|NCT04164732|520462372|FG001|Treatment run-in Period|Adverse Event|0|||
144344059|NCT04164732|520462373|FG002|Treatment run-in Period|Adverse Event|0|||
144344060|NCT04164732|520462371|FG000|Treatment run-in Period|Physician Decision|1|||
144344061|NCT04164732|520462372|FG001|Treatment run-in Period|Physician Decision|0|||
144344062|NCT04164732|520462373|FG002|Treatment run-in Period|Physician Decision|0|||
144344063|NCT04164732|520462371|FG000|Treatment run-in Period|Screen Failure|1|||
144344064|NCT04164732|520462372|FG001|Treatment run-in Period|Screen Failure|0|||
144344065|NCT04164732|520462373|FG002|Treatment run-in Period|Screen Failure|0|||
144344066|NCT04164732|520462371|FG000|Randomized Treatment Period|Adverse Event|0|||
144344067|NCT04164732|520462372|FG001|Randomized Treatment Period|Adverse Event|1|||
144344068|NCT04164732|520462373|FG002|Randomized Treatment Period|Adverse Event|0|||
144344069|NCT04164732|520462371|FG000|Randomized Treatment Period|Protocol Deviation|0|||
144344070|NCT04164732|520462372|FG001|Randomized Treatment Period|Protocol Deviation|1|||
144344071|NCT04164732|520462373|FG002|Randomized Treatment Period|Protocol Deviation|1|||
144344072|NCT04164732|520462371|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
144344073|NCT04164732|520462372|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
144344074|NCT04164732|520462373|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
144344075|NCT00661622|520462374|FG000|Overall Study|Protocol Violation|1|||
144344076|NCT00661622|520462375|FG001|Overall Study|Protocol Violation|0|||
144344077|NCT00395850|520462377|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
144344078|NCT00395850|520462378|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
144344079|NCT00395850|520462379|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
144344080|NCT00395850|520462380|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
144344081|NCT00395850|520462377|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
144344082|NCT00395850|520462378|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
144344083|NCT00395850|520462379|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
144344084|NCT00395850|520462380|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
144344085|NCT00395850|520462377|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
144344086|NCT00395850|520462378|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
144344087|NCT00395850|520462379|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
144344088|NCT00395850|520462380|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
144344089|NCT00395850|520462377|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
144344090|NCT00395850|520462378|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
144344091|NCT00395850|520462379|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
144344092|NCT00395850|520462380|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
144344093|NCT00395850|520462377|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
144344094|NCT00395850|520462378|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
144344095|NCT00395850|520462379|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
144344096|NCT00395850|520462380|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
144344097|NCT00395850|520462377|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
144344098|NCT00395850|520462378|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
144344099|NCT00395850|520462379|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
144344100|NCT00395850|520462380|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
144344101|NCT00395850|520462377|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
144344102|NCT00395850|520462378|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
144344103|NCT00395850|520462379|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
144344104|NCT00395850|520462380|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
144344105|NCT01844778|520462385|FG000|Overall Study|Protocol deviation|0|||
144344106|NCT01844778|520462386|FG001|Overall Study|Protocol deviation|1|||
144344107|NCT01844778|520462387|FG002|Overall Study|Protocol deviation|2|||
144344108|NCT01844778|520462385|FG000|Overall Study|Withdrawal by Subject|2|||
144344109|NCT01844778|520462386|FG001|Overall Study|Withdrawal by Subject|0|||
144344110|NCT01844778|520462387|FG002|Overall Study|Withdrawal by Subject|0|||
144344111|NCT01844778|520462385|FG000|Overall Study|Adverse Event|0|||
144344112|NCT01844778|520462386|FG001|Overall Study|Adverse Event|2|||
144344113|NCT01844778|520462387|FG002|Overall Study|Adverse Event|2|||
144344114|NCT01620762|520462389|FG000|Overall Study|Protocol Violation|1|||
144344115|NCT01620762|520462390|FG001|Overall Study|Protocol Violation|1|||
144344116|NCT01620762|520462391|FG002|Overall Study|Protocol Violation|1|||
144344117|NCT01620762|520462389|FG000|Overall Study|Adverse Event|9|||
144344118|NCT01620762|520462390|FG001|Overall Study|Adverse Event|5|||
144344119|NCT01620762|520462391|FG002|Overall Study|Adverse Event|2|||
144344120|NCT01620762|520462389|FG000|Overall Study|Withdrawal by Subject|23|||
144344121|NCT01620762|520462390|FG001|Overall Study|Withdrawal by Subject|26|||
144344122|NCT01620762|520462391|FG002|Overall Study|Withdrawal by Subject|27|||
144344123|NCT01620762|520462389|FG000|Overall Study|Lost to Follow-up|11|||
144344124|NCT01620762|520462390|FG001|Overall Study|Lost to Follow-up|17|||
144344125|NCT01620762|520462391|FG002|Overall Study|Lost to Follow-up|10|||
144344126|NCT01620762|520462389|FG000|Overall Study|Protocol deviation|1|||
144344127|NCT01620762|520462390|FG001|Overall Study|Protocol deviation|1|||
144344128|NCT01620762|520462391|FG002|Overall Study|Protocol deviation|6|||
144344129|NCT01620762|520462389|FG000|Overall Study|Subject deterioration|0|||
144344130|NCT01620762|520462390|FG001|Overall Study|Subject deterioration|1|||
144344131|NCT01620762|520462391|FG002|Overall Study|Subject deterioration|1|||
144344132|NCT01620762|520462389|FG000|Overall Study|Non-specified|3|||
144344133|NCT01620762|520462390|FG001|Overall Study|Non-specified|6|||
144344134|NCT01620762|520462391|FG002|Overall Study|Non-specified|5|||
144344135|NCT01620762|520462389|FG000|Overall Study|Use of prohibted therapies|0|||
144344136|NCT01620762|520462390|FG001|Overall Study|Use of prohibted therapies|1|||
144344137|NCT01620762|520462391|FG002|Overall Study|Use of prohibted therapies|1|||
144344138|NCT00705146|520462396|FG000|Overall Study|Lost to Follow-up|1|||
144344139|NCT00705146|520462397|FG001|Overall Study|Lost to Follow-up|1|||
144344140|NCT02951429|520462405|FG000|Overall Study|Adverse Event|3|||
144344141|NCT02951429|520462406|FG001|Overall Study|Adverse Event|7|||
144344142|NCT02951429|520462405|FG000|Overall Study|Death|28|||
144344143|NCT02951429|520462406|FG001|Overall Study|Death|36|||
144344144|NCT02951429|520462405|FG000|Overall Study|Lack of Efficacy|0|||
144344145|NCT02951429|520462406|FG001|Overall Study|Lack of Efficacy|1|||
144344146|NCT02951429|520462405|FG000|Overall Study|Lost to Follow-up|0|||
144344147|NCT02951429|520462406|FG001|Overall Study|Lost to Follow-up|1|||
144344148|NCT02951429|520462405|FG000|Overall Study|Lung Transplantation|9|||
144344149|NCT02951429|520462406|FG001|Overall Study|Lung Transplantation|6|||
144344150|NCT02951429|520462405|FG000|Overall Study|Other|1|||
144344151|NCT02951429|520462406|FG001|Overall Study|Other|3|||
144344152|NCT02951429|520462405|FG000|Overall Study|Progressive Disease|1|||
144344153|NCT02951429|520462406|FG001|Overall Study|Progressive Disease|1|||
144344154|NCT02951429|520462405|FG000|Overall Study|Withdrawal by Subject|7|||
144344155|NCT02951429|520462406|FG001|Overall Study|Withdrawal by Subject|11|||
144344156|NCT02951429|520462405|FG000|Overall Study|Participant ongoing in the study|23|||
144344157|NCT02951429|520462406|FG001|Overall Study|Participant ongoing in the study|17|||
144344158|NCT01620528|520462407|FG000|Treatment Period|Did Not Receive Study Drug|0|||
144344159|NCT01620528|520462408|FG001|Treatment Period|Did Not Receive Study Drug|0|||
144344160|NCT01620528|520462409|FG002|Treatment Period|Did Not Receive Study Drug|1|||
144344161|NCT01620528|520462407|FG000|Treatment Period|Withdrawal by Subject|35|||
144344162|NCT01620528|520462408|FG001|Treatment Period|Withdrawal by Subject|21|||
144344163|NCT01620528|520462409|FG002|Treatment Period|Withdrawal by Subject|16|||
144344164|NCT01620528|520462407|FG000|Treatment Period|Adverse Event|17|||
144344165|NCT01620528|520462408|FG001|Treatment Period|Adverse Event|13|||
144344166|NCT01620528|520462409|FG002|Treatment Period|Adverse Event|21|||
144344167|NCT01620528|520462407|FG000|Treatment Period|Lost to Follow-up|16|||
144344168|NCT01620528|520462408|FG001|Treatment Period|Lost to Follow-up|8|||
144344169|NCT01620528|520462409|FG002|Treatment Period|Lost to Follow-up|14|||
144344170|NCT01620528|520462407|FG000|Treatment Period|Other|9|||
144344171|NCT01620528|520462408|FG001|Treatment Period|Other|5|||
144344172|NCT01620528|520462409|FG002|Treatment Period|Other|7|||
144344173|NCT01620528|520462407|FG000|Treatment Period|Subject Noncompliant|11|||
144344174|NCT01620528|520462408|FG001|Treatment Period|Subject Noncompliant|2|||
144344175|NCT01620528|520462409|FG002|Treatment Period|Subject Noncompliant|2|||
144344176|NCT01620528|520462407|FG000|Treatment Period|Pregnancy|7|||
144344177|NCT01620528|520462408|FG001|Treatment Period|Pregnancy|2|||
144344178|NCT01620528|520462409|FG002|Treatment Period|Pregnancy|2|||
144344179|NCT01620528|520462407|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
144344180|NCT01620528|520462408|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
144344181|NCT01620528|520462409|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
144344182|NCT01620528|520462407|FG000|Treatment Period|Exclusionary Medication Received|0|||
144344183|NCT01620528|520462408|FG001|Treatment Period|Exclusionary Medication Received|1|||
144344184|NCT01620528|520462409|FG002|Treatment Period|Exclusionary Medication Received|0|||
144344185|NCT01620528|520462407|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
144344186|NCT01620528|520462408|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
144344187|NCT01620528|520462409|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
144344188|NCT01620528|520462407|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
144344189|NCT01620528|520462408|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
144344190|NCT01620528|520462409|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
144344191|NCT01620528|520462407|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
144344192|NCT01620528|520462408|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
144344193|NCT01620528|520462409|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
144344194|NCT01620528|520462407|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
144344195|NCT01620528|520462408|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
144344196|NCT01620528|520462409|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
144344197|NCT01620528|520462407|FG000|Post-Treatment Follow-Up Period|Other|6|||
144344198|NCT01620528|520462408|FG001|Post-Treatment Follow-Up Period|Other|4|||
144344199|NCT01620528|520462409|FG002|Post-Treatment Follow-Up Period|Other|2|||
144344200|NCT00767819|520462412|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
144344201|NCT00767819|520462413|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
144344202|NCT00767819|520462414|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
144344203|NCT00767819|520462412|FG000|Overall Study|Withdrawal by Subject|1|||
144344204|NCT00767819|520462413|FG001|Overall Study|Withdrawal by Subject|1|||
144344205|NCT00767819|520462414|FG002|Overall Study|Withdrawal by Subject|0|||
144344206|NCT00767819|520462412|FG000|Overall Study|Administrative problems|0|||
144344207|NCT00767819|520462413|FG001|Overall Study|Administrative problems|1|||
144344208|NCT00767819|520462414|FG002|Overall Study|Administrative problems|0|||
144344209|NCT00767819|520462412|FG000|Overall Study|Death|2|||
144344210|NCT00767819|520462413|FG001|Overall Study|Death|3|||
144344211|NCT00767819|520462414|FG002|Overall Study|Death|0|||
144344212|NCT00767819|520462412|FG000|Overall Study|Adverse Event|2|||
144344213|NCT00767819|520462413|FG001|Overall Study|Adverse Event|0|||
144344214|NCT00767819|520462414|FG002|Overall Study|Adverse Event|0|||
144344215|NCT00767819|520462412|FG000|Overall Study|Abnormal lab values|1|||
144344216|NCT00767819|520462413|FG001|Overall Study|Abnormal lab values|0|||
144344217|NCT00767819|520462414|FG002|Overall Study|Abnormal lab values|0|||
144344218|NCT00767819|520462412|FG000|Overall Study|Lost to Follow-up|1|||
144344219|NCT00767819|520462413|FG001|Overall Study|Lost to Follow-up|0|||
144344220|NCT00767819|520462414|FG002|Overall Study|Lost to Follow-up|0|||
144344221|NCT01628965|520462415|FG000|Overall Study|Adverse Event|30|||
144344222|NCT01628965|520462415|FG000|Overall Study|Lack of Efficacy|7|||
144344223|NCT01628965|520462415|FG000|Overall Study|Withdrawal by Subject|3|||
144344224|NCT01628965|520462415|FG000|Overall Study|Lost to Follow-up|1|||
144344225|NCT01628965|520462415|FG000|Overall Study|Discontinuation criteria|8|||
144344226|NCT04356352|520462418|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
144344227|NCT04356352|520462419|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
144344228|NCT04356352|520462420|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
144344229|NCT04356352|520462418|FG000|Overall Study|Protocol Violation|0|||
144344230|NCT04356352|520462419|FG001|Overall Study|Protocol Violation|3|||
144344231|NCT04356352|520462420|FG002|Overall Study|Protocol Violation|1|||
144344232|NCT01138501|520462421|FG000|Overall Study|Protocol Violation|2|||
144344233|NCT01138501|520462421|FG000|Overall Study|Withdrawal by Subject|3|||
144344234|NCT00847197|520462422|FG000|Overall Study|Adverse Event|21|||
144344235|NCT00847197|520462423|FG001|Overall Study|Adverse Event|3|||
144344236|NCT00847197|520462422|FG000|Overall Study|Protocol Violation|0|||
144344237|NCT00847197|520462423|FG001|Overall Study|Protocol Violation|1|||
144344238|NCT00847197|520462422|FG000|Overall Study|Withdrawal by Subject|3|||
144344239|NCT00847197|520462423|FG001|Overall Study|Withdrawal by Subject|1|||
144344240|NCT05128578|520465203|FG000|Overall Study|Withdrawal by Subject|9|||
144344241|NCT05128578|520465203|FG000|Overall Study|Lost to Follow-up|5|||
144344242|NCT02679755|520465204|FG000|Overall Study|Death|0|||
144344243|NCT02679755|520465205|FG001|Overall Study|Death|3|||
144344244|NCT02679755|520465204|FG000|Overall Study|Global deterioration of health status|1|||
144344245|NCT02679755|520465205|FG001|Overall Study|Global deterioration of health status|8|||
144344246|NCT02679755|520465204|FG000|Overall Study|Lost to Follow-up|1|||
144344247|NCT02679755|520465205|FG001|Overall Study|Lost to Follow-up|0|||
144344248|NCT02679755|520465204|FG000|Overall Study|Objective progression or relapse|24|||
144344249|NCT02679755|520465205|FG001|Overall Study|Objective progression or relapse|83|||
144344250|NCT02679755|520465204|FG000|Overall Study|Not defined|0|||
144344251|NCT02679755|520465205|FG001|Overall Study|Not defined|2|||
144344252|NCT02679755|520465204|FG000|Overall Study|Withdrawal by participant|6|||
144344253|NCT02679755|520465205|FG001|Overall Study|Withdrawal by participant|3|||
144344254|NCT02679755|520465204|FG000|Overall Study|Adverse Event|1|||
144344255|NCT02679755|520465205|FG001|Overall Study|Adverse Event|4|||
144344256|NCT02679755|520465204|FG000|Overall Study|Adverse events not related to study drug|1|||
144344257|NCT02679755|520465205|FG001|Overall Study|Adverse events not related to study drug|2|||
144344258|NCT01061359|520465206|FG000|Overall Study|Death|32|||
144344259|NCT01061359|520465206|FG000|Overall Study|Lost to Follow-up|1072|||
144344260|NCT01061359|520465206|FG000|Overall Study|Relapse|187|||
144344261|NCT01061359|520465206|FG000|Overall Study|Secondary neoplasm|11|||
144344262|NCT02610777|520465209|FG000|Overall Study|Lost to Follow-up|1|||
144344263|NCT02610777|520465210|FG001|Overall Study|Lost to Follow-up|0|||
144344264|NCT02610777|520465209|FG000|Overall Study|Site Terminated by Sponsor|9|||
144344265|NCT02610777|520465210|FG001|Overall Study|Site Terminated by Sponsor|8|||
144344266|NCT02610777|520465209|FG000|Overall Study|Withdrawal by Subject|2|||
144344267|NCT02610777|520465210|FG001|Overall Study|Withdrawal by Subject|2|||
144344268|NCT02610777|520465209|FG000|Overall Study|Reason not Specified|0|||
144344269|NCT02610777|520465210|FG001|Overall Study|Reason not Specified|1|||
144344270|NCT02610777|520465209|FG000|Overall Study|Death|50|||
144344271|NCT02610777|520465210|FG001|Overall Study|Death|47|||
144344272|NCT00660179|520465211|FG000|Overall Study|Death|44|||
144344273|NCT00660179|520465212|FG001|Overall Study|Death|47|||
144344274|NCT00660179|520465213|FG002|Overall Study|Death|34|||
144344275|NCT00660179|520465211|FG000|Overall Study|Withdrawal of consent|4|||
144344276|NCT00660179|520465212|FG001|Overall Study|Withdrawal of consent|6|||
144344277|NCT00660179|520465213|FG002|Overall Study|Withdrawal of consent|4|||
144344278|NCT00660179|520465211|FG000|Overall Study|Lost to Follow-up|7|||
144344279|NCT00660179|520465212|FG001|Overall Study|Lost to Follow-up|5|||
144344280|NCT00660179|520465213|FG002|Overall Study|Lost to Follow-up|2|||
144344281|NCT00660179|520465211|FG000|Overall Study|Administrative reason|0|||
144344282|NCT00660179|520465212|FG001|Overall Study|Administrative reason|0|||
144344283|NCT00660179|520465213|FG002|Overall Study|Administrative reason|1|||
144344284|NCT00660179|520465211|FG000|Overall Study|Incorrect randomization|1|||
144344285|NCT00660179|520465212|FG001|Overall Study|Incorrect randomization|0|||
144344286|NCT00660179|520465213|FG002|Overall Study|Incorrect randomization|0|||
144344287|NCT04171219|520465218|FG000|Overall Study|Adverse Event|1|||
144344288|NCT04171219|520465219|FG001|Overall Study|Adverse Event|0|||
144344289|NCT04171219|520465218|FG000|Overall Study|Death|0|||
144344290|NCT04171219|520465219|FG001|Overall Study|Death|1|||
144344291|NCT04171219|520465218|FG000|Overall Study|Lack of Efficacy|9|||
144344292|NCT04171219|520465219|FG001|Overall Study|Lack of Efficacy|13|||
144344293|NCT04171219|520465218|FG000|Overall Study|Withdrawal by Subject|1|||
144344294|NCT04171219|520465219|FG001|Overall Study|Withdrawal by Subject|2|||
144344295|NCT04171219|520465218|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
144344296|NCT04171219|520465219|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
144344297|NCT04171219|520465218|FG000|Overall Study|Clinical PD/Patient choice|1|||
144344298|NCT04171219|520465219|FG001|Overall Study|Clinical PD/Patient choice|0|||
144344299|NCT04171219|520465218|FG000|Overall Study|Toxicity/ Patient choice|1|||
144344300|NCT04171219|520465219|FG001|Overall Study|Toxicity/ Patient choice|0|||
144344301|NCT02974257|520465222|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
144344302|NCT02974257|520465223|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
144344303|NCT02974257|520465222|FG000|Overall Study|Clinical indication for thiamine|1|||
144344304|NCT02974257|520465223|FG001|Overall Study|Clinical indication for thiamine|0|||
144344305|NCT02974257|520465222|FG000|Overall Study|Already on thiamine|1|||
144344306|NCT02974257|520465223|FG001|Overall Study|Already on thiamine|0|||
144344307|NCT02974257|520465222|FG000|Overall Study|Extubated prior to study drug|0|||
144344308|NCT02974257|520465223|FG001|Overall Study|Extubated prior to study drug|1|||
144344309|NCT02974257|520465222|FG000|Overall Study|Death|0|||
144344310|NCT02974257|520465223|FG001|Overall Study|Death|1|||
144344311|NCT00398567|520465226|FG000|Overall Study|Disease Progression|3|||
144344312|NCT00398567|520465227|FG001|Overall Study|Disease Progression|4|||
144344313|NCT00398567|520465228|FG002|Overall Study|Disease Progression|27|||
144344314|NCT00398567|520465226|FG000|Overall Study|Withdrawal by Subject|1|||
144344315|NCT00398567|520465227|FG001|Overall Study|Withdrawal by Subject|0|||
144344316|NCT00398567|520465228|FG002|Overall Study|Withdrawal by Subject|4|||
144344317|NCT00398567|520465226|FG000|Overall Study|Adverse Event|0|||
144344318|NCT00398567|520465227|FG001|Overall Study|Adverse Event|0|||
144344319|NCT00398567|520465228|FG002|Overall Study|Adverse Event|2|||
144344320|NCT00398567|520465226|FG000|Overall Study|Protocol Violation|0|||
144344321|NCT00398567|520465227|FG001|Overall Study|Protocol Violation|0|||
144344322|NCT00398567|520465228|FG002|Overall Study|Protocol Violation|1|||
144344323|NCT03437577|520465233|FG000|Pre-Randomization|Withdrawal by Subject|0|||
144344324|NCT03437577|520465234|FG001|Pre-Randomization|Withdrawal by Subject|0|||
144344325|NCT03437577|520465235|FG002|Pre-Randomization|Withdrawal by Subject|10|||
144344326|NCT03437577|520465233|FG000|Post-Randomization|Physician Decision|0|||
144344327|NCT03437577|520465234|FG001|Post-Randomization|Physician Decision|2|||
144344328|NCT03437577|520465235|FG002|Post-Randomization|Physician Decision|0|||
144344329|NCT00536471|520465238|FG000|Overall Study|Lost to Follow-up|48|||
144344330|NCT00536471|520465239|FG001|Overall Study|Lost to Follow-up|23|||
144344331|NCT00536471|520465240|FG002|Overall Study|Lost to Follow-up|48|||
144344332|NCT00536471|520465241|FG003|Overall Study|Lost to Follow-up|22|||
144344333|NCT00536471|520465238|FG000|Overall Study|Adverse Event|32|||
144344334|NCT00536471|520465239|FG001|Overall Study|Adverse Event|16|||
144344335|NCT00536471|520465240|FG002|Overall Study|Adverse Event|28|||
144344336|NCT00536471|520465241|FG003|Overall Study|Adverse Event|13|||
144344337|NCT00536471|520465238|FG000|Overall Study|Withdrawal by Subject|40|||
144344338|NCT00536471|520465239|FG001|Overall Study|Withdrawal by Subject|24|||
144344339|NCT00536471|520465240|FG002|Overall Study|Withdrawal by Subject|43|||
144344340|NCT00536471|520465241|FG003|Overall Study|Withdrawal by Subject|21|||
144344341|NCT00536471|520465238|FG000|Overall Study|Lack of Efficacy|17|||
144344342|NCT00536471|520465239|FG001|Overall Study|Lack of Efficacy|18|||
144344343|NCT00536471|520465240|FG002|Overall Study|Lack of Efficacy|11|||
144344344|NCT00536471|520465241|FG003|Overall Study|Lack of Efficacy|9|||
144344345|NCT00536471|520465238|FG000|Overall Study|Protocol Violation|8|||
144344346|NCT00536471|520465239|FG001|Overall Study|Protocol Violation|1|||
144344347|NCT00536471|520465240|FG002|Overall Study|Protocol Violation|2|||
144344348|NCT00536471|520465241|FG003|Overall Study|Protocol Violation|3|||
144344349|NCT00536471|520465238|FG000|Overall Study|Physician Decision|11|||
144344350|NCT00536471|520465239|FG001|Overall Study|Physician Decision|1|||
144344351|NCT00536471|520465240|FG002|Overall Study|Physician Decision|3|||
144344352|NCT00536471|520465241|FG003|Overall Study|Physician Decision|2|||
144344353|NCT00536471|520465238|FG000|Overall Study|Death|0|||
144344354|NCT00536471|520465239|FG001|Overall Study|Death|0|||
144344355|NCT00536471|520465240|FG002|Overall Study|Death|1|||
144344356|NCT00536471|520465241|FG003|Overall Study|Death|2|||
144344357|NCT00536471|520465238|FG000|Overall Study|Sponsor Decision|0|||
144344358|NCT00536471|520465239|FG001|Overall Study|Sponsor Decision|1|||
144344359|NCT00536471|520465240|FG002|Overall Study|Sponsor Decision|3|||
144344360|NCT00536471|520465241|FG003|Overall Study|Sponsor Decision|2|||
144344361|NCT04273893|520465244|FG000|Overall Study|Withdrawal by Subject|0|||
144344362|NCT04273893|520465245|FG001|Overall Study|Withdrawal by Subject|2|||
144344363|NCT04273893|520465244|FG000|Overall Study|Treatment of Disease Progression|0|||
144344364|NCT04273893|520465245|FG001|Overall Study|Treatment of Disease Progression|2|||
144344365|NCT04273893|520465244|FG000|Overall Study|Death|1|||
144344366|NCT04273893|520465245|FG001|Overall Study|Death|2|||
144344367|NCT04273893|520465244|FG000|Overall Study|Lost to Follow-up|0|||
144344368|NCT04273893|520465245|FG001|Overall Study|Lost to Follow-up|2|||
144344369|NCT04273893|520465244|FG000|Overall Study|Physician Decision|1|||
144344370|NCT04273893|520465245|FG001|Overall Study|Physician Decision|0|||
144344371|NCT00856544|520465254|FG000|Overall Study|Randomized but not treated|3|||
144344372|NCT00856544|520465255|FG001|Overall Study|Randomized but not treated|0|||
144344373|NCT00856544|520465256|FG002|Overall Study|Randomized but not treated|0|||
144344374|NCT00856544|520465257|FG003|Overall Study|Randomized but not treated|0|||
144344375|NCT00856544|520465254|FG000|Overall Study|Death|0|||
144344376|NCT00856544|520465255|FG001|Overall Study|Death|2|||
144344377|NCT00856544|520465256|FG002|Overall Study|Death|0|||
144344378|NCT00856544|520465257|FG003|Overall Study|Death|0|||
144344379|NCT00856544|520465254|FG000|Overall Study|Adverse Event|20|||
144344380|NCT00856544|520465255|FG001|Overall Study|Adverse Event|29|||
144344381|NCT00856544|520465256|FG002|Overall Study|Adverse Event|2|||
144344382|NCT00856544|520465257|FG003|Overall Study|Adverse Event|3|||
144344383|NCT00856544|520465254|FG000|Overall Study|Lack of Efficacy|16|||
144344384|NCT00856544|520465255|FG001|Overall Study|Lack of Efficacy|12|||
144344385|NCT00856544|520465256|FG002|Overall Study|Lack of Efficacy|3|||
144344386|NCT00856544|520465257|FG003|Overall Study|Lack of Efficacy|3|||
144344387|NCT00856544|520465254|FG000|Overall Study|Other|9|||
144344388|NCT00856544|520465255|FG001|Overall Study|Other|16|||
144344389|NCT00856544|520465256|FG002|Overall Study|Other|1|||
144344390|NCT00856544|520465257|FG003|Overall Study|Other|6|||
144344391|NCT00856544|520465254|FG000|Overall Study|Lost to Follow-up|1|||
144344392|NCT00856544|520465255|FG001|Overall Study|Lost to Follow-up|2|||
144344393|NCT00856544|520465256|FG002|Overall Study|Lost to Follow-up|2|||
144344394|NCT00856544|520465257|FG003|Overall Study|Lost to Follow-up|0|||
144344395|NCT00856544|520465254|FG000|Overall Study|Withdrawal by Subject|8|||
144344396|NCT00856544|520465255|FG001|Overall Study|Withdrawal by Subject|5|||
144344397|NCT00856544|520465256|FG002|Overall Study|Withdrawal by Subject|0|||
144344398|NCT00856544|520465257|FG003|Overall Study|Withdrawal by Subject|1|||
144344399|NCT01036321|520465258|FG000|Overall Study|Ineligible after randomization|0|||
144344400|NCT01036321|520465259|FG001|Overall Study|Ineligible after randomization|1|||
144344401|NCT01036321|520465258|FG000|Overall Study|Withdrawal by Subject|3|||
144344402|NCT01036321|520465259|FG001|Overall Study|Withdrawal by Subject|2|||
144344403|NCT01036321|520465258|FG000|Overall Study|Adverse Event|2|||
144344404|NCT01036321|520465259|FG001|Overall Study|Adverse Event|1|||
144344405|NCT00381693|520465260|FG000|Overall Study|Death|1|||
144344406|NCT00381693|520465260|FG000|Overall Study|Adverse Event|4|||
144344407|NCT00381693|520465260|FG000|Overall Study|Patient Choice|1|||
144344408|NCT00381693|520465260|FG000|Overall Study|Progression|2|||
144344409|NCT02003534|520465263|FG000|Overall Study|Lost to Follow-up|47|||
144344410|NCT03920254|520465265|FG000|Overall Study|Adverse Event|1|||
144344411|NCT03920254|520465266|FG001|Overall Study|Adverse Event|0|||
144344412|NCT03920254|520465267|FG002|Overall Study|Adverse Event|0|||
144344413|NCT03920254|520465265|FG000|Overall Study|Physician Decision|0|||
144344414|NCT03920254|520465266|FG001|Overall Study|Physician Decision|1|||
144344415|NCT03920254|520465267|FG002|Overall Study|Physician Decision|2|||
144344416|NCT03920254|520465265|FG000|Overall Study|Study Terminated By Sponsor|12|||
144344417|NCT03920254|520465266|FG001|Overall Study|Study Terminated By Sponsor|17|||
144344418|NCT03920254|520465267|FG002|Overall Study|Study Terminated By Sponsor|12|||
144344419|NCT03920254|520465265|FG000|Overall Study|Withdrawal by Subject|0|||
144344420|NCT03920254|520465266|FG001|Overall Study|Withdrawal by Subject|0|||
144344421|NCT03920254|520465267|FG002|Overall Study|Withdrawal by Subject|1|||
144344422|NCT05274269|520465268|FG000|Overall Study|Adverse Event|0|||
144344423|NCT05274269|520465269|FG001|Overall Study|Adverse Event|3|||
144344424|NCT05274269|520465268|FG000|Overall Study|Death|0|||
144344425|NCT05274269|520465269|FG001|Overall Study|Death|1|||
144344426|NCT05274269|520465268|FG000|Overall Study|Other|0|||
144344427|NCT05274269|520465269|FG001|Overall Study|Other|2|||
144344428|NCT05274269|520465268|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
144344429|NCT05274269|520465269|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
144344430|NCT02206035|520465270|FG000|Overall Study|Physician Decision|10|||
144344431|NCT02206035|520465271|FG001|Overall Study|Physician Decision|0|||
144344432|NCT02206035|520465272|FG002|Overall Study|Physician Decision|175|||
144344433|NCT02936843|520465273|FG000|Overall Study|Lost to Follow-up|3|||
144344434|NCT02936843|520465274|FG001|Overall Study|Lost to Follow-up|1|||
144344435|NCT02936843|520465273|FG000|Overall Study|Withdrawal by Subject|1|||
144344436|NCT02936843|520465274|FG001|Overall Study|Withdrawal by Subject|1|||
144344437|NCT00709618|520465275|FG000|Overall Study|Withdrawal by Subject|4|||
144344438|NCT00709618|520465275|FG000|Overall Study|Lost to Follow-up|1|||
144344439|NCT00709618|520465275|FG000|Overall Study|Study Closed/Terminated|25|||
144344440|NCT00894361|520465278|FG000|Overall Study|deaths and less than 2 years followup|24|||
144344441|NCT00894361|520465279|FG001|Overall Study|deaths and less than 2 years followup|64|||
144344442|NCT00286494|520465284|FG000|Overall Study|Hyperglycemic rescue|12|||
144344443|NCT00286494|520465285|FG001|Overall Study|Hyperglycemic rescue|19|||
144344444|NCT00286494|520465286|FG002|Overall Study|Hyperglycemic rescue|18|||
144344445|NCT00286494|520465284|FG000|Overall Study|Withdrawal by Subject|2|||
144344446|NCT00286494|520465285|FG001|Overall Study|Withdrawal by Subject|10|||
144344447|NCT00286494|520465286|FG002|Overall Study|Withdrawal by Subject|9|||
144344448|NCT00286494|520465284|FG000|Overall Study|Adverse Event|3|||
144344449|NCT00286494|520465285|FG001|Overall Study|Adverse Event|8|||
144344450|NCT00286494|520465286|FG002|Overall Study|Adverse Event|6|||
144344451|NCT00286494|520465284|FG000|Overall Study|Physician Decision|5|||
144344452|NCT00286494|520465285|FG001|Overall Study|Physician Decision|5|||
144344453|NCT00286494|520465286|FG002|Overall Study|Physician Decision|1|||
144344454|NCT00286494|520465284|FG000|Overall Study|Lost to Follow-up|3|||
144344455|NCT00286494|520465285|FG001|Overall Study|Lost to Follow-up|1|||
144344456|NCT00286494|520465286|FG002|Overall Study|Lost to Follow-up|3|||
144344457|NCT00286494|520465284|FG000|Overall Study|Protocol Violation|1|||
144344458|NCT00286494|520465285|FG001|Overall Study|Protocol Violation|1|||
144344459|NCT00286494|520465286|FG002|Overall Study|Protocol Violation|2|||
144344460|NCT04776317|520465287|FG000|Overall Study|Physician Decision|0|||
144344461|NCT04776317|520465288|FG001|Overall Study|Physician Decision|1|||
144344462|NCT04776317|520465289|FG002|Overall Study|Physician Decision|0|||
144344463|NCT04776317|520465290|FG003|Overall Study|Physician Decision|0|||
144344464|NCT04776317|520465291|FG004|Overall Study|Physician Decision|0|||
144344465|NCT04776317|520465292|FG005|Overall Study|Physician Decision|0|||
144344466|NCT04776317|520465293|FG006|Overall Study|Physician Decision|0|||
144344467|NCT04776317|520465294|FG007|Overall Study|Physician Decision|0|||
144344468|NCT04776317|520465295|FG008|Overall Study|Physician Decision|0|||
144344469|NCT04776317|520465296|FG009|Overall Study|Physician Decision|0|||
144344470|NCT04776317|520465297|FG010|Overall Study|Physician Decision|0|||
144344471|NCT04776317|520465298|FG011|Overall Study|Physician Decision|0|||
144344472|NCT04776317|520465299|FG012|Overall Study|Physician Decision|0|||
144344473|NCT04776317|520465300|FG013|Overall Study|Physician Decision|0|||
144344474|NCT04776317|520465301|FG014|Overall Study|Physician Decision|0|||
144344475|NCT04776317|520465287|FG000|Overall Study|Protocol Violation|0|||
144344476|NCT04776317|520465288|FG001|Overall Study|Protocol Violation|0|||
144344477|NCT04776317|520465289|FG002|Overall Study|Protocol Violation|1|||
144344478|NCT04776317|520465290|FG003|Overall Study|Protocol Violation|0|||
144344479|NCT04776317|520465291|FG004|Overall Study|Protocol Violation|0|||
144344480|NCT04776317|520465292|FG005|Overall Study|Protocol Violation|0|||
144344481|NCT04776317|520465293|FG006|Overall Study|Protocol Violation|0|||
144344482|NCT04776317|520465294|FG007|Overall Study|Protocol Violation|0|||
144344483|NCT04776317|520465295|FG008|Overall Study|Protocol Violation|0|||
144344484|NCT04776317|520465296|FG009|Overall Study|Protocol Violation|0|||
144344485|NCT04776317|520465297|FG010|Overall Study|Protocol Violation|0|||
144344486|NCT04776317|520465298|FG011|Overall Study|Protocol Violation|0|||
144344487|NCT04776317|520465299|FG012|Overall Study|Protocol Violation|0|||
144344488|NCT04776317|520465300|FG013|Overall Study|Protocol Violation|0|||
144344489|NCT04776317|520465301|FG014|Overall Study|Protocol Violation|0|||
144344490|NCT04776317|520465287|FG000|Overall Study|Withdrawal by Subject|0|||
144344491|NCT04776317|520465288|FG001|Overall Study|Withdrawal by Subject|0|||
144344492|NCT04776317|520465289|FG002|Overall Study|Withdrawal by Subject|0|||
144344493|NCT04776317|520465290|FG003|Overall Study|Withdrawal by Subject|0|||
144344494|NCT04776317|520465291|FG004|Overall Study|Withdrawal by Subject|1|||
144344495|NCT04776317|520465292|FG005|Overall Study|Withdrawal by Subject|0|||
144344496|NCT04776317|520465293|FG006|Overall Study|Withdrawal by Subject|0|||
144344497|NCT04776317|520465294|FG007|Overall Study|Withdrawal by Subject|0|||
144344498|NCT04776317|520465295|FG008|Overall Study|Withdrawal by Subject|0|||
144344499|NCT04776317|520465296|FG009|Overall Study|Withdrawal by Subject|0|||
144344500|NCT04776317|520465297|FG010|Overall Study|Withdrawal by Subject|0|||
144344501|NCT04776317|520465298|FG011|Overall Study|Withdrawal by Subject|0|||
144344502|NCT04776317|520465299|FG012|Overall Study|Withdrawal by Subject|0|||
144344503|NCT04776317|520465300|FG013|Overall Study|Withdrawal by Subject|0|||
144344504|NCT04776317|520465301|FG014|Overall Study|Withdrawal by Subject|0|||
144344505|NCT05438576|520465302|FG000|Overall Study|Death|1|||
144344506|NCT05438576|520465303|FG001|Overall Study|Death|1|||
144344507|NCT05438576|520465302|FG000|Overall Study|Withdrawal by Subject|4|||
144344508|NCT05438576|520465303|FG001|Overall Study|Withdrawal by Subject|2|||
144344509|NCT05438576|520465302|FG000|Overall Study|Not Eligible|2|||
144344510|NCT05438576|520465303|FG001|Overall Study|Not Eligible|1|||
144344511|NCT05438576|520465302|FG000|Overall Study|Did not complete baseline testing|22|||
144344512|NCT05438576|520465303|FG001|Overall Study|Did not complete baseline testing|4|||
144344513|NCT01415401|520465312|FG000|Overall Study|Adverse Event|5|||
144344514|NCT01415401|520465312|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
144344515|NCT01415401|520465312|FG000|Overall Study|Terminated by Sponsor|1|||
144344516|NCT00994422|520465313|FG000|Overall Study|Lost to Follow-up|7|||
144344517|NCT00994422|520465314|FG001|Overall Study|Lost to Follow-up|1|||
144344518|NCT03422536|520465315|FG000|Randomized|Physician Decision|1|||
144344519|NCT03422536|520465316|FG001|Randomized|Physician Decision|1|||
144344520|NCT03422536|520465315|FG000|Allocation - Received Intervention|Disease progression|19|||
144344521|NCT03422536|520465316|FG001|Allocation - Received Intervention|Disease progression|25|||
144344522|NCT03422536|520465315|FG000|Allocation - Received Intervention|Death|1|||
144344523|NCT03422536|520465316|FG001|Allocation - Received Intervention|Death|3|||
144344524|NCT03422536|520465315|FG000|Allocation - Received Intervention|Adverse Event|1|||
144344525|NCT03422536|520465316|FG001|Allocation - Received Intervention|Adverse Event|0|||
144344526|NCT03422536|520465315|FG000|Allocation - Received Intervention|Physician Decision|1|||
144344527|NCT03422536|520465316|FG001|Allocation - Received Intervention|Physician Decision|1|||
144344528|NCT03422536|520465315|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
144344529|NCT03422536|520465316|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
144344530|NCT03422536|520465315|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
144344531|NCT03422536|520465316|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
144344532|NCT00532298|520465317|FG000|Overall Study|Adverse Event|1|||
144344533|NCT00532298|520465318|FG001|Overall Study|Adverse Event|0|||
144344534|NCT00532298|520465319|FG002|Overall Study|Adverse Event|0|||
144344535|NCT00532298|520465320|FG003|Overall Study|Adverse Event|0|||
144344536|NCT00532298|520465321|FG004|Overall Study|Adverse Event|1|||
144344537|NCT00532298|520465322|FG005|Overall Study|Adverse Event|1|||
144344538|NCT00532298|520465317|FG000|Overall Study|Lost to Follow-up|1|||
144344539|NCT00532298|520465318|FG001|Overall Study|Lost to Follow-up|1|||
144344540|NCT00532298|520465319|FG002|Overall Study|Lost to Follow-up|1|||
144344541|NCT00532298|520465320|FG003|Overall Study|Lost to Follow-up|0|||
144344542|NCT00532298|520465321|FG004|Overall Study|Lost to Follow-up|0|||
144344543|NCT00532298|520465322|FG005|Overall Study|Lost to Follow-up|1|||
144344544|NCT05232864|520465326|FG000|Overall Study|Adverse Event|0|||
144344545|NCT05232864|520465327|FG001|Overall Study|Adverse Event|1|||
144344546|NCT05232864|520465326|FG000|Overall Study|Study terminated by sponsor|16|||
144344547|NCT05232864|520465327|FG001|Overall Study|Study terminated by sponsor|14|||
144344548|NCT02023996|520465329|FG000|Overall Study|Protocol Violation|6|||
144344549|NCT04765202|520465334|FG000|Overall Study|Lost to Follow-up|1|||
144344550|NCT04765202|520465335|FG001|Overall Study|Lost to Follow-up|1|||
144344551|NCT04765202|520465336|FG002|Overall Study|Lost to Follow-up|2|||
144344552|NCT04765202|520465337|FG003|Overall Study|Lost to Follow-up|2|||
144344553|NCT04765202|520465334|FG000|Overall Study|Physician Decision|0|||
144344554|NCT04765202|520465335|FG001|Overall Study|Physician Decision|0|||
144344555|NCT04765202|520465336|FG002|Overall Study|Physician Decision|1|||
144344556|NCT04765202|520465337|FG003|Overall Study|Physician Decision|1|||
144344557|NCT04929249|520465338|FG000|Overall Study|Adverse Event|2|||
144344558|NCT04929249|520465339|FG001|Overall Study|Adverse Event|1|||
144344559|NCT04929249|520465338|FG000|Overall Study|Death|2|||
144344560|NCT04929249|520465339|FG001|Overall Study|Death|1|||
144344561|NCT04929249|520465338|FG000|Overall Study|Lost to Follow-up|3|||
144344562|NCT04929249|520465339|FG001|Overall Study|Lost to Follow-up|11|||
144344563|NCT04929249|520465338|FG000|Overall Study|Technical problems|0|||
144344564|NCT04929249|520465339|FG001|Overall Study|Technical problems|1|||
144344565|NCT04929249|520465338|FG000|Overall Study|Subject decision|6|||
144344566|NCT04929249|520465339|FG001|Overall Study|Subject decision|8|||
144344567|NCT04929249|520465338|FG000|Overall Study|Withdrew consent|0|||
144344568|NCT04929249|520465339|FG001|Overall Study|Withdrew consent|8|||
144344569|NCT00095173|520465349|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
144344570|NCT00095173|520465350|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
144344571|NCT00095173|520465351|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
144344572|NCT00095173|520465352|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
144344573|NCT00095173|520465353|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
144344574|NCT00095173|520465354|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
144344575|NCT00095173|520465349|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
144344576|NCT00095173|520465350|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
144344577|NCT00095173|520465351|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
144344578|NCT00095173|520465352|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
144344579|NCT00095173|520465353|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
144344580|NCT00095173|520465354|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
144344581|NCT00095173|520465349|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
144344582|NCT00095173|520465350|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
144344583|NCT00095173|520465351|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
144344584|NCT00095173|520465352|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
144344585|NCT00095173|520465353|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
144344586|NCT00095173|520465354|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
144344587|NCT00095173|520465349|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
144344588|NCT00095173|520465350|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
144344589|NCT00095173|520465351|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
144344590|NCT00095173|520465352|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
144344591|NCT00095173|520465353|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
144344592|NCT00095173|520465354|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
144344593|NCT00095173|520465349|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
144344594|NCT00095173|520465350|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
144344595|NCT00095173|520465351|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
144344596|NCT00095173|520465352|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
144344597|NCT00095173|520465353|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
144344598|NCT00095173|520465354|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
144344599|NCT00095173|520465349|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
144344600|NCT00095173|520465350|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
144344601|NCT00095173|520465351|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
144344602|NCT00095173|520465352|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
144344603|NCT00095173|520465353|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
144344604|NCT00095173|520465354|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
144344605|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Death|0|||
144344606|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Death|0|||
144344607|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Death|0|||
144344608|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Death|0|||
144344609|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Death|0|||
144344610|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Death|1|||
144344611|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
144344612|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
144344613|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
144344614|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
144344615|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
144344616|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
144344617|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
144344618|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
144344619|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
144344620|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
144344621|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
144344622|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
144344623|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
144344624|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
144344625|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
144344626|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
144344627|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
144344628|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
144344629|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
144344630|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
144344631|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
144344632|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
144344633|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
144344634|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
144344635|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
144344636|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
144344637|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
144344638|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
144344639|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
144344640|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
144344641|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
144344642|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
144344643|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
144344644|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
144344645|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
144344646|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
144344647|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
144344648|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
144344649|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
144344650|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
144344651|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
144344652|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
144344653|NCT00095173|520465349|FG000|Open-Label Extension Phase (Period C)|Other|0|||
144344654|NCT00095173|520465350|FG001|Open-Label Extension Phase (Period C)|Other|0|||
144344655|NCT00095173|520465351|FG002|Open-Label Extension Phase (Period C)|Other|0|||
144344656|NCT00095173|520465352|FG003|Open-Label Extension Phase (Period C)|Other|4|||
144344657|NCT00095173|520465353|FG004|Open-Label Extension Phase (Period C)|Other|6|||
144344658|NCT00095173|520465354|FG005|Open-Label Extension Phase (Period C)|Other|8|||
144344659|NCT00330681|520465361|FG000|Overall Study|Adverse Event|3|||
144344660|NCT00330681|520465362|FG001|Overall Study|Adverse Event|6|||
144344661|NCT00330681|520465361|FG000|Overall Study|Protocol Violation|0|||
144344662|NCT00330681|520465362|FG001|Overall Study|Protocol Violation|1|||
144344663|NCT00330681|520465361|FG000|Overall Study|Withdrawal by Subject|5|||
144344664|NCT00330681|520465362|FG001|Overall Study|Withdrawal by Subject|5|||
144344665|NCT00330681|520465361|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
144344666|NCT00330681|520465362|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
144344667|NCT02461745|520465364|FG000|Overall Study|Lack of Efficacy|9|||
144344668|NCT02461745|520465365|FG001|Overall Study|Lack of Efficacy|1|||
144344669|NCT02461745|520465364|FG000|Overall Study|Lost to Follow-up|2|||
144344670|NCT02461745|520465365|FG001|Overall Study|Lost to Follow-up|2|||
144344671|NCT02461745|520465364|FG000|Overall Study|Withdrawal by Subject|3|||
144344672|NCT02461745|520465365|FG001|Overall Study|Withdrawal by Subject|1|||
144344673|NCT00211887|520465366|FG000|Overall Study|Adverse Event|8|||
144344674|NCT00211887|520465367|FG001|Overall Study|Adverse Event|4|||
144344675|NCT00211887|520465368|FG002|Overall Study|Adverse Event|6|||
144344676|NCT00211887|520465366|FG000|Overall Study|Death|1|||
144344677|NCT00211887|520465367|FG001|Overall Study|Death|1|||
144344678|NCT00211887|520465368|FG002|Overall Study|Death|1|||
144344679|NCT00211887|520465366|FG000|Overall Study|Lost to Follow-up|28|||
144344680|NCT00211887|520465367|FG001|Overall Study|Lost to Follow-up|13|||
144344681|NCT00211887|520465368|FG002|Overall Study|Lost to Follow-up|9|||
144344682|NCT00211887|520465366|FG000|Overall Study|Non-medical reason|31|||
144344683|NCT00211887|520465367|FG001|Overall Study|Non-medical reason|14|||
144344684|NCT00211887|520465368|FG002|Overall Study|Non-medical reason|8|||
144344685|NCT00211887|520465366|FG000|Overall Study|Other medical reason|15|||
144344686|NCT00211887|520465367|FG001|Overall Study|Other medical reason|11|||
144344687|NCT00211887|520465368|FG002|Overall Study|Other medical reason|7|||
144344688|NCT00211887|520465366|FG000|Overall Study|Side effects|19|||
144344689|NCT00211887|520465367|FG001|Overall Study|Side effects|13|||
144344690|NCT00211887|520465368|FG002|Overall Study|Side effects|5|||
144344691|NCT00852241|520465369|FG000|Overall Study|Physician Decision|18|||
144344692|NCT00619307|520465371|FG000|Overall Study|Adverse Event|0|||
144344693|NCT00619307|520465372|FG001|Overall Study|Adverse Event|1|||
144344694|NCT00619307|520465371|FG000|Overall Study|Lost to Follow-up|0|||
144344695|NCT00619307|520465372|FG001|Overall Study|Lost to Follow-up|1|||
144344696|NCT00619307|520465371|FG000|Overall Study|Protocol Violation|3|||
144344697|NCT00619307|520465372|FG001|Overall Study|Protocol Violation|0|||
144344698|NCT00619307|520465371|FG000|Overall Study|Withdrew consent|1|||
144344699|NCT00619307|520465372|FG001|Overall Study|Withdrew consent|0|||
144344700|NCT00619307|520465371|FG000|Overall Study|Severe migraine|0|||
144344701|NCT00619307|520465372|FG001|Overall Study|Severe migraine|1|||
144344702|NCT00619307|520465371|FG000|Overall Study|MS attack plus steroids|0|||
144344703|NCT00619307|520465372|FG001|Overall Study|MS attack plus steroids|1|||
144344704|NCT00118430|520465375|FG000|Overall Study|Withdrawal by Subject|6|||
144344705|NCT00118430|520465376|FG001|Overall Study|Withdrawal by Subject|2|||
144344706|NCT00118430|520465377|FG002|Overall Study|Withdrawal by Subject|0|||
144344707|NCT00118430|520465375|FG000|Overall Study|Lost to Follow-up|15|||
144344708|NCT00118430|520465376|FG001|Overall Study|Lost to Follow-up|22|||
144344709|NCT00118430|520465377|FG002|Overall Study|Lost to Follow-up|28|||
144344710|NCT02147288|520465378|FG000|Overall Study|post-operative hematoma|1|||
144344711|NCT02147288|520465379|FG001|Overall Study|post-operative hematoma|1|||
144344712|NCT02147288|520465380|FG002|Overall Study|post-operative hematoma|0|||
144344713|NCT02147288|520465381|FG003|Overall Study|post-operative hematoma|0|||
144344714|NCT02147288|520465382|FG004|Overall Study|post-operative hematoma|0|||
144344715|NCT02147288|520465383|FG005|Overall Study|post-operative hematoma|0|||
144344716|NCT02147288|520465384|FG006|Overall Study|post-operative hematoma|0|||
144344717|NCT02147288|520465385|FG007|Overall Study|post-operative hematoma|0|||
144344718|NCT02147288|520465386|FG008|Overall Study|post-operative hematoma|0|||
144344719|NCT02147288|520465387|FG009|Overall Study|post-operative hematoma|0|||
144344720|NCT02147288|520465378|FG000|Overall Study|complications from concurrent hernia rep|0|||
144344721|NCT02147288|520465379|FG001|Overall Study|complications from concurrent hernia rep|1|||
144344722|NCT02147288|520465380|FG002|Overall Study|complications from concurrent hernia rep|0|||
144344723|NCT02147288|520465381|FG003|Overall Study|complications from concurrent hernia rep|0|||
144344724|NCT02147288|520465382|FG004|Overall Study|complications from concurrent hernia rep|0|||
144344725|NCT02147288|520465383|FG005|Overall Study|complications from concurrent hernia rep|0|||
144344726|NCT02147288|520465384|FG006|Overall Study|complications from concurrent hernia rep|0|||
144344727|NCT02147288|520465385|FG007|Overall Study|complications from concurrent hernia rep|0|||
144344728|NCT02147288|520465386|FG008|Overall Study|complications from concurrent hernia rep|0|||
144344729|NCT02147288|520465387|FG009|Overall Study|complications from concurrent hernia rep|0|||
144344730|NCT02069392|520465390|FG000|Overall Study|Withdrawal by Subject|4|||
144344731|NCT02069392|520465391|FG001|Overall Study|Withdrawal by Subject|2|||
144344732|NCT00269633|520465392|FG000|Overall Study|Withdrawal by Subject|1|||
144344733|NCT00269633|520465393|FG001|Overall Study|Withdrawal by Subject|0|||
144344734|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Adverse Event|33|||
144344735|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
144344736|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
144344737|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
144344738|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Physician Decision|6|||
144344739|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
144344740|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
144344741|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
144344742|NCT00965419|520465394|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
144344743|NCT00965419|520465394|FG000|Follow-up Phase|Adverse Event|9|||
144344744|NCT00965419|520465394|FG000|Follow-up Phase|Protocol Violation|4|||
144344745|NCT00965419|520465394|FG000|Follow-up Phase|Withdrawal by Subject|8|||
144344746|NCT00965419|520465394|FG000|Follow-up Phase|Physician Decision|4|||
144344747|NCT00965419|520465394|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
144344748|NCT00965419|520465394|FG000|Follow-up Phase|Lack of Efficacy|28|||
144344749|NCT04412707|520465395|FG000|Cycle 1|Death|0|||
144344750|NCT04412707|520465396|FG001|Cycle 1|Death|3|||
144344751|NCT04412707|520465395|FG000|Cycle 1|Disease progression|1|||
144344752|NCT04412707|520465396|FG001|Cycle 1|Disease progression|2|||
144344753|NCT04412707|520465395|FG000|Cycle 2|Death|0|||
144344754|NCT04412707|520465396|FG001|Cycle 2|Death|1|||
144344755|NCT04412707|520465395|FG000|Cycle 2|Disease progression|3|||
144344756|NCT04412707|520465396|FG001|Cycle 2|Disease progression|0|||
144344757|NCT04412707|520465395|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
144344758|NCT04412707|520465396|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
144344759|NCT04412707|520465395|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
144344760|NCT04412707|520465396|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
144344761|NCT04412707|520465395|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
144344762|NCT04412707|520465396|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
144344763|NCT04412707|520465395|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
144344764|NCT04412707|520465396|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
144344765|NCT02927938|520465397|FG000|Overall Study|Death|0|||
144344766|NCT02927938|520465398|FG001|Overall Study|Death|1|||
144344767|NCT02927938|520465399|FG002|Overall Study|Death|0|||
144344768|NCT02927938|520465400|FG003|Overall Study|Death|4|||
144344769|NCT02927938|520465397|FG000|Overall Study|Early Study Termination|1|||
144344770|NCT02927938|520465398|FG001|Overall Study|Early Study Termination|5|||
144344771|NCT02927938|520465399|FG002|Overall Study|Early Study Termination|4|||
144344772|NCT02927938|520465400|FG003|Overall Study|Early Study Termination|3|||
144344773|NCT02476006|520465401|FG000|Overall Study|Death|4|||
144344774|NCT02476006|520465401|FG000|Overall Study|Lack of treatment efficacy|2|||
144344775|NCT02476006|520465401|FG000|Overall Study|Pregnancy|1|||
144344776|NCT02476006|520465401|FG000|Overall Study|Participant did not wish to continue|39|||
144344777|NCT02476006|520465401|FG000|Overall Study|Adverse Event|41|||
144344778|NCT02476006|520465401|FG000|Overall Study|Poor compliance to study protocol|3|||
144344779|NCT02476006|520465401|FG000|Overall Study|Sponsor decision|6|||
144344780|NCT02476006|520465401|FG000|Overall Study|Lost to Follow-up|5|||
144344781|NCT02476006|520465401|FG000|Overall Study|Physician Decision|5|||
144344782|NCT02476006|520465401|FG000|Overall Study|Study ended treatment not available|4|||
144344783|NCT02476006|520465401|FG000|Overall Study|Switched to commercial drug|4|||
144344784|NCT02476006|520465401|FG000|Overall Study|Excluded from study|1|||
144344785|NCT02476006|520465401|FG000|Overall Study|Protocol Violation|1|||
144344786|NCT02476006|520465401|FG000|Overall Study|Enrolled but not treated|4|||
144344787|NCT02475278|520467152|FG000|Overall Study|Lost to Follow-up|1|||
144344788|NCT02475278|520467152|FG000|Overall Study|Reason Not Specified|1|||
144344789|NCT01946152|520467153|FG000|Overall Study|Adverse Event|1|||
144344790|NCT01946152|520467154|FG001|Overall Study|Adverse Event|0|||
144344791|NCT01946152|520467155|FG002|Overall Study|Adverse Event|0|||
144344792|NCT01946152|520467156|FG003|Overall Study|Adverse Event|0|||
144344793|NCT01946152|520467153|FG000|Overall Study|Withdrawal by Subject|0|||
144344794|NCT01946152|520467154|FG001|Overall Study|Withdrawal by Subject|2|||
144344795|NCT01946152|520467155|FG002|Overall Study|Withdrawal by Subject|0|||
144344796|NCT01946152|520467156|FG003|Overall Study|Withdrawal by Subject|0|||
144344797|NCT01946152|520467153|FG000|Overall Study|Progression|0|||
144344798|NCT01946152|520467154|FG001|Overall Study|Progression|1|||
144344799|NCT01946152|520467155|FG002|Overall Study|Progression|4|||
144344800|NCT01946152|520467156|FG003|Overall Study|Progression|7|||
144344801|NCT01946152|520467153|FG000|Overall Study|Physician Decision|0|||
144344802|NCT01946152|520467154|FG001|Overall Study|Physician Decision|0|||
144344803|NCT01946152|520467155|FG002|Overall Study|Physician Decision|1|||
144344804|NCT01946152|520467156|FG003|Overall Study|Physician Decision|0|||
144344805|NCT01946152|520467153|FG000|Overall Study|Second malignancy|0|||
144344806|NCT01946152|520467154|FG001|Overall Study|Second malignancy|0|||
144344807|NCT01946152|520467155|FG002|Overall Study|Second malignancy|1|||
144344808|NCT01946152|520467156|FG003|Overall Study|Second malignancy|0|||
144344809|NCT01946152|520467153|FG000|Overall Study|Adverse Event|0|||
144344810|NCT01946152|520467154|FG001|Overall Study|Adverse Event|0|||
144344811|NCT01946152|520467155|FG002|Overall Study|Adverse Event|0|||
144344812|NCT01946152|520467156|FG003|Overall Study|Adverse Event|1|||
144344813|NCT03712787|520467157|FG000|Overall Study|Adverse Event|2|||
144344814|NCT03712787|520467158|FG001|Overall Study|Adverse Event|3|||
144344815|NCT03712787|520467159|FG002|Overall Study|Adverse Event|0|||
144344816|NCT03712787|520467160|FG003|Overall Study|Adverse Event|4|||
144344817|NCT03712787|520467157|FG000|Overall Study|Withdrawal by Subject|4|||
144344818|NCT03712787|520467158|FG001|Overall Study|Withdrawal by Subject|14|||
144344819|NCT03712787|520467159|FG002|Overall Study|Withdrawal by Subject|12|||
144344820|NCT03712787|520467160|FG003|Overall Study|Withdrawal by Subject|8|||
144344821|NCT03712787|520467157|FG000|Overall Study|Lost to Follow-up|1|||
144344822|NCT03712787|520467158|FG001|Overall Study|Lost to Follow-up|1|||
144344823|NCT03712787|520467159|FG002|Overall Study|Lost to Follow-up|2|||
144344824|NCT03712787|520467160|FG003|Overall Study|Lost to Follow-up|1|||
144344825|NCT03712787|520467157|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
144344826|NCT03712787|520467158|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
144344827|NCT03712787|520467159|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
144344828|NCT03712787|520467160|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
144344829|NCT03712787|520467157|FG000|Overall Study|COVID-19 Infection|0|||
144344830|NCT03712787|520467158|FG001|Overall Study|COVID-19 Infection|1|||
144344831|NCT03712787|520467159|FG002|Overall Study|COVID-19 Infection|0|||
144344832|NCT03712787|520467160|FG003|Overall Study|COVID-19 Infection|0|||
144344833|NCT03712787|520467157|FG000|Overall Study|Other, Not Specified|79|||
144344834|NCT03712787|520467158|FG001|Overall Study|Other, Not Specified|77|||
144344835|NCT03712787|520467159|FG002|Overall Study|Other, Not Specified|74|||
144344836|NCT03712787|520467160|FG003|Overall Study|Other, Not Specified|78|||
144344837|NCT05111249|520467161|FG000|Overall Study|Lost to Follow-up|0|||
144344838|NCT05111249|520467162|FG001|Overall Study|Lost to Follow-up|2|||
144344839|NCT05111249|520467161|FG000|Overall Study|Physician Decision|0|||
144344840|NCT05111249|520467162|FG001|Overall Study|Physician Decision|1|||
144344841|NCT05111249|520467161|FG000|Overall Study|Participant decision|1|||
144344842|NCT05111249|520467162|FG001|Overall Study|Participant decision|5|||
144344843|NCT03688074|520467165|FG000|Overall Study|Adverse Event|0|||
144344844|NCT03688074|520467166|FG001|Overall Study|Adverse Event|1|||
144344845|NCT03688074|520467165|FG000|Overall Study|Other|1|||
144344846|NCT03688074|520467166|FG001|Overall Study|Other|0|||
144344847|NCT03056339|520467167|FG000|Overall Study|Failed Requirements|0|||
144344848|NCT03056339|520467168|FG001|Overall Study|Failed Requirements|2|||
144344849|NCT03056339|520467169|FG002|Overall Study|Failed Requirements|7|||
144344850|NCT03056339|520467170|FG003|Overall Study|Failed Requirements|1|||
144344851|NCT01363908|520467173|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
144344852|NCT01363908|520467174|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
144344853|NCT01363908|520467173|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
144344854|NCT01363908|520467174|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
144344855|NCT01363908|520467173|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
144344856|NCT01363908|520467174|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
144344857|NCT01363908|520467173|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
144344858|NCT01363908|520467174|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
144344859|NCT02644343|520467175|FG000|Overall Study|Withdrawal by Subject|1|||
144344860|NCT02783599|520467178|FG000|Overall Study|Progressive disease|23|||
144344861|NCT02783599|520467178|FG000|Overall Study|Surgical Resection|10|||
144344862|NCT02783599|520467178|FG000|Overall Study|Adverse Event|4|||
144344863|NCT02783599|520467178|FG000|Overall Study|Physician Decision|2|||
144344864|NCT02783599|520467178|FG000|Overall Study|Death|1|||
144344865|NCT01564732|520467179|FG000|Overall Study|Early termination by the study sponsor|6|||
144344866|NCT01564732|520467180|FG001|Overall Study|Early termination by the study sponsor|5|||
144344867|NCT00394706|520467196|FG000|Overall Study|Withdrawal by Subject|2|||
144344868|NCT00394706|520467197|FG001|Overall Study|Withdrawal by Subject|0|||
144344869|NCT00394706|520467198|FG002|Overall Study|Withdrawal by Subject|1|||
144344870|NCT00394706|520467199|FG003|Overall Study|Withdrawal by Subject|0|||
144344871|NCT00394706|520467200|FG004|Overall Study|Withdrawal by Subject|0|||
144344872|NCT00394706|520467201|FG005|Overall Study|Withdrawal by Subject|2|||
144344873|NCT00394706|520467202|FG006|Overall Study|Withdrawal by Subject|1|||
144344874|NCT00394706|520467203|FG007|Overall Study|Withdrawal by Subject|0|||
144344875|NCT00394706|520467196|FG000|Overall Study|Lost to Follow-up|2|||
144344876|NCT00394706|520467197|FG001|Overall Study|Lost to Follow-up|2|||
144344877|NCT00394706|520467198|FG002|Overall Study|Lost to Follow-up|8|||
144344878|NCT00394706|520467199|FG003|Overall Study|Lost to Follow-up|1|||
144344879|NCT00394706|520467200|FG004|Overall Study|Lost to Follow-up|2|||
144344880|NCT00394706|520467201|FG005|Overall Study|Lost to Follow-up|5|||
144344881|NCT00394706|520467202|FG006|Overall Study|Lost to Follow-up|2|||
144344882|NCT00394706|520467203|FG007|Overall Study|Lost to Follow-up|0|||
144344883|NCT03040674|520467205|FG000|Overall Study|Lost to Follow-up|225|||
144344884|NCT03040674|520467205|FG000|Overall Study|Death|23|||
144344885|NCT05173012|520467206|FG000|Overall Study|Adverse Event|2|||
144344886|NCT05173012|520467207|FG001|Overall Study|Adverse Event|3|||
144344887|NCT05173012|520467208|FG002|Overall Study|Adverse Event|4|||
144344888|NCT05173012|520467209|FG003|Overall Study|Adverse Event|13|||
144344889|NCT05173012|520467210|FG004|Overall Study|Adverse Event|0|||
144344890|NCT05173012|520467211|FG005|Overall Study|Adverse Event|0|||
144344891|NCT05173012|520467212|FG006|Overall Study|Adverse Event|2|||
144344892|NCT05173012|520467213|FG007|Overall Study|Adverse Event|4|||
144344893|NCT05173012|520467206|FG000|Overall Study|Lost to Follow-up|0|||
144344894|NCT05173012|520467207|FG001|Overall Study|Lost to Follow-up|0|||
144344895|NCT05173012|520467208|FG002|Overall Study|Lost to Follow-up|0|||
144344896|NCT05173012|520467209|FG003|Overall Study|Lost to Follow-up|1|||
144344897|NCT05173012|520467210|FG004|Overall Study|Lost to Follow-up|0|||
144344898|NCT05173012|520467211|FG005|Overall Study|Lost to Follow-up|0|||
144344899|NCT05173012|520467212|FG006|Overall Study|Lost to Follow-up|0|||
144344900|NCT05173012|520467213|FG007|Overall Study|Lost to Follow-up|0|||
144344901|NCT05173012|520467206|FG000|Overall Study|Withdrawal by Subject|1|||
144344902|NCT05173012|520467207|FG001|Overall Study|Withdrawal by Subject|0|||
144344903|NCT05173012|520467208|FG002|Overall Study|Withdrawal by Subject|1|||
144344904|NCT05173012|520467209|FG003|Overall Study|Withdrawal by Subject|3|||
144344905|NCT05173012|520467210|FG004|Overall Study|Withdrawal by Subject|1|||
144344906|NCT05173012|520467211|FG005|Overall Study|Withdrawal by Subject|0|||
144344907|NCT05173012|520467212|FG006|Overall Study|Withdrawal by Subject|1|||
144344908|NCT05173012|520467213|FG007|Overall Study|Withdrawal by Subject|0|||
144344909|NCT05173012|520467206|FG000|Overall Study|Protocol Deviation|0|||
144344910|NCT05173012|520467207|FG001|Overall Study|Protocol Deviation|0|||
144344911|NCT05173012|520467208|FG002|Overall Study|Protocol Deviation|0|||
144344912|NCT05173012|520467209|FG003|Overall Study|Protocol Deviation|1|||
144344913|NCT05173012|520467210|FG004|Overall Study|Protocol Deviation|0|||
144344914|NCT05173012|520467211|FG005|Overall Study|Protocol Deviation|0|||
144344915|NCT05173012|520467212|FG006|Overall Study|Protocol Deviation|0|||
144344916|NCT05173012|520467213|FG007|Overall Study|Protocol Deviation|0|||
144344917|NCT05173012|520467206|FG000|Overall Study|Other|0|||
144344918|NCT05173012|520467207|FG001|Overall Study|Other|0|||
144344919|NCT05173012|520467208|FG002|Overall Study|Other|0|||
144344920|NCT05173012|520467209|FG003|Overall Study|Other|2|||
144344921|NCT05173012|520467210|FG004|Overall Study|Other|0|||
144344922|NCT05173012|520467211|FG005|Overall Study|Other|0|||
144344923|NCT05173012|520467212|FG006|Overall Study|Other|0|||
144344924|NCT05173012|520467213|FG007|Overall Study|Other|0|||
144344925|NCT00517361|520467214|FG000|Overall Study|Death|6|||
144344926|NCT00517361|520467214|FG000|Overall Study|The study was terminated|5|||
144344927|NCT03517228|520467218|FG000|Overall Study|Withdrawal by Subject|2|||
144344928|NCT03517228|520467218|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
144344929|NCT03517228|520467218|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
144344930|NCT03517228|520467218|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
144344931|NCT03517228|520467218|FG000|Overall Study|Canceled due to device being updated|1|||
144344932|NCT03517228|520467218|FG000|Overall Study|No V Cares in stock|1|||
144344933|NCT03517228|520467218|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
144344934|NCT03781414|520467225|FG000|Overall Study|Study terminated by sponsor|39|||
144344935|NCT03781414|520467226|FG001|Overall Study|Study terminated by sponsor|34|||
144344936|NCT03781414|520467227|FG002|Overall Study|Study terminated by sponsor|25|||
144344937|NCT03781414|520467225|FG000|Overall Study|Adverse Event|3|||
144344938|NCT03781414|520467226|FG001|Overall Study|Adverse Event|6|||
144344939|NCT03781414|520467227|FG002|Overall Study|Adverse Event|3|||
144344940|NCT03781414|520467225|FG000|Overall Study|Physician Decision|2|||
144344941|NCT03781414|520467226|FG001|Overall Study|Physician Decision|0|||
144344942|NCT03781414|520467227|FG002|Overall Study|Physician Decision|1|||
144344943|NCT03781414|520467225|FG000|Overall Study|Withdrawal by Subject|2|||
144344944|NCT03781414|520467226|FG001|Overall Study|Withdrawal by Subject|3|||
144344945|NCT03781414|520467227|FG002|Overall Study|Withdrawal by Subject|3|||
144344946|NCT03781414|520467225|FG000|Overall Study|Death|1|||
144344947|NCT03781414|520467226|FG001|Overall Study|Death|4|||
144344948|NCT03781414|520467227|FG002|Overall Study|Death|0|||
144344949|NCT03781414|520467225|FG000|Overall Study|Lost to Follow-up|1|||
144344950|NCT03781414|520467226|FG001|Overall Study|Lost to Follow-up|1|||
144344951|NCT03781414|520467227|FG002|Overall Study|Lost to Follow-up|0|||
144344952|NCT02881762|520467228|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
144344953|NCT02881762|520467229|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
144344954|NCT00836186|520467230|FG000|Overall Study|Blood could not be drawn|1|||
144344955|NCT04124705|520467233|FG000|Titration Period|Adverse Event|9|||
144344956|NCT04124705|520467234|FG001|Titration Period|Adverse Event|5|||
144344957|NCT04124705|520467233|FG000|Titration Period|Withdrawal by Subject|6|||
144344958|NCT04124705|520467234|FG001|Titration Period|Withdrawal by Subject|3|||
144344959|NCT04124705|520467233|FG000|Titration Period|Lost to Follow-up|0|||
144344960|NCT04124705|520467234|FG001|Titration Period|Lost to Follow-up|1|||
144344961|NCT04124705|520467233|FG000|Titration Period|Death|1|||
144344962|NCT04124705|520467234|FG001|Titration Period|Death|1|||
144344963|NCT04124705|520467233|FG000|Titration Period|Lack of Efficacy|2|||
144344964|NCT04124705|520467234|FG001|Titration Period|Lack of Efficacy|0|||
144344965|NCT04124705|520467233|FG000|Titration Period|Physician Decision|2|||
144344966|NCT04124705|520467234|FG001|Titration Period|Physician Decision|0|||
144344967|NCT04124705|520467233|FG000|Titration Period|Non-compliance with Study Drug|2|||
144344968|NCT04124705|520467234|FG001|Titration Period|Non-compliance with Study Drug|0|||
144344969|NCT04124705|520467233|FG000|Titration Period|Other|4|||
144344970|NCT04124705|520467234|FG001|Titration Period|Other|9|||
144344971|NCT04124705|520467233|FG000|Stabilization Period|Adverse Event|4|||
144344972|NCT04124705|520467234|FG001|Stabilization Period|Adverse Event|2|||
144344973|NCT04124705|520467233|FG000|Stabilization Period|Withdrawal by Subject|1|||
144344974|NCT04124705|520467234|FG001|Stabilization Period|Withdrawal by Subject|1|||
144344975|NCT04124705|520467233|FG000|Stabilization Period|Lost to Follow-up|0|||
144344976|NCT04124705|520467234|FG001|Stabilization Period|Lost to Follow-up|1|||
144344977|NCT04124705|520467233|FG000|Stabilization Period|Lack of Efficacy|4|||
144344978|NCT04124705|520467234|FG001|Stabilization Period|Lack of Efficacy|2|||
144344979|NCT04124705|520467233|FG000|Stabilization Period|Protocol Deviation|0|||
144344980|NCT04124705|520467234|FG001|Stabilization Period|Protocol Deviation|2|||
144344981|NCT04124705|520467233|FG000|Stabilization Period|Other|2|||
144344982|NCT04124705|520467234|FG001|Stabilization Period|Other|2|||
144344983|NCT02123823|520467235|FG000|Overall Study|Lack of Efficacy|0|||
144344984|NCT02123823|520467236|FG001|Overall Study|Lack of Efficacy|2|||
144344985|NCT02123823|520467237|FG002|Overall Study|Lack of Efficacy|8|||
144344986|NCT02123823|520467238|FG003|Overall Study|Lack of Efficacy|10|||
144344987|NCT02123823|520467235|FG000|Overall Study|Progressive disease|3|||
144344988|NCT02123823|520467236|FG001|Overall Study|Progressive disease|19|||
144344989|NCT02123823|520467237|FG002|Overall Study|Progressive disease|52|||
144344990|NCT02123823|520467238|FG003|Overall Study|Progressive disease|53|||
144344991|NCT02123823|520467235|FG000|Overall Study|Withdrawal by Subject|0|||
144344992|NCT02123823|520467236|FG001|Overall Study|Withdrawal by Subject|0|||
144344993|NCT02123823|520467237|FG002|Overall Study|Withdrawal by Subject|7|||
144344994|NCT02123823|520467238|FG003|Overall Study|Withdrawal by Subject|2|||
144344995|NCT02123823|520467235|FG000|Overall Study|Adverse Event|0|||
144344996|NCT02123823|520467236|FG001|Overall Study|Adverse Event|0|||
144344997|NCT02123823|520467237|FG002|Overall Study|Adverse Event|3|||
144344998|NCT02123823|520467238|FG003|Overall Study|Adverse Event|5|||
144344999|NCT01636986|520467239|FG000|Overall Study|Withdrawal by Subject|0|||
144345000|NCT01636986|520467240|FG001|Overall Study|Withdrawal by Subject|1|||
144345001|NCT01636986|520467239|FG000|Overall Study|Corneal Staining|0|||
144345002|NCT01636986|520467240|FG001|Overall Study|Corneal Staining|1|||
144345003|NCT01496846|520467243|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
144345004|NCT01496846|520467244|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
144345005|NCT01496846|520467245|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
144345006|NCT01496846|520467246|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
144345007|NCT01496846|520467247|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
144345008|NCT01496846|520467248|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
144345009|NCT01772576|520467249|FG000|Overall Study|Death|15|||
144345010|NCT01772576|520467249|FG000|Overall Study|Protocol Violation|1|||
144345011|NCT01772576|520467249|FG000|Overall Study|Lost to Follow-up|3|||
144345012|NCT01772576|520467249|FG000|Overall Study|Study device not used|3|||
144345013|NCT01772576|520467249|FG000|Overall Study|Adverse Event|6|||
144345014|NCT01772576|520467249|FG000|Overall Study|Withdrawal by Subject|6|||
144345015|NCT00923845|520467250|FG000|Induction Therapy|Poor performance status|0|||
144345016|NCT00923845|520467251|FG001|Induction Therapy|Poor performance status|2|||
144345017|NCT00379912|520467253|FG000|Overall Study|Lack of Efficacy|1|||
144345018|NCT00379912|520467254|FG001|Overall Study|Lack of Efficacy|0|||
144345019|NCT02578186|520467255|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
144345020|NCT02578186|520467256|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
144345021|NCT02578186|520467255|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
144345022|NCT02578186|520467256|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
144345023|NCT02873338|520467257|FG000|Overall Study|Adverse Event|0|||
144345024|NCT02873338|520467258|FG001|Overall Study|Adverse Event|2|||
144345025|NCT02873338|520467259|FG002|Overall Study|Adverse Event|1|||
144345026|NCT02873338|520467257|FG000|Overall Study|Death|2|||
144345027|NCT02873338|520467258|FG001|Overall Study|Death|1|||
144345028|NCT02873338|520467259|FG002|Overall Study|Death|1|||
144345029|NCT02873338|520467257|FG000|Overall Study|Withdrawal by Subject|2|||
144345030|NCT02873338|520467258|FG001|Overall Study|Withdrawal by Subject|1|||
144345031|NCT02873338|520467259|FG002|Overall Study|Withdrawal by Subject|3|||
144345032|NCT02873338|520467257|FG000|Overall Study|Lack of Efficacy|0|||
144345033|NCT02873338|520467258|FG001|Overall Study|Lack of Efficacy|2|||
144345034|NCT02873338|520467259|FG002|Overall Study|Lack of Efficacy|0|||
144345035|NCT02873338|520467257|FG000|Overall Study|Other or Missing|14|||
144345036|NCT02873338|520467258|FG001|Overall Study|Other or Missing|15|||
144345037|NCT02873338|520467259|FG002|Overall Study|Other or Missing|13|||
144345038|NCT02669121|520467260|FG000|Overall Study|Adverse Event|4|||
144345039|NCT02669121|520467261|FG001|Overall Study|Adverse Event|5|||
144345040|NCT02669121|520467260|FG000|Overall Study|Lost to Follow-up|15|||
144345041|NCT02669121|520467261|FG001|Overall Study|Lost to Follow-up|27|||
144345042|NCT02669121|520467260|FG000|Overall Study|Withdrawal by Subject|132|||
144345043|NCT02669121|520467261|FG001|Overall Study|Withdrawal by Subject|140|||
144345044|NCT02669121|520467260|FG000|Overall Study|Pregnancy|0|||
144345045|NCT02669121|520467261|FG001|Overall Study|Pregnancy|1|||
144345046|NCT02669121|520467260|FG000|Overall Study|Discharged from US Military Active Service|117|||
144345047|NCT02669121|520467261|FG001|Overall Study|Discharged from US Military Active Service|91|||
144345048|NCT02669121|520467260|FG000|Overall Study|Reason not Specified|22|||
144345049|NCT02669121|520467261|FG001|Overall Study|Reason not Specified|18|||
144345050|NCT03216746|520467262|FG000|Overall Study|Lost to Follow-up|6|||
144345051|NCT03216746|520467263|FG001|Overall Study|Lost to Follow-up|8|||
144345052|NCT03216746|520467264|FG002|Overall Study|Lost to Follow-up|5|||
144345053|NCT03216746|520467265|FG003|Overall Study|Lost to Follow-up|6|||
144345054|NCT04384523|520467266|FG000|Overall Study|Lost to Follow-up|0|||
144345055|NCT04384523|520467267|FG001|Overall Study|Lost to Follow-up|0|||
144345056|NCT04384523|520467268|FG002|Overall Study|Lost to Follow-up|0|||
144345057|NCT04384523|520467269|FG003|Overall Study|Lost to Follow-up|0|||
144345058|NCT04384523|520467270|FG004|Overall Study|Lost to Follow-up|0|||
144345059|NCT04384523|520467271|FG005|Overall Study|Lost to Follow-up|1|||
144345060|NCT04384523|520467266|FG000|Overall Study|Protocol Violation|0|||
144345061|NCT04384523|520467267|FG001|Overall Study|Protocol Violation|1|||
144345062|NCT04384523|520467268|FG002|Overall Study|Protocol Violation|0|||
144345063|NCT04384523|520467269|FG003|Overall Study|Protocol Violation|0|||
144345064|NCT04384523|520467270|FG004|Overall Study|Protocol Violation|0|||
144345065|NCT04384523|520467271|FG005|Overall Study|Protocol Violation|0|||
144345066|NCT04384523|520467266|FG000|Overall Study|Withdrawal by Subject|1|||
144345067|NCT04384523|520467267|FG001|Overall Study|Withdrawal by Subject|0|||
144345068|NCT04384523|520467268|FG002|Overall Study|Withdrawal by Subject|0|||
144345069|NCT04384523|520467269|FG003|Overall Study|Withdrawal by Subject|0|||
144345070|NCT04384523|520467270|FG004|Overall Study|Withdrawal by Subject|0|||
144345071|NCT04384523|520467271|FG005|Overall Study|Withdrawal by Subject|0|||
144345072|NCT00635882|520467272|FG000|Overall Study|Protocol Violation|1|||
144345073|NCT00635882|520467273|FG001|Overall Study|Protocol Violation|0|||
144345074|NCT00635882|520467274|FG002|Overall Study|Protocol Violation|0|||
144345075|NCT00635882|520467275|FG003|Overall Study|Protocol Violation|0|||
144345076|NCT00635882|520467276|FG004|Overall Study|Protocol Violation|0|||
144345077|NCT00635882|520467277|FG005|Overall Study|Protocol Violation|0|||
144345078|NCT02687581|520467278|FG000|Overall Study|Withdrawal by Subject|1|||
144345079|NCT02687581|520467279|FG001|Overall Study|Withdrawal by Subject|0|||
144345080|NCT02687581|520467280|FG002|Overall Study|Withdrawal by Subject|0|||
144345081|NCT02687581|520467281|FG003|Overall Study|Withdrawal by Subject|1|||
144345082|NCT02687581|520467278|FG000|Overall Study|Lost to Follow-up|2|||
144345083|NCT02687581|520467279|FG001|Overall Study|Lost to Follow-up|2|||
144345084|NCT02687581|520467280|FG002|Overall Study|Lost to Follow-up|0|||
144345085|NCT02687581|520467281|FG003|Overall Study|Lost to Follow-up|0|||
144345086|NCT02687581|520467278|FG000|Overall Study|the device is too small for the patient.|1|||
144345087|NCT02687581|520467279|FG001|Overall Study|the device is too small for the patient.|0|||
144345088|NCT02687581|520467280|FG002|Overall Study|the device is too small for the patient.|0|||
144345089|NCT02687581|520467281|FG003|Overall Study|the device is too small for the patient.|0|||
144345090|NCT00835341|520467282|FG000|Overall Study|Lost to Follow-up|3|||
144345091|NCT00835341|520467283|FG001|Overall Study|Lost to Follow-up|12|||
144345092|NCT04405076|520467285|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
144345093|NCT04405076|520467286|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
144345094|NCT04405076|520467287|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
144345095|NCT04405076|520467288|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
144345096|NCT04405076|520467289|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
144345097|NCT04405076|520467290|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
144345098|NCT04405076|520467291|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
144345099|NCT04405076|520467292|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
144345100|NCT04405076|520467293|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
144345101|NCT04405076|520467285|FG000|Part A (Blinded Phase)|Physician Decision|1|||
144345102|NCT04405076|520467286|FG001|Part A (Blinded Phase)|Physician Decision|2|||
144345103|NCT04405076|520467287|FG002|Part A (Blinded Phase)|Physician Decision|0|||
144345104|NCT04405076|520467288|FG003|Part A (Blinded Phase)|Physician Decision|0|||
144345105|NCT04405076|520467289|FG004|Part A (Blinded Phase)|Physician Decision|0|||
144345106|NCT04405076|520467290|FG005|Part A (Blinded Phase)|Physician Decision|0|||
144345107|NCT04405076|520467291|FG006|Part A (Blinded Phase)|Physician Decision|0|||
144345108|NCT04405076|520467292|FG007|Part A (Blinded Phase)|Physician Decision|0|||
144345109|NCT04405076|520467293|FG008|Part A (Blinded Phase)|Physician Decision|0|||
144345110|NCT04405076|520467285|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
144345111|NCT04405076|520467286|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
144345112|NCT04405076|520467287|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
144345113|NCT04405076|520467288|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
144345114|NCT04405076|520467289|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
144345115|NCT04405076|520467290|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
144345116|NCT04405076|520467291|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
144345117|NCT04405076|520467292|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
144345118|NCT04405076|520467293|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
144345119|NCT04405076|520467285|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
144345120|NCT04405076|520467286|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345121|NCT04405076|520467287|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345122|NCT04405076|520467288|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345123|NCT04405076|520467289|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345124|NCT04405076|520467290|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345125|NCT04405076|520467291|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345126|NCT04405076|520467292|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345127|NCT04405076|520467293|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
144345128|NCT04405076|520467285|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
144345129|NCT04405076|520467286|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
144345130|NCT04405076|520467287|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345131|NCT04405076|520467288|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345132|NCT04405076|520467289|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345133|NCT04405076|520467290|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345134|NCT04405076|520467291|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345135|NCT04405076|520467292|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345136|NCT04405076|520467293|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
144345137|NCT04405076|520467285|FG000|Part A (Blinded Phase)|Other than Specified|0|||
144345138|NCT04405076|520467286|FG001|Part A (Blinded Phase)|Other than Specified|0|||
144345139|NCT04405076|520467287|FG002|Part A (Blinded Phase)|Other than Specified|3|||
144345140|NCT04405076|520467288|FG003|Part A (Blinded Phase)|Other than Specified|0|||
144345141|NCT04405076|520467289|FG004|Part A (Blinded Phase)|Other than Specified|0|||
144345142|NCT04405076|520467290|FG005|Part A (Blinded Phase)|Other than Specified|0|||
144345143|NCT04405076|520467291|FG006|Part A (Blinded Phase)|Other than Specified|0|||
144345144|NCT04405076|520467292|FG007|Part A (Blinded Phase)|Other than Specified|0|||
144345145|NCT04405076|520467293|FG008|Part A (Blinded Phase)|Other than Specified|0|||
144345146|NCT04405076|520467285|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
144345147|NCT04405076|520467286|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
144345148|NCT04405076|520467287|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
144345149|NCT04405076|520467288|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
144345150|NCT04405076|520467289|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
144345151|NCT04405076|520467290|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
144345152|NCT04405076|520467291|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
144345153|NCT04405076|520467292|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
144345154|NCT04405076|520467293|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
144345155|NCT04405076|520467285|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345156|NCT04405076|520467286|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345157|NCT04405076|520467287|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345158|NCT04405076|520467288|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345159|NCT04405076|520467289|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
144345160|NCT04405076|520467290|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345161|NCT04405076|520467291|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345162|NCT04405076|520467292|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345163|NCT04405076|520467293|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
144345164|NCT04405076|520467285|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
144345165|NCT04405076|520467286|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
144345166|NCT04405076|520467287|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
144345167|NCT04405076|520467288|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
144345168|NCT04405076|520467289|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
144345169|NCT04405076|520467290|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
144345170|NCT04405076|520467291|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
144345171|NCT04405076|520467292|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
144345172|NCT04405076|520467293|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
144345173|NCT04405076|520467285|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345174|NCT04405076|520467286|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345175|NCT04405076|520467287|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345176|NCT04405076|520467288|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345177|NCT04405076|520467289|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345178|NCT04405076|520467290|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345179|NCT04405076|520467291|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
144345180|NCT04405076|520467292|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
144345181|NCT04405076|520467293|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
144345182|NCT04405076|520467285|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345183|NCT04405076|520467286|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345184|NCT04405076|520467287|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345185|NCT04405076|520467288|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345186|NCT04405076|520467289|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345187|NCT04405076|520467290|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345188|NCT04405076|520467291|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
144345189|NCT04405076|520467292|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345190|NCT04405076|520467293|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
144345191|NCT04310566|520467294|FG000|Period 1|Study Termination due to COVID-19|15|||
144345192|NCT04310566|520467295|FG001|Period 1|Study Termination due to COVID-19|17|||
144345193|NCT04310566|520467294|FG000|Period 1|Protocol Violation|0|||
144345194|NCT04310566|520467295|FG001|Period 1|Protocol Violation|1|||
144345195|NCT04310566|520467294|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
144345196|NCT04310566|520467295|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
144345197|NCT04310566|520467294|FG000|Period 1|Lost to Follow-up|1|||
144345198|NCT04310566|520467295|FG001|Period 1|Lost to Follow-up|0|||
144345199|NCT04310566|520467294|FG000|Period 1|Withdrawal by Subject|0|||
144345200|NCT04310566|520467295|FG001|Period 1|Withdrawal by Subject|1|||
144345201|NCT04310566|520467294|FG000|Period 2|Study Termination|7|||
144345202|NCT04310566|520467295|FG001|Period 2|Study Termination|5|||
144345203|NCT00384332|520467298|FG000|Overall Study|Lost to Follow-up|4|||
144345204|NCT00384332|520467299|FG001|Overall Study|Lost to Follow-up|0|||
144345205|NCT02560012|520467300|FG000|Overall Study|Study Terminated|2|||
144345206|NCT02218008|520467301|FG000|Stage 1 (S1)|Adverse Event|6|||
144345207|NCT02218008|520467302|FG001|Stage 1 (S1)|Adverse Event|5|||
144345208|NCT02218008|520467303|FG002|Stage 1 (S1)|Adverse Event|11|||
144345209|NCT02218008|520467304|FG003|Stage 1 (S1)|Adverse Event|0|||
144345210|NCT02218008|520467305|FG004|Stage 1 (S1)|Adverse Event|0|||
144345211|NCT02218008|520467306|FG005|Stage 1 (S1)|Adverse Event|0|||
144345212|NCT02218008|520467301|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
144345213|NCT02218008|520467302|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
144345214|NCT02218008|520467303|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
144345215|NCT02218008|520467304|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
144345216|NCT02218008|520467305|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
144345217|NCT02218008|520467306|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
144345218|NCT02218008|520467301|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
144345219|NCT02218008|520467302|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
144345220|NCT02218008|520467303|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
144345221|NCT02218008|520467304|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
144345222|NCT02218008|520467305|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
144345223|NCT02218008|520467306|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
144345224|NCT02218008|520467301|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
144345225|NCT02218008|520467302|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
144345226|NCT02218008|520467303|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
144345227|NCT02218008|520467304|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
144345228|NCT02218008|520467305|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
144345229|NCT02218008|520467306|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
144345230|NCT02218008|520467301|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
144345231|NCT02218008|520467302|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
144345232|NCT02218008|520467303|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
144345233|NCT02218008|520467304|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
144345234|NCT02218008|520467305|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
144345235|NCT02218008|520467306|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
144345236|NCT02218008|520467301|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
144345237|NCT02218008|520467302|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
144345238|NCT02218008|520467303|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
144345239|NCT02218008|520467304|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
144345240|NCT02218008|520467305|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
144345241|NCT02218008|520467306|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
144345242|NCT02218008|520467301|FG000|Stage 1 (S1)|Pregnancy|0|||
144345243|NCT02218008|520467302|FG001|Stage 1 (S1)|Pregnancy|0|||
144345244|NCT02218008|520467303|FG002|Stage 1 (S1)|Pregnancy|1|||
144345245|NCT02218008|520467304|FG003|Stage 1 (S1)|Pregnancy|0|||
144345246|NCT02218008|520467305|FG004|Stage 1 (S1)|Pregnancy|0|||
144345247|NCT02218008|520467306|FG005|Stage 1 (S1)|Pregnancy|0|||
144345248|NCT02218008|520467301|FG000|Stage 1 (S1)|Protocol Violation|0|||
144345249|NCT02218008|520467302|FG001|Stage 1 (S1)|Protocol Violation|0|||
144345250|NCT02218008|520467303|FG002|Stage 1 (S1)|Protocol Violation|1|||
144345251|NCT02218008|520467304|FG003|Stage 1 (S1)|Protocol Violation|0|||
144345252|NCT02218008|520467305|FG004|Stage 1 (S1)|Protocol Violation|0|||
144345253|NCT02218008|520467306|FG005|Stage 1 (S1)|Protocol Violation|0|||
144345254|NCT02218008|520467301|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
144345255|NCT02218008|520467302|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
144345256|NCT02218008|520467303|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
144345257|NCT02218008|520467304|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
144345258|NCT02218008|520467305|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
144345259|NCT02218008|520467306|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
144345260|NCT02218008|520467301|FG000|Stage 2 (S2)|Adverse Event|0|||
144345261|NCT02218008|520467302|FG001|Stage 2 (S2)|Adverse Event|0|||
144345262|NCT02218008|520467303|FG002|Stage 2 (S2)|Adverse Event|0|||
144345263|NCT02218008|520467304|FG003|Stage 2 (S2)|Adverse Event|2|||
144345264|NCT02218008|520467305|FG004|Stage 2 (S2)|Adverse Event|3|||
144345265|NCT02218008|520467306|FG005|Stage 2 (S2)|Adverse Event|3|||
144345266|NCT02218008|520467301|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
144345267|NCT02218008|520467302|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
144345268|NCT02218008|520467303|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
144345269|NCT02218008|520467304|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
144345270|NCT02218008|520467305|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
144345271|NCT02218008|520467306|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
144345272|NCT02218008|520467301|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
144345273|NCT02218008|520467302|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
144345274|NCT02218008|520467303|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
144345275|NCT02218008|520467304|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
144345276|NCT02218008|520467305|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
144345277|NCT02218008|520467306|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
144345278|NCT02218008|520467301|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
144345279|NCT02218008|520467302|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
144345280|NCT02218008|520467303|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
144345281|NCT02218008|520467304|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
144345282|NCT02218008|520467305|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
144345283|NCT02218008|520467306|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
144345284|NCT02218008|520467301|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
144345285|NCT02218008|520467302|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
144345286|NCT02218008|520467303|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
144345287|NCT02218008|520467304|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
144345288|NCT02218008|520467305|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
144345289|NCT02218008|520467306|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
144345290|NCT01278797|520467307|FG000|Period 1|Adverse Event|0|||
144345291|NCT01278797|520467308|FG001|Period 1|Adverse Event|1|||
144345292|NCT01278797|520467307|FG000|Period 1|Protocol Violation|1|||
144345293|NCT01278797|520467308|FG001|Period 1|Protocol Violation|0|||
144345294|NCT04000581|520467309|FG000|Overall Study|Withdrawal by Subject|0|||
144345295|NCT04000581|520467310|FG001|Overall Study|Withdrawal by Subject|1|||
144345296|NCT01088399|520467315|FG000|Overall Study|Adverse Event|211|||
144345297|NCT01088399|520467316|FG001|Overall Study|Adverse Event|16|||
144345298|NCT01088399|520467317|FG002|Overall Study|Adverse Event|0|||
144345299|NCT01088399|520467315|FG000|Overall Study|Death|204|||
144345300|NCT01088399|520467316|FG001|Overall Study|Death|45|||
144345301|NCT01088399|520467317|FG002|Overall Study|Death|0|||
144345302|NCT01088399|520467315|FG000|Overall Study|Lack of Efficacy|298|||
144345303|NCT01088399|520467316|FG001|Overall Study|Lack of Efficacy|7|||
144345304|NCT01088399|520467317|FG002|Overall Study|Lack of Efficacy|5|||
144345305|NCT01088399|520467315|FG000|Overall Study|Lost to Follow-up|1070|||
144345306|NCT01088399|520467316|FG001|Overall Study|Lost to Follow-up|278|||
144345307|NCT01088399|520467317|FG002|Overall Study|Lost to Follow-up|58|||
144345308|NCT01088399|520467315|FG000|Overall Study|Physician Decision|531|||
144345309|NCT01088399|520467316|FG001|Overall Study|Physician Decision|88|||
144345310|NCT01088399|520467317|FG002|Overall Study|Physician Decision|16|||
144345311|NCT01088399|520467315|FG000|Overall Study|Withdrawal by Subject|544|||
144345312|NCT01088399|520467316|FG001|Overall Study|Withdrawal by Subject|195|||
144345313|NCT01088399|520467317|FG002|Overall Study|Withdrawal by Subject|33|||
144345314|NCT01088399|520467315|FG000|Overall Study|Change to or start of somatropin therapy|234|||
144345315|NCT01088399|520467316|FG001|Overall Study|Change to or start of somatropin therapy|17|||
144345316|NCT01088399|520467317|FG002|Overall Study|Change to or start of somatropin therapy|12|||
144345317|NCT01088399|520467315|FG000|Overall Study|Sponsor decision|1573|||
144345318|NCT01088399|520467316|FG001|Overall Study|Sponsor decision|298|||
144345319|NCT01088399|520467317|FG002|Overall Study|Sponsor decision|7|||
144345320|NCT01088399|520467315|FG000|Overall Study|Protocol Violation|10|||
144345321|NCT01088399|520467316|FG001|Overall Study|Protocol Violation|1|||
144345322|NCT01088399|520467317|FG002|Overall Study|Protocol Violation|0|||
144345323|NCT01088399|520467315|FG000|Overall Study|Enrollment criteria not met|48|||
144345324|NCT01088399|520467316|FG001|Overall Study|Enrollment criteria not met|119|||
144345325|NCT01088399|520467317|FG002|Overall Study|Enrollment criteria not met|70|||
144345326|NCT01088399|520467315|FG000|Overall Study|Study summary visit not completed|2398|||
144345327|NCT01088399|520467316|FG001|Overall Study|Study summary visit not completed|283|||
144345328|NCT01088399|520467317|FG002|Overall Study|Study summary visit not completed|80|||
144345329|NCT00620113|520467318|FG000|Overall Study|Adverse Event|3|||
144345330|NCT00620113|520467319|FG001|Overall Study|Adverse Event|2|||
144345331|NCT00620113|520467320|FG002|Overall Study|Adverse Event|2|||
144345332|NCT00620113|520467321|FG003|Overall Study|Adverse Event|1|||
144345333|NCT00620113|520467318|FG000|Overall Study|Lack of Efficacy|2|||
144345334|NCT00620113|520467319|FG001|Overall Study|Lack of Efficacy|3|||
144345335|NCT00620113|520467320|FG002|Overall Study|Lack of Efficacy|0|||
144345336|NCT00620113|520467321|FG003|Overall Study|Lack of Efficacy|2|||
144345337|NCT00620113|520467318|FG000|Overall Study|Physician Decision|1|||
144345338|NCT00620113|520467319|FG001|Overall Study|Physician Decision|0|||
144345339|NCT00620113|520467320|FG002|Overall Study|Physician Decision|0|||
144345340|NCT00620113|520467321|FG003|Overall Study|Physician Decision|2|||
144345341|NCT00620113|520467318|FG000|Overall Study|Protocol Violation|2|||
144345342|NCT00620113|520467319|FG001|Overall Study|Protocol Violation|1|||
144345343|NCT00620113|520467320|FG002|Overall Study|Protocol Violation|0|||
144345344|NCT00620113|520467321|FG003|Overall Study|Protocol Violation|0|||
144345345|NCT00620113|520467318|FG000|Overall Study|Withdrawal by Subject|5|||
144345346|NCT00620113|520467319|FG001|Overall Study|Withdrawal by Subject|1|||
144345347|NCT00620113|520467320|FG002|Overall Study|Withdrawal by Subject|3|||
144345348|NCT00620113|520467321|FG003|Overall Study|Withdrawal by Subject|5|||
144345349|NCT01504412|520469032|FG000|Overall Study|Adverse Event|1|||
144345350|NCT01504412|520469033|FG001|Overall Study|Adverse Event|8|||
144345351|NCT01504412|520469034|FG002|Overall Study|Adverse Event|1|||
144345352|NCT01504412|520469035|FG003|Overall Study|Adverse Event|7|||
144345353|NCT01504412|520469036|FG004|Overall Study|Adverse Event|10|||
144345354|NCT01504412|520469032|FG000|Overall Study|Withdrawal by Subject|2|||
144345355|NCT01504412|520469033|FG001|Overall Study|Withdrawal by Subject|1|||
144345356|NCT01504412|520469034|FG002|Overall Study|Withdrawal by Subject|1|||
144345357|NCT01504412|520469035|FG003|Overall Study|Withdrawal by Subject|5|||
144345358|NCT01504412|520469036|FG004|Overall Study|Withdrawal by Subject|1|||
144345359|NCT01504412|520469032|FG000|Overall Study|Other|2|||
144345360|NCT01504412|520469033|FG001|Overall Study|Other|1|||
144345361|NCT01504412|520469034|FG002|Overall Study|Other|1|||
144345362|NCT01504412|520469035|FG003|Overall Study|Other|6|||
144345363|NCT01504412|520469036|FG004|Overall Study|Other|1|||
144345364|NCT01504412|520469032|FG000|Overall Study|Lost to Follow-up|0|||
144345365|NCT01504412|520469033|FG001|Overall Study|Lost to Follow-up|2|||
144345366|NCT01504412|520469034|FG002|Overall Study|Lost to Follow-up|0|||
144345367|NCT01504412|520469035|FG003|Overall Study|Lost to Follow-up|0|||
144345368|NCT01504412|520469036|FG004|Overall Study|Lost to Follow-up|0|||
144345369|NCT01504412|520469032|FG000|Overall Study|Lack of Efficacy|0|||
144345370|NCT01504412|520469033|FG001|Overall Study|Lack of Efficacy|0|||
144345371|NCT01504412|520469034|FG002|Overall Study|Lack of Efficacy|1|||
144345372|NCT01504412|520469035|FG003|Overall Study|Lack of Efficacy|0|||
144345373|NCT01504412|520469036|FG004|Overall Study|Lack of Efficacy|1|||
144345374|NCT01504412|520469032|FG000|Overall Study|Death|0|||
144345375|NCT01504412|520469033|FG001|Overall Study|Death|0|||
144345376|NCT01504412|520469034|FG002|Overall Study|Death|0|||
144345377|NCT01504412|520469035|FG003|Overall Study|Death|1|||
144345378|NCT01504412|520469036|FG004|Overall Study|Death|0|||
144345379|NCT04809285|520469037|FG000|Phase 1|Lost to Follow-up|6|||
144345380|NCT04809285|520469037|FG000|Phase 1|Protocol Violation|2|||
144345381|NCT04809285|520469037|FG000|Phase 1|Physician Decision|3|||
144345382|NCT04809285|520469037|FG000|Phase 1|Withdrawal by Subject|29|||
144345383|NCT04809285|520469037|FG000|Phase 2|Protocol Violation|3|||
144345384|NCT04809285|520469037|FG000|Phase 2|Withdrawal by Subject|4|||
144345385|NCT02837029|520469038|FG000|Screening|Failed to meet screening requirements.|7|||
144345386|NCT02837029|520469039|FG001|Screening|Failed to meet screening requirements.|3|||
144345387|NCT02837029|520469040|FG002|Screening|Failed to meet screening requirements.|0|||
144345388|NCT02837029|520469038|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
144345389|NCT02837029|520469039|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
144345390|NCT02837029|520469040|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
144345391|NCT02837029|520469038|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
144345392|NCT02837029|520469039|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
144345393|NCT02837029|520469040|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
144345394|NCT02837029|520469038|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
144345395|NCT02837029|520469039|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
144345396|NCT02837029|520469040|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
144345397|NCT02837029|520469038|FG000|Cycle 2 and Beyond|Adverse Event|1|||
144345398|NCT02837029|520469039|FG001|Cycle 2 and Beyond|Adverse Event|0|||
144345399|NCT02837029|520469040|FG002|Cycle 2 and Beyond|Adverse Event|0|||
144345400|NCT02837029|520469038|FG000|2 Year Follow-up|Death|6|||
144345401|NCT02837029|520469039|FG001|2 Year Follow-up|Death|7|||
144345402|NCT02837029|520469040|FG002|2 Year Follow-up|Death|0|||
144345403|NCT02034877|520469041|FG000|Overall Study|Lost to Follow-up|0|||
144345404|NCT02034877|520469042|FG001|Overall Study|Lost to Follow-up|3|||
144345405|NCT02034877|520469041|FG000|Overall Study|No Longer Willing to Participate|0|||
144345406|NCT02034877|520469042|FG001|Overall Study|No Longer Willing to Participate|3|||
144345407|NCT02598297|520469047|FG000|Overall Study|Study terminated by Sponsor|21|||
144345408|NCT02598297|520469048|FG001|Overall Study|Study terminated by Sponsor|23|||
144345409|NCT02598297|520469047|FG000|Overall Study|Adverse Event|1|||
144345410|NCT02598297|520469048|FG001|Overall Study|Adverse Event|1|||
144345411|NCT02598297|520469047|FG000|Overall Study|Physician Decision|1|||
144345412|NCT02598297|520469048|FG001|Overall Study|Physician Decision|0|||
144345413|NCT02598297|520469047|FG000|Overall Study|Subject/guardian decision|1|||
144345414|NCT02598297|520469048|FG001|Overall Study|Subject/guardian decision|0|||
144345415|NCT02598297|520469047|FG000|Overall Study|Followed for survival|1|||
144345416|NCT02598297|520469048|FG001|Overall Study|Followed for survival|0|||
144345417|NCT00887549|520469051|FG000|Induction Therapy|Adverse Event|8|||
144345418|NCT00887549|520469051|FG000|Induction Therapy|Physician Decision|1|||
144345419|NCT00887549|520469051|FG000|Induction Therapy|Progressive Disease|13|||
144345420|NCT00887549|520469051|FG000|Induction Therapy|Death due to Study Disease|4|||
144345421|NCT00887549|520469051|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
144345422|NCT00887549|520469051|FG000|Maintenance Therapy|Adverse Event|16|||
144345423|NCT00887549|520469051|FG000|Maintenance Therapy|Physician Decision|1|||
144345424|NCT00887549|520469051|FG000|Maintenance Therapy|Progressive Disease|25|||
144345425|NCT00887549|520469051|FG000|Maintenance Therapy|Death due to adverse event|1|||
144345426|NCT01934010|520469052|FG000|Overall Study|Adverse Event|1|||
144345427|NCT01934010|520469053|FG001|Overall Study|Adverse Event|1|||
144345428|NCT01934010|520469054|FG002|Overall Study|Adverse Event|0|||
144345429|NCT01934010|520469052|FG000|Overall Study|Withdrawal by Subject|15|||
144345430|NCT01934010|520469053|FG001|Overall Study|Withdrawal by Subject|6|||
144345431|NCT01934010|520469054|FG002|Overall Study|Withdrawal by Subject|2|||
144345432|NCT01934010|520469052|FG000|Overall Study|Lost to Follow-up|7|||
144345433|NCT01934010|520469053|FG001|Overall Study|Lost to Follow-up|4|||
144345434|NCT01934010|520469054|FG002|Overall Study|Lost to Follow-up|0|||
144345435|NCT00100789|520469055|FG000|Overall Study|Adverse Event|10|||
144345436|NCT00100789|520469055|FG000|Overall Study|Withdrawal by Subject|1|||
144345437|NCT00100789|520469055|FG000|Overall Study|Progression/relapse|42|||
144345438|NCT00100789|520469055|FG000|Overall Study|Death|2|||
144345439|NCT00100789|520469055|FG000|Overall Study|Not protocol specified|5|||
144345440|NCT00100789|520469055|FG000|Overall Study|Ineligible|3|||
144345441|NCT00100789|520469055|FG000|Overall Study|Never received treatment|1|||
144345442|NCT01393821|520469056|FG000|Overall Study|Cancel|1|||
144345443|NCT01393821|520469057|FG001|Overall Study|Cancel|1|||
144345444|NCT01393821|520469056|FG000|Overall Study|not evaluable for primary endpoint|4|||
144345445|NCT01393821|520469057|FG001|Overall Study|not evaluable for primary endpoint|2|||
144345446|NCT00377858|520469068|FG000|Overall Study|Withdrawal by Subject|12|||
144345447|NCT00377858|520469069|FG001|Overall Study|Withdrawal by Subject|11|||
144345448|NCT00377858|520469068|FG000|Overall Study|Lost to Follow-up|6|||
144345449|NCT00377858|520469069|FG001|Overall Study|Lost to Follow-up|1|||
144345450|NCT00377858|520469068|FG000|Overall Study|Physician Decision|5|||
144345451|NCT00377858|520469069|FG001|Overall Study|Physician Decision|5|||
144345452|NCT00377858|520469068|FG000|Overall Study|Protocol Violation|3|||
144345453|NCT00377858|520469069|FG001|Overall Study|Protocol Violation|4|||
144345454|NCT00377858|520469068|FG000|Overall Study|Adverse Event|2|||
144345455|NCT00377858|520469069|FG001|Overall Study|Adverse Event|1|||
144345456|NCT00377858|520469068|FG000|Overall Study|Entry Criteria Not Met|2|||
144345457|NCT00377858|520469069|FG001|Overall Study|Entry Criteria Not Met|0|||
144345458|NCT00377858|520469068|FG000|Overall Study|Sponsor Decision|1|||
144345459|NCT00377858|520469069|FG001|Overall Study|Sponsor Decision|2|||
144345460|NCT00377858|520469068|FG000|Overall Study|Death|0|||
144345461|NCT00377858|520469069|FG001|Overall Study|Death|3|||
144345462|NCT03534141|520469070|FG000|Overall Study|Enrolled in other clinical trial|1|||
144345463|NCT03534141|520469071|FG001|Overall Study|Enrolled in other clinical trial|0|||
144345464|NCT03534141|520469070|FG000|Overall Study|Liver transplant aborted after randomization|0|||
144345465|NCT03534141|520469071|FG001|Overall Study|Liver transplant aborted after randomization|2|||
144345466|NCT03534141|520469070|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
144345467|NCT03534141|520469071|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
144345468|NCT02506192|520469072|FG000|Overall Study|Withdrawal by Subject|1|||
144345469|NCT02506192|520469073|FG001|Overall Study|Withdrawal by Subject|1|||
144345470|NCT04303572|520469074|FG000|Overall Study|Study closed due to poor enrollment|1|||
144345471|NCT06312592|520469075|FG000|Overall Study|Lost to Follow-up|29|||
144345472|NCT06312592|520469076|FG001|Overall Study|Lost to Follow-up|13|||
144345473|NCT06136897|520469079|FG000|Overall Study|Ineligible|3|||
144345474|NCT06136897|520469079|FG000|Overall Study|Mutation status not confirmed|7|||
144345475|NCT06136897|520469079|FG000|Overall Study|Adverse Event|2|||
144345476|NCT06136897|520469079|FG000|Overall Study|Death|1|||
144345477|NCT06136897|520469079|FG000|Overall Study|Disease progression|18|||
144345478|NCT06136897|520469079|FG000|Overall Study|Other complicating disease|1|||
144345479|NCT06136897|520469079|FG000|Overall Study|Withdrawal by Subject|1|||
144345480|NCT06136897|520469079|FG000|Overall Study|Still on treatment|1|||
144345481|NCT06136897|520469079|FG000|Overall Study|Lost to Follow-up|1|||
144345482|NCT03785405|520469080|FG000|Overall Study|Adverse Event|16|||
144345483|NCT03785405|520469081|FG001|Overall Study|Adverse Event|1|||
144345484|NCT03785405|520469080|FG000|Overall Study|Death|6|||
144345485|NCT03785405|520469081|FG001|Overall Study|Death|4|||
144345486|NCT03785405|520469080|FG000|Overall Study|Guardian decision|4|||
144345487|NCT03785405|520469081|FG001|Overall Study|Guardian decision|1|||
144345488|NCT03785405|520469080|FG000|Overall Study|Lost to Follow-up|1|||
144345489|NCT03785405|520469081|FG001|Overall Study|Lost to Follow-up|0|||
144345490|NCT03785405|520469080|FG000|Overall Study|Physician Decision|8|||
144345491|NCT03785405|520469081|FG001|Overall Study|Physician Decision|5|||
144345492|NCT03785405|520469080|FG000|Overall Study|Participant decision|2|||
144345493|NCT03785405|520469081|FG001|Overall Study|Participant decision|0|||
144345494|NCT03785405|520469080|FG000|Overall Study|Other|1|||
144345495|NCT03785405|520469081|FG001|Overall Study|Other|0|||
144345496|NCT03785405|520469080|FG000|Overall Study|No treatment was received|0|||
144345497|NCT03785405|520469081|FG001|Overall Study|No treatment was received|1|||
144345498|NCT03705559|520469082|FG000|Overall Study|COVID Shut down|1|||
144345499|NCT01948063|520469083|FG000|Overall Study|Boston MCI halted research protocol|0|||
144345500|NCT01948063|520469084|FG001|Overall Study|Boston MCI halted research protocol|1|||
144345501|NCT01948063|520469083|FG000|Overall Study|Discovered an enrollment in other study|0|||
144345502|NCT01948063|520469084|FG001|Overall Study|Discovered an enrollment in other study|1|||
144345503|NCT01948063|520469083|FG000|Overall Study|Blood samples were accidentally thawed|1|||
144345504|NCT01948063|520469084|FG001|Overall Study|Blood samples were accidentally thawed|0|||
144345505|NCT01858766|520469085|FG000|Overall Study|Randomized but Never Treated|0|||
144345506|NCT01858766|520469086|FG001|Overall Study|Randomized but Never Treated|0|||
144345507|NCT01858766|520469087|FG002|Overall Study|Randomized but Never Treated|0|||
144345508|NCT01858766|520469088|FG003|Overall Study|Randomized but Never Treated|0|||
144345509|NCT01858766|520469089|FG004|Overall Study|Randomized but Never Treated|0|||
144345510|NCT01858766|520469090|FG005|Overall Study|Randomized but Never Treated|1|||
144345511|NCT01858766|520469091|FG006|Overall Study|Randomized but Never Treated|0|||
144345512|NCT01858766|520469092|FG007|Overall Study|Randomized but Never Treated|0|||
144345513|NCT01858766|520469093|FG008|Overall Study|Randomized but Never Treated|0|||
144345514|NCT01858766|520469094|FG009|Overall Study|Randomized but Never Treated|0|||
144345515|NCT01858766|520469095|FG010|Overall Study|Randomized but Never Treated|0|||
144345516|NCT01858766|520469096|FG011|Overall Study|Randomized but Never Treated|0|||
144345517|NCT01858766|520469097|FG012|Overall Study|Randomized but Never Treated|0|||
144345518|NCT01858766|520469098|FG013|Overall Study|Randomized but Never Treated|0|||
144345519|NCT01858766|520469099|FG014|Overall Study|Randomized but Never Treated|0|||
144345520|NCT01858766|520469100|FG015|Overall Study|Randomized but Never Treated|0|||
144345521|NCT01858766|520469101|FG016|Overall Study|Randomized but Never Treated|0|||
144345522|NCT01858766|520469102|FG017|Overall Study|Randomized but Never Treated|1|||
144345523|NCT01858766|520469103|FG018|Overall Study|Randomized but Never Treated|0|||
144345524|NCT01858766|520469085|FG000|Overall Study|Death|0|||
144345525|NCT01858766|520469086|FG001|Overall Study|Death|0|||
144345526|NCT01858766|520469087|FG002|Overall Study|Death|1|||
144345527|NCT01858766|520469088|FG003|Overall Study|Death|0|||
144345528|NCT01858766|520469089|FG004|Overall Study|Death|0|||
144345529|NCT01858766|520469090|FG005|Overall Study|Death|0|||
144345530|NCT01858766|520469091|FG006|Overall Study|Death|0|||
144345531|NCT01858766|520469092|FG007|Overall Study|Death|0|||
144345532|NCT01858766|520469093|FG008|Overall Study|Death|0|||
144345533|NCT01858766|520469094|FG009|Overall Study|Death|0|||
144345534|NCT01858766|520469095|FG010|Overall Study|Death|0|||
144345535|NCT01858766|520469096|FG011|Overall Study|Death|0|||
144345536|NCT01858766|520469097|FG012|Overall Study|Death|0|||
144345537|NCT01858766|520469098|FG013|Overall Study|Death|0|||
144345538|NCT01858766|520469099|FG014|Overall Study|Death|0|||
144345539|NCT01858766|520469100|FG015|Overall Study|Death|0|||
144345540|NCT01858766|520469101|FG016|Overall Study|Death|0|||
144345541|NCT01858766|520469102|FG017|Overall Study|Death|0|||
144345542|NCT01858766|520469103|FG018|Overall Study|Death|0|||
144345543|NCT01858766|520469085|FG000|Overall Study|Lack of Efficacy|1|||
144345544|NCT01858766|520469086|FG001|Overall Study|Lack of Efficacy|0|||
144345545|NCT01858766|520469087|FG002|Overall Study|Lack of Efficacy|0|||
144345546|NCT01858766|520469088|FG003|Overall Study|Lack of Efficacy|0|||
144345547|NCT01858766|520469089|FG004|Overall Study|Lack of Efficacy|1|||
144345548|NCT01858766|520469090|FG005|Overall Study|Lack of Efficacy|2|||
144345549|NCT01858766|520469091|FG006|Overall Study|Lack of Efficacy|0|||
144345550|NCT01858766|520469092|FG007|Overall Study|Lack of Efficacy|0|||
144345551|NCT01858766|520469093|FG008|Overall Study|Lack of Efficacy|0|||
144345552|NCT01858766|520469094|FG009|Overall Study|Lack of Efficacy|0|||
144345553|NCT01858766|520469095|FG010|Overall Study|Lack of Efficacy|0|||
144345554|NCT01858766|520469096|FG011|Overall Study|Lack of Efficacy|3|||
144345555|NCT01858766|520469097|FG012|Overall Study|Lack of Efficacy|5|||
144345556|NCT01858766|520469098|FG013|Overall Study|Lack of Efficacy|3|||
144345557|NCT01858766|520469099|FG014|Overall Study|Lack of Efficacy|5|||
144345558|NCT01858766|520469100|FG015|Overall Study|Lack of Efficacy|5|||
144345559|NCT01858766|520469101|FG016|Overall Study|Lack of Efficacy|2|||
144345560|NCT01858766|520469102|FG017|Overall Study|Lack of Efficacy|3|||
144345561|NCT01858766|520469103|FG018|Overall Study|Lack of Efficacy|3|||
144345562|NCT01858766|520469085|FG000|Overall Study|Lost to Follow-up|0|||
144345563|NCT01858766|520469086|FG001|Overall Study|Lost to Follow-up|0|||
144345564|NCT01858766|520469087|FG002|Overall Study|Lost to Follow-up|0|||
144345565|NCT01858766|520469088|FG003|Overall Study|Lost to Follow-up|0|||
144345566|NCT01858766|520469089|FG004|Overall Study|Lost to Follow-up|0|||
144345567|NCT01858766|520469090|FG005|Overall Study|Lost to Follow-up|1|||
144345568|NCT01858766|520469091|FG006|Overall Study|Lost to Follow-up|0|||
144345569|NCT01858766|520469092|FG007|Overall Study|Lost to Follow-up|2|||
144345570|NCT01858766|520469093|FG008|Overall Study|Lost to Follow-up|0|||
144345571|NCT01858766|520469094|FG009|Overall Study|Lost to Follow-up|0|||
144345572|NCT01858766|520469095|FG010|Overall Study|Lost to Follow-up|0|||
144345573|NCT01858766|520469096|FG011|Overall Study|Lost to Follow-up|1|||
144345574|NCT01858766|520469097|FG012|Overall Study|Lost to Follow-up|0|||
144345575|NCT01858766|520469098|FG013|Overall Study|Lost to Follow-up|0|||
144345576|NCT01858766|520469099|FG014|Overall Study|Lost to Follow-up|3|||
144345577|NCT01858766|520469100|FG015|Overall Study|Lost to Follow-up|1|||
144345578|NCT01858766|520469101|FG016|Overall Study|Lost to Follow-up|1|||
144345579|NCT01858766|520469102|FG017|Overall Study|Lost to Follow-up|0|||
144345580|NCT01858766|520469103|FG018|Overall Study|Lost to Follow-up|1|||
144345581|NCT01858766|520469085|FG000|Overall Study|Withdrew Consent|0|||
144345582|NCT01858766|520469086|FG001|Overall Study|Withdrew Consent|0|||
144345583|NCT01858766|520469087|FG002|Overall Study|Withdrew Consent|0|||
144345584|NCT01858766|520469088|FG003|Overall Study|Withdrew Consent|0|||
144345585|NCT01858766|520469089|FG004|Overall Study|Withdrew Consent|0|||
144345586|NCT01858766|520469090|FG005|Overall Study|Withdrew Consent|0|||
144345587|NCT01858766|520469091|FG006|Overall Study|Withdrew Consent|0|||
144345588|NCT01858766|520469092|FG007|Overall Study|Withdrew Consent|0|||
144345589|NCT01858766|520469093|FG008|Overall Study|Withdrew Consent|0|||
144345590|NCT01858766|520469094|FG009|Overall Study|Withdrew Consent|0|||
144345591|NCT01858766|520469095|FG010|Overall Study|Withdrew Consent|0|||
144345592|NCT01858766|520469096|FG011|Overall Study|Withdrew Consent|1|||
144345593|NCT01858766|520469097|FG012|Overall Study|Withdrew Consent|0|||
144345594|NCT01858766|520469098|FG013|Overall Study|Withdrew Consent|0|||
144345595|NCT01858766|520469099|FG014|Overall Study|Withdrew Consent|0|||
144345596|NCT01858766|520469100|FG015|Overall Study|Withdrew Consent|0|||
144345597|NCT01858766|520469101|FG016|Overall Study|Withdrew Consent|0|||
144345598|NCT01858766|520469102|FG017|Overall Study|Withdrew Consent|0|||
144345599|NCT01858766|520469103|FG018|Overall Study|Withdrew Consent|0|||
144345600|NCT00245037|520469106|FG000|Overall Study|Death|17|||
144345601|NCT04752358|520469109|FG000|Overall Study|Death|2|||
144345602|NCT04752358|520469110|FG001|Overall Study|Death|1|||
144345603|NCT00719355|520469113|FG000|Overall Study|Death|0|||
144345604|NCT00719355|520469114|FG001|Overall Study|Death|1|||
144345605|NCT00719355|520469113|FG000|Overall Study|Medical|14|||
144345606|NCT00719355|520469114|FG001|Overall Study|Medical|5|||
144345607|NCT00719355|520469113|FG000|Overall Study|Compliance|4|||
144345608|NCT00719355|520469114|FG001|Overall Study|Compliance|6|||
144345609|NCT00719355|520469113|FG000|Overall Study|Moved|0|||
144345610|NCT00719355|520469114|FG001|Overall Study|Moved|1|||
144345611|NCT03364738|520469119|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
144345612|NCT03364738|520469119|FG000|Overall Study|Withdrawal by Subject|1|||
144345613|NCT03364738|520469119|FG000|Overall Study|Adverse Event|1|||
144345614|NCT03245398|520469120|FG000|Overall Study|Travelled to another island|1|||
144345615|NCT03245398|520469121|FG001|Overall Study|Travelled to another island|0|||
144345616|NCT01824355|520469122|FG000|Overall Study|Adverse Event|2|||
144345617|NCT01824355|520469122|FG000|Overall Study|unevaluable reference method results per|1|||
144345618|NCT04531241|520469129|FG000|Period 1|Withdrawal by Subject|2|||
144345619|NCT04531241|520469130|FG001|Period 1|Withdrawal by Subject|0|||
144345620|NCT04531241|520469129|FG000|Period 1|Dispesed incorrect lens power|1|||
144345621|NCT04531241|520469130|FG001|Period 1|Dispesed incorrect lens power|0|||
144345622|NCT04531241|520469129|FG000|Period 1|Protocol Violation|1|||
144345623|NCT04531241|520469130|FG001|Period 1|Protocol Violation|0|||
144345624|NCT04531241|520469129|FG000|Period 1|No longer eligible|0|||
144345625|NCT04531241|520469130|FG001|Period 1|No longer eligible|1|||
144345626|NCT04531241|520469129|FG000|Period 1|Lens Discomfort|0|||
144345627|NCT04531241|520469130|FG001|Period 1|Lens Discomfort|1|||
144345628|NCT04531241|520469129|FG000|Period 2|Covid-19 Related|1|||
144345629|NCT04531241|520469130|FG001|Period 2|Covid-19 Related|1|||
144345630|NCT03724890|520469131|FG000|Overall Study|Death|2|||
144345631|NCT03724890|520469132|FG001|Overall Study|Death|6|||
144345632|NCT03724890|520469133|FG002|Overall Study|Death|3|||
144345633|NCT03724890|520469134|FG003|Overall Study|Death|5|||
144345634|NCT03724890|520469135|FG004|Overall Study|Death|2|||
144345635|NCT03724890|520469136|FG005|Overall Study|Death|0|||
144345636|NCT03724890|520469137|FG006|Overall Study|Death|2|||
144345637|NCT03724890|520469138|FG007|Overall Study|Death|3|||
144345638|NCT03724890|520469139|FG008|Overall Study|Death|4|||
144345639|NCT03724890|520469140|FG009|Overall Study|Death|2|||
144345640|NCT03724890|520469141|FG010|Overall Study|Death|2|||
144345641|NCT03724890|520469131|FG000|Overall Study|Lost to Follow-up|0|||
144345642|NCT03724890|520469132|FG001|Overall Study|Lost to Follow-up|3|||
144345643|NCT03724890|520469133|FG002|Overall Study|Lost to Follow-up|0|||
144345644|NCT03724890|520469134|FG003|Overall Study|Lost to Follow-up|1|||
144345645|NCT03724890|520469135|FG004|Overall Study|Lost to Follow-up|2|||
144345646|NCT03724890|520469136|FG005|Overall Study|Lost to Follow-up|2|||
144345647|NCT03724890|520469137|FG006|Overall Study|Lost to Follow-up|1|||
144345648|NCT03724890|520469138|FG007|Overall Study|Lost to Follow-up|0|||
144345649|NCT03724890|520469139|FG008|Overall Study|Lost to Follow-up|2|||
144345650|NCT03724890|520469140|FG009|Overall Study|Lost to Follow-up|0|||
144345651|NCT03724890|520469141|FG010|Overall Study|Lost to Follow-up|0|||
144345652|NCT03724890|520469131|FG000|Overall Study|Withdrawal by Subject|1|||
144345653|NCT03724890|520469132|FG001|Overall Study|Withdrawal by Subject|2|||
144345654|NCT03724890|520469133|FG002|Overall Study|Withdrawal by Subject|1|||
144345655|NCT03724890|520469134|FG003|Overall Study|Withdrawal by Subject|0|||
144345656|NCT03724890|520469135|FG004|Overall Study|Withdrawal by Subject|0|||
144345657|NCT03724890|520469136|FG005|Overall Study|Withdrawal by Subject|1|||
144345658|NCT03724890|520469137|FG006|Overall Study|Withdrawal by Subject|0|||
144345659|NCT03724890|520469138|FG007|Overall Study|Withdrawal by Subject|0|||
144345660|NCT03724890|520469139|FG008|Overall Study|Withdrawal by Subject|2|||
144345661|NCT03724890|520469140|FG009|Overall Study|Withdrawal by Subject|2|||
144345662|NCT03724890|520469141|FG010|Overall Study|Withdrawal by Subject|1|||
144345663|NCT03724890|520469131|FG000|Overall Study|Other|1|||
144345664|NCT03724890|520469132|FG001|Overall Study|Other|0|||
144345665|NCT03724890|520469133|FG002|Overall Study|Other|0|||
144345666|NCT03724890|520469134|FG003|Overall Study|Other|0|||
144345667|NCT03724890|520469135|FG004|Overall Study|Other|0|||
144345668|NCT03724890|520469136|FG005|Overall Study|Other|0|||
144345669|NCT03724890|520469137|FG006|Overall Study|Other|0|||
144345670|NCT03724890|520469138|FG007|Overall Study|Other|1|||
144345671|NCT03724890|520469139|FG008|Overall Study|Other|1|||
144345672|NCT03724890|520469140|FG009|Overall Study|Other|0|||
144345673|NCT03724890|520469141|FG010|Overall Study|Other|2|||
144345674|NCT04427072|520469143|FG000|Randomized Treatment Phase|Progressive disease|9|||
144345675|NCT04427072|520469144|FG001|Randomized Treatment Phase|Progressive disease|4|||
144345676|NCT04427072|520469143|FG000|Randomized Treatment Phase|Adverse Event|3|||
144345677|NCT04427072|520469144|FG001|Randomized Treatment Phase|Adverse Event|1|||
144345678|NCT04427072|520469143|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
144345679|NCT04427072|520469144|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
144345680|NCT04427072|520469143|FG000|Randomized Treatment Phase|Death|0|||
144345681|NCT04427072|520469144|FG001|Randomized Treatment Phase|Death|1|||
144345682|NCT04427072|520469143|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
144345683|NCT04427072|520469144|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
144345684|NCT04427072|520469143|FG000|Extension Treatment Phase|Progressive disease|0|||
144345685|NCT04427072|520469144|FG001|Extension Treatment Phase|Progressive disease|5|||
144345686|NCT02106403|520469153|FG000|Follow-Up Visit 3|Other Reason|0|||
144345687|NCT02106403|520469154|FG001|Follow-Up Visit 3|Other Reason|0|||
144345688|NCT02106403|520469155|FG002|Follow-Up Visit 3|Other Reason|0|||
144345689|NCT02106403|520469156|FG003|Follow-Up Visit 3|Other Reason|0|||
144345690|NCT02106403|520469157|FG004|Follow-Up Visit 3|Other Reason|0|||
144345691|NCT02106403|520469158|FG005|Follow-Up Visit 3|Other Reason|1|||
144345692|NCT01128946|520469162|FG000|Period I|Protocol Violation|0|||
144345693|NCT01128946|520469163|FG001|Period I|Protocol Violation|1|||
144345694|NCT01128946|520469164|FG002|Period I|Protocol Violation|0|||
144345695|NCT01128946|520469165|FG003|Period I|Protocol Violation|0|||
144345696|NCT01128946|520469162|FG000|Period I|Withdrawal by Subject|0|||
144345697|NCT01128946|520469163|FG001|Period I|Withdrawal by Subject|0|||
144345698|NCT01128946|520469164|FG002|Period I|Withdrawal by Subject|1|||
144345699|NCT01128946|520469165|FG003|Period I|Withdrawal by Subject|1|||
144345700|NCT01128946|520469162|FG000|Period II|Protocol Violation|0|||
144345701|NCT01128946|520469163|FG001|Period II|Protocol Violation|1|||
144345702|NCT01128946|520469164|FG002|Period II|Protocol Violation|0|||
144345703|NCT01128946|520469165|FG003|Period II|Protocol Violation|0|||
144345704|NCT01128946|520469162|FG000|Period II|Withdrawal by Subject|0|||
144345705|NCT01128946|520469163|FG001|Period II|Withdrawal by Subject|0|||
144345706|NCT01128946|520469164|FG002|Period II|Withdrawal by Subject|0|||
144345707|NCT01128946|520469165|FG003|Period II|Withdrawal by Subject|1|||
144345708|NCT01128946|520469162|FG000|Period III|Protocol Violation|1|||
144345709|NCT01128946|520469163|FG001|Period III|Protocol Violation|0|||
144345710|NCT01128946|520469164|FG002|Period III|Protocol Violation|0|||
144345711|NCT01128946|520469165|FG003|Period III|Protocol Violation|0|||
144345712|NCT04698993|520469166|FG000|Overall Study|PCR results not accessible|2|||
144345713|NCT04698993|520469167|FG001|Overall Study|PCR results not accessible|7|||
144345714|NCT04698993|520469166|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
144345715|NCT04698993|520469167|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
144345716|NCT00621140|520469168|FG000|Overall Study|Adverse Event|4|||
144345717|NCT00621140|520469169|FG001|Overall Study|Adverse Event|5|||
144345718|NCT00621140|520469168|FG000|Overall Study|Lost to Follow-up|1|||
144345719|NCT00621140|520469169|FG001|Overall Study|Lost to Follow-up|2|||
144345720|NCT00621140|520469168|FG000|Overall Study|Withdrawal by Subject|4|||
144345721|NCT00621140|520469169|FG001|Overall Study|Withdrawal by Subject|6|||
144345722|NCT00621140|520469168|FG000|Overall Study|Other incl. lack of efficacy|6|||
144345723|NCT00621140|520469169|FG001|Overall Study|Other incl. lack of efficacy|5|||
144345724|NCT00145574|520469170|FG000|Double Blind|Adverse Event|0|||
144345725|NCT00145574|520469171|FG001|Double Blind|Adverse Event|3|||
144345726|NCT00145574|520469172|FG002|Double Blind|Adverse Event|1|||
144345727|NCT00145574|520469170|FG000|Double Blind|Withdrawal by Subject|1|||
144345728|NCT00145574|520469171|FG001|Double Blind|Withdrawal by Subject|1|||
144345729|NCT00145574|520469172|FG002|Double Blind|Withdrawal by Subject|1|||
144345730|NCT00145574|520469170|FG000|Double Blind|required restricted medicine|0|||
144345731|NCT00145574|520469171|FG001|Double Blind|required restricted medicine|1|||
144345732|NCT00145574|520469172|FG002|Double Blind|required restricted medicine|0|||
144345733|NCT00145574|520469170|FG000|Open Label Long-term Extension|Adverse Event|0|||
144345734|NCT00145574|520469171|FG001|Open Label Long-term Extension|Adverse Event|0|||
144345735|NCT00145574|520469172|FG002|Open Label Long-term Extension|Adverse Event|5|||
144345736|NCT00145574|520469170|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
144345737|NCT00145574|520469171|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
144345738|NCT00145574|520469172|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
144345739|NCT00145574|520469170|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
144345740|NCT00145574|520469171|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
144345741|NCT00145574|520469172|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
144345742|NCT00145574|520469170|FG000|Open Label Long-term Extension|required restricted medicine|0|||
144345743|NCT00145574|520469171|FG001|Open Label Long-term Extension|required restricted medicine|0|||
144345744|NCT00145574|520469172|FG002|Open Label Long-term Extension|required restricted medicine|1|||
144345745|NCT00527904|520469173|FG000|Overall Study|Adverse Event|45|||
144345746|NCT00527904|520469173|FG000|Overall Study|Withdrawal by Subject|21|||
144345747|NCT00527904|520469173|FG000|Overall Study|Lost to Follow-up|8|||
144345748|NCT00527904|520469173|FG000|Overall Study|misc|22|||
144345749|NCT01711645|520469182|FG000|Overall Study|Withdrawal by Subject|8|||
144345750|NCT01711645|520469182|FG000|Overall Study|Lost to Follow-up|6|||
144345751|NCT01711645|520469182|FG000|Overall Study|Physician Decision|5|||
144345752|NCT00408434|520469185|FG000|Overall Study|Adverse Event|0|||
144345753|NCT00408434|520469186|FG001|Overall Study|Adverse Event|0|||
144345754|NCT00408434|520469187|FG002|Overall Study|Adverse Event|1|||
144345755|NCT00408434|520469188|FG003|Overall Study|Adverse Event|0|||
144345756|NCT00408434|520469189|FG004|Overall Study|Adverse Event|0|||
144345757|NCT00408434|520469190|FG005|Overall Study|Adverse Event|0|||
144345758|NCT00408434|520469191|FG006|Overall Study|Adverse Event|0|||
144345759|NCT00408434|520469185|FG000|Overall Study|Progressive disease|6|||
144345760|NCT00408434|520469186|FG001|Overall Study|Progressive disease|3|||
144345761|NCT00408434|520469187|FG002|Overall Study|Progressive disease|4|||
144345762|NCT00408434|520469188|FG003|Overall Study|Progressive disease|3|||
144345763|NCT00408434|520469189|FG004|Overall Study|Progressive disease|3|||
144345764|NCT00408434|520469190|FG005|Overall Study|Progressive disease|1|||
144345765|NCT00408434|520469191|FG006|Overall Study|Progressive disease|4|||
144345766|NCT00408434|520469185|FG000|Overall Study|Other|0|||
144345767|NCT00408434|520469186|FG001|Overall Study|Other|0|||
144345768|NCT00408434|520469187|FG002|Overall Study|Other|1|||
144345769|NCT00408434|520469188|FG003|Overall Study|Other|0|||
144345770|NCT00408434|520469189|FG004|Overall Study|Other|2|||
144345771|NCT00408434|520469190|FG005|Overall Study|Other|1|||
144345772|NCT00408434|520469191|FG006|Overall Study|Other|0|||
144345773|NCT00408434|520469185|FG000|Overall Study|Terminated by Investigator|0|||
144345774|NCT00408434|520469186|FG001|Overall Study|Terminated by Investigator|0|||
144345775|NCT00408434|520469187|FG002|Overall Study|Terminated by Investigator|0|||
144345776|NCT00408434|520469188|FG003|Overall Study|Terminated by Investigator|0|||
144345777|NCT00408434|520469189|FG004|Overall Study|Terminated by Investigator|1|||
144345778|NCT00408434|520469190|FG005|Overall Study|Terminated by Investigator|1|||
144345779|NCT00408434|520469191|FG006|Overall Study|Terminated by Investigator|0|||
144345780|NCT02038075|520469192|FG000|Overall Study|Withdrawal by Subject|3|||
144345781|NCT02038075|520469193|FG001|Overall Study|Withdrawal by Subject|0|||
144345782|NCT00588354|520469194|FG000|Baseline to 2 Weeks|Adverse Event|1|||
144345783|NCT00588354|520469195|FG001|Baseline to 2 Weeks|Adverse Event|0|||
144345784|NCT00588354|520469194|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
144345785|NCT00588354|520469195|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
144345786|NCT00588354|520469194|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
144345787|NCT00588354|520469195|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
144345788|NCT03477838|520469199|FG000|Overall Study|Lost to Follow-up|14|||
144345789|NCT02519595|520469200|FG000|Overall Study|Protocol Violation|8|||
144345790|NCT02519595|520469201|FG001|Overall Study|Protocol Violation|22|||
144345791|NCT02519595|520469202|FG002|Overall Study|Protocol Violation|16|||
144345792|NCT00850538|520469205|FG000|Overall Study|unable/unwilling to complete MRI|13|||
144345793|NCT00850538|520469205|FG000|Overall Study|specimen missed due to scheduling error|14|||
144345794|NCT00850538|520469205|FG000|Overall Study|specimen unusable|7|||
144345795|NCT00850538|520469205|FG000|Overall Study|Withdrawal by Subject|3|||
144345796|NCT00850538|520469205|FG000|Overall Study|radiology error|2|||
144345797|NCT00850538|520469205|FG000|Overall Study|Protocol Violation|2|||
144345798|NCT03188510|520469206|FG000|Overall Study|Inappropriate behavior with site staff|0|||
144345799|NCT03188510|520469207|FG001|Overall Study|Inappropriate behavior with site staff|1|||
144345800|NCT03188510|520469208|FG002|Overall Study|Inappropriate behavior with site staff|0|||
144345801|NCT04230213|520469215|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
144345802|NCT04230213|520469216|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
144345803|NCT04230213|520469217|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
144345804|NCT04230213|520469215|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
144345805|NCT04230213|520469216|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
144345806|NCT04230213|520469217|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
144345807|NCT04230213|520469215|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
144345808|NCT04230213|520469216|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
144345809|NCT04230213|520469217|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
144345810|NCT04230213|520469215|FG000|TP2: Week 10 to Week 16|Other|0|||
144345811|NCT04230213|520469216|FG001|TP2: Week 10 to Week 16|Other|2|||
144345812|NCT04230213|520469217|FG002|TP2: Week 10 to Week 16|Other|1|||
144345813|NCT04230213|520469215|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
144345814|NCT04230213|520469216|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
144345815|NCT04230213|520469217|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
144345816|NCT04230213|520469215|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
144345817|NCT04230213|520469216|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
144345818|NCT04230213|520469217|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
144360189|NCT03037385|520527409|FG001|Overall Study|Progressive Disease|1|||
144345819|NCT04230213|520469215|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
144345820|NCT04230213|520469216|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
144345821|NCT04230213|520469217|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
144345822|NCT04230213|520469215|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
144345823|NCT04230213|520469216|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
144345824|NCT04230213|520469217|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
144345825|NCT04230213|520469215|FG000|TP3: Week 16 to Week 22|Other|0|||
144345826|NCT04230213|520469216|FG001|TP3: Week 16 to Week 22|Other|1|||
144345827|NCT04230213|520469217|FG002|TP3: Week 16 to Week 22|Other|3|||
144345828|NCT04230213|520469215|FG000|TP4: Week 22 to Week 32|Other|0|||
144345829|NCT04230213|520469216|FG001|TP4: Week 22 to Week 32|Other|5|||
144345830|NCT04230213|520469217|FG002|TP4: Week 22 to Week 32|Other|5|||
144345831|NCT04230213|520469215|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
144345832|NCT04230213|520469216|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
144345833|NCT04230213|520469217|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
144345834|NCT04230213|520469215|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
144345835|NCT04230213|520469216|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
144345836|NCT04230213|520469217|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
144345837|NCT04230213|520469215|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
144345838|NCT04230213|520469216|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
144345839|NCT04230213|520469217|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
144345840|NCT04230213|520469215|FG000|Follow up: Week 32 to Week 36|Other|0|||
144345841|NCT04230213|520469216|FG001|Follow up: Week 32 to Week 36|Other|1|||
144345842|NCT04230213|520469217|FG002|Follow up: Week 32 to Week 36|Other|1|||
144345843|NCT01698814|520470342|FG000|Overall Study|Adverse Event|0|||
144345844|NCT01698814|520470343|FG001|Overall Study|Adverse Event|2|||
144345845|NCT01698814|520470342|FG000|Overall Study|Lost to Follow-up|0|||
144345846|NCT01698814|520470343|FG001|Overall Study|Lost to Follow-up|1|||
144345847|NCT01698814|520470342|FG000|Overall Study|Pregnancy|1|||
144345848|NCT01698814|520470343|FG001|Overall Study|Pregnancy|0|||
144345849|NCT01698814|520470342|FG000|Overall Study|Randomized in error|1|||
144345850|NCT01698814|520470343|FG001|Overall Study|Randomized in error|0|||
144345851|NCT00368641|520470344|FG000|Overall Study|Adverse Event|2|||
144345852|NCT00368641|520470345|FG001|Overall Study|Adverse Event|1|||
144345853|NCT00368641|520470344|FG000|Overall Study|Death|1|||
144345854|NCT00368641|520470345|FG001|Overall Study|Death|0|||
144345855|NCT00368641|520470344|FG000|Overall Study|Withdrawal by Subject|1|||
144345856|NCT00368641|520470345|FG001|Overall Study|Withdrawal by Subject|0|||
144345857|NCT00368641|520470344|FG000|Overall Study|Sponsor decision to terminate study|2|||
144345858|NCT00368641|520470345|FG001|Overall Study|Sponsor decision to terminate study|5|||
144345859|NCT01685697|520470352|FG000|Overall Study|Protocol Violation|3|||
144345860|NCT01685697|520470353|FG001|Overall Study|Protocol Violation|3|||
144345861|NCT02703324|520470354|FG000|Period Two|Withdrawal by Subject|0|||
144345862|NCT02703324|520470355|FG001|Period Two|Withdrawal by Subject|0|||
144345863|NCT02703324|520470356|FG002|Period Two|Withdrawal by Subject|1|||
144345864|NCT02703324|520470357|FG003|Period Two|Withdrawal by Subject|0|||
144345865|NCT02703324|520470358|FG004|Period Two|Withdrawal by Subject|0|||
144345866|NCT02703324|520470359|FG005|Period Two|Withdrawal by Subject|0|||
144345867|NCT00203424|520470363|FG000|Treatment Period|Withdrawal by Subject|4|||
144345868|NCT00203424|520470363|FG000|Treatment Period|Adverse Event|5|||
144345869|NCT00203424|520470363|FG000|Treatment Period|progressive disease|2|||
144345870|NCT00203424|520470363|FG000|Follow-up Period|Withdrawal by Subject|1|||
144345871|NCT00203424|520470363|FG000|Follow-up Period|progressive disease|4|||
144345872|NCT00203424|520470363|FG000|Follow-up Period|Lost to Follow-up|1|||
144345873|NCT00475709|520470364|FG000|Overall Study|Did not meet eligibility criteria|8|||
144345874|NCT00475709|520470364|FG000|Overall Study|Death|41|||
144345875|NCT00475709|520470364|FG000|Overall Study|Device Explant|6|||
144345876|NCT00475709|520470364|FG000|Overall Study|Lost to Follow-up|21|||
144345877|NCT00555672|520470365|FG000|Overall Study|Death|0|||
144345878|NCT00555672|520470366|FG001|Overall Study|Death|2|||
144345879|NCT00555672|520470365|FG000|Overall Study|Adverse Event|8|||
144345880|NCT00555672|520470366|FG001|Overall Study|Adverse Event|2|||
144345881|NCT00555672|520470365|FG000|Overall Study|Objective progression or relapse|11|||
144345882|NCT00555672|520470366|FG001|Overall Study|Objective progression or relapse|5|||
144345883|NCT00555672|520470365|FG000|Overall Study|Other|3|||
144345884|NCT00555672|520470366|FG001|Overall Study|Other|1|||
144345885|NCT00555672|520470365|FG000|Overall Study|Participant refused|2|||
144345886|NCT00555672|520470366|FG001|Overall Study|Participant refused|0|||
144345887|NCT01053988|520470367|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
144345888|NCT01053988|520470368|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144345889|NCT01053988|520470369|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144345890|NCT01053988|520470370|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144345891|NCT01053988|520470371|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144345892|NCT01053988|520470372|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
144345893|NCT01053988|520470367|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
144345894|NCT01053988|520470368|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144345895|NCT01053988|520470369|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144345896|NCT01053988|520470370|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144345897|NCT01053988|520470371|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144345898|NCT01053988|520470372|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
144345899|NCT01053988|520470367|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
144345900|NCT01053988|520470368|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144345901|NCT01053988|520470369|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144345902|NCT01053988|520470370|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144345903|NCT01053988|520470371|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144345904|NCT01053988|520470372|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
144345905|NCT01053988|520470367|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
144345906|NCT01053988|520470368|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
144345907|NCT01053988|520470369|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
144345908|NCT01053988|520470370|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
144345909|NCT01053988|520470371|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
144345910|NCT01053988|520470372|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
144345911|NCT01053988|520470367|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
144345912|NCT01053988|520470368|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
144345913|NCT01053988|520470369|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
144345914|NCT01053988|520470370|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
144345915|NCT01053988|520470371|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
144345916|NCT01053988|520470372|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
144345917|NCT01053988|520470367|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
144345918|NCT01053988|520470368|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144345919|NCT01053988|520470369|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144345920|NCT01053988|520470370|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144345921|NCT01053988|520470371|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144345922|NCT01053988|520470372|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
144345923|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
144345924|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
144345925|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
144345926|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
144345927|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
144345928|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
144345929|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144345930|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
144345931|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
144345932|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
144345933|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
144345934|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
144345935|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
144345936|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
144345937|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
144345938|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
144345939|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
144345940|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
144345941|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
144345942|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
144345943|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
144345944|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
144345945|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
144345946|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
144345947|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
144345948|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
144345949|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
144345950|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
144345951|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
144345952|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
144345953|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144345954|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
144345955|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
144360190|NCT03037385|520527410|FG002|Overall Study|Progressive Disease|1|||
144345956|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
144345957|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
144345958|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
144345959|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
144345960|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
144345961|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
144345962|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
144345963|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
144345964|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
144345965|NCT01053988|520470367|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
144345966|NCT01053988|520470368|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
144345967|NCT01053988|520470369|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
144345968|NCT01053988|520470370|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
144345969|NCT01053988|520470371|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
144345970|NCT01053988|520470372|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
144345971|NCT01922271|520470373|FG000|WASHOUT Period|Withdrawal by Subject|1|||
144345972|NCT01922271|520470374|FG001|WASHOUT Period|Withdrawal by Subject|0|||
144345973|NCT03400176|520470379|FG000|Dose Escalation|Progressive disease|1|||
144345974|NCT03400176|520470380|FG001|Dose Escalation|Progressive disease|1|||
144345975|NCT03400176|520470381|FG002|Dose Escalation|Progressive disease|0|||
144345976|NCT03400176|520470382|FG003|Dose Escalation|Progressive disease|0|||
144345977|NCT03400176|520470383|FG004|Dose Escalation|Progressive disease|1|||
144345978|NCT03400176|520470379|FG000|Dose Escalation|Patient decision|0|||
144345979|NCT03400176|520470380|FG001|Dose Escalation|Patient decision|0|||
144345980|NCT03400176|520470381|FG002|Dose Escalation|Patient decision|0|||
144345981|NCT03400176|520470382|FG003|Dose Escalation|Patient decision|0|||
144345982|NCT03400176|520470383|FG004|Dose Escalation|Patient decision|1|||
144345983|NCT03400176|520470379|FG000|Dose Expansion|Patient decision|0|||
144345984|NCT03400176|520470380|FG001|Dose Expansion|Patient decision|0|||
144345985|NCT03400176|520470381|FG002|Dose Expansion|Patient decision|0|||
144345986|NCT03400176|520470382|FG003|Dose Expansion|Patient decision|1|||
144345987|NCT03400176|520470383|FG004|Dose Expansion|Patient decision|0|||
144345988|NCT03400176|520470379|FG000|Dose Expansion|Adverse Event|0|||
144345989|NCT03400176|520470380|FG001|Dose Expansion|Adverse Event|0|||
144345990|NCT03400176|520470381|FG002|Dose Expansion|Adverse Event|0|||
144345991|NCT03400176|520470382|FG003|Dose Expansion|Adverse Event|1|||
144345992|NCT03400176|520470383|FG004|Dose Expansion|Adverse Event|0|||
144345993|NCT03400176|520470379|FG000|Dose Expansion|Physician Decision|0|||
144345994|NCT03400176|520470380|FG001|Dose Expansion|Physician Decision|0|||
144345995|NCT03400176|520470381|FG002|Dose Expansion|Physician Decision|0|||
144345996|NCT03400176|520470382|FG003|Dose Expansion|Physician Decision|1|||
144345997|NCT03400176|520470383|FG004|Dose Expansion|Physician Decision|0|||
144345998|NCT03400176|520470379|FG000|Dose Expansion|Progressive disease|0|||
144345999|NCT03400176|520470380|FG001|Dose Expansion|Progressive disease|0|||
144346000|NCT03400176|520470381|FG002|Dose Expansion|Progressive disease|1|||
144346001|NCT03400176|520470382|FG003|Dose Expansion|Progressive disease|1|||
144346002|NCT03400176|520470383|FG004|Dose Expansion|Progressive disease|0|||
144346003|NCT02104947|520470388|FG000|Overall Study|Withdrawal by Subject|10|||
144346004|NCT02104947|520470389|FG001|Overall Study|Withdrawal by Subject|3|||
144346005|NCT02104947|520470388|FG000|Overall Study|Lost to Follow-up|4|||
144346006|NCT02104947|520470389|FG001|Overall Study|Lost to Follow-up|4|||
144346007|NCT02104947|520470388|FG000|Overall Study|Protocol Violation|6|||
144346008|NCT02104947|520470389|FG001|Overall Study|Protocol Violation|8|||
144346009|NCT02104947|520470388|FG000|Overall Study|Adverse Event|57|||
144346010|NCT02104947|520470389|FG001|Overall Study|Adverse Event|38|||
144346011|NCT02104947|520470388|FG000|Overall Study|Other than stated above|2|||
144346012|NCT02104947|520470389|FG001|Overall Study|Other than stated above|3|||
144346013|NCT01090063|520470398|FG000|Screen|Screen Failed|4|||
144346014|NCT01090063|520470398|FG000|Treatment|Withdrawal by Subject|4|||
144346015|NCT01371734|520470407|FG000|Overall Study|Other|2|||
144346016|NCT01371734|520470408|FG001|Overall Study|Other|1|||
144346017|NCT01371734|520470409|FG002|Overall Study|Other|2|||
144346018|NCT01371734|520470407|FG000|Overall Study|Withdrawal by Subject|3|||
144346019|NCT01371734|520470408|FG001|Overall Study|Withdrawal by Subject|4|||
144346020|NCT01371734|520470409|FG002|Overall Study|Withdrawal by Subject|9|||
144346021|NCT01371734|520470407|FG000|Overall Study|Lost to Follow-up|5|||
144346022|NCT01371734|520470408|FG001|Overall Study|Lost to Follow-up|3|||
144346023|NCT01371734|520470409|FG002|Overall Study|Lost to Follow-up|1|||
144346024|NCT01371734|520470407|FG000|Overall Study|Protocol Violation|3|||
144346025|NCT01371734|520470408|FG001|Overall Study|Protocol Violation|1|||
144346026|NCT01371734|520470409|FG002|Overall Study|Protocol Violation|2|||
144346027|NCT01371734|520470407|FG000|Overall Study|Adverse Event|8|||
144346028|NCT01371734|520470408|FG001|Overall Study|Adverse Event|8|||
144346029|NCT01371734|520470409|FG002|Overall Study|Adverse Event|3|||
144346030|NCT01371734|520470407|FG000|Overall Study|Lack of Efficacy|2|||
144346031|NCT01371734|520470408|FG001|Overall Study|Lack of Efficacy|2|||
144346032|NCT01371734|520470409|FG002|Overall Study|Lack of Efficacy|0|||
144346033|NCT00206440|520470410|FG000|Overall Study|Protocol Violation|1|||
144346034|NCT00206440|520470411|FG001|Overall Study|Protocol Violation|2|||
144346035|NCT00206440|520470410|FG000|Overall Study|Adverse Event|4|||
144346036|NCT00206440|520470411|FG001|Overall Study|Adverse Event|2|||
144346037|NCT00958165|520470412|FG000|Overall Study|Lost to Follow-up|5|||
144346038|NCT00958165|520470412|FG000|Overall Study|Not eligible|9|||
144346039|NCT01298765|520470413|FG000|Titration Period|Adverse Event|26|||
144346040|NCT01298765|520470413|FG000|Titration Period|Death|1|||
144346041|NCT01298765|520470413|FG000|Titration Period|Lack of Efficacy|21|||
144346042|NCT01298765|520470413|FG000|Titration Period|Lost to Follow-up|9|||
144346043|NCT01298765|520470413|FG000|Titration Period|Physician Decision|1|||
144346044|NCT01298765|520470413|FG000|Titration Period|Withdrawal by Subject|10|||
144346045|NCT01298765|520470413|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
144346046|NCT01298765|520470413|FG000|Long-Term Treatment Period|Adverse Event|19|||
144346047|NCT01298765|520470413|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
144346048|NCT01298765|520470413|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
144346049|NCT01298765|520470413|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
144346050|NCT01298765|520470413|FG000|Long-Term Treatment Period|Physician Decision|1|||
144346051|NCT01298765|520470413|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
144346052|NCT03565237|520470414|FG000|Overall Study|Non-compliance of Investigational Product|1|||
144346053|NCT03565237|520470414|FG000|Overall Study|Physician Decision|1|||
144346054|NCT01140061|520470420|FG000|Part I|Adverse Event|1|||
144346055|NCT01140061|520470421|FG001|Part I|Adverse Event|0|||
144346056|NCT01140061|520470422|FG002|Part I|Adverse Event|0|||
144346057|NCT01140061|520470423|FG003|Part I|Adverse Event|0|||
144346058|NCT01140061|520470424|FG004|Part I|Adverse Event|0|||
144346059|NCT01140061|520470425|FG005|Part I|Adverse Event|0|||
144346060|NCT01140061|520470426|FG006|Part I|Adverse Event|0|||
144346061|NCT01140061|520470427|FG007|Part I|Adverse Event|0|||
144346062|NCT01140061|520470428|FG008|Part I|Adverse Event|0|||
144346063|NCT01140061|520470429|FG009|Part I|Adverse Event|0|||
144346064|NCT01140061|520470420|FG000|Extension|Laboratory Adverse Event|0|||
144346065|NCT01140061|520470421|FG001|Extension|Laboratory Adverse Event|0|||
144346066|NCT01140061|520470422|FG002|Extension|Laboratory Adverse Event|0|||
144346067|NCT01140061|520470423|FG003|Extension|Laboratory Adverse Event|0|||
144346068|NCT01140061|520470424|FG004|Extension|Laboratory Adverse Event|0|||
144346069|NCT01140061|520470425|FG005|Extension|Laboratory Adverse Event|0|||
144346070|NCT01140061|520470426|FG006|Extension|Laboratory Adverse Event|0|||
144346071|NCT01140061|520470427|FG007|Extension|Laboratory Adverse Event|0|||
144346072|NCT01140061|520470428|FG008|Extension|Laboratory Adverse Event|0|||
144346073|NCT01140061|520470429|FG009|Extension|Laboratory Adverse Event|1|||
144346074|NCT00428389|520470431|FG000|Core Phase|Adverse Event|6|||
144346075|NCT00428389|520470432|FG001|Core Phase|Adverse Event|4|||
144346076|NCT00428389|520470431|FG000|Core Phase|Lack of Efficacy|2|||
144346077|NCT00428389|520470432|FG001|Core Phase|Lack of Efficacy|0|||
144346078|NCT00428389|520470431|FG000|Core Phase|Abnormal test procedure result(s)|0|||
144346079|NCT00428389|520470432|FG001|Core Phase|Abnormal test procedure result(s)|1|||
144346080|NCT00428389|520470431|FG000|Core Phase|Withdrawal by Subject|3|||
144346081|NCT00428389|520470432|FG001|Core Phase|Withdrawal by Subject|4|||
144346082|NCT00428389|520470431|FG000|Core Phase|Protocol deviation|0|||
144346083|NCT00428389|520470432|FG001|Core Phase|Protocol deviation|2|||
144346084|NCT00428389|520470431|FG000|Extension Phase|Adverse Event|17|||
144346085|NCT00428389|520470432|FG001|Extension Phase|Adverse Event|11|||
144346086|NCT00428389|520470431|FG000|Extension Phase|Lack of Efficacy|4|||
144346087|NCT00428389|520470432|FG001|Extension Phase|Lack of Efficacy|3|||
144346088|NCT00428389|520470431|FG000|Extension Phase|Withdrawal by Subject|6|||
144346089|NCT00428389|520470432|FG001|Extension Phase|Withdrawal by Subject|6|||
144346090|NCT00428389|520470431|FG000|Extension Phase|Lost to Follow-up|0|||
144346091|NCT00428389|520470432|FG001|Extension Phase|Lost to Follow-up|3|||
144346092|NCT00428389|520470431|FG000|Extension Phase|Death|1|||
144346093|NCT00428389|520470432|FG001|Extension Phase|Death|0|||
144346094|NCT00428389|520470431|FG000|Extension Phase|Protocol Violation|3|||
144346095|NCT00428389|520470432|FG001|Extension Phase|Protocol Violation|2|||
144346096|NCT00428389|520470431|FG000|Extension Phase|Administrative problems|1|||
144346097|NCT00428389|520470432|FG001|Extension Phase|Administrative problems|1|||
144346098|NCT00766051|520470433|FG000|Overall Study|Withdrawal by Subject|2|||
144346099|NCT00766051|520470434|FG001|Overall Study|Withdrawal by Subject|0|||
144346100|NCT02708355|520470435|FG000|Overall Study|Adverse Event|1|||
144346101|NCT02708355|520470436|FG001|Overall Study|Adverse Event|0|||
144346102|NCT02708355|520470437|FG002|Overall Study|Adverse Event|0|||
144346103|NCT01320202|520470438|FG000|Overall Study|Adverse Event|5|||
144346104|NCT01320202|520470439|FG001|Overall Study|Adverse Event|5|||
144346105|NCT01320202|520470438|FG000|Overall Study|Death|5|||
144346106|NCT01320202|520470439|FG001|Overall Study|Death|3|||
144346107|NCT01320202|520470438|FG000|Overall Study|Lost to Follow-up|1|||
144346108|NCT01320202|520470439|FG001|Overall Study|Lost to Follow-up|0|||
144346109|NCT01320202|520470438|FG000|Overall Study|Physician Decision|3|||
144346110|NCT01320202|520470439|FG001|Overall Study|Physician Decision|1|||
144346111|NCT01320202|520470438|FG000|Overall Study|Protocol Violation|2|||
144346112|NCT01320202|520470439|FG001|Overall Study|Protocol Violation|1|||
144346113|NCT01320202|520470438|FG000|Overall Study|Withdrawal by Subject|10|||
144346114|NCT01320202|520470439|FG001|Overall Study|Withdrawal by Subject|3|||
144346115|NCT01320202|520470438|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
144346116|NCT01320202|520470439|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
144346117|NCT01320202|520470438|FG000|Overall Study|kidney transplant|1|||
144346118|NCT01320202|520470439|FG001|Overall Study|kidney transplant|2|||
144346119|NCT01320202|520470438|FG000|Overall Study|blood transfusion|1|||
144346120|NCT01320202|520470439|FG001|Overall Study|blood transfusion|7|||
144346121|NCT01320202|520470438|FG000|Overall Study|moved/changed dialysis|5|||
144346122|NCT01320202|520470439|FG001|Overall Study|moved/changed dialysis|2|||
144346123|NCT01320202|520470438|FG000|Overall Study|sponsor request|2|||
144346124|NCT01320202|520470439|FG001|Overall Study|sponsor request|0|||
144346125|NCT01320202|520470438|FG000|Overall Study|ineligible|3|||
144346126|NCT01320202|520470439|FG001|Overall Study|ineligible|0|||
144346127|NCT01320202|520470438|FG000|Overall Study|regained renal function|1|||
144346128|NCT01320202|520470439|FG001|Overall Study|regained renal function|0|||
144346129|NCT04090242|520470440|FG000|Overall Study|Withdrawal by Subject|1|||
144346130|NCT04090242|520470441|FG001|Overall Study|Withdrawal by Subject|0|||
144346131|NCT02305238|520470442|FG000|Overall Study|Death|2|||
144346132|NCT02305238|520470443|FG001|Overall Study|Death|1|||
144346133|NCT02305238|520470444|FG002|Overall Study|Death|0|||
144346134|NCT02305238|520470442|FG000|Overall Study|Progressive disease|4|||
144346135|NCT02305238|520470443|FG001|Overall Study|Progressive disease|4|||
144346136|NCT02305238|520470444|FG002|Overall Study|Progressive disease|0|||
144346137|NCT02305238|520470442|FG000|Overall Study|Logistical difficulties|1|||
144346138|NCT02305238|520470443|FG001|Overall Study|Logistical difficulties|3|||
144346139|NCT02305238|520470444|FG002|Overall Study|Logistical difficulties|0|||
144346140|NCT02305238|520470442|FG000|Overall Study|Protocol Violation|0|||
144346141|NCT02305238|520470443|FG001|Overall Study|Protocol Violation|3|||
144346142|NCT02305238|520470444|FG002|Overall Study|Protocol Violation|0|||
144346143|NCT02305238|520470442|FG000|Overall Study|Physician Decision|2|||
144346144|NCT02305238|520470443|FG001|Overall Study|Physician Decision|1|||
144346145|NCT02305238|520470444|FG002|Overall Study|Physician Decision|0|||
144346146|NCT02305238|520470442|FG000|Overall Study|Adverse Event|4|||
144346147|NCT02305238|520470443|FG001|Overall Study|Adverse Event|2|||
144346148|NCT02305238|520470444|FG002|Overall Study|Adverse Event|0|||
144346149|NCT02305238|520470442|FG000|Overall Study|Withdrawal by Subject|3|||
144346150|NCT02305238|520470443|FG001|Overall Study|Withdrawal by Subject|4|||
144346151|NCT02305238|520470444|FG002|Overall Study|Withdrawal by Subject|0|||
144346152|NCT02305238|520470442|FG000|Overall Study|Randomized failure|0|||
144346153|NCT02305238|520470443|FG001|Overall Study|Randomized failure|0|||
144346154|NCT02305238|520470444|FG002|Overall Study|Randomized failure|8|||
144346155|NCT02305238|520470442|FG000|Overall Study|Required procedure failed|0|||
144346156|NCT02305238|520470443|FG001|Overall Study|Required procedure failed|1|||
144346157|NCT02305238|520470444|FG002|Overall Study|Required procedure failed|0|||
144346158|NCT02513472|520470445|FG000|Overall Study|Radiological Disease Progression|45|||
144346159|NCT02513472|520470446|FG001|Overall Study|Radiological Disease Progression|57|||
144346160|NCT02513472|520470445|FG000|Overall Study|Clinical Disease Progression|5|||
144346161|NCT02513472|520470446|FG001|Overall Study|Clinical Disease Progression|13|||
144346162|NCT02513472|520470445|FG000|Overall Study|Adverse Event|8|||
144346163|NCT02513472|520470446|FG001|Overall Study|Adverse Event|11|||
144346164|NCT02513472|520470445|FG000|Overall Study|Withdrawal by Subject|0|||
144346165|NCT02513472|520470446|FG001|Overall Study|Withdrawal by Subject|4|||
144346166|NCT02513472|520470445|FG000|Overall Study|Subject Choice|2|||
144346167|NCT02513472|520470446|FG001|Overall Study|Subject Choice|7|||
144346168|NCT02513472|520470445|FG000|Overall Study|Treatment Completed as per Protocol|3|||
144346169|NCT02513472|520470446|FG001|Overall Study|Treatment Completed as per Protocol|3|||
144346170|NCT02513472|520470445|FG000|Overall Study|Other|3|||
144346171|NCT02513472|520470446|FG001|Overall Study|Other|6|||
144346172|NCT01019369|520470447|FG000|Overall Study|Lost to Follow-up|10|||
144346173|NCT01019369|520470448|FG001|Overall Study|Lost to Follow-up|6|||
144346174|NCT01019369|520470447|FG000|Overall Study|Withdrawal by Subject|0|||
144346175|NCT01019369|520470448|FG001|Overall Study|Withdrawal by Subject|1|||
144346176|NCT00604695|520470449|FG000|Overall Study|Did not receive first bolus.|0|||
144346177|NCT00604695|520470450|FG001|Overall Study|Did not receive first bolus.|4|||
144346178|NCT03214406|520470451|FG000|Overall Study|did not meet enrollment criteria|9|||
144346179|NCT03214406|520470452|FG001|Overall Study|did not meet enrollment criteria|13|||
144346180|NCT03214406|520470451|FG000|Overall Study|Withdrawal by Subject|1|||
144346181|NCT03214406|520470452|FG001|Overall Study|Withdrawal by Subject|0|||
144346182|NCT03214406|520470451|FG000|Overall Study|Lost to Follow-up|0|||
144346183|NCT03214406|520470452|FG001|Overall Study|Lost to Follow-up|2|||
144346184|NCT01098305|520470455|FG000|Overall Study|Lost to Follow-up|31|||
144346185|NCT01098305|520470456|FG001|Overall Study|Lost to Follow-up|33|||
144346186|NCT04565951|520470461|FG000|Overall Study|Lost to Follow-up|66|||
144346187|NCT04565951|520470462|FG001|Overall Study|Lost to Follow-up|38|||
144346188|NCT04565951|520470461|FG000|Overall Study|Withdrawal by Subject|14|||
144346189|NCT04565951|520470462|FG001|Overall Study|Withdrawal by Subject|7|||
144346190|NCT04565951|520470461|FG000|Overall Study|Death|0|||
144346191|NCT04565951|520470462|FG001|Overall Study|Death|1|||
144346192|NCT01771250|520470466|FG000|Period 1|Met exclusion criteria|1|||
144346193|NCT01771250|520470467|FG001|Period 1|Met exclusion criteria|0|||
144346194|NCT01180296|520470468|FG000|Overall Study|Protocol Violation|1|||
144346195|NCT01180296|520470469|FG001|Overall Study|Protocol Violation|2|||
144346196|NCT03058692|520472342|FG000|Overall Study|Lost to Follow-up|2|||
144346197|NCT03058692|520472343|FG001|Overall Study|Lost to Follow-up|1|||
144346198|NCT03058692|520472342|FG000|Overall Study|Withdrawal by Subject|1|||
144346199|NCT03058692|520472343|FG001|Overall Study|Withdrawal by Subject|1|||
144346200|NCT00806988|520472344|FG000|Overall Study|Death|15|||
144346201|NCT00806988|520472345|FG001|Overall Study|Death|16|||
144346202|NCT00806988|520472344|FG000|Overall Study|Withdrawal by Subject|8|||
144346203|NCT00806988|520472345|FG001|Overall Study|Withdrawal by Subject|8|||
144346204|NCT00806988|520472344|FG000|Overall Study|Lost to Follow-up|4|||
144346205|NCT00806988|520472345|FG001|Overall Study|Lost to Follow-up|19|||
144346206|NCT04775953|520472347|FG000|Overall Study|Lost to Follow-up|6|||
144346207|NCT04775953|520472348|FG001|Overall Study|Lost to Follow-up|11|||
144346208|NCT04775953|520472347|FG000|Overall Study|Death|5|||
144346209|NCT04775953|520472348|FG001|Overall Study|Death|4|||
144346210|NCT04775953|520472347|FG000|Overall Study|Withdrawal by Subject|3|||
144346211|NCT04775953|520472348|FG001|Overall Study|Withdrawal by Subject|3|||
144346212|NCT04775953|520472347|FG000|Overall Study|Protocol Violation|2|||
144346213|NCT04775953|520472348|FG001|Overall Study|Protocol Violation|0|||
144346214|NCT04775953|520472347|FG000|Overall Study|Participant non-compliance|0|||
144346215|NCT04775953|520472348|FG001|Overall Study|Participant non-compliance|1|||
144346216|NCT00855959|520472349|FG000|Overall Study|Adverse Event|2|||
144346217|NCT00855959|520472349|FG000|Overall Study|Lost to Follow-up|2|||
144346218|NCT00855959|520472349|FG000|Overall Study|Withdrawal by Subject|3|||
144346219|NCT00855959|520472349|FG000|Overall Study|Pregnancy|1|||
144346220|NCT00855959|520472349|FG000|Overall Study|Incorrect enrolment|1|||
144346221|NCT02813889|520472350|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
144346222|NCT02813889|520472351|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
144346223|NCT04014062|520472357|FG000|Period I: Dosing|Medical Grounds|4|||
144346224|NCT04014062|520472358|FG001|Period I: Dosing|Medical Grounds|5|||
144346225|NCT04014062|520472357|FG000|Period I: Dosing|Withdrawal by Subject|3|||
144346226|NCT04014062|520472358|FG001|Period I: Dosing|Withdrawal by Subject|1|||
144346227|NCT03038126|520472359|FG000|Overall Study|Death|1|||
144346228|NCT03038126|520472360|FG001|Overall Study|Death|1|||
144346229|NCT03038126|520472359|FG000|Overall Study|Withdrawal by Subject|5|||
144346230|NCT03038126|520472360|FG001|Overall Study|Withdrawal by Subject|0|||
144346231|NCT03038126|520472359|FG000|Overall Study|Lost to Follow-up|0|||
144346232|NCT03038126|520472360|FG001|Overall Study|Lost to Follow-up|1|||
144346233|NCT03038126|520472359|FG000|Overall Study|Long Term Hospitalization|2|||
144346234|NCT03038126|520472360|FG001|Overall Study|Long Term Hospitalization|0|||
144346235|NCT03038126|520472359|FG000|Overall Study|Too Ill to Participate|1|||
144346236|NCT03038126|520472360|FG001|Overall Study|Too Ill to Participate|2|||
144346237|NCT02451917|520472361|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
144346238|NCT02451917|520472362|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
144346239|NCT02451917|520472361|FG000|First Intervention (24 Weeks)|Death|0|||
144346240|NCT02451917|520472362|FG001|First Intervention (24 Weeks)|Death|1|||
144346241|NCT02451917|520472361|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
144346242|NCT02451917|520472362|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
144346243|NCT01724866|520472363|FG000|Overall Study|Adverse Event|0|||
144346244|NCT01724866|520472364|FG001|Overall Study|Adverse Event|0|||
144346245|NCT01724866|520472365|FG002|Overall Study|Adverse Event|1|||
144346246|NCT01724866|520472366|FG003|Overall Study|Adverse Event|1|||
144346247|NCT01724866|520472363|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
144346248|NCT01724866|520472364|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
144346249|NCT01724866|520472365|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
144346250|NCT01724866|520472366|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
144346251|NCT01724866|520472363|FG000|Overall Study|Investigator's Discretion|0|||
144346252|NCT01724866|520472364|FG001|Overall Study|Investigator's Discretion|1|||
144346253|NCT01724866|520472365|FG002|Overall Study|Investigator's Discretion|1|||
144346254|NCT01724866|520472366|FG003|Overall Study|Investigator's Discretion|0|||
144346255|NCT01724866|520472363|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
144346256|NCT01724866|520472364|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
144346257|NCT01724866|520472365|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
144346258|NCT01724866|520472366|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
144360191|NCT03037385|520527411|FG003|Overall Study|Progressive Disease|5|||
144346259|NCT01724866|520472363|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
144346260|NCT01724866|520472364|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
144346261|NCT01724866|520472365|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
144346262|NCT01724866|520472366|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
144346263|NCT00411671|520472369|FG000|Overall Study|Adverse Event|15|||
144346264|NCT00411671|520472369|FG000|Overall Study|Death|2|||
144346265|NCT00411671|520472369|FG000|Overall Study|Lost to Follow-up|3|||
144346266|NCT01424501|520472370|FG000|Overall Study|Withdrawal by Subject|1|||
144346267|NCT01424501|520472371|FG001|Overall Study|Withdrawal by Subject|0|||
144346268|NCT01424501|520472372|FG002|Overall Study|Withdrawal by Subject|1|||
144346269|NCT01424501|520472373|FG003|Overall Study|Withdrawal by Subject|0|||
144346270|NCT01424501|520472374|FG004|Overall Study|Withdrawal by Subject|0|||
144346271|NCT01424501|520472375|FG005|Overall Study|Withdrawal by Subject|0|||
144346272|NCT01424501|520472370|FG000|Overall Study|Lost to Follow-up|0|||
144346273|NCT01424501|520472371|FG001|Overall Study|Lost to Follow-up|1|||
144346274|NCT01424501|520472372|FG002|Overall Study|Lost to Follow-up|1|||
144346275|NCT01424501|520472373|FG003|Overall Study|Lost to Follow-up|0|||
144346276|NCT01424501|520472374|FG004|Overall Study|Lost to Follow-up|0|||
144346277|NCT01424501|520472375|FG005|Overall Study|Lost to Follow-up|0|||
144346278|NCT01980095|520472376|FG000|Overall Study|Lost to Follow-up|6|||
144346279|NCT01980095|520472377|FG001|Overall Study|Lost to Follow-up|7|||
144346280|NCT01980095|520472376|FG000|Overall Study|Withdrawal by Subject|2|||
144346281|NCT01980095|520472377|FG001|Overall Study|Withdrawal by Subject|3|||
144346282|NCT01980095|520472376|FG000|Overall Study|Poor compliance|5|||
144346283|NCT01980095|520472377|FG001|Overall Study|Poor compliance|0|||
144346284|NCT01980095|520472376|FG000|Overall Study|Safety issue|0|||
144346285|NCT01980095|520472377|FG001|Overall Study|Safety issue|1|||
144346286|NCT01980095|520472376|FG000|Overall Study|Study drug discontinued|1|||
144346287|NCT01980095|520472377|FG001|Overall Study|Study drug discontinued|0|||
144346288|NCT01980095|520472376|FG000|Overall Study|Randomized by mistake|1|||
144346289|NCT01980095|520472377|FG001|Overall Study|Randomized by mistake|0|||
144346290|NCT04737278|520472378|FG000|Overall Study|Lost to Follow-up|1|||
144346291|NCT04737278|520472379|FG001|Overall Study|Lost to Follow-up|1|||
144346292|NCT04737278|520472378|FG000|Overall Study|Withdrawal by Subject|1|||
144346293|NCT04737278|520472379|FG001|Overall Study|Withdrawal by Subject|0|||
144346294|NCT04737278|520472378|FG000|Overall Study|Protocol Violation|1|||
144346295|NCT04737278|520472379|FG001|Overall Study|Protocol Violation|1|||
144346296|NCT04737278|520472378|FG000|Overall Study|failure to complete questionnaire|1|||
144346297|NCT04737278|520472379|FG001|Overall Study|failure to complete questionnaire|1|||
144346298|NCT00546000|520472384|FG000|Overall Study|Adverse Event|1|||
144346299|NCT00546000|520472384|FG000|Overall Study|Lost to Follow-up|1|||
144346300|NCT00546000|520472384|FG000|Overall Study|Baseline HPA Axis Supression|2|||
144346301|NCT01362608|520472389|FG000|Overall Study|Protocol Violation|0|||
144346302|NCT01362608|520472390|FG001|Overall Study|Protocol Violation|1|||
144346303|NCT01362608|520472389|FG000|Overall Study|Lost to Follow-up|3|||
144346304|NCT01362608|520472390|FG001|Overall Study|Lost to Follow-up|1|||
144346305|NCT01362608|520472389|FG000|Overall Study|Withdrawal by Subject|1|||
144346306|NCT01362608|520472390|FG001|Overall Study|Withdrawal by Subject|2|||
144346307|NCT01362608|520472389|FG000|Overall Study|Lack of Efficacy|0|||
144346308|NCT01362608|520472390|FG001|Overall Study|Lack of Efficacy|2|||
144346309|NCT01362608|520472389|FG000|Overall Study|Adverse Event|0|||
144346310|NCT01362608|520472390|FG001|Overall Study|Adverse Event|2|||
144346311|NCT01128244|520472398|FG000|Overall Study|Adverse Event|1|||
144346312|NCT01128244|520472398|FG000|Overall Study|Scheduling conflict|2|||
144346313|NCT04506502|520472402|FG000|Overall Study|Withdrawal by Subject|1|||
144346314|NCT04506502|520472402|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
144346315|NCT01449006|520472403|FG000|Overall Study|Lost to Follow-up|1|||
144346316|NCT01449006|520472404|FG001|Overall Study|Lost to Follow-up|0|||
144346317|NCT01449006|520472403|FG000|Overall Study|Withdrawal by Subject|1|||
144346318|NCT01449006|520472404|FG001|Overall Study|Withdrawal by Subject|0|||
144346319|NCT01449006|520472403|FG000|Overall Study|Protocol Violation|1|||
144346320|NCT01449006|520472404|FG001|Overall Study|Protocol Violation|0|||
144346321|NCT03526146|520472405|FG000|Overall Study|Lost to Follow-up|5|||
144346322|NCT03526146|520472405|FG000|Overall Study|Withdrawal by Subject|6|||
144346323|NCT03526146|520472405|FG000|Overall Study|class canceled due to COVID-19|4|||
144346324|NCT04112303|520472415|FG000|Overall Study|Death|1|||
144346325|NCT03472950|520472416|FG000|Overall Study|Lost to Follow-up|0|||
144346326|NCT03472950|520472417|FG001|Overall Study|Lost to Follow-up|1|||
144346327|NCT03472950|520472416|FG000|Overall Study|Adverse Event|0|||
144346328|NCT03472950|520472417|FG001|Overall Study|Adverse Event|3|||
144346329|NCT00195091|520472420|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
144346330|NCT01979952|520472430|FG000|Overall Study|Adverse Event|4|||
144346331|NCT01979952|520472431|FG001|Overall Study|Adverse Event|5|||
144346332|NCT01979952|520472430|FG000|Overall Study|Protocol Violation|1|||
144346333|NCT01979952|520472431|FG001|Overall Study|Protocol Violation|0|||
144346334|NCT01979952|520472430|FG000|Overall Study|Withdrawal by Subject|2|||
144346335|NCT01979952|520472431|FG001|Overall Study|Withdrawal by Subject|1|||
144346336|NCT01979952|520472430|FG000|Overall Study|Other than specified above|1|||
144346337|NCT01979952|520472431|FG001|Overall Study|Other than specified above|0|||
144346338|NCT04079816|520472432|FG000|Overall Study|Request of Subject|2|||
144346339|NCT04079816|520472432|FG000|Overall Study|Unable to draw samples|1|||
144346340|NCT02576795|520472433|FG000|Overall Study|Lost to Follow-up|0|||
144346341|NCT02576795|520472434|FG001|Overall Study|Lost to Follow-up|0|||
144346342|NCT02576795|520472435|FG002|Overall Study|Lost to Follow-up|1|||
144346343|NCT02576795|520472436|FG003|Overall Study|Lost to Follow-up|0|||
144346344|NCT01702246|520472437|FG000|Overall Study|Lost to Follow-up|2|||
144346345|NCT01702246|520472437|FG000|Overall Study|Withdrawal by Subject|2|||
144346346|NCT01702246|520472437|FG000|Overall Study|Physician Decision|1|||
144346347|NCT01635855|520472448|FG000|Overall Study|Withdrawal by Subject|4|||
144346348|NCT00429169|520472454|FG000|Overall Study|Lost to Follow-up|0|||
144346349|NCT00429169|520472455|FG001|Overall Study|Lost to Follow-up|1|||
144346350|NCT00429169|520472454|FG000|Overall Study|Ineligibility discovered after entry|2|||
144346351|NCT00429169|520472455|FG001|Overall Study|Ineligibility discovered after entry|1|||
144346352|NCT01746173|520472460|FG000|Overall Study|Disease Progression|2|||
144346353|NCT00172042|520472463|FG000|Overall Study|Adverse Event|27|||
144346354|NCT00172042|520472464|FG001|Overall Study|Adverse Event|13|||
144346355|NCT00172042|520472463|FG000|Overall Study|Abnormal laboratory value(s)|5|||
144346356|NCT00172042|520472464|FG001|Overall Study|Abnormal laboratory value(s)|1|||
144346357|NCT00172042|520472463|FG000|Overall Study|Abnormal test procedure(s)|0|||
144346358|NCT00172042|520472464|FG001|Overall Study|Abnormal test procedure(s)|3|||
144346359|NCT00172042|520472463|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
144346360|NCT00172042|520472464|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
144346361|NCT00172042|520472463|FG000|Overall Study|Patient no longer requires study drug|10|||
144346362|NCT00172042|520472464|FG001|Overall Study|Patient no longer requires study drug|8|||
144346363|NCT00172042|520472463|FG000|Overall Study|Protocol Violation|8|||
144346364|NCT00172042|520472464|FG001|Overall Study|Protocol Violation|7|||
144346365|NCT00172042|520472463|FG000|Overall Study|Withdrawal by Subject|37|||
144346366|NCT00172042|520472464|FG001|Overall Study|Withdrawal by Subject|25|||
144346367|NCT00172042|520472463|FG000|Overall Study|Lost to Follow-up|3|||
144346368|NCT00172042|520472464|FG001|Overall Study|Lost to Follow-up|5|||
144346369|NCT00172042|520472463|FG000|Overall Study|Administrative problems|13|||
144346370|NCT00172042|520472464|FG001|Overall Study|Administrative problems|10|||
144346371|NCT00172042|520472463|FG000|Overall Study|Death|42|||
144346372|NCT00172042|520472464|FG001|Overall Study|Death|42|||
144346373|NCT00483938|520472465|FG000|Overall Study|Protocol Violation|0|||
144346374|NCT00483938|520472466|FG001|Overall Study|Protocol Violation|0|||
144346375|NCT00483938|520472467|FG002|Overall Study|Protocol Violation|0|||
144346376|NCT00483938|520472468|FG003|Overall Study|Protocol Violation|0|||
144346377|NCT00483938|520472469|FG004|Overall Study|Protocol Violation|0|||
144346378|NCT00483938|520472470|FG005|Overall Study|Protocol Violation|0|||
144346379|NCT00483938|520472471|FG006|Overall Study|Protocol Violation|3|||
144346380|NCT00483938|520472465|FG000|Overall Study|Withdrawal by Subject|1|||
144346381|NCT00483938|520472466|FG001|Overall Study|Withdrawal by Subject|6|||
144346382|NCT00483938|520472467|FG002|Overall Study|Withdrawal by Subject|0|||
144346383|NCT00483938|520472468|FG003|Overall Study|Withdrawal by Subject|0|||
144346384|NCT00483938|520472469|FG004|Overall Study|Withdrawal by Subject|1|||
144346385|NCT00483938|520472470|FG005|Overall Study|Withdrawal by Subject|3|||
144346386|NCT00483938|520472471|FG006|Overall Study|Withdrawal by Subject|2|||
144346387|NCT00483938|520472465|FG000|Overall Study|Lost to Follow-up|1|||
144346388|NCT00483938|520472466|FG001|Overall Study|Lost to Follow-up|2|||
144346389|NCT00483938|520472467|FG002|Overall Study|Lost to Follow-up|0|||
144346390|NCT00483938|520472468|FG003|Overall Study|Lost to Follow-up|2|||
144346391|NCT00483938|520472469|FG004|Overall Study|Lost to Follow-up|1|||
144346392|NCT00483938|520472470|FG005|Overall Study|Lost to Follow-up|1|||
144346393|NCT00483938|520472471|FG006|Overall Study|Lost to Follow-up|3|||
144346394|NCT00483938|520472465|FG000|Overall Study|Death|0|||
144346395|NCT00483938|520472466|FG001|Overall Study|Death|2|||
144346396|NCT00483938|520472467|FG002|Overall Study|Death|0|||
144346397|NCT00483938|520472468|FG003|Overall Study|Death|0|||
144346398|NCT00483938|520472469|FG004|Overall Study|Death|0|||
144346399|NCT00483938|520472470|FG005|Overall Study|Death|0|||
144346400|NCT00483938|520472471|FG006|Overall Study|Death|0|||
144346401|NCT00483938|520472465|FG000|Overall Study|Other|3|||
144346402|NCT00483938|520472466|FG001|Overall Study|Other|9|||
144346403|NCT00483938|520472467|FG002|Overall Study|Other|0|||
144346404|NCT00483938|520472468|FG003|Overall Study|Other|4|||
144346405|NCT00483938|520472469|FG004|Overall Study|Other|0|||
144346406|NCT00483938|520472470|FG005|Overall Study|Other|4|||
144346407|NCT00483938|520472471|FG006|Overall Study|Other|32|||
144346408|NCT00106353|520472472|FG000|Part 1|Disease progression|3|||
144346409|NCT00106353|520472473|FG001|Part 1|Disease progression|4|||
144346410|NCT00106353|520472474|FG002|Part 1|Disease progression|1|||
144346411|NCT00106353|520472475|FG003|Part 1|Disease progression|3|||
144346412|NCT00106353|520472476|FG004|Part 1|Disease progression|0|||
144346413|NCT00106353|520472477|FG005|Part 1|Disease progression|0|||
144346414|NCT00106353|520472478|FG006|Part 1|Disease progression|0|||
144346415|NCT00106353|520472472|FG000|Part 1|Withdrawal by Subject|0|||
144346416|NCT00106353|520472473|FG001|Part 1|Withdrawal by Subject|0|||
144346417|NCT00106353|520472474|FG002|Part 1|Withdrawal by Subject|1|||
144346418|NCT00106353|520472475|FG003|Part 1|Withdrawal by Subject|2|||
144346419|NCT00106353|520472476|FG004|Part 1|Withdrawal by Subject|0|||
144346420|NCT00106353|520472477|FG005|Part 1|Withdrawal by Subject|0|||
144346421|NCT00106353|520472478|FG006|Part 1|Withdrawal by Subject|0|||
144346422|NCT00106353|520472472|FG000|Part 1|Symptomatic deterioration|0|||
144346423|NCT00106353|520472473|FG001|Part 1|Symptomatic deterioration|0|||
144346424|NCT00106353|520472474|FG002|Part 1|Symptomatic deterioration|1|||
144346425|NCT00106353|520472475|FG003|Part 1|Symptomatic deterioration|0|||
144346426|NCT00106353|520472476|FG004|Part 1|Symptomatic deterioration|0|||
144346427|NCT00106353|520472477|FG005|Part 1|Symptomatic deterioration|0|||
144346428|NCT00106353|520472478|FG006|Part 1|Symptomatic deterioration|0|||
144346429|NCT00106353|520472472|FG000|Part 1|Entered follow-up phase|1|||
144346430|NCT00106353|520472473|FG001|Part 1|Entered follow-up phase|1|||
144346431|NCT00106353|520472474|FG002|Part 1|Entered follow-up phase|0|||
144346432|NCT00106353|520472475|FG003|Part 1|Entered follow-up phase|1|||
144346433|NCT00106353|520472476|FG004|Part 1|Entered follow-up phase|0|||
144346434|NCT00106353|520472477|FG005|Part 1|Entered follow-up phase|0|||
144346435|NCT00106353|520472478|FG006|Part 1|Entered follow-up phase|0|||
144346436|NCT00106353|520472472|FG000|Part 1|Adverse Event|0|||
144346437|NCT00106353|520472473|FG001|Part 1|Adverse Event|0|||
144346438|NCT00106353|520472474|FG002|Part 1|Adverse Event|0|||
144346439|NCT00106353|520472475|FG003|Part 1|Adverse Event|1|||
144346440|NCT00106353|520472476|FG004|Part 1|Adverse Event|0|||
144346441|NCT00106353|520472477|FG005|Part 1|Adverse Event|0|||
144346442|NCT00106353|520472478|FG006|Part 1|Adverse Event|0|||
144346443|NCT00106353|520472472|FG000|Part 2|Disease progression|0|||
144346444|NCT00106353|520472473|FG001|Part 2|Disease progression|0|||
144346445|NCT00106353|520472474|FG002|Part 2|Disease progression|0|||
144346446|NCT00106353|520472475|FG003|Part 2|Disease progression|0|||
144346447|NCT00106353|520472476|FG004|Part 2|Disease progression|8|||
144346448|NCT00106353|520472477|FG005|Part 2|Disease progression|14|||
144346449|NCT00106353|520472478|FG006|Part 2|Disease progression|13|||
144346450|NCT00106353|520472472|FG000|Part 2|Death|0|||
144346451|NCT00106353|520472473|FG001|Part 2|Death|0|||
144346452|NCT00106353|520472474|FG002|Part 2|Death|0|||
144346453|NCT00106353|520472475|FG003|Part 2|Death|0|||
144346454|NCT00106353|520472476|FG004|Part 2|Death|3|||
144346455|NCT00106353|520472477|FG005|Part 2|Death|0|||
144346456|NCT00106353|520472478|FG006|Part 2|Death|1|||
144346457|NCT00106353|520472472|FG000|Part 2|Symptomatic deterioration|0|||
144346458|NCT00106353|520472473|FG001|Part 2|Symptomatic deterioration|0|||
144346459|NCT00106353|520472474|FG002|Part 2|Symptomatic deterioration|0|||
144346460|NCT00106353|520472475|FG003|Part 2|Symptomatic deterioration|0|||
144346461|NCT00106353|520472476|FG004|Part 2|Symptomatic deterioration|3|||
144346462|NCT00106353|520472477|FG005|Part 2|Symptomatic deterioration|0|||
144346463|NCT00106353|520472478|FG006|Part 2|Symptomatic deterioration|0|||
144346464|NCT00106353|520472472|FG000|Part 2|Adverse Event|0|||
144346465|NCT00106353|520472473|FG001|Part 2|Adverse Event|0|||
144346466|NCT00106353|520472474|FG002|Part 2|Adverse Event|0|||
144346467|NCT00106353|520472475|FG003|Part 2|Adverse Event|0|||
144346468|NCT00106353|520472476|FG004|Part 2|Adverse Event|0|||
144346469|NCT00106353|520472477|FG005|Part 2|Adverse Event|2|||
144346470|NCT00106353|520472478|FG006|Part 2|Adverse Event|1|||
144346471|NCT00106353|520472472|FG000|Part 2|Other|0|||
144346472|NCT00106353|520472473|FG001|Part 2|Other|0|||
144346473|NCT00106353|520472474|FG002|Part 2|Other|0|||
144346474|NCT00106353|520472475|FG003|Part 2|Other|0|||
144346475|NCT00106353|520472476|FG004|Part 2|Other|1|||
144346476|NCT00106353|520472477|FG005|Part 2|Other|1|||
144346477|NCT00106353|520472478|FG006|Part 2|Other|1|||
144346478|NCT00106353|520472472|FG000|Part 2|Withdrawal by Subject|0|||
144346479|NCT00106353|520472473|FG001|Part 2|Withdrawal by Subject|0|||
144346480|NCT00106353|520472474|FG002|Part 2|Withdrawal by Subject|0|||
144346481|NCT00106353|520472475|FG003|Part 2|Withdrawal by Subject|0|||
144346482|NCT00106353|520472476|FG004|Part 2|Withdrawal by Subject|1|||
144346483|NCT00106353|520472477|FG005|Part 2|Withdrawal by Subject|0|||
144346484|NCT00106353|520472478|FG006|Part 2|Withdrawal by Subject|0|||
144346485|NCT00106353|520472472|FG000|Part 2|Physician Decision|0|||
144346486|NCT00106353|520472473|FG001|Part 2|Physician Decision|0|||
144346487|NCT00106353|520472474|FG002|Part 2|Physician Decision|0|||
144346488|NCT00106353|520472475|FG003|Part 2|Physician Decision|0|||
144346489|NCT00106353|520472476|FG004|Part 2|Physician Decision|0|||
144346490|NCT00106353|520472477|FG005|Part 2|Physician Decision|1|||
144346491|NCT00106353|520472478|FG006|Part 2|Physician Decision|0|||
144346492|NCT01371552|520472479|FG000|Part 1, First 3 Days|Inconvenience|0|||
144346493|NCT01371552|520472480|FG001|Part 1, First 3 Days|Inconvenience|0|||
144346494|NCT01371552|520472481|FG002|Part 1, First 3 Days|Inconvenience|1|||
144346495|NCT01371552|520472482|FG003|Part 1, First 3 Days|Inconvenience|0|||
144346496|NCT01371552|520472483|FG004|Part 1, First 3 Days|Inconvenience|0|||
144346497|NCT01371552|520472484|FG005|Part 1, First 3 Days|Inconvenience|0|||
144346498|NCT03364309|520472485|FG000|Induction Period|Adverse Event|4|||
144346499|NCT03364309|520472486|FG001|Induction Period|Adverse Event|0|||
144346500|NCT03364309|520472487|FG002|Induction Period|Adverse Event|1|||
144346501|NCT03364309|520472488|FG003|Induction Period|Adverse Event|0|||
144346502|NCT03364309|520472489|FG004|Induction Period|Adverse Event|0|||
144346503|NCT03364309|520472490|FG005|Induction Period|Adverse Event|0|||
144346504|NCT03364309|520472491|FG006|Induction Period|Adverse Event|0|||
144346505|NCT03364309|520472492|FG007|Induction Period|Adverse Event|0|||
144346506|NCT03364309|520472493|FG008|Induction Period|Adverse Event|0|||
144346507|NCT03364309|520472494|FG009|Induction Period|Adverse Event|0|||
144346508|NCT03364309|520472495|FG010|Induction Period|Adverse Event|0|||
144346509|NCT03364309|520472496|FG011|Induction Period|Adverse Event|0|||
144346510|NCT03364309|520472497|FG012|Induction Period|Adverse Event|0|||
144346511|NCT03364309|520472498|FG013|Induction Period|Adverse Event|0|||
144346512|NCT03364309|520472499|FG014|Induction Period|Adverse Event|0|||
144346513|NCT03364309|520472500|FG015|Induction Period|Adverse Event|0|||
144346514|NCT03364309|520472501|FG016|Induction Period|Adverse Event|0|||
144346515|NCT03364309|520472502|FG017|Induction Period|Adverse Event|0|||
144346516|NCT03364309|520472503|FG018|Induction Period|Adverse Event|0|||
144346517|NCT03364309|520472485|FG000|Induction Period|Withdrawal by Subject|1|||
144346518|NCT03364309|520472486|FG001|Induction Period|Withdrawal by Subject|3|||
144346519|NCT03364309|520472487|FG002|Induction Period|Withdrawal by Subject|0|||
144346520|NCT03364309|520472488|FG003|Induction Period|Withdrawal by Subject|0|||
144346521|NCT03364309|520472489|FG004|Induction Period|Withdrawal by Subject|0|||
144346522|NCT03364309|520472490|FG005|Induction Period|Withdrawal by Subject|0|||
144346523|NCT03364309|520472491|FG006|Induction Period|Withdrawal by Subject|0|||
144346524|NCT03364309|520472492|FG007|Induction Period|Withdrawal by Subject|0|||
144346525|NCT03364309|520472493|FG008|Induction Period|Withdrawal by Subject|0|||
144346526|NCT03364309|520472494|FG009|Induction Period|Withdrawal by Subject|0|||
144346527|NCT03364309|520472495|FG010|Induction Period|Withdrawal by Subject|0|||
144346528|NCT03364309|520472496|FG011|Induction Period|Withdrawal by Subject|0|||
144346529|NCT03364309|520472497|FG012|Induction Period|Withdrawal by Subject|0|||
144346530|NCT03364309|520472498|FG013|Induction Period|Withdrawal by Subject|0|||
144346531|NCT03364309|520472499|FG014|Induction Period|Withdrawal by Subject|0|||
144346532|NCT03364309|520472500|FG015|Induction Period|Withdrawal by Subject|0|||
144346533|NCT03364309|520472501|FG016|Induction Period|Withdrawal by Subject|0|||
144346534|NCT03364309|520472502|FG017|Induction Period|Withdrawal by Subject|0|||
144346535|NCT03364309|520472503|FG018|Induction Period|Withdrawal by Subject|0|||
144346536|NCT03364309|520472485|FG000|Induction Period|Lost to Follow-up|1|||
144346537|NCT03364309|520472486|FG001|Induction Period|Lost to Follow-up|0|||
144346538|NCT03364309|520472487|FG002|Induction Period|Lost to Follow-up|0|||
144346539|NCT03364309|520472488|FG003|Induction Period|Lost to Follow-up|0|||
144346540|NCT03364309|520472489|FG004|Induction Period|Lost to Follow-up|0|||
144346541|NCT03364309|520472490|FG005|Induction Period|Lost to Follow-up|0|||
144346542|NCT03364309|520472491|FG006|Induction Period|Lost to Follow-up|0|||
144346543|NCT03364309|520472492|FG007|Induction Period|Lost to Follow-up|0|||
144346544|NCT03364309|520472493|FG008|Induction Period|Lost to Follow-up|0|||
144346545|NCT03364309|520472494|FG009|Induction Period|Lost to Follow-up|0|||
144346546|NCT03364309|520472495|FG010|Induction Period|Lost to Follow-up|0|||
144346547|NCT03364309|520472496|FG011|Induction Period|Lost to Follow-up|0|||
144346548|NCT03364309|520472497|FG012|Induction Period|Lost to Follow-up|0|||
144346549|NCT03364309|520472498|FG013|Induction Period|Lost to Follow-up|0|||
144346550|NCT03364309|520472499|FG014|Induction Period|Lost to Follow-up|0|||
144346551|NCT03364309|520472500|FG015|Induction Period|Lost to Follow-up|0|||
144346552|NCT03364309|520472501|FG016|Induction Period|Lost to Follow-up|0|||
144346553|NCT03364309|520472502|FG017|Induction Period|Lost to Follow-up|0|||
144346554|NCT03364309|520472503|FG018|Induction Period|Lost to Follow-up|0|||
144346555|NCT03364309|520472485|FG000|Induction Period|Physician Decision|0|||
144346556|NCT03364309|520472486|FG001|Induction Period|Physician Decision|1|||
144346557|NCT03364309|520472487|FG002|Induction Period|Physician Decision|0|||
144346558|NCT03364309|520472488|FG003|Induction Period|Physician Decision|0|||
144346559|NCT03364309|520472489|FG004|Induction Period|Physician Decision|0|||
144346560|NCT03364309|520472490|FG005|Induction Period|Physician Decision|0|||
144346561|NCT03364309|520472491|FG006|Induction Period|Physician Decision|0|||
144346562|NCT03364309|520472492|FG007|Induction Period|Physician Decision|0|||
144346563|NCT03364309|520472493|FG008|Induction Period|Physician Decision|0|||
144346564|NCT03364309|520472494|FG009|Induction Period|Physician Decision|0|||
144346565|NCT03364309|520472495|FG010|Induction Period|Physician Decision|0|||
144346566|NCT03364309|520472496|FG011|Induction Period|Physician Decision|0|||
144346567|NCT03364309|520472497|FG012|Induction Period|Physician Decision|0|||
144346568|NCT03364309|520472498|FG013|Induction Period|Physician Decision|0|||
144346569|NCT03364309|520472499|FG014|Induction Period|Physician Decision|0|||
144346570|NCT03364309|520472500|FG015|Induction Period|Physician Decision|0|||
144346571|NCT03364309|520472501|FG016|Induction Period|Physician Decision|0|||
144346572|NCT03364309|520472502|FG017|Induction Period|Physician Decision|0|||
144346573|NCT03364309|520472503|FG018|Induction Period|Physician Decision|0|||
144346574|NCT03364309|520472485|FG000|Maintenance Period|Withdrawal by Subject|0|||
144360192|NCT03037385|520527412|FG004|Overall Study|Progressive Disease|2|||
144346575|NCT03364309|520472486|FG001|Maintenance Period|Withdrawal by Subject|0|||
144346576|NCT03364309|520472487|FG002|Maintenance Period|Withdrawal by Subject|0|||
144346577|NCT03364309|520472488|FG003|Maintenance Period|Withdrawal by Subject|1|||
144346578|NCT03364309|520472489|FG004|Maintenance Period|Withdrawal by Subject|3|||
144346579|NCT03364309|520472490|FG005|Maintenance Period|Withdrawal by Subject|1|||
144346580|NCT03364309|520472491|FG006|Maintenance Period|Withdrawal by Subject|3|||
144346581|NCT03364309|520472492|FG007|Maintenance Period|Withdrawal by Subject|0|||
144346582|NCT03364309|520472493|FG008|Maintenance Period|Withdrawal by Subject|1|||
144346583|NCT03364309|520472494|FG009|Maintenance Period|Withdrawal by Subject|1|||
144346584|NCT03364309|520472495|FG010|Maintenance Period|Withdrawal by Subject|2|||
144346585|NCT03364309|520472496|FG011|Maintenance Period|Withdrawal by Subject|0|||
144346586|NCT03364309|520472497|FG012|Maintenance Period|Withdrawal by Subject|0|||
144346587|NCT03364309|520472498|FG013|Maintenance Period|Withdrawal by Subject|0|||
144346588|NCT03364309|520472499|FG014|Maintenance Period|Withdrawal by Subject|0|||
144346589|NCT03364309|520472500|FG015|Maintenance Period|Withdrawal by Subject|0|||
144346590|NCT03364309|520472501|FG016|Maintenance Period|Withdrawal by Subject|0|||
144346591|NCT03364309|520472502|FG017|Maintenance Period|Withdrawal by Subject|0|||
144346592|NCT03364309|520472503|FG018|Maintenance Period|Withdrawal by Subject|0|||
144346593|NCT03364309|520472485|FG000|Maintenance Period|Adverse Event|0|||
144346594|NCT03364309|520472486|FG001|Maintenance Period|Adverse Event|0|||
144346595|NCT03364309|520472487|FG002|Maintenance Period|Adverse Event|0|||
144346596|NCT03364309|520472488|FG003|Maintenance Period|Adverse Event|0|||
144346597|NCT03364309|520472489|FG004|Maintenance Period|Adverse Event|2|||
144346598|NCT03364309|520472490|FG005|Maintenance Period|Adverse Event|0|||
144346599|NCT03364309|520472491|FG006|Maintenance Period|Adverse Event|3|||
144346600|NCT03364309|520472492|FG007|Maintenance Period|Adverse Event|0|||
144346601|NCT03364309|520472493|FG008|Maintenance Period|Adverse Event|1|||
144346602|NCT03364309|520472494|FG009|Maintenance Period|Adverse Event|0|||
144346603|NCT03364309|520472495|FG010|Maintenance Period|Adverse Event|2|||
144346604|NCT03364309|520472496|FG011|Maintenance Period|Adverse Event|0|||
144346605|NCT03364309|520472497|FG012|Maintenance Period|Adverse Event|0|||
144346606|NCT03364309|520472498|FG013|Maintenance Period|Adverse Event|0|||
144346607|NCT03364309|520472499|FG014|Maintenance Period|Adverse Event|0|||
144346608|NCT03364309|520472500|FG015|Maintenance Period|Adverse Event|0|||
144346609|NCT03364309|520472501|FG016|Maintenance Period|Adverse Event|0|||
144346610|NCT03364309|520472502|FG017|Maintenance Period|Adverse Event|0|||
144346611|NCT03364309|520472503|FG018|Maintenance Period|Adverse Event|0|||
144346612|NCT03364309|520472485|FG000|Maintenance Period|Relapsed|0|||
144346613|NCT03364309|520472486|FG001|Maintenance Period|Relapsed|0|||
144346614|NCT03364309|520472487|FG002|Maintenance Period|Relapsed|0|||
144346615|NCT03364309|520472488|FG003|Maintenance Period|Relapsed|43|||
144346616|NCT03364309|520472489|FG004|Maintenance Period|Relapsed|7|||
144346617|NCT03364309|520472490|FG005|Maintenance Period|Relapsed|45|||
144346618|NCT03364309|520472491|FG006|Maintenance Period|Relapsed|10|||
144346619|NCT03364309|520472492|FG007|Maintenance Period|Relapsed|2|||
144346620|NCT03364309|520472493|FG008|Maintenance Period|Relapsed|0|||
144346621|NCT03364309|520472494|FG009|Maintenance Period|Relapsed|0|||
144346622|NCT03364309|520472495|FG010|Maintenance Period|Relapsed|0|||
144346623|NCT03364309|520472496|FG011|Maintenance Period|Relapsed|0|||
144346624|NCT03364309|520472497|FG012|Maintenance Period|Relapsed|0|||
144346625|NCT03364309|520472498|FG013|Maintenance Period|Relapsed|0|||
144346626|NCT03364309|520472499|FG014|Maintenance Period|Relapsed|0|||
144346627|NCT03364309|520472500|FG015|Maintenance Period|Relapsed|0|||
144346628|NCT03364309|520472501|FG016|Maintenance Period|Relapsed|0|||
144346629|NCT03364309|520472502|FG017|Maintenance Period|Relapsed|0|||
144346630|NCT03364309|520472503|FG018|Maintenance Period|Relapsed|0|||
144346631|NCT03364309|520472485|FG000|Maintenance Period|Lack of Efficacy|0|||
144346632|NCT03364309|520472486|FG001|Maintenance Period|Lack of Efficacy|0|||
144346633|NCT03364309|520472487|FG002|Maintenance Period|Lack of Efficacy|0|||
144346634|NCT03364309|520472488|FG003|Maintenance Period|Lack of Efficacy|0|||
144346635|NCT03364309|520472489|FG004|Maintenance Period|Lack of Efficacy|0|||
144346636|NCT03364309|520472490|FG005|Maintenance Period|Lack of Efficacy|0|||
144346637|NCT03364309|520472491|FG006|Maintenance Period|Lack of Efficacy|0|||
144346638|NCT03364309|520472492|FG007|Maintenance Period|Lack of Efficacy|0|||
144346639|NCT03364309|520472493|FG008|Maintenance Period|Lack of Efficacy|1|||
144346640|NCT03364309|520472494|FG009|Maintenance Period|Lack of Efficacy|3|||
144346641|NCT03364309|520472495|FG010|Maintenance Period|Lack of Efficacy|2|||
144346642|NCT03364309|520472496|FG011|Maintenance Period|Lack of Efficacy|0|||
144346643|NCT03364309|520472497|FG012|Maintenance Period|Lack of Efficacy|0|||
144346644|NCT03364309|520472498|FG013|Maintenance Period|Lack of Efficacy|0|||
144346645|NCT03364309|520472499|FG014|Maintenance Period|Lack of Efficacy|0|||
144346646|NCT03364309|520472500|FG015|Maintenance Period|Lack of Efficacy|0|||
144346647|NCT03364309|520472501|FG016|Maintenance Period|Lack of Efficacy|0|||
144346648|NCT03364309|520472502|FG017|Maintenance Period|Lack of Efficacy|0|||
144346649|NCT03364309|520472503|FG018|Maintenance Period|Lack of Efficacy|0|||
144346650|NCT03364309|520472485|FG000|Maintenance Period|Death|0|||
144346651|NCT03364309|520472486|FG001|Maintenance Period|Death|0|||
144346652|NCT03364309|520472487|FG002|Maintenance Period|Death|0|||
144346653|NCT03364309|520472488|FG003|Maintenance Period|Death|0|||
144346654|NCT03364309|520472489|FG004|Maintenance Period|Death|0|||
144346655|NCT03364309|520472490|FG005|Maintenance Period|Death|0|||
144346656|NCT03364309|520472491|FG006|Maintenance Period|Death|0|||
144346657|NCT03364309|520472492|FG007|Maintenance Period|Death|0|||
144346658|NCT03364309|520472493|FG008|Maintenance Period|Death|1|||
144346659|NCT03364309|520472494|FG009|Maintenance Period|Death|0|||
144346660|NCT03364309|520472495|FG010|Maintenance Period|Death|0|||
144346661|NCT03364309|520472496|FG011|Maintenance Period|Death|0|||
144346662|NCT03364309|520472497|FG012|Maintenance Period|Death|0|||
144346663|NCT03364309|520472498|FG013|Maintenance Period|Death|0|||
144346664|NCT03364309|520472499|FG014|Maintenance Period|Death|0|||
144346665|NCT03364309|520472500|FG015|Maintenance Period|Death|0|||
144346666|NCT03364309|520472501|FG016|Maintenance Period|Death|0|||
144346667|NCT03364309|520472502|FG017|Maintenance Period|Death|0|||
144346668|NCT03364309|520472503|FG018|Maintenance Period|Death|0|||
144346669|NCT03364309|520472485|FG000|Maintenance Period|Lost to Follow-up|0|||
144346670|NCT03364309|520472486|FG001|Maintenance Period|Lost to Follow-up|0|||
144346671|NCT03364309|520472487|FG002|Maintenance Period|Lost to Follow-up|0|||
144346672|NCT03364309|520472488|FG003|Maintenance Period|Lost to Follow-up|0|||
144346673|NCT03364309|520472489|FG004|Maintenance Period|Lost to Follow-up|0|||
144346674|NCT03364309|520472490|FG005|Maintenance Period|Lost to Follow-up|0|||
144346675|NCT03364309|520472491|FG006|Maintenance Period|Lost to Follow-up|0|||
144346676|NCT03364309|520472492|FG007|Maintenance Period|Lost to Follow-up|0|||
144346677|NCT03364309|520472493|FG008|Maintenance Period|Lost to Follow-up|1|||
144346678|NCT03364309|520472494|FG009|Maintenance Period|Lost to Follow-up|0|||
144346679|NCT03364309|520472495|FG010|Maintenance Period|Lost to Follow-up|0|||
144346680|NCT03364309|520472496|FG011|Maintenance Period|Lost to Follow-up|0|||
144346681|NCT03364309|520472497|FG012|Maintenance Period|Lost to Follow-up|0|||
144346682|NCT03364309|520472498|FG013|Maintenance Period|Lost to Follow-up|0|||
144346683|NCT03364309|520472499|FG014|Maintenance Period|Lost to Follow-up|0|||
144346684|NCT03364309|520472500|FG015|Maintenance Period|Lost to Follow-up|0|||
144346685|NCT03364309|520472501|FG016|Maintenance Period|Lost to Follow-up|0|||
144346686|NCT03364309|520472502|FG017|Maintenance Period|Lost to Follow-up|0|||
144346687|NCT03364309|520472503|FG018|Maintenance Period|Lost to Follow-up|0|||
144346688|NCT03364309|520472485|FG000|Maintenance Period|Miscellaneous|0|||
144346689|NCT03364309|520472486|FG001|Maintenance Period|Miscellaneous|0|||
144346690|NCT03364309|520472487|FG002|Maintenance Period|Miscellaneous|0|||
144346691|NCT03364309|520472488|FG003|Maintenance Period|Miscellaneous|0|||
144346692|NCT03364309|520472489|FG004|Maintenance Period|Miscellaneous|0|||
144346693|NCT03364309|520472490|FG005|Maintenance Period|Miscellaneous|0|||
144346694|NCT03364309|520472491|FG006|Maintenance Period|Miscellaneous|0|||
144346695|NCT03364309|520472492|FG007|Maintenance Period|Miscellaneous|0|||
144346696|NCT03364309|520472493|FG008|Maintenance Period|Miscellaneous|1|||
144346697|NCT03364309|520472494|FG009|Maintenance Period|Miscellaneous|0|||
144346698|NCT03364309|520472495|FG010|Maintenance Period|Miscellaneous|0|||
144346699|NCT03364309|520472496|FG011|Maintenance Period|Miscellaneous|0|||
144346700|NCT03364309|520472497|FG012|Maintenance Period|Miscellaneous|0|||
144346701|NCT03364309|520472498|FG013|Maintenance Period|Miscellaneous|0|||
144346702|NCT03364309|520472499|FG014|Maintenance Period|Miscellaneous|0|||
144346703|NCT03364309|520472500|FG015|Maintenance Period|Miscellaneous|0|||
144346704|NCT03364309|520472501|FG016|Maintenance Period|Miscellaneous|0|||
144346705|NCT03364309|520472502|FG017|Maintenance Period|Miscellaneous|0|||
144346706|NCT03364309|520472503|FG018|Maintenance Period|Miscellaneous|0|||
144346707|NCT03364309|520472485|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346708|NCT03364309|520472486|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346709|NCT03364309|520472487|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346710|NCT03364309|520472488|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346711|NCT03364309|520472489|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346712|NCT03364309|520472490|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346713|NCT03364309|520472491|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346714|NCT03364309|520472492|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346715|NCT03364309|520472493|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346716|NCT03364309|520472494|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346717|NCT03364309|520472495|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346718|NCT03364309|520472496|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346719|NCT03364309|520472497|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346720|NCT03364309|520472498|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
144346721|NCT03364309|520472499|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
144346722|NCT03364309|520472500|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
144346723|NCT03364309|520472501|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346724|NCT03364309|520472502|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346725|NCT03364309|520472503|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
144346726|NCT03364309|520472485|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346727|NCT03364309|520472486|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346728|NCT03364309|520472487|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346729|NCT03364309|520472488|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346730|NCT03364309|520472489|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346731|NCT03364309|520472490|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346732|NCT03364309|520472491|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346733|NCT03364309|520472492|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346734|NCT03364309|520472493|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346735|NCT03364309|520472494|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346736|NCT03364309|520472495|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346737|NCT03364309|520472496|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346738|NCT03364309|520472497|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346739|NCT03364309|520472498|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346740|NCT03364309|520472499|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
144346741|NCT03364309|520472500|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346742|NCT03364309|520472501|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346743|NCT03364309|520472502|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346744|NCT03364309|520472503|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
144346745|NCT03364309|520472485|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
144346746|NCT03364309|520472486|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
144346747|NCT03364309|520472487|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
144346748|NCT03364309|520472488|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
144346749|NCT03364309|520472489|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
144346750|NCT03364309|520472490|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
144346751|NCT03364309|520472491|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
144346752|NCT03364309|520472492|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
144346753|NCT03364309|520472493|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
144346754|NCT03364309|520472494|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
144346755|NCT03364309|520472495|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
144346756|NCT03364309|520472496|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
144346757|NCT03364309|520472497|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
144346758|NCT03364309|520472498|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
144346759|NCT03364309|520472499|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
144346760|NCT03364309|520472500|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
144346761|NCT03364309|520472501|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
144346762|NCT03364309|520472502|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
144346763|NCT03364309|520472503|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
144346764|NCT03364309|520472485|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346765|NCT03364309|520472486|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346766|NCT03364309|520472487|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346767|NCT03364309|520472488|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346768|NCT03364309|520472489|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346769|NCT03364309|520472490|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346770|NCT03364309|520472491|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346771|NCT03364309|520472492|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346772|NCT03364309|520472493|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346773|NCT03364309|520472494|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346774|NCT03364309|520472495|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346775|NCT03364309|520472496|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346776|NCT03364309|520472497|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346777|NCT03364309|520472498|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346778|NCT03364309|520472499|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346779|NCT03364309|520472500|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
144346780|NCT03364309|520472501|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
144346781|NCT03364309|520472502|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
144346782|NCT03364309|520472503|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
144346783|NCT03364309|520472485|FG000|Post-Treatment Followup Period|Adverse Event|0|||
144346784|NCT03364309|520472486|FG001|Post-Treatment Followup Period|Adverse Event|0|||
144346785|NCT03364309|520472487|FG002|Post-Treatment Followup Period|Adverse Event|0|||
144346786|NCT03364309|520472488|FG003|Post-Treatment Followup Period|Adverse Event|0|||
144346787|NCT03364309|520472489|FG004|Post-Treatment Followup Period|Adverse Event|0|||
144346788|NCT03364309|520472490|FG005|Post-Treatment Followup Period|Adverse Event|0|||
144346789|NCT03364309|520472491|FG006|Post-Treatment Followup Period|Adverse Event|0|||
144346790|NCT03364309|520472492|FG007|Post-Treatment Followup Period|Adverse Event|0|||
144346791|NCT03364309|520472493|FG008|Post-Treatment Followup Period|Adverse Event|0|||
144346792|NCT03364309|520472494|FG009|Post-Treatment Followup Period|Adverse Event|0|||
144346793|NCT03364309|520472495|FG010|Post-Treatment Followup Period|Adverse Event|0|||
144346794|NCT03364309|520472496|FG011|Post-Treatment Followup Period|Adverse Event|0|||
144346795|NCT03364309|520472497|FG012|Post-Treatment Followup Period|Adverse Event|0|||
144346796|NCT03364309|520472498|FG013|Post-Treatment Followup Period|Adverse Event|0|||
144346797|NCT03364309|520472499|FG014|Post-Treatment Followup Period|Adverse Event|0|||
144346798|NCT03364309|520472500|FG015|Post-Treatment Followup Period|Adverse Event|0|||
144346799|NCT03364309|520472501|FG016|Post-Treatment Followup Period|Adverse Event|2|||
144346800|NCT03364309|520472502|FG017|Post-Treatment Followup Period|Adverse Event|6|||
144346801|NCT03364309|520472503|FG018|Post-Treatment Followup Period|Adverse Event|1|||
144346802|NCT03364309|520472485|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346803|NCT03364309|520472486|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346804|NCT03364309|520472487|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346805|NCT03364309|520472488|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346806|NCT03364309|520472489|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346807|NCT03364309|520472490|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346808|NCT03364309|520472491|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346809|NCT03364309|520472492|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346810|NCT03364309|520472493|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346811|NCT03364309|520472494|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346812|NCT03364309|520472495|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346813|NCT03364309|520472496|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346814|NCT03364309|520472497|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346815|NCT03364309|520472498|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346816|NCT03364309|520472499|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346817|NCT03364309|520472500|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346818|NCT03364309|520472501|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346819|NCT03364309|520472502|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
144346820|NCT03364309|520472503|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
144346821|NCT03364309|520472485|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
144346822|NCT03364309|520472486|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
144346823|NCT03364309|520472487|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
144346824|NCT03364309|520472488|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
144346825|NCT03364309|520472489|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
144346826|NCT03364309|520472490|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
144346827|NCT03364309|520472491|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
144346828|NCT03364309|520472492|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
144346829|NCT03364309|520472493|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
144346830|NCT03364309|520472494|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
144346831|NCT03364309|520472495|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
144346832|NCT03364309|520472496|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
144346833|NCT03364309|520472497|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
144346834|NCT03364309|520472498|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
144346835|NCT03364309|520472499|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
144346836|NCT03364309|520472500|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
144346837|NCT03364309|520472501|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
144346838|NCT03364309|520472502|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
144346839|NCT03364309|520472503|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
144346840|NCT02328027|520472504|FG000|Overall Study|Withdrawal by Subject|0|||
144346841|NCT02328027|520472505|FG001|Overall Study|Withdrawal by Subject|1|||
144346842|NCT02465203|520472506|FG000|Overall Study|Protocol Violation|1|||
144346843|NCT02465203|520472507|FG001|Overall Study|Protocol Violation|1|||
144346844|NCT02465203|520472508|FG002|Overall Study|Protocol Violation|1|||
144346845|NCT02465203|520472506|FG000|Overall Study|Study terminated by sponsor|50|||
144346846|NCT02465203|520472507|FG001|Overall Study|Study terminated by sponsor|34|||
144346847|NCT02465203|520472508|FG002|Overall Study|Study terminated by sponsor|11|||
144346848|NCT02465203|520472506|FG000|Overall Study|New therapy for study indication|4|||
144346849|NCT02465203|520472507|FG001|Overall Study|New therapy for study indication|0|||
144346850|NCT02465203|520472508|FG002|Overall Study|New therapy for study indication|0|||
144346851|NCT02465203|520472506|FG000|Overall Study|Patient/guardian decision|1|||
144346852|NCT02465203|520472507|FG001|Overall Study|Patient/guardian decision|1|||
144346853|NCT02465203|520472508|FG002|Overall Study|Patient/guardian decision|1|||
144346854|NCT02508428|520472519|FG000|Overall Study|Death|32|||
144346855|NCT02508428|520472520|FG001|Overall Study|Death|33|||
144346856|NCT02508428|520472519|FG000|Overall Study|Liner revised|3|||
144346857|NCT02508428|520472520|FG001|Overall Study|Liner revised|19|||
144346858|NCT02508428|520472519|FG000|Overall Study|Incomplete follow-up|17|||
144346859|NCT02508428|520472520|FG001|Overall Study|Incomplete follow-up|15|||
144346860|NCT04371666|520472521|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
144346861|NCT04371666|520472522|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
144346862|NCT04371666|520472521|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
144346863|NCT04371666|520472522|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
144346864|NCT04371666|520472521|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
144346865|NCT04371666|520472522|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
144346866|NCT04371666|520472521|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
144346867|NCT04371666|520472522|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
144346868|NCT04371666|520472521|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
144346869|NCT04371666|520472522|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
144346870|NCT04371666|520472521|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
144346871|NCT04371666|520472522|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
144346872|NCT00534976|520472529|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
144346873|NCT00534976|520472530|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
144346874|NCT00534976|520472529|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
144346875|NCT00534976|520472530|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
144346876|NCT00534976|520472529|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
144346877|NCT00534976|520472530|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
144346878|NCT00861471|520472531|FG000|Overall Study|Withdrawal by Subject|1|||
144346879|NCT00861471|520472531|FG000|Overall Study|Adverse Event|2|||
144346880|NCT00861471|520472531|FG000|Overall Study|Lack of Efficacy|3|||
144346881|NCT00861471|520472531|FG000|Overall Study|treatment for lumbar laminectomy|1|||
144346882|NCT00861471|520472531|FG000|Overall Study|Physician Decision|2|||
144346883|NCT02092025|520472532|FG000|Overall Study|Case Report Forms Uncollected|44|||
144346884|NCT02092025|520472532|FG000|Overall Study|Protocol Deviation|24|||
144346885|NCT00264537|520472533|FG000|Overall Study|Death|0|||
144346886|NCT00264537|520472534|FG001|Overall Study|Death|3|||
144346887|NCT00264537|520472535|FG002|Overall Study|Death|3|||
144346888|NCT00264537|520472536|FG003|Overall Study|Death|2|||
144346889|NCT00264537|520472533|FG000|Overall Study|Lost to Follow-up|3|||
144346890|NCT00264537|520472534|FG001|Overall Study|Lost to Follow-up|4|||
144346891|NCT00264537|520472535|FG002|Overall Study|Lost to Follow-up|7|||
144346892|NCT00264537|520472536|FG003|Overall Study|Lost to Follow-up|6|||
144346893|NCT00264537|520472533|FG000|Overall Study|Adverse Event|21|||
144346894|NCT00264537|520472534|FG001|Overall Study|Adverse Event|32|||
144346895|NCT00264537|520472535|FG002|Overall Study|Adverse Event|24|||
144346896|NCT00264537|520472536|FG003|Overall Study|Adverse Event|34|||
144346897|NCT00264537|520472533|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
144346898|NCT00264537|520472534|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
144346899|NCT00264537|520472535|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
144346900|NCT00264537|520472536|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
144346901|NCT00264537|520472533|FG000|Overall Study|Other|21|||
144346902|NCT00264537|520472534|FG001|Overall Study|Other|11|||
144346903|NCT00264537|520472535|FG002|Overall Study|Other|10|||
144346904|NCT00264537|520472536|FG003|Overall Study|Other|11|||
144346905|NCT00264537|520472533|FG000|Overall Study|Not treated|0|||
144346906|NCT00264537|520472534|FG001|Overall Study|Not treated|2|||
144346907|NCT00264537|520472535|FG002|Overall Study|Not treated|1|||
144346908|NCT00264537|520472536|FG003|Overall Study|Not treated|0|||
144346909|NCT02123576|520472537|FG000|Overall Study|Adverse Event|1|||
144346910|NCT02123576|520472538|FG001|Overall Study|Adverse Event|0|||
144346911|NCT00934128|520472539|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
144346912|NCT00934128|520472540|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
144346913|NCT00934128|520472539|FG000|First Intervention (2 Hours)|Adverse Event|4|||
144346914|NCT00934128|520472540|FG001|First Intervention (2 Hours)|Adverse Event|1|||
144346915|NCT00934128|520472539|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
144346916|NCT00934128|520472540|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
144346917|NCT00934128|520472539|FG000|Washout Period (1 Hour)|Patient preference|1|||
144346918|NCT00934128|520472540|FG001|Washout Period (1 Hour)|Patient preference|3|||
144346919|NCT00934128|520472539|FG000|Washout Period (1 Hour)|Pain|1|||
144346920|NCT00934128|520472540|FG001|Washout Period (1 Hour)|Pain|0|||
144346921|NCT00934128|520472539|FG000|Washout Period (1 Hour)|Too tired|1|||
144346922|NCT00934128|520472540|FG001|Washout Period (1 Hour)|Too tired|0|||
144346923|NCT00934128|520472539|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
144346924|NCT00934128|520472540|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
144346925|NCT00934128|520472539|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
144346926|NCT00934128|520472540|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
144346927|NCT02834247|520472541|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
144346928|NCT02834247|520472542|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
144346929|NCT02834247|520472543|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
144346930|NCT02834247|520472544|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
144346931|NCT02834247|520472541|FG000|Dose Escalation Phase|Death|5|||
144346932|NCT02834247|520472542|FG001|Dose Escalation Phase|Death|6|||
144346933|NCT02834247|520472543|FG002|Dose Escalation Phase|Death|5|||
144346934|NCT02834247|520472544|FG003|Dose Escalation Phase|Death|0|||
144346935|NCT02834247|520472541|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
144346936|NCT02834247|520472542|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
144346937|NCT02834247|520472543|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
144346938|NCT02834247|520472544|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
144346939|NCT02834247|520472541|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
144346940|NCT02834247|520472542|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
144346941|NCT02834247|520472543|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
144346942|NCT02834247|520472544|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
144346943|NCT02834247|520472541|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
144346944|NCT02834247|520472542|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
144346945|NCT02834247|520472543|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
144346946|NCT02834247|520472544|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
144346947|NCT02834247|520472541|FG000|Dose Expansion Phase|Death|0|||
144346948|NCT02834247|520472542|FG001|Dose Expansion Phase|Death|0|||
144346949|NCT02834247|520472543|FG002|Dose Expansion Phase|Death|0|||
144346950|NCT02834247|520472544|FG003|Dose Expansion Phase|Death|8|||
144346951|NCT02834247|520472541|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
144346952|NCT02834247|520472542|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
144346953|NCT02834247|520472543|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
144346954|NCT02834247|520472544|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
144346955|NCT02834247|520472541|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
144346956|NCT02834247|520472542|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
144346957|NCT02834247|520472543|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
144346958|NCT02834247|520472544|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
144346959|NCT01807299|520472545|FG000|Overall Study|Protocol Violation|3|||
144346960|NCT01807299|520472546|FG001|Overall Study|Protocol Violation|1|||
144346961|NCT01807299|520472547|FG002|Overall Study|Protocol Violation|0|||
144346962|NCT01807299|520472548|FG003|Overall Study|Protocol Violation|2|||
144346963|NCT00615017|520474364|FG000|Overall Study|Adverse Event|0|||
144346964|NCT00615017|520474365|FG001|Overall Study|Adverse Event|1|||
144346965|NCT00615017|520474366|FG002|Overall Study|Adverse Event|2|||
144346966|NCT00615017|520474367|FG003|Overall Study|Adverse Event|0|||
144346967|NCT00615017|520474368|FG004|Overall Study|Adverse Event|0|||
144346968|NCT00615017|520474369|FG005|Overall Study|Adverse Event|1|||
144346969|NCT00615017|520474364|FG000|Overall Study|Death|0|||
144346970|NCT00615017|520474365|FG001|Overall Study|Death|0|||
144346971|NCT00615017|520474366|FG002|Overall Study|Death|2|||
144346972|NCT00615017|520474367|FG003|Overall Study|Death|0|||
144346973|NCT00615017|520474368|FG004|Overall Study|Death|1|||
144346974|NCT00615017|520474369|FG005|Overall Study|Death|1|||
144346975|NCT00615017|520474364|FG000|Overall Study|Sepsis resolved|0|||
144346976|NCT00615017|520474365|FG001|Overall Study|Sepsis resolved|0|||
144346977|NCT00615017|520474366|FG002|Overall Study|Sepsis resolved|1|||
144346978|NCT00615017|520474367|FG003|Overall Study|Sepsis resolved|0|||
144346979|NCT00615017|520474368|FG004|Overall Study|Sepsis resolved|0|||
144346980|NCT00615017|520474369|FG005|Overall Study|Sepsis resolved|0|||
144346981|NCT00615017|520474364|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
144346982|NCT00615017|520474365|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
144346983|NCT00615017|520474366|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
144346984|NCT00615017|520474367|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
144346985|NCT00615017|520474368|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
144346986|NCT00615017|520474369|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
144346987|NCT00615017|520474364|FG000|Overall Study|Physician discontinued drug|0|||
144346988|NCT00615017|520474365|FG001|Overall Study|Physician discontinued drug|0|||
144346989|NCT00615017|520474366|FG002|Overall Study|Physician discontinued drug|0|||
144346990|NCT00615017|520474367|FG003|Overall Study|Physician discontinued drug|0|||
144346991|NCT00615017|520474368|FG004|Overall Study|Physician discontinued drug|0|||
144346992|NCT00615017|520474369|FG005|Overall Study|Physician discontinued drug|1|||
144346993|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
144346994|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
144346995|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
144346996|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
144346997|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
144346998|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
144346999|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
144347000|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
144347001|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
144347002|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
144347003|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
144347004|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
144347005|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
144347006|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
144347007|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
144347008|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
144347009|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
144347010|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
144347011|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
144347012|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
144347013|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
144347014|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
144347015|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
144347016|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
144347017|NCT03777059|520474370|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
144347018|NCT03777059|520474371|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
144347019|NCT03777059|520474372|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
144347020|NCT03777059|520474373|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
144347021|NCT03777059|520474370|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
144347022|NCT03777059|520474371|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
144347023|NCT03777059|520474372|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
144347024|NCT03777059|520474373|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
144347025|NCT03777059|520474370|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
144347026|NCT03777059|520474371|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
144347027|NCT03777059|520474372|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
144347028|NCT03777059|520474373|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
144347029|NCT03777059|520474370|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
144347030|NCT03777059|520474371|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
144347031|NCT03777059|520474372|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
144347032|NCT03777059|520474373|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
144347033|NCT03777059|520474370|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
144347034|NCT03777059|520474371|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
144347035|NCT03777059|520474372|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
144347036|NCT03777059|520474373|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
144347037|NCT03350815|520474376|FG000|Period 1|Adverse Event|10|||
144347038|NCT03350815|520474377|FG001|Period 1|Adverse Event|0|||
144347039|NCT03350815|520474378|FG002|Period 1|Adverse Event|0|||
144347040|NCT03350815|520474379|FG003|Period 1|Adverse Event|0|||
144347041|NCT03350815|520474376|FG000|Period 1|Technical problems|1|||
144347042|NCT03350815|520474377|FG001|Period 1|Technical problems|0|||
144347043|NCT03350815|520474378|FG002|Period 1|Technical problems|0|||
144347044|NCT03350815|520474379|FG003|Period 1|Technical problems|0|||
144347045|NCT03350815|520474376|FG000|Period 1|Lost to Follow-up|3|||
144347046|NCT03350815|520474377|FG001|Period 1|Lost to Follow-up|0|||
144347047|NCT03350815|520474378|FG002|Period 1|Lost to Follow-up|0|||
144347048|NCT03350815|520474379|FG003|Period 1|Lost to Follow-up|0|||
144347049|NCT03350815|520474376|FG000|Period 1|Physician Decision|1|||
144347050|NCT03350815|520474377|FG001|Period 1|Physician Decision|0|||
144347051|NCT03350815|520474378|FG002|Period 1|Physician Decision|0|||
144347052|NCT03350815|520474379|FG003|Period 1|Physician Decision|0|||
144347053|NCT03350815|520474376|FG000|Period 1|Withdrawal by Subject|8|||
144347054|NCT03350815|520474377|FG001|Period 1|Withdrawal by Subject|0|||
144347055|NCT03350815|520474378|FG002|Period 1|Withdrawal by Subject|0|||
144347056|NCT03350815|520474379|FG003|Period 1|Withdrawal by Subject|0|||
144347057|NCT03350815|520474376|FG000|Period 1|Lack of Efficacy|15|||
144347058|NCT03350815|520474377|FG001|Period 1|Lack of Efficacy|0|||
144347059|NCT03350815|520474378|FG002|Period 1|Lack of Efficacy|0|||
144347060|NCT03350815|520474379|FG003|Period 1|Lack of Efficacy|0|||
144347061|NCT03350815|520474376|FG000|Period 1|Non-compliance with study treatment|2|||
144347062|NCT03350815|520474377|FG001|Period 1|Non-compliance with study treatment|0|||
144347063|NCT03350815|520474378|FG002|Period 1|Non-compliance with study treatment|0|||
144347064|NCT03350815|520474379|FG003|Period 1|Non-compliance with study treatment|0|||
144347065|NCT03350815|520474376|FG000|Period 1|Protocol Violation|3|||
144347066|NCT03350815|520474377|FG001|Period 1|Protocol Violation|0|||
144347067|NCT03350815|520474378|FG002|Period 1|Protocol Violation|0|||
144347068|NCT03350815|520474379|FG003|Period 1|Protocol Violation|0|||
144347069|NCT03350815|520474376|FG000|Period 2|Adverse Event|0|||
144347070|NCT03350815|520474377|FG001|Period 2|Adverse Event|3|||
144347071|NCT03350815|520474378|FG002|Period 2|Adverse Event|5|||
144347072|NCT03350815|520474379|FG003|Period 2|Adverse Event|0|||
144347073|NCT03350815|520474376|FG000|Period 2|Technical problem|0|||
144347074|NCT03350815|520474377|FG001|Period 2|Technical problem|1|||
144347075|NCT03350815|520474378|FG002|Period 2|Technical problem|0|||
144347076|NCT03350815|520474379|FG003|Period 2|Technical problem|0|||
144347077|NCT03350815|520474376|FG000|Period 2|Lost to Follow-up|0|||
144347078|NCT03350815|520474377|FG001|Period 2|Lost to Follow-up|3|||
144347079|NCT03350815|520474378|FG002|Period 2|Lost to Follow-up|3|||
144347080|NCT03350815|520474379|FG003|Period 2|Lost to Follow-up|0|||
144347081|NCT03350815|520474376|FG000|Period 2|Physician Decision|0|||
144347082|NCT03350815|520474377|FG001|Period 2|Physician Decision|0|||
144347083|NCT03350815|520474378|FG002|Period 2|Physician Decision|1|||
144347084|NCT03350815|520474379|FG003|Period 2|Physician Decision|0|||
144347085|NCT03350815|520474376|FG000|Period 2|Withdrawal by Subject|0|||
144347086|NCT03350815|520474377|FG001|Period 2|Withdrawal by Subject|3|||
144347087|NCT03350815|520474378|FG002|Period 2|Withdrawal by Subject|4|||
144347088|NCT03350815|520474379|FG003|Period 2|Withdrawal by Subject|0|||
144347089|NCT03350815|520474376|FG000|Period 2|Lack of Efficacy|0|||
144347090|NCT03350815|520474377|FG001|Period 2|Lack of Efficacy|6|||
144347091|NCT03350815|520474378|FG002|Period 2|Lack of Efficacy|2|||
144347092|NCT03350815|520474379|FG003|Period 2|Lack of Efficacy|0|||
144347093|NCT03350815|520474376|FG000|Period 2|Protocol Violation|0|||
144347094|NCT03350815|520474377|FG001|Period 2|Protocol Violation|0|||
144347095|NCT03350815|520474378|FG002|Period 2|Protocol Violation|1|||
144347096|NCT03350815|520474379|FG003|Period 2|Protocol Violation|0|||
144347097|NCT03350815|520474376|FG000|Period 2|New therapy for study indication|0|||
144347098|NCT03350815|520474377|FG001|Period 2|New therapy for study indication|0|||
144347099|NCT03350815|520474378|FG002|Period 2|New therapy for study indication|1|||
144347100|NCT03350815|520474379|FG003|Period 2|New therapy for study indication|0|||
144347101|NCT02517541|520474384|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
144347102|NCT02517541|520474384|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
144347103|NCT02517541|520474384|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
144347104|NCT02517541|520474384|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
144347105|NCT02517541|520474384|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
144347106|NCT02517541|520474384|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
144347107|NCT00699608|520474385|FG000|First Intervention|Withdrawal by Subject|0|||
144347108|NCT00699608|520474386|FG001|First Intervention|Withdrawal by Subject|0|||
144347109|NCT00699608|520474387|FG002|First Intervention|Withdrawal by Subject|1|||
144347110|NCT00699608|520474388|FG003|First Intervention|Withdrawal by Subject|0|||
144347111|NCT00699608|520474389|FG004|First Intervention|Withdrawal by Subject|0|||
144347112|NCT00699608|520474390|FG005|First Intervention|Withdrawal by Subject|0|||
144347113|NCT00699608|520474385|FG000|First Intervention|Protocol Violation|0|||
144347114|NCT00699608|520474386|FG001|First Intervention|Protocol Violation|0|||
144347115|NCT00699608|520474387|FG002|First Intervention|Protocol Violation|0|||
144347116|NCT00699608|520474388|FG003|First Intervention|Protocol Violation|0|||
144347117|NCT00699608|520474389|FG004|First Intervention|Protocol Violation|1|||
144347118|NCT00699608|520474390|FG005|First Intervention|Protocol Violation|0|||
144347119|NCT00699608|520474385|FG000|Second Intervention|Adverse Event|0|||
144347120|NCT00699608|520474386|FG001|Second Intervention|Adverse Event|0|||
144347121|NCT00699608|520474387|FG002|Second Intervention|Adverse Event|1|||
144347122|NCT00699608|520474388|FG003|Second Intervention|Adverse Event|0|||
144347123|NCT00699608|520474389|FG004|Second Intervention|Adverse Event|0|||
144347124|NCT00699608|520474390|FG005|Second Intervention|Adverse Event|0|||
144347125|NCT00699608|520474385|FG000|Second Intervention|Withdrawal by Subject|0|||
144347126|NCT00699608|520474386|FG001|Second Intervention|Withdrawal by Subject|0|||
144347127|NCT00699608|520474387|FG002|Second Intervention|Withdrawal by Subject|0|||
144347128|NCT00699608|520474388|FG003|Second Intervention|Withdrawal by Subject|1|||
144347129|NCT00699608|520474389|FG004|Second Intervention|Withdrawal by Subject|0|||
144347130|NCT00699608|520474390|FG005|Second Intervention|Withdrawal by Subject|0|||
144347131|NCT02828436|520474391|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
144347132|NCT02828436|520474392|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
144347133|NCT02828436|520474391|FG000|Period 1|Lost to Follow-up|0|||
144347134|NCT02828436|520474392|FG001|Period 1|Lost to Follow-up|1|||
144347135|NCT02828436|520474391|FG000|Period 2|Withdrawal by Subject|4|||
144347136|NCT02828436|520474392|FG001|Period 2|Withdrawal by Subject|0|||
144347137|NCT02828436|520474391|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
144347138|NCT02828436|520474392|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
144347139|NCT02828436|520474391|FG000|Period 2|Lost to Follow-up|1|||
144347140|NCT02828436|520474392|FG001|Period 2|Lost to Follow-up|0|||
144347141|NCT01136408|520474393|FG000|Overall Study|Adverse Event|4|||
144347142|NCT01136408|520474394|FG001|Overall Study|Adverse Event|8|||
144347143|NCT01136408|520474395|FG002|Overall Study|Adverse Event|4|||
144347144|NCT01136408|520474393|FG000|Overall Study|Protocol Violation|1|||
144347145|NCT01136408|520474394|FG001|Overall Study|Protocol Violation|1|||
144347146|NCT01136408|520474395|FG002|Overall Study|Protocol Violation|1|||
144347147|NCT03078556|520474398|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
144347148|NCT03078556|520474399|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
144347149|NCT03078556|520474400|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
144347150|NCT03078556|520474401|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
144347151|NCT03078556|520474398|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
144347152|NCT03078556|520474399|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
144347153|NCT03078556|520474400|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
144347154|NCT03078556|520474401|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
144347155|NCT03078556|520474398|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
144347156|NCT03078556|520474399|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
144347157|NCT03078556|520474400|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
144347158|NCT03078556|520474401|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
144347159|NCT03078556|520474398|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
144347160|NCT03078556|520474399|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
144347161|NCT03078556|520474400|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
144347162|NCT03078556|520474401|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
144347163|NCT04421482|520474403|FG000|Overall Study|Physician Decision|1|||
144347164|NCT03010319|520474404|FG000|Overall Study|Adverse Event|15|||
144347165|NCT03010319|520474405|FG001|Overall Study|Adverse Event|9|||
144347166|NCT03010319|520474404|FG000|Overall Study|Withdrawal by Subject|1|||
144347167|NCT03010319|520474405|FG001|Overall Study|Withdrawal by Subject|6|||
144347168|NCT03010319|520474404|FG000|Overall Study|Physician Decision|2|||
144347169|NCT03010319|520474405|FG001|Overall Study|Physician Decision|4|||
144347170|NCT03010319|520474404|FG000|Overall Study|Sponsor requested withdrawal|2|||
144347171|NCT03010319|520474405|FG001|Overall Study|Sponsor requested withdrawal|2|||
144347172|NCT03010319|520474404|FG000|Overall Study|Death|1|||
144347173|NCT03010319|520474405|FG001|Overall Study|Death|0|||
144347174|NCT03010319|520474404|FG000|Overall Study|Lost to Follow-up|0|||
144347175|NCT03010319|520474405|FG001|Overall Study|Lost to Follow-up|1|||
144347176|NCT03010319|520474404|FG000|Overall Study|Other Reason|5|||
144347177|NCT03010319|520474405|FG001|Overall Study|Other Reason|7|||
144347178|NCT02128724|520474406|FG000|Overall Study|Death|1|||
144347179|NCT02128724|520474407|FG001|Overall Study|Death|0|||
144347180|NCT02128724|520474408|FG002|Overall Study|Death|0|||
144347181|NCT02128724|520474409|FG003|Overall Study|Death|0|||
144347182|NCT02128724|520474406|FG000|Overall Study|Adverse Event|0|||
144347183|NCT02128724|520474407|FG001|Overall Study|Adverse Event|1|||
144347184|NCT02128724|520474408|FG002|Overall Study|Adverse Event|0|||
144347185|NCT02128724|520474409|FG003|Overall Study|Adverse Event|0|||
144347186|NCT02128724|520474406|FG000|Overall Study|Physician Decision|0|||
144347187|NCT02128724|520474407|FG001|Overall Study|Physician Decision|0|||
144347188|NCT02128724|520474408|FG002|Overall Study|Physician Decision|0|||
144347189|NCT02128724|520474409|FG003|Overall Study|Physician Decision|2|||
144347190|NCT02128724|520474406|FG000|Overall Study|Withdrawal by Subject|0|||
144347191|NCT02128724|520474407|FG001|Overall Study|Withdrawal by Subject|0|||
144347192|NCT02128724|520474408|FG002|Overall Study|Withdrawal by Subject|0|||
144347193|NCT02128724|520474409|FG003|Overall Study|Withdrawal by Subject|1|||
144347194|NCT01442714|520474410|FG000|Overall Study|Death|11|||
144347195|NCT01442714|520474410|FG000|Overall Study|Withdrawal by Subject|1|||
144347196|NCT04306510|520474411|FG000|Overall Study|Voluntarily withdrawal|1|||
144347197|NCT04306510|520474411|FG000|Overall Study|Enrolled but Not Treated|1|||
144347198|NCT04720417|520474414|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
144347199|NCT03329092|520474415|FG000|Overall Study|Other|2|||
144347200|NCT03329092|520474416|FG001|Overall Study|Other|2|||
144347201|NCT03329092|520474415|FG000|Overall Study|Withdrawal by Subject|16|||
144347202|NCT03329092|520474416|FG001|Overall Study|Withdrawal by Subject|3|||
144347203|NCT03329092|520474415|FG000|Overall Study|Physician Decision|1|||
144347204|NCT03329092|520474416|FG001|Overall Study|Physician Decision|0|||
144347205|NCT03329092|520474415|FG000|Overall Study|Death|17|||
144347206|NCT03329092|520474416|FG001|Overall Study|Death|11|||
144347207|NCT03329092|520474415|FG000|Overall Study|Adverse Event|3|||
144347208|NCT03329092|520474416|FG001|Overall Study|Adverse Event|1|||
144347209|NCT03329092|520474415|FG000|Overall Study|Lost to Follow-up|1|||
144347210|NCT03329092|520474416|FG001|Overall Study|Lost to Follow-up|1|||
144347211|NCT03314987|520474417|FG000|Overall Study|Lost to Follow-up|13|||
144347212|NCT03314987|520474418|FG001|Overall Study|Lost to Follow-up|13|||
144347213|NCT03574779|520474419|FG000|Overall Study|Screening failure|13|||
144347214|NCT03574779|520474420|FG001|Overall Study|Screening failure|83|||
144347215|NCT02751580|520474421|FG000|Overall Study|Lost to Follow-up|4|||
144347216|NCT02751580|520474421|FG000|Overall Study|Death|2|||
144347217|NCT02588261|520474422|FG000|Overall Study|Study Terminated by Sponsor|157|||
144347218|NCT02588261|520474423|FG001|Overall Study|Study Terminated by Sponsor|142|||
144347219|NCT02588261|520474422|FG000|Overall Study|Protocol Deviation|1|||
144347220|NCT02588261|520474423|FG001|Overall Study|Protocol Deviation|0|||
144347221|NCT02588261|520474422|FG000|Overall Study|Death|1|||
144347222|NCT02588261|520474423|FG001|Overall Study|Death|2|||
144347223|NCT02588261|520474422|FG000|Overall Study|Withdrawal by Subject|12|||
144347224|NCT02588261|520474423|FG001|Overall Study|Withdrawal by Subject|8|||
144347225|NCT02588261|520474422|FG000|Overall Study|Noncompliance with Study Drug|0|||
144347226|NCT02588261|520474423|FG001|Overall Study|Noncompliance with Study Drug|1|||
144347227|NCT02588261|520474422|FG000|Overall Study|Miscellaneous|5|||
144347228|NCT02588261|520474423|FG001|Overall Study|Miscellaneous|4|||
144347229|NCT02588261|520474422|FG000|Overall Study|Progressive Disease|61|||
144347230|NCT02588261|520474423|FG001|Overall Study|Progressive Disease|82|||
144347231|NCT02588261|520474422|FG000|Overall Study|Adverse Event|29|||
144347232|NCT02588261|520474423|FG001|Overall Study|Adverse Event|24|||
144347233|NCT02588261|520474422|FG000|Overall Study|Lost to Follow-up|1|||
144347234|NCT02588261|520474423|FG001|Overall Study|Lost to Follow-up|0|||
144347235|NCT04829916|520474427|FG000|Overall Study|Withdrawal by Subject|1|||
144347236|NCT04829916|520474428|FG001|Overall Study|Withdrawal by Subject|0|||
144347237|NCT03781778|520474430|FG000|Overall Study|Withdrawal by Subject|2|||
144347238|NCT03781778|520474431|FG001|Overall Study|Withdrawal by Subject|2|||
144347239|NCT04343755|520474439|FG000|Overall Study|Death|11|||
144347240|NCT04343755|520474439|FG000|Overall Study|Screen Failure|1|||
144347241|NCT03755882|520474440|FG000|Period 1|Protocol Violation|1|||
144347242|NCT03755882|520474441|FG001|Period 1|Protocol Violation|0|||
144347243|NCT03755882|520474440|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
144347244|NCT03755882|520474441|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
144347245|NCT02292446|520474442|FG000|Overall Study|Adverse Event|12|||
144347246|NCT02292446|520474442|FG000|Overall Study|Death|1|||
144347247|NCT02292446|520474442|FG000|Overall Study|Disease progression|2|||
144347248|NCT02292446|520474442|FG000|Overall Study|Subject/guardian decision|2|||
144347249|NCT02292446|520474442|FG000|Overall Study|Withdrawal by Subject|3|||
144347250|NCT02652156|520474444|FG000|Overall Study|Physician Decision|1|||
144347251|NCT02652156|520474445|FG001|Overall Study|Physician Decision|0|||
144347252|NCT02652156|520474446|FG002|Overall Study|Physician Decision|0|||
144347253|NCT00496080|520474450|FG000|Overall Study|Lost to Follow-up|9|||
144347254|NCT00496080|520474450|FG000|Overall Study|Surgical re-intervention|7|||
144347255|NCT00496080|520474450|FG000|Overall Study|Withdrawal by Subject|5|||
144347256|NCT00496080|520474450|FG000|Overall Study|Physician Decision|6|||
144347257|NCT01290757|520474455|FG000|Overall Study|Adverse Event|1|||
144347258|NCT01290757|520474456|FG001|Overall Study|Adverse Event|0|||
144347259|NCT01290757|520474455|FG000|Overall Study|Protocol Violation|1|||
144347260|NCT01290757|520474456|FG001|Overall Study|Protocol Violation|1|||
144347261|NCT01290757|520474455|FG000|Overall Study|Other|0|||
144347262|NCT01290757|520474456|FG001|Overall Study|Other|1|||
144347263|NCT00570310|520474457|FG000|Overall Study|Adverse Event|1|||
144347264|NCT00570310|520474458|FG001|Overall Study|Adverse Event|2|||
144347265|NCT00570310|520474457|FG000|Overall Study|Lack of Efficacy|1|||
144347266|NCT00570310|520474458|FG001|Overall Study|Lack of Efficacy|4|||
144347267|NCT03329846|520474461|FG000|Overall Study|Disease progression|4|||
144347268|NCT03329846|520474462|FG001|Overall Study|Disease progression|6|||
144347269|NCT03329846|520474461|FG000|Overall Study|Study drug toxicity|1|||
144347270|NCT03329846|520474462|FG001|Overall Study|Study drug toxicity|0|||
144347271|NCT03329846|520474461|FG000|Overall Study|Participant request to discontinue treatment|0|||
144347272|NCT03329846|520474462|FG001|Overall Study|Participant request to discontinue treatment|1|||
144347273|NCT03329846|520474461|FG000|Overall Study|Participant withdrew consent|1|||
144347274|NCT03329846|520474462|FG001|Overall Study|Participant withdrew consent|0|||
144347275|NCT03329846|520474461|FG000|Overall Study|Other reasons|2|||
144347276|NCT03329846|520474462|FG001|Overall Study|Other reasons|2|||
144347277|NCT00479336|520474463|FG000|Overall Study|Adverse Event|1|||
144347278|NCT00479336|520474464|FG001|Overall Study|Adverse Event|1|||
144347279|NCT00479336|520474465|FG002|Overall Study|Adverse Event|1|||
144347280|NCT00479336|520474466|FG003|Overall Study|Adverse Event|3|||
144347281|NCT00479336|520474463|FG000|Overall Study|Lack of Efficacy|1|||
144347282|NCT00479336|520474464|FG001|Overall Study|Lack of Efficacy|0|||
144347283|NCT00479336|520474465|FG002|Overall Study|Lack of Efficacy|0|||
144347284|NCT00479336|520474466|FG003|Overall Study|Lack of Efficacy|0|||
144347285|NCT00479336|520474463|FG000|Overall Study|Protocol Violation|0|||
144347286|NCT00479336|520474464|FG001|Overall Study|Protocol Violation|1|||
144347287|NCT00479336|520474465|FG002|Overall Study|Protocol Violation|0|||
144347288|NCT00479336|520474466|FG003|Overall Study|Protocol Violation|0|||
144347289|NCT00479336|520474463|FG000|Overall Study|Withdrawal by Subject|1|||
144347290|NCT00479336|520474464|FG001|Overall Study|Withdrawal by Subject|2|||
144347291|NCT00479336|520474465|FG002|Overall Study|Withdrawal by Subject|0|||
144347292|NCT00479336|520474466|FG003|Overall Study|Withdrawal by Subject|0|||
144347293|NCT00479336|520474463|FG000|Overall Study|Physician Decision|0|||
144347294|NCT00479336|520474464|FG001|Overall Study|Physician Decision|1|||
144347295|NCT00479336|520474465|FG002|Overall Study|Physician Decision|0|||
144347296|NCT00479336|520474466|FG003|Overall Study|Physician Decision|2|||
144347297|NCT00479336|520474463|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
144347298|NCT00479336|520474464|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
144347299|NCT00479336|520474465|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
144347300|NCT00479336|520474466|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
144347301|NCT00108862|520474467|FG000|Overall Study|Death|31|||
144347302|NCT00108862|520474468|FG001|Overall Study|Death|37|||
144347303|NCT00108862|520474467|FG000|Overall Study|Withdrawal by Subject|10|||
144347304|NCT00108862|520474468|FG001|Overall Study|Withdrawal by Subject|6|||
144347305|NCT00108862|520474467|FG000|Overall Study|Lost to Follow-up|27|||
144347306|NCT00108862|520474468|FG001|Overall Study|Lost to Follow-up|19|||
144347307|NCT03066193|520474469|FG000|Overall Study|Withdrawal by Subject|1|||
144347308|NCT02021643|520474470|FG000|Overall Study|Enrolled but Never Treated|1|||
144347309|NCT02021643|520474471|FG001|Overall Study|Enrolled but Never Treated|0|||
144347310|NCT02021643|520474472|FG002|Overall Study|Enrolled but Never Treated|0|||
144347311|NCT02021643|520474473|FG003|Overall Study|Enrolled but Never Treated|0|||
144347312|NCT02021643|520474470|FG000|Overall Study|Adverse Event|0|||
144347313|NCT02021643|520474471|FG001|Overall Study|Adverse Event|1|||
144347314|NCT02021643|520474472|FG002|Overall Study|Adverse Event|0|||
144347315|NCT02021643|520474473|FG003|Overall Study|Adverse Event|0|||
144347316|NCT02021643|520474470|FG000|Overall Study|Death|0|||
144347317|NCT02021643|520474471|FG001|Overall Study|Death|1|||
144347318|NCT02021643|520474472|FG002|Overall Study|Death|0|||
144347319|NCT02021643|520474473|FG003|Overall Study|Death|0|||
144347320|NCT02021643|520474470|FG000|Overall Study|Investigator's Discretion|1|||
144347321|NCT02021643|520474471|FG001|Overall Study|Investigator's Discretion|0|||
144347322|NCT02021643|520474472|FG002|Overall Study|Investigator's Discretion|0|||
144347323|NCT02021643|520474473|FG003|Overall Study|Investigator's Discretion|0|||
144347324|NCT02021643|520474470|FG000|Overall Study|Lack of Efficacy|7|||
144347325|NCT02021643|520474471|FG001|Overall Study|Lack of Efficacy|6|||
144347326|NCT02021643|520474472|FG002|Overall Study|Lack of Efficacy|0|||
144347327|NCT02021643|520474473|FG003|Overall Study|Lack of Efficacy|12|||
144347328|NCT02021643|520474470|FG000|Overall Study|Lost to Follow-up|0|||
144347329|NCT02021643|520474471|FG001|Overall Study|Lost to Follow-up|1|||
144347330|NCT02021643|520474472|FG002|Overall Study|Lost to Follow-up|0|||
144347331|NCT02021643|520474473|FG003|Overall Study|Lost to Follow-up|0|||
144347332|NCT02021643|520474470|FG000|Overall Study|Withdrew Consent|0|||
144347333|NCT02021643|520474471|FG001|Overall Study|Withdrew Consent|1|||
144347334|NCT02021643|520474472|FG002|Overall Study|Withdrew Consent|0|||
144347335|NCT02021643|520474473|FG003|Overall Study|Withdrew Consent|0|||
144347336|NCT01746368|520474477|FG000|Overall Study|Lost to Follow-up|2|||
144347337|NCT01746368|520474478|FG001|Overall Study|Lost to Follow-up|0|||
144347338|NCT01746368|520474477|FG000|Overall Study|Withdrawal by Subject|0|||
144347339|NCT01746368|520474478|FG001|Overall Study|Withdrawal by Subject|1|||
144347340|NCT05636852|520474479|FG000|Overall Study|Withdrawal by Subject|1|||
144347341|NCT05636852|520474479|FG000|Overall Study|Other than specified|1|||
144347342|NCT01076036|520474482|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
144347343|NCT02221674|520474483|FG000|Overall Study|Lost to Follow-up|1|||
144347344|NCT02221674|520474484|FG001|Overall Study|Lost to Follow-up|0|||
144347345|NCT02221674|520474485|FG002|Overall Study|Lost to Follow-up|0|||
144347346|NCT05292131|520474486|FG000|Overall Study|Lost to Follow-up|1|||
144347347|NCT05292131|520474487|FG001|Overall Study|Lost to Follow-up|1|||
144347348|NCT05292131|520474486|FG000|Overall Study|Withdrawal by Subject|0|||
144347349|NCT05292131|520474487|FG001|Overall Study|Withdrawal by Subject|1|||
144347350|NCT02557542|520474489|FG000|Overall Study|Poor recruitment|3|||
144347351|NCT02557542|520474490|FG001|Overall Study|Poor recruitment|0|||
144347352|NCT04390880|520474491|FG000|Overall Study|Withdrawal by Subject|1|||
144347353|NCT01345188|520474492|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
144347354|NCT01345188|520474492|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
144347355|NCT00577824|520474493|FG000|Overall Study|Adverse Event|6|||
144347356|NCT00577824|520474494|FG001|Overall Study|Adverse Event|18|||
144347357|NCT00577824|520474495|FG002|Overall Study|Adverse Event|1|||
144347358|NCT00577824|520474493|FG000|Overall Study|Patient decision|0|||
144347359|NCT00577824|520474494|FG001|Overall Study|Patient decision|1|||
144347360|NCT00577824|520474495|FG002|Overall Study|Patient decision|1|||
144347361|NCT00577824|520474493|FG000|Overall Study|Protocol Violation|1|||
144347362|NCT00577824|520474494|FG001|Overall Study|Protocol Violation|1|||
144347363|NCT00577824|520474495|FG002|Overall Study|Protocol Violation|0|||
144347364|NCT00362648|520474496|FG000|Overall Study|Adverse Event|12|||
144347365|NCT00362648|520474497|FG001|Overall Study|Adverse Event|21|||
144347366|NCT00362648|520474498|FG002|Overall Study|Adverse Event|1|||
144347367|NCT00362648|520474499|FG003|Overall Study|Adverse Event|0|||
144347368|NCT00362648|520474496|FG000|Overall Study|Lost to Follow-up|62|||
144347369|NCT00362648|520474497|FG001|Overall Study|Lost to Follow-up|69|||
144347370|NCT00362648|520474498|FG002|Overall Study|Lost to Follow-up|4|||
144347371|NCT00362648|520474499|FG003|Overall Study|Lost to Follow-up|3|||
144347372|NCT00362648|520474496|FG000|Overall Study|Protocol Violation|4|||
144347373|NCT00362648|520474497|FG001|Overall Study|Protocol Violation|2|||
144347374|NCT00362648|520474498|FG002|Overall Study|Protocol Violation|2|||
144347375|NCT00362648|520474499|FG003|Overall Study|Protocol Violation|2|||
144347376|NCT00362648|520474496|FG000|Overall Study|Withdrawal by Subject|48|||
144347377|NCT00362648|520474497|FG001|Overall Study|Withdrawal by Subject|42|||
144347378|NCT00362648|520474498|FG002|Overall Study|Withdrawal by Subject|2|||
144347379|NCT00362648|520474499|FG003|Overall Study|Withdrawal by Subject|6|||
144347380|NCT05715242|520474500|FG000|Overall Study|Lost to Follow-up|0|||
144347381|NCT05715242|520474501|FG001|Overall Study|Lost to Follow-up|0|||
144347382|NCT05715242|520474502|FG002|Overall Study|Lost to Follow-up|1|||
144347383|NCT05715242|520474503|FG003|Overall Study|Lost to Follow-up|0|||
144347384|NCT05715242|520474504|FG004|Overall Study|Lost to Follow-up|0|||
144347385|NCT05715242|520474505|FG005|Overall Study|Lost to Follow-up|1|||
144347386|NCT05715242|520474506|FG006|Overall Study|Lost to Follow-up|0|||
144347387|NCT05715242|520474507|FG007|Overall Study|Lost to Follow-up|0|||
144347388|NCT05715242|520474508|FG008|Overall Study|Lost to Follow-up|0|||
144347389|NCT05715242|520474509|FG009|Overall Study|Lost to Follow-up|0|||
144347390|NCT05715242|520474510|FG010|Overall Study|Lost to Follow-up|0|||
144347391|NCT05715242|520474511|FG011|Overall Study|Lost to Follow-up|0|||
144347392|NCT05715242|520474512|FG012|Overall Study|Lost to Follow-up|0|||
144347393|NCT05715242|520474513|FG013|Overall Study|Lost to Follow-up|0|||
144347394|NCT05715242|520474514|FG014|Overall Study|Lost to Follow-up|0|||
144347395|NCT05715242|520474515|FG015|Overall Study|Lost to Follow-up|0|||
144347396|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
144347397|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
144347398|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
144347399|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Death|0|||
144347400|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Death|2|||
144347401|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Death|0|||
144347402|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
144347403|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
144347404|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
144347405|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
144347406|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
144347407|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
144347408|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
144347409|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
144347410|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
144347411|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
144347412|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
144347413|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
144347414|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
144347415|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
144347416|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
144347417|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Recovery|1|||
144347418|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Recovery|0|||
144347419|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Recovery|1|||
144347420|NCT00195663|520474518|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
144347421|NCT00195663|520474519|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
144347422|NCT00195663|520474520|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
144347423|NCT00195663|520474518|FG000|Open-Label Extension Period|Adverse Event|21|||
144347424|NCT00195663|520474519|FG001|Open-Label Extension Period|Adverse Event|32|||
144347425|NCT00195663|520474520|FG002|Open-Label Extension Period|Adverse Event|36|||
144347426|NCT00195663|520474518|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
144347427|NCT00195663|520474519|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
144347428|NCT00195663|520474520|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
144347429|NCT00195663|520474518|FG000|Open-Label Extension Period|Recovery|0|||
144347430|NCT00195663|520474519|FG001|Open-Label Extension Period|Recovery|2|||
144347431|NCT00195663|520474520|FG002|Open-Label Extension Period|Recovery|2|||
144347432|NCT00195663|520474518|FG000|Open-Label Extension Period|Protocol Violation|3|||
144347433|NCT00195663|520474519|FG001|Open-Label Extension Period|Protocol Violation|4|||
144347434|NCT00195663|520474520|FG002|Open-Label Extension Period|Protocol Violation|4|||
144347435|NCT00195663|520474518|FG000|Open-Label Extension Period|Death|2|||
144347436|NCT00195663|520474519|FG001|Open-Label Extension Period|Death|2|||
144347437|NCT00195663|520474520|FG002|Open-Label Extension Period|Death|2|||
144347438|NCT00195663|520474518|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
144347439|NCT00195663|520474519|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
144347440|NCT00195663|520474520|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
144347441|NCT00195663|520474518|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
144347442|NCT00195663|520474519|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
144347443|NCT00195663|520474520|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
144347444|NCT00195663|520474518|FG000|Open-Label Extension Period|Administrative reasons|11|||
144347445|NCT00195663|520474519|FG001|Open-Label Extension Period|Administrative reasons|11|||
144347446|NCT00195663|520474520|FG002|Open-Label Extension Period|Administrative reasons|13|||
144347447|NCT03228212|520474523|FG000|Period 1|Adverse Event|1|||
144347448|NCT03228212|520474524|FG001|Period 1|Adverse Event|0|||
144347449|NCT03228212|520474523|FG000|Period 1|no longer meets eligibility criteria|0|||
144347450|NCT03228212|520474524|FG001|Period 1|no longer meets eligibility criteria|1|||
144347451|NCT03228212|520474523|FG000|Period 2|Lost to Follow-up|1|||
144347452|NCT03228212|520474524|FG001|Period 2|Lost to Follow-up|0|||
144347453|NCT04426318|520476099|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
144347454|NCT04426318|520476100|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
144347455|NCT02287467|520476101|FG000|Overall Study|Protocol Violation|12|||
144347456|NCT02287467|520476102|FG001|Overall Study|Protocol Violation|9|||
144347457|NCT05729568|520476103|FG000|Overall Study|Still on Study|52|||
144347458|NCT05729568|520476104|FG001|Overall Study|Still on Study|26|||
144347459|NCT05729568|520476103|FG000|Overall Study|Randomized but Never Treated|3|||
144347460|NCT05729568|520476104|FG001|Overall Study|Randomized but Never Treated|0|||
144347461|NCT05729568|520476103|FG000|Overall Study|Adverse Event|0|||
144347462|NCT05729568|520476104|FG001|Overall Study|Adverse Event|1|||
144347463|NCT05729568|520476103|FG000|Overall Study|Investigator's Discretion|1|||
144347464|NCT05729568|520476104|FG001|Overall Study|Investigator's Discretion|0|||
144347465|NCT00637416|520476115|FG000|Overall Study|Lost to Follow-up|1|||
144347466|NCT00637416|520476116|FG001|Overall Study|Lost to Follow-up|1|||
144347467|NCT00637416|520476115|FG000|Overall Study|Unable to take study drug|0|||
144347468|NCT00637416|520476116|FG001|Overall Study|Unable to take study drug|1|||
144347469|NCT00132808|520476117|FG000|Stratum I|Adverse Event|2|||
144347470|NCT00132808|520476118|FG001|Stratum I|Adverse Event|1|||
144347471|NCT00132808|520476119|FG002|Stratum I|Adverse Event|0|||
144347472|NCT00132808|520476117|FG000|Stratum I|Lost to Follow-up|3|||
144347473|NCT00132808|520476118|FG001|Stratum I|Lost to Follow-up|4|||
144347474|NCT00132808|520476119|FG002|Stratum I|Lost to Follow-up|1|||
144347475|NCT00132808|520476117|FG000|Stratum I|Withdrawal by Subject|4|||
144347476|NCT00132808|520476118|FG001|Stratum I|Withdrawal by Subject|7|||
144347477|NCT00132808|520476119|FG002|Stratum I|Withdrawal by Subject|3|||
144347478|NCT00132808|520476117|FG000|Stratum I|Abnormal test procedure result (s)|0|||
144347479|NCT00132808|520476118|FG001|Stratum I|Abnormal test procedure result (s)|0|||
144347480|NCT00132808|520476119|FG002|Stratum I|Abnormal test procedure result (s)|1|||
144347481|NCT00132808|520476117|FG000|Stratum II|Adverse Event|1|||
144347482|NCT00132808|520476118|FG001|Stratum II|Adverse Event|2|||
144347483|NCT00132808|520476119|FG002|Stratum II|Adverse Event|1|||
144347484|NCT00132808|520476117|FG000|Stratum II|Death|1|||
144347485|NCT00132808|520476118|FG001|Stratum II|Death|0|||
144347486|NCT00132808|520476119|FG002|Stratum II|Death|0|||
144347487|NCT00132808|520476117|FG000|Stratum II|Lost to Follow-up|2|||
144347488|NCT00132808|520476118|FG001|Stratum II|Lost to Follow-up|2|||
144347489|NCT00132808|520476119|FG002|Stratum II|Lost to Follow-up|1|||
144347490|NCT00132808|520476117|FG000|Stratum II|Protocol Violation|0|||
144347491|NCT00132808|520476118|FG001|Stratum II|Protocol Violation|2|||
144347492|NCT00132808|520476119|FG002|Stratum II|Protocol Violation|1|||
144347493|NCT00132808|520476117|FG000|Stratum II|Withdrawal by Subject|4|||
144347494|NCT00132808|520476118|FG001|Stratum II|Withdrawal by Subject|9|||
144347495|NCT00132808|520476119|FG002|Stratum II|Withdrawal by Subject|6|||
144347496|NCT02204072|520476122|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
144347497|NCT02204072|520476123|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
144347498|NCT02204072|520476124|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
144347499|NCT02204072|520476125|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
144347500|NCT02204072|520476126|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
144347501|NCT02204072|520476122|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
144347502|NCT02204072|520476123|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
144347503|NCT02204072|520476124|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
144347504|NCT02204072|520476125|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
144347505|NCT02204072|520476126|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
144347506|NCT02204072|520476122|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
144347507|NCT02204072|520476123|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
144347508|NCT02204072|520476124|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
144347509|NCT02204072|520476125|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
144347510|NCT02204072|520476126|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
144347511|NCT02204072|520476122|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
144347512|NCT02204072|520476123|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
144347513|NCT02204072|520476124|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
144347514|NCT02204072|520476125|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
144347515|NCT02204072|520476126|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
144347516|NCT03983304|520476127|FG000|Overall Study|Withdrawal by Subject|5|||
144347517|NCT03983304|520476127|FG000|Overall Study|Lost to Follow-up|2|||
144347518|NCT01587040|520476133|FG000|Overall Study|Protocol Violation|0|||
144347519|NCT01587040|520476134|FG001|Overall Study|Protocol Violation|0|||
144347520|NCT01587040|520476135|FG002|Overall Study|Protocol Violation|1|||
144347521|NCT01587040|520476136|FG003|Overall Study|Protocol Violation|0|||
144347522|NCT01587040|520476133|FG000|Overall Study|Adverse Event|0|||
144347523|NCT01587040|520476134|FG001|Overall Study|Adverse Event|1|||
144347524|NCT01587040|520476135|FG002|Overall Study|Adverse Event|10|||
144347525|NCT01587040|520476136|FG003|Overall Study|Adverse Event|0|||
144347526|NCT01587040|520476133|FG000|Overall Study|Disease progression|12|||
144347527|NCT01587040|520476134|FG001|Overall Study|Disease progression|1|||
144347528|NCT01587040|520476135|FG002|Overall Study|Disease progression|15|||
144347529|NCT01587040|520476136|FG003|Overall Study|Disease progression|3|||
144347530|NCT01587040|520476133|FG000|Overall Study|Other than specified|5|||
144347531|NCT01587040|520476134|FG001|Overall Study|Other than specified|1|||
144347532|NCT01587040|520476135|FG002|Overall Study|Other than specified|11|||
144347533|NCT01587040|520476136|FG003|Overall Study|Other than specified|1|||
144347534|NCT01518374|520476139|FG000|Overall Study|Withdrawal by Subject|2|||
144347535|NCT01518374|520476139|FG000|Overall Study|Protocol Violation|3|||
144347536|NCT01518374|520476139|FG000|Overall Study|Lost to Follow-up|2|||
144347537|NCT04300309|520476140|FG000|Overall Study|Lost to Follow-up|1|||
144347538|NCT04300309|520476141|FG001|Overall Study|Lost to Follow-up|0|||
144347539|NCT04607837|520476147|FG000|Overall Study|Adverse Event|8|||
144347540|NCT04607837|520476148|FG001|Overall Study|Adverse Event|2|||
144347541|NCT04607837|520476147|FG000|Overall Study|Withdrawal by Subject|8|||
144347542|NCT04607837|520476148|FG001|Overall Study|Withdrawal by Subject|7|||
144347543|NCT04607837|520476147|FG000|Overall Study|Physician Decision|2|||
144347544|NCT04607837|520476148|FG001|Overall Study|Physician Decision|0|||
144347545|NCT04607837|520476147|FG000|Overall Study|Lack of Efficacy|2|||
144347546|NCT04607837|520476148|FG001|Overall Study|Lack of Efficacy|0|||
144347547|NCT04607837|520476147|FG000|Overall Study|Participant terminated by sponsor|1|||
144347548|NCT04607837|520476148|FG001|Overall Study|Participant terminated by sponsor|0|||
144347549|NCT04607837|520476147|FG000|Overall Study|Disease worsening|36|||
144347550|NCT04607837|520476148|FG001|Overall Study|Disease worsening|36|||
144347551|NCT04607837|520476147|FG000|Overall Study|Other|1|||
144347552|NCT04607837|520476148|FG001|Overall Study|Other|0|||
144347553|NCT02362464|520476149|FG000|Overall Study|Switched to alternative therapy|1|||
144347554|NCT02362464|520476149|FG000|Overall Study|Refused further treatment|1|||
144347555|NCT02362464|520476149|FG000|Overall Study|Physician Decision|4|||
144347556|NCT04346654|520476151|FG000|Overall Study|Adverse Event|2|||
144347557|NCT04346654|520476152|FG001|Overall Study|Adverse Event|0|||
144347558|NCT04346654|520476151|FG000|Overall Study|Non-response|1|||
144347559|NCT04346654|520476152|FG001|Overall Study|Non-response|1|||
144347560|NCT04346654|520476151|FG000|Overall Study|Withdrawal by Subject|2|||
144347561|NCT04346654|520476152|FG001|Overall Study|Withdrawal by Subject|0|||
144347562|NCT04346654|520476151|FG000|Overall Study|Lost to Follow-up|0|||
144347563|NCT04346654|520476152|FG001|Overall Study|Lost to Follow-up|1|||
144347564|NCT04346654|520476151|FG000|Overall Study|Pregnancy|0|||
144347565|NCT04346654|520476152|FG001|Overall Study|Pregnancy|1|||
144347566|NCT00465452|520476153|FG000|Overall Study|Adverse Event|1|||
144347567|NCT05870865|520476190|FG000|Randomized|Did not receive study treatment|2|||
144347568|NCT05870865|520476191|FG001|Randomized|Did not receive study treatment|4|||
144347569|NCT05870865|520476192|FG002|Randomized|Did not receive study treatment|4|||
144347570|NCT05870865|520476193|FG003|Randomized|Did not receive study treatment|3|||
144347571|NCT05870865|520476190|FG000|Treatment Period|Adverse Event|1|||
144347572|NCT05870865|520476191|FG001|Treatment Period|Adverse Event|1|||
144347573|NCT05870865|520476192|FG002|Treatment Period|Adverse Event|1|||
144347574|NCT05870865|520476193|FG003|Treatment Period|Adverse Event|1|||
144347575|NCT05870865|520476190|FG000|Treatment Period|Lost to Follow-up|0|||
144347576|NCT05870865|520476191|FG001|Treatment Period|Lost to Follow-up|1|||
144347577|NCT05870865|520476192|FG002|Treatment Period|Lost to Follow-up|2|||
144347578|NCT05870865|520476193|FG003|Treatment Period|Lost to Follow-up|0|||
144347579|NCT05870865|520476190|FG000|Treatment Period|Protocol Violation|0|||
144347580|NCT05870865|520476191|FG001|Treatment Period|Protocol Violation|0|||
144347581|NCT05870865|520476192|FG002|Treatment Period|Protocol Violation|0|||
144347582|NCT05870865|520476193|FG003|Treatment Period|Protocol Violation|1|||
144347583|NCT05870865|520476190|FG000|Treatment Period|Withdrawal by Subject|0|||
144347584|NCT05870865|520476191|FG001|Treatment Period|Withdrawal by Subject|1|||
144347585|NCT05870865|520476192|FG002|Treatment Period|Withdrawal by Subject|1|||
144347586|NCT05870865|520476193|FG003|Treatment Period|Withdrawal by Subject|1|||
144347587|NCT02343406|520476194|FG000|Overall Study|Progressive disease|72|||
144347588|NCT02343406|520476195|FG001|Overall Study|Progressive disease|70|||
144347589|NCT02343406|520476196|FG002|Overall Study|Progressive disease|43|||
144347590|NCT02343406|520476197|FG003|Overall Study|Progressive disease|15|||
144347591|NCT02343406|520476198|FG004|Overall Study|Progressive disease|5|||
144347592|NCT02343406|520476194|FG000|Overall Study|Adverse Event|6|||
144347593|NCT02343406|520476195|FG001|Overall Study|Adverse Event|8|||
144347594|NCT02343406|520476196|FG002|Overall Study|Adverse Event|6|||
144347595|NCT02343406|520476197|FG003|Overall Study|Adverse Event|3|||
144347596|NCT02343406|520476198|FG004|Overall Study|Adverse Event|0|||
144347597|NCT02343406|520476194|FG000|Overall Study|Withdrawal by Subject|6|||
144347598|NCT02343406|520476195|FG001|Overall Study|Withdrawal by Subject|4|||
144347599|NCT02343406|520476196|FG002|Overall Study|Withdrawal by Subject|8|||
144347600|NCT02343406|520476197|FG003|Overall Study|Withdrawal by Subject|3|||
144347601|NCT02343406|520476198|FG004|Overall Study|Withdrawal by Subject|0|||
144347602|NCT02343406|520476194|FG000|Overall Study|Death|2|||
144347603|NCT02343406|520476195|FG001|Overall Study|Death|1|||
144347604|NCT02343406|520476196|FG002|Overall Study|Death|0|||
144347605|NCT02343406|520476197|FG003|Overall Study|Death|0|||
144347606|NCT02343406|520476198|FG004|Overall Study|Death|0|||
144347607|NCT02343406|520476194|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
144347608|NCT02343406|520476195|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
144347609|NCT02343406|520476196|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
144347610|NCT02343406|520476197|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
144347611|NCT02343406|520476198|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
144347612|NCT02343406|520476194|FG000|Overall Study|Other primary malignancy|0|||
144347613|NCT02343406|520476195|FG001|Overall Study|Other primary malignancy|1|||
144347614|NCT02343406|520476196|FG002|Overall Study|Other primary malignancy|0|||
144347615|NCT02343406|520476197|FG003|Overall Study|Other primary malignancy|0|||
144347616|NCT02343406|520476198|FG004|Overall Study|Other primary malignancy|0|||
144347617|NCT02343406|520476194|FG000|Overall Study|Other, not specified|2|||
144347618|NCT02343406|520476195|FG001|Overall Study|Other, not specified|1|||
144347619|NCT02343406|520476196|FG002|Overall Study|Other, not specified|1|||
144347620|NCT02343406|520476197|FG003|Overall Study|Other, not specified|4|||
144347621|NCT02343406|520476198|FG004|Overall Study|Other, not specified|0|||
144347622|NCT00858637|520476199|FG000|Active Comparison Phase|Adverse Event|14|||
144347623|NCT00858637|520476200|FG001|Active Comparison Phase|Adverse Event|0|||
144347624|NCT00858637|520476201|FG002|Active Comparison Phase|Adverse Event|0|||
144347625|NCT00858637|520476202|FG003|Active Comparison Phase|Adverse Event|9|||
144347626|NCT00858637|520476203|FG004|Active Comparison Phase|Adverse Event|0|||
144347627|NCT00858637|520476204|FG005|Active Comparison Phase|Adverse Event|0|||
144347628|NCT00858637|520476199|FG000|Active Comparison Phase|Death|1|||
144347629|NCT00858637|520476200|FG001|Active Comparison Phase|Death|0|||
144347630|NCT00858637|520476201|FG002|Active Comparison Phase|Death|0|||
144347631|NCT00858637|520476202|FG003|Active Comparison Phase|Death|1|||
144347632|NCT00858637|520476203|FG004|Active Comparison Phase|Death|0|||
144347633|NCT00858637|520476204|FG005|Active Comparison Phase|Death|0|||
144347634|NCT00858637|520476199|FG000|Active Comparison Phase|Physician Decision|1|||
144347635|NCT00858637|520476200|FG001|Active Comparison Phase|Physician Decision|0|||
144347636|NCT00858637|520476201|FG002|Active Comparison Phase|Physician Decision|0|||
144347637|NCT00858637|520476202|FG003|Active Comparison Phase|Physician Decision|1|||
144347638|NCT00858637|520476203|FG004|Active Comparison Phase|Physician Decision|0|||
144347639|NCT00858637|520476204|FG005|Active Comparison Phase|Physician Decision|0|||
144347640|NCT00858637|520476199|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
144347641|NCT00858637|520476200|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
144347642|NCT00858637|520476201|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
144347643|NCT00858637|520476202|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
144347644|NCT00858637|520476203|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
144347645|NCT00858637|520476204|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
144347646|NCT00858637|520476199|FG000|Active Comparison Phase|Other Reasons|1|||
144347647|NCT00858637|520476200|FG001|Active Comparison Phase|Other Reasons|0|||
144347648|NCT00858637|520476201|FG002|Active Comparison Phase|Other Reasons|0|||
144347649|NCT00858637|520476202|FG003|Active Comparison Phase|Other Reasons|1|||
144347650|NCT00858637|520476203|FG004|Active Comparison Phase|Other Reasons|0|||
144347651|NCT00858637|520476204|FG005|Active Comparison Phase|Other Reasons|0|||
144347652|NCT00858637|520476199|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
144347653|NCT00858637|520476200|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
144347654|NCT00858637|520476201|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
144347655|NCT00858637|520476202|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
144347656|NCT00858637|520476203|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
144347657|NCT00858637|520476204|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
144347658|NCT00858637|520476199|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
144347659|NCT00858637|520476200|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
144347660|NCT00858637|520476201|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
144347661|NCT00858637|520476202|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
144347662|NCT00858637|520476203|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
144347663|NCT00858637|520476204|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
144347664|NCT01380834|520476205|FG000|Overall Study|Physician Decision|1|||
144347665|NCT01380834|520476206|FG001|Overall Study|Physician Decision|0|||
144347666|NCT04677504|520476209|FG000|Overall Study|Death|51|||
144347667|NCT04677504|520476210|FG001|Overall Study|Death|49|||
144347668|NCT04677504|520476209|FG000|Overall Study|Progressive Disease|1|||
144347669|NCT04677504|520476210|FG001|Overall Study|Progressive Disease|0|||
144347670|NCT04677504|520476209|FG000|Overall Study|Symptomatic Deterioration|1|||
144347671|NCT04677504|520476210|FG001|Overall Study|Symptomatic Deterioration|0|||
144347672|NCT04677504|520476209|FG000|Overall Study|Withdrawal by Subject|2|||
144347673|NCT04677504|520476210|FG001|Overall Study|Withdrawal by Subject|5|||
144347674|NCT04677504|520476209|FG000|Overall Study|Study Terminated By Sponsor|28|||
144347675|NCT04677504|520476210|FG001|Overall Study|Study Terminated By Sponsor|24|||
144347676|NCT04677504|520476209|FG000|Overall Study|Adverse Event|0|||
144347677|NCT04677504|520476210|FG001|Overall Study|Adverse Event|1|||
144347678|NCT03182907|520476211|FG000|Overall Study|Death|3|||
144347679|NCT03182907|520476212|FG001|Overall Study|Death|0|||
144347680|NCT03182907|520476211|FG000|Overall Study|Protocol Violation|4|||
144347681|NCT03182907|520476212|FG001|Overall Study|Protocol Violation|0|||
144347682|NCT03182907|520476211|FG000|Overall Study|Lost to Follow-up|1|||
144347683|NCT03182907|520476212|FG001|Overall Study|Lost to Follow-up|0|||
144347684|NCT03182907|520476211|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
144347685|NCT03182907|520476212|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
144347686|NCT02058563|520476216|FG000|Overall Study|Lost to Follow-up|26|||
144347687|NCT02058563|520476217|FG001|Overall Study|Lost to Follow-up|22|||
144347688|NCT02058563|520476216|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
144347689|NCT02058563|520476217|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
144347690|NCT02058563|520476216|FG000|Overall Study|Consent Withdrawal|1|||
144347691|NCT02058563|520476217|FG001|Overall Study|Consent Withdrawal|1|||
144347692|NCT02058563|520476216|FG000|Overall Study|Other (patient incarcerated)|0|||
144347693|NCT02058563|520476217|FG001|Overall Study|Other (patient incarcerated)|1|||
144347694|NCT00166439|520476218|FG000|Overall Study|Ineligible|5|||
144347695|NCT04039217|520476221|FG000|Overall Study|Lost to Follow-up|1|||
144347696|NCT00167310|520476222|FG000|Overall Study|Protocol Violation|5|||
144347697|NCT00167310|520476223|FG001|Overall Study|Protocol Violation|3|||
144347698|NCT00167310|520476222|FG000|Overall Study|Withdrawal by Subject|3|||
144347699|NCT00167310|520476223|FG001|Overall Study|Withdrawal by Subject|7|||
144347700|NCT00615992|520476224|FG000|Overall Study|Protocol Violation|67|||
144347701|NCT03304873|520476225|FG000|Overall Study|Lost to Follow-up|1|||
144347702|NCT03304873|520476226|FG001|Overall Study|Lost to Follow-up|8|||
144347703|NCT03319212|520476227|FG000|Overall Study|Discontinued as moving out of local area|0|||
144347704|NCT03319212|520476228|FG001|Overall Study|Discontinued as moving out of local area|1|||
144347705|NCT03319212|520476227|FG000|Overall Study|Adverse Event|2|||
144347706|NCT03319212|520476228|FG001|Overall Study|Adverse Event|2|||
144347707|NCT03319212|520476227|FG000|Overall Study|Withdrawal by Subject|0|||
144347708|NCT03319212|520476228|FG001|Overall Study|Withdrawal by Subject|1|||
144347709|NCT03319212|520476227|FG000|Overall Study|Lost to Follow-up|0|||
144347710|NCT03319212|520476228|FG001|Overall Study|Lost to Follow-up|1|||
144347711|NCT03319212|520476227|FG000|Overall Study|Physician Decision|1|||
144347712|NCT03319212|520476228|FG001|Overall Study|Physician Decision|0|||
144347713|NCT01546688|520476229|FG000|Overall Study|Adverse Event|0|||
144347714|NCT01546688|520476230|FG001|Overall Study|Adverse Event|4|||
144347715|NCT01546688|520476229|FG000|Overall Study|Withdrawal by Subject|2|||
144347716|NCT01546688|520476230|FG001|Overall Study|Withdrawal by Subject|1|||
144347717|NCT01546688|520476229|FG000|Overall Study|Lack of Efficacy|1|||
144347718|NCT01546688|520476230|FG001|Overall Study|Lack of Efficacy|0|||
144347719|NCT00782483|520476234|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
144347720|NCT01868477|520476235|FG000|Overall Study|Adverse Event|2|||
144347721|NCT01868477|520476236|FG001|Overall Study|Adverse Event|4|||
144347722|NCT01868477|520476235|FG000|Overall Study|Disease progression|1|||
144347723|NCT01868477|520476236|FG001|Overall Study|Disease progression|1|||
144347724|NCT01868477|520476235|FG000|Overall Study|Withdrawal by Subject|1|||
144347725|NCT01868477|520476236|FG001|Overall Study|Withdrawal by Subject|0|||
144347726|NCT01052077|520476238|FG000|Phase A|Lost to Follow-up|22|||
144347727|NCT01052077|520476239|FG001|Phase A|Lost to Follow-up|0|||
144347728|NCT01052077|520476240|FG002|Phase A|Lost to Follow-up|0|||
144347729|NCT01052077|520476241|FG003|Phase A|Lost to Follow-up|0|||
144347730|NCT01052077|520476238|FG000|Phase A|Adverse Event|32|||
144347731|NCT01052077|520476239|FG001|Phase A|Adverse Event|0|||
144347732|NCT01052077|520476240|FG002|Phase A|Adverse Event|0|||
144347733|NCT01052077|520476241|FG003|Phase A|Adverse Event|0|||
144347734|NCT01052077|520476238|FG000|Phase A|Met Withdrawal Criteria|26|||
144347735|NCT01052077|520476239|FG001|Phase A|Met Withdrawal Criteria|0|||
144347736|NCT01052077|520476240|FG002|Phase A|Met Withdrawal Criteria|0|||
144347737|NCT01052077|520476241|FG003|Phase A|Met Withdrawal Criteria|0|||
144347738|NCT01052077|520476238|FG000|Phase A|Physician Decision|10|||
144347739|NCT01052077|520476239|FG001|Phase A|Physician Decision|0|||
144347740|NCT01052077|520476240|FG002|Phase A|Physician Decision|0|||
144347741|NCT01052077|520476241|FG003|Phase A|Physician Decision|0|||
144347742|NCT01052077|520476238|FG000|Phase A|Withdrawal by Subject|29|||
144347743|NCT01052077|520476239|FG001|Phase A|Withdrawal by Subject|0|||
144347744|NCT01052077|520476240|FG002|Phase A|Withdrawal by Subject|0|||
144347745|NCT01052077|520476241|FG003|Phase A|Withdrawal by Subject|0|||
144347746|NCT01052077|520476238|FG000|Phase A|Protocol Deviation|27|||
144347747|NCT01052077|520476239|FG001|Phase A|Protocol Deviation|0|||
144347748|NCT01052077|520476240|FG002|Phase A|Protocol Deviation|0|||
144347749|NCT01052077|520476241|FG003|Phase A|Protocol Deviation|0|||
144347750|NCT01052077|520476238|FG000|Phase B|Lost to Follow-up|0|||
144347751|NCT01052077|520476239|FG001|Phase B|Lost to Follow-up|2|||
144347752|NCT01052077|520476240|FG002|Phase B|Lost to Follow-up|3|||
144347753|NCT01052077|520476241|FG003|Phase B|Lost to Follow-up|0|||
144347754|NCT01052077|520476238|FG000|Phase B|Adverse Event|0|||
144347755|NCT01052077|520476239|FG001|Phase B|Adverse Event|9|||
144347756|NCT01052077|520476240|FG002|Phase B|Adverse Event|2|||
144347757|NCT01052077|520476241|FG003|Phase B|Adverse Event|0|||
144347758|NCT01052077|520476238|FG000|Phase B|Met Withdrawal Criteria|0|||
144347759|NCT01052077|520476239|FG001|Phase B|Met Withdrawal Criteria|2|||
144347760|NCT01052077|520476240|FG002|Phase B|Met Withdrawal Criteria|1|||
144347761|NCT01052077|520476241|FG003|Phase B|Met Withdrawal Criteria|0|||
144347762|NCT01052077|520476238|FG000|Phase B|Physician Decision|0|||
144347763|NCT01052077|520476239|FG001|Phase B|Physician Decision|1|||
144347764|NCT01052077|520476240|FG002|Phase B|Physician Decision|1|||
144347765|NCT01052077|520476241|FG003|Phase B|Physician Decision|0|||
144347766|NCT01052077|520476238|FG000|Phase B|Withdrawal by Subject|0|||
144347767|NCT01052077|520476239|FG001|Phase B|Withdrawal by Subject|0|||
144347768|NCT01052077|520476240|FG002|Phase B|Withdrawal by Subject|5|||
144347769|NCT01052077|520476241|FG003|Phase B|Withdrawal by Subject|0|||
144347770|NCT01052077|520476238|FG000|Phase B|Protocol Deviation|0|||
144347771|NCT01052077|520476239|FG001|Phase B|Protocol Deviation|3|||
144347772|NCT01052077|520476240|FG002|Phase B|Protocol Deviation|4|||
144347773|NCT01052077|520476241|FG003|Phase B|Protocol Deviation|0|||
144347774|NCT01052077|520476238|FG000|Phase B|Lack of Efficacy|0|||
144347775|NCT01052077|520476239|FG001|Phase B|Lack of Efficacy|1|||
144347776|NCT01052077|520476240|FG002|Phase B|Lack of Efficacy|0|||
144347777|NCT01052077|520476241|FG003|Phase B|Lack of Efficacy|0|||
144347778|NCT01052077|520476238|FG000|Phase A+|Lost to Follow-up|0|||
144347779|NCT01052077|520476239|FG001|Phase A+|Lost to Follow-up|0|||
144347780|NCT01052077|520476240|FG002|Phase A+|Lost to Follow-up|0|||
144347781|NCT01052077|520476241|FG003|Phase A+|Lost to Follow-up|8|||
144347782|NCT01052077|520476238|FG000|Phase A+|Adverse Event|0|||
144347783|NCT01052077|520476239|FG001|Phase A+|Adverse Event|0|||
144347784|NCT01052077|520476240|FG002|Phase A+|Adverse Event|0|||
144347785|NCT01052077|520476241|FG003|Phase A+|Adverse Event|4|||
144347786|NCT01052077|520476238|FG000|Phase A+|Met Withdrawal Criteria|0|||
144347787|NCT01052077|520476239|FG001|Phase A+|Met Withdrawal Criteria|0|||
144347788|NCT01052077|520476240|FG002|Phase A+|Met Withdrawal Criteria|0|||
144347789|NCT01052077|520476241|FG003|Phase A+|Met Withdrawal Criteria|2|||
144347790|NCT01052077|520476238|FG000|Phase A+|Withdrawal by Subject|0|||
144347791|NCT01052077|520476239|FG001|Phase A+|Withdrawal by Subject|0|||
144347792|NCT01052077|520476240|FG002|Phase A+|Withdrawal by Subject|0|||
144347793|NCT01052077|520476241|FG003|Phase A+|Withdrawal by Subject|7|||
144347794|NCT01811186|520476243|FG000|Overall Study|Adverse Event|54|||
144347795|NCT01811186|520476244|FG001|Overall Study|Adverse Event|38|||
144347796|NCT01811186|520476243|FG000|Overall Study|Protocol Violation|5|||
144347797|NCT01811186|520476244|FG001|Overall Study|Protocol Violation|6|||
144347798|NCT01811186|520476243|FG000|Overall Study|Withdrawal by Subject|5|||
144347799|NCT01811186|520476244|FG001|Overall Study|Withdrawal by Subject|10|||
144347800|NCT01811186|520476243|FG000|Overall Study|Lack of Efficacy|3|||
144347801|NCT01811186|520476244|FG001|Overall Study|Lack of Efficacy|6|||
144347802|NCT01811186|520476243|FG000|Overall Study|Lost to Follow-up|4|||
144347803|NCT01811186|520476244|FG001|Overall Study|Lost to Follow-up|2|||
144347804|NCT00042991|520476249|FG000|Overall Study|Adverse Event|1|||
144347805|NCT00042991|520476250|FG001|Overall Study|Adverse Event|4|||
144347806|NCT00042991|520476251|FG002|Overall Study|Adverse Event|2|||
144347807|NCT00042991|520476252|FG003|Overall Study|Adverse Event|0|||
144347808|NCT00042991|520476253|FG004|Overall Study|Adverse Event|0|||
144347809|NCT00042991|520476254|FG005|Overall Study|Adverse Event|1|||
144347810|NCT00042991|520476255|FG006|Overall Study|Adverse Event|0|||
144347811|NCT00042991|520476249|FG000|Overall Study|Withdrawal by Subject|0|||
144347812|NCT00042991|520476250|FG001|Overall Study|Withdrawal by Subject|7|||
144347813|NCT00042991|520476251|FG002|Overall Study|Withdrawal by Subject|2|||
144347814|NCT00042991|520476252|FG003|Overall Study|Withdrawal by Subject|0|||
144347815|NCT00042991|520476253|FG004|Overall Study|Withdrawal by Subject|1|||
144347816|NCT00042991|520476254|FG005|Overall Study|Withdrawal by Subject|0|||
144347817|NCT00042991|520476255|FG006|Overall Study|Withdrawal by Subject|0|||
144347818|NCT00042991|520476249|FG000|Overall Study|Disease Progression|5|||
144347819|NCT00042991|520476250|FG001|Overall Study|Disease Progression|29|||
144347820|NCT00042991|520476251|FG002|Overall Study|Disease Progression|2|||
144347821|NCT00042991|520476252|FG003|Overall Study|Disease Progression|2|||
144347822|NCT00042991|520476253|FG004|Overall Study|Disease Progression|1|||
144347823|NCT00042991|520476254|FG005|Overall Study|Disease Progression|4|||
144347824|NCT00042991|520476255|FG006|Overall Study|Disease Progression|2|||
144347825|NCT00042991|520476249|FG000|Overall Study|Alternative Therapy|0|||
144347826|NCT00042991|520476250|FG001|Overall Study|Alternative Therapy|0|||
144347827|NCT00042991|520476251|FG002|Overall Study|Alternative Therapy|0|||
144347828|NCT00042991|520476252|FG003|Overall Study|Alternative Therapy|0|||
144347829|NCT00042991|520476253|FG004|Overall Study|Alternative Therapy|1|||
144347830|NCT00042991|520476254|FG005|Overall Study|Alternative Therapy|0|||
144347831|NCT00042991|520476255|FG006|Overall Study|Alternative Therapy|0|||
144347832|NCT04072887|520476256|FG000|Overall Study|Withdrawal by Subject|3|||
144347833|NCT04072887|520476257|FG001|Overall Study|Withdrawal by Subject|8|||
144347834|NCT04072887|520476258|FG002|Overall Study|Withdrawal by Subject|1|||
144347835|NCT04072887|520476259|FG003|Overall Study|Withdrawal by Subject|3|||
144347836|NCT04072887|520476260|FG004|Overall Study|Withdrawal by Subject|3|||
144347837|NCT04072887|520476261|FG005|Overall Study|Withdrawal by Subject|13|||
144347838|NCT04072887|520476256|FG000|Overall Study|Adverse Event|2|||
144347839|NCT04072887|520476257|FG001|Overall Study|Adverse Event|4|||
144347840|NCT04072887|520476258|FG002|Overall Study|Adverse Event|1|||
144347841|NCT04072887|520476259|FG003|Overall Study|Adverse Event|4|||
144347842|NCT04072887|520476260|FG004|Overall Study|Adverse Event|0|||
144347843|NCT04072887|520476261|FG005|Overall Study|Adverse Event|1|||
144347844|NCT04072887|520476256|FG000|Overall Study|Physician Decision|2|||
144347845|NCT04072887|520476257|FG001|Overall Study|Physician Decision|0|||
144347846|NCT04072887|520476258|FG002|Overall Study|Physician Decision|0|||
144347847|NCT04072887|520476259|FG003|Overall Study|Physician Decision|0|||
144347848|NCT04072887|520476260|FG004|Overall Study|Physician Decision|0|||
144347849|NCT04072887|520476261|FG005|Overall Study|Physician Decision|1|||
144347850|NCT04072887|520476256|FG000|Overall Study|Lost to Follow-up|1|||
144347851|NCT04072887|520476257|FG001|Overall Study|Lost to Follow-up|3|||
144347852|NCT04072887|520476258|FG002|Overall Study|Lost to Follow-up|0|||
144347853|NCT04072887|520476259|FG003|Overall Study|Lost to Follow-up|0|||
144347854|NCT04072887|520476260|FG004|Overall Study|Lost to Follow-up|0|||
144347855|NCT04072887|520476261|FG005|Overall Study|Lost to Follow-up|0|||
144347856|NCT04072887|520476256|FG000|Overall Study|Death|0|||
144347857|NCT04072887|520476257|FG001|Overall Study|Death|2|||
144347858|NCT04072887|520476258|FG002|Overall Study|Death|0|||
144347859|NCT04072887|520476259|FG003|Overall Study|Death|2|||
144347860|NCT04072887|520476260|FG004|Overall Study|Death|3|||
144347861|NCT04072887|520476261|FG005|Overall Study|Death|0|||
144347862|NCT03193736|520476262|FG000|Overall Study|Death|2|||
144347863|NCT03193736|520476262|FG000|Overall Study|Withdrawal by Subject|1|||
144347864|NCT03193736|520476262|FG000|Overall Study|Lost to Follow-up|1|||
144347865|NCT03193736|520476262|FG000|Overall Study|implant not received|1|||
144347866|NCT00856297|520476263|FG000|Overall Study|Unable to classify|2|||
144347867|NCT00856297|520476264|FG001|Overall Study|Unable to classify|0|||
144347868|NCT00856297|520476265|FG002|Overall Study|Unable to classify|0|||
144347869|NCT00856297|520476266|FG003|Overall Study|Unable to classify|0|||
144347870|NCT00856297|520476267|FG004|Overall Study|Unable to classify|0|||
144347871|NCT03369236|520476268|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
144347872|NCT03369236|520476269|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
144347873|NCT03369236|520476268|FG000|Open-label Extension Period|Lack of Efficacy|2|||
144347874|NCT03369236|520476269|FG001|Open-label Extension Period|Lack of Efficacy|1|||
144347875|NCT03369236|520476268|FG000|Open-label Extension Period|Adverse Event|0|||
144347876|NCT03369236|520476269|FG001|Open-label Extension Period|Adverse Event|1|||
144347877|NCT03369236|520476268|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
144347878|NCT03369236|520476269|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
144347879|NCT00423449|520476270|FG000|Overall Study|Clinical Adverse Event|1|||
144347880|NCT00423449|520476271|FG001|Overall Study|Clinical Adverse Event|0|||
144347881|NCT00423449|520476272|FG002|Overall Study|Clinical Adverse Event|1|||
144347882|NCT00423449|520476273|FG003|Overall Study|Clinical Adverse Event|8|||
144347883|NCT00423449|520476274|FG004|Overall Study|Clinical Adverse Event|2|||
144347884|NCT00423449|520476270|FG000|Overall Study|Death|1|||
144347885|NCT00423449|520476271|FG001|Overall Study|Death|0|||
144347886|NCT00423449|520476272|FG002|Overall Study|Death|2|||
144347887|NCT00423449|520476273|FG003|Overall Study|Death|1|||
144347888|NCT00423449|520476274|FG004|Overall Study|Death|1|||
144347889|NCT00423449|520476270|FG000|Overall Study|Progressive Disease|1|||
144347890|NCT00423449|520476271|FG001|Overall Study|Progressive Disease|3|||
144347891|NCT00423449|520476272|FG002|Overall Study|Progressive Disease|8|||
144347892|NCT00423449|520476273|FG003|Overall Study|Progressive Disease|11|||
144347893|NCT00423449|520476274|FG004|Overall Study|Progressive Disease|4|||
144347894|NCT00423449|520476270|FG000|Overall Study|Laboratory Adverse Event|0|||
144347895|NCT00423449|520476271|FG001|Overall Study|Laboratory Adverse Event|1|||
144347896|NCT00423449|520476272|FG002|Overall Study|Laboratory Adverse Event|2|||
144347897|NCT00423449|520476273|FG003|Overall Study|Laboratory Adverse Event|0|||
144347898|NCT00423449|520476274|FG004|Overall Study|Laboratory Adverse Event|0|||
144347899|NCT00423449|520476270|FG000|Overall Study|Other|0|||
144347900|NCT00423449|520476271|FG001|Overall Study|Other|0|||
144347901|NCT00423449|520476272|FG002|Overall Study|Other|0|||
144347902|NCT00423449|520476273|FG003|Overall Study|Other|1|||
144347903|NCT00423449|520476274|FG004|Overall Study|Other|0|||
144347904|NCT00423449|520476270|FG000|Overall Study|Protocol Violation|0|||
144347905|NCT00423449|520476271|FG001|Overall Study|Protocol Violation|0|||
144347906|NCT00423449|520476272|FG002|Overall Study|Protocol Violation|2|||
144347907|NCT00423449|520476273|FG003|Overall Study|Protocol Violation|1|||
144347908|NCT00423449|520476274|FG004|Overall Study|Protocol Violation|0|||
144347909|NCT01153724|520476275|FG000|Treatment Period 1|Withdrawal by Subject|1|||
144347910|NCT01153724|520476275|FG000|Treatment Period 2|Adverse Event|1|||
144347911|NCT01153724|520476275|FG000|Treatment Period 2|Other reason not defined above|1|||
144347912|NCT02697435|520476276|FG000|Overall Study|Withdrawal by Subject|1|||
144347913|NCT02697435|520476277|FG001|Overall Study|Withdrawal by Subject|0|||
144347914|NCT02697435|520476276|FG000|Overall Study|Physician Decision|0|||
144347915|NCT02697435|520476277|FG001|Overall Study|Physician Decision|4|||
144347916|NCT00367835|520476278|FG000|Overall Study|Adverse Event|14|||
144347917|NCT00367835|520476279|FG001|Overall Study|Adverse Event|1|||
144347918|NCT00367835|520476278|FG000|Overall Study|Protocol Violation|1|||
144347919|NCT00367835|520476279|FG001|Overall Study|Protocol Violation|7|||
144347920|NCT00367835|520476278|FG000|Overall Study|Withdrawal by Subject|7|||
144347921|NCT00367835|520476279|FG001|Overall Study|Withdrawal by Subject|6|||
144347922|NCT00367835|520476278|FG000|Overall Study|Lost to Follow-up|1|||
144347923|NCT00367835|520476279|FG001|Overall Study|Lost to Follow-up|4|||
144347924|NCT00367835|520476278|FG000|Overall Study|Lack of Efficacy|3|||
144347925|NCT00367835|520476279|FG001|Overall Study|Lack of Efficacy|12|||
144347926|NCT00367835|520476278|FG000|Overall Study|Subject in juvenile detention center|1|||
144347927|NCT00367835|520476279|FG001|Overall Study|Subject in juvenile detention center|0|||
144347928|NCT00367835|520476278|FG000|Overall Study|refused blood collection|1|||
144347929|NCT00367835|520476279|FG001|Overall Study|refused blood collection|0|||
144347930|NCT00367835|520476278|FG000|Overall Study|Did not respond to calls|1|||
144347931|NCT00367835|520476279|FG001|Overall Study|Did not respond to calls|0|||
144347932|NCT00367835|520476278|FG000|Overall Study|History of lead poisoning|0|||
144347933|NCT00367835|520476279|FG001|Overall Study|History of lead poisoning|1|||
144347934|NCT01445080|520476283|FG000|Overall Study|Adverse Event|5|||
144347935|NCT01445080|520476284|FG001|Overall Study|Adverse Event|3|||
144347936|NCT01445080|520476285|FG002|Overall Study|Adverse Event|11|||
144347937|NCT01445080|520476286|FG003|Overall Study|Adverse Event|6|||
144347938|NCT01445080|520476287|FG004|Overall Study|Adverse Event|2|||
144347939|NCT01445080|520476288|FG005|Overall Study|Adverse Event|3|||
144347940|NCT01445080|520476289|FG006|Overall Study|Adverse Event|0|||
144347941|NCT01445080|520476290|FG007|Overall Study|Adverse Event|3|||
144347942|NCT01445080|520476291|FG008|Overall Study|Adverse Event|10|||
144347943|NCT01445080|520476283|FG000|Overall Study|Physician Decision|0|||
144347944|NCT01445080|520476284|FG001|Overall Study|Physician Decision|0|||
144347945|NCT01445080|520476285|FG002|Overall Study|Physician Decision|1|||
144347946|NCT01445080|520476286|FG003|Overall Study|Physician Decision|0|||
144347947|NCT01445080|520476287|FG004|Overall Study|Physician Decision|0|||
144347948|NCT01445080|520476288|FG005|Overall Study|Physician Decision|3|||
144347949|NCT01445080|520476289|FG006|Overall Study|Physician Decision|2|||
144347950|NCT01445080|520476290|FG007|Overall Study|Physician Decision|2|||
144347951|NCT01445080|520476291|FG008|Overall Study|Physician Decision|0|||
144347952|NCT01445080|520476283|FG000|Overall Study|Withdrawal by Subject|1|||
144347953|NCT01445080|520476284|FG001|Overall Study|Withdrawal by Subject|0|||
144347954|NCT01445080|520476285|FG002|Overall Study|Withdrawal by Subject|0|||
144347955|NCT01445080|520476286|FG003|Overall Study|Withdrawal by Subject|1|||
144347956|NCT01445080|520476287|FG004|Overall Study|Withdrawal by Subject|0|||
144347957|NCT01445080|520476288|FG005|Overall Study|Withdrawal by Subject|0|||
144347958|NCT01445080|520476289|FG006|Overall Study|Withdrawal by Subject|0|||
144347959|NCT01445080|520476290|FG007|Overall Study|Withdrawal by Subject|0|||
144347960|NCT01445080|520476291|FG008|Overall Study|Withdrawal by Subject|2|||
144347961|NCT01445080|520476283|FG000|Overall Study|Ineligible/Inevaluable|1|||
144347962|NCT01445080|520476284|FG001|Overall Study|Ineligible/Inevaluable|2|||
144347963|NCT01445080|520476285|FG002|Overall Study|Ineligible/Inevaluable|0|||
144347964|NCT01445080|520476286|FG003|Overall Study|Ineligible/Inevaluable|1|||
144347965|NCT01445080|520476287|FG004|Overall Study|Ineligible/Inevaluable|2|||
144347966|NCT01445080|520476288|FG005|Overall Study|Ineligible/Inevaluable|3|||
144347967|NCT01445080|520476289|FG006|Overall Study|Ineligible/Inevaluable|0|||
144347968|NCT01445080|520476290|FG007|Overall Study|Ineligible/Inevaluable|0|||
144347969|NCT01445080|520476291|FG008|Overall Study|Ineligible/Inevaluable|6|||
144347970|NCT01574651|520476292|FG000|Overall Study|Lost to Follow-up|2|||
144347971|NCT01574651|520476293|FG001|Overall Study|Lost to Follow-up|4|||
144347972|NCT01574651|520476292|FG000|Overall Study|Administrative problems|0|||
144347973|NCT01574651|520476293|FG001|Overall Study|Administrative problems|1|||
144347974|NCT01574651|520476292|FG000|Overall Study|Death|3|||
144347975|NCT01574651|520476293|FG001|Overall Study|Death|3|||
144347976|NCT01574651|520476292|FG000|Overall Study|Patient's inability to use the device|0|||
144347977|NCT01574651|520476293|FG001|Overall Study|Patient's inability to use the device|1|||
144347978|NCT01574651|520476292|FG000|Overall Study|Adverse Event|36|||
144347979|NCT01574651|520476293|FG001|Overall Study|Adverse Event|27|||
144347980|NCT01574651|520476292|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144347981|NCT01574651|520476293|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144347982|NCT01574651|520476292|FG000|Overall Study|Abnormal test procedure result(s)|1|||
144347983|NCT01574651|520476293|FG001|Overall Study|Abnormal test procedure result(s)|1|||
144347984|NCT01574651|520476292|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
144347985|NCT01574651|520476293|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
144347986|NCT01574651|520476292|FG000|Overall Study|Protocol Violation|3|||
144347987|NCT01574651|520476293|FG001|Overall Study|Protocol Violation|5|||
144347988|NCT01574651|520476292|FG000|Overall Study|Withdrawal by Subject|9|||
144347989|NCT01574651|520476293|FG001|Overall Study|Withdrawal by Subject|10|||
144347990|NCT00445770|520476294|FG000|Overall Study|Adverse Event|9|||
144347991|NCT00445770|520476295|FG001|Overall Study|Adverse Event|15|||
144347992|NCT00445770|520476296|FG002|Overall Study|Adverse Event|19|||
144347993|NCT00445770|520476294|FG000|Overall Study|Lack of Efficacy|38|||
144347994|NCT00445770|520476295|FG001|Overall Study|Lack of Efficacy|13|||
144347995|NCT00445770|520476296|FG002|Overall Study|Lack of Efficacy|6|||
144347996|NCT00445770|520476294|FG000|Overall Study|Lost to Follow-up|0|||
144347997|NCT00445770|520476295|FG001|Overall Study|Lost to Follow-up|2|||
144347998|NCT00445770|520476296|FG002|Overall Study|Lost to Follow-up|0|||
144347999|NCT00445770|520476294|FG000|Overall Study|Other|6|||
144348000|NCT00445770|520476295|FG001|Overall Study|Other|5|||
144348001|NCT00445770|520476296|FG002|Overall Study|Other|6|||
144348002|NCT03857542|520476297|FG000|Overall Study|Adverse Event|1|||
144348003|NCT03857542|520476298|FG001|Overall Study|Adverse Event|3|||
144348004|NCT03857542|520476297|FG000|Overall Study|Withdrawal by Subject|2|||
144348005|NCT03857542|520476298|FG001|Overall Study|Withdrawal by Subject|1|||
144348006|NCT03857542|520476297|FG000|Overall Study|Lost to Follow-up|2|||
144348007|NCT03857542|520476298|FG001|Overall Study|Lost to Follow-up|1|||
144348008|NCT03857542|520476297|FG000|Overall Study|Reason not Specified|1|||
144348009|NCT03857542|520476298|FG001|Overall Study|Reason not Specified|0|||
144348010|NCT00811174|520476305|FG000|Overall Study|Protocol Violation|2|||
144348011|NCT00811174|520476305|FG000|Overall Study|Sponsors Decision|1|||
144348012|NCT00999544|520477894|FG000|Overall Study|Withdrawal by Subject|1|||
144348013|NCT01392547|520477895|FG000|Overall Study|Adverse Event|2|||
144348014|NCT01392547|520477895|FG000|Overall Study|Non-compliance|2|||
144348015|NCT01392547|520477895|FG000|Overall Study|Withdrawal criteria|3|||
144348016|NCT01392547|520477895|FG000|Overall Study|Unclassified|1|||
144348017|NCT02936635|520477897|FG000|Overall Study|Adverse Event|43|||
144348018|NCT02936635|520477898|FG001|Overall Study|Adverse Event|25|||
144348019|NCT02936635|520477897|FG000|Overall Study|Progressive Disease|10|||
144348020|NCT02936635|520477898|FG001|Overall Study|Progressive Disease|18|||
144348021|NCT02936635|520477897|FG000|Overall Study|Sponsor Discretion|10|||
144348022|NCT02936635|520477898|FG001|Overall Study|Sponsor Discretion|16|||
144348023|NCT02936635|520477897|FG000|Overall Study|Death|9|||
144348024|NCT02936635|520477898|FG001|Overall Study|Death|15|||
144348025|NCT02936635|520477897|FG000|Overall Study|Withdrawal by Subject|8|||
144348026|NCT02936635|520477898|FG001|Overall Study|Withdrawal by Subject|15|||
144348027|NCT02936635|520477897|FG000|Overall Study|Physician Decision|2|||
144348028|NCT02936635|520477898|FG001|Overall Study|Physician Decision|9|||
144348029|NCT02936635|520477897|FG000|Overall Study|Lost to Follow-up|1|||
144348030|NCT02936635|520477898|FG001|Overall Study|Lost to Follow-up|2|||
144348031|NCT02936635|520477897|FG000|Overall Study|Protocol Violation|1|||
144348032|NCT02936635|520477898|FG001|Overall Study|Protocol Violation|0|||
144348033|NCT02936635|520477897|FG000|Overall Study|Lack of effect/Entry into other study|31|||
144348034|NCT02936635|520477898|FG001|Overall Study|Lack of effect/Entry into other study|65|||
144348035|NCT02407223|520477899|FG000|Overall Study|Adverse Event|1|||
144348036|NCT02407223|520477900|FG001|Overall Study|Adverse Event|0|||
144348037|NCT02407223|520477901|FG002|Overall Study|Adverse Event|1|||
144348038|NCT02407223|520477899|FG000|Overall Study|Lack of Efficacy|6|||
144348039|NCT02407223|520477900|FG001|Overall Study|Lack of Efficacy|6|||
144348040|NCT02407223|520477901|FG002|Overall Study|Lack of Efficacy|4|||
144348041|NCT02407223|520477899|FG000|Overall Study|Lost to Follow-up|1|||
144348042|NCT02407223|520477900|FG001|Overall Study|Lost to Follow-up|0|||
144348043|NCT02407223|520477901|FG002|Overall Study|Lost to Follow-up|2|||
144348044|NCT02407223|520477899|FG000|Overall Study|Withdrawal by Subject|2|||
144348045|NCT02407223|520477900|FG001|Overall Study|Withdrawal by Subject|4|||
144348046|NCT02407223|520477901|FG002|Overall Study|Withdrawal by Subject|4|||
144348047|NCT02407223|520477899|FG000|Overall Study|Study Terminated by Sponsor|77|||
144348048|NCT02407223|520477900|FG001|Overall Study|Study Terminated by Sponsor|80|||
144348049|NCT02407223|520477901|FG002|Overall Study|Study Terminated by Sponsor|86|||
144348050|NCT02407223|520477899|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
144348051|NCT02407223|520477900|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
144348052|NCT02407223|520477901|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
144348053|NCT02407223|520477899|FG000|Overall Study|Other|29|||
144348054|NCT02407223|520477900|FG001|Overall Study|Other|27|||
144348055|NCT02407223|520477901|FG002|Overall Study|Other|25|||
144348056|NCT00447226|520477902|FG000|12-Week Open-label Phase|Adverse Event|0|||
144348057|NCT00447226|520477903|FG001|12-Week Open-label Phase|Adverse Event|3|||
144348058|NCT00447226|520477902|FG000|12-Week Open-label Phase|Protocol Violation|0|||
144348059|NCT00447226|520477903|FG001|12-Week Open-label Phase|Protocol Violation|1|||
144348060|NCT00447226|520477902|FG000|12-Week Open-label Phase|Disease Progression|0|||
144348061|NCT00447226|520477903|FG001|12-Week Open-label Phase|Disease Progression|20|||
144348062|NCT00447226|520477902|FG000|12-Week Open-label Phase|Physician Decision|0|||
144348063|NCT00447226|520477903|FG001|12-Week Open-label Phase|Physician Decision|1|||
144348064|NCT00447226|520477902|FG000|Double-blind Phase|Disease Progression|4|||
144348065|NCT00447226|520477903|FG001|Double-blind Phase|Disease Progression|3|||
144348066|NCT00584012|520477911|FG000|Overall Study|Withdrawal by Subject|1|||
144348067|NCT04404556|520477912|FG000|Intervention|Withdrawal by Subject|15|||
144348068|NCT04404556|520477913|FG001|Intervention|Withdrawal by Subject|3|||
144348069|NCT04404556|520477912|FG000|Intervention|Did not complete all intervention sessions|2|||
144348070|NCT04404556|520477913|FG001|Intervention|Did not complete all intervention sessions|1|||
144348071|NCT04404556|520477912|FG000|Post-Intervention|Missing Data|1|||
144348072|NCT04404556|520477913|FG001|Post-Intervention|Missing Data|2|||
144348073|NCT04404556|520477912|FG000|Follow-up 1|Withdrawal by Subject|5|||
144348074|NCT04404556|520477913|FG001|Follow-up 1|Withdrawal by Subject|1|||
144348075|NCT04404556|520477912|FG000|Follow-up 1|Missing Data|4|||
144348076|NCT04404556|520477913|FG001|Follow-up 1|Missing Data|7|||
144348077|NCT04404556|520477912|FG000|Follow-up 2|Withdrawal by Subject|1|||
144348078|NCT04404556|520477913|FG001|Follow-up 2|Withdrawal by Subject|1|||
144348079|NCT04404556|520477912|FG000|Follow-up 2|Missing Data|6|||
144348080|NCT04404556|520477913|FG001|Follow-up 2|Missing Data|5|||
144348081|NCT00763386|520477915|FG000|Overall Study|Adverse Event|43|||
144348082|NCT00763386|520477916|FG001|Overall Study|Adverse Event|33|||
144348083|NCT00763386|520477915|FG000|Overall Study|Death|1|||
144348084|NCT00763386|520477916|FG001|Overall Study|Death|2|||
144348085|NCT00763386|520477915|FG000|Overall Study|Lost to Follow-up|3|||
144348086|NCT00763386|520477916|FG001|Overall Study|Lost to Follow-up|3|||
144348087|NCT00763386|520477915|FG000|Overall Study|Withdrawal by Subject|0|||
144348088|NCT00763386|520477916|FG001|Overall Study|Withdrawal by Subject|1|||
144348089|NCT00763386|520477915|FG000|Overall Study|CRF missing|0|||
144348090|NCT00763386|520477916|FG001|Overall Study|CRF missing|1|||
144348091|NCT00763386|520477915|FG000|Overall Study|Study Prosthesis Removed|1|||
144348092|NCT00763386|520477916|FG001|Overall Study|Study Prosthesis Removed|0|||
144348093|NCT00502671|520477917|FG000|Overall Study|Disease Progression|13|||
144348094|NCT00502671|520477917|FG000|Overall Study|Personal Reasons|22|||
144348095|NCT00502671|520477917|FG000|Overall Study|Lost to Follow-up|7|||
144348096|NCT00502671|520477917|FG000|Overall Study|Protocol Violation|16|||
144348097|NCT00502671|520477917|FG000|Overall Study|Adverse Event|19|||
144348098|NCT01402817|520477918|FG000|Overall Study|Withdrawal by Subject|3|||
144348099|NCT01402817|520477918|FG000|Overall Study|Study Suspended by FDA|8|||
144348100|NCT00681629|520477919|FG000|Overall Study|Study termination|4|||
144348101|NCT00681629|520477920|FG001|Overall Study|Study termination|2|||
144348102|NCT00681629|520477919|FG000|Overall Study|Adverse Event|1|||
144348103|NCT00681629|520477920|FG001|Overall Study|Adverse Event|0|||
144348104|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
144348105|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144348106|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144348107|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144348108|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
144348109|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
144348110|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144348111|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144348112|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144348113|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
144348114|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
144348115|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144348116|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144348117|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144348118|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
144348119|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
144348120|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144348121|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144348122|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144348123|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
144348124|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
144348125|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144348126|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144348127|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144348128|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
144348129|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
144348130|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144348131|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144348132|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144348133|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
144348134|NCT01173601|520477922|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
144348135|NCT01173601|520477923|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144348136|NCT01173601|520477924|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144348137|NCT01173601|520477925|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144348138|NCT01173601|520477926|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
144348139|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
144348140|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
144348141|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
144348142|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
144348143|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
144348144|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
144348145|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
144348146|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
144348147|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
144348148|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
144348149|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
144348150|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
144348151|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
144348152|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
144348153|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
144348154|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144348155|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
144348156|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
144348157|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
144348158|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
144348159|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
144348160|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
144348161|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
144348162|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
144348163|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
144348164|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
144348165|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
144348166|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
144348167|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
144348168|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
144348169|NCT01173601|520477922|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
144348170|NCT01173601|520477923|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
144348171|NCT01173601|520477924|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
144348172|NCT01173601|520477925|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
144348173|NCT01173601|520477926|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
144348174|NCT02274792|520477927|FG000|Overall Study|Withdrawal by Subject|13|||
144348175|NCT02274792|520477927|FG000|Overall Study|Lost to Follow-up|8|||
144348176|NCT02274792|520477927|FG000|Overall Study|Protocol Specified Criteria|2|||
144348177|NCT02274792|520477927|FG000|Overall Study|Sponsor Decision|2|||
144348178|NCT01510158|520477928|FG000|Overall Study|Adverse Event|7|||
144348179|NCT01510158|520477929|FG001|Overall Study|Adverse Event|8|||
144348180|NCT01510158|520477930|FG002|Overall Study|Adverse Event|5|||
144348181|NCT01510158|520477928|FG000|Overall Study|Gout flare|1|||
144348182|NCT01510158|520477929|FG001|Overall Study|Gout flare|0|||
144348183|NCT01510158|520477930|FG002|Overall Study|Gout flare|0|||
144348184|NCT01510158|520477928|FG000|Overall Study|Protocol Violation|17|||
144348185|NCT01510158|520477929|FG001|Overall Study|Protocol Violation|16|||
144348186|NCT01510158|520477930|FG002|Overall Study|Protocol Violation|24|||
144348187|NCT01510158|520477928|FG000|Overall Study|Sponsor terminated study.|2|||
144348188|NCT01510158|520477929|FG001|Overall Study|Sponsor terminated study.|0|||
144348189|NCT01510158|520477930|FG002|Overall Study|Sponsor terminated study.|2|||
144348190|NCT01510158|520477928|FG000|Overall Study|Lost to Follow-up|13|||
144348191|NCT01510158|520477929|FG001|Overall Study|Lost to Follow-up|16|||
144348192|NCT01510158|520477930|FG002|Overall Study|Lost to Follow-up|9|||
144348193|NCT01510158|520477928|FG000|Overall Study|Withdrawal by Subject|10|||
144348194|NCT01510158|520477929|FG001|Overall Study|Withdrawal by Subject|13|||
144348195|NCT01510158|520477930|FG002|Overall Study|Withdrawal by Subject|10|||
144348196|NCT01510158|520477928|FG000|Overall Study|Death|1|||
144348197|NCT01510158|520477929|FG001|Overall Study|Death|0|||
144348198|NCT01510158|520477930|FG002|Overall Study|Death|0|||
144348199|NCT05258149|520477937|FG000|Period 1|Protocol Deviation|1|||
144348200|NCT05258149|520477938|FG001|Period 1|Protocol Deviation|0|||
144348201|NCT05258149|520477937|FG000|Period 1|Adverse Event|0|||
144348202|NCT05258149|520477938|FG001|Period 1|Adverse Event|1|||
144348203|NCT05258149|520477937|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
144348204|NCT05258149|520477938|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
144348205|NCT05258149|520477937|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
144348206|NCT05258149|520477938|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
144348207|NCT05258149|520477937|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
144348208|NCT05258149|520477938|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
144348209|NCT05786508|520477939|FG000|Overall Study|Withdrawal by Subject|2|||
144348210|NCT05786508|520477940|FG001|Overall Study|Withdrawal by Subject|0|||
144348211|NCT01957202|520477941|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348212|NCT01957202|520477942|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
144348213|NCT01957202|520477943|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348214|NCT01957202|520477944|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348215|NCT01957202|520477945|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348216|NCT01957202|520477946|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348217|NCT01957202|520477947|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348218|NCT01957202|520477948|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348219|NCT01957202|520477949|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348220|NCT01957202|520477950|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348221|NCT01957202|520477951|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348222|NCT01957202|520477952|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348223|NCT01957202|520477953|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348224|NCT01957202|520477954|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348225|NCT01957202|520477955|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348226|NCT01957202|520477956|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348227|NCT01957202|520477957|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
144348228|NCT01957202|520477958|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
144348229|NCT01957202|520477941|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348230|NCT01957202|520477942|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348231|NCT01957202|520477943|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348232|NCT01957202|520477944|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348233|NCT01957202|520477945|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348234|NCT01957202|520477946|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348235|NCT01957202|520477947|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348236|NCT01957202|520477948|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348237|NCT01957202|520477949|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348238|NCT01957202|520477950|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348239|NCT01957202|520477951|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348240|NCT01957202|520477952|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348241|NCT01957202|520477953|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348242|NCT01957202|520477954|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348243|NCT01957202|520477955|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348244|NCT01957202|520477956|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348245|NCT01957202|520477957|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
144348246|NCT01957202|520477958|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
144348247|NCT01397461|520477961|FG000|Overall Study|Withdrawal by Subject|2|||
144348248|NCT01397461|520477962|FG001|Overall Study|Withdrawal by Subject|1|||
144348249|NCT01397461|520477963|FG002|Overall Study|Withdrawal by Subject|0|||
144348250|NCT01397461|520477961|FG000|Overall Study|Lost to Follow-up|0|||
144348251|NCT01397461|520477962|FG001|Overall Study|Lost to Follow-up|2|||
144348252|NCT01397461|520477963|FG002|Overall Study|Lost to Follow-up|1|||
144348253|NCT01397461|520477961|FG000|Overall Study|Lack of Efficacy|0|||
144348254|NCT01397461|520477962|FG001|Overall Study|Lack of Efficacy|3|||
144348255|NCT01397461|520477963|FG002|Overall Study|Lack of Efficacy|0|||
144348256|NCT01397461|520477961|FG000|Overall Study|Not treated|0|||
144348257|NCT01397461|520477962|FG001|Overall Study|Not treated|0|||
144348258|NCT01397461|520477963|FG002|Overall Study|Not treated|1|||
144348259|NCT04181762|520477964|FG000|Overall Study|Adverse Event|1|||
144348260|NCT04181762|520477965|FG001|Overall Study|Adverse Event|3|||
144348261|NCT04181762|520477964|FG000|Overall Study|Lost to Follow-up|1|||
144348262|NCT04181762|520477965|FG001|Overall Study|Lost to Follow-up|1|||
144348263|NCT04181762|520477964|FG000|Overall Study|Physician Decision|1|||
144348264|NCT04181762|520477965|FG001|Overall Study|Physician Decision|3|||
144348265|NCT04181762|520477964|FG000|Overall Study|Pregnancy|0|||
144348266|NCT04181762|520477965|FG001|Overall Study|Pregnancy|1|||
144348267|NCT04181762|520477964|FG000|Overall Study|Lack of Efficacy|2|||
144348268|NCT04181762|520477965|FG001|Overall Study|Lack of Efficacy|2|||
144348269|NCT04181762|520477964|FG000|Overall Study|Study terminated by sponsor|95|||
144348270|NCT04181762|520477965|FG001|Overall Study|Study terminated by sponsor|97|||
144348271|NCT04181762|520477964|FG000|Overall Study|Subject decision|11|||
144348272|NCT04181762|520477965|FG001|Overall Study|Subject decision|4|||
144348273|NCT04181762|520477964|FG000|Overall Study|Death|1|||
144348274|NCT04181762|520477965|FG001|Overall Study|Death|1|||
144348275|NCT04181762|520477964|FG000|Overall Study|Protocol deviation|1|||
144348276|NCT04181762|520477965|FG001|Overall Study|Protocol deviation|0|||
144348277|NCT04181762|520477964|FG000|Overall Study|Withdrawal of informed consent|1|||
144348278|NCT04181762|520477965|FG001|Overall Study|Withdrawal of informed consent|3|||
144348279|NCT06041919|520477966|FG000|Overall Study|Lost to Follow-up|1|||
144348280|NCT06041919|520477967|FG001|Overall Study|Lost to Follow-up|0|||
144348281|NCT06041919|520477968|FG002|Overall Study|Lost to Follow-up|0|||
144348282|NCT06041919|520477969|FG003|Overall Study|Lost to Follow-up|0|||
144348283|NCT06041919|520477970|FG004|Overall Study|Lost to Follow-up|0|||
144348284|NCT06041919|520477966|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
144348285|NCT06041919|520477967|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
144348286|NCT06041919|520477968|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
144348287|NCT06041919|520477969|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
144348288|NCT06041919|520477970|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
144348289|NCT04526145|520477971|FG000|Overall Study|Withdrawal by Subject|5|||
144348302|NCT01514201|520477977|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
144348303|NCT01514201|520477978|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
144348304|NCT01514201|520477979|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
144348305|NCT01514201|520477980|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
144348306|NCT01514201|520477977|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
144348307|NCT01514201|520477978|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
144348308|NCT01514201|520477979|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
144348309|NCT01514201|520477980|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
144348310|NCT01514201|520477977|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
144360193|NCT03037385|520527413|FG005|Overall Study|Progressive Disease|0|||
144348311|NCT01514201|520477978|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
144348312|NCT01514201|520477979|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
144348313|NCT01514201|520477980|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
144348314|NCT01514201|520477977|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
144348315|NCT01514201|520477978|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
144348316|NCT01514201|520477979|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
144348317|NCT01514201|520477980|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
144348318|NCT01514201|520477977|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
144348319|NCT01514201|520477978|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
144348320|NCT01514201|520477979|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
144348321|NCT01514201|520477980|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
144348322|NCT01514201|520477977|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
144348323|NCT01514201|520477978|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
144348324|NCT01514201|520477979|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
144348325|NCT01514201|520477980|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
144348326|NCT01514201|520477977|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
144348327|NCT01514201|520477978|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
144348328|NCT01514201|520477979|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
144348329|NCT01514201|520477980|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
144348330|NCT01514201|520477977|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
144348331|NCT01514201|520477978|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
144348332|NCT01514201|520477979|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
144348333|NCT01514201|520477980|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
144348334|NCT01514201|520477977|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
144348335|NCT01514201|520477978|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
144348336|NCT01514201|520477979|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
144348337|NCT01514201|520477980|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
144348338|NCT01514201|520477977|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
144348339|NCT01514201|520477978|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
144348340|NCT01514201|520477979|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
144348341|NCT01514201|520477980|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
144348342|NCT01514201|520477977|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
144348343|NCT01514201|520477978|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
144348344|NCT01514201|520477979|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
144348345|NCT01514201|520477980|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
144348346|NCT01514201|520477977|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
144348347|NCT01514201|520477978|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
144348348|NCT01514201|520477979|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
144348349|NCT01514201|520477980|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
144348350|NCT05888181|520477982|FG000|Overall Study|Lost to Follow-up|1|||
144348351|NCT05888181|520477983|FG001|Overall Study|Lost to Follow-up|1|||
144348352|NCT05888181|520477984|FG002|Overall Study|Lost to Follow-up|0|||
144348353|NCT02534909|520477995|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
144348354|NCT01625000|520477998|FG000|Overall Study|Physician Decision|15|||
144348355|NCT01625000|520477999|FG001|Overall Study|Physician Decision|7|||
144348356|NCT01625000|520478000|FG002|Overall Study|Physician Decision|7|||
144348357|NCT01625000|520478001|FG003|Overall Study|Physician Decision|2|||
144348358|NCT01625000|520478002|FG004|Overall Study|Physician Decision|15|||
144348359|NCT01625000|520477998|FG000|Overall Study|Protocol Violation|3|||
144348360|NCT01625000|520477999|FG001|Overall Study|Protocol Violation|10|||
144348361|NCT01625000|520478000|FG002|Overall Study|Protocol Violation|4|||
144348362|NCT01625000|520478001|FG003|Overall Study|Protocol Violation|1|||
144348363|NCT01625000|520478002|FG004|Overall Study|Protocol Violation|2|||
144348364|NCT01625000|520477998|FG000|Overall Study|Withdrawal by Subject|19|||
144348365|NCT01625000|520477999|FG001|Overall Study|Withdrawal by Subject|16|||
144348366|NCT01625000|520478000|FG002|Overall Study|Withdrawal by Subject|11|||
144348367|NCT01625000|520478001|FG003|Overall Study|Withdrawal by Subject|9|||
144348368|NCT01625000|520478002|FG004|Overall Study|Withdrawal by Subject|17|||
144348369|NCT01625000|520477998|FG000|Overall Study|Adverse Event (including Death)|15|||
144348370|NCT01625000|520477999|FG001|Overall Study|Adverse Event (including Death)|19|||
144348371|NCT01625000|520478000|FG002|Overall Study|Adverse Event (including Death)|11|||
144348372|NCT01625000|520478001|FG003|Overall Study|Adverse Event (including Death)|7|||
144348373|NCT01625000|520478002|FG004|Overall Study|Adverse Event (including Death)|21|||
144348374|NCT00566852|520478003|FG000|Overall Study|Protocol Violation|22|||
144348375|NCT00566852|520478004|FG001|Overall Study|Protocol Violation|24|||
144348376|NCT00566852|520478003|FG000|Overall Study|Death|95|||
144348377|NCT00566852|520478004|FG001|Overall Study|Death|78|||
144348378|NCT00566852|520478003|FG000|Overall Study|Withdrawal by Subject|30|||
144348379|NCT00566852|520478004|FG001|Overall Study|Withdrawal by Subject|25|||
144348380|NCT00566852|520478003|FG000|Overall Study|Patient refusal|37|||
144348381|NCT00566852|520478004|FG001|Overall Study|Patient refusal|37|||
144348382|NCT00566852|520478003|FG000|Overall Study|Not tested due to disability|6|||
144348383|NCT00566852|520478004|FG001|Overall Study|Not tested due to disability|12|||
144348384|NCT00566852|520478003|FG000|Overall Study|Missing reason not specified|1|||
144348385|NCT00566852|520478004|FG001|Overall Study|Missing reason not specified|2|||
144348386|NCT00566852|520478003|FG000|Overall Study|Missing reason not reported|16|||
144348387|NCT00566852|520478004|FG001|Overall Study|Missing reason not reported|20|||
144348388|NCT01147055|520478005|FG000|First Intervention Period|Lost to Follow-up|1|||
144348389|NCT01147055|520478006|FG001|First Intervention Period|Lost to Follow-up|0|||
144348390|NCT04137731|520478007|FG000|Overall Study|Surgery Cancellation|1|||
144348391|NCT04137731|520478008|FG001|Overall Study|Surgery Cancellation|2|||
144348392|NCT04137731|520478007|FG000|Overall Study|Withdrawal by Subject|2|||
144348393|NCT04137731|520478008|FG001|Overall Study|Withdrawal by Subject|0|||
144348394|NCT04137731|520478007|FG000|Overall Study|Protocol Violation|0|||
144348395|NCT04137731|520478008|FG001|Overall Study|Protocol Violation|1|||
144348396|NCT02715609|520478016|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
144348397|NCT02715609|520478017|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
144348398|NCT02715609|520478018|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
144348399|NCT02715609|520478016|FG000|Overall Study|Withdrawal by Subject|0|||
144348400|NCT02715609|520478017|FG001|Overall Study|Withdrawal by Subject|0|||
144348401|NCT02715609|520478018|FG002|Overall Study|Withdrawal by Subject|1|||
144348402|NCT00310817|520478019|FG000|Overall Study|AE or Death|3|||
144348403|NCT00310817|520478020|FG001|Overall Study|AE or Death|1|||
144348404|NCT00310817|520478021|FG002|Overall Study|AE or Death|0|||
144348405|NCT00310817|520478022|FG003|Overall Study|AE or Death|0|||
144348406|NCT00310817|520478019|FG000|Overall Study|Withdrawal by Subject|1|||
144348407|NCT00310817|520478020|FG001|Overall Study|Withdrawal by Subject|4|||
144348408|NCT00310817|520478021|FG002|Overall Study|Withdrawal by Subject|6|||
144348409|NCT00310817|520478022|FG003|Overall Study|Withdrawal by Subject|7|||
144348410|NCT00310817|520478019|FG000|Overall Study|Lost to Follow-up|2|||
144348411|NCT00310817|520478020|FG001|Overall Study|Lost to Follow-up|1|||
144348412|NCT00310817|520478021|FG002|Overall Study|Lost to Follow-up|0|||
144348413|NCT00310817|520478022|FG003|Overall Study|Lost to Follow-up|0|||
144348414|NCT00310817|520478019|FG000|Overall Study|Inappropriate Enrollment|1|||
144348415|NCT00310817|520478020|FG001|Overall Study|Inappropriate Enrollment|0|||
144348416|NCT00310817|520478021|FG002|Overall Study|Inappropriate Enrollment|1|||
144348417|NCT00310817|520478022|FG003|Overall Study|Inappropriate Enrollment|0|||
144348418|NCT00310817|520478019|FG000|Overall Study|Protocol Violation|1|||
144348419|NCT00310817|520478020|FG001|Overall Study|Protocol Violation|1|||
144348420|NCT00310817|520478021|FG002|Overall Study|Protocol Violation|1|||
144348421|NCT00310817|520478022|FG003|Overall Study|Protocol Violation|1|||
144348422|NCT00310817|520478019|FG000|Overall Study|Unable to classify|3|||
144348423|NCT00310817|520478020|FG001|Overall Study|Unable to classify|1|||
144348424|NCT00310817|520478021|FG002|Overall Study|Unable to classify|0|||
144348425|NCT00310817|520478022|FG003|Overall Study|Unable to classify|0|||
144348426|NCT04209205|520478025|FG000|Overall Study|Adverse Event|2|||
144348427|NCT04209205|520478026|FG001|Overall Study|Adverse Event|3|||
144348428|NCT04209205|520478025|FG000|Overall Study|Lost to Follow-up|3|||
144348429|NCT04209205|520478026|FG001|Overall Study|Lost to Follow-up|1|||
144348430|NCT04209205|520478025|FG000|Overall Study|Physician Decision|1|||
144348431|NCT04209205|520478026|FG001|Overall Study|Physician Decision|1|||
144348432|NCT04209205|520478025|FG000|Overall Study|Subject decision|10|||
144348433|NCT04209205|520478026|FG001|Overall Study|Subject decision|10|||
144348434|NCT04209205|520478025|FG000|Overall Study|Progressive disease|1|||
144348435|NCT04209205|520478026|FG001|Overall Study|Progressive disease|0|||
144348436|NCT04209205|520478025|FG000|Overall Study|Protocol deviation|0|||
144348437|NCT04209205|520478026|FG001|Overall Study|Protocol deviation|1|||
144348438|NCT04209205|520478025|FG000|Overall Study|New therapy for study indication|1|||
144348439|NCT04209205|520478026|FG001|Overall Study|New therapy for study indication|0|||
144348440|NCT04209205|520478025|FG000|Overall Study|Adverse event - placebo not switched|0|||
144348441|NCT04209205|520478026|FG001|Overall Study|Adverse event - placebo not switched|1|||
144348442|NCT04209205|520478025|FG000|Overall Study|Subject decision - placebo not switched|0|||
144348443|NCT04209205|520478026|FG001|Overall Study|Subject decision - placebo not switched|5|||
144348444|NCT04209205|520478025|FG000|Overall Study|Death - placebo not switched|0|||
144348445|NCT04209205|520478026|FG001|Overall Study|Death - placebo not switched|1|||
144348446|NCT03828019|520478031|FG000|Overall Study|Withdrawal by Subject|3|||
144348447|NCT03828019|520478032|FG001|Overall Study|Withdrawal by Subject|8|||
144348448|NCT03828019|520478031|FG000|Overall Study|Lost to Follow-up|1|||
144348449|NCT03828019|520478032|FG001|Overall Study|Lost to Follow-up|6|||
144348450|NCT03828019|520478031|FG000|Overall Study|Incarcerated|1|||
144348451|NCT03828019|520478032|FG001|Overall Study|Incarcerated|0|||
144348452|NCT03828019|520478031|FG000|Overall Study|Adverse Event|0|||
144348453|NCT03828019|520478032|FG001|Overall Study|Adverse Event|1|||
144348454|NCT00048347|520478033|FG000|Overall Study|Screen failure|2|||
144348455|NCT04522141|520478034|FG000|Overall Study|Withdrawal by Subject|1|||
144348456|NCT04522141|520478035|FG001|Overall Study|Withdrawal by Subject|0|||
144348457|NCT03052049|520478036|FG000|Overall Study|Withdrawal by Subject|2|||
144348458|NCT03508609|520478037|FG000|Overall Study|Withdrawal by Subject|1|||
144348459|NCT00999518|520478041|FG000|Overall Study|Adverse Event|1|||
144348460|NCT00999518|520478042|FG001|Overall Study|Adverse Event|6|||
144348461|NCT00999518|520478043|FG002|Overall Study|Adverse Event|3|||
144348462|NCT00999518|520478044|FG003|Overall Study|Adverse Event|1|||
144348463|NCT00999518|520478045|FG004|Overall Study|Adverse Event|2|||
144348464|NCT00999518|520478041|FG000|Overall Study|Lack of Efficacy|2|||
144348465|NCT00999518|520478042|FG001|Overall Study|Lack of Efficacy|0|||
144348466|NCT00999518|520478043|FG002|Overall Study|Lack of Efficacy|0|||
144348467|NCT00999518|520478044|FG003|Overall Study|Lack of Efficacy|2|||
144348468|NCT00999518|520478045|FG004|Overall Study|Lack of Efficacy|2|||
144348469|NCT00999518|520478041|FG000|Overall Study|Lost to Follow-up|0|||
144348470|NCT00999518|520478042|FG001|Overall Study|Lost to Follow-up|0|||
144348471|NCT00999518|520478043|FG002|Overall Study|Lost to Follow-up|0|||
144348472|NCT00999518|520478044|FG003|Overall Study|Lost to Follow-up|4|||
144348473|NCT00999518|520478045|FG004|Overall Study|Lost to Follow-up|1|||
144348474|NCT00999518|520478041|FG000|Overall Study|Did not meet entrance criteria|0|||
144348475|NCT00999518|520478042|FG001|Overall Study|Did not meet entrance criteria|0|||
144348476|NCT00999518|520478043|FG002|Overall Study|Did not meet entrance criteria|0|||
144348477|NCT00999518|520478044|FG003|Overall Study|Did not meet entrance criteria|0|||
144348478|NCT00999518|520478045|FG004|Overall Study|Did not meet entrance criteria|1|||
144348479|NCT00999518|520478041|FG000|Overall Study|Study terminated by sponsor|10|||
144348480|NCT00999518|520478042|FG001|Overall Study|Study terminated by sponsor|6|||
144348481|NCT00999518|520478043|FG002|Overall Study|Study terminated by sponsor|5|||
144348482|NCT00999518|520478044|FG003|Overall Study|Study terminated by sponsor|5|||
144348483|NCT00999518|520478045|FG004|Overall Study|Study terminated by sponsor|9|||
144348484|NCT00999518|520478041|FG000|Overall Study|Pregnancy|0|||
144348485|NCT00999518|520478042|FG001|Overall Study|Pregnancy|0|||
144348486|NCT00999518|520478043|FG002|Overall Study|Pregnancy|1|||
144348487|NCT00999518|520478044|FG003|Overall Study|Pregnancy|0|||
144348488|NCT00999518|520478045|FG004|Overall Study|Pregnancy|0|||
144348489|NCT00999518|520478041|FG000|Overall Study|Protocol Violation|0|||
144348490|NCT00999518|520478042|FG001|Overall Study|Protocol Violation|1|||
144348491|NCT00999518|520478043|FG002|Overall Study|Protocol Violation|0|||
144348492|NCT00999518|520478044|FG003|Overall Study|Protocol Violation|0|||
144348493|NCT00999518|520478045|FG004|Overall Study|Protocol Violation|2|||
144348494|NCT00999518|520478041|FG000|Overall Study|Withdrawal by Subject|5|||
144348495|NCT00999518|520478042|FG001|Overall Study|Withdrawal by Subject|4|||
144348496|NCT00999518|520478043|FG002|Overall Study|Withdrawal by Subject|10|||
144348497|NCT00999518|520478044|FG003|Overall Study|Withdrawal by Subject|6|||
144348498|NCT00999518|520478045|FG004|Overall Study|Withdrawal by Subject|1|||
144348499|NCT00999518|520478041|FG000|Overall Study|Other|5|||
144348500|NCT00999518|520478042|FG001|Overall Study|Other|7|||
144348501|NCT00999518|520478043|FG002|Overall Study|Other|1|||
144348502|NCT00999518|520478044|FG003|Overall Study|Other|4|||
144348503|NCT00999518|520478045|FG004|Overall Study|Other|5|||
144348504|NCT00999518|520478041|FG000|Overall Study|Randomized but not Treated|1|||
144348505|NCT00999518|520478042|FG001|Overall Study|Randomized but not Treated|1|||
144348506|NCT00999518|520478043|FG002|Overall Study|Randomized but not Treated|2|||
144348507|NCT00999518|520478044|FG003|Overall Study|Randomized but not Treated|0|||
144348508|NCT00999518|520478045|FG004|Overall Study|Randomized but not Treated|1|||
144348509|NCT00250276|520478046|FG000|Overall Study|Serious Adverse Event|0|||
144348510|NCT00250276|520478047|FG001|Overall Study|Serious Adverse Event|0|||
144348511|NCT00250276|520478048|FG002|Overall Study|Serious Adverse Event|1|||
144348512|NCT00250276|520478049|FG003|Overall Study|Serious Adverse Event|0|||
144348513|NCT00250276|520478046|FG000|Overall Study|Non-serious Adverse Event|2|||
144348514|NCT00250276|520478047|FG001|Overall Study|Non-serious Adverse Event|0|||
144348515|NCT00250276|520478048|FG002|Overall Study|Non-serious Adverse Event|0|||
144348516|NCT00250276|520478049|FG003|Overall Study|Non-serious Adverse Event|2|||
144348517|NCT00250276|520478046|FG000|Overall Study|Protocol Violation|0|||
144348518|NCT00250276|520478047|FG001|Overall Study|Protocol Violation|1|||
144348519|NCT00250276|520478048|FG002|Overall Study|Protocol Violation|0|||
144348520|NCT00250276|520478049|FG003|Overall Study|Protocol Violation|0|||
144348521|NCT00250276|520478046|FG000|Overall Study|Withdrawal by Subject|1|||
144348522|NCT00250276|520478047|FG001|Overall Study|Withdrawal by Subject|2|||
144348523|NCT00250276|520478048|FG002|Overall Study|Withdrawal by Subject|3|||
144348524|NCT00250276|520478049|FG003|Overall Study|Withdrawal by Subject|2|||
144348525|NCT00250276|520478046|FG000|Overall Study|Migrated/moved from study area|3|||
144348526|NCT00250276|520478047|FG001|Overall Study|Migrated/moved from study area|0|||
144348527|NCT00250276|520478048|FG002|Overall Study|Migrated/moved from study area|2|||
144348528|NCT00250276|520478049|FG003|Overall Study|Migrated/moved from study area|7|||
144348529|NCT00250276|520478046|FG000|Overall Study|Lost to Follow-up|11|||
144348530|NCT00250276|520478047|FG001|Overall Study|Lost to Follow-up|18|||
144348531|NCT00250276|520478048|FG002|Overall Study|Lost to Follow-up|13|||
144348532|NCT00250276|520478049|FG003|Overall Study|Lost to Follow-up|8|||
144348533|NCT03543137|520478050|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
144348534|NCT03543137|520478051|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
144348535|NCT03543137|520478050|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
144348536|NCT03543137|520478051|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
144348537|NCT03543137|520478050|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
144348538|NCT03543137|520478051|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
144348539|NCT04864639|520480157|FG000|Overall Study|Death|1|||
144348540|NCT04864639|520480157|FG000|Overall Study|Lost to Follow-up|1|||
144348541|NCT01478971|520480161|FG000|Standard of Care Period|Adverse Event|1|||
144348542|NCT01478971|520480161|FG000|Standard of Care Period|Withdrawal by Subject|3|||
144348543|NCT01478971|520480161|FG000|Standard of Care Period|Death|8|||
144348544|NCT01478971|520480161|FG000|Standard of Care Period|Lost to Follow-up|9|||
144348545|NCT01478971|520480161|FG000|Standard of Care Period|Other|4|||
144348546|NCT01478971|520480161|FG000|Peginesatide Treatment Period|Adverse Event|1|||
144348547|NCT01478971|520480161|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
144348548|NCT01478971|520480161|FG000|Peginesatide Treatment Period|Death|4|||
144348549|NCT01478971|520480161|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
144348550|NCT01478971|520480161|FG000|Peginesatide Treatment Period|Other|4|||
144348551|NCT01525615|520480162|FG000|Overall Study|Adverse Event|11|||
144348552|NCT01525615|520480163|FG001|Overall Study|Adverse Event|7|||
144348553|NCT01525615|520480164|FG002|Overall Study|Adverse Event|5|||
144348554|NCT01525615|520480162|FG000|Overall Study|Lost to Follow-up|1|||
144348555|NCT01525615|520480163|FG001|Overall Study|Lost to Follow-up|0|||
144348556|NCT01525615|520480164|FG002|Overall Study|Lost to Follow-up|0|||
144348557|NCT01525615|520480162|FG000|Overall Study|Withdrawal by Subject|1|||
144348558|NCT01525615|520480163|FG001|Overall Study|Withdrawal by Subject|0|||
144348559|NCT01525615|520480164|FG002|Overall Study|Withdrawal by Subject|0|||
144348560|NCT01525615|520480162|FG000|Overall Study|Other reason not described above|1|||
144348561|NCT01525615|520480163|FG001|Overall Study|Other reason not described above|0|||
144348562|NCT01525615|520480164|FG002|Overall Study|Other reason not described above|1|||
144348563|NCT04050618|520480165|FG000|First Intervention|Withdrawal by Subject|2|||
144348564|NCT04050618|520480166|FG001|First Intervention|Withdrawal by Subject|0|||
144348565|NCT04050618|520480165|FG000|Second Intervention|Withdrawal by Subject|1|||
144348566|NCT04050618|520480166|FG001|Second Intervention|Withdrawal by Subject|0|||
144348567|NCT02451943|520480175|FG000|Overall Study|Withdrawal by Subject|13|||
144348568|NCT02451943|520480176|FG001|Overall Study|Withdrawal by Subject|16|||
144348569|NCT02451943|520480175|FG000|Overall Study|Lost to Follow-up|3|||
144348570|NCT02451943|520480176|FG001|Overall Study|Lost to Follow-up|4|||
144348571|NCT02451943|520480175|FG000|Overall Study|Sponsor Decision|0|||
144348572|NCT02451943|520480176|FG001|Overall Study|Sponsor Decision|4|||
144348573|NCT00412893|520480181|FG000|Overall Study|Adverse Event|31|||
144348574|NCT00412893|520480182|FG001|Overall Study|Adverse Event|53|||
144348575|NCT00412893|520480181|FG000|Overall Study|Death|17|||
144348576|NCT00412893|520480182|FG001|Overall Study|Death|21|||
144348577|NCT00412893|520480181|FG000|Overall Study|Insufficient Therapeutic Response|39|||
144348578|NCT00412893|520480182|FG001|Overall Study|Insufficient Therapeutic Response|23|||
144348579|NCT00412893|520480181|FG000|Overall Study|Lost to Follow-up|2|||
144348580|NCT00412893|520480182|FG001|Overall Study|Lost to Follow-up|1|||
144348581|NCT00412893|520480181|FG000|Overall Study|Violation of Selection at Entry|17|||
144348582|NCT00412893|520480182|FG001|Overall Study|Violation of Selection at Entry|10|||
144348583|NCT00412893|520480181|FG000|Overall Study|Other Protocol Violation|10|||
144348584|NCT00412893|520480182|FG001|Overall Study|Other Protocol Violation|6|||
144348585|NCT00412893|520480181|FG000|Overall Study|Did Not Cooperate|12|||
144348586|NCT00412893|520480182|FG001|Overall Study|Did Not Cooperate|9|||
144348587|NCT00412893|520480181|FG000|Overall Study|Administrative Reason|12|||
144348588|NCT00412893|520480182|FG001|Overall Study|Administrative Reason|15|||
144348589|NCT00412893|520480181|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
144348590|NCT00412893|520480182|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
144348591|NCT03951077|520480183|FG000|Overall Study|Adverse Event|1|||
144348592|NCT03951077|520480184|FG001|Overall Study|Adverse Event|0|||
144348593|NCT03951077|520480185|FG002|Overall Study|Adverse Event|0|||
144348594|NCT03951077|520480186|FG003|Overall Study|Adverse Event|0|||
144348595|NCT03951077|520480187|FG004|Overall Study|Adverse Event|0|||
144348596|NCT03951077|520480188|FG005|Overall Study|Adverse Event|0|||
144348597|NCT03951077|520480183|FG000|Overall Study|Withdrawal by Subject|3|||
144348598|NCT03951077|520480184|FG001|Overall Study|Withdrawal by Subject|3|||
144348599|NCT03951077|520480185|FG002|Overall Study|Withdrawal by Subject|0|||
144348600|NCT03951077|520480186|FG003|Overall Study|Withdrawal by Subject|3|||
144348601|NCT03951077|520480187|FG004|Overall Study|Withdrawal by Subject|3|||
144348602|NCT03951077|520480188|FG005|Overall Study|Withdrawal by Subject|2|||
144348603|NCT03951077|520480183|FG000|Overall Study|Lost to Follow-up|1|||
144348604|NCT03951077|520480184|FG001|Overall Study|Lost to Follow-up|1|||
144348605|NCT03951077|520480185|FG002|Overall Study|Lost to Follow-up|2|||
144348606|NCT03951077|520480186|FG003|Overall Study|Lost to Follow-up|3|||
144348607|NCT03951077|520480187|FG004|Overall Study|Lost to Follow-up|2|||
144348608|NCT03951077|520480188|FG005|Overall Study|Lost to Follow-up|3|||
144348609|NCT03951077|520480183|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
144360194|NCT03037385|520527414|FG006|Overall Study|Progressive Disease|1|||
144348610|NCT03951077|520480184|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
144348611|NCT03951077|520480185|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
144348612|NCT03951077|520480186|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
144348613|NCT03951077|520480187|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
144348614|NCT03951077|520480188|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
144348615|NCT03951077|520480183|FG000|Overall Study|Other, Not Specified|12|||
144348616|NCT03951077|520480184|FG001|Overall Study|Other, Not Specified|10|||
144348617|NCT03951077|520480185|FG002|Overall Study|Other, Not Specified|10|||
144348618|NCT03951077|520480186|FG003|Overall Study|Other, Not Specified|5|||
144348619|NCT03951077|520480187|FG004|Overall Study|Other, Not Specified|9|||
144348620|NCT03951077|520480188|FG005|Overall Study|Other, Not Specified|6|||
144348621|NCT03951077|520480183|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
144348622|NCT03951077|520480184|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
144348623|NCT03951077|520480185|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
144348624|NCT03951077|520480186|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
144348625|NCT03951077|520480187|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
144348626|NCT03951077|520480188|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
144348627|NCT01473732|520480190|FG000|Overall Study|Adverse Event|1|||
144348628|NCT01473732|520480191|FG001|Overall Study|Adverse Event|0|||
144348629|NCT01473732|520480190|FG000|Overall Study|Death|1|||
144348630|NCT01473732|520480191|FG001|Overall Study|Death|0|||
144348631|NCT03579940|520480195|FG000|Period 2|Withdrawal by Subject|0|||
144348632|NCT03579940|520480196|FG001|Period 2|Withdrawal by Subject|0|||
144348633|NCT03579940|520480197|FG002|Period 2|Withdrawal by Subject|1|||
144348634|NCT03579940|520480198|FG003|Period 2|Withdrawal by Subject|0|||
144348635|NCT03579940|520480199|FG004|Period 2|Withdrawal by Subject|0|||
144348636|NCT03579940|520480200|FG005|Period 2|Withdrawal by Subject|0|||
144348637|NCT03579940|520480201|FG006|Period 2|Withdrawal by Subject|0|||
144348638|NCT03579940|520480202|FG007|Period 2|Withdrawal by Subject|0|||
144348639|NCT03579940|520480203|FG008|Period 2|Withdrawal by Subject|0|||
144348640|NCT03579940|520480204|FG009|Period 2|Withdrawal by Subject|0|||
144348641|NCT03579940|520480205|FG010|Period 2|Withdrawal by Subject|0|||
144348642|NCT00671034|520480206|FG000|Overall Study|Adverse Event|5|||
144348643|NCT00671034|520480207|FG001|Overall Study|Adverse Event|7|||
144348644|NCT00671034|520480208|FG002|Overall Study|Adverse Event|1|||
144348645|NCT00671034|520480206|FG000|Overall Study|Death|3|||
144348646|NCT00671034|520480207|FG001|Overall Study|Death|2|||
144348647|NCT00671034|520480208|FG002|Overall Study|Death|1|||
144348648|NCT00671034|520480206|FG000|Overall Study|Physician Decision|12|||
144348649|NCT00671034|520480207|FG001|Overall Study|Physician Decision|4|||
144348650|NCT00671034|520480208|FG002|Overall Study|Physician Decision|5|||
144348651|NCT00671034|520480206|FG000|Overall Study|VHR ALL feature|8|||
144348652|NCT00671034|520480207|FG001|Overall Study|VHR ALL feature|3|||
144348653|NCT00671034|520480208|FG002|Overall Study|VHR ALL feature|5|||
144348654|NCT00671034|520480206|FG000|Overall Study|Refusal|5|||
144348655|NCT00671034|520480207|FG001|Overall Study|Refusal|3|||
144348656|NCT00671034|520480208|FG002|Overall Study|Refusal|5|||
144348657|NCT00671034|520480206|FG000|Overall Study|includes Alternative therapy, etc.|6|||
144348658|NCT00671034|520480207|FG001|Overall Study|includes Alternative therapy, etc.|1|||
144348659|NCT00671034|520480208|FG002|Overall Study|includes Alternative therapy, etc.|7|||
144348660|NCT00853151|520480209|FG000|Overall Study|Adverse Event|1|||
144348661|NCT00853151|520480210|FG001|Overall Study|Adverse Event|4|||
144348662|NCT00853151|520480211|FG002|Overall Study|Adverse Event|2|||
144348663|NCT00853151|520480212|FG003|Overall Study|Adverse Event|0|||
144348664|NCT00853151|520480209|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
144348665|NCT00853151|520480210|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144348666|NCT00853151|520480211|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144348667|NCT00853151|520480212|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
144348668|NCT00853151|520480209|FG000|Overall Study|Lost to Follow-up|2|||
144348669|NCT00853151|520480210|FG001|Overall Study|Lost to Follow-up|0|||
144348670|NCT00853151|520480211|FG002|Overall Study|Lost to Follow-up|3|||
144348671|NCT00853151|520480212|FG003|Overall Study|Lost to Follow-up|0|||
144348672|NCT00853151|520480209|FG000|Overall Study|Death|1|||
144348673|NCT00853151|520480210|FG001|Overall Study|Death|0|||
144348674|NCT00853151|520480211|FG002|Overall Study|Death|0|||
144348675|NCT00853151|520480212|FG003|Overall Study|Death|1|||
144348676|NCT00853151|520480209|FG000|Overall Study|Protocol Violation|0|||
144348677|NCT00853151|520480210|FG001|Overall Study|Protocol Violation|0|||
144348678|NCT00853151|520480211|FG002|Overall Study|Protocol Violation|0|||
144348679|NCT00853151|520480212|FG003|Overall Study|Protocol Violation|1|||
144348680|NCT00853151|520480209|FG000|Overall Study|Withdrawal by Subject|5|||
144348681|NCT00853151|520480210|FG001|Overall Study|Withdrawal by Subject|4|||
144348682|NCT00853151|520480211|FG002|Overall Study|Withdrawal by Subject|2|||
144348683|NCT00853151|520480212|FG003|Overall Study|Withdrawal by Subject|1|||
144348684|NCT00853151|520480209|FG000|Overall Study|Physician Decision|0|||
144348685|NCT00853151|520480210|FG001|Overall Study|Physician Decision|2|||
144348686|NCT00853151|520480211|FG002|Overall Study|Physician Decision|1|||
144348687|NCT00853151|520480212|FG003|Overall Study|Physician Decision|0|||
144348688|NCT00853151|520480209|FG000|Overall Study|Sponsor Decision|0|||
144348689|NCT00853151|520480210|FG001|Overall Study|Sponsor Decision|3|||
144348690|NCT00853151|520480211|FG002|Overall Study|Sponsor Decision|0|||
144348691|NCT00853151|520480212|FG003|Overall Study|Sponsor Decision|0|||
144348692|NCT00713544|520480213|FG000|Overall Study|Adverse Event|5|||
144348693|NCT00713544|520480214|FG001|Overall Study|Adverse Event|3|||
144348694|NCT00713544|520480215|FG002|Overall Study|Adverse Event|7|||
144348695|NCT00713544|520480216|FG003|Overall Study|Adverse Event|7|||
144348696|NCT00713544|520480217|FG004|Overall Study|Adverse Event|3|||
144348697|NCT00713544|520480218|FG005|Overall Study|Adverse Event|5|||
144348698|NCT00713544|520480213|FG000|Overall Study|Withdrawal by Subject|2|||
144348699|NCT00713544|520480214|FG001|Overall Study|Withdrawal by Subject|0|||
144348700|NCT00713544|520480215|FG002|Overall Study|Withdrawal by Subject|3|||
144348701|NCT00713544|520480216|FG003|Overall Study|Withdrawal by Subject|2|||
144348702|NCT00713544|520480217|FG004|Overall Study|Withdrawal by Subject|3|||
144348703|NCT00713544|520480218|FG005|Overall Study|Withdrawal by Subject|1|||
144348704|NCT00713544|520480213|FG000|Overall Study|Protocol Violation|0|||
144348705|NCT00713544|520480214|FG001|Overall Study|Protocol Violation|0|||
144348706|NCT00713544|520480215|FG002|Overall Study|Protocol Violation|0|||
144348707|NCT00713544|520480216|FG003|Overall Study|Protocol Violation|0|||
144348708|NCT00713544|520480217|FG004|Overall Study|Protocol Violation|0|||
144348709|NCT00713544|520480218|FG005|Overall Study|Protocol Violation|1|||
144348710|NCT00713544|520480213|FG000|Overall Study|Physician Decision|0|||
144348711|NCT00713544|520480214|FG001|Overall Study|Physician Decision|0|||
144348712|NCT00713544|520480215|FG002|Overall Study|Physician Decision|0|||
144348713|NCT00713544|520480216|FG003|Overall Study|Physician Decision|0|||
144348714|NCT00713544|520480217|FG004|Overall Study|Physician Decision|0|||
144348715|NCT00713544|520480218|FG005|Overall Study|Physician Decision|2|||
144348716|NCT00713544|520480213|FG000|Overall Study|Lack of Efficacy|0|||
144348717|NCT00713544|520480214|FG001|Overall Study|Lack of Efficacy|1|||
144348718|NCT00713544|520480215|FG002|Overall Study|Lack of Efficacy|0|||
144348719|NCT00713544|520480216|FG003|Overall Study|Lack of Efficacy|1|||
144348720|NCT00713544|520480217|FG004|Overall Study|Lack of Efficacy|1|||
144348721|NCT00713544|520480218|FG005|Overall Study|Lack of Efficacy|0|||
144348722|NCT00713544|520480213|FG000|Overall Study|Lost to Follow-up|0|||
144348723|NCT00713544|520480214|FG001|Overall Study|Lost to Follow-up|0|||
144348724|NCT00713544|520480215|FG002|Overall Study|Lost to Follow-up|1|||
144348725|NCT00713544|520480216|FG003|Overall Study|Lost to Follow-up|0|||
144348726|NCT00713544|520480217|FG004|Overall Study|Lost to Follow-up|0|||
144348727|NCT00713544|520480218|FG005|Overall Study|Lost to Follow-up|0|||
144348728|NCT00713544|520480213|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
144348729|NCT00713544|520480214|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
144348730|NCT00713544|520480215|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
144348731|NCT00713544|520480216|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
144348732|NCT00713544|520480217|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
144348733|NCT00713544|520480218|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
144348734|NCT00713544|520480213|FG000|Overall Study|Incorrect enrollment|0|||
144348735|NCT00713544|520480214|FG001|Overall Study|Incorrect enrollment|1|||
144348736|NCT00713544|520480215|FG002|Overall Study|Incorrect enrollment|0|||
144348737|NCT00713544|520480216|FG003|Overall Study|Incorrect enrollment|0|||
144348738|NCT00713544|520480217|FG004|Overall Study|Incorrect enrollment|0|||
144348739|NCT00713544|520480218|FG005|Overall Study|Incorrect enrollment|0|||
144348740|NCT00713544|520480213|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
144348741|NCT00713544|520480214|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
144348742|NCT00713544|520480215|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
144348743|NCT00713544|520480216|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
144348744|NCT00713544|520480217|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
144348745|NCT00713544|520480218|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
144348746|NCT02380287|520480221|FG000|Overall Study|Adverse Event|0|||
144348747|NCT02380287|520480222|FG001|Overall Study|Adverse Event|0|||
144348748|NCT02380287|520480223|FG002|Overall Study|Adverse Event|1|||
144348749|NCT02380287|520480224|FG003|Overall Study|Adverse Event|0|||
144348750|NCT02380287|520480225|FG004|Overall Study|Adverse Event|0|||
144348751|NCT02380287|520480226|FG005|Overall Study|Adverse Event|0|||
144348752|NCT02380287|520480227|FG006|Overall Study|Adverse Event|0|||
144348753|NCT02380287|520480228|FG007|Overall Study|Adverse Event|0|||
144348754|NCT01751984|520480229|FG000|Overall Study|Adverse Event|5|||
144348755|NCT01751984|520480230|FG001|Overall Study|Adverse Event|3|||
144348756|NCT01751984|520480229|FG000|Overall Study|Withdrawal by Subject|0|||
144348757|NCT01751984|520480230|FG001|Overall Study|Withdrawal by Subject|1|||
144348758|NCT01751984|520480229|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
144348759|NCT01751984|520480230|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
144348760|NCT04473963|520480231|FG000|Overall Study|Withdrawal by Subject|1|||
144348761|NCT04473963|520480232|FG001|Overall Study|Withdrawal by Subject|1|||
144348762|NCT04473963|520480233|FG002|Overall Study|Withdrawal by Subject|0|||
144348763|NCT04473963|520480231|FG000|Overall Study|Not inducible in AF|0|||
144348764|NCT04473963|520480232|FG001|Overall Study|Not inducible in AF|0|||
144348765|NCT04473963|520480233|FG002|Overall Study|Not inducible in AF|2|||
144348766|NCT01641601|520480234|FG000|Overall Study|Study discontinued.|3|||
144348767|NCT01641601|520480235|FG001|Overall Study|Study discontinued.|5|||
144348768|NCT00587158|520480236|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
144348769|NCT00587158|520480237|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
144348770|NCT00587158|520480236|FG000|Overall Study|Physician Decision|0|||
144348771|NCT00587158|520480237|FG001|Overall Study|Physician Decision|1|||
144348772|NCT00587158|520480236|FG000|Overall Study|Lost to Follow-up|1|||
144348773|NCT00587158|520480237|FG001|Overall Study|Lost to Follow-up|2|||
144348774|NCT00587158|520480236|FG000|Overall Study|Death|0|||
144348775|NCT00587158|520480237|FG001|Overall Study|Death|1|||
144348776|NCT00587158|520480236|FG000|Overall Study|Subject did not want to take study med|0|||
144348777|NCT00587158|520480237|FG001|Overall Study|Subject did not want to take study med|1|||
144348778|NCT00832416|520480238|FG000|Overall Study|Lack of Efficacy|17|||
144348779|NCT00832416|520480239|FG001|Overall Study|Lack of Efficacy|15|||
144348780|NCT00832416|520480240|FG002|Overall Study|Lack of Efficacy|13|||
144348781|NCT00832416|520480241|FG003|Overall Study|Lack of Efficacy|52|||
144348782|NCT00832416|520480238|FG000|Overall Study|Withdrawal by Subject|5|||
144348783|NCT00832416|520480239|FG001|Overall Study|Withdrawal by Subject|7|||
144348784|NCT00832416|520480240|FG002|Overall Study|Withdrawal by Subject|2|||
144348785|NCT00832416|520480241|FG003|Overall Study|Withdrawal by Subject|10|||
144348786|NCT00832416|520480238|FG000|Overall Study|Physician Decision|2|||
144348787|NCT00832416|520480239|FG001|Overall Study|Physician Decision|12|||
144348788|NCT00832416|520480240|FG002|Overall Study|Physician Decision|5|||
144348789|NCT00832416|520480241|FG003|Overall Study|Physician Decision|10|||
144348790|NCT00832416|520480238|FG000|Overall Study|Administrative|0|||
144348791|NCT00832416|520480239|FG001|Overall Study|Administrative|0|||
144348792|NCT00832416|520480240|FG002|Overall Study|Administrative|0|||
144348793|NCT00832416|520480241|FG003|Overall Study|Administrative|1|||
144348794|NCT00832416|520480238|FG000|Overall Study|Adverse Event|21|||
144348795|NCT00832416|520480239|FG001|Overall Study|Adverse Event|19|||
144348796|NCT00832416|520480240|FG002|Overall Study|Adverse Event|41|||
144348797|NCT00832416|520480241|FG003|Overall Study|Adverse Event|10|||
144348798|NCT00832416|520480238|FG000|Overall Study|Death|1|||
144348799|NCT00832416|520480239|FG001|Overall Study|Death|0|||
144348800|NCT00832416|520480240|FG002|Overall Study|Death|0|||
144348801|NCT00832416|520480241|FG003|Overall Study|Death|0|||
144348802|NCT02114606|520480242|FG000|Overall Study|Unable to swallow Cytosponge|6|||
144348803|NCT02152761|520480254|FG000|Epoch: Treatment Epoch|Technical problems|0|||
144348804|NCT02152761|520480255|FG001|Epoch: Treatment Epoch|Technical problems|0|||
144348805|NCT02152761|520480256|FG002|Epoch: Treatment Epoch|Technical problems|0|||
144348806|NCT02152761|520480257|FG003|Epoch: Treatment Epoch|Technical problems|1|||
144348807|NCT02152761|520480254|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
144348808|NCT02152761|520480255|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
144348809|NCT02152761|520480256|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
144348810|NCT02152761|520480257|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
144348811|NCT02152761|520480254|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
144348812|NCT02152761|520480255|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
144348813|NCT02152761|520480256|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
144348814|NCT02152761|520480257|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
144348815|NCT02152761|520480254|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
144348816|NCT02152761|520480255|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
144348817|NCT02152761|520480256|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
144348818|NCT02152761|520480257|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
144348819|NCT02152761|520480254|FG000|Epoch: Treatment Epoch|Death|0|||
144348820|NCT02152761|520480255|FG001|Epoch: Treatment Epoch|Death|3|||
144348821|NCT02152761|520480256|FG002|Epoch: Treatment Epoch|Death|1|||
144348822|NCT02152761|520480257|FG003|Epoch: Treatment Epoch|Death|0|||
144348823|NCT02152761|520480254|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
144348824|NCT02152761|520480255|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
144348825|NCT02152761|520480256|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
144348826|NCT02152761|520480257|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
144348827|NCT02152761|520480254|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
144348828|NCT02152761|520480255|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
144348829|NCT02152761|520480256|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
144348830|NCT02152761|520480257|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
144348831|NCT02152761|520480254|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
144348832|NCT02152761|520480255|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
144348833|NCT02152761|520480256|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
144348834|NCT02152761|520480257|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
144348835|NCT02152761|520480254|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
144348836|NCT02152761|520480255|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
144348837|NCT02152761|520480256|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
144348838|NCT02152761|520480257|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
144348839|NCT02152761|520480254|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
144348840|NCT02152761|520480255|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
144348841|NCT02152761|520480256|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
144348842|NCT02152761|520480257|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
144348843|NCT01456169|520480258|FG000|Overall Study|Adverse Event|1|||
144348844|NCT01456169|520480259|FG001|Overall Study|Adverse Event|2|||
144348845|NCT01456169|520480260|FG002|Overall Study|Adverse Event|7|||
144348846|NCT01456169|520480258|FG000|Overall Study|Major Protocol Deviation|3|||
144348847|NCT01456169|520480259|FG001|Overall Study|Major Protocol Deviation|2|||
144348848|NCT01456169|520480260|FG002|Overall Study|Major Protocol Deviation|3|||
144348849|NCT01456169|520480258|FG000|Overall Study|Voluntary Withdrawal|3|||
144348850|NCT01456169|520480259|FG001|Overall Study|Voluntary Withdrawal|0|||
144348851|NCT01456169|520480260|FG002|Overall Study|Voluntary Withdrawal|2|||
144348852|NCT01456169|520480258|FG000|Overall Study|Lack of Efficacy|2|||
144348853|NCT01456169|520480259|FG001|Overall Study|Lack of Efficacy|0|||
144348854|NCT01456169|520480260|FG002|Overall Study|Lack of Efficacy|0|||
144348855|NCT01456169|520480258|FG000|Overall Study|Other|1|||
144348856|NCT01456169|520480259|FG001|Overall Study|Other|1|||
144348857|NCT01456169|520480260|FG002|Overall Study|Other|0|||
144348858|NCT01797263|520480264|FG000|Overall Study|Withdrawal by Subject|21|||
144348859|NCT01797263|520480265|FG001|Overall Study|Withdrawal by Subject|25|||
144348860|NCT01797263|520480264|FG000|Overall Study|Death|1|||
144348861|NCT01797263|520480265|FG001|Overall Study|Death|0|||
144348862|NCT01797263|520480264|FG000|Overall Study|Lost to Follow-up|15|||
144348863|NCT01797263|520480265|FG001|Overall Study|Lost to Follow-up|15|||
144348864|NCT02342223|520480266|FG000|Overall Study|Lost to Follow-up|1|||
144348865|NCT04098809|520480269|FG000|Overall Study|Withdrawal by Subject|1|||
144348866|NCT04098809|520480270|FG001|Overall Study|Withdrawal by Subject|3|||
144348867|NCT04098809|520480269|FG000|Overall Study|Physician Decision|2|||
144348868|NCT04098809|520480270|FG001|Overall Study|Physician Decision|1|||
144348869|NCT01200368|520480271|FG000|Infant Series|Adverse Event|2|||
144348870|NCT01200368|520480272|FG001|Infant Series|Adverse Event|2|||
144348871|NCT01200368|520480273|FG002|Infant Series|Adverse Event|3|||
144348872|NCT01200368|520480271|FG000|Infant Series|Withdrawal by Subject|0|||
144348873|NCT01200368|520480272|FG001|Infant Series|Withdrawal by Subject|2|||
144348874|NCT01200368|520480273|FG002|Infant Series|Withdrawal by Subject|2|||
144348875|NCT01200368|520480271|FG000|Infant Series|Did not meet entrance criteria|0|||
144348876|NCT01200368|520480272|FG001|Infant Series|Did not meet entrance criteria|1|||
144348877|NCT01200368|520480273|FG002|Infant Series|Did not meet entrance criteria|0|||
144348878|NCT01200368|520480271|FG000|Infant Series|Randomized, not vaccinated|0|||
144348879|NCT01200368|520480272|FG001|Infant Series|Randomized, not vaccinated|1|||
144348880|NCT01200368|520480273|FG002|Infant Series|Randomized, not vaccinated|1|||
144348881|NCT01200368|520480271|FG000|Infant Series|Other|1|||
144348882|NCT01200368|520480272|FG001|Infant Series|Other|0|||
144348883|NCT01200368|520480273|FG002|Infant Series|Other|0|||
144348884|NCT01200368|520480271|FG000|After Infant Series|Adverse Event|6|||
144348885|NCT01200368|520480272|FG001|After Infant Series|Adverse Event|6|||
144348886|NCT01200368|520480273|FG002|After Infant Series|Adverse Event|3|||
144348887|NCT01200368|520480271|FG000|After Infant Series|Withdrawal by Subject|10|||
144348888|NCT01200368|520480272|FG001|After Infant Series|Withdrawal by Subject|8|||
144348889|NCT01200368|520480273|FG002|After Infant Series|Withdrawal by Subject|4|||
144348890|NCT01200368|520480271|FG000|After Infant Series|Lost to Follow-up|1|||
144348891|NCT01200368|520480272|FG001|After Infant Series|Lost to Follow-up|0|||
144348892|NCT01200368|520480273|FG002|After Infant Series|Lost to Follow-up|0|||
144348893|NCT01200368|520480271|FG000|After Infant Series|Other|1|||
144348894|NCT01200368|520480272|FG001|After Infant Series|Other|2|||
144348895|NCT01200368|520480273|FG002|After Infant Series|Other|2|||
144348896|NCT01200368|520480271|FG000|Toddler Dose|Adverse Event|0|||
144348897|NCT01200368|520480272|FG001|Toddler Dose|Adverse Event|3|||
144348898|NCT01200368|520480273|FG002|Toddler Dose|Adverse Event|1|||
144348899|NCT02741596|520480274|FG000|Overall Study|Adverse Event|1|||
144348900|NCT02741596|520480275|FG001|Overall Study|Adverse Event|5|||
144348901|NCT02741596|520480274|FG000|Overall Study|Lost to Follow-up|1|||
144348902|NCT02741596|520480275|FG001|Overall Study|Lost to Follow-up|1|||
144348903|NCT02741596|520480274|FG000|Overall Study|Physician Decision|2|||
144348904|NCT02741596|520480275|FG001|Overall Study|Physician Decision|1|||
144348905|NCT02741596|520480274|FG000|Overall Study|Pregnancy|3|||
144348906|NCT02741596|520480275|FG001|Overall Study|Pregnancy|1|||
144348907|NCT02741596|520480274|FG000|Overall Study|Other (Unspecified)|0|||
144348908|NCT02741596|520480275|FG001|Overall Study|Other (Unspecified)|3|||
144348909|NCT02741596|520480274|FG000|Overall Study|Subject withdrawn-Other|17|||
144348910|NCT02741596|520480275|FG001|Overall Study|Subject withdrawn-Other|4|||
144348911|NCT02741596|520480274|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
144348912|NCT02741596|520480275|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
144348913|NCT04854551|520480278|FG000|Overall Study|Withdrawal by Subject|1|||
144348914|NCT04854551|520480279|FG001|Overall Study|Withdrawal by Subject|1|||
144348915|NCT02859246|520480280|FG000|Overall Study|Screen fails|3|||
144348916|NCT02859246|520480280|FG000|Overall Study|Adverse Event|1|||
144360195|NCT03037385|520527415|FG007|Overall Study|Progressive Disease|0|||
144348917|NCT02859246|520480280|FG000|Overall Study|Withdrawal by Subject|1|||
144348918|NCT05280717|520480281|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
144348919|NCT05280717|520480282|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
144348920|NCT05280717|520480283|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
144348921|NCT05280717|520480284|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
144348922|NCT05280717|520480285|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
144348923|NCT05280717|520480286|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
144348924|NCT05280717|520480287|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
144348925|NCT05280717|520480281|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
144348926|NCT05280717|520480282|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
144348927|NCT05280717|520480283|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
144348928|NCT05280717|520480284|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
144348929|NCT05280717|520480285|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
144348930|NCT05280717|520480286|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
144348931|NCT05280717|520480287|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
144348932|NCT05280717|520480281|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
144348933|NCT05280717|520480282|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
144348934|NCT05280717|520480283|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
144348935|NCT05280717|520480284|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
144348936|NCT05280717|520480285|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
144348937|NCT05280717|520480286|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
144348938|NCT05280717|520480287|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
144348939|NCT05280717|520480281|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
144348940|NCT05280717|520480282|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
144348941|NCT05280717|520480283|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
144348942|NCT05280717|520480284|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
144348943|NCT05280717|520480285|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
144348944|NCT05280717|520480286|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
144348945|NCT05280717|520480287|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
144348946|NCT05280717|520480281|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
144348947|NCT05280717|520480282|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
144348948|NCT05280717|520480283|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
144348949|NCT05280717|520480284|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
144348950|NCT05280717|520480285|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
144348951|NCT05280717|520480286|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
144348952|NCT05280717|520480287|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
144348953|NCT05280717|520480281|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
144348954|NCT05280717|520480282|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
144348955|NCT05280717|520480283|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
144348956|NCT05280717|520480284|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
144348957|NCT05280717|520480285|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
144348958|NCT05280717|520480286|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
144348959|NCT05280717|520480287|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
144348960|NCT00080301|520480288|FG000|Overall Study|Randomized but Never Treated|5|||
144348961|NCT00080301|520480289|FG001|Overall Study|Randomized but Never Treated|10|||
144348962|NCT00080301|520480288|FG000|Overall Study|Still on Treatment as of CSR date|0|||
144348963|NCT00080301|520480289|FG001|Overall Study|Still on Treatment as of CSR date|1|||
144348964|NCT00181766|520480290|FG000|Overall Study|Lost to Follow-up|6|||
144348965|NCT00181766|520480290|FG000|Overall Study|Adverse Event|4|||
144348966|NCT00181766|520480290|FG000|Overall Study|non-compliance|2|||
144348967|NCT00687804|520480291|FG000|Core Study|Adverse Event|5|||
144348968|NCT00687804|520480292|FG001|Core Study|Adverse Event|3|||
144348969|NCT00687804|520480293|FG002|Core Study|Adverse Event|3|||
144348970|NCT00687804|520480291|FG000|Core Study|Abnormal laboratory value(s)|1|||
144348971|NCT00687804|520480292|FG001|Core Study|Abnormal laboratory value(s)|0|||
144348972|NCT00687804|520480293|FG002|Core Study|Abnormal laboratory value(s)|0|||
144348973|NCT00687804|520480291|FG000|Core Study|Lack of Efficacy|1|||
144348974|NCT00687804|520480292|FG001|Core Study|Lack of Efficacy|1|||
144348975|NCT00687804|520480293|FG002|Core Study|Lack of Efficacy|1|||
144348976|NCT00687804|520480291|FG000|Core Study|Withdrawal by Subject|4|||
144348977|NCT00687804|520480292|FG001|Core Study|Withdrawal by Subject|7|||
144348978|NCT00687804|520480293|FG002|Core Study|Withdrawal by Subject|7|||
144348979|NCT00687804|520480291|FG000|Core Study|Lost to Follow-up|0|||
144348980|NCT00687804|520480292|FG001|Core Study|Lost to Follow-up|1|||
144348981|NCT00687804|520480293|FG002|Core Study|Lost to Follow-up|0|||
144348982|NCT00687804|520480291|FG000|Core Study|Death|2|||
144348983|NCT00687804|520480292|FG001|Core Study|Death|2|||
144348984|NCT00687804|520480293|FG002|Core Study|Death|2|||
144348985|NCT00687804|520480291|FG000|Core Study|Protocol Violation|1|||
144348986|NCT00687804|520480292|FG001|Core Study|Protocol Violation|1|||
144348987|NCT00687804|520480293|FG002|Core Study|Protocol Violation|0|||
144348988|NCT00687804|520480291|FG000|Open-Label Extension Study|Adverse Event|2|||
144348989|NCT00687804|520480292|FG001|Open-Label Extension Study|Adverse Event|2|||
144348990|NCT00687804|520480293|FG002|Open-Label Extension Study|Adverse Event|2|||
144348991|NCT00687804|520480291|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
144348992|NCT00687804|520480292|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
144348993|NCT00687804|520480293|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
144348994|NCT00687804|520480291|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
144348995|NCT00687804|520480292|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
144348996|NCT00687804|520480293|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
144348997|NCT00687804|520480291|FG000|Open-Label Extension Study|Administrative problems|1|||
144348998|NCT00687804|520480292|FG001|Open-Label Extension Study|Administrative problems|1|||
144348999|NCT00687804|520480293|FG002|Open-Label Extension Study|Administrative problems|0|||
144349000|NCT00687804|520480291|FG000|Open-Label Extension Study|Death|2|||
144349001|NCT00687804|520480292|FG001|Open-Label Extension Study|Death|3|||
144349002|NCT00687804|520480293|FG002|Open-Label Extension Study|Death|3|||
144349003|NCT00413218|520480294|FG000|Overall Study|Randomized but didn't receive study drug|2|||
144349004|NCT00413218|520480295|FG001|Overall Study|Randomized but didn't receive study drug|8|||
144349005|NCT00413218|520480294|FG000|Overall Study|Death|57|||
144349006|NCT00413218|520480295|FG001|Overall Study|Death|56|||
144349007|NCT00413218|520480294|FG000|Overall Study|Lost to Follow-up|14|||
144349008|NCT00413218|520480295|FG001|Overall Study|Lost to Follow-up|17|||
144349009|NCT00413218|520480294|FG000|Overall Study|Admin|20|||
144349010|NCT00413218|520480295|FG001|Overall Study|Admin|14|||
144349011|NCT00413218|520480294|FG000|Overall Study|Missing|1|||
144349012|NCT00413218|520480295|FG001|Overall Study|Missing|0|||
144349013|NCT00413218|520480294|FG000|Overall Study|Withdrawal by Subject|9|||
144349014|NCT00413218|520480295|FG001|Overall Study|Withdrawal by Subject|1|||
144349015|NCT01196026|520480297|FG000|Overall Study|Withdrawal by Subject|1|||
144349016|NCT01196026|520480298|FG001|Overall Study|Withdrawal by Subject|4|||
144349017|NCT01196026|520480299|FG002|Overall Study|Withdrawal by Subject|0|||
144349018|NCT01196026|520480300|FG003|Overall Study|Withdrawal by Subject|0|||
144349019|NCT01196026|520480301|FG004|Overall Study|Withdrawal by Subject|0|||
144349020|NCT01196026|520480302|FG005|Overall Study|Withdrawal by Subject|0|||
144349021|NCT01196026|520480297|FG000|Overall Study|Lost to Follow-up|0|||
144349022|NCT01196026|520480298|FG001|Overall Study|Lost to Follow-up|3|||
144349023|NCT01196026|520480299|FG002|Overall Study|Lost to Follow-up|0|||
144349024|NCT01196026|520480300|FG003|Overall Study|Lost to Follow-up|0|||
144349025|NCT01196026|520480301|FG004|Overall Study|Lost to Follow-up|1|||
144349026|NCT01196026|520480302|FG005|Overall Study|Lost to Follow-up|0|||
144349027|NCT01196026|520480297|FG000|Overall Study|Other|0|||
144349028|NCT01196026|520480298|FG001|Overall Study|Other|1|||
144349029|NCT01196026|520480299|FG002|Overall Study|Other|0|||
144349030|NCT01196026|520480300|FG003|Overall Study|Other|0|||
144349031|NCT01196026|520480301|FG004|Overall Study|Other|0|||
144349032|NCT01196026|520480302|FG005|Overall Study|Other|0|||
144349033|NCT04034004|520480303|FG000|Overall Study|Withdrawal by Subject|1|||
144349034|NCT04034004|520480304|FG001|Overall Study|Withdrawal by Subject|2|||
144349035|NCT04034004|520480305|FG002|Overall Study|Withdrawal by Subject|2|||
144349036|NCT04034004|520480306|FG003|Overall Study|Withdrawal by Subject|3|||
144349037|NCT04034004|520480303|FG000|Overall Study|could not find vein to administer IV|2|||
144349038|NCT04034004|520480304|FG001|Overall Study|could not find vein to administer IV|1|||
144349039|NCT04034004|520480305|FG002|Overall Study|could not find vein to administer IV|0|||
144349040|NCT04034004|520480306|FG003|Overall Study|could not find vein to administer IV|0|||
144349041|NCT04034004|520480303|FG000|Overall Study|nurse accidentally unblinded subject|0|||
144349042|NCT04034004|520480304|FG001|Overall Study|nurse accidentally unblinded subject|0|||
144349043|NCT04034004|520480305|FG002|Overall Study|nurse accidentally unblinded subject|0|||
144349044|NCT04034004|520480306|FG003|Overall Study|nurse accidentally unblinded subject|1|||
144349045|NCT04317040|520480308|FG000|Overall Study|Lost to Follow-up|2|||
144349046|NCT04317040|520480309|FG001|Overall Study|Lost to Follow-up|0|||
144349047|NCT04317040|520480308|FG000|Overall Study|Death|16|||
144349048|NCT04317040|520480309|FG001|Overall Study|Death|18|||
144349049|NCT04317040|520480308|FG000|Overall Study|Withdrawal by Subject|0|||
144349050|NCT04317040|520480309|FG001|Overall Study|Withdrawal by Subject|1|||
144349051|NCT04317040|520480308|FG000|Overall Study|Incomplete assessments|0|||
144349052|NCT04317040|520480309|FG001|Overall Study|Incomplete assessments|1|||
144349053|NCT03672292|520480310|FG000|Overall Study|Adverse Event|3|||
144349054|NCT03672292|520480311|FG001|Overall Study|Adverse Event|1|||
144349055|NCT03672292|520480310|FG000|Overall Study|Physician Decision|0|||
144349056|NCT03672292|520480311|FG001|Overall Study|Physician Decision|1|||
144349057|NCT03672292|520480310|FG000|Overall Study|Withdrawal by Subject|1|||
144349058|NCT03672292|520480311|FG001|Overall Study|Withdrawal by Subject|2|||
144349059|NCT00799903|520480312|FG000|Overall Study|Investigator Site Closed|25|||
144349060|NCT00799903|520480313|FG001|Overall Study|Investigator Site Closed|23|||
144349061|NCT00799903|520480312|FG000|Overall Study|Withdrawal by Subject|179|||
144349062|NCT00799903|520480313|FG001|Overall Study|Withdrawal by Subject|175|||
144349063|NCT00799903|520480312|FG000|Overall Study|Lost to Follow-up|69|||
144349064|NCT00799903|520480313|FG001|Overall Study|Lost to Follow-up|80|||
144349065|NCT02518971|520480314|FG000|Overall Study|Lost to Follow-up|0|||
144349066|NCT02518971|520480315|FG001|Overall Study|Lost to Follow-up|1|||
144349067|NCT02518971|520480314|FG000|Overall Study|Physician Decision|6|||
144349068|NCT02518971|520480315|FG001|Overall Study|Physician Decision|6|||
144349069|NCT02518971|520480314|FG000|Overall Study|Protocol Violation|6|||
144349070|NCT02518971|520480315|FG001|Overall Study|Protocol Violation|4|||
144349071|NCT02518971|520480314|FG000|Overall Study|Withdrawal by Subject|4|||
144349072|NCT02518971|520480315|FG001|Overall Study|Withdrawal by Subject|5|||
144349073|NCT02518971|520480314|FG000|Overall Study|Side effects|1|||
144349074|NCT02518971|520480315|FG001|Overall Study|Side effects|0|||
144349075|NCT02518971|520480314|FG000|Overall Study|medication lost in mail|0|||
144349076|NCT02518971|520480315|FG001|Overall Study|medication lost in mail|1|||
144349077|NCT02518971|520480314|FG000|Overall Study|eligibility criteria no longer met|6|||
144349078|NCT02518971|520480315|FG001|Overall Study|eligibility criteria no longer met|3|||
144349079|NCT03088917|520480316|FG000|Overall Study|In care/cured elsewhere|15|||
144349080|NCT03088917|520480316|FG000|Overall Study|Refuse re-evaluation|13|||
144349081|NCT03088917|520480316|FG000|Overall Study|Contact not established|13|||
144349082|NCT03088917|520480316|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
144349083|NCT03088917|520480316|FG000|Overall Study|Moved outside study region|50|||
144349084|NCT00757237|520480317|FG000|Overall Study|Lost to Follow-up|0|||
144349085|NCT00757237|520480318|FG001|Overall Study|Lost to Follow-up|1|||
144349086|NCT00757237|520480317|FG000|Overall Study|Protocol Violation|0|||
144349087|NCT00757237|520480318|FG001|Overall Study|Protocol Violation|2|||
144349088|NCT00757237|520480317|FG000|Overall Study|Physician Decision|2|||
144349089|NCT00757237|520480318|FG001|Overall Study|Physician Decision|3|||
144349090|NCT00757237|520480317|FG000|Overall Study|Withdrawal by Subject|8|||
144349091|NCT00757237|520480318|FG001|Overall Study|Withdrawal by Subject|12|||
144349092|NCT00757237|520480317|FG000|Overall Study|Safety or Tolerability|3|||
144349093|NCT00757237|520480318|FG001|Overall Study|Safety or Tolerability|5|||
144349094|NCT00757237|520480317|FG000|Overall Study|Other|0|||
144349095|NCT00757237|520480318|FG001|Overall Study|Other|2|||
144349096|NCT05150990|520480325|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
144349097|NCT05150990|520480326|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
144349098|NCT05150990|520480325|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
144349099|NCT05150990|520480326|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
144349100|NCT05150990|520480325|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
144349101|NCT05150990|520480326|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
144349102|NCT05150990|520480325|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
144349103|NCT05150990|520480326|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
144349104|NCT05150990|520480325|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
144349105|NCT05150990|520480326|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
144349106|NCT05150990|520480325|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
144349107|NCT05150990|520480326|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
144349108|NCT05150990|520480325|FG000|Overall Study|Death (unrelated to the intervention)|1|||
144349109|NCT05150990|520480326|FG001|Overall Study|Death (unrelated to the intervention)|2|||
144349110|NCT00779025|520480327|FG000|Overall Study|Withdrawal by Subject|1|||
144349111|NCT02735343|520480348|FG000|Overall Study|screen fail|0|||
144349112|NCT02735343|520480349|FG001|Overall Study|screen fail|2|||
144349113|NCT04752332|520480352|FG000|Overall Study|Adverse Event|3|||
144349114|NCT04752332|520480353|FG001|Overall Study|Adverse Event|1|||
144349115|NCT04752332|520480352|FG000|Overall Study|Disease Relapse|1|||
144349116|NCT04752332|520480353|FG001|Overall Study|Disease Relapse|0|||
144349117|NCT04752332|520480352|FG000|Overall Study|Non-compliance With Study Drug|2|||
144349118|NCT04752332|520480353|FG001|Overall Study|Non-compliance With Study Drug|0|||
144349119|NCT04752332|520480352|FG000|Overall Study|Physician Decision|2|||
144349120|NCT04752332|520480353|FG001|Overall Study|Physician Decision|1|||
144349121|NCT04752332|520480352|FG000|Overall Study|Protocol Violation|1|||
144349122|NCT04752332|520480353|FG001|Overall Study|Protocol Violation|1|||
144349123|NCT04752332|520480352|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
144349124|NCT04752332|520480353|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
144349125|NCT04752332|520480352|FG000|Overall Study|Study Terminated by Sponsor|10|||
144349126|NCT04752332|520480353|FG001|Overall Study|Study Terminated by Sponsor|48|||
144349127|NCT04752332|520480352|FG000|Overall Study|Withdrawal by Subject|11|||
144349128|NCT04752332|520480353|FG001|Overall Study|Withdrawal by Subject|3|||
144349129|NCT02915978|520480354|FG000|Overall Study|Adverse Event|2|||
144349130|NCT02915978|520480355|FG001|Overall Study|Adverse Event|1|||
144349131|NCT02915978|520480356|FG002|Overall Study|Adverse Event|0|||
144349132|NCT00924443|520480357|FG000|Overall Study|Physician Decision|2|||
144349133|NCT00924443|520480357|FG000|Overall Study|Protocol Violation|1|||
144349134|NCT01594931|520482247|FG000|Overall Study|Adverse Event|3|||
144349135|NCT01594931|520482248|FG001|Overall Study|Adverse Event|1|||
144349136|NCT01594931|520482249|FG002|Overall Study|Adverse Event|1|||
144349137|NCT01594931|520482247|FG000|Overall Study|Withdrawal by Subject|2|||
144349138|NCT01594931|520482248|FG001|Overall Study|Withdrawal by Subject|1|||
144349139|NCT01594931|520482249|FG002|Overall Study|Withdrawal by Subject|1|||
144349140|NCT01594931|520482247|FG000|Overall Study|Lack of Efficacy|7|||
144349141|NCT01594931|520482248|FG001|Overall Study|Lack of Efficacy|2|||
144349142|NCT01594931|520482249|FG002|Overall Study|Lack of Efficacy|2|||
144349143|NCT01594931|520482247|FG000|Overall Study|Lost to Follow-up|4|||
144349144|NCT01594931|520482248|FG001|Overall Study|Lost to Follow-up|3|||
144349145|NCT01594931|520482249|FG002|Overall Study|Lost to Follow-up|3|||
144349146|NCT01594931|520482247|FG000|Overall Study|Protocol Violation|2|||
144349147|NCT01594931|520482248|FG001|Overall Study|Protocol Violation|1|||
144349148|NCT01594931|520482249|FG002|Overall Study|Protocol Violation|0|||
144349149|NCT01594931|520482247|FG000|Overall Study|No defiined|11|||
144349150|NCT01594931|520482248|FG001|Overall Study|No defiined|4|||
144349151|NCT01594931|520482249|FG002|Overall Study|No defiined|7|||
144349152|NCT01101035|520482250|FG000|Overall Study|Adverse Event|191|||
144349153|NCT01101035|520482251|FG001|Overall Study|Adverse Event|172|||
144349154|NCT01101035|520482250|FG000|Overall Study|Major Protocol Deviation|52|||
144349155|NCT01101035|520482251|FG001|Overall Study|Major Protocol Deviation|46|||
144349156|NCT01101035|520482250|FG000|Overall Study|Lost to Follow-up|226|||
144349157|NCT01101035|520482251|FG001|Overall Study|Lost to Follow-up|223|||
144349158|NCT01101035|520482250|FG000|Overall Study|Voluntary Withdrawal|595|||
144349159|NCT01101035|520482251|FG001|Overall Study|Voluntary Withdrawal|587|||
144349160|NCT01101035|520482250|FG000|Overall Study|Reason not Specified|333|||
144349161|NCT01101035|520482251|FG001|Overall Study|Reason not Specified|363|||
144349162|NCT00922623|520482252|FG000|Overall Study|Other|4|||
144349163|NCT00922623|520482252|FG000|Overall Study|Lost to Follow-up|1|||
144349164|NCT02871635|520482253|FG000|Overall Study|Primary lack of efficacy|4|||
144349165|NCT02871635|520482254|FG001|Overall Study|Primary lack of efficacy|4|||
144349166|NCT02871635|520482253|FG000|Overall Study|Protocol Violation|3|||
144349167|NCT02871635|520482254|FG001|Overall Study|Protocol Violation|1|||
144349168|NCT02871635|520482253|FG000|Overall Study|Lost to Follow-up|1|||
144349169|NCT02871635|520482254|FG001|Overall Study|Lost to Follow-up|2|||
144349170|NCT02871635|520482253|FG000|Overall Study|Pregnancy|0|||
144349171|NCT02871635|520482254|FG001|Overall Study|Pregnancy|2|||
144349172|NCT02871635|520482253|FG000|Overall Study|Physician Decision|1|||
144349173|NCT02871635|520482254|FG001|Overall Study|Physician Decision|1|||
144349174|NCT02871635|520482253|FG000|Overall Study|Withdrawal by Subject|3|||
144349175|NCT02871635|520482254|FG001|Overall Study|Withdrawal by Subject|4|||
144349176|NCT02871635|520482253|FG000|Overall Study|Adverse Event|4|||
144349177|NCT02871635|520482254|FG001|Overall Study|Adverse Event|4|||
144349178|NCT02871635|520482253|FG000|Overall Study|Secondary lack of efficacy|2|||
144349179|NCT02871635|520482254|FG001|Overall Study|Secondary lack of efficacy|1|||
144349180|NCT00217425|520482255|FG000|Overall Study|Never started treatment|2|||
144349181|NCT00217425|520482255|FG000|Overall Study|Patient ineligible|5|||
144349182|NCT00217425|520482255|FG000|Overall Study|Lack of Efficacy|13|||
144349183|NCT00217425|520482255|FG000|Overall Study|Adverse Event|8|||
144349184|NCT00217425|520482255|FG000|Overall Study|Withdrawal by Subject|4|||
144349185|NCT00217425|520482255|FG000|Overall Study|Other complicating disease|1|||
144349186|NCT00217425|520482255|FG000|Overall Study|Other|4|||
144349187|NCT01395901|520482256|FG000|Overall Study|Lost to Follow-up|4|||
144349188|NCT01395901|520482257|FG001|Overall Study|Lost to Follow-up|0|||
144349189|NCT01395901|520482256|FG000|Overall Study|Randomized but not received study drug|5|||
144349190|NCT01395901|520482257|FG001|Overall Study|Randomized but not received study drug|4|||
144349191|NCT01395901|520482256|FG000|Overall Study|Adverse Event|0|||
144349192|NCT01395901|520482257|FG001|Overall Study|Adverse Event|1|||
144349193|NCT01395901|520482256|FG000|Overall Study|Withdrawal of consent|1|||
144349194|NCT01395901|520482257|FG001|Overall Study|Withdrawal of consent|0|||
144349195|NCT01217944|520482258|FG000|Overall Study|Protocol Violation|1|||
144349196|NCT01217944|520482259|FG001|Overall Study|Protocol Violation|1|||
144349197|NCT01217944|520482260|FG002|Overall Study|Protocol Violation|0|||
144349198|NCT01217944|520482258|FG000|Overall Study|Lost to Follow-up|3|||
144349199|NCT01217944|520482259|FG001|Overall Study|Lost to Follow-up|1|||
144349200|NCT01217944|520482260|FG002|Overall Study|Lost to Follow-up|0|||
144349201|NCT01217944|520482258|FG000|Overall Study|Withdrawal by Subject|1|||
144349202|NCT01217944|520482259|FG001|Overall Study|Withdrawal by Subject|2|||
144349203|NCT01217944|520482260|FG002|Overall Study|Withdrawal by Subject|0|||
144349204|NCT01217944|520482258|FG000|Overall Study|Lack of Efficacy|1|||
144349205|NCT01217944|520482259|FG001|Overall Study|Lack of Efficacy|0|||
144349206|NCT01217944|520482260|FG002|Overall Study|Lack of Efficacy|0|||
144349207|NCT00269919|520482261|FG000|Overall Study|Other|26|||
144349208|NCT00269919|520482261|FG000|Overall Study|Started but not treated|1|||
144349209|NCT02471014|520482262|FG000|Overall Study|Lost to Follow-up|2|||
144349210|NCT02471014|520482263|FG001|Overall Study|Lost to Follow-up|2|||
144349211|NCT00950846|520482266|FG000|Overall Study|Death|6|||
144349212|NCT00950846|520482266|FG000|Overall Study|Lost to Follow-up|3|||
144349213|NCT00950846|520482266|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
144349214|NCT02178995|520482269|FG000|Double Blind|Adverse Event|0|||
144349215|NCT02178995|520482270|FG001|Double Blind|Adverse Event|0|||
144349216|NCT02178995|520482271|FG002|Double Blind|Adverse Event|0|||
144349217|NCT02178995|520482272|FG003|Double Blind|Adverse Event|0|||
144349218|NCT02178995|520482273|FG004|Double Blind|Adverse Event|0|||
144349219|NCT02178995|520482274|FG005|Double Blind|Adverse Event|1|||
144349220|NCT02178995|520482275|FG006|Double Blind|Adverse Event|0|||
144349221|NCT02178995|520482276|FG007|Double Blind|Adverse Event|1|||
144349222|NCT02178995|520482277|FG008|Double Blind|Adverse Event|1|||
144349223|NCT02178995|520482269|FG000|Double Blind|Lost to Follow-up|0|||
144349224|NCT02178995|520482270|FG001|Double Blind|Lost to Follow-up|1|||
144349225|NCT02178995|520482271|FG002|Double Blind|Lost to Follow-up|0|||
144349226|NCT02178995|520482272|FG003|Double Blind|Lost to Follow-up|0|||
144349227|NCT02178995|520482273|FG004|Double Blind|Lost to Follow-up|0|||
144349228|NCT02178995|520482274|FG005|Double Blind|Lost to Follow-up|0|||
144349229|NCT02178995|520482275|FG006|Double Blind|Lost to Follow-up|0|||
144349230|NCT02178995|520482276|FG007|Double Blind|Lost to Follow-up|1|||
144349231|NCT02178995|520482277|FG008|Double Blind|Lost to Follow-up|0|||
144349232|NCT02178995|520482269|FG000|Open Label|Adverse Event|2|||
144349233|NCT02178995|520482270|FG001|Open Label|Adverse Event|0|||
144349234|NCT02178995|520482271|FG002|Open Label|Adverse Event|0|||
144349235|NCT02178995|520482272|FG003|Open Label|Adverse Event|0|||
144349236|NCT02178995|520482273|FG004|Open Label|Adverse Event|0|||
144349237|NCT02178995|520482274|FG005|Open Label|Adverse Event|0|||
144349238|NCT02178995|520482275|FG006|Open Label|Adverse Event|0|||
144349239|NCT02178995|520482276|FG007|Open Label|Adverse Event|0|||
144349240|NCT02178995|520482277|FG008|Open Label|Adverse Event|0|||
144349241|NCT00981461|520482278|FG000|Overall Study|Lost to Follow-up|5|||
144349242|NCT00981461|520482279|FG001|Overall Study|Lost to Follow-up|2|||
144349243|NCT03361293|520482282|FG000|Overall Study|Lost to Follow-up|0|||
144349244|NCT03361293|520482283|FG001|Overall Study|Lost to Follow-up|2|||
144349245|NCT03361293|520482282|FG000|Overall Study|Withdrawal by Subject|1|||
144349246|NCT03361293|520482283|FG001|Overall Study|Withdrawal by Subject|3|||
144349247|NCT00483405|520482284|FG000|Overall Study|Adverse Event|8|||
144349248|NCT00483405|520482284|FG000|Overall Study|Lack of Efficacy|14|||
144349249|NCT00483405|520482284|FG000|Overall Study|Death|3|||
144349250|NCT00483405|520482284|FG000|Overall Study|Withdrawal by Subject|2|||
144349251|NCT00483405|520482284|FG000|Overall Study|Other complicating disease|1|||
144349252|NCT00571038|520482285|FG000|Overall Study|Lost to Follow-up|1|||
144349253|NCT00571038|520482286|FG001|Overall Study|Lost to Follow-up|4|||
144349254|NCT00571038|520482285|FG000|Overall Study|Death|7|||
144349255|NCT00571038|520482286|FG001|Overall Study|Death|5|||
144349256|NCT00571038|520482285|FG000|Overall Study|Withdrawal by Subject|1|||
144349257|NCT00571038|520482286|FG001|Overall Study|Withdrawal by Subject|3|||
144349258|NCT00571038|520482285|FG000|Overall Study|Moved out of state|2|||
144349259|NCT00571038|520482286|FG001|Overall Study|Moved out of state|2|||
144349260|NCT01426958|520482287|FG000|Overall Study|Adverse Event|2|||
144349261|NCT01843023|520482295|FG000|Overall Study|Death|1|||
144349262|NCT01843023|520482296|FG001|Overall Study|Death|0|||
144349263|NCT01843023|520482295|FG000|Overall Study|Lost to Follow-up|24|||
144349264|NCT01843023|520482296|FG001|Overall Study|Lost to Follow-up|29|||
144349265|NCT01843023|520482295|FG000|Overall Study|Withdrawal by Subject|8|||
144349266|NCT01843023|520482296|FG001|Overall Study|Withdrawal by Subject|6|||
144349267|NCT00466921|520482297|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
144349268|NCT00466921|520482297|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
144349269|NCT00466921|520482297|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
144349270|NCT00466921|520482297|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
144349271|NCT00466921|520482297|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
144349272|NCT00466921|520482297|FG000|Follow up for a Minimum of 1 Year|Death|6|||
144349273|NCT03305770|520482298|FG000|Overall Study|Physician Decision - prior to dispense|0|||
144349274|NCT03305770|520482299|FG001|Overall Study|Physician Decision - prior to dispense|1|||
144349275|NCT03305770|520482298|FG000|Overall Study|Subject moved|1|||
144349276|NCT03305770|520482299|FG001|Overall Study|Subject moved|0|||
144349277|NCT03539601|520482300|FG000|Overall Study|Withdraw by parent/guardian|1|||
144349278|NCT03539601|520482301|FG001|Overall Study|Withdraw by parent/guardian|0|||
144349279|NCT03539601|520482302|FG002|Overall Study|Withdraw by parent/guardian|1|||
144349280|NCT03539601|520482303|FG003|Overall Study|Withdraw by parent/guardian|0|||
144349281|NCT03539601|520482300|FG000|Overall Study|Adverse Event|0|||
144349282|NCT03539601|520482301|FG001|Overall Study|Adverse Event|2|||
144349283|NCT03539601|520482302|FG002|Overall Study|Adverse Event|0|||
144349284|NCT03539601|520482303|FG003|Overall Study|Adverse Event|0|||
144349285|NCT03539601|520482300|FG000|Overall Study|Lost to Follow-up|2|||
144349286|NCT03539601|520482301|FG001|Overall Study|Lost to Follow-up|4|||
144349287|NCT03539601|520482302|FG002|Overall Study|Lost to Follow-up|5|||
144349288|NCT03539601|520482303|FG003|Overall Study|Lost to Follow-up|0|||
144349289|NCT03539601|520482300|FG000|Overall Study|Withdrawal by Subject|2|||
144349290|NCT03539601|520482301|FG001|Overall Study|Withdrawal by Subject|0|||
144349291|NCT03539601|520482302|FG002|Overall Study|Withdrawal by Subject|0|||
144349292|NCT03539601|520482303|FG003|Overall Study|Withdrawal by Subject|1|||
144349293|NCT03539601|520482300|FG000|Overall Study|Randomized but not treated|1|||
144349294|NCT03539601|520482301|FG001|Overall Study|Randomized but not treated|1|||
144349295|NCT03539601|520482302|FG002|Overall Study|Randomized but not treated|0|||
144349296|NCT03539601|520482303|FG003|Overall Study|Randomized but not treated|0|||
144349297|NCT02741635|520482309|FG000|Overall Study|Withdrawal by Subject|1|||
144349298|NCT01427933|520482313|FG000|Overall Study|Withdrawal by Subject|5|||
144349299|NCT01427933|520482314|FG001|Overall Study|Withdrawal by Subject|8|||
144349300|NCT01427933|520482313|FG000|Overall Study|Lost to Follow-up|1|||
144349301|NCT01427933|520482314|FG001|Overall Study|Lost to Follow-up|5|||
144349302|NCT01427933|520482313|FG000|Overall Study|Other|1|||
144349303|NCT01427933|520482314|FG001|Overall Study|Other|0|||
144349304|NCT01427933|520482313|FG000|Overall Study|Investigator's Decision|1|||
144349305|NCT01427933|520482314|FG001|Overall Study|Investigator's Decision|0|||
144349306|NCT01633541|520482315|FG000|Overall Study|Death|1|||
144349307|NCT01633541|520482316|FG001|Overall Study|Death|0|||
144349308|NCT03472326|520482319|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
144349309|NCT03472326|520482320|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
144349310|NCT03472326|520482321|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
144349311|NCT03472326|520482322|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
144349312|NCT03472326|520482319|FG000|Part 2: Combination Therapy|Pregnancy|0|||
144349313|NCT03472326|520482320|FG001|Part 2: Combination Therapy|Pregnancy|0|||
144349314|NCT03472326|520482321|FG002|Part 2: Combination Therapy|Pregnancy|0|||
144349315|NCT03472326|520482322|FG003|Part 2: Combination Therapy|Pregnancy|1|||
144349316|NCT01010971|520482323|FG000|Overall Study|Adverse Event|2|||
144349317|NCT01010971|520482324|FG001|Overall Study|Adverse Event|4|||
144349318|NCT01010971|520482325|FG002|Overall Study|Adverse Event|3|||
144349319|NCT01010971|520482323|FG000|Overall Study|Withdrawal by Subject|0|||
144349320|NCT01010971|520482324|FG001|Overall Study|Withdrawal by Subject|2|||
144349321|NCT01010971|520482325|FG002|Overall Study|Withdrawal by Subject|5|||
144349322|NCT01010971|520482323|FG000|Overall Study|Lost to Follow-up|0|||
144349323|NCT01010971|520482324|FG001|Overall Study|Lost to Follow-up|2|||
144349324|NCT01010971|520482325|FG002|Overall Study|Lost to Follow-up|3|||
144349325|NCT01010971|520482323|FG000|Overall Study|Other|1|||
144349326|NCT01010971|520482324|FG001|Overall Study|Other|0|||
144349327|NCT01010971|520482325|FG002|Overall Study|Other|2|||
144349328|NCT05447663|520482326|FG000|Overall Study|Study terminated by Sponsor|5|||
144349329|NCT05447663|520482326|FG000|Overall Study|Death|2|||
144349330|NCT05447663|520482326|FG000|Overall Study|Withdrawal by Subject|1|||
144349331|NCT04669301|520482327|FG000|Overall Study|Lost to Follow-up|0|||
144349332|NCT04669301|520482328|FG001|Overall Study|Lost to Follow-up|1|||
144349333|NCT04669301|520482329|FG002|Overall Study|Lost to Follow-up|0|||
144349334|NCT04669301|520482327|FG000|Overall Study|Withdrawal by Subject|3|||
144349335|NCT04669301|520482328|FG001|Overall Study|Withdrawal by Subject|2|||
144349336|NCT04669301|520482329|FG002|Overall Study|Withdrawal by Subject|0|||
144349337|NCT01221350|520482332|FG000|Overall Study|Discontinued intervention (GERD)|1|||
144349338|NCT01221350|520482333|FG001|Overall Study|Discontinued intervention (GERD)|0|||
144349339|NCT01221350|520482332|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
144349340|NCT01221350|520482333|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
144349341|NCT01221350|520482332|FG000|Overall Study|Withdrawal by Subject|4|||
144349342|NCT01221350|520482333|FG001|Overall Study|Withdrawal by Subject|2|||
144349343|NCT05236257|520482336|FG000|Overall Study|Ongoing with study treatment|29|||
144349344|NCT05236257|520482337|FG001|Overall Study|Ongoing with study treatment|1|||
144349345|NCT05236257|520482336|FG000|Overall Study|Discontinued study treatment|22|||
144349346|NCT05236257|520482337|FG001|Overall Study|Discontinued study treatment|41|||
144349347|NCT00548145|520482340|FG000|Overall Study|Death|0|||
144349348|NCT00548145|520482341|FG001|Overall Study|Death|1|||
144349349|NCT00548145|520482340|FG000|Overall Study|Withdrawal by Subject|0|||
144349350|NCT00548145|520482341|FG001|Overall Study|Withdrawal by Subject|2|||
144349351|NCT00548145|520482340|FG000|Overall Study|Physician Decision|1|||
144349352|NCT00548145|520482341|FG001|Overall Study|Physician Decision|1|||
144349353|NCT00874848|520482342|FG000|Overall Study|Adverse Event|13|||
144349354|NCT00874848|520482343|FG001|Overall Study|Adverse Event|2|||
144349355|NCT00874848|520482342|FG000|Overall Study|Progressive neoplastic disease|38|||
144349356|NCT00874848|520482343|FG001|Overall Study|Progressive neoplastic disease|18|||
144349357|NCT00874848|520482342|FG000|Overall Study|Withdrawal by Subject|7|||
144349358|NCT00874848|520482343|FG001|Overall Study|Withdrawal by Subject|4|||
144349359|NCT00874848|520482342|FG000|Overall Study|Noncompliance|1|||
144349360|NCT00874848|520482343|FG001|Overall Study|Noncompliance|1|||
144349361|NCT00874848|520482342|FG000|Overall Study|Failure to comply with protocol|0|||
144349362|NCT00874848|520482343|FG001|Overall Study|Failure to comply with protocol|1|||
144349363|NCT00874848|520482342|FG000|Overall Study|Physician Decision|0|||
144349364|NCT00874848|520482343|FG001|Overall Study|Physician Decision|2|||
144349365|NCT02451124|520482348|FG000|Overall Study|Withdrawal by Subject|1|||
144349366|NCT03301350|520482349|FG000|Overall Study|Withdrawal by Subject|4|||
144349367|NCT03301350|520482349|FG000|Overall Study|Adverse Event|1|||
144349368|NCT03301350|520482349|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
144349369|NCT03301350|520482349|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
144349370|NCT03301350|520482349|FG000|Overall Study|no detail provided|1|||
144349371|NCT01248949|520482350|FG000|Overall Study|Lost to Follow-up|2|||
144349372|NCT01248949|520482351|FG001|Overall Study|Lost to Follow-up|2|||
144349373|NCT01248949|520482352|FG002|Overall Study|Lost to Follow-up|2|||
144349374|NCT01248949|520482353|FG003|Overall Study|Lost to Follow-up|1|||
144349375|NCT01248949|520482354|FG004|Overall Study|Lost to Follow-up|0|||
144349376|NCT01248949|520482350|FG000|Overall Study|Withdrawal by Subject|5|||
144349377|NCT01248949|520482351|FG001|Overall Study|Withdrawal by Subject|3|||
144349378|NCT01248949|520482352|FG002|Overall Study|Withdrawal by Subject|11|||
144349379|NCT01248949|520482353|FG003|Overall Study|Withdrawal by Subject|3|||
144349380|NCT01248949|520482354|FG004|Overall Study|Withdrawal by Subject|1|||
144349381|NCT01248949|520482350|FG000|Overall Study|Death|22|||
144349382|NCT01248949|520482351|FG001|Overall Study|Death|7|||
144349383|NCT01248949|520482352|FG002|Overall Study|Death|21|||
144349384|NCT01248949|520482353|FG003|Overall Study|Death|6|||
144349385|NCT01248949|520482354|FG004|Overall Study|Death|2|||
144349386|NCT01248949|520482350|FG000|Overall Study|Alternative Therapy|1|||
144349387|NCT01248949|520482351|FG001|Overall Study|Alternative Therapy|0|||
144349388|NCT01248949|520482352|FG002|Overall Study|Alternative Therapy|0|||
144349389|NCT01248949|520482353|FG003|Overall Study|Alternative Therapy|0|||
144349390|NCT01248949|520482354|FG004|Overall Study|Alternative Therapy|0|||
144349391|NCT01248949|520482350|FG000|Overall Study|Alternative Therapy.|1|||
144349392|NCT01248949|520482351|FG001|Overall Study|Alternative Therapy.|0|||
144349393|NCT01248949|520482352|FG002|Overall Study|Alternative Therapy.|0|||
144349394|NCT01248949|520482353|FG003|Overall Study|Alternative Therapy.|0|||
144349395|NCT01248949|520482354|FG004|Overall Study|Alternative Therapy.|0|||
144349396|NCT01248949|520482350|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
144349397|NCT01248949|520482351|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
144349398|NCT01248949|520482352|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
144349399|NCT01248949|520482353|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
144349400|NCT01248949|520482354|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
144349401|NCT01248949|520482350|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
144349402|NCT01248949|520482351|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
144349403|NCT01248949|520482352|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
144349404|NCT01248949|520482353|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
144349405|NCT01248949|520482354|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
144349406|NCT01248949|520482350|FG000|Overall Study|Participant Went To Hospice|0|||
144349407|NCT01248949|520482351|FG001|Overall Study|Participant Went To Hospice|0|||
144349408|NCT01248949|520482352|FG002|Overall Study|Participant Went To Hospice|1|||
144349409|NCT01248949|520482353|FG003|Overall Study|Participant Went To Hospice|0|||
144349410|NCT01248949|520482354|FG004|Overall Study|Participant Went To Hospice|0|||
144349411|NCT01248949|520482350|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
144349412|NCT01248949|520482351|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
144349413|NCT01248949|520482352|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
144349414|NCT01248949|520482353|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
144349415|NCT01248949|520482354|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
144349416|NCT01248949|520482350|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
144349417|NCT01248949|520482351|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
144349418|NCT01248949|520482352|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
144349419|NCT01248949|520482353|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
144349420|NCT01248949|520482354|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
144349421|NCT01248949|520482350|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
144349422|NCT01248949|520482351|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
144349423|NCT01248949|520482352|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
144349424|NCT01248949|520482353|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
144349425|NCT01248949|520482354|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
144349426|NCT01248949|520482350|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
144349427|NCT01248949|520482351|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
144349428|NCT01248949|520482352|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
144349429|NCT01248949|520482353|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
144349430|NCT01248949|520482354|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
144349431|NCT00286429|520482355|FG000|Overall Study|Adverse Event|4|||
144349432|NCT00286429|520482356|FG001|Overall Study|Adverse Event|1|||
144349433|NCT00286429|520482357|FG002|Overall Study|Adverse Event|6|||
144349434|NCT00286429|520482355|FG000|Overall Study|Lack of Efficacy|52|||
144349435|NCT00286429|520482356|FG001|Overall Study|Lack of Efficacy|27|||
144349436|NCT00286429|520482357|FG002|Overall Study|Lack of Efficacy|25|||
144349437|NCT00286429|520482355|FG000|Overall Study|Lost to Follow-up|2|||
144349438|NCT00286429|520482356|FG001|Overall Study|Lost to Follow-up|4|||
144349439|NCT00286429|520482357|FG002|Overall Study|Lost to Follow-up|3|||
144349440|NCT00286429|520482355|FG000|Overall Study|Physician Decision|10|||
144349441|NCT00286429|520482356|FG001|Overall Study|Physician Decision|7|||
144349442|NCT00286429|520482357|FG002|Overall Study|Physician Decision|7|||
144349443|NCT00286429|520482355|FG000|Overall Study|Protocol Violation|3|||
144349444|NCT00286429|520482356|FG001|Overall Study|Protocol Violation|5|||
144349445|NCT00286429|520482357|FG002|Overall Study|Protocol Violation|4|||
144349446|NCT00286429|520482355|FG000|Overall Study|Withdrawal by Subject|3|||
144349447|NCT00286429|520482356|FG001|Overall Study|Withdrawal by Subject|2|||
144349448|NCT00286429|520482357|FG002|Overall Study|Withdrawal by Subject|6|||
144349449|NCT00286429|520482355|FG000|Overall Study|Administrative Error|1|||
144349450|NCT00286429|520482356|FG001|Overall Study|Administrative Error|1|||
144349451|NCT00286429|520482357|FG002|Overall Study|Administrative Error|1|||
144349452|NCT00286429|520482355|FG000|Overall Study|Administrative Decision|0|||
144349453|NCT00286429|520482356|FG001|Overall Study|Administrative Decision|1|||
144349454|NCT00286429|520482357|FG002|Overall Study|Administrative Decision|0|||
144349455|NCT01746225|520482360|FG000|Overall Study|Death|1|||
144349456|NCT01746225|520482361|FG001|Overall Study|Death|0|||
144349457|NCT01746225|520482362|FG002|Overall Study|Death|1|||
144349458|NCT01746225|520482360|FG000|Overall Study|Withdrawal by Subject|5|||
144349459|NCT01746225|520482361|FG001|Overall Study|Withdrawal by Subject|15|||
144349460|NCT01746225|520482362|FG002|Overall Study|Withdrawal by Subject|19|||
144349461|NCT01746225|520482360|FG000|Overall Study|Physician Decision|14|||
144349462|NCT01746225|520482361|FG001|Overall Study|Physician Decision|11|||
144349463|NCT01746225|520482362|FG002|Overall Study|Physician Decision|3|||
144349464|NCT01746225|520482360|FG000|Overall Study|Adverse Event|15|||
144349465|NCT01746225|520482361|FG001|Overall Study|Adverse Event|12|||
144349466|NCT01746225|520482362|FG002|Overall Study|Adverse Event|17|||
144349467|NCT01746225|520482360|FG000|Overall Study|Continuing Treatment|5|||
144349468|NCT01746225|520482361|FG001|Overall Study|Continuing Treatment|8|||
144349469|NCT01746225|520482362|FG002|Overall Study|Continuing Treatment|3|||
144349470|NCT03245775|520482365|FG000|Overall Study|Lost to Follow-up|25|||
144349471|NCT03245775|520482366|FG001|Overall Study|Lost to Follow-up|26|||
144349472|NCT03245775|520482367|FG002|Overall Study|Lost to Follow-up|16|||
144349473|NCT03245775|520482368|FG003|Overall Study|Lost to Follow-up|16|||
144349474|NCT02713828|520482371|FG000|Overall Study|Death|2|||
144349475|NCT02713828|520482372|FG001|Overall Study|Death|0|||
144349476|NCT02713828|520482371|FG000|Overall Study|Withdrawal by Subject|1|||
144349477|NCT02713828|520482372|FG001|Overall Study|Withdrawal by Subject|0|||
144349478|NCT02713828|520482371|FG000|Overall Study|study terminated but patient allowed to|2|||
144349479|NCT02713828|520482372|FG001|Overall Study|study terminated but patient allowed to|0|||
144349480|NCT03302247|520482373|FG000|Overall Study|the study has closed prematurely|2|||
144349481|NCT03302247|520482373|FG000|Overall Study|Death|1|||
144349482|NCT03197376|520482374|FG000|Primary and Booster Phase|Adverse Event|0|||
144349483|NCT03197376|520482375|FG001|Primary and Booster Phase|Adverse Event|0|||
144349484|NCT03197376|520482376|FG002|Primary and Booster Phase|Adverse Event|0|||
144349485|NCT03197376|520482377|FG003|Primary and Booster Phase|Adverse Event|1|||
144349486|NCT03197376|520482374|FG000|Primary and Booster Phase|Death|1|||
144349487|NCT03197376|520482375|FG001|Primary and Booster Phase|Death|0|||
144349488|NCT03197376|520482376|FG002|Primary and Booster Phase|Death|0|||
144349489|NCT03197376|520482377|FG003|Primary and Booster Phase|Death|2|||
144349490|NCT03197376|520482374|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
144349491|NCT03197376|520482375|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
144349492|NCT03197376|520482376|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
144349493|NCT03197376|520482377|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
144349494|NCT03197376|520482374|FG000|Primary and Booster Phase|Physician Decision|1|||
144349495|NCT03197376|520482375|FG001|Primary and Booster Phase|Physician Decision|0|||
144349496|NCT03197376|520482376|FG002|Primary and Booster Phase|Physician Decision|1|||
144349497|NCT03197376|520482377|FG003|Primary and Booster Phase|Physician Decision|3|||
144349498|NCT03197376|520482374|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
144349499|NCT03197376|520482375|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
144349500|NCT03197376|520482376|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
144349501|NCT03197376|520482377|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
144349502|NCT03197376|520482374|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
144349503|NCT03197376|520482375|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
144349504|NCT03197376|520482376|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
144349505|NCT03197376|520482377|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
144349506|NCT03197376|520482374|FG000|Primary and Booster Phase|Not vaccine related|1|||
144349507|NCT03197376|520482375|FG001|Primary and Booster Phase|Not vaccine related|2|||
144349508|NCT03197376|520482376|FG002|Primary and Booster Phase|Not vaccine related|0|||
144349509|NCT03197376|520482377|FG003|Primary and Booster Phase|Not vaccine related|6|||
144349510|NCT03197376|520482374|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
144349511|NCT03197376|520482375|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
144349512|NCT03197376|520482376|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
144349513|NCT03197376|520482377|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
144349514|NCT03197376|520482374|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
144349515|NCT03197376|520482375|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
144349516|NCT03197376|520482376|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
144349517|NCT03197376|520482377|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
144349518|NCT03197376|520482374|FG000|Immune Persistence Phase|Not vaccine related|1|||
144349519|NCT03197376|520482375|FG001|Immune Persistence Phase|Not vaccine related|0|||
144349520|NCT03197376|520482376|FG002|Immune Persistence Phase|Not vaccine related|1|||
144349521|NCT03197376|520482377|FG003|Immune Persistence Phase|Not vaccine related|1|||
144349522|NCT01123395|520482379|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
144349523|NCT01123395|520482380|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
144349524|NCT03691571|520482381|FG000|Overall Study|Withdrawal by Subject|9|||
144349525|NCT03691571|520482382|FG001|Overall Study|Withdrawal by Subject|2|||
144349526|NCT03887221|520482384|FG000|Overall Study|Protocol Violation|1|||
144349527|NCT03887221|520482385|FG001|Overall Study|Protocol Violation|0|||
144349528|NCT00947115|520482386|FG000|Overall Study|Missed reporting interval|3|||
144349529|NCT00947115|520482387|FG001|Overall Study|Missed reporting interval|4|||
144349530|NCT00947115|520482388|FG002|Overall Study|Missed reporting interval|2|||
144349531|NCT00947115|520482386|FG000|Overall Study|Physician Decision|0|||
144349532|NCT00947115|520482387|FG001|Overall Study|Physician Decision|2|||
144349533|NCT00947115|520482388|FG002|Overall Study|Physician Decision|0|||
144349534|NCT00947115|520482386|FG000|Overall Study|Death|0|||
144349535|NCT00947115|520482387|FG001|Overall Study|Death|1|||
144349536|NCT00947115|520482388|FG002|Overall Study|Death|1|||
144349537|NCT00947115|520482386|FG000|Overall Study|Migrated from study area|2|||
144349538|NCT00947115|520482387|FG001|Overall Study|Migrated from study area|0|||
144349539|NCT00947115|520482388|FG002|Overall Study|Migrated from study area|0|||
144349540|NCT00947115|520482386|FG000|Overall Study|Withdrawal by Subject|1|||
144349541|NCT00947115|520482387|FG001|Overall Study|Withdrawal by Subject|3|||
144349542|NCT00947115|520482388|FG002|Overall Study|Withdrawal by Subject|4|||
144349543|NCT00947115|520482386|FG000|Overall Study|Lost to Follow-up|11|||
144349544|NCT00947115|520482387|FG001|Overall Study|Lost to Follow-up|12|||
144349545|NCT00947115|520482388|FG002|Overall Study|Lost to Follow-up|8|||
144349546|NCT02487030|520482389|FG000|Overall Study|Lack of Efficacy|2|||
144349547|NCT02487030|520482390|FG001|Overall Study|Lack of Efficacy|4|||
144349548|NCT02487030|520482391|FG002|Overall Study|Lack of Efficacy|1|||
144349549|NCT02487030|520482392|FG003|Overall Study|Lack of Efficacy|0|||
144349550|NCT02487030|520482393|FG004|Overall Study|Lack of Efficacy|1|||
144349551|NCT02487030|520482394|FG005|Overall Study|Lack of Efficacy|0|||
144349552|NCT02487030|520482395|FG006|Overall Study|Lack of Efficacy|0|||
144349553|NCT02487030|520482389|FG000|Overall Study|Lost to Follow-up|0|||
144349554|NCT02487030|520482390|FG001|Overall Study|Lost to Follow-up|0|||
144349555|NCT02487030|520482391|FG002|Overall Study|Lost to Follow-up|1|||
144349556|NCT02487030|520482392|FG003|Overall Study|Lost to Follow-up|1|||
144349557|NCT02487030|520482393|FG004|Overall Study|Lost to Follow-up|0|||
144349558|NCT02487030|520482394|FG005|Overall Study|Lost to Follow-up|1|||
144349559|NCT02487030|520482395|FG006|Overall Study|Lost to Follow-up|0|||
144349560|NCT02487030|520482389|FG000|Overall Study|Adverse Event|0|||
144349561|NCT02487030|520482390|FG001|Overall Study|Adverse Event|0|||
144349562|NCT02487030|520482391|FG002|Overall Study|Adverse Event|0|||
144349563|NCT02487030|520482392|FG003|Overall Study|Adverse Event|1|||
144349564|NCT02487030|520482393|FG004|Overall Study|Adverse Event|0|||
144349565|NCT02487030|520482394|FG005|Overall Study|Adverse Event|0|||
144349566|NCT02487030|520482395|FG006|Overall Study|Adverse Event|0|||
144349567|NCT02487030|520482389|FG000|Overall Study|Death|0|||
144349568|NCT02487030|520482390|FG001|Overall Study|Death|0|||
144349569|NCT02487030|520482391|FG002|Overall Study|Death|0|||
144349570|NCT02487030|520482392|FG003|Overall Study|Death|0|||
144349571|NCT02487030|520482393|FG004|Overall Study|Death|1|||
144349572|NCT02487030|520482394|FG005|Overall Study|Death|0|||
144349573|NCT02487030|520482395|FG006|Overall Study|Death|0|||
144349574|NCT00900029|520482398|FG000|Overall Study|Lost to Follow-up|0|||
144349575|NCT00900029|520482399|FG001|Overall Study|Lost to Follow-up|2|||
144349576|NCT00900029|520482400|FG002|Overall Study|Lost to Follow-up|1|||
144349577|NCT00900029|520482401|FG003|Overall Study|Lost to Follow-up|4|||
144349578|NCT00900029|520482402|FG004|Overall Study|Lost to Follow-up|4|||
144349579|NCT00900029|520482398|FG000|Overall Study|Withdrawal by Subject|2|||
144349580|NCT00900029|520482399|FG001|Overall Study|Withdrawal by Subject|2|||
144349581|NCT00900029|520482400|FG002|Overall Study|Withdrawal by Subject|1|||
144349582|NCT00900029|520482401|FG003|Overall Study|Withdrawal by Subject|1|||
144349583|NCT00900029|520482402|FG004|Overall Study|Withdrawal by Subject|1|||
144349584|NCT00900029|520482398|FG000|Overall Study|Adverse Event|0|||
144349585|NCT00900029|520482399|FG001|Overall Study|Adverse Event|0|||
144349586|NCT00900029|520482400|FG002|Overall Study|Adverse Event|1|||
144349587|NCT00900029|520482401|FG003|Overall Study|Adverse Event|1|||
144349588|NCT00900029|520482402|FG004|Overall Study|Adverse Event|1|||
144349589|NCT00900029|520482398|FG000|Overall Study|Death|1|||
144349590|NCT00900029|520482399|FG001|Overall Study|Death|0|||
144349591|NCT00900029|520482400|FG002|Overall Study|Death|0|||
144349592|NCT00900029|520482401|FG003|Overall Study|Death|1|||
144349593|NCT00900029|520482402|FG004|Overall Study|Death|0|||
144349594|NCT02587819|520482403|FG000|Overall Study|Adverse Event|1|||
144349595|NCT02587819|520482403|FG000|Overall Study|Lost to Follow-up|1|||
144349596|NCT00511238|520482406|FG000|Overall Study|Adverse Event|13|||
144349597|NCT00511238|520482407|FG001|Overall Study|Adverse Event|33|||
144349598|NCT00511238|520482406|FG000|Overall Study|Withdrawal by Subject|2|||
144349599|NCT00511238|520482407|FG001|Overall Study|Withdrawal by Subject|22|||
144349600|NCT00511238|520482406|FG000|Overall Study|Progressive Disease|23|||
144349601|NCT00511238|520482407|FG001|Overall Study|Progressive Disease|157|||
144349602|NCT00511238|520482406|FG000|Overall Study|various reasons|4|||
144349603|NCT00511238|520482407|FG001|Overall Study|various reasons|14|||
144349604|NCT00163020|520482408|FG000|Overall Study|Lost to Follow-up|0|||
144349605|NCT00163020|520482409|FG001|Overall Study|Lost to Follow-up|2|||
144349606|NCT03937713|520483950|FG000|Overall Study|Withdrawal by Subject|3|||
144349607|NCT03937713|520483951|FG001|Overall Study|Withdrawal by Subject|6|||
144349608|NCT03937713|520483950|FG000|Overall Study|Lost to Follow-up|1|||
144349609|NCT03937713|520483951|FG001|Overall Study|Lost to Follow-up|0|||
144349610|NCT02420379|520483957|FG000|Overall Study|Withdrawal by Subject|0|||
144349611|NCT02420379|520483958|FG001|Overall Study|Withdrawal by Subject|3|||
144349612|NCT02420379|520483957|FG000|Overall Study|Unable to complete due to schooling|0|||
144349613|NCT02420379|520483958|FG001|Overall Study|Unable to complete due to schooling|1|||
144349614|NCT02420379|520483957|FG000|Overall Study|Transitioned to commercial drug|1|||
144349615|NCT02420379|520483958|FG001|Overall Study|Transitioned to commercial drug|0|||
144349616|NCT00086047|520483960|FG000|Overall Study|Lost to Follow-up|7|||
144349617|NCT00086047|520483961|FG001|Overall Study|Lost to Follow-up|6|||
144349618|NCT00086047|520483960|FG000|Overall Study|Physician Decision|0|||
144349619|NCT00086047|520483961|FG001|Overall Study|Physician Decision|1|||
144349620|NCT00786799|520483970|FG000|Overall Study|Lost to Follow-up|1|||
144349621|NCT00786799|520483971|FG001|Overall Study|Lost to Follow-up|1|||
144349622|NCT02631551|520483972|FG000|Overall Study|Adverse Event|1|||
144349623|NCT02631551|520483973|FG001|Overall Study|Adverse Event|2|||
144349624|NCT02631551|520483974|FG002|Overall Study|Adverse Event|4|||
144349625|NCT02631551|520483975|FG003|Overall Study|Adverse Event|0|||
144349626|NCT02631551|520483972|FG000|Overall Study|Lack of Efficacy|0|||
144349627|NCT02631551|520483973|FG001|Overall Study|Lack of Efficacy|0|||
144349628|NCT02631551|520483974|FG002|Overall Study|Lack of Efficacy|1|||
144349629|NCT02631551|520483975|FG003|Overall Study|Lack of Efficacy|0|||
144349630|NCT02631551|520483972|FG000|Overall Study|Lost to Follow-up|1|||
144349631|NCT02631551|520483973|FG001|Overall Study|Lost to Follow-up|2|||
144349632|NCT02631551|520483974|FG002|Overall Study|Lost to Follow-up|0|||
144349633|NCT02631551|520483975|FG003|Overall Study|Lost to Follow-up|3|||
144349634|NCT02631551|520483972|FG000|Overall Study|Withdrawal by Subject|2|||
144349635|NCT02631551|520483973|FG001|Overall Study|Withdrawal by Subject|2|||
144349636|NCT02631551|520483974|FG002|Overall Study|Withdrawal by Subject|0|||
144349637|NCT02631551|520483975|FG003|Overall Study|Withdrawal by Subject|5|||
144349638|NCT02631551|520483972|FG000|Overall Study|Protocol deviation|3|||
144349639|NCT02631551|520483973|FG001|Overall Study|Protocol deviation|6|||
144349640|NCT02631551|520483974|FG002|Overall Study|Protocol deviation|3|||
144349641|NCT02631551|520483975|FG003|Overall Study|Protocol deviation|0|||
144349642|NCT02631551|520483972|FG000|Overall Study|Non-compliance with study procedures|0|||
144349643|NCT02631551|520483973|FG001|Overall Study|Non-compliance with study procedures|0|||
144349644|NCT02631551|520483974|FG002|Overall Study|Non-compliance with study procedures|1|||
144349645|NCT02631551|520483975|FG003|Overall Study|Non-compliance with study procedures|1|||
144349646|NCT02631551|520483972|FG000|Overall Study|Non-compliance with study drug|1|||
144349647|NCT02631551|520483973|FG001|Overall Study|Non-compliance with study drug|0|||
144349648|NCT02631551|520483974|FG002|Overall Study|Non-compliance with study drug|0|||
144349649|NCT02631551|520483975|FG003|Overall Study|Non-compliance with study drug|0|||
144349650|NCT02631551|520483972|FG000|Overall Study|Other, specific reasons not collected|5|||
144349651|NCT02631551|520483973|FG001|Overall Study|Other, specific reasons not collected|7|||
144349652|NCT02631551|520483974|FG002|Overall Study|Other, specific reasons not collected|2|||
144349653|NCT02631551|520483975|FG003|Overall Study|Other, specific reasons not collected|2|||
144349654|NCT02073682|520483976|FG000|Overall Study|Low Creatinine Clearance|1|||
144349655|NCT02073682|520483977|FG001|Overall Study|Low Creatinine Clearance|2|||
144349656|NCT02073682|520483976|FG000|Overall Study|Death|86|||
144349657|NCT02073682|520483977|FG001|Overall Study|Death|100|||
144349658|NCT02073682|520483976|FG000|Overall Study|Cancer Cured|10|||
144349659|NCT02073682|520483977|FG001|Overall Study|Cancer Cured|15|||
144349660|NCT02073682|520483976|FG000|Overall Study|ID: Patient Noncompliance|1|||
144349661|NCT02073682|520483977|FG001|Overall Study|ID: Patient Noncompliance|2|||
144349662|NCT02073682|520483976|FG000|Overall Study|ID: Palliative Treatment Only|10|||
144349663|NCT02073682|520483977|FG001|Overall Study|ID: Palliative Treatment Only|7|||
144349664|NCT02073682|520483976|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
144349665|NCT02073682|520483977|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
144349666|NCT02073682|520483976|FG000|Overall Study|Platelet Count <50,000/mL|1|||
144349667|NCT02073682|520483977|FG001|Overall Study|Platelet Count <50,000/mL|2|||
144349668|NCT02073682|520483976|FG000|Overall Study|Surgery/Medical Procedure|3|||
144349669|NCT02073682|520483977|FG001|Overall Study|Surgery/Medical Procedure|1|||
144349670|NCT02073682|520483976|FG000|Overall Study|Withdrawal by Subject|6|||
144349671|NCT02073682|520483977|FG001|Overall Study|Withdrawal by Subject|8|||
144349672|NCT02073682|520483976|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
144349673|NCT02073682|520483977|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
144349674|NCT02073682|520483976|FG000|Overall Study|Cancer Progression|53|||
144349675|NCT02073682|520483977|FG001|Overall Study|Cancer Progression|33|||
144349676|NCT02073682|520483976|FG000|Overall Study|Protocol Violation|1|||
144349677|NCT02073682|520483977|FG001|Overall Study|Protocol Violation|0|||
144349678|NCT02073682|520483976|FG000|Overall Study|Adverse Event|79|||
144349679|NCT02073682|520483977|FG001|Overall Study|Adverse Event|62|||
144349680|NCT02073682|520483976|FG000|Overall Study|No reason provided|11|||
144349681|NCT02073682|520483977|FG001|Overall Study|No reason provided|9|||
144349682|NCT02073682|520483976|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
144349683|NCT02073682|520483977|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
144349684|NCT02073682|520483976|FG000|Overall Study|Lost to Follow-up|1|||
144349685|NCT02073682|520483977|FG001|Overall Study|Lost to Follow-up|1|||
144349686|NCT02073682|520483976|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
144349687|NCT02073682|520483977|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
144349688|NCT04390243|520483978|FG000|Overall Study|Death|1|||
144349689|NCT04390243|520483978|FG000|Overall Study|Disease Progression|4|||
144349690|NCT04390243|520483978|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
144349691|NCT01687296|520483990|FG000|Overall Study|Lack of Efficacy|1|||
144349692|NCT01687296|520483991|FG001|Overall Study|Lack of Efficacy|1|||
144349693|NCT01687296|520483990|FG000|Overall Study|Protocol Violation|0|||
144349694|NCT01687296|520483991|FG001|Overall Study|Protocol Violation|1|||
144349695|NCT01687296|520483990|FG000|Overall Study|Withdrawal by Subject|6|||
144349696|NCT01687296|520483991|FG001|Overall Study|Withdrawal by Subject|3|||
144349697|NCT02336230|520483995|FG000|Overall Study|Adverse Event|1|||
144349698|NCT02336230|520483995|FG000|Overall Study|Withdrawal of consent|1|||
144349699|NCT02336230|520483995|FG000|Overall Study|Death|9|||
144349700|NCT02336230|520483995|FG000|Overall Study|Dose not received due to shipping delay|1|||
144349701|NCT02336230|520483995|FG000|Overall Study|Discontinuation of MSC infusion|1|||
144349702|NCT02524171|520483996|FG000|6-month Follow-up|Lost to Follow-up|53|||
144349703|NCT02524171|520483997|FG001|6-month Follow-up|Lost to Follow-up|45|||
144349704|NCT02524171|520483996|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
144349705|NCT02524171|520483997|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
144349706|NCT00216671|520483998|FG000|Overall Study|Adverse Event|4|||
144349707|NCT00216671|520483999|FG001|Overall Study|Adverse Event|9|||
144349708|NCT00216671|520483998|FG000|Overall Study|Pregnancy|0|||
144349709|NCT00216671|520483999|FG001|Overall Study|Pregnancy|1|||
144349710|NCT00216671|520483998|FG000|Overall Study|Withdrawal by Subject|4|||
144349711|NCT00216671|520483999|FG001|Overall Study|Withdrawal by Subject|2|||
144349712|NCT00216671|520483998|FG000|Overall Study|Refused Injections|3|||
144349713|NCT00216671|520483999|FG001|Overall Study|Refused Injections|13|||
144349714|NCT00216671|520483998|FG000|Overall Study|No Need to Continue Medication|1|||
144349715|NCT00216671|520483999|FG001|Overall Study|No Need to Continue Medication|1|||
144349716|NCT00216671|520483998|FG000|Overall Study|Insufficient Response|9|||
144349717|NCT00216671|520483999|FG001|Overall Study|Insufficient Response|4|||
144349718|NCT00216671|520483998|FG000|Overall Study|Lost to Follow-up|3|||
144349719|NCT00216671|520483999|FG001|Overall Study|Lost to Follow-up|5|||
144349720|NCT00216671|520483998|FG000|Overall Study|Non compliant|2|||
144349721|NCT00216671|520483999|FG001|Overall Study|Non compliant|2|||
144349722|NCT00216671|520483998|FG000|Overall Study|Ineligible|0|||
144349723|NCT00216671|520483999|FG001|Overall Study|Ineligible|2|||
144349724|NCT00216671|520483998|FG000|Overall Study|Physician Decision|1|||
144349725|NCT00216671|520483999|FG001|Overall Study|Physician Decision|1|||
144349726|NCT00216671|520483998|FG000|Overall Study|Protocol Violation|3|||
144349727|NCT00216671|520483999|FG001|Overall Study|Protocol Violation|5|||
144349728|NCT00216671|520483998|FG000|Overall Study|Relapse|1|||
144349729|NCT00216671|520483999|FG001|Overall Study|Relapse|0|||
144349730|NCT00216671|520483998|FG000|Overall Study|Investigator Illness|0|||
144349731|NCT00216671|520483999|FG001|Overall Study|Investigator Illness|1|||
144349732|NCT00216671|520483998|FG000|Overall Study|Patient Moved|0|||
144349733|NCT00216671|520483999|FG001|Overall Study|Patient Moved|1|||
144349734|NCT00216671|520483998|FG000|Overall Study|Ineligible, no efficacy data|2|||
144349735|NCT00216671|520483999|FG001|Overall Study|Ineligible, no efficacy data|2|||
144349736|NCT00216671|520483998|FG000|Overall Study|Insufficient Response Adverse Event|2|||
144349737|NCT00216671|520483999|FG001|Overall Study|Insufficient Response Adverse Event|1|||
144349738|NCT00226811|520484000|FG000|Overall Study|Death|8|||
144349739|NCT00226811|520484000|FG000|Overall Study|Adverse Event|11|||
144349740|NCT00226811|520484000|FG000|Overall Study|Lack of Efficacy|55|||
144349741|NCT00226811|520484000|FG000|Overall Study|Withdrawal by Subject|2|||
144349742|NCT03386721|520484001|FG000|Overall Study|Death|12|||
144349743|NCT03386721|520484002|FG001|Overall Study|Death|21|||
144349744|NCT03386721|520484003|FG002|Overall Study|Death|2|||
144349745|NCT03386721|520484004|FG003|Overall Study|Death|5|||
144349746|NCT03386721|520484005|FG004|Overall Study|Death|1|||
144349747|NCT03386721|520484006|FG005|Overall Study|Death|12|||
144349748|NCT03386721|520484007|FG006|Overall Study|Death|1|||
144349749|NCT03386721|520484008|FG007|Overall Study|Death|1|||
144349750|NCT03386721|520484009|FG008|Overall Study|Death|12|||
144349751|NCT03386721|520484010|FG009|Overall Study|Death|20|||
144349752|NCT03386721|520484011|FG010|Overall Study|Death|21|||
144349753|NCT03386721|520484012|FG011|Overall Study|Death|21|||
144349754|NCT03386721|520484013|FG012|Overall Study|Death|14|||
144349755|NCT03386721|520484014|FG013|Overall Study|Death|2|||
144349756|NCT03386721|520484015|FG014|Overall Study|Death|1|||
144349757|NCT03386721|520484001|FG000|Overall Study|Lost to Follow-up|1|||
144349758|NCT03386721|520484002|FG001|Overall Study|Lost to Follow-up|3|||
144349759|NCT03386721|520484003|FG002|Overall Study|Lost to Follow-up|0|||
144349760|NCT03386721|520484004|FG003|Overall Study|Lost to Follow-up|0|||
144349761|NCT03386721|520484005|FG004|Overall Study|Lost to Follow-up|0|||
144349762|NCT03386721|520484006|FG005|Overall Study|Lost to Follow-up|2|||
144349763|NCT03386721|520484007|FG006|Overall Study|Lost to Follow-up|1|||
144349764|NCT03386721|520484008|FG007|Overall Study|Lost to Follow-up|0|||
144349765|NCT03386721|520484009|FG008|Overall Study|Lost to Follow-up|1|||
144349766|NCT03386721|520484010|FG009|Overall Study|Lost to Follow-up|2|||
144349767|NCT03386721|520484011|FG010|Overall Study|Lost to Follow-up|1|||
144349768|NCT03386721|520484012|FG011|Overall Study|Lost to Follow-up|0|||
144349769|NCT03386721|520484013|FG012|Overall Study|Lost to Follow-up|0|||
144349770|NCT03386721|520484014|FG013|Overall Study|Lost to Follow-up|0|||
144349771|NCT03386721|520484015|FG014|Overall Study|Lost to Follow-up|0|||
144349772|NCT03386721|520484001|FG000|Overall Study|Reason not specified|3|||
144349773|NCT03386721|520484002|FG001|Overall Study|Reason not specified|0|||
144349774|NCT03386721|520484003|FG002|Overall Study|Reason not specified|0|||
144349775|NCT03386721|520484004|FG003|Overall Study|Reason not specified|0|||
144349776|NCT03386721|520484005|FG004|Overall Study|Reason not specified|0|||
144349777|NCT03386721|520484006|FG005|Overall Study|Reason not specified|3|||
144349778|NCT03386721|520484007|FG006|Overall Study|Reason not specified|1|||
144349779|NCT03386721|520484008|FG007|Overall Study|Reason not specified|0|||
144349780|NCT03386721|520484009|FG008|Overall Study|Reason not specified|0|||
144349781|NCT03386721|520484010|FG009|Overall Study|Reason not specified|1|||
144349782|NCT03386721|520484011|FG010|Overall Study|Reason not specified|2|||
144349783|NCT03386721|520484012|FG011|Overall Study|Reason not specified|6|||
144349784|NCT03386721|520484013|FG012|Overall Study|Reason not specified|1|||
144349785|NCT03386721|520484014|FG013|Overall Study|Reason not specified|0|||
144349786|NCT03386721|520484015|FG014|Overall Study|Reason not specified|0|||
144349787|NCT03386721|520484001|FG000|Overall Study|Progressive Disease|0|||
144349788|NCT03386721|520484002|FG001|Overall Study|Progressive Disease|0|||
144349789|NCT03386721|520484003|FG002|Overall Study|Progressive Disease|1|||
144349790|NCT03386721|520484004|FG003|Overall Study|Progressive Disease|0|||
144349791|NCT03386721|520484005|FG004|Overall Study|Progressive Disease|0|||
144349792|NCT03386721|520484006|FG005|Overall Study|Progressive Disease|1|||
144349793|NCT03386721|520484007|FG006|Overall Study|Progressive Disease|0|||
144349794|NCT03386721|520484008|FG007|Overall Study|Progressive Disease|0|||
144349795|NCT03386721|520484009|FG008|Overall Study|Progressive Disease|2|||
144349796|NCT03386721|520484010|FG009|Overall Study|Progressive Disease|1|||
144349797|NCT03386721|520484011|FG010|Overall Study|Progressive Disease|1|||
144349798|NCT03386721|520484012|FG011|Overall Study|Progressive Disease|0|||
144349799|NCT03386721|520484013|FG012|Overall Study|Progressive Disease|1|||
144349800|NCT03386721|520484014|FG013|Overall Study|Progressive Disease|0|||
144349801|NCT03386721|520484015|FG014|Overall Study|Progressive Disease|0|||
144349802|NCT03386721|520484001|FG000|Overall Study|Site Terminated by Sponsor|5|||
144349803|NCT03386721|520484002|FG001|Overall Study|Site Terminated by Sponsor|5|||
144349804|NCT03386721|520484003|FG002|Overall Study|Site Terminated by Sponsor|0|||
144349805|NCT03386721|520484004|FG003|Overall Study|Site Terminated by Sponsor|0|||
144349806|NCT03386721|520484005|FG004|Overall Study|Site Terminated by Sponsor|1|||
144349807|NCT03386721|520484006|FG005|Overall Study|Site Terminated by Sponsor|3|||
144349808|NCT03386721|520484007|FG006|Overall Study|Site Terminated by Sponsor|0|||
144349809|NCT03386721|520484008|FG007|Overall Study|Site Terminated by Sponsor|1|||
144349810|NCT03386721|520484009|FG008|Overall Study|Site Terminated by Sponsor|4|||
144349811|NCT03386721|520484010|FG009|Overall Study|Site Terminated by Sponsor|5|||
144349812|NCT03386721|520484011|FG010|Overall Study|Site Terminated by Sponsor|3|||
144349813|NCT03386721|520484012|FG011|Overall Study|Site Terminated by Sponsor|11|||
144349814|NCT03386721|520484013|FG012|Overall Study|Site Terminated by Sponsor|6|||
144349815|NCT03386721|520484014|FG013|Overall Study|Site Terminated by Sponsor|0|||
144349816|NCT03386721|520484015|FG014|Overall Study|Site Terminated by Sponsor|0|||
144349817|NCT03386721|520484001|FG000|Overall Study|Symptomatic Deterioration|0|||
144349818|NCT03386721|520484002|FG001|Overall Study|Symptomatic Deterioration|0|||
144349819|NCT03386721|520484003|FG002|Overall Study|Symptomatic Deterioration|0|||
144349820|NCT03386721|520484004|FG003|Overall Study|Symptomatic Deterioration|0|||
144349821|NCT03386721|520484005|FG004|Overall Study|Symptomatic Deterioration|0|||
144349822|NCT03386721|520484006|FG005|Overall Study|Symptomatic Deterioration|0|||
144349823|NCT03386721|520484007|FG006|Overall Study|Symptomatic Deterioration|0|||
144349824|NCT03386721|520484008|FG007|Overall Study|Symptomatic Deterioration|0|||
144349825|NCT03386721|520484009|FG008|Overall Study|Symptomatic Deterioration|1|||
144349826|NCT03386721|520484010|FG009|Overall Study|Symptomatic Deterioration|0|||
144349827|NCT03386721|520484011|FG010|Overall Study|Symptomatic Deterioration|0|||
144349828|NCT03386721|520484012|FG011|Overall Study|Symptomatic Deterioration|1|||
144349829|NCT03386721|520484013|FG012|Overall Study|Symptomatic Deterioration|0|||
144349830|NCT03386721|520484014|FG013|Overall Study|Symptomatic Deterioration|0|||
144349831|NCT03386721|520484015|FG014|Overall Study|Symptomatic Deterioration|0|||
144349832|NCT03386721|520484001|FG000|Overall Study|Withdrawal by Subject|1|||
144349833|NCT03386721|520484002|FG001|Overall Study|Withdrawal by Subject|2|||
144349834|NCT03386721|520484003|FG002|Overall Study|Withdrawal by Subject|0|||
144349835|NCT03386721|520484004|FG003|Overall Study|Withdrawal by Subject|0|||
144349836|NCT03386721|520484005|FG004|Overall Study|Withdrawal by Subject|0|||
144349837|NCT03386721|520484006|FG005|Overall Study|Withdrawal by Subject|0|||
144349838|NCT03386721|520484007|FG006|Overall Study|Withdrawal by Subject|0|||
144349839|NCT03386721|520484008|FG007|Overall Study|Withdrawal by Subject|0|||
144349840|NCT03386721|520484009|FG008|Overall Study|Withdrawal by Subject|2|||
144349841|NCT03386721|520484010|FG009|Overall Study|Withdrawal by Subject|1|||
144349842|NCT03386721|520484011|FG010|Overall Study|Withdrawal by Subject|3|||
144349843|NCT03386721|520484012|FG011|Overall Study|Withdrawal by Subject|2|||
144349844|NCT03386721|520484013|FG012|Overall Study|Withdrawal by Subject|3|||
144349845|NCT03386721|520484014|FG013|Overall Study|Withdrawal by Subject|0|||
144349846|NCT03386721|520484015|FG014|Overall Study|Withdrawal by Subject|0|||
144349847|NCT01100320|520484019|FG000|Period 1|Withdrawal by Subject|2|||
144349848|NCT01100320|520484020|FG001|Period 1|Withdrawal by Subject|4|||
144349849|NCT01100320|520484019|FG000|Period 1|Positive Drug Screen|1|||
144349850|NCT01100320|520484020|FG001|Period 1|Positive Drug Screen|1|||
144349851|NCT01100320|520484019|FG000|Period 1|Adverse Event|2|||
144349852|NCT01100320|520484020|FG001|Period 1|Adverse Event|2|||
144349853|NCT01100320|520484019|FG000|Period 2|Withdrawal by Subject|1|||
144349854|NCT01100320|520484020|FG001|Period 2|Withdrawal by Subject|1|||
144349855|NCT00550953|520484021|FG000|Overall Study|Adverse Event|4|||
144349856|NCT00550953|520484022|FG001|Overall Study|Adverse Event|3|||
144349857|NCT00550953|520484021|FG000|Overall Study|Not able to visit the site|2|||
144349858|NCT00550953|520484022|FG001|Overall Study|Not able to visit the site|3|||
144349859|NCT03797586|520484023|FG000|Overall Study|Lost to Follow-up|3|||
144349860|NCT03797586|520484024|FG001|Overall Study|Lost to Follow-up|6|||
144349861|NCT03797586|520484023|FG000|Overall Study|Death|1|||
144349862|NCT03797586|520484024|FG001|Overall Study|Death|1|||
144349863|NCT03797586|520484023|FG000|Overall Study|Adverse Event|0|||
144349864|NCT03797586|520484024|FG001|Overall Study|Adverse Event|2|||
144349865|NCT04980612|520484025|FG000|Overall Study|Withdrawal by Subject|7|||
144349866|NCT04980612|520484026|FG001|Overall Study|Withdrawal by Subject|5|||
144349867|NCT01502228|520484029|FG000|Overall Study|Death|1|||
144349868|NCT01219985|520484030|FG000|Overall Study|Physician Decision|20|||
144349869|NCT02446717|520484031|FG000|Overall Study|Adverse Event|0|||
144349870|NCT02446717|520484032|FG001|Overall Study|Adverse Event|0|||
144349871|NCT02446717|520484033|FG002|Overall Study|Adverse Event|1|||
144349872|NCT02446717|520484034|FG003|Overall Study|Adverse Event|0|||
144349873|NCT02446717|520484035|FG004|Overall Study|Adverse Event|0|||
144349874|NCT02446717|520484031|FG000|Overall Study|Lost to Follow-up|0|||
144349875|NCT02446717|520484032|FG001|Overall Study|Lost to Follow-up|1|||
144349876|NCT02446717|520484033|FG002|Overall Study|Lost to Follow-up|1|||
144349877|NCT02446717|520484034|FG003|Overall Study|Lost to Follow-up|0|||
144349878|NCT02446717|520484035|FG004|Overall Study|Lost to Follow-up|1|||
144349879|NCT02446717|520484031|FG000|Overall Study|Withdrew consent|0|||
144349880|NCT02446717|520484032|FG001|Overall Study|Withdrew consent|0|||
144349881|NCT02446717|520484033|FG002|Overall Study|Withdrew consent|0|||
144349882|NCT02446717|520484034|FG003|Overall Study|Withdrew consent|1|||
144349883|NCT02446717|520484035|FG004|Overall Study|Withdrew consent|0|||
144349884|NCT02680665|520484036|FG000|Overall Study|No visit after the first prescription|5|||
144349885|NCT04797780|520484037|FG000|Overall Study|Lost to Follow-up|1|||
144349886|NCT04797780|520484038|FG001|Overall Study|Lost to Follow-up|1|||
144349887|NCT04797780|520484037|FG000|Overall Study|Withdrawal by Subject|14|||
144349888|NCT04797780|520484038|FG001|Overall Study|Withdrawal by Subject|9|||
144349889|NCT04797780|520484037|FG000|Overall Study|Death|49|||
144349890|NCT04797780|520484038|FG001|Overall Study|Death|20|||
144349891|NCT02863328|520484043|FG000|Overall Study|Lost to Follow-up|4|||
144349892|NCT02863328|520484044|FG001|Overall Study|Lost to Follow-up|10|||
144349893|NCT02863328|520484043|FG000|Overall Study|Withdrawal by Subject|7|||
144349894|NCT02863328|520484044|FG001|Overall Study|Withdrawal by Subject|12|||
144349895|NCT02863328|520484043|FG000|Overall Study|Died|0|||
144349896|NCT02863328|520484044|FG001|Overall Study|Died|1|||
144349897|NCT01870726|520484045|FG000|Overall Study|Withdrawal of informed consent|0|||
144349898|NCT01870726|520484046|FG001|Overall Study|Withdrawal of informed consent|0|||
144349899|NCT01870726|520484047|FG002|Overall Study|Withdrawal of informed consent|0|||
144349900|NCT01870726|520484048|FG003|Overall Study|Withdrawal of informed consent|1|||
144349901|NCT01870726|520484049|FG004|Overall Study|Withdrawal of informed consent|0|||
144349902|NCT01870726|520484050|FG005|Overall Study|Withdrawal of informed consent|0|||
144349903|NCT01870726|520484051|FG006|Overall Study|Withdrawal of informed consent|0|||
144349904|NCT01870726|520484045|FG000|Overall Study|Withdrawal by Subject|0|||
144349905|NCT01870726|520484046|FG001|Overall Study|Withdrawal by Subject|1|||
144349906|NCT01870726|520484047|FG002|Overall Study|Withdrawal by Subject|0|||
144349907|NCT01870726|520484048|FG003|Overall Study|Withdrawal by Subject|0|||
144349908|NCT01870726|520484049|FG004|Overall Study|Withdrawal by Subject|0|||
144349909|NCT01870726|520484050|FG005|Overall Study|Withdrawal by Subject|0|||
144349910|NCT01870726|520484051|FG006|Overall Study|Withdrawal by Subject|0|||
144349911|NCT01870726|520484045|FG000|Overall Study|Adverse Event|0|||
144349912|NCT01870726|520484046|FG001|Overall Study|Adverse Event|0|||
144349913|NCT01870726|520484047|FG002|Overall Study|Adverse Event|0|||
144349914|NCT01870726|520484048|FG003|Overall Study|Adverse Event|0|||
144349915|NCT01870726|520484049|FG004|Overall Study|Adverse Event|1|||
144349916|NCT01870726|520484050|FG005|Overall Study|Adverse Event|1|||
144349917|NCT01870726|520484051|FG006|Overall Study|Adverse Event|0|||
144349918|NCT01870726|520484045|FG000|Overall Study|Progressive disease|5|||
144349919|NCT01870726|520484046|FG001|Overall Study|Progressive disease|5|||
144349920|NCT01870726|520484047|FG002|Overall Study|Progressive disease|4|||
144349921|NCT01870726|520484048|FG003|Overall Study|Progressive disease|5|||
144349922|NCT01870726|520484049|FG004|Overall Study|Progressive disease|6|||
144349923|NCT01870726|520484050|FG005|Overall Study|Progressive disease|4|||
144349924|NCT01870726|520484051|FG006|Overall Study|Progressive disease|10|||
144349925|NCT00595478|520484052|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
144349926|NCT00595478|520484053|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
144349927|NCT00595478|520484052|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
144349928|NCT00595478|520484053|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
144349929|NCT02978833|520484061|FG000|Overall Study|Study terminated|1|||
144349930|NCT02978833|520484062|FG001|Overall Study|Study terminated|1|||
144349931|NCT00186901|520484064|FG000|Overall Study|Pregnancy|6|||
144349932|NCT00186901|520484065|FG001|Overall Study|Pregnancy|3|||
144349933|NCT00186901|520484066|FG002|Overall Study|Pregnancy|0|||
144349934|NCT00186901|520484064|FG000|Overall Study|Lost to Follow-up|6|||
144349935|NCT00186901|520484065|FG001|Overall Study|Lost to Follow-up|3|||
144349936|NCT00186901|520484066|FG002|Overall Study|Lost to Follow-up|0|||
144349937|NCT00186901|520484064|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
144349938|NCT00186901|520484065|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
144349939|NCT00186901|520484066|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
144349940|NCT00186901|520484064|FG000|Overall Study|ALL relapse or second malignancy|1|||
144349941|NCT00186901|520484065|FG001|Overall Study|ALL relapse or second malignancy|2|||
144349942|NCT00186901|520484066|FG002|Overall Study|ALL relapse or second malignancy|0|||
144349943|NCT00186901|520484064|FG000|Overall Study|Withdrawal by Subject|4|||
144349944|NCT00186901|520484065|FG001|Overall Study|Withdrawal by Subject|5|||
144349945|NCT00186901|520484066|FG002|Overall Study|Withdrawal by Subject|0|||
144349946|NCT00186901|520484064|FG000|Overall Study|Open label|3|||
144349947|NCT00186901|520484065|FG001|Overall Study|Open label|2|||
144349948|NCT00186901|520484066|FG002|Overall Study|Open label|0|||
144349949|NCT00186901|520484064|FG000|Overall Study|Limited adherence to study requirements|20|||
144349950|NCT00186901|520484065|FG001|Overall Study|Limited adherence to study requirements|23|||
144349951|NCT00186901|520484066|FG002|Overall Study|Limited adherence to study requirements|0|||
144349952|NCT00186901|520484064|FG000|Overall Study|Bone Mineral Density > 0|0|||
144349953|NCT00186901|520484065|FG001|Overall Study|Bone Mineral Density > 0|0|||
144349954|NCT00186901|520484066|FG002|Overall Study|Bone Mineral Density > 0|149|||
144349955|NCT00555217|520484067|FG000|Overall Study|Withdrawal by Subject|35|||
144349956|NCT00555217|520484068|FG001|Overall Study|Withdrawal by Subject|31|||
144349957|NCT00555217|520484067|FG000|Overall Study|Lost to Follow-up|19|||
144349958|NCT00555217|520484068|FG001|Overall Study|Lost to Follow-up|20|||
144349959|NCT00555217|520484067|FG000|Overall Study|close out sites|21|||
144349960|NCT00555217|520484068|FG001|Overall Study|close out sites|17|||
144349961|NCT02363959|520484074|FG000|Overall Study|Medical instability|1|||
144349962|NCT02363959|520484075|FG001|Overall Study|Medical instability|0|||
144349963|NCT02663622|520484076|FG000|Overall Study|Death|3|||
144349964|NCT02663622|520484077|FG001|Overall Study|Death|1|||
144349965|NCT02663622|520484078|FG002|Overall Study|Death|1|||
144349966|NCT02663622|520484079|FG003|Overall Study|Death|8|||
144349967|NCT02663622|520484076|FG000|Overall Study|Protocol Violation|0|||
144349968|NCT02663622|520484077|FG001|Overall Study|Protocol Violation|0|||
144349969|NCT02663622|520484078|FG002|Overall Study|Protocol Violation|0|||
144349970|NCT02663622|520484079|FG003|Overall Study|Protocol Violation|1|||
144349971|NCT04618744|520484080|FG000|Overall Study|Adverse Event|0|||
144349972|NCT04618744|520484081|FG001|Overall Study|Adverse Event|1|||
144349973|NCT04618744|520484080|FG000|Overall Study|Withdrawal by Subject|0|||
144349974|NCT04618744|520484081|FG001|Overall Study|Withdrawal by Subject|1|||
144349975|NCT00930930|520484082|FG000|Overall Study|Death|1|||
144349976|NCT00930930|520484083|FG001|Overall Study|Death|0|||
144349977|NCT00930930|520484082|FG000|Overall Study|Physician Decision|1|||
144349978|NCT00930930|520484083|FG001|Overall Study|Physician Decision|0|||
144349979|NCT00930930|520484082|FG000|Overall Study|Adverse Event|13|||
144349980|NCT00930930|520484083|FG001|Overall Study|Adverse Event|3|||
144349981|NCT00930930|520484082|FG000|Overall Study|Withdrawal by Subject|3|||
144349982|NCT00930930|520484083|FG001|Overall Study|Withdrawal by Subject|1|||
144349983|NCT00930930|520484082|FG000|Overall Study|Disease progression|2|||
144349984|NCT00930930|520484083|FG001|Overall Study|Disease progression|3|||
144349985|NCT00930930|520484082|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
144349986|NCT00930930|520484083|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
144349987|NCT00930930|520484082|FG000|Overall Study|patients not compliant|1|||
144349988|NCT00930930|520484083|FG001|Overall Study|patients not compliant|1|||
144349989|NCT02709330|520484084|FG000|Overall Study|Death|5|||
144349990|NCT02709330|520484085|FG001|Overall Study|Death|0|||
144349991|NCT02709330|520484084|FG000|Overall Study|Lost to Follow-up|2|||
144349992|NCT02709330|520484085|FG001|Overall Study|Lost to Follow-up|0|||
144349993|NCT02709330|520484084|FG000|Overall Study|Physician Decision|2|||
144349994|NCT02709330|520484085|FG001|Overall Study|Physician Decision|0|||
144349995|NCT02709330|520484084|FG000|Overall Study|Withdrawal by Subject|4|||
144349996|NCT02709330|520484085|FG001|Overall Study|Withdrawal by Subject|0|||
144349997|NCT03772665|520484086|FG000|Overall Study|Protocol Violation|1|||
144349998|NCT03772665|520484087|FG001|Overall Study|Protocol Violation|0|||
144349999|NCT00859547|520485450|FG000|Overall Study|Lost to Follow-up|1|||
144350000|NCT00859547|520485450|FG000|Overall Study|Parent withdrew consent|1|||
144350001|NCT01410890|520485451|FG000|Overall Study|Withdrawal by Subject|0|||
144350002|NCT01410890|520485452|FG001|Overall Study|Withdrawal by Subject|1|||
144350003|NCT01799226|520485458|FG000|Overall Study|Withdrawal by Subject|1|||
144350004|NCT01799226|520485459|FG001|Overall Study|Withdrawal by Subject|0|||
144350005|NCT01799226|520485458|FG000|Overall Study|Disqualified at Day 14|1|||
144350006|NCT01799226|520485459|FG001|Overall Study|Disqualified at Day 14|0|||
144350007|NCT00991939|520485462|FG000|Overall Study|Lost to Follow-up|0|||
144350008|NCT00991939|520485463|FG001|Overall Study|Lost to Follow-up|1|||
144350009|NCT00991939|520485462|FG000|Overall Study|Withdrawal by Subject|1|||
144350010|NCT00991939|520485463|FG001|Overall Study|Withdrawal by Subject|0|||
144350011|NCT00991939|520485462|FG000|Overall Study|Entire study terminated|4|||
144350012|NCT00991939|520485463|FG001|Overall Study|Entire study terminated|1|||
144350013|NCT00714415|520485464|FG000|Overall Study|Lack of Efficacy|1|||
144350014|NCT00714415|520485465|FG001|Overall Study|Lack of Efficacy|0|||
144350015|NCT00714415|520485464|FG000|Overall Study|Death|1|||
144350016|NCT00714415|520485465|FG001|Overall Study|Death|0|||
144350017|NCT00740584|520485468|FG000|Overall Study|Withdrawal by Subject|1|||
144350018|NCT01461707|520485471|FG000|Overall Study|Withdrawal by Subject|1|||
144350019|NCT01461707|520485472|FG001|Overall Study|Withdrawal by Subject|0|||
144350020|NCT01450761|520485473|FG000|Randomization|Subject no longer meets study criteria|1|||
144350021|NCT01450761|520485474|FG001|Randomization|Subject no longer meets study criteria|2|||
144350022|NCT01450761|520485473|FG000|Randomization|Withdrawal by Subject|2|||
144350023|NCT01450761|520485474|FG001|Randomization|Withdrawal by Subject|0|||
144350024|NCT01450761|520485473|FG000|Randomization|Disease progression|0|||
144350025|NCT01450761|520485474|FG001|Randomization|Disease progression|2|||
144350026|NCT01450761|520485473|FG000|Randomization|Adverse Event unrelated to study drug|1|||
144350027|NCT01450761|520485474|FG001|Randomization|Adverse Event unrelated to study drug|0|||
144350028|NCT01450761|520485473|FG000|Randomization|Other|0|||
144350029|NCT01450761|520485474|FG001|Randomization|Other|1|||
144350030|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Disease progression|33|||
144350031|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Disease progression|32|||
144350032|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
144350033|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
144350034|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
144350035|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
144350036|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
144350037|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
144350038|NCT01450761|520485473|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
144350039|NCT01450761|520485474|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
144350040|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Death|3|||
144350041|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Death|3|||
144350042|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Other|2|||
144350043|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Other|2|||
144350044|NCT01450761|520485473|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
144350045|NCT01450761|520485474|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
144350046|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
144350047|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
144350048|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
144350049|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
144350050|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
144350051|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
144360196|NCT03037385|520527416|FG008|Overall Study|Progressive Disease|0|||
144350052|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
144350053|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
144350054|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
144350055|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
144350056|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Death|5|||
144350057|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Death|6|||
144350058|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
144350059|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
144350060|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
144350061|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
144350062|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
144350063|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
144350064|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
144350065|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
144350066|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
144350067|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
144350068|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
144350069|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
144350070|NCT01450761|520485473|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
144350071|NCT01450761|520485474|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
144350072|NCT03801174|520485496|FG000|Overall Study|Withdrawal by Subject|14|||
144350073|NCT03801174|520485497|FG001|Overall Study|Withdrawal by Subject|15|||
144350074|NCT03801174|520485496|FG000|Overall Study|Death|1|||
144350075|NCT03801174|520485497|FG001|Overall Study|Death|0|||
144350076|NCT03801174|520485496|FG000|Overall Study|Pregnancy|2|||
144350077|NCT03801174|520485497|FG001|Overall Study|Pregnancy|2|||
144350078|NCT03801174|520485496|FG000|Overall Study|Lost to Follow-up|19|||
144350079|NCT03801174|520485497|FG001|Overall Study|Lost to Follow-up|10|||
144350080|NCT03801174|520485496|FG000|Overall Study|Other|4|||
144350081|NCT03801174|520485497|FG001|Overall Study|Other|3|||
144350082|NCT03801174|520485496|FG000|Overall Study|Lack of Efficacy|4|||
144350083|NCT03801174|520485497|FG001|Overall Study|Lack of Efficacy|0|||
144350084|NCT03801174|520485496|FG000|Overall Study|Unwilling to complete activities|5|||
144350085|NCT03801174|520485497|FG001|Overall Study|Unwilling to complete activities|6|||
144350086|NCT03801174|520485496|FG000|Overall Study|Moved out of area|3|||
144350087|NCT03801174|520485497|FG001|Overall Study|Moved out of area|0|||
144350088|NCT00855816|520485498|FG000|Overall Study|Withdrawal by Subject|22|||
144350089|NCT00855816|520485499|FG001|Overall Study|Withdrawal by Subject|15|||
144350090|NCT00855816|520485498|FG000|Overall Study|Lost to Follow-up|3|||
144350091|NCT00855816|520485499|FG001|Overall Study|Lost to Follow-up|5|||
144350092|NCT00855816|520485498|FG000|Overall Study|Death|1|||
144350093|NCT00855816|520485499|FG001|Overall Study|Death|0|||
144350094|NCT00855816|520485498|FG000|Overall Study|Became ineligible|0|||
144350095|NCT00855816|520485499|FG001|Overall Study|Became ineligible|1|||
144350096|NCT01965704|520485503|FG000|Overall Study|Withdrawal by Subject|2|||
144350097|NCT01965704|520485504|FG001|Overall Study|Withdrawal by Subject|2|||
144350098|NCT01965704|520485505|FG002|Overall Study|Withdrawal by Subject|1|||
144350099|NCT01965704|520485506|FG003|Overall Study|Withdrawal by Subject|1|||
144350100|NCT01965704|520485503|FG000|Overall Study|Delivered at home|1|||
144350101|NCT01965704|520485504|FG001|Overall Study|Delivered at home|1|||
144350102|NCT01965704|520485505|FG002|Overall Study|Delivered at home|0|||
144350103|NCT01965704|520485506|FG003|Overall Study|Delivered at home|0|||
144350104|NCT01965704|520485503|FG000|Overall Study|Experienced complications|0|||
144350105|NCT01965704|520485504|FG001|Overall Study|Experienced complications|0|||
144350106|NCT01965704|520485505|FG002|Overall Study|Experienced complications|2|||
144350107|NCT01965704|520485506|FG003|Overall Study|Experienced complications|2|||
144350108|NCT01965704|520485503|FG000|Overall Study|Adverse Event|0|||
144350109|NCT01965704|520485504|FG001|Overall Study|Adverse Event|0|||
144350110|NCT01965704|520485505|FG002|Overall Study|Adverse Event|1|||
144350111|NCT01965704|520485506|FG003|Overall Study|Adverse Event|1|||
144350112|NCT01965704|520485503|FG000|Overall Study|Did not meet inclusion criteria|0|||
144350113|NCT01965704|520485504|FG001|Overall Study|Did not meet inclusion criteria|0|||
144350114|NCT01965704|520485505|FG002|Overall Study|Did not meet inclusion criteria|1|||
144350115|NCT01965704|520485506|FG003|Overall Study|Did not meet inclusion criteria|1|||
144350116|NCT00337207|520485514|FG000|Overall Study|Withdrawal by Subject|3|||
144350117|NCT01521507|520485515|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
144350118|NCT01521507|520485516|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
144350119|NCT01521507|520485515|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
144350120|NCT01521507|520485516|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
144350121|NCT01521507|520485515|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
144350122|NCT01521507|520485516|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
144350123|NCT01521507|520485515|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
144350124|NCT01521507|520485516|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
144350125|NCT01521507|520485515|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
144350126|NCT01521507|520485516|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
144350127|NCT01521507|520485515|FG000|Stage 2: Observational Design|Physician Decision|1|||
144350128|NCT01521507|520485516|FG001|Stage 2: Observational Design|Physician Decision|0|||
144350129|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
144350130|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
144350131|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
144350132|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
144350133|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
144350134|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
144350135|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
144350136|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
144350137|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
144350138|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
144350139|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
144350140|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
144350141|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
144350142|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
144350143|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
144350144|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
144350145|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
144350146|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
144350147|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
144350148|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
144350149|NCT03573323|520485517|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
144350150|NCT03573323|520485518|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
144350151|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
144350152|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
144350153|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
144350154|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
144350155|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
144350156|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
144350157|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
144350158|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
144350159|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
144350160|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
144350161|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
144350162|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
144350163|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
144350164|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
144350165|NCT03573323|520485517|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
144350166|NCT03573323|520485518|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
144350167|NCT03188432|520485519|FG000|Overall Study|Death|3|||
144350168|NCT03188432|520485519|FG000|Overall Study|Withdrawal by Subject|15|||
144350169|NCT03188432|520485519|FG000|Overall Study|Did not complete protocol treatment|9|||
144350170|NCT00700713|520485520|FG000|Overall Study|Protocol Violation|1|||
144350171|NCT00700713|520485521|FG001|Overall Study|Protocol Violation|0|||
144350172|NCT00700713|520485522|FG002|Overall Study|Protocol Violation|1|||
144350173|NCT00700713|520485520|FG000|Overall Study|Withdrawal by Subject|0|||
144350174|NCT00700713|520485521|FG001|Overall Study|Withdrawal by Subject|0|||
144350175|NCT00700713|520485522|FG002|Overall Study|Withdrawal by Subject|1|||
144350176|NCT05730387|520485523|FG000|Overall Study|Stillbirth|0|||
144350177|NCT05730387|520485524|FG001|Overall Study|Stillbirth|262|||
144350178|NCT05730387|520485523|FG000|Overall Study|Died during or after delivery|2|||
144350179|NCT05730387|520485524|FG001|Overall Study|Died during or after delivery|85|||
144350180|NCT05730387|520485523|FG000|Overall Study|Died after being admitted|0|||
144350181|NCT05730387|520485524|FG001|Overall Study|Died after being admitted|44|||
144350182|NCT05730387|520485523|FG000|Overall Study|Lost to Follow-up|69|||
144350183|NCT05730387|520485524|FG001|Overall Study|Lost to Follow-up|77|||
144350184|NCT02728089|520485525|FG000|Overall Study|Physician Decision|2|||
144350185|NCT02728089|520485525|FG000|Overall Study|Withdrawal by Subject|1|||
144350186|NCT02905266|520485526|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
144350187|NCT02905266|520485527|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
144350188|NCT02905266|520485526|FG000|Treatment Phase Part 1|Disease Progression|6|||
144350189|NCT02905266|520485527|FG001|Treatment Phase Part 1|Disease Progression|7|||
144350190|NCT02905266|520485526|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
144350191|NCT02905266|520485527|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
144350192|NCT02905266|520485526|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
144350193|NCT02905266|520485527|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
144350194|NCT02905266|520485526|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
144350195|NCT02905266|520485527|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
144350196|NCT02905266|520485526|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
144350197|NCT02905266|520485527|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
144350198|NCT02905266|520485526|FG000|Transition From Part 1 to Part 2|Death|0|||
144350199|NCT02905266|520485527|FG001|Transition From Part 1 to Part 2|Death|1|||
144350200|NCT02905266|520485526|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
144350201|NCT02905266|520485527|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
144350202|NCT02905266|520485526|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
144350203|NCT02905266|520485527|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
144350204|NCT02905266|520485526|FG000|Maintenance Phase Part 2|Disease Progression|9|||
144350205|NCT02905266|520485527|FG001|Maintenance Phase Part 2|Disease Progression|2|||
144350206|NCT02905266|520485526|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
144350207|NCT02905266|520485527|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
144350208|NCT02905266|520485526|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
144350209|NCT02905266|520485527|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
144350210|NCT00596752|520485533|FG000|Overall Study|Other Reason|44|||
144350211|NCT00596752|520485534|FG001|Overall Study|Other Reason|49|||
144350212|NCT00596752|520485533|FG000|Overall Study|Adverse Event|34|||
144350213|NCT00596752|520485534|FG001|Overall Study|Adverse Event|34|||
144350214|NCT00596752|520485533|FG000|Overall Study|Lost to Follow-up|22|||
144350215|NCT00596752|520485534|FG001|Overall Study|Lost to Follow-up|38|||
144350216|NCT00596752|520485533|FG000|Overall Study|Withdrawal by Subject|12|||
144350217|NCT00596752|520485534|FG001|Overall Study|Withdrawal by Subject|9|||
144350218|NCT00596752|520485533|FG000|Overall Study|Unsatisfactory Compliance|9|||
144350219|NCT00596752|520485534|FG001|Overall Study|Unsatisfactory Compliance|6|||
144350220|NCT00596752|520485533|FG000|Overall Study|Lack of Efficacy|4|||
144350221|NCT00596752|520485534|FG001|Overall Study|Lack of Efficacy|7|||
144350222|NCT00596752|520485533|FG000|Overall Study|Protocol Violation|1|||
144350223|NCT00596752|520485534|FG001|Overall Study|Protocol Violation|0|||
144350224|NCT02940496|520485535|FG000|Overall Study|Adverse Event|1|||
144350225|NCT02940496|520485536|FG001|Overall Study|Adverse Event|0|||
144350226|NCT02940496|520485535|FG000|Overall Study|Death|2|||
144350227|NCT02940496|520485536|FG001|Overall Study|Death|0|||
144350228|NCT02940496|520485535|FG000|Overall Study|Hospice Care|1|||
144350229|NCT02940496|520485536|FG001|Overall Study|Hospice Care|0|||
144350230|NCT02940496|520485535|FG000|Overall Study|No MRE Done|1|||
144350231|NCT02940496|520485536|FG001|Overall Study|No MRE Done|0|||
144350232|NCT02940496|520485535|FG000|Overall Study|MRE Failure|1|||
144350233|NCT02940496|520485536|FG001|Overall Study|MRE Failure|0|||
144350234|NCT02586727|520485537|FG000|Overall Study|Lost to Follow-up|1|||
144350235|NCT02586727|520485538|FG001|Overall Study|Lost to Follow-up|0|||
144350236|NCT04089761|520485539|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
144350237|NCT04089761|520485539|FG000|"Run In Phase"|Lost to Follow-up|1|||
144350238|NCT04089761|520485539|FG000|"Treatment Phase"|No evaluable data|5|||
144350239|NCT04089761|520485539|FG000|"Treatment Phase"|Lost to Follow-up|1|||
144350240|NCT05907395|520485542|FG000|Period 1|No longer met eligibility criteria|0|||
144350241|NCT05907395|520485543|FG001|Period 1|No longer met eligibility criteria|1|||
144350242|NCT05907395|520485544|FG002|Period 1|No longer met eligibility criteria|0|||
144350243|NCT05907395|520485545|FG003|Period 1|No longer met eligibility criteria|0|||
144350244|NCT05907395|520485546|FG004|Period 1|No longer met eligibility criteria|0|||
144350245|NCT05907395|520485547|FG005|Period 1|No longer met eligibility criteria|1|||
144350246|NCT05907395|520485548|FG006|Period 1|No longer met eligibility criteria|1|||
144350247|NCT05907395|520485549|FG007|Period 1|No longer met eligibility criteria|0|||
144350248|NCT05907395|520485550|FG008|Period 1|No longer met eligibility criteria|0|||
144350249|NCT05907395|520485551|FG009|Period 1|No longer met eligibility criteria|0|||
144350250|NCT05907395|520485552|FG010|Period 1|No longer met eligibility criteria|0|||
144350251|NCT05907395|520485553|FG011|Period 1|No longer met eligibility criteria|0|||
144350252|NCT05907395|520485542|FG000|Period 2|Adverse Event|0|||
144350253|NCT05907395|520485543|FG001|Period 2|Adverse Event|0|||
144350254|NCT05907395|520485544|FG002|Period 2|Adverse Event|0|||
144350255|NCT05907395|520485545|FG003|Period 2|Adverse Event|1|||
144350256|NCT05907395|520485546|FG004|Period 2|Adverse Event|0|||
144350257|NCT05907395|520485547|FG005|Period 2|Adverse Event|0|||
144350258|NCT05907395|520485548|FG006|Period 2|Adverse Event|0|||
144350259|NCT05907395|520485549|FG007|Period 2|Adverse Event|1|||
144350260|NCT05907395|520485550|FG008|Period 2|Adverse Event|0|||
144350261|NCT05907395|520485551|FG009|Period 2|Adverse Event|0|||
144350262|NCT05907395|520485552|FG010|Period 2|Adverse Event|0|||
144350263|NCT05907395|520485553|FG011|Period 2|Adverse Event|0|||
144350264|NCT05907395|520485542|FG000|Period 2|Personal reason|0|||
144350265|NCT05907395|520485543|FG001|Period 2|Personal reason|0|||
144350266|NCT05907395|520485544|FG002|Period 2|Personal reason|0|||
144350267|NCT05907395|520485545|FG003|Period 2|Personal reason|0|||
144350268|NCT05907395|520485546|FG004|Period 2|Personal reason|0|||
144350269|NCT05907395|520485547|FG005|Period 2|Personal reason|0|||
144350270|NCT05907395|520485548|FG006|Period 2|Personal reason|0|||
144350271|NCT05907395|520485549|FG007|Period 2|Personal reason|0|||
144350272|NCT05907395|520485550|FG008|Period 2|Personal reason|0|||
144350273|NCT05907395|520485551|FG009|Period 2|Personal reason|1|||
144350274|NCT05907395|520485552|FG010|Period 2|Personal reason|0|||
144350275|NCT05907395|520485553|FG011|Period 2|Personal reason|0|||
144350276|NCT05907395|520485542|FG000|Period 3|Adverse Event|0|||
144350277|NCT05907395|520485543|FG001|Period 3|Adverse Event|0|||
144350278|NCT05907395|520485544|FG002|Period 3|Adverse Event|0|||
144350279|NCT05907395|520485545|FG003|Period 3|Adverse Event|0|||
144350280|NCT05907395|520485546|FG004|Period 3|Adverse Event|1|||
144350281|NCT05907395|520485547|FG005|Period 3|Adverse Event|0|||
144350282|NCT05907395|520485548|FG006|Period 3|Adverse Event|0|||
144350283|NCT05907395|520485549|FG007|Period 3|Adverse Event|0|||
144350284|NCT05907395|520485550|FG008|Period 3|Adverse Event|0|||
144350285|NCT05907395|520485551|FG009|Period 3|Adverse Event|0|||
144350286|NCT05907395|520485552|FG010|Period 3|Adverse Event|0|||
144350287|NCT05907395|520485553|FG011|Period 3|Adverse Event|0|||
144350288|NCT04544956|520485554|FG000|Overall Study|Withdrawal by Subject|1|||
144350289|NCT02119663|520485555|FG000|Overall Study|Disease progression|26|||
144350290|NCT02119663|520485556|FG001|Overall Study|Disease progression|27|||
144350291|NCT02119663|520485555|FG000|Overall Study|Adverse Event|5|||
144350292|NCT02119663|520485556|FG001|Overall Study|Adverse Event|5|||
144350293|NCT02119663|520485555|FG000|Overall Study|Death|3|||
144350294|NCT02119663|520485556|FG001|Overall Study|Death|2|||
144350295|NCT02119663|520485555|FG000|Overall Study|Physician Decision|1|||
144350296|NCT02119663|520485556|FG001|Overall Study|Physician Decision|2|||
144350297|NCT02119663|520485555|FG000|Overall Study|Other unspecified|2|||
144350298|NCT02119663|520485556|FG001|Overall Study|Other unspecified|0|||
144350299|NCT02119663|520485555|FG000|Overall Study|Subject decision|0|||
144350300|NCT02119663|520485556|FG001|Overall Study|Subject decision|1|||
144350301|NCT02119663|520485555|FG000|Overall Study|Study Terminated by the Sponsor|3|||
144350302|NCT02119663|520485556|FG001|Overall Study|Study Terminated by the Sponsor|4|||
144350303|NCT00699660|520485557|FG000|Overall Study|Lost to Follow-up|4|||
144350304|NCT00699660|520485558|FG001|Overall Study|Lost to Follow-up|2|||
144350305|NCT00699660|520485557|FG000|Overall Study|missing reports and recording failures|10|||
144350306|NCT00699660|520485558|FG001|Overall Study|missing reports and recording failures|6|||
144350307|NCT00103740|520485561|FG000|Period 1 - Core|Adverse Event|1|||
144350308|NCT00103740|520485562|FG001|Period 1 - Core|Adverse Event|0|||
144350309|NCT00103740|520485561|FG000|Period 1 - Core|Protocol Violation|3|||
144350310|NCT00103740|520485562|FG001|Period 1 - Core|Protocol Violation|2|||
144350311|NCT00103740|520485561|FG000|Period 1 - Core|Patient withdrew consent|3|||
144350312|NCT00103740|520485562|FG001|Period 1 - Core|Patient withdrew consent|2|||
144350313|NCT00103740|520485561|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
144350314|NCT00103740|520485562|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
144350315|NCT00103740|520485561|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
144350316|NCT00103740|520485562|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
144350317|NCT00103740|520485561|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
144350318|NCT00103740|520485562|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
144350319|NCT00103740|520485561|FG000|Period 2 - Extended Observation Period|Death|6|||
144350320|NCT00103740|520485562|FG001|Period 2 - Extended Observation Period|Death|2|||
144350321|NCT00103740|520485561|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
144350322|NCT00103740|520485562|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
144350323|NCT01099397|520485563|FG000|Overall Study|Lost to Follow-up|4|||
144350324|NCT01099397|520485563|FG000|Overall Study|Protocol Violation|4|||
144350325|NCT01099397|520485563|FG000|Overall Study|Withdrawal by Subject|5|||
144350326|NCT00992459|520485566|FG000|Overall Study|Withdrawal by Subject|0|||
144350327|NCT00992459|520485567|FG001|Overall Study|Withdrawal by Subject|1|||
144350328|NCT00992459|520485566|FG000|Overall Study|Adverse Event|1|||
144350329|NCT00992459|520485567|FG001|Overall Study|Adverse Event|0|||
144350330|NCT00950248|520485575|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
144350331|NCT00950248|520485576|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
144350332|NCT00950248|520485577|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
144350333|NCT00950248|520485575|FG000|Year 1: Baseline|worsening of symptoms|2|||
144350334|NCT00950248|520485576|FG001|Year 1: Baseline|worsening of symptoms|0|||
144350335|NCT00950248|520485577|FG002|Year 1: Baseline|worsening of symptoms|0|||
144350336|NCT00950248|520485575|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
144350337|NCT00950248|520485576|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
144350338|NCT00950248|520485577|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
144350339|NCT00950248|520485575|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
144350340|NCT00950248|520485576|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
144350341|NCT00950248|520485577|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
144350342|NCT00950248|520485575|FG000|Year 2&3 Treatment Randomization|Death|0|||
144350343|NCT00950248|520485576|FG001|Year 2&3 Treatment Randomization|Death|0|||
144350344|NCT00950248|520485577|FG002|Year 2&3 Treatment Randomization|Death|1|||
144350345|NCT00950248|520485575|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
144350346|NCT00950248|520485576|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
144350347|NCT00950248|520485577|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
144350348|NCT00003199|520485578|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
144350349|NCT00003199|520485578|FG000|Overall Study|Lack of insurance clearance|2|||
144350350|NCT00003199|520485578|FG000|Overall Study|Screen fail|15|||
144350351|NCT00940498|520485580|FG000|Overall Study|Death|2|||
144350352|NCT00940498|520485581|FG001|Overall Study|Death|0|||
144350353|NCT00940498|520485582|FG002|Overall Study|Death|0|||
144350354|NCT00940498|520485583|FG003|Overall Study|Death|1|||
144350355|NCT00940498|520485584|FG004|Overall Study|Death|5|||
144350356|NCT00940498|520485585|FG005|Overall Study|Death|0|||
144350357|NCT00940498|520485586|FG006|Overall Study|Death|1|||
144350358|NCT00940498|520485587|FG007|Overall Study|Death|0|||
144350359|NCT00940498|520485580|FG000|Overall Study|Lost to Follow-up|1|||
144350360|NCT00940498|520485581|FG001|Overall Study|Lost to Follow-up|1|||
144350361|NCT00940498|520485582|FG002|Overall Study|Lost to Follow-up|2|||
144350362|NCT00940498|520485583|FG003|Overall Study|Lost to Follow-up|0|||
144350363|NCT00940498|520485584|FG004|Overall Study|Lost to Follow-up|1|||
144350364|NCT00940498|520485585|FG005|Overall Study|Lost to Follow-up|0|||
144350365|NCT00940498|520485586|FG006|Overall Study|Lost to Follow-up|0|||
144350366|NCT00940498|520485587|FG007|Overall Study|Lost to Follow-up|1|||
144350367|NCT00940498|520485580|FG000|Overall Study|Disease Progression|0|||
144350368|NCT00940498|520485581|FG001|Overall Study|Disease Progression|0|||
144350369|NCT00940498|520485582|FG002|Overall Study|Disease Progression|1|||
144350370|NCT00940498|520485583|FG003|Overall Study|Disease Progression|1|||
144350371|NCT00940498|520485584|FG004|Overall Study|Disease Progression|0|||
144350372|NCT00940498|520485585|FG005|Overall Study|Disease Progression|1|||
144350373|NCT00940498|520485586|FG006|Overall Study|Disease Progression|0|||
144350374|NCT00940498|520485587|FG007|Overall Study|Disease Progression|0|||
144350375|NCT00940498|520485580|FG000|Overall Study|Physician Decision|0|||
144350376|NCT00940498|520485581|FG001|Overall Study|Physician Decision|0|||
144350377|NCT00940498|520485582|FG002|Overall Study|Physician Decision|0|||
144350378|NCT00940498|520485583|FG003|Overall Study|Physician Decision|0|||
144350379|NCT00940498|520485584|FG004|Overall Study|Physician Decision|2|||
144350380|NCT00940498|520485585|FG005|Overall Study|Physician Decision|0|||
144350381|NCT00940498|520485586|FG006|Overall Study|Physician Decision|0|||
144350382|NCT00940498|520485587|FG007|Overall Study|Physician Decision|0|||
144350383|NCT00940498|520485580|FG000|Overall Study|Not treated due to disease related pain|0|||
144350384|NCT00940498|520485581|FG001|Overall Study|Not treated due to disease related pain|0|||
144350385|NCT00940498|520485582|FG002|Overall Study|Not treated due to disease related pain|0|||
144350386|NCT00940498|520485583|FG003|Overall Study|Not treated due to disease related pain|0|||
144350387|NCT00940498|520485584|FG004|Overall Study|Not treated due to disease related pain|1|||
144350388|NCT00940498|520485585|FG005|Overall Study|Not treated due to disease related pain|0|||
144350389|NCT00940498|520485586|FG006|Overall Study|Not treated due to disease related pain|0|||
144350390|NCT00940498|520485587|FG007|Overall Study|Not treated due to disease related pain|0|||
144350391|NCT01657292|520485588|FG000|Overall Study|Adverse Event|6|||
144350392|NCT01657292|520485588|FG000|Overall Study|Withdrawal by Subject|2|||
144350393|NCT01657292|520485588|FG000|Overall Study|Violation of eligibility criteria|1|||
144350394|NCT01657292|520485588|FG000|Overall Study|Change of therapy|1|||
144350395|NCT00650845|520485590|FG000|Overall Study|Withdrawal by Subject|5|||
144350396|NCT00650845|520485591|FG001|Overall Study|Withdrawal by Subject|0|||
144350397|NCT00650845|520485590|FG000|Overall Study|Protocol Violation|0|||
144350398|NCT00650845|520485591|FG001|Overall Study|Protocol Violation|13|||
144350399|NCT03761810|520485592|FG000|Overall Study|Adverse Event|12|||
144350400|NCT03761810|520485593|FG001|Overall Study|Adverse Event|0|||
144350401|NCT03761810|520485592|FG000|Overall Study|Lost to Follow-up|15|||
144350402|NCT03761810|520485593|FG001|Overall Study|Lost to Follow-up|7|||
144350403|NCT03761810|520485592|FG000|Overall Study|Pregnancy|1|||
144350404|NCT03761810|520485593|FG001|Overall Study|Pregnancy|0|||
144350405|NCT03761810|520485592|FG000|Overall Study|Withdrawal by Subject|14|||
144350406|NCT03761810|520485593|FG001|Overall Study|Withdrawal by Subject|5|||
144350407|NCT03761810|520485592|FG000|Overall Study|Physician Decision|1|||
144350408|NCT03761810|520485593|FG001|Overall Study|Physician Decision|0|||
144350409|NCT03761810|520485592|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
144350410|NCT03761810|520485593|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
144350411|NCT03761810|520485592|FG000|Overall Study|Other Than Specified|1|||
144350412|NCT03761810|520485593|FG001|Overall Study|Other Than Specified|0|||
144350413|NCT03932760|520485594|FG000|Overall Study|Became Ineligible|2|||
144350414|NCT03932760|520485595|FG001|Overall Study|Became Ineligible|5|||
144350415|NCT03932760|520485594|FG000|Overall Study|Withdrawal by Subject|6|||
144350416|NCT03932760|520485595|FG001|Overall Study|Withdrawal by Subject|6|||
144350417|NCT00869518|520485596|FG000|Overall Study|Lost to Follow-up|1|||
144350418|NCT00869518|520485597|FG001|Overall Study|Lost to Follow-up|1|||
144350419|NCT04178720|520485598|FG000|Overall Study|Withdrawal by Subject|2|||
144350420|NCT04178720|520485599|FG001|Overall Study|Withdrawal by Subject|0|||
144350421|NCT04178720|520485598|FG000|Overall Study|Relocation|0|||
144350422|NCT04178720|520485599|FG001|Overall Study|Relocation|1|||
144350423|NCT03922620|520485602|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
144350424|NCT03922620|520485603|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
144350425|NCT00983385|520485604|FG000|Observation Period|Not eligible to be dosed|20|||
144350426|NCT00983385|520485604|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
144350427|NCT01223183|520485606|FG000|Imaging Day 1|Physician Decision|0|||
144350428|NCT01223183|520485607|FG001|Imaging Day 1|Physician Decision|1|||
144350429|NCT01223183|520485606|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
144350430|NCT01223183|520485607|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
144350431|NCT01223183|520485606|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
144350432|NCT01223183|520485607|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
144350433|NCT02098746|520488677|FG000|Overall Study|Changes of Investigator|2|||
144350434|NCT02098746|520488677|FG000|Overall Study|Other Miscellaneous Reasons|1|||
144350435|NCT02098746|520488677|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
144350436|NCT02098746|520488677|FG000|Overall Study|Data Not Available After Treatment|1|||
144350437|NCT00997035|520488678|FG000|3-week Followup Visit|Lost to Follow-up|9|||
144350438|NCT00997035|520488679|FG001|3-week Followup Visit|Lost to Follow-up|6|||
144350439|NCT00997035|520488678|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
144350440|NCT00997035|520488679|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
144350441|NCT02544503|520488683|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
144350442|NCT02544503|520488684|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
144350443|NCT02544503|520488683|FG000|Overall Study|Lost to Follow-up|9|||
144350444|NCT02544503|520488684|FG001|Overall Study|Lost to Follow-up|0|||
144350445|NCT02544503|520488683|FG000|Overall Study|Withdrawal by Subject|1|||
144350446|NCT02544503|520488684|FG001|Overall Study|Withdrawal by Subject|0|||
144350447|NCT01080807|520488685|FG000|Overall Study|Adverse Event|9|||
144350448|NCT01080807|520488686|FG001|Overall Study|Adverse Event|1|||
144350449|NCT01080807|520488685|FG000|Overall Study|Lack of Efficacy|0|||
144350450|NCT01080807|520488686|FG001|Overall Study|Lack of Efficacy|1|||
144350451|NCT01080807|520488685|FG000|Overall Study|Withdrawal by Subject|7|||
144350452|NCT01080807|520488686|FG001|Overall Study|Withdrawal by Subject|2|||
144350453|NCT01080807|520488685|FG000|Overall Study|Protocol Violation|7|||
144350454|NCT01080807|520488686|FG001|Overall Study|Protocol Violation|6|||
144350455|NCT01080807|520488685|FG000|Overall Study|Lost to Follow-up|6|||
144350456|NCT01080807|520488686|FG001|Overall Study|Lost to Follow-up|4|||
144350457|NCT01080807|520488685|FG000|Overall Study|Noncompliance with drug administration|1|||
144350458|NCT01080807|520488686|FG001|Overall Study|Noncompliance with drug administration|1|||
144350459|NCT01080807|520488685|FG000|Overall Study|Noncompliance to study procedures|1|||
144350460|NCT01080807|520488686|FG001|Overall Study|Noncompliance to study procedures|1|||
144350461|NCT01080807|520488685|FG000|Overall Study|Began working day shift|0|||
144350462|NCT01080807|520488686|FG001|Overall Study|Began working day shift|2|||
144350463|NCT01080807|520488685|FG000|Overall Study|Laid off or terminated from job|1|||
144350464|NCT01080807|520488686|FG001|Overall Study|Laid off or terminated from job|2|||
144350465|NCT01080807|520488685|FG000|Overall Study|Stopped working consistent night shifts|0|||
144350466|NCT01080807|520488686|FG001|Overall Study|Stopped working consistent night shifts|1|||
144350467|NCT01080807|520488685|FG000|Overall Study|Work schedule changing|1|||
144350468|NCT01080807|520488686|FG001|Overall Study|Work schedule changing|1|||
144350469|NCT01080807|520488685|FG000|Overall Study|Work schedule and travel|0|||
144350470|NCT01080807|520488686|FG001|Overall Study|Work schedule and travel|1|||
144350471|NCT01080807|520488685|FG000|Overall Study|Switched to first shift|1|||
144350472|NCT01080807|520488686|FG001|Overall Study|Switched to first shift|0|||
144350473|NCT01080807|520488685|FG000|Overall Study|Moved away without notifying center|1|||
144350474|NCT01080807|520488686|FG001|Overall Study|Moved away without notifying center|0|||
144350475|NCT04685798|520488687|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
144350476|NCT04640311|520488688|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
144350477|NCT04640311|520488689|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350478|NCT04640311|520488690|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350479|NCT04640311|520488691|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350480|NCT04640311|520488692|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350481|NCT04640311|520488693|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350482|NCT04640311|520488694|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350483|NCT04640311|520488695|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350484|NCT04640311|520488696|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350485|NCT04640311|520488697|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350486|NCT04640311|520488698|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350487|NCT04640311|520488699|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350488|NCT04640311|520488700|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350489|NCT04640311|520488688|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350490|NCT04640311|520488689|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
144350491|NCT04640311|520488690|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350492|NCT04640311|520488691|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350493|NCT04640311|520488692|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350494|NCT04640311|520488693|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350495|NCT04640311|520488694|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350496|NCT04640311|520488695|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350497|NCT04640311|520488696|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350498|NCT04640311|520488697|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350499|NCT04640311|520488698|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350500|NCT04640311|520488699|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350501|NCT04640311|520488700|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
144350502|NCT04640311|520488688|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350503|NCT04640311|520488689|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
144350504|NCT04640311|520488690|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350505|NCT04640311|520488691|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350506|NCT04640311|520488692|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350507|NCT04640311|520488693|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350508|NCT04640311|520488694|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350509|NCT04640311|520488695|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350510|NCT04640311|520488696|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350511|NCT04640311|520488697|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350512|NCT04640311|520488698|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350513|NCT04640311|520488699|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350514|NCT04640311|520488700|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350515|NCT04640311|520488688|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
144350516|NCT04640311|520488689|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
144350517|NCT04640311|520488690|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
144350518|NCT04640311|520488691|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350519|NCT04640311|520488692|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350520|NCT04640311|520488693|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350521|NCT04640311|520488694|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350522|NCT04640311|520488695|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350523|NCT04640311|520488696|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350524|NCT04640311|520488697|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350525|NCT04640311|520488698|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350526|NCT04640311|520488699|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350527|NCT04640311|520488700|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
144350528|NCT04640311|520488688|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350529|NCT04640311|520488689|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350530|NCT04640311|520488690|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
144350531|NCT04640311|520488691|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350532|NCT04640311|520488692|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350533|NCT04640311|520488693|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350534|NCT04640311|520488694|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350535|NCT04640311|520488695|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350536|NCT04640311|520488696|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350537|NCT04640311|520488697|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350538|NCT04640311|520488698|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350539|NCT04640311|520488699|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350540|NCT04640311|520488700|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
144350541|NCT04640311|520488688|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350542|NCT04640311|520488689|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350543|NCT04640311|520488690|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350544|NCT04640311|520488691|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
144350545|NCT04640311|520488692|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350546|NCT04640311|520488693|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350547|NCT04640311|520488694|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
144350548|NCT04640311|520488695|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350549|NCT04640311|520488696|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350550|NCT04640311|520488697|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350551|NCT04640311|520488698|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350552|NCT04640311|520488699|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350553|NCT04640311|520488700|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
144350554|NCT04640311|520488688|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350555|NCT04640311|520488689|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350556|NCT04640311|520488690|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350557|NCT04640311|520488691|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350558|NCT04640311|520488692|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350559|NCT04640311|520488693|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
144350560|NCT04640311|520488694|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350561|NCT04640311|520488695|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350562|NCT04640311|520488696|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
144350563|NCT04640311|520488697|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350564|NCT04640311|520488698|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350565|NCT04640311|520488699|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350566|NCT04640311|520488700|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
144350567|NCT04640311|520488688|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350568|NCT04640311|520488689|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350569|NCT04640311|520488690|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350570|NCT04640311|520488691|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350571|NCT04640311|520488692|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350572|NCT04640311|520488693|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350573|NCT04640311|520488694|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
144350574|NCT04640311|520488695|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350575|NCT04640311|520488696|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350576|NCT04640311|520488697|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350577|NCT04640311|520488698|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
144350578|NCT04640311|520488699|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350579|NCT04640311|520488700|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
144350580|NCT04640311|520488688|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350581|NCT04640311|520488689|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350582|NCT04640311|520488690|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350583|NCT04640311|520488691|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350584|NCT04640311|520488692|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350585|NCT04640311|520488693|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350586|NCT04640311|520488694|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350587|NCT04640311|520488695|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350588|NCT04640311|520488696|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350589|NCT04640311|520488697|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350590|NCT04640311|520488698|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350591|NCT04640311|520488699|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
144350592|NCT04640311|520488700|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
144350593|NCT01388907|520488701|FG000|Overall Study|Adverse Event|2|||
144350594|NCT01388907|520488702|FG001|Overall Study|Adverse Event|0|||
144350595|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
144350596|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
144350597|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
144350598|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
144350599|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
144350600|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
144350601|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
144350602|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
144350603|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
144350604|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
144350605|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
144350606|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
144350607|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
144350608|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
144350609|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
144350610|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
144350611|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
144350612|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
144350613|NCT01910402|520488703|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
144350614|NCT01910402|520488704|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
144350615|NCT01910402|520488705|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
144350616|NCT01910402|520488703|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
144350617|NCT01910402|520488704|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
144350618|NCT01910402|520488705|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
144350619|NCT01910402|520488703|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
144350620|NCT01910402|520488704|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
144350621|NCT01910402|520488705|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
144350622|NCT01910402|520488703|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
144350623|NCT01910402|520488704|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
144350624|NCT01910402|520488705|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
144350625|NCT01910402|520488703|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
144350626|NCT01910402|520488704|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
144350627|NCT01910402|520488705|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
144350628|NCT01910402|520488703|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
144350629|NCT01910402|520488704|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
144350630|NCT01910402|520488705|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
144350631|NCT01910402|520488703|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
144350632|NCT01910402|520488704|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
144350633|NCT01910402|520488705|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
144350634|NCT03594773|520488706|FG000|Overall Study|Withdrawal by Subject|3|||
144350635|NCT03594773|520488707|FG001|Overall Study|Withdrawal by Subject|2|||
144350636|NCT03594773|520488706|FG000|Overall Study|Lost to Follow-up|3|||
144350637|NCT03594773|520488707|FG001|Overall Study|Lost to Follow-up|4|||
144350638|NCT00193206|520488708|FG000|Preoperative Therapy|Lack of Efficacy|2|||
144350639|NCT00193206|520488708|FG000|Preoperative Therapy|Adverse Event|2|||
144350640|NCT00193206|520488708|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
144350641|NCT00193206|520488708|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
144350642|NCT00193206|520488708|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
144350643|NCT00193206|520488708|FG000|Postoperative Therapy|Physician Decision|3|||
144350644|NCT00193206|520488708|FG000|Postoperative Therapy|Intercurrent Illness|2|||
144350645|NCT00193206|520488708|FG000|Postoperative Therapy|Lack of Efficacy|1|||
144350646|NCT00193206|520488708|FG000|Postoperative Therapy|Protocol Violation|1|||
144350647|NCT01172535|520488713|FG000|Overall Study|Death|3|||
144350648|NCT01172535|520488713|FG000|Overall Study|Withdrawal by Subject|2|||
144350649|NCT01172535|520488713|FG000|Overall Study|Lost to Follow-up|1|||
144350650|NCT01172535|520488713|FG000|Overall Study|Ineligible at study entry|1|||
144350651|NCT01172535|520488713|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
144350652|NCT01818596|520488721|FG000|Overall Study|Enrolled but Not Treated|4|||
144350653|NCT01818596|520488722|FG001|Overall Study|Enrolled but Not Treated|0|||
144350654|NCT01818596|520488721|FG000|Overall Study|Adverse Event|7|||
144350655|NCT01818596|520488722|FG001|Overall Study|Adverse Event|0|||
144350656|NCT01818596|520488721|FG000|Overall Study|Death|3|||
144350657|NCT01818596|520488722|FG001|Overall Study|Death|0|||
144350658|NCT01818596|520488721|FG000|Overall Study|Investigator's Discretion|4|||
144350659|NCT01818596|520488722|FG001|Overall Study|Investigator's Discretion|0|||
144350660|NCT01818596|520488721|FG000|Overall Study|Protocol Violation|1|||
144350661|NCT01818596|520488722|FG001|Overall Study|Protocol Violation|0|||
144350662|NCT01818596|520488721|FG000|Overall Study|Withdrew Consent|5|||
144350663|NCT01818596|520488722|FG001|Overall Study|Withdrew Consent|0|||
144350664|NCT01818596|520488721|FG000|Overall Study|Lost to Follow-up|7|||
144350665|NCT01818596|520488722|FG001|Overall Study|Lost to Follow-up|0|||
144350666|NCT03461146|520488723|FG000|Overall Study|Adverse Event|2|||
144350667|NCT03461146|520488723|FG000|Overall Study|Physician Decision|1|||
144350668|NCT02915263|520488728|FG000|Overall Study|Covid|3|||
144350669|NCT02915263|520488729|FG001|Overall Study|Covid|2|||
144350670|NCT01479868|520488735|FG000|Overall Study|Adverse Event|1|||
144350671|NCT01479868|520488735|FG000|Overall Study|Lost to Follow-up|4|||
144350672|NCT01479868|520488735|FG000|Overall Study|Protocol Violation|1|||
144350673|NCT01479868|520488735|FG000|Overall Study|Withdrawal by Subject|1|||
144350674|NCT01479868|520488735|FG000|Overall Study|Sponsor's Decision|1|||
144350675|NCT01479868|520488735|FG000|Overall Study|Initiation of new HCV Therapy|1|||
144350676|NCT01879683|520488736|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
144350677|NCT01618669|520488737|FG000|Overall Study|Lost to Follow-up|1|||
144350678|NCT01618669|520488738|FG001|Overall Study|Lost to Follow-up|1|||
144350679|NCT01618669|520488737|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
144350680|NCT01618669|520488738|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
144350681|NCT01618669|520488737|FG000|Overall Study|Adverse Event|16|||
144350682|NCT01618669|520488738|FG001|Overall Study|Adverse Event|7|||
144350683|NCT01618669|520488737|FG000|Overall Study|Protocol Violation|5|||
144350684|NCT01618669|520488738|FG001|Overall Study|Protocol Violation|3|||
144350685|NCT01618669|520488737|FG000|Overall Study|Withdrawal by Subject|9|||
144350686|NCT01618669|520488738|FG001|Overall Study|Withdrawal by Subject|9|||
144350687|NCT01618669|520488737|FG000|Overall Study|Miscellaneous Reason|0|||
144350688|NCT01618669|520488738|FG001|Overall Study|Miscellaneous Reason|1|||
144350689|NCT01177007|520488741|FG000|Overall Study|Lost to Follow-up|2|||
144350690|NCT01177007|520488741|FG000|Overall Study|Death|4|||
144350691|NCT01177007|520488741|FG000|Overall Study|Entered hospice care|5|||
144350692|NCT01177007|520488741|FG000|Overall Study|Required additional Y90 treatment|6|||
144350693|NCT01177007|520488741|FG000|Overall Study|Change in treatment modality|21|||
144350694|NCT03600740|520488745|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
144350695|NCT01702558|520488746|FG000|Overall Study|Withdrawal by Subject|0|||
144350696|NCT01702558|520488747|FG001|Overall Study|Withdrawal by Subject|0|||
144350697|NCT01702558|520488748|FG002|Overall Study|Withdrawal by Subject|0|||
144350698|NCT01702558|520488749|FG003|Overall Study|Withdrawal by Subject|12|||
144350699|NCT01702558|520488750|FG004|Overall Study|Withdrawal by Subject|4|||
144350700|NCT01702558|520488746|FG000|Overall Study|Lost to Follow-up|0|||
144350701|NCT01702558|520488747|FG001|Overall Study|Lost to Follow-up|0|||
144350702|NCT01702558|520488748|FG002|Overall Study|Lost to Follow-up|0|||
144350703|NCT01702558|520488749|FG003|Overall Study|Lost to Follow-up|3|||
144350704|NCT01702558|520488750|FG004|Overall Study|Lost to Follow-up|0|||
144350705|NCT01702558|520488746|FG000|Overall Study|Death|4|||
144350706|NCT01702558|520488747|FG001|Overall Study|Death|3|||
144350707|NCT01702558|520488748|FG002|Overall Study|Death|3|||
144350708|NCT01702558|520488749|FG003|Overall Study|Death|16|||
144350709|NCT01702558|520488750|FG004|Overall Study|Death|20|||
144350710|NCT01702558|520488746|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
144350711|NCT01702558|520488747|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
144350712|NCT01702558|520488748|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
144350713|NCT01702558|520488749|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
144350714|NCT01702558|520488750|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
144350715|NCT01702558|520488746|FG000|Overall Study|Study Terminated by Sponsor|0|||
144350716|NCT01702558|520488747|FG001|Overall Study|Study Terminated by Sponsor|1|||
144350717|NCT01702558|520488748|FG002|Overall Study|Study Terminated by Sponsor|0|||
144350718|NCT01702558|520488749|FG003|Overall Study|Study Terminated by Sponsor|0|||
144350719|NCT01702558|520488750|FG004|Overall Study|Study Terminated by Sponsor|1|||
144350720|NCT01702558|520488746|FG000|Overall Study|Other|0|||
144350721|NCT01702558|520488747|FG001|Overall Study|Other|0|||
144350722|NCT01702558|520488748|FG002|Overall Study|Other|0|||
144350723|NCT01702558|520488749|FG003|Overall Study|Other|16|||
144350724|NCT01702558|520488750|FG004|Overall Study|Other|17|||
144350725|NCT03259087|520488751|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
144350726|NCT03259087|520488752|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
144350727|NCT03259087|520488753|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
144350728|NCT03259087|520488754|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
144350729|NCT03259087|520488755|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
144350730|NCT03259087|520488751|FG000|Period 2 of Part 2|Adverse Event|0|||
144350731|NCT03259087|520488752|FG001|Period 2 of Part 2|Adverse Event|0|||
144350732|NCT03259087|520488753|FG002|Period 2 of Part 2|Adverse Event|0|||
144350733|NCT03259087|520488754|FG003|Period 2 of Part 2|Adverse Event|0|||
144350734|NCT03259087|520488755|FG004|Period 2 of Part 2|Adverse Event|1|||
144350735|NCT02396212|520488756|FG000|Overall Study|Adverse Event|1|||
144350736|NCT02396212|520488756|FG000|Overall Study|Lack of Efficacy|2|||
144350737|NCT04950465|520488757|FG000|Overall Study|Lost to Follow-up|1|||
144350738|NCT04950465|520488758|FG001|Overall Study|Lost to Follow-up|0|||
144350739|NCT04950465|520488759|FG002|Overall Study|Lost to Follow-up|0|||
144350740|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Progressive disease|50|||
144350741|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Progressive disease|110|||
144350742|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Progressive disease|0|||
144350743|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Progressive disease|0|||
144350744|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
144350745|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
144350746|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144350747|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
144350748|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Adverse Event|7|||
144350749|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Adverse Event|7|||
144350750|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Adverse Event|0|||
144350751|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Adverse Event|0|||
144350752|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Other|1|||
144350753|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Other|3|||
144350754|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Other|0|||
144350755|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Other|0|||
144350756|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Physician Decision|6|||
144350757|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Physician Decision|3|||
144350758|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Physician Decision|0|||
144350759|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Physician Decision|0|||
144350760|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Death|1|||
144350761|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Death|1|||
144350762|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Death|0|||
144350763|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Death|0|||
144350764|NCT01695135|520488778|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
144350765|NCT01695135|520488779|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
144350766|NCT01695135|520488780|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
144350767|NCT01695135|520488781|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
144350768|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
144350769|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
144350770|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
144350771|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
144350772|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
144350773|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
144350774|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
144350775|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
144350776|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
144350777|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
144350778|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
144350779|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
144350780|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Other|0|||
144350781|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Other|0|||
144350782|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Other|4|||
144350783|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Other|7|||
144350784|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
144350785|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
144350786|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
144350787|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
144350788|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Death|0|||
144350789|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Death|0|||
144350790|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Death|2|||
144350791|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Death|7|||
144350792|NCT01695135|520488778|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
144350793|NCT01695135|520488779|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
144350794|NCT01695135|520488780|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
144350795|NCT01695135|520488781|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
144350796|NCT05202418|520488789|FG000|Overall Study|Withdrawal by Subject|2|||
144350797|NCT05202418|520488790|FG001|Overall Study|Withdrawal by Subject|1|||
144350798|NCT05202418|520488789|FG000|Overall Study|Lost to Follow-up|1|||
144350799|NCT05202418|520488790|FG001|Overall Study|Lost to Follow-up|1|||
144350800|NCT02562716|520488791|FG000|Overall Study|Adverse Event|7|||
144350801|NCT02562716|520488792|FG001|Overall Study|Adverse Event|14|||
144350802|NCT02562716|520488791|FG000|Overall Study|Withdrawal unrelated to AE|7|||
144350803|NCT02562716|520488792|FG001|Overall Study|Withdrawal unrelated to AE|1|||
144350804|NCT02562716|520488791|FG000|Overall Study|Progression|8|||
144350805|NCT02562716|520488792|FG001|Overall Study|Progression|10|||
144350806|NCT02562716|520488791|FG000|Overall Study|Death|2|||
144350807|NCT02562716|520488792|FG001|Overall Study|Death|1|||
144350808|NCT02562716|520488791|FG000|Overall Study|Not protocol specified|4|||
144350809|NCT02562716|520488792|FG001|Overall Study|Not protocol specified|2|||
144350810|NCT02753946|520488793|FG000|Overall Study|Adverse Event|7|||
144350811|NCT02753946|520488794|FG001|Overall Study|Adverse Event|6|||
144350812|NCT02753946|520488793|FG000|Overall Study|Withdrawal by Subject|6|||
144350813|NCT02753946|520488794|FG001|Overall Study|Withdrawal by Subject|1|||
144350814|NCT02753946|520488793|FG000|Overall Study|Lack of Efficacy|1|||
144350815|NCT02753946|520488794|FG001|Overall Study|Lack of Efficacy|0|||
144350816|NCT02753946|520488793|FG000|Overall Study|Physician Decision|0|||
144350817|NCT02753946|520488794|FG001|Overall Study|Physician Decision|2|||
144350818|NCT00556998|520488795|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
144350819|NCT00556998|520488795|FG000|Voriconazole Intravenous (IV)|Other|4|||
144350820|NCT00556998|520488795|FG000|Voriconazole Oral|Adverse Event|1|||
144350821|NCT00556998|520488795|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
144350822|NCT02519439|520488796|FG000|Overall Study|Study Termination|19|||
144350823|NCT02519439|520488796|FG000|Overall Study|Withdrawal by Subject|1|||
144350824|NCT02519439|520488796|FG000|Overall Study|Adverse Event|1|||
144350825|NCT03030417|520488799|FG000|Dose Expansion|Disease progression before treatment|0|||
144350826|NCT03030417|520488800|FG001|Dose Expansion|Disease progression before treatment|0|||
144350827|NCT03030417|520488801|FG002|Dose Expansion|Disease progression before treatment|0|||
144350828|NCT03030417|520488802|FG003|Dose Expansion|Disease progression before treatment|0|||
144350829|NCT03030417|520488803|FG004|Dose Expansion|Disease progression before treatment|0|||
144350830|NCT03030417|520488804|FG005|Dose Expansion|Disease progression before treatment|0|||
144350831|NCT03030417|520488805|FG006|Dose Expansion|Disease progression before treatment|0|||
144350832|NCT03030417|520488806|FG007|Dose Expansion|Disease progression before treatment|0|||
144350833|NCT03030417|520488807|FG008|Dose Expansion|Disease progression before treatment|0|||
144350834|NCT03030417|520488808|FG009|Dose Expansion|Disease progression before treatment|0|||
144350835|NCT03030417|520488809|FG010|Dose Expansion|Disease progression before treatment|0|||
144350836|NCT03030417|520488810|FG011|Dose Expansion|Disease progression before treatment|0|||
144350837|NCT03030417|520488811|FG012|Dose Expansion|Disease progression before treatment|1|||
144350838|NCT01078441|520488812|FG000|Overall Study|Withdrawal by Subject|1|||
144350839|NCT01425801|520488813|FG000|Period 1|Withdrawal by Subject|0|||
144350840|NCT01425801|520488814|FG001|Period 1|Withdrawal by Subject|0|||
144350841|NCT01425801|520488815|FG002|Period 1|Withdrawal by Subject|0|||
144350842|NCT01425801|520488816|FG003|Period 1|Withdrawal by Subject|0|||
144350843|NCT01425801|520488817|FG004|Period 1|Withdrawal by Subject|1|||
144350844|NCT01425801|520488818|FG005|Period 1|Withdrawal by Subject|0|||
144350845|NCT01425801|520488813|FG000|Period 2|Withdrawal by Subject|0|||
144350846|NCT01425801|520488814|FG001|Period 2|Withdrawal by Subject|0|||
144350847|NCT01425801|520488815|FG002|Period 2|Withdrawal by Subject|0|||
144350848|NCT01425801|520488816|FG003|Period 2|Withdrawal by Subject|0|||
144350849|NCT01425801|520488817|FG004|Period 2|Withdrawal by Subject|1|||
144350850|NCT01425801|520488818|FG005|Period 2|Withdrawal by Subject|0|||
144350851|NCT01425801|520488813|FG000|Period 3|Stability criteria not fullfilled|0|||
144350852|NCT01425801|520488814|FG001|Period 3|Stability criteria not fullfilled|0|||
144350853|NCT01425801|520488815|FG002|Period 3|Stability criteria not fullfilled|1|||
144350854|NCT01425801|520488816|FG003|Period 3|Stability criteria not fullfilled|0|||
144350855|NCT01425801|520488817|FG004|Period 3|Stability criteria not fullfilled|0|||
144350856|NCT01425801|520488818|FG005|Period 3|Stability criteria not fullfilled|0|||
144350857|NCT01425801|520488813|FG000|Period 4|Not able to maintain visit schedule|0|||
144350858|NCT01425801|520488814|FG001|Period 4|Not able to maintain visit schedule|0|||
144350859|NCT01425801|520488815|FG002|Period 4|Not able to maintain visit schedule|1|||
144350860|NCT01425801|520488816|FG003|Period 4|Not able to maintain visit schedule|0|||
144350861|NCT01425801|520488817|FG004|Period 4|Not able to maintain visit schedule|0|||
144350862|NCT01425801|520488818|FG005|Period 4|Not able to maintain visit schedule|0|||
144350863|NCT02714569|520488819|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
144350864|NCT02714569|520488820|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
144350865|NCT02714569|520488821|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
144350866|NCT02714569|520488822|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
144350867|NCT02714569|520488823|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
144350868|NCT02714569|520488824|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
144350869|NCT02714569|520488825|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
144350870|NCT02714569|520488826|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
144350871|NCT02714569|520488827|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
144350872|NCT02714569|520488828|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
144350873|NCT02714569|520488829|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
144350874|NCT02714569|520488819|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350875|NCT02714569|520488820|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350876|NCT02714569|520488821|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350877|NCT02714569|520488822|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
144350878|NCT02714569|520488823|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350879|NCT02714569|520488824|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350880|NCT02714569|520488825|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350881|NCT02714569|520488826|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350882|NCT02714569|520488827|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350883|NCT02714569|520488828|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350884|NCT02714569|520488829|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
144350885|NCT02714569|520488819|FG000|Part A Third Intervention|Adverse Event|0|||
144350886|NCT02714569|520488820|FG001|Part A Third Intervention|Adverse Event|0|||
144350887|NCT02714569|520488821|FG002|Part A Third Intervention|Adverse Event|1|||
144350888|NCT02714569|520488822|FG003|Part A Third Intervention|Adverse Event|0|||
144350889|NCT02714569|520488823|FG004|Part A Third Intervention|Adverse Event|0|||
144350890|NCT02714569|520488824|FG005|Part A Third Intervention|Adverse Event|0|||
144350891|NCT02714569|520488825|FG006|Part A Third Intervention|Adverse Event|0|||
144350892|NCT02714569|520488826|FG007|Part A Third Intervention|Adverse Event|0|||
144350893|NCT02714569|520488827|FG008|Part A Third Intervention|Adverse Event|0|||
144350894|NCT02714569|520488828|FG009|Part A Third Intervention|Adverse Event|0|||
144350895|NCT02714569|520488829|FG010|Part A Third Intervention|Adverse Event|0|||
144350896|NCT02714569|520488819|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
144350897|NCT02714569|520488820|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350898|NCT02714569|520488821|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350899|NCT02714569|520488822|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350900|NCT02714569|520488823|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350901|NCT02714569|520488824|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
144350902|NCT02714569|520488825|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350903|NCT02714569|520488826|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350904|NCT02714569|520488827|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350905|NCT02714569|520488828|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350906|NCT02714569|520488829|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
144350907|NCT02714569|520488819|FG000|Part B (Overall)|Lost to Follow-up|0|||
144350908|NCT02714569|520488820|FG001|Part B (Overall)|Lost to Follow-up|0|||
144350909|NCT02714569|520488821|FG002|Part B (Overall)|Lost to Follow-up|0|||
144350910|NCT02714569|520488822|FG003|Part B (Overall)|Lost to Follow-up|0|||
144350911|NCT02714569|520488823|FG004|Part B (Overall)|Lost to Follow-up|0|||
144350912|NCT02714569|520488824|FG005|Part B (Overall)|Lost to Follow-up|0|||
144350913|NCT02714569|520488825|FG006|Part B (Overall)|Lost to Follow-up|1|||
144350914|NCT02714569|520488826|FG007|Part B (Overall)|Lost to Follow-up|0|||
144350915|NCT02714569|520488827|FG008|Part B (Overall)|Lost to Follow-up|0|||
144350916|NCT02714569|520488828|FG009|Part B (Overall)|Lost to Follow-up|0|||
144350917|NCT02714569|520488829|FG010|Part B (Overall)|Lost to Follow-up|0|||
144350918|NCT02714569|520488819|FG000|Part B (Overall)|Withdrawal by Subject|0|||
144350919|NCT02714569|520488820|FG001|Part B (Overall)|Withdrawal by Subject|0|||
144350920|NCT02714569|520488821|FG002|Part B (Overall)|Withdrawal by Subject|0|||
144350921|NCT02714569|520488822|FG003|Part B (Overall)|Withdrawal by Subject|0|||
144350922|NCT02714569|520488823|FG004|Part B (Overall)|Withdrawal by Subject|0|||
144350923|NCT02714569|520488824|FG005|Part B (Overall)|Withdrawal by Subject|0|||
144350924|NCT02714569|520488825|FG006|Part B (Overall)|Withdrawal by Subject|0|||
144350925|NCT02714569|520488826|FG007|Part B (Overall)|Withdrawal by Subject|1|||
144350926|NCT02714569|520488827|FG008|Part B (Overall)|Withdrawal by Subject|0|||
144350927|NCT02714569|520488828|FG009|Part B (Overall)|Withdrawal by Subject|1|||
144350928|NCT02714569|520488829|FG010|Part B (Overall)|Withdrawal by Subject|0|||
144350929|NCT02714569|520488819|FG000|Part B (Overall)|Adverse Event|0|||
144350930|NCT02714569|520488820|FG001|Part B (Overall)|Adverse Event|0|||
144350931|NCT02714569|520488821|FG002|Part B (Overall)|Adverse Event|0|||
144350932|NCT02714569|520488822|FG003|Part B (Overall)|Adverse Event|0|||
144350933|NCT02714569|520488823|FG004|Part B (Overall)|Adverse Event|0|||
144350934|NCT02714569|520488824|FG005|Part B (Overall)|Adverse Event|0|||
144350935|NCT02714569|520488825|FG006|Part B (Overall)|Adverse Event|0|||
144350936|NCT02714569|520488826|FG007|Part B (Overall)|Adverse Event|0|||
144350937|NCT02714569|520488827|FG008|Part B (Overall)|Adverse Event|0|||
144350938|NCT02714569|520488828|FG009|Part B (Overall)|Adverse Event|1|||
144350939|NCT02714569|520488829|FG010|Part B (Overall)|Adverse Event|0|||
144350940|NCT04915729|520488830|FG000|Overall Study|Lost to Follow-up|20|||
144350941|NCT04915729|520488831|FG001|Overall Study|Lost to Follow-up|10|||
144350942|NCT04915729|520488830|FG000|Overall Study|Withdrawal by Subject|12|||
144350943|NCT04915729|520488831|FG001|Overall Study|Withdrawal by Subject|5|||
144350944|NCT04915729|520488830|FG000|Overall Study|Death|34|||
144350945|NCT04915729|520488831|FG001|Overall Study|Death|44|||
144350946|NCT04915729|520488830|FG000|Overall Study|not treated|3|||
144350947|NCT04915729|520488831|FG001|Overall Study|not treated|6|||
144350948|NCT04915729|520488830|FG000|Overall Study|Investigator removed subject|1|||
144350949|NCT04915729|520488831|FG001|Overall Study|Investigator removed subject|2|||
144350950|NCT04915729|520488830|FG000|Overall Study|questionnaire result not evaluated|1|||
144350951|NCT04915729|520488831|FG001|Overall Study|questionnaire result not evaluated|0|||
144350952|NCT04915729|520488830|FG000|Overall Study|refuse of hospital visit|1|||
144350953|NCT04915729|520488831|FG001|Overall Study|refuse of hospital visit|3|||
144350954|NCT04915729|520488830|FG000|Overall Study|Subject withdrew|1|||
144350955|NCT04915729|520488831|FG001|Overall Study|Subject withdrew|0|||
144350956|NCT04961541|520488832|FG000|Overall Study|Adverse Event|0|||
144350957|NCT04961541|520488833|FG001|Overall Study|Adverse Event|0|||
144350958|NCT04961541|520488834|FG002|Overall Study|Adverse Event|0|||
144350959|NCT04961541|520488835|FG003|Overall Study|Adverse Event|0|||
144350960|NCT04961541|520488836|FG004|Overall Study|Adverse Event|0|||
144350961|NCT04961541|520488837|FG005|Overall Study|Adverse Event|1|||
144350962|NCT04961541|520488838|FG006|Overall Study|Adverse Event|0|||
144350963|NCT04961541|520488839|FG007|Overall Study|Adverse Event|0|||
144350964|NCT04961541|520488840|FG008|Overall Study|Adverse Event|0|||
144350965|NCT04961541|520488841|FG009|Overall Study|Adverse Event|0|||
144350966|NCT04961541|520488842|FG010|Overall Study|Adverse Event|0|||
144350967|NCT04961541|520488843|FG011|Overall Study|Adverse Event|0|||
144350968|NCT04961541|520488844|FG012|Overall Study|Adverse Event|0|||
144350969|NCT04961541|520488845|FG013|Overall Study|Adverse Event|0|||
144350970|NCT04961541|520488832|FG000|Overall Study|Lost to Follow-up|0|||
144350971|NCT04961541|520488833|FG001|Overall Study|Lost to Follow-up|0|||
144350972|NCT04961541|520488834|FG002|Overall Study|Lost to Follow-up|3|||
144350973|NCT04961541|520488835|FG003|Overall Study|Lost to Follow-up|0|||
144350974|NCT04961541|520488836|FG004|Overall Study|Lost to Follow-up|0|||
144350975|NCT04961541|520488837|FG005|Overall Study|Lost to Follow-up|0|||
144350976|NCT04961541|520488838|FG006|Overall Study|Lost to Follow-up|1|||
144350977|NCT04961541|520488839|FG007|Overall Study|Lost to Follow-up|1|||
144350978|NCT04961541|520488840|FG008|Overall Study|Lost to Follow-up|0|||
144350979|NCT04961541|520488841|FG009|Overall Study|Lost to Follow-up|1|||
144350980|NCT04961541|520488842|FG010|Overall Study|Lost to Follow-up|0|||
144350981|NCT04961541|520488843|FG011|Overall Study|Lost to Follow-up|0|||
144350982|NCT04961541|520488844|FG012|Overall Study|Lost to Follow-up|1|||
144350983|NCT04961541|520488845|FG013|Overall Study|Lost to Follow-up|0|||
144350984|NCT04961541|520488832|FG000|Overall Study|Withdrawal by Subject|0|||
144350985|NCT04961541|520488833|FG001|Overall Study|Withdrawal by Subject|0|||
144350986|NCT04961541|520488834|FG002|Overall Study|Withdrawal by Subject|1|||
144350987|NCT04961541|520488835|FG003|Overall Study|Withdrawal by Subject|1|||
144350988|NCT04961541|520488836|FG004|Overall Study|Withdrawal by Subject|0|||
144350989|NCT04961541|520488837|FG005|Overall Study|Withdrawal by Subject|0|||
144350990|NCT04961541|520488838|FG006|Overall Study|Withdrawal by Subject|0|||
144350991|NCT04961541|520488839|FG007|Overall Study|Withdrawal by Subject|0|||
144350992|NCT04961541|520488840|FG008|Overall Study|Withdrawal by Subject|0|||
144350993|NCT04961541|520488841|FG009|Overall Study|Withdrawal by Subject|1|||
144350994|NCT04961541|520488842|FG010|Overall Study|Withdrawal by Subject|0|||
144350995|NCT04961541|520488843|FG011|Overall Study|Withdrawal by Subject|0|||
144350996|NCT04961541|520488844|FG012|Overall Study|Withdrawal by Subject|0|||
144350997|NCT04961541|520488845|FG013|Overall Study|Withdrawal by Subject|0|||
144350998|NCT01684202|520488846|FG000|Dose-escalation Period|Adverse Event|0|||
144350999|NCT01684202|520488847|FG001|Dose-escalation Period|Adverse Event|1|||
144351000|NCT01684202|520488848|FG002|Dose-escalation Period|Adverse Event|0|||
144351001|NCT01684202|520488849|FG003|Dose-escalation Period|Adverse Event|0|||
144351002|NCT01684202|520488846|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
144351003|NCT01684202|520488847|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
144351004|NCT01684202|520488848|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
144351005|NCT01684202|520488849|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
144351006|NCT01684202|520488846|FG000|Maintenance Period|Adverse Event|1|||
144351007|NCT01684202|520488847|FG001|Maintenance Period|Adverse Event|1|||
144351008|NCT01684202|520488848|FG002|Maintenance Period|Adverse Event|1|||
144351009|NCT01684202|520488849|FG003|Maintenance Period|Adverse Event|1|||
144351010|NCT01684202|520488846|FG000|Maintenance Period|Physician Decision|0|||
144351011|NCT01684202|520488847|FG001|Maintenance Period|Physician Decision|1|||
144351012|NCT01684202|520488848|FG002|Maintenance Period|Physician Decision|0|||
144351013|NCT01684202|520488849|FG003|Maintenance Period|Physician Decision|0|||
144351014|NCT01684202|520488846|FG000|Maintenance Period|Withdrawal by Subject|0|||
144351015|NCT01684202|520488847|FG001|Maintenance Period|Withdrawal by Subject|1|||
144351016|NCT01684202|520488848|FG002|Maintenance Period|Withdrawal by Subject|0|||
144351017|NCT01684202|520488849|FG003|Maintenance Period|Withdrawal by Subject|0|||
144351018|NCT03710642|520488850|FG000|Overall Study|Adverse Event|5|||
144351019|NCT03710642|520488851|FG001|Overall Study|Adverse Event|1|||
144351020|NCT03710642|520488850|FG000|Overall Study|non-site physician recommendation|1|||
144351021|NCT03710642|520488851|FG001|Overall Study|non-site physician recommendation|0|||
144351022|NCT03710642|520488850|FG000|Overall Study|Participant unwilling or unable to participate|1|||
144351023|NCT03710642|520488851|FG001|Overall Study|Participant unwilling or unable to participate|1|||
144351024|NCT03710642|520488850|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
144351025|NCT03710642|520488851|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
144351026|NCT03710642|520488850|FG000|Overall Study|NA-no code provided|1|||
144351027|NCT03710642|520488851|FG001|Overall Study|NA-no code provided|0|||
144351028|NCT03710642|520488850|FG000|Overall Study|Withdrawal by Subject|1|||
144351029|NCT03710642|520488851|FG001|Overall Study|Withdrawal by Subject|0|||
144351030|NCT01970306|520488852|FG000|Overall Study|Not eligible|3|||
144351031|NCT01970306|520488852|FG000|Overall Study|Not able to be treated|9|||
144351032|NCT02864901|520488853|FG000|Overall Study|Withdrawal by Subject|1|||
144351033|NCT02864901|520488854|FG001|Overall Study|Withdrawal by Subject|0|||
144351034|NCT01369784|520488855|FG000|Overall Study|Protocol Violation|12|||
144351035|NCT02292719|520488856|FG000|Overall Study|Withdrawal by Subject|0|||
144351036|NCT02292719|520488857|FG001|Overall Study|Withdrawal by Subject|0|||
144351037|NCT02292719|520488858|FG002|Overall Study|Withdrawal by Subject|0|||
144351038|NCT02292719|520488859|FG003|Overall Study|Withdrawal by Subject|1|||
144351039|NCT02292719|520488860|FG004|Overall Study|Withdrawal by Subject|1|||
144351040|NCT02292719|520488861|FG005|Overall Study|Withdrawal by Subject|0|||
144351041|NCT02292719|520488856|FG000|Overall Study|Subject enrolled in new study.|0|||
144351042|NCT02292719|520488857|FG001|Overall Study|Subject enrolled in new study.|0|||
144351043|NCT02292719|520488858|FG002|Overall Study|Subject enrolled in new study.|1|||
144351044|NCT02292719|520488859|FG003|Overall Study|Subject enrolled in new study.|0|||
144351045|NCT02292719|520488860|FG004|Overall Study|Subject enrolled in new study.|0|||
144351046|NCT02292719|520488861|FG005|Overall Study|Subject enrolled in new study.|0|||
144351047|NCT05973006|520488864|FG000|Overall Study|Early termination|3|||
144351048|NCT05973006|520488865|FG001|Overall Study|Early termination|9|||
144351049|NCT05167825|520488866|FG000|Overall Study|Ongoing|3|||
144351050|NCT02326597|520488871|FG000|Overall Study|Lost to Follow-up|42|||
144351051|NCT02326597|520488872|FG001|Overall Study|Lost to Follow-up|32|||
144351052|NCT00770601|520488875|FG000|Overall Study|Withdrawal by Subject|1|||
144351053|NCT00428948|520488876|FG000|Overall Study|Lost to Follow-up|15|||
144351054|NCT00428948|520488877|FG001|Overall Study|Lost to Follow-up|8|||
144351055|NCT00428948|520488876|FG000|Overall Study|Adverse Event|148|||
144351056|NCT00428948|520488877|FG001|Overall Study|Adverse Event|24|||
144351057|NCT00428948|520488876|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
144351058|NCT00428948|520488877|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
144351059|NCT00428948|520488876|FG000|Overall Study|Investigator Withdrew Subject|3|||
144351060|NCT00428948|520488877|FG001|Overall Study|Investigator Withdrew Subject|4|||
144351061|NCT00428948|520488876|FG000|Overall Study|Subject Withdrew Consent|50|||
144351062|NCT00428948|520488877|FG001|Overall Study|Subject Withdrew Consent|30|||
144351063|NCT00428948|520488876|FG000|Overall Study|Protocol Deviation|1|||
144351064|NCT00428948|520488877|FG001|Overall Study|Protocol Deviation|1|||
144351065|NCT01900652|520488879|FG000|Overall Study|Progressive Disease|1|||
144351066|NCT01900652|520488880|FG001|Overall Study|Progressive Disease|0|||
144351067|NCT01900652|520488879|FG000|Overall Study|Consent withdrawn by subject|1|||
144351068|NCT01900652|520488880|FG001|Overall Study|Consent withdrawn by subject|1|||
144351069|NCT01900652|520488879|FG000|Overall Study|Death|3|||
144351070|NCT01900652|520488880|FG001|Overall Study|Death|0|||
144351071|NCT01900652|520488879|FG000|Overall Study|Adverse Event|2|||
144351072|NCT01900652|520488880|FG001|Overall Study|Adverse Event|1|||
144351073|NCT01900652|520488879|FG000|Overall Study|Physician Decision|1|||
144351074|NCT01900652|520488880|FG001|Overall Study|Physician Decision|1|||
144351075|NCT01633788|520490743|FG000|Overall Study|Adverse Event|1|||
144351076|NCT01633788|520490744|FG001|Overall Study|Adverse Event|3|||
144351077|NCT01633788|520490745|FG002|Overall Study|Adverse Event|3|||
144351078|NCT01633788|520490746|FG003|Overall Study|Adverse Event|3|||
144351079|NCT01633788|520490743|FG000|Overall Study|Lost to Follow-up|2|||
144351080|NCT01633788|520490744|FG001|Overall Study|Lost to Follow-up|2|||
144351081|NCT01633788|520490745|FG002|Overall Study|Lost to Follow-up|2|||
144351082|NCT01633788|520490746|FG003|Overall Study|Lost to Follow-up|0|||
144351083|NCT01633788|520490743|FG000|Overall Study|Personal Reasons|3|||
144351084|NCT01633788|520490744|FG001|Overall Study|Personal Reasons|1|||
144351085|NCT01633788|520490745|FG002|Overall Study|Personal Reasons|1|||
144351086|NCT01633788|520490746|FG003|Overall Study|Personal Reasons|3|||
144351087|NCT01633788|520490743|FG000|Overall Study|Protocol Violation|1|||
144351088|NCT01633788|520490744|FG001|Overall Study|Protocol Violation|0|||
144351089|NCT01633788|520490745|FG002|Overall Study|Protocol Violation|1|||
144351090|NCT01633788|520490746|FG003|Overall Study|Protocol Violation|0|||
144351091|NCT01633788|520490743|FG000|Overall Study|Other Reasons|0|||
144351092|NCT01633788|520490744|FG001|Overall Study|Other Reasons|2|||
144351093|NCT01633788|520490745|FG002|Overall Study|Other Reasons|3|||
144351094|NCT01633788|520490746|FG003|Overall Study|Other Reasons|7|||
144351095|NCT01929226|520490747|FG000|Overall Study|Lost to Follow-up|4|||
144351096|NCT01929226|520490748|FG001|Overall Study|Lost to Follow-up|0|||
144351097|NCT01929226|520490747|FG000|Overall Study|Withdrawal by Subject|1|||
144351098|NCT01929226|520490748|FG001|Overall Study|Withdrawal by Subject|1|||
144351099|NCT03553758|520490749|FG000|Overall Study|Lost to Follow-up|1|||
144351100|NCT01467505|520490754|FG000|Overall Study|Adverse Event|1|||
144351101|NCT01467505|520490755|FG001|Overall Study|Adverse Event|0|||
144351102|NCT01467505|520490754|FG000|Overall Study|Withdrawal by Subject|4|||
144351103|NCT01467505|520490755|FG001|Overall Study|Withdrawal by Subject|0|||
144351104|NCT01467505|520490754|FG000|Overall Study|Study Terminated by Sponsor|28|||
144351105|NCT01467505|520490755|FG001|Overall Study|Study Terminated by Sponsor|3|||
144351106|NCT02807623|520490756|FG000|Overall Study|Lost to Follow-up|23|||
144351107|NCT02807623|520490757|FG001|Overall Study|Lost to Follow-up|18|||
144351108|NCT02807623|520490758|FG002|Overall Study|Lost to Follow-up|22|||
144351109|NCT02807623|520490756|FG000|Overall Study|Drug intolerance|0|||
144351110|NCT02807623|520490757|FG001|Overall Study|Drug intolerance|1|||
144351111|NCT02807623|520490758|FG002|Overall Study|Drug intolerance|0|||
144351112|NCT02807623|520490756|FG000|Overall Study|incomplete blood draw|0|||
144351113|NCT02807623|520490757|FG001|Overall Study|incomplete blood draw|2|||
144351114|NCT02807623|520490758|FG002|Overall Study|incomplete blood draw|1|||
144351115|NCT03449758|520490760|FG000|Overall Study|Major protocol deviation|1|||
144351116|NCT03449758|520490760|FG000|Overall Study|Treatment inefficacy|5|||
144351117|NCT03449758|520490760|FG000|Overall Study|Adverse Event|9|||
144351118|NCT03449758|520490760|FG000|Overall Study|Consent withdrawal|1|||
144351119|NCT03449758|520490760|FG000|Overall Study|Other unspecified reason|3|||
144351120|NCT03310723|520490761|FG000|Overall Study|Withdrawal by Subject|0|||
144351121|NCT03310723|520490762|FG001|Overall Study|Withdrawal by Subject|1|||
144351122|NCT03310723|520490761|FG000|Overall Study|Protocol Violation|0|||
144351123|NCT03310723|520490762|FG001|Overall Study|Protocol Violation|2|||
144351124|NCT00330759|520490765|FG000|Overall Study|Death|316|||
144351125|NCT00330759|520490766|FG001|Overall Study|Death|310|||
144351126|NCT00330759|520490765|FG000|Overall Study|Disease progression|104|||
144351127|NCT00330759|520490766|FG001|Overall Study|Disease progression|126|||
144351128|NCT00330759|520490765|FG000|Overall Study|Withdrawal by Subject|143|||
144351129|NCT00330759|520490766|FG001|Overall Study|Withdrawal by Subject|124|||
144351130|NCT00330759|520490765|FG000|Overall Study|Adverse Event|48|||
144351131|NCT00330759|520490766|FG001|Overall Study|Adverse Event|36|||
144351132|NCT00330759|520490765|FG000|Overall Study|Participant request|31|||
144351133|NCT00330759|520490766|FG001|Overall Study|Participant request|22|||
144351134|NCT00330759|520490765|FG000|Overall Study|Lost to Follow-up|16|||
144351135|NCT00330759|520490766|FG001|Overall Study|Lost to Follow-up|22|||
144351136|NCT00330759|520490765|FG000|Overall Study|Noncompliance|15|||
144351137|NCT00330759|520490766|FG001|Overall Study|Noncompliance|17|||
144351138|NCT00330759|520490765|FG000|Overall Study|Physician Decision|1|||
144351139|NCT00330759|520490766|FG001|Overall Study|Physician Decision|2|||
144351140|NCT00330759|520490765|FG000|Overall Study|Protocol deviation|0|||
144351141|NCT00330759|520490766|FG001|Overall Study|Protocol deviation|2|||
144351142|NCT00330759|520490765|FG000|Overall Study|Ineligibility determined|2|||
144351143|NCT00330759|520490766|FG001|Overall Study|Ineligibility determined|1|||
144351144|NCT00330759|520490765|FG000|Overall Study|Other|36|||
144351145|NCT00330759|520490766|FG001|Overall Study|Other|44|||
144351146|NCT04070989|520490768|FG000|Overall Study|Death|1|||
144351147|NCT04070989|520490769|FG001|Overall Study|Death|0|||
144351148|NCT04070989|520490770|FG002|Overall Study|Death|0|||
144351149|NCT04070989|520490768|FG000|Overall Study|Study Terminated by Sponsor|7|||
144351150|NCT04070989|520490769|FG001|Overall Study|Study Terminated by Sponsor|8|||
144351151|NCT04070989|520490770|FG002|Overall Study|Study Terminated by Sponsor|23|||
144351152|NCT04070989|520490768|FG000|Overall Study|Withdrawal by Subject|0|||
144351153|NCT04070989|520490769|FG001|Overall Study|Withdrawal by Subject|1|||
144351154|NCT04070989|520490770|FG002|Overall Study|Withdrawal by Subject|0|||
144351155|NCT04070989|520490768|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
144351156|NCT04070989|520490769|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
144351157|NCT04070989|520490770|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
144351158|NCT04070989|520490768|FG000|Overall Study|Other|1|||
144351159|NCT04070989|520490769|FG001|Overall Study|Other|1|||
144351160|NCT04070989|520490770|FG002|Overall Study|Other|0|||
144351161|NCT00592904|520490790|FG000|Overall Study|Adverse Event|15|||
144351162|NCT00592904|520490791|FG001|Overall Study|Adverse Event|25|||
144351163|NCT00592904|520490792|FG002|Overall Study|Adverse Event|13|||
144351164|NCT00592904|520490793|FG003|Overall Study|Adverse Event|5|||
144351165|NCT00592904|520490790|FG000|Overall Study|Protocol Violation|1|||
144351166|NCT00592904|520490791|FG001|Overall Study|Protocol Violation|1|||
144351167|NCT00592904|520490792|FG002|Overall Study|Protocol Violation|0|||
144351168|NCT00592904|520490793|FG003|Overall Study|Protocol Violation|1|||
144351169|NCT00592904|520490790|FG000|Overall Study|Withdrawal by Subject|4|||
144351170|NCT00592904|520490791|FG001|Overall Study|Withdrawal by Subject|16|||
144351171|NCT00592904|520490792|FG002|Overall Study|Withdrawal by Subject|1|||
144351172|NCT00592904|520490793|FG003|Overall Study|Withdrawal by Subject|2|||
144351173|NCT00592904|520490790|FG000|Overall Study|Lack of Efficacy|2|||
144351174|NCT00592904|520490791|FG001|Overall Study|Lack of Efficacy|7|||
144351175|NCT00592904|520490792|FG002|Overall Study|Lack of Efficacy|2|||
144351176|NCT00592904|520490793|FG003|Overall Study|Lack of Efficacy|3|||
144351177|NCT00592904|520490790|FG000|Overall Study|Physician Decision|0|||
144351178|NCT00592904|520490791|FG001|Overall Study|Physician Decision|3|||
144351179|NCT00592904|520490792|FG002|Overall Study|Physician Decision|1|||
144351180|NCT00592904|520490793|FG003|Overall Study|Physician Decision|0|||
144351181|NCT00592904|520490790|FG000|Overall Study|Other|3|||
144351182|NCT00592904|520490791|FG001|Overall Study|Other|3|||
144351183|NCT00592904|520490792|FG002|Overall Study|Other|0|||
144351184|NCT00592904|520490793|FG003|Overall Study|Other|0|||
144351185|NCT00824473|520490794|FG000|Overall Study|Adverse Event|4|||
144351186|NCT00824473|520490795|FG001|Overall Study|Adverse Event|5|||
144351187|NCT00824473|520490794|FG000|Overall Study|Lack of Efficacy|2|||
144351188|NCT00824473|520490795|FG001|Overall Study|Lack of Efficacy|2|||
144351189|NCT00824473|520490794|FG000|Overall Study|Protocol Violation|2|||
144351190|NCT00824473|520490795|FG001|Overall Study|Protocol Violation|0|||
144351191|NCT00824473|520490794|FG000|Overall Study|Non-Compliance|4|||
144351192|NCT00824473|520490795|FG001|Overall Study|Non-Compliance|2|||
144351193|NCT00824473|520490794|FG000|Overall Study|Withdrawal by Subject|2|||
144351194|NCT00824473|520490795|FG001|Overall Study|Withdrawal by Subject|3|||
144351195|NCT00824473|520490794|FG000|Overall Study|Other|1|||
144351196|NCT00824473|520490795|FG001|Overall Study|Other|1|||
144351197|NCT01359904|520490796|FG000|Overall Study|Withdrawal by Subject|1|||
144351198|NCT01359904|520490797|FG001|Overall Study|Withdrawal by Subject|0|||
144351199|NCT03191630|520490799|FG000|Overall Study|Lost to Follow-up|7|||
144351200|NCT03191630|520490800|FG001|Overall Study|Lost to Follow-up|7|||
144351201|NCT01550757|520490801|FG000|Overall Study|Lost to Follow-up|21|||
144351202|NCT01550757|520490802|FG001|Overall Study|Lost to Follow-up|14|||
144351203|NCT01550757|520490803|FG002|Overall Study|Lost to Follow-up|42|||
144351204|NCT01550757|520490804|FG003|Overall Study|Lost to Follow-up|53|||
144351205|NCT01550757|520490801|FG000|Overall Study|Withdrawal by Subject|2|||
144351206|NCT01550757|520490802|FG001|Overall Study|Withdrawal by Subject|0|||
144351207|NCT01550757|520490803|FG002|Overall Study|Withdrawal by Subject|3|||
144351208|NCT01550757|520490804|FG003|Overall Study|Withdrawal by Subject|1|||
144351209|NCT02640547|520490808|FG000|Overall Study|Failure to Return|1|||
144351210|NCT02640547|520490808|FG000|Overall Study|Withdrawal by Subject|1|||
144351211|NCT02640547|520490808|FG000|Overall Study|Death|6|||
144351212|NCT02640547|520490808|FG000|Overall Study|Miscellaneous|3|||
144351213|NCT03018691|520490811|FG000|Overall Study|Adverse Event|1|||
144351214|NCT03018691|520490812|FG001|Overall Study|Adverse Event|1|||
144351215|NCT03018691|520490813|FG002|Overall Study|Adverse Event|4|||
144351216|NCT03018691|520490811|FG000|Overall Study|Lack of Efficacy|0|||
144351217|NCT03018691|520490812|FG001|Overall Study|Lack of Efficacy|0|||
144351218|NCT03018691|520490813|FG002|Overall Study|Lack of Efficacy|1|||
144351219|NCT03018691|520490811|FG000|Overall Study|Withdrawal by Subject|0|||
144351220|NCT03018691|520490812|FG001|Overall Study|Withdrawal by Subject|0|||
144351221|NCT03018691|520490813|FG002|Overall Study|Withdrawal by Subject|1|||
144351222|NCT03018691|520490811|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144351223|NCT03018691|520490812|FG001|Overall Study|Withdrawal by parent/guardian|0|||
144351224|NCT03018691|520490813|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144351225|NCT01020786|520490814|FG000|Induction Period|Entry Criteria Not Met|2|||
144351226|NCT01020786|520490814|FG000|Induction Period|Adverse Event|10|||
144351227|NCT01020786|520490814|FG000|Induction Period|Progressive Disease|31|||
144351228|NCT01020786|520490814|FG000|Induction Period|Investigator Decision|3|||
144351229|NCT01020786|520490814|FG000|Induction Period|Withdrawal by Subject|3|||
144351230|NCT01020786|520490814|FG000|Maintenance Period|Adverse Event|8|||
144351231|NCT01020786|520490814|FG000|Maintenance Period|Progressive Disease|43|||
144351232|NCT01020786|520490814|FG000|Maintenance Period|Withdrawal by Subject|8|||
144351233|NCT01020786|520490814|FG000|Maintenance Period|Sponsor Decision|1|||
144351234|NCT00837213|520490819|FG000|Overall Study|Lost to Follow-up|3|||
144351235|NCT00837213|520490820|FG001|Overall Study|Lost to Follow-up|2|||
144351236|NCT00837213|520490819|FG000|Overall Study|Withdrawal by Subject|2|||
144351237|NCT00837213|520490820|FG001|Overall Study|Withdrawal by Subject|2|||
144351238|NCT00837213|520490819|FG000|Overall Study|not stated|1|||
144351239|NCT00837213|520490820|FG001|Overall Study|not stated|1|||
144351240|NCT04497116|520490822|FG000|Overall Study|Lost to Follow-up|1|||
144351241|NCT04497116|520490823|FG001|Overall Study|Lost to Follow-up|0|||
144351242|NCT04497116|520490824|FG002|Overall Study|Lost to Follow-up|0|||
144351243|NCT04497116|520490825|FG003|Overall Study|Lost to Follow-up|0|||
144351244|NCT04497116|520490826|FG004|Overall Study|Lost to Follow-up|0|||
144351245|NCT04497116|520490827|FG005|Overall Study|Lost to Follow-up|0|||
144351246|NCT04497116|520490828|FG006|Overall Study|Lost to Follow-up|0|||
144351247|NCT04497116|520490829|FG007|Overall Study|Lost to Follow-up|3|||
144351248|NCT04497116|520490830|FG008|Overall Study|Lost to Follow-up|3|||
144351249|NCT04497116|520490831|FG009|Overall Study|Lost to Follow-up|0|||
144351250|NCT04497116|520490832|FG010|Overall Study|Lost to Follow-up|0|||
144351251|NCT04497116|520490833|FG011|Overall Study|Lost to Follow-up|0|||
144351252|NCT04497116|520490834|FG012|Overall Study|Lost to Follow-up|0|||
144351253|NCT04497116|520490835|FG013|Overall Study|Lost to Follow-up|0|||
144351254|NCT04497116|520490836|FG014|Overall Study|Lost to Follow-up|0|||
144351255|NCT04497116|520490837|FG015|Overall Study|Lost to Follow-up|0|||
144351256|NCT04497116|520490838|FG016|Overall Study|Lost to Follow-up|0|||
144351257|NCT04497116|520490839|FG017|Overall Study|Lost to Follow-up|0|||
144351258|NCT04497116|520490840|FG018|Overall Study|Lost to Follow-up|0|||
144351259|NCT04497116|520490841|FG019|Overall Study|Lost to Follow-up|0|||
144351260|NCT04497116|520490842|FG020|Overall Study|Lost to Follow-up|0|||
144351261|NCT04497116|520490843|FG021|Overall Study|Lost to Follow-up|0|||
144351262|NCT04497116|520490844|FG022|Overall Study|Lost to Follow-up|1|||
144351263|NCT04497116|520490845|FG023|Overall Study|Lost to Follow-up|0|||
144351264|NCT04497116|520490846|FG024|Overall Study|Lost to Follow-up|0|||
144351265|NCT04497116|520490822|FG000|Overall Study|Sponsor decision to terminate study|0|||
144351266|NCT04497116|520490823|FG001|Overall Study|Sponsor decision to terminate study|0|||
144351267|NCT04497116|520490824|FG002|Overall Study|Sponsor decision to terminate study|0|||
144351268|NCT04497116|520490825|FG003|Overall Study|Sponsor decision to terminate study|0|||
144351269|NCT04497116|520490826|FG004|Overall Study|Sponsor decision to terminate study|0|||
144351270|NCT04497116|520490827|FG005|Overall Study|Sponsor decision to terminate study|0|||
144351271|NCT04497116|520490828|FG006|Overall Study|Sponsor decision to terminate study|1|||
144351272|NCT04497116|520490829|FG007|Overall Study|Sponsor decision to terminate study|0|||
144351273|NCT04497116|520490830|FG008|Overall Study|Sponsor decision to terminate study|0|||
144351274|NCT04497116|520490831|FG009|Overall Study|Sponsor decision to terminate study|1|||
144351275|NCT04497116|520490832|FG010|Overall Study|Sponsor decision to terminate study|0|||
144351276|NCT04497116|520490833|FG011|Overall Study|Sponsor decision to terminate study|0|||
144351277|NCT04497116|520490834|FG012|Overall Study|Sponsor decision to terminate study|0|||
144351278|NCT04497116|520490835|FG013|Overall Study|Sponsor decision to terminate study|0|||
144351279|NCT04497116|520490836|FG014|Overall Study|Sponsor decision to terminate study|0|||
144351280|NCT04497116|520490837|FG015|Overall Study|Sponsor decision to terminate study|0|||
144351281|NCT04497116|520490838|FG016|Overall Study|Sponsor decision to terminate study|0|||
144351282|NCT04497116|520490839|FG017|Overall Study|Sponsor decision to terminate study|0|||
144351283|NCT04497116|520490840|FG018|Overall Study|Sponsor decision to terminate study|0|||
144351284|NCT04497116|520490841|FG019|Overall Study|Sponsor decision to terminate study|1|||
144351285|NCT04497116|520490842|FG020|Overall Study|Sponsor decision to terminate study|0|||
144351286|NCT04497116|520490843|FG021|Overall Study|Sponsor decision to terminate study|0|||
144351287|NCT04497116|520490844|FG022|Overall Study|Sponsor decision to terminate study|0|||
144351288|NCT04497116|520490845|FG023|Overall Study|Sponsor decision to terminate study|0|||
144351289|NCT04497116|520490846|FG024|Overall Study|Sponsor decision to terminate study|0|||
144351290|NCT04497116|520490822|FG000|Overall Study|Death|4|||
144351291|NCT04497116|520490823|FG001|Overall Study|Death|5|||
144351292|NCT04497116|520490824|FG002|Overall Study|Death|2|||
144351293|NCT04497116|520490825|FG003|Overall Study|Death|2|||
144351294|NCT04497116|520490826|FG004|Overall Study|Death|1|||
144351295|NCT04497116|520490827|FG005|Overall Study|Death|1|||
144351296|NCT04497116|520490828|FG006|Overall Study|Death|3|||
144351297|NCT04497116|520490829|FG007|Overall Study|Death|10|||
144351298|NCT04497116|520490830|FG008|Overall Study|Death|37|||
144351299|NCT04497116|520490831|FG009|Overall Study|Death|17|||
144351300|NCT04497116|520490832|FG010|Overall Study|Death|2|||
144351301|NCT04497116|520490833|FG011|Overall Study|Death|1|||
144351302|NCT04497116|520490834|FG012|Overall Study|Death|1|||
144351303|NCT04497116|520490835|FG013|Overall Study|Death|3|||
144351304|NCT04497116|520490836|FG014|Overall Study|Death|18|||
144351305|NCT04497116|520490837|FG015|Overall Study|Death|3|||
144351306|NCT04497116|520490838|FG016|Overall Study|Death|2|||
144351307|NCT04497116|520490839|FG017|Overall Study|Death|1|||
144351308|NCT04497116|520490840|FG018|Overall Study|Death|4|||
144351309|NCT04497116|520490841|FG019|Overall Study|Death|17|||
144351310|NCT04497116|520490842|FG020|Overall Study|Death|1|||
144351311|NCT04497116|520490843|FG021|Overall Study|Death|0|||
144351312|NCT04497116|520490844|FG022|Overall Study|Death|3|||
144351313|NCT04497116|520490845|FG023|Overall Study|Death|5|||
144351314|NCT04497116|520490846|FG024|Overall Study|Death|4|||
144351315|NCT04497116|520490822|FG000|Overall Study|Withdrawal by Subject|1|||
144351316|NCT04497116|520490823|FG001|Overall Study|Withdrawal by Subject|0|||
144351317|NCT04497116|520490824|FG002|Overall Study|Withdrawal by Subject|1|||
144351318|NCT04497116|520490825|FG003|Overall Study|Withdrawal by Subject|0|||
144351319|NCT04497116|520490826|FG004|Overall Study|Withdrawal by Subject|0|||
144351320|NCT04497116|520490827|FG005|Overall Study|Withdrawal by Subject|0|||
144351321|NCT04497116|520490828|FG006|Overall Study|Withdrawal by Subject|0|||
144351322|NCT04497116|520490829|FG007|Overall Study|Withdrawal by Subject|7|||
144351323|NCT04497116|520490830|FG008|Overall Study|Withdrawal by Subject|14|||
144351324|NCT04497116|520490831|FG009|Overall Study|Withdrawal by Subject|3|||
144351325|NCT04497116|520490832|FG010|Overall Study|Withdrawal by Subject|3|||
144351326|NCT04497116|520490833|FG011|Overall Study|Withdrawal by Subject|0|||
144351327|NCT04497116|520490834|FG012|Overall Study|Withdrawal by Subject|1|||
144351328|NCT04497116|520490835|FG013|Overall Study|Withdrawal by Subject|0|||
144351329|NCT04497116|520490836|FG014|Overall Study|Withdrawal by Subject|7|||
144351330|NCT04497116|520490837|FG015|Overall Study|Withdrawal by Subject|1|||
144351331|NCT04497116|520490838|FG016|Overall Study|Withdrawal by Subject|3|||
144351332|NCT04497116|520490839|FG017|Overall Study|Withdrawal by Subject|1|||
144351333|NCT04497116|520490840|FG018|Overall Study|Withdrawal by Subject|1|||
144351334|NCT04497116|520490841|FG019|Overall Study|Withdrawal by Subject|5|||
144351335|NCT04497116|520490842|FG020|Overall Study|Withdrawal by Subject|2|||
144351336|NCT04497116|520490843|FG021|Overall Study|Withdrawal by Subject|2|||
144351337|NCT04497116|520490844|FG022|Overall Study|Withdrawal by Subject|2|||
144351338|NCT04497116|520490845|FG023|Overall Study|Withdrawal by Subject|4|||
144351339|NCT04497116|520490846|FG024|Overall Study|Withdrawal by Subject|3|||
144351340|NCT04497116|520490822|FG000|Overall Study|Physician Decision|0|||
144351341|NCT04497116|520490823|FG001|Overall Study|Physician Decision|0|||
144351342|NCT04497116|520490824|FG002|Overall Study|Physician Decision|0|||
144351343|NCT04497116|520490825|FG003|Overall Study|Physician Decision|0|||
144351344|NCT04497116|520490826|FG004|Overall Study|Physician Decision|0|||
144351345|NCT04497116|520490827|FG005|Overall Study|Physician Decision|0|||
144351346|NCT04497116|520490828|FG006|Overall Study|Physician Decision|0|||
144351347|NCT04497116|520490829|FG007|Overall Study|Physician Decision|0|||
144351348|NCT04497116|520490830|FG008|Overall Study|Physician Decision|0|||
144351349|NCT04497116|520490831|FG009|Overall Study|Physician Decision|0|||
144351350|NCT04497116|520490832|FG010|Overall Study|Physician Decision|0|||
144351351|NCT04497116|520490833|FG011|Overall Study|Physician Decision|0|||
144351352|NCT04497116|520490834|FG012|Overall Study|Physician Decision|0|||
144351353|NCT04497116|520490835|FG013|Overall Study|Physician Decision|0|||
144351354|NCT04497116|520490836|FG014|Overall Study|Physician Decision|0|||
144351355|NCT04497116|520490837|FG015|Overall Study|Physician Decision|0|||
144351356|NCT04497116|520490838|FG016|Overall Study|Physician Decision|0|||
144351357|NCT04497116|520490839|FG017|Overall Study|Physician Decision|0|||
144351358|NCT04497116|520490840|FG018|Overall Study|Physician Decision|0|||
144351359|NCT04497116|520490841|FG019|Overall Study|Physician Decision|0|||
144351360|NCT04497116|520490842|FG020|Overall Study|Physician Decision|0|||
144351361|NCT04497116|520490843|FG021|Overall Study|Physician Decision|0|||
144351362|NCT04497116|520490844|FG022|Overall Study|Physician Decision|0|||
144351363|NCT04497116|520490845|FG023|Overall Study|Physician Decision|1|||
144351364|NCT04497116|520490846|FG024|Overall Study|Physician Decision|0|||
144351365|NCT04497116|520490822|FG000|Overall Study|Clinical Progression Related|0|||
144351366|NCT04497116|520490823|FG001|Overall Study|Clinical Progression Related|0|||
144351367|NCT04497116|520490824|FG002|Overall Study|Clinical Progression Related|0|||
144351368|NCT04497116|520490825|FG003|Overall Study|Clinical Progression Related|0|||
144351369|NCT04497116|520490826|FG004|Overall Study|Clinical Progression Related|0|||
144351370|NCT04497116|520490827|FG005|Overall Study|Clinical Progression Related|0|||
144351371|NCT04497116|520490828|FG006|Overall Study|Clinical Progression Related|0|||
144351372|NCT04497116|520490829|FG007|Overall Study|Clinical Progression Related|0|||
144351373|NCT04497116|520490830|FG008|Overall Study|Clinical Progression Related|0|||
144351374|NCT04497116|520490831|FG009|Overall Study|Clinical Progression Related|1|||
144351375|NCT04497116|520490832|FG010|Overall Study|Clinical Progression Related|0|||
144351376|NCT04497116|520490833|FG011|Overall Study|Clinical Progression Related|0|||
144351377|NCT04497116|520490834|FG012|Overall Study|Clinical Progression Related|0|||
144351378|NCT04497116|520490835|FG013|Overall Study|Clinical Progression Related|0|||
144351379|NCT04497116|520490836|FG014|Overall Study|Clinical Progression Related|0|||
144351380|NCT04497116|520490837|FG015|Overall Study|Clinical Progression Related|0|||
144351381|NCT04497116|520490838|FG016|Overall Study|Clinical Progression Related|0|||
144351382|NCT04497116|520490839|FG017|Overall Study|Clinical Progression Related|0|||
144351383|NCT04497116|520490840|FG018|Overall Study|Clinical Progression Related|0|||
144351384|NCT04497116|520490841|FG019|Overall Study|Clinical Progression Related|0|||
144351385|NCT04497116|520490842|FG020|Overall Study|Clinical Progression Related|0|||
144351386|NCT04497116|520490843|FG021|Overall Study|Clinical Progression Related|0|||
144351387|NCT04497116|520490844|FG022|Overall Study|Clinical Progression Related|0|||
144351388|NCT04497116|520490845|FG023|Overall Study|Clinical Progression Related|0|||
144351389|NCT04497116|520490846|FG024|Overall Study|Clinical Progression Related|0|||
144351390|NCT02698826|520490850|FG000|Overall Study|Death|13|||
144351391|NCT02698826|520490850|FG000|Overall Study|Adverse Event|1|||
144351392|NCT02478463|520490855|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
144351393|NCT02478463|520490855|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
144351394|NCT02478463|520490855|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
144351395|NCT01508169|520490856|FG000|Overall Study|Adverse Event|1|||
144351396|NCT01508169|520490857|FG001|Overall Study|Adverse Event|0|||
144351397|NCT01508169|520490856|FG000|Overall Study|Withdrawal by Subject|1|||
144351398|NCT01508169|520490857|FG001|Overall Study|Withdrawal by Subject|0|||
144351399|NCT01508169|520490856|FG000|Overall Study|Lost to Follow-up|1|||
144351400|NCT01508169|520490857|FG001|Overall Study|Lost to Follow-up|2|||
144351401|NCT01623115|520490863|FG000|Overall Study|Randomized but not treated|0|||
144351402|NCT01623115|520490864|FG001|Overall Study|Randomized but not treated|1|||
144351403|NCT01623115|520490863|FG000|Overall Study|Physician Decision|1|||
144351404|NCT01623115|520490864|FG001|Overall Study|Physician Decision|0|||
144351405|NCT01623115|520490863|FG000|Overall Study|Participants moved|1|||
144351406|NCT01623115|520490864|FG001|Overall Study|Participants moved|5|||
144351407|NCT01623115|520490863|FG000|Overall Study|Adverse Event|10|||
144351408|NCT01623115|520490864|FG001|Overall Study|Adverse Event|13|||
144351409|NCT01623115|520490863|FG000|Overall Study|Poor compliance to protocol|4|||
144351410|NCT01623115|520490864|FG001|Overall Study|Poor compliance to protocol|10|||
144351411|NCT01623115|520490863|FG000|Overall Study|Consent withdrawn by participant|2|||
144351412|NCT01623115|520490864|FG001|Overall Study|Consent withdrawn by participant|6|||
144351413|NCT01623115|520490863|FG000|Overall Study|Related to study drug administration|0|||
144351414|NCT01623115|520490864|FG001|Overall Study|Related to study drug administration|2|||
144351415|NCT01623115|520490863|FG000|Overall Study|Last visit outside protocol visit window|14|||
144351416|NCT01623115|520490864|FG001|Overall Study|Last visit outside protocol visit window|26|||
144351417|NCT01623115|520490863|FG000|Overall Study|Site closure|1|||
144351418|NCT01623115|520490864|FG001|Overall Study|Site closure|7|||
144351419|NCT01623115|520490863|FG000|Overall Study|Death|0|||
144351420|NCT01623115|520490864|FG001|Overall Study|Death|4|||
144351421|NCT01623115|520490863|FG000|Overall Study|Other than specified above|0|||
144351422|NCT01623115|520490864|FG001|Overall Study|Other than specified above|3|||
144351423|NCT02366195|520490865|FG000|Overall Study|Protocol-specified criteria|3|||
144351424|NCT02366195|520490865|FG000|Overall Study|Withdrawal by Subject|9|||
144351425|NCT02366195|520490865|FG000|Overall Study|Lost to Follow-up|1|||
144351426|NCT02366195|520490865|FG000|Overall Study|Death|41|||
144351427|NCT01338818|520490866|FG000|Overall Study|Adverse Event|8|||
144351428|NCT01338818|520490866|FG000|Overall Study|Lack of Efficacy|5|||
144351429|NCT01338818|520490866|FG000|Overall Study|no longer require study drug|1|||
144351430|NCT01338818|520490866|FG000|Overall Study|Withdrawal by Subject|11|||
144351431|NCT01338818|520490866|FG000|Overall Study|Lost to Follow-up|4|||
144351432|NCT01338818|520490866|FG000|Overall Study|Administrative problems|3|||
144351433|NCT01338818|520490866|FG000|Overall Study|Protocol Deviation|4|||
144351434|NCT01620086|520490867|FG000|Overall Study|Withdrawal by Subject|3|||
144351435|NCT01620086|520490868|FG001|Overall Study|Withdrawal by Subject|3|||
144351436|NCT01620086|520490869|FG002|Overall Study|Withdrawal by Subject|0|||
144351437|NCT01620086|520490867|FG000|Overall Study|failed study criteria|1|||
144351438|NCT01620086|520490868|FG001|Overall Study|failed study criteria|4|||
144351439|NCT01620086|520490869|FG002|Overall Study|failed study criteria|0|||
144351440|NCT01620086|520490867|FG000|Overall Study|Physician Decision|1|||
144351441|NCT01620086|520490868|FG001|Overall Study|Physician Decision|0|||
144351442|NCT01620086|520490869|FG002|Overall Study|Physician Decision|0|||
144351443|NCT00580723|520490870|FG000|Overall Study|Did not want to participate in extension|3|||
144351444|NCT00580723|520490870|FG000|Overall Study|Lost to Follow-up|5|||
144351445|NCT00684996|520490871|FG000|Overall Study|Adverse Event|1|||
144351446|NCT00684996|520490871|FG000|Overall Study|Refusal unrelated to adverse event|1|||
144351447|NCT00684996|520490871|FG000|Overall Study|Progression/relapse|2|||
144351448|NCT00684996|520490871|FG000|Overall Study|Other reasons not protocol specified|1|||
144351449|NCT02175017|520490874|FG000|Overall Study|Did not receive the investigational product|1|||
144351450|NCT02175017|520490875|FG001|Overall Study|Did not receive the investigational product|2|||
144351451|NCT02175017|520490874|FG000|Overall Study|Withdrawal by Subject|6|||
144351452|NCT02175017|520490875|FG001|Overall Study|Withdrawal by Subject|3|||
144351453|NCT02175017|520490874|FG000|Overall Study|Met an exclusion criteria|0|||
144351454|NCT02175017|520490875|FG001|Overall Study|Met an exclusion criteria|1|||
144351455|NCT02175017|520490874|FG000|Overall Study|Adverse Event|3|||
144351456|NCT02175017|520490875|FG001|Overall Study|Adverse Event|10|||
144351457|NCT02175017|520490874|FG000|Overall Study|Disease progression|20|||
144351458|NCT02175017|520490875|FG001|Overall Study|Disease progression|27|||
144351459|NCT02175017|520490874|FG000|Overall Study|Other than above reasons|3|||
144351460|NCT02175017|520490875|FG001|Overall Study|Other than above reasons|0|||
144351461|NCT02491983|520490876|FG000|Overall Study|Physician Decision|1|||
144351462|NCT02491983|520490877|FG001|Overall Study|Physician Decision|0|||
144351463|NCT02491983|520490876|FG000|Overall Study|Not meet selection criteria|1|||
144351464|NCT02491983|520490877|FG001|Overall Study|Not meet selection criteria|0|||
144351465|NCT02491983|520490876|FG000|Overall Study|Withdrawal by Subject|0|||
144351466|NCT02491983|520490877|FG001|Overall Study|Withdrawal by Subject|1|||
144351467|NCT00191308|520490878|FG000|Overall Study|Adverse Event|1|||
144351468|NCT00782717|520490880|FG000|Overall Study|Adverse Event|2|||
144351469|NCT00782717|520490881|FG001|Overall Study|Adverse Event|5|||
144351470|NCT00782717|520490880|FG000|Overall Study|Patient decision unrelated to AE|6|||
144351471|NCT00782717|520490881|FG001|Overall Study|Patient decision unrelated to AE|3|||
144351472|NCT00782717|520490880|FG000|Overall Study|Noncompliance|2|||
144351473|NCT00782717|520490881|FG001|Overall Study|Noncompliance|1|||
144351474|NCT00782717|520490880|FG000|Overall Study|Treatment failure|3|||
144351475|NCT00782717|520490881|FG001|Overall Study|Treatment failure|14|||
144351476|NCT00782717|520490880|FG000|Overall Study|Enrollment close prior to surgery|1|||
144351477|NCT00782717|520490881|FG001|Overall Study|Enrollment close prior to surgery|0|||
144351478|NCT00782717|520490880|FG000|Overall Study|Did not meet entrance criteria|1|||
144351479|NCT00782717|520490881|FG001|Overall Study|Did not meet entrance criteria|3|||
144351480|NCT00782717|520490880|FG000|Overall Study|Exited in error|0|||
144351481|NCT00782717|520490881|FG001|Overall Study|Exited in error|2|||
144351482|NCT04739436|520490882|FG000|Overall Study|Lost to Follow-up|21|||
144351483|NCT04739436|520490883|FG001|Overall Study|Lost to Follow-up|23|||
144351484|NCT04739436|520490882|FG000|Overall Study|Withdrawal by Subject|4|||
144351485|NCT04739436|520490883|FG001|Overall Study|Withdrawal by Subject|6|||
144351486|NCT04739436|520490882|FG000|Overall Study|not randomized properly|1|||
144351487|NCT04739436|520490883|FG001|Overall Study|not randomized properly|0|||
144351488|NCT02701283|520490885|FG000|Overall Study|Death|25|||
144351489|NCT02701283|520490886|FG001|Overall Study|Death|29|||
144351490|NCT02701283|520490887|FG002|Overall Study|Death|19|||
144351491|NCT02701283|520490885|FG000|Overall Study|Lost to Follow-up|3|||
144351492|NCT02701283|520490886|FG001|Overall Study|Lost to Follow-up|8|||
144351493|NCT02701283|520490887|FG002|Overall Study|Lost to Follow-up|1|||
144351494|NCT02701283|520490885|FG000|Overall Study|Withdrawal by Subject|12|||
144351495|NCT02701283|520490886|FG001|Overall Study|Withdrawal by Subject|41|||
144351496|NCT02701283|520490887|FG002|Overall Study|Withdrawal by Subject|1|||
144351497|NCT02701283|520490885|FG000|Overall Study|Missed 2-year visit|22|||
144351498|NCT02701283|520490886|FG001|Overall Study|Missed 2-year visit|27|||
144351499|NCT02701283|520490887|FG002|Overall Study|Missed 2-year visit|0|||
144351500|NCT02701283|520490885|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
144351501|NCT02701283|520490886|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
144351502|NCT02701283|520490887|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
144351503|NCT00892775|520490888|FG000|Overall Study|Protocol Violation|1|||
144351504|NCT00892775|520490889|FG001|Overall Study|Protocol Violation|0|||
144351505|NCT00892775|520490888|FG000|Overall Study|Subject difficulties with blood drawing|1|||
144351506|NCT00892775|520490889|FG001|Overall Study|Subject difficulties with blood drawing|0|||
144351507|NCT00892775|520490888|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
144351508|NCT00892775|520490889|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
144351509|NCT00892775|520490888|FG000|Overall Study|Migrated/ moved from study area|1|||
144351510|NCT00892775|520490889|FG001|Overall Study|Migrated/ moved from study area|0|||
144351511|NCT00892775|520490888|FG000|Overall Study|Withdrawal by Subject|0|||
144351512|NCT00892775|520490889|FG001|Overall Study|Withdrawal by Subject|1|||
144351513|NCT00892775|520490888|FG000|Overall Study|Lost to Follow-up|1|||
144351514|NCT00892775|520490889|FG001|Overall Study|Lost to Follow-up|0|||
144351515|NCT00398320|520490890|FG000|Overall Study|Death|1|||
144351516|NCT00398320|520490890|FG000|Overall Study|Adverse Event|4|||
144351517|NCT00398320|520490890|FG000|Overall Study|Physician Decision|1|||
144351518|NCT00064792|520490891|FG000|Overall Study|Withdrawal by Subject|2|||
144351519|NCT00064792|520490892|FG001|Overall Study|Withdrawal by Subject|0|||
144351520|NCT00064792|520490891|FG000|Overall Study|Adverse Event|3|||
144351521|NCT00064792|520490892|FG001|Overall Study|Adverse Event|0|||
144351522|NCT03160898|520490893|FG000|Overall Study|Adverse Event|4|||
144351523|NCT03160898|520490894|FG001|Overall Study|Adverse Event|8|||
144351524|NCT03160898|520490895|FG002|Overall Study|Adverse Event|7|||
144351525|NCT03160898|520490896|FG003|Overall Study|Adverse Event|10|||
144351526|NCT03160898|520490893|FG000|Overall Study|Death|1|||
144351527|NCT03160898|520490894|FG001|Overall Study|Death|0|||
144351528|NCT03160898|520490895|FG002|Overall Study|Death|0|||
144351529|NCT03160898|520490896|FG003|Overall Study|Death|1|||
144351530|NCT03160898|520490893|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
144351531|NCT03160898|520490894|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
144351532|NCT03160898|520490895|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
144351533|NCT03160898|520490896|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
144351534|NCT03160898|520490893|FG000|Overall Study|Lost to Follow-up|1|||
144351535|NCT03160898|520490894|FG001|Overall Study|Lost to Follow-up|1|||
144351536|NCT03160898|520490895|FG002|Overall Study|Lost to Follow-up|1|||
144351537|NCT03160898|520490896|FG003|Overall Study|Lost to Follow-up|2|||
144351538|NCT03160898|520490893|FG000|Overall Study|Physician Decision|1|||
144351539|NCT03160898|520490894|FG001|Overall Study|Physician Decision|0|||
144351540|NCT03160898|520490895|FG002|Overall Study|Physician Decision|0|||
144351541|NCT03160898|520490896|FG003|Overall Study|Physician Decision|1|||
144351542|NCT03160898|520490893|FG000|Overall Study|Progressive Disease|4|||
144351543|NCT03160898|520490894|FG001|Overall Study|Progressive Disease|1|||
144351544|NCT03160898|520490895|FG002|Overall Study|Progressive Disease|2|||
144351545|NCT03160898|520490896|FG003|Overall Study|Progressive Disease|1|||
144351546|NCT03160898|520490893|FG000|Overall Study|Protocol Violation|1|||
144351547|NCT03160898|520490894|FG001|Overall Study|Protocol Violation|0|||
144351548|NCT03160898|520490895|FG002|Overall Study|Protocol Violation|2|||
144351549|NCT03160898|520490896|FG003|Overall Study|Protocol Violation|0|||
144351550|NCT03160898|520490893|FG000|Overall Study|Sponsor Discretion|2|||
144351551|NCT03160898|520490894|FG001|Overall Study|Sponsor Discretion|0|||
144351552|NCT03160898|520490895|FG002|Overall Study|Sponsor Discretion|0|||
144351553|NCT03160898|520490896|FG003|Overall Study|Sponsor Discretion|0|||
144351554|NCT03160898|520490893|FG000|Overall Study|Withdrawal by Subject|1|||
144351555|NCT03160898|520490894|FG001|Overall Study|Withdrawal by Subject|3|||
144351556|NCT03160898|520490895|FG002|Overall Study|Withdrawal by Subject|2|||
144351557|NCT03160898|520490896|FG003|Overall Study|Withdrawal by Subject|1|||
144351558|NCT03160898|520490893|FG000|Overall Study|Other|2|||
144351559|NCT03160898|520490894|FG001|Overall Study|Other|0|||
144351560|NCT03160898|520490895|FG002|Overall Study|Other|2|||
144351561|NCT03160898|520490896|FG003|Overall Study|Other|2|||
144351562|NCT03405818|520490897|FG000|Overall Study|Withdrawal by Subject|4|||
144351563|NCT03405818|520490897|FG000|Overall Study|Lost to Follow-up|4|||
144351564|NCT00291486|520490900|FG000|Overall Study|Adverse Event|0|||
144351565|NCT00291486|520490901|FG001|Overall Study|Adverse Event|3|||
144351566|NCT00291486|520490902|FG002|Overall Study|Adverse Event|0|||
144351567|NCT00291486|520490903|FG003|Overall Study|Adverse Event|1|||
144351568|NCT00291486|520490904|FG004|Overall Study|Adverse Event|0|||
144351569|NCT00291486|520490900|FG000|Overall Study|Withdrawal by Subject|0|||
144351570|NCT00291486|520490901|FG001|Overall Study|Withdrawal by Subject|0|||
144351571|NCT00291486|520490902|FG002|Overall Study|Withdrawal by Subject|0|||
144351572|NCT00291486|520490903|FG003|Overall Study|Withdrawal by Subject|0|||
144351573|NCT00291486|520490904|FG004|Overall Study|Withdrawal by Subject|1|||
144351574|NCT00291486|520490900|FG000|Overall Study|Disease progression|1|||
144351575|NCT00291486|520490901|FG001|Overall Study|Disease progression|0|||
144351576|NCT00291486|520490902|FG002|Overall Study|Disease progression|1|||
144351577|NCT00291486|520490903|FG003|Overall Study|Disease progression|0|||
144351578|NCT00291486|520490904|FG004|Overall Study|Disease progression|0|||
144351579|NCT01045694|520490907|FG000|Overall Study|Withdrawal by Subject|2|||
144351580|NCT01408459|520490911|FG000|Overall Study|Withdrawal by Subject|1|||
144351581|NCT01408459|520490912|FG001|Overall Study|Withdrawal by Subject|1|||
144351582|NCT04725500|520490913|FG000|Screening|Screen Failure|26|||
144351583|NCT04725500|520490913|FG000|Screening|Withdrawal by Subject|1|||
144351584|NCT04725500|520490913|FG000|2 Week Take Home|Screen Fail|5|||
144351585|NCT01792115|520490914|FG000|Overall Study|Lost to Follow-up|0|||
144351586|NCT01792115|520490915|FG001|Overall Study|Lost to Follow-up|1|||
144351587|NCT01792115|520490916|FG002|Overall Study|Lost to Follow-up|0|||
144351588|NCT03811340|520492919|FG000|Overall Study|subjects did not complete the survey.|90|||
144351589|NCT01045967|520492920|FG000|Second Intervention|Protocol Violation|0|||
144351590|NCT01045967|520492921|FG001|Second Intervention|Protocol Violation|1|||
144351591|NCT05104450|520492922|FG000|Overall Study|Death|1|||
144351592|NCT05104450|520492923|FG001|Overall Study|Death|2|||
144351593|NCT05104450|520492922|FG000|Overall Study|Withdrawal by Subject|3|||
144351594|NCT05104450|520492923|FG001|Overall Study|Withdrawal by Subject|1|||
144351595|NCT02562235|520492924|FG000|Overall Study|Adverse Event|3|||
144351596|NCT01380769|520492925|FG000|Overall Study|Withdrawal by Subject|7|||
144351597|NCT01380769|520492926|FG001|Overall Study|Withdrawal by Subject|11|||
144351598|NCT01380769|520492925|FG000|Overall Study|Physician Decision|1|||
144351599|NCT01380769|520492926|FG001|Overall Study|Physician Decision|1|||
144351600|NCT01380769|520492925|FG000|Overall Study|Adverse Event|1|||
144351601|NCT01380769|520492926|FG001|Overall Study|Adverse Event|1|||
144351602|NCT01380769|520492925|FG000|Overall Study|Protocol Violation|0|||
144351603|NCT01380769|520492926|FG001|Overall Study|Protocol Violation|1|||
144351604|NCT02107703|520492940|FG000|Overall Study|Withdrawal by Subject|46|||
144351605|NCT02107703|520492941|FG001|Overall Study|Withdrawal by Subject|21|||
144351606|NCT02107703|520492940|FG000|Overall Study|Lost to Follow-up|20|||
144351607|NCT02107703|520492941|FG001|Overall Study|Lost to Follow-up|9|||
144351608|NCT02107703|520492940|FG000|Overall Study|On study treatment/follow up|48|||
144351609|NCT02107703|520492941|FG001|Overall Study|On study treatment/follow up|5|||
144351610|NCT03456076|520492946|FG000|Overall Study|Withdrawal by Subject|5|||
144351611|NCT03456076|520492947|FG001|Overall Study|Withdrawal by Subject|9|||
144351612|NCT03456076|520492946|FG000|Overall Study|Protocol deviation|0|||
144351613|NCT03456076|520492947|FG001|Overall Study|Protocol deviation|1|||
144351614|NCT03456076|520492946|FG000|Overall Study|Lost to Follow-up|0|||
144351615|NCT03456076|520492947|FG001|Overall Study|Lost to Follow-up|1|||
144351616|NCT03456076|520492946|FG000|Overall Study|Death|2|||
144351617|NCT03456076|520492947|FG001|Overall Study|Death|5|||
144351618|NCT03456076|520492946|FG000|Overall Study|Study ongoing|123|||
144351619|NCT03456076|520492947|FG001|Overall Study|Study ongoing|111|||
144351620|NCT00466440|520492948|FG000|Overall Study|Adverse Event|0|||
144351621|NCT00466440|520492949|FG001|Overall Study|Adverse Event|3|||
144351622|NCT00466440|520492950|FG002|Overall Study|Adverse Event|1|||
144351623|NCT00466440|520492948|FG000|Overall Study|Death|1|||
144351624|NCT00466440|520492949|FG001|Overall Study|Death|1|||
144351625|NCT00466440|520492950|FG002|Overall Study|Death|0|||
144351626|NCT00466440|520492948|FG000|Overall Study|Progressive disease|13|||
144351627|NCT00466440|520492949|FG001|Overall Study|Progressive disease|5|||
144351628|NCT00466440|520492950|FG002|Overall Study|Progressive disease|4|||
144351629|NCT00466440|520492948|FG000|Overall Study|Lost to Follow-up|0|||
144351630|NCT00466440|520492949|FG001|Overall Study|Lost to Follow-up|1|||
144351631|NCT00466440|520492950|FG002|Overall Study|Lost to Follow-up|0|||
144351632|NCT00466440|520492948|FG000|Overall Study|Physician Decision|0|||
144351633|NCT00466440|520492949|FG001|Overall Study|Physician Decision|1|||
144351634|NCT00466440|520492950|FG002|Overall Study|Physician Decision|2|||
144351635|NCT00466440|520492948|FG000|Overall Study|Protocol entry criteria not met|0|||
144351636|NCT00466440|520492949|FG001|Overall Study|Protocol entry criteria not met|0|||
144351637|NCT00466440|520492950|FG002|Overall Study|Protocol entry criteria not met|4|||
144351638|NCT00466440|520492948|FG000|Overall Study|Withdrawal by Subject|0|||
144351639|NCT00466440|520492949|FG001|Overall Study|Withdrawal by Subject|1|||
144351640|NCT00466440|520492950|FG002|Overall Study|Withdrawal by Subject|0|||
144351641|NCT00466440|520492948|FG000|Overall Study|Sponsor decision|0|||
144351642|NCT00466440|520492949|FG001|Overall Study|Sponsor decision|0|||
144351643|NCT00466440|520492950|FG002|Overall Study|Sponsor decision|1|||
144351644|NCT03187132|520492951|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
144351645|NCT03187132|520492952|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
144351646|NCT03187132|520492951|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
144351647|NCT03187132|520492952|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
144351648|NCT03187132|520492951|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
144351649|NCT03187132|520492952|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
144351650|NCT03187132|520492951|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
144351651|NCT03187132|520492952|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
144351652|NCT03187132|520492951|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
144351653|NCT03187132|520492952|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
144351654|NCT03187132|520492951|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
144351655|NCT03187132|520492952|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
144351656|NCT03187132|520492951|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
144351657|NCT03187132|520492952|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
144351658|NCT03187132|520492951|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
144351659|NCT03187132|520492952|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
144351660|NCT03187132|520492951|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
144351661|NCT03187132|520492952|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
144351662|NCT03187132|520492951|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
144351663|NCT03187132|520492952|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
144351664|NCT03187132|520492951|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
144351665|NCT03187132|520492952|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
144351666|NCT02045095|520492953|FG000|Overall Study|Other|0|||
144351667|NCT02045095|520492954|FG001|Overall Study|Other|0|||
144351668|NCT02045095|520492955|FG002|Overall Study|Other|1|||
144351669|NCT02045095|520492956|FG003|Overall Study|Other|0|||
144351670|NCT02045095|520492957|FG004|Overall Study|Other|0|||
144351671|NCT02045095|520492958|FG005|Overall Study|Other|2|||
144351672|NCT02045095|520492959|FG006|Overall Study|Other|0|||
144351673|NCT02045095|520492953|FG000|Overall Study|Progressive Disease|3|||
144351674|NCT02045095|520492954|FG001|Overall Study|Progressive Disease|3|||
144351675|NCT02045095|520492955|FG002|Overall Study|Progressive Disease|2|||
144351676|NCT02045095|520492956|FG003|Overall Study|Progressive Disease|4|||
144351677|NCT02045095|520492957|FG004|Overall Study|Progressive Disease|2|||
144351678|NCT02045095|520492958|FG005|Overall Study|Progressive Disease|4|||
144351679|NCT02045095|520492959|FG006|Overall Study|Progressive Disease|1|||
144351680|NCT02045095|520492953|FG000|Overall Study|Withdrawal by Subject|0|||
144351681|NCT02045095|520492954|FG001|Overall Study|Withdrawal by Subject|0|||
144351682|NCT02045095|520492955|FG002|Overall Study|Withdrawal by Subject|0|||
144351683|NCT02045095|520492956|FG003|Overall Study|Withdrawal by Subject|0|||
144351684|NCT02045095|520492957|FG004|Overall Study|Withdrawal by Subject|3|||
144351685|NCT02045095|520492958|FG005|Overall Study|Withdrawal by Subject|0|||
144351686|NCT02045095|520492959|FG006|Overall Study|Withdrawal by Subject|0|||
144351687|NCT02045095|520492953|FG000|Overall Study|Adverse Event|0|||
144351688|NCT02045095|520492954|FG001|Overall Study|Adverse Event|1|||
144351689|NCT02045095|520492955|FG002|Overall Study|Adverse Event|1|||
144351690|NCT02045095|520492956|FG003|Overall Study|Adverse Event|0|||
144351691|NCT02045095|520492957|FG004|Overall Study|Adverse Event|0|||
144351692|NCT02045095|520492958|FG005|Overall Study|Adverse Event|2|||
144351693|NCT02045095|520492959|FG006|Overall Study|Adverse Event|0|||
144351694|NCT02525588|520492960|FG000|Overall Study|Death|3|||
144351695|NCT02525588|520492961|FG001|Overall Study|Death|1|||
144351696|NCT02525588|520492960|FG000|Overall Study|Lost to Follow-up|2|||
144351697|NCT02525588|520492961|FG001|Overall Study|Lost to Follow-up|0|||
144351698|NCT02525588|520492960|FG000|Overall Study|Withdrawal by Subject|1|||
144351699|NCT02525588|520492961|FG001|Overall Study|Withdrawal by Subject|1|||
144351700|NCT02525588|520492960|FG000|Overall Study|Adverse Event|0|||
144351701|NCT02525588|520492961|FG001|Overall Study|Adverse Event|1|||
144351702|NCT03369418|520492964|FG000|Overall Study|Withdrawal by Subject|3|||
144351703|NCT03369418|520492965|FG001|Overall Study|Withdrawal by Subject|3|||
144351704|NCT01485094|520492966|FG000|Overall Study|Adverse Event|1|||
144351705|NCT01485094|520492967|FG001|Overall Study|Adverse Event|1|||
144351706|NCT01485094|520492968|FG002|Overall Study|Adverse Event|1|||
144351707|NCT01485094|520492966|FG000|Overall Study|Lost to Follow-up|1|||
144351708|NCT01485094|520492967|FG001|Overall Study|Lost to Follow-up|0|||
144351709|NCT01485094|520492968|FG002|Overall Study|Lost to Follow-up|0|||
144351710|NCT01485094|520492966|FG000|Overall Study|Withdrawal by Subject|1|||
144351711|NCT01485094|520492967|FG001|Overall Study|Withdrawal by Subject|1|||
144351712|NCT01485094|520492968|FG002|Overall Study|Withdrawal by Subject|0|||
144351713|NCT04524858|520492971|FG000|Overall Study|Adverse Event|1|||
144351714|NCT00113841|520492975|FG000|Overall Study|Disease progression|0|||
144351715|NCT00113841|520492976|FG001|Overall Study|Disease progression|2|||
144351716|NCT00113841|520492975|FG000|Overall Study|Non-compliant|1|||
144351717|NCT00113841|520492976|FG001|Overall Study|Non-compliant|0|||
144351718|NCT01788566|520492977|FG000|Overall Study|Death|4|||
144351719|NCT01788566|520492977|FG000|Overall Study|Adverse Event|1|||
144351720|NCT01788566|520492977|FG000|Overall Study|Clinical Progressive Disease|3|||
144351721|NCT01539759|520492980|FG000|Overall Study|Lost to Follow-up|6|||
144351722|NCT01539759|520492981|FG001|Overall Study|Lost to Follow-up|8|||
144351723|NCT01076959|520492982|FG000|Overall Study|Adverse Event|767|||
144351724|NCT01076959|520492982|FG000|Overall Study|Lack of Efficacy|849|||
144351725|NCT01076959|520492982|FG000|Overall Study|Non-compliance|274|||
144351726|NCT01076959|520492982|FG000|Overall Study|Lost to Follow-up|241|||
144351727|NCT01076959|520492982|FG000|Overall Study|Other|119|||
144351728|NCT02868554|520492983|FG000|Overall Study|Lost to Follow-up|3|||
144351729|NCT02868554|520492984|FG001|Overall Study|Lost to Follow-up|0|||
144351730|NCT02868554|520492985|FG002|Overall Study|Lost to Follow-up|1|||
144351731|NCT03081884|520492986|FG000|Overall Study|deferred prostate cancer treatment|1|||
144351732|NCT03081884|520492986|FG000|Overall Study|metastasis managed with systemic therapy|3|||
144351733|NCT03948334|520492987|FG000|Overall Study|Adverse Event|1|||
144351734|NCT03948334|520492988|FG001|Overall Study|Adverse Event|4|||
144351735|NCT03948334|520492987|FG000|Overall Study|Lack of Efficacy|2|||
144351736|NCT03948334|520492988|FG001|Overall Study|Lack of Efficacy|0|||
144351737|NCT03948334|520492987|FG000|Overall Study|Lost to Follow-up|1|||
144351738|NCT03948334|520492988|FG001|Overall Study|Lost to Follow-up|0|||
144351739|NCT03948334|520492987|FG000|Overall Study|Physician Decision|1|||
144351740|NCT03948334|520492988|FG001|Overall Study|Physician Decision|0|||
144351741|NCT03948334|520492987|FG000|Overall Study|Pregnancy|0|||
144351742|NCT03948334|520492988|FG001|Overall Study|Pregnancy|1|||
144351743|NCT03948334|520492987|FG000|Overall Study|Protocol Deviation|1|||
144351744|NCT03948334|520492988|FG001|Overall Study|Protocol Deviation|0|||
144351745|NCT03948334|520492987|FG000|Overall Study|Study terminated by Sponsor|50|||
144351746|NCT03948334|520492988|FG001|Overall Study|Study terminated by Sponsor|51|||
144351747|NCT03948334|520492987|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
144351748|NCT03948334|520492988|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
144351749|NCT03066596|520492989|FG000|Overall Study|Withdrawal by Subject|4|||
144351750|NCT03066596|520492990|FG001|Overall Study|Withdrawal by Subject|2|||
144351751|NCT03066596|520492989|FG000|Overall Study|Lost to Follow-up|14|||
144351752|NCT03066596|520492990|FG001|Overall Study|Lost to Follow-up|10|||
144351753|NCT02330055|520492991|FG000|Overall Study|technical issues|2|||
144351754|NCT02330055|520492992|FG001|Overall Study|technical issues|0|||
144351755|NCT02330055|520492991|FG000|Overall Study|participant forgot to wear device|5|||
144351756|NCT02330055|520492992|FG001|Overall Study|participant forgot to wear device|5|||
144351757|NCT02330055|520492991|FG000|Overall Study|data for less than 60 minutes|3|||
144351758|NCT02330055|520492992|FG001|Overall Study|data for less than 60 minutes|3|||
144351759|NCT02330055|520492991|FG000|Overall Study|participant did not sleep|0|||
144351760|NCT02330055|520492992|FG001|Overall Study|participant did not sleep|1|||
144351761|NCT04628780|520492996|FG000|Overall Study|Death|0|||
144351762|NCT04628780|520492997|FG001|Overall Study|Death|1|||
144351763|NCT04628780|520492998|FG002|Overall Study|Death|0|||
144351764|NCT04628780|520492999|FG003|Overall Study|Death|0|||
144351765|NCT04628780|520493000|FG004|Overall Study|Death|1|||
144351766|NCT04628780|520493001|FG005|Overall Study|Death|0|||
144351767|NCT04628780|520492996|FG000|Overall Study|Physician Decision|2|||
144351768|NCT04628780|520492997|FG001|Overall Study|Physician Decision|0|||
144351769|NCT04628780|520492998|FG002|Overall Study|Physician Decision|0|||
144351770|NCT04628780|520492999|FG003|Overall Study|Physician Decision|0|||
144351771|NCT04628780|520493000|FG004|Overall Study|Physician Decision|2|||
144351772|NCT04628780|520493001|FG005|Overall Study|Physician Decision|0|||
144351773|NCT04628780|520492996|FG000|Overall Study|Progressive disease|2|||
144351774|NCT04628780|520492997|FG001|Overall Study|Progressive disease|2|||
144351775|NCT04628780|520492998|FG002|Overall Study|Progressive disease|2|||
144351776|NCT04628780|520492999|FG003|Overall Study|Progressive disease|3|||
144351777|NCT04628780|520493000|FG004|Overall Study|Progressive disease|9|||
144351778|NCT04628780|520493001|FG005|Overall Study|Progressive disease|4|||
144351779|NCT04628780|520492996|FG000|Overall Study|Withdrawal by Subject|0|||
144351780|NCT04628780|520492997|FG001|Overall Study|Withdrawal by Subject|1|||
144351781|NCT04628780|520492998|FG002|Overall Study|Withdrawal by Subject|2|||
144351782|NCT04628780|520492999|FG003|Overall Study|Withdrawal by Subject|0|||
144351783|NCT04628780|520493000|FG004|Overall Study|Withdrawal by Subject|3|||
144351784|NCT04628780|520493001|FG005|Overall Study|Withdrawal by Subject|1|||
144351785|NCT04628780|520492996|FG000|Overall Study|Global deterioration of health status|0|||
144351786|NCT04628780|520492997|FG001|Overall Study|Global deterioration of health status|0|||
144351787|NCT04628780|520492998|FG002|Overall Study|Global deterioration of health status|0|||
144351788|NCT04628780|520492999|FG003|Overall Study|Global deterioration of health status|0|||
144351789|NCT04628780|520493000|FG004|Overall Study|Global deterioration of health status|1|||
144351790|NCT04628780|520493001|FG005|Overall Study|Global deterioration of health status|1|||
144351791|NCT03269994|520493003|FG000|Overall Study|Withdrawal by Subject|4|||
144351792|NCT03269994|520493004|FG001|Overall Study|Withdrawal by Subject|5|||
144351793|NCT03269994|520493003|FG000|Overall Study|Unresectable at surgery|39|||
144351794|NCT03269994|520493004|FG001|Overall Study|Unresectable at surgery|58|||
144351795|NCT03269994|520493003|FG000|Overall Study|Patient canceled surgery|5|||
144351796|NCT03269994|520493004|FG001|Overall Study|Patient canceled surgery|14|||
144351797|NCT03269994|520493003|FG000|Overall Study|Preoperative progression|14|||
144351798|NCT03269994|520493004|FG001|Overall Study|Preoperative progression|9|||
144351799|NCT03269994|520493003|FG000|Overall Study|Preoperative infection|10|||
144351800|NCT03269994|520493004|FG001|Overall Study|Preoperative infection|4|||
144351801|NCT03269994|520493003|FG000|Overall Study|Kidney insufficiency|1|||
144351802|NCT03269994|520493004|FG001|Overall Study|Kidney insufficiency|0|||
144351803|NCT03269994|520493003|FG000|Overall Study|Drug allergy|0|||
144351804|NCT03269994|520493004|FG001|Overall Study|Drug allergy|2|||
144351805|NCT03269994|520493003|FG000|Overall Study|Operation changed to different resection|9|||
144351806|NCT03269994|520493004|FG001|Overall Study|Operation changed to different resection|0|||
144351807|NCT03269994|520493003|FG000|Overall Study|Preoperative steroid|0|||
144351808|NCT03269994|520493004|FG001|Overall Study|Preoperative steroid|3|||
144351809|NCT03269994|520493003|FG000|Overall Study|Accrual Closed|2|||
144351810|NCT03269994|520493004|FG001|Overall Study|Accrual Closed|0|||
144351811|NCT03269994|520493003|FG000|Overall Study|Operation changed to different resection|0|||
144351812|NCT03269994|520493004|FG001|Overall Study|Operation changed to different resection|10|||
144351813|NCT04378270|520493007|FG000|Overall Study|Lack of Efficacy|1|||
144351814|NCT04378270|520493007|FG000|Overall Study|Withdrawal by Subject|1|||
144351815|NCT04378270|520493007|FG000|Overall Study|Screen Failure|1|||
144351816|NCT04378270|520493007|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
144351817|NCT01327599|520493008|FG000|Overall Study|Adverse Event|1|||
144351818|NCT01327599|520493008|FG000|Overall Study|Could Not Attend Visit|1|||
144351819|NCT01327599|520493008|FG000|Overall Study|Withdrawal of Consent|1|||
144351820|NCT01132313|520493009|FG000|Overall Study|Lack of Efficacy|1|||
144351821|NCT01132313|520493010|FG001|Overall Study|Lack of Efficacy|0|||
144351822|NCT01132313|520493011|FG002|Overall Study|Lack of Efficacy|0|||
144351823|NCT01132313|520493012|FG003|Overall Study|Lack of Efficacy|0|||
144351824|NCT01132313|520493013|FG004|Overall Study|Lack of Efficacy|0|||
144351825|NCT01132313|520493014|FG005|Overall Study|Lack of Efficacy|0|||
144351826|NCT01132313|520493015|FG006|Overall Study|Lack of Efficacy|0|||
144351827|NCT01132313|520493016|FG007|Overall Study|Lack of Efficacy|3|||
144351828|NCT01132313|520493017|FG008|Overall Study|Lack of Efficacy|14|||
144351829|NCT01132313|520493018|FG009|Overall Study|Lack of Efficacy|16|||
144351830|NCT01132313|520493019|FG010|Overall Study|Lack of Efficacy|0|||
144351831|NCT01132313|520493020|FG011|Overall Study|Lack of Efficacy|0|||
144351832|NCT01132313|520493009|FG000|Overall Study|Not treated|2|||
144351833|NCT01132313|520493010|FG001|Overall Study|Not treated|0|||
144351834|NCT01132313|520493011|FG002|Overall Study|Not treated|0|||
144351835|NCT01132313|520493012|FG003|Overall Study|Not treated|0|||
144351836|NCT01132313|520493013|FG004|Overall Study|Not treated|2|||
144351837|NCT01132313|520493014|FG005|Overall Study|Not treated|1|||
144351838|NCT01132313|520493015|FG006|Overall Study|Not treated|3|||
144351839|NCT01132313|520493016|FG007|Overall Study|Not treated|0|||
144351840|NCT01132313|520493017|FG008|Overall Study|Not treated|0|||
144351841|NCT01132313|520493018|FG009|Overall Study|Not treated|0|||
144351842|NCT01132313|520493019|FG010|Overall Study|Not treated|0|||
144351843|NCT01132313|520493020|FG011|Overall Study|Not treated|0|||
144351844|NCT01132313|520493009|FG000|Overall Study|Adverse Event|0|||
144351845|NCT01132313|520493010|FG001|Overall Study|Adverse Event|0|||
144351846|NCT01132313|520493011|FG002|Overall Study|Adverse Event|4|||
144351847|NCT01132313|520493012|FG003|Overall Study|Adverse Event|10|||
144351848|NCT01132313|520493013|FG004|Overall Study|Adverse Event|19|||
144351849|NCT01132313|520493014|FG005|Overall Study|Adverse Event|6|||
144351850|NCT01132313|520493015|FG006|Overall Study|Adverse Event|5|||
144351851|NCT01132313|520493016|FG007|Overall Study|Adverse Event|3|||
144351852|NCT01132313|520493017|FG008|Overall Study|Adverse Event|7|||
144351853|NCT01132313|520493018|FG009|Overall Study|Adverse Event|2|||
144351854|NCT01132313|520493019|FG010|Overall Study|Adverse Event|0|||
144351855|NCT01132313|520493020|FG011|Overall Study|Adverse Event|0|||
144351856|NCT01132313|520493009|FG000|Overall Study|Protocol Violation|0|||
144351857|NCT01132313|520493010|FG001|Overall Study|Protocol Violation|0|||
144351858|NCT01132313|520493011|FG002|Overall Study|Protocol Violation|0|||
144351859|NCT01132313|520493012|FG003|Overall Study|Protocol Violation|1|||
144351860|NCT01132313|520493013|FG004|Overall Study|Protocol Violation|0|||
144351861|NCT01132313|520493014|FG005|Overall Study|Protocol Violation|0|||
144351862|NCT01132313|520493015|FG006|Overall Study|Protocol Violation|0|||
144351863|NCT01132313|520493016|FG007|Overall Study|Protocol Violation|0|||
144351864|NCT01132313|520493017|FG008|Overall Study|Protocol Violation|0|||
144351865|NCT01132313|520493018|FG009|Overall Study|Protocol Violation|0|||
144351866|NCT01132313|520493019|FG010|Overall Study|Protocol Violation|0|||
144351867|NCT01132313|520493020|FG011|Overall Study|Protocol Violation|0|||
144351868|NCT01132313|520493009|FG000|Overall Study|Lost to Follow-up|0|||
144351869|NCT01132313|520493010|FG001|Overall Study|Lost to Follow-up|0|||
144351870|NCT01132313|520493011|FG002|Overall Study|Lost to Follow-up|1|||
144351871|NCT01132313|520493012|FG003|Overall Study|Lost to Follow-up|0|||
144351872|NCT01132313|520493013|FG004|Overall Study|Lost to Follow-up|0|||
144351873|NCT01132313|520493014|FG005|Overall Study|Lost to Follow-up|0|||
144351874|NCT01132313|520493015|FG006|Overall Study|Lost to Follow-up|0|||
144351875|NCT01132313|520493016|FG007|Overall Study|Lost to Follow-up|1|||
144351876|NCT01132313|520493017|FG008|Overall Study|Lost to Follow-up|0|||
144351877|NCT01132313|520493018|FG009|Overall Study|Lost to Follow-up|0|||
144351878|NCT01132313|520493019|FG010|Overall Study|Lost to Follow-up|0|||
144351879|NCT01132313|520493020|FG011|Overall Study|Lost to Follow-up|0|||
144351880|NCT01132313|520493009|FG000|Overall Study|Withdrawal by Subject|0|||
144351881|NCT01132313|520493010|FG001|Overall Study|Withdrawal by Subject|0|||
144351882|NCT01132313|520493011|FG002|Overall Study|Withdrawal by Subject|3|||
144351883|NCT01132313|520493012|FG003|Overall Study|Withdrawal by Subject|3|||
144351884|NCT01132313|520493013|FG004|Overall Study|Withdrawal by Subject|6|||
144351885|NCT01132313|520493014|FG005|Overall Study|Withdrawal by Subject|0|||
144351886|NCT01132313|520493015|FG006|Overall Study|Withdrawal by Subject|1|||
144351887|NCT01132313|520493016|FG007|Overall Study|Withdrawal by Subject|0|||
144351888|NCT01132313|520493017|FG008|Overall Study|Withdrawal by Subject|0|||
144351889|NCT01132313|520493018|FG009|Overall Study|Withdrawal by Subject|2|||
144351890|NCT01132313|520493019|FG010|Overall Study|Withdrawal by Subject|0|||
144351891|NCT01132313|520493020|FG011|Overall Study|Withdrawal by Subject|0|||
144351892|NCT01132313|520493009|FG000|Overall Study|Lack of antiviral response|0|||
144351893|NCT01132313|520493010|FG001|Overall Study|Lack of antiviral response|0|||
144351894|NCT01132313|520493011|FG002|Overall Study|Lack of antiviral response|12|||
144351895|NCT01132313|520493012|FG003|Overall Study|Lack of antiviral response|18|||
144351896|NCT01132313|520493013|FG004|Overall Study|Lack of antiviral response|18|||
144351897|NCT01132313|520493014|FG005|Overall Study|Lack of antiviral response|18|||
144351898|NCT01132313|520493015|FG006|Overall Study|Lack of antiviral response|21|||
144351899|NCT01132313|520493016|FG007|Overall Study|Lack of antiviral response|0|||
144351900|NCT01132313|520493017|FG008|Overall Study|Lack of antiviral response|0|||
144351901|NCT01132313|520493018|FG009|Overall Study|Lack of antiviral response|0|||
144351902|NCT01132313|520493019|FG010|Overall Study|Lack of antiviral response|1|||
144351903|NCT01132313|520493020|FG011|Overall Study|Lack of antiviral response|0|||
144351904|NCT01132313|520493009|FG000|Overall Study|Other reason not defined above|0|||
144351905|NCT01132313|520493010|FG001|Overall Study|Other reason not defined above|0|||
144351906|NCT01132313|520493011|FG002|Overall Study|Other reason not defined above|0|||
144351907|NCT01132313|520493012|FG003|Overall Study|Other reason not defined above|0|||
144351908|NCT01132313|520493013|FG004|Overall Study|Other reason not defined above|0|||
144351909|NCT01132313|520493014|FG005|Overall Study|Other reason not defined above|0|||
144351910|NCT01132313|520493015|FG006|Overall Study|Other reason not defined above|0|||
144351911|NCT01132313|520493016|FG007|Overall Study|Other reason not defined above|1|||
144351912|NCT01132313|520493017|FG008|Overall Study|Other reason not defined above|0|||
144351913|NCT01132313|520493018|FG009|Overall Study|Other reason not defined above|0|||
144351914|NCT01132313|520493019|FG010|Overall Study|Other reason not defined above|0|||
144351915|NCT01132313|520493020|FG011|Overall Study|Other reason not defined above|0|||
144351916|NCT01236521|520493021|FG000|Overall Study|Withdrawal by Subject|12|||
144351917|NCT01236521|520493022|FG001|Overall Study|Withdrawal by Subject|17|||
144351918|NCT01236521|520493021|FG000|Overall Study|Death|2|||
144351919|NCT01236521|520493022|FG001|Overall Study|Death|1|||
144351920|NCT01236521|520493021|FG000|Overall Study|Lost to Follow-up|9|||
144351921|NCT01236521|520493022|FG001|Overall Study|Lost to Follow-up|7|||
144351922|NCT04707469|520493028|FG000|Overall Study|Site closure|0|||
144351923|NCT04707469|520493029|FG001|Overall Study|Site closure|2|||
144351924|NCT04707469|520493030|FG002|Overall Study|Site closure|0|||
144351925|NCT04707469|520493028|FG000|Overall Study|Physician Decision|2|||
144351926|NCT04707469|520493029|FG001|Overall Study|Physician Decision|2|||
144351927|NCT04707469|520493030|FG002|Overall Study|Physician Decision|2|||
144351928|NCT04707469|520493028|FG000|Overall Study|Death|1|||
144351929|NCT04707469|520493029|FG001|Overall Study|Death|6|||
144351930|NCT04707469|520493030|FG002|Overall Study|Death|2|||
144351931|NCT04707469|520493028|FG000|Overall Study|Lost to Follow-up|9|||
144351932|NCT04707469|520493029|FG001|Overall Study|Lost to Follow-up|19|||
144351933|NCT04707469|520493030|FG002|Overall Study|Lost to Follow-up|14|||
144351934|NCT04707469|520493028|FG000|Overall Study|Withdrawal by Subject|17|||
144351935|NCT04707469|520493029|FG001|Overall Study|Withdrawal by Subject|16|||
144351936|NCT04707469|520493030|FG002|Overall Study|Withdrawal by Subject|12|||
144351937|NCT03201419|520493031|FG000|Overall Study|Adverse Event|3|||
144351938|NCT03201419|520493032|FG001|Overall Study|Adverse Event|1|||
144351939|NCT03201419|520493033|FG002|Overall Study|Adverse Event|0|||
144351940|NCT03201419|520493034|FG003|Overall Study|Adverse Event|0|||
144351941|NCT03201419|520493035|FG004|Overall Study|Adverse Event|1|||
144351942|NCT03201419|520493036|FG005|Overall Study|Adverse Event|1|||
144351943|NCT03201419|520493037|FG006|Overall Study|Adverse Event|5|||
144351944|NCT03201419|520493038|FG007|Overall Study|Adverse Event|0|||
144351945|NCT03201419|520493039|FG008|Overall Study|Adverse Event|0|||
144351946|NCT03201419|520493031|FG000|Overall Study|Lost to Follow-up|1|||
144351947|NCT03201419|520493032|FG001|Overall Study|Lost to Follow-up|0|||
144351948|NCT03201419|520493033|FG002|Overall Study|Lost to Follow-up|0|||
144351949|NCT03201419|520493034|FG003|Overall Study|Lost to Follow-up|0|||
144351950|NCT03201419|520493035|FG004|Overall Study|Lost to Follow-up|0|||
144351951|NCT03201419|520493036|FG005|Overall Study|Lost to Follow-up|0|||
144351952|NCT03201419|520493037|FG006|Overall Study|Lost to Follow-up|0|||
144351953|NCT03201419|520493038|FG007|Overall Study|Lost to Follow-up|0|||
144351954|NCT03201419|520493039|FG008|Overall Study|Lost to Follow-up|0|||
144351955|NCT03201419|520493031|FG000|Overall Study|Protocol Deviation|0|||
144351956|NCT03201419|520493032|FG001|Overall Study|Protocol Deviation|0|||
144351957|NCT03201419|520493033|FG002|Overall Study|Protocol Deviation|0|||
144351958|NCT03201419|520493034|FG003|Overall Study|Protocol Deviation|0|||
144351959|NCT03201419|520493035|FG004|Overall Study|Protocol Deviation|0|||
144351960|NCT03201419|520493036|FG005|Overall Study|Protocol Deviation|0|||
144351961|NCT03201419|520493037|FG006|Overall Study|Protocol Deviation|1|||
144351962|NCT03201419|520493038|FG007|Overall Study|Protocol Deviation|0|||
144351963|NCT03201419|520493039|FG008|Overall Study|Protocol Deviation|0|||
144351964|NCT03201419|520493031|FG000|Overall Study|Withdrawal by Subject|4|||
144351965|NCT03201419|520493032|FG001|Overall Study|Withdrawal by Subject|2|||
144351966|NCT03201419|520493033|FG002|Overall Study|Withdrawal by Subject|1|||
144351967|NCT03201419|520493034|FG003|Overall Study|Withdrawal by Subject|0|||
144351968|NCT03201419|520493035|FG004|Overall Study|Withdrawal by Subject|0|||
144351969|NCT03201419|520493036|FG005|Overall Study|Withdrawal by Subject|0|||
144351970|NCT03201419|520493037|FG006|Overall Study|Withdrawal by Subject|0|||
144351971|NCT03201419|520493038|FG007|Overall Study|Withdrawal by Subject|1|||
144351972|NCT03201419|520493039|FG008|Overall Study|Withdrawal by Subject|2|||
144351973|NCT03201419|520493031|FG000|Overall Study|Other|0|||
144351974|NCT03201419|520493032|FG001|Overall Study|Other|0|||
144351975|NCT03201419|520493033|FG002|Overall Study|Other|1|||
144351976|NCT03201419|520493034|FG003|Overall Study|Other|0|||
144351977|NCT03201419|520493035|FG004|Overall Study|Other|0|||
144351978|NCT03201419|520493036|FG005|Overall Study|Other|0|||
144351979|NCT03201419|520493037|FG006|Overall Study|Other|0|||
144351980|NCT03201419|520493038|FG007|Overall Study|Other|0|||
144351981|NCT03201419|520493039|FG008|Overall Study|Other|0|||
144351982|NCT04266795|520493042|FG000|Overall Study|Adverse Event|10|||
144351983|NCT04266795|520493043|FG001|Overall Study|Adverse Event|19|||
144351984|NCT04266795|520493042|FG000|Overall Study|Death|7|||
144351985|NCT04266795|520493043|FG001|Overall Study|Death|8|||
144351986|NCT04266795|520493042|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
144351987|NCT04266795|520493043|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
144351988|NCT04266795|520493042|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
144351989|NCT04266795|520493043|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
144351990|NCT04266795|520493042|FG000|Overall Study|Progressive Disease|12|||
144351991|NCT04266795|520493043|FG001|Overall Study|Progressive Disease|9|||
144351992|NCT04266795|520493042|FG000|Overall Study|Withdrawal by Patient|5|||
144351993|NCT04266795|520493043|FG001|Overall Study|Withdrawal by Patient|6|||
144351994|NCT04266795|520493042|FG000|Overall Study|Disease Relapse|3|||
144351995|NCT04266795|520493043|FG001|Overall Study|Disease Relapse|6|||
144351996|NCT04266795|520493042|FG000|Overall Study|Reason not Specified|12|||
144351997|NCT04266795|520493043|FG001|Overall Study|Reason not Specified|10|||
144351998|NCT04266795|520493042|FG000|Overall Study|Participants Ongoing on Treatment|25|||
144351999|NCT04266795|520493043|FG001|Overall Study|Participants Ongoing on Treatment|23|||
144352000|NCT03043872|520493044|FG000|Overall Study|Withdrawal by Subject|6|||
144352001|NCT03043872|520493045|FG001|Overall Study|Withdrawal by Subject|6|||
144352002|NCT03043872|520493046|FG002|Overall Study|Withdrawal by Subject|15|||
144352003|NCT03043872|520493044|FG000|Overall Study|Lost to Follow-up|2|||
144352004|NCT03043872|520493045|FG001|Overall Study|Lost to Follow-up|1|||
144352005|NCT03043872|520493046|FG002|Overall Study|Lost to Follow-up|1|||
144352006|NCT03043872|520493044|FG000|Overall Study|Death|270|||
144352007|NCT03043872|520493045|FG001|Overall Study|Death|269|||
144352008|NCT03043872|520493046|FG002|Overall Study|Death|296|||
144352009|NCT03868943|520493047|FG000|Overall Study|Adverse Event|1|||
144352010|NCT02777827|520493048|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
144352011|NCT02777827|520493049|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
144352012|NCT02777827|520493050|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
144352013|NCT02777827|520493051|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
144352014|NCT02777827|520493052|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
144352015|NCT02777827|520493053|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
144352016|NCT04551066|520493054|FG000|Overall Study|Death|5|||
144352017|NCT04551066|520493055|FG001|Overall Study|Death|3|||
144352018|NCT04551066|520493054|FG000|Overall Study|Lost to Follow-up|1|||
144352019|NCT04551066|520493055|FG001|Overall Study|Lost to Follow-up|0|||
144352020|NCT04551066|520493054|FG000|Overall Study|Sponsor Decision|104|||
144352021|NCT04551066|520493055|FG001|Overall Study|Sponsor Decision|117|||
144352022|NCT04551066|520493054|FG000|Overall Study|Withdrawal by Subject|8|||
144352023|NCT04551066|520493055|FG001|Overall Study|Withdrawal by Subject|2|||
144352024|NCT04551066|520493054|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
144352025|NCT04551066|520493055|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
144352026|NCT04551066|520493054|FG000|Overall Study|Adverse Event|2|||
144352027|NCT04551066|520493055|FG001|Overall Study|Adverse Event|0|||
144352028|NCT04551066|520493054|FG000|Overall Study|Physician Decision|2|||
144352029|NCT04551066|520493055|FG001|Overall Study|Physician Decision|0|||
144352030|NCT04551066|520493054|FG000|Overall Study|Protocol Violation|1|||
144352031|NCT04551066|520493055|FG001|Overall Study|Protocol Violation|0|||
144352032|NCT04551066|520493054|FG000|Overall Study|Lack of Efficacy|0|||
144352033|NCT04551066|520493055|FG001|Overall Study|Lack of Efficacy|1|||
144352034|NCT04551066|520493054|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
144352035|NCT04551066|520493055|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
144352036|NCT00369577|520493056|FG000|Overall Study|Withdrawal by Subject|0|||
144352037|NCT00369577|520493057|FG001|Overall Study|Withdrawal by Subject|0|||
144352038|NCT00369577|520493058|FG002|Overall Study|Withdrawal by Subject|1|||
144352039|NCT03790917|520493059|FG000|Overall Study|Death|1|||
144352040|NCT04186871|520493060|FG000|Overall Study|Lack of Efficacy|0|||
144352041|NCT04186871|520493061|FG001|Overall Study|Lack of Efficacy|1|||
144352042|NCT04186871|520493062|FG002|Overall Study|Lack of Efficacy|0|||
144352043|NCT04186871|520493063|FG003|Overall Study|Lack of Efficacy|0|||
144352044|NCT04186871|520493064|FG004|Overall Study|Lack of Efficacy|1|||
144352045|NCT04186871|520493065|FG005|Overall Study|Lack of Efficacy|1|||
144352046|NCT04186871|520493060|FG000|Overall Study|Adverse Event|1|||
144352047|NCT04186871|520493061|FG001|Overall Study|Adverse Event|1|||
144352048|NCT04186871|520493062|FG002|Overall Study|Adverse Event|0|||
144352049|NCT04186871|520493063|FG003|Overall Study|Adverse Event|0|||
144352050|NCT04186871|520493064|FG004|Overall Study|Adverse Event|0|||
144352051|NCT04186871|520493065|FG005|Overall Study|Adverse Event|2|||
144352052|NCT04186871|520493060|FG000|Overall Study|Study terminated by sponsor|1|||
144352053|NCT04186871|520493061|FG001|Overall Study|Study terminated by sponsor|2|||
144352054|NCT04186871|520493062|FG002|Overall Study|Study terminated by sponsor|0|||
144352055|NCT04186871|520493063|FG003|Overall Study|Study terminated by sponsor|1|||
144352056|NCT04186871|520493064|FG004|Overall Study|Study terminated by sponsor|0|||
144352057|NCT04186871|520493065|FG005|Overall Study|Study terminated by sponsor|0|||
144352058|NCT04186871|520493060|FG000|Overall Study|Other reasons|0|||
144352059|NCT04186871|520493061|FG001|Overall Study|Other reasons|0|||
144352060|NCT04186871|520493062|FG002|Overall Study|Other reasons|0|||
144352061|NCT04186871|520493063|FG003|Overall Study|Other reasons|0|||
144352062|NCT04186871|520493064|FG004|Overall Study|Other reasons|0|||
144352063|NCT04186871|520493065|FG005|Overall Study|Other reasons|1|||
144352064|NCT04186871|520493060|FG000|Overall Study|Withdrawal by Subject|0|||
144352065|NCT04186871|520493061|FG001|Overall Study|Withdrawal by Subject|0|||
144352066|NCT04186871|520493062|FG002|Overall Study|Withdrawal by Subject|0|||
144352067|NCT04186871|520493063|FG003|Overall Study|Withdrawal by Subject|0|||
144352068|NCT04186871|520493064|FG004|Overall Study|Withdrawal by Subject|0|||
144352069|NCT04186871|520493065|FG005|Overall Study|Withdrawal by Subject|1|||
144352070|NCT04186871|520493060|FG000|Overall Study|Lost to Follow-up|0|||
144352071|NCT04186871|520493061|FG001|Overall Study|Lost to Follow-up|0|||
144352072|NCT04186871|520493062|FG002|Overall Study|Lost to Follow-up|0|||
144352073|NCT04186871|520493063|FG003|Overall Study|Lost to Follow-up|0|||
144352074|NCT04186871|520493064|FG004|Overall Study|Lost to Follow-up|0|||
144352075|NCT04186871|520493065|FG005|Overall Study|Lost to Follow-up|1|||
144352076|NCT00543387|520493075|FG000|Panel 1 + Panel 2|Adverse Event|0|||
144352077|NCT00543387|520493076|FG001|Panel 1 + Panel 2|Adverse Event|1|||
144352078|NCT00543387|520493077|FG002|Panel 1 + Panel 2|Adverse Event|0|||
144352079|NCT00543387|520493078|FG003|Panel 1 + Panel 2|Adverse Event|0|||
144352080|NCT00543387|520493079|FG004|Panel 1 + Panel 2|Adverse Event|0|||
144352081|NCT00543387|520493080|FG005|Panel 1 + Panel 2|Adverse Event|0|||
144352082|NCT00543387|520493081|FG006|Panel 1 + Panel 2|Adverse Event|0|||
144352083|NCT00543387|520493082|FG007|Panel 1 + Panel 2|Adverse Event|1|||
144352084|NCT00543387|520493083|FG008|Panel 1 + Panel 2|Adverse Event|1|||
144352085|NCT00543387|520493084|FG009|Panel 1 + Panel 2|Adverse Event|0|||
144352086|NCT00543387|520493085|FG010|Panel 1 + Panel 2|Adverse Event|0|||
144352087|NCT00543387|520493075|FG000|Panel 1 + Panel 2|Physician Decision|0|||
144352088|NCT00543387|520493076|FG001|Panel 1 + Panel 2|Physician Decision|0|||
144352089|NCT00543387|520493077|FG002|Panel 1 + Panel 2|Physician Decision|1|||
144352090|NCT00543387|520493078|FG003|Panel 1 + Panel 2|Physician Decision|0|||
144352091|NCT00543387|520493079|FG004|Panel 1 + Panel 2|Physician Decision|0|||
144352092|NCT00543387|520493080|FG005|Panel 1 + Panel 2|Physician Decision|0|||
144352093|NCT00543387|520493081|FG006|Panel 1 + Panel 2|Physician Decision|0|||
144352094|NCT00543387|520493082|FG007|Panel 1 + Panel 2|Physician Decision|1|||
144352095|NCT00543387|520493083|FG008|Panel 1 + Panel 2|Physician Decision|0|||
144352096|NCT00543387|520493084|FG009|Panel 1 + Panel 2|Physician Decision|0|||
144352097|NCT00543387|520493085|FG010|Panel 1 + Panel 2|Physician Decision|0|||
144352098|NCT00543387|520493075|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
144352099|NCT00543387|520493076|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
144352100|NCT00543387|520493077|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
144352101|NCT00543387|520493078|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
144352102|NCT00543387|520493079|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
144352103|NCT00543387|520493080|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
144352104|NCT00543387|520493081|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
144352105|NCT00543387|520493082|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
144352106|NCT00543387|520493083|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
144352107|NCT00543387|520493084|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
144352108|NCT00543387|520493085|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
144352109|NCT00543387|520493075|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352110|NCT00543387|520493076|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352111|NCT00543387|520493077|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352112|NCT00543387|520493078|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352113|NCT00543387|520493079|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352114|NCT00543387|520493080|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352115|NCT00543387|520493081|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
144352116|NCT00543387|520493082|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352117|NCT00543387|520493083|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352118|NCT00543387|520493084|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352119|NCT00543387|520493085|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
144352120|NCT00543387|520493075|FG000|Crossover Participants|Progressive Disease|0|||
144352121|NCT00543387|520493076|FG001|Crossover Participants|Progressive Disease|0|||
144352122|NCT00543387|520493077|FG002|Crossover Participants|Progressive Disease|0|||
144352123|NCT00543387|520493078|FG003|Crossover Participants|Progressive Disease|0|||
144352124|NCT00543387|520493079|FG004|Crossover Participants|Progressive Disease|0|||
144352125|NCT00543387|520493080|FG005|Crossover Participants|Progressive Disease|0|||
144352126|NCT00543387|520493081|FG006|Crossover Participants|Progressive Disease|0|||
144352127|NCT00543387|520493082|FG007|Crossover Participants|Progressive Disease|0|||
144352128|NCT00543387|520493083|FG008|Crossover Participants|Progressive Disease|0|||
144352129|NCT00543387|520493084|FG009|Crossover Participants|Progressive Disease|1|||
144352130|NCT00543387|520493085|FG010|Crossover Participants|Progressive Disease|2|||
144352131|NCT00543387|520493075|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
144352132|NCT00543387|520493076|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
144352133|NCT00543387|520493077|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
144352134|NCT00543387|520493078|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
144352135|NCT00543387|520493079|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
144352136|NCT00543387|520493080|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
144352137|NCT00543387|520493081|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
144352138|NCT00543387|520493082|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
144352139|NCT00543387|520493083|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
144352140|NCT00543387|520493084|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
144352141|NCT00543387|520493085|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
144352142|NCT00549445|520493086|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
144352143|NCT00549445|520493087|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
144352144|NCT03566082|520493088|FG000|Overall Study|Death|7|||
144352145|NCT03566082|520493088|FG000|Overall Study|Failures (revision required)|2|||
144352146|NCT03566082|520493088|FG000|Overall Study|Lost to Follow-up|8|||
144352147|NCT01389882|520494569|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
144352148|NCT01389882|520494570|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
144352149|NCT01389882|520494569|FG000|Overall Study|Withdrawal by Subject|0|||
144352150|NCT01389882|520494570|FG001|Overall Study|Withdrawal by Subject|1|||
144352151|NCT03790111|520494571|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
144352152|NCT03654690|520494585|FG000|Overall Study|Withdrawal by Subject|1|||
144352153|NCT03654690|520494586|FG001|Overall Study|Withdrawal by Subject|0|||
144352154|NCT03654690|520494587|FG002|Overall Study|Withdrawal by Subject|0|||
144352155|NCT00354679|520494593|FG000|Overall Study|Patient Not Treated|1|||
144352156|NCT00965081|520494594|FG000|Overall Study|Adverse Event|14|||
144352157|NCT00965081|520494595|FG001|Overall Study|Adverse Event|9|||
144352158|NCT00965081|520494594|FG000|Overall Study|Lack of Efficacy|2|||
144352159|NCT00965081|520494595|FG001|Overall Study|Lack of Efficacy|5|||
144352160|NCT00965081|520494594|FG000|Overall Study|Lost to Follow-up|4|||
144352161|NCT00965081|520494595|FG001|Overall Study|Lost to Follow-up|5|||
144352162|NCT00965081|520494594|FG000|Overall Study|Physician Decision|2|||
144352163|NCT00965081|520494595|FG001|Overall Study|Physician Decision|0|||
144352164|NCT00965081|520494594|FG000|Overall Study|Protocol Violation|2|||
144352165|NCT00965081|520494595|FG001|Overall Study|Protocol Violation|5|||
144352166|NCT00965081|520494594|FG000|Overall Study|Sponsor Decision|1|||
144352167|NCT00965081|520494595|FG001|Overall Study|Sponsor Decision|0|||
144352168|NCT00965081|520494594|FG000|Overall Study|Withdrawal by Subject|4|||
144352169|NCT00965081|520494595|FG001|Overall Study|Withdrawal by Subject|7|||
144352170|NCT00965081|520494594|FG000|Overall Study|Switched to Rescue Arm|5|||
144352171|NCT00965081|520494595|FG001|Overall Study|Switched to Rescue Arm|12|||
144352172|NCT01367834|520494598|FG000|Overall Study|Withdrawal by Subject|2|||
144352173|NCT01367834|520494599|FG001|Overall Study|Withdrawal by Subject|2|||
144352174|NCT01367834|520494598|FG000|Overall Study|Study was ended.|0|||
144352175|NCT01367834|520494599|FG001|Overall Study|Study was ended.|1|||
144352176|NCT00988598|520494600|FG000|Overall Study|Withdrawal by Subject|2|||
144352177|NCT00988598|520494601|FG001|Overall Study|Withdrawal by Subject|0|||
144352178|NCT01141712|520494607|FG000|Overall Study|Disease progression|3|||
144352179|NCT04435366|520494615|FG000|Year 1 (12 Months)|Adverse Event|3|||
144352180|NCT04435366|520494616|FG001|Year 1 (12 Months)|Adverse Event|0|||
144352181|NCT04435366|520494617|FG002|Year 1 (12 Months)|Adverse Event|2|||
144352182|NCT04435366|520494615|FG000|Year 1 (12 Months)|Death|2|||
144352183|NCT04435366|520494616|FG001|Year 1 (12 Months)|Death|0|||
144352184|NCT04435366|520494617|FG002|Year 1 (12 Months)|Death|1|||
144352185|NCT04435366|520494615|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
144352186|NCT04435366|520494616|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
144352187|NCT04435366|520494617|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
144352188|NCT04435366|520494615|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
144352189|NCT04435366|520494616|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
144352190|NCT04435366|520494617|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
144352191|NCT04435366|520494615|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
144352192|NCT04435366|520494616|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
144352193|NCT04435366|520494617|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
144352194|NCT04435366|520494615|FG000|Year 1 (12 Months)|Not treated|0|||
144352195|NCT04435366|520494616|FG001|Year 1 (12 Months)|Not treated|0|||
144352196|NCT04435366|520494617|FG002|Year 1 (12 Months)|Not treated|1|||
144352197|NCT04435366|520494615|FG000|Year 2 (12 Months)|Death|1|||
144352198|NCT04435366|520494616|FG001|Year 2 (12 Months)|Death|4|||
144352199|NCT04435366|520494617|FG002|Year 2 (12 Months)|Death|6|||
144352200|NCT04435366|520494615|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
144352201|NCT04435366|520494616|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
144352202|NCT04435366|520494617|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
144352203|NCT04435366|520494615|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
144352204|NCT04435366|520494616|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
144352205|NCT04435366|520494617|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
144352206|NCT04435366|520494615|FG000|Year 2 (12 Months)|Adverse Event|2|||
144352207|NCT04435366|520494616|FG001|Year 2 (12 Months)|Adverse Event|1|||
144352208|NCT04435366|520494617|FG002|Year 2 (12 Months)|Adverse Event|6|||
144352209|NCT04112810|520494622|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
144352210|NCT05963022|520494623|FG000|Overall Study|Adverse Event|0|||
144352211|NCT05963022|520494624|FG001|Overall Study|Adverse Event|1|||
144352212|NCT05963022|520494625|FG002|Overall Study|Adverse Event|1|||
144352213|NCT05963022|520494626|FG003|Overall Study|Adverse Event|0|||
144352214|NCT05963022|520494623|FG000|Overall Study|Protocol Violation|0|||
144352215|NCT05963022|520494624|FG001|Overall Study|Protocol Violation|3|||
144352216|NCT05963022|520494625|FG002|Overall Study|Protocol Violation|0|||
144352217|NCT05963022|520494626|FG003|Overall Study|Protocol Violation|0|||
144352218|NCT05963022|520494623|FG000|Overall Study|Pregnancy|0|||
144352219|NCT05963022|520494624|FG001|Overall Study|Pregnancy|1|||
144352220|NCT05963022|520494625|FG002|Overall Study|Pregnancy|1|||
144352221|NCT05963022|520494626|FG003|Overall Study|Pregnancy|1|||
144352222|NCT05963022|520494623|FG000|Overall Study|Withdrawal by Subject|0|||
144352223|NCT05963022|520494624|FG001|Overall Study|Withdrawal by Subject|0|||
144352224|NCT05963022|520494625|FG002|Overall Study|Withdrawal by Subject|2|||
144352225|NCT05963022|520494626|FG003|Overall Study|Withdrawal by Subject|1|||
144352226|NCT05963022|520494623|FG000|Overall Study|Lost to Follow-up|0|||
144352227|NCT05963022|520494624|FG001|Overall Study|Lost to Follow-up|0|||
144352228|NCT05963022|520494625|FG002|Overall Study|Lost to Follow-up|0|||
144352229|NCT05963022|520494626|FG003|Overall Study|Lost to Follow-up|1|||
144352230|NCT05963022|520494623|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
144352231|NCT05963022|520494624|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
144352232|NCT05963022|520494625|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
144352233|NCT05963022|520494626|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
144352234|NCT01358825|520494627|FG000|Overall Study|Blood sample not drawn|0|||
144352235|NCT01358825|520494628|FG001|Overall Study|Blood sample not drawn|1|||
144352236|NCT01012258|520494629|FG000|Overall Study|Death|14|||
144352237|NCT01012258|520494629|FG000|Overall Study|Lost to Follow-up|1|||
144352238|NCT01012258|520494629|FG000|Overall Study|Adverse Event|1|||
144352239|NCT01012258|520494629|FG000|Overall Study|Progressive Disease (PD)|18|||
144352240|NCT01012258|520494629|FG000|Overall Study|Symptomatic Deterioration|1|||
144352241|NCT01012258|520494629|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
144352242|NCT01012258|520494629|FG000|Overall Study|Another Tumor Discovered|1|||
144352243|NCT01012258|520494629|FG000|Overall Study|Ongoing|29|||
144352244|NCT01814527|520494632|FG000|Overall Study|RTP greater than 30 days|6|||
144352245|NCT01814527|520494633|FG001|Overall Study|RTP greater than 30 days|1|||
144352246|NCT03571204|520494636|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
144352247|NCT03571204|520494637|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
144352248|NCT03571204|520494638|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
144352249|NCT03571204|520494636|FG000|Overall Study|Physician Decision|0|||
144352250|NCT03571204|520494637|FG001|Overall Study|Physician Decision|1|||
144352251|NCT03571204|520494638|FG002|Overall Study|Physician Decision|0|||
144352252|NCT03575403|520494643|FG000|Overall Study|Adverse Event|1|||
144352253|NCT03575403|520494644|FG001|Overall Study|Adverse Event|0|||
144352254|NCT03575403|520494645|FG002|Overall Study|Adverse Event|0|||
144352255|NCT03575403|520494643|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
144352256|NCT03575403|520494644|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
144352257|NCT03575403|520494645|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
144352258|NCT05114473|520494646|FG000|Overall Study|Lost to Follow-up|2|||
144352259|NCT05114473|520494647|FG001|Overall Study|Lost to Follow-up|2|||
144352260|NCT05114473|520494648|FG002|Overall Study|Lost to Follow-up|0|||
144352261|NCT00773513|520494649|FG000|Overall Study|Renal Transplant|254|||
144352262|NCT00773513|520494650|FG001|Overall Study|Renal Transplant|263|||
144352263|NCT00773513|520494649|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
144352264|NCT00773513|520494650|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
144352265|NCT00773513|520494649|FG000|Overall Study|Withdrew Consent|68|||
144352266|NCT00773513|520494650|FG001|Overall Study|Withdrew Consent|69|||
144352267|NCT00773513|520494649|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
144352268|NCT00773513|520494650|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
144352269|NCT00773513|520494649|FG000|Overall Study|Failure to Return|22|||
144352270|NCT00773513|520494650|FG001|Overall Study|Failure to Return|8|||
144352271|NCT00773513|520494649|FG000|Overall Study|Insufficient Therapeutic Response|1|||
144352272|NCT00773513|520494650|FG001|Overall Study|Insufficient Therapeutic Response|18|||
144352273|NCT00773513|520494649|FG000|Overall Study|Reason Not Specified|159|||
144352274|NCT00773513|520494650|FG001|Overall Study|Reason Not Specified|126|||
144352275|NCT00773513|520494649|FG000|Overall Study|Death|531|||
144352276|NCT00773513|520494650|FG001|Overall Study|Death|545|||
144352277|NCT02959437|520494651|FG000|Overall Study|Death|33|||
144352278|NCT02959437|520494652|FG001|Overall Study|Death|3|||
144352279|NCT02959437|520494653|FG002|Overall Study|Death|0|||
144352280|NCT02959437|520494654|FG003|Overall Study|Death|0|||
144352281|NCT02959437|520494651|FG000|Overall Study|Lost to Follow-up|3|||
144352282|NCT02959437|520494652|FG001|Overall Study|Lost to Follow-up|1|||
144352283|NCT02959437|520494653|FG002|Overall Study|Lost to Follow-up|0|||
144352284|NCT02959437|520494654|FG003|Overall Study|Lost to Follow-up|0|||
144352285|NCT02959437|520494651|FG000|Overall Study|Withdrawal by Subject|11|||
144352286|NCT02959437|520494652|FG001|Overall Study|Withdrawal by Subject|3|||
144352287|NCT02959437|520494653|FG002|Overall Study|Withdrawal by Subject|0|||
144352288|NCT02959437|520494654|FG003|Overall Study|Withdrawal by Subject|0|||
144352289|NCT02959437|520494651|FG000|Overall Study|Progressive Disease|9|||
144352290|NCT02959437|520494652|FG001|Overall Study|Progressive Disease|1|||
144352291|NCT02959437|520494653|FG002|Overall Study|Progressive Disease|0|||
144352292|NCT02959437|520494654|FG003|Overall Study|Progressive Disease|0|||
144352293|NCT02959437|520494651|FG000|Overall Study|Study Terminated by Sponsor|4|||
144352294|NCT02959437|520494652|FG001|Overall Study|Study Terminated by Sponsor|0|||
144352295|NCT02959437|520494653|FG002|Overall Study|Study Terminated by Sponsor|0|||
144352296|NCT02959437|520494654|FG003|Overall Study|Study Terminated by Sponsor|0|||
144352297|NCT02959437|520494651|FG000|Overall Study|Other Unspecified|2|||
144352298|NCT02959437|520494652|FG001|Overall Study|Other Unspecified|0|||
144352299|NCT02959437|520494653|FG002|Overall Study|Other Unspecified|0|||
144352300|NCT02959437|520494654|FG003|Overall Study|Other Unspecified|0|||
144352301|NCT03359174|520494659|FG000|Overall Study|Adverse Event|1|||
144352302|NCT03089580|520494668|FG000|Overall Study|Lost to Follow-up|2|||
144352303|NCT04170543|520494669|FG000|Overall Study|Death|1|||
144352304|NCT04170543|520494670|FG001|Overall Study|Death|1|||
144352305|NCT04170543|520494671|FG002|Overall Study|Death|1|||
144352306|NCT04170543|520494672|FG003|Overall Study|Death|1|||
144352307|NCT04170543|520494673|FG004|Overall Study|Death|1|||
144352308|NCT04170543|520494669|FG000|Overall Study|Lost to Follow-up|3|||
144352309|NCT04170543|520494670|FG001|Overall Study|Lost to Follow-up|3|||
144352310|NCT04170543|520494671|FG002|Overall Study|Lost to Follow-up|0|||
144352311|NCT04170543|520494672|FG003|Overall Study|Lost to Follow-up|3|||
144352312|NCT04170543|520494673|FG004|Overall Study|Lost to Follow-up|1|||
144352313|NCT04170543|520494669|FG000|Overall Study|Withdrawal by Subject|13|||
144352314|NCT04170543|520494670|FG001|Overall Study|Withdrawal by Subject|6|||
144352315|NCT04170543|520494671|FG002|Overall Study|Withdrawal by Subject|5|||
144352316|NCT04170543|520494672|FG003|Overall Study|Withdrawal by Subject|4|||
144352317|NCT04170543|520494673|FG004|Overall Study|Withdrawal by Subject|9|||
144352318|NCT04170543|520494669|FG000|Overall Study|Not able to transition to phase 2b|8|||
144352319|NCT04170543|520494670|FG001|Overall Study|Not able to transition to phase 2b|0|||
144352320|NCT04170543|520494671|FG002|Overall Study|Not able to transition to phase 2b|10|||
144352321|NCT04170543|520494672|FG003|Overall Study|Not able to transition to phase 2b|0|||
144352322|NCT04170543|520494673|FG004|Overall Study|Not able to transition to phase 2b|6|||
144352323|NCT04170543|520494669|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
144352324|NCT04170543|520494670|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
144352325|NCT04170543|520494671|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
144352326|NCT04170543|520494672|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
144352327|NCT04170543|520494673|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
144352328|NCT04170543|520494669|FG000|Overall Study|Not Treated|0|||
144352329|NCT04170543|520494670|FG001|Overall Study|Not Treated|0|||
144352330|NCT04170543|520494671|FG002|Overall Study|Not Treated|0|||
144352331|NCT04170543|520494672|FG003|Overall Study|Not Treated|0|||
144352332|NCT04170543|520494673|FG004|Overall Study|Not Treated|2|||
144352333|NCT04170543|520494669|FG000|Overall Study|(CRF)|16|||
144352334|NCT04170543|520494670|FG001|Overall Study|(CRF)|15|||
144352335|NCT04170543|520494671|FG002|Overall Study|(CRF)|12|||
144352336|NCT04170543|520494672|FG003|Overall Study|(CRF)|17|||
144352337|NCT04170543|520494673|FG004|Overall Study|(CRF)|17|||
144352338|NCT04170543|520494669|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
144352339|NCT04170543|520494670|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
144352340|NCT04170543|520494671|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
144352341|NCT04170543|520494672|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
144352342|NCT04170543|520494673|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
144352343|NCT03622814|520494674|FG000|Overall Study|Lost to Follow-up|8|||
144352344|NCT03622814|520494675|FG001|Overall Study|Lost to Follow-up|14|||
144352345|NCT04417361|520494676|FG000|Overall Study|Withdrawal by Subject|1|||
144352346|NCT04417361|520494677|FG001|Overall Study|Withdrawal by Subject|0|||
144352347|NCT04417361|520494676|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
144352348|NCT04417361|520494677|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
144352349|NCT04303559|520494678|FG000|Overall Study|Study closed due to poor enrollment.|1|||
144352350|NCT01156714|520494681|FG000|Overall Study|Withdrawal by Subject|9|||
144352351|NCT01156714|520494682|FG001|Overall Study|Withdrawal by Subject|4|||
144352352|NCT01156714|520494683|FG002|Overall Study|Withdrawal by Subject|3|||
144352353|NCT04661150|520494689|FG000|Overall Study|Ongoing in study|19|||
144352354|NCT04661150|520494690|FG001|Overall Study|Ongoing in study|20|||
144352355|NCT04661150|520494689|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
144352356|NCT04661150|520494690|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
144352357|NCT04661150|520494689|FG000|Overall Study|Death|2|||
144352358|NCT04661150|520494690|FG001|Overall Study|Death|0|||
144352359|NCT04965688|520494691|FG000|Overall Study|Withdrawal by Subject|2|||
144352360|NCT05864586|520494692|FG000|Overall Study|Ineligible|4|||
144352361|NCT05864586|520494693|FG001|Overall Study|Ineligible|12|||
144352362|NCT05864586|520494692|FG000|Overall Study|Pregnancy|0|||
144352363|NCT05864586|520494693|FG001|Overall Study|Pregnancy|1|||
144352364|NCT05864586|520494692|FG000|Overall Study|Withdrawal by Subject|0|||
144352365|NCT05864586|520494693|FG001|Overall Study|Withdrawal by Subject|1|||
144352366|NCT03635424|520494694|FG000|Overall Study|Adverse Event|1|||
144352367|NCT03635424|520494694|FG000|Overall Study|Death|1|||
144352368|NCT03635424|520494694|FG000|Overall Study|Device not implanted|1|||
144352369|NCT03915470|520494695|FG000|Overall Study|Death|3|||
144352370|NCT03915470|520494696|FG001|Overall Study|Death|1|||
144352371|NCT03915470|520494695|FG000|Overall Study|Adverse Event|1|||
144352372|NCT03915470|520494696|FG001|Overall Study|Adverse Event|0|||
144352373|NCT03915470|520494695|FG000|Overall Study|Physician Decision|1|||
144352374|NCT03915470|520494696|FG001|Overall Study|Physician Decision|0|||
144352375|NCT03915470|520494695|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
144352376|NCT03915470|520494696|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
144352377|NCT00434109|520494699|FG000|Overall Study|Physician Decision|9|||
144352378|NCT00434109|520494699|FG000|Overall Study|Adverse Event|5|||
144352379|NCT00434109|520494699|FG000|Overall Study|Protocol Violation|1|||
144352380|NCT00434109|520494699|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
144352381|NCT02452424|520494702|FG000|Overall Study|Death|2|||
144352382|NCT02452424|520494703|FG001|Overall Study|Death|2|||
144352383|NCT02452424|520494704|FG002|Overall Study|Death|2|||
144352384|NCT02452424|520494705|FG003|Overall Study|Death|6|||
144352385|NCT02452424|520494706|FG004|Overall Study|Death|2|||
144352386|NCT02452424|520494707|FG005|Overall Study|Death|0|||
144352387|NCT02452424|520494708|FG006|Overall Study|Death|5|||
144352388|NCT02452424|520494709|FG007|Overall Study|Death|1|||
144352389|NCT02452424|520494710|FG008|Overall Study|Death|3|||
144352390|NCT02452424|520494711|FG009|Overall Study|Death|1|||
144352391|NCT02452424|520494712|FG010|Overall Study|Death|0|||
144352392|NCT02452424|520494702|FG000|Overall Study|Lost to Follow-up|0|||
144352393|NCT02452424|520494703|FG001|Overall Study|Lost to Follow-up|1|||
144352394|NCT02452424|520494704|FG002|Overall Study|Lost to Follow-up|1|||
144352395|NCT02452424|520494705|FG003|Overall Study|Lost to Follow-up|0|||
144352396|NCT02452424|520494706|FG004|Overall Study|Lost to Follow-up|0|||
144352397|NCT02452424|520494707|FG005|Overall Study|Lost to Follow-up|0|||
144352398|NCT02452424|520494708|FG006|Overall Study|Lost to Follow-up|0|||
144352399|NCT02452424|520494709|FG007|Overall Study|Lost to Follow-up|0|||
144352400|NCT02452424|520494710|FG008|Overall Study|Lost to Follow-up|0|||
144352401|NCT02452424|520494711|FG009|Overall Study|Lost to Follow-up|0|||
144352402|NCT02452424|520494712|FG010|Overall Study|Lost to Follow-up|0|||
144352403|NCT02452424|520494702|FG000|Overall Study|Withdrawal by Subject|0|||
144352404|NCT02452424|520494703|FG001|Overall Study|Withdrawal by Subject|0|||
144352405|NCT02452424|520494704|FG002|Overall Study|Withdrawal by Subject|3|||
144352406|NCT02452424|520494705|FG003|Overall Study|Withdrawal by Subject|2|||
144352407|NCT02452424|520494706|FG004|Overall Study|Withdrawal by Subject|0|||
144352408|NCT02452424|520494707|FG005|Overall Study|Withdrawal by Subject|0|||
144352409|NCT02452424|520494708|FG006|Overall Study|Withdrawal by Subject|1|||
144352410|NCT02452424|520494709|FG007|Overall Study|Withdrawal by Subject|0|||
144352411|NCT02452424|520494710|FG008|Overall Study|Withdrawal by Subject|1|||
144352412|NCT02452424|520494711|FG009|Overall Study|Withdrawal by Subject|1|||
144352413|NCT02452424|520494712|FG010|Overall Study|Withdrawal by Subject|0|||
144352414|NCT02452424|520494702|FG000|Overall Study|Other|0|||
144352415|NCT02452424|520494703|FG001|Overall Study|Other|0|||
144352416|NCT02452424|520494704|FG002|Overall Study|Other|1|||
144352417|NCT02452424|520494705|FG003|Overall Study|Other|0|||
144352418|NCT02452424|520494706|FG004|Overall Study|Other|0|||
144352419|NCT02452424|520494707|FG005|Overall Study|Other|1|||
144352420|NCT02452424|520494708|FG006|Overall Study|Other|4|||
144352421|NCT02452424|520494709|FG007|Overall Study|Other|3|||
144352422|NCT02452424|520494710|FG008|Overall Study|Other|0|||
144352423|NCT02452424|520494711|FG009|Overall Study|Other|0|||
144352424|NCT02452424|520494712|FG010|Overall Study|Other|1|||
144352425|NCT02452424|520494702|FG000|Overall Study|Progressive disease (per RECIST)|0|||
144352426|NCT02452424|520494703|FG001|Overall Study|Progressive disease (per RECIST)|0|||
144352427|NCT02452424|520494704|FG002|Overall Study|Progressive disease (per RECIST)|0|||
144352428|NCT02452424|520494705|FG003|Overall Study|Progressive disease (per RECIST)|0|||
144352429|NCT02452424|520494706|FG004|Overall Study|Progressive disease (per RECIST)|0|||
144352430|NCT02452424|520494707|FG005|Overall Study|Progressive disease (per RECIST)|0|||
144352431|NCT02452424|520494708|FG006|Overall Study|Progressive disease (per RECIST)|0|||
144352432|NCT02452424|520494709|FG007|Overall Study|Progressive disease (per RECIST)|0|||
144352433|NCT02452424|520494710|FG008|Overall Study|Progressive disease (per RECIST)|2|||
144352434|NCT02452424|520494711|FG009|Overall Study|Progressive disease (per RECIST)|0|||
144352435|NCT02452424|520494712|FG010|Overall Study|Progressive disease (per RECIST)|0|||
144352436|NCT02452424|520494702|FG000|Overall Study|Adverse Event|0|||
144352437|NCT02452424|520494703|FG001|Overall Study|Adverse Event|0|||
144352438|NCT02452424|520494704|FG002|Overall Study|Adverse Event|0|||
144352439|NCT02452424|520494705|FG003|Overall Study|Adverse Event|0|||
144352440|NCT02452424|520494706|FG004|Overall Study|Adverse Event|0|||
144352441|NCT02452424|520494707|FG005|Overall Study|Adverse Event|0|||
144352442|NCT02452424|520494708|FG006|Overall Study|Adverse Event|0|||
144352443|NCT02452424|520494709|FG007|Overall Study|Adverse Event|0|||
144352444|NCT02452424|520494710|FG008|Overall Study|Adverse Event|0|||
144352445|NCT02452424|520494711|FG009|Overall Study|Adverse Event|0|||
144352446|NCT02452424|520494712|FG010|Overall Study|Adverse Event|1|||
144352447|NCT01463306|520494713|FG000|Overall Study|Adverse Event|6|||
144352448|NCT01463306|520494714|FG001|Overall Study|Adverse Event|9|||
144352449|NCT01463306|520494715|FG002|Overall Study|Adverse Event|3|||
144352450|NCT01463306|520494713|FG000|Overall Study|Death|3|||
144352451|NCT01463306|520494714|FG001|Overall Study|Death|3|||
144352452|NCT01463306|520494715|FG002|Overall Study|Death|0|||
144352453|NCT01463306|520494713|FG000|Overall Study|Lack of Efficacy|22|||
144352454|NCT01463306|520494714|FG001|Overall Study|Lack of Efficacy|16|||
144352455|NCT01463306|520494715|FG002|Overall Study|Lack of Efficacy|1|||
144352456|NCT01463306|520494713|FG000|Overall Study|Lost to Follow-up|5|||
144352457|NCT01463306|520494714|FG001|Overall Study|Lost to Follow-up|2|||
144352458|NCT01463306|520494715|FG002|Overall Study|Lost to Follow-up|0|||
144352459|NCT01463306|520494713|FG000|Overall Study|Protocol Violation|4|||
144352460|NCT01463306|520494714|FG001|Overall Study|Protocol Violation|0|||
144352461|NCT01463306|520494715|FG002|Overall Study|Protocol Violation|0|||
144352462|NCT01463306|520494713|FG000|Overall Study|Withdrawal by Subject|19|||
144352463|NCT01463306|520494714|FG001|Overall Study|Withdrawal by Subject|9|||
144352464|NCT01463306|520494715|FG002|Overall Study|Withdrawal by Subject|1|||
144352465|NCT01463306|520494713|FG000|Overall Study|Other|26|||
144352466|NCT01463306|520494714|FG001|Overall Study|Other|13|||
144352467|NCT01463306|520494715|FG002|Overall Study|Other|0|||
144352468|NCT01463306|520494713|FG000|Overall Study|Approval expiry at site|1|||
144352469|NCT01463306|520494714|FG001|Overall Study|Approval expiry at site|0|||
144352470|NCT01463306|520494715|FG002|Overall Study|Approval expiry at site|0|||
144352471|NCT01059318|520494716|FG000|Core Study (26 Week)|Adverse Event|3|||
144352472|NCT01059318|520494716|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
144352473|NCT01059318|520494716|FG000|Extension (36 Week)|Adverse Event|3|||
144352474|NCT00176462|520494726|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
144352475|NCT00176462|520494727|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
144352476|NCT00176462|520494726|FG000|Induction (4 Weeks)|Death|1|||
144352477|NCT00176462|520494727|FG001|Induction (4 Weeks)|Death|2|||
144352478|NCT00176462|520494726|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
144352479|NCT00176462|520494727|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
144352480|NCT00176462|520494726|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
144352481|NCT00176462|520494727|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
144352482|NCT00176462|520494726|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
144352483|NCT00176462|520494727|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
144352484|NCT00176462|520494726|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
144352485|NCT00176462|520494727|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
144352486|NCT00176462|520494726|FG000|Consolidation (12 Weeks)|Not documented|0|||
144352487|NCT00176462|520494727|FG001|Consolidation (12 Weeks)|Not documented|1|||
144352488|NCT00176462|520494726|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
144352489|NCT00176462|520494727|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
144352490|NCT00176462|520494726|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
144352491|NCT00176462|520494727|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
144352492|NCT01150097|520494729|FG000|Months 24 to 36 Post-transplantation|Death|2|||
144352493|NCT01150097|520494730|FG001|Months 24 to 36 Post-transplantation|Death|0|||
144352494|NCT01150097|520494731|FG002|Months 24 to 36 Post-transplantation|Death|0|||
144352495|NCT01150097|520494729|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
144352496|NCT01150097|520494730|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
144352497|NCT01150097|520494731|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
144352498|NCT01150097|520494729|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
144352499|NCT01150097|520494730|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
144352500|NCT01150097|520494731|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
144352501|NCT01150097|520494729|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
144352502|NCT01150097|520494730|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
144352503|NCT01150097|520494731|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
144352504|NCT01150097|520494729|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
144352505|NCT01150097|520494730|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
144352506|NCT01150097|520494731|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
144352507|NCT01150097|520494729|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
144352508|NCT01150097|520494730|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
144352509|NCT01150097|520494731|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
144352510|NCT01150097|520494729|FG000|Months 24 to 48 Post-transplantation|Death|2|||
144352511|NCT01150097|520494730|FG001|Months 24 to 48 Post-transplantation|Death|0|||
144352512|NCT01150097|520494731|FG002|Months 24 to 48 Post-transplantation|Death|0|||
144352513|NCT01301833|520494732|FG000|Overall Study|Adverse Event|7|||
144352514|NCT01301833|520494733|FG001|Overall Study|Adverse Event|5|||
144352515|NCT01301833|520494734|FG002|Overall Study|Adverse Event|5|||
144352516|NCT01301833|520494735|FG003|Overall Study|Adverse Event|5|||
144352517|NCT01301833|520494732|FG000|Overall Study|Lack of Efficacy|1|||
144352518|NCT01301833|520494733|FG001|Overall Study|Lack of Efficacy|1|||
144352519|NCT01301833|520494734|FG002|Overall Study|Lack of Efficacy|0|||
144352520|NCT01301833|520494735|FG003|Overall Study|Lack of Efficacy|0|||
144352521|NCT01301833|520494732|FG000|Overall Study|Physician Decision|3|||
144352522|NCT01301833|520494733|FG001|Overall Study|Physician Decision|1|||
144352523|NCT01301833|520494734|FG002|Overall Study|Physician Decision|1|||
144352524|NCT01301833|520494735|FG003|Overall Study|Physician Decision|0|||
144352525|NCT01301833|520494732|FG000|Overall Study|Withdrawal by Subject|3|||
144352526|NCT01301833|520494733|FG001|Overall Study|Withdrawal by Subject|1|||
144352527|NCT01301833|520494734|FG002|Overall Study|Withdrawal by Subject|1|||
144352528|NCT01301833|520494735|FG003|Overall Study|Withdrawal by Subject|2|||
144352529|NCT01301833|520494732|FG000|Overall Study|Personal matter|1|||
144352530|NCT01301833|520494733|FG001|Overall Study|Personal matter|0|||
144352531|NCT01301833|520494734|FG002|Overall Study|Personal matter|0|||
144352532|NCT01301833|520494735|FG003|Overall Study|Personal matter|0|||
144352533|NCT02719171|520496356|FG000|Overall Study|Adverse Event|1|||
144352534|NCT02719171|520496357|FG001|Overall Study|Adverse Event|2|||
144352535|NCT02719171|520496358|FG002|Overall Study|Adverse Event|0|||
144352536|NCT02719171|520496359|FG003|Overall Study|Adverse Event|0|||
144352537|NCT02719171|520496360|FG004|Overall Study|Adverse Event|2|||
144352538|NCT02719171|520496356|FG000|Overall Study|Lost to Follow-up|0|||
144352539|NCT02719171|520496357|FG001|Overall Study|Lost to Follow-up|0|||
144352540|NCT02719171|520496358|FG002|Overall Study|Lost to Follow-up|1|||
144352541|NCT02719171|520496359|FG003|Overall Study|Lost to Follow-up|0|||
144352542|NCT02719171|520496360|FG004|Overall Study|Lost to Follow-up|0|||
144352543|NCT02719171|520496356|FG000|Overall Study|Subject Withdrawal|0|||
144352544|NCT02719171|520496357|FG001|Overall Study|Subject Withdrawal|2|||
144352545|NCT02719171|520496358|FG002|Overall Study|Subject Withdrawal|2|||
144352546|NCT02719171|520496359|FG003|Overall Study|Subject Withdrawal|1|||
144352547|NCT02719171|520496360|FG004|Overall Study|Subject Withdrawal|0|||
144352548|NCT02719171|520496356|FG000|Overall Study|Other|0|||
144352549|NCT02719171|520496357|FG001|Overall Study|Other|0|||
144352550|NCT02719171|520496358|FG002|Overall Study|Other|0|||
144352551|NCT02719171|520496359|FG003|Overall Study|Other|1|||
144352552|NCT02719171|520496360|FG004|Overall Study|Other|0|||
144352553|NCT02614729|520496361|FG000|Overall Study|Withdrawal by Subject|1|||
144352554|NCT02614729|520496362|FG001|Overall Study|Withdrawal by Subject|0|||
144352555|NCT00227721|520496363|FG000|Overall Study|On study, but never treated.|1|||
144352556|NCT02539797|520496373|FG000|Overall Study|Lost to Follow-up|0|||
144352557|NCT02539797|520496374|FG001|Overall Study|Lost to Follow-up|1|||
144352558|NCT02539797|520496375|FG002|Overall Study|Lost to Follow-up|0|||
144352559|NCT00383786|520496378|FG000|Overall Study|Protocol Violation|2|||
144352560|NCT00383786|520496379|FG001|Overall Study|Protocol Violation|6|||
144352561|NCT00383786|520496378|FG000|Overall Study|Withdrawal by Subject|2|||
144352562|NCT00383786|520496379|FG001|Overall Study|Withdrawal by Subject|5|||
144352563|NCT00383786|520496378|FG000|Overall Study|Physician Decision|0|||
144352564|NCT00383786|520496379|FG001|Overall Study|Physician Decision|1|||
144352565|NCT02252146|520496380|FG000|Overall Study|Lack of Efficacy|4|||
144352566|NCT02252146|520496380|FG000|Overall Study|Entered hospice care|1|||
144352567|NCT02252146|520496380|FG000|Overall Study|Inability to travel to study site|1|||
144352568|NCT00531284|520496383|FG000|Overall Study|Progressive Disease|1|||
144352569|NCT00531284|520496384|FG001|Overall Study|Progressive Disease|3|||
144352570|NCT00531284|520496385|FG002|Overall Study|Progressive Disease|5|||
144352571|NCT00531284|520496386|FG003|Overall Study|Progressive Disease|42|||
144352572|NCT00531284|520496387|FG004|Overall Study|Progressive Disease|4|||
144352573|NCT00531284|520496388|FG005|Overall Study|Progressive Disease|4|||
144352574|NCT00531284|520496389|FG006|Overall Study|Progressive Disease|3|||
144352575|NCT00531284|520496390|FG007|Overall Study|Progressive Disease|8|||
144352576|NCT00531284|520496391|FG008|Overall Study|Progressive Disease|6|||
144352577|NCT00531284|520496392|FG009|Overall Study|Progressive Disease|3|||
144352578|NCT00531284|520496393|FG010|Overall Study|Progressive Disease|3|||
144352579|NCT00531284|520496394|FG011|Overall Study|Progressive Disease|14|||
144352580|NCT00531284|520496395|FG012|Overall Study|Progressive Disease|2|||
144352581|NCT00531284|520496396|FG013|Overall Study|Progressive Disease|1|||
144352582|NCT00531284|520496397|FG014|Overall Study|Progressive Disease|2|||
144352583|NCT00531284|520496398|FG015|Overall Study|Progressive Disease|11|||
144352584|NCT00531284|520496399|FG016|Overall Study|Progressive Disease|5|||
144352585|NCT00531284|520496383|FG000|Overall Study|Adverse Event|0|||
144352586|NCT00531284|520496384|FG001|Overall Study|Adverse Event|1|||
144352587|NCT00531284|520496385|FG002|Overall Study|Adverse Event|1|||
144352588|NCT00531284|520496386|FG003|Overall Study|Adverse Event|7|||
144352589|NCT00531284|520496387|FG004|Overall Study|Adverse Event|0|||
144352590|NCT00531284|520496388|FG005|Overall Study|Adverse Event|2|||
144352591|NCT00531284|520496389|FG006|Overall Study|Adverse Event|3|||
144352592|NCT00531284|520496390|FG007|Overall Study|Adverse Event|2|||
144352593|NCT00531284|520496391|FG008|Overall Study|Adverse Event|3|||
144352594|NCT00531284|520496392|FG009|Overall Study|Adverse Event|0|||
144352595|NCT00531284|520496393|FG010|Overall Study|Adverse Event|0|||
144352596|NCT00531284|520496394|FG011|Overall Study|Adverse Event|5|||
144352597|NCT00531284|520496395|FG012|Overall Study|Adverse Event|0|||
144352598|NCT00531284|520496396|FG013|Overall Study|Adverse Event|1|||
144352599|NCT00531284|520496397|FG014|Overall Study|Adverse Event|1|||
144352600|NCT00531284|520496398|FG015|Overall Study|Adverse Event|0|||
144352601|NCT00531284|520496399|FG016|Overall Study|Adverse Event|2|||
144352602|NCT00531284|520496383|FG000|Overall Study|Withdrawal by Subject|1|||
144352603|NCT00531284|520496384|FG001|Overall Study|Withdrawal by Subject|0|||
144352604|NCT00531284|520496385|FG002|Overall Study|Withdrawal by Subject|0|||
144352605|NCT00531284|520496386|FG003|Overall Study|Withdrawal by Subject|4|||
144352606|NCT00531284|520496387|FG004|Overall Study|Withdrawal by Subject|0|||
144352607|NCT00531284|520496388|FG005|Overall Study|Withdrawal by Subject|0|||
144352608|NCT00531284|520496389|FG006|Overall Study|Withdrawal by Subject|0|||
144352609|NCT00531284|520496390|FG007|Overall Study|Withdrawal by Subject|0|||
144352610|NCT00531284|520496391|FG008|Overall Study|Withdrawal by Subject|0|||
144352611|NCT00531284|520496392|FG009|Overall Study|Withdrawal by Subject|0|||
144352612|NCT00531284|520496393|FG010|Overall Study|Withdrawal by Subject|0|||
144352613|NCT00531284|520496394|FG011|Overall Study|Withdrawal by Subject|3|||
144352614|NCT00531284|520496395|FG012|Overall Study|Withdrawal by Subject|0|||
144352615|NCT00531284|520496396|FG013|Overall Study|Withdrawal by Subject|1|||
144352616|NCT00531284|520496397|FG014|Overall Study|Withdrawal by Subject|0|||
144352617|NCT00531284|520496398|FG015|Overall Study|Withdrawal by Subject|1|||
144352618|NCT00531284|520496399|FG016|Overall Study|Withdrawal by Subject|1|||
144352619|NCT00531284|520496383|FG000|Overall Study|Other|1|||
144352620|NCT00531284|520496384|FG001|Overall Study|Other|0|||
144352621|NCT00531284|520496385|FG002|Overall Study|Other|0|||
144352622|NCT00531284|520496386|FG003|Overall Study|Other|10|||
144352623|NCT00531284|520496387|FG004|Overall Study|Other|2|||
144352624|NCT00531284|520496388|FG005|Overall Study|Other|1|||
144352625|NCT00531284|520496389|FG006|Overall Study|Other|0|||
144352626|NCT00531284|520496390|FG007|Overall Study|Other|0|||
144352627|NCT00531284|520496391|FG008|Overall Study|Other|2|||
144352628|NCT00531284|520496392|FG009|Overall Study|Other|1|||
144352629|NCT00531284|520496393|FG010|Overall Study|Other|0|||
144352630|NCT00531284|520496394|FG011|Overall Study|Other|2|||
144352631|NCT00531284|520496395|FG012|Overall Study|Other|0|||
144352632|NCT00531284|520496396|FG013|Overall Study|Other|0|||
144352633|NCT00531284|520496397|FG014|Overall Study|Other|1|||
144352634|NCT00531284|520496398|FG015|Overall Study|Other|0|||
144352635|NCT00531284|520496399|FG016|Overall Study|Other|0|||
144352636|NCT02219464|520496401|FG000|Overall Study|Withdrawal by Subject|1|||
144352637|NCT02219464|520496402|FG001|Overall Study|Withdrawal by Subject|0|||
144352638|NCT02219464|520496401|FG000|Overall Study|case cancelled|1|||
144352639|NCT02219464|520496402|FG001|Overall Study|case cancelled|0|||
144352640|NCT02219464|520496401|FG000|Overall Study|catheter malfunction|1|||
144352641|NCT02219464|520496402|FG001|Overall Study|catheter malfunction|0|||
144352642|NCT00984256|520496403|FG000|Overall Study|Withdrawal by Subject|0|||
144352643|NCT00984256|520496404|FG001|Overall Study|Withdrawal by Subject|1|||
144352644|NCT03057496|520496405|FG000|Overall Study|Withdrawal by Subject|8|||
144352645|NCT03057496|520496405|FG000|Overall Study|Lost to Follow-up|5|||
144352646|NCT03057496|520496405|FG000|Overall Study|Did not use device during home trial|3|||
144352647|NCT03057496|520496405|FG000|Overall Study|Device failure|2|||
144352648|NCT00280917|520496409|FG000|Overall Study|Adverse Event|1|||
144352649|NCT00280917|520496410|FG001|Overall Study|Adverse Event|1|||
144352650|NCT00280917|520496411|FG002|Overall Study|Adverse Event|4|||
144352651|NCT00280917|520496412|FG003|Overall Study|Adverse Event|1|||
144352652|NCT00280917|520496409|FG000|Overall Study|Change Therapy|1|||
144352653|NCT00280917|520496410|FG001|Overall Study|Change Therapy|2|||
144352654|NCT00280917|520496411|FG002|Overall Study|Change Therapy|0|||
144352655|NCT00280917|520496412|FG003|Overall Study|Change Therapy|0|||
144352656|NCT00280917|520496409|FG000|Overall Study|Withdrawal by Subject|0|||
144352657|NCT00280917|520496410|FG001|Overall Study|Withdrawal by Subject|2|||
144352658|NCT00280917|520496411|FG002|Overall Study|Withdrawal by Subject|0|||
144352659|NCT00280917|520496412|FG003|Overall Study|Withdrawal by Subject|1|||
144352660|NCT00280917|520496409|FG000|Overall Study|Noncompliance|0|||
144352661|NCT00280917|520496410|FG001|Overall Study|Noncompliance|1|||
144352662|NCT00280917|520496411|FG002|Overall Study|Noncompliance|2|||
144352663|NCT00280917|520496412|FG003|Overall Study|Noncompliance|0|||
144352664|NCT03529110|520496413|FG000|Overall Study|Progressive Disease|66|||
144352665|NCT03529110|520496414|FG001|Overall Study|Progressive Disease|158|||
144352666|NCT03529110|520496413|FG000|Overall Study|Clinical Progression|4|||
144352667|NCT03529110|520496414|FG001|Overall Study|Clinical Progression|12|||
144352668|NCT03529110|520496413|FG000|Overall Study|Adverse Event|35|||
144352669|NCT03529110|520496414|FG001|Overall Study|Adverse Event|17|||
144352670|NCT03529110|520496413|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
144352671|NCT03529110|520496414|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
144352672|NCT03529110|520496413|FG000|Overall Study|Lack of Efficacy|3|||
144352673|NCT03529110|520496414|FG001|Overall Study|Lack of Efficacy|3|||
144352674|NCT03529110|520496413|FG000|Overall Study|Physician Decision|2|||
144352675|NCT03529110|520496414|FG001|Overall Study|Physician Decision|8|||
144352676|NCT03529110|520496413|FG000|Overall Study|Miscellaneous|2|||
144352677|NCT03529110|520496414|FG001|Overall Study|Miscellaneous|5|||
144352678|NCT01584232|520496415|FG000|Overall Study|Adverse Event|3|||
144352679|NCT01584232|520496416|FG001|Overall Study|Adverse Event|1|||
144352680|NCT01584232|520496415|FG000|Overall Study|Withdrawal by Subject|2|||
144352681|NCT01584232|520496416|FG001|Overall Study|Withdrawal by Subject|1|||
144352682|NCT01584232|520496415|FG000|Overall Study|Physician Decision|2|||
144352683|NCT01584232|520496416|FG001|Overall Study|Physician Decision|1|||
144352684|NCT01584232|520496415|FG000|Overall Study|Lost to Follow-up|1|||
144352685|NCT01584232|520496416|FG001|Overall Study|Lost to Follow-up|0|||
144352686|NCT02723773|520496418|FG000|Overall Study|Adverse Event|934|||
144352687|NCT02723773|520496419|FG001|Overall Study|Adverse Event|3|||
144352688|NCT02723773|520496420|FG002|Overall Study|Adverse Event|1|||
144352689|NCT02723773|520496421|FG003|Overall Study|Adverse Event|9|||
144352690|NCT02723773|520496418|FG000|Overall Study|Protocol Violation|1|||
144352691|NCT02723773|520496419|FG001|Overall Study|Protocol Violation|0|||
144352692|NCT02723773|520496420|FG002|Overall Study|Protocol Violation|0|||
144352693|NCT02723773|520496421|FG003|Overall Study|Protocol Violation|0|||
144352694|NCT02723773|520496418|FG000|Overall Study|Withdrawal by Subject|360|||
144352695|NCT02723773|520496419|FG001|Overall Study|Withdrawal by Subject|5|||
144352696|NCT02723773|520496420|FG002|Overall Study|Withdrawal by Subject|6|||
144352697|NCT02723773|520496421|FG003|Overall Study|Withdrawal by Subject|10|||
144352698|NCT02723773|520496418|FG000|Overall Study|Migrated/moved from study area|37|||
144352699|NCT02723773|520496419|FG001|Overall Study|Migrated/moved from study area|0|||
144352700|NCT02723773|520496420|FG002|Overall Study|Migrated/moved from study area|0|||
144352701|NCT02723773|520496421|FG003|Overall Study|Migrated/moved from study area|1|||
144352702|NCT02723773|520496418|FG000|Overall Study|Lost to Follow-up|198|||
144352703|NCT02723773|520496419|FG001|Overall Study|Lost to Follow-up|0|||
144352704|NCT02723773|520496420|FG002|Overall Study|Lost to Follow-up|0|||
144352705|NCT02723773|520496421|FG003|Overall Study|Lost to Follow-up|0|||
144352706|NCT02723773|520496418|FG000|Overall Study|Other|189|||
144352707|NCT02723773|520496419|FG001|Overall Study|Other|1|||
144352708|NCT02723773|520496420|FG002|Overall Study|Other|2|||
144352709|NCT02723773|520496421|FG003|Overall Study|Other|2|||
144352710|NCT00404651|520496432|FG000|Overall Study|Serious Adverse Event|0|||
144352711|NCT00404651|520496433|FG001|Overall Study|Serious Adverse Event|0|||
144352712|NCT00404651|520496434|FG002|Overall Study|Serious Adverse Event|2|||
144352713|NCT00404651|520496435|FG003|Overall Study|Serious Adverse Event|0|||
144352714|NCT00404651|520496432|FG000|Overall Study|Protocol Violation|10|||
144352715|NCT00404651|520496433|FG001|Overall Study|Protocol Violation|5|||
144352716|NCT00404651|520496434|FG002|Overall Study|Protocol Violation|14|||
144352717|NCT00404651|520496435|FG003|Overall Study|Protocol Violation|5|||
144352718|NCT00404651|520496432|FG000|Overall Study|Lost to Follow-up|15|||
144352719|NCT00404651|520496433|FG001|Overall Study|Lost to Follow-up|11|||
144352720|NCT00404651|520496434|FG002|Overall Study|Lost to Follow-up|13|||
144352721|NCT00404651|520496435|FG003|Overall Study|Lost to Follow-up|10|||
144352722|NCT00404651|520496432|FG000|Overall Study|Withdrawal by Subject|14|||
144352723|NCT00404651|520496433|FG001|Overall Study|Withdrawal by Subject|12|||
144352724|NCT00404651|520496434|FG002|Overall Study|Withdrawal by Subject|16|||
144352725|NCT00404651|520496435|FG003|Overall Study|Withdrawal by Subject|6|||
144352726|NCT01121146|520496447|FG000|Overall Study|Death|17|||
144352727|NCT01121146|520496448|FG001|Overall Study|Death|15|||
144352728|NCT01121146|520496447|FG000|Overall Study|Adverse Event|2|||
144352729|NCT01121146|520496448|FG001|Overall Study|Adverse Event|11|||
144352730|NCT01121146|520496447|FG000|Overall Study|Lost to Follow-up|7|||
144352731|NCT01121146|520496448|FG001|Overall Study|Lost to Follow-up|16|||
144352732|NCT01132807|520496452|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
144352733|NCT01132807|520496453|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
144352734|NCT01132807|520496454|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
144352735|NCT01132807|520496452|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
144352736|NCT01132807|520496453|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
144352737|NCT01132807|520496454|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
144352738|NCT05030350|520496457|FG000|Overall Study|Adverse Event|13|||
144352739|NCT05030350|520496457|FG000|Overall Study|Lack of Efficacy|8|||
144352740|NCT05030350|520496457|FG000|Overall Study|Lost to Follow-up|35|||
144352741|NCT05030350|520496457|FG000|Overall Study|Pregnancy|2|||
144352742|NCT05030350|520496457|FG000|Overall Study|Protocol Violation|2|||
144352743|NCT05030350|520496457|FG000|Overall Study|Withdrawal by Subject|60|||
144352744|NCT05030350|520496457|FG000|Overall Study|Study terminated by sponsor|349|||
144352745|NCT05030350|520496457|FG000|Overall Study|Positive Drug Screen|4|||
144352746|NCT05030350|520496457|FG000|Overall Study|Other|8|||
144352747|NCT02711137|520496458|FG000|Overall Study|Death|1|||
144352748|NCT02711137|520496459|FG001|Overall Study|Death|4|||
144352749|NCT02711137|520496460|FG002|Overall Study|Death|5|||
144352750|NCT02711137|520496461|FG003|Overall Study|Death|5|||
144352751|NCT02711137|520496462|FG004|Overall Study|Death|3|||
144352752|NCT02711137|520496463|FG005|Overall Study|Death|1|||
144352753|NCT02711137|520496464|FG006|Overall Study|Death|61|||
144352754|NCT02711137|520496465|FG007|Overall Study|Death|3|||
144352755|NCT02711137|520496466|FG008|Overall Study|Death|0|||
144352756|NCT02711137|520496467|FG009|Overall Study|Death|1|||
144352757|NCT02711137|520496468|FG010|Overall Study|Death|1|||
144352758|NCT02711137|520496469|FG011|Overall Study|Death|1|||
144352759|NCT02711137|520496470|FG012|Overall Study|Death|0|||
144352760|NCT02711137|520496471|FG013|Overall Study|Death|0|||
144352761|NCT02711137|520496472|FG014|Overall Study|Death|0|||
144352762|NCT02711137|520496458|FG000|Overall Study|Study Terminated by Sponsor|0|||
144352763|NCT02711137|520496459|FG001|Overall Study|Study Terminated by Sponsor|0|||
144352764|NCT02711137|520496460|FG002|Overall Study|Study Terminated by Sponsor|1|||
144352765|NCT02711137|520496461|FG003|Overall Study|Study Terminated by Sponsor|0|||
144352766|NCT02711137|520496462|FG004|Overall Study|Study Terminated by Sponsor|0|||
144352767|NCT02711137|520496463|FG005|Overall Study|Study Terminated by Sponsor|0|||
144352768|NCT02711137|520496464|FG006|Overall Study|Study Terminated by Sponsor|1|||
144352769|NCT02711137|520496465|FG007|Overall Study|Study Terminated by Sponsor|0|||
144352770|NCT02711137|520496466|FG008|Overall Study|Study Terminated by Sponsor|0|||
144352771|NCT02711137|520496467|FG009|Overall Study|Study Terminated by Sponsor|0|||
144352772|NCT02711137|520496468|FG010|Overall Study|Study Terminated by Sponsor|0|||
144352773|NCT02711137|520496469|FG011|Overall Study|Study Terminated by Sponsor|0|||
144352774|NCT02711137|520496470|FG012|Overall Study|Study Terminated by Sponsor|0|||
144352775|NCT02711137|520496471|FG013|Overall Study|Study Terminated by Sponsor|0|||
144352776|NCT02711137|520496472|FG014|Overall Study|Study Terminated by Sponsor|0|||
144352777|NCT02711137|520496458|FG000|Overall Study|Physician Decision|1|||
144352778|NCT02711137|520496459|FG001|Overall Study|Physician Decision|0|||
144352779|NCT02711137|520496460|FG002|Overall Study|Physician Decision|2|||
144352780|NCT02711137|520496461|FG003|Overall Study|Physician Decision|1|||
144352781|NCT02711137|520496462|FG004|Overall Study|Physician Decision|1|||
144352782|NCT02711137|520496463|FG005|Overall Study|Physician Decision|0|||
144352783|NCT02711137|520496464|FG006|Overall Study|Physician Decision|12|||
144352784|NCT02711137|520496465|FG007|Overall Study|Physician Decision|2|||
144352785|NCT02711137|520496466|FG008|Overall Study|Physician Decision|1|||
144352786|NCT02711137|520496467|FG009|Overall Study|Physician Decision|1|||
144352787|NCT02711137|520496468|FG010|Overall Study|Physician Decision|3|||
144352788|NCT02711137|520496469|FG011|Overall Study|Physician Decision|2|||
144352789|NCT02711137|520496470|FG012|Overall Study|Physician Decision|1|||
144352790|NCT02711137|520496471|FG013|Overall Study|Physician Decision|1|||
144352791|NCT02711137|520496472|FG014|Overall Study|Physician Decision|2|||
144352792|NCT02711137|520496458|FG000|Overall Study|Other|0|||
144352793|NCT02711137|520496459|FG001|Overall Study|Other|1|||
144352794|NCT02711137|520496460|FG002|Overall Study|Other|0|||
144352795|NCT02711137|520496461|FG003|Overall Study|Other|0|||
144352796|NCT02711137|520496462|FG004|Overall Study|Other|0|||
144352797|NCT02711137|520496463|FG005|Overall Study|Other|0|||
144352798|NCT02711137|520496464|FG006|Overall Study|Other|3|||
144352799|NCT02711137|520496465|FG007|Overall Study|Other|0|||
144352800|NCT02711137|520496466|FG008|Overall Study|Other|0|||
144352801|NCT02711137|520496467|FG009|Overall Study|Other|0|||
144352802|NCT02711137|520496468|FG010|Overall Study|Other|0|||
144352803|NCT02711137|520496469|FG011|Overall Study|Other|0|||
144352804|NCT02711137|520496470|FG012|Overall Study|Other|0|||
144352805|NCT02711137|520496471|FG013|Overall Study|Other|0|||
144352806|NCT02711137|520496472|FG014|Overall Study|Other|1|||
144352807|NCT02711137|520496458|FG000|Overall Study|Withdrawal by Subject|1|||
144352808|NCT02711137|520496459|FG001|Overall Study|Withdrawal by Subject|0|||
144352809|NCT02711137|520496460|FG002|Overall Study|Withdrawal by Subject|0|||
144352810|NCT02711137|520496461|FG003|Overall Study|Withdrawal by Subject|1|||
144352811|NCT02711137|520496462|FG004|Overall Study|Withdrawal by Subject|1|||
144352812|NCT02711137|520496463|FG005|Overall Study|Withdrawal by Subject|0|||
144352813|NCT02711137|520496464|FG006|Overall Study|Withdrawal by Subject|7|||
144352814|NCT02711137|520496465|FG007|Overall Study|Withdrawal by Subject|0|||
144352815|NCT02711137|520496466|FG008|Overall Study|Withdrawal by Subject|0|||
144352816|NCT02711137|520496467|FG009|Overall Study|Withdrawal by Subject|0|||
144352817|NCT02711137|520496468|FG010|Overall Study|Withdrawal by Subject|0|||
144352818|NCT02711137|520496469|FG011|Overall Study|Withdrawal by Subject|0|||
144352819|NCT02711137|520496470|FG012|Overall Study|Withdrawal by Subject|0|||
144352820|NCT02711137|520496471|FG013|Overall Study|Withdrawal by Subject|1|||
144352821|NCT02711137|520496472|FG014|Overall Study|Withdrawal by Subject|0|||
144352822|NCT02711137|520496458|FG000|Overall Study|Lost to Follow-up|1|||
144352823|NCT02711137|520496459|FG001|Overall Study|Lost to Follow-up|0|||
144352824|NCT02711137|520496460|FG002|Overall Study|Lost to Follow-up|0|||
144352825|NCT02711137|520496461|FG003|Overall Study|Lost to Follow-up|0|||
144352826|NCT02711137|520496462|FG004|Overall Study|Lost to Follow-up|0|||
144352827|NCT02711137|520496463|FG005|Overall Study|Lost to Follow-up|0|||
144352828|NCT02711137|520496464|FG006|Overall Study|Lost to Follow-up|2|||
144352829|NCT02711137|520496465|FG007|Overall Study|Lost to Follow-up|0|||
144352830|NCT02711137|520496466|FG008|Overall Study|Lost to Follow-up|0|||
144352831|NCT02711137|520496467|FG009|Overall Study|Lost to Follow-up|0|||
144352832|NCT02711137|520496468|FG010|Overall Study|Lost to Follow-up|0|||
144352833|NCT02711137|520496469|FG011|Overall Study|Lost to Follow-up|0|||
144352834|NCT02711137|520496470|FG012|Overall Study|Lost to Follow-up|0|||
144352835|NCT02711137|520496471|FG013|Overall Study|Lost to Follow-up|0|||
144352836|NCT02711137|520496472|FG014|Overall Study|Lost to Follow-up|0|||
144352837|NCT00742183|520496475|FG000|Overall Study|Adverse Event|2|||
144352838|NCT00742183|520496476|FG001|Overall Study|Adverse Event|2|||
144352839|NCT00742183|520496475|FG000|Overall Study|Death|1|||
144352840|NCT00742183|520496476|FG001|Overall Study|Death|0|||
144352841|NCT00742183|520496475|FG000|Overall Study|Physician Decision|0|||
144352842|NCT00742183|520496476|FG001|Overall Study|Physician Decision|2|||
144352843|NCT00742183|520496475|FG000|Overall Study|Lost to Follow-up|4|||
144352844|NCT00742183|520496476|FG001|Overall Study|Lost to Follow-up|4|||
144352845|NCT00742183|520496475|FG000|Overall Study|Required skin-graft|1|||
144352846|NCT00742183|520496476|FG001|Overall Study|Required skin-graft|1|||
144352847|NCT00742183|520496475|FG000|Overall Study|Withdrawal by Subject|1|||
144352848|NCT00742183|520496476|FG001|Overall Study|Withdrawal by Subject|0|||
144352849|NCT00742183|520496475|FG000|Overall Study|Lack of Efficacy|0|||
144352850|NCT00742183|520496476|FG001|Overall Study|Lack of Efficacy|3|||
144352851|NCT03922581|520496481|FG000|Overall Study|Lost to Follow-up|20|||
144352852|NCT03922581|520496482|FG001|Overall Study|Lost to Follow-up|9|||
144352853|NCT03922581|520496481|FG000|Overall Study|Physician Decision|1|||
144352854|NCT03922581|520496482|FG001|Overall Study|Physician Decision|1|||
144352855|NCT03922581|520496481|FG000|Overall Study|Withdrawal by Subject|1|||
144352856|NCT03922581|520496482|FG001|Overall Study|Withdrawal by Subject|0|||
144352857|NCT00764699|520496483|FG000|Overall Study|PI left and study terminated|3|||
144352858|NCT01508312|520496484|FG000|Overall Study|Lost to Follow-up|1|||
144352859|NCT01508312|520496485|FG001|Overall Study|Lost to Follow-up|0|||
144352860|NCT01508312|520496486|FG002|Overall Study|Lost to Follow-up|0|||
144352861|NCT01508312|520496487|FG003|Overall Study|Lost to Follow-up|0|||
144352862|NCT01508312|520496484|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
144352863|NCT01508312|520496485|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
144352864|NCT01508312|520496486|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
144352865|NCT01508312|520496487|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
144352866|NCT01508312|520496484|FG000|Overall Study|Adverse Event|0|||
144352867|NCT01508312|520496485|FG001|Overall Study|Adverse Event|0|||
144352868|NCT01508312|520496486|FG002|Overall Study|Adverse Event|2|||
144352869|NCT01508312|520496487|FG003|Overall Study|Adverse Event|0|||
144352870|NCT01508312|520496484|FG000|Overall Study|Lack of Efficacy|0|||
144352871|NCT01508312|520496485|FG001|Overall Study|Lack of Efficacy|0|||
144352872|NCT01508312|520496486|FG002|Overall Study|Lack of Efficacy|1|||
144352873|NCT01508312|520496487|FG003|Overall Study|Lack of Efficacy|0|||
144352874|NCT01508312|520496484|FG000|Overall Study|Withdrawal by Subject|0|||
144352875|NCT01508312|520496485|FG001|Overall Study|Withdrawal by Subject|0|||
144352876|NCT01508312|520496486|FG002|Overall Study|Withdrawal by Subject|1|||
144352877|NCT01508312|520496487|FG003|Overall Study|Withdrawal by Subject|0|||
144352878|NCT02223715|520496488|FG000|Overall Study|Death|31|||
144352879|NCT02223715|520496488|FG000|Overall Study|Lost to Follow-up|73|||
144352880|NCT01745367|520496489|FG000|Overall Study|Death|1|||
144352881|NCT01745367|520496490|FG001|Overall Study|Death|0|||
144352882|NCT01745367|520496489|FG000|Overall Study|Withdrawal by Subject|1|||
144352883|NCT01745367|520496490|FG001|Overall Study|Withdrawal by Subject|2|||
144352884|NCT01745367|520496489|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
144352885|NCT01745367|520496490|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
144352886|NCT01745367|520496489|FG000|Overall Study|Other Reasons Unspecified|0|||
144352887|NCT01745367|520496490|FG001|Overall Study|Other Reasons Unspecified|2|||
144352888|NCT03906071|520496493|FG000|Overall Study|Death|180|||
144352889|NCT03906071|520496494|FG001|Overall Study|Death|185|||
144352890|NCT03906071|520496493|FG000|Overall Study|Lost to Follow-up|3|||
144352891|NCT03906071|520496494|FG001|Overall Study|Lost to Follow-up|3|||
144352892|NCT03906071|520496493|FG000|Overall Study|Withdrawal by Subject|15|||
144352893|NCT03906071|520496494|FG001|Overall Study|Withdrawal by Subject|27|||
144352894|NCT03906071|520496493|FG000|Overall Study|Other|2|||
144352895|NCT03906071|520496494|FG001|Overall Study|Other|1|||
144352896|NCT04445662|520496498|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
144352897|NCT04445662|520496499|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
144352898|NCT04445662|520496498|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
144352899|NCT04445662|520496499|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
144352900|NCT04445662|520496498|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
144352901|NCT04445662|520496499|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
144352902|NCT04445662|520496498|FG000|Post-treatment (12-24 weeks)|Death|1|||
144352903|NCT04445662|520496499|FG001|Post-treatment (12-24 weeks)|Death|0|||
144352904|NCT01332994|520496500|FG000|Overall Study|Adverse Event|34|||
144352905|NCT01332994|520496500|FG000|Overall Study|Death|1|||
144352906|NCT01332994|520496500|FG000|Overall Study|Lack of Efficacy|1|||
144352907|NCT01332994|520496500|FG000|Overall Study|Lost to Follow-up|4|||
144352908|NCT01332994|520496500|FG000|Overall Study|Protocol Violation|6|||
144352909|NCT01332994|520496500|FG000|Overall Study|Withdrawal by Subject|15|||
144352910|NCT01332994|520496500|FG000|Overall Study|Administrative Problem|2|||
144352911|NCT01332994|520496500|FG000|Overall Study|Other|8|||
144352912|NCT00279916|520496501|FG000|Overall Study|Withdrawal by Subject|4|||
144352913|NCT00279916|520496502|FG001|Overall Study|Withdrawal by Subject|3|||
144352914|NCT00279916|520496501|FG000|Overall Study|Lost to Follow-up|3|||
144352915|NCT00279916|520496502|FG001|Overall Study|Lost to Follow-up|2|||
144352916|NCT00731679|520496506|FG000|Overall Study|Adverse Event|7|||
144352917|NCT00731679|520496507|FG001|Overall Study|Adverse Event|8|||
144352918|NCT00731679|520496506|FG000|Overall Study|Withdrawal by Subject|8|||
144352919|NCT00731679|520496507|FG001|Overall Study|Withdrawal by Subject|8|||
144352920|NCT00731679|520496506|FG000|Overall Study|Lost to Follow-up|7|||
144352921|NCT00731679|520496507|FG001|Overall Study|Lost to Follow-up|8|||
144352922|NCT00731679|520496506|FG000|Overall Study|Noncompliance|0|||
144352923|NCT00731679|520496507|FG001|Overall Study|Noncompliance|1|||
144352924|NCT00731679|520496506|FG000|Overall Study|Pregnancy|0|||
144352925|NCT00731679|520496507|FG001|Overall Study|Pregnancy|1|||
144352926|NCT02488005|520496508|FG000|Overall Study|Lost to Follow-up|2|||
144352927|NCT03384940|520496509|FG000|Overall Study|Progressive disease|36|||
144352928|NCT03384940|520496510|FG001|Overall Study|Progressive disease|11|||
144352929|NCT03384940|520496511|FG002|Overall Study|Progressive disease|13|||
144352930|NCT03384940|520496509|FG000|Overall Study|Clinical progression|4|||
144352931|NCT03384940|520496510|FG001|Overall Study|Clinical progression|0|||
144352932|NCT03384940|520496511|FG002|Overall Study|Clinical progression|3|||
144352933|NCT03384940|520496509|FG000|Overall Study|Adverse Event|7|||
144352934|NCT03384940|520496510|FG001|Overall Study|Adverse Event|1|||
144352935|NCT03384940|520496511|FG002|Overall Study|Adverse Event|1|||
144352936|NCT03384940|520496509|FG000|Overall Study|Withdrawal by Subject|3|||
144352937|NCT03384940|520496510|FG001|Overall Study|Withdrawal by Subject|1|||
144352938|NCT03384940|520496511|FG002|Overall Study|Withdrawal by Subject|0|||
144352939|NCT03384940|520496509|FG000|Overall Study|Physician Decision|1|||
144352940|NCT03384940|520496510|FG001|Overall Study|Physician Decision|1|||
144352941|NCT03384940|520496511|FG002|Overall Study|Physician Decision|0|||
144352942|NCT03384940|520496509|FG000|Overall Study|Death|2|||
144352943|NCT03384940|520496510|FG001|Overall Study|Death|1|||
144352944|NCT03384940|520496511|FG002|Overall Study|Death|0|||
144352945|NCT03384940|520496509|FG000|Overall Study|Other|0|||
144352946|NCT03384940|520496510|FG001|Overall Study|Other|0|||
144352947|NCT03384940|520496511|FG002|Overall Study|Other|1|||
144352948|NCT03087513|520496512|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
144352949|NCT01987102|520496513|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
144352950|NCT01987102|520496514|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
144352951|NCT01987102|520496513|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
144352952|NCT01987102|520496514|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
144352953|NCT01987102|520496513|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
144352954|NCT01987102|520496514|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
144352955|NCT01987102|520496513|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
144352956|NCT01987102|520496514|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
144352957|NCT01987102|520496513|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
144352958|NCT01987102|520496514|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
144352959|NCT01987102|520496513|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
144352960|NCT01987102|520496514|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
144352961|NCT05081219|520496515|FG000|Overall Study|Withdrawal by Subject|4|||
144352962|NCT05081219|520496516|FG001|Overall Study|Withdrawal by Subject|0|||
144352963|NCT05081219|520496517|FG002|Overall Study|Withdrawal by Subject|0|||
144352964|NCT05081219|520496518|FG003|Overall Study|Withdrawal by Subject|1|||
144352965|NCT04896593|520496522|FG000|Overall Study|Withdrawal by Subject|2|||
144352966|NCT04896593|520496522|FG000|Overall Study|Lost to Follow-up|1|||
144352967|NCT04896593|520496522|FG000|Overall Study|Did not complete onboarding|2|||
144352968|NCT00452790|520496523|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
144352969|NCT00452790|520496524|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
144352970|NCT00452790|520496523|FG000|Infant Series|Parent/legal guardian request|8|||
144352971|NCT00452790|520496524|FG001|Infant Series|Parent/legal guardian request|6|||
144352972|NCT00452790|520496523|FG000|Infant Series|Failed to return|4|||
144352973|NCT00452790|520496524|FG001|Infant Series|Failed to return|1|||
144352974|NCT00452790|520496523|FG000|Infant Series|Protocol Violation|1|||
144352975|NCT00452790|520496524|FG001|Infant Series|Protocol Violation|3|||
144352976|NCT00452790|520496523|FG000|Infant Series|Lost to Follow-up|2|||
144352977|NCT00452790|520496524|FG001|Infant Series|Lost to Follow-up|2|||
144352978|NCT00452790|520496523|FG000|Infant Series|Adverse Event|1|||
144352979|NCT00452790|520496524|FG001|Infant Series|Adverse Event|2|||
144352980|NCT00452790|520496523|FG000|Infant Series|Other reasons|1|||
144352981|NCT00452790|520496524|FG001|Infant Series|Other reasons|2|||
144352982|NCT00452790|520496523|FG000|Infant Series|Investigator request|0|||
144352983|NCT00452790|520496524|FG001|Infant Series|Investigator request|1|||
144352984|NCT00452790|520496523|FG000|Infant Series|Death|0|||
144352985|NCT00452790|520496524|FG001|Infant Series|Death|1|||
144352986|NCT00452790|520496523|FG000|After Infant Series|Investigator request|10|||
144352987|NCT00452790|520496524|FG001|After Infant Series|Investigator request|10|||
144352988|NCT00452790|520496523|FG000|After Infant Series|Adverse Event|4|||
144352989|NCT00452790|520496524|FG001|After Infant Series|Adverse Event|1|||
144352990|NCT00452790|520496523|FG000|After Infant Series|Parent/legal guardian request|1|||
144352991|NCT00452790|520496524|FG001|After Infant Series|Parent/legal guardian request|3|||
144352992|NCT00452790|520496523|FG000|After Infant Series|Lost to Follow-up|4|||
144352993|NCT00452790|520496524|FG001|After Infant Series|Lost to Follow-up|0|||
144352994|NCT00452790|520496523|FG000|After Infant Series|Failed to return|1|||
144352995|NCT00452790|520496524|FG001|After Infant Series|Failed to return|0|||
144352996|NCT00452790|520496523|FG000|After Infant Series|Other reasons|1|||
144352997|NCT00452790|520496524|FG001|After Infant Series|Other reasons|0|||
144352998|NCT00452790|520496523|FG000|Toddler Dose|Failed to return|0|||
144352999|NCT00452790|520496524|FG001|Toddler Dose|Failed to return|1|||
144353000|NCT00452790|520496523|FG000|Toddler Dose|Parent/legal guardian request|0|||
144353001|NCT00452790|520496524|FG001|Toddler Dose|Parent/legal guardian request|1|||
144353002|NCT04177212|520496528|FG000|Overall Study|Withdrawal by Subject|9|||
144353003|NCT04177212|520496529|FG001|Overall Study|Withdrawal by Subject|7|||
144353004|NCT04177212|520496528|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
144353005|NCT04177212|520496529|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
144353006|NCT04177212|520496528|FG000|Overall Study|Physician Decision|1|||
144353007|NCT04177212|520496529|FG001|Overall Study|Physician Decision|0|||
144353008|NCT04177212|520496528|FG000|Overall Study|Lost to Follow-up|0|||
144353009|NCT04177212|520496529|FG001|Overall Study|Lost to Follow-up|3|||
144353010|NCT04177212|520496528|FG000|Overall Study|Adverse Event|0|||
144353011|NCT04177212|520496529|FG001|Overall Study|Adverse Event|1|||
144353012|NCT04177212|520496528|FG000|Overall Study|Other|1|||
144353013|NCT04177212|520496529|FG001|Overall Study|Other|2|||
144353014|NCT01279681|520496530|FG000|Overall Study|Disease Progression|9|||
144353015|NCT01279681|520496531|FG001|Overall Study|Disease Progression|6|||
144353016|NCT01279681|520496530|FG000|Overall Study|Withdrawal by Subject|3|||
144353017|NCT01279681|520496531|FG001|Overall Study|Withdrawal by Subject|4|||
144353018|NCT01279681|520496530|FG000|Overall Study|Adverse Event|2|||
144353019|NCT01279681|520496531|FG001|Overall Study|Adverse Event|3|||
144353020|NCT01279681|520496530|FG000|Overall Study|Death|0|||
144353021|NCT01279681|520496531|FG001|Overall Study|Death|1|||
144353022|NCT01279681|520496530|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
144353023|NCT01279681|520496531|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
144353024|NCT01279681|520496530|FG000|Overall Study|Physician Decision|1|||
144353025|NCT01279681|520496531|FG001|Overall Study|Physician Decision|0|||
144353026|NCT01279681|520496530|FG000|Overall Study|Other Reason|0|||
144353027|NCT01279681|520496531|FG001|Overall Study|Other Reason|2|||
144353028|NCT02796677|520498233|FG000|Overall Study|Adverse Event|11|||
144353029|NCT02796677|520498234|FG001|Overall Study|Adverse Event|22|||
144353030|NCT02796677|520498235|FG002|Overall Study|Adverse Event|14|||
144353031|NCT02796677|520498236|FG003|Overall Study|Adverse Event|14|||
144353032|NCT02796677|520498233|FG000|Overall Study|Protocol Violation|7|||
144353033|NCT02796677|520498234|FG001|Overall Study|Protocol Violation|5|||
144353034|NCT02796677|520498235|FG002|Overall Study|Protocol Violation|4|||
144353035|NCT02796677|520498236|FG003|Overall Study|Protocol Violation|8|||
144353036|NCT02796677|520498233|FG000|Overall Study|Lost to Follow-up|1|||
144353037|NCT02796677|520498234|FG001|Overall Study|Lost to Follow-up|5|||
144353038|NCT02796677|520498235|FG002|Overall Study|Lost to Follow-up|2|||
144353039|NCT02796677|520498236|FG003|Overall Study|Lost to Follow-up|2|||
144353040|NCT02796677|520498233|FG000|Overall Study|Lack of Efficacy|7|||
144353041|NCT02796677|520498234|FG001|Overall Study|Lack of Efficacy|9|||
144353042|NCT02796677|520498235|FG002|Overall Study|Lack of Efficacy|14|||
144353043|NCT02796677|520498236|FG003|Overall Study|Lack of Efficacy|20|||
144353044|NCT02796677|520498233|FG000|Overall Study|Withdrawal by Subject|4|||
144353045|NCT02796677|520498234|FG001|Overall Study|Withdrawal by Subject|14|||
144353046|NCT02796677|520498235|FG002|Overall Study|Withdrawal by Subject|6|||
144353047|NCT02796677|520498236|FG003|Overall Study|Withdrawal by Subject|7|||
144353048|NCT02796677|520498233|FG000|Overall Study|Progressive disease|6|||
144353049|NCT02796677|520498234|FG001|Overall Study|Progressive disease|15|||
144353050|NCT02796677|520498235|FG002|Overall Study|Progressive disease|13|||
144353051|NCT02796677|520498236|FG003|Overall Study|Progressive disease|18|||
144353052|NCT02796677|520498233|FG000|Overall Study|Reason not mentioned|2|||
144353053|NCT02796677|520498234|FG001|Overall Study|Reason not mentioned|3|||
144353054|NCT02796677|520498235|FG002|Overall Study|Reason not mentioned|0|||
144353055|NCT02796677|520498236|FG003|Overall Study|Reason not mentioned|5|||
144353056|NCT03798717|520498237|FG000|Overall Study|Failed Screening|0|||
144353057|NCT03798717|520498238|FG001|Overall Study|Failed Screening|0|||
144353058|NCT03798717|520498239|FG002|Overall Study|Failed Screening|0|||
144353059|NCT03798717|520498240|FG003|Overall Study|Failed Screening|0|||
144353060|NCT03798717|520498241|FG004|Overall Study|Failed Screening|0|||
144353061|NCT03798717|520498242|FG005|Overall Study|Failed Screening|1|||
144353062|NCT03798717|520498237|FG000|Overall Study|Physician Decision|1|||
144353063|NCT03798717|520498238|FG001|Overall Study|Physician Decision|0|||
144353064|NCT03798717|520498239|FG002|Overall Study|Physician Decision|1|||
144353065|NCT03798717|520498240|FG003|Overall Study|Physician Decision|0|||
144353066|NCT03798717|520498241|FG004|Overall Study|Physician Decision|0|||
144353067|NCT03798717|520498242|FG005|Overall Study|Physician Decision|0|||
144353068|NCT03798717|520498237|FG000|Overall Study|Withdrawal by Subject|0|||
144353069|NCT03798717|520498238|FG001|Overall Study|Withdrawal by Subject|0|||
144353070|NCT03798717|520498239|FG002|Overall Study|Withdrawal by Subject|0|||
144353071|NCT03798717|520498240|FG003|Overall Study|Withdrawal by Subject|1|||
144353072|NCT03798717|520498241|FG004|Overall Study|Withdrawal by Subject|0|||
144353073|NCT03798717|520498242|FG005|Overall Study|Withdrawal by Subject|0|||
144353074|NCT03798717|520498237|FG000|Overall Study|Lost to Follow-up|1|||
144353075|NCT03798717|520498238|FG001|Overall Study|Lost to Follow-up|0|||
144353076|NCT03798717|520498239|FG002|Overall Study|Lost to Follow-up|0|||
144353077|NCT03798717|520498240|FG003|Overall Study|Lost to Follow-up|1|||
144353078|NCT03798717|520498241|FG004|Overall Study|Lost to Follow-up|0|||
144353079|NCT03798717|520498242|FG005|Overall Study|Lost to Follow-up|0|||
144353080|NCT03798717|520498237|FG000|Overall Study|Adverse Event|0|||
144353081|NCT03798717|520498238|FG001|Overall Study|Adverse Event|1|||
144353082|NCT03798717|520498239|FG002|Overall Study|Adverse Event|0|||
144353083|NCT03798717|520498240|FG003|Overall Study|Adverse Event|0|||
144353084|NCT03798717|520498241|FG004|Overall Study|Adverse Event|0|||
144353085|NCT03798717|520498242|FG005|Overall Study|Adverse Event|0|||
144353086|NCT03798717|520498237|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
144353087|NCT03798717|520498238|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
144353088|NCT03798717|520498239|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
144353089|NCT03798717|520498240|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
144353090|NCT03798717|520498241|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
144353091|NCT03798717|520498242|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
144353092|NCT04002960|520498244|FG000|Overall Study|Withdrawn prior to Completion|2|||
144353093|NCT00961181|520498247|FG000|Overall Study|Death|2|||
144353094|NCT00961181|520498247|FG000|Overall Study|Withdrawal by Subject|2|||
144353095|NCT00961181|520498247|FG000|Overall Study|Lost to Follow-up|1|||
144353096|NCT01777308|520498250|FG000|Overall Study|Withdrawal by Subject|5|||
144353097|NCT01777308|520498251|FG001|Overall Study|Withdrawal by Subject|1|||
144353098|NCT01777308|520498250|FG000|Overall Study|Migrated/moved from study area|1|||
144353099|NCT01777308|520498251|FG001|Overall Study|Migrated/moved from study area|0|||
144353100|NCT01777308|520498250|FG000|Overall Study|Lost to Follow-up|7|||
144353101|NCT01777308|520498251|FG001|Overall Study|Lost to Follow-up|2|||
144353102|NCT01777308|520498250|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
144353103|NCT01777308|520498251|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
144353104|NCT03212326|520498253|FG000|Overall Study|Physician Decision|4|||
144353105|NCT00985673|520498254|FG000|Overall Study|Lost to Follow-up|6|||
144353106|NCT00985673|520498255|FG001|Overall Study|Lost to Follow-up|7|||
144353107|NCT00985673|520498256|FG002|Overall Study|Lost to Follow-up|6|||
144353108|NCT00985673|520498257|FG003|Overall Study|Lost to Follow-up|10|||
144353109|NCT00985673|520498258|FG004|Overall Study|Lost to Follow-up|5|||
144353110|NCT00985673|520498259|FG005|Overall Study|Lost to Follow-up|3|||
144353111|NCT00985673|520498254|FG000|Overall Study|Withdrawal by Subject|0|||
144353112|NCT00985673|520498255|FG001|Overall Study|Withdrawal by Subject|4|||
144353113|NCT00985673|520498256|FG002|Overall Study|Withdrawal by Subject|5|||
144353114|NCT00985673|520498257|FG003|Overall Study|Withdrawal by Subject|2|||
144353115|NCT00985673|520498258|FG004|Overall Study|Withdrawal by Subject|2|||
144353116|NCT00985673|520498259|FG005|Overall Study|Withdrawal by Subject|3|||
144353117|NCT00985673|520498254|FG000|Overall Study|Other|1|||
144353118|NCT00985673|520498255|FG001|Overall Study|Other|0|||
144353119|NCT00985673|520498256|FG002|Overall Study|Other|1|||
144353120|NCT00985673|520498257|FG003|Overall Study|Other|0|||
144353121|NCT00985673|520498258|FG004|Overall Study|Other|1|||
144353122|NCT00985673|520498259|FG005|Overall Study|Other|0|||
144353123|NCT03493945|520498260|FG000|Phase I Dose Escalation|Ineligible|0|||
144353124|NCT03493945|520498261|FG001|Phase I Dose Escalation|Ineligible|0|||
144353125|NCT03493945|520498262|FG002|Phase I Dose Escalation|Ineligible|1|||
144353126|NCT03493945|520498263|FG003|Phase I Dose Escalation|Ineligible|0|||
144353127|NCT03493945|520498264|FG004|Phase I Dose Escalation|Ineligible|0|||
144353128|NCT03493945|520498265|FG005|Phase I Dose Escalation|Ineligible|0|||
144353129|NCT03493945|520498266|FG006|Phase I Dose Escalation|Ineligible|0|||
144353130|NCT03493945|520498260|FG000|Phase I Dose Escalation|New therapy|0|||
144353131|NCT03493945|520498261|FG001|Phase I Dose Escalation|New therapy|1|||
144353132|NCT03493945|520498262|FG002|Phase I Dose Escalation|New therapy|0|||
144353133|NCT03493945|520498263|FG003|Phase I Dose Escalation|New therapy|0|||
144353134|NCT03493945|520498264|FG004|Phase I Dose Escalation|New therapy|0|||
144353135|NCT03493945|520498265|FG005|Phase I Dose Escalation|New therapy|0|||
144353136|NCT03493945|520498266|FG006|Phase I Dose Escalation|New therapy|0|||
144353137|NCT03493945|520498260|FG000|Phase II Dose Expansion|Refused further treatment|0|||
144353138|NCT03493945|520498261|FG001|Phase II Dose Expansion|Refused further treatment|0|||
144353139|NCT03493945|520498262|FG002|Phase II Dose Expansion|Refused further treatment|0|||
144353140|NCT03493945|520498263|FG003|Phase II Dose Expansion|Refused further treatment|0|||
144353141|NCT03493945|520498264|FG004|Phase II Dose Expansion|Refused further treatment|1|||
144353142|NCT03493945|520498265|FG005|Phase II Dose Expansion|Refused further treatment|1|||
144353143|NCT03493945|520498266|FG006|Phase II Dose Expansion|Refused further treatment|0|||
144353144|NCT03493945|520498260|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
144353145|NCT03493945|520498261|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
144353146|NCT03493945|520498262|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
144353147|NCT03493945|520498263|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
144353148|NCT03493945|520498264|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
144353149|NCT03493945|520498265|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
144353150|NCT03493945|520498266|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
144353151|NCT01517750|520498267|FG000|Overall Study|Lost to Follow-up|1|||
144353152|NCT01517750|520498268|FG001|Overall Study|Lost to Follow-up|2|||
144353153|NCT01517750|520498269|FG002|Overall Study|Lost to Follow-up|4|||
144353154|NCT01517750|520498270|FG003|Overall Study|Lost to Follow-up|1|||
144353155|NCT04388111|520498271|FG000|Overall Study|Lost to Follow-up|5|||
144353156|NCT04388111|520498272|FG001|Overall Study|Lost to Follow-up|3|||
144353157|NCT04388111|520498271|FG000|Overall Study|Adverse Event|1|||
144353158|NCT04388111|520498272|FG001|Overall Study|Adverse Event|1|||
144353159|NCT04388111|520498271|FG000|Overall Study|Protocol Violation|2|||
144353160|NCT04388111|520498272|FG001|Overall Study|Protocol Violation|4|||
144353161|NCT04388111|520498271|FG000|Overall Study|Withdrawal by Subject|1|||
144353162|NCT04388111|520498272|FG001|Overall Study|Withdrawal by Subject|0|||
144353163|NCT02735239|520498273|FG000|Overall Study|Adverse Event|0|||
144353164|NCT02735239|520498274|FG001|Overall Study|Adverse Event|0|||
144353165|NCT02735239|520498275|FG002|Overall Study|Adverse Event|4|||
144353166|NCT02735239|520498276|FG003|Overall Study|Adverse Event|0|||
144353167|NCT02735239|520498277|FG004|Overall Study|Adverse Event|0|||
144353168|NCT02735239|520498278|FG005|Overall Study|Adverse Event|0|||
144353169|NCT02735239|520498273|FG000|Overall Study|Death|1|||
144353170|NCT02735239|520498274|FG001|Overall Study|Death|1|||
144353171|NCT02735239|520498275|FG002|Overall Study|Death|0|||
144353172|NCT02735239|520498276|FG003|Overall Study|Death|0|||
144353173|NCT02735239|520498277|FG004|Overall Study|Death|0|||
144353174|NCT02735239|520498278|FG005|Overall Study|Death|0|||
144353175|NCT02735239|520498273|FG000|Overall Study|Physician Decision|0|||
144353176|NCT02735239|520498274|FG001|Overall Study|Physician Decision|0|||
144353177|NCT02735239|520498275|FG002|Overall Study|Physician Decision|1|||
144353178|NCT02735239|520498276|FG003|Overall Study|Physician Decision|0|||
144353179|NCT02735239|520498277|FG004|Overall Study|Physician Decision|0|||
144353180|NCT02735239|520498278|FG005|Overall Study|Physician Decision|0|||
144353181|NCT02735239|520498273|FG000|Overall Study|Progressive disease|3|||
144353182|NCT02735239|520498274|FG001|Overall Study|Progressive disease|1|||
144353183|NCT02735239|520498275|FG002|Overall Study|Progressive disease|3|||
144353184|NCT02735239|520498276|FG003|Overall Study|Progressive disease|0|||
144353185|NCT02735239|520498277|FG004|Overall Study|Progressive disease|0|||
144353186|NCT02735239|520498278|FG005|Overall Study|Progressive disease|2|||
144353187|NCT02735239|520498273|FG000|Overall Study|Withdrawal by Subject|0|||
144353188|NCT02735239|520498274|FG001|Overall Study|Withdrawal by Subject|1|||
144353189|NCT02735239|520498275|FG002|Overall Study|Withdrawal by Subject|0|||
144353190|NCT02735239|520498276|FG003|Overall Study|Withdrawal by Subject|0|||
144353191|NCT02735239|520498277|FG004|Overall Study|Withdrawal by Subject|0|||
144353192|NCT02735239|520498278|FG005|Overall Study|Withdrawal by Subject|0|||
144353193|NCT01790594|520498280|FG000|Overall Study|Death|1|||
144353194|NCT01790594|520498281|FG001|Overall Study|Death|0|||
144353195|NCT01790594|520498282|FG002|Overall Study|Death|0|||
144353196|NCT01790594|520498280|FG000|Overall Study|Physician Decision|2|||
144353197|NCT01790594|520498281|FG001|Overall Study|Physician Decision|1|||
144353198|NCT01790594|520498282|FG002|Overall Study|Physician Decision|0|||
144353199|NCT01790594|520498280|FG000|Overall Study|Withdrawal by Subject|2|||
144353200|NCT01790594|520498281|FG001|Overall Study|Withdrawal by Subject|0|||
144353201|NCT01790594|520498282|FG002|Overall Study|Withdrawal by Subject|0|||
144353202|NCT01790594|520498280|FG000|Overall Study|Transplant was not done|0|||
144353203|NCT01790594|520498281|FG001|Overall Study|Transplant was not done|0|||
144353204|NCT01790594|520498282|FG002|Overall Study|Transplant was not done|3|||
144353205|NCT01790594|520498280|FG000|Overall Study|Terminated prior to week 76|0|||
144353206|NCT01790594|520498281|FG001|Overall Study|Terminated prior to week 76|2|||
144353207|NCT01790594|520498282|FG002|Overall Study|Terminated prior to week 76|0|||
144353208|NCT01855412|520498283|FG000|Overall Study|Death|77|||
144353209|NCT01855412|520498284|FG001|Overall Study|Death|123|||
144353210|NCT01855412|520498285|FG002|Overall Study|Death|30|||
144353211|NCT01855412|520498283|FG000|Overall Study|Lost to Follow-up|28|||
144353212|NCT01855412|520498284|FG001|Overall Study|Lost to Follow-up|46|||
144353213|NCT01855412|520498285|FG002|Overall Study|Lost to Follow-up|15|||
144353214|NCT01855412|520498283|FG000|Overall Study|Withdrawal by Subject|77|||
144353215|NCT01855412|520498284|FG001|Overall Study|Withdrawal by Subject|123|||
144353216|NCT01855412|520498285|FG002|Overall Study|Withdrawal by Subject|24|||
144353217|NCT01855412|520498283|FG000|Overall Study|Physician Decision|25|||
144353218|NCT01855412|520498284|FG001|Overall Study|Physician Decision|31|||
144353219|NCT01855412|520498285|FG002|Overall Study|Physician Decision|3|||
144353220|NCT01855412|520498283|FG000|Overall Study|Site Closure|4|||
144353221|NCT01855412|520498284|FG001|Overall Study|Site Closure|18|||
144353222|NCT01855412|520498285|FG002|Overall Study|Site Closure|1|||
144353223|NCT01855412|520498283|FG000|Overall Study|Reason not Specified|1|||
144353224|NCT01855412|520498284|FG001|Overall Study|Reason not Specified|2|||
144353225|NCT01855412|520498285|FG002|Overall Study|Reason not Specified|3|||
144353226|NCT03347123|520498289|FG000|Overall Study|Death|1|||
144353227|NCT03347123|520498290|FG001|Overall Study|Death|2|||
144353228|NCT03347123|520498291|FG002|Overall Study|Death|0|||
144353229|NCT03347123|520498292|FG003|Overall Study|Death|0|||
144353230|NCT03347123|520498293|FG004|Overall Study|Death|0|||
144353231|NCT03347123|520498294|FG005|Overall Study|Death|0|||
144353232|NCT03347123|520498295|FG006|Overall Study|Death|0|||
144353233|NCT03347123|520498289|FG000|Overall Study|Withdrawal by Subject|1|||
144353234|NCT03347123|520498290|FG001|Overall Study|Withdrawal by Subject|0|||
144353235|NCT03347123|520498291|FG002|Overall Study|Withdrawal by Subject|0|||
144353236|NCT03347123|520498292|FG003|Overall Study|Withdrawal by Subject|0|||
144353237|NCT03347123|520498293|FG004|Overall Study|Withdrawal by Subject|0|||
144353238|NCT03347123|520498294|FG005|Overall Study|Withdrawal by Subject|0|||
144353239|NCT03347123|520498295|FG006|Overall Study|Withdrawal by Subject|0|||
144353240|NCT03347123|520498289|FG000|Overall Study|Reason not Specified|3|||
144353241|NCT03347123|520498290|FG001|Overall Study|Reason not Specified|4|||
144353242|NCT03347123|520498291|FG002|Overall Study|Reason not Specified|0|||
144353243|NCT03347123|520498292|FG003|Overall Study|Reason not Specified|0|||
144353244|NCT03347123|520498293|FG004|Overall Study|Reason not Specified|0|||
144353245|NCT03347123|520498294|FG005|Overall Study|Reason not Specified|0|||
144353246|NCT03347123|520498295|FG006|Overall Study|Reason not Specified|0|||
144353247|NCT03431441|520498303|FG000|Overall Study|Withdrawal by Subject|2|||
144353248|NCT03431441|520498303|FG000|Overall Study|Adverse Event|2|||
144353249|NCT03431441|520498303|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
144353250|NCT00346216|520498304|FG000|Overall Study|Other|181|||
144353251|NCT00346216|520498305|FG001|Overall Study|Other|231|||
144353252|NCT00346216|520498306|FG002|Overall Study|Other|205|||
144353253|NCT00346216|520498304|FG000|Overall Study|No longer willing to participate|600|||
144353254|NCT00346216|520498305|FG001|Overall Study|No longer willing to participate|606|||
144353255|NCT00346216|520498306|FG002|Overall Study|No longer willing to participate|585|||
144353256|NCT00346216|520498304|FG000|Overall Study|Withdrawal by Subject|661|||
144353257|NCT00346216|520498305|FG001|Overall Study|Withdrawal by Subject|692|||
144353258|NCT00346216|520498306|FG002|Overall Study|Withdrawal by Subject|651|||
144353259|NCT00346216|520498304|FG000|Overall Study|Lost to Follow-up|611|||
144353260|NCT00346216|520498305|FG001|Overall Study|Lost to Follow-up|588|||
144353261|NCT00346216|520498306|FG002|Overall Study|Lost to Follow-up|542|||
144353262|NCT00346216|520498304|FG000|Overall Study|Physician Decision|80|||
144353263|NCT00346216|520498305|FG001|Overall Study|Physician Decision|76|||
144353264|NCT00346216|520498306|FG002|Overall Study|Physician Decision|59|||
144353265|NCT00346216|520498304|FG000|Overall Study|Does not meet entrance criteria|13|||
144353266|NCT00346216|520498305|FG001|Overall Study|Does not meet entrance criteria|10|||
144353267|NCT00346216|520498306|FG002|Overall Study|Does not meet entrance criteria|8|||
144353268|NCT00346216|520498304|FG000|Overall Study|Death|189|||
144353269|NCT00346216|520498305|FG001|Overall Study|Death|192|||
144353270|NCT00346216|520498306|FG002|Overall Study|Death|228|||
144353271|NCT00346216|520498304|FG000|Overall Study|Study terminated by sponsor|11|||
144353272|NCT00346216|520498305|FG001|Overall Study|Study terminated by sponsor|4|||
144353273|NCT00346216|520498306|FG002|Overall Study|Study terminated by sponsor|8|||
144353274|NCT00346216|520498304|FG000|Overall Study|Missing Subject Summary Status|62|||
144353275|NCT00346216|520498305|FG001|Overall Study|Missing Subject Summary Status|61|||
144353276|NCT00346216|520498306|FG002|Overall Study|Missing Subject Summary Status|62|||
144353277|NCT01276639|520498307|FG000|Week 0 to 16|Death|1|||
144353278|NCT01276639|520498308|FG001|Week 0 to 16|Death|0|||
144353279|NCT01276639|520498309|FG002|Week 0 to 16|Death|0|||
144353280|NCT01276639|520498310|FG003|Week 0 to 16|Death|0|||
144353281|NCT01276639|520498311|FG004|Week 0 to 16|Death|0|||
144353282|NCT01276639|520498307|FG000|Week 0 to 16|Adverse Event|11|||
144353283|NCT01276639|520498308|FG001|Week 0 to 16|Adverse Event|8|||
144353284|NCT01276639|520498309|FG002|Week 0 to 16|Adverse Event|11|||
144353285|NCT01276639|520498310|FG003|Week 0 to 16|Adverse Event|0|||
144353286|NCT01276639|520498311|FG004|Week 0 to 16|Adverse Event|0|||
144353287|NCT01276639|520498307|FG000|Week 0 to 16|Lack of Efficacy|20|||
144353288|NCT01276639|520498308|FG001|Week 0 to 16|Lack of Efficacy|15|||
144353289|NCT01276639|520498309|FG002|Week 0 to 16|Lack of Efficacy|25|||
144353290|NCT01276639|520498310|FG003|Week 0 to 16|Lack of Efficacy|0|||
144353291|NCT01276639|520498311|FG004|Week 0 to 16|Lack of Efficacy|0|||
144353292|NCT01276639|520498307|FG000|Week 0 to 16|Lost to Follow-up|3|||
144353293|NCT01276639|520498308|FG001|Week 0 to 16|Lost to Follow-up|5|||
144353294|NCT01276639|520498309|FG002|Week 0 to 16|Lost to Follow-up|3|||
144353295|NCT01276639|520498310|FG003|Week 0 to 16|Lost to Follow-up|0|||
144353296|NCT01276639|520498311|FG004|Week 0 to 16|Lost to Follow-up|0|||
144353297|NCT01276639|520498307|FG000|Week 0 to 16|Withdrawal by Subject|8|||
144353298|NCT01276639|520498308|FG001|Week 0 to 16|Withdrawal by Subject|5|||
144353299|NCT01276639|520498309|FG002|Week 0 to 16|Withdrawal by Subject|4|||
144353300|NCT01276639|520498310|FG003|Week 0 to 16|Withdrawal by Subject|0|||
144353301|NCT01276639|520498311|FG004|Week 0 to 16|Withdrawal by Subject|0|||
144353302|NCT01276639|520498307|FG000|Week 0 to 16|Other|7|||
144353303|NCT01276639|520498308|FG001|Week 0 to 16|Other|7|||
144353304|NCT01276639|520498309|FG002|Week 0 to 16|Other|2|||
144353305|NCT01276639|520498310|FG003|Week 0 to 16|Other|0|||
144353306|NCT01276639|520498311|FG004|Week 0 to 16|Other|0|||
144353307|NCT01276639|520498307|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
144353308|NCT01276639|520498308|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
144353309|NCT01276639|520498309|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
144353310|NCT01276639|520498310|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
144353311|NCT01276639|520498311|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
144353312|NCT01276639|520498307|FG000|Week 16 to 52|Death|1|||
144353313|NCT01276639|520498308|FG001|Week 16 to 52|Death|0|||
144353314|NCT01276639|520498309|FG002|Week 16 to 52|Death|0|||
144353315|NCT01276639|520498310|FG003|Week 16 to 52|Death|0|||
144353316|NCT01276639|520498311|FG004|Week 16 to 52|Death|0|||
144353317|NCT01276639|520498307|FG000|Week 16 to 52|Adverse Event|10|||
144353318|NCT01276639|520498308|FG001|Week 16 to 52|Adverse Event|13|||
144353319|NCT01276639|520498309|FG002|Week 16 to 52|Adverse Event|0|||
144353320|NCT01276639|520498310|FG003|Week 16 to 52|Adverse Event|1|||
144353321|NCT01276639|520498311|FG004|Week 16 to 52|Adverse Event|3|||
144353322|NCT01276639|520498307|FG000|Week 16 to 52|Lack of Efficacy|99|||
144353323|NCT01276639|520498308|FG001|Week 16 to 52|Lack of Efficacy|71|||
144353324|NCT01276639|520498309|FG002|Week 16 to 52|Lack of Efficacy|0|||
144353325|NCT01276639|520498310|FG003|Week 16 to 52|Lack of Efficacy|14|||
144353326|NCT01276639|520498311|FG004|Week 16 to 52|Lack of Efficacy|13|||
144353327|NCT01276639|520498307|FG000|Week 16 to 52|Lost to Follow-up|3|||
144353328|NCT01276639|520498308|FG001|Week 16 to 52|Lost to Follow-up|1|||
144353329|NCT01276639|520498309|FG002|Week 16 to 52|Lost to Follow-up|0|||
144353330|NCT01276639|520498310|FG003|Week 16 to 52|Lost to Follow-up|0|||
144353331|NCT01276639|520498311|FG004|Week 16 to 52|Lost to Follow-up|1|||
144353332|NCT01276639|520498307|FG000|Week 16 to 52|Withdrawal by Subject|4|||
144353333|NCT01276639|520498308|FG001|Week 16 to 52|Withdrawal by Subject|4|||
144353334|NCT01276639|520498309|FG002|Week 16 to 52|Withdrawal by Subject|0|||
144353335|NCT01276639|520498310|FG003|Week 16 to 52|Withdrawal by Subject|0|||
144353336|NCT01276639|520498311|FG004|Week 16 to 52|Withdrawal by Subject|1|||
144353337|NCT01276639|520498307|FG000|Week 16 to 52|Other|10|||
144353338|NCT01276639|520498308|FG001|Week 16 to 52|Other|12|||
144353339|NCT01276639|520498309|FG002|Week 16 to 52|Other|0|||
144353340|NCT01276639|520498310|FG003|Week 16 to 52|Other|1|||
144353341|NCT01276639|520498311|FG004|Week 16 to 52|Other|3|||
144353342|NCT03956550|520498312|FG000|Overall Study|Sponsor decision|65|||
144353343|NCT03956550|520498313|FG001|Overall Study|Sponsor decision|66|||
144353344|NCT03956550|520498314|FG002|Overall Study|Sponsor decision|64|||
144353345|NCT03956550|520498312|FG000|Overall Study|Adverse Event|0|||
144353346|NCT03956550|520498313|FG001|Overall Study|Adverse Event|1|||
144353347|NCT03956550|520498314|FG002|Overall Study|Adverse Event|0|||
144353348|NCT03956550|520498312|FG000|Overall Study|Withdrawal by Subject|5|||
144353349|NCT03956550|520498313|FG001|Overall Study|Withdrawal by Subject|5|||
144353350|NCT03956550|520498314|FG002|Overall Study|Withdrawal by Subject|6|||
144353351|NCT02222558|520498315|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
144353352|NCT02222558|520498316|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
144353353|NCT02222558|520498317|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
144353354|NCT02222558|520498318|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
144353355|NCT02222558|520498319|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
144353356|NCT02222558|520498320|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
144353357|NCT02222558|520498315|FG000|Period 3|Withdrawal by Subject|0|||
144353358|NCT02222558|520498316|FG001|Period 3|Withdrawal by Subject|0|||
144353359|NCT02222558|520498317|FG002|Period 3|Withdrawal by Subject|0|||
144353360|NCT02222558|520498318|FG003|Period 3|Withdrawal by Subject|0|||
144353361|NCT02222558|520498319|FG004|Period 3|Withdrawal by Subject|0|||
144353362|NCT02222558|520498320|FG005|Period 3|Withdrawal by Subject|1|||
144353363|NCT02322281|520498323|FG000|Overall Study|Progressive Disease|42|||
144353364|NCT02322281|520498324|FG001|Overall Study|Progressive Disease|14|||
144353365|NCT02322281|520498325|FG002|Overall Study|Progressive Disease|49|||
144353366|NCT02322281|520498323|FG000|Overall Study|Adverse Event|3|||
144353367|NCT02322281|520498324|FG001|Overall Study|Adverse Event|4|||
144353368|NCT02322281|520498325|FG002|Overall Study|Adverse Event|6|||
144353369|NCT02322281|520498323|FG000|Overall Study|Death|3|||
144353370|NCT02322281|520498324|FG001|Overall Study|Death|3|||
144353371|NCT02322281|520498325|FG002|Overall Study|Death|3|||
144353372|NCT02322281|520498323|FG000|Overall Study|Withdrawal by Subject|1|||
144353373|NCT02322281|520498324|FG001|Overall Study|Withdrawal by Subject|1|||
144353374|NCT02322281|520498325|FG002|Overall Study|Withdrawal by Subject|6|||
144353375|NCT02322281|520498323|FG000|Overall Study|Physician Decision|2|||
144353376|NCT02322281|520498324|FG001|Overall Study|Physician Decision|0|||
144353377|NCT02322281|520498325|FG002|Overall Study|Physician Decision|5|||
144353378|NCT02322281|520498323|FG000|Overall Study|Study Terminated by Sponsor|2|||
144353379|NCT02322281|520498324|FG001|Overall Study|Study Terminated by Sponsor|0|||
144353380|NCT02322281|520498325|FG002|Overall Study|Study Terminated by Sponsor|0|||
144353381|NCT02322281|520498323|FG000|Overall Study|Missing|0|||
144353382|NCT02322281|520498324|FG001|Overall Study|Missing|0|||
144353383|NCT02322281|520498325|FG002|Overall Study|Missing|1|||
144353384|NCT02322281|520498323|FG000|Overall Study|Miscellaneous|0|||
144353385|NCT02322281|520498324|FG001|Overall Study|Miscellaneous|0|||
144353386|NCT02322281|520498325|FG002|Overall Study|Miscellaneous|4|||
144353387|NCT01285401|520498326|FG000|Overall Study|Prematurely withdrawn from the study|17|||
144353388|NCT01285401|520498327|FG001|Overall Study|Prematurely withdrawn from the study|29|||
144353389|NCT00936702|520498328|FG000|Overall Study|Disease progression|34|||
144353390|NCT00936702|520498328|FG000|Overall Study|Adverse Event|8|||
144353391|NCT00936702|520498328|FG000|Overall Study|Withdrawal by Subject|2|||
144353392|NCT00936702|520498328|FG000|Overall Study|Alternative Treatment|1|||
144353393|NCT00936702|520498328|FG000|Overall Study|Other|1|||
144353394|NCT02420093|520498329|FG000|Overall Study|Withdrawal by Subject|1|||
144353395|NCT02420093|520498330|FG001|Overall Study|Withdrawal by Subject|1|||
144353396|NCT05470387|520498334|FG000|Overall Study|Protocol Violation|0|||
144353397|NCT05470387|520498335|FG001|Overall Study|Protocol Violation|3|||
144353398|NCT03480152|520498339|FG000|Phase I|Signed consent. Died before treatment.|1|||
144353399|NCT03480152|520498340|FG001|Phase I|Signed consent. Died before treatment.|0|||
144353400|NCT03480152|520498341|FG002|Phase I|Signed consent. Died before treatment.|0|||
144353401|NCT01308736|520498342|FG000|Overall Study|Did not attend a single session|6|||
144353402|NCT01308736|520498343|FG001|Overall Study|Did not attend a single session|5|||
144353403|NCT01946139|520498344|FG000|Overall Study|Withdrawal by Subject|8|||
144353404|NCT01946139|520498344|FG000|Overall Study|ineligible|8|||
144353405|NCT01946139|520498344|FG000|Overall Study|Specimens not available|4|||
144353406|NCT01363700|520498353|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
144353407|NCT01363700|520498354|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
144353408|NCT01363700|520498355|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
144353409|NCT01363700|520498356|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
144353410|NCT01363700|520498357|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
144353411|NCT02721875|520498358|FG000|Overall Study|Progressive disease/relapse|1|||
144353412|NCT02721875|520498359|FG001|Overall Study|Progressive disease/relapse|0|||
144353413|NCT00857285|520498360|FG000|Overall Study|Adverse Event|4|||
144353414|NCT00857285|520498361|FG001|Overall Study|Adverse Event|2|||
144353415|NCT00857285|520498360|FG000|Overall Study|Lack of Efficacy|0|||
144353416|NCT00857285|520498361|FG001|Overall Study|Lack of Efficacy|2|||
144353417|NCT00857285|520498360|FG000|Overall Study|Protocol Violation|3|||
144353418|NCT00857285|520498361|FG001|Overall Study|Protocol Violation|1|||
144353419|NCT00857285|520498360|FG000|Overall Study|Withdrawal by Subject|4|||
144353420|NCT00857285|520498361|FG001|Overall Study|Withdrawal by Subject|0|||
144353421|NCT00857285|520498360|FG000|Overall Study|Randomization criteria not met|1|||
144353422|NCT00857285|520498361|FG001|Overall Study|Randomization criteria not met|1|||
144353423|NCT01329978|520498370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
144353424|NCT01329978|520498371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
144353425|NCT01329978|520498372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
144353426|NCT01329978|520498373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
144353427|NCT01329978|520498374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
144353428|NCT01329978|520498370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
144353429|NCT01329978|520498371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
144353430|NCT01329978|520498372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
144353431|NCT01329978|520498373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
144353432|NCT01329978|520498374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
144353433|NCT01329978|520498370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
144353434|NCT01329978|520498371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
144353435|NCT01329978|520498372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
144353436|NCT01329978|520498373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
144353437|NCT01329978|520498374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
144353438|NCT01329978|520498370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
144353439|NCT01329978|520498371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
144353440|NCT01329978|520498372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
144353441|NCT01329978|520498373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
144353442|NCT01329978|520498374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
144353443|NCT01329978|520498370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
144353444|NCT01329978|520498371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
144353445|NCT01329978|520498372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
144353446|NCT01329978|520498373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
144353447|NCT01329978|520498374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
144353448|NCT01329978|520498370|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
144353449|NCT01329978|520498371|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
144353450|NCT01329978|520498372|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
144353451|NCT01329978|520498373|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
144353452|NCT01329978|520498374|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
144353453|NCT01329978|520498370|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
144353454|NCT01329978|520498371|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
144353455|NCT01329978|520498372|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
144353456|NCT01329978|520498373|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
144353457|NCT01329978|520498374|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
144353458|NCT03901144|520498375|FG000|Overall Study|Lost to Follow-up|1|||
144353459|NCT03901144|520498376|FG001|Overall Study|Lost to Follow-up|1|||
144353460|NCT03901144|520498377|FG002|Overall Study|Lost to Follow-up|1|||
144353461|NCT03901144|520498378|FG003|Overall Study|Lost to Follow-up|1|||
144353462|NCT01807598|520498379|FG000|Overall Study|Withdrawal by Subject|4|||
144353463|NCT01807598|520498379|FG000|Overall Study|Adverse Event|1|||
144353464|NCT01807598|520498379|FG000|Overall Study|Other Physician Decision|1|||
144353465|NCT01288989|520498382|FG000|Overall Study|Death|0|||
144353466|NCT01288989|520498383|FG001|Overall Study|Death|0|||
144353467|NCT01288989|520498384|FG002|Overall Study|Death|0|||
144353468|NCT01288989|520498385|FG003|Overall Study|Death|1|||
144353469|NCT01288989|520498386|FG004|Overall Study|Death|0|||
144353470|NCT01288989|520498382|FG000|Overall Study|Dose limiting toxicity|1|||
144353471|NCT01288989|520498383|FG001|Overall Study|Dose limiting toxicity|0|||
144353472|NCT01288989|520498384|FG002|Overall Study|Dose limiting toxicity|0|||
144353473|NCT01288989|520498385|FG003|Overall Study|Dose limiting toxicity|0|||
144353474|NCT01288989|520498386|FG004|Overall Study|Dose limiting toxicity|0|||
144353475|NCT01288989|520498382|FG000|Overall Study|Adverse Event|0|||
144353476|NCT01288989|520498383|FG001|Overall Study|Adverse Event|0|||
144353477|NCT01288989|520498384|FG002|Overall Study|Adverse Event|0|||
144353478|NCT01288989|520498385|FG003|Overall Study|Adverse Event|0|||
144353479|NCT01288989|520498386|FG004|Overall Study|Adverse Event|2|||
144353480|NCT01288989|520498382|FG000|Overall Study|Physician Decision|0|||
144353481|NCT01288989|520498383|FG001|Overall Study|Physician Decision|0|||
144353482|NCT01288989|520498384|FG002|Overall Study|Physician Decision|0|||
144353483|NCT01288989|520498385|FG003|Overall Study|Physician Decision|0|||
144353484|NCT01288989|520498386|FG004|Overall Study|Physician Decision|1|||
144353485|NCT01288989|520498382|FG000|Overall Study|Withdrawal by Subject|0|||
144353486|NCT01288989|520498383|FG001|Overall Study|Withdrawal by Subject|0|||
144353487|NCT01288989|520498384|FG002|Overall Study|Withdrawal by Subject|0|||
144353488|NCT01288989|520498385|FG003|Overall Study|Withdrawal by Subject|0|||
144353489|NCT01288989|520498386|FG004|Overall Study|Withdrawal by Subject|3|||
144353490|NCT00165672|520498388|FG000|Overall Study|Adverse Event|0|||
144353491|NCT00165672|520498389|FG001|Overall Study|Adverse Event|1|||
144353492|NCT05477485|520498390|FG000|Overall Study|Lost to Follow-up|0|||
144353493|NCT05477485|520498391|FG001|Overall Study|Lost to Follow-up|4|||
144353494|NCT04194944|520498392|FG000|Overall Study|Lost to Follow-up|3|||
144353495|NCT04194944|520498393|FG001|Overall Study|Lost to Follow-up|0|||
144353496|NCT04194944|520498392|FG000|Overall Study|Withdrawal by Subject|2|||
144353497|NCT04194944|520498393|FG001|Overall Study|Withdrawal by Subject|2|||
144353498|NCT04194944|520498392|FG000|Overall Study|On Treatment|93|||
144353499|NCT04194944|520498393|FG001|Overall Study|On Treatment|30|||
144353500|NCT06235905|520498394|FG000|Overall Study|Adverse Event|1|||
144353501|NCT06235905|520498394|FG000|Overall Study|Non-compliant with protocol procedures|1|||
144353502|NCT00319254|520498395|FG000|Overall Study|Withdrawal by Subject|4|||
144353503|NCT00319254|520498395|FG000|Overall Study|Death|46|||
144353504|NCT00319254|520498395|FG000|Overall Study|Lost to Follow-up|2|||
144353505|NCT00319254|520498395|FG000|Overall Study|Enrolled, Not Treated|2|||
144353506|NCT02544321|520500623|FG000|Overall Study|Withdrawal by Subject|1|||
144353507|NCT02544321|520500624|FG001|Overall Study|Withdrawal by Subject|2|||
144353508|NCT02544321|520500623|FG000|Overall Study|Adverse Event|1|||
144353509|NCT02544321|520500624|FG001|Overall Study|Adverse Event|1|||
144353510|NCT02544321|520500623|FG000|Overall Study|Protocol Violation|0|||
144353511|NCT02544321|520500624|FG001|Overall Study|Protocol Violation|1|||
144353512|NCT01307319|520500625|FG000|Overall Study|Adverse Event|2|||
144353513|NCT01307319|520500626|FG001|Overall Study|Adverse Event|2|||
144353514|NCT01307319|520500627|FG002|Overall Study|Adverse Event|1|||
144353515|NCT01307319|520500625|FG000|Overall Study|Lost to Follow-up|1|||
144353516|NCT01307319|520500626|FG001|Overall Study|Lost to Follow-up|0|||
144353517|NCT01307319|520500627|FG002|Overall Study|Lost to Follow-up|1|||
144353518|NCT01307319|520500625|FG000|Overall Study|Protocol Violation|1|||
144353519|NCT01307319|520500626|FG001|Overall Study|Protocol Violation|1|||
144353520|NCT01307319|520500627|FG002|Overall Study|Protocol Violation|0|||
144353521|NCT01307319|520500625|FG000|Overall Study|Withdrawal by Subject|0|||
144353522|NCT01307319|520500626|FG001|Overall Study|Withdrawal by Subject|1|||
144353523|NCT01307319|520500627|FG002|Overall Study|Withdrawal by Subject|2|||
144353524|NCT01307319|520500625|FG000|Overall Study|Other|0|||
144353525|NCT01307319|520500626|FG001|Overall Study|Other|4|||
144353526|NCT01307319|520500627|FG002|Overall Study|Other|3|||
144353527|NCT02152631|520500628|FG000|Overall Study|Adverse Event|32|||
144353528|NCT02152631|520500629|FG001|Overall Study|Adverse Event|4|||
144353529|NCT02152631|520500628|FG000|Overall Study|Withdrawal by Subject|13|||
144353530|NCT02152631|520500629|FG001|Overall Study|Withdrawal by Subject|16|||
144353531|NCT02152631|520500628|FG000|Overall Study|Noncompliance with study drug|1|||
144353532|NCT02152631|520500629|FG001|Overall Study|Noncompliance with study drug|0|||
144353533|NCT02152631|520500628|FG000|Overall Study|Physician Decision|1|||
144353534|NCT02152631|520500629|FG001|Overall Study|Physician Decision|2|||
144353535|NCT02152631|520500628|FG000|Overall Study|Lost to Follow-up|0|||
144353536|NCT02152631|520500629|FG001|Overall Study|Lost to Follow-up|1|||
144353537|NCT02152631|520500628|FG000|Overall Study|On Treatment|19|||
144353538|NCT02152631|520500629|FG001|Overall Study|On Treatment|3|||
144353539|NCT00527735|520500630|FG000|Overall Study|Disease progression|47|||
144353540|NCT00527735|520500631|FG001|Overall Study|Disease progression|61|||
144353541|NCT00527735|520500632|FG002|Overall Study|Disease progression|53|||
144353542|NCT00527735|520500630|FG000|Overall Study|Death|23|||
144353543|NCT00527735|520500631|FG001|Overall Study|Death|13|||
144353544|NCT00527735|520500632|FG002|Overall Study|Death|15|||
144353545|NCT00527735|520500630|FG000|Overall Study|Completed treatment in treatment phase|14|||
144353546|NCT00527735|520500631|FG001|Overall Study|Completed treatment in treatment phase|13|||
144353547|NCT00527735|520500632|FG002|Overall Study|Completed treatment in treatment phase|18|||
144353548|NCT00527735|520500630|FG000|Overall Study|Adverse Event|10|||
144353549|NCT00527735|520500631|FG001|Overall Study|Adverse Event|6|||
144353550|NCT00527735|520500632|FG002|Overall Study|Adverse Event|7|||
144353551|NCT00527735|520500630|FG000|Overall Study|Not identified|5|||
144353552|NCT00527735|520500631|FG001|Overall Study|Not identified|5|||
144353553|NCT00527735|520500632|FG002|Overall Study|Not identified|5|||
144353554|NCT00527735|520500630|FG000|Overall Study|Withdrawal by Subject|5|||
144353555|NCT00527735|520500631|FG001|Overall Study|Withdrawal by Subject|4|||
144353556|NCT00527735|520500632|FG002|Overall Study|Withdrawal by Subject|3|||
144353557|NCT00527735|520500630|FG000|Overall Study|No longer met study criteria|2|||
144353558|NCT00527735|520500631|FG001|Overall Study|No longer met study criteria|2|||
144353559|NCT00527735|520500632|FG002|Overall Study|No longer met study criteria|1|||
144353560|NCT00527735|520500630|FG000|Overall Study|Lost to Follow-up|0|||
144353561|NCT00527735|520500631|FG001|Overall Study|Lost to Follow-up|0|||
144353562|NCT00527735|520500632|FG002|Overall Study|Lost to Follow-up|3|||
144353563|NCT00527735|520500630|FG000|Overall Study|Poor compliance or noncompliance|0|||
144353564|NCT00527735|520500631|FG001|Overall Study|Poor compliance or noncompliance|1|||
144353565|NCT00527735|520500632|FG002|Overall Study|Poor compliance or noncompliance|1|||
144353566|NCT00527735|520500630|FG000|Overall Study|Completed treatment during maintenance|2|||
144353567|NCT00527735|520500631|FG001|Overall Study|Completed treatment during maintenance|2|||
144353568|NCT00527735|520500632|FG002|Overall Study|Completed treatment during maintenance|1|||
144353569|NCT03985761|520500635|FG000|Overall Study|Withdrawal by Subject|2|||
144353570|NCT03985761|520500636|FG001|Overall Study|Withdrawal by Subject|3|||
144353571|NCT02366312|520500640|FG000|Overall Study|Lost to Follow-up|0|||
144353572|NCT02366312|520500641|FG001|Overall Study|Lost to Follow-up|1|||
144353573|NCT02532465|520500642|FG000|Overall Study|Protocol Violation|1|||
144353574|NCT02532465|520500643|FG001|Overall Study|Protocol Violation|0|||
144353575|NCT02532465|520500642|FG000|Overall Study|Lack of Efficacy|0|||
144353576|NCT02532465|520500643|FG001|Overall Study|Lack of Efficacy|1|||
144353577|NCT03719131|520500645|FG000|Overall Study|Death|1|||
144353578|NCT03719131|520500646|FG001|Overall Study|Death|2|||
144353579|NCT01544920|520500647|FG000|Overall Study|Adverse Event|0|||
144353580|NCT01544920|520500648|FG001|Overall Study|Adverse Event|3|||
144353581|NCT01544920|520500647|FG000|Overall Study|Death|0|||
144353582|NCT01544920|520500648|FG001|Overall Study|Death|1|||
144353583|NCT01544920|520500647|FG000|Overall Study|Lost to Follow-up|11|||
144353584|NCT01544920|520500648|FG001|Overall Study|Lost to Follow-up|12|||
144353585|NCT01544920|520500647|FG000|Overall Study|Protocol Violation|0|||
144353586|NCT01544920|520500648|FG001|Overall Study|Protocol Violation|2|||
144353587|NCT01544920|520500647|FG000|Overall Study|Physician Decision|4|||
144353588|NCT01544920|520500648|FG001|Overall Study|Physician Decision|1|||
144353589|NCT01544920|520500647|FG000|Overall Study|Withdrawal by Subject|4|||
144353590|NCT01544920|520500648|FG001|Overall Study|Withdrawal by Subject|4|||
144353591|NCT03244917|520500657|FG000|Overall Study|Lost to Follow-up|2|||
144353592|NCT03244917|520500658|FG001|Overall Study|Lost to Follow-up|2|||
144353593|NCT03001557|520500659|FG000|Core Phase|Randomized but not treated|0|||
144353594|NCT03001557|520500660|FG001|Core Phase|Randomized but not treated|0|||
144353595|NCT03001557|520500661|FG002|Core Phase|Randomized but not treated|1|||
144353596|NCT03001557|520500662|FG003|Core Phase|Randomized but not treated|0|||
144353597|NCT03001557|520500663|FG004|Core Phase|Randomized but not treated|0|||
144353598|NCT03001557|520500664|FG005|Core Phase|Randomized but not treated|0|||
144353599|NCT03001557|520500665|FG006|Core Phase|Randomized but not treated|0|||
144353600|NCT03001557|520500666|FG007|Core Phase|Randomized but not treated|0|||
144353601|NCT03001557|520500659|FG000|Extension Phase|Adverse Event|0|||
144353602|NCT03001557|520500660|FG001|Extension Phase|Adverse Event|0|||
144353603|NCT03001557|520500661|FG002|Extension Phase|Adverse Event|0|||
144353604|NCT03001557|520500662|FG003|Extension Phase|Adverse Event|0|||
144353605|NCT03001557|520500663|FG004|Extension Phase|Adverse Event|0|||
144353606|NCT03001557|520500664|FG005|Extension Phase|Adverse Event|2|||
144353607|NCT03001557|520500665|FG006|Extension Phase|Adverse Event|0|||
144353608|NCT03001557|520500666|FG007|Extension Phase|Adverse Event|0|||
144353609|NCT03001557|520500659|FG000|Extension Phase|Withdrawal by Subject|0|||
144353610|NCT03001557|520500660|FG001|Extension Phase|Withdrawal by Subject|0|||
144353611|NCT03001557|520500661|FG002|Extension Phase|Withdrawal by Subject|0|||
144353612|NCT03001557|520500662|FG003|Extension Phase|Withdrawal by Subject|0|||
144353613|NCT03001557|520500663|FG004|Extension Phase|Withdrawal by Subject|0|||
144353614|NCT03001557|520500664|FG005|Extension Phase|Withdrawal by Subject|1|||
144353615|NCT03001557|520500665|FG006|Extension Phase|Withdrawal by Subject|5|||
144353616|NCT03001557|520500666|FG007|Extension Phase|Withdrawal by Subject|2|||
144353617|NCT03001557|520500659|FG000|Extension Phase|Lost to Follow-up|0|||
144353618|NCT03001557|520500660|FG001|Extension Phase|Lost to Follow-up|0|||
144353619|NCT03001557|520500661|FG002|Extension Phase|Lost to Follow-up|0|||
144353620|NCT03001557|520500662|FG003|Extension Phase|Lost to Follow-up|0|||
144353621|NCT03001557|520500663|FG004|Extension Phase|Lost to Follow-up|0|||
144353622|NCT03001557|520500664|FG005|Extension Phase|Lost to Follow-up|0|||
144353623|NCT03001557|520500665|FG006|Extension Phase|Lost to Follow-up|2|||
144353624|NCT03001557|520500666|FG007|Extension Phase|Lost to Follow-up|1|||
144353625|NCT03001557|520500659|FG000|Extension Phase|Administrative Reason|0|||
144353626|NCT03001557|520500660|FG001|Extension Phase|Administrative Reason|0|||
144353627|NCT03001557|520500661|FG002|Extension Phase|Administrative Reason|0|||
144353628|NCT03001557|520500662|FG003|Extension Phase|Administrative Reason|0|||
144353629|NCT03001557|520500663|FG004|Extension Phase|Administrative Reason|0|||
144353630|NCT03001557|520500664|FG005|Extension Phase|Administrative Reason|1|||
144353631|NCT03001557|520500665|FG006|Extension Phase|Administrative Reason|3|||
144353632|NCT03001557|520500666|FG007|Extension Phase|Administrative Reason|3|||
144353633|NCT03001557|520500659|FG000|Extension Phase|Loss of caregiver|0|||
144353634|NCT03001557|520500660|FG001|Extension Phase|Loss of caregiver|0|||
144353635|NCT03001557|520500661|FG002|Extension Phase|Loss of caregiver|0|||
144353636|NCT03001557|520500662|FG003|Extension Phase|Loss of caregiver|0|||
144353637|NCT03001557|520500663|FG004|Extension Phase|Loss of caregiver|0|||
144353638|NCT03001557|520500664|FG005|Extension Phase|Loss of caregiver|0|||
144353639|NCT03001557|520500665|FG006|Extension Phase|Loss of caregiver|1|||
144353640|NCT03001557|520500666|FG007|Extension Phase|Loss of caregiver|0|||
144353641|NCT03001557|520500659|FG000|Extension Phase|Others|0|||
144353642|NCT03001557|520500660|FG001|Extension Phase|Others|0|||
144353643|NCT03001557|520500661|FG002|Extension Phase|Others|0|||
144353644|NCT03001557|520500662|FG003|Extension Phase|Others|0|||
144353645|NCT03001557|520500663|FG004|Extension Phase|Others|0|||
144353646|NCT03001557|520500664|FG005|Extension Phase|Others|1|||
144353647|NCT03001557|520500665|FG006|Extension Phase|Others|3|||
144353648|NCT03001557|520500666|FG007|Extension Phase|Others|0|||
144353649|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
144353650|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
144353651|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Death|1|||
144353652|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Death|2|||
144353653|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
144353654|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
144353655|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
144353656|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
144353657|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
144353658|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
144353659|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
144353660|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
144353661|NCT01794000|520500667|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
144353662|NCT01794000|520500668|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
144353663|NCT01794000|520500667|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
144353664|NCT01794000|520500668|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
144353665|NCT01272232|520500671|FG000|Weeks 0-56|Adverse Event|39|||
144353666|NCT01272232|520500672|FG001|Weeks 0-56|Adverse Event|18|||
144353667|NCT01272232|520500673|FG002|Weeks 0-56|Adverse Event|7|||
144353668|NCT01272232|520500671|FG000|Weeks 0-56|Lack of Efficacy|0|||
144353669|NCT01272232|520500672|FG001|Weeks 0-56|Lack of Efficacy|0|||
144353670|NCT01272232|520500673|FG002|Weeks 0-56|Lack of Efficacy|3|||
144353671|NCT01272232|520500671|FG000|Weeks 0-56|Protocol Violation|12|||
144353672|NCT01272232|520500672|FG001|Weeks 0-56|Protocol Violation|8|||
144353673|NCT01272232|520500673|FG002|Weeks 0-56|Protocol Violation|13|||
144353674|NCT01272232|520500671|FG000|Weeks 0-56|Withdrawal criteria|32|||
144353675|NCT01272232|520500672|FG001|Weeks 0-56|Withdrawal criteria|14|||
144353676|NCT01272232|520500673|FG002|Weeks 0-56|Withdrawal criteria|37|||
144353677|NCT01272232|520500671|FG000|Weeks 0-56|Unclassified|16|||
144353678|NCT01272232|520500672|FG001|Weeks 0-56|Unclassified|7|||
144353679|NCT01272232|520500673|FG002|Weeks 0-56|Unclassified|12|||
144353680|NCT01272232|520500671|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
144353681|NCT01272232|520500672|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
144353682|NCT01272232|520500673|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
144353683|NCT01272232|520500671|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
144353684|NCT01272232|520500672|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
144353685|NCT01272232|520500673|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
144353686|NCT01272232|520500671|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
144353687|NCT01272232|520500672|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
144353688|NCT01272232|520500673|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
144353689|NCT01272232|520500671|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
144353690|NCT01272232|520500672|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
144353691|NCT01272232|520500673|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
144353692|NCT01272232|520500671|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
144353693|NCT01272232|520500672|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
144353694|NCT01272232|520500673|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
144353695|NCT00796666|520500674|FG000|Overall Study|Death|2|||
144353696|NCT00796666|520500675|FG001|Overall Study|Death|4|||
144353697|NCT00796666|520500674|FG000|Overall Study|Withdrawal by Subject|2|||
144353698|NCT00796666|520500675|FG001|Overall Study|Withdrawal by Subject|0|||
144353699|NCT00796666|520500674|FG000|Overall Study|Adverse Event|7|||
144353700|NCT00796666|520500675|FG001|Overall Study|Adverse Event|5|||
144353701|NCT00796666|520500674|FG000|Overall Study|Protocol Violation|1|||
144353702|NCT00796666|520500675|FG001|Overall Study|Protocol Violation|0|||
144353703|NCT00796666|520500674|FG000|Overall Study|Other|1|||
144353704|NCT00796666|520500675|FG001|Overall Study|Other|0|||
144353705|NCT00796666|520500674|FG000|Overall Study|Terminated by sponsor|53|||
144353706|NCT00796666|520500675|FG001|Overall Study|Terminated by sponsor|55|||
144353707|NCT00796666|520500674|FG000|Overall Study|Randomized and not treated|1|||
144353708|NCT00796666|520500675|FG001|Overall Study|Randomized and not treated|0|||
144353709|NCT02159066|520500676|FG000|Part I|Adverse Event|7|||
144353710|NCT02159066|520500677|FG001|Part I|Adverse Event|5|||
144353711|NCT02159066|520500678|FG002|Part I|Adverse Event|0|||
144353712|NCT02159066|520500679|FG003|Part I|Adverse Event|0|||
144353713|NCT02159066|520500680|FG004|Part I|Adverse Event|0|||
144353714|NCT02159066|520500681|FG005|Part I|Adverse Event|0|||
144353715|NCT02159066|520500676|FG000|Part I|Death|11|||
144353716|NCT02159066|520500677|FG001|Part I|Death|9|||
144353717|NCT02159066|520500678|FG002|Part I|Death|0|||
144353718|NCT02159066|520500679|FG003|Part I|Death|0|||
144353719|NCT02159066|520500680|FG004|Part I|Death|0|||
144353720|NCT02159066|520500681|FG005|Part I|Death|0|||
144353721|NCT02159066|520500676|FG000|Part I|Progressive Disease|37|||
144353722|NCT02159066|520500677|FG001|Part I|Progressive Disease|46|||
144353723|NCT02159066|520500678|FG002|Part I|Progressive Disease|0|||
144353724|NCT02159066|520500679|FG003|Part I|Progressive Disease|0|||
144353725|NCT02159066|520500680|FG004|Part I|Progressive Disease|0|||
144353726|NCT02159066|520500681|FG005|Part I|Progressive Disease|0|||
144353727|NCT02159066|520500676|FG000|Part I|New Therapy for Study Indication|5|||
144353728|NCT02159066|520500677|FG001|Part I|New Therapy for Study Indication|4|||
144353729|NCT02159066|520500678|FG002|Part I|New Therapy for Study Indication|0|||
144353730|NCT02159066|520500679|FG003|Part I|New Therapy for Study Indication|0|||
144353731|NCT02159066|520500680|FG004|Part I|New Therapy for Study Indication|0|||
144353732|NCT02159066|520500681|FG005|Part I|New Therapy for Study Indication|0|||
144353733|NCT02159066|520500676|FG000|Part I|Termination of participants from the study|3|||
144353734|NCT02159066|520500677|FG001|Part I|Termination of participants from the study|3|||
144353735|NCT02159066|520500678|FG002|Part I|Termination of participants from the study|0|||
144353736|NCT02159066|520500679|FG003|Part I|Termination of participants from the study|0|||
144353737|NCT02159066|520500680|FG004|Part I|Termination of participants from the study|0|||
144353738|NCT02159066|520500681|FG005|Part I|Termination of participants from the study|0|||
144353739|NCT02159066|520500676|FG000|Part I|Physician Decision|2|||
144353740|NCT02159066|520500677|FG001|Part I|Physician Decision|9|||
144353741|NCT02159066|520500678|FG002|Part I|Physician Decision|0|||
144353742|NCT02159066|520500679|FG003|Part I|Physician Decision|0|||
144353743|NCT02159066|520500680|FG004|Part I|Physician Decision|0|||
144353744|NCT02159066|520500681|FG005|Part I|Physician Decision|0|||
144353745|NCT02159066|520500676|FG000|Part I|Participant/Guardian Decision|9|||
144353746|NCT02159066|520500677|FG001|Part I|Participant/Guardian Decision|3|||
144353747|NCT02159066|520500678|FG002|Part I|Participant/Guardian Decision|0|||
144353748|NCT02159066|520500679|FG003|Part I|Participant/Guardian Decision|0|||
144353749|NCT02159066|520500680|FG004|Part I|Participant/Guardian Decision|0|||
144353750|NCT02159066|520500681|FG005|Part I|Participant/Guardian Decision|0|||
144353751|NCT02159066|520500676|FG000|Part I|Missing Data|1|||
144353752|NCT02159066|520500677|FG001|Part I|Missing Data|0|||
144353753|NCT02159066|520500678|FG002|Part I|Missing Data|0|||
144353754|NCT02159066|520500679|FG003|Part I|Missing Data|0|||
144353755|NCT02159066|520500680|FG004|Part I|Missing Data|0|||
144353756|NCT02159066|520500681|FG005|Part I|Missing Data|0|||
144353757|NCT02159066|520500676|FG000|Part II|Adverse Event|0|||
144353758|NCT02159066|520500677|FG001|Part II|Adverse Event|0|||
144353759|NCT02159066|520500678|FG002|Part II|Adverse Event|1|||
144353760|NCT02159066|520500679|FG003|Part II|Adverse Event|0|||
144353761|NCT02159066|520500680|FG004|Part II|Adverse Event|1|||
144353762|NCT02159066|520500681|FG005|Part II|Adverse Event|1|||
144353763|NCT02159066|520500676|FG000|Part II|Death|0|||
144353764|NCT02159066|520500677|FG001|Part II|Death|0|||
144353765|NCT02159066|520500678|FG002|Part II|Death|1|||
144353766|NCT02159066|520500679|FG003|Part II|Death|0|||
144353767|NCT02159066|520500680|FG004|Part II|Death|2|||
144353768|NCT02159066|520500681|FG005|Part II|Death|1|||
144353769|NCT02159066|520500676|FG000|Part II|Progressive Disease|0|||
144353770|NCT02159066|520500677|FG001|Part II|Progressive Disease|0|||
144353771|NCT02159066|520500678|FG002|Part II|Progressive Disease|35|||
144353772|NCT02159066|520500679|FG003|Part II|Progressive Disease|1|||
144353773|NCT02159066|520500680|FG004|Part II|Progressive Disease|7|||
144353774|NCT02159066|520500681|FG005|Part II|Progressive Disease|4|||
144353775|NCT02159066|520500676|FG000|Part II|New Therapy for Study Indication|0|||
144353776|NCT02159066|520500677|FG001|Part II|New Therapy for Study Indication|0|||
144353777|NCT02159066|520500678|FG002|Part II|New Therapy for Study Indication|0|||
144353778|NCT02159066|520500679|FG003|Part II|New Therapy for Study Indication|0|||
144353779|NCT02159066|520500680|FG004|Part II|New Therapy for Study Indication|1|||
144353780|NCT02159066|520500681|FG005|Part II|New Therapy for Study Indication|0|||
144353781|NCT02159066|520500676|FG000|Part II|Physician Decision|0|||
144353782|NCT02159066|520500677|FG001|Part II|Physician Decision|0|||
144353783|NCT02159066|520500678|FG002|Part II|Physician Decision|1|||
144353784|NCT02159066|520500679|FG003|Part II|Physician Decision|0|||
144353785|NCT02159066|520500680|FG004|Part II|Physician Decision|0|||
144353786|NCT02159066|520500681|FG005|Part II|Physician Decision|0|||
144353787|NCT02159066|520500676|FG000|Part II|Participant/Guardian Decision|0|||
144353788|NCT02159066|520500677|FG001|Part II|Participant/Guardian Decision|0|||
144353789|NCT02159066|520500678|FG002|Part II|Participant/Guardian Decision|0|||
144353790|NCT02159066|520500679|FG003|Part II|Participant/Guardian Decision|0|||
144353791|NCT02159066|520500680|FG004|Part II|Participant/Guardian Decision|2|||
144353792|NCT02159066|520500681|FG005|Part II|Participant/Guardian Decision|0|||
144353793|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
144353794|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
144353795|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
144353796|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353797|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353798|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353799|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353800|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353801|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353802|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353803|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353804|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353805|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
144353806|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353807|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
144353808|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353809|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
144353810|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353811|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353812|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
144353813|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
144353814|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
144353815|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
144353816|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353817|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
144353818|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353819|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353820|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
144353821|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
144353822|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
144353823|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
144353824|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
144353825|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
144353826|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
144353827|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
144353828|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
144353829|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
144353830|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
144353831|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
144353832|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
144353833|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
144353834|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
144353835|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
144353836|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
144353837|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
144353838|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
144353839|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353840|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353841|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
144353842|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353843|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353844|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353845|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353846|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353847|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353848|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
144353849|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353850|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353851|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353852|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
144353853|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353854|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353855|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353856|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353857|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
144353858|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
144353859|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353860|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
144353861|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353862|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
144353863|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353864|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
144353865|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353866|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
144353867|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
144353868|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353869|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353870|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353871|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
144353872|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353873|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353874|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353875|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353876|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353877|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353878|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
144353879|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353880|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353881|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353882|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
144353883|NCT01147666|520500682|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353884|NCT01147666|520500683|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353885|NCT01147666|520500684|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353886|NCT01147666|520500685|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353887|NCT01147666|520500686|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353888|NCT01147666|520500687|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353889|NCT01147666|520500688|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353890|NCT01147666|520500689|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353891|NCT01147666|520500690|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353892|NCT01147666|520500691|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353893|NCT01147666|520500692|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353894|NCT01147666|520500693|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
144353895|NCT01147666|520500694|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
144353896|NCT01147666|520500695|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
144353897|NCT01147666|520500696|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
144353898|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
144353899|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
144353900|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
144353901|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
144353902|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
144353903|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
144353904|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
144353905|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
144353906|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
144353907|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
144353908|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
144353909|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
144353910|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
144353911|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
144353912|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
144353913|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353914|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353915|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353916|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353917|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
144353918|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
144353919|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
144353920|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
144353921|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353922|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
144353923|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353924|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353925|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
144353926|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
144353927|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
144353928|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353929|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353930|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353931|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
144353932|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353933|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353934|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353935|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353936|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353937|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353938|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353939|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353940|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353941|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353942|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
144353943|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353944|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353945|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353946|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353947|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
144353948|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
144353949|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353950|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
144353951|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353952|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
144353953|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353954|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353955|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353956|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
144353957|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
144353958|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353959|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353960|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353961|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
144353962|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353963|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353964|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353965|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353966|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353967|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353968|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
144353969|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353970|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353971|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353972|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
144353973|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353974|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353975|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353976|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353977|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353978|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353979|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353980|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353981|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353982|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353983|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353984|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353985|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
144353986|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353987|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
144353988|NCT01147666|520500682|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353989|NCT01147666|520500683|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353990|NCT01147666|520500684|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353991|NCT01147666|520500685|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353992|NCT01147666|520500686|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353993|NCT01147666|520500687|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353994|NCT01147666|520500688|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353995|NCT01147666|520500689|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353996|NCT01147666|520500690|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353997|NCT01147666|520500691|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353998|NCT01147666|520500692|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144353999|NCT01147666|520500693|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144354000|NCT01147666|520500694|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
144354001|NCT01147666|520500695|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
144354002|NCT01147666|520500696|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
144354003|NCT00474955|520500698|FG000|Overall Study|Adverse Event|2|||
144354004|NCT00474955|520500698|FG000|Overall Study|Drug unavailability|1|||
144354005|NCT00474955|520500698|FG000|Overall Study|Personal reasons|5|||
144354006|NCT02576639|520500699|FG000|Overall Study|Withdrawal by Subject|1|||
144354007|NCT02576639|520500700|FG001|Overall Study|Withdrawal by Subject|2|||
144354008|NCT02576639|520500701|FG002|Overall Study|Withdrawal by Subject|1|||
144354009|NCT02576639|520500702|FG003|Overall Study|Withdrawal by Subject|0|||
144354010|NCT02576639|520500703|FG004|Overall Study|Withdrawal by Subject|1|||
144354011|NCT02576639|520500699|FG000|Overall Study|Adverse Event|1|||
144354012|NCT02576639|520500700|FG001|Overall Study|Adverse Event|0|||
144354013|NCT02576639|520500701|FG002|Overall Study|Adverse Event|1|||
144354014|NCT02576639|520500702|FG003|Overall Study|Adverse Event|1|||
144354015|NCT02576639|520500703|FG004|Overall Study|Adverse Event|2|||
144354016|NCT02576639|520500699|FG000|Overall Study|Physician Decision|0|||
144354017|NCT02576639|520500700|FG001|Overall Study|Physician Decision|0|||
144354018|NCT02576639|520500701|FG002|Overall Study|Physician Decision|0|||
144354019|NCT02576639|520500702|FG003|Overall Study|Physician Decision|0|||
144354020|NCT02576639|520500703|FG004|Overall Study|Physician Decision|1|||
144354021|NCT01135134|520500704|FG000|Overall Study|Adverse Event|1|||
144354022|NCT01135134|520500705|FG001|Overall Study|Adverse Event|1|||
144354023|NCT01135134|520500704|FG000|Overall Study|Did not meet protocol eligibility|1|||
144354024|NCT01135134|520500705|FG001|Overall Study|Did not meet protocol eligibility|0|||
144354025|NCT00255190|520500710|FG000|Overall Study|Adverse Event|17|||
144354026|NCT00255190|520500711|FG001|Overall Study|Adverse Event|36|||
144354027|NCT00255190|520500710|FG000|Overall Study|Protocol Violation|2|||
144354028|NCT00255190|520500711|FG001|Overall Study|Protocol Violation|2|||
144354029|NCT00255190|520500710|FG000|Overall Study|Lost to Follow-up|10|||
144354030|NCT00255190|520500711|FG001|Overall Study|Lost to Follow-up|27|||
144354031|NCT00255190|520500710|FG000|Overall Study|Withdrew Consent|17|||
144354032|NCT00255190|520500711|FG001|Overall Study|Withdrew Consent|48|||
144354033|NCT00255190|520500710|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
144354034|NCT00255190|520500711|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
144354035|NCT00255190|520500710|FG000|Overall Study|Erosive esophagitis not healed|0|||
144354036|NCT00255190|520500711|FG001|Overall Study|Erosive esophagitis not healed|20|||
144354037|NCT00255190|520500710|FG000|Overall Study|Various|4|||
144354038|NCT00255190|520500711|FG001|Overall Study|Various|23|||
144354039|NCT01156480|520500715|FG000|Overall Study|change in diagnosis|0|||
144354040|NCT01156480|520500716|FG001|Overall Study|change in diagnosis|1|||
144354041|NCT04537793|520500717|FG000|Part B (24 Weeks)|Adverse Event|0|||
144354042|NCT04537793|520500718|FG001|Part B (24 Weeks)|Adverse Event|1|||
144354043|NCT01176058|520500720|FG000|Overall Study|Adverse Event|1|||
144354044|NCT01176058|520500721|FG001|Overall Study|Adverse Event|0|||
144354045|NCT01176058|520500720|FG000|Overall Study|Insufficient clinical response|2|||
144354046|NCT01176058|520500721|FG001|Overall Study|Insufficient clinical response|2|||
144354047|NCT01176058|520500720|FG000|Overall Study|Insufficient mycological response|0|||
144354048|NCT01176058|520500721|FG001|Overall Study|Insufficient mycological response|1|||
144354049|NCT01176058|520500720|FG000|Overall Study|Withdrawal by Subject|1|||
144354050|NCT01176058|520500721|FG001|Overall Study|Withdrawal by Subject|0|||
144354051|NCT01217463|520500724|FG000|Overall Study|Adverse Event|8|||
144354052|NCT01217463|520500725|FG001|Overall Study|Adverse Event|5|||
144354053|NCT01217463|520500724|FG000|Overall Study|Physician Decision|0|||
144354054|NCT01217463|520500725|FG001|Overall Study|Physician Decision|1|||
144354055|NCT01217463|520500724|FG000|Overall Study|Withdrawal by Subject|3|||
144354056|NCT01217463|520500725|FG001|Overall Study|Withdrawal by Subject|0|||
144354057|NCT01217463|520500724|FG000|Overall Study|Surgery on the Target Limb|0|||
144354058|NCT01217463|520500725|FG001|Overall Study|Surgery on the Target Limb|1|||
144354059|NCT01217463|520500724|FG000|Overall Study|Patient Non-compliant|1|||
144354060|NCT01217463|520500725|FG001|Overall Study|Patient Non-compliant|0|||
144354061|NCT01217463|520500724|FG000|Overall Study|Other|1|||
144354062|NCT01217463|520500725|FG001|Overall Study|Other|1|||
144354063|NCT01569841|520500728|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
144354064|NCT01569841|520500729|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
144354065|NCT01859923|520500737|FG000|Overall Study|Adverse Event|0|||
144354066|NCT01859923|520500738|FG001|Overall Study|Adverse Event|0|||
144354067|NCT01859923|520500739|FG002|Overall Study|Adverse Event|1|||
144354068|NCT01859923|520500740|FG003|Overall Study|Adverse Event|1|||
144354069|NCT00057863|520500746|FG000|Overall Study|Death|1|||
144354070|NCT00057863|520500746|FG000|Overall Study|Withdrawal by Subject|2|||
144354071|NCT00764361|520500747|FG000|Overall Study|Withdrawal by Subject|2|||
144354072|NCT00764361|520500748|FG001|Overall Study|Withdrawal by Subject|3|||
144354073|NCT00764361|520500747|FG000|Overall Study|Adverse Event|0|||
144354074|NCT00764361|520500748|FG001|Overall Study|Adverse Event|1|||
144354075|NCT02090426|520500749|FG000|Overall Study|Lost to Follow-up|12|||
144354076|NCT02090426|520500750|FG001|Overall Study|Lost to Follow-up|6|||
144354077|NCT02079038|520500751|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
144354078|NCT02079038|520500752|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
144354079|NCT02079038|520500751|FG000|Modified Intent to Treat Population|Death|1|||
144354080|NCT02079038|520500752|FG001|Modified Intent to Treat Population|Death|0|||
144354081|NCT02079038|520500751|FG000|Completed 6 Months|Lost to Follow-up|2|||
144354082|NCT02079038|520500752|FG001|Completed 6 Months|Lost to Follow-up|1|||
144354083|NCT03634085|520500753|FG000|Overall Study|Adverse Event|1|||
144354084|NCT03634085|520500754|FG001|Overall Study|Adverse Event|0|||
144354085|NCT03634085|520500753|FG000|Overall Study|Withdrawal by Subject|0|||
144354086|NCT03634085|520500754|FG001|Overall Study|Withdrawal by Subject|2|||
144354087|NCT04276233|520500755|FG000|Overall Study|Adverse Event|1|||
144354088|NCT04276233|520500755|FG000|Overall Study|Lost to Follow-up|3|||
144354089|NCT04276233|520500755|FG000|Overall Study|Physician Decision|4|||
144354090|NCT04276233|520500755|FG000|Overall Study|Withdrawal by Subject|2|||
144354091|NCT01721161|520500760|FG000|Overall Study|Adverse Event|2|||
144354092|NCT01721161|520500761|FG001|Overall Study|Adverse Event|3|||
144354093|NCT01721161|520500760|FG000|Overall Study|Lost to Follow-up|1|||
144354094|NCT01721161|520500761|FG001|Overall Study|Lost to Follow-up|2|||
144354095|NCT01721161|520500760|FG000|Overall Study|Withdrawal by Subject|1|||
144354096|NCT01721161|520500761|FG001|Overall Study|Withdrawal by Subject|1|||
144354097|NCT01721161|520500760|FG000|Overall Study|Other|0|||
144354098|NCT01721161|520500761|FG001|Overall Study|Other|1|||
144354099|NCT00148759|520500762|FG000|Overall Study|Withdrawal by Subject|1|||
144354100|NCT00148759|520500763|FG001|Overall Study|Withdrawal by Subject|1|||
144354101|NCT00148759|520500762|FG000|Overall Study|Lost to Follow-up|1|||
144354102|NCT00148759|520500763|FG001|Overall Study|Lost to Follow-up|0|||
144354103|NCT01454596|520500764|FG000|Overall Study|Death|0|||
144354104|NCT01454596|520500765|FG001|Overall Study|Death|0|||
144354105|NCT01454596|520500766|FG002|Overall Study|Death|0|||
144354106|NCT01454596|520500767|FG003|Overall Study|Death|0|||
144354107|NCT01454596|520500768|FG004|Overall Study|Death|0|||
144354108|NCT01454596|520500769|FG005|Overall Study|Death|0|||
144354109|NCT01454596|520500770|FG006|Overall Study|Death|0|||
144354110|NCT01454596|520500771|FG007|Overall Study|Death|0|||
144354111|NCT01454596|520500772|FG008|Overall Study|Death|0|||
144354112|NCT01454596|520500773|FG009|Overall Study|Death|1|||
144354113|NCT01454596|520500774|FG010|Overall Study|Death|1|||
144354114|NCT01454596|520500775|FG011|Overall Study|Death|0|||
144354115|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
144354116|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
144354117|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
144354118|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
144354119|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
144354120|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
144354121|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Death|7|||
144354122|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Death|5|||
144354123|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Death|6|||
144354124|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
144354125|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
144354126|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
144354127|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
144354128|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
144354129|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
144354130|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Other|1|||
144354131|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Other|0|||
144354132|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Other|0|||
144354133|NCT00104650|520500779|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
144354134|NCT00104650|520500780|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
144354135|NCT00104650|520500781|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
144354136|NCT00104650|520500779|FG000|Follow-up Period|Physician Decision|1|||
144354137|NCT00104650|520500780|FG001|Follow-up Period|Physician Decision|1|||
144354138|NCT00104650|520500781|FG002|Follow-up Period|Physician Decision|0|||
144354139|NCT00104650|520500779|FG000|Follow-up Period|Adverse Event|1|||
144354140|NCT00104650|520500780|FG001|Follow-up Period|Adverse Event|0|||
144354141|NCT00104650|520500781|FG002|Follow-up Period|Adverse Event|1|||
144354142|NCT00104650|520500779|FG000|Follow-up Period|Withdrawal by Subject|0|||
144354143|NCT00104650|520500780|FG001|Follow-up Period|Withdrawal by Subject|3|||
144354144|NCT00104650|520500781|FG002|Follow-up Period|Withdrawal by Subject|3|||
144354145|NCT00104650|520500779|FG000|Follow-up Period|Death|6|||
144354146|NCT00104650|520500780|FG001|Follow-up Period|Death|6|||
144354147|NCT00104650|520500781|FG002|Follow-up Period|Death|4|||
144354148|NCT00104650|520500779|FG000|Follow-up Period|Disease progression|3|||
144354149|NCT00104650|520500780|FG001|Follow-up Period|Disease progression|1|||
144354150|NCT00104650|520500781|FG002|Follow-up Period|Disease progression|0|||
144354151|NCT00104650|520500779|FG000|Follow-up Period|Lost to Follow-up|0|||
144354152|NCT00104650|520500780|FG001|Follow-up Period|Lost to Follow-up|1|||
144354153|NCT00104650|520500781|FG002|Follow-up Period|Lost to Follow-up|2|||
144354154|NCT00104650|520500779|FG000|Follow-up Period|Other|0|||
144354155|NCT00104650|520500780|FG001|Follow-up Period|Other|1|||
144354156|NCT00104650|520500781|FG002|Follow-up Period|Other|0|||
144354157|NCT02294058|520500782|FG000|Overall Study|Adverse Event|16|||
144354158|NCT02294058|520500783|FG001|Overall Study|Adverse Event|7|||
144354159|NCT02294058|520500784|FG002|Overall Study|Adverse Event|13|||
144354160|NCT02294058|520500782|FG000|Overall Study|Lack of Efficacy|3|||
144354161|NCT02294058|520500783|FG001|Overall Study|Lack of Efficacy|3|||
144354162|NCT02294058|520500784|FG002|Overall Study|Lack of Efficacy|0|||
144354163|NCT02294058|520500782|FG000|Overall Study|Lost to Follow-up|1|||
144354164|NCT02294058|520500783|FG001|Overall Study|Lost to Follow-up|0|||
144354165|NCT02294058|520500784|FG002|Overall Study|Lost to Follow-up|2|||
144354166|NCT02294058|520500782|FG000|Overall Study|Withdrawal by Subject|10|||
144354167|NCT02294058|520500783|FG001|Overall Study|Withdrawal by Subject|14|||
144354168|NCT02294058|520500784|FG002|Overall Study|Withdrawal by Subject|13|||
144354169|NCT02294058|520500782|FG000|Overall Study|Physician Decision|2|||
144354170|NCT02294058|520500783|FG001|Overall Study|Physician Decision|1|||
144354171|NCT02294058|520500784|FG002|Overall Study|Physician Decision|0|||
144354172|NCT02294058|520500782|FG000|Overall Study|Miscellaneous|4|||
144354173|NCT02294058|520500783|FG001|Overall Study|Miscellaneous|1|||
144354174|NCT02294058|520500784|FG002|Overall Study|Miscellaneous|1|||
144354175|NCT02800863|520500790|FG000|Overall Study|Adverse Event|14|||
144354176|NCT02800863|520500790|FG000|Overall Study|Another Device Implanted|1|||
144354177|NCT02800863|520500790|FG000|Overall Study|Device Explanted|1|||
144354178|NCT02800863|520500790|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
144354179|NCT02800863|520500790|FG000|Overall Study|Health Issues|1|||
144354180|NCT02800863|520500790|FG000|Overall Study|Insurance Denial|8|||
144354181|NCT02800863|520500790|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
144354182|NCT02800863|520500790|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
144354183|NCT02800863|520500790|FG000|Overall Study|Screen Failure|1|||
144354184|NCT02800863|520500790|FG000|Overall Study|Sponsor Request|6|||
144354185|NCT02800863|520500790|FG000|Overall Study|Death|3|||
144354186|NCT02800863|520500790|FG000|Overall Study|Subject Implant at Another Facility|1|||
144354187|NCT02800863|520500790|FG000|Overall Study|Lost to Follow-up|26|||
144354188|NCT02800863|520500790|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
144354189|NCT02800863|520500790|FG000|Overall Study|Subject and/or Family Request|64|||
144354190|NCT02800863|520500790|FG000|Overall Study|Trial Failure|81|||
144354191|NCT02800863|520500790|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
144354192|NCT03957551|520500791|FG000|Overall Study|Adverse Event|2|||
144354193|NCT03957551|520500792|FG001|Overall Study|Adverse Event|2|||
144354194|NCT03957551|520500793|FG002|Overall Study|Adverse Event|6|||
144354195|NCT03957551|520500791|FG000|Overall Study|Physician Decision|1|||
144354196|NCT03957551|520500792|FG001|Overall Study|Physician Decision|0|||
144354197|NCT03957551|520500793|FG002|Overall Study|Physician Decision|2|||
144354198|NCT03957551|520500791|FG000|Overall Study|Withdrawal by Subject|1|||
144354199|NCT03957551|520500792|FG001|Overall Study|Withdrawal by Subject|0|||
144354200|NCT03957551|520500793|FG002|Overall Study|Withdrawal by Subject|2|||
144354201|NCT03957551|520500791|FG000|Overall Study|Disease progression|1|||
144354202|NCT03957551|520500792|FG001|Overall Study|Disease progression|0|||
144354203|NCT03957551|520500793|FG002|Overall Study|Disease progression|8|||
144354204|NCT03775486|520500794|FG000|Initial Therapy Phase|Other reason provided|0|||
144354205|NCT03775486|520500795|FG001|Initial Therapy Phase|Other reason provided|15|||
144354206|NCT03775486|520500794|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
144354207|NCT03775486|520500795|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
144354208|NCT03775486|520500794|FG000|Initial Therapy Phase|Protocol Violation|0|||
144354209|NCT03775486|520500795|FG001|Initial Therapy Phase|Protocol Violation|2|||
144354210|NCT03775486|520500794|FG000|Initial Therapy Phase|Adverse Event|0|||
144354211|NCT03775486|520500795|FG001|Initial Therapy Phase|Adverse Event|34|||
144354212|NCT03775486|520500794|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
144354213|NCT03775486|520500795|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
144354214|NCT03775486|520500794|FG000|Maintenance Phase|Withdrawal by Subject|13|||
144354215|NCT03775486|520500795|FG001|Maintenance Phase|Withdrawal by Subject|12|||
144354216|NCT03775486|520500794|FG000|Maintenance Phase|Death|44|||
144354217|NCT03775486|520500795|FG001|Maintenance Phase|Death|45|||
144354218|NCT01572480|520500796|FG000|Participants Enrolled|Withdrawal by Subject|1|||
144354219|NCT01572480|520500796|FG000|Drug Administration|Discontinued drug/Off Study|1|||
144354220|NCT01572480|520500796|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
144354221|NCT01572480|520500796|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
144354222|NCT00801216|520500797|FG000|Overall Study|Screening Failure|2|||
144354223|NCT05214768|520500798|FG000|Induction Period|Withdrawal by Subject|1|||
144354224|NCT05214768|520500799|FG001|Induction Period|Withdrawal by Subject|0|||
144354225|NCT05214768|520500800|FG002|Induction Period|Withdrawal by Subject|0|||
144354226|NCT05214768|520500801|FG003|Induction Period|Withdrawal by Subject|0|||
144354227|NCT05214768|520500802|FG004|Induction Period|Withdrawal by Subject|0|||
144354228|NCT05214768|520500803|FG005|Induction Period|Withdrawal by Subject|0|||
144354229|NCT05214768|520500798|FG000|Induction Period|Physician Decision|1|||
144354230|NCT05214768|520500799|FG001|Induction Period|Physician Decision|0|||
144354231|NCT05214768|520500800|FG002|Induction Period|Physician Decision|0|||
144354232|NCT05214768|520500801|FG003|Induction Period|Physician Decision|0|||
144354233|NCT05214768|520500802|FG004|Induction Period|Physician Decision|0|||
144354234|NCT05214768|520500803|FG005|Induction Period|Physician Decision|0|||
144354235|NCT05214768|520500798|FG000|Maintenance Period|Other Reasons|0|||
144354236|NCT05214768|520500799|FG001|Maintenance Period|Other Reasons|0|||
144354237|NCT05214768|520500800|FG002|Maintenance Period|Other Reasons|1|||
144354238|NCT05214768|520500801|FG003|Maintenance Period|Other Reasons|1|||
144354239|NCT05214768|520500802|FG004|Maintenance Period|Other Reasons|0|||
144354240|NCT05214768|520500803|FG005|Maintenance Period|Other Reasons|0|||
144354241|NCT05214768|520500798|FG000|Maintenance Period|Withdrawal by Subject|0|||
144354242|NCT05214768|520500799|FG001|Maintenance Period|Withdrawal by Subject|0|||
144354243|NCT05214768|520500800|FG002|Maintenance Period|Withdrawal by Subject|0|||
144354244|NCT05214768|520500801|FG003|Maintenance Period|Withdrawal by Subject|1|||
144354245|NCT05214768|520500802|FG004|Maintenance Period|Withdrawal by Subject|0|||
144354246|NCT05214768|520500803|FG005|Maintenance Period|Withdrawal by Subject|0|||
144354247|NCT05214768|520500798|FG000|Maintenance Period|Lack of Efficacy|0|||
144354248|NCT05214768|520500799|FG001|Maintenance Period|Lack of Efficacy|0|||
144354249|NCT05214768|520500800|FG002|Maintenance Period|Lack of Efficacy|1|||
144354250|NCT05214768|520500801|FG003|Maintenance Period|Lack of Efficacy|0|||
144354251|NCT05214768|520500802|FG004|Maintenance Period|Lack of Efficacy|1|||
144354252|NCT05214768|520500803|FG005|Maintenance Period|Lack of Efficacy|0|||
144354253|NCT05214768|520500798|FG000|Open Label Extension Period|Physician Decision|0|||
144354254|NCT05214768|520500799|FG001|Open Label Extension Period|Physician Decision|0|||
144354255|NCT05214768|520500800|FG002|Open Label Extension Period|Physician Decision|0|||
144354256|NCT05214768|520500801|FG003|Open Label Extension Period|Physician Decision|0|||
144354257|NCT05214768|520500802|FG004|Open Label Extension Period|Physician Decision|0|||
144354258|NCT05214768|520500803|FG005|Open Label Extension Period|Physician Decision|1|||
144354259|NCT05214768|520500798|FG000|Open Label Extension Period|Lack of Efficacy|0|||
144354260|NCT05214768|520500799|FG001|Open Label Extension Period|Lack of Efficacy|0|||
144354261|NCT05214768|520500800|FG002|Open Label Extension Period|Lack of Efficacy|0|||
144354262|NCT05214768|520500801|FG003|Open Label Extension Period|Lack of Efficacy|0|||
144354263|NCT05214768|520500802|FG004|Open Label Extension Period|Lack of Efficacy|0|||
144354264|NCT05214768|520500803|FG005|Open Label Extension Period|Lack of Efficacy|1|||
144354265|NCT05214768|520500798|FG000|Open Label Extension Period|Ongoing Study|0|||
144354266|NCT05214768|520500799|FG001|Open Label Extension Period|Ongoing Study|0|||
144354267|NCT05214768|520500800|FG002|Open Label Extension Period|Ongoing Study|0|||
144354268|NCT05214768|520500801|FG003|Open Label Extension Period|Ongoing Study|0|||
144354269|NCT05214768|520500802|FG004|Open Label Extension Period|Ongoing Study|0|||
144354270|NCT05214768|520500803|FG005|Open Label Extension Period|Ongoing Study|42|||
144354271|NCT05481359|520500804|FG000|Overall Study|Lost to Follow-up|3|||
144354272|NCT05481359|520500804|FG000|Overall Study|Withdrawal by Subject|1|||
144354273|NCT05473026|520502706|FG000|Overall Study|Lost to Follow-up|5|||
144354274|NCT05473026|520502707|FG001|Overall Study|Lost to Follow-up|2|||
144354275|NCT02038153|520502710|FG000|Overall Study|Withdrawal by Subject|1|||
144354276|NCT02647281|520502711|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354277|NCT02647281|520502712|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354278|NCT02647281|520502713|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354279|NCT02647281|520502714|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354280|NCT02647281|520502715|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354281|NCT02647281|520502716|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354282|NCT02647281|520502717|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354283|NCT02647281|520502718|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
144354284|NCT02647281|520502719|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
144354285|NCT01050634|520502720|FG000|Overall Study|Enrolled, but Not Treated|56|||
144354286|NCT01050634|520502720|FG000|Overall Study|Death|2|||
144354287|NCT01050634|520502720|FG000|Overall Study|Adverse Event|42|||
144354288|NCT01050634|520502720|FG000|Overall Study|Lost to Follow-up|2|||
144354289|NCT01050634|520502720|FG000|Overall Study|Other|21|||
144354290|NCT01050634|520502720|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
144354291|NCT03400852|520502726|FG000|Blinded Treatment Period|Physician Decision|0|||
144354292|NCT03400852|520502727|FG001|Blinded Treatment Period|Physician Decision|1|||
144354293|NCT03400852|520502728|FG002|Blinded Treatment Period|Physician Decision|0|||
144354294|NCT03400852|520502726|FG000|Blinded Treatment Period|Adverse Event|1|||
144354295|NCT03400852|520502727|FG001|Blinded Treatment Period|Adverse Event|1|||
144354296|NCT03400852|520502728|FG002|Blinded Treatment Period|Adverse Event|0|||
144354297|NCT03400852|520502726|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
144354298|NCT03400852|520502727|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
144354299|NCT03400852|520502728|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
144354300|NCT03400852|520502726|FG000|Open Label Period|Physician Decision|0|||
144354301|NCT03400852|520502727|FG001|Open Label Period|Physician Decision|0|||
144354302|NCT03400852|520502728|FG002|Open Label Period|Physician Decision|1|||
144354303|NCT03400852|520502726|FG000|Open Label Period|Study terminated by sponsor|0|||
144354304|NCT03400852|520502727|FG001|Open Label Period|Study terminated by sponsor|0|||
144354305|NCT03400852|520502728|FG002|Open Label Period|Study terminated by sponsor|21|||
144354306|NCT03294590|520502732|FG000|Overall Study|Lost to Follow-up|105|||
144354307|NCT03294590|520502733|FG001|Overall Study|Lost to Follow-up|107|||
144354308|NCT00628030|520502734|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
144354309|NCT00628030|520502735|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
144354310|NCT00628030|520502734|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
144354311|NCT00628030|520502735|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
144354312|NCT00628030|520502734|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
144354313|NCT00628030|520502735|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
144354314|NCT01255423|520502736|FG000|Overall Study|Abnormal Laboratory value|3|||
144354315|NCT01255423|520502737|FG001|Overall Study|Abnormal Laboratory value|2|||
144354316|NCT01255423|520502736|FG000|Overall Study|Use of prohibited medications|0|||
144354317|NCT01255423|520502737|FG001|Overall Study|Use of prohibited medications|1|||
144354318|NCT03367858|520502738|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
144354319|NCT03367858|520502739|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
144354320|NCT03367858|520502738|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
144354321|NCT03367858|520502739|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
144354322|NCT03367858|520502738|FG000|3 Month Follow Up|Lost to Follow-up|8|||
144354323|NCT03367858|520502739|FG001|3 Month Follow Up|Lost to Follow-up|3|||
144354324|NCT03367858|520502738|FG000|3 Month Follow Up|Moved out of study area|2|||
144354325|NCT03367858|520502739|FG001|3 Month Follow Up|Moved out of study area|6|||
144354326|NCT03367858|520502738|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
144354327|NCT03367858|520502739|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
144354328|NCT03367858|520502738|FG000|3 Month Follow Up|MRI contraindication|2|||
144354329|NCT03367858|520502739|FG001|3 Month Follow Up|MRI contraindication|1|||
144354330|NCT03367858|520502738|FG000|3 Month Follow Up|Incarcerated|0|||
144354331|NCT03367858|520502739|FG001|3 Month Follow Up|Incarcerated|1|||
144354332|NCT03367858|520502738|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
144354333|NCT03367858|520502739|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
144354334|NCT03367858|520502738|FG000|6 Month Follow Up|Lost to Follow-up|5|||
144354335|NCT03367858|520502739|FG001|6 Month Follow Up|Lost to Follow-up|2|||
144354336|NCT03367858|520502738|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
144354337|NCT03367858|520502739|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
144354338|NCT03367858|520502738|FG000|12 Month Follow Up|Lost to Follow-up|3|||
144354339|NCT03367858|520502739|FG001|12 Month Follow Up|Lost to Follow-up|3|||
144354340|NCT03367858|520502738|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
144354341|NCT03367858|520502739|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
144354342|NCT00256724|520502740|FG000|Overall Study|Physician Decision|2|||
144354343|NCT00256724|520502741|FG001|Overall Study|Physician Decision|5|||
144354344|NCT00256724|520502740|FG000|Overall Study|Protocol Violation|3|||
144354345|NCT00256724|520502741|FG001|Overall Study|Protocol Violation|3|||
144354346|NCT01858363|520502742|FG000|Overall Study|Death|35|||
144354347|NCT01858363|520502743|FG001|Overall Study|Death|9|||
144354348|NCT01858363|520502742|FG000|Overall Study|Withdrawal by Subject|28|||
144354349|NCT01858363|520502743|FG001|Overall Study|Withdrawal by Subject|14|||
144354350|NCT01858363|520502742|FG000|Overall Study|Lost to Follow-up|13|||
144354351|NCT01858363|520502743|FG001|Overall Study|Lost to Follow-up|3|||
144354352|NCT00296816|520502746|FG000|Overall Study|Disease Progression|37|||
144354353|NCT00296816|520502746|FG000|Overall Study|Adverse Event|18|||
144354354|NCT00296816|520502746|FG000|Overall Study|Investigator/Participant request|5|||
144354355|NCT00296816|520502746|FG000|Overall Study|Non-compliance|1|||
144354356|NCT00296816|520502746|FG000|Overall Study|Missing for end of treatment|4|||
144354357|NCT00296816|520502746|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
144354358|NCT00296816|520502746|FG000|Overall Study|Poor performance status|1|||
144354359|NCT00296816|520502746|FG000|Overall Study|Relocation to Florida|1|||
144354360|NCT00296816|520502746|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
144354361|NCT00296816|520502746|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
144354362|NCT00296816|520502746|FG000|Overall Study|Neuropathy/patient preference|1|||
144354363|NCT00296816|520502746|FG000|Overall Study|Proteinuria|1|||
144354364|NCT00296816|520502746|FG000|Overall Study|ineligibility due to radiation treatment|1|||
144354365|NCT01054456|520502747|FG000|Overall Study|Other|1|||
144354366|NCT01292187|520502748|FG000|Overall Study|Adverse Event|10|||
144354367|NCT01292187|520502749|FG001|Overall Study|Adverse Event|5|||
144354368|NCT01292187|520502748|FG000|Overall Study|Withdrawal by Subject|6|||
144354369|NCT01292187|520502749|FG001|Overall Study|Withdrawal by Subject|5|||
144354370|NCT01292187|520502748|FG000|Overall Study|All other reasons|1|||
144354371|NCT01292187|520502749|FG001|Overall Study|All other reasons|3|||
144354372|NCT00687401|520502751|FG000|Overall Study|Protocol Violation|7|||
144354373|NCT00687401|520502751|FG000|Overall Study|Adverse Event|6|||
144354374|NCT00687401|520502751|FG000|Overall Study|Lack of Efficacy|6|||
144354375|NCT00687401|520502751|FG000|Overall Study|Withdrawal by Subject|4|||
144354376|NCT00687401|520502751|FG000|Overall Study|Did not return for visit|3|||
144354377|NCT00687401|520502751|FG000|Overall Study|For reasons different from those above|4|||
144354378|NCT02552966|520502752|FG000|Overall Study|Lost to Follow-up|2|||
144354379|NCT02552966|520502752|FG000|Overall Study|Withdrawal by Subject|3|||
144354380|NCT02888106|520502760|FG000|Overall Study|Withdrawal by Subject|1|||
144354381|NCT02888106|520502761|FG001|Overall Study|Withdrawal by Subject|2|||
144354382|NCT02888106|520502762|FG002|Overall Study|Withdrawal by Subject|0|||
144354383|NCT02888106|520502763|FG003|Overall Study|Withdrawal by Subject|1|||
144354384|NCT02888106|520502764|FG004|Overall Study|Withdrawal by Subject|0|||
144354385|NCT02888106|520502765|FG005|Overall Study|Withdrawal by Subject|0|||
144354386|NCT02888106|520502760|FG000|Overall Study|Lost to Follow-up|1|||
144354387|NCT02888106|520502761|FG001|Overall Study|Lost to Follow-up|0|||
144354388|NCT02888106|520502762|FG002|Overall Study|Lost to Follow-up|0|||
144354389|NCT02888106|520502763|FG003|Overall Study|Lost to Follow-up|1|||
144354390|NCT02888106|520502764|FG004|Overall Study|Lost to Follow-up|0|||
144354391|NCT02888106|520502765|FG005|Overall Study|Lost to Follow-up|1|||
144354392|NCT02888106|520502760|FG000|Overall Study|Adverse Event|2|||
144354393|NCT02888106|520502761|FG001|Overall Study|Adverse Event|0|||
144354394|NCT02888106|520502762|FG002|Overall Study|Adverse Event|0|||
144354395|NCT02888106|520502763|FG003|Overall Study|Adverse Event|0|||
144354396|NCT02888106|520502764|FG004|Overall Study|Adverse Event|0|||
144354397|NCT02888106|520502765|FG005|Overall Study|Adverse Event|0|||
144354398|NCT02888106|520502760|FG000|Overall Study|Withdrawal of consent|0|||
144354399|NCT02888106|520502761|FG001|Overall Study|Withdrawal of consent|0|||
144354400|NCT02888106|520502762|FG002|Overall Study|Withdrawal of consent|0|||
144354401|NCT02888106|520502763|FG003|Overall Study|Withdrawal of consent|0|||
144354402|NCT02888106|520502764|FG004|Overall Study|Withdrawal of consent|1|||
144354403|NCT02888106|520502765|FG005|Overall Study|Withdrawal of consent|0|||
144354404|NCT02888106|520502760|FG000|Overall Study|Pregnancy|1|||
144354405|NCT02888106|520502761|FG001|Overall Study|Pregnancy|0|||
144354406|NCT02888106|520502762|FG002|Overall Study|Pregnancy|0|||
144354407|NCT02888106|520502763|FG003|Overall Study|Pregnancy|0|||
144354408|NCT02888106|520502764|FG004|Overall Study|Pregnancy|0|||
144354409|NCT02888106|520502765|FG005|Overall Study|Pregnancy|0|||
144354410|NCT00430716|520502770|FG000|Double Blind Phase|Death|1|||
144354411|NCT00430716|520502771|FG001|Double Blind Phase|Death|0|||
144354412|NCT00430716|520502772|FG002|Double Blind Phase|Death|0|||
144354413|NCT00430716|520502770|FG000|Double Blind Phase|No longer willing to participate|2|||
144354414|NCT00430716|520502771|FG001|Double Blind Phase|No longer willing to participate|1|||
144354415|NCT00430716|520502772|FG002|Double Blind Phase|No longer willing to participate|1|||
144354416|NCT00430716|520502770|FG000|Double Blind Phase|Other|0|||
144354417|NCT00430716|520502771|FG001|Double Blind Phase|Other|2|||
144354418|NCT00430716|520502772|FG002|Double Blind Phase|Other|0|||
144354419|NCT00430716|520502770|FG000|Double Blind Phase|Study terminated by sponsor|1|||
144354420|NCT00430716|520502771|FG001|Double Blind Phase|Study terminated by sponsor|1|||
144354421|NCT00430716|520502772|FG002|Double Blind Phase|Study terminated by sponsor|2|||
144354422|NCT00430716|520502770|FG000|Double Blind Phase|Adverse Event|1|||
144354423|NCT00430716|520502771|FG001|Double Blind Phase|Adverse Event|1|||
144354424|NCT00430716|520502772|FG002|Double Blind Phase|Adverse Event|3|||
144354425|NCT00430716|520502770|FG000|Double Blind Phase|Not treated|1|||
144354426|NCT00430716|520502771|FG001|Double Blind Phase|Not treated|0|||
144354427|NCT00430716|520502772|FG002|Double Blind Phase|Not treated|0|||
144354428|NCT00430716|520502770|FG000|Open Label Phase|Lost to Follow-up|1|||
144354429|NCT00430716|520502771|FG001|Open Label Phase|Lost to Follow-up|0|||
144354430|NCT00430716|520502772|FG002|Open Label Phase|Lost to Follow-up|1|||
144354431|NCT00430716|520502770|FG000|Open Label Phase|No longer willing to participate|0|||
144354432|NCT00430716|520502771|FG001|Open Label Phase|No longer willing to participate|1|||
144354433|NCT00430716|520502772|FG002|Open Label Phase|No longer willing to participate|1|||
144354434|NCT00430716|520502770|FG000|Open Label Phase|Other|3|||
144354435|NCT00430716|520502771|FG001|Open Label Phase|Other|1|||
144354436|NCT00430716|520502772|FG002|Open Label Phase|Other|1|||
144354437|NCT00430716|520502770|FG000|Open Label Phase|Protocol Violation|1|||
144354438|NCT00430716|520502771|FG001|Open Label Phase|Protocol Violation|0|||
144354439|NCT00430716|520502772|FG002|Open Label Phase|Protocol Violation|0|||
144354440|NCT00430716|520502770|FG000|Open Label Phase|Study terminated by sponsor|4|||
144354441|NCT00430716|520502771|FG001|Open Label Phase|Study terminated by sponsor|5|||
144354442|NCT00430716|520502772|FG002|Open Label Phase|Study terminated by sponsor|4|||
144354443|NCT01188772|520502776|FG000|Overall Study|Randomized but Not Treated|0|||
144354444|NCT01188772|520502777|FG001|Overall Study|Randomized but Not Treated|1|||
144354445|NCT01188772|520502778|FG002|Overall Study|Randomized but Not Treated|0|||
144354446|NCT01188772|520502779|FG003|Overall Study|Randomized but Not Treated|0|||
144354447|NCT01188772|520502776|FG000|Overall Study|Adverse Event|0|||
144354448|NCT01188772|520502777|FG001|Overall Study|Adverse Event|1|||
144354449|NCT01188772|520502778|FG002|Overall Study|Adverse Event|2|||
144354450|NCT01188772|520502779|FG003|Overall Study|Adverse Event|0|||
144354451|NCT01188772|520502776|FG000|Overall Study|Lost to Follow-up|4|||
144354452|NCT01188772|520502777|FG001|Overall Study|Lost to Follow-up|1|||
144354453|NCT01188772|520502778|FG002|Overall Study|Lost to Follow-up|1|||
144354454|NCT01188772|520502779|FG003|Overall Study|Lost to Follow-up|1|||
144354455|NCT01188772|520502776|FG000|Overall Study|Non-responder|0|||
144354456|NCT01188772|520502777|FG001|Overall Study|Non-responder|0|||
144354457|NCT01188772|520502778|FG002|Overall Study|Non-responder|3|||
144354458|NCT01188772|520502779|FG003|Overall Study|Non-responder|0|||
144354459|NCT01188772|520502776|FG000|Overall Study|Physician Decision|0|||
144354460|NCT01188772|520502777|FG001|Overall Study|Physician Decision|0|||
144354461|NCT01188772|520502778|FG002|Overall Study|Physician Decision|1|||
144354462|NCT01188772|520502779|FG003|Overall Study|Physician Decision|0|||
144354463|NCT01188772|520502776|FG000|Overall Study|Terminated by Sponsor|0|||
144354464|NCT01188772|520502777|FG001|Overall Study|Terminated by Sponsor|0|||
144354465|NCT01188772|520502778|FG002|Overall Study|Terminated by Sponsor|1|||
144354466|NCT01188772|520502779|FG003|Overall Study|Terminated by Sponsor|0|||
144354467|NCT01188772|520502776|FG000|Overall Study|Treatment Failure|0|||
144354468|NCT01188772|520502777|FG001|Overall Study|Treatment Failure|0|||
144354469|NCT01188772|520502778|FG002|Overall Study|Treatment Failure|1|||
144354470|NCT01188772|520502779|FG003|Overall Study|Treatment Failure|0|||
144354471|NCT01188772|520502776|FG000|Overall Study|Virologic Failure|1|||
144354472|NCT01188772|520502777|FG001|Overall Study|Virologic Failure|0|||
144354473|NCT01188772|520502778|FG002|Overall Study|Virologic Failure|0|||
144354474|NCT01188772|520502779|FG003|Overall Study|Virologic Failure|0|||
144354475|NCT01188772|520502776|FG000|Overall Study|Withdrawal by Subject|0|||
144354476|NCT01188772|520502777|FG001|Overall Study|Withdrawal by Subject|0|||
144354477|NCT01188772|520502778|FG002|Overall Study|Withdrawal by Subject|2|||
144354478|NCT01188772|520502779|FG003|Overall Study|Withdrawal by Subject|0|||
144354479|NCT01433172|520502780|FG000|Overall Study|Withdrawal by Subject|0|||
144354480|NCT01433172|520502781|FG001|Overall Study|Withdrawal by Subject|1|||
144354481|NCT01433172|520502782|FG002|Overall Study|Withdrawal by Subject|0|||
144354482|NCT01433172|520502780|FG000|Overall Study|Disease Progression|0|||
144354483|NCT01433172|520502781|FG001|Overall Study|Disease Progression|0|||
144354484|NCT01433172|520502782|FG002|Overall Study|Disease Progression|1|||
144354485|NCT01433172|520502780|FG000|Overall Study|Death|0|||
144354486|NCT01433172|520502781|FG001|Overall Study|Death|2|||
144354487|NCT01433172|520502782|FG002|Overall Study|Death|0|||
144354488|NCT01894607|520502786|FG000|Overall Study|Ineligible|1|||
144354489|NCT03259555|520502797|FG000|Overall Study|Adverse Event|6|||
144354490|NCT03259555|520502798|FG001|Overall Study|Adverse Event|4|||
144354491|NCT03259555|520502797|FG000|Overall Study|Lack of Efficacy|6|||
144354492|NCT03259555|520502798|FG001|Overall Study|Lack of Efficacy|4|||
144354493|NCT03259555|520502797|FG000|Overall Study|Lost to Follow-up|0|||
144354494|NCT03259555|520502798|FG001|Overall Study|Lost to Follow-up|2|||
144354495|NCT03259555|520502797|FG000|Overall Study|Non-Compliance With Study Drug|1|||
144354496|NCT03259555|520502798|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144354497|NCT03259555|520502797|FG000|Overall Study|Progressive Disease|0|||
144354498|NCT03259555|520502798|FG001|Overall Study|Progressive Disease|2|||
144354499|NCT03259555|520502797|FG000|Overall Study|Withdrawal by Subject|19|||
144354500|NCT03259555|520502798|FG001|Overall Study|Withdrawal by Subject|16|||
144354501|NCT03259555|520502797|FG000|Overall Study|Physician Decision|1|||
144354502|NCT03259555|520502798|FG001|Overall Study|Physician Decision|2|||
144354503|NCT03259555|520502797|FG000|Overall Study|Other|1|||
144354504|NCT03259555|520502798|FG001|Overall Study|Other|0|||
144354505|NCT00607087|520502799|FG000|Overall Study|Withdrawal by Subject|9|||
144354506|NCT00607087|520502800|FG001|Overall Study|Withdrawal by Subject|4|||
144354507|NCT00607087|520502801|FG002|Overall Study|Withdrawal by Subject|4|||
144354508|NCT00607087|520502799|FG000|Overall Study|Adverse Event|3|||
144354509|NCT00607087|520502800|FG001|Overall Study|Adverse Event|2|||
144354510|NCT00607087|520502801|FG002|Overall Study|Adverse Event|3|||
144354511|NCT00607087|520502799|FG000|Overall Study|Other reason|1|||
144354512|NCT00607087|520502800|FG001|Overall Study|Other reason|5|||
144354513|NCT00607087|520502801|FG002|Overall Study|Other reason|2|||
144354514|NCT00607087|520502799|FG000|Overall Study|Poor compliance to protocol|1|||
144354515|NCT00607087|520502800|FG001|Overall Study|Poor compliance to protocol|0|||
144354516|NCT00607087|520502801|FG002|Overall Study|Poor compliance to protocol|1|||
144354517|NCT00607087|520502799|FG000|Overall Study|Lost to Follow-up|1|||
144354518|NCT00607087|520502800|FG001|Overall Study|Lost to Follow-up|0|||
144354519|NCT00607087|520502801|FG002|Overall Study|Lost to Follow-up|0|||
144354520|NCT00607087|520502799|FG000|Period 1|Withdrawal by Subject|7|||
144354521|NCT00607087|520502800|FG001|Period 1|Withdrawal by Subject|2|||
144354522|NCT00607087|520502801|FG002|Period 1|Withdrawal by Subject|3|||
144354523|NCT00607087|520502799|FG000|Period 1|Adverse Event|3|||
144354524|NCT00607087|520502800|FG001|Period 1|Adverse Event|0|||
144354525|NCT00607087|520502801|FG002|Period 1|Adverse Event|0|||
144354526|NCT00607087|520502799|FG000|Period 1|Poor compliance to protocol|1|||
144354527|NCT00607087|520502800|FG001|Period 1|Poor compliance to protocol|0|||
144354528|NCT00607087|520502801|FG002|Period 1|Poor compliance to protocol|0|||
144354529|NCT00607087|520502799|FG000|Period 1|Lost to Follow-up|1|||
144354530|NCT00607087|520502800|FG001|Period 1|Lost to Follow-up|0|||
144354531|NCT00607087|520502801|FG002|Period 1|Lost to Follow-up|0|||
144354532|NCT00607087|520502799|FG000|Period 1|Other reason|0|||
144354533|NCT00607087|520502800|FG001|Period 1|Other reason|4|||
144354534|NCT00607087|520502801|FG002|Period 1|Other reason|2|||
144354535|NCT00607087|520502799|FG000|Period 2|Withdrawal by Subject|0|||
144354536|NCT00607087|520502800|FG001|Period 2|Withdrawal by Subject|1|||
144354537|NCT00607087|520502801|FG002|Period 2|Withdrawal by Subject|1|||
144354538|NCT00607087|520502799|FG000|Period 2|Other reason|1|||
144354539|NCT00607087|520502800|FG001|Period 2|Other reason|1|||
144354540|NCT00607087|520502801|FG002|Period 2|Other reason|0|||
144354541|NCT00607087|520502799|FG000|Period 2|Adverse Event|0|||
144354542|NCT00607087|520502800|FG001|Period 2|Adverse Event|1|||
144354543|NCT00607087|520502801|FG002|Period 2|Adverse Event|3|||
144354544|NCT00607087|520502799|FG000|Period 2|Poor compliance to protocol|0|||
144354545|NCT00607087|520502800|FG001|Period 2|Poor compliance to protocol|0|||
144354546|NCT00607087|520502801|FG002|Period 2|Poor compliance to protocol|1|||
144354547|NCT00607087|520502799|FG000|Period 3|Withdrawal by Subject|2|||
144354548|NCT00607087|520502800|FG001|Period 3|Withdrawal by Subject|1|||
144354549|NCT00607087|520502801|FG002|Period 3|Withdrawal by Subject|0|||
144354550|NCT00607087|520502799|FG000|Period 3|Adverse Event|0|||
144354551|NCT00607087|520502800|FG001|Period 3|Adverse Event|1|||
144354552|NCT00607087|520502801|FG002|Period 3|Adverse Event|0|||
144354553|NCT02717494|520502803|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
144354554|NCT02717494|520502804|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
144354555|NCT02717494|520502805|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
144354556|NCT02717494|520502803|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
144354557|NCT02717494|520502804|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
144354558|NCT02717494|520502805|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
144354559|NCT02717494|520502803|FG000|First Intervention (Step 1)|Death|0|||
144354560|NCT02717494|520502804|FG001|First Intervention (Step 1)|Death|0|||
144354561|NCT02717494|520502805|FG002|First Intervention (Step 1)|Death|1|||
144354562|NCT02717494|520502803|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
144354563|NCT02717494|520502804|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
144354564|NCT02717494|520502805|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
144354565|NCT04393493|520502810|FG000|First 4 Days of Intervention|Early improvement|5|||
144354566|NCT04393493|520502811|FG001|First 4 Days of Intervention|Early improvement|7|||
144354567|NCT01125800|520502812|FG000|Phase I|Protocol Violation|0|||
144354568|NCT01125800|520502813|FG001|Phase I|Protocol Violation|3|||
144354569|NCT01125800|520502814|FG002|Phase I|Protocol Violation|1|||
144354570|NCT01125800|520502815|FG003|Phase I|Protocol Violation|1|||
144354571|NCT01125800|520502816|FG004|Phase I|Protocol Violation|0|||
144354572|NCT01125800|520502812|FG000|Phase I|Adverse Event|2|||
144354573|NCT01125800|520502813|FG001|Phase I|Adverse Event|2|||
144354574|NCT01125800|520502814|FG002|Phase I|Adverse Event|1|||
144354575|NCT01125800|520502815|FG003|Phase I|Adverse Event|7|||
144354576|NCT01125800|520502816|FG004|Phase I|Adverse Event|0|||
144354577|NCT01125800|520502812|FG000|Phase I|Administrative problems|1|||
144354578|NCT01125800|520502813|FG001|Phase I|Administrative problems|0|||
144354579|NCT01125800|520502814|FG002|Phase I|Administrative problems|0|||
144354580|NCT01125800|520502815|FG003|Phase I|Administrative problems|0|||
144354581|NCT01125800|520502816|FG004|Phase I|Administrative problems|0|||
144354582|NCT01125800|520502812|FG000|Phase I|Withdrawal by Subject|0|||
144354583|NCT01125800|520502813|FG001|Phase I|Withdrawal by Subject|0|||
144354584|NCT01125800|520502814|FG002|Phase I|Withdrawal by Subject|1|||
144354585|NCT01125800|520502815|FG003|Phase I|Withdrawal by Subject|0|||
144354586|NCT01125800|520502816|FG004|Phase I|Withdrawal by Subject|0|||
144354587|NCT01125800|520502812|FG000|Phase I|Disease progression|5|||
144354588|NCT01125800|520502813|FG001|Phase I|Disease progression|4|||
144354589|NCT01125800|520502814|FG002|Phase I|Disease progression|1|||
144354590|NCT01125800|520502815|FG003|Phase I|Disease progression|3|||
144354591|NCT01125800|520502816|FG004|Phase I|Disease progression|0|||
144354592|NCT01125800|520502812|FG000|Phase II|Protocol Violation|0|||
144354593|NCT01125800|520502813|FG001|Phase II|Protocol Violation|0|||
144354594|NCT01125800|520502814|FG002|Phase II|Protocol Violation|0|||
144354595|NCT01125800|520502815|FG003|Phase II|Protocol Violation|0|||
144354596|NCT01125800|520502816|FG004|Phase II|Protocol Violation|1|||
144354597|NCT01125800|520502812|FG000|Phase II|Adverse Event|0|||
144354598|NCT01125800|520502813|FG001|Phase II|Adverse Event|0|||
144354599|NCT01125800|520502814|FG002|Phase II|Adverse Event|0|||
144354600|NCT01125800|520502815|FG003|Phase II|Adverse Event|0|||
144354601|NCT01125800|520502816|FG004|Phase II|Adverse Event|2|||
144354602|NCT01125800|520502812|FG000|Phase II|Disease progression|0|||
144354603|NCT01125800|520502813|FG001|Phase II|Disease progression|0|||
144354604|NCT01125800|520502814|FG002|Phase II|Disease progression|0|||
144354605|NCT01125800|520502815|FG003|Phase II|Disease progression|1|||
144354606|NCT01125800|520502816|FG004|Phase II|Disease progression|8|||
144354607|NCT03370718|520502817|FG000|Overall Study|Withdrawal by Subject|1|||
144354608|NCT03116685|520502820|FG000|Overall Study|Physician Decision|0|||
144354609|NCT03116685|520502821|FG001|Overall Study|Physician Decision|1|||
144354610|NCT05579977|520502823|FG000|Treatment Phase|Other|0|||
144354611|NCT05579977|520502824|FG001|Treatment Phase|Other|0|||
144354612|NCT05579977|520502825|FG002|Treatment Phase|Other|0|||
144354613|NCT05579977|520502826|FG003|Treatment Phase|Other|2|||
144354614|NCT05579977|520502827|FG004|Treatment Phase|Other|1|||
144354615|NCT05579977|520502828|FG005|Treatment Phase|Other|2|||
144354616|NCT05579977|520502829|FG006|Treatment Phase|Other|1|||
144354617|NCT05579977|520502830|FG007|Treatment Phase|Other|2|||
144354618|NCT05579977|520502831|FG008|Treatment Phase|Other|2|||
144354619|NCT05579977|520502832|FG009|Treatment Phase|Other|1|||
144354620|NCT05579977|520502833|FG010|Treatment Phase|Other|0|||
144354621|NCT05579977|520502834|FG011|Treatment Phase|Other|0|||
144354622|NCT05579977|520502835|FG012|Treatment Phase|Other|3|||
144354623|NCT05579977|520502823|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
144354624|NCT05579977|520502824|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
144354625|NCT05579977|520502825|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
144354626|NCT05579977|520502826|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
144354627|NCT05579977|520502827|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
144354628|NCT05579977|520502828|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
144354629|NCT05579977|520502829|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
144354630|NCT05579977|520502830|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
144354631|NCT05579977|520502831|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
144354632|NCT05579977|520502832|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
144354633|NCT05579977|520502833|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
144354634|NCT05579977|520502834|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
144354635|NCT05579977|520502835|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
144354636|NCT05579977|520502823|FG000|Treatment Phase|Withdrawal by Subject|2|||
144354637|NCT05579977|520502824|FG001|Treatment Phase|Withdrawal by Subject|0|||
144354638|NCT05579977|520502825|FG002|Treatment Phase|Withdrawal by Subject|0|||
144354639|NCT05579977|520502826|FG003|Treatment Phase|Withdrawal by Subject|1|||
144354640|NCT05579977|520502827|FG004|Treatment Phase|Withdrawal by Subject|2|||
144354641|NCT05579977|520502828|FG005|Treatment Phase|Withdrawal by Subject|0|||
144354642|NCT05579977|520502829|FG006|Treatment Phase|Withdrawal by Subject|1|||
144354643|NCT05579977|520502830|FG007|Treatment Phase|Withdrawal by Subject|8|||
144354644|NCT05579977|520502831|FG008|Treatment Phase|Withdrawal by Subject|3|||
144354645|NCT05579977|520502832|FG009|Treatment Phase|Withdrawal by Subject|3|||
144354646|NCT05579977|520502833|FG010|Treatment Phase|Withdrawal by Subject|5|||
144354647|NCT05579977|520502834|FG011|Treatment Phase|Withdrawal by Subject|1|||
144354648|NCT05579977|520502835|FG012|Treatment Phase|Withdrawal by Subject|3|||
144354649|NCT05579977|520502823|FG000|Treatment Phase|Study terminated by sponsor|70|||
144354650|NCT05579977|520502824|FG001|Treatment Phase|Study terminated by sponsor|70|||
144354651|NCT05579977|520502825|FG002|Treatment Phase|Study terminated by sponsor|61|||
144354652|NCT05579977|520502826|FG003|Treatment Phase|Study terminated by sponsor|59|||
144354653|NCT05579977|520502827|FG004|Treatment Phase|Study terminated by sponsor|63|||
144354654|NCT05579977|520502828|FG005|Treatment Phase|Study terminated by sponsor|53|||
144354655|NCT05579977|520502829|FG006|Treatment Phase|Study terminated by sponsor|66|||
144354656|NCT05579977|520502830|FG007|Treatment Phase|Study terminated by sponsor|48|||
144354657|NCT05579977|520502831|FG008|Treatment Phase|Study terminated by sponsor|47|||
144354658|NCT05579977|520502832|FG009|Treatment Phase|Study terminated by sponsor|37|||
144354659|NCT05579977|520502833|FG010|Treatment Phase|Study terminated by sponsor|44|||
144354660|NCT05579977|520502834|FG011|Treatment Phase|Study terminated by sponsor|36|||
144354661|NCT05579977|520502835|FG012|Treatment Phase|Study terminated by sponsor|32|||
144354662|NCT05579977|520502823|FG000|Treatment Phase|Pregnancy|0|||
144354663|NCT05579977|520502824|FG001|Treatment Phase|Pregnancy|0|||
144354664|NCT05579977|520502825|FG002|Treatment Phase|Pregnancy|0|||
144354665|NCT05579977|520502826|FG003|Treatment Phase|Pregnancy|0|||
144354666|NCT05579977|520502827|FG004|Treatment Phase|Pregnancy|0|||
144354667|NCT05579977|520502828|FG005|Treatment Phase|Pregnancy|0|||
144354668|NCT05579977|520502829|FG006|Treatment Phase|Pregnancy|0|||
144354669|NCT05579977|520502830|FG007|Treatment Phase|Pregnancy|0|||
144354670|NCT05579977|520502831|FG008|Treatment Phase|Pregnancy|0|||
144354671|NCT05579977|520502832|FG009|Treatment Phase|Pregnancy|1|||
144354672|NCT05579977|520502833|FG010|Treatment Phase|Pregnancy|0|||
144354673|NCT05579977|520502834|FG011|Treatment Phase|Pregnancy|0|||
144354674|NCT05579977|520502835|FG012|Treatment Phase|Pregnancy|0|||
144354675|NCT05579977|520502823|FG000|Treatment Phase|Physician Decision|0|||
144354676|NCT05579977|520502824|FG001|Treatment Phase|Physician Decision|0|||
144354677|NCT05579977|520502825|FG002|Treatment Phase|Physician Decision|0|||
144354678|NCT05579977|520502826|FG003|Treatment Phase|Physician Decision|0|||
144354679|NCT05579977|520502827|FG004|Treatment Phase|Physician Decision|0|||
144354680|NCT05579977|520502828|FG005|Treatment Phase|Physician Decision|0|||
144354681|NCT05579977|520502829|FG006|Treatment Phase|Physician Decision|0|||
144354682|NCT05579977|520502830|FG007|Treatment Phase|Physician Decision|0|||
144354683|NCT05579977|520502831|FG008|Treatment Phase|Physician Decision|0|||
144354684|NCT05579977|520502832|FG009|Treatment Phase|Physician Decision|0|||
144354685|NCT05579977|520502833|FG010|Treatment Phase|Physician Decision|0|||
144354686|NCT05579977|520502834|FG011|Treatment Phase|Physician Decision|1|||
144354687|NCT05579977|520502835|FG012|Treatment Phase|Physician Decision|0|||
144354688|NCT05579977|520502823|FG000|Treatment Phase|Lost to Follow-up|0|||
144354689|NCT05579977|520502824|FG001|Treatment Phase|Lost to Follow-up|0|||
144354690|NCT05579977|520502825|FG002|Treatment Phase|Lost to Follow-up|0|||
144354691|NCT05579977|520502826|FG003|Treatment Phase|Lost to Follow-up|1|||
144354692|NCT05579977|520502827|FG004|Treatment Phase|Lost to Follow-up|1|||
144354693|NCT05579977|520502828|FG005|Treatment Phase|Lost to Follow-up|1|||
144354694|NCT05579977|520502829|FG006|Treatment Phase|Lost to Follow-up|0|||
144354695|NCT05579977|520502830|FG007|Treatment Phase|Lost to Follow-up|1|||
144354696|NCT05579977|520502831|FG008|Treatment Phase|Lost to Follow-up|2|||
144354697|NCT05579977|520502832|FG009|Treatment Phase|Lost to Follow-up|2|||
144354698|NCT05579977|520502833|FG010|Treatment Phase|Lost to Follow-up|1|||
144354699|NCT05579977|520502834|FG011|Treatment Phase|Lost to Follow-up|4|||
144354700|NCT05579977|520502835|FG012|Treatment Phase|Lost to Follow-up|3|||
144354701|NCT05579977|520502823|FG000|Treatment Phase|Death|1|||
144354702|NCT05579977|520502824|FG001|Treatment Phase|Death|0|||
144354703|NCT05579977|520502825|FG002|Treatment Phase|Death|0|||
144354704|NCT05579977|520502826|FG003|Treatment Phase|Death|0|||
144354705|NCT05579977|520502827|FG004|Treatment Phase|Death|0|||
144354706|NCT05579977|520502828|FG005|Treatment Phase|Death|0|||
144354707|NCT05579977|520502829|FG006|Treatment Phase|Death|0|||
144354708|NCT05579977|520502830|FG007|Treatment Phase|Death|0|||
144354709|NCT05579977|520502831|FG008|Treatment Phase|Death|0|||
144354710|NCT05579977|520502832|FG009|Treatment Phase|Death|0|||
144354711|NCT05579977|520502833|FG010|Treatment Phase|Death|0|||
144354712|NCT05579977|520502834|FG011|Treatment Phase|Death|0|||
144354713|NCT05579977|520502835|FG012|Treatment Phase|Death|0|||
144354714|NCT05579977|520502823|FG000|Treatment Phase|Adverse Event|0|||
144354715|NCT05579977|520502824|FG001|Treatment Phase|Adverse Event|3|||
144354716|NCT05579977|520502825|FG002|Treatment Phase|Adverse Event|11|||
144354717|NCT05579977|520502826|FG003|Treatment Phase|Adverse Event|10|||
144354718|NCT05579977|520502827|FG004|Treatment Phase|Adverse Event|5|||
144354719|NCT05579977|520502828|FG005|Treatment Phase|Adverse Event|17|||
144354720|NCT05579977|520502829|FG006|Treatment Phase|Adverse Event|5|||
144354721|NCT05579977|520502830|FG007|Treatment Phase|Adverse Event|5|||
144354722|NCT05579977|520502831|FG008|Treatment Phase|Adverse Event|12|||
144354723|NCT05579977|520502832|FG009|Treatment Phase|Adverse Event|20|||
144354724|NCT05579977|520502833|FG010|Treatment Phase|Adverse Event|15|||
144354725|NCT05579977|520502834|FG011|Treatment Phase|Adverse Event|24|||
144354726|NCT05579977|520502835|FG012|Treatment Phase|Adverse Event|23|||
144354727|NCT05579977|520502823|FG000|Treatment Phase|Randomized not treated|0|||
144354728|NCT05579977|520502824|FG001|Treatment Phase|Randomized not treated|0|||
144354729|NCT05579977|520502825|FG002|Treatment Phase|Randomized not treated|0|||
144354730|NCT05579977|520502826|FG003|Treatment Phase|Randomized not treated|0|||
144354731|NCT05579977|520502827|FG004|Treatment Phase|Randomized not treated|1|||
144354732|NCT05579977|520502828|FG005|Treatment Phase|Randomized not treated|0|||
144354733|NCT05579977|520502829|FG006|Treatment Phase|Randomized not treated|0|||
144354734|NCT05579977|520502830|FG007|Treatment Phase|Randomized not treated|0|||
144354735|NCT05579977|520502831|FG008|Treatment Phase|Randomized not treated|0|||
144354736|NCT05579977|520502832|FG009|Treatment Phase|Randomized not treated|0|||
144354737|NCT05579977|520502833|FG010|Treatment Phase|Randomized not treated|0|||
144354738|NCT05579977|520502834|FG011|Treatment Phase|Randomized not treated|0|||
144354739|NCT05579977|520502835|FG012|Treatment Phase|Randomized not treated|0|||
144354740|NCT05579977|520502823|FG000|Follow up|Death|1|||
144354741|NCT05579977|520502824|FG001|Follow up|Death|0|||
144354742|NCT05579977|520502825|FG002|Follow up|Death|0|||
144354743|NCT05579977|520502826|FG003|Follow up|Death|0|||
144354744|NCT05579977|520502827|FG004|Follow up|Death|0|||
144354745|NCT05579977|520502828|FG005|Follow up|Death|0|||
144354746|NCT05579977|520502829|FG006|Follow up|Death|0|||
144354747|NCT05579977|520502830|FG007|Follow up|Death|0|||
144354748|NCT05579977|520502831|FG008|Follow up|Death|0|||
144354749|NCT05579977|520502832|FG009|Follow up|Death|0|||
144354750|NCT05579977|520502833|FG010|Follow up|Death|0|||
144354751|NCT05579977|520502834|FG011|Follow up|Death|0|||
144354752|NCT05579977|520502835|FG012|Follow up|Death|0|||
144354753|NCT05579977|520502823|FG000|Follow up|Lost to Follow-up|0|||
144354754|NCT05579977|520502824|FG001|Follow up|Lost to Follow-up|0|||
144354755|NCT05579977|520502825|FG002|Follow up|Lost to Follow-up|0|||
144354756|NCT05579977|520502826|FG003|Follow up|Lost to Follow-up|1|||
144354757|NCT05579977|520502827|FG004|Follow up|Lost to Follow-up|1|||
144354758|NCT05579977|520502828|FG005|Follow up|Lost to Follow-up|2|||
144354759|NCT05579977|520502829|FG006|Follow up|Lost to Follow-up|1|||
144354760|NCT05579977|520502830|FG007|Follow up|Lost to Follow-up|1|||
144354761|NCT05579977|520502831|FG008|Follow up|Lost to Follow-up|3|||
144354762|NCT05579977|520502832|FG009|Follow up|Lost to Follow-up|2|||
144354763|NCT05579977|520502833|FG010|Follow up|Lost to Follow-up|2|||
144354764|NCT05579977|520502834|FG011|Follow up|Lost to Follow-up|4|||
144354765|NCT05579977|520502835|FG012|Follow up|Lost to Follow-up|4|||
144354766|NCT05579977|520502823|FG000|Follow up|Withdrawal by Subject|2|||
144354767|NCT05579977|520502824|FG001|Follow up|Withdrawal by Subject|0|||
144354768|NCT05579977|520502825|FG002|Follow up|Withdrawal by Subject|0|||
144354769|NCT05579977|520502826|FG003|Follow up|Withdrawal by Subject|0|||
144354770|NCT05579977|520502827|FG004|Follow up|Withdrawal by Subject|1|||
144354771|NCT05579977|520502828|FG005|Follow up|Withdrawal by Subject|0|||
144354772|NCT05579977|520502829|FG006|Follow up|Withdrawal by Subject|1|||
144354773|NCT05579977|520502830|FG007|Follow up|Withdrawal by Subject|4|||
144354774|NCT05579977|520502831|FG008|Follow up|Withdrawal by Subject|2|||
144354775|NCT05579977|520502832|FG009|Follow up|Withdrawal by Subject|3|||
144354776|NCT05579977|520502833|FG010|Follow up|Withdrawal by Subject|3|||
144354777|NCT05579977|520502834|FG011|Follow up|Withdrawal by Subject|1|||
144354778|NCT05579977|520502835|FG012|Follow up|Withdrawal by Subject|3|||
144354779|NCT01611194|520502837|FG000|Overall Study|Lost to Follow-up|0|||
144354780|NCT01611194|520502838|FG001|Overall Study|Lost to Follow-up|1|||
144354781|NCT01611194|520502837|FG000|Overall Study|Withdrawal by Subject|0|||
144354782|NCT01611194|520502838|FG001|Overall Study|Withdrawal by Subject|1|||
144354783|NCT01611194|520502837|FG000|Overall Study|drug use|0|||
144354784|NCT01611194|520502838|FG001|Overall Study|drug use|1|||
144354785|NCT00348673|520502839|FG000|Stage 1|Randomized but not Treated|0|||
144354786|NCT00348673|520502840|FG001|Stage 1|Randomized but not Treated|0|||
144354787|NCT00348673|520502841|FG002|Stage 1|Randomized but not Treated|1|||
144354788|NCT00348673|520502842|FG003|Stage 1|Randomized but not Treated|0|||
144354789|NCT00348673|520502843|FG004|Stage 1|Randomized but not Treated|0|||
144354790|NCT00348673|520502844|FG005|Stage 1|Randomized but not Treated|0|||
144354791|NCT00348673|520502845|FG006|Stage 1|Randomized but not Treated|0|||
144354792|NCT00348673|520502846|FG007|Stage 1|Randomized but not Treated|0|||
144354793|NCT00348673|520502847|FG008|Stage 1|Randomized but not Treated|0|||
144354794|NCT01712204|520502852|FG000|Overall Study|Adverse Event|3|||
144354795|NCT01712204|520502853|FG001|Overall Study|Adverse Event|1|||
144354796|NCT01712204|520502852|FG000|Overall Study|Withdrawal by Subject|3|||
144354797|NCT01712204|520502853|FG001|Overall Study|Withdrawal by Subject|3|||
144354798|NCT01712204|520502852|FG000|Overall Study|Lost to Follow-up|1|||
144354799|NCT01712204|520502853|FG001|Overall Study|Lost to Follow-up|0|||
144354800|NCT01712204|520502852|FG000|Overall Study|Protocol Violation|1|||
144354801|NCT01712204|520502853|FG001|Overall Study|Protocol Violation|1|||
144354802|NCT02360228|520502854|FG000|Overall Study|Withdrawal by Subject|1|||
144354803|NCT02360228|520502855|FG001|Overall Study|Withdrawal by Subject|0|||
144354804|NCT02360228|520502856|FG002|Overall Study|Withdrawal by Subject|0|||
144354805|NCT02360228|520502854|FG000|Overall Study|Self-discontinued medication|0|||
144354806|NCT02360228|520502855|FG001|Overall Study|Self-discontinued medication|1|||
144354807|NCT02360228|520502856|FG002|Overall Study|Self-discontinued medication|0|||
144354808|NCT02360228|520502854|FG000|Overall Study|Unstable symptoms during screening|0|||
144354809|NCT02360228|520502855|FG001|Overall Study|Unstable symptoms during screening|0|||
144354810|NCT02360228|520502856|FG002|Overall Study|Unstable symptoms during screening|1|||
144354811|NCT02464410|520502857|FG000|Overall Study|Death|3|||
144354812|NCT02464410|520502858|FG001|Overall Study|Death|4|||
144354813|NCT02464410|520502857|FG000|Overall Study|Lost to Follow-up|7|||
144354814|NCT02464410|520502858|FG001|Overall Study|Lost to Follow-up|9|||
144354815|NCT02464410|520502857|FG000|Overall Study|Withdrawal by Subject|12|||
144354816|NCT02464410|520502858|FG001|Overall Study|Withdrawal by Subject|3|||
144354817|NCT02679287|520502859|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
144354818|NCT02679287|520502860|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
144354819|NCT02679287|520502859|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
144354820|NCT02679287|520502860|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
144354821|NCT02679287|520502859|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
144354822|NCT02679287|520502860|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
144354823|NCT02679287|520502859|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
144354824|NCT02679287|520502860|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
144354825|NCT02679287|520502859|FG000|Period 2|Work/Scheduling Conflict|1|||
144354826|NCT02679287|520502860|FG001|Period 2|Work/Scheduling Conflict|0|||
144354827|NCT02679287|520502859|FG000|Period 2|Disliked Mobile System|2|||
144354828|NCT02679287|520502860|FG001|Period 2|Disliked Mobile System|0|||
144354829|NCT02679287|520502859|FG000|Period 3|Work/Scheduling Conflict|0|||
144354830|NCT02679287|520502860|FG001|Period 3|Work/Scheduling Conflict|1|||
144354831|NCT01114828|520502861|FG000|Overall Study|Adverse Event|1|||
144354832|NCT01114828|520502862|FG001|Overall Study|Adverse Event|1|||
144354833|NCT01114828|520502861|FG000|Overall Study|Lack of Efficacy|0|||
144354834|NCT01114828|520502862|FG001|Overall Study|Lack of Efficacy|2|||
144354835|NCT01114828|520502861|FG000|Overall Study|Protocol Violation|2|||
144354836|NCT01114828|520502862|FG001|Overall Study|Protocol Violation|0|||
144354837|NCT01114828|520502861|FG000|Overall Study|Withdrawal by Subject|0|||
144354838|NCT01114828|520502862|FG001|Overall Study|Withdrawal by Subject|1|||
144354839|NCT01943591|520502865|FG000|Overall Study|Lost to Follow-up|3|||
144354840|NCT01943591|520502866|FG001|Overall Study|Lost to Follow-up|4|||
144354841|NCT01943591|520502865|FG000|Overall Study|Death|2|||
144354842|NCT01943591|520502866|FG001|Overall Study|Death|7|||
144354843|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
144354844|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
144354845|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
144354846|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
144354847|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
144354848|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
144354849|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
144354850|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
144354851|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
144354852|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
144354853|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
144354854|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
144354855|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
144354856|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
144354857|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
144354858|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
144354859|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
144354860|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
144354861|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
144354862|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
144354863|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
144354864|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
144354865|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
144354866|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
144354867|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
144354868|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
144354869|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
144354870|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
144354871|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
144354872|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
144354873|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
144354874|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
144354875|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
144354876|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
144354877|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
144354878|NCT02831764|520505535|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
144354879|NCT02831764|520505536|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
144354880|NCT02831764|520505537|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
144354881|NCT02831764|520505538|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
144354882|NCT02831764|520505539|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
144354883|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
144354884|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
144354885|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
144354886|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
144354887|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
144354888|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144354889|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144360197|NCT03037385|520527417|FG009|Overall Study|Progressive Disease|30|||
144354890|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
144354891|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144354892|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
144354893|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144354894|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144354895|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
144354896|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
144354897|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
144354898|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
144354899|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
144354900|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
144354901|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
144354902|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
144354903|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
144354904|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
144354905|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
144354906|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
144354907|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
144354908|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
144354909|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
144354910|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
144354911|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
144354912|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
144354913|NCT02831764|520505535|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
144354914|NCT02831764|520505536|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
144354915|NCT02831764|520505537|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
144354916|NCT02831764|520505538|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
144354917|NCT02831764|520505539|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
144354918|NCT02831764|520505535|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144354919|NCT02831764|520505536|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144354920|NCT02831764|520505537|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144354921|NCT02831764|520505538|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
144354922|NCT02831764|520505539|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
144354923|NCT02831764|520505535|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144354924|NCT02831764|520505536|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144354925|NCT02831764|520505537|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144354926|NCT02831764|520505538|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
144354927|NCT02831764|520505539|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
144354928|NCT02831764|520505535|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144354929|NCT02831764|520505536|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144354930|NCT02831764|520505537|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144354931|NCT02831764|520505538|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
144354932|NCT02831764|520505539|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
144354933|NCT02831764|520505535|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144354934|NCT02831764|520505536|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144354935|NCT02831764|520505537|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144354936|NCT02831764|520505538|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
144354937|NCT02831764|520505539|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
144354938|NCT00865345|520505540|FG000|Overall Study|Withdrawal by Subject|2|||
144354939|NCT01519323|520505541|FG000|Overall Study|Death|3|||
144354940|NCT01519323|520505542|FG001|Overall Study|Death|2|||
144354941|NCT01519323|520505541|FG000|Overall Study|Study terminated by sponsor|0|||
144354942|NCT01519323|520505542|FG001|Overall Study|Study terminated by sponsor|1|||
144354943|NCT00453154|520505546|FG000|Double BIind Maintenance|Adverse Event|0|||
144354944|NCT00453154|520505547|FG001|Double BIind Maintenance|Adverse Event|0|||
144354945|NCT00453154|520505548|FG002|Double BIind Maintenance|Adverse Event|3|||
144354946|NCT00453154|520505549|FG003|Double BIind Maintenance|Adverse Event|12|||
144354947|NCT00453154|520505546|FG000|Double BIind Maintenance|Death|0|||
144354948|NCT00453154|520505547|FG001|Double BIind Maintenance|Death|0|||
144354949|NCT00453154|520505548|FG002|Double BIind Maintenance|Death|2|||
144354950|NCT00453154|520505549|FG003|Double BIind Maintenance|Death|1|||
144354951|NCT00453154|520505546|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
144354952|NCT00453154|520505547|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
144354953|NCT00453154|520505548|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
144354954|NCT00453154|520505549|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
144354955|NCT00453154|520505546|FG000|Double BIind Maintenance|Progression|0|||
144354956|NCT00453154|520505547|FG001|Double BIind Maintenance|Progression|0|||
144354957|NCT00453154|520505548|FG002|Double BIind Maintenance|Progression|29|||
144354958|NCT00453154|520505549|FG003|Double BIind Maintenance|Progression|26|||
144354959|NCT00453154|520505546|FG000|Double BIind Maintenance|Medical Issues|0|||
144354960|NCT00453154|520505547|FG001|Double BIind Maintenance|Medical Issues|0|||
144354961|NCT00453154|520505548|FG002|Double BIind Maintenance|Medical Issues|3|||
144354962|NCT00453154|520505549|FG003|Double BIind Maintenance|Medical Issues|1|||
144354963|NCT00453154|520505546|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
144354964|NCT00453154|520505547|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
144354965|NCT00453154|520505548|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
144354966|NCT00453154|520505549|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
144354967|NCT03291067|520505551|FG000|Overall Study|Adverse Event|0|||
144354968|NCT03291067|520505552|FG001|Overall Study|Adverse Event|2|||
144354969|NCT03291067|520505553|FG002|Overall Study|Adverse Event|17|||
144354970|NCT03291067|520505554|FG003|Overall Study|Adverse Event|3|||
144354971|NCT03291067|520505551|FG000|Overall Study|Lost to Follow-up|2|||
144354972|NCT03291067|520505552|FG001|Overall Study|Lost to Follow-up|1|||
144354973|NCT03291067|520505553|FG002|Overall Study|Lost to Follow-up|0|||
144354974|NCT03291067|520505554|FG003|Overall Study|Lost to Follow-up|1|||
144354975|NCT03291067|520505551|FG000|Overall Study|Physician Decision|0|||
144354976|NCT03291067|520505552|FG001|Overall Study|Physician Decision|0|||
144354977|NCT03291067|520505553|FG002|Overall Study|Physician Decision|1|||
144354978|NCT03291067|520505554|FG003|Overall Study|Physician Decision|0|||
144354979|NCT03291067|520505551|FG000|Overall Study|Protocol Violation|5|||
144354980|NCT03291067|520505552|FG001|Overall Study|Protocol Violation|3|||
144354981|NCT03291067|520505553|FG002|Overall Study|Protocol Violation|4|||
144354982|NCT03291067|520505554|FG003|Overall Study|Protocol Violation|2|||
144354983|NCT03291067|520505551|FG000|Overall Study|Withdrawal by Subject|3|||
144354984|NCT03291067|520505552|FG001|Overall Study|Withdrawal by Subject|4|||
144354985|NCT03291067|520505553|FG002|Overall Study|Withdrawal by Subject|7|||
144354986|NCT03291067|520505554|FG003|Overall Study|Withdrawal by Subject|5|||
144354987|NCT03291067|520505551|FG000|Overall Study|Other|0|||
144354988|NCT03291067|520505552|FG001|Overall Study|Other|4|||
144354989|NCT03291067|520505553|FG002|Overall Study|Other|4|||
144354990|NCT03291067|520505554|FG003|Overall Study|Other|6|||
144354991|NCT04154943|520505555|FG000|Overall Study|Study Ongoing|68|||
144354992|NCT04154943|520505555|FG000|Overall Study|Lost to Follow-up|1|||
144354993|NCT04154943|520505555|FG000|Overall Study|Decision by the Investigator|1|||
144354994|NCT04154943|520505555|FG000|Overall Study|Death|5|||
144354995|NCT04154943|520505555|FG000|Overall Study|Withdrawal by Subject|4|||
144354996|NCT00101686|520505556|FG000|Overall Study|Progressive Disease|37|||
144354997|NCT00101686|520505557|FG001|Overall Study|Progressive Disease|28|||
144354998|NCT00101686|520505558|FG002|Overall Study|Progressive Disease|37|||
144354999|NCT00101686|520505559|FG003|Overall Study|Progressive Disease|38|||
144355000|NCT00101686|520505560|FG004|Overall Study|Progressive Disease|28|||
144355001|NCT00101686|520505561|FG005|Overall Study|Progressive Disease|25|||
144355002|NCT00101686|520505562|FG006|Overall Study|Progressive Disease|5|||
144355003|NCT00101686|520505563|FG007|Overall Study|Progressive Disease|7|||
144355004|NCT00101686|520505564|FG008|Overall Study|Progressive Disease|10|||
144355005|NCT00101686|520505565|FG009|Overall Study|Progressive Disease|8|||
144355006|NCT00101686|520505556|FG000|Overall Study|initiation other anti-cancer treatment|4|||
144355007|NCT00101686|520505557|FG001|Overall Study|initiation other anti-cancer treatment|3|||
144355008|NCT00101686|520505558|FG002|Overall Study|initiation other anti-cancer treatment|4|||
144355009|NCT00101686|520505559|FG003|Overall Study|initiation other anti-cancer treatment|3|||
144355010|NCT00101686|520505560|FG004|Overall Study|initiation other anti-cancer treatment|1|||
144355011|NCT00101686|520505561|FG005|Overall Study|initiation other anti-cancer treatment|1|||
144355012|NCT00101686|520505562|FG006|Overall Study|initiation other anti-cancer treatment|2|||
144355013|NCT00101686|520505563|FG007|Overall Study|initiation other anti-cancer treatment|2|||
144355014|NCT00101686|520505564|FG008|Overall Study|initiation other anti-cancer treatment|3|||
144355015|NCT00101686|520505565|FG009|Overall Study|initiation other anti-cancer treatment|3|||
144355016|NCT00101686|520505556|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
144355017|NCT00101686|520505557|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
144355018|NCT00101686|520505558|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
144355019|NCT00101686|520505559|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
144355020|NCT00101686|520505560|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
144355021|NCT00101686|520505561|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
144355022|NCT00101686|520505562|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
144355023|NCT00101686|520505563|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
144355024|NCT00101686|520505564|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
144355025|NCT00101686|520505565|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
144355026|NCT00101686|520505556|FG000|Overall Study|unacceptable toxicity|3|||
144355027|NCT00101686|520505557|FG001|Overall Study|unacceptable toxicity|9|||
144355028|NCT00101686|520505558|FG002|Overall Study|unacceptable toxicity|10|||
144355029|NCT00101686|520505559|FG003|Overall Study|unacceptable toxicity|6|||
144355030|NCT00101686|520505560|FG004|Overall Study|unacceptable toxicity|16|||
144355031|NCT00101686|520505561|FG005|Overall Study|unacceptable toxicity|10|||
144355032|NCT00101686|520505562|FG006|Overall Study|unacceptable toxicity|4|||
144355033|NCT00101686|520505563|FG007|Overall Study|unacceptable toxicity|2|||
144355034|NCT00101686|520505564|FG008|Overall Study|unacceptable toxicity|1|||
144355035|NCT00101686|520505565|FG009|Overall Study|unacceptable toxicity|4|||
144355036|NCT00101686|520505556|FG000|Overall Study|Randomized but did not receive treament|1|||
144355037|NCT00101686|520505557|FG001|Overall Study|Randomized but did not receive treament|6|||
144355038|NCT00101686|520505558|FG002|Overall Study|Randomized but did not receive treament|2|||
144355039|NCT00101686|520505559|FG003|Overall Study|Randomized but did not receive treament|2|||
144355040|NCT00101686|520505560|FG004|Overall Study|Randomized but did not receive treament|2|||
144355041|NCT00101686|520505561|FG005|Overall Study|Randomized but did not receive treament|2|||
144355042|NCT00101686|520505562|FG006|Overall Study|Randomized but did not receive treament|0|||
144355043|NCT00101686|520505563|FG007|Overall Study|Randomized but did not receive treament|1|||
144355044|NCT00101686|520505564|FG008|Overall Study|Randomized but did not receive treament|0|||
144355045|NCT00101686|520505565|FG009|Overall Study|Randomized but did not receive treament|1|||
144355046|NCT00101686|520505556|FG000|Overall Study|intercurrent non-cancer related illness|0|||
144355047|NCT00101686|520505557|FG001|Overall Study|intercurrent non-cancer related illness|0|||
144355048|NCT00101686|520505558|FG002|Overall Study|intercurrent non-cancer related illness|2|||
144355049|NCT00101686|520505559|FG003|Overall Study|intercurrent non-cancer related illness|0|||
144355050|NCT00101686|520505560|FG004|Overall Study|intercurrent non-cancer related illness|1|||
144355051|NCT00101686|520505561|FG005|Overall Study|intercurrent non-cancer related illness|3|||
144355052|NCT00101686|520505562|FG006|Overall Study|intercurrent non-cancer related illness|1|||
144355053|NCT00101686|520505563|FG007|Overall Study|intercurrent non-cancer related illness|0|||
144355054|NCT00101686|520505564|FG008|Overall Study|intercurrent non-cancer related illness|1|||
144355055|NCT00101686|520505565|FG009|Overall Study|intercurrent non-cancer related illness|1|||
144355056|NCT00101686|520505556|FG000|Overall Study|Physician Decision|10|||
144355057|NCT00101686|520505557|FG001|Overall Study|Physician Decision|13|||
144355058|NCT00101686|520505558|FG002|Overall Study|Physician Decision|6|||
144355059|NCT00101686|520505559|FG003|Overall Study|Physician Decision|7|||
144355060|NCT00101686|520505560|FG004|Overall Study|Physician Decision|8|||
144355061|NCT00101686|520505561|FG005|Overall Study|Physician Decision|9|||
144355062|NCT00101686|520505562|FG006|Overall Study|Physician Decision|5|||
144355063|NCT00101686|520505563|FG007|Overall Study|Physician Decision|5|||
144355064|NCT00101686|520505564|FG008|Overall Study|Physician Decision|1|||
144355065|NCT00101686|520505565|FG009|Overall Study|Physician Decision|1|||
144355066|NCT00101686|520505556|FG000|Overall Study|Other|1|||
144355067|NCT00101686|520505557|FG001|Overall Study|Other|4|||
144355068|NCT00101686|520505558|FG002|Overall Study|Other|1|||
144355069|NCT00101686|520505559|FG003|Overall Study|Other|6|||
144355070|NCT00101686|520505560|FG004|Overall Study|Other|2|||
144355071|NCT00101686|520505561|FG005|Overall Study|Other|12|||
144355072|NCT00101686|520505562|FG006|Overall Study|Other|1|||
144355073|NCT00101686|520505563|FG007|Overall Study|Other|5|||
144355074|NCT00101686|520505564|FG008|Overall Study|Other|3|||
144355075|NCT00101686|520505565|FG009|Overall Study|Other|3|||
144355076|NCT00101686|520505556|FG000|Overall Study|Withdrawal by Subject|9|||
144355077|NCT00101686|520505557|FG001|Overall Study|Withdrawal by Subject|8|||
144355078|NCT00101686|520505558|FG002|Overall Study|Withdrawal by Subject|6|||
144355079|NCT00101686|520505559|FG003|Overall Study|Withdrawal by Subject|8|||
144355080|NCT00101686|520505560|FG004|Overall Study|Withdrawal by Subject|8|||
144355081|NCT00101686|520505561|FG005|Overall Study|Withdrawal by Subject|7|||
144355082|NCT00101686|520505562|FG006|Overall Study|Withdrawal by Subject|7|||
144355083|NCT00101686|520505563|FG007|Overall Study|Withdrawal by Subject|7|||
144355084|NCT00101686|520505564|FG008|Overall Study|Withdrawal by Subject|8|||
144355085|NCT00101686|520505565|FG009|Overall Study|Withdrawal by Subject|9|||
144355086|NCT00985465|520505566|FG000|Overall Study|Withdrawal by Subject|1|||
144355087|NCT00985465|520505567|FG001|Overall Study|Withdrawal by Subject|2|||
144355088|NCT00985465|520505566|FG000|Overall Study|Considered to be part of the other group|0|||
144355089|NCT00985465|520505567|FG001|Overall Study|Considered to be part of the other group|1|||
144355090|NCT03827655|520505568|FG000|Overall Study|Death|0|||
144355091|NCT03827655|520505569|FG001|Overall Study|Death|0|||
144355092|NCT03827655|520505570|FG002|Overall Study|Death|0|||
144355093|NCT03827655|520505571|FG003|Overall Study|Death|0|||
144355094|NCT03827655|520505572|FG004|Overall Study|Death|1|||
144355095|NCT03827655|520505568|FG000|Overall Study|Protocol Deviation|1|||
144355096|NCT03827655|520505569|FG001|Overall Study|Protocol Deviation|0|||
144355097|NCT03827655|520505570|FG002|Overall Study|Protocol Deviation|1|||
144355098|NCT03827655|520505571|FG003|Overall Study|Protocol Deviation|1|||
144355099|NCT03827655|520505572|FG004|Overall Study|Protocol Deviation|0|||
144355100|NCT03827655|520505568|FG000|Overall Study|Withdrawal by Subject|3|||
144355101|NCT03827655|520505569|FG001|Overall Study|Withdrawal by Subject|2|||
144355102|NCT03827655|520505570|FG002|Overall Study|Withdrawal by Subject|2|||
144355103|NCT03827655|520505571|FG003|Overall Study|Withdrawal by Subject|0|||
144355104|NCT03827655|520505572|FG004|Overall Study|Withdrawal by Subject|1|||
144355105|NCT03827655|520505568|FG000|Overall Study|Reason not Specified|3|||
144355106|NCT03827655|520505569|FG001|Overall Study|Reason not Specified|1|||
144355107|NCT03827655|520505570|FG002|Overall Study|Reason not Specified|1|||
144355108|NCT03827655|520505571|FG003|Overall Study|Reason not Specified|1|||
144355109|NCT03827655|520505572|FG004|Overall Study|Reason not Specified|1|||
144355110|NCT03649217|520505573|FG000|Overall Study|subject had severe ataxia not initially found|1|||
144355111|NCT03649217|520505573|FG000|Overall Study|subject had cognitive issues not initially found|1|||
144355112|NCT02520726|520505574|FG000|Overall Study|Lost to Follow-up|3|||
144355113|NCT02520726|520505575|FG001|Overall Study|Lost to Follow-up|2|||
144355114|NCT01092728|520505576|FG000|Overall Study|Withdrawal by Subject|2|||
144355115|NCT01092728|520505577|FG001|Overall Study|Withdrawal by Subject|0|||
144355116|NCT01092728|520505576|FG000|Overall Study|Adverse Event|0|||
144355117|NCT01092728|520505577|FG001|Overall Study|Adverse Event|1|||
144355118|NCT01092728|520505576|FG000|Overall Study|Disease Progression|1|||
144355119|NCT01092728|520505577|FG001|Overall Study|Disease Progression|13|||
144355120|NCT01092728|520505576|FG000|Overall Study|Prohibited Concomitant Medications|1|||
144355121|NCT01092728|520505577|FG001|Overall Study|Prohibited Concomitant Medications|0|||
144355122|NCT02336607|520505578|FG000|Overall Study|Physician Decision|1|||
144355123|NCT02336607|520505579|FG001|Overall Study|Physician Decision|4|||
144355124|NCT02336607|520505580|FG002|Overall Study|Physician Decision|3|||
144355125|NCT02336607|520505581|FG003|Overall Study|Physician Decision|15|||
144355126|NCT02336607|520505578|FG000|Overall Study|Lack of Efficacy|1|||
144355127|NCT02336607|520505579|FG001|Overall Study|Lack of Efficacy|0|||
144355128|NCT02336607|520505580|FG002|Overall Study|Lack of Efficacy|0|||
144355129|NCT02336607|520505581|FG003|Overall Study|Lack of Efficacy|2|||
144355130|NCT02336607|520505578|FG000|Overall Study|Lost to Follow-up|2|||
144355131|NCT02336607|520505579|FG001|Overall Study|Lost to Follow-up|1|||
144355132|NCT02336607|520505580|FG002|Overall Study|Lost to Follow-up|0|||
144355133|NCT02336607|520505581|FG003|Overall Study|Lost to Follow-up|21|||
144355134|NCT02336607|520505578|FG000|Overall Study|Protocol Violation|0|||
144355135|NCT02336607|520505579|FG001|Overall Study|Protocol Violation|1|||
144355136|NCT02336607|520505580|FG002|Overall Study|Protocol Violation|1|||
144355137|NCT02336607|520505581|FG003|Overall Study|Protocol Violation|3|||
144355138|NCT02336607|520505578|FG000|Overall Study|Adverse Event|0|||
144355139|NCT02336607|520505579|FG001|Overall Study|Adverse Event|2|||
144355140|NCT02336607|520505580|FG002|Overall Study|Adverse Event|2|||
144355141|NCT02336607|520505581|FG003|Overall Study|Adverse Event|26|||
144355142|NCT02336607|520505578|FG000|Overall Study|Withdrawal by Subject|0|||
144355143|NCT02336607|520505579|FG001|Overall Study|Withdrawal by Subject|2|||
144355144|NCT02336607|520505580|FG002|Overall Study|Withdrawal by Subject|0|||
144355145|NCT02336607|520505581|FG003|Overall Study|Withdrawal by Subject|20|||
144355146|NCT00721396|520505585|FG000|Overall Study|Adverse Event|4|||
144355147|NCT00721396|520505586|FG001|Overall Study|Adverse Event|7|||
144355148|NCT00721396|520505587|FG002|Overall Study|Adverse Event|2|||
144355149|NCT00721396|520505588|FG003|Overall Study|Adverse Event|0|||
144355150|NCT00721396|520505585|FG000|Overall Study|Withdrawal by Subject|12|||
144355151|NCT00721396|520505586|FG001|Overall Study|Withdrawal by Subject|15|||
144355152|NCT00721396|520505587|FG002|Overall Study|Withdrawal by Subject|3|||
144355153|NCT00721396|520505588|FG003|Overall Study|Withdrawal by Subject|7|||
144355154|NCT00721396|520505585|FG000|Overall Study|Lost to Follow-up|7|||
144355155|NCT00721396|520505586|FG001|Overall Study|Lost to Follow-up|9|||
144355156|NCT00721396|520505587|FG002|Overall Study|Lost to Follow-up|3|||
144355157|NCT00721396|520505588|FG003|Overall Study|Lost to Follow-up|3|||
144355158|NCT00721396|520505585|FG000|Overall Study|Protocol Violation|4|||
144355159|NCT00721396|520505586|FG001|Overall Study|Protocol Violation|3|||
144355160|NCT00721396|520505587|FG002|Overall Study|Protocol Violation|1|||
144355161|NCT00721396|520505588|FG003|Overall Study|Protocol Violation|0|||
144355162|NCT00721396|520505585|FG000|Overall Study|Inappropriate enrollment|0|||
144355163|NCT00721396|520505586|FG001|Overall Study|Inappropriate enrollment|2|||
144355164|NCT00721396|520505587|FG002|Overall Study|Inappropriate enrollment|0|||
144355165|NCT00721396|520505588|FG003|Overall Study|Inappropriate enrollment|0|||
144355166|NCT00721396|520505585|FG000|Overall Study|Administrative reason|3|||
144355167|NCT00721396|520505586|FG001|Overall Study|Administrative reason|0|||
144355168|NCT00721396|520505587|FG002|Overall Study|Administrative reason|1|||
144355169|NCT00721396|520505588|FG003|Overall Study|Administrative reason|0|||
144355170|NCT01216202|520505589|FG000|Overall Study|Withdrawal by Subject|8|||
144355171|NCT01216202|520505590|FG001|Overall Study|Withdrawal by Subject|0|||
144355172|NCT01216202|520505589|FG000|Overall Study|Death|0|||
144355173|NCT01216202|520505590|FG001|Overall Study|Death|2|||
144355174|NCT01216202|520505589|FG000|Overall Study|Lost to Follow-up|14|||
144355175|NCT01216202|520505590|FG001|Overall Study|Lost to Follow-up|0|||
144355176|NCT00614380|520505597|FG000|Overall Study|Adverse Event|14|||
144355177|NCT00614380|520505598|FG001|Overall Study|Adverse Event|4|||
144355178|NCT00614380|520505599|FG002|Overall Study|Adverse Event|0|||
144355179|NCT00614380|520505600|FG003|Overall Study|Adverse Event|0|||
144355180|NCT00614380|520505597|FG000|Overall Study|Lost to Follow-up|6|||
144355181|NCT00614380|520505598|FG001|Overall Study|Lost to Follow-up|1|||
144355182|NCT00614380|520505599|FG002|Overall Study|Lost to Follow-up|0|||
144355183|NCT00614380|520505600|FG003|Overall Study|Lost to Follow-up|0|||
144355184|NCT00614380|520505597|FG000|Overall Study|Non compliant with the protocol|12|||
144355185|NCT00614380|520505598|FG001|Overall Study|Non compliant with the protocol|2|||
144355186|NCT00614380|520505599|FG002|Overall Study|Non compliant with the protocol|1|||
144355187|NCT00614380|520505600|FG003|Overall Study|Non compliant with the protocol|2|||
144355188|NCT00614380|520505597|FG000|Overall Study|Consent withdrawn|3|||
144355189|NCT00614380|520505598|FG001|Overall Study|Consent withdrawn|1|||
144355190|NCT00614380|520505599|FG002|Overall Study|Consent withdrawn|0|||
144355191|NCT00614380|520505600|FG003|Overall Study|Consent withdrawn|0|||
144355192|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355193|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355194|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355195|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
144355196|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355197|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355198|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355199|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355200|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355201|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
144355202|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
144355203|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
144355204|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
144355205|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
144355206|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
144355207|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
144355208|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
144355209|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
144355210|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
144355211|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
144355212|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
144355213|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
144355214|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
144355215|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
144355216|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
144355217|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
144355218|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
144355219|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
144355220|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
144355221|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
144355222|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
144355223|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
144355224|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
144355225|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
144355226|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
144355227|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
144355228|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
144355229|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
144355230|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
144355231|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
144355232|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
144355233|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355234|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
144355235|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355236|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
144355237|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355238|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355239|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355240|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355241|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
144355242|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
144355243|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355244|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355245|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355246|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
144355247|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
144355248|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355249|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355250|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355251|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
144355252|NCT02365649|520505601|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355253|NCT02365649|520505602|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355254|NCT02365649|520505603|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
144355255|NCT02365649|520505604|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355256|NCT02365649|520505605|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355257|NCT02365649|520505606|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355258|NCT02365649|520505607|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355259|NCT02365649|520505608|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355260|NCT02365649|520505609|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355261|NCT02365649|520505610|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
144355262|NCT02365649|520505601|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355263|NCT02365649|520505602|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355264|NCT02365649|520505603|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355265|NCT02365649|520505604|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355266|NCT02365649|520505605|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355267|NCT02365649|520505606|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355268|NCT02365649|520505607|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
144355269|NCT02365649|520505608|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355270|NCT02365649|520505609|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355271|NCT02365649|520505610|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
144355272|NCT02365649|520505601|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355273|NCT02365649|520505602|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355274|NCT02365649|520505603|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355275|NCT02365649|520505604|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355276|NCT02365649|520505605|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355277|NCT02365649|520505606|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355278|NCT02365649|520505607|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
144355279|NCT02365649|520505608|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
144355280|NCT02365649|520505609|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
144355281|NCT02365649|520505610|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
144355282|NCT02365649|520505601|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
144355283|NCT02365649|520505602|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
144355284|NCT02365649|520505603|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
144355285|NCT02365649|520505604|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
144355286|NCT02365649|520505605|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
144355287|NCT02365649|520505606|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
144355288|NCT02365649|520505607|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
144355289|NCT02365649|520505608|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
144355290|NCT02365649|520505609|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
144355291|NCT02365649|520505610|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
144355292|NCT02365649|520505601|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355293|NCT02365649|520505602|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355294|NCT02365649|520505603|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355295|NCT02365649|520505604|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355296|NCT02365649|520505605|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355297|NCT02365649|520505606|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355298|NCT02365649|520505607|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
144355299|NCT02365649|520505608|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
144355300|NCT02365649|520505609|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
144355301|NCT02365649|520505610|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
144355302|NCT02365649|520505601|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355303|NCT02365649|520505602|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355304|NCT02365649|520505603|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355305|NCT02365649|520505604|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355306|NCT02365649|520505605|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355307|NCT02365649|520505606|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355308|NCT02365649|520505607|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
144355309|NCT02365649|520505608|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355310|NCT02365649|520505609|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
144355311|NCT02365649|520505610|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
144355312|NCT01506271|520505611|FG000|Overall Study|Progressive disease|0|||
144355313|NCT01506271|520505612|FG001|Overall Study|Progressive disease|1|||
144355314|NCT01506271|520505613|FG002|Overall Study|Progressive disease|0|||
144355315|NCT01506271|520505611|FG000|Overall Study|Protocol Violation|3|||
144355316|NCT01506271|520505612|FG001|Overall Study|Protocol Violation|1|||
144355317|NCT01506271|520505613|FG002|Overall Study|Protocol Violation|0|||
144355318|NCT01506271|520505611|FG000|Overall Study|Death|0|||
144355319|NCT01506271|520505612|FG001|Overall Study|Death|1|||
144355320|NCT01506271|520505613|FG002|Overall Study|Death|0|||
144355321|NCT01506271|520505611|FG000|Overall Study|Adverse Event|0|||
144355322|NCT01506271|520505612|FG001|Overall Study|Adverse Event|2|||
144355323|NCT01506271|520505613|FG002|Overall Study|Adverse Event|0|||
144355324|NCT01506271|520505611|FG000|Overall Study|Insufficient supply of study drug|1|||
144355325|NCT01506271|520505612|FG001|Overall Study|Insufficient supply of study drug|0|||
144355326|NCT01506271|520505613|FG002|Overall Study|Insufficient supply of study drug|0|||
144355327|NCT01506271|520505611|FG000|Overall Study|Withdrawal by Subject|0|||
144355328|NCT01506271|520505612|FG001|Overall Study|Withdrawal by Subject|1|||
144355329|NCT01506271|520505613|FG002|Overall Study|Withdrawal by Subject|1|||
144355330|NCT01506271|520505611|FG000|Overall Study|Lost to Follow-up|0|||
144355331|NCT01506271|520505612|FG001|Overall Study|Lost to Follow-up|1|||
144355332|NCT01506271|520505613|FG002|Overall Study|Lost to Follow-up|2|||
144355333|NCT02021565|520505627|FG000|Baseline Through Intervention|Death|0|||
144355334|NCT02021565|520505628|FG001|Baseline Through Intervention|Death|1|||
144355335|NCT02021565|520505627|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
144355336|NCT02021565|520505628|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
144355337|NCT02021565|520505627|FG000|Baseline Through Intervention|Protocol Violation|0|||
144355338|NCT02021565|520505628|FG001|Baseline Through Intervention|Protocol Violation|7|||
144355339|NCT02021565|520505627|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
144355340|NCT02021565|520505628|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
144355341|NCT02021565|520505627|FG000|3-month Follow-up|Death|3|||
144355342|NCT02021565|520505628|FG001|3-month Follow-up|Death|0|||
144355343|NCT02021565|520505627|FG000|3-month Follow-up|Withdrawal by Subject|4|||
144355344|NCT02021565|520505628|FG001|3-month Follow-up|Withdrawal by Subject|0|||
144355345|NCT02021565|520505627|FG000|3-month Follow-up|Protocol Violation|3|||
144355346|NCT02021565|520505628|FG001|3-month Follow-up|Protocol Violation|2|||
144355347|NCT03084796|520505631|FG000|Overall Study|Adverse Event|4|||
144355348|NCT03084796|520505632|FG001|Overall Study|Adverse Event|5|||
144355349|NCT03084796|520505633|FG002|Overall Study|Adverse Event|6|||
144355350|NCT03084796|520505634|FG003|Overall Study|Adverse Event|2|||
144355351|NCT03084796|520505635|FG004|Overall Study|Adverse Event|3|||
144355352|NCT03084796|520505636|FG005|Overall Study|Adverse Event|5|||
144355353|NCT03084796|520505631|FG000|Overall Study|Withdrawal by Subject|3|||
144355354|NCT03084796|520505632|FG001|Overall Study|Withdrawal by Subject|5|||
144355355|NCT03084796|520505633|FG002|Overall Study|Withdrawal by Subject|2|||
144355356|NCT03084796|520505634|FG003|Overall Study|Withdrawal by Subject|1|||
144355357|NCT03084796|520505635|FG004|Overall Study|Withdrawal by Subject|3|||
144355358|NCT03084796|520505636|FG005|Overall Study|Withdrawal by Subject|0|||
144355359|NCT03084796|520505631|FG000|Overall Study|Protocol Violation|0|||
144355360|NCT03084796|520505632|FG001|Overall Study|Protocol Violation|0|||
144355361|NCT03084796|520505633|FG002|Overall Study|Protocol Violation|1|||
144355362|NCT03084796|520505634|FG003|Overall Study|Protocol Violation|0|||
144355363|NCT03084796|520505635|FG004|Overall Study|Protocol Violation|1|||
144355364|NCT03084796|520505636|FG005|Overall Study|Protocol Violation|1|||
144355365|NCT03084796|520505631|FG000|Overall Study|Lack of Efficacy|0|||
144355366|NCT03084796|520505632|FG001|Overall Study|Lack of Efficacy|0|||
144355367|NCT03084796|520505633|FG002|Overall Study|Lack of Efficacy|1|||
144355368|NCT03084796|520505634|FG003|Overall Study|Lack of Efficacy|0|||
144355369|NCT03084796|520505635|FG004|Overall Study|Lack of Efficacy|1|||
144355370|NCT03084796|520505636|FG005|Overall Study|Lack of Efficacy|0|||
144355371|NCT03084796|520505631|FG000|Overall Study|Lost to Follow-up|0|||
144355372|NCT03084796|520505632|FG001|Overall Study|Lost to Follow-up|0|||
144355373|NCT03084796|520505633|FG002|Overall Study|Lost to Follow-up|1|||
144355374|NCT03084796|520505634|FG003|Overall Study|Lost to Follow-up|1|||
144355375|NCT03084796|520505635|FG004|Overall Study|Lost to Follow-up|3|||
144355376|NCT03084796|520505636|FG005|Overall Study|Lost to Follow-up|1|||
144355377|NCT03084796|520505631|FG000|Overall Study|Randomization error|0|||
144355378|NCT03084796|520505632|FG001|Overall Study|Randomization error|0|||
144355379|NCT03084796|520505633|FG002|Overall Study|Randomization error|1|||
144355380|NCT03084796|520505634|FG003|Overall Study|Randomization error|0|||
144355381|NCT03084796|520505635|FG004|Overall Study|Randomization error|0|||
144355382|NCT03084796|520505636|FG005|Overall Study|Randomization error|0|||
144355383|NCT00154297|520505639|FG000|Overall Study|Death|5|||
144355384|NCT00154297|520505640|FG001|Overall Study|Death|2|||
144355385|NCT00154297|520505639|FG000|Overall Study|Withdrawal by Subject|0|||
144355386|NCT00154297|520505640|FG001|Overall Study|Withdrawal by Subject|5|||
144355387|NCT00154297|520505639|FG000|Overall Study|Lost to Follow-up|3|||
144355388|NCT00154297|520505640|FG001|Overall Study|Lost to Follow-up|0|||
144355389|NCT00650767|520505641|FG000|Overall Study|Adverse Event|0|||
144355390|NCT00650767|520505642|FG001|Overall Study|Adverse Event|3|||
144355391|NCT00650767|520505643|FG002|Overall Study|Adverse Event|10|||
144355392|NCT00650767|520505644|FG003|Overall Study|Adverse Event|8|||
144355393|NCT00650767|520505641|FG000|Overall Study|Death|1|||
144355394|NCT00650767|520505642|FG001|Overall Study|Death|0|||
144355395|NCT00650767|520505643|FG002|Overall Study|Death|0|||
144355396|NCT00650767|520505644|FG003|Overall Study|Death|0|||
144355397|NCT00650767|520505641|FG000|Overall Study|Withdrawal by Subject|2|||
144355398|NCT00650767|520505642|FG001|Overall Study|Withdrawal by Subject|4|||
144355399|NCT00650767|520505643|FG002|Overall Study|Withdrawal by Subject|3|||
144355400|NCT00650767|520505644|FG003|Overall Study|Withdrawal by Subject|3|||
144355401|NCT00650767|520505641|FG000|Overall Study|Lost to Follow-up|1|||
144355402|NCT00650767|520505642|FG001|Overall Study|Lost to Follow-up|1|||
144355403|NCT00650767|520505643|FG002|Overall Study|Lost to Follow-up|1|||
144355404|NCT00650767|520505644|FG003|Overall Study|Lost to Follow-up|0|||
144355405|NCT00650767|520505641|FG000|Overall Study|Other|1|||
144355406|NCT00650767|520505642|FG001|Overall Study|Other|1|||
144355407|NCT00650767|520505643|FG002|Overall Study|Other|0|||
144355408|NCT00650767|520505644|FG003|Overall Study|Other|0|||
144355409|NCT01774799|520505645|FG000|Overall Study|Lost to Follow-up|1|||
144355410|NCT01774799|520505646|FG001|Overall Study|Lost to Follow-up|1|||
144355411|NCT01774799|520505647|FG002|Overall Study|Lost to Follow-up|0|||
144355412|NCT01774799|520505648|FG003|Overall Study|Lost to Follow-up|0|||
144355413|NCT02910466|520505649|FG000|Overall Study|Adverse Event|1|||
144355414|NCT02910466|520505649|FG000|Overall Study|Withdrawal by Subject|3|||
144355415|NCT02910466|520505649|FG000|Overall Study|Lost to Follow-up|5|||
144355416|NCT02910466|520505649|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
144355417|NCT02910466|520505649|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
144355418|NCT01808196|520505659|FG000|Overall Study|Lost to Follow-up|1|||
144355419|NCT00141102|520505662|FG000|Overall Study|Adverse Event|233|||
144355420|NCT00141102|520505663|FG001|Overall Study|Adverse Event|305|||
144355421|NCT00141102|520505662|FG000|Overall Study|Laboratory Abnormality|9|||
144355422|NCT00141102|520505663|FG001|Overall Study|Laboratory Abnormality|33|||
144355423|NCT00141102|520505662|FG000|Overall Study|Lack of Efficacy|21|||
144355424|NCT00141102|520505663|FG001|Overall Study|Lack of Efficacy|26|||
144355425|NCT00141102|520505662|FG000|Overall Study|Lost to Follow-up|29|||
144355426|NCT00141102|520505663|FG001|Overall Study|Lost to Follow-up|32|||
144355427|NCT00141102|520505662|FG000|Overall Study|Other|87|||
144355428|NCT00141102|520505663|FG001|Overall Study|Other|76|||
144355429|NCT00141102|520505662|FG000|Overall Study|Withdrawal by Subject|112|||
144355430|NCT00141102|520505663|FG001|Overall Study|Withdrawal by Subject|142|||
144355431|NCT00141102|520505662|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
144355432|NCT00141102|520505663|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
144355433|NCT00141102|520505662|FG000|Overall Study|Death|2|||
144355434|NCT00141102|520505663|FG001|Overall Study|Death|2|||
144355435|NCT03061201|520505666|FG000|Overall Study|Participants Terminated at Month 36|0|||
144355436|NCT03061201|520505667|FG001|Overall Study|Participants Terminated at Month 36|1|||
144355437|NCT03061201|520505668|FG002|Overall Study|Participants Terminated at Month 36|0|||
144355438|NCT03061201|520505669|FG003|Overall Study|Participants Terminated at Month 36|1|||
144355439|NCT03061201|520505666|FG000|Overall Study|Lost to Follow-up|1|||
144355440|NCT03061201|520505667|FG001|Overall Study|Lost to Follow-up|0|||
144355441|NCT03061201|520505668|FG002|Overall Study|Lost to Follow-up|0|||
144355442|NCT03061201|520505669|FG003|Overall Study|Lost to Follow-up|0|||
144355443|NCT06172348|520505670|FG000|Treatment Period 2|Adverse Event|0|||
144355444|NCT06172348|520505671|FG001|Treatment Period 2|Adverse Event|0|||
144355445|NCT06172348|520505672|FG002|Treatment Period 2|Adverse Event|1|||
144355446|NCT06172348|520505673|FG003|Treatment Period 2|Adverse Event|0|||
144355447|NCT06172348|520505674|FG004|Treatment Period 2|Adverse Event|0|||
144355448|NCT06172348|520505675|FG005|Treatment Period 2|Adverse Event|0|||
144355449|NCT04037891|520505676|FG000|Open-label Period|Withdrawal by Subject|1|||
144355450|NCT04037891|520505677|FG001|Open-label Period|Withdrawal by Subject|0|||
144355451|NCT04037891|520505678|FG002|Open-label Period|Withdrawal by Subject|0|||
144355452|NCT04037891|520505676|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
144355453|NCT04037891|520505677|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
144355454|NCT04037891|520505678|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
144355455|NCT05274958|520505679|FG000|Overall Study|Only completed 1 set of PROMs|22|||
144355456|NCT05274958|520505680|FG001|Overall Study|Only completed 1 set of PROMs|35|||
144355457|NCT00866814|520505684|FG000|Overall Study|Lost to Follow-up|12|||
144355458|NCT00866814|520505684|FG000|Overall Study|Adverse Event|2|||
144355459|NCT00866814|520505684|FG000|Overall Study|Physician Decision|1|||
144355460|NCT00866814|520505684|FG000|Overall Study|Death|1|||
144355461|NCT00866814|520505684|FG000|Overall Study|No longer wished to participate|1|||
144355462|NCT00866814|520505684|FG000|Overall Study|Unable to meet follow-up requirements|2|||
144355463|NCT00866814|520505684|FG000|Overall Study|Moved to area without study site|1|||
144355464|NCT04491136|520505685|FG000|Overall Study|Patient withdraw informed consent|9|||
144355465|NCT04491136|520505685|FG000|Overall Study|Adverse Event|2|||
144355466|NCT04491136|520505685|FG000|Overall Study|Death|3|||
144355467|NCT04491136|520505685|FG000|Overall Study|Lost to Follow-up|3|||
144355468|NCT04491136|520505685|FG000|Overall Study|Physician Decision|45|||
144355469|NCT04491136|520505685|FG000|Overall Study|sponsor terminated the study early|16|||
144355470|NCT04491136|520505685|FG000|Overall Study|Patient/guardian's decision|1|||
144355473|NCT01505374|520505705|FG000|Overall Study|Lost to Follow-up|1|||
144355474|NCT01505374|520505706|FG001|Overall Study|Lost to Follow-up|0|||
144355475|NCT00794950|520505709|FG000|BCG Induction|Withdrawal by Subject|2|||
144355476|NCT00794950|520505709|FG000|BCG Induction|ineligible|3|||
144355477|NCT00794950|520505709|FG000|BCG Induction|noncompliant w. BCG|1|||
144355478|NCT00794950|520505709|FG000|BCG Induction|Adverse Event|1|||
144355479|NCT00794950|520505709|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
144355480|NCT00794950|520505709|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
144355481|NCT00794950|520505709|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
144355482|NCT00794950|520505709|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
144355483|NCT02485704|520505710|FG000|Overall Study|Lost to Follow-up|4|||
144355484|NCT02485704|520505711|FG001|Overall Study|Lost to Follow-up|5|||
144355485|NCT02485704|520505710|FG000|Overall Study|Withdrawal by Subject|0|||
144355486|NCT02485704|520505711|FG001|Overall Study|Withdrawal by Subject|3|||
144355487|NCT02485704|520505710|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
144355488|NCT02485704|520505711|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
144355489|NCT01777776|520505714|FG000|Overall Study|Adverse Event|2|||
144355490|NCT01777776|520505715|FG001|Overall Study|Adverse Event|4|||
144355491|NCT01777776|520505716|FG002|Overall Study|Adverse Event|0|||
144355492|NCT01777776|520505717|FG003|Overall Study|Adverse Event|0|||
144355493|NCT01777776|520505714|FG000|Overall Study|Disease Progression|4|||
144355494|NCT01777776|520505715|FG001|Overall Study|Disease Progression|8|||
144355495|NCT01777776|520505716|FG002|Overall Study|Disease Progression|6|||
144355496|NCT01777776|520505717|FG003|Overall Study|Disease Progression|3|||
144355497|NCT01777776|520505714|FG000|Overall Study|Withdrawal by Subject|0|||
144355498|NCT01777776|520505715|FG001|Overall Study|Withdrawal by Subject|0|||
144355499|NCT01777776|520505716|FG002|Overall Study|Withdrawal by Subject|0|||
144355500|NCT01777776|520505717|FG003|Overall Study|Withdrawal by Subject|1|||
144355501|NCT00851786|520505718|FG000|Overall Study|Withdrawal by Subject|0|||
144355502|NCT00851786|520505719|FG001|Overall Study|Withdrawal by Subject|1|||
144355503|NCT00851786|520505718|FG000|Overall Study|Protocol Violation|0|||
144355504|NCT00851786|520505719|FG001|Overall Study|Protocol Violation|1|||
144355505|NCT00851786|520505718|FG000|Overall Study|Lost to Follow-up|1|||
144355506|NCT00851786|520505719|FG001|Overall Study|Lost to Follow-up|0|||
144355507|NCT00851786|520505718|FG000|Overall Study|Incarceration|1|||
144355508|NCT00851786|520505719|FG001|Overall Study|Incarceration|0|||
144355509|NCT00851786|520505718|FG000|Overall Study|Site Closure|1|||
144355510|NCT00851786|520505719|FG001|Overall Study|Site Closure|0|||
144355511|NCT00851786|520505718|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
144355512|NCT00851786|520505719|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
144355513|NCT01232868|520507532|FG000|Overall Study|Lost to Follow-up|2|||
144355514|NCT01232868|520507533|FG001|Overall Study|Lost to Follow-up|4|||
144355515|NCT04481243|520507534|FG000|Overall Study|Withdrawal by Subject|4|||
144355516|NCT04564846|520507535|FG000|Overall Study|Withdrawal by Subject|2|||
144355517|NCT04564846|520507536|FG001|Overall Study|Withdrawal by Subject|1|||
144355518|NCT04564846|520507535|FG000|Overall Study|Physician Decision|0|||
144355519|NCT04564846|520507536|FG001|Overall Study|Physician Decision|1|||
144355520|NCT04564846|520507535|FG000|Overall Study|Lost to Follow-up|0|||
144355521|NCT04564846|520507536|FG001|Overall Study|Lost to Follow-up|1|||
144355522|NCT04564846|520507535|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
144355523|NCT04564846|520507536|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
144355524|NCT04564846|520507535|FG000|Overall Study|Subject non-compliance|1|||
144355525|NCT04564846|520507536|FG001|Overall Study|Subject non-compliance|0|||
144355526|NCT03737123|520507537|FG000|Study Treatment|Adverse Event|2|||
144355527|NCT03737123|520507538|FG001|Study Treatment|Adverse Event|0|||
144355528|NCT03737123|520507537|FG000|Study Treatment|Disease Progression|2|||
144355529|NCT03737123|520507538|FG001|Study Treatment|Disease Progression|0|||
144355530|NCT03737123|520507537|FG000|Study Treatment|Withdrawal by Subject|2|||
144355531|NCT03737123|520507538|FG001|Study Treatment|Withdrawal by Subject|0|||
144355532|NCT03737123|520507537|FG000|Follow up|Death|1|||
144355533|NCT03737123|520507538|FG001|Follow up|Death|0|||
144355534|NCT03737123|520507537|FG000|Follow up|Withdrawal by Subject|1|||
144355535|NCT03737123|520507538|FG001|Follow up|Withdrawal by Subject|0|||
144355536|NCT03737123|520507537|FG000|Follow up|Termination of study|4|||
144355537|NCT03737123|520507538|FG001|Follow up|Termination of study|0|||
144355538|NCT03858049|520507550|FG000|Overall Study|Adverse Event|16|||
144355539|NCT03858049|520507551|FG001|Overall Study|Adverse Event|9|||
144355540|NCT03858049|520507550|FG000|Overall Study|Other|1|||
144355541|NCT03858049|520507551|FG001|Overall Study|Other|1|||
144355542|NCT02079740|520507552|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
144355543|NCT02079740|520507553|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
144355544|NCT02079740|520507554|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
144355545|NCT02079740|520507555|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
144355546|NCT02079740|520507556|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
144355547|NCT02079740|520507557|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
144355548|NCT02079740|520507558|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
144355549|NCT02079740|520507559|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
144355550|NCT02079740|520507560|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
144355551|NCT02079740|520507561|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
144355552|NCT02079740|520507562|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
144355553|NCT02079740|520507563|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
144355554|NCT02079740|520507564|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
144355555|NCT02079740|520507552|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
144355556|NCT02079740|520507553|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
144355557|NCT02079740|520507554|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
144355558|NCT02079740|520507555|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
144355559|NCT02079740|520507556|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
144355560|NCT02079740|520507557|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
144355561|NCT02079740|520507558|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
144355562|NCT02079740|520507559|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
144355563|NCT02079740|520507560|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
144355564|NCT02079740|520507561|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
144355565|NCT02079740|520507562|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
144355566|NCT02079740|520507563|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
144355567|NCT02079740|520507564|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
144355568|NCT02079740|520507552|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355569|NCT02079740|520507553|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355570|NCT02079740|520507554|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355571|NCT02079740|520507555|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355572|NCT02079740|520507556|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355573|NCT02079740|520507557|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355574|NCT02079740|520507558|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355575|NCT02079740|520507559|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
144355576|NCT02079740|520507560|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355577|NCT02079740|520507561|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355578|NCT02079740|520507562|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355579|NCT02079740|520507563|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355580|NCT02079740|520507564|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
144355581|NCT02079740|520507552|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355582|NCT02079740|520507553|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355583|NCT02079740|520507554|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355584|NCT02079740|520507555|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355585|NCT02079740|520507556|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355586|NCT02079740|520507557|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355587|NCT02079740|520507558|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355588|NCT02079740|520507559|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
144355589|NCT02079740|520507560|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355590|NCT02079740|520507561|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355591|NCT02079740|520507562|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355592|NCT02079740|520507563|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355593|NCT02079740|520507564|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
144355594|NCT02079740|520507552|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355595|NCT02079740|520507553|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355596|NCT02079740|520507554|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355597|NCT02079740|520507555|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355598|NCT02079740|520507556|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355599|NCT02079740|520507557|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355600|NCT02079740|520507558|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355601|NCT02079740|520507559|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355602|NCT02079740|520507560|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355603|NCT02079740|520507561|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
144355604|NCT02079740|520507562|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
144355605|NCT02079740|520507563|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
144355606|NCT02079740|520507564|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
144355607|NCT04617782|520507565|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
144355608|NCT04617782|520507565|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
144355609|NCT04617782|520507565|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
144355610|NCT04617782|520507565|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
144355611|NCT04617782|520507565|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
144355612|NCT04617782|520507565|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
144355613|NCT01131507|520507570|FG000|Overall Study|Adverse Event|1|||
144355614|NCT01131507|520507570|FG000|Overall Study|Lost to Follow-up|1|||
144355615|NCT01131507|520507570|FG000|Overall Study|Withdrawal by Subject|1|||
144355616|NCT01474317|520507578|FG000|Overall Study|Adverse Event|1|||
144355617|NCT01474317|520507578|FG000|Overall Study|Subject ineligible for study|1|||
144355618|NCT00387881|520507579|FG000|Overall Study|Lost to Follow-up|23|||
144355619|NCT00387881|520507580|FG001|Overall Study|Lost to Follow-up|23|||
144355620|NCT00387881|520507579|FG000|Overall Study|Protocol Violation|2|||
144355621|NCT00387881|520507580|FG001|Overall Study|Protocol Violation|12|||
144355622|NCT00387881|520507579|FG000|Overall Study|Withdrawal by Subject|15|||
144355623|NCT00387881|520507580|FG001|Overall Study|Withdrawal by Subject|18|||
144355624|NCT00387881|520507579|FG000|Overall Study|Sponsor terminated Study|0|||
144355625|NCT00387881|520507580|FG001|Overall Study|Sponsor terminated Study|1|||
144355626|NCT00387881|520507579|FG000|Overall Study|Not eligible|6|||
144355627|NCT00387881|520507580|FG001|Overall Study|Not eligible|7|||
144355628|NCT00387881|520507579|FG000|Overall Study|No opportunity to treat headache|32|||
144355629|NCT00387881|520507580|FG001|Overall Study|No opportunity to treat headache|34|||
144355630|NCT00387881|520507579|FG000|Overall Study|Not otherwise specified|11|||
144355631|NCT00387881|520507580|FG001|Overall Study|Not otherwise specified|7|||
144355632|NCT03629886|520507581|FG000|Overall Study|Migrated / moved from the study area|0|||
144355633|NCT03629886|520507582|FG001|Overall Study|Migrated / moved from the study area|55|||
144355634|NCT03629886|520507581|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
144355635|NCT03629886|520507582|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
144355636|NCT03629886|520507581|FG000|Overall Study|Study vaccine not administrated|0|||
144355637|NCT03629886|520507582|FG001|Overall Study|Study vaccine not administrated|3|||
144355638|NCT03629886|520507581|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
144355639|NCT03629886|520507582|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
144355640|NCT03629886|520507581|FG000|Overall Study|Refused vaccination step of the study|0|||
144355641|NCT03629886|520507582|FG001|Overall Study|Refused vaccination step of the study|44|||
144355642|NCT03683173|520507583|FG000|Completed Follow-up|Unavailable|235|||
144355643|NCT03683173|520507584|FG001|Completed Follow-up|Unavailable|217|||
144355644|NCT03683173|520507583|FG000|Completed Follow-up|Refused|69|||
144355645|NCT03683173|520507584|FG001|Completed Follow-up|Refused|59|||
144355646|NCT03683173|520507583|FG000|Completed Follow-up|Disconnected phone|65|||
144355647|NCT03683173|520507584|FG001|Completed Follow-up|Disconnected phone|95|||
144355648|NCT03683173|520507583|FG000|Completed Follow-up|Health issue/deceased|10|||
144355649|NCT03683173|520507584|FG001|Completed Follow-up|Health issue/deceased|4|||
144355650|NCT03683173|520507583|FG000|Completed Follow-up|Moved away|8|||
144355651|NCT03683173|520507584|FG001|Completed Follow-up|Moved away|1|||
144355652|NCT03016312|520507585|FG000|Overall Study|discontinued before the treatment started|0|||
144355653|NCT03016312|520507586|FG001|Overall Study|discontinued before the treatment started|1|||
144355654|NCT03016312|520507585|FG000|Overall Study|Withdrawal by Subject|37|||
144355655|NCT03016312|520507586|FG001|Overall Study|Withdrawal by Subject|44|||
144355656|NCT03016312|520507585|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
144355657|NCT03016312|520507586|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
144355658|NCT03016312|520507585|FG000|Overall Study|Physician Decision|1|||
144355659|NCT03016312|520507586|FG001|Overall Study|Physician Decision|3|||
144355660|NCT03016312|520507585|FG000|Overall Study|Lost to Follow-up|12|||
144355661|NCT03016312|520507586|FG001|Overall Study|Lost to Follow-up|12|||
144355662|NCT03016312|520507585|FG000|Overall Study|Death|210|||
144355663|NCT03016312|520507586|FG001|Overall Study|Death|184|||
144355664|NCT03016312|520507585|FG000|Overall Study|loss to contact|1|||
144355665|NCT03016312|520507586|FG001|Overall Study|loss to contact|0|||
144355666|NCT03016312|520507585|FG000|Overall Study|started a new cancer therapy|1|||
144355667|NCT03016312|520507586|FG001|Overall Study|started a new cancer therapy|0|||
144355668|NCT00496015|520507587|FG000|Overall Study|Other|1|||
144355669|NCT00496015|520507588|FG001|Overall Study|Other|0|||
144355670|NCT00496015|520507589|FG002|Overall Study|Other|0|||
144355671|NCT00496015|520507590|FG003|Overall Study|Other|1|||
144355672|NCT00496015|520507591|FG004|Overall Study|Other|0|||
144355673|NCT01535807|520507593|FG000|Overall Study|Withdrawal by Subject|1|||
144355674|NCT01535807|520507594|FG001|Overall Study|Withdrawal by Subject|1|||
144355675|NCT01535807|520507593|FG000|Overall Study|Data collection error|1|||
144355676|NCT01535807|520507594|FG001|Overall Study|Data collection error|1|||
144355677|NCT02730728|520507597|FG000|Overall Study|Withdrawal by Subject|0|||
144355678|NCT02730728|520507598|FG001|Overall Study|Withdrawal by Subject|1|||
144355679|NCT02730728|520507599|FG002|Overall Study|Withdrawal by Subject|0|||
144355680|NCT02730728|520507597|FG000|Overall Study|Lack of Efficacy|0|||
144355681|NCT02730728|520507598|FG001|Overall Study|Lack of Efficacy|1|||
144355682|NCT02730728|520507599|FG002|Overall Study|Lack of Efficacy|1|||
144355683|NCT01702844|520507611|FG000|Overall Study|Adverse Event|9|||
144355684|NCT01702844|520507611|FG000|Overall Study|Death|1|||
144355685|NCT01702844|520507611|FG000|Overall Study|Withdrawal by Subject|3|||
144355686|NCT01702844|520507611|FG000|Overall Study|Physician Decision|6|||
144355687|NCT02123134|520507612|FG000|Overall Study|Withdrawal of consent|3|||
144355688|NCT02123134|520507613|FG001|Overall Study|Withdrawal of consent|2|||
144355689|NCT02123134|520507612|FG000|Overall Study|Administrative decision|0|||
144355690|NCT02123134|520507613|FG001|Overall Study|Administrative decision|1|||
144355691|NCT01731912|520507619|FG000|Overall Study|noncompliance|2|||
144355692|NCT02043938|520507620|FG000|Overall Study|Withdrawal by Subject|7|||
144355693|NCT02043938|520507620|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
144355694|NCT02043938|520507620|FG000|Overall Study|No show by subject|1|||
144355695|NCT02043938|520507620|FG000|Overall Study|Investigator decision|1|||
144355696|NCT03010527|520507621|FG000|Overall Study|Death|0|||
144355697|NCT03010527|520507622|FG001|Overall Study|Death|0|||
144355698|NCT03010527|520507623|FG002|Overall Study|Death|1|||
144355699|NCT03010527|520507621|FG000|Overall Study|Adverse Event|0|||
144355700|NCT03010527|520507622|FG001|Overall Study|Adverse Event|4|||
144355701|NCT03010527|520507623|FG002|Overall Study|Adverse Event|2|||
144355702|NCT03010527|520507621|FG000|Overall Study|Protocol Violation|0|||
144355703|NCT03010527|520507622|FG001|Overall Study|Protocol Violation|1|||
144355704|NCT03010527|520507623|FG002|Overall Study|Protocol Violation|0|||
144355705|NCT03010527|520507621|FG000|Overall Study|Lost to Follow-up|0|||
144355706|NCT03010527|520507622|FG001|Overall Study|Lost to Follow-up|2|||
144355707|NCT03010527|520507623|FG002|Overall Study|Lost to Follow-up|1|||
144355708|NCT03010527|520507621|FG000|Overall Study|Withdrawal by Subject|0|||
144355709|NCT03010527|520507622|FG001|Overall Study|Withdrawal by Subject|3|||
144355710|NCT03010527|520507623|FG002|Overall Study|Withdrawal by Subject|4|||
144355711|NCT03010527|520507621|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
144355712|NCT03010527|520507622|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
144355713|NCT03010527|520507623|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
144355714|NCT03010527|520507621|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
144355715|NCT03010527|520507622|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
144355716|NCT03010527|520507623|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
144355717|NCT03010527|520507621|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
144355718|NCT03010527|520507622|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
144355719|NCT03010527|520507623|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
144355720|NCT01458639|520507624|FG000|Overall Study|Physician Decision|4|||
144355721|NCT01458639|520507624|FG000|Overall Study|Equipment issue|1|||
144355722|NCT01458639|520507624|FG000|Overall Study|Inability to obtain subject blood sample|1|||
144355723|NCT02656017|520507625|FG000|Overall Study|Study burden|3|||
144355724|NCT02656017|520507626|FG001|Overall Study|Study burden|3|||
144355725|NCT02656017|520507625|FG000|Overall Study|Adverse Event|2|||
144355726|NCT02656017|520507626|FG001|Overall Study|Adverse Event|1|||
144355727|NCT02656017|520507625|FG000|Overall Study|Unable/unwilling to take study medication|2|||
144355728|NCT02656017|520507626|FG001|Overall Study|Unable/unwilling to take study medication|1|||
144355729|NCT02656017|520507625|FG000|Overall Study|Began Tolvaptan|1|||
144355730|NCT02656017|520507626|FG001|Overall Study|Began Tolvaptan|1|||
144355731|NCT02656017|520507625|FG000|Overall Study|Withdrawal by Subject|1|||
144355732|NCT02656017|520507626|FG001|Overall Study|Withdrawal by Subject|0|||
144355733|NCT01755234|520507627|FG000|Overall Study|Lost to Follow-up|11|||
144355734|NCT01755234|520507628|FG001|Overall Study|Lost to Follow-up|6|||
144355735|NCT01755234|520507627|FG000|Overall Study|Change in surgical case|2|||
144355736|NCT01755234|520507628|FG001|Overall Study|Change in surgical case|1|||
144355737|NCT01755234|520507627|FG000|Overall Study|case cancelled|1|||
144355738|NCT01755234|520507628|FG001|Overall Study|case cancelled|0|||
144355739|NCT01755234|520507627|FG000|Overall Study|Withdrawal by Subject|0|||
144355740|NCT01755234|520507628|FG001|Overall Study|Withdrawal by Subject|1|||
144355741|NCT01755234|520507627|FG000|Overall Study|unblinded|1|||
144355742|NCT01755234|520507628|FG001|Overall Study|unblinded|0|||
144355743|NCT00248495|520507629|FG000|Overall Study|Withdrawal by Subject|1|||
144355744|NCT03812380|520507630|FG000|Overall Study|Protocol Violation|3|||
144355745|NCT03812380|520507631|FG001|Overall Study|Protocol Violation|3|||
144355746|NCT03812380|520507630|FG000|Overall Study|Withdrawal by Subject|5|||
144355747|NCT03812380|520507631|FG001|Overall Study|Withdrawal by Subject|4|||
144355748|NCT03812380|520507630|FG000|Overall Study|Early termination of study|14|||
144355749|NCT03812380|520507631|FG001|Overall Study|Early termination of study|14|||
144355750|NCT00981149|520507632|FG000|Overall Study|Lost to Follow-up|1|||
144355751|NCT00981149|520507633|FG001|Overall Study|Lost to Follow-up|2|||
144355752|NCT00981149|520507632|FG000|Overall Study|Withdrawal by Subject|1|||
144355753|NCT00981149|520507633|FG001|Overall Study|Withdrawal by Subject|1|||
144355754|NCT04244253|520507636|FG000|Overall Study|Adverse Event|2|||
144355755|NCT04244253|520507637|FG001|Overall Study|Adverse Event|2|||
144355756|NCT04244253|520507638|FG002|Overall Study|Adverse Event|4|||
144355757|NCT04244253|520507636|FG000|Overall Study|Protocol Violation|1|||
144355758|NCT04244253|520507637|FG001|Overall Study|Protocol Violation|2|||
144355759|NCT04244253|520507638|FG002|Overall Study|Protocol Violation|1|||
144355760|NCT04244253|520507636|FG000|Overall Study|Withdrawal by Subject|0|||
144355761|NCT04244253|520507637|FG001|Overall Study|Withdrawal by Subject|1|||
144355762|NCT04244253|520507638|FG002|Overall Study|Withdrawal by Subject|6|||
144355763|NCT04244253|520507636|FG000|Overall Study|Non-Compliance With Study Drug|0|||
144355764|NCT04244253|520507637|FG001|Overall Study|Non-Compliance With Study Drug|0|||
144355765|NCT04244253|520507638|FG002|Overall Study|Non-Compliance With Study Drug|1|||
144355766|NCT00622505|520507639|FG000|Overall Study|Adverse Event|9|||
144355767|NCT00622505|520507640|FG001|Overall Study|Adverse Event|7|||
144355768|NCT00622505|520507639|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
144355769|NCT00622505|520507640|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
144355770|NCT00622505|520507639|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
144355771|NCT00622505|520507640|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
144355772|NCT00622505|520507639|FG000|Overall Study|Withdrawal by Subject|12|||
144355773|NCT00622505|520507640|FG001|Overall Study|Withdrawal by Subject|5|||
144355774|NCT00622505|520507639|FG000|Overall Study|Administrative Problems|2|||
144355775|NCT00622505|520507640|FG001|Overall Study|Administrative Problems|4|||
144355776|NCT00622505|520507639|FG000|Overall Study|Death|2|||
144355777|NCT00622505|520507640|FG001|Overall Study|Death|2|||
144355778|NCT00619515|520507641|FG000|Overall Study|Study Termination by IRB|73|||
144355779|NCT03275740|520507660|FG000|Overall Study|Adverse Event|0|||
144355780|NCT03275740|520507661|FG001|Overall Study|Adverse Event|0|||
144355781|NCT03275740|520507662|FG002|Overall Study|Adverse Event|0|||
144355782|NCT03275740|520507663|FG003|Overall Study|Adverse Event|0|||
144355783|NCT03275740|520507664|FG004|Overall Study|Adverse Event|1|||
144355784|NCT03275740|520507665|FG005|Overall Study|Adverse Event|0|||
144355785|NCT03275740|520507666|FG006|Overall Study|Adverse Event|0|||
144355786|NCT03275740|520507667|FG007|Overall Study|Adverse Event|0|||
144355787|NCT03275740|520507668|FG008|Overall Study|Adverse Event|0|||
144355788|NCT03275740|520507669|FG009|Overall Study|Adverse Event|0|||
144355789|NCT03275740|520507670|FG010|Overall Study|Adverse Event|0|||
144355790|NCT03275740|520507671|FG011|Overall Study|Adverse Event|0|||
144355791|NCT03275740|520507660|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355792|NCT03275740|520507661|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355793|NCT03275740|520507662|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355794|NCT03275740|520507663|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355795|NCT03275740|520507664|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355796|NCT03275740|520507665|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
144355797|NCT03275740|520507666|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355798|NCT03275740|520507667|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355799|NCT03275740|520507668|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355800|NCT03275740|520507669|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355801|NCT03275740|520507670|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355802|NCT03275740|520507671|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
144355803|NCT03275740|520507660|FG000|Overall Study|Withdrawal by Subject|0|||
144355804|NCT03275740|520507661|FG001|Overall Study|Withdrawal by Subject|0|||
144355805|NCT03275740|520507662|FG002|Overall Study|Withdrawal by Subject|0|||
144355806|NCT03275740|520507663|FG003|Overall Study|Withdrawal by Subject|0|||
144355807|NCT03275740|520507664|FG004|Overall Study|Withdrawal by Subject|0|||
144355808|NCT03275740|520507665|FG005|Overall Study|Withdrawal by Subject|0|||
144355809|NCT03275740|520507666|FG006|Overall Study|Withdrawal by Subject|0|||
144355810|NCT03275740|520507667|FG007|Overall Study|Withdrawal by Subject|0|||
144355811|NCT03275740|520507668|FG008|Overall Study|Withdrawal by Subject|1|||
144355812|NCT03275740|520507669|FG009|Overall Study|Withdrawal by Subject|1|||
144355813|NCT03275740|520507670|FG010|Overall Study|Withdrawal by Subject|0|||
144355814|NCT03275740|520507671|FG011|Overall Study|Withdrawal by Subject|0|||
144355815|NCT00890825|520507672|FG000|Overall Study|Withdrawal by Subject|1|||
144355816|NCT00890825|520507673|FG001|Overall Study|Withdrawal by Subject|0|||
144355817|NCT00890825|520507672|FG000|Overall Study|Alive at data cut off (DCO)|13|||
144355818|NCT00890825|520507673|FG001|Overall Study|Alive at data cut off (DCO)|14|||
144355819|NCT04701333|520507674|FG000|Overall Study|Lost to Follow-up|3|||
144355820|NCT04701333|520507675|FG001|Overall Study|Lost to Follow-up|7|||
144355821|NCT04701333|520507674|FG000|Overall Study|Withdrawal by Subject|0|||
144355822|NCT04701333|520507675|FG001|Overall Study|Withdrawal by Subject|1|||
144355823|NCT02920892|520507676|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
144355824|NCT02920892|520507677|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
144355825|NCT02920892|520507678|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
144355826|NCT02920892|520507676|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
144355827|NCT02920892|520507677|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
144355828|NCT02920892|520507678|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
144355829|NCT02920892|520507676|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
144355830|NCT02920892|520507677|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
144355831|NCT02920892|520507678|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
144355832|NCT02920892|520507676|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
144355833|NCT02920892|520507677|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
144355834|NCT02920892|520507678|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
144355835|NCT02920892|520507676|FG000|Placebo-Controlled Period|Physician Decision|0|||
144355836|NCT02920892|520507677|FG001|Placebo-Controlled Period|Physician Decision|0|||
144355837|NCT02920892|520507678|FG002|Placebo-Controlled Period|Physician Decision|1|||
144355838|NCT02920892|520507676|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
144355839|NCT02920892|520507677|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
144355840|NCT02920892|520507678|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
144355841|NCT02920892|520507676|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
144355842|NCT02920892|520507677|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
144355843|NCT02920892|520507678|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
144355844|NCT02920892|520507676|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
144355845|NCT02920892|520507677|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
144355846|NCT02920892|520507678|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
144355847|NCT00462306|520507679|FG000|Overall Study|insufficient data|0|||
144355848|NCT00462306|520507680|FG001|Overall Study|insufficient data|13|||
144355849|NCT01391663|520507681|FG000|Overall Study|Withdrawal by Subject|0|||
144355850|NCT01391663|520507682|FG001|Overall Study|Withdrawal by Subject|0|||
144355851|NCT01391663|520507683|FG002|Overall Study|Withdrawal by Subject|1|||
144355852|NCT01391663|520507684|FG003|Overall Study|Withdrawal by Subject|0|||
144355853|NCT03515824|520507685|FG000|Overall Study|Death|3|||
144355854|NCT03515824|520507686|FG001|Overall Study|Death|2|||
144355855|NCT03515824|520507687|FG002|Overall Study|Death|6|||
144355856|NCT03515824|520507688|FG003|Overall Study|Death|0|||
144355857|NCT03515824|520507685|FG000|Overall Study|Lost to Follow-up|0|||
144355858|NCT03515824|520507686|FG001|Overall Study|Lost to Follow-up|1|||
144355859|NCT03515824|520507687|FG002|Overall Study|Lost to Follow-up|1|||
144355860|NCT03515824|520507688|FG003|Overall Study|Lost to Follow-up|0|||
144355861|NCT03515824|520507685|FG000|Overall Study|Study terminated by sponsor|0|||
144355862|NCT03515824|520507686|FG001|Overall Study|Study terminated by sponsor|1|||
144355863|NCT03515824|520507687|FG002|Overall Study|Study terminated by sponsor|6|||
144355864|NCT03515824|520507688|FG003|Overall Study|Study terminated by sponsor|0|||
144355865|NCT03515824|520507685|FG000|Overall Study|Status not recorded|0|||
144355866|NCT03515824|520507686|FG001|Overall Study|Status not recorded|0|||
144355867|NCT03515824|520507687|FG002|Overall Study|Status not recorded|2|||
144355868|NCT03515824|520507688|FG003|Overall Study|Status not recorded|0|||
144355869|NCT00920855|520507689|FG000|Overall Study|Adverse Event|1|||
144355870|NCT00920855|520507690|FG001|Overall Study|Adverse Event|1|||
144355871|NCT00920855|520507691|FG002|Overall Study|Adverse Event|4|||
144355872|NCT00920855|520507689|FG000|Overall Study|Withdrawal by Subject|2|||
144355873|NCT00920855|520507690|FG001|Overall Study|Withdrawal by Subject|1|||
144355874|NCT00920855|520507691|FG002|Overall Study|Withdrawal by Subject|6|||
144355875|NCT00920855|520507689|FG000|Overall Study|Disease progression|2|||
144355876|NCT00920855|520507690|FG001|Overall Study|Disease progression|1|||
144355877|NCT00920855|520507691|FG002|Overall Study|Disease progression|10|||
144355878|NCT00920855|520507689|FG000|Overall Study|Noncompliance to study medication|0|||
144355879|NCT00920855|520507690|FG001|Overall Study|Noncompliance to study medication|0|||
144355880|NCT00920855|520507691|FG002|Overall Study|Noncompliance to study medication|1|||
144355881|NCT00920855|520507689|FG000|Overall Study|Response plateau; started maintenance|0|||
144355882|NCT00920855|520507690|FG001|Overall Study|Response plateau; started maintenance|0|||
144355883|NCT00920855|520507691|FG002|Overall Study|Response plateau; started maintenance|1|||
144355884|NCT00510835|520507695|FG000|Overall Study|Withdrawal by Subject|6|||
144355885|NCT00510835|520507696|FG001|Overall Study|Withdrawal by Subject|2|||
144355886|NCT00510835|520507697|FG002|Overall Study|Withdrawal by Subject|2|||
144355887|NCT05470985|520507698|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
144355888|NCT05470985|520507699|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
144355889|NCT05470985|520507698|FG000|Double Blind Treatment Period|Physician Decision|0|||
144355890|NCT05470985|520507699|FG001|Double Blind Treatment Period|Physician Decision|1|||
144355891|NCT05470985|520507698|FG000|Long Term Extension|Adverse Event|0|||
144355892|NCT05470985|520507699|FG001|Long Term Extension|Adverse Event|1|||
144355893|NCT05470985|520507698|FG000|Long Term Extension|Study terminated by sponsor|2|||
144355894|NCT05470985|520507699|FG001|Long Term Extension|Study terminated by sponsor|0|||
144355895|NCT04332107|520507703|FG000|Day 3|Lost to Follow-up|23|||
144355896|NCT04332107|520507704|FG001|Day 3|Lost to Follow-up|14|||
144355897|NCT04332107|520507703|FG000|Day 3|Missing outcome data|3|||
144355898|NCT04332107|520507704|FG001|Day 3|Missing outcome data|6|||
144355899|NCT04332107|520507703|FG000|Day 14|Lost to Follow-up|13|||
144355900|NCT04332107|520507704|FG001|Day 14|Lost to Follow-up|4|||
144355901|NCT04332107|520507703|FG000|Day 14|Missing outcome data|4|||
144355902|NCT04332107|520507704|FG001|Day 14|Missing outcome data|4|||
144355903|NCT04332107|520507703|FG000|Day 21|Lost to Follow-up|10|||
144355904|NCT04332107|520507704|FG001|Day 21|Lost to Follow-up|2|||
144355905|NCT00871871|520507705|FG000|Part I|Adverse Event|0|||
144355906|NCT00871871|520507706|FG001|Part I|Adverse Event|2|||
144355907|NCT00871871|520507707|FG002|Part I|Adverse Event|0|||
144355908|NCT00871871|520507708|FG003|Part I|Adverse Event|0|||
144355909|NCT00871871|520507705|FG000|Part I|Withdrawal by Subject|3|||
144355910|NCT00871871|520507706|FG001|Part I|Withdrawal by Subject|0|||
144355911|NCT00871871|520507707|FG002|Part I|Withdrawal by Subject|0|||
144355912|NCT00871871|520507708|FG003|Part I|Withdrawal by Subject|0|||
144355913|NCT00871871|520507705|FG000|Part I|Laboratory abnormality|0|||
144355914|NCT00871871|520507706|FG001|Part I|Laboratory abnormality|1|||
144355915|NCT00871871|520507707|FG002|Part I|Laboratory abnormality|0|||
144355916|NCT00871871|520507708|FG003|Part I|Laboratory abnormality|0|||
144355917|NCT00871871|520507705|FG000|Part II|Lack of Efficacy|0|||
144355918|NCT00871871|520507706|FG001|Part II|Lack of Efficacy|0|||
144355919|NCT00871871|520507707|FG002|Part II|Lack of Efficacy|1|||
144355920|NCT00871871|520507708|FG003|Part II|Lack of Efficacy|0|||
144355921|NCT00871871|520507705|FG000|Part II|Withdrawal by Subject|0|||
144355922|NCT00871871|520507706|FG001|Part II|Withdrawal by Subject|0|||
144355923|NCT00871871|520507707|FG002|Part II|Withdrawal by Subject|2|||
144355924|NCT00871871|520507708|FG003|Part II|Withdrawal by Subject|1|||
144355925|NCT00871871|520507705|FG000|Part II|Adverse Event|0|||
144355926|NCT00871871|520507706|FG001|Part II|Adverse Event|0|||
144355927|NCT00871871|520507707|FG002|Part II|Adverse Event|1|||
144355928|NCT00871871|520507708|FG003|Part II|Adverse Event|2|||
144355929|NCT00871871|520507705|FG000|Part II|Protocol Violation|0|||
144355930|NCT00871871|520507706|FG001|Part II|Protocol Violation|0|||
144355931|NCT00871871|520507707|FG002|Part II|Protocol Violation|0|||
144355932|NCT00871871|520507708|FG003|Part II|Protocol Violation|1|||
144355933|NCT00479713|520507709|FG000|Overall Study|Adverse Event|8|||
144355934|NCT00479713|520507710|FG001|Overall Study|Adverse Event|6|||
144355935|NCT00479713|520507709|FG000|Overall Study|Death|1|||
144355936|NCT00479713|520507710|FG001|Overall Study|Death|0|||
144355937|NCT00479713|520507709|FG000|Overall Study|Lost to Follow-up|0|||
144355938|NCT00479713|520507710|FG001|Overall Study|Lost to Follow-up|1|||
144355939|NCT00479713|520507709|FG000|Overall Study|Protocol Violation|0|||
144355940|NCT00479713|520507710|FG001|Overall Study|Protocol Violation|1|||
144355941|NCT00479713|520507709|FG000|Overall Study|Withdrawal by Subject|4|||
144355942|NCT00479713|520507710|FG001|Overall Study|Withdrawal by Subject|1|||
144355943|NCT03863509|520507711|FG000|Overall Study|COVID-19 shutdown period|0|||
144355944|NCT03863509|520507712|FG001|Overall Study|COVID-19 shutdown period|4|||
144355945|NCT03863509|520507713|FG002|Overall Study|COVID-19 shutdown period|0|||
144355946|NCT03863509|520507711|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
144355947|NCT03863509|520507712|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
144355948|NCT03863509|520507713|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
144355949|NCT03863509|520507711|FG000|Overall Study|Lost to Follow-up|8|||
144355950|NCT03863509|520507712|FG001|Overall Study|Lost to Follow-up|0|||
144355951|NCT03863509|520507713|FG002|Overall Study|Lost to Follow-up|2|||
144355952|NCT03863509|520507711|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
144355953|NCT03863509|520507712|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
144355954|NCT03863509|520507713|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
144355955|NCT03863509|520507711|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
144355956|NCT03863509|520507712|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
144355957|NCT03863509|520507713|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
144355958|NCT03799341|520507714|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
144355959|NCT03799341|520507715|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
144355960|NCT03799341|520507716|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
144355961|NCT03799341|520507714|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
144355962|NCT03799341|520507715|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
144355963|NCT03799341|520507716|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
144355964|NCT03799341|520507714|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
144355965|NCT03799341|520507715|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
144355966|NCT03799341|520507716|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
144355967|NCT03799341|520507714|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
144355968|NCT03799341|520507715|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
144355969|NCT03799341|520507716|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
144355970|NCT03799341|520507714|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
144355971|NCT03799341|520507715|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
144355972|NCT03799341|520507716|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
144355973|NCT03799341|520507714|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
144355974|NCT03799341|520507715|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
144355975|NCT03799341|520507716|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
144355976|NCT00990106|520507717|FG000|Overall Study|"too busy to continue"|1|||
144355977|NCT00990106|520507718|FG001|Overall Study|"too busy to continue"|2|||
144355978|NCT00990106|520507717|FG000|Overall Study|Lost to Follow-up|1|||
144355979|NCT00990106|520507718|FG001|Overall Study|Lost to Follow-up|3|||
144355980|NCT00990106|520507717|FG000|Overall Study|Withdrawal by Subject|2|||
144355981|NCT00990106|520507718|FG001|Overall Study|Withdrawal by Subject|1|||
144355982|NCT00990106|520507717|FG000|Overall Study|opted for open label prazosin|1|||
144355983|NCT00990106|520507718|FG001|Overall Study|opted for open label prazosin|1|||
144355984|NCT00990106|520507717|FG000|Overall Study|relocation/deployment|4|||
144355985|NCT00990106|520507718|FG001|Overall Study|relocation/deployment|1|||
144355986|NCT00990106|520507717|FG000|Overall Study|started exclusionary medication|0|||
144355987|NCT00990106|520507718|FG001|Overall Study|started exclusionary medication|1|||
144355988|NCT00990106|520507717|FG000|Overall Study|planned major surgery|0|||
144355989|NCT00990106|520507718|FG001|Overall Study|planned major surgery|1|||
144355990|NCT00990106|520507717|FG000|Overall Study|scheduling conflicts|0|||
144355991|NCT00990106|520507718|FG001|Overall Study|scheduling conflicts|2|||
144355992|NCT03446313|520507719|FG000|Overall Study|Lost to Follow-up|1|||
144355993|NCT03446313|520507720|FG001|Overall Study|Lost to Follow-up|2|||
144355994|NCT03446313|520507719|FG000|Overall Study|Failed primary screening|3|||
144355995|NCT03446313|520507720|FG001|Overall Study|Failed primary screening|0|||
144355996|NCT03446313|520507719|FG000|Overall Study|Diagnosed with terminal cancer|1|||
144355997|NCT03446313|520507720|FG001|Overall Study|Diagnosed with terminal cancer|0|||
144355998|NCT03446313|520507719|FG000|Overall Study|Excluded from analysis|1|||
144355999|NCT03446313|520507720|FG001|Overall Study|Excluded from analysis|1|||
144356000|NCT01342913|520508524|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
144356001|NCT01342913|520508525|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144356002|NCT01342913|520508526|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
144356003|NCT01342913|520508524|FG000|2-week Run-in Period|Physician Decision|6|||
144356004|NCT01342913|520508525|FG001|2-week Run-in Period|Physician Decision|0|||
144356005|NCT01342913|520508526|FG002|2-week Run-in Period|Physician Decision|0|||
144356006|NCT01342913|520508524|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
144356007|NCT01342913|520508525|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
144356008|NCT01342913|520508526|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
144356009|NCT01342913|520508524|FG000|2-week Run-in Period|Adverse Event|2|||
144356010|NCT01342913|520508525|FG001|2-week Run-in Period|Adverse Event|0|||
144356011|NCT01342913|520508526|FG002|2-week Run-in Period|Adverse Event|0|||
144356012|NCT01342913|520508524|FG000|2-week Run-in Period|Protocol Violation|5|||
144356013|NCT01342913|520508525|FG001|2-week Run-in Period|Protocol Violation|0|||
144356014|NCT01342913|520508526|FG002|2-week Run-in Period|Protocol Violation|0|||
144356015|NCT01342913|520508524|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
144356016|NCT01342913|520508525|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
144356017|NCT01342913|520508526|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
144356018|NCT01342913|520508524|FG000|Double-Blind Treatment Period|Adverse Event|0|||
144356019|NCT01342913|520508525|FG001|Double-Blind Treatment Period|Adverse Event|3|||
144356020|NCT01342913|520508526|FG002|Double-Blind Treatment Period|Adverse Event|6|||
144356021|NCT01342913|520508524|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
144356022|NCT01342913|520508525|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
144356023|NCT01342913|520508526|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
144356024|NCT01342913|520508524|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
144356025|NCT01342913|520508525|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
144356026|NCT01342913|520508526|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
144356027|NCT01342913|520508524|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
144356028|NCT01342913|520508525|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
144356029|NCT01342913|520508526|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
144356030|NCT01342913|520508524|FG000|Double-Blind Treatment Period|Physician Decision|0|||
144356031|NCT01342913|520508525|FG001|Double-Blind Treatment Period|Physician Decision|2|||
144356032|NCT01342913|520508526|FG002|Double-Blind Treatment Period|Physician Decision|0|||
144356033|NCT01342913|520508524|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
144356034|NCT01342913|520508525|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144356035|NCT01342913|520508526|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
144356036|NCT05482308|520508531|FG000|Overall Study|Withdrawal by Subject|1|||
144356037|NCT05482308|520508532|FG001|Overall Study|Withdrawal by Subject|0|||
144356038|NCT05482308|520508531|FG000|Overall Study|No longer meets eligibility criteria|0|||
144356039|NCT05482308|520508532|FG001|Overall Study|No longer meets eligibility criteria|1|||
144356040|NCT04319198|520508533|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
144356041|NCT04319198|520508534|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
144356042|NCT04319198|520508535|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
144356043|NCT04319198|520508533|FG000|Overall Study|Death|0|||
144356044|NCT04319198|520508534|FG001|Overall Study|Death|3|||
144356045|NCT04319198|520508535|FG002|Overall Study|Death|3|||
144356046|NCT04319198|520508533|FG000|Overall Study|Reason Not Specified|0|||
144356047|NCT04319198|520508534|FG001|Overall Study|Reason Not Specified|2|||
144356048|NCT04319198|520508535|FG002|Overall Study|Reason Not Specified|4|||
144356049|NCT04319198|520508533|FG000|Overall Study|Withdrawal of Consent|0|||
144356050|NCT04319198|520508534|FG001|Overall Study|Withdrawal of Consent|0|||
144356051|NCT04319198|520508535|FG002|Overall Study|Withdrawal of Consent|5|||
144356052|NCT04319198|520508533|FG000|Overall Study|Site Terminated by Sponsor|0|||
144356053|NCT04319198|520508534|FG001|Overall Study|Site Terminated by Sponsor|1|||
144356054|NCT04319198|520508535|FG002|Overall Study|Site Terminated by Sponsor|0|||
144356055|NCT05801991|520508536|FG000|Overall Study|Lost to Follow-up|1|||
144356056|NCT05801991|520508537|FG001|Overall Study|Lost to Follow-up|0|||
144356057|NCT02193776|520508540|FG000|Overall Study|Consent withdrawn|1|||
144356058|NCT02193776|520508541|FG001|Overall Study|Consent withdrawn|0|||
144356059|NCT02193776|520508542|FG002|Overall Study|Consent withdrawn|0|||
144356060|NCT02193776|520508543|FG003|Overall Study|Consent withdrawn|0|||
144356061|NCT02193776|520508540|FG000|Overall Study|Failure to comply with protocol|0|||
144356062|NCT02193776|520508541|FG001|Overall Study|Failure to comply with protocol|1|||
144356063|NCT02193776|520508542|FG002|Overall Study|Failure to comply with protocol|0|||
144356064|NCT02193776|520508543|FG003|Overall Study|Failure to comply with protocol|0|||
144356065|NCT02193776|520508540|FG000|Overall Study|Investigator/Sponsor decision|1|||
144356066|NCT02193776|520508541|FG001|Overall Study|Investigator/Sponsor decision|1|||
144356067|NCT02193776|520508542|FG002|Overall Study|Investigator/Sponsor decision|0|||
144356068|NCT02193776|520508543|FG003|Overall Study|Investigator/Sponsor decision|0|||
144356069|NCT02193776|520508540|FG000|Overall Study|Death|1|||
144356070|NCT02193776|520508541|FG001|Overall Study|Death|0|||
144356071|NCT02193776|520508542|FG002|Overall Study|Death|0|||
144356072|NCT02193776|520508543|FG003|Overall Study|Death|0|||
144356073|NCT02193776|520508540|FG000|Overall Study|Adverse event/Specific toxicity|5|||
144356074|NCT02193776|520508541|FG001|Overall Study|Adverse event/Specific toxicity|5|||
144356075|NCT02193776|520508542|FG002|Overall Study|Adverse event/Specific toxicity|2|||
144356076|NCT02193776|520508543|FG003|Overall Study|Adverse event/Specific toxicity|2|||
144356077|NCT01169103|520508545|FG000|Overall Study|Lost to Follow-up|3|||
144356078|NCT01169103|520508546|FG001|Overall Study|Lost to Follow-up|3|||
144356079|NCT01169103|520508545|FG000|Overall Study|Withdrawal by Subject|3|||
144356080|NCT01169103|520508546|FG001|Overall Study|Withdrawal by Subject|1|||
144356081|NCT02634333|520508547|FG000|Overall Study|Completed out of Window|3|||
144356082|NCT02634333|520508548|FG001|Overall Study|Completed out of Window|2|||
144356083|NCT02634333|520508547|FG000|Overall Study|Missed Visit|5|||
144356084|NCT02634333|520508548|FG001|Overall Study|Missed Visit|2|||
144356085|NCT02634333|520508547|FG000|Overall Study|Lost to Follow-up|12|||
144356086|NCT02634333|520508548|FG001|Overall Study|Lost to Follow-up|7|||
144356087|NCT02634333|520508547|FG000|Overall Study|Withdrawal by Subject|9|||
144356088|NCT02634333|520508548|FG001|Overall Study|Withdrawal by Subject|13|||
144356089|NCT02634333|520508547|FG000|Overall Study|Death|11|||
144356090|NCT02634333|520508548|FG001|Overall Study|Death|8|||
144356091|NCT02611479|520508549|FG000|Baseline Enrollment|Exited study|13|||
144356092|NCT02611479|520508549|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
144356093|NCT02611479|520508549|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
144356094|NCT02611479|520508549|FG000|Data Cleaning|No baseline function or pain metrics|2|||
144356095|NCT02741245|520508554|FG000|Overall Study|Adverse Event|0|||
144356096|NCT02741245|520508555|FG001|Overall Study|Adverse Event|0|||
144356097|NCT02741245|520508556|FG002|Overall Study|Adverse Event|0|||
144356098|NCT02741245|520508557|FG003|Overall Study|Adverse Event|2|||
144356099|NCT02741245|520508558|FG004|Overall Study|Adverse Event|2|||
144356100|NCT02741245|520508554|FG000|Overall Study|Protocol Violation|0|||
144356101|NCT02741245|520508555|FG001|Overall Study|Protocol Violation|1|||
144356102|NCT02741245|520508556|FG002|Overall Study|Protocol Violation|0|||
144356103|NCT02741245|520508557|FG003|Overall Study|Protocol Violation|1|||
144356104|NCT02741245|520508558|FG004|Overall Study|Protocol Violation|0|||
144356105|NCT02741245|520508554|FG000|Overall Study|Withdrawal by Subject|0|||
144356106|NCT02741245|520508555|FG001|Overall Study|Withdrawal by Subject|0|||
144356107|NCT02741245|520508556|FG002|Overall Study|Withdrawal by Subject|0|||
144356108|NCT02741245|520508557|FG003|Overall Study|Withdrawal by Subject|1|||
144356109|NCT02741245|520508558|FG004|Overall Study|Withdrawal by Subject|0|||
144356110|NCT00152503|520508559|FG000|Overall Study|Adverse Event|4|||
144356111|NCT03253679|520508560|FG000|Overall Study|Screen Failure|1|||
144356112|NCT04816214|520508561|FG000|Overall Study|Progressive Disease|4|||
144356113|NCT04816214|520508562|FG001|Overall Study|Progressive Disease|0|||
144356114|NCT04816214|520508563|FG002|Overall Study|Progressive Disease|0|||
144356115|NCT04816214|520508561|FG000|Overall Study|Death|1|||
144356116|NCT04816214|520508562|FG001|Overall Study|Death|0|||
144356117|NCT04816214|520508563|FG002|Overall Study|Death|0|||
144356118|NCT04816214|520508561|FG000|Overall Study|Study Terminated by Sponsor|1|||
144356119|NCT04816214|520508562|FG001|Overall Study|Study Terminated by Sponsor|0|||
144356120|NCT04816214|520508563|FG002|Overall Study|Study Terminated by Sponsor|0|||
144356121|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
144356122|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
144356123|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
144356124|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
144356125|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
144356126|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
144356127|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
144356128|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
144356129|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
144356130|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
144356131|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
144356132|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
144356133|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
144356134|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
144356135|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
144356136|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
144356137|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
144356138|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
144356139|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
144356140|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
144356141|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
144356142|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
144356143|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
144356144|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
144356145|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
144356146|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
144356147|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
144356148|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
144356149|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
144356150|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
144356151|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
144356152|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
144356153|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
144356154|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
144356155|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
144356156|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
144356157|NCT02586623|520508564|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
144356158|NCT02586623|520508565|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
144356159|NCT02586623|520508566|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
144356160|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
144356161|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
144356162|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
144356163|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
144356164|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
144356165|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
144356166|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
144356167|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
144356168|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
144356169|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
144356170|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
144356171|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
144356172|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
144356173|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
144356174|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
144356175|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
144356176|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
144356177|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
144356178|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
144356179|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
144356180|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
144356181|NCT02586623|520508564|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
144356182|NCT02586623|520508565|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
144356183|NCT02586623|520508566|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
144356184|NCT05051579|520508570|FG000|Overall Study|Withdrawal by Subject|3|||
144356185|NCT05051579|520508571|FG001|Overall Study|Withdrawal by Subject|5|||
144356186|NCT05051579|520508572|FG002|Overall Study|Withdrawal by Subject|2|||
144356187|NCT05051579|520508573|FG003|Overall Study|Withdrawal by Subject|1|||
144356188|NCT05051579|520508574|FG004|Overall Study|Withdrawal by Subject|4|||
144356189|NCT05051579|520508575|FG005|Overall Study|Withdrawal by Subject|0|||
144356190|NCT05051579|520508576|FG006|Overall Study|Withdrawal by Subject|4|||
144356191|NCT05051579|520508570|FG000|Overall Study|Lost to Follow-up|1|||
144356192|NCT05051579|520508571|FG001|Overall Study|Lost to Follow-up|0|||
144356193|NCT05051579|520508572|FG002|Overall Study|Lost to Follow-up|0|||
144356194|NCT05051579|520508573|FG003|Overall Study|Lost to Follow-up|0|||
144356195|NCT05051579|520508574|FG004|Overall Study|Lost to Follow-up|1|||
144356196|NCT05051579|520508575|FG005|Overall Study|Lost to Follow-up|0|||
144356197|NCT05051579|520508576|FG006|Overall Study|Lost to Follow-up|1|||
144356198|NCT05051579|520508570|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
144356199|NCT05051579|520508571|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
144356200|NCT05051579|520508572|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
144356201|NCT05051579|520508573|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
144356202|NCT05051579|520508574|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
144356203|NCT05051579|520508575|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
144356204|NCT05051579|520508576|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
144356205|NCT05051579|520508570|FG000|Overall Study|Adverse Event|2|||
144356206|NCT05051579|520508571|FG001|Overall Study|Adverse Event|1|||
144356207|NCT05051579|520508572|FG002|Overall Study|Adverse Event|0|||
144356208|NCT05051579|520508573|FG003|Overall Study|Adverse Event|4|||
144356209|NCT05051579|520508574|FG004|Overall Study|Adverse Event|1|||
144356210|NCT05051579|520508575|FG005|Overall Study|Adverse Event|2|||
144356211|NCT05051579|520508576|FG006|Overall Study|Adverse Event|0|||
144356212|NCT05051579|520508570|FG000|Overall Study|Inadvertent Enrollment|0|||
144356213|NCT05051579|520508571|FG001|Overall Study|Inadvertent Enrollment|0|||
144356214|NCT05051579|520508572|FG002|Overall Study|Inadvertent Enrollment|0|||
144356215|NCT05051579|520508573|FG003|Overall Study|Inadvertent Enrollment|0|||
144356216|NCT05051579|520508574|FG004|Overall Study|Inadvertent Enrollment|0|||
144356217|NCT05051579|520508575|FG005|Overall Study|Inadvertent Enrollment|0|||
144356218|NCT05051579|520508576|FG006|Overall Study|Inadvertent Enrollment|1|||
144356219|NCT05051579|520508570|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
144356220|NCT05051579|520508571|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
144356221|NCT05051579|520508572|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
144356222|NCT05051579|520508573|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
144356223|NCT05051579|520508574|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
144356224|NCT05051579|520508575|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
144356225|NCT05051579|520508576|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
144356226|NCT05051579|520508570|FG000|Overall Study|Sponsor Decision|0|||
144356227|NCT05051579|520508571|FG001|Overall Study|Sponsor Decision|0|||
144356228|NCT05051579|520508572|FG002|Overall Study|Sponsor Decision|0|||
144356229|NCT05051579|520508573|FG003|Overall Study|Sponsor Decision|0|||
144356230|NCT05051579|520508574|FG004|Overall Study|Sponsor Decision|1|||
144356231|NCT05051579|520508575|FG005|Overall Study|Sponsor Decision|0|||
144356232|NCT05051579|520508576|FG006|Overall Study|Sponsor Decision|0|||
144356233|NCT05051579|520508570|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
144356234|NCT05051579|520508571|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
144356235|NCT05051579|520508572|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
144356236|NCT05051579|520508573|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
144356237|NCT05051579|520508574|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
144356238|NCT05051579|520508575|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
144356239|NCT05051579|520508576|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
144356240|NCT00717249|520508579|FG000|Overall Study|Lens Discomfort|4|||
144356241|NCT00717249|520508580|FG001|Overall Study|Lens Discomfort|1|||
144356242|NCT00717249|520508579|FG000|Overall Study|Unsatisfactory visual Response|0|||
144356243|NCT00717249|520508580|FG001|Overall Study|Unsatisfactory visual Response|2|||
144356244|NCT00717249|520508579|FG000|Overall Study|Adverse Event|4|||
144356245|NCT00717249|520508580|FG001|Overall Study|Adverse Event|2|||
144356246|NCT00717249|520508579|FG000|Overall Study|Lost to Follow-up|2|||
144356247|NCT00717249|520508580|FG001|Overall Study|Lost to Follow-up|0|||
144356248|NCT00717249|520508579|FG000|Overall Study|Withdrawal by Subject|1|||
144356249|NCT00717249|520508580|FG001|Overall Study|Withdrawal by Subject|2|||
144356250|NCT00717249|520508579|FG000|Overall Study|Pregnancy|6|||
144356251|NCT00717249|520508580|FG001|Overall Study|Pregnancy|3|||
144356252|NCT00717249|520508579|FG000|Overall Study|Protocol Violation|0|||
144356253|NCT00717249|520508580|FG001|Overall Study|Protocol Violation|2|||
144356254|NCT00717249|520508579|FG000|Overall Study|Subject became Ineligible|1|||
144356255|NCT00717249|520508580|FG001|Overall Study|Subject became Ineligible|1|||
144356256|NCT00717249|520508579|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
144356257|NCT00717249|520508580|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
144356258|NCT00717249|520508579|FG000|Overall Study|Gastric Surgery|0|||
144356259|NCT00717249|520508580|FG001|Overall Study|Gastric Surgery|1|||
144356260|NCT00717249|520508579|FG000|Overall Study|Diagnosed with Diabetes|1|||
144356261|NCT00717249|520508580|FG001|Overall Study|Diagnosed with Diabetes|0|||
144356262|NCT00717249|520508579|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
144356263|NCT00717249|520508580|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
144356264|NCT00717249|520508579|FG000|Overall Study|Subject relocated|1|||
144356265|NCT00717249|520508580|FG001|Overall Study|Subject relocated|0|||
144356266|NCT00717249|520508579|FG000|Overall Study|Headaches|1|||
144356267|NCT00717249|520508580|FG001|Overall Study|Headaches|0|||
144356268|NCT01670721|520508581|FG000|Overall Study|Participant's decision|15|||
144356269|NCT01670721|520508581|FG000|Overall Study|Other than specified above|38|||
144356270|NCT03100149|520508584|FG000|Overall Study|Adverse Event|0|||
144356271|NCT03100149|520508585|FG001|Overall Study|Adverse Event|1|||
144356272|NCT03100149|520508586|FG002|Overall Study|Adverse Event|0|||
144356273|NCT03100149|520508584|FG000|Overall Study|Participant Moved out of Country|0|||
144356274|NCT03100149|520508585|FG001|Overall Study|Participant Moved out of Country|0|||
144356275|NCT03100149|520508586|FG002|Overall Study|Participant Moved out of Country|1|||
144356276|NCT03100149|520508584|FG000|Overall Study|Withdrawal by Subject|0|||
144356277|NCT03100149|520508585|FG001|Overall Study|Withdrawal by Subject|3|||
144356278|NCT03100149|520508586|FG002|Overall Study|Withdrawal by Subject|1|||
144356279|NCT02926638|520508592|FG000|Overall Study|Progression|2|||
144356280|NCT02926638|520508593|FG001|Overall Study|Progression|5|||
144356281|NCT02926638|520508592|FG000|Overall Study|Ineligible|1|||
144356282|NCT02926638|520508593|FG001|Overall Study|Ineligible|0|||
144356283|NCT02926638|520508592|FG000|Overall Study|Not protocol specified|1|||
144356284|NCT02926638|520508593|FG001|Overall Study|Not protocol specified|0|||
144356285|NCT01871519|520508595|FG000|Overall Study|Death|26|||
144356286|NCT01871519|520508595|FG000|Overall Study|Lost to Follow-up|15|||
144356287|NCT01871519|520508595|FG000|Overall Study|Withdrawal by Subject|49|||
144356288|NCT00320515|520508596|FG000|Overall Study|Death|33|||
144356289|NCT00320515|520508596|FG000|Overall Study|Lost to Follow-up|6|||
144356290|NCT00320515|520508596|FG000|Overall Study|Physician Decision|2|||
144356291|NCT00320515|520508596|FG000|Overall Study|Withdrawal by Subject|8|||
144356292|NCT01063153|520508597|FG000|Overall Study|Found Ineligible During Screening|2|||
144356293|NCT01063153|520508598|FG001|Overall Study|Found Ineligible During Screening|0|||
144356294|NCT01063153|520508597|FG000|Overall Study|Lost to Follow-up|0|||
144356295|NCT01063153|520508598|FG001|Overall Study|Lost to Follow-up|7|||
144356296|NCT01063153|520508597|FG000|Overall Study|Withdrawal by Subject|0|||
144356297|NCT01063153|520508598|FG001|Overall Study|Withdrawal by Subject|1|||
144356298|NCT01063153|520508597|FG000|Overall Study|Physician Decision|0|||
144356299|NCT01063153|520508598|FG001|Overall Study|Physician Decision|4|||
144356300|NCT00350844|520508599|FG000|Overall Study|Lost to Follow-up|1|||
144356301|NCT01420926|520508600|FG000|Overall Study|Adverse Event|6|||
144356302|NCT01420926|520508601|FG001|Overall Study|Adverse Event|4|||
144356303|NCT01420926|520508600|FG000|Overall Study|Death|18|||
144356304|NCT01420926|520508601|FG001|Overall Study|Death|17|||
144356305|NCT01420926|520508600|FG000|Overall Study|Withdrawal by Subject|11|||
144356306|NCT01420926|520508601|FG001|Overall Study|Withdrawal by Subject|17|||
144356307|NCT01420926|520508600|FG000|Overall Study|Non-protocol treatment|17|||
144356308|NCT01420926|520508601|FG001|Overall Study|Non-protocol treatment|20|||
144356309|NCT01420926|520508600|FG000|Overall Study|Physician Decision|8|||
144356310|NCT01420926|520508601|FG001|Overall Study|Physician Decision|5|||
144356311|NCT00445549|520510106|FG000|Overall Study|progressive disease|12|||
144356312|NCT01405768|520510113|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
144356313|NCT01405768|520510114|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
144356314|NCT03489863|520510118|FG000|Overall Study|Withdrawal by Subject|0|||
144356315|NCT03489863|520510119|FG001|Overall Study|Withdrawal by Subject|1|||
144356316|NCT02995980|520510120|FG000|Overall Study|Lost to Follow-up|14|||
144356317|NCT02792231|520510121|FG000|Overall Study|Patient/guardian decision|32|||
144356318|NCT02792231|520510122|FG001|Overall Study|Patient/guardian decision|42|||
144356319|NCT02792231|520510121|FG000|Overall Study|Adverse Event|15|||
144356320|NCT02792231|520510122|FG001|Overall Study|Adverse Event|11|||
144356321|NCT02792231|520510121|FG000|Overall Study|Physician Decision|14|||
144356322|NCT02792231|520510122|FG001|Overall Study|Physician Decision|12|||
144356323|NCT02792231|520510121|FG000|Overall Study|Lack of Efficacy|7|||
144356324|NCT02792231|520510122|FG001|Overall Study|Lack of Efficacy|9|||
144356325|NCT02792231|520510121|FG000|Overall Study|Lost to Follow-up|9|||
144356326|NCT02792231|520510122|FG001|Overall Study|Lost to Follow-up|5|||
144356327|NCT02792231|520510121|FG000|Overall Study|Pregnancy|1|||
144356328|NCT02792231|520510122|FG001|Overall Study|Pregnancy|3|||
144356329|NCT02792231|520510121|FG000|Overall Study|Non-compliance with study treatment|2|||
144356330|NCT02792231|520510122|FG001|Overall Study|Non-compliance with study treatment|1|||
144356331|NCT02792231|520510121|FG000|Overall Study|Protocol deviation|2|||
144356332|NCT02792231|520510122|FG001|Overall Study|Protocol deviation|0|||
144356333|NCT02792231|520510121|FG000|Overall Study|Technical problems|0|||
144356334|NCT02792231|520510122|FG001|Overall Study|Technical problems|1|||
144356335|NCT05196828|520510123|FG000|Overall Study|Withdrawal by Subject|2|||
144356336|NCT05196828|520510124|FG001|Overall Study|Withdrawal by Subject|0|||
144356337|NCT05196828|520510123|FG000|Overall Study|Lost to Follow-up|0|||
144356338|NCT05196828|520510124|FG001|Overall Study|Lost to Follow-up|4|||
144356339|NCT05196828|520510123|FG000|Overall Study|Adverse Event|1|||
144356340|NCT05196828|520510124|FG001|Overall Study|Adverse Event|0|||
144356341|NCT04073186|520510125|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
144356342|NCT04073186|520510125|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
144356343|NCT04073186|520510125|FG000|First Wearing Cycle|Protocol Violation|1|||
144356344|NCT04073186|520510125|FG000|First Wearing Cycle|Lens Discomfort|2|||
144356345|NCT04073186|520510125|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
144356346|NCT04073186|520510125|FG000|Second Wearing Cycle|Adverse Event|1|||
144356347|NCT00473434|520510126|FG000|Overall Study|Physician Decision|3|||
144360273|NCT00772538|520527436|FG001|Overall Study|Protocol Violation|3|||
144356348|NCT00473434|520510126|FG000|Overall Study|Withdrawal by Subject|9|||
144356349|NCT00473434|520510126|FG000|Overall Study|Compliance|3|||
144356350|NCT00473434|520510126|FG000|Overall Study|Lack of Efficacy|3|||
144356351|NCT00473434|520510126|FG000|Overall Study|Adverse Event|3|||
144356352|NCT00473434|520510126|FG000|Overall Study|Patient was selling medication to others|1|||
144356353|NCT00473434|520510126|FG000|Overall Study|Safety evaluation|1|||
144356354|NCT00473434|520510126|FG000|Overall Study|Reason not specified|6|||
144356355|NCT00473434|520510126|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
144356356|NCT00473434|520510126|FG000|Overall Study|Switching to trial medication|1|||
144356357|NCT00473434|520510126|FG000|Overall Study|No longer required|1|||
144356358|NCT03360682|520510127|FG000|Overall Study|Adverse Event|3|||
144356359|NCT00423657|520510128|FG000|Overall Study|Withdrew consent|10|||
144356360|NCT00423657|520510129|FG001|Overall Study|Withdrew consent|8|||
144356361|NCT00423657|520510128|FG000|Overall Study|Non-compliance|0|||
144356362|NCT00423657|520510129|FG001|Overall Study|Non-compliance|1|||
144356363|NCT00423657|520510128|FG000|Overall Study|Other|15|||
144356364|NCT00423657|520510129|FG001|Overall Study|Other|16|||
144356365|NCT00423657|520510128|FG000|Overall Study|Request of sponsor/investigator|1|||
144356366|NCT00423657|520510129|FG001|Overall Study|Request of sponsor/investigator|0|||
144356367|NCT02748863|520510130|FG000|Treatment Period 1|Adverse Event|0|||
144356368|NCT02748863|520510131|FG001|Treatment Period 1|Adverse Event|1|||
144356369|NCT02748863|520510132|FG002|Treatment Period 1|Adverse Event|0|||
144356370|NCT02748863|520510133|FG003|Treatment Period 1|Adverse Event|0|||
144356371|NCT02748863|520510134|FG004|Treatment Period 1|Adverse Event|0|||
144356372|NCT02748863|520510130|FG000|Treatment Period 1|Lack of Efficacy|0|||
144356373|NCT02748863|520510131|FG001|Treatment Period 1|Lack of Efficacy|0|||
144356374|NCT02748863|520510132|FG002|Treatment Period 1|Lack of Efficacy|1|||
144356375|NCT02748863|520510133|FG003|Treatment Period 1|Lack of Efficacy|0|||
144356376|NCT02748863|520510134|FG004|Treatment Period 1|Lack of Efficacy|0|||
144356377|NCT02748863|520510130|FG000|Treatment Period 1|Withdrawal by Subject|0|||
144356378|NCT02748863|520510131|FG001|Treatment Period 1|Withdrawal by Subject|1|||
144356379|NCT02748863|520510132|FG002|Treatment Period 1|Withdrawal by Subject|1|||
144356380|NCT02748863|520510133|FG003|Treatment Period 1|Withdrawal by Subject|0|||
144356381|NCT02748863|520510134|FG004|Treatment Period 1|Withdrawal by Subject|0|||
144356382|NCT02748863|520510130|FG000|Treatment Period 2|Lost to Follow-up|2|||
144356383|NCT02748863|520510131|FG001|Treatment Period 2|Lost to Follow-up|0|||
144356384|NCT02748863|520510132|FG002|Treatment Period 2|Lost to Follow-up|0|||
144356385|NCT02748863|520510133|FG003|Treatment Period 2|Lost to Follow-up|0|||
144356386|NCT02748863|520510134|FG004|Treatment Period 2|Lost to Follow-up|0|||
144356387|NCT02748863|520510130|FG000|Treatment Period 2|Adverse Event|3|||
144356388|NCT02748863|520510131|FG001|Treatment Period 2|Adverse Event|2|||
144356389|NCT02748863|520510132|FG002|Treatment Period 2|Adverse Event|0|||
144356390|NCT02748863|520510133|FG003|Treatment Period 2|Adverse Event|2|||
144356391|NCT02748863|520510134|FG004|Treatment Period 2|Adverse Event|0|||
144356392|NCT02748863|520510130|FG000|Treatment Period 2|Lack of Efficacy|0|||
144356393|NCT02748863|520510131|FG001|Treatment Period 2|Lack of Efficacy|1|||
144356394|NCT02748863|520510132|FG002|Treatment Period 2|Lack of Efficacy|0|||
144356395|NCT02748863|520510133|FG003|Treatment Period 2|Lack of Efficacy|0|||
144356396|NCT02748863|520510134|FG004|Treatment Period 2|Lack of Efficacy|0|||
144356397|NCT02748863|520510130|FG000|Treatment Period 2|Pregnancy|0|||
144356398|NCT02748863|520510131|FG001|Treatment Period 2|Pregnancy|0|||
144356399|NCT02748863|520510132|FG002|Treatment Period 2|Pregnancy|0|||
144356400|NCT02748863|520510133|FG003|Treatment Period 2|Pregnancy|0|||
144356401|NCT02748863|520510134|FG004|Treatment Period 2|Pregnancy|1|||
144356402|NCT02422498|520510135|FG000|Overall Study|Inevaluable|4|||
144356403|NCT03206216|520510136|FG000|Overall Study|Withdrawal by Subject|0|||
144356404|NCT03206216|520510137|FG001|Overall Study|Withdrawal by Subject|1|||
144356405|NCT00231777|520510139|FG000|Overall Study|Lost to Follow-up|3|||
144356406|NCT00231777|520510140|FG001|Overall Study|Lost to Follow-up|0|||
144356407|NCT00231777|520510139|FG000|Overall Study|Other|3|||
144356408|NCT00231777|520510140|FG001|Overall Study|Other|2|||
144356409|NCT00657046|520510143|FG000|Overall Study|Adverse Event|1|||
144356410|NCT00657046|520510144|FG001|Overall Study|Adverse Event|1|||
144356411|NCT00657046|520510145|FG002|Overall Study|Adverse Event|0|||
144356412|NCT00657046|520510143|FG000|Overall Study|Protocol Violation|2|||
144356413|NCT00657046|520510144|FG001|Overall Study|Protocol Violation|2|||
144356414|NCT00657046|520510145|FG002|Overall Study|Protocol Violation|0|||
144356415|NCT00657046|520510143|FG000|Overall Study|Withdrawal by Subject|1|||
144356416|NCT00657046|520510144|FG001|Overall Study|Withdrawal by Subject|0|||
144356417|NCT00657046|520510145|FG002|Overall Study|Withdrawal by Subject|0|||
144356418|NCT00657046|520510143|FG000|Overall Study|Death|0|||
144356419|NCT00657046|520510144|FG001|Overall Study|Death|0|||
144356420|NCT00657046|520510145|FG002|Overall Study|Death|1|||
144356421|NCT00657046|520510143|FG000|Overall Study|Surgery|0|||
144356422|NCT00657046|520510144|FG001|Overall Study|Surgery|0|||
144356423|NCT00657046|520510145|FG002|Overall Study|Surgery|1|||
144356424|NCT06237049|520510146|FG000|Overall Study|Death|0|||
144356425|NCT06237049|520510147|FG001|Overall Study|Death|0|||
144356426|NCT06237049|520510148|FG002|Overall Study|Death|0|||
144356427|NCT06237049|520510149|FG003|Overall Study|Death|1|||
144356428|NCT06237049|520510146|FG000|Overall Study|Lost to Follow-up|11|||
144356429|NCT06237049|520510147|FG001|Overall Study|Lost to Follow-up|5|||
144356430|NCT06237049|520510148|FG002|Overall Study|Lost to Follow-up|8|||
144356431|NCT06237049|520510149|FG003|Overall Study|Lost to Follow-up|8|||
144356432|NCT06237049|520510146|FG000|Overall Study|Protocol Violation|0|||
144356433|NCT06237049|520510147|FG001|Overall Study|Protocol Violation|1|||
144356434|NCT06237049|520510148|FG002|Overall Study|Protocol Violation|0|||
144356435|NCT06237049|520510149|FG003|Overall Study|Protocol Violation|1|||
144356436|NCT06237049|520510146|FG000|Overall Study|Withdrawal by Subject|4|||
144356437|NCT06237049|520510147|FG001|Overall Study|Withdrawal by Subject|2|||
144356438|NCT06237049|520510148|FG002|Overall Study|Withdrawal by Subject|1|||
144356439|NCT06237049|520510149|FG003|Overall Study|Withdrawal by Subject|0|||
144356440|NCT02525471|520510150|FG000|Overall Study|Screen Failure|6|||
144356441|NCT02525471|520510150|FG000|Overall Study|Withdrawal by Subject|4|||
144356442|NCT02525471|520510150|FG000|Overall Study|Death|1|||
144356443|NCT00867165|520510151|FG000|Overall Study|Adverse Event|3|||
144356444|NCT00867165|520510152|FG001|Overall Study|Adverse Event|0|||
144356445|NCT00867165|520510151|FG000|Overall Study|Withdrawal by Subject|1|||
144356446|NCT00867165|520510152|FG001|Overall Study|Withdrawal by Subject|0|||
144356447|NCT00844376|520510153|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
144356448|NCT00844376|520510154|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
144356449|NCT00988884|520510155|FG000|Overall Study|Adverse Event|0|||
144356450|NCT00988884|520510156|FG001|Overall Study|Adverse Event|1|||
144356451|NCT00988884|520510155|FG000|Overall Study|Lost to Follow-up|20|||
144356452|NCT00988884|520510156|FG001|Overall Study|Lost to Follow-up|16|||
144356453|NCT00988884|520510155|FG000|Overall Study|Protocol Violation|0|||
144356454|NCT00988884|520510156|FG001|Overall Study|Protocol Violation|1|||
144356455|NCT00988884|520510155|FG000|Overall Study|Withdrawal by Subject|15|||
144356456|NCT00988884|520510156|FG001|Overall Study|Withdrawal by Subject|18|||
144356457|NCT02738008|520510157|FG000|Overall Study|Study Terminated by Sponsor|1|||
144356458|NCT02738008|520510158|FG001|Overall Study|Study Terminated by Sponsor|5|||
144356459|NCT02738008|520510159|FG002|Overall Study|Study Terminated by Sponsor|3|||
144356460|NCT02738008|520510157|FG000|Overall Study|Adverse Event|0|||
144356461|NCT02738008|520510158|FG001|Overall Study|Adverse Event|1|||
144356462|NCT02738008|520510159|FG002|Overall Study|Adverse Event|2|||
144356463|NCT04621448|520510160|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
144356464|NCT04621448|520510161|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
144356465|NCT04621448|520510162|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
144356466|NCT04621448|520510163|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
144356467|NCT04621448|520510160|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
144356468|NCT04621448|520510161|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
144356469|NCT04621448|520510162|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
144356470|NCT04621448|520510163|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
144356471|NCT04621448|520510160|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
144356472|NCT04621448|520510161|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
144356473|NCT04621448|520510162|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
144356474|NCT04621448|520510163|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
144356475|NCT04621448|520510160|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
144356476|NCT04621448|520510161|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
144356477|NCT04621448|520510162|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
144356478|NCT04621448|520510163|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
144356479|NCT03550378|520510172|FG000|Overall Study|Death|0|||
144356480|NCT03550378|520510173|FG001|Overall Study|Death|1|||
144356481|NCT04486235|520510176|FG000|Overall Study|Pregnancy|1|||
144356482|NCT04486235|520510177|FG001|Overall Study|Pregnancy|0|||
144356483|NCT04486235|520510176|FG000|Overall Study|Lost to Follow-up|1|||
144356484|NCT04486235|520510177|FG001|Overall Study|Lost to Follow-up|0|||
144356485|NCT04590014|520510178|FG000|Overall Study|Withdrawal by Subject|1|||
144356486|NCT04590014|520510179|FG001|Overall Study|Withdrawal by Subject|0|||
144356487|NCT03935126|520510180|FG000|Overall Study|Study termination by sponsor|3|||
144356488|NCT00468299|520510181|FG000|Overall Study|Withdrawal by Subject|0|||
144356489|NCT00468299|520510182|FG001|Overall Study|Withdrawal by Subject|1|||
144356490|NCT00399516|520510183|FG000|Overall Study|Lost to Follow-up|2|||
144356491|NCT03546621|520510186|FG000|Overall Study|Withdrawal by Subject|0|||
144356492|NCT03546621|520510187|FG001|Overall Study|Withdrawal by Subject|1|||
144356493|NCT03546621|520510188|FG002|Overall Study|Withdrawal by Subject|2|||
144356494|NCT03546621|520510189|FG003|Overall Study|Withdrawal by Subject|1|||
144356495|NCT03546621|520510186|FG000|Overall Study|Lost to Follow-up|0|||
144356496|NCT03546621|520510187|FG001|Overall Study|Lost to Follow-up|1|||
144356497|NCT03546621|520510188|FG002|Overall Study|Lost to Follow-up|0|||
144356498|NCT03546621|520510189|FG003|Overall Study|Lost to Follow-up|0|||
144356499|NCT03546621|520510186|FG000|Overall Study|Adverse Event|0|||
144356500|NCT03546621|520510187|FG001|Overall Study|Adverse Event|1|||
144356501|NCT03546621|520510188|FG002|Overall Study|Adverse Event|0|||
144356502|NCT03546621|520510189|FG003|Overall Study|Adverse Event|1|||
144356503|NCT03546621|520510186|FG000|Overall Study|Progressive disease|0|||
144356504|NCT03546621|520510187|FG001|Overall Study|Progressive disease|0|||
144356505|NCT03546621|520510188|FG002|Overall Study|Progressive disease|0|||
144356506|NCT03546621|520510189|FG003|Overall Study|Progressive disease|1|||
144356507|NCT00377520|520510195|FG000|Overall Study|Ineligible (Prior radiation)|1|||
144356508|NCT00660192|520510196|FG000|Overall Study|Lost to Follow-up|2|||
144356509|NCT00660192|520510197|FG001|Overall Study|Lost to Follow-up|3|||
144356510|NCT01091675|520510202|FG000|Overall Study|Adverse Event|7|||
144356511|NCT01091675|520510202|FG000|Overall Study|Lack of Efficacy|27|||
144356512|NCT03040141|520510204|FG000|Overall Study|Death|1|||
144356513|NCT03040141|520510205|FG001|Overall Study|Death|2|||
144356514|NCT03040141|520510206|FG002|Overall Study|Death|3|||
144356515|NCT03040141|520510204|FG000|Overall Study|Withdrawal by Subject|3|||
144356516|NCT03040141|520510205|FG001|Overall Study|Withdrawal by Subject|1|||
144356517|NCT03040141|520510206|FG002|Overall Study|Withdrawal by Subject|1|||
144356518|NCT03040141|520510204|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
144356519|NCT03040141|520510205|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
144356520|NCT03040141|520510206|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
144356521|NCT03040141|520510204|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
144356522|NCT03040141|520510205|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
144356523|NCT03040141|520510206|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
144356524|NCT04908397|520510207|FG000|Overall Study|Withdrawal by Subject|2|||
144356525|NCT03318549|520510208|FG000|Overall Study|Withdrawal by Subject|5|||
144356526|NCT03318549|520510209|FG001|Overall Study|Withdrawal by Subject|19|||
144356527|NCT03318549|520510210|FG002|Overall Study|Withdrawal by Subject|2|||
144356528|NCT03318549|520510211|FG003|Overall Study|Withdrawal by Subject|0|||
144356529|NCT03318549|520510212|FG004|Overall Study|Withdrawal by Subject|0|||
144356530|NCT03318549|520510213|FG005|Overall Study|Withdrawal by Subject|0|||
144356531|NCT03318549|520510214|FG006|Overall Study|Withdrawal by Subject|0|||
144356532|NCT03318549|520510208|FG000|Overall Study|Physician Decision|0|||
144356533|NCT03318549|520510209|FG001|Overall Study|Physician Decision|4|||
144356534|NCT03318549|520510210|FG002|Overall Study|Physician Decision|1|||
144356535|NCT03318549|520510211|FG003|Overall Study|Physician Decision|0|||
144356536|NCT03318549|520510212|FG004|Overall Study|Physician Decision|0|||
144356537|NCT03318549|520510213|FG005|Overall Study|Physician Decision|0|||
144356538|NCT03318549|520510214|FG006|Overall Study|Physician Decision|0|||
144356539|NCT03318549|520510208|FG000|Overall Study|Lost to Follow-up|0|||
144356540|NCT03318549|520510209|FG001|Overall Study|Lost to Follow-up|3|||
144356541|NCT03318549|520510210|FG002|Overall Study|Lost to Follow-up|3|||
144356542|NCT03318549|520510211|FG003|Overall Study|Lost to Follow-up|0|||
144356543|NCT03318549|520510212|FG004|Overall Study|Lost to Follow-up|0|||
144356544|NCT03318549|520510213|FG005|Overall Study|Lost to Follow-up|0|||
144356545|NCT03318549|520510214|FG006|Overall Study|Lost to Follow-up|0|||
144356546|NCT00539994|520510215|FG000|Overall Study|Lost to Follow-up|2|||
144356547|NCT00539994|520510216|FG001|Overall Study|Lost to Follow-up|1|||
144356548|NCT00539994|520510217|FG002|Overall Study|Lost to Follow-up|0|||
144356549|NCT00539994|520510215|FG000|Overall Study|Withdrawal by Subject|1|||
144356550|NCT00539994|520510216|FG001|Overall Study|Withdrawal by Subject|0|||
144356551|NCT00539994|520510217|FG002|Overall Study|Withdrawal by Subject|1|||
144356552|NCT00539994|520510215|FG000|Overall Study|Physician Decision|0|||
144356553|NCT00539994|520510216|FG001|Overall Study|Physician Decision|0|||
144356554|NCT00539994|520510217|FG002|Overall Study|Physician Decision|1|||
144356555|NCT01917747|520510219|FG000|Overall Study|Withdrawal by Subject|1|||
144356556|NCT01917747|520510220|FG001|Overall Study|Withdrawal by Subject|2|||
144356557|NCT01917747|520510219|FG000|Overall Study|Lost to Follow-up|18|||
144356558|NCT01917747|520510220|FG001|Overall Study|Lost to Follow-up|9|||
144356559|NCT01787461|520510225|FG000|Overall Study|Adverse Event|4|||
144356560|NCT01787461|520510226|FG001|Overall Study|Adverse Event|3|||
144356561|NCT01787461|520510225|FG000|Overall Study|Lost to Follow-up|3|||
144356562|NCT01787461|520510226|FG001|Overall Study|Lost to Follow-up|2|||
144356563|NCT01787461|520510225|FG000|Overall Study|No longer met eligibility criteria|1|||
144356564|NCT01787461|520510226|FG001|Overall Study|No longer met eligibility criteria|0|||
144356565|NCT01787461|520510225|FG000|Overall Study|Withdrawal by Subject|3|||
144356566|NCT01787461|520510226|FG001|Overall Study|Withdrawal by Subject|4|||
144356567|NCT01787461|520510225|FG000|Overall Study|Protocol Violation|3|||
144356568|NCT01787461|520510226|FG001|Overall Study|Protocol Violation|0|||
144356569|NCT04879628|520510228|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
144356570|NCT04879628|520510229|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
144356571|NCT04879628|520510230|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
144356572|NCT04879628|520510231|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
144356573|NCT04879628|520510228|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
144356574|NCT04879628|520510229|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
144356575|NCT04879628|520510230|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
144356576|NCT04879628|520510231|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
144359688|NCT03007966|520524986|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
144356577|NCT04879628|520510228|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
144356578|NCT04879628|520510229|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
144356579|NCT04879628|520510230|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
144356580|NCT04879628|520510231|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
144356581|NCT04879628|520510228|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
144356582|NCT04879628|520510229|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
144356583|NCT04879628|520510230|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
144356584|NCT04879628|520510231|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
144356585|NCT03649074|520510232|FG000|Overall Study|Lost to Follow-up|2|||
144356586|NCT03649074|520510233|FG001|Overall Study|Lost to Follow-up|1|||
144356587|NCT03649074|520510232|FG000|Overall Study|Adverse Event|1|||
144356588|NCT03649074|520510233|FG001|Overall Study|Adverse Event|0|||
144356589|NCT03649074|520510232|FG000|Overall Study|Physician Decision|1|||
144356590|NCT03649074|520510233|FG001|Overall Study|Physician Decision|0|||
144356591|NCT03649074|520510232|FG000|Overall Study|Withdrawal by Subject|0|||
144356592|NCT03649074|520510233|FG001|Overall Study|Withdrawal by Subject|2|||
144356593|NCT03649074|520510232|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
144356594|NCT03649074|520510233|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
144356595|NCT03649074|520510232|FG000|Overall Study|Other|1|||
144356596|NCT03649074|520510233|FG001|Overall Study|Other|0|||
144356597|NCT03861273|520510240|FG000|Screening Phase (3 Weeks)|Other|1|||
144356598|NCT03861273|520510240|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
144356599|NCT03861273|520510240|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
144356600|NCT03861273|520510240|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
144356601|NCT03861273|520510240|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
144356602|NCT00191334|520510243|FG000|Overall Study|Adverse Event|4|||
144356603|NCT00191334|520510243|FG000|Overall Study|Disease Progression or Relapse|8|||
144356604|NCT00191334|520510243|FG000|Overall Study|Physician Decision|1|||
144356605|NCT00191334|520510243|FG000|Overall Study|Withdrawal by Subject|4|||
144356606|NCT01116648|520510244|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
144356607|NCT01116648|520510245|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
144356608|NCT01116648|520510246|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
144356609|NCT01116648|520510247|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
144356610|NCT01116648|520510248|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
144356611|NCT01116648|520510249|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
144356612|NCT01116648|520510250|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
144356613|NCT01116648|520510251|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
144356614|NCT01116648|520510252|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
144356615|NCT01116648|520510253|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
144356616|NCT01116648|520510254|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
144356617|NCT01116648|520510255|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
144356618|NCT01116648|520510256|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
144356619|NCT01116648|520510257|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
144356620|NCT01116648|520510258|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
144356621|NCT04539938|520510259|FG000|Overall Study|Death|30|||
144356622|NCT04539938|520510259|FG000|Overall Study|Withdrawal by Subject|4|||
144356623|NCT03064490|520510260|FG000|Overall Study|Physician Decision|5|||
144356624|NCT02775916|520510261|FG000|Overall Study|Adverse Event|1|||
144356625|NCT02775916|520510262|FG001|Overall Study|Adverse Event|0|||
144356626|NCT02775916|520510261|FG000|Overall Study|Subject/Guardian Decision|2|||
144356627|NCT02775916|520510262|FG001|Overall Study|Subject/Guardian Decision|0|||
144356628|NCT01393158|520511970|FG000|Overall Study|Adverse Event|1|||
144356629|NCT01393158|520511971|FG001|Overall Study|Adverse Event|0|||
144356630|NCT00762359|520511973|FG000|Overall Study|Adverse Event|20|||
144356631|NCT00762359|520511974|FG001|Overall Study|Adverse Event|23|||
144356632|NCT00762359|520511973|FG000|Overall Study|Protocol Violation|21|||
144356633|NCT00762359|520511974|FG001|Overall Study|Protocol Violation|13|||
144356634|NCT00762359|520511973|FG000|Overall Study|Withdrawal by Subject|13|||
144356635|NCT00762359|520511974|FG001|Overall Study|Withdrawal by Subject|10|||
144356636|NCT00762359|520511973|FG000|Overall Study|Lack of Efficacy|0|||
144356637|NCT00762359|520511974|FG001|Overall Study|Lack of Efficacy|4|||
144356638|NCT00762359|520511973|FG000|Overall Study|Institution closed|2|||
144356639|NCT00762359|520511974|FG001|Overall Study|Institution closed|3|||
144356640|NCT00762359|520511973|FG000|Overall Study|Physician Decision|2|||
144356641|NCT00762359|520511974|FG001|Overall Study|Physician Decision|3|||
144356642|NCT00762359|520511973|FG000|Overall Study|Removal|0|||
144356643|NCT00762359|520511974|FG001|Overall Study|Removal|1|||
144356644|NCT00762359|520511973|FG000|Overall Study|Withdrew consent|1|||
144356645|NCT00762359|520511974|FG001|Overall Study|Withdrew consent|0|||
144356646|NCT01690052|520511977|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
144356647|NCT01690052|520511978|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
144356648|NCT00882440|520511979|FG000|Overall Study|Adverse Event|2|||
144356649|NCT00882440|520511980|FG001|Overall Study|Adverse Event|2|||
144356650|NCT00882440|520511981|FG002|Overall Study|Adverse Event|2|||
144356651|NCT00882440|520511982|FG003|Overall Study|Adverse Event|1|||
144356652|NCT00882440|520511983|FG004|Overall Study|Adverse Event|1|||
144356653|NCT00882440|520511984|FG005|Overall Study|Adverse Event|4|||
144356654|NCT00882440|520511985|FG006|Overall Study|Adverse Event|2|||
144356655|NCT00882440|520511979|FG000|Overall Study|Lack of Efficacy|3|||
144356656|NCT00882440|520511980|FG001|Overall Study|Lack of Efficacy|5|||
144356657|NCT00882440|520511981|FG002|Overall Study|Lack of Efficacy|2|||
144356658|NCT00882440|520511982|FG003|Overall Study|Lack of Efficacy|0|||
144356659|NCT00882440|520511983|FG004|Overall Study|Lack of Efficacy|0|||
144356660|NCT00882440|520511984|FG005|Overall Study|Lack of Efficacy|3|||
144356661|NCT00882440|520511985|FG006|Overall Study|Lack of Efficacy|0|||
144356662|NCT00882440|520511979|FG000|Overall Study|Lost to Follow-up|2|||
144356663|NCT00882440|520511980|FG001|Overall Study|Lost to Follow-up|0|||
144356664|NCT00882440|520511981|FG002|Overall Study|Lost to Follow-up|1|||
144356665|NCT00882440|520511982|FG003|Overall Study|Lost to Follow-up|1|||
144356666|NCT00882440|520511983|FG004|Overall Study|Lost to Follow-up|1|||
144356667|NCT00882440|520511984|FG005|Overall Study|Lost to Follow-up|0|||
144356668|NCT00882440|520511985|FG006|Overall Study|Lost to Follow-up|1|||
144356669|NCT00882440|520511979|FG000|Overall Study|Protocol Violation|0|||
144356670|NCT00882440|520511980|FG001|Overall Study|Protocol Violation|0|||
144356671|NCT00882440|520511981|FG002|Overall Study|Protocol Violation|1|||
144356672|NCT00882440|520511982|FG003|Overall Study|Protocol Violation|1|||
144356673|NCT00882440|520511983|FG004|Overall Study|Protocol Violation|1|||
144356674|NCT00882440|520511984|FG005|Overall Study|Protocol Violation|0|||
144356675|NCT00882440|520511985|FG006|Overall Study|Protocol Violation|0|||
144356676|NCT00882440|520511979|FG000|Overall Study|Withdrawal by Subject|2|||
144356677|NCT00882440|520511980|FG001|Overall Study|Withdrawal by Subject|1|||
144356678|NCT00882440|520511981|FG002|Overall Study|Withdrawal by Subject|1|||
144356679|NCT00882440|520511982|FG003|Overall Study|Withdrawal by Subject|0|||
144356680|NCT00882440|520511983|FG004|Overall Study|Withdrawal by Subject|6|||
144356681|NCT00882440|520511984|FG005|Overall Study|Withdrawal by Subject|0|||
144356682|NCT00882440|520511985|FG006|Overall Study|Withdrawal by Subject|1|||
144356683|NCT00882440|520511979|FG000|Overall Study|Patient Uncooperative|2|||
144356684|NCT00882440|520511980|FG001|Overall Study|Patient Uncooperative|0|||
144356685|NCT00882440|520511981|FG002|Overall Study|Patient Uncooperative|0|||
144356686|NCT00882440|520511982|FG003|Overall Study|Patient Uncooperative|0|||
144356687|NCT00882440|520511983|FG004|Overall Study|Patient Uncooperative|1|||
144356688|NCT00882440|520511984|FG005|Overall Study|Patient Uncooperative|0|||
144356689|NCT00882440|520511985|FG006|Overall Study|Patient Uncooperative|0|||
144356690|NCT00683878|520511986|FG000|Overall Study|Lack of Efficacy|3|||
144356691|NCT00683878|520511987|FG001|Overall Study|Lack of Efficacy|0|||
144356692|NCT00683878|520511988|FG002|Overall Study|Lack of Efficacy|1|||
144356693|NCT00683878|520511986|FG000|Overall Study|Adverse Event|4|||
144356694|NCT00683878|520511987|FG001|Overall Study|Adverse Event|3|||
144356695|NCT00683878|520511988|FG002|Overall Study|Adverse Event|3|||
144356696|NCT00683878|520511986|FG000|Overall Study|Withdrawal by Subject|9|||
144356697|NCT00683878|520511987|FG001|Overall Study|Withdrawal by Subject|8|||
144356698|NCT00683878|520511988|FG002|Overall Study|Withdrawal by Subject|6|||
144356699|NCT00683878|520511986|FG000|Overall Study|Death|0|||
144356700|NCT00683878|520511987|FG001|Overall Study|Death|1|||
144356701|NCT00683878|520511988|FG002|Overall Study|Death|0|||
144356702|NCT00683878|520511986|FG000|Overall Study|Lost to Follow-up|4|||
144356703|NCT00683878|520511987|FG001|Overall Study|Lost to Follow-up|2|||
144356704|NCT00683878|520511988|FG002|Overall Study|Lost to Follow-up|4|||
144356705|NCT00683878|520511986|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
144356706|NCT00683878|520511987|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
144356707|NCT00683878|520511988|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
144356708|NCT02869633|520511992|FG000|Overall Study|Death|2|||
144356709|NCT02869633|520511993|FG001|Overall Study|Death|1|||
144356710|NCT02869633|520511992|FG000|Overall Study|Patient refused follow-up|1|||
144356711|NCT02869633|520511993|FG001|Overall Study|Patient refused follow-up|0|||
144356712|NCT02869633|520511992|FG000|Overall Study|Provider discretion|1|||
144356713|NCT02869633|520511993|FG001|Overall Study|Provider discretion|0|||
144356714|NCT02869633|520511992|FG000|Overall Study|Investigator decision|1|||
144356715|NCT02869633|520511993|FG001|Overall Study|Investigator decision|0|||
144356716|NCT02869633|520511992|FG000|Overall Study|Lost to Follow-up|0|||
144356717|NCT02869633|520511993|FG001|Overall Study|Lost to Follow-up|1|||
144356718|NCT02869633|520511992|FG000|Overall Study|Not eligible|6|||
144356719|NCT02869633|520511993|FG001|Overall Study|Not eligible|1|||
144356720|NCT02869633|520511992|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
144356721|NCT02869633|520511993|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
144356722|NCT02869633|520511992|FG000|Overall Study|Withdrawal by Subject|0|||
144356723|NCT02869633|520511993|FG001|Overall Study|Withdrawal by Subject|1|||
144356724|NCT04024891|520511994|FG000|Overall Study|Pregnancy|0|||
144356725|NCT04024891|520511995|FG001|Overall Study|Pregnancy|1|||
144356726|NCT01693029|520512018|FG000|Overall Study|Withdrawal by Subject|15|||
144356727|NCT01693029|520512019|FG001|Overall Study|Withdrawal by Subject|22|||
144356728|NCT01693029|520512018|FG000|Overall Study|Kidney transplantation|7|||
144356729|NCT01693029|520512019|FG001|Overall Study|Kidney transplantation|7|||
144356730|NCT01693029|520512018|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
144356731|NCT01693029|520512019|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
144356732|NCT01693029|520512018|FG000|Overall Study|Protocol Violation|6|||
144356733|NCT01693029|520512019|FG001|Overall Study|Protocol Violation|7|||
144356734|NCT01693029|520512018|FG000|Overall Study|Change in dialysis modality|2|||
144356735|NCT01693029|520512019|FG001|Overall Study|Change in dialysis modality|1|||
144356736|NCT01693029|520512018|FG000|Overall Study|Physician Decision|0|||
144356737|NCT01693029|520512019|FG001|Overall Study|Physician Decision|2|||
144356738|NCT01693029|520512018|FG000|Overall Study|Lost to Follow-up|0|||
144356739|NCT01693029|520512019|FG001|Overall Study|Lost to Follow-up|1|||
144356740|NCT01693029|520512018|FG000|Overall Study|Adverse Event|1|||
144356741|NCT01693029|520512019|FG001|Overall Study|Adverse Event|6|||
144356742|NCT01693029|520512018|FG000|Overall Study|Death|5|||
144356743|NCT01693029|520512019|FG001|Overall Study|Death|8|||
144356744|NCT01693029|520512018|FG000|Overall Study|Non-compliance|2|||
144356745|NCT01693029|520512019|FG001|Overall Study|Non-compliance|1|||
144356746|NCT01451723|520512021|FG000|Overall Study|study halted|6|||
144356747|NCT01451723|520512022|FG001|Overall Study|study halted|5|||
144356748|NCT01329263|520512023|FG000|Overall Study|Lost to Follow-up|4|||
144356749|NCT01329263|520512024|FG001|Overall Study|Lost to Follow-up|21|||
144356750|NCT01329263|520512023|FG000|Overall Study|Withdrawal by Subject|1|||
144356751|NCT01329263|520512024|FG001|Overall Study|Withdrawal by Subject|2|||
144356752|NCT01631435|520512026|FG000|Overall Study|Adverse Event|2|||
144356753|NCT01631435|520512026|FG000|Overall Study|Withdrawal by Subject|2|||
144356754|NCT01631435|520512026|FG000|Overall Study|incomplete study procedure|5|||
144356755|NCT00833040|520512027|FG000|Overall Study|Adverse Event|0|||
144356756|NCT00833040|520512028|FG001|Overall Study|Adverse Event|0|||
144356757|NCT00833040|520512029|FG002|Overall Study|Adverse Event|0|||
144356758|NCT00833040|520512030|FG003|Overall Study|Adverse Event|0|||
144356759|NCT00833040|520512031|FG004|Overall Study|Adverse Event|0|||
144356760|NCT00833040|520512032|FG005|Overall Study|Adverse Event|1|||
144356761|NCT00416624|520512035|FG000|Overall Study|Withdrawal by Subject|1|||
144356762|NCT00416624|520512036|FG001|Overall Study|Withdrawal by Subject|6|||
144356763|NCT00416624|520512037|FG002|Overall Study|Withdrawal by Subject|4|||
144356764|NCT00416624|520512038|FG003|Overall Study|Withdrawal by Subject|9|||
144356765|NCT00416624|520512035|FG000|Overall Study|Death|4|||
144356766|NCT00416624|520512036|FG001|Overall Study|Death|7|||
144356767|NCT00416624|520512037|FG002|Overall Study|Death|7|||
144356768|NCT00416624|520512038|FG003|Overall Study|Death|1|||
144356769|NCT00416624|520512035|FG000|Overall Study|Adverse Event|8|||
144356770|NCT00416624|520512036|FG001|Overall Study|Adverse Event|3|||
144356771|NCT00416624|520512037|FG002|Overall Study|Adverse Event|2|||
144356772|NCT00416624|520512038|FG003|Overall Study|Adverse Event|2|||
144356773|NCT00416624|520512035|FG000|Overall Study|Other|8|||
144356774|NCT00416624|520512036|FG001|Overall Study|Other|11|||
144356775|NCT00416624|520512037|FG002|Overall Study|Other|5|||
144356776|NCT00416624|520512038|FG003|Overall Study|Other|5|||
144356777|NCT00416624|520512035|FG000|Overall Study|Cancel|1|||
144356778|NCT00416624|520512036|FG001|Overall Study|Cancel|0|||
144356779|NCT00416624|520512037|FG002|Overall Study|Cancel|0|||
144356780|NCT00416624|520512038|FG003|Overall Study|Cancel|0|||
144356781|NCT01005251|520512039|FG000|Overall Study|Withdrawal by Subject|2|||
144356782|NCT01005251|520512040|FG001|Overall Study|Withdrawal by Subject|5|||
144356783|NCT01005251|520512041|FG002|Overall Study|Withdrawal by Subject|3|||
144356784|NCT01005251|520512042|FG003|Overall Study|Withdrawal by Subject|4|||
144356785|NCT01005251|520512043|FG004|Overall Study|Withdrawal by Subject|9|||
144356786|NCT01005251|520512039|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
144356787|NCT01005251|520512040|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
144356788|NCT01005251|520512041|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
144356789|NCT01005251|520512042|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
144356790|NCT01005251|520512043|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
144356791|NCT01005251|520512039|FG000|Overall Study|Adverse Event|2|||
144356792|NCT01005251|520512040|FG001|Overall Study|Adverse Event|6|||
144356793|NCT01005251|520512041|FG002|Overall Study|Adverse Event|8|||
144356794|NCT01005251|520512042|FG003|Overall Study|Adverse Event|5|||
144356795|NCT01005251|520512043|FG004|Overall Study|Adverse Event|4|||
144356796|NCT01005251|520512039|FG000|Overall Study|Protocol Violation|1|||
144356797|NCT01005251|520512040|FG001|Overall Study|Protocol Violation|0|||
144356798|NCT01005251|520512041|FG002|Overall Study|Protocol Violation|0|||
144356799|NCT01005251|520512042|FG003|Overall Study|Protocol Violation|0|||
144356800|NCT01005251|520512043|FG004|Overall Study|Protocol Violation|2|||
144356801|NCT01005251|520512039|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
144356802|NCT01005251|520512040|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
144356803|NCT01005251|520512041|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
144356804|NCT01005251|520512042|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
144356805|NCT01005251|520512043|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
144356806|NCT01005251|520512039|FG000|Overall Study|Lost to Follow-up|1|||
144356807|NCT01005251|520512040|FG001|Overall Study|Lost to Follow-up|4|||
144356808|NCT01005251|520512041|FG002|Overall Study|Lost to Follow-up|2|||
144356809|NCT01005251|520512042|FG003|Overall Study|Lost to Follow-up|0|||
144356810|NCT01005251|520512043|FG004|Overall Study|Lost to Follow-up|0|||
144356811|NCT01005251|520512039|FG000|Overall Study|Physician Decision|0|||
144356812|NCT01005251|520512040|FG001|Overall Study|Physician Decision|0|||
144356813|NCT01005251|520512041|FG002|Overall Study|Physician Decision|0|||
144356814|NCT01005251|520512042|FG003|Overall Study|Physician Decision|0|||
144356815|NCT01005251|520512043|FG004|Overall Study|Physician Decision|2|||
144356816|NCT01005251|520512039|FG000|Overall Study|Patient moved|1|||
144356817|NCT01005251|520512040|FG001|Overall Study|Patient moved|0|||
144356818|NCT01005251|520512041|FG002|Overall Study|Patient moved|0|||
144356819|NCT01005251|520512042|FG003|Overall Study|Patient moved|0|||
144356820|NCT01005251|520512043|FG004|Overall Study|Patient moved|0|||
144356821|NCT01005251|520512039|FG000|Overall Study|Wrong drug dispensed|0|||
144356822|NCT01005251|520512040|FG001|Overall Study|Wrong drug dispensed|1|||
144356823|NCT01005251|520512041|FG002|Overall Study|Wrong drug dispensed|0|||
144356824|NCT01005251|520512042|FG003|Overall Study|Wrong drug dispensed|0|||
144356825|NCT01005251|520512043|FG004|Overall Study|Wrong drug dispensed|0|||
144356826|NCT01005251|520512039|FG000|Overall Study|Randomized in error|0|||
144356827|NCT01005251|520512040|FG001|Overall Study|Randomized in error|0|||
144356828|NCT01005251|520512041|FG002|Overall Study|Randomized in error|1|||
144356829|NCT01005251|520512042|FG003|Overall Study|Randomized in error|1|||
144356830|NCT01005251|520512043|FG004|Overall Study|Randomized in error|0|||
144356831|NCT01005251|520512039|FG000|Overall Study|Lack of Efficacy|0|||
144356832|NCT01005251|520512040|FG001|Overall Study|Lack of Efficacy|0|||
144356833|NCT01005251|520512041|FG002|Overall Study|Lack of Efficacy|1|||
144356834|NCT01005251|520512042|FG003|Overall Study|Lack of Efficacy|1|||
144356835|NCT01005251|520512043|FG004|Overall Study|Lack of Efficacy|0|||
144356836|NCT00962208|520512045|FG000|Overall Study|Could not achieve good vision|9|||
144356837|NCT00962208|520512046|FG001|Overall Study|Could not achieve good vision|0|||
144356838|NCT00962208|520512045|FG000|Overall Study|Contraindicated to continue study|5|||
144356839|NCT00962208|520512046|FG001|Overall Study|Contraindicated to continue study|1|||
144356840|NCT00962208|520512045|FG000|Overall Study|Lost to Follow-up|0|||
144356841|NCT00962208|520512046|FG001|Overall Study|Lost to Follow-up|9|||
144356842|NCT00657540|520512047|FG000|Overall Study|Lost to Follow-up|1|||
144356843|NCT00657540|520512048|FG001|Overall Study|Lost to Follow-up|4|||
144356844|NCT04245111|520512049|FG000|Overall Study|Lost to Follow-up|5|||
144356845|NCT04245111|520512050|FG001|Overall Study|Lost to Follow-up|1|||
144356846|NCT04245111|520512051|FG002|Overall Study|Lost to Follow-up|1|||
144356847|NCT02469623|520512052|FG000|Overall Study|Not consented for long-term follow-up|4|||
144356848|NCT02469623|520512052|FG000|Overall Study|Lost to Follow-up|4|||
144356849|NCT02469623|520512052|FG000|Overall Study|Withdrawal by Subject|2|||
144356850|NCT02469623|520512052|FG000|Overall Study|Death|3|||
144356851|NCT03309878|520512053|FG000|Overall Study|Adverse Event|1|||
144356852|NCT03309878|520512054|FG001|Overall Study|Adverse Event|0|||
144356853|NCT03309878|520512055|FG002|Overall Study|Adverse Event|0|||
144356854|NCT03309878|520512056|FG003|Overall Study|Adverse Event|0|||
144356855|NCT03309878|520512053|FG000|Overall Study|Did not maintain eligibility|2|||
144356856|NCT03309878|520512054|FG001|Overall Study|Did not maintain eligibility|1|||
144356857|NCT03309878|520512055|FG002|Overall Study|Did not maintain eligibility|0|||
144356858|NCT03309878|520512056|FG003|Overall Study|Did not maintain eligibility|0|||
144356859|NCT03309878|520512053|FG000|Overall Study|Withdrawal by Subject|0|||
144356860|NCT03309878|520512054|FG001|Overall Study|Withdrawal by Subject|1|||
144356861|NCT03309878|520512055|FG002|Overall Study|Withdrawal by Subject|0|||
144356862|NCT03309878|520512056|FG003|Overall Study|Withdrawal by Subject|0|||
144356863|NCT01096316|520512057|FG000|Overall Study|Lost to Follow-up|15|||
144356864|NCT01096316|520512058|FG001|Overall Study|Lost to Follow-up|9|||
144356865|NCT01884077|520512059|FG000|Overall Study|screen fail|0|||
144356866|NCT01884077|520512060|FG001|Overall Study|screen fail|2|||
144356867|NCT01884077|520512059|FG000|Overall Study|canceled surgery|2|||
144356868|NCT01884077|520512060|FG001|Overall Study|canceled surgery|0|||
144356869|NCT01884077|520512059|FG000|Overall Study|Lost to Follow-up|0|||
144356870|NCT01884077|520512060|FG001|Overall Study|Lost to Follow-up|4|||
144356871|NCT01884077|520512059|FG000|Overall Study|study closed|6|||
144356872|NCT01884077|520512060|FG001|Overall Study|study closed|4|||
144356873|NCT02836652|520512061|FG000|Overall Study|Death|3|||
144356874|NCT02836652|520512062|FG001|Overall Study|Death|3|||
144356875|NCT02836652|520512061|FG000|Overall Study|Transplant/Explant|3|||
144356876|NCT02836652|520512062|FG001|Overall Study|Transplant/Explant|4|||
144356877|NCT02836652|520512061|FG000|Overall Study|Withdrawn|9|||
144356878|NCT02836652|520512062|FG001|Overall Study|Withdrawn|9|||
144356879|NCT02836652|520512061|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
144356880|NCT02836652|520512062|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
144356881|NCT02349633|520512063|FG000|Overall Study|Death|0|||
144356882|NCT02349633|520512064|FG001|Overall Study|Death|1|||
144356883|NCT02349633|520512065|FG002|Overall Study|Death|0|||
144356884|NCT02349633|520512066|FG003|Overall Study|Death|0|||
144356885|NCT02349633|520512067|FG004|Overall Study|Death|0|||
144356886|NCT02349633|520512068|FG005|Overall Study|Death|1|||
144356887|NCT02349633|520512069|FG006|Overall Study|Death|1|||
144356888|NCT02349633|520512070|FG007|Overall Study|Death|1|||
144356889|NCT02349633|520512071|FG008|Overall Study|Death|0|||
144356890|NCT02349633|520512072|FG009|Overall Study|Death|1|||
144356891|NCT02349633|520512073|FG010|Overall Study|Death|0|||
144356892|NCT02349633|520512074|FG011|Overall Study|Death|0|||
144356893|NCT02349633|520512075|FG012|Overall Study|Death|0|||
144356894|NCT02349633|520512076|FG013|Overall Study|Death|0|||
144356895|NCT02349633|520512063|FG000|Overall Study|Withdrawal by Subject|0|||
144356896|NCT02349633|520512064|FG001|Overall Study|Withdrawal by Subject|0|||
144356897|NCT02349633|520512065|FG002|Overall Study|Withdrawal by Subject|0|||
144356898|NCT02349633|520512066|FG003|Overall Study|Withdrawal by Subject|1|||
144356899|NCT02349633|520512067|FG004|Overall Study|Withdrawal by Subject|0|||
144356900|NCT02349633|520512068|FG005|Overall Study|Withdrawal by Subject|0|||
144356901|NCT02349633|520512069|FG006|Overall Study|Withdrawal by Subject|0|||
144356902|NCT02349633|520512070|FG007|Overall Study|Withdrawal by Subject|2|||
144356903|NCT02349633|520512071|FG008|Overall Study|Withdrawal by Subject|2|||
144356904|NCT02349633|520512072|FG009|Overall Study|Withdrawal by Subject|1|||
144356905|NCT02349633|520512073|FG010|Overall Study|Withdrawal by Subject|0|||
144356906|NCT02349633|520512074|FG011|Overall Study|Withdrawal by Subject|0|||
144356907|NCT02349633|520512075|FG012|Overall Study|Withdrawal by Subject|0|||
144356908|NCT02349633|520512076|FG013|Overall Study|Withdrawal by Subject|0|||
144356909|NCT02349633|520512063|FG000|Overall Study|Withdrawal of informed consent|0|||
144356910|NCT02349633|520512064|FG001|Overall Study|Withdrawal of informed consent|0|||
144356911|NCT02349633|520512065|FG002|Overall Study|Withdrawal of informed consent|0|||
144356912|NCT02349633|520512066|FG003|Overall Study|Withdrawal of informed consent|1|||
144356913|NCT02349633|520512067|FG004|Overall Study|Withdrawal of informed consent|1|||
144356914|NCT02349633|520512068|FG005|Overall Study|Withdrawal of informed consent|0|||
144356915|NCT02349633|520512069|FG006|Overall Study|Withdrawal of informed consent|0|||
144356916|NCT02349633|520512070|FG007|Overall Study|Withdrawal of informed consent|3|||
144356917|NCT02349633|520512071|FG008|Overall Study|Withdrawal of informed consent|0|||
144356918|NCT02349633|520512072|FG009|Overall Study|Withdrawal of informed consent|0|||
144356919|NCT02349633|520512073|FG010|Overall Study|Withdrawal of informed consent|0|||
144356920|NCT02349633|520512074|FG011|Overall Study|Withdrawal of informed consent|0|||
144356921|NCT02349633|520512075|FG012|Overall Study|Withdrawal of informed consent|0|||
144356922|NCT02349633|520512076|FG013|Overall Study|Withdrawal of informed consent|0|||
144356923|NCT02349633|520512063|FG000|Overall Study|Transition to compassionate use|0|||
144356924|NCT02349633|520512064|FG001|Overall Study|Transition to compassionate use|0|||
144356925|NCT02349633|520512065|FG002|Overall Study|Transition to compassionate use|0|||
144356926|NCT02349633|520512066|FG003|Overall Study|Transition to compassionate use|0|||
144356927|NCT02349633|520512067|FG004|Overall Study|Transition to compassionate use|1|||
144356928|NCT02349633|520512068|FG005|Overall Study|Transition to compassionate use|0|||
144356929|NCT02349633|520512069|FG006|Overall Study|Transition to compassionate use|0|||
144356930|NCT02349633|520512070|FG007|Overall Study|Transition to compassionate use|3|||
144356931|NCT02349633|520512071|FG008|Overall Study|Transition to compassionate use|0|||
144356932|NCT02349633|520512072|FG009|Overall Study|Transition to compassionate use|1|||
144356933|NCT02349633|520512073|FG010|Overall Study|Transition to compassionate use|0|||
144356934|NCT02349633|520512074|FG011|Overall Study|Transition to compassionate use|0|||
144356935|NCT02349633|520512075|FG012|Overall Study|Transition to compassionate use|0|||
144356936|NCT02349633|520512076|FG013|Overall Study|Transition to compassionate use|0|||
144356937|NCT02349633|520512063|FG000|Overall Study|Early termination of survival follow-up|0|||
144356938|NCT02349633|520512064|FG001|Overall Study|Early termination of survival follow-up|0|||
144356939|NCT02349633|520512065|FG002|Overall Study|Early termination of survival follow-up|0|||
144356940|NCT02349633|520512066|FG003|Overall Study|Early termination of survival follow-up|0|||
144356941|NCT02349633|520512067|FG004|Overall Study|Early termination of survival follow-up|0|||
144356942|NCT02349633|520512068|FG005|Overall Study|Early termination of survival follow-up|0|||
144356943|NCT02349633|520512069|FG006|Overall Study|Early termination of survival follow-up|0|||
144356944|NCT02349633|520512070|FG007|Overall Study|Early termination of survival follow-up|4|||
144356945|NCT02349633|520512071|FG008|Overall Study|Early termination of survival follow-up|0|||
144356946|NCT02349633|520512072|FG009|Overall Study|Early termination of survival follow-up|0|||
144356947|NCT02349633|520512073|FG010|Overall Study|Early termination of survival follow-up|0|||
144356948|NCT02349633|520512074|FG011|Overall Study|Early termination of survival follow-up|0|||
144356949|NCT02349633|520512075|FG012|Overall Study|Early termination of survival follow-up|0|||
144356950|NCT02349633|520512076|FG013|Overall Study|Early termination of survival follow-up|0|||
144356951|NCT02349633|520512063|FG000|Overall Study|Termination by sponsor|0|||
144356952|NCT02349633|520512064|FG001|Overall Study|Termination by sponsor|0|||
144356953|NCT02349633|520512065|FG002|Overall Study|Termination by sponsor|0|||
144356954|NCT02349633|520512066|FG003|Overall Study|Termination by sponsor|0|||
144356955|NCT02349633|520512067|FG004|Overall Study|Termination by sponsor|0|||
144356956|NCT02349633|520512068|FG005|Overall Study|Termination by sponsor|0|||
144356957|NCT02349633|520512069|FG006|Overall Study|Termination by sponsor|0|||
144356958|NCT02349633|520512070|FG007|Overall Study|Termination by sponsor|1|||
144356959|NCT02349633|520512071|FG008|Overall Study|Termination by sponsor|0|||
144356960|NCT02349633|520512072|FG009|Overall Study|Termination by sponsor|2|||
144356961|NCT02349633|520512073|FG010|Overall Study|Termination by sponsor|0|||
144356962|NCT02349633|520512074|FG011|Overall Study|Termination by sponsor|0|||
144356963|NCT02349633|520512075|FG012|Overall Study|Termination by sponsor|0|||
144356964|NCT02349633|520512076|FG013|Overall Study|Termination by sponsor|0|||
144356965|NCT02349633|520512063|FG000|Overall Study|Other|0|||
144356966|NCT02349633|520512064|FG001|Overall Study|Other|0|||
144356967|NCT02349633|520512065|FG002|Overall Study|Other|0|||
144356968|NCT02349633|520512066|FG003|Overall Study|Other|0|||
144356969|NCT02349633|520512067|FG004|Overall Study|Other|0|||
144356970|NCT02349633|520512068|FG005|Overall Study|Other|0|||
144356971|NCT02349633|520512069|FG006|Overall Study|Other|0|||
144356972|NCT02349633|520512070|FG007|Overall Study|Other|2|||
144356973|NCT02349633|520512071|FG008|Overall Study|Other|0|||
144356974|NCT02349633|520512072|FG009|Overall Study|Other|0|||
144356975|NCT02349633|520512073|FG010|Overall Study|Other|0|||
144356976|NCT02349633|520512074|FG011|Overall Study|Other|0|||
144356977|NCT02349633|520512075|FG012|Overall Study|Other|0|||
144356978|NCT02349633|520512076|FG013|Overall Study|Other|0|||
144356979|NCT02648204|520512081|FG000|Overall Study|Withdrawal by Subject|12|||
144356980|NCT02648204|520512082|FG001|Overall Study|Withdrawal by Subject|8|||
144356981|NCT02648204|520512083|FG002|Overall Study|Withdrawal by Subject|2|||
144356982|NCT02648204|520512084|FG003|Overall Study|Withdrawal by Subject|6|||
144356983|NCT02648204|520512081|FG000|Overall Study|Lost to Follow-up|5|||
144356984|NCT02648204|520512082|FG001|Overall Study|Lost to Follow-up|8|||
144356985|NCT02648204|520512083|FG002|Overall Study|Lost to Follow-up|4|||
144356986|NCT02648204|520512084|FG003|Overall Study|Lost to Follow-up|6|||
144356987|NCT02648204|520512081|FG000|Overall Study|Missing follow-up information|4|||
144356988|NCT02648204|520512082|FG001|Overall Study|Missing follow-up information|4|||
144356989|NCT02648204|520512083|FG002|Overall Study|Missing follow-up information|4|||
144356990|NCT02648204|520512084|FG003|Overall Study|Missing follow-up information|2|||
144356991|NCT02648204|520512081|FG000|Overall Study|Death|1|||
144356992|NCT02648204|520512082|FG001|Overall Study|Death|1|||
144356993|NCT02648204|520512083|FG002|Overall Study|Death|2|||
144356994|NCT02648204|520512084|FG003|Overall Study|Death|2|||
144356995|NCT02648204|520512081|FG000|Overall Study|Adverse Event|0|||
144356996|NCT02648204|520512082|FG001|Overall Study|Adverse Event|0|||
144356997|NCT02648204|520512083|FG002|Overall Study|Adverse Event|1|||
144356998|NCT02648204|520512084|FG003|Overall Study|Adverse Event|0|||
144356999|NCT01008943|520512089|FG000|Overall Study|Withdrawal by Subject|1|||
144357000|NCT02356159|520512092|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
144357001|NCT02356159|520512093|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
144357002|NCT02356159|520512094|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
144357003|NCT02356159|520512095|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
144357004|NCT02356159|520512096|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
144357005|NCT02356159|520512097|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
144357006|NCT00861705|520512098|FG000|Overall Study|Never Began Treatment|7|||
144357007|NCT00861705|520512099|FG001|Overall Study|Never Began Treatment|3|||
144357008|NCT00861705|520512100|FG002|Overall Study|Never Began Treatment|0|||
144357009|NCT00861705|520512101|FG003|Overall Study|Never Began Treatment|1|||
144357010|NCT06418152|520512102|FG000|Overall Study|Frequent DBS setting changes|1|||
144357011|NCT06418152|520512102|FG000|Overall Study|Withdrawal by Subject|2|||
144357012|NCT00667628|520512103|FG000|Overall Study|Lost to Follow-up|1|||
144357013|NCT00667628|520512104|FG001|Overall Study|Lost to Follow-up|0|||
144357014|NCT00667628|520512103|FG000|Overall Study|Death|6|||
144357015|NCT00667628|520512104|FG001|Overall Study|Death|6|||
144357016|NCT00667628|520512103|FG000|Overall Study|Investigator Considers in Best Interest|1|||
144357017|NCT00667628|520512104|FG001|Overall Study|Investigator Considers in Best Interest|0|||
144357018|NCT00667628|520512103|FG000|Overall Study|Sponsor Terminated Study|17|||
144357019|NCT00667628|520512104|FG001|Overall Study|Sponsor Terminated Study|21|||
144357020|NCT04663321|520512105|FG000|Overall Study|Study terminated by Sponsor|2|||
144357021|NCT04663321|520512106|FG001|Overall Study|Study terminated by Sponsor|1|||
144357022|NCT04663321|520512107|FG002|Overall Study|Study terminated by Sponsor|2|||
144357023|NCT04663321|520512105|FG000|Overall Study|Withdrawal by Subject|10|||
144357024|NCT04663321|520512106|FG001|Overall Study|Withdrawal by Subject|3|||
144357025|NCT04663321|520512107|FG002|Overall Study|Withdrawal by Subject|2|||
144357026|NCT04663321|520512105|FG000|Overall Study|Not provided|0|||
144357027|NCT04663321|520512106|FG001|Overall Study|Not provided|0|||
144357028|NCT04663321|520512107|FG002|Overall Study|Not provided|1|||
144357029|NCT01962441|520512112|FG000|Randomized Period|Randomized but Never Treated|4|||
144357030|NCT01962441|520512113|FG001|Randomized Period|Randomized but Never Treated|2|||
144357031|NCT01962441|520512114|FG002|Randomized Period|Randomized but Never Treated|3|||
144357032|NCT01962441|520512112|FG000|Randomized Period|Lost to Follow-up|2|||
144357033|NCT01962441|520512113|FG001|Randomized Period|Lost to Follow-up|4|||
144357034|NCT01962441|520512114|FG002|Randomized Period|Lost to Follow-up|4|||
144357035|NCT01962441|520512112|FG000|Randomized Period|Withdrew Consent|3|||
144357036|NCT01962441|520512113|FG001|Randomized Period|Withdrew Consent|3|||
144357037|NCT01962441|520512114|FG002|Randomized Period|Withdrew Consent|2|||
144357038|NCT01962441|520512112|FG000|Randomized Period|Adverse Event|1|||
144357039|NCT01962441|520512113|FG001|Randomized Period|Adverse Event|1|||
144357040|NCT01962441|520512114|FG002|Randomized Period|Adverse Event|0|||
144357041|NCT01962441|520512112|FG000|Randomized Period|Death|0|||
144357042|NCT01962441|520512113|FG001|Randomized Period|Death|0|||
144357043|NCT01962441|520512114|FG002|Randomized Period|Death|2|||
144357044|NCT01962441|520512112|FG000|Randomized Period|Protocol Violation|0|||
144357045|NCT01962441|520512113|FG001|Randomized Period|Protocol Violation|1|||
144357046|NCT01962441|520512114|FG002|Randomized Period|Protocol Violation|0|||
144357047|NCT01962441|520512112|FG000|Retreatment Substudy|Lack of Efficacy|1|||
144357048|NCT01962441|520512113|FG001|Retreatment Substudy|Lack of Efficacy|0|||
144357049|NCT01962441|520512114|FG002|Retreatment Substudy|Lack of Efficacy|0|||
144357050|NCT01962441|520512112|FG000|Retreatment Substudy|Lost to Follow-up|1|||
144357051|NCT01962441|520512113|FG001|Retreatment Substudy|Lost to Follow-up|0|||
144357052|NCT01962441|520512114|FG002|Retreatment Substudy|Lost to Follow-up|0|||
144357053|NCT04862065|520512115|FG000|Screening|Protocol Violation|54|||
144357054|NCT04862065|520512116|FG001|Screening|Protocol Violation|0|||
144357055|NCT04862065|520512117|FG002|Screening|Protocol Violation|0|||
144357056|NCT04862065|520512115|FG000|Screening|Insufficient Sample|1|||
144357057|NCT04862065|520512116|FG001|Screening|Insufficient Sample|0|||
144357058|NCT04862065|520512117|FG002|Screening|Insufficient Sample|0|||
144357059|NCT04862065|520512115|FG000|Follow-Up|Lost to Follow-up|3|||
144357060|NCT04862065|520512116|FG001|Follow-Up|Lost to Follow-up|0|||
144357061|NCT04862065|520512117|FG002|Follow-Up|Lost to Follow-up|0|||
144357062|NCT01453140|520512118|FG000|Overall Study|Adverse Event|3|||
144357063|NCT00743249|520512119|FG000|Overall Study|Adverse Event|0|||
144357064|NCT00743249|520512120|FG001|Overall Study|Adverse Event|4|||
144357065|NCT00743249|520512119|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
144357066|NCT00743249|520512120|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
144357067|NCT00743249|520512119|FG000|Overall Study|Unsuccessful insertion of stent|2|||
144357068|NCT00743249|520512120|FG001|Overall Study|Unsuccessful insertion of stent|1|||
144357069|NCT00718510|520512121|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
144357070|NCT00718510|520512122|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
144357071|NCT00718510|520512121|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
144357072|NCT00718510|520512122|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
144357073|NCT02653326|520512126|FG000|Overall Study|Lost to Follow-up|10|||
144357074|NCT02653326|520512127|FG001|Overall Study|Lost to Follow-up|7|||
144357075|NCT01960140|520512133|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
144357076|NCT01239381|520512134|FG000|Overall Study|Protocol Violation|1|||
144357077|NCT01239381|520512134|FG000|Overall Study|Withdrawal by Subject|1|||
144357078|NCT02903160|520512135|FG000|Overall Study|Adverse Event|2|||
144357079|NCT02903160|520512135|FG000|Overall Study|Death|1|||
144357080|NCT02903160|520512135|FG000|Overall Study|Lost to Follow-up|2|||
144357081|NCT02903160|520512135|FG000|Overall Study|Withdrawal by Subject|1|||
144357082|NCT02903160|520512135|FG000|Overall Study|Medical Insurance Barriers|1|||
144357083|NCT04678115|520512139|FG000|Overall Study|Lost to Follow-up|1|||
144357084|NCT04678115|520512140|FG001|Overall Study|Lost to Follow-up|0|||
144357085|NCT01300234|520512141|FG000|Overall Study|Adverse Event|1|||
144357086|NCT01300234|520512142|FG001|Overall Study|Adverse Event|1|||
144357087|NCT01300234|520512141|FG000|Overall Study|Protocol Violation|2|||
144357088|NCT01300234|520512142|FG001|Overall Study|Protocol Violation|3|||
144357089|NCT01300234|520512141|FG000|Overall Study|Withdrawal by Subject|5|||
144357090|NCT01300234|520512142|FG001|Overall Study|Withdrawal by Subject|9|||
144357091|NCT01300234|520512141|FG000|Overall Study|Lost to Follow-up|14|||
144357092|NCT01300234|520512142|FG001|Overall Study|Lost to Follow-up|12|||
144357093|NCT01300234|520512141|FG000|Overall Study|Pregnancy|2|||
144357094|NCT01300234|520512142|FG001|Overall Study|Pregnancy|1|||
144357095|NCT01300234|520512141|FG000|Overall Study|Participant reached stopping critera|2|||
144357096|NCT01300234|520512142|FG001|Overall Study|Participant reached stopping critera|0|||
144357097|NCT01300234|520512141|FG000|Overall Study|Participant stopped medication|1|||
144357098|NCT01300234|520512142|FG001|Overall Study|Participant stopped medication|1|||
144357099|NCT01300234|520512141|FG000|Overall Study|Participant refused return to hospital|1|||
144357100|NCT01300234|520512142|FG001|Overall Study|Participant refused return to hospital|0|||
144357101|NCT04158583|520512143|FG000|Overall Study|Withdrawal by Subject|1|||
144357102|NCT04158583|520512144|FG001|Overall Study|Withdrawal by Subject|1|||
144357103|NCT04158583|520512145|FG002|Overall Study|Withdrawal by Subject|0|||
144357104|NCT04158583|520512146|FG003|Overall Study|Withdrawal by Subject|0|||
144357105|NCT04158583|520512147|FG004|Overall Study|Withdrawal by Subject|1|||
144357106|NCT04158583|520512148|FG005|Overall Study|Withdrawal by Subject|0|||
144357107|NCT04158583|520512149|FG006|Overall Study|Withdrawal by Subject|0|||
144357108|NCT04158583|520512150|FG007|Overall Study|Withdrawal by Subject|0|||
144357109|NCT04158583|520512151|FG008|Overall Study|Withdrawal by Subject|2|||
144357110|NCT04158583|520512152|FG009|Overall Study|Withdrawal by Subject|0|||
144357111|NCT04158583|520512143|FG000|Overall Study|Study Terminated by Sponsor|0|||
144357112|NCT04158583|520512144|FG001|Overall Study|Study Terminated by Sponsor|0|||
144357113|NCT04158583|520512145|FG002|Overall Study|Study Terminated by Sponsor|0|||
144357114|NCT04158583|520512146|FG003|Overall Study|Study Terminated by Sponsor|1|||
144357115|NCT04158583|520512147|FG004|Overall Study|Study Terminated by Sponsor|0|||
144357116|NCT04158583|520512148|FG005|Overall Study|Study Terminated by Sponsor|0|||
144357117|NCT04158583|520512149|FG006|Overall Study|Study Terminated by Sponsor|0|||
144357118|NCT04158583|520512150|FG007|Overall Study|Study Terminated by Sponsor|0|||
144357119|NCT04158583|520512151|FG008|Overall Study|Study Terminated by Sponsor|0|||
144357120|NCT04158583|520512152|FG009|Overall Study|Study Terminated by Sponsor|0|||
144357121|NCT04158583|520512143|FG000|Overall Study|Progressive Disease|1|||
144357122|NCT04158583|520512144|FG001|Overall Study|Progressive Disease|0|||
144357123|NCT04158583|520512145|FG002|Overall Study|Progressive Disease|3|||
144357124|NCT04158583|520512146|FG003|Overall Study|Progressive Disease|5|||
144357125|NCT04158583|520512147|FG004|Overall Study|Progressive Disease|0|||
144357126|NCT04158583|520512148|FG005|Overall Study|Progressive Disease|1|||
144357127|NCT04158583|520512149|FG006|Overall Study|Progressive Disease|6|||
144357128|NCT04158583|520512150|FG007|Overall Study|Progressive Disease|2|||
144357129|NCT04158583|520512151|FG008|Overall Study|Progressive Disease|1|||
144357130|NCT04158583|520512152|FG009|Overall Study|Progressive Disease|2|||
144357131|NCT04158583|520512143|FG000|Overall Study|Lost to Follow-up|0|||
144357132|NCT04158583|520512144|FG001|Overall Study|Lost to Follow-up|0|||
144357133|NCT04158583|520512145|FG002|Overall Study|Lost to Follow-up|1|||
144357134|NCT04158583|520512146|FG003|Overall Study|Lost to Follow-up|1|||
144357135|NCT04158583|520512147|FG004|Overall Study|Lost to Follow-up|1|||
144357136|NCT04158583|520512148|FG005|Overall Study|Lost to Follow-up|0|||
144357137|NCT04158583|520512149|FG006|Overall Study|Lost to Follow-up|0|||
144357138|NCT04158583|520512150|FG007|Overall Study|Lost to Follow-up|0|||
144357139|NCT04158583|520512151|FG008|Overall Study|Lost to Follow-up|0|||
144357140|NCT04158583|520512152|FG009|Overall Study|Lost to Follow-up|0|||
144357141|NCT04158583|520512143|FG000|Overall Study|Due To Patient Status|0|||
144357142|NCT04158583|520512144|FG001|Overall Study|Due To Patient Status|0|||
144357143|NCT04158583|520512145|FG002|Overall Study|Due To Patient Status|0|||
144357144|NCT04158583|520512146|FG003|Overall Study|Due To Patient Status|0|||
144357145|NCT04158583|520512147|FG004|Overall Study|Due To Patient Status|0|||
144357146|NCT04158583|520512148|FG005|Overall Study|Due To Patient Status|0|||
144357147|NCT04158583|520512149|FG006|Overall Study|Due To Patient Status|0|||
144357148|NCT04158583|520512150|FG007|Overall Study|Due To Patient Status|0|||
144357149|NCT04158583|520512151|FG008|Overall Study|Due To Patient Status|1|||
144357150|NCT04158583|520512152|FG009|Overall Study|Due To Patient Status|0|||
144357151|NCT04158583|520512143|FG000|Overall Study|Death|3|||
144357152|NCT04158583|520512144|FG001|Overall Study|Death|4|||
144357153|NCT04158583|520512145|FG002|Overall Study|Death|2|||
144357154|NCT04158583|520512146|FG003|Overall Study|Death|2|||
144357155|NCT04158583|520512147|FG004|Overall Study|Death|4|||
144357156|NCT04158583|520512148|FG005|Overall Study|Death|3|||
144357157|NCT04158583|520512149|FG006|Overall Study|Death|5|||
144357158|NCT04158583|520512150|FG007|Overall Study|Death|2|||
144357159|NCT04158583|520512151|FG008|Overall Study|Death|0|||
144357160|NCT04158583|520512152|FG009|Overall Study|Death|1|||
144357161|NCT04158583|520512143|FG000|Overall Study|Clinical Progression Disease|0|||
144357162|NCT04158583|520512144|FG001|Overall Study|Clinical Progression Disease|0|||
144357163|NCT04158583|520512145|FG002|Overall Study|Clinical Progression Disease|0|||
144357164|NCT04158583|520512146|FG003|Overall Study|Clinical Progression Disease|1|||
144357165|NCT04158583|520512147|FG004|Overall Study|Clinical Progression Disease|0|||
144357166|NCT04158583|520512148|FG005|Overall Study|Clinical Progression Disease|0|||
144357167|NCT04158583|520512149|FG006|Overall Study|Clinical Progression Disease|0|||
144357168|NCT04158583|520512150|FG007|Overall Study|Clinical Progression Disease|0|||
144357169|NCT04158583|520512151|FG008|Overall Study|Clinical Progression Disease|0|||
144357170|NCT04158583|520512152|FG009|Overall Study|Clinical Progression Disease|0|||
144357171|NCT04158583|520512143|FG000|Overall Study|Clinical Progression|0|||
144357172|NCT04158583|520512144|FG001|Overall Study|Clinical Progression|0|||
144357173|NCT04158583|520512145|FG002|Overall Study|Clinical Progression|0|||
144357174|NCT04158583|520512146|FG003|Overall Study|Clinical Progression|0|||
144357175|NCT04158583|520512147|FG004|Overall Study|Clinical Progression|1|||
144357176|NCT04158583|520512148|FG005|Overall Study|Clinical Progression|0|||
144357177|NCT04158583|520512149|FG006|Overall Study|Clinical Progression|2|||
144357178|NCT04158583|520512150|FG007|Overall Study|Clinical Progression|0|||
144357179|NCT04158583|520512151|FG008|Overall Study|Clinical Progression|0|||
144357180|NCT04158583|520512152|FG009|Overall Study|Clinical Progression|0|||
144357181|NCT04158583|520512143|FG000|Overall Study|Clinical Deterioration|0|||
144357182|NCT04158583|520512144|FG001|Overall Study|Clinical Deterioration|0|||
144357183|NCT04158583|520512145|FG002|Overall Study|Clinical Deterioration|0|||
144357184|NCT04158583|520512146|FG003|Overall Study|Clinical Deterioration|1|||
144357185|NCT04158583|520512147|FG004|Overall Study|Clinical Deterioration|0|||
144357186|NCT04158583|520512148|FG005|Overall Study|Clinical Deterioration|0|||
144357187|NCT04158583|520512149|FG006|Overall Study|Clinical Deterioration|0|||
144357188|NCT04158583|520512150|FG007|Overall Study|Clinical Deterioration|0|||
144357189|NCT04158583|520512151|FG008|Overall Study|Clinical Deterioration|0|||
144357190|NCT04158583|520512152|FG009|Overall Study|Clinical Deterioration|1|||
144357191|NCT00644423|520513620|FG000|Overall Study|Lost to Follow-up|1|||
144357192|NCT00644423|520513621|FG001|Overall Study|Lost to Follow-up|1|||
144357193|NCT02426580|520513622|FG000|Overall Study|Death|2|||
144357194|NCT02426580|520513623|FG001|Overall Study|Death|2|||
144357195|NCT02426580|520513622|FG000|Overall Study|Lost to Follow-up|0|||
144357196|NCT02426580|520513623|FG001|Overall Study|Lost to Follow-up|9|||
144357197|NCT02426580|520513622|FG000|Overall Study|transfer to hemodialysis|5|||
144357198|NCT02426580|520513623|FG001|Overall Study|transfer to hemodialysis|5|||
144357199|NCT02426580|520513622|FG000|Overall Study|Kidney transplant|3|||
144357200|NCT02426580|520513623|FG001|Overall Study|Kidney transplant|0|||
144357201|NCT02426580|520513622|FG000|Overall Study|Allergic to egg white|1|||
144357202|NCT02426580|520513623|FG001|Overall Study|Allergic to egg white|0|||
144357203|NCT00383552|520513626|FG000|Overall Study|Adverse Event|7|||
144357204|NCT00383552|520513627|FG001|Overall Study|Adverse Event|6|||
144357205|NCT00383552|520513628|FG002|Overall Study|Adverse Event|9|||
144357206|NCT00383552|520513629|FG003|Overall Study|Adverse Event|6|||
144357207|NCT00383552|520513626|FG000|Overall Study|Lack of Efficacy|4|||
144357208|NCT00383552|520513627|FG001|Overall Study|Lack of Efficacy|13|||
144357209|NCT00383552|520513628|FG002|Overall Study|Lack of Efficacy|29|||
144357210|NCT00383552|520513629|FG003|Overall Study|Lack of Efficacy|42|||
144357211|NCT00383552|520513626|FG000|Overall Study|Lost to Follow-up|0|||
144357212|NCT00383552|520513627|FG001|Overall Study|Lost to Follow-up|1|||
144357213|NCT00383552|520513628|FG002|Overall Study|Lost to Follow-up|5|||
144357214|NCT00383552|520513629|FG003|Overall Study|Lost to Follow-up|1|||
144357215|NCT00383552|520513626|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
144357216|NCT00383552|520513627|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
144357217|NCT00383552|520513628|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
144357218|NCT00383552|520513629|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
144357219|NCT00383552|520513626|FG000|Overall Study|Did not wish to continue (related)|1|||
144357220|NCT00383552|520513627|FG001|Overall Study|Did not wish to continue (related)|0|||
144357221|NCT00383552|520513628|FG002|Overall Study|Did not wish to continue (related)|2|||
144357222|NCT00383552|520513629|FG003|Overall Study|Did not wish to continue (related)|3|||
144357223|NCT00383552|520513626|FG000|Overall Study|Noncompliance with the protocol|11|||
144357224|NCT00383552|520513627|FG001|Overall Study|Noncompliance with the protocol|6|||
144357225|NCT00383552|520513628|FG002|Overall Study|Noncompliance with the protocol|8|||
144357226|NCT00383552|520513629|FG003|Overall Study|Noncompliance with the protocol|10|||
144357227|NCT00383552|520513626|FG000|Overall Study|Did not meet protocol eligibility|8|||
144357228|NCT00383552|520513627|FG001|Overall Study|Did not meet protocol eligibility|6|||
144357229|NCT00383552|520513628|FG002|Overall Study|Did not meet protocol eligibility|2|||
144357230|NCT00383552|520513629|FG003|Overall Study|Did not meet protocol eligibility|3|||
144357231|NCT00383552|520513626|FG000|Overall Study|Administrative|1|||
144357232|NCT00383552|520513627|FG001|Overall Study|Administrative|0|||
144357233|NCT00383552|520513628|FG002|Overall Study|Administrative|1|||
144357234|NCT00383552|520513629|FG003|Overall Study|Administrative|1|||
144357235|NCT03096834|520513630|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
144357236|NCT03096834|520513631|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
144357237|NCT03096834|520513632|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
144357238|NCT03096834|520513633|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
144357239|NCT03096834|520513630|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
144357240|NCT03096834|520513631|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
144357241|NCT03096834|520513632|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
144357242|NCT03096834|520513633|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
144357243|NCT03096834|520513630|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
144357244|NCT03096834|520513631|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
144357245|NCT03096834|520513632|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
144357246|NCT03096834|520513633|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
144357247|NCT03096834|520513630|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
144357248|NCT03096834|520513631|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
144357249|NCT03096834|520513632|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
144357250|NCT03096834|520513633|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
144357251|NCT03096834|520513630|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
144357252|NCT03096834|520513631|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
144357253|NCT03096834|520513632|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
144357254|NCT03096834|520513633|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
144357255|NCT03096834|520513630|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
144357256|NCT03096834|520513631|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
144357257|NCT03096834|520513632|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
144357258|NCT03096834|520513633|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
144357259|NCT03096834|520513630|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
144357260|NCT03096834|520513631|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
144357261|NCT03096834|520513632|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
144357262|NCT03096834|520513633|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
144357263|NCT03096834|520513630|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
144357264|NCT03096834|520513631|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
144357265|NCT03096834|520513632|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
144357266|NCT03096834|520513633|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
144357267|NCT03096834|520513630|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
144357268|NCT03096834|520513631|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
144357269|NCT03096834|520513632|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
144357270|NCT03096834|520513633|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
144357271|NCT03096834|520513630|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
144357272|NCT03096834|520513631|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
144357273|NCT03096834|520513632|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
144357274|NCT03096834|520513633|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
144357275|NCT03096834|520513630|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
144357276|NCT03096834|520513631|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
144357277|NCT03096834|520513632|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
144357278|NCT03096834|520513633|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
144357279|NCT03096834|520513630|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
144357280|NCT03096834|520513631|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
144357281|NCT03096834|520513632|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
144357282|NCT03096834|520513633|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
144357283|NCT02173769|520513638|FG000|Overall Study|Protocol Violation|4|||
144357284|NCT04233801|520513639|FG000|Overall Study|Other than listed|0|||
144357285|NCT04233801|520513640|FG001|Overall Study|Other than listed|0|||
144357286|NCT04233801|520513641|FG002|Overall Study|Other than listed|1|||
144357287|NCT04233801|520513639|FG000|Overall Study|Withdrawal by Subject|0|||
144357288|NCT04233801|520513640|FG001|Overall Study|Withdrawal by Subject|2|||
144357289|NCT04233801|520513641|FG002|Overall Study|Withdrawal by Subject|3|||
144357290|NCT01381016|520513644|FG000|Overall Study|Lost to Follow-up|1|||
144357291|NCT01381016|520513645|FG001|Overall Study|Lost to Follow-up|1|||
144357292|NCT01381016|520513644|FG000|Overall Study|Screen Failure|2|||
144357293|NCT01381016|520513645|FG001|Overall Study|Screen Failure|2|||
144357294|NCT01381016|520513644|FG000|Overall Study|Withdrawal by Subject|0|||
144357295|NCT01381016|520513645|FG001|Overall Study|Withdrawal by Subject|1|||
144357296|NCT01381016|520513644|FG000|Overall Study|Physician Decision|0|||
144357297|NCT01381016|520513645|FG001|Overall Study|Physician Decision|2|||
144357298|NCT02210000|520513646|FG000|Overall Study|Study Terminated|11|||
144357299|NCT02210000|520513647|FG001|Overall Study|Study Terminated|12|||
144357300|NCT02210000|520513646|FG000|Overall Study|Withdrawal by Subject|7|||
144357301|NCT02210000|520513647|FG001|Overall Study|Withdrawal by Subject|1|||
144357302|NCT02210000|520513646|FG000|Overall Study|Adverse Event|1|||
144357303|NCT02210000|520513647|FG001|Overall Study|Adverse Event|5|||
144357304|NCT02210000|520513646|FG000|Overall Study|Lost to Follow-up|0|||
144357305|NCT02210000|520513647|FG001|Overall Study|Lost to Follow-up|2|||
144357306|NCT02210000|520513646|FG000|Overall Study|Physician Decision|0|||
144357307|NCT02210000|520513647|FG001|Overall Study|Physician Decision|1|||
144357308|NCT01421017|520513648|FG000|Overall Study|Withdrawal by Subject|2|||
144357309|NCT01421017|520513649|FG001|Overall Study|Withdrawal by Subject|0|||
144357310|NCT01421017|520513650|FG002|Overall Study|Withdrawal by Subject|0|||
144357311|NCT01421017|520513648|FG000|Overall Study|POD|0|||
144357312|NCT01421017|520513649|FG001|Overall Study|POD|6|||
144357313|NCT01421017|520513650|FG002|Overall Study|POD|3|||
144357314|NCT00308139|520513651|FG000|Overall Study|Adverse Event|20|||
144357315|NCT00308139|520513652|FG001|Overall Study|Adverse Event|14|||
144357316|NCT00308139|520513651|FG000|Overall Study|Lost to Follow-up|13|||
144357317|NCT00308139|520513652|FG001|Overall Study|Lost to Follow-up|8|||
144357318|NCT00308139|520513651|FG000|Overall Study|Protocol Violation|3|||
144357319|NCT00308139|520513652|FG001|Overall Study|Protocol Violation|2|||
144357320|NCT00308139|520513651|FG000|Overall Study|Withdrawal of Consent|40|||
144357321|NCT00308139|520513652|FG001|Overall Study|Withdrawal of Consent|42|||
144357322|NCT00308139|520513651|FG000|Overall Study|Investigator Decision|11|||
144357323|NCT00308139|520513652|FG001|Overall Study|Investigator Decision|10|||
144357324|NCT00308139|520513651|FG000|Overall Study|Loss of Glucose Control|5|||
144357325|NCT00308139|520513652|FG001|Overall Study|Loss of Glucose Control|7|||
144357326|NCT00308139|520513651|FG000|Overall Study|Administrative|1|||
144357327|NCT00308139|520513652|FG001|Overall Study|Administrative|4|||
144357328|NCT00308139|520513651|FG000|Overall Study|Other|1|||
144357329|NCT00308139|520513652|FG001|Overall Study|Other|0|||
144357330|NCT02313766|520513655|FG000|Overall Study|surgery cancelled|1|||
144357331|NCT02313766|520513656|FG001|Overall Study|surgery cancelled|0|||
144357332|NCT02313766|520513657|FG002|Overall Study|surgery cancelled|0|||
144357333|NCT02313766|520513655|FG000|Overall Study|Lost to Follow-up|0|||
144357334|NCT02313766|520513656|FG001|Overall Study|Lost to Follow-up|2|||
144357335|NCT02313766|520513657|FG002|Overall Study|Lost to Follow-up|0|||
144357336|NCT02313766|520513655|FG000|Overall Study|Adverse Event|0|||
144357337|NCT02313766|520513656|FG001|Overall Study|Adverse Event|1|||
144357338|NCT02313766|520513657|FG002|Overall Study|Adverse Event|0|||
144357339|NCT00791388|520513661|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
144357340|NCT00791388|520513662|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
144357341|NCT00791388|520513663|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
144357342|NCT00791388|520513664|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
144357343|NCT00791388|520513665|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
144357344|NCT00791388|520513661|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
144357345|NCT00791388|520513662|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
144357346|NCT00791388|520513663|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
144357347|NCT00791388|520513664|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
144357348|NCT00791388|520513665|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
144357349|NCT00791388|520513661|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
144357350|NCT00791388|520513662|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
144357351|NCT00791388|520513663|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
144357352|NCT00791388|520513664|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
144357353|NCT00791388|520513665|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
144357354|NCT00141453|520513673|FG000|Overall Study|Protocol Violation|6|||
144357355|NCT00141453|520513674|FG001|Overall Study|Protocol Violation|5|||
144357356|NCT00443040|520513677|FG000|Overall Study|Withdrawal by Subject|1|||
144357357|NCT00443040|520513678|FG001|Overall Study|Withdrawal by Subject|0|||
144357358|NCT00443040|520513679|FG002|Overall Study|Withdrawal by Subject|0|||
144357359|NCT00443040|520513677|FG000|Overall Study|Converted to an open laparotomy|3|||
144357360|NCT00443040|520513678|FG001|Overall Study|Converted to an open laparotomy|0|||
144357361|NCT00443040|520513679|FG002|Overall Study|Converted to an open laparotomy|1|||
144357362|NCT06039579|520513684|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357363|NCT06039579|520513685|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357364|NCT06039579|520513686|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357365|NCT06039579|520513687|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357366|NCT06039579|520513688|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357367|NCT06039579|520513689|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357368|NCT06039579|520513690|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
144357369|NCT06039579|520513691|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
144357370|NCT02763644|520513696|FG000|Overall Study|Patient/guardian decision|1|||
144357371|NCT02763644|520513697|FG001|Overall Study|Patient/guardian decision|0|||
144357372|NCT02763644|520513696|FG000|Overall Study|Death|1|||
144357373|NCT02763644|520513697|FG001|Overall Study|Death|1|||
144357374|NCT02763644|520513696|FG000|Overall Study|Adverse Event|1|||
144357375|NCT02763644|520513697|FG001|Overall Study|Adverse Event|1|||
144357376|NCT01220167|520513698|FG000|Period 3|Urine positive for substance abuse|0|||
144357377|NCT01220167|520513699|FG001|Period 3|Urine positive for substance abuse|1|||
144357378|NCT01220167|520513700|FG002|Period 3|Urine positive for substance abuse|0|||
144357379|NCT05789745|520513701|FG000|Overall Study|Withdrawal by Subject|0|||
144357380|NCT05789745|520513702|FG001|Overall Study|Withdrawal by Subject|0|||
144357381|NCT05789745|520513703|FG002|Overall Study|Withdrawal by Subject|0|||
144357382|NCT05789745|520513704|FG003|Overall Study|Withdrawal by Subject|0|||
144357383|NCT05789745|520513705|FG004|Overall Study|Withdrawal by Subject|1|||
144357384|NCT02055898|520513708|FG000|First Intervention (5 Days)|Physician Decision|2|||
144357385|NCT02055898|520513709|FG001|First Intervention (5 Days)|Physician Decision|0|||
144357386|NCT02055898|520513708|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
144357387|NCT02055898|520513709|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
144357388|NCT02201524|520513711|FG000|Overall Study|Adverse Event|0|||
144357389|NCT02201524|520513712|FG001|Overall Study|Adverse Event|2|||
144357390|NCT02201524|520513713|FG002|Overall Study|Adverse Event|1|||
144357391|NCT02201524|520513714|FG003|Overall Study|Adverse Event|0|||
144357392|NCT02201524|520513711|FG000|Overall Study|Insufficient clinical response|1|||
144357393|NCT02201524|520513712|FG001|Overall Study|Insufficient clinical response|0|||
144357394|NCT02201524|520513713|FG002|Overall Study|Insufficient clinical response|0|||
144357395|NCT02201524|520513714|FG003|Overall Study|Insufficient clinical response|0|||
144357396|NCT02201524|520513711|FG000|Overall Study|Lost to Follow-up|0|||
144357397|NCT02201524|520513712|FG001|Overall Study|Lost to Follow-up|0|||
144357398|NCT02201524|520513713|FG002|Overall Study|Lost to Follow-up|2|||
144357399|NCT02201524|520513714|FG003|Overall Study|Lost to Follow-up|0|||
144357400|NCT02201524|520513711|FG000|Overall Study|No longer meets eligibility criteria|0|||
144357401|NCT02201524|520513712|FG001|Overall Study|No longer meets eligibility criteria|0|||
144357402|NCT02201524|520513713|FG002|Overall Study|No longer meets eligibility criteria|0|||
144357403|NCT02201524|520513714|FG003|Overall Study|No longer meets eligibility criteria|2|||
144357404|NCT02201524|520513711|FG000|Overall Study|Protocol Violation|0|||
144357405|NCT02201524|520513712|FG001|Overall Study|Protocol Violation|0|||
144357406|NCT02201524|520513713|FG002|Overall Study|Protocol Violation|0|||
144357407|NCT02201524|520513714|FG003|Overall Study|Protocol Violation|1|||
144357408|NCT02201524|520513711|FG000|Overall Study|Withdrawal by Subject|0|||
144357409|NCT02201524|520513712|FG001|Overall Study|Withdrawal by Subject|0|||
144357410|NCT02201524|520513713|FG002|Overall Study|Withdrawal by Subject|1|||
144357411|NCT02201524|520513714|FG003|Overall Study|Withdrawal by Subject|1|||
144357412|NCT02201524|520513711|FG000|Overall Study|Other|1|||
144357413|NCT02201524|520513712|FG001|Overall Study|Other|1|||
144357414|NCT02201524|520513713|FG002|Overall Study|Other|0|||
144357415|NCT02201524|520513714|FG003|Overall Study|Other|0|||
144357416|NCT02314052|520513715|FG000|Cycle One|Adverse Event|0|||
144357417|NCT02314052|520513716|FG001|Cycle One|Adverse Event|0|||
144357418|NCT02314052|520513717|FG002|Cycle One|Adverse Event|0|||
144357419|NCT02314052|520513718|FG003|Cycle One|Adverse Event|1|||
144357420|NCT02314052|520513719|FG004|Cycle One|Adverse Event|0|||
144357421|NCT02314052|520513720|FG005|Cycle One|Adverse Event|0|||
144357422|NCT00472108|520513722|FG000|Overall Study|Lost to Follow-up|0|||
144357423|NCT00472108|520513723|FG001|Overall Study|Lost to Follow-up|1|||
144357424|NCT04551989|520513724|FG000|Overall Study|Adverse Event|4|||
144357425|NCT04551989|520513724|FG000|Overall Study|Protocol Violation|3|||
144357426|NCT04551989|520513724|FG000|Overall Study|Lost to Follow-up|1|||
144357427|NCT04551989|520513724|FG000|Overall Study|Physician Decision|3|||
144357428|NCT00088530|520513725|FG000|Overall Study|Progressive/Relapsed Disease|28|||
144357429|NCT00088530|520513726|FG001|Overall Study|Progressive/Relapsed Disease|39|||
144357430|NCT00088530|520513725|FG000|Overall Study|Adverse Event|15|||
144357431|NCT00088530|520513726|FG001|Overall Study|Adverse Event|9|||
144357432|NCT00088530|520513725|FG000|Overall Study|Withdrawal by Subject|2|||
144357433|NCT00088530|520513726|FG001|Overall Study|Withdrawal by Subject|5|||
144357434|NCT00088530|520513725|FG000|Overall Study|Lost to Follow-up|2|||
144357435|NCT00088530|520513726|FG001|Overall Study|Lost to Follow-up|0|||
144357436|NCT00088530|520513725|FG000|Overall Study|Physician Decision|2|||
144357437|NCT00088530|520513726|FG001|Overall Study|Physician Decision|0|||
144357438|NCT00088530|520513725|FG000|Overall Study|Sponsor decision|0|||
144357439|NCT00088530|520513726|FG001|Overall Study|Sponsor decision|1|||
144357440|NCT00088530|520513725|FG000|Overall Study|Patient never treated|1|||
144357441|NCT00088530|520513726|FG001|Overall Study|Patient never treated|0|||
144357442|NCT02174731|520513729|FG000|Overall Study|Participant decision|67|||
144357443|NCT02174731|520513730|FG001|Overall Study|Participant decision|64|||
144357444|NCT02174731|520513729|FG000|Overall Study|Incorrect enrolment before randomization|0|||
144357445|NCT02174731|520513730|FG001|Overall Study|Incorrect enrolment before randomization|1|||
144357446|NCT02174731|520513729|FG000|Overall Study|Missing|2|||
144357447|NCT02174731|520513730|FG001|Overall Study|Missing|0|||
144357448|NCT04575155|520513731|FG000|2 Month|Withdrawal by Subject|1|||
144357449|NCT04575155|520513732|FG001|2 Month|Withdrawal by Subject|1|||
144357450|NCT04575155|520513731|FG000|2 Month|Lost to Follow-up|5|||
144357451|NCT04575155|520513732|FG001|2 Month|Lost to Follow-up|3|||
144357452|NCT04575155|520513731|FG000|2 Month|Ineligible|1|||
144357453|NCT04575155|520513732|FG001|2 Month|Ineligible|0|||
144357454|NCT03915717|520513735|FG000|Overall Study|EchoMark Not Implanted|6|||
144357455|NCT03748823|520513737|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
144357456|NCT03748823|520513738|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
144357457|NCT03748823|520513737|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
144357458|NCT03748823|520513738|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
144357459|NCT03748823|520513737|FG000|Extension Period|Withdrawal by Subject|9|||
144357460|NCT03748823|520513738|FG001|Extension Period|Withdrawal by Subject|12|||
144357461|NCT03748823|520513737|FG000|Extension Period|Death|2|||
144357462|NCT03748823|520513738|FG001|Extension Period|Death|2|||
144357463|NCT03748823|520513737|FG000|Extension Period|Other than Specified|0|||
144357464|NCT03748823|520513738|FG001|Extension Period|Other than Specified|1|||
144357465|NCT03748823|520513737|FG000|Extension Period|Protocol Violation|1|||
144357466|NCT03748823|520513738|FG001|Extension Period|Protocol Violation|0|||
144357467|NCT03748823|520513737|FG000|Extension Period|Lost to Follow-up|0|||
144357468|NCT03748823|520513738|FG001|Extension Period|Lost to Follow-up|1|||
144357469|NCT03748823|520513737|FG000|Extension Period|Lack of Efficacy|0|||
144357470|NCT03748823|520513738|FG001|Extension Period|Lack of Efficacy|1|||
144357471|NCT03748823|520513737|FG000|Extension Period|Physician Decision|1|||
144357472|NCT03748823|520513738|FG001|Extension Period|Physician Decision|2|||
144357473|NCT01664910|520513741|FG000|Overall Study|Adverse Event|0|||
144357474|NCT01664910|520513742|FG001|Overall Study|Adverse Event|0|||
144357475|NCT01664910|520513743|FG002|Overall Study|Adverse Event|1|||
144357476|NCT02734693|520513745|FG000|Overall Study|Adverse Event|1|||
144357477|NCT02734693|520513746|FG001|Overall Study|Adverse Event|3|||
144357478|NCT02734693|520513747|FG002|Overall Study|Adverse Event|3|||
144357479|NCT02734693|520513745|FG000|Overall Study|Lack of Efficacy|1|||
144357480|NCT02734693|520513746|FG001|Overall Study|Lack of Efficacy|0|||
144357481|NCT02734693|520513747|FG002|Overall Study|Lack of Efficacy|0|||
144357482|NCT02734693|520513745|FG000|Overall Study|Lost to Follow-up|2|||
144357483|NCT02734693|520513746|FG001|Overall Study|Lost to Follow-up|0|||
144357484|NCT02734693|520513747|FG002|Overall Study|Lost to Follow-up|0|||
144357485|NCT02734693|520513745|FG000|Overall Study|Protocol Violation|1|||
144357486|NCT02734693|520513746|FG001|Overall Study|Protocol Violation|0|||
144357487|NCT02734693|520513747|FG002|Overall Study|Protocol Violation|0|||
144357488|NCT02734693|520513745|FG000|Overall Study|Withdrawal by Subject|1|||
144357489|NCT02734693|520513746|FG001|Overall Study|Withdrawal by Subject|0|||
144357490|NCT02734693|520513747|FG002|Overall Study|Withdrawal by Subject|0|||
144357491|NCT00689390|520513752|FG000|Overall Study|Adverse Event|19|||
144357492|NCT00689390|520513753|FG001|Overall Study|Adverse Event|0|||
144357493|NCT00689390|520513752|FG000|Overall Study|Lost to Follow-up|179|||
144357494|NCT00689390|520513753|FG001|Overall Study|Lost to Follow-up|7|||
144357495|NCT00689390|520513752|FG000|Overall Study|Withdrawal by Subject|117|||
144357496|NCT00689390|520513753|FG001|Overall Study|Withdrawal by Subject|3|||
144357497|NCT00689390|520513752|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
144357498|NCT00689390|520513753|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
144357499|NCT00689390|520513752|FG000|Overall Study|Non-Compliance With Protocol|21|||
144357500|NCT00689390|520513753|FG001|Overall Study|Non-Compliance With Protocol|0|||
144357501|NCT00689390|520513752|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
144357502|NCT00689390|520513753|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
144357503|NCT00689390|520513752|FG000|Overall Study|Administrative|37|||
144357504|NCT00689390|520513753|FG001|Overall Study|Administrative|0|||
144357505|NCT01384734|520513754|FG000|Overall Study|Adverse Event|0|||
144357506|NCT01384734|520513755|FG001|Overall Study|Adverse Event|3|||
144357507|NCT01384734|520513756|FG002|Overall Study|Adverse Event|0|||
144357508|NCT01384734|520513757|FG003|Overall Study|Adverse Event|2|||
144357509|NCT01384734|520513758|FG004|Overall Study|Adverse Event|7|||
144357510|NCT01384734|520513754|FG000|Overall Study|Death|1|||
144357511|NCT01384734|520513755|FG001|Overall Study|Death|0|||
144357512|NCT01384734|520513756|FG002|Overall Study|Death|1|||
144357513|NCT01384734|520513757|FG003|Overall Study|Death|0|||
144357514|NCT01384734|520513758|FG004|Overall Study|Death|0|||
144357515|NCT01384734|520513754|FG000|Overall Study|Continuation criteria not met|0|||
144357516|NCT01384734|520513755|FG001|Overall Study|Continuation criteria not met|0|||
144357517|NCT01384734|520513756|FG002|Overall Study|Continuation criteria not met|1|||
144357518|NCT01384734|520513757|FG003|Overall Study|Continuation criteria not met|1|||
144357519|NCT01384734|520513758|FG004|Overall Study|Continuation criteria not met|0|||
144357520|NCT01384734|520513754|FG000|Overall Study|Lack of Efficacy|3|||
144357521|NCT01384734|520513755|FG001|Overall Study|Lack of Efficacy|7|||
144357522|NCT01384734|520513756|FG002|Overall Study|Lack of Efficacy|4|||
144357523|NCT01384734|520513757|FG003|Overall Study|Lack of Efficacy|4|||
144357524|NCT01384734|520513758|FG004|Overall Study|Lack of Efficacy|2|||
144357525|NCT01384734|520513754|FG000|Overall Study|Lost to Follow-up|5|||
144357526|NCT01384734|520513755|FG001|Overall Study|Lost to Follow-up|3|||
144357527|NCT01384734|520513756|FG002|Overall Study|Lost to Follow-up|3|||
144357528|NCT01384734|520513757|FG003|Overall Study|Lost to Follow-up|8|||
144357529|NCT01384734|520513758|FG004|Overall Study|Lost to Follow-up|5|||
144357530|NCT01384734|520513754|FG000|Overall Study|Non-compliance with study drug|1|||
144357531|NCT01384734|520513755|FG001|Overall Study|Non-compliance with study drug|2|||
144357532|NCT01384734|520513756|FG002|Overall Study|Non-compliance with study drug|6|||
144357533|NCT01384734|520513757|FG003|Overall Study|Non-compliance with study drug|0|||
144357534|NCT01384734|520513758|FG004|Overall Study|Non-compliance with study drug|2|||
144357535|NCT01384734|520513754|FG000|Overall Study|Pregnancy|0|||
144357536|NCT01384734|520513755|FG001|Overall Study|Pregnancy|1|||
144357537|NCT01384734|520513756|FG002|Overall Study|Pregnancy|0|||
144357538|NCT01384734|520513757|FG003|Overall Study|Pregnancy|0|||
144357539|NCT01384734|520513758|FG004|Overall Study|Pregnancy|1|||
144357540|NCT01384734|520513754|FG000|Overall Study|Sponsor terminated|0|||
144357541|NCT01384734|520513755|FG001|Overall Study|Sponsor terminated|0|||
144357542|NCT01384734|520513756|FG002|Overall Study|Sponsor terminated|0|||
144357543|NCT01384734|520513757|FG003|Overall Study|Sponsor terminated|0|||
144357544|NCT01384734|520513758|FG004|Overall Study|Sponsor terminated|1|||
144357545|NCT01384734|520513754|FG000|Overall Study|Withdrawal by Subject|5|||
144357546|NCT01384734|520513755|FG001|Overall Study|Withdrawal by Subject|5|||
144357547|NCT01384734|520513756|FG002|Overall Study|Withdrawal by Subject|6|||
144357548|NCT01384734|520513757|FG003|Overall Study|Withdrawal by Subject|7|||
144357549|NCT01384734|520513758|FG004|Overall Study|Withdrawal by Subject|9|||
144357550|NCT01384734|520513754|FG000|Overall Study|Investigator relocating|0|||
144357551|NCT01384734|520513755|FG001|Overall Study|Investigator relocating|2|||
144357552|NCT01384734|520513756|FG002|Overall Study|Investigator relocating|0|||
144357553|NCT01384734|520513757|FG003|Overall Study|Investigator relocating|3|||
144357554|NCT01384734|520513758|FG004|Overall Study|Investigator relocating|1|||
144357555|NCT01384734|520513754|FG000|Overall Study|Unable to come back for visit|1|||
144357556|NCT01384734|520513755|FG001|Overall Study|Unable to come back for visit|0|||
144357557|NCT01384734|520513756|FG002|Overall Study|Unable to come back for visit|1|||
144357558|NCT01384734|520513757|FG003|Overall Study|Unable to come back for visit|1|||
144357559|NCT01384734|520513758|FG004|Overall Study|Unable to come back for visit|0|||
144357560|NCT01384734|520513754|FG000|Overall Study|Prison|0|||
144357561|NCT01384734|520513755|FG001|Overall Study|Prison|0|||
144357562|NCT01384734|520513756|FG002|Overall Study|Prison|1|||
144357563|NCT01384734|520513757|FG003|Overall Study|Prison|0|||
144357564|NCT01384734|520513758|FG004|Overall Study|Prison|0|||
144357565|NCT01384734|520513754|FG000|Overall Study|As per Exclusion criteria|0|||
144357566|NCT01384734|520513755|FG001|Overall Study|As per Exclusion criteria|1|||
144357567|NCT01384734|520513756|FG002|Overall Study|As per Exclusion criteria|0|||
144357568|NCT01384734|520513757|FG003|Overall Study|As per Exclusion criteria|0|||
144357569|NCT01384734|520513758|FG004|Overall Study|As per Exclusion criteria|0|||
144357570|NCT01384734|520513754|FG000|Overall Study|Missed End of treatment visit|0|||
144357571|NCT01384734|520513755|FG001|Overall Study|Missed End of treatment visit|0|||
144357572|NCT01384734|520513756|FG002|Overall Study|Missed End of treatment visit|0|||
144357573|NCT01384734|520513757|FG003|Overall Study|Missed End of treatment visit|1|||
144357574|NCT01384734|520513758|FG004|Overall Study|Missed End of treatment visit|0|||
144357575|NCT01384734|520513754|FG000|Overall Study|Adhesion problem|0|||
144357576|NCT01384734|520513755|FG001|Overall Study|Adhesion problem|0|||
144357577|NCT01384734|520513756|FG002|Overall Study|Adhesion problem|0|||
144357578|NCT01384734|520513757|FG003|Overall Study|Adhesion problem|1|||
144357579|NCT01384734|520513758|FG004|Overall Study|Adhesion problem|0|||
144357580|NCT01384734|520513754|FG000|Overall Study|Early termination|0|||
144357581|NCT01384734|520513755|FG001|Overall Study|Early termination|0|||
144357582|NCT01384734|520513756|FG002|Overall Study|Early termination|0|||
144357583|NCT01384734|520513757|FG003|Overall Study|Early termination|0|||
144357584|NCT01384734|520513758|FG004|Overall Study|Early termination|1|||
144357585|NCT01384734|520513754|FG000|Overall Study|Physician Decision|1|||
144357586|NCT01384734|520513755|FG001|Overall Study|Physician Decision|0|||
144357587|NCT01384734|520513756|FG002|Overall Study|Physician Decision|0|||
144357588|NCT01384734|520513757|FG003|Overall Study|Physician Decision|0|||
144357589|NCT01384734|520513758|FG004|Overall Study|Physician Decision|0|||
144357590|NCT00360412|520513759|FG000|Overall Study|Adverse Event|37|||
144357591|NCT00360412|520513760|FG001|Overall Study|Adverse Event|65|||
144357592|NCT00360412|520513759|FG000|Overall Study|Protocol Violation|2|||
144357593|NCT00360412|520513760|FG001|Overall Study|Protocol Violation|5|||
144357594|NCT00360412|520513759|FG000|Overall Study|Patient withdrew consent|27|||
144357595|NCT00360412|520513760|FG001|Overall Study|Patient withdrew consent|52|||
144357596|NCT00360412|520513759|FG000|Overall Study|Lack of therapeutic efficacy|46|||
144357597|NCT00360412|520513760|FG001|Overall Study|Lack of therapeutic efficacy|61|||
144357598|NCT00360412|520513759|FG000|Overall Study|Physician Decision|2|||
144357599|NCT00360412|520513760|FG001|Overall Study|Physician Decision|4|||
144357600|NCT00360412|520513759|FG000|Overall Study|Other|5|||
144357601|NCT00360412|520513760|FG001|Overall Study|Other|6|||
144357602|NCT00360412|520513759|FG000|Overall Study|Study termination by Sponsor|214|||
144357603|NCT00360412|520513760|FG001|Overall Study|Study termination by Sponsor|469|||
144357604|NCT02354235|520513761|FG000|Overall Study|Adverse Event|2|||
144357605|NCT02354235|520513762|FG001|Overall Study|Adverse Event|2|||
144357606|NCT02354235|520513761|FG000|Overall Study|Physician Decision|0|||
144357607|NCT02354235|520513762|FG001|Overall Study|Physician Decision|1|||
144357608|NCT02354235|520513761|FG000|Overall Study|Withdrawal by Subject|1|||
144357609|NCT02354235|520513762|FG001|Overall Study|Withdrawal by Subject|3|||
144357610|NCT02354235|520513761|FG000|Overall Study|Conflict with the stopping criteria|0|||
144357611|NCT02354235|520513762|FG001|Overall Study|Conflict with the stopping criteria|1|||
144357612|NCT00948064|520514920|FG000|Phase I|No treatment received|1|||
144357613|NCT00948064|520514921|FG001|Phase I|No treatment received|0|||
144357614|NCT00948064|520514922|FG002|Phase I|No treatment received|0|||
144357615|NCT00948064|520514920|FG000|Phase II|Physician Decision|0|||
144357616|NCT00948064|520514921|FG001|Phase II|Physician Decision|0|||
144357617|NCT00948064|520514922|FG002|Phase II|Physician Decision|1|||
144357618|NCT00948064|520514920|FG000|Phase II|Withdrawal by Subject|0|||
144357619|NCT00948064|520514921|FG001|Phase II|Withdrawal by Subject|1|||
144357620|NCT00948064|520514922|FG002|Phase II|Withdrawal by Subject|0|||
144357621|NCT03409796|520514931|FG000|Overall Study|Adverse Event|2|||
144357622|NCT03409796|520514932|FG001|Overall Study|Adverse Event|0|||
144357623|NCT03409796|520514931|FG000|Overall Study|Other|0|||
144357624|NCT03409796|520514932|FG001|Overall Study|Other|1|||
144357625|NCT00966654|520514947|FG000|Overall Study|Study was terminated,PI left institution|12|||
144357626|NCT01600326|520514950|FG000|Overall Study|Lost to Follow-up|1|||
144357627|NCT01600326|520514951|FG001|Overall Study|Lost to Follow-up|1|||
144357628|NCT04456504|520514952|FG000|Overall Study|Lost to Follow-up|2|||
144357629|NCT02421172|520514953|FG000|Period 1|Adverse Event|1|||
144357630|NCT02421172|520514954|FG001|Period 1|Adverse Event|0|||
144357631|NCT02421172|520514955|FG002|Period 1|Adverse Event|0|||
144357632|NCT02421172|520514956|FG003|Period 1|Adverse Event|0|||
144357633|NCT02421172|520514957|FG004|Period 1|Adverse Event|0|||
144357634|NCT02421172|520514953|FG000|Period 1|Lost to Follow-up|3|||
144357635|NCT02421172|520514954|FG001|Period 1|Lost to Follow-up|1|||
144357636|NCT02421172|520514955|FG002|Period 1|Lost to Follow-up|0|||
144357637|NCT02421172|520514956|FG003|Period 1|Lost to Follow-up|0|||
144357638|NCT02421172|520514957|FG004|Period 1|Lost to Follow-up|0|||
144357639|NCT02421172|520514953|FG000|Period 1|Patient/guardian decision|0|||
144357640|NCT02421172|520514954|FG001|Period 1|Patient/guardian decision|1|||
144357641|NCT02421172|520514955|FG002|Period 1|Patient/guardian decision|0|||
144357642|NCT02421172|520514956|FG003|Period 1|Patient/guardian decision|0|||
144357643|NCT02421172|520514957|FG004|Period 1|Patient/guardian decision|0|||
144357644|NCT02421172|520514953|FG000|Period 2|Adverse Event|0|||
144357645|NCT02421172|520514954|FG001|Period 2|Adverse Event|0|||
144357646|NCT02421172|520514955|FG002|Period 2|Adverse Event|4|||
144357647|NCT02421172|520514956|FG003|Period 2|Adverse Event|0|||
144357648|NCT02421172|520514957|FG004|Period 2|Adverse Event|0|||
144357649|NCT02421172|520514953|FG000|Period 2|Lost to Follow-up|0|||
144357650|NCT02421172|520514954|FG001|Period 2|Lost to Follow-up|0|||
144357651|NCT02421172|520514955|FG002|Period 2|Lost to Follow-up|0|||
144357652|NCT02421172|520514956|FG003|Period 2|Lost to Follow-up|1|||
144357653|NCT02421172|520514957|FG004|Period 2|Lost to Follow-up|0|||
144357654|NCT02421172|520514953|FG000|Period 2|Patient/guardian decision|0|||
144357655|NCT02421172|520514954|FG001|Period 2|Patient/guardian decision|0|||
144357656|NCT02421172|520514955|FG002|Period 2|Patient/guardian decision|3|||
144357657|NCT02421172|520514956|FG003|Period 2|Patient/guardian decision|2|||
144357658|NCT02421172|520514957|FG004|Period 2|Patient/guardian decision|1|||
144357659|NCT00928486|520514958|FG000|Overall Study|Adverse Event|2|||
144357660|NCT00928486|520514958|FG000|Overall Study|Disease Progression|7|||
144357661|NCT00928486|520514958|FG000|Overall Study|Withdrawal by Subject|1|||
144357662|NCT03452540|520514964|FG000|Overall Study|Adverse Event|1|||
144357663|NCT03452540|520514964|FG000|Overall Study|Withdrawal by Subject|1|||
144357664|NCT03452540|520514964|FG000|Overall Study|Other SAE and AE|2|||
144357665|NCT02694744|520514968|FG000|Overall Study|Adverse Event|2|||
144357666|NCT02694744|520514969|FG001|Overall Study|Adverse Event|1|||
144357667|NCT02694744|520514968|FG000|Overall Study|Withdrawal by Subject|2|||
144357668|NCT02694744|520514969|FG001|Overall Study|Withdrawal by Subject|1|||
144357669|NCT02694744|520514968|FG000|Overall Study|Physician Decision|1|||
144357670|NCT02694744|520514969|FG001|Overall Study|Physician Decision|2|||
144357671|NCT02694744|520514968|FG000|Overall Study|Lost to Follow-up|1|||
144357672|NCT02694744|520514969|FG001|Overall Study|Lost to Follow-up|0|||
144357673|NCT02694744|520514968|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
144357674|NCT02694744|520514969|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
144357675|NCT00686777|520514970|FG000|Overall Study|Adverse Event|2|||
144357676|NCT00686777|520514970|FG000|Overall Study|Pregnancy|1|||
144357677|NCT00686777|520514970|FG000|Overall Study|Withdrawal by Subject|2|||
144357678|NCT00686777|520514970|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
144357679|NCT00686777|520514970|FG000|Overall Study|No Visit|1|||
144357680|NCT00667888|520514971|FG000|Overall Study|Death|1|||
144357681|NCT00667888|520514972|FG001|Overall Study|Death|1|||
144357682|NCT00667888|520514971|FG000|Overall Study|Withdrawal by Subject|6|||
144357683|NCT00667888|520514972|FG001|Overall Study|Withdrawal by Subject|3|||
144357684|NCT00667888|520514971|FG000|Overall Study|Proceed with other treatment|3|||
144357685|NCT00667888|520514972|FG001|Overall Study|Proceed with other treatment|3|||
144357686|NCT00667888|520514971|FG000|Overall Study|Ineligible after SIM|0|||
144357687|NCT00667888|520514972|FG001|Overall Study|Ineligible after SIM|2|||
144357688|NCT01945021|520514973|FG000|Overall Study|Adverse Event|1|||
144357689|NCT01945021|520514973|FG000|Overall Study|Withdrawal of consent|12|||
144357690|NCT01945021|520514973|FG000|Overall Study|Lost to Follow-up|5|||
144357691|NCT01945021|520514973|FG000|Overall Study|Death|65|||
144357692|NCT02163902|520514974|FG000|Overall Study|Subject's Request|3|||
144357693|NCT02163902|520514975|FG001|Overall Study|Subject's Request|4|||
144357694|NCT02163902|520514974|FG000|Overall Study|Lost to Follow-up|6|||
144357695|NCT02163902|520514975|FG001|Overall Study|Lost to Follow-up|7|||
144357696|NCT02163902|520514974|FG000|Overall Study|Administrative Decision|2|||
144357697|NCT02163902|520514975|FG001|Overall Study|Administrative Decision|2|||
144357698|NCT00499681|520514976|FG000|Overall Study|toxicity|0|||
144357699|NCT00499681|520514977|FG001|Overall Study|toxicity|1|||
144357700|NCT00499681|520514976|FG000|Overall Study|disease progression|0|||
144357701|NCT00499681|520514977|FG001|Overall Study|disease progression|1|||
144357702|NCT02140047|520514978|FG000|Overall Study|Withdrawal by parent/guardian|1|||
144357703|NCT02140047|520514979|FG001|Overall Study|Withdrawal by parent/guardian|1|||
144357704|NCT02140047|520514980|FG002|Overall Study|Withdrawal by parent/guardian|0|||
144357705|NCT00883779|520514981|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
144357706|NCT00883779|520514982|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
144357707|NCT00883779|520514981|FG000|Primary Study Treatment Phase|Disease progression|75|||
144357708|NCT00883779|520514982|FG001|Primary Study Treatment Phase|Disease progression|59|||
144357709|NCT00883779|520514981|FG000|Primary Study Treatment Phase|Adverse Event|16|||
144357710|NCT00883779|520514982|FG001|Primary Study Treatment Phase|Adverse Event|16|||
144357711|NCT00883779|520514981|FG000|Primary Study Treatment Phase|Death|2|||
144357712|NCT00883779|520514982|FG001|Primary Study Treatment Phase|Death|3|||
144357713|NCT00883779|520514981|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
144357714|NCT00883779|520514982|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
144357715|NCT00883779|520514981|FG000|Primary Study Treatment Phase|Other|3|||
144357716|NCT00883779|520514982|FG001|Primary Study Treatment Phase|Other|0|||
144357717|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Adverse Event|2|||
144357718|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Adverse Event|3|||
144357719|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Death|1|||
144357720|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Death|3|||
144357721|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
144357722|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
144357723|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
144357724|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
144357725|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Disease progression|103|||
144357726|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Disease progression|122|||
144357727|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Other|3|||
144357728|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Other|0|||
144357729|NCT00883779|520514981|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
144357730|NCT00883779|520514982|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
144357731|NCT00883779|520514981|FG000|Off-study Phase|Death|185|||
144357732|NCT00883779|520514982|FG001|Off-study Phase|Death|174|||
144357733|NCT00883779|520514981|FG000|Off-study Phase|Refused treatment|1|||
144357734|NCT00883779|520514982|FG001|Off-study Phase|Refused treatment|1|||
144357735|NCT00883779|520514981|FG000|Off-study Phase|Failure to return|5|||
144357736|NCT00883779|520514982|FG001|Off-study Phase|Failure to return|6|||
144357737|NCT00883779|520514981|FG000|Off-study Phase|Other|18|||
144357738|NCT00883779|520514982|FG001|Off-study Phase|Other|21|||
144357739|NCT00079040|520514983|FG000|Overall Study|Withdrew before treatment|1|||
144357740|NCT00079040|520514983|FG000|Overall Study|Ineligible|1|||
144357741|NCT03119259|520514984|FG000|Overall Study|Withdrawn as no longer eligible|1|||
144357742|NCT03119259|520514985|FG001|Overall Study|Withdrawn as no longer eligible|0|||
144357743|NCT03119259|520514984|FG000|Overall Study|Withdrawal by Subject|4|||
144357744|NCT03119259|520514985|FG001|Overall Study|Withdrawal by Subject|2|||
144357745|NCT03119259|520514984|FG000|Overall Study|Lost to Follow-up|0|||
144357746|NCT03119259|520514985|FG001|Overall Study|Lost to Follow-up|1|||
144357747|NCT00739401|520514990|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
144357748|NCT00739401|520514990|FG000|Overall Study|Death|3|||
144357749|NCT00739401|520514990|FG000|Overall Study|Withdrawal by Subject|4|||
144357750|NCT00325897|520514991|FG000|Overall Study|Lost to Follow-up|12|||
144357751|NCT00325897|520514992|FG001|Overall Study|Lost to Follow-up|13|||
144357752|NCT00982735|520514993|FG000|Overall Study|Lost to Follow-up|6|||
144357753|NCT00982735|520514993|FG000|Overall Study|Patient ineligible for trial|224|||
144357754|NCT01290523|520514995|FG000|Overall Study|Death|3|||
144357755|NCT03071263|520514996|FG000|Overall Study|Adverse Event|1|||
144357756|NCT03071263|520514997|FG001|Overall Study|Adverse Event|3|||
144357757|NCT03071263|520514996|FG000|Overall Study|Withdrawal by Subject|1|||
144357758|NCT03071263|520514997|FG001|Overall Study|Withdrawal by Subject|3|||
144357759|NCT03071263|520514996|FG000|Overall Study|Physician Decision|1|||
144357760|NCT03071263|520514997|FG001|Overall Study|Physician Decision|0|||
144357761|NCT03071263|520514996|FG000|Overall Study|Participant moved to another city|0|||
144357762|NCT03071263|520514997|FG001|Overall Study|Participant moved to another city|1|||
144357763|NCT00647296|520514999|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
144357764|NCT00647296|520515000|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
144357765|NCT00647296|520515001|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
144357766|NCT00647296|520515002|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
144357767|NCT00647296|520514999|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
144357768|NCT00647296|520515000|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
144357769|NCT00647296|520515001|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
144357770|NCT00647296|520515002|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
144357771|NCT00647296|520514999|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
144357772|NCT00647296|520515000|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
144357773|NCT00647296|520515001|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
144357774|NCT00647296|520515002|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
144357775|NCT00647296|520514999|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
144357776|NCT00647296|520515000|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
144357777|NCT00647296|520515001|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
144357778|NCT00647296|520515002|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
144357779|NCT00647296|520514999|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
144357780|NCT00647296|520515000|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
144357781|NCT00647296|520515001|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
144357782|NCT00647296|520515002|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
144357783|NCT00647296|520514999|FG000|Part 2: 4-week Placebo Washout|Death|3|||
144357784|NCT00647296|520515000|FG001|Part 2: 4-week Placebo Washout|Death|0|||
144357785|NCT00647296|520515001|FG002|Part 2: 4-week Placebo Washout|Death|0|||
144357786|NCT00647296|520515002|FG003|Part 2: 4-week Placebo Washout|Death|0|||
144357787|NCT00647296|520514999|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
144357788|NCT00647296|520515000|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
144357789|NCT00647296|520515001|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
144357790|NCT00647296|520515002|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
144357791|NCT00647296|520514999|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
144357792|NCT00647296|520515000|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
144357793|NCT00647296|520515001|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
144357794|NCT00647296|520515002|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
144357795|NCT00647296|520514999|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
144357796|NCT00647296|520515000|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
144357797|NCT00647296|520515001|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
144357798|NCT00647296|520515002|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
144357799|NCT00647296|520514999|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
144357800|NCT00647296|520515000|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
144357801|NCT00647296|520515001|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
144357802|NCT00647296|520515002|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
144357803|NCT00647296|520514999|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
144357804|NCT00647296|520515000|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
144357805|NCT00647296|520515001|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
144357806|NCT00647296|520515002|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
144357807|NCT02922725|520515003|FG000|Overall Study|Withdrawal by Subject|1|||
144357808|NCT02922725|520515004|FG001|Overall Study|Withdrawal by Subject|0|||
144357809|NCT02922725|520515005|FG002|Overall Study|Withdrawal by Subject|0|||
144357810|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
144357811|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
144357812|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
144357813|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
144357814|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
144357815|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
144357816|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
144357817|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
144357818|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
144357819|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
144357820|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
144357821|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
144357822|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
144357823|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
144357824|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
144357825|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
144357826|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
144357827|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
144357828|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
144357829|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
144357830|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
144357831|NCT00550407|520515006|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
144357832|NCT00550407|520515007|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
144357833|NCT00550407|520515008|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
144357834|NCT00550407|520515006|FG000|26-Week Randomized Phase|Adverse Event|0|||
144357835|NCT00550407|520515007|FG001|26-Week Randomized Phase|Adverse Event|5|||
144357836|NCT00550407|520515008|FG002|26-Week Randomized Phase|Adverse Event|2|||
144357837|NCT00550407|520515006|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
144357838|NCT00550407|520515007|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
144357839|NCT00550407|520515008|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
144357840|NCT00550407|520515006|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
144357841|NCT00550407|520515007|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
144357842|NCT00550407|520515008|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
144357843|NCT00550407|520515006|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
144357844|NCT00550407|520515007|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
144357845|NCT00550407|520515008|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
144357846|NCT00584415|520515009|FG000|Overall Study|Adverse Event|7|||
144357847|NCT00556894|520515010|FG000|Overall Study|Adverse Event|2|||
144357848|NCT00556894|520515011|FG001|Overall Study|Adverse Event|3|||
144357849|NCT00556894|520515012|FG002|Overall Study|Adverse Event|3|||
144357850|NCT00556894|520515010|FG000|Overall Study|Death|1|||
144357851|NCT00556894|520515011|FG001|Overall Study|Death|0|||
144357852|NCT00556894|520515012|FG002|Overall Study|Death|0|||
144357853|NCT00556894|520515010|FG000|Overall Study|regulatory decision in Bulgaria|10|||
144357854|NCT00556894|520515011|FG001|Overall Study|regulatory decision in Bulgaria|14|||
144357855|NCT00556894|520515012|FG002|Overall Study|regulatory decision in Bulgaria|13|||
144357856|NCT00556894|520515010|FG000|Overall Study|Change in therapy|2|||
144357857|NCT00556894|520515011|FG001|Overall Study|Change in therapy|1|||
144357858|NCT00556894|520515012|FG002|Overall Study|Change in therapy|2|||
144357859|NCT00556894|520515010|FG000|Overall Study|Withdrawal by Subject|1|||
144357860|NCT00556894|520515011|FG001|Overall Study|Withdrawal by Subject|1|||
144357861|NCT00556894|520515012|FG002|Overall Study|Withdrawal by Subject|1|||
144357862|NCT03883581|520515013|FG000|Overall Study|Withdrawal by Subject|4|||
144357863|NCT04612725|520515014|FG000|Overall Study|Adverse Event|1|||
144357864|NCT04612725|520515015|FG001|Overall Study|Adverse Event|3|||
144357865|NCT04612725|520515016|FG002|Overall Study|Adverse Event|1|||
144357866|NCT04612725|520515017|FG003|Overall Study|Adverse Event|0|||
144357867|NCT04612725|520515018|FG004|Overall Study|Adverse Event|1|||
144357868|NCT04612725|520515014|FG000|Overall Study|Lost to Follow-up|0|||
144357869|NCT04612725|520515015|FG001|Overall Study|Lost to Follow-up|1|||
144357870|NCT04612725|520515016|FG002|Overall Study|Lost to Follow-up|0|||
144357871|NCT04612725|520515017|FG003|Overall Study|Lost to Follow-up|0|||
144357872|NCT04612725|520515018|FG004|Overall Study|Lost to Follow-up|0|||
144357873|NCT04612725|520515014|FG000|Overall Study|Physician Decision|2|||
144357874|NCT04612725|520515015|FG001|Overall Study|Physician Decision|0|||
144357875|NCT04612725|520515016|FG002|Overall Study|Physician Decision|0|||
144357876|NCT04612725|520515017|FG003|Overall Study|Physician Decision|0|||
144357877|NCT04612725|520515018|FG004|Overall Study|Physician Decision|0|||
144357878|NCT04612725|520515014|FG000|Overall Study|Study terminated by sponsor|3|||
144357879|NCT04612725|520515015|FG001|Overall Study|Study terminated by sponsor|1|||
144357880|NCT04612725|520515016|FG002|Overall Study|Study terminated by sponsor|2|||
144357881|NCT04612725|520515017|FG003|Overall Study|Study terminated by sponsor|4|||
144357882|NCT04612725|520515018|FG004|Overall Study|Study terminated by sponsor|5|||
144357883|NCT04612725|520515014|FG000|Overall Study|Withdrawal by Subject|8|||
144357884|NCT04612725|520515015|FG001|Overall Study|Withdrawal by Subject|3|||
144357885|NCT04612725|520515016|FG002|Overall Study|Withdrawal by Subject|5|||
144357886|NCT04612725|520515017|FG003|Overall Study|Withdrawal by Subject|1|||
144357887|NCT04612725|520515018|FG004|Overall Study|Withdrawal by Subject|9|||
144357888|NCT04612725|520515014|FG000|Overall Study|Other|0|||
144357889|NCT04612725|520515015|FG001|Overall Study|Other|0|||
144357890|NCT04612725|520515016|FG002|Overall Study|Other|0|||
144357891|NCT04612725|520515017|FG003|Overall Study|Other|0|||
144357892|NCT04612725|520515018|FG004|Overall Study|Other|1|||
144357893|NCT05190120|520515019|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
144357894|NCT05190120|520515020|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
144357895|NCT05190120|520515021|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
144357896|NCT05190120|520515022|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
144357897|NCT05190120|520515019|FG000|Overall Study|Lost to Follow-up|5|||
144357898|NCT05190120|520515020|FG001|Overall Study|Lost to Follow-up|0|||
144357899|NCT05190120|520515021|FG002|Overall Study|Lost to Follow-up|2|||
144357900|NCT05190120|520515022|FG003|Overall Study|Lost to Follow-up|3|||
144357901|NCT03069352|520515023|FG000|Overall Study|Ongoing|12|||
144357902|NCT03069352|520515024|FG001|Overall Study|Ongoing|40|||
144357903|NCT02621424|520515025|FG000|Overall Study|Withdrawal by Subject|1|||
144357904|NCT02621424|520515026|FG001|Overall Study|Withdrawal by Subject|2|||
144357905|NCT05148234|520515028|FG000|Phase I|Ineligible|0|||
144357906|NCT05148234|520515029|FG001|Phase I|Ineligible|0|||
144357907|NCT05148234|520515030|FG002|Phase I|Ineligible|0|||
144357908|NCT05148234|520515031|FG003|Phase I|Ineligible|0|||
144357909|NCT05148234|520515032|FG004|Phase I|Ineligible|0|||
144357910|NCT05148234|520515033|FG005|Phase I|Ineligible|0|||
144357911|NCT05148234|520515034|FG006|Phase I|Ineligible|0|||
144357912|NCT05148234|520515035|FG007|Phase I|Ineligible|1|||
144357913|NCT05148234|520515028|FG000|Phase I|Company closed the trial.|0|||
144357914|NCT05148234|520515029|FG001|Phase I|Company closed the trial.|1|||
144357915|NCT05148234|520515030|FG002|Phase I|Company closed the trial.|0|||
144357916|NCT05148234|520515031|FG003|Phase I|Company closed the trial.|0|||
144357917|NCT05148234|520515032|FG004|Phase I|Company closed the trial.|0|||
144357918|NCT05148234|520515033|FG005|Phase I|Company closed the trial.|0|||
144357919|NCT05148234|520515034|FG006|Phase I|Company closed the trial.|0|||
144357920|NCT05148234|520515035|FG007|Phase I|Company closed the trial.|0|||
144357921|NCT00410956|520515036|FG000|Overall Study|Adverse Event|1|||
144357922|NCT00410956|520515036|FG000|Overall Study|Death|2|||
144357923|NCT00410956|520515036|FG000|Overall Study|Lack of Efficacy|10|||
144357924|NCT00410956|520515036|FG000|Overall Study|Physician Decision|6|||
144357925|NCT01650194|520515037|FG000|Overall Study|Progressive Disease (PD)|35|||
144357926|NCT01650194|520515037|FG000|Overall Study|Withdrawal by Subject|2|||
144357927|NCT01650194|520515037|FG000|Overall Study|Miscellaneous|10|||
144357928|NCT01928927|520515038|FG000|Overall Study|Lost to Follow-up|1|||
144357929|NCT01928927|520515039|FG001|Overall Study|Lost to Follow-up|0|||
144357930|NCT01928927|520515038|FG000|Overall Study|Withdrawal by Subject|1|||
144357931|NCT01928927|520515039|FG001|Overall Study|Withdrawal by Subject|1|||
144357932|NCT00878501|520516373|FG000|Overall Study|Adverse Event|11|||
144357933|NCT00878501|520516374|FG001|Overall Study|Adverse Event|3|||
144357934|NCT00878501|520516375|FG002|Overall Study|Adverse Event|3|||
144357935|NCT00878501|520516373|FG000|Overall Study|Lack of Efficacy|2|||
144357936|NCT00878501|520516374|FG001|Overall Study|Lack of Efficacy|1|||
144357937|NCT00878501|520516375|FG002|Overall Study|Lack of Efficacy|0|||
144357938|NCT00878501|520516373|FG000|Overall Study|Withdrawal by Subject|2|||
144357939|NCT00878501|520516374|FG001|Overall Study|Withdrawal by Subject|1|||
144357940|NCT00878501|520516375|FG002|Overall Study|Withdrawal by Subject|2|||
144357941|NCT00878501|520516373|FG000|Overall Study|Protocol Violation|0|||
144357942|NCT00878501|520516374|FG001|Overall Study|Protocol Violation|0|||
144357943|NCT00878501|520516375|FG002|Overall Study|Protocol Violation|1|||
144357944|NCT00878501|520516373|FG000|Overall Study|Incorrect enrolment|1|||
144357945|NCT00878501|520516374|FG001|Overall Study|Incorrect enrolment|2|||
144357946|NCT00878501|520516375|FG002|Overall Study|Incorrect enrolment|0|||
144357947|NCT00878501|520516373|FG000|Overall Study|Intake of prohibited concom. medication|0|||
144357948|NCT00878501|520516374|FG001|Overall Study|Intake of prohibited concom. medication|0|||
144357949|NCT00878501|520516375|FG002|Overall Study|Intake of prohibited concom. medication|1|||
144357950|NCT00878501|520516373|FG000|Overall Study|Mis-randomisation of patient|1|||
144357951|NCT00878501|520516374|FG001|Overall Study|Mis-randomisation of patient|0|||
144357952|NCT00878501|520516375|FG002|Overall Study|Mis-randomisation of patient|0|||
144357953|NCT00878501|520516373|FG000|Overall Study|Administrative|0|||
144357954|NCT00878501|520516374|FG001|Overall Study|Administrative|0|||
144357955|NCT00878501|520516375|FG002|Overall Study|Administrative|1|||
144357956|NCT04416204|520516376|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
144357957|NCT04416204|520516377|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
144357958|NCT04416204|520516378|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
144357959|NCT04416204|520516379|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
144357960|NCT01453049|520516381|FG000|Overall Study|Protocol Violation|2|||
144357961|NCT01453049|520516382|FG001|Overall Study|Protocol Violation|5|||
144357962|NCT01453049|520516381|FG000|Overall Study|Lost to Follow-up|2|||
144357963|NCT01453049|520516382|FG001|Overall Study|Lost to Follow-up|1|||
144357964|NCT01453049|520516381|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
144357965|NCT01453049|520516382|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
144357966|NCT01453049|520516381|FG000|Overall Study|Withdrawal by Subject|1|||
144357967|NCT01453049|520516382|FG001|Overall Study|Withdrawal by Subject|0|||
144357968|NCT01453049|520516381|FG000|Overall Study|Randomized in Error|1|||
144357969|NCT01453049|520516382|FG001|Overall Study|Randomized in Error|0|||
144357970|NCT03287791|520516387|FG000|Overall Study|Insufficient Therapeutic Response|0|||
144357971|NCT03287791|520516388|FG001|Overall Study|Insufficient Therapeutic Response|0|||
144357972|NCT03287791|520516389|FG002|Overall Study|Insufficient Therapeutic Response|1|||
144357973|NCT03287791|520516387|FG000|Overall Study|Adverse Event|0|||
144357974|NCT03287791|520516388|FG001|Overall Study|Adverse Event|4|||
144357975|NCT03287791|520516389|FG002|Overall Study|Adverse Event|3|||
144357976|NCT03287791|520516387|FG000|Overall Study|Withdrawal by Subject|12|||
144357977|NCT03287791|520516388|FG001|Overall Study|Withdrawal by Subject|12|||
144357978|NCT03287791|520516389|FG002|Overall Study|Withdrawal by Subject|17|||
144357979|NCT03287791|520516387|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
144357980|NCT03287791|520516388|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
144357981|NCT03287791|520516389|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
144357982|NCT03287791|520516387|FG000|Overall Study|Lost to Follow-up|8|||
144357983|NCT03287791|520516388|FG001|Overall Study|Lost to Follow-up|14|||
144357984|NCT03287791|520516389|FG002|Overall Study|Lost to Follow-up|11|||
144357985|NCT03287791|520516387|FG000|Overall Study|Protocol Violation|7|||
144357986|NCT03287791|520516388|FG001|Overall Study|Protocol Violation|2|||
144357987|NCT03287791|520516389|FG002|Overall Study|Protocol Violation|1|||
144357988|NCT03287791|520516387|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
144357989|NCT03287791|520516388|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
144357990|NCT03287791|520516389|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
144357991|NCT03287791|520516387|FG000|Overall Study|Too much time between 2 visits|0|||
144357992|NCT03287791|520516388|FG001|Overall Study|Too much time between 2 visits|1|||
144357993|NCT03287791|520516389|FG002|Overall Study|Too much time between 2 visits|0|||
144357994|NCT03287791|520516387|FG000|Overall Study|Non-compliance|0|||
144357995|NCT03287791|520516388|FG001|Overall Study|Non-compliance|1|||
144357996|NCT03287791|520516389|FG002|Overall Study|Non-compliance|0|||
144357997|NCT03287791|520516387|FG000|Overall Study|Did not meet inclusion criteria|1|||
144357998|NCT03287791|520516388|FG001|Overall Study|Did not meet inclusion criteria|0|||
144357999|NCT03287791|520516389|FG002|Overall Study|Did not meet inclusion criteria|0|||
144358000|NCT03095651|520516391|FG000|Overall Study|Lost to Follow-up|1|||
144358001|NCT03095651|520516392|FG001|Overall Study|Lost to Follow-up|1|||
144358002|NCT03095651|520516393|FG002|Overall Study|Lost to Follow-up|0|||
144358003|NCT03095651|520516394|FG003|Overall Study|Lost to Follow-up|1|||
144358004|NCT03095651|520516395|FG004|Overall Study|Lost to Follow-up|0|||
144358005|NCT03095651|520516396|FG005|Overall Study|Lost to Follow-up|0|||
144358006|NCT03095651|520516397|FG006|Overall Study|Lost to Follow-up|0|||
144358007|NCT03095651|520516398|FG007|Overall Study|Lost to Follow-up|0|||
144358008|NCT03095651|520516391|FG000|Overall Study|Withdrawal by Subject|0|||
144358009|NCT03095651|520516392|FG001|Overall Study|Withdrawal by Subject|0|||
144358010|NCT03095651|520516393|FG002|Overall Study|Withdrawal by Subject|0|||
144358011|NCT03095651|520516394|FG003|Overall Study|Withdrawal by Subject|0|||
144358012|NCT03095651|520516395|FG004|Overall Study|Withdrawal by Subject|0|||
144358013|NCT03095651|520516396|FG005|Overall Study|Withdrawal by Subject|1|||
144358014|NCT03095651|520516397|FG006|Overall Study|Withdrawal by Subject|0|||
144358015|NCT03095651|520516398|FG007|Overall Study|Withdrawal by Subject|0|||
144358016|NCT02891174|520516404|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
144358017|NCT02891174|520516405|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
144358018|NCT02891174|520516404|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
144358019|NCT02891174|520516405|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
144358020|NCT02891174|520516404|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
144358021|NCT02891174|520516405|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
144358022|NCT02891174|520516404|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
144358023|NCT02891174|520516405|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
144358024|NCT02891174|520516404|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
144358025|NCT02891174|520516405|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
144358026|NCT02891174|520516404|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
144358027|NCT02891174|520516405|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
144358028|NCT02891174|520516404|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
144358029|NCT02891174|520516405|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
144358030|NCT04235140|520516406|FG000|Overall Study|Adverse Event|2|||
144358031|NCT04235140|520516406|FG000|Overall Study|Lost to Follow-up|1|||
144358032|NCT04235140|520516406|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
144358033|NCT04235140|520516406|FG000|Overall Study|Commercial drug is available for participants|7|||
144358034|NCT00768989|520516409|FG000|Prior to Week 24|Withdrawal by Subject|1|||
144358035|NCT00768989|520516410|FG001|Prior to Week 24|Withdrawal by Subject|0|||
144358036|NCT00768989|520516409|FG000|Prior to Week 24|Adverse Event|3|||
144358037|NCT00768989|520516410|FG001|Prior to Week 24|Adverse Event|0|||
144358038|NCT00768989|520516409|FG000|Prior to Week 24|Lost to Follow-up|0|||
144358039|NCT00768989|520516410|FG001|Prior to Week 24|Lost to Follow-up|1|||
144358040|NCT00768989|520516409|FG000|Prior to Week 24|Protocol Violation|0|||
144358041|NCT00768989|520516410|FG001|Prior to Week 24|Protocol Violation|2|||
144358042|NCT00768989|520516409|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
144358043|NCT00768989|520516410|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
144358044|NCT00768989|520516409|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
144358045|NCT00768989|520516410|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
144358046|NCT00768989|520516409|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
144358047|NCT00768989|520516410|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
144358048|NCT00768989|520516409|FG000|On or After Week 36|Lack of Efficacy|1|||
144358049|NCT00768989|520516410|FG001|On or After Week 36|Lack of Efficacy|0|||
144358050|NCT00768989|520516409|FG000|On or After Week 36|Adverse Event|0|||
144358051|NCT00768989|520516410|FG001|On or After Week 36|Adverse Event|1|||
144358052|NCT00768989|520516409|FG000|On or After Week 36|Lost to Follow-up|1|||
144358053|NCT00768989|520516410|FG001|On or After Week 36|Lost to Follow-up|0|||
144358054|NCT00768989|520516409|FG000|On or After Week 36|Poor Compliance|1|||
144358055|NCT00768989|520516410|FG001|On or After Week 36|Poor Compliance|0|||
144358056|NCT00768989|520516409|FG000|On or After Week 36|Protocol Violation|1|||
144358057|NCT00768989|520516410|FG001|On or After Week 36|Protocol Violation|0|||
144358058|NCT00768989|520516409|FG000|On or After Week 36|Did not attend termination visit|2|||
144358059|NCT00768989|520516410|FG001|On or After Week 36|Did not attend termination visit|0|||
144358060|NCT00768989|520516409|FG000|On or After Week 36|Sponsor Termination|45|||
144358061|NCT00768989|520516410|FG001|On or After Week 36|Sponsor Termination|26|||
144358062|NCT00866177|520516413|FG000|Overall Study|Withdrawal by Subject|1|||
144358063|NCT00866177|520516413|FG000|Overall Study|Not Treated|151|||
144358064|NCT03585660|520516417|FG000|Overall Study|operator error|1|||
144358065|NCT03585660|520516417|FG000|Overall Study|technical error|2|||
144358066|NCT03585660|520516417|FG000|Overall Study|hip prosthesis|2|||
144358067|NCT03585660|520516417|FG000|Overall Study|did not undergo biopsy|8|||
144358068|NCT03585660|520516417|FG000|Overall Study|scanner problem|2|||
144358069|NCT00435409|520516418|FG000|Overall Study|Protocol Violation|1|||
144358070|NCT00435409|520516419|FG001|Overall Study|Protocol Violation|2|||
144358071|NCT00435409|520516420|FG002|Overall Study|Protocol Violation|0|||
144358072|NCT00435409|520516418|FG000|Overall Study|Lost to Follow-up|1|||
144358073|NCT00435409|520516419|FG001|Overall Study|Lost to Follow-up|2|||
144358074|NCT00435409|520516420|FG002|Overall Study|Lost to Follow-up|0|||
144358075|NCT00435409|520516418|FG000|Overall Study|Death|8|||
144358076|NCT00435409|520516419|FG001|Overall Study|Death|6|||
144358077|NCT00435409|520516420|FG002|Overall Study|Death|6|||
144358078|NCT00435409|520516418|FG000|Overall Study|Objective progression or relapse|158|||
144358079|NCT00435409|520516419|FG001|Overall Study|Objective progression or relapse|93|||
144358080|NCT00435409|520516420|FG002|Overall Study|Objective progression or relapse|58|||
144358081|NCT00435409|520516418|FG000|Overall Study|Global deterioration of health status|0|||
144358082|NCT00435409|520516419|FG001|Overall Study|Global deterioration of health status|0|||
144358083|NCT00435409|520516420|FG002|Overall Study|Global deterioration of health status|4|||
144358084|NCT00435409|520516418|FG000|Overall Study|Withdrawal by Subject|8|||
144358085|NCT00435409|520516419|FG001|Overall Study|Withdrawal by Subject|7|||
144358086|NCT00435409|520516420|FG002|Overall Study|Withdrawal by Subject|1|||
144358087|NCT00435409|520516418|FG000|Overall Study|Other|45|||
144358088|NCT00435409|520516419|FG001|Overall Study|Other|30|||
144358089|NCT00435409|520516420|FG002|Overall Study|Other|1|||
144358090|NCT00435409|520516418|FG000|Overall Study|Adverse Event|0|||
144358091|NCT00435409|520516419|FG001|Overall Study|Adverse Event|0|||
144358092|NCT00435409|520516420|FG002|Overall Study|Adverse Event|8|||
144358093|NCT00435409|520516418|FG000|Overall Study|Sponsor decision|0|||
144358094|NCT00435409|520516419|FG001|Overall Study|Sponsor decision|3|||
144358095|NCT00435409|520516420|FG002|Overall Study|Sponsor decision|0|||
144358096|NCT05635461|520516421|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
144358097|NCT05635461|520516422|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
144358098|NCT05635461|520516423|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
144358099|NCT05635461|520516424|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
144358100|NCT05635461|520516425|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
144358101|NCT05635461|520516426|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
144358102|NCT05635461|520516421|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
144358103|NCT05635461|520516422|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
144358104|NCT05635461|520516423|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
144358105|NCT05635461|520516424|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
144358106|NCT05635461|520516425|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
144358107|NCT05635461|520516426|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
144358108|NCT05635461|520516421|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
144358109|NCT05635461|520516422|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
144358110|NCT05635461|520516423|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
144358111|NCT05635461|520516424|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
144358112|NCT05635461|520516425|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
144358113|NCT05635461|520516426|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
144358114|NCT03661723|520516429|FG000|Overall Study|Disease Progression|4|||
144358115|NCT03661723|520516430|FG001|Overall Study|Disease Progression|24|||
144358116|NCT03661723|520516431|FG002|Overall Study|Disease Progression|4|||
144358117|NCT03661723|520516432|FG003|Overall Study|Disease Progression|19|||
144358118|NCT03661723|520516429|FG000|Overall Study|Withdrawal by Subject|1|||
144358119|NCT03661723|520516430|FG001|Overall Study|Withdrawal by Subject|0|||
144358120|NCT03661723|520516431|FG002|Overall Study|Withdrawal by Subject|2|||
144358121|NCT03661723|520516432|FG003|Overall Study|Withdrawal by Subject|4|||
144358122|NCT03661723|520516429|FG000|Overall Study|Physician Decision|1|||
144358123|NCT03661723|520516430|FG001|Overall Study|Physician Decision|0|||
144358124|NCT03661723|520516431|FG002|Overall Study|Physician Decision|0|||
144358125|NCT03661723|520516432|FG003|Overall Study|Physician Decision|0|||
144358126|NCT03661723|520516429|FG000|Overall Study|Clinical Deterioration|0|||
144358127|NCT03661723|520516430|FG001|Overall Study|Clinical Deterioration|0|||
144358128|NCT03661723|520516431|FG002|Overall Study|Clinical Deterioration|0|||
144358129|NCT03661723|520516432|FG003|Overall Study|Clinical Deterioration|1|||
144358130|NCT00117637|520516433|FG000|First Intervention (Period 1)|Adverse Event|11|||
144358131|NCT00117637|520516434|FG001|First Intervention (Period 1)|Adverse Event|16|||
144358132|NCT00117637|520516433|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
144358133|NCT00117637|520516434|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
144358134|NCT00117637|520516433|FG000|First Intervention (Period 1)|Protocol Violation|1|||
144358135|NCT00117637|520516434|FG001|First Intervention (Period 1)|Protocol Violation|0|||
144358136|NCT00117637|520516433|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
144358137|NCT00117637|520516434|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
144358138|NCT00117637|520516433|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
144358139|NCT00117637|520516434|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
144358140|NCT00117637|520516433|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
144358141|NCT00117637|520516434|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
144358142|NCT00117637|520516433|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
144359994|NCT04258423|520525132|FG001|Overall Study|Study Closure|2|||
144358143|NCT00117637|520516434|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
144358144|NCT00117637|520516433|FG000|First Intervention (Period 1)|reason not reported|0|||
144358145|NCT00117637|520516434|FG001|First Intervention (Period 1)|reason not reported|1|||
144358146|NCT00117637|520516433|FG000|Second Intervention (Period 2)|Adverse Event|0|||
144358147|NCT00117637|520516434|FG001|Second Intervention (Period 2)|Adverse Event|9|||
144358148|NCT00117637|520516433|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
144358149|NCT00117637|520516434|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
144358150|NCT00117637|520516433|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
144358151|NCT00117637|520516434|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
144358152|NCT00117637|520516433|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
144358153|NCT00117637|520516434|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
144358154|NCT00117637|520516433|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
144358155|NCT00117637|520516434|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
144358156|NCT00117637|520516433|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
144358157|NCT00117637|520516434|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
144358158|NCT00117637|520516433|FG000|Second Intervention (Period 2)|reason not reported|1|||
144358159|NCT00117637|520516434|FG001|Second Intervention (Period 2)|reason not reported|0|||
144358160|NCT01620060|520516436|FG000|Overall Study|Adverse Event|9|||
144358161|NCT01620060|520516436|FG000|Overall Study|Protocol Violation|1|||
144358162|NCT01620060|520516436|FG000|Overall Study|Withdrawal by Subject|1|||
144358163|NCT01620060|520516436|FG000|Overall Study|Did not comply with Study Produre|1|||
144358164|NCT01620060|520516436|FG000|Overall Study|Family emergency|1|||
144358165|NCT01620060|520516436|FG000|Overall Study|Per Sponsor Decision|2|||
144358166|NCT02269124|520516437|FG000|Overall Study|Lost to Follow-up|1|||
144358167|NCT02269124|520516438|FG001|Overall Study|Lost to Follow-up|0|||
144358168|NCT02269124|520516437|FG000|Overall Study|Withdrawal by Subject|0|||
144358169|NCT02269124|520516438|FG001|Overall Study|Withdrawal by Subject|2|||
144358170|NCT00614575|520516439|FG000|Overall Study|Adverse Event|106|||
144358171|NCT00614575|520516439|FG000|Overall Study|Lost to Follow-up|55|||
144358172|NCT00614575|520516439|FG000|Overall Study|Lack of Efficacy|14|||
144358173|NCT00614575|520516439|FG000|Overall Study|Withdrawal by Subject|6|||
144358174|NCT00614575|520516439|FG000|Overall Study|Death|3|||
144358175|NCT00614575|520516439|FG000|Overall Study|Physician Decision|2|||
144358176|NCT00614575|520516439|FG000|Overall Study|No data were collected.|18|||
144358177|NCT00614575|520516439|FG000|Overall Study|Irregularly enrolled patients|23|||
144358178|NCT00614575|520516439|FG000|Overall Study|No treatment|1|||
144358179|NCT01582061|520516440|FG000|Overall Study|Lack of Efficacy|3|||
144358180|NCT01582061|520516441|FG001|Overall Study|Lack of Efficacy|23|||
144358181|NCT01582061|520516440|FG000|Overall Study|Adverse Event|12|||
144358182|NCT01582061|520516441|FG001|Overall Study|Adverse Event|8|||
144358183|NCT01582061|520516440|FG000|Overall Study|Withdrawal by Subject|10|||
144358184|NCT01582061|520516441|FG001|Overall Study|Withdrawal by Subject|4|||
144358185|NCT01582061|520516440|FG000|Overall Study|Abnormal laboratory value(s)|1|||
144358186|NCT01582061|520516441|FG001|Overall Study|Abnormal laboratory value(s)|0|||
144358187|NCT01582061|520516440|FG000|Overall Study|Death|0|||
144358188|NCT01582061|520516441|FG001|Overall Study|Death|1|||
144358189|NCT01582061|520516440|FG000|Overall Study|condition no longer requires study drug|1|||
144358190|NCT01582061|520516441|FG001|Overall Study|condition no longer requires study drug|0|||
144358191|NCT01582061|520516440|FG000|Overall Study|Lost to Follow-up|1|||
144358192|NCT01582061|520516441|FG001|Overall Study|Lost to Follow-up|0|||
144358193|NCT04664153|520516444|FG000|Overall Study|Lack of Efficacy|0|||
144358194|NCT04664153|520516445|FG001|Overall Study|Lack of Efficacy|0|||
144358195|NCT04664153|520516446|FG002|Overall Study|Lack of Efficacy|1|||
144358196|NCT04664153|520516447|FG003|Overall Study|Lack of Efficacy|0|||
144358197|NCT04664153|520516444|FG000|Overall Study|Physician Decision|0|||
144358198|NCT04664153|520516445|FG001|Overall Study|Physician Decision|0|||
144358199|NCT04664153|520516446|FG002|Overall Study|Physician Decision|1|||
144358200|NCT04664153|520516447|FG003|Overall Study|Physician Decision|0|||
144358201|NCT04664153|520516444|FG000|Overall Study|Withdrawal by Subject|3|||
144358202|NCT04664153|520516445|FG001|Overall Study|Withdrawal by Subject|2|||
144358203|NCT04664153|520516446|FG002|Overall Study|Withdrawal by Subject|1|||
144358204|NCT04664153|520516447|FG003|Overall Study|Withdrawal by Subject|2|||
144358205|NCT04664153|520516444|FG000|Overall Study|Other|0|||
144358206|NCT04664153|520516445|FG001|Overall Study|Other|1|||
144358207|NCT04664153|520516446|FG002|Overall Study|Other|0|||
144358208|NCT04664153|520516447|FG003|Overall Study|Other|0|||
144358209|NCT04664153|520516444|FG000|Overall Study|Adverse Event|4|||
144358210|NCT04664153|520516445|FG001|Overall Study|Adverse Event|0|||
144358211|NCT04664153|520516446|FG002|Overall Study|Adverse Event|1|||
144358212|NCT04664153|520516447|FG003|Overall Study|Adverse Event|0|||
144358213|NCT00097500|520516448|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
144358214|NCT00097500|520516449|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
144358215|NCT00097500|520516448|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
144358216|NCT00097500|520516449|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
144358217|NCT00097500|520516448|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
144358218|NCT00097500|520516449|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
144358219|NCT00097500|520516448|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
144358220|NCT00097500|520516449|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
144358221|NCT00097500|520516448|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
144358222|NCT00097500|520516449|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
144358223|NCT00097500|520516448|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
144358224|NCT00097500|520516449|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
144358225|NCT00097500|520516448|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
144358226|NCT00097500|520516449|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
144358227|NCT00642356|520516453|FG000|Overall Study|Adverse Event|1|||
144358228|NCT00642356|520516454|FG001|Overall Study|Adverse Event|0|||
144358229|NCT00642356|520516453|FG000|Overall Study|Protocol Violation|0|||
144358230|NCT00642356|520516454|FG001|Overall Study|Protocol Violation|3|||
144358231|NCT00642356|520516453|FG000|Overall Study|Lack of Efficacy|1|||
144358232|NCT00642356|520516454|FG001|Overall Study|Lack of Efficacy|0|||
144358233|NCT01009060|520516463|FG000|Overall Study|Adverse Event|1|||
144358234|NCT01009060|520516464|FG001|Overall Study|Adverse Event|2|||
144358235|NCT01009060|520516463|FG000|Overall Study|Protocol Violation|0|||
144358236|NCT01009060|520516464|FG001|Overall Study|Protocol Violation|1|||
144358237|NCT01009060|520516463|FG000|Overall Study|Lost to Follow-up|1|||
144358238|NCT01009060|520516464|FG001|Overall Study|Lost to Follow-up|0|||
144358239|NCT01009060|520516463|FG000|Overall Study|Physician Decision|1|||
144358240|NCT01009060|520516464|FG001|Overall Study|Physician Decision|1|||
144358241|NCT01009060|520516463|FG000|Overall Study|Withdrawal by Subject|1|||
144358242|NCT01009060|520516464|FG001|Overall Study|Withdrawal by Subject|1|||
144358243|NCT00005906|520516465|FG000|Overall Study|Lack of Efficacy|3|||
144358244|NCT00300755|520516468|FG000|Overall Study|Adverse Event|1|||
144358245|NCT00300755|520516469|FG001|Overall Study|Adverse Event|2|||
144358246|NCT00300755|520516470|FG002|Overall Study|Adverse Event|1|||
144358247|NCT00300755|520516468|FG000|Overall Study|Withdrawal by Subject|0|||
144358248|NCT00300755|520516469|FG001|Overall Study|Withdrawal by Subject|2|||
144358249|NCT00300755|520516470|FG002|Overall Study|Withdrawal by Subject|0|||
144358250|NCT00300755|520516468|FG000|Overall Study|Protocol Violation|0|||
144358251|NCT00300755|520516469|FG001|Overall Study|Protocol Violation|0|||
144358252|NCT00300755|520516470|FG002|Overall Study|Protocol Violation|1|||
144358253|NCT04571944|520516471|FG000|Overall Study|Death|1|||
144358254|NCT04571944|520516472|FG001|Overall Study|Death|0|||
144358255|NCT04571944|520516471|FG000|Overall Study|Withdrawal by Subject|3|||
144358256|NCT04571944|520516472|FG001|Overall Study|Withdrawal by Subject|0|||
144358257|NCT04571944|520516471|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
144358258|NCT04571944|520516472|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
144358259|NCT01362348|520516474|FG000|Overall Study|Protocol-defined stopping criteria|9|||
144358260|NCT01362348|520516474|FG000|Overall Study|Study closed/terminated|5|||
144358261|NCT00651924|520516475|FG000|Overall Study|Withdrawal by PI|0|||
144358262|NCT00651924|520516476|FG001|Overall Study|Withdrawal by PI|2|||
144358263|NCT00651924|520516475|FG000|Overall Study|Withdrawal by Subject|0|||
144358264|NCT00651924|520516476|FG001|Overall Study|Withdrawal by Subject|5|||
144358265|NCT00960063|520516477|FG000|Overall Study|Adverse Event|1|||
144358266|NCT00960063|520516478|FG001|Overall Study|Adverse Event|0|||
144358267|NCT00960063|520516479|FG002|Overall Study|Adverse Event|0|||
144358268|NCT00960063|520516477|FG000|Overall Study|Progression of Disease|0|||
144358269|NCT00960063|520516478|FG001|Overall Study|Progression of Disease|0|||
144358270|NCT00960063|520516479|FG002|Overall Study|Progression of Disease|3|||
144358271|NCT02675907|520516480|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
144358272|NCT02675907|520516481|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
144358273|NCT02675907|520516480|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
144358274|NCT02675907|520516481|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
144358275|NCT02675907|520516480|FG000|Study Overall|Lack of Efficacy|1|||
144358276|NCT02675907|520516481|FG001|Study Overall|Lack of Efficacy|0|||
144358277|NCT02675907|520516480|FG000|Study Overall|Withdrawal by Subject|2|||
144358278|NCT02675907|520516481|FG001|Study Overall|Withdrawal by Subject|2|||
144358279|NCT02675907|520516480|FG000|Study Overall|Lost to Follow-up|0|||
144358280|NCT02675907|520516481|FG001|Study Overall|Lost to Follow-up|2|||
144358281|NCT01611792|520516482|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
144358282|NCT01611792|520516483|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
144358283|NCT01611792|520516482|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
144358284|NCT01611792|520516483|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
144358285|NCT02898454|520516487|FG000|Overall Study|Adverse Event|4|||
144358286|NCT02898454|520516488|FG001|Overall Study|Adverse Event|1|||
144358287|NCT02898454|520516489|FG002|Overall Study|Adverse Event|2|||
144358288|NCT02898454|520516487|FG000|Overall Study|Protocol Violation|1|||
144358289|NCT02898454|520516488|FG001|Overall Study|Protocol Violation|0|||
144358290|NCT02898454|520516489|FG002|Overall Study|Protocol Violation|1|||
144358291|NCT02898454|520516487|FG000|Overall Study|Lack of Efficacy|4|||
144358292|NCT02898454|520516488|FG001|Overall Study|Lack of Efficacy|1|||
144358293|NCT02898454|520516489|FG002|Overall Study|Lack of Efficacy|0|||
144358294|NCT02898454|520516487|FG000|Overall Study|Withdrawal by Subject|6|||
144358295|NCT02898454|520516488|FG001|Overall Study|Withdrawal by Subject|3|||
144358296|NCT02898454|520516489|FG002|Overall Study|Withdrawal by Subject|3|||
144358297|NCT02898454|520516487|FG000|Overall Study|Lost to Follow-up|1|||
144358298|NCT02898454|520516488|FG001|Overall Study|Lost to Follow-up|0|||
144358299|NCT02898454|520516489|FG002|Overall Study|Lost to Follow-up|0|||
144358300|NCT02898454|520516487|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
144358301|NCT02898454|520516488|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
144358302|NCT02898454|520516489|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
144358303|NCT02343263|520516490|FG000|Overall Study|Physician Decision|5|||
144358304|NCT02343263|520516491|FG001|Overall Study|Physician Decision|3|||
144358305|NCT02343263|520516492|FG002|Overall Study|Physician Decision|1|||
144358306|NCT04264442|520516496|FG000|Overall Study|Lack of Efficacy|6|||
144358307|NCT04264442|520516496|FG000|Overall Study|Lost to Follow-up|2|||
144358308|NCT04264442|520516496|FG000|Overall Study|Sponsor Decision|23|||
144358309|NCT04264442|520516496|FG000|Overall Study|Withdrawal by Subject|11|||
144358310|NCT04264442|520516496|FG000|Overall Study|Study Termination|5|||
144358311|NCT03289208|520516501|FG000|Overall Study|Adverse Event|1|||
144358312|NCT03289208|520516502|FG001|Overall Study|Adverse Event|0|||
144358313|NCT03289208|520516503|FG002|Overall Study|Adverse Event|0|||
144358314|NCT03062358|520516504|FG000|Overall Study|Death|269|||
144358315|NCT03062358|520516505|FG001|Overall Study|Death|145|||
144358316|NCT03062358|520516504|FG000|Overall Study|Withdrawal by Subject|2|||
144358317|NCT03062358|520516505|FG001|Overall Study|Withdrawal by Subject|1|||
144358318|NCT03062358|520516504|FG000|Overall Study|Sponsor Decision|29|||
144358319|NCT03062358|520516505|FG001|Overall Study|Sponsor Decision|7|||
144358320|NCT04750642|520516508|FG000|Overall Study|Adverse Event|1|||
144358321|NCT04750642|520516509|FG001|Overall Study|Adverse Event|0|||
144358322|NCT04750642|520516508|FG000|Overall Study|Withdrawal by Subject|0|||
144358323|NCT04750642|520516509|FG001|Overall Study|Withdrawal by Subject|1|||
144358324|NCT04750642|520516508|FG000|Overall Study|Protocol Violation|0|||
144358325|NCT04750642|520516509|FG001|Overall Study|Protocol Violation|1|||
144358326|NCT00880698|520516511|FG000|Overall Study|Death|0|||
144358327|NCT00880698|520516512|FG001|Overall Study|Death|0|||
144358328|NCT00880698|520516513|FG002|Overall Study|Death|1|||
144358329|NCT00880698|520516514|FG003|Overall Study|Death|2|||
144358330|NCT00880698|520516511|FG000|Overall Study|Lost to Follow-up|1|||
144358331|NCT00880698|520516512|FG001|Overall Study|Lost to Follow-up|3|||
144358332|NCT00880698|520516513|FG002|Overall Study|Lost to Follow-up|0|||
144358333|NCT00880698|520516514|FG003|Overall Study|Lost to Follow-up|1|||
144358334|NCT00740220|520518618|FG000|Overall Study|screen failures (non-COPD patients)|9|||
144358335|NCT01602224|520518619|FG000|Overall Study|Adverse Event|0|||
144358336|NCT01602224|520518620|FG001|Overall Study|Adverse Event|1|||
144358337|NCT01602224|520518621|FG002|Overall Study|Adverse Event|0|||
144358338|NCT01602224|520518619|FG000|Overall Study|Investigator Decison|1|||
144358339|NCT01602224|520518620|FG001|Overall Study|Investigator Decison|0|||
144358340|NCT01602224|520518621|FG002|Overall Study|Investigator Decison|0|||
144358341|NCT01602224|520518619|FG000|Overall Study|Lost to Follow-up|0|||
144358342|NCT01602224|520518620|FG001|Overall Study|Lost to Follow-up|0|||
144358343|NCT01602224|520518621|FG002|Overall Study|Lost to Follow-up|1|||
144358344|NCT01602224|520518619|FG000|Overall Study|Protocol Violation|0|||
144358345|NCT01602224|520518620|FG001|Overall Study|Protocol Violation|1|||
144358346|NCT01602224|520518621|FG002|Overall Study|Protocol Violation|0|||
144358347|NCT01602224|520518619|FG000|Overall Study|Sponsor Decision|2|||
144358348|NCT01602224|520518620|FG001|Overall Study|Sponsor Decision|3|||
144358349|NCT01602224|520518621|FG002|Overall Study|Sponsor Decision|2|||
144358350|NCT01602224|520518619|FG000|Overall Study|Withdrawal by Subject|5|||
144358351|NCT01602224|520518620|FG001|Overall Study|Withdrawal by Subject|3|||
144358352|NCT01602224|520518621|FG002|Overall Study|Withdrawal by Subject|3|||
144358353|NCT04906499|520518626|FG000|Overall Study|Lack of time|1|||
144358354|NCT01908426|520518627|FG000|Overall Study|Adverse Event|98|||
144358355|NCT01908426|520518628|FG001|Overall Study|Adverse Event|11|||
144358356|NCT01908426|520518627|FG000|Overall Study|Clinical Deterioration|72|||
144358357|NCT01908426|520518628|FG001|Overall Study|Clinical Deterioration|38|||
144358358|NCT01908426|520518627|FG000|Overall Study|Lack of Efficacy|3|||
144358359|NCT01908426|520518628|FG001|Overall Study|Lack of Efficacy|0|||
144358360|NCT01908426|520518627|FG000|Overall Study|Lost to Follow-up|0|||
144358361|NCT01908426|520518628|FG001|Overall Study|Lost to Follow-up|1|||
144358362|NCT01908426|520518627|FG000|Overall Study|Physician Decision|3|||
144358363|NCT01908426|520518628|FG001|Overall Study|Physician Decision|3|||
144358364|NCT01908426|520518627|FG000|Overall Study|Withdrawal by Subject|11|||
144358365|NCT01908426|520518628|FG001|Overall Study|Withdrawal by Subject|6|||
144358366|NCT01908426|520518627|FG000|Overall Study|Progressive Disease|206|||
144358367|NCT01908426|520518628|FG001|Overall Study|Progressive Disease|152|||
144358368|NCT01908426|520518627|FG000|Overall Study|Protocol Violation|1|||
144358369|NCT01908426|520518628|FG001|Overall Study|Protocol Violation|0|||
144358370|NCT01908426|520518627|FG000|Overall Study|No Study Treatment Given|3|||
144359995|NCT01601535|520525135|FG000|Phase 1|Adverse Event|1|||
144358371|NCT01908426|520518628|FG001|Overall Study|No Study Treatment Given|0|||
144358372|NCT03346434|520518629|FG000|Overall Study|Randomized in Error|0|||
144358373|NCT03346434|520518630|FG001|Overall Study|Randomized in Error|0|||
144358374|NCT03346434|520518631|FG002|Overall Study|Randomized in Error|0|||
144358375|NCT03346434|520518632|FG003|Overall Study|Randomized in Error|0|||
144358376|NCT03346434|520518633|FG004|Overall Study|Randomized in Error|1|||
144358377|NCT03346434|520518634|FG005|Overall Study|Randomized in Error|0|||
144358378|NCT03346434|520518629|FG000|Overall Study|Withdrawal by Subject|0|||
144358379|NCT03346434|520518630|FG001|Overall Study|Withdrawal by Subject|0|||
144358380|NCT03346434|520518631|FG002|Overall Study|Withdrawal by Subject|1|||
144358381|NCT03346434|520518632|FG003|Overall Study|Withdrawal by Subject|0|||
144358382|NCT03346434|520518633|FG004|Overall Study|Withdrawal by Subject|1|||
144358383|NCT03346434|520518634|FG005|Overall Study|Withdrawal by Subject|0|||
144358384|NCT03346434|520518629|FG000|Overall Study|Lost to Follow-up|0|||
144358385|NCT03346434|520518630|FG001|Overall Study|Lost to Follow-up|0|||
144358386|NCT03346434|520518631|FG002|Overall Study|Lost to Follow-up|0|||
144358387|NCT03346434|520518632|FG003|Overall Study|Lost to Follow-up|0|||
144358388|NCT03346434|520518633|FG004|Overall Study|Lost to Follow-up|1|||
144358389|NCT03346434|520518634|FG005|Overall Study|Lost to Follow-up|1|||
144358390|NCT03346434|520518629|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
144358391|NCT03346434|520518630|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
144358392|NCT03346434|520518631|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
144358393|NCT03346434|520518632|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
144358394|NCT03346434|520518633|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
144358395|NCT03346434|520518634|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
144358396|NCT03525444|520518635|FG000|Overall Study|Adverse Event|0|||
144358397|NCT03525444|520518636|FG001|Overall Study|Adverse Event|1|||
144358398|NCT03525444|520518635|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
144358399|NCT03525444|520518636|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
144358400|NCT03525444|520518635|FG000|Overall Study|Other|0|||
144358401|NCT03525444|520518636|FG001|Overall Study|Other|1|||
144358402|NCT02973100|520518640|FG000|Overall Study|Adverse Event|1|||
144358403|NCT02973100|520518641|FG001|Overall Study|Adverse Event|2|||
144358404|NCT02973100|520518642|FG002|Overall Study|Adverse Event|1|||
144358405|NCT02973100|520518643|FG003|Overall Study|Adverse Event|2|||
144358406|NCT02973100|520518640|FG000|Overall Study|Lost to Follow-up|3|||
144358407|NCT02973100|520518641|FG001|Overall Study|Lost to Follow-up|1|||
144358408|NCT02973100|520518642|FG002|Overall Study|Lost to Follow-up|1|||
144358409|NCT02973100|520518643|FG003|Overall Study|Lost to Follow-up|0|||
144358410|NCT02973100|520518640|FG000|Overall Study|Withdrawal by Subject|3|||
144358411|NCT02973100|520518641|FG001|Overall Study|Withdrawal by Subject|5|||
144358412|NCT02973100|520518642|FG002|Overall Study|Withdrawal by Subject|1|||
144358413|NCT02973100|520518643|FG003|Overall Study|Withdrawal by Subject|4|||
144358414|NCT02973100|520518640|FG000|Overall Study|Notification of change in address|0|||
144358415|NCT02973100|520518641|FG001|Overall Study|Notification of change in address|0|||
144358416|NCT02973100|520518642|FG002|Overall Study|Notification of change in address|0|||
144358417|NCT02973100|520518643|FG003|Overall Study|Notification of change in address|1|||
144358418|NCT02973100|520518640|FG000|Overall Study|Failed to attend Safety followup period|0|||
144358419|NCT02973100|520518641|FG001|Overall Study|Failed to attend Safety followup period|0|||
144358420|NCT02973100|520518642|FG002|Overall Study|Failed to attend Safety followup period|1|||
144358421|NCT02973100|520518643|FG003|Overall Study|Failed to attend Safety followup period|0|||
144358422|NCT00812708|520518644|FG000|Overall Study|Device could not be implanted|2|||
144358423|NCT00812708|520518644|FG000|Overall Study|Lack of medical insurance|1|||
144358424|NCT00812708|520518644|FG000|Overall Study|Switched to another study|1|||
144358425|NCT00812708|520518644|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
144358426|NCT00812708|520518644|FG000|Overall Study|Signed consent but later withdrew|3|||
144358427|NCT01959503|520518648|FG000|Overall Study|Death|2|||
144358428|NCT01959503|520518649|FG001|Overall Study|Death|1|||
144358429|NCT01959503|520518648|FG000|Overall Study|Randomized but not treated|1|||
144358430|NCT01959503|520518649|FG001|Overall Study|Randomized but not treated|1|||
144358431|NCT01419236|520518650|FG000|Overall Study|Adverse Event|1|||
144358432|NCT01419236|520518651|FG001|Overall Study|Adverse Event|0|||
144358433|NCT01419236|520518650|FG000|Overall Study|Lack of Efficacy|0|||
144358434|NCT01419236|520518651|FG001|Overall Study|Lack of Efficacy|1|||
144358435|NCT01419236|520518650|FG000|Overall Study|Lost to Follow-up|1|||
144358436|NCT01419236|520518651|FG001|Overall Study|Lost to Follow-up|0|||
144358437|NCT01419236|520518650|FG000|Overall Study|Physician Decision|1|||
144358438|NCT01419236|520518651|FG001|Overall Study|Physician Decision|0|||
144358439|NCT01419236|520518650|FG000|Overall Study|Withdrawal by Subject|1|||
144358440|NCT01419236|520518651|FG001|Overall Study|Withdrawal by Subject|4|||
144358441|NCT01419236|520518650|FG000|Overall Study|Entry Criteria Not Met|1|||
144358442|NCT01419236|520518651|FG001|Overall Study|Entry Criteria Not Met|0|||
144358443|NCT03224130|520518652|FG000|Overall Study|consent issue|0|||
144358444|NCT03224130|520518653|FG001|Overall Study|consent issue|1|||
144358445|NCT04124939|520518654|FG000|Overall Study|Lost to Follow-up|1|||
144358446|NCT04124939|520518655|FG001|Overall Study|Lost to Follow-up|3|||
144358447|NCT02587520|520518657|FG000|Overall Study|Protocol Violation|2|||
144358448|NCT02587520|520518658|FG001|Overall Study|Protocol Violation|0|||
144358449|NCT02587520|520518659|FG002|Overall Study|Protocol Violation|0|||
144358450|NCT02587520|520518660|FG003|Overall Study|Protocol Violation|2|||
144358451|NCT02587520|520518661|FG004|Overall Study|Protocol Violation|0|||
144358452|NCT02587520|520518662|FG005|Overall Study|Protocol Violation|1|||
144358453|NCT02587520|520518663|FG006|Overall Study|Protocol Violation|1|||
144358454|NCT02587520|520518664|FG007|Overall Study|Protocol Violation|1|||
144358455|NCT02587520|520518665|FG008|Overall Study|Protocol Violation|3|||
144358456|NCT02587520|520518666|FG009|Overall Study|Protocol Violation|3|||
144358457|NCT02587520|520518667|FG010|Overall Study|Protocol Violation|1|||
144358458|NCT02587520|520518668|FG011|Overall Study|Protocol Violation|2|||
144358459|NCT02587520|520518669|FG012|Overall Study|Protocol Violation|0|||
144358460|NCT02587520|520518670|FG013|Overall Study|Protocol Violation|0|||
144358461|NCT02587520|520518671|FG014|Overall Study|Protocol Violation|0|||
144358462|NCT02587520|520518672|FG015|Overall Study|Protocol Violation|0|||
144358463|NCT02587520|520518673|FG016|Overall Study|Protocol Violation|0|||
144358464|NCT02587520|520518674|FG017|Overall Study|Protocol Violation|0|||
144358465|NCT02587520|520518657|FG000|Overall Study|Adverse Event|0|||
144358466|NCT02587520|520518658|FG001|Overall Study|Adverse Event|0|||
144358467|NCT02587520|520518659|FG002|Overall Study|Adverse Event|0|||
144358468|NCT02587520|520518660|FG003|Overall Study|Adverse Event|0|||
144358469|NCT02587520|520518661|FG004|Overall Study|Adverse Event|0|||
144358470|NCT02587520|520518662|FG005|Overall Study|Adverse Event|0|||
144358471|NCT02587520|520518663|FG006|Overall Study|Adverse Event|0|||
144358472|NCT02587520|520518664|FG007|Overall Study|Adverse Event|0|||
144358473|NCT02587520|520518665|FG008|Overall Study|Adverse Event|0|||
144358474|NCT02587520|520518666|FG009|Overall Study|Adverse Event|0|||
144358475|NCT02587520|520518667|FG010|Overall Study|Adverse Event|0|||
144358476|NCT02587520|520518668|FG011|Overall Study|Adverse Event|1|||
144358477|NCT02587520|520518669|FG012|Overall Study|Adverse Event|0|||
144358478|NCT02587520|520518670|FG013|Overall Study|Adverse Event|0|||
144358479|NCT02587520|520518671|FG014|Overall Study|Adverse Event|0|||
144358480|NCT02587520|520518672|FG015|Overall Study|Adverse Event|0|||
144358481|NCT02587520|520518673|FG016|Overall Study|Adverse Event|0|||
144358482|NCT02587520|520518674|FG017|Overall Study|Adverse Event|0|||
144358483|NCT02587520|520518657|FG000|Overall Study|Withdrawal by Subject|0|||
144358484|NCT02587520|520518658|FG001|Overall Study|Withdrawal by Subject|0|||
144358485|NCT02587520|520518659|FG002|Overall Study|Withdrawal by Subject|1|||
144358486|NCT02587520|520518660|FG003|Overall Study|Withdrawal by Subject|1|||
144358487|NCT02587520|520518661|FG004|Overall Study|Withdrawal by Subject|0|||
144358488|NCT02587520|520518662|FG005|Overall Study|Withdrawal by Subject|1|||
144358489|NCT02587520|520518663|FG006|Overall Study|Withdrawal by Subject|1|||
144358490|NCT02587520|520518664|FG007|Overall Study|Withdrawal by Subject|0|||
144358491|NCT02587520|520518665|FG008|Overall Study|Withdrawal by Subject|0|||
144358492|NCT02587520|520518666|FG009|Overall Study|Withdrawal by Subject|0|||
144358493|NCT02587520|520518667|FG010|Overall Study|Withdrawal by Subject|0|||
144358494|NCT02587520|520518668|FG011|Overall Study|Withdrawal by Subject|0|||
144358495|NCT02587520|520518669|FG012|Overall Study|Withdrawal by Subject|0|||
144358496|NCT02587520|520518670|FG013|Overall Study|Withdrawal by Subject|1|||
144358497|NCT02587520|520518671|FG014|Overall Study|Withdrawal by Subject|0|||
144358498|NCT02587520|520518672|FG015|Overall Study|Withdrawal by Subject|0|||
144358499|NCT02587520|520518673|FG016|Overall Study|Withdrawal by Subject|0|||
144358500|NCT02587520|520518674|FG017|Overall Study|Withdrawal by Subject|0|||
144358501|NCT02587520|520518657|FG000|Overall Study|Lost to Follow-up|0|||
144358502|NCT02587520|520518658|FG001|Overall Study|Lost to Follow-up|2|||
144358503|NCT02587520|520518659|FG002|Overall Study|Lost to Follow-up|0|||
144358504|NCT02587520|520518660|FG003|Overall Study|Lost to Follow-up|2|||
144358505|NCT02587520|520518661|FG004|Overall Study|Lost to Follow-up|0|||
144358506|NCT02587520|520518662|FG005|Overall Study|Lost to Follow-up|1|||
144358507|NCT02587520|520518663|FG006|Overall Study|Lost to Follow-up|1|||
144358508|NCT02587520|520518664|FG007|Overall Study|Lost to Follow-up|1|||
144358509|NCT02587520|520518665|FG008|Overall Study|Lost to Follow-up|0|||
144358510|NCT02587520|520518666|FG009|Overall Study|Lost to Follow-up|2|||
144358511|NCT02587520|520518667|FG010|Overall Study|Lost to Follow-up|2|||
144358512|NCT02587520|520518668|FG011|Overall Study|Lost to Follow-up|1|||
144358513|NCT02587520|520518669|FG012|Overall Study|Lost to Follow-up|0|||
144358514|NCT02587520|520518670|FG013|Overall Study|Lost to Follow-up|0|||
144358515|NCT02587520|520518671|FG014|Overall Study|Lost to Follow-up|0|||
144358516|NCT02587520|520518672|FG015|Overall Study|Lost to Follow-up|0|||
144358517|NCT02587520|520518673|FG016|Overall Study|Lost to Follow-up|0|||
144358518|NCT02587520|520518674|FG017|Overall Study|Lost to Follow-up|0|||
144358519|NCT03562195|520518680|FG000|Overall Study|Adverse Event|0|||
144358520|NCT03562195|520518681|FG001|Overall Study|Adverse Event|6|||
144358521|NCT03562195|520518680|FG000|Overall Study|Lack of Efficacy|0|||
144358522|NCT03562195|520518681|FG001|Overall Study|Lack of Efficacy|5|||
144358523|NCT03562195|520518680|FG000|Overall Study|Protocol Violation|0|||
144358524|NCT03562195|520518681|FG001|Overall Study|Protocol Violation|1|||
144358525|NCT03562195|520518680|FG000|Overall Study|Lost to Follow-up|0|||
144358526|NCT03562195|520518681|FG001|Overall Study|Lost to Follow-up|1|||
144358527|NCT03562195|520518680|FG000|Overall Study|Physician Decision|1|||
144358528|NCT03562195|520518681|FG001|Overall Study|Physician Decision|0|||
144358529|NCT03562195|520518680|FG000|Overall Study|Withdrawal by Subject|3|||
144358530|NCT03562195|520518681|FG001|Overall Study|Withdrawal by Subject|0|||
144358531|NCT02529852|520518682|FG000|Overall Study|Withdrawal by Subject|2|||
144358532|NCT01045460|520518683|FG000|Overall Study|Physician Decision|3|||
144358533|NCT01045460|520518684|FG001|Overall Study|Physician Decision|2|||
144358534|NCT01045460|520518683|FG000|Overall Study|Lost to Follow-up|0|||
144358535|NCT01045460|520518684|FG001|Overall Study|Lost to Follow-up|1|||
144358536|NCT01045460|520518683|FG000|Overall Study|Lack of Efficacy|3|||
144358537|NCT01045460|520518684|FG001|Overall Study|Lack of Efficacy|0|||
144358538|NCT00524485|520518688|FG000|Overall Study|Withdrawal by Subject|5|||
144358539|NCT01600885|520518691|FG000|First Period|Adverse Event|1|||
144358540|NCT01600885|520518692|FG001|First Period|Adverse Event|1|||
144358541|NCT01600885|520518691|FG000|First Period|moved out of area|1|||
144358542|NCT01600885|520518692|FG001|First Period|moved out of area|0|||
144358543|NCT04201431|520518693|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
144358544|NCT04201431|520518694|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
144358545|NCT04201431|520518695|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
144358546|NCT04079296|520518700|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
144358547|NCT04079296|520518701|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
144358548|NCT04079296|520518702|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
144358549|NCT04079296|520518703|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
144358550|NCT04079296|520518704|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
144358551|NCT04079296|520518700|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
144358552|NCT04079296|520518701|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
144358553|NCT04079296|520518702|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
144358554|NCT04079296|520518703|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
144358555|NCT04079296|520518704|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
144358556|NCT04079296|520518700|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
144358557|NCT04079296|520518701|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
144358558|NCT04079296|520518702|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
144358559|NCT04079296|520518703|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
144358560|NCT04079296|520518704|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
144358561|NCT04079296|520518700|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
144358562|NCT04079296|520518701|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
144358563|NCT04079296|520518702|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
144358564|NCT04079296|520518703|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
144358565|NCT04079296|520518704|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
144358566|NCT04079296|520518700|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
144358567|NCT04079296|520518701|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
144358568|NCT04079296|520518702|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
144358569|NCT04079296|520518703|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
144358570|NCT04079296|520518704|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
144358571|NCT04079296|520518700|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
144358572|NCT04079296|520518701|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
144358573|NCT04079296|520518702|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
144358574|NCT04079296|520518703|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
144358575|NCT04079296|520518704|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
144358576|NCT04079296|520518700|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
144358577|NCT04079296|520518701|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
144358578|NCT04079296|520518702|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
144358579|NCT04079296|520518703|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
144358580|NCT04079296|520518704|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
144358581|NCT04079296|520518700|FG000|Dose Expansion Phase (168 Days)|Death|0|||
144358582|NCT04079296|520518701|FG001|Dose Expansion Phase (168 Days)|Death|0|||
144358583|NCT04079296|520518702|FG002|Dose Expansion Phase (168 Days)|Death|0|||
144358584|NCT04079296|520518703|FG003|Dose Expansion Phase (168 Days)|Death|1|||
144358585|NCT04079296|520518704|FG004|Dose Expansion Phase (168 Days)|Death|0|||
144358586|NCT00467740|520518708|FG000|Overall Study|Adverse Event|0|||
144358587|NCT00467740|520518709|FG001|Overall Study|Adverse Event|0|||
144358588|NCT00467740|520518710|FG002|Overall Study|Adverse Event|1|||
144358589|NCT00467740|520518711|FG003|Overall Study|Adverse Event|0|||
144358590|NCT00467740|520518712|FG004|Overall Study|Adverse Event|0|||
144358591|NCT00467740|520518708|FG000|Overall Study|Protocol Violation|0|||
144358592|NCT00467740|520518709|FG001|Overall Study|Protocol Violation|0|||
144358593|NCT00467740|520518710|FG002|Overall Study|Protocol Violation|1|||
144358594|NCT00467740|520518711|FG003|Overall Study|Protocol Violation|0|||
144358595|NCT00467740|520518712|FG004|Overall Study|Protocol Violation|0|||
144358596|NCT00467740|520518708|FG000|Overall Study|Lost to Follow-up|0|||
144358597|NCT00467740|520518709|FG001|Overall Study|Lost to Follow-up|1|||
144358598|NCT00467740|520518710|FG002|Overall Study|Lost to Follow-up|0|||
144358599|NCT00467740|520518711|FG003|Overall Study|Lost to Follow-up|0|||
144358600|NCT00467740|520518712|FG004|Overall Study|Lost to Follow-up|0|||
144358601|NCT00467740|520518708|FG000|Overall Study|Withdrawal by Subject|1|||
144358602|NCT00467740|520518709|FG001|Overall Study|Withdrawal by Subject|1|||
144358603|NCT00467740|520518710|FG002|Overall Study|Withdrawal by Subject|0|||
144358604|NCT00467740|520518711|FG003|Overall Study|Withdrawal by Subject|1|||
144358605|NCT00467740|520518712|FG004|Overall Study|Withdrawal by Subject|0|||
144358606|NCT00467740|520518708|FG000|Overall Study|Lack of Efficacy|0|||
144358607|NCT00467740|520518709|FG001|Overall Study|Lack of Efficacy|1|||
144358608|NCT00467740|520518710|FG002|Overall Study|Lack of Efficacy|0|||
144358609|NCT00467740|520518711|FG003|Overall Study|Lack of Efficacy|0|||
144358610|NCT00467740|520518712|FG004|Overall Study|Lack of Efficacy|0|||
144358611|NCT04949191|520518713|FG000|Overall Study|Non-compliance with Study Drug|1|||
144358612|NCT04949191|520518714|FG001|Overall Study|Non-compliance with Study Drug|0|||
144358613|NCT04949191|520518715|FG002|Overall Study|Non-compliance with Study Drug|0|||
144358614|NCT04949191|520518716|FG003|Overall Study|Non-compliance with Study Drug|0|||
144358615|NCT04949191|520518713|FG000|Overall Study|Progressive Disease|0|||
144358616|NCT04949191|520518714|FG001|Overall Study|Progressive Disease|1|||
144358617|NCT04949191|520518715|FG002|Overall Study|Progressive Disease|0|||
144358618|NCT04949191|520518716|FG003|Overall Study|Progressive Disease|0|||
144358619|NCT04949191|520518713|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
144358620|NCT04949191|520518714|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
144358621|NCT04949191|520518715|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
144358622|NCT04949191|520518716|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
144358623|NCT04949191|520518713|FG000|Overall Study|Sponsor Terminated Study|0|||
144358624|NCT04949191|520518714|FG001|Overall Study|Sponsor Terminated Study|0|||
144358625|NCT04949191|520518715|FG002|Overall Study|Sponsor Terminated Study|1|||
144358626|NCT04949191|520518716|FG003|Overall Study|Sponsor Terminated Study|1|||
144358627|NCT00730158|520518717|FG000|Overall Study|Withdrawal by Subject|1|||
144358628|NCT00730158|520518718|FG001|Overall Study|Withdrawal by Subject|1|||
144358629|NCT01168349|520518719|FG000|Overall Study|Death|157|||
144358630|NCT01168349|520518719|FG000|Overall Study|Lost to Follow-up|34|||
144358631|NCT01168349|520518719|FG000|Overall Study|Withdrawal by Subject|9|||
144358632|NCT01168349|520518719|FG000|Overall Study|Kidney transplantation|3|||
144358633|NCT01168349|520518719|FG000|Overall Study|Other|22|||
144358634|NCT01168349|520518719|FG000|Overall Study|Protocol Violation|76|||
144358635|NCT03535974|520518720|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
144358636|NCT03535974|520518721|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
144358637|NCT03535974|520518722|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
144358638|NCT03535974|520518720|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
144358639|NCT03535974|520518721|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
144358640|NCT03535974|520518722|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
144358641|NCT04059549|520518723|FG000|Overall Study|Withdrawal by Subject|2|||
144358642|NCT04059549|520518724|FG001|Overall Study|Withdrawal by Subject|0|||
144358643|NCT01919229|520518726|FG000|Overall Study|Subject/guardian decision|0|||
144358644|NCT01919229|520518727|FG001|Overall Study|Subject/guardian decision|0|||
144358645|NCT01919229|520518728|FG002|Overall Study|Subject/guardian decision|1|||
144358646|NCT01011673|520518729|FG000|Randomized|Secondary headache|2|||
144358647|NCT01011673|520518730|FG001|Randomized|Secondary headache|1|||
144358648|NCT01011673|520518729|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
144358649|NCT01011673|520518730|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
144358650|NCT00549640|520518731|FG000|Overall Study|Withdrawal by Subject|6|||
144358651|NCT00549640|520518732|FG001|Overall Study|Withdrawal by Subject|12|||
144358652|NCT00549640|520518731|FG000|Overall Study|Adverse Event|5|||
144358653|NCT00549640|520518732|FG001|Overall Study|Adverse Event|0|||
144358654|NCT00549640|520518731|FG000|Overall Study|Lost to Follow-up|7|||
144358655|NCT00549640|520518732|FG001|Overall Study|Lost to Follow-up|4|||
144358656|NCT00626275|520518735|FG000|Part A - Treatment Period 1|Adverse Event|1|||
144358657|NCT00626275|520518736|FG001|Part A - Treatment Period 1|Adverse Event|0|||
144358658|NCT00626275|520518737|FG002|Part A - Treatment Period 1|Adverse Event|0|||
144358659|NCT00626275|520518738|FG003|Part A - Treatment Period 1|Adverse Event|0|||
144358660|NCT00626275|520518739|FG004|Part A - Treatment Period 1|Adverse Event|0|||
144358661|NCT00626275|520518740|FG005|Part A - Treatment Period 1|Adverse Event|0|||
144358662|NCT00626275|520518741|FG006|Part A - Treatment Period 1|Adverse Event|0|||
144358663|NCT00626275|520518742|FG007|Part A - Treatment Period 1|Adverse Event|0|||
144358664|NCT00626275|520518735|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358665|NCT00626275|520518736|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358666|NCT00626275|520518737|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
144358667|NCT00626275|520518738|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358668|NCT00626275|520518739|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358669|NCT00626275|520518740|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358670|NCT00626275|520518741|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358671|NCT00626275|520518742|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
144358672|NCT00626275|520518735|FG000|Part B|Lost to Follow-up|0|||
144358673|NCT00626275|520518736|FG001|Part B|Lost to Follow-up|0|||
144358674|NCT00626275|520518737|FG002|Part B|Lost to Follow-up|0|||
144358675|NCT00626275|520518738|FG003|Part B|Lost to Follow-up|0|||
144358676|NCT00626275|520518739|FG004|Part B|Lost to Follow-up|0|||
144358677|NCT00626275|520518740|FG005|Part B|Lost to Follow-up|0|||
144358678|NCT00626275|520518741|FG006|Part B|Lost to Follow-up|1|||
144358679|NCT00626275|520518742|FG007|Part B|Lost to Follow-up|0|||
144358680|NCT00626275|520518735|FG000|Part B|Withdrawal by Subject|0|||
144358681|NCT00626275|520518736|FG001|Part B|Withdrawal by Subject|0|||
144358682|NCT00626275|520518737|FG002|Part B|Withdrawal by Subject|0|||
144358683|NCT00626275|520518738|FG003|Part B|Withdrawal by Subject|0|||
144358684|NCT00626275|520518739|FG004|Part B|Withdrawal by Subject|0|||
144358685|NCT00626275|520518740|FG005|Part B|Withdrawal by Subject|0|||
144358686|NCT00626275|520518741|FG006|Part B|Withdrawal by Subject|0|||
144358687|NCT00626275|520518742|FG007|Part B|Withdrawal by Subject|1|||
144358688|NCT04999839|520518743|FG000|Overall Study|Adverse Event|1|||
144358689|NCT04999839|520518744|FG001|Overall Study|Adverse Event|1|||
144358690|NCT04999839|520518745|FG002|Overall Study|Adverse Event|1|||
144358691|NCT04999839|520518746|FG003|Overall Study|Adverse Event|1|||
144358692|NCT04999839|520518747|FG004|Overall Study|Adverse Event|1|||
144358693|NCT04999839|520518743|FG000|Overall Study|Lost to Follow-up|2|||
144358694|NCT04999839|520518744|FG001|Overall Study|Lost to Follow-up|0|||
144358695|NCT04999839|520518745|FG002|Overall Study|Lost to Follow-up|2|||
144358696|NCT04999839|520518746|FG003|Overall Study|Lost to Follow-up|4|||
144358697|NCT04999839|520518747|FG004|Overall Study|Lost to Follow-up|1|||
144358698|NCT04999839|520518743|FG000|Overall Study|Withdrawal by Subject|6|||
144358699|NCT04999839|520518744|FG001|Overall Study|Withdrawal by Subject|5|||
144358700|NCT04999839|520518745|FG002|Overall Study|Withdrawal by Subject|3|||
144358701|NCT04999839|520518746|FG003|Overall Study|Withdrawal by Subject|2|||
144358702|NCT04999839|520518747|FG004|Overall Study|Withdrawal by Subject|2|||
144358703|NCT04999839|520518743|FG000|Overall Study|Lack of Efficacy|0|||
144358704|NCT04999839|520518744|FG001|Overall Study|Lack of Efficacy|1|||
144358705|NCT04999839|520518745|FG002|Overall Study|Lack of Efficacy|0|||
144358706|NCT04999839|520518746|FG003|Overall Study|Lack of Efficacy|0|||
144358707|NCT04999839|520518747|FG004|Overall Study|Lack of Efficacy|0|||
144358708|NCT04999839|520518743|FG000|Overall Study|Physician Decision|0|||
144358709|NCT04999839|520518744|FG001|Overall Study|Physician Decision|0|||
144358710|NCT04999839|520518745|FG002|Overall Study|Physician Decision|0|||
144358711|NCT04999839|520518746|FG003|Overall Study|Physician Decision|0|||
144358712|NCT04999839|520518747|FG004|Overall Study|Physician Decision|1|||
144358713|NCT04999839|520518743|FG000|Overall Study|Sponsor request|0|||
144358714|NCT04999839|520518744|FG001|Overall Study|Sponsor request|1|||
144358715|NCT04999839|520518745|FG002|Overall Study|Sponsor request|0|||
144358716|NCT04999839|520518746|FG003|Overall Study|Sponsor request|0|||
144358717|NCT04999839|520518747|FG004|Overall Study|Sponsor request|0|||
144358718|NCT04999839|520518743|FG000|Overall Study|Other|0|||
144358719|NCT04999839|520518744|FG001|Overall Study|Other|0|||
144358720|NCT04999839|520518745|FG002|Overall Study|Other|1|||
144358721|NCT04999839|520518746|FG003|Overall Study|Other|0|||
144358722|NCT04999839|520518747|FG004|Overall Study|Other|0|||
144358723|NCT03740048|520518748|FG000|Overall Study|Withdrawal by Subject|1|||
144358724|NCT03740048|520518749|FG001|Overall Study|Withdrawal by Subject|1|||
144358725|NCT03740048|520518748|FG000|Overall Study|Death|1|||
144358726|NCT03740048|520518749|FG001|Overall Study|Death|6|||
144358727|NCT03740048|520518748|FG000|Overall Study|Switched to thrice-weekly HD|2|||
144358728|NCT03740048|520518749|FG001|Overall Study|Switched to thrice-weekly HD|0|||
144358729|NCT03740048|520518748|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
144358730|NCT03740048|520518749|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
144358731|NCT03740048|520518748|FG000|Overall Study|Lost to Follow-up|0|||
144358732|NCT03740048|520518749|FG001|Overall Study|Lost to Follow-up|1|||
144358733|NCT03740048|520518748|FG000|Overall Study|Non-compliance with HD|0|||
144358734|NCT03740048|520518749|FG001|Overall Study|Non-compliance with HD|1|||
144358735|NCT01476722|520518751|FG000|Overall Study|Adverse Event|1|||
144358736|NCT03261336|520518752|FG000|Overall Study|Adverse Event|1|||
144358737|NCT00292942|520518754|FG000|Overall Study|Withdrawal by Subject|0|||
144358738|NCT00292942|520518755|FG001|Overall Study|Withdrawal by Subject|0|||
144358739|NCT00292942|520518756|FG002|Overall Study|Withdrawal by Subject|1|||
144358740|NCT00292942|520518757|FG003|Overall Study|Withdrawal by Subject|0|||
144358741|NCT00292942|520518754|FG000|Overall Study|Adverse Event|0|||
144358742|NCT00292942|520518755|FG001|Overall Study|Adverse Event|0|||
144358743|NCT00292942|520518756|FG002|Overall Study|Adverse Event|0|||
144358744|NCT00292942|520518757|FG003|Overall Study|Adverse Event|1|||
144358745|NCT00644358|520518758|FG000|Overall Study|Adverse Event|124|||
144358746|NCT00644358|520518758|FG000|Overall Study|Lost to Follow-up|105|||
144358747|NCT00644358|520518758|FG000|Overall Study|Consent Withdrawal|64|||
144358748|NCT00644358|520518758|FG000|Overall Study|Lack of Effectiveness|39|||
144358749|NCT00644358|520518758|FG000|Overall Study|Protocol Violation|5|||
144358750|NCT00644358|520518758|FG000|Overall Study|Noncompliance|14|||
144358751|NCT00644358|520518758|FG000|Overall Study|Other Unspecified|11|||
144358752|NCT00758771|520518764|FG000|Overall Study|Withdrawal by Subject|1|||
144358753|NCT00758771|520518765|FG001|Overall Study|Withdrawal by Subject|1|||
144358754|NCT00758771|520518764|FG000|Overall Study|Did not meet eligibility criteria|2|||
144358755|NCT00758771|520518765|FG001|Overall Study|Did not meet eligibility criteria|4|||
144358756|NCT00528957|520518766|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
144358757|NCT00528957|520518767|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
144358758|NCT00528957|520518766|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
144358759|NCT00528957|520518767|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
144358760|NCT00528957|520518766|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
144358761|NCT00528957|520518767|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
144358762|NCT00528957|520518766|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
144358763|NCT00528957|520518767|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
144358764|NCT00528957|520518766|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
144358765|NCT00528957|520518767|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
144358766|NCT00528957|520518766|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
144358767|NCT00528957|520518767|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
144358768|NCT00528957|520518766|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
144358769|NCT00528957|520518767|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
144358770|NCT00528957|520518766|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
144358771|NCT00528957|520518767|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
144358772|NCT00528957|520518766|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
144358773|NCT00528957|520518767|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
144358774|NCT00528957|520518766|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
144358775|NCT00528957|520518767|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
144358776|NCT00528957|520518766|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
144358777|NCT00528957|520518767|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
144358778|NCT00528957|520518766|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
144358779|NCT00528957|520518767|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
144358780|NCT00528957|520518766|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
144358781|NCT00528957|520518767|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
144358782|NCT00528957|520518766|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
144358783|NCT00528957|520518767|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
144358784|NCT00528957|520518766|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
144358785|NCT00528957|520518767|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
144358786|NCT00528957|520518766|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
144358787|NCT00528957|520518767|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
144358788|NCT00539981|520518768|FG000|Overall Study|Adverse events (AE)|3|||
144358789|NCT00539981|520518769|FG001|Overall Study|Adverse events (AE)|3|||
144358790|NCT00539981|520518768|FG000|Overall Study|Lost to Follow-up|260|||
144358791|NCT00539981|520518769|FG001|Overall Study|Lost to Follow-up|251|||
144358792|NCT00539981|520518768|FG000|Overall Study|Withdrew consent|22|||
144358793|NCT00539981|520518769|FG001|Overall Study|Withdrew consent|14|||
144358794|NCT00539981|520518768|FG000|Overall Study|Death|1|||
144358795|NCT00539981|520518769|FG001|Overall Study|Death|1|||
144358796|NCT00539981|520518768|FG000|Overall Study|Other reason-unspecified|9|||
144358797|NCT00539981|520518769|FG001|Overall Study|Other reason-unspecified|13|||
144358798|NCT01323582|520518770|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
144358799|NCT01323582|520518771|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
144358800|NCT01323582|520518770|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
144358801|NCT01323582|520518771|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
144358802|NCT01323582|520518770|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
144358803|NCT01323582|520518771|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
144358804|NCT01759420|520518772|FG000|Overall Study|Screen failure|5|||
144358805|NCT01759420|520518772|FG000|Overall Study|Inaccurate EKG machine readings|1|||
144358806|NCT01129622|520518773|FG000|Overall Study|Withdrawal by Subject|2|||
144358807|NCT04972162|520518780|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
144358808|NCT04972162|520518781|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
144358809|NCT00633477|520521063|FG000|Overall Study|Death|1|||
144358810|NCT00633477|520521064|FG001|Overall Study|Death|0|||
144358811|NCT00633477|520521063|FG000|Overall Study|Randomized but not treated|1|||
144358812|NCT00633477|520521064|FG001|Overall Study|Randomized but not treated|0|||
144358813|NCT00770653|520521068|FG000|Overall Study|Adverse Event|13|||
144358814|NCT00770653|520521069|FG001|Overall Study|Adverse Event|5|||
144358815|NCT00770653|520521068|FG000|Overall Study|Protocol Violation|8|||
144358816|NCT00770653|520521069|FG001|Overall Study|Protocol Violation|6|||
144358817|NCT00770653|520521068|FG000|Overall Study|Withdrawal by Subject|4|||
144358818|NCT00770653|520521069|FG001|Overall Study|Withdrawal by Subject|7|||
144358819|NCT00770653|520521068|FG000|Overall Study|Lack of Compliance|1|||
144358820|NCT00770653|520521069|FG001|Overall Study|Lack of Compliance|4|||
144358821|NCT00770653|520521068|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
144358822|NCT00770653|520521069|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
144358823|NCT00770653|520521068|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
144358824|NCT00770653|520521069|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
144358825|NCT00770653|520521068|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
144358826|NCT00770653|520521069|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
144358827|NCT00770653|520521068|FG000|Overall Study|Lost to Follow-up|1|||
144358828|NCT00770653|520521069|FG001|Overall Study|Lost to Follow-up|2|||
144358829|NCT00770653|520521068|FG000|Overall Study|Physician Decision|1|||
144358830|NCT00770653|520521069|FG001|Overall Study|Physician Decision|0|||
144358831|NCT00179621|520521071|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
144358832|NCT00179621|520521072|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
144358833|NCT00179621|520521073|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
144358834|NCT00179621|520521074|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
144358835|NCT00179621|520521071|FG000|Double-Blind Period|Adverse Event|2|||
144358836|NCT00179621|520521072|FG001|Double-Blind Period|Adverse Event|7|||
144358837|NCT00179621|520521073|FG002|Double-Blind Period|Adverse Event|4|||
144358838|NCT00179621|520521074|FG003|Double-Blind Period|Adverse Event|0|||
144358839|NCT00179621|520521071|FG000|Double-Blind Period|Withdrawal by Subject|2|||
144358840|NCT00179621|520521072|FG001|Double-Blind Period|Withdrawal by Subject|1|||
144358841|NCT00179621|520521073|FG002|Double-Blind Period|Withdrawal by Subject|3|||
144358842|NCT00179621|520521074|FG003|Double-Blind Period|Withdrawal by Subject|0|||
144358843|NCT00179621|520521071|FG000|Double-Blind Period|Death|0|||
144358844|NCT00179621|520521072|FG001|Double-Blind Period|Death|1|||
144358845|NCT00179621|520521073|FG002|Double-Blind Period|Death|2|||
144358846|NCT00179621|520521074|FG003|Double-Blind Period|Death|0|||
144358847|NCT00179621|520521071|FG000|Double-Blind Period|Protocol Violation|1|||
144358848|NCT00179621|520521072|FG001|Double-Blind Period|Protocol Violation|0|||
144358849|NCT00179621|520521073|FG002|Double-Blind Period|Protocol Violation|0|||
144358850|NCT00179621|520521074|FG003|Double-Blind Period|Protocol Violation|0|||
144358851|NCT00179621|520521071|FG000|Double-Blind Period|Other|0|||
144358852|NCT00179621|520521072|FG001|Double-Blind Period|Other|2|||
144358853|NCT00179621|520521073|FG002|Double-Blind Period|Other|2|||
144358854|NCT00179621|520521074|FG003|Double-Blind Period|Other|0|||
144358855|NCT00179621|520521071|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
144358856|NCT00179621|520521072|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
144358857|NCT00179621|520521073|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
144358858|NCT00179621|520521074|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
144358859|NCT00179621|520521071|FG000|Open-Label Period|Adverse Event|0|||
144358860|NCT00179621|520521072|FG001|Open-Label Period|Adverse Event|6|||
144358861|NCT00179621|520521073|FG002|Open-Label Period|Adverse Event|5|||
144358862|NCT00179621|520521074|FG003|Open-Label Period|Adverse Event|6|||
144358863|NCT00179621|520521071|FG000|Open-Label Period|Withdrawal by Subject|0|||
144358864|NCT00179621|520521072|FG001|Open-Label Period|Withdrawal by Subject|2|||
144358865|NCT00179621|520521073|FG002|Open-Label Period|Withdrawal by Subject|2|||
144358866|NCT00179621|520521074|FG003|Open-Label Period|Withdrawal by Subject|2|||
144358867|NCT00179621|520521071|FG000|Open-Label Period|Death|0|||
144358868|NCT00179621|520521072|FG001|Open-Label Period|Death|0|||
144358869|NCT00179621|520521073|FG002|Open-Label Period|Death|1|||
144358870|NCT00179621|520521074|FG003|Open-Label Period|Death|2|||
144358871|NCT00179621|520521071|FG000|Open-Label Period|Other|0|||
144358872|NCT00179621|520521072|FG001|Open-Label Period|Other|1|||
144358873|NCT00179621|520521073|FG002|Open-Label Period|Other|1|||
144358874|NCT00179621|520521074|FG003|Open-Label Period|Other|2|||
144358875|NCT00262860|520521079|FG000|Overall Study|Adverse Event|2|||
144358876|NCT02741128|520521080|FG000|Overall Study|Protocol Violation|4|||
144358877|NCT02741128|520521081|FG001|Overall Study|Protocol Violation|1|||
144358878|NCT02741128|520521080|FG000|Overall Study|Withdrawal by Subject|2|||
144358879|NCT02741128|520521081|FG001|Overall Study|Withdrawal by Subject|0|||
144358880|NCT02741128|520521080|FG000|Overall Study|Lost to Follow-up|1|||
144358881|NCT02741128|520521081|FG001|Overall Study|Lost to Follow-up|0|||
144358882|NCT01419769|520521082|FG000|Overall Study|Did not receive the AXIOS stent|3|||
144358883|NCT01419769|520521082|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
144358884|NCT03598036|520521089|FG000|Overall Study|Withdrawal by Subject|1|||
144358885|NCT03598036|520521090|FG001|Overall Study|Withdrawal by Subject|0|||
144358886|NCT04607668|520521099|FG000|Overall Study|Death|49|||
144358887|NCT04607668|520521100|FG001|Overall Study|Death|26|||
144358888|NCT04607668|520521099|FG000|Overall Study|Lost to Follow-up|3|||
144358889|NCT04607668|520521100|FG001|Overall Study|Lost to Follow-up|4|||
144358890|NCT04607668|520521099|FG000|Overall Study|Study terminated by Sponsor|92|||
144358891|NCT04607668|520521100|FG001|Overall Study|Study terminated by Sponsor|114|||
144358892|NCT04607668|520521099|FG000|Overall Study|Withdrawal by Subject|12|||
144358893|NCT04607668|520521100|FG001|Overall Study|Withdrawal by Subject|11|||
144358894|NCT04607668|520521099|FG000|Overall Study|Other, unspecified|8|||
144358895|NCT04607668|520521100|FG001|Overall Study|Other, unspecified|7|||
144358896|NCT02250326|520521101|FG000|Treatment|Death|1|||
144358897|NCT02250326|520521102|FG001|Treatment|Death|13|||
144358898|NCT02250326|520521103|FG002|Treatment|Death|2|||
144358899|NCT02250326|520521101|FG000|Treatment|Adverse Event|8|||
144358900|NCT02250326|520521102|FG001|Treatment|Adverse Event|8|||
144358901|NCT02250326|520521103|FG002|Treatment|Adverse Event|9|||
144358902|NCT02250326|520521101|FG000|Treatment|Progressive Disease|42|||
144358903|NCT02250326|520521102|FG001|Treatment|Progressive Disease|40|||
144358904|NCT02250326|520521103|FG002|Treatment|Progressive Disease|47|||
144358905|NCT02250326|520521101|FG000|Treatment|Symptomatic Deterioration|9|||
144358906|NCT02250326|520521102|FG001|Treatment|Symptomatic Deterioration|4|||
144358907|NCT02250326|520521103|FG002|Treatment|Symptomatic Deterioration|10|||
144358908|NCT02250326|520521101|FG000|Treatment|Withdrawal by Subject|11|||
144358909|NCT02250326|520521102|FG001|Treatment|Withdrawal by Subject|6|||
144358910|NCT02250326|520521103|FG002|Treatment|Withdrawal by Subject|4|||
144358911|NCT02250326|520521101|FG000|Treatment|Other reasons|8|||
144358912|NCT02250326|520521102|FG001|Treatment|Other reasons|7|||
144358913|NCT02250326|520521103|FG002|Treatment|Other reasons|7|||
144358914|NCT02250326|520521101|FG000|Extension Period|Progressive Disease|0|||
144358915|NCT02250326|520521102|FG001|Extension Period|Progressive Disease|2|||
144358916|NCT02250326|520521103|FG002|Extension Period|Progressive Disease|0|||
144358917|NCT02250326|520521101|FG000|Extension Period|Withdrawal by Subject|0|||
144358918|NCT02250326|520521102|FG001|Extension Period|Withdrawal by Subject|1|||
144358919|NCT02250326|520521103|FG002|Extension Period|Withdrawal by Subject|0|||
144358920|NCT02250326|520521101|FG000|Extension Period|Withdrawal by investigator|0|||
144358921|NCT02250326|520521102|FG001|Extension Period|Withdrawal by investigator|1|||
144358922|NCT02250326|520521103|FG002|Extension Period|Withdrawal by investigator|0|||
144358923|NCT01838694|520521104|FG000|Overall Study|Adverse Event|0|||
144358924|NCT01838694|520521105|FG001|Overall Study|Adverse Event|1|||
144358925|NCT00672555|520521106|FG000|Overall Study|Lost to Follow-up|4|||
144358926|NCT00672555|520521106|FG000|Overall Study|Did not want to answer questionnaire|2|||
144358927|NCT04516746|520521112|FG000|Overall Study|Randomized but not Treated|51|||
144358928|NCT04516746|520521113|FG001|Overall Study|Randomized but not Treated|19|||
144358929|NCT04516746|520521112|FG000|Overall Study|Adverse Event|0|||
144358930|NCT04516746|520521113|FG001|Overall Study|Adverse Event|1|||
144358931|NCT04516746|520521112|FG000|Overall Study|Death|62|||
144358932|NCT04516746|520521113|FG001|Overall Study|Death|32|||
144358933|NCT04516746|520521112|FG000|Overall Study|Lost to Follow-up|3431|||
144358934|NCT04516746|520521113|FG001|Overall Study|Lost to Follow-up|1831|||
144358935|NCT04516746|520521112|FG000|Overall Study|Withdrawal by Subject|1946|||
144358936|NCT04516746|520521113|FG001|Overall Study|Withdrawal by Subject|1696|||
144358937|NCT04516746|520521112|FG000|Overall Study|Physician Decision|10|||
144358938|NCT04516746|520521113|FG001|Overall Study|Physician Decision|8|||
144358939|NCT04516746|520521112|FG000|Overall Study|Other|35|||
144358940|NCT04516746|520521113|FG001|Overall Study|Other|16|||
144358941|NCT01751061|520521114|FG000|Overall Study|Death|1|||
144358942|NCT01751061|520521115|FG001|Overall Study|Death|0|||
144358943|NCT01751061|520521114|FG000|Overall Study|patient death|5|||
144358944|NCT01751061|520521115|FG001|Overall Study|patient death|0|||
144358945|NCT01751061|520521114|FG000|Overall Study|Lost to Follow-up|40|||
144358946|NCT01751061|520521115|FG001|Overall Study|Lost to Follow-up|25|||
144358947|NCT01751061|520521114|FG000|Overall Study|patient regained decisional capacity|4|||
144358948|NCT01751061|520521115|FG001|Overall Study|patient regained decisional capacity|8|||
144358949|NCT01751061|520521114|FG000|Overall Study|Withdrawal by Subject|4|||
144358950|NCT01751061|520521115|FG001|Overall Study|Withdrawal by Subject|1|||
144358951|NCT01751061|520521114|FG000|Overall Study|Physician Decision|2|||
144358952|NCT01751061|520521115|FG001|Overall Study|Physician Decision|0|||
144358953|NCT02153086|520521119|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
144358954|NCT02153086|520521119|FG000|Overall Study|Other|2|||
144358955|NCT00446849|520521120|FG000|Acute Phase|Lack of Efficacy|64|||
144358956|NCT00446849|520521120|FG000|Acute Phase|Protocol Violation|10|||
144358957|NCT00446849|520521120|FG000|Acute Phase|Consent withdrawn|4|||
144358958|NCT00446849|520521120|FG000|Acute Phase|Lost to Follow-up|2|||
144358959|NCT00446849|520521120|FG000|Acute Phase|Physician Decision|1|||
144358960|NCT00446849|520521120|FG000|Acute Phase|noncompliance|1|||
144358961|NCT00446849|520521120|FG000|Maintenance Phase|Lack of Efficacy|40|||
144358962|NCT00446849|520521120|FG000|Maintenance Phase|Protocol Violation|7|||
144358963|NCT00446849|520521120|FG000|Maintenance Phase|Adverse Event|6|||
144358964|NCT00446849|520521120|FG000|Maintenance Phase|Consent withdrawn|5|||
144358965|NCT00446849|520521120|FG000|Maintenance Phase|Lost to Follow-up|3|||
144358966|NCT00446849|520521120|FG000|Maintenance Phase|Pregnancy|1|||
144358967|NCT00446849|520521120|FG000|Maintenance Phase|noncompliance|2|||
144358968|NCT00446849|520521120|FG000|Maintenance Phase|prohibited medication use|2|||
144358969|NCT00446849|520521120|FG000|Maintenance Phase|antibiotic use|1|||
144358970|NCT00446849|520521120|FG000|Maintenance Phase|study closure|1|||
144358971|NCT00446849|520521120|FG000|Maintenance Phase|hydrocodone use|1|||
144358972|NCT00446849|520521120|FG000|Maintenance Phase|concomitant medication use|1|||
144358973|NCT01194830|520521121|FG000|Overall Study|Adverse Event|3|||
144358974|NCT01194830|520521122|FG001|Overall Study|Adverse Event|2|||
144358975|NCT01194830|520521121|FG000|Overall Study|Protocol Violation|5|||
144358976|NCT01194830|520521122|FG001|Overall Study|Protocol Violation|4|||
144358977|NCT01194830|520521121|FG000|Overall Study|Lost to Follow-up|9|||
144358978|NCT01194830|520521122|FG001|Overall Study|Lost to Follow-up|7|||
144358979|NCT01194830|520521121|FG000|Overall Study|Withdrawal by Subject|2|||
144358980|NCT01194830|520521122|FG001|Overall Study|Withdrawal by Subject|1|||
144358981|NCT01194830|520521121|FG000|Overall Study|Lack of Efficacy|1|||
144358982|NCT01194830|520521122|FG001|Overall Study|Lack of Efficacy|1|||
144358983|NCT01194830|520521121|FG000|Overall Study|Non-compliance issues|4|||
144358984|NCT01194830|520521122|FG001|Overall Study|Non-compliance issues|4|||
144358985|NCT01194830|520521121|FG000|Overall Study|Other Reason|12|||
144358986|NCT01194830|520521122|FG001|Overall Study|Other Reason|8|||
144358987|NCT03115359|520521123|FG000|Overall Study|Withdrawal by Subject|29|||
144358988|NCT03115359|520521124|FG001|Overall Study|Withdrawal by Subject|39|||
144358989|NCT03115359|520521123|FG000|Overall Study|Scheduling conflict|25|||
144358990|NCT03115359|520521124|FG001|Overall Study|Scheduling conflict|23|||
144358991|NCT03115359|520521123|FG000|Overall Study|Personal reasons including health|12|||
144358992|NCT03115359|520521124|FG001|Overall Study|Personal reasons including health|9|||
144358993|NCT03115359|520521123|FG000|Overall Study|Transportation barriers|3|||
144358994|NCT03115359|520521124|FG001|Overall Study|Transportation barriers|0|||
144358995|NCT03115359|520521123|FG000|Overall Study|No longer interested|5|||
144358996|NCT03115359|520521124|FG001|Overall Study|No longer interested|4|||
144358997|NCT03115359|520521123|FG000|Overall Study|No reason provided|45|||
144358998|NCT03115359|520521124|FG001|Overall Study|No reason provided|47|||
144358999|NCT01317472|520521127|FG000|Overall Study|Withdrawal by Subject|1|||
144359000|NCT01317472|520521128|FG001|Overall Study|Withdrawal by Subject|0|||
144359001|NCT01317472|520521127|FG000|Overall Study|Unrelated hospitalization|1|||
144359002|NCT01317472|520521128|FG001|Overall Study|Unrelated hospitalization|0|||
144359003|NCT01815918|520521129|FG000|Overall Study|Patient samples not analyzable|3|||
144359004|NCT01815918|520521130|FG001|Overall Study|Patient samples not analyzable|4|||
144359005|NCT01815918|520521129|FG000|Overall Study|Lack of Efficacy|15|||
144359006|NCT01815918|520521130|FG001|Overall Study|Lack of Efficacy|15|||
144359007|NCT03284710|520521133|FG000|Overall Study|Withdrawal by Subject|1|||
144359008|NCT03284710|520521134|FG001|Overall Study|Withdrawal by Subject|0|||
144359009|NCT03284710|520521135|FG002|Overall Study|Withdrawal by Subject|1|||
144359010|NCT03284710|520521136|FG003|Overall Study|Withdrawal by Subject|6|||
144359011|NCT03284710|520521133|FG000|Overall Study|Lost to Follow-up|3|||
144359012|NCT03284710|520521134|FG001|Overall Study|Lost to Follow-up|3|||
144359013|NCT03284710|520521135|FG002|Overall Study|Lost to Follow-up|1|||
144359014|NCT03284710|520521136|FG003|Overall Study|Lost to Follow-up|0|||
144359015|NCT03284710|520521133|FG000|Overall Study|Physician Decision|1|||
144359016|NCT03284710|520521134|FG001|Overall Study|Physician Decision|0|||
144359017|NCT03284710|520521135|FG002|Overall Study|Physician Decision|0|||
144359018|NCT03284710|520521136|FG003|Overall Study|Physician Decision|0|||
144359019|NCT03284710|520521133|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
144359020|NCT03284710|520521134|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
144359021|NCT03284710|520521135|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
144359022|NCT03284710|520521136|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
144359023|NCT03284710|520521133|FG000|Overall Study|HIV Infection|0|||
144359024|NCT03284710|520521134|FG001|Overall Study|HIV Infection|2|||
144359025|NCT03284710|520521135|FG002|Overall Study|HIV Infection|2|||
144359026|NCT03284710|520521136|FG003|Overall Study|HIV Infection|1|||
144359027|NCT02412306|520521139|FG000|Overall Study|Lost to Follow-up|0|||
144359028|NCT02412306|520521140|FG001|Overall Study|Lost to Follow-up|1|||
144359029|NCT02412306|520521141|FG002|Overall Study|Lost to Follow-up|0|||
144359030|NCT02412306|520521142|FG003|Overall Study|Lost to Follow-up|0|||
144359031|NCT02412306|520521143|FG004|Overall Study|Lost to Follow-up|0|||
144359032|NCT02412306|520521139|FG000|Overall Study|Withdrawal by Subject|0|||
144359033|NCT02412306|520521140|FG001|Overall Study|Withdrawal by Subject|0|||
144359034|NCT02412306|520521141|FG002|Overall Study|Withdrawal by Subject|1|||
144359035|NCT02412306|520521142|FG003|Overall Study|Withdrawal by Subject|0|||
144359036|NCT02412306|520521143|FG004|Overall Study|Withdrawal by Subject|0|||
144359037|NCT02412306|520521139|FG000|Overall Study|Death|5|||
144359038|NCT02412306|520521140|FG001|Overall Study|Death|7|||
144359039|NCT02412306|520521141|FG002|Overall Study|Death|15|||
144359040|NCT02412306|520521142|FG003|Overall Study|Death|0|||
144359041|NCT02412306|520521143|FG004|Overall Study|Death|2|||
144359042|NCT03760029|520521156|FG000|Overall Study|Death|1|||
144359043|NCT03760029|520521157|FG001|Overall Study|Death|0|||
144359044|NCT03760029|520521158|FG002|Overall Study|Death|0|||
144359045|NCT03760029|520521156|FG000|Overall Study|Lost to Follow-up|0|||
144359046|NCT03760029|520521157|FG001|Overall Study|Lost to Follow-up|2|||
144359047|NCT03760029|520521158|FG002|Overall Study|Lost to Follow-up|1|||
144359048|NCT03760029|520521156|FG000|Overall Study|Withdrawal by Subject|1|||
144359049|NCT03760029|520521157|FG001|Overall Study|Withdrawal by Subject|4|||
144359050|NCT03760029|520521158|FG002|Overall Study|Withdrawal by Subject|1|||
144359051|NCT03760029|520521156|FG000|Overall Study|Withdrawal by parent/guardian|4|||
144359052|NCT03760029|520521157|FG001|Overall Study|Withdrawal by parent/guardian|4|||
144359053|NCT03760029|520521158|FG002|Overall Study|Withdrawal by parent/guardian|1|||
144359054|NCT03760029|520521156|FG000|Overall Study|Other|2|||
144359055|NCT03760029|520521157|FG001|Overall Study|Other|1|||
144359056|NCT03760029|520521158|FG002|Overall Study|Other|0|||
144359057|NCT03532542|520521164|FG000|Overall Study|Death|1|||
144359058|NCT03532542|520521165|FG001|Overall Study|Death|0|||
144359059|NCT03532542|520521164|FG000|Overall Study|Study Terminated by Sponsor|41|||
144359060|NCT03532542|520521165|FG001|Overall Study|Study Terminated by Sponsor|65|||
144359061|NCT03532542|520521164|FG000|Overall Study|Withdrawal by Subject|6|||
144359062|NCT03532542|520521165|FG001|Overall Study|Withdrawal by Subject|5|||
144359063|NCT00436332|520521166|FG000|Overall Study|Adverse Event|9|||
144359064|NCT00436332|520521166|FG000|Overall Study|Withdrawal by Subject|2|||
144359065|NCT00436332|520521166|FG000|Overall Study|Progression|59|||
144359066|NCT00436332|520521166|FG000|Overall Study|Death|2|||
144359067|NCT00436332|520521166|FG000|Overall Study|Not Protocol Specified|6|||
144359068|NCT00436332|520521166|FG000|Overall Study|Ineligible|2|||
144359069|NCT00436332|520521166|FG000|Overall Study|Never Received Treatment|3|||
144359070|NCT01924845|520521167|FG000|Overall Study|Adverse Event|3|||
144359071|NCT01924845|520521167|FG000|Overall Study|Withdrawal by Subject|2|||
144359072|NCT01924845|520521167|FG000|Overall Study|Protocol Violation|1|||
144359073|NCT00062439|520521168|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
144359074|NCT00062439|520521168|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
144359075|NCT00062439|520521168|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
144359076|NCT00062439|520521168|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
144359077|NCT00062439|520521168|FG000|Post Chemoradiation Assessment|Death|1|||
144359078|NCT00062439|520521168|FG000|Post Chemoradiation Assessment|Disease progression|2|||
144359079|NCT00062439|520521168|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
144359080|NCT00062439|520521168|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
144359081|NCT00062439|520521168|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
144359082|NCT00062439|520521168|FG000|Surgery|Physician Decision|4|||
144359083|NCT00062439|520521168|FG000|Surgery|Death|1|||
144359084|NCT00062439|520521168|FG000|Surgery|Adverse Event|2|||
144359085|NCT00062439|520521168|FG000|Consolidation Chemotherapy|Adverse Event|2|||
144359086|NCT04698343|520521169|FG000|Overall Study|Withdrawal by Subject|6|||
144359087|NCT04698343|520521169|FG000|Overall Study|Physician Decision|2|||
144359088|NCT04698343|520521169|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
144359089|NCT04698343|520521169|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
144359090|NCT04698343|520521169|FG000|Overall Study|Personal reasons|3|||
144359091|NCT04698343|520521169|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
144359092|NCT00286442|520521170|FG000|Overall Study|Hyperglycemic Rescue|19|||
144359093|NCT00286442|520521171|FG001|Overall Study|Hyperglycemic Rescue|17|||
144359094|NCT00286442|520521172|FG002|Overall Study|Hyperglycemic Rescue|25|||
144359095|NCT00286442|520521170|FG000|Overall Study|Adverse Event|7|||
144359096|NCT00286442|520521171|FG001|Overall Study|Adverse Event|6|||
144359097|NCT00286442|520521172|FG002|Overall Study|Adverse Event|1|||
144359098|NCT00286442|520521170|FG000|Overall Study|Protocol Violation|2|||
144359099|NCT00286442|520521171|FG001|Overall Study|Protocol Violation|4|||
144359100|NCT00286442|520521172|FG002|Overall Study|Protocol Violation|2|||
144359101|NCT00286442|520521170|FG000|Overall Study|Lost to Follow-up|5|||
144359102|NCT00286442|520521171|FG001|Overall Study|Lost to Follow-up|2|||
144359103|NCT00286442|520521172|FG002|Overall Study|Lost to Follow-up|1|||
144359104|NCT00286442|520521170|FG000|Overall Study|Physician Decision|1|||
144359105|NCT00286442|520521171|FG001|Overall Study|Physician Decision|1|||
144359106|NCT00286442|520521172|FG002|Overall Study|Physician Decision|1|||
144359107|NCT00286442|520521170|FG000|Overall Study|Administrative Error|1|||
144359108|NCT00286442|520521171|FG001|Overall Study|Administrative Error|1|||
144359109|NCT00286442|520521172|FG002|Overall Study|Administrative Error|0|||
144359110|NCT00286442|520521170|FG000|Overall Study|Withdrawal by Subject|2|||
144359111|NCT00286442|520521171|FG001|Overall Study|Withdrawal by Subject|14|||
144359112|NCT00286442|520521172|FG002|Overall Study|Withdrawal by Subject|2|||
144359113|NCT02756338|520521173|FG000|Overall Study|Withdrawn by Investigator|1|||
144359114|NCT02756338|520521173|FG000|Overall Study|Device Replaced with Pacemaker|4|||
144359115|NCT01339689|520521176|FG000|Overall Study|Adverse Event|1|||
144359116|NCT01339689|520521177|FG001|Overall Study|Adverse Event|2|||
144359117|NCT01339689|520521176|FG000|Overall Study|Lost to Follow-up|9|||
144359118|NCT01339689|520521177|FG001|Overall Study|Lost to Follow-up|3|||
144359119|NCT01339689|520521176|FG000|Overall Study|Withdrawal by Subject|3|||
144359120|NCT01339689|520521177|FG001|Overall Study|Withdrawal by Subject|0|||
144359121|NCT01339689|520521176|FG000|Overall Study|Noncompliance|1|||
144359122|NCT01339689|520521177|FG001|Overall Study|Noncompliance|0|||
144359123|NCT01339689|520521176|FG000|Overall Study|Relocated out of area|0|||
144359124|NCT01339689|520521177|FG001|Overall Study|Relocated out of area|1|||
144359125|NCT01339689|520521176|FG000|Overall Study|Other|2|||
144359126|NCT01339689|520521177|FG001|Overall Study|Other|2|||
144359127|NCT01339689|520521176|FG000|Overall Study|multiple reasons|1|||
144359128|NCT01339689|520521177|FG001|Overall Study|multiple reasons|1|||
144359129|NCT02678351|520521178|FG000|Overall Study|Withdrawal by Subject|1|||
144359130|NCT01632020|520521179|FG000|Overall Study|Withdrawal by Subject|1|||
144359131|NCT01632020|520521180|FG001|Overall Study|Withdrawal by Subject|0|||
144359132|NCT01632020|520521179|FG000|Overall Study|Adverse Event|1|||
144359133|NCT01632020|520521180|FG001|Overall Study|Adverse Event|0|||
144359134|NCT02051764|520521181|FG000|Overall Study|Study terminated by sponsor|0|||
144359135|NCT02051764|520521182|FG001|Overall Study|Study terminated by sponsor|7|||
144359136|NCT00591006|520521183|FG000|Overall Study|Withdrawal by Subject|0|||
144359137|NCT00591006|520521184|FG001|Overall Study|Withdrawal by Subject|0|||
144359138|NCT00591006|520521185|FG002|Overall Study|Withdrawal by Subject|0|||
144359139|NCT00591006|520521186|FG003|Overall Study|Withdrawal by Subject|0|||
144359140|NCT00591006|520521187|FG004|Overall Study|Withdrawal by Subject|0|||
144359141|NCT00591006|520521188|FG005|Overall Study|Withdrawal by Subject|0|||
144359142|NCT00591006|520521189|FG006|Overall Study|Withdrawal by Subject|0|||
144359143|NCT00591006|520521190|FG007|Overall Study|Withdrawal by Subject|0|||
144359144|NCT00591006|520521191|FG008|Overall Study|Withdrawal by Subject|0|||
144359145|NCT00591006|520521192|FG009|Overall Study|Withdrawal by Subject|0|||
144359146|NCT00591006|520521193|FG010|Overall Study|Withdrawal by Subject|0|||
144359147|NCT00591006|520521194|FG011|Overall Study|Withdrawal by Subject|0|||
144359148|NCT00591006|520521195|FG012|Overall Study|Withdrawal by Subject|0|||
144359149|NCT00591006|520521196|FG013|Overall Study|Withdrawal by Subject|0|||
144359150|NCT00591006|520521197|FG014|Overall Study|Withdrawal by Subject|0|||
144359151|NCT00591006|520521198|FG015|Overall Study|Withdrawal by Subject|1|||
144359152|NCT00591006|520521199|FG016|Overall Study|Withdrawal by Subject|0|||
144359153|NCT00591006|520521200|FG017|Overall Study|Withdrawal by Subject|0|||
144359154|NCT00591006|520521201|FG018|Overall Study|Withdrawal by Subject|0|||
144359155|NCT00591006|520521202|FG019|Overall Study|Withdrawal by Subject|0|||
144359156|NCT00591006|520521203|FG020|Overall Study|Withdrawal by Subject|0|||
144359157|NCT00591006|520521204|FG021|Overall Study|Withdrawal by Subject|0|||
144359158|NCT00591006|520521205|FG022|Overall Study|Withdrawal by Subject|0|||
144359159|NCT00591006|520521206|FG023|Overall Study|Withdrawal by Subject|1|||
144359160|NCT00591006|520521183|FG000|Overall Study|Adverse Event|0|||
144359161|NCT00591006|520521184|FG001|Overall Study|Adverse Event|0|||
144359162|NCT00591006|520521185|FG002|Overall Study|Adverse Event|0|||
144359163|NCT00591006|520521186|FG003|Overall Study|Adverse Event|0|||
144359164|NCT00591006|520521187|FG004|Overall Study|Adverse Event|0|||
144359165|NCT00591006|520521188|FG005|Overall Study|Adverse Event|0|||
144359166|NCT00591006|520521189|FG006|Overall Study|Adverse Event|0|||
144359167|NCT00591006|520521190|FG007|Overall Study|Adverse Event|0|||
144359168|NCT00591006|520521191|FG008|Overall Study|Adverse Event|0|||
144359169|NCT00591006|520521192|FG009|Overall Study|Adverse Event|0|||
144359170|NCT00591006|520521193|FG010|Overall Study|Adverse Event|0|||
144359171|NCT00591006|520521194|FG011|Overall Study|Adverse Event|0|||
144359172|NCT00591006|520521195|FG012|Overall Study|Adverse Event|0|||
144359173|NCT00591006|520521196|FG013|Overall Study|Adverse Event|0|||
144359174|NCT00591006|520521197|FG014|Overall Study|Adverse Event|0|||
144359175|NCT00591006|520521198|FG015|Overall Study|Adverse Event|0|||
144359176|NCT00591006|520521199|FG016|Overall Study|Adverse Event|0|||
144359177|NCT00591006|520521200|FG017|Overall Study|Adverse Event|0|||
144359178|NCT00591006|520521201|FG018|Overall Study|Adverse Event|0|||
144359179|NCT00591006|520521202|FG019|Overall Study|Adverse Event|0|||
144359180|NCT00591006|520521203|FG020|Overall Study|Adverse Event|0|||
144359181|NCT00591006|520521204|FG021|Overall Study|Adverse Event|0|||
144359182|NCT00591006|520521205|FG022|Overall Study|Adverse Event|1|||
144359183|NCT00591006|520521206|FG023|Overall Study|Adverse Event|0|||
144359184|NCT03473236|520521214|FG000|Overall Study|Withdrawal by Subject|0|||
144359185|NCT03473236|520521215|FG001|Overall Study|Withdrawal by Subject|0|||
144359186|NCT03473236|520521216|FG002|Overall Study|Withdrawal by Subject|0|||
144359187|NCT03473236|520521217|FG003|Overall Study|Withdrawal by Subject|0|||
144359188|NCT03473236|520521218|FG004|Overall Study|Withdrawal by Subject|0|||
144359189|NCT03473236|520521219|FG005|Overall Study|Withdrawal by Subject|1|||
144359190|NCT03473236|520521220|FG006|Overall Study|Withdrawal by Subject|0|||
144359191|NCT03473236|520521221|FG007|Overall Study|Withdrawal by Subject|0|||
144359192|NCT03473236|520521222|FG008|Overall Study|Withdrawal by Subject|1|||
144359193|NCT03473236|520521223|FG009|Overall Study|Withdrawal by Subject|0|||
144359194|NCT03155724|520521225|FG000|Overall Study|Death|3|||
144359195|NCT03155724|520521225|FG000|Overall Study|Physician Decision|1|||
144359196|NCT03155724|520521225|FG000|Overall Study|Study closure|7|||
144359197|NCT00525512|520521235|FG000|Double-Blind Phase|Adverse Event|48|||
144359198|NCT00525512|520521236|FG001|Double-Blind Phase|Adverse Event|28|||
144359199|NCT00525512|520521237|FG002|Double-Blind Phase|Adverse Event|0|||
144359200|NCT00525512|520521238|FG003|Double-Blind Phase|Adverse Event|0|||
144359201|NCT00525512|520521235|FG000|Double-Blind Phase|Protocol Violation|3|||
144359202|NCT00525512|520521236|FG001|Double-Blind Phase|Protocol Violation|1|||
144359203|NCT00525512|520521237|FG002|Double-Blind Phase|Protocol Violation|0|||
144359204|NCT00525512|520521238|FG003|Double-Blind Phase|Protocol Violation|0|||
144359205|NCT00525512|520521235|FG000|Double-Blind Phase|Lost to Follow-up|3|||
144359206|NCT00525512|520521236|FG001|Double-Blind Phase|Lost to Follow-up|7|||
144359207|NCT00525512|520521237|FG002|Double-Blind Phase|Lost to Follow-up|0|||
144359208|NCT00525512|520521238|FG003|Double-Blind Phase|Lost to Follow-up|0|||
144359209|NCT00525512|520521235|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
144359210|NCT00525512|520521236|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
144359211|NCT00525512|520521237|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
144359212|NCT00525512|520521238|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
144359213|NCT00525512|520521235|FG000|Double-Blind Phase|Lack of Efficacy|13|||
144359214|NCT00525512|520521236|FG001|Double-Blind Phase|Lack of Efficacy|5|||
144359215|NCT00525512|520521237|FG002|Double-Blind Phase|Lack of Efficacy|0|||
144359216|NCT00525512|520521238|FG003|Double-Blind Phase|Lack of Efficacy|0|||
144359217|NCT00525512|520521235|FG000|Double-Blind Phase|Other reason (not specified)|12|||
144359218|NCT00525512|520521236|FG001|Double-Blind Phase|Other reason (not specified)|13|||
144359219|NCT00525512|520521237|FG002|Double-Blind Phase|Other reason (not specified)|0|||
144359220|NCT00525512|520521238|FG003|Double-Blind Phase|Other reason (not specified)|0|||
144359221|NCT00525512|520521235|FG000|Open-Label Phase|Adverse Event|0|||
144359222|NCT00525512|520521236|FG001|Open-Label Phase|Adverse Event|0|||
144359223|NCT00525512|520521237|FG002|Open-Label Phase|Adverse Event|1|||
144359224|NCT00525512|520521238|FG003|Open-Label Phase|Adverse Event|0|||
144359225|NCT00525512|520521235|FG000|Open-Label Phase|Lost to Follow-up|0|||
144359226|NCT00525512|520521236|FG001|Open-Label Phase|Lost to Follow-up|0|||
144359227|NCT00525512|520521237|FG002|Open-Label Phase|Lost to Follow-up|1|||
144359228|NCT00525512|520521238|FG003|Open-Label Phase|Lost to Follow-up|0|||
144359229|NCT00525512|520521235|FG000|Open-Label Phase|Other reason (not specified)|0|||
144359230|NCT00525512|520521236|FG001|Open-Label Phase|Other reason (not specified)|0|||
144359231|NCT00525512|520521237|FG002|Open-Label Phase|Other reason (not specified)|4|||
144359232|NCT00525512|520521238|FG003|Open-Label Phase|Other reason (not specified)|5|||
144359233|NCT02370420|520521239|FG000|Overall Study|Physician Decision|3|||
144359234|NCT02370420|520521240|FG001|Overall Study|Physician Decision|3|||
144359235|NCT02370420|520521239|FG000|Overall Study|Lost to Follow-up|11|||
144359236|NCT02370420|520521240|FG001|Overall Study|Lost to Follow-up|9|||
144359237|NCT00880620|520521241|FG000|Overall Study|Adverse Event|4|||
144359238|NCT00880620|520521242|FG001|Overall Study|Adverse Event|5|||
144359239|NCT00880620|520521243|FG002|Overall Study|Adverse Event|15|||
144359240|NCT00880620|520521244|FG003|Overall Study|Adverse Event|15|||
144359241|NCT00880620|520521241|FG000|Overall Study|Death|0|||
144359242|NCT00880620|520521242|FG001|Overall Study|Death|0|||
144359243|NCT00880620|520521243|FG002|Overall Study|Death|1|||
144359244|NCT00880620|520521244|FG003|Overall Study|Death|0|||
144359245|NCT00880620|520521241|FG000|Overall Study|Lack of Efficacy|12|||
144359246|NCT00880620|520521242|FG001|Overall Study|Lack of Efficacy|4|||
144359247|NCT00880620|520521243|FG002|Overall Study|Lack of Efficacy|0|||
144359248|NCT00880620|520521244|FG003|Overall Study|Lack of Efficacy|1|||
144359249|NCT00880620|520521241|FG000|Overall Study|Lost to Follow-up|0|||
144359250|NCT00880620|520521242|FG001|Overall Study|Lost to Follow-up|1|||
144359251|NCT00880620|520521243|FG002|Overall Study|Lost to Follow-up|1|||
144359252|NCT00880620|520521244|FG003|Overall Study|Lost to Follow-up|0|||
144359253|NCT00880620|520521241|FG000|Overall Study|Protocol Violation|0|||
144359254|NCT00880620|520521242|FG001|Overall Study|Protocol Violation|1|||
144359255|NCT00880620|520521243|FG002|Overall Study|Protocol Violation|0|||
144359256|NCT00880620|520521244|FG003|Overall Study|Protocol Violation|2|||
144359257|NCT00880620|520521241|FG000|Overall Study|Withdrawal by Subject|4|||
144359258|NCT00880620|520521242|FG001|Overall Study|Withdrawal by Subject|3|||
144359259|NCT00880620|520521243|FG002|Overall Study|Withdrawal by Subject|1|||
144359260|NCT00880620|520521244|FG003|Overall Study|Withdrawal by Subject|3|||
144359261|NCT00880620|520521241|FG000|Overall Study|Noncompliance|0|||
144359262|NCT00880620|520521242|FG001|Overall Study|Noncompliance|0|||
144359263|NCT00880620|520521243|FG002|Overall Study|Noncompliance|1|||
144359264|NCT00880620|520521244|FG003|Overall Study|Noncompliance|1|||
144359265|NCT00880620|520521241|FG000|Overall Study|Other|1|||
144359266|NCT00880620|520521242|FG001|Overall Study|Other|1|||
144359267|NCT00880620|520521243|FG002|Overall Study|Other|2|||
144359268|NCT00880620|520521244|FG003|Overall Study|Other|2|||
144359269|NCT05893862|520521245|FG000|Overall Study|Physician Decision|0|||
144359270|NCT05893862|520521246|FG001|Overall Study|Physician Decision|1|||
144359271|NCT05893862|520521247|FG002|Overall Study|Physician Decision|0|||
144359272|NCT05893862|520521248|FG003|Overall Study|Physician Decision|0|||
144359273|NCT05893862|520521249|FG004|Overall Study|Physician Decision|1|||
144359274|NCT05893862|520521250|FG005|Overall Study|Physician Decision|0|||
144359275|NCT05893862|520521245|FG000|Overall Study|Withdrawal by Subject|1|||
144359276|NCT05893862|520521246|FG001|Overall Study|Withdrawal by Subject|7|||
144359277|NCT05893862|520521247|FG002|Overall Study|Withdrawal by Subject|1|||
144359278|NCT05893862|520521248|FG003|Overall Study|Withdrawal by Subject|3|||
144359279|NCT05893862|520521249|FG004|Overall Study|Withdrawal by Subject|3|||
144359280|NCT05893862|520521250|FG005|Overall Study|Withdrawal by Subject|2|||
144359281|NCT05893862|520521245|FG000|Overall Study|Adverse Event|1|||
144359282|NCT05893862|520521246|FG001|Overall Study|Adverse Event|4|||
144359283|NCT05893862|520521247|FG002|Overall Study|Adverse Event|2|||
144359284|NCT05893862|520521248|FG003|Overall Study|Adverse Event|2|||
144359285|NCT05893862|520521249|FG004|Overall Study|Adverse Event|1|||
144359286|NCT05893862|520521250|FG005|Overall Study|Adverse Event|0|||
144359287|NCT01400698|520521251|FG000|Overall Study|Lost to Follow-up|2|||
144359288|NCT01400698|520521252|FG001|Overall Study|Lost to Follow-up|5|||
144359289|NCT01400698|520521253|FG002|Overall Study|Lost to Follow-up|2|||
144359290|NCT01400698|520521254|FG003|Overall Study|Lost to Follow-up|1|||
144359291|NCT01400698|520521255|FG004|Overall Study|Lost to Follow-up|4|||
144359292|NCT01400698|520521256|FG005|Overall Study|Lost to Follow-up|3|||
144359293|NCT01400698|520521251|FG000|Overall Study|Withdrawal by Subject|8|||
144359294|NCT01400698|520521252|FG001|Overall Study|Withdrawal by Subject|2|||
144359295|NCT01400698|520521253|FG002|Overall Study|Withdrawal by Subject|0|||
144359296|NCT01400698|520521254|FG003|Overall Study|Withdrawal by Subject|4|||
144359297|NCT01400698|520521255|FG004|Overall Study|Withdrawal by Subject|1|||
144359298|NCT01400698|520521256|FG005|Overall Study|Withdrawal by Subject|3|||
144359299|NCT01400698|520521251|FG000|Overall Study|Protocol Violation|0|||
144359300|NCT01400698|520521252|FG001|Overall Study|Protocol Violation|1|||
144359301|NCT01400698|520521253|FG002|Overall Study|Protocol Violation|0|||
144359302|NCT01400698|520521254|FG003|Overall Study|Protocol Violation|0|||
144359303|NCT01400698|520521255|FG004|Overall Study|Protocol Violation|1|||
144359304|NCT01400698|520521256|FG005|Overall Study|Protocol Violation|0|||
144359305|NCT01400698|520521251|FG000|Overall Study|Non-compliance|0|||
144359306|NCT01400698|520521252|FG001|Overall Study|Non-compliance|1|||
144359307|NCT01400698|520521253|FG002|Overall Study|Non-compliance|0|||
144359308|NCT01400698|520521254|FG003|Overall Study|Non-compliance|1|||
144359309|NCT01400698|520521255|FG004|Overall Study|Non-compliance|0|||
144359310|NCT01400698|520521256|FG005|Overall Study|Non-compliance|0|||
144359311|NCT01400698|520521251|FG000|Overall Study|Adverse Event|1|||
144359312|NCT01400698|520521252|FG001|Overall Study|Adverse Event|0|||
144359313|NCT01400698|520521253|FG002|Overall Study|Adverse Event|0|||
144359314|NCT01400698|520521254|FG003|Overall Study|Adverse Event|0|||
144359315|NCT01400698|520521255|FG004|Overall Study|Adverse Event|0|||
144359316|NCT01400698|520521256|FG005|Overall Study|Adverse Event|0|||
144359317|NCT01400698|520521251|FG000|Overall Study|Other|4|||
144359318|NCT01400698|520521252|FG001|Overall Study|Other|2|||
144359319|NCT01400698|520521253|FG002|Overall Study|Other|0|||
144359320|NCT01400698|520521254|FG003|Overall Study|Other|2|||
144359321|NCT01400698|520521255|FG004|Overall Study|Other|1|||
144359322|NCT01400698|520521256|FG005|Overall Study|Other|0|||
144359323|NCT02919761|520521257|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
144359324|NCT02919761|520521258|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
144359325|NCT02919761|520521259|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
144359326|NCT02919761|520521257|FG000|Part 1: Open Label|Adverse Event|1|||
144359327|NCT02919761|520521258|FG001|Part 1: Open Label|Adverse Event|0|||
144359328|NCT02919761|520521259|FG002|Part 1: Open Label|Adverse Event|0|||
144359329|NCT02919761|520521257|FG000|Part 1: Open Label|Lost to Follow-up|1|||
144359330|NCT02919761|520521258|FG001|Part 1: Open Label|Lost to Follow-up|0|||
144359331|NCT02919761|520521259|FG002|Part 1: Open Label|Lost to Follow-up|0|||
144359332|NCT02919761|520521257|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
144359333|NCT02919761|520521258|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
144359334|NCT02919761|520521259|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
144359335|NCT02919761|520521257|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
144359336|NCT02919761|520521258|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
144359337|NCT02919761|520521259|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
144359338|NCT02919761|520521257|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
144359339|NCT02919761|520521258|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
144359340|NCT02919761|520521259|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
144359341|NCT02919761|520521257|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
144359342|NCT02919761|520521258|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
144359343|NCT02919761|520521259|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
144359344|NCT02919761|520521257|FG000|Part 1: Open Label|Termination by Sponsor|1|||
144359345|NCT02919761|520521258|FG001|Part 1: Open Label|Termination by Sponsor|0|||
144359346|NCT02919761|520521259|FG002|Part 1: Open Label|Termination by Sponsor|0|||
144359347|NCT02919761|520521257|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
144359348|NCT02919761|520521258|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
144359349|NCT02919761|520521259|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
144359350|NCT02919761|520521257|FG000|Part 2: Double-blind|Adverse Event|0|||
144359351|NCT02919761|520521258|FG001|Part 2: Double-blind|Adverse Event|1|||
144359352|NCT02919761|520521259|FG002|Part 2: Double-blind|Adverse Event|0|||
144359353|NCT02919761|520521257|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
144359354|NCT02919761|520521258|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
144359355|NCT02919761|520521259|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
144359356|NCT02919761|520521257|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
144359357|NCT02919761|520521258|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
144359358|NCT02919761|520521259|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
144359359|NCT02919761|520521257|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
144359360|NCT02919761|520521258|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
144359361|NCT02919761|520521259|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
144359362|NCT02919761|520521257|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
144359363|NCT02919761|520521258|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
144359364|NCT02919761|520521259|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
144359365|NCT02919761|520521257|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
144359366|NCT02919761|520521258|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
144359367|NCT02919761|520521259|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
144359368|NCT02919761|520521257|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
144359369|NCT02919761|520521258|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
144359370|NCT02919761|520521259|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
144359371|NCT05543265|520522702|FG000|Overall Study|Lost to Follow-up|3|||
144359372|NCT05543265|520522703|FG001|Overall Study|Lost to Follow-up|3|||
144359373|NCT05543265|520522702|FG000|Overall Study|Withdrawal by Subject|0|||
144359374|NCT05543265|520522703|FG001|Overall Study|Withdrawal by Subject|1|||
144359375|NCT05316597|520522704|FG000|First Session|Withdrawal by Subject|0|||
144359376|NCT05316597|520522705|FG001|First Session|Withdrawal by Subject|1|||
144359377|NCT05316597|520522704|FG000|Washout Period|Lost to Follow-up|1|||
144359378|NCT05316597|520522705|FG001|Washout Period|Lost to Follow-up|2|||
144359379|NCT05316597|520522704|FG000|Washout Period|Physician Decision|1|||
144359380|NCT05316597|520522705|FG001|Washout Period|Physician Decision|1|||
144359381|NCT05316597|520522704|FG000|Washout Period|Excluded before second session|1|||
144359382|NCT05316597|520522705|FG001|Washout Period|Excluded before second session|1|||
144359383|NCT05316597|520522704|FG000|Washout Period|Withdrawal by Subject|0|||
144359384|NCT05316597|520522705|FG001|Washout Period|Withdrawal by Subject|4|||
144359385|NCT04750824|520522709|FG000|Overall Study|Toxicity/intolerability|3|||
144359386|NCT04750824|520522710|FG001|Overall Study|Toxicity/intolerability|1|||
144359387|NCT04750824|520522709|FG000|Overall Study|Death|1|||
144359388|NCT04750824|520522710|FG001|Overall Study|Death|3|||
144359389|NCT04750824|520522709|FG000|Overall Study|Scheduled duration of therapy complete|1|||
144359390|NCT04750824|520522710|FG001|Overall Study|Scheduled duration of therapy complete|9|||
144359391|NCT04750824|520522709|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
144359392|NCT04750824|520522710|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
144359393|NCT00807911|520522711|FG000|Overall Study|Withdrawal by Subject|12|||
144359394|NCT00807911|520522712|FG001|Overall Study|Withdrawal by Subject|10|||
144359395|NCT00807911|520522711|FG000|Overall Study|Ineligible|0|||
144359396|NCT00807911|520522712|FG001|Overall Study|Ineligible|4|||
144359397|NCT03547518|520522720|FG000|Overall Study|Lost to Follow-up|2|||
144359398|NCT03547518|520522721|FG001|Overall Study|Lost to Follow-up|0|||
144359399|NCT02953652|520522725|FG000|Overall Study|Adverse Event|18|||
144359400|NCT02953652|520522725|FG000|Overall Study|Withdrawal by Subject|6|||
144359401|NCT02953652|520522725|FG000|Overall Study|Protocol Violation|1|||
144359402|NCT02953652|520522725|FG000|Overall Study|Disease Progression|27|||
144359403|NCT03192176|520522727|FG000|Overall Study|Adverse Event|1|||
144359404|NCT03192176|520522728|FG001|Overall Study|Adverse Event|0|||
144359405|NCT03192176|520522729|FG002|Overall Study|Adverse Event|4|||
144359406|NCT03192176|520522730|FG003|Overall Study|Adverse Event|5|||
144359407|NCT03192176|520522731|FG004|Overall Study|Adverse Event|3|||
144359408|NCT03192176|520522732|FG005|Overall Study|Adverse Event|2|||
144359409|NCT03192176|520522733|FG006|Overall Study|Adverse Event|3|||
144359410|NCT03192176|520522734|FG007|Overall Study|Adverse Event|3|||
144359411|NCT03192176|520522727|FG000|Overall Study|Lost to Follow-up|0|||
144359412|NCT03192176|520522728|FG001|Overall Study|Lost to Follow-up|0|||
144359413|NCT03192176|520522729|FG002|Overall Study|Lost to Follow-up|1|||
144359414|NCT03192176|520522730|FG003|Overall Study|Lost to Follow-up|2|||
144359415|NCT03192176|520522731|FG004|Overall Study|Lost to Follow-up|3|||
144359416|NCT03192176|520522732|FG005|Overall Study|Lost to Follow-up|1|||
144359417|NCT03192176|520522733|FG006|Overall Study|Lost to Follow-up|1|||
144359418|NCT03192176|520522734|FG007|Overall Study|Lost to Follow-up|1|||
144359419|NCT03192176|520522727|FG000|Overall Study|Physician Decision|1|||
144359420|NCT03192176|520522728|FG001|Overall Study|Physician Decision|0|||
144359421|NCT03192176|520522729|FG002|Overall Study|Physician Decision|0|||
144359422|NCT03192176|520522730|FG003|Overall Study|Physician Decision|0|||
144359423|NCT03192176|520522731|FG004|Overall Study|Physician Decision|0|||
144359424|NCT03192176|520522732|FG005|Overall Study|Physician Decision|2|||
144359425|NCT03192176|520522733|FG006|Overall Study|Physician Decision|1|||
144359426|NCT03192176|520522734|FG007|Overall Study|Physician Decision|0|||
144359427|NCT03192176|520522727|FG000|Overall Study|Protocol Deviation|1|||
144359428|NCT03192176|520522728|FG001|Overall Study|Protocol Deviation|1|||
144359429|NCT03192176|520522729|FG002|Overall Study|Protocol Deviation|0|||
144359430|NCT03192176|520522730|FG003|Overall Study|Protocol Deviation|0|||
144359431|NCT03192176|520522731|FG004|Overall Study|Protocol Deviation|2|||
144359432|NCT03192176|520522732|FG005|Overall Study|Protocol Deviation|0|||
144359433|NCT03192176|520522733|FG006|Overall Study|Protocol Deviation|0|||
144359434|NCT03192176|520522734|FG007|Overall Study|Protocol Deviation|0|||
144359435|NCT03192176|520522727|FG000|Overall Study|Withdrawal by Subject|3|||
144359436|NCT03192176|520522728|FG001|Overall Study|Withdrawal by Subject|4|||
144359437|NCT03192176|520522729|FG002|Overall Study|Withdrawal by Subject|0|||
144359438|NCT03192176|520522730|FG003|Overall Study|Withdrawal by Subject|4|||
144359439|NCT03192176|520522731|FG004|Overall Study|Withdrawal by Subject|3|||
144359440|NCT03192176|520522732|FG005|Overall Study|Withdrawal by Subject|4|||
144359441|NCT03192176|520522733|FG006|Overall Study|Withdrawal by Subject|4|||
144359442|NCT03192176|520522734|FG007|Overall Study|Withdrawal by Subject|2|||
144359443|NCT03192176|520522727|FG000|Overall Study|Miscellaneous|1|||
144359444|NCT03192176|520522728|FG001|Overall Study|Miscellaneous|0|||
144359445|NCT03192176|520522729|FG002|Overall Study|Miscellaneous|1|||
144359446|NCT03192176|520522730|FG003|Overall Study|Miscellaneous|1|||
144359447|NCT03192176|520522731|FG004|Overall Study|Miscellaneous|1|||
144359448|NCT03192176|520522732|FG005|Overall Study|Miscellaneous|2|||
144359449|NCT03192176|520522733|FG006|Overall Study|Miscellaneous|0|||
144359450|NCT03192176|520522734|FG007|Overall Study|Miscellaneous|1|||
144359451|NCT02384551|520522737|FG000|Overall Study|Lost to Follow-up|13|||
144359452|NCT02384551|520522738|FG001|Overall Study|Lost to Follow-up|14|||
144359453|NCT02384551|520522739|FG002|Overall Study|Lost to Follow-up|14|||
144359454|NCT02384551|520522740|FG003|Overall Study|Lost to Follow-up|14|||
144359455|NCT04349891|520522741|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
144359456|NCT04349891|520522742|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
144359457|NCT04349891|520522741|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
144359458|NCT04349891|520522742|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
144359459|NCT04349891|520522741|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
144359460|NCT04349891|520522742|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
144359461|NCT04349891|520522741|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
144359462|NCT04349891|520522742|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
144359463|NCT02927301|520522747|FG000|Overall Study|Death|39|||
144359464|NCT02927301|520522747|FG000|Overall Study|Lost to Follow-up|8|||
144359465|NCT02927301|520522747|FG000|Overall Study|Physician Decision|2|||
144359466|NCT02927301|520522747|FG000|Overall Study|Withdrawal by Subject|12|||
144359467|NCT02927301|520522747|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
144359468|NCT04247347|520522750|FG000|Overall Study|Withdrawal by Subject|2|||
144359469|NCT04247347|520522751|FG001|Overall Study|Withdrawal by Subject|3|||
144359470|NCT04247347|520522752|FG002|Overall Study|Withdrawal by Subject|3|||
144359471|NCT04247347|520522750|FG000|Overall Study|Lost to Follow-up|1|||
144359472|NCT04247347|520522751|FG001|Overall Study|Lost to Follow-up|1|||
144359473|NCT04247347|520522752|FG002|Overall Study|Lost to Follow-up|1|||
144359474|NCT03035032|520522753|FG000|Overall Study|Adverse Event|2|||
144359475|NCT03035032|520522753|FG000|Overall Study|Death|9|||
144359476|NCT03035032|520522753|FG000|Overall Study|Lost to Follow-up|1|||
144359477|NCT03035032|520522753|FG000|Overall Study|Progressive Disease|22|||
144359478|NCT03035032|520522753|FG000|Overall Study|Protocol Violation|2|||
144359479|NCT03035032|520522753|FG000|Overall Study|Withdrawal by Subject|2|||
144359480|NCT03035032|520522753|FG000|Overall Study|Physician Decision|5|||
144359481|NCT00836589|520522756|FG000|Overall Study|Lost to Follow-up|246|||
144359482|NCT00836589|520522756|FG000|Overall Study|Death|429|||
144359483|NCT00836589|520522756|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
144359484|NCT02914639|520522758|FG000|Overall Study|Withdrawal by Subject|0|||
144359485|NCT02914639|520522759|FG001|Overall Study|Withdrawal by Subject|2|||
144359486|NCT01018030|520522761|FG000|Overall Study|Adverse Event|10|||
144359487|NCT01018030|520522762|FG001|Overall Study|Adverse Event|5|||
144359488|NCT01018030|520522763|FG002|Overall Study|Adverse Event|5|||
144359489|NCT01018030|520522761|FG000|Overall Study|Withdrawal by Subject|2|||
144359490|NCT01018030|520522762|FG001|Overall Study|Withdrawal by Subject|2|||
144359491|NCT01018030|520522763|FG002|Overall Study|Withdrawal by Subject|4|||
144359492|NCT01018030|520522761|FG000|Overall Study|Lost to Follow-up|2|||
144359493|NCT01018030|520522762|FG001|Overall Study|Lost to Follow-up|0|||
144359494|NCT01018030|520522763|FG002|Overall Study|Lost to Follow-up|3|||
144359495|NCT01018030|520522761|FG000|Overall Study|Protocol Violation|2|||
144359496|NCT01018030|520522762|FG001|Overall Study|Protocol Violation|1|||
144359497|NCT01018030|520522763|FG002|Overall Study|Protocol Violation|0|||
144359498|NCT01018030|520522761|FG000|Overall Study|Physician Decision|1|||
144359499|NCT01018030|520522762|FG001|Overall Study|Physician Decision|0|||
144359500|NCT01018030|520522763|FG002|Overall Study|Physician Decision|1|||
144359501|NCT01018030|520522761|FG000|Overall Study|Lack of Efficacy|1|||
144359502|NCT01018030|520522762|FG001|Overall Study|Lack of Efficacy|0|||
144359503|NCT01018030|520522763|FG002|Overall Study|Lack of Efficacy|0|||
144359504|NCT01018030|520522761|FG000|Overall Study|Did Not Receive Study Drug|1|||
144359505|NCT01018030|520522762|FG001|Overall Study|Did Not Receive Study Drug|3|||
144359506|NCT01018030|520522763|FG002|Overall Study|Did Not Receive Study Drug|0|||
144359507|NCT00189540|520522764|FG000|Overall Study|Withdrawal by Subject|3|||
144359508|NCT00189540|520522765|FG001|Overall Study|Withdrawal by Subject|0|||
144359509|NCT00189540|520522764|FG000|Overall Study|Death|4|||
144359510|NCT00189540|520522765|FG001|Overall Study|Death|1|||
144359511|NCT01089504|520522766|FG000|Overall Study|Lost to Follow-up|1|||
144359512|NCT01089504|520522767|FG001|Overall Study|Lost to Follow-up|1|||
144359513|NCT01089504|520522766|FG000|Overall Study|Withdrawal by Subject|2|||
144359514|NCT01089504|520522767|FG001|Overall Study|Withdrawal by Subject|0|||
144359515|NCT00001832|520522768|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
144359516|NCT00001832|520522769|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
144359517|NCT00001832|520522770|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
144359518|NCT00001832|520522771|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
144359519|NCT00001832|520522772|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
144359520|NCT00001832|520522773|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
144359521|NCT00001832|520522774|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
144359522|NCT00001832|520522775|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
144359523|NCT00001832|520522776|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
144359524|NCT00001832|520522777|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
144359525|NCT00001832|520522778|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
144359526|NCT00001832|520522779|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
144359527|NCT00001832|520522780|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
144359528|NCT00001832|520522781|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
144359529|NCT00001832|520522782|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
144359530|NCT00001832|520522768|FG000|Treatment Period|Death during treatment|0|||
144359531|NCT00001832|520522769|FG001|Treatment Period|Death during treatment|0|||
144359532|NCT00001832|520522770|FG002|Treatment Period|Death during treatment|0|||
144359533|NCT00001832|520522771|FG003|Treatment Period|Death during treatment|0|||
144359534|NCT00001832|520522772|FG004|Treatment Period|Death during treatment|0|||
144359535|NCT00001832|520522773|FG005|Treatment Period|Death during treatment|1|||
144359996|NCT01601535|520525136|FG001|Phase 1|Adverse Event|0|||
144359997|NCT01601535|520525137|FG002|Phase 1|Adverse Event|2|||
144359998|NCT01601535|520525138|FG003|Phase 1|Adverse Event|1|||
144359999|NCT01601535|520525139|FG004|Phase 1|Adverse Event|0|||
144360000|NCT01601535|520525140|FG005|Phase 1|Adverse Event|0|||
144360001|NCT01601535|520525135|FG000|Phase 1|Withdrawal by Subject|2|||
144360002|NCT01601535|520525136|FG001|Phase 1|Withdrawal by Subject|1|||
144359536|NCT00001832|520522774|FG006|Treatment Period|Death during treatment|0|||
144359537|NCT00001832|520522775|FG007|Treatment Period|Death during treatment|0|||
144359538|NCT00001832|520522776|FG008|Treatment Period|Death during treatment|0|||
144359539|NCT00001832|520522777|FG009|Treatment Period|Death during treatment|0|||
144359540|NCT00001832|520522778|FG010|Treatment Period|Death during treatment|0|||
144359541|NCT00001832|520522779|FG011|Treatment Period|Death during treatment|0|||
144359689|NCT03007966|520524987|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
144359690|NCT00474487|520524991|FG000|Overall Study|Withdrawal by Subject|6|||
144359691|NCT00474487|520524992|FG001|Overall Study|Withdrawal by Subject|0|||
144359692|NCT00474487|520524993|FG002|Overall Study|Withdrawal by Subject|0|||
144359693|NCT00474487|520524994|FG003|Overall Study|Withdrawal by Subject|0|||
144359694|NCT00474487|520524991|FG000|Overall Study|Lost to Follow-up|20|||
144359695|NCT00474487|520524992|FG001|Overall Study|Lost to Follow-up|1|||
144359696|NCT00474487|520524993|FG002|Overall Study|Lost to Follow-up|7|||
144359697|NCT00474487|520524994|FG003|Overall Study|Lost to Follow-up|0|||
144359698|NCT00474487|520524991|FG000|Overall Study|Inappropriate enrollment|4|||
144359699|NCT00474487|520524992|FG001|Overall Study|Inappropriate enrollment|0|||
144359700|NCT00474487|520524993|FG002|Overall Study|Inappropriate enrollment|7|||
144359701|NCT00474487|520524994|FG003|Overall Study|Inappropriate enrollment|0|||
144359702|NCT00474487|520524991|FG000|Overall Study|Death|0|||
144359703|NCT00474487|520524992|FG001|Overall Study|Death|1|||
144359704|NCT00474487|520524993|FG002|Overall Study|Death|0|||
144359705|NCT00474487|520524994|FG003|Overall Study|Death|0|||
144359706|NCT01428258|520524995|FG000|Intervention 1|Withdrawal by Subject|2|||
144359707|NCT01428258|520524996|FG001|Intervention 1|Withdrawal by Subject|0|||
144359708|NCT00419393|520524997|FG000|Overall Study|Adverse Event|5|||
144359709|NCT00419393|520524997|FG000|Overall Study|Protocol Violation|5|||
144359710|NCT00419393|520524997|FG000|Overall Study|Withdrawal by Subject|7|||
144359711|NCT00419393|520524997|FG000|Overall Study|Other: Sponsor request|3|||
144359712|NCT00419393|520524997|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
144359713|NCT00419393|520524997|FG000|Overall Study|Other: Site closure|1|||
144359714|NCT00419393|520524997|FG000|Overall Study|Other: Other health problems|1|||
144359715|NCT00419393|520524997|FG000|Overall Study|Other: Investigator decision|1|||
144359716|NCT00979901|520524998|FG000|Overall Study|Adverse Event|1|||
144359717|NCT00979901|520524999|FG001|Overall Study|Adverse Event|3|||
144359718|NCT00979901|520525000|FG002|Overall Study|Adverse Event|9|||
144359719|NCT00979901|520525001|FG003|Overall Study|Adverse Event|2|||
144359720|NCT00979901|520524998|FG000|Overall Study|Lack of Efficacy|8|||
144359721|NCT00979901|520524999|FG001|Overall Study|Lack of Efficacy|4|||
144359722|NCT00979901|520525000|FG002|Overall Study|Lack of Efficacy|9|||
144359723|NCT00979901|520525001|FG003|Overall Study|Lack of Efficacy|0|||
144359724|NCT00979901|520524998|FG000|Overall Study|Lost to Follow-up|1|||
144359725|NCT00979901|520524999|FG001|Overall Study|Lost to Follow-up|1|||
144359726|NCT00979901|520525000|FG002|Overall Study|Lost to Follow-up|2|||
144359727|NCT00979901|520525001|FG003|Overall Study|Lost to Follow-up|0|||
144359728|NCT00979901|520524998|FG000|Overall Study|Protocol Violation|2|||
144359729|NCT00979901|520524999|FG001|Overall Study|Protocol Violation|2|||
144359730|NCT00979901|520525000|FG002|Overall Study|Protocol Violation|7|||
144359731|NCT00979901|520525001|FG003|Overall Study|Protocol Violation|1|||
144359732|NCT00979901|520524998|FG000|Overall Study|Withdrawal by Subject|2|||
144359733|NCT00979901|520524999|FG001|Overall Study|Withdrawal by Subject|1|||
144359734|NCT00979901|520525000|FG002|Overall Study|Withdrawal by Subject|1|||
144359735|NCT00979901|520525001|FG003|Overall Study|Withdrawal by Subject|1|||
144359736|NCT00979901|520524998|FG000|Overall Study|Noncompliance|1|||
144359737|NCT00979901|520524999|FG001|Overall Study|Noncompliance|0|||
144359738|NCT00979901|520525000|FG002|Overall Study|Noncompliance|0|||
144359739|NCT00979901|520525001|FG003|Overall Study|Noncompliance|0|||
144359740|NCT00979901|520524998|FG000|Overall Study|out-of-state|1|||
144359741|NCT00979901|520524999|FG001|Overall Study|out-of-state|0|||
144359742|NCT00979901|520525000|FG002|Overall Study|out-of-state|0|||
144359743|NCT00979901|520525001|FG003|Overall Study|out-of-state|0|||
144359744|NCT00979901|520524998|FG000|Overall Study|vacation|1|||
144359745|NCT00979901|520524999|FG001|Overall Study|vacation|0|||
144359746|NCT00979901|520525000|FG002|Overall Study|vacation|0|||
144359747|NCT00979901|520525001|FG003|Overall Study|vacation|0|||
144359748|NCT00979901|520524998|FG000|Overall Study|elevated lab values pre-randomization|1|||
144359749|NCT00979901|520524999|FG001|Overall Study|elevated lab values pre-randomization|0|||
144359750|NCT00979901|520525000|FG002|Overall Study|elevated lab values pre-randomization|0|||
144359751|NCT00979901|520525001|FG003|Overall Study|elevated lab values pre-randomization|0|||
144359752|NCT00979901|520524998|FG000|Overall Study|Discontinued in Error|0|||
144359753|NCT00979901|520524999|FG001|Overall Study|Discontinued in Error|1|||
144359754|NCT00979901|520525000|FG002|Overall Study|Discontinued in Error|0|||
144359755|NCT00979901|520525001|FG003|Overall Study|Discontinued in Error|0|||
144359756|NCT00979901|520524998|FG000|Overall Study|Left Country|0|||
144359757|NCT00979901|520524999|FG001|Overall Study|Left Country|0|||
144359758|NCT00979901|520525000|FG002|Overall Study|Left Country|1|||
144359759|NCT00979901|520525001|FG003|Overall Study|Left Country|0|||
144359760|NCT00979901|520524998|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
144359761|NCT00979901|520524999|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
144359762|NCT00979901|520525000|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
144359763|NCT00979901|520525001|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
144359764|NCT03924622|520525003|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
144359765|NCT03924622|520525004|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
144359766|NCT03924622|520525005|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
144359767|NCT03924622|520525006|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
144359768|NCT03924622|520525007|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
144359769|NCT03924622|520525008|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
144359770|NCT05546476|520525011|FG000|Period 1: Part A|Adverse Event|2|||
144359771|NCT05546476|520525012|FG001|Period 1: Part A|Adverse Event|0|||
144359772|NCT05546476|520525013|FG002|Period 1: Part A|Adverse Event|0|||
144359773|NCT05546476|520525014|FG003|Period 1: Part A|Adverse Event|1|||
144359774|NCT05546476|520525011|FG000|Period 1: Part A|Death|4|||
144359775|NCT05546476|520525012|FG001|Period 1: Part A|Death|4|||
144359776|NCT05546476|520525013|FG002|Period 1: Part A|Death|5|||
144359777|NCT05546476|520525014|FG003|Period 1: Part A|Death|6|||
144359778|NCT05546476|520525011|FG000|Period 1: Part A|Lack of Efficacy|0|||
144359779|NCT05546476|520525012|FG001|Period 1: Part A|Lack of Efficacy|0|||
144359780|NCT05546476|520525013|FG002|Period 1: Part A|Lack of Efficacy|0|||
144359781|NCT05546476|520525014|FG003|Period 1: Part A|Lack of Efficacy|1|||
144359782|NCT05546476|520525011|FG000|Period 1: Part A|Lost to Follow-up|0|||
144359783|NCT05546476|520525012|FG001|Period 1: Part A|Lost to Follow-up|0|||
144359784|NCT05546476|520525013|FG002|Period 1: Part A|Lost to Follow-up|0|||
144359785|NCT05546476|520525014|FG003|Period 1: Part A|Lost to Follow-up|1|||
144359786|NCT05546476|520525011|FG000|Period 1: Part A|Physician Decision|1|||
144359787|NCT05546476|520525012|FG001|Period 1: Part A|Physician Decision|0|||
144359788|NCT05546476|520525013|FG002|Period 1: Part A|Physician Decision|0|||
144359789|NCT05546476|520525014|FG003|Period 1: Part A|Physician Decision|0|||
144359790|NCT05546476|520525011|FG000|Period 1: Part A|Progressive disease|3|||
144359791|NCT05546476|520525012|FG001|Period 1: Part A|Progressive disease|5|||
144359792|NCT05546476|520525013|FG002|Period 1: Part A|Progressive disease|0|||
144359793|NCT05546476|520525014|FG003|Period 1: Part A|Progressive disease|1|||
144359794|NCT05546476|520525011|FG000|Period 1: Part A|Withdrawal by Subject|1|||
144359795|NCT05546476|520525012|FG001|Period 1: Part A|Withdrawal by Subject|1|||
144359796|NCT05546476|520525013|FG002|Period 1: Part A|Withdrawal by Subject|1|||
144359797|NCT05546476|520525014|FG003|Period 1: Part A|Withdrawal by Subject|2|||
144359798|NCT05546476|520525011|FG000|Period 1: Part A|Global deterioration of health status|2|||
144359799|NCT05546476|520525012|FG001|Period 1: Part A|Global deterioration of health status|2|||
144359800|NCT05546476|520525013|FG002|Period 1: Part A|Global deterioration of health status|1|||
144359801|NCT05546476|520525014|FG003|Period 1: Part A|Global deterioration of health status|4|||
144359802|NCT05546476|520525011|FG000|Period 1: Part A|Other: Unspecified|0|||
144359803|NCT05546476|520525012|FG001|Period 1: Part A|Other: Unspecified|2|||
144359804|NCT05546476|520525013|FG002|Period 1: Part A|Other: Unspecified|0|||
144359805|NCT05546476|520525014|FG003|Period 1: Part A|Other: Unspecified|0|||
144359806|NCT05546476|520525011|FG000|Period 2: Part B|Ongoing|26|||
144359807|NCT05546476|520525012|FG001|Period 2: Part B|Ongoing|27|||
144359808|NCT05546476|520525013|FG002|Period 2: Part B|Ongoing|35|||
144359809|NCT05546476|520525014|FG003|Period 2: Part B|Ongoing|29|||
144359810|NCT02814916|520525018|FG000|Overall Study|Withdrawal of consent|0|||
144359811|NCT02814916|520525019|FG001|Overall Study|Withdrawal of consent|2|||
144359812|NCT02814916|520525020|FG002|Overall Study|Withdrawal of consent|0|||
144359813|NCT02814916|520525018|FG000|Overall Study|Lost to Follow-up|0|||
144359814|NCT02814916|520525019|FG001|Overall Study|Lost to Follow-up|1|||
144359815|NCT02814916|520525020|FG002|Overall Study|Lost to Follow-up|0|||
144359816|NCT02814916|520525018|FG000|Overall Study|Other, not specified|0|||
144359817|NCT02814916|520525019|FG001|Overall Study|Other, not specified|1|||
144359818|NCT02814916|520525020|FG002|Overall Study|Other, not specified|0|||
144359819|NCT04890652|520525024|FG000|Overall Study|Withdrawal by Subject|2|||
144359820|NCT01706458|520525025|FG000|Overall Study|Physician Decision|3|||
144359821|NCT01706458|520525026|FG001|Overall Study|Physician Decision|4|||
144359822|NCT01903356|520525039|FG000|Overall Study|Lost to Follow-up|7|||
144359823|NCT01903356|520525039|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
144359824|NCT01903356|520525039|FG000|Overall Study|Violated the dosage and administration|3|||
144359825|NCT01553084|520525051|FG000|Overall Study|Withdrawal by Subject|15|||
144359826|NCT01553084|520525052|FG001|Overall Study|Withdrawal by Subject|13|||
144359827|NCT01553084|520525053|FG002|Overall Study|Withdrawal by Subject|35|||
144359828|NCT03988400|520525054|FG000|Overall Study|Adverse Event|1|||
144359829|NCT03988400|520525055|FG001|Overall Study|Adverse Event|0|||
144359830|NCT03988400|520525054|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
144359831|NCT03988400|520525055|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
144359832|NCT03988400|520525054|FG000|Overall Study|Lost to Follow-up|0|||
144359833|NCT03988400|520525055|FG001|Overall Study|Lost to Follow-up|1|||
144359834|NCT02542865|520525057|FG000|Overall Study|Identified as screen failure|1|||
144359835|NCT02542865|520525058|FG001|Overall Study|Identified as screen failure|0|||
144359836|NCT02542865|520525057|FG000|Overall Study|Withdrawal by Subject|16|||
144359837|NCT02542865|520525058|FG001|Overall Study|Withdrawal by Subject|0|||
144359838|NCT02240485|520525059|FG000|3 Months Post-admission|Lost to Follow-up|1|||
144359839|NCT02240485|520525060|FG001|3 Months Post-admission|Lost to Follow-up|5|||
144360003|NCT01601535|520525137|FG002|Phase 1|Withdrawal by Subject|1|||
144359840|NCT02240485|520525059|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
144359841|NCT02240485|520525060|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
144359842|NCT02240485|520525059|FG000|9 Months Post-admission|Lost to Follow-up|3|||
144359843|NCT02240485|520525060|FG001|9 Months Post-admission|Lost to Follow-up|1|||
144359844|NCT02240485|520525059|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
144359845|NCT02240485|520525060|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
144359846|NCT02240485|520525059|FG000|18 Months Post-admission|Lost to Follow-up|1|||
144359847|NCT02240485|520525060|FG001|18 Months Post-admission|Lost to Follow-up|1|||
144359848|NCT02240485|520525059|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
144359849|NCT02240485|520525060|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
144359850|NCT00953667|520525061|FG000|Overall Study|Lost to Follow-up|11|||
144359851|NCT00953667|520525061|FG000|Overall Study|Physician Decision|35|||
144359852|NCT00953667|520525061|FG000|Overall Study|Withdrawal by Subject|63|||
144359853|NCT00953667|520525061|FG000|Overall Study|Adverse Event|10|||
144359854|NCT00953667|520525061|FG000|Overall Study|poor venous access,unable to draw blood|4|||
144359855|NCT04038359|520525062|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
144359856|NCT04038359|520525063|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
144359857|NCT04038359|520525062|FG000|Overall Study|Death|8|||
144359858|NCT04038359|520525063|FG001|Overall Study|Death|7|||
144359859|NCT04038359|520525062|FG000|Overall Study|Lost to Follow-up|3|||
144359860|NCT04038359|520525063|FG001|Overall Study|Lost to Follow-up|0|||
144359861|NCT04038359|520525062|FG000|Overall Study|Participant Moved|1|||
144359862|NCT04038359|520525063|FG001|Overall Study|Participant Moved|0|||
144359863|NCT04038359|520525062|FG000|Overall Study|Withdrawal by Subject|4|||
144359864|NCT04038359|520525063|FG001|Overall Study|Withdrawal by Subject|3|||
144359865|NCT04038359|520525062|FG000|Overall Study|Physician Decision|3|||
144359866|NCT04038359|520525063|FG001|Overall Study|Physician Decision|2|||
144359867|NCT04038359|520525062|FG000|Overall Study|Adverse Event|0|||
144359868|NCT04038359|520525063|FG001|Overall Study|Adverse Event|2|||
144359869|NCT04038359|520525062|FG000|Overall Study|Progressive Disease|0|||
144359870|NCT04038359|520525063|FG001|Overall Study|Progressive Disease|1|||
144359871|NCT03259230|520525064|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
144359872|NCT03259230|520525065|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
144359873|NCT02913482|520525066|FG000|Overall Study|Death|0|||
144359874|NCT02913482|520525067|FG001|Overall Study|Death|2|||
144359875|NCT02913482|520525068|FG002|Overall Study|Death|2|||
144359876|NCT02913482|520525066|FG000|Overall Study|Progressive Disease|1|||
144359877|NCT02913482|520525067|FG001|Overall Study|Progressive Disease|1|||
144359878|NCT02913482|520525068|FG002|Overall Study|Progressive Disease|1|||
144359879|NCT02913482|520525066|FG000|Overall Study|Reason not specified|0|||
144359880|NCT02913482|520525067|FG001|Overall Study|Reason not specified|0|||
144359881|NCT02913482|520525068|FG002|Overall Study|Reason not specified|1|||
144359882|NCT02913482|520525066|FG000|Overall Study|Withdrawal by Subject|0|||
144359883|NCT02913482|520525067|FG001|Overall Study|Withdrawal by Subject|1|||
144359884|NCT02913482|520525068|FG002|Overall Study|Withdrawal by Subject|1|||
144359885|NCT05468814|520525069|FG000|Overall Study|Lost to Follow-up|5|||
144359886|NCT05468814|520525070|FG001|Overall Study|Lost to Follow-up|6|||
144359887|NCT04716426|520525074|FG000|Overall Study|Vaccination|1|||
144359888|NCT04716426|520525075|FG001|Overall Study|Vaccination|1|||
144359889|NCT04716426|520525074|FG000|Overall Study|Contamination|1|||
144359890|NCT04716426|520525075|FG001|Overall Study|Contamination|0|||
144359891|NCT01046565|520525078|FG000|Overall Study|Adverse Event|2|||
144359892|NCT01046565|520525078|FG000|Overall Study|Withdrawal by Subject|7|||
144359893|NCT01650558|520525079|FG000|Overall Study|Migration out of study area|61|||
144359894|NCT01650558|520525080|FG001|Overall Study|Migration out of study area|71|||
144359895|NCT01650558|520525081|FG002|Overall Study|Migration out of study area|56|||
144359896|NCT01650558|520525079|FG000|Overall Study|Lost to Follow-up|10|||
144359897|NCT01650558|520525080|FG001|Overall Study|Lost to Follow-up|13|||
144359898|NCT01650558|520525081|FG002|Overall Study|Lost to Follow-up|6|||
144359899|NCT01650558|520525079|FG000|Overall Study|Death|10|||
144359900|NCT01650558|520525080|FG001|Overall Study|Death|6|||
144359901|NCT01650558|520525081|FG002|Overall Study|Death|8|||
144359902|NCT01650558|520525079|FG000|Overall Study|Withdrawal by Subject|1|||
144359903|NCT01650558|520525080|FG001|Overall Study|Withdrawal by Subject|1|||
144359904|NCT01650558|520525081|FG002|Overall Study|Withdrawal by Subject|3|||
144359905|NCT01650558|520525079|FG000|Overall Study|Non-compliant participant|1|||
144359906|NCT01650558|520525080|FG001|Overall Study|Non-compliant participant|0|||
144359907|NCT01650558|520525081|FG002|Overall Study|Non-compliant participant|2|||
144359908|NCT01650558|520525079|FG000|Overall Study|Physician Decision|0|||
144359909|NCT01650558|520525080|FG001|Overall Study|Physician Decision|1|||
144359910|NCT01650558|520525081|FG002|Overall Study|Physician Decision|0|||
144359911|NCT00918385|520525082|FG000|Monotherapy|Adverse Event|1|||
144359912|NCT00918385|520525083|FG001|Monotherapy|Adverse Event|6|||
144359913|NCT00918385|520525082|FG000|Monotherapy|Complicating illness|1|||
144359914|NCT00918385|520525083|FG001|Monotherapy|Complicating illness|0|||
144359915|NCT00918385|520525082|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
144359916|NCT00918385|520525083|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
144359917|NCT00918385|520525082|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
144359918|NCT00918385|520525083|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
144359919|NCT00918385|520525082|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
144359920|NCT00918385|520525083|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
144359921|NCT00918385|520525082|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
144359922|NCT00918385|520525083|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
144359923|NCT01069484|520525085|FG000|Overall Study|Death-in-near-family|1|||
144359924|NCT01069484|520525086|FG001|Overall Study|Death-in-near-family|0|||
144359925|NCT01069484|520525085|FG000|Overall Study|No specific reason|8|||
144359926|NCT01069484|520525086|FG001|Overall Study|No specific reason|2|||
144359927|NCT01069484|520525085|FG000|Overall Study|Illness mother or child|3|||
144359928|NCT01069484|520525086|FG001|Overall Study|Illness mother or child|1|||
144359929|NCT02978417|520525089|FG000|Overall Study|Lost to Follow-up|2|||
144359930|NCT02978417|520525090|FG001|Overall Study|Lost to Follow-up|2|||
144359931|NCT00083889|520525101|FG000|Overall Study|Adverse Event|76|||
144359932|NCT00083889|520525102|FG001|Overall Study|Adverse Event|86|||
144359933|NCT00083889|520525101|FG000|Overall Study|Protocol Violation|2|||
144359934|NCT00083889|520525102|FG001|Overall Study|Protocol Violation|2|||
144359935|NCT00083889|520525101|FG000|Overall Study|Withdrawal by Subject|22|||
144359936|NCT00083889|520525102|FG001|Overall Study|Withdrawal by Subject|24|||
144359937|NCT00083889|520525101|FG000|Overall Study|Lack of Efficacy|240|||
144359938|NCT00083889|520525102|FG001|Overall Study|Lack of Efficacy|219|||
144359939|NCT00083889|520525101|FG000|Overall Study|Decision of sponsor|32|||
144359940|NCT00083889|520525102|FG001|Overall Study|Decision of sponsor|4|||
144359941|NCT00083889|520525101|FG000|Overall Study|Randomized: did not take study drug|0|||
144359942|NCT00083889|520525102|FG001|Overall Study|Randomized: did not take study drug|15|||
144359943|NCT00083889|520525101|FG000|Overall Study|Completed on marketed sunitinub|3|||
144359944|NCT00083889|520525102|FG001|Overall Study|Completed on marketed sunitinub|0|||
144359945|NCT00083889|520525101|FG000|Overall Study|Crossover to SU011248|0|||
144359946|NCT00083889|520525102|FG001|Overall Study|Crossover to SU011248|25|||
144359947|NCT00960375|520525103|FG000|Overall Study|Lost to Follow-up|20|||
144359948|NCT00960375|520525104|FG001|Overall Study|Lost to Follow-up|22|||
144359949|NCT03624881|520525105|FG000|Overall Study|Screen Failure|14|||
144359950|NCT03624881|520525106|FG001|Overall Study|Screen Failure|0|||
144359951|NCT03624881|520525105|FG000|Overall Study|No Catheter Inserted|6|||
144359952|NCT03624881|520525106|FG001|Overall Study|No Catheter Inserted|1|||
144359953|NCT03624881|520525105|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
144359954|NCT03624881|520525106|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
144359955|NCT03624881|520525105|FG000|Overall Study|Death|2|||
144359956|NCT03624881|520525106|FG001|Overall Study|Death|0|||
144359957|NCT03624881|520525105|FG000|Overall Study|Lost to Follow-up|10|||
144359958|NCT03624881|520525106|FG001|Overall Study|Lost to Follow-up|4|||
144359959|NCT03624881|520525105|FG000|Overall Study|Withdrawal by Subject|12|||
144359960|NCT03624881|520525106|FG001|Overall Study|Withdrawal by Subject|1|||
144359961|NCT02138890|520525113|FG000|Overall Study|Adverse Event|1|||
144359962|NCT02138890|520525114|FG001|Overall Study|Adverse Event|0|||
144359963|NCT00112736|520525115|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
144359964|NCT00112736|520525116|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
144359965|NCT05435339|520525117|FG000|Overall Study|Death|1|||
144359966|NCT05435339|520525118|FG001|Overall Study|Death|0|||
144359967|NCT05435339|520525119|FG002|Overall Study|Death|3|||
144359968|NCT05435339|520525120|FG003|Overall Study|Death|1|||
144359969|NCT05435339|520525121|FG004|Overall Study|Death|3|||
144359970|NCT05435339|520525122|FG005|Overall Study|Death|2|||
144359971|NCT05435339|520525123|FG006|Overall Study|Death|4|||
144359972|NCT05435339|520525124|FG007|Overall Study|Death|6|||
144359973|NCT05435339|520525117|FG000|Overall Study|Sponsor Decision|0|||
144359974|NCT05435339|520525118|FG001|Overall Study|Sponsor Decision|1|||
144359975|NCT05435339|520525119|FG002|Overall Study|Sponsor Decision|0|||
144359976|NCT05435339|520525120|FG003|Overall Study|Sponsor Decision|0|||
144359977|NCT05435339|520525121|FG004|Overall Study|Sponsor Decision|2|||
144359978|NCT05435339|520525122|FG005|Overall Study|Sponsor Decision|1|||
144359979|NCT05435339|520525123|FG006|Overall Study|Sponsor Decision|2|||
144359980|NCT05435339|520525124|FG007|Overall Study|Sponsor Decision|2|||
144359981|NCT05435339|520525117|FG000|Overall Study|Withdrawal by Subject|0|||
144359982|NCT05435339|520525118|FG001|Overall Study|Withdrawal by Subject|0|||
144359983|NCT05435339|520525119|FG002|Overall Study|Withdrawal by Subject|0|||
144359984|NCT05435339|520525120|FG003|Overall Study|Withdrawal by Subject|0|||
144359985|NCT05435339|520525121|FG004|Overall Study|Withdrawal by Subject|1|||
144359986|NCT05435339|520525122|FG005|Overall Study|Withdrawal by Subject|0|||
144359987|NCT05435339|520525123|FG006|Overall Study|Withdrawal by Subject|1|||
144359988|NCT05435339|520525124|FG007|Overall Study|Withdrawal by Subject|1|||
144359989|NCT03019406|520525125|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
144359990|NCT03019406|520525126|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
144359991|NCT03019406|520525127|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
144359992|NCT03019406|520525128|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
144359993|NCT04258423|520525131|FG000|Overall Study|Study Closure|2|||
144360043|NCT04764162|520525143|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
144360044|NCT04764162|520525144|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
144360045|NCT05556265|520525145|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
144360046|NCT05556265|520525146|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
144360047|NCT05556265|520525147|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
144360048|NCT05556265|520525148|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
144360049|NCT05556265|520525149|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
144360050|NCT05556265|520525145|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
144360051|NCT05556265|520525146|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
144360052|NCT05556265|520525147|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
144360053|NCT05556265|520525148|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
144360054|NCT05556265|520525149|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
144360055|NCT05556265|520525145|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
144360056|NCT05556265|520525146|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
144360057|NCT05556265|520525147|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
144360058|NCT05556265|520525148|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
144360059|NCT05556265|520525149|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
144360060|NCT05556265|520525145|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
144360061|NCT05556265|520525146|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
144360062|NCT05556265|520525147|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
144360063|NCT05556265|520525148|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
144360064|NCT05556265|520525149|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
144360065|NCT05556265|520525145|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
144360066|NCT05556265|520525146|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
144360067|NCT05556265|520525147|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
144360068|NCT05556265|520525148|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
144360069|NCT05556265|520525149|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
144360070|NCT05556265|520525145|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
144360071|NCT05556265|520525146|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
144360072|NCT05556265|520525147|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
144360073|NCT05556265|520525148|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
144360074|NCT05556265|520525149|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
144360075|NCT05556265|520525145|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
144360076|NCT05556265|520525146|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
144360077|NCT05556265|520525147|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
144360078|NCT05556265|520525148|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
144360079|NCT05556265|520525149|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
144360080|NCT05556265|520525145|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
144360081|NCT05556265|520525146|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
144360082|NCT05556265|520525147|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
144360083|NCT05556265|520525148|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
144360084|NCT05556265|520525149|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
144360085|NCT05556265|520525145|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
144360086|NCT05556265|520525146|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
144360087|NCT05556265|520525147|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
144360088|NCT05556265|520525148|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
144360089|NCT05556265|520525149|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
144360090|NCT03077542|520525150|FG000|Overall Study|Death|4|||
144360091|NCT03077542|520525151|FG001|Overall Study|Death|0|||
144360092|NCT03077542|520525150|FG000|Overall Study|Physician Decision|6|||
144360093|NCT03077542|520525151|FG001|Overall Study|Physician Decision|1|||
144360094|NCT03077542|520525150|FG000|Overall Study|Withdrawal by Subject|0|||
144360095|NCT03077542|520525151|FG001|Overall Study|Withdrawal by Subject|1|||
144360096|NCT03980730|520525152|FG000|Overall Study|Study Terminated by Sponsor|0|||
144360097|NCT03980730|520525153|FG001|Overall Study|Study Terminated by Sponsor|3|||
144360098|NCT03980730|520525152|FG000|Overall Study|Adverse Event|2|||
144360099|NCT03980730|520525153|FG001|Overall Study|Adverse Event|0|||
144360100|NCT03980730|520525152|FG000|Overall Study|Sponsor Request|0|||
144360101|NCT03980730|520525153|FG001|Overall Study|Sponsor Request|1|||
144360102|NCT01300728|520525154|FG000|Overall Study|Withdrawal by Subject|1|||
144360103|NCT01300728|520525155|FG001|Overall Study|Withdrawal by Subject|1|||
144360104|NCT01300728|520525154|FG000|Overall Study|Physician Decision|1|||
144360105|NCT01300728|520525155|FG001|Overall Study|Physician Decision|0|||
144360106|NCT02081677|520527398|FG000|Overall Study|Adverse Event|0|||
144360110|NCT02081677|520527398|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
144360111|NCT02081677|520527399|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
144360112|NCT02081677|520527400|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
144360113|NCT02081677|520527401|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
144360114|NCT02081677|520527398|FG000|Overall Study|Not comfortable with lens care system|1|||
144360115|NCT02081677|520527399|FG001|Overall Study|Not comfortable with lens care system|0|||
144360116|NCT02081677|520527400|FG002|Overall Study|Not comfortable with lens care system|0|||
144360117|NCT02081677|520527401|FG003|Overall Study|Not comfortable with lens care system|0|||
144360118|NCT02081677|520527398|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
144360119|NCT02081677|520527399|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
144360120|NCT02081677|520527400|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
144360121|NCT02081677|520527401|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
144360122|NCT01097668|520527402|FG000|Overall Study|Withdrawal by Subject|1|||
144360123|NCT01097668|520527403|FG001|Overall Study|Withdrawal by Subject|2|||
144360124|NCT01097668|520527402|FG000|Overall Study|Lost to Follow-up|1|||
144360125|NCT01097668|520527403|FG001|Overall Study|Lost to Follow-up|0|||
144360126|NCT01910298|520527404|FG000|Overall Study|Adverse Event|1|||
144360127|NCT01910298|520527405|FG001|Overall Study|Adverse Event|0|||
144360128|NCT01910298|520527404|FG000|Overall Study|Withdrawal by Subject|2|||
144360129|NCT01910298|520527405|FG001|Overall Study|Withdrawal by Subject|7|||
144360130|NCT01910298|520527404|FG000|Overall Study|Protocol Deviation|0|||
144360131|NCT01910298|520527405|FG001|Overall Study|Protocol Deviation|5|||
144360132|NCT01910298|520527404|FG000|Overall Study|Lost to Follow-up|1|||
144360133|NCT01910298|520527405|FG001|Overall Study|Lost to Follow-up|1|||
144360134|NCT01910298|520527404|FG000|Overall Study|Study Terminated by Sponsor|1|||
144360135|NCT01910298|520527405|FG001|Overall Study|Study Terminated by Sponsor|17|||
144360136|NCT01910298|520527404|FG000|Overall Study|Other Miscellaneous Reasons|0|||
144360137|NCT01910298|520527405|FG001|Overall Study|Other Miscellaneous Reasons|2|||
144360138|NCT03037385|520527408|FG000|Overall Study|Adverse Event|0|||
144360139|NCT03037385|520527409|FG001|Overall Study|Adverse Event|0|||
144360140|NCT03037385|520527410|FG002|Overall Study|Adverse Event|1|||
144360141|NCT03037385|520527411|FG003|Overall Study|Adverse Event|0|||
144360142|NCT03037385|520527412|FG004|Overall Study|Adverse Event|0|||
144360143|NCT03037385|520527413|FG005|Overall Study|Adverse Event|0|||
144360144|NCT03037385|520527414|FG006|Overall Study|Adverse Event|0|||
144360145|NCT03037385|520527415|FG007|Overall Study|Adverse Event|0|||
144360146|NCT03037385|520527416|FG008|Overall Study|Adverse Event|0|||
144360147|NCT03037385|520527417|FG009|Overall Study|Adverse Event|6|||
144360148|NCT03037385|520527408|FG000|Overall Study|Death|1|||
144360149|NCT03037385|520527409|FG001|Overall Study|Death|4|||
144360150|NCT03037385|520527410|FG002|Overall Study|Death|2|||
144360151|NCT03037385|520527411|FG003|Overall Study|Death|2|||
144360152|NCT03037385|520527412|FG004|Overall Study|Death|5|||
144360153|NCT03037385|520527413|FG005|Overall Study|Death|2|||
144360154|NCT03037385|520527414|FG006|Overall Study|Death|1|||
144360155|NCT03037385|520527415|FG007|Overall Study|Death|4|||
144360156|NCT03037385|520527416|FG008|Overall Study|Death|3|||
144360157|NCT03037385|520527417|FG009|Overall Study|Death|240|||
144360158|NCT03037385|520527408|FG000|Overall Study|Initiation of Another Therapy|1|||
144360159|NCT03037385|520527409|FG001|Overall Study|Initiation of Another Therapy|0|||
144360160|NCT03037385|520527410|FG002|Overall Study|Initiation of Another Therapy|0|||
144360161|NCT03037385|520527411|FG003|Overall Study|Initiation of Another Therapy|0|||
144360162|NCT03037385|520527412|FG004|Overall Study|Initiation of Another Therapy|0|||
144360163|NCT03037385|520527413|FG005|Overall Study|Initiation of Another Therapy|0|||
144360164|NCT03037385|520527414|FG006|Overall Study|Initiation of Another Therapy|0|||
144360165|NCT03037385|520527415|FG007|Overall Study|Initiation of Another Therapy|1|||
144360166|NCT03037385|520527416|FG008|Overall Study|Initiation of Another Therapy|0|||
144360167|NCT03037385|520527417|FG009|Overall Study|Initiation of Another Therapy|2|||
144360168|NCT03037385|520527408|FG000|Overall Study|Lost to Follow-up|0|||
144360169|NCT03037385|520527409|FG001|Overall Study|Lost to Follow-up|0|||
144360170|NCT03037385|520527410|FG002|Overall Study|Lost to Follow-up|0|||
144360171|NCT03037385|520527411|FG003|Overall Study|Lost to Follow-up|0|||
144360172|NCT03037385|520527412|FG004|Overall Study|Lost to Follow-up|0|||
144360173|NCT03037385|520527413|FG005|Overall Study|Lost to Follow-up|1|||
144360174|NCT03037385|520527414|FG006|Overall Study|Lost to Follow-up|0|||
144360175|NCT03037385|520527415|FG007|Overall Study|Lost to Follow-up|0|||
144360176|NCT03037385|520527416|FG008|Overall Study|Lost to Follow-up|0|||
144360177|NCT03037385|520527417|FG009|Overall Study|Lost to Follow-up|16|||
144360178|NCT03037385|520527408|FG000|Overall Study|Physician Decision|0|||
144360179|NCT03037385|520527409|FG001|Overall Study|Physician Decision|0|||
144360180|NCT03037385|520527410|FG002|Overall Study|Physician Decision|0|||
144360181|NCT03037385|520527411|FG003|Overall Study|Physician Decision|0|||
144360182|NCT03037385|520527412|FG004|Overall Study|Physician Decision|0|||
144360183|NCT03037385|520527413|FG005|Overall Study|Physician Decision|0|||
144360184|NCT03037385|520527414|FG006|Overall Study|Physician Decision|0|||
144360185|NCT03037385|520527415|FG007|Overall Study|Physician Decision|0|||
144360186|NCT03037385|520527416|FG008|Overall Study|Physician Decision|0|||
144360187|NCT03037385|520527417|FG009|Overall Study|Physician Decision|1|||
144360198|NCT03037385|520527408|FG000|Overall Study|Withdrawal by Subject|0|||
144360199|NCT03037385|520527409|FG001|Overall Study|Withdrawal by Subject|0|||
144360200|NCT03037385|520527410|FG002|Overall Study|Withdrawal by Subject|1|||
144360201|NCT03037385|520527411|FG003|Overall Study|Withdrawal by Subject|2|||
144360202|NCT03037385|520527412|FG004|Overall Study|Withdrawal by Subject|1|||
144360203|NCT03037385|520527413|FG005|Overall Study|Withdrawal by Subject|3|||
144360204|NCT03037385|520527414|FG006|Overall Study|Withdrawal by Subject|0|||
144360205|NCT03037385|520527415|FG007|Overall Study|Withdrawal by Subject|0|||
144360206|NCT03037385|520527416|FG008|Overall Study|Withdrawal by Subject|0|||
144360207|NCT03037385|520527417|FG009|Overall Study|Withdrawal by Subject|52|||
144360208|NCT03037385|520527408|FG000|Overall Study|Reason Not Specified|0|||
144360209|NCT03037385|520527409|FG001|Overall Study|Reason Not Specified|1|||
144360210|NCT03037385|520527410|FG002|Overall Study|Reason Not Specified|0|||
144360211|NCT03037385|520527411|FG003|Overall Study|Reason Not Specified|4|||
144360212|NCT03037385|520527412|FG004|Overall Study|Reason Not Specified|3|||
144360213|NCT03037385|520527413|FG005|Overall Study|Reason Not Specified|6|||
144360214|NCT03037385|520527414|FG006|Overall Study|Reason Not Specified|2|||
144360215|NCT03037385|520527415|FG007|Overall Study|Reason Not Specified|0|||
144360216|NCT03037385|520527416|FG008|Overall Study|Reason Not Specified|1|||
144360217|NCT03037385|520527417|FG009|Overall Study|Reason Not Specified|181|||
144360218|NCT04515771|520527418|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
144360219|NCT04515771|520527419|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
144360220|NCT04515771|520527418|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
144360221|NCT04515771|520527419|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
144360222|NCT04515771|520527418|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
144360223|NCT04515771|520527419|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
144360224|NCT01021020|520527420|FG000|Period I|Protocol Violation|1|||
144360225|NCT01021020|520527420|FG000|Period I|Withdrawal by Subject|1|||
144360226|NCT01021020|520527420|FG000|14 Day Washout Period A|Physician Decision|1|||
144360227|NCT00948246|520527423|FG000|Overall Study|Lost to Follow-up|11|||
144360228|NCT00948246|520527423|FG000|Overall Study|Adverse Event|11|||
144360229|NCT00948246|520527423|FG000|Overall Study|Death|1|||
144360230|NCT00948246|520527423|FG000|Overall Study|Withdrawal by Subject|1|||
144360231|NCT00148317|520527424|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
144360232|NCT00148317|520527424|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
144360233|NCT00148317|520527424|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
144360234|NCT00286468|520527426|FG000|Overall Study|Hyperglycemic Rescue|28|||
144360235|NCT00286468|520527427|FG001|Overall Study|Hyperglycemic Rescue|30|||
144360236|NCT00286468|520527428|FG002|Overall Study|Hyperglycemic Rescue|31|||
144360237|NCT00286468|520527426|FG000|Overall Study|Adverse Event|2|||
144360238|NCT00286468|520527427|FG001|Overall Study|Adverse Event|6|||
144360239|NCT00286468|520527428|FG002|Overall Study|Adverse Event|4|||
144360240|NCT00286468|520527426|FG000|Overall Study|Protocol Violation|0|||
144360241|NCT00286468|520527427|FG001|Overall Study|Protocol Violation|3|||
144360242|NCT00286468|520527428|FG002|Overall Study|Protocol Violation|1|||
144360243|NCT00286468|520527426|FG000|Overall Study|Lost to Follow-up|1|||
144360244|NCT00286468|520527427|FG001|Overall Study|Lost to Follow-up|1|||
144360245|NCT00286468|520527428|FG002|Overall Study|Lost to Follow-up|2|||
144360246|NCT00286468|520527426|FG000|Overall Study|Withdrawal by Subject|3|||
144360247|NCT00286468|520527427|FG001|Overall Study|Withdrawal by Subject|8|||
144360248|NCT00286468|520527428|FG002|Overall Study|Withdrawal by Subject|11|||
144360249|NCT00286468|520527426|FG000|Overall Study|Physician Decision|3|||
144360250|NCT00286468|520527427|FG001|Overall Study|Physician Decision|2|||
144360251|NCT00286468|520527428|FG002|Overall Study|Physician Decision|1|||
144360252|NCT04742556|520527429|FG000|Overall Study|Withdrawal by Subject|0|||
144360253|NCT04742556|520527430|FG001|Overall Study|Withdrawal by Subject|1|||
144360254|NCT04742556|520527431|FG002|Overall Study|Withdrawal by Subject|0|||
144360255|NCT04742556|520527429|FG000|Overall Study|Adverse Event|0|||
144360256|NCT04742556|520527430|FG001|Overall Study|Adverse Event|0|||
144360257|NCT04742556|520527431|FG002|Overall Study|Adverse Event|2|||
144360258|NCT04742556|520527429|FG000|Overall Study|Clinical disease progression|0|||
144360259|NCT04742556|520527430|FG001|Overall Study|Clinical disease progression|1|||
144360260|NCT04742556|520527431|FG002|Overall Study|Clinical disease progression|2|||
144360261|NCT04742556|520527429|FG000|Overall Study|Objective disease progression|3|||
144360262|NCT04742556|520527430|FG001|Overall Study|Objective disease progression|2|||
144360263|NCT04742556|520527431|FG002|Overall Study|Objective disease progression|4|||
144360264|NCT02923726|520527432|FG000|Overall Study|Death|196|||
144360265|NCT02923726|520527433|FG001|Overall Study|Death|175|||
144360266|NCT02923726|520527432|FG000|Overall Study|Withdrawal by Subject|337|||
144360267|NCT02923726|520527433|FG001|Overall Study|Withdrawal by Subject|307|||
144360268|NCT02399215|520527434|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
144360269|NCT02399215|520527434|FG000|Overall Study|Withdrawal by Subject|1|||
144360270|NCT00772538|520527435|FG000|Overall Study|Adverse Event|6|||
144360271|NCT00772538|520527436|FG001|Overall Study|Adverse Event|6|||
144360272|NCT00772538|520527435|FG000|Overall Study|Protocol Violation|3|||
144360276|NCT00772538|520527435|FG000|Overall Study|Withdrawal by Subject|3|||
144360277|NCT00772538|520527436|FG001|Overall Study|Withdrawal by Subject|8|||
144360278|NCT00772538|520527435|FG000|Overall Study|Lack of Efficacy|0|||
144360279|NCT00772538|520527436|FG001|Overall Study|Lack of Efficacy|1|||
144360280|NCT00772538|520527435|FG000|Overall Study|Other|7|||
144360281|NCT00772538|520527436|FG001|Overall Study|Other|7|||
144360282|NCT03617172|520527439|FG000|Overall Study|Lost to Follow-up|1|||
144360283|NCT03617172|520527440|FG001|Overall Study|Lost to Follow-up|0|||
144360284|NCT00713609|520527441|FG000|Overall Study|Adverse Event|2|||
144360285|NCT00713609|520527442|FG001|Overall Study|Adverse Event|0|||
144360286|NCT00713609|520527443|FG002|Overall Study|Adverse Event|2|||
144360287|NCT00713609|520527444|FG003|Overall Study|Adverse Event|2|||
144360288|NCT00713609|520527445|FG004|Overall Study|Adverse Event|3|||
144360289|NCT00713609|520527446|FG005|Overall Study|Adverse Event|1|||
144360290|NCT00713609|520527441|FG000|Overall Study|Lost to Follow-up|5|||
144360291|NCT00713609|520527442|FG001|Overall Study|Lost to Follow-up|7|||
144360292|NCT00713609|520527443|FG002|Overall Study|Lost to Follow-up|5|||
144360293|NCT00713609|520527444|FG003|Overall Study|Lost to Follow-up|5|||
144360294|NCT00713609|520527445|FG004|Overall Study|Lost to Follow-up|7|||
144360295|NCT00713609|520527446|FG005|Overall Study|Lost to Follow-up|0|||
144360296|NCT00713609|520527441|FG000|Overall Study|Lack of Efficacy|1|||
144360297|NCT00713609|520527442|FG001|Overall Study|Lack of Efficacy|3|||
144360298|NCT00713609|520527443|FG002|Overall Study|Lack of Efficacy|0|||
144360299|NCT00713609|520527444|FG003|Overall Study|Lack of Efficacy|0|||
144360300|NCT00713609|520527445|FG004|Overall Study|Lack of Efficacy|1|||
144360301|NCT00713609|520527446|FG005|Overall Study|Lack of Efficacy|0|||
144360302|NCT00713609|520527441|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
144360303|NCT00713609|520527442|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
144360304|NCT00713609|520527443|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
144360305|NCT00713609|520527444|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
144360306|NCT00713609|520527445|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
144360307|NCT00713609|520527446|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
144360308|NCT00713609|520527441|FG000|Overall Study|Withdrawal by Subject|6|||
144360309|NCT00713609|520527442|FG001|Overall Study|Withdrawal by Subject|1|||
144360310|NCT00713609|520527443|FG002|Overall Study|Withdrawal by Subject|5|||
144360311|NCT00713609|520527444|FG003|Overall Study|Withdrawal by Subject|1|||
144360312|NCT00713609|520527445|FG004|Overall Study|Withdrawal by Subject|5|||
144360313|NCT00713609|520527446|FG005|Overall Study|Withdrawal by Subject|7|||
144360314|NCT00713609|520527441|FG000|Overall Study|Protocol Violation|6|||
144360315|NCT00713609|520527442|FG001|Overall Study|Protocol Violation|3|||
144360316|NCT00713609|520527443|FG002|Overall Study|Protocol Violation|1|||
144360317|NCT00713609|520527444|FG003|Overall Study|Protocol Violation|1|||
144360318|NCT00713609|520527445|FG004|Overall Study|Protocol Violation|2|||
144360319|NCT00713609|520527446|FG005|Overall Study|Protocol Violation|0|||
144360320|NCT03305666|520527447|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
144360321|NCT03305666|520527448|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
144360322|NCT03780452|520527449|FG000|Overall Study|Screening failure|2|||
144360323|NCT01001221|520527450|FG000|Overall Study|Adverse Event|1|||
144360324|NCT01001221|520527451|FG001|Overall Study|Adverse Event|2|||
144360325|NCT01001221|520527452|FG002|Overall Study|Adverse Event|0|||
144360326|NCT01001221|520527453|FG003|Overall Study|Adverse Event|2|||
144360327|NCT01001221|520527454|FG004|Overall Study|Adverse Event|0|||
144360328|NCT01001221|520527450|FG000|Overall Study|Disease progression|3|||
144360329|NCT01001221|520527451|FG001|Overall Study|Disease progression|2|||
144360330|NCT01001221|520527452|FG002|Overall Study|Disease progression|2|||
144360331|NCT01001221|520527453|FG003|Overall Study|Disease progression|4|||
144360332|NCT01001221|520527454|FG004|Overall Study|Disease progression|0|||
144360333|NCT01001221|520527450|FG000|Overall Study|Other|1|||
144360334|NCT01001221|520527451|FG001|Overall Study|Other|1|||
144360335|NCT01001221|520527452|FG002|Overall Study|Other|0|||
144360336|NCT01001221|520527453|FG003|Overall Study|Other|0|||
144360337|NCT01001221|520527454|FG004|Overall Study|Other|0|||
144360338|NCT01001221|520527450|FG000|Overall Study|Not treated; protocol exclusion|0|||
144360339|NCT01001221|520527451|FG001|Overall Study|Not treated; protocol exclusion|0|||
144360340|NCT01001221|520527452|FG002|Overall Study|Not treated; protocol exclusion|1|||
144360341|NCT01001221|520527453|FG003|Overall Study|Not treated; protocol exclusion|0|||
144360342|NCT01001221|520527454|FG004|Overall Study|Not treated; protocol exclusion|0|||
144360343|NCT01176032|520527455|FG000|Overall Study|Adverse Event|1|||
144360344|NCT01176032|520527456|FG001|Overall Study|Adverse Event|0|||
144360345|NCT01176032|520527455|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
144360346|NCT01176032|520527456|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
144360347|NCT01176032|520527455|FG000|Overall Study|Protocol Violation|1|||
144360348|NCT01176032|520527456|FG001|Overall Study|Protocol Violation|0|||
144360349|NCT01176032|520527455|FG000|Overall Study|Informed consent withdrawn|3|||
144360350|NCT01176032|520527456|FG001|Overall Study|Informed consent withdrawn|0|||
144360351|NCT01176032|520527455|FG000|Overall Study|Other|1|||
144360352|NCT01176032|520527456|FG001|Overall Study|Other|0|||
144360353|NCT01469221|520527457|FG000|Double Blind Phase|Protocol Violation|1|||
144360354|NCT01469221|520527458|FG001|Double Blind Phase|Protocol Violation|0|||
144360355|NCT01469221|520527459|FG002|Double Blind Phase|Protocol Violation|0|||
144360356|NCT01469221|520527457|FG000|Double Blind Phase|Physician Decision|1|||
144360357|NCT01469221|520527458|FG001|Double Blind Phase|Physician Decision|1|||
144360358|NCT01469221|520527459|FG002|Double Blind Phase|Physician Decision|0|||
144360359|NCT01469221|520527457|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
144360360|NCT01469221|520527458|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
144360361|NCT01469221|520527459|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
144360362|NCT04913610|520527461|FG000|Randomized Participants|Did Not Receive Treatment|0|||
144360363|NCT04913610|520527462|FG001|Randomized Participants|Did Not Receive Treatment|0|||
144360364|NCT04913610|520527463|FG002|Randomized Participants|Did Not Receive Treatment|1|||
144360365|NCT04913610|520527464|FG003|Randomized Participants|Did Not Receive Treatment|1|||
144360366|NCT04913610|520527465|FG004|Randomized Participants|Did Not Receive Treatment|0|||
144360367|NCT04913610|520527461|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
144360368|NCT04913610|520527462|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
144360369|NCT04913610|520527463|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
144360370|NCT04913610|520527464|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
144360371|NCT04913610|520527465|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
144360372|NCT01791244|520527473|FG000|Overall Study|Adverse Event|5|||
144360373|NCT01791244|520527474|FG001|Overall Study|Adverse Event|7|||
144360374|NCT01791244|520527473|FG000|Overall Study|Insufficient clinical response|10|||
144360375|NCT01791244|520527474|FG001|Overall Study|Insufficient clinical response|10|||
144360376|NCT01791244|520527473|FG000|Overall Study|Laboratory Abnormality|0|||
144360377|NCT01791244|520527474|FG001|Overall Study|Laboratory Abnormality|1|||
144360378|NCT05121766|520527479|FG000|Overall Study|Covid reinfection|3|||
144360379|NCT05121766|520527480|FG001|Overall Study|Covid reinfection|0|||
144360380|NCT05121766|520527479|FG000|Overall Study|Withdrawal by Subject|3|||
144360381|NCT05121766|520527480|FG001|Overall Study|Withdrawal by Subject|1|||
144360382|NCT05121766|520527479|FG000|Overall Study|Adverse Event|2|||
144360383|NCT05121766|520527480|FG001|Overall Study|Adverse Event|4|||
144360384|NCT05121766|520527479|FG000|Overall Study|Lost to Follow-up|0|||
144360385|NCT05121766|520527480|FG001|Overall Study|Lost to Follow-up|1|||
144360386|NCT01033240|520527482|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
144360387|NCT01033240|520527483|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
144360388|NCT01033240|520527484|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
144360389|NCT01033240|520527482|FG000|Overall Study|Death|2|||
144360390|NCT01033240|520527483|FG001|Overall Study|Death|0|||
144360391|NCT01033240|520527484|FG002|Overall Study|Death|0|||
144360392|NCT01033240|520527482|FG000|Overall Study|Withdrew Consent|2|||
144360393|NCT01033240|520527483|FG001|Overall Study|Withdrew Consent|9|||
144360394|NCT01033240|520527484|FG002|Overall Study|Withdrew Consent|2|||
144360395|NCT01033240|520527482|FG000|Overall Study|Disease Progression|35|||
144360396|NCT01033240|520527483|FG001|Overall Study|Disease Progression|32|||
144360397|NCT01033240|520527484|FG002|Overall Study|Disease Progression|41|||
144360398|NCT01033240|520527482|FG000|Overall Study|Investigator Discretion|0|||
144360399|NCT01033240|520527483|FG001|Overall Study|Investigator Discretion|0|||
144360400|NCT01033240|520527484|FG002|Overall Study|Investigator Discretion|2|||
144360401|NCT01033240|520527482|FG000|Overall Study|Other|0|||
144360402|NCT01033240|520527483|FG001|Overall Study|Other|1|||
144360403|NCT01033240|520527484|FG002|Overall Study|Other|2|||
144360404|NCT02960217|520527485|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
144360405|NCT02960217|520527486|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
144360406|NCT02960217|520527485|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
144360407|NCT02960217|520527486|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
144360408|NCT02960217|520527485|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
144360409|NCT02960217|520527486|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
144360410|NCT02960217|520527485|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
144360411|NCT02960217|520527486|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
144360412|NCT02960217|520527485|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
144360413|NCT02960217|520527486|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
144360414|NCT02960217|520527485|FG000|Open-Label Extension Phase|Adverse Event|1|||
144360415|NCT02960217|520527486|FG001|Open-Label Extension Phase|Adverse Event|0|||
144360416|NCT02960217|520527485|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
144360417|NCT02960217|520527486|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
144360418|NCT02960217|520527485|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
144360419|NCT02960217|520527486|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
144360420|NCT02960217|520527485|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
144360421|NCT02960217|520527486|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
144360422|NCT00168844|520527489|FG000|Overall Study|Adverse Event|31|||
144360423|NCT00168844|520527490|FG001|Overall Study|Adverse Event|32|||
144360424|NCT00168844|520527491|FG002|Overall Study|Adverse Event|48|||
144360425|NCT00168844|520527489|FG000|Overall Study|Lost to Follow-up|4|||
144360426|NCT00168844|520527490|FG001|Overall Study|Lost to Follow-up|5|||
144360428|NCT00168844|520527489|FG000|Overall Study|Withdrawal by Subject|12|||
144360429|NCT00168844|520527490|FG001|Overall Study|Withdrawal by Subject|9|||
144360430|NCT00168844|520527491|FG002|Overall Study|Withdrawal by Subject|19|||
144360431|NCT00168844|520527489|FG000|Overall Study|Protocol Violation|2|||
144360432|NCT00168844|520527490|FG001|Overall Study|Protocol Violation|2|||
144360433|NCT00168844|520527491|FG002|Overall Study|Protocol Violation|4|||
144360434|NCT00168844|520527489|FG000|Overall Study|Other|6|||
144360435|NCT00168844|520527490|FG001|Overall Study|Other|7|||
144360436|NCT00168844|520527491|FG002|Overall Study|Other|9|||
144360437|NCT03557970|520527494|FG000|Overall Study|Study closure|1|||
144360438|NCT03557970|520527495|FG001|Overall Study|Study closure|0|||
144360439|NCT03557970|520527494|FG000|Overall Study|Physician Decision|0|||
144360440|NCT03557970|520527495|FG001|Overall Study|Physician Decision|1|||
144360441|NCT03557970|520527494|FG000|Overall Study|Death|0|||
144360442|NCT03557970|520527495|FG001|Overall Study|Death|1|||
144360443|NCT03668873|520527496|FG000|Overall Study|Lost to Follow-up|6|||
144360444|NCT03668873|520527497|FG001|Overall Study|Lost to Follow-up|3|||
144360445|NCT00849940|520527510|FG000|Overall Study|Physician Decision|4|||
144360446|NCT00321789|520527511|FG000|Overall Study|Lost to Follow-up|4|||
144360447|NCT00321789|520527512|FG001|Overall Study|Lost to Follow-up|7|||
144360448|NCT00321789|520527511|FG000|Overall Study|Withdrawal by Subject|6|||
144360449|NCT00321789|520527512|FG001|Overall Study|Withdrawal by Subject|6|||
144360450|NCT00321789|520527511|FG000|Overall Study|Protocol Violation|5|||
144360451|NCT00321789|520527512|FG001|Overall Study|Protocol Violation|3|||
144360452|NCT02362724|520527513|FG000|Overall Study|Withdrawal by Subject|3|||
144360453|NCT02362724|520527514|FG001|Overall Study|Withdrawal by Subject|1|||
144360454|NCT02362724|520527513|FG000|Overall Study|Adverse Event|3|||
144360455|NCT02362724|520527514|FG001|Overall Study|Adverse Event|0|||
144360456|NCT02025179|520527515|FG000|Overall Study|Lost to Follow-up|0|||
144360457|NCT02025179|520527516|FG001|Overall Study|Lost to Follow-up|0|||
144360458|NCT02025179|520527517|FG002|Overall Study|Lost to Follow-up|1|||
144360459|NCT00301808|520527521|FG000|Overall Study|Adverse Event|5|||
144360460|NCT00301808|520527521|FG000|Overall Study|Death|3|||
144360461|NCT00301808|520527521|FG000|Overall Study|Lack of Efficacy|4|||
144360462|NCT01607957|520527522|FG000|Overall Study|Not treated|1|||
144360463|NCT01607957|520527523|FG001|Overall Study|Not treated|1|||
144360464|NCT01607957|520527522|FG000|Overall Study|Death|367|||
144360465|NCT01607957|520527523|FG001|Overall Study|Death|211|||
144360466|NCT01607957|520527522|FG000|Overall Study|Lost to Follow-up|3|||
144360467|NCT01607957|520527523|FG001|Overall Study|Lost to Follow-up|3|||
144360468|NCT01607957|520527522|FG000|Overall Study|Participant refusal|1|||
144360469|NCT01607957|520527523|FG001|Overall Study|Participant refusal|0|||
144360470|NCT04972786|520527526|FG000|First Intervention (1 Day)|Adverse Event|1|||
144360471|NCT04972786|520527527|FG001|First Intervention (1 Day)|Adverse Event|0|||
144360472|NCT02016781|520527528|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
144360473|NCT02016781|520527529|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
144360474|NCT02016781|520527528|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
144360475|NCT02016781|520527529|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
144360476|NCT02016781|520527528|FG000|Final Database Lock|Withdrawal by Subject|2|||
144360477|NCT02016781|520527529|FG001|Final Database Lock|Withdrawal by Subject|1|||
144360478|NCT02016781|520527528|FG000|Final Database Lock|Lost to Follow-up|11|||
144360479|NCT02016781|520527529|FG001|Final Database Lock|Lost to Follow-up|4|||
144360480|NCT02016781|520527528|FG000|Final Database Lock|Missing data|0|||
144360481|NCT02016781|520527529|FG001|Final Database Lock|Missing data|3|||
144360482|NCT03724942|520527533|FG000|Overall Study|Adverse Event|20|||
144360483|NCT03724942|520527534|FG001|Overall Study|Adverse Event|14|||
144360484|NCT03724942|520527533|FG000|Overall Study|Lack of Efficacy|0|||
144360485|NCT03724942|520527534|FG001|Overall Study|Lack of Efficacy|1|||
144360486|NCT03724942|520527533|FG000|Overall Study|Physician Decision|5|||
144360487|NCT03724942|520527534|FG001|Overall Study|Physician Decision|2|||
144360488|NCT03724942|520527533|FG000|Overall Study|Protocol Violation|1|||
144360489|NCT03724942|520527534|FG001|Overall Study|Protocol Violation|0|||
144360490|NCT03724942|520527533|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
144360491|NCT03724942|520527534|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
144360492|NCT03724942|520527533|FG000|Overall Study|Withdrawal by Legal Representative|3|||
144360493|NCT03724942|520527534|FG001|Overall Study|Withdrawal by Legal Representative|0|||
144360494|NCT02429830|520527535|FG000|Overall Study|Lost to Follow-up|1|||
144360495|NCT02429830|520527535|FG000|Overall Study|Device Explant|2|||
